<SEC-DOCUMENT>0000914475-22-000013.txt : 20220211
<SEC-HEADER>0000914475-22-000013.hdr.sgml : 20220211
<ACCEPTANCE-DATETIME>20220211171118
ACCESSION NUMBER:		0000914475-22-000013
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		92
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220211
DATE AS OF CHANGE:		20220211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NEUROCRINE BIOSCIENCES INC
		CENTRAL INDEX KEY:			0000914475
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330525145
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22705
		FILM NUMBER:		22622617

	BUSINESS ADDRESS:	
		STREET 1:		12780 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 617-7600

	MAIL ADDRESS:	
		STREET 1:		12780 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>nbix-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b,d:c35e9d12d921455aa45f30d1d4130202--><html xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:nbix="http://www.neurocrine.com/20211231" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>nbix-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl8zLTEtMS0xLTI0NTg3_fcf41756-5594-4146-8e59-8e66e3b4ee86">false</ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl80LTEtMS0xLTI0NTg3_7c7b7da4-a5db-48a5-a475-675dbe366472">2021</ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl81LTEtMS0xLTI0NTg3_1a7bb336-11fa-4d7f-87d7-3ff629678fe5">FY</ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl82LTEtMS0xLTI0NTg3_ba39c8e7-8bdb-4c30-9bff-59b2ec767722">0000914475</ix:nonNumeric><ix:nonNumeric contextRef="i6f25e6030cba44eeaeb535268d2aec62_D20180101-20181231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMC0xLTEtMjk1OTY_5ea9ac00-e603-441e-9579-bb39249f3899">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDIvZnJhZzo2ZjhiNGM1YzA1OGY0ZDAxOTE0MDdhMWViNmM5MmQ1Mi90ZXh0cmVnaW9uOjZmOGI0YzVjMDU4ZjRkMDE5MTQwN2ExZWI2YzkyZDUyXzQ3_90039d47-18bb-4eca-aafa-a3cc047cdbac">one</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDIvZnJhZzo2ZjhiNGM1YzA1OGY0ZDAxOTE0MDdhMWViNmM5MmQ1Mi90ZXh0cmVnaW9uOjZmOGI0YzVjMDU4ZjRkMDE5MTQwN2ExZWI2YzkyZDUyXzQ3_cf39e409-b35d-4e9a-a30d-6d99d9f6d438">one</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="8" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTcvZnJhZzphZTg3YzAzMWVmZDA0NmUyOTkzYTlhYWRjMzdhYWIzYi90YWJsZTphYzdmY2Y2ODc2NWE0ZGNjOWVjMDg2NzZhYzA2MDYzOS90YWJsZXJhbmdlOmFjN2ZjZjY4NzY1YTRkY2M5ZWMwODY3NmFjMDYwNjM5XzItMS0xLTEtMjQ1ODc_e1a0ec94-c327-499f-9f0a-07625453b571">0.00131711</ix:nonFraction><ix:nonNumeric contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODc5_2f705c83-17a2-4b52-a632-b67c9ccf6649">P13Y7M6D</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="nbix-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic58f0d332b1740bcbfe3ae799b6c76f1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i524e39f5a339434b949a0ca71590d62a_I20220207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i410ba3ab0060406a970171c67adc140c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a090e172d54a3390fc3154fe0c83e2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i235dcd3608564d60b4d0f9676da9af24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34e6de166964d63af8e67b2f42daf09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i4a39bd69114b41f3a7575046b42fd208_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670cc6e75e624e85a72e5224f486c622_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88608bd64b9d491d965911eb2f10d0ba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f4ab3853b3242c7858dcf9b3a67bb47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i798a316339674cf592518cb98cd4340d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57e3f974b4374e128e00062b09a226b8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c451fdb8934177af07aab2f9815261_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i850a1c2e6bbe421b9e53c336f81ae194_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8328f9cd2d94115acc9db87f97b7e95_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c5963bd49a44d8ab23a5f66be2f6e7_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief1e07453fb8400290d05177cdbc914a_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id623863c89314565b0c613c6e4844cd9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b1e1efe40c742aa916cca25579067f4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f25e6030cba44eeaeb535268d2aec62_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieebdcec5b54b4ac6bdd2c1d5c2eba719_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15f9746d0c4c45cbbdbb3cee1e0be1d3_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9be0134c1cf94658b1ea4f2a9d3aabd0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e5a9db50e334fceb17223af88813a25_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57f40d95bd5147f493ce76a1d0d54aa9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5d3840166f542059e79068112c8351f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee36651c7ea24ee1aa1a126bc3592f0f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50270a33ffaf46e699671aaa2d154c06_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2f0e73949934202a967b64bd1dbcc51_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e86243316844136bf4f9112f308abd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e59d7192ea042ceb2f48ae50260ec53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff0345a87ec74fc2a1683ba954ad2eea_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icecbc009167140a6a443a748af98ebb3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id963b79121954d3ea702db8ac5aaec24_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21b050c801745578a610cadda27dda1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic234985e15bc4a1d876dca26f6503d8e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e85c7f4bf3e4e8a9b237b4341c4b9a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i534bd413a5404e2da06b975889c1c349_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f297dfb69c64f82a416c17120802d81_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a1c966228ae4eef899ad097142a3675_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ee2ff30f3694c999d1bfea3cac16df0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48483359c04e4e06bd637a90f9af6854_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f748abc48034713a36960dffd357755_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="subsidiary"><xbrli:measure>nbix:subsidiary</xbrli:measure></xbrli:unit><xbrli:context id="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b8d7ede3b7d42c98a7b4985db5ee059_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2d2cb1ed67a045fab2a95fa6a800c0a0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8d3727d3ea944fea7f664879d4c85b0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i945a7d74da95458e8a3fe747ece465cd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a0c5ec3d79147229881155f9e94893d_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>nbix:segment</xbrli:measure></xbrli:unit><xbrli:context id="i43c71899173f405dbe3d33122d8cc5f3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:HeptaresTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c18d17c4d449729c00a0ccd9f18346_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:HeptaresTherapeuticsLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia23be7e269184e22820e45d5995df04f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5e99701bd3641d5a09bb0c7b27a6b9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a59621400074ae78191449ef71bd45d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:IdorsiaPharmaceuticalsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i456ae801af6b4bcc85cf441dbbfd2d07_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:IdorsiaPharmaceuticalsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib237ea6839b14af68a00881661bda1d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10dced8bd21b43fc85950bc06dc71600_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6d6f5ca848240c5ac2c7ad24cd32191_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43094c3fedcd4655bb4323ec7e023ff3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b0e316d5b94182bbf5816c348e19d7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d30d0be95cb415b8e4d465eff571719_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e86bc6f5114de09a4f88e130139396_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4c4fe5c60424af0bcadedd757afff96_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e054e20087341ada5c247008d55c3b7_D20190101-20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f5841fc889c4d08846ef46e8a70311f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86636d6fafc9428a9d7466bfe935ab09_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3045b62535f464b86c604c3234e0d9c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibad5cee165ce4cf8891c0de774e460a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebafbee9477a4c18a360adb95c24c539_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13f8068eb08a4699b20184347a6e696a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76d0ccd9a2e24853bab0ecd66739a001_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451e907724df41c5908356a4f2323922_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ef358c546644634864929f3c2061c03_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f9ae86c7e9144a1bae39b561ed9746c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i454f573ac4474e279abf38d39ec2838c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fddadf6fcb24a699f2fa1cbf8dd90f5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0db30671c08348dab7eba8e85cf822e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b9930a1b5945c1bdf18b24ad954df4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f71aac91af1491f9facb5b304bc26ab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fbe0b4e8d8444179db90d05853c145d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d81c1abc6d4b73ad93fc98b7974149_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8ff02291a68451db9fb0056413edd22_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e005455b14444cac5e10f4c73e0446_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="security"><xbrli:measure>nbix:security</xbrli:measure></xbrli:unit><xbrli:context id="ib0735a600c0d40f49b4766b4bceeb49c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic01bd7b047c1401a899b33800d0940b5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cc646be8f346209fda92f0f7069e29_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie25af8b80ac74893a5e4045458ebe3d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76a49edc4ee149f98fe61f36a1419ed3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if35fcf69010c43dba3cbbf868e2b0935_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccfdb59917c64d368e0d64701f53126a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04d318b9ca2d49ba84b1a9cb4b48b0ec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fc4ae0f5aa4acab5c143236c0015b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aba8816099b49f2b953b15fdf4c39b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadfb23126df048dbb4bac68dde154ace_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1c4f4456c9492990b2e5c6e5a0abd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc5ff81f5ac24f46bf859c4b7eee092a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ff788d8c75a4d8b9999c533dabd5da6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4d41477f874a44b2eba85537a90148_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeb2651610fa4d00b5e2ac296d947a60_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8dceb0bae28a43219d613b3ec3a546bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b4b9585d44440bfaf6270349255857e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10fea06938594614aa8b26da5cf66581_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic56519559b60412eb627bc0dd14040fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0f374dbf03747a2a83ac15d4ac0a895_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0ada51f1409498abba0c3063df43360_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i876dd799b2e4471c969a5ee5b51f6040_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0efb41a1a6274a0fa1294d81a1e66e3e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa7306db60774a77859d10b85a4592ba_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43241c1d857141b3a9d4aa8134c3faa9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib50a2b7c2c194c41a768ce0f89919060_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d11505b7354bdb8dd782858dcfdce3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadb175bdb8bf48208387a96572f64706_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70c342cd44742ebb040c59491a90fca_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb7c841968874564a68757c7554e2071_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic77011f1e4f6476984258b7755256168_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0def021d29df4ec18dc8a7252ae17d0a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10f1318702cc48bd9a8576b930cc668f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84e3b1a6faf84f6db9b5b5a39c51c46c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7057cb4559b6490ab7be7846300e2a22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a4cc70d0fde4bd498a8a0983c081d59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9f1618b76d04cb19552c0380c3a41a8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43e9f130272d4e318928d9dafd608b88_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cf0666db5964cb0b1c6c44c2bb1140a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbeb38fcafcd44cf92ecbae65ec65d39_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d7321b1fe734028a54ac2f80b9681ed_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35e8c83d4e9e4b538a866c7908923299_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0302646986a64378a658c9ee1c53404a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c29b15534a34aa1bd91898138b443d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f3cf54d0e5248aeb00d32bbd4fe0441_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia476ce9b48f74567b16e1107fc4d5f58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342378a3e6bf401686eecb77ea0a41b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib96e57d5b9fc4cb2a73243bdd55f6767_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf7b779b22d24eb6b77769f385e8229f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd4b276a5774cf7bb670de6b43ee0b4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47234201a06341db8895b8958db19f97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6692ce12fc644c68b73fb3a2340f8955_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55302882586a46d2ad57cdca3f162199_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d5b407bace949d5a87fb8d9069a7e54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17791cc67ea8442dae07024c287c5a9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f43889d0d9d4bfab3fb6c31e2cfe848_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia17bbaa87ba6441bae1e26b9009ae2e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02ed2ad514134c8abd326f4aa918a949_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide17712ce808468da6c2d67ca2751e47_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadbe113298b847b29bf4f91e55934f46_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bb2904499f043418ddda2535a27e40f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i011bbd35393d4e94b37558ebd5a2d436_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56afca00a6145f1a8cb8913d7007d6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-02</xbrli:startDate><xbrli:endDate>2017-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80a878a1eb5a45cca632daa2d96abd21_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88996bf4af1e44edb618cc379576a171_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-02</xbrli:startDate><xbrli:endDate>2017-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-02</xbrli:startDate><xbrli:endDate>2017-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1c20b9ca378493e9004243174a5bb6c_I20170502"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4255ef0f065341c38adf6ce89cc06fa5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d16c122f0c14c3992a051928c9d5bfd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4babbf9b0ae54bd68b403bf9135804ce_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1cd1bce8a314e4b8d4f01b7b48efb31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i514d273d4829444bb2f094cc035cbd85_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nbix:ScientificEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8949e231305a4303b6a93baa2c50ef7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nbix:ScientificEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i018745fbe176486d9a40f767eb4cddfb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89da8fd5abc84ebc90ff0e08c8e74ae0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc1e7a31965e41d398a354180cf8e854_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id096d2e9e4db408388a0546974b8a714_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5697c0bc55240d2a8a8a2235b016776_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36e1a597b4cd4605869672a9be81b61a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6121635642d44cadaead83be87d2fe62_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d2ef4094777484ab20a42ddbdcf479d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5766d218ac54177beed97641411133f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4461a18f4b94ca1b02b8be10c79cda1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d90a3769ad6449da089e4e3f18d3d7a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfdf32908a434e5d91386e010cdf2b9b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861174ad0c8446e0ab825a068912a989_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b3593b7e0f4137b9d9cb95a340d296_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie926624338174ce3a9a95588da6b7482_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if55c2dd5020b439ab20a6854804adfb2_I20110531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:TwoThousandAndElevenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2011-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i131a19b02d4549ae975f25ad4ec218e0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:TwoThousandAndElevenPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b8b371eafd4e9bb87813ab1ee9b7f3_I20180531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9a1371b813245e8b49ad33c120478c5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7daa1d827ed84d04bc8d829d69e3b5a5_I20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:A2020EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21a8268dccfc48f59cd4814f44c54a4f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:A2020EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2e9814a27b4d21828b870c0c7bba39_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6383419676f5414c97631fba30d073e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563c70f91f7d45baadb5b41baf1f5dee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i086d3bf04898438689679b7c70886c50_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f20287d2f5d47629aa5cb895c7b9e67_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21700785bb0c4daa8be1c905aeeb15f6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc56f68087124b8b8cfe42e19151218a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e84a209c2b443968257a0960b35e6f0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca72bf2007745ac9be527c3a44edef0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9dd80ab56044cb5b1502c3c0b0084c6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib439fe7fca70420e85d14235298d0807_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c44c1a195de478c824a69cb855d11ea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bc4f833719d407fb605d6e3f05afc23_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i360e7030403c47f48b0818bcce72318e_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d20c96869ad45d18f300e0ed27f7ee7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i670a859ff8a84b0ba0c51a248450c900_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib60edb8359ba4965aa27229d88b89dff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9700de8000ff49f19b9b94d8714b9b95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94ec3a34a5c1464a98687009bb85c0ee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib009e76fc516405f817eb74aed96c1cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia69ac08c927f48ea9cf1305bd5fc5f9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib860e40dbf6b4206ac8fb74ce9822840_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-08</xbrli:startDate><xbrli:endDate>2022-02-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000914475</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="renewaloption"><xbrli:measure>nbix:renewalOption</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div id="ic35e9d12d921455aa45f30d1d4130202_1"></div><div style="min-height:31.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington,&#160;D.C. 20549</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcz_6e79ae72-890f-421c-8dad-7d7731f5387f">10-K</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:469.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:61.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6YmM4NjY3MmEwOWEwNGM5MjliMzI5MmNhZTdhMzE1MTEvdGFibGVyYW5nZTpiYzg2NjcyYTA5YTA0YzkyOWIzMjkyY2FlN2EzMTUxMV8wLTAtMS0xLTI0NTg3_f48233f2-b764-4ea1-80e5-ef74a0136ae3">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY4_ba0142b6-c67f-4212-b6bd-fb37cf9be636"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY4_8837d1b6-0895-4464-bf1f-1a60f084c666">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:12.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:487.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:43.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6Y2EwOGI2NmVjNTQ2NGQ1Mjg4MDU3MzE0OTc3YWQ2NjEvdGFibGVyYW5nZTpjYTA4YjY2ZWM1NDY0ZDUyODgwNTczMTQ5NzdhZDY2MV8wLTAtMS0xLTI0NTg3_aceaa6de-175f-436c-8d7f-9b2f2c30cc03">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from __________to__________</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission file number </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjYx_4b74c1e8-dac9-447f-9cc9-4de8fb55bc0e">0-22705</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY5_4283ab91-9600-495b-929a-1658cd2835d7">NEUROCRINE BIOSCIENCES, INC.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:549.00pt"><tr><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:49.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:164.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:175.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8wLTAtMS0xLTI0NTg3_85ece88c-0d3a-4e7f-9e92-510b601fd43d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8wLTQtMS0xLTI0NTg3_23047807-9f1e-44b8-b334-78b16c26f56c">33-0525145</ix:nonNumeric></span></td></tr><tr style="height:21pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTAtMS0xLTI0NTg3_4b0aef7a-e7d3-4fd1-a648-14cf90672330">12780 El Camino Real,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTEtMS0xLTI0NTg3_bc928ad0-cd95-4b09-bf2e-5e887e13bf54">San&#160;Diego,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTItMS0xLTI0NTg3_43efce9a-f69e-4ef2-ae7e-aa9976f2d60a">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTQtMS0xLTI0NTg3_687ff7ab-08d0-4da7-a367-3ec6124debeb">92130</ix:nonNumeric></span></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY0_f7828515-77cf-435d-aa60-89850b7c115a">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcw_168a3f83-ece1-4a14-b8bb-783a90444657">617-7600</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.140%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.053%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.141%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTAtMS0xLTI0NTg3_9704f5b6-8521-4bc7-b539-5ba9ece8902f">Common Stock, $0.001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTItMS0xLTI0NTg3_c6977152-44ad-4f86-87e8-4d89986d4930">NBIX</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTQtMS0xLTI0NTg3_06b6b43f-a00f-473c-a968-c19f5b2377dc">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Title of each class)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Trading Symbol)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Name of each exchange on which registered)</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act:</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Title of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">class</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjYy_47ef7c5f-0917-449a-8796-a13c1f80683c">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY1_d6d29554-c8fd-4d5e-a748-f9ba8a82d59a">No</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcx_f5a20e8c-8425-42f4-99c3-9d283a002bbc">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;&#160;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcy_704b81fb-ee15-4a27-8351-5f145c901793">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"></td><td style="width:15.179%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.535%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.146%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTAtMS0xLTI0NTg3_604e96c1-4fcc-4f85-8538-f94ae915330c">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9745;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTEwLTEtMS0yNDU4Nw_3b714b55-0d72-45f5-b150-112f367a4a60">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTEzLTEtMS0yNDU4Nw_fa527ea9-5d6b-40c8-a6b5-72d0bcb81207">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY2_ef0ca1fe-f1fc-460c-9640-8564141e8ff0">&#9745;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act). Yes&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY3_4df4a362-0603-4e2f-b422-16e0b590dcb0">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9745;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of registrant&#8217;s common stock held by non-affiliates of the registrant, computed by reference to the closing price as of the last business day of the registrant&#8217;s most recently completed second fiscal quarter, June 30, 2021, was approximately $<ix:nonFraction unitRef="usd" contextRef="ic58f0d332b1740bcbfe3ae799b6c76f1_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8yODQ0_57d16aca-7a28-400f-80d6-7faa87b3c198">9,105,256,378</ix:nonFraction>.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;7, 2022, <ix:nonFraction unitRef="shares" contextRef="i524e39f5a339434b949a0ca71590d62a_I20220207" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8yODU4_aa85fc6d-2787-4936-a7f9-74a85a215c55">95,242,683</ix:nonFraction> shares of the registrant&#8217;s common stock were outstanding.</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjc0_0712e898-9ccf-4632-9f9d-6910df8e0f72" escape="true">Portions of the registrant&#8217;s definitive proxy statement relating to the registrant&#8217;s annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days following the end of the registrant&#8217;s fiscal year ended December 31, 2021 are incorporated by reference into Part III of this Form 10-K.</ix:nonNumeric></span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.996%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.515%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_10">PART I</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_16">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_61">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_61">15</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_67">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_67">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_70">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_70">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_73">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_73">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_76">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_76">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_79">PART&#160;II</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_82">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_82">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_94">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_94">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_112">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_112">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_115">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_115">42</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_181">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_181">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_184">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_184">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_193">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_193">70</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_196">PART&#160;III</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_199">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_199">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_202">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_202">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_205">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_205">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_208">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_208">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_211">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_211">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_214">PART&#160;IV</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_217">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#ic35e9d12d921455aa45f30d1d4130202_217">72</a></span></div></td></tr></table></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are registered trademarks of Neurocrine Biosciences, Inc. Any other brand names or trademarks appearing in this Annual Report that are not the property of Neurocrine Biosciences, Inc. are the property of their respective holders.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART&#160;I</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_13"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form&#160;10-K and the information incorporated herein by reference contain forward-looking statements that involve a number of risks and uncertainties. Although our forward-looking statements reflect the good faith judgment of our management, these statements can only be based on facts and factors currently known by us. Consequently, these forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from results and outcomes discussed in the forward-looking statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements can be identified by the use of forward-looking words such as &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;hopes,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;plan,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;continue,&#8221; &#8220;seeks,&#8221; &#8220;pro forma,&#8221; or &#8220;anticipates,&#8221; or other similar words (including their use in the negative), or by discussions of future matters such as the development of new products, technology enhancements, possible changes in legislation and other statements that are not historical. These statements include but are not limited to statements under the captions &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and &#8220;Business,&#8221; as well as other sections in this report. You should be aware that the occurrence of any of the events discussed under the heading in Part I titled &#8220;Item&#160;1A. Risk Factors&#8221; and elsewhere in this report could substantially harm our business, results of operations and financial condition and that if any of these events occurs, the trading price of our common stock could decline and you could lose all or a part of the value of your shares of our common stock.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cautionary statements made in this report are intended to be applicable to all related forward-looking statements wherever they may appear in this report. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we assume no obligation to update our forward-looking statements, even if new information becomes available in the future.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_16"></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_19"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options. For three decades, we have applied our unique insight into neuroscience to advance medicines for neurology, neuroendocrinology and neuropsychiatry-related disorders and diseases. Our efforts have resulted in United States Food and Drug Administration, or FDA, approved treatments for tardive dyskinesia, Parkinson&#8217;s disease, endometriosis* and uterine fibroids* and a diversified portfolio of investigational therapies with the potential to address unmet clinical needs of patients worldwide living with neurological, endocrine and psychiatric disorders. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(*in collaboration with AbbVie Inc., or AbbVie)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has dramatically changed the ways in which we live and interact with one another. While we adapt to this new shared reality, our purpose remains unchanged: to relieve suffering for people with great needs, but few options.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the initial impact of the pandemic has subsided, we are uncertain as to how more transmissible variants may impact our business. We remain committed to (1) prioritizing the safety, health and well-being of patients and their caregivers, healthcare providers, and our employees; (2) ensuring patients with tardive dyskinesia are well supported and have continued uninterrupted access to INGREZZA, for which we have not experienced and currently do not expect any supply disruption; and (3) advancing clinical studies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our field-based employees have resumed in-person interactions in accordance with location-specific guidance. Our office-based employees have returned to the office under flexible work arrangement guidelines to help balance business needs, employee health, well-being and safety and the evolving work environment. However, as the effects of the pandemic continue to rapidly evolve with the emergence of new COVID-19 variants, a remote work model may nevertheless need to be reinstated at some point in the future. We continue to evaluate the impact of global spikes or surges in COVID-19 infection and hospitalization rates, as well as the impact of emerging COVID-19 variants on the efficacy of vaccines.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most hospitals, community mental health facilities, physicians&#8217; offices, pharmacies and other healthcare facilities have relaxed their policies that limited access of patients and our employees to such facilities and limited the ability of patients, pharmacies and prescribers to interact with each other. However, we anticipate these policies may change from time to time as communities or regions grapple with outbreaks. The ultimate impact of the COVID-19 pandemic, including any lasting effects on our revenue and the way we conduct our business, is highly uncertain and subject to continued change. We recognize that this pandemic will continue to present unique challenges for us throughout 2022.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Product Pipeline</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Commercially Available Medicines<br/></span></div><div style="text-align:center"><img src="nbix-20211231_g1.jpg" alt="nbix-20211231_g1.jpg" style="height:252px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> (valbenazine). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched INGREZZA in the United States in May 2017 as the first FDA-approved drug for the treatment of tardive dyskinesia. INGREZZA net product sales totaled $1.1 billion for 2021, $993.1 million for 2020 and $752.9 million for 2019 and represent the significant majority of our total net product sales.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INGREZZA provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 mg, 60 mg and 80 mg capsules), with a recommended dose of 40 mg taken for the first seven days of treatment and an option to take 40 mg, 60 mg or 80 mg thereafter, depending on the patient&#8217;s dosing needs.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We out-licensed the rights to valbenazine in Japan and other select Asian markets to Mitsubishi Tanabe Pharmaceutical Company, or MTPC, in 2015, in which markets valbenazine is a royalty-bearing product for us. In 2021, MTPC received approvals for marketing authorization for valbenazine for the treatment of tardive dyskinesia in Indonesia, Singapore, South Korea and Thailand. In addition, MTPC has submitted filings for marketing authorization, which are currently under review, in Japan and Malaysia.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tardive dyskinesia is a movement disorder that is characterized by uncontrollable, abnormal and repetitive movements of the face, torso and/or other body parts, which may be disruptive and negatively impact patients. The condition is associated with prolonged use of treatments that block dopamine receptors in the brain, such as antipsychotics commonly prescribed to treat mental illnesses such as schizophrenia, bipolar disorder, depression and certain anti-nausea medications. In patients with tardive dyskinesia, these treatments are thought to result in irregular dopamine signaling in a region of the brain that controls movement. The symptoms of tardive dyskinesia can be severe and are often persistent and irreversible. Tardive dyskinesia affects an estimated 600,000 people in the United States.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> (opicapone). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched ONGENTYS in the United States in September 2020 as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. We acquired the United States and Canada rights to ONGENTYS in February 2017.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ONGENTYS is a once-daily, peripheral, selective and reversible catechol-O-methyltransferase, or COMT, inhibitor. COMT inhibitors are utilized to prolong the duration of effect of levodopa, the primary treatment option for Parkinson&#8217;s disease patients, during periods of the day where the effects of levodopa wear off and motor symptoms worsen, also known as &#8220;off&#8221; time.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Parkinson&#8217;s disease is a chronic, progressive and debilitating neurodegenerative disorder that is caused by low dopamine levels produced in the brain. Dopamine helps transmit signals between the areas of the brain that control all purposeful movements, including talking, walking and writing. As Parkinson&#8217;s disease progresses, dopamine production steadily decreases, resulting in increased problems with motor symptoms including slowed movement, tremor, rigidity, impaired posture and balance and difficulty with speech and writing. Parkinson&#8217;s disease affects an estimated 1 million people in the United States and more than 10 million people worldwide.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ORILISSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> (elagolix tablets). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie launched ORILISSA in the United States in August 2018 as an FDA-approved oral medication for the management of moderate to severe endometriosis pain in women. We out-licensed the global rights to elagolix to AbbVie in 2010. Elagolix is a royalty-bearing product for us.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Endometriosis affects nearly 200&#160;million women worldwide, including more than 10&#160;million women in the United States.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ORIAHNN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> (elagolix, estradiol, and norethindrone acetate capsules and elagolix capsules). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie launched ORIAHNN in the United States in June 2020 as the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. We out-licensed the global rights to elagolix to AbbVie in 2010. Elagolix is a royalty-bearing product for us.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Uterine fibroids are benign hormonally responsive tumors that form in the wall of the uterus with a prevalence rate of at least 25% and are a leading indication for hysterectomy, resulting in the performance of more than 200,000 hysterectomies per year in the United States alone.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our Pipeline of Investigational Therapies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br/></span></div><div style="text-align:center"><img src="nbix-20211231_g2.jpg" alt="nbix-20211231_g2.jpg" style="height:403px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Neurology</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chorea in Huntington Disease (valbenazine &#8211; VMAT2 Inhibitor).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have announced positive top-line data from the KINECT-HD study, a Phase III randomized, double-blind, placebo-controlled clinical study evaluating the efficacy, safety, and tolerability of valbenazine in 120 adult patients with chorea in Huntington disease. The study met the primary endpoint of reduction in severity of chorea, the cardinal motor feature in Huntington disease, as measured by the change in the Unified Huntington&#8217;s Disease Rating Scale, or UHDRS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, total maximal chorea, or TMC, score from baseline to the average score at weeks 10 and 12. Treatment with valbenazine resulted in a placebo-adjusted mean reduction in the TMC score of 3.2 units (p &lt; 0.0001), indicating a highly statistically significant improvement in chorea. The TMC score is part of the motor assessment of the UHDRS and measures chorea in seven different body parts, including the face, oral-buccal-lingual region, trunk, and each limb independently. The TMC score is the sum of the individual scores and ranges from 0 to 28. The secondary endpoints of Clinical Global Impression of Change (CGI-C) Response Status and Patient Global Impression of Change (PGI-C) Response Status were also statistically significant in favor of treatment with valbenazine. We plan to submit a supplemental new drug application for valbenazine for the treatment of Huntington chorea with the FDA in the second half of 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VMAT2 is a protein concentrated in the human brain that is essential for the transmission of nerve impulses between neurons. VMAT2 is primarily responsible for packaging and transporting monoamines (dopamine, norepinephrine, serotonin and histamine) in neurons. Specifically, dopamine enables neurotransmission among nerve cells that are involved in voluntary and involuntary motor control. In neurology, disease states such as tardive dyskinesia, Huntington chorea and tardive dystonia are characterized in part by a hyperdopaminergic state in the brain and modulation of neuronal dopamine levels may provide symptomatic benefits for patients with these conditions, among others. Huntington disease is a hereditary progressive neurodegenerative disorder, in which destruction of neuronal cells within the brain results in motor, cognitive, and psychiatric symptoms. Symptoms generally appear between the ages of 30 to 50 and worsen over a 10 to 25-year period. Many patients with Huntington disease experience chorea, a troublesome involuntary movement disorder, in which patients develop sudden, irregular, unpredictable, and non-stereotyped movements. Chorea can affect various body parts, and may interfere with speech, swallowing, posture, and gait. Approximately 90% of the estimated 30,000 people affected by Huntington disease in the United Sates will develop chorea over the course of the disease.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dyskinetic Cerebral Palsy (valbenazine &#8211; VMAT2 Inhibitor).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase III randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and tolerability of valbenazine for the treatment of dyskinetic cerebral palsy in 144 pediatric and adult patients (aged 6 and older). We anticipate having top-line data for this clinical study in 2023. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VMAT2 is a protein concentrated in the human brain that is essential for the transmission of nerve impulses between neurons. VMAT2 is primarily responsible for packaging and transporting monoamines (dopamine, norepinephrine, serotonin and histamine) in neurons. Specifically, dopamine enables neurotransmission among nerve cells that are involved in voluntary and involuntary motor control. In neurology, disease states such as tardive dyskinesia, Huntington chorea and tardive dystonia are characterized in part by a hyperdopaminergic state in the brain and modulation of neuronal dopamine levels may provide symptomatic benefits for patients with these conditions, among others. Dyskinetic cerebral palsy is a non-progressive, permanent disorder marked by involuntary movement and is a result of damage to the fetal or infant brain&#8217;s basal ganglia. The basal ganglia are responsible for submitting messages to the body to help coordinate and control movements. When damaged, voluntary movements are compromised, resulting in involuntary and abnormal movements. It affects development and movement and has long term effects on patients&#8217; quality of life. The long-term outlook for patients with dyskinetic cerebral palsy will depend upon the severity of the brain damage and how well the treatment works. Dyskinetic cerebral palsy affects up to 15% of the estimated 500,000 to 1 million people affected by cerebral palsy in the United States. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Essential Tremor (NBI-827104 &#8211; T-Type Calcium Channel Blocker).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have initiated a Phase II randomized, double-blind, placebo-controlled, crossover clinical study to evaluate the efficacy, safety, tolerability and pharmacokinetics of NBI-827104 in 28 adult patients with essential tremor. We anticipate having top-line data from this clinical study during the middle of 2022. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-827104 is a potent, selective, orally active and brain penetrating T-type calcium channel blocker. We acquired the global rights to NBI-827104 in May 2020. Essential tremor is one of the most common neurological disorders in adults. The disorder is characterized by involuntary, rhythmic, oscillatory movements that most often affect the upper limbs. As the disease progresses, tremor severity often increases and spreads to other parts of the body. Essential tremor has a significant impact on the activities of daily living often resulting in functional disability as the disease progresses and is associated with a high comorbidity rate of social phobia, depression and anxiety. Essential tremor affects an estimated 10 million people in the United States.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Epilepsy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Epilepsy is one of the most common neurological disorders and is characterized by abnormal electrical activity in the brain that leads to unpredictable seizures that can vary in frequency, from less than one per year to several per day A description of our investigational treatments for potential use in epilepsy follow.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Epileptic Encephalopathy with Continuous Spike and Wave During Sleep, or EE-CSWS (NBI-827104 &#8211; T-Type Calcium Channel Blocker). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated the STEAMBOAT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> study, a Phase II multi-center, randomized, double-blind, placebo-controlled, parallel-group clinical study to evaluate the efficacy, safety, tolerability and pharmacokinetics of NBI-827104 in 24 pediatric patients (aged 4 to 12 years) with EE-CSWS, a rare pediatric form of epilepsy. We anticipate having top-line data from this clinical study during the second half of 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-827104 is a potent, selective, orally active and brain penetrating T-type calcium channel blocker. Due to the differentiated mechanism of action of this molecule, when compared to non-selective calcium channel inhibitors, treatment with NBI-827104 could lead to an enhanced benefit risk profile for patients with this rare pediatric form of epilepsy. We acquired the global rights to NBI-827104 in May 2020. EE-CSWS is a rare pediatric form of epilepsy. The typical onset of EE-CSWS occurs in children (aged 2 to 4 years) with a variety of seizure types, including atypical absence seizures, generalized tonic-clonic seizures and focal seizures, that occur primarily during sleep. Seizures associated with EE-CSWS, which often resolve around puberty, interfere with processes critical to learning and memory. Children with EE-CSWS often present with neurocognitive regression that can remain even after the seizures associated with EE-CSWS have resolved. It is estimated that EE-CSWS affects less than 2% of the estimated 470,000 children with active epilepsy in the United States. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SCN8A-DEE (NBI-921352 &#8211; Nav1.6 Sodium Channel Inhibitor). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated the KAYAK</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> study, a Phase II randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and pharmacokinetics of NBI-921352 as adjunctive therapy in 52 adolescent patients (aged 12 to 21 years) with SCN8A-DEE. In January 2022, the study protocol was amended to include pediatric patients (aged 2 to 11 years) with SCN8A-DEE. The FDA has granted us orphan drug and rare pediatric disease designations for NBI-921352 in SCN8A-DEE. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-921352 is a potent, highly selective Nav1.6 sodium channel inhibitor being developed to treat pediatric patients with SCN8A-DEE and other potential indications, including adult focal epilepsy. We acquired the global rights to NBI-921352 in December 2019. SCN8A-DEE is a rare, extremely severe, single-gene epilepsy caused by mutations in the SCN8A gene that activates Nav1.6, the most highly expressed sodium channel in the excitatory pathways of the central nervous system. Children born with SCN8A-DEE typically start experiencing seizures between birth and 18 months of age, and most have multiple seizures per day. Other symptoms include learning difficulties, muscle spasms, low or high muscle tone, poor coordination, developmental delay and features similar to autism. As SCN8a mutations were discovered only recently, prevalence estimates will be determined in the future as awareness of and access to genetic surveillance increases.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Focal Onset Seizures (NBI-921352 &#8211; Nav1.6 Sodium Channel Inhibitor). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase II randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and pharmacokinetics of NBI-921352 as adjunctive therapy in 100 adult patients with focal onset seizures. We anticipate having top-line data for this clinical study in 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-921352 is a potent, highly selective Nav1.6 sodium channel inhibitor being developed to treat pediatric patients with SCN8A-DEE and other potential indications, including adult focal epilepsy. We acquired the global rights to NBI-921352 in December 2019. Focal epilepsy is a neurological condition in which the predominant symptom is recurring seizures that affect one hemisphere of the brain. Focal epilepsies are also known as partial-onset seizures and include idiopathic location-related epilepsies, frontal lobe epilepsy, temporal lobe epilepsy, parietal lobe epilepsy and occipital lobe epilepsy. It is estimated that focal onset seizures affect 1.8 million adults in the United States, approximately 35% of whom are refractory to existing treatments.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Neuroendocrinology</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Congenital Adrenal Hyperplasia, or CAH.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Classic CAH in Adults (crinecerfont &#8211; CRF1 Antagonist). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated the CAHtalyst study, a global, registrational Phase III randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of crinecerfont in 165 adult patients with classic CAH, followed by an open-label treatment period. We anticipate having top-line data for this clinical study in 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Classic CAH in Pediatrics (crinecerfont &#8211; CRF1 Antagonist). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a global, registrational Phase III randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of crinecerfont in 81 pediatric patients (aged 2 to 17 years) with classic CAH. We anticipate having top-line data for this clinical study in 2023.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been granted orphan drug designation for crinecerfont in the treatment of classic CAH in the United States and the European Union. Crinecerfont&#160;is a potent, selective, orally active, corticotropin-releasing factor1, or CRF1, receptor antagonist as demonstrated in a range of in vitro and in vivo assays. CRF1 is a hypothalamic hormone released directly into the hypophyseal portal vasculature which acts on the CRF1 receptor, a G protein-coupled receptor, or GPCR, in the anterior pituitary to stimulate the release of the adrenocorticotropin hormone, or ACTH. The primary role of ACTH is the stimulation of the synthesis and release of adrenal steroids, including cortisol. Cortisol from the adrenals have a negative feedback role at the level of the hypothalamus that decreases CRF1 release as well as at the level of the pituitary to inhibit the release of ACTH. This tight control loop is known as the hypothalamic-pituitary-adrenal axis. Blockade of CRF1 receptors at the pituitary has been shown to decrease the release of ACTH, which in turn decreases the production of adrenal steroids including androgens, and potentially the symptoms associated with classic CAH. Lower ACTH levels would also reduce the amount of exogenous corticosteroid necessary for classic CAH patients to thrive avoiding the side-effects currently associated with excessive steroid therapy. Corticosteroids are the current standard of care for classic CAH and are used chronically to both correct the endogenous cortisol deficiency and to reduce the excessive ACTH levels and androgen excess. However, the dose and duration of steroid use required to suppress ACTH is well above the normal physiological level of cortisol; resulting in metabolic syndrome, bone loss, growth impairment and Cushing&#8217;s syndrome as common and serious side effects. Classic CAH refers to a group of autosomal recessive genetic conditions that result in an enzyme deficiency that alters the production of adrenal hormones. If left untreated, classic CAH can result in salt wasting, dehydration and eventually death. Even with cortisol replacement, persistent elevation of ACTH from the pituitary gland results in excessive androgen levels, leading to virilization of females including precocious puberty, menstrual irregularity, short stature, hirsutism, acne and fertility problems. Classic CAH affects an estimated 30,000 people in the United States and 50,000 people in the European Union.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Neuropsychiatry</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schizophrenia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Schizophrenia is a spectrum of serious neuropsychiatric brain diseases in which people interpret reality abnormally. Schizophrenia may result in some combination of hallucinations, delusions and extremely disordered thinking and behavior that impairs daily life. People with schizophrenia typically require lifelong treatment. Early treatment may help improve long-term prognosis and get symptoms under control before serious complications develop. Schizophrenia affects an estimated 3.5 million people in the United States. A description of our investigational treatments for potential use in schizophrenia follow.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Adjunctive Treatment of Schizophrenia (valbenazine </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> VMAT2 Inhibitor). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase III randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy, safety and tolerability of valbenazine when administered orally once daily as adjunctive treatment in 400 adolescent and adult patients (aged 13 years and older) with schizophrenia who have had an inadequate response to antipsychotics. We anticipate having top-line data for this clinical study in 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VMAT2 is a protein concentrated in the human brain that is essential for the transmission of nerve impulses between neurons. VMAT2 is primarily responsible for packaging and transporting monoamines (dopamine, norepinephrine, serotonin and histamine) in neurons. Specifically, dopamine enables neurotransmission among nerve cells that are involved in voluntary and involuntary motor control. In psychiatry, disease states such as schizophrenia are characterized in part by a hyperdopaminergic state in the brain and modulation of neuronal dopamine levels may provide symptomatic benefits for patients with this condition, among others. Approximately 30% of the estimated 3.5 million people affected by schizophrenia in the United States fail to respond to current antipsychotic therapy.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Schizophrenia (NBI-1117568 &#8211; Muscarinic M4 Agonist).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to submit an investigational new drug application and initiate a placebo-controlled Phase II clinical study of NBI-1117568 as a potential treatment for schizophrenia in 2022. NBI-1117568 is a potential first-in-class muscarinic M4 receptor agonist with the potential to be developed for the treatment of schizophrenia. As a selective M4 orthosteric agonist, NBI-1117568 offers the potential for an improved safety profile without the need for combination therapy to ameliorate off-target effects or for cooperativity with acetylcholine. Muscarinic receptors are central to brain function and validated as drug targets in psychosis and cognitive disorders. We acquired the global rights to NBI-1117568 in December 2021. All currently approved antipsychotic medications are believed to work through direct action on monoaminergic receptors, with approximately 40% of patients reporting negative side effects and approximately 30% not benefiting adequately from these medications.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cognitive Impairment Associated with Schizophrenia, or CIAS (luvadaxistat</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8211; DAAO Inhibitor). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase II randomized, double-blind, parallel, placebo-controlled clinical study to evaluate the efficacy, safety, tolerability and pharmacokinetics of luvadaxistat when administered orally once daily as adjunctive treatment in 308 adult patients with CIAS. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Luvadaxistat is a potential first-in-class D-Amino Acid Oxidase, or DAAO, inhibitor with the potential to be developed for the treatment of cognitive impairment associated with schizophrenia. We acquired the global rights to luvadaxistat in June 2020. CIAS, which may include deficits in attention, working memory and executive function, has a negative impact on patients&#8217; quality of life and ability to function. Although cognitive symptoms in schizophrenia are well characterized, no formal diagnostic criteria exist. Furthermore, no pharmacological agents are approved to treat the condition, and no marketed therapy tested to date has established clear, meaningful efficacy, which underscores the difficulty of drug development in this arena and accentuates the unmet need for proven treatment options. Approximately 80% of the estimated 3.5 million people affected by schizophrenia in the United States experience clinically relevant cognitive impairment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Major Depressive Disorder.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Major depressive disorder is characterized by a persistently depressed mood or loss of interest in daily activities that is present most of the day in addition to other symptoms that can impact normal daily functioning, relationships and overall quality of life. Treatments range from selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, atypical antipsychotics, tricyclic antidepressants and psychotherapies, among others. Major depressive disorder affects more than 16 million people in the United States. A description of our investigational treatments for potential use in major depressive disorder follow.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inadequate Response to Treatment in Major Depressive Disorder (NBI-1065845 &#8211; AMPA Potentiator). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase II randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of NBI-1065845 as adjunctive treatment in 212 adult patients with inadequate response to treatment in major depressive disorder. We anticipate having top-line data for this clinical study in 2023. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-1065845 is a potential first-in-class Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid, or AMPA, potentiator with the potential to be developed for the treatment of inadequate response to treatment in major depressive disorder, also known as treatment-resistant depression. We acquired the global rights to NBI-1065845 in June 2020. NBI-1065845 is currently designated as a 50:50 profit-share product with Takeda Pharmaceutical Company Limited, which retains a one-time opt-out right to convert the designation to a royalty-bearing product. Major depressive disorder is one of the leading causes of disability. While there are a number of marketed treatments for major depressive disorder, approximately 30% of the more than 16 million people affected by the disorder in the United States do not adequately respond to treatment.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anhedonia in Major Depressive Disorder (NBI-1065846 &#8211; GPR Agonist). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have initiated a Phase II randomized, double-blind, placebo-controlled, two-period cross-over, Proof of Activity clinical study to evaluate the effects of NBI-1065846 as adjunctive treatment in 88 adult patients with major depressive disorder experiencing anhedonia. We anticipate having top-line data for this clinical study in 2023. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NBI-1065846 is a potential first-in-class G Protein-Coupled Receptor 139, or GPR139, agonist with the potential to be developed for the treatment of anhedonia in major depressive disorder. We acquired the global rights NBI-1065846 in June 2020. NBI-1065846 is currently designated as a 50:50 profit-share product with Takeda Pharmaceutical Company Limited, which retains a one-time opt-out right to convert the designation to a royalty-bearing product. Anhedonia is characterized by the inability to experience pleasure and has been associated with changes in neurotransmitter levels involved in the brain&#8217;s reward system. Anhedonia is a core symptom of major depressive disorder and also frequently presents in people with bipolar depression, schizophrenia, substance-abuse disorders, Parkinson&#8217;s disease, diabetes and coronary artery disease. </span></div><div id="ic35e9d12d921455aa45f30d1d4130202_25"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercializing Our Product Portfolio.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched INGREZZA in the United States in May 2017 as the first FDA-approved drug for the treatment of tardive dyskinesia. In September 2020, we launched ONGENTYS in the United States as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. Our experience in marketing and selling pharmaceutical products began with INGREZZA&#8217;s approval in 2017, when we hired our salesforce and established our distribution and reimbursement capabilities, all of which are necessary to successfully commercialize our marketed products and products candidates. Our specialty salesforce in the United States consists of approximately 250</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">experienced sales professionals focused on educating healthcare professionals, including psychiatrists and neurologists, who treat patients with tardive dyskinesia and Parkinson&#8217;s disease. In the third quarter of 2021, we announced an expansion of our specialty salesforce, which is expected to be completed in the second quarter of 2022, to approximately 350 experienced sales professionals that will establish three dedicated sales teams focused on psychiatry, neurology and providers in long-term care, respectively. Our</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercial team is comprised of experienced professionals in marketing, access and reimbursement, managed markets, market research, commercial operations and salesforce planning and management. In addition, our commercial infrastructure includes capabilities in manufacturing, medical affairs, quality control and compliance. We intend to retain commercial rights to certain products, including INGREZZA, that we can effectively and efficiently develop, secure regulatory approval and commercialize, which includes products with a concentrated prescriber base and well-defined patient population that can be accessed with an efficient patient and prescriber outreach program.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advancing Life-Changing Discoveries in Neurology, Neuroendocrinology and Neuropsychiatry. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that by continuing to advance and expand our product pipeline, we can mitigate some of the risks associated with drug development. We currently have multiple programs in various stages of research and development, including symptomatic disease modifying treatments. We take a portfolio approach to managing our pipeline that balances the size of market opportunities with clear and defined clinical and regulatory paths to approval. By doing so, we focus our internal development resources on innovative therapies with improved probabilities of technical and commercial success.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discovering Novel Medicines to Address Unmet Patient Needs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to identify and validate new medicines on novel targets for internal development or collaboration. We believe the creativity and productivity of our discovery research group will continue to be a critical component for our ongoing success.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquiring Rights to Commercial Products and Drug Development Candidates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We aim to continue to selectively acquire rights to commercial products and programs in all stages of clinical development to capitalize on our commercial and drug development capabilities.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_1771"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Collaboration and License Agreements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our independent efforts to develop and market products, we may enter into collaboration and license agreements from time to time to enhance our drug development and commercial capabilities. Refer to Note 2 to the consolidated financial statements for more information on our significant collaboration and license agreements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_31"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We actively seek to protect our products and product candidates and related inventions and improvements that we consider important to our business. We own a portfolio of United States and ex-United States patents and patent applications and have licensed rights to a number of United States and ex-United States patents and patent applications. Our owned and licensed patents and patent applications cover or relate to our products and product candidates, including certain formulations, used to treat particular conditions and methods of administration, drug delivery technologies and delivery profiles and methods of manufacturing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own or have licensed rights to the following United States patents relating to INGREZZA and our other products and product candidates in our pipeline (in addition to non-United States patents and certain patents covering our early-stage product candidates):</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">INGREZZA, our highly selective VMAT2 inhibitor for the treatment of tardive dyskinesia, is covered by 19 issued United States patents that are listed in the FDA&#8217;s Orange Book and are set to expire between 2027 and 2040. There is also a potential patent term extension of up to an additional 2 years for United States Patent No. 8,039,627, which is currently set to expire in 2029 and is the earliest patent covering valbenazine, the active pharmaceutical ingredient contained in INGREZZA. In Japan and certain other East Asian markets, we are actively pursuing most of the patents corresponding to those listed in the FDA&#8217;s Orange Book entry for INGREZZA.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ONGENTYS, a highly selective COMT inhibitor for Parkinson&#8217;s disease, is covered by 9 issued United States patents that are listed in the FDA&#8217;s Orange Book and set to expire between 2026 to 2035 (not including a potential patent term extension of up to an additional 4 years for one of these patents).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORILISSA, our small molecule GnRH antagonist for the treatment of endometriosis pain, is covered by 5 issued United States patents that are listed in the FDA&#8217;s Orange Book (the number of patents being dependent on dosage amount) and are set to expire between 2024 to 2036 (not including patent term extension of up to 5 years for patents listed in the Orange Book expiring in 2024).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORIAHNN, containing our small molecule GnRH antagonist for the treatment of menstrual bleeding associated with uterine fibroids, is covered by 4issued United States patents that are listed in the FDA&#8217;s Orange Book and are set to expire between 2024 to 2034 (not including a potential patent term extension of up to an additional 5 years for one of the patents).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valbenazine, our highly selective VMAT2 inhibitor under further clinical development for the treatment of chorea in Huntington&#8217;s disease, is covered by at least 12 of the issued United States patents that are listed in the FDA&#8217;s Orange Book entry for INGREZZA and are set to expire between 2027 and 2038 . There is also a potential patent term extension of up to an additional 2 years for United States Patent No. 8,039,627, which is currently set to expire in 2029. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Crinecerfont, a CRF1 antagonist for the treatment of congenital adrenal hyperplasia (CAH), is covered by United States Patent No. 10,905,690, which expires in 2035 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Luvadaxistat, a DAAO inhibitor for the treatment of cognitive impairment associated with Schizophrenia (CIAS), is covered by United States Patent No. 9,290,456, among others, which expires in 2032 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NBI-827104, an inhibitor of T-type calcium channels for the treatment of CSWS epilepsy, is covered by United States Patent No. US 9,932,314, among others, which expires in 2035 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NBI-921352, an inhibitor of the Nav1.6 voltage-gated sodium channel for the treatment of SCN8A-DEE epilepsy, is covered by United States Patent No. US 10,246,453, among others, which expires in 2037 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NBI-1065845, a positive allosteric modulator of AMPA for the treatment of inadequate response to treatment in major depressive disorder is covered by United States Patent No. 8,778,934, among others, which expires in 2031 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NBI-1065846, a GPR139 agonist for the treatment of anhedonia in major depressive disorder, is covered by United States Patent No. 9,556,130, among others, which expires in 2035 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NBI-1117568, a selective M4 agonist for the treatment of schizophrenia, is covered by United States Patent No. 10,961,225, among others, which expire in 2035 (not including a potential patent term extension of up to an additional 5 years).</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the potential patent term extensions referenced above, the products and product candidates in our pipeline may be subject to additional terms of exclusivity that we may obtain by future patent issuances.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, the United States, European Union and Japan each provide data and marketing exclusivity for new medicinal compounds. If this protection is available, no competitor may use the original applicant&#8217;s data as the basis of a generic marketing application during the period of data and marketing exclusivity, which is measured from the date of marketing approval by the FDA or corresponding foreign regulatory authority. This period of exclusivity is generally 5 years in the United States, 6 years in Japan and 10 years in the European Union, except that for biologics, the period of exclusivity in the United States is 12 years under the Biologics Price Competition and Innovation Act. In addition, if granted orphan drug designation, certain of our product candidates, including crinecerfont, may also be eligible for marketing exclusivity in the United States for 7 years and European Union for 10 years.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Item 1A. Risk Factors for a discussion of the challenges we may face in obtaining or maintaining patent and/or trade secret protection and Item 3. Legal Proceedings f</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or a description of our legal proceedings related to intellectual property matters.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_34"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Manufacturing and Supply</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on, and intend to continue to rely on, third-party manufacturers for the production of INGREZZA and our product candidates. Raw materials, active pharmaceutical ingredients, or API, and other supplies required for the production of INGREZZA and our product candidates are sourced from various third-party manufacturers and suppliers in quantities adequate to meet our needs. Continuing adequate supply of such raw materials and API is assured through our long-term commercial supply and manufacturing agreements with multiple manufacturers and our continued focus on the expansion and diversification of our third-party manufacturing relationships. In addition, we rely on BIAL &#8211; Portela &amp; Ca, S.A. for the commercial supply of ONGENTYS.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our outsourced manufacturing strategy enables us to direct our financial resources to the maximization of our opportunities with INGREZZA and ONGENTYS, investment in our internal R&amp;D programs and expansion of our clinical pipeline through business development opportunities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our third-party manufacturers, suppliers and service providers may be subject to routine current Good Manufacturing Practice, or cGMP, inspections by the FDA or comparable agencies in other jurisdictions. We depend on our third-party partners and our quality system oversight of them for continued compliance with cGMP requirements and applicable foreign standards.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_37"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Marketing, Sales and Distribution </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our experience in marketing and selling pharmaceutical products began with INGREZZA&#8217;s approval in 2017, when we hired our salesforce and established our distribution and reimbursement capabilities, all of which are necessary to successfully commercialize our marketed products and products candidates. Our expanded specialty salesforce in the United States will consist of approximately 350 experienced sales professionals divided into three dedicated sales teams focused on psychiatry, neurology and long-term care. We anticipate completing our salesforce expansion during the second quarter of 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For INGREZZA, our customers in the United States consist of a limited network of specialty pharmacy providers that deliver INGREZZA to patients by mail, wholesale distributors that distribute INGREZZA primarily to certain specialty pharmacies, and specialty distributors that distribute INGREZZA primarily to closed-door pharmacies and government facilities. For ONGENTYS, our customers in the United States consist primarily of wholesale distributors. We rely on third-party service providers to perform a variety of functions related to the packaging, storage and distribution of INGREZZA and ONGENTYS.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_40"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business activities are subject to extensive regulation by the United States and other countries. Regulation by government authorities in the United States and foreign countries is a significant factor in the development, manufacture, distribution, tracking, marketing and sale of our proposed products and in our ongoing research and product development activities. All of our products in development will require regulatory approval by government agencies prior to commercialization. The process of obtaining these approvals and the subsequent compliance with appropriate federal and state statutes and regulations require the expenditure of substantial time and financial resources.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, federal and state healthcare laws restrict business practices in the pharmaceutical industry. These laws include, without limitation, federal and state fraud and abuse laws, false claims laws, data privacy and security laws, as well as transparency laws regarding payments or other items of value provided to healthcare providers. We have a comprehensive compliance program designed to ensure our business practices remain compliant.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Anti-Kickback Statute makes it illegal for any person or entity to knowingly and willfully, directly or indirectly, solicit, receive, offer, or pay any remuneration that is intended to induce the referral of business, including the purchase, order, lease of any good, facility, item or service for which payment may be made under a federal healthcare program, such as Medicare or Medicaid.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal civil and criminal false claims laws and the federal civil monetary penalties law, which prohibit among other things, any person or entity from knowingly presenting, or causing to be presented, for payment to, or approval by, federal programs, including Medicare and Medicaid, claims for items or services, including drugs, that are false or fraudulent or not provided as claimed and knowingly making, or causing to be made, a false record or to avoid or decrease an obligation to pay money to the federal government.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996, or HIPAA, created additional federal criminal statutes that prohibit, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may be subject to HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, and their privacy and security regulations, which impose certain obligations, including the adoption of administrative, physical and technical safeguards to protect individually identifiable health information on covered entities subject to HIPAA (i.e., health plans, healthcare clearinghouses and certain healthcare providers) and their business associates that perform certain services for or on their behalf involving the use or disclosure of individually identifiable health information as well as their covered subcontractors.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies to report annually to the Centers for Medicare&#160;and Medicaid Services, or CMS, information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physician assistants and nurse practitioners) and teaching hospitals, as well as information regarding ownership and investment interests held by physicians and their immediate family members.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, many states have similar healthcare statutes or regulations that may be broader in scope and may apply regardless of payor. Additionally, to the extent that our product is sold in a foreign country, we may be subject to similar foreign laws.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these laws, where applicable, can result in significant penalties, including the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, imprisonment, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, and additional reporting requirements and regulatory oversight, any of which could adversely affect our ability to operate our business and our results of operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Development and Marketing Approval for Products. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preclinical studies generally are conducted in laboratory animals to evaluate the potential safety and efficacy of a product. Drug developers submit the results of preclinical studies to the FDA as a part of an investigational new drug application, or IND, before clinical trials can begin in humans. Typically, clinical evaluation involves a time consuming and costly three-phase process.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:90.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase I</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials are conducted with a small number of subjects to determine the early safety profile, maximum tolerated dose and pharmacokinetic properties of the product in human volunteers or in patients with the target disease.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase II</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trials are conducted with groups of patients afflicted with a specific disease in order to determine preliminary efficacy, optimal dosages and expanded evidence of safety.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phase III</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Larger, multi-center, comparative clinical trials are conducted with patients afflicted with a specific disease in order to determine safety and efficacy as primary support for regulatory approval by the FDA to market a product candidate for a specific disease.</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA closely monitors the progress of each of the three phases of clinical trials that are conducted in the United States and may, at its discretion, re-evaluate, alter, suspend or terminate the testing based upon the data accumulated to that point and the FDA&#8217;s assessment of the risk/benefit ratio to the patient. Institutional Review Boards, Institutional Ethics Committees and Data Safety Monitoring Boards also closely monitor the conduct of our trials and may also place holds on our clinical trials or recommend that we voluntarily do so. Clinical trials conducted in foreign countries are also subject to oversight by regulatory authorities in those countries.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once Phase&#160;III trials are completed, drug developers submit the results of preclinical studies and clinical trials to the FDA in the form of an NDA for approval to commence commercial sales. In most cases, the submission of an NDA is subject to a substantial application user fee. Under the Prescription Drug User Fee Act, or PDUFA, the FDA has a goal of ten months from the date of filing of a standard NDA for a new molecular entity to review and act on the submission. The FDA generally has a six-month review goal of priority NDAs.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the Pediatric Research Equity Act of 2003 as amended and reauthorized, certain applications or supplements to an application must contain data that are adequate to assess the safety and effectiveness of the drug for the claimed indications in all relevant pediatric subpopulations, and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may, on its own initiative or at the request of the applicant, grant deferrals for submission of some or all pediatric data until after approval of the product for use in adults or full or partial waivers from the pediatric data requirements.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA also may require submission of a risk evaluation and mitigation strategy to ensure that the benefits of the drug outweigh its risks. The risk evaluation and mitigation strategy could include medication guides, physician communication plans, assessment plans and/or additional elements to assure safe use, such as restricted distribution methods, patient registries, or other risk minimization tools.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an application for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The FDA reviews an NDA to determine, among other things, whether the drug is safe and effective for its intended use and whether the facility in which it is manufactured, processed, packaged or held meets standards designed to assure the product&#8217;s continued safety, quality and purity.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with current Good Manufacturing Practice requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with Good Clinical Practice requirements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a complete response letter. A complete response letter generally contains a statement of specific conditions that must be met in order to secure final approval of the application and may require additional clinical or preclinical testing in order for FDA to reconsider the application. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#8217;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that contraindications, warnings or precautions be included in the product labeling, require that post-approval studies, including Phase IV clinical trials, be conducted to further assess a drug&#8217;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a risk evaluation and mitigation strategy, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes and additional labeling claims, are subject to further testing requirements and FDA review and approval.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will also have to complete an approval process similar to that in the United States in order to commercialize our product candidates in each foreign country. The approval procedure and the time required for approval vary from country to country and may involve additional testing. Foreign approvals may not be granted on a timely basis, or at all. In addition, regulatory approval of prices is required in most countries other than the United States The resulting prices may not be sufficient to generate an acceptable return to us or our corporate collaborators.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, there are currently two potential tracks for seeking marketing approval for a product not authorized in any European Union member state: a decentralized procedure and a centralized procedure. In the decentralized procedure, identical applications for marketing authorization are submitted simultaneously to the national regulatory agencies. Regulatory review is led by one member state (the reference-member state), and its assessment&#8212;based on safety, quality and efficacy&#8212;is reviewed and approved (assuming there are no concerns that the product poses a serious risk to public health) by the other member states from which the applicant is seeking approval (the concerned-member states). The decentralized procedure leads to a series of single national approvals in all relevant countries. In the centralized procedure, which is required of all products derived from biotechnology, a company submits a single marketing authorization application to the European Medicines Agency, or EMA, which conducts an evaluation of the dossier, drawing upon its scientific resources across Europe. If the drug product is proven to fulfill the requirements for quality, safety and efficacy, the EMA&#8217;s Committee for Medicinal Products of Human Use, or CHMP, adopts a positive opinion, which is transmitted to the European Commission for final decision on grant of the marketing authorization. While the EC generally follows the CHMP&#8217;s opinion, it is not bound to do so. Subsequent commercialization is enabled by country-by-country reimbursement approval.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Orphan Drug Designation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Orphan Drug Act, the FDA may grant orphan drug designation to a drug intended to treat a rare disease or condition, which is a disease or condition that affects fewer than 200,000 individuals in the United States, or if it affects more than 200,000, there is no reasonable expectation that sales of the drug in the United States will be sufficient to offset the costs of developing and making the drug available in the United States Orphan drug designation must be requested before submitting an NDA. Orphan drug designation does not convey any advantage in or shorten the duration of the regulatory review and approval process.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA approves a sponsor&#8217;s marketing application for a designated orphan drug for use in the rare disease or condition for which it was designated, the sponsor is eligible for a seven-year period of marketing exclusivity, during which the FDA may not approve another sponsor&#8217;s marketing application for a drug with the same active moiety and intended for the same use or indication as the approved orphan drug, except in limited circumstances, such as if a subsequent sponsor demonstrates its product is clinically superior. During a sponsor&#8217;s orphan drug exclusivity period, competitors, however, may receive approval for drugs with different active moieties for the same indication as the approved orphan drug, or for drugs with the same active moiety as the approved orphan drug, but for different indications. Orphan drug exclusivity could block the approval of one of our products for 7 years if a competitor obtains approval for a drug with the same active moiety intended for the same indication before we do, unless we are able to demonstrate that grounds for withdrawal of the orphan drug exclusivity exist, or that our product is clinically superior. Further, if a designated orphan drug receives marketing approval for an indication broader than the rare disease or condition for which it received orphan drug designation, it may not be entitled to exclusivity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legislation similar to the Orphan Drug Act has been enacted in other countries outside of the United States, including the European Union. The orphan legislation in the European Union is available for therapies addressing conditions that affect five or fewer out of 10,000 persons, are life&#8209;threatening or chronically debilitating conditions and for which no satisfactory treatment is authorized. The market exclusivity period is for 10 years, although that period can be reduced to 6 years if, at the end of the fifth year, available evidence establishes that the product does not justify maintenance of market exclusivity.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Post-Approval Requirements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims are subject to prior FDA review and approval. There also are continuing, annual program user fee requirements for any marketed products, as well as new application fees for supplemental applications with clinical data.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase IV clinical trials, and surveillance to further assess and monitor the product&#8217;s safety and effectiveness after commercialization.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state agencies and are subject to periodic unannounced inspections by the FDA and these state agencies for compliance with current Good Manufacturing Practices, or cGMP, requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP compliance.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a risk evaluation and mitigation strategy program. Other potential consequences include, among other things:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning letters or holds on post-approval clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product approvals;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of products; or</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions or the imposition of civil or criminal penalties.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA strictly regulates marketing, labeling, advertising and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#8217;s FDA approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability. Physicians may prescribe legally available products for uses that are not described in the product&#8217;s labeling and that differ from those tested by us and approved by the FDA. The FDA does not regulate behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#8217;s communications on the subject of off-label use of their products.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_46"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Reimbursement</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we obtain regulatory approval. In the United States and markets in other countries, sales of any products for which we receive regulatory approval will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such drug products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, third-party payors include federal and state healthcare programs, government authorities, private managed care providers, private health insurers and other organizations. No uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our drug products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical drug products and medical services, in addition to questioning their safety and efficacy. Such payors may limit coverage to specific drug products on an approved list, also known as a formulary, which might not include all of the FDA-approved drugs for a particular indication.&#160;We may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain the FDA approvals. Nonetheless, our products or product candidates, including INGREZZA, may not be considered medically necessary or cost-effective.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the process for determining whether a third-party payor will provide coverage for a drug product may be separate from the process for setting the price of a drug product or for establishing the reimbursement rate that such a payor will pay for the drug product. A payor&#8217;s decision to provide coverage for a drug product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#8217;s determination to provide coverage for a drug product does not assure that other payors will also provide coverage for the drug product. Adequate third-party payor reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The marketability of any product or product candidates for which we or our collaborators receive regulatory approval for commercial sale may suffer if third-party payors fail to provide coverage and adequate reimbursement. In addition, emphasis on managed care in the United States has increased and we expect will continue to increase the pressure on pharmaceutical pricing. Coverage policies and third-party payor reimbursement rates may change at any time. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_49"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Healthcare Reform</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States and some foreign jurisdictions are considering or have enacted a number of legislative and regulatory proposals to change the healthcare system in ways that could affect our ability to sell our products profitably. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of example, in March&#160;2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, collectively the ACA, was signed into law, which intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add transparency requirements for the healthcare and health insurance industries, impose taxes and fees on the health industry and impose additional health policy reforms.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and lower reimbursement, and in additional downward pressure on the price that we receive for any approved product. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private third-party payor.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been legal and political challenges to certain aspects of the ACA. Since January 2017, the Trump administration signed several executive orders and other directives designed to delay, circumvent, or loosen certain requirements mandated by the ACA. Concurrently, Congress considered legislation that would repeal or repeal and replace all or part of the ACA. For example, legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act, includes a provision that repealed, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#8220;individual mandate&#8221;. On June 17, 2021, the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress. Thus, the ACA will remain in effect in its current form. Prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject to judicial or Congressional challenges in the future. It is unclear how such challenges and the healthcare reform measures of the Biden administration will impact the ACA.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted. These changes include, among others, aggregate reductions to Medicare payments to providers of up to 2% per fiscal year pursuant to the Budget Control Act of 2011, which began in 2013 and, due to subsequent legislative amendments, including the Investment and Jobs Act, will remain in effect through 2031, except for a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic, unless additional Congressional action is taken. Under current legislation, the actual reduction in Medicare payments will vary from 1% in 2022 to up to 3% in the final fiscal year of this sequestration.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, there has been heightened governmental scrutiny recently over pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several Congressional hearings and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to drug pricing that sought to implement several of the administration&#8217;s proposals. As a result, the FDA concurrently released a final rule and guidance in September 2020, providing pathways for states to build and submit importation plans for drugs from Canada. This rule is undergoing legal challenge.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, on November 20, 2020, the U.S. Department of Health and Human Services, or HHS, finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers. This rule has been stayed by the Biden Administration until 2023 while pending litigation is heard in the courts.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2020, CMS issued an interim final rule implementing President Trump&#8217;s Most Favored Nation executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective January 1, 2021. As a result of litigation challenging the Most Favored Nation model, on December 27, 2021, CMS published a final rule that rescinds the Most Favored Nation model interim final rule. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in July 2021, the Biden administration released an executive order, &#8220;Promoting Competition in the American Economy,&#8221; with multiple provisions aimed at prescription drugs. In response to Biden&#8217;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. No legislation or administrative actions have been finalized to implement these principles. It is unclear whether these or similar policy initiatives will be implemented in the future. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_52"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries are subject to rapid and intense technological change. We face, and will continue to face, competition in the development and marketing of our products and product candidates from academic institutions, government agencies, research institutions and biotechnology and pharmaceutical companies. Many of our competitors have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approval and marketing than we do.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition may also arise from, among other things, new drug development technologies, new or improved treatment options for preventing or reducing the incidence of disease in diseases our products treat and new small molecule or other classes of therapeutic agents. Such developments by competitors could reduce or eliminate the use of our products or may limit the utility and application of ongoing clinical trials for our product candidates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tardive Dyskinesia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INGREZZA competes with AUSTEDO (deutetrabenazine), which was approved by the FDA for the treatment of tardive dyskinesia in adults in August 2017 and is marketed by Teva Pharmaceutical Industries, and several clinical development-stage programs targeting tardive dyskinesia and related movement disorders. Additionally, there are a number of commercially available medicines used to treat tardive dyskinesia off-label, such as Xenazine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (tetrabenazine) and generic equivalents, and various antipsychotic medications (e.g., clozapine), anticholinergics, benzodiazepines (off-label), and botulinum toxin.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parkinson&#8217;s Disease. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ONGENTYS competes with two other FDA-approved COMT inhibitors and their generic equivalents. Additionally, there are a number of alternative adjunctive treatment options (FDA-approved and in clinical development) for Parkinson&#8217;s patients which compete with ONGENTYS, including various L-dopa preparations, dopamine agonists, MAO-B inhibitors and others. In terms of potential future competition, there are several programs in late-stage clinical development.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Endometriosis and Uterine Fibroids. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ORILISSA and ORIAHNN each compete with several FDA-approved products for the treatment of endometriosis, uterine fibroids, infertility and central precocious puberty. Additionally, there is also competition from surgical intervention, including hysterectomies and ablations. Separate from these options, there are many programs in clinical development which serve as potential future competition. Lastly, there are numerous medicines used to treat the symptoms of disease (vs. endometriosis or uterine fibroids directly) which may also serve as competition: oral contraceptives, NSAIDs and other pain medications, including opioids.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Congenital Adrenal Hyperplasia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For CAH, high doses of corticosteroids are the current standard of care to both correct the endogenous cortisol deficiency as well as reduce the excessive ACTH levels. In the United States alone, there are more than two dozen companies manufacturing steroid-based products. In addition, there are several programs in clinical development targeting CAH and several companies developing medicinal treatments for CAH.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Epilepsy.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our investigational treatments for potential use in epilepsy may in the future compete with numerous approved anti-seizure medications and development-stage programs being pursued by several other companies. Commonly used anti-seizure medications include phenytoin, levetiracetam, brivaracetam, cenobamate, carbamazepine, clobazam, lamotrigine, valproate, oxcarbazepine, topiramate, lacosamide, perampanel and cannabidiol, among others. There are currently no FDA-approved treatments specifically indicated for the early infantile epileptic encephalopathies SCN8A-DEE and EE-CSWS; however, a number of different anti-seizure medications are currently used in these patient populations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neuropsychiatry.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our investigational treatments for potential use in schizophrenia and depression may in the future compete with several development-stage programs being pursued by other companies. Currently, there are no FDA-approved treatments specifically indicated for CIAS; however, there are a number of different anti-psychotic medications currently used in these patient populations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our investigational treatments for potential use in neurology, neuroendocrinology and neuropsychiatry may in the future compete with numerous approved products and development-stage programs being pursued by several other companies.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_55"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Employees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have grown to a team of more than 900 employees as of December 31, 2021, all of whom were employed in the United States. Our highly qualified and experienced team, which includes scientists, physicians and professionals across sales, marketing, manufacturing, regulatory, finance and other essential functions are critical to our success. We also leverage temporary workers to provide flexibility for our business needs. During 2021, we added over 200 new employees to our team. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to add additional employees in 2022 with a focus on expanding our commercial salesforce, research, and development organizations. We continually evaluate our business needs and opportunities and balance in house expertise and capacity with external expertise and capacity. Currently, we rely on third-party contract manufacturers.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Culture.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our human capital management investments is evidenced by our low employee turnover, a number which is regularly reviewed by our Board of Directors as part of their oversight of our human capital strategy. In recognition of our efforts, in 2021, we received the following rewards:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">#4 in Fortune Best Workplaces in Health Care &amp; Biopharma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">#7 in Fortune Best Small &amp; Medium Workplaces</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">#13 in Fortune Best Workplaces for Women</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">#25 in Fortune Best Workplaces for Millennials</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Engagement, Talent Development &amp; Benefits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future success largely depends upon our continued ability to attract and retain highly skilled employees. We provide our employees with competitive salaries and bonuses, opportunities for equity ownership, development programs that enable continued learning and growth and a robust employment package that promotes well-being across all aspects of their lives, including health care, retirement planning and paid time off. As part of our promotion and retention efforts, we also invest in ongoing leadership development programs as well as offer tuition reimbursement. In addition, we regularly conduct an employee survey to gauge employee engagement and identify areas of focus.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversity &amp; Inclusion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of our success is rooted in the diversity of our teams and our commitment to inclusion. We value diversity at all levels and continue to focus on extending our diversity and inclusion initiatives across our entire workforce. We believe that our business benefits from the different perspectives a diverse workforce brings, and we pride ourselves on having a strong, inclusive and positive culture based on our shared mission and values.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_58"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were originally incorporated in California in January 1992 and reincorporated in Delaware in May 1996. Our principal executive offices are located at 12780 El Camino Real, San Diego, California 92130. Our telephone number is (858) 617-7600.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Annual Reports on Form&#160;10-K, Quarterly Reports on Form&#160;10-Q, Current Reports on Form&#160;8-K and amendments to reports filed pursuant to Sections&#160;13(a) and 15(d) of the Securities Exchange Act of 1934, as amended, are available free of charge on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.neurocrine.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as soon as reasonably practicable after such reports are available on the Securities and Exchange Commission, or SEC, website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Additionally, copies of our Annual Report will be made available, free of charge, upon written request. Information found on, or accessible through, our website is not a part of, and is not incorporated into, this Annual Report on Form 10-K.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_61"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following information sets forth risk factors that could cause our actual results to differ materially from those contained in forward-looking statements we have made in this Annual Report on Form&#160;10-K and those we may make from time to time. If any of the following risks actually occur, our business, operating results, prospects or financial condition could be harmed. Additional risks not presently known to us, or that we currently deem immaterial, may also affect our business operations.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_64"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks and uncertainties related to our business, many of which are beyond our control.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, risks associated with our business include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to continue to successfully commercialize INGREZZA, ONGENTYS, or any of our product candidates if they are approved in the future.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If physicians and patients do not continue to accept INGREZZA or do not accept ONGENTYS, or our sales and marketing efforts are not effective, we may not generate sufficient revenue.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Governmental and third-party payors may impose sales and pharmaceutical pricing controls on our products or limit coverage and/or reimbursement for our products that could limit our product revenues and delay sustained profitability.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business could be adversely affected by the effects of health pandemics or epidemics, including the COVID-19 pandemic, which could also cause significant disruption in the operations of third-party manufacturers, contract research organizations, or CROs, or other third parties upon whom we rely.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We face intense competition, and if we are unable to compete effectively, the demand for our products may be reduced.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Because the development of our product candidates is subject to a substantial degree of technological uncertainty, we may not succeed in developing any of our product candidates.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our clinical studies may be delayed for safety or other reasons, or fail to demonstrate the safety and efficacy of our product candidates, which could prevent or significantly delay their regulatory approval.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on our current collaborators for the development and commercialization of several of our products and product candidates and may need to enter into future collaborations to develop and commercialize certain of our product candidates.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Use of our approved products or those of our collaborators could be associated with side effects or adverse events.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have recently increased the size of our organization and will need to continue to increase the size of our organization. We may encounter difficulties with managing our growth, which could adversely affect our results of operations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to retain and recruit qualified scientists and other employees or if any of our key senior executives discontinues his or her employment with us, it may delay our development efforts or impact our commercialization of INGREZZA, ONGENTYS or any product candidate approved by the FDA.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We currently have no manufacturing capabilities. If third-party manufacturers of INGREZZA, ONGENTYS or any of our product candidates fail to devote sufficient time and resources to our concerns, or if their performance is substandard, our clinical trials and product introductions may be delayed, and our costs may rise.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We currently depend on a limited number of third-party suppliers. The loss of these suppliers, or delays or problems in the supply of INGREZZA or ONGENTYS, could materially and adversely affect our ability to successfully commercialize INGREZZA or ONGENTYS.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We license some of our core technologies and drug candidates from third parties. If we default on any of our obligations under those licenses, or violate the terms of these licenses, we could lose our rights to those technologies and drug candidates or be forced to pay damages.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to protect our intellectual property, our competitors could develop and market products based on our discoveries, which may reduce demand for our products.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Health care reform measures and other recent legislative initiatives could adversely affect our business.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a history of losses and expect to increase our expenses for the foreseeable future, and we may not be able to sustain profitability.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our customers are concentrated and therefore the loss of a significant customer may harm our business.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we cannot raise additional funding, we may be unable to complete development of our product candidates or establish commercial and manufacturing capabilities in the future.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Company</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to continue to successfully commercialize INGREZZA, ONGENTYS, or any of our product candidates if they are approved in the future.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to produce INGREZZA revenues consistent with expectations ultimately depends on our ability to continue to successfully commercialize INGREZZA and secure adequate third-party reimbursement. Our experience in marketing and selling pharmaceutical products began with INGREZZA&#8217;s approval in 2017, when we hired our salesforce and established our distribution and reimbursement capabilities, all of which are necessary to successfully commercialize our current and future products. We have continued to invest in our commercial infrastructure and distribution capabilities in the past 4 years, including the expansion of our specialty salesforce, which we announced in the third quarter of 2021 and anticipate completing in the second quarter of 2022. While our team members and consultants have experience marketing and selling pharmaceutical products, we may face difficulties related to managing the rapid growth of our personnel and infrastructure, and there can be no guarantee that we will be able to maintain the personnel, systems, arrangements and capabilities necessary to continue to successfully commercialize INGREZZA, or to successfully commercialize ONGENTYS or any product candidate approved by the FDA in the future. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our business has been and may continue to be adversely affected by the effects of health pandemics or epidemics, including the ongoing COVID-19 pandemic. In parts of the country where the pandemic is having a greater impact, some hospitals, community mental health facilities and other healthcare facilities continue to have policies that limit access of our sales representatives, medical affairs personnel and patients to such facilities. These policies are likely to change from time to time as communities or regions grapple with outbreaks. In addition, many health care practitioners have adopted telehealth for patient interactions, which may impact the ability of the health care practitioner to screen for and diagnose tardive dyskinesia. Further, during the COVID-19 pandemic, the use of physician telehealth services increased significantly, fueled by an expansion of coverage and reimbursement from government and other payors. The limitations that telehealth places on the ability to conduct a thorough visual and physical examination may impact the ability of providers to screen for movement disorders, leading to potentially fewer patients to be diagnosed and referred for treatment. The ultimate impact of the COVID-19 pandemic, including any lasting effects on the way we conduct our business, is highly uncertain and subject to continued change. If we fail to maintain successful marketing, sales and reimbursement capabilities, our product revenues may suffer.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If physicians and patients do not continue to accept INGREZZA or do not accept ONGENTYS or our sales and marketing efforts are not effective, we may not generate sufficient revenue.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercial success of INGREZZA or ONGENTYS will depend upon the acceptance of those products as safe and effective by the medical community and patients.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market acceptance of INGREZZA or ONGENTYS could be affected by a number of factors, including:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of receipt of marketing approvals for additional indications;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the safety and efficacy of the products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing of our products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability of healthcare payor coverage and adequate reimbursement for the products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public perception regarding any products we may develop;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of existing competitor products addressing our target markets or the emergence of equivalent or superior products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost-effectiveness of the products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the medical community, patients and payors do not continue to accept our products as being safe, effective, superior and/or cost-effective, we may not generate sufficient revenue.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental and third-party payors may impose sales and pharmaceutical pricing controls on our products or limit coverage and/or reimbursement for our products or impose policies that could limit our product revenues and delay sustained profitability.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to continue to commercialize INGREZZA successfully or to successfully commercialize ONGENTYS, will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available. The continuing efforts of government and third-party payors to contain or reduce the costs of health care and the price of prescription drugs through various means may impact our revenues. These payors&#8217; efforts could decrease the price that we receive for any products we may develop and sell in the future.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming we obtain coverage for a given product by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. Patients who are prescribed medications for the treatment of their conditions, and their prescribing physicians, generally rely on third-party payors to reimburse all or part of the costs associated with their prescription drugs. Patients are unlikely to use our products unless coverage is provided and reimbursement is adequate to cover all or a significant portion of the out-of-pocket cost of our products. Coverage decisions may depend upon clinical and economic standards that disfavor new drug products when more established or lower cost therapeutic alternatives are already available or subsequently become available regardless of whether they are approved by the FDA for that particular use. Coverage decisions by payors for our competitors' products may also impact coverage for our products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government authorities and other third-party payors are developing increasingly sophisticated methods of controlling healthcare costs, such as by limiting coverage and the amount of reimbursement for particular medications. Further, no uniform policy requirement for coverage and reimbursement for drug products exists among third-party payors in the United States. Therefore, coverage and reimbursement for drug products can differ significantly from payor to payor. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. In addition, communications from government officials regarding health care costs and pharmaceutical pricing could have a negative impact on our stock price, even if such communications do not ultimately impact coverage or reimbursement decisions for our products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There may also be significant delays in obtaining coverage and reimbursement for newly approved drugs or indications, and coverage may be more limited than the purposes for which the drug is approved by the FDA or comparable foreign regulatory authorities. Moreover, eligibility for coverage and reimbursement does not imply that a drug will be paid for in all cases or at a rate that covers our costs, including research, development, manufacture, sale and distribution. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If coverage and reimbursement are not available or reimbursement is available only to limited levels, we may not successfully commercialize INGREZZA, ONGENTYS or any other product candidate for which we obtain marketing approval. Our inability to promptly obtain coverage and profitable reimbursement rates from both government-funded and private payors for any approved products that we develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition. Further, a majority of our current revenue is derived from federal healthcare program payors, including Medicare and Medicaid. Thus, changes in government reimbursement policies, reductions in payments and/or our suspension or exclusion from participation in federal healthcare programs could have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, during the COVID-19 pandemic, the use of physician telehealth services has rapidly increased, fueled by an unprecedented expansion of coverage and reimbursement across insurers. The limitations that telehealth places on the ability to conduct a thorough physical examination may impact the ability of providers to screen for movement disorders, leading potentially fewer patients to be diagnosed and/or treated.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely affected by the effects of health pandemics or epidemics, including the COVID-19 pandemic, which could also cause significant disruption in the operations of third-party manufacturers CROs, or other third parties upon whom we rely.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business could be adversely affected by the effects of health pandemics or epidemics, which could also cause significant disruption in the operations of third-party manufacturers, CROs and other third parties upon whom we rely. As a result of the ongoing COVID-19 pandemic, we may experience disruptions that could severely impact our supply chain, ongoing and future clinical trials and commercialization of INGREZZA and ONGENTYS. For example, the COVID-19 pandemic has resulted in travel restrictions and the shutdown or delay of business activities in various regions. In response to the COVID-19 pandemic, we implemented a remote work model for all employees except certain key essential members involved in business-critical activities.&#160;Most of our field-based employees have resumed in-person interactions in accordance with location-specific guidance. Our office-based employees have returned to the office under flexible work guidelines to help balance business needs, employee health, well-being and safety and the evolving work environment. However, as the effects of the pandemic continue to rapidly evolve with the emergence of new COVID-19 variants, a remote work model may nevertheless need to be reinstated at some point in the future. We continue to evaluate the impact of global spikes or surges in COVID-19 infection and hospitalization rates, as well as the impact of emerging COVID-19 variants on the efficacy of vaccines. The effects of a remote and flexible work model may negatively impact productivity, disrupt our business and delay our clinical programs and timelines, the magnitude of which will depend, in part, on the length and severity of the restrictions and other limitations on our ability to conduct our business in the ordinary course. In addition, we may face several challenges or disruptions upon a return back to the workplace, including re-integration challenges by our employees and distractions to management related to such transition. These and similar, and perhaps more severe, disruptions in our operations due to the COVID-19 pandemic could negatively impact our business, operating results and financial condition.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarantines, stay at home orders, travel restrictions and other state and local restrictions, or the perception that such orders, shutdowns or other restrictions on the conduct of business operations could occur, related to COVID-19 or other infectious diseases, could impact personnel at third-party manufacturing facilities in the United States and other countries, or the availability or cost of materials, which would disrupt our supply chain.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, clinical site initiation and patient enrollment may be delayed due to concerns for patient safety and prioritization of healthcare resources toward the COVID-19 pandemic. Some patients may not be able to comply with clinical trial protocols if quarantines impede patient travel or interrupt healthcare services. Similarly, our ability to recruit and retain patients, principal investigators and site staff may be hindered, which would adversely impact our clinical trial operations. Increases in COVID-19 cases or hospitalizations in the future could cause us or any of our clinical sites to again limit or suspend our patient enrollment and screening activities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic, which has caused a broad impact globally, may materially affect us economically. While the potential economic impact brought by, and the duration of, the COVID-19 pandemic may be difficult to assess or predict, the pandemic has caused disruption in the global financial markets. This disruption, if sustained or recurrent, could make it more difficult for us to access capital, which could in the future negatively affect our liquidity. In addition, a recession or market correction resulting from the COVID-19 pandemic could materially affect our business and the value of our common stock.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effects of the COVID-19 pandemic continue to rapidly evolve. The ultimate impact of the COVID-19 pandemic or a similar health pandemic or epidemic is highly uncertain and subject to continued change. We do not yet know the full extent of potential delays or impacts on our business, our clinical trials, healthcare systems or the global economy as a whole. These effects could have a material impact on our operations, or the operations of third parties on whom we rely.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face intense competition, and if we are unable to compete effectively, the demand for our products may be reduced.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The biotechnology and pharmaceutical industries are subject to rapid and intense technological change. We face, and will continue to face, competition in the development and marketing of our products and product candidates from academic institutions, government agencies, research institutions and biotechnology and pharmaceutical companies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competition may also arise from, among other things:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other drug development technologies;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">methods of preventing or reducing the incidence of disease, including vaccines; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new small molecule or other classes of therapeutic agents.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developments by others (including the development of generic equivalents) may render our product candidates or technologies obsolete or noncompetitive.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are commercializing and performing research on or developing products for the treatment of several disorders including endometriosis, tardive dyskinesia, uterine fibroids, essential tremor, classic congenital adrenal hyperplasia, pain, Parkinson&#8217;s disease and other neurology, neuroendocrinology and neuropsychiatry-related diseases and disorders, and there are a number of competitors to our products and product candidates. If one or more of our competitors&#8217; products or programs are successful (including the development of generic equivalents), the market for our products may be reduced or eliminated.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">INGREZZA competes with AUSTEDO (deutetrabenazine), which was approved by the FDA for the treatment of tardive dyskinesia in adults in August 2017 and is marketed by Teva Pharmaceutical Industries, and several clinical development-stage programs targeting tardive dyskinesia and related movement disorders. Additionally, there are a number of commercially available medicines used to treat tardive dyskinesia off-label, such as Xenazine</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (tetrabenazine) and generic equivalents, and various antipsychotic medications (e.g., clozapine), anticholinergics, benzodiazepines (off-label), and botulinum toxin.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ONGENTYS competes with two other FDA-approved COMT inhibitors and their generic equivalents. Additionally, there are a number of alternative adjunctive treatment options (FDA-approved and in clinical development) for Parkinson&#8217;s patients which compete with ONGENTYS, including various L-dopa preparations, dopamine agonists, MAO-B inhibitors and others. In terms of potential future competition, there are several programs in late-stage clinical development.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ORILISSA and ORIAHNN each compete with several FDA-approved products for the treatment of endometriosis, uterine fibroids, infertility and central precocious puberty. Additionally, there is also competition from surgical intervention, including hysterectomies and ablations. Separate from these options, there are many programs in clinical development which serve as potential future competition. Lastly, there are numerous medicines used to treat the symptoms of disease (vs. endometriosis or uterine fibroids directly) which may also serve as competition: oral contraceptives, NSAIDs and other pain medications, including opioids.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">For CAH, high doses of corticosteroids are the current standard of care to both correct the endogenous cortisol deficiency as well as reduce the excessive ACTH levels. In the United States alone, there are more than two dozen companies manufacturing steroid-based products. In addition, there are several programs in clinical development targeting CAH and several companies developing medicinal treatments for CAH.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our investigational treatments for potential use in epilepsy may in the future compete with numerous approved anti-seizure medications and development-stage programs being pursued by several other companies. Commonly used anti-seizure medications include phenytoin, levetiracetam, brivaracetam, cenobamate, carbamazepine, clobazam, lamotrigine, valproate, oxcarbazepine, topiramate, lacosamide, perampanel and cannabidiol, among others. There are currently no FDA-approved treatments specifically indicated for the early infantile epileptic encephalopathies SCN8A-DEE and EE-CSWS; however, a number of different anti-seizure medications are currently used in these patient populations.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our investigational treatments for potential use in schizophrenia and depression may in the future compete with several development-stage programs being pursued by other companies. Currently, there are no FDA-approved treatments specifically indicated for CIAS; however, there are a number of different anti-psychotic medications currently used in these patient populations.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our investigational treatments for potential use in neurology, neuroendocrinology and neuropsychiatry may in the future compete with numerous approved products and development-stage programs being pursued by several other companies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compared to us, many of our competitors and potential competitors have substantially greater:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capital resources;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales and marketing experience;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">research and development resources, including personnel and technology;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory experience;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preclinical study and clinical testing experience;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manufacturing, marketing and distribution experience; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, increased competition in certain disorders or therapies may make it more difficult for us to recruit or enroll patients in our clinical trials for similar disorders or therapies.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because the development of our product candidates is subject to a substantial degree of technological uncertainty, we may not succeed in developing any of our product candidates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only a small number of research and development programs ultimately result in commercially successful drugs. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential products that appear to be promising at early stages of development may not reach the market for a number of reasons. These reasons include the possibilities that the potential products may:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be found ineffective or cause harmful side effects during preclinical studies or clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fail to receive necessary regulatory approvals on a timely basis or at all;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be precluded from commercialization by proprietary rights of third parties;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be difficult to manufacture on a large scale; or</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be uneconomical to commercialize or fail to achieve market acceptance.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our product candidates encounters any of these potential problems, we may never successfully market that product candidate.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our clinical trials may be delayed for safety or other reasons or fail to demonstrate the safety and efficacy of our product candidates, which could prevent or significantly delay their regulatory approval.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining regulatory approval for the sale of any of our potential products, we must subject these product candidates to extensive preclinical and clinical testing to demonstrate their safety and efficacy for humans. Clinical trials are expensive, time-consuming and may take years to complete and the outcomes are uncertain.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the clinical trials of our product candidates, we face the risks that:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or similar foreign regulatory authority may not allow an IND or foreign equivalent filings required to initiate human clinical studies for our drug candidates or the FDA may require additional preclinical studies as a condition of the initiation of Phase I clinical studies, or additional clinical studies for progression from Phase&#160;I to Phase&#160;II, or Phase&#160;II to Phase&#160;III, or for NDA approval;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the product candidate may not prove to be effective or as effective as other competing product candidates;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may discover that a product candidate may cause harmful side effects or results of required toxicology or other studies may not be acceptable to the FDA;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical trial results may not replicate the results of previous trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA or similar foreign regulatory authorities may require use of new or experimental endpoints that may prove insensitive to treatment effects;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we or the FDA or similar foreign regulatory authorities may suspend the trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results may not be statistically significant;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical site initiation or patient recruitment and enrollment may be slower or more difficult than expected;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA may not accept the data from any trial or trial site outside of the United States;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patients may drop out of the trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unforeseen disruptions or delays may occur, caused by man-made or natural disasters or public health pandemics or epidemics or other business interruptions, including, for example, the COVID-19 pandemic; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory requirements may change.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These risks and uncertainties impact all of our clinical programs and any of the clinical, regulatory or operational events described above could change our planned clinical and regulatory activities. In addition, due to the impact of the COVID-19 pandemic, clinical site initiation and new patient enrollment has been negatively impacted. Additionally, any of these events described above could result in suspension of a program and/or obviate any filings for necessary regulatory approvals.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, late-stage clinical trials are often conducted with patients having the most advanced stages of disease. During the course of treatment, these patients can die or suffer other adverse medical effects for reasons that may not be related to the pharmaceutical agent being tested but which can nevertheless adversely affect clinical trial conduct, completion and results. Any failure or substantial delay in completing clinical trials for our product candidates may severely harm our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the clinical trials are successfully completed, we cannot guarantee that the FDA or foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our product candidates for approval. To the extent that the results of the trials are not satisfactory to the FDA or foreign regulatory authorities for support of a marketing application, approval of our product candidates may be significantly delayed, or we may be required to expend significant additional resources, which may not be available to us, to conduct additional trials in support of potential approval of our product candidates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our current collaborators for the development and commercialization of several of our products and product candidates and may need to enter into future collaborations to develop and commercialize certain of our product candidates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on our current collaborators for the development and commercialization of several of our products and product candidates and may need to enter into future collaborations to develop and commercialize certain of our product candidates. For example, we depend on AbbVie for the manufacture and commercialization of ORILISSA and ORIAHNN and for the continued development of elagolix. We collaborate with MTPC for the development and commercialization of valbenazine for movement disorders in Japan and other select Asian markets. We also rely on BIAL for the commercial supply of ONGENTYS. In addition, we collaborate with Xenon Pharmaceuticals, Inc. for the development of NBI-921352, Idorsia Pharmaceuticals Ltd for the development of NBI-827104, Takeda Pharmaceutical Company Limited for the development of luvadaxistat, NBI-1065845 and NBI-1065846 and Heptares Therapeutics Limited for the development of NBI-1117568.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future collaborations and licenses could subject us to a number of risks, including:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may sell, transfer or divest assets or programs related to our partnered product or product candidates; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to undertake the expenditure of substantial operational, financial and management resources; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to assume substantial actual or contingent liabilities; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to control the amount and timing of resources that our strategic collaborators devote to the development or commercialization of our products or product candidates; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may not be able to influence our strategic collaborator&#8217;s decisions regarding the development and collaboration of our partnered product and product candidates, and as a result, our collaboration partners may not pursue or prioritize the development and commercialization of those partnered products and product candidates in a manner that is in our best interest;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may select indications or design clinical trials in a way that may be less successful than if we were doing so; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not conduct collaborative activities in a timely manner, provide insufficient funding, terminate a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new version of a product candidate for clinical testing; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not pursue further development and commercialization of products resulting from the strategic collaboration arrangement or may elect to discontinue research and development programs; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disagreements or disputes may arise between us and our strategic collaborators that result in delays or in costly litigation or arbitration that diverts management&#8217;s attention and consumes resources; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may experience financial difficulties; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators may not properly maintain, enforce or defend our intellectual property rights or may use our proprietary information in a manner that could jeopardize or invalidate our proprietary information or expose us to potential litigation; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators could terminate the arrangement or allow it to expire, which would delay the development and commercialization and may increase the cost of developing and commercializing our products or product candidates; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic collaborators could develop, either alone or with others, products or product candidates that may compete with ours. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these issues arise, it may delay and/or negatively impact the development and commercialization of drug candidates and, ultimately, our generation of product revenues.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully commercialize ONGENTYS.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, we received FDA approval for ONGENTYS as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors in adult Parkinson&#8217;s disease patients, and in September 2020, we launched the commercial sale of ONGENTYS with our existing commercial infrastructure. The successful commercialization of ONGENTYS is subject to many risks, and there are numerous examples of unsuccessful product launches and failures, including by pharmaceutical companies with more experience and resources than us. If we are unable to effectively train our employees and equip them with effective materials, including medical and sales literature to help them inform and educate health care practitioners about the benefits of ONGENTYS and its proper administration, our commercialization of ONGENTYS may not be successful. Even if we are successful in effectively training and equipping our salesforce, there are many factors that could cause the commercialization of ONGENTYS to be unsuccessful, including a number of factors that are outside our control. Health care practitioners may not prescribe ONGENTYS and patients may be unwilling to use ONGENTYS if insurance coverage is not provided or reimbursement is inadequate. In addition, our ability to train our employees and effectively communicate with potential prescribers could be adversely affected by the effects of health pandemics or epidemics, including the ongoing COVID-19 pandemic.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of our approved products or those of our collaborators could be associated with side effects or adverse events.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with most pharmaceutical products, use of our approved products or those of our collaborators could be associated with side effects or adverse events which can vary in severity (from minor adverse reactions to death) and frequency (infrequent or prevalent). Side effects or adverse events associated with the use of our products or those of our collaborators may be observed at any time, including after a product is commercialized, and reports of any such side effects or adverse events may negatively impact demand for our or our collaborators&#8217; products or affect our or our collaborators&#8217; ability to maintain regulatory approval for such products. Side effects or other safety issues associated with the use of our approved products or those of our collaborators could require us or our collaborators to modify or halt commercialization of these products or expose us to product liability lawsuits which will harm our business. We or our collaborators may be required by regulatory agencies to conduct additional studies regarding the safety and efficacy of our products which we have not planned or anticipated. Furthermore, there can be no assurance that we or our collaborators will resolve any issues related to any product related adverse events to the satisfaction of the FDA or any regulatory agency in a timely manner or ever, which could harm our business, prospects and financial condition.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have recently increased the size of our organization and will need to continue to increase the size of our organization. We may encounter difficulties with managing our growth, which could adversely affect our results of operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had more than 900 full-time employees. Although we have substantially increased the size of our organization, we may need to add additional qualified personnel and resources, especially with the planned increase in the size of our salesforce. Our current infrastructure may be inadequate to support our development and commercialization efforts and expected growth. Future growth will impose significant added responsibilities on our organization, including the need to identify, recruit, maintain and integrate additional employees, and may take time away from running other aspects of our business, including development and commercialization of our product candidates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future financial performance and our ability to commercialize INGREZZA, ONGENTYS and any other product candidates that receive regulatory approval will depend, in part, on our ability to manage any future growth effectively. In particular, as we commercialize INGREZZA and ONGENTYS, we will need to support the training and ongoing activities of our salesforce and will likely need to continue to expand the size of our employee base for managerial, operational, financial and other resources. To that end, we must be able to successfully:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage our development efforts effectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">integrate additional management, administrative and manufacturing personnel;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further develop our marketing and sales organization; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compensate our employees on adequate terms in an increasingly competitive, inflationary market;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract and retain personnel; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain sufficient administrative, accounting and management information systems and controls.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to accomplish these tasks or successfully manage our operations and, accordingly, may not achieve our research, development and commercialization goals. Our failure to accomplish any of these goals could harm our financial results and prospects.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to retain and recruit qualified scientists and other employees or if any of our key senior executives discontinues his or her employment with us, it may delay our development efforts or impact our commercialization of INGREZZA, ONGENTYS or any product candidate approved by the FDA. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on the principal members of our management, commercial and scientific staff. The loss of any of these people could impede the achievement of our objectives, including the successful commercialization of INGREZZA, ONGENTYS or any product candidate approved by the FDA. Furthermore, recruiting and retaining qualified scientific personnel to perform research and development work in the future, along with personnel with experience marketing and selling pharmaceutical products, is critical to our success. We may be unable to attract and retain personnel on acceptable terms given effects of the COVID-19 pandemic, as well as the competition among biotechnology, pharmaceutical and health care companies, universities and non-profit research institutions for experienced scientists and individuals with experience marketing and selling pharmaceutical products. We may face </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">particular retention challenges in light of the recent rapid growth in our personnel and infrastructure and the perceived impact of those changes upon our corporate culture. In addition, we rely on a significant number of consultants to assist us in formulating our research and development strategy and our commercialization strategy. Our consultants may have commitments to, or advisory or consulting agreements with, other entities that may limit their availability to us.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently have no manufacturing capabilities. If third-party manufacturers of INGREZZA, ONGENTYS or any of our product candidates fail to devote sufficient time and resources to our concerns, or if their performance is substandard, our clinical trials and product introductions may be delayed, and our costs may rise.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past utilized, and intend to continue to utilize, third-party manufacturers to produce the drug compounds we use in our clinical trials and for the commercialization of our products. We have limited experience in manufacturing products for commercial purposes and do not currently have any manufacturing facilities. Establishing internal commercial manufacturing capabilities would require significant time and resources, and we may not be able to timely or successfully establish such capabilities. Consequently, we depend on, and will continue to depend on, several contract manufacturers for all production of products for development and commercial purposes, including INGREZZA and ONGENTYS. If we are unable to obtain or retain third-party manufacturers, we will not be able to develop or commercialize our products, including INGREZZA and ONGENTYS. The manufacture of our products for clinical trials and commercial purposes is subject to specific FDA regulations, including current Good Manufacturing Practice regulations. Our third-party manufacturers, including BIAL and its suppliers, might not comply with FDA regulations relating to manufacturing our products for clinical trials and commercial purposes or other regulatory requirements now or in the future. Our reliance on contract manufacturers also exposes us to the following risks:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contract manufacturers may encounter difficulties in achieving volume production, quality control or quality assurance, and also may experience shortages in qualified personnel. As a result, our contract manufacturers might not be able to meet our clinical schedules or adequately manufacture our products in commercial quantities when required;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">switching manufacturers may be difficult because the number of potential manufacturers is limited. It may be difficult or impossible for us to find a replacement manufacturer quickly on acceptable terms, or at all;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our contract manufacturers may not perform as agreed or may not remain in the contract manufacturing business for the time required to successfully produce, store or distribute our products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">drug manufacturers are subject to ongoing periodic unannounced inspection by the FDA, the United States Drug Enforcement Administration, and other agencies to ensure strict compliance with cGMP and other government regulations and corresponding foreign standards. We do not have control over third-party manufacturers&#8217; compliance with these regulations and standards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current dependence upon third parties for the manufacture of our products may reduce our profit margin, if any, on the sale of INGREZZA, ONGENTYS, or our future products and our ability to develop and deliver products on a timely and competitive basis.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We currently depend on a limited number of third-party suppliers. The loss of these suppliers, or delays or problems in the supply of INGREZZA or ONGENTYS, could materially and adversely affect our ability to successfully commercialize INGREZZA or ONGENTYS.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacture of pharmaceutical products requires significant expertise and capital investment, including the development of process controls required to consistently produce the active pharmaceutical ingredients, or API, the finished drug product and packaging in sufficient quantities while meeting detailed product specifications on a repeated basis. Manufacturers of pharmaceutical products may encounter difficulties in production, such as difficulties with production costs and yields, process controls, quality control and quality assurance, including testing of stability, impurities and impurity levels and other product specifications by validated test methods, compliance with strictly enforced United States, state and non-United States regulations, and disruptions or delays caused by man-made or natural disasters, pandemics or epidemics, or other business interruptions, including, for example, the COVID-19 pandemic. We depend on a limited number of suppliers for the production and packaging of INGREZZA and its API. If our third-party suppliers for INGREZZA encounter these or any other manufacturing, quality or compliance difficulties, we may be unable to meet commercial demand for INGREZZA, which could </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materially and adversely affect our ability to successfully commercialize INGREZZA. In addition, under the terms of our agreement with BIAL, although we are responsible for the management of all ONGENTYS commercialization activities, we rely on BIAL and its suppliers to supply all drug product for the commercialization of ONGENTYS. BIAL relies on third-party contract manufacturers to produce ONGENTYS. These contract manufacturers may encounter difficulties in achieving volume production, quality control, or quality assurance. As a result, these contract manufacturers may not be able to adequately produce ONGENTYS in commercial quantities when required, which may impact our ability to deliver ONGENTYS on a timely basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if our suppliers fail or refuse to supply us with INGREZZA or its API for any reason, it would take a significant amount of time and expense to qualify a new supplier. The FDA and similar international regulatory bodies must approve manufacturers of the active and inactive pharmaceutical ingredients and certain packaging materials used in pharmaceutical products. The loss of a supplier could require us to obtain regulatory clearance and to incur validation and other costs associated with the transfer of the API or product manufacturing processes. If there are delays in qualifying new suppliers or facilities or if a new supplier is unable to meet FDA or a similar international regulatory body&#8217;s requirements for approval, there could be a shortage of INGREZZA, which could materially and adversely affect our ability to successfully commercialize INGREZZA. If BIAL is unable or refuses to supply us with ONGENTYS drug product for any reason, or does not meet FDA or international regulators&#8217; requirements for approval, we have limited opportunity to qualify a new supplier. This could materially and adversely affect our ability to successfully commercialize ONGENTYS.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The independent clinical investigators and contract research organizations that we rely upon to conduct our clinical trials may not be diligent, careful or timely, and may make mistakes, in the conduct of our trials.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on independent clinical investigators and CROs to conduct our clinical trials under their agreements with us. The investigators are not our employees, and we cannot control the amount or timing of resources that they devote to our programs. If our independent investigators fail to devote sufficient time and resources to our drug development programs, or if their performance is substandard, or not in compliance with Good Clinical Practices, it may delay or prevent the approval of our regulatory applications and our introduction of new treatments. The CROs we contract with for execution of our clinical trials play a significant role in the conduct of the trials and the subsequent collection and analysis of data. Failure of the CROs to meet their obligations could adversely affect clinical development of our products. Moreover, these independent investigators and CROs may also have relationships with other commercial entities, some of which may compete with us. If independent investigators and CROs assist our competitors at our expense, it could harm our competitive position.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not and will not have access to all information regarding the products and product candidates we licensed to AbbVie.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not and will not have access to all information regarding elagolix, including potentially material information about commercialization plans, medical information strategies, clinical trial design and execution, safety reports from clinical trials, safety reports, regulatory affairs, process development, manufacturing and other areas known by AbbVie. In addition, we have confidentiality obligations under our agreement with AbbVie. Thus, our ability to keep our shareholders informed about the status of elagolix will be limited by the degree to which AbbVie keeps us informed and allows us to disclose such information to the public. If AbbVie fails to keep us informed about commercialization efforts related to elagolix, or the status of the clinical development or regulatory approval pathway of other product candidates licensed to it, we may make operational and/or investment decisions that we would not have made had we been fully informed, which may materially and adversely affect our business and operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to ongoing obligations and continued regulatory review for INGREZZA. Additionally, our other product candidates, if approved, could be subject to labeling and other post-marketing requirements and restrictions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory approvals for any of our product candidates may be subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase IV clinical trials, and surveillance to monitor the safety and efficacy of the product candidate. For example, with respect to the FDA&#8217;s approval of INGREZZA for tardive dyskinesia in April 2017, we are subject to certain post-marketing requirements and commitments. In addition, with respect to INGREZZA, and any product candidate that the FDA or a comparable foreign regulatory authority approves, the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, advertising, promotion and recordkeeping for the product will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with current Good Clinical Practices for any clinical trials that we conduct post-approval. Failure to comply with these ongoing regulatory requirements, or later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with our third-party manufacturers or manufacturing processes, may result in, among other things:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on the marketing or manufacturing of the product, changes in the product&#8217;s label, withdrawal of the product from the market, or voluntary or mandatory product recalls;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fines, warning or untitled letters or holds on clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us, or suspension or revocation of product license approvals;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse inspection findings or other activities that temporarily delay manufacture and distribution of our products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product seizure or detention, or refusal to permit the import or export of products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">product injunctions or the imposition of civil or criminal penalties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The occurrence of any of these events may adversely affect our business, prospects and ability to achieve or sustain profitability on a sustained basis.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If the market opportunities for our products and product candidates are smaller than we believe they are, our expected revenues may be adversely affected, and our business may suffer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the diseases that INGREZZA, ONGENTYS and our other product candidates are being developed to address are in underserved and underdiagnosed populations. Our projections of both the number of people who have these diseases, as well as the subset of people with these diseases who will seek treatment utilizing our products or product candidates, may not be accurate. If our estimates of the prevalence or number of patients potentially on therapy prove to be inaccurate, the market opportunities for INGREZZA, ONGENTYS and our other product candidates may be smaller than we believe they are, our prospects for generating expected revenue may be adversely affected and our business may suffer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We license some of our core technologies and drug candidates from third parties. If we default on any of our obligations under those licenses, or violate the terms of these licenses, we could lose our rights to those technologies and drug candidates or be forced to pay damages.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on licenses from third parties for some of our key technologies. These licenses typically subject us to various commercialization, reporting and other obligations. If we fail to comply with these obligations, we could lose important rights. If we were to default on our obligations under any of our licenses, we could lose some or all of our rights to develop, market and sell products covered by these licenses. For example, BIAL may terminate our license agreement, pursuant to which we have rights to commercialize ONGENTYS, if we fail to use commercially reasonable efforts to comply with specified obligations under the license agreement, or if we otherwise breach the license agreement. In addition, several of our collaboration and license agreements allow our licensors to terminate such agreements if we challenge the validity or enforceability of certain intellectual property rights or if we commit a material breach in whole or in part of the agreement and do not cure such breach within the agreed upon cure period. In addition, if we were to violate any of the terms of our licenses, we could become subject to damages. Likewise, if we were to lose our rights under a license to use proprietary research tools, it could adversely affect our existing collaborations or adversely affect our ability to form new collaborations. We also face the risk that our licensors could, for a number of reasons, lose patent protection or lose their rights to the technologies we have licensed, thereby impairing or extinguishing our rights under our licenses with them.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the 2024 Notes, if triggered, may adversely affect our financial condition, operating results, or liquidity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes, is triggered, holders of 2024 Notes will be entitled to convert their 2024 Notes at any time during specified periods at their option. If one or more of the holders of the 2024 Notes elects to convert their notes, unless we satisfy </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our conversion obligation by delivering only shares of our common stock with respect to any conversion premium, we would be required to settle all or a portion of our conversion obligation through the payment of cash, which could adversely affect our liquidity. The conditional convertibility of the 2024 Notes will be monitored at each quarterly reporting date and analyzed dependent upon market prices of our common stock during the prescribed measurement periods. In the event that we have the election to redeem the 2024 Notes or the holders of the 2024 Notes have the election to convert the 2024 Notes at any time during the prescribed measurement period, the 2024 Notes would then be considered a current obligation and classified as such. We are not aware of any events or market conditions that would allow us to redeem the 2024 Notes or the holders of the 2024 Notes to convert the 2024 Notes for the quarterly period ended December&#160;31, 2021, or as of the date of this report.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our indebtedness and liabilities could limit the cash flow available for our operations, expose us to risks that could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we sold $517.5&#160;million aggregate principal amount of the 2024 Notes. In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $136.2&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $186.9&#160;million in cash. As of December&#160;31, 2021, $381.2 million aggregate principal amount of the 2024 Notes remained outstanding. We may also incur additional indebtedness to meet future financing needs. Our indebtedness could have significant negative consequences for our security holders and our business, results of operations and financial condition by, among other things:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing our vulnerability to adverse economic and industry conditions;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our ability to obtain additional financing;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requiring the dedication of a substantial portion of our cash flow from operations to service our indebtedness, which will reduce the amount of cash available for other purposes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting our flexibility to plan for, or react to, changes in our business;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diluting the interests of our existing stockholders as a result of issuing shares of our common stock upon conversion of the 2024 Notes; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">placing us at a possible competitive disadvantage with competitors that are less leveraged than us or have better access to capital.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business may not generate sufficient funds, and we may otherwise be unable to maintain sufficient cash reserves, to pay amounts due under the 2024 Notes and any additional indebtedness that we may incur. In addition, our cash needs may increase in the future. In addition, any future indebtedness that we may incur may contain financial and other restrictive covenants that limit our ability to operate our business, raise capital or make payments under our other indebtedness. If we fail to comply with these covenants or to make payments under our indebtedness when due, then we would be in default under that indebtedness, which could, in turn, result in that and our other indebtedness becoming immediately payable in full.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a history of losses and expect to increase our expenses for the foreseeable future, and we may not be able to sustain profitability.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred significant net losses and negative cash flow from operations. As of December&#160;31, 2021, we had an accumulated deficit of $0.6 billion as a result of historical operating losses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received FDA approval for INGREZZA for tardive dyskinesia in April 2017 and for ONGENTYS for Parkinson&#8217;s disease in April 2020. Our partner AbbVie received FDA approval for ORILISSA for endometriosis in July 2018 and for ORIAHNN for uterine fibroids in May 2020. However, we have not yet obtained regulatory approvals for any other product candidates. Even if we continue to succeed in commercializing INGREZZA, or if we successfully commercialize ONGENTYS or are successful in developing and commercializing any of our other product candidates, we may not be able to sustain profitability. We also expect to continue to incur significant operating and capital expenditures as we:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commercialize INGREZZA for tardive dyskinesia;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commercialize ONGENTYS for Parkinson&#8217;s disease;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seek regulatory approvals for our product candidates or for additional indications for our current products;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">develop, formulate, manufacture and commercialize our product candidates;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">in-license or acquire new product development opportunities;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement additional internal systems and infrastructure; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire additional clinical, scientific, sales and marketing personnel.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to increase our expenses and other investments in the coming years as we fund our operations, in-licensing or acquisition opportunities, and capital expenditures. While we were profitable for the year ended December&#160;31, 2021, our future operating results and profitability may fluctuate from period to period due to the factors described above, and we will need to generate significant revenues to achieve and maintain profitability and positive cash flow on a sustained basis. We may not be able to generate these revenues, and we may never achieve profitability on a sustained basis in the future. Our failure to maintain or increase profitability on a sustained basis could negatively impact the market price of our common stock.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims that we or our employees have wrongfully used or disclosed alleged trade secrets of their former employers.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As is commonplace in the biotechnology industry, we employ individuals who were previously employed at other biotechnology or pharmaceutical companies, including our competitors or potential competitors. Although no claims against us are currently pending, we may be subject to claims that these employees or we have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because our operating results may vary significantly in future periods, our stock price may decline.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our quarterly revenues, expenses and operating results have fluctuated in the past and are likely to fluctuate significantly in the future. Our financial results are unpredictable and may fluctuate, for among other reasons, due to seasonality and timing of customer purchases and commercial sales of INGREZZA, impact of the commercial launch of ONGENTYS and ORIAHNN, royalties from out-licensed products, the impact of Medicare Part D coverage, our achievement of product development objectives and milestones, clinical trial enrollment and expenses, research and development expenses and the timing and nature of contract manufacturing, contract research payments, fluctuations in our effective tax rate, and disruptions caused by man-made or natural disasters or public health pandemics or epidemics or other business interruptions, including, for example, the COVID-19 pandemic. A high portion of our costs are predetermined on an annual basis, due in part to our significant research and development costs. Thus, small declines in revenue could disproportionately affect financial results in a quarter. While we were profitable for the year ended December&#160;31, 2021, our future operating results and profitability may fluctuate from period to period, and even if we become profitable on a quarterly or annual basis, we may not be able to sustain or increase our profitability. Moreover, as our company and our market capitalization have grown, our financial performance has become increasingly subject to quarterly and annual comparisons with the expectations of securities analysts or investors. The failure of our financial results to meet these expectations, either in a single quarterly or annual period over a sustained period time, could cause our stock price to decline.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flows, financial condition or results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New income, sales, use or other tax laws, statutes, rules, regulations or ordinances could be enacted at any time, which could adversely affect our business and financial condition. Further, existing tax laws, statutes, rules, regulations or ordinances could be interpreted, changed, modified or applied adversely to us. For example, the Biden administration and Congress have proposed various United States federal tax law changes which, if enacted, could have a material impact on our business, cash flows, financial condition, or results of operations. In addition, it is uncertain if and to what extent various states will conform to federal tax laws. Future tax reform legislation could have a material impact on the value of our deferred tax assets, could result in significant one-time charges, and could increase our future United States tax expense.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net operating loss, or NOL, carryforwards generated in tax years beginning on or prior to December 31, 2017, are only permitted to be carried forward for 20 years under applicable US tax law. Under current law, our federal NOLs generated in tax years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such federal NOLs in tax years beginning after December 31, 2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to federal tax laws. In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and corresponding provisions of state law, if a corporation undergoes an &#8220;ownership change,&#8221; which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation&#8217;s ability to use its pre-change NOL carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. We do not believe we have experienced any previous ownership changes, but the determination is complex and there can be no assurance we are correct. Furthermore, we may experience ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, our pre-2018 NOL carryforwards may expire prior to being used and our NOL carryforwards generated in tax years beginning after December 31, 2017, will be subject to a percentage limitation and, if we undergo an ownership change (or if we previously underwent such an ownership change), our ability to use all of our pre-change NOLs and other pre-change tax attributes (such as research tax credits) to offset our post-change income or taxes may be limited. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. In addition, at the state level, there may be periods during which the use of NOLs is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. As a result, we may be unable to use all or a material portion of our NOLs and other tax attributes, which could adversely affect our future cash flows.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our effective tax rate may fluctuate, and we may incur obligations in tax jurisdictions in excess of accrued amounts.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate is derived from a combination of applicable tax rates in the various places that we operate. In preparing our financial statements, we estimate the amount of tax that will become payable in each of such places. Nevertheless, our effective tax rate may be different than experienced in the past due to numerous factors, including changes in the mix of our profitability from state to state, the results of examinations and audits of our tax filings, our inability to secure or sustain acceptable agreements with tax authorities, changes in accounting for income taxes and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations and may result in tax obligations in excess of amounts accrued in our financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, on December 31, 2020, we determined, based on our facts and circumstances, that it was more likely than not that a substantial portion of our deferred tax assets would be realized and, as a result, substantially all of our valuation allowance against our deferred tax assets was released. Therefore, beginning in 2021, we commenced recording income tax expense at an estimated tax rate that will likely approximate statutory tax rates, which could result in a significant reduction in our net income and net income per share.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The price of our common stock is volatile.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market prices for securities of biotechnology and pharmaceutical companies historically have been highly volatile, and the market for these securities has from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. The COVID-19 pandemic, for example, has negatively affected the stock market and investor sentiment and has resulted in significant volatility. Furthermore, especially as we and our market capitalization have grown, the price of our common stock has been increasingly affected by quarterly and annual comparisons with the valuations and recommendations of the analysts who cover our business. If our results do not meet these analysts&#8217; forecasts, the expectations of our investors or the financial guidance we provide to investors in any period, which is based on assumptions that may be incorrect or that may change from quarter to quarter, the market price of our common stock could decline. Over the course of the last twelve months, the price of our common stock has ranged from approximately $72 per share to approximately $120 per share. The market price of our common stock may fluctuate in response to many factors, including:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of INGREZZA and our other products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the status and cost of our post-marketing commitments for INGREZZA;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the results of our clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reports of safety issues related to INGREZZA, ONGENTYS, ORILISSA, or ORIAHNN;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments concerning new and existing collaboration agreements;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements of technological innovations or new therapeutic products by us or others;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and market conditions, including economic and market conditions affecting the biotechnology industry;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments in patent or other proprietary rights;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments related to the FDA and foreign regulatory agencies;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future sales of our common stock by us or our stockholders;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comments by securities analysts;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions or departures of key personnel;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in our operating results;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential litigation matters and developments in existing litigation matters, such as the ANDA litigation matters;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government regulation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government and third-party payor coverage and reimbursement;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of any of our product candidates, if approved, to achieve commercial success;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions caused by man-made or natural disasters, pandemics or epidemics or other business interruptions, including, for example, the COVID-19 pandemic; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">public concern as to the safety of our drugs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are a member of the S&amp;P MidCap 400 index. If we cease to be represented in the S&amp;P MidCap 400 index, or other indexes or indexed products, as a result of our market capitalization falling below the threshold for inclusion in the index, certain institutional shareholders may, due to their internal policies and investment guidelines, be required to sell their shareholdings. Such sales may result in further negative pressure on our stock price and, when combined with reduced trading volume and liquidity, could adversely affect the value of your investment and your ability to sell your shares.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our customers are concentrated and therefore the loss of a significant customer may harm our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements for the distribution of INGREZZA with a limited number of specialty pharmacy providers and distributors, and all of our product sales of INGREZZA are to these customers. Two of these customers represented approximately 82% of our total product revenue for 2021 and a significant majority of our accounts receivable balance as of December&#160;31, 2021. If any of these significant customers becomes subject to bankruptcy, is unable to pay us for our products or is acquired by a company that wants to terminate the relationship with us, or if we otherwise lose any of these significant customers, our revenue, results of operations and cash flows would be adversely affected. Even if we replace the loss of a significant customer, we cannot predict with certainty that such transition would not result in a decline in our revenue, results of operations and cash flows.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot raise additional funding, we may be unable to complete development of our product candidates or establish commercial and manufacturing capabilities in the future.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may require additional funding to continue our research and development programs, to conduct preclinical studies and clinical trials, for operating expenses, to pursue regulatory approvals for our product candidates, for the costs involved in filing and prosecuting patent applications and enforcing or defending patent claims, if any, and the cost of product in-licensing and any possible acquisitions. In addition, we may require additional funding to establish manufacturing and marketing capabilities in the future. We believe that our existing capital resources, together with investment income and future payments due under our strategic alliances, will be sufficient to satisfy our current and projected funding requirements for at least the next twelve months. However, these resources might be insufficient to conduct research and development programs, the cost of product in-taking and possible </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">acquisitions, fully commercialize products and operate the company to the full extent currently planned. If we cannot obtain adequate funds, we may be required to curtail significantly our commercial plans or one or more of our research and development programs or obtain funds through additional arrangements with corporate collaborators or others that may require us to relinquish rights to some of our technologies or product candidates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercial success of INGREZZA, ONGENTYS, ORILISSA and/or ORIAHNN;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">debt services obligations on the 2024 Notes;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued scientific progress in our R&amp;D and clinical development programs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the magnitude and complexity of our research and development programs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">progress with preclinical testing and clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and costs involved in obtaining regulatory approvals;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost involved in filing and pursuing patent applications, enforcing patent claims, or engaging in interference proceedings or other patent litigation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competing technological and market developments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments related to any future litigation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of commercialization activities and arrangements, including advertising campaigns;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of manufacturing our product candidates; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic on our business; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of any strategic alliances, collaborations, product in-licensing, or acquisitions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek additional funding through strategic alliances and may seek additional funding through public or private sales of our securities, including equity securities. In addition, during the second quarter of 2017, we issued the 2024 Notes and we have previously financed capital purchases and may continue to pursue opportunities to obtain additional debt financing in the future. In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $136.2&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $186.9&#160;million in cash. As of December&#160;31, 2021, $381.2 million aggregate principal amount of the 2024 Notes remained outstanding. Additional equity or debt financing might not be available on reasonable terms, if at all. In addition, disruptions due to the COVID-19 pandemic could make it more difficult for us to access capital. Any additional equity financings will be dilutive to our stockholders and any additional debt financings may involve operating covenants that restrict our business.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with changing regulation of corporate governance and public disclosure may result in additional expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changing laws, regulations and standards relating to corporate governance and public disclosure, including the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and Nasdaq rules, are creating uncertainty for companies such as ours. These laws, regulations and standards are subject to varying interpretations in some cases due to their lack of specificity, and as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies, which could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We are committed to maintaining high standards of corporate governance and public disclosure. As a result, our efforts to comply with evolving laws, regulations and standards have resulted in, and are likely to continue to result in, increased selling, general and administrative expenses and management time related to compliance activities. If we fail to comply with these laws, regulations and standards, our reputation may be harmed and we might be subject to sanctions or investigation by regulatory authorities, such as the SEC. Any such action could adversely affect our financial results and the market price of our common stock.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing use of social media could give rise to liability and result in harm to our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our employees are increasingly utilizing social media tools and our website as a means of communication. Despite our efforts to monitor social media communications, there is risk that the unauthorized use of social media by our employees to communicate about our products or business, or any inadvertent disclosure of material, nonpublic information through these means, may result in violations of applicable laws and regulations, which may give rise to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">liability and result in harm to our business. In addition, there is also risk of inappropriate disclosure of sensitive information, which could result in significant legal and financial exposure and reputational damages that could potentially have a material adverse impact on our business, financial condition and results of operations. Furthermore, negative posts or comments about us or our products on social media could seriously damage our reputation, brand image and goodwill.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Industry</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect our intellectual property, our competitors could develop and market products based on our discoveries, which may reduce demand for our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success will depend on our ability to, among other things:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain patent protection for our products;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">preserve our trade secrets;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prevent third parties from infringing upon our proprietary rights; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">operate without infringing upon the proprietary rights of others, both in the United States and internationally.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the substantial length of time and expense associated with bringing new products through the development and regulatory approval processes in order to reach the marketplace, the pharmaceutical industry places considerable importance on obtaining patent and trade secret protection for new technologies, products and processes. Accordingly, we intend to seek patent protection for our proprietary technology and compounds. However, we face the risk that we may not obtain any of these patents and that the breadth of claims we obtain, if any, may not provide adequate protection of our proprietary technology or compounds.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely upon unpatented trade secrets and improvements, unpatented know-how and continuing technological innovation to develop and maintain our competitive position, which we seek to protect, in part, through confidentiality agreements with our commercial collaborators, employees and consultants. We also have invention or patent assignment agreements with our employees and some, but not all, of our commercial collaborators and consultants. However, if our employees, commercial collaborators or consultants breach these agreements, we may not have adequate remedies for any such breach, and our trade secrets may otherwise become known or independently discovered by our competitors.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although we own a number of patents, the issuance of a patent is not conclusive as to its validity or enforceability, and third parties may challenge the validity or enforceability of our patents. We cannot assure you how much protection, if any, will be given to our patents if we attempt to enforce them and they are challenged in court or in other proceedings. It is possible that a competitor may successfully challenge our patents or that challenges will result in limitations of their coverage. Moreover, competitors may infringe our patents or successfully avoid them through design innovation. In addition, potential competitors have in the past and may in the future file an ANDA with the FDA seeking approval to market a generic version of our products, or our competitors&#8217; products, before the expiration of the patents covering our products or our competitors&#8217; products, as applicable. To prevent infringement or unauthorized use, we have in the past and may in the future need to file infringement claims, which are expensive and time-consuming. For example, we are currently engaged in various intellectual property litigation matters against potential competitors related to INGREZZA. Refer to Item 3. Legal Proceedings f</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or a more detailed description of these matters.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, in an infringement proceeding a court may decide that a patent of ours or a patent of a competitor is not valid or is unenforceable or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover its technology. Interference proceedings declared by the United States Patent and Trademark Office may be necessary to determine the priority of inventions with respect to our patent applications (or those of our licensors) or a patent of a competitor. Litigation or interference proceedings may fail and, even if successful, may result in substantial costs and be a distraction to management. Litigation or interference proceedings, including proceedings of a competitor, may also result in a competitor entering the marketplace faster than expected. We cannot assure you that we will be able to prevent misappropriation of our proprietary rights, particularly in countries where the laws may not protect such rights as fully as in the United States.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care reform measures and other recent legislative initiatives could adversely affect our business.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The business and financial condition of pharmaceutical and biotechnology companies are affected by the efforts of governmental and third-party payors to contain or reduce the costs of health care and to lower drug prices. In the United States, comprehensive health care reform legislation has been enacted by the Federal government and we expect that there will continue to be a number of federal and state proposals to implement government control over the pricing of prescription pharmaceuticals. In addition, increasing emphasis on reducing the cost of health care in the United States will continue to put pressure on the pricing and reimbursement of prescription pharmaceuticals. Moreover, in some foreign jurisdictions, pricing of prescription pharmaceuticals is already subject to government control. Additionally, other federal and state legislation impose obligations on manufacturers of pharmaceutical products, among others, related to product tracking and tracing. Among the requirements of this legislation, manufacturers are required to provide certain information regarding the drug product provided to individuals and entities to which product ownership is transferred, label drug product with a product identifier, and keep certain records regarding distribution of the drug product. Further, under this legislation, manufacturers will have drug product investigation, quarantine, disposition, notification and purchaser license verification responsibilities related to counterfeit, diverted, stolen and intentionally adulterated products, as well as products that are the subject of fraudulent transactions or which are otherwise unfit for distribution such that they would be reasonably likely to result in serious health consequences or death.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or collectively the ACA, was signed into law, which was intended to broaden access to health insurance, reduce or constrain the growth of healthcare spending, enhance remedies against fraud and abuse, add transparency requirements for the healthcare and health insurance industries, impose taxes and fees on the health industry and impose additional health policy reforms. Among the provisions of the ACA of importance to our drug products and potential drug candidates are:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an annual, nondeductible fee on any entity that manufactures, or imports, specified branded prescription drugs and biologic agents, apportioned among these entities according to their market share in certain government healthcare programs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to 23.1% and 13.0% of the average manufacturer price for branded and generic drugs, respectively;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">extension of a manufacturer&#8217;s Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to certain individuals with income at or below 133% of the federal poverty level, thereby potentially increasing a manufacturer&#8217;s Medicaid rebate liability;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new Medicare Part&#160;D coverage gap discount program, in which manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for a manufacturer&#8217;s outpatient drugs to be covered under Medicare Part&#160;D;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expansion of the entities eligible for discounts under the Public Health Service pharmaceutical pricing program; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been executive legal and political challenges to certain aspects of the ACA. For example, on June 17, 2021 the United States Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#8220;individual mandate&#8221; was repealed by Congress. Thus, the ACA will remain in effect in its current form.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, prior to the United States Supreme Court ruling, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace, which began February 15, 2021 and remained open through August 15, 2021. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject to judicial or Congressional challenges in the future. It is unclear how any such challenges and the healthcare reform measures of the Biden administration will impact the ACA.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legislative changes have been proposed and adopted since the ACA was enacted. These changes include aggregate reductions to Medicare payments to providers of up to 2%&#160;per fiscal year pursuant to the Budget Control Act of 2011, which began in 2013 and, due to subsequent legislative amendments to the statute, including the Infrastructure Investment and Jobs Act, will remain in effect through 2031, except for a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic, unless additional Congressional action is taken. Under current legislation, the actual reduction in Medicare payments will vary from 1% in 2022 to up to 3% in the final fiscal year of this sequestration. The American Taxpayer Relief Act of 2012, among other things, further reduced Medicare payments to several providers, including hospitals and cancer treatment centers, increased the statute of limitations period for the government to recover overpayments to providers from 3 to 5 years.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional changes that may affect our business include the expansion of new programs such as Medicare payment for performance initiatives for physicians under the Medicare Access and CHIP Reauthorization Act of 2015, which ended the use of the statutory formula, also referred to as the Sustainable Growth Rate, for clinician payment and established a quality payment incentive program, also referred to as the Quality Payment Program. This program provides clinicians with two ways to participate, including through the Advanced Alternative Payment Models, or APMs, and the Merit-based Incentive Payment System, or MIPS. In November 2019, the Centers for Medicare &amp; Medicaid Services, or CMS, issued a final rule finalizing the changes to the Quality Payment Program. At this time, it remains unclear how the introduction of the Quality Payment Program will impact overall physician reimbursement.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, there has been heightened governmental scrutiny recently over pharmaceutical pricing practices in light of the rising cost of prescription drugs and biologics. Such scrutiny has resulted in several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for products. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that attempted to implement several of the administration&#8217;s proposals. As a result, the FDA concurrently released a final rule and guidance in September 2020 providing pathways for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, the United States Department of Health and Human Services, or HHS, finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed by the Biden administration until January 1, 2023. On November 20, 2020, CMS issued an interim final rule implementing President Trump&#8217;s Most Favored Nation executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries. As a result of litigation challenging the Most Favored Nation model, on December 27, 2021, CMS published a final rule that rescinds the Most Favored Nation interim final rule. In July 2021, the Biden administration released an executive order, &#8220;Promoting Competition in the American Economy,&#8221; with multiple provisions aimed at prescription drugs. In response to Biden&#8217;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue to advance these principles. No legislation or administrative actions have been finalized to implement these principles. In addition, Congress is considering drug pricing as part of other </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reform measures. It is unclear whether these or similar policy initiatives will be implemented in the future. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the ACA, as well as other healthcare reform measures that may be adopted in the future, may result in more rigorous coverage criteria and lower reimbursement, and in additional downward pressure on the price that we receive for any approved product. In particular, it is possible that additional governmental action is taken in response to the COVID-19 pandemic. Any reduction in reimbursement from Medicare or other government-funded programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain sustained profitability or commercialize our drugs, particularly since the majority of our current revenue is derived from federal healthcare programs, including Medicare and Medicaid.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently unable to predict what additional legislation or regulation, if any, relating to the health care industry may be enacted in the future or what effect recently enacted federal legislation or any such additional legislation or regulation would have on our business. The pendency or approval of such proposals or reforms could result in a decrease in our stock price or limit our ability to raise capital or to enter into collaboration agreements for the further development and commercialization of our programs and products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any relationships with healthcare professionals, principal investigators, consultants, customers (actual and potential) and third-party payors in connection with our current and future business activities are and will continue to be subject, directly or indirectly, to federal and state healthcare laws. If we are unable to comply, or have not fully complied, with such laws, we could&#160;face penalties, contractual damages, reputational harm, diminished profits and future earnings and curtailment or restructuring of our operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business operations and activities may be directly, or indirectly, subject to various federal and state healthcare laws, including without limitation, fraud and abuse laws, false claims laws, data privacy and security laws, as well as transparency laws regarding payments or other items of value provided to healthcare providers. These laws may restrict or prohibit a wide range of business activities, including, but not limited to, research, manufacturing, distribution, pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. These laws may impact, among other things, our current activities with principal investigators and research subjects, as well as current and future sales, marketing, patient co-payment assistance and education programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such laws include:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute which prohibits, among other things, persons and entities from knowingly and willfully soliciting, offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, order or recommendation of, any good or service, for which payment may be made under a federal healthcare program such as Medicare and Medicaid;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims laws, including the federal civil False Claims Act, and Civil Monetary Penalties Laws, which impose criminal and civil penalties against individuals or entities for, among other things, knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Health Insurance Portability and Accountability Act, or HIPAA, which imposes criminal and civil liability for, among other things, executing a scheme to defraud any healthcare benefit program or making false statements relating to healthcare matters;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, and its implementing regulations, which also imposes obligations, including mandatory contractual terms, on covered entities, including certain healthcare providers, health plans and healthcare clearinghouses, as well as their business associates and their covered subcontractors, with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#8217;s Health Insurance Program, with specific exceptions, to report annually to CMS information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physician assistants and nurse practitioners) and teaching hospitals, and applicable manufacturers and applicable group purchasing organizations to report annually to CMS ownership and investment interests held by physicians and their immediate family members; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">analogous state, local and foreign laws and regulations, such as state anti-kickback and false claims laws, which may apply to sales or marketing arrangements and claims involving healthcare items or services reimbursed by non-governmental third party payors, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#8217;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government; state laws that require drug manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures or drug pricing; state laws that require disclosure of price increases above certain identified thresholds as well as of new commercial launches in the state; state and local laws that require the registration of pharmaceutical sales representatives; state and local &#8220;drug take back&#8221; laws and regulations; and state and foreign laws governing the privacy and security of health information in some circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. While our interactions with healthcare professionals, including our speaker programs and other arrangements, such as our contributions to patient assistance programs, have been structured to comply with these laws and related guidance, it is possible that governmental and enforcement authorities will conclude that our business practices may not comply with current or future statutes, regulations or case law interpreting applicable fraud and abuse or other healthcare laws. If our operations or activities are found to be in violation of any of the laws described above or any other governmental regulations that apply to us, we may be subject to, without limitation, significant civil, criminal and administrative penalties, damages, monetary fines, disgorgement, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, additional reporting requirements and oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, contractual damages, reputational harm, diminished profits and future earnings and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any sales of our product once commercialized outside the United States will also likely subject us to foreign equivalents of the healthcare laws mentioned above, among other foreign laws.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could face liability if a regulatory authority determines that we are promoting INGREZZA, ONGENTYS or any of our product candidates that receives regulatory approval, for &#8220;off-label&#8221; uses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company may not promote &#8220;off-label&#8221; uses for its drug products. An off-label use is the use of a product for an indication that is not described in the product&#8217;s FDA-approved label in the United States or for uses in other jurisdictions that differ from those approved by the applicable regulatory agencies. Physicians, on the other hand, may prescribe products for off-label uses. Although the FDA and other regulatory agencies do not regulate a physician&#8217;s choice of drug treatment made in the physician&#8217;s independent medical judgment, they do restrict promotional communications from companies or their salesforce with respect to off-label uses of products for which marketing clearance has not been issued. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#8217;s FDA approved labeling. A company that is found to have promoted off-label use of its product may be subject to significant liability, including civil and criminal sanctions. We intend to comply with the requirements and restrictions of the FDA and other regulatory agencies with respect to our promotion of our products, including INGREZZA and ONGENTYS, but we cannot be sure that the FDA or other regulatory agencies will agree that we have not violated their restrictions. As a result, we may be subject to criminal and civil liability. In addition, our management&#8217;s attention could be diverted to handle any such alleged violations. If the FDA or any other governmental agency initiates an enforcement action against us, or if we are the subject of a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> suit brought by a private plaintiff on behalf of the government, and it is determined that we violated prohibitions relating to the promotion of products for unapproved uses, we could be subject to substantial civil or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">criminal fines or damage awards and other sanctions such as consent decrees and corporate integrity agreements pursuant to which our activities would be subject to ongoing scrutiny and monitoring to ensure compliance with applicable laws and regulations. Any such fines, awards or other sanctions would have an adverse effect on our revenue, business, financial prospects and reputation.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our information technology systems or data is or were compromised, we could experience adverse impacts resulting from such compromise, including, but not limited to, interruptions to our operations such as our clinical trials, claims that we breached our data protection obligations, harm to our reputation, and a loss of customers or sales.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are increasingly dependent on information technology systems and infrastructure, including mobile technologies, to operate our business. In the ordinary course of our business, we collect, use, safeguard, share, transfer and otherwise process confidential and sensitive electronic information on our networks and in our data centers. This information includes, among other things, our intellectual property and proprietary information, the confidential information of our collaborators and licensees, and the personally identifiable information of our employees. It is important to our operations and business strategy that this electronic information remains secure and is perceived to be secure. The size and complexity of our information technology systems, and those of third-party vendors with whom we contract, and the volume of data we retain, make such systems potentially vulnerable to breakdown, malicious intrusion, security breaches, ransomware attacks, social engineering attacks, supply-chain attacks, and other cyber-attacks. Ransomware attacks are becoming increasingly prevalent and severe. To alleviate the financial, operational and reputational impact of a ransomware attack, it may be preferable to make extortion payments, but we may be unwilling or unable to do so (including, for example, if applicable laws or regulations prohibit such payments). Similarly, supply chain attacks have increased in frequency and severity, and we cannot guarantee that third parties in our supply chain have not been compromised or that they do not contain exploitable defects or bugs that could result in a breach of or disruption to our information technology systems and infrastructure or the information technology systems and infrastructure of third parties that support our operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, if the COVID-19 pandemic requires us to reinstate a remote workforce model, our information technology systems and data will be at increased risk as more of our employees work from home, utilizing network connections outside our premises.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, natural disasters, public health pandemics or epidemics (including, for example, the COVID-19 pandemic), terrorism, war and telecommunication and electrical failures may result in damage to or the interruption or impairment of key business processes, or the loss or corruption of confidential information, including intellectual property, proprietary business information and personal information. Information security risks have significantly increased in recent years in part due to the proliferation of new technologies and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign private parties and state actors. A security breach or privacy violation that leads to disclosure or modification of or prevents access to personally identifiable information or other protected information could harm our reputation, compel us to comply with federal and/or state breach notification laws and foreign law equivalents, subject us to mandatory corrective action, require us to verify the correctness of database contents and otherwise subject us to liability under laws and regulations that protect personal data, resulting in increased costs or loss of revenue. Similarly, the loss of clinical trial data from completed or ongoing or planned clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Additionally, theft of our intellectual property or proprietary business information could require substantial expenditures to remedy. If we are unable to prevent such security breaches or privacy violations or implement satisfactory remedial measures, our operations could be disrupted, and we may suffer loss of reputation, financial loss and other regulatory penalties because of lost or misappropriated information. In addition, these breaches and other inappropriate access can be difficult to detect, and any delay in identifying them may lead to increased harm of the type described above. Moreover, the prevalent use of mobile devices that access confidential information increases the risk of data security breaches, which could lead to the loss of confidential information, trade secrets or other intellectual property. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any information security vulnerabilities. Although to our knowledge we have not experienced any material incident or disruption to date, we and our vendors have been the target of cybersecurity incidents of this nature and expect them to continue. While we have implemented security measures to protect our data security and information technology systems, such measures may not prevent such </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">events. Significant disruptions of our information technology systems or breaches of data security could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to obtain or maintain orphan drug designation or other regulatory exclusivity for some of our product candidates, our competitive position would be harmed.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to any patent protection, we rely on forms of regulatory exclusivity to protect our products such as orphan drug designation. A product candidate that receives orphan drug designation can benefit from a streamlined regulatory process as well as potential commercial benefits following approval. Currently, this designation provides market exclusivity in the United States for 7 years and the European Union for 10 years if a product is the first such product approved for such orphan indication. This market exclusivity does not, however, pertain to indications other than those for which the drug was specifically designated in the approval, nor does it prevent other types of drugs from receiving orphan designations or approvals in these same indications. Further, even after an orphan drug is approved, the FDA can subsequently approve the same drug for the same condition if the FDA concludes that the new drug is clinically superior to the orphan product or a market shortage occurs.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, orphan exclusivity may be reduced to 6 years if the drug no longer satisfies the original designation criteria or can be lost altogether if the marketing authorization holder consents to a second orphan drug application or cannot supply enough drug, or when a second applicant demonstrates its drug is &#8220;clinically superior&#8221; to the original orphan drug. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not have adequate patent protection for our products, then the relative importance of obtaining regulatory exclusivity is even greater. We may not be successful obtaining orphan drug designations for any indications and, even if we succeed, such product candidates with such orphan drug designations may fail to achieve FDA approval. Even if a product candidate with orphan drug designation may receive marketing approval from the FDA, it may fail to result in or maintain orphan drug exclusivity upon approval, which would harm our competitive position.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The technologies we use in our research as well as the drug targets we select may infringe the patents or violate the proprietary rights of third&#160;parties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that third parties will not assert patent or other intellectual property infringement claims against us or our collaborators with respect to technologies used in potential products. If a patent infringement suit were brought against us or our collaborators, we or our collaborators could be forced to stop or delay developing, manufacturing or selling potential products that are claimed to infringe a third party&#8217;s intellectual property unless that party grants us or our collaborators rights to use its intellectual property. In such cases, we could be required to obtain licenses to patents or proprietary rights of others in order to continue to commercialize our products. However, we may not be able to obtain any licenses required under any patents or proprietary rights of third parties on acceptable terms, or at all. Even if our collaborators or we were able to obtain rights to the third party&#8217;s intellectual property, these rights may be non-exclusive, thereby giving our competitors access to the same intellectual property. Ultimately, we may be unable to commercialize some of our potential products or may have to cease some of our business operations as a result of patent infringement claims, which could severely harm our business.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business operations may subject us to disputes, claims and lawsuits, which may be costly and time-consuming and could materially and adversely impact our financial position and results of operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in disputes, claims and lawsuits relating to our business operations. In particular, we may face claims related to the safety of our products, intellectual property matters, employment matters, tax matters, commercial disputes, competition, sales and marketing practices, environmental matters, personal injury, insurance coverage and acquisition or divestiture-related matters. Any dispute, claim or lawsuit may divert management&#8217;s attention away from our business, we may incur significant expenses in addressing or defending any dispute, claim or lawsuit, and we may be required to pay damage awards or settlements or become subject to equitable remedies that could adversely affect our operations and financial results. For example, we are currently engaged in various intellectual property litigation matters against potential competitors related to INGREZZA. Refer to Item 3. Legal Proceedings f</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or a more detailed description of these matters.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation related to these disputes may be costly and time-consuming and could materially and adversely impact our financial position and results of operations if resolved against us. In addition, the uncertainty associated with litigation could lead to increased volatility in our stock price.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employees, independent contractors, principal investigators, consultants, commercial partners and vendors may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to the risk of employee fraud or other misconduct. Misconduct by employees and independent contractors, such as principal investigators, consultants, commercial partners and vendors, or by employees of our commercial partners could include failures to comply with FDA regulations, to provide accurate information to the FDA, to comply with manufacturing standards we have established, to comply with federal and state healthcare fraud and abuse laws, to report financial information or data accurately, to maintain the confidentiality of our trade secrets or the trade secrets of our commercial partners, or to disclose unauthorized activities to us. In particular, sales, marketing and other business arrangements in the healthcare industry are subject to extensive laws intended to prevent fraud, kickbacks, self-dealing and other abusive practices. Employee and independent contractor misconduct could also involve the improper use of individually identifiable information, including, without limitation, information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. Any action against our employees, independent contractors, principal investigators, consultants, commercial partners or vendors for violations of these laws could result in significant civil, criminal and administrative penalties, fines and imprisonment.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face potential product liability exposure far in excess of our insurance coverage.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of any of our potential products in clinical trials, and the sale of any approved products, including INGREZZA and ONGENTYS, may expose us to liability claims. These claims might be made directly by consumers, health care providers, pharmaceutical companies or others selling our products. We have product liability insurance coverage for our clinical trials in the amount of $45.0 million per occurrence and $45.0 million in the aggregate. In addition, we have product liability insurance related to the sale of INGREZZA and ONGENTYS in the amount of $45.0 million per occurrence and $45.0 million in the aggregate. However, our insurance may not reimburse us or may not be sufficient to reimburse us for any expenses or losses we may suffer. Moreover, insurance coverage is becoming increasingly expensive, and we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses due to liability from any current or future clinical trials or approved products. A successful product liability claim, or series of claims, brought against us would decrease our cash reserves and could cause our stock price to fall. Furthermore, regardless of the eventual outcome of a product liability claim, any product liability claim against us may decrease demand for our approved products, including INGREZZA and ONGENTYS, damage our reputation, result in regulatory investigations that could require costly recalls or product modifications, cause clinical trial participants to withdrawal, result in costs to defend the related litigation, decrease our revenue, and divert management&#8217;s attention from managing our business.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our activities involve hazardous materials, and we may be liable for any resulting contamination or injuries.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research activities involve the controlled use of hazardous materials. We cannot eliminate the risk of accidental contamination or injury from these materials. If an accident occurs, a court may hold us liable for any resulting damages, which may harm our results of operations and cause us to use a substantial portion of our cash reserves, which would force us to seek additional financing.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent and changing obligations related to data privacy and information security. Our actual or perceived failure to comply with such obligations could have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we process confidential and sensitive electronic information, including personal information, on our networks and in our data centers. We are subject to numerous federal, state, local and foreign laws, orders, codes, regulations and regulatory guidance regarding privacy, data protection, information security and the processing of personal information, the number and scope of which are expanding, changing, subject to differing applications and interpretations, and may be inconsistent among countries. Our data processing activities may also subject us to other data privacy and security obligations, such as industry standards, external and internal privacy and security policies, contracts and other obligations that govern the processing of data by us and by third parties on our behalf.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws in Europe regarding privacy, data protection, information security and the processing of personal data have been significantly reformed and continue to undergo reform. For example, the European Union&#8217;s General Data Protection Regulation, or the EU GDPR, and the United Kingdom&#8217;s GDPR, or the UK GDPR, impose strict requirements for processing the personal data of individuals located, respectively, within the European Economic Area, or EEA, and the United Kingdom, or the UK. The EU GDPR and the UK GDPR enhance data protection obligations for processors and controllers of personal data, including, for example, obligations relating to: processing health and other sensitive data; obtaining consent of individuals; providing notice to individuals regarding data processing activities; responding to data subject requests; taking certain measures when engaging third-party processors; notifying data subjects and regulators of data breaches; and implementing safeguards to protect the security and confidentiality of personal data. The EU GDPR and the UK GDPR impose substantial fines for breaches of data protection requirements, which can be up to four percent of global revenue or 20 million euros, whichever is greater, and also confer a private right of action on data subjects for breaches of data protection requirements. The EU GDPR, the UK GDPR and other changes in laws or regulations associated with the enhanced protection of certain types of sensitive data, such as EU regulations governing clinical trial data and other healthcare data, could require us to change our business practices or lead to government enforcement actions, private litigation or significant penalties against us and could have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain jurisdictions have enacted data localization laws and cross-border personal data transfers laws. For example, absent appropriate safeguards or other circumstances, the EU GDPR generally restricts the transfer of personal data to countries outside of the EEA, such as the United States, which the European Commission does not consider to provide an adequate level of personal data protection. If we cannot implement a valid compliance mechanism for cross-border personal data transfers, we may face increased exposure to regulatory actions, substantial fines and injunctions against processing or transferring personal data from Europe or elsewhere. The inability to import personal data to the United States may significantly and negatively impact our business operations, including by limiting our ability to conduct clinical trial activities in Europe and elsewhere; limiting our ability to collaborate with parties subject to European and other data protection laws or requiring us to increase our personal data processing capabilities in Europe and/or elsewhere at significant expense.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws regarding privacy, data protection, information security and the processing of personal information are also becoming increasingly common in the United States at both the federal and state level. For example, the California Consumer Privacy Act, or CCPA, which went into effect in 2020, imposes obligations on businesses to which it applies. These obligations include, without limitation, providing specific disclosures in privacy notices, affording California residents certain rights related to their personal data, and requiring businesses subject to the CCPA to implement certain measures to effectuate California residents&#8217; personal data rights. The CCPA allows for statutory fines for noncompliance (up to $7,500 per violation). In addition, it is anticipated that the California Privacy Rights Act of 2020, or the CPRA, effective January 1, 2023, will expand the CCPA. For example, the CPRA establishes a new California Privacy Protection Agency to implement and enforce the CCPA (as amended), which could increase the risk of an enforcement action. Other states have also enacted data privacy laws. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations related to data privacy and security are quickly changing in an increasingly stringent fashion. These obligations may be subject to differing applications and interpretations, which may be inconsistent among jurisdictions or in conflict. Preparing for and complying with these obligations requires us to devote significant resources (including, without limitation, financial and time-related resources). These obligations may necessitate changes to our information technologies, systems and practices and those of any third parties that process personal data on our behalf. In addition, these obligations may even require us to change to our business model.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we endeavor to comply with all applicable data privacy and security obligations, we may at times fail (or be perceived to have failed) to do so. Moreover, despite our efforts, our personnel or third-parties upon whom we rely may fail to comply such obligations that impacts our compliance posture. If we fail, or are perceived to have failed, to address or comply with data privacy and security obligations, we could face significant consequences. These consequences may include, but are not limited to, government enforcement actions, litigation, additional reporting requirements and/or oversight, bans on processing personal data and orders to destroy or not use personal data. Any of these events could have a material adverse effect on our reputation, business, financial condition or results of operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_67"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_70"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Properties</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters are located in San Diego, California. We believe that our property and equipment are generally well maintained, in good operating condition and suitable for the conduct of our business.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of our leased facilities, which include our corporate headquarters and consist of office space and research and development laboratories, follow. </span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.893%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.081%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Address</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Square Feet</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12780 El Camino Real, San Diego, California</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office Space, Research and Development Laboratories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">141,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12790 El Camino Real, San Diego, California</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office Space</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10420 Wateridge Circle, San Diego, California</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and Development Laboratories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12777 High Bluff Drive, San Diego, California</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office Space</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12770 El Camino Real, San Diego, California</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Office Space</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2022, we entered into a lease agreement for a four-building campus facility consisting of up to approximately 535,000 gross square feet, to be constructed in San Diego, California, pursuant to which we also secured a 6-year option for the construction of a fifth building consisting of up to approximately 121,000 gross square feet and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters and expect to begin subleasing our existing leased facilities.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_73"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;3. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Legal</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Proceedings</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2021, we received notices from (i) Teva Pharmaceuticals Development, Inc., (ii) Lupin Limited, (iii) Crystal Pharmaceutical (Suzhou) Co. Ltd., and (iv) Zydus Pharmaceuticals (USA) Inc. (each an &#8220;ANDA Filer&#8221;) that each company had filed an abbreviated new drug application, or ANDA, with the FDA seeking approval of a generic version of INGREZZA. The ANDAs each contained a Paragraph IV Patent Certification alleging that certain of our patents covering INGREZZA are invalid and/or will not be infringed by each ANDA Filer&#8217;s manufacture, use or sale of the medicine for which the ANDA was submitted. We filed suit in the United States District Court for the District of Delaware in July 2021 against (i) Teva Pharmaceuticals, Inc. and its affiliates Teva Pharmaceuticals Development, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd., (ii) Lupin Limited and its affiliates Lupin Pharmaceuticals, Inc., and Lupin Atlantis Holdings S.A., (iii) Crystal Pharmaceutical (Suzhou) Co., Ltd., and its affiliate Crystal Pharmatech Co., Ltd., and (iv) Zydus Pharmaceuticals (USA) Inc. and its affiliates Zydus Worldwide DMCC, Cadila Healthcare Limited d/b/a Zydus Cadila and Zydus Healthcare (USA) LLC. We also filed suit in the United States District Court for the District of New Jersey in July 2021 against Zydus Pharmaceuticals (USA) Inc. and its affiliates Zydus Worldwide DMCC, Cadila Healthcare Limited d/b/a Zydus Cadila and Zydus Healthcare (USA) LLC seeking to prevent any ANDA Filer from selling a generic version of INGREZZA.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may also become subject to other legal proceedings or claims arising in the ordinary course of our business. We currently believe that none of the claims or actions pending against us is likely to have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations. Given the unpredictability inherent in litigation, however, we cannot predict the outcome of these matters.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_76"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;4. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_79"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART&#160;II</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_82"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 5. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;NBIX&#8221;.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;7, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, there were approximately 47 stockholders of record of our common stock. We have not paid any cash dividends on our common stock since inception and do not anticipate paying cash dividends in the foreseeable future.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about our equity compensation plans is incorporated herein by reference to Item&#160;12 of Part&#160;III of this Annual Report on Form&#160;10-K.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of our equity securities and we did not repurchase any of our equity securities during 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph and Cumulative Total Return*</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the cumulative total stockholder return assuming the investment of $100 on December&#160;31, 2016 (and the reinvestment of dividends thereafter) in each of (i)&#160;Neurocrine Biosciences, Inc.&#8217;s common stock, (ii)&#160;the Nasdaq Composite Index and (iii)&#160;the Nasdaq Biotechnology Index. The comparisons in the graph below are based upon historical data and are not indicative of, or intended to forecast, future performance of our common stock or Indexes.</span></div><div style="text-align:center"><img src="nbix-20211231_g3.jpg" alt="nbix-20211231_g3.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The material in this section is not &#8220;soliciting material&#8221;, is not deemed &#8220;filed&#8221; with the Securities and Exchange Commission, or SEC, and is not to be incorporated by reference into any of our SEC filings whether made before or after the date hereof and irrespective of any general incorporation language in any such SEC filing except to the extent we specifically incorporate this section by reference.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations section contains forward-looking statements pertaining to, among other things, the commercialization of our product and product candidates, the expected continuation of our collaborative agreements, the receipt of research and development payments thereunder, the future achievement of various milestones in product development and the receipt of payments related thereto, the potential receipt of royalty payments, preclinical testing and clinical trials of potential products, the period of time that our existing capital resources will meet our funding requirements, and our financial results of operations. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various risks and uncertainties, including those set forth in this Annual Report on Form&#160;10-K under the heading &#8220;Item&#160;1A. Risk&#160;Factors.&#8221; See &#8220;Forward-Looking Statements&#8221; in Part&#160;I of this Annual Report on Form&#160;10-K.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_91"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Neurocrine Biosciences, our purpose is simple: to relieve suffering for people with great needs, but few options. For three decades, we have applied our unique insight into neuroscience to advance medicines for neurological, endocrine and psychiatric disorders. Our efforts have resulted in United States Food and Drug Administration, or FDA, approved treatments for tardive dyskinesia, Parkinson&#8217;s disease, endometriosis* and uterine fibroids* and a diversified portfolio of investigational therapies with the potential to address unmet clinical needs of patients worldwide living with neurological, endocrine and psychiatric disorders. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(*in collaboration with AbbVie Inc., or AbbVie)</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We launched INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (valbenazine) in the United States in May 2017 as the first FDA-approved drug for the treatment of tardive dyskinesia and launched ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (opicapone) in the United States in September 2020 as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. INGREZZA net product sales represent the significant majority of our total net product sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our partner AbbVie launched ORILISSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix tablets) in the United States in August 2018 and launched ORIAHNN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix, estradiol and norethindrone acetate capsules and elagolix capsules) in the United States in June 2020. We receive royalties at tiered percentage rates on AbbVie net sales of elagolix.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Highlights</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">INGREZZA net product sales for 2021 increased $88.8 million, or 8.9%, to $1.1 billion, primarily driven by increased total prescriptions reflecting higher customer demand and increased commercial activities.</span></div><div style="margin-bottom:6pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">On February 8, 2022, we entered into a lease agreement for a four-building campus facility to be constructed in San Diego, California, pursuant to which we also secured a 6-year option for the construction of a fifth building and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters and expect to begin subleasing our existing leased facilities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pipeline Highlights</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">In the fourth quarter of 2021, we announced positive top-line data from the Phase III KINECT-HD study evaluating the efficacy, safety and tolerability of valbenazine in 120 adult patients with chorea in Huntington disease, also known as Huntington chorea. The study met the primary endpoint of reduction in severity of chorea. We plan to submit a supplemental new drug application for valbenazine for the treatment of Huntington chorea with the FDA in second half of 2022.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Completed strategic partnership with Heptares Therapeutics Limited, or Heptares, to expand clinical pipeline for psychiatry disorders. Upfront fee associated with the agreement totaled $100.0 million, which, including certain transaction-related costs, was expensed as in-process research and development in 2021.</span></div><div style="margin-bottom:6pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">In 2021, Mitsubishi Tanabe Pharma Corporation, or MTPC, received approvals for marketing authorization for valbenazine for the treatment of tardive dyskinesia in Indonesia, Singapore, South Korea and Thailand. In addition, MTPC has submitted filings for marketing authorization, which are currently under review, in Japan and Malaysia.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has dramatically changed the ways in which we live and interact with one another. While we adapt to this new shared reality, our purpose remains unchanged: to relieve suffering for people with great needs, but few options.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the initial impact of the pandemic has subsided, we are uncertain as to how more transmissible variants may impact our business. We remain committed to (1) prioritizing the safety, health and well-being of patients and their caregivers, healthcare providers and our employees; (2) ensuring patients with tardive dyskinesia are well supported and have continued uninterrupted access to INGREZZA, for which we have not experienced and currently do not expect any supply disruption; and (3) advancing clinical studies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our field-based employees have resumed in-person interactions in accordance with location-specific guidance. Our office-based employees have returned to the office under flexible work arrangement guidelines to help balance business needs, employee health, well-being and safety and the evolving work environment. However, as the effects of the pandemic continue to rapidly evolve with the emergence of new COVID-19 variants, a remote work model may nevertheless need to be reinstated at some point in the future. We continue to evaluate the impact of global spikes or surges in COVID-19 infection and hospitalization rates, as well as the impact of emerging COVID-19 variants on the efficacy of vaccines.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most hospitals, community mental health facilities, physicians&#8217; offices, pharmacies and other healthcare facilities have relaxed their policies that limited access of patients and our employees to such facilities and limited the ability of patients, pharmacies and prescribers to interact with each other. However, we anticipate these policies may change from time to time as communities or regions grapple with outbreaks. The ultimate impact of the COVID-19 pandemic, including any lasting effects on our revenue and the way we conduct our business, is highly uncertain and subject to continued change. We recognize that this pandemic will continue to present unique challenges for us throughout 2022.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_94"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Product Sales by Sales Product.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">INGREZZA net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">993.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ONGENTYS net product sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,090.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in total net product sales primarily reflected increased INGREZZA net product sales mainly driven by increased total prescriptions reflecting higher customer demand and increased commercial activities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in total net product sales primarily reflected increased INGREZZA net product sales driven by increased total prescriptions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenues by Category.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elagolix royalties</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash collaboration revenue and other</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total collaboration revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, total collaboration revenue primarily reflected the achievement of a $15.0 million milestone associated with MTPC's marketing authorization application submission for valbenazine for the treatment of tardive dyskinesia in Japan and royalties earned on AbbVie net sales of elagolix.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020, total collaboration revenue primarily reflected the achievement of a $30.0 million milestone associated with the FDA&#8217;s approval of AbbVie&#8217;s ORIAHNN for uterine fibroids in 2020 and royalties earned on AbbVie net sales of elagolix.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2019, total collaboration revenue primarily reflected the achievement of a $20.0 million milestone associated with the FDA&#8217;s acceptance of AbbVie&#8217;s new drug application submission for elagolix for uterine fibroids and royalties earned on AbbVie net sales of elagolix.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cost of sales from 2020 to 2021 and 2019 to 2020 reflected increased INGREZZA net product sales driven by increased total prescriptions.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research and Development, or R&amp;D, Expenses by Category. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We support our drug discovery and development efforts through the commitment of significant resources to discovery, R&amp;D programs, and business development opportunities. Costs are reflected in the applicable development stage based upon the program status when incurred. Therefore, the same program could be reflected in different development stages in the same reporting period. For several of our programs, the R&amp;D activities are part of our collaborative arrangements.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Late stage </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Early stage </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and discovery </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities and other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total R&amp;D expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Late Stage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consists of costs incurred for product candidates in Phase II registrational studies and all subsequent activities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in late stage R&amp;D expense primarily reflected continued investment in Phase III programs for crinecerfont in congenital adrenal hyperplasia and valbenazine in Huntington disease and initiation of a Phase III program for valbenazine as adjunctive treatment of schizophrenia, offset by decreased investment associated with the termination of the NBIb-1817 program for Parkinson&#8217;s disease, which became effective in August 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in late stage R&amp;D expense primarily reflected increased investment in Phase III programs for crinecerfont in congenital adrenal hyperplasia and continued enrollment in the Phase III program for valbenazine Huntington disease.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Stage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consists of costs incurred for product candidates after the approval of an investigational new drug application by the applicable regulatory agency through Phase II non-registrational studies. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in early stage R&amp;D expense primarily reflected continued enrollment in Phase II programs for NBI-827104 in epileptic encephalopathy with continuous spike and wave during sleep and essential tremor and initiation of Phase II programs for NBI-921352 in focal onset seizure and SCN8A developmental epileptic encephalopathy.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in early stage R&amp;D expense primarily reflected increased investment in three in-licensed psychiatry clinical development programs beginning in mid-2020 and two in-licensed epilepsy clinical development programs beginning at the end of 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Discovery.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consists of costs incurred prior to the approval of an investigational new drug application by the applicable regulatory agency.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in research and discovery R&amp;D expense primarily reflected a full year of investment in psychiatry and epilepsy preclinical development programs in-licensed in 2020, offset by decreased investment in preclinical gene therapy programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in research and discovery R&amp;D expense primarily reflected increased investment in preclinical gene therapy programs and an epilepsy preclinical development program in-licensed in 2020.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Milestone.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Consists of costs incurred for development and/or regulatory milestones in connection with our collaborative arrangements.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expensed a milestone of $5.4 million associated with the European Union&#8217;s approval for the NBI-921352 clinical trial application in September 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we expensed a milestone of $20.0 million associated the FDA&#8217;s approval for ONGENTYS for Parkinson&#8217;s disease.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we expensed a milestone of $10.0 million associated with the FDA&#8217;s acceptance of the new drug application for opicapone as an adjunctive therapy to levodopa/DOPA decarboxylase inhibitors in adult Parkinson's disease patients.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payroll and Benefits.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Consists of costs incurred for salaries and wages, payroll taxes, benefits and share-based compensation associated with employees involved in R&amp;D activities. Share-based compensation may fluctuate from period to period based on factors that are not within our control, such as our stock price on the dates share-based grants are issued.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in payroll and benefits R&amp;D expense primarily reflected increased personnel expenses on higher headcount and a $14.7 million increase in non-cash share-based compensation expense, including a $6.4 million charge related to the modification of certain share-based awards.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in payroll and benefits R&amp;D expense primarily reflected increased personnel expenses on higher headcount.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facilities and Other.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consists of indirect costs incurred for the benefit of multiple programs, including depreciation, information technology and facility-based expenses, such as rent expense.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Acquired In-Process Research and Development, or IPR&amp;D.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPR&amp;D expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, we expensed as IPR&amp;D $100.3 million in connection with the payment of the upfront fee pursuant to our collaboration with Heptares.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we expensed as IPR&amp;D $46.0 million and $118.5 million, respectively, in connection with the payments of the upfront fees pursuant to our collaborations with Idorsia Pharmaceuticals Ltd, or Idorsia, and Takeda Pharmaceutical Company Limited, or Takeda.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we expensed as IPR&amp;D $118.1 million and $36.2 million, respectively, in connection with the payments of the upfront fees pursuant to our collaborations with Voyager Therapeutics, Inc., or Voyager, and Xenon Pharmaceuticals, Inc., or Xenon.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative, or SG&amp;A. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SG&amp;A expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">583.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">433.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in SG&amp;A expense primarily reflected increased investment to support our commercial initiatives, including the May 2021 launch of our INGREZZA direct-to-consumer advertising campaign, "TD Spotlight", increased personnel expenses on higher headcount and a $19.5 million increase in non-cash share-based compensation expense.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in SG&amp;A expense primarily reflected increased personnel expenses on higher headcount and continued investment in INGREZZA marketing.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, Net.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the decrease in other expense, net, reflected a net unrealized gain of $20.9 million recognized to adjust our equity investments in Voyager and Xenon to fair value, a non-recurring debt extinguishment charge of $18.4 million in November 2020 associated with the partial repurchase of our convertible senior notes and decreased interest expense resulting from a lower convertible debt balance throughout 2021, partially offset by decreased interest income stemming from lower yields on our debt security investments.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in other expense, net, primarily reflected a debt extinguishment charge of $18.4 million in November 2020 associated with the partial repurchase of our convertible senior notes.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Provision for (Benefit from) Income Taxes.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(300.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, the effective tax rate was lower than federal and state tax rates primarily due to excess tax benefits associated with share-based compensation and research tax credits. Beginning in the first quarter of 2021, we began recording a provision for income taxes using an effective tax rate approximating federal and state statutory tax rates. Due to the ability to offset any pre-tax income against previously benefited federal net operating losses, no federal cash tax was incurred in 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020, the benefit from income taxes reflected a $296.3 million benefit associated with the release of substantially all of our valuation allowance against our deferred tax assets on December 31, 2020. The effective tax rate for 2020 varied from the statutory tax rate primarily due to changes in our valuation allowance, net of other permanent book/tax differences, tax credits generated and impacts of changes in tax laws.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2019, the provision for income taxes reflected estimated and current state income taxes. The effective tax rate for 2019 varied from the statutory tax rate primarily due to changes in our valuation allowance, net of other permanent book/tax differences, tax credits generated and impacts of changes in tax laws. As of December 31, 2019, we had a full valuation allowance against our net deferred tax assets as realization was uncertain.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Income and Diluted Earnings per Share.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the decrease in net income and diluted earnings per share primarily reflected a $296.3 million benefit associated with the release of substantially all of our valuation allowance against our deferred tax assets on December 31, 2020, increased investment to support our commercial initiatives, including the May 2021 launch of our INGREZZA direct-to-consumer advertising campaign, "TD Spotlight", and increased investment in our expanded clinical portfolio, partially offset by increased INGREZZA net product sales and decreased IPR&amp;D expense reflecting lower upfront payments for asset acquisitions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in net income and diluted earnings per share primarily reflected a $296.3 million benefit associated with the release of substantially all of our valuation allowance against our deferred tax assets on December 31, 2020 and increased INGREZZA net product sales, partially offset by ongoing support for the commercial launch of INGREZZA for tardive dyskinesia and progression of our clinical pipeline.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_97"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing capital resources, funds generated by anticipated INGREZZA net product sales and investment income will be sufficient to satisfy our current and projected funding requirements for at least the next twelve&#160;months. However, we cannot guarantee that our existing capital resources and anticipated revenues will be sufficient to conduct and complete all of our research and development programs or commercialization activities as planned. We may seek to access the public or private equity markets whenever conditions are favorable or pursue opportunities to obtain additional debt financing in the future. We may also seek additional funding through strategic alliances or other financing mechanisms. However, we cannot provide assurance that adequate funding will be available on terms acceptable to us, if at all. In addition, the disruption of global financial markets caused by the COVID-19 pandemic, if sustained or recurrent, could make it more difficult for us to access capital, which could in the future negatively affect our liquidity.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Regarding Our Financial Condition.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable securities</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working Capital:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">972.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,016.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total working capital</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Information Regarding Our Cash Flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in)  financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by Operating Activities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 compared to 2020, the increase in net cash provided by operating activities primarily reflected increased INGREZZA net product sales and lower upfront payments for asset acquisitions, partially offset by increased investment to support our commercial initiatives and advancing our expanded clinical portfolio.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020 compared to 2019, the increase in net cash provided by operating activities primarily reflected increased INGREZZA net product sales, partially offset by incremental INGREZZA investment and progression of our clinical pipeline.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash (Used in) Provided by Investing Activities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic fluctuations in net cash (used in) provided by investing activities are generally driven by timing differences related to the purchases, sales and maturities of debt security investments and changes in our portfolio-mix.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021, net cash used in investing activities reflected a $4.6 million equity investment in Xenon associated with the European Union&#8217;s approval of our clinical trial application in September 2021 for NBI-921352 for the treatment of focal onset seizures in adults.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2019, net cash used in investing activities reflected equity investments of $54.7 million in Voyager and $14.2 million in Xenon associated with newly entered into collaboration and license agreements.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by (Used in) Financing Activities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2021 and 2019, net cash provided by investing activities reflected proceeds from issuances of our common stock under benefit plans.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2020, net cash used in financing activities primarily reflected the partial repurchase of $136.2 million aggregate principal amount of our convertible senior notes for an aggregate repurchase price of $186.9 million in cash, partially offset by proceeds from issuances of our common stock under benefit plans.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_106"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the pharmaceutical industry, it can take a significant amount of time and capital resources to successfully complete all stages of research and development and commercialize a product candidate, which ultimate length of time and spend required cannot be accurately estimated as it varies substantially according to the type, complexity, novelty and intended use of a product candidate. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The funding necessary to execute our business strategies is subject to numerous uncertainties and we may be required to make substantial expenditures if unforeseen difficulties arise in certain areas of our business. In particular, our future capital requirements will depend on many factors, including:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the commercial success of INGREZZA, ONGENTYS, ORILISSA and/or ORIAHNN;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued scientific progress in our R&amp;D and clinical development programs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the magnitude and complexity of our research and development programs;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">progress with preclinical testing and clinical trials;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the time and costs involved in obtaining regulatory approvals;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of commercialization activities and arrangements, including our advertising campaigns;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of manufacturing of our product candidates;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in filing and pursuing patent applications, enforcing patent claims, or engaging in interference proceedings or other patent litigation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competing technological and market developments;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments related to any future litigation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic on our business; and</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the foregoing factors, we have significant future capital requirements, including:</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">External Business Developments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our independent efforts to develop and market products, we may enter into collaboration and license agreements or acquire businesses from time-to-time to enhance our drug development and commercial capabilities. With respect to our existing collaboration and license agreements, we may be required to make potential future payments of up to $10.9 billion upon the achievement of certain event-based milestones. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2 to the consolidated financial statements for more information on our significant collaboration and license agreements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, we completed a private placement of $517.5 million in aggregate principal amount of 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes. At our election, we may redeem all, or any portion, of the 2024 Notes under certain circumstances. The 2024 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by us. There are customary events of default with respect to the 2024 Notes, including that upon certain events of default, 100% of the principal and accrued and unpaid interest on the notes would become due and payable. In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $136.2&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $186.9&#160;million in cash. As of December 31, 2021, $381.2 million aggregate principal amount of the 2024 Notes remained outstanding. With respect to the 2024 Notes, unless earlier converted, redeemed or repurchased, we would be required to pay interest of $8.6 million in 2022, $8.6 million in 2023 and $4.3 million in 2024 and pay the aggregate principal amount outstanding of $381.2 million upon maturity of the notes in 2024. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 5 to the consolidated financial statements for more information on the 2024 Notes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating leases, which have terms that expire beginning 2024 through 2031, consist of office space and research and development laboratories, including our corporate headquarters. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2022, we entered into a lease agreement for a four-building campus facility to be constructed in San Diego, California, pursuant to which we also secured a 6-year option for the construction of a fifth building and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters and expect to begin subleasing our existing leased facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 10 to the consolidated financial statements for more information on our leases, including a presentation of our approximate future minimum lease payments under non-cancelable operating leases.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_100"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations is based upon financial statements that we have prepared in accordance with accounting principles generally accepted in the United&#160;States of America, or GAAP. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities and expenses, and related disclosures. On an on-going basis, we evaluate these estimates, including those related to revenue recognition and share-based compensation. Estimates are based on historical experience, information received from third parties and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. Historically, revisions to our estimates have not resulted in a material change to the financial statements. The items in our financial statements requiring significant estimates and judgments are as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Product Sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Rebates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period, which are primarily based on actual historical rebates, estimated payor mix, state and federal regulations and related contractual terms. Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of calculating share-based compensation, we estimate the fair value of share-based compensation awards using a Black-Scholes option-pricing model. The determination of the fair value of share-based compensation awards utilizing the Black-Scholes model is affected by our stock price and a number of assumptions, including but not limited to expected stock price volatility over the term of the awards and the expected term of stock options. Our stock options have characteristics significantly different from those of traded options, and changes in the assumptions can materially affect the fair value estimates. For example, an increase in the underlying stock price results in a significant increase in the Black-Scholes option-pricing. The fair value of performance-based restricted stock units, or PRSUs, is estimated based on the closing sale price of our common stock on the date of grant. Expense recognition for PRSUs commences when attainment of the associated performance-based criteria is determined to be probable.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If factors change and we employ different assumptions, share-based compensation expense may differ significantly from what we have recorded in the past. If there is a difference between the assumptions used in determining share-based compensation expense and the actual factors which become known over time, we may change the input factors used in determining share-based compensation expense for future grants. These changes, if any, may materially impact our results of operations in the period such changes are made. For actual forfeitures, we recognize the adjustment to compensation expense in the period the forfeitures occur.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax benefit (provision) is computed under the asset and liability method. Significant estimates are required in determining our income tax benefit (provision). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. We continue to maintain a valuation allowance against our California state deferred tax assets.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_103"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 1 to the consolidated financial statements for information on accounting pronouncements that have impacted or are expected to materially impact our consolidated financial condition, results of operations, or cash flows.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_112"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to interest rate risk on our short-term investments. The primary objective of our investment activities is to preserve principal while at the same time maximizing yields without significantly increasing risk. To achieve this objective, we invest in highly liquid and high-quality government and other debt securities. To minimize our exposure due to adverse shifts in interest rates, we invest in short-term securities and ensure that the maximum average maturity of our investments does not exceed twelve months. If a 1% change in interest rates were to have occurred on December&#160;31, 2021, this change would not have had a material effect on the fair value of our investment portfolio as of that date. Due to the short holding period of our investments, we have concluded that we do not have a material financial market risk exposure.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_115"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;8. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Supplementary Data</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_118"></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:93.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.509%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_121">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMTgvZnJhZzo5NWQyOTQxN2I1MmU0YWFmYWMyYWEzMzRlZDM0YjFlOC90YWJsZTpmOWNiMjNlZDgwNzM0NTg5OTQyYzA1NjZmMzY1MTRmZS90YWJsZXJhbmdlOmY5Y2IyM2VkODA3MzQ1ODk5NDJjMDU2NmYzNjUxNGZlXzEtMC0xLTEtNDk4ODAvdGV4dHJlZ2lvbjplYzQwZGU2ODc4ZTk0YTJiYjE4NGVhNDkyYjhkMWZlOF8xMDk5NTExNjI4NTE0_869b256b-081f-479d-bc18-f0d08a1e7b9e">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_121">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_124">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_124">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ee;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_127">Consolidated Statements of Income and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_127">63</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_130">Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_130">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_133">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_133">65</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_136">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ic35e9d12d921455aa45f30d1d4130202_136">66</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_121"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Neurocrine Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Neurocrine Biosciences, Inc. (the &#8220;Company&#8221;) as of December 31, 2021 and 2020, the related consolidated statements of income and comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;11, 2022 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Reserves for government rebates related to product sales</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells drugs to specialty pharmacies and specialty distributors in the U.S. (collectively, &#8220;customers&#8221;). As described in Note 1 to the consolidated financial statements, the Company recognizes revenues for sales of INGREZZA to its customers after deducting management&#8217;s estimates of reserves, including drug coverage gap rebates it will provide under government programs (&#8220;government rebates&#8221;). Estimated government rebates are presented within accounts payable and accrued liabilities on the consolidated balance sheet.</span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing the estimates of government rebates was complex and judgmental due to the level of uncertainty involved in management&#8217;s assumptions used in the measurement process. In particular, management was required to estimate, for product that remains in the distribution channel at December 31, 2021, the portion of product that is expected to be subject to a government rebate and the applicable contractual government rebate percentage by forecasting the revenue, the payor type underlying the revenue and the applicable rebate amount for the payor type.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested the Company&#8217;s internal controls over management&#8217;s process for estimating the portion of product that is expected to be subject to a government rebate for product that remains in the distribution channel at December 31, 2021, including controls over management&#8217;s forecast of revenue and the accuracy of data used in the calculation.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.112%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To test management&#8217;s estimate of government rebate reserves our audit procedures included, among others, evaluating the methodologies used, testing the significant assumptions discussed above and testing the completeness and accuracy of the underlying data used by the Company in its analyses. Specifically, we compared the significant assumptions to third-party reports used by the Company to estimate product remaining in the distribution channel at December 31, 2021. In addition, we compared the underlying government rebate percentages used in the Company&#8217;s analyses to those published by the applicable government entity. We assessed the historical accuracy of management&#8217;s rebate estimates, tested payments of rebates and performed a sensitivity analysis of significant assumptions to evaluate the impact of changes in the rebate allowance that would result from changes in the assumptions.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjEvZnJhZzpiNWY2MThkMDQzYmY0NjZhOWRmNTAzYWNkMWQ2MWQ2ZC90ZXh0cmVnaW9uOmI1ZjYxOGQwNDNiZjQ2NmE5ZGY1MDNhY2QxZDYxZDZkXzM4NDgyOTA3MDExMzA_bb00d961-0421-463d-ba58-5a5910781ddd">Ernst&#160;&amp; Young LLP</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1992.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjEvZnJhZzpiNWY2MThkMDQzYmY0NjZhOWRmNTAzYWNkMWQ2MWQ2ZC90ZXh0cmVnaW9uOmI1ZjYxOGQwNDNiZjQ2NmE5ZGY1MDNhY2QxZDYxZDZkXzM4NDgyOTA3MDExNTA_e4520900-59b5-4d5a-ba86-4fc5e84ae3b2">San Diego, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_124"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzQtMS0xLTEtMjQ1ODc_f3dfbbaf-7c31-4d71-8cf6-b64999b95777">340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzQtMy0xLTEtMjQ1ODc_f0e339fe-da5e-4f6c-ad07-06d1e141989a">187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities available-for-sale (amortized cost was $<ix:nonFraction unitRef="usd" contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjo2ZTM3OTIyOTRhNDc0NDlhYmY2NWQxZTNjYjdhYTU5ZV81NQ_faf4b98f-3f16-4d1f-aff4-32a98cccf41e">370.6</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjo2ZTM3OTIyOTRhNDc0NDlhYmY2NWQxZTNjYjdhYTU5ZV82OA_119f84fe-2d21-449e-9d49-e66d9bba2ea3">612.4</ix:nonFraction> as of December&#160;31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMS0xLTEtMjQ1ODc_f22f4ce1-f5f4-4ec7-922e-c13e8d452bb1">370.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMy0xLTEtMjQ1ODc_67360c6c-7955-4602-adb5-b15cbd967606">613.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzYtMS0xLTEtMjQ1ODc_e12d6166-9fcd-432f-bdee-b486d062b8b2">185.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzYtMy0xLTEtMjQ1ODc_3417264f-30d3-47f6-a86f-f861465961b0">157.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzctMS0xLTEtMjQ1ODc_87fbab69-3882-4953-a4bc-22da83d7faaf">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzctMy0xLTEtMjQ1ODc_3780a988-6cd3-4671-8d4e-e83057ef11e5">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzgtMS0xLTEtMjQ1ODc_a9694c7a-f019-4b53-837f-2dd8ad4acd1d">45.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzgtMy0xLTEtMjQ1ODc_4e8a9c34-5486-45ab-a4a1-26940fbc25c7">30.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzktMS0xLTEtMjQ1ODc_cffd50b6-51f2-4dd8-806b-4375ee1bc3ab">972.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzktMy0xLTEtMjQ1ODc_3d42ecec-c4e0-49cf-8c34-3ecb6c13ac50">1,016.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTEtMS0xLTI5ODY3_d946a499-2a0a-4f97-a94e-abcd8e4c803d">315.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTMtMS0xLTI5ODY3_9d07ccf1-03f0-4a7c-a5c7-c36b5cac64a8">319.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:8.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt securities available-for-sale (amortized cost was $<ix:nonFraction unitRef="usd" contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTAtMS0xLTI0NTg3L3RleHRyZWdpb246ZTZmMGU4ODczYWNjNGNlNmFiYzk2MTFkMGM4ZTRjZjZfNTU_ceed7519-013e-461a-a29f-f4c9f81e0742">563.2</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTAtMS0xLTI0NTg3L3RleHRyZWdpb246ZTZmMGU4ODczYWNjNGNlNmFiYzk2MTFkMGM4ZTRjZjZfNjg_3b82adf3-0455-4437-91fa-ad3d3d0dbfcb">226.7</ix:nonFraction> as of December&#160;31, 2021 and 2020, respectively)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTEtMS0xLTI0NTg3_443ebc73-15c6-413c-8ba9-f742d9db2d69">560.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTMtMS0xLTI0NTg3_8de8cb2f-7248-46b3-9c1c-03da00c1935b">227.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzExLTEtMS0xLTI0NTg3_357a2e9c-c54a-42d1-bd73-5c019b757850">97.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzExLTMtMS0xLTI0NTg3_277d7815-eb33-4734-8347-905b42c8a9e0">82.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEyLTEtMS0xLTI0NTg3_1998ade6-66c7-4dfb-a3ae-f991fbe98c61">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEyLTMtMS0xLTI0NTg3_41956496-2f97-40bc-84a2-274101e85deb">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEzLTEtMS0xLTI0NTg3_1a5a9fb5-b7e5-41c0-876a-4a05e297f90f">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEzLTMtMS0xLTI0NTg3_e35f9779-724c-4da9-a7c9-72614aa91ebd">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE2LTEtMS0xLTI0NTg3_ae3e8dc3-40e1-43bd-ae8d-8d43fd8b2fbf">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE2LTMtMS0xLTI0NTg3_9d8b8400-b3c3-4afd-9e78-a828b01e8901">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE3LTEtMS0xLTI0NTg3_88879b85-f95d-4337-87e6-b17d339e6a06">2,072.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE3LTMtMS0xLTI0NTg3_6a014be4-64e4-4f4c-865a-349bbe8a80e0">1,734.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIxLTEtMS0xLTI0NTg3_e6aab7c8-9d40-45aa-ba95-29f04f7bab83">225.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIxLTMtMS0xLTI0NTg3_e3baa3d4-5c47-4364-8e2c-f116ea29ac49">168.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIzLTEtMS0xLTI0NTg3_5cf8b5a9-3b52-4605-938c-d3d3881b8666">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIzLTMtMS0xLTI0NTg3_e4d57e3c-8d51-4086-b5e3-77aaa165f712">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI0LTEtMS0xLTI0NTg3_6f4dfa15-0a76-477f-8c73-b7c54661db62">245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI0LTMtMS0xLTI0NTg3_49a62fbc-bedc-4999-bdc3-f9aa223a11c4">186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI1LTEtMS0xLTI0NTg3_8c8b6f1f-f7ec-470b-8906-09b2cde0bad7">335.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI1LTMtMS0xLTI0NTg3_50a9ac35-a2a5-4c0e-b27c-d95180f195bd">317.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI2LTEtMS0xLTI0NTg3_cf994635-bf9c-43a7-97cb-226d898f8213">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI2LTMtMS0xLTI0NTg3_142b46b0-de8e-4cd0-9283-b662fb6e4ab4">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI3LTEtMS0xLTI0NTg3_05046822-fd9e-42f4-a8e5-820828f8bb0c">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI3LTMtMS0xLTI0NTg3_995e2e74-6239-4c0b-ae00-54fa81e192cf">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI4LTEtMS0xLTI0NTg3_3307d2f8-35a9-4374-b650-20de58ecfdab">698.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI4LTMtMS0xLTI0NTg3_78d2d9b4-e58a-44f5-9164-94b4e023836c">608.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMjI_1e77621e-51b3-4084-9dce-e2feff2473f4"><ix:nonFraction unitRef="usdPerShare" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMjI_ee35ee6f-144e-4e0c-8fc3-8270f9299695">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMzY_6587f058-e16f-4227-a8a6-2547c3e8b4cf"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMzY_74e9a6fb-d15a-4a0c-aa2a-1d6db7900bd3">5.0</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_37a3c994-d378-4412-ab29-984dd1fca032"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_663f95c2-acfd-4ba1-80af-c84521d0bbbf"><ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_a37e5174-c8f8-4a9a-bc91-1f3101d83199"><ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_a7702628-22a7-4526-86a9-47ff3a187408">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021 and 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTEtMS0xLTI0NTg3_c10bded1-cff2-41e1-b5d3-93ec530643af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTMtMS0xLTI0NTg3_558e3bc1-121b-4c0d-80da-711588fed0fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:14.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMTk_19548e99-3e54-4b4b-a55a-c7b218e080b6"><ix:nonFraction unitRef="usdPerShare" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMTk_1fee38cf-1c4d-4705-ad62-12b187006aac">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMzM_14973553-4e26-460d-b64c-03b841b41929"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMzM_a4038097-8a89-4658-9658-438e7f85ead3">220.0</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTA_dcb47ef6-3956-4567-9226-6def6ceda60a"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTA_f253a4ef-75eb-409e-81fb-e3398b3bddf7">94.9</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTc_301c7b47-f135-470e-a4d9-2eaa389841dc"><ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTc_bf0a7149-212b-4419-b955-dfeab2768655">93.5</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTEtMS0xLTI0NTg3_e1fd48e5-099f-42b7-9a1c-27d72a7931b7">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTMtMS0xLTI0NTg3_300dadf8-91ae-4643-a59a-65fae93f134b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMzLTEtMS0xLTI0NTg3_855c5e52-ba8f-45f0-b991-3c8647612bff">2,011.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMzLTMtMS0xLTI0NTg3_b936cf3d-0da5-4ea7-828b-e7b878a1ce97">1,849.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM0LTEtMS0xLTI0NTg3_8b612672-e930-45ad-9b84-c25c4a2b4726">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM0LTMtMS0xLTI0NTg3_a3da2d1f-9370-4023-85f4-cd1b7fdd2599">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM1LTEtMS0xLTI0NTg3_73cdbfbc-0c8a-4af2-a26b-68a3ffa1dfaa">635.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM1LTMtMS0xLTI0NTg3_46ced0c5-ac4b-4978-a3f9-b033b7d652df">725.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM2LTEtMS0xLTI0NTg3_efdbc9bf-3ea9-4013-9ab3-5a7f91505abc">1,374.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM2LTMtMS0xLTI0NTg3_596e3974-338b-4f75-b4ce-827cc123e830">1,126.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM3LTEtMS0xLTI0NTg3_0e385d8b-87ab-4436-9110-9d8402bc8e24">2,072.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM3LTMtMS0xLTI0NTg3_a8bbc1f2-7311-4601-8a17-0792465a41e3">1,734.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_127"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND COMPREHENSIVE INCOME</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a39bd69114b41f3a7575046b42fd208_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtMS0xLTEtMjQ1ODc_18c04a74-4cb7-4968-a69e-f74444527924">1,090.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670cc6e75e624e85a72e5224f486c622_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtMy0xLTEtMjQ1ODc_6295e660-3198-4c8a-a75a-047131786099">994.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88608bd64b9d491d965911eb2f10d0ba_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtNS0xLTEtMjQ1ODc_a7598c33-4fa3-4b03-84b3-d07943966ebd">752.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Collaboration revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f4ab3853b3242c7858dcf9b3a67bb47_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtMS0xLTEtMjQ1ODc_a47822d9-c154-4010-99b4-cdf0c44046ec">43.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i798a316339674cf592518cb98cd4340d_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtMy0xLTEtMjQ1ODc_3053f708-eaed-46bb-8bee-f8c04ea77e78">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e3f974b4374e128e00062b09a226b8_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtNS0xLTEtMjQ1ODc_33cd8d28-dfe1-41c3-9b1d-967ea00fbace">35.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtMS0xLTEtMjQ1ODc_19555290-9856-4be4-8e76-e6a9573786d7">1,133.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtMy0xLTEtMjQ1ODc_f28043f1-69a6-48df-959b-5f0cad6eb65f">1,045.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtNS0xLTEtMjQ1ODc_297ae999-d394-4924-a5a5-fb3af2781680">788.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctMS0xLTEtMjQ1ODc_b46b2614-3858-41a5-b558-241884d80a77">14.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctMy0xLTEtMjQ1ODc_9b8a2ae5-9ed2-455d-ac8d-c1e7a1dfc810">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:CostOfSales" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctNS0xLTEtMjQ1ODc_93bceb4e-e5e7-4ebb-8e88-33d5bb2e6b60">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtMS0xLTEtMjQ1ODc_e102d360-da7f-4dd6-a21c-05610ec7fcad">328.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtMy0xLTEtMjQ1ODc_2b8cf6d1-d586-4219-99a9-c39920472f3b">275.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtNS0xLTEtMjQ1ODc_da7ccb26-4853-4492-8a57-c122fe45b1e6">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired in-process research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktMS0xLTEtMjQ1ODc_e341f22b-8b26-46a1-be1b-7cf0ceb65f9f">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktMy0xLTEtMjQ1ODc_a131dbbc-2b8e-4360-b3bb-c536d588f518">164.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktNS0xLTEtMjQ1ODc_9ed4e7de-01f0-4b46-8e73-bc86c0169b9e">154.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTEtMS0xLTI0NTg3_686a8c52-e3c3-48ad-b6fd-599ca5b0ca66">583.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTMtMS0xLTI0NTg3_c04399c9-340c-4fa1-9f37-4164ab4e925b">433.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTUtMS0xLTI0NTg3_fd0105bd-1d7e-4d60-b8e8-6aaa688f7a44">354.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTEtMS0xLTI0NTg3_39671fad-98bc-43b3-be12-89af4ccde43b">1,031.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTMtMS0xLTI0NTg3_bc526b00-a251-4b8c-b51e-685fe1ca90ec">882.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTUtMS0xLTI0NTg3_bd9407a5-d523-4c32-a496-99ff365799a8">715.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTEtMS0xLTI0NTg3_d11de969-05bf-4e75-baf6-6300813dc31c">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTMtMS0xLTI0NTg3_570bdeaf-7390-4f15-a462-f847a3129325">163.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTUtMS0xLTI0NTg3_e7fb7352-167c-421f-a2a7-679b579b2074">72.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other (expense) income: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTEtMS0xLTI0NTg3_227bcf03-8053-4e8d-be99-906b41a83188">25.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTMtMS0xLTI0NTg3_d06ff8b4-9441-4755-9cc2-0e96e74d71cd">32.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTUtMS0xLTI0NTg3_4d2939bb-7536-4dcd-b6ce-7e52e7ac2b25">32.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTEtMS0xLTI0NTg3_86a4b6d4-5342-4fb9-8b3d-6dc813cbf4fc">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTMtMS0xLTI0NTg3_fc0eb855-f743-4cb5-86bb-939ac3a2f68a">17.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTUtMS0xLTI0NTg3_bfdea611-21bc-4d4c-93e5-c3c08e0b4d5f">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTEtMS0xLTI0NTg3_0533937a-ea44-4ccc-81f6-d318459ace00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTMtMS0xLTI0NTg3_7db8f832-acc9-4558-bda0-9dc99b930a69">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTUtMS0xLTI0NTg3_9631fc78-28d5-45b8-85df-5b051730acd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Investment income and other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:InvestmentIncomeAndOtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTEtMS0xLTI0NTg3_d0370d93-15f6-4f36-a6b0-88b99063f631">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:InvestmentIncomeAndOtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTMtMS0xLTI0NTg3_81c7dd3f-125d-41ce-b209-4b7fa6094dfa">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:InvestmentIncomeAndOtherNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTUtMS0xLTI0NTg3_d3e4f2a8-07d1-40f9-a0d4-d950154a8a1f">19.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTEtMS0xLTI0NTg3_010a7e0e-94d3-4e9e-8267-e458076a99c6">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTMtMS0xLTI0NTg3_4afa24a2-f871-4ee0-a736-5349a1c4caa4">56.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTUtMS0xLTI0NTg3_8ee542ca-1760-449b-a007-3de12e18d167">25.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income before provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTEtMS0xLTI0NTg3_9d5242f6-ccca-4616-af8e-749533ac1c28">101.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTMtMS0xLTI0NTg3_859b172c-43c5-418a-ac28-adcda70d48ce">106.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTUtMS0xLTI0NTg3_48611f97-c52e-48c2-b8ae-67ec864e623e">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTEtMS0xLTI0NTg3_acd24d25-76a7-4c0e-8688-a46f3da66c9b">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTMtMS0xLTI0NTg3_23c53463-ee7b-4d01-8392-2b22a4c460c5">300.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTUtMS0xLTI0NTg3_05c9972c-508a-47ce-9aba-14f44529c29b">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTEtMS0xLTI0NTg3_862a06a8-4997-401c-95f3-ca3b75fbc30b">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTMtMS0xLTI0NTg3_82c70a43-cf11-4a51-b665-1d025b591028">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTUtMS0xLTI0NTg3_d9bc9324-3c3d-49b5-bef3-68fbca79b36f">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized (loss) gain on debt securities available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTEtMS0xLTI0NTg3_615c1446-8552-4154-9140-06938688ae50">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTMtMS0xLTI0NTg3_5756b379-68a3-49c1-a058-a2325b839e51">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTUtMS0xLTI0NTg3_99f58f3b-eba2-4137-b197-1abc287be816">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTEtMS0xLTI0NTg3_bda6617f-9d30-461f-8d83-b1b3b2049e8d">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTMtMS0xLTI0NTg3_442c35f6-5495-4b76-b426-6e58bd867d8c">407.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTUtMS0xLTI0NTg3_7f990035-e50d-474e-9ab8-73707aaa0f61">40.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share, basic</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTEtMS0xLTI0NTg3_bcb4c70a-d336-4700-b313-64f214ee7903">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTMtMS0xLTI0NTg3_aa723d57-159d-4c16-bed6-1216d474ddca">4.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTUtMS0xLTI0NTg3_b8601815-977c-43c4-81a1-f30182f7b4d9">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share, diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTEtMS0xLTI0NTg3_204827d5-a524-4d49-b3c6-4f0f9d2fa867">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTMtMS0xLTI0NTg3_8f81895b-35b7-4772-a005-3ce531c080ae">4.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTUtMS0xLTI0NTg3_292c7c1b-7c38-4c61-80bb-734e2811c12b">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTEtMS0xLTI0NTg3_4d0dd282-f4b6-4cc6-99ce-4b96245b3b1d">94.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTMtMS0xLTI0NTg3_82bde8d4-4bb7-403f-9f24-52b11fe669ae">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTUtMS0xLTI0NTg3_a5f133ad-1796-4daf-91ab-ac6c13e78050">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTEtMS0xLTI0NTg3_7bd7717a-7f22-4cf6-ada0-97fbf4984c60">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTMtMS0xLTI0NTg3_96752df4-831e-4f51-9151-05385bb6c1b2">97.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTUtMS0xLTI0NTg3_17fdc62c-5f56-4064-8263-ef02d61dceb5">95.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.281%"></td><td style="width:0.1%"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive Income (Loss) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total Stockholders&#8217; Equity</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i37c451fdb8934177af07aab2f9815261_I20181231" decimals="INF" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMS0xLTEtMjQ1ODc_28953c28-0159-401f-b160-28db70ab6752">90.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c451fdb8934177af07aab2f9815261_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMy0xLTEtMjQ1ODc_e8c78128-d265-426e-971b-c2757f88654e">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i850a1c2e6bbe421b9e53c336f81ae194_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItNS0xLTEtMjQ1ODc_7e997c8c-c6ab-40b6-82dc-5c54f74fba99">1,660.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8328f9cd2d94115acc9db87f97b7e95_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItNy0xLTEtMjQ1ODc_4b5b6d26-d2fc-4839-b33f-b3e642d0db1c">2.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c5963bd49a44d8ab23a5f66be2f6e7_I20181231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItOS0xLTEtMjQ1ODc_bdf8bf34-379d-4d10-a3d3-5e0c53b132d1">1,177.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMTEtMS0xLTI0NTg3_b7b57e18-306c-4871-b233-c60e0ed6a170">480.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id623863c89314565b0c613c6e4844cd9_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzMtOS0xLTEtMjQ1ODc_5057e45b-8cc4-4761-a198-7e6f4f8c1604">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzMtMTEtMS0xLTI0NTg3_1f10d57a-2d67-4c70-b4ae-f41dcd3f7bf9">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on debt securities available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b1e1efe40c742aa916cca25579067f4_D20190101-20191231" decimals="-5" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzQtNy0xLTEtMjQ1ODc_cca85ee9-cb98-44df-9dad-438a3265292a">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzQtMTEtMS0xLTI0NTg3_b89521d9-7d01-4346-bdd2-7e01c05a7dfb">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzUtNS0xLTEtMjQ1ODc_a65959f8-d5f0-43f8-976b-b27b4cbe5d17">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzUtMTEtMS0xLTI0NTg3_43e5b4dc-5145-4038-b205-79b24e99e472">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMC0xLTEtMjk1OTY_5ea9ac00-e603-441e-9579-bb39249f3899">Cumulative-effect adjustment to equity due to adoption of ASU 2016-02</span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieebdcec5b54b4ac6bdd2c1d5c2eba719_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtOS0xLTEtMjk2MDk_41554713-e6af-422a-8e40-8546effa6147">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15f9746d0c4c45cbbdbb3cee1e0be1d3_I20181231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMTEtMS0xLTI5NjE1_7cac3641-a296-46ff-84ee-76c978c024f9">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of common stock under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9be0134c1cf94658b1ea4f2a9d3aabd0_D20190101-20191231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMS0xLTEtMjQ1ODc_bb8899f5-95cf-44a8-bc32-9fc473f180d4">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtNS0xLTEtMjQ1ODc_4671fc34-da3d-40b4-b320-a84992a33dbc">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMTEtMS0xLTI0NTg3_d786fb72-a1ff-4cf2-8d96-30ed72ba455c">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e5a9db50e334fceb17223af88813a25_I20191231" decimals="INF" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMS0xLTEtMjQ1ODc_5db91718-56b3-4c27-9a0b-7bdf4e6448c4">92.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e5a9db50e334fceb17223af88813a25_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMy0xLTEtMjQ1ODc_59bf0cfa-9b48-451b-b162-7a70f59f4b06">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57f40d95bd5147f493ce76a1d0d54aa9_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtNS0xLTEtMjQ1ODc_7fef4c44-4578-4fcb-a209-e9f9b1bb7610">1,768.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5d3840166f542059e79068112c8351f_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtNy0xLTEtMjQ1ODc_071d8dee-474c-4587-90cf-5f6024d5207d">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee36651c7ea24ee1aa1a126bc3592f0f_I20191231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtOS0xLTEtMjQ1ODc_0bcf6220-6fb3-497d-a478-88bb22dd62c7">1,132.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMTEtMS0xLTI0NTg3_b86fce5f-3e55-4e85-bf85-64b3a2c7f6ea">636.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f0e73949934202a967b64bd1dbcc51_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzktOS0xLTEtMjQ1ODc_858abf42-99f8-4390-a70e-6d7e170fef4a">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzktMTEtMS0xLTI0NTg3_c752109a-61df-46a6-afcf-ee997e900fc1">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain on debt securities available-for sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e86243316844136bf4f9112f308abd5_D20200101-20201231" decimals="-5" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEwLTctMS0xLTI0NTg3_aa7a12e2-fccf-4869-ba98-5cea132c4167">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEwLTExLTEtMS0yNDU4Nw_e4963091-58d0-48f6-9087-cc7829cb3a95">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzExLTUtMS0xLTI0NTg3_8653031b-2f05-450b-98e7-bb7aec51b918">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzExLTExLTEtMS0yNDU4Nw_d8bbab90-1138-4d4c-894d-c651cdf152f7">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity component of repurchased convertible senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTUtMS0xLTI5Njgz_ed9d620f-fc27-4451-a93e-8f6e24ae20e3">47.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTExLTEtMS0yOTY4OQ_ce4e63ec-9893-4404-9d4b-6be5ff89e7ef">47.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of common stock under stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e59d7192ea042ceb2f48ae50260ec53_D20200101-20201231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTEtMS0xLTI0NTg3_cf7d8ba0-cbeb-4b2b-96d0-fa0454cbeb2c">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTUtMS0xLTI0NTg3_46d898a0-a698-4ee1-8693-440e6ea490f0">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTExLTEtMS0yNDU4Nw_600ed36a-e63d-405c-a1ed-175d5d04a6f1">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff0345a87ec74fc2a1683ba954ad2eea_I20201231" decimals="INF" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTEtMS0xLTI0NTg3_2082b4f8-d8e9-49c6-844a-efe543da7380">93.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff0345a87ec74fc2a1683ba954ad2eea_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTMtMS0xLTI0NTg3_f51006d2-1f7d-47c7-9889-e1a8dd339083">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icecbc009167140a6a443a748af98ebb3_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTUtMS0xLTI0NTg3_04ff6dd9-5757-4e67-9b5b-a89307611cd3">1,849.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id963b79121954d3ea702db8ac5aaec24_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTctMS0xLTI0NTg3_8820e443-f9c9-4710-abd3-f4be6cbd0eb3">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia21b050c801745578a610cadda27dda1_I20201231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTktMS0xLTI0NTg3_d79d0737-003c-408d-9f93-6ba8ada5633a">725.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTExLTEtMS0yNDU4Nw_f16fdc53-9b3d-4329-9632-f2d71220c501">1,126.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic234985e15bc4a1d876dca26f6503d8e_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE3LTktMS0xLTI0NTg3_429c2a8a-734b-44ab-a594-233020f15460">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE3LTExLTEtMS0yNDU4Nw_40cebac8-bdcf-4b18-8101-452678c9b70b">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized loss on debt securities available-for-sale, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e85c7f4bf3e4e8a9b237b4341c4b9a7_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE4LTctMS0xLTI0NTg3_1765d70f-11f9-4897-8c22-4181ee264f50">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:MarketableSecuritiesUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE4LTExLTEtMS0yNDU4Nw_3231adc2-16d5-4cf3-a4ba-175eda7c68c7">3.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534bd413a5404e2da06b975889c1c349_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE5LTUtMS0xLTI0NTg3_015e071d-5a90-42c1-96bc-aa73ee04ddd5">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE5LTExLTEtMS0yNDU4Nw_ca9095ea-14da-4aba-9345-e66a54ed9f9a">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.25pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of common stock under stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f297dfb69c64f82a416c17120802d81_D20210101-20211231" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTEtMS0xLTI0NTg3_296074c0-47fe-4dac-9d55-12f8130d1c45">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i534bd413a5404e2da06b975889c1c349_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTUtMS0xLTI0NTg3_d44079a8-76d8-478e-95a2-eb9c625a2df5">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTExLTEtMS0yNDU4Nw_4e2abfc5-a0bf-4a05-a67a-ff53b59395f2">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8a1c966228ae4eef899ad097142a3675_I20211231" decimals="INF" name="us-gaap:SharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTEtMS0xLTI0NTg3_dd1bde34-59a9-4b74-a9b5-5496669eb33f">94.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a1c966228ae4eef899ad097142a3675_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTMtMS0xLTI0NTg3_236f9299-86d9-4255-ad2b-4714784696b8">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee2ff30f3694c999d1bfea3cac16df0_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTUtMS0xLTI0NTg3_15d92c5c-61a9-4723-b3a0-f8d06053b828">2,011.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48483359c04e4e06bd637a90f9af6854_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTctMS0xLTI0NTg3_d2fa9997-655b-4c72-9c32-0e44d5c5877b">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f748abc48034713a36960dffd357755_I20211231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTktMS0xLTI0NTg3_ec1c81d3-c6ea-4c84-bab5-d2f2c8a74e2a">635.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTExLTEtMS0yNDU4Nw_fac19c74-1f6b-471b-8cab-099380f440a1">1,374.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtMS0xLTEtMjQ1ODc_332ef259-e0dd-48d2-8649-c6a8bde69f6d">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtMy0xLTEtMjQ1ODc_87461311-4f6b-413c-a81e-b90f0c66f573">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtNS0xLTEtMjQ1ODc_0df320de-5ed5-4ad0-ac02-249e8a398608">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reconciliation of net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtMS0xLTEtMjQ1ODc_789c990e-4749-4e2e-920c-fe5b500a164c">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtMy0xLTEtMjQ1ODc_e3a99296-d6a6-4d6b-b371-970cc18a787b">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtNS0xLTEtMjQ1ODc_9cdf98df-3668-40a9-a8fa-1447d3dc85c9">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtMS0xLTEtMjQ1ODc_29a33b50-a492-40e8-8e45-3a39487d381d">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtMy0xLTEtMjQ1ODc_0279f45d-572a-4bbf-8a21-f53ac04f83b1">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtNS0xLTEtMjQ1ODc_c35c2161-5f57-478e-9902-4531b24f3205">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctMS0xLTEtMjQ1ODc_6593cd24-036c-4416-95a5-886ceca0b22f">16.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctMy0xLTEtMjQ1ODc_ba3a5309-2961-4dd3-9ccf-b828d40538a4">20.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctNS0xLTEtMjQ1ODc_89ec5265-139e-454b-bb11-2a8e56497e04">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtMS0xLTEtMjQ1ODc_b4211be7-109a-4689-b92a-7dc0adf1f76f">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtMy0xLTEtMjQ1ODc_5cacce82-a23b-4a0c-92d4-4fffb1ae239c">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtNS0xLTEtMjQ1ODc_9d1e3976-786f-4709-b9f7-0b03f55e0e6e">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktMS0xLTEtMjQ1ODc_93111576-80d3-4b26-af9b-7d35e9c2c081">20.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktMy0xLTEtMjQ1ODc_0b9d814c-f13f-4e43-aba9-620bcda13d52">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktNS0xLTEtMjQ1ODc_b23a2963-6741-48a0-9272-2ef3eb6ce639">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTEtMS0xLTI0NTg3_146f6ad3-30f0-4b58-8dd6-8fcece58f75e">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTMtMS0xLTI0NTg3_3490b1f9-b99d-40e1-bdc1-6cb49d862cf1">310.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTUtMS0xLTI0NTg3_5e466e6e-c1cb-4326-b6a7-75e0300d0214">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on extinguishment of convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTEtMS0xLTI0NTg3_398ae897-83bc-44e2-9514-222b15028b3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTMtMS0xLTI0NTg3_128b1fc9-2c5d-41c8-b78f-f77fad051e95">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTUtMS0xLTI0NTg3_e7c989c3-528f-449c-8a40-100d786e73e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTEtMS0xLTI0NTg3_5a705233-5f6e-419a-bc4c-09514c9a72b5">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTMtMS0xLTI0NTg3_c650faed-76f2-401b-bbf2-32301f8ecce5">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTUtMS0xLTI0NTg3_5103a015-0990-4b30-9bb4-b5ef4ba6567e">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTEtMS0xLTI0NTg3_dcd30494-674e-4961-80b4-7cd967673a86">28.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTMtMS0xLTI0NTg3_166a22f4-8f56-4e2c-988d-a54dbc4456fb">30.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTUtMS0xLTI0NTg3_8846d880-de51-4089-be1d-051c726a0dfc">69.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTEtMS0xLTI0NTg3_5d81e187-9cb0-4ba3-b9e9-9ca67810f9e0">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTMtMS0xLTI0NTg3_2461a53a-f1dc-4b0b-940c-987d61f8ee40">10.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTUtMS0xLTI0NTg3_40134bda-3a91-4213-9edb-62322780e6d6">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTEtMS0xLTI0NTg3_f7ea7f93-06a4-429e-9b0b-8a9965590eba">56.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTMtMS0xLTI0NTg3_89dac54d-0a58-40c3-bcfb-f8b444d4a999">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTUtMS0xLTI0NTg3_322da7b8-e3e7-4810-add0-9fb5e9c3320e">54.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTEtMS0xLTI0NTg3_71f0b9f6-49c7-4342-8f8f-cdab133f5fa2">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTMtMS0xLTI0NTg3_658f27c0-8d85-4dea-b263-769baa752106">23.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTUtMS0xLTI0NTg3_d2bb89f8-1a16-4c54-b4ec-0e4e92be9e8a">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTEtMS0xLTI0NTg3_851def7e-a3aa-4dc9-9869-63d7f624bf26">256.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTMtMS0xLTI0NTg3_c010fbd0-f092-4033-812b-eb2725ad661f">228.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTUtMS0xLTI0NTg3_67562569-3f8d-4ecd-8238-dce43cc5e51c">147.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of debt securities available-for-sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTEtMS0xLTI0NTg3_8f094152-c3c6-4875-ae6f-5c8127f46a84">800.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTMtMS0xLTI0NTg3_bf78ee2c-b143-43ae-bd47-5610d2d7df6e">735.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTUtMS0xLTI0NTg3_4ae937d8-a30a-4a52-b37e-4b0249198ab6">797.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and maturities of debt securities available-for-sale</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTEtMS0xLTI0NTg3_38c1e75f-ed74-4325-95bb-41e0d3ce9abe">697.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTMtMS0xLTI0NTg3_57ed0760-3b2d-403f-b543-927ebd3bee60">750.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTUtMS0xLTI0NTg3_fe049e50-196d-443d-afc3-9056757a73cb">669.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTEtMS0xLTI0NTg3_f7b832fd-abde-4fc3-b330-64abd79e6a02">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTMtMS0xLTI0NTg3_e9be5a6e-d456-4296-90dd-44e24c271746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTUtMS0xLTI0NTg3_8d3a90ad-a195-4f5c-840b-abbab6fe73b0">68.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTEtMS0xLTI0NTg3_914bcc76-34b5-444f-950b-0e77caf711a2">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTMtMS0xLTI0NTg3_55343d1d-e286-42ec-98b3-bab4dad2e794">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTUtMS0xLTI0NTg3_eaecffaf-5f64-412a-82c5-971324dee7c3">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTEtMS0xLTI0NTg3_5b2602fb-5399-4955-913c-eb4497ebd8a5">130.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTMtMS0xLTI0NTg3_e102a1be-3563-458f-a84a-f7893d7951f5">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTUtMS0xLTI0NTg3_19770768-574a-416b-9c39-c0ee1564af56">211.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flows from Financing Activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuances of common stock under benefit plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTEtMS0xLTI0NTg3_d44b4cc3-8361-4b4c-bc0a-5416083d34b9">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTMtMS0xLTI0NTg3_86026f8d-4608-4294-9c52-d4e0ec5fa1a7">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTUtMS0xLTI0NTg3_cc512d38-8f5e-407f-8ad6-a6fb722244bd">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Partial repurchase of convertible senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTEtMS0xLTI0NTg3_931993df-75c1-4cdc-b19f-2d7b1183e03e">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTMtMS0xLTI0NTg3_7bbac2b7-7ea1-4911-9049-f9e855d0c012">186.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTUtMS0xLTI0NTg3_fbcfd2a2-47ce-487a-ad58-42bba7a906fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTEtMS0xLTI0NTg3_a7e47558-9153-4660-a10f-b36bc08e8a4e">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTMtMS0xLTI0NTg3_2fe7d080-4050-413c-b044-9b87ef992405">157.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTUtMS0xLTI0NTg3_a6618147-cd5c-471a-a4c1-e4ac8c323e4a">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTEtMS0xLTI0NTg3_9d35fcb4-78d1-4068-a467-011a658c14cc">153.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTMtMS0xLTI0NTg3_6f564330-7bdc-4ca0-ace6-b37ac51f7258">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTUtMS0xLTI0NTg3_c5181db4-7e91-4ed8-9c92-f1a2129ded24">31.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTEtMS0xLTI0NTg3_b68b9fc0-65b6-49a2-a9ba-403722bb7aa7">190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTMtMS0xLTI0NTg3_564ab491-488c-4efd-9437-5a8801d2e2b9">115.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTUtMS0xLTI0NTg3_ae9a4ddd-c139-488c-ade8-d533f6c05c00">147.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTEtMS0xLTI0NTg3_2ad9a86e-ad98-4b2b-be4b-6a25f4b333f1">344.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTMtMS0xLTI0NTg3_25c80f40-a3ad-4678-a65b-0ca77ed144bb">190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTUtMS0xLTI0NTg3_365b3843-5538-4d87-8696-af1d0395c228">115.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental Disclosure:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash capital expenditures</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTEtMS0xLTI0NTg3_2b3ccb64-b2df-4f6a-9994-be643b792836">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTMtMS0xLTI0NTg3_d257a107-220b-48e7-aca1-8e4c332c9570">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTUtMS0xLTI0NTg3_449bd881-cc7e-4de6-83e0-ddb21c171525">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets acquired through operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTEtMS0xLTI0NTg3_f7c2edbd-f7f3-42ec-9a07-03eb624594d2">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTMtMS0xLTI0NTg3_ba48bfbf-528a-4b3d-b690-c2ad022cf700">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTUtMS0xLTQwOTg2_5e252e05-1e33-4ed2-81ee-f9c76cc6ad6a">77.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTEtMS0xLTI0NTg3_94fe2b53-6c16-4d1c-bb8a-370c4ca16b22">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTMtMS0xLTI0NTg3_8141cfb2-8e70-4261-a252-4fe7d744cc12">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTUtMS0xLTI0NTg3_31cdb921-3b0f-4149-8586-28390a1e440b">11.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTEtMS0xLTI0NTg3_6246f11a-97a4-42b0-b37e-7ada0bb58275">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTMtMS0xLTI0NTg3_02c29b64-e881-4e07-81c0-a47aa0c9195f">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTUtMS0xLTI0NTg3_314e523f-75a6-4dfb-91c7-47fc3a938524">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_136"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NEUROCRINE BIOSCIENCES, INC.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES&#160;TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_139"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.&#160;<ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg0_bafcb067-7d33-4c3e-8b94-29f42a158ced" continuedAt="i6cf871bdca284fcaab8c402fd6e333b3" escape="true">Organization and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i6cf871bdca284fcaab8c402fd6e333b3" continuedAt="ic9a901853a9648abbb577228d9f4d9f3"><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="nbix:BusinessDescriptionPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc3_a5f1a908-d64f-4fde-ad9b-de11eea87c34" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc., or Neurocrine Biosciences, the Company, we, our or us, was incorporated in California in 1992 and reincorporated in Delaware in 1996. Neurocrine Continental, Inc., is a Delaware corporation and a wholly owned subsidiary of Neurocrine Biosciences. We also have <ix:nonFraction unitRef="subsidiary" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="nbix:NumberOfIrishSubsidiaries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM2Nw_440a340e-835d-4c94-a6d9-13c64b95c0d2">two</ix:nonFraction> wholly-owned Irish subsidiaries, Neurocrine Therapeutics, Ltd. and Neurocrine Europe, Ltd. both of which were formed in December 2014 and are inactive.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk0_0cb85d09-4cdd-42ed-9438-af218172979b" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Neurocrine Biosciences as well as our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg3_bb42aabf-ed9a-4841-8079-7e21ca06cbb8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc4_462220c7-96db-4231-a11d-5f298636e4df" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry Segment and Geographic Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a single industry segment&#160;&#8211; the discovery, development and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. We had no foreign-based operations during any of the years presented.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg5_36e08d7f-e883-4485-b062-9f78f78f5af0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments that are readily convertible into cash without penalty and have an original maturity of three months or less at the time of purchase to be cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkw_da860ec9-3921-4f99-ba6b-87027f59dcd0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of customer allowances for prompt payment discounts, chargebacks and any allowance for doubtful accounts. We estimate the allowance for doubtful accounts based on existing contractual payment terms, actual payment patterns of our customers and individual customer circumstances. To date, an allowance for doubtful accounts has not been material.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkx_69acd660-2a65-4898-a896-edb590734fc1" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of investments in certificates of deposit, corporate debt securities and securities of government-sponsored entities. We classify debt securities as available-for-sale. Debt securities available-for-sale are recorded at fair value, with unrealized gains and losses included in other comprehensive income or loss, net of tax. We exclude accrued interest from both the fair value and amortized cost basis of debt securities. A debt security is placed on nonaccrual status at the time any principal or interest payments become <ix:nonNumeric contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM0Mjc_44d8b549-2579-4d8f-8e2e-08f41d252f91">90</ix:nonNumeric> days delinquent. Interest accrued but not received for a debt security placed on nonaccrual status is reversed against interest income.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income includes amortization of purchase premium or discount. Premiums and discounts on debt securities are amortized using the effective interest rate method. Gains and losses on sales of debt securities are recorded on the trade date in investment income and other, net, and determined using the specific identification method.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc5_ef7034ee-dbe0-4411-852c-bd38fefafaec" continuedAt="ic2c436f7db8f42adac2b346c5aecd210" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For debt securities available-for-sale in an unrealized loss position, we first assess whether we intend to sell, or it is more likely than not that we will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic9a901853a9648abbb577228d9f4d9f3" continuedAt="ia8dbfe2eb3064b7e95b5c2a4ac0b1e42"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic2c436f7db8f42adac2b346c5aecd210">Accrued interest receivables on debt securities available-for-sale totaled $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InterestReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzUzODI_ea5f2e36-ff60-4b59-a7db-1e6cfbd12e41">2.2</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InterestReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NjcwMTk_14672360-094d-476f-b36f-1dbcc900bd20">3.7</ix:nonFraction> million as of December&#160;31, 2020. We do not measure an allowance for credit losses for accrued interest receivables. For the purposes of identifying and measuring an impairment, accrued interest is excluded from both the fair value and amortized cost basis of the debt security. Uncollectible accrued interest receivables associated with an impaired debt security are reversed against interest income upon identification of the impairment. <ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzU3OTg_2442c281-65dd-4011-9cd9-a87d1974bbca"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzU3OTg_89431985-01c5-4dfb-b5c2-016ec9563883">No</ix:nonFraction></ix:nonFraction> accrued interest receivables were written off during 2021, 2020 or 2019.</ix:continuation></span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgw_f62eaabb-31a7-4e97-8b4c-d5588cd818fb" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record cash equivalents, debt securities available-for-sale and equity security investments at fair value based on a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). The fair value hierarchy consists of the following three levels:</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Unobservable inputs that reflect our own assumptions about the assumptions that market participants would use in pricing the asset or liability when there is little, if any, market activity for the asset or liability at the measurement date.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities available-for-sale are classified as Level 2 and carried at fair value. We estimate the fair value of debt securities available-for-sale by utilizing third-party pricing services. These pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Such inputs include market pricing based on real-time trade data for similar instruments, issuer credit spreads, benchmark yields, broker/dealer quotes and other observable inputs. We validate valuations obtained from third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing data in certain instances.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities of certain companies that are subject to holding period restrictions longer than one year are classified as Level 3 and carried at fair value using an option pricing valuation model. The most significant assumptions within the option pricing valuation model are the stock price volatility, which is based on the historical volatility of similar companies and the discount for lack of marketability related to the term of the restrictions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deem transfers between levels of the fair value hierarchy to have occurred at the end of the reporting period during which the event or change in circumstances that caused the transfer occurred.</span></div></ix:nonNumeric><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc2_9ebb2f77-115e-4d00-a6fe-9841cd9666e9" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value. We determine the cost of inventory using the standard-cost method, which approximates actual cost based on the first-in, first-out method. We assess the valuation of our inventory on a quarterly basis and adjust the value for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand. Inventory costs resulting from these adjustments are recognized as cost of sales in the period in which they are incurred. When future commercialization is considered probable and the future economic benefit is expected to be realized, based on management&#8217;s judgment, we capitalize pre-launch inventory costs prior to regulatory approval.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgx_b860cc0d-0747-4ac4-b4c8-6293b2cf2e7f" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated over the estimated useful lives of the assets using the straight-line method. Equipment is depreciated over an average estimated useful life of <ix:nonNumeric contextRef="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzkzODk_ebc2fc8e-f0c8-4895-a829-be44c7404a9b">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzkzOTU_7f4611e1-7d5e-40ff-bc14-175dcc6a1732">7</ix:nonNumeric> years. Leasehold improvements are depreciated over the shorter of their estimated useful lives or the remaining lease term. Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NDE_6a526d7a-518f-4b88-aaf7-bb5d8ed0cc1d">10.9</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NTI_9191b79a-05ed-4700-beb2-51b0edcdb120">8.6</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NjY_504fa41c-5703-4024-936f-5d0f86cc5234">7.4</ix:nonFraction> million for 2019.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg2_8037018c-f1f2-44a7-9f37-3129bd7e5dc6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows. If&#160;the carrying amount is not recoverable, we measure the amount of any impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset.</span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia8dbfe2eb3064b7e95b5c2a4ac0b1e42" continuedAt="i7a4bdeb5400546ff9ea2eb9b3937d396"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjcz_8509862d-44c5-4354-b1ff-657c19eceb9e" continuedAt="i8434da712e8c4900a7178fbafdde7e80" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized using a five-step model: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Product Sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the United States, we sell INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (valbenazine) primarily to specialty pharmacy providers and distributors and ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (opicapone) primarily to wholesale distributors. We recognize net product sales when the customer obtains control of our product, which occurs at a point in time, typically upon delivery of our product to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. Such estimates are based on information received from external sources (such as written or oral information obtained from our customers with respect to their period-end inventory levels and sales to end-users during the reporting period), as supplemented by management&#8217;s judgement. Our process for estimating reserves established for these variable consideration components does not differ materially from historical practices. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant categories of sales discounts and allowances are as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Discounts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Product discounts are based on payment terms extended to our customers at the time of sale, which include incentives offered for prompt payment. We maintain a reserve for product discounts based on our historical experience, including the timing of customer payments. To date, actual product discounts have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period. Such estimates are based on actual historical rebates by state, estimated payor mix, state and federal regulations and relevant contractual terms, as supplemented by management&#8217;s judgement. Our rebate accrual calculations require us to project the magnitude of our sales that will be subject to these rebates. There is a significant time-lag in our receiving rebate notices from each state (generally, several months or longer after a sale is recognized). Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The difference between the list price, or the price at which we sell our products to our customers, and the contracted price, or the price at which our customers sell our products to qualified healthcare professionals, is charged back to us by our customers. In addition to actual chargebacks received, we maintain a reserve for chargebacks based on estimated contractual discounts on product inventory levels on-hand in our distribution channel. To date, actual chargebacks have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payor and Pharmacy Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates as a percentage of sales under payor and pharmacy contracts. We estimate these rebates based on actual historical rebates, contractual rebate percentages, sales made through the payor channel and purchases made by pharmacies. To date, actual payor and pharmacy rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient Financial Assistance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To help patients afford our products, we offer financial assistance to qualified patients with prescription drug co-payments required by insurance as well as free trial vouchers to qualifying new patients. We accrue for patient financial assistance based on estimated claims and the cost per claim we expect to receive associated with inventory that remains in the distribution channel at period end. To date, actual copay assistance and free trial vouchers have not differed materially from our estimates.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7a4bdeb5400546ff9ea2eb9b3937d396" continuedAt="i6e0e99850871415996a3da5114a72d81"><ix:continuation id="i8434da712e8c4900a7178fbafdde7e80"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributor and Other Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In connection with the sales of our products, we pay distributor and other fees, which are generally recorded as a reduction of revenue, to certain customers that provide us with inventory management, data and distribution services. To the extent we can demonstrate a separable benefit and fair value for these services, we classify the associated costs in selling, general and administrative expenses. These costs are typically known at the time of sale, resulting in minimal adjustments subsequent to the period of sale.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We offer our customers product return rights primarily limited to errors in shipment, damaged product and expiring product, provided it is within a specified period of the product expiration date, as set forth in the associated distribution agreement. Where actual returns history is not available, we estimate a returns allowance based on benchmarking data for similar products and industry experience. We record this estimate as a reduction of revenue in the period the related sale is recognized. Once product is returned, it is destroyed. To date, actual product returns have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into collaboration and licensing agreements under which we out-license certain rights to our product candidates to third parties. The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees; development, regulatory and/or commercial milestone payments; and royalties on net sales of licensed products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses of Intellectual Property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, we assess the nature of the combined performance obligation to determine whether it is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Milestones.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At the inception of each arrangement that includes developmental, regulatory or commercial milestones, we evaluate whether achieving the milestones is considered probable and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. Amounts for milestones that are not within our control, such as where achievement of the specified event is dependent on the development activities of a third party or approvals from regulators, are not considered probable of being achieved until the specified event occurs. Revenue is recognized from the satisfaction of performance obligations in the amount billable to the customer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For arrangements that include sales-based royalties, and under which the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). Each quarterly period, sales-based royalties are recorded based on estimated quarterly net sales of the associated collaboration products. Differences between actual results and estimated amounts are adjusted for in the period in which they become known, which typically follows the quarterly period in which the estimate was made. To date, actual royalties received have not differed materially from our estimates.</span></div></ix:continuation><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjky_0cf087f5-d7cf-4323-999d-95dc57db6129" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and debt securities available-for-sale. We have established guidelines to limit our exposure to credit risk by diversifying our investment portfolio and by placing investments with high credit quality financial institutions and maturities that maintain safety and liquidity. To date, we have not experienced any credit losses and do not believe we are exposed to any significant credit risk in relation to these financial instruments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to credit risk from our accounts receivable related to our product sales. Our two largest customers represented approximately <ix:nonFraction unitRef="number" contextRef="i5b8d7ede3b7d42c98a7b4985db5ee059_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwMzkw_c272af31-b289-4ada-b52f-3d8a6e263e8b">82</ix:nonFraction>% of our total product revenues for 2021 and approximately <ix:nonFraction unitRef="number" contextRef="i2d2cb1ed67a045fab2a95fa6a800c0a0_D20190101-20191231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwNDQ4_00f6873e-5743-42bf-9fa1-2c5ad361b64b"><ix:nonFraction unitRef="number" contextRef="ic8d3727d3ea944fea7f664879d4c85b0_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwNDQ4_3c8e3c91-8209-4611-b52e-376b9e8eaf88">86</ix:nonFraction></ix:nonFraction>% for both 2020 and 2019, as well as the significant majority of our accounts receivable balances at December&#160;31, 2021 and 2020. To date, we have not experienced any significant losses with respect to the collection of these accounts receivable.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6e0e99850871415996a3da5114a72d81" continuedAt="i84ebebdd209a4dbc91a1fc65b23bad9b"><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkz_31909535-0a7f-4ecf-9133-5c797578c9b7" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes third-party manufacturing, transportation, freight and indirect overhead costs associated with the manufacture and distribution of INGREZZA and ONGENTYS, royalty fees on net sales of ORILISSA and ORIAHNN, and adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk3_a5546a3c-2626-4ef5-a7e9-d036a60dae31" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, or R&amp;D, expenses consist primarily of salaries, payroll taxes, employee benefits and share-based compensation charges for those individuals involved in ongoing R&amp;D efforts; as well as scientific consulting fees, preclinical and clinical trial costs, R&amp;D facilities costs, laboratory supply costs and depreciation of scientific equipment. All such costs are expensed as R&amp;D when incurred. These expenses result from our independent R&amp;D efforts, as well as efforts associated with collaborations, in-licenses and third-party funded research arrangements, including event-based milestones.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc0_36cf9e89-a811-4285-866b-0eac15f8a783" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Acquisitions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of an asset that does not (or a group of assets that do not) meet the definition of a business using the cost accumulation method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the asset (or assets) acquired on the basis of its (or their) relative fair value(s) on the measurement date. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in R&amp;D activities which have no alternative future use are expensed as in-process research and development, or IPR&amp;D, on the acquisition date. Future costs to develop these assets are expensed as R&amp;D when incurred.</span></ix:nonNumeric></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgy_df99036e-3456-4ff0-9542-6a6bc922afea" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed when services are performed or goods are delivered and are included in selling, general and administrative expense in our consolidated statements of income. We incurred advertising costs related to INGREZZA and ONGENTYS of $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjAz_6bd647af-cb20-48c7-866d-a0bba854f2f0">139.8</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjE0_95cb1a9d-9ac3-423b-ad7b-985ce6628515">64.8</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjI4_65569162-7212-4e72-b9c5-6730f11714a2">40.6</ix:nonFraction> million for 2019.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk1_dedb8135-abed-4ed5-94bf-a72080e17544" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant stock options to purchase our common stock to eligible employees and directors and also grant certain employees restricted stock units, or RSUs, and performance-based restricted stock units, or PRSUs. Additionally, we allow employees to participate in an employee stock purchase plan, or ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock options and shares to be issued under the ESPP using the Black-Scholes option-pricing model on the date of grant. RSUs are valued based on the closing price of our common stock on the date of grant. The fair value of equity instruments expected to vest is recognized and amortized on a straight-line basis over the requisite service period of the award, which is generally <ix:nonNumeric contextRef="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzMzc3_a2c4fe6e-400d-4fea-9071-fdcee7729735">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzMzgz_c6200ab0-e1e5-40d1-bead-b312ef2b362d">4</ix:nonNumeric> years; however, certain provisions in our equity compensation plans provide for shorter vesting periods under certain circumstances. The fair value of shares to be issued under the ESPP is recognized and amortized on a straight-line basis over the purchase period, which is generally <ix:nonNumeric contextRef="i945a7d74da95458e8a3fe747ece465cd_D20210101-20211231" name="nbix:ESPPPurchasePeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzNjY0_a810f6a9-3db5-46b0-b51e-913244946f6f">6</ix:nonNumeric> months. PRSUs vest upon the achievement of certain predefined company-specific performance-based criteria. Expense related to PRSUs is generally recognized ratably over the expected performance period once the predefined performance-based criteria for vesting becomes probable.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk2_be42f50f-116d-4efb-b31c-2436e07b957f" continuedAt="i7815bfc733a14e8a860e2104580e29a3" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our income tax provision (benefit) is computed under the asset and liability method. Significant estimates are required in determining our income tax provision (benefit). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to </span></ix:nonNumeric></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i84ebebdd209a4dbc91a1fc65b23bad9b" continuedAt="i5b1abbd30aad465ba3a949576856b195"><ix:continuation id="i7815bfc733a14e8a860e2104580e29a3"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. Refer to Note 9 to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities based on the technical merits of the position. An adverse resolution of one or more of these uncertain tax positions in any period could have a material impact on the results of operations for that period.</span></div></ix:continuation><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgz_42a16674-b50f-4e97-b08c-68238dc3c4c9" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the treasury stock method and reflect the weighted average number of common and potentially dilutive shares outstanding during the period, excluding those which effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt instruments that may be settled entirely or partly in cash may, in certain circumstances where the borrower has the ability and intent to settle in cash, be accounted for under the treasury stock method. In December 2021, we entered into the First Supplemental Indenture, dated as of May 2, 2017, by and between the Company and U.S. Bank National Association, as Trustee, or the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the <ix:nonFraction unitRef="number" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NjQyMjk_54aba427-4e3b-4372-9405-689de6a6703a">2.25</ix:nonFraction>% convertible senior notes due May 15, 2024, or the 2024 Notes, in cash upon conversion and to settle any conversion premium in either cash or shares of our common stock. As a result, and consistent with historical practice, only the shares required to settle any conversion premium would be considered dilutive under the treasury stock method. Further, PRSUs for which the performance condition has not been achieved are excluded from the calculation of diluted earnings per share.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg1_986ddd08-c7d5-457a-9b50-f1a29ed0df4d" continuedAt="i34c4ac3ffb164d858b426583f421e135" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, we adopted Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, using the modified retrospective transition method. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application of Topic 740. The adoption of ASU 2019-12 did not result in a cumulative-effect adjustment to retained earnings. The comparative prior period information continues to be reported under the accounting standards in effect during those periods. The impact of the adoption is expected to be immaterial to our financial position, results of operations and cash flows on an ongoing basis.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements.</span></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i5b1abbd30aad465ba3a949576856b195" continuedAt="i2b8146ff8c6b4dbc8243c569928e412b"><ix:continuation id="i34c4ac3ffb164d858b426583f421e135" continuedAt="i7ea5e15fa55643b18a504bc436b5c8f1">ASU 2020-06.</ix:continuation></ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b8146ff8c6b4dbc8243c569928e412b"><ix:continuation id="i7ea5e15fa55643b18a504bc436b5c8f1"> In August 2020, the FASB issued ASU 2020-06,&#160;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity's own equity. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Instead, entities will account for convertible debt instruments wholly as debt, unless certain other conditions are met. The adoption of ASU 2020-06 is expected to prospectively reduce reported interest expense and increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders&#8217; equity to liabilities as it relates to the 2024 Notes. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We will adopt <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d">ASU 2020-06</span> on January 1, 2022 using the modified retrospective transition method, which allows for a cumulative-effect adjustment in the period of adoption and does not require restatement of prior period amounts. Under this transition method, the cumulative effect of the accounting change is expected to increase the carrying amount of the 2024 Notes by $<ix:nonFraction unitRef="usd" contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231" decimals="-5" name="us-gaap:ConvertibleDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMTg5_f9177336-a3f1-4fb3-be0d-b8233e66258e">42.2</ix:nonFraction>&#160;million, reduce deferred tax liabilities by $<ix:nonFraction unitRef="usd" contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NzI5MzA_62682cdf-122a-46ab-9bd9-1945af0a5966">10.0</ix:nonFraction>&#160;million, reduce the accumulated deficit by $<ix:nonFraction unitRef="usd" contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjI3_5c2ac297-9ccb-4508-9499-9cfc0bb38a0c">74.6</ix:nonFraction>&#160;million, reduce additional paid-in capital by $<ix:nonFraction unitRef="usd" contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231" decimals="-5" sign="-" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjcx_4059bee6-32db-455a-aec7-fe514a3840b1">106.8</ix:nonFraction>&#160;million.</ix:continuation></ix:continuation> </span></div><div id="ic35e9d12d921455aa45f30d1d4130202_145"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEzMjE3_c6062e8f-3370-4d5d-be9d-09c50ef2cd94" continuedAt="ibca6fc1e75434c1fb9c5d878f7d4fc0c" escape="true">Collaboration and License Agreements</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEzMjE5_f31de7d7-d85b-4477-a487-210c7243dfc4" escape="true">Under the terms of our existing collaboration and license agreements, we may be required to make potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-8" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzIzNw_a5c20507-5cd2-434c-a9cc-cc96b69faff1">10.9</ix:nonFraction> billion upon the achievement of certain event-based milestones. Such contingent payments are recorded when paid or payable.</ix:nonNumeric></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibca6fc1e75434c1fb9c5d878f7d4fc0c" continuedAt="i8e94bba348ee4e1f9e3701b6693eaf54"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heptares Therapeutics Limited, or Heptares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We entered into a collaboration and license agreement with Heptares, which became effective in December 2021, to develop and commercialize certain compounds containing sub-type selective muscarinic M1, M4, or dual M1/M4 receptor agonists, which compounds we have the exclusive rights to develop, manufacture and commercialize worldwide, excluding in Japan, where Heptares retains the rights to develop, manufacture, and commercialize all compounds comprised of M1 receptor agonists, subject to certain exceptions. We are responsible for all development, manufacturing, and commercialization costs. With respect to such rights retained by Heptares, we retain the rights to opt in to profit sharing arrangements, pursuant to which we and Heptares will equally share in the operating profits and losses for such compounds in Japan. Subject to specified conditions, we may elect to exercise such opt-in rights with respect to each such compound either before initiation of the first proof of concept Phase II clinical trial for such compound or following our receipt from Heptares of the top-line data from such clinical trial for such compound. In addition, we have entered into a 2-year research collaboration with Heptares that, unless extended by the parties, is scheduled to expire in December 2023.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Heptares $<ix:nonFraction unitRef="usd" contextRef="i43c71899173f405dbe3d33122d8cc5f3_D20210101-20211231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzEzNTI_e80d4795-dec9-4e3a-ae38-5dd5674c0b86">100.0</ix:nonFraction>&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;D in 2021. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Heptares may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i79c18d17c4d449729c00a0ccd9f18346_I20211231" decimals="-8" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzEzMzc_8c78db92-4238-4641-b482-4b9b064b9059">2.6</ix:nonFraction>&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which the royalty term for such licensed product has expired in such country. On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a licensed product and terminate on the later of (i) the expiration of the last patent covering such licensed product in such country, (ii) a number of years from the first commercial sale of such licensed product in such country and (iii) the expiration of regulatory exclusivity for such licensed product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement in its entirety or with respect to one or more targets upon 180 days&#8217; written notice to Heptares during the research collaboration term and upon 90 days&#8217; written notice to Heptares following the expiration of the research collaboration term. Following the expiration of the research collaboration term, Heptares may terminate the agreement on a target-by-target basis in the event that we do not conduct any material development activities outside of Japan with respect to a certain compound or licensed product within the applicable target class for a continuous period of not less than 365 days and do not commence any such activities within 120 days of receiving written notice. Either party may terminate the agreement, subject to specified conditions, (i) in the event of material breach by the other party, subject to a cure period, (ii) if the other party challenges the validity or enforceability of certain intellectual property rights, subject to a cure period, or (iii) if the other party becomes insolvent or takes certain actions related to insolvency.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Takeda Pharmaceutical Company Limited, or Takeda.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we entered into an exclusive license agreement with Takeda, pursuant to which we acquired the exclusive rights to develop and commercialize certain early to mid-stage psychiatry compounds, including luvadaxistat, NBI-1065845, NBI-1065846 and four non-clinical stage compounds. Luvadaxistat and the 4 non-clinical stage compounds have each been designated as a royalty-bearing product. NBI-1065845 and NBI-1065846 are currently each designated as a profit-share product. We are responsible for all manufacturing, development and commercialization costs of any royalty-bearing product. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Takeda $<ix:nonFraction unitRef="usd" contextRef="ia23be7e269184e22820e45d5995df04f_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NjUzMDA_28023171-2d86-42f0-8506-c8e951fc728b">120.0</ix:nonFraction>&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Takeda may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="ia5e99701bd3641d5a09bb0c7b27a6b9f_I20211231" decimals="-8" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzE5Mzk_4f50175d-e470-4354-8071-52fda6e9c1ae">1.9</ix:nonFraction>&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any royalty-bearing product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to NBI-1065845 and NBI-1065846, we and Takeda will equally share in the operating profits and losses. Takeda retains the rights to opt-out of the profit-sharing arrangements, pursuant to which Takeda would be entitled to receive potential future payments upon the achievement of certain event-based milestones with respect to such compounds and receive royalties on the future net sales of such compounds (in lieu of equally sharing in the operating profits and losses). Takeda may elect to exercise such opt-out right for such compound immediately following the completion of a second Phase II clinical trial for such compound, or, under certain circumstances related to the development and commercialization activities to be performed by us, before the initiation of a Phase III clinical trial for such compound.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i8e94bba348ee4e1f9e3701b6693eaf54" continuedAt="icaf973ba0b60470eaa45f18bef5c7515"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which, (i) for any royalty-bearing product, the royalty term has expired in such country; and (ii) for any profit-share product, for so long as we continue to develop, manufacture, or commercialize such licensed product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a royalty-bearing product and terminate on the later of (i) the expiration of the last patent covering such royalty-bearing product in such country, (ii) a number of years from the first commercial sale of such royalty-bearing product in such country and (iii) the expiration of regulatory exclusivity for such royalty-bearing product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement in its entirety or in one or more (but not all) of the United States, Japan, the European Union and the United Kingdom, or, collectively, the major markets, upon 6 months&#8217; written notice to Takeda (i) with respect to all licensed products prior to the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes, as defined in the agreement, prior to the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. We may terminate the agreement in its entirety or in one or more (but not all) of the major markets upon 12 months&#8217; written notice to Takeda (i) with respect to all licensed products following the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes following the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. Takeda may terminate the agreement, subject to specified conditions, (i) if we challenge the validity or enforceability of certain Takeda intellectual property rights or (ii) on a target class-by-target class basis, in the event that we do not conduct any material development or commercialization activities with respect to any licensed product within such target class for a specified continuous period. Subject to a cure period, either party may terminate the agreement in the event of any material breach, solely with respect to the target class of a licensed product to which such material breach relates, or in its entirety in the event of any material breach that relates to all licensed products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Idorsia Pharmaceuticals Ltd, or Idorsia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we entered into a collaboration and license agreement with Idorsia, pursuant to which we acquired the global rights to NBI-827104, a potent, selective, orally active and brain penetrating T-type calcium channel blocker in clinical development for the treatment of a rare pediatric epilepsy and other potential indications, including essential tremor. We are responsible for all manufacturing, development and commercialization costs of any collaboration product. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Idorsia $<ix:nonFraction unitRef="usd" contextRef="i7a59621400074ae78191449ef71bd45d_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzI2NzI_ab809a79-58d7-478b-a717-ad177926c3aa">45.0</ix:nonFraction>&#160;million upfront, which was expensed as IPR&amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Idorsia may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i456ae801af6b4bcc85cf441dbbfd2d07_I20211231" decimals="-8" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzIzOTE_b96c6242-1898-4317-a276-4c6057e5d530">1.7</ix:nonFraction>&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement, in its entirety or with respect to a particular compound or development candidate, upon 90 days&#8217; written notice to Idorsia. Further, in the event a party commits a material breach and fails to cure such material breach within 90 days after receiving written notice thereof, the non-breaching party may terminate the agreement in its entirety immediately upon written notice to the breaching party.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Xenon Pharmaceuticals Inc., or Xenon. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we entered into a collaboration and license agreement with Xenon to identify, research and develop sodium channel inhibitors, including NBI-921352 and three preclinical candidates, which compounds we have the exclusive rights to develop and commercialize. We are responsible for all development and manufacturing costs of any collaboration product, subject to certain exceptions.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Xenon may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="ib237ea6839b14af68a00881661bda1d9_I20211231" decimals="-5" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODI3MTU_46371734-a868-4e04-b6c1-16ade31983c7">1.7</ix:nonFraction>&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product. Xenon retains the right to elect to co-develop one product in a major indication, pursuant to which Xenon would receive a mid-single digit percentage increase in royalties earned on the future net sales of such product in the United States and we and Xenon would equally share in the development costs of such product in the applicable indication, except where such development costs relate solely to the regulatory approval of such product outside the United States. </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="icaf973ba0b60470eaa45f18bef5c7515" continuedAt="i247b0f04b2b04598a5acd4fb16a981bd"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Xenon $<ix:nonFraction unitRef="usd" contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231" decimals="-5" name="nbix:UpfrontPaymentsMade" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQxNjI_316b318b-0f4f-4f11-8ffb-642567c52e87">30.0</ix:nonFraction>&#160;million upfront and purchased approximately <ix:nonFraction unitRef="shares" contextRef="ic6d6f5ca848240c5ac2c7ad24cd32191_I20191231" decimals="-5" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg0MjI_389c0357-a229-4fbc-8df6-5c632bfb0c9f">1.4</ix:nonFraction>&#160;million shares of Xenon common stock (at $<ix:nonFraction unitRef="usdPerShare" contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231" decimals="3" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQyMTc_c0b16d79-052d-4298-891b-b8de87edbbf9">14.196</ix:nonFraction> per share) for $<ix:nonFraction unitRef="usd" contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231" decimals="-5" name="nbix:MilestoneEquityPurchasePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg0MzU_a8535cd4-3aca-4cc3-ad86-075fad74f93a">20.0</ix:nonFraction>&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $<ix:nonFraction unitRef="usd" contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQ2OTk_528e262e-1497-4756-8354-8dd49768bb9c">14.1</ix:nonFraction>&#160;million after considering Xenon&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $<ix:nonFraction unitRef="usd" contextRef="i43094c3fedcd4655bb4323ec7e023ff3_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQ4NTQ_c83793f3-016c-4fa5-a60e-45ef050e6421">36.2</ix:nonFraction>&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;D in 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the European Union&#8217;s approval for the clinical trial application for NBI-921352 for the treatment of focal onset seizures in adults in September 2021, we paid Xenon a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930" decimals="-5" name="nbix:MilestonePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg1ODE_28c664ce-fdad-40d7-9340-b29fd5c85a08">10.0</ix:nonFraction>&#160;million, including a purchase of approximately <ix:nonFraction unitRef="shares" contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930" decimals="-5" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2MTA_183bbdb9-97be-4eab-8ce1-327e1154c83b">0.3</ix:nonFraction>&#160;million shares of Xenon common stock (at $<ix:nonFraction unitRef="usdPerShare" contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930" decimals="4" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2MjM_e846157f-750e-48e8-b38b-cac64f549d8d">19.9755</ix:nonFraction> per share). The purchased shares were recorded at a fair value of $<ix:nonFraction unitRef="usd" contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2NDc_f34b4a82-664b-416e-bc1f-a000a9a2f957">4.6</ix:nonFraction>&#160;million after considering Xenon&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $<ix:nonFraction unitRef="usd" contextRef="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzM4NDgyOTA4NjQ2NDI_ae5ca332-ae63-4069-adcf-c8ecdc0ea0af">5.4</ix:nonFraction>&#160;million of the milestone payment was expensed as R&amp;D.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the expiration of the royalty term for such product in such country. Upon the expiration of the royalty term for a particular licensed product and country, the license obtained by us with respect to such product and country will become fully paid, royalty free, perpetual and irrevocable. We may terminate the agreement upon 90 days&#8217; written notice to Xenon, provided that such unilateral termination will not be effective for certain products until we have used commercially reasonable efforts to complete certain specified clinical studies. Either party may terminate the agreement in the event of a material breach in whole or in part, subject to specified conditions.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager Therapeutics, Inc., or Voyager.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we entered into a collaboration and license agreement with Voyager, pursuant to which we acquired certain rights to develop and commercialize the NBIb-1817 for Parkinson&#8217;s disease program, Friedreich&#8217;s ataxia program and two undisclosed programs. We are responsible for all development costs of any collaboration product, subject to certain co-development and co-commercialization rights retained by Voyager. In February 2021, we notified Voyager of our termination of the NBIb-1817 for Parkinson&#8217;s disease program, which became effective August 2, 2021. The termination did not apply to any program other than the NBIb-1817 for Parkinson&#8217;s disease program.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Voyager may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i2d30d0be95cb415b8e4d465eff571719_I20211231" decimals="-5" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODE1MDc_379c8e2b-b36f-421b-83a6-f2f7ad3f241f">1.3</ix:nonFraction>&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Voyager $<ix:nonFraction unitRef="usd" contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231" decimals="-5" name="nbix:UpfrontPaymentsMade" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzU0NTI_4aa1d42a-468b-4d0f-9ff8-00ae24cfc125">115.0</ix:nonFraction>&#160;million upfront and purchased approximately <ix:nonFraction unitRef="shares" contextRef="if4c4fe5c60424af0bcadedd757afff96_I20191231" decimals="-5" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTgxNjM_f1db092f-8b38-495c-aec3-e63bc400dfac">4.2</ix:nonFraction>&#160;million shares of Voyager common stock (at $<ix:nonFraction unitRef="usdPerShare" contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231" decimals="4" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzU1MDk_74fcdf86-e984-4117-9485-679be96345cc">11.9625</ix:nonFraction> per share) for $<ix:nonFraction unitRef="usd" contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231" decimals="-5" name="nbix:MilestoneEquityPurchasePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTgxODA_3fb70e52-28b8-4cbc-9fbb-add95a0981c1">50.0</ix:nonFraction>&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $<ix:nonFraction unitRef="usd" contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzYzOTg_ce287ac1-c02d-41d9-a4d6-db5463548983">54.7</ix:nonFraction>&#160;million after considering Voyager&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $<ix:nonFraction unitRef="usd" contextRef="i4e054e20087341ada5c247008d55c3b7_D20190101-20190331" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzY1NTU_c72f5cf3-ced9-44e1-938f-2b6fb52f579e">113.1</ix:nonFraction>&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;D in 2019. In addition, we paid Voyager $<ix:nonFraction unitRef="usd" contextRef="i7f5841fc889c4d08846ef46e8a70311f_D20190401-20190630" decimals="-5" name="us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1Mjc1NDQ_418aef47-9b67-4c38-9678-0c039e76faf6">5.0</ix:nonFraction>&#160;million upfront, which was expensed as IPR&amp;D in 2019, to acquire the rights outside the United States to the Friedreich&#8217;s ataxia program. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the agreement will continue in effect until the expiration of the last to expire royalty term with respect to any collaboration product or the last expiration or termination of any exercised co-development and co-commercialization rights by Voyager as provided for in the agreement. We may terminate the agreement upon 180 days&#8217; written notice to Voyager prior to the first commercial sale of any collaboration product or upon 1 year after the date of notice if such notice is provided after the first commercial sale of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BIAL &#8211; Portela &amp; Ca, S.A., or BIAL.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We acquired the United States and Canada rights to ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(opicapone) from BIAL in 2017, and launched ONGENTYS in the United States in September 2020 as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. We are responsible for all commercialization costs of ONGENTYS in the United States and Canada and rely on BIAL for the commercial supply of ONGENTYS.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, BIAL may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i86636d6fafc9428a9d7466bfe935ab09_I20211231" decimals="-5" name="nbix:PotentialMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc0OTE3MzE_a3d0ee67-335f-4044-9f5b-0d03e93faafb">75.0</ix:nonFraction>&#160;million upon the achievement of certain event-based milestones. In addition, with respect to ONGENTYS, in the event we fail to meet certain minimum sales requirements for a particular year in comparison to our annual sales forecast for such year, we would be obligated to pay BIAL an amount equal to the difference between the actual net </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i247b0f04b2b04598a5acd4fb16a981bd" continuedAt="i7d117eacac0c4f12bb8596e0bcaa1186"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales and minimum sales requirements for such year. Further, upon our written request to BIAL 12 months prior to the estimated expiration of the term of a licensed product, we will negotiate the continuation of BIAL&#8217;s supply of such licensed product after the term. After the term, and if BIAL is no longer supplying such licensed product, BIAL would be entitled to receive a low double-digit royalty on our future quarterly net sales of such licensed product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the FDA&#8217;s approval for ONGENTYS for Parkinson&#8217;s disease in April 2020, we paid BIAL a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="if3045b62535f464b86c604c3234e0d9c_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjUwNjg_e56fd045-2672-4ae5-8750-d986623b4cb9">20.0</ix:nonFraction>&#160;million, which was expensed as R&amp;D in 2020. In connection with the FDA&#8217;s acceptance of the NDA for opicapone for Parkinson&#8217;s disease in 2019, we paid BIAL a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="ibad5cee165ce4cf8891c0de774e460a5_D20190101-20191231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjUyNDU_8f434cf6-de33-4f5d-8d57-f848fb0a2579">10.0</ix:nonFraction>&#160;million, which was expensed as R&amp;D in 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until a generic product with respect to such licensed product is sold in a country and sales of such generic product are greater than a specified percentage of total sales of such licensed product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement upon 9 months&#8217; written notice to BIAL. BIAL may terminate the agreement in the event we fail to meet the minimum sales requirements for any 2 years, or under certain circumstances involving a change of control of Neurocrine Biosciences. Under certain circumstances where BIAL elects to terminate the agreement in connection with a change of control of Neurocrine Biosciences, BIAL would be obligated to pay us a termination fee. Either party may terminate the agreement if the other party materially breaches the agreement and does not cure the breach within a specified notice period, or upon the other party&#8217;s insolvency.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mitsubishi Tanabe Pharma Corporation, or MTPC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We out-licensed the rights to valbenazine in Japan and other select Asian markets to MTPC in 2015. MTPC is responsible for all development, manufacturing and commercialization costs of valbenazine in such markets.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231" decimals="-5" name="nbix:PotentialMilestonePaymentReceipts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTUxNzM_6765f4c8-b396-40c1-9340-5f2bbee43ab6">55.0</ix:nonFraction>&#160;million upon the achievement of certain event-based milestones and would be entitled to receive royalties at tiered percentage rates on MTPC&#8217;s future net sales of valbenazine for the longer of <ix:nonNumeric contextRef="iebafbee9477a4c18a360adb95c24c539_D20210101-20211231" name="nbix:PatentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NjIyNjA_8fe84203-7fab-4fad-a5cb-217e4232c6b0">10</ix:nonNumeric> years or the life of the related patent rights. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with MTPC&#8217;s submission of a filing for marketing authorization for valbenazine for the treatment of tardive dyskinesia in Japan in April 2021, we received a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDA1Njc_a93f2608-a055-47f1-a494-20f2f643ce0c">15.0</ix:nonFraction>&#160;million, which was recognized as collaboration revenue in 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently conducting the KINECT-HD study, a placebo-controlled Phase III study of valbenazine in adult Huntington disease patients with chorea. In connection with our performance of the study, we recognized non-cash collaboration revenue of $<ix:nonFraction unitRef="usd" contextRef="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3NDI_3ed9f2f3-27f3-4c84-874a-5ea30f97e24f">5.7</ix:nonFraction>&#160;million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i13f8068eb08a4699b20184347a6e696a_D20200101-20201231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3MTk_9c412aae-0aa7-4147-9e5d-d2289dc32e9d">2.6</ix:nonFraction>&#160;million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i76d0ccd9a2e24853bab0ecd66739a001_D20190101-20191231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3MzQ_05c33722-9aa4-447b-a795-be504071d5fe">0.9</ix:nonFraction>&#160;million for 2019. As of December&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231" decimals="-5" name="us-gaap:DeferredRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODk0NDU_9fd7abe2-7acb-4094-9b99-b6c969b217b9">1.0</ix:nonFraction>&#160;million of revenue is being deferred in connection with our continuing performance obligations under the collaboration and will be recognized as non-cash collaboration revenue over the remaining study period using an input method according to costs incurred to-date relative to estimated total costs associated with the study.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MTPC may terminate the agreement upon 180 days&#8217; written notice to us. In such event, all out-licensed product rights would revert to us.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AbbVie Inc., or AbbVie. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We out-licensed the global rights to elagolix to AbbVie in 2010. AbbVie is responsible for all development and commercialization costs of elagolix. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $<ix:nonFraction unitRef="usd" contextRef="i451e907724df41c5908356a4f2323922_I20211231" decimals="-5" name="nbix:PotentialMilestonePaymentReceipts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjA4NjQ_006ff27f-3d4c-4aad-8e10-7b5ce335620b">366.0</ix:nonFraction>&#160;million upon the achievement of certain event-based milestones and will continue to receive royalties at tiered percentage rates on AbbVie&#8217;s quarterly net sales of elagolix for the longer of <ix:nonNumeric contextRef="i3ef358c546644634864929f3c2061c03_D20210101-20211231" name="nbix:PatentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE4MDMxMjM_c531b906-b680-49f3-b9c4-c307fcb0a55d">10</ix:nonNumeric> years or the life of the related patent rights.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie launched ORILISSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix tablets) in the United States in August 2018 as an FDA-approved oral medication for the management of moderate to severe endometriosis pain in women. In June 2020, AbbVie launched ORIAHNN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix, estradiol and norethindrone acetate capsules and elagolix capsules) in the United States as an FDA-approved oral medication for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. We recognized elagolix royalty revenue of $<ix:nonFraction unitRef="usd" contextRef="i4f9ae86c7e9144a1bae39b561ed9746c_D20210101-20211231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODk0NjA_69ae7616-9562-43fc-912d-1dd46d122b31">22.3</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i454f573ac4474e279abf38d39ec2838c_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3NDE3NjY_b12e171c-1e0f-4fe5-8ee5-e20f2fdb6a35">19.2</ix:nonFraction>&#160;million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i3fddadf6fcb24a699f2fa1cbf8dd90f5_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3NDE3ODQ_2ffa49da-d7cc-4345-ae86-7a50ceca06ac">14.3</ix:nonFraction>&#160;million for 2019.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i7d117eacac0c4f12bb8596e0bcaa1186"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the FDA&#8217;s approval for AbbVie&#8217;s ORIAHNN for uterine fibroids in May 2020, we received a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="i0db30671c08348dab7eba8e85cf822e8_D20200101-20201231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MTIyNTQ_1eda00a2-e898-4823-ba99-16d0ab7a2212">30.0</ix:nonFraction>&#160;million, which was recognized as collaboration revenue in 2020. In connection with the FDA&#8217;s acceptance of AbbVie&#8217;s NDA for ORIAHNN for uterine fibroids in 2019, we received a regulatory milestone of $<ix:nonFraction unitRef="usd" contextRef="i16b9930a1b5945c1bdf18b24ad954df4_D20190101-20191231" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MTIyNzE_5ab6bbe0-bc93-4b72-ad43-9ffc83694ae3">20.0</ix:nonFraction>&#160;million, which was recognized as collaboration revenue in 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie may terminate the agreement upon 180 days&#8217; written notice to us. In such event, all out-licensed product rights would revert to us.</span></div></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_148"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2MDI_74f67843-064b-4649-92c1-31d759327961" continuedAt="i372a5aed04cf489dbe2bb3915beb33fc" escape="true">Debt Securities</ix:nonNumeric></span></div><ix:continuation id="i372a5aed04cf489dbe2bb3915beb33fc"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2MDM_13bf591f-e8ba-4d18-ab13-c9acf72065d5" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, unrealized gain and loss recognized in accumulated other comprehensive income (loss) and fair value of debt securities available-for-sale at December&#160;31, 2021, aggregated by major security type and contractual maturity:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.073%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contractual<br/>Maturity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMy0xLTEtMjg4NjU_182a94db-b476-4662-a63b-75bf97f16277">204.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItNS0xLTEtMjg4NjU_35456a31-bc2b-4f5d-90e3-8c100de6d952">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItNy0xLTEtMjg4NjU_29377ffb-4c1b-412c-a7e7-59613ac32e80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItOS0xLTEtMjg4NjU_b01e24f8-1637-45cf-8a48-fe87e997a0bc">204.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTEtMS0xLTI4ODY1_087f7080-0783-422e-bd19-7d1ad61d68fb">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTMtMS0xLTI4ODY1_29d71f03-af00-45a6-a561-a54390752115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTUtMS0xLTI4ODY1_33d39b3c-7a63-4e9a-8dd4-bccb71b4e7ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTctMS0xLTI4ODY1_adfa77ba-be5e-4290-8b32-91af5c57e2e1">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMy0xLTEtMjg4NjU_cdb6fb71-09a1-42bd-b141-6b6265a6cd1d">128.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtNS0xLTEtMjg4NjU_0e4e4aa1-4030-4ba0-90b9-7e7c9fd4474b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtNy0xLTEtMjg4NjU_6e4cf324-024a-4004-8692-929f0f43bc92">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtOS0xLTEtMjg4NjU_9cff80b4-bf4f-4e1e-9041-0c68c76d5967">128.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTEtMS0xLTI4ODY1_1e0d79cb-d6ad-4d56-8bdd-2fbf35e5c490">299.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTMtMS0xLTI4ODY1_28fa6f7f-7644-4f1d-ad4e-454e0d4d091b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTUtMS0xLTI4ODY1_0ba16bfa-937c-4761-8242-40d1ef423b11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTctMS0xLTI4ODY1_582d6171-b3a3-4aa1-b0d9-8aeecdb03afd">300.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMy0xLTEtMjg4NjU_7222385a-218f-4c1a-b2c8-f884e8fc8b76">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtNS0xLTEtMjg4NjU_b0e50a4b-b202-44d1-9a09-09319366d1c0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtNy0xLTEtMjg4NjU_fe021baf-a8c6-47ee-afde-99927cb08ab1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtOS0xLTEtMjg4NjU_5f1b8134-2757-4faa-86f5-8a39b893b142">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTEtMS0xLTI4ODY1_571e59c3-6453-49bc-875c-28f69fe6eaf3">230.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTMtMS0xLTI4ODY1_73edbacf-1f35-425c-9b4e-00fb9d230b31">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTUtMS0xLTI4ODY1_255324c4-bd13-4a5c-89f6-09b70714e617">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTctMS0xLTI4ODY1_b583e27c-05d3-4883-8e78-b1d6ab12eddc">231.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMy0xLTEtMjg4NjU_faf4b98f-3f16-4d1f-aff4-32a98cccf41e">370.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtNS0xLTEtMjg4NjU_5542f171-ee1a-49dc-87fa-2892875e08c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtNy0xLTEtMjg4NjU_76634ecc-f2da-4869-a27c-e29101e97663">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtOS0xLTEtMjg4NjU_3295d1da-884a-4f07-a6c8-e4828689d706">370.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTEtMS0xLTI4ODY1_119f84fe-2d21-449e-9d49-e66d9bba2ea3">612.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTMtMS0xLTI4ODY1_9a6b078e-81cb-463e-a655-4c19f8e61896">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTUtMS0xLTI4ODY1_53809edc-60f2-4174-aa71-b174bd37eb96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTctMS0xLTI4ODY1_2011c1d9-5cf5-49c3-bc0c-cd9facee318a">613.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMy0xLTEtMjg4NjU_201c46a6-bcab-448b-9189-2500cb119c00">358.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctNS0xLTEtMjg4NjU_b42e4212-a679-4fcf-98bc-d31cdeb8c806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctNy0xLTEtMjg4NjU_20b94b80-1bbe-471e-bddf-29e23534bbd0">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctOS0xLTEtMjg4NjU_dde04c60-935f-428f-9978-efbddf722236">357.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTEtMS0xLTI4ODY1_cf46199b-4f72-4e97-8b69-882ff7adc50a">144.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTMtMS0xLTI4ODY1_354048e9-f173-4dd9-a2ba-2dfaf9389562">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTUtMS0xLTI4ODY1_9e5409a6-9816-4c88-8a30-608f3a31e973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTctMS0xLTI4ODY1_e23127e4-cef6-4527-b94d-7050c27c64ff">145.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMy0xLTEtMjg4NjU_cca5c3f0-00c4-4295-802a-eae934c740ac">204.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtNS0xLTEtMjg4NjU_26a42a33-c458-4233-91dd-8337ec73a01b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtNy0xLTEtMjg4NjU_e0c04d7b-8797-4aad-8dd9-dd302083fb67">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtOS0xLTEtMjg4NjU_4bada154-e57d-479a-8126-03c17083f6a1">203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTEtMS0xLTI4ODY1_b5ab03c9-22a9-4129-9451-4bf118878063">81.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTMtMS0xLTI4ODY1_ef24b79e-b6be-4524-b3e1-a126cb9e4fb0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTUtMS0xLTI4ODY1_0af0c9c0-bed0-41a9-84a6-e6123a068c43">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTctMS0xLTI4ODY1_542b6e5d-3d56-49e0-9af4-97848b37ad0b">81.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMy0xLTEtMjg4NjU_ceed7519-013e-461a-a29f-f4c9f81e0742">563.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktNS0xLTEtMjg4NjU_fbc91e8e-e2db-4027-911c-886de80b3250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktNy0xLTEtMjg4NjU_c9641ac6-7be0-4ffd-840f-4a434e4ddc33">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktOS0xLTEtMjg4NjU_343993c1-36a0-4b58-b227-fdcb69e18f70">560.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTEtMS0xLTI4ODY1_3b82adf3-0455-4437-91fa-ad3d3d0dbfcb">226.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTMtMS0xLTI4ODY1_087e51c6-8ba8-4e08-99df-adb4618ccc79">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTUtMS0xLTI4ODY1_4caa3933-c980-4e33-882b-5c2f3b630a00">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTctMS0xLTI4ODY1_e7a6bc83-c4f8-46e6-b1dc-6d08259ca413">227.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our security portfolio consisted of <ix:nonFraction unitRef="security" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="nbix:DebtSecuritiesAvailableForSalePositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2NDkyNjc0NDM2MjY_c609ea2e-35c6-4292-9ca1-8e4adc88beee">164</ix:nonFraction> debt securities available-for-sale, including <ix:nonFraction unitRef="security" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2NDkyNjc0NDM3MTI_e2f4d8d2-4006-45be-8b2e-35e5c892ab62">136</ix:nonFraction> such securities that were in an unrealized loss position but of high credit quality. Unrealized losses on these investments were primarily due to changes in interest rates. We do not intend to sell these investments and it is not more likely than not that we will be required to sell these investments before recovery of their amortized cost basis. We did not recognize an allowance for credit losses as of December&#160;31, 2021 or 2020.</span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzM4NDgyOTA3MDIwMTE_531b6cfb-ce8c-4a5b-9161-1942d60c8bc2" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes debt securities available-for-sale in an unrealized loss position for less than 12 months, aggregated by major security type. There were no debt securities available-for-sale in an unrealized loss position for longer than 12 months as of December&#160;31, 2021 or 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0735a600c0d40f49b4766b4bceeb49c_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMS0xLTEtMjg4ODI_b6c3c3d3-4b82-4d00-b5d3-ba3aa3756827">428.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0735a600c0d40f49b4766b4bceeb49c_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMy0xLTEtMjg4ODI_26c23268-0170-4bd5-9310-89f1dd7446b1">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01bd7b047c1401a899b33800d0940b5_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMTItMS0xLTQxMDg3_b1f41b17-4dd7-4ca5-aa33-128c312bb7f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic01bd7b047c1401a899b33800d0940b5_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMTQtMS0xLTQxMDg4_6d15009e-371d-4512-9fe0-1f5846e40798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24cc646be8f346209fda92f0f7069e29_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMS0xLTEtMjg4ODI_063de587-682c-49dc-afaa-ceb60f115fb6">230.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24cc646be8f346209fda92f0f7069e29_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMy0xLTEtMjg4ODI_dc798081-cd23-42a6-a84d-9760674692b6">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie25af8b80ac74893a5e4045458ebe3d2_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMTItMS0xLTI4ODgy_d71a3a37-8399-4c5d-a121-794fd34f788a">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie25af8b80ac74893a5e4045458ebe3d2_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMTQtMS0xLTI4ODgy_6f8e95ea-0615-4609-9fc8-5137c7a2fef6">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMS0xLTEtMjg4ODI_100cec30-1ae7-4451-8365-4e482f10f951">659.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMy0xLTEtMjg4ODI_9894a680-16ae-4104-a720-db04b6dd300f">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMTItMS0xLTI4ODgy_076d75da-76be-48eb-b2ac-6501a4d6affb">95.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMTQtMS0xLTI4ODgy_1512f75c-782b-4b93-8fc7-99d8cc2cb32b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_151"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzk1MA_598e38bb-87d4-4cf2-9801-ac283e7c449d" continuedAt="i14f8725f68664991a8010f61604636ca" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i14f8725f68664991a8010f61604636ca"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDYwOTY_c1a77f5b-d66c-4b05-81e3-e74f512e7fff" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments, which were measured at fair value on a recurring basis, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.398%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76a49edc4ee149f98fe61f36a1419ed3_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMS0xLTEtMjg5MTY_873bf537-ebe3-4f9d-b0d9-1d31e0c1b0d3">340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if35fcf69010c43dba3cbbf868e2b0935_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMy0xLTEtMjg5MTY_93da4f3e-2279-4373-8271-68a1f9c74625">340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccfdb59917c64d368e0d64701f53126a_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtNS0xLTEtMjg5MTY_f449602a-c50e-457a-80c9-6c3bce1870c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04d318b9ca2d49ba84b1a9cb4b48b0ec_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtNy0xLTEtMjg5MTY_7f03096b-1663-47b1-a697-f6a14c63f93a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1fc4ae0f5aa4acab5c143236c0015b6_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtOS0xLTEtMjg5MTY_8752e761-985d-4cfd-b8f3-fa986d4ff5f5">187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aba8816099b49f2b953b15fdf4c39b2_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTEtMS0xLTI4OTE2_02166528-e22e-450b-aee8-4e37750ab35b">187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadfb23126df048dbb4bac68dde154ace_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTMtMS0xLTI4OTE2_74b62d21-5b6a-4bcc-a949-faa3c24a649e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1c4f4456c9492990b2e5c6e5a0abd1_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTUtMS0xLTI4OTE2_f4144249-47c1-4717-99d5-8689634e7268">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc5ff81f5ac24f46bf859c4b7eee092a_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMS0xLTEtMjg5MTY_5d213410-b087-447a-84c2-3fb3cd284e25">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ff788d8c75a4d8b9999c533dabd5da6_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMy0xLTEtMjg5MTY_bb1be795-421a-4cff-939b-168cb8a1df93">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4d41477f874a44b2eba85537a90148_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctNS0xLTEtMjg5MTY_07204e7a-e1b5-4d70-939f-7097566d00df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeb2651610fa4d00b5e2ac296d947a60_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctNy0xLTEtMjg5MTY_b40a0c77-a92e-413f-9a9a-803d3665b74c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dceb0bae28a43219d613b3ec3a546bd_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctOS0xLTEtMjg5MTY_c73d3e46-a061-4bf7-bee3-60d5f75e1eaf">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b4b9585d44440bfaf6270349255857e_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTEtMS0xLTI4OTE2_429178af-66a9-473d-bfe8-69c9018b4eba">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10fea06938594614aa8b26da5cf66581_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTMtMS0xLTI4OTE2_4120c452-5c99-469f-a3b0-8d24ad34a948">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic56519559b60412eb627bc0dd14040fa_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTUtMS0xLTI4OTE2_1fb43291-2150-4d58-9aba-491706aec387">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0f374dbf03747a2a83ac15d4ac0a895_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTEtMS0xLTI4OTE2_dde6c9c2-87fa-4663-bc24-2421075042dc">204.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0ada51f1409498abba0c3063df43360_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTMtMS0xLTI4OTE2_e685641e-4aa4-48c1-bca1-d6d85e52b346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876dd799b2e4471c969a5ee5b51f6040_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTUtMS0xLTI4OTE2_3da4daef-c705-4897-8baf-e2eca74d967e">204.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0efb41a1a6274a0fa1294d81a1e66e3e_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTctMS0xLTI4OTE2_e5854d6d-1100-4ee8-8b63-4123ab8ea6e9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa7306db60774a77859d10b85a4592ba_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTktMS0xLTI4OTE2_40ce6777-46c4-4eec-8b64-444ece1d783c">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43241c1d857141b3a9d4aa8134c3faa9_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTExLTEtMS0yODkxNg_c2c59977-153b-4b5a-a9f9-ffe58b479638">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib50a2b7c2c194c41a768ce0f89919060_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTEzLTEtMS0yODkxNg_f412a700-baaa-4046-8cef-7b3c07a6d240">82.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d11505b7354bdb8dd782858dcfdce3_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTE1LTEtMS0yODkxNg_212267b7-5efc-4dc8-a226-f335c5d51875">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadb175bdb8bf48208387a96572f64706_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTEtMS0xLTI4OTE2_85fa14b8-e65f-4496-a957-128cda08c027">485.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if70c342cd44742ebb040c59491a90fca_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTMtMS0xLTI4OTE2_62902703-18c8-4399-ba11-f470b57ebbb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7c841968874564a68757c7554e2071_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTUtMS0xLTI4OTE2_b7b170d0-f182-4cea-85fd-86a548c81384">485.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77011f1e4f6476984258b7755256168_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTctMS0xLTI4OTE2_feea1827-4696-484b-8e43-1de913af9ef4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0def021d29df4ec18dc8a7252ae17d0a_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTktMS0xLTI4OTE2_88cc39b6-3dce-4ae9-90b0-33bdd297396b">445.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10f1318702cc48bd9a8576b930cc668f_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTExLTEtMS0yODkxNg_97d16ef1-89df-4481-9134-cf0e0c3a7098">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84e3b1a6faf84f6db9b5b5a39c51c46c_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTEzLTEtMS0yODkxNg_ee3f6001-48cd-4d1d-8ba6-b799f8f677df">445.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7057cb4559b6490ab7be7846300e2a22_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTE1LTEtMS0yODkxNg_f67a1e97-46f7-4432-8da1-b5c902a0f3bc">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4cc70d0fde4bd498a8a0983c081d59_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTEtMS0xLTI4OTE2_7b657bf1-556e-427f-9a7b-fff2915f7cb4">240.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9f1618b76d04cb19552c0380c3a41a8_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTMtMS0xLTI4OTE2_98eb4594-52ff-4f02-a848-a240015ae034">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43e9f130272d4e318928d9dafd608b88_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTUtMS0xLTI4OTE2_a755ed8e-028e-4ce5-91df-cface838cf58">240.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf0666db5964cb0b1c6c44c2bb1140a_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTctMS0xLTI4OTE2_96887993-334f-458d-862f-04c01166efd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbeb38fcafcd44cf92ecbae65ec65d39_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTktMS0xLTI4OTE2_121110ee-aa86-4bb1-aef7-b7f288992078">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d7321b1fe734028a54ac2f80b9681ed_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTExLTEtMS0yODkxNg_06206161-c6fe-4048-98ec-f7adf9a51a6f">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35e8c83d4e9e4b538a866c7908923299_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTEzLTEtMS0yODkxNg_836a49bc-8c51-4540-b894-ad633ef8e07e">312.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0302646986a64378a658c9ee1c53404a_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTE1LTEtMS0yODkxNg_fb312975-e9c6-4f26-b971-4196a73b0acf">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities&#8211;biotechnology industry</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c29b15534a34aa1bd91898138b443d9_I20211231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTEtMS0xLTI4OTE2_0f9c4359-a55f-4c0b-a660-dc4f8fe85e78">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f3cf54d0e5248aeb00d32bbd4fe0441_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTMtMS0xLTI4OTE2_2bedffd1-5d8e-42fa-8d19-12b7af671369">52.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia476ce9b48f74567b16e1107fc4d5f58_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTUtMS0xLTI4OTE2_2d039ef2-3ea1-4b09-a771-d91bd10e7c29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i342378a3e6bf401686eecb77ea0a41b6_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTctMS0xLTI4OTE2_0a5d32a0-4d7b-4a8f-a47c-3b347f4cdae4">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96e57d5b9fc4cb2a73243bdd55f6767_I20201231" decimals="-5" name="us-gaap:Investments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTktMS0xLTI4OTE2_eb20f98f-3f2d-4a6d-bb0f-1b148cad5024">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf7b779b22d24eb6b77769f385e8229f_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTExLTEtMS0yODkxNg_aceddd29-6e4d-47eb-9b40-62f1e1a1e2f1">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd4b276a5774cf7bb670de6b43ee0b4_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTEzLTEtMS0yODkxNg_a7b6720c-d38e-419e-b1b3-6d7114f194d0">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47234201a06341db8895b8958db19f97_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTE1LTEtMS0yODkxNg_bba5122c-86cc-40e5-902b-635255b36971">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6692ce12fc644c68b73fb3a2340f8955_I20211231" decimals="-5" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTEtMS0xLTI4OTE2_8bd662e0-1403-4c7b-a5a8-7e0919a1ee3e">1,338.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55302882586a46d2ad57cdca3f162199_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTMtMS0xLTI4OTE2_9a767faf-cf13-4b29-9631-0554784b29a5">396.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d5b407bace949d5a87fb8d9069a7e54_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTUtMS0xLTI4OTE2_379d7633-5396-4ed3-9947-a24addf86338">931.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17791cc67ea8442dae07024c287c5a9b_I20211231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTctMS0xLTI4OTE2_a01e4819-6110-423a-a68c-2c5f116cdcff">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f43889d0d9d4bfab3fb6c31e2cfe848_I20201231" decimals="-5" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTktMS0xLTI4OTE2_03dbe89c-56fd-4a9d-99be-c0bca7ad84b7">1,069.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia17bbaa87ba6441bae1e26b9009ae2e3_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTExLTEtMS0yODkxNg_674407b1-0105-4415-9b4e-a129f5b0698f">190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02ed2ad514134c8abd326f4aa918a949_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTEzLTEtMS0yODkxNg_328d3490-f024-49e4-a181-725a22dc4ce4">841.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide17712ce808468da6c2d67ca2751e47_I20201231" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTE1LTEtMS0yODkxNg_6256fe3d-f547-47af-9527-76f7712c5b7a">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDYwOTc_d95b91aa-c490-447a-ad71-e8f04417751e" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of equity security investments, which were measured at fair value on a recurring basis using significant unobservable inputs (Level 3):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadbe113298b847b29bf4f91e55934f46_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItMy0xLTEtMjg5MTY_cdd7fbb5-e615-4dd8-8b60-5736a653190c">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb2904499f043418ddda2535a27e40f_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItNS0xLTEtMjg5MTY_fb0b2d1b-1e06-46b5-9d04-606a6097ed48">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i011bbd35393d4e94b37558ebd5a2d436_I20181231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItNy0xLTEtMjg5MTY_e6407dc9-7f76-43ee-94e8-8e8745ac9a74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtMy0xLTEtMjg5MTY_85fe138c-9cb0-487a-b42b-ddace29fe2f2">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtNS0xLTEtMjg5MTY_ba3dd606-337b-4e6c-a840-3613747aae31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtNy0xLTEtMjg5MTY_08702635-5195-4a4e-a6ae-353b3b87494e">68.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtMy0xLTEtMjg5MTY_eac55f12-ab81-4bd6-b6c4-4fe5dd9a4b92">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtNS0xLTEtMjg5MTY_1c637ce7-aadc-4dcb-b39f-a3dd91a53ec5">17.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtNy0xLTEtMjg5MTY_30d074bc-ef07-4b16-ae9b-63e9b05635d2">13.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMS0xLTEtNDA4Mzg_65ca84ab-6838-4fa5-ab9d-59a112757bc3">52.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMy0xLTEtNDA4MzI_1b98eddf-ce71-4baa-8745-1158def4dc71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNS0xLTEtNDA4MjY_9399b0aa-102b-44f0-9d9d-e639af4fd89b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie56afca00a6145f1a8cb8913d7007d6a_I20211231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMy0xLTEtMjg5MTY_139ebcd7-62c2-40df-bcaf-d447385c9045">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadbe113298b847b29bf4f91e55934f46_I20201231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNS0xLTEtMjg5MTY_009d1e33-0d36-41bb-b040-5f47d07ceb2c">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb2904499f043418ddda2535a27e40f_I20191231" decimals="-5" name="us-gaap:EquitySecuritiesFvNiRestricted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNy0xLTEtMjg5MTY_be208228-dae8-45a5-b330-25c2feec31e7">55.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) In September 2021, we purchased <ix:nonFraction unitRef="shares" contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930" decimals="-5" name="us-gaap:InvestmentOwnedBalanceShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzE2NDkyNjc0NDI5NjU_3c4a9069-eeb1-4c5e-a0ba-8df518e14267">0.3</ix:nonFraction>&#160;million shares of Xenon's common stock, valued at $<ix:nonFraction unitRef="usd" contextRef="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930" decimals="-5" name="us-gaap:PaymentsToAcquireRestrictedInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzE2NDkyNjc0NDMwMTE_e6604194-c77a-4d4c-9d0b-baa5e0340304">4.6</ix:nonFraction>&#160;million on the date of purchase, in connection with the European Union&#8217;s approval of the clinical trial application for NBI-921352.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) In the fourth quarter of 2021, our equity security investment in Xenon was transferred from Level 3 to Level 1 as the associated holding period restriction expired.</span></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the discount for lack of marketability used in the valuation analysis of our Voyager equity security investment was <ix:nonFraction unitRef="number" contextRef="i2d30d0be95cb415b8e4d465eff571719_I20211231" decimals="INF" name="nbix:DiscountForMarketabilityUsedInValuationAnalysis" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDc4OTk_b02a059a-835d-4f8a-aae6-4be635066b3c">2.5</ix:nonFraction>%. Unrealized gains and losses on equity security investments are included in other income (expense), net.</span></div></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_154"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU0_791c5066-fe07-459f-9b1f-619bcd586812" continuedAt="i32d5e7807b73409cb172614c6de80ad5" escape="true">Convertible Senior Notes</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32d5e7807b73409cb172614c6de80ad5" continuedAt="i0676be9de48e4fb29bdd182eccc633a4">On May&#160;2, 2017, we completed a private placement of&#160;$<ix:nonFraction unitRef="usd" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzg1_58479f0f-bf69-4f2b-a6e1-c150a7987366">517.5</ix:nonFraction> million&#160;in aggregate principal amount of&#160;the 2024 Notes and entered into the 2017 Indenture with respect to the 2024 Notes. The net proceeds from the issuance of the 2024 Notes were approximately $<ix:nonFraction unitRef="usd" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQzNDk_d48765d0-a981-4b1a-b544-466cf79e073f">502.8</ix:nonFraction> million, after deducting commissions and the offering expenses payable by us. The 2024 Notes accrue interest at a fixed rate of&#160;<ix:nonFraction unitRef="number" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQ2MjM_ccdffc29-9212-49a1-9429-c00abe7aa2dd">2.25</ix:nonFraction>%&#160;per year, payable semiannually in arrears on May&#160;15 and November&#160;15 of each year, and mature on May 15, 2024.</ix:continuation></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0676be9de48e4fb29bdd182eccc633a4" continuedAt="i0ea6f88ed4524fa28bd0762693439704"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $<ix:nonFraction unitRef="usd" contextRef="i80a878a1eb5a45cca632daa2d96abd21_I20201130" decimals="-5" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMwNTY_680d2d70-dc2e-4a58-b50d-39bd2359cfa7">136.2</ix:nonFraction>&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $<ix:nonFraction unitRef="usd" contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130" decimals="-5" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMxNDI_dbcc2ca6-db4d-4aaf-a576-abfc4bb8b2b8">186.9</ix:nonFraction>&#160;million in cash. We accounted for the partial repurchase of the 2024 Notes as a debt extinguishment. As a result, we attributed $<ix:nonFraction unitRef="usd" contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130" decimals="-5" name="nbix:FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMyNjY_8277488a-5574-4784-9d7d-2fde366bf1ed">130.7</ix:nonFraction>&#160;million of the aggregate repurchase price to the liability component based on the fair value of the liability component immediately before extinguishment. The fair value of the liability component was calculated at settlement using a discounted cash flow analysis with a discount rate of <ix:nonFraction unitRef="number" contextRef="i88996bf4af1e44edb618cc379576a171_I20201130" decimals="4" name="us-gaap:DebtInstrumentMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM1NTA_808638cf-3159-45a9-8337-a299eac4ae0e">3.37</ix:nonFraction>%, which was the market rate for similar notes that have no conversion rights. The difference of $<ix:nonFraction unitRef="usd" contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM2NDk_66ce2875-ccbe-4dd3-98c9-b6472f3ed0f8">56.3</ix:nonFraction>&#160;million between the fair value of the aggregate consideration remitted to certain holders of the 2024 Notes and the fair value of the liability component was attributed to the reacquisition of the equity component and recognized as a reduction to additional paid-in capital. The carrying amount of the liability of $<ix:nonFraction unitRef="usd" contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130" decimals="-5" name="nbix:CarryingAmountOfLiabilityComponentAtSettlement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM5NjA_6f2adba8-d809-4b66-b134-59795280aa0a">112.4</ix:nonFraction>&#160;million at settlement was recognized as a reduction to the 2024 Notes and resulted in an $<ix:nonFraction unitRef="usd" contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQwNTU_261036a0-88c6-46a1-a82f-312771d2a384">18.4</ix:nonFraction>&#160;million loss on extinguishment.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem for cash all or part of the 2024 Notes if the last reported sale price (as defined in the 2024 Indenture) of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNTI_704c9fea-3744-489c-abf6-81299eb1bc3a">130</ix:nonFraction>% of the conversion price then in effect (equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentConvertibleStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNTg_889f09f1-cf86-40f1-8853-d45df6d9fcf1">98.70</ix:nonFraction> as of December&#160;31, 2021) for at least&#160;<ix:nonFraction unitRef="d" contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNzA_1ad8dc82-d683-4baf-a0b0-a932aa6e884f">20</ix:nonFraction>&#160;trading days (whether or not consecutive) during any&#160;<ix:nonFraction unitRef="d" contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNjY_f26a82fd-5f36-4ac9-9ff4-9dbbc979ee9e">30</ix:nonFraction>&#160;consecutive trading-day period ending on, and including, the trading day immediately before the date which we provide notice of redemption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2024 Notes may convert the 2024 Notes at any time prior to the close of business on the business day immediately preceding May&#160;15, 2024, only under the following circumstances:</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">during any calendar quarter (and only during such calendar quarter), if the last reported sale price of our common stock for at least&#160;<ix:nonFraction unitRef="d" contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzk0Mg_e74d5714-7f11-4863-a40b-2e1dff307a0c">20</ix:nonFraction>&#160;trading days (whether or not consecutive) during a period of&#160;<ix:nonFraction unitRef="d" contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDY_8a16ca51-3bd2-449d-9b4e-04b9b64bcb9e">30</ix:nonFraction>&#160;consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than&#160;<ix:nonFraction unitRef="number" contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzExMjc_bf50b03b-c43d-4475-b26d-6c133cdcd33b">130</ix:nonFraction>%&#160;of the conversion price (equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" decimals="2" name="us-gaap:DebtInstrumentConvertibleStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzODU_889f09f1-cf86-40f1-8853-d45df6d9fcf1">98.70</ix:nonFraction> as of December&#160;31, 2021) on each applicable trading day;</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">during the&#160;<ix:nonFraction unitRef="d" contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzExOTc_32c6d42e-d672-49c8-84d4-14197868738b">5</ix:nonFraction>&#160;business-day period immediately after any&#160;<ix:nonFraction unitRef="d" contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEyNDI_b01ed4a7-8f53-478e-b7a1-799d703a67eb">5</ix:nonFraction>&#160;consecutive trading-day period (the measurement period) in which the trading price (as defined in the 2024 Indenture) per&#160;$<ix:nonFraction unitRef="usd" contextRef="ib1c20b9ca378493e9004243174a5bb6c_I20170502" decimals="INF" name="nbix:PrincipalAmountOnConversionRate" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEzNjc_e57c80f1-f196-466e-888b-37e1489cf60b">1,000</ix:nonFraction>&#160;principal amount of the 2024 Notes for each trading day of the measurement period was less than&#160;<ix:nonFraction unitRef="number" contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502" decimals="INF" name="nbix:MinimumPercentageOfTradingPriceToLastReportedSalePrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE0NjY_a592879e-5db5-4fe8-9a37-fea0cd22c4e9">98</ix:nonFraction>%&#160;of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of our assets; or</span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">if we call the 2024 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after January&#160;15, 2024, until the close of business on the scheduled trading day immediately preceding May&#160;15, 2024, holders may convert their 2024 Notes at any time.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we entered into the First Supplemental Indenture to the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2024 Notes in cash upon conversion and to settle any conversion premium, calculated based on the per share volume-weighted average price for each of the&#160;<ix:nonNumeric contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" name="nbix:TradingDaysDuringObservationPeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzIyMTA_3de684eb-3704-4c4d-aabc-4535651d0942">30</ix:nonNumeric>&#160;consecutive trading days during the observation period (as more fully described in the 2024 Indenture), in either cash or shares of our common stock. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest, and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2024 Notes will be paid pursuant to the terms of the 2024 Indenture.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial conversion rate for the 2024 Notes is&#160;13.1711&#160;shares of common stock per&#160;$<ix:nonFraction unitRef="usd" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="INF" name="nbix:PrincipalAmountOnConversionRate" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM1MDY_374c26bb-0ca6-459f-90b9-353d231c6e8c">1,000</ix:nonFraction>&#160;principal amount, which is equivalent to an initial conversion price of&#160;approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="INF" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM1OTU_934f5195-e7f0-42b4-89dd-64cb7f27bb52">75.92</ix:nonFraction>&#160;per share of our common stock. At the initial conversion rate, settlement of the 2024 Notes for shares of our common stock would approximate <ix:nonFraction unitRef="shares" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM3Mzk_67275a95-f73b-42c5-aa71-48e12293e447">5.0</ix:nonFraction> million shares. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2024 Notes represented a premium of approximately&#160;<ix:nonFraction unitRef="number" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="3" name="nbix:DebtInstrumentConvertibleConversionPremium" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM5NjM_2b0b4d0d-1e36-45c5-ba1e-2d8117a4758b">42.5</ix:nonFraction>%&#160;to the closing sale price of&#160;$<ix:nonFraction unitRef="usdPerShare" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="2" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM5OTU_138da351-f8fc-4ee6-88db-620a47a74ea4">53.28</ix:nonFraction>&#160;per share of our common stock on the Nasdaq Global Select Market on April&#160;26, 2017, the date that we priced the private offering of the 2024 Notes.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i0ea6f88ed4524fa28bd0762693439704"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change, as defined in the 2024 Indenture, subject to certain conditions, holders of the 2024 Notes may require us to repurchase for cash all or part of their 2024 Notes at a repurchase price equal to&#160;<ix:nonFraction unitRef="number" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzU2NTY_ab373912-633a-4fe4-9d0e-4cd9132d7695">100</ix:nonFraction>%&#160;of the principal amount of the 2024 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#8216;&#8216;make-whole fundamental change&#8217;&#8217; (as defined in the 2024 Indenture) occurs prior to January&#160;15, 2024, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert their notes in connection with the make-whole fundamental change.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes are our general unsecured obligations that rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the 2024 Notes, and equal in right of payment to our unsecured indebtedness.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2024 Notes were classified as a long-term liability as of December&#160;31, 2021, the future convertibility and associated balance sheet classification will be monitored at each quarterly reporting date and analyzed dependent upon market prices of our common stock during the prescribed measurement periods. In the event that we have the election to redeem the 2024 Notes or the holders of the 2024 Notes have the election to convert the 2024 Notes at any time during the prescribed measurement period, the 2024 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to separately account for the liability and equity components of the 2024 Notes. The liability component of the instrument was valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $<ix:nonFraction unitRef="usd" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="-5" name="nbix:CarryingAmountOfLiabilityComponentUponIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY3OTI_8d3abc53-ecc4-4188-be51-de955adf32fd">368.3</ix:nonFraction> million&#160;was calculated using a&#160;<ix:nonFraction unitRef="number" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="3" name="us-gaap:DebtInstrumentInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY4MTg_01847326-130b-47d6-bba5-171070e65644">7.5</ix:nonFraction>%&#160;assumed borrowing rate. The equity component of $<ix:nonFraction unitRef="usd" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="-5" name="us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY4Njk_98d48c62-be44-4a80-866a-ffbb76f5ab5c">149.2</ix:nonFraction> million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2024 Notes and recorded in additional paid-in capital on the consolidated balance sheet on the issuance date. The equity component is treated as a discount on the liability component of the 2024 Notes, which is currently being amortized over the <ix:nonNumeric contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU2_554e44fb-3594-4cda-8720-6ec41a6fe74c">7-year</ix:nonNumeric> term of the 2024 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. As of December&#160;31, 2021, the remaining period over which the discount on the liability component will be amortized was approximately <ix:nonNumeric contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231" name="us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzc1NDI_c944be01-1df3-4c4e-8290-311018e72b64">2.4</ix:nonNumeric> years. We plan to adopt ASU 2020-06 on January 1, 2022 using the modified retrospective transition method. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Refer to Note 1 to the consolidated financial statements for more information.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated the total transaction costs of approximately&#160;$<ix:nonFraction unitRef="usd" contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502" decimals="-5" name="us-gaap:DeferredFinanceCostsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzc2MDQ_21c1ab7d-b6f8-4650-9660-d1eec5e9e1fb">14.7</ix:nonFraction> million&#160;related to the issuance of the 2024 Notes to the liability and equity components of the 2024 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the&#160;<ix:nonNumeric contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM4NDgyOTA3MjEzNTE_9079522c-14bc-4e69-b176-c9ea1c78db8a">7-year</ix:nonNumeric> term of the 2024 Notes, and transaction costs attributable to the equity component are netted with the equity component in stockholders&#8217; equity.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by us. The 2024 Indenture contains customary events of default with respect to the 2024 Notes, including that upon certain events of default,&#160;<ix:nonFraction unitRef="number" contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" decimals="INF" name="nbix:EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzgzMzI_4ed1246e-cdbf-4234-add4-59068e6552f4">100</ix:nonFraction>%&#160;of the principal and accrued and unpaid interest on the 2024 Notes will automatically become due and payable.</span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU3_a256c976-d068-425f-8859-efee36121f26" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes, net of discounts and deferred financing costs, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzItMS0xLTEtMjQ1ODc_1a578a0f-f584-4f93-9610-50bb1066c940">381.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzItMy0xLTEtMjQ1ODc_110bcadf-62d7-456d-8d4a-9850ce109288">381.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzMtMS0xLTEtMjQ1ODc_3d674c0a-03d7-4374-b498-660459803fa2">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzMtMy0xLTEtMjQ1ODc_1ebdad9e-af62-46e6-b2ca-da194a7a4d48">4.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzQtMS0xLTEtMjQ1ODc_aabcd9ee-5ad0-47ca-8fb8-642050864ef2">43.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzQtMy0xLTEtMjQ1ODc_9146a284-b33c-419f-a324-c24bf66141b4">59.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:ConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzUtMS0xLTEtMjQ1ODc_37d5431b-85b8-4c49-ba21-e6f9b824dfcb">335.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:ConvertibleDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzUtMy0xLTEtMjQ1ODc_e4c19f79-bd43-4976-824f-839e53e88cce">317.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes were recorded at the estimated value of a similar non-convertible instrument on the date of issuance and accretes to the face value of the 2024 Notes over their <ix:nonNumeric contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU4_ee8b3334-76b1-4714-8c35-e912c8396f81">7-year</ix:nonNumeric> term. The fair value of the 2024 Notes, which was estimated utilizing market quotations from an over-the-counter trading market (Level 2), was $<ix:nonFraction unitRef="usd" contextRef="i4255ef0f065341c38adf6ce89cc06fa5_I20211231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NjIyMjg_cfb1fe46-8e57-4701-bcb4-307260bfd510">464.7</ix:nonFraction> million as of December&#160;31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="i3d16c122f0c14c3992a051928c9d5bfd_I20201231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NjIyMzI_96f480ab-8907-4b9d-be3d-e9837fb3dfee">514.3</ix:nonFraction> million as of December&#160;31, 2020.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_160"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1MA_b4f0fa78-2ab2-4475-b405-8ebfe8392046" continuedAt="ib32eb24a4d704b0ea261d94dadfdaf24" escape="true">Other Balance Sheet Details</ix:nonNumeric></span></div><ix:continuation id="ib32eb24a4d704b0ea261d94dadfdaf24"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1MQ_1dbe8d02-c962-42f1-af8a-d0299ad2df81" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzItMS0xLTEtMjQ1ODc_f5be87af-1bb9-4be7-aae5-3929cdcb6299">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzItMy0xLTEtMjQ1ODc_4899a7c1-f563-45c7-87ea-0ebb64c9ebd3">16.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzMtMS0xLTEtMjQ1ODc_f8acf7ee-be85-4c8f-ba67-c15403eecab6">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzMtMy0xLTEtMjQ1ODc_5d9fa296-af7b-434e-aa0e-987b43310f90">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzQtMS0xLTEtMjQ1ODc_256cf462-6bfd-42d8-bcd5-37e6f9b365d8">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzQtMy0xLTEtMjQ1ODc_87be39e2-9a00-45a2-ad90-759d859f793a">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzUtMS0xLTEtMjQ1ODc_507cd53b-a099-4fa8-8662-ae9f4288414e">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzUtMy0xLTEtMjQ1ODc_45d95c82-ada3-4199-8a8f-2ada4b4f28c6">28.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1Mg_e895a3da-fbb7-4f58-b261-32a76935474a" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4babbf9b0ae54bd68b403bf9135804ce_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzItMS0xLTEtMjQ1ODc_9ab5ddc5-689c-47d8-acef-fe21bffe218e">34.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1cd1bce8a314e4b8d4f01b7b48efb31_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzItMy0xLTEtMjQ1ODc_9f57f737-7378-471b-acb8-d35c282d6137">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scientific equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i514d273d4829444bb2f094cc035cbd85_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzMtMS0xLTEtMjQ1ODc_29839064-e933-43c3-ab0f-fc45f431506b">51.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8949e231305a4303b6a93baa2c50ef7c_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzMtMy0xLTEtMjQ1ODc_21c7d81b-939a-4cfd-adfd-d89e23b3388c">39.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i018745fbe176486d9a40f767eb4cddfb_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzQtMS0xLTEtMjQ1ODc_ffcbc0c4-f83c-4337-bd80-af09615674fa">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89da8fd5abc84ebc90ff0e08c8e74ae0_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzQtMy0xLTEtMjQ1ODc_fd08014f-bd72-404f-893a-ccd344a31972">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc1e7a31965e41d398a354180cf8e854_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzUtMS0xLTEtMjQ1ODc_d9ce409b-3e57-483b-816c-ed9d615ebeb4">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id096d2e9e4db408388a0546974b8a714_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzUtMy0xLTEtMjQ1ODc_63c8c5c2-1a0f-4365-8e3a-a289b5b010bd">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzYtMS0xLTEtMjQ1ODc_6918dd60-2a05-4621-84c3-a4f6c09821bb">110.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzYtMy0xLTEtMjQ1ODc_762570c3-6861-4808-b28b-04a703ef4606">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzctMS0xLTEtMjQ1ODc_e51ad6ca-d537-41fa-9cac-73f4c50747f3">51.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzctMy0xLTEtMjQ1ODc_ace918ff-dd46-4cff-bf0e-e483d4dc3043">41.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzgtMS0xLTEtMjQ1ODc_e25dad5a-f4df-441c-ade0-6c0c795454f3">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzgtMy0xLTEtMjQ1ODc_3ca14496-4aef-4dd0-ac4f-cfa8ca62bbd7">44.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1Mw_9f642e81-41de-4488-a32f-b2f22485a7bc" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee related costs </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzItMS0xLTEtMjQ1ODc_1c08d906-e1a3-4bd9-ab98-12d33460f8c8">50.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzItMy0xLTEtMjQ1ODc_81b898e9-49d7-4f86-9d39-dc8c33cb9fdd">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue-related reserves for discounts and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:RevenueRelatedReservesForDiscountsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzMtMS0xLTEtMjQ1ODc_b8916128-d4b6-461c-b6fa-8abec1fdeda3">62.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:RevenueRelatedReservesForDiscountsAndAllowances" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzMtMy0xLTEtMjQ1ODc_f26e044d-e11a-403c-905d-d1cc9ed4ea1f">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:AccruedResearchAndDevelopmentExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzQtMS0xLTEtMjQ1ODc_5ee27bb8-b314-4a5b-ae4a-95868ce4f523">32.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:AccruedResearchAndDevelopmentExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzQtMy0xLTEtMjQ1ODc_7a0af7f6-d43f-407b-beb5-80d0c350e3a9">32.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:AccruedBrandedPrescriptionDrugFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzUtMS0xLTEtMjQ1ODc_e2d92c11-6cf4-40b6-b89c-d25d1647021e">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:AccruedBrandedPrescriptionDrugFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzUtMy0xLTEtMjQ1ODc_3a18815f-c86e-4bac-8346-95eefcc2cfcf">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzYtMS0xLTEtMjQ1ODc_e2e8fb52-acbe-43a3-bb5b-a0ec61837ebe">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzYtMy0xLTEtMjQ1ODc_a4696a0e-24d3-4fbd-839a-78864be272e3">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzctMS0xLTEtMjQ1ODc_43be0b5c-235e-4fcc-b801-ff6047ba1d35">225.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzctMy0xLTEtMjQ1ODc_6e37478b-0899-481c-b015-1cb39fd25e4b">168.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="nbix:SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1NA_1783d46f-0767-46d1-a3f6-45acf9ebce36" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzItMS0xLTEtMjQ1ODc_8af4e3b0-0004-438a-9922-1fe81c4f63de">340.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzItMy0xLTEtMjQ1ODc_eab1fb26-7b91-42e6-8163-a778a8b75265">187.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzMtMS0xLTEtMjQ1ODc_69706941-bc24-493d-a23c-d4d1ea101139">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzMtMy0xLTEtMjQ1ODc_e9bbc091-0624-424d-8bf3-7620c1a626de">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzQtMS0xLTEtMjQ1ODc_84fccf05-c0b7-4123-8396-b938cb3c6449">344.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzQtMy0xLTEtMjQ1ODc_d6073e43-ded5-47b8-a80e-6829b1036b76">190.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. Earnings <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzI0MA_f1108e8d-265a-4062-84c9-1ea3d954c760" continuedAt="idf8ab5fda42b49789ee9a87c001c5b03" escape="true">Per Share</ix:nonNumeric></span></div><ix:continuation id="idf8ab5fda42b49789ee9a87c001c5b03"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzI0MQ_db26e447-0343-415a-83ee-8fc6e718df82" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share were calculated as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income - basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItMS0xLTEtMjQ1ODc_12f8c320-66fb-4e50-886f-16b09c08411f">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItMy0xLTEtMjQ1ODc_cead22be-894b-4cfd-b149-81f819937830">407.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItNS0xLTEtMjQ1ODc_8a9dfac8-4f6b-4c19-9c24-926d4b68c572">37.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtMS0xLTEtMjQ1ODc_f919ff0a-ac5c-4544-85ee-68eb430fb03c">94.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtMy0xLTEtMjQ1ODc_d6d3f806-83a4-48d1-95f0-f670f2f9977c">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtNS0xLTEtMjQ1ODc_35c3e44b-8fb7-44d9-91cb-0e8dcd86cc8b">91.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib5697c0bc55240d2a8a8a2235b016776_D20210101-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctMS0xLTEtMjQ1ODc_df06fc50-5ed3-43f2-bd49-effb1fa0ebf1">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36e1a597b4cd4605869672a9be81b61a_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctMy0xLTEtMjQ1ODc_2a17da17-da36-4a54-982d-f3dd89cf5ba3">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6121635642d44cadaead83be87d2fe62_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctNS0xLTEtMjQ1ODc_4ddbfe3b-4ed2-4694-82f0-73760871b623">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d2ef4094777484ab20a42ddbdcf479d_D20210101-20211231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtMS0xLTEtMjQ1ODc_e7e1637a-9a4a-41ef-a2f1-855dfc2d0a4e">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5766d218ac54177beed97641411133f_D20200101-20201231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtMy0xLTEtMjQ1ODc_944b3d3d-8ae3-4be9-a650-63551794c7c2">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4461a18f4b94ca1b02b8be10c79cda1_D20190101-20191231" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtNS0xLTEtMjQ1ODc_32241e3d-b825-46ce-a112-3b10a6c8e4e4">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d90a3769ad6449da089e4e3f18d3d7a_D20210101-20211231" decimals="-5" name="nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktMS0xLTEtMjQ1ODc_1b9b4268-7a8a-47d6-afd2-8d518dd1be77">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfdf32908a434e5d91386e010cdf2b9b_D20200101-20201231" decimals="-5" name="nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktMy0xLTEtMjQ1ODc_d159452c-5555-460c-8c09-8e7fac367ab9">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i861174ad0c8446e0ab825a068912a989_D20190101-20191231" decimals="-5" name="nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktNS0xLTEtMjQ1ODc_1e1ad727-1eb6-4bf8-8302-973024efd752">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTEtMS0xLTI0NTg3_b8a6597a-1bdd-4c50-9042-8f172eeb48c1">97.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTMtMS0xLTI0NTg3_3c99aa39-c231-4b34-aa73-ceb9545c98b9">97.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTUtMS0xLTI0NTg3_10d37733-68ba-490f-99db-758f80fdc6dd">95.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTEtMS0xLTI0NTg3_3e6cdd70-3185-4933-b06e-bb16caf07cfe">0.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTMtMS0xLTI0NTg3_d923ee6b-409c-4bd3-9222-02e5e1127818">4.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTUtMS0xLTI0NTg3_c39d3006-e438-46f4-802f-c60053d79859">0.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTEtMS0xLTI0NTg3_329f17fa-ddbc-4dfd-90dd-6502bbe19f9a">0.92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTMtMS0xLTI0NTg3_be003758-4678-41c6-b260-fb49b80281f5">4.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTUtMS0xLTI0NTg3_3b4190ec-4410-4106-a238-e5e6eb7d2594">0.39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive were <ix:nonFraction unitRef="shares" contextRef="i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzE5NQ_55575638-a842-4e25-8375-89d72d9d4789">4.1</ix:nonFraction> million for 2021, <ix:nonFraction unitRef="shares" contextRef="i27b3593b7e0f4137b9d9cb95a340d296_D20200101-20201231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzE5OQ_0fa0d4c9-f33d-4906-a568-db7b061d0351">2.5</ix:nonFraction> million for 2020 and <ix:nonFraction unitRef="shares" contextRef="ie926624338174ce3a9a95588da6b7482_D20190101-20191231" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzIwNg_3643a475-20fc-422d-a0fb-9f970b04d609">2.1</ix:nonFraction> million for 2019.</span></div></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_166"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTY_95393ee4-3801-47e1-b5dd-2b7c17088885" continuedAt="ia17bcab9595e45fd89e4125c2b0f38b9" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="ia17bcab9595e45fd89e4125c2b0f38b9" continuedAt="i5f443a2bf701419a93db40b2687af3b0"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May&#160;2011, we adopted the 2011 Equity Incentive Plan, as amended, or the 2011 Plan. The 2011 Plan authorized <ix:nonFraction unitRef="shares" contextRef="if55c2dd5020b439ab20a6854804adfb2_I20110531" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE0OQ_b140beb4-55cc-4cfb-8521-2d32c9962a96">21</ix:nonFraction> million shares of common stock for issuance and allowed for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, or RSUs, performance stock awards, performance-based restricted stock units, or PRSUs, and certain other awards. During 2020, the 2011 Plan was merged into the 2020 Plan (defined below). As a result, there were <ix:nonFraction unitRef="shares" contextRef="i131a19b02d4549ae975f25ad4ec218e0_I20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUyNQ_71d06868-d0a5-4ea0-aa72-85b60acec262">no</ix:nonFraction> shares of common stock remaining available for future grant under the 2011 Plan.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we adopted the 2018 Employee Stock Purchase Plan, or ESPP, pursuant to which <ix:nonFraction unitRef="shares" contextRef="i66b8b371eafd4e9bb87813ab1ee9b7f3_I20180531" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzY5OQ_c920123e-ad10-4904-bee7-dc6c264ffa84">0.3</ix:nonFraction> million shares of common stock are authorized for issuance. As of December 31, 2021, <ix:nonFraction unitRef="shares" contextRef="if9a1371b813245e8b49ad33c120478c5_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2Xzc3Ng_256e33fb-ab50-437d-8d09-73aefca59a32">0.1</ix:nonFraction>&#160;million shares of common stock remain available for future grant under the 2018 ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we adopted the 2020 Equity Incentive Plan, or the 2020 Plan. The 2020 Plan authorized <ix:nonFraction unitRef="shares" contextRef="i7daa1d827ed84d04bc8d829d69e3b5a5_I20200531" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2Xzk1Ng_35794b89-9f51-4761-a525-57bb2240f96f">3.3</ix:nonFraction>&#160;million shares of common stock for issuance and allows for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, performance stock awards, PRSUs and certain other awards. The 2011 Plan was merged into the 2020 Plan and, as a result, all remaining shares in the 2011 Plan were transferred into the 2020 Plan. As of December 31, 2021, <ix:nonFraction unitRef="shares" contextRef="i21a8268dccfc48f59cd4814f44c54a4f_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzEzMTQ_5b7a19f0-2f10-491e-843b-a0207ee73ac7">5.4</ix:nonFraction>&#160;million shares of common stock remain available for future grant under the 2020 Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUxMDA_a15a91ba-2da7-44cb-9264-d04e43ad5d5d" continuedAt="i2205e403083040e7b1b37e9023722742" escape="true">The effect of share-based compensation expense on our consolidated statements of income and comprehensive income by line-item follows:</ix:nonNumeric></span></div><ix:continuation id="i2205e403083040e7b1b37e9023722742" continuedAt="id4ccab94f2db4dac83555c9d57fe43d2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2e9814a27b4d21828b870c0c7bba39_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItMS0xLTEtMjQ1ODc_7efd0e8a-399c-4ebf-b141-487321468b0e">85.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6383419676f5414c97631fba30d073e1_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItMy0xLTEtMjQ1ODc_e7e458e8-34a6-4408-b36d-72852d40fe99">66.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i563c70f91f7d45baadb5b41baf1f5dee_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItNS0xLTEtMjQ1ODc_a9b59505-69de-4910-8e5f-ff32b4d0c11b">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i086d3bf04898438689679b7c70886c50_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtMS0xLTEtMjQ1ODc_8e260c32-829b-4d82-b3fe-97046849893e">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f20287d2f5d47629aa5cb895c7b9e67_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtMy0xLTEtMjQ1ODc_9b4e2def-dd20-4202-bbbd-3419d730acbd">33.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21700785bb0c4daa8be1c905aeeb15f6_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtNS0xLTEtMjQ1ODc_e7a0c6d5-6fe7-4b27-b748-cd8889c62685">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtMS0xLTEtMjQ1ODc_cbe7b4d7-e345-4257-9592-8bdf23df8b55">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtMy0xLTEtMjQ1ODc_03fab4eb-4b90-48a7-ba8d-fe9b1209eee3">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtNS0xLTEtMjQ1ODc_0749d824-ccef-4171-b7eb-5876e90f7efe">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by award-type follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItMS0xLTEtMjQ1ODc_464e619b-7b17-43b4-acc8-91bfeb91c4c4">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItMy0xLTEtMjQ1ODc_efe2a319-73b4-45c8-b75d-880540f51da6">47.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItNS0xLTEtMjQ1ODc_b8ce35f0-91b4-4130-add8-be5dc952f3a8">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtMS0xLTEtMjQ1ODc_af95b5cf-4998-4ce5-b72a-5ba35af2bdc7">62.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtMy0xLTEtMjQ1ODc_0f56fa96-8e7e-4dcd-88d6-8987eb146ea6">44.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtNS0xLTEtMjQ1ODc_55ca4ad6-eb97-45c6-bc69-138de0a35738">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtMS0xLTEtMjQ1ODc_4a860a49-9ce3-4b90-b9df-6fccc16ae15a">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtMy0xLTEtMjQ1ODc_d76e8124-0ccd-4c68-8ed6-133f2d2c1f19">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtNS0xLTEtMjQ1ODc_802db124-f077-4353-9042-d1b74c7eecb3">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc56f68087124b8b8cfe42e19151218a_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtMS0xLTEtMjQ1ODc_b496d491-2c76-4611-a187-0f5d93d1e741">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e84a209c2b443968257a0960b35e6f0_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtMy0xLTEtMjQ1ODc_a0981a3b-7068-4b56-b1bd-5b77e804aebf">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca72bf2007745ac9be527c3a44edef0_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtNS0xLTEtMjQ1ODc_202f0ac7-37af-4565-92df-f82c7854a9ba">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtMS0xLTEtMjQ1ODc_14317e6d-2c66-4c16-b3d6-b58488c7ed71">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtMy0xLTEtMjQ1ODc_e143bce2-f5e0-4131-b5bf-a8cade1f0a59">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtNS0xLTEtMjQ1ODc_173dc8f3-7740-4ef6-a3a2-00c77cad27f3">75.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5f443a2bf701419a93db40b2687af3b0" continuedAt="ibbae3d033a2840099eb28cc5ca81368a"><ix:continuation id="id4ccab94f2db4dac83555c9d57fe43d2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized share-based compensation expense by award-type and the weighted-average period over which such expense is expected to be recognized, as applicable, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.726%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.729%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Recognition Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9dd80ab56044cb5b1502c3c0b0084c6_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzEtMS0xLTEtMjQ1ODc_595bb3cf-5b6c-4c73-acdb-0d7180eeb0fb">101.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzEtMy0xLTEtMjQ1ODc_0429462b-8c53-4ce4-b4ea-6512e5778b8b">2.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzItMS0xLTEtMjQ1ODc_27696b72-7a9f-4a0c-9b43-066c270d862d">150.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzItMy0xLTEtMjQ1ODc_4519995e-f7ab-4d42-93da-33b352f19de8">2.2</ix:nonNumeric> years</span></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Typically, stock options have a <ix:nonNumeric contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTc_34036960-a7d9-45ae-bad4-478e22f3902f">10-year</ix:nonNumeric> term and vest over a <ix:nonNumeric contextRef="ib439fe7fca70420e85d14235298d0807_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE4OTA_aeedf41a-eda8-4018-9479-392104de06b2">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i3c44c1a195de478c824a69cb855d11ea_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTI_03211a20-db1d-4875-87ef-d253b5536851">4-year</ix:nonNumeric> period. The exercise price of stock options granted is equal to the closing price of our common stock on the date of grant. We estimate the fair value of stock options using the Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various and highly sensitive assumptions including expected volatility, term and interest rates. The weighted-average grant-date fair values of stock options granted were $<ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNjI_af31b7ce-bb62-4f7d-ae11-3684d982e0d0">45.02</ix:nonFraction> for 2021, $<ix:nonFraction unitRef="usdPerShare" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNjY_4297b3b6-6b9a-4689-b46c-b2fea1aac9d3">45.67</ix:nonFraction> for 2020 and $<ix:nonFraction unitRef="usdPerShare" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNzM_bb84998f-863f-43b6-8bc0-9ac7f519d21e">41.74</ix:nonFraction> for 2019.</span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTg_d5af3960-6fa6-4926-8820-b4710dc7905d" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItMS0xLTEtMjQ1ODc_6f14a732-c0b0-4308-ad1c-a790554ce27c">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItMy0xLTEtMjQ1ODc_9249cedb-e3de-46dd-b17d-c4c4bab2928b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItNS0xLTEtMjQ1ODc_c0017734-6c39-479a-903d-01f0d8c362db">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtMS0xLTEtMjQ1ODc_b93617d9-ad9c-4e8f-9396-6506d416f7cb">45.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtMy0xLTEtMjQ1ODc_b67e1a29-fb3f-4271-a781-0f348fd8f3e1">48.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtNS0xLTEtMjQ1ODc_770edc5a-f5b8-47fd-8a30-a99333ad73c4">54.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtMS0xLTEtMjQ1ODc_fa19cdf8-d52e-42b0-b6f7-62e2d860a4cb">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtMy0xLTEtMjQ1ODc_4da788be-aa63-49e3-a2c4-006cc6992faa">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtNS0xLTEtMjQ1ODc_b04bf89b-3aa2-463f-88ec-475de27e0444">0.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtMS0xLTEtMjQ1ODc_561ba715-2514-47af-9ff7-dd19bdc802a8">5.2</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtMy0xLTEtMjQ1ODc_004b2a00-4665-4432-a349-8c882454a275">5.3</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtNS0xLTEtMjQ1ODc_4e50781a-5468-4390-b84d-01a0bc454a25">5.4</ix:nonNumeric> years</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average valuation assumptions were determined as follows:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected volatility of common stock is estimated based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of our stock options.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected option term is estimated based on historical experience as well as the status of the employee. For example, directors and officers have a longer expected option term than all other employees. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risk-free interest rate for periods within the contractual life of a stock option is based upon observed interest rates appropriate for the expected term of our employee stock options. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have not historically declared or paid dividends and do not intend to do so in the foreseeable future. </span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTM_6fbb40e5-26ee-4e7d-855c-8e409b3a1327" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzEtMS0xLTEtMjQ1ODc_de02bdd0-4538-48bb-9577-db4729545f11">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzEtMy0xLTEtMjQ1ODc_cce10cec-a2e1-46b7-950e-2be29bde357c">62.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzItMS0xLTEtMjQ1ODc_d73ddb06-b59e-4f9b-a81c-af6862b97016">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzItMy0xLTEtMjQ1ODc_39c6a082-e5e1-408d-b024-0ec27ac94c75">110.74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzMtMS0xLTEtMjQ1ODc_a5e8ae2d-64d2-4320-bd4e-6fdb42e90245">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzMtMy0xLTEtMjQ1ODc_c88de8e3-9f0e-4a8f-b41d-f9597353ce65">28.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzQtMS0xLTEtMjQ1ODc_53350fa7-6428-4e1b-bbfa-76fbdbfcd0dd">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzQtMy0xLTEtMjQ1ODc_98291adc-599f-45c8-b8ae-4ad15f73c264">103.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtMS0xLTEtMjQ1ODc_69995397-b8c4-4add-9629-ce9a9ebe2f4d">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtMy0xLTEtMjQ1ODc_cb4a919a-b7a6-43bf-afc7-6cabe93d7d58">76.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtNS0xLTEtMjQ1ODc_7cd0127e-409b-4d3d-acc6-c7f25581857d">6.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtNy0xLTEtMjQ1ODc_38e2e023-b3cc-4919-8859-a8d5e606052e">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtMS0xLTEtMjQ1ODc_8fe59d90-4b77-40f1-add4-440a817a332e">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtMy0xLTEtMjQ1ODc_914709a1-f30f-417e-aefb-ea4ff287481b">63.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtNS0xLTEtMjQ1ODc_8e3befa4-a1f7-4ec7-9216-b9b93b3c36b9">5.5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtNy0xLTEtMjQ1ODc_eebd177a-f9c8-4775-84ad-ecaf6e081505">134.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MDk_bffd0a58-e5d4-49a5-ade6-e8e3afa7457c">58.0</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MTM_a42f1ba5-c213-4f92-b72c-d9ccdbe03fa7">40.2</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MjA_4db1d484-1912-4320-abd4-8cb640f3e379">64.3</ix:nonFraction> million for 2019. Cash received from stock option exercises was $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MDU_061dd5a2-1371-4f8b-82f3-ba667eba5806">20.7</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MDk_4caed97a-3b61-4209-9f4a-539686320ac4">23.5</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MTY_f9c294de-9dd0-455b-9911-1ca0c75abe59">27.3</ix:nonFraction> million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs typically vest over a <ix:nonNumeric contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTQ_3a6299da-21fe-47f9-9682-265a0611a29b">4-year</ix:nonNumeric> period. The fair value of RSUs is based on the closing sale price of our common stock on the date of issuance. RSUs may be subject to a deferred delivery arrangement at the election of eligible employees.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibbae3d033a2840099eb28cc5ca81368a"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTU_38657800-38f1-44d3-b130-0c19d7e06a98" continuedAt="ia98703c60d3b408a85e616d64aecb6ae" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to RSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0bc4f833719d407fb605d6e3f05afc23_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzEtMS0xLTEtMjQ1ODc_ae3b21e4-187c-4fde-91f5-0570695c2ca4">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0bc4f833719d407fb605d6e3f05afc23_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzEtMy0xLTEtMjQ1ODc_6a6783af-812a-4ca5-abe4-b198c979f1c0">89.60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzItMS0xLTEtMjQ1ODc_256d9d91-8bea-4290-9538-572b4ebe2d38">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzItMy0xLTEtMjQ1ODc_2b030a9d-7871-4cb5-ac6c-51fa6996d66c">104.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzMtMS0xLTEtMjQ1ODc_40628e1f-90b8-40d6-859d-c3422f5e1cb0">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzMtMy0xLTEtMjQ1ODc_35fe08e4-4a80-48a5-bf55-cd0b18576309">82.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzQtMS0xLTEtMjQ1ODc_c6330966-70f3-48b2-a6f7-5f41acf92e91">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzQtMy0xLTEtMjQ1ODc_e756b439-2dc2-42df-8b05-d67220232ae6">101.71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtMS0xLTEtMjQ1ODc_8bf9e5da-e29b-4498-a895-883455105018">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtMy0xLTEtMjQ1ODc_2b1de87f-ec28-4dab-9729-e5c9ec5f2a4b">99.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtNS0xLTEtMjQ1ODc_215cebd0-72ee-4db7-b45f-7377b663e238">1.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtNy0xLTEtMjQ1ODc_a51bc306-c07b-48e6-881f-cdf371116b18">174.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2021, our board of directors approved an equity grant of approximately <ix:nonFraction unitRef="shares" contextRef="i360e7030403c47f48b0818bcce72318e_D20210801-20210831" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE2NDkyNjc0NDcyMTg_c15c57ff-6a8b-4b2c-9caf-cb25c1a56830">0.5</ix:nonFraction>&#160;million RSUs, which will vest over a <ix:nonNumeric contextRef="i360e7030403c47f48b0818bcce72318e_D20210801-20210831" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzYwNDczMTM5NTg1MzY_26e39ff0-2828-478a-8281-5eef8422e363">2-year</ix:nonNumeric> period, to our full-time employees other than our executive officers.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs that vested was $<ix:nonFraction unitRef="usd" contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMTQ_5a4974f3-208c-4ef5-9097-7cc92a81a877">64.3</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMTg_8b5b5094-de84-40ff-b482-6c1fc2d8dd99">49.7</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMjU_2603bd40-42db-48f9-8eff-6a500181d5bd">36.1</ix:nonFraction> million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRSUs vest based on the achievement of certain predefined Company-specific performance criteria and expire <ix:nonNumeric contextRef="i8d20c96869ad45d18f300e0ed27f7ee7_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQxOTI_fc645662-ac50-46b2-9389-3ad384684bf0">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i670a859ff8a84b0ba0c51a248450c900_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQxOTg_d0225239-ef2f-4af3-af05-c3c0b898c765">4</ix:nonNumeric> years from the grant date. The fair value of PRSUs is estimated based on the closing sale price of our common stock on the date of grant.&#160;Expense recognition for PRSUs commences when attainment of the performance-based criteria is determined to be probable. </span></div><ix:continuation id="ia98703c60d3b408a85e616d64aecb6ae"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to PRSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.808%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>PRSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib60edb8359ba4965aa27229d88b89dff_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzEtMS0xLTEtMjQ1ODc_460c773e-4381-4798-af1e-88fd70275479">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib60edb8359ba4965aa27229d88b89dff_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzEtMy0xLTEtMjQ1ODc_fd2c8fb5-e5b3-4ff0-8b3f-ae258639563a">102.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzItMS0xLTEtMjQ1ODc_36596665-59d5-46db-87b5-84d89649f9f2">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzItMy0xLTEtMjQ1ODc_d6804c96-b5c1-48f8-a970-360bdb3905ec">114.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtMS0xLTEtMjQ1ODc_f6b26d14-5191-4277-9fb9-e1be8b19bc00">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtMy0xLTEtMjQ1ODc_ae129ece-af0e-4acc-b857-7f8a80d66abf">109.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtNS0xLTEtMjQ1ODc_d4b1b2f1-afd7-4ff5-b26b-81c8bbac0f6d">1.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtNy0xLTEtMjQ1ODc_62ae6186-4954-4c21-a21e-f21868c1c72b">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized share-based compensation expense for PRSUs was $<ix:nonFraction unitRef="usd" contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ1NzQ_3a03f973-f682-4fbb-8c44-dc78ecddf734">32.0</ix:nonFraction> million. The total fair value of PRSUs that vested was $<ix:nonFraction unitRef="usd" contextRef="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NDE_ae907993-f206-4ce5-9d7e-f0dc38b91aed">13.5</ix:nonFraction>&#160;million for 2020. <ix:nonFraction unitRef="usd" contextRef="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NTU_c15052fa-6e79-45bb-a729-60872348f172"><ix:nonFraction unitRef="usd" contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NTU_d13cd016-00e4-4f00-9c4d-5c5858d66752">No</ix:nonFraction></ix:nonFraction> PRSUs vested during 2021 or 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the ESPP, eligible employees may purchase shares of our common stock at a discount semi-annually based on a percentage of their annual compensation. The discounted purchase price is equal to the lower of <ix:nonFraction unitRef="number" contextRef="i94ec3a34a5c1464a98687009bb85c0ee_D20210101-20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ5MjQ_9bd2f149-a9fc-4778-96b1-0410af658101">85</ix:nonFraction>% of (i) the market value per share of the common stock on the first day of the offering period or (ii) the market value per share of common stock on the purchase date.</span></div></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_169"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTY_e83a333c-fc54-46bb-8c01-c408b25a8fd1" continuedAt="i370d5ba912b54f0b8efc2026620824e8" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i370d5ba912b54f0b8efc2026620824e8" continuedAt="i42e2613932e84cdcae72539e9525a6b5"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTc_e35b498f-7cf2-46e2-a8b7-7dfe48b82911" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of income tax expense (benefit) for continuing operations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtMS0xLTEtMjQ1ODc_af7b0b0f-1b28-4da8-9d8a-b8fb1768d1bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtMy0xLTEtMjQ1ODc_d8afa970-726f-41cd-ad38-696143f79d78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtNS0xLTEtMjQ1ODc_41c63556-355b-41b6-9d06-77f524c137f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtMS0xLTEtMjQ1ODc_63608f58-81a4-4961-a2eb-c38827d100fb">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtMy0xLTEtMjQ1ODc_b7935488-470a-4a03-ae89-fa454603c6c2">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtNS0xLTEtMjQ1ODc_7bdf8870-6d61-43b7-bb58-f4461f4e084d">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtMS0xLTEtMjQ1ODc_807d2207-21c9-4da7-8f0f-3915b6064aeb">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtMy0xLTEtMjQ1ODc_fd533f29-8b9b-4cd6-ae69-64aa26982909">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtNS0xLTEtMjQ1ODc_200f0329-2d7f-4b99-bed4-ec538ec9386c">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctMS0xLTEtMjQ1ODc_3b5ef156-25a4-41b2-be25-8528a30c6869">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctMy0xLTEtMjQ1ODc_c7500877-2b27-4959-ba41-5cc8dc95bd60">287.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctNS0xLTEtMjQ1ODc_9e3de00b-ef12-41ee-997b-b0d9792d560d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtMS0xLTEtMjQ1ODc_c8422fac-9c22-4263-b615-40cc1ea1fa1d">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtMy0xLTEtMjQ1ODc_03af3481-c430-40fe-893b-c047ca209342">23.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtNS0xLTEtMjQ1ODc_e4be7cfd-d105-44f0-a9d6-0c4707a8e220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktMS0xLTEtMjQ1ODc_5303b765-7e45-416c-b53c-8878a1ae9bae">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktMy0xLTEtMjQ1ODc_e4721dda-5e95-4352-8170-8c9c736faabb">310.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktNS0xLTEtMjQ1ODc_59ec356b-3624-4390-8159-5e119b15e09d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTEtMS0xLTI0NTg3_12435662-c3b7-438d-95ce-6058263f336a">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTMtMS0xLTI0NTg3_826407f2-5214-4212-a6a2-7f7f09457e2e">300.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTUtMS0xLTI0NTg3_07409906-89f3-4f39-a899-2aebbfc887b0">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i42e2613932e84cdcae72539e9525a6b5" continuedAt="ia0370056206f4edcbf3b359f712f78ae"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTg_b7e7134d-04c5-4354-9c23-a58c5a3f4020" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income taxes at <ix:nonFraction unitRef="number" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_048f3b20-81e8-4c9d-a660-d43362c4c2d9"><ix:nonFraction unitRef="number" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_56e3098e-f0d8-49ce-af7b-d98b6d2e610c"><ix:nonFraction unitRef="number" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_b123720f-408b-4187-bca4-0081f9a9e90a">21</ix:nonFraction></ix:nonFraction></ix:nonFraction>%</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMS0xLTEtMjQ1ODc_ac9999df-5672-4c5e-80f9-0b856275f4fe">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMy0xLTEtMjQ1ODc_37ac6e29-528c-46ab-8429-183219d32826">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItNS0xLTEtMjQ1ODc_4dcd294a-52ac-4fe1-a392-a9957fdae03a">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtMS0xLTEtMjQ1ODc_7ef7d024-730f-4caf-adc8-ef4abcb39e16">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtMy0xLTEtMjQ1ODc_6d44822e-f541-48b5-af8e-b4723f46d1ef">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtNS0xLTEtMjQ1ODc_354914e8-aa8e-47f4-91a4-ed3ee6edc2e6">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtMS0xLTEtMjQ1ODc_657f7f86-18d9-4649-a81b-f8a78d11e609">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtMy0xLTEtMjQ1ODc_d1943e54-151e-4131-bd32-f988a8246528">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtNS0xLTEtMjQ1ODc_0fbd67dc-849e-496d-ab9d-9a7fc933911a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtMS0xLTEtMjQ1ODc_163d61fe-3c81-47c5-9aae-331a051644e1">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtMy0xLTEtMjQ1ODc_77981c0c-97b6-490b-8156-5311fc8842c0">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtNS0xLTEtMjQ1ODc_bcc1bb55-ca99-49f5-9f97-d9b538f85d78">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtMS0xLTEtMjQ1ODc_7c0671c1-3ac9-4398-9895-96bc8e35212a">11.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtMy0xLTEtMjQ1ODc_95379f57-0a5e-4edd-9cf8-fdcc33f28d4f">6.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtNS0xLTEtMjQ1ODc_2d4bce55-69ab-42df-943e-6c546b20d491">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctMS0xLTEtMjQ1ODc_e0fc976c-d1f3-4566-a2fb-c5c63ef79987">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctMy0xLTEtMjQ1ODc_2cd6dc6e-3060-4421-9400-edceeb265883">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctNS0xLTEtMjQ1ODc_2fe2100a-011d-4897-a3a9-4a89bd83bc64">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtMS0xLTEtMjQ1ODc_44ec2278-5b94-432d-b11d-dc902fc2dce9">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtMy0xLTEtMjQ1ODc_d133959c-9b15-4ba7-8dcf-eb1e96c15db2">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtNS0xLTEtMjQ1ODc_0494357a-8a4a-4baa-b233-3ed8e5f60696">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="nbix:IncomeTaxReconciliationExpirationOfTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktMS0xLTEtMjQ1ODc_53d138fe-7285-4566-8982-2e36f65d5329">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="nbix:IncomeTaxReconciliationExpirationOfTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktMy0xLTEtMjQ1ODc_97b116a2-526b-4a23-88db-e0d23a2224e7">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="nbix:IncomeTaxReconciliationExpirationOfTaxCredits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktNS0xLTEtMjQ1ODc_e257c9a7-df80-448c-b0bc-2a77b8ac316e">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTEtMS0xLTI0NTg3_91ad187c-0781-4efa-8add-9c3141352195">22.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTMtMS0xLTI0NTg3_c9a9e705-d202-4957-83d2-725f1d74c58d">39.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTUtMS0xLTI0NTg3_340a34ed-8e6d-40cf-a422-741fddaf3aec">10.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTEtMS0xLTI0NTg3_7cb4d8af-9353-4ed4-9264-c3ba4d3a9683">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTMtMS0xLTI0NTg3_ace9b9c1-cdc4-44c2-8b78-dc785cc962e8">296.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTUtMS0xLTI0NTg3_b9568a70-2073-4585-89cf-059b3681aba7">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTEtMS0xLTI0NTg3_96bb2cbf-bbc6-4735-bc9f-e8d8340bc3c2">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTMtMS0xLTI0NTg3_c3b76735-953e-42a0-8f99-d3ddb341391f">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTUtMS0xLTI0NTg3_e99d4b99-8f1a-44da-91c3-18dcfb6137cc">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTEtMS0xLTI0NTg3_2a4173c4-6416-4b18-ae0e-31e25107aed8">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTMtMS0xLTI0NTg3_bcecc749-9379-4a2f-ab00-b74719620e95">300.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTUtMS0xLTI0NTg3_3084687b-4b5d-48eb-b8f6-cd39168a40a1">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTQ_0c4014ef-f5b5-480d-a778-602faac3de2d" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets as of December 31, 2021 and 2020 are listed below. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzMtMS0xLTEtMjQ1ODc_8a7990be-39f3-487f-b309-d31e0925a05e">90.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzMtMy0xLTEtMjQ1ODc_7533008a-1aff-4086-95a2-e4f12ab32c3c">111.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzQtMS0xLTEtMjQ1ODc_d048ce51-89e2-4f08-8a3a-b7359b5107d0">129.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzQtMy0xLTEtMjQ1ODc_166bcde1-ebab-48cb-9f01-426f6c17725c">109.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzUtMS0xLTEtMjQ1ODc_8f15ae06-566d-4712-a8ab-14b3f82277e4">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzUtMy0xLTEtMjQ1ODc_ef4993ed-5fe0-43dc-8c7e-65dcb8ed8fcd">24.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzYtMS0xLTEtMjQ1ODc_a34ca331-7c29-40d5-8f92-b1c05055b11a">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzYtMy0xLTEtMjQ1ODc_da5ff208-5521-48db-8ce6-509f85a7d492">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:DeferredTaxAssetsOperatingLeasesAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzctMS0xLTEtMjQ1ODc_33cc466e-7bda-4518-9198-6a1befe307b0">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:DeferredTaxAssetsOperatingLeasesAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzctMy0xLTEtMjQ1ODc_cf42561a-cf57-4f8c-ad44-12a2e7f6de50">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzgtMS0xLTEtMjQ1ODc_7dceca8b-a12b-47eb-aaa7-845f7f535d40">86.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzgtMy0xLTEtMjQ1ODc_17c0a64a-7221-4b38-b945-4f9d78c5c9a1">86.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzktMS0xLTEtMjQ1ODc_7367f931-9119-4f51-8262-3e654c85e4e7">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzktMy0xLTEtMjQ1ODc_a19872f5-11e4-4ddc-a5a8-094f9af91e92">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEwLTEtMS0xLTI0NTg3_6cf84c3f-2165-4abd-a697-0343c205ae73">413.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEwLTMtMS0xLTI0NTg3_11a37eba-933d-4684-a0a2-d1e092e5945b">411.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEyLTEtMS0xLTI0NTg3_ecd2b928-0fdc-4ab2-92fe-27b0c318229e">9.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEyLTMtMS0xLTI0NTg3_479292d1-cf75-4d9d-bfa1-62ecda846d13">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEzLTEtMS0xLTI0NTg3_57e75f60-871f-4d74-bee1-c16b5af9189e">23.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEzLTMtMS0xLTI0NTg3_7b36df67-34ad-481d-a46c-3c21c0089588">19.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE0LTEtMS0xLTI0NTg3_12793934-568a-4e64-a95f-5d679dddd6a6">10.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE0LTMtMS0xLTI0NTg3_edca93d7-d9a6-444e-86cf-30fff6ba0c5c">8.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE1LTEtMS0xLTI0NTg3_9bb2ea4d-c244-4d75-8541-31d72ed6cedb">43.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE1LTMtMS0xLTI0NTg3_cca91c09-45e7-47fa-899d-b465d0ab1aa6">42.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net of deferred tax assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="nbix:DeferredTaxAssetsLiabilitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE2LTEtMS0xLTI0NTg3_35b4eb2d-93ec-4c23-a6e3-ff366e10dd0c">369.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="nbix:DeferredTaxAssetsLiabilitiesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE2LTMtMS0xLTI0NTg3_d7cedbfe-b4c8-41ed-9ecb-b05cd1262dcc">369.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE3LTEtMS0xLTI0NTg3_e68267f5-2544-4543-9dfd-76da6508ea30">54.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE3LTMtMS0xLTI0NTg3_24f0dfdb-c39c-47d0-a98a-87996a71cf9d">49.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE4LTEtMS0xLTI0NTg3_936aeec7-9e3d-4d99-acc6-d8db0e9a055d">315.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE4LTMtMS0xLTI0NTg3_df746360-9a62-44e2-9417-fd808259ddc8">319.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our deferred tax assets were primarily the result of federal net operating loss carry forwards, capitalized research costs, acquired intangible assets and tax credit carryforwards. As of December 31, 2021 and 2020, we recorded a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzYyMg_e68267f5-2544-4543-9dfd-76da6508ea30">54.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzYyOQ_24f0dfdb-c39c-47d0-a98a-87996a71cf9d">49.8</ix:nonFraction> million, respectively, against our gross deferred tax asset balance.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of each reporting date, management considers new evidence, both positive and negative, that could affect its assessment of the future realizability of our deferred tax assets. As of December 31, 2021, management determined there was sufficient positive evidence to conclude that it is more likely than not deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzIxOTkwMjMyNTk2NjU_936aeec7-9e3d-4d99-acc6-d8db0e9a055d">315.1</ix:nonFraction> million are realizable. The recorded valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzIxOTkwMjMyNTk4MjU_e68267f5-2544-4543-9dfd-76da6508ea30">54.8</ix:nonFraction> million consisted primarily of state net operating loss and credit carryforwards for which management could not conclude it is more likely than not to be realized.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had federal and state income tax net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ib009e76fc516405f817eb74aed96c1cd_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE1OTM_2a5bbce6-8421-4568-881c-977e4291bcd2">421.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE2MDA_60554a58-066f-4aa3-8829-abd9c953cefe">329.9</ix:nonFraction> million, respectively. The federal net operating losses will begin to expire in 2028, unless previously utilized.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia0370056206f4edcbf3b359f712f78ae"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California net operating losses will begin to expire in 2031 unless previously utilized and the net operating losses related to other states will begin to expire in 2026.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had federal and state R&amp;D tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ib009e76fc516405f817eb74aed96c1cd_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE5NTA_fa81a3ac-a474-4ec3-a162-46f7cf82a379">107.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE5NTc_176bf114-3f94-4276-a8a7-ae4762f1deaf">66.3</ix:nonFraction> million, respectively. A portion of the federal R&amp;D tax credit carryforwards expired in 2021. The remaining federal R&amp;D tax credits will continue to expire beginning in 2022, unless previously utilized. The California R&amp;D tax credits carry forward indefinitely and the R&amp;D tax credits related to other states will begin to expire in 2022, unless previously utilized.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the future utilization of our net operating loss and R&amp;D tax credit carryforwards to offset future taxable income may be subject to an annual limitation, pursuant to Internal Revenue Code Sections 382 and 383, as a result of ownership changes that could occur in the future. No ownership changes have occurred through December&#160;31, 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to recognize interest or penalties related to income tax matters in income tax expense. Interest and penalties related to income tax matters were not material for 2021, 2020 or 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the United States and various state jurisdictions. Our tax years for 2001 for federal and since inception for California and forward are subject to examination by federal and state tax authorities due to the carryforward of unutilized net operating losses and R&amp;D tax credits.</span></div><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTU_4aa982d4-48e5-402e-80e0-3d8edd5f64fd" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to unrecognized tax benefits follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItMS0xLTEtMjQ1ODc_46fae3b2-665d-4b7e-a108-8293dbeea0a5">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItMy0xLTEtMjQ1ODc_b19d0b81-5478-4439-b00d-dbd58710b3f2">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItNS0xLTEtMjQ1ODc_4f907dc3-eabb-408a-80c0-ce0fbc977720">54.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtMS0xLTEtMjQ1ODc_31ca0272-bed7-4c71-925a-92386394417d">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtMy0xLTEtMjQ1ODc_74d3af92-2758-4613-ad82-3b408c86653e">5.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtNS0xLTEtMjQ1ODc_67006df6-f13c-469f-b5cf-87b8be947355">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtMS0xLTEtMjQ1ODc_cc243fc6-f9ce-45bd-85ce-409ca1e1fba2">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtMy0xLTEtMjQ1ODc_9bbeaeb4-87bd-4a9a-8c41-145e2bb7e078">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtNS0xLTEtMjQ1ODc_2d9d52cc-508e-4ab4-9d85-56a6eb2063c8">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtMS0xLTEtMjQ1ODc_e6993d64-95d7-4759-a20b-6795a8eb5a64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtMy0xLTEtMjQ1ODc_ee4eec18-646a-40cc-9fa3-bf780c4e9a30">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtNS0xLTEtMjQ1ODc_7aa1b70e-9d62-4294-9734-0104825d64de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtMS0xLTEtMjQ1ODc_e79a7a70-75c3-42f0-b6e8-082a451c4807">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtMy0xLTEtMjQ1ODc_16877886-2a21-4372-a730-74dede1cd3aa">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtNS0xLTEtMjQ1ODc_e03f2bb0-0e4e-468e-b7c6-8d8f2b047fea">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctMS0xLTEtMjQ1ODc_9ad483f3-7123-4ea1-bb7d-adac7a7ee6ec">64.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctMy0xLTEtMjQ1ODc_bdeb00c1-b12b-4ee6-9acc-d0dd13e81358">60.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctNS0xLTEtMjQ1ODc_2dfcf9c2-62e6-4c72-9cd6-ad5c13685bde">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded those deferred tax assets that are not more-likely-than-not to be sustained under the technical merits of the tax position. Such unrecognized tax benefits totaled $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM1NzQ_9a5da594-5fdd-4840-adf7-60a176ecbc02">4.9</ix:nonFraction> million for current year tax positions, as reflected in the table above.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $<ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM2NTk_ed0839f6-1364-4989-ac5b-aabbabb635c4">57.4</ix:nonFraction> million of unrecognized tax benefits that, if recognized and realized, would affect the effective tax rate, subject to the valuation allowance. We do not expect a significant change in our unrecognized tax benefits in the next twelve months.</span></div></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_172"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzE0Mjg_639d778e-e62f-4d94-b7dd-da00df61306f" continuedAt="i84ff86a1009c492c8af8a311bca5ad5d" escape="true">Leases</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i84ff86a1009c492c8af8a311bca5ad5d" continuedAt="idb04ce0e204b4d30a2fa2a337de510cb">Our corporate headquarters, for which we have operating leases with terms that expire beginning 2024 through 2031, are located in San Diego, California, and consist of office space and research and development laboratories. Certain of these lease agreements contain clauses for renewal at our option. As we were not reasonably certain to exercise any such options at commencement of these leases, no such options were recognized as part of the associated lease liabilities or right-of-use assets. </ix:continuation></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idb04ce0e204b4d30a2fa2a337de510cb"><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzYwNDczMTM5NjY2OTI_a2bb1291-31ae-4bc2-a3f6-6731ca9bf1b7" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present supplemental operating lease information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItMS0xLTEtMjkzOTY_aa7836ed-3fae-454d-9464-a0598545cb11">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItMy0xLTEtMjkzOTY_d159e1bb-bfcb-4cd1-8068-a78b46df0838">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItNS0xLTEtMjk0NzU_626d5441-58be-4f82-bf25-0857f60181bf">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtMS0xLTEtMjkzOTY_9e783b67-e54b-4d21-a548-0543ea8d08f3">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtMy0xLTEtMjkzOTY_1624e383-af72-4990-92a0-c4a791b61e6e">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtNS0xLTEtMjk0ODE_da7c3c0e-9d16-4af8-baea-b22e37b13039">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzYtMy0xLTEtMjkzOTY_1d587ebd-5e1b-4d0e-9990-89361de9b102">8.8</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzYtNS0xLTEtMjk0MzE_74b05f7e-0a9d-4a59-92a2-ac258d13b274">10.3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzctMy0xLTEtMjkzOTY_2f5c09ea-abfe-478c-869b-f55311590100">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzctNS0xLTEtMjk0MzE_b9dab1a3-5d31-46e4-a2e9-b6b5406dee7a">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash related to letters of credit issued in lieu of cash security deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia69ac08c927f48ea9cf1305bd5fc5f9f_I20211231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzktMy0xLTEtNDEwNjU_620174e1-ebf4-460b-a8da-c9372d9e0db1">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib860e40dbf6b4206ac8fb74ce9822840_I20201231" decimals="-5" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzktNS0xLTEtNDEwNjM_f80e620c-a64d-47ce-a873-52afaf236721">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzE0Mjk_3f370887-b390-4b1e-8c88-d0e6cf0d29af" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximate future minimum lease payments under operating leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEtMS0xLTEtMjQ1ODc_6762052b-d95d-4280-bcde-23423c864622">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzItMS0xLTEtMjQ1ODc_0e75688b-c0b6-45d1-90c9-f25882e93466">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzMtMS0xLTEtMjQ1ODc_2bf4f80a-53be-47cd-8066-9676d18dd48d">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzQtMS0xLTEtMjQ1ODc_6a10bf77-ba4e-4bf1-80a7-1b66b96e4ab7">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzUtMS0xLTEtMjQ1ODc_81c8dba2-d316-419c-a12f-b3d55ba3d506">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzYtMS0xLTEtMjQ1ODc_596273ac-3822-493d-9baa-c5e171c54f4a">70.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzctMS0xLTEtMjQ1ODc_8e87d889-81a8-40e9-bbd1-bfb0be27b181">154.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accreted interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzgtMS0xLTEtMjQ1ODc_53a95c06-f4a3-4119-b377-318e7aaf19b8">32.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzktMS0xLTEtMjQ1ODc_aa286543-969a-4751-bf2f-0016facfe11a">121.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab">Less current operating lease liabilities included in other current liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTEtMS0xLTI0NTg3_4988b776-058b-44b7-bd5e-c7dc943ac462">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410ba3ab0060406a970171c67adc140c_I20211231" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzExLTEtMS0xLTI0NTg3_3fc60ec6-4340-4bf2-8e67-26a4e6338263">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="ic35e9d12d921455aa45f30d1d4130202_175"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzM0OA_f20a0880-117b-4080-8de7-f9f21a39775b" continuedAt="i0c29989968f44128a1db6ffd9f06c138" escape="true">Retirement Plan</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0c29989968f44128a1db6ffd9f06c138">We have a 401(k) defined contribution savings plan, or the 401(k)&#160;Plan. The 401(k) Plan is for the benefit of all qualifying employees and permits voluntary contributions by employees up to <ix:nonFraction unitRef="number" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzIyMA_8d105992-3cd1-4c36-93d0-b60fe60f6bbc">60</ix:nonFraction>% of base salary limited by the IRS-imposed maximum. Employer contributions were $<ix:nonFraction unitRef="usd" contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMwMg_927ef71d-ee6d-4b8e-a394-0e8bbe169123">8.1</ix:nonFraction> million for 2021, $<ix:nonFraction unitRef="usd" contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMwNg_c5a180e0-4bc1-4b2c-b198-5260b5dc6faf">6.7</ix:nonFraction> million for 2020 and $<ix:nonFraction unitRef="usd" contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMxNA_35ca2d90-5df6-486d-b042-d3e9153386e1">4.9</ix:nonFraction> million for 2019.</ix:continuation></span></div><div id="ic35e9d12d921455aa45f30d1d4130202_1787"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODYx_0558dcc9-1d2b-418f-90cb-afbeb818cd3b" continuedAt="i490a138c6160470ba4f9c3c32ac4d24a" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="i490a138c6160470ba4f9c3c32ac4d24a"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2022, we entered into a lease agreement for a four-building campus facility to be constructed in San Diego, California, pursuant to which we also secured a <ix:nonNumeric contextRef="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208" name="nbix:LesseeOperatingLeaseOptionTermToConstructFifthBuilding" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF8zODQ4MjkwNzAxMzY5_1a1ef4d8-481e-41cd-b80e-682a5aaf85af">6-year</ix:nonNumeric> option for the construction of a fifth building and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the lease, on a building-by-building basis, base rent will be subject to a <ix:nonNumeric contextRef="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208" name="nbix:RentAbatementPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF8zODQ4MjkwNzAxMzYx_84a4673c-8462-4431-b1e1-24b2bfc8262d">10-month</ix:nonNumeric> rent abatement period following the respective lease commencement date, which dates will be determined in the future based upon achievement of substantial completion of construction with respect to each such building in the condition suitable for the installation of our furniture, fixtures and equipment, and on which date we will record a lease liability, corresponding right-of-use asset, and begin lease expense recognition with respect to each such building. After the rent abatement period, monthly base rent will be $<ix:nonFraction unitRef="usd" contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208" decimals="0" name="nbix:LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODYz_e9a9ce7f-d2dd-4cb9-9268-d5a015fd36bc">6</ix:nonFraction> per square foot, subject to annual escalations of <ix:nonFraction unitRef="number" contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208" decimals="INF" name="nbix:AnnualRentEscalationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODY3_ec47246e-e5ee-43e3-a500-29f126bafaab">3</ix:nonFraction>% during the initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODc5_2f705c83-17a2-4b52-a632-b67c9ccf6649">13.6-year</span> lease term, which term we have the option to renew for <ix:nonFraction unitRef="renewaloption" contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208" decimals="INF" name="nbix:NumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODgw_389ebea1-6104-43b0-9431-86a2eb967cf8">two</ix:nonFraction> additional terms of <ix:nonNumeric contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODgx_ea0c10e5-61b5-4ea8-8d41-be18c26afa46">5</ix:nonNumeric> years each.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_181"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Changes and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_184"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the timelines specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As required by SEC Rule&#160;13a-15(b), we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the year covered by this report. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_187"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, and includes those policies and procedures that:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#160;&#160;&#160;&#160;Pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#160;&#160;&#160;&#160;Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorization of our management and directors;&#160;and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">&#160;&#160;&#160;&#160;Provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal control over financial reporting cannot provide absolute assurance of achieving financial reporting objectives because of its inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or improper management override. Because of such limitations, there is a risk that material misstatements may not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk. Management is responsible for establishing and maintaining adequate internal control over financial reporting for the company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has used the framework set forth in the report entitled Internal Control-Integrated Framework (2013&#160;framework)&#160;published by the Committee of Sponsoring Organizations of the Treadway Commission (2013&#160;framework), known as COSO, to evaluate the effectiveness of our internal control over financial reporting. Based on this assessment, management has concluded that our internal control over financial reporting was effective as of December&#160;31, 2021. Ernst&#160;&amp; Young, LLP, our independent registered public accounting firm, has issued an attestation report on our internal control over financial reporting as of December&#160;31, 2021, which is included herein.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_190"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of Neurocrine Biosciences, Inc.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited Neurocrine Biosciences, Inc.&#8217;s internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), (the COSO criteria). In our opinion, Neurocrine Biosciences, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2021 and 2020, the related consolidated statements of income and comprehensive income, stockholders&#8216; equity, and cash flows, for each of the three years in the period ended December 31, 2021, and the related notes and our report dated February&#160;11, 2022 expressed an unqualified opinion thereon. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:6pt;padding-left:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ernst &amp; Young LLP</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_193"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;9B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2022, we entered into a lease agreement, or the Lease, with Gemdale Aperture Phase I, LLC for the lease of approximately 535,000 gross square feet of office, laboratory and ancillary space, or the Premises, on a 15.72-acre campus located at 6040 Edgewood Bend Court, San Diego, California 92130, or the Property, for our future principal executive offices, and laboratory space for research and development and related uses. The Premises will be delivered to us in two phases, with the initial Premises consisting of two buildings containing a total of approximately 240,000 gross square feet, or Phase 1, and the subsequent premises consisting of two buildings containing a total of approximately 295,000 gross square feet, or Phase 2. We also have the option to expand into a to-be-constructed fifth building, which would contain approximately 121,000 gross square feet, subject to the terms set forth in the Lease. Subject to certain conditions set forth in the Lease, we also have a right of first refusal to purchase the Property. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commencement date for Phase 1 is expected to occur on or around March 28, 2023, or the Phase 1 Commencement Date, and the commencement date for Phase 2 is expected to occur on or around February 1, 2025. The Lease will have an initial term of approximately 13 years and 7 months, commencing on the Phase 1 Commencement Date, unless terminated earlier, or the Term. We have two options to extend the Term by five years each.  Base rent for each of Phase 1 and Phase 2 will be abated for 10 months following the Phase 1 Commencement Date and Phase 2 Commencement Date, respectively. Following the abatement period for Phase 1, the base rent payable for Phase 1 will be $6.00 per gross square foot, or approximately $1.4 million per month, which amount will increase by 3% per year over the Term. Following the abatement period for Phase 2, the per gross square foot base rent payable for Phase 2 will be equal to the per gross square foot base rent being paid for the Phase 1 Premises at such time. We will also enter into a letter of credit equal to base rent due for the Premises during the last month of the initial Term.    </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon vacating our current principal executive offices at 12780 El Camino Real, San Diego, California 92130, we intend to sublet such facilities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the material terms of the Lease is qualified in its entirety by reference to the full text of the Lease, a copy of which will be filed as an exhibit to a subsequent filing with the SEC.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_196"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART&#160;III</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_199"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;10. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders, to be filed pursuant to Regulation&#160;14A with the SEC within 120&#160;days of December&#160;31, 2021. Such information is incorporated herein by reference.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of ethics that applies to our Chief Executive Officer, Chief Financial Officer, and to all of our other officers, directors, employees and agents. The code of ethics is available at the Corporate Governance section of the Investors page on our website at www.neurocrine.com. We intend to disclose future amendments to, or waivers from, certain provisions of our code of ethics on the above website within four business days following the date of such amendment or waiver. Information found on, or accessible through, our website is not part of, and is not incorporated into, this Annual Report on Form 10-K.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_202"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders, to be filed pursuant to Regulation&#160;14A with the SEC within 120&#160;days of December&#160;31, 2021. Such information is incorporated herein by reference.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_205"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders, to be filed pursuant to Regulation&#160;14A with the SEC within 120&#160;days of December&#160;31, 2021. Such information is incorporated herein by reference.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_208"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;13. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders, to be filed pursuant to Regulation&#160;14A with the SEC within 120&#160;days of December&#160;31, 2021. Such information is incorporated herein by reference.</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_211"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item&#160;14. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Principal Accounting Fees and Services</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement for our 2022 Annual Meeting of Stockholders, to be filed pursuant to Regulation&#160;14A with the SEC within 120&#160;days of December&#160;31, 2021. Such information is incorporated herein by reference.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_214"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ic35e9d12d921455aa45f30d1d4130202_217"></div><div style="-sec-extract:summary;margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exhibits, Financial Statement Schedules</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;Documents filed as part of this report.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. List of Financial Statements. The following are included in Item&#160;8 of this report:</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of December&#160;31, 2021 and 2020</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Income and Comprehensive Income for the years ended December&#160;31, 2021, 2020 and 2019</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity for the years ended December&#160;31, 2021, 2020 and 2019</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2021, 2020 and 2019</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to the Consolidated Financial Statements</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. List of all Financial Statement schedules. All schedules are omitted because they are not applicable, or the required information is shown in the Financial Statements or notes thereto.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. List of Exhibits required by Item&#160;601 of Regulation&#160;S-K. See part (b)&#160;below.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b) Exhibits. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed as part of, or incorporated by reference into, this report:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459018026844/nbix-ex31_91.htm">Certificate of Incorporation, as amended</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 3.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on November 5, 2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447521000036/nbix-20210331exhibit3_2.htm">Bylaws</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 3.2 of the Company's Quarterly Report on Form 10-Q filed on May 5, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/0000898430-96-002108.txt">Form of Common Stock Certificate</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to the Company&#8217;s Registration Statement on Form S-1 (Registration No. 333-03172)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517154199/d390610dex41.htm">Indenture, dated as of May&#160;2, 2017, by and between the Company and U.S. Bank National Association, as Trustee</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.1 of the Company&#8217;s Current Report on Form 8-K filed on May 2, 2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="nbix-20211231exhibit43.htm">First Supplemental Indenture, dated as of December 22, 2021, by and between the Company and U.S. Bank National Association, as Trustee</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517154199/d390610dex991.htm">Form of Note representing the Company&#8217;s 2.25% Convertible Notes due 2024</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 99.1 of the Company&#8217;s Current Report on Form 8-K filed on May 2, 2017</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459020003773/nbix-ex44_74.htm">Description of Common Stock of the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 4.4 of the Company&#8217;s Annual Report on Form 10-K filed on February 7, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit211.htm">Subsidiaries of the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit231.htm">Consent of Independent Registered Public Accounting Firm</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit311.htm">Certification of Chief Executive Officer pursuant to Rules&#160;13a-14 and 15d-14 promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit312.htm">Certification of Chief Financial Officer pursuant to Rules&#160;13a-14 and 15d-14 promulgated under the Securities Exchange Act of 1934</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32***</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit32.htm">Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18&#160;U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Instance Document. &#8211; the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibit 101)</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Collaboration and License Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">:</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447521000036/nbix-20210331exhibit101.htm">Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August&#160;31, 2011</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company's Quarterly Report on Form 10-Q filed on May 5, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447521000036/nbix-20210331exhibit102.htm">First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxemburg S.a.r.l.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.2 of the Company's Quarterly Report on Form 10-Q filed on May 5, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447521000036/nbix-20210331exhibit103.htm">Collaboration and License Agreement dated March&#160;31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company's Quarterly Report on Form 10-Q filed on May 5, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447521000036/nbix-20210331exhibit104.htm">License Agreement dated February&#160;9, 2017 between BIAL&#8211; Portela&#160;&amp; CA, S.A. and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.4 of the Company's Quarterly Report on Form 10-Q filed on May 5, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.5*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019002328/nbix-ex105_822.htm">Collaboration and License Agreement dated January 28, 2019 between Voyager Therapeutics, Inc. and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.5 of the Company&#8217;s Annual Report on Form 10-K filed on February 7, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019002328/nbix-ex106_401.htm">Stock Purchase Agreement dated January 28, 2019 between Voyager Therapeutics, Inc. and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.6 of the Company&#8217;s Annual Report on Form 10-K filed on February 7, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019002328/nbix-ex107_400.htm">Investor Agreement dated January 28, 2019 between Voyager Therapeutics, Inc. and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.7 of the Company&#8217;s Annual Report on Form 10-K filed on February 7, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019026602/nbix-ex101_71.htm">Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on July 29, 2019</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.9**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447520000018/nbix-20200630exhibit103.htm">Exclusive License Agreement dated June 12, 2020 between Takeda Pharmaceutical Company Limited and the Company</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company&#8217;s Quarterly Report on Form 10-Q filed on August 3, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.10**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%;text-decoration:underline" href="nbix-20211231exhibit1010.htm">Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company</a></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Equity Plans and Related Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517181670/d363882dex991.htm">Neurocrine Biosciences, Inc. 2011 Equity Incentive Plan, as amended</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 99.1 of the Company&#8217;s Current Report on Form 8-K filed on May 30, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312515209053/d934906dex991.htm">Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2011 Equity Incentive Plan, and Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for use under the Neurocrine Biosciences, Inc. 2011 Equity Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 99.1 of the Company&#8217;s Current Report on Form 8-K filed on June 1, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.13</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312518042794/d520757dex1017.htm">Neurocrine Biosciences, Inc. Inducement Plan, as amended</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.17 of the Company&#8217;s Annual Report on Form 10-K filed on February 13, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312515268390/d938011dex101.htm">Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. Inducement Plan, and Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement for use under the Neurocrine Biosciences, Inc. Inducement Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on July 29, 2015</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.15</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312518178679/d592659dex992.htm">Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan dated May 30, 2018</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 99.2 of the Company&#8217;s Current Report on Form 8-K filed on May 30, 2018</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.16</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000091447520000018/nbix-20200630exhibit101.htm">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on August 3, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.17</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="nbix-20211231exhibit1017.htm">Form of Stock Option Grant Notice and Option Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan, and Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement for use under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</a></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Agreements with Officers and Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.18</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000093639207000628/a32155exv10w3.htm">Amended and Restated Employment Agreement effective August&#160;1, 2007 between the Company and Kevin C. Gorman,&#160;Ph.D.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company&#8217;s Quarterly Report on Form 10-Q filed on August 3, 2007</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312511030707/dex1032.htm">Form of Amendment to Employment Agreement for executive officers, effective as of December 15, 2010</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.32 of the Company&#8217;s Annual Report on Form 10-K filed on February 11, 2008</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.20</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459020003773/nbix-ex1016_75.htm">Employment Agreement dated November 3, 2014 between the Company and Kyle Gano</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.16 of the Company&#8217;s Annual Report on Form 10-K filed on February 6, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.21</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517043838/d324435dex103.htm">Employment Agreement dated May 26, 2015 between the Company and Eric Benevich</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company&#8217;s Annual Report on Form 10-K filed on February 14, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.22</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312518042794/d520757dex1026.htm">Employment Agreement effective November&#160;29, 2017 between the Company and Matthew C. Abernethy</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.26 of the Company&#8217;s Annual Report on Form 10-K filed on February 13, 2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.23</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517329460/d466738dex101.htm">Form of Indemnity Agreement entered into between the Company and its officers and directors</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on November 1, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.24</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">+</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019026602/nbix-ex102_72.htm">Employment Agreement dated January 8, 2018 between the Company and Eiry W. Roberts, M.D.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.2 of the Company&#8217;s Quarterly Report on Form 10-Q filed on July 29, 2019</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%;text-decoration:underline">Agreements Related to Real Property</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">:</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312512015472/d284170dex992.htm">Amended and Restated Lease dated November 1, 2011 between the Company and Kilroy Realty, L.P.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 99.2 of the Company&#8217;s Current Report on Form 8-K filed on January 18, 2012</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:78.228%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517247437/d253292dex101.htm">First Amendment to Amended and Restated Lease between the Company and Kilroy Realty, L.P., dated June&#160;5, 2017</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on August 3, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000119312517329460/d466738dex103.htm">Second Amendment to Amended and Restated Lease between the Company and Kilroy Realty, L.P., dated October&#160;12, 2017</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company&#8217;s Quarterly Report on Form 10-Q filed on November 1, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000093639207000926/a36358exv10w3.htm">Letter of Credit dated December 3, 2007, issued by Wells Fargo Bank, N.A. for the benefit of Kilroy Realty, L.P., as amended on November&#160;20, 2014 and June 19, 2017</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.3 of the Company&#8217;s Current Report on Form 8-K filed on December 10, 2007; Exhibit 10.5 of the Company&#8217;s Annual Report on Form 10-K filed on February 9, 2015; and Exhibit 10.2 of the Company&#8217;s Quarterly Report on Form 10-Q filed on August 3, 2017</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Description:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/914475/000156459019039803/nbix-ex101_32.htm">Third Amendment to Amended and Restated Lease between the Company and Kilroy Realty, L.P. dated August 7, 2019</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reference:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporated by reference to Exhibit 10.1 of the Company&#8217;s Quarterly Report on Form 10-Q filed on November 4, 2019</span></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management contract or compensatory plan or arrangement.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential treatment has been granted with respect to certain portions of the exhibit.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain information in this exhibit has been omitted pursuant to Item 601 of Regulation S-K.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">***</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">These certifications are being furnished solely to accompany this annual report pursuant to 18&#160;U.S.C. Section&#160;1350 and are not being filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of Neurocrine Biosciences, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as specifically noted above, the Company&#8217;s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K have a Commission File Number of 000-22705.</span></td></tr></table></div><div style="margin-bottom:6pt;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)&#160;Financial Statement Schedules. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Item&#160;15(a)(2) above.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_220"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.971%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NEUROCRINE BIOSCIENCES, INC.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kevin C. Gorman</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin C. Gorman</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Matthew C. Abernethy</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew C. Abernethy</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="ic35e9d12d921455aa45f30d1d4130202_223"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin C. Gorman and Matthew C. Abernethy, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution for him or her, and in his or her name in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power of authority to do and perform each and every act and thing requisite and necessary to be done therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, and any of them, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the Registrant and in the capacities indicated as of February&#160;11, 2022:</span></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.105%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Kevin C. Gorman</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kevin C. Gorman, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">/ Matthew C. Abernethy</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Matthew C. Abernethy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">William H. Rastetter</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chairman of the Board of Directors</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William H. Rastetter, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Gary A. Lyons</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gary A. Lyons</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Johanna Mercier</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Johanna Mercier</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">George J. Morrow</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">George J. Morrow</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Leslie V. Norwalk</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Leslie V. Norwalk</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Richard F. Pops</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Richard F. Pops</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Shalini Sharp</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shalini Sharp</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Stephen A. Sherwin</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stephen A. Sherwin, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>nbix-20211231exhibit43.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i81ba555a0f7144ea9beb3fb34ff7b881_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 4.3</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NEUROCRINE BIOSCIENCES, INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">AND </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. BANK NATIONAL ASSOCIATION,</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Trustee </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FIRST SUPPLEMENTAL INDENTURE </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:136%">Dated as of December 20, 2021</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2.25% Convertible Senior Notes due 2024</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">FIRST SUPPLEMENTAL INDENTURE, dated as of December 20, 2021 (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), among </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Neurocrine Biosciences</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, Inc., a Delaware corporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), as issuer, and U.S. Bank National Association, a national banking association organized under the laws of the United States of America, as trustee (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Trustee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), to the Indenture, dated as of May 2, 2017 (as supplemented or otherwise modified prior to the date hereof, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;), between the Company and the Trustee. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company has heretofore executed and delivered the Indenture, pursuant to which the Company issued its 2.25% Convertible Senior Notes due 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Notes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8221;) in the original aggregate principal amount of $517,500,000&#59;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, Section&#160;8.01(G) of the Indenture provides that the Company and the Trustee may amend or supplement the Indenture without the consent of any Holder to irrevocably elect or eliminate any Settlement Method or Specified Dollar Amount&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">, that no such election or elimination will affect any settlement method theretofore elected (or deemed to be elected) with respect to any Note pursuant to Section 5.03(A) of the Indenture&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, in connection with the execution and delivery of this Supplemental Indenture, the Trustee has received an Officer&#8217;s Certificate and an Opinion of Counsel as contemplated by Sections 8.06, 11.02 and 11.03 of the Indenture&#59; and </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WHEREAS, the Company has requested that the Trustee execute and deliver this Supplemental Indenture and have satisfied all requirements necessary to make this Supplemental Indenture a valid instrument in accordance with its terms. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">WITNESSETH&#58; </font></div><div style="margin-bottom:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the Company covenants and agrees with the Trustee as follows for the equal and ratable benefit of the Holders&#58; </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE 1 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">DEFINITIONS</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 1.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Definitions in the Supplemental Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. Unless otherwise specified herein or the context otherwise requires&#58; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(a)&#160;a term defined in the Indenture has the same meaning when used in this Supplemental Indenture unless the definition of such term is amended or supplemented pursuant to this Supplemental Indenture&#59; </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)&#160;the terms defined in this Article and in this Supplemental Indenture include the plural as well as the singular&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(c)&#160;unless otherwise stated, a reference to a Section or Article is to a Section or Article of this Supplemental Indenture. </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE 2 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">SETTLEMENT METHOD</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;2.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Irrevocable Elimination of Physical Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In accordance with Section 8.01(G) of the Indenture, the Company hereby irrevocably elects to eliminate Physical Settlement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> that this election shall not affect any Settlement Method heretofore elected (or deemed to be elected).  </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;2.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Amendment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-2-</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The definition of &#8220;Specified Dollar Amount&#8221; in Section 1.01 of the Indenture is hereby amended and restated in its entirety to read as follows&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8220;Specified Dollar Amount&#8221; means, with respect to the conversion of a Note to which Combination Settlement applies, the maximum cash amount per $1,000 principal amount of such Note deliverable upon such conversion (excluding cash in lieu of any fractional share of Common Stock)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">provided </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">that the Specified Dollar Amount shall in no event be less than $1,000.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">ARTICLE 3 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">MISCELLANEOUS </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;3.01. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Ratification of Indenture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The Indenture, as supplemented by this Supplemental Indenture, is in all respects ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;3.02. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Trustee Not Responsible for Recitals</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. The recitals herein contained are made by the Company and not by the Trustee, and the Trustee assumes no responsibility for the correctness thereof. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. All of the provisions contained in the Indenture in respect of the rights, privileges, immunities, powers, and duties of the Trustee shall be applicable in respect of the Supplemental Indenture as fully and with like force and effect as though set forth in full herein. </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.03 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">All agreements of the Company and the Trustee in this Supplemental Indenture will bind their respective successors.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;3.04. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. THIS SUPPLEMENTAL INDENTURE AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section&#160;3.05. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Headings, Etc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">The titles and headings of the articles and sections of this Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.06. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Execution in Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. This Supplemental Indenture may be executed in any number of counterparts, each of which shall be an original, but such counterparts shall together constitute but one and the same instrument. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. </font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.07. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. In the event any provision of this Supplemental Indenture, or any portion thereof, shall be invalid, illegal or unenforceable, then (to the extent permitted by law) the validity, legality or enforceability of the remaining provisions, or any portion thereof, shall not in any way be affected or impaired.</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Section 3.08. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:100%">Waiver of Jury Trial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">. EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE OR THE TRANSACTIONS CONTEMPLATED HEREBY.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:12pt;margin-top:5pt;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">-3-</font></div><div><font><br></font></div></div></div><div id="i81ba555a0f7144ea9beb3fb34ff7b881_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:24.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of the day and year first above written. </font></div><div style="padding-left:271.89pt"><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">NEUROCRINE BIOSCIENCES, INC.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"><div><font><br></font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Matthew C. Abernethy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">U.S. BANK NATIONAL ASSOCIATION,</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">as Trustee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Benjamin Krueger</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Vice President</font></td></tr></table></div><div><font><br></font></div><div style="height:73.44pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SIGNATURE PAGE TO FIRST SUPPLEMENTAL INDENTURE</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.10
<SEQUENCE>3
<FILENAME>nbix-20211231exhibit1010.htm
<DESCRIPTION>EX-10.10
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5fd101b39b3a41d9b25dcd8e45d99cc1_1"></div><div style="min-height:94.5pt;width:100%"><div style="padding-right:-21pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit 10.10</font></div><div style="margin-bottom:0.18pt;padding-right:-21pt"><font><br></font></div><div style="padding-right:-21pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;***&#93;, HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT NEUROCRINE BIOSCIENCES, INC. TREATS AS PRIVATE OR CONFIDENTIAL</font></div></div><div style="margin-bottom:11pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt;text-align:center"><font><br></font></div><div style="margin-bottom:11pt;text-align:center"><font><br></font></div><div style="margin-bottom:11pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:140%">Dated 22  November 2021</font></div><div style="margin-bottom:11pt;text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:1px;margin-bottom:5pt;vertical-align:text-bottom;width:264px"></div><div style="margin-bottom:12pt;padding-right:85.05pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:85.05pt"><font><br></font></div><div style="margin-bottom:12pt;padding-right:85.05pt"><font><br></font></div><div style="margin-bottom:18pt;padding-left:42.52pt;padding-right:42.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">&#160;&#160;&#160;&#160;HEPTARES THERAPEUTICS LIMITED&#160;&#160;&#160;&#160;(1)</font></div><div style="margin-bottom:18pt;padding-left:42.52pt;padding-right:42.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">&#160;&#160;&#160;&#160;AND</font></div><div style="margin-bottom:18pt;padding-left:42.52pt;padding-right:42.52pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">&#160;&#160;&#160;&#160;NEUROCRINE BIOSCIENCES, INC.&#160;&#160;&#160;&#160;(2)</font></div><div style="margin-bottom:12pt;padding-right:85.05pt"><font><br></font></div><div style="margin-bottom:11pt;text-align:center"><font><br></font></div><div style="margin-bottom:0.18pt;padding-left:51.91pt;padding-right:51.91pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.163%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.75pt solid #000000;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COLLABORATION AND LICENSE AGREEMENT</font></td></tr></table></div><div style="margin-bottom:11pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:11pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:140%">&#160;&#160;&#160;&#160;</font></div><div style="height:82.08pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div></div></div><div id="i5fd101b39b3a41d9b25dcd8e45d99cc1_4"></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">CONTENTS</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:209%">Clause&#160;&#160;&#160;&#160;Heading&#160;&#160;&#160;&#160;Page</font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">1</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">DEFINITIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">LICENSE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">13</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">GOVERNANCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">DEVELOPMENT AND DILIGENCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">20</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">5</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">FINANCIAL PROVISIONS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">24</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">6</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">CONFIDENTIALITY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">30</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">7</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">INTELLECTUAL PROPERTY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">32</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">8</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">TERM AND TERMINATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">36</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">9</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">REPRESENTATIONS, WARRANTIES AND COVENANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">42</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">10</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">ANTI-BRIBERY AND ANTI-CORRUPTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">44</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">11</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">INDEMNIFICATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">45</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">12</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">MISCELLANEOUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">48</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SCHEDULE 1 Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:180%">&#91;***&#93;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">SCHEDULE 2</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">Existing Patents</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:180%">&#91;***&#93;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">SCHEDULE 3</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">Press Release</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">53</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">SCHEDULE 4</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:199%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:199%">COMPOUND STRUCTURES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:180%">&#91;***&#93;</font></div></td></tr></table></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div></div></div><div id="i5fd101b39b3a41d9b25dcd8e45d99cc1_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">THIS COLLABORATION AND LICENSE AGREEMENT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) is entered into as of 22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2021 (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Execution Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTIES</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.23pt">HEPTARES THERAPEUTICS LIMITED</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a company organized under the laws of England having company number 06267989 and having its principal place of business at the Steinmetz Building, Granta Park, Great Abington, Cambridge, Cambridgeshire, CB21 6DG, United Kingdom (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;)&#59; and</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:23.23pt">NEUROCRINE BIOSCIENCES, INC.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, a company organized under the laws of Delaware and having its principal place of business at 12780 El Camino Real, San Diego, California 92130 (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neurocrine</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In this Agreement, Neurocrine and Heptares are collectively referred to as the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; and each individually a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;. </font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BACKGROUND</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">Heptares owns or controls certain Patents and Know-How which may be useful in Developing, manufacturing and Commercializing compounds.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(B)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">Neurocrine has expertise in the Development, manufacture and Commercialization of pharmaceutical products.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(C)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Prior to the Effective Date Heptares has discovered and developed a number of selective muscarinic M1, M4 and M1&#47;M4 receptor agonist compounds for the treatment of various neurological and psychiatric diseases and conditions. One such M4 receptor agonist compound is planned to commence Phase II Clinical Trials and a second is planned to commence Phase I Clinical Trials. The Parties desire to enter into a collaboration and license agreement to further Develop and Commercialize all selective muscarinic M1, M4 and M1&#47;M4 receptor agonist compounds controlled by Heptares or its Affiliates.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(D)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Heptares and its Affiliates will retain the right to Develop and Commercialize and otherwise Exploit all M1 Target Agonists (including the M1 Lead Candidate) in all indications in Japan and Neurocrine will have options to co-develop and co-commercialize such M1 Target Agonists in Japan with Heptares.</font></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, in consideration of the respective covenants set forth herein, the Parties agree as follows&#58;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">DEFINITIONS</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">As used in this Agreement, the following terms shall have the meanings set forth below&#58;</font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acting Improperly</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the meaning set forth in clause&#160;10.1(a)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affiliate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any person which directly or indirectly controls, is controlled by or is under common control with the Party in question at the relevant time.  As used in this definition of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> the term &#34;control&#34; shall mean, as to any person, (a) direct or indirect ownership of fifty percent (50%) or more (or such lesser percentage which is the maximum allowed to be owned by a foreign corporation in a particular jurisdiction) of the voting interests or other ownership interests in the person in question&#59; or (b) possession, directly or indirectly, of the power to direct or cause the direction of management or policies of the person in question (whether through ownership of securities or other ownership interests, by contract or otherwise)&#59;  </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Agreement</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the meaning set forth in the Preamble&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the research, development and license agreement between Heptares and &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the letter agreement &#91;***&#93; between Heptares and &#91;***&#93;, in the form agreed to in advance by Neurocrine&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the letter from &#91;***&#93; to Heptares &#91;***&#93; giving notice of termination of the &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alliance Manager</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 3.9&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Anti-Corruption Laws</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the U.S. Foreign Corrupt Practices Act, as amended, the UK Bribery Act 2010, as amended, and any other applicable anti-corruption laws and laws for the prevention of fraud, racketeering, money laundering or terrorism&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Arising IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all Arising Know-How and Arising Patents&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Arising Know- How</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any and all Know-How conceived, generated or developed by or on behalf of either Party or jointly by the Parties in the performance of the Research and Development Programs or any other obligations under this Agreement or exercise of rights under this Agreement, in all cases excluding Heptares Platform Improvements&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Arising Patents</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any and all Patents that claim or cover Arising Know-How&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Auditor</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.10(b)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bankruptcy Code</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 8.6(b)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Blocking Third Party Patent Right</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to any country, a Patent in such country controlled by a Third Party that is reasonably necessary or useful to Exploit any Compound or Licensed Product&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Business Day</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Monday, Tuesday, Wednesday, Thursday or Friday that is not a public holiday in London, England or San Diego, California, USA&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Calendar Quarter</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a period of three (3) consecutive months corresponding to the calendar quarters commencing on the first day of January, April, July or October&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Calendar Year</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a period of twelve (12) consecutive months corresponding to the calendar year commencing on the first day of January&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">cGCP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">current Good Clinical Practices as specified in the United States Code of Federal Regulations, ICH Guideline E6, or equivalent Laws of an applicable Governmental Authority of any other relevant country where a clinical trial is being conducted&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">cGMP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">current Good Manufacturing Practices as specified in the United States Code of Federal Regulations, ICH Guideline Q7A, or equivalent Laws of an applicable Governmental Authority of any other relevant country at the time of manufacture&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Compounds</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the compounds known as &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Trial</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any of a Phase I Clinical Trial, Phase II Clinical Trial, Phase III Clinical Trial or a clinical trial conducted after the obtaining of Regulatory Approval&#59;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CMO</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract Manufacturing Organisation&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Combination Products</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products in forms suitable for human or veterinary applications that contain a Compound together with one or more other active ingredients that are sold either as a fixed dose&#47;unit or as separate doses&#47;units in a single package or for a single invoice price and separately packaged&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercialize</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any and all activities (whether before or after Regulatory Approval for a product) directed to commercially manufacturing, obtaining pricing and reimbursement approvals and regulatory activities pertaining to same, promotion, marketing, importing, distribution or sale (and offer for sale or import or export for sale) for a product. &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercializing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; and &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercialization</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; shall have corresponding meanings&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commercially Reasonable Efforts</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">efforts that &#91;***&#93; and taking into account other relevant factors including &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Committee Deadlock</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 3.6&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Competitive Product</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Target Agonist&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compounds</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all (a) Heptares Existing Compounds and (b) new Target Agonists discovered, identified or developed as a result of carrying out the Research and Development Programs, and in each case any derivative of the foregoing and any &#91;***&#93; of any such new Target Agonist or Heptares Existing Compounds&#59;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Confidential Information</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all secret, confidential or proprietary information, Know-How, whether provided in written, oral, graphic, video, computer or other form, provided by or on behalf of one Party (the &#34;Disclosing Party&#34;) or its Affiliates to the other Party (the &#34;Receiving Party&#34;) or its Affiliates pursuant to this Agreement, including information relating to the Disclosing Party&#8217;s existing or proposed research, development efforts or Patent applications, business or Exploitation of any Compound or Licensed Product and any other materials that have not been made available by the Disclosing Party to the general public.  All information disclosed by a Party under the following agreements between the Parties including&#58; &#91;***&#93; (collectively, the &#8220;CDAs&#8221;) will be deemed such Party&#8217;s Confidential Information hereunder.  Notwithstanding the foregoing sentences, Confidential Information shall not include any information or materials that&#58;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;were already known to the Receiving Party (other than under an obligation of confidentiality) at the time of disclosure by the Disclosing Party to the extent such Receiving Party has documentary evidence to that effect&#59;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;were generally available to the public or otherwise part of the public domain at the time of its disclosure to the Receiving Party through no breach of this Agreement by the Receiving Party&#59;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;became generally available to the public or otherwise part of the public domain after its disclosure, other than through any act or omission of a Party in breach of this Agreement&#59;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;were subsequently lawfully disclosed to the Receiving Party by a Third Party who is not bound by any obligation of confidentiality with respect to such information&#59; or</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;were independently discovered or developed by or on behalf of the Receiving Party without the use of the Confidential Information belonging to the Disclosing Party and the Receiving Party has documentary evidence to that effect&#59;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for purposes hereof, Confidential Information constituting (i) the Licensed Know-How that is specific to the Compounds and Licensed Products shall be deemed to be the Confidential Information of Neurocrine (and Neurocrine shall be the Disclosing Party and Heptares shall be the Receiving Party with respect thereto) and (ii) the existence, scope and terms and conditions of this Agreement shall be the Confidential Information of both Parties (and both Parties shall be the Receiving Party and the Disclosing Party with respect thereto)&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">specific aspects or details of Confidential Information shall not be deemed to be within the public domain or in the possession of the Receiving Party merely because the Confidential Information is embraced by more general information in the public domain or in the possession of the Receiving Party.  Further, any combination of Confidential Information shall not be considered in the public domain or in the possession of the Receiving Party merely because individual elements of such Confidential Information are in the public domain or in the possession of the receiving Party unless the combination and its principles are in the public domain or in the possession of the Receiving Party&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consumer Price Index</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the consumer price index (all items) (United Kingdom) as published by the Office for National Statistics for the United Kingdom, or such other index as may be published in substitution&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Control</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and its correlative terms, &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controlled</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; or &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controls</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; shall mean, with respect to any intellectual property right or other intangible property, that a Party owns or has a license or sublicense to such item or right (other than by operation of the licenses in this Agreement), and has the ability to grant access, license or sublicense in or to such right without violating the terms of any agreement or other arrangement with any Third Party.  Notwithstanding the foregoing, except for intellectual property in-licensed by Heptares as of the Effective Date (including under the &#91;***&#93; and the &#91;***&#93;), Third Party intellectual property shall only be considered &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Controlled</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; by a Party, if &#91;***&#93;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Crystal Structure</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an X-ray structure determination of a receptor, typically within the following parameters&#58; &#91;***&#93;&#59;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">discovery and research activities and any and all activities, including non-clinical, pre-clinical and clinical trials, post approval studies, supporting manufacturing, production process development and formulation and related regulatory activities, directed to obtaining and maintaining Regulatory Approval for a product.  &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Develop</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; and &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Developing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; shall have corresponding meanings&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development Costs</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93; costs incurred at &#91;***&#93; in performing the activities under the Research and Development Plans&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 4.9(c)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discontinued Patent</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 7.1&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dispute Auditor</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.10(d)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Distributor</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Third Party appointed by Neurocrine or any of its Affiliates or its or their Sublicensees to distribute, market and sell Licensed Product(s), with or without packaging rights, in one or more countries in the Territory, in circumstances where the person purchases its requirements of Licensed Product(s) from Neurocrine or its Affiliates or its or their Sublicensees&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Effective Date</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means with respect to this Agreement the date of the expiration or termination of any applicable waiting period under the HSR Act&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EMA</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the European Medicines Agency and any successor or replacement agency&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EU</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the European Union as at the Effective Date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">European Major Markets</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the UK, Germany, France, Spain and Italy&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Existing Patents</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 9.2(b)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exploit</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to make, have made, import, use, sell or offer for sale, including to Develop, Commercialize, register, hold or keep (whether for disposal or otherwise), have used, export, transport, distribute, promote, market or have sold or otherwise dispose of.  &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exploitation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34; means the act of Exploiting a compound, product or process&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FDA</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the US Food and Drug Administration, and any successor or replacement agency&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Field</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all human and non-human diagnostic, prophylactic and therapeutic uses&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Option</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;2.4&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Option Information Package</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;2.4&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Force Majeure Event</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 12.4&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Formulation</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any pharmaceutical formulation (1) used in a commercial dosage form of a Licensed Product to attenuate its pharmacokinetics (e.g., minimizing Cmax, extending half-life, etc.) and (2) leading to an Arising Patent that is listed in the FDA Orange Book and any equivalent of such Patent in any other country other than the US&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FTE</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a full-time equivalent person year consisting of a total of &#91;***&#93; hours of work per Calendar Year directed to scientific, medical, technical, research, clinical and regulatory activities under the Research and Development Plans&#59; overtime, and work on weekends, holidays, and the like &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FTE Rate</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Heptares&#8217; at cost FTE rate which is $&#91;***&#93; per annum and &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Future Affiliate</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Affiliate that becomes an Affiliate of Heptares after the Execution Date as a result of Heptares or its parent company, Sosei Group Corporation, being acquired by or merging with a Third Party.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">GAAP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to a Party or its Affiliates or its or their sublicensees, US generally accepted accounting principles, International Financial Reporting Standards or such other similar national standards as such Party, Affiliate or sublicensee adopts, in each case, consistently applied&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Generic Penetration</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.4(b)&#59;</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Generic Product</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with respect to a Licensed Product, any pharmaceutical or biological product that is distributed by a Third Party under a Regulatory Approval approved by a Regulatory Authority &#91;***&#93; including any product authorized for sale (a) in the U.S. pursuant to &#91;***&#93;, (b) in the EU pursuant to &#91;***&#93; or (c) in any other country or jurisdiction pursuant to &#91;***&#93;.  A Licensed Product distributed under an NDA or foreign equivalent Drug Approval Application held by Neurocrine (i.e., an authorized generic product) will not constitute a Generic Product with respect to such Licensed Product&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Global Major Markets</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the US, European Major Markets, and Japan&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Governmental Authority</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any court, tribunal, arbitrator, agency, legislative body, commission, official or other instrumentality of (a) any government of any country, (b) a federal, state, province, county, city or other political subdivision thereof or (c) any supranational body&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Government Official</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) any person employed by or acting on behalf of a government, government-controlled agency or entity or public international organization, (b) any political party, party official or candidate, (c) any person who holds or performs the duties of an appointment, office or position created by custom or convention or (d) any person who holds himself out to be the authorized intermediary of any of the foregoing&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hatch-Waxman Act</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the U.S. &#34;Drug Price Competition and Patent Term Restoration Act&#34; of 1984, including as set forth at 21 U.S.C. &#167;355(b)(2)(A)(iv) or (j)(2)(A)(vii)(IV)&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Existing Compounds</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any and all Target Agonists (i) claimed or covered by the Heptares Existing Compound Patents or (ii) discovered, identified or developed by or on behalf of Heptares or any of its Affiliates prior to the Effective Date, including the Clinical Compounds and the Nonclinical Compounds&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Existing Compound IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares Existing Compound Know-How and Heptares Existing Compound Patents&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Existing Compound Know-How</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any and all Know-How relating to the Heptares Existing Compounds that is Controlled by Heptares or any of its Affiliates as of the Effective Date&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Existing Compound Patents</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Patents filed &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Muscarinic Assay</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">an &#91;***&#93; assay that measures &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Platform</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares&#8217; proprietary platform covering &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Platform Improvement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 2.2(b)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Platform IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all Patents and Know-How owned or Controlled by Heptares before the Effective Date or after the Effective Date during the Term that cover or comprise the Heptares Platform or Heptares Platform Improvements, but excluding (a) any Patents that claim or cover a Target Agonist (including its manufacture or use) and (B) any Know-How that specifically relates to a Target Agonist (including its manufacture or use)&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Retained Rights</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the right of Heptares and its Affiliates to continue to Develop and Commercialize and otherwise Exploit either alone or with or for the benefit of a Third Party, subject to Neurocrine&#8217;s rights under this Agreement, all M1 Target Agonists (including the M1 Lead Candidate) in all indications in Japan. Such right shall include the right to carry out Clinical Trials of M1 Target Agonists in all indications throughout the Territory for the purpose of supporting Development, Commercialization and Exploitation of M1 Target Agonists (including the M1 Lead Candidate) in all indications in Japan, subject to the oversight and approval of the JSC in accordance with clause 3.2&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Retained Rights IP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means all Know-How conceived, generated or developed by or on behalf of Heptares or any of its Affiliates or licensees in exercising the Heptares Retained Rights and all Patents Controlled by Heptares or its Affiliates that claim or cover such Know-How&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSR Act</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">means the Hart Scott Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSR Filing</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;12.12(a).</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the compound known by that reference number and having the structure as described in Schedule 4&#59;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the compound known by that reference number and having the structure described in Schedule 4&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the compound known by that reference number and having the structure described in Schedule 4&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the compound known by that reference number and having the structure described in Schedule 4&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the compound known by that reference number and having the structure described in Schedule 4&#59;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the compound known by that reference number and having the structure described in Schedule 4&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the plan and associated budget attached at Schedule 1 as amended in accordance with clause 4.2&#59;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the Development of &#91;***&#93;, to be conducted by the Parties pursuant to the &#91;***&#93; Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the plan and associated budget to be prepared by the Parties as amended in accordance with clause 4.2&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the Development of &#91;***&#93;, to be conducted by the Parties pursuant to the &#91;***&#93; Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the plan and associated budget to be prepared by the Parties as amended in accordance with clause 4.2&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the Development of &#91;***&#93;, to be conducted by the Parties pursuant to the &#91;***&#93; Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the plan and associated budget to be prepared by the Parties as amended in accordance with clause 4.2&#59; </font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the Development of &#91;***&#93;, to be conducted by the Parties pursuant to the &#91;***&#93; Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the plan and associated budget to be prepared by the Parties as amended in accordance with clause 4.2&#59; </font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the Development of &#91;***&#93;, to be conducted by the Parties pursuant to the &#91;***&#93; Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IND</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any Investigational New Drug application, as defined in Title 21 of the Code of Federal Regulations, on file with the FDA before commencement of Clinical Trials, or any comparable filing with any relevant Regulatory Authority in any country or jurisdiction in the Territory&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IND Acceptance</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">with respect to an IND submitted to the FDA, either (a) &#91;***&#93; days after submission of such IND to the FDA, if at such time the FDA has confirmed in writing that it has no comments to such IND, or (b) if the FDA indicates during such &#91;***&#93;-day period that it will have comments to the IND, &#91;***&#93;.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification Claim Notice</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth at clause 11.3&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Party</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth at clause 11.3&#59;</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnifying Party</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth at clause 11.3&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnitee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth at clause 11.3&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indication</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">each separate and distinct disease, disorder, illness, health condition, or interruption, cessation or disruption of a bodily function, system, tissue type or organ, for which a separate IND must be submitted and a Regulatory Approval by the submission of a new or supplemental NDA is required.  &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Infringement</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth at clause&#160;7.6&#59;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Initiation</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">of a Clinical Trial shall mean the first dosing of the first patient in the relevant Clinical Trial of a Compound or Licensed Product, as applicable&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Patent</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">any Patent that claims or covers Arising Know-How owned jointly by the Parties pursuant to clause&#160;7.11&#59;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JPT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 3.8&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Steering Committee </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JSC</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 3.1&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Know-How</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all technical, scientific, regulatory and other know-how and information, trade secrets, knowledge, technology, methods, processes, practices, formulae, instructions, skills, techniques, procedures, experiences, ideas, concepts, designs, drawings, assembly procedures, computer programs, apparatuses, specifications, data, results and other material, (whether or not patented or patentable) in written, electronic or any other form now known or hereafter developed&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Knowledge</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the actual knowledge of, in the case of Heptares, &#91;***&#93;, based on such individuals&#8217; good faith understanding of the facts and information in their possession or control after reasonable inquiry, including reasonable inquiry of Third Parties&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Launch</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">on a Licensed Product-by-Licensed Product and country-by-country basis, the first invoiced commercial sale which is a Net Sale by Neurocrine, its Affiliates or their respective Sublicensees of such Licensed Product after grant of Regulatory Approval in such country for such Licensed Product&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Law</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all laws, statutes, ordinances, rules, regulations, writs, judgments, decrees, injunctions (whether preliminary or final), orders and other pronouncements having the effect of law of any Governmental Authority&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensed IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Licensed Know-How and Licensed Patents&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensed Know-How</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all Know-How owned or Controlled as of the Effective Date or during the Term by Heptares or its Affiliates (excluding (i) any Know-How owned or Controlled by any Future Affiliate as of the date such Future Affiliate becomes an Affiliate of Heptares&#59; or (ii) any additional Know-How owned or Controlled by any Future Affiliate after the date on which such Future Affiliate becomes an Affiliate of Heptares if such Know-How is created without the use of or access to the Heptares Platform IP, Neurocrine Background IP, Neurocrine Patents, or the Licensed IP, except to the extent such Know&#8212;How is used by Heptares or any of its Affiliates in the Development of, or otherwise incorporated in, any Compound or Licensed Product) that is necessary or reasonably useful for the Exploitation of Compounds or Licensed Products in the Field in the Territory. Licensed Know-How shall include all Heptares Existing Compound Know-How, any Know-How in the Heptares Retained Rights IP and Heptares&#8217; interest in Arising Know-How, but excludes the Heptares Platform IP&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensed Patents</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any and all Patents that are owned or Controlled by Heptares or its Affiliates as of the Effective Date or during the Term (excluding (i) any Patents owned or Controlled by any Future Affiliate as of the date such Future Affiliate becomes an Affiliate of Heptares&#59; or (ii) any additional Patents owned or Controlled by any Future Affiliate after the date on which such Future Affiliate becomes an Affiliate of Heptares if such Patents cover only inventions made without the use of or access to the Heptares Platform IP, Neurocrine Background IP, Neurocrine Patents, or the Licensed IP, except to the extent such Patents are used by Heptares or any of its Affiliates in the Development of, or otherwise incorporated in, any Compound or Licensed Product) that are necessary or reasonably useful for the Exploitation of Compounds or Licensed Products in the Field in the Territory.  Licensed Patents shall include all Heptares Existing Compound Patents, all Patents in the Heptares Retained Rights IP and Heptares&#8217; interest in Arising Patents (including any Joint Patents) but shall exclude the Heptares Platform IP&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Licensed Products</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any and all pharmaceutical products containing a Compound as an active ingredient, including Combination Products, in any and all formulations, forms, presentations, dosages and formulations&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 11.1&#59;</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the meaning set forth in the definition of Target&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1&#47;M4</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the meaning set forth in the definition of Target&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M4</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the meaning set forth in the definition of Target&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1 Lead Candidate</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93; or such other M1 Target Agonist selected by Neurocrine (which may be selected from one of the other advanced lead M1 Target Agonists including the Compounds known as</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;&#59;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1 Lead Candidate Research and Development Plan</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the plan and associated budget to be prepared by the Parties as amended in accordance with clause 4.2&#59; </font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1 Lead Candidate Research and Development Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the program for the selection and Development of a M1 Lead Candidate, to be conducted by the Parties pursuant to the M1 Lead Candidate Research and Development Plan during the Research Term&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1 Target Agonist</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) M1 Target Agonists include the compounds identified as such on Schedule 4&#59; (ii) any Small Molecule that &#91;***&#93;.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1&#47;M4 Dual Target Agonist</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) M1&#47;M4 Dual Target Agonists include the compounds identified as such on Schedule 4&#59; (ii) any Small Molecule that &#91;***&#93;.</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M4 Target Agonist</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i) M4 Target Agonists include the compounds identified as such on Schedule 4&#59; (ii) any Small Molecule that &#91;***&#93;.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Materials</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any tangible chemical or biological material, including any small molecules, DNA, RNA, clones, cells, and any expression product, progeny, derivative or other improvement thereto, along with any tangible chemical or biological material&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MHLW</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ministry of Health, Labour and Welfare of Japan and any successor or replacement&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Events</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.2(a)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.2(a)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NDA</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a New Drug Application filed with the FDA in conformance with applicable Laws, or the foreign equivalent of any such application in any other country filed with a Regulatory Authority to obtain marketing approval for a pharmaceutical product including a marketing authorisation application (MAA) filed with the EMA or equivalent filed with the MHRA in the UK&#59;</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net Sales</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to a Licensed Product for any period, the net sales of such Licensed Product in such period reported by &#91;***&#93;&#59; </font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for example, such net sales may consist of &#91;***&#93;, less deductions calculated in accordance with &#91;***&#93; for&#58; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;&#91;***&#93;&#59; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;&#91;***&#93;&#59; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;&#91;***&#93;&#59;</font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)&#160;&#160;&#160;&#160;&#91;***&#93;&#59; and </font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)&#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of determining Net Sales, a Licensed Product shall be deemed to be sold when &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that a Licensed Product is sold in any country and Calendar Quarter in the form of a Combination Product, Net Sales of such Combination Product in such Calendar Quarter shall be adjusted by multiplying actual Net Sales of such Combination Product in such country and Calendar Quarter calculated pursuant to the foregoing definition of Net Sales by the fraction A&#47;(A+B), where A is the average invoice price in such country and Calendar Quarter of any Licensed Product that contains the same Compound(s) as such Combination Product as its sole active ingredient(s), if sold separately in such country and Calendar Quarter and B is the average invoice price in such country and Calendar Quarter of each product that contains active ingredient(s) other than the Compound(s) contained in such Combination Product as its sole active ingredient(s), if sold separately in such country and Calendar Quarter&#59; provided that the invoice price in a country for each Licensed Product that contains only the Compound(s) and each product that contains solely active ingredient(s) other than the Compound(s), included in the Combination Product shall be for a quantity comparable to that used in such Combination Product and of substantially the same class, purity and potency or functionality, as applicable.  If either such Licensed Product that contains the Compound(s) as its sole active ingredient or a product that contains the active ingredient(s) (other than the Licensed Product), in the Combination Product as its sole active ingredient(s) is not sold separately in a particular country and Calendar Quarter, &#91;***&#93;. </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the above, Net Sales shall be calculated in accordance with &#91;***&#93;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neurocrine Background IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all Patents or Know-How that are Controlled by Neurocrine or its Affiliates as at the Effective Date or during the Research Term as are necessary or reasonably useful for Heptares to perform activities under the Research and Development Programs&#59;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Neurocrine Patent</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Patent that claims or covers Arising Know-How owned solely by Neurocrine pursuant to clause 7.11&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonclinical Compounds</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) the compounds known as &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Party Representatives</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 10.1&#59;</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patents</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">all patents or patent applications, including any continuations, continuations-in-part, divisions, provisional or any substitute applications, PCT applications, any patent issued with respect to any such patent applications, any reissue, re-examination, renewal or extension (including any supplementary protection certificate) of any such patent, and any confirmation patent or registration patent or patent of addition based on any such patent, and all foreign counterparts of any of the foregoing&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patent Challenge</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 8.7&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;5.7&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase I Clinical Trial</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as to a specific Licensed Product, a first clinical study conducted in humans&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase II Clinical Trial</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as to a specific Licensed Product for a specific Indication, a clinical study in patients conducted in accordance with cGCP which may use a variety of study designs and is intended to confirm efficacy, evaluate safety and efficacy in target patient populations, and&#47;or inform the design or endpoints for a subsequent trial, as described in ICH Guideline E8, General Considerations for Clinical Trials&#59; A Phase II Clinical Trial may be carried out in two stages&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase III Clinical Trial</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as to a specific Licensed Product for a specific Indication, a clinical study conducted in humans in accordance with cGCP to demonstrate or confirm the therapeutic benefit of the Licensed Product in such Indication and to provide an adequate basis for obtaining Regulatory Approval, as described in ICH Guideline E8, General Considerations for Clinical Trials&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PMDA</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Pharmaceuticals and Medical Devices Agency in Japan or any successor organisation thereto&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product Trademark</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 8.8(b)(viii)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Receptor Model</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a set of co-ordinates representing the 3D structure of a receptor, &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regulatory Approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any and all approvals (excluding pricing and reimbursement approvals), licenses, registrations or authorizations of any Regulatory Authority, necessary to commercially develop, make, test, distribute, sell or market a product in a country, including any&#58; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;approval for a product (including any supplements and amendments thereto)&#59; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;pre- and post-approval marketing approvals or authorizations (including any manufacturing approval or authorization related thereto)&#59; </font></div><div style="padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;labelling approval&#59; and </font></div><div style="margin-bottom:0.18pt;padding-left:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;technical, medical and scientific licenses&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regulatory Authority</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any national, supranational, regional, state or local regulatory agency, department, bureau, commission, council or other governmental entity (including the FDA, the EMA, PMDA and MHLW and any other agencies in any country) regulating or otherwise exercising authority with respect to the research, development, manufacture, distribution, marketing, storage, transportation, use or sale of pharmaceutical products&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Regulatory Exclusivity Period</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to each Licensed Product in any country in the Territory, a period of exclusivity (other than Patent exclusivity) granted or afforded by Law or by a Regulatory Authority in such country that confers exclusive marketing rights with respect to such Licensed Product in such country or prevents another party from using or otherwise relying on the data supporting the approval of the NDA for such Licensed Product without the prior written consent of the NDA-holder including regulatory data exclusivity and orphan drug designations&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and Development Plans</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the &#91;***&#93; Research and Development Plan, the &#91;***&#93; Research and Development Plan, the &#91;***&#93; Research and Development Plan, M1 Lead Candidate Research and Development Plan, the &#91;***&#93; Research and Development Plan and the &#91;***&#93; Research and Development Plan&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research and Development Programs</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the &#91;***&#93; Research and Development Program, the &#91;***&#93; Research and Development Program, &#91;***&#93; Research and Development Program, the M1 Lead Candidate Research and Development Program, the &#91;***&#93; Research and Development Program and the &#91;***&#93; Research and Development Program&#59;</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Research Term</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the period from the Effective Date until the second anniversary of the Effective Date or such later date as maybe agreed by the Parties through the JSC&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reversion IP</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on a Reversion Product-by-Reversion Product basis, all Patents and Know-How that at the Termination Date are Controlled by Neurocrine or its Affiliates and are necessary or are then being used by Neurocrine for the Exploitation of such Reversion Product&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reversion Product</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any Compound or Licensed Product (excluding a Combination Product involving the combination of a Compound with a proprietary product or compound owned or controlled by Neurocrine or its Affiliates, unless agreed otherwise by the Parties in writing) in relation to which this Agreement is terminated&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Royalty Payment</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.3&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Royalty Term</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.3(c)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second Licensed Product</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.2(f)(i)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second Option</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;2.4&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second Option Information Package</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause&#160;2.4&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Officer</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Chief Executive Officer of Sosei Group Corporation and the Chief Business Development and Strategy Officer of Neurocrine, or the functional successor in their respective organizations&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Small Molecule</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a molecule of molecular weight of less than &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">StaR</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Sublicensee</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">an Affiliate or Third Party to which Neurocrine has granted a sublicense under clause 2.1 to develop, make, have made, use, sell offer for sale, import or commercialize a Licensed Product, but excluding Distributors and wholesalers and resellers and Third Parties conducting Development, manufacturing or Commercialization on behalf of Neurocrine or its Affiliates&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Successful</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to a Clinical Trial, that the results of such Clinical Trial (a) meet the pre-specified primary endpoint(s) set forth in the protocol for such Clinical Trial and (b) do not indicate a safety finding that either &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Successful Completion of a Carcinogenicity Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to studies approved by the FDA to identify a &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Successful Completion of a Long-Term Toxicity Program</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with respect to animal studies, that the results of such animal studies &#91;***&#93;&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Agreements</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">shall mean&#58;</font></div><div style="margin-bottom:0.18pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="margin-bottom:0.18pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="margin-bottom:0.18pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="margin-bottom:0.18pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93; Assigned Patent</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Patents assigned to Heptares pursuant to the assignment between &#91;***&#93; and Heptares Therapeutics Limited &#91;***&#93;, which include the following Patents&#58; </font></div><div style="padding-left:38.75pt;padding-right:2.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="padding-left:38.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="padding-left:38.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div><div style="padding-left:38.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">&#91;***&#93;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">each of muscarinic receptor subtype 1 (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), muscarinic receptor subtype 4 (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), or both muscarinic receptor subtype 1 and muscarinic receptor subtype 4, where, for clarity, each receptor is targeted (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">M1&#47;M4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;)&#59; M1, M4 and M1&#47;M4 collectively, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Targets</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;&#59; </font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target Agonists</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">M1 Target Agonists, M4 Target Agonists and M1&#47;M4 Dual Target Agonists.</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.858%"><tr><td style="width:1.0%"></td><td style="width:15.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 8.1&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Termination Date</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date on which any termination of this Agreement becomes effective&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Territory</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">worldwide (save for Japan in relation to the Heptares Retained Rights unless Neurocrine exercises its First Option or Second Option pursuant to clause&#160;2.4)&#59; </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Licensed Product</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.2(f)(i)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any person who is not a Party or an Affiliate of a Party&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party Claim</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 11.1&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party Payments</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">the meaning set forth in clause 5.4(a)&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the United States of America, including all of its territories and possessions&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">USD or $</font></td><td colspan="3" style="padding:2px 3.75pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States Dollars&#59;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valid Claim</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:25.45pt;padding-right:2.75pt;text-align:justify;text-indent:-22.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.48pt">a claim of an issued and unexpired patent included within the Licensed Patents which has not been abandoned, cancelled or held permanently revoked, unenforceable or invalid by a decision of a court or other governmental agency of competent jurisdiction unappealed within the time allowed for appeal, or which has not been admitted to be invalid or unenforceable through reissue or disclaimer or otherwise&#59; or</font></div><div style="padding-left:25.45pt;padding-right:2.75pt;text-align:justify;text-indent:-22.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.48pt">a claim of a pending patent application included within the Licensed Patents which claim was filed and is being prosecuted in good faith and has not been cancelled, withdrawn from consideration, abandoned or finally disallowed without the possibility of appeal or refiling of the application&#59; provided that such prosecution has not been on-going for more than &#91;***&#93; years from such claim&#8217;s &#91;***&#93;&#59;</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VAT</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:25.45pt;padding-right:2.75pt;text-align:justify;text-indent:-22.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.48pt">in relation to any jurisdiction within the EU, the tax imposed by the Council Directive on the common system of value added tax (2006&#47;112) and any national legislation implementing that directive together with legislation supplemental thereto and the equivalent tax (if any) in that jurisdiction&#59; and </font></div><div style="margin-bottom:18pt;padding-left:25.45pt;padding-right:2.75pt;text-align:justify;text-indent:-22.7pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.48pt">in any other country or jurisdiction, any other value added, goods and services or similar tax chargeable on the supply or deemed supply of goods or services under applicable legislation&#59; but, in each event, excluding any US sales tax.</font></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="padding-left:0.35pt;text-align:justify;text-indent:-0.35pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless the context of this Agreement otherwise requires&#58; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Words referring to a particular gender include every gender&#59; words using the singular or plural number also include the plural or singular number, respectively&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the terms &#34;hereof,&#34; &#34;herein,&#34; &#34;hereby,&#34; and other similar words refer to this entire Agreement&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">the words &#34;include&#34;, &#34;includes&#34;, and &#34;including&#34; when used in this Agreement shall be deemed to be followed by the words &#34;without limitation&#34;, unless otherwise specified&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the term &#34;clause&#34; refers to the specified clause of this Agreement&#59; and </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">references to any &#34;person&#34; include individuals, sole proprietorships, partnerships, limited partnerships, limited liability partnerships, corporations, limited liability companies, business trusts, joint stock companies, trusts, incorporated associations, joint ventures or similar entities or organisations, and the successors and permitted assigns of that person.  Whenever this Agreement refers to a number of days, unless otherwise specified, such number shall refer to calendar days.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">LICENSE</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Licenses granted by Heptares</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions of this Agreement, Heptares grants to Neurocrine, and Neurocrine hereby accepts&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">an exclusive (save as to allow Heptares to carry out the Research and Development Programs in accordance with this Agreement and to allow Heptares to exercise the Heptares Retained Rights), royalty-bearing, sublicensable (through multiple tiers) license to and under the Licensed IP to Exploit Compounds and Licensed Products in the Field in the Territory.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">a non-exclusive, sublicensable to subcontractors in accordance with clause 4.5, license to and under the Heptares Platform IP for Neurocrine to conduct activities under the Research and Development Programs.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">a non-exclusive, sublicensable (through multiple tiers but solely in conjunction with a license to Exploit a Compound or Licensed Product) license to and under the Heptares Platform IP to the extent necessary to Exploit Compounds and Licensed Products in the Field in the Territory.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Provision of Licensed Know-How</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Within &#91;***&#93; days of the Effective Date, Heptares shall provide Neurocrine with copies, or where applicable, samples of the Licensed Know-How existing at the Effective Date, including Word, Excel and PDF versions of study reports, raw datasets, TLFs, CSRs, INDs or other applications or communications with any Regulatory Authority, any Regulatory Approval, etc. in a manner reasonably agreeable to Neurocrine.  To assist with the transfer of such Licensed Know-How, Heptares will make its personnel reasonably available to Neurocrine as requested by Neurocrine and Heptares will provide up to &#91;***&#93; of assistance in connection with this transfer from Heptares&#8217; FTEs in the aggregate at no cost to Neurocrine.  If such assistance is provided at Neurocrine&#8217;s facilities, &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Thereafter, at a reasonable frequency during the Term, at no additional cost or expense to Neurocrine, Heptares shall provide all Licensed Know-How that has not previously been provided to Neurocrine (whether under this Agreement or otherwise) for use solely in accordance with the license granted under clause 2.1.  Heptares shall be under no obligation to disclose Know-How within the Heptares Platform IP unless it is necessary or reasonably useful to Exploit Compounds.  If the Parties agree that any such Know-How should be transferred to Neurocrine in connection with the performance of the Research and Development Programs, any Know-How conceived, generated or developed by Neurocrine (solely or jointly with Heptares) using such transferred Know-How that is an improvement to the Heptares Platform and does not relate specifically to Compounds (a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Heptares Platform </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Improvement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) shall be owned by Heptares.  Any Know-How that is an improvement to the Heptares Platform and does not relate specifically to Compounds and that is conceived, generated or developed solely by Heptares shall also be deemed to be a Heptares Platform Improvement and shall be owned by Heptares. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Retained Rights</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms of clause 2.4, Heptares and its Affiliates retain the exclusive right under the Licensed IP to exercise the Heptares Retained Rights, and Neurocrine shall have no rights under the Licensed IP or the Heptares Platform IP to Exploit Compounds or Licensed Products that are M1 Target Agonists in Japan. Heptares shall not conduct any Clinical Trial under the Heptares Retained Rights without the JSC&#8217;s approval of the design of such Clinical Trial.  Heptares shall, and shall ensure that its Affiliates and licensees will, exercise the Heptares Retained Rights in compliance with all applicable Laws and in accordance with professional and ethical standards customary in the pharmaceutical and biotechnology industry.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Neurocrine Option</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall keep Neurocrine regularly updated with regard to its progress in exercising the Heptares Retained Rights through the JSC, by providing to Neurocrine every &#91;***&#93; months a report summarising in reasonable detail Heptares&#8217; Development activities and plans under the Heptares Retained Rights. In addition, if Neurocrine has any concerns regarding any such report, Neurocrine will provide details of such concerns to Heptares and at Neurocrine&#8217;s reasonable request, Heptares shall make available appropriate personnel to meet with Neurocrine to discuss such concerns. Heptares shall provide to Neurocrine the proposed protocol for the first proof of concept Phase II Clinical Trial for the first M1 Target Agonist being Developed by or on behalf of Heptares or its Affiliate in Japan together with a plan and budget for the remainder of the development program for such first M1 Target Agonist in Japan (the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> &#34;First Option Information Package</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  Following receipt of the First Option Information Package Neurocrine will have a period of &#91;***&#93; days to exercise an option </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> &#8220;First Option&#8221;)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, by notice in writing to Heptares &#91;***&#93;. If Neurocrine exercises the First Option the Parties will agree in good faith within &#91;***&#93; days an amendment to this Agreement as necessary to reflect the exercise by Neurocrine of the First Option, including on matters such as &#91;***&#93;. If Neurocrine does not exercise the First Option and Heptares does not &#91;***&#93; Neurocrine will have the second option (the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Second Option&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">), following Neurocrine's receipt from Heptares of &#91;***&#93; (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Second Option Information Package</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) &#91;***&#93;. Neurocrine shall have a period of &#91;***&#93; days from the date of its receipt of the Second Option Information Package to exercise the Second Option by notice in writing to Heptares. If Neurocrine exercises the Second Option the Parties will agree in good faith within &#91;***&#93; days an amendment to this Agreement as necessary to reflect the exercise by Neurocrine of the Second Option, including on matters such as &#91;***&#93;. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whether or not Neurocrine exercises the First Option or the Second Option, Neurocrine will have (i) the right to access and use the Heptares Retained Rights IP and (ii) a right to cross reference (to the extent permitted by applicable Law) all Regulatory Approvals (including filings for such approvals) for M1 Target Agonists Controlled by Heptares, its Affiliates or licensees in Japan in each case for the purposes of Exploiting Licensed Products outside Japan in accordance with this Agreement.  Heptares will have (i) the right to access and use the Licensed IP and all Arising IP and (ii) a right to cross reference (to the extent permitted by applicable Law) all Regulatory Approvals (including filings for such approvals) for M1 Target Agonists Controlled by Neurocrine, its Affiliates or Sublicensees outside Japan in each case for the purposes of Exploiting M1 Target Agonists in Japan in accordance with this Agreement. The Parties will also negotiate in good faith applicable terms to govern Clinical Trials conducted jointly by the Parties for the benefit of the Compounds and Licensed Products in the Territory and the M1 Target Agonists in Japan.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">License to Neurocrine Background IP and Arising IP</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the terms and conditions of this Agreement, Neurocrine grants to Heptares, and Heptares hereby accepts, a non-exclusive, royalty-free license to and under (a) the Neurocrine Background IP for the sole purpose of carrying out the Research and Development Programs in accordance with the Research and Development Plans and (b) Neurocrine&#8217;s interest in the Arising IP for the purposes of Heptares exercising the Heptares Retained Rights. Neurocrine shall, as reasonably requested by Heptares from time to time, disclose to Heptares all Know-How forming part of Arising IP owned by Neurocrine to the extent reasonably necessary or useful for exercising the Heptares Retained Rights. Heptares may grant sublicenses under this license to subcontractors appointed in accordance with clause 4.5 and shall be entitled to sub-license such rights granted under clause (b) through multiple tiers in connection with its exercise of the Heptares Retained Rights. Any such sublicense shall be granted on terms that are consistent with the terms of this Agreement. Heptares shall provide a copy of each such sublicense agreement with a Third Party, which may be redacted of any terms not </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">required to confirm consistency with the terms of this Agreement, to Neurocrine and shall be responsible for ensuring that each such sublicensee complies with the terms of this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Exclusivity</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to clause 2.7, during the Term, Heptares shall not and shall procure that its Affiliates shall not, directly or indirectly (including by licensing, authorising or enabling a Third Party) Exploit any Competitive Product. For clarity Heptares' exercise of the Heptares Retained Rights shall not be a breach of this Clause 2.6. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Competitive Transactions</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clause 2.6 shall not apply to a Third Party that is not an Affiliate of Heptares at the Effective Date but subsequently becomes an Affiliate as a result of a merger with or acquisition of Heptares occurring after the Effective Date (each a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Competitive Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), provided however that if at the time of such Competitive Transaction the Third Party counterparty (that becomes an Affiliate) is Developing or Commercializing a Competitive Product or if such Affiliate thereafter commences Developing or Commercializing a Competitive Product, then such Affiliate may continue to Develop and Commercialize such Competitive Product but may not, directly or indirectly use or practice under any of the Heptares Platform, Heptares Platform IP, Heptares Platform Improvements, or Licensed IP, including Heptares Existing Compound Patents, Arising IP, Neurocrine Background IP or Reversion IP in connection therewith. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Retention of Rights</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Except as expressly provided herein, Heptares grants no other right or license, including any rights or licenses to the Licensed IP, the Heptares Platform IP or any other Patent or intellectual property rights not otherwise expressly granted herein. </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Except as expressly provided herein, Neurocrine grants no other right or license, including any rights or licenses to the Neurocrine Background IP, Arising IP or any other Patent or intellectual property rights not otherwise expressly granted herein.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Sublicensing</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall be entitled to grant to its Affiliates or one or more Third Parties a sublicense of the rights granted to Neurocrine under clause 2.1 and clause&#160;2.4 without the prior written consent of Heptares. Any such sublicense shall be granted on terms that are consistent with the terms of this Agreement. Neurocrine shall provide a copy of each such sublicense agreement with a Third Party Sublicensee, which may be redacted of any terms not required to confirm consistency with the terms of this Agreement, to Heptares and shall be responsible for ensuring that each such Sublicensee complies with the terms of this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">&#91;***&#93; Assigned Patent</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neither Party shall without the consent of the other Exploit a Compound or Licensed Product that is claimed by the &#91;***&#93; Assigned Patent.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Confirmatory Patent License</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall, if requested to do so by Neurocrine, immediately enter into confirmatory license agreements substantially in the form reasonably requested by Neurocrine for purposes of recording the licenses granted under this Agreement with such patent offices in the Territory as Neurocrine considers appropriate.  </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Preservation of Licenses</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall not, and if any Licensed IP or Heptares Platform IP is owned by or transferred to an Affiliate in accordance with this Agreement (which transfer to an Affiliate may be done only with the prior written consent of Neurocrine, which may not be unreasonably withheld), shall procure that its Affiliates shall not, (a) encumber the Licensed IP (including the Heptares Retained Rights IP) or the Heptares Platform IP in a manner which is inconsistent with the rights and licenses granted to Neurocrine under this Agreement&#59; (b) transfer or assign any of the Licensed IP (including the Heptares Retained Rights IP) or the Heptares Platform IP to an Affiliate or Third Party, unless such transfer or assignment is subject to the rights of and obligations to Neurocrine under this Agreement (and for clarity any assignment of this Agreement is subject to clause 12.1)&#59; or (c) grant any rights or licenses under the Licensed IP (including the Heptares Retained Rights IP) or the Heptares Platform IP that are inconsistent with the rights and licenses granted to Neurocrine under this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Third Party Technology</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">If either Party becomes aware of any Third Party&#8217;s Patents or Know-How that are necessary or useful to Develop, manufacture or Commercialize in the Field any Compound or Licensed Product (collectively, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party Technology</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;), such Party shall promptly notify the other Party, and the Parties shall promptly thereafter meet to discuss such Third Party Technology.  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neurocrine shall have the first right (but no obligation) to attempt to obtain a license to any Third Party Technology, and shall notify Heptares in writing prior to initiating licensing negotiations for any such Third Party Technology.  If Neurocrine obtains such license for any Third Party Technology that is necessary or useful to Exploit M1 Target Agonists in Japan, Heptares will have the right to obtain a sublicense thereunder (if permitted under such license agreement provided that Neurocrine shall use its reasonable efforts to obtain the right to grant such a sublicense) to practice the Heptares Retained Rights, subject to the Parties&#8217; agreement on &#91;***&#93; to such Third Party Technology.  If Neurocrine elects not to obtain any such license, then Heptares shall have the right (but no obligation) to negotiate and enter into a license agreement with such Third Party with respect to such Third Party Technology&#59; provided that Heptares shall not enter into any such license unless the Third Party Technology so licensed, to the extent otherwise within the scope of the definition of Licensed IP, would be Controlled by Heptares (assuming the Parties&#8217; agreement on cost allocation)&#59; and provided further that Heptares shall notify Neurocrine in writing prior to initiating licensing negotiations for any such Third Party Technology, and prior to entering into such license agreement, Heptares shall provide Neurocrine with a copy thereof and reasonable opportunity to comment thereon and shall consider all such comments of Neurocrine in good faith, and shall not enter into such license agreement without Neurocrine&#8217;s prior written approval, which shall not be unreasonably withheld.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">If Heptares enters into any agreement with a Third Party after the Execution Date under which it Controls Third Party Technology (provided that Heptares shall use its reasonable efforts when obtaining such a license to include the right to grant sublicenses under any such license) that is necessary or useful to Develop, manufacture or Commercialize any Compound or Licensed Product, then if Neurocrine desires to obtain a sublicense thereunder, the Parties shall negotiate in good faith and determine an allocation between the Parties of any payments thereunder that are owed to such Third Party on account of Neurocrine&#8217;s Development, manufacture or Commercialization of Licensed Products.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">GOVERNANCE  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Establishment of JSC</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Within &#91;***&#93; days of the Effective Date, the Parties shall establish a Joint Steering Committee (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Joint Steering Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; or &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JSC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) for the Research and Development Programs and to provide a forum for communication between the Parties with regard to the Heptares Retained Rights. The JSC shall consist of &#91;***&#93; members appointed by each Party neither of whom may be a Senior Officer.  The initial members of the JSC will be nominated by the Parties promptly following the Effective Date.  Such representatives shall be individuals suitable in seniority and experience and having delegated authority to make decisions of the JSC with respect to matters within the scope of the JSC&#8217;s responsibilities.  &#91;***&#93; will appoint one of its representatives as the chair of the JSC.  The JSC shall operate in accordance with the provisions of clauses 3.2 through 3.8, and shall have no authority to alter or amend the terms and conditions of this Agreement, including any payment conditions or terms, periods for performance, or obligations of the Parties.  A Party may change one or more of its </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">representatives serving on the JSC at any time upon written notice to the other Party.  At its meetings, the JSC shall discuss the matters described below and such other matters as are reasonably requested by either Party&#8217;s Alliance Manager.  The JSC shall continue throughout the Term of the Agreement. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Responsibilities of JSC</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The JSC shall, during the Research Term and thereafter perform the following functions&#58; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">facilitate communication between the Parties&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">discuss and review activities relating to the Research and Development Programs&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">discuss any matters relating to manufacturing activities as further described in Clause 4.11&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">review and approve any initial Research and Development Plan (including the budget) not prepared as of the Effective Date and any updates or amendments to the Research and Development Plans (including the budgets)&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">establish JPTs and resolving disputes arising from such JPTs&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">provide a forum for communication between the Parties regarding the Heptares Retained Rights and for coordinating the activities of Heptares in its exercise of the Heptares Retained Rights with the activities of Neurocrine in relation to the Compounds and Licensed Products in the Territory&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">provide a forum for communication between the Parties for Regulatory Approval and Commercialization of Compounds and Licensed Products by Neurocrine in the Territory and applications for Regulatory Approval and Commercialization of M1 Target Agonists by Heptares in Japan&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">approve the design of Clinical Trials proposed to be conducted in or outside of Japan by Heptares as part of Heptares exercising the Heptares Retained Rights, review and approve any proposed publications of Heptares resulting from the Heptares Retained Rights and establish a process for sharing of data and information relating to those trials, which may include, for example, agreeing provisions so that (1) feedback received from a Regulatory Authority by a Party in respect of any such trial shall be shared with the other Party, and (2) the Party not conducting the Clinical Trial shall have full access to the clinical study report and all data arising from it, including clinical datasets, for inclusion in the case of Neurocrine, a Neurocrine regulatory filing for a Regulatory Approval for a Licensed Product in the Territory or, in the case of Heptares, a Heptares regulatory filing for a Regulatory Approval for a Licensed Product in Japan (to the extent within the Heptares Retained Rights)&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">provide a forum for Neurocrine to &#91;***&#93;&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">provide a forum for the Parties to exercise their oversight responsibilities as set forth in Section 4.10&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">provide a forum for Neurocrine to &#91;***&#93;&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">determining whether in the case of a Licensed Product that contains an M1 Target Agonist, either an IND should be filed for such a Licensed Product or a Clinical Trial application for such Licensed Product should be filed in Europe&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:20.46pt">discuss and resolve matters referred from the IP Committee pursuant to clause&#160;7.5&#59; and </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">perform such other functions as are specifically designated for the JSC in this Agreement or as the Parties otherwise agree in writing.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Meetings</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The JSC shall meet at least &#91;***&#93; during the Research Term and every &#91;***&#93; months thereafter during the Term, or at a frequency determined by the JSC, and JSC meetings can be called at other times by agreement between the Parties for any reason including if it is necessary to resolve Committee Deadlocks in accordance with clause 3.6.  JSC meetings may be conducted by telephone, video-conference or in person, with at least one meeting per year being in person (where practicable).  Any in-person JSC meetings shall be held on an alternating basis between Heptares&#8217; and Neurocrine&#8217;s facilities, unless otherwise agreed by the Parties.  Each Party shall be responsible for its own expenses in attending such meetings.  As appropriate, the JSC may invite a reasonable number of non-voting employees, consultants and scientific advisors to attend its meetings as non-voting observers&#59; provided that such invitees are bound by appropriate confidentiality obligations.  Each Party may also call for special meetings of the JSC to discuss particular matters requested by such Party.  The Alliance Managers shall provide the members of the JSC with no less than &#91;***&#93; Business Days&#8217; notice of each regularly scheduled meeting and, to the extent reasonably practicable under the circumstances, no less than &#91;***&#93; Business Days&#8217; notice of any special meetings called by either Party. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Minutes</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minutes will be kept of all JSC meetings by chair of the JSC (or his or her designees) and sent to all members of the JSC by facsimile or e-mail for review and approval within &#91;***&#93; days after each such meeting.  The JSC shall formally accept the minutes of the previous meeting at or before the next meeting of the JSC.  Minutes will be deemed approved unless any member of the JSC objects to the accuracy of such minutes by providing written notice to the other members of the JSC prior to the next meeting of the JSC.  Minutes shall list action items and shall designate any issues that need to be resolved by the JSC or applicable resolution process.  In the event of any objection to the minutes that is not resolved by mutual agreement of the Parties, such minutes will be amended to reflect such unresolved dispute.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Decision Making within JSC</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decisions of the JSC shall be made by unanimous vote, with each Party having one (1) vote.  In order to make any decision, the applicable JSC must have present (in person or via telephone or videoconference) and voting at least one representative of each Party.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Referral to Senior Officers</font></div><div style="margin-bottom:18pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the JSC cannot resolve a matter within its responsibilities by consensus (a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Committee Deadlock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), then either Party may escalate such Committee Deadlock to the Senior Officers for further consideration&#59; provided that such escalation and further consideration shall not prevent a Party from exercising its casting vote on the JSC or implementing any decision of the JSC following such escalation.  Either Party shall have the right to select a Third Party who has experience of issues that are relevant to the disputed issue to present their views to the Senior Officer of the other Party who shall in good faith listen and consider such views.  If the Senior Officers are unable to resolve a Committee Deadlock, including a Committee Deadlock regarding the approval of a proposed amended budget for a Research and Development Plan or the allocation of the budget to activities under the Research and Development Plans, then &#91;***&#93;.  &#91;***&#93; shall also not have final decision making authority with regard to &#91;***&#93;. &#91;***&#93; shall not, when exercising its final decision making authority &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">Limitation of Powers</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The JSC is not a substitute for the rights of the Parties under this Agreement and is intended to coordinate and facilitate the activities of the Parties.  The JSC will not be involved with the day-to-day management of activities to be performed by a Party under this Agreement.  The JSC will have no power to amend this Agreement. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Joint Project Teams</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The JSC shall establish a separate joint project team for each Research and Development Program (each a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JPT</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;). Each JPT will consist of an equal number of appropriate representatives from each Party. The JPTs will provide a forum for communication between the Parties regarding each Research and Development Program and for making day-to-day operational decisions regarding each Research </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and Development Program. All such decisions shall be made by consensus of the members of the applicable JPT and any disputes shall be referred to the JSC for resolution. The JPTs shall meet at a frequency established by the JSC.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Alliance Managers</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each Party shall designate an individual to serve as the main point of contact for such Party to exchange information, facilitate communication and coordinate the Parties&#8217; activities under this Agreement (each, an &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Alliance Manager</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  The Alliance Managers shall on no less frequently than &#91;***&#93; provide oral reports to the JSC (or designate an appropriate representative to attend meetings and provide such reports on the Alliance Manager&#8217;s behalf)&#59; provided, however, that the Alliance Managers shall not be counted as members of the JSC (and shall not vote on matters discussed at any JSC meeting).  Each Party may change its designated Alliance Manager from time to time upon written notice to the other Party. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">DEVELOPMENT AND DILIGENCE</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">The Research and Development Programs</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">The Parties shall conduct the activities designated to them in the Research and Development Plans to Develop the Clinical Compounds and Nonclinical Compounds.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Following the completion of each Research and Development Program, as between Neurocrine and Heptares, Neurocrine shall have responsibility and sole decision-making authority for progressing the Development and Commercialization of the applicable Licensed Products (except with respect to the Heptares Retained Rights) including the Clinical Compounds and the Nonclinical Compounds.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Research and Development Plans</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Research and Development Plan and associated budget for Heptares&#8217; activities under the Research and Development Plan and plan for Neurocrine's activities in relation to &#91;***&#93; at the Execution Date is attached at Schedule 1.  The Parties have agreed to the initial budget for Heptares&#8217; activities under the Research and Development Plan set out in Schedule 1 for the Development Costs for the Development activities planned in the first &#91;***&#93; months following the Effective Date. Within &#91;***&#93; days following  the Effective Date, the Parties will mutually agree, through the JSC (and during such &#91;***&#93; day period &#91;***&#93; shall not have final decision making authority with regard to any proposed amendment), on an amendment to such initial Research and Development Plan and budget so that such Research and Development Plan and budget shall be divided into separate sections one for each of &#91;***&#93; (and each such section shall be considered a separate Research and Development Plan for the purposes of this Agreement). Such final Research and Development Plans shall cover Heptares&#8217; activities and budgets&#59; and Neurocrine's activities under the Research and Development Plans for the remaining period of the Research Term.  If a Party believes that the Research and Development Plans (including the budget included therein) should be amended, that Party shall propose such amendment to the other Party and the matter shall be discussed at the JSC.  The terms of, and activities set forth in, the Research and Development Plans shall at all times be conducted in compliance with all applicable Laws and in accordance with professional and ethical standards customary in the pharmaceutical and biotechnology industry, taking into account, where applicable, each Party&#8217;s health care compliance policies and applicable standard operating procedures.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Research and Development Efforts</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the Research Term, Heptares shall carry out the activities allocated to it under the Research and Development Plans in accordance with good scientific standards and practices and in compliance in all material respects with the requirements of applicable Laws and regulations. Heptares will allocate to each Research and Development Plan the number of FTEs set out in each such plan.  Heptares will carry out the Research and Development Programs in conformity with standard pharmaceutical and biotechnology industry practices and the terms and conditions of this Agreement and will prepare and maintain, or will cause to be prepared and maintained, complete and accurate laboratory notebooks and other written records, accounts, notes, reports and data with respect to such activities and, upon Neurocrine&#8217;s written request and at its expense, will send legible copies of the aforesaid to Neurocrine.  For the avoidance of doubt, Heptares shall have no obligation to devote any efforts or resources in connection with the Heptares Retained Rights.  Nothing in this Agreement </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(including any results generated under the Heptares Retained Rights) shall impose or create any obligation on Heptares to develop M1 Target Agonists (including the selected M1 Lead Candidate) in any indications in Japan.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Neurocrine Research and Development Efforts</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">During the Research Term, Neurocrine will perform the activities allocated to it under the Research and Development Plans in accordance with good scientific standards and practices and in compliance in all material respects with the requirements of applicable Laws and regulations.  Neurocrine shall carry out the Research and Development Programs in conformity with standard pharmaceutical and biotechnology industry practices and the terms and conditions of this Agreement.  Neurocrine will prepare and maintain, or will cause to be prepared and maintained, complete and accurate laboratory notebooks and other written records, accounts, notes, reports and data with respect to such activities. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Subcontracts</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Either Party may perform its Development under the Research and Development Programs pursuant to this Agreement through one or more Third Party subcontractors, provided that (i) Heptares obtains Neurocrine&#8217;s prior written approval of any such subcontractor, which approval shall not be unreasonably withheld, (ii) such Party engages each Third Party subcontractor through a written agreement consistent with the terms and conditions of this Agreement, (iii) no rights of either Party under this Agreement are diminished or otherwise adversely affected as a result of such subcontracting, (iv) the subcontractor undertakes the obligations of confidentiality and non-use regarding Confidential Information which are substantially the same as those undertaken by the Parties pursuant to clause 6 hereof, and (v) except for academic and non-profit institutions engaged by Neurocrine, the subcontractor agrees that any intellectual property developed in the course of the work hereunder (other than improvements to the subcontractor&#8217;s background technology that do not relate specifically to a Compound or Licensed Product) shall be licensed or assigned to the Party engaging the subcontractor or such Party&#8217;s designee, so as to permit license or re-assignment as required by the terms and conditions of this Agreement. The Party engaging any such Third Party subcontractor shall be responsible for all compensation due to the Third Party subcontractor (or its employees or agents) arising from such subcontracting, including by operation of local Law on account of any inventive contributions of the subcontractor&#8217;s employees or agents with respect to any intellectual property developed in the course of the work hereunder.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Materials</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each Party will, during the Research Term, as a matter of course and as described in the Research and Development Plans or upon the other Party&#8217;s reasonable written request, furnish to each other samples of Materials which it Controls and which are necessary for the other Party to carry out the Research and Development Plans.  Each Party will use such Materials only in accordance with the Research and Development Plans and otherwise in accordance with the terms and conditions of this Agreement.  Except with the prior written consent of the supplying Party, the Party receiving any Materials will not distribute or otherwise allow the release of Materials to any Third Party&#59; provided that the Parties may transfer Compounds or other Materials to Third Parties appointed as subcontractors in accordance with clause 4.5&#59; provided that in addition to obligations of confidentiality and non-use of information, each such Third Party agrees to use the Materials solely for the performance of activities for the transferring Party and not to transfer them to any other Third Party.  Except as otherwise provided in this Agreement, all Materials will remain the sole property of the supplying Party, will be used in compliance with all applicable Laws, and will be used with prudence and appropriate caution in any experimental work because not all of their characteristics may be known.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Reports</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Parties shall keep each other reasonably informed as to the progress achieved and results, discoveries and technical developments made in the course of performing activities under the Research and Development Programs. Each Party shall prepare and provide to the other Party a written report every Calendar Quarter that (a) summarizes the activities performed by such Party under each Research and Development Program and (b) identifies any issues or circumstances of which it is aware that may prevent or adversely affect in a material manner future work under the Research and Development Programs.  The Parties may agree that minutes or presentations from JSC meetings may be used to satisfy this reporting requirement.  The JSC shall determine the key information to be exchanged and the mechanisms for exchanging further information as required. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Development Costs</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">&#91;***&#93; shall be responsible for its costs incurred in conducting activities in connection with the Research and Development Programs in accordance with the Research and Development Plans.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neurocrine shall reimburse Heptares for the Development Costs incurred by Heptares in carrying out the Research and Development Programs provided that such Development Costs are in accordance with the budget agreed by the Parties and forming part of the applicable Research and Development Plan &#91;***&#93;.  Heptares shall invoice Neurocrine within &#91;***&#93; days of the end of each Calendar Quarter during the Research Term for the Development Costs incurred by Heptares in connection with such activities in the prior Calendar Quarter in an appropriate level of detail consistent with Heptares' standard invoice format. Heptares shall include with each invoice documentation for any out-of-pocket costs in excess of fifty thousand USD ($50,000) and any other supporting documentation for the invoiced costs will be provided by Heptares upon the reasonable request of Neurocrine. Such invoices shall be paid by Neurocrine within &#91;***&#93; days of receipt of invoice. If Heptares anticipates that the costs to undertake any activities under the Research and Development Plans will exceed the applicable budget, Heptares shall notify the JSC, which will determine whether to adjust the budget accordingly.  Heptares shall not be responsible for conducting any activities allocated to Heptares in the Research and Development Plans if the budget for those activities has not been approved.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Ongoing Development and Commercialization</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neurocrine shall use Commercially Reasonable Efforts to Develop and obtain Regulatory Approvals for (a) at least one Licensed Product that is an M4 Target Agonist, and (b) at least one Licensed Product that is an M1 Target Agonist or an M1&#47;M4 Dual Target Agonist in each case in each of the Global Major Markets.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Subject to obtaining the required Regulatory Approvals, use Commercially Reasonable Efforts to Commercialize (a) at least one Licensed Product that is an M4 Target Agonist, and (b) at least one Licensed Product that is an M1 Target Agonist or an M1&#47;M4 Dual Target Agonist in each case in each of the Global Major Markets.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Promptly following the end of the Research Term, Neurocrine shall prepare a development plan setting out the activities that Neurocrine plans to carry out for the further development of Licensed Products and estimated timelines for completion of such activities (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Development Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) and shall provide a copy of the same to Heptares.  Neurocrine shall consider in good faith and take into account the comments of Heptares on the content of the Development Plan.  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neurocrine shall provide to Heptares every &#91;***&#93; months a report summarizing in reasonable detail Neurocrine&#8217;s Development activities and plans with respect to Licensed Products.  In addition, if Heptares has any concerns regarding the report, Heptares will provide details of such concerns to Neurocrine and at Heptares&#8217; reasonable request, Neurocrine shall make available appropriate personnel to meet with Heptares to discuss such concerns. The Parties shall work together to align on a report to be provided to &#91;***&#93; for the purposes of complying with Heptares' reporting obligations under the &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Regulatory Matters</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the remaining provisions of this clause, Neurocrine shall, unless the Parties agree otherwise,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">own, and be responsible for preparing, seeking, submitting and maintaining, all regulatory filings and Regulatory Approvals for Licensed Products in the Territory, including (i) preparing any regulatory submissions necessary for carrying out the activities set out in the Research and Development Plans and (ii) preparing all reports necessary as part of a regulatory filing or Regulatory Approval. On a Target Agonist-by-Target Agonist basis until such time as Neurocrine has completed the first Successful Phase II Clinical Trial for a Licensed Product containing an M1 Target Agonist, an M4 Target Agonist or an M1&#47;M4 Dual Target Agonist, Neurocrine shall consult with and shall provide Heptares with an opportunity to review and comment on all substantive, non-administrative regulatory submissions with respect to each such Licensed Product reasonably in advance of when Neurocrine intends to submit such regulatory submissions to a Regulatory Authority. Heptares shall provide its comments within &#91;***&#93; Business Days, or such other period of time agreed to by the Parties, and </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall consider such comments in good faith.  Neurocrine shall promptly provide Heptares with a copy, in electronic form, of all substantive, non-administrative regulatory submissions related to Licensed Products that are sent to or received from a Regulatory Authority during such period. Neurocrine shall use good faith efforts during the Research Term to invite one or more representatives of Heptares to any meeting or substantive telephone conference call with a Regulatory Authority with respect to any matter related to Licensed Products or any Research and Development Program during such period to observe and participate in any such meeting or conference call.  Until the first Regulatory Approval of any Licensed Product, Neurocrine shall promptly furnish the JSC with copies of all minutes from any substantive meetings with a Regulatory Authority with respect to any IND related to a Research and Development Program. The Parties may agree through the JSC that Heptares shall carry out certain activities relating to Phase I Clinical Trials of M1 and M1&#47;M4 Nonclinical Compounds (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Phase I Activities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;). If the Parties agree that Heptares shall carry out the Phase I Activities the Parties shall also discuss and agree the protocol design and budgets for the Phase I Activities and Heptares will conduct such studies as approved by the JSC which budgets shall be used to update the applicable Research and Development Plan.  Any regulatory submissions that are required to be made to a Regulatory Authority with respect to such clinical activities and any correspondence or meetings with any such Regulatory Authority with regard to such clinical activities provided that, subject to applicable Law, &#91;***&#93; shall have final decision making authority with regard to the foregoing. &#91;***&#93; shall not, when exercising its final decision making authority in relation to any Clinical Trial of which Heptares is the sponsor, exercise such a right in a manner that would cause Heptares to be in breach of applicable Law. Heptares shall, unless the Parties agree otherwise,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">own, and be responsible for (i) preparing, seeking, submitting and maintaining, all regulatory filings and Regulatory Approvals, and (ii) carrying out all Clinical Trials, in each case as part of exercising the Heptares Retained Rights. Heptares shall prepare and file such filings and Regulatory Approvals and carry out such Clinical Trials in consultation with Neurocrine. Each Party shall keep the other regularly informed with regard to the progress of and results of any Clinical Trial that it carries out in relation to a Licensed Product.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Manufacturing</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise agreed by the Parties or set forth herein, Neurocrine shall be responsible for all manufacture and supply of Compounds and Licensed Products for use in the Territory, including all pre-clinical requirements of Licensed Products necessary to carry out the &#91;***&#93; Research and Development Program and the M1 Lead Candidate Research and Development Program.  As between the Parties, and subject to the oversight of the JSC, Heptares shall be responsible for transferring to Neurocrine or its designee the cGMP batches of Licensed Product incorporating &#91;***&#93; and &#91;***&#93; manufactured on behalf of Heptares prior to the Execution Date. Heptares shall also be responsible for manufacturing an additional CMC batch of &#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Promptly following the Effective Date, Heptares will transfer to Neurocrine or its designee the cGMP batches of Licensed Product incorporating &#91;***&#93; and &#91;***&#93; which have been manufactured for Heptares by a Third Party CMO prior to the Execution Date. The costs of any manufacturing activities that Heptares carries out in accordance with this clause will be included in the Development Costs and will be reimbursed by Neurocrine.  Within &#91;***&#93; days of the Effective Date the Parties will agree a plan for the technology transfer of the manufacturing process for each Licensed Product to Neurocrine. The timing of such transfer will differ for each Licensed Product depending on when it is intended that Neurocrine will take over the responsibility to manufacture the Licensed Product. Once such plan is agreed the Parties will carry out the transfer of the manufacturing process for each Licensed Product in accordance with such plan. Such transfer shall include, if requested by Neurocrine, Heptares using commercially reasonable efforts to effect assignments of any agreements with any Third Party CMO or other service provider entered into by Heptares to the extent that such agreements exclusively relate to such Licensed Product.  Neurocrine shall be responsible for all other manufacturing activities relating to Licensed Products.  Heptares has used prior to the Execution Date and shall be free to use after the Execution Date a Third Party CMO to manufacture Licensed Products. Heptares&#8217; obligations under this Agreement to manufacture Licensed Products shall be qualified by and shall be subject to the terms of each such agreement with the applicable Third Party CMO, and unless resulting from Heptares&#8217; acts or omissions, Heptares shall not be responsible for any failure by a Third Party to supply Licensed Product or for any other liability arising from the use of any Licensed Product manufactured by such a Third Party.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If requested by Heptares, Neurocrine will, where Neurocrine is Developing the same Compound or Licensed Product, negotiate in good faith and agree the terms of a supply agreement to govern the supply of such Compounds and Licensed Products to Heptares by Neurocrine for the purposes of the exercise by Heptares of the Heptares Retained Rights, at a supply price equal to Neurocrine's fully-burdened cost plus (i) &#91;***&#93; percent (&#91;***&#93;%) for clinical supply or (ii) &#91;***&#93; percent (&#91;***&#93;%) for commercial supply.  Heptares shall also be entitled at its option and cost to manufacture or have manufactured by a Third Party CMO any M1 Target Agonists anywhere in the Territory as required by </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares to exercise the Heptares Retained Rights.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Pharmacovigilance</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not later than the start of the first Clinical Trial by or on behalf of Heptares in the exercise of the Heptares Retained Rights the Parties will negotiate in good faith and enter into a safety data exchange agreement to govern the Parties' obligations to each other with regard to the exchange of safety data relating to the Licensed Products. Neurocrine will be responsible for creating and maintaining the global safety database for the Licensed Products.  With respect to each Research and Development Program, Neurocrine shall be responsible for the monitoring and reporting of safety information, if any, related to such Research and Development Program to all relevant Regulatory Authorities.  Neurocrine shall provide copies of such safety information to Heptares to the extent any such filings or any interaction with a Regulatory Authority requires information relating to Compounds or Development activities undertaken by Heptares pursuant to this Agreement and Heptares shall provide such assistance as Neurocrine may reasonably request in connection with the preparation of such filings or provision of information to the Regulatory Authority at Neurocrine&#8217;s cost. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Compliance with Laws</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each Party shall perform its responsibilities under this Agreement, including the manufacture of products, in accordance with all applicable Laws. Promptly following the Effective Date, the Parties shall negotiate in good faith and enter into a data processing agreement to govern the sharing between the Parties of any personal data ( as defined in the EU General Data Protection Regulation) including any applicable clinical data, in accordance with applicable Law.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">FINANCIAL PROVISIONS</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Upfront Payments</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In partial consideration of the rights granted under clause 2.1, within ten (10) days of the Effective Date of this Agreement, Neurocrine shall pay Heptares a one-time lump sum payment of one hundred million USD ($100,000,000) in upfront cash which shall be non-refundable and non-creditable against other payments due hereunder.  Such payment shall be made by means of wire transfer of immediately available funds to an account designated in advance in writing by Heptares to Neurocrine.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">Milestone Payments </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">As additional consideration for the grant of rights under this Agreement, and on the terms and subject to the conditions set forth herein, Neurocrine shall make the following one-time payments set forth in clauses 5.2(b) &#8211; 5.2(e) to Heptares (collectively the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) after the achievement by or on behalf of Neurocrine of the corresponding event set forth below (collectively, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Events</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  Neurocrine will notify Heptares in writing promptly, but in any event no later than (i) &#91;***&#93; days following the achievement of a Milestone Event in clause 5.2(b)-(d) and (ii) &#91;***&#93; days following the end of the Calendar Quarter in which a Milestone Event in clause 5.2(e) is achieved.  Neurocrine shall pay to Heptares the Milestone Payment corresponding to such Milestone Event within &#91;***&#93; days of receipt of an invoice issued by Heptares in respect of such Milestone Payment following achievement of such Milestone Event.  Such payment shall be made by means of wire transfer of immediately available funds to an account designated in advance in writing by Heptares to Neurocrine.  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Clinical Compound Milestone Payments applying to Licensed Products incorporating &#91;***&#93; (to </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">be paid only one time for &#91;***&#93; per milestone event)&#58; </font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.704%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Event</font></td><td colspan="9" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Disease State or Indication</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td></tr></table></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Clinical Compound Milestone Payments applying to Licensed Products incorporating either &#91;***&#93; (to be paid only one time on first achievement of the milestone event by either &#91;***&#93; so that if the same milestone event is achieved in relation to both &#91;***&#93; the Milestone Payment shall only be paid once in relation to the first such Licensed Product that achieves the milestone event)&#58;</font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.704%"><tr><td style="width:1.0%"></td><td style="width:48.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.591%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Event</font></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:209%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:18pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Nonclinical Compound Milestone Payments applying to &#91;***&#93; Licensed Products incorporating </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;&#58;</font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.704%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Event</font></td><td colspan="6" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td></tr><tr style="height:14pt"><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total (including Japan)</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total (excluding Japan)</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td></tr></table></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neurocrine shall make the following one-time payments to Heptares upon the first achievement of annual (Calendar Year) Net Sales milestones for each Licensed Product for up to but no more than &#91;***&#93; Licensed Products.  Sales of &#91;***&#93; will not count towards the sales milestones in the table below&#58; </font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.704%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Milestone Event</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Net Sales in the Territory Exceed $&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Net Sales in the Territory Exceed $&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Net Sales in the Territory Exceed $&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Net Sales in the Territory Exceed $&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$&#91;***&#93;</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$&#91;***&#93;</font></td></tr></table></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>The total sales milestones payable under this clause 5.2(e) shall not exceed $1.0625 billion.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">Payments due under the milestones set out in clause 5.2(d) shall be triggered as follows where applicable&#58;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">&#91;***&#93; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.35pt">&#91;***&#93;  </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">&#91;***&#93; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Royalty Payments</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On a Licensed Product-by-Licensed Product and country-by-country basis, Neurocrine shall pay Heptares a royalty on Net Sales of Licensed Products in the Territory as set forth below (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Royalty </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  The Royalty Payment shall be payable on a country-by-country and Licensed Product-by-Licensed Product basis from the date of Launch of a Licensed Product by Neurocrine in a particular country until the later of&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the expiration of the last Valid Claim in such country covering the new chemical entity of such Licensed Product, or the Formulation or use of such Licensed Product in an Indication for which such Licensed Product obtained Regulatory Approval in such country&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">expiration or termination of the Regulatory Exclusivity Period for such Licensed Product in such country&#59; and</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">&#91;***&#93; years following the date of Launch of such Licensed Product in such country,</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Royalty Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall have no obligation to pay any royalty with respect to Net Sales of any Licensed Product in any country after the Royalty Term for such Licensed Product in such country has expired&#59; provided that if and only to the extent that the obligation of Heptares to pay a royalty to &#91;***&#93; in respect of any Licensed Product as defined in &#91;***&#93; in a country extends beyond the Royalty Term in which case Neurocrine shall continue to pay Heptares only the royalty on Net Sales of such Licensed Product and Amendment Letter Product in such country at the rate (as may be reduced) set forth in &#91;***&#93; until the date that such obligation ceases instead of the royalty rates calculated as set forth below. Heptares represents and warrants to Neurocrine that &#91;***&#93;.  Heptares shall provide Neurocrine prompt written notice (in any event within &#91;***&#93; days) of &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:0.55pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Royalty Payments for Licensed Products shall be paid as a percentage of Net Sales in the Territory in each Calendar Year as follows depending on whether the Licensed Product incorporates a Clinical Compound or a Nonclinical Compound&#58;</font></div><div style="margin-bottom:0.18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.704%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Net Sales in the Territory&#58;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Clinical Compound Royalty Rate</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonclinical Compound Royalty Rate</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">Less than $&#91;***&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">&#91;***&#93;%</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to $&#91;***&#93; and less than $&#91;***&#93;</font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to $&#91;***&#93; and less than $&#91;***&#93;</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">Greater than or equal to $&#91;***&#93;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:18pt;padding-left:2.75pt;padding-right:2.75pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:209%">&#91;***&#93;%</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;%</font></td></tr></table></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><br>For clarity, these royalty rates are tiered and are based on the aggregate of Net Sales in the Territory in a given Calendar Year, such that, for example, if Net Sales of Licensed Product &#91;***&#93; in a given Calendar Year, the royalty payable for such Calendar Year is &#91;***&#93;.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Reduction of Royalty </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Blocking Third Party Patent Rights.  If, during the Term, Neurocrine determines, in its reasonable judgment, that it is necessary to obtain rights under any Blocking Third Party Patent Rights in order to Exploit a Licensed Product in accordance with this Agreement, then Neurocrine shall promptly notify Heptares.  In the event a license or acquisition of Blocking Third Party Patent Rights is obtained, and any amounts are paid by Neurocrine or its Affiliate or Sublicensee to any Third Party to license or acquire such Blocking Third Party Patent Rights (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party Payments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), Neurocrine shall have the right to reduce the Royalty Payments otherwise payable to Heptares under clause 5.3 in a given period by up to &#91;***&#93; percent (&#91;***&#93;%) of the Third Party Payments made in such period, subject to clause 5.4(d) below. </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Generic Products.  On a Licensed Product-by-Licensed Product basis, if in any country in the Territory during the Royalty Term for a Licensed Product unit sales of all Generic Products in such country in a Calendar Quarter as a percentage of the sum of unit sales of such Licensed Product (including all such Generic Products) in such country (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Generic Penetration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) are at least &#91;***&#93; percent (&#91;***&#93;%), the royalty rates in clause 5.3 shall be reduced by &#91;***&#93; percent (&#91;***&#93;%) until the end of the Royalty Term for such Licensed Product in such country, subject to </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">clause 5.4(d) below.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">No Valid Claim. The royalty rates set out in clause 5.3 shall be reduced by &#91;***&#93; percent (&#91;***&#93;%) in any country in the Territory where there is not a Valid Claim covering the new chemical entity of such Licensed Product, or the Formulation or the use of such Licensed Product in an Indication for which such Licensed Product obtained Regulatory Approval in such country, subject to clause 5.4(d) below. </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Maximum Royalty Adjustment. The royalty payable with respect to Net Sales of a Licensed Product sold by Neurocrine or its Affiliates or Sublicensees in any country of the Territory in any Calendar Quarter shall not as a result of adjustments made pursuant to clauses 5.4(a), 5.4(b) and 5.4(c) be less than &#91;***&#93; percent (&#91;***&#93;%) of the Royalty Payments payable pursuant to clause 5.3 prior to such adjustments thereof.  Credits not exhausted in any Calendar Quarter may be carried into future Calendar Quarters.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Third Party Payments</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Parties acknowledge and agree that Heptares shall remain responsible for, and shall promptly discharge, any and all payments payable to &#91;***&#93; (or its successor-in-interest) in connection with &#91;***&#93;.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Royalty Payments and Statement</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall within &#91;***&#93; days of the end of each Calendar Quarter provide to Heptares a flash report showing the estimated Net Sales made in such Calendar Quarter and an estimate of the royalties payable to Heptares in respect of such estimated Net Sales. Neurocrine shall pay to Heptares the Royalty Payment quarterly in accordance with this clause 5.6 by means of wire transfer of immediately available funds to an account designated in advance in writing by Heptares to Neurocrine.  Neurocrine shall calculate all amounts payable to Heptares pursuant to clause 5.3 as adjusted pursuant to clause 5.4 at the end of each Calendar Quarter, which amounts shall be converted to USD, in accordance with clause 5.9.  Neurocrine shall pay to Heptares the royalty amounts due with respect to a given Calendar Quarter within &#91;***&#93; days after the end of such Calendar Quarter.  Each payment of royalties due to Heptares shall be accompanied by a report setting forth for such Calendar Quarter the following information for Licensed Product&#58; (a) the amount of gross sales and Net Sales of Licensed Product on a Licensed Product-by-Licensed Product and country-by-country basis (including such amounts expressed in local currency and converted to USD)&#59; and (b) a calculation of the amount of royalties due to Heptares on account of Net Sales of Licensed Product.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Taxes</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The milestones, royalties and other amounts payable by Neurocrine to Heptares pursuant to this Agreement (each, a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) shall be paid free and clear of any and all taxes, except for any withholding taxes required by applicable Law.  Except as provided in this clause 5.7 and subject to clause 5.8, Heptares shall be solely responsible for paying any and all taxes (other than withholding taxes required by applicable Law to be deducted from Payments and remitted by Neurocrine) levied on account of, or measured in whole or in part by reference to, any Payments it receives.  Neurocrine shall deduct or withhold from the Payments any taxes that it is required by applicable Law to deduct or withhold.  Notwithstanding the foregoing, if Heptares is entitled under any applicable tax treaty to a reduction of rate of, or the elimination of, applicable withholding tax, it may deliver to Neurocrine or the appropriate Governmental Authority (with the assistance of Neurocrine to the extent that this is reasonably required and is expressly requested in writing) the prescribed forms necessary to reduce the applicable rate of withholding tax or to relieve Neurocrine of its obligation to withhold such tax and Neurocrine shall apply the reduced rate of withholding tax or dispense with withholding tax, as the case may be&#59; provided that Neurocrine has received evidence, in a form satisfactory to Neurocrine, of Heptares&#8217; delivery of all applicable forms (and, if necessary, its receipt of appropriate governmental authorization) prior to the time that the Payments are due.  If, in accordance with the foregoing, Neurocrine withholds any amount, it shall pay to Heptares the balance when due, make timely payment to the proper taxing authority of the withheld amount and send to Heptares proof of such payment within &#91;***&#93; days following such payment.  If any such withholding tax is assessed against, or paid (but in each case not withheld), by Neurocrine, then Heptares will pay the relevant amount of such withholding tax to Neurocrine. In the event that a Governmental Authority retroactively determines that a payment made by Neurocrine to Heptares under this Agreement should have been subject to withholding taxes (or to additional withholding taxes), and Neurocrine remits such withholding taxes to the Governmental Authority, including any interest and penalties that may be imposed thereon, at the option of Neurocrine, then Heptares will pay the relevant amount of any withholding tax (excluding any interest and penalties thereon which shall be payable by Neurocrine) to </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">VAT</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notwithstanding anything contained in clause 5.7, this clause 5.8 shall apply with respect to VAT.  All Payments or other consideration are exclusive of VAT.  If any VAT is chargeable in respect of any Payments or other consideration, the paying Party (being the Party making the payment or providing the other consideration), shall pay VAT which is accountable to a tax authority by the payee Party (being the recipient of the payments or other consideration) at the applicable rate in respect of any such Payments following the receipt of a VAT invoice in the appropriate form in compliance with applicable Law issued by the payee in respect of those Payments or other consideration, such VAT to be payable on the later of the due date of the payment of the Payments (or provision of other consideration) to which such VAT relates and &#91;***&#93; days after the receipt by the paying Party of the applicable invoice relating to that VAT payment. The Parties shall issue valid invoices for all goods and services supplied under this Agreement consistent with the applicable Law governing such VAT, and to the extent any invoice is not initially issued in an appropriate form, the Parties shall cooperate to provide such information or assistance as may be necessary to enable the issuance of such invoice consistent with the applicable Law governing such VAT. Where under the terms of this Agreement one Party is liable to indemnify or reimburse the other Party (or an Affiliate of that other Party) in respect of any costs, charges or expenses, the payment shall only include an amount equal to any VAT thereon not otherwise recoverable by the other Party (or its Affiliate), subject to that Party or representative member using all reasonable efforts to recover such amount of VAT as may be practicable.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Currency Exchange</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All payments to either Party under this Agreement shall be made by deposit of USD in the requisite amount to such bank account as the receiving Party may from time to time designate by written notice to the paying Party.  For the purpose of calculating any sums due under, or otherwise reimbursable pursuant to, this Agreement (including the calculation of Net Sales expressed in currencies other than USD), Neurocrine shall convert any amount expressed in a foreign currency into USD equivalents using its, its Affiliate&#8217;s or Sublicensee&#8217;s standard conversion methodology consistent with GAAP.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Records Retention&#59; Financial Audit&#59; Consolidation Reporting</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Record Retention.  Each Party shall and shall cause its Affiliates and its and their Sublicensees to, keep complete and accurate financial books and records pertaining to the Development and Commercialization of Licensed Products hereunder (including with respect to Neurocrine, Net Sales of Licensed Products and with respect to Heptares, Development Costs) to the extent required to calculate and verify all amounts payable hereunder.  Each Party shall, and shall cause its Affiliates and its and their Sublicensees to, retain such books and records until the later of (a) &#91;***&#93; years after the end of the period to which such books and records pertain and (b) the expiration of the applicable tax statute of limitations (or any extensions thereof) or for such longer period as may be required by applicable Law.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Financial Audit.  Each Party shall have the right to have an independent certified public accounting firm of internationally recognized standing reasonably acceptable to the other Party (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Auditor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) to have access during normal business hours, upon reasonable prior written notice, to such of the records of the other Party and its Affiliates as may be required to verify the accuracy of the calculation of Development Costs, Milestone Payments, Net Sales and Royalty Payments due for any year, no more frequently than once per year.  The same records may be audited only once.  All information subject to review under this clause 5.10(b) is subject to the confidentiality provisions of clause 6 and the auditing Party shall cause the Auditor to enter into a reasonably acceptable confidentiality agreement with the audited Party obligating such firm to retain all such financial information in confidence pursuant to such confidentiality agreement.  The Auditor shall disclose to the auditing Party only the amounts which the Auditor believes to be due and payable hereunder to such Party or, in the case of Development Costs, to have been due and payable hereunder to the audited Party and shall provide a copy of the same to the audited Party, and shall disclose no other information revealed in such audit.  Any and all records of the audited Party and its Affiliates examined by such Auditor shall be deemed the audited Party&#8217;s Confidential Information, which may not be disclosed by said Auditor to any Third Party or (except for the information expressly sought to be confirmed by the auditing Party as set forth in this clause 5.10(b)) to the auditing Party.  The auditing Party shall bear all costs of such audit, unless the audit reveals a discrepancy in its favour of more than &#91;***&#93; percent (&#91;***&#93;%), in which case the audited Party shall bear the cost of the audit. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Payment of Additional Amounts.  If, based on the results of any audit conducted under clause 5.10(b), additional payments are owed to the auditing Party or the auditing Party was overcharged for Development Costs under this Agreement, then the audited Party shall make such additional payments or refund Development Costs within &#91;***&#93; days after the Auditor&#8217;s written report is delivered to the Parties, with interest calculated thereon in accordance with clause 5.12.  If the results of the audit show that the audited Party over-reported and overpaid amounts due or the audited Party undercharged Development Costs, then the auditing Party shall refund excess amounts or pay additional Development Costs within &#91;***&#93; days after the Auditor&#8217;s written report is delivered.  If the report is contested by either, the Parties shall follow the dispute resolution procedures described in clause 5.10(d).  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Audit Dispute.  In the event of a dispute with respect to any audit under clause 5.10(b), Heptares and Neurocrine shall work in good faith to resolve the disagreement.  If the Parties are unable to reach a mutually acceptable resolution of any such dispute within &#91;***&#93; days, the dispute shall be submitted for resolution to a certified public accounting firm jointly selected by each Party&#8217;s certified public accountants or to such other person as the Parties shall mutually agree (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dispute Auditor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  The decision of the Dispute Auditor shall be final and the costs of such dispute resolution as well as the initial audit shall be borne between the Parties in such manner as the Auditor shall determine.  Not later than &#91;***&#93; days after such decision and in accordance with such decision, the Parties shall make reconciling payments as described in Section 5.10(c).</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Payment Details</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any payments due to be paid by Neurocrine to Heptares shall be made to the account details set out below&#58;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">or such other account as Heptares shall designate before any such payment is due.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Interest on Late Payments</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If any payment due to either Party under this Agreement is not paid when due, then such paying Party shall pay interest thereon (before and after any judgment) at an annual rate (but with interest accruing on a daily basis) of &#91;***&#93;% above the &#91;***&#93; rate, as adjusted from time to time on the first &#91;***&#93; business day of each month, such interest to run from the date on which payment of such sum became due until payment thereof in full together with such interest.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">CONFIDENTIALITY</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Protection of Confidential Information</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Receiving Party shall not disclose or disseminate Confidential Information of the Disclosing Party to any Third Party, unless expressly permitted hereunder, and shall not use such Confidential Information for any purpose other than in performing the Receiving Party&#8217;s obligations or exercising the Receiving Party&#8217;s rights hereunder.  In addition, the Receiving Party shall take reasonable steps to protect the Confidential Information of the Disclosing Party from unauthorized use or disclosure, which steps shall be no less than those the Receiving Party takes to protect its own confidential and&#47;or proprietary material of a similar nature.  The foregoing obligations shall apply equally to all copies, extracts and summaries of the Disclosing Party&#8217;s Confidential Information.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Certain Permitted Disclosures</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Disclosure Required by Law.  Notwithstanding the foregoing, each of Heptares and Neurocrine may disclose Confidential Information of the other Party to a Third Party to the extent such disclosure is made in response to a valid order of a court of competent jurisdiction or other supra-national, federal, national, regional, state, provincial and local governmental or regulatory body of competent jurisdiction or, if in the reasonable opinion of the Receiving Party&#8217;s legal counsel, such disclosure is otherwise required by Law, including by reason of filing with securities regulators&#59; provided, however, that if a Party is required by Law to make any such disclosure of the Disclosing Party&#8217;s Confidential Information, to the extent it may </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">legally do so it shall give reasonable advance notice to the Disclosing Party of such disclosure to permit the Disclosing Party to use its reasonable efforts to secure confidential treatment of such Confidential Information prior to disclosure (whether through protective orders or otherwise)&#59; and provided, further, that the Confidential Information disclosed in response to such court or governmental order shall be limited to that information which is legally required to be disclosed in response to such court or governmental order. </font></div><div style="margin-bottom:18pt;padding-left:70.6pt;text-align:justify;text-indent:-35.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.08pt">Disclosure to Certain Third Parties.  The Receiving Party may disclose such of the Disclosing Party&#8217;s Confidential Information to its Affiliates, and its and their respective employees and permitted subcontractors who have a need to know such Confidential Information and who are bound by written obligations of confidentiality and non-use at least as stringent as those by which the Receiving Party is bound hereunder.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Exploitation of Compounds and Licensed Products by Neurocrine.  Neurocrine and its Affiliates and its and their Sublicensees may disclose the Confidential Information of Heptares that is specific to Compounds or Licensed Products to the extent that such disclosure is made to its or their attorneys, auditors, advisors, consultants, contractors, existing or prospective collaboration partners, licensees, sublicensees, any Regulatory Authorities or other Third Parties for use by such persons as may be reasonably necessary or useful in connection with the Exploitation of Compounds or Licensed Products (including in connection with any filing, application or request for Regulatory Approval by or on behalf of Neurocrine or any of its Affiliates or its or their Sublicensees) or otherwise in connection with the performance of its obligations or exercise of Neurocrine&#8217;s rights as contemplated by this Agreement, provided that each recipient (other than Regulatory Authorities) is bound by written obligations of confidentiality and non-use at least as stringent as those by which the Receiving Party is bound hereunder.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Exploitation of Compounds and Licensed Products by Heptares.  Heptares and its Affiliates and its and their licensees and sublicensees may disclose the Confidential Information of Neurocrine that is specific to Compounds or Licensed Products to the extent that such disclosure is made to its or their attorneys, auditors, advisors, consultants, contractors, existing or prospective collaboration partners, licensees, sublicensees, any Regulatory Authorities or other Third Parties for use by such persons as may be reasonably necessary or useful in connection with and to the extent that Heptares has a license to use such Confidential Information for the Heptares Retained Rights (including in connection with any filing, application or request for Regulatory Approval by or on behalf of Heptares or any of its Affiliates or its or their licensees or sublicensees) or otherwise in connection with the performance of its obligations or exercise of Heptares&#8217; rights as contemplated by this Agreement, provided that each recipient (other than Regulatory Authorities) is bound by written obligations of confidentiality and non-use at least as stringent as those by which the Receiving Party is bound hereunder.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Patent Filings.  Neurocrine may disclose Confidential Information of Heptares to a Third Party to the extent such disclosure is made by or on behalf of Neurocrine to a patent authority as may be reasonably necessary or useful for purposes of obtaining or enforcing a Patent covering a Compound or a Licensed Product.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">Disclosure to Investors and Acquirers.  The Receiving Party may disclose such of the Disclosing Party&#8217;s Confidential Information to potential or actual investors or acquirers as may be necessary in connection with their evaluation of such potential or actual investment or acquisition&#59; provided, however, that such persons shall be bound by written obligations of confidentiality and non-use at least as stringent as those by which the Receiving Party is bound under this clause 6 (provided that the term of the obligations may be shorter but not less than &#91;***&#93; years).</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">Return of Confidential Information.  Upon expiration or termination of this Agreement, the Receiving Party shall promptly return, or at the Disclosing Party&#8217;s request, destroy or delete, all of the Disclosing Party&#8217;s Confidential Information except to the extent that the Receiving Party has a continuing license to use such Confidential Information, provided that the Receiving Party may retain one copy for its legal files, subject to its continuing obligations under this clause 6.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">Unauthorized Use.  If either Party becomes aware or has knowledge of any unauthorized use or disclosure of the Disclosing Party&#8217;s Confidential Information, it shall promptly notify the Disclosing Party of such unauthorized use or disclosure.  </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Public Disclosure</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Neither Party shall use the name, logo or trademark of the other Party or of any director, officer, employee or agent of the other Party or any adaptation thereof in any advertising, promotional or sales literature, publicity or in any document employed to obtain funds or financing without the prior written approval of the Party or individual whose name is to be used.  The restrictions imposed by this clause 6.5 shall not prohibit either Party from making any disclosure identifying the other Party that is required by applicable Law or the rules of a stock exchange on which the securities of the disclosing Party are listed (or to which an application for listing has been submitted).  As exceptions to the foregoing&#58;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">The Parties shall issue a joint press release substantially in the form set out at Schedule 3.  Neither Party shall issue any other public announcement, press release or other public disclosure regarding this Agreement or its subject matter, or shall publicly disclose the terms of this Agreement, without the other Party&#8217;s prior written consent, except for any such disclosure that is in the opinion of the disclosing Party&#8217;s or its Affiliate&#8217;s counsel, required by applicable Law or the rules of a stock exchange on which the securities of the disclosing Party or its Affiliate are listed (or to which an application for listing has been submitted).  In the event a Party or its Affiliate is, in the opinion of its legal counsel, required to make such a public disclosure, such Party shall, or shall procure that its Affiliate shall, submit the proposed disclosure (including, if applicable, a proposed redacted version of this Agreement to be filed with a regulator or stock exchange) in writing to the other Party as far in advance as reasonably practicable so as to provide a reasonable opportunity to comment thereon.  Neither Party shall be required to seek the permission of the other Party to repeat any information regarding the terms of this Agreement or any amendment to this Agreement that has already been publicly disclosed by such Party or its Affiliate or by the other Party or its Affiliate, in accordance with this clause 6.5, provided that such information remains accurate as of such time and provided the frequency and form of such disclosure are reasonable.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Publications.  Neurocrine shall be free to publicly disclose research, development and commercial information (including with respect to regulatory matters) regarding the Compounds and Licensed Products, provided that during the Research Term, any publication of Heptares Existing Compound Know-How shall be subject to prior review by Heptares for issues of patentability and protection of its Confidential Information, in a manner consistent with applicable Law and industry practices.  Any proposed public disclosure of research, development and commercial information (including with respect to regulatory matters) regarding M1 Target Agonists in connection with the Heptares Retained Rights shall be subject to the review and approval of the JSC, provided that during the Research Term, any publication of Heptares Existing Compound Know-How shall be subject to prior review by Neurocrine for issues of patentability in a manner consistent with applicable Law and industry practices.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.56pt">Subject to limited disclosure in accordance with clauses 6.2 and 6.5, the content and terms of this Agreement shall be considered Confidential Information of the Parties and shall remain subject to the obligations set out in clause 6.1.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">INTELLECTUAL PROPERTY</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Preparation, Filing, Prosecution and Maintenance of Patents</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall have the right and the obligation as provided in this clause 7.1 and subject to the remaining provisions of this clause 7.1, at its cost through the use of internal or outside counsel as it may reasonably determine, to prepare, file, prosecute and maintain the Licensed Patents in the Territory and the Neurocrine Patents and Joint Patents worldwide, and to be responsible for any related interference, re-issuance, re-examination and opposition&#59; provided that if Neurocrine proposes to make any new filing (of a patent application or any other substantive communication) for a Patent in the Licensed Patents in the Territory or the Neurocrine Patents or Joint Patents worldwide, Neurocrine shall provide a draft of any such proposed filing to Heptares for review and comment and will consider Heptares&#8217; comments in good faith.  Neurocrine shall prosecute and maintain the Licensed Patents (including Joint Patents) and the Neurocrine Patents in at least the US and EU, in each case consistent with Neurocrine&#8217;s patent strategy for Patents owned by Neurocrine.  Heptares shall prosecute and maintain the Licensed Patents (including Joint Patents) and the Neurocrine Patents  that cover M1 Target Agonists in Japan, in each case consistent with Heptares' patent strategy for Patents owned by Heptares, and provided that if Heptares proposes to make any new filing (of a </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">patent application or any other substantive communication) for any such Patent in Japan, Heptares shall provide a draft of any such proposed filing to Neurocrine for review and comment and will consider Neurocrine's comments in good faith provided that Heptares shall not make any such proposed filing if Neurocrine believes that such filing would be reasonably likely to have a material adverse effect on the Development and Commercialization of any Licensed Product in the Territory or on any of the Licensed Patents or any  of the Neurocrine Patents in the Territory.  In the event Neurocrine decides that it is no longer interested in prosecuting or maintaining any particular Patent(s) from among the Licensed Patents (including Joint Patents) or any Neurocrine Patents in a particular country (each a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discontinued Patent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) and Neurocrine is not and has not filed a continuation or divisional application to such Discontinued Patent, Neurocrine shall notify Heptares and provide Heptares with an opportunity to assume, at Heptares&#8217; expense, control of the prosecution and&#47;or maintenance of such Discontinued Patent.   </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Patent Term Extension and Supplementary Protection Certificate</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As between the Parties, Neurocrine shall have the sole right to make decisions regarding and to apply for (in each case in consultation with Heptares) patent term extensions, including supplementary protection certificates and any other extensions that are now or become available in the future, wherever applicable, for Licensed Patents (including Joint Patents) and Neurocrine Patents in any country save for any such Patents that cover M1 Target Agonists in Japan.  Heptares shall retain the sole right to apply for (in each case in consultation with Neurocrine), patent term extensions, including supplementary protection certificates and any other extensions that are now or become available in the future, wherever applicable, for Licensed Patents (including Joint Patents) and Neurocrine Patents that cover M1 Target Agonists in Japan.  Each Party shall provide prompt and reasonable assistance, as requested by the other Party, including by taking such action as is required under any applicable Law to obtain such extension or supplementary protection certificate.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Patent Listings</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As between the Parties, Neurocrine shall have the sole right to make all filings with Regulatory Authorities in the Territory with respect to Licensed Patents (including Joint Patents) and Neurocrine Patents, including as required or allowed in the US, in the FDA&#8217;s Orange Book or other international equivalents (save in relation to Licensed Patents (including Joint Patents) and Neurocrine Patents that cover M1 Target Agonists in Japan, where Heptares shall retain such right). </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Information Exchange with Heptares</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall keep Heptares reasonably apprised of material developments regarding the preparation, filing, maintenance and prosecution of Licensed Patents in the Territory and Neurocrine Patents, shall provide Heptares with a reasonable opportunity to comment and make requests regarding the same and shall take such requests into account.  Heptares shall keep Neurocrine reasonably apprised of material developments regarding the preparation, filing, maintenance and prosecution of Licensed Patents (including Joint Patents) and Neurocrine Patents that cover M1 Target Agonists in Japan, shall provide Neurocrine with a reasonable opportunity to comment and make requests regarding the same and shall not make any filing if Neurocrine believes that such filing would be reasonably likely to have a material adverse effect on the Development and Commercialization of any Licensed Product in the Territory or on any of the Licensed Patents or any of the Neurocrine Patents in the Territory.  Neurocrine shall also provide to Heptares an updated list of the Licensed Patents every six months from the Effective Date which details the current status of each Licensed Patent. Heptares shall cooperate with Neurocrine to the extent reasonably necessary for Neurocrine to prosecute the Licensed Patents in the Territory, including the execution and delivery of documents at Neurocrine&#8217;s reasonable cost.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">IP Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Within &#91;***&#93; days after the Effective Date, the Parties shall establish a joint IP committee by each Party designating one of its representatives as a member of such committee (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IP Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;). Each member shall have the appropriate background and expertise to contribute to the IP Committee. Each Party may change its representative on the IP Committee from time to time by notice to the other Party. The IP Committee shall meet as often as the IP Committee shall decide and shall act as a forum for discussing matters relating to clauses 7.1-7.4 above. The members of the IP Committee may decide to refer matters on which they cannot agree to the JSC for discussion and resolution.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Infringement of the Patents </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event that either Party learns of any infringement of any Licensed Patents (including Joint Patents) or Neurocrine Patents under this Agreement or any certification filed under the Hatch-Waxman Act or declaratory judgment action claiming that any Licensed Patents or Neurocrine Patents are invalid or unenforceable or claiming that any such Patents would not be infringed by the making, use, offer for sale, sale or import of a product for which an application under the Hatch-Waxman Act is filed or any equivalent or similar certification or notice in any jurisdiction worldwide (each an &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Infringement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), such Party shall promptly, but in all cases within &#91;***&#93; days of any notice of Infringement, inform the other Party and shall provide the other Party with reasonable evidence of such Infringement of which it is aware.  Neurocrine shall have the sole right, but not the obligation, to initiate and litigate at its sole cost and expense any Infringement action against any party believed to be infringing the Licensed Patents (including Joint Patents) or Neurocrine Patents, except that Heptares shall have the first right, but not the obligation, to initiate and litigate at its sole cost and expense any Infringement action against any party believed to be infringing the Licensed Patents or Neurocrine Patents that cover the M1 Target Agonists in Japan provided that Heptares shall not take any such action if Neurocrine believes that taking such action would be reasonably likely to have a material adverse effect on the Development and Commercialization of any Licensed Product in the Territory or on any of the Licensed Patents or any of the Neurocrine Patents in the Territory.  In the event the Party having such right (&#34;the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Enforcing Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) elects to initiate such proceeding, the Enforcing Party shall have the sole right to direct the litigation, to name the other Party in any such litigation proceeding as a party, and to elect when, whether and on what terms to settle such litigation at its cost and to receive any awards. The other Party shall cooperate fully in any Infringement action pursuant to this clause 7.6, including by being named as a necessary party to, such action at the Enforcing Party&#8217;s cost and subject to the other Party being indemnified by the Enforcing Party in respect of all costs and liabilities associated with being so named.  In the event that the Enforcing Party elects not to initiate such proceeding to enforce Licensed Patents, Heptares Existing Compound Patents or Arising Patents owned solely by Heptares, the other Party shall have the right to initiate and litigate the claim of Infringement at other Party&#8217;s sole cost and expense, and to name the Enforcing Party in any such litigation proceeding as a party, and to elect when, whether and on what terms to settle such litigation and to receive any awards&#59; provided that, if the Enforcing Party has notified the other Party that it had elected not to initiate such proceedings because it reasonably believed that such proceedings would be detrimental or prejudicial to the Enforcing Party's rights under this Agreement, the other Party shall not have the right to initiate or litigate any proceedings with respect to such Infringement.  In any event, the Party not directing such proceeding shall reasonably assist the Party directing such proceeding and cooperate in any such litigation at the request and expense of the Party directing the proceeding. Each Party may at its own expense and with its own counsel join any proceeding initiated and directed by the other Party under this clause 7.6.  Heptares shall (at Neurocrine&#8217;s request and expense) use its reasonable efforts to cause &#91;***&#93; to (a)&#160;reasonably assist Heptares and Neurocrine and cooperate in any such litigation with respect to any Licensed Patent licensed to Heptares pursuant to the &#91;***&#93; and (b)&#160;join such litigation if &#91;***&#93; is deemed to be a necessary party to such litigation, in each case to the extent provided in and subject to the terms of the &#91;***&#93;.  Before taking any action under this clause 7.6, the Party seeking to initiate the action shall give written notice to the other Party informing it of the steps it considers need to be taken and the Parties shall, before any such action is initiated, discuss in good faith the manner, timing and the Party responsible for initiating such action(s).  Any damages awarded to Neurocrine or to Heptares that are attributable to loss of sales or profits with respect to Licensed Products in the Territory shall, &#91;***&#93;.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Defence of Claims Brought by Third Parties</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to clause 7.8 in respect of the Heptares Platform and to clause 11, if a Third Party initiates a proceeding claiming that any patent owned by or licensed to such Third Party is infringed by the Exploitation of a Compound or Licensed Product under this Agreement, the Party against which the claim has been brought shall have the right, but not the obligation, to defend against such proceeding at its sole cost and expense.  In the event such Party elects to defend against such proceeding, that Party shall have the sole right to direct the defence and to elect when, whether and on what terms to settle such claim.  In the event a proposed settlement involves Neurocrine obtaining a license under Blocking Third Party Patent Rights, the provisions of clause 5.4(a) shall apply.  The other Party shall reasonably assist the defending Party in the defence of such proceeding and cooperate in any such litigation at the request and expense of the defending Party, including, if requested by the defending Party, joining such action, and executing all papers and performing such acts as the defending Party may reasonably require.  The other Party may at its own expense and with its own counsel join any defence initiated and directed by the defending Party under this clause 7.7.  Each Party shall provide the other with prompt written notice of the commencement of any such proceeding, or of any allegation of infringement of which a Party becomes aware and that is of the type described in this clause 7.7, and such Party shall promptly furnish the other with a copy of any Third Party notice communicating the alleged infringement and with copies of all pleadings and evidence served or filed in any suit or proceeding relating to such Third Party infringement claim. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Platform IP</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall own the Heptares Platform and the Heptares Platform IP.  Heptares shall also own all Heptares Platform Improvements, whether or not created, invented, identified or synthesised by Heptares, Neurocrine or jointly by Heptares and Neurocrine during the Term.  At the request of Heptares and at Heptares&#8217; expense, Neurocrine shall, and shall procure that any of its employees, agents and subcontractors shall, do all acts and things (including making declarations, oaths and providing assistance in relation to the supply of information for any patent applications) and execute all documents that may be reasonably necessary under the Laws of any country for ensuring that all rights in any Heptares Platform Improvements are assigned to Heptares together with the right to sue for past infringement and recover damages.  Heptares will be solely responsible, at its expense, for the preparation, filing, prosecution, maintenance and enforcement of all Patents within the Heptares Platform IP including, without limitation, any related interference, re-issuance, re-examination and opposition proceedings.  Heptares will be solely responsible for defending any proceedings initiated by a Third Party claiming that the Heptares Platform IP are invalid or any patent owned by or licensed to such Third Party is infringed by use of the Heptares Platform or any Heptares Platform Improvement to identify, generate or optimise compounds.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Ownership of Neurocrine Background IP</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As between the Parties, Neurocrine shall own all Neurocrine Background IP.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Ownership of Heptares Existing Compound IP</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As between the Parties, Heptares shall own the Heptares Existing Compound IP.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Ownership of Arising IP</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ownership of all Arising IP shall be based on inventorship, as determined in accordance with the rules of inventorship under United States patent laws.  Each Party shall solely own all Arising Know-How made solely by its and its Affiliates&#8217; employees, agents, or independent contractors, and all Arising Patents that claim or cover such Arising Know-How.  The Parties shall jointly own all Arising Know-How that is made jointly by employees, agents, or independent contractors of one Party and its Affiliates together with employees, agents, or independent contractors of the other Party and its Affiliates, and all Arising Patents that claim or cover such Arising Know-How.  Except to the extent either Party is restricted by the licenses granted to the other Party or exclusivity or non-compete obligations under this Agreement, each Party shall be entitled to practice, license, assign and otherwise exploit the jointly-owned Arising IP without the duty of accounting or seeking consent from the other Party.  Each Party shall promptly disclose to the other Party all Arising Know-How made by such Party to which the other Party has a license hereunder during the Term, including all invention disclosures or other similar documents submitted to such Party by its or its Affiliates&#8217; employees, agents or independent contractors relating to such inventions, and shall also respond promptly to reasonable requests from the other Party for additional information relating to such inventions.  Each employee, agent or independent contractor of a Party or its respective Affiliates performing work under this Agreement shall, prior to commencing such work, be bound by invention assignment obligations, including&#58; (i) promptly reporting any invention, discovery, process or other intellectual property right&#59; (ii) presently assigning to the applicable Party or Affiliate all of his or her right, title and interest in and to any invention, discovery, process or other intellectual property&#59; (iii) cooperating in the preparation, filing, prosecution, maintenance and enforcement of any patent and patent application&#59; and (iv) performing all acts and signing, executing, acknowledging and delivering any and all documents required for effecting the obligations and purposes of this Agreement.  It is understood and agreed that such invention assignment agreement need not reference or be specific to this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Co-operation</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At the request of Neurocrine or Heptares (as the case may be), the other Party shall, and shall procure that any of its or its Affiliates&#8217; employees, agents and subcontractors shall, do all acts and things (including making declarations, oaths and providing assistance in relation to the supply of information for any patent applications) and execute all documents that may be reasonably necessary or useful in connection with the filing, prosecution and maintenance of Patents under this clause 7.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Trademarks for Licensed Product</font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall be solely responsible for developing, selecting, searching, registering and maintaining, and shall be the exclusive owner of, all trademarks, trade dress, logos, slogans, designs, copyrights and domain names used on and&#47;or in connection with Licensed Products provided that Heptares shall be responsible for the foregoing for Licensed Products that are M1 Target Agonists for use in all indications in Japan. Upon Heptares&#8217; request, the Parties shall negotiate and enter into a trademark license agreement pursuant to which Neurocrine will grant Heptares an exclusive, payment free, sub-licensable license under any trademarks and trade dress used by or on behalf of Neurocrine exclusively in connection with the Licensed Products, for the purposes of exercising the Heptares Retained Rights.</font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Trademarks for Heptares Platform</font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall be solely responsible for developing, selecting, searching, registering and maintaining, and shall be the exclusive owner of, all trademarks, trade dress, logos, slogans, designs, copyrights and domain names used on and&#47;or in connection with the Heptares Platform, Heptares Platform IP and Heptares Platform Improvements. </font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Joint Research Agreemen</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">t</font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement is a joint research agreement within the meaning of pre-AIA 35 U.S.C. &#167; 103(c) and AIA 35 U.S.C. &#167; 102(c).</font></div><div style="margin-bottom:18pt;padding-left:35.3pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">TERM AND TERMINATION</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Term</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unless terminated earlier pursuant to this clause 8 the term of this Agreement shall commence on the Effective Date (except for clauses 6, 9.3 and 12.12, which shall commence on the Execution Date) and shall continue in full force and effect on a Licensed Product-by-Licensed Product and country-by-country basis until the expiration of the Royalty Term in such country (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  Upon expiration of the Royalty Term, on a Licensed Product-by-Licensed Product and country-by-country basis the license granted to Neurocrine pursuant to clause 2.1 shall be a fully paid, irrevocable, perpetual license.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Termination at Will by Neurocrine</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall have the right to terminate this Agreement for any reason or no reason&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">in its entirety or on a Target-by-Target basis during the Research Term on one hundred and eighty (180) days&#8217; written notice to Heptares&#59; and</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">following the end of the Research Term, in its entirety or on a Target-by-Target basis, on ninety (90) days&#8217; prior written notice to Heptares.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall remain liable to pay (a) any Milestone Payments that have become due for payment and&#47;or (b) Royalty Payments on Net Sales by Neurocrine (in accordance with GAAP), in each case (a) and (b) on or before the Termination Date.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Termination by Heptares</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall have the right to terminate this Agreement on a Target-by-Target basis on one hundred and twenty (120) days&#8217; written notice to Neurocrine if after the end of the Research Term, for a continuous period of not less than three hundred and sixty five (365) days, no material Development activities have been undertaken by or on behalf of Neurocrine on (a) any Compound or Licensed Product that is an M4 Target Agonist or (b) Compounds or Licensed Products that are M1 Target Agonists and Compounds or Licensed Products that are M1&#47;M4 Dual Target Agonists&#59; provided that, (i) if the absence of material Development Activities relates to one of (a) or (b) but not both (a) and (b) </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the rights of Heptares set out in this clause shall apply only to the Target Agonist in relation to which no such material Development activities have been undertaken and (ii) at least three (3) months prior to providing notice of the termination, Heptares shall notify Neurocrine of its concerns and the Parties shall discuss in good faith the reasons why Neurocrine is not undertaking such material Development activities and its plans for recommencing such activities and if there is a dispute regarding Heptares' right to terminate under this clause the Parties shall refer the matter to the dispute resolution provisions of clause 8.5&#59; provided that Heptares shall not have the right to terminate this Agreement pursuant to this clause 8.3 if&#58; (A) Neurocrine recommences material Development activities during either the one hundred and twenty (120) day notice period or the &#91;***&#93; months period prior to such notice period or (B) Neurocrine is acting in accordance with activities that have been approved by Heptares at the JSC, in either case the Heptares notice of termination shall be withdrawn automatically and shall be void ab initio.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Material Breach</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In the event of a material breach of this Agreement, the non-breaching Party shall have the right to terminate this Agreement in its entirety (if the breach is material to the Agreement as a whole) by written notice to the breaching Party specifying the nature of such breach in reasonable detail.  Such termination shall become effective &#91;***&#93; days from receipt of such notice by the breaching Party, except that such period shall be &#91;***&#93; days in the event the basis of the alleged material breach is a failure to make payment(s) under this Agreement, unless the breaching Party has cured such breach within such &#91;***&#93; or &#91;***&#93; day period (as applicable).  Notwithstanding the foregoing&#58; (a) except in the event the basis of the alleged material breach is a failure to make payment(s) under this Agreement, such &#91;***&#93;-day cure period shall be extended for an additional &#91;***&#93; days or such longer period as is reasonably required to cure such breach if the breaching Party is employing ongoing, good faith efforts to cure such alleged material breach&#59; (b) in the event the basis of the alleged material breach is a failure to make payment(s) under this Agreement and the alleged breaching Party (i) notifies the non-breaching Party, during such thirty (30)-day cure period, of a bona fide dispute regarding whether such payment(s) are due&#59; and (ii) pays the undisputed portion of such payment(s) on or before providing such notice, such &#91;***&#93;-day cure period shall be tolled pending resolution of such dispute pursuant to clause 8.5, and in the event the dispute is finally resolved against the Party allegedly in material breach, the applicable cure period shall commence upon such final resolution&#59; and (c) in the event the basis of the alleged material breach is other than a failure to make payment(s) under this Agreement and the alleged breaching Party notifies the non-breaching Party, during such &#91;***&#93;-day cure period, of a bona fide dispute regarding the alleged breach, such &#91;***&#93;-day cure period shall be tolled pending resolution of such dispute pursuant to clause 8.5, and in the event the dispute is finally resolved against the Party allegedly in material breach, the applicable cure period shall commence upon such final resolution.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Dispute Resolution</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any dispute arising out of an allegation of material breach of this Agreement or any other dispute, controversy or claim that may arise out of or in connection with this Agreement, will be resolved as follows&#58; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the Senior Officers will meet to attempt to resolve the dispute by good faith negotiations.  If the Senior Officers cannot resolve the dispute within &#91;***&#93; days after a Party requests such negotiations, then each Party will attempt in good faith to settle the dispute by mediation pursuant to clause 8.5(b)&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the mediation of any dispute is to be administered in the United Kingdom by the Centre for Effective Dispute Resolution (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CEDR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) or such other mediator as may be mutually agreed to by the Parties.  If mediation is unsuccessful, the Parties may initiate arbitration in accordance with clause 12.3&#59; and</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">notwithstanding anything to the contrary in this Agreement, if either Party in its sole judgment believes that any such breach or dispute could cause it irreparable harm, such Party shall be entitled to seek equitable relief from a court of competent jurisdiction in order to avoid such irreparable harm and will not be required to follow the procedures set forth in this clause 8.5.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Insolvency </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Either Party may terminate this Agreement if, at any time (i) the other Party files in any court or agency pursuant to any statute or regulation of any state or country a petition in bankruptcy or </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">insolvency or for reorganization (save for solvent reorganization or solvent reconstruction) or for an arrangement or for the appointment of a receiver or trustee of the Party or of substantially all of its assets, (ii) the other Party proposes a written agreement of composition or extension of substantially all of its debts, (iii) the other Party is served with an involuntary petition against it, filed in any insolvency proceeding, and such petition is not dismissed within &#91;***&#93; days after the filing thereof, (iv) the other Party proposes to be a party to any dissolution or liquidation or (v) the other Party makes an assignment of substantially all of its assets for the benefit of creditors. </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">All rights and licenses granted under or pursuant to any clause of this Agreement are for the purposes of Section 365(n) of Title 11, United States Code (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bankruptcy Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) licenses of rights to &#34;intellectual property&#34; as defined in Section 101(56) of the Bankruptcy Code (and any equivalent provisions under the bankruptcy or insolvency laws of any other relevant jurisdiction).  The Parties shall retain and may fully exercise all of their respective rights and elections under the Bankruptcy Code provided that they comply with the terms of this Agreement. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Patent Challenge</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a Party or its Affiliate directly commences, or knowingly assists a Third Party (save where such assistance is ordered by a court, patent office or other tribunal) to commence any interference or opposition proceeding, challenges the validity or enforceability in any patent office or court proceedings of, or opposes any extension of or the grant of a supplementary protection certificate with respect to a Patent licensed to such Party by the other Party hereunder (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Patent Challenge</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), the other Party may terminate such Party&#8217;s license to the applicable Patent on sixty (60) days&#8217; written notice stating its intention to terminate the license if the Patent Challenge has not been stopped within such period, provided that (a) a Party may not terminate a license pursuant to this clause 8.7 if the Patent Challenge had been commenced by an Affiliate of the other Party prior to such Affiliate becoming an Affiliate of such other Party&#59; and (b) a Party shall not have the right to terminate a license if such Patent Challenge is a defence to any claim that the Exploitation of a compound which is not a Compound or Licensed Product infringes a Patent.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Effect of Expiration or Termination of this Agreement </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Accrued Obligations.  Expiration or termination of this Agreement for any reason shall not release either Party from any obligation or liability which, at the time of such expiration or the Termination Date, has already accrued to the other Party or which is attributable to a period prior to such expiration or the Termination Date.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Termination by Neurocrine at Will or by Heptares for Material Breach, Insolvency or by Heptares pursuant to clauses 8.3 and 8.7.  If (i)&#160;this Agreement is terminated in its entirety by Neurocrine pursuant to clause 8.2 or by Heptares pursuant to clause 8.3, 8.4, or 8.6, then the following provisions shall apply to this Agreement in its entirety and to all Compounds, Licensed Products, Arising Patents, and Licensed Patents or (ii)&#160;if this Agreement is terminated on a Target-by-Target basis by Neurocrine pursuant to clause 8.2 or on a Target-by-Target basis or Licensed Patent-by-Licensed Patent basis by Heptares pursuant to clause 8.3 or 8.7, then clause (ix) shall apply, but this Agreement shall remain in full force and effect with respect to all other Compounds, Licensed Products and Licensed Patents&#58; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the license and rights granted to Neurocrine under clause 2.1 and to Heptares under clause&#160;2.5(a) (but not clause 2.5(b)) shall terminate&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.35pt">Neurocrine shall reimburse Heptares for all Third Party committed and non-cancelable Development Costs provided such commitments have been made pursuant to an approved Research and Development Plan and budget&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">except as otherwise expressly provided herein all rights and obligations of each Party hereunder will cease with respect to all Compounds or Licensed Products including all rights, licenses and sublicenses granted by a Party to the other hereunder, provided that clause 5 will survive with regard to any outstanding payment obligations accrued as of the Termination Date&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Neurocrine and its Affiliates will immediately cease all activity using the Heptares </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Platform&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">subject to clause 8.8(d), Neurocrine shall grant Heptares an exclusive, worldwide, sublicensable (through multiple tiers of sublicensees), royalty-bearing (as set out in this sub-clause) license under the Reversion IP solely to Exploit Reversion Products after the Termination Date in the Field in the Territory&#59; provided that in consideration for such license, on a Reversion Product-by-Reversion Product basis, Heptares shall pay Neurocrine</font></div><div style="margin-bottom:18pt;padding-left:141.75pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(A)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">a royalty of (i) &#91;***&#93; percent (&#91;***&#93;%) of Net Sales of any such Reversion Product if the Termination Date occurs &#91;***&#93;, (ii) &#91;***&#93; percent (&#91;***&#93;%) of Net Sales of any such Reversion Product if the Termination Date occurs &#91;***&#93;, (iii) &#91;***&#93; percent (&#91;***&#93;%) of Net Sales of any such Reversion Product if the Termination Date occurs &#91;***&#93;. The terms of clauses 5.3 and 5.4 shall apply to the payment of any such royalty except that (i) all references to Neurocrine shall be replaced by Heptares and vice versa, (ii) the royalty rate shall be the applicable rate set out above and (iii) &#91;***&#93;. If the Agreement is terminated by Heptares pursuant to clauses 8.4 or 8.6, the royalty rates set out in this subsection shall be reduced by &#91;***&#93; percent (&#91;***&#93;%)&#59;  </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Neurocrine will at Heptares&#8217; cost (A) transfer to Heptares any IND and Regulatory Approval (or filing therefor) related solely to any Reversion Products, in each case which are Controlled by Neurocrine or its Affiliates at the Termination Date, (B) provide access to Know-How Controlled by Neurocrine and its Affiliates that are licensed to Heptares under clause 8.8(b)(v) above and (C) to the extent owned and possessed by Neurocrine or its Affiliates, transfer to Heptares all tangible chemical or biological material embodying the Reversion Products and reasonable quantities of other Materials Controlled by Neurocrine and its Affiliates that are licensed to Heptares under this clause&#59; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.35pt">Neurocrine shall, and shall procure that its Affiliates shall, at Heptares&#8217; request and cost, for a reasonable period not exceeding &#91;***&#93; days following the Termination Date, provide Heptares with such assistance as Heptares may reasonably require in order to transfer the ongoing Development, manufacture and Commercialization of any Reversion Products to Heptares, to the extent contemplated by this clause 8.8(b)&#59; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(viii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:17.13pt">Neurocrine shall grant Heptares an exclusive, worldwide, sublicensable (through multiple tiers of sublicensees) license under any trademark (if any) registered by or on behalf of Neurocrine that is owned by Neurocrine or its Affiliates and used exclusively to Exploit a Reversion Product as at the Termination Date (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product Trademark</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;)&#59; provided that Neurocrine may, at its election, instead of granting such exclusive license, transfer such trademark to Heptares&#59;  </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ix)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">If the termination applies to a particular Target or class of Target Agonists or, in the case of clause 8.7 a Licensed Patent that covers a particular Target or class of Target Agonists, then notwithstanding anything to the contrary in this clause&#160;8.8, (A)&#160;the above provisions and other relevant provisions of this clause&#160;8 will apply to the particular Target or class of Target Agonists in relation to which this Agreement has been terminated, (B)&#160;if any Licensed Patent and&#47;or Arising Patent relates to both a Compound or Licensed Product for which this Agreement is terminated and a Compound or Licensed Product for which this Agreement remains in effect, then Neurocrine shall retain all rights with respect to prosecution, maintenance, defense and enforcement of such Licensed Patents and&#47;or Arising Patents as set forth in clauses 7.1, 7.2, 7.3, 7.4, 7.6 and 7.7, except that Neurocrine shall have no obligation to defend or enforce any Licensed Patent and&#47;or Arising Patents with respect to any Reversion Product and Heptares may do so provided that Neurocrine shall have the right to participate in any such action or proceeding to protect its interest in any Compound or Licensed Product to which Neurocrine retains a license under this Agreement, and (C)&#160;the Parties will agree in good faith any necessary amendments to this clause to take account of any such partial termination including to address any instance where a terminal disclaimer occurs between any US patent in the Agreement and a US patent that has been terminated to ensure that the patents that are still in the Agreement remain enforceable, as well as take account of any overlap between Reversion Products that are claimed in the Licensed Patents where such same patents also claim Licensed Products that are not subject to the termination&#59; and</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(x)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">If the Agreement is terminated as contemplated by this clause&#160;8.8 in relation to M1 Target Agonists the provisions of clause&#160;2.4 shall terminate and any provisions in clause&#160;3.6 giving &#91;***&#93; final decision making or approval rights in relation to the exercise of the Heptares Retained Rights shall terminate (except as such provisions apply to any Compound or Licensed Product to which &#91;***&#93; retains a license under this Agreement, in which case it shall continue in effect) or in clause&#160;7 giving Neurocrine the prosecution, defence or enforcement of Licensed Patents (including Joint Patents) covering M1 Target Agonists shall terminate (except in the case described in clause (ix) above with respect to Licensed Patents covering M1 Target Agonists and any Compound or Licensed Product to which Neurocrine retains a license under this Agreement, in which case it shall continue in effect). Additionally if after the end of the Research Term, for a continuous period of not less than three hundred and sixty five (365) days, no material Development activities have been undertaken by or on behalf of Neurocrine on  Compounds or Licensed Products that are M1 Target Agonists, the provisions in clause&#160;3.6 giving &#91;***&#93; final decision making or approval rights in relation to the exercise of the Heptares Retained Rights shall terminate (except as such provisions apply to any Compound or Licensed Product to which &#91;***&#93; retains a license under this Agreement, in which case it shall continue in effect) or in clause&#160;7 giving Neurocrine the prosecution, defence or enforcement of Licensed Patents (including Joint Patents) covering M1 Target Agonists shall terminate (except in the case described in clause (ix) above with respect to Licensed Patents covering M1 Target Agonists and any Compound or Licensed Product to which Neurocrine retains a license under this Agreement, in which case it shall continue in effect).</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Termination by Neurocrine for Material Breach or Insolvency. If Neurocrine terminates this Agreement in its entirety pursuant to clause 8.4 or 8.6, then the following provisions shall apply to this Agreement in its entirety and to all Compounds, Licensed Products and Patents&#58; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">the license and rights granted to Neurocrine under clause 2.1 and to Heptares under clause&#160;2.5(a) (but not clause 2.5(b)) shall terminate&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.35pt">Neurocrine shall reimburse Heptares for all Third Party committed and non-cancelable Development Costs provided such commitments have been made pursuant to an approved Research and Development Plan and budget.</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">except as otherwise expressly provided herein all rights and obligations of each Party hereunder will cease with respect to all Compounds or Licensed Products including all rights, licenses and sublicenses granted by a Party to the other hereunder, provided that clause 5 will survive with regard to any outstanding payment obligations accrued as of the Termination Date&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">Neurocrine and its Affiliates will immediately cease all activity using the Heptares Platform&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Neurocrine shall, at Heptares&#8217; request, negotiate a royalty-bearing license from Neurocrine to Heptares under the Reversion IP and Product Trademarks for the Exploitation of Reversion Products&#59; </font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:21.57pt">The prosecution of all Licensed Patents and, to the extent they are subject to a license granted pursuant to clause 8.8(c)(v), Arising Patents shall be transferred to Heptares, including the rights contained in clause 7.2&#59; and</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:19.35pt">From the Termination Date, Neurocrine and its Affiliates and Sublicensees shall not Exploit Reversion Products in a country.  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Termination by Neurocrine for Patent Challenge. If this Agreement is terminated by Neurocrine on a Licensed Patent-by-Licensed Patent basis by Neurocrine pursuant to clause 8.7, then the license and rights granted to Heptares under clause&#160;2.5 shall terminate, but this Agreement shall otherwise remain in full force and effect with respect to all other Compounds, Licensed Products and Licensed Patents.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Notwithstanding any other provision in this clause 8.8, if there are any Clinical Trials being conducted at the Termination Date, Neurocrine shall be entitled to continue Exploiting </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compounds and Products to the extent and for the period necessary to effect an orderly transfer or wind down of such Clinical Trials in a timely manner and in accordance with all Laws.  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Survival</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upon the expiration or termination of this Agreement for any reason, all rights and obligations of the Parties under this Agreement (or with respect to a particular Target or class of Target Agonists, or Licensed Patent that covers a Target or class of Target Agonists, in relation to which this Agreement has been terminated, as applicable) shall terminate.  Notwithstanding any provision herein to the contrary, the rights and obligations of the Parties set forth in the Preamble, clause 1 (Definitions), clause 2.5(b), clause 2.8 (Retention of Rights), clause 5 (Financial Provisions) (solely with respect to payment obligations that have accrued prior to the effective date of such expiration or termination), clause 5.10 (Record Retention&#59; Financial Audit&#59; Consolidation Reporting), clause 6 (Confidentiality), clause 7.8 (Heptares Platform IP), clause 7.9 (Ownership of Neurocrine Background IP), clause 7.10 (Ownership of Heptares Existing Compound IP), clause 7.11 (Ownership of Arising IP), clause 7.12 (Co-operation), clause 7.14 (Trademarks for Heptares Platform), clause&#160;8.1 (Term), last sentence with respect to any fully paid, irrevocable, and perpetual license, clause 8.5 (Dispute Resolution), clause 8.8 (Effect of Expiration or Termination of this Agreement) and any clauses referenced therein as continuing in effect, this clause 8.9 (Survival), clause 8.10 (Effect of Termination on Sublicenses), clause 8.11 (Termination not Sole Remedy), clause 11 (Indemnification), clause 12.1 (Assignment), clause 12.2 (Governing Law), clause 12.3 (Arbitration), clause 12.6 (No Agency), clause 12.8 (Entire Agreement&#59; Amendment), clause 12.9 (Illegality, Non-enforceability), clause 12.11 (Notices), clause 12.13 (Further Assurances), clause 12.14 (No Strict Construction), clause 12.15 (Headings) and clause 12.17 (Non-Exclusive Remedies) and shall survive the expiration or termination of this Agreement for any reason. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Effect of termination on Sublicenses</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If this Agreement terminates for any reason, any Sublicensee that is not an Affiliate of Neurocrine will, from the Termination Date, automatically and without any additional consideration become a direct licensee of Heptares with respect to the rights sublicensed to the Sublicensee by Neurocrine under this Agreement&#59; so long as (a) such Sublicensee is not in breach of its sublicense agreement, (b) such Sublicensee agrees in writing to comply with all of the terms of this Agreement to the extent applicable to the rights originally sublicensed to it by Neurocrine, and (c) such Sublicensee agrees to pay directly to Heptares such Sublicensee&#8217;s payments under this Agreement to the extent applicable to the rights sublicensed to it by Neurocrine.  The foregoing shall not apply if a Sublicensee provides written notice to Heptares that it does not wish to receive and retain the rights afforded to it pursuant to this clause 8.10.  At Neurocrine&#8217;s request, Heptares will enter into a standby license with any Sublicensee confirming the benefits conferred on such Sublicensee by this clause 8.10.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Termination Not Sole Remedy</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Termination is not the sole remedy under this Agreement and, whether or not termination is effected, all other remedies at equity or law shall remain available to the Parties.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Right to Offset</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine will have the right to offset any damages awarded to Neurocrine on account of a breach of this Agreement by Heptares against any payments owed by Neurocrine to Heptares under this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Right to Terminate in Relation to HSR</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Either Party may terminate this Agreement by notice in writing to the other Party if the expiration or termination of any applicable waiting period under the HSR Act with respect to this Agreement has not been satisfied (or if permitted by applicable Law, waived) on or before one hundred and twenty (120) days following the Execution Date (the &#8220;Outside Date&#8221;).</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If a Party terminates this Agreement pursuant to this clause 8.13, then this Agreement shall be of no further force or effect, except that the rights and obligations of the Parties set forth in clauses 6 and 12.12 and this clause 8.13, and any relevant definitions in clause 1 (Definitions), shall survive such termination of this Agreement.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:29.89pt">REPRESENTATIONS, WARRANTIES AND COVENANTS  </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Mutual Representations</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of the Execution Date, each of Heptares and Neurocrine represents, warrants and, as applicable, covenants to the other Party that&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">such Party is an entity duly organized, validly existing and in good standing under the Laws of the state or country (as applicable) of its organization, is qualified to do business and is in good standing as a foreign entity in each jurisdiction in which the conduct of its business or the ownership of its properties requires such qualification and failure to have such would prevent it from performing its obligations under this Agreement, and has full power and authority to enter into this Agreement and to carry out the provisions hereof&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">such Party is duly authorized, by all requisite action, to execute and deliver this Agreement and the effective delivery and performance of this Agreement by such Party does not require any shareholder action or approval, and the person executing this Agreement on behalf of such Party is duly authorized to do so by all requisite action&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">except pursuant to clause 12.12, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any Governmental Authority is required on the part of such Party in connection with the valid effective delivery and performance of this Agreement by it&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">such Party (i) has not employed (and, to its knowledge, has not used a contractor or consultant that has employed) and (ii) in the future shall not employ (or, to its Knowledge, use any contractor or consultant that employs) any person debarred by the FDA or subject to a similar sanction of EMA or foreign equivalent, or any person which is the subject of an FDA debarment investigation or proceeding (or similar proceeding of EMA or foreign equivalent), for the conduct of its activities under this Agreement&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">this Agreement is a legal and valid obligation binding upon such Party and enforceable in accordance with its terms except as enforceability may be limited by (i) bankruptcy, insolvency, reorganization, moratorium or similar Laws affecting the enforcement of creditors&#8217; rights&#59; and (ii) equitable principles of general applicability&#59; and</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">the delivery and performance by it of this Agreement and its compliance with the terms and provisions of this Agreement does not and shall not conflict with or result in a breach of any of the terms or provisions of (a) any other contractual or other obligations of such Party, (b) the provisions of its operating documents or bylaws, or (c) any order, writ, injunction or decree of any Governmental Authority entered against it or by which it or any of its property is bound. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares&#8217; Additional Representations, Warranties and Covenants</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares represents and warrants that as at the Execution Date&#58; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">it has full right and authority to grant the rights granted under this Agreement, and is sole owner or exclusive licensee of all Licensed Know-How (except as provided in the &#91;***&#93;), free of any encumbrance, lien or claim of ownership by any Third Party&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">all Licensed Patents in existence as of the Execution Date (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Existing Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) are (i) set forth on Schedule 2 and identified by owner, serial number, filing date, country, and status, (ii) subsisting, (iii) solely and exclusively owned by (except as indicated on Schedule 2) or, if indicated on Schedule 2, licensed to Heptares, free of any encumbrance, lien or claim of ownership by any Third Party, (iv) being diligently prosecuted in the respective patent offices, and (v) filed and maintained properly and correctly and all applicable fees have been paid on or before the due date for payment, and the claims included in any issued patents included in the Existing Patents are in full force and effect as of the Execution Date&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">Heptares does not have Knowledge of any fact or circumstance that would cause it to reasonably conclude that any of the Licensed Patents is, or will be upon issuance, invalid or </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">unenforceable&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">the inventorship of each Licensed Patent is properly identified on each granted patent and on relevant documents filed at the US Patent Office&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Heptares has disclosed to the US Patent Office in writing (i) all information that is (A) known to any individual associated with the filing or prosecution (as defined in 37 C.F.R. &#167; 1.56(c)) of the Licensed Patents and (B) material to patentability of the Licensed Patents (as defined in 37 C.F.R. &#167; 1.56(b)), or that would be considered material to patentability as defined in 37 C.F.R. &#167; 1.56(b) but for an exception under 35 U.S.C. &#167; 102(b) and (ii) and  each piece of such information has been disclosed in every relevant U.S. Licensed Patent&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">Heptares is not aware of any reference or prior art that would preclude the issuance of any claim in a Licensed Patent&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Heptares has no Knowledge of any claim, whether or not brought or asserted by any person alleging that (i) the Existing Patents are invalid or unenforceable or (ii) the conception, development, reduction to practice, disclosing, copying, making, assigning or licensing of the Existing Patents or the Exploitation of the Compounds or Licensed Products as contemplated herein, violates, infringes, constitutes misappropriation or otherwise conflicts or interferes with, or would violate, infringe or otherwise conflict or interfere with, any intellectual property rights of a Third Party&#59; or (iii) any challenges or disputes exist relating to the inventorship, ownership, scope, duration, priority or right to use any of any of the Existing Patents&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">to Heptares&#8217; Knowledge, no person is infringing or threatening to infringe or misappropriating or threatening to misappropriate the Existing Patents or Licensed Know-How&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">to Heptares&#8217; Knowledge, the Exploitation of</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Compounds in accordance with the terms of this Agreement will not infringe the intellectual property rights of any Third Party&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">to Heptares&#8217; Knowledge, Heptares and its Affiliates do not own or Control any Patent, other than the Licensed Patents, that is necessary or, to Heptares&#8217; reasonable belief as of the Execution Date, reasonably useful to carry out the Development or other Exploitation of Compounds and Licensed Products in accordance with the terms of this Agreement&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">to Heptares&#8217; Knowledge, the documents, data and information that are included in the Licensed Know-How transferred to Neurocrine pursuant to clause 2.2(a) constitute all of the Know-How owned or Controlled by Heptares that is reasonably necessary for the Development, manufacture or other Exploitation of Compounds and Licensed Products in accordance with the terms of this Agreement&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(l)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">except as set out in the &#91;***&#93; and the &#91;***&#93; Agreements, Heptares has not previously assigned, transferred, conveyed, or granted any license or other rights to its right, title and interest in any Patents or Know-How licensed hereunder, in any way that would materially conflict with or limit the scope of any of the rights or licenses granted to Neurocrine hereunder, and Heptares has to its Knowledge disclosed to Neurocrine all Know-How, Patents and regulatory materials arising under or as a result of the &#91;***&#93; and the &#91;***&#93; Agreements, including, without limitation, all &#91;***&#93; for any Compounds and Licensed Products generated by &#91;***&#93; pursuant to the &#91;***&#93;&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(m)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:20.46pt">Heptares has disclosed to Neurocrine all regulatory filings, materials and communications related to the Compounds and Licensed Products Controlled by, owned by or otherwise in the possession of Heptares or its Affiliates&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(n)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Heptares owns all Know-How generated by Third Party service providers in connection with the Development or manufacture of Compounds and Licensed Products&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(o)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Heptares has disclosed to Neurocrine a complete list of all Target Agonists identified, discovered or developed by or on behalf of Heptares or its Affiliates&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(p)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">there are no pending, and to Heptares&#8217; Knowledge, no threatened, adverse actions, suits or proceedings (including interferences, reissues, reexaminations, cancellations, oppositions, </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">nullity actions, invalidation actions or post-grant reviews) against Heptares involving the Licensed IP or any Compound or Licensed Product&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(q)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">all discovery, research, Development and manufacture of Compounds and Licensed Products by or on behalf of Heptares and its Affiliates prior to the Execution Date was conducted in accordance with all applicable Laws, including cGCP and cGMP&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(r)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:25.46pt">the materials transferred to Neurocrine under clause 4.11 will have been manufactured, stored, packaged and shipped in accordance with all applicable Laws, including cGMP, and will comply with the applicable specifications&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">neither Heptares nor its Affiliates, nor any of its or their respective directors, officers, employees or agents has (i) committed an act, (ii) made a statement or (iii) failed to act or make statement, in any case ((i), (ii) or (iii)), that (x) would be or create an untrue statement of material fact or fraudulent statement to the FDA or any other Regulatory Authority with respect to the research, Development and manufacture of any Compound or Licensed Product or (y) could reasonably be expected to provide a basis for the FDA or any other Regulatory Authority to invoke its policy respecting &#8220;Fraud, Untrue Statements of Material Facts, Bribery and Illegal Gratuities&#8221;, set forth in 56 Fed. Reg. 46191 (September 10, 1991) and any amendments thereto or any analogous laws or policies, with respect to the research, Development and manufacture of any Compound or Licensed Product&#59; and</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(t)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">Heptares has disclosed to Neurocrine all information it has Knowledge of or in its Control related to the Licensed IP, Compounds or Licensed Products that Heptares and its agents uses or has used in connection with,  and which in each case Heptares reasonably believes would be material to, the Licensed IP or the Development and Commercialization of Compounds and Licensed Products as contemplated by this Agreement, and all such information is complete and accurate&#59; and (ii)&#160;Heptares and its agents has not failed to disclose any information it has Knowledge of or in its or its Affiliate&#8217;s Control related to the Licensed IP, Compounds or Licensed Products that would cause the information actually disclosed to Neurocrine to be misleading or incomplete in any material respect.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">Heptares Covenant</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares agrees that all activities performed by Heptares in relation to the discovery, research Development and manufacture of Compounds and Licensed Products in the period between the Execution Date and the Effective Date shall be conducted in accordance with all applicable Laws, including cGCP and cGMP.  Heptares agrees, on behalf of itself and its Affiliates, not to take any action or fail to take any action in the period between the Execution Date and the Effective Date that would cause or be reasonably likely to cause any of the representations and warranties by Heptares set forth in clause&#160;9.1 or 9.2 to be untrue in any material respect if made as of the Effective Date.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:21.56pt">No Other Warranties</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as expressly set forth in this Agreement, neither Party makes any warranties or conditions, express, implied, statutory or otherwise, with respect to the subject matter of this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.33pt">ANTI-BRIBERY AND ANTI-CORRUPTION</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">Each Party agrees, on behalf of itself, its officers, directors and employees and on behalf of its Affiliates, agents, representatives, consultants and subcontractors hired in connection with the subject matter of this Agreement (together with the Party, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Party Representatives</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) that for the performance of its obligations under this Agreement&#58; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">The Party Representatives shall not directly or indirectly pay, offer or promise to pay, authorize the payment of any money or give, offer or promise to give, or authorize the giving of anything else of value, to&#58; (i) any Government Official in order to influence official action&#59; (ii) any person (whether or not a Government Official) (A) to influence such person to act in breach of a duty of good faith, impartiality or trust (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acting Improperly</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;), (B) to reward such person for Acting Improperly or (C) where such person would be acting improperly by receiving the money or other thing of value&#59; (iii) any person (whether or not a Government Official) while knowing or having reason to know that all or any portion of the money or other thing of value will be paid, </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">offered, promised or given to, or will otherwise benefit, a Government Official in order to influence official action for or against either Party in connection with the matters that are the subject of this Agreement&#59; or (iv) any person (whether or not a Government Official) to reward that person for Acting Improperly or to induce that person to Act Improperly.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">The Party Representatives shall not, directly or indirectly, solicit, receive or agree to accept any payment of money or anything else of value in violation of the Anti-Corruption Laws.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">The Party Representatives shall comply with the Anti-Corruption Laws and shall not take any action that will, or would reasonably be expected to, cause the other Party or its Affiliates to be in violation of any such laws or policies.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">Each Party represents and warrants to the other that as of the Effective Date, such Party and its Party Representatives have not taken any action that if conducted after the Effective Date would violate clauses 10.1 through 10.3&#59;</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">Each Party shall promptly provide the other with written notice upon becoming aware of any breach or violation by a Party or other Party Representative of any representation, warranty or undertaking set forth in clauses 10.1 through 10.4 above.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.33pt">INDEMNIFICATION</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Heptares</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heptares shall defend, indemnify and hold Neurocrine, its Affiliates and its and their respective directors, officers, employees and agents, at Heptares&#8217; cost and expense, harmless from and against any and all losses, costs, damages, liabilities, fees or expenses (including reasonable attorneys&#8217; fees and expenses) (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Losses</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) incurred in connection with or arising out of any Third Party claims, suits, investigations or demands (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Third Party Claim</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;)&#58;  </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">arising out of or in connection with the exercise of the Heptares Retained Rights&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">resulting from the Exploitation of any Reversion Product&#59;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">arising out of or in connection with any breach by Heptares of this Agreement, including the warranties or covenants contained in clause&#160;2.10, clause 9 or clause 10 herein&#59; or</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">arising out of or in connection with any negligence or wilful misconduct of Heptares or its Affiliates or of its or their respective directors, officers, employees or agents in the exercise of any of Heptares&#8217; rights or the performance of any of its obligations under this Agreement,</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in each case except to the extent that such Losses are subject to indemnification by Neurocrine pursuant to clause 11.2 below (or would be subject to indemnification if the claim were made against Heptares). </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Neurocrine</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine shall defend, indemnify and hold Heptares, its Affiliates and its and their respective directors, officers, employees and agents, at Neurocrine&#8217;s cost and expense, harmless from and against any and all Losses incurred in connection with or arising out of any Third Party Claims&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">resulting from (i) the conduct of the activities by or on behalf of the Parties or their Affiliates under each Research and Development Program (excluding breach, negligence or wilful misconduct of Heptares or its Affiliates in conducting activities under any Research and Development Program) and (ii) the Exploitation of Licensed Products by Neurocrine, its Affiliates or Sublicensees during the Term&#59; </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">arising out of or in connection with any breach by Neurocrine of this Agreement, including the </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">warranties or covenants contained in clauses&#160;9.1 and 10 herein&#59; or </font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">arising out of or in connection with any negligence or wilful misconduct of Neurocrine or its Affiliates or of its or their respective directors, officers, employees or agents in the exercise of any of its rights or the performance of any of its obligations under this Agreement,</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in each case except to the extent that such Losses are subject to indemnification by Heptares pursuant to clause 11.1 above (or would be subject to indemnification if the claim were made against Neurocrine). </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Notice of Claim</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All indemnification claims in respect of any person seeking indemnification under clause 11.1 or 11.2 (collectively, the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnitees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; and each an &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnitee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) shall be made by the corresponding Party (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnified Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  The Indemnified Party shall give the indemnifying Party (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnifying Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) prompt written notice (an &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnification Claim Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;) of any Losses or the discovery of any fact upon which such Indemnified Party intends to base a request for indemnification under clause 11.1 or 11.2, but in no event shall the Indemnifying Party be liable for any Losses that result from any delay by the Indemnified Party in providing such notice.  Each Indemnification Claim Notice must contain a description of the claim and the nature and amount of such Loss (to the extent that the nature and amount of such Loss are known at such time).  Together with the Indemnification Claim Notice, the Indemnified Party shall furnish promptly to the Indemnifying Party copies of all notices and documents (including court papers) received by any Indemnitee in connection with the Third Party Claim.  The Indemnifying Party shall not be obligated to indemnify the Indemnified Party to the extent any admission or statement made by the Indemnified Party materially prejudices the defence of such Third Party Claim.  Where required the Indemnifying Party shall promptly send a copy of the Indemnification Claim Notice to its relevant insurers and shall permit them to exercise their rights of subrogation and hereafter in this clause 11. &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Indemnifying Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34; shall be deemed to include any such insurers.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">The obligations of an Indemnifying Party under this clause 11 shall be governed by and contingent upon the following&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">at its option, the Indemnifying Party may assume control of the defence of any Third Party Claim (which, for the avoidance of doubt, shall include the conduct of all dealings with such Third Party) by giving written notice to the Indemnified Party within &#91;***&#93; days after the Indemnifying Party&#8217;s receipt of an Indemnification Claim Notice.  The assumption of control of the defence of a Third Party Claim by the Indemnifying Party shall not be construed as an acknowledgement that the Indemnifying Party is liable to indemnify any Indemnitee in respect of the Third Party Claim, nor shall it constitute a waiver by the Indemnifying Party of any defences it may assert against any Indemnified Party&#8217;s claim for indemnification.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">upon the assumption of the control of the defence of a Third Party Claim by the Indemnifying Party&#58;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.57pt">subject to the provisions of clause 11.4(c), it shall have the right to and shall assume sole control and responsibility for dealing with the Third Party and the Third Party Claim, including the right to settle the claim on any terms the Indemnifying Party chooses, but at all times in accordance with the provisions of clauses 11.4(c) and 11.4(d)&#59;</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:24.35pt">if it chooses, the Indemnifying Party may appoint as counsel in the defence of the Third Party Claim any law firm or counsel selected by the Indemnifying Party&#59; and</font></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:22.13pt">except as expressly provided in clause 11.4(c), the Indemnifying Party shall not be liable to the Indemnified Party for any legal expenses subsequently incurred by such Indemnified Party or any Indemnitee in connection with the analysis, defence, or settlement of the Third Party Claim.  In the event that it is ultimately determined that the Indemnifying Party is not obligated to indemnify, defend or hold harmless an Indemnitee from and against the Third Party Claim, the Indemnified Party shall reimburse the Indemnifying Party for any and all costs and expenses (including lawyers&#8217; fees and costs of suit) and any Losses incurred by the Indemnifying Party in its defence of the Third Party Claim with respect to such Indemnified Party or </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:106.35pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnitee.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.79pt">without limiting the remainder of this clause 11.4, any Indemnitee shall be entitled to participate in, but not control, the defence of a Third Party Claim by having its views regularly solicited by the Indemnifying Party and, where proceedings are commenced, to retain counsel of its choice for such purpose&#59; provided that such retention shall be at the Indemnitee&#8217;s own expense unless (i) the Indemnifying Party has failed to assume the defence and retain counsel in accordance with clause 11.4(a) and 11.4(b)(ii) (in which case the Indemnified Party shall control the defence), (ii) the interests of the Indemnitee and the Indemnifying Party with respect to such Third Party Claim are sufficiently adverse to prohibit the representation by the same counsel of both Parties under any legal requirement, ethical rules or equitable principles or (iii) the employment thereof has been specifically authorised in writing by the Indemnifying Party.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">with respect to any Losses relating solely to the payment of money to the Third Party to settle the Third Party Claim and that will not result in the Indemnified Party or the Indemnitee becoming subject to injunctive relief, and as to which the Indemnifying Party shall have acknowledged in writing the obligation to indemnify the Indemnitee under clause 11.4(a), the Indemnifying Party shall have sole authority to consent to the entry of any judgment, enter into any settlement or otherwise dispose of such Losses, without the prior written consent of the Indemnified Party.  With respect to all other Losses or where the Indemnified Party will be subject to injunctive relief, where the Indemnifying Party has assumed the defence of a Third Party Claim in accordance with clause 11.4(a), the Indemnifying Party must not consent to the entry of any judgment, enter into any settlement or otherwise dispose of such Losses, unless it obtains the prior written consent of the Indemnified Party (which consent shall not be unreasonably withheld or delayed).</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">if the Indemnifying Party chooses not to take control of the defence or prosecute any Third Party Claim, the Indemnified Party shall retain control of the defence thereof, but no Indemnified Party or Indemnitee shall admit any liability with respect to, or settle, compromise or discharge, any such Third Party Claim without the prior written consent of the Indemnifying Party, which consent shall not be unreasonably withheld or delayed.  The Indemnifying Party shall not be liable for any settlement or other disposition of Losses by an Indemnified Party or an Indemnitee under such a Third Party Claim that is reached without the written consent of the Indemnifying Party which consent will not be unreasonably withheld or delayed.</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:26.02pt">if the Indemnifying Party chooses to control the defence of any Third Party Claim, the Indemnified Party shall, and shall cause each other Indemnitee to, reasonably cooperate in the defence thereof and shall furnish such records, information and testimony, provide such witnesses and attend such conferences, discovery proceedings, hearings, trials and appeals as may be reasonably requested in connection therewith.  Such cooperation shall include access during normal business hours by the Indemnifying Party to, and reasonable retention by the Indemnified Party of, records and information that are reasonably relevant to such Third Party Claim, and making the Indemnified Party, the Indemnitees and its and their employees and agents available on a mutually convenient basis to provide additional information and explanation of any records or information provided, and the Indemnifying Party shall reimburse the Indemnified Party for all of its related reasonable out-of-pocket expenses.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">Except as expressly provided above, the reasonable and verifiable costs and expenses, including fees and disbursements of counsel, incurred by the Indemnified Party where it participates in the defence under clause 11.4(c) shall be reimbursed on a quarterly basis by the Indemnifying Party, without prejudice to the Indemnifying Party&#8217;s right to contest the Indemnified Party&#8217;s right to indemnification and subject to refund in the event the Indemnifying Party is ultimately held not to be obligated to indemnify the Indemnified Party.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Insurance</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each Party shall have and maintain, at its sole cost and expense, an adequate liability insurance or self-insurance program (including product liability insurance) to protect against potential liabilities and risk arising out of activities to be performed under this Agreement and upon such terms (including coverages, deductible limits and self-insured retentions) as are customary in the pharmaceutical industry generally for the activities to be conducted by such Party under this Agreement.  Such liability insurance or self-insurance program shall insure against all types of liability, including personal injury, physical injury or property damage arising out of such Party&#8217;s activities hereunder.  This clause 11.6 shall not create any limitation on the Parties&#8217; liability under this Agreement.  Such insurance information shall be kept in confidence in the same manner as any other Confidential Information </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed by the Parties hereunder.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Consequential Damages</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In no event shall either Party or any of its Affiliates or Sublicensees or licensees be liable for special, indirect, incidental, punitive, treble or consequential damages or indirect lost profits, whether based on contract, tort or any other legal theory&#59; provided, however, that this limitation shall not limit (a) the indemnification obligation of such Party in respect of amounts actually awarded against an Indemnified Party as a part of a Third Party Claim under the provisions of this clause 11 and (b) a Party&#8217;s liability for breach of its obligations under clause&#160;6.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:16pt">Nothing in this Agreement shall exclude or limit a Party&#8217;s liability for death or personal injury caused by its negligence or for fraud.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:24.33pt">MISCELLANEOUS</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Assignment</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement, or any of the rights and obligations under this Agreement, may not be assigned or otherwise transferred by either Party without the prior written consent of the other Party&#59; provided, however, that either Party may assign this Agreement, or any of the rights and obligations under this Agreement, without the consent of the other Party (a) to any of its Affiliates, if the assigning Party guarantees the full performance of its Affiliates&#8217; obligations hereunder, or (b) to any person acquiring all or substantially all of its assets or business to which this Agreement relates, whether by merger, acquisition, sale of assets or otherwise.  In all cases, the assigning Party shall provide the other Party with prompt written notice of any such assignment and the permitted assignee shall assume the obligations of the assigning Party hereunder in writing.  No assignment of this Agreement shall act as a novation or release of either Party from responsibility for the performance of any accrued obligations. This Agreement shall be binding upon successors and permitted assigns of the Parties.  Any assignment not in accordance with this clause&#160;12.1 will be null and void.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Governing Law</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement and any dispute or claim arising out of or in connection with it (whether contractual or non-contractual in nature such as claims in tort, from breach of statute or regulation or otherwise) shall be governed by and construed in accordance with the laws of England, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction&#59; provided that any dispute with respect to infringement, validity, or enforceability of any Patent,  shall be governed by and construed and enforced in accordance with the laws of the jurisdiction in which such Patent is issued or published. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Arbitration</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to clause 8.5, any dispute or claim arising out of or in connection with this Agreement, including any question regarding its existence, validity or termination shall be referred to and finally resolved by arbitration under the Rules of Arbitration of the International Chamber of Commerce which only are deemed incorporated into this clause 12.3.  The seat, or legal place, of arbitration shall be London.  The language to be used in the arbitration procedures shall be English.  The arbitration proceedings including any outcome shall be confidential except (i) to the extent that disclosure may be required of a Party to fulfill a legal duty, protect or pursue a legal right, or enforce or challenge an award in bona fide legal proceedings before a state court or other judicial authority, (ii) with the consent of all Parties, (iii) where needed for the preparation or presentation of a claim or defense in this arbitration, (iv) where such information is already in the public domain other than as a result of a breach of this clause, or (v) by order of the arbitral tribunal upon application of a Party.  Nothing in this clause 12.3 will preclude either Party from seeking equitable interim or provisional relief from a court of competent jurisdiction including a temporary restraining order, preliminary injunction or other interim equitable relief, concerning a dispute either prior to or during any arbitration if necessary to protect the interests of such Party or to preserve the status quo pending the arbitration proceeding.  The number of arbitrators shall be three (3) of which each Party shall appoint one (1), the arbitrators so appointed will select the third and final arbitrator.  The arbitrators shall have experience of pharmaceutical licensing disputes.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Force Majeure</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neither Party shall be liable to the other for any failure or delay in the fulfilment of its obligations under this Agreement (other than the payment of monies due and owing to a Party under this Agreement), when any such failure or delay is caused by fire, flood, earthquakes, explosions, sabotage, terrorism, pandemics, epidemics, civil commotions, riots, invasions, wars, peril of the sea or requirements of Governmental Authorities (each, a &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Force Majeure Event</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#34;).  In the event that either Party is prevented from discharging its obligations under this Agreement on account of a Force Majeure Event, the performing Party shall notify the other Party forthwith, and shall nevertheless make every endeavour, in the utmost good faith, to discharge its obligations, even if in a partial or compromised manner.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Expenses</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except as otherwise expressly provided herein or mutually agreed, all costs and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be borne by the Party incurring such costs and expenses.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">No Agency</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nothing herein contained shall be deemed to create an agency, joint venture, amalgamation, partnership or similar relationship between Heptares and Neurocrine.  Notwithstanding any of the provisions of this Agreement, neither Party shall at any time enter into, incur, or hold itself out to Third Parties as having authority to enter into or incur, on behalf of the other Party, any commitment, expense, or liability whatsoever, and all contracts, expenses and liabilities undertaken or incurred by one Party in connection with or relating to the Development of Compound or the Exploitation of Licensed Product shall be undertaken, incurred or paid exclusively by that Party, and not as an agent or representative of the other Party.  All persons employed by a Party will be the employees of such Party and not of the other Party and all costs and obligations incurred by reason of any such employment shall be for the account and expense of such first Party.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">No Third Party Beneficiaries</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Except for any rights and immunities granted in this Agreement to any Affiliates, the Contracts (Rights of Third Parties) Act 1999 shall not apply to this Agreement.  No person who is not a party to this Agreement (including any employee, officer, agent, representative or subcontractor of either Party) shall have the right (whether under the Contracts (Rights of Third Parties) Act 1999 or otherwise) to enforce any provision of this Agreement which expressly or by implication confers a benefit on that person without the express prior agreement in writing of the Parties, which agreement must refer to this clause 12.7. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Entire Agreement&#59; Amendment</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement (including all schedules and exhibits hereto) sets forth and constitutes the entire agreement and understanding between the Parties with respect to the subject matter hereof and supersedes all prior agreements or understandings, promises, misrepresentations and representations, whether oral or written, with respect to such matters, including the CDAs, which are hereby terminated in their entirety.  Each Party confirms that it is not relying on any representations, misrepresentations or warranties of the other Party except as specifically set forth in this Agreement.  This Agreement may be amended or modified only by a writing signed by both Parties.  No release or discharge shall be binding upon the Parties unless in a writing signed by both Parties. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:16pt">Illegality&#59; Non-Enforceability</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If the whole or any part of this Agreement is or becomes or is declared illegal, invalid or unenforceable in any jurisdiction for any reason (including both by reason of the provisions of any legislation and also by reason of any decision of any court or Governmental Authority which either has jurisdiction over this Agreement or has jurisdiction over any of the Parties)&#58;</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">in the case of the illegality, invalidity or un-enforceability of the whole of this Agreement, it shall terminate in relation to the jurisdiction in question&#59; or</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">in the case of the illegality, invalidity or un-enforceability of part of this Agreement, that part shall be severed from this Agreement in the jurisdiction in question and that illegality, invalidity or un-enforceability shall not in any way whatsoever prejudice or affect the remaining parts of this Agreement which shall continue in full force and effect provided that the said remaining parts continue to satisfy the commercial intentions of the Parties and provided that the remaining parts do constitute a substantial part of this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Extension&#59; Waiver</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At any time, either Heptares or Neurocrine may (a) with respect to obligations owed to it or the performance of other acts for its benefit, extend the time for the performance of such obligations or such other acts to be performed hereunder by the other, (b) waive any inaccuracies in the representations and warranties of the other contained herein or in any document delivered pursuant hereto, (c) waive compliance with any of the conditions to the obligations of the other contained herein and (d) waive the benefit of any other right hereunder, the other Party&#8217;s failure to perform, or a breach by the other Party of, its obligations under this Agreement.  Any agreement on the part of either Party to any such extension or waiver shall be valid only if set forth in an instrument executed by such Party.  No such waiver shall be operative as a waiver of any other right hereunder or of any breach or failure by the other Party whether of a similar nature or otherwise.  The failure of any Party to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Notices</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All communications, including notices, requests, demands, waivers, consents or approvals, required to be made under this Agreement shall be effective upon receipt, and shall be sent to the addresses set out below, or to such other addresses as may be designated by one Party to the other by notice pursuant hereto, by (a) internationally recognized overnight courier&#59; (b) prepaid registered or certified mail, return receipt requested&#59; or (c) an electronic copy of such communication to be sent by email as follows&#58; </font></div><div style="margin-bottom:18pt;padding-left:180.2pt;text-indent:-144.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Heptares, as follows&#58; &#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="margin-bottom:18pt;padding-left:180.2pt;text-indent:-144.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58; &#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="padding-left:35.3pt;text-align:justify"><font><br></font></div><div style="padding-left:35.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If to Neurocrine, as follows&#58; &#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="padding-left:35.3pt;text-align:justify"><font><br></font></div><div style="padding-left:35.3pt;text-align:justify"><font><br></font></div><div style="padding-left:35.3pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">With a copy to&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#91;***&#93;</font></div><div style="padding-left:35.3pt;text-align:justify"><font><br></font></div><div style="padding-left:35.3pt;text-align:justify"><font><br></font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This clause 12.11 is not intended to govern the day-to-day business communications necessary between the Parties in performing their obligations under the terms of this Agreement, which may be made by any means mutually agreeable to the Parties. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">HSR Act</font></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">Heptares and Neurocrine shall as soon as reasonably practicable, but in any event within &#91;***&#93; Business Days after the Execution Date, file a Notification and Report Form (an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HSR Filing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8221;) pursuant to the HSR Act and each Party shall use commercially reasonable efforts to obtain early termination or expiration of the waiting period under the HSR Act, including by requesting early termination of the HSR waiting period.  In connection with obtaining any necessary approvals under the HSR Act, each Party shall promptly and in good faith respond to any request for additional information by the U.S. Federal Trade Commission and U.S. Department of Justice in connection with such notification and otherwise cooperate in good faith with each other and such Governmental Authority, provided that no Party shall have any obligation to (i) litigate any action or claim filed by a Governmental Authority in state or federal court alleging violation of any antitrust or other laws, (ii) sell, divest, hold separate or license any of their assets or lines of business, or (iii) change or modify any course of conduct or otherwise make any commitments to any Governmental Authority regarding future operations of Neurocrine&#8217;s or Heptares&#8217; business.  For the avoidance of doubt, Neurocrine shall be responsible for paying any filing fees required in connection with such HSR Act filing. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;padding-left:70.9pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:23.23pt">For any HSR Filings required, neither Neurocrine nor Heptares shall, and each shall use reasonable best efforts to cause their respective Affiliates not to, directly or indirectly take any action, including, directly or indirectly, acquiring or investing in any person or acquiring, leasing or licensing any assets, or agreement to do any of the foregoing, if doing so would reasonably be expected to impose any material delay in the obtaining of, or significantly increase the risk of not obtaining, any required approval under the HSR Act. Neurocrine and Heptares will promptly provide the other with copies of all substantive written communications (and memoranda setting forth the substance of all substantive oral communications) between each of them, any of their subsidiaries and their respective agents, representatives and advisors, on the one hand, and any Governmental Authority, on the other hand, with respect to this Agreement. Without limiting the foregoing, Neurocrine and Heptares shall&#58; (i) promptly inform the other of any communication to or from the U.S. Federal Trade Commission or the U.S. Department of Justice regarding the Agreement&#59; (ii) permit each other to review in advance any proposed substantive written communication to any such Governmental Authority and incorporate reasonable comments thereto&#59; (iii) give the other prompt written notice of the commencement of any legal proceeding with respect to the Agreement&#59; (iv) not agree to participate in any substantive meeting or discussion with any such Governmental Authority in respect of any filing, investigation or inquiry concerning this Agreement unless, to the extent reasonably practicable, it consults with the other Party in advance and, to the extent permitted by such Governmental Authority, gives the other Party the opportunity to attend&#59; (v) keep the other reasonably informed as to the status of any such legal proceeding&#59; and (vi) promptly furnish each other with copies of all correspondence, filings (except for filings made under the HSR Act) and written communications between such Party and their Affiliates and their respective agents, representatives and advisors, on one hand, and any such Governmental Authority, on the other hand, in each case, with respect to this Agreement&#59; provided that materials required to be supplied pursuant to this clause may be redacted (1) to remove references concerning valuation, (2) as necessary to comply with contractual arrangements, (3) as necessary to comply with applicable Law, and (4) as necessary to address reasonable privilege or confidentiality concerns&#59; provided further, that a Party may reasonably designate any competitively sensitive material provided to another party under this clause as &#8220;Outside Counsel Only&#8221;.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Further Assurances</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Each Party shall perform, or caused to be performed, all further acts and things and execute and deliver such further documents as may be necessary or as the other Party may reasonably require to implement or give effect to this Agreement.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">No Strict Construction</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement shall be construed as if it were drafted jointly by the Parties.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Headings</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The headings herein are for convenience purposes only and shall not be used to interpret any of the provisions hereof.</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Counterparts</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">This Agreement may be executed in any number of counterparts, each of which shall be deemed an original and all of which taken together shall be deemed to constitute one and the same instrument.  This Agreement may be executed electronically.  An executed signature page of this Agreement delivered by PDF format via email shall be as effective as an original executed signature page. </font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify;text-indent:-35.45pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;padding-left:10.44pt">Non-Exclusive Remedies</font></div><div style="margin-bottom:18pt;padding-left:35.45pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The remedies set forth in this Agreement shall be in addition to, and shall not be to the exclusion of, any other remedies available to the Parties at Law, in equity or under this Agreement.</font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">, this Agreement has been signed by the duly authorized representatives of the Parties on the day and year first before written.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNED by&#160;Chris Cargill&#160;&#160;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for and on behalf of<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HEPTARES THERAPEUTICS LIMITED</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </font></div><div style="margin-bottom:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Chris Cargill</font></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SIGNED by Kyle Gano&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">for and on behalf of <br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NEUROCRINE BIOSCIENCES, INC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.      </font></div><div style="margin-bottom:18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Kyle Gano</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</font></div></div></div><div id="i5fd101b39b3a41d9b25dcd8e45d99cc1_10"></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SCHEDULE 3</font></div><div style="margin-bottom:18pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Press Release</font></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;53</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;54</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_2a.jpg" src="image_2a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;55</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_3a.jpg" src="image_3a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;56</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_4a.jpg" src="image_4a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;57</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_5a.jpg" src="image_5a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;58</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_6a.jpg" src="image_6a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="margin-bottom:18pt;text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;59</font></div></div></div><hr style="page-break-after:always"><div style="min-height:71.28pt;width:100%"><div style="margin-bottom:18pt;text-align:center"><font><br></font></div></div><div style="margin-bottom:18pt;text-align:justify"><img alt="image_7a.jpg" src="image_7a.jpg" style="height:856px;margin-bottom:5pt;vertical-align:text-bottom;width:605px"></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;60</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>4
<FILENAME>nbix-20211231exhibit1017.htm
<DESCRIPTION>EX-10.17
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3f2c3c8deaac47a3ab4d21eaab39f171_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.17</font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Option Grant Notice</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) has granted to you (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) an option to purchase the number of shares of Common Stock set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The Option is subject to all of the terms and conditions set forth in this Option Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Option Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and the Plan, all of which are available by logging into your E*TRADE account and which are incorporated herein in their entirety.  Capitalized terms not explicitly defined in this Grant Notice but defined in the Agreement or the Plan will have the meanings set forth in the Agreement or the Plan, as applicable.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Grant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting Commencement Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of Shares of Common Stock&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercise Price (Per Share)&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Exercise Price&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expiration Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Type of Grant&#58;            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You have been granted an Incentive Stock Option.  However, due to the $100,000 Rule (as described below), the Option (or a certain portion thereof) may be treated as a Nonstatutory Stock Option.  Please log into your E*TRADE account to see the exact details of your grant.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      Subject to Section 2 of the Agreement, the Option will vest as follows&#58; &#91;________&#93;.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exercise Schedule&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    Same as Vesting Schedule</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant Acknowledgements&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By your electronic acceptance of the Option via your E*TRADE account, you understand and agree that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Option is governed by this Grant Notice, the Agreement and the Plan, all of which are made a part of this document.  Unless otherwise provided in the Plan, this Grant Notice and the Agreement may not be modified, amended or revised except in a writing signed by you and a duly authorized officer of the Company.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If the Option is an Incentive Stock Option, it (plus other outstanding Incentive Stock Options granted to you) cannot be first </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">exercisable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for more than $100,000 in value (measured by exercise price) in any calendar year.  Any excess over $100,000 is a Nonstatutory Stock Option.  For purposes of this Grant Notice, such rule is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">$100,000 Rule</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Copies of this Grant Notice, the Agreement, the Plan and the Prospectus are available via your E*TRADE account and may be viewed and printed by you.  You consent to receive this Grant Notice, the Agreement, the Plan, the Prospectus and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">You have read and are familiar with the provisions of this Grant Notice, the Agreement, the Plan and the Prospectus.  In the event of any conflict between the provisions in this Grant Notice, the Agreement or the Prospectus and the provisions of the Plan, the provisions of the Plan will control.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of the Date of Grant, this Grant Notice, the Agreement and the Plan set forth the entire understanding between you and the Company regarding the Option and supersede all prior oral and written agreements, promises and&#47;or representations regarding the Option, with the exception of any written employment, offer letter, severance or other agreement, or any written severance plan or policy, in each case that specifies the terms that should govern the Option.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Option Agreement</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the accompanying Option Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Option Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Neurocrine Biosciences, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) has granted you an option under the Neurocrine Biosciences, Inc. 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to purchase the number of shares of Common Stock set forth in the Grant Notice at the exercise price set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  Capitalized terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan will have the meanings set forth in the Grant Notice or the Plan, as applicable.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general terms and conditions applicable to your Option are as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Governing Plan Document.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Your Option is subject to all the provisions of the Plan, including but not limited to the provisions in&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Section 6 of the Plan regarding the impact of a Capitalization Adjustment, dissolution, liquidation, or Transaction on your Option&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">Section 9(f) of the Plan regarding the Company&#8217;s and any Affiliate&#8217;s (if applicable) retained rights to terminate your Continuous Service notwithstanding the grant of your Option&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Section 8(c) of the Plan regarding the tax consequences of your Option.  </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your Option is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan.  In the event of any conflict between the provisions in this Agreement or the Grant Notice and the provisions of the Plan, the provisions of the Plan will control.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Vesting.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Subject to the limitations contained in this Agreement, your Option will vest in accordance with the vesting schedule set forth in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service, except as otherwise explicitly provided in the Plan (in connection with a Transaction or certain terminations of Continuous Service following such Transaction) or this Agreement.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">If you are an Employee or Director, in each case as of the date of termination of your Continuous Service, then in the event of a termination of your Continuous Service due to your death or Disability, your Option will become vested, as of the date of such termination, in accordance with the vesting schedule set forth in the Grant Notice as if you had provided an additional six months of Continuous Service as of the date of such termination.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">If you are an Employee as of the date of termination of your Continuous Service, then in the event of a termination of your Continuous Service due to your Retirement, your Option will become fully vested as of the date of such Retirement.  For purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of your Continuous Service upon or after you have reached age 60 with at least 5 years of Continuous Service, provided that you comply with any other requirements in the Company&#8217;s then-current policy regarding Retirement.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">If you are a Director as of the date of a Transaction, then in the event of a Transaction during your Continuous Service, your Option will become fully vested as of the date of such Transaction.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Exercise.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">You may generally exercise the vested portion of your Option (and the unvested portion of your Option if permitted by the Grant Notice) for whole shares of Common Stock at any time during its term by delivery of payment of the exercise price and any Withholding Obligation, as set forth in Section 6, and other required documentation to the Plan Administrator in accordance with the exercise procedures established by the Plan Administrator, which may include an electronic submission.  Please review Sections 4(i), 4(j) and 7(b)(v) of the Plan, which may restrict or prohibit your ability to exercise your Option during certain periods.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">To the extent permitted by Applicable Law, you may pay the exercise price of your Option by cash or check or as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">pursuant to a &#8220;cashless exercise&#8221; program, as provided in Section 4(c)(ii) of the Plan, if at the time of exercise the Common Stock is publicly traded&#59;</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">by delivery of already owned shares of Common Stock, as provided in Section 4(c)(iii) of the Plan, if at the time of exercise the Common Stock is publicly traded&#59; or</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">subject to approval by the Company and&#47;or the Committee, as applicable, at or prior to the time of exercise, if your Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement, as provided in Section 4(c)(iv) of the Plan.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Term.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  You may not exercise your Option before the commencement of its term or after its term expires.  The term of your Option commences on the Date of Grant and expires upon the earliest of the following&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">immediately upon the termination of your Continuous Service for Cause&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">if you are an Employee as of the date of termination of your Continuous Service, then three months after the termination of your Continuous Service for any reason other than Cause, Disability, death or Retirement&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if you are a Director as of the date of termination of your Continuous Service, then three years after the termination of your Continuous Service for any reason other than Cause&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">if you are a Consultant as of the date of termination of your Continuous Service, then 30 days after the termination of your Continuous Service for any reason other than Cause&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">e.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if you are an Employee as of the date of termination of your Continuous Service, then 12 months after the termination of your Continuous Service due to your Disability&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">f.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">if you are an Employee as of the date of termination of your Continuous Service, then 18 months after your death if you die during your Continuous Service&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">if you are an Employee as of the date of termination of your Continuous Service, then 12 months after the termination of your Continuous Service due to your Retirement&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">h.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">immediately upon a Transaction if the Board has determined that your Option will terminate in connection with such Transaction&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.73pt">the Expiration Date set forth in the Grant Notice&#59; or</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">j.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:12.17pt">the day before the 10th anniversary of the Date of Grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you are an Employee as of the date of termination of your Continuous Service, then notwithstanding the foregoing, if you die during the period provided in Section 4(b) above, the term of your Option will not expire until the earlier of (i) 18 months after the termination of your Continuous Service, (ii) a Transaction if the Board has determined that your Option will terminate in connection with such Transaction, (iii) the Expiration Date set forth in the Grant Notice, or (iv) the day before the 10th anniversary of the Date of Grant.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Post-Termination Exercise Period of your Option may be extended as provided in Section 4(i) of the Plan.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To obtain the federal income tax advantages associated with an Incentive Stock Option, the Code requires that at all times beginning on the date of grant of your Option and ending on the day three months before the date of your Option&#8217;s exercise, you must be an employee of the Company or an Affiliate, except in the event of your death or Disability.  If the Company provides for the extended exercisability of your Option under certain circumstances for your benefit, your Option will not necessarily be treated as an Incentive Stock Option if you exercise your Option more than three months after the date your employment terminates.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Transferability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Except as otherwise provided in Section 4(e) of the Plan, your Option is not transferable, except by will or by the applicable laws of descent and distribution, and is exercisable during your life only by you.  Notwithstanding the foregoing, by delivering written notice to the Company, in a form satisfactory </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Company, you may designate a third party who, in the event of your death, will thereafter be entitled to exercise your Option.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Withholding Obligations.  </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">As provided in Section 8 of the Plan, at the time you exercise your Option, in whole or in part, or at any time thereafter as requested by the Company, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for (including by means of a &#8220;cashless exercise&#8221; pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board to the extent permitted by the Company), any sums required to satisfy the federal, state, local and foreign tax withholding obligations, if any, which arise in connection with your Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in accordance with the withholding procedures established by the Company.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">Upon your request and subject to approval by the Company and&#47;or the Committee, as applicable, and in compliance with any applicable legal conditions or restrictions, the Company may withhold from fully vested shares of Common Stock otherwise issuable to you upon exercise of your Option a number of whole shares of Common Stock with a Fair Market Value on the date of exercise not in excess of the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of your Option as a liability for financial accounting purposes).</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">You may not exercise your Option unless the Withholding Obligation is satisfied.  Accordingly, you may not be able to exercise your Option even though your Option is vested, and the Company will have no obligation to issue any shares of Common Stock subject to your Option, unless and until the Withholding Obligation is satisfied.  In the event that the amount of the Withholding Obligation was greater than the amount actually withheld by the Company (or an Affiliate, if applicable), you agree to indemnify and hold the Company (and Affiliate, if applicable) harmless from any failure to withhold the proper amount.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Incentive Stock Option Disposition Requirement.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If your Option is an Incentive Stock Option, you must notify the Company in writing within 15 days after the date of any disposition of any of the shares of Common Stock issued upon exercise of your Option that occurs within two years after the date of grant of your Option or within one year after such shares of Common Stock are transferred upon exercise of your Option.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Transaction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Your Option is subject to the terms of any agreement governing a Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">No Liability for Taxes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  As a condition to accepting your Option, you hereby (a) agree to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your Option or other Company compensation and (b) acknowledge that you were advised to consult with your own personal tax, financial and other legal advisors regarding the tax consequences of your Option and have either done so or knowingly and voluntarily declined to do so.  Additionally, you acknowledge that your Option is exempt from Section 409A only if the exercise price of your Option is at least equal to the &#8220;fair market value&#8221; of the Common Stock on the date of grant as determined by the Internal Revenue Service and there is no other impermissible deferral of compensation associated with your Option.  Additionally, as a condition to accepting your Option, you agree to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates in the event that the Internal Revenue Service asserts that such exercise price is less than the &#8220;fair market value&#8221; of the Common Stock on the date of grant as subsequently determined by the Internal Revenue Service.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If any part of this Agreement, the Grant Notice or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement, the Grant Notice or the Plan not declared to be unlawful or invalid.  Any Section of this Agreement, the Grant Notice or the Plan (or part of such a Section) so declared to be unlawful or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Other Documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  You hereby acknowledge receipt of or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In addition, you acknowledge receipt of the Company&#8217;s Trading Policy.</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RSU Award Grant Notice</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) has granted to you (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) a restricted stock unit award for the number of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The RSU Award is subject to all of the terms and conditions set forth in this RSU Award Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the RSU Award Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and the Plan, all of which are available by logging into your E*TRADE account and which are incorporated herein in their entirety.  Capitalized terms not explicitly defined in this Grant Notice but defined in the Agreement or the Plan will have the meanings set forth in the Agreement or the Plan, as applicable.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Grant&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting Commencement Date&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Number of RSUs&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">                                                                                </font></div><div style="margin-bottom:6pt;text-indent:0.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">                  Subject to Section 3 of the Agreement, the RSU Award will vest as follows&#58; &#91;________&#93;.   </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance Schedule&#58;                 </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One share of Common Stock will be issued for each RSU which vests at the time set forth in Section 4 of the Agreement.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Obligation&#58;     </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the fullest extent permitted under the Plan and Applicable Law, any Withholding Obligation (as set forth in Section 6 of the Agreement) will be satisfied through a &#8220;Sell to Cover&#8221; procedure as described in Section 6 of the Agreement&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that in order to effectuate such Sell to Cover, the Company and any applicable broker-dealer may require you to execute certain documents authorizing and directing such Sell to Cover in accordance with the requirements of Rule 10b5-1(c) under the Exchange Act.</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Participant Acknowledgements&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> By your electronic acceptance of the RSU Award via your E*TRADE account, you understand and agree that&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The RSU Award is governed by this Grant Notice, the Agreement and the Plan, all of which are made a part of this document.  Unless otherwise provided in the Plan, this Grant Notice and the Agreement may not be modified, amended or revised except in a writing signed by you and a duly authorized officer of the Company.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Copies of this Grant Notice, the Agreement, the Plan and the Prospectus are available via your E*TRADE account and may be viewed and printed by you.  You consent to receive this Grant Notice, the Agreement, the Plan, the Prospectus and any other Plan-related documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">You have read and are familiar with the provisions of this Grant Notice, the Agreement, the Plan and the Prospectus.  In the event of any conflict between the provisions in this Grant Notice, the Agreement or the Prospectus and the provisions of the Plan, the provisions of the Plan will control.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of the Date of Grant, this Grant Notice, the Agreement and the Plan set forth the entire understanding between you and the Company regarding the RSU Award and supersede all prior oral and written agreements, promises and&#47;or representations regarding the RSU Award, with the exception of any written employment, offer letter, severance or other agreement, or any written severance plan or policy, in each case that specifies the terms that should govern the RSU Award.  </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Neurocrine Biosciences, Inc. 2020 Equity Incentive Plan</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RSU Award Agreement</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the accompanying RSU Award Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grant Notice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this RSU Award Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Neurocrine Biosciences, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) has granted you a restricted stock unit award under the Neurocrine Biosciences, Inc. 2020</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for the number of restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) set forth in the Grant Notice (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  Capitalized terms not explicitly defined in this Agreement but defined in the Grant Notice or the Plan will have the meanings set forth in the Grant Notice or the Plan, as applicable.</font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The general terms and conditions applicable to your RSU Award are as follows&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Governing Plan Document.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Your RSU Award is subject to all the provisions of the Plan, including but not limited to the provisions in&#58; </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Section 6 of the Plan regarding the impact of a Capitalization Adjustment, dissolution, liquidation, or Transaction on your RSU Award&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">Section 9(f) of the Plan regarding the Company&#8217;s and any Affiliate&#8217;s (if applicable) retained rights to terminate your Continuous Service notwithstanding the grant of your RSU Award&#59; and </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Section 8(c) of the Plan regarding the tax consequences of your RSU Award.  </font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your RSU Award is further subject to all interpretations, amendments, rules and regulations, which may from time to time be promulgated and adopted pursuant to the Plan.  In the event of any conflict between the provisions in this Agreement or the Grant Notice and the provisions of the Plan, the provisions of the Plan will control.  </font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Grant of the RSU Award.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSU Award represents your right to be issued on a future date a number of shares of Common Stock that is equal to the number of RSUs set forth in the Grant Notice, as adjusted to reflect any Capitalization Adjustment, subject to your satisfaction of the vesting conditions set forth in the Grant Notice and this Agreement.  Any additional RSUs that become subject to your RSU Award pursuant to any Capitalization Adjustment will be subject, in a manner determined by the Board, to the same forfeiture restrictions, restrictions on transferability, and time and manner of issuance as applicable to the other RSUs covered by your RSU Award.  Your RSU Award was granted in consideration of your services to the Company or an Affiliate.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Vesting.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Subject to the limitations contained in this Agreement, your RSU Award will vest in accordance with the vesting schedule set forth in the Grant Notice, provided that vesting will cease upon the termination of your Continuous Service, except as otherwise explicitly provided in the Plan (in connection with a Transaction or certain terminations of Continuous Service following such Transaction) or this Agreement.  Upon such termination of your Continuous Service, you will forfeit (at no cost to the Company) any RSUs subject to your RSU Award that have not vested as of the date of such termination and you will have no further right, title or interest in such RSUs or the shares of Common Stock to be issued in respect of such RSUs.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">If you are an Employee or Director, in each case as of the date of termination of your Continuous Service, then in the event of a termination of your Continuous Service due to your death or Disability, your RSU Award will become vested, as of the date of such termination, in accordance with the vesting schedule set forth in the Grant Notice as if you had provided an additional six months of Continuous Service as of the date of such termination.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">If you are a Director as of the date of a Transaction, then in the event of a Transaction during your Continuous Service, your RSU Award will become fully vested as of the date of such Transaction.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Date of Issuance.  </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The issuance of any shares of Common Stock in respect of your RSU Award is (i) subject to satisfaction of any Withholding Obligation, as set forth in Section 6, and (ii) intended to comply </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with Treasury Regulations Section 1.409A-1(b)(4) and will be construed and administered in such a manner.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">In the event one or more RSUs subject to your RSU Award vests, the Company will issue to you, on the applicable vesting date, one share of Common Stock for each RSU that vests on such date (and for purposes of this Agreement, such issuance date is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Original Issuance Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if the Original Issuance Date falls on a date that is not a business day, such shares will instead be issued to you on the next following business day. </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Notwithstanding the foregoing, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">if</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58;</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-23.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">your  RSU Award is otherwise subject to a Withholding Obligation on the Original Issuance Date,</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-26.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the Original Issuance Date does not occur (x) during an &#8220;open window period&#8221; applicable to you, as determined by the Company in accordance with the Company&#8217;s Trading Policy, or (y) on a date when you are otherwise permitted to sell shares of Common Stock on an established stock exchange or stock market (including but not limited to under a previously established written trading plan that meets the requirements of Rule 10b5-1 under the Exchange Act and was entered into in compliance with the Company&#8217;s policies (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">10b5-1 Arrangement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)), and</font></div><div style="margin-bottom:6pt;padding-left:108pt;text-align:justify;text-indent:-28.81pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the Company elects, prior to the Original Issuance Date, (x) not to satisfy such Withholding Obligation by withholding shares of Common Stock from the shares of Common Stock otherwise due, on the Original Issuance Date, to you under your RSU Award, (y) not to permit you to enter into a &#8220;same day sale&#8221; commitment with a broker-dealer in order to satisfy such Withholding Obligation (including but not limited to a commitment under a 10b5-1 Arrangement), and (z) not to permit you to pay such Withholding Obligation in cash,</font></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">then</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the shares of Common Stock that would otherwise be issued to you on the Original Issuance Date will not be issued to you on the Original Issuance Date and will instead be issued to you on the first business day when you are not prohibited from selling shares of Common Stock on an established stock exchange or stock market, but in no event later than December 31 of the calendar year in which the Original Issuance Date occurs (that is, the last day of your taxable year in which the Original Issuance Date occurs), or, if permitted in a manner that complies with Treasury Regulations Section 1.409A-1(b)(4), no later than the date that is the 15th day of the third calendar month of the year following the year in which the shares of Common Stock in respect of your RSU Award are no longer subject to a &#8220;substantial risk of forfeiture&#8221; within the meaning of Treasury Regulations Section 1.409A-1(d).</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">To the extent your RSU Award is a Non-Exempt Award, the provisions of Section 11 of the Plan will apply.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Transferability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Except as otherwise provided in the Plan, your RSU Award is not transferable, except by will or by the applicable laws of descent and distribution.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Withholding Obligations.  </font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">As provided in Section 8 of the Plan, you hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree to make adequate provision for, any sums required to satisfy the federal, state, local and foreign tax withholding obligations, if any, which arise in connection with your RSU Award (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Withholding Obligation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) in accordance with the withholding procedures established by the Company.  Additionally, the Company may, in its sole discretion, satisfy all or any portion of the Withholding Obligation by any of the following means or by a combination of such means&#58; (i) causing you to tender a cash payment&#59; (ii) permitting or requiring you to enter into a &#8220;same day sale&#8221; commitment, if applicable, with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FINRA Dealer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) whereby you irrevocably elect to sell a portion of the shares to be issued in connection with your RSU Award to satisfy the Withholding Obligation and whereby the FINRA Dealer irrevocably commits to forward the proceeds necessary to satisfy the Withholding Obligation directly to the Company </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and&#47;or its Affiliates (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sell to Cover</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; arrangement)&#59; or (iii) such other method permitted under the Plan.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.94pt">Upon your request and subject to approval by the Company and&#47;or the Committee, as applicable, and in compliance with any applicable legal conditions or restrictions, the Company may withhold from the shares of Common Stock otherwise issuable to you in connection with your RSU Award a number of whole shares of Common Stock with a Fair Market Value on the date of issuance not in excess of the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of your RSU Award as a liability for financial accounting purposes).</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Unless the Withholding Obligation is satisfied, the Company will have no obligation to issue to you any shares of Common Stock in respect of your RSU Award.  In the event the Withholding Obligation arises prior to the issuance to you of any shares of Common Stock or it is determined after such issuance that the amount of the Withholding Obligation was greater than the amount actually withheld by the Company (or an Affiliate, if applicable), you agree to indemnify and hold the Company (and Affiliate, if applicable) harmless from any failure to withhold the proper amount.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Dividends.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will receive no dividends or dividend equivalents with respect to your RSU Award&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that this sentence will not apply with respect to any shares of Common Stock that are issued to you in connection with your RSU Award after such shares have been issued to you.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">Transaction.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Your RSU Award is subject to the terms of any agreement governing a Transaction involving the Company, including, without limitation, a provision for the appointment of a stockholder representative that is authorized to act on your behalf with respect to any escrow, indemnities and any contingent consideration.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:10.5pt">No Liability for Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a condition to accepting your RSU Award, you hereby (a) agree to not make any claim against the Company, or any of its Officers, Directors, Employees or Affiliates related to tax liabilities arising from your RSU Award or other Company compensation and (b) acknowledge that you were advised to consult with your own personal tax, financial and other legal advisors regarding the tax consequences of your RSU Award and have either done so or knowingly and voluntarily declined to do so.</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Severability.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  If any part of this Agreement, the Grant Notice or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement, the Grant Notice or the Plan not declared to be unlawful or invalid.  Any Section of this Agreement, the Grant Notice or the Plan (or part of such a Section) so declared to be unlawful or invalid will, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.</font></div><div style="margin-bottom:18pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:5.5pt">Other Documents.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  You hereby acknowledge receipt of or the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Prospectus.  In addition, you acknowledge receipt of the Company&#8217;s Trading Policy.</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*  *  *  *</font></div><div style="margin-bottom:6pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>5
<FILENAME>nbix-20211231exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4cbcb2d87c3c4e788851ad3c5df02557_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEUROCRINE BIOSCIENCES INC. SUBSIDIARIES</font></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:57.692%"><tr><td style="width:1.0%"></td><td style="width:73.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.456%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Jurisdiction</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine Continental, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware, USA</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine Europe, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine Therapeutics, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ireland</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>6
<FILENAME>nbix-20211231exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i343a046796334fc0af123edcf6e81c9f_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Registration Statements (Form S-8 Nos. 333-175889, 333-190178, 333-197916, and 333-212871) pertaining to the 2011 Equity Incentive Plan of Neurocrine Biosciences, Inc.,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) Registration Statements (Form S-8 Nos. 333-199837, and 333-216067) pertaining to the Inducement Plan of Neurocrine Biosciences, Inc.,  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Registration Statements (Form S-8 Nos. 333-205933 and 333-223020) pertaining to the 2011 Equity Incentive Plan and Inducement Plan of Neurocrine Biosciences, Inc.,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4) Registration Statements (Form S-8 No. 333-226971) pertaining to the 2011 Equity Incentive Plan and 2018 Employee Stock Purchase Plan of Neurocrine Biosciences, Inc.,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5) Registration Statements (Form S-8 No. 333-234501) pertaining to the 2011 Equity Incentive Plan, and</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6) Registration Statements (Form S-8 No. 333-240301) pertaining to the 2020 Equity Incentive Plan</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February&#160;11, 2022 with respect to the consolidated financial statements of Neurocrine Biosciences, Inc., and the effectiveness of internal control over financial reporting of Neurocrine Biosciences, Inc., included in this Annual Report (Form 10-K) of Neurocrine Biosciences, Inc. for the year ended December&#160;31, 2021.</font></div><div style="margin-top:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.051%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Ernst &#38; Young LLP</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;11, 2022</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>7
<FILENAME>nbix-20211231exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i27681e2df838451ea784dde659bb3608_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin C. Gorman, Chief Executive Officer of Neurocrine Biosciences, Inc., certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Neurocrine Biosciences, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this annual report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;11, 2022</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:147.75pt"><tr><td style="width:1.0pt"></td><td style="width:145.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kevin C. Gorman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin C. Gorman</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>8
<FILENAME>nbix-20211231exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5b5defa8ad06407480e86a6f2c008a47_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Matthew C. Abernethy, Chief Financial Officer of Neurocrine Biosciences, Inc., certify that&#58;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of Neurocrine Biosciences, Inc.&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report&#59;</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent function)&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;11, 2022</font></div><div style="margin-top:5pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:147.75pt"><tr><td style="width:1.0pt"></td><td style="width:145.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Matthew C. Abernethy</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew C. Abernethy</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>9
<FILENAME>nbix-20211231exhibit32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i557ceccdd4f24fb280b1ba7eaf4760f6_1"></div><div style="min-height:54pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATIONS OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Neurocrine Biosciences, Inc. (the &#8220;Company&#8221;) for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Kevin C. Gorman, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d), of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.011%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Kevin C. Gorman</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin C. Gorman</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr></table></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Neurocrine Biosciences, Inc. (the &#8220;Company&#8221;) for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Matthew C. Abernethy, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section&#160;13(a) or 15(d), of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">That information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:12pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;11, 2022</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Matthew C. Abernethy</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew C. Abernethy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>nbix-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nbix="http://www.neurocrine.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.neurocrine.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nbix-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nbix-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nbix-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="nbix-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.neurocrine.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.neurocrine.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001003 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsIncomeandComprehensiveIncome" roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome">
        <link:definition>1003005 - Statement - Consolidated Statements Income and Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1004006 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1005007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPolicies" roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Organization and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>2403401 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreements" roleURI="http://www.neurocrine.com/role/CollaborationandLicenseAgreements">
        <link:definition>2104102 - Disclosure - Collaboration and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CollaborationandLicenseAgreementsAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails">
        <link:definition>2405402 - Disclosure - Collaboration and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSecurities" roleURI="http://www.neurocrine.com/role/DebtSecurities">
        <link:definition>2106103 - Disclosure - Debt Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSecuritiesTables" roleURI="http://www.neurocrine.com/role/DebtSecuritiesTables">
        <link:definition>2307301 - Disclosure - Debt Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" roleURI="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails">
        <link:definition>2408403 - Disclosure - Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails" roleURI="http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails">
        <link:definition>2409404 - Disclosure - Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtSecuritiesAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails">
        <link:definition>2410405 - Disclosure - Debt Securities - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.neurocrine.com/role/FairValueMeasurements">
        <link:definition>2111104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.neurocrine.com/role/FairValueMeasurementsTables">
        <link:definition>2312302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2413406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails" roleURI="http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails">
        <link:definition>2414407 - Disclosure - Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2415408 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotes" roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotes">
        <link:definition>2116105 - Disclosure - Convertible Senior Notes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesTables" roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesTables">
        <link:definition>2317303 - Disclosure - Convertible Senior Notes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails">
        <link:definition>2418409 - Disclosure - Convertible Senior Notes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails" roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails">
        <link:definition>2419410 - Disclosure - Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetails" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetails">
        <link:definition>2120106 - Disclosure - Other Balance Sheet Details</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetailsTables" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables">
        <link:definition>2321304 - Disclosure - Other Balance Sheet Details (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetailsInventoriesDetails" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails">
        <link:definition>2422411 - Disclosure - Other Balance Sheet Details - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetailsPropertyandEquipmentDetails" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails">
        <link:definition>2423412 - Disclosure - Other Balance Sheet Details - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>2424413 - Disclosure - Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2425414 - Disclosure - Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.neurocrine.com/role/EarningsPerShare">
        <link:definition>2126107 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.neurocrine.com/role/EarningsPerShareTables">
        <link:definition>2327305 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofNetIncomeLossPerShareDetails" roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails">
        <link:definition>2428415 - Disclosure - Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails" roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails">
        <link:definition>2429416 - Disclosure - Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://www.neurocrine.com/role/ShareBasedCompensation">
        <link:definition>2130108 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationTables">
        <link:definition>2331306 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails">
        <link:definition>2432417 - Disclosure - Share-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails">
        <link:definition>2433418 - Disclosure - Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails">
        <link:definition>2434419 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails">
        <link:definition>2435420 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails">
        <link:definition>2436421 - Disclosure - Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails">
        <link:definition>2437422 - Disclosure - Share-Based Compensation - Summary of Activity Related to Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails" roleURI="http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails">
        <link:definition>2438423 - Disclosure - Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.neurocrine.com/role/IncomeTaxes">
        <link:definition>2139109 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.neurocrine.com/role/IncomeTaxesTables">
        <link:definition>2340307 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails" roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails">
        <link:definition>2441424 - Disclosure - Income Taxes - Components of Income Tax Expense for Continuing Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails" roleURI="http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails">
        <link:definition>2442425 - Disclosure - Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesComponentsofDeferredTaxAssetsDetails" roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails">
        <link:definition>2443426 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails">
        <link:definition>2444427 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails" roleURI="http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails">
        <link:definition>2445428 - Disclosure - Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.neurocrine.com/role/Leases">
        <link:definition>2146110 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.neurocrine.com/role/LeasesTables">
        <link:definition>2347308 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalInformationDetails" roleURI="http://www.neurocrine.com/role/LeasesSupplementalInformationDetails">
        <link:definition>2448429 - Disclosure - Leases - Supplemental Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails" roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails">
        <link:definition>2449430 - Disclosure - Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1" roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1">
        <link:definition>2449430 - Disclosure - Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlan" roleURI="http://www.neurocrine.com/role/RetirementPlan">
        <link:definition>2150111 - Disclosure - Retirement Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlanAdditionalInformationDetails" roleURI="http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails">
        <link:definition>2451431 - Disclosure - Retirement Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.neurocrine.com/role/SubsequentEvents">
        <link:definition>2152112 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.neurocrine.com/role/SubsequentEventsDetails">
        <link:definition>2453432 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="nbix_A225ConvertibleSeniorNotesMember" abstract="true" name="A225ConvertibleSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DeferredTaxAssetsLiabilitiesGross" abstract="false" name="DeferredTaxAssetsLiabilitiesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" abstract="true" name="SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_MilestoneEquityPurchasePayment" abstract="false" name="MilestoneEquityPurchasePayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_ScientificEquipmentMember" abstract="true" name="ScientificEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_PotentialMilestonePayments" abstract="false" name="PotentialMilestonePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_ConversionPeriodOneMember" abstract="true" name="ConversionPeriodOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" abstract="false" name="DebtSecuritiesAvailableForSalePositionNumberOfPositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nbix_MitsubishiTanabePharmaCorporationMember" abstract="true" name="MitsubishiTanabePharmaCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DebtInstrumentConvertibleConversionPremium" abstract="false" name="DebtInstrumentConvertibleConversionPremium" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nbix_ConversionPeriodTwoMember" abstract="true" name="ConversionPeriodTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_InvestmentIncomeAndOtherNet" abstract="false" name="InvestmentIncomeAndOtherNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" abstract="true" name="StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="nbix_CollaborationRevenueMember" abstract="true" name="CollaborationRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nbix_AnnualRentEscalationPercentage" abstract="false" name="AnnualRentEscalationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nbix_LongTermInvestmentsMember" abstract="true" name="LongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DeferredTaxAssetsOperatingLeasesAssets" abstract="false" name="DeferredTaxAssetsOperatingLeasesAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_MilestonePayment" abstract="false" name="MilestonePayment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_NumberOfIrishSubsidiaries" abstract="false" name="NumberOfIrishSubsidiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nbix_TwoThousandAndElevenPlanMember" abstract="true" name="TwoThousandAndElevenPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" abstract="false" name="DeferredTaxLiabilitiesConvertibleSeniorNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_BusinessDescriptionPolicyPolicyTextBlock" abstract="false" name="BusinessDescriptionPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="nbix_CarryingAmountOfLiabilityComponentAtSettlement" abstract="false" name="CarryingAmountOfLiabilityComponentAtSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_IncomeTaxesLineItems" abstract="true" name="IncomeTaxesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nbix_RevenueRelatedReservesForDiscountsAndAllowances" abstract="false" name="RevenueRelatedReservesForDiscountsAndAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_PatentTerm" abstract="false" name="PatentTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nbix_A2020EquityIncentivePlanMember" abstract="true" name="A2020EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DiscountForMarketabilityUsedInValuationAnalysis" abstract="false" name="DiscountForMarketabilityUsedInValuationAnalysis" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nbix_NumberOfRenewalOptions" abstract="false" name="NumberOfRenewalOptions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="nbix_UpfrontPaymentsMade" abstract="false" name="UpfrontPaymentsMade" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_AbbvieIncMember" abstract="true" name="AbbvieIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" abstract="false" name="SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" abstract="false" name="LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_XenonPharmaceuticalsIncMember" abstract="true" name="XenonPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_DebtInstrumentConversionAxis" abstract="true" name="DebtInstrumentConversionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="nbix_PerformanceBasedRestrictedStockUnitMember" abstract="true" name="PerformanceBasedRestrictedStockUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_ESPPPurchasePeriod" abstract="false" name="ESPPPurchasePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" abstract="false" name="LesseeOperatingLeaseOptionTermToConstructFifthBuilding" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nbix_CarryingAmountOfLiabilityComponentUponIssuance" abstract="false" name="CarryingAmountOfLiabilityComponentUponIssuance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_AccruedResearchAndDevelopmentExpenseCurrent" abstract="false" name="AccruedResearchAndDevelopmentExpenseCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_AccruedBrandedPrescriptionDrugFee" abstract="false" name="AccruedBrandedPrescriptionDrugFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" abstract="false" name="DeferredTaxLiabilitiesOperatingLeasesLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" abstract="false" name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_IncomeTaxesTable" abstract="true" name="IncomeTaxesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" abstract="false" name="MinimumPercentageOfTradingPriceToLastReportedSalePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nbix_CashAndMoneyMarketFundMember" abstract="true" name="CashAndMoneyMarketFundMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_TradingDaysDuringObservationPeriod" abstract="false" name="TradingDaysDuringObservationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nbix_OtherBalanceSheetDetailsAbstract" abstract="true" name="OtherBalanceSheetDetailsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nbix_DebtInstrumentConversionDomain" abstract="true" name="DebtInstrumentConversionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_PotentialMilestonePaymentReceipts" abstract="false" name="PotentialMilestonePaymentReceipts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" abstract="false" name="FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_HeptaresTherapeuticsLimitedMember" abstract="true" name="HeptaresTherapeuticsLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_IncomeTaxReconciliationExpirationOfTaxCredits" abstract="false" name="IncomeTaxReconciliationExpirationOfTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" abstract="false" name="IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" abstract="false" name="ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_LargestTwoCustomersMember" abstract="true" name="LargestTwoCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_CostOfSales" abstract="false" name="CostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_VoyagerTherapeuticsMember" abstract="true" name="VoyagerTherapeuticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" abstract="false" name="EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="nbix_TakedaPharmaceuticalCompanyLimitedMember" abstract="true" name="TakedaPharmaceuticalCompanyLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_RentAbatementPeriod" abstract="false" name="RentAbatementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="nbix_BIALMember" abstract="true" name="BIALMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_IdorsiaPharmaceuticalsLtdMember" abstract="true" name="IdorsiaPharmaceuticalsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="nbix_PrincipalAmountOnConversionRate" abstract="false" name="PrincipalAmountOnConversionRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" abstract="false" name="IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>nbix-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5cbc5bf2-34e0-40ff-b1d9-5b6c46252467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_AssetsCurrent_5cbc5bf2-34e0-40ff-b1d9-5b6c46252467" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5b93415a-5427-4af8-8ba4-418f9ea4e109" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5b93415a-5427-4af8-8ba4-418f9ea4e109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_dffa1f65-b219-42fd-99b2-d7b990d17fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_dffa1f65-b219-42fd-99b2-d7b990d17fc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_17fea375-4971-47b2-8e79-be91b0bbe1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_17fea375-4971-47b2-8e79-be91b0bbe1cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_f1113599-64ec-42e8-8ce8-f670f374018d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_f1113599-64ec-42e8-8ce8-f670f374018d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2b5cf597-97bb-4bc9-b1ab-fc59cf454f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2b5cf597-97bb-4bc9-b1ab-fc59cf454f4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_24484e90-e056-4d3f-9c46-fb4a2b19df25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_64fccf5b-97b5-4435-a558-071927b45b02" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_24484e90-e056-4d3f-9c46-fb4a2b19df25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f906a84a-2dcc-41da-aeae-5a2099fe91c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:to="loc_us-gaap_PreferredStockValue_f906a84a-2dcc-41da-aeae-5a2099fe91c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f8312a8b-8dc4-4546-92c6-2ec06153ff7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:to="loc_us-gaap_CommonStockValue_f8312a8b-8dc4-4546-92c6-2ec06153ff7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_331ab562-13d9-432d-8688-9decfd42ab2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_331ab562-13d9-432d-8688-9decfd42ab2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2b156931-7b72-4133-b9aa-60dd8c107352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2b156931-7b72-4133-b9aa-60dd8c107352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bfd62b4a-ed53-4c6a-9c3c-824bb0c1e4bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_806d2965-c3b3-41e9-a001-8fc2a8812fae" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_bfd62b4a-ed53-4c6a-9c3c-824bb0c1e4bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_75d5ae5a-ade3-4047-bf36-0154fd854656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ed8586d5-4d13-42b9-bd22-07c79e21b7f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75d5ae5a-ade3-4047-bf36-0154fd854656" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_ed8586d5-4d13-42b9-bd22-07c79e21b7f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_01cb24ec-f835-4351-82f1-d0f348374f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_75d5ae5a-ade3-4047-bf36-0154fd854656" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_01cb24ec-f835-4351-82f1-d0f348374f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0e96b8f5-39ba-49b2-b8fe-cab14e801ae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4a839ca1-3042-4613-9fd7-e05ba57925f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0e96b8f5-39ba-49b2-b8fe-cab14e801ae9" xlink:to="loc_us-gaap_LiabilitiesCurrent_4a839ca1-3042-4613-9fd7-e05ba57925f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_3bf6ef79-c3cb-42e0-9672-e2d9b3278333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0e96b8f5-39ba-49b2-b8fe-cab14e801ae9" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_3bf6ef79-c3cb-42e0-9672-e2d9b3278333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_667e9089-4388-4f0e-a9ae-1a1c7d0b90e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0e96b8f5-39ba-49b2-b8fe-cab14e801ae9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_667e9089-4388-4f0e-a9ae-1a1c7d0b90e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_1bf59e17-9907-4e60-8575-bff051bebfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_0e96b8f5-39ba-49b2-b8fe-cab14e801ae9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_1bf59e17-9907-4e60-8575-bff051bebfe0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_086998fc-5493-4c9f-ac63-5085a2e194b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_086998fc-5493-4c9f-ac63-5085a2e194b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_7369c99d-04c9-40ce-9cec-3f1411fd1645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_7369c99d-04c9-40ce-9cec-3f1411fd1645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1e05b8a2-f4ec-4f46-91c4-03001bdf23ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1e05b8a2-f4ec-4f46-91c4-03001bdf23ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4bee7f09-d3f4-466b-9995-9f33a9156ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:to="loc_us-gaap_InventoryNet_4bee7f09-d3f4-466b-9995-9f33a9156ca1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_ccdded1a-45ad-4ff4-8294-1490ff87b52a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ada277dd-da35-45dd-b050-545ddc67691f" xlink:to="loc_us-gaap_OtherAssetsCurrent_ccdded1a-45ad-4ff4-8294-1490ff87b52a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_21ea9716-65e1-44f6-9d35-333be6dbdcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9cca5eac-8969-4b28-9ae3-303b6cd313c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_21ea9716-65e1-44f6-9d35-333be6dbdcf1" xlink:to="loc_us-gaap_Liabilities_9cca5eac-8969-4b28-9ae3-303b6cd313c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_159b14b8-4c5a-4fd6-b9da-5aedd4d12497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_21ea9716-65e1-44f6-9d35-333be6dbdcf1" xlink:to="loc_us-gaap_StockholdersEquity_159b14b8-4c5a-4fd6-b9da-5aedd4d12497" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsIncomeandComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c7f2515-6397-4335-bbda-38f00076567f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_90fa5f66-b328-4655-b352-36513f7f0e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c7f2515-6397-4335-bbda-38f00076567f" xlink:to="loc_us-gaap_OperatingIncomeLoss_90fa5f66-b328-4655-b352-36513f7f0e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_99cdb0c5-b33b-4bd8-9dd9-89909513c732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c7f2515-6397-4335-bbda-38f00076567f" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_99cdb0c5-b33b-4bd8-9dd9-89909513c732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8a870d62-f2a2-48e1-ac26-9df0f6cb2c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d07321b4-45d2-403e-b84d-dfb900102918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8a870d62-f2a2-48e1-ac26-9df0f6cb2c68" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d07321b4-45d2-403e-b84d-dfb900102918" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_34fed014-9662-48ce-9f9e-1244bddb4ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8a870d62-f2a2-48e1-ac26-9df0f6cb2c68" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_34fed014-9662-48ce-9f9e-1244bddb4ea4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_57a20e8a-76df-47d7-bf5c-31e63cc0c1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_66d22357-1d18-4430-a176-2e58917b3ae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_57a20e8a-76df-47d7-bf5c-31e63cc0c1aa" xlink:to="loc_us-gaap_InterestExpense_66d22357-1d18-4430-a176-2e58917b3ae6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c264cf36-2a4a-4a4f-ab31-314165069844" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_57a20e8a-76df-47d7-bf5c-31e63cc0c1aa" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c264cf36-2a4a-4a4f-ab31-314165069844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_57f7fac1-3cff-4188-ae5d-d5b5119ab352" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_57a20e8a-76df-47d7-bf5c-31e63cc0c1aa" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_57f7fac1-3cff-4188-ae5d-d5b5119ab352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_InvestmentIncomeAndOtherNet_73fd26ff-ee90-466e-9afc-c39d312abd28" xlink:href="nbix-20211231.xsd#nbix_InvestmentIncomeAndOtherNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_57a20e8a-76df-47d7-bf5c-31e63cc0c1aa" xlink:to="loc_nbix_InvestmentIncomeAndOtherNet_73fd26ff-ee90-466e-9afc-c39d312abd28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_4a8872a0-2b3b-47a1-98e4-a85ab55e0ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_368a3762-32ab-4529-8516-ca4a2e17dc0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4a8872a0-2b3b-47a1-98e4-a85ab55e0ded" xlink:to="loc_us-gaap_NetIncomeLoss_368a3762-32ab-4529-8516-ca4a2e17dc0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8a61d323-f040-4d00-9acf-e92622fa7ce7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_4a8872a0-2b3b-47a1-98e4-a85ab55e0ded" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8a61d323-f040-4d00-9acf-e92622fa7ce7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3d6abf8f-d62d-4084-99fe-0cb5e690bec8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1af6e18e-5169-4a45-972e-ad773174c75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3d6abf8f-d62d-4084-99fe-0cb5e690bec8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1af6e18e-5169-4a45-972e-ad773174c75b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e1380c70-8847-44f0-8597-1151054b2b5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3d6abf8f-d62d-4084-99fe-0cb5e690bec8" xlink:to="loc_us-gaap_OperatingExpenses_e1380c70-8847-44f0-8597-1151054b2b5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c8a1974b-25d4-4f0a-9d60-f973ac07ba1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CostOfSales_7e59b23c-782e-4cd3-852e-8ab590f0d737" xlink:href="nbix-20211231.xsd#nbix_CostOfSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c8a1974b-25d4-4f0a-9d60-f973ac07ba1e" xlink:to="loc_nbix_CostOfSales_7e59b23c-782e-4cd3-852e-8ab590f0d737" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c9c476d9-a9e3-4fc4-9f7d-a63b29068dc5" xlink:href="nbix-20211231.xsd#nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c8a1974b-25d4-4f0a-9d60-f973ac07ba1e" xlink:to="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c9c476d9-a9e3-4fc4-9f7d-a63b29068dc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_002a8d4d-dca0-483b-af12-a5fb0ab8c741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c8a1974b-25d4-4f0a-9d60-f973ac07ba1e" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_002a8d4d-dca0-483b-af12-a5fb0ab8c741" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_944f5402-3954-434d-b8f7-b5e524da4420" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c8a1974b-25d4-4f0a-9d60-f973ac07ba1e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_944f5402-3954-434d-b8f7-b5e524da4420" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0b2e31c-4ab2-44a9-897f-792f1ebe83de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_07c9c106-f68a-43f1-8b60-ad674cb1e166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0b2e31c-4ab2-44a9-897f-792f1ebe83de" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_07c9c106-f68a-43f1-8b60-ad674cb1e166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_61c0cf40-d170-4842-9936-66cd393888e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0b2e31c-4ab2-44a9-897f-792f1ebe83de" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_61c0cf40-d170-4842-9936-66cd393888e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_f53aa1ae-6c3b-4e9f-a787-2c6b7f677758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0b2e31c-4ab2-44a9-897f-792f1ebe83de" xlink:to="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_f53aa1ae-6c3b-4e9f-a787-2c6b7f677758" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_44524d1c-70db-4c6d-af09-91cd8925db6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e0b2e31c-4ab2-44a9-897f-792f1ebe83de" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_44524d1c-70db-4c6d-af09-91cd8925db6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a6ba4fd-36f3-4035-bcaf-3b613dac2f5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bee5db2b-684c-4097-aadb-cd382164d006" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a6ba4fd-36f3-4035-bcaf-3b613dac2f5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bee5db2b-684c-4097-aadb-cd382164d006" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9826c18-151e-4a54-affe-952e3c247f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a6ba4fd-36f3-4035-bcaf-3b613dac2f5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c9826c18-151e-4a54-affe-952e3c247f7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6ede006b-8d57-4579-a02b-d7e17008e0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a6ba4fd-36f3-4035-bcaf-3b613dac2f5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6ede006b-8d57-4579-a02b-d7e17008e0c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8f4f1ae2-e9d1-4113-b30a-c1601666f7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_NetIncomeLoss_8f4f1ae2-e9d1-4113-b30a-c1601666f7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_7aeda1ca-0161-4aa5-b323-8c8405f19c63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_ShareBasedCompensation_7aeda1ca-0161-4aa5-b323-8c8405f19c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4459681f-8be0-4d77-a5c8-4972acf52e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_Depreciation_4459681f-8be0-4d77-a5c8-4972acf52e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_801315bb-c3af-4962-bf4d-32ad0b395bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_801315bb-c3af-4962-bf4d-32ad0b395bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_7718f6ca-a61c-4811-95a3-8423cb265477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_7718f6ca-a61c-4811-95a3-8423cb265477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_57e6c578-c489-45fe-b5a4-c6018bdd111f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_57e6c578-c489-45fe-b5a4-c6018bdd111f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_92f9d7d5-0967-4027-b2de-19deac35b3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_92f9d7d5-0967-4027-b2de-19deac35b3e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_891d169b-24f9-4238-a46c-c17369e28632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_891d169b-24f9-4238-a46c-c17369e28632" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_d087b0de-6294-4f4f-b2cf-a0c5244bf129" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_d087b0de-6294-4f4f-b2cf-a0c5244bf129" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4e225229-3916-4a20-8891-a06704ca0b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_4e225229-3916-4a20-8891-a06704ca0b4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_cdd4a437-7fac-45ba-8331-9d7b51c13810" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_cdd4a437-7fac-45ba-8331-9d7b51c13810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5c3d459c-f716-41c7-b4e5-d0408d8313be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5c3d459c-f716-41c7-b4e5-d0408d8313be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_2200519f-5bc0-42c3-8b85-0b1cf640f40b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0fc8d598-32de-4338-84bc-869cd6ce9364" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_2200519f-5bc0-42c3-8b85-0b1cf640f40b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6314c9b1-62d3-4f3f-b9de-c5b574e7edc8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ff804033-24ae-4ed2-82e8-da6735fc9ccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6314c9b1-62d3-4f3f-b9de-c5b574e7edc8" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_ff804033-24ae-4ed2-82e8-da6735fc9ccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_67dd198e-da47-4eeb-9ece-6fe5d46905ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6314c9b1-62d3-4f3f-b9de-c5b574e7edc8" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_67dd198e-da47-4eeb-9ece-6fe5d46905ce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_76dd85ff-0dcf-4752-bb35-b95f300fce63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_878bf9a9-6d3c-4d29-8dd8-457ef35a27ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_76dd85ff-0dcf-4752-bb35-b95f300fce63" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_878bf9a9-6d3c-4d29-8dd8-457ef35a27ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a1d059d0-6f7f-4c35-b905-cd1a39558ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_76dd85ff-0dcf-4752-bb35-b95f300fce63" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_a1d059d0-6f7f-4c35-b905-cd1a39558ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b48ea2bf-10b2-4d36-8cbd-900fb10ed90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_76dd85ff-0dcf-4752-bb35-b95f300fce63" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b48ea2bf-10b2-4d36-8cbd-900fb10ed90c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_92f00a52-a67e-4578-bdd6-f53a564d75de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e0a1e508-87eb-4f69-bff4-a1a15838d4f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebt_92f00a52-a67e-4578-bdd6-f53a564d75de" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e0a1e508-87eb-4f69-bff4-a1a15838d4f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b55714d1-9c8d-4821-906e-44b11213988f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebt_92f00a52-a67e-4578-bdd6-f53a564d75de" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b55714d1-9c8d-4821-906e-44b11213988f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_012670b2-2cf7-4a9d-9b02-b8c3a8bd31f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleDebt_92f00a52-a67e-4578-bdd6-f53a564d75de" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_012670b2-2cf7-4a9d-9b02-b8c3a8bd31f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_da135449-d800-4888-8551-d3737c5cd3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_cf769696-9d35-40cb-aa28-319ad4ff87a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da135449-d800-4888-8551-d3737c5cd3d7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_cf769696-9d35-40cb-aa28-319ad4ff87a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_22a03b6f-2f37-4dd6-bb6d-f68db91551ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da135449-d800-4888-8551-d3737c5cd3d7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_22a03b6f-2f37-4dd6-bb6d-f68db91551ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa20d507-9c86-4b30-b025-de44320b9750" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_da135449-d800-4888-8551-d3737c5cd3d7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_fa20d507-9c86-4b30-b025-de44320b9750" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e6896e66-ba4c-4c74-8194-0ffb731b4ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_1ceee5a7-fd7a-43e6-a6b1-ff2d148c7f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e6896e66-ba4c-4c74-8194-0ffb731b4ca7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_1ceee5a7-fd7a-43e6-a6b1-ff2d148c7f09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0e1ee474-51f5-4020-be50-d6c83f95ffd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_e6896e66-ba4c-4c74-8194-0ffb731b4ca7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0e1ee474-51f5-4020-be50-d6c83f95ffd1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_00a741a3-5219-4f0b-82f0-7240ebad7987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_00a741a3-5219-4f0b-82f0-7240ebad7987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances_962890b3-8768-4966-9de2-da3dc21acd7c" xlink:href="nbix-20211231.xsd#nbix_RevenueRelatedReservesForDiscountsAndAllowances"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:to="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances_962890b3-8768-4966-9de2-da3dc21acd7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent_f675acf6-94c5-4262-a13d-90f37aaf99eb" xlink:href="nbix-20211231.xsd#nbix_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:to="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent_f675acf6-94c5-4262-a13d-90f37aaf99eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedBrandedPrescriptionDrugFee_44f67466-d923-4dee-b28f-b844927588a2" xlink:href="nbix-20211231.xsd#nbix_AccruedBrandedPrescriptionDrugFee"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:to="loc_nbix_AccruedBrandedPrescriptionDrugFee_44f67466-d923-4dee-b28f-b844927588a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_fa91982f-6f2b-4c0c-91d6-ba6791254b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_88511dfa-186d-48fe-8cdc-be0b58c454ed" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_fa91982f-6f2b-4c0c-91d6-ba6791254b45" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_44d9edf9-9fba-49e3-86c4-8c3348a64634" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a35a7f3-e1d1-4f66-a59a-3f7374ea0316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents_44d9edf9-9fba-49e3-86c4-8c3348a64634" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7a35a7f3-e1d1-4f66-a59a-3f7374ea0316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_d775c4f5-76a8-4c92-92a5-3606b1df01dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents_44d9edf9-9fba-49e3-86c4-8c3348a64634" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_d775c4f5-76a8-4c92-92a5-3606b1df01dc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareScheduleofNetIncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96b1143f-8352-4625-ab8e-bec31a22b2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d853d634-84dd-465a-8884-0d3753b9779d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96b1143f-8352-4625-ab8e-bec31a22b2fe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d853d634-84dd-465a-8884-0d3753b9779d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_060196d5-0a25-4caa-9130-cd11abe3892e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96b1143f-8352-4625-ab8e-bec31a22b2fe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_060196d5-0a25-4caa-9130-cd11abe3892e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_833802a7-bcee-493a-879e-62ccd9735ed4" xlink:href="nbix-20211231.xsd#nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_96b1143f-8352-4625-ab8e-bec31a22b2fe" xlink:to="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_833802a7-bcee-493a-879e-62ccd9735ed4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_457c2448-a95b-405e-915e-01e4c340bd59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21f65437-52ba-46aa-b315-485c7cf30ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_457c2448-a95b-405e-915e-01e4c340bd59" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_21f65437-52ba-46aa-b315-485c7cf30ad8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3b55a021-b9f8-4d76-9c7f-4bbf78dbdf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_457c2448-a95b-405e-915e-01e4c340bd59" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3b55a021-b9f8-4d76-9c7f-4bbf78dbdf26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_781d658d-e72b-4e12-a817-48173b36d68d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e7984eb7-ddea-4b0d-b23c-2d535c149a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_781d658d-e72b-4e12-a817-48173b36d68d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e7984eb7-ddea-4b0d-b23c-2d535c149a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1d09dac9-7164-4db1-b3a6-f7a85a7d1674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_781d658d-e72b-4e12-a817-48173b36d68d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1d09dac9-7164-4db1-b3a6-f7a85a7d1674" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9a396901-b152-4221-80ae-2bdd9ca57c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c300a06c-a36f-4008-966c-c82152068c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9a396901-b152-4221-80ae-2bdd9ca57c8a" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_c300a06c-a36f-4008-966c-c82152068c2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_49c89ebe-2b83-44e5-bbdc-33e3b35eb86a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_9a396901-b152-4221-80ae-2bdd9ca57c8a" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_49c89ebe-2b83-44e5-bbdc-33e3b35eb86a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46722458-e045-4a0b-ae00-19c334b801d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_46722458-e045-4a0b-ae00-19c334b801d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_eadabac7-490c-4eb7-bd01-20059b18b9d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_eadabac7-490c-4eb7-bd01-20059b18b9d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8a58bee2-f67a-49a9-8df1-957118d52045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_8a58bee2-f67a-49a9-8df1-957118d52045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_24a2ebf5-75ce-4774-bc06-8ddce51d722b" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_24a2ebf5-75ce-4774-bc06-8ddce51d722b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1c567e08-ea66-4037-ae64-13078115eb02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_1c567e08-ea66-4037-ae64-13078115eb02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_1a6fab25-dcd2-400d-bc8d-2f84b3b8a3a7" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_1a6fab25-dcd2-400d-bc8d-2f84b3b8a3a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_8474d537-869a-43ad-bd7d-bb626212642c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_8474d537-869a-43ad-bd7d-bb626212642c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_61b104ce-218b-47f7-b780-4d5fa0f4b38a" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationExpirationOfTaxCredits"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_61b104ce-218b-47f7-b780-4d5fa0f4b38a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_0a899cd1-b720-4342-99c7-e00fe836d2b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_0a899cd1-b720-4342-99c7-e00fe836d2b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5f0bfa16-99b3-4774-9b0f-7beceb95b345" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_5f0bfa16-99b3-4774-9b0f-7beceb95b345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c32df48a-4da6-4481-8f9d-21855f1a5c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_362986f0-f2ad-40f4-9c30-8c7230ce35fc" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_c32df48a-4da6-4481-8f9d-21855f1a5c29" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_70d23718-3a8d-4524-9ac0-ff333229156f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_47ff6188-2dcc-4d8c-a275-15c6aef6f669" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_70d23718-3a8d-4524-9ac0-ff333229156f" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_47ff6188-2dcc-4d8c-a275-15c6aef6f669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_d243e5f8-f5cb-4dc9-85cd-acccc532e122" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_70d23718-3a8d-4524-9ac0-ff333229156f" xlink:to="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_d243e5f8-f5cb-4dc9-85cd-acccc532e122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_033502b2-d042-45dc-a9d2-f32850f8cdf6" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_70d23718-3a8d-4524-9ac0-ff333229156f" xlink:to="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_033502b2-d042-45dc-a9d2-f32850f8cdf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2eb6574c-03a4-4994-9c0b-fb189972430d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1f7b077d-3e91-4ee3-97d3-07fc2956096b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2eb6574c-03a4-4994-9c0b-fb189972430d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_1f7b077d-3e91-4ee3-97d3-07fc2956096b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsLiabilitiesGross_74704c65-0ff3-4315-bd33-588e0bf7de2f" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_2eb6574c-03a4-4994-9c0b-fb189972430d" xlink:to="loc_nbix_DeferredTaxAssetsLiabilitiesGross_74704c65-0ff3-4315-bd33-588e0bf7de2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsLiabilitiesGross_53b14fb9-4e3a-42c6-bbd9-c25fd9015ad6" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsLiabilitiesGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b635650d-84e4-45c4-877b-54693f9a9cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nbix_DeferredTaxAssetsLiabilitiesGross_53b14fb9-4e3a-42c6-bbd9-c25fd9015ad6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b635650d-84e4-45c4-877b-54693f9a9cc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_49a94a3e-a0e2-4eda-b220-7b0d12a49c23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_nbix_DeferredTaxAssetsLiabilitiesGross_53b14fb9-4e3a-42c6-bbd9-c25fd9015ad6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_49a94a3e-a0e2-4eda-b220-7b0d12a49c23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_f93d99cc-88a2-468b-b0f6-7c6e0d9c8831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_f93d99cc-88a2-468b-b0f6-7c6e0d9c8831" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_6400b205-8991-42b4-9a28-1fb3e55efc7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_6400b205-8991-42b4-9a28-1fb3e55efc7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_58c518ca-3e8e-40d4-9784-4309c664d60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_58c518ca-3e8e-40d4-9784-4309c664d60c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets_09cc1107-5ed4-4da7-9af5-55f5838bf263" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsOperatingLeasesAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets_09cc1107-5ed4-4da7-9af5-55f5838bf263" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8ddd3026-857e-4459-89c1-68a181f15949" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8ddd3026-857e-4459-89c1-68a181f15949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_f04d524a-84e4-4d59-83d4-fd8b0768467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_f04d524a-84e4-4d59-83d4-fd8b0768467e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_8cacb217-825a-4b7a-af56-6394eb7fc3ad" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_9093a7ac-afc9-4218-8818-3e7dea36e8f0" xlink:to="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_8cacb217-825a-4b7a-af56-6394eb7fc3ad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_27342669-2b0e-4b57-b81a-fd72d01dceb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b365e019-d6a1-4e23-b731-9bf7e53d6218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_27342669-2b0e-4b57-b81a-fd72d01dceb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b365e019-d6a1-4e23-b731-9bf7e53d6218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eba37886-4d17-4758-8506-609f92028fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_27342669-2b0e-4b57-b81a-fd72d01dceb6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_eba37886-4d17-4758-8506-609f92028fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_40ac4388-eec4-4eb7-af90-c66eacf5857a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_40ac4388-eec4-4eb7-af90-c66eacf5857a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c0c10492-dc13-4892-a1f5-dbebde54e723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c0c10492-dc13-4892-a1f5-dbebde54e723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_29c831fc-de52-40e7-a148-eae1c5ea9a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_29c831fc-de52-40e7-a148-eae1c5ea9a7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aa065e20-0ace-40f8-b3be-0c89d83b9570" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_aa065e20-0ace-40f8-b3be-0c89d83b9570" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5cc66e06-efc9-47a8-bcb9-b85b9b467a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5cc66e06-efc9-47a8-bcb9-b85b9b467a8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bc8dba37-67ad-487c-a1fa-27e2cf52e9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_df428359-2c4a-4a81-87ff-b4c3828bd3b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_bc8dba37-67ad-487c-a1fa-27e2cf52e9ab" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4e5407e5-fd61-4457-ab8e-1084f26c4b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2ca001e3-c54f-4836-a962-4d0ac5b6672c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4e5407e5-fd61-4457-ab8e-1084f26c4b20" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2ca001e3-c54f-4836-a962-4d0ac5b6672c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a4918630-9dde-45aa-83b3-dbe3561a7b66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4e5407e5-fd61-4457-ab8e-1084f26c4b20" xlink:to="loc_us-gaap_OperatingLeaseLiability_a4918630-9dde-45aa-83b3-dbe3561a7b66" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>nbix-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ie775c297f0b04a478f5a19fb68354aa9_ConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_99a19795-cb63-44da-8fa0-8431ecd7cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_99a19795-cb63-44da-8fa0-8431ecd7cec5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1914610e-4c2c-4057-9aac-ef90dbe29728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1914610e-4c2c-4057-9aac-ef90dbe29728" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1bc4a922-c62e-4e3e-9b3e-94c83773a6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1bc4a922-c62e-4e3e-9b3e-94c83773a6ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a3e98421-ae51-487c-b7de-87fc0ec6e1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a3e98421-ae51-487c-b7de-87fc0ec6e1bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ea32921e-6779-486a-8ba0-a251d74c4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ea32921e-6779-486a-8ba0-a251d74c4fca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4525b3a7-0769-4e9b-b8a0-a513eefdd184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4525b3a7-0769-4e9b-b8a0-a513eefdd184" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3dd05ea4-049b-46bf-9247-b54212ccb3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3dd05ea4-049b-46bf-9247-b54212ccb3d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d2106646-f8ab-460a-ae3c-99a0830ca04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesIssued_d2106646-f8ab-460a-ae3c-99a0830ca04b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8e96aad0-5940-4013-a197-8a3cf5c26a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8e96aad0-5940-4013-a197-8a3cf5c26a83" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:to="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ffd4c4a4-9487-4274-88fb-03df52541319_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ffd4c4a4-9487-4274-88fb-03df52541319_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9c9d9cdc-beaf-4a65-855f-8ec3b0799368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9c9d9cdc-beaf-4a65-855f-8ec3b0799368" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LongTermInvestmentsMember_c6469036-e1b4-46fd-b906-db43d263d6da" xlink:href="nbix-20211231.xsd#nbix_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:to="loc_nbix_LongTermInvestmentsMember_c6469036-e1b4-46fd-b906-db43d263d6da" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsIncomeandComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="extended" id="i14d1963ed9204c2084a22963e3d60f17_ConsolidatedStatementsIncomeandComprehensiveIncome">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31a16723-c594-49fc-8520-1d2885d2144d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31a16723-c594-49fc-8520-1d2885d2144d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CostOfSales_ae939883-f146-4c0d-b55b-587aaf11bd06" xlink:href="nbix-20211231.xsd#nbix_CostOfSales"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_nbix_CostOfSales_ae939883-f146-4c0d-b55b-587aaf11bd06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_a1eba4fc-39b9-421c-9c91-a440dc12e264" xlink:href="nbix-20211231.xsd#nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_a1eba4fc-39b9-421c-9c91-a440dc12e264" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_6782f4c6-fd47-4a7a-980e-a1b9dba94001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_6782f4c6-fd47-4a7a-980e-a1b9dba94001" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_07a89fc7-0e98-43fa-8161-6caaef921d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_07a89fc7-0e98-43fa-8161-6caaef921d83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_864e0f56-3e02-4246-8501-c7de6d3daca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_OperatingExpenses_864e0f56-3e02-4246-8501-c7de6d3daca1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01985602-d715-456e-ba66-50e4d289b1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OperatingIncomeLoss_01985602-d715-456e-ba66-50e4d289b1ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ba1a6789-7887-4f96-b447-83dc27d75683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_InterestExpense_ba1a6789-7887-4f96-b447-83dc27d75683" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d03eda5c-b75c-4234-adc1-f2f3ee2acf73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d03eda5c-b75c-4234-adc1-f2f3ee2acf73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e9d172b-caf9-47da-bea0-b5892f3b7ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e9d172b-caf9-47da-bea0-b5892f3b7ec3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_InvestmentIncomeAndOtherNet_aa5d9748-c10d-4e99-a169-ba4cda59f4a8" xlink:href="nbix-20211231.xsd#nbix_InvestmentIncomeAndOtherNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_nbix_InvestmentIncomeAndOtherNet_aa5d9748-c10d-4e99-a169-ba4cda59f4a8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dfbb3bb8-1ad1-4593-a903-106d19c45125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dfbb3bb8-1ad1-4593-a903-106d19c45125" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_364d7f7e-375d-4ba5-a98b-b173aef7bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_364d7f7e-375d-4ba5-a98b-b173aef7bfda" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1441d696-4bae-4f12-9e0c-97d1a401bd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1441d696-4bae-4f12-9e0c-97d1a401bd0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38d08e6f-f046-4311-97e1-ec293966a351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_NetIncomeLoss_38d08e6f-f046-4311-97e1-ec293966a351" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8b4f98a1-e1bd-44fb-b675-08efbae753ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8b4f98a1-e1bd-44fb-b675-08efbae753ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3766fe6-46c4-4244-96af-048df57a0aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3766fe6-46c4-4244-96af-048df57a0aad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_40f9b239-90ba-46a8-b509-6a9cb0ad73fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_EarningsPerShareBasic_40f9b239-90ba-46a8-b509-6a9cb0ad73fd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_752d5a45-3724-468f-aca7-fb93f3c0df92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_EarningsPerShareDiluted_752d5a45-3724-468f-aca7-fb93f3c0df92" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fd07d62-3aef-4276-b03d-a9f562a0e817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fd07d62-3aef-4276-b03d-a9f562a0e817" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b5f5f91c-a1a9-42d1-8399-b0df7d3bf9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b5f5f91c-a1a9-42d1-8399-b0df7d3bf9a0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:to="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:to="loc_srt_ProductsAndServicesDomain_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:to="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_cace2740-19df-4645-ac41-285e1db2526f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:to="loc_us-gaap_ProductMember_cace2740-19df-4645-ac41-285e1db2526f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CollaborationRevenueMember_8e86c604-2c30-47c6-99e2-f4115ab654cf" xlink:href="nbix-20211231.xsd#nbix_CollaborationRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:to="loc_nbix_CollaborationRevenueMember_8e86c604-2c30-47c6-99e2-f4115ab654cf" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i2faf173170154d46b84c159983ebfc5b_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e4944cd9-3d8a-46a0-afd4-643f924caac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_SharesOutstanding_e4944cd9-3d8a-46a0-afd4-643f924caac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fcfe765f-7532-41a5-8ead-6eb8550fb0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockholdersEquity_fcfe765f-7532-41a5-8ead-6eb8550fb0ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b36dd30-976f-4bc3-a301-a17bbec53f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_NetIncomeLoss_0b36dd30-976f-4bc3-a301-a17bbec53f07" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_55497cbd-e581-4b99-bc58-4be28516d521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_55497cbd-e581-4b99-bc58-4be28516d521" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726813ea-f16e-4c50-bb3f-3cb2b9728da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726813ea-f16e-4c50-bb3f-3cb2b9728da1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7c7816e4-8b42-4be5-9950-dc52e6bb403b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7c7816e4-8b42-4be5-9950-dc52e6bb403b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ac9429b5-ea82-4265-9b12-6db494056005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ac9429b5-ea82-4265-9b12-6db494056005" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2bc21d39-a80c-4055-a76d-2ee21d78b402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2bc21d39-a80c-4055-a76d-2ee21d78b402" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_97243f28-b665-49b6-9e99-563d9ca89a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_97243f28-b665-49b6-9e99-563d9ca89a7f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_575b8249-d6b2-4a63-8eb5-bbd9ef6af5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8286ef09-a9fa-48b6-b695-d6a09575d356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_045b5282-25bf-4218-aef7-cdd2b71fa198_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:to="loc_us-gaap_EquityComponentDomain_045b5282-25bf-4218-aef7-cdd2b71fa198_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:to="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_00a79199-9ff0-40ed-8741-817ff1d17315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_CommonStockMember_00a79199-9ff0-40ed-8741-817ff1d17315" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f3fcb03f-a541-4181-a397-ff711c566964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f3fcb03f-a541-4181-a397-ff711c566964" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52cb9e1f-8184-4e37-9e8a-c6b021a33305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52cb9e1f-8184-4e37-9e8a-c6b021a33305" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54c718de-20a5-4ef7-96ac-869502ee855e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_RetainedEarningsMember_54c718de-20a5-4ef7-96ac-869502ee855e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_01365367-18ab-49e1-915f-325f379798d0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_01365367-18ab-49e1-915f-325f379798d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cfa73331-0db0-4d53-83ca-fd7164a7664e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cfa73331-0db0-4d53-83ca-fd7164a7664e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="i55153bd872a3478489955c23aba9b939_OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfIrishSubsidiaries_20f7a749-0067-435e-aeab-46d5744d323c" xlink:href="nbix-20211231.xsd#nbix_NumberOfIrishSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_nbix_NumberOfIrishSubsidiaries_20f7a749-0067-435e-aeab-46d5744d323c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_9401227e-64af-4ea5-ab75-7b5c293e95d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_NumberOfOperatingSegments_9401227e-64af-4ea5-ab75-7b5c293e95d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_067c4553-bb2b-4a82-b36d-fafa4afc844a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_NumberOfReportableSegments_067c4553-bb2b-4a82-b36d-fafa4afc844a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_b1edc096-4453-4939-bf99-f0ef73a41e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_b1edc096-4453-4939-bf99-f0ef73a41e3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_68a1012e-be0c-4697-9613-3bb7009c6c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_InterestReceivableCurrent_68a1012e-be0c-4697-9613-3bb7009c6c7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_5eda1e99-012d-40a8-bb33-2fb5cff73b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_5eda1e99-012d-40a8-bb33-2fb5cff73b03" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb323abd-f2f8-4799-94a3-a947a5155953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb323abd-f2f8-4799-94a3-a947a5155953" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b89b716-0511-4ee7-8eba-89bd88e25400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_Depreciation_3b89b716-0511-4ee7-8eba-89bd88e25400" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_660f315b-3181-4fd9-88df-7cfc0d0a7cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_660f315b-3181-4fd9-88df-7cfc0d0a7cd5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_f5bab785-777c-49cd-b939-083ae5b360b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AdvertisingExpense_f5bab785-777c-49cd-b939-083ae5b360b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_28f7deb2-5251-4ca3-b347-1d4d5daed318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_28f7deb2-5251-4ca3-b347-1d4d5daed318" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ESPPPurchasePeriod_772131cf-0000-436a-92f6-08a8521c315f" xlink:href="nbix-20211231.xsd#nbix_ESPPPurchasePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_nbix_ESPPPurchasePeriod_772131cf-0000-436a-92f6-08a8521c315f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b46d261-ee61-4393-ab29-72f777bd5430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b46d261-ee61-4393-ab29-72f777bd5430" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b17c561-6a42-412e-b331-5f7dbf971f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b17c561-6a42-412e-b331-5f7dbf971f41" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_b0534a59-823e-4f67-acf5-bf8860177484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_b0534a59-823e-4f67-acf5-bf8860177484" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3523c107-0a5e-456b-8a24-ea75318e1a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3523c107-0a5e-456b-8a24-ea75318e1a9f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf1411ef-3d36-4598-9458-07f3546b8ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf1411ef-3d36-4598-9458-07f3546b8ad5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2330bc3b-d7a0-41d0-8054-5639bb7405cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2330bc3b-d7a0-41d0-8054-5639bb7405cd" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18e2565f-6403-4c44-8cbb-5ac85f9be87d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_18e2565f-6403-4c44-8cbb-5ac85f9be87d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_3be82551-4c42-49af-96af-2f6c65301335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_3be82551-4c42-49af-96af-2f6c65301335" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1430932a-9520-4ac4-9e36-b806ffb09ca8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1430932a-9520-4ac4-9e36-b806ffb09ca8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_b1ffa96c-34b4-4c77-8715-5db16d6b36e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_b1ffa96c-34b4-4c77-8715-5db16d6b36e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b82378d4-55eb-4abf-ac56-3b049b0cf3b6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_b82378d4-55eb-4abf-ac56-3b049b0cf3b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LargestTwoCustomersMember_9f97b09f-e82e-41a3-be7e-8ec60806d788" xlink:href="nbix-20211231.xsd#nbix_LargestTwoCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:to="loc_nbix_LargestTwoCustomersMember_9f97b09f-e82e-41a3-be7e-8ec60806d788" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_349243d4-78fc-4caa-a047-7ce16ff3c2e7_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:to="loc_srt_RangeMember_349243d4-78fc-4caa-a047-7ce16ff3c2e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:to="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_33e43a6a-755c-48b1-9a5c-b4ad5b3de8fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:to="loc_srt_MinimumMember_33e43a6a-755c-48b1-9a5c-b4ad5b3de8fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ddcb1ae6-24e4-4cb3-8035-82d83da3b55a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:to="loc_srt_MaximumMember_ddcb1ae6-24e4-4cb3-8035-82d83da3b55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_516478e7-e800-48e0-bcac-4f86e4b0b12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:to="loc_us-gaap_EmployeeStockMember_516478e7-e800-48e0-bcac-4f86e4b0b12d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_a6060055-4b35-498c-ae95-c5205c2539ff_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_a6060055-4b35-498c-ae95-c5205c2539ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_30adf205-e113-4bd3-8b8e-65b659bde227" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:to="loc_srt_ProFormaMember_30adf205-e113-4bd3-8b8e-65b659bde227" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_085431d9-5d67-4dd6-8eb9-cf0f1230a489" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_085431d9-5d67-4dd6-8eb9-cf0f1230a489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7d8a66a2-f2b8-446a-8be9-da6212473d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7d8a66a2-f2b8-446a-8be9-da6212473d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_33b28105-32e6-4506-99b9-dde6ed3e107c" xlink:href="nbix-20211231.xsd#nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:to="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_33b28105-32e6-4506-99b9-dde6ed3e107c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#CollaborationandLicenseAgreementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="extended" id="i7bde0e4d83ff4b2a83e5f93f71cbca62_CollaborationandLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePayments_486a6455-9204-4702-9f07-2be391059a51" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PotentialMilestonePayments_486a6455-9204-4702-9f07-2be391059a51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c007fb35-7f4f-4ebe-9323-7dc700775aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c007fb35-7f4f-4ebe-9323-7dc700775aed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_UpfrontPaymentsMade_33d7ab08-c1f6-4e10-9e7f-18b11a13cc99" xlink:href="nbix-20211231.xsd#nbix_UpfrontPaymentsMade"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_UpfrontPaymentsMade_33d7ab08-c1f6-4e10-9e7f-18b11a13cc99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_0b1c57ca-4f33-4f68-8dfe-88bbb1754157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_0b1c57ca-4f33-4f68-8dfe-88bbb1754157" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_489ca236-bd0a-4db0-8c12-1dd53f2f985c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_SharePrice_489ca236-bd0a-4db0-8c12-1dd53f2f985c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestoneEquityPurchasePayment_0e37b9ee-edc2-4ce3-8f62-f34d7316d863" xlink:href="nbix-20211231.xsd#nbix_MilestoneEquityPurchasePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_MilestoneEquityPurchasePayment_0e37b9ee-edc2-4ce3-8f62-f34d7316d863" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_441d3813-ecca-4399-a871-189c2d2392c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_441d3813-ecca-4399-a871-189c2d2392c1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestonePayment_401ab16a-c013-448f-ae0a-d26593777db6" xlink:href="nbix-20211231.xsd#nbix_MilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_MilestonePayment_401ab16a-c013-448f-ae0a-d26593777db6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1d9113f0-e8a9-4f50-9be6-6900476dcb86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1d9113f0-e8a9-4f50-9be6-6900476dcb86" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestoneEquityPurchasePayment_712a913b-745d-4c7a-824e-a7f54d9d7449" xlink:href="nbix-20211231.xsd#nbix_MilestoneEquityPurchasePayment"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePaymentReceipts_6a621bde-bccd-4aa1-90c5-20066190f180" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePaymentReceipts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PotentialMilestonePaymentReceipts_6a621bde-bccd-4aa1-90c5-20066190f180" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PatentTerm_c1085df5-30d8-49fe-97ab-2ad4a60f55a8" xlink:href="nbix-20211231.xsd#nbix_PatentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PatentTerm_c1085df5-30d8-49fe-97ab-2ad4a60f55a8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b29042d8-5d90-41a3-99be-a52b5dacf116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b29042d8-5d90-41a3-99be-a52b5dacf116" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_aa1fd2a5-2936-48e5-9e2b-b05bf890a28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_aa1fd2a5-2936-48e5-9e2b-b05bf890a28c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_de9dc85b-f65f-4067-b825-0fa04576a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_DeferredRevenue_de9dc85b-f65f-4067-b825-0fa04576a061" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9baf1c8f-4250-41b7-8f6a-ed6562882344_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9baf1c8f-4250-41b7-8f6a-ed6562882344_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d0c38182-f389-41bc-9de8-5a3c00ba7727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d0c38182-f389-41bc-9de8-5a3c00ba7727" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7067f35e-22c8-49f4-aa71-5803f94c3c3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:to="loc_us-gaap_EquityComponentDomain_7067f35e-22c8-49f4-aa71-5803f94c3c3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:to="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1aabdbe9-9693-40e4-9733-e0eba6e21716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:to="loc_us-gaap_CommonStockMember_1aabdbe9-9693-40e4-9733-e0eba6e21716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47843dea-83b8-46dc-b73f-132b95f3884f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_47843dea-83b8-46dc-b73f-132b95f3884f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_6f5fcb3e-9841-48ae-94e0-9751b7641412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:to="loc_us-gaap_PatentsMember_6f5fcb3e-9841-48ae-94e0-9751b7641412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bf431c80-e3b1-4185-afc3-277614c7527f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:to="loc_srt_ProductsAndServicesDomain_bf431c80-e3b1-4185-afc3-277614c7527f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:to="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_54972a9d-773c-4995-be7c-8604ef1ba744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:to="loc_us-gaap_RoyaltyMember_54972a9d-773c-4995-be7c-8604ef1ba744" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2e013610-d476-4f1f-a696-3509fed84855_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:to="loc_srt_RangeMember_2e013610-d476-4f1f-a696-3509fed84855_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:to="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1f85b179-2a31-4603-943a-f17c26812047" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:to="loc_srt_MinimumMember_1f85b179-2a31-4603-943a-f17c26812047" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5fadf602-0313-453d-aee8-51621972da90_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5fadf602-0313-453d-aee8-51621972da90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_HeptaresTherapeuticsLimitedMember_9a39610d-7267-4389-9023-bc6a3903f941" xlink:href="nbix-20211231.xsd#nbix_HeptaresTherapeuticsLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_HeptaresTherapeuticsLimitedMember_9a39610d-7267-4389-9023-bc6a3903f941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember_83068265-cd8d-4aaa-9404-46e63ddfc0ef" xlink:href="nbix-20211231.xsd#nbix_TakedaPharmaceuticalCompanyLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember_83068265-cd8d-4aaa-9404-46e63ddfc0ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IdorsiaPharmaceuticalsLtdMember_6729feb9-3108-43e0-9faf-8364871a9d1c" xlink:href="nbix-20211231.xsd#nbix_IdorsiaPharmaceuticalsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_IdorsiaPharmaceuticalsLtdMember_6729feb9-3108-43e0-9faf-8364871a9d1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_XenonPharmaceuticalsIncMember_c0dbbc65-ae94-4da9-be01-93cc75e338c5" xlink:href="nbix-20211231.xsd#nbix_XenonPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_XenonPharmaceuticalsIncMember_c0dbbc65-ae94-4da9-be01-93cc75e338c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_VoyagerTherapeuticsMember_abe4e76e-ee25-4bee-a1c7-47ea44542ada" xlink:href="nbix-20211231.xsd#nbix_VoyagerTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_VoyagerTherapeuticsMember_abe4e76e-ee25-4bee-a1c7-47ea44542ada" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_BIALMember_4ab9c33d-db9a-4d44-9ca6-87ae2a97db90" xlink:href="nbix-20211231.xsd#nbix_BIALMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_BIALMember_4ab9c33d-db9a-4d44-9ca6-87ae2a97db90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MitsubishiTanabePharmaCorporationMember_71185823-05dc-452e-8e98-8187b3962583" xlink:href="nbix-20211231.xsd#nbix_MitsubishiTanabePharmaCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_MitsubishiTanabePharmaCorporationMember_71185823-05dc-452e-8e98-8187b3962583" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AbbvieIncMember_f78358ac-05b5-41e0-8c66-32f4b0ec2976" xlink:href="nbix-20211231.xsd#nbix_AbbvieIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_AbbvieIncMember_f78358ac-05b5-41e0-8c66-32f4b0ec2976" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="extended" id="i9cc7db8c44384d6a9bb24d7be8cb2a57_DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d9da091b-39e1-42eb-9722-b56b75e01379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d9da091b-39e1-42eb-9722-b56b75e01379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9582e16f-0f40-4378-8e51-a5b42c861532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9582e16f-0f40-4378-8e51-a5b42c861532" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0862a68c-da4a-4d29-b11a-9a274017e260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0862a68c-da4a-4d29-b11a-9a274017e260" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b9a1e7ec-91f8-4027-966b-7a2c16398614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b9a1e7ec-91f8-4027-966b-7a2c16398614" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f58cd67c-dccb-40f1-9312-66c47c5460ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f58cd67c-dccb-40f1-9312-66c47c5460ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e6bb03ab-ac39-4fa0-a012-00b133a24324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e6bb03ab-ac39-4fa0-a012-00b133a24324" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LongTermInvestmentsMember_ddbeb470-1267-4c04-ba73-fcdb7744da8a" xlink:href="nbix-20211231.xsd#nbix_LongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:to="loc_nbix_LongTermInvestmentsMember_ddbeb470-1267-4c04-ba73-fcdb7744da8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6c53759d-adc2-422d-bb2e-dd4bd98538d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_6c53759d-adc2-422d-bb2e-dd4bd98538d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_592fb73b-6686-4698-a66e-b444713583f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:to="loc_us-gaap_CommercialPaperMember_592fb73b-6686-4698-a66e-b444713583f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_adaa639e-eeed-4d25-ac3b-ed75e8797969_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_adaa639e-eeed-4d25-ac3b-ed75e8797969_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_7cc506e5-4360-4729-8d4b-0652546a8db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_7cc506e5-4360-4729-8d4b-0652546a8db3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a7227692-4453-431c-85df-0447ac5e450d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a7227692-4453-431c-85df-0447ac5e450d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails" xlink:type="extended" id="i54d24cdb325c480fa08c555057b01895_DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71f6468c-5685-47b1-9017-72deb96526c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71f6468c-5685-47b1-9017-72deb96526c0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_635f71eb-d58a-4dca-b5b4-f0fbb8d7c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_635f71eb-d58a-4dca-b5b4-f0fbb8d7c35b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:to="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86f4b4fe-a991-4cbc-ae3b-d4580777f680_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_86f4b4fe-a991-4cbc-ae3b-d4580777f680_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_fbea71cd-2b02-48cf-8da1-edc145a86f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_fbea71cd-2b02-48cf-8da1-edc145a86f0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2074baad-527b-4925-a5ca-af1e1374fdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2074baad-527b-4925-a5ca-af1e1374fdd8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="ife864967c332442eb65c44b964424c54_FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_13c230c3-6cf5-4623-a9cb-dc836bfdb82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:to="loc_us-gaap_Investments_13c230c3-6cf5-4623-a9cb-dc836bfdb82b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4a93ae9c-0cf8-490a-81f0-9c9de49dd63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4a93ae9c-0cf8-490a-81f0-9c9de49dd63b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cb6e785-64ec-4b5e-aa0b-090c14decd20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6cb6e785-64ec-4b5e-aa0b-090c14decd20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9613d76a-6c16-4636-a445-000807011ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9613d76a-6c16-4636-a445-000807011ece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_41f5a4a7-1dae-4f75-9244-4621a196d0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_41f5a4a7-1dae-4f75-9244-4621a196d0f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_718ecfee-805a-4993-9999-e5c9778fb0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_718ecfee-805a-4993-9999-e5c9778fb0cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_70539cf1-95e8-4a5b-a249-6e40057a8734_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_70539cf1-95e8-4a5b-a249-6e40057a8734_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CashAndMoneyMarketFundMember_0d3dc4b2-535d-48cb-a1df-c2f8b6870384" xlink:href="nbix-20211231.xsd#nbix_CashAndMoneyMarketFundMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_nbix_CashAndMoneyMarketFundMember_0d3dc4b2-535d-48cb-a1df-c2f8b6870384" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_8d06fa96-c550-4486-9ff3-8be351f54be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_us-gaap_CertificatesOfDepositMember_8d06fa96-c550-4486-9ff3-8be351f54be2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4b549f9f-7c3e-4b92-b2f0-3e198741dd11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_us-gaap_CommercialPaperMember_4b549f9f-7c3e-4b92-b2f0-3e198741dd11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16f52720-05a7-465d-8e2b-c46e3e160f54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_16f52720-05a7-465d-8e2b-c46e3e160f54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dca340b3-e1f0-4b18-8cee-d76f02fad2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dca340b3-e1f0-4b18-8cee-d76f02fad2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5e80e136-b54d-4d29-8bd2-dabc7114d5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5e80e136-b54d-4d29-8bd2-dabc7114d5a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_b84d3e19-af0f-40fe-b728-d8d9679d11de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_EquitySecuritiesMember_b84d3e19-af0f-40fe-b728-d8d9679d11de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_039eacef-78c7-41c2-8169-d8e4883d0a13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_039eacef-78c7-41c2-8169-d8e4883d0a13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_966bbbcc-1b56-46c1-8cb0-79489b52cade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_966bbbcc-1b56-46c1-8cb0-79489b52cade" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended" id="id259e33007944ded9c7bf6b9848b7959_FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_c134df5e-1116-4020-90bd-f1a1948de2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_c134df5e-1116-4020-90bd-f1a1948de2dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_c1838ce5-f96d-4b6e-a7c5-a7d1af9a86f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_c1838ce5-f96d-4b6e-a7c5-a7d1af9a86f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_709335e5-4d64-46ea-8132-da93b4091768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_709335e5-4d64-46ea-8132-da93b4091768" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_7854a469-99a3-4578-988b-4a65563727cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_7854a469-99a3-4578-988b-4a65563727cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_94143aff-7f97-4282-97b3-cd80ec134e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_11181401-697e-47e2-a6fc-4f69403cc8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_11181401-697e-47e2-a6fc-4f69403cc8f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8f4c05d7-d048-4eee-a426-d5485684ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8f4c05d7-d048-4eee-a426-d5485684ba9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_813be4e2-e86f-4db0-ac75-8dd84b650f57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:to="loc_us-gaap_CollateralDomain_813be4e2-e86f-4db0-ac75-8dd84b650f57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:to="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3f8513ca-8f2c-464c-b1a4-c41419aec26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:to="loc_us-gaap_EquitySecuritiesMember_3f8513ca-8f2c-464c-b1a4-c41419aec26c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c60f13a3-e07e-49bc-9240-4fa9f8c8d505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c60f13a3-e07e-49bc-9240-4fa9f8c8d505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_XenonPharmaceuticalsIncMember_bcdfca4d-4cb1-4c75-9bdf-dcbb860acb6d" xlink:href="nbix-20211231.xsd#nbix_XenonPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:to="loc_nbix_XenonPharmaceuticalsIncMember_bcdfca4d-4cb1-4c75-9bdf-dcbb860acb6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_9897f52b-0792-46e1-b5e9-cf5ed7a7ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:to="loc_us-gaap_CollaborativeArrangementMember_9897f52b-0792-46e1-b5e9-cf5ed7a7ccca" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="ib2b58914145c41f487752f2eea0a5c38_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis_29f5278f-ebb5-4c11-b93a-d455ef6b1c48" xlink:href="nbix-20211231.xsd#nbix_DiscountForMarketabilityUsedInValuationAnalysis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:to="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis_29f5278f-ebb5-4c11-b93a-d455ef6b1c48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:to="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_306502c3-19dc-4110-ba3c-2fee5a144a1e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_306502c3-19dc-4110-ba3c-2fee5a144a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_VoyagerTherapeuticsMember_0d7967fe-c204-46df-8cb1-6f577a83303a" xlink:href="nbix-20211231.xsd#nbix_VoyagerTherapeuticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:to="loc_nbix_VoyagerTherapeuticsMember_0d7967fe-c204-46df-8cb1-6f577a83303a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5452a915-53b1-434b-971b-64b4f0f86615_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_5452a915-53b1-434b-971b-64b4f0f86615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_070b55e9-61db-44c2-aa42-61090a5fec8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_070b55e9-61db-44c2-aa42-61090a5fec8e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="extended" id="i758d9e6294d143c7951fbaef8f2554e9_ConvertibleSeniorNotesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_db1e493e-95b4-4ce3-9f94-8b2931228fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_db1e493e-95b4-4ce3-9f94-8b2931228fec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_cb10e5ce-6c14-443c-8e2e-2c6d272b5295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_cb10e5ce-6c14-443c-8e2e-2c6d272b5295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e5ff4a4-60bd-4a0f-9bc5-8b16012735d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e5ff4a4-60bd-4a0f-9bc5-8b16012735d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_bc98b274-d01d-430a-812c-ea5cc8d60508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_bc98b274-d01d-430a-812c-ea5cc8d60508" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_1496de50-64a6-4bbb-8584-f120742cfa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_RepaymentsOfDebt_1496de50-64a6-4bbb-8584-f120742cfa3c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_ad75f1be-73be-412d-8376-4aec8ba0ae96" xlink:href="nbix-20211231.xsd#nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_ad75f1be-73be-412d-8376-4aec8ba0ae96" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_b46def16-1ee2-4aa1-be34-2a3be18834dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_b46def16-1ee2-4aa1-be34-2a3be18834dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_70cbb5c2-b3ec-4e49-81cb-1042b1373689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_70cbb5c2-b3ec-4e49-81cb-1042b1373689" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement_90b73cb6-0533-47d2-a042-d075b8cc05d4" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentAtSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement_90b73cb6-0533-47d2-a042-d075b8cc05d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e00d9dcc-ace2-4d96-af03-4f3d08eb9fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e00d9dcc-ace2-4d96-af03-4f3d08eb9fc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8d49dec1-f5de-45f3-a53d-92d46f88c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8d49dec1-f5de-45f3-a53d-92d46f88c4ec" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_337ee00d-6b17-4f1f-94c3-89c750a64c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_337ee00d-6b17-4f1f-94c3-89c750a64c73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_63e7b667-1ae4-4efa-9e44-b6ce5bb94e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_63e7b667-1ae4-4efa-9e44-b6ce5bb94e74" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b5aa1d1c-45d1-44fe-b5b6-66996673823a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b5aa1d1c-45d1-44fe-b5b6-66996673823a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PrincipalAmountOnConversionRate_a724353f-3e99-402f-a070-6eb5420849fd" xlink:href="nbix-20211231.xsd#nbix_PrincipalAmountOnConversionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_PrincipalAmountOnConversionRate_a724353f-3e99-402f-a070-6eb5420849fd" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_ad2b54b6-7e1f-49b0-a211-d742a22081dc" xlink:href="nbix-20211231.xsd#nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_ad2b54b6-7e1f-49b0-a211-d742a22081dc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TradingDaysDuringObservationPeriod_2e80b9f8-cd7b-4954-9110-49a538fe8fa3" xlink:href="nbix-20211231.xsd#nbix_TradingDaysDuringObservationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_TradingDaysDuringObservationPeriod_2e80b9f8-cd7b-4954-9110-49a538fe8fa3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_53590913-65f8-4d4c-bb11-6b33b9abe0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_53590913-65f8-4d4c-bb11-6b33b9abe0bf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e9fa1363-3410-4a35-9ccd-6c2cde5a9022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e9fa1363-3410-4a35-9ccd-6c2cde5a9022" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_5e80a4be-f054-43e3-9ad7-b835de3dd047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_5e80a4be-f054-43e3-9ad7-b835de3dd047" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConvertibleConversionPremium_da4b93c9-5593-4cf2-8a75-80b5869f4116" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConvertibleConversionPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_DebtInstrumentConvertibleConversionPremium_da4b93c9-5593-4cf2-8a75-80b5869f4116" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_fd406df6-adb5-4880-aaec-7b32ff00268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_SharePrice_fd406df6-adb5-4880-aaec-7b32ff00268c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_65b8334a-9fc9-4c38-82d1-9ff4bd5467ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_65b8334a-9fc9-4c38-82d1-9ff4bd5467ea" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance_b3cf0c96-c288-4889-b2ff-fcacbcc2d1ea" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentUponIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance_b3cf0c96-c288-4889-b2ff-fcacbcc2d1ea" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c53e0c39-f427-4caa-8b79-f406af4b8d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c53e0c39-f427-4caa-8b79-f406af4b8d4e" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_3e4fa766-8b1f-4a1a-9f8c-747426e050cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_3e4fa766-8b1f-4a1a-9f8c-747426e050cf" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_83a14d92-08e2-444d-b130-f2e7ece63005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentTerm_83a14d92-08e2-444d-b130-f2e7ece63005" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a8f32250-8bf0-4fde-813a-804daeeb207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a8f32250-8bf0-4fde-813a-804daeeb207f" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_266da457-a9a8-4562-b1d1-85d123bc601c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_266da457-a9a8-4562-b1d1-85d123bc601c" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_1b0cf335-e1d3-4c06-a347-cfae466be718" xlink:href="nbix-20211231.xsd#nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_1b0cf335-e1d3-4c06-a347-cfae466be718" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0b45f079-d836-4649-9503-25529ef28683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0b45f079-d836-4649-9503-25529ef28683" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f154b09-ab37-4ab9-9798-62fd80a9dcf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f154b09-ab37-4ab9-9798-62fd80a9dcf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_15872835-1410-43dc-ae49-a6803178fa43" xlink:href="nbix-20211231.xsd#nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:to="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_15872835-1410-43dc-ae49-a6803178fa43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_4131b6cb-e48b-41bb-80fd-f500d564e891_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_4131b6cb-e48b-41bb-80fd-f500d564e891_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7849df84-f674-4fa2-a5d8-7ed335982218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7849df84-f674-4fa2-a5d8-7ed335982218" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionDomain_448ce827-a736-4e35-88fb-7961cb3321e8_default" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:to="loc_nbix_DebtInstrumentConversionDomain_448ce827-a736-4e35-88fb-7961cb3321e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:to="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodOneMember_97097a40-c0bc-42b4-adcf-c2a9ab960731" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:to="loc_nbix_ConversionPeriodOneMember_97097a40-c0bc-42b4-adcf-c2a9ab960731" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodTwoMember_62f4fe6d-ae06-4ba9-be68-1414a99a830e" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:to="loc_nbix_ConversionPeriodTwoMember_62f4fe6d-ae06-4ba9-be68-1414a99a830e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended" id="i89b28dcd912e44b999e1ee4fe5cf5396_OtherBalanceSheetDetailsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5fee967e-8d2c-42b3-a93a-46e1db82b6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5fee967e-8d2c-42b3-a93a-46e1db82b6c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c8d460c-d75c-4452-8016-cf32521e2cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c8d460c-d75c-4452-8016-cf32521e2cee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4d19f96-f6c5-46b0-921c-04959cdedc42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4d19f96-f6c5-46b0-921c-04959cdedc42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2695ecfc-7879-41ad-8beb-30daef8de093_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2695ecfc-7879-41ad-8beb-30daef8de093_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4e47e399-aca6-40c2-b79d-ea5ae2c3d5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4e47e399-aca6-40c2-b79d-ea5ae2c3d5d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ScientificEquipmentMember_2cf71f44-6b46-4837-99c9-833cbd84a3ff" xlink:href="nbix-20211231.xsd#nbix_ScientificEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_nbix_ScientificEquipmentMember_2cf71f44-6b46-4837-99c9-833cbd84a3ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d4129a10-f276-40b6-90b7-e3252f5ba340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_ComputerEquipmentMember_d4129a10-f276-40b6-90b7-e3252f5ba340" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_eb3e16b5-8afe-4ef8-84a8-b93f82fc4afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_eb3e16b5-8afe-4ef8-84a8-b93f82fc4afa" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareScheduleofNetIncomeLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="extended" id="i69af478fc6084b06afda477a12109b92_EarningsPerShareScheduleofNetIncomeLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1de08dc2-b235-4305-9b9d-80dd78ee93b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_NetIncomeLoss_1de08dc2-b235-4305-9b9d-80dd78ee93b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ca7c5b4-0908-4f72-8f29-176022b870d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ca7c5b4-0908-4f72-8f29-176022b870d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_312d598e-ca95-4d1f-b912-07199aac225d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_312d598e-ca95-4d1f-b912-07199aac225d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_fdc8275f-4042-401b-9b2c-efd53886b7e2" xlink:href="nbix-20211231.xsd#nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_fdc8275f-4042-401b-9b2c-efd53886b7e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05e2c3a1-2475-4c87-8bd1-741ef89df8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05e2c3a1-2475-4c87-8bd1-741ef89df8d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_702695d2-7581-45c7-aba1-8e0789738134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:to="loc_us-gaap_EarningsPerShareBasic_702695d2-7581-45c7-aba1-8e0789738134" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be80695f-2593-48da-b90e-ef98d00be8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be80695f-2593-48da-b90e-ef98d00be8fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f934ea07-73dd-4dce-9dcc-9c89a53fbda4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f934ea07-73dd-4dce-9dcc-9c89a53fbda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_344d3c00-18cd-4edb-b626-5c0358844587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:to="loc_us-gaap_EmployeeStockOptionMember_344d3c00-18cd-4edb-b626-5c0358844587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6b008b5d-2388-49f7-ad56-a9142f8e8b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:to="loc_us-gaap_RestrictedStockMember_6b008b5d-2388-49f7-ad56-a9142f8e8b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:to="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_66d39004-8801-48a4-823a-d927700bcc2c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_66d39004-8801-48a4-823a-d927700bcc2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A225ConvertibleSeniorNotesMember_4660567f-2015-4819-99a1-239e82931e36" xlink:href="nbix-20211231.xsd#nbix_A225ConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:to="loc_nbix_A225ConvertibleSeniorNotesMember_4660567f-2015-4819-99a1-239e82931e36" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails" xlink:type="extended" id="ib1d55017dbb44eddb8b86a8dc20e97b7_EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca4195af-5413-44c3-a58e-88c8af5c035b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca4195af-5413-44c3-a58e-88c8af5c035b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0032d959-3bac-4027-9bb6-eb856707c923_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0032d959-3bac-4027-9bb6-eb856707c923_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_a097a726-72c7-4933-9872-2fc227421331" xlink:href="nbix-20211231.xsd#nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:to="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_a097a726-72c7-4933-9872-2fc227421331" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended" id="ie405c06d74e54bf8b3426666b4d77708_ShareBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_fb652ca0-57a4-42c4-bfba-86068eb4abaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_fb652ca0-57a4-42c4-bfba-86068eb4abaf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da5a192a-b2f9-4d62-8133-85040479e70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da5a192a-b2f9-4d62-8133-85040479e70d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_594590c8-5079-4944-8548-653fba4a53c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_594590c8-5079-4944-8548-653fba4a53c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0164f639-2de6-40ef-81af-8007e8c953dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0164f639-2de6-40ef-81af-8007e8c953dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a413af90-0f7e-487c-88f5-44f9f6099206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a413af90-0f7e-487c-88f5-44f9f6099206" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bf281f89-653e-498f-8dea-d02eb5ac5944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bf281f89-653e-498f-8dea-d02eb5ac5944" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_5f6162a3-8b69-4606-a56a-938ed0b989eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_5f6162a3-8b69-4606-a56a-938ed0b989eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb50f209-0e6a-432e-8074-cd7c64173e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb50f209-0e6a-432e-8074-cd7c64173e64" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4ea7af98-aa21-4817-999f-801e14840ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4ea7af98-aa21-4817-999f-801e14840ba9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c8d7e242-0fa7-4b35-8c52-ae917111a7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c8d7e242-0fa7-4b35-8c52-ae917111a7f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:to="loc_us-gaap_PlanNameDomain_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:to="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TwoThousandAndElevenPlanMember_4917433a-4537-42a3-9316-b51a0aab9417" xlink:href="nbix-20211231.xsd#nbix_TwoThousandAndElevenPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:to="loc_nbix_TwoThousandAndElevenPlanMember_4917433a-4537-42a3-9316-b51a0aab9417" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A2020EquityIncentivePlanMember_199d1e09-19f9-44d6-be77-bf63df0bd61b" xlink:href="nbix-20211231.xsd#nbix_A2020EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:to="loc_nbix_A2020EquityIncentivePlanMember_199d1e09-19f9-44d6-be77-bf63df0bd61b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98118896-fb96-4f5d-94c2-9f0ad0f17d0c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98118896-fb96-4f5d-94c2-9f0ad0f17d0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fdfa1080-1a19-4aac-9303-cb457bb97ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fdfa1080-1a19-4aac-9303-cb457bb97ad4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a2722a99-f2a7-44b0-84f5-52b8bd26ce9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a2722a99-f2a7-44b0-84f5-52b8bd26ce9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_dcab6983-65a0-4b75-883b-99838ac131b4" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_dcab6983-65a0-4b75-883b-99838ac131b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6a7fd3de-ba17-4881-be1d-cfac13e25b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_EmployeeStockMember_6a7fd3de-ba17-4881-be1d-cfac13e25b36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c565cf7f-d789-4f12-9645-e9cef86929cd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:to="loc_srt_RangeMember_c565cf7f-d789-4f12-9645-e9cef86929cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:to="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5662e837-cfb7-48db-85f4-3719398299a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:to="loc_srt_MinimumMember_5662e837-cfb7-48db-85f4-3719398299a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01d5d24f-8263-4415-8575-41cb2fefd201" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:to="loc_srt_MaximumMember_01d5d24f-8263-4415-8575-41cb2fefd201" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails" xlink:type="extended" id="i78a4178336404acea42bac6f12efb4ca_ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c6d16192-a6f1-4cea-a3a1-10333cf30411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c6d16192-a6f1-4cea-a3a1-10333cf30411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_195e2418-1620-4ae5-83ee-ec7d0a65ac22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_195e2418-1620-4ae5-83ee-ec7d0a65ac22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_644bd3da-97bf-4786-98f2-5f9a93bd9716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_644bd3da-97bf-4786-98f2-5f9a93bd9716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e75bfef3-33c8-456e-9b62-55a292d20f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e75bfef3-33c8-456e-9b62-55a292d20f0e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails" xlink:type="extended" id="ice801772e21c460aa1881e17d2c206fc_ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ce0e23c-cb1e-44a1-9ea4-3753fe5e858e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ce0e23c-cb1e-44a1-9ea4-3753fe5e858e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:to="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e18da172-22f4-428e-9472-cae454d755d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e18da172-22f4-428e-9472-cae454d755d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ad71ffc5-e299-4318-8777-6277bb0f4da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ad71ffc5-e299-4318-8777-6277bb0f4da6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9f444afb-5d7d-4b6c-8a31-258808ed0e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9f444afb-5d7d-4b6c-8a31-258808ed0e17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_fc137f76-2bca-467a-9695-fd3042580318" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_fc137f76-2bca-467a-9695-fd3042580318" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_5255e833-e0fc-4632-b230-596687b48a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_EmployeeStockMember_5255e833-e0fc-4632-b230-596687b48a68" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails" xlink:type="extended" id="i7b41309f172f4c3780ebd7e9b57aab36_ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ff6963f0-bfbc-4e2e-b30e-b686474cb561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ff6963f0-bfbc-4e2e-b30e-b686474cb561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7e9f469b-5091-45c8-b78d-59a26ab2dd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7e9f469b-5091-45c8-b78d-59a26ab2dd1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:to="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_394f8f2f-094f-453b-a462-f7e4f81ea37f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_394f8f2f-094f-453b-a462-f7e4f81ea37f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_07e52a3a-9d8e-4120-bbd8-c2b62a537066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_07e52a3a-9d8e-4120-bbd8-c2b62a537066" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_109fe560-e117-40d9-b987-415bd2aca78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_109fe560-e117-40d9-b987-415bd2aca78a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails" xlink:type="extended" id="ic38aad72d0684c9586cbe923f5364551_ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_366925ec-b740-456f-917f-ae79a8745347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_366925ec-b740-456f-917f-ae79a8745347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7adce39c-9506-4b64-b028-a71a37ffff58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7adce39c-9506-4b64-b028-a71a37ffff58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9b60ccfc-d17a-441e-99fb-4f8dfade6ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9b60ccfc-d17a-441e-99fb-4f8dfade6ed8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb598e82-290b-465c-8c07-be97a556a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb598e82-290b-465c-8c07-be97a556a06b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:to="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00c910fe-e187-4165-887d-33fa4e155711_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_00c910fe-e187-4165-887d-33fa4e155711_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_64112201-d81e-4b27-a565-625108fea6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_64112201-d81e-4b27-a565-625108fea6f9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails" xlink:type="extended" id="ibf1d4a9e86944eb68024c39ed7c44da0_ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4838ebfb-a942-4cb0-b09c-fc2c46c802d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4838ebfb-a942-4cb0-b09c-fc2c46c802d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7dca21a5-62ba-4271-b332-61a1c169da0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7dca21a5-62ba-4271-b332-61a1c169da0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26359ebf-bf1e-46be-a145-604550de52dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26359ebf-bf1e-46be-a145-604550de52dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b6e4e4ed-3eea-4b8f-ab94-13e2f88c4efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b6e4e4ed-3eea-4b8f-ab94-13e2f88c4efd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e625433-49df-46c8-865d-770fbfa9d9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_84eb9803-18d9-4372-9011-a516dfd10a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_84eb9803-18d9-4372-9011-a516dfd10a29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d3f6fd3-b714-4ec5-b822-4c6c99750fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d3f6fd3-b714-4ec5-b822-4c6c99750fc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7ef4dffa-b461-4f82-90f4-d4822196895b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7ef4dffa-b461-4f82-90f4-d4822196895b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_17d25928-39bc-456a-84e5-87c0b60de595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_17d25928-39bc-456a-84e5-87c0b60de595" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_028038e2-e895-44c2-9504-2074f406a2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b2b0b0f4-3044-4ac4-8a80-19169800962e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b2b0b0f4-3044-4ac4-8a80-19169800962e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_0436c4a2-648d-4a63-8829-313d058af612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_0436c4a2-648d-4a63-8829-313d058af612" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:to="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be19db0b-8a6b-4ca0-9029-930fc473db3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be19db0b-8a6b-4ca0-9029-930fc473db3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_58a4f77d-3a73-48fd-a948-e3a40f6d8bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_58a4f77d-3a73-48fd-a948-e3a40f6d8bae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_6aa24cfa-1606-40ab-a8a5-73ae1f54f9be" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_6aa24cfa-1606-40ab-a8a5-73ae1f54f9be" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended" id="if24e0679f10b4eafa4e665fbc7a45e80_IncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a3b2b51-8a2e-4b28-b8d8-57405cafdfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a3b2b51-8a2e-4b28-b8d8-57405cafdfe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c7953230-b05f-47ca-837d-1817ce2fa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c7953230-b05f-47ca-837d-1817ce2fa2ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b96b3219-77e6-4720-9e6d-0301e434c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b96b3219-77e6-4720-9e6d-0301e434c5c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_28679688-9b7f-4428-94fb-42240884d623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_28679688-9b7f-4428-94fb-42240884d623" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6f366e08-b727-4a38-8c00-4d1e0700d2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6f366e08-b727-4a38-8c00-4d1e0700d2f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0adba173-6449-43db-900b-5d3b71afd88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0adba173-6449-43db-900b-5d3b71afd88c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_056a5f84-0575-4843-af7b-094773020c07_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_056a5f84-0575-4843-af7b-094773020c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_d29b234e-5788-4804-9adc-a488e3090091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_d29b234e-5788-4804-9adc-a488e3090091" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_04717939-2b11-415a-9816-11c6cf4864d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_04717939-2b11-415a-9816-11c6cf4864d4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSupplementalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/LeasesSupplementalInformationDetails" xlink:type="extended" id="i8125b7e22ca14c47b9e0b3d90e8a32c5_LeasesSupplementalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_7c2bdc8d-5e99-4643-8252-66fb9cd27348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseCost_7c2bdc8d-5e99-4643-8252-66fb9cd27348" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_91a65481-6dbc-4c4b-9087-a7fa3338454c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeasePayments_91a65481-6dbc-4c4b-9087-a7fa3338454c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b51e993b-e4ed-4ab1-93fd-b1b201fd170a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b51e993b-e4ed-4ab1-93fd-b1b201fd170a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c082c72a-b21a-4c15-bde4-47387c7ec969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c082c72a-b21a-4c15-bde4-47387c7ec969" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_10275731-eb1e-4a50-b184-2c268e077a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_10275731-eb1e-4a50-b184-2c268e077a58" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:to="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ff04f691-a329-4a0c-960f-a54b5f166450_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:to="loc_us-gaap_CreditFacilityDomain_ff04f691-a329-4a0c-960f-a54b5f166450_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:to="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7d3dcc57-4727-4e7e-9e6e-bb114db153aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:to="loc_us-gaap_LetterOfCreditMember_7d3dcc57-4727-4e7e-9e6e-bb114db153aa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.neurocrine.com/role/SubsequentEventsDetails" xlink:type="extended" id="i51845f5e08ae4e1cb56e2e36ff84d950_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f9cc4690-a842-429d-9adb-5ba6f3bc78cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f9cc4690-a842-429d-9adb-5ba6f3bc78cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_a3bb06bf-c5a5-4db0-acda-c3cb1fd56531" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_a3bb06bf-c5a5-4db0-acda-c3cb1fd56531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AnnualRentEscalationPercentage_d3aabd94-307c-44f8-b363-34fe976d3d76" xlink:href="nbix-20211231.xsd#nbix_AnnualRentEscalationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_AnnualRentEscalationPercentage_d3aabd94-307c-44f8-b363-34fe976d3d76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RentAbatementPeriod_b902194f-4248-429d-b12d-7e9ce6414fe8" xlink:href="nbix-20211231.xsd#nbix_RentAbatementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_RentAbatementPeriod_b902194f-4248-429d-b12d-7e9ce6414fe8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfRenewalOptions_b6029ecc-803f-44bf-bf4e-4e1bd3f4cc40" xlink:href="nbix-20211231.xsd#nbix_NumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_NumberOfRenewalOptions_b6029ecc-803f-44bf-bf4e-4e1bd3f4cc40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_04a0142d-288b-4b4f-86fd-0223d4c2ff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_04a0142d-288b-4b4f-86fd-0223d4c2ff0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_1d697c65-fe2d-4a84-b202-3edb1a212abb" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_1d697c65-fe2d-4a84-b202-3edb1a212abb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_de0d41c0-f700-4cc5-8159-f3e34d8d7274_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_de0d41c0-f700-4cc5-8159-f3e34d8d7274_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8f0bd1bc-d4b8-4c20-a59a-89e197b0bd61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:to="loc_us-gaap_SubsequentEventMember_8f0bd1bc-d4b8-4c20-a59a-89e197b0bd61" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>nbix-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_nbix_DebtInstrumentConversionDomain_56d5bfa6-faea-4d60-b96c-beda50bb1f82_terseLabel_en-US" xlink:label="lab_nbix_DebtInstrumentConversionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion [Domain]</link:label>
    <link:label id="lab_nbix_DebtInstrumentConversionDomain_label_en-US" xlink:label="lab_nbix_DebtInstrumentConversionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion [Domain]</link:label>
    <link:label id="lab_nbix_DebtInstrumentConversionDomain_documentation_en-US" xlink:label="lab_nbix_DebtInstrumentConversionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionDomain" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DebtInstrumentConversionDomain" xlink:to="lab_nbix_DebtInstrumentConversionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f9e947b4-96e9-4ad4-975d-3e321b7cce87_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Disclosure:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_283e93e7-b742-4a65-90cb-fd3c157efd5e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock_88d2b626-d4e1-4085-9fe9-8999ea2e0117_terseLabel_en-US" xlink:label="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock_label_en-US" xlink:label="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Reconciliation Of Cash Cash Equivalents And Restricted Cash [Table Text Block]</link:label>
    <link:label id="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock_documentation_en-US" xlink:label="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of reconciliation of cash cash equivalents and restricted cash.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:href="nbix-20211231.xsd#nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:to="lab_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_4fcc1f9c-b8be-4302-b277-9eb109a65465_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_9fcf9b56-d2c2-40c2-b34f-6f994b89b59b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income taxes, rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_6b75c514-8695-4c5d-8eaf-1292a434226e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_7d5dd191-61cd-43e8-9592-f1599bfec176_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f2684b32-d0a9-4a05-a3dd-61fc44352e29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_af08d997-844a-43a1-9297-7679410136c4_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d8043728-4ad4-4ec5-bc1e-d558e6891ff9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_7c9566dd-8a7f-456e-9f0e-d3d6b6d331e4_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_819fa9f6-c685-4412-90ab-fba01062c7a2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_cc1c782b-0c47-4e71-9255-f06689c423f1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_c6f36cf9-d713-4c25-a9ab-bc409e226573_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_3850e4b6-0d31-4b87-9cec-e5e926d33801_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3eef2fa2-be44-44b4-8acf-dc7a7b94c338_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_c951fce1-7267-48e7-add8-d35705ad8692_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_969fe415-03b2-45dc-a93a-7f227941280b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued employee related costs</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_017b71a4-a55d-40bb-9338-425fcd24511d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d2c8c667-2cec-4ebf-94f9-6dc9841d0ce4_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_a99fd36e-0bb5-49b5-aac0-2389c5eed49b_terseLabel_en-US" xlink:label="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum percentage of common stock price trigger</link:label>
    <link:label id="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_label_en-US" xlink:label="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Percentage Of Trading Price To Last Reported Sale Price</link:label>
    <link:label id="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_documentation_en-US" xlink:label="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The minimum percentage of the product of the common stock trading price multiplied by the conversion rate during the measurement period as compared to the principal note amount that triggers a conversion option on the notes, if it falls below this percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:href="nbix-20211231.xsd#nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:to="lab_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_d5ba33ca-9874-48c1-aad1-1101aa2b3fd8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Industry Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3456cfa4-2b60-4251-9eae-963896b4e8ed_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4214c8cf-cce4-446c-bf20-544e23fa7880_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_bd93724f-45e5-4e1f-8f5c-0106a690e422_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2628b6f6-e5fc-4bf2-b6e2-1b6003cb5b0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_UpfrontPaymentsMade_a1348a60-b3e2-40a9-bdf4-7da0d2187679_terseLabel_en-US" xlink:label="lab_nbix_UpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments made</link:label>
    <link:label id="lab_nbix_UpfrontPaymentsMade_label_en-US" xlink:label="lab_nbix_UpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront Payments Made</link:label>
    <link:label id="lab_nbix_UpfrontPaymentsMade_documentation_en-US" xlink:label="lab_nbix_UpfrontPaymentsMade" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Upfront payments made under a collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_UpfrontPaymentsMade" xlink:href="nbix-20211231.xsd#nbix_UpfrontPaymentsMade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_UpfrontPaymentsMade" xlink:to="lab_nbix_UpfrontPaymentsMade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_53dd3d2c-5baa-4a26-8ab9-88170df44788_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a8f73709-bc66-4682-9a40-437d22773d2c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_46b9d77e-a817-4763-8f39-95a81b8992e4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_InvestmentIncomeAndOtherNet_a5632e4f-f2ff-4237-b460-b8aa9be9a692_terseLabel_en-US" xlink:label="lab_nbix_InvestmentIncomeAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income and other, net</link:label>
    <link:label id="lab_nbix_InvestmentIncomeAndOtherNet_label_en-US" xlink:label="lab_nbix_InvestmentIncomeAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income And Other Net</link:label>
    <link:label id="lab_nbix_InvestmentIncomeAndOtherNet_documentation_en-US" xlink:label="lab_nbix_InvestmentIncomeAndOtherNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income and other net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_InvestmentIncomeAndOtherNet" xlink:href="nbix-20211231.xsd#nbix_InvestmentIncomeAndOtherNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_InvestmentIncomeAndOtherNet" xlink:to="lab_nbix_InvestmentIncomeAndOtherNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_d271e8ac-5ac6-408c-b46e-3c2b80c8e2d3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f84fd714-5e2a-471e-8648-358aa028ab83_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d8750fc-c879-4dd2-9be8-8c833e3be059_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_e90a85e6-89ae-472d-a449-6ea2bab3f48c_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019ef99b-c19e-4b0d-a71d-90e8e12efebd_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_28e73f65-59cf-4a33-b5db-95cddbd4bd84_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_59cae32d-1ee4-4755-9aed-b26ce003d04d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility of common stock</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c57dc926-6d1c-4c6a-bdbb-f35ee1a8dff4_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_27d3be91-6bb8-4519-98bb-60d0b5f0cff1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options exercised in period intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_ae074a2c-1c62-4301-a7aa-f868bb1b9b68_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_c0383ffd-a8d8-40ab-9abf-cb6eb11dc884_terseLabel_en-US" xlink:label="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024 Notes (in shares)</link:label>
    <link:label id="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_label_en-US" xlink:label="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities</link:label>
    <link:label id="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_documentation_en-US" xlink:label="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:href="nbix-20211231.xsd#nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:to="lab_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_2c344185-ee29-4c08-8d44-06fd1e63dbcd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_080e7dfe-6aef-4ba2-822b-0ddb2a196dd3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_TwoThousandAndElevenPlanMember_c2cfe8c1-6cb3-41b8-9b74-4b1a0ac95ced_terseLabel_en-US" xlink:label="lab_nbix_TwoThousandAndElevenPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan</link:label>
    <link:label id="lab_nbix_TwoThousandAndElevenPlanMember_label_en-US" xlink:label="lab_nbix_TwoThousandAndElevenPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand And Eleven Plan [Member]</link:label>
    <link:label id="lab_nbix_TwoThousandAndElevenPlanMember_documentation_en-US" xlink:label="lab_nbix_TwoThousandAndElevenPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Two Thousand and Eleven Plan [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TwoThousandAndElevenPlanMember" xlink:href="nbix-20211231.xsd#nbix_TwoThousandAndElevenPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_TwoThousandAndElevenPlanMember" xlink:to="lab_nbix_TwoThousandAndElevenPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c1051f38-98cc-4699-b7a0-dec5560be343_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_be46a1eb-97bb-4935-ba6d-9551c41f5562_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_642478a2-404e-4e89-8ac5-2aa685111ddd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9effd8f6-0748-48b3-b53c-0c403b37fc9d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_5b0507c8-872b-4287-8a11-ad5a20116bde_verboseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anti-dilutive shares excluded from diluted per share amounts (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_38c59d91-be91-4cf7-8140-c0bbe69d5130_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_1e93495e-dbd6-4cc7-a545-8c894e6695d8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_591576f8-34ae-40d2-990f-de809b7f7305_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_4b28cc0f-83ff-4813-8d73-ba5075da82ca_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_8b89b841-f408-4dac-9bcc-f66b438fc50c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_352180a0-ab87-4a2b-9afd-5b5c92f1b7a7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_b40d2104-a144-4e21-8ba2-6dde6afae6b0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of PRSUs vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_b048c0fe-8ef4-4d43-9502-94e614dcbbd3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (loss) gain on debt securities available-for-sale</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b5ec616d-0523-4cdc-bf21-e7cad30effd9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued to settle notes at initial conversion rate (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRestrictedInvestments_948b2aaf-364a-4dc5-b186-17a1a976ec72_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRestrictedInvestments_d2cd2208-06bf-4074-a0bb-29ebd1b0376f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases to acquire equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRestrictedInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Restricted Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireRestrictedInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_270b44f6-6c63-4731-a3ba-ef7fc3bdc3e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7e58dd67-6f81-4888-9ca5-65cd79644a47_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_50fa5a85-0871-4329-a286-d62bf5cd0bcd_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_CashAndMoneyMarketFundMember_7f24c158-ddff-4d06-aa96-52e15a5895f8_terseLabel_en-US" xlink:label="lab_nbix_CashAndMoneyMarketFundMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and money market funds</link:label>
    <link:label id="lab_nbix_CashAndMoneyMarketFundMember_label_en-US" xlink:label="lab_nbix_CashAndMoneyMarketFundMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Money Market Fund [Member]</link:label>
    <link:label id="lab_nbix_CashAndMoneyMarketFundMember_documentation_en-US" xlink:label="lab_nbix_CashAndMoneyMarketFundMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency on hand as well as demand deposits with banks or financial institutions, and funds that invest in short-term money-market instruments, for example, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CashAndMoneyMarketFundMember" xlink:href="nbix-20211231.xsd#nbix_CashAndMoneyMarketFundMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_CashAndMoneyMarketFundMember" xlink:to="lab_nbix_CashAndMoneyMarketFundMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_23ef8cd5-d41e-4371-adf0-604d1756ca73_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_7745ec33-7a36-4a7b-82cb-3ce774f7d9f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost, gross unrealized gain (loss) positions and estimated fair value for available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis_a03d0f86-479b-42d7-b3e3-748191c7e176_terseLabel_en-US" xlink:label="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount for marketability in valuation analysis</link:label>
    <link:label id="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis_label_en-US" xlink:label="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount For Marketability Used In Valuation Analysis</link:label>
    <link:label id="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis_documentation_en-US" xlink:label="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount For Marketability Used In Valuation Analysis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:href="nbix-20211231.xsd#nbix_DiscountForMarketabilityUsedInValuationAnalysis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:to="lab_nbix_DiscountForMarketabilityUsedInValuationAnalysis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_54f24e99-2bb5-49ae-9fa6-eb1f102dcc7c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8cf20b16-d06a-4e57-8e79-3bd1aa1d196a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7bda18d0-8990-43cf-b7ca-2d38d45ebb47_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_PrincipalAmountOnConversionRate_db548511-ea3d-417e-8e69-44faae6a3581_terseLabel_en-US" xlink:label="lab_nbix_PrincipalAmountOnConversionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount on conversion rate</link:label>
    <link:label id="lab_nbix_PrincipalAmountOnConversionRate_label_en-US" xlink:label="lab_nbix_PrincipalAmountOnConversionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount On Conversion Rate</link:label>
    <link:label id="lab_nbix_PrincipalAmountOnConversionRate_documentation_en-US" xlink:label="lab_nbix_PrincipalAmountOnConversionRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal amount on conversion rate.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PrincipalAmountOnConversionRate" xlink:href="nbix-20211231.xsd#nbix_PrincipalAmountOnConversionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_PrincipalAmountOnConversionRate" xlink:to="lab_nbix_PrincipalAmountOnConversionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_8c658ef4-29de-4ca7-b7b6-ad3ff6a8c7d3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_0d85660f-e4e1-4fe8-9c3b-495df7602fcf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding as of December&#160;31, 2021 and 2020</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c8b40460-ffc0-440a-ad6f-a71e0e7bf218_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8d859d3d-6762-4a88-9b18-83910733cad9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9ee1ccdc-14ed-4df0-b74f-65f55ec4e98f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0656125f-a7bd-4348-bf97-37ec6e776c32_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive common stock trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_57cfbd5a-046e-4667-a08e-82ef8e52bf4d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_9bc63bc8-4106-455b-afa0-6996ffbdddbc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_538ca6a1-7142-45db-80ce-5458222808f4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_40312f92-e2a9-4561-b9a2-0c7693d6392b_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_NumberOfRenewalOptions_80b5ac06-00e2-4681-97b6-e1c070babbbb_terseLabel_en-US" xlink:label="lab_nbix_NumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lease renewal options</link:label>
    <link:label id="lab_nbix_NumberOfRenewalOptions_label_en-US" xlink:label="lab_nbix_NumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NumberOfRenewalOptions</link:label>
    <link:label id="lab_nbix_NumberOfRenewalOptions_documentation_en-US" xlink:label="lab_nbix_NumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The number of renewal options under the terms of the lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfRenewalOptions" xlink:href="nbix-20211231.xsd#nbix_NumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_NumberOfRenewalOptions" xlink:to="lab_nbix_NumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_TradingDaysDuringObservationPeriod_7396e924-6da5-4c3a-941b-56b4fe0bd1f5_terseLabel_en-US" xlink:label="lab_nbix_TradingDaysDuringObservationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading days during observation period</link:label>
    <link:label id="lab_nbix_TradingDaysDuringObservationPeriod_label_en-US" xlink:label="lab_nbix_TradingDaysDuringObservationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Days During Observation Period</link:label>
    <link:label id="lab_nbix_TradingDaysDuringObservationPeriod_documentation_en-US" xlink:label="lab_nbix_TradingDaysDuringObservationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading days during observation period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TradingDaysDuringObservationPeriod" xlink:href="nbix-20211231.xsd#nbix_TradingDaysDuringObservationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_TradingDaysDuringObservationPeriod" xlink:to="lab_nbix_TradingDaysDuringObservationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b1c13e9c-80ad-4899-b891-f20ab7a32790_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and License Agreements</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance_b495c2b8-f9c1-4a26-b37e-bb68f84e9370_terseLabel_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the liability component upon issuance</link:label>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance_label_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount Of Liability Component Upon Issuance</link:label>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance_documentation_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The carrying amount of the liability component upon issuance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentUponIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:to="lab_nbix_CarryingAmountOfLiabilityComponentUponIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_481eedb5-fa99-4960-a83f-db4d76fe51e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_OtherBalanceSheetDetailsAbstract_3568a06b-d49e-4edf-ae7d-e4ad340ea5fb_terseLabel_en-US" xlink:label="lab_nbix_OtherBalanceSheetDetailsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Details [Abstract]</link:label>
    <link:label id="lab_nbix_OtherBalanceSheetDetailsAbstract_label_en-US" xlink:label="lab_nbix_OtherBalanceSheetDetailsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Details [Abstract]</link:label>
    <link:label id="lab_nbix_OtherBalanceSheetDetailsAbstract_documentation_en-US" xlink:label="lab_nbix_OtherBalanceSheetDetailsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other balance sheet details.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract" xlink:to="lab_nbix_OtherBalanceSheetDetailsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_07576d9c-0814-4451-9909-a208828dc400_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross unrealized losses and fair value available-for-sale investments in unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_fb2a33de-7ac3-4724-821f-9d3603e31125_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_d01a9581-e325-4e99-bdb0-da065ddc7502_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_440ef279-fbb7-4724-9daa-f319cddaf40b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal amount repurchased</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9e043e6f-dbd4-4a2a-8d0d-c36a1f3715d2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets acquired through operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_5df66aeb-e639-4ab4-86ca-99ddcd2c5ab7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_b44bb330-106e-412f-b25b-ff6d43e6da40_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_cbeb6f80-3204-4085-a3f3-f8b6be221a94_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_cbf497b5-0830-42c5-8e91-b3a6753eae35_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_MilestoneEquityPurchasePayment_a9a803f0-b233-4d61-ae0c-b5bbabe78c08_terseLabel_en-US" xlink:label="lab_nbix_MilestoneEquityPurchasePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone equity purchase payment</link:label>
    <link:label id="lab_nbix_MilestoneEquityPurchasePayment_label_en-US" xlink:label="lab_nbix_MilestoneEquityPurchasePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Equity Purchase Payment</link:label>
    <link:label id="lab_nbix_MilestoneEquityPurchasePayment_documentation_en-US" xlink:label="lab_nbix_MilestoneEquityPurchasePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Equity Purchase Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestoneEquityPurchasePayment" xlink:href="nbix-20211231.xsd#nbix_MilestoneEquityPurchasePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_MilestoneEquityPurchasePayment" xlink:to="lab_nbix_MilestoneEquityPurchasePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent_91ea3346-f079-4546-b678-fad9728c6453_terseLabel_en-US" xlink:label="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued development costs</link:label>
    <link:label id="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent_label_en-US" xlink:label="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Research And Development Expense Current</link:label>
    <link:label id="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent_documentation_en-US" xlink:label="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued research and development expense current.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:href="nbix-20211231.xsd#nbix_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:to="lab_nbix_AccruedResearchAndDevelopmentExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_f92a54b2-1153-4560-a504-536ba1bdde13_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_34226430-4f35-401f-9017-34c978530ef9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7a39581b-9c79-4a39-8f37-51851fb07877_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8c3ce4c8-5fa7-4363-a17d-19d689729a37_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_7254a5a8-c7c2-4c02-84ff-865daa96d981_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year ending December 31, 2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_NumberOfIrishSubsidiaries_b4660ac9-96c9-4e60-93a7-407a6020055b_terseLabel_en-US" xlink:label="lab_nbix_NumberOfIrishSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of wholly owned Irish subsidiaries</link:label>
    <link:label id="lab_nbix_NumberOfIrishSubsidiaries_label_en-US" xlink:label="lab_nbix_NumberOfIrishSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Irish Subsidiaries</link:label>
    <link:label id="lab_nbix_NumberOfIrishSubsidiaries_documentation_en-US" xlink:label="lab_nbix_NumberOfIrishSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Irish Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfIrishSubsidiaries" xlink:href="nbix-20211231.xsd#nbix_NumberOfIrishSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_NumberOfIrishSubsidiaries" xlink:to="lab_nbix_NumberOfIrishSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_A225ConvertibleSeniorNotesMember_81472c20-6db8-45ab-afc4-94986062c548_terseLabel_en-US" xlink:label="lab_nbix_A225ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Senior Notes</link:label>
    <link:label id="lab_nbix_A225ConvertibleSeniorNotesMember_label_en-US" xlink:label="lab_nbix_A225ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Senior Notes [Member]</link:label>
    <link:label id="lab_nbix_A225ConvertibleSeniorNotesMember_documentation_en-US" xlink:label="lab_nbix_A225ConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Senior Notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A225ConvertibleSeniorNotesMember" xlink:href="nbix-20211231.xsd#nbix_A225ConvertibleSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_A225ConvertibleSeniorNotesMember" xlink:to="lab_nbix_A225ConvertibleSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_436f981d-f489-4a38-8605-8f2f791b6acb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_77438fe1-5c36-49f2-af2d-b6ea0cbff113_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_42753f8e-5926-4d35-b21f-39ddd10d2f68_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, employer contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_A2020EquityIncentivePlanMember_6475d693-6bb0-408a-b086-b5491ce401a9_terseLabel_en-US" xlink:label="lab_nbix_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Plan</link:label>
    <link:label id="lab_nbix_A2020EquityIncentivePlanMember_label_en-US" xlink:label="lab_nbix_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_nbix_A2020EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_nbix_A2020EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A2020EquityIncentivePlanMember" xlink:href="nbix-20211231.xsd#nbix_A2020EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_A2020EquityIncentivePlanMember" xlink:to="lab_nbix_A2020EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_aa180a22-bb70-4de7-8d23-d69b5a9fc336_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_MilestonePayment_12c286bb-93a1-4e38-9846-be9ef78457e7_terseLabel_en-US" xlink:label="lab_nbix_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payment</link:label>
    <link:label id="lab_nbix_MilestonePayment_label_en-US" xlink:label="lab_nbix_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payment</link:label>
    <link:label id="lab_nbix_MilestonePayment_documentation_en-US" xlink:label="lab_nbix_MilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made for milestones under a collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestonePayment" xlink:href="nbix-20211231.xsd#nbix_MilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_MilestonePayment" xlink:to="lab_nbix_MilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_367e63da-34e4-41dd-9746-70973d1632e1_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_32f471d4-cd6b-45ae-9017-0bc715fef7c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partial repurchase of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_e014934d-c3b1-4680-b25a-210b91cb61d9_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a12f3341-ae7c-47b5-aee5-c3fdcdf860b5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0417afe6-6587-4511-b02f-009409443ff7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of common stock authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_6f604ec2-6167-4739-84b1-3ab7b75a6090_totalLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_3b11de9e-fc8c-43da-bd0c-0fdeface382e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_LargestTwoCustomersMember_c6f69a8b-3301-444b-9eb4-85e5b2ed6c77_terseLabel_en-US" xlink:label="lab_nbix_LargestTwoCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest two customers</link:label>
    <link:label id="lab_nbix_LargestTwoCustomersMember_label_en-US" xlink:label="lab_nbix_LargestTwoCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Two Customers [Member]</link:label>
    <link:label id="lab_nbix_LargestTwoCustomersMember_documentation_en-US" xlink:label="lab_nbix_LargestTwoCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Largest Two Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LargestTwoCustomersMember" xlink:href="nbix-20211231.xsd#nbix_LargestTwoCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_LargestTwoCustomersMember" xlink:to="lab_nbix_LargestTwoCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_9a4b5729-15bf-4eb8-b4da-b45045f5d16a_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_34cfbfd6-1ecd-4129-b1aa-a9e3773bc5ec_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_PatentTerm_efd17332-5564-4571-ada3-dd0d6c04ad34_terseLabel_en-US" xlink:label="lab_nbix_PatentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent term</link:label>
    <link:label id="lab_nbix_PatentTerm_label_en-US" xlink:label="lab_nbix_PatentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patent term</link:label>
    <link:label id="lab_nbix_PatentTerm_documentation_en-US" xlink:label="lab_nbix_PatentTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term of the patent, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PatentTerm" xlink:href="nbix-20211231.xsd#nbix_PatentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_PatentTerm" xlink:to="lab_nbix_PatentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRestricted_8452aa23-27b8-4fc4-afba-ffa1a0b44c40_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRestricted_c30fd06b-3737-45fd-b1b6-134eff01a7e1_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities fair value amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRestricted_ae51e4f4-7043-4a22-ac63-88c8b01e0df9_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, beginning balance</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRestricted_d3181345-9b95-4bb3-8670-b72853b345d9_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities, ending balance</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRestricted_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Restricted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRestricted" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRestricted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_44664a64-3402-485f-b963-41b38e5a11dd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets on recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_8f813b6f-808f-4795-905a-4a9a3b241f93_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_69fce6ca-b896-47dc-abcc-631937c5ccb2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_44feb776-990b-4659-9aa3-509f304fd499_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_2ac76b1c-cbd6-44a7-bc5c-ca9ccea40b1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_138c2288-f97d-49a4-98f4-c9e6e14c47b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_f9cd34bc-ebd8-4477-8139-d61e766a69ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_8f75b30d-6c0d-43c1-8bc7-74b740138cf4_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_ac77a3a1-999d-4d10-902a-8f795d325339_negatedTerseLabel_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_label_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Operating Leases Liabilities</link:label>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_documentation_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities operating leases liabilities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:to="lab_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6a027995-24b4-4c38-aa34-05bca061803c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_f20247f5-70a4-4ede-8d77-99107a3105c9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_22831348-4031-4a9d-8b5e-129f7d46fb89_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_125f25fe-c4ca-4d2f-b413-49c120b08948_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year ending December 31, 2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_70c1c7cb-d190-4dac-a664-c26977fab555_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5d0aa4b2-b304-4b7d-8cce-ec81d1b591dd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and maturities of debt securities available-for-sale</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_4b3b548a-382d-443d-b1be-99c38301ebeb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_67eefad6-6ad1-4412-8e94-e3ff955d07ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_aaaec701-87d4-44d7-a561-a9a03d413b57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement_4ac48938-9068-4ec3-997b-40ae2224a144_terseLabel_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the liability component at settlement</link:label>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement_label_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount Of Liability Component At Settlement</link:label>
    <link:label id="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement_documentation_en-US" xlink:label="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the liability component at settlement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentAtSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:to="lab_nbix_CarryingAmountOfLiabilityComponentAtSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_261e7d56-8309-48ac-b187-77cd206c9788_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a0e847a2-ede4-487e-a0c5-632271f61bf1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_25cd08c7-74dc-41cf-9355-2f8e0f48b75a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits that would affect effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e5e1cc24-f963-4017-b7d0-5020c3573624_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_6234e82c-d021-4774-9269-e7567aab791b_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_AccruedBrandedPrescriptionDrugFee_3b62ea47-07a5-486b-9dbc-3222be1e4557_terseLabel_en-US" xlink:label="lab_nbix_AccruedBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current branded prescription drug fee</link:label>
    <link:label id="lab_nbix_AccruedBrandedPrescriptionDrugFee_label_en-US" xlink:label="lab_nbix_AccruedBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Branded Prescription Drug Fee</link:label>
    <link:label id="lab_nbix_AccruedBrandedPrescriptionDrugFee_documentation_en-US" xlink:label="lab_nbix_AccruedBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Branded Prescription Drug Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedBrandedPrescriptionDrugFee" xlink:href="nbix-20211231.xsd#nbix_AccruedBrandedPrescriptionDrugFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_AccruedBrandedPrescriptionDrugFee" xlink:to="lab_nbix_AccruedBrandedPrescriptionDrugFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9530cfe9-bcc5-4098-b15f-1507b6df54e4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_0a537953-1c2c-4c09-8819-7c29d964ae4d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_96eae33d-096a-4bee-8e81-74beb91f143f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_af3fefbf-c9ed-4403-bd4a-1c12ee5c3d4a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_dee416ea-1d4d-49d2-ab33-2dd467bea1a9_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_24f2c860-8238-48d6-9e15-f758fbdc60cb_terseLabel_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer compensation</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_label_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Nondeductible Expense Officer Compensation Cost</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_documentation_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation nondeductible expense officer compensation cost.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:to="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_879430f6-8bd8-4f34-84ef-cd18a6bb90e2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e119c12d-461e-4e36-8f1d-b4f22efc0a08_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_2ff962ad-8a35-46e6-9540-f9d2b56c703c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying amount of the equity component upon issuance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Carrying Amount of Equity Component</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:to="lab_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_a64bb8e2-b251-449b-ac97-385d31ce032b_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available-for-sale (amortized cost was $370.6 and $612.4 as of December&#160;31, 2021 and 2020, respectively)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_BIALMember_dddd884f-1a3f-4a22-9dcd-fc219a9d673e_terseLabel_en-US" xlink:label="lab_nbix_BIALMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">B I A L</link:label>
    <link:label id="lab_nbix_BIALMember_label_en-US" xlink:label="lab_nbix_BIALMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">B I A L [Member]</link:label>
    <link:label id="lab_nbix_BIALMember_documentation_en-US" xlink:label="lab_nbix_BIALMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to BIAL, an entity with which Neurocrine has a license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_BIALMember" xlink:href="nbix-20211231.xsd#nbix_BIALMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_BIALMember" xlink:to="lab_nbix_BIALMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_31da21c3-41b7-4b33-bb58-b3772a3f37ef_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year ending December 31, 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_b3513c84-1963-429f-8413-477716bbcd19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_442218a1-0e32-454a-b7ff-4ef4f4339e34_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_6cef7503-ed91-4604-a191-6978407080c6_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_91f0fbd2-c8e7-47be-a461-372ed66c3e4b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_f3cb9c94-8f26-405d-bdcb-dfeb144a584f_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d73b5c86-cdb3-4648-9305-23411b6b1d75_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_27828c17-845e-468f-979b-5d2a8621c1bb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_0cbe74af-de35-4b52-83a2-5655a61d4d51_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_143acadb-0bc2-4b08-a3bd-1f1fa3e7a29a_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7c85db95-603b-4c02-a83e-3740ac96246c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6e331182-2c40-4904-94e8-e4ca1f0fba25_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_e96ca216-fea9-427b-adf1-1d05d5a50a5e_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_4391cce2-94e2-4ba5-9d25-5e8d9927d9b2_terseLabel_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly base rent per square foot</link:label>
    <link:label id="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_label_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot</link:label>
    <link:label id="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_documentation_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Monthly Base Rent Per Square Foot</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:to="lab_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_3d0e0e59-b253-4d79-a924-2322cc6c6713_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_ac58187f-8da5-4816-9d7e-655026a135b4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_ed1c5610-1e46-4b4d-a481-ac06a045e6d6_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash related to letters of credit issued in lieu of cash security deposits</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_8595e8df-d892-481e-ab7a-202e88b198de_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_52c0ddcf-040b-4493-9b26-2944db55c1c2_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_c89c5bda-85f5-4c37-811e-d1f20ee5a156_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e3f8e97d-8671-44f2-bd79-0cef7a8cebb3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of income tax expense for continuing operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0cb9ceb0-cc3a-4375-a8bb-58d210a8eaad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_993b6b5e-ed70-4081-b8bf-4fbc31b56a3a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8a7ed85f-5e13-46f9-930c-03eba5af618d_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f3fe0a0d-0aaf-4ce2-8ee6-ba81b5b2b183_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_94959aa9-576d-4764-b4bc-a5a541edc621_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_de22a690-0ab6-494e-94c8-60611c2cf383_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities&#8211;biotechnology industry</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6bfa108b-8d49-48c8-a8dd-37781d149194_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_2c50ca21-8cfb-4462-9d3a-6dfecd5407bc_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_34aee368-f382-4e9b-a842-87e446803e0b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_0f49fe63-2fe4-42e4-bef1-e0b43320894d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_456d2459-f9aa-4f70-8639-60d278fc92b6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_809381cb-ae34-4f13-93e0-30ddec9a3ade_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 220.0 shares authorized; 94.9 and 93.5 shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_89120083-c933-4d48-9ec0-304ae23c676b_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0e568711-eb2a-4935-92a3-d28d662670ed_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Recognition Period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_199a036a-924d-49a5-a16a-073e0d44a3ba_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Unvested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d03d705b-c6aa-4fc3-8862-bae412101b8f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Unvested (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_9991a578-ee6e-4c79-ab7a-704ba763b0fa_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_8d3d2b96-ff4b-4dab-9c06-250aa454fe18_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_3706052b-c6ff-468c-b8ea-645cd06f5e30_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c195696a-8a07-442f-9512-e155df15862e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8806e0c3-397d-4d73-8e2e-8e860c98af3e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_60a0bc10-5e0a-48d1-9487-a10a4ac2a7f6_terseLabel_en-US" xlink:label="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible senior notes due 2024</link:label>
    <link:label id="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_label_en-US" xlink:label="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Convertible Notes Two Point Two Five Percent Due In May Two Thousand Twenty Four [Member]</link:label>
    <link:label id="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_documentation_en-US" xlink:label="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the 2.25% Convertible Senior Notes Due in May 2024.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:href="nbix-20211231.xsd#nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:to="lab_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_eaa4b427-10f0-4167-8360-f1ff1933d205_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_8bacf0eb-efb5-4ce1-bd61-9f8645684afb_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f1f30cff-0fc5-48ab-ae90-7c2a4cf9120e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average assumptions for stock option grants using black-scholes option-pricing model</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_7bcb90c1-7b78-47ea-8cf7-e4b14842a658_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentMeasurementInput_6b779824-826c-4691-96ed-3eaa121c045b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentMeasurementInput" xlink:to="lab_us-gaap_DebtInstrumentMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_4980b5a1-8b6a-4b08-ba25-54add2873116_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember_33f21702-e19f-4790-b740-84da9df6d979_terseLabel_en-US" xlink:label="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda</link:label>
    <link:label id="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember_label_en-US" xlink:label="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda Pharmaceutical Company Limited [Member]</link:label>
    <link:label id="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember_documentation_en-US" xlink:label="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Takeda Pharmaceutical Company Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:href="nbix-20211231.xsd#nbix_TakedaPharmaceuticalCompanyLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:to="lab_nbix_TakedaPharmaceuticalCompanyLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_c37eecbf-4515-41b5-a279-fe67cb5d4805_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d4c694d9-6a39-4dcc-8845-54860594ba7a_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c9e2be00-eb19-4437-8c1f-bcaad2f09afe_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_cadf5da1-04db-48bf-9f09-b7d10b388b31_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_9c965bab-9a6e-4085-b0d7-990c53402c7d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_e5d1fc70-2904-4a26-9e62-e5982c2371fb_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d0ff9add-4b18-4115-b1f8-9250e6145fde_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accreted interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_4815fe9e-e38c-46a0-a76c-795129e402bf_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_195eb1a3-c08e-49f6-8455-35d0b1de5c27_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_04a5b41c-11d5-45d6-b4ae-a964f0a50e2c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0b7b28ba-81f1-4b0c-a19b-9d5c841080fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of equity securities measured at fair value on recurring basis using significant unobservable inputs</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_1f5b76cb-5e24-42aa-9b91-7e8e7da02c2c_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f9903cb0-c8a4-4aca-9e0c-57f004406fa0_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expense</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_86aa562b-da8b-44b1-8261-d9bf2d9049e0_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_1ac8397e-fe8e-4e79-9fa9-bd20dc72eb09_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_00329d4f-419d-44fc-a0b3-01912f92ae58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_a85a0d50-731e-4b02-afb5-a24535e6c83a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d8f55281-78e6-4f58-899b-d2aa91ea35b9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_99b15dc6-dbcb-4afd-8cd4-d6352dcd915d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_2f6ae708-9fb4-4eef-98de-b6a16b5eaad3_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest receivables</link:label>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableCurrent" xlink:to="lab_us-gaap_InterestReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_ef6163b7-543b-4ffb-9996-9ddb79c781d8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_d9bd5ab1-abdf-4c55-a48b-dec3f6dd3fea_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_e1ef20e7-b505-41d3-bd64-cc1076b05e45_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_f332b321-376c-4318-84eb-619a536b09ad_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_78a92390-c615-4470-beb2-e264d7bfa2b5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current operating lease liabilities included in other current liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_64b2277e-33ff-44ba-ae47-aabe7ce7c650_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3a6f554a-3087-4606-adfc-1ddd47d5fa3c_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_6e29234d-54b5-46f9-a0f1-c205ebe0fbca_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and License Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_11b968fd-e7ad-4a87-9f6e-12a11bcb76d4_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_b4650564-e89d-49f4-ae58-7b146dbc7335_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_ee6157eb-839b-4f49-bf23-440304f29a63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_81cfe120-7298-4df8-8616-49a5b0149d74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfers out of Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_2e0c3307-f595-4e2a-8fdc-2b31152fc2fd_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_b2109274-816e-4756-a598-495546d0e73c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a1398859-7323-4d83-a39e-79b10eb1596e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_10d2630f-a880-4b38-9b98-7a1f5393b1d4_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate repurchase price paid in cash</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_c76c44af-b2b9-4407-badb-19c0bb29920a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueProductLineMember" xlink:to="lab_us-gaap_SalesRevenueProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralDomain_8eb5dfc2-28e7-48e6-a8a6-a2a57357ab54_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:label id="lab_us-gaap_CollateralDomain_label_en-US" xlink:label="lab_us-gaap_CollateralDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralDomain" xlink:to="lab_us-gaap_CollateralDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_8257215c-093b-461f-b8ac-2aca12366659_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of debt securities available-for-sale</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_30457e4c-6000-4697-8955-f04cd3695292_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_a68fafbe-a4f3-4ef4-8bcb-e80ce033f251_terseLabel_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_05ad409f-89c2-4e87-a87f-a1a580dc7468_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary and changes in restricted stock units outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_99326e4d-ac95-466b-85bd-9afec613738d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_f1e47c73-483e-4b56-b935-f09583d434d2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_PotentialMilestonePaymentReceipts_d9d5d757-6c8f-43b7-a5d7-8f75bfd1ef0d_terseLabel_en-US" xlink:label="lab_nbix_PotentialMilestonePaymentReceipts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential milestone payment receipts</link:label>
    <link:label id="lab_nbix_PotentialMilestonePaymentReceipts_label_en-US" xlink:label="lab_nbix_PotentialMilestonePaymentReceipts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Milestone Payment Receipts</link:label>
    <link:label id="lab_nbix_PotentialMilestonePaymentReceipts_documentation_en-US" xlink:label="lab_nbix_PotentialMilestonePaymentReceipts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential later stage milestone payments and royalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePaymentReceipts" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePaymentReceipts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_PotentialMilestonePaymentReceipts" xlink:to="lab_nbix_PotentialMilestonePaymentReceipts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_6460ac0a-f8b0-468f-bb84-516789ec811c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_988d2f37-77a0-46f6-8f50-7ccae2d097ac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_d675e1ad-746f-4ccf-9465-4f7cd1f093b8_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired in-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Asset Acquired Other than Through Business Combination, Written-off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="lab_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_eeb7abf3-a445-4e5d-8fea-94b7ec44c612_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2a0ab42c-16c8-4efe-ac65-bf9286dfda37_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_41454073-1696-4e69-8e3a-4ec8dcb2efeb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_0e53d0b9-b3e6-4620-afe4-db0258b29f71_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e1d832bb-ad76-45dc-b885-6a5ca43cfb77_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_08048b15-4cbc-4d92-9abe-19f6f85b427f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5310612e-0f72-4426-b33f-417472eae325_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_420ad61c-086d-45b5-93d2-0e9a37ffba76_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_CostOfSales_dd57a054-2138-413d-803c-c3c90904566e_terseLabel_en-US" xlink:label="lab_nbix_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_nbix_CostOfSales_label_en-US" xlink:label="lab_nbix_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Sales</link:label>
    <link:label id="lab_nbix_CostOfSales_documentation_en-US" xlink:label="lab_nbix_CostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CostOfSales" xlink:href="nbix-20211231.xsd#nbix_CostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_CostOfSales" xlink:to="lab_nbix_CostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_50bd9c13-0554-4c7d-be46-674cce774dba_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_18a2f21b-93d1-4544-9ac6-9dc2d2692fbb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7ddcb7ff-e2b0-42ed-88b4-b79933b3bce3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_95a9e926-7f86-457c-9ed3-c281ded676ad_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of minimum lease payments for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_f7a39f2d-12d8-45e4-ac8d-498b4b6e9f4e_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_9be468bb-6fac-4788-9504-b7f042365159_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_2761810f-c4a4-4fcc-974e-b6853381cfa2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f1adfa24-55b1-4bd9-be04-617350fdc89f_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_d6b7a86d-82ec-46ed-9f3c-923bed78ff60_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of repurchased convertible senior notes, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_438c0a0c-1ad7-4593-8a9c-f9fc473022e0_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity component of repurchased convertible senior notes</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_95b5ffac-666a-4ecc-8b58-1b30ca5037a3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carry forward, net</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c269d866-25a5-4999-aca5-f16cd641a03a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DebtInstrumentConvertibleConversionPremium_593a0d1a-a6b2-41d1-8993-3bf2f5939ab3_terseLabel_en-US" xlink:label="lab_nbix_DebtInstrumentConvertibleConversionPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion premium</link:label>
    <link:label id="lab_nbix_DebtInstrumentConvertibleConversionPremium_label_en-US" xlink:label="lab_nbix_DebtInstrumentConvertibleConversionPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument Convertible Conversion Premium</link:label>
    <link:label id="lab_nbix_DebtInstrumentConvertibleConversionPremium_documentation_en-US" xlink:label="lab_nbix_DebtInstrumentConvertibleConversionPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The percentage of excess of the price paid for the convertible note over the closing stock price on the closing date of the convertible note.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConvertibleConversionPremium" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConvertibleConversionPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DebtInstrumentConvertibleConversionPremium" xlink:to="lab_nbix_DebtInstrumentConvertibleConversionPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_f0e08bf2-c3fc-4ee0-b533-58533627b849_terseLabel_en-US" xlink:label="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_label_en-US" xlink:label="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expense Excluding Research And Development Asset Acquired Other Than Through Business Combination Written Off</link:label>
    <link:label id="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_documentation_en-US" xlink:label="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding the write-off for research and development assets that were acquired in a transaction other than a business combination during the period. Excludes software research and development, which has a separate concept.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:href="nbix-20211231.xsd#nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:to="lab_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_d6df916a-6c5f-421c-b5d3-356efef46f24_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_4c646758-e466-4c2b-ae69-119dde6059a7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7a88d189-08fe-482f-8f69-9eecffa2ce31_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_3f1e0dbe-4cfa-4445-bfd5-d4e7c10943c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_dc29c960-f015-4f52-810d-4e25f93cd1cc_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_19f40085-61da-4214-8c86-29f2f7f91adb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on extinguishment of convertible senior notes</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_34dc0ce4-a6aa-48c8-a518-1f7ce031ecc7_terseLabel_en-US" xlink:label="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Events of default percentage of principal and accrued and unpaid interest due and payable upon default</link:label>
    <link:label id="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_label_en-US" xlink:label="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Events Of Default Percentage Of Principal And Accrued And Unpaid Interest Due And Payable Upon Default</link:label>
    <link:label id="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_documentation_en-US" xlink:label="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Events of default percentage of principal and accrued and unpaid interest due and payable upon default.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:href="nbix-20211231.xsd#nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:to="lab_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_5ccd0b36-e3ff-438d-9797-e9d5661ef251_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DebtInstrumentConversionAxis_e2ea4b2c-82b8-4ea6-866f-c7f78fc75bfd_terseLabel_en-US" xlink:label="lab_nbix_DebtInstrumentConversionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion [Axis]</link:label>
    <link:label id="lab_nbix_DebtInstrumentConversionAxis_label_en-US" xlink:label="lab_nbix_DebtInstrumentConversionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion [Axis]</link:label>
    <link:label id="lab_nbix_DebtInstrumentConversionAxis_documentation_en-US" xlink:label="lab_nbix_DebtInstrumentConversionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionAxis" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DebtInstrumentConversionAxis" xlink:to="lab_nbix_DebtInstrumentConversionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_b2db40cf-c750-4bf1-99af-5109bee81926_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_77e454d7-2f0c-4943-9bda-a7bb688e975a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity related to unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_17a1b8eb-4be4-4c41-a0e2-3ef088b9f53a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2a774240-4631-4e96-bd43-5ade009f3fab_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_df37b3c9-afe7-422d-bce6-b49b6e438a52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_6c2d8c94-5d85-4334-8181-7448ef1e5448_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_d4ec9c5e-e7da-4bcd-b344-0c00f459147a_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5e29eee9-84ce-4998-b3a6-0facd3a72303_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_ff238e0d-9217-4a6d-9eed-64e9a02689f0_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_d870dd35-c737-4f28-8baa-e7a1808d72df_verboseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market price of common stock (in USD per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_d2f8b866-ee3b-4ee6-aadc-dd1907ccf64a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_ee16ea44-6ccc-429b-89a3-7f0690d040a0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_9bb7212c-6616-49cb-af84-b9777aa876d5_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual term of stock options</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_da7f313a-6a9f-4842-81df-ada53dd0be5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_90ae9b91-f208-4047-ba35-7b00a0fe080f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_bd519904-d93a-42ef-97db-892b27453cab_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_3e6fdf57-fa4a-4098-bac0-e673afb88747_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_b673e641-69b8-4ea4-b5ad-ae824747df2a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_HeptaresTherapeuticsLimitedMember_84cd76af-e591-47a0-ad34-f71c0bd60abb_terseLabel_en-US" xlink:label="lab_nbix_HeptaresTherapeuticsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heptares</link:label>
    <link:label id="lab_nbix_HeptaresTherapeuticsLimitedMember_label_en-US" xlink:label="lab_nbix_HeptaresTherapeuticsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heptares Therapeutics Limited [Member]</link:label>
    <link:label id="lab_nbix_HeptaresTherapeuticsLimitedMember_documentation_en-US" xlink:label="lab_nbix_HeptaresTherapeuticsLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Heptares Therapeutics Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_HeptaresTherapeuticsLimitedMember" xlink:href="nbix-20211231.xsd#nbix_HeptaresTherapeuticsLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_HeptaresTherapeuticsLimitedMember" xlink:to="lab_nbix_HeptaresTherapeuticsLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_fa60dcbd-b0d2-47c3-a92f-e87aa2683b71_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_2c7dd160-dbda-49ef-9015-b3543728a86f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_de0b2566-a183-4b26-9e2a-fb79174fb313_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a00f25c0-b509-494a-9729-1f10d1ae35f5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining discount amortization period</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Remaining Discount Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_0881ae57-2f8f-480a-bd52-d6c4872c0e2d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash received from stock option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebt_8f8c3874-79cd-40b1-be74-c07999614027_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebt" xlink:to="lab_us-gaap_ConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_aa3459d5-4952-4bae-b1bd-4beb548ebe08_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_6c8bcd87-ec9f-4245-9b15-5b9fe0bfc26e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_25451be4-243f-456f-b79e-d1942f602b84_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a4832ac1-aa56-4fb6-9dea-c2749c2b3dcb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bde61db3-be5b-4b17-8589-c01016546754_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_85cf2fb1-b9be-4125-916d-37bd659dd120_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_79f3e696-18cb-443d-85b2-bb5d90716e33_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c0b3ca24-74cd-4ef7-9629-59d7a289c49b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_73cf81f9-3b1e-4ece-a02f-4446cebfbc0d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_eb861032-9f3c-4a85-b4be-0c60ca1c4989_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_9cb8a5c5-fa62-4056-b30c-89848d319218_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7046ecfb-c7ff-4fe9-a668-0fa5e0608eb2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_d3d9da65-a300-432b-9aa4-2d7b2d9cc3dc_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_8275e101-59dd-4147-b588-e3e664d1c83b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ab582778-6dc1-479d-a377-cad7edcfbd0a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e32bc864-a666-48c6-b9b1-89d4f1ca9db6_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_ffd28de1-e36c-4e53-b8d8-0ddf128f7f49_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_6f4646a5-b474-41cf-9d86-4420a331860f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_d0aa59d5-f50b-4719-aa83-8a2915e974cb_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_b8659f67-e706-433e-bf6e-b0a5118386cf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_3794e56c-e283-4200-9865-c677793b74ca_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_20b2e403-b82c-4246-815c-01b5883f121f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_CollaborationRevenueMember_856b8a5a-daa4-4d8d-ba92-19eafa85199a_terseLabel_en-US" xlink:label="lab_nbix_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue</link:label>
    <link:label id="lab_nbix_CollaborationRevenueMember_label_en-US" xlink:label="lab_nbix_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Revenue [Member]</link:label>
    <link:label id="lab_nbix_CollaborationRevenueMember_documentation_en-US" xlink:label="lab_nbix_CollaborationRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration revenue.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CollaborationRevenueMember" xlink:href="nbix-20211231.xsd#nbix_CollaborationRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_CollaborationRevenueMember" xlink:to="lab_nbix_CollaborationRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_6eb59107-0ae2-4fc2-a0ae-403f4aaffd82_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4b26dde3-920e-4acf-b6ef-59ecbd903022_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_4a61f8a6-84dd-42d6-a61b-92dcd4139af8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_256fe910-2251-483a-aa32-b24dde22ac45_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2de8d4c9-bac0-44d8-acb2-2eb395c56411_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_ddc8f446-501a-431b-a67f-9f73b4fe02db_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_293004c6-2946-4499-8037-fc67502af595_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0da34a53-687a-423b-aac4-4c816d18206c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_d91c0fb2-4366-4fa0-84ec-376679513e9b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_d86ea41c-8ffc-406f-994f-6834fdb3a7d7_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_ac7f748a-26ec-44a1-9c9b-b25e11c7dc22_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_06c2942b-b6a1-4874-81a0-dfcb7388c84a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair values of stock options granted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_1a077358-fc09-49bc-b719-c5312621a7fd_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_6749689f-d1f4-4a86-b0ea-f062736e4dcb_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock under stock plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_eb19e1b9-16a9-4750-9c20-3d3612d13e3d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year ending December 31, 2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_AuditorInformationAbstract_label_en-US" xlink:label="lab_nbix_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_nbix_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_nbix_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AuditorInformationAbstract" xlink:href="nbix-20211231.xsd#nbix_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_AuditorInformationAbstract" xlink:to="lab_nbix_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_c91a5f3c-3c47-458b-b58e-c3fc445cca8e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction cost related to issuance of convertible senior note</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_73d8b1a3-666a-4070-8f46-919f9e55b94f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_8161564c-cebf-4648-b047-4e740d355beb_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtNoncurrent" xlink:to="lab_us-gaap_ConvertibleDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_de412f42-fc70-44b1-a8cb-b01fca13bd87_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available-for-sale (amortized cost was $563.2 and $226.7 as of December&#160;31, 2021 and 2020, respectively)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_368ad8ca-8413-45cc-b680-3d851701ffa0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_3e9931ea-e630-4b67-8686-d72d621d67e2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock price trigger (in USD per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4303f49e-4e53-43d4-bd3c-2ac0177d8c46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_03d71132-a5bf-4e08-8b6f-6eb6e0ffed78_verboseLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_44c8d8cc-ad80-4f00-8aea-cc6e9dc667bf_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock under stock plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_2cdb422e-a796-4431-9d8b-8ed5265790fd_terseLabel_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee option term for construction of fifth building</link:label>
    <link:label id="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_label_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LesseeOperatingLeaseOptionTermToConstructFifthBuilding</link:label>
    <link:label id="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_documentation_en-US" xlink:label="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of term of lessee's option for the construction of a fifth building under operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:to="lab_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_da4707ec-0563-47b1-9fbc-8306ab724f4d_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_9e276bf5-a3a9-45cb-945a-64ed854c2bde_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestmentsMember" xlink:to="lab_us-gaap_ShortTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_794c0015-efc2-4684-a567-5f8e14668d76_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_bfc2cb24-a1e1-49ba-89d2-5b2d255464b3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Year ending December 31, 2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_19492dd3-c268-408b-820d-c4d24534f10a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_RentAbatementPeriod_32e7cca1-e34a-4a83-ae96-1ea5ded20204_terseLabel_en-US" xlink:label="lab_nbix_RentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent abatement period</link:label>
    <link:label id="lab_nbix_RentAbatementPeriod_label_en-US" xlink:label="lab_nbix_RentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Abatement Period</link:label>
    <link:label id="lab_nbix_RentAbatementPeriod_documentation_en-US" xlink:label="lab_nbix_RentAbatementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent Abatement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RentAbatementPeriod" xlink:href="nbix-20211231.xsd#nbix_RentAbatementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_RentAbatementPeriod" xlink:to="lab_nbix_RentAbatementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_3e97f3d5-5b9c-4e42-80a8-16cd301fef03_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discounted purchase price percentage of common stock authorized for issuance</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_72c920df-430f-42da-8ffd-fed82df10deb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_PerformanceBasedRestrictedStockUnitMember_5ff22921-9cee-4f86-ac8d-826936893d66_terseLabel_en-US" xlink:label="lab_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRSUs</link:label>
    <link:label id="lab_nbix_PerformanceBasedRestrictedStockUnitMember_label_en-US" xlink:label="lab_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Based Restricted Stock Unit [Member]</link:label>
    <link:label id="lab_nbix_PerformanceBasedRestrictedStockUnitMember_documentation_en-US" xlink:label="lab_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units which are awarded to employees after certain performance targets are met.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:to="lab_nbix_PerformanceBasedRestrictedStockUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_9fc6376e-d0f7-4687-81ea-6aa1fd1a7ed4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_919a60db-309b-4f2e-a39e-5ac169c0a8d4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9feccb83-7727-49fb-ad68-ba1685bb5f9e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_f8ca7975-3a0d-48bb-a2be-1e9fe1ae84be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_248e7fe9-5c66-416b-8415-0bcabc55cdd1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_c4db92a6-b8fd-405d-8778-1804ff277874_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_d1ccd743-040b-4622-8b40-c8bac59ad909_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c55bafd1-6fee-4fbb-973b-bf869d73095c_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7296c20c-b04a-4a04-8975-0afc0100b89a_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Total</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_8baf6acd-a8c6-44dd-a798-0cf09e56b42a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_6baff2a9-c7ce-4c3b-8cbb-ed1f65cd7631_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_1c762a2d-ed9b-4e15-81a4-4bc001487ea5_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_397a18e8-1598-4f25-8153-8b3b9bbdcb09_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ed457579-1123-45ad-915d-d824a5927410_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3dbf794d-5d6a-4219-846d-24413b5effa6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_44d051e2-875f-49d3-a64e-e191bb9c502c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold common stock trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_71e79d53-43ec-4098-bc49-4f93042d4305_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_7375221e-6882-4ab8-ad61-729d1f673624_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share based compensation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_a2ac1ec6-2192-451a-ad89-93063ac2b1ff_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a83ed838-7f80-476d-944c-61fb16d2c506_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_f6bcb5c8-2f71-4615-83db-dfa97c3319bd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuances of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_c7bc52db-8252-4473-b91a-cd3df01d10de_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_c32fb70c-b1dc-4104-8d57-631224faa13f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_00882cff-708b-49ac-ac9e-ed7c1b1491f4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a0547ae9-b2e3-408a-a692-847fa26e45c6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_2525b1e2-3892-4a1b-aa0a-313b5656d68d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term, Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_ESPPPurchasePeriod_3083b1d9-1c4b-4e1a-a5e4-4c0684ab7ded_terseLabel_en-US" xlink:label="lab_nbix_ESPPPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP purchase period</link:label>
    <link:label id="lab_nbix_ESPPPurchasePeriod_label_en-US" xlink:label="lab_nbix_ESPPPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Purchase Period</link:label>
    <link:label id="lab_nbix_ESPPPurchasePeriod_documentation_en-US" xlink:label="lab_nbix_ESPPPurchasePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP Purchase Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ESPPPurchasePeriod" xlink:href="nbix-20211231.xsd#nbix_ESPPPurchasePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_ESPPPurchasePeriod" xlink:to="lab_nbix_ESPPPurchasePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2ebd293d-723b-4bf7-8a87-3ff34adf8d1d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_8879d8cb-a90c-482f-8b91-2873f7cc214d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_de1949a2-62aa-442b-b46e-2a7aea3532a3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_ae82159f-291d-4878-92d4-a49e933090f9_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_62f9d508-412c-4aba-8f7e-91451527da62_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Details</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_47c32701-1c4b-465d-8b12-a069703579e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_fdf970af-c85b-436a-b622-1dbc5a881f09_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_19127868-df3c-412c-82b6-6a61f412e570_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_1fd17bf0-1f3b-4582-80f5-48bb22fefc89_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_d61c9ce7-2dd3-456e-9dcd-ebaaa12b585c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_dbf838f7-d0ca-4138-b815-2929a03259b4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_ee92ee30-085f-4d8e-ab4a-e68304238158_terseLabel_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired tax attributes</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_label_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Expiration Of Tax Credits</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_documentation_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation, expiration of tax credits.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationExpirationOfTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:to="lab_nbix_IncomeTaxReconciliationExpirationOfTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_01b45076-5aa4-4af1-be0a-f6d8b7370ef7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_2e8308fb-5999-432d-8b5e-825fa84e9b40_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c385de29-0a6b-4184-bc10-5034f86f326d_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of supplemental operating lease information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_83c4ca19-0686-426e-9aac-deb539ea2668_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_f710948d-86f4-4bb7-95d6-05bada9446dd_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_18db00af-3a92-4960-8d36-7dc7da9ad38b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c48ce6aa-ed38-4d9b-a4a7-769442045dfa_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6578649d-d129-4e7b-ba16-6dff359616d9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_7a324b46-b9de-4282-b35f-07857fa06c85_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_a52d97a1-1c48-490d-a5f4-beec376577c0_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and local jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_a907162a-0f10-41a3-9484-e1acef7019ba_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive securities:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_b0237912-30b8-4428-8714-b54e5e325f6f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold percentage of common stock price trigger</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_c492069d-db6b-49a5-b36a-23544e4a3686_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_MitsubishiTanabePharmaCorporationMember_85e0edc9-2a73-45cf-9087-649d0855b36e_terseLabel_en-US" xlink:label="lab_nbix_MitsubishiTanabePharmaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MTPC</link:label>
    <link:label id="lab_nbix_MitsubishiTanabePharmaCorporationMember_label_en-US" xlink:label="lab_nbix_MitsubishiTanabePharmaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mitsubishi Tanabe Pharma Corporation [Member]</link:label>
    <link:label id="lab_nbix_MitsubishiTanabePharmaCorporationMember_documentation_en-US" xlink:label="lab_nbix_MitsubishiTanabePharmaCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to the Mitsubishi Tanabe Pharma Corporation.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MitsubishiTanabePharmaCorporationMember" xlink:href="nbix-20211231.xsd#nbix_MitsubishiTanabePharmaCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_MitsubishiTanabePharmaCorporationMember" xlink:to="lab_nbix_MitsubishiTanabePharmaCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_372f8b4b-ef62-4bcc-92bd-e13a9413f351_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible List]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_164b661b-4e18-43ac-8cc5-0cc51a673b00_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e32d96f0-2078-4eae-b81e-98a94f50c6a5_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_PotentialMilestonePayments_73774dd9-a32e-49ad-8927-599d47d7c155_terseLabel_en-US" xlink:label="lab_nbix_PotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential milestone payments</link:label>
    <link:label id="lab_nbix_PotentialMilestonePayments_label_en-US" xlink:label="lab_nbix_PotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential Milestone Payments</link:label>
    <link:label id="lab_nbix_PotentialMilestonePayments_documentation_en-US" xlink:label="lab_nbix_PotentialMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of potential milestone payments to be paid under a license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePayments" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_PotentialMilestonePayments" xlink:to="lab_nbix_PotentialMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2e94620d-266b-46fc-ba7d-7c6e731f18f7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_ee0121fc-f2b1-4db9-8c91-092d5b10b7f6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c4ba59cf-60fe-4744-8798-085f095fb638_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_e58c40e2-23a8-4ee9-9959-39cc26034ecc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested, weighted average remaining contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1c286cc8-24cb-4de5-8e20-4941e5a7ca40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions_f83bcd26-fb67-4d56-b06c-3e62902b1892_terseLabel_en-US" xlink:label="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale position number of positions</link:label>
    <link:label id="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions_label_en-US" xlink:label="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Available For Sale Position Number Of Positions</link:label>
    <link:label id="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions_documentation_en-US" xlink:label="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities available for sale position number of positions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:href="nbix-20211231.xsd#nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:to="lab_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_fe722d5b-ee35-4555-bcab-9d8645a76fbf_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_dd5c43df-46a7-4102-9b4f-cad910567f4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes on earnings subject to income taxes differs from statutory federal rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2fd34c03-8937-4d90-83c2-3f0ac2286036_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_a26d1c43-d27f-48a8-b4d8-0cf623aa08b5_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_3be24704-0c61-4ec4-a691-a3cb0cf05df4_terseLabel_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Branded prescription drug fee</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_label_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Reconciliation Nondeductible Expense Branded Prescription Drug Fee</link:label>
    <link:label id="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_documentation_en-US" xlink:label="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax reconciliation nondeductible expense branded prescription drug fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:to="lab_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_edf6532d-9ed8-4b1c-bca1-c70e7cc420cd_negatedTerseLabel_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes</link:label>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_label_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Convertible Senior Notes</link:label>
    <link:label id="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_documentation_en-US" xlink:label="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities convertible senior notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:to="lab_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAxis_2bef5cfc-f015-4452-95cb-70f3e194654d_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:label id="lab_us-gaap_CollateralAxis_label_en-US" xlink:label="lab_us-gaap_CollateralAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Held [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAxis" xlink:to="lab_us-gaap_CollateralAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_2d4fcd2f-c236-4aed-a1bc-ea69e35795e9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments measured at fair value on recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_945f580a-7751-4530-802c-92e0a4aedcb6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_ab8a1e1f-2960-46be-947f-5fe1c6924f33_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_b2ad7bc5-6c9a-455e-a48f-3ed26bfcb727_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_936c7d34-66c4-4bf0-8e76-a30ee53c7a6a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_597aefc0-8125-470d-ab79-b98a1223ed0b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5bd04db2-ec10-4a17-8227-ee34febe5701_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_AnnualRentEscalationPercentage_f36fae9e-d505-4133-8cd9-841222762f65_terseLabel_en-US" xlink:label="lab_nbix_AnnualRentEscalationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual rent escalation percentage</link:label>
    <link:label id="lab_nbix_AnnualRentEscalationPercentage_label_en-US" xlink:label="lab_nbix_AnnualRentEscalationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AnnualRentEscalationPercentage</link:label>
    <link:label id="lab_nbix_AnnualRentEscalationPercentage_documentation_en-US" xlink:label="lab_nbix_AnnualRentEscalationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AnnualRentEscalationPercentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AnnualRentEscalationPercentage" xlink:href="nbix-20211231.xsd#nbix_AnnualRentEscalationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_AnnualRentEscalationPercentage" xlink:to="lab_nbix_AnnualRentEscalationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd96eee0-71db-4eeb-88d7-83f5de694687_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_ec7f5a8b-3892-4cdf-a3dd-096439643465_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_37889486-12ba-4553-a6a6-c8f571aad847_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1b9b14cf-939d-4e44-ae37-2865ddf7597c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_695fce53-6b24-48d2-9610-12a8e67e1719_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6b7972ea-5e89-4283-a6cd-0469b16bbe57_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_LongTermInvestmentsMember_f23bf8c5-d5e8-4a89-a224-5ef77f6c02a5_terseLabel_en-US" xlink:label="lab_nbix_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investments</link:label>
    <link:label id="lab_nbix_LongTermInvestmentsMember_label_en-US" xlink:label="lab_nbix_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Investments [Member]</link:label>
    <link:label id="lab_nbix_LongTermInvestmentsMember_documentation_en-US" xlink:label="lab_nbix_LongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments which are intended be sold or mature more than one year from the balance sheet date or operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LongTermInvestmentsMember" xlink:href="nbix-20211231.xsd#nbix_LongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_LongTermInvestmentsMember" xlink:to="lab_nbix_LongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3877934a-0ca7-4058-bbd3-fdde4588ce68_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_fef1a2a1-358b-419f-9294-e92e47f85bdf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_e26ba844-8c45-49bb-8868-84cbbdc8b594_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_8e177e5d-ecc0-4269-bf83-1fa7078d751b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_2cb1e255-8db2-4e97-a1e1-801db2d9ba21_terseLabel_en-US" xlink:label="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized research and development</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_label_en-US" xlink:label="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Capitalized Research And Development</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_documentation_en-US" xlink:label="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research and development costs capitalized.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:to="lab_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_e1b99755-0422-47f1-9a8a-a26f4c92552d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_8671e0ba-69ee-4ea2-95cd-12fca77ca5d2_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development tax credit carry forwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e7748480-cd14-4be0-9a9d-3251226e3d95_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_ab855300-e3b6-44dd-b10b-03099087a68f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_7c898b77-d852-454c-83b2-30a7cae86a5e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_0906ffe0-d841-4158-b920-0b99e33f5ab0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9926ffa1-d9cd-42fc-8ef6-f22ea3ec859b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c9adb8a6-c35c-4b90-baec-63c47abf03bb_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_7fc92897-146a-43a9-ba1d-15168a30fa99_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_90ac7a68-3d38-40de-ae90-51844fab6d5d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProFormaMember_8cb8a3de-1fc8-4bd0-a6f4-648250657e57_terseLabel_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma</link:label>
    <link:label id="lab_srt_ProFormaMember_label_en-US" xlink:label="lab_srt_ProFormaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pro Forma [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProFormaMember" xlink:to="lab_srt_ProFormaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_7db95c79-1308-45de-8bcd-7e132d58b4e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible senior notes net of discounts and deferred financing costs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5581ad63-bf4e-4274-ba02-2c75c48a55f2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_be79f5fe-c2cb-46c9-a057-3e4f50f5181b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_48733328-758c-4778-b3a3-731a3e6bfc98_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_15bf62de-2ff2-4322-aef8-5a506eb93668_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_eaa0c962-b844-4391-be84-aed00a2f150c_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a8bf8ddb-c9c9-4f17-8306-e255b2c193dc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_fc3e0502-36e5-41ea-a436-8fe575dd428f_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_c6da861e-cbf3-4df0-90ad-49915541d365_negatedLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_4d0a8524-693b-4cb4-a082-08bf915cddfa_verboseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) included in earnings</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_c7a1ebef-8066-4c98-8aa6-ada945253572_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncomeTaxesTable_317c9cad-e91e-4bdf-9f53-28cae8fec008_terseLabel_en-US" xlink:label="lab_nbix_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_nbix_IncomeTaxesTable_label_en-US" xlink:label="lab_nbix_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:label id="lab_nbix_IncomeTaxesTable_documentation_en-US" xlink:label="lab_nbix_IncomeTaxesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesTable" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncomeTaxesTable" xlink:to="lab_nbix_IncomeTaxesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_af8b072f-115e-4b96-a90a-cdd322429c6d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance, Outstanding (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_73b059e1-8032-466d-bc77-75fc0e7dbcbd_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance, Outstanding (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_3be953b9-b92c-4940-9b9f-7aab470b0d15_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of debt securities available-for-sale in an unrealized loss position</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_57cc7500-d828-48d8-a9b9-eb01581cf534_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_8202cfeb-ba0c-47f1-82c9-4c9c99a28642_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_622fce56-e757-4ef1-95b5-8f6f3f28acf6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_aa097477-e903-459c-be16-a917b04eaa12_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_50224ad3-818b-4d2f-87f4-2c40226eb327_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_4a255311-b8e8-4d1f-bb09-6f65581cd77b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_efbc46d4-9ca9-4593-a46e-0f248dde7598_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_d8ec87d5-3c21-4019-9f5f-72275c5b7f01_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_64faca4a-3b00-4378-8ef9-8d4081e497ac_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities of government-sponsored entities</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_a44e1447-9a57-4857-91a5-b21926b65f0b_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_4a58832f-b9ce-4b67-96a5-524aa01aa140_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_VoyagerTherapeuticsMember_2b17ac0c-54b2-464e-8a1e-3d3adc9204f5_terseLabel_en-US" xlink:label="lab_nbix_VoyagerTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voyager</link:label>
    <link:label id="lab_nbix_VoyagerTherapeuticsMember_label_en-US" xlink:label="lab_nbix_VoyagerTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voyager Therapeutics [Member]</link:label>
    <link:label id="lab_nbix_VoyagerTherapeuticsMember_documentation_en-US" xlink:label="lab_nbix_VoyagerTherapeuticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voyager therapeutics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_VoyagerTherapeuticsMember" xlink:href="nbix-20211231.xsd#nbix_VoyagerTherapeuticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_VoyagerTherapeuticsMember" xlink:to="lab_nbix_VoyagerTherapeuticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_60b71d08-5771-4957-aae8-1fad2ea3d1ac_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11e2b794-ba0c-4c73-844a-848b8e080324_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_869f7c17-1c93-4f35-9bff-17b58915ae4d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_325eadeb-e39e-4451-ba3f-8089d07c31fd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances_7f9205c1-c2d7-4c03-9f14-90ab31cb5cb4_terseLabel_en-US" xlink:label="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue-related reserves for discounts and allowances</link:label>
    <link:label id="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances_label_en-US" xlink:label="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Related Reserves For Discounts And Allowances</link:label>
    <link:label id="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances_documentation_en-US" xlink:label="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue-related reserves for discounts and allowances.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:href="nbix-20211231.xsd#nbix_RevenueRelatedReservesForDiscountsAndAllowances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:to="lab_nbix_RevenueRelatedReservesForDiscountsAndAllowances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_212c0a4a-559d-4426-beb5-6c566a15b3f1_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities number of shares (in shares)</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedBalanceShares_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, Balance, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedBalanceShares" xlink:to="lab_us-gaap_InvestmentOwnedBalanceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_e6dec9ff-aa30-4306-a2b1-ddc9effdff51_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_ConversionPeriodOneMember_e72d0d8d-9037-4463-a3d4-24ed94699fbc_terseLabel_en-US" xlink:label="lab_nbix_ConversionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period One</link:label>
    <link:label id="lab_nbix_ConversionPeriodOneMember_label_en-US" xlink:label="lab_nbix_ConversionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period One [Member]</link:label>
    <link:label id="lab_nbix_ConversionPeriodOneMember_documentation_en-US" xlink:label="lab_nbix_ConversionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodOneMember" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_ConversionPeriodOneMember" xlink:to="lab_nbix_ConversionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_2f3915fb-f7f7-43fc-8331-68aeb76b009a_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_bfa946e5-30dd-44d8-973d-407d16c64066_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_4f6d2444-c023-4c3a-b27a-4b56a924cea3_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_646e2d40-e386-49c2-b40a-149c88e277a6_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock_69a98f05-28ce-44f8-8e96-901cbf097449_terseLabel_en-US" xlink:label="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Activities</link:label>
    <link:label id="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock_label_en-US" xlink:label="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description Policy [Policy Text Block]</link:label>
    <link:label id="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description Policy [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:href="nbix-20211231.xsd#nbix_BusinessDescriptionPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:to="lab_nbix_BusinessDescriptionPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_f8b04656-551d-41df-b931-50e5964a8ace_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_380fa7cf-4c83-4f82-9c68-fda11bcbc2b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ad1d1e7b-d6ae-4a18-9d84-025311ab790b_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_dd78abc7-ce57-4600-99f6-112bb38991dd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_5b063f84-53b5-439d-8b37-c2e3bfb81285_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value vested in period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0254b343-edc7-4cff-a27d-ecdfc652c1d1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c2d49351-038f-4c3c-99c3-5ff039c157ee_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_ScientificEquipmentMember_4f72fee9-f27a-4f10-bec2-3e3db9fa3510_terseLabel_en-US" xlink:label="lab_nbix_ScientificEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific equipment</link:label>
    <link:label id="lab_nbix_ScientificEquipmentMember_label_en-US" xlink:label="lab_nbix_ScientificEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific Equipment [Member]</link:label>
    <link:label id="lab_nbix_ScientificEquipmentMember_documentation_en-US" xlink:label="lab_nbix_ScientificEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scientific equipment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ScientificEquipmentMember" xlink:href="nbix-20211231.xsd#nbix_ScientificEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_ScientificEquipmentMember" xlink:to="lab_nbix_ScientificEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_423c63d6-1f37-49d5-b635-4ad6896731b0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value measurements recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_099da1b1-f837-433d-9a64-3ca7ce3948d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_8a3688ff-8765-4122-8c16-d52535371c7e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, award requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_e792e733-c446-4ef4-8d1a-036138a8c4bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary and changes in stock options outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_27369179-7d80-47b9-a8d7-f63044ee94eb_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations for the assessment of taxes</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_7e982f36-9a72-4b14-b69e-ff7f52a0cda5_terseLabel_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and summary of significant accounting policies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_93c71906-5a66-48b4-a6e4-b59c7df2d740_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_d71d12ac-a2da-440a-b0df-22606fec5442_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_abe68530-e08c-4b06-a01f-60a49cbee321_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income:</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_97abf0a2-e7cb-441a-a5ac-16f6bee8d555_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IncomeTaxesLineItems_fbffa84b-a9f1-41c1-aba9-bff439086ef0_terseLabel_en-US" xlink:label="lab_nbix_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_nbix_IncomeTaxesLineItems_label_en-US" xlink:label="lab_nbix_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:label id="lab_nbix_IncomeTaxesLineItems_documentation_en-US" xlink:label="lab_nbix_IncomeTaxesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesLineItems" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IncomeTaxesLineItems" xlink:to="lab_nbix_IncomeTaxesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_c8facaf4-1d46-421d-b08f-b586e234ef6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_36d00739-d997-400f-a712-4ee2f5ad645f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_04186ef2-ebc6-435d-a5a0-8e82e71b5d5a_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4d101e17-cdf0-431d-b906-6caff6e24e94_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ab1ca4d3-ac35-4eae-b70f-251fb555e225_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_0bb0943a-072d-4a61-85aa-d22b7be87eaf_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c42ea8d0-38b5-43bd-ad77-01d4f506a128_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_e8ea4429-6052-4c71-9640-36db59298f00_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_c2379a5c-4c06-4752-9156-d9383dcb19db_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Losses, Policy for Uncollectible Amounts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_63dfa708-f1bb-4baa-898e-14b6e13a53dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_03b978f5-c48c-4b2d-a1db-f0bbba93c96f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Released (in USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_7b8e103b-d0b7-48c2-bc32-5c2491886bd8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumed borrowing rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="lab_us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_IdorsiaPharmaceuticalsLtdMember_35f23dea-17d0-4649-a66b-e695b9b394bf_terseLabel_en-US" xlink:label="lab_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia</link:label>
    <link:label id="lab_nbix_IdorsiaPharmaceuticalsLtdMember_label_en-US" xlink:label="lab_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia Pharmaceuticals Ltd [Member]</link:label>
    <link:label id="lab_nbix_IdorsiaPharmaceuticalsLtdMember_documentation_en-US" xlink:label="lab_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia Pharmaceuticals Ltd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:href="nbix-20211231.xsd#nbix_IdorsiaPharmaceuticalsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:to="lab_nbix_IdorsiaPharmaceuticalsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_b8d718d3-1ec3-48a8-a62d-da4520cf1522_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a44e4ff3-650c-4514-b009-8784e1dc3207_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_63e6376b-b5cd-40c2-a42d-491ffaeb0d05_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_629eb604-c279-4628-aecc-52dc60964242_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected option term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_dc0ab18f-aa2a-4f48-b559-e9fc88a8f533_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_27dc4058-5a55-4a24-8e5d-9c1e0e3ef0e3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_7b6225b5-0705-4a07-9778-f35d2878f00f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_838458d0-c4e3-40fd-a936-296f951fa28a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_b20b6692-bc8a-48d5-a2f8-a2988ed0592d_terseLabel_en-US" xlink:label="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the liability component immediately before extinguishment</link:label>
    <link:label id="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_label_en-US" xlink:label="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Of Liability Component Immediately Before Extinguishment</link:label>
    <link:label id="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_documentation_en-US" xlink:label="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of the liability component immediately before extinguishment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:href="nbix-20211231.xsd#nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:to="lab_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_154d8a8f-e0a1-44fc-bac3-5815a8090549_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest receivables write-off threshold period</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, Threshold Period, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_830bc0fa-1114-4626-9c26-087131d84193_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DeferredTaxAssetsLiabilitiesGross_865e1c42-af3d-4ef1-91bd-d30402b69d29_totalLabel_en-US" xlink:label="lab_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net of deferred tax assets and liabilities</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsLiabilitiesGross_label_en-US" xlink:label="lab_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Liabilities Gross</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsLiabilitiesGross_documentation_en-US" xlink:label="lab_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets (liabilities) gross.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsLiabilitiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:to="lab_nbix_DeferredTaxAssetsLiabilitiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_fa7a4d3d-7e50-4d19-803e-6d8a358d9285_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_1a64e504-aa36-4c86-8882-44c409e3c6c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_f799af95-73e2-45b6-90ac-db1a9e134fcc_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on debt securities available-for sale</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_12f65572-6083-40b8-a5df-ae227e3d6425_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_3434ec17-37a1-4452-864d-67c625784e63_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_d6c6379b-28b9-4690-ab18-413491a8e6e1_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted and Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_1a2124b4-6714-4801-9057-efd44b11f65b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_f015da6a-ea30-4992-a5d8-086a6d70eece_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest receivables write-off</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_XenonPharmaceuticalsIncMember_ed7432eb-16ed-4b10-9e58-59c9d5d80560_terseLabel_en-US" xlink:label="lab_nbix_XenonPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xenon</link:label>
    <link:label id="lab_nbix_XenonPharmaceuticalsIncMember_label_en-US" xlink:label="lab_nbix_XenonPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xenon Pharmaceuticals Inc [Member]</link:label>
    <link:label id="lab_nbix_XenonPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_nbix_XenonPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xenon Pharmaceuticals Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_XenonPharmaceuticalsIncMember" xlink:href="nbix-20211231.xsd#nbix_XenonPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_XenonPharmaceuticalsIncMember" xlink:to="lab_nbix_XenonPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_ConversionPeriodTwoMember_c60d4605-ad34-43b6-bd93-e235f3a4b881_terseLabel_en-US" xlink:label="lab_nbix_ConversionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period Two</link:label>
    <link:label id="lab_nbix_ConversionPeriodTwoMember_label_en-US" xlink:label="lab_nbix_ConversionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period Two [Member]</link:label>
    <link:label id="lab_nbix_ConversionPeriodTwoMember_documentation_en-US" xlink:label="lab_nbix_ConversionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Period Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodTwoMember" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_ConversionPeriodTwoMember" xlink:to="lab_nbix_ConversionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets_ed902fc0-df8e-4518-b7de-2296b81be510_terseLabel_en-US" xlink:label="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets_label_en-US" xlink:label="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets Operating Leases Assets</link:label>
    <link:label id="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets_documentation_en-US" xlink:label="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets operating leases assets.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsOperatingLeasesAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:to="lab_nbix_DeferredTaxAssetsOperatingLeasesAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2f49a54a-1954-4a9b-b333-e647a00426c7_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bdd2a639-42c0-4662-9c70-7a8a5446acc1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_614dc81b-98e7-4dca-ba02-b0807f88928a_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_52dcc097-0efb-4c02-86f1-3f465ca70c3a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_88d1b63f-78e5-4151-ab0f-367f62e5c903_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal income taxes at 21%</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_31278b80-ab58-4b7a-a1e6-0bf0c65c89f9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_6206f67b-a735-4f0f-b2e7-6ce6c73d4011_terseLabel_en-US" xlink:label="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options restricted stock and convertible senior notes</link:label>
    <link:label id="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_label_en-US" xlink:label="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Restricted Stock And Convertible Senior Notes [Member]</link:label>
    <link:label id="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_documentation_en-US" xlink:label="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options, restricted stock and convertible senior notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:href="nbix-20211231.xsd#nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:to="lab_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_b21ba6ab-7ac3-41b5-a223-356ac136f59a_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Than 12 Months, Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_593f8f55-abc2-4317-bf36-10cfed364970_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_4a2c787f-11c2-4006-b628-b3eea794a09a_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_fbcb1b8e-6589-42c6-a14d-5a9ae173a8c6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f47015f9-7c2b-4f28-bf15-c72c047e3476_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_b71517c5-2243-44c8-b476-051be8cbc9a3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_db87fc68-519f-4ca8-be1c-6aff5cacad24_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_e6d19e6c-6e63-4847-96c7-5726113471fe_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_8fc7d98b-2ba5-4c8c-8bf0-e773f957cb91_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_9c0ae884-9045-4aff-ad74-634e440525f9_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_c2369d3e-1233-4a97-9b14-100a7659f728_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount, net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_nbix_AbbvieIncMember_36c25e63-fa2d-4143-8dee-830fdaae05c8_terseLabel_en-US" xlink:label="lab_nbix_AbbvieIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AbbVie</link:label>
    <link:label id="lab_nbix_AbbvieIncMember_label_en-US" xlink:label="lab_nbix_AbbvieIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Abbvie Inc [Member]</link:label>
    <link:label id="lab_nbix_AbbvieIncMember_documentation_en-US" xlink:label="lab_nbix_AbbvieIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information related to AbbVie Inc., an entity with which Neurocrine has a collaboration agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AbbvieIncMember" xlink:href="nbix-20211231.xsd#nbix_AbbvieIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_nbix_AbbvieIncMember" xlink:to="lab_nbix_AbbvieIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_614a3810-514b-44fc-8562-661d452de260_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined contribution plan, maximum employee contribution percentage</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_bce20722-3e89-4f0b-b5e8-590efb218949_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_7d12c0ce-c593-4f4e-8a6e-359358cf55a3_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_0a0bac18-750a-4515-aab1-8dbf7f381300_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term, Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>nbix-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:4d0c41ec-98ac-4237-944f-6ed980fa17bf,g:c59744bf-4f3a-4268-8f35-b2f3cf78da8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.neurocrine.com/role/CoverPage" xlink:type="simple" xlink:href="nbix-20211231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1f9bf5f3-5a69-4a51-8a16-3cd404e2fa9c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentType_1f9bf5f3-5a69-4a51-8a16-3cd404e2fa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_2d37cf6f-97ca-4518-839c-f8cf90eb4b9d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentAnnualReport_2d37cf6f-97ca-4518-839c-f8cf90eb4b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_69e24dab-d698-4c76-963e-bda09e0a5de4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentPeriodEndDate_69e24dab-d698-4c76-963e-bda09e0a5de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_61c4b581-79ef-4a1b-aa9c-909cf9bc3c92" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_CurrentFiscalYearEndDate_61c4b581-79ef-4a1b-aa9c-909cf9bc3c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_70662964-fa21-455b-9df8-0795c72e7ffc" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentTransitionReport_70662964-fa21-455b-9df8-0795c72e7ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7e20b2b7-b498-4a94-b061-58882c1d5c11" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityFileNumber_7e20b2b7-b498-4a94-b061-58882c1d5c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_45cfb390-e0e9-4cfc-872a-3fe4bfb70415" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityRegistrantName_45cfb390-e0e9-4cfc-872a-3fe4bfb70415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_24de4da6-901d-4cf4-9e8f-4124e9540ffd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_24de4da6-901d-4cf4-9e8f-4124e9540ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_710aabe5-69e1-4cae-977b-3b6bbc40e769" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityTaxIdentificationNumber_710aabe5-69e1-4cae-977b-3b6bbc40e769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a26efadd-0580-430d-96e5-c0a6dfb0aaab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityAddressAddressLine1_a26efadd-0580-430d-96e5-c0a6dfb0aaab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_b3109e52-d06f-4d5f-9b52-b04bf000ef66" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityAddressCityOrTown_b3109e52-d06f-4d5f-9b52-b04bf000ef66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_71864a65-4f8f-4d9e-846c-12e0ccd372c3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityAddressStateOrProvince_71864a65-4f8f-4d9e-846c-12e0ccd372c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_c8067fdd-6958-4a09-9296-70aae827d052" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityAddressPostalZipCode_c8067fdd-6958-4a09-9296-70aae827d052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_5d665815-f700-41bd-9f3d-c91b875338b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_CityAreaCode_5d665815-f700-41bd-9f3d-c91b875338b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c9606a7b-0e0a-48b0-8b2f-78b90125120f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_LocalPhoneNumber_c9606a7b-0e0a-48b0-8b2f-78b90125120f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_ac74198d-a08b-4bba-9f75-56295d56f0cf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_Security12bTitle_ac74198d-a08b-4bba-9f75-56295d56f0cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_b11c92b4-1432-45e7-9153-2098a0408c48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_TradingSymbol_b11c92b4-1432-45e7-9153-2098a0408c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_f5a77644-1a71-437c-81c0-996c32fccfb6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_SecurityExchangeName_f5a77644-1a71-437c-81c0-996c32fccfb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_6ebdd440-3f80-4ecf-a73c-aa0b673d8507" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_6ebdd440-3f80-4ecf-a73c-aa0b673d8507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_76c5e347-f2f2-492f-a9ab-a4f52ddc2c74" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityVoluntaryFilers_76c5e347-f2f2-492f-a9ab-a4f52ddc2c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_63c04c30-2f5f-40c4-acc3-2ac809f35fd3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityCurrentReportingStatus_63c04c30-2f5f-40c4-acc3-2ac809f35fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_5458e764-3d6d-4372-becf-128669c439e7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityInteractiveDataCurrent_5458e764-3d6d-4372-becf-128669c439e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3c14c9ce-20cb-4761-b15b-6d407565c499" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityFilerCategory_3c14c9ce-20cb-4761-b15b-6d407565c499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_87d1f305-d0fc-40f8-af4b-9fe07683baeb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntitySmallBusiness_87d1f305-d0fc-40f8-af4b-9fe07683baeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_9eee4b14-c5ed-4df0-9aa4-494cf322d159" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityEmergingGrowthCompany_9eee4b14-c5ed-4df0-9aa4-494cf322d159" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_5e7e57e5-9a1a-4999-b1ce-0705a9e8453e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_5e7e57e5-9a1a-4999-b1ce-0705a9e8453e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_62dfefae-18c0-4981-bc7d-5d0de143acd8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityShellCompany_62dfefae-18c0-4981-bc7d-5d0de143acd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_90665cda-979b-40aa-867b-735131b6af40" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityPublicFloat_90665cda-979b-40aa-867b-735131b6af40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_181b5c9d-3d3a-44d8-95d5-bf3a7de9c05d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_181b5c9d-3d3a-44d8-95d5-bf3a7de9c05d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_70fa9512-4fd7-434d-98a5-e96a421d6553" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_70fa9512-4fd7-434d-98a5-e96a421d6553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bdef18f5-2222-4159-a60b-f4ae7bacdff3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_AmendmentFlag_bdef18f5-2222-4159-a60b-f4ae7bacdff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ef7bd42b-3514-41bf-b085-baf939cef986" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentFiscalYearFocus_ef7bd42b-3514-41bf-b085-baf939cef986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_91f035fe-509b-4a5a-b747-1f539998be85" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_91f035fe-509b-4a5a-b747-1f539998be85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b228f154-41fb-4649-911e-1d359e62ee5f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_00770998-ccd8-4076-9972-977541e5eb0e" xlink:to="loc_dei_EntityCentralIndexKey_b228f154-41fb-4649-911e-1d359e62ee5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/AuditInformation" xlink:type="simple" xlink:href="nbix-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AuditorInformationAbstract_e495ed0e-1107-446f-bfb7-47f430b57c0a" xlink:href="nbix-20211231.xsd#nbix_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_eb4a5cc9-b023-4a35-8c7c-26bb10f03b9d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_AuditorInformationAbstract_e495ed0e-1107-446f-bfb7-47f430b57c0a" xlink:to="loc_dei_AuditorFirmId_eb4a5cc9-b023-4a35-8c7c-26bb10f03b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_5434a21f-82a4-4ade-8e84-5855a6b2203f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_AuditorInformationAbstract_e495ed0e-1107-446f-bfb7-47f430b57c0a" xlink:to="loc_dei_AuditorName_5434a21f-82a4-4ade-8e84-5855a6b2203f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_785b8e6c-857f-480a-96a3-f3aa5ab9fc80" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_AuditorInformationAbstract_e495ed0e-1107-446f-bfb7-47f430b57c0a" xlink:to="loc_dei_AuditorLocation_785b8e6c-857f-480a-96a3-f3aa5ab9fc80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_975ed4ac-6d2a-47d7-9fdb-29350b18e6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_975ed4ac-6d2a-47d7-9fdb-29350b18e6a2" xlink:to="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce0747dd-02a4-4b49-b33d-0ff9655745f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ce0747dd-02a4-4b49-b33d-0ff9655745f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_40fad232-b62e-4195-becf-bb77f98e47d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_40fad232-b62e-4195-becf-bb77f98e47d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a8de2c01-7394-4700-ad3e-4b9331d9125c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a8de2c01-7394-4700-ad3e-4b9331d9125c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_477bcc9d-86bb-422f-b14f-f3575ba1cd81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_InventoryNet_477bcc9d-86bb-422f-b14f-f3575ba1cd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6e3fa51e-357a-4d9b-ae38-750ccadb6fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_OtherAssetsCurrent_6e3fa51e-357a-4d9b-ae38-750ccadb6fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a7b44af5-2bb4-40d6-885f-3f277ca8a530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4bd4b760-48ac-4120-b20e-33429211a498" xlink:to="loc_us-gaap_AssetsCurrent_a7b44af5-2bb4-40d6-885f-3f277ca8a530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_ecbd1665-46f4-4999-94c6-20d1c453e752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_ecbd1665-46f4-4999-94c6-20d1c453e752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_42281025-a989-427b-b2d9-774b2cbd194f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_42281025-a989-427b-b2d9-774b2cbd194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6f10f421-89dc-484a-88c9-b7a9617d32a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6f10f421-89dc-484a-88c9-b7a9617d32a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_53d97cc0-9ef1-44e3-a419-38f293c243eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_53d97cc0-9ef1-44e3-a419-38f293c243eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b90dfd4c-a353-4f77-9823-860f4d537e16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b90dfd4c-a353-4f77-9823-860f4d537e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_0f0c14b9-70f9-4b97-89b2-c65f4eb32ef3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_0f0c14b9-70f9-4b97-89b2-c65f4eb32ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_66e6b868-8ab3-4cc0-8c02-76eb10417d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e9121a1c-20b1-4ebd-852f-3df1c392c622" xlink:to="loc_us-gaap_Assets_66e6b868-8ab3-4cc0-8c02-76eb10417d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_975ed4ac-6d2a-47d7-9fdb-29350b18e6a2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_8a541395-3737-445e-8996-3ee62a887131" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_8a541395-3737-445e-8996-3ee62a887131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3344bf22-ba54-4ef7-9eca-79981a0ee61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a541395-3737-445e-8996-3ee62a887131" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_3344bf22-ba54-4ef7-9eca-79981a0ee61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_4586f8d3-89db-4a62-80b7-8fba6a788aee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a541395-3737-445e-8996-3ee62a887131" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_4586f8d3-89db-4a62-80b7-8fba6a788aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4ba681fe-d70b-4033-b25d-dca6c1950269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_8a541395-3737-445e-8996-3ee62a887131" xlink:to="loc_us-gaap_LiabilitiesCurrent_4ba681fe-d70b-4033-b25d-dca6c1950269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_8debf107-0bed-447c-b8cc-8a4794973ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_8debf107-0bed-447c-b8cc-8a4794973ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_497aef31-1ede-49e4-a031-e970636be2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_497aef31-1ede-49e4-a031-e970636be2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2fffd652-ccc3-49fd-b27b-b7125d794ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2fffd652-ccc3-49fd-b27b-b7125d794ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3bb27f92-075a-433a-956d-11c2427e26e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_Liabilities_3bb27f92-075a-433a-956d-11c2427e26e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_099a34b7-1f0e-44bc-b3d5-bd923111cb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_PreferredStockValue_099a34b7-1f0e-44bc-b3d5-bd923111cb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_1691e10b-1963-49a9-b1b7-571a69c7a80a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_CommonStockValue_1691e10b-1963-49a9-b1b7-571a69c7a80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c678d7c0-3168-42d4-9f34-8732fa83f66d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c678d7c0-3168-42d4-9f34-8732fa83f66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcbce9ff-1820-4196-a463-38be02c6e7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fcbce9ff-1820-4196-a463-38be02c6e7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_10b264e4-accb-426d-a4fb-527f275b1ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_10b264e4-accb-426d-a4fb-527f275b1ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b03a605-6875-4d05-b278-2274b2129faf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_5da42ec5-3066-41db-bcd1-66b19c6e9289" xlink:to="loc_us-gaap_StockholdersEquity_3b03a605-6875-4d05-b278-2274b2129faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbaf2483-d9f0-4812-8e90-597f8dce4f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_288ae851-f019-4a14-9bfa-840454cfabe8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_cbaf2483-d9f0-4812-8e90-597f8dce4f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_39542cbd-c07f-486c-8a23-4b6f19b5a6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_39542cbd-c07f-486c-8a23-4b6f19b5a6eb" xlink:to="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:to="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_ffd4c4a4-9487-4274-88fb-03df52541319" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_9c9d9cdc-beaf-4a65-855f-8ec3b0799368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_9c9d9cdc-beaf-4a65-855f-8ec3b0799368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LongTermInvestmentsMember_c6469036-e1b4-46fd-b906-db43d263d6da" xlink:href="nbix-20211231.xsd#nbix_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_be786b5b-fb84-48be-9418-d8d8ff620cd5" xlink:to="loc_nbix_LongTermInvestmentsMember_c6469036-e1b4-46fd-b906-db43d263d6da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2aa06d78-1495-415c-9936-caa935970ef1" xlink:to="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_99a19795-cb63-44da-8fa0-8431ecd7cec5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_99a19795-cb63-44da-8fa0-8431ecd7cec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1914610e-4c2c-4057-9aac-ef90dbe29728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1914610e-4c2c-4057-9aac-ef90dbe29728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1bc4a922-c62e-4e3e-9b3e-94c83773a6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1bc4a922-c62e-4e3e-9b3e-94c83773a6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_a3e98421-ae51-487c-b7de-87fc0ec6e1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_a3e98421-ae51-487c-b7de-87fc0ec6e1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_ea32921e-6779-486a-8ba0-a251d74c4fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_ea32921e-6779-486a-8ba0-a251d74c4fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4525b3a7-0769-4e9b-b8a0-a513eefdd184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4525b3a7-0769-4e9b-b8a0-a513eefdd184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_3dd05ea4-049b-46bf-9247-b54212ccb3d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_3dd05ea4-049b-46bf-9247-b54212ccb3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d2106646-f8ab-460a-ae3c-99a0830ca04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesIssued_d2106646-f8ab-460a-ae3c-99a0830ca04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8e96aad0-5940-4013-a197-8a3cf5c26a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e110b314-d6f4-470d-8d10-b49fb9a0e35a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8e96aad0-5940-4013-a197-8a3cf5c26a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsIncomeandComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_6b64afee-96e9-40aa-bfc4-c4d882513027" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_6b64afee-96e9-40aa-bfc4-c4d882513027" xlink:to="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:to="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_fc1d6fc2-3af1-4f40-8cab-1b51ff8251c0" xlink:to="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_cace2740-19df-4645-ac41-285e1db2526f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:to="loc_us-gaap_ProductMember_cace2740-19df-4645-ac41-285e1db2526f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CollaborationRevenueMember_8e86c604-2c30-47c6-99e2-f4115ab654cf" xlink:href="nbix-20211231.xsd#nbix_CollaborationRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6a836290-246b-4d9c-9561-6ca22888a98c" xlink:to="loc_nbix_CollaborationRevenueMember_8e86c604-2c30-47c6-99e2-f4115ab654cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_416168f3-97a1-45dd-a101-0c12d3904dea" xlink:to="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31a16723-c594-49fc-8520-1d2885d2144d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_95901a94-869d-465c-8672-495b85e66385" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_31a16723-c594-49fc-8520-1d2885d2144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CostOfSales_ae939883-f146-4c0d-b55b-587aaf11bd06" xlink:href="nbix-20211231.xsd#nbix_CostOfSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_nbix_CostOfSales_ae939883-f146-4c0d-b55b-587aaf11bd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_a1eba4fc-39b9-421c-9c91-a440dc12e264" xlink:href="nbix-20211231.xsd#nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_a1eba4fc-39b9-421c-9c91-a440dc12e264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_6782f4c6-fd47-4a7a-980e-a1b9dba94001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_6782f4c6-fd47-4a7a-980e-a1b9dba94001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_07a89fc7-0e98-43fa-8161-6caaef921d83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_07a89fc7-0e98-43fa-8161-6caaef921d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_864e0f56-3e02-4246-8501-c7de6d3daca1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_576b1359-6e1a-417e-b184-7c12c52823d0" xlink:to="loc_us-gaap_OperatingExpenses_864e0f56-3e02-4246-8501-c7de6d3daca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_01985602-d715-456e-ba66-50e4d289b1ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OperatingIncomeLoss_01985602-d715-456e-ba66-50e4d289b1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ba1a6789-7887-4f96-b447-83dc27d75683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_InterestExpense_ba1a6789-7887-4f96-b447-83dc27d75683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d03eda5c-b75c-4234-adc1-f2f3ee2acf73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_d03eda5c-b75c-4234-adc1-f2f3ee2acf73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e9d172b-caf9-47da-bea0-b5892f3b7ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_7e9d172b-caf9-47da-bea0-b5892f3b7ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_InvestmentIncomeAndOtherNet_aa5d9748-c10d-4e99-a169-ba4cda59f4a8" xlink:href="nbix-20211231.xsd#nbix_InvestmentIncomeAndOtherNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_nbix_InvestmentIncomeAndOtherNet_aa5d9748-c10d-4e99-a169-ba4cda59f4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_dfbb3bb8-1ad1-4593-a903-106d19c45125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_cf6c5a51-a673-4fd0-b7b4-f68b58250f00" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_dfbb3bb8-1ad1-4593-a903-106d19c45125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_364d7f7e-375d-4ba5-a98b-b173aef7bfda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_364d7f7e-375d-4ba5-a98b-b173aef7bfda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1441d696-4bae-4f12-9e0c-97d1a401bd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1441d696-4bae-4f12-9e0c-97d1a401bd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_38d08e6f-f046-4311-97e1-ec293966a351" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_NetIncomeLoss_38d08e6f-f046-4311-97e1-ec293966a351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8b4f98a1-e1bd-44fb-b675-08efbae753ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_8b4f98a1-e1bd-44fb-b675-08efbae753ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3766fe6-46c4-4244-96af-048df57a0aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b3766fe6-46c4-4244-96af-048df57a0aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_40f9b239-90ba-46a8-b509-6a9cb0ad73fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_EarningsPerShareBasic_40f9b239-90ba-46a8-b509-6a9cb0ad73fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_752d5a45-3724-468f-aca7-fb93f3c0df92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_EarningsPerShareDiluted_752d5a45-3724-468f-aca7-fb93f3c0df92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fd07d62-3aef-4276-b03d-a9f562a0e817" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5fd07d62-3aef-4276-b03d-a9f562a0e817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b5f5f91c-a1a9-42d1-8399-b0df7d3bf9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81665f85-5470-425e-81ad-740fab310281" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b5f5f91c-a1a9-42d1-8399-b0df7d3bf9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8398ada7-5bc8-42a2-b63b-88866d49a8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8398ada7-5bc8-42a2-b63b-88866d49a8cc" xlink:to="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_045b5282-25bf-4218-aef7-cdd2b71fa198" xlink:to="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_00a79199-9ff0-40ed-8741-817ff1d17315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_CommonStockMember_00a79199-9ff0-40ed-8741-817ff1d17315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_f3fcb03f-a541-4181-a397-ff711c566964" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_f3fcb03f-a541-4181-a397-ff711c566964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52cb9e1f-8184-4e37-9e8a-c6b021a33305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_52cb9e1f-8184-4e37-9e8a-c6b021a33305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_54c718de-20a5-4ef7-96ac-869502ee855e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_17a3ea2f-f6fc-4bfc-9f92-8402571a1dff" xlink:to="loc_us-gaap_RetainedEarningsMember_54c718de-20a5-4ef7-96ac-869502ee855e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_01365367-18ab-49e1-915f-325f379798d0" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cfa73331-0db0-4d53-83ca-fd7164a7664e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_a1e3dbdd-a17e-4897-abd0-0f07b95af03f" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_cfa73331-0db0-4d53-83ca-fd7164a7664e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9ba54e4a-2b86-47a9-a166-c7892fbb5da1" xlink:to="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_e4944cd9-3d8a-46a0-afd4-643f924caac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_SharesOutstanding_e4944cd9-3d8a-46a0-afd4-643f924caac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fcfe765f-7532-41a5-8ead-6eb8550fb0ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockholdersEquity_fcfe765f-7532-41a5-8ead-6eb8550fb0ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b36dd30-976f-4bc3-a301-a17bbec53f07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_NetIncomeLoss_0b36dd30-976f-4bc3-a301-a17bbec53f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_55497cbd-e581-4b99-bc58-4be28516d521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_MarketableSecuritiesUnrealizedGainLoss_55497cbd-e581-4b99-bc58-4be28516d521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726813ea-f16e-4c50-bb3f-3cb2b9728da1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726813ea-f16e-4c50-bb3f-3cb2b9728da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7c7816e4-8b42-4be5-9950-dc52e6bb403b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_7c7816e4-8b42-4be5-9950-dc52e6bb403b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ac9429b5-ea82-4265-9b12-6db494056005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ac9429b5-ea82-4265-9b12-6db494056005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2bc21d39-a80c-4055-a76d-2ee21d78b402" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2bc21d39-a80c-4055-a76d-2ee21d78b402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_97243f28-b665-49b6-9e99-563d9ca89a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_97243f28-b665-49b6-9e99-563d9ca89a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_575b8249-d6b2-4a63-8eb5-bbd9ef6af5d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_SharesOutstanding_575b8249-d6b2-4a63-8eb5-bbd9ef6af5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8286ef09-a9fa-48b6-b695-d6a09575d356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2dbf69f6-c2db-4255-b3bc-994e639dad13" xlink:to="loc_us-gaap_StockholdersEquity_8286ef09-a9fa-48b6-b695-d6a09575d356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d711543-d1d3-47d4-9ecc-038ba7099c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d711543-d1d3-47d4-9ecc-038ba7099c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b92810a7-eeb1-48e6-82b7-85097bbbc57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d711543-d1d3-47d4-9ecc-038ba7099c07" xlink:to="loc_us-gaap_NetIncomeLoss_b92810a7-eeb1-48e6-82b7-85097bbbc57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d711543-d1d3-47d4-9ecc-038ba7099c07" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_cdef2034-6837-40df-95e6-584eb2746974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_ShareBasedCompensation_cdef2034-6837-40df-95e6-584eb2746974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6f0cfaf2-69d7-4afd-9941-a13f2ea15eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_Depreciation_6f0cfaf2-69d7-4afd-9941-a13f2ea15eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_8630c6dc-fe20-4a05-99f6-3e8993a50642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_8630c6dc-fe20-4a05-99f6-3e8993a50642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_96575b07-bf16-433d-92cd-f0931633d3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_96575b07-bf16-433d-92cd-f0931633d3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_acdefc5d-59eb-4526-afed-4f64225d945e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_acdefc5d-59eb-4526-afed-4f64225d945e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_a75a21ec-3568-43fa-92c9-ca7ed1113a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_a75a21ec-3568-43fa-92c9-ca7ed1113a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1762d06e-5886-457b-921e-0af52a07d3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1762d06e-5886-457b-921e-0af52a07d3e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a82ddd4c-1295-41c6-967e-a9c2b5c90732" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_a82ddd4c-1295-41c6-967e-a9c2b5c90732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_a0e3a1a9-d3b1-409e-9f6d-3d835d663408" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d5015d8-5cc6-4d20-9f52-43cfef27ecbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5d5015d8-5cc6-4d20-9f52-43cfef27ecbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6e207722-0ed2-4cea-8a7b-1b09b259f8df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6e207722-0ed2-4cea-8a7b-1b09b259f8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9422e1fe-c03f-4a68-ba53-e87339f3effb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_9422e1fe-c03f-4a68-ba53-e87339f3effb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_9a2cdf1a-43a7-43c3-9f6d-9dc22430260e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_8ad2e85d-6f29-4907-8a5f-1b0773e933a9" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet_9a2cdf1a-43a7-43c3-9f6d-9dc22430260e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_648a2549-e09e-4b9c-8a4e-753772ebc706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9d711543-d1d3-47d4-9ecc-038ba7099c07" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_648a2549-e09e-4b9c-8a4e-753772ebc706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_716c3e62-8383-430f-b141-25bfe1548ef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_716c3e62-8383-430f-b141-25bfe1548ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0a3e5068-1fe8-4947-a709-455480016a4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0a3e5068-1fe8-4947-a709-455480016a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_b74f8ace-a110-414a-99e2-c4d8d5d3409d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:to="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_b74f8ace-a110-414a-99e2-c4d8d5d3409d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45f07ceb-d57d-4eef-82b4-cdadda458635" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_45f07ceb-d57d-4eef-82b4-cdadda458635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c00d0c92-9550-45d0-ab80-b7d55ef16a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_49e066ff-46a3-498c-8442-493e076c7713" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_c00d0c92-9550-45d0-ab80-b7d55ef16a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19335774-913d-4938-b916-f36b1fa4b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19335774-913d-4938-b916-f36b1fa4b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fbb947c8-14fc-4388-8d1d-6b798220e8dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19335774-913d-4938-b916-f36b1fa4b1b1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fbb947c8-14fc-4388-8d1d-6b798220e8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_25d6bf10-5f42-4cca-bfd9-45001a5921d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19335774-913d-4938-b916-f36b1fa4b1b1" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_25d6bf10-5f42-4cca-bfd9-45001a5921d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2adeebd2-87d2-48c8-b158-0e5224c1a9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_19335774-913d-4938-b916-f36b1fa4b1b1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2adeebd2-87d2-48c8-b158-0e5224c1a9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_494d267c-fc1a-4117-bce7-702ae117a651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_494d267c-fc1a-4117-bce7-702ae117a651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a19d3b7e-a604-421f-8a4d-2d2703fccbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a19d3b7e-a604-421f-8a4d-2d2703fccbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c31da322-ca27-4fda-a856-7216cc62c915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c31da322-ca27-4fda-a856-7216cc62c915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6d2fd888-a9d1-4b6c-b8e2-ca1b049e9e78" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_33d7c8d7-052f-4099-b850-277f1982c63d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_33d7c8d7-052f-4099-b850-277f1982c63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c3916505-1394-41d0-a7aa-839a8521d002" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c3916505-1394-41d0-a7aa-839a8521d002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_dc8f1742-8cd4-4ae1-b7b0-bc9370a2caf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:to="loc_us-gaap_InterestPaidNet_dc8f1742-8cd4-4ae1-b7b0-bc9370a2caf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_73067d94-b124-4aaa-8a88-2617aa3595f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_933acf25-9426-4565-807e-1d7ea00f7ddf" xlink:to="loc_us-gaap_IncomeTaxesPaid_73067d94-b124-4aaa-8a88-2617aa3595f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="nbix-20211231.xsd#OrganizationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7f896626-8d52-4b11-a8ae-e70a4b05bcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_355947b9-74ba-42e2-b41f-7fbddbac56f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7f896626-8d52-4b11-a8ae-e70a4b05bcd0" xlink:to="loc_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock_355947b9-74ba-42e2-b41f-7fbddbac56f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="nbix-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_BusinessDescriptionPolicyPolicyTextBlock_4e7bbe36-a058-4200-892c-43005834020a" xlink:href="nbix-20211231.xsd#nbix_BusinessDescriptionPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_nbix_BusinessDescriptionPolicyPolicyTextBlock_4e7bbe36-a058-4200-892c-43005834020a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4d0c38b1-fc22-439a-9e71-18be8d8841d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4d0c38b1-fc22-439a-9e71-18be8d8841d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_ac868dea-1cec-459d-94e9-4e9664866729" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_UseOfEstimates_ac868dea-1cec-459d-94e9-4e9664866729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_8d50d874-8c64-4b76-a959-af62b5023775" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_8d50d874-8c64-4b76-a959-af62b5023775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_23d370f8-f5e8-4220-8aff-344c25b03e00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_23d370f8-f5e8-4220-8aff-344c25b03e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_d7d51455-b53c-40dd-b419-02388efaf4ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_d7d51455-b53c-40dd-b419-02388efaf4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_4d4c5805-4b2e-4da4-8cad-5d3621597080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_4d4c5805-4b2e-4da4-8cad-5d3621597080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_87e7ffd3-4dd8-44d1-b719-5f85776e7798" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts_87e7ffd3-4dd8-44d1-b719-5f85776e7798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_a33f7ef8-992a-400d-b95a-478bccdb4b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_a33f7ef8-992a-400d-b95a-478bccdb4b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_11fd7c3e-77fe-4715-80e6-88bd4b78ba54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_11fd7c3e-77fe-4715-80e6-88bd4b78ba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f8849e87-8b35-4ee9-add5-f375aba004fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_f8849e87-8b35-4ee9-add5-f375aba004fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3c436597-616a-482e-bb66-dcb74eccd1ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3c436597-616a-482e-bb66-dcb74eccd1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_50d29a6f-3299-4934-80eb-6d1deda25c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_50d29a6f-3299-4934-80eb-6d1deda25c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_1379491b-fae2-4cdd-8dae-281a4987ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_1379491b-fae2-4cdd-8dae-281a4987ce81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_8c7dc472-435a-4ec6-ad51-72cc283137ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_8c7dc472-435a-4ec6-ad51-72cc283137ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_2a0ff156-9e81-4c9b-90fe-ce8ba9a78315" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_2a0ff156-9e81-4c9b-90fe-ce8ba9a78315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_91eec60a-896c-4145-b799-4f4f1b3aba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_91eec60a-896c-4145-b799-4f4f1b3aba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_118a2fc2-3f2e-4ee8-a3c4-64645d1db077" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_118a2fc2-3f2e-4ee8-a3c4-64645d1db077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f4af3bf1-ecfe-4e55-83af-60f1916e61f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f4af3bf1-ecfe-4e55-83af-60f1916e61f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_24fa59f2-d6b1-4217-a476-6c6d9d18b5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_24fa59f2-d6b1-4217-a476-6c6d9d18b5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_98ee22ca-7d23-4c76-9706-a1f39e800f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_98ee22ca-7d23-4c76-9706-a1f39e800f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9ceaecf0-f8cf-4712-94ff-b69e86d20ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_152b253f-1cb8-4c66-bf39-072cb42a6feb" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9ceaecf0-f8cf-4712-94ff-b69e86d20ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed57f4da-733a-46a7-a4c2-4baf99dcdb84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed57f4da-733a-46a7-a4c2-4baf99dcdb84" xlink:to="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_18e2565f-6403-4c44-8cbb-5ac85f9be87d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_3be82551-4c42-49af-96af-2f6c65301335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b2aa6085-5e57-4afb-bd2c-1d6e6c27014c" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_3be82551-4c42-49af-96af-2f6c65301335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1430932a-9520-4ac4-9e36-b806ffb09ca8" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_b1ffa96c-34b4-4c77-8715-5db16d6b36e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_422ccd68-870c-47c5-b877-90efb9769d0c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_b1ffa96c-34b4-4c77-8715-5db16d6b36e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_b82378d4-55eb-4abf-ac56-3b049b0cf3b6" xlink:to="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LargestTwoCustomersMember_9f97b09f-e82e-41a3-be7e-8ec60806d788" xlink:href="nbix-20211231.xsd#nbix_LargestTwoCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_35813eb4-ae11-4b46-b446-34447246f7a7" xlink:to="loc_nbix_LargestTwoCustomersMember_9f97b09f-e82e-41a3-be7e-8ec60806d788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_349243d4-78fc-4caa-a047-7ce16ff3c2e7" xlink:to="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_33e43a6a-755c-48b1-9a5c-b4ad5b3de8fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:to="loc_srt_MinimumMember_33e43a6a-755c-48b1-9a5c-b4ad5b3de8fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ddcb1ae6-24e4-4cb3-8035-82d83da3b55a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_eb8893c7-e1cb-484c-9988-948263db0838" xlink:to="loc_srt_MaximumMember_ddcb1ae6-24e4-4cb3-8035-82d83da3b55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_c4fb3a53-967c-4ca7-a7cf-8eba1a05767a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_516478e7-e800-48e0-bcac-4f86e4b0b12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c146908b-3522-4a5c-ae16-b5371f328d57" xlink:to="loc_us-gaap_EmployeeStockMember_516478e7-e800-48e0-bcac-4f86e4b0b12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_a6060055-4b35-498c-ae95-c5205c2539ff" xlink:to="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProFormaMember_30adf205-e113-4bd3-8b8e-65b659bde227" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProFormaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_f6d6900c-c36a-4a53-bafc-3055a1a2f25e" xlink:to="loc_srt_ProFormaMember_30adf205-e113-4bd3-8b8e-65b659bde227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_bee4c9da-79bf-46ca-8705-15f5fe6c8fc1" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_085431d9-5d67-4dd6-8eb9-cf0f1230a489" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_0a32b39a-2eee-4f79-b848-affa6f199fb8" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_085431d9-5d67-4dd6-8eb9-cf0f1230a489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7d8a66a2-f2b8-446a-8be9-da6212473d10" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_33b28105-32e6-4506-99b9-dde6ed3e107c" xlink:href="nbix-20211231.xsd#nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3f99c087-f673-4c42-8d99-9ebd1dd639e1" xlink:to="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_33b28105-32e6-4506-99b9-dde6ed3e107c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:href="nbix-20211231.xsd#nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_e3b7f657-2ccd-49f1-af61-49010156bd6e" xlink:to="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfIrishSubsidiaries_20f7a749-0067-435e-aeab-46d5744d323c" xlink:href="nbix-20211231.xsd#nbix_NumberOfIrishSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_nbix_NumberOfIrishSubsidiaries_20f7a749-0067-435e-aeab-46d5744d323c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_9401227e-64af-4ea5-ab75-7b5c293e95d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_NumberOfOperatingSegments_9401227e-64af-4ea5-ab75-7b5c293e95d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_067c4553-bb2b-4a82-b36d-fafa4afc844a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_NumberOfReportableSegments_067c4553-bb2b-4a82-b36d-fafa4afc844a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_b1edc096-4453-4939-bf99-f0ef73a41e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff_b1edc096-4453-4939-bf99-f0ef73a41e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_68a1012e-be0c-4697-9613-3bb7009c6c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_InterestReceivableCurrent_68a1012e-be0c-4697-9613-3bb7009c6c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_5eda1e99-012d-40a8-bb33-2fb5cff73b03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff_5eda1e99-012d-40a8-bb33-2fb5cff73b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb323abd-f2f8-4799-94a3-a947a5155953" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_bb323abd-f2f8-4799-94a3-a947a5155953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3b89b716-0511-4ee7-8eba-89bd88e25400" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_Depreciation_3b89b716-0511-4ee7-8eba-89bd88e25400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_660f315b-3181-4fd9-88df-7cfc0d0a7cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_660f315b-3181-4fd9-88df-7cfc0d0a7cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_f5bab785-777c-49cd-b939-083ae5b360b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AdvertisingExpense_f5bab785-777c-49cd-b939-083ae5b360b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_28f7deb2-5251-4ca3-b347-1d4d5daed318" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_28f7deb2-5251-4ca3-b347-1d4d5daed318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ESPPPurchasePeriod_772131cf-0000-436a-92f6-08a8521c315f" xlink:href="nbix-20211231.xsd#nbix_ESPPPurchasePeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_nbix_ESPPPurchasePeriod_772131cf-0000-436a-92f6-08a8521c315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b46d261-ee61-4393-ab29-72f777bd5430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_5b46d261-ee61-4393-ab29-72f777bd5430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b17c561-6a42-412e-b331-5f7dbf971f41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_0b17c561-6a42-412e-b331-5f7dbf971f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtNoncurrent_b0534a59-823e-4f67-acf5-bf8860177484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_ConvertibleDebtNoncurrent_b0534a59-823e-4f67-acf5-bf8860177484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3523c107-0a5e-456b-8a24-ea75318e1a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_3523c107-0a5e-456b-8a24-ea75318e1a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf1411ef-3d36-4598-9458-07f3546b8ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_cf1411ef-3d36-4598-9458-07f3546b8ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_2330bc3b-d7a0-41d0-8054-5639bb7405cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_22a3a52c-967b-4a67-b208-d32e1ec92075" xlink:to="loc_us-gaap_AdditionalPaidInCapital_2330bc3b-d7a0-41d0-8054-5639bb7405cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/CollaborationandLicenseAgreements" xlink:type="simple" xlink:href="nbix-20211231.xsd#CollaborationandLicenseAgreements"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/CollaborationandLicenseAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e29573a0-073e-49cf-9fe9-b023ef6cf169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d30112a2-f848-4bc9-b4de-82aa37e99fba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e29573a0-073e-49cf-9fe9-b023ef6cf169" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_d30112a2-f848-4bc9-b4de-82aa37e99fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d05fb3d-e6cf-42f7-a425-6343a92daea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e29573a0-073e-49cf-9fe9-b023ef6cf169" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3d05fb3d-e6cf-42f7-a425-6343a92daea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#CollaborationandLicenseAgreementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6ffb83e8-7c0f-45ad-b47c-471f39423680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6ffb83e8-7c0f-45ad-b47c-471f39423680" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9baf1c8f-4250-41b7-8f6a-ed6562882344" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d0c38182-f389-41bc-9de8-5a3c00ba7727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_62d6624a-ceee-45fc-b97a-63859f4b1e73" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d0c38182-f389-41bc-9de8-5a3c00ba7727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_7067f35e-22c8-49f4-aa71-5803f94c3c3f" xlink:to="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1aabdbe9-9693-40e4-9733-e0eba6e21716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3270b85e-42cc-45b6-9417-b53c03c41bb0" xlink:to="loc_us-gaap_CommonStockMember_1aabdbe9-9693-40e4-9733-e0eba6e21716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_47843dea-83b8-46dc-b73f-132b95f3884f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_6f5fcb3e-9841-48ae-94e0-9751b7641412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_bef1706f-3974-4cb4-abeb-52a1dd7f7a8a" xlink:to="loc_us-gaap_PatentsMember_6f5fcb3e-9841-48ae-94e0-9751b7641412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_bf431c80-e3b1-4185-afc3-277614c7527f" xlink:to="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_54972a9d-773c-4995-be7c-8604ef1ba744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_37129c78-c065-488d-8a84-1240e3d700be" xlink:to="loc_us-gaap_RoyaltyMember_54972a9d-773c-4995-be7c-8604ef1ba744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2e013610-d476-4f1f-a696-3509fed84855" xlink:to="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1f85b179-2a31-4603-943a-f17c26812047" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1b685078-3842-4726-8638-3b539df46cbd" xlink:to="loc_srt_MinimumMember_1f85b179-2a31-4603-943a-f17c26812047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5fadf602-0313-453d-aee8-51621972da90" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_HeptaresTherapeuticsLimitedMember_9a39610d-7267-4389-9023-bc6a3903f941" xlink:href="nbix-20211231.xsd#nbix_HeptaresTherapeuticsLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_HeptaresTherapeuticsLimitedMember_9a39610d-7267-4389-9023-bc6a3903f941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember_83068265-cd8d-4aaa-9404-46e63ddfc0ef" xlink:href="nbix-20211231.xsd#nbix_TakedaPharmaceuticalCompanyLimitedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_TakedaPharmaceuticalCompanyLimitedMember_83068265-cd8d-4aaa-9404-46e63ddfc0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IdorsiaPharmaceuticalsLtdMember_6729feb9-3108-43e0-9faf-8364871a9d1c" xlink:href="nbix-20211231.xsd#nbix_IdorsiaPharmaceuticalsLtdMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_IdorsiaPharmaceuticalsLtdMember_6729feb9-3108-43e0-9faf-8364871a9d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_XenonPharmaceuticalsIncMember_c0dbbc65-ae94-4da9-be01-93cc75e338c5" xlink:href="nbix-20211231.xsd#nbix_XenonPharmaceuticalsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_XenonPharmaceuticalsIncMember_c0dbbc65-ae94-4da9-be01-93cc75e338c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_VoyagerTherapeuticsMember_abe4e76e-ee25-4bee-a1c7-47ea44542ada" xlink:href="nbix-20211231.xsd#nbix_VoyagerTherapeuticsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_VoyagerTherapeuticsMember_abe4e76e-ee25-4bee-a1c7-47ea44542ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_BIALMember_4ab9c33d-db9a-4d44-9ca6-87ae2a97db90" xlink:href="nbix-20211231.xsd#nbix_BIALMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_BIALMember_4ab9c33d-db9a-4d44-9ca6-87ae2a97db90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MitsubishiTanabePharmaCorporationMember_71185823-05dc-452e-8e98-8187b3962583" xlink:href="nbix-20211231.xsd#nbix_MitsubishiTanabePharmaCorporationMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_MitsubishiTanabePharmaCorporationMember_71185823-05dc-452e-8e98-8187b3962583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AbbvieIncMember_f78358ac-05b5-41e0-8c66-32f4b0ec2976" xlink:href="nbix-20211231.xsd#nbix_AbbvieIncMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9802258e-7549-442c-906c-3687359197f0" xlink:to="loc_nbix_AbbvieIncMember_f78358ac-05b5-41e0-8c66-32f4b0ec2976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_967de9ed-d8dd-4ae2-8832-4f3261ee5b42" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePayments_486a6455-9204-4702-9f07-2be391059a51" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PotentialMilestonePayments_486a6455-9204-4702-9f07-2be391059a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c007fb35-7f4f-4ebe-9323-7dc700775aed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff_c007fb35-7f4f-4ebe-9323-7dc700775aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_UpfrontPaymentsMade_33d7ab08-c1f6-4e10-9e7f-18b11a13cc99" xlink:href="nbix-20211231.xsd#nbix_UpfrontPaymentsMade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_UpfrontPaymentsMade_33d7ab08-c1f6-4e10-9e7f-18b11a13cc99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_0b1c57ca-4f33-4f68-8dfe-88bbb1754157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_0b1c57ca-4f33-4f68-8dfe-88bbb1754157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_489ca236-bd0a-4db0-8c12-1dd53f2f985c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_SharePrice_489ca236-bd0a-4db0-8c12-1dd53f2f985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestoneEquityPurchasePayment_0e37b9ee-edc2-4ce3-8f62-f34d7316d863" xlink:href="nbix-20211231.xsd#nbix_MilestoneEquityPurchasePayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_MilestoneEquityPurchasePayment_0e37b9ee-edc2-4ce3-8f62-f34d7316d863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_441d3813-ecca-4399-a871-189c2d2392c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_441d3813-ecca-4399-a871-189c2d2392c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestonePayment_401ab16a-c013-448f-ae0a-d26593777db6" xlink:href="nbix-20211231.xsd#nbix_MilestonePayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_MilestonePayment_401ab16a-c013-448f-ae0a-d26593777db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1d9113f0-e8a9-4f50-9be6-6900476dcb86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1d9113f0-e8a9-4f50-9be6-6900476dcb86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MilestoneEquityPurchasePayment_712a913b-745d-4c7a-824e-a7f54d9d7449" xlink:href="nbix-20211231.xsd#nbix_MilestoneEquityPurchasePayment"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PotentialMilestonePaymentReceipts_6a621bde-bccd-4aa1-90c5-20066190f180" xlink:href="nbix-20211231.xsd#nbix_PotentialMilestonePaymentReceipts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PotentialMilestonePaymentReceipts_6a621bde-bccd-4aa1-90c5-20066190f180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PatentTerm_c1085df5-30d8-49fe-97ab-2ad4a60f55a8" xlink:href="nbix-20211231.xsd#nbix_PatentTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_nbix_PatentTerm_c1085df5-30d8-49fe-97ab-2ad4a60f55a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b29042d8-5d90-41a3-99be-a52b5dacf116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b29042d8-5d90-41a3-99be-a52b5dacf116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_aa1fd2a5-2936-48e5-9e2b-b05bf890a28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_aa1fd2a5-2936-48e5-9e2b-b05bf890a28c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_de9dc85b-f65f-4067-b825-0fa04576a061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_f211542b-4775-4d38-a3fb-f1d058d236e7" xlink:to="loc_us-gaap_DeferredRevenue_de9dc85b-f65f-4067-b825-0fa04576a061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecurities" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecurities"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/DebtSecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1d2b01a4-8c90-462e-9ffa-39bfe62599f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c1c8c8af-f83b-4c0d-835e-b353d2b88a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1d2b01a4-8c90-462e-9ffa-39bfe62599f3" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c1c8c8af-f83b-4c0d-835e-b353d2b88a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8cff0d17-322a-409a-b244-9d48daec0d79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_423b514d-55ed-4406-8977-bd309ff8fab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8cff0d17-322a-409a-b244-9d48daec0d79" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_423b514d-55ed-4406-8977-bd309ff8fab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1260d776-56d9-48a5-8ae1-5c136f843c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8cff0d17-322a-409a-b244-9d48daec0d79" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_1260d776-56d9-48a5-8ae1-5c136f843c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d056b2a6-a78b-40c2-bbbc-96b6b2defec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_d056b2a6-a78b-40c2-bbbc-96b6b2defec3" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_f58cd67c-dccb-40f1-9312-66c47c5460ae" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_e6bb03ab-ac39-4fa0-a012-00b133a24324" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_e6bb03ab-ac39-4fa0-a012-00b133a24324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LongTermInvestmentsMember_ddbeb470-1267-4c04-ba73-fcdb7744da8a" xlink:href="nbix-20211231.xsd#nbix_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_b487979d-8748-4a0f-97c7-6662d46497d1" xlink:to="loc_nbix_LongTermInvestmentsMember_ddbeb470-1267-4c04-ba73-fcdb7744da8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_6c53759d-adc2-422d-bb2e-dd4bd98538d2" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_592fb73b-6686-4698-a66e-b444713583f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_773fe977-0f13-45c4-ae50-8240e322f8d3" xlink:to="loc_us-gaap_CommercialPaperMember_592fb73b-6686-4698-a66e-b444713583f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_adaa639e-eeed-4d25-ac3b-ed75e8797969" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_7cc506e5-4360-4729-8d4b-0652546a8db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_7cc506e5-4360-4729-8d4b-0652546a8db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a7227692-4453-431c-85df-0447ac5e450d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5109a8b1-e21a-440c-84c0-3cc0fe8a4384" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_a7227692-4453-431c-85df-0447ac5e450d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_f5818f31-d770-4292-b1fb-85b8693aba26" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d9da091b-39e1-42eb-9722-b56b75e01379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d9da091b-39e1-42eb-9722-b56b75e01379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9582e16f-0f40-4378-8e51-a5b42c861532" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_9582e16f-0f40-4378-8e51-a5b42c861532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0862a68c-da4a-4d29-b11a-9a274017e260" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0862a68c-da4a-4d29-b11a-9a274017e260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b9a1e7ec-91f8-4027-966b-7a2c16398614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_2275594e-e5f7-4f5b-880b-261890a230c3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_b9a1e7ec-91f8-4027-966b-7a2c16398614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8ad4f2d1-c605-404d-bb25-7d8127d06842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_8ad4f2d1-c605-404d-bb25-7d8127d06842" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:to="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_86f4b4fe-a991-4cbc-ae3b-d4580777f680" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_fbea71cd-2b02-48cf-8da1-edc145a86f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_fbea71cd-2b02-48cf-8da1-edc145a86f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_2074baad-527b-4925-a5ca-af1e1374fdd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c34385b3-9cb4-4d13-a549-41e8c50cf458" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_2074baad-527b-4925-a5ca-af1e1374fdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_6dacc705-8666-4519-8576-5db1992f4895" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71f6468c-5685-47b1-9017-72deb96526c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_71f6468c-5685-47b1-9017-72deb96526c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_635f71eb-d58a-4dca-b5b4-f0fbb8d7c35b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_34b80cd5-300f-45f9-b6bc-ea3fc2ba6590" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_635f71eb-d58a-4dca-b5b4-f0fbb8d7c35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#DebtSecuritiesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_61ce03e4-7562-4fe6-8f42-43dedd0ccb2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions_33c48e39-8528-44d8-b8d7-1e7bc34f1a1d" xlink:href="nbix-20211231.xsd#nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_61ce03e4-7562-4fe6-8f42-43dedd0ccb2c" xlink:to="loc_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions_33c48e39-8528-44d8-b8d7-1e7bc34f1a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cfb1a7b3-5193-41d9-8ebc-1c7b68337da4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_61ce03e4-7562-4fe6-8f42-43dedd0ccb2c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_cfb1a7b3-5193-41d9-8ebc-1c7b68337da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7970bf45-965d-4d88-8dcf-c5c635f65c70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_136cb5be-25e3-474b-898a-14058336d499" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7970bf45-965d-4d88-8dcf-c5c635f65c70" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_136cb5be-25e3-474b-898a-14058336d499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8ed2617c-9d3d-4daf-b0c7-cbb4a01a339e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a3ba029f-8b2c-416a-b160-c41f80bc4a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8ed2617c-9d3d-4daf-b0c7-cbb4a01a339e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_a3ba029f-8b2c-416a-b160-c41f80bc4a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_66f1cec2-9bee-426d-9f7d-fed168e959c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8ed2617c-9d3d-4daf-b0c7-cbb4a01a339e" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_66f1cec2-9bee-426d-9f7d-fed168e959c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3e6ea2db-697b-4b71-bdae-82965637bbfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3e6ea2db-697b-4b71-bdae-82965637bbfe" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6cb6e785-64ec-4b5e-aa0b-090c14decd20" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9613d76a-6c16-4636-a445-000807011ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9613d76a-6c16-4636-a445-000807011ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_41f5a4a7-1dae-4f75-9244-4621a196d0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_41f5a4a7-1dae-4f75-9244-4621a196d0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_718ecfee-805a-4993-9999-e5c9778fb0cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7735975a-78bb-42bd-8dcd-68c2c5c8bfcd" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_718ecfee-805a-4993-9999-e5c9778fb0cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_70539cf1-95e8-4a5b-a249-6e40057a8734" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CashAndMoneyMarketFundMember_0d3dc4b2-535d-48cb-a1df-c2f8b6870384" xlink:href="nbix-20211231.xsd#nbix_CashAndMoneyMarketFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_nbix_CashAndMoneyMarketFundMember_0d3dc4b2-535d-48cb-a1df-c2f8b6870384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_8d06fa96-c550-4486-9ff3-8be351f54be2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_us-gaap_CertificatesOfDepositMember_8d06fa96-c550-4486-9ff3-8be351f54be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_4b549f9f-7c3e-4b92-b2f0-3e198741dd11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_af433194-f154-464f-9968-9768e1b6df18" xlink:to="loc_us-gaap_CommercialPaperMember_4b549f9f-7c3e-4b92-b2f0-3e198741dd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_16f52720-05a7-465d-8e2b-c46e3e160f54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dca340b3-e1f0-4b18-8cee-d76f02fad2ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dca340b3-e1f0-4b18-8cee-d76f02fad2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5e80e136-b54d-4d29-8bd2-dabc7114d5a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_5e80e136-b54d-4d29-8bd2-dabc7114d5a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_b84d3e19-af0f-40fe-b728-d8d9679d11de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d0990fb3-1559-4993-9230-db028ed7a5fd" xlink:to="loc_us-gaap_EquitySecuritiesMember_b84d3e19-af0f-40fe-b728-d8d9679d11de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_039eacef-78c7-41c2-8169-d8e4883d0a13" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_966bbbcc-1b56-46c1-8cb0-79489b52cade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_d372fca7-a4d0-4e9d-880b-bd4ec3f9341b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_966bbbcc-1b56-46c1-8cb0-79489b52cade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_474efecd-0fc2-4729-ac05-562067c4afaa" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_13c230c3-6cf5-4623-a9cb-dc836bfdb82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:to="loc_us-gaap_Investments_13c230c3-6cf5-4623-a9cb-dc836bfdb82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4a93ae9c-0cf8-490a-81f0-9c9de49dd63b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_58c9b316-3111-4f4e-898f-e98183d68f44" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4a93ae9c-0cf8-490a-81f0-9c9de49dd63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_31f83aec-c7ef-4a68-8912-6b8ba62dfe11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_31f83aec-c7ef-4a68-8912-6b8ba62dfe11" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3b82f7-d7fa-4c03-9e3f-afb5a90b9913" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_8f4c05d7-d048-4eee-a426-d5485684ba9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_06c4cd14-97ad-47e1-ad61-acc869e88d6e" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_8f4c05d7-d048-4eee-a426-d5485684ba9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollateralDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralAxis_813be4e2-e86f-4db0-ac75-8dd84b650f57" xlink:to="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_3f8513ca-8f2c-464c-b1a4-c41419aec26c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollateralDomain_e15732d6-71f7-4d05-959b-fb7af710a8ab" xlink:to="loc_us-gaap_EquitySecuritiesMember_3f8513ca-8f2c-464c-b1a4-c41419aec26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bfbfb9d3-2057-4a0e-b7b3-6b1e5f2482af" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_c60f13a3-e07e-49bc-9240-4fa9f8c8d505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_edfb8245-8891-4110-a606-1435f455f15b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_c60f13a3-e07e-49bc-9240-4fa9f8c8d505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_5c73a7d1-a4ba-4e1d-84a7-01e614d3169d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_XenonPharmaceuticalsIncMember_bcdfca4d-4cb1-4c75-9bdf-dcbb860acb6d" xlink:href="nbix-20211231.xsd#nbix_XenonPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37b4cdff-08cd-440a-9167-c2f5b701043d" xlink:to="loc_nbix_XenonPharmaceuticalsIncMember_bcdfca4d-4cb1-4c75-9bdf-dcbb860acb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_edbc3286-3c1e-45fa-ac12-d4dd0b03a05a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_9897f52b-0792-46e1-b5e9-cf5ed7a7ccca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d99b16fa-bd6f-4bae-9842-e6fe90122198" xlink:to="loc_us-gaap_CollaborativeArrangementMember_9897f52b-0792-46e1-b5e9-cf5ed7a7ccca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_5f56e376-f2b6-4b71-9074-68a83d338fe5" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_e4ce048f-3556-4537-adaf-df632965b558" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_c134df5e-1116-4020-90bd-f1a1948de2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_c134df5e-1116-4020-90bd-f1a1948de2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_c1838ce5-f96d-4b6e-a7c5-a7d1af9a86f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireRestrictedInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_PaymentsToAcquireRestrictedInvestments_c1838ce5-f96d-4b6e-a7c5-a7d1af9a86f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_709335e5-4d64-46ea-8132-da93b4091768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_709335e5-4d64-46ea-8132-da93b4091768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_7854a469-99a3-4578-988b-4a65563727cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_7854a469-99a3-4578-988b-4a65563727cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRestricted_94143aff-7f97-4282-97b3-cd80ec134e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquitySecuritiesFvNiRestricted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRestricted_94143aff-7f97-4282-97b3-cd80ec134e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedBalanceShares_11181401-697e-47e2-a6fc-4f69403cc8f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentOwnedBalanceShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract_5c22b217-a55f-41e7-b8f5-292db40956fe" xlink:to="loc_us-gaap_InvestmentOwnedBalanceShares_11181401-697e-47e2-a6fc-4f69403cc8f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8283fbde-5969-4103-9e1d-c42dd8d70e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8283fbde-5969-4103-9e1d-c42dd8d70e2f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:to="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_306502c3-19dc-4110-ba3c-2fee5a144a1e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_VoyagerTherapeuticsMember_0d7967fe-c204-46df-8cb1-6f577a83303a" xlink:href="nbix-20211231.xsd#nbix_VoyagerTherapeuticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4fb315bd-4853-42f7-8cd2-59ec13876fdf" xlink:to="loc_nbix_VoyagerTherapeuticsMember_0d7967fe-c204-46df-8cb1-6f577a83303a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:to="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_5452a915-53b1-434b-971b-64b4f0f86615" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_070b55e9-61db-44c2-aa42-61090a5fec8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_d72f19e2-a998-4f92-83f5-a9b8e7b37af7" xlink:to="loc_us-gaap_CollaborativeArrangementMember_070b55e9-61db-44c2-aa42-61090a5fec8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_2a740f4f-9536-485d-af6d-686d21e84e82" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis_29f5278f-ebb5-4c11-b93a-d455ef6b1c48" xlink:href="nbix-20211231.xsd#nbix_DiscountForMarketabilityUsedInValuationAnalysis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_d9e64957-3c0d-48fa-809f-8a9112cf7ab9" xlink:to="loc_nbix_DiscountForMarketabilityUsedInValuationAnalysis_29f5278f-ebb5-4c11-b93a-d455ef6b1c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotes" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotes"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_14325a3e-3060-4628-af2d-384e9acbd68a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_2d102acd-7be3-4f53-85c2-cc89aa1e6651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_14325a3e-3060-4628-af2d-384e9acbd68a" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_2d102acd-7be3-4f53-85c2-cc89aa1e6651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotesTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_4c5d4b31-9d40-4f86-8056-8f58b486c8c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_374f9f90-c427-4816-a48d-bbb14f794e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_4c5d4b31-9d40-4f86-8056-8f58b486c8c8" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_374f9f90-c427-4816-a48d-bbb14f794e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_66406940-e009-4c02-bbaa-38bd0fb28430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_66406940-e009-4c02-bbaa-38bd0fb28430" xlink:to="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8f154b09-ab37-4ab9-9798-62fd80a9dcf0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_15872835-1410-43dc-ae49-a6803178fa43" xlink:href="nbix-20211231.xsd#nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_96021622-597b-4e84-830d-2547b3a588da" xlink:to="loc_nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember_15872835-1410-43dc-ae49-a6803178fa43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_4131b6cb-e48b-41bb-80fd-f500d564e891" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_7849df84-f674-4fa2-a5d8-7ed335982218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_dc0a5c58-6402-472f-9e8e-45468b6c16b5" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_7849df84-f674-4fa2-a5d8-7ed335982218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConversionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_DebtInstrumentConversionAxis_448ce827-a736-4e35-88fb-7961cb3321e8" xlink:to="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodOneMember_97097a40-c0bc-42b4-adcf-c2a9ab960731" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:to="loc_nbix_ConversionPeriodOneMember_97097a40-c0bc-42b4-adcf-c2a9ab960731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ConversionPeriodTwoMember_62f4fe6d-ae06-4ba9-be68-1414a99a830e" xlink:href="nbix-20211231.xsd#nbix_ConversionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_DebtInstrumentConversionDomain_7dd07e34-98b1-465b-863b-04849157b65e" xlink:to="loc_nbix_ConversionPeriodTwoMember_62f4fe6d-ae06-4ba9-be68-1414a99a830e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_30738d96-39ee-4e5f-af6d-e82abc8cbc4b" xlink:to="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_db1e493e-95b4-4ce3-9f94-8b2931228fec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_db1e493e-95b4-4ce3-9f94-8b2931228fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_cb10e5ce-6c14-443c-8e2e-2c6d272b5295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_cb10e5ce-6c14-443c-8e2e-2c6d272b5295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e5ff4a4-60bd-4a0f-9bc5-8b16012735d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7e5ff4a4-60bd-4a0f-9bc5-8b16012735d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_bc98b274-d01d-430a-812c-ea5cc8d60508" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_bc98b274-d01d-430a-812c-ea5cc8d60508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_1496de50-64a6-4bbb-8584-f120742cfa3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_RepaymentsOfDebt_1496de50-64a6-4bbb-8584-f120742cfa3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_ad75f1be-73be-412d-8376-4aec8ba0ae96" xlink:href="nbix-20211231.xsd#nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment_ad75f1be-73be-412d-8376-4aec8ba0ae96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentMeasurementInput_b46def16-1ee2-4aa1-be34-2a3be18834dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMeasurementInput"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentMeasurementInput_b46def16-1ee2-4aa1-be34-2a3be18834dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_70cbb5c2-b3ec-4e49-81cb-1042b1373689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments_70cbb5c2-b3ec-4e49-81cb-1042b1373689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement_90b73cb6-0533-47d2-a042-d075b8cc05d4" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentAtSettlement"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_CarryingAmountOfLiabilityComponentAtSettlement_90b73cb6-0533-47d2-a042-d075b8cc05d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e00d9dcc-ace2-4d96-af03-4f3d08eb9fc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e00d9dcc-ace2-4d96-af03-4f3d08eb9fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8d49dec1-f5de-45f3-a53d-92d46f88c4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_8d49dec1-f5de-45f3-a53d-92d46f88c4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_337ee00d-6b17-4f1f-94c3-89c750a64c73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleStockPriceTrigger"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleStockPriceTrigger_337ee00d-6b17-4f1f-94c3-89c750a64c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_63e7b667-1ae4-4efa-9e44-b6ce5bb94e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_63e7b667-1ae4-4efa-9e44-b6ce5bb94e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b5aa1d1c-45d1-44fe-b5b6-66996673823a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_b5aa1d1c-45d1-44fe-b5b6-66996673823a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PrincipalAmountOnConversionRate_a724353f-3e99-402f-a070-6eb5420849fd" xlink:href="nbix-20211231.xsd#nbix_PrincipalAmountOnConversionRate"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_PrincipalAmountOnConversionRate_a724353f-3e99-402f-a070-6eb5420849fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_ad2b54b6-7e1f-49b0-a211-d742a22081dc" xlink:href="nbix-20211231.xsd#nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice_ad2b54b6-7e1f-49b0-a211-d742a22081dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TradingDaysDuringObservationPeriod_2e80b9f8-cd7b-4954-9110-49a538fe8fa3" xlink:href="nbix-20211231.xsd#nbix_TradingDaysDuringObservationPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_TradingDaysDuringObservationPeriod_2e80b9f8-cd7b-4954-9110-49a538fe8fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_53590913-65f8-4d4c-bb11-6b33b9abe0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_53590913-65f8-4d4c-bb11-6b33b9abe0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e9fa1363-3410-4a35-9ccd-6c2cde5a9022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_e9fa1363-3410-4a35-9ccd-6c2cde5a9022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_5e80a4be-f054-43e3-9ad7-b835de3dd047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_5e80a4be-f054-43e3-9ad7-b835de3dd047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DebtInstrumentConvertibleConversionPremium_da4b93c9-5593-4cf2-8a75-80b5869f4116" xlink:href="nbix-20211231.xsd#nbix_DebtInstrumentConvertibleConversionPremium"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_DebtInstrumentConvertibleConversionPremium_da4b93c9-5593-4cf2-8a75-80b5869f4116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_fd406df6-adb5-4880-aaec-7b32ff00268c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_SharePrice_fd406df6-adb5-4880-aaec-7b32ff00268c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_65b8334a-9fc9-4c38-82d1-9ff4bd5467ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_65b8334a-9fc9-4c38-82d1-9ff4bd5467ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance_b3cf0c96-c288-4889-b2ff-fcacbcc2d1ea" xlink:href="nbix-20211231.xsd#nbix_CarryingAmountOfLiabilityComponentUponIssuance"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_CarryingAmountOfLiabilityComponentUponIssuance_b3cf0c96-c288-4889-b2ff-fcacbcc2d1ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c53e0c39-f427-4caa-8b79-f406af4b8d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentInterestRateDuringPeriod_c53e0c39-f427-4caa-8b79-f406af4b8d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_3e4fa766-8b1f-4a1a-9f8c-747426e050cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent_3e4fa766-8b1f-4a1a-9f8c-747426e050cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_83a14d92-08e2-444d-b130-f2e7ece63005" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentTerm_83a14d92-08e2-444d-b130-f2e7ece63005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a8f32250-8bf0-4fde-813a-804daeeb207f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1_a8f32250-8bf0-4fde-813a-804daeeb207f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_266da457-a9a8-4562-b1d1-85d123bc601c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_266da457-a9a8-4562-b1d1-85d123bc601c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_1b0cf335-e1d3-4c06-a347-cfae466be718" xlink:href="nbix-20211231.xsd#nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault_1b0cf335-e1d3-4c06-a347-cfae466be718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_0b45f079-d836-4649-9503-25529ef28683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_505447f9-0cfa-43ba-94e3-8380b9044774" xlink:to="loc_us-gaap_DebtInstrumentFairValue_0b45f079-d836-4649-9503-25529ef28683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e0f7c619-7726-44e9-ab9f-118122a5aa85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_a6a0aa57-5f10-4509-9166-f69e4b8ca70f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0f7c619-7726-44e9-ab9f-118122a5aa85" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_a6a0aa57-5f10-4509-9166-f69e4b8ca70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b0cf3831-54ce-40c1-a4f6-7feb53a6b674" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0f7c619-7726-44e9-ab9f-118122a5aa85" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b0cf3831-54ce-40c1-a4f6-7feb53a6b674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b34adf2f-97fb-48f4-8e54-25413adb3dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0f7c619-7726-44e9-ab9f-118122a5aa85" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_b34adf2f-97fb-48f4-8e54-25413adb3dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebt_9b56bcdf-89db-42da-8ddd-43372404381d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e0f7c619-7726-44e9-ab9f-118122a5aa85" xlink:to="loc_us-gaap_ConvertibleDebt_9b56bcdf-89db-42da-8ddd-43372404381d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract_2e11d4fd-4e7d-46cd-a82c-375e813ccd94" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a3ad95ab-174f-49b0-a6e0-288102b304ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_2e11d4fd-4e7d-46cd-a82c-375e813ccd94" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a3ad95ab-174f-49b0-a6e0-288102b304ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract_d4e0aecb-ebbe-45cf-9fde-2cbde592719b" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7bda3b69-fba0-426e-9295-966750c4e5a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_d4e0aecb-ebbe-45cf-9fde-2cbde592719b" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7bda3b69-fba0-426e-9295-966750c4e5a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0ac75d66-7581-4213-b177-d69bd8ffe6de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_d4e0aecb-ebbe-45cf-9fde-2cbde592719b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_0ac75d66-7581-4213-b177-d69bd8ffe6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_10ff87b6-b574-4e09-abce-e0b461b03db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_d4e0aecb-ebbe-45cf-9fde-2cbde592719b" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_10ff87b6-b574-4e09-abce-e0b461b03db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock_9736ea23-345f-4078-af8f-5e68a6af16b3" xlink:href="nbix-20211231.xsd#nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_d4e0aecb-ebbe-45cf-9fde-2cbde592719b" xlink:to="loc_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock_9736ea23-345f-4078-af8f-5e68a6af16b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract_80b5f282-e4fc-43be-aaa6-8724f24d4db3" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0a4f8838-d921-4cc5-a041-98c50627a3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_80b5f282-e4fc-43be-aaa6-8724f24d4db3" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_0a4f8838-d921-4cc5-a041-98c50627a3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9506f3ca-3e0e-4912-893c-75f9395a1d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_80b5f282-e4fc-43be-aaa6-8724f24d4db3" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_9506f3ca-3e0e-4912-893c-75f9395a1d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9ac1cc64-3f88-496c-bc02-b8facfe084a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_80b5f282-e4fc-43be-aaa6-8724f24d4db3" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9ac1cc64-3f88-496c-bc02-b8facfe084a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2dd26972-e477-4527-9f8e-6ac7bf7c538d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_80b5f282-e4fc-43be-aaa6-8724f24d4db3" xlink:to="loc_us-gaap_InventoryNet_2dd26972-e477-4527-9f8e-6ac7bf7c538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_699bbf2e-7ab8-4ab4-8f0b-73a75c9e5615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_699bbf2e-7ab8-4ab4-8f0b-73a75c9e5615" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2695ecfc-7879-41ad-8beb-30daef8de093" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_4e47e399-aca6-40c2-b79d-ea5ae2c3d5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_4e47e399-aca6-40c2-b79d-ea5ae2c3d5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_ScientificEquipmentMember_2cf71f44-6b46-4837-99c9-833cbd84a3ff" xlink:href="nbix-20211231.xsd#nbix_ScientificEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_nbix_ScientificEquipmentMember_2cf71f44-6b46-4837-99c9-833cbd84a3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_d4129a10-f276-40b6-90b7-e3252f5ba340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_ComputerEquipmentMember_d4129a10-f276-40b6-90b7-e3252f5ba340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_eb3e16b5-8afe-4ef8-84a8-b93f82fc4afa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_96856c26-b2f4-4fbe-8aab-d0b7e94487e4" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_eb3e16b5-8afe-4ef8-84a8-b93f82fc4afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0b912bac-7507-42a2-b72c-e6dac86e3993" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_5fee967e-8d2c-42b3-a93a-46e1db82b6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_5fee967e-8d2c-42b3-a93a-46e1db82b6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c8d460c-d75c-4452-8016-cf32521e2cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9c8d460c-d75c-4452-8016-cf32521e2cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4d19f96-f6c5-46b0-921c-04959cdedc42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_cd471f9d-2aac-4114-a8ed-4931cf07fabe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4d19f96-f6c5-46b0-921c-04959cdedc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c2a38e7b-251f-49e9-8b78-2e6d6fe70684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c2a38e7b-251f-49e9-8b78-2e6d6fe70684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances_0c5d7b5e-f1d8-45f3-a074-41ec90a1238f" xlink:href="nbix-20211231.xsd#nbix_RevenueRelatedReservesForDiscountsAndAllowances"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_nbix_RevenueRelatedReservesForDiscountsAndAllowances_0c5d7b5e-f1d8-45f3-a074-41ec90a1238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent_d912ab49-ab1f-4049-aaa3-0ffb7cd92763" xlink:href="nbix-20211231.xsd#nbix_AccruedResearchAndDevelopmentExpenseCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_nbix_AccruedResearchAndDevelopmentExpenseCurrent_d912ab49-ab1f-4049-aaa3-0ffb7cd92763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AccruedBrandedPrescriptionDrugFee_aecad897-046e-40fb-abd1-7e480aa2d9e6" xlink:href="nbix-20211231.xsd#nbix_AccruedBrandedPrescriptionDrugFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_nbix_AccruedBrandedPrescriptionDrugFee_aecad897-046e-40fb-abd1-7e480aa2d9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_206f61fc-64a2-40ea-ba62-5ed8236d466e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_206f61fc-64a2-40ea-ba62-5ed8236d466e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_27445297-b3a2-4f38-a3a1-a85bfe545572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_79d9710d-3731-40eb-a76b-cd97761706b5" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_27445297-b3a2-4f38-a3a1-a85bfe545572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_nbix_OtherBalanceSheetDetailsAbstract_acda5b44-d37f-4207-83f4-cc0ada3041dc" xlink:href="nbix-20211231.xsd#nbix_OtherBalanceSheetDetailsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7459bb8e-fa52-496c-b1ca-e321d090b04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_acda5b44-d37f-4207-83f4-cc0ada3041dc" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7459bb8e-fa52-496c-b1ca-e321d090b04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a98b9302-7ef5-4d9e-b980-6c494be79b80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_acda5b44-d37f-4207-83f4-cc0ada3041dc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_a98b9302-7ef5-4d9e-b980-6c494be79b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_9faa9ee8-68c2-4a83-9bfb-400780503e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_OtherBalanceSheetDetailsAbstract_acda5b44-d37f-4207-83f4-cc0ada3041dc" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_9faa9ee8-68c2-4a83-9bfb-400780503e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShare" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e960c1da-e7c9-4300-a984-a5a146536227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_caa8b83d-ce60-45be-af32-d0695a96f00b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e960c1da-e7c9-4300-a984-a5a146536227" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_caa8b83d-ce60-45be-af32-d0695a96f00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_13ec3613-2b40-4ce0-8131-3d8600fa8708" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_692bcb52-c363-4878-a2c6-860165fabd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_13ec3613-2b40-4ce0-8131-3d8600fa8708" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_692bcb52-c363-4878-a2c6-860165fabd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareScheduleofNetIncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0c9e8fbe-f2ec-4027-8260-ed803d2a6bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0c9e8fbe-f2ec-4027-8260-ed803d2a6bc9" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f934ea07-73dd-4dce-9dcc-9c89a53fbda4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_344d3c00-18cd-4edb-b626-5c0358844587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:to="loc_us-gaap_EmployeeStockOptionMember_344d3c00-18cd-4edb-b626-5c0358844587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6b008b5d-2388-49f7-ad56-a9142f8e8b09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_9b2c537b-71a2-462b-8c23-3dd4baea2036" xlink:to="loc_us-gaap_RestrictedStockMember_6b008b5d-2388-49f7-ad56-a9142f8e8b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:to="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_66d39004-8801-48a4-823a-d927700bcc2c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A225ConvertibleSeniorNotesMember_4660567f-2015-4819-99a1-239e82931e36" xlink:href="nbix-20211231.xsd#nbix_A225ConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_beb58d76-f584-4fcc-a5ab-2507a757be25" xlink:to="loc_nbix_A225ConvertibleSeniorNotesMember_4660567f-2015-4819-99a1-239e82931e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_e3a32013-0b1c-417e-a22f-ef8c0bdafd22" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1de08dc2-b235-4305-9b9d-80dd78ee93b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_NetIncomeLoss_1de08dc2-b235-4305-9b9d-80dd78ee93b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ca7c5b4-0908-4f72-8f29-176022b870d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_60d17360-d61f-43f0-a09e-fc02e7cd8ad7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6ca7c5b4-0908-4f72-8f29-176022b870d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_312d598e-ca95-4d1f-b912-07199aac225d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_312d598e-ca95-4d1f-b912-07199aac225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_fdc8275f-4042-401b-9b2c-efd53886b7e2" xlink:href="nbix-20211231.xsd#nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities_fdc8275f-4042-401b-9b2c-efd53886b7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05e2c3a1-2475-4c87-8bd1-741ef89df8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract_23bd006b-8615-4988-a668-ab7442d0dad8" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_05e2c3a1-2475-4c87-8bd1-741ef89df8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_2ea0dc18-80c4-4279-b3b8-c39ece24ecec" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_702695d2-7581-45c7-aba1-8e0789738134" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:to="loc_us-gaap_EarningsPerShareBasic_702695d2-7581-45c7-aba1-8e0789738134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be80695f-2593-48da-b90e-ef98d00be8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_83e2c10d-93a9-4a23-b887-2de9053e2e1b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be80695f-2593-48da-b90e-ef98d00be8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5983b23f-23d6-452c-b85d-5442a826bcf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5983b23f-23d6-452c-b85d-5442a826bcf1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0032d959-3bac-4027-9bb6-eb856707c923" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_a097a726-72c7-4933-9872-2fc227421331" xlink:href="nbix-20211231.xsd#nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_50c763f5-e634-4eb6-94b3-5b1057b3a7a8" xlink:to="loc_nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember_a097a726-72c7-4933-9872-2fc227421331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5690137e-82c0-415c-87d0-03f1fe20ae3b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca4195af-5413-44c3-a58e-88c8af5c035b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_f0924910-2509-4826-b37c-8a024a416c9f" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_ca4195af-5413-44c3-a58e-88c8af5c035b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8ca0ccb2-4719-4f5d-a305-9fa000877166" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_67e54bcb-2248-40d7-924a-25841920fed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8ca0ccb2-4719-4f5d-a305-9fa000877166" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_67e54bcb-2248-40d7-924a-25841920fed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38550699-00ab-43c8-916c-22a67067ff71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ef0eb46e-4e2a-492c-94aa-13174739d855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38550699-00ab-43c8-916c-22a67067ff71" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ef0eb46e-4e2a-492c-94aa-13174739d855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e4780ff2-ae3a-4e03-a484-7f0b15e414e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38550699-00ab-43c8-916c-22a67067ff71" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e4780ff2-ae3a-4e03-a484-7f0b15e414e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3cd3b9c4-f72a-44c0-b97e-0982cec99060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38550699-00ab-43c8-916c-22a67067ff71" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3cd3b9c4-f72a-44c0-b97e-0982cec99060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1aadccc2-3648-4a77-8511-bee915cb2ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_38550699-00ab-43c8-916c-22a67067ff71" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_1aadccc2-3648-4a77-8511-bee915cb2ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0359d6a5-87dc-43aa-99d0-f91008fa3210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0359d6a5-87dc-43aa-99d0-f91008fa3210" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_cbd3f1cd-cc91-42b6-87e1-27c76195ec5a" xlink:to="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_TwoThousandAndElevenPlanMember_4917433a-4537-42a3-9316-b51a0aab9417" xlink:href="nbix-20211231.xsd#nbix_TwoThousandAndElevenPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:to="loc_nbix_TwoThousandAndElevenPlanMember_4917433a-4537-42a3-9316-b51a0aab9417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_A2020EquityIncentivePlanMember_199d1e09-19f9-44d6-be77-bf63df0bd61b" xlink:href="nbix-20211231.xsd#nbix_A2020EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fbe34057-69b2-4624-a8db-5a2f45928747" xlink:to="loc_nbix_A2020EquityIncentivePlanMember_199d1e09-19f9-44d6-be77-bf63df0bd61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_98118896-fb96-4f5d-94c2-9f0ad0f17d0c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_fdfa1080-1a19-4aac-9303-cb457bb97ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_fdfa1080-1a19-4aac-9303-cb457bb97ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a2722a99-f2a7-44b0-84f5-52b8bd26ce9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a2722a99-f2a7-44b0-84f5-52b8bd26ce9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_dcab6983-65a0-4b75-883b-99838ac131b4" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_dcab6983-65a0-4b75-883b-99838ac131b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6a7fd3de-ba17-4881-be1d-cfac13e25b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eb9d19-93f7-4be6-8963-a6a54b76d1e7" xlink:to="loc_us-gaap_EmployeeStockMember_6a7fd3de-ba17-4881-be1d-cfac13e25b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c565cf7f-d789-4f12-9645-e9cef86929cd" xlink:to="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5662e837-cfb7-48db-85f4-3719398299a2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:to="loc_srt_MinimumMember_5662e837-cfb7-48db-85f4-3719398299a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_01d5d24f-8263-4415-8575-41cb2fefd201" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b4620b9c-42dc-4194-a053-d07688b0ed13" xlink:to="loc_srt_MaximumMember_01d5d24f-8263-4415-8575-41cb2fefd201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_468864d4-7519-48ad-892a-464905fadcb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_fb652ca0-57a4-42c4-bfba-86068eb4abaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_fb652ca0-57a4-42c4-bfba-86068eb4abaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da5a192a-b2f9-4d62-8133-85040479e70d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_da5a192a-b2f9-4d62-8133-85040479e70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_594590c8-5079-4944-8548-653fba4a53c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_594590c8-5079-4944-8548-653fba4a53c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0164f639-2de6-40ef-81af-8007e8c953dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_0164f639-2de6-40ef-81af-8007e8c953dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a413af90-0f7e-487c-88f5-44f9f6099206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_a413af90-0f7e-487c-88f5-44f9f6099206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_bf281f89-653e-498f-8dea-d02eb5ac5944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_bf281f89-653e-498f-8dea-d02eb5ac5944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_5f6162a3-8b69-4606-a56a-938ed0b989eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_5f6162a3-8b69-4606-a56a-938ed0b989eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb50f209-0e6a-432e-8074-cd7c64173e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_fb50f209-0e6a-432e-8074-cd7c64173e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4ea7af98-aa21-4817-999f-801e14840ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_4ea7af98-aa21-4817-999f-801e14840ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c8d7e242-0fa7-4b35-8c52-ae917111a7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_142a98b6-48b4-40ee-9ff5-2bbad0166576" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c8d7e242-0fa7-4b35-8c52-ae917111a7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba8c8b2b-7cbc-43a8-a2a8-d27e5e9f6a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba8c8b2b-7cbc-43a8-a2a8-d27e5e9f6a3f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_195e2418-1620-4ae5-83ee-ec7d0a65ac22" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_644bd3da-97bf-4786-98f2-5f9a93bd9716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_644bd3da-97bf-4786-98f2-5f9a93bd9716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e75bfef3-33c8-456e-9b62-55a292d20f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c0d67557-7dea-4eb7-b884-e3bc49ee3a8f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e75bfef3-33c8-456e-9b62-55a292d20f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e77a729a-1135-4e9a-af47-743b06fe9df2" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c6d16192-a6f1-4cea-a3a1-10333cf30411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d67f8ac4-c4c3-450e-ae37-ee216ccbc21e" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c6d16192-a6f1-4cea-a3a1-10333cf30411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7fd02f7-c807-4ac0-9e31-cfd6ab814741" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a7fd02f7-c807-4ac0-9e31-cfd6ab814741" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:to="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e18da172-22f4-428e-9472-cae454d755d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ad71ffc5-e299-4318-8777-6277bb0f4da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ad71ffc5-e299-4318-8777-6277bb0f4da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9f444afb-5d7d-4b6c-8a31-258808ed0e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9f444afb-5d7d-4b6c-8a31-258808ed0e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_fc137f76-2bca-467a-9695-fd3042580318" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_fc137f76-2bca-467a-9695-fd3042580318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_5255e833-e0fc-4632-b230-596687b48a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_26d9ce28-1c83-4dde-9796-92c871e0b3ff" xlink:to="loc_us-gaap_EmployeeStockMember_5255e833-e0fc-4632-b230-596687b48a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8a19a28a-cd24-499a-8ca4-3465248c0101" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ce0e23c-cb1e-44a1-9ea4-3753fe5e858e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_019345b8-7b7e-49ef-8861-d25c27d97295" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_9ce0e23c-cb1e-44a1-9ea4-3753fe5e858e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_15b8e25b-ffe3-4b19-a8a3-89ef9dc3aa78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_15b8e25b-ffe3-4b19-a8a3-89ef9dc3aa78" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:to="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_394f8f2f-094f-453b-a462-f7e4f81ea37f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_07e52a3a-9d8e-4120-bbd8-c2b62a537066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_07e52a3a-9d8e-4120-bbd8-c2b62a537066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_109fe560-e117-40d9-b987-415bd2aca78a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4be2d27c-6e5c-4e0b-8354-b8ce09dd3d7f" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_109fe560-e117-40d9-b987-415bd2aca78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_f0a0f112-8fc2-45ba-aa1c-9a4a370302de" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ff6963f0-bfbc-4e2e-b30e-b686474cb561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ff6963f0-bfbc-4e2e-b30e-b686474cb561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7e9f469b-5091-45c8-b78d-59a26ab2dd1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_04f19f47-a23c-46ed-877d-7d09b7ef0cad" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7e9f469b-5091-45c8-b78d-59a26ab2dd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a44bb711-764a-4aab-8ddf-7a54879b9416" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a44bb711-764a-4aab-8ddf-7a54879b9416" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:to="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_00c910fe-e187-4165-887d-33fa4e155711" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_64112201-d81e-4b27-a565-625108fea6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_604cc9d4-d61a-4304-a1ab-564351aaa6c9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_64112201-d81e-4b27-a565-625108fea6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b8e87871-93e9-42df-8c65-e5daa8c653fe" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_366925ec-b740-456f-917f-ae79a8745347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_366925ec-b740-456f-917f-ae79a8745347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7adce39c-9506-4b64-b028-a71a37ffff58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7adce39c-9506-4b64-b028-a71a37ffff58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9b60ccfc-d17a-441e-99fb-4f8dfade6ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9b60ccfc-d17a-441e-99fb-4f8dfade6ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb598e82-290b-465c-8c07-be97a556a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c7b09ad7-7779-466b-9b53-3c5a456bccb7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_cb598e82-290b-465c-8c07-be97a556a06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_463df47e-513d-4abc-afb7-fd2055e5e2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_463df47e-513d-4abc-afb7-fd2055e5e2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_010e211b-f1bc-4f15-a089-a239044393c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_010e211b-f1bc-4f15-a089-a239044393c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fe5515f0-2c7f-4a47-944a-9a3b8f9808ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fe5515f0-2c7f-4a47-944a-9a3b8f9808ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0fc52801-42a2-4d0d-9af9-a61925aba056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_0fc52801-42a2-4d0d-9af9-a61925aba056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b7be14a-5901-4158-96a0-53f29c33a18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_85fc2101-b09e-4ce6-80bf-06b049f7ab55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b7be14a-5901-4158-96a0-53f29c33a18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7d72dc9e-82af-41e1-8ace-da693537f05c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_7d72dc9e-82af-41e1-8ace-da693537f05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9ef40dfa-8147-4d84-bf33-4cae5d098286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_9ef40dfa-8147-4d84-bf33-4cae5d098286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_63dbc9d3-9861-40a9-8747-f294ed87e529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_63dbc9d3-9861-40a9-8747-f294ed87e529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23095ae4-b192-49a0-a732-1b67a370f25d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_23095ae4-b192-49a0-a732-1b67a370f25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3f7f1068-d3a9-48ad-9b5f-9453ed7114df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3f7f1068-d3a9-48ad-9b5f-9453ed7114df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b3a08f01-7805-411f-9f37-eabc14ec10aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_5e277df7-1400-4987-b65a-b4239234dd9b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b3a08f01-7805-411f-9f37-eabc14ec10aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6ec8e2ca-8092-4e22-8ad7-ff60b5ec572c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6ec8e2ca-8092-4e22-8ad7-ff60b5ec572c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_eda3e66a-846c-453b-b64c-4fdf1c42efa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_eda3e66a-846c-453b-b64c-4fdf1c42efa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_ef1fd624-4686-4d92-beef-601efcd41706" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_ef1fd624-4686-4d92-beef-601efcd41706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a565c515-2a06-4c1f-ac7d-af1c05e21537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a565c515-2a06-4c1f-ac7d-af1c05e21537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a2e35347-c972-4f41-8f67-f242086b0679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eeabe1aa-e878-476c-bcb6-695824b951f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_a2e35347-c972-4f41-8f67-f242086b0679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03722dd1-772a-4605-a237-7427ccac5765" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_03722dd1-772a-4605-a237-7427ccac5765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac3ab618-d027-457f-bea4-a84e67b56fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_22f812b8-18d9-43b0-953c-557623bc47fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_ac3ab618-d027-457f-bea4-a84e67b56fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8feab002-e7eb-469b-bc73-5349fccef080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8feab002-e7eb-469b-bc73-5349fccef080" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:to="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_be19db0b-8a6b-4ca0-9029-930fc473db3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_58a4f77d-3a73-48fd-a948-e3a40f6d8bae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_58a4f77d-3a73-48fd-a948-e3a40f6d8bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_PerformanceBasedRestrictedStockUnitMember_6aa24cfa-1606-40ab-a8a5-73ae1f54f9be" xlink:href="nbix-20211231.xsd#nbix_PerformanceBasedRestrictedStockUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4ca9a55e-e65f-4066-8f37-3d8877e40084" xlink:to="loc_nbix_PerformanceBasedRestrictedStockUnitMember_6aa24cfa-1606-40ab-a8a5-73ae1f54f9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5ff781cb-aab9-46aa-882e-5fa7c6e55113" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4838ebfb-a942-4cb0-b09c-fc2c46c802d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4838ebfb-a942-4cb0-b09c-fc2c46c802d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7dca21a5-62ba-4271-b332-61a1c169da0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7dca21a5-62ba-4271-b332-61a1c169da0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26359ebf-bf1e-46be-a145-604550de52dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_26359ebf-bf1e-46be-a145-604550de52dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b6e4e4ed-3eea-4b8f-ab94-13e2f88c4efd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_b6e4e4ed-3eea-4b8f-ab94-13e2f88c4efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e625433-49df-46c8-865d-770fbfa9d9d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_23fedcc3-58a1-4d14-a8c0-ec557145a6f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9e625433-49df-46c8-865d-770fbfa9d9d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_84eb9803-18d9-4372-9011-a516dfd10a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_84eb9803-18d9-4372-9011-a516dfd10a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d3f6fd3-b714-4ec5-b822-4c6c99750fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4d3f6fd3-b714-4ec5-b822-4c6c99750fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7ef4dffa-b461-4f82-90f4-d4822196895b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_7ef4dffa-b461-4f82-90f4-d4822196895b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_17d25928-39bc-456a-84e5-87c0b60de595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_17d25928-39bc-456a-84e5-87c0b60de595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_028038e2-e895-44c2-9504-2074f406a2f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_438bb9aa-b1cb-4f5c-894e-9b5b45b040ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_028038e2-e895-44c2-9504-2074f406a2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ce52431b-05ac-4ad2-9b14-86825699f47f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b2b0b0f4-3044-4ac4-8a80-19169800962e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_b2b0b0f4-3044-4ac4-8a80-19169800962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_0436c4a2-648d-4a63-8829-313d058af612" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract_20890d5e-4e8a-4e4b-aa26-06b4a7b06c41" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_0436c4a2-648d-4a63-8829-313d058af612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxes" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_88921405-24d6-40a0-8e05-88d507f73dce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d5589dfb-1fa5-41e0-bbb9-9dc2da96c6ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_88921405-24d6-40a0-8e05-88d507f73dce" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d5589dfb-1fa5-41e0-bbb9-9dc2da96c6ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f3c22d-664a-435e-9004-428412645699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_081c1460-9708-423a-9752-985d921d522b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f3c22d-664a-435e-9004-428412645699" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_081c1460-9708-423a-9752-985d921d522b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_38dc8e26-89fb-4564-817d-b151ac79806a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f3c22d-664a-435e-9004-428412645699" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_38dc8e26-89fb-4564-817d-b151ac79806a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0dd0db49-d98c-4aba-b0d6-bf6083e7a0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f3c22d-664a-435e-9004-428412645699" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_0dd0db49-d98c-4aba-b0d6-bf6083e7a0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_90746556-7272-48c4-969c-68eb5cf06642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f3c22d-664a-435e-9004-428412645699" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_90746556-7272-48c4-969c-68eb5cf06642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_36248ba7-6c14-421c-bbfb-38fe6195b221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_66130220-5363-497f-83dd-a7d234bc667d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36248ba7-6c14-421c-bbfb-38fe6195b221" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_66130220-5363-497f-83dd-a7d234bc667d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f07c6357-c20c-4d40-bb76-5b669f4abd49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_66130220-5363-497f-83dd-a7d234bc667d" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_f07c6357-c20c-4d40-bb76-5b669f4abd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_656b6533-01fd-4624-b8c1-b55c2d497408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_66130220-5363-497f-83dd-a7d234bc667d" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_656b6533-01fd-4624-b8c1-b55c2d497408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_049ab0b5-fd57-4cb3-a8bd-a1125edfee36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_66130220-5363-497f-83dd-a7d234bc667d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_049ab0b5-fd57-4cb3-a8bd-a1125edfee36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_e09c1ade-47e8-4640-ab3b-0656b8af3173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36248ba7-6c14-421c-bbfb-38fe6195b221" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_e09c1ade-47e8-4640-ab3b-0656b8af3173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7ecd56b6-cbab-46f4-b74a-9f17cb9b105f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_e09c1ade-47e8-4640-ab3b-0656b8af3173" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_7ecd56b6-cbab-46f4-b74a-9f17cb9b105f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cd098d15-3e22-4690-ad04-15308db33884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_e09c1ade-47e8-4640-ab3b-0656b8af3173" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_cd098d15-3e22-4690-ad04-15308db33884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dc637730-2000-43b3-8eca-76f06921094b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_e09c1ade-47e8-4640-ab3b-0656b8af3173" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_dc637730-2000-43b3-8eca-76f06921094b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bd2b1c63-4108-4ed9-b107-8ffc6aeacc67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_36248ba7-6c14-421c-bbfb-38fe6195b221" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bd2b1c63-4108-4ed9-b107-8ffc6aeacc67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6c680bc6-34db-4a2b-ae7c-6b1f5a3ae8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6c680bc6-34db-4a2b-ae7c-6b1f5a3ae8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5016a9ee-7422-4e81-bb0e-c483228ef607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_5016a9ee-7422-4e81-bb0e-c483228ef607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_dc89ed5c-146d-4589-9b02-98f5a3c5e125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_dc89ed5c-146d-4589-9b02-98f5a3c5e125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_31aaa04c-2105-43e0-97c0-9cbbd2b5a678" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_31aaa04c-2105-43e0-97c0-9cbbd2b5a678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_64c7dd47-a822-4433-92fb-cae6f36d3668" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee_64c7dd47-a822-4433-92fb-cae6f36d3668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_4b6edc6b-3a67-4cb4-8c62-f43776537664" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_4b6edc6b-3a67-4cb4-8c62-f43776537664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_3b287d7b-023c-43d4-963e-c4a0bab4a355" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost_3b287d7b-023c-43d4-963e-c4a0bab4a355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_99b70da9-a7f4-4b85-89f8-bb4a5f109935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_99b70da9-a7f4-4b85-89f8-bb4a5f109935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_0bfe89d4-0413-4e4f-a364-b9bbaeca9b49" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxReconciliationExpirationOfTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_nbix_IncomeTaxReconciliationExpirationOfTaxCredits_0bfe89d4-0413-4e4f-a364-b9bbaeca9b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_11b038dc-1f36-418a-bb0c-0dd5c1a0ac58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_11b038dc-1f36-418a-bb0c-0dd5c1a0ac58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fff3a608-d3b9-4e4a-90ba-7065d3eafd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_fff3a608-d3b9-4e4a-90ba-7065d3eafd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7b1118ef-24c8-4a58-ad36-c364e112caf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_7b1118ef-24c8-4a58-ad36-c364e112caf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ffa82290-f0bb-495c-9aeb-4eb75928a39b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f7c3c903-1121-4145-a3c0-525183d7a716" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ffa82290-f0bb-495c-9aeb-4eb75928a39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesComponentsofDeferredTaxAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3be3597c-0cc4-4021-9192-6334954094e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_3be3597c-0cc4-4021-9192-6334954094e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1e2a9a0f-adc9-4f77-8680-b65ea8230863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_1e2a9a0f-adc9-4f77-8680-b65ea8230863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_b1f4ab75-573d-4790-bcb7-4f075f1261df" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment_b1f4ab75-573d-4790-bcb7-4f075f1261df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_a07cc358-2fda-4d01-bc15-4bea536d75a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_a07cc358-2fda-4d01-bc15-4bea536d75a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets_1c566074-4445-4e51-b897-ae03424e2fb5" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsOperatingLeasesAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_nbix_DeferredTaxAssetsOperatingLeasesAssets_1c566074-4445-4e51-b897-ae03424e2fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_48d48719-91aa-4a3e-a8be-5a5930448df4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_48d48719-91aa-4a3e-a8be-5a5930448df4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_067ff4c4-3d75-4685-9cc1-3a74f5c8acf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_067ff4c4-3d75-4685-9cc1-3a74f5c8acf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_6fdc5e68-1319-4962-856c-e89ac28358c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_c4b23baa-e716-4e8e-bef3-ae1f9a78d6fc" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_6fdc5e68-1319-4962-856c-e89ac28358c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_6bd0b7ce-201f-41c4-91d0-487cd4a49adc" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:to="loc_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes_6bd0b7ce-201f-41c4-91d0-487cd4a49adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_2a17636a-e54f-480f-8503-06d5dbcef9f1" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:to="loc_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities_2a17636a-e54f-480f-8503-06d5dbcef9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_407f68a2-33d8-4d85-9b35-937b7984df94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_407f68a2-33d8-4d85-9b35-937b7984df94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_1394d3f7-e79f-4443-ae57-fe9f732571fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_03995007-457f-404a-afb8-44cd0cfd4b2a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_1394d3f7-e79f-4443-ae57-fe9f732571fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_DeferredTaxAssetsLiabilitiesGross_aea8c416-efff-47e5-8d7f-980871f8ba84" xlink:href="nbix-20211231.xsd#nbix_DeferredTaxAssetsLiabilitiesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:to="loc_nbix_DeferredTaxAssetsLiabilitiesGross_aea8c416-efff-47e5-8d7f-980871f8ba84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4ff2fcde-0471-405a-ae2d-1498f02e8ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4ff2fcde-0471-405a-ae2d-1498f02e8ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_715193d0-9a55-44d1-8138-e480fddc3b53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_23274c72-9812-4e8f-90bf-6af764574158" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_715193d0-9a55-44d1-8138-e480fddc3b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_686a274d-a4d7-48fc-b00e-a776994ece93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_686a274d-a4d7-48fc-b00e-a776994ece93" xlink:to="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_056a5f84-0575-4843-af7b-094773020c07" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_d29b234e-5788-4804-9adc-a488e3090091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_d29b234e-5788-4804-9adc-a488e3090091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_04717939-2b11-415a-9816-11c6cf4864d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_d53d4531-fc1b-4261-b4b5-aa5f1b2ea970" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_04717939-2b11-415a-9816-11c6cf4864d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:href="nbix-20211231.xsd#nbix_IncomeTaxesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesTable_c2569912-78d0-4bdb-a59f-af0100662aee" xlink:to="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a3b2b51-8a2e-4b28-b8d8-57405cafdfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_5a3b2b51-8a2e-4b28-b8d8-57405cafdfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c7953230-b05f-47ca-837d-1817ce2fa2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c7953230-b05f-47ca-837d-1817ce2fa2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_b96b3219-77e6-4720-9e6d-0301e434c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_OperatingLossCarryforwards_b96b3219-77e6-4720-9e6d-0301e434c5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_28679688-9b7f-4428-94fb-42240884d623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_28679688-9b7f-4428-94fb-42240884d623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6f366e08-b727-4a38-8c00-4d1e0700d2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_6f366e08-b727-4a38-8c00-4d1e0700d2f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0adba173-6449-43db-900b-5d3b71afd88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_nbix_IncomeTaxesLineItems_e7b3f3b0-c8ad-49b6-a7db-e281cc023962" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0adba173-6449-43db-900b-5d3b71afd88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_44c4f65e-f2e1-42c3-9a64-1ef7ffdc35de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_44c4f65e-f2e1-42c3-9a64-1ef7ffdc35de" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_05add8ae-20d5-45ae-9c66-d428df2f57d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_05add8ae-20d5-45ae-9c66-d428df2f57d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_fdc41965-1c63-4ca5-8820-a33defefc491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_fdc41965-1c63-4ca5-8820-a33defefc491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d6dfb99e-f874-4d7e-9cec-9b64d1913789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d6dfb99e-f874-4d7e-9cec-9b64d1913789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7f66a8e5-dfaa-4807-a68c-0a92360c2d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_7f66a8e5-dfaa-4807-a68c-0a92360c2d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_421b203c-c9c3-43a1-a09f-f87896b49d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_421b203c-c9c3-43a1-a09f-f87896b49d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_01131ed0-25c2-4fac-af1d-ae8298739e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_01131ed0-25c2-4fac-af1d-ae8298739e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d62fc00a-4fe8-4f55-941a-5769bea9deff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_fab07918-d881-46b2-a993-57e1f345367d" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d62fc00a-4fe8-4f55-941a-5769bea9deff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/Leases" xlink:type="simple" xlink:href="nbix-20211231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_fe15d9aa-fc48-4930-ae57-e00ae01f75de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7d0b1e14-fdfe-4d24-bae0-078db93a24fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_fe15d9aa-fc48-4930-ae57-e00ae01f75de" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7d0b1e14-fdfe-4d24-bae0-078db93a24fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesTables" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9c8c1a38-174c-41bf-970d-d1215f1c54ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_3192ac2d-7a17-4064-b2fa-c23ed50125c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c8c1a38-174c-41bf-970d-d1215f1c54ff" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_3192ac2d-7a17-4064-b2fa-c23ed50125c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3a6f1574-c114-4285-9490-cd92f2d63064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c8c1a38-174c-41bf-970d-d1215f1c54ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_3a6f1574-c114-4285-9490-cd92f2d63064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSupplementalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSupplementalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/LeasesSupplementalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f3023a92-82dc-428a-90e4-d166945bdb17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f3023a92-82dc-428a-90e4-d166945bdb17" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:to="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ff04f691-a329-4a0c-960f-a54b5f166450" xlink:to="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_7d3dcc57-4727-4e7e-9e6e-bb114db153aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0486c2d0-1a4f-4dc4-86b5-6d026d0b2efe" xlink:to="loc_us-gaap_LetterOfCreditMember_7d3dcc57-4727-4e7e-9e6e-bb114db153aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_a181f1aa-bc4f-47ee-8033-34a61a8740f5" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_7c2bdc8d-5e99-4643-8252-66fb9cd27348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseCost_7c2bdc8d-5e99-4643-8252-66fb9cd27348" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_91a65481-6dbc-4c4b-9087-a7fa3338454c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeasePayments_91a65481-6dbc-4c4b-9087-a7fa3338454c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b51e993b-e4ed-4ab1-93fd-b1b201fd170a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b51e993b-e4ed-4ab1-93fd-b1b201fd170a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c082c72a-b21a-4c15-bde4-47387c7ec969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_c082c72a-b21a-4c15-bde4-47387c7ec969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_10275731-eb1e-4a50-b184-2c268e077a58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_5f02c57f-67fd-44a4-8520-34191bcbefe4" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_10275731-eb1e-4a50-b184-2c268e077a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3cd32b24-e92f-4c4f-86b4-8fcc70e6fdff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3cd32b24-e92f-4c4f-86b4-8fcc70e6fdff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1a4ac622-1ad0-4165-b606-f1b98b7f36bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1a4ac622-1ad0-4165-b606-f1b98b7f36bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8719e4cc-49c5-4cc0-b5f8-551f324b70c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8719e4cc-49c5-4cc0-b5f8-551f324b70c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638039b6-02b5-4da9-80a9-fb5776dc20a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_638039b6-02b5-4da9-80a9-fb5776dc20a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_23adc361-cd8d-439d-ad0e-641a9d26e99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_23adc361-cd8d-439d-ad0e-641a9d26e99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_60fd1b83-ad74-4fe0-9381-b1c74003ac77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_60fd1b83-ad74-4fe0-9381-b1c74003ac77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_add7db7a-0fa3-43a2-b5f2-2a205d1d14ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_add7db7a-0fa3-43a2-b5f2-2a205d1d14ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cf9c80d-97bb-44d8-b72e-ac1821de45ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cf9c80d-97bb-44d8-b72e-ac1821de45ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b6d73f38-c0fe-4fba-bd59-fefee2c7693e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b6d73f38-c0fe-4fba-bd59-fefee2c7693e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_c49ed344-f340-4eeb-b113-eb510eeb5143" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_OperatingLeaseLiability_c49ed344-f340-4eeb-b113-eb510eeb5143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_15ff079e-efce-4acc-afb4-3111d2ce0331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_15ff079e-efce-4acc-afb4-3111d2ce0331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_394c66a6-38e3-4266-adf7-823ec68e5753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5bafcbe2-d734-4462-a6a5-4c9d34907e99" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_394c66a6-38e3-4266-adf7-823ec68e5753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="nbix-20211231.xsd#LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.neurocrine.com/role/RetirementPlan" xlink:type="simple" xlink:href="nbix-20211231.xsd#RetirementPlan"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/RetirementPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b2c9d9a1-5ccf-4493-bcb4-84ee98bc4884" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fa584f97-f69d-4d8c-9936-9f03f72d1d4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_b2c9d9a1-5ccf-4493-bcb4-84ee98bc4884" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_fa584f97-f69d-4d8c-9936-9f03f72d1d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#RetirementPlanAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_458a989a-caf7-4940-b9e5-3c083f46e6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_2aef2db4-812f-4b9b-afca-6eb559154264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_458a989a-caf7-4940-b9e5-3c083f46e6fb" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_2aef2db4-812f-4b9b-afca-6eb559154264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_29e9a5f3-ffff-42f5-9998-35f73cb52d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_458a989a-caf7-4940-b9e5-3c083f46e6fb" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_29e9a5f3-ffff-42f5-9998-35f73cb52d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/SubsequentEvents" xlink:type="simple" xlink:href="nbix-20211231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_583c16a9-ee36-4147-adf7-52d720f60961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_4c281e5c-0a12-4d3d-af53-336286cc2173" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_583c16a9-ee36-4147-adf7-52d720f60961" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_4c281e5c-0a12-4d3d-af53-336286cc2173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.neurocrine.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="nbix-20211231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.neurocrine.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_53520c86-d2c5-4302-9086-9763c78ac389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_53520c86-d2c5-4302-9086-9763c78ac389" xlink:to="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_de0d41c0-f700-4cc5-8159-f3e34d8d7274" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_8f0bd1bc-d4b8-4c20-a59a-89e197b0bd61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_063dbd84-4f59-47c8-ac8c-02c2c7991711" xlink:to="loc_us-gaap_SubsequentEventMember_8f0bd1bc-d4b8-4c20-a59a-89e197b0bd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_d00f4fa7-928b-42fa-bbad-d5e6a7431db7" xlink:to="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f9cc4690-a842-429d-9adb-5ba6f3bc78cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f9cc4690-a842-429d-9adb-5ba6f3bc78cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_a3bb06bf-c5a5-4db0-acda-c3cb1fd56531" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot_a3bb06bf-c5a5-4db0-acda-c3cb1fd56531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_AnnualRentEscalationPercentage_d3aabd94-307c-44f8-b363-34fe976d3d76" xlink:href="nbix-20211231.xsd#nbix_AnnualRentEscalationPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_AnnualRentEscalationPercentage_d3aabd94-307c-44f8-b363-34fe976d3d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_RentAbatementPeriod_b902194f-4248-429d-b12d-7e9ce6414fe8" xlink:href="nbix-20211231.xsd#nbix_RentAbatementPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_RentAbatementPeriod_b902194f-4248-429d-b12d-7e9ce6414fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_NumberOfRenewalOptions_b6029ecc-803f-44bf-bf4e-4e1bd3f4cc40" xlink:href="nbix-20211231.xsd#nbix_NumberOfRenewalOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_NumberOfRenewalOptions_b6029ecc-803f-44bf-bf4e-4e1bd3f4cc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_04a0142d-288b-4b4f-86fd-0223d4c2ff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_04a0142d-288b-4b4f-86fd-0223d4c2ff0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_1d697c65-fe2d-4a84-b202-3edb1a212abb" xlink:href="nbix-20211231.xsd#nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_b01f17a5-1a57-4451-8568-bae9503a17b4" xlink:to="loc_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding_1d697c65-fe2d-4a84-b202-3edb1a212abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_0a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0a.jpg
MB5!.1PT*&@H    -24A$4@  !64    &" (    D*6LN    1DE$051X7NW8
ML1$ , P",>^_-.EQ-K!4<DSP,P   ,!M6?H!    7-.U0"\     NA8DGPD
E   X3B\     FEX     M >>0)4.!O6G=0    !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>image_1a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_1a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
MHR2NZ_9/TVVNO .H2W%NDI_M&3B2,?\ /.*N$_:X^7QO8X_Y\HO_ $9+7(?#
MKXUZA\-=#ETZTM!/')<?:?\ 6_\ VK_IG7YM+'X;+N)JM?$? ?H,<#B<?PW1
MIX;N?9.I>#]"UBU,-YH]G<QGO+ A'\J^$OB9IMOH?Q UVRT\QQ6UM>2&.*'_
M )9\5W&O?M,>+-0M3%97$FGY_P"6T1CE_P#:5<SX(\":Y\5O$WF#S)1))YMS
MJ$L<O_/6L\_S3"YZZ6'RVG[]^QMD.6XK(54Q6/J6IV[GVEX!N[B_\'V%Q=AQ
M<NLN\2=?]8:^&?A_#'+\2/#T<D?F12:M;?NY?^NM?H!8VD>G626L*;(XDQ^E
M?G3I^H7&AZY'J-G)Y5U;7/FQR_\ 32O4XQ_V;ZC[76WZ<AY7"*^MK'^QTNO_
M ),_0D>$]%P/^)19G_MWC_PH_P"$3T7_ *!%G_X#Q_X5\<_\-(>//^@L_P#W
MYM__ (W1_P -'>._^@TW_?FW_P#C=>E_KCDJ_P"77X'F?ZHYQOSK[_\ @'VG
M8Z?;:?"([.WCMHNR0QA!^E?$W[05U<W?Q&N?M#R QB2*/S/^>?F2U]0_ _Q3
M?^+OAS8:IJ,ZW%V[R;Y%3;_RT(K@/V@?@K+XG8:]I$:F_7RHVMU1_P!Z!))Z
M?]=379Q%AJF<933J8%:?&<W#N*IY7FTX8OTN;'[,]CH:^"3-IYMY[[?']JDC
M^_YGE1YS7J7B#PGI/BFU\C5=.M[V(]5FCR*^"M'\3^)_ 5UY6GW=YHLGF?O8
M6_=_^0J]?\(_M7ZAIL,<.OV<FJ ];N.1(S_W[\L5Y&3<49?2P]/ XVG[.WEH
M>MFW#68U<34QV$J>T3\]3ZCTO2['1K*.VL+:*UMXQ\D4,?EH/P J^WS#-87A
M7Q78^+M)AU"PD$UO*,A@V:W>G%?JU%TJE.]+8_,ZBJ4ZC57<=2T45T&84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
MHHHH **3</6C</6@!:*3</6C</6@5Q:*3</6C</6@+BT4FX>M&X>M 7%HI-P
M]:-P]: N+12;AZT;AZT!<6BDW#UHW#UH"XM%)N'K1N'K0%Q:*3</6C</6@+B
MT4FX>M&X>M 7%HI-P]:-P]: N+12;AZT;AZT!<6BDW#UHW#UH"XM%)N'K1N'
MK0%Q:*3</6C</6@+BT4FX>M&X>M 7%HI-P]:-P]: N(O6DI-P]:JW4HE&!TJ
M9)V'=$,DGFU'117%9]CN3044446?8=T%%%%%GV"Z"BBBBS[!=!11119]@N@H
MHHHL^P7044446?8+H****+/L%T%%%%%GV"Z"BBBBS[!=!11119]@N@HHHHL^
MP7044446?8+H****+/L%T%21R>54=%.S%=,TXVW+FG5GVLOD\5?W#UKJIW.&
M=B2BDW#UHW#UK05Q:*3</6C</6@+BT4FX>M&X>M 7%HI-P]:-P]: N+12;AZ
MT;AZT!<6BDW#UIFX>M 7)**CW#UHW#UH"XM-FE2%,R'BB281CUK&NKS[9)_T
MRIV871%--YTM145+FNJS,KHBJ6C-&:+,+H**,T9HLPNB*I:,T9HLPN@HHS1F
MLK,+H**,T9K6S"Z"BC-&:+,+H**,T9HLPN@HHS1FBS"Z"BC-&:+,+H**,T9H
MLPN@HHS1FLK,+H**,T9K6S"Z"HJES45%F%T%6K6[^RR8JK118+HZ..431Y2I
M:P;6\^QR?],JVMP]:Y;,UNB2BDW#UHW#UI!<6BDW#UHW#UH"XM%)N'K1N'K0
M%Q:*3</6C</6@+BT4FX>M&X>M 7%HI-P]:-P]: N+3*3</6J&H7GD_NXZ>H7
M0FH7?_+..LNBBNI1L9705+1FC-%F%T%%&:,T6870449HS19A=!11FC-96870
M449HS6MF%T%%&:,T6870449HS19A=!11FC-%F%T%%&:,T6870449HS19A=!1
M1FC-%F%T%%&:,T6870449J*BS"Z):*,T9HLPNC4L;PR_NY/]:*N5S\/[FMBU
MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
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MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
M<X<5YAXH_9[\'>)(3MTI-+G$7EB733]GV?2,?)^8-?D69<!\T_:X&I;R/U?+
M..I17LL?3OYH^(UH-?3.I?L>V<TF=+\0SVMOY>/+O(!<.?R,=&F_L>V<,F=4
M\0SW5OY>/+LX!;N/S,E?&_ZEYSSV]F?4_P"N64^S^-_<?,W [YKOOAC\&-;^
M)%P952;3M(\KC4FB_=RY_P">7_/0>]?3_A?]GOP;X;A&=*35)S%Y9EU(_:/,
M^L9_=_D!7IQBVJ F$%?995P)RS]KF,[^1\EF?',I4_98&G;S.:\#^!],\!Z'
M#IFEVZPP1]6QF21^[N>YKJ?X:3CO3^,>U?KE*E3HTU3I;'Y74J3JS=2H]6+1
M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
M0=\6?^!-K_\ (M'_  [?^&__ $'?%G_@3:__ "+1_K+@NS#^Q,:?G+17Z-?\
M.W_AO_T'?%G_ ($VO_R+1_P[?^&__0=\6?\ @3:__(M'^LN"[,/[$QI^<M%?
MHU_P[?\ AO\ ]!WQ9_X$VO\ \BT?\.W_ (;_ /0=\6?^!-K_ /(M'^LN"[,/
M[$QI^<M%?HU_P[?^&_\ T'?%G_@3:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_
MK+@NS#^Q,:?G+17Z-?\ #M_X;_\ 0=\6?^!-K_\ (M7+/_@FK\-+GS"-=\5^
M^;FU_P#D6D^)L$NC#^P\:?FS17Z867_!-WX86-_%<RZCXFOX89/->UFOH_)D
M_P"F9\N(28_&O6? _P"RS\+/AQ<MJ&A^"]/CNQ+%<1W-UYE[+%)&/W;Q&4OY
M1'K'BN2MQ5A*:_<Q9M2X<Q'_ "]9^;OP)_98\:_'>Z6XM+;^Q/#A.9-:OXI/
M*D E\LFV_P">D@_>?]^O];%D5^F/P3^ 7A3X#>'Y=,\-VT@%Q)YMU>W?[VZN
M2"?+\R3OL' KU#:HXQ3AA5KXK,,ZQ.8.TG:'8^OP.5TL$M!]+24M>&>T%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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MSSOW4=!B%WJ7_+*.L^BBM3(**** "BBB@ HHHH **** "BBB@ HHHH ****
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M*7BFG"C->?7WQU^'FEWUQ97OC[PQ:74$GDR6D^L6T4L4G_/,@R#!]J(PG4^
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MG/1 9".>*K_\+&\+_P#")_\ "3?\)-I?_".;MO\ ;?VZ+[)_K/*_UO\ J_\
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MK1-<NXHO-EMM.U.*YD\K_GI^[H]C5_B"]M2_AW.JI"*,USOB;Q]X9\%_9?\
MA(?$6D>'C<G%M_:M_%:^8?\ IGYM'LG5*NJ1T6ZC=6-X9\8:%XTL9;O0==TW
M7+6.3RI+O3[J*ZB\S_GEF/ZUG7GQ0\'Z9XB'A^\\4Z+:Z]YD47]E2ZE%'=>9
M)_JHO*ZG-'L:NPO;4SJ<[J\P\9?M&_#;X?>-(/"_B#Q7;Z;K,GEY@FBDQ%YO
M^J,LN/+B_P"VM=8/'GAK_A*/^$;_ .$ATK_A),X_LC[;']K_ -5YG^J_UO\
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M=UZ^CT_2K&+S;FZE_P"6=<[\,?C1X/\ C)I]Y=>$=:CU:.QD\JY CEBDB/\
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M4LOF<1>5%6MJ%Y:Z;8RWU[<QVEK;1>;+--+Y4445'LGV'=$U%<1_PNWX<_\
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M\N*,%Y#^0/Y5A^!?B=X/^)5@+KPQXAT_781%%(_V6<231B09C\V/[\>1S^\
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M6Q^U+^RK;_LXV&@>+/">OZE]F^W16@-W*/M5O=8DECFADBCCX_=_Y_Y9]/\
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M^,FJ^$M+T7P+HNI&RDUFVFN=66)93(;4XCBC,G:.7$WF>T7OB3YR_P";Z/\
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M[+++YO\ JY998I8O_14M>JZU\ ?@U^U-_:'B7PCKOV75I?-ENKO29,?O9?\
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MYZ</98RK2I;'G7_!/?\ Y+3K7_8O2_\ I5:UQG[9G_)RGC#ZVO\ Z2Q5V?\
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M7RA%YL473_GD.O\ RS_[95SG_!0C_DM.B_\ 8O1?^E5U7U#_ ,V6_P#<@_\
MN/K2I6J8?!X;V7]:F"H0J8C$>U/GG_@GGXPU*'QGXD\+>9YNE7-C_:GE2_\
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M2!'++'Z>;YN8_P !7TK\0O@#!XV^ 8^&%EJLFE6D=I96$=_)']HE6*VDB(R
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M$LDL=?5.X4<-7MU,\S&K3]G5J'E4\GP=.I[14SS_ ..7PO'QC^%>L^#3J?\
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MS:/YLL47_77S:^F_@G\ O"7P+TNX@\-Q70EOQ%]NO]0N/-EN?+$OE?\ 3/\
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M ']\V7_T57V/166'S#$8:G[.G4-:F"P^)J>TJ4SYN^'/[&=E\,_C%:>,]/\
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M#_KJWH_WD2&L:@4R6BBBLC4**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2
MEHHH **** "BBB@!**6B@!*6BB@ I*6B@ HHHH **** "BBB@ HHHH ****
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MDZA9^3+YL?\ JJUJ)H?.AKG-3GZ*EN[/R:BK4P"BBB@84444 %%%% !1110
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M2R2>5%F/N8O*E_[^U[?^S'^S9X#M?@9X1GU7PMH^O:GK%A'JMQ?ZIIL4LO\
MI$8D$9\SS#^[C,<77&%]S7DQP5##8.GBL3?]YLCTIXS$8G$U,/AOL';?"']J
M;X??&P)!H>K"TUF0DC1=47[/='_6?ZL=)>(B^8S)@?I[4<8/I7Y!?&"TC_9I
M_:FU4^"E>TA\/WMM<V4$TTA_UD44IA./WGE_O?*_ZYU^O2GS!G^\,US9I@J>
M%5*K2^"HM#;+L94Q/M*57XX'@?[=W_)K/C+_ 'K#_P!+K:OD3]@GX%^"_C5-
MXW7QCH2ZLFFK9&V8W4L7E&0W/F#]U+_TSC_*OKK]NYL_LL^,?]ZQ_P#2ZVKP
M?_@EK_K/B8/7^S/_ &ZKUL'.I3R2M4I]_P#Y \[&0IU<UI4ZG8SOVO/V*]"\
M&^#9O%_@*QDTVWTN'.H:+NFN0\60/M,9/FR Q[AYB_<\H9_Y9X?L/^"=?QTN
MO%V@ZE\/]9NY+S4-%076FS2L7/V'(B\O@?\ +)_+ZG_EH!_RSKZ8_:$ /P%^
M)/'_ #+>I?\ I-)7P1_P3-&?CQKG_8MW/_I5:U5&I4Q^4U?;Z^SM;YDU8?4<
MQI^R_P"7A]U_%SXW>$_@CH<>H^)]2:R$PE%K:QH9+J[D0<QQ1YY/0<X3,B<\
MUX?9_P#!1[X8W^H16\FG>)M/BFD\IKJZLHQ%'_TT/ERF3'X5\>_M*>.;;QU^
MU!XCNO$1U./0M.U?^S)(;>??-%:VTOE2BU$G[H>9Y4DG_722O4O''Q^_9SUO
MX9ZUX;T+X87ECJTVFS6NG:DVC6T4L-SY?[F22X\WS/\ 6>7SUK6&30ITJ+J4
MW/VG8FIFDZM2HH5.2Q]L>*/CQX4\,_!V3XE^;)K7A>-(Y(YM* >282RI$-HD
M*?\ +20=2/Z5D?!/]HWPQ\?]/U>Y\-P:A:RZ:\4=S9ZA&(YOWF?+EQ&9/^>4
M@Z]8Z^3_ -AS0KSXH?!/XV>! MI+!=6T+V<=Y#F)+Z6&:(2MZ@?9K;Z>77*_
M\$[_ !A_PC_QV?199KP0>(--EM4AC&8C=1?O1+)[^7%)_P!_:XJV34_9XE?\
MO*7Y'7#-*JJX>_\ #J'V-\=?VKO!_P !=<T_2-<LM5U&_OK;[6(=*@BD\N+)
MCS+YDL?<2?\ ?LUW/@SXC:?XQ^&]MXT6VNM!TBZMY+O;K</V:6*$'/F2@GB/
M \S.<>7S7YR?M4:E<?&7]K*ZT'3=2BN@E]:^'+":6/RXK:7_ %4L1/E<_P"D
MRRU[I_P4%U:+P!\(O GP]T6UDM-,NI3S#<2 ?9K***..*3_GIDRQ'G_GE6<\
MGIOZM2_Y>5#6GFE2^(J_\NZ9VVM?\%$OA=I&J/;VUKX@UJ&,<W^GV47E/^$L
ML<G_ )#KTGX/_M)>"_CE')%X=OYHM5@C\VYTJ_A,=U''YF/,Q_&,X.8\C]['
MTXKX>^ /Q;^!/PU\%"V\8^!=3\3>*+B7S;VZN=,M;Z*/_GE%%YLO[H>7_+_K
MG7.>$/'&BR?MB>&]?^'EE-X;T&]UNPAMK6:.+*17/E1747E#S/*/[V7TKMK9
M)02JTJ5.=Z9RTLVQ#]G4J5(:G<_\%)O^2Y:)G_H78O\ TJNJ^Z?@+_R0_P"'
M9/3_ (1VP_\ 26*OA?\ X*4?\ETT7_L7HO\ TJNJ]<^/OC6[\(_L$^";:R:2
M%]<T?1]*,L-QY7EQ?9?-EY_Z:Q1&+_MK1BL/]9R[!42,+B/JV,QM4[KQG^WM
M\*?".H&U@N]1\3R^;+#*=$MO,BC\KOYLIB\W_MEYM+X!_;F^%WQ"OIK*6_NO
M"LX4[)=?BCMX9#C_ )ZB62./_MIBO$?^"?\ \$_"WB[PMXE\6>(])T[7V%Z-
M+MK6_M?.BMO+BBEEE'F?\]?,BZC_ )9]?WAKE_V_O@_X7^&^O>$]6\,Z?'HQ
MUR*ZBN;6UB$5M^Z\K]['$.(S^]K!9?EU7&?V:N?VAL\PQ]/#_7?^79]Y_%7X
MD:=\'_ ^J^+M8M[BZT_3O*\V*QC\V7][+'%P/^VM>3Z=^VU\-;[X>3>,KJ;4
M-(@^VR6%OI]Y;1FYNI8XHY/W4<4DN>)8_P!Y_+@UYKXU\9ZE\0/^";KZ[K,W
MGZA-;6MK+,3_ *SRM4AB\V3_ *:?NJ\J_8!^#GA_XD^,O$NM>(;.WU6VT2UB
MBBL+^V$L4DESYG[WG_KE+_W]_P"F5<V'RG#TL'5K8G_EW,ZL1F&(J8BG2P__
M "\A<^GOAA^W%\//BKXNM/#D%OJVBZE>_NK9]8CBCBEE_P">68Y9/WM?15?E
M1^W#\,?#_P *_C-%:>&K/[!8ZEID6J2VL7^JCEEEEB_=_P#/*/\ =5^D_P (
M=<OO%GPJ\$ZQJ,@N=1U#0[&[N9?+\OS))8HY)#7'FN7X>E2I8G#_ ,.H;9;C
M,15JU,/B/^79UW_+3\*_%7P-X#O?'UKXHDT]_P![H&B2ZQY?_/2*.6**7/\
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M=:XSX5_ SP;\&?[0/A72?[)^W>5]I'VF67S/*\WRO];_ -=:[ZOF:]2'M/\
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M^'_'?@>Q:[\R667Q!>6,5]YO^M_UO[KS8O\ EE%^Z\VOMOX/:3X(T[PC]N\
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MGA[XB:'+I'B#2K;6K.8X\JZAW&,X*>9'WCDY_P!8.:\R7]A7X**<?\(5D_\
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M_.+]B+]ISPO\(M#U_P +>,KW^RM-EN?[4LKB*VED_>']U+'+Y0Z_NHO^6?\
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MTZWU2PF_UMK?Q"6.3_ME7CG_  Q#\%?^A-_\J=]_\=K:GF6'K8:G1Q2?[O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM6C\,:KI/]A^*6@\\&.>/[+>&,1B419/F>8?WC^4/,Q''GS#6#^UY^UUXR^
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M_P!/,TJ91C*5-U>QE3S3"59JFCZQM=)AEDSF2M#^RX?5_P Z^<_VGOVIK?\
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MV(CE)$8/EW/^M_>R1?\ 7//>H_LW$*G[1F_]J8?VGLS[+KPC]IS]IQOV</\
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M45 %K3X?.NJVZIZ7#Y<.\]ZN5R&H^BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6DH AF_U+?2OR/\
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MZ7VU:XF6F6V?;_VPTP\=<;=?U[QX/_P2U^[\3_\ N%_^W5>#?MT?\G4>-O\
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MMZ'I#:Q\.%TZ(7T4MMF%;C[5F7][&/,BD,?E1QESY>9/]7(1Q\T_&3X^Z_\
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M4J<%[/\ GOKL>)B:U6K0_>3/OUCC]A\?]D]_]Q=?*W_!.,;OC=K.?^A>E_\
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M[]UK[Y]G_LS^"-,\*_ 7P0-)LX;/[=I-K?W(AX\RYEBBDDE_/-?,'[7W[/\
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M,>7&*DIE/K(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MBB@ HHHH **** "F4^B@"A<:<DP^7@UES6<L-=!22PB05HJ@'-U+6I)IT?\
M ,50ETV2*F9$5%%%; %%%14 2T444 %%144 2T4>34L6FR2T@*M6H;.6:M"'
M38XA\_-6ZR]J+V94M=-CA]ZMT^BLC8**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F4^B
M@"/RA4?V..K%% %/[#'Z4S^SQZU>Q1BL?9FG.RC_ &>/6C^SQZU>Q1BCV8_:
M,H_V>/6IOLL?I4U%/V1G[1B>2GI2T^BM1!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% #**?10!6ELXINL=0_V5%ZR?
MG5^B@#+_ +)'K47]DR?],ZV,48K3VC Q_P"R9/\ IG1_9,GJ*V,48H]HP,W^
MQXO^>LE68=/AAZ1BK5%9@,I]%% #*?110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %,I]% $4D*2?>3-5O[-BJ]10!E_V1_P!-
M*B_LB3UK8S[49]J/:,#'_LF3TCH_L>3_ )Z5K45I[1D\AG_V1[U+%IL57:6L
MRB+R8X^B4ZGT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 44E% "T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,@CD!,D9SOP1R.U 'J]>1_&C]HSX=_L\V.E7WC[Q/!X>M[Z=H;*,PS7,LK*
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M?^"CGPH_:,\<1^$=".NZ/XCNP?L%EK%D ;TB*267RI(7EC'EQQY_>F/MC/(
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M ?<?P\\8V/Q&\!^&_%VFQ30V6OZ9:ZG;)<C]XD4L0EC#\^CUU5?$6M?\%/\
M]GGX:^)--\$Z9<ZE>:-8^59#4_#NFQ_V1IT22^3Y8(D0R1QB/=FVCD0QD>7O
MY%?7OA?Q7IWC?PKH_B+1[@W6CZM9Q7UG<>64WPRQB2.3#^Q!_&@#H***_'K_
M (*6_ME>%OC/J%E\(K6SU;2K#POXKNE\1ZC=644THEMC); V0^T_O1B2Z.)?
M+_Y8\Q\T ?L+7BWAO]J'PSXH_:.\4?!6TT[58_%?AW38]3O+J:.+["\4BVQ
MBD$OF$_Z5%_RS Z^G.'^RQ^VEX)_:Y'B@^#M+U[3?^$?^S?:O[<MX8B_VCS?
M+,?E2R?\\9/TKX=_8\_:,^&_PG\5?'_X^^,V?3-%\8>(KB#PQ]HMXI=7NSYE
MS>W-M%&A)CPLUCYA)$/F-%F3I0!^L]%?-?[,O[<?PT_:LU2_T;PE-K%CKUG%
M)>2:1K5D8IA;1^5&9?-C,D6/,E48\WS.^,5ZI\7/C'X0^"?@Z7Q'XVUZ'PWI
M*NEN+B6*24O(^,)''&#)(>_R#L?0T >@45\*^%_^"PWP*U[5K>TOK+Q=X=@<
M?O-2U/38GMX_]\6\TLG/M'^5?=5 !117R/\ &O\ X*4_!SX'^-+OPO-=:IXJ
MUNPDEM=1MO#MM%+]AEC',<LDLL49.3C$9?RS'()-AH ^N**\<_9Q_:/\+?M0
M?#\^,/!ZZA%9Q74EE<V^HP"*X@F3_EG)C,>?+DBE_=R'_68ZY%<'^T-^W_\
M"?\ 9MULZ#KU_J.M>)_W;3Z)H5K]HN;:*0,1)*9)(XH\[1^[\SS/WL1V8.:
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M_:IO7F CD&!)(0/W>/*BDX-SYH_U4D?SG\3G^,O_  46OO"?@+7/@IJ_PF\
M:7X@MM4U_6-:NI8[DQ>5*G^BF:VBY\O[2/\ 5R@221;_ "AU .U_;>8_%+XO
M?!C]DWPX1X9\/:R(]8UI;$_98_[+MO,$5M:^7F/A+:Z(BEA,8DCM2,8-?8GA
M?X4>$_!/P[MO 6DZ!8V?@VWLC8_V*81+;R1R']Y%)YF?,$A+^9Y@S)YG)R37
MQS^WQ\'?BQX;^.7@3]H?X1V1\2ZOX5L8M,N=!BL3=W!C,LV9!&#F6*074D<G
MEXDB!$@[O$YOVL_VG_C=_P 4OX!_9WU'X::O=<2^)?&TD_V6RB8^498Q+;1
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MEU@:M>RG4]=CBC1_[/M8OLT<O[T2-_RR\N7'E^8!YD<GM/\ P2Y^#VM?!_\
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MW\3]8\)ZEX4\/&S_ .$<L)=3M9HSJ.R2VBCNK622(1RQ[-.\TD'CSHL>9UH
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MPU;ZK:V[S6 C$,L,LD?ED1S10BQBCDBD)SYN<\.?I#_@GWX'\0_#7]D7X?\
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MP<\1?&;P1\,I&T2U\+Z<;@6RWR3'S+B[$<5S'B26*7C$?FQPPB3[DD9^E?\
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M_5Q>AW_5/P)UKXF^(/!\UY\4/#>F^$-:GU*Y:TT73+HW9MK'@0K<S9,<DO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>G>-_"NC^(M'N#=:/JUG%?6=QY93?#+&)(Y,/[$'\:_%?]I37M9^-?PX\?\
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MGPK\/?"/ABV&[Q%JS6^F0V]MJ-L)3)):RQ11#S,1:;-CS,@FYP=@YK[ITO\
M9E^$6CZI:ZCIGPM\&:9?V<D=Q;WEGH%K%+!)&<QR1R"($$8'(Z4 6/B%\=O
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MRWL=-LXI+FXNKF01101Q_P"LD=SP !Z^E?/W_#Q+]G;_ (2S^P?^%GZ?]O\
MMOV#S/L=U]E\SS=F[[3Y7D^7_P!-?,\O'.<5W7[07[-?A/\ :<\-Z5H/C9[Z
MYT?3=6AU=;.QN/)6XDC2:/RI3U\LB9P?+,<G PXKP+]K[]E_X > ?V4_&FH7
M7P[T/0E\/Z/(-)U*QLY(KH7IA-M8^;-%^]F)EECSYID'223N: /L31]<L/$>
MEVFI:=>6]]IMY%'<V]U;2"6*>.3_ %<B..""/3UK8KX?_P""1&G:[8?LAP2:
MQ+<G3[[7+V;1O/N3*JV?R1$1#_ED/M$5R?+XY+/CYP3]P4 %%?%7Q'_X*N?
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MPW90RVBR"1HR@EEEB\P\9\R/,9$@Q(: /</VFOVG?#/[*?@/3O%OBW3=5O\
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M[2?[-_Q=8ZEHUM9:Q_9^O>)+=+DQ16,=S#)Y#^5ZQ2W_ .[QF6/S1^\QQO\
M[=GC36/V@?&WA_\ 9:\!QS3:AK<]KJ?B[5+58;F#2=,202#S8R<@@^3<8WQD
M_P"C1C?]IQ7:?\%1?@]K7Q@_9<GA\/VNH:GJ^B:Q::I#I>FV4EU<WG^LMC&D
M<?/ N?,SSQ%47[ OP!\3^$='UOXO?%!]0N_BUX\'VG4UU>WC6XTZU#'RK88R
M8_, CD>/]V(]D,7E1^50!X?^VMH>@7'[5'[)?P6TCPQ/J>E^'Y;:5])GMC?6
MQTB2YMH_*_>&2201Q:;<&3S!CRQU/.%_X*-?M8&X^*-M^S_I_B^W^'?ANY6-
MO&?BHV]U<S1Q2Q^9]E$44>\@Q>6?W>?-\V.,R1)YM>C+\./&GQ)_X*I1^+]5
MT/4M(\'^!O#?E:5K TJ7[-J?F6^#$;H_N_,$FIW1_=GI;8QD%Z^I_$7[/_PM
M\9:U<ZSXB^&_A#7]8N,"?4-3T*UN;B; V?/))'GH/TH ^&?CC^W#^S]X7_9$
M\6?#7X*ZWIWVB;27T/3-$;2;^.(0W,HBN3YDL4>)/*DFE\R23F3D^8<@^S_\
M$Q_'W@C5OV:/#?@KPSXH_P"$FU;PO9Q3ZRBV,UM]AFO9+BY\G,G$AC8RQ[XR
M0?+SWQ7DG_!1+]E6S\1Z=\-/ _PG^#.DZ7?Z]KV;[Q5X?\.K%%IL,8$0^UR6
MUN3'%(;GS"<_\NQ.#BONSP'\)/!GPQDOSX.\&Z#X2^WB/[5_8>G16(N/+SY?
MF"(#./,DZ^IH N_$/QC8_#GP'XD\7:E%--9:!IEUJ=REL/WCQ11&60)SZ)7Q
M-_P2]^#-MJ/@76?C[XN33_$'CWQMK%WJ%KJTEI$9K./S9HII$_= VTDLLMSY
M@B/EF/RN@S7V?\5O B_$GX6^,/!PNOL+>(-(O=+^U>7YGV?[3%)%YFSOCS#7
MYT_LN_%G]I7X%?#.#X,V/[-^K:OK^CS7L.F:Y?22V-@A,DTN9I94^S2@2&3]
MY'<1B6,QI&<XDH ZO]M#P1X?\1?\%!_V;K;PKI5O_P )_<:G%K&O^1^[:ZL;
M6XBDAFE)Q'(8X[6_Z$R$0A.?W0K2_P""@-H_[07[27P-_9R6\NK*PU.:7Q%K
M;2>5&LEJ@F \F7RY)%F$5M? # CS)%G/_+/S7]E']F/XOZ9_P4-O_%GQ5NK_
M %2_T>SNM2N/%,-C<2Z;J\LUM';?9XKF2.) (X[H_(!^[^RM&(\#CU/]MWP9
M\2?A[^U+\*/V@?A_X,U+XCMHEC)H=]H6GV,DDBQ_Z5D_NB9!YL5U.!)Y12-X
MH\^9Y@2@#Z,^/&A_#SX<?LN>.;/6/".B+X"TG1[N7_A&<1Z;8W,N3+%%'Y?$
M4DMP8_+DCRXDE!'[S%?(/[&/C&\_97_X)I^,OBA<QV^I->:E>:KH]M&#(!-)
M)%IL/VK)CX%S#\_ER?ZH@CGBN&_;G^+_ ,9?C1^SW<>(?&GAN?X(_#\26UO9
M>&[Z62ZOO$NIBZ?]W*!'&]M%%%#++^]CC!>*/_6^9&8OJJW_ &6;GQ]_P3AT
M/X/Z7 W@W6;[PW8W#PZK'*/*U+S8KZ99@3YD7F7/F9'_ "R\P_N_D\N@#/\
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M?@YJ/QD\(:CK$NI:1KWAIY?-E'EQ12B6**.Y,7 B(CD$?SK-B24<C7^(M_\
MM+_M\:1;^!C\*E^"_P +]4O(X-:U'Q$QDOQY)\[(BE\J22//DF/RX1F2+!F$
M?F8 /T'\+^*].\;^%='\1:/<&ZT?5K.*^L[CRRF^&6,21R8?V(/XU\M_\%5?
M$VFZ#^Q3XOL=0G\J\UJ]T^PL5,?,LHNX[GR_;]U;2\_[%?4GA?PIIW@CPKH_
MAW1[<VNCZ39Q6-G;^87V0Q1B../+_P"R /PKXR_X*B> _&OQH\-_##X;>$/"
M5_JYUKQ(+FYUR&VFEM=(*1FVC-T8HI/*B_TUY#(3P+>3 /8 Z;Q(NF?!_P#X
M)@W-AK%D?"K0?#7[!=6C6;0-'J-S9"+9+"!Q+)=7'[S(SYDA,AZFO/\ _@F#
M^QEI'PU^'^A_%[Q!8&\\;^(+$W6F->&-X](L9.(S%@G][-$?,,G41R>7B/\
M>>9Z;_P4XM_$VO?LLZAX7\*^#=6\9:AX@U*RLI+?1;66YELHHY?M)N#'%'(=
MN;81]O\ 6CZ5]#?"GP(OPV^%O@_P<;K[<WA_2++2_M7E^7]H^S11Q>9L[9\L
M4 ?$WP%UBPUO_@KQ\=;K3KN"[AC\+);/+;R>9^\B_LB*6+C^Y)'(A[@BOT-K
MX2_X)M^!O&L'B;X]?$KQAX0U'P1_PG7B075OH&K6\L-W&/-N+B0XEBC\R/\
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MR>?.O@K^T]X^_9_^'MCX1\(?L6^.K#3K7][),TEZ;N]F(^>>9_[,'F2$X!]
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M%OP\LH+>2WTVQM=(T^\F^7R[.:&2.'S)3R3';B,&4]_G/4T 9/\ P3D\"3>
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M%'(F4ZX(- 'I5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)O[26I
M_M2^%_BE8:O\%-%T'Q9X/N=*^S7FCZLUM#Y-\)68767EAD.8S%$/WA'[N7,8
M_=FOK*B@#\^/^&:_CG^V-XR\.:A^TC'I?@[X<:!+)*? OARX).IW('^ME,<L
MH /FF/S/-\P".011Q^<9:_0>BB@ HHHH **** "BBB@ HHHH **** "BBB@
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M7&/WLN9 /WES)_UTD^G** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ2.2,A/M'EYPHDYS7VC\(_B/H_QB^'7AWQIH5S]ITC7+-+R#+IO3/WHG\MF
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M/$T'BV3PAHVC_8/#%A:VED+J*3[/Y4L=PADP8\W-_)_K3)EXNPV5^T-?&'[
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MN8Y;J09B$H,8D,D<?[LQ_2G@?]K[PG\5OV;?&7Q?\(Z?J-[8^&K+4)KG2]4
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M+X:Z9'>KX;U^:(65TUQ';RRW4F9+<XS-:Q^5YI!\D'!$DB5]%?!+X)_$6/\
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MA3Q=^S]-\9-(AU*\\'PZ3=:S(OV8+=".V$GG1>63CS 8I(^NPX_UF.:^:?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7C%G^S/X8
MA_:0O?C1>:GJVL>+)-,_LJUM-2EBFL=,CQ'S:1^5YD1.)/\ EI_R\S?\]./9
MZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ^*_C5\#/VIIOC'XD\2?!_XPZ;HGA?6HK7&A^(7:=;*6&(1,+=)+:YC
MC63F0F/RLF3!!V T? W]AKQ!:?%:#XP?'OQ=;?$WXC6T44>G6T-OLTW1VCDD
MV2Q#$8D8#;(/W48CD>23$DF)*^U** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"_2O&/\ PBX\5K?:M'I7V3[?]B$9DBFE\SS/*D_YY8QCO7T+0 4444 %%%%
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MM7U'Q5-)=^((-2MY3-:Z6) ?.AD\R*+/E0WI_P"6A_==.GF3?MB?M@#]EI_
M]G8^";_QYXB\7W<MMI^F6=S]G8M&8AM'[J5WD\RYB$<8CYR>F!D ^HJ*** "
MBBB@ HHHH **** "BBB@ HHKA?BY\1]'^#OPZ\1>--=N?LVD:'9O>3X=-[X^
M[$GF,H,DAQ'&,\O(!WH [JBO@7]G_P#;#_:,_:.\9:)XBTCX+Z3;?!.\U*.T
MN-1DU#9>Q1#$4UQ%-+)&+@1RDR?N[;GRS$#Y@)'WU0 4444 %%%% !117/\
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MJ/VPM&_9GBTK1X]/G\9?$'Q!+&FC^$=+DQ<W"R2>7YKGRY#&"W[N,>6?,DX
M/[PQ@'TM17YN>./VQ/VN_@'I,/C+XL?!#PZ/!5K/Y-Y)HM^4D3S 5CS)'=W0
MC'F>5^\DBQSY>09!7WS\//&-C\1O ?AOQ=IL4T-EK^F6NIVR7(_>)%+$)8P_
M/H] '545\]?MG?M3G]D7X7Z5XQ_X1<>*UOM6CTK[)]O^Q",R132^9YGE2?\
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M7V:7S)8_+S)'B3F&7F,D<=>:],H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ I*6B@#PC]H[XM:EX AT[3="EACU*\
M!DEF($CP1)@_ZOJ=_(S_ +!KYIL_B9XLL[J.XA\1ZMYJ2>8?-O))8B/2O?\
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M ])A\9?%CX(>'1X*M9_)O)-%ORDB>8"L>9([NZ$8\SROWDD6.?+R#(*^[_\
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M\6OC5X^N/&6B?&GX>P> ]:T22V%M>6,4GV"]CFCD.(I/,DCD,7ECS#'(?]<
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MG$8'EU][^-OA[X4^(VEPZ;XJ\-Z3XFL8Y?M,5IK5C%=0I* ?WGER \_.?SH
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M]!\#>&HYAI&CQM'$UQ)YDLGF2F221_=WDD?CU[=*^%?$G@8>%_\ @HE^R?\
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M_P 3_$>J>*[G3?"_A_18[G3&;28A^ZOKFZN#*,R C,?E1B,0RR2F,8J71O\
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MML?^6?/V/\7/B/H_P=^'7B+QIKMS]FTC0[-[R?#IO?'W8D\QE!DD.(XQGEY
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MO+Z3QQX__:3^)MC930>&O%_BD3:=)=M&)/\ 6W5Q(DD8D./+CO;?GI^\XSV
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M_P $^?!5UX)_8S^%VEW\D$DL^GR:G_HYX\N\GENHQ]1'<1YJW^WIXU_X0/\
M8\^*NH_9OMIGTB32_+\SR\?;9!9[SP>$^T;_ 'V=NM 'YO?L'^)/VG-*\->,
MO%?PC^'^A>.3KVK;==\0>)-1_P!+NKJ*,2A&\R^BS_Q]&3S/+R3,<R'M^B'[
M5'[86C?LSQ:5H\>GS^,OB#X@EC31_".ER8N;A9)/+\USY<AC!;]W&/+/F2<
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M5/%']G>#]$UC^U-6\/\ V'SFU< C$?VGS8Y;?]T;F/,>?]?T_=BOHB@#YO\
MV4_V6=,_99T?Q*\WB"_\8>,O$FH"_P!<\3:@ICDO&#2&,F+S)#UEEY),DDDK
MDGH$\ T*&\^./_!6;6=8MKFV;0OA7H*Z<E_IUL9DEDDBDC^RRS"4QQS>;?77
MO_HAC\L$2$?17[5'[.OCC]H ^&?^$/\ C'X@^$2Z2+DW)T,3?Z<9/*\L2>5<
MQ?ZORY.N?];VQ4/[)_['_A;]DGP[J]MX=O=2US6M9-O+JVJ7S@"XDB0@>5$.
M(HP9)2!^\D_>X,CX& "M^W9\"?'G[2'P/;P/X%U;2-(GN]3MIM2.LO)'#<6D
M7F/Y68XI3GS?L[CC_EF?H?:OAYX.L?ASX#\-^$=-EFFLM TRUTRV>Y/[QXHH
MA%&7X]$KJJ* /BC]IS]@_6_B!\9+3XT_"CQF_@;XIVK1&1I_,^RWCQ^7%'(9
M,/Y?^C@Q21^7)'*!@QC,GF<7??L+?'+]HF:TL/VD_C%;ZKX5TJ4W-KI?@^WC
MC:>9XI(_,>0VL4<9CQ'@^5+Q)+S'G)_0NB@#Q3]HCX4Z]XU_9P\3?#KX:OI7
MAN^U#3XM'L?MB&&QM[+,<<T("1R>6/LWFQ#"<9'3&:V?V<?A3%\#_@CX*\$1
MQV\<^DZ;%#>FVG>6*2\8>9<R1F3G$DLDLGXXQ7J5% 'R7\ ?V6/&'@7]JSXN
M_&/QGK=AJMQXE7^S]#72I#^YTX2?(EU&88_WD<5K9(-A/_+3))YJG^W%^RQX
MY_:"U;X8>)?AQX@TOP_XJ\#ZG-J-JVM12>4-_DR12@^7)\T<EK'^Z,9!$ASC
M&'^P** /F?PGX\\8?LP_LZ^(_&'[0OC6V\9:OIDTMW<7>AZ;'&(XG,45M:P^
M7%%YGF2?\M)(X_FEY_=Q^97EG_!,'1_BU<_"[5_&OQ,\4>*-;3Q++:OH>G^(
M[R:Y,5C$CXNXVDD.!-YI'(CR(8Y/W@DCKZ&^+G[._A3]H3Q%X-U+QB-2U'2O
M"]_+>P^'_/VZ;?3;<1RW46/WOE_\L^@_>2@B2.0U[+0 5^<\W[ 'Q6^ _P 1
M-<UO]F'XEZ?X4TG6SBYT?Q&OFQVL08&*(9AN?M.#YNR22-)(XVQYDF^4U^C%
M% 'Q#\&OV%_$<WQ@TKXS_';Q\WQ%^)&G21K86-I:1C2K$Q^:D>=\0R 9(Y4\
MJ.'RY<R?O3^\KN/VS/V9?%/[3&J?"O2;:\TH_#[2==&I^*=(U">6*6]B!CC
M@>*/?N$4EV/]9'_K1Z#'U-10!R/Q$L?$>I?#_P 1V?A"^M],\4W.GW$6DW]R
MH$5O>&,B*23]W(,"3!/[L\ \5XQ^PS^S+??LI_ X>$M:U&WOM>O-1N-3U273
MY3):"5_+BB$1:*.3'DPQ=O\ 6&3GI7TK10!^>_CW]C'XZ>!OVA?&OQ!_9_\
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MQX^$GB7P%K#F&UURS,$-UM)^RSY,D4VWS(_,\J2..7R\C/EX/6OBWP;^Q_\
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MZIJVO?8/L)FX+"/[.)9(QB66ZDRF,^:1C]V*^B: "O%?VL_@O>_M!?L^>,?
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M?VGO$WQ:_:T^+/@33]/TR\^&G@B*.T.LQ12QWXU+,<9AD\R3#CS(K\?NXO\
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MV7VZ^TD6<P,,1$1\PRF,1_\ +Q%P),_O.G6@#TNBBB@ HHHH **** "BBB@
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M_P"7>7@R9_=].E 'I=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$[V.QUG1?WN(Y3'D2D21_NMTL5S'Y.9)(_*Y/(KQ+2OV=?VW6T>T\.W'QO\
M!?AWPOY<>GR?\(_ID4,MC8[?+/V416$1C,<>?+$<D>/^>D> 1]+?LU?LR:-^
MS+X;U2ULM4O?$_B+7KO^TM;\3:MY?VN^NM@\PEQ^\*&022".620@RR?O#DT
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M\.#<VEWXJ\5W%JR:?Y^V6ULHK@2M=,/3S;;R@#LSYKD9\J2F_P#!0]E^ O\
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M/B)I'A7]D_6?#%S*/[7\6WEI;Z?:Q2)YA$-S%=32[<Y\L"(1D@'YY8P?OYH
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M)XQYE>F?LO\ [(]M^SOJFO>*=8\7:K\1OB)K\$5KJ?B/7C^^,<61%%$3YDB
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MFXNKF01101Q_ZR1W/  'KZ4 ?.W[$?[7MC^UY\/+B^^S'2/&6C"*'7+"%?\
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M>[OO+-U=32RDF69XXHA(1Q'G'^KBB% 'K-%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R%^V/^PZ/VE-
M2T7QEX;\1S^"OB7X>A,6G:L!((YA%YDUK$=C$PE)I"?.BY&9,QR'R_+^O:*
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MSXN_&/QGK=AJMQXE7^S]#72I#^YTX2?(EU&88_WD<5K9(-A/_+3))YKZTHH
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M_M'?L_ZIX=\/^*/B3X:F^%.BQ70C\-Z-:?:)KB2432 --):Q21@32F3(D/W
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MBBB@ HKQ/XT?M-^&O@7X^^&WA+6[#5[S4O'VI'2]+?3XXI(HY!);19F,DL9
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M ^Z\/_#3X<:3?W-A:ZGK)MY+B[E MB(KC,=Q^\(D$H\J(1@2F,R2$ U5T/\
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M6KNF_P#!-GXO:%I=GIVG?M=^,M.T^SCCM[>UL[2ZAA@BC \N-(QJ& !VQZ4
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M?ASX#\-^$=-EFFLM TRUTRV>Y/[QXHHA%&7X]$H Y7]I+XUV7[/7P6\3^/\
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M'OC2T>>WOM/TXQ6%Q;11S?9[V5A;VTOER?(1'-)$2/0'(/2O:Z_._P#X*_\
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MM?M47VORY/\ EG'&Q/EDY($>1DR#R6^\/_\ !02SL_\ A*D\4>"=1D9X[_\
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M7X1^,OB;X;>,=<GNHGNM$4^3%8QW,D)MCY4L4DA,MLLOF>;LQQY61YE?I?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !17Y0?$#QS_ ,%$?#=C
MXB\5ZI';^'- T^*YU2ZAMO\ A'YHK&VC!EDV ^9*XCC7OYC\=R>>.^#?QV_;
MT_:&\-7'B/P!KP\0:1:WDEA)<_9="MMLPCBD\O\ >QQD\2Q]/6@#]D**\E_9
MXO/B5J'P;\,-\5[*"Q^(/DS0ZLEJ8BI:.61(Y,Q2>6#)&(W/E\9DP G;UJ@
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M_!2S]K3X@_LO_P#"KO\ A![G3[?^V;Z^NKX7ML)_/BM_LVVWYZ1R&Y)D\O\
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M9/@K^SA^RSX*GBGM]1TW3=8EOK6XFCE,%Y,;*XN8M\?R$1RR2@'G@=3UKO\
MX*^,/%/_  2S^.6K> _B7;76K?"CQ5*MU9^([(2FWA\OY/M<<0)&[YXH[F+_
M %O$9'F 1>: >D?\$]?C3\1?!_[17Q(^ GQ9\3:EK6MVX>YT^_U[4)))3/;D
M"6*V^TCSI8I8I%N(^?\ 5PF01XD<AGP_^*?C;]H3_@J-XET+3O&.O67PZ\#F
MY>Z\.G5)K&*;[$?LQ BMCB;-_,),2G]Y$,2< 15PG_!2+3;KX(_'CX8_M,_#
MJZ6Y;7/*DEO[02RV%Q-;1Q&%GNHY<&.ZM?W7E1^7YD5O+C/F25ZY_P $>?A7
M)X1^!?B+QW>+<1S>+]0$-KB5)(I+.R$L<<@'5#YLEU&1(?\ EDG &,@'B_PJ
MUC]HO_@HW\2_$/C#2/B7K'P=\":?<)I\4&A7=ZD4.8Y98XHTB,4=S+_J_-DE
MDC.)H\#'EQU>\ _%+XY?L7_MJZ'\*_'?B_4OB;X=\77MA:6TFN:E+<B6VN;D
MPVU[%YGF/;2QR>;YD1XD\MQSB*6L#]A3]J^#]B#Q/XM^#/QGT.Z\)V*ZG+?2
M:@MO+)+8WQBC'ERQQF3S898H8C')$".0?WD<@DCDN/C5>_\ !0'_ (* ?"34
MO ^FZI9^%O"=Q:W_ )&M3?ZF*VG^U75U)'")$MS(3%;#)/F&.V!D&<1@'[ T
M5X#I_P"UYX)O/VG;SX$3V^K67C6WA$J7$D$1LIF-M'=>7&Z2>9D129^>-!^[
M/)XRO[4'[6WAG]D_2]"U3Q9H'B35--U>26U2ZT"QCEBM98P/W<TDDT80R GR
M\9SY4A[4 ?/GP;_Y3(?'3_L3+;_T5HU<Y^U9IOQ8\8?M/ZSH^J?M&:1\"/AI
M9QVUQHJS>);;3[^ZCEM )9([:*2.24"ZBE&;F2,#)\O."!B?L+_$2X^.W_!1
MGXW_ !+LX5N_#EQI%Q8V^J6MM-';&)+FUBL?,\P?)));VGF8.#^[DX'('S'\
M0M6^&FA_MN_&/4?V@=+\9>(;*#7[[[!HVGQ<W,1E<6YFE>YAE2*.U$7E"+L8
M^1''LE /J3_@FU\9_B5=?'SQY\(/&7C^+XB:98:;+K$&L1ZN-9W2QS6T6;6^
M,A_=2QS9,?6,@#$<GF@^"73?M#_M"?MD?%;X=_#_ .*WB;31INOZQ*%NO$][
M:6%G:0WSQ?=B8D &2*,1QQG[XZ &N^_X)F:QX/U[]N3XBW_P_P##LOA;P?)X
M5N#IFES74MS(D8NM/0F223+'S#F7&2$\S&2!7G7PY_:8T#]E7_@H1\;?%OB#
M1M0UC2[S6M>TN?\ LWRQ<0[]3,OF(CG#\PB/[Z<29SQR =W\2/%GQS_X)U_M
M$>#KWQE\4-?^)OPXUGAWOKR:Y-Y;#RQ>)]EEN3Y5S%YD9CE\S!S%^\(\V(>N
M?MF:;\;_ !5^T5:6$WQATKX"?"B&)#I6L7'BB+2/M^?LWVTB*.;S;F:.24X$
MGEQ 1@9C\PR2?.'[7G[0%G_P45^*'PF\$_#7PWJUK<VTUQ:)<:W& S2W4D1D
MEDBMC+LBBCM_-DER>#+\@\O)Y3XJ:MX)U+]O3XKZE^T9!XE_LB'4;W[-9Z;;
MI;2W'V<Q_8+:7@?NI+6*.+S(\$^;%)YH!,H /=?V-_C5\1/!/[="_"6_^,9^
M,G@_5A<P_P!JRZG)JEK*D=G-<P2VTAED\J3 V21@F/[X_>&.*09?[4'C[XZ>
M*O\ @H%XO^%'PX\?ZYHK:U]ALK73XM;FM;:VB^PVMU+-'_SQQY<DA,7[P_O8
M_P!YYACD\T_8KUCP?K__  4G\)7_ ,/_  [+X8\'O+J1TW3)KF6YDCC&EW*$
MO))EOWAS)C)">;C) S7N/_.=3_/_ $+% '+ZOXH^/?\ P3]_: ^&]U\2?BMJ
M'B_P/XB$4.H76I:E<ZE:"(&'[>!;RDRB2V,GF1RQC]X/+X_>2Q5^OE?E9_P7
M*_YHK_W&O_;"ONKQ)^U#X9\+_M'>%_@K=Z=JLGBOQ%ILFIV=U#'%]A2*-;DD
M2R&7S ?]%E_Y9D=/7@ W_P!H#Q)J/@WX _$?Q)HUQ]EU?1_#>I:A8W6T/Y4L
M5K+)&^'ZX(%?&7_!%GPQI]K\ ?''B*&%O[9OO$WV&YN ^?,BM[:&2)!]#<R_
M]_/:OO?Q1X4T[QOX5UCP[K%N;K1]6LY;&\M_,*;X98S')'E/]DD?C7Y'?LZ_
MM#>)/^"8_C3Q1\(_BUX5OK_1;Z\_M.&YT62+]V/*DC-S;>8L?VF*;RK<<RQ^
M5Y3\"3S(Z /V1K\M?CEHOQR\;?M-^*(?'7[0FD?L^>"X99$T2U7Q;'8SW6F"
M6Y%O<Q645S&93(8QYDDLD9S+Q_JO*C[;Q!_P6,\%:I)I^G_#[X:>+?%?B.[O
M8[2+3-0\FR,AD)'[DQ&YDDD\SRP(Q'SGCI@_%EOXN^&D/[3/Q3UK]J+3O$WC
M#Q%;>()X18^$;G-A)*DDL,L9>::.X$46(/LX208CCP1CB@#ZJ_X)B_'KXD:S
M\=/'GPM\5^/F^(6D:=8W5^FL3:C)J:F:WN8;;S+6ZDY>VE$ID_",C9^\W^%W
M3?M#_M"?MD?%;X=_#_XK>)M-&FZ_K$H6Z\3WMI86=I#?/%]V)B0 9(HQ''&?
MOCH :[[_ ()F:QX/U[]N3XBW_P /_#LOA;P?)X5N#IFES74MS(D8NM/0F223
M+'S#F7&2$\S&2!71?L%_\I3/VC/IXC_]/5M0!Y%\>)/VC_V8_CY8?"S2OC=X
MH\;:MXQTRWM=/:ZOI-TJWLIMA&$NI98[>7SHF_>QR<#!$D>2!K_&&Z_:(_8"
M\=?"KQ+XS^+^K>.;;4Y9;BZT-]?O;BVF^S2)YUN?M&05EBDBQ+Y>8WE?Y1Y4
M<C^C?MZ?\I3/V<_IX<_]/5S3?^"Y7_-%?^XU_P"V% ''?\%5K'7=6_;@^&.G
M>%)+BV\4W6@Z9!I4EG<?9Y1>R:I="(Q2Y'EMYA!$F>/6K7[0'P5_:G_9;^%.
MF?$VY^/FO>))M)OD_M;3X=:O9;>Q_>K';R8N9-MU&Y,?F1O$,&3&R2/>X3_@
MJ3XX_P"%9?MZ?";QB+3[<OA_1M)U4VN_R_M!M]4NY?+WXXSY8%6OVS/^"G'P
M\_: _9Z\1^ ?"GA[Q-%J&M26PDN]:BMK>*".*ZBN.!%++O\ ]5LQQ]_//0@%
M3]N#]KSQMXT^ /[.?CSPCXEU_P $7?B*SU<:M#H6H36,4MU;R6D4AQ'-S&)1
M+Y?F9Q'+SR<5W=C^S1^TM\)?AG>_$GQ7\<=?U!K/P;X@OM<\-W6O7[R:=,-,
MN!:"*4221S2QRO'(3^[\IXLQF3&:^?/VY/AM??"']E7]E'PQJ*W']HQ:;K-]
M<QW5N;::WEN9;2ZEMY(CR#&9?+_[9]!TK];?VK_^36?C+_V)FL_^D,M 'P;^
MS'^T[XZ\)?\ !-KXO_$;4O$&K>+?$^D^();#3M1UR^DNYK42Q6$4,G[WS.(I
M;DR^7T.#7(^ /V??VP/CE\(Q\4[#XR:]:7FN&75+/PW-X@O["6YCS+S&@\N*
M+S-D?DQ\1&.4'S(P,5R?P7^&A^)7_!)_XKB#3O[1U/P]XODU^S'G>6+;[-:V
M/VF7DC)%K)=<'/;^/%>N_ '_ (*M>!/AW^S3X?T#6]'UF^\<>&]+BTFVTVQM
MHX;2^$,<L=O()3,?+'EQ6PE)&?,E)BC<#@ Y/]B;XJ:_\$/#?[8_CCQN]M'X
MXTB:VEU W40EADUEY]03RI1;<?O+IQ'^[Q&,YR!S7F\J_'OQ!^RAK'[2*?M"
M:Y<K#K'EZAX:L=;N8OLT<EP(3_JI!'#+YLL<GV81"/R9(WSR(ZV/V:_BE?Z[
M\"_VX?'-U8Z;/JOB&QMVN+5+L6%JCW\E_',8S*3_ *O[23'%DR2X$8^>05\;
M>$=+^&]Y8RR>*?$_BC1;WS3Y4.C^&K;4HS'V)DDO[;GV\O\ &@#]/_V8OB-X
MV^!?["7C?X_^,?'_ (@^(MWJUF/[)T;79YKZ+3KN*^NK*+]Y)<_O(I99(9)?
M+\LB./C><5X3\*#\1_C5X&U3QQXE_;6TSX?:QJC7%S8:!<>,Y;6;S?-F!2YA
M\Z(649,<9C\J.3]W+D1@#!^BU7P%^T-_P33\6_#S]GXZA,NA6$9/A[6CYNL*
M\-V+Z0RQP^8'DN?*E,?E_NS)(8QY9C*1_('[,OC+]D.'X:R:=\9O .I2^+].
MM[BX.KV=[?21:M\_F111QQ2QB*7YS%R!'^YR91YE 'V1_P $KOVB/&/C^/X@
M_#KQYXOM?$VI>&98YM-NI]12^OIXY991<XN!(_VF&*01XE'F ><!YAC,0'Z'
M5\)?L<>+OV;=!^%OQ+^+OPG^'6O>&[/P_92G6)M2BEENIHK:+[28K:66XECY
M &8HY1TB,N,Q&OHC]F7]IWPS^U9X#U'Q;X2TW5;#3++49-+>+6HHHIC-'%%*
M>(Y9!C$J]_PH ^$?^"Y7_-%?^XU_[85^J=?!/_!7#X.7?Q ^ FD>*-)T&?6=
M0\(ZBUS<R6\Q9K'3I8I/M,OE9_>#S(K7/!,8CSQ'YAKG/AY_P6*^',GPVM;W
MQEH/B&'QC$88K^RT>".6WED(DS+;223#$?[M/W<F)!YH \T"22@#9^#?_*9#
MXZ?]B9;?^BM&K\Y/C7\2M:^'7[2'[2,&BW'V7_A)M7UC0KR96='^SR:H)I1&
M4/\ RT%OY9!SF.60=\U]C_\ !+?2]:^*W[47QG^-BZ7_ &9X:U@WT'ERN[[;
MJ]OX[LQ12^6(Y?*CB_>'(/[V'C$G'&?LX_"?1/CA^WM^U+X'\2),VCZM'X@@
ME:WD,<D937K66.2,^L<D:/\ T/< ^\/V&?@S\-/A'\$=%N/AEJ%OXCLO$"1W
MUYXL2(+-J\@!'S _ZH1'S(Q;_P#+/]YG]YYI/TO7Y3?"GXM>-_\ @F)\5XOA
M3\5'GUOX-:I+-+H6OQ12R"V5I 6N(D)/ WC[1:CF,GS(\^9_I/VK_P -J>"O
M^&J/^% _V5KW_"9XS]N^SQ?V?_QX_;<>9YOF?ZOC_5]: /5OB)?>(]-^'_B.
M\\(6-OJ?BFVT^XETFPN6!BN+P1DQ1R?O(Q@R8!_>#@GFOR4\60_'&Y\&^.?&
M'Q!_:QTOPGX]TF.21O 6E^-XHKN26V+QS6SPV4JPVTOEQ?NXX8Y/,DDQ)Y9S
M7Z8_M<:KXG\/_LQ_$O4O!^H6^F:_::!<W$-W-/+%]GC2,F:2)XOG$PB\TQ'_
M )ZB/.!FOQG^"_B_]E?P5\,99OB)X$\:>//B!+$[&W6_%KI22"27RUBDBFCE
MC$D?E^89(Y3\N8P.00#[N_9=^/WQ ^*W_!.'XI>(->UZYE\2>%K#6],L]?AF
MEBOB(M,2:*660'/FQF7'FC!/EJ3F3]X?F?\ 98^&?[4'[6'A_6?$/A_XY^)?
M#V@:;-)8?;=0\4WV;F^\HRB)(XY"=N9+;S)&Z"7,8EV>77J?[!7_ "BS_:-^
MOB/_ -,EM7K/_!%;_DUGQ3_V.5U_Z0V- 'FG[#'[37CWX<_$+X]>!?BKKVJ^
M.(? =AJ6O2WDFHRWLL)TZ3R;J*W^T?O)5EW1F/S)(P/*Z R25P7P%\-_M-_M
MWW7CWXA6OQGUCP+IL<LD%A:Z;JUQ;V,E[Y2&.UCMHI?W$4<;Q>9*?,D_>#B6
M3S,'[//@V^^(G[;W[8WA/3YK>*^U_0/&&EV[7/\ JTEFU2**,O\ BXJK^P/^
MVUX1_9'\'^,?AY\2]#U[3]0AU:ZU(7%I;[Y4E^RK'+:2PN8WBD\RUCC!Y'F2
M_O/*$9DH POV4_"?CGP%_P %3/#'A[XD:I<:[XTL'OHK[4;F[DO3<_\ $FF,
M4GFR?.1Y1BY/. !Q7ZA_M9_!>]_:"_9\\8^ +#4+?2[_ %=(&MKBX4/%YD5U
M%<1A_9S$$]L]^E?FA^SI\9K+]H+_ (*RZ-X_L+*72[#5Y+Q;:UN'+OY46BRV
MZ;_0N(@^.<9_&OT4_;._:G/[(OPOTKQC_P (N/%:WVK1Z5]D^W_8A&9(II?,
M\SRI/^>6,8[T ?G9^SY^VM\3_P!@Q[/X0_%3P'</X=TV26>&&6'[-J-K%)=?
MO9+>3_574.\71C[2/)Q,(P,?=?[2GQ@^('BK]FFP\;_LYZGI6IKJ,R7CZ[//
M:Q1V.F1QS/<S9O)(XHRDD4<<@E!,8:3(!'[OY8_:J_X*/_ SX_?L[Z]X8'A#
M7M<\07PF33+?5K6&W_LVYC"^3?>9%+(!Q++CR\F3RI(Y/+CD!/G/Q^T_QO\
M#W_@EG\"-&>6UTS0;_4)9]4MO/D^TW*W,ES?:>N$/EM%Y;&62.3D2"V.,@T
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MK?PM\#? 3P9H?B31_$T&O^'-/LM(GM=-MX;A;H1PE/M$4LDL6!^[C+B3&#*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRK,\8_!?X=_$/4UU+Q?X%\,^)]2CC\A+O6M(MKN1(^T8DDC) ^?I[UWU% '
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M=M3.H_#CP?>G5;P7U_\ :="M9#?77[S]_+F+]Y+^]E_>')_>R>IKTNB@#B/
M?PD\&?#&2_/@[P;H/A+[>(_M7]AZ=%8BX\O/E^8(@,X\R3KZFCQY\)/!GQ.D
ML#XQ\&Z#XM^P"3[+_;FG17PM_,QYGEB4'&?+CZ>@KMZ* .!\'?!?X=_#S4VU
M+PAX%\,^&-2DC\A[O1=(MK21X^\9DCC!(^3I[59_X5)X+_X3O_A-?^$.T'_A
M,<_\C%_9L7]H?ZKR?^/G'F8\K]WUZ>W%=K10 5YMXB_9_P#A;XRUJYUGQ%\-
M_"&OZQ<8$^H:GH5K<W$V!L^>22//0?I7I-% 'E7_  RC\$?^B.^ /_"8L?\
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M>B@#S;Q%^S_\+?&6M7.L^(OAOX0U_6+C GU#4]"M;FXFP-GSR21YZ#]*I_\
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M]FTC0[-+.#*)O?'WI'\M5!DD.9)#CEY">]=U10 4444 %%%% !1110 4444
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MW7_A=P_X9=_X7'_8;;_^$._X2[^Q/M7_ $Y?:OLWG>7Z?N_,\OWQVKQKPO\
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MIS>&8KF&SLKJ8Q^9;".Y42@@1I)^]CC($PZC$DDO[!7WOVC/^RR^(_\ VVH
M])^!OQK?XK_\)CI.HZ0WA?QKX3UB71M6T5KC[0(OXK>YC)CCEDMIH_WD4LD<
M>_\ >8X&:R/ O[14?Q&_:#\=_#?PUH_VW2?!=C$NK^*EU.)XUU.5N+%(ADG
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M,T*Z\/\ B/PE!?QP37FGY>YA-MYD,A)\XY(B)E?RXHXX^9#7IGP+_:X\"?M
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MQ"^.WQ0_:E^-7PT\$>*+'PKX9T1=#FC\47>FVUU+H:2V/FO#;6Q -S)<R_\
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M,M:^/'[)MYHWCKQY\5['XM?"Q;Z*P\5+=Z!;:-<Z+#<31QQ7\0M_,DF\N20
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MDQQQ@ <\\>]1ZEX3T/5_$&E:Y?Z3I]UK>CF7^SK^ZM8WN;/S1Y<GE2=4\P
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MO-=#_9^^%_A6/41H?PX\(Z2NI64MA?+I^A6T/VJUD_UL,GEQ_O(S@?NSP<4
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M-.BEN[7RI3+%Y4KCS(\2?O!@]<T ?+7[%_Q&TWXM?M3?M.>+=)M]0M]*U/\
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M)#BOHRN!\8_!?X=_$/4UU+Q?X%\,^)]2CC\A+O6M(MKN1(^T8DDC) ^?I[T
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M<8'/R#\J/&WP]\*?$;2X=-\5>&])\36,<OVF*TUJQBNH4E /[SRY >?G/YT
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M93)&8QD^4?D/F8DC)^GJ\\TOX*_#S2/&#^*M-\">&M/\4O)+=G7+;2+>._\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M  ]?2@#8HK'T?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B..""/3UK8H
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M_P 8FU^PMX@TBRU3[+YGF?9_M,4<OE[^^/,% ':4444 %%%% !1110 4444
M%%%% !1110 45ROQ#\8V/PY\!^)/%VI13366@:9=:G<I;#]X\441ED"<^B4?
M#SQC8_$;P'X;\7:;%-#9:_IEKJ=LER/WB12Q"6,/SZ/0!U5%%% !17FGP%^-
M.D?M!?"W1_'OAZSO[/1M6\W[+#J:1QW'[J62(^9Y<D@',1[_ . ]+H ****
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MB,PRQF,'RR?>(?B9X3N?B$_@2U\0V%SXOM;.2]N=&M9?.NK:)/*.^7!_=?\
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M<Z%XRUKQ99R_\(BOPSN9DBN[Z''FVUT+U\QQ@21R/<@8B0DXD_>>5V'[//\
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MX5C_ ,(U_P +6U3_ (3+S_[2^U_:_-M_MWV#'R>7Y>/*\WG_ )Z5[O\ %O\
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MS2(L9\NVEDX&"<G]N3XE^%;KX@? #P+::_I]YXML_BKH-]=:+:SB2ZM8D/\
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MX=>+/A]ILP;7[;X?&_\ [5MK, F2YC%R1&1$0"1GD9_U8S)'WG[4G[3-_P#
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M_*0?Z3YMQ')F*,DRR&39UKJ/^&/=$_X1;_A)/^&H/C9_PC7V3[?_ &S_ ,+
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M_:&_Y/J_9'_[F[_TUQ5]5T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7>'O"WCGQ?XQTS3?LGB'Q2+7^U[S[7+)]J^RQ>5;_NR?+3$?_/,#KSFNYHH
M*\ ^*W[$_P %_CEXK?Q-XS\#0ZMKLD2Q2W\=]=VN_8 $WB*6/S#CC>>< #M7
MO]% 'F7PR^ ?@'X/Z]XDU7P3X7L?#5QXA^RG44TQ3%;2?9PWE;(?]7'CS9/N
M ?GT[76-#L/$>EW>FZC9V]]IMY%);7%K<QB6*>.3_61NAX((]?6MBB@#YA\-
M_P#!./\ 9S\)ZU;ZM9?#"PDN(,[8M5N[J^M\$?QQ7$LD;X^E?3U%% 'C'PU_
M95^%'P7\?:GXR\%>$(/#NNZC#-;7,MG<W!A,,DD<CQQVWF>5$/,BB_U<8QM
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M\2?\$X_V<_%FM7&K7OPPL([B?&Z+2KNZL;? '\$5O+'&F?I61^V%X)U+PK\
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MFT?XV/\ %K2_"-O8>/'GEG_M:"YNES-+&8I7^S^;Y67CDDY\OJ2YR3FO<**
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M_A:W_"Q?[-/_  E_]C_V#_:'VF3_ (\?-\[RO+SY?^MYZ9]ZXCXR_LF_"O\
M: U33-3^('A&+7]0TV#[+!.+NYMIO*))\HR12QF0;NGF9QO?&/,->UT4 >:?
M"'X"^ /@?H;Z5X&\*V/AN&51]H>WS)<7.-Y7S99,R2XWOCS"<9KDOBY^QU\&
MOCGK0UGQKX"L-7UC)\R^M99K*ZNON1YFDMI(S-@1Q@>83Y>., FO>** /-/A
M#\!? 'P/T-]*\#>%;'PW#*H^T/;YDN+G&\KYLLF9)<;WQYA.,UK?#WX7^'/A
MC_PD2>'-/;3_ .W]6N=>U$>?)+]HOK@CS9?G/?RQQTXZ5VM% '%_\*M\-_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX-;QNWC(:M!)I5LI%]++;0Q&V6.8R".*/S9<RRR"3RXA(_8UY]XL_:!_:;^
M?@W3/B-\7/"?@"]\ VLUL==L?"<UT-8TV.?]V&_>2FWD\N66-2(VD!X[9E0
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MH \:_::_:=\,_LI^ ].\6^+=-U6_TR]U&/2TBT6**683212RCB26,8Q$W?\
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M(Y8AO/[S ]A^Z,O8_P#"X-<_X;._X5'Y&F_\(S_P@?\ PE/VCRY/M?VG[?\
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M@+)(?)BN8X?WLDLR1OB+,9Q)')B2/S#& ?2=%?(>A_M"?%WX0_%KPWX5^/\
MX<\-IH?C*6+3M \6>!(KJ6RBU)I#_H-T)?G!E&#&<#_MI^\,/UY0 5\HW/\
MP4 T=/$WB;1M(^#_ ,7?%[>'M7NM#O;[PWX:COK7[3;R>7)^\2;KWY X[5]7
M5^=7[._[87PA_9[\3?'[P]X^\7#0-9NOBQXAU"*W73;JY)A,D48DS%%)CF*3
MKZ&@#ZG^#O[4'A'XW:EJ>@Z9!JWAKQEI$(O-4\'^)]-EL=4LXG)\N22%A@Y_
M=/F,R8$T><>8*Z3_ (7?H_\ POC_ (5/]DU#_A(/^$<_X2C[7LC^R?9/M/V;
M9GS/,\WS>WEXQW[5\U?LZ>.+;]I/]L+Q1\7_  DUDG@31_!__"'V,TVI12W]
M[(VHR3"YELD)EMHB8Y<+<^7)(HBD Y<1^U?\+@US_AL[_A4?D:;_ ,(S_P (
M'_PE/VCRY/M?VG[?]E\K/F>7Y>SG_5YSWH ]UHKY.\1?M$?$/XA?&#QG\-O@
M5H7A:\N/!?V7_A(/%7B[4I6L1/,9/]"ABMLR>9P<R9Q&898S&#Y9+?"OQX^,
M?PU^,'AWP=\=O#_A&'1O%I^RZ!XP\%27*6$6I_O/] N?M)SYLH \K 'L)/WA
MB /K.BOF'XX_'/XB:?\ &[0/@[\)="T2Z\:7&D/XGU'5O%LLW]E66G>;)".(
MF$KR&8 <# S'UR?+]1^">H?$>[\-WT?Q1TO0[/Q7:WSPM<>&;R26PO(O+22.
M6)9/WD7^M,?ER<DQ&3I(* /3:Y7XA^,;'X<^ _$GB[4HIIK+0-,NM3N4MA^\
M>**(RR!.?1*^7M)_:*^,/[1>K^*)/@+HW@2/P?X8UF;1'\1>--4N;B/5Y8S&
M<VL5B3LC7.?,D)$L<T1&,2 =^OQG^(^D_ 'XH>)?&O@S3_#?C;P797_DQ0SR
MW.F:M+;6$5S'?0Y$<@MI'DP(\F1/+9"_F @ 'L7P\\8V/Q&\!^&_%VFQ30V6
MOZ9:ZG;)<C]XD4L0EC#\^CUU5?.>J?M+OX)_9/\ "/Q6UK2SJ_B77=*TN:R\
M-Z1\DVJ:G>Q1>5:VL;G><R2$X_>2"*-SB3'/!>(_B!^V#X1T&;Q6/ 'PUU#2
M+9AJ#^"])NKZ?7C:@YDM$F_X]Y+E(\C,8()C/EQR<1D ^R:*^5?B[^V!]A_8
MEN_CO\-X[;48V@MY;*W\06SD O?Q6LL<T<,@.4S*.)",Q_QCFL:\^(W[77C6
MUUKQ'X/^'O@7POH&&FT/P_XVGNO[=NHA$'C\WR91%%+(?^64IB,1S')T\P@'
MV'17C?P/^/6B_'#X!Z/\57C/AC1+ZSFO+P:G<Q>58_9II(KHO*1CR\Q2?O#C
M]V,D1FO#/ /QV_:._:3\,V_CSX4>'/A[X9\#7,]Q;:</'MY?3WU]Y<LD?VG%
MI^[B4\1^4<D21R\D&.@#[7HKYV\0?M.ZKX!_9Y_X6%XT^'VH>'O%LU^^D6'@
M*&^%U?WVI?:I+:WMHI-@\WS?+\W,4<G[HF2/S<#/G_B/X@?M@^$=!F\5CP!\
M-=0TBV8:@_@O2;J^GUXVH.9+1)O^/>2Y2/(S&""8SY<<G$9 /LFBOG#Q-^V-
MX3TO]E.?X\Z+9:EK/AHV0GM]/P+:X><W'V80R$_ZLBX_=R2#S  "8_,R,P?"
M36OVFYO$^@/\4_#?P^?P[J4.;R#PS<7"7^CRF+S$,HE+QS 21^41%)D/*'!,
M<9H ^EJ*** /,_A%\:M(^,R^,TTBUO[/_A%?$E[X7OOMZ1QF2ZM?+\V2/9(<
MQYD')P3Z#OZ97A?[-/QFUSXQ+\5&UJVL+<^%?'>J>%;/[##)&9;:V\KRY)?,
MD/[P^9SC XX%>&^&?VF/C_\ %KQEX[\(_#SP%X;EN/"WC;4]%G\6>)3+%HUO
M8V^1:Q8CF\V6ZDDC_>&+Y(\Q9CQ+E #[FKG?^$JT7_A)_P#A&_[7L/\ A)OL
M?V_^R/M2?:_LWF>5Y_E?ZSRM_P"[\S&,\=:\#^!WQS^(FH?&[7_@[\6M"T2U
M\:6^D)XGT[5O"4LW]E7NG>;'">)6,J2"8D<C!Q)TP/,^</\ C*+_ (;O_P":
M1?\ "Q_^%:?]13^Q_P"R_P"U/^_OVKSO^V?E^] 'Z6T5\^_%_P"/.O\ P7\"
M^!K*[\+1^/OBOXKEM],M/"_A^]^R0W5X(A)=2QR2YDCMHL2GS3&?+S%YAC!,
M@\Q\=?&#]J7X%:5!XS^(GACX=>+/A]ILP;7[;X?&_P#[5MK, F2YC%R1&1$0
M"1GD9_U8S)& ?:%%?,7[2W[5LWPK^&OPG\=>"]-;Q7H_C'Q+I=AY,5C-+=76
MG744DN;6(R1'[3((X_*\SCYCD5P7BKXQ?M>^"?!&M?$;6_ 7PTL?#&DF74[S
MPB-3N9-;CTV*7,H^U1N;4R"$&3S![GRL_NZ /MJBO)[[X^>&M)^ B?&/4!=6
M/A2308O$*0W0BBN/*EB$D<7^L\LS2;XXQ'YF#(1SSFO _ GQ4_:T^)7@[2_'
MFF^#?A>GAG58?[9L?"MS>WRZQ=6$A$L,(N@?LPFDC\O$AQ&/-!DCC(,8 /=/
M@/\ &K_A=3?$/.BG1CX2\9:EX3S]I^T?:OLOE9N/]6/++^9_J^<8ZFO8*^&_
MV)?B=::-\'_VD/B/J>DZMI^G6'Q&\2Z_<Z7>6_E7]M$EK#</%+&3\LH&08^S
M_F.G^#/Q5_:<^)-OX3\;7_@[P#;?#SQ!<0W0T:WO[G^W+?2[EQY4WG'_ $:0
MQ1R)<$  R1J8\1RG90!]>T444 <[_P )5HO_  D__"-_VO8?\)-]C^W_ -D?
M:D^U_9O,\KS_ "O]9Y6_]WYF,9XZUT5?FE_QE%_PW?\ \TB_X6/_ ,*T_P"H
MI_8_]E_VI_W]^U>=_P!L_+]Z^H/C=^T1J'[/?P]\ +K.C67BOXI>*+VRT2S\
M-Z%J0LK>_P!3D$8F\J2X_>1VPDX\P@C]Y#YG^LS0!]&T5\=>*/%/[97@71;G
MQ#?^%_A-XOT_3-MS<Z#X6.I_VI>Q _O([;S?D\W9D@X/?$<AQ&?HOX1_$?1_
MC%\.O#OC30KG[3I&N6:7D&73>F?O1/Y;,!)&<QR#/#QD=J .ZHHKYA^./QS^
M(FG_ !NT#X._"70M$NO&EQI#^)]1U;Q;+-_95EIWFR0CB)A*\AF ' P,Q]<G
MRP#Z>KG--\6:'J_B#5=#L-6T^ZUO1S%_:-A:W4;W-GYH\R/S8^J>8 2,]>WJ
M///A_J'QCNOACXFMO%FC^$],^)5J+F+3KK3+BYDT2_<PB2VF(/\ I$<?F/Y4
MD9_>?N99!Q(E?'7P<_X:A_X:I_:'_L7_ (5+_P )E_Q3O_"1_P!H?VI_9W_'
ME)]D^R>7^\_U>?,\WOC'% 'Z5T5X5\3_ (Q:_P""_P!HSX(^ +&&PET;QQ_;
MG]HRW,3^?%]AM8YHS$=_4DD'(/K4G[8WQFUW]GG]GCQ5\0- @L+O5]'^S>1!
MJ4<DELWFW44)\P1R1G_EKGKV'6@#W&BO'OVDOV@M$_9L^$.L^.M85+];=XX+
M334N8XY+RZD($<<?F=3UD. <1QR28.,5Y%IOC7]KCPKIEAXK\9^"_AYKF@V\
M:76K>&?!TU\/$&QL>9';B20V\LT.<^4)")?*,<;DR"@#V']ESXX/^TE\#?#W
MQ%;1O^$?76?M.W3A=&Y\H17,L)!D\N//,6>G>O7:_.']G+XP>*/@3_P3_P#@
M?XUTZ32W\$VNO2VWC![^VDEELM,N-8FB-W"8I1S'N \ORY<^:.!Y9S]O?&SX
MD6?P9^$OB[QK>F"1-"TZ6^$-Q<BW%Q*B9B@\P@\R2^7'TZR=^E 'H%%>=?!C
M5O%.M_"GPCJ_C.W@L/%.J:?#?ZE8VEC)9"TEE19#:F*6620-'DQG)R3&>$Z5
MZ+0!YK_PN_1_^%\?\*G^R:A_PD'_  CG_"4?:]D?V3[)]I^S;,^9YGF^;V\O
M&._:O2J\*_X7!KG_  V=_P *C\C3?^$9_P"$#_X2G[1Y<GVO[3]O^R^5GS/+
M\O9S_J\Y[UYK\>OVFOB=X _:,_X55\/? <?CS4M0\%_VWI<0)C,=]]KEA\R[
MN9)8XH[6.*,\8$DDABC\P>9D 'U_17QS<_'3X\_!/X@> +7XT:%X$O\ PAXO
MUB'PS;ZC\/GNENK+4)O^/;S8[H_O(SB7(C';.<@1R_8U !7.:;XLT/5_$&JZ
M'8:MI]UK>CF+^T;"UNHWN;/S1YD?FQ]4\P D9Z]O4.\7?V]_PBNL_P#"-?V?
M_P )1]DD_LW^U-_V3[3L/E>=Y?S^5OZXYQG':OSU^#G_  U#_P -4_M#_P!B
M_P#"I?\ A,O^*=_X2/\ M#^U/[._X\I/LGV3R_WG^KSYGF]\8XH ^R_CQ\:O
M^%*M\/,:*=9/BWQEIOA//VG[/]E^U>;BX_U9\PIY?^KXSGJ*]@KX^_X*-ZT?
M#?AOX(:T-/U#5CI?Q6T.\.GZ7"9KJX\J*ZD\J*//SR'& .Y-8WBKXQ?M>^"?
M!&M?$;6_ 7PTL?#&DF74[SPB-3N9-;CTV*7,H^U1N;4R"$&3S![GRL_NZ /M
MJBO!_'W[3VC^#OV>])^*=CI>IZLNO6=C-H/AN/RX]1U&XOO+-K:QQ_-F7$O(
MC\SY8Y"!)BO+O$?Q _;!\(Z#-XK'@#X:ZAI%LPU!_!>DW5]/KQM0<R6B3?\
M'O)<I'D9C!!,9\N.3B,@'V317 ?!OXJZ'\</AGH/CGPU),=(UB-I(EN(_+EC
M\N4QR1O[H\<B<>G?K7?T <[XD\6:)X7^P)K.KZ?H[:G>1Z?9?VA=)";FYD)$
M<40?_62G'$8Y_*NBKX!_X*!?\+O_ .$\^%W]F_\ "!?\(=_PLG0?^$6^V?;O
MM_\ :GE2^5]NQ^[^S>;YV?*_>8\KOFO?_P#A-?BY\.?V=OB1XN^)8\(2>,M
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MBVTX>/;R^GOK[RY9(_M.+3]W$IXC\HY(DCEY(,=>D?L[_'+QCXQ\4>*OAO\
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M"S3;OP__ ,))?7NCO$+_ %K_ $Y(A8VL@ EMI(TMKF3S(R^1YGF1F./GRIO
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M2?)S7I/BKX7>'O%/CGPAXQU/3?M?B'PL+K^R+S[7+']E^U1>5<?NP?+?,?\
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M\^7_ *WGIGWKE_C1^SG\._VAK'2K'Q]X8@\0V]C.TUE(9IK:6)F #@212)(
M0.8\X)2,X^3@ ^<_V_/#-K=?%S]GOQ!XF\6ZI\/O!MOJ>KZ->^,M%U'[%=:=
M=75K&;4++R8Q+]FDCDD(\L1^9O,?!K;\??L3^%]"\(:E<>-_VD_C'8>%I(C;
M:C-XA\=Q1V)BE_=&*;S8O+P_F>7@\'.._/TG#\*O!\GPXL/ 5SH&GZAX/L;&
MVL8]&U)/MMKY5MY?E1R"7)D\ORH_]9SP*\;\-_\ !./]G/PGK5OJUE\,+"2X
M@SMBU6[NKZWP1_'%<2R1OCZ4 <=^U?X+LOASX!_90\)Z?-/-8Z#\4/">EVS3
M_P"L>*&*:.,R>_[L5[Q^U?\ \FL_&7_L3-9_](9:Z+XA?"_PY\3O^$=3Q'I[
M:A_8&K6VO:<//DB^SWUN3Y4OR'MYAXZ<]*U?%'A33O&_A76/#NL6YNM'U:SE
ML;RW\PIOAEC,<D>4_P!DD?C0!\9?&SPKJ'C#_@D;IEEI5O\ :;J+P#X>U"1"
MX0""VCM+F9_^_<4GY5]0>&_CIX-\4_"'1_B<->L-*\':E9Q78U#5+Z&%+;S#
ML\J:3S#%%()3Y1_><2 IG-=;X7\*:=X(\*Z/X=T>W-KH^DV<5C9V_F%]D,48
MCCCR_P#L@#\*\6_X8)^ /_"<_P#"7?\ "I/#_P#:V_\ X]]LG]GX\KRL_8/^
M/7I_TRZ_O/O\T >0_L0^._ FN?"G]H+Q1KNIZ,OP]USXG:Y+)J&O%+>QN;*Y
MCMO+\T7..)1*!Y<N,^;@CM53XT^%7_X)Z> &^(GPX\9:CIO@JPO;>*3X6:]=
M"]T_46DE$9BL)IOWMG)B6ZNI/+\SS"#QY<>*^FV_9U^'S>$_&7AR3PI#=Z%X
MTU*XU;7-,NKB6475Y<&/S9LO(?+/[N,CRL>64S'@UR/PV_8:^!?PE\30>(O#
M?P\T^'6X#NM[K4+FXOO(D#B02QBYDD$<@*#]ZN'&.H'% 'T+1110!\AWFL6.
MG_\ !4S3H;R[M[6XO_A+]DM(Y90AN)?[7EE,<8/WSY<4KX Z1D\57_:]\0Q?
M"_\ :*_9F^(VO,+3P9I.L:MHE]JAFACCMIM1M$BM_-,LHQ$/*EDDD'W(XSWQ
MGVCXT?LY_#O]H:QTJQ\?>&(/$-O8SM-92&::VEB9@ X$D4B2 $#F/."4C./D
MXZ*'X5>#Y/AQ8> KG0-/U#P?8V-M8QZ-J2?;;7RK;R_*CD$N3)Y?E1_ZSG@4
M 9?Q&^-W@KX6_"^Z\?ZQX@L?^$<:P-W93PWT1_M,>2TT4=J9)!'+++'&3& ?
MWGTKS/\ X)R^%=1\(?L6_#*QU2'[)<RV5SJ$2!PX,-S=2W,+_C'+&?QJ/PW_
M ,$X_P!G/PGK5OJUE\,+"2X@SMBU6[NKZWP1_'%<2R1OCZ5]/4 %> ?%CX%_
M#7]H+Q@[RZQ=:;\2_"<$5K_PD'@[6OL.OZ+'<?O-CF,_*)8Q+@2Q_P"KEE,?
MWR:]_KP#XK?L3_!?XY>*W\3>,_ T.K:[)$L4M_'?7=KOV !-XBEC\PXXWGG
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MM-2TV'5[Z\\*:U%I.FZ<HACC^R"WBCDC>:.821'RA&9),#R_,SG[4^%/PO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC#Q1'\4?AKXGUZT\+Z7JE];F'Q%87=SYBVR3$?N;J&-(%\R4[)I'FD?G9Y9
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MKI_B._\ %%KHW]H^40))8K:YBWF/S,J"#VP?+D$D:9?[%/Q$TWXK?M4?M/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\):9&\0Z?X7UXV]KK$DLDTDDEQ'+')OS]ID'EY$>.!&,G/U910!XC\$?V7?
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M\(O@KI'P97QF^D75_>?\)5XDO?%%]]O>.0QW5UY?FQQ[(QB/,8X.2/4]G?\
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M"N?^+GP<\(?&SP=+X<\;:##XDTEG2X%O++)$4D3&'CDC(DC/;Y#W/J:] HH
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M:3>7EDDDD,CY).3S[=10!\U>,/V(_!WB?Q5J?B7P_P"(_&WPLUO6I/M6N2^
M_$$FF_VM,3D/<QXDC^4F3!0#)ED)R:[/X%_LZ^'_ (%+K5_I=]KOB/Q-K@C.
MK^(O$VIS7M_J/E>9]E\V1CY?[N.0QCRXQQCKBO8J* /,_A%\%=(^#*^,WTBZ
MO[S_ (2KQ)>^*+[[>\<ACNKKR_-CCV1C$>8QP<D>I[>;?$S]B_0/B!\3M;\;
MZ;X]^(O@#6]<BMHM6_X0W7_L$5XUO'Y4,LN8WR1'\GT[#,A/TK10!Y)\%_V?
MO"'P!T_5(/#%E=M?:U/]HUC6M2NI+J_U.X .9KB>0$DD^9)CB/?++@#S#G.^
M"_[,GAKX%^/OB3XMT2_U>\U+Q]J0U35$U"2*2*.027,N(1'%&0";F3@F0\#G
MBO;** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYH&M7&FZ]XO\77%P$U/4XHK6.6#[-;".7S8A^[\V021R1Q1XD& " >Q_L_\
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M^=?^<IG_ '1O_P!S5?5E !1110 5Y1^U?_R:S\9?^Q,UG_TAEKU>O*/VK_\
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MQXJU/PUX?\.>-OBGK>BR?9=<B\!^'Y-2_LF8' 2YDS''\Q$F A.#%(#@UO\
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M:;R;_EG;PQ?\M'/U[$G"9QZ=7SG^U%\8-7^%]UX(T+P9X*L?B%\4_$5W>_\
M"+Z7J5PMM'!);V,QGOO-DP@,<<HC,?F1/)'*X$G6@#)\$_MQ^%O%GQ%T#P;K
M_@WQ]\*M4U\RII4GC[1?[,@U*6/R_P#1XI#(?WF91@=#T_UDD8/I7QL_: \+
M_L^Z1X8U'Q6]Q%I^NZ];>'DO8'B\JVEE\S$UQ)+*@CAC$1,DF3CC@]OD+]HC
M_AH;_A)/@'_PMK_A6/\ PC?_  MCP]Y'_"%_VE]K^U>9+MW_ &GY/*V>;GOG
M9VKUO_@H-I-EK>E_ 73;^S@O],OOBWH5I<VMRGF17$4HN1)&\9X((]: *O\
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M[;F'PYX9L=#OW/6,Q7T?F21?O!'G Y&4[UUWQE^"GQ'\>>/M-\5?#OXVZO\
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MB7]EW3?@MXDN9];T:VT.QT66_M?]%EE^RI$([F/[WED20QRX/F#C!WBO;:*
M/DL?L>^.?%6_0?B!^T#XO\8?#F/]W'X;M[6+3+N[A4^4+>_OXAYUW%)"9(Y?
M]5YA/F<&O5_V7/@>_P"S;\#?#WPZ;6?^$@71OM.W41:FV\T2W,LQ)C\R3',N
M.O:O7:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6]].T-E&89KF65E +D1Q1O(0 >9,8!>,9^?D ]<HKR/X+_M&?#O]H:QU6^\
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ME,^+G[8OP:^!FM#1O&OCVPTC6,GS+&UBFO;JU^Y)B:.VCD,.1)&1Y@'F9XR
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M  \2_9V_X2S^P?\ A9^G_;_MOV#S/L=U]E\SS=F[[3Y7D^7_ --?,\O'.<4
M?3-%%?,W_#Q+]G;_ (2S^P?^%GZ?]O\ MOV#S/L=U]E\SS=F[[3Y7D^7_P!-
M?,\O'.<4 >[^&_%FB>*/MZ:-J^GZPVF7DFGWO]GW23&VN8R!)%*$_P!7*,\Q
MGG\ZZ*OE3]@K[W[1G_99?$?_ +;5]5T %%>3^-/VC/AS\-]=U'0?$_B:VT75
M=/T#_A)[F.ZAE CL?/\ LWF[_+V$^;^[$8_>$]$KF/A3^VQ\%_CEXK3PSX,\
M<PZMKLD32Q6$EC=VN_8"7V&6*/S#CG8.< GM0![_ $5YYXZ^,?@[X>^*/#N@
M>)=>M]"U'7H;^ZL?M<<@B>*RA\ZZD>;'EQB.+]YF4CI[5C? []I[X9_M(-K/
M_"N_$I\1'1Q#]N86%S;>3YOF>4#YT<><^5)T]* /7**^8?$G_!1S]G/PGK5Q
MI-[\3["2X@QNETJTNKZWP1_!+;Q21OCZU]#:/KEAXCTNTU+3KRWOM-O(H[FW
MNK:02Q3QR?ZN1''!!'IZT ;%8'B;Q/H?@W1+G6=>U;3]"T>W/^D7^J74=M;+
MSL DDD( YXY]J\9^)/[<OP+^$OB:?P[XD^(FGPZW =MQ:Z?;7%]Y$@<QF*0V
MT<@CD!0_NFPXQT YKS__ (*)^*M&\:?\$_\ XB:UX>U33_$&DW T\6]]IMS'
M=6SXU2U0^7)&<''/\J /L6BO#?VE-)\ :O+\*?\ A/\ 7K[1!:^.]+NO#ZZ?
M%G[;K"^=]FMI/W4F(Y/WF2?+''^L%=[\0OBAX<^&/_".OXCU!M/_ +?U:VT'
M3CY$DOVB^N"?*B^0=_+//3CK0!VM%?,W_#Q+]G;_ (2S^P?^%GZ?]O\ MOV#
MS/L=U]E\SS=F[[3Y7D^7_P!-?,\O'.<5U/[8^D^ =:_9S\76?Q5UK4/#?@&0
M6O\ :>I:7'YEQ%_I41BV?NI3_K1$.(SUH ]PHK \3>)]#\&Z)<ZSKVK:?H6C
MVY_TB_U2ZCMK9>=@$DDA '/'/M7C/PV_;E^!?Q:\30>'?#?Q$T^;6YSMM[74
M+:XL?/D+B,11FYCC$DA+C]TN7.>A'- 'T+17G_Q<^,?A#X)^#I?$?C;7H?#>
MDJZ6XN)8I)2\CXPD<<8,DA[_ "#L?0URGP:_:R^%?[0&J:GIGP_\71:_J&FP
M?:IX#:7-M-Y1('FB.6*,R#=U\O.-Z9QY@H ])_X2K1?^$G_X1O\ M>P_X2;[
M']O_ +(^U)]K^S>9Y7G^5_K/*W_N_,QC/'6NBKY3_P"<IG_=&_\ W-5]64 %
M%<MXY\<Z#\,_">I>)O$VK6^CZ+I\7F7%[<$X3T]SS_ !7GOP:_:R^%?[0&J:
MGIGP_P#%T6OZAIL'VJ> VES;3>42!YHCEBC,@W=?+SC>F<>8* /:Z*XO_A:7
MAO\ X6M_PKK^TC_PE_\ 8_\ ;W]G_9I/^/'S?)\WS,>7_K>.N?:D^(7Q0\.?
M#'_A'7\1Z@VG_P!OZM;:#IQ\B27[1?7!/E1?(._EGGIQUH TM2\6:'I'B#2M
M#O\ 5M/M=;U@R_V=875U&ES>>4/,D\J/J_E@@G'3OZGHZ^1/VG-6LO#W[9O[
M+>K:C=P66F6$7B^YN;NYD$44$2:7'YDDCGH .]=5X#_X*!? 3XE>+M+\->'O
MB)#>ZQJ4GV>TAN-)OK82R?W/,EA1,\C S0!](T5\=_\ !0+]L32_V?\ X<ZS
MX<\/>*_[ ^+MU96M]HEJ=-:YW0F^$<TF7BDMUS%%<C]X0>..<5V&E_MZ_ S5
MO".M>)K#QO<7?A[0I+5=3OH?#^I'[&;DR>27'V;(63RI/WF.I SF1* /I2BB
MO+])^.G@7Q-\/]>\<:9K?VWP9HHOC>:S'9RFU>.V)%S+$?+Q<QC9)^\A\Q#@
MX)H ]0HKYH\6?\% /@+X%O-.AUGXAPP2:EIEMJ]LD>FWEP?LUQ%YD)<10DQD
MQXD\N7$F)!P.,^W>!O'.@_$SPGIOB;PSJUOK&BZA%YEO>VY.']?<<_P$4 =3
M17SU\2?VY?@7\)?$T_AWQ)\1-/AUN [;BUT^VN+[R) YC,4AMHY!'("A_=-A
MQCH!S7KG@;QSH/Q,\)Z;XF\,ZM;ZQHNH1>9;WMN3A_7W'/\  10!U-%%>*?&
M7]K+X5_L_P"J:9IGQ \71:!J&I0?:H(!:7-S-Y0)'FF.**0QC=T\S&=CXSY9
MH ]KHKEO WCG0?B9X3TWQ-X9U:WUC1=0B\RWO;<G#^ON.?X"*\C^)/[<OP+^
M$OB:?P[XD^(FGPZW =MQ:Z?;7%]Y$@<QF*0VT<@CD!0_NFPXQT YH ^A:P/#
M/B?0_&6B6VLZ#JVGZ[H]P?\ 1[_2[J.YMFYV$1R1D@\\<>]5? WCG0?B9X3T
MWQ-X9U:WUC1=0B\RWO;<G#^ON.?X"*^?O^"7?_)B_P ,_KJG_ITNZ /JJBOF
M'Q)_P4<_9S\)ZU<:3>_$^PDN(,;I=*M+J^M\$?P2V\4D;X^M?0VCZY8>(]+M
M-2TZ\M[[3;R*.YM[JVD$L4\<G^KD1QP01Z>M &Q17SU\2?VY?@7\)?$T_AWQ
M)\1-/AUN [;BUT^VN+[R) YC,4AMHY!'("A_=-AQCH!S6+^TY^V9\/?A7\$+
M[6=-\?Z?_;GB32=3_P"$1U#2XSJ5M<7UO&$RDL44D7[N:2//F<=1V. #Z?HK
MYE_9%_:^\"_M"^%?#?AJS\7_ /"1?$FV\.6U_P"(;?\ LZ6VQ,$BCN9 3%'$
M?WTO_++UXJ/X:^-O@Y^S_P"!?C)XOLO%^HMX>@\=7]SXJO+VUFF^P:S++;13
M6\4:1>88O,DB P)/]8?WG7 !]/445POA/XG>'?'7B#Q5I.AZK)JEQX=O5TW4
MI8+>9K:&[(), FV^7))'@>8D9S'G$F"10!W5%?,/B3_@HY^SGX3UJXTF]^)]
MA)<08W2Z5:75];X(_@EMXI(WQ]:^AM'URP\1Z7::EIUY;WVFWD4=S;W5M()8
MIXY/]7(CC@@CT]: -BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]&M?!_PS\:>!?&O@S3\C3)OB);7R:G80DD16/F6A,<T<<:IB0XQG CCCC0
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MSY7EQR^9&/W@\OG&1R,&@#B?^"7?_)B_PS^NJ?\ ITNZR?BQXHNOVJ/BA/\
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M6\56M[;WUE:RXQ:XMAY9$62!(=\DG)/:,=Y^S9\!Y_@-X-UO3K_Q)<>+M?\
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M_@[K_C3]HSX(^/[&:PBT;P/_ &Y_:,5S*_GR_;K6.&,1#9U!!)R1Z4 >6_\
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M7?@KXX-YXGU&PU7P[X2L[K1OA_:P7,L\MO:W%]<W-S=72R1"-+V2.6*(R6^
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M4(R9)(HY/,Q++B0@C<.* /+?"7QQ_:!UWQ-I%AK7[,W_  C^CW%]%%>:NOQ
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MXY\9ZEXWU#7++4M/U3Q L M+B6.]>;)CC)E2+RXY/+0#,?[L< <  M?LH?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!ROQ#\'6/Q&\!^)/".I2S0V6OZ9=:9<O;']XD4L1BD*<>CT?#SP=8_#
MGP'X;\(Z;+--9:!IEKIEL]R?WCQ11"*,OQZ)5#PK\4?#WBGQSXO\':9J7VOQ
M#X6%I_:]G]DEC^R_:HO-M_WA'EOF/G]V3TYQ7<T %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'FO_"D-
M'_X7Q_PMC[7J'_"0?\(Y_P (O]DWQ_9/LGVG[3OQY?F>;YO?S,8[=Z]*HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \G^%_P "M!^%OC/Q[XDL+C5]5UKQIJ8OM2O]8NS<;1'DPVT70QQ1>9((
MQC@'&<".NN^(?@ZQ^(W@/Q)X1U*6:&RU_3+K3+E[8_O$BEB,4A3CT>NJHH Y
M7X>>#K'X<^ _#?A'399IK+0-,M=,MGN3^\>**(11E^/1*ZJBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2>)O$^A^#=$N=9U[5M/T+1[<_P"D7^J74=M;+SL DDD( YXY]J^3/CO^Q?\
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MI(3<W,A(CBB#_P"LE..(QS^5?.O_ #E,_P"Z-_\ N:I?V]?O?LY_]EE\.?\
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MO%E_J_AK1_B!X=U'5IY+J[N+"]MXTNHS))++LCBN/+B"$1G.^3H_'TS^U?\
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M_O/+ZXY]Z /O"BBB@#'UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>
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M !*^%_CSQ7K_ ,3IK?59-#TVW\"^#+\&.*=M!MI))0YAM\Q@2$VQ'F%Y@8I
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M9O-DM+DW.?/'F2.(Y \DGR2&0C>B1^U_!/Q%\6O$O]L:A\1O"N@^!K.X$/\
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M0_!NE_";1/ *:I'9:"NK#5M0U*XO;8122&6+]U'"(\8_Y:>9$^1^]!C^PJ*
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M0_!NE_";1/ *:I'9:"NK#5M0U*XO;8122&6+]U'"(\8_Y:>9$^1^]!C^PJ*
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MU[5M/T+1[<_Z1?ZI=1VULO.P"220@#GCGVKY#_X*!_%KP7\4/V'_ (L+X/\
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MKZ3UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>  /7TH V**\V\._M
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M (2/[=_9W]D_V[;?:_M?F>7Y7D^9YGF>;^[\OKGCVK._:@T7_A(/@9XDT_\
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M!)@T_3-=M;FXFP-_R1QR9Z#]*\>_X*B?\F+_ !,^NE_^G2TH ^JJ**\KTO\
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M_N4?_37+7U70 45SOB3Q9HGA?[ FLZOI^CMJ=Y'I]E_:%TD)N;F0D1Q1!_\
M62G'$8Y_*N6_X:"^%_\ PE/_  C?_"R?"/\ PD?V[^SO[)_MVV^U_:_,\ORO
M)\SS/,\W]WY?7/'M0!Z716!XF\3Z'X-T2YUG7M6T_0M'MS_I%_JEU';6R\[
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MY<@!Y22&,@]0?:?VAO@?XW?XM>"_C3\+%T^Z\9^';*YTS5O#^H7TUK'K^FR
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M @TWXH_M3>!K&UT'6/@;IOQ+U2QCCAN/%6C>,K33+;4<@?O?LTD7F1D<>9P
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MX,\"Z%X<NX;);'[?864:74L7!\N2X(\R3F.,_O">@Y/;R[]H3P!XX^,'AOX
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MC+\"_P!IKQ[\0?AYX#T[XJ>'?B%96)O=/_M>+2+O2[FPA$,69)B8Y(I(VD/
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ML3?$#P!'=MXJ^(OBC2-8N-7O7N),ZIK-[;RQ%O,N9.G,,7FGR_,\KS" 9"*
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M&]1\9? 'XC^&]&M_M6KZOX;U+3[&UW!/-EEM98XTR_3)(KQSQG^S;XB^)G[
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M6Y,K2F+RY(\G$7EF,G]Y'))'CG->A?\ #&'P,_X1W^P/^%3>$OL/V/[#Y_\
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M6Z^*WQ7^ 7P7NK@6_@SQAJU_J>OP1-,LE_%IL,=S]E)CEC_=R[SGN)!%(/\
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M\5/"'[2V@_&OX9>%-/\ B'')X;D\'ZOX7N]033;E(OM,EU'<Q7$A\O\ UOE
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MP3Y9X/-'[7?PS\2_$AO@S_PC>FF_'A[XD:/X@U)O/C3[/96WG>;)\Y&2/,'
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M!X4^'?P[L/B]\-K[6+G4_#]K'XH.FW?AZ*0@_9)/M?FAX\D>68CU$LDN#(,
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M9LFDZN3B6<27$AC=;C<\AV '(CC_ '8BC\P ](U'X:^$_P!EKPC\9_B5\.]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O'_CQ\%?^%U-\/,:T=&/A+QEIOBS'V;[1]J^R^;BW_P!8/++^
M9_K.<8Z&O8** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3TK8HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR*ZEMW*>SF(O[9[]:]JKP[]E+Q=\,_&_P+\+W/PFCA@\%6\7V:+2H@(Y--G
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MB^;HAMM7N;#Q#9R2Q":UNOM0   _>#$@_P!6?^6GE21 'W7\=/%6MZ/^V/\
MLSZ'9ZMJ%KI&LGQ-_:5A:W,D5O>^381R0^;&#B7RSR,CJ?PKZ<KY4_:&_P"3
MZOV1_P#N;O\ TUQ5X-^TU\:?AEXN_:F\6_#_ ..'CC5_#'PW\):?8V\7A&Q-
MZ;/Q'?7,:W<ES<O91[P(LVX2(G_61^8,?O(Y #])**_*/PK\4O@;\(?CU\,[
MO]E_QM-;IXGUZP\,>*O!EQ:ZE+87MC+-C[<)+H926'S>/G/^LZ >:)?I+]HY
M-<^.'[5O@KX&G5=1TGP!:^&KGQ=XLBTW4I+2;7+224V4=@3''YGE>9_K(_,
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M?W[,GPVU3QU\*_&%YX;\WQ+XR^).@Z#KEZ=0N2;RQEBDBDB\OS-D?[N*(9C
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M&#XVP:GXNA\1ZM?3>%O#]QKER;3P]IL<IM?)B2+R1YI,7[R3GS!%#)_K/,H
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M"WP/L]$U,Z#K-Q\5=#BL=4^RBY-G,8[H13>2_$GED[O+/!QCO7$?&3_@GO\
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MNTQY<>8\^7''G)S0!]BT5\D_L<W^I_#[Q1\5?@7/K^I^)-+^&]]IG]B:SJK
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MM]J!Q<_V1%';O:K*1'&3P^<,!C/EX  2MK]@K[W[1G_99?$?_MM0!]5T444
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M=76\DM+G5?\ A%I(]+M_M%_))YKRR2 QQ1K-^\/E\8K] Z* /E;]HOPKXO\
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M[PYI'EO?2Z9++YD,MM$8\R&*:3S)!YF3Y<0_=QF60?7=% 'S#\/_ -I#Q_\
M&/XK:)I.C?!3QAX/\!P[IM;\1>.[4:==1$PW/E1V]KO_ 'G[U+<>8&DQD@Q#
MB2N6^.C>,/@W^UYH/QDM/ &O>/?!=YX/D\&7UIX3M_M6IV4HNI+N.;[+P)(S
MQ&#GC]X3_P LQ)]CT4 ?)O[55GK/Q0\+_LX:QHWAG7P1\2?#FO7VGRZ=)]MT
MRV,4TDANHDSY1BW@2$G]V<UT'[<OPI\0_$7X&S:EX,FFC\<>"M0M_%_A](8!
M.9;VS,A\ORO*D\PF.27RXP.9?+!XSGZ2HH ^8/V2?">N:IX@^)OQD\3:1?\
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MQ9:_L3K%K7B']DT_";PA=WJ66K^,].\21>(+JR28#_6D"2X^S>;%#D"3R\]
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ME\$_'7BR?P[9I8:9XD\!V4>KVFHVL<LD<1/E^4+;9%'& )"99!AY!%W^[:*
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ME% 'S'\=/"NMZQ^V/^S/K=GI.H76D:,?$W]I7]K;22V]EYUA''#YL@&(O,/
MR>H_&N=\=6?C3]F[]HKQ=\5-"\!ZO\0?!'CK3K'_ (26WT,QW6KZ=?67^C6I
MMK;,?FQ21RQC;EY/];(3&(PDGU]10!\Z?#']ICQ%\5?&>GZ;IGP1\>>&?#H\
MQM9UOQO;Q:-]A)BD-OY-L9))+KS)8S&=F/+S&><U]%T44 ?"5O\ $S6OV?\
M]L+X_:YJ'PA^)GB[2/%/_"/_ -FWW@_PU)?VY-K8>7+^])C'67'&>5<>F='7
MK[X@_ME_$3X8&R^'.O?#+X;^#/$EKXHU+5/'ED;35+R^M23%;6MEYN?+(E.9
MCD=>\7ER_;E% 'S'\=/"NMZQ^V/^S/K=GI.H76D:,?$W]I7]K;22V]EYUA''
M#YL@&(O,/ R>H_&N7_:;\(?$?X<_'CPO\>/AEX;G\=3:9H5UX?\ $?A*"_C@
MFO-/R]S";;S(9"3YQR1$3*_EQ1QQ\R&OL2B@#X2^-7QQ^*G[3O@G5?AA\+?@
MGXZ\)S^(K-[#4_$GCRRCTBTTZUDECCE(\SS1<[XI) 1&1+&,O&)>WIGBSXJ:
MG^RA<>"O FF?"?Q]X_\  MCX:@L;/Q%X8MQJ5RDUOMB^SW-K&L?E'RA')YV<
M')$<?$FWZAHH ^-_V>?#_B?QI^T_XI^*MA\.=2^$OPZU7PXM@=-U5(["_P!;
MU/[=)-+?W-C'_JY!FYBWRGS")(Y!D2$1X-CJGC/]C'X_?$Q?^%>>-OB/\,/'
M^HR^*].E\&V,>IW6G:G)@WT=Q$$C*"3CRR9/]7&@ D<RF/[FHH \*_9[^+'Q
M ^,6H>(=7\3_  UU#X;^%8S%'X?CUN3&J7H$MT)GN8>#;\1VQ\LCJQ_>R#%>
M=?L7_!_4=2_X)_Z%\-O&VG:IX9FU/3=8TS4;:XMVM;VWBNKNZ!_=RQ_(3%+D
M9'<5]=44 ?$WPO\ COX[_9S^'WA_X<_$?X$^/-:UGPY8Q:7::U\/-'&L:9>V
M-L/*MI?,\W,<I$>?+DP1Q(1'YGEI]%?!7QYX@^(WA>ZU7Q)X#U+X?(]Z_P#9
MFG:Q>13W=Q8^7')#<S1QY^S2GS&!MB28S&?:O3Z* /F3_@G7X9U?P7^QW\/M
M$\0Z7J&AZO:M?BXL=3MI+6XA)O[F0>9'(,C((/3H:3X%^%=;T?\ ;'_:8UN\
MTG4+72-9/AG^S;^ZMI(K>]\FPDCF\J0C$OEG@X/4_C7TY10!\%?!WQKXT_8A
MAU_X2ZY\*OB)\0/"&F:F]_X0U[P7HT>I[M-N)))/LUSY?E;)8Y?,)Z\RG $7
ME&3W'X7R^,OVD/@CXQL_BKX&N_AK%XHAN-,M]*CODGOX],N+&-#)(^WY)O,F
MN?W<D2&/ !CR.?H2B@#XF^%_QW\=_LY_#[P_\.?B/\"?'FM:SX<L8M+M-:^'
MFCC6-,O;&V'E6TOF>;F.4B//ER8(XD(C\SRT]9C^.WQ(N/@IXH\>+\%-6M]8
ML9S-H_A&ZU*+^T-3L<1G[1((XY/LTWEO)_HN))=\1CY-?0%% 'Y^?'_Q=XC_
M &P/"=IX/\$? KQYX7\>6]Y:W>G>./'&D1Z'%X<1+B&66YMKHR22B7,<0,4(
M\PQY(SY>#^@=%% 'P-\>O&WQ ^'_ .WP?$/P_P#"%OX]U#3OA.)[_P /F:2W
MN[RR75)<BUD"2?O?,,<@CY\Q(Y$ ,ACK0^*GB_QE^V]X;L_ACI'PE\9^"?!F
MHZG9MXN\1>-[)-'DMK*.9;@K8QF23SI9##C/ER)&?+\P?O/,C]T_X4_KG_#9
MW_"W//TW_A&?^$#_ .$6^S^9)]K^T_;_ +5YN/+\OR]G'^LSGM7NM 'S%^VQ
MX8UGQ8WP*71])U356T[XJZ'J%Y_9]K)+]FM8S,)9I=@_=QC(S(>!D>M<9^TS
MI>O^!_VI/!?Q3U/X<:M\7?A[:Z#+HL6EZ):?VC?:%JWVLW,>H16<@P#((HHO
M-C(/[ODC]VDGVA10!\"VOB[XH?&[]M;X$^+;OX0>*/!WPST./74T_4M:LC'?
M>9-9212M?1)))]E'F1Q1QB7'F<N"1(!'Z]\=/"NMZQ^V/^S/K=GI.H76D:,?
M$W]I7]K;22V]EYUA''#YL@&(O,/ R>H_&OIRB@#YD_X**>&=7\:?L=_$'1/#
MVEZAKFKW36 M['3+:2ZN)B+^VD/EQQC)P 3TZ"MKXR?M$:_\&?B%I6FO\'_&
M?CCPM>:<;F/7/!=M_:4JWV_:;62UX\L>7^\\TR<Y  /SD?0-% 'QO^SSX?\
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MR1A+BRBL+:$"3$<GF&,GS/,Y_0.B@#YF_:D^'OB[5/$OPT^*/P\TBW\5^,_
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ME7/B75%L?#GC#PC.1H-Q*+;S?LTOVB7S8I2_[N($?OI.(X_W?F/]54 %%%%
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M* "BBB@ HHKY\_85^)OB3XR?LL^"?&'C#4O[8\1:E]N%S>"".'S?+OKB*/\
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MM,<V'/E2"0 21Q]_P->;>.OC!^U+\"M*@\9_$3PQ\.O%GP^TV8-K]M\/C?\
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M&+XQ:WX7U3P-;>/-3LK;3_#FO6PAOHK/3[8V\5S-W1I2TG[H@>7Y0P91()*
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M=YLL49(SC?[<9S\@)&I\1/CMX$_:$_8X^-?B+P'KO_"0Z1:^&M<T][U[6:U
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M/ 7Q(\-:'JVG_"7X?:?JK6?B#4]+-NNNWUR9+%Q:[I?GB\N(2@^7YD9BDCD
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M&@#Y6_;P^(>OZ!XB^$?A*3QQ??"[X>^+-9FM?$7C32$ECNK/RO+DM[5+H?\
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M/V.?C7H@\:>,/&R3>'=<O/[0\9ZG]OO(O^)>8_*23RQ^Z_=Y _Z:2'OQF_\
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M>?LT^*I_%_PW^,]E<:5/I6HRV,NE>)O#]S.TG[MHX[ZVDACE\H212DQRYCE
M.>,@GL?V#[/Q=9?!S6;3Q+H^N>'=$@\0WT7A#0_$<12^L?#X\K[+;R"3][^[
M/FQCS23@#!,?EF@#Z=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /FSX2_#7QAJ'[3GQ2^*OCS0;?3%=(?"?@^
M/[;'-+'I,4DLDTQ\H>7MN93%*!+^]C.^/@ >9])T44 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ1::>FFW*1?:8[62VEMXQY?^M\T@@DX')/F>7$ ?6=>;?\+$UW_A?'_"!?\
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MT#Q%XQU6'PKH.M_#"71[+6M6;[-8RWD6I_:9(3<L!&"(QDY(YDC[R1Y^L/\
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MQ+%/')_K(W0\$$>OK1H^AV'AS2[33=.L[>QTVSBCMK>UMHQ%%!''_JXT0<
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MDZOY8) ST[>A-2\)Z'J_B#2M<O\ 2=/NM;T<R_V=?W5K&]S9^:/+D\J3JGF
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M9\,:'X-T2VT;0=)T_0M'MS_H]AI=K';6R\[R8XXP .>>/>M^@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXBZ'8Z)\0_ ]];Q:G)H<I?3+V*Z$DMK-;&0F4?NX^4DZ9!XR8XP#Z+HKXO\
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MXL? OX:_M!>,'>76+K3?B7X3@BM?^$@\':U]AU_18[C]YL<QGY1+&)<"6/\
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M]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M 'RG_ ,,>Z)_PBW_"2?\
M#4'QL_X1K[)]O_MG_A8"?9?LOE>9Y_F^3Y?E>7^\\S.,<YKB?VKOAKX8^#__
M  2S\1^%/!>K3Z]X6M([&ZT[4[JXBN?M,5QK,-SO\V,".49E."!@C![U[#_P
M[M_9V_X2S^WO^%8:?]O^V_;_ "_MEU]E\SS=^W[-YOD^7_TR\OR\<8Q7.?\
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M^%47Q5U_X8>%_ %GIMT^D>%KJ.WU36Y;FWEEDN8KG_60QQ?:;:)X\2QG$?\
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MC% %?P_^SG\#8_@)X#^"FK:CI_B[P;>^;J'AR'5M6B^VZG^\DN7FMI;?RBX
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M!X.<=^?J/X>>#K'X<^ _#?A'399IK+0-,M=,MGN3^\>**(11E^/1*\+\-_\
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M2V\P[/*FD\PQ12"4^4?WG$@*9S7IM?.W_#!/P!_X3G_A+O\ A4GA_P#M;?\
M\>^V3^S\>5Y6?L'_ !Z]/^F77]Y]_F@#P;]F(_\ "ZOV8?VMQX-_XG/_  F'
MC+Q=_8V!Y N_M5C%]F_UN/+\SS(_]9C&><51_91_9K\/_&G]G_P;KV@_M#_&
M*)4TVVL[[3=$\9^3:Z=>QQ1>;;1PB(F(1Y'EQG_EGY9]Z^V_A[\+_#GPQ_X2
M)/#FGMI_]OZM<Z]J(\^27[1?7!'FR_.>_ECCIQTKR_XD_L-? OXM>)I_$7B3
MX>:?-K<YW7%UI]S<6/GR%S(99!;21B20ES^];+G/4CB@"O\ LR_ OP5\*=<^
M(&K>%/B%K_Q(UO6+ZWT[7]3\1:W#J=Q;75B)$\F62.,%)8UF(\N3GB/I7RSH
MOQ8U_P" O[/OQ:_9Y\.6UUI?CWPWXHA\'>"9II<2WMOK=Q+)8R_:8I5$=UY/
MVJ;S#Y4<9\GJ<QU]]?#7X4^$_A'X;@\/^"O#NG^&-%BP?LUA'Y?F2;%0RRD<
MRRD11#S),N<<FLW6/@/X%U[XR:)\3]0T7[1X\T6R^PV.K&\F!@B(E'EB(2>7
M_P O$O)CS^\Z]* /!/VO?@;!X-_X)W^*_A]X)TP/IN@Z/:LB$Q12-#:W4-S<
MW,I'EQM)Y<4TLF!^\D)XSP:_@?\ 9+T/XF>$=-\3>&?VGOCIK&B:A%YD%Y;>
M-L[S_P!^<C_<ZU]G5\P^)/\ @G'^SGXLUJXU:]^&%A'<3XW1:5=W5C;X _@B
MMY8XTS]* .67X0^#?A7^P[\<&\#>,=0^(6D>)-&\0ZY)X@O]4BU*2\N)+&2*
M5OM,48$G,7)Y/F&3)[5S/QL\*ZAXP_X)&Z99:5;_ &FZB\ ^'M0D0N$ @MH[
M2YF?_OW%)^5?6<WPJ\'Q_#B_\!6V@:?I_@^^L;FQDT;34^Q6OE7/F>;'&(L&
M/S/-D_U?/)K:\+^%-.\$>%='\.Z/;FUT?2;.*QL[?S"^R&*,1QQY?_9 'X4
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M -S5>Y^*OA=X>\4^.?"'C'4]-^U^(?"PNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\
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MCR\G&?0 ]AHKAO%7Q1\/>%O'/A#P=J>I?9/$/BD7?]D6?V263[5]EB\VX_>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1$!S&9#OS%(!F_L\_P#)]7[7'_<H_P#IKEKQ3X!_#7XO^(OB-\?['P?\:_\
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M1O'NG?$7P=XWUGX;?$O2]..CV^N6,<=[:W-D9?,\NYLI1Y<R@F0H,QXD</\
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M646ZZMXHP]];7.8XQ:R1YQ',9)(X^OE_O5DW^6?,K@-%^"_[17B'2;;4=/\
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M !EX?\9>/OA5JNOF)]5C\ ZU_9D&I2Q^9_I$L8C/[S,IR>AZ_P"LDD)^HJ*
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M^D:* /G7XR?L7>!OC!XYM?'*S:[X+\?V[*I\4^#=4_L_4'B$4L01V"F,GRY
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 45Q/CSXM^#/AC)8#QCXRT'PE]N$GV7^W-1BL1
M<>7CS/+,I&<>9'T]17;4 %%8^L:Y8>'-+N]2U&\M['3;.*2YN+JYD$44$<?^
MLD=SP !Z^E0>&?$^A^,M$MM9T'5M/UW1[@_Z/?Z7=1W-LW.PB.2,D'GCCWH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ /7_@+\:=(_:"^%NC^/?#UG?V>C:MYOV6'4TCCN/W4LD1\SRY) .8CW_P
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MKB@!V@_\%$O ES/X8DU_P7\0? /ACQ&\4=EXN\6:$EEHP::/S8P;KS3_ *P
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M?(VO?\%$O EM/XGDT#P7\0?'WACPX\L=[XN\)Z$E[HQ:&/S9 +KS1_JP1\_
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M_A)/@'_PMK_A6/\ PC?_  MCP]Y'_"%_VE]K^U>9+MW_ &GY/*V>;GOG9VH
M^LOV@/VAO"_[/.DZ9>Z^=0O=4UB_BL-(T'1;?[5J>K3$@>3;Q9&<;QG. ,@
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M/!KWW_@H-I-EK>E_ 73;^S@O],OOBWH5I<VMRGF17$4HN1)&\9X((]: *O\
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M^*WPO\-_&#P#JG@_Q?IIU;P[J/D_:;/[3)#YOERQRQCS(R)!^\CCZ'MWKMJ
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MY?$9\R/R]TF,^80?H3X\?!7_ (74WP\QK1T8^$O&6F^+,?9OM'VK[+YN+?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]ZWZ^5?^"7?_)B_PS^NJ?\
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MXH\!_LK_ !)UWPA'=-KEOIP2.>S\WSK:)Y(HY[F/RSO0Q122R^8#^[\K?T%
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ML% 'N5%%?*?_ #E,_P"Z-_\ N:H ^K**\H_:O_Y-9^,O_8F:S_Z0RT?LH?\
M)K/P:_[$S1O_ $ABH ]7HKYZ^)/[<OP+^$OB:?P[XD^(FGPZW =MQ:Z?;7%]
MY$@<QF*0VT<@CD!0_NFPXQT YKUSP-XYT'XF>$]-\3>&=6M]8T74(O,M[VW)
MP_K[CG^ B@#J:*^9]:_;]^ ?AOPWX;UO4OB';0Z9KT,MWIC+IU])+-%%++"\
MAB$/F1_O8Y4S(!YGEOC/-=]X1_:/^'7C_P"%.K?$K0?$\&J^#-*CN)K[4HXI
M@;=;>/S)1)%L\T,(B)/+\O/MR* /6J*_/SP#_P %._AG_P +R^+ \4_$MO\
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MN6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_K)'<\  >OI0!L45X!\*?VV/@O\
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M!/B5XNTOPUX>^(D-[K&I2?9[2&XTF^MA+)_<\R6%$SR,#- 'TC17AO[2FD^
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MBJ\^W321F6VMO-\R.+RXS^\/F<9P.#DT >Z5\'_&+X1#XO?\%&K71&\8^+_
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MD7G6PF&J31>9)&<I(/+ED&'XZ=P#7VQ7A7_"G]<_X;._X6YY^F_\(S_P@?\
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M2DV]E++$3)YL.?*E$8CXH \S_9L_Y0XZM_V)7BS_ -&ZA7U3^RA_R:S\&O\
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M?B;Q9JDE[?26I\H^2>$C('V:/DQF08QG'%>^T4 %%%% !1110 4444 %%%%
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M/V??A;H_@+P]>7]YHVD^;]EFU-XY+C][+)*?,\N.,'F4]O\ $^ET44 %%%%
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M(W_:]A_PDWV/[?\ V1]J3[7]F\SRO/\ *_UGE;_W?F8QGCK0!T5%%% '._\
M"*Z+_P )/_PDG]D6'_"3?8_L']K_ &5/M?V;S/-\CS?]9Y6_]YY><9YZUT5%
M% !16/K&N6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_K)'<\  >OI1H^N6'B/2
M[34M.O+>^TV\BCN;>ZMI!+%/')_JY$<<$$>GK0!L4444 %%%% !1110 4444
M %%<#X.^-'P[^(>IMIOA#QUX9\3ZE'']H:ST75[:[D2/O(8XY"0/GZ^]=]0
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M#]GCPE9^"[;XGZ=>ZIK&K/X)NKN&RAU.XLK.,PF2YER (O-E<QG]W+]QP>*
M/4/ ?_!0+X"?$KQ=I?AKP]\1(;W6-2D^SVD-QI-];"63^YYDL*)GD8&:];^*
MWQ0\-_!_P#JGC#Q?J1TGP[IWD_:;S[-)-Y7F2QQ1GRXP9#^\DCZ#OVKX[_:(
MU'XY_M$?"O6?!7B/]DB'9?Q-]AU";QWILYT^^\LB&Y0  @QY[$;^8SQ(16Q^
MVEIFNZ'_ ,$O-1TSQ7+<R>)[70?#\.JS75Q]HG:]2ZL1-YDF3YA,F<R9.>M
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MGRH8Y), 8R^,#S(\D>8*^H_V4/\ DUGX-?\ 8F:-_P"D,5?/W[#?PT\*W7Q
M^/\ XZN] T^\\6V?Q5UZQM=:NH!)=6L2'_5Q<?N_^/J7/E\OYF#T& #WSX+_
M +1GP[_:&L=5OO /B>#Q#;V,ZPWL8AFMI8F8$H3'+&D@! XDQ@E)!GY.-'XO
M?'KX?_!#0TU7QSXJL?#<,JG[.EQF2XN<; WE11YDEQO3/E@XS7AUGH]CI_\
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M<)''&#(Y[X09XSVKWGX-?M9?"O\ : U34],^'_BZ+7]0TV#[5/ ;2YMIO*)
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MN;CC H ]B\#>.=!^)GA/3?$WAG5K?6-%U"+S+>]MR</Z^XY_@(KR/XD_MR_
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#.N_M#?L\>*OA_H$]A::OK'V;R)]2DDCME\JZBF/F&..0_\ ++'3N.E>XT4
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M#?P/\<>#)?AWJDES<Z/I_BY+W[3X9:627$5K@2^8 #$?WN0903Y?,GF_<M%
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M&9;:V\WS(XO+C/[P^9QG X.37;?&SP7=_$3X.>/?"NG-#%J.O>'[_2K:6?\
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M$-G4$$G)'I7NM% 'A7_"G]<_X;._X6YY^F_\(S_P@?\ PBWV?S)/M?VG[?\
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M^C^$_!GCOP'XN\.V^CV44=KX\6]\W3+J./\ TB*VFMHXY);;S"/+\WE(_+C
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!+%/')_JY$<<$$>GK0!L45YI_P -!?"__A*?^$;_ .%D^$?^$C^W?V=_9/\
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MXY,]!^E;WC;XA>%/ASI<.I>*O$FD^&;&27[-%=ZU?16L+RD']WYDA'/R'\J
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MKX6_F9\OS#$3C/ER=?0UK^)O$^A^#=$N=9U[5M/T+1[<_P"D7^J74=M;+SL
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M_P /^/\ 16BTCQQX\\07J6GVD8O=*O(XHA(#%)F+S )!CB0>U<+\,[']IO\
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MX@_8^\!^(M0\!>&[_7;R'4[2XU:XTBVDN[B.2^N;=XY)?+\P@Q9B/./+..G
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MA=6UQ%Y5];2"+D++&1^\$9D_=83R]_F  ^1?C5?_  U\>_#G4K7P;^R5\5_
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M7P!^(_AO1K?[5J^K^&]2T^QM=P3S99;66.-,OTR2*\4\>?LPZS\3/V)OA_X
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MSE?,P#(:?\(?#.E_L_\ [;WC+X:>$K4:;X*\4>#X_&\^BJSFVL]0%^;1Q:1
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX_X0G/\ PF?_  LSQ?\ V)_JO^/_ ,J'[-_K?W?^M\O_ %G'KQ7F7[(/PK^
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M=+N@"_\ \$Z_$VK^-/V._A]K?B'5-0US5[IK\W%]J=S)=7$Q%_<QCS))#DX
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MM;U.]B%U%-<K$(R\<0CP(_-^22&)QQ+**]9^#?[*/A3X ?$&75/A_?ZUX?\
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M#_Q9=ZB_PA^'VDV,-]X6LM7EMHM;U.]B%U%-<K$(R\<0CP(_-^22&)QQ+**
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MQC)H ]!HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\0Z5\<_#EOX;OV:SDNK+2-02:VLC<W<D<>;:V%C-<>6V9/WOF$Q^6F*^N_\
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MR'@9'K7T[10!\P?M8?"GQOK_ (@^&/Q+^&MDVL^.?A_JTDPTB>_BM(M2TZZ
MBO81)+$8PYC2,"0D8C,IYD$5<)X@_;*^*WCGP;_8OPZ_9T^)FC?$75;%X8[C
MQ)IT6G:9I4QMY291=7 \N7RY<;$ECB$N.Q(C/VU10!\0^,/V,_$^A_L1> _
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MGX0_!32_A9X/_9@\6:9\4;*R^Q22RZ1#;>'+W4X8Q%)?2ZCYD:2^9'")2?\
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M_'+2K]]1^&GC/X=7VFQVPN;?Q;IIM8Y9)/,WBUE_Y;>7Y9R3'']^/@;N./\
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M/?&'C;PW(=#TO6/#UA')H.IPC L3]O\ W26T0C\N-Y/+/EB/S)?WA>,?=]%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD_B%,T7@3Q'-!XCA\(2Q:=<-'X@NDCDATLB//VF1)2(R(^),2<8!SQFORO\
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MUDE^S6L9F$LTNP?NXQD9D/ R/6OIV@#X^_X)R_VU_P (S\</^$A_L[_A)?\
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M5X.MK:0_VUXT2/3[J2]WQC[-'89,AB\N3S!<DXS')'C(S7S+_P +(\>?"/\
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M(_>"3/[VOT(_;$^'/BKXP?LY^/?"?@BXDB\3:E9+%;[;G[+]HC$L3RVWF_\
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MQ@'Q#\2OBK^S)\"X[#XB_LO^-I_#_P 2=$D7S=$-MJ]S8>(;.26(36MU]J
M '[P8D'^K/\ RT\J2+[*_;@U#7_'/B?X0? K1=1N/#]C\2-3OEUW5;:Y$4O]
MDV40DNK6/]U)S+'(<=OW?ER9CEDQM>%OVLO$?Q,\3:+HOAOX _$ZSDFOHAJ>
MI>,=-BT*UL;$R".6XCEEED\Z6+>#]G&#(/,]*D_:P^%/C?7_ !!\,?B7\-;)
MM9\<_#_5I)AI$]_%:1:EIUT!%>PB26(QAS&D8$A(Q&93S((J /,?CY^PC\-/
MA+\"?B+XH^%%IJ'PX\2V?AS47NKJUU&XOHM1L?L\GVFPN8KF22,Q2Q]Q@QR"
M*4?ZO!^EOV4/^36?@U_V)FC?^D,5?.?QN^/OQ0^/'P=\=^&/AW\!/&NF0WGA
M^]M]1U7QY9?V8889+:4^7:VL9DEO9I(Q+$BQG]W+)$9!@U](?LTZ5>Z+^SK\
M+M+U&SGTZ_T_PMI=I=VMU'Y<L$T=K$LD<D?8Y!&* /-/VZO@7X%^+'P'\7^(
M_%.A_P!J:QX,\-:Q?Z'=&[FC^SR_9/,\S$<@$G,,7$F1QTYK*_8;_9C^&GPW
M^&'@'XD>&?#?]G>,M?\ !MB=3OEOKB07/VF&WFE!CDD,8S)&#P!C'O7NOQL\
M%W?Q$^#GCWPKIS0Q:CKWA^_TJVEG_P!7')-;211[_;,@S7B?[&?Q5\0W/A70
M/A;XH^%?C/P)KWA#0DL;O5-4T[_B37#6;1VV+6]SB4R#$@&,8\S#R !R >"_
M C]D[P]^T9XT^.%U\0-;U;5?!>D_%KQ"UMX+M;@VMC-?' EN;F2/][*1'+$(
MP)(_+,<G42R"O3/@C\.=-_9U_;@\0_"GP)-J.G?#O5_ L?BX^';FY-S:VNIK
M?):"2(RYD&8H\GYSD^T<8C[O]B?PQK/A-OCJNL:3JFE-J/Q5US4+/^T+62+[
M3:R&$131;Q^\C.#B0<'!]*3_ (177/\ AXQ_PDG]BZE_PC__  JG^S_[8^SR
M?9/M7]L>9Y/G;?+\WR_WGE]<4 4OV>?^3ZOVN/\ N4?_ $URU\YZIX'^%'B;
M]HWXE1_M8PZK8^(M2\07-IX)U+Q/>W-AH3Z#$#+#':7-L\4((CE'FB63_62Q
M=99)@?IOX%^%=;T?]L?]IC6[S2=0M=(UD^&?[-O[JVDBM[WR;"2.;RI",2^6
M>#@]3^-<3J_[5&M^.?#MYX0\7_LI?$34M<NI7LYM N]%BO\ P[+=I,!$)-0E
MQ"83)'&_VCRS&F?,^<#) /K#PCX<7PGX8T;0QJ-_JS:;9Q6W]H:E*9KJX\N,
M)YLLF/WDAQDGN3FN6^,_P(\#?M!^&;3PYX^T,^(]'M+U+^.S%W-;?O?+DC$I
M,4D9SB63OWZ5RW['?PY\5?!_]G/P%X3\;W$DOB;3;)HKC=<_:OL\9EE>*V\W
M_IE$8HN#Y8\H",D8->Z4 ?G_ /\ !,/]F/X9M\#/AK\8SX:'_"Q\:D!K?V^Y
M!_X^KJV'[GS?*_U/[O\ U?O[U2_X9WL/VC_VU/VC=$\3^(M6L_!5O/X6NM4\
M-Z;)]F&MS+9;X8KJ4?O/)C\N8^7&03YL<F\>3'78_L1^(?%GP5TC0/V?/%GP
MS\76&K:#>WT">-M/L//\-W$+F6^67[5P$\PR^4(R.NS/ER$QQ^@? OPKK>C_
M +8_[3&MWFDZA:Z1K)\,_P!FW]U;216][Y-A)'-Y4A&)?+/!P>I_&@#RZ+X*
M^'?V2OVT?@MI7PK.I>&_#GCZPURSU_05OI+FUN?L-K]IMI?WOF2"0/+U!Z#
M_P!9+YA\9OA5_P +F_X*(6WABXU[4-(\/W'PKCDUZTT]Q'-J]A_:\OF6!D_U
MD44DGE>88SDQI)%QYN1ZC\=/"NMZQ^V/^S/K=GI.H76D:,?$W]I7]K;22V]E
MYUA''#YL@&(O,/ R>H_&F_\ "*ZY_P /&/\ A)/[%U+_ (1__A5/]G_VQ]GD
M^R?:O[8\SR?.V^7YOE_O/+ZXH R?C!H_AK]@;]C[XDZE\)]!&@I$1=6\2WDU
MR(K^Y>&R6YS<&7/E_NI/+Z'RL'J36=X5_P"";7PKUSPWI%_\5]'OOB!\19;.
M-=<\2ZEXDU*2:\N1& _SB6+]VF/+CS'GRXX\Y.:]E_:A^#C?'WX$>,O 45PM
MI<ZM9#[)-NV1BZBD26U\S]W(?*,T47F8&?+S^'@OA_\ ;*^*W@;P;_8OQ%_9
MT^)FL_$72K%(9+CPWIT6HZ9JLPMXB)3=6X\N+S)<[TBCE$6>Y!C !TG['-_J
M?P^\4?%7X%SZ_J?B32_AO?:9_8FLZJP-P-.OK7S8;&10,_Z/Y9'F9_Y: ".*
M.,1U<_X)=_\ )B_PS^NJ?^G2[JW^R?\ "GQOH'B#XG?$OXE63:-XY^(&K1S'
M2(+^*[BTW3K4&*RA,D40C+B-Y 9 3F,1'B0RUXI\$?B5\3?V)?A_JGPCU[X(
M^-/'D'A^6]D\)ZYX0T\W-MJUM+<W$D9NO+DE^RDR<X_>2".49C_=YE /7_V>
M?^3ZOVN/^Y1_]-<M>(_!_P#9M^&?[67P0U[XF_'*6_N?'4MYK,>NW=YKES:G
MP<8KJ8BRBBDDV6L=O&?-$5R)/+\PDYC(%>F?LJKXY\-_'/\ :0\<?%OPY9^
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M1])U356T[XJZ'J%Y_9]K)+]FM8S,)9I=@_=QC(S(>!D>M 'DW[;'QL\)Z?\
M'[PA\+_B5XXU7X?_  O;0)M?US^R3<D^)#-+);1Z9+]GC,L<7EQW!DYQ('(Q
M'((Y!\W?$KXJ_LR? N.P^(O[+_C:?P_\2=$D7S=$-MJ]S8>(;.26(36MU]J
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MO[;'AC6?%C? I='TG5-5;3OBKH>H7G]GVLDOV:UC,PEFEV#]W&,C,AX&1ZT
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M ?$/Q*^*O[,GP+CL/B+^R_XVG\/_ !)T21?-T0VVKW-AXALY)8A-:W7VH
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M'] T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_F2?:_M/V_[5YN/+\OR]G'^LSGM7NM%% !1110 4444 %%%% !1110 4444
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M*_-#XG3>'?@SX7F\=?"K]LG4O%7B[PZQU&/PSXS^(%OK.G:O!&A\RU^SQ_\
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M.09),@'V!7SQ^R)\3/$OQ(;XS?\ "2:B;\>'OB1K'A_35\B-/L]E;>3Y4?R
M9(\P\GFO//V'_B)J>J^.OC'\.(_B2?BQX3\'7UA-H'BNXN%O;JY@OHI99(9K
MI)#]H\DQF,2=<B3H/+CC\K_9_P#@MXY^-'C+XVPVGQ.U;X??#[3?BSXAGN+7
MPBSVVL:E>'Y?WET<B.*,>01'Y;^87E\P<1$ 'Z/5YM_PD'Q _P"%\_V/_8^F
M_P#"K?\ A&OM/]N^:/M?]L?:L?9L>;GR_LW[S_5=?^6G:OG?P/'X\_9=_:>\
M(_#+4O'&L?$KX?\ Q)AO;C3;SQ3J$ESK&BWMC;":8><1^]AD'E@1\?>[>7(;
MCL_^$JUS_AXQ_P (W_;6I?\ "/\ _"J?[0_L?[1)]D^U?VQY?G>3N\OS?+_=
M^9UQ0!L?!GXG>)/%7[4G[0/@_4]2^T^'O"@\/C2;/R8T^RBYL9);C]X%#RYD
M&?WA..U=W\(]:^(&L/XS_P"$]T;3]"6U\27UKX?%C(K"]T<&/[)=28EDQ))^
M\S_J^G^K%>/_ +//_)]7[7'_ '*/_IKEJ]^Q/XGUGQ8WQU;6-6U356T[XJZY
MI]G_ &A=22_9K6,PF*&+>?W<8R<1C@9/K0!].T5^??[1GP3TW]GWP%_PD-]\
M<OVB->U*[OX='T30]*\8F6YU3490?*M8B+<]3&23C^$X$DF(SV7Q&\6^//V0
M?V.?"FA:IXZM]7^*&L:I:^'4\:>(9GEL+.]O99))+FXFF)D\FWA\S$D@/^JC
M)B"9B !]I45^<OB#PUX970;S6= _;QO_ /A8D8%[:2:EX[LAH4MZ#YK"6P3B
M.VE.0(AO$8/27&P]MKW[97C#Q-^P_P"!_B#X:T:*T^)WC[4X/"FB6D+1/:QZ
ME)<S0%_WS@("+:22/S/,\N22,.702&@#[DKY\_85^)OB3XR?LL^"?&'C#4O[
M8\1:E]N%S>"".'S?+OKB*/\ =Q 1@^7&@X':N%T?]CSQM\/-/T_5_"_Q_P#B
M+K7CS3XTEA@\7:O+>^';^ZVCS8[FR \P0R9?I(9(O,#@N8ZT_P#@EW_R8O\
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M[-(3@2F0R5])^%_"FG>"/"NC^'='MS:Z/I-G%8V=OYA?9#%&(XX\O_L@#\*
M/-/V2OBB?CE^SCX"\:7;SW%]J&G"*_N+F*.'[1>Q,;>YE\N/Y ))HY2!Z$8
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MZ7= 'U51110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC^U%XV\?_&7X<P>,OAKXVT_3KE?%M]X=35;7PU>VL7V4V\L?ER21+<#[-B3
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M/BSIOB#X9WEO?2QZ=?:AI\UW8:U"LN8Y;6XMDD\S]R;:22,@>69A&<[37,?
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M=% 'BG[//[5GP[_:BTN\N? NIW5]<:;';RZEI]W9R6\MD;@2>7')D>5(<1R
M^7(X^3KTS[7110 5\)2_&KP[^R5^VC\:=5^*@U+PWX<\?6.AWF@:\UC)<VMS
M]AM?LUS%^Z\R02!Y>A'09/\ K(O,^[:* /E3]H;_ )/J_9'_ .YN_P#37%76
M_MM:+XQ\1?LJ_$?3? =E=:EXCO-*^SQ6L$4;RW%O)+&+J*.-^K&V\X8 \S_G
MG^\Q7OU% 'Y0_$#XK_LG:A^S-XCTCX,_">U\5^*_[ N9?L@\+2R7^@021?O;
MVZOI89#BV\WF02R8D\K!$?[R/ZR_YQ9_]T;_ /<+7U910!Y1^RA_R:S\&O\
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MVBV"ZB)"=3M8?*\J_CWQ1_NY=[8QY@Z_O#7IE !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:?&?X\>!OV?/#-IXC\?:X?#FCW=ZEA'>"TFN?WOER2"(B*.0YQ%)V[=:]+H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M  K7Q%_T53Q9_P" VC__ "!1RQ_F#G_N'?9_V:,_[-<#_P *U\1?]%4\6?\
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M]%4\6?\ @-H__P @4<L?Y@Y_[AWV?]FC/^S7 _\ "M?$7_15/%G_ (#:/_\
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MY@Y_[AWV?]FC/^S7 _\ "M?$7_15/%G_ (#:/_\ (%'_  K7Q%_T53Q9_P"
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M_P" VC__ "!1RQ_F#G_N'?9_V:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\
M"M?$7_15/%G_ (#:/_\ (%'+'^8.?^X=]G_9HS_LUP/_  K7Q%_T53Q9_P"
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M_P" VC__ "!1_P *U\1?]%4\6?\ @-H__P @4<L?Y@Y_[AWV?]FC/^S7 _\
M"M?$7_15/%G_ (#:/_\ (%'_  K7Q%_T53Q9_P" VC__ "!1RQ_F#G_N'?9_
MV:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\ "M?$7_15/%G_ (#:/_\ (%'+
M'^8.?^X=]G_9HS_LUP/_  K7Q%_T53Q9_P" VC__ "!1_P *U\1?]%4\6?\
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M'?9_V:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\ "M?$7_15/%G_ (#:/_\
M(%'+'^8.?^X=]G_9HS_LUP/_  K7Q%_T53Q9_P" VC__ "!1_P *U\1?]%4\
M6?\ @-H__P @4<L?Y@Y_[AWV?]FC/^S7 _\ "M?$7_15/%G_ (#:/_\ (%'_
M  K7Q%_T53Q9_P" VC__ "!1RQ_F#G_N'?9_V:,_[-<#_P *U\1?]%4\6?\
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M]%4\6?\ @-H__P @4<L?Y@Y_[AWV?]FC/^S7 _\ "M?$7_15/%G_ (#:/_\
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MY@Y_[AWV?]FC/^S7 _\ "M?$7_15/%G_ (#:/_\ (%'_  K7Q%_T53Q9_P"
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M_P" VC__ "!1RQ_F#G_N'?9_V:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\
M"M?$7_15/%G_ (#:/_\ (%'+'^8.?^X=]G_9HS_LUP/_  K7Q%_T53Q9_P"
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M_P" VC__ "!1_P *U\1?]%4\6?\ @-H__P @4<L?Y@Y_[AWV?]FC/^S7 _\
M"M?$7_15/%G_ (#:/_\ (%'_  K7Q%_T53Q9_P" VC__ "!1RQ_F#G_N'?9_
MV:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\ "M?$7_15/%G_ (#:/_\ (%'+
M'^8.?^X=]G_9HS_LUP/_  K7Q%_T53Q9_P" VC__ "!1_P *U\1?]%4\6?\
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M'?9_V:,_[-<#_P *U\1?]%4\6?\ @-H__P @4?\ "M?$7_15/%G_ (#:/_\
M(%'+'^8.?^X=]S_=_6EY_N_K7 ?\*U\1_P#15/%G_@-H_P#\@5<\.^$=7T&\
MFN+SQIKGB*,Q;!:ZG%81QI_MC[/:Q/G\?PJ.3^^+G?\ (=O1112-@HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
%** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_2a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_2a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
M;E^#&H>.M+TSQ/HMOYUWI,<L=[_I/E?Z*/WA'YC]:^ UZUYV4XE5<-32W1ZO
M$6"J8;'5&]F?86@_\$^AKFDV6HQ?$/$-Q!'<(?['/_+09S_Q\U?E_P""<LJ@
M,?B&K ]_[%/_ ,DUY3\*_P!K[QE\.='AT66/3[_2XO*$326H,L40C$?2.6,=
MA4?QD_:T\4_%;1Y-$\JRT_1Y)(Y)#':XFDV'./\ 6R^@KS'2S;VK7M#W5B>'
M?JRJ.E>IV/6V_P""<\H^7_A8:8]]%(_]N:L^(/V<G^ /P6\9J^O+X@.I0'[M
MF;81>7;7..LDG_/0U\=:?<:CK&I6EA9/YMY<RQ111_NO];7Z(_#7X*O#^S7+
MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** &_PU\J?M?_\ (6\/_2Y_]I5]5]J^5/VO_P#D+>'_ *7/_M*OB.,O
M^1/5/L>$?^1O2.S_ &7M)M+KX<&2>,2O]KEZ^N:]?_X1ZP4L?('3^\:\J_94
MY^&1'_3W+_.O:&S\P]J[\AHTGE6&NOL'GYY6J?VEB->IY/\ M :)9VGPGUR2
M.+]YY<?\?_36.O&/V2?^2F7?_8*D_P#1L5>[?M$?\DA\0?[D?_HV.O"?V1N?
MB9=_]@F3_P!&Q5\=G%*-'B;!<J/J,KJ.7#>+N^O^1[G^TH/^+,:[_OVO_I3'
M7S)^SSI]OJWQ2TNVO(O.BDCE_P#15?3G[2O_ "1G7?\ ?M?_ $IBKY)^%/C.
MW\ ^-+77+B.26&UCDS%%_P!<J\[BJ<*>?8:I6^#W/_2]3U>%Z=6ID.*IT=_?
M_P#2$?;/_"N/#O\ T"__ "))_C1_PK7P[_T"_P#R*_\ C7D7_#7&C_\ 0,O_
M /OQ'_\ ':/^&N-'_P"@9?\ _?B/_P".U]?_ &WD%_L?A_D?(_V/Q!;_ )>?
MB?0>T0PU\1?M)_\ )8-<_P!RW_\ 1<=?4_PY^)%M\1=->\MX)8HFY E3!ZN/
M_9*^6?VDS_Q>#7/]RW_]%QUXW&.(IXK)Z=6EMSK]3U>#Z%7#9O5I5=_9O]#W
M+P'\!? VL>"="O;O2//N[G3[:6:3[7<#?)Y0Y_UE=KHOP;\)^'I/,T_2C%)[
M7$O_ ,75GX5X/PW\)^7C=_9-KG/_ %R2NNY'3:&K[# Y;@OJ].?LH?<?(8O,
ML:ZE2#K3MZL=# L,02, 8I].HKZ-)+1'D^IY#^TQ_P DBUC_ 'H?_2B*O"/V
M7_\ DIEA]9/_ $5+7N_[3'_)(M8_WH?_ $HBKPC]E_\ Y*98?63_ -%RU^0<
M0?\ )3X;_MS_ -+/U7(_^2;Q?_;_ .2/M#CI7R#^U+XQDU+QC_8$<O\ HME'
M'-)^[SB7]YD?]^Y*^IO%.N0^&=!U#49CA+:WDFS[(F3_ "KX)T^UU+XC>,HK
M;]W+J%]Q_P \O]7%_P#:J]3C7&3]A3P%+XZC/.X-P2=6ICZW\.D:'@'XGZK\
M-9)9-*@LY99?^6MU%+)_G_5UU>N?M+^*]>TB]TZYMM)^RW<<EK)BUE_Y:#'_
M #U]Z^@U_9O\ 101H=$<@?\ 3[<?_'*1?V;/A\>FBL?^WVX_^.5X^'X:SW#T
M_8TL2E3[?U$]*MQ)D.)J^VJX5NI\O\SXOT_4I--U*UU.W_=36TOVJ*OT"\%^
M)+7Q=X>M=5LR_P!FN-Y3S$P?OX_I7RU^T7\*M*\ _P!EWNCV_P!FT^Y>2.6/
M<7ZF/L?^VE=O^R?XZBDTF7PO*?\ 2K>26XB&S'[K]U_\=K'AEU<BS6IEF)^V
M:\2>RSG+:6:89'*_M=?\CQ9?]>47_HR6MO\ 9Q^'6B>,/ ]_/J5H+J3[;)&9
M-\D?_+*/WK&_:Z'_ !7%C_UY1?\ HR6O0/V0S_Q;[45[_P!HR?\ HN*GAZ-*
MMQ55IU5=$XJK5H\+49TG;4^?_BMX+E^'WCN^BMX_*M3<^999D\SG_6GC_MK7
MU#\ ?'EKXQ\&VMJ7!U+3K>*.Y79C'4(?_'#6=^TG\.6\7^$XM0M,+>:5YEQN
M,F,Q^7^\'_D..OG3X/\ CZ3X<>,/-E_X]KGR[6X/E^9B/S,?UK.*_P!5<]U_
M@5#?_DILD7_/VD?=8P8W;U7^E?GUX#M8[KXC:%;7'[V*34HXY/\ O[7Z"1\V
MY_W<_I7YX^'=4BT#Q=IFJRQ^;#9WL=S+_P!LY:]/C9TO:X)U-KO_ -M/.X+4
MO8XY4M[?_)GW5_PK?P[_ - S/OYDG^-'_"M?#O\ T"__ "*_^->1#]KC1P!_
MQ++_ /[\1_\ QVC_ (:YT?\ Z!E__P!^(_\ X[7O+.L@M]C\#P?['X@_Z>?B
M>]:3I=KI-H+:SB\F%.D8J[QCIFO,?AI\9;7XD7$\5I;W$)C3S/WT8':,_P!\
M_P#/05Y3\7OVBM1L=<FTOPT3;/;2F&2:>WSB1/,R/T%>K6SO+\%@UB5_#\CS
M,/DF-Q6*^K?\O#Z#\3>$=*\7V#VNJ6_G0,-A!=T_E7S!\?\ X*Z5\/\ 3;76
M-%+QP7%SY<L<CEPG[KW]HW_.O0-"_:QT.6QB_M:"[BN\?O-EN/+'_CYKS+XX
M?'"W^)=K:Z=ID;Q:;;W/FGS(L22?NNP_[^_E7Q7$.89)C\%4J1LZG3N?69!E
M^=X''TZ;35/KV-']E/Q-<6GC>31<?Z#/;R3#]WC][^Z'\HS7U^&^4FOE_P#9
M/\ RQW$GBNX_U<L<EM'^\SQ^Z_J)*^H,=J^GX1IU:>54_:GA\55*57,ZCH[#
MZ***^U/D0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E%%% 'F%_X+EM_C
M!HVN6UL[6LD<IN90>(Y/*\L?I5WXR:'>>)/#VGV-FGF327R<>WERUZ!GI1C&
M:XO80]G.FNIK[0RO"_ANV\+:/#IUEO\ )BZ>;S6P124XFNJR@K&0M%,I]6 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
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MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DI:* /!_P!J+P;)X@\%Q:M;0">ZTN0OEMX/V=_]:./^ '_MG7R+][I7Z1:A
M8PZA9RV]Q&LT$B;'CD V-FOA+XK?#NX^&?BB6S_?RZ9)^\M+B5L[D[J?I7XC
MQUE-2%59C3^9^P<$YORP> J^J.)HHHK\;/UL****0!1113 =C;UKZY_9=\&R
M>'_!<NK7$ @NM4D#Y7>3]G3_ %0Y_P"!G_MI7SU\*?AW<?$OQ1'9_OXM,C_>
M7=Q&V-J=E'UK[MT^QAT^SBM[=%A@C38D<8&Q<5^R<"Y34E5>8U/D?DG&V;\T
M%@*7JR_112U^W'X^>,?M/?"M_C!\&/$/A^RMXI-::+[3IWF0QR$7,1\P",R<
M1F3F(R=A*37X\5^]7#*1CBOS6_;R_9K?P3X@F^(6@V]W-HVL7,LVK1H#)#8W
M4G67K_JY2#_VU..?,CCK[GAC,EAZOU:J]'^9\;GV!=5?6:>Y\?4445^GGP&H
M4444#U"BBB@6H4444!J%%%% :A1110&H5O>./&VL_$;Q1?>(=?O!?:O>>4+B
MY$440D\J+RO^67_7*L&BIY5=2MJ;WTL%;VE^-]9T/PMKOAVTNQ'H^O?9CJ-J
M8HLW'ER^9%BL&BG**DK-!ML%;VJ>-M8UOPOH7AV[NUDT?0?M)TZU$46;?S)?
M,ES6#10XJ33:V#T/9]!_;&^+OAC0[#1=*\5_9+#3;6.TMHO[,L9?+BCQ%'_R
MR]A5#QU^U1\3_B=X6OO#GB+Q,NI:/>"/[1;M86L9D\N7S>L<7_3*O)Z*X%EV
M#57VJHK[C;Z[B?X?M#TCX?\ [1?Q*^%>FR:=X:\6WMAIXZ6LL<=U%%STBBE\
MWRA^\Z154^(_QO\ ''Q?\L>*_$5WJ<-O_J[11%#:GB0>;Y47[KS<22#S?:N"
MHJOJ>$]K[;V0?6JOL_9^T.]^&_QO\<?"#S!X4\17>F0W!_>6C"*:T'$8\WRI
M?W7FXCC'F^]6_B!^T5\2OBGIL>G>)?%EY?Z>>MK%'':Q2\])8HO*\T?N^DM>
M;T4?4\)[7VWLM0^M5?9^S]H%%%%=QQZF_P"./&^M?$CQ5?>(O$%X+[6+WRA<
MW0BBB$GE1>5_RR_ZY4>!_&^M?#?Q58^(O#]X+'6++S1;71BBF$?FQ>5_RU_Z
MZU@45S^QH^Q]A;3L:^TJ^U]J=]\,?CAXT^"[:FW@W61I;:D(Q<DVL4OF>7YG
ME?ZV+_II)7<_\-T?&P_\SM_Y2+'_ .-5X116%7+L'6?MJM%7-H8K$T_W=.H;
M_P#PG&L_\)S_ ,)A]M'_  D7]I?VQ]J\J+'VGS?-\WRO]5_K:]7'[='QK'_,
M[?\ E(L?_C5>$T45<'@ZUO:T5H%/$U:?\.H==\2/BEXG^+^N1:UXKU!=4O[:
MV^RQRK:Q0_NOWLG_ "R_ZZ25Z1_PW/\ &O\ Z';_ ,I%C_\ &J\)HHGE^#J6
MI5*2TV#ZSB:6U0]2\<?M,?$;XCV-C9^*->BUFTL[Z*_CLY-,M?)\V+V\K]Y_
MK?\ 52UP/B?Q7JGC77KW7-:NWU/5[MP\]PXP' Z #TK+HK>CA:-#^#2L8U*U
M6K_$"NDUCXC>(O$%[X<O+K5)!<^'[*VL=-NH?]%EMH[<YC_U7_/,D_O:YNBM
M94(RUD@55H]OT_\ ;/\ C3IMG;V<7C22:*"/RD$UC;2R'W\R6+S)37D&LZWJ
M/B;4I-1UC4;S5;ZX&)+J_N9999!_UUEK/HKCHX.A0;=*DC:IB:M7^)4/6/ O
M[57Q0^&?A6Q\.>'?$XT[1[,2_9K86-K*8_,E\WK)%_TUJ_KW[8WQ=\4:'?Z-
MJOBL7=AJ5K):7,?]F6,?F129BD_Y9>YKQBBE_9V#=7VKHH/KN)_A^T"BBBO0
M./4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4
M**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH'J%%%% M0HHHH#4**** U"BB
MB@-0HHHH'J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&
MH4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H44
M44!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!
MJ%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% @HHKL?A+\+=4^,7CO2_
M#.D1R8N)0+FZBC$ALK<G$ES)D]8R0![D5C6JTJ%+VM4WI4O;/V5(^H_^";/P
MKEU3Q7K/C^[CC%K8Q'3K/S(XI0;F012R21]XO+C_ '?'47#?2OT67O7%_"_X
M=Z3\*/!.D^$]&A>/2]+0QPF63S)'YWO(?<R,?Q-=KTK\0S'&/'8F59GZQE^&
M^JX=4Q]%%%>8>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ,_AKE?''@?3/'FAS:9JENLT$@X;&)(W[.A[&NLXQ[4SCM6%6E3K4_9U%H:
M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
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M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
MFU_^1:/^';7PU_Z#OBO_ ,";7_Y%H_UIR[L'^KF,/S<HK](_^';7PU_Z#OBO
M_P ";7_Y%H_X=M?#7_H.^*__  )M?_D6C_6G+NP?ZN8P_-RBOTC_ .';7PU_
MZ#OBO_P)M?\ Y%H_X=M?#7_H.^*__ FU_P#D6C_6G+NP?ZN8P_-RBOTC_P"'
M;7PU_P"@[XK_ / FU_\ D6C_ (=M?#7_ *#OBO\ \";7_P"1:/\ 6G+NP?ZN
M8P_-RBOTC_X=M?#7_H.^*_\ P)M?_D6C_AVU\-?^@[XK_P# FU_^1:/]:<N[
M!_JYC#\W**_2/_AVU\-?^@[XK_\  FU_^1:/^';7PU_Z#OBO_P ";7_Y%H_U
MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
M0=\6?^!-K_\ (M'_  [?^&__ $'?%G_@3:__ "+1_K+@NS#^Q,:?G+17Z-?\
M.W_AO_T'?%G_ ($VO_R+1_P[?^&__0=\6?\ @3:__(M'^LN"[,/[$QI^<M%?
MHU_P[?\ AO\ ]!WQ9_X$VO\ \BT?\.W_ (;_ /0=\6?^!-K_ /(M'^LN"[,/
M[$QI^<M%?HU_P[?^&_\ T'?%G_@3:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_
MK+@NS#^Q,:?G+17Z-?\ #M_X;_\ 0=\6?^!-K_\ (M7+/_@FK\-+GS"-=\5^
M^;FU_P#D6D^)L$NC#^P\:?FS17Z867_!-WX86-_%<RZCXFOX89/->UFOH_)D
M_P"F9\N(28_&O6? _P"RS\+/AQ<MJ&A^"]/CNQ+%<1W-UYE[+%)&/W;Q&4OY
M1'K'BN2MQ5A*:_<Q9M2X<Q'_ "]9^;OP)_98\:_'>Z6XM+;^Q/#A.9-:OXI/
M*D E\LFV_P">D@_>?]^O];%D5^F/P3^ 7A3X#>'Y=,\-VT@%Q)YMU>W?[VZN
M2"?+\R3OL' KU#:HXQ3AA5KXK,,ZQ.8.TG:'8^OP.5TL$M!]+24M>&>T%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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MD$L4\<G^KD1QP01Z>M;% !1110 4444 %%%% !1110 445Q7P]^*'ASXG?\
M"1/X<U!M0_L#5KG0=1/D21?9[ZW(\V+YQV\P<].>M ':T444 %%%% !1110
M445X7^TM\9M<^#J_"MM%MK"X/BKQWI?A6\^W0R2&*VN?-\R2+RY!^\'E\9R.
M>10![I117F7Q]^(6N?"?X3ZSXH\/>#M2\?ZS8F'[/X;TG?\ :;K?-'&3'LBE
M/[L2&3_5GB/\: /3:*** "BBB@ HHHH 0U1NO]95XUX/^V5\8M=_9]_9Y\2>
M/_#]O9WFKZ0;7RX-2CDDMF\VZBA(D$<D?:7UK*H:T]SV&BO%OVP/C#KG[/\
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MCCQ'X>^$WP@OOB>WAV[^P:UJY\066EZ?%<>7'+Y,,LID\V6,R,)8^/*(&?\
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M*** "B&:6'_5T44 ;=G>>=4M<_#-+#_JZVK6\\Z*LC4MT444&P4444 %%%%
M!1110 45%7!_"GQ]K7CYO%QUGP=?>%/[#\1WVC67]I+)G4[:+RO*OXO,CC_=
M2_\ ;3_KI2 ]!J*I:RM0O/._=1TS$+O4O^64=9]<)X2\=:OXB^)WC[PS>^$K
M[2M+\/"P^P^(IO-\K6/M47FR^5^Z_P"67^J_ULM=W6ID%%%% !1110 4444
M%%%% !1110 45POPO\?ZMX['C :QX3OO"7]B>(+K1K$ZAYN=2MHO*\J_B_=1
M?NI?\RUW5 !17-?$;XC>&_A%X)U#Q=XJU(Z3H%CY1NKL12R^5YDOE1?NHOWO
M^MEKI: "BBB@ HHHH T+34O^64E==:Q^3;@5PT,/G2^577Z?J&3Y<G6LJAK2
M-2BF4^N0ZPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \R\8?!/1_
M&7Q6^'WQ O;R_AUKP3]O.F0VSH+>3[;"(9O,'EY/ '0CUI?A%\%=(^#*^,WT
MBZO[S_A*O$E[XHOOM[QR&.ZNO+\V./9&,1YC'!R1ZGMZ910!\<_\$R_#4,W[
M.J_$F[ OO&?Q U>_US7M5DCACEFD%U+#A?*C&(_W1D$?:267IG%?4WBCPIIW
MC?PKK'AW6+<W6CZM9RV-Y;^84WPRQF.2/*?[)(_&OBS]FOX@:=^QOKWB;X#?
M$[6W\*^&+'5KB;P%XEUO,%EJ6G2@74L/VHVT4/F0^8/-D,G,MT8X_N1UZ[\2
M?VS/ NG:;)HOPU\2Z3\2/B;KD,T'AGP_X9E34Q<7H4!#<O%)Y<,49<22222Q
M_NHI2"?+H \R_97\;:[H'_!+2+Q3;ZI.VO:-X6UZXL[Z<"X-N;62]%MQ(""(
MA%$ G0",#%?3/[/_ (DU'QE\ ?AQXDUFX^U:OK'AO3=0OKK:$\V66UBDD?"=
M,DFO*M%_9QU+X;_L':G\']'1M:\2MX.U/3EC6<".XU*XAF>2..201?NOM,S[
M#(!^[ZGJ:\^_9B_;F^"6C_LL^")M>\<6&AS>&-&L=$U+3[TG[>);:**$&*UC
M\R26,Y\P21 C Y(\N01@'K/[(GQ,\2_$AOC-_P ))J)OQX>^)&L>']-7R(T^
MSV5MY/E1_(!DCS#R>:\#_9EU[]IC]JSX*^%_%1^*FG_#6V07,,>K0^'K+5+O
MQ!+]IE\R66+]W%:QQ82*-$_>2&*61^#'7H7_  3DUH^)/#?QOUHZ?J&DG5/B
MMKEX-/U2$PW5OYL5K)Y4L>?DD&<$=B*U_P#@EW_R8O\ #/ZZI_Z=+N@#ZJKX
ML^/7Q'^.=Q^U9_PJ[X2SZ1Y6I> #JL3ZTT<=KHUS]ODB_M XBDDD/EQQQ1Q<
MQ^9,DAC(CDK[3KX/^-WQJ\.? 7_@HM9>)/%QO[3PZWPJCM+G5+2PENH]/\S5
MY/+FN?+!D$1D2.+.#^\FC'&<T 7_ (F>*OCY^QK;Z?\ $?QM\0X/C7\,[:9;
M3Q+8?V!9:-?:;'++%'%=VYC/[W]Y@>62.),=_-B^A?CU+\31X&32OA':Z4/%
M6H2&W35=7N-MII$9BD<W1C,<GFG<D<<<?(WR(2/+C<5\Z_MK?&SP+\?OA.GP
M6^'?BO3/&/C?Q]J=GI^G0Z#=)?Q6?E745S+=7,EN9/+ACCBZ]<9(!$<ICT?V
M_/$RZAJOPE\$>*?$FJ^"/A/XKU/4+3Q1XET.YDM&A(M#';6DMP<Q"*6263S(
MY8R"(\](I#0!%XAUKXZ_LO\ Q"^%U]XQ^*=A\7?"'C#Q);>#;W3[OP_!H]S9
MS7/,-U#);Y\SR_*ESYF!C@#]YYD74?M4?%SXH^ ?C9\$?"_PR_L^_NO%O]NI
M<:;JABCM998K:+R9)9/*\T16WF/,4B(DE$1CZD5\E?%+PK^S#\/_ (\_ 71O
M@HFGZEXNN?'>CWEY?:'K-QJEI%8"[$9BDDDN9(_->4QX R<1$GR\Q^9]>?M#
M?\GU?LC_ /<W?^FN*@#HM!^#?QML? OC#3-4_:&&L^)-2^S'1]>'@JQ@_LGR
MY<W.;<2>7<>:F(_WF/+QD&OG']B7X9?%VZ\4_$R[L_C:;/1M'^*VI1>(M,/A
M*UE_X2":.2V-U+YQ.;7[0./+CR(NHS7Z+U\1_L?_ !0\(_#_ .)WQZ\!>*M=
MT[POXSU#XJZI?6&CZU+]BN;V&],7V62W\S'F^;Y9P(\GF,_\M8\@%GX]?$?X
MYW'[5G_"KOA+/I'E:EX .JQ/K31QVNC7/V^2+^T#B*220^7''%'%S'YDR2&,
MB.2H/$.M?'7]E_XA?"Z^\8_%.P^+OA#QAXDMO!M[I]WX?@T>YLYKGF&ZADM\
M^9Y?E2Y\S QP!^\\R+KO^<IG_=&__<U2_MZ_>_9S_P"RR^'/_;F@#6^.GQ:\
M>3?%CPS\'/A;-I-GXKUC3;G5];UK68'E_P"$?TD2&W6[AA.([F5ICB./) ,0
M\R/RY#)'YG\3/%7Q\_8UM]/^(_C;XAP?&OX9VTRVGB6P_L"RT:^TV.66*.*[
MMS&?WO[S \LD<28[^;%S'[8GPO\ AO-^UMX$\5?&_3%NOA?XA\./X6MM2-Q<
MV]KINKPW;W,,MS+&4\J.6*22-"9#TE) CC\P5[K]GS]@2/5=!TRVE\-ZGJ6N
M:C;:396NA^*[_4))+J8D1 I;W4GEC/\ RTDQ&.YYH ]R_;;^+WCSX.^&_AG?
M^ (?M>LZQX]TW1I=(S%&-4AECN?]%\V6,B+S3'&#)UCZ]J32K7XR?!+PUXY^
M)WQ,^(VG^.K33/#=]JB^"=-T*'3;6VN8HS<".*^YEEC01RQ!I(\D2^81D8JG
M^WK][]G/_LLOAS_VYKW7XK?%#PW\'_ .J>,/%^I'2?#NG>3]IO/LTDWE>9+'
M%&?+C!D/[R2/H._:@#YE_9WA_:#^*'ACP1\5KCXU^&M6T?7)HM2NO!-KH,7V
M&*SDF_>VL5['_I'FQ1;\ YQ-!Y4ID'F2&Y_P48U34=+\+? ^\T33#KVLV_Q5
MT.6QTO[4+8WDPCNC%#YK\1^81M\P\#.>U>1?'?Q%\&/@G"WC_P#9P\;:39?%
M&ZU.QMK;P/X#U>*]TOQ-*98XQ#=:9;&0!1";GRS&(L22YW>;(F?=OV]?O?LY
M_P#99?#G_MS0!P?Q%\,_M7_#?X:^)/B7J/QP\-S:CH4-SKEUX*M?"T/]EO:Q
M.TTELE]@7./LT9[>9GCS?^6M=K^TI^T)XETO]@.?XQ>$)O\ A%?$-YI&CZI:
MC]U=?8OM-S:^9%^]C\N0B.5X\F/\*];_ &K_ /DUGXR_]B9K/_I#+7RM^TG_
M ,H<=)_[$KPG_P"C=/H ]]_;J^)OB3X-_LL^-O&'@_4O['\1:;]A%M>&".;R
MO,OK>*3]W*#&3Y<CCD=Z\[OOAU^US\0;/6?$(^+6@?"V_O&,^E>"K'0+;5[:
MT3RU\F&XOI8_,\WS,B62..2/.9(\@B,;O_!43_DQ?XF?72__ $Z6E;OA_P#;
MH^"&I>&[_5;[QO8>$[G3GFAU/0_$A-EK%C/%&));<V<F)9)$)*8B$@\P%$+F
M@#:_93^.FJ?'+P#JUYK^A_\ "/\ C#P[K-UX;\0:;',);>/4;81^;Y,@)_=_
MO!P2<'<,R8$DG2_'_P"+6F? ?X2>)?'NL(9K70[,SPVNXC[5/DQQ0[O+D\OS
M9)(XO,P<>9D]*\C_ &#=+NY_AKXT\:3V5U8V'Q%\:ZOXQTBUOXC%=QV%S)$(
MC,F.#*(Q)^[,D921#N.:Z/\ ;J^'6L?%S]D_XD>&]!A^T:P]C%=6UMY<CR7+
M6T\5UY48CR9))!%Y<:XY<_6@#S[PQX-_:M^(7AO0_'%S\7="\&Z_?64>J+\.
MY/!@^P0L(P4M;FZDD^U1>;\OF_\ +2,O*(_]6*W_ (U?M#?$3X=>"O@_H>FZ
M)I4_QV\?36VG_P!@W*7$NG6,PBBDU"XD^S>:3%;&0?\ +7B.0R9D$1JUX5_;
M\^"FM?!W2/'>K_$#0] DNK2&XOM -]]JU"QE.(Y8/LR1_:9!'+G]X(N0#(/W
M=><_M0_$N/3M:_9>_:5M].G;X?:;)+_:\DL4C7&FV>KVD4<=S((HY>(N<CO(
M8XQS+D '1>(OA#^UEX2T.YUC0OV@[+QYK.F@7EOX;U+P78:?;ZD8R";62YCD
MS'YH)';!Q^\C_P!8.0_:]^+FE_';_@F#XE\>Z0GE6FMV6F3S6I);[+/_ &I:
MQRPY,<?F>5)')%YF!GR\CK7J?Q*_;_\ @IX#^&4_BO3OB#H/B6[DLFN--T>R
MO_,NKF7RC+%#+%&LDMMOQY9>6,>62-_/%?.7Q0^'.K_"7_@C:WAK7X/L^L)9
M6%U<V^V2-[=KG6X;GRI!( 8Y(Q+Y<@(X<>U 'N/_  4U_P"3&_B5]-,_].EK
M7J?QWD^)B^"1I7PFM=*B\5:C(;==5U:X$=II,9CE/VHQF.3S#N2.../GYY4)
MS''(*\P_X*?1>7^Q+\2C[:9_Z=+6N4_;V\1I=:Q\)/ _BGQ'JO@OX6^*M4O[
M3Q-XDT>YEM3$1:>7;6DUP?W0BEDED\SSH\8CSTBDKF.D/$&M?'+]F7XA?#*^
M\7_$^R^+?A/Q=XCMO!]UIT^@6^CW-I+=<Q744EOGS/+\N7/F<=@/WGF1:/\
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MRO\ P3[L=;NOA7XI\=:SIZZ-_P +"\7:GXPLM+>25I+2VN?*$8E9TCW?ZKS
M1_K8I(Y/:@1YI^S7X@_:5_:H^"_A;Q1+\4+'X<VL8N(8]6A\/66IW7B"7[3)
MNEEB/EQ6J18CBCCC'F2&*61^#%7OOQPT+XX^-/&&DZ)\._$VC_#OPM:H+G4?
M%MW;Q:G?7,F)!]EM[24>7\ABCDDDD,?^MC\O_5R"3DO^"97_ "9#\-?IJ?\
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M/;_3;?3+[5EF6XMK>3$?F174T,ACR>_E>9^->NU\M_\ !,K_ ),A^&OTU/\
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ML7.F>'[J'PN=2N]?BC/_ !]R?:O*$<?_ #S$8[RQR_ZKF;]B>:S\>_&7X_\
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M9^(OQ5'Q.-T(18G_ (1VUT?[#CS?-_U7^M\W,77IY7O7C-Y\//VM/'UKK'B
M?%;0OA9>W&9M,\'6>AVNJ6]G'Y8\J*XOI8_,\SS 1+)'')'G,D>1B,>M7'[0
M&@>.OA#XN\3_  DUK2_'NLZ7HDNJ6>EZ>YN93<_999+2*6UC/FH99(_]7^[D
MR".#7PKX'\/?L@77P$M/B9\5_%MQ\3O'&H:=#>ZQ'K'B>>773="".&2RBMXY
M8I,"6,B,R?\ +/DR^4,T ?=O[*OQHOOV@/V??!_CV^TZ'3+[6$E%Q;VLG[OS
M(KJ:VD,>>@_=>9^-?,O[.^O_ +2G[57P3\+^*6^)EG\/K:,7,*:M!X>LM3NO
M$$GVF3S998OW<5K''A(HXXQYDABED?K%7JG_  3*_P"3(?AK]-3_ /3I=4O_
M  3*_P"3&_AK]-3_ /3I=4#L4/B%\1OB3\4/C1K/PM^%6KZ3X7M=!TZVNO$O
MBZ]L?M]S87-R/,M;6UMI"(Y3+'%DR'S(Q%*/]7)'^\YO_A-?C'^S/\4/!-A\
M1_%D'Q9\!^-]3MO#EOJUKI%KIEUI.IR_ZK$,0_>12?\ M+M_RU\S^+GPF^#=
MO^VIXW/Q_L[:+3/&6GV-_P"%]9N[V[L-/C^RVWDW5M+<1R11>9^[CEZGCRO^
M6DOEUUO@?X,?L9V/Q6\%6/@W^Q=7\<R77]H:/%HOB&^U/RY;7%SYLOE2RQ1X
M\H<2_P"L[5H9G8?';XE_$#7_ -I/PI\$O 7C/2?AW/<Z)+XDN?$MY:QWUS<C
MSI8A:6UM*?+/$1E/3]US_P LL2>T?!_P_P".O"_AV]T[Q]XFL?&FJ1W6;76K
M+3/L$ES:F*/B6*,^7'*)3+%^[_Y9115YG\</%G[-WQ0UC6OA[\5-7\*G5/#Y
MB\VTUZZ^PS6QN?*E'V6YD\HY_=Q^9Y4GKYM87[&/Q$O_ !+X@^)_A?3_ !=J
MOQ#^'WA?4;6S\/>+]9?[3<WLKQ&2^B-U@?:C%(/W?7]W+U,9CH ^C_$^FZEJ
MGA75K'1-5_L/5;FVFCL=46U%R;*7ROW4OE?\M?*_YY5\%_"?X4_&75OVF?CW
MIVG?'IM)U_3?[ .KZT?!EC-_:WFV,IA_<F3RX?*CS'^[_P!9FOT+KX]\&?$K
MPO\ !_\ ;;_:#@\;Z_9>#/\ A(K3P[?Z//K<GV&&^CBM3%++%+)^Z_ULOE8_
MZZ_\\I: .Y^//QD\90_%CP9\'/AI]BMO%VNVUUJNIZ]J-C+<Q:#IF/+%R8_]
M5+(9A((_,E\L211QR?ZVN'^(VC_M(_L_^&)OB&/BU8_%?3/#P.H:QX4U#PU9
M:.+JQCC)EEBN8LGS8N)!_P"U?]5*OQZ\>6W[.O[8O@[XJ>+BL'@+7O"-QX4N
M=5CAN9#IMS'=&^C\Q(XI<^:<1Q@<_P"M/ A-6?VM?VM?ANWP5\1^%/"?B72?
M'GB_Q9ILNA:/HGAJ[%[+-+<XMN#;>;Y9_>B7RI.9?+\J@#ZB\-^(M.\9^&=+
MU_1[@W6F:M;17]E=&+RC)'+%YL4M<9\:Y_B-)X-;3OA7:Z2GBG4I#;Q:KJ\@
MCM=)C\J3_2O*,4GF',<4<<?/[R7/^KCD%:GP?\(WG@#X2>!_"U_);R7^AZ'8
MZ7<R6QS'))%:Q12^4:^>?V\O$$-SJWPH\#^)?$FK^"?A=XIU._M?$WB32+F6
MV\K%IY=M:RR_ZKRY9)9/-\Z+&(C_ ,\I* (/$&O?&_\ 9J\=?#6Y\7_$ZR^*
MWA+Q9XAM_"5W83>'[?2)K26Z(\FYADB_UA_=S?ZTXP/^FGFQ];^T1\5O&C?%
M3P=\&?A9?QZ-XQ\11R:KJ_B*ZLI+E=#TN*4@S>68O+D\V2*2+$G&?W?_ "UC
MD3Y2^*GA']FCP3\;O@9I/P9@L[[Q9=>.-'NKF_T/6)=3M(;$77EF*222:2+S
M9)#&>!P(^V?WGT5\:/$R? O]MSP'\0_$GEVO@?Q5X:E\$R:Q(\L<.G7(NC=Q
MF;]WY8$@\N/_ %G_ #VEX$5 'E?[:WA3XX?#_P#9G\9)XL\<:=\5_"NI+9V]
M_=SZ/;:-=:)+'>Q/%+%L)%S'*1Y<B?ZT$Q'H):^E_P!HKXC>(_A#XT^%OB4Z
MG]D^&7]L2:3XMA$41\O[5%Y5A=2RR_ZJVBE_ULOFQ_ZV+_6UX'_P4*_:9^'?
MBO\ 9U\7>"O"GB*W\9:]?16-Y(?#?_$PM;*U^WPDRW5S'^ZC'F((\?ZSS)HN
MTM?5W[07PPC^-?P8\9^"WCMYI=6TR6*V^U2R111W/^MMI)?+!_U<D<4G- %/
M]I;XLGX$_ WQ=XYBM?MMWI-M_HL/E^;%]JEE\J+S?WL7[OS98O-_Z95QWBOP
M[\>6^'/@?PEX7\3Z;;^+;B+S/%7C_4(HI/L)BDA\V.UMHXHXI3*993&)(XQY
M=L1)B202#P_X8?$#7OVN_&GP&T;7[.XBF\!PW/B7QW:747E^7K%M++8V'FF.
M(&*Z$L4MS]EE$8\N4_ZVMC]K2X\->-OVE/!WP]^+7B:^\'_"*Y\/2:G"\-[+
M8Z=K>IQ7<6;&ZE_U?E111"3GRY(_._UO[R*@#M/!?BWXO?!7]I/P/\/O'WCJ
MR^*.@_$"VO\ ['?C1X](N],N;&(RRXBB_=RPR1&(<G.3_P L_*_>ZO[4GQ<^
M)G@3XS_!?PO\-TL;^[\4_P!NI<:5JWEQVDLL5M%Y,DDGE>;Y4/F22F.+$DGE
M&/K@5\R>!]/^ OAG_@H!\']$^"%M;+)8PZQ-K6H:;JLU]:3&33)?*BAEDDES
MY8$N?+_O]?\ GG]-_'B7SOVVOV43_P!C9_Z:XJZJ9D>=_%+4/VC?V6?AC;_%
M7Q)\7=*^(MGHD]J?$/A";0+;3X9HY95BD%M=QQ^;Q))'Y;>7'_ST_P"F<GM/
M[57QR\1?"UO GA?P%IUCK7Q'\;:Q_9ND6FK)=26UO'%@7-S*(A_JHLQ9Y'^L
M\WD1&N;_ ."E_P#R9!\2_IIG_ITM:S?VTM6NOA7\5?@3\8KNW-SX2\(ZMJ&F
M:W/$)3+81:C#';?:OW<<G[J+'_?PQQC_ %E!D;6D_#_]HWP/KFC:E)\6].^*
MVDR:I;6NK:)JOA:VTHQ6,DT7VFZMI8I1F2*,']U+P09>LGE ZGQQ^*GCB;XL
M>'/A'\+[G2;/Q7K&FS:OJ^N:K%)-_86F"3RQ=11<)<R&4CRX^@\K]Y'Y<GF1
MZ.N?MG?"#3-<\.Z-9>.-)\1ZWXAU.WTG3]/\.7,6H'S9)HXLRR0GRHAB4']Z
M<XCE\OS*^?\ ]KSX9_#J3]J[P-XJ^-VGI?\ PTUSPZWA:VU 3W-K:Z9JT5VT
MT,EU)$8_+BDBEE\O]X1\LI.(H_,H Z7XC>*?CS^Q_;6/Q#\8_$&V^,WPXMY_
MLGB2P_L&TT:^TV*6:***ZMC'_K?WF!Y?'^LZ<^=%]H5\ W7P!_8-CU31M,MY
M?#NIZCK6H0Z796FB>*;_ %"62YE)$0\NVNI?+&?^6LF(_P Z^_J /@W]O7P#
M\2+KQE\+]3L?BG]@T'4/B-H5IH>B+X>MY#HE\8I0+[S<^9<XDCEE\J3C][BO
M8O'_ (1\<>"_V0?C/9>//B#_ ,+'UI_#>LS1ZK_8T6F>5#]@/[KR8NO_ "U_
M>?\ 36L/]O[4X_#_ (1^$7B:^BN(]"\-?$K0M:UBYBMWE^PVL0F\V67R_P#K
MI'[DR8%=[\<?'GAGXC_LJ?&/5/"WB32?$^GP^%=8MI;K1;V*[ABE^P2GRO,C
MX/\ K: / _@'X)_:3^('P=\ ZAIGQ$TGX1>%+7PKIEII.DV&CVVMW-U#':X^
MUW,DH_=M+^ZE$49_U<@!'F1GS/6OV;_C[K6O?!?QQJ_Q0EM+35?AOJ^J:#XA
MUFP\R6.\%C%'++=",1 YZ?N\=N@SY==[^R[_ ,FS?"#_ +%#1O\ T@BKYR^!
MOA:\^(7PC_:W\(:=)!'>ZY\0O%EA;279Q%'++%%%'YGIWH U/!L?[1/[1'A6
MP\>K\2M*^#^GZQ$+C2_#FE>'K?5@EC+^]MI;JXFD!\Z2.4#,?'"?ZN0R(.R_
M9A^,'B[QE=>+O /Q'TRWA^('@66VM=6U#3Y8OLNI17,7FVMS$?\ EF98HAF+
M Z_\LO\ 5Q_*_P "?@_^R!XH^&ND+XYM=)\,^.M/B73O$&G>*?$ESI5U%J,8
M"77[J2ZC'^LR<=OP\NOJ?]E'P7\#_#>F^*-2^!\=O]@FU$:7JUW:W-S=127%
MKT\J6YE_><70_>Q?NL2BM:9F7/V+?B)XC^+?[,O@SQ9XHU3^V->OOMWVJ\\J
M.+S#%?RQ1CRHP(_]7%Z5X?\ LYZ]^T9^U!\'?#GB0?$VR^'MK";F)-5M?#]K
MJ=SKL@N9 99(SY<5JD?[N*./_62F*663CRJ]&_X)O?\ )E_P\^NH?^G"ZH_X
M)N_\F7_#O_M__P#3A=4"/I6OD_QEXZ^*/Q@_:8\9_#+P+\1-+^%EGX+TVUNI
MY?[,BU.^U>6YCCE,OE2CY(HA+Y?7@R1\'S?W7UA7S%\6-8_9F^..I7\'BOQC
MX>T/Q;X9U.72XM<FU'^QM9TRZMO-QY4LOE2_NI9#+_RUB\VM0/8M!UC5_AS\
M)Y=2^)>MV6HZAH=K=76J:YI]M+%#+:Q>;_I7E?\ /7RHHI98HO\ EKYOE5X;
MX)MOVB?V@O".G^.5^)6E?!_3M8B%QI?AO2O#UOJP2QE_>VTMU<32 ^=)'*!F
M/CA/]7(9$$?P$UCQ+^T9^R;\2]!76+K4[.Z?7?"WA3Q-K4<L4VIZ;Y7E6MW=
M2^5F3_6>7++Y0_U?_/7S*\2^!/P?_9 \4?#72%\<6ND^&?'6GQ+IWB#3O%/B
M2YTJZBU&,!+K]U)=1C_69..WX>760SZG_9@^,'B[QE=>+O /Q'TRWA^('@66
MVM=6U#3Y8OLNI17,7FVMS$?^69EBB&8L#K_RR_U4?E?[)OQ6T[X(_P#!-G0_
M&NJQ^;:Z19ZE/':Y+?:9/[3NHXH^!^Z\V26*/S>U>I_LH>"O@?X;TWQ1J7P/
MCM_L$VHC2]6N[6YN;J*2XM>GE2W,O[SBZ'[V+]UB45\Z_#'P'J_Q,_X)(Q:!
MH"-=:K):7=S%;+'+)))]FUB:Y\F/RP27D\O$8QS)QWH ];3X:_M3^+/#AUZY
M^,6B^!/$MS:^</"&G^%K:ZL+&8Q?NHOM4OFR>OF2?O,9E\KS17<? G]HX^//
M@_XF\4>.-,/A;5/!-U?:9XJAA/VJ*UN;&+S;J2'RO-\V+O[9Q^]_UDGSEX*^
M$?["'C;POIFNQR^&])6\3S#I^M>,;FRNK4C_ )921R7?ZBO;_AW\+?AKXB_9
M-\8Z'\"8K6U\-^,M-U2&REN9KWR9;J2*6U\V3[3^\B_U7_D*@#DOAW+^T)^T
MKX-L/B';?$NP^$&E:OYTNF^&K3PI'J<GV7S2(9I);KGS)>#^[ C\KRI/^6M6
M_P!H+P[\9/%_[+FMZEK?B[3/ FLZ9H6N_P#"2Z)I&CPWMIKEM&LOE>5++*9+
M826\?7_6D2<@>7@)^S+^U=\.-#_9T\.V?C#Q/I/@OQ'X0TW^QM8T'5;HQWL$
MEC$L1'V:7$DOF1QB3RXHNI\K/F15Z'XO\?:=\?\ ]D?QYK_@JWN]6L-<\/ZY
M;:9']E!DOI(XKJV'EQ?ZS][)%^['^M_E0!S?[%_@3XBZ#\-O NM>(_BD/$_A
M*\\)6/\ 9OAL>'[>U_L[S889(O\ 2H_WLOE1 Q_C7*Z7\2OBQXZ^"?[1UWX7
MUMIO&7A?QMK.G^'I?LL4LL-C:R6T@MHXO)/F2;/-CC&,F27'H:]"_8Y^+W@G
MQQ\#/AUH.A^*-)O_ !#IOAFPBOM(AN8OM5M]FABCE,L7^LQYE<]^Q!_S<!_V
M5K7O_:5 'N/PM\?Z3\5OAWX>\6Z'-Y^F:Q;1W:'S8_-C/>*7RR?WD7^JD&>)
M*\ \ _M/ZE'^SGX]^/WB:^%UX6NKFZE\*Z"T?E"WM8IOLMK%*8XI)!<S7/\
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MQF.2*&'^TR?-DEB/E222 ",R>9Y?[NE_9/\ B1XC^)"_&'_A(=1.H?\ "/\
MQ%UC0--W6\:?9K&+RA%%F,<_ZS]*]VKY;_8?F\E?V@_^RO\ B/\ G:UK8#R/
M]GGQ?^T_^TU\*?#?B0?$?2_ 6CM%?0OKL6D6NI7^M77VGF4VOEQQ6\44>Z+C
M$I\N0XD\V,)ZY^S/\1/'&J>,_B;\,?B'JEKXF\0^ [NU\OQ)I\?V4:E:WL4D
MT)EMAB.*6.//$7'N?+,DF3_P3?\ ^3,/AY]=0_\ 3A=5+\!O^3TOVI/^Y7_]
M():#,ZGX2_$3Q%XB_::^.OA+4-5^VZ%X:_L(:39^7'%]E^TV$LLO[W DE_>?
M\]2:\R\$>-?C#^UHNO>*? GQ L_A5\.[/5[JPT"ZA\,_VE=ZU%$?^/J0W7E>
M7'VC\L?\]8I?]572? ;_ )/2_:D_[E?_ -():X;]B_XQ>&?@E\,;_P"#WQ'U
M_1O!7B_P+K%S8-#K%_\ 98K^&6:6YBNH?M(BS%)YA'_7,12<>;0!]&_!N/XD
M66BZEIGQ+N=-U'5=-U'[)9ZYI<(B74K+RH?*NI8_-_=2>9YOFQ?41?NL9ZOQ
M-J6I:3X;U:^T73O[;U6VMI9;'2UN?LQOI?*_=1>;_P LO-_YZURWP8^.WA']
MH+0=4USP1?7&HZ+INI_V7_:$UM+%YLOE12_NO-_>_P#+6N7_ &Q/%_B/P)^S
M+\0M;\)K</KUKIGEQS6HE,MM%))%'+<Q"+_5F**263S?^67E5J8]3R/X@>'_
M -J/X>_#_P 0?$2_^,GAV2^T6.ZUF?P9;>&HCI;VL4OFRVL=W@7/^J'7 D_Z
M:_\ +6O4_B)^TC_PBW[(<WQB72?*N[OP]:ZI;:>I^T117-U%%Y44O^J,L?FR
MQ>;_ -,Z^,/C)X#_ &0_!_P%USQ-8:\/B%XVU:SEDTW4)O$$MWK-S?W)DEBF
MNK:.6/RO+R/-\V+_ )9X_P!8<2^^?%":^M_^"7%E)9:+;Z_,? 6CQ_9+FT^U
M>7%Y5KYMR(O6*+S91+_RR\KS:R-CF_VF6_:7^"'P?U;XD'XU:3+):S6T][H&
MG^%[6*UM1+,(O)MY98I))A%))&/WFT^6>O:O9?B]\4_$_P"R[^SE9W.LZN/B
M=\2+FY&BZ1,---O_ &QJ%S)+Y<7V6V_YYQ_A)Y?:26OD_3/CI\*/&\&CV7Q&
M_:=\2>)OA_;26NH1^"=5\(>5<R>5-%+';:G=112B^'!\WM))^]KZ5_;>N+O4
M?@GX-^(GA>V@\3:?X,\3:9XXEBLY?^/ZPB,O,4L<4F?];YOF_P#/+S9: %U7
MX/\ [3>H:5=ZG;_'_2+#7)(I7AT2U\'6QT^VE(Q]FCN9?,E$8)\L2RQ^9P,@
M\U>T3]HK6O&7[)?Q#\7R6EMX:^(?A#3M7T_5[.W'F0Z;K-C%)_J_,/E2#/E2
M]9>)?+_>5T/_  V]\"/^$+_X2C_A9VB?V5G'E^=+]O\ ];Y7_'C_ ,?/_D+_
M *:UX=\*--U:Z_8;^/OC76]+.C)\0!XF\66>G,TGG6]M<VO[OS&\N,?\LO,!
M&1+%)$>^*!&[\+[+]I;XX>"/"_B^[^)NF?#+2K[1-/>WM;31+76+F^S$?.N[
MH2"*.+S,K*(XLCRY/+(\R/$GJG[)?Q6\4_%#P)X@MO&L=C-XK\)>(+GPEJ.H
M:?GR[Z6V\K_2?+P/+QYN.G4'_5_ZJNC_ &8?^3:OA+_V)^E_^DL5>:?L/_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)@,@2_ZP=CZ;VI>$]#U?Q!I6N7^DZ?=:WHYE_LZ_NK6-[FS\T>7)Y4G5/,
M..O?T'1T4 %</KGPI\&>+O$FF^(]9\(:)K'B'3?*:RU;4-.BEN[7RI3+%Y4K
MCS(\2?O!@]<UW%% '._\(KHO_"3_ /"2?V18?\)-]C^P?VO]E3[7]F\SS?(\
MW_6>5O\ WGEYQGGK1XD\)Z)XH^P/K.D:?K#:9>1ZA9?VA:I,;:YC),<L1?\
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M_LBR_P"$D^Q?8/[8^S1_:_LWF>;Y/F?ZSRO,_P"673-;E% 6"N%\6_!?X?\
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MAX$\-?$#38M-\5>'])\3V$<GVF.UU6QBNHHY/^>OE2UT%% ')Z3\,?!V@_V
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M]/TS;<W.@^%CJ?\ :E[$#^\CMO-^3S=F2#@]\1R'$9 /L6BOF+XV?M7'P_\
ML4WGQS\ 1Z?J9DL[&[L8M6_?0IYMW%#)%-Y,H_>Q^9)&0).)8\<]#J?"_P 6
M?'WQQXTTS7]6\,>%/!_PHO6DFBT?5FNSXMBA,<GDF7_EVCDDD$3F(_ZJ.0QD
M^8AH ]G_ .$JT7_A)_\ A&_[7L/^$F^Q_;_[(^U)]K^S>9Y7G^5_K/*W_N_,
MQC/'6O/?VAOV@--_9Y\"-XAOM,U+7]2O+Z+1]$T/383-<ZIJ,NXQ6T6!QGRS
MSCH#@22$1GXV_P",HO\ AN__ )I%_P +'_X5I_U%/['_ ++_ +4_[^_:O._[
M9^7[UJ_MK_\ #1'V_P""?]J_\*T_L[_A/?#7]D_9/[1\W^WOLS9^T9X^Q?:?
MM./+_>^7Y7?- 'US\#/B#\2O'5QK8^(OPH_X5:;80FQ'_"2VNL&^R9/-/[D#
MRO+Q%UZ^9[5Z_7@VF_$KQQ\'_@?XM\;?'NY\(0WVAM)=#_A"WG%I);"./RHO
M]*(/VB24R1@#@^9$!UKS/PC\1/VLOBSX9TGQCX0\/_"3PMX6UZV2_P!,TSQ-
M>:E>7\<,D>8Y));91$1(,2#C(#X/- 'V+7@7PC_:@T_XB_LIGXW:EH-QHEC'
MIVI:I=:3:W0NI8XK*2:.39)B,29%OGMG(%3?LT?'/5OC%X5U:T\8Z WA+XB>
M&;W^R_$WA[SE/D2[?,CNH1DM]FF!_=.>#MDQ)*(_,/B?[%WC*[^'/_!+?3_%
M>G+%)J.@^'_$6JVT-Q_JY)(;N^ECW^V8Q0!]<_#SQC8_$;P'X;\7:;%-#9:_
MIEKJ=LER/WB12Q"6,/SZ/755XCH7QZL]&_99T;XQ^-!#802>%K7Q%J"6C[%\
MV:VCE,,/FR=9))!'%&TG):(9KRCPC\1/VLOBSX9TGQCX0\/_  D\+>%M>MDO
M],TSQ->:E>7\<,D>8Y));91$1(,2#C(#X/- 'V+17A'[-'QSU;XQ>%=6M/&.
M@-X2^(GAF]_LOQ-X>\Y3Y$NWS([J$9+?9I@?W3G@[9,22B/S#[O0!Y%^U'\<
M'_9M^!OB'XBKHW_"0+HWV;=IQNC;>:);F*$ 2>7)CF7/3M7KM?*O_!43_DQ?
MXF?72_\ TZ6E>G_M ?&BU^ ?P[N_$UQI\_B&Z\Z*RTK0K)PEWJVH2R&.&UA&
M.6S@D())/+24^7)MQ0!ZW17QMXC^('[8/A'09O%8\ ?#74-(MF&H/X+TFZOI
M]>-J#F2T2;_CWDN4CR,Q@@F,^7')Q&=ZX_:^AUS4/V?O%7AJ*+_A57Q#U.YT
M;4=5U*UE%_97[1M]@M8T23J]S%-%)($DB_=_ZP##D ^JZ*\Q^/\ \6M,^ _P
MD\2^/=80S6NAV9GAM=Q'VJ?)CBAW>7)Y?FR21Q>9@X\S)Z5YIXQ_: \9_!WX
M5_#X>(/"<7C'XT^+KB*QA\&Z#-'8C[28O,N<&26;$5K&,27.9(\^6?W<<N8P
M#Z9HKXO\=?&#]J7X%:5!XS^(GACX=>+/A]ILP;7[;X?&_P#[5MK, F2YC%R1
M&1$0"1GD9_U8S)'V?[2W[5LWPK^&OPG\=>"]-;Q7H_C'Q+I=AY,5C-+=76G7
M44DN;6(R1'[3((X_*\SCYCD4 ?3M%>#_  7U;X\ZQXFO+WXF:7X%\/\ A"XL
MI);'2=#NKJYUFQF\Z,QQ7,TG^CR^7&9!))%P9 ,#'%>:7GQ&_:Z\:VNM>(_!
M_P /? OA?0,--H?A_P ;3W7]NW40B#Q^;Y,HBBED/_+*4Q&(YCDZ>80#[#HK
MQ/X1_M&:'\5/V=+#XR7T-QX<\.MI]SJ-['=GSC9K:F6.Y/[L?O /*EQQDX4[
M,\5\^>)OV@_VJ+KX*7OQFT+P7\-=,\$G2/[?M]!U&^OKW6$LO)$IEDEC\JVD
M'ECSL @^7B/_ %N00#[OHKPK]F_XB>,_%7P&L_'?Q:N?".EG4[--=M[C0I)8
MK6VTN2VBF4W1N3B.4?O?,(/EC YZUY9X9^,7[2/[0&C6OC#X9^"_ O@GP9J&
M3ID/Q$N;Y]3OX028K[R[0".*.2-DQ&<YQD221R(2 ?9%%?,7P:_:Z/B+X7_$
M6^\>>%-0\*>._AC8R3^,?#L<6X_NXI9?-M7)\N2.6.%S'^\_'R_+EDY_X,_%
M7]ISXDV_A/QM?^#O -M\//$%Q#=#1K>_N?[<M]+N7'E3><?]&D,4<B7!  ,D
M:F/$<IV4 ?7M%%% '.^)/%FB>%_L":SJ^GZ.VIWD>GV7]H720FYN9"1'%$'_
M -9*<<1CG\JQ_B_XR7X<_"WQAXP%D+\^'M(NM5^R^;Y1N/LT4DOE^9V_U=?'
M?_!0+_A=_P#PGGPN_LW_ (0+_A#O^%DZ#_PBWVS[=]O_ +4\J7ROMV/W?V;S
M?.SY7[S'E=\UZ_\ $3_A:'_#&?QK_P"%K_\ "'_\)+_PC>N?9O\ A#/M7V3[
M+_9QQO\ M/[SS?,\S..,>7[T >M?"CQJ/B5\,?"/BTV7V#_A(-(M=4^R^9YG
MV?[3%%+Y?F?]M*ZVOAC]GOQI^TOXN^#_ (!7X<>#O!OA3P;IOA72+*VOOB%)
M<_:=6FCM1%+<PQ6TF8X?W7[OS0/,0Q2 D28C]N_9O_:%E^+/POU_Q!XSTR'P
M7K/A'5+K0?%,<US$;"UN[:,&YECD$I B_>#J3C)&9,>8>3V9TGO-%?(OAGXO
M?M&_'S1[7QA\-?!W@;P5X/U DZ;%\1+F^?4]0A!/E7WEVH$<,<D;)B,YSC(D
MDCDC)]!_9F_:$O?C-8^(-$\6^'+GP?\ $KP=/%8^)-#EB'E0R2\PS6TF3YD4
MOEF2/!/_ &T'ERR9V"Y[S117BO[4WQPU+X)> M*O?#^AGQ'XL\1:S;>'M TY
MY1%;2WUR)?*\V4D?NOW?3// S%GS(T;-GM586I>+-"T77]+T.^U6RM-;U<RG
M3;":ZCCNKWROWDGE1_\ +3RA^7->7?!W5/CROBB:P^*VD^!9-)ELWN+75/!=
MW=+]GDCDBS%-%<C]YYGF$B2,?N_)D!_UL=?,G[1G_#07_#9GP4^R?\*U^W?;
MO$W_  A?G_;_ "_LOV8>=_:??S?LWE?ZK_EIGM6UC$_0FBOFSX[?&/XH?L_?
MLA:QX^U^T\)7WQ&TEHOM,6E1W3Z-^]OHXA@221RG]U(._P#K*U/AGXP^._C3
MQGI^O:KX9\+>$?A3?&22+1]4:Z/BF*(QR>3YPQ]GCDDD\MS&?]5')Y?^L%96
M-;GO]%?,'C#XZ?$_XC?$3Q/X&^"/A;PU<1^%)8;?5O&7BV[F.F277E[I;"VB
MMOWDDL0DB,AS^[\N2.2/F+S)OA+^T'X^T?XS1?";XW>'=*TGQ5K$4FH^&->\
M+I<RZ-JT<47F74(\T^;'+$/,/[P>O _=&76QE<^F:*^.?%W[2GQEU'X_?$[X
M3?#7P'I7B*^\/R:*;#6M0>6&QTVWN;:*6ZEOY1+F7F3]W%%^\P)9/WGE8.[X
M$^.7Q>\"_'CPK\,_C3X?\)S_ /"96=S)H&M^"9KG[.DMM&9;F*YCNCYI_=>7
M^] P,@?O,R>46"Y]4T5\W_$;XW?$WQ1\5M>^'7P9T7PG<ZIX9L[.]U[7_%UW
M=);6DER)?)LDMHHA(\AC\N42 F, 2QD"3%<5^SG\;OVAOB!^T%XO\#^.M)\!
M:3I?@N:.+7%TL7IN;C[3;2RVDUJ?-DCP?)C?][L.R3IYAX+!<^J-2\6:'H_B
M#2M"O]6LK76]7,ITVPNKJ..ZO?*_>2>5%_RT\H>G3GZUQ7[3WQN?]G+X)>(?
MB*NBCQ NCFUW:>;G[-YHENHHN)?+DQ_K:^2/VC/^&@O^&S/@I]D_X5K]N^W>
M)O\ A"_/^W^7]E^S#SO[3[^;]F\K_5?\M,]J[_\ ;D_X33_AW1XW_P"%A_V#
M_P )AFR^V_\ ",^9_9__ "&+7RO*\W][CRO+Z^_M3L(^RJ*^2+[XC?M:^-+?
M6_$/A+X=^!O#.@8:71] \:3W)UVYC\H21^;Y4@BBED_YY2F/R\^7)P/,/1_\
M-F:+_P ,9?\ #0G_  CNH?V?]C\W^Q/.3SOM7VK[)Y7F_P#/'[3_ ,M,?ZOG
MRL_NZ15SZ4HKYT^$?B+]I27Q)H+_ !0\-^ SX>U*$_:+?PW<W*7VDS>4)8S*
M)#)%*!)'Y6(I#_K1)DQQFOHNLC5,***^:?BQ^T5XLD^,W_"F_A#H6AZS\0%T
MDZQJ6K>(=0\K3=%B\V/'F10_O9)) <^6/+/[V&3]Y&3@!L^EJ\6_:%_:&'P5
M7PKH^C>%;SQSX[\77WV3P]X:L9/*:X,?EFYFDN/]7%'%'(,GMW_=^9)'Y9>_
M';X\? GQ%X?U'XU:#X%O/AUJ]\FF7VO>!WNHAH<TCPQ0W-Z;H_\ 'L3D>9P!
MW;_5QR>9?M&?\-!?\-F?!3[)_P *U^W?;O$W_"%^?]O\O[+]F'G?VGW\W[-Y
M7^J_Y:9[5M8Q/L+X,^+O&_C/PS=7_C_P!_PK?6X[Z2*+2O[<BU3S8O+B/F^;
M%QU\W]U_TRKT>N0^%_\ PFG_  A-A_PL7^PO^$OS+]M_X1KS?[/_ -;)Y7E>
M;^]_U7E=>:Z^L35'E7C[XVMX%^-_PI^'7]C&Z_X3LZIF_-SY?V+[#;";_5^5
M^\\S..H_E7JM?&7[97B[5?!/[4G[,^K:+X=U#Q?JZ#Q-%9:+IA\J:ZFDLH8H
M@99.(H@7!EE/^JC$LE.UCXR?M2?!OPS9>/OB3X*\!:WX0MO*GU_2/!WVLZSI
MUJ8_WLG[R7R7\G_EIY9D'!Y\O]['J9'V717S]\:/VKM(^&?@'P+K_AO2W\=:
MM\0+ZSM_"^CQ7T=C)J/VD1F.8F;F*+$D9/[KB26(2>7YE<+XF\5?MA>"=%N=
M?OO#/PG\7V&FXN;K0?#1U/\ M2^B&/-BMC+^[\WR\GH>,XCD.(R!<^NZQ?#/
MB;1?&6B6^LZ#JMGK6CSG%O?:7<QW-JY_U>(Y8Z\LU+XC>-?B]\$/"7C3X$7/
MA*:]UPQW/_%:/-]DCMO+E\V+_12<7,4OE1^WE2>E?/G_  3#C^-4GP3^&VX>
M S\&_P#B9_=^W?V__P ?5U_V[?\ 'U_Y"]Z/9C=0^H/A[\:I/'GQL^+/P\&B
M#3W\ _V1C4%N?,-]]NM9)@/+\L>5Y? ZR9]J]EK\]E\;?%#0/VUOVDM#^$_@
MRU\3>*=4G\*;M3UR;R]'TBUCL ));K$HDD)\P%(HOWAQ*_/E^6_K'@#X[?&+
MP+\>?"WPS^-GA_PA,?&5E<RZ!KG@B:Y^SI-;1M+<PW,=T?,/[KRSY@&!D#Y\
MR>5U'*?4VH2[>*JU+=2^=)@5%7)4.NF%%?'^D_M#?%[]HC6/%$WP)T7P+'X2
M\-ZS+H[^)/&>J75S%JTL9CYMHK$_NXUZ^9)Q+%+%C&)!75?"3XY?$:R^+-Q\
M*OC-H6@:)XHOK1M4\-ZYX;>4Z5J\4?EF>UC%R?-^T1']YLZ^60<1@)))%B;G
MTM17BGPO^+VN^-OVA_C7X!OH+.'1O YT/^SI(HI/M$GVZUDFD,I\SD@\=O6C
MXH?%[7?!/[0_P4\ V,%G-HWC@ZY_:,DL4GVB/[#:QS1F(^9P2>._K2L%SVNB
MOFC]I3]I#Q?\%/BE\)?#WAKP>WCAO&(U>&32[9<7<TMM#";81RF7RXHO-ES+
M+()/+B$DG:O0_@K_ ,+JWZQ_PMS_ (0/;B'^S?\ A"OMO7]YYWG?:?\ MEC'
M_37-%C7F/5***\6_:0_:%MO@+H?AZ+3=(7Q7XO\ %6KP:/HOAR/5(K&6^FD.
M/];)S'&/^>@!Q))%_P ],T#;/::S]0L_^6L=?*_B?Q5^V'X)T6YUZ^\,_"?Q
M?8:;BYNM!\-'4_[4OH@?WL5L9?W?F^7DC@\9Q'(<1GI_C5^U2WA_]C&\^./@
M&/3]2,EG8W5C'JV9HAYEU%%)%-Y,O^MB\R2,_O.)8SUK6QE<]KHKQ#X>^)_C
MGXS\::=KVJ>%O#'A'X77PEECT75&NO\ A*88S'^Y\T8^S12R2>5(8O\ EE'*
M8_\ 65RVH?&GXQ?%+QKXLTWX,:3X&M?#WA/5Y-"OM:\9SWSF]OTBB\V&.**/
MS(C%+^[/F_ZS]UY?0UJ9'T]17R]^Q[\:/C1\;M6\6W/Q!TGPAHFB>']2NO#E
MW:Z4+H7\6J6WE&4?ZV6/RL2R?C[<G0\3>,OVD/%GC;Q!%\/?!_A#PWX2TU_L
M-KJ'CZ6Y^TZM-'++%))%';2_NXL1?N_-QYD?E2Y(D_=@'TC17C?[,/QLU/XV
M>!=1N?$.@'PUXL\/ZQ=>'-?L8YA)%'>VWE>;Y4@)'E_O1W..1^]_UM>-:#^T
MK\>?BIXL\<>%OA[X$\.M+X;\9:EH]QXKU_S8M%M;",'RHB8Y?-ENI"/WHB'[
ML>5^[_>YC /LFN#\)_&#2/&WQ0^('@*RM;Z'5O!?V#[=-+%%Y,OVJ+S8O*_>
MUYI\$_C9\0;SXSZY\)?BMH6BVOBZWTB/Q)INJ>%991I=[8^;%%C]X?-CD\T]
M?8\<?O>A^&?Q>UCQM^T-\:? E[;V<6E>"_['^PR112^;+]JM999?-_>T >S4
M5\V^.]0_:>T/4/$&HV%S\%].\(V4]S=6MYK\NIQ2Q:?'GRY;J7_5Y\K'F?C6
MC^SC\;?'_C?X%ZYX]\?>&X)9H9+F[T>U\+6-U_Q.-+CB_=2VUM<R>9^]_>^5
MY@B\S,- 'T#5/5]3L/#^EW6IZE=6VG:?8QRW5S=W<OE1111?ZV666ODKQ'\5
MOVL?!7@O5?B'K7@3X=6OAK23+?WOA8W]U)K4-C'-^\_TD2&V\P1?O/,_\A?\
MLJWOVHO%WC_XA?LKW?BCX;Q>'(O"&N>"[_5-<A\5?:CJ$=C+8^;%]E\K]UYO
ME>=_K?\ IE0!]+Z1J=AX@TNUU/3;JVU'3[Z.*ZMKNTE\V*6*7_52Q2UR/PJ^
M+VD_%S_A+CH]M>6@\+>(+KPO??;DBC\VZM?*\V6+$O$7[VO&_P!B?_A<G_"M
M_ __  EW_""?\(#_ ,(C8_V1_87V[^U/]5#Y7VKS?W7^J\WS?*_Y:XKNOV=?
MBYJWQ>_X6;_;$%G:_P#"+>.-3\+V7]GPRP^9;6OE>5)+^]YD_>T >R5#7RII
M/Q_^+7[0.L^*'^!.C^"(O"'AC69=(D\1>+]0FFBU>6,1_P#'M%8G]W$,_P"L
M/$L<L73$E=3\(?C9\0+'XL3?"WXR:%H^E>)KZV.J^']:\-RRC2]7CB\KS;6+
M[3^\-S%G_OV"<#B64 ^C;2K=?&_B;]I;XP7GQ^^)?PN^'/@?2?$&H:&^C_8-
M;U#S([#3;:YBCEN9;^3S<R<R?NXXOWF/-/[WRN>G\"?'+XO^"_CUX:^'/QG\
M/^%)F\:65U)H&M>")KG[,DMK%YMS%<QW1\W_ %7EGS,#&1_K/^6753,JA]34
M5\L^._C;\7_''QZ\2_#GX+^'_"D1\%V5J^OZUXWFN/LTDMU'YMM%;1VQ\T?N
MO,/F8.<'_5?\M?<OAA>^*]3\&Z=<>-=*M-&\5#SH;ZVTRY\^TEDCE>/S83_S
MREQYHCD_>1>;Y9YK6YD=I117C'[6WQ*\9?!WX&:YXX\#65CJFL:$$NYK+4;&
M:ZB>U\SRY1B*2+R_+\SS/-_YYQ2?4 'L5$TWDUXW\;/CI/X*_9OO/B=X!TP^
M,;F]L[*70+00R_Z=+?310VQ$/^M(_P!)C/E#]X?]7^[SFK/P>^->F_$[]G7P
MI\1[Z]L;2VO-'^U:G>9^SVMM+%_Q]',O^KBBEBEY_P"F5 !\;OB]I7P)^&^L
M>._$%I>WNE::8A=0Z='%+-^]EBBX\V6+/,HKIO$WBK2/".CW6K:[J]EHFEVY
MQ)J&H7,5K%'_ ,LO];+7S%K/[47CS2?V(]3^.%SHVD:?KUV\5WIFC75M=>1:
MV,M_%:Q"7][^]/E'S/-B\H?O(OW?>L3_ (*;?\+'_P"%#^*?[*_X13_A6/V:
MQ_M3[5]I_MK[5]OBQY/_ "R\K/V7_P BUJ9'V;7FO[-GQD/[07P9T'X@G2/[
M#&L&Z(T_[3]I\H174L7^M\J+_GE2_!K_ (6_NUK_ (6Q_P (-C$/]F?\(?\
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M)\O_ *9>7Y>.,8KZ!T?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_ -7&B#@
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M^'_C3^S_ .#=>T']H?XQ1*FFVUG?:;HGC/R;73KV.*+S;:.$1$Q"/(\N,_\
M+/RS[U[)^P#X#UCP'\%]=ANM(UGPOH-_XIU34/#7AKQ +F.\TG29)?+AMI8I
M?]4<QR28!<?O?,R3(:Z?XD_L-? OXM>)I_$7B3X>:?-K<YW7%UI]S<6/GR%S
M(99!;21B20ES^];+G/4CB@#F_A#\'?A%\$=)^*OB6_\ BE=>.-.UN:'1O%^J
M>/O$%M?10RVPEM3:W4I2, _Z3Y1CES_RS  R*\V^-/A5_P#@GIX ;XB?#CQE
MJ.F^"K"]MXI/A9KUT+W3]1:241F*PFF_>V<F);JZD\OS/,(/'EQXKZ;M?V;?
MAM8?"^]^&MCX,TNS\"W<0AN=)A@,:W&(TC\R60'S))<1Q_OB?,S&#YF:Y'X;
M?L-? OX2^)H/$7AOX>:?#K<!W6]UJ%S<7WD2!Q()8Q<R2".0%!^]7#C'4#B@
M#Z%HHHH ^1?^"@VK66B:7\!=2O[R"PTRQ^+>A7=S=7+^7%;Q1"Y,DCR'@ #U
MKV/]J_\ Y-9^,O\ V)FL_P#I#+77>.? V@_$SPGJ7AGQ-I-OK&BZA%Y=Q97
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M[,WPP^/GV5_'W@ZRUJZM BQZANEMKOR@9/W7VF(QR^5^]D/EY\O//7H?"/\
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M_37%7NWA7X7>'O"WCGQ?XQTS3?LGB'Q2+7^U[S[7+)]J^RQ>5;_NR?+3$?\
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MS^9KT+X;_L]_#_X2^#-7\'>%O#=O:>%-4FDFO]'N99;V&X\R.*.7S/M,LO\
MRRBZ=* /D;X__!>R\#_LX>*_'GC/]IGQ_P"(;G6=,N7MFM=;%KHNM7%U%*]K
M:Q6,0E'E2@_<BD\OR_-/[J.O8/\ G&?_ -TD_P#<-6SHO_!/_P#9]\.+?K;?
M#>RE%[;R6,G]H7-U='RY!@>499?W4H XEB_>CG'6O<O#?AW3O!GAG2] T>W^
MRZ9I-M%865J9?-,<<47E114 >=?LFZE8ZS^S+\*;NRNH+R&/PWIMJ)K:02$R
MQ6T44L9]XY8I8Z\Y_88_YN!_[*WKW_M*O2/AO^S!\,?@[XVU/Q9X-\)V_A_7
M-3BDM+J6UNI?*\J22*22**+S?*CQ)'&/W47'2NN\$_#KPY\.?[>'A[3VL/[?
MU>ZU[4MTLLOVF^E_ULO[W_KE0!\Y?\$Y?&6G6/P/M_A?>75O8>//!&HZGI>L
M:))=1&Y_=W4LDLL444N9(P;F.'S?^>H/7@TOCSQIIOQ0_;U^#NB^$[BVUV?P
M+INNZGXAFM+R&6&P^TP_8?*(\W/FQ2QCS(_^FL?7MZE\4OV1?A!\:-675?&7
M@FRU'4F),U_'++9RS?ZN+,LEM+%YI'EQX\WIVKJ?A7\$? OP1T>32_ _A6S\
M/6\H'FR1_O9;C'FX$LLG[R7'F2?ZWICB@#QOX$?\GK?M4_3PO_Z:YJT/CQ_R
M>M^RA_W-O_IKBKV3P[\.?#?A7QMXI\6Z?IIM-?\ % M1J]X999?M7V6+RHOW
M7^KB_=?\\JGU7X9>'?%7C'PKXMU/3#=Z_P"%Q=#2;S[5+%]E%S%Y<O[K_5R9
MB_YZUK3,JAYCX^_9_P#!GQ?\::EX[\#>++GP=\2M-E&FW7BKP?>1R'[3;XQ;
M7]K_ *NZ$<AA\V*7]YB**/.,5:_8[^,FI?&3P%XBEU74K/Q#=^&/$U[X93Q'
MI>([768K41>7?".(F.(2QR9_=DQ_A@"OX[_8)^ _Q$\6:GXEU[P#!?:Q?O\
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M>W?#3X5^%_A+X9M_#_A#P]9^'=(A'$5I'Y7F2>6(_-E/_+67]U%^]E_>58\
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M&667RO,E\V7][+^]_P!;+1X)^'/ASX<_V\/#^GM8?VWJ]UKVI;II9?,OI?\
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M%_C+XE6/Q!UGPG;S^,M.EMKN/5([F6/$ML08I9(HY?*D^Z/]9V&*VOBI\$O
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M#5[_ .)/#NG>+?#VJ:!K%N;K2]6MI;"]M1+Y)DCEB\J6*J'_  KGPW_PK?\
MX0#^SC_PB/\ 9']@_8/.ES]A\KRO*\W_ %O^JI@<S^S#_P FU?"7_L3]+_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^6;Q%I=E+,8HI?.,OV68@^5_JC^\\P<1?O#%W?[>OWOV<_\ LLOAS_VYI?\
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MS+XV:A)X7_86_99\<3V$MYHO@;4O!GB75_L.SS$LHK3RSY8>0;SYDT4>,_\
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M#/4_$FFZ3J?A^S\(>(1IC:Y;16LD5TTF$D\PQ2Q2#RS\^/.D \O) ,]-T/\
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M\*18:9IZ21QVT<G]JRR^;=2R21B.&/RO4>9(8X^#+FONZOC;X@?$SPI\,?\
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ME+_TURUQ7[>?AFUN/BY^S_KGB/Q9JG@#P=!J6KZ1?>,M$U'[#=Z=<W-K']E
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M%TN9=&U:..+S;J'][^]CEB _Y:?I^Z\WYPE_X:2_X;>.?^%5?\+ _P"%=_\
M43_LO^S/[4_[^_:?-_[9>57O?Q.NK+QQ^WE\$](T.\M=2U7P3IVN:IKUK#(
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MB7$E?H3^T]_R;3\6O^Q/U3_TEEKYH_X)$_\ )MGB3_L;KC_TCM*#/H>0Z?\
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M[(O/M<L?V7[5%Y5Q^[!\M\Q_\] >G&*E_P"%6^&_^%K?\+%_LT_\)?\ V/\
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MPNI;J>XN+I8)HI(9DAFEE,EOYD4LL9,1CZGV%>K?\*M\-_\ "J?^%=?V:?\
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M,OB!+XVUOX>:=>^)+B]_M"XD::Y%M/-D9>6V$OE29/\ K 4Q(<F0')KZ(HH
M\T^&?P9\(?!O3]5T_P %:#;^';#4-2DU2XM;623RA/((A(8X\GREQ%'^ZCQ'
M@8Q7(^,/V3_A=XV^+&F?$?6O",5SXVT^6VNK?5(KFXM]LMM*)8I7CCE\N0Y
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M:9J5K;:CI]]'+:W-I=Q>;%+%+_K8I8JXOX'_ +,WPV_9Y76C\/\ PW_PCO\
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M_P"/H;;PY''XF,=R)/,$R2"'[/'%Y9-M+=2?O.,Q1]^*]T_X)_? N_\ @/\
MLVZ-I^K>?!KNM2G7=0LY!C[++,D?E1&/RXY4,44</F1G)\WS>2*^F:*R ***
M*V **** "BBB@"*I:BJ6@"*MK2?^/6L6NBM8_+MT7T%8U!4R:BBBLC8****
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M@N)HI./>/\Z^CO@O^T9\._VAK'5;[P#XG@\0V]C.L-[&(9K:6)F!*$QRQI(
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M\:M+\4K\6/AI<?#_ %'29;;[%*^E7-C'?QRB;*B*XS@Q&+)(D/$L? ZR?5-
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M6?"WPAK?B73O[+\1ZAI-G=ZE8F&2$VMW)%&\L7ER?/'B3(VGD8YH [BOF/\
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M ."F/B?7OB]9?"_XV> _^$)\5:C=QVEG=6=M<VIBFF$7V6VN;2;S)$\SS/\
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M7(CC@@CT]: -BOS^_P"'T_P2_P"A7\??^ %C_P#)=?H#7XR?\$__ (M?LN^
M_@UJ^F_&RR\+WGBJ;7I9;:;6O"TFIS?8?L]L(P)!;2X'F"7"9]3CU /T5_9O
M_;*^&G[4T,\/@K5[N+7+:+[5<Z%JD/V>]MXO-*"0XS'(.!S'))CS8Q)@G%2?
M"/\ :_\  WQA^-'COX8Z/!K5GXI\(S7$=U#>01I%<+;W/V>:2&2.5\@2F/\
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MGY4ZOC'PA^VU\0OC!ING:Q\*/V>M5\::"VF6L]UJ]_KL>D6OVR7/FVUI+<Q
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M0/0J*^#?^":/Q ^)1^"7PT\-GX4C_A78_M(?\)W_ ,)%;9_X^;J7_CP_UO\
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M;K<EC/?0A(HXXI<B08 MXAB+R\]\FG?!?]BGX>?L^^+K'Q%X.&I6EY;>'/\
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M=S'>Q^;:F(2CS1^['ER9]C_USY+X!_\ )[O[5O\ W*?_ *:Y:]/^#?P$\'?
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M^&O!6BP^'](C>2Y-O'-++YDD@P))))3YDG_ZO2@#N****V **** (JEJ*I:
M(JEM(?.DJ*MG3[40Q[^YK$"W&/+C%24RGUD:A1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<5
M\0OBAX<^&/\ PCK^(]0;3_[?U:VT'3CY$DOVB^N"?*B^0=_+//3CK0!VM%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45CZQ
MKEAX<TN[U+4;RWL=-LXI+FXNKF01101Q_P"LD=SP !Z^E&CZY8>(]+M-2TZ\
MM[[3;R*.YM[JVD$L4\<G^KD1QP01Z>M &Q1110 4444 %%%% !117.^&_%FB
M>*/MZ:-J^GZPVF7DFGWO]GW23&VN8R!)%*$_U<HSS&>?SH Z*BBB@ HHHH *
M*X;PK\4?#WBGQSXO\':9J7VOQ#X6%I_:]G]DEC^R_:HO-M_WA'EOF/G]V3TY
MQ6OX;\6:)XH^WIHVKZ?K#:9>2:?>_P!GW23&VN8R!)%*$_U<HSS&>?SH Z*B
MBB@ HHHH **** "BBB@ HHKBOA[\4/#GQ._X2)_#FH-J']@:M<Z#J)\B2+[/
M?6Y'FQ?..WF#GISUH [6BBN=_P"$JT7_ (2?_A&_[7L/^$F^Q_;_ .R/M2?:
M_LWF>5Y_E?ZSRM_[OS,8SQUH Z*BBB@ HKBOA[\4/#GQ._X2)_#FH-J']@:M
M<Z#J)\B2+[/?6Y'FQ?..WF#GISUKM: "BBO%/C+^UE\*_P!G_5-,TSX@>+HM
M U#4H/M4$ M+FYF\H$CS3'%%(8QNZ>9C.Q\9\LT >NW</_+2JE5/"WBS3O'7
MA71_$6D7!NM'U:SBOK.X\HIOADC$D4F'YZ$'\:UKJ(1\UC4IFU.H5:***Y3J
M"BBN,\3?$[P]X5\;^%?"6IZDUGXB\4"Z.DV8M99?M7V:+S9?WF/+C(BY_>8_
M&@39V=%%% PHHHH **** "BBB@ HHHH **** "BL+PWXLT/Q/]N71M8L=7.F
M7LMA>C3[J.8VMS%@2Q2^7_JY1WCK=H$%%8?_  E>B_\ "5_\(U_:]E_PDGV+
M[?\ V/\ :8_M?V;S/*\[R_\ 6>5YG_+7IFMR@$PHHJ2./S: >Q-:0_\ +62K
M=%%>@< ^BBB@ HKD[#XA>%=6\:7OA*U\2:5=^*+&$W-SH<%_')>VT6(_WDL.
M?,C&)8^2/^6H]16IK&N6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_K)'<\  >O
MI0!L45CZ/KEAXCTNTU+3KRWOM-O(H[FWNK:02Q3QR?ZN1''!!'IZUL4 %%,I
M] !4<T?G1XJ2F4 <_-#Y,OE245L75KY\?_33UK'E_<UJ9!145%; 2T5%5;6-
M5L/#NE76IZC>V^GZ=8Q2W-S=74OE11QQ?ZV666D!>HJCH^JV'B+2K74].O;?
M4-.OHHKFVNK67S8I(Y?]5+%+5Z@ HHHI@%%%% !17E7_  U1\&?^BN>!?_"F
ML/\ X[7H^CZK8>(M*M=3TZ]M]0TZ^BBN;:ZM9?-BDCE_U4L4M("GX@\)Z'XH
M%BVLZ/9:N=,O8K^Q_M"UCE-K<Q9\J6+S/]7+_P!-*VJQ=-\6:'K7B#5=#L=6
MLKO6]',1U/3XKJ*2ZLO-_>1>;%_RS\T?TK:H0!1113 BJ6BB@ HK(\3>*M#\
M&:)<ZSX@U:ST31[<XDO]4N8[:UB/^J_ULE:]("*I?]=16G8V?E?O)/\ 6T-V
M GL[46D>*FI]%<IJ%%%% !1110 4444 %,I]% &-J%GY/[V.J%=%)'Y@YK'N
MK/[))_TRK6F9$5%145L!+116/XJ\3:=X+\+ZIX@UFX^S:/I-G+?7MR(O,,<4
M4?FRR_N_:D!L45C^%?$VG>-/"^E^(-&N/M.CZM9Q7UE<F+RS)%+'YL4O[SVK
M8H ****8!1110 45R?@'XF>&_B9_;W_"/:@;_P#L#5[G0M2S:RQ?9[Z+_6Q?
MO?\ KK6KX9\5:'XST2VUGP_JUGK>CW!Q'?Z7<QW-K*?]5_K8Z5P->BBBF 44
M44 %%%% !452U%0 445:M;/SI/\ IE2 MZ?9_P#+62M"BGURFH4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >2?&C]H'PA\ =/TN?Q/>W;7VM3_9]
M'T73;62ZO]3N% Q#;P1DDDGRX\\1[Y8LD>8,\?\ #;]L30?B'XTT[P?JG@WQ
MY\./$.L&0Z/:>-_#LM@=3\J*26Y\F0&1/W4:9(D,?^LC SFN%\52:?J'_!43
MP=I^MWX(TSX<7.I:#:7EZ41-1EO98I9(8B<22&V$N?\ IG%G_EED?5M]H=CJ
M%]I=S=V<-S-83_:;222/?]GF\J2(R1Y/R'RI)4R.TA'<Y /%OBS^UUX-^%WB
MZ7P=;Z5XH\?^.;&*.YNO#'@?2I-2O[6VD _?38Q'&.8^#)YG[V(XQ)FH/A-^
MV/X5^*WQ ;P)=>&_%OP[\8S67]H6>B>.-+&F76HQ?O0[VX,A\S8(CD<' )&?
M+D,? _L,2Z=>_$;]I_69[S[=XMD^(][I]X9KTS7*:=;?N[%/+)S'$,W,<?3_
M %9CR?*XM_MS:M8Z7XT_9KN+74+?3_%4GQ,TVWM)HY5BOOL,BR1WT<6/WGE2
M^9#'*/\ 5G,0DZB@#K/C1^VM\//V??%U]X=\8G4K2\MO#G_"11RI%'LNXS=&
MUCMHLOYDER9 <#'E^6#(9 !QCZ#^WQX(F\8:=H/C7PQXR^#[:K#/+9:A\2=)
MBT>SN#$!YD8E:8C/[P'!&.>N7C!RKS1['4/^"IFG37EI;W5Q8?"7[7:22Q!S
M;R_VO+$9(R?N'RY94R#TD(YIW_!0;2;+6]+^ NFW]G!?Z9??%O0K2YM;E/,B
MN(I1<B2-XSP01ZT -T?_ (*/?#;5-2T2:YT3QEH7@C6-2DTRP\?:QH?V?P[<
M2;I I-SYN<.89.3&/+S^\$?ER8]Q^/7QITC]GWX6ZQX]\0V=_>:-I/E?:H=,
M2.2X_>RQQ#R_,DC!YE'?_ ^0?\%1/^3%_B9]=+_].EI1_P %1/\ DQ?XF?72
M_P#TZ6E %#7O^"B7@2VG\3R:!X+^(/C[PQX<>6.]\7>$]"2]T8M#'YL@%UYH
M_P!6"/GX'_+0$QD2'WWPO\5_"?C;X=VWCW2=?L;SP;<61OO[:,PBMXXXS^\E
MD\S'EB,A_,\PYC\OD9!KI-'T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_]7&B
M#@ #T]*_,+Q(W_"%_L(?MB6GA[&@VEK\5]2L+:+2C]ECBMC?6$)BC$8P(_*)
MC,8X\O(Z<4 ?44/_  4$T#6$:]\'_"OXM?$+PS*Q^S>)?#/A*6>PO1_RT\F2
M5XI/W<GF1G,?6,XKV7X+_&?PI\?_  #I_C#P;J1OM/N"(Y(92/M-G-_RTMYH
MO^6;CZ]P1E,9Z#X=Z=X?TCX?^&;#PI/:R>&+73+6WTF6UN/M,)LXXE6+RY<G
MS 8\8?/.0>:^=/V7=2LYOVO/VJ;'0KZ"30+?5-#N#9:?,/LL=])92"^E\I/W
M8EDEB(E(_>&2+]YR* /;O@+\:=(_:"^%NC^/?#UG?V>C:MYOV6'4TCCN/W4L
MD1\SRY) .8CW_P  WP?\;-'\9?%;X@_#^RL[^'6O!/V :G-<H@MY/ML)FA\L
M^9D\ ]0/2O(O^"7?_)B_PS^NJ?\ ITNZ3]GG_D^K]KC_ +E'_P!-<M &C\3/
MV[/A[\+/&WBSPCJ]OK5YXOT*\TVP@T72K6.YNM:EO8_,CCL8A*&<QJ1YAD$8
MR8P,F2,'2^$W[8_A7XK?$!O EUX;\6_#OQC-9?VA9Z)XXTL:9=:C%^]#O;@R
M'S-@B.1P< D9\N0Q\=\!]+LKC]O;]J?4I+2W?4;:'PS:0W3QCS8HI;#,D8?K
M^\,41QG_ )9QU>_:&_Y/J_9'_P"YN_\ 37%0!VOQM_:T\*? O7]"\-WFFZ]X
MO\8:T9'LO"OA&Q%]JDD48D,EQY7F#]U^[('.>), ^7+Y?S1\?OVDM$^,FK_
MO0QH7BCP/XKM/BUX9O9?#?C;3?[.OY+(_:$^U0Q$G?#YF8_,'208X_=UZ5\'
M;K3=6_X*,?M$3:K?I-XATC2-!L-%@N;TF6'3I;:*6ZCBB)($?V@V[G X>7_I
MJ<S_ +>FBV<VM_LY:FUI ^H6_P 6]"M8KKRQYL<4OF&6/?UQ(88L_P#7./T!
MH ]&^-O[6GA3X%Z_H7AN\TW7O%_C#6C(]EX5\(V(OM4DBC$ADN/*\P?NOW9
MYSQ)@'RY?+ZWX)?&'3?C9X:OM7L=&UWPW=6-\VGWNB>)=/\ L5]93>5%+Y<L
M1SC,<T4G4\2#FO-/C+\"?'MQ\9M/^,?PL\2Z7IOCFTT-O#EQHOBBT>72M0LC
M<"0;Y8P)82CN\GR9\PQQ#Y!YGF=-\"/CQ=?%W4/%.@Z_X8N/ GQ#\)RVT.O^
M&IKV.^6U6YC,MM+%<Q?NY?,B'3JAR#C^, ],\7>(U\)^&-9UPZ=?ZLVFV<MS
M_9^FQ&:ZN/+C+^5%'G]Y(<8 [DU\&?"_]M[6K;]HOXX75]\,/C5K^BSMH?\
M9WA6UT"2XN= Q;2>:9;4RXMOM!Q*,?ZS&3TS7Z*U\J?L\_\ )]7[7'_<H_\
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M$#S,HZ;),8<8.,5ZE7YX_!O5+&^_8M_;!M]%OK>[\*VFN^-+70HM.E\RQMK
MV7F116PC/E1PYD,@\O\ =_O3CKP ?<GP\\8V/Q&\!^&_%VFQ30V6OZ9:ZG;)
M<C]XD4L0EC#\^CUSOPB^-6D?&9?&::1:W]G_ ,(KXDO?"]]]O2.,R75KY?FR
M1[)#F/,@Y."?0=ZG[*'_ ":S\&O^Q,T;_P!(8J\K_8*^]^T9_P!EE\1_^VU
M&9X>_P""BW@?QEX7TC5O!O@CXA^/+B[BDDO=*\+Z"FH76DCS98XA?".8I$9?
M*D>-/,Y09XXKZ^KY"_X)9Z/96/[$O@6XM+6&WDOIM1N+IXX]AGE%[<Q"23&-
MY\N*).>T8]!7U[0!X[\=/VBO#_P*71;#5+'7?$?B;7!(-(\.^&=,FO;_ %'R
MO+^U>5&H\O\ =QR"0^9(.,]<5Y/X-_X*&^&?'GQ2M?AW9_"_XI:;XKEDBBN+
M34O#T41TZ.22,?:;J,7/F11#SHR9"/XL^F>>^.?C>+X1_MV:'XMT[P[KGQ O
MG^'$MAJ_ASPY:>9?Z;9#4XC;7T2$@77F7,AB,4?,8C,IXKJO@;IOB'XL?M-Z
MU\;[_P %:[\/_#,/@Z'PII&G^)(HHK_4#]NEN+FXEB\SS+;RY(Q'Y<@/F"02
M9'(H [/XK?M=>"O@[\29O _B*+5I->DT"/7;*UT^UCF.IF6Z-K%8VL7F>9)<
MRR XC\O&,YDXKI_AC\;K7XC> M4\5ZEX6\4?#/3M+DFCNH?'EA_9<R11Q1RR
M7.#+CR<2']Z3UBEKQJ\T>QU#_@J9ITUY:6]U<6'PE^UVDDL0<V\O]KRQ&2,G
M[A\N65,@])".:V_^"DVL7^B?L6?$VYTZYN+*1H+*V,MO)Y9,4M];12Q\=I(Y
M9$/;!H S8?\ @H)H&L(U[X/^%?Q:^(7AF5C]F\2^&?"4L]A>C_EIY,DKQ2?N
MY/,C.8^L9Q7=:'^UAX+\8?L^ZA\9/#,&H>)/#FFV4EU?6&G"/^T+7RL2W,4L
M4DD<2RQ1@R']YR.8C()(_,]+^'>G>'](^'_AFP\*3VLGABUTRUM])EM;C[3"
M;..)5B\N7)\P&/&'SSD'FOFK]G>;1?$'[4G[7?AVV%CK/@M[S1Q<Z/#Y<U@U
MS+8RQ:AYD7^K\R22,QRC&28B).1R ?0&C_%S0=0^#-G\49Y+K2?"MQH4?B.1
M[F+=-;6)MOM&98XS)R(SDB/)],U7^ OQITC]H+X6Z/X]\/6=_9Z-JWF_98=3
M2..X_=2R1'S/+DD YB/?_ ?"&BZI>>"_V*?&/[/%GJ\.A>/+#QL?ACILFHQD
M'4XM2O?.CNIK;RI#;0W-K)<^7)^\&(R8Y,X ]-^%?C+3/V2_B-^U)X&L-%:'
M0]%LIOB=X?TO[,;47D;V*_;8HY8X_*2VCEBBABQ'D?/_ *WRS@ ]I\0_&[P-
M\3/AQ\<$O=*UK5/!G@E-3T?Q#*I2(7YBMC)?VUL!*),QQL(S(PC'[W]U(>HZ
M/PMX[\*>#/V7-(\;:)I>HV7@+2/!T6LV&G!Q)=Q:;%8B6*+]Y)_K!$ .9>2.
M9*\0\,_#&\^&?_!-+QK:ZPMS)XIU;P1K&NZY=7]N8KZ6^O+2:YE-UYA\R26,
MR>47E/F?N?PKI/\ G%G_ -T;_P#<+0!FV_\ P42\%:_>&/PAX(^(GQ(']GV6
MHWG_  A&@IJ(T[[5#YD=M=$3<2XZXX!!3K'(![A\%_C/X4^/_@'3_&'@W4C?
M:?<$1R0RD?:;.;_EI;S1?\LW'U[@C*8SB?L=Z39Z/^RS\)+:PLX+*WE\+:==
M&.V01CS)K>.65R/5Y))']\U\\_!'3M,U/X$?MH66L:G_ &#HUSX]\9QWVI-;
MFZ-E ;2(23>4AS+Y8)/ECKC% '6>(O\ @I5X T'0+SQ-:>"/B9XC\!Q$%/&V
ME^&C'HTWS"+$<UQ)%TE_=\@?O 17MWP"^-EG\?O J^*=+\,>)_#6FR2+'9Q>
M*K+[+-=Q&**6.XB >020N)1B4'G!],GX\\(_&_QYXR_8UT;X-Z-\"O'E]XNU
M?P+'H-CJGDPQ>'YH9+#9'<C4I)1&,VQ$OED?ZS]UP>:^Y/A3X$7X;?"WP?X.
M-U]N;P_I%EI?VKR_+^T?9HHXO,V=L^6* .TKXUTG_@I5\/?%FFZ!-X3\+>._
M'NLZE9SW\NA^%M(BO=1TZ&*Z^S>9=11R_N_,ZCGH8R?+\R//V57R%_P2ST>R
ML?V)? MQ:6L-O)?3:C<73QQ[#/*+VYB$DF,;SY<42<]HQZ"@#UK]G_\ :&\+
M_M#:3J=[H!U"RU31[^6PU?0=:M_LNIZ3,"1Y-Q%DXSL.,9!P03YD<@%#]FO5
MO &KR_%;_A -!OM$%KX[U2U\0-J$N?MNL+Y/VFYC_>R8CD_=X \L<?ZL5YK9
MZ/8Z?_P5,U&:SM+>UN+_ .$OVN[DBB"&XE_M>*(22$??/EQ1)DGI&!Q6C^P5
M][]HS_LLOB/_ -MJ ,#2?^"E7P]\6:;H$WA/PMX[\>ZSJ5G/?RZ'X6TB*]U'
M3H8KK[-YEU%'+^[\SJ.>AC)\OS(\^S_L_P#[0WA?]H;2=3O= .H66J:/?RV&
MKZ#K5O\ 9=3TF8$CR;B+)QG8<8R#@@GS(Y /)?\ @EGH]E8_L2^!;BTM8;>2
M^FU&XNGCCV&>47MS$)),8WGRXHDY[1CT%+9Z/8Z?_P %3-1FL[2WM;B_^$OV
MN[DBB"&XE_M>*(22$??/EQ1)DGI&!Q0!W?Q9_:Z\&_"[Q=+X.M]*\4>/_'-C
M%'<W7ACP/I4FI7]K;2 ?OIL8CC',?!D\S][$<8DS5OX)?M:>%/CIK^N^&[/3
M=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#^Z_> 'G/,>0/,B\SY@^!;?M"ZE\0
MOV@]<^&)^&=W:R?$G5M.O=1\=#49-4?[-Y<<4(EMO^7:*)D$49_U>9 ,"O0_
M#?P#^._B[]J#X8?%3XFI\+[.+PBFH6LLWA$WZWMS%<6DD4,;FXC/F".20D#S
M!CS9.YH Z?\ 9Y_Y/J_:X_[E'_TURUW/[->K> -7E^*W_" :#?:(+7QWJEKX
M@;4)<_;=87R?M-S'^]DQ')^[P!Y8X_U8KAOV>?\ D^K]KC_N4?\ TURT?L%?
M>_:,_P"RR^(__;:@"+7O^"B'PZTK7M4\/6&A^+?$OC.R\17WA[_A%?#^G)>:
MG</9C,MU'$)?^/;'_;0D2'R\1R$=U\$OVM/"GQTU_7?#=GINO>$/&&BF-[WP
MKXNL18ZI'%((S'<>5YA_=?O #SGF/('F1>9YS^P7HMG#K?[1NIK:0)J%Q\6]
M=M9;KRQYLD47EF*/?UQ&9I<?]=)/4FM#_G*9_P!T;_\ <U0!U?Q9_:Z\&_"[
MQ=+X.M]*\4>/_'-C%'<W7ACP/I4FI7]K;2 ?OIL8CC',?!D\S][$<8DS5OX)
M?M:>%/CIK^N^&[/3=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#^Z_> 'G/,>0/
M,B\SY@^!;?M"ZE\0OV@]<^&)^&=W:R?$G5M.O=1\=#49-4?[-Y<<4(EMO^7:
M*)D$49_U>9 ,"O0_#?P#^._B[]J#X8?%3XFI\+[.+PBFH6LLWA$WZWMS%<6D
MD4,;FXC/F".20D#S!CS9.YH ^TJ*** /+?@G\<M*^..E>)[S3]'U31Y?#>NW
M7AW4;#5Q;B6*]MQ&90##++&1F7&1(>A^M9OPM_:1\,?&#Q]\2?"'A@ZE<WW@
M&[BLM2N;JW$-M)-(9OW<?_+0F-[>6(Y0#@$>9G->(:5?Z#^RW^VE\6KK5HK?
M1O"WC[PK'XR_M(V_V>*&XTQ95OK>*.,'[5,8Y9;V7R_WG.?+.?,KQGX'V]U\
M#?B'^S3\4M?2&;5/B]IVJ:5XKUNSL#]GENM1NO[4TS_5Q1^7=32311'S 8_+
MB('[N+S* /NB\^-6B6_QITWX6K:ZI?>*+K29=<N#;1(+:RL8I3$LLKR2#(EE
M_=@1^801\XC'-?'GP'_:H\*_ #Q!\9?#=[I^N>,?&&O?%_Q)/9>%?!MC]NU-
MXHQ&9+@Q&0?N_P!V1UY(DQD1R>7[5^RWI-]X]^-GQV^*VMV=Y:7$VO\ _"&:
M'%J"%S;V&F$1RR6UQ@ 17-SYDDD48V"6(Y,AYK-_8+T6SAUO]HW4UM($U"X^
M+>NVLMUY8\V2*+RS%'OZXC,TN/\ KI)ZDT >C?!+]K3PI\=-?UWPW9Z;KWA#
MQAHIC>]\*^+K$6.J1Q2",QW'E>8?W7[P \YYCR!YD7F2?VM\/_\ ALC^Q_[
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M_P"D$M #/"OCGPIX%_9ETKQMHFFWMOX'T?PC%K-CIS'S;J+3XK'S8HOWDO\
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MNFL5U"RT7QMIHTR[U*(^;YLEOF7]X1Y1XZ\9&1')Y9\5OVO/"?PQ\?+X'M-
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M<:%JS7NBW-W>W&LV]CY4NY?-BS;2R^5T/Z1YX /LW_A*M#_X17_A)?[7L_\
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M'XKZY:6UK;)Y<<44/V41111=NG3MBO-_V<_^40VK_P#8H>*/_1M_68'I%O\
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M==>:^V/A;X*'PS^&/A#PE]L%^?#^CVNE?:A%Y7VGRHHHO-\K_ME0!U=%%%;
M%%15?M=/\W_64K@16MGYW_7*MJ*+RZ%C$?2I*Y34**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MIIU;P[J/D_:;/[3)#YOERQRQCS(R)!^\CCZ'MWH ^=K/]D/XD^%;F^T#P?\
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M-CA]ZMT^BLC8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P <V,4=S=>&/ ^E2:E?VMM(!^^FQB.,<Q\&3S/WL1QB3-0?";]L?PK\5OB
MW@2Z\-^+?AWXQFLO[0L]$\<:6-,NM1B_>AWMP9#YFP1'(X. 2,^7(8P#Z(HK
MYW^+/[8_A7X4_$!? EKX;\6_$3QC#9?VA>:)X'TL:G=:=%^Z"/< 2#R]XE&!
MR<$$X\R,R>I?"GXB:=\5O >F>)M+@U"RM[XS1O8ZI;&VN[66*:2*6VEBX\N2
M*6.2,CUC/)ZT =M6/K&N6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_ *R1W/
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M.D?L^_"W6/'OB&SO[S1M)\K[5#IB1R7'[V6.(>7YDD8/,H[_ .! /2Z*^?O
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MT'X9^$]2\3>)M6M]'T73XO,N+VX)PGI[GG^ "OG@?\%"/ ]EC4=6\"_$S0O
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M" >T_88_2F?V>/6LWQ1XJTWP1X5UCQ%K%P;71])LY;Z\N/++[(8HS)))A/\
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MJ7_@J)_R8O\ $SZZ7_Z=+2NV_:*_9Y_X7?\ \(GK6C^+-0\#>._"-[]K\/\
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M_MH7W[4NI_L@>*KOXDZ?\,-*\*7*:=+J6GZ7]N&J6[?;[<)$"9)+;(E\O?\
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M^L^%_#WC'4O &LWQA^S^)-)W_:;79-'(1'LEB/[P1F/_ %@XD_"@#TVBN6\
MZ#?^&/ GAW1=2U>XUV]TS3;:RN=5N?\ 6WLL<8CDN),D\R$;^2>O6NIH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $H
MI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0/-$<L49D&[KY><;TSCS!65XT_;7^"_PX\?:GX)\2^/[?1O$FG)Y]S9W5A=
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M\:/KEAXCTNTU+3KRWOM-O(H[FWNK:02Q3QR?ZN1''!!'IZT ;%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\7?MH?\
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M>-D\'ZNG@NSB\YO$$MK)%8MG0X[;Y)9!LD/FR"/RXSD8/:,XC_X*W?!OQO\
M&;5/@UI7@GPIJWBF>.74XII-/MY)([4R&Q$9EE_U<0.&^>0@<>U ''_MZ?\
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M_#OA'XP^&;)YUT/PS\3M<T;1[*:>23[#91>28XH_,)P,R.?<R9)KV_\ 9_\
M#>H^#?@#\./#>LV_V75](\-Z;I]]:[@_E2Q6L4<B93K@@UP7[(GPS\2_#=OC
M-_PDFFFP'B'XD:QX@TUO/C?[197/D^5)\A."?+/!YH ^AZ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"_L*_!CPE\+M+\%:A\//"_B*2UTX6&H:Y=Z5$+V]D*8EN?.R98RSM(0!)F/
M\LC8* /=_$WB?0_!NB7.LZ]JVGZ%H]N?](O]4NH[:V7G8!))(0!SQS[5D_\
M"V_!?_"=_P#"%?\ "8Z#_P )CG_D7?[2B_M#_5>=_P >V?,QY7[SIT]N:^9?
MV^O!-E\.O^";OB7PGITTLUCH&F:'I=LUQCS'BBO[*-"_'7"5[?\ #+]F;X=?
M"W^RK[3/"^GW_B6S>69_%VJ6T5QK=U-+YGG7$U[CS)))?,DR<_\ +3TXH 7X
M#Z"FBR?$(M\2Q\2/M?C'4[L;KCS?^$?\PP_\2?\ ULFSR>/W?[O'F?ZL5J7W
M[0'POTG1=,UJ\^(OA*QT;53)_9VI7.N6L5K>^4?+E\J4R8E\L\''M^'C_P"P
M5][]HS_LLOB/_P!MJ\<_X)Q?LL_#?Q3^S?X-\>^+?#</C37[V"_LX_\ A) +
M^ULK9-0E"PVMM)F.(>9&92=OF>9--SB0B@#[O\,^)]#\9:);:SH.K:?KNCW!
M_P!'O]+NH[FV;G81')&2#SQQ[U3\;?$+PI\.=+AU+Q5XDTGPS8R2_9HKO6KZ
M*UA>4@_N_,D(Y^0_E7S+^R/X4L/A[^U-^U!X.\-P_P!D>%-/OO#U]9:-;RD6
MMO+=6#R7+QQ!L1^9A>G]R,=(QCP32?B#X3\7?M"?&[Q9\0_@;X]^,NMV?B6[
M\):<=$\*_P!NZ+I>F66(XXHXY9,17,AS+(<?\M<Q^7YLF0#]%?!/Q"\*?$;2
MYM2\*^)-)\36,<OV:6[T6^BNH4E '[OS(R>?G'YUU=?G3\&Y1;_MH>#=<^%/
MP@^)WP=\&^(+&]L_&NFZUX6.FZ-<&*U=["6.-/,BAE$F03^[[8_UTOF?HM0!
M\2?&;PEKGQB_;P@\ K\2_'W@KPU;_#=->,/@O7Y+ R7(U.2++@ IS')UQG]V
MG)'%5?'?A/QI^Q_XP^%.I>'_ (O>,_&&C>+?&NF^%=:T/Q]>IJXECN1-B2UE
M\J-[8Q@2_P"K_P!83%GB/RWJ_&7P=X[\9?\ !16"Q\ _$+_A6^N)\*HY9=6_
ML.'5?,A_MB0&'RICCDF,^9_TS]ZY7XX> _'W[.?B;PA\=OBSJ]C^T)X<\)WL
M45VESIG]D77AJ.63RXKNPMH[G[+-*998B?,C,F8K;!CQYL0!]=?'C04UJ3X>
ME?B6/AO]D\8Z9=G;<>5_PD'EF;_B3_ZV/?YW/[O]YGR_]6:]'UC7+#PYI=WJ
M6HWEO8Z;9Q27-Q=7,@BB@CC_ -9([G@ #U]*^;/V]?O?LY_]EE\.?^W-<Q\<
M/"O_  O_ /;J^'OPS\4-%=^!/"_AB7QU)H\D,LD6JWGVDVB17(\P1%8_W<@S
M&>&EC.1+P ?1/AW]H#X6^,M:MM&\._$CPAK^L7!)@T_3-=M;FXFP-_R1QR9Z
M#]*['6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_ %DCN>  /7TKY5_:J_92
M^%NG_ 7QKKWAWP3I7@SQ!X7TZZ\2:/K_ (/L8M,OK6]LHI)HOWT40.,QD'/K
MD8D$<@S?VAO"OCG]J_\ 9#^%6L:5H,'B.]U*30O$WB+PA9:O)I<6LV?E>;=6
M,<A.(U\R2)QYDF1Y><F2.,$ ^GO ?Q;\&?$Z2_'@[QEH/BW["(_M7]AZC%?"
MW\S/E^88B<9\N3KZ&M?Q-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV 222$
M <\<^U?.O[-.O_ CQAX^O)/ O@&W^&7Q+T?3WBU/PU?>'_[!U2VLKB6*0>;;
M1_NY1F*UD\P&3RQ)'GR_-Q7(6O@'3_VCOV]OB9_PG=EI_B+PQ\+M*TS3-'\.
M:E:_:;6274K;[3)=212R>69.)(_]7R##WAR0#ZM\$_$+PI\1M+FU+PKXDTGQ
M-8QR_9I;O1;Z*ZA24 ?N_,C)Y^<?G7%_ ?04T63XA%OB6/B1]K\8ZG=C=<>;
M_P (_P"88?\ B3_ZV39Y/'[O]WCS/]6*B\(?LP_#CX=_%"+QQX2\-6/A36AI
M4VB31Z%;16=K<0R313#S8HEP908A^\X)$ASG$?E^ ?L\^,[SX=_!S]L7Q98+
M#+J.@_$7QCJEM#<?ZN22&VBECW^V8Q0!]2^,?C1\._AYJ:Z;XO\ '7AGPQJ4
MD?VA;/6M7MK21X^T@CDD!(^3K[5TVCZY8>(]+M-2TZ\M[[3;R*.YM[JVD$L4
M\<G^KD1QP01Z>M?F7^S]K_PLT+X5>'YO$7[+?Q3^)_B;5HH]9U;Q;JW@6/6C
MJEY<Q"66:*YED^:(EOW?3(.\Y>21S[A_P3XM=9\-ZY\5M#M/"WCSPC\*+?4+
M&Z\'Z#X^L'MKFP^TB4WL<7F=8Q*O \Q^"#_K))#( ?3>J_&OX?Z#IE[J6H>.
MO#>GZ;9:C+HUS=W6K6T<=M?1C]Y:R.9.)@,$Q?ZP=QZ:W@GXA>%/B-I<VI>%
M?$FD^)K&.7[-+=Z+?174*2@#]WYD9//SC\Z^*?V5/V9_A]\6?'_QR\6>-]$;
MQ1=:3\5O$%IINE:O,;G3+7F,RR_9O]6\DOFQB0R[_P#CVAQ@QYKK_AW\/O#O
MPE_X*/:_X=\':5#X5T'6_AA%K%[HNDK]FL9;R+4_LT<PME(C!$8P, <R2=Y)
M,@'U/XV^(7A3X<Z7#J7BKQ)I/AFQDE^S17>M7T5K"\I!_=^9(1S\A_*KGAGQ
M/H?C+1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]Z^-_@#\(]!_:1^.?Q
MY^)/Q'T;2?&4^E^*;GP+H^FZI9_:K73+*R.3)%'-))&3+YD;G]V,2"4CB5Z]
M=U'X:^$_V6O"/QG^)7P[T#3_  ]J,OAS[=/I,<'E:69].MKF2*46\>/+$GF8
MD$9&?+S@2&0D ],\8_&CX=_#S4UTWQ?XZ\,^&-2DC^T+9ZUJ]M:2/'VD$<D@
M)'R=?:NFT?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B..""/3UK\R_P!G
M[7_A9H7PJ\/S>(OV6_BG\3_$VK11ZSJWBW5O L>M'5+RYB$LLT5S+)\T1+?N
M^F0=YR\DCGW#_@GQ:ZSX;USXK:':>%O'GA'X46^H6-UX/T'Q]8/;7-A]I$IO
M8XO,ZQB5>!YC\$'_ %DDAD /IG5/C5\/-(\8)X5U+QWX:T_Q2\D5H-#N=7MX
M[_S)2OE1B'S/,)D\R,@ <\>M>AU^8WPC\#_#/X(^'+GP!^U'\*K6W\0:UJ=S
MY_Q2UJU_M.RUR6YD81G^TCF:RF*"23#^5Y<</G2&.24U^G- 'C?[2OQTT/X$
M_"_Q%K-WX@T'2_$<>CWUYH>GZW>1Q#4[J&(R)%''YD<DN9/+4B,Y_>#UJO\
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MB.*(/_K)3CB,<_E5K6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_ %DCN>
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M&P5Y)_P4$^!W@GP7^PKK1M]!L-1UCPCHVC:!IGB'4K&&34X;6.^MHL?:/+W
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MCO\ 5KR**27RQY7V:XBMIHQB/RQ'+%T/.0#Z[\1?M ?"WP;K5SHWB+XD>$-
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M)'>?\)%_:?E_9?[2^P2_V5YO_+3R]_VK/_++&?-XQ0![=_PU=\$?^BQ> /\
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M"\I!_=^9(1S\A_*OE'_@F+\)_!;_ +*_PV\;?\(=H(\8DZF?^$A_LV+^T/\
MC^NHO^/G'F8\K]WUZ>U4?@#\(]!_:1^.?QY^)/Q'T;2?&4^E^*;GP+H^FZI9
M_:K73+*R.3)%'-))&3+YD;G]V,2"4CB5Z /K'P'\6_!GQ.DOQX.\9:#XM^PB
M/[5_8>HQ7PM_,SY?F&(G&?+DZ^AKPG_G*9_W1O\ ]S5<E\=OA?X7_9P^+GP.
M^(_PY\/:?X1UO5O&5CX(U*QT>$6-A?:;?"7S/.MH?+#R1M&KQGU$9D$GEQ[.
MM_YRF?\ =&__ '-4 >G?V&/^&G_[8_X6:_\ R)WV3_A6OVGYO^/[=_:_E>;Z
M?Z/YGE=./-[5V?C;XA>%/ASI<.I>*O$FD^&;&27[-%=ZU?16L+RD']WYDA'/
MR'\J^?O^<IG_ '1O_P!S5<)\ ?A'H/[2/QS^//Q)^(^C:3XRGTOQ3<^!='TW
M5+/[5:Z9961R9(HYI)(R9?,C<_NQB02D<2O0!]8^ _BWX,^)TE^/!WC+0?%O
MV$1_:O[#U&*^%OYF?+\PQ$XSY<G7T-=M7Q-\=OA?X7_9P^+GP.^(_P .?#VG
M^$=;U;QE8^"-2L='A%C87VFWPE\SSK:'RP\D;1J\9]1&9!)Y<>S[9H *^9/%
M'[%2^)/%&K:T/CO\:M(;4;V6Z.GZ/XM\BTM?-D,ACAB$)\N,= ,\"OINB@#\
M[/V/?V=]<_:(_9S\)>/M>^/_ ,;+36=6^U?:(M-\9R16P\JZEA&P21R'_EEZ
M^M>G?%3P]_PB/[7?[&VA+J5_JG]GV?B>V-]J4OFW5SY>D1)YLLG_ "TE.,D^
MI-;?_!+O_DQ?X9_75/\ TZ7=<9^VA\.=-^+7[4W[,?A+5KC4+?2M3_X2>.\^
MP7+6TMS#]A@>6V,D8SY<H!BD ZQR2#/.: /I3P[^T!\+?&6M6VC>'?B1X0U_
M6+@DP:?IFNVMS<38&_Y(XY,]!^E>DU\ ?MY?LX_#7X0_LBZWXG\&>"M)\)>)
M/"DVE3Z-KVC6YM+^UD%[;Q"3[3&?,D.R0\R9_>?O/]8 1Z)_P4>\87^A_!71
MM MUUF73O&'B?3/#.KP^&\_VI+83&62:*QYP99?)$6) 4<2%#UH ]P_X:"^%
M_P#PE/\ PC?_  LGPC_PD?V[^SO[)_MVV^U_:_,\ORO)\SS/,\W]WY?7/'M7
MI=?F?XCM_@7XJ^'\_A!OV+_B]I-LUG]DBU32OAW%#J< 0?NY4N?-\PR@@',F
M_P S&)/,!.?K;]BZ\\;ZE^S+X'E^(\6KQ^,X[>X@OQX@ADBO_DNI8XC+YGSY
M,4<1\P\OD.>N: />J\T_X:"^%_\ PE/_  C?_"R?"/\ PD?V[^SO[)_MVV^U
M_:_,\ORO)\SS/,\W]WY?7/'M7!_MU?$76/A'^R?\2/$F@S?9]82QBM;:Y\R1
M)+9KF>*U\V,QX,<D8E\R-L\./K5#P+^PK\&/"7PNTOP5J'P\\+^(I+73A8:A
MKEWI40O;V0IB6Y\[)EC+.TA $F8\#RR-@H ROV"OO?M&?]EE\1_^VU>V^,?C
M1\._AYJ:Z;XO\=>&?#&I21_:%L]:U>VM)'C[2".20$CY.OM7R)^RKJE]\$OV
M=?VK=1TV\NO$5]X1\;>*KBWNO$4IN);V6UM8MDMU(/+\TR&+,A!&<GI7EG[/
MVO\ PLT+X5>'YO$7[+?Q3^)_B;5HH]9U;Q;JW@6/6CJEY<Q"66:*YED^:(EO
MW?3(.\Y>21R ?IIH^N6'B/2[34M.O+>^TV\BCN;>ZMI!+%/')_JY$<<$$>GK
M7,^,?C1\._AYJ:Z;XO\ '7AGPQJ4D?VA;/6M7MK21X^T@CDD!(^3K[5\P_\
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M..UT:Y^WQR_V>,RR22'RXY)9)>8_,F>,2$1QUZ?_ ,*Q\1?\-Y?\+$_LP_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BOF/XZ>*M;T?]L?\
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MMEX<\6&Z\"Z!8W5GXICUY_M.J:N1:I'8R^;Y.3+YH\R4[XLYSSTH ]AHHHH
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M#WQ%;1O^$?76?M.W3A=&Y\H17,L)!D\N//,6>G>@#UVBOF/X%^*M;UC]L?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6-)4&[AB^QP>=Y/_ #RDDB\V,2@9B\SS!_JZR/@7\08?V7_$WA;P1K_[-O\
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MUSQ5;1:1JGB"26WBCAM9+:,F2XBB,=M(DDI\O]W)C!B < [#_G*9_P!T;_\
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M[8E?2KCR_+L)9?W<D0A^S1CRMYZ= @CDDZ?]C'3OBG>_M%?M$>+_ (E>!Y_
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M_$#5EEFT>1+J.YLM.LHA:V<,T<H'[W]W-(9 /WGF@\#$<8!2_P"<IG_=&_\
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M#?[7F@_&2T\ :]X]\%WG@^3P9?6GA.W^U:G92BZDNXYOLO DC/$8.>/WA/\
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MQK=YI.H6ND:R?#/]FW]U;216][Y-A)'-Y4A&)?+/!P>I_&CXZ>%=;UC]L?\
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MB]%\,?%NB_!36_@2/@+>:U8R7WAZ+3[V+4[75I+>+%R9;F)!FY$441)D,DA
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MC\?8* /S(_8=_8M\'_'K]F[P'XK^*&H:OXST^.+4K;0O#8N9++3M*C-]()7
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MHB:^/FB*X^U?:(1;$20R2R21[8\X\O\ U9,1^S?VG_\ A+_CY^S;X4\7^%?
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG'V@$^2?,EC\Q/+QYDG4_2]%% !1110 4444 %%%% !1110 4444 %%%% '
M_&SP7=_$3X.>/?"NG-#%J.O>'[_2K:6?_5QR36TD4>_VS(,T?!/P7=_#OX.>
M O"NHM#+J.@^'[#2KF6#_5R20VT<4FSVS&<5WU% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!X5\3_@[K_C3]HSX(^/[&:P
MBT;P/_;G]HQ7,K^?+]NM8X8Q$-G4$$G)'I7NM%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?(<OP
M)^-OP0\7>.-1^"OB7P;K6A>,_$%QXDOM%\=6%RC:=?3>693;36I'F"0C_EJ/
MW8BC R3+(=+X6_ ;XJ>)OC3H_P 3_CAXE\.:O?\ AR*\M_#OASPG:RI8Z6US
M';QS7(N7V2R>8D4@,4OF ";((Q@?55% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?[-L+JYDEM[+SK"22;RHR<1>8>3@=1^%>2?"'X;>,/VS_@[_ ,+9O?C7\0_
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MYX4/C3PA>RB&\N+:.&2+5+;R3$=I+H_E@B.7!Z1R>6//M:_:0^(_Q.\'Z?\
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MECJ-_JEU$9;:W2Y\S?Y7DOYG^K(\R.42#F)P >E_M=_$SQ+\-V^#/_"-ZB;
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M?R9/+(DMH[J4B(7(DB_U1C'F9,= 'T[17PO\:OC,OCW]I'Q)\+-7^--I\$O
MOA+3K=]9EMM1MM,UC6;^Z_TF(65U*<QQ11>5YAC ?]Y)&1()1)'Q^G_$ZW_9
MX^.'P]@\"?M!?\+S\&>-M6LO#&K^'_$7BY-9U33YII"(;^UDC)\N,?\ +08
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MO)_LW2]3D5+6;,T?F^83+%TB\PC]X.0.O2OE3XA_LY_$;]GGX6R_$GPA\?\
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M.,GO0!]0_$2^\1Z;\/\ Q'>>$+&WU/Q3;:?<2Z387+ Q7%X(R8HY/WD8P9,
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MAOP!\*_#OC_6+^]BM9;70/AT/^)?#)*(S>W/G6T0CMHS)'YDF3CS!P:^[:*
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M+]A^#/PQ\2>%?VI/V@?&&IZ;]F\/>*QX?.DWGG1O]J%M8R17'[L,7BQ(<?O
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MM(X8H?WF3YH,DWF8EDCXC\LU]+T ?*?_ #E,_P"Z-_\ N:I?V>?^3ZOVN/\
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MX=_LBT\02FPE$RQ?NHS*+;R_+SVDEDZ 9D^C/VAO^3ZOV1_^YN_]-<5?5=%
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MVFC%J3F,$RF0$R2&,+@'S,2Q^Q?M#?\ )]7[(_\ W-W_ *:XJ7_@J)_R8O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAOQII/@CPMX8^(FJZ6WBZZTVWO[TV\>!;6%M9>5Y9$3;)))92)")DP_[J0.
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M>']H/XH>&/!'Q6N/C7X:U;1]<FBU*Z\$VN@Q?88K.2;][:Q7L?\ I'FQ1;\
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M^+O :_M+?M'>$=/\?I\4=-^">G:TGVG2?#6E>&;;7,V,G[VUFN;FXDYEECD
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MF^'_ (_DM&\5?$7Q1I&CV^D626\F=4UF]MXI0OEVT?3F:7RAY?F>5Y8(,@-
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MTZOX@_X0BQG_ +6,EA(;?%N9/+M_*C_=_N_]9G)YZ_I70 5Q/PI^*'AOXP>
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M5\<W7P"\8>(=/^(9T_P);6.GPZAX*;0X9/M\QU*+$WVXD21?ZR+]V./W6/\
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M=2\7^!?#/B?4HX_(2[UK2+:[D2/M&))(R0/GZ>];G_"*Z+_PC'_"-_V18?\
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M,T<@QU$@C,GER;/TA\,^&-#\&Z);:-H.DZ?H6CVY_P!'L-+M8[:V7G>3''&
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MC^%?'6G11Z5XETGQ5XGNM'OH]2AB"7)>"6YCP#*"?W>!SC$9WQCZY_9!\"_
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M/B+]G_X6^,M:N=9\1?#?PAK^L7&!/J&IZ%:W-Q-@;/GDDCST'Z5Z30!\J_\
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MO?M&?]EE\1_^VU?1/AOPGHGA?[>^C:1I^CMJ=Y)J%[_9]JD)N;F0@R2RE/\
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MPV]_#;V)AEEBEE_=G$DOE]<G;+C_ %4F/MRN(\>?"3P9\3I+ ^,?!N@^+?L
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** "BBB@ HHK'UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_ -9([G@
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M(1Y8C\S>8^#0!L>.OC!^U+\"M*@\9_$3PQ\.O%GP^TV8-K]M\/C?_P!JVUF
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M??M!?L^>#O']_I]OI=_JZ3K<V\#!XO,BNI;=RGLYB+^V>_6O/OV]?O?LY_\
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M^Q3K5EX;TO\ :4U/4[RWL=,L_BYXFN;BYN9/*CMXT$)DDDD/08YYZ 4 <_\
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M_BKH?QP^&>@^.?#4DQTC6(VDB6XC\N6/RY3')&_NCQR)QZ=^M?/7_#'NB?\
M"+?\))_PU!\;/^$:^R?;_P"V?^%@)]E^R^5YGG^;Y/E^5Y?[SS,XQSFO</V<
M?AIX7^#_ ,%?#'A/P5J]QK?A>VBFN--U6XN8[@W$5S+)<^9YL0$<@S*<$#!&
M#0!\J_\ !0+_ (7?_P )Y\+O[-_X0+_A#O\ A9.@_P#"+?;/MWV_^U/*E\K[
M=C]W]F\WSL^5^\QY7?-?0NF_$KQQ\'_@?XM\;?'NY\(0WVAM)=#_ (0MYQ:2
M6PCC\J+_ $H@_:))3)& .#YD0'6O/O\ @H-JUEHFE_ 74K^\@L-,L?BWH5W<
MW5R_EQ6\40N3)(\AX  ]:Z#_ (*->%=1\7_L6_$VQTN'[7<Q65MJ$J%P@$-M
M=17,S_A'%(?PH Y3PC\1/VLOBSX9TGQCX0\/_"3PMX6UZV2_TS3/$UYJ5Y?Q
MPR1YCDDEME$1$@Q(.,@/@\UZ=^S1\<]6^,7A75K3QCH#>$OB)X9O?[+\3>'O
M.4^1+M\R.ZA&2WV:8']TYX.V3$DHC\P]3\.?C=X*^*7POM?'^C^(+'_A'%L!
M=WL\U]$/[,'DK-+'=&.0QQ2Q1R R G]W]*\)_9"\0Q?%#]HK]IGXC:"PN_!F
MK:QI.B6.J":&2.YFTZT>*X\HQ2G,1\V*2.0_?CD'?. #ZB\7>(U\)^&-9UPZ
M=?ZLVFV<MS_9^FQ&:ZN/+C+^5%'G]Y(<8 [DU\C^*OC%^U[X)\$:U\1M;\!?
M#2Q\,:29=3O/"(U.YDUN/38I<RC[5&YM3((09/,'N?*S^[KV/]L?XMZE\!_V
M:_'/C31CC6["R6&QF8@?9Y;F:*UCF/F1R ^4TJR^7C]YY9'&21\K?M#_  +L
MO 7[,OBSQ]XW_:B^(?B6[U;3;J6S;3_$'V70M=N;F*22UMXK&,2#R90PS'%(
M8_+$CCRXQ\@!]D7WQ\\-:3\!$^,>H"ZL?"DF@Q>(4ANA%%<>5+$)(XO]9Y9F
MDWQQB/S,&0CGG->!^!/BI^UI\2O!VE^/--\&_"]/#.JP_P!LV/A6YO;Y=8NK
M"0B6&$70/V8321^7B0XC'F@R1QD&,8WQL\*ZAXP_X)&Z99:5;_:;J+P#X>U"
M1"X0""VCM+F9_P#OW%)^5?4'AOXZ>#?%/PAT?XG#7K#2O!VI6<5V-0U2^AA2
MV\P[/*FD\PQ12"4^4?WG$@*9S0!\;_L__%OQ7X7_ &8?VH?B5X(\.O#X@M?B
M7KFNIH_BJ PR6L/^BRW0N81+&1)%;&7,0DSYD>.>E?>OA?Q7IWC?PKH_B+1[
M@W6CZM9Q7UG<>64WPRQB2.3#^Q!_&OES_@G-XFTWQEX5^./B+1[C[7HNL?%?
M7-0L[D(4$D,L=K)')A^1P:\/T7XL:_\  7]GWXM?L\^'+:ZTOQ[X;\40^#O!
M,TTN);VWUNXEDL9?M,4JB.Z\G[5-YA\J.,^3U.8Z /J?X(?M!ZS\4?AYX^^*
M$VEM>^"(+V^/A#3]!MY9]2U:RLA)')<C?*,R7,L<@BMC'$8_+&?,SOKS'Q5\
M8OVO?!/@C6OB-K?@+X:6/AC23+J=YX1&IW,FMQZ;%+F4?:HW-J9!"#)Y@]SY
M6?W==[\<M6MOV*?V)];/@6#RCX4T>/3-+D?R8I(YI98[87<G[DQR2"27[0_[
MO][)D?\ +3-?/G[0_P "[+P%^S+XL\?>-_VHOB'XEN]6TVZELVT_Q!]ET+7;
MFYBDDM;>*QC$@\F4,,QQ2&/RQ(X\N,?( ?1O[0G[3U]X'_8SN_C7X+T^WDEF
MT[2]4T^TU^/*^7>3VP ECBDX/EW&<"3@]_7C[SXC?M=>-;76O$?@_P"'O@7P
MOH&&FT/P_P"-I[K^W;J(1!X_-\F4112R'_EE*8C$<QR=/,/!?M)_\H<=)_[$
MKPG_ .C=/K] * /&_@?\>M%^.'P#T?XJO&?#&B7UG->7@U.YB\JQ^S32171>
M4C'EYBD_>''[L9(C->&> ?CM^T=^TGX9M_'GPH\.?#WPSX&N9[BVTX>/;R^G
MOK[RY9(_M.+3]W$IXC\HY(DCEY(,=97[)/AO4_&?_!*/_A&]'MS=:QK'AOQ+
MI]E:^9L\R:6YOXXXP7Z<GOTQ7K'[%7Q>\->,?V0? .O6VHVUGIOAG0(=,U>6
M_N8HA9364/ES><1(1$-L?F_O,?NY8G.* +?B#]IW5? /[//_  L+QI\/M0\/
M>+9K]](L/ 4-\+J_OM2^U26UO;12;!YOF^7YN8HY/W1,D?FX&?/_ !'\0/VP
M?".@S>*QX ^&NH:1;,-0?P7I-U?3Z\;4',EHDW_'O)<I'D9C!!,9\N.3B,X'
M[=&O:'\8?V??A_XUT/Q)=#P)H?Q%L+K5O%^AW BELK&*YN;&6ZM9<$R-'+*/
M+DB#]I!D<UTG_#'NB?\ "+?\))_PU!\;/^$:^R?;_P"V?^%@)]E^R^5YGG^;
MY/E^5Y?[SS,XQSF@#Z%^#?Q5T/XX?#/0?'/AJ28Z1K$;21+<1^7+'Y<ICDC?
MW1XY$X]._6O-/VQOV@-<_9U\+^ ]7T?13XB&L>,+'0+^QAM9;J[DM)8Y9)1:
MQ1R1YNOW0$><C)Z<UVW[./PT\+_!_P""OACPGX*U>XUOPO;137&FZK<7,=P;
MB*YEDN?,\V(".09E."!@C!KRC]O7[W[.?_99?#G_ +<T <AXJ^,7[7O@GP1K
M7Q&UOP%\-+'PQI)EU.\\(C4[F36X]-BES*/M4;FU,@A!D\P>Y\K/[NO5OBQ^
MU=X5^&O[,-O\9[JWNI['4=.M+W2=&N9H[:ZO9+I%F@MASMR ^9#'YA$<4IQ)
MLKK?VK_^36?C+_V)FL_^D,M?)/QLU"3PO^PM^RSXXGL);S1? VI>#/$NK_8=
MGF)916GEGRP\@WGS)HH\9_Y: ],D 'J6KZ]^V9)IMWJVG>'?@]#&\<EU:>&[
MN?4Y=0C)4R1VLDP\NWDFQB/S,QQ&3G(%:7B#]JKQ#XH_8_\ $?Q5\ >';>W\
M8Z!',=3\,:\^6TFYM91_:$-THDB<>5#YD@&8Y2/*/E_O/+KW3_A;?@O_ (03
M_A-?^$QT'_A#L_\ (Q?VE%_9_P#K?)_X^<^7CS?W?7K[\5\\_P#!.N^D\5?#
M7XC>-H;*:PT3QU\1-;\2:2UUL\Y[*5XHQO"2'8WF0RQXS_RSST() /IOPOXK
MT[QOX5T?Q%H]P;K1]6LXKZSN/+*;X98Q)')A_8@_C7R_H_[9U]>?!_QC\7KO
M1+;5/"EUKS:%\._#^E@C4_$O[[[-%*#))G=-,)?W(MQ+%'#(<2UX9HOQ8U_X
M"_L^_%K]GGPY;76E^/?#?BB'P=X)FFEQ+>V^MW$LEC+]IBE41W7D_:IO,/E1
MQGR>IS'7H_[;WP9T3X9_LP_"?1-(N[_PUX&\!^,]#N-8UW2Y([>^TVQ_>6\M
M_'Y2#_2?-N(Y,Q1DF60R;.M '1^(_B!^V#X1T&;Q6/ 'PUU#2+9AJ#^"])NK
MZ?7C:@YDM$F_X]Y+E(\C,8()C/EQR<1GM_B+\6-"^-W["?Q$\<>&O.?2=8\$
M:U)']HB\N6,I:W,;Q2#U22.1./UZUQO_  Q[HG_"+?\ "2?\-0?&S_A&OLGV
M_P#MG_A8"?9?LOE>9Y_F^3Y?E>7^\\S.,<YK>USX:^%O@[_P3V\<^%?!>JW&
MN>%K7P1KMSIVIW-Q'<&ZBN+:ZN?,\R,".4$RG! P1@]* /3_ -E#_DUGX-?]
MB9HW_I#%7#?M"?M':O\ #WQQX.^&G@?0['Q-\3O&S7 L+74-4^S6FF0QQ<WU
MUUD\K(8B./!E\F41OY@P>Y_90_Y-9^#7_8F:-_Z0Q5XAX\\1P?#W_@I!X%U7
M7L6&C^-? <WA/2-0DGB6+^THM0%R8I/WH;D>5$,?ZR2:- #DT =A\/\ Q=^T
M+HWQ&T/1OB7X.\':MH&O7$T U[P'<7R#1C';2S9NX[F/]X)C$L22*4"'@G]Y
M&#I_'/QI\9H_%FB^#_@[X)TF]DDC^VZMXJ\8221Z-91GSA%;)Y4@FEF+Q@GR
MP1%F+(Q+F/TO5_BKX2T7QOH?@_4-?L(O%>LDFPT;S UY)$(Y9#*(A\WEXMI?
MWF-F8\9S7R_XT?Q+^TY^UCX[^%47Q5U_X8>%_ %GIMT^D>%KJ.WU36Y;FWEE
MDN8KG_60QQ?:;:)X\2QG$?\ JS(, '=? [XY_$34/C=K_P '?BUH6B6OC2WT
MA/$^G:MX2EF_LJ]T[S8X3Q*QE203$CD8.).F!YG&^*OVH/C3?_'[XF?"?X;^
M!=(\2W^@SZ)]@UW41+#8:=;7%O'+=2ZA)YN9#F0"**("0QB:3$GE8?@OV<=%
MT#PA_P %&O%&@:%\1O$WQ)?2?AW+::CJ'BW6!J=Y9W@U2W\VU68(!B/]V?+P
M<222=#D5[%^SS_R?5^UQ_P!RC_Z:Y: *W@#X[?&+P+\>/"WPR^-?A_PA.?&E
MG<RZ!K?@>:Y^SI-;1M+<PW,=T?,/[KRSY@&!D#Y\R>5O_M*_M%:_\/?&'@?X
M8?#?3-*USXL>,II?L,.L71CL=-LXOWDUU=1I)YA!2*3R\#GRI2.8_*DR?VAO
M^3ZOV1_^YN_]-<58GCSQ'!\/?^"D'@75=>Q8:/XU\!S>$](U"2>)8O[2BU 7
M)BD_>AN1Y40Q_K))HT .30!XS^W)XK^/ND?LL^.-"^+OAOPGJ>CZV+**TUSX
M>&Z\G39HKVWEQ?1W7(CE (CDCZ21B,_ZV,CZX_:6^,VN?!U?A6VBVUA<'Q5X
M[TOPK>?;H9)#%;7/F^9)%Y<@_>#R^,Y'/(KQG_@J;\4/">E?LK^+_!M]K^G1
M^+=9^P'3]&DE'VN2,7T4AD\O.1'BVE_>'Y,QX]JZ_P#;U^]^SG_V67PY_P"W
M- &M^TK^T5K_ ,/?&'@?X8?#?3-*USXL>,II?L,.L71CL=-LXOWDUU=1I)YA
M!2*3R\#GRI2.8_*D^:/VY/%?Q]TC]EGQQH7Q=\-^$]3T?6Q916FN?#PW7DZ;
M-%>V\N+Z.ZY$<H!$<D?22,1G_6QD>S>//$<'P]_X*0>!=5U[%AH_C7P'-X3T
MC4))XEB_M*+4!<F*3]Z&Y'E1#'^LDFC0 Y-9?_!4WXH>$]*_97\7^#;[7].C
M\6ZS]@.GZ-)*/M<D8OHI#)Y><B/%M+^\/R9CQ[4 ?4'Q2\5:EX+\"ZIK.B>&
M=3\8:S"8H['1M-(CFNII)4AC!DDXAB!DS++_ ,LXQ+)CBOE?Q9^T#^TW\ _!
MNF?$;XN>$_ %[X!M9K8Z[8^$YKH:QIL<_P"[#?O)3;R>7++&I$;2 \=LRIZ=
M^VQ\7M:^#GPU\._V)X@@\):AXG\4Z;X<'BNXCBDBT..5S+-=RQ2_NI0(XIL@
ME/\ 6#D8KY$_;N^ UC\"_P!FN:/Q%\?/B5XN\6:K]E@L_#_B#Q(9+'59(IHI
M+B06AC)\N/F3F0^6?+'F$XW@'L7_  50_P"%I?\ "@?%W]G?\(C_ ,*K^P:?
M_:_VS[5_;7VK^TX\?9L?N?+S]ESYG./,]J^@?A)JWQ<\.Z7XDU/XZ:A\/+#3
MK***YM+KPE)=1PVT48E-S)<R773CRN01TDS7 _\ !43_ ),7^)GUTO\ ].EI
M7JGQHTD_%;]G/QWI_A"6#7'\2>%KZ'2Y+.XC\J^-S:R>28I"?+Q)YG^LSCYL
M^] 'AOAGXQ?M(_M :-:^,/AGX+\"^"?!FH9.F0_$2YOGU._A!)BOO+M (XHY
M(V3$9SG&1))'(A/I/[,?[0E]\;M.\0:!XMT&X\'?%+P;+#8^)]"ECS%%+("8
MKFWDP0\4PB9TY./^FB&.23YN_91_9K\/_&G]G_P;KV@_M#_&*)4TVVL[[3=$
M\9^3:Z=>QQ1>;;1PB(F(1Y'EQG_EGY9]Z]Z_9U^$?P^^!-[\3?%6F?$O5O&L
M][)';^*=<\5>(+:_^P2:?')F*:98X_*,<4W[P2GY (QQS0!YS\.?V@OVCOCQ
MI=S\3?AQX'\!GX937DYTC1_$-]<PZ[JUK ?+D EB)MHI99(Y(T,O$9!SYD8\
MR3[<KXC^*'P=T7]G?X=ZY\9?@A\0%^'>B06LFNW'A]98[_PMX@,G[U4CMI)
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MRE^SS_R?5^UQ_P!RC_Z:Y:3_ )RF?]T;_P#<U0!]%^+O[>_X176?^$:_L_\
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M$<'P]_X*0>!=5U[%AH_C7P'-X3TC4))XEB_M*+4!<F*3]Z&Y'E1#'^LDFC0
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M-_R?5^R/_P!S=_Z:XJ^JZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:?!CX$>!OV?/#-WX<\ Z&?#FCW=Z]_)9F[FN?WOEQQF4&620YQ%'W[=*U_\
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M#WBGQSX0\8ZGIOVOQ#X6%U_9%Y]KEC^R_:HO*N/W8/EOF/\ YZ ].,5W-%%
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M11^:2,QXH ]S^ OQITC]H+X6Z/X]\/6=_9Z-JWF_98=32..X_=2R1'S/+DD
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M3_CC\'+KX/\ A[7IWL+'Q4?$=MJUA#>X!2.Y,48%N) 9,22'^$G[@DDC]/\
MC[\=-0^#L.B:9X=\#ZQ\2?&VO3F/3=!TO]WF*.6));BXN?+*6T,7VF(&23C,
MD6< R21@'MU>9>,/C9H_@WXK?#[X?WMG?S:UXV^WC3)K9$-O']BA$TWF'S,C
M@CH#Z5Y=\-?VJ?$VI_%S2/AE\5_A;JGPI\4:_9R7GA^7^UX]7M-3\GS&N8O/
MAC\N.6.,"3![==F8A)2_:&_Y/J_9'_[F[_TUQ4 ?5=<7_P +2\-_\+6_X5U_
M:1_X2_\ L?\ M[^S_LTG_'CYOD^;YF/+_P!;QUS[5VE>%_\ "Q]&_P"&S/\
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M(6K?#CX7_#76/BIXT\.Q6MUK86\AT?3M.CF0R1(;F?@RD&,B(#F,R'?F*0
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MWE 'T'\>OC3I'[/OPMUCQ[XAL[^\T;2?*^U0Z8D<EQ^]ECB'E^9)&#S*._\
M@?2Z^,?^"@'CC0?B;_P3P\;^)O#.JV^M:+J$>F/;WEOG]Y_Q,[7/!]\_(17T
M?\9/BKH?P/\ AGKWCGQ+),-(T>-9)5MX_,ED\R41QQI[N\D:<^O;K0!W]%?&
MNO?MA?%SP3X?N/%NM?LR^(+/X?6Z"[N]5_X2.W.J6VG$C-S)IN#)'*$/F21&
M0>7SYD@ +U]0^!O'.@_$SPGIOB;PSJUOK&BZA%YEO>VY.']?<<_P$4 =317
M?&3XJZ'\#_AGKWCGQ+),-(T>-9)5MX_,ED\R41QQI[N\D:<^O;K7@>I?M/?M
M 1Z1?:W9?LJZQ=^'UAEOK477BRRAU*6WQOC\RQ$<DL4IC)/V<>9()/W8S0!]
M1ZQKEAX<TN[U+4;RWL=-LXI+FXNKF01101Q_ZR1W/  'KZ5X#\&_VT-%^-WC
M#3](\,> ?B%+H&HR7"6OC2X\/&+091%YN9/M7F=',1C'[O\ UAQ7 _M#?M#:
MW\4?V.M0\7_#+P!<>-/"'BSPKK2:MJMUJT.FOH$21/%(7MY1FYV?Z3\L?4VY
MP2) :Z3]A?XA?$S7OACX"T'Q+\)F\)^#;'P=9#3?%@\16U]_:7EPV\<.+:,"
M2'S(LR<YQC'4T ?6%%%?*_B+]K?Q5KWC/Q'H'P>^#>K?%%?"^HS:5K>J76KV
MVB6,-[%@&&WDGS]H*'S/,X'EGRSR)$- 'U117SS\$/VFM2^(?Q$UWX=>.?A]
M??#+XCZ59QZM'H=U?#4H+S36,<1NH;J*,1$"5S&0/SR)!'TO@/XY2>.OC=\6
MOATNA_8'\!_V1C45NO,^W?;K4S#]UY8\KR\ =9,]>.E 'L-%>/>//CE)X%^-
MWPE^'3:']O?QY_:^=1:Z\O[#]AM1,?W7EGS?,R1UCQUYZ5RO[2G[5UA^SCX\
M^'&CZIX=O]<M/&']HQ1S:7^\O$FMHXS%;0VWEGSI+F6:.(#S(P#CF@#Z+HKR
M#X&?$'XE>.KC6Q\1?A1_PJTVPA-B/^$EM=8-]DR>:?W('E>7B+KU\SVKH/C)
M\5=#^!_PSU[QSXEDF&D:/&LDJV\?F2R>9*(XXT]W>2-.?7MUH [^BOFGX1_M
M ?%KQUXDT.W\9?L_:O\ #_0-<C_T36/[;M[XVTWE>:@NK81QRVP\N.09D'$O
ME18S(,>(_P#!0+XA?$R#QQ\+=-L/A0=0\-Z3\1]"O]#\0'Q';1'6[X12F.R^
MS8WVV9'EC\V3C]SD]10!^@E%>$6/QH\<Z5\"_'GC[Q]\,/\ A"-;\,V5]?Q>
M&_\ A((;\7<-M:^<)?M,,6(_,_>1\@D>7GO7"?#/]KSQQ\;T\'ZQX)^"^H:G
MX#U/['%JOBBZ\00V264\FS[<MM#+'YE[':F3R_-C$?F212I&.,D ^LJ*^:_B
MA^TEXTTOXDW?@CX8?!O5OB9?Z3$9-<U(ZE'H]A8R&.&6.U%U/'Y<LWE7,<GE
M@\)(AY_>"/H/V=?VAO\ A=__  EFBZQX3U#P-X[\(WOV3Q!X9OI!<M;F3S#;
M31W Q'+'+'&Q!'U'[ORY) #W2BOS4_X7)\<?^&\O[;_X9W?_ (3;_A6W]G_\
M(I_PF]C_ ,>']I^9]N^U>7Y?^M_=^7U[].*^O_BE^T)9?!GX6^&?%?CSPYJM
MIK.MR6>FIX3T11J=[)J=PF38Q&,B.5@1( <@2>6,=@0#VRBOCG7/VR/B7\*X
M].UOXQ? '4/ 7@9KZ.UU#Q'8>*+76?[.\TD1RRVUM%O$?F84DGO@>9(8XW]6
M^,'[06D_#?PYX1FT'3[KXA:]XQF%OX5T70+RW8ZBQB,HF\TR<6N/+\RY'F",
M3))C% 'N%%?#6L?MM?&SPS\3O#?@2_\ V8)[3Q1XBBFFTFS_ .$VMO*NO+22
M28"X^S^43&D9)3S 0"G'[R//O!^.MY:_M,6OPMU?PU%I5AJGAZ76-$\12:B5
M_M*2*6-);(1-"/WT8:20B.63$823^/Y #VVBO'/C[\;I/@EHGA1K?1/^$@UC
MQ5XFL/"VFP2W9M;;[5=9VR32>7*8XP(Y,^7')VXYX]CH **_.?\ :.^)WQ=3
M]L_X)2V_P2:>?0[_ ,3Q>&K9?%]I_P 5+";;9)-G'^B[(@DOER\G>8Z^K-6^
M.3_#?]GF^^)GQ8\,W7@6XTZ!YM2T"VO8M3EA)NC%#''-%B.0R$Q>@'F /C!-
M 'ME%?(FI?M/?M 1Z1?:W9?LJZQ=^'UAEOK477BRRAU*6WQOC\RQ$<DL4IC)
M/V<>9()/W8S7OGP;^*NA_'#X9Z#XY\-23'2-8C:2);B/RY8_+E,<D;^Z/'(G
M'IWZT =_17/^*/%>G>"/"NL>(M8N#:Z/I-G+?7EQY9?9#%&9)),)[ G\*^8M
M-_:^^*/B[3[7QAX6_9M\3:Q\-;F.*^AUJ;7;&VU2>R'S221:9DR2-CS/*C$F
M91Y1&/,H ^O:*\:\0?M+>%/"/[/T/QDU>'4K/P?-I-KK,:_9@UT8[D1^3%Y8
M./,)ECCZ[!G_ %F.:\IU+]I[]H"/2+[6[+]E76+OP^L,M]:BZ\664.I2V^-\
M?F6(CDEBE,9)^SCS)!)^[&: /KNBO$K/]H[0_$O[+NI?&GPW;3ZWHUMH=]K4
M5C=?Z+++]E24R6TGWO+(DADBR/,'&1O%>-^$/VVOB%\8--T[6/A1^SUJOC30
M6TRUGNM7O]=CTBU^V2Y\VVM);F("Y$,B2122)C]Y&>,;#( ?:-%?%^D_M_W_
M ,1=/T>P^&OP;\3>,?B.)I;7Q'X5FD_LV'PU+&)!(EU?RP^4#))%((^GF>60
M?+D'EUZY^SK^T-_PN_\ X2S1=8\)ZAX&\=^$;W[)X@\,WT@N6MS)YAMIH[@8
MCECECC8@CZC]WY<D@!U'PB^-6D?&9?&::1:W]G_PBOB2]\+WWV](XS)=6OE^
M;)'LD.8\R#DX)]!W],K\X?@%^T1KOP]\;?&_P5X ^&>K?%/QA>?%O7[ZYM+>
MY%C8Z99$#RY;F^DC,41DEMIA'&>3Y<G.?+$GT5\'?VJW\>?%+4?AE\2?!=Q\
M*/B;#!]NL?#M_J*7L6K613/FVUS&!%,5Q+OC&<>62"?+E\L ]@_X6EX;_P"%
MK?\ "NO[2/\ PE_]C_V]_9_V:3_CQ\WR?-\S'E_ZWCKGVKM*\+_X6/HW_#9G
M_""_\(78?\)-_P ('_;?_"7;H_M?V7^T/*^P?ZKS/*W_ +W_ %F,_P#+/O7F
MGQ _;BNO#/QH\=?"WPQ\,-7\=>.]$GTZ/3M,TFX(%_%=1QR2W5S+Y7EV,-MY
MD">9)YF3+']P>:4 /K^BOF'X:_M4^)M3^+FD?#+XK_"W5/A3XHU^SDO/#\O]
MKQZO::GY/F-<Q>?#'Y<<L<8$F#VZ[,Q"3;^,W[2;_#GQ[IWPZ\'>"-9^)/Q+
MU33CK-OH=C)'96MM9"7R_,N;V4^7"I(D"'$F9$"?)YD>0#Z#HKY6\$_M@:K;
M?%C3?A[\8OAO<?!K6_$4(E\-W%UK<>IV.K3!\26WVF*,1Q2Y\O\ =G.?,'0R
M1>9]4T %%>&_'C]HBT^"=UX9T2S\/:MXU\<^+KFXMO#_ (;T>'8;F:*(/)))
M-)B.*%"\7F2G.P.9/+(CDQY7KG[9'Q+^%<>G:W\8O@#J'@+P,U]':ZAXCL/%
M%KK/]G>:2(Y9;:VBWB/S,*23WP/,D,<;@'V-17C_ ,>/C5_PI5OAYC13K)\6
M^,M-\)Y^T_9_LOVKS<7'^K/F%/+_ -7QG/45UGQ6\=K\-OA;XP\8BU^W-X?T
MB]U3[+YGE_:/LT4DOE[^V?+- ':45\[?$7]JA_A[^Q[:_'9O"_\ :'VC2-+U
M8: U_P"61]MEMAY7VGRC_JQ<]?+Y\OM2?"W]H'QW\6_&FDSZ3\(-03X1ZD99
M;'X@7VL16LEQ (G,=S_9D@^T>5+*/W>3_JY8Y, <  ^BJ**^8?B5^U3XFTSX
MN:O\,OA1\+=4^*WBC0+..\\02_VO'I%IIGG>6UM%Y\T?ER2R1DR8';IOQ*(P
M#U'QA\;-'\&_%;X??#^]L[^;6O&WV\:9-;(AMX_L4(FF\P^9D<$= ?2O3:_/
MS4/C1JOQ'_;@_9IT+Q9X.O\ X>^/-#/B6?4M!O+E;N(0W&F$VUQ;74?[JXBD
M$<@XYCDCEC/W03[+\9/VOA\*_CQ;?"ZQ\&:CXK\2:KX<CUC0(=-G_>ZC?27+
MPI:$&+RXHA'#)+)=22 1QQ2<$CD ^GJ*^8?&W[4/CGX3_LS^+?BGX\^$?_"+
M:OH=Y#'#X7;Q+%=?:X)9;6(2BZBC(CYFE_=^63^Z]Z^GJ "BO$OV=OVAK'XY
M?L\:1\5M3TZ#P;IM[#>W5Q!<7XFALH;:YEBDD>X\N,#_ %1D.0/T)KQ3Q)^W
M1\2[/X=7/Q+T']FWQ#JOPP6S_M"'7-3U^VL;V2VQ@SO81QRR)%W\S)'E8ESY
M?- 'VQ17D/[.?Q5\2_&CX;V/C'Q)X'/@5]1V7.EVG]KQ:E]JL)(HI8KKS(XQ
MY?F>9CRCR/+[9KOO%'BO3O!'A76/$6L7!M='TFSEOKRX\LOLABC,DDF$]@3^
M% '05YG\(OC5I'QF7QFFD6M_9_\ "*^)+WPO??;TCC,EU:^7YLD>R0YCS(.3
M@GT'?P'0?VPOBYXV\/V_BW1?V9?$%Y\/KA#=VFJ_\)';C5+G3@3BYCTW DDE
M*#S(XA(?,X\N0@AZG_X)S>)M-\9>%?CCXBT>X^UZ+K'Q7US4+.Y"%!)#+':R
M1R8?D<&@#[#HKY TW]L+Q]\5H#K7P7^!&K?$+P+]HE@C\3:IK]KH8OI8I"CO
M;Q2@R218"XEXY\R/RP8S7J'[.O[1N@_M*^$[R[T^";0O$FDR?8?$'A?4?DO=
M*O1P8Y5X;&8Y-DF!G!R!(DD<8![?7$_%;XH>&_@_X!U3QAXOU(Z3X=T[R?M-
MY]FDF\KS)8XHSY<8,A_>21]!W[5\W>'_ -M3QO\ $E;_ ,2_#[X#>(/&OPFL
M[Z2)/%4>L16UW?0Q<74MKITL8EN /WGEH#^\(V?NY<QIZM^V%\1-&^%O[.WB
MKQ3XA\'V'C_1M/\ LIN/#NI^7]FNO,NHH\2>9%+_ *LR"7_5G_5]NP![C17C
MWQV^.UO\&[;P_::?H%]XN\;>)[U].T+PUI<D27-[*(I)3)(92#';1X'FS<B(
M29(Q7SWK'[;7QL\,_$[PWX$O_P!F">T\4>(HIIM)L_\ A-K;RKKRTDDF N/L
M_E$QI&24\P$ IQ^\CR ?<M%>%?M1_M,:=^S!X9\)>(]9T_[5I&L>)+70;ZZ,
MYC_L^&2.:22ZPD<AD\L0G]V!SZUY-JG[:7Q7T/PS=^,M5_9C\4:=\-;&226Y
MU:[UNVBU6"PCE,<ES)IGE^8"(QYA3.P 9\SR_P!Y0!]G45S_ (7\5Z=XW\*Z
M/XBT>X-UH^K6<5]9W'EE-\,L8DCDP_L0?QK)^*WQ$T[X4^ ]3\3:I!J%[;V)
MAC2QTNV-S=W4LLT<45M%%SYDDLLD<8'K(.1UH [:BOB^Z_;4^(OP^TWP[XF^
M*O[/VK> /AM?2VZ7WB2/7H]2ETH2Y\J2YLXXA+&/,,8?S,$9Q@R8C;W/]J/X
MX/\ LV_ WQ#\15T;_A(%T;[-NTXW1MO-$MS%" )/+DQS+GIVH ]=HKXXD_;*
M^*'B*WUWQ#\.?V</$'C#P#9_O+#7[_68]*N=6B\I9/M-M8R1&62*7(,1C!\W
MT\PF,>V>"/VAO!_CSX&P_%NPO+NW\$MIUQJEQ-=6TGG6L5N7%R'C&23&8Y<B
M/.3$?+\P$9 /6Z\S^$7QJTCXS+XS32+6_L_^$5\27OA>^^WI'&9+JU\OS9(]
MDAS'F0<G!/H._@.@_MA?%SQMX?M_%NB_LR^(+SX?7"&[M-5_X2.W&J7.G G%
MS'IN!))*4'F1Q"0^9QY<A!#U/_P3F\3:;XR\*_''Q%H]Q]KT76/BOKFH6=R$
M*"2&6.UDCDP_(X- 'V'1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ?(G[3VLV.B_ML?LEW.HW<-G#)-XEMTDN9!&/-EL
M88HH_K)))&G3KBF_\%3-8LK']B7QU;W=U#;R7TVG6]JDDFPSRB]MI3''G&\^
M7%*_':,^AKV'X\_L\^#OVE/ ;>$O'%E<W6G1S"YMI;6:2*:UNO*EB2>,@X)3
MSI,"021\\@]O$=6_X)J_#WQ9INOQ>+/%/COQ[K.I6<%A%KGBG5XKW4=.ABNO
MM/EVLLD7[OS.AXZ&0#R_,DR ;_[>OWOV<_\ LLOAS_VYKU3]J_\ Y-9^,O\
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MD7F8&?+R.M>G5\O^)OV#_ $FKW>L>!M<\6_!NZO!C48?AKK!TBUO]F/*\Z(
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MAEL])E\ORXKBUA2..,2Q1_NX\[HP'(,9H ]N_90_Y-9^#7_8F:-_Z0Q5Y_\
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M=VUU;/YD5Q%*+8QR)(.""/2KG_#N7X<;?['_ +>\>?\ "MMV/^%:?\)5<_\
M"/[>O^J_UN?-_P!)_P!;_K>>G%>K?!/]G_PO^S[I'B?3O"B7$6GZ[KUSXA>R
MG2+RK:67R\PV\<42".&,1 1QX)'/)[ 'K%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:9-;(AMX_L4(FF\P^9D<$= ?2@#TVBBB@ HHHH **** "BBB@ HHHH ****
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MT!]* /3:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_5K;0=./D22_:+ZX)\J+Y!W\L\]..M=K0 4444 %%%% !1110 4444 %%%%
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M>*/&OBS6(M&TG15N/LXE_BN+F0B.26.VAC_>2RQQR;/W>>#FO'?VP-2'P/\
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MP_\  #P/X)\:W,=OKWA?Q'KUCI<NJ6MZ?)MK*YCEF^W1>7'+]I CBW>7'_K
M>#6I^V)JUGH_[+/Q;N;^\@LK>7PMJ-J)+EQ&/,FMY(HD!]7DDC3WS7S?\6M)
MOM$_9U_8DTO4;*XT^_L?'/@JTNK6YC,4L$L=K()(Y(^Q&#Q[4 =7JG[:7Q7T
M/PS=^,M5_9C\4:=\-;&226YU:[UNVBU6"PCE,<ES)IGE^8"(QYA3.P 9\SR_
MWE6-2_;B\5>+AJ>K_!CX&>(/BKX$TZT%U_PE3WITB*^D/F>9'8PW$/FW6PQM
M&?*&\2 IY?\ J_,]O_:O_P"36?C+_P!B9K/_ *0RT?LH?\FL_!K_ +$S1O\
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M_L3-9_\ 2&6C]E#_ )-9^#7_ &)FC?\ I#%0!2_9Y_: TW]H;P(OB&QTS4M
MU*SOI='UO0]2A,-SI>HQ;3+;2Y'./,'..A&1'(#&/._$7[6_BK7O&?B/0/@]
M\&]6^**^%]1FTK6]4NM7MM$L8;V+ ,-O)/G[04/F>9P/+/EGD2(:9^P5][]H
MS_LLOB/_ -MJQ/\ @ERNFZ7^RCIVB1:>NFZ_H^LZG8>(K:6R-K<1:B+G.R;(
M'[T6\EL.^  G'ED  ] ^"'[36I?$/XB:[\.O'/P^OOAE\1]*LX]6CT.ZOAJ4
M%YIK&.(W4-U%&(B!*YC('YY$@CY36?VO?'6O_$3Q=X;^$7P4U+XGZ;X4OFTG
M5==N=>BT.W_M($^;;0_:8SYOE_*"0>"W388WDJ_&S4%\0?\ !0+]F[1;&.XO
M=0T#3/$.KZG%':R_Z#9W-M]GBFD?'E[9)87BZ]?>2.M+Q%^S9X]^&/C#Q/XR
M^ WC:VT>Y\1:G)K.L^"_%T<E[H5]>RK^\FC>,"XM3S)*?*,GF2"),1QQXH ]
MO_X6-I]G\*AXYUJVU'PUI4.D'7;Z'5K<QW5C"(C+()HD!_>1@'*#N.YKYQ?]
ML+XM^)O#;>,O W[,VO\ B#P'=67V_3]0U#Q):V-_>1; 2XL LDO.#Y?E^891
MY9CSY@KF_P!J#XM-^TY_P3&\4>/?#^@WULNJ65K=2:7C[3+;FVU.(77,?!BC
M%O+)YN!^[&\B/D#K]%^"_P"T5XATFVU'3_VO8+_3KR*.XMKJU^'FF213QR#]
MW)&_F\@C!% 'M_P7^,_A3X_^ =/\8>#=2-]I]P1')#*1]ILYO^6EO-%_RS<?
M7N",IC/IU>%_LO\ P#U+]GGPSXMLM7\6_P#";ZMXD\2W7B>]U1=-%CF>XCB$
MH\I)9.\6>"/]97NE 'AOQX_:(M/@G=>&=$L_#VK>-?'/BZYN+;P_X;T>'8;F
M:*(/)))-)B.*%"\7F2G.P.9/+(CDQY7KG[9'Q+^%<>G:W\8O@#J'@+P,U]':
MZAXCL/%%KK/]G>:2(Y9;:VBWB/S,*23WP/,D,<;KXJCT_3_^"HG@[4-;L0!J
M?PXN=-T&[O+(NCZC%>RRRQPRD8CD%L9<_P#3.7'_ "UP?5?VTO$VF^$?V3_B
MU?:K/]GM9?#5]IZ2;-^);F(VT2?C++&/QH \!_X*J>*O'-K\ O&'A[3_ (>'
M4/ ES8Z?-J'C5M<AC^P3#4HL0_82#)+_ *N+]X./WN?^69KZ/^!GQ!^)7CJX
MUL?$7X4?\*M-L(38C_A);76#?9,GFG]R!Y7EXBZ]?,]J^9OVI-,O]%_X)(VV
MEW]I<6.H:?X5\,VMU:7$9CD@FCFL!)'(AZ$$'BOOB@ KY4_:&_Y/J_9'_P"Y
MN_\ 37%7U77RI^T-_P GU?LC_P#<W?\ IKBH [WX^_'34/@[#HFF>'? ^L?$
MGQMKTYCTW0=+_=YBCEB26XN+GRREM#%]IB!DDXS)%G ,DD?'_#7]JGQ-J?Q<
MTCX9?%?X6ZI\*?%&OV<EYX?E_M>/5[34_)\QKF+SX8_+CECC DP>W79F(20?
M'KXC?$SQ!\:M"^"GPCUO2?">L2Z!_P )-K/B+6;'[2UM8F]CMA]B0DQRR_Z[
M,<L8C(*8DC->+7WA#Q[X/_;T_9RT[XA_&&'XHWYMO$-W;6W]@VVCRZ9&UC(/
M,*0GYQ*8^/,Z&WDQF@"K^T=\3OBZG[9_P2EM_@DT\^AW_B>+PU;+XOM/^*EA
M-MLDFSC_ $79$$E\N7D[S'7U9JWQR?X;_L\WWQ,^+'AFZ\"W&G0/-J6@6U[%
MJ<L)-T8H8XYHL1R&0F+T \P!\8)K@/VAO^3ZOV1_^YN_]-<59'_!1_3]1NOA
MY\*KS3=4;PW_ &9\2=&N[KQ)-;^;;:''F6,7TOF_NA'')+%_K3L.0.] %?7O
MVPOBYX)\/W'BW6OV9?$%G\/K=!=W>J_\)';G5+;3B1FYDTW!DCE"'S)(C(/+
MY\R0 %Z])^+7[4?A_P"'O[+.H?&OPFEOXV\/PI;36L5K>&V%QYMW';',OER>
M68S(<H4)!CV&N5_X9W_:<_Z.X_\ ,;:9_P#'*\G_ &G?@>W[-O\ P2I\4?#E
MM9_X2!=&^RA=0%K]F\X2Z[#,28O,DQS+CJ>GX4 >\_"W]H'QW\6_&FDSZ3\(
M-03X1ZD99;'X@7VL16LEQ (G,=S_ &9(/M'E2RC]WD_ZN6.3 ' ^BJ** . ^
M,GQ5T/X'_#/7O'/B628:1H\:R2K;Q^9+)YDHCCC3W=Y(TY]>W6O*/A'^T!\6
MO'7B30[?QE^S]J_P_P! UR/_ $36/[;M[XVTWE>:@NK81QRVP\N.09D'$OE1
M8S(,>K_&3X5:'\</AGKW@;Q+',=(UB-8Y6MY/+EC\N421R)[H\<;\^G?I7@(
M\6?$O]D_QMX*T;QAXHC^*/PU\3Z]:>%]+U2^MS#XBL+NY\Q;9)B/W-U#&D"^
M9*=DTCS2/SL\L@'G'_!0+XA?$R#QQ\+=-L/A0=0\-Z3\1]"O]#\0'Q';1'6[
MX12F.R^S8WVV9'EC\V3C]SD]17U-X'^+'B9?ACXA\9?%;P,?A2^B?:+FYLO[
M8BUC%A%$)6NO,MD_ZZ#R\$_N_>O,OV]?O?LY_P#99?#G_MS7I?[4/QC;X!?
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M]#6!^VYX<\3ZE^T5^S++X9\6'X?7?V_6]-B\83:;'?6UE<W5K$(H2DQ\LR7
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MW_M-:E\//B)H7PZ\#?#Z^^)OQ'U6SDU:30[6^&FP6>FJ9(A=374L9B ,J",
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MX9?%?X6ZI\*?%&OV<EYX?E_M>/5[34_)\QKF+SX8_+CECC DP>W79F(24?\
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MXQ-\ O\ @E'I/CR"V:[GTFRU+[)"R;XC=2ZO<Q6OF?O(SY7G21&3!!V9QZ4
M=MJG[:7Q7T/PS=^,M5_9C\4:=\-;&226YU:[UNVBU6"PCE,<ES)IGE^8"(QY
MA3.P 9\SR_WE>N_'[Q5IWC?]C7XD>(]%N/MFD:MX$U._LK@QE!)%+822128?
M!'!!_&OFK]H7X<?M%:7^SW\1M?\ B+^T-H>E:>^DZE)?>%M+\+6QTZ2*3S$B
ML8K^7RI1YOF1Q D>9F3'[PX)]:_YQ9_]T;_]PM &1J_Q"T;X4_\ !-7P5XH\
M0^#K'Q_HNG^#O#IG\.ZIY?V:Z\Q;2("3?%+_ *LR"3_5GF+MV]V^,WB[QUX-
M\,VVH> /A[_PLK7&ODBFTG^VX=+\F'RY"9O-EXX(C'EX_P"6GM7R9^TG_P H
M<=)_[$KPG_Z-T^OL;XN?$?1_@[\.O$7C37;G[-I&AV;WD^'3>^/NQ)YC*#)(
M<1QC/+R =Z /G"3]L+XL^&_B%X"\)^+OV>6\.'Q9K$6EVTL/C2VU&ZBC)!N;
MG[+!#YLD4,>9))/]6.,N,BO2OC9^T-K_ ,/_ !EH_@KP'\,=6^*/C.\C^WW5
MI;7'V"PTVQ)G$,US?RQF*)I'MI1'&>OER<\1B3GOV8/AAKWB+Q3JOQ]\?:;J
M.@?$7Q9:"PM_#=Y/)Y?AW2!)F*T\LG_6RF.*YE.(SYDA'E0GS/,P?'/CCXP?
M&K]H#Q+\-/A-XPTWX<:+X'ATR37]?O\ 2OM]^]U=V]Q-'%;12DQ20^7Y7F&7
MRY!(.#CJ =Q\$/VFM2^(?Q$UWX=>.?A]??#+XCZ59QZM'H=U?#4H+S36,<1N
MH;J*,1$"5S&0/SR)!'\M?\+D^./_  WE_;?_  SN_P#PFW_"MO[/_P"$4_X3
M>Q_X\/[3\S[=]J\OR_\ 6_N_+Z]^G%=I\"=$\7^&O^"C>M:-XV^)T'Q1U^U^
M&;>=J,>D6VF&S!U."2.V>*'/($@ESU/G#T%>E_\ .4S_ +HW_P"YJ@#HOC3\
M48O"OAWX*7OC;X<6.H:QXC\8:'I?]DW]S%<?V!J-Q'(?M,4OE2"66V(?]Y'Y
M>>T@KM_CQ\=M!^ /A"TUO6=/U35I-0U*#2-/TO0;3[5?7UY*"8HHH\\L?*DX
M/]SC)P*\G_;U^]^SG_V67PY_[<UC?M8QV%C^U=^R=K7B*P\W0(-:U>P-U<61
MNK:+4;FWA%A&3MXE-Q&#%QP8]^1Y9( #Q-^U=\<O &DS^(/&/[,6H:3X4T[$
MVK:CIWC*QU*XM;;(\V:.WCC_ 'GE\OS@<')09QZ?\;?VE-*^%/[,-[\9-%T]
M_%NBK9V-_8VYE-B;N*YFACADS)$3'Q,).8^W2O5?%'BO3O!'A76/$6L7!M='
MTFSEOKRX\LOLABC,DDF$]@3^%?FOK.BW^C?\$0TM=0MI[*62""Y6*XC\O,4O
MB)98I.>SQRQN.V"* /H&3]LKXH>(K?7?$/PY_9P\0>,/ -G^\L-?O]9CTJYU
M:+RED^TVUC)$99(I<@Q&,'S?3S"8Q]$?!OXJZ'\</AGH/CGPU),=(UB-I(EN
M(_+EC\N4QR1O[H\<B<>G?K7?U\J_\$N_^3%_AG]=4_\ 3I=T ?55%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?L?>%G^-UU\2_#GB#QAX#U*]O[74-7T?PQJGV'3M:GAD\SS+NW,?[SS-Q\P
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MC_\ "^/^%L?:]0_X2#_A'/\ A%_LF^/[)]D^T_:=^/+\SS?-[^9C';O7I5%
M'CG[0'[//A?]H;2=,LM?&H66J:/?Q7^D:]HMQ]EU/29@0?.MY<'&=@SG(. 0
M/,CC(SO$G[+^C^-/V<KCX.>(/%OB[7M&G_X^/$&J:G'<:RY%T+G]Y<21$?\
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M^T^4]_>W4AEN[Z6.,1B2:4CCU$<>(P9)/+C&36Q\(O@KI'P97QF^D75_>?\
M"5>)+WQ1??;WCD,=U=>7YL<>R,8CS&.#DCU/;TRB@#S7_A2&C_\ "^/^%L?:
M]0_X2#_A'/\ A%_LF^/[)]D^T_:=^/+\SS?-[^9C';O3/&'P3T?QE\5OA]\0
M+V\OX=:\$_;SID-LZ"WD^VPB&;S!Y>3P!T(]:]-HH \R\8?!/1_&7Q6^'WQ
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M-T2YUG7M6T_0M'MS_I%_JEU';6R\[ )))" .>.?:M^ODWXO?M!?"GXM?L?\
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MB**3S4B,A_=_O,9_Z92"@#M-8URP\.:7=ZEJ-Y;V.FV<4ES<75S((HH(X_\
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M-_#LM@=3\J*26Y\F0&1/W4:9(D,?^LC SFK7Q9_:Z\&_"[Q=+X.M]*\4>/\
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M[K]X ><\QY \R+S)/[6^'_\ PV1_8_\ 8%__ ,+4_P"$$^V?VUO_ -%_L?\
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M../T/_A2(_X:B_X7'_;C;/\ A#O^$1_L3[+S_P ?OVK[3YWF>O[OR_+]\]J
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MHQ\)>,M-\68^S?:/M7V7S<6_^L'EE_,_UG.,=#0!YI^WK][]G/\ [++X<_\
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MWX3>"-!\7_%2XTF34)M4\13_ &>UT#3)+ZVBDFDX5Y8Y7C.8XI/,!MHWV2X
M/C6J?\+M_P"&XOV9_P#A<'_"![L^)O[-_P"$'^W?] P>=YWVG_MCCR_^FF:]
M\^-_[,NI?$/XB:%\1? WQ!OOAE\1]*LY-)DURUL1J4%YIK&246LUK+((B!*X
MD!/Y9$9CXGP1^Q3K6F_M!>!/C+XI^+FK^.O&.A1W=KJ7V_2X;:UNXY+>6")+
M:*(@6HC$I+_ZWS),G]V2: -']H;_ )/J_9'_ .YN_P#37%2>,O@O\4/AM\:O
M%_Q<^$-[I/B&3Q1%8_\ "0>"?$B>2M\+.(QQFQO8\&*8Q@11B4&(&:220G"
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M8M&TZ.:2,^7-=VUK)_IOERBVECC,D>#$>OF&@#<_YQ9_]T;_ /<+7E?[2?\
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M-[%G$UQ'!G[04/E^7R/+/F#D2.* &?M#?\GU?LC_ /<W?^FN*O-Y_BVWP/\
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MVH_@>_[27P-\0_#I=9_X1]=9^S;M1-J;GRA%<Q3 B/S(\\Q8Z]Z]=H ^5?\
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MOJ-M#X9M(;IXQYL44MAF2,/U_>&*(XS_ ,LXZ9^WIHMG-K?[.6IM:0/J%O\
M%O0K6*Z\L>;'%+YAECW]<2&&+/\ USC] :\N;X&:A\8OVUOVDM2\.>-M6^&O
MCCP_-X5?3O$&EYE)BDLO,EM[FV\P1W,,OV>+]U)QF.(G(\R.3W3X<_LJZMIO
MQ"TGXC_%#XE:Q\5/&GAV*ZM=$+6<.CZ=IT<R".5Q;0<&4@R RD\QF,;,Q1D
M'BL#?&W5OV[/C_<_"Y_ 5Y>Z-9>']/EF^( OI9;.UEL?.$5C]GYBBDD\R22/
M@&01G&<FM_QO\"_VCOC)X\^%^J_$0?!V+3?!GBC3_$!N= &I"_"12YEBBDEB
M/$G7R^,R10\\5[#\9OV;'^(WCW3OB+X.\;ZS\-OB7I>G'1[?7+&..]M;FR,O
MF>7<V4H\N903(4&8\2.'^?RX\0?"WX _$S0?B!I?B+XA_'CQ!XZ&DF466E6.
MDVNAV$OF0R1RBZBAS]JZQR1Y(\HQ=\T <]^T-_R?5^R/_P!S=_Z:XJ3_ )RF
M?]T;_P#<U7I?CSX&R>.OC=\)?B*VN?8'\!_VOG3FM?,^W?;K40G][Y@\KR\$
M]),]..M/_P"%(C_AJ+_A<?\ ;C;/^$._X1'^Q/LO/_'[]J^T^=YGK^[\OR_?
M/:@#R3X#Z797'[>W[4^I26EN^HVT/AFTANGC'FQ12V&9(P_7]X8HCC/_ "SC
MJ]^T-_R?5^R/_P!S=_Z:XJ]*\!_ V3P+\;OBU\15US[>_CS^R,:<MKY?V'[#
M:F$?O?,/F^9D'I'CISUH\>? V3QU\;OA+\16US[ _@/^U\Z<UKYGV[[=:B$_
MO?,'E>7@GI)GIQUH ^78&^-NK?MV?'^Y^%S^ KR]T:R\/Z?+-\0!?2RV=K+8
M^<(K'[/S%%))YDDD? ,@C.,Y-;_C?X%_M'?&3QY\+]5^(@^#L6F^#/%&G^(#
M<Z -2%^$BES+%%)+$>).OE\9DBAYXKV'XS?LV/\ $;Q[IWQ%\'>-]9^&WQ+T
MO3CH]OKEC''>VMS9&7S/+N;*4>7,H)D*#,>)'#_/Y<>(/A;\ ?B9H/Q TOQ%
M\0_CQX@\=#23*++2K'2;70["7S(9(Y1=10Y^U=8Y(\D>48N^: /HJBO$OC5\
M&?%7Q-\=_#?7]%^)FK^!=-\+:G]NU/1=/\WR]?A\VVD^S3>7-& ,12)R)1^]
MZ=17MM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!PWBKX7>'O%/CGPAXQU/3?M?
MB'PL+K^R+S[7+']E^U1>5<?NP?+?,?\ ST!Z<8KN:** "BBB@ HHHH ****
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M3IYD4LQCD[920$8S7T?H^AV'AS2[33=.L[>QTVSBCMK>UMHQ%%!''_JXT0<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5Q7P]^%_ASX8_P#"1)X<T]M/_M_5KG7M1'GR2_:+ZX(\V7YSW\L<=..E=K10
M 4444 <-X5^%WA[PMXY\7^,=,TW[)XA\4BU_M>\^URR?:OLL7E6_[LGRTQ'_
M ,\P.O.:[FBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y#5OBCX/\ #]])8ZIX
MIT73K^,9DMKS48HI(_P)S0!U]%%% !117.:7XQTO6?$6MZ'9W/FZIHIA%]"8
MW_=^;'YD7YCF@#HZ*YS2_&.EZSXBUO0[.Y\W5-%,(OH3&_[OS8_,B_,<UT=
M!117-_\ "8:1_P )E_PB7VH?V[]A_M/[)L?/V;S?+W[\8_UG^>] '24444 %
M%%% !1110 4444 %%%8VE:UIVK&\6QOK:]%I<26MPMK*'\N08S')SP_3@T ;
M-%%% !1110 445GWU]:Z5:2W5W<1VMK;Q^9)-(_EQQIZG\J -"BN'_X75X _
MZ'KPW_X.+;_XY746-]:ZK:175I<1W5K<1^9'-&_F1R)ZC\Z -"BBB@ HHHH
M**** "BL:ZU_3;*^L+&>\MXKZ]\S[-:R2@23^6,R; >7P,?SJKJGC'2]&\1:
M)H=Y<^5JFM&86,(C?]YY4?F2_D.: .CHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /%?C!J&J>(O%GA/X>:)J]]HDVKR27VKWVER8NK6PA)/'_//S9"(
M_-S_ -]\BMRV_9Y^&]CH)TJ+P?I1M?*DC,DEJ)+G$G7]Z?WGZUS=XYTO]K:Q
MFGB\F&^\&R6EG-,>+B6.^$LL<8_CD$?[SCH.?6O;ZT(.,^&WPWTSX7Z'-I&C
MSWDVF2W,EU';75QYHMA(<^5'QQ&#G KC+S]ICP_)?3)X?T'Q/XUMX)/)>_\
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MW6GF?\LIA?8\P?\ ?RF!I6?[4GAR'5K.Q\0:)XB\%+>DK;77B733:QRR?N^
M<]<RC\C7J?B;Q-IO@_0[O6-9O([#2[./S)KJ8\**Y+X_:3!K?P5\;VUY$L\4
M>D7%R$SC]Y$AEC/_ 'W&/RKRS7+J?XC:M^SWI_B,1:QIVN6DNL:A:SI'Y5S=
MPV,<L<F /667]V/W9SST%(#J+K]JCP_IJ"\NO#/C"TT+?%C7Y=%8:?Y,G^KF
M\W/^KY'..]>PV-]:ZM:175I<1W5K<1^9'-&_F1R)Z@_C1?6-KJUI+:W=O'=6
MMQ'Y<D,B>9'(GH?SKR3]F1!9^&_&6A0*D6F:+XMU/3=/A _U=N)1*(_P,CT
M5-._:L\)Z_I=A<:3IGB#Q!JMU'YO]AZ39?:KZWB\R2/S)?*/E1].\G_+1/6N
MR\3?%KP_X0\/Z/J&L1W=K>:L@-EHQMB]_<3>6#Y(BQGS?X,>IQFN$_8S\,Z=
MH_P3TC5;*TC@OM7>5[ZX_P"6DWES2QQD_@/U-=;\1OB9I/@77M)TF+1I-?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/VCRY/M?VG[?]E\K/F>7Y>SG_5YSWH ]UHHHH **** "BN)^*WQ0\-_!_P
MZIXP\7ZD=)\.Z=Y/VF\^S23>5YDL<49\N,&0_O)(^@[]J[:@ HHHH **** "
MBBB@ HHHH **** "BBO#/VK/CIJGP-\ Z3>:!H?_  D'C#Q%K-KX;\/Z;),(
MK>34;D2>5YTA(_=_NSP",G:,QY,D8![G17D7P2_X79C6O^%P?\(']Z'^S/\
MA!_MW7$GG>=]I_[98\O_ *:9[5Z[0 45Q7P]^*'ASXG?\)$_AS4&U#^P-6N=
M!U$^1)%]GOK<CS8OG';S!STYZUY__P +@US_ (;._P"%1^1IO_",_P#"!_\
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M#\,_ /P_E_LBYUXZ#_:4FK:N#F6 1W$8C1;?:\9V$G)CD_>"6/R^F_YRF?\
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M\SR_*ESYF!C@#]YYD7HOQT^+7CR;XL>&?@Y\+9M)L_%>L:;<ZOK>M:S \O\
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MO"O[,/P_^//P%T;X*)I^I>+KGQWH]Y>7VAZS<:I:16 NQ&8I))+F2/S7E,>
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MQT^'4/!3:'#)]OF.I18F^W$B2+_61?NQQ^ZQ_P M#7HG_!43_DQ?XF?72_\
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MO)%?+IGV^QBG,W]GWO\ :%B9;:0D<&,GT <$2 8D%?27[4'QEU/X)_#.#4-
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M_P#A'_&'AW6;KPWX@TV.82V\>HVPC\WR9 3^[_>#@DX.X9DP))/E#P%\'/\
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M\YDCR"(Q+_P4,\)Z;X)_X)Z^,_#NC6WV32=)L]'L;*WWF3RXHK^TCB3Y^P
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M_P  >)/A?^Q[\'+^VL8?$6I?!O4O#^OZI8V+R_Z;'IL?E3^5)Y70>9YGF/&
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M3-]DBCBAR(Y/+$LDD<?F8./,R>E<M^UM^V'\)YO@5X\\/>'_ !A8>,O$6O\
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M%% ')Z?\/?"ND^-+WQ;:^&]*M/%%]";:XUR"PCCO;F+$?[N6;'F2#$4?!/\
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M9IGB:\U*\OXX9(\QR22VRB(B08D'&0'P>: /L6BO"/V:/CGJWQB\*ZM:>,=
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M2/ SZ1)9O/:ZIX(O+D?9Y8Y8@8IHKGF3S!(2'CQY?V:0'F6.OF#]HS_AH?\
MX;2^"7V3_A6/]H?;?$O_  @WG_VEY?V7[*/._M/_ *:?9_*QY/'F9[4 ?HO1
M7S!\7/CE\1?@;\"O#%[XAT/0_$GQA\0:W%X9T[3_  S-+#HSZE<RR_9LR7)$
MGE>5$/,&>9.,Q@^9'T_P=U3X^MXHGL?BUI'@9](DLWGM=4\$7ER/L\L<L0,4
MT5SS)Y@D)#QX\O[-(#S+'0![Q7C_ ,>/C5_PI5OAYC13K)\6^,M-\)Y^T_9_
MLOVKS<7'^K/F%/+_ -7QG/45[!7Q]_P4;UH^&_#?P0UH:?J&K'2_BMH=X=/T
MN$S75QY45U)Y44>?GD., =R: /L&BOBS4/B9^V3HWAN\\9S?#;X=G2[::6ZE
M\#6EW=77B,64<N##'+')]FEE\KG,><Y&(C(?*KV32/VG/!.K?LYR?&V&\NH_
M!D>ES:B#<".*Z_=L8S:CS6V>:9$$0'F8>7@&@#V^N5^(?C&Q^'/@/Q)XNU**
M::RT#3+K4[E+8?O'BBB,L@3GT2OF-?'7[8'C#PJ?%^A?#[X;^%K"XM/M=EX/
M\37=]/K47R9$4LB>5$)9#VD\KRQ(!)@AZZ_PW^U:OQ&_9;\>_%/1M'N-%\1>
M$M/U(ZAX;UZVD#:9J]C:F62TG \LR $Q\C!P1GRY,QQ@'MOP\\8V/Q&\!^&_
M%VFQ30V6OZ9:ZG;)<C]XD4L0EC#\^CUU5>%?\+@US_AC'_A;GD:;_P )-_P@
M?_"4_9_+D^R?:?L'VKRL>9YGE[^/]9G'>O&?AM\;/VJ_CQX7T?Q9X,\"> _"
M/AVXT>RECNO'C7OFZG=21_Z1+;0VTDDD5MY@'E^;R\?ER L)/D /MNBODGP;
M^VE+_P ,O^._B5XX\/'PYXG\ 7MUH7B#1X)M]I+K%OY,8ABEC\W]W++-$F2#
MY9D;F01^:?.OV@OVBOVL_@=\-KWXD:CX7^%\7AR*>$RZ3#<7ES?Z='+)Y<:W
M$GFQQ2F.22.*0Q'F0Y \N@#[[HKB_A7_ ,)O_P ()IO_  L7^P_^$QS-]N_X
M1GS?[/\ ];)Y7D^;^\QY7EYW<YS7:4 %>0_\+N'_  U%_P *<_L-MG_"'?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:9J?Q \(Q:_J&FP?98)Q=W-M-Y1)/E&2*6,R#=T\S.-[XQYAJW\.?V7?A?\
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M9]-U>$21M+I%E))9:?%)$8X_+\M8I.0/,(D!D.:]Q^*WPO\ #?Q@\ ZIX/\
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M29\V.7(S'0!],+)X0^"WPWL+>XOK'PIX.T"RMK".?4[WR;:UA01PQ))-*?\
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M;>,="\0W_B;29#:W6G:7*LD?VZ$$>:) ;N+ $9D!(_=\&M?_ (8]T3_A%O\
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M/X&>"H]&FT;X<Z;:7VEZM#KEG?\ VFY>ZAN8@/*_TAY/-,8(!\DDQ$\F//-
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M/]GO2_%TGB.'X6:2^HS223>3</-+9 R;AC[%))]G  ?B/RL)V XKZ5H ^,?
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M>O?Z6\*_"[P]X6\<^+_&.F:;]D\0^*1:_P!KWGVN63[5]EB\JW_=D^6F(_\
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MXN_&K2/@RO@Q-7M;^\_X2KQ)9>%['[ D<ACNKKS/*DDWR#$>8SR,D>A[>F4
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M9_\ !NO:#^T/\8HE33;:SOM-T3QGY-KIU['%%YMM'"(B8A'D>7&?^6?EGWH
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M?C+)\*?C=H6AZ'XHOK1]4\.:WX;EE.D:U#'Y?VFWB^T$R_:8B?,,8_Y9Y)1
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI** %HI
M,TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !16!X9\3Z'XRT2VUG0=6T_7='N#_ */?Z7=1W-LW.PB.2,D'GCCW
MK?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M6,2PR1V$DPTZ+(BCY\R63RI2X<QYDT_A7>>+OVK/V%_BOX+US75NH/A&-/\
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M/PYTS]GW3/#VNZQIL5S\3?#VBW,ZZA<>=>V3";S(KB4R;YM_EC?YA/F'DY-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3]DGXB?M+?#CPY\-/@AKMGK<U[+?QZUK&NW40TZ6UB-U#+'"+F7SN8OX_+'
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ME<SXQ^"_P[^(>IKJ7B_P+X9\3ZE''Y"7>M:1;7<B1]HQ))&2!\_3WH ^.O\
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MYXEO;&ZTWQ1X<TOP%#-I=L;>\TP_V8)M7MXC+%D1FZOC@DR9,0ZI'$:^\J*
M/S7_ &&]0U[XQ?$[X=>&_%&E:A:ZS^SOI.K:+J=^+BU\K^TKF8V-K:".//F1
MQ6-M*/-'62+D]/-]]_;U^]^SG_V67PY_[<U]5T4 ?*G[0W_)]7[(_P#W-W_I
MKBI/^<IG_=&__<U7U910 5\I_P#.4S_NC?\ [FJ^K** /F7]NSX7ZI\1/A#H
MNHZ?X<7QQ>>#?$5EXJD\(^4LHUN*W\T2VG.>L4LA_P!7(9#&(Q&2]>+?\+\_
M8CW?8/\ A6^A_P#"9Y\G_A"_^%;'^V?MV,?V?Y?V7R_M7F_NL>9CS.-^.:_0
M.B@#Y=^./P5M_C3^Q/K/@?P/X9/@N36-&BU+3?#ATV*Q>WF$L=\+62$&..&6
M26/RY.?W<DI)SCGA/"G_  4\^'"^"M&M?$D.MGXM,T-CJ?@#2?#UT-0&I^:(
MI88DD_=9\W)$9E\S'&/-_=U]NT4 ?$O[3?A/4/'VC? 'XT:K\*+[QI9^'O.F
M\0_#)M,&H7:1:G:1))^ZD&99;69$_=&+W/E>7FN2D^/_ .Q/K6VQ\%?##P]\
M0_$<Q!MO#7AGX;F34+W',OEI+:1QGRXQ)(<R#B,]>_Z#T4 ?(?\ P4AT.Q\/
M?L$^/M*TVUM]/TVSATNVMK6VC\J."./4+7RXXT'&,8'%>C?M=?!_5/C=\"/$
M&B^'I#9^,+$Q:SH%U"0+B#4;67S8?)E\R/R9)/+,/F^8/+\S/;GW:B@#X<_9
M+\:7_P"UY\95^-][%:G2?"OA>R\,6";3+:C7;F**ZU6YM8I#YEJ8_-BM>_FQ
MG/FD9%3?M6> ]#\)?M(>%OB]XX\ CXA?#:3PW-X8UQ/[%345\.^5=-=1:F\>
M)"\6WS8Y"(QY<8/),@C/V[10!\)>$_BK^QW\3/$FD^&_ 'PK\.^/]8O[V*UE
MM= ^'0_XE\,DHC-[<^=;1".VC,D?F29./,'!K[MHHH ^"?VS+CP=HG[4GPYU
MWX[Z)<:C\$[/09XM*U%K.2XL;/7VN1+(+I(OWL@DMK:./RI!)'(<_NR!*1Y]
MX3\;_#+QM^WI\ ;CX2?#>'PSX-5-<:V\5:?X=_LBT\02FPE$RQ?NHS*+;R_+
MSVDEDZ 9D_3>B@ KY._X* 6VIZ?\/_A[XOL-)U'6M,\#>/\ 2/%.LQ:>BRW$
M>G6WG>;+%&2,XW^W&<_("1]8T4 ?)?Q@UCPU^WS^Q]\2=-^$^O#7DE(M;>5;
M.:V$M_;/#>K;8N!%CS/W4?F=!YN3T(KF-'_X*;?#/P_X0C7XIQZ]X$^).FV$
M;:GX4O-!N8KF6Z-K%*?LZYD$<<IDQ%YTD9[R8!S7VW10!\E_L9Z'XLU[Q[\9
M_B]XLT'4O"#^/-7M(=.T35-/-K<Q:=8Q26UM++&99"DD@DY0]XC(/W<L=<-+
M\:O#O[)7[:/QIU7XJ#4O#?ASQ]8Z'>:!KS6,ES:W/V&U^S7,7[KS)!('EZ$=
M!D_ZR+S/NVB@#X)_;,N/!VB?M2?#G7?COHEQJ/P3L]!GBTK46LY+BQL]?:Y$
ML@NDB_>R"2VMHX_*D$D<AS^[($I'GWA/QO\ #+QM^WI\ ;CX2?#>'PSX-5-<
M:V\5:?X=_LBT\02FPE$RQ?NHS*+;R_+SVDEDZ 9D_3>B@#Y3_P"<IG_=&_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G_
M !1XKT[P1X5UCQ%K%P;71])LY;Z\N/++[(8HS)))A/8$_A7R)\,U_:3_ &IO
M!6G_ !%L/BAI_P $-%U@RRZ5X8L_"$6I2&R\Z4PW-Q-=$$RR#!S%B-X_*<8\
MPBOIWXV>"[OXB?!SQ[X5TYH8M1U[P_?Z5;2S_P"KCDFMI(H]_MF09KYG_97_
M &P?ACX?_9K\+6'CCQ1I7@+Q#X)TTZ%K/AW6+[RM0MIK&$0_\>SB.64R1QB3
MRHXW/F2&/F2(T >V:;X@^,UO\#7N]4\.^&;CXN+)-:K96UQ*FCAOMIBBN?,)
MDE\G[/Y=P8_]:X!0".3@?-_Q8O/VD_V4OA?;?%CQ3\7M+^)ECHLMH?$?@Z;P
M[;:=%/')*(7^SWL47FGRY94V$I&./,(/^JDV_P!I[]I"W\7?LO>%O'7@W6M>
M\/> ?$7C*VTO6?%6DK<VU_I>CQ7\L5S?PF(;XC));(H\Q#D3B,Q^9)7R=^V1
M\-?V/_A/\"_L/PVO],\5_$2\%O;V6J:7XBDU.2(1R1?:;BY\N4V\?F1^8!^[
M!\R7]W'@$Q@'W]^VQ\</$'P0^$^G2>%[C2](UWQ1X@M_#-IKFOSF*RTEKB.5
MC>2\'Y8Q$?8<2$2 >7)N?!OX?_&/P3XMN5\>_%>Q^*7A^ZLI#NE\-PZ1=64Z
MR1^5Y?V<E)8I$,OF>9R#'%Y?!DK5^.GQ.^%'A=]"\'_%74=#M-/\4>:;>U\2
M6HDL+D6WER2"620>4@&Z(_O2/QKYB^$'B;PA\)_VJ/ /PZ^ ?C2Y\8> ->T[
M4;GQ!X9M=9DUO2?#D<40DM9;64>9]F,UR9?-S))DS#(&8J )?CPOQ+7]OK[!
M\([;25\6:A\)OLD>J:Q/LMM*B.J2R&[\LQR>;AHXXTCP?GEC)S''(*W_ !#K
M7QU_9?\ B%\+K[QC\4[#XN^$/&'B2V\&WNGW?A^#1[FSFN>8;J&2WSYGE^5+
MGS,#' '[SS(NN_YRF?\ =&__ '-4O[>OWOV<_P#LLOAS_P!N: /JNBO,_B%\
M=O _PE\3^#?#OBG6SIFL>,KW[!H=F;267[3+YD4?EYCCQ'S-%S(0.>O%>F4
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW^K:?:ZWK!E_LZPNKJ-+F\\H>9)Y4?5_+!!..G?U/1T %%%% !1110 4444
M%%%% !117)>)?B-X5\)ZMH^F:[XETG1;[6I?LNFVM_>QV\U])F,&*&.3'FMF
M2,8&2/,'K0!UM%%% !1110 4444 %%%% !1110 4444 %%%% !117._\)5HO
M_"3_ /"-_P!KV'_"3?8_M_\ 9'VI/M?V;S/*\_RO]9Y6_P#=^9C&>.M '144
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !24M)0!R'C[QM!X!\&ZEKTUM)=16:Y\F/J_S[/ZBODW4
M?VD_'UY>/<P:M;Z?$XXMK:SC,<?XR\U]#_M#^#Y_&WPWN?L5O+>7ME-'>6UO
M&<&0@X(_[]O(*^*"217XSQKF.8X7&4Z=*;A3\C]9X/RW 8O#U9UZ?M*A]B?
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MT ?J-X$_:2^%?Q'OX-.\+?$3PSK6I7-Q/%'IUKJ<1N7,9D63RX@=[C]U))O
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MB9;J)8X?L/F9>7$4L<45T\<0\SK^[!,GF<_9GQD_Y3(? O\ [$RY_P#16LT
M?7OQ.^,'A#X-V.DZAXR\10>'-/U'4HM(M[N[C?ROM$@E,8DDP?*7$4A\V3$8
MQR:_/']O3_E*9^SG]/#G_IZN:]3_ ."U/_)K/A;_ +'*U_\ 2&^KRS]O3_E*
M9^SG]/#G_IZN: /T;\>?%OP9\,9+ >,?&6@^$OMPD^R_VYJ,5B+CR\>9Y9E(
MSCS(^GJ*I_"_XR^!OC-IIU+P5XQTKQ+$L,4DD>GW2/+;>9S'YL6?,B)Y^20
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M8^%OQ4E\6?\ !*WXT>!KYYGF\&ZGI4]KNA2.**RO=3MY(XUZ&3]['=2$R?\
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M$)\7S#3_ +('<Q0ZD^!:W*QB,\R$"W./+!\V.23_ %0K]:?VK_\ DUGXR_\
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M3O%/Q$\,Z+J5M<012:==:G$+E#(8UC\R(G>@_>QR;R,!/WA.P$CD?VA/VMO
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MIJ&AZO:M8&WOM,N9+6XA)O[:,^7)&<C()'7H:^FZ^5?^"HG_ "8O\3/KI?\
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MFTK3[VQTR36+JUN[V**:WL8SB2ZDCR"(@<YD/R9_7\][J2SO/C[\)O%/P8^
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M=_$/4VTWPAXZ\,^)]2CC^T-9Z+J]M=R)'WD,<<A('S]?>OB/X"_#?Q5\7/\
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M0?\ X3;[+]E_LS,WV[9YG[KS?MN_'F_OL>9Y?[O-/_8G^&/PWO/VB/CYXY\
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M(_\ W-W_ *:XJ /HSQ-XGT/P;HESK.O:MI^A:/;G_2+_ %2ZCMK9>=@$DDA
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M#^&GMO$D_BJZUZ%](ML:I+'8QRK)<_N_WQ$A,F9,\DGO6W^W'IJ^&?@+X/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[3_VW/VR]-\.Z793? '4-2UJU'EW.IW/@_4]MVGE1^63'$8UCER)"Y'[L^8
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MW@-?N%10!^:__!'?X3^-?A>?BU_PEW@[7_"7V\:3]F76],FLC<>7]M\SR_-
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MTBXL;51%(DGDVEO+^\EEFDB_>2Y(C')/$45=Y_PJKQI_P^,_X3C_ (0[7O\
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M6MYKT6K7VNVT4WFQVEL;;'D#S(T$DA>.3YXS&3L=)/9?VL_@O>_M!?L^>,?
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MZU^SK\+M4U&\GU&_U#PMI=W=W5U)YDL\TEK$TDDDG<Y).: /4Z*** "BBB@
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MF6$@R>7'GF+/3O0!Z[1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGA[P-?G1?%?CKQ%8^$;'6OM/E?V=+=,_[S(CD.?W9C_=XDC\PR)S'@XFK?\
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M1:Y<:G'J0/F?;Y?W8224R_O),>7W\ORSR/8-4_:8^)GQ _8(^&&IV&HQZ?\
M$OXE>((O!*:]:2?9A9RR75S$;KY(Y"IDCML$Q8\LR^9%CRU2O6_^&T/%&[^R
M/^&;_B]_PF7_ !Z_9?[(B_L?[?G9Y?\ :?F^7]F\SC[5Y>/+_>8Q6E^U!\)_
M'GQV_9YT"ZT*V;PS\5O#]]IWC#2-*N+V":.VU.WY^S22^5Y4N!)*!TC\T1Y/
MEYH Y[2?^":_PK\"Z?;7/P[CU;P/X^TR)/[-\<1:E<7-W%=(H'FR6\DOV>59
M>1+%Y81XY)8\1Y!&I_P2[_Y,7^&?UU3_ -.EW4,?[4?Q6\8E_#7A+]G_ ,8:
M7X])\F\NO&ACL?#FF/@QR2QWJ$_;HHIMAV1!9)8M[Q]*U?\ @G7X9U?P7^QW
M\/M$\0Z7J&AZO:M?BXL=3MI+6XA)O[F0>9'(,C((/3H: /9?BM\+_#?Q@\ Z
MIX/\7Z:=6\.ZCY/VFS^TR0^;Y<L<L8\R,B0?O(X^A[=Z^(/V(_V//A)K7BCX
MF>(KWPIYNL^!?BMJ=AX?N1J5T/L,-D]M):Q_ZW]Z(R/^6N<]\]:_16OB7X-Z
M]XK_ &:_C1\1_ VO_"[QAK^F^./'EQXGT?Q=X8L#?Z;%'J,L<?\ I<OR?9O)
M\H&3)/5SC8(WD &^,/",_P"UI^UY\0/A_P"++O47^$/P^TFQAOO"UEJ\MM%K
M>IWL0NHIKE8A&7CB$>!'YOR20Q..)917+_'K]FOP-^P[X5@^.OPEL]0\(ZGX
M1O+<:IH]KJ$]Q:Z_IMQ=0PRV4QN9)?+Z@B0# (SY9D\MX^O^)-E\1OV:_P!I
M[Q!\7?"?@W5OB5X"\;Z;8V_B?1=(FB?4+*]M98[:*[@M_*\R4"V)Q%&3EWE,
MAC CKG/BSXF^(_[<RV7PST?X6>-?AU\-[K4=/N/%?B/QE;Q:5<M9QRR2R6UM
M;2QRF0DQPD2QYQ(%60"(DD ^^*_/S]O[]F3X;:IXZ^%?C"\\-^;XE\9?$G0=
M!UR].H7)-Y8RQ2121>7YFR/]W%$,Q@'BOT#KY?\ VX/!?BWQ5X"\&:_X-\/-
MXJU'P%XTT[QD=!BE,-QJ<5MYADBA_=G,G[WICH#CS),1D ?\1/@3X$_9[_8X
M^-?AWP'H7_"/:1=>&M<U![)[J:Z!F_L\QF3,LDAZ11]^W;FO(OV?_P!@/X>_
M%3X._#WQG\4)]7^)>L:EX6TD6T-]J$UE:Z39_9@T5M:QVTD>T"-T$AD+^9(I
MD^0RO7LWBSXC:C^T!^R?\6IM-\ ^-/#%_)H.KZ7;:)XITDVNHW4AL3Y?DPYD
M\P2>8(^Y+JPQ7H/[-.E7NB_LZ_"[2]1LY].O]/\ "VEVEW:W4?ERP31VL2R1
MR1]CD$8H ^<_V5OB%JGPC_9M^-BW.HZAXKTGX1>*/$&D:+!JDZFXETW3K:.2
M*U>81<=3R1^[!P!Y<8C'SAX"\:?LB?$;P?IVO_M"?$G4_B7\3-0@^U:G=:M#
MK47]F^:1*=/MH[8>5'#%)(^/*)Y\S&V,^6GU=^S=\(=1UGP-^TQX3\6Z9K&@
MZ;XN^(?B:.)I+<VTUS8W444:W5L9(R",9\N3!C)]<5C?"_X[^._V<_A]X?\
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M-S*@QYDAS'))R*^P: /E7_@EW_R8O\,_KJG_ *=+ND_9Y_Y/J_:X_P"Y1_\
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M?.1)&9!7RE\2/$G[&OA'PS<^)_@3X[OOA_\ %70C_:?A_4K*UUBY-S/%&?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\S
M^$7QJTCXS+XS32+6_L_^$5\27OA>^^WI'&9+JU\OS9(]DAS'F0<G!/H.^K\4
MO (^)W@/4O#0\0:YX4^V-$?[6\-7GV._MS'*DG[J4?=)V>63@\,17Q!^Q/\
MLT_VEXD^)NMGXJ_$VU/A/XKZI9_V?:^(=EKK'V:2VD\V_C\K_2)91Q*>/,'I
M0!])?\+.\1?\-Y?\*[_M,_\ "&_\*V_M_P#L[RH_^/[^T_)\WS,>9_J^,9QW
MZU]"5\#?'KP3\0/B!^WP?#WP_P#%]OX"U#4?A.(+_P 0&&2XN[.R;5)<FUC#
MQ_O?,$<8DX\M))'!$@CJ[\0?A_XL_9%^('PA\1:!\8?'WC72?%'C.Q\(:QH'
MCW5O[4MY8;T\2Q8\ORI(_)XQR2W_ #S\R.0 ^[**^.OVO]:^)+?M%?L\^$OA
MUXM/A&^\0?\ "0PW$UT))K$QI;0YFDMAA+B6&(RR11R?N_-"9X)-:GC#1?\
MAA/X"?$SQ[!XY\>?$BXCLK;[%#XXUG^TX[:Z\PPV_EC]UY<1EN8C+@\I%QR.
M0#ZQHKX[\*_L@^-O'WA?1?$/Q(^//Q;T[QY>V<<VK6/AG7XM,L+67RP##';6
M\1C_ '?$9>(XD(,G_+2NB_9%\>>,H=2^(GP?\>ZZWBSQ=\-KNUMO^$D2'9_:
M6G75MYUC),3)G[2 )!(?^N?[R4[Y" ?45%?,7[$_B?6?%C?'5M8U;5-5;3OB
MKKFGV?\ :%U)+]FM8S"8H8MY_=QC)Q&.!D^M)_PE6N?\/&/^$;_MK4O^$?\
M^%4_VA_8_P!HD^R?:O[8\OSO)W>7YOE_N_,ZXH ^GJ*^(_"?A?Q)^V%XS^*>
MIZI\5/'7P\\-^$_&5[X3TC0?!&IQ:68S;10_:+B6Y$/F7/FR?O!')_JLR8)S
M4/\ P3Q\#^*++5?B?JGBOXJ>-/'E[X;\4ZIX*6VUK5I)M/EAMC;'[5]EE,AC
MF+9 /F']W(1[T >N?!GXG>)/%7[4G[0/@_4]2^T^'O"@\/C2;/R8T^RBYL9)
M;C]X%#RYD&?WA..U?0U?G?\ \*W\>?%S]M;]I#0/#7CNZ^'/APW'A6?7[_0D
MD_MJX5+%?*M[67.+82#S#)*<D>7%Q)&90>RT/1_%O[+O[5WPM\&V?Q2\7>/O
M!GQ&LM4AOK'QU>G4[FQFL+;[3'-;2C'E^9YBQF/R^<-GS#Y?E@'V]7F7C#XV
M:/X-^*WP^^'][9W\VM>-OMXTR:V1#;Q_8H1--YA\S(X(Z ^E>FU^=/[1G[-1
MN/VT/@I:_P#"U?B=;MXUOO$UV9H?$!\W1/*M?-\K3/W7^C1'S?+[_NP![T ?
MHM17R3^T%XG\3?LG?LZZ-X;\$ZKKWC?QUK.KP>%O#>K>*KF*_NY;Z]EFD$MS
M++Y<>8XQ*D9/RC$(D!C!-0ZM^PWK^K:5?W,_[2'QA@\5743R2WMKKHM[!;UU
MR98K*.,>5%YIXBCD&(\QB3% 'UY17@'[(/Q:\0?$[X9ZM;>,)+>Y\<>#_$%[
MX4U^^L46*UN[VUD4>=$..)(Y8B?W<?[PRXCC&!76?M+:K>Z+^SK\4=4TZ\GT
MZ_T_PMJEW:75K)Y<L$T=K*T<D<G8Y .: /4Z*^+_ -F_X&^-_B#X#^%GQ*^(
M?QF\8_VNNGZ9J,&@^&]7EMM*EL4BA>*.^20&2ZEESYEQ(Y&3,8Q^[C0UQ7B3
MXOV/[07Q6^(NE^+/VB&^"O@7PEK#Z%IV@Z/K=MHFM7M];<75[//)F3[+YDLD
M<:# D\J,D1R1GS #]!:*^!/@C\5KKX4_M/>'?AAX>^-%M\=OA_XYCN[BVO-1
M\11:OK&@7MK:^;()IHL^9%*(_DC_ '?? 'ER&7?\)^%_$G[87C/XIZGJGQ4\
M=?#SPWX3\97OA/2-!\$:G%I9C-M%#]HN);D0^9<^;)^\$<G^JS)@G- 'VY17
MP[_P3Q\#^*++5?B?JGBOXJ>-/'E[X;\4ZIX*6VUK5I)M/EAMC;'[5]EE,ACF
M+9 /F']W(1[UZ-\"_%6MZQ^V/^TQH=YJVH76D:,?#/\ 9MA=7,DMO9>=8223
M>5&3B+S#R<#J/PH ^G*^>_\ A9WB+_AO+_A7?]IG_A#?^%;?V_\ V=Y4?_']
M_:?D^;YF/,_U?&,X[]:Q_CIXJUO1_P!L?]F?0[/5M0M=(UD^)O[2L+6YDBM[
MWR;".2'S8P<2^6>1D=3^%9__ #E,_P"Z-_\ N:H ^K**^7OVGO"^J>)M2\/7
M'B?XZ?\ "E_AA;;!--H^IKI&IZMJ3BYS$;Z601Q11H(I(X@)/,_?9'[N-QYS
M^RSXZG\/_M3^(_A7X=^,%Q\:?A]=>%5\46VJ:GJ\>K7VF7@N8[:6T-]'(<@C
M]YY?&,QX /F22@'T[_PN_1_^%\?\*G^R:A_PD'_".?\ "4?:]D?V3[)]I^S;
M,^9YGF^;V\O&._:O2J_-7_ADD_\ #>7_  A/_"Z/BYG_ (5K_;'_  D'_"4G
M^V?^0IY/V;[3Y/\ Q[?\M/*Q_K.<U[S^T=XT\<?#.'X+_!OX9ZYJ)\<^+[M=
M+7Q9KJ1:C<V^FV,*&^NY3*Z1R7.QHI#D?O )L;9#&: /K&BOC;Q3^Q%XPT?0
MKJ^\$?M%?%M/&=KBXTO_ (2CQ&VH:8\T;!UCN81$/,B/(.01R28Y,>6=Z'X_
MW?QG_P""?NN?%&P^UZ%K-UX*U:X:YLU:W-K?6UM<PRRPXD)C'G1.8R)-X'ED
M]#0!]5T5\0_ 3]G[QM\7OA9\-O'_ ,1/C%X\BO[S2M,N8]$\'^(I=,T^2S,4
M9B^U'_6W%Q+_ *R:7S$/[WRX\"*//:?L0>.M7_X17QC\+O%>L:MK7C7X:^(K
MK2[_ %365N3=:I92S2R6-\QES@21DA(Q)+^[BC.<21T ?55%?,/[.GB;7/BM
M\?/CAXON-2OW\)Z'K,?@G1M%DNI(HK.2RASJ$AMH_P!U)YDTD1CEDS+Y8(S&
M/W=?3U !17Y^^,OAS;_;/$\WQ2_;-O?!?Q5O/WLFB^&_%L.C:1HTDEK'Y42V
M,DPDECCZB0F*26,@G$F9#]#?L4?%W6_CG^S%X)\:>*7MI=<U&.X2YEMTV"7R
MKJ6W#[,<%_*STQS0![Y17YN_LD?"+XJ?M+_ GP-XL\<?'GQIH^A1P7]MIMMX
M2U>6WU*Z;[;)_I-]>R&0RG*2Q"/R\1QQ1<C]X#[-^SOKGCGX2_M&>)?@+XN\
M63_$+1ET+_A,/#7B/5KF2358K-[H6_V2ZDQB4B3)$@[#_IJ(X@#Z\HKX#U+P
MO\5?CM^UM\>_!.F?%?5? O@+29_#5U?+IMQ*VHPYL!*;:P)D\NR64F:228<^
M9%#Q(/,K4US2/&W[%OQ8^'%YI?Q$\4?$GX?>.-?L?"&JZ/X]U62]OK*]N9)/
M)N[6;RMN %D,D6.>G/F1R0@'W117Q+\9H_B3XY_;JM?AUX9\?ZEX3\-7WPYC
MO=8-I<2&>&#^TY(Y);"/_5QWLG[N'[21^ZCDE(R42KOQKN?$G[''P#;1O _B
MCQAX_P#'GC'Q)::#X:U+QQJ,>J36]_= QA=\GE1QQB."4QYR/-E'F#83@ ^S
M:*^0]6_8;U_5M*O[F?\ :0^,,'BJZB>26]M==%O8+>NN3+%91QCRHO-/$4<@
MQ'F,28K(T;Q)\3_VD_V.OB%X6M=>N-)^-GA/5+[PQ=:YX?8V2WVIZ;+'+FUE
M$D?EBYC\N,R'R@#-+^Z$8Q0!]IT5Y1\(?CAH/Q<^!N@?%!;BVTG0[W3_ +=>
MRW4NR&P\L8NHWEDV<121R@RX _=$UXS^SM_PM/XJ?L^^)?B-9^)+CPYXW^(V
MJ?VCI$?B"*6YMO#6D_:/*ACMK4XBE(MEDGCE\N+[2\L9ER/WE 'U[7SY^W5\
M3?$GP;_99\;>,/!^I?V/XBTW["+:\,$<WE>9?6\4G[N4&,GRY''([U\=_%CQ
M!IG[.GPUM/B!\/?VO=4^)GC[P]):M<>'-:\8VVK:?K@D=8KF,6(E\R,?O#)G
MS)#&D?7/[Q/IW_@J)_R8O\3/KI?_ *=+2@#ZJHHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KX5_9U^-'A[]GCXR_%SX6?$0ZAX
M:\5^+/B5=:YX=%Y:220:M;:E*D-J8I(A(/O18/F8 W8)S'*(_NJB@#Y3_P"<
MIG_=&_\ W-4O[>OWOV<_^RR^'/\ VYKZKHH ^5/VAO\ D^K]D?\ [F[_ --<
M5=I^V/\ "/4OCQ^S7XY\%Z,,ZW?V2S6,+ '[1+;3174<)\R2,#S6B6+S,_N_
M,)YP0?=Z* /B31_^"FWPS\/^$(U^*<>O>!/B3IMA&VI^%+S0;F*YENC:Q2G[
M.N9!''*9,1>=)&>\F <UT_[&>A^+->\>_&?XO>+-!U+P@_CS5[2'3M$U33S:
MW,6G6,4EM;2RQF60I)().4/>(R#]W+'7UI10!^?7PU_:$T+]B_XL?%_PC\6H
M-2\,:'XH\87WC'P_XM&GW-Q8ZE'<_9C):Q^7%DR0@Q9*;TSY@X C,MCX _%R
MX^.G_!0!?& \+:MX5TC4/A)NTB/63&EU>V!U6(BY\N//E R&41]=\<<<G D%
M??M% 'Y,WU[J>I_'CXZ7NLZ/\=I]4_X3*ZLSXD^!=V);:\M(HXHK2QO1$/*$
MMK"(\8_>_P"E2B7$D=?8W[(/Q<^%VIZ+>_##P)X:USX;ZAX/!=_!?BZWEM]3
M@CF/G?:/*DEDDDC,EQ_ST./-3IYD>?/OA1H?[0G[(_@73?AGHGPCT?XNZ%I,
MUQ+IGB'3/%46D9MI;F:0Q7%M<C_79D8_N\Q@21C),9)[SX"_#GXF:_\ &K7?
MC7\7-$TGPGK,N@?\(SHWAW1K[[2UM8F]DN3]M?!CEF_U.)(I!&07S'&: (?V
M>?\ D^K]KC_N4?\ TURT?M#?\GU?LC_]S=_Z:XJ^JZ* "OCO]LC6E^%/QP_9
M_P#C#KFFZC)X%\(WFKV>NZE8Q&Y_L[[=:Q6UM++&#O\ +WY)*@]AS))'&_V)
M10!\<_M0ZA/^TA^S3X4^*?P1D;QC=>%?$5KXPT2S^P38U:2QFDBDA\J0Q2\$
M2G@>9)Y7EQC]Z#2?\/0/@Y]E^S^1XN_X33[?]@_X5_\ \(_-_;?VK[3Y/D>5
M_JO-SSL\[/;'F_NZ^QZ* /F3]A'P#XJ\)_!W6_$/CFP.B^*_'7B*^\77VB_9
MO*_LZ6Z9/W>#)(<_NQ)^\Q)'Y@C?F/)]$_:O_P"36?C+_P!B9K/_ *0RUZO1
M0!Y1^RA_R:S\&O\ L3-&_P#2&*OD"YT[X4?LT_&#XKVGQ^^'-A>^&_$WB6;Q
M+H'Q&U?PNNIVT_VT!VTP>7%,\4D4D<V ?]8!))B+,?F?HM10!\F_LW^,OV>?
MB1\1!>?"#X9Z<PTVRDN$\<Z3X)CTVQMY^(I;%+IXHY!<^7*)#&!@Q2'D\BOD
MN^O=3U/X\?'2]UG1_CM/JG_"975F?$GP+NQ+;7EI%'%%:6-Z(AY0EM81'C'[
MW_2I1+B2.OUFKX>^%&A_M"?LC^!=-^&>B?"/1_B[H6DS7$NF>(=,\51:1FVE
MN9I#%<6UR/\ 79D8_N\Q@21C),9) /0?V0?BY\+M3T6]^&'@3PUKGPWU#P>"
M[^"_%UO+;ZG!',?.^T>5)+)))&9+C_GH<>:G3S(\^8>(?BM;?L=_MI?$OQ)\
M1=.U*R^&_P 2+/1Y;3QA;VEQ<6MC=65I)%]EN/+BYDDV2N!'O(&SC#R&/TKX
M"_#GXF:_\:M=^-?Q<T32?">LRZ!_PC.C>'=&OOM+6UB;V2Y/VU\&.6;_ %.)
M(I!&07S'&:^I: /SR_X:(L/VC_VU/V<M;\,>'=6L_!5O/XIM=+\2:E']F&MS
M+9;)I;:(_O/)C\N$>9( 3YLD>P>3)7L/_.4S_NC?_N:KZLHH _.?XW:Y\)_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M6?M]/=_%GXS^/_$']CS74UC;$1'[7>1 RO)]FEE!BMK:.:7@1QO'GSHQY>*
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M^LZ5U7Q>^/7P_P#@AH::KXY\56/AN&53]G2XS)<7.-@;RHH\R2XWIGRP<9H
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M%ECJ_P 1O%&N:;'+K'B36_$&I_:[F]C_ '4L1/FQ\121F&,X_P!7%'S)_K*
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M WCG0?B9X3TWQ-X9U:WUC1=0B\RWO;<G#^ON.?X"* .IHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2E
MI* /,?CMX)E\>> [FQLTCEU19$N+,2R; ) <9S_N&05\07UA>:7>26>H6]QI
M]S&,R1W4?ERQU^E6W<N#TJ)H5]%'X5\%GO"M'.:BQ"J<E0^SR/B:MDE-TU3Y
MTSYI_9;^&.JZ?=MXKU &U@NK8V]K:R_ZQXR\;B0_797TWZT(H4' Q2U]+E>6
MT\KPRPU/H?/YCF%7-,2\35W8ZEHHKV#S#Y5_X*B?\F+_ !,^NE_^G2TK,_X)
M9ZQ97W[$O@6WM+J&XDL9M1M[I(Y-Y@E-[<RB.3&=A\N6)^>T@]17T[XH\*:=
MXW\*ZQX=UBW-UH^K6<MC>6_F%-\,L9CDCRG^R2/QK\N/ W[+?[8W[&_B74-(
M^$5QIWC'PC<W\>H^4MS9"UN/+D8>5+%=/')#))%'%YOV<\CRQYI,8P ?K/7Y
M/?\ !+[]FGP5\:O#_B_XN?$?3K7QWK7_  D,EA OB"&2[59/)$ES<2AY/+N6
ME^UC_6QDQF(29R:[/X,_!/\ ;2^(?QJ\.^*OBUX\U#PAX>\/7UK-<:=#J\4<
M>IQ1R22F 6UB?)DSQ'))+_RSE'^M\LQUR/AS]C_]I?\ 8M^.FL:A\ [&W\<>
M"]1CVM#J5[;117,7[WRXKJ*66']]%G(EBQG/4"22*@#"_:#^#/A7]F__ (*3
M?!V?X>W T&+Q%JVFW]SH>GM)$;(RWQMIA%^Z");2QB0>4)#C]Z,1Q^4#M>,_
MV;=!_:;_ ."K'Q*T#Q//<+H>DZ;8ZQ<VEJ C7OEV5A%]G\S(\L?O@3CG"X&,
M[ZZG]GW]C/XZ_$C]H[1/C'^T9J=O)=Z RR6VE37,4UW+);_\>IB%K_H\,4<L
MAE(#<R1'S(L2F2O<OAK\#_''A_\ X*1?%7XHZAH)B\!Z[X<BL+#5OM$1\V80
MZ;F/R?,\T?\ 'M,,F/'[OKR* /C_ /;X_8Q\(>$?V@/@EH?@F"U\'Z5X\EC\
M-26L%O)<"VEBEMK8769),R$QW$0/3F$R9,DI-:/_  4J_8S^&?[/WP!\#:]X
M,TJXTG5;+4XM GNFF,G]IQ20W%R9;GCYY?,BR'& /,,?W(XA']6?ME_ GQU\
M5OCO^S7XE\*Z,=6T3P=XE_M#6Y_M$4)M(?M5A*'Q)(#)Q#+Q&">,4_\ X*:?
M WQO^T)\"-!\.^ =!_X2+6K;Q);ZC+:_:8K;$(MKJ(R%I9(QG,L?&?ZT >,_
M\%:O!(^)WQ4_9E\'B[^P?\)!J]_I)NQ'YGD?:)M-B\S9[&3I65^W;^P/\+?@
M_P#LAW&M>#M(_LS6?"UW:7$VK7$DES=:G'*\5I+'(_F8!_U4W"&-/+D\N./S
M9*]X_;+^!/CKXK?'?]FOQ+X5T8ZMHG@[Q+_:&MS_ &B*$VD/VJPE#XDD!DXA
MEXC!/&*]$_;J^&7B3XR?LL^-O!_@_3?[8\0ZE]A-O9F>.'S?+OK>63]Y*1&#
MY<;GD]J /C3P_P#\$_OAII__  3LUSQC?VUQJOC+4/"G_":QZ\Q\J:SECLI+
MF&VB'(\G#^7)U\W/F<8B\KP#XQ_$K6-!_P"":_[._@RSG\G1O$E]KEWJ/E._
MF3?9=3D\J,C(!CW7(DY!^>*,]J_4G_A6/B+_ (8-_P"%=_V8?^$R_P"%;?V!
M_9WFQ_\ ']_9GD^5YF?+_P!9QG.._2OF.;]@'QA\3OV!?AU\-M3M])\*?$CP
MKJEU?PG5A',#%+<W1EMS<V_F^4)(Y8I?D\S)AB!'>, ^?->L1JWP27P#;_L'
M>++74K.R>'3_ !/+%>G5$NC%*!=331V$3W 623S#"3Y60!@80#L].TOQOX7_
M ."0GQ/\.^./#^K^'9=(UZVBTZPUK3)+*5+*2_L)<CS(QO!FEN?WG/\ 2MW2
MK?\ X*/:+X?71H;(S^3]G\F^NKC0KJ[B6..1/*,LDO[T29C+R2^9)^[!\S_6
M"3Z&^+_PE^-'Q6_X)ZZEX+\4QVWBCXQ:K';/<P6\]O:@L-4CN/*\S]W$#';
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MA7QAJ/C6*WTK6?%$UL1HD,B3&RCMS-S++&3$3)YO2/(  R<Y2/YM_9E_9?\
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M_P =7AL_$5K#)##;Q7%L+FYN3:I:QS2QVT9A\G[/)(.)$D\R,$C'4 ^^=/\
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M[3Y\^FR226S>;=2S#RS)'&?^6N.G8]:/V.?@SKO[//[/'A7X?Z_/87>KZ/\
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MXI^,_@:PNH? B^#(/#Z^([K3);'_ (2"\DOO,\ZW,D0\X11VHMI9)/W@\N(
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M2TS1M(TFXGU^UTA] MKBUDN)5B,H/F&6264F3_61C,8/ER8KZ4^)_P '=?\
M&G[1GP1\?V,UA%HW@?\ MS^T8KF5_/E^W6L<,8B&SJ""3DCTK!^+GP)\<V/Q
M3G^*_P 'O$VDZ!XMN=.BTO6="U^TEDT?7UCD/DRW,D/[V.6%)'Q+B0XCCCS'
M'Y@D /#_ (A>&?C=\:OC9\'O%=Y^SNWP[UGPOXEL9K[Q?:^-K*[NO[',Q-W:
M/'%Y9EB(ES_'@>:H'[V3/Z!U\Y_"_P )_M&WGCC2=4^)?BOP%HOAK3C*9?#_
M (%TZZE_MAI8W'[ZXNOWEOY4HBD'E9\S,GF5]&4 %?*O_!+O_DQ?X9_75/\
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M=%_X1C_A&_[(L/\ A&?L?V#^R/LJ?9/LWE^5Y'E?ZORMG[OR\8QQTKQ?XC?
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M7_[+7A_Q5IEMJ^B73^)I9;&Z7,4IBLK:6,2 _?\ WD<?R=^_%8WB;]F?X_\
MQ:\9>!/%WQ#\>^&Y;CPMXVTS6H/"?AH2Q:-;V-O@W4N9(?-ENI)(_P!V)?DC
MS+B3$N$M?MH>$=3\;?M4?LQZ/HGB34O!^L,/$TUEK6F@2S6LT=E#+$QCDXEC
M)0"6(\2QF2//- 'I_P"V%\*/".O?LB_$31;OP_ILFF:%X>N;_2;5(C'#IDUM
M:2?9I(/+_P!5Y>,87 \O,9S&2*\*^/UUJGQ"_8H_9F\+:QK5]):?$36/!^@^
M(+PRB6ZNH;JU\V0^;*)/WOFQQR^8>X[\Y[#6/@7^TS\<O"MOX$^*?C_P9X=\
M'SQ1QZIJW@>VNCK.L1@*)K:0S"*&(2IYA>2.,<X3RS&\J5[%\?/V;/#OQ\^!
M>H?#"[BM] TM8X_['N+"QC/]D21;?),41X  W1D1^7F*22,%,YH ]._X171?
M^$8_X1O^R+#_ (1G[']@_LC[*GV3[-Y?E>1Y7^K\K9^[\O&,<=*^&_A*O]D_
ML2_M:>$;0F+P]X-U;QKH.B6F\G[%8Q6S2QQ;S^\D_>32',A).>O&*] _X0W]
MM'['_P (S_PL?X9_8OMNS_A./[(N/[:^R_:L^9]D\K[%YOE?N_*Z=O-S^]KK
M_#?[*%I\+?V0?$/P9\(W<4^J:OX?U/3Y-8OH/LPOK^YADC-S,(@0!^\QSYD@
MBBC&9#&* +G[$?PT\)_#W]F_X?7GAWP_INEZAKWAK2[_ %.\LX<7-[+);"0O
M++C?)^\EDP#]S<<8%<A_P3YTFRT32_CUIMA9P6&F6/Q;UVTMK6V3RXK>*(6P
MCC2,<  >E>^?!/P7=_#OX.> O"NHM#+J.@^'[#2KF6#_ %<DD-M'%)L]LQG%
M<3^S3\&=<^#J_%1=:N;"X/BKQWJGBJS^PS22&*VN?*\N.7S(Q^\'E\XR.1@T
M >Z4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !24M% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7F7C#X)Z/XR^*WP^^(%[>7\.M>"?MYTR&V=!;R?;81#-Y@\O)X Z
M$>M>FT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?/W
MQ9_9%\&_%'Q=+XQMM5\4> /'-]%';77B?P/JLFFW]U;1@?N9L9CD'$?)C\S]
MU$,XCQ7T#10!\W?"[]B?PA\._B99?$*^\2>,?B!XTL$,&G:WXRUN2^GL82DL
M<D46!&,$7$HQ+YF.V#7TC110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %>:?'KX+:1^T%\+=8\!>(;R_L]
M&U;ROM4VF/''<?NI8Y1Y?F1R <Q#M_B/2Z* "BBB@ HHHH **** "BBB@ HH
MHH **** "N<TWPGH>D>(-5URPTG3[76]8,7]HW]K:QI<WGE#RX_-DZOY8) S
MT[>AZ.B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *\R\8?!/1_&7Q6^'WQ O;R_AUKP3]O.F0VSH+>3[;"(9O,'EY/ '0CUKTV
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCD_U<B..""/3UK8K'T?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_ -7&B#@
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M?VIOVH/!WAN'^R/"FGWWAZ^LM&MY2+6WENK!Y+EXX@V(_,PO3^Y&.D8Q]BT
M%%%<7\6?^$G_ .%5^+O^$+S_ ,)G_9-[_8?^JQ]N\I_LW^M_=?ZWR_\ 6<>O
M>@#*\1?M ?"WP;K5SHWB+XD>$- UBW(,^GZGKMK;7$.1O^>.23/0_K7%_'3X
MA>%?B1^R7\9]2\)^)-)\3V47A36+:6ZT:]BNH4E^PR_N_,C)&?G'YU\3_P#&
M(G_#NO\ YD'_ (3W_A#O^F7]O?V]Y?\ X%?\?O\ VS\K_IWKZCO/A9;?![_@
MG5XK\/?V#I_AK68OAK='6K:PABC$VHC1_+N99?*XDE)BYDYSQR: /6_V4/\
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M>&?#&I21_:%L]:U>VM)'C[2".20$CY.OM7S7\'_ MC\"?V^?$_P]\$S7.D>
MO$7@G_A-;CPUP+"VU3[?]E\RVC S$#&#^['!X[1Q"/AM<\;_ +.EC\8OB';6
M/P8\9?M >-/[2E_X2G7(/"Q\1'3+G[1=)%:?Z3@1"+R_)C$48C,448\R7RZ
M/O/1]<L/$>EVFI:=>6]]IMY%'<V]U;2"6*>.3_5R(XX((]/6OFS]@K[W[1G_
M &67Q'_[;5SG_!,^\CN/A7\2M/T^SU70_#VF?$+5;+2?#NLM)]IT>S\NV>.T
M=))'\ID,DADCR?WC2=\YZ/\ 8*^]^T9_V67Q'_[;4 ?5=%%% !7 ^#OC1\._
MB'J;:;X0\=>&?$^I1Q_:&L]%U>VNY$C[R&..0D#Y^OO7$_MB?#GQ5\8/V<_'
MOA/P1<21>)M2LEBM]MS]E^T1B6)Y;;S?^FL0EBY/EGS2)"!DUX_^SI=? MOB
M+X9\(-\)K7X,?&'P]%)+8:+JFF?9K^X6.UDM9I;>_C&-2A/F7($AD)E\J27R
M_P!WY@ /K7Q-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV 222$ <\<^U9'@
M/XM^#/B=)?CP=XRT'Q;]A$?VK^P]1BOA;^9GR_,,1.,^7)U]#7S]^VEXB^#6
MCWW@!OBWI^O^,+Y;R7_A'O VC6\MS'K%_P";:QB7[+D1321"0!(I9,&.YE'E
MR%\#PGP7XF\)W'[=_P #[CP!\'/%OP.;4++7-/U:'6O#W]@V^MPI9-+$@ABD
M\N40R?O'X!R(<Y\N/ !] _\ .4S_ +HW_P"YJOHWQ-XGT/P;HESK.O:MI^A:
M/;G_ $B_U2ZCMK9>=@$DDA '/'/M7SE_SE,_[HW_ .YJO!_C!XVT/Q1^V_XY
MB^(?PM\;?&+3O &G:;8:!H_A'0O[8T^U-Y;?:KJXOK:63R_-E\SRHST,</3S
M(HY  ?=W@/XM^#/B=)?CP=XRT'Q;]A$?VK^P]1BOA;^9GR_,,1.,^7)U]#1X
M\^+?@SX8R6 \8^,M!\)?;A)]E_MS48K$7'EX\SRS*1G'F1]/45^?]U)9WGQ]
M^$WBGX,? #XH?!_6X/$%KI'B&1O!@TS1[[0YIA]J6YBB\R/C(Q*0.!G.8XC'
MWGQ;\"V'PZ_:J\:?$SXP?"BY^)_POU72M,L=+\11V_\ ;<7A6*)";O[382\Q
M19CEN)+B-#Y8X&7N)!0!]Q:/KEAXCTNTU+3KRWOM-O(H[FWNK:02Q3QR?ZN1
M''!!'IZUL5YE\"8_ S?"S1;KX7?V:? MYYM[IHTG(M0TL\DLHCC/,7[R23]U
MQY9!CQ'Y>!Z;0 5@>)O$^A^#=$N=9U[5M/T+1[<_Z1?ZI=1VULO.P"220@#G
MCGVK?KY5_P""HG_)B_Q,^NE_^G2TH ]A\1?M ?"WP;K5SHWB+XD>$- UBW(,
M^GZGKMK;7$.1O^>.23/0_K6GX\^+?@SX8R6 \8^,M!\)?;A)]E_MS48K$7'E
MX\SRS*1G'F1]/45Y1X?_ &%_@AIOAN_TJ^\$6'BRYU%YIM3USQ(#>ZQ?3RQB
M.6X-Y)F6.1R"^8C&/,)= AKPC_@GO^S3X"^)?[.O@GXB^.]'7X@>)+NPN-+B
M?Q>YU*VT^QMKJ6&*VMK>7,<<4?E @ 9S)+S@XH ^[-'URP\1Z7::EIUY;WVF
MWD4=S;W5M()8IXY/]7(CC@@CT]:\X^ ^@IHLGQ"+?$L?$C[7XQU.[&ZX\W_A
M'_,,/_$G_P!;)L\GC]W^[QYG^K%>2_\ !/338_#OA'XP^&;)YUT/PS\3M<T;
M1[*:>23[#91>28XH_,)P,R.?<R9)J]^P5][]HS_LLOB/_P!MJ %_X)=_\F+_
M  S^NJ?^G2[KV'Q%^T!\+?!NM7.C>(OB1X0T#6+<@SZ?J>NVMM<0Y&_YXY),
M]#^M?#GPO^(VK_"7_@C:OB70)_L^L)97]K;7&Z2-[=KG6YK;S8S&08Y(Q+YD
M9!X<>U1^'+?X%^%?A_!X07]B_P"+VK6RV?V275-5^'<4VISAQ^\E>Y\WS!*2
M2<Q[/+SB/RP!@ _3"O/-+^-7P\U?Q@_A73?'?AK4/%*22VAT.VU>WDO_ #(B
MWFQF'S/,!C\N0D$<<^E?,W[(?AWXC:[^R3\2/!Y3Q=X4O[:^U;0O LGCJ"6Q
MU.RT[[-'_9[2R1Q^8/+DEQOBR(_+Q'Q& .._9IT'X+?#.'X=_#'XI?!R#X8?
M%JSGL3INKZS8QRC6M2BE%UYEEJ\6?,(D$68O-P#<1VW[S_5T >W_ +3_ .UU
MHWP)UCP3HFF>(O"1UF^\8:;I'B+3]2O8_M.G:9<+))-=/&)8S%@>4?-D_=CS
M<GJ*]S\$_$+PI\1M+FU+PKXDTGQ-8QR_9I;O1;Z*ZA24 ?N_,C)Y^<?G7RA^
MWI\*_!EUXD^"NO2^$=#DUG6OBMX>T[4[^738C<W]L1+&89I<$R1$1Q#RY.,1
M^U>]>-K#0_V<?@/\0];^'OA?0?#HT;1[[78["QTZ.VM9+F&U,@,D47E]?*C!
M/!Q0!T7C'XT?#OX>:FNF^+_'7AGPQJ4D?VA;/6M7MK21X^T@CDD!(^3K[5O^
M&?$^A^,M$MM9T'5M/UW1[@_Z/?Z7=1W-LW.PB.2,D'GCCWKY3_8\_90^&]Y\
M /!^N^,/"/A_Q]XM\562>)-6\0^)=(CO;NXFO?\ 2,&2Y,I)02I'D'YROF8!
MD-/^$/AG2_V?_P!M[QE\-/"5J--\%>*/!\?C>?159S;6>H"_-HXM(@0D4<L9
M#2#!YCC \N.,1@ ^A]5^-?P_T'3+W4M0\=>&]/TVRU&71KF[NM6MHX[:^C'[
MRUD<R<3 8)B_U@[CTUO!/Q"\*?$;2YM2\*^)-)\36,<OV:6[T6^BNH4E '[O
MS(R>?G'YU\4_LJ?LS_#[XL^/_CEXL\;Z(WBBZTGXK>(+33=*U>8W.F6O,9EE
M^S?ZMY)?-C$AEW_\>T.,&/-=?\._A]X=^$O_  4>U_P[X.TJ'PKH.M_#"+6+
MW1=)7[-8RWD6I_9HYA;*1&"(Q@8 YDD[R29 /J?QM\0O"GPYTN'4O%7B32?#
M-C)+]FBN]:OHK6%Y2#^[\R0CGY#^5'@GXA>%/B-I<VI>%?$FD^)K&.7[-+=Z
M+?174*2@#]WYD9//SC\Z_.K2?B#X3\7?M"?&[Q9\0_@;X]^,NMV?B6[\):<=
M$\*_V[HNEZ998CCBCCEDQ%<R',LAQ_RUS'Y?FR9ZKX-RBW_;0\&ZY\*?A!\3
MO@[X-\06-[9^-=-UKPL=-T:X,5J[V$L<:>9%#*),@G]WVQ_KI?, /N#QY\6_
M!GPQDL!XQ\9:#X2^W"3[+_;FHQ6(N/+QYGEF4C./,CZ>HK>T?7+#Q'I=IJ6G
M7EO?:;>11W-O=6T@EBGCD_U<B..""/3UKX=^+?@6P^'7[57C3XF?&#X47/Q/
M^%^JZ5IECI?B*.W_ +;B\*Q1(3=_:;"7F*+,<MQ)<1H?+' R]Q(*^K?@3'X&
M;X6:+=?"[^S3X%O/-O=-&DY%J&EGDEE$<9YB_>22?NN/+(,>(_+P #TVBBB@
M KRO5/VFOA%H^J76G:G\4O!FF7]G));W%G>:_:Q2P21G$D<D9E!!&#P>E>/?
M\%#K[6IOA'X2\!Z)J4>C+\1O&&F^#KW5%CE:6TM;DRM*8O+DCR<1>68R?WD<
MDD>.<UZ%_P ,8? S_A'?[ _X5-X2^P_8_L/G_P!DQ_:_*V>5_P ?6/-\S'_+
M7S/,[YSS0!9_:B^,VE?!;X/^+M1D\7:3X9\5/H.HS:!'J5S;Q275Y';$QB&.
M7_6MYAB^3!ZC(KY[_8;^#?[/MU%X&\=Z-KEAXM^-XTD:[K&I-XGDO=3CN+J'
M%T9K82]C<F(F2+(R,_O.3ROA/PMHOBG]BSX]>&_$NC:=XM_X5!?>+_"WAK6/
M$%I'>W]K:6UMYL,GFR#]W*-T:?NA'@0Q<#97T?\ L;_"KP9X1^ ?PR\2:-X1
MT/1_$&I>#=,:\U;3M-BBNKKS;6&6422QC?)F3]YR>N* /HFBBB@ KS3_ (:"
M^%__  E/_"-_\+)\(_\ "1_;O[._LG^W;;[7]K\SR_*\GS/,\SS?W?E]<\>U
M:7Q8GT^S^%/B^74]8O\ PQI4.D7DEYK6F2&.ZL8_*D,ES$8^1)'CS 0.H]>*
M_-KQ]XE_9TUK]G#Q?IOP^_9G\:7^B1:7J0TCQY;^$1):B6(RF.Z.J2R_:?)C
MECY\PY$8,;Q_\LZ /U&UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>
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MK:'9G4-+F,-U;^;%=1^;%)CY)!G(/8B@#W;_ (:"^%__  E/_"-_\+)\(_\
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M[-Y?F^?YO^K\K9^\\S.,<]*XK]J__DUGXR_]B9K/_I#+7E7_ #BS_P"Z-_\
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MT'Q]8/;7-A]I$IO8XO,ZQB5>!YC\$'_622&0 ^W**** "BBB@ HHHH ****
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M_2@#XR^#/[.O[3/P[\/^$M17PK\ ;CQ5H^GQ6T6O:YI=TVNP1)"(HX9;FVC
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M^$OCR'XL>&?C'\+8=)O/%>CZ;<Z1K>BZS.\7_"0:29#<+:0S',=M*LPS')@
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MX4JWP\QHIUD^+?&6F^$\_:?L_P!E^U>;BX_U9\PIY?\ J^,YZBO8* "BBB@
MHHHH **** "BBOF+]B?Q/K/BQOCJVL:MJFJMIWQ5US3[/^T+J27[-:QF$Q0Q
M;S^[C&3B,<#)]: /IVBBO,O!^C_$&S^*OQ"O_$&NZ=?^!+XV'_"+Z79QJ+FQ
M\N(B^$O[H9\R7!_UDGMY?2@#TVBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !7AW['/P9UW]GG]GCPK\/\ 7Y["[U?1
M_M/GSZ;)));-YMU+,/+,D<9_Y:XZ=CUKW&B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** /"OAA\'=?\%_M&?&[Q_?36$NC>./[#_LZ*VE?SXOL
M-K)#()1LZDD$8)]*]UHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBF^8@ZLOYTFTMP'44@8-T.:6F 4444
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M"G5_%)I]OHOP_P#&$1BCDF^SQQV5C>R))YD1CDBCMX8[Z(Q_O1^[MX^C?*:
M/O/4/VO/!-G^T[9_ B"WU:]\:W$)E>XC@B%E"PMI+KRY'>3S,F*//R1N/W@Y
M'./*_BS_ ,%2/@O\'/'VJ>%+B/Q1XBO]-FFL[V31]/C,=M=12O%+$3<RQ9P8
MNL8,?/7K7S[_ ,$YB_Q@_:$^,W[2GC"+^SM+M?M MIM9'VB&Q^T'S)#'?2D"
M+[+:Q1Q= /*N?^6<?!X[X,_%;QSX\\6?$!_V:?V7/!-QX-U2:ZAFO-<TUY#-
M;R>49K6:YDN8[>-9-T4GV&(^7'G_ %9 ,A /T6_9U_:?\%?M0^$;K7?!E]<2
M36=QY-[I5Y%&E[9YR8S+&&QB0#,<F<'&.J2 ?E[_ ,$V/VG?#'[*/@7XL^+?
M%ECJVIZ9>ZEH6EHFBQ12S"62+4Y1Q)+&,8B;G/:O?O\ @D3H5]X5\=?M$Z/?
MZ-;Z!J.GZEIEI<:59RF6*SEC>_CEA20RR[Q'[R/]37/_ /!#7_FM7_<%_P#;
M^@#QW]@7]O;1/V9V^(K?$0^+?$R^);ZVU"V&GM%=,+K]Z;J67S9H_P!Y+YD6
M9.3)Y7/2OK;_ (LC_P /5O\ F?\ _A<F?^G'^P?^0%_X$_\ 'K_Y$]J\K_X(
M:_\ -:O^X+_[?TG_ #G4_P _]"Q0!].?&O\ X*4_!SX'^-+OPO-=:IXJUNPD
MEM=1MO#MM%+]AEC',<LDLL49.3C$9?RS'()-AK0_9O\ ^"@?PR_:4\63>&-
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MGP#_ &J_VE?AE?\ @?Q@?@?#8W,T=Q%=Z>NKFYM98Y0WFQ221R"-B-T>0/\
M5RRCIT]F^,OP)\>W'QFT_P",?PL\2Z7IOCFTT-O#EQHOBBT>72M0LC<"0;Y8
MP)82CN\GR9\PQQ#Y!YGF 'I?P2^,.F_&SPU?:O8Z-KOANZL;YM/O=$\2Z?\
M8KZRF\J*7RY8CG&8YHI.IXD'->DUXC\"/CQ=?%W4/%.@Z_X8N/ GQ#\)RVT.
MO^&IKV.^6U6YC,MM+%<Q?NY?,B'3JAR#C^/VZ@#PKX8:QX"O/VC/C?8^'M%U
M#3_'UB=#'BO5)Y,V]]YEK(;'R@92/W<65.(XSG'^LZUR7C;]N/PMX3^(NO\
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M2O&/@G3K_P '?##3[+4;Y+75#)-<V4,5S<FZD?\ >2N<R1RR?ZQSCTQ7.?\
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M=_$*2R:ZMM!\":G+H^KZ_JGE6UC]IMHO-NPAW[P(<CS)9$CC/_+,R $U\O\
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M9YQBI?V"]%LX=;_:-U-;2!-0N/BWKMK+=>6/-DBB\LQ1[^N(S-+C_KI)ZDT
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MP:W_ ()?M:>%/CIK^N^&[/3=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#^Z_>
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MD-Y#'-XEN$CN8Q(/-BL898I/K')'&_7KB@#2^&O[?'@GXC>+?"FA:CX:\9>
M3XOA,OA_4/&>C1V%GJQS%MAMI1+()/,$L9&.N1SEX\_5-?*G[>OWOV<_^RR^
M'/\ VYKZKH ^5?\ @J)_R8O\3/KI?_ITM*H:]_P42\"6T_B>30/!?Q!\?>&/
M#CRQWOB[PGH27NC%H8_-D NO-'^K!'S\#_EH"8R)#?\ ^"HG_)B_Q,^NE_\
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M!Y R!'YGECZ"_P"&,?&W_#Q[_AH+^T=!_P"$,Z?V=]JE^W_\@;[#_J_*\O\
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MB#@ #T]* /#OB+^RN_Q"_8]M?@2WBC^S_L^D:7I(U]K#S"?L4ML?-^S>:/\
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M!T?]DWXQ?#_3(O#GP\_:8UGPWX-TR..UTS2]<\)6&KW,$848C^U2%#(H/$?
M\N/9'_RS!KZ'^%O@$?#'P'IOAH^(-<\5_8VE/]K>);S[9?W!DE>3][*?O$;_
M "P<#A0*[>B@ KYA^)7[*WB;4_BYJ_Q-^%'Q2U3X4^*-?LX[/Q!%_9$>KVFI
M^3Y:VTOD32>7'+'&#'D=NFS,ID^GJ* /'O'GP-D\=?&[X2_$5M<^P/X#_M?.
MG-:^9]N^W6HA/[WS!Y7EX)Z29Z<=:YWXS?LV/\1O'NG?$7P=XWUGX;?$O2].
M.CV^N6,<=[:W-D9?,\NYLI1Y<R@F0H,QXD</\_EQX^@Z* /G7X6_ 'XF:#\0
M-+\1?$/X\>(/'0TDRBRTJQTFUT.PE\R&2.4744.?M76.2/)'E&+OFNL_X4B/
M^&HO^%Q_VXVS_A#O^$1_L3[+S_Q^_:OM/G>9Z_N_+\OWSVKUZB@#G_%'A33O
M&_A76/#NL6YNM'U:SEL;RW\PIOAEC,<D>4_V21^-?,.C_LF_&+X?Z9%X<^'G
M[3&L^&_!NF1QVNF:7KGA*PU>Y@C"C$?VJ0H9%!XCX'EQ[(_^68-?7U% 'F/A
MOX-Z;I/P=F^'.MZQKWC;1+JUNK&]OO$NHFXU"]BN#)YL4MQ'Y9)_>&,'@X '
MO7BFF_L9_$#1;"V\&Z?^T?XSTSX3VD<=M:Z-9V-I#K-K%&,QQQ:NH\P 2XZ1
M?ZH>5TKZYHH \*_9<_9GT[]F#PSXM\.:-J'VK2-8\276O6-J(#'_ &?#)'#'
M':Y>20R>6(1^\)Y]*]UHHH \>\!_ V3P+\;OBU\15US[>_CS^R,:<MKY?V'[
M#:F$?O?,/F^9D'I'CISUJ]\>/@3H/Q^\(6FB:SJ&J:3)I^I0:OI^J:#=_9;Z
MQO(@1%+%)CAAYLG)_O\ &#@UZG10!\82?L7_ !;\:>'=/\)>/_VF_$^N^"(X
MS;7EAH^B6VF7][%Y,D0CEOA++)(#O_>"42B7G//[P?5_A?PIIW@CPKH_AW1[
M<VNCZ39Q6-G;^87V0Q1B../+_P"R /PKH** /A']G/X/Z=XN_;2^,'CW376;
MP-X.\1WT>BVN.!XBOK2UCUR;)D\WCRO+V2@Q?O\ ,0'EU[U^T5^SS_PN_P#X
M1/6M'\6:AX&\=^$;W[7X?\36,8N7MS)Y8N89+<XCECECC4$'Z']WYD<G:?"/
MX.>$/@GX.B\.>"=!A\-Z2KO<&WBEDE+R/G+R22$R2'M\Y[#T%>@4 ?%VH?L)
M^+O'7CKX?^-_B-\<-7\:>*O!>OV^IV!;1+:RT_['%-'+) +6'_5S221C_2/,
M/R!!Y9\L8]Q^/'P5_P"%U-\/,:T=&/A+QEIOBS'V;[1]J^R^;BW_ -8/++^9
M_K.<8Z&O8** . ^,GPJT/XX?#/7O WB6.8Z1K$:QRM;R>7+'Y<HDCD3W1XXW
MY]._2N2_9V^%OQ&^%.GW^F^/?BQ<_%*+R;:+3I;K1H[*:R\OS!(9)?,DDN#+
MF/YY"3^Z]Z]LHH \*^"7[->E?"G]F&R^#>M:@_BW15L[ZPOK@1&Q-W%<S323
M1XCE)CXF,?$G;K7FVC_LF_&+X?Z9%X<^'G[3&L^&_!NF1QVNF:7KGA*PU>Y@
MC"C$?VJ0H9%!XCX'EQ[(_P#EF#7U]10!X#XK_9SUVZ^"OA[P1X8^+WC31-<T
M/4EU.V\7:G=?VGJ%T1)+)Y5Z#Y?VF+][CRS@?NHNNSGE?#O[)'BK7O&?AS7_
M (P_&35OBBOA?48=5T32[72+;1+&&]BSB:XC@S]H*'R_+Y'EGS!R)'%?5%%
M!7D7[4?P/?\ :2^!OB'X=+K/_"/KK/V;=J)M3<^4(KF*8$1^9'GF+'7O7KM%
M !7QQX?_ &*_&_PV6_\ #7P^^//B#P5\)KR^DE3PK'H\5S=V,,O-U%:ZC+(9
M;<']YY;@?NR=_P"\ES(_V/10!X!^R+^S#:_LF^!=<\)Z7KL^NZ;J6O7.LV\E
MY;B*:WCDCABCADP3YI A.9,1Y)_U8K?^ _P5_P"%*M\0\ZT=9/BWQEJ7BS'V
M;[/]E^U>5FW_ -8?,*>7_K.,YZ"O8** /(?^%(C_ (:B_P"%Q_VXVS_A#O\
MA$?[$^R\_P#'[]J^T^=YGK^[\OR_?/:OCS]E3]GS0?VH/#7BGXU:5\0_&OPU
MU;QQX@OKK4?#_P ._$9MH+ Q3/Y<5U(?,>68[S<<^6/]*_=Q1QXS^D-?/7Q)
M_8:^!?Q:\33^(O$GP\T^;6YSNN+K3[FXL?/D+F0RR"VDC$DA+G]ZV7.>I'%
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M[I-M(+H0RW5O):R)'Y,D@\R3RAS&>ISCK7!?\% OVQ-+_9_^'.L^'/#WBO\
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M7DFGWO\ 9]TDQMKF,@212A/]7*,\QGG\ZZ*OE3]@K[W[1G_99?$?_MM7U70
M45\'?&C_ (*(^!O!?[2WP\\,6'C]K/PEI-[KFG?$"V7197:.:*$1VB9-L9#_
M *2)!FW.#WXKZM\%_&3PC\1OAC#\1-#UZWE\%R17%R-:O$>UB2**22.623S1
M&8Q&8Y <XX&?>@#T2BOF;_AXE^SM_P )9_8/_"S]/^W_ &W[!YGV.Z^R^9YN
MS=]I\KR?+_Z:^9Y>.<XKZ!UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_P!9
M([G@ #U]* -BBOF;_AXE^SM_PEG]@_\ "S]/^W_;?L'F?8[K[+YGF[-WVGRO
M)\O_ *:^9Y>.<XKV/XK?%#PW\'_ .J>,/%^I'2?#NG>3]IO/LTDWE>9+'%&?
M+C!D/[R2/H._:@#MJ*^;O'G_  4"^ GPU\7:IX:\0_$2&RUC39/L]W#;Z3?7
M(BD_N>9%"Z9X.1FO>='URP\1Z7::EIUY;WVFWD4=S;W5M()8IXY/]7(CC@@C
MT]: -BBBOF?6OV_?@'X;\-^&];U+XAVT.F:]#+=Z8RZ=?22S112RPO(8A#YD
M?[V.5,R >9Y;XSS0!],45Y_\(_C'X0^-G@Z+Q'X)UZ'Q)I+.]N;B**2(I(F<
MI)'(!)&>_P X[CU%<]\6_P!I[X6_L_\ V9/'WC:PT&\N@C1:?MDN;PQGS,2?
M9HA)+Y7[J0>;CR\C&?4 ]AHKR/X+_M&?#O\ :&L=5OO /B>#Q#;V,ZPWL8AF
MMI8F8$H3'+&D@! XDQ@E)!GY.,_QO^UM\)_AO>^+(?$?B^VTR;PG-9VNKQSV
MEQNADO(C+;1QXB_?>9'%))B+>0$.: /;**\T\._'OX?^+/A/;?$NR\3:=%X!
MN6_=^(-3)LK88E^SDR?:!&8_WH,?/4_6N%^&W[<OP+^+7B:#P[X;^(FGS:W.
M=MO:ZA;7%CY\A<1B*,W,<8DD)<?NERYST(YH ^A:*X;XE?%;PG\(_#<_B#QK
MXBT_PQHL61]IOY/+\R38SB*('F64B*4^7'ESC@5YS\*?VV/@O\<O%:>&?!GC
MF'5M=DB:6*PDL;NUW[ 2^PRQ1^8<<[!S@$]J /?Z*\\\=?&/P=\/?%'AW0/$
MNO6^A:CKT-_=6/VN.01/%90^==2/-CRXQ'%^\S*1T]J\Q\!_\% O@)\2O%VE
M^&O#WQ$AO=8U*3[/:0W&DWUL)9/[GF2PHF>1@9H ^D:*^._^"@7[8FE_L_\
MPYUGPYX>\5_V!\7;JRM;[1+4Z:USNA-\(YI,O%);KF**Y'[P@\<<XKVCX'?M
M/?#/]I!M9_X5WXE/B(Z.(?MS"PN;;R?-\SR@?.CCSGRI.GI0!ZY17S=X\_X*
M!? 3X:^+M4\->(?B)#9:QILGV>[AM])OKD12?W/,BA=,\'(S7O.CZY8>(]+M
M-2TZ\M[[3;R*.YM[JVD$L4\<G^KD1QP01Z>M &Q17S#XD_X*.?LY^$]:N-)O
M?B?827$&-TNE6EU?6^"/X);>*2-\?6O4_@Q\>/ W[0?AF[\1^ =</B/1[2]>
MPDO#:36W[WRXY#$!+'&<XEC[=^M 'I=%?/7Q)_;E^!?PE\33^'?$GQ$T^'6X
M#MN+73[:XOO(D#F,Q2&VCD$<@*']TV'&.@'->N>!O'.@_$SPGIOB;PSJUOK&
MBZA%YEO>VY.']?<<_P !% '4T45X/\7/VQ?@U\#-:&C>-?'MAI&L9/F6-K%-
M>W5K]R3$T=M'(8<B2,CS /,SQD T >\45Y'\%_VC/AW^T-8ZK?> ?$\'B&WL
M9UAO8Q#-;2Q,P)0F.6-) "!Q)C!*2#/R<9_C?]K;X3_#>]\60^(_%]MIDWA.
M:SM=7CGM+C=#)>1&6VCCQ%^^\R.*23$6\@(<T >V45XI\&OVLOA7^T!JFIZ9
M\/\ Q=%K^H:;!]JG@-I<VTWE$@>:(Y8HS(-W7R\XWIG'F"O:Z ,#Q-XGT/P;
MHESK.O:MI^A:/;G_ $B_U2ZCMK9>=@$DDA '/'/M5/P3\0O"GQ&TN;4O"OB3
M2?$UC'+]FEN]%OHKJ%)0!^[\R,GGYQ^=?G[^U_\ M*?!#QI^TQ\)/#?BWQ*=
M6\"^#=9UP^,-)NK"]-I%>0PB*T\R(1XN<7,<L? D&#+G]W(<_6'@GXN? GX=
M?L^R_$WPB=)\+_"B67[5)?:+H<MK"\GVD6N\VT<0D!,L8CYC].U 'OM%%>'Z
MW^V'\(= ^$&@_%*_\6"+P%K5X;"QU8:;<GS90904\KRO-ZV\HSL_Y9T >X45
M\2_L*?MV>'/C#X'\#^#/%_C8ZO\ &C4S?+=6:Z3)$93'+<RH?,BA%L,6T2'@
M]O4U]0^%?BCX>\4^.?%_@[3-2^U^(?"PM/[7L_LDL?V7[5%YMO\ O"/+?,?/
M[LGISB@#N:*X;Q5\4?#WA;QSX0\':GJ7V3Q#XI%W_9%G]DED^U?98O-N/W@'
MEIB/G]X1UXS57QU\8_!WP]\4>'= \2Z];Z%J.O0W]U8_:XY!$\5E#YUU(\V/
M+C$<7[S,I'3VH ]#HKR/X'?M/?#/]I!M9_X5WXE/B(Z.(?MS"PN;;R?-\SR@
M?.CCSGRI.GI7GOB3_@HY^SGX3UJXTF]^)]A)<08W2Z5:75];X(_@EMXI(WQ]
M: /IZBL?1]<L/$>EVFI:=>6]]IMY%'<V]U;2"6*>.3_5R(XX((]/6MB@ HKY
MGUK]OWX!^&_#?AO6]2^(=M#IFO0RW>F,NG7TDLT44LL+R&(0^9'^]CE3,@'F
M>6^,\UZQ\(_C'X0^-G@Z+Q'X)UZ'Q)I+.]N;B**2(I(F<I)'(!)&>_SCN/44
M >@45X/\7/VQ?@U\#-:&C>-?'MAI&L9/F6-K%->W5K]R3$T=M'(8<B2,CS /
M,SQD UW'PC^,?A#XV>#HO$?@G7H?$FDL[VYN(HI(BDB9RDD<@$D9[_..X]10
M!Z!17Y^_\//OAG_PU)_R4O\ XLW_ ,(;N_Y =S_R'/MW_7M]I_X]NW^J_&ON
M+POXKT[QOX5T?Q%H]P;K1]6LXKZSN/+*;X98Q)')A_8@_C0!T%%>?_%SXQ^$
M/@GX.E\1^-M>A\-Z2KI;BXEBDE+R/C"1QQ@R2'O\@['T-8?P7_:,^'?[0UCJ
MM]X!\3P>(;>QG6&]C$,UM+$S E"8Y8TD ('$F,$I(,_)P >N45XI\9?VLOA7
M^S_JFF:9\0/%T6@:AJ4'VJ" 6ES<S>4"1YICBBD,8W=/,QG8^,^6:ZOX1_&/
MPA\;/!T7B/P3KT/B326=[<W$44D121,Y22.0"2,]_G'<>HH W=-\6:'J_B#5
M=#L-6T^ZUO1S%_:-A:W4;W-GYH\R/S8^J>8 2,]>WJ.CKY4_9Y_Y/J_:X_[E
M'_TURUV?Q<_;%^#7P,UH:-XU\>V&D:QD^98VL4U[=6OW),31VT<AAR)(R/,
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M&#PA\;OVM/V2O$G@?Q!!XCTG=XOMVFBBDA*2)ID64DCD D0]\.,\Y[U]8?\
M"TO#?_"UO^%=?VD?^$O_ +'_ +>_L_[-)_QX^;Y/F^9CR_\ 6\=<^U ':45Q
M7Q"^*'ASX8_\(Z_B/4&T_P#M_5K;0=./D22_:+ZX)\J+Y!W\L\]..M1_$KXK
M>$_A'X;G\0>-?$6G^&-%BR/M-_)Y?F2;&<11 \RRD12GRX\N<<"@#N:*\'^$
M?[8OP:^.>M'1O!7CVPU?6,CR[&ZBFLKJZ^_)B&.YCC,V!'(3Y8/EXYP"*\&^
M-'_!1'P-X+_:6^'GABP\?M9^$M)O=<T[X@6RZ+*[1S10B.T3)MC(?])$@S;G
M![\4 ?>-%>(WG[6'PFT_X,Z9\6KWQ=;VW@.^N&AM=4>WND\^7S98O+2W\KS9
M"'CEX\OI&7Z#-:7P7_:,^'?[0UCJM]X!\3P>(;>QG6&]C$,UM+$S E"8Y8TD
M ('$F,$I(,_)P >N445Y'\:/VC/AW^SS8Z5?>/O$\'AZWOIVALHS#-<RRLH!
M<B.*-Y" #S)C +QC/S\@'=>)/%FB>%_L":SJ^GZ.VIWD>GV7]H720FYN9"1'
M%$'_ -9*<<1CG\JZ*O@7X_?M!?#K]HZQ^"6H_#_Q3!KT&F?&;PU'>QK'-;31
M%A<[#Y4T<<F",X?&#Y<F"?+-?8/Q*^*WA/X1^&Y_$'C7Q%I_AC18LC[3?R>7
MYDFQG$40/,LI$4I\N/+G' H [FBO /A3^VQ\%_CEXK3PSX,\<PZMKLD32Q6$
MEC=VN_8"7V&6*/S#CG8.< GM7HWA7XH^'O%/CGQ?X.TS4OM?B'PL+3^U[/[)
M+']E^U1>;;_O"/+?,?/[LGISB@#N:*X;XA?%#PY\)]$M-6\5:H=/M[N\CL;:
MWCMY;JXN+J4XC@BAB$DDLA/1(P2>:S?B]\>OA_\ !#0TU7QSXJL?#<,JG[.E
MQF2XN<; WE11YDEQO3/E@XS0!Z77._\ "5:+_P )/_PC?]KV'_"3?8_M_P#9
M'VI/M?V;S/*\_P K_6>5O_=^9C&>.M>;?!K]K+X5_M :IJ>F?#_Q=%K^H:;!
M]JG@-I<VTWE$@>:(Y8HS(-W7R\XWIG'F"O/O^<IG_=&__<U0!]645YI\7OCU
M\/\ X(:&FJ^.?%5CX;AE4_9TN,R7%SC8&\J*/,DN-Z9\L'&:XOX4_ML?!?XY
M>*T\,^#/',.K:[)$TL5A)8W=KOV E]AEBC\PXYV#G )[4 >_T5YYXZ^,?@[X
M>^*/#N@>)=>M]"U'7H;^ZL?M<<@B>*RA\ZZD>;'EQB.+]YF4CI[5YCX#_P""
M@7P$^)7B[2_#7A[XB0WNL:E)]GM(;C2;ZV$LG]SS)843/(P,T ?2-%8'B;Q/
MH?@W1+G6=>U;3]"T>W/^D7^J74=M;+SL DDD( YXY]J\-\!_\% O@)\2O%VE
M^&O#WQ$AO=8U*3[/:0W&DWUL)9/[GF2PHF>1@9H ^D:*Q]8URP\.:7=ZEJ-Y
M;V.FV<4ES<75S((HH(X_]9([G@ #U]*\&\!_\% O@)\2O%VE^&O#WQ$AO=8U
M*3[/:0W&DWUL)9/[GF2PHF>1@9H ]R\,^)]#\9:);:SH.K:?KNCW!_T>_P!+
MNH[FV;G81')&2#SQQ[UOU\J_\$N_^3%_AG]=4_\ 3I=U]54 %%<3\*?BAX;^
M,'@'2_&'A#4CJWAW4?.^S7GV:2'S?+EDBD/ER 2#]Y')U';O3/"OQ1\/>*?'
M/B_P=IFI?:_$/A86G]KV?V26/[+]JB\VW_>$>6^8^?W9/3G% '<T5\^^,OVV
MO@M\/]-U"_UKQQ;V$6GZ]=>&;A7M+EY&U"U"_:81&(C)((_,BS(!Y7[R/Y^:
MZ;X+_M&?#O\ :&L=5OO /B>#Q#;V,ZPWL8AFMI8F8$H3'+&D@! XDQ@E)!GY
M. #URN<U+Q9H>D>(-*T._P!6T^UUO6#+_9UA=74:7-YY0\R3RH^K^6""<=._
MJ?-_C+^UE\*_V?\ 5-,TSX@>+HM U#4H/M4$ M+FYF\H$CS3'%%(8QNZ>9C.
MQ\9\LUX-XE^,'A#XW?M:?LE>)/ _B"#Q'I.[Q?;M-%%)"4D33(LI)'(!(A[X
M<9YSWH ^Y**X;XE?%;PG\(_#<_B#QKXBT_PQHL61]IOY/+\R38SB*('F64B*
M4^7'ESC@5YS\*?VV/@O\<O%:>&?!GCF'5M=DB:6*PDL;NUW[ 2^PRQ1^8<<[
M!S@$]J /?Z*\\\=?&/P=\/?%'AW0/$NO6^A:CKT-_=6/VN.01/%90^==2/-C
MRXQ'%^\S*1T]JQO@=^T]\,_VD&UG_A7?B4^(CHXA^W,+"YMO)\WS/*!\Z./.
M?*DZ>E 'KE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q?Q6\"+\2?A;XP\'
M"Z^PMX@TB]TO[5Y?F?9_M,4D7F;.^/,-?+OPL\>7_P"S#X)\)_"[XW?#*QT/
MPGI?V.VL?'WA^(7GAN2>*6.2.ZO0ZB2P?[3);8FE'[RX\V7]V!FOI+XO:)XP
MUSX:ZW9?#_Q%'X4\8S1[M-U*>VCNHXI!*)"'CEXQ(,Q]#L\W(!Q7S9X^^!/[
M1W[2?AFX\!_%?Q'\/?#/@:YGM[G4?^$"L[Z>^OO+ECD^S9N_W<2GF3S1DB2.
M+@@R4 =9^WK][]G/_LLOAS_VYKG?VNO N@?$G]K_ /9:\/\ BK3+;5]$NG\3
M2RV-TN8I3%96TL8D!^_^\CC^3OWXKUG]I;X,ZY\8E^%:Z+<V%N?"OCO2_%5Y
M]NFDC,MM;>;YD<7EQG]X?,XS@<')I/B?\'=?\:?M&?!'Q_8S6$6C>!_[<_M&
M*YE?SY?MUK'#&(ALZ@@DY(]* /+?^"F'A?1+/]A7Q?#!I&G1V>B?V9_9<,5K
M'Y=A_IMK$#$ /W7[J22/]WCY)".AH_;4\3:=X#^,?[//BWQ+<O<^#]&UC5+O
M4-!5/M=QY@L#)%J8M,'S(['RI)9)1^\A$F8\DUZM^V-\&==_:&_9X\5?#_0)
M["TU?6/LWD3ZE))';+Y5U%,?,,<<A_Y98Z=QTKQ?]JSPKJ/QX_:J^%/@7P5X
MIU'P'X]\(:3?^,5\51J)8K:QDECM?)2VZW$DDL48;S)(X_*\S(E\S8 #/T7Q
MAX3_ &KOVROA-X^^%]O<ZMH'@G3=9.N^+)-%NK2VN#+#'%;V$<LD0WRQ_:C+
MY?'[N4FN^_;U^]^SG_V67PY_[<UY_P#&:Y_:,_9.\$I\4=6^-FG?%;PWH-]:
MG5O"^H>%;;1S<VTL@MSY=S;^9()!)+&1VX)/F8\J3W?]I;X,ZY\8E^%:Z+<V
M%N?"OCO2_%5Y]NFDC,MM;>;YD<7EQG]X?,XS@<')H ^?/VEM<\67W[>G@FRT
M/X9Q_%R;PQX(E\0Z1H-UJUKIITV^DOS%)?\ F2_ZS BMXQ&<@'$D8!3-<Y^U
M!I?[0'[3'@:UL1^S!)X;\8:5?1:AX?\ %UOX^L6N]'FCEB+R1;/*/[P1XQYG
M4))UBC(^E_CK\!_$OC#QSX6^)'PY\40>$?B+X<AN;:.:[L1)8ZW9O^\^P7P3
M]X8C)&.<_NS)+)&GF8(Q/"7A[]JOQ)XJTD^./%GPV\*>'K*\AN[I?!NF7M[<
MZG%'+^\LG^V?NXHI8S)^]C_> K'C@F@#Z>KX[_:^\/1?%#]HK]F;X<Z\HN_!
MFK:QJVMWVE^3#)'<S:=:)+;^:)8CF(^;+')&/OQR'OC'V)7AG[2W[/%M\?\
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MUCQ(VB745MHUC;Q2RR127$D7[HW)BC$: >7))",D$9I/VC/AGJ&I_#+]F/\
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MD_;&^#.N_M#?L\>*OA_H$]A::OK'V;R)]2DDCME\JZBF/F&..0_\LL=.XZ4
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MVOB:VU.#4=7^U1R?:7CB(_>F)IAGRN/WASF4T:#X=^(G[&OQ"^)WB2+X=?\
M"T/ ?C;Q)<^(KG6/!4 /B/3_ #>1;2V,G_'U$)92(_+D_=C[3*^/,\NO>?@A
MH'Q9TYM<U+XL^+-"U6_U#R?LOA_P[IOD6&D>7YHD,-Q)^]N/-_=R8EP8R"!G
M->/6/A/]LRSM7T.Y\<?#&_L?.DMAXNO-,N!K'V:67BY^RQXM1+'&<B+_ %>8
M\$R?ZP@'T3\)?$GA3Q?\.?#6K>!KG3;OPA<62?V=_9<8BMXXD_=[(XQ_J]F/
M+\K_ )9^7LP,8'CW_!1KQ5J/A#]BWXFWVES?9+F6RMM/E<H'!AN;J*VF3\8Y
M9!^->C?LV_!2R_9Z^"WACP!IVH3:K!HL<O\ IMQ'Y9EDDEEED.S)V#?*_'IQ
M6U\7/AQH_P 8OAUXB\%Z[;?:=(URS>SGPB;TS]V1/,5@)(SB2,XX>,'M0 ?"
M/X<:/\'?AUX=\%Z%;?9M(T.S2S@RB;WQ]Z1_+509)#F20XY>0GO7S]^R;I-K
MX!_:0_:6^'WAJS@T'P=H^K:'K%EH=FBI#:7%]8%[DQ\=)#%'^ZSY<6 (P!7.
M^%_@Y^UW\)_!(\">"_'7PV\2>&[.RCL-%U[Q)IMS9ZG8Q1V\<4:>5%')%^Z*
M$Q^;YI/60GB,>U?LT_L\6WP T+Q#)J.KKXM\8^*M8GUO7?$;Z7#8RWTTASQ%
M&,QQCKY9)Q))*1_K,4 </^P5][]HS_LLOB/_ -MJ^JZ\+_9I^#.N?!U?BHNM
M7-A<'Q5X[U3Q59_89I)#%;7/E>7'+YD8_>#R^<9'(P:]TH ^0?C1\4M,\.?M
M(V]MX ^"-Q\8OC'8Z?9Q7&KQ7%O;P:'92?;I(XI;V7S192R"2;]V4B\V.9?W
MA_=QUPWP)UOQ?XE_X*-ZUK/C;X8P?"[7[KX9MYVG1ZO;:F;P#4X(X[EY8<<D
M1B+'4>2/45Z'X_\ @3\8O OQX\4_$WX*>(/"$Y\:6=M%K^B>.(;G[.DUM&L5
MM-;26H\P_NO,'EDX&2?GS'Y5?X'_ +-GQ7\*_M1ZC\6?B+XZT?Q7-KGA@Z9-
M:Z=;2VO]F3FXBE^RVJ/UM(_)P)"?,D,F9(\DN0##^(7PQ\)?%'_@IAIUEXPT
M&P\1Z=I_PI&H6]KJD7G6PF&J31>9)&<I(/+ED&'XZ=P#6Y^WIHMG-K?[.6IM
M:0/J%O\ %O0K6*Z\L>;'%+YAECW]<2&&+/\ USC] :]'_P"%/ZY_PV=_PMSS
M]-_X1G_A _\ A%OL_F2?:_M/V_[5YN/+\OR]G'^LSGM2_M+?!G7/C$OPK71;
MFPMSX5\=Z7XJO/MTTD9EMK;S?,CB\N,_O#YG&<#@Y- 'FOQ9BU'X&?MI_#KX
M@PSVMKX/^(H7P/X@B-N1NU+]Y+IDW[N3]Y+(3]F$DD9\J.*7D>:,7+*0_%__
M (* :G-.!<Z)\&_#D5I!;W!\J2+6-6'F&YA$>?-C-E&(B)3@28*1_P#+2MW]
MOGP;X:\7?LB?$:/Q3]GMK?3-,DU2SN;AXD,-_$I-MY4D@.#)+B+ P\@F,8/[
MRK?[&?PSUOP/\(9]<\3PMIWC'QUJUUXUUVRCCDC2QNKT^8;6.*1?,C\J/R\Q
MR>81)YG/2@#Z*KXR_:Z\"Z!\2?VO_P!EKP_XJTRVU?1+I_$TLMC=+F*4Q65M
M+&) ?O\ [R./Y._?BOLVOB/]M#PCJ?C;]JC]F/1]$\2:EX/UAAXFFLM:TT"6
M:UFCLH98F,<G$L9* 2Q'B6,R1YYH ]/_ &POA1X1U[]D7XB:+=^']-DTS0O#
MUS?Z3:I$8X=,FMK23[-)!Y?^J\O&,+@>7F,YC)%> ?M":?%\5OV2_P!C[3?%
M,UQKT/B3Q3X0BU>6\N)3)>_:+"43>9+GS,R>8WSYSDUW6L? O]IGXY>%;?P)
M\4_'_@SP[X/GBCCU35O ]M='6=8C 436TAF$4,0E3S"\D<8YPGEF-Y4KU#X]
M_ &[^(>G?"'3_""Z3HVG>"O&VCZ_-:R*;:*.PLA*/*MHXXS\PW@1IQ'QU% '
M6?&C5C\*?V<_'>H>$(H-#?PWX6OIM+CL[>/RK$VUK)Y(BC(\O$?E_P"KQCY<
M>U<7^PE\--%^&_[*/P[L]&MA"-8TFVUV]E9(_,N+FZBCFD:38O/#K&,YQ''&
M,\5[EK&AV'B/2[O3=1L[>^TV\BDMKBUN8Q+%/')_K(W0\$$>OK7Q]\/_ -GS
M]I#]FG3QX1^$WC3P'XG^&]OYTFF6/CVRN;>ZT[S+J:1XO,LA^]SYN3*YZ](X
MP,$ VO!.F6'@+_@HMXTT7P[IT>BZ9XN^'T/BC6;6QC ^W:E%JDEL+OUC)CEE
MR(\"0N9#F0YJ#]C/PW#XL^+G[2/Q+U4MJ'BY_'M]X22[:*,"WTZR$(BBCP@/
M0QA^?G^S1$\C)[#]F?\ 9GUGX4^)_$OC[XA^*;;QW\5_%D%LFI:Y#IL5K%:P
MQ111_9K?RT'&4YD_=^;Y41,0,>:Q/$7[._Q#^'OQ@\9_$GX%:[X6L[CQI]E_
MX2#PKXNTV5;$SPF3_389;;$GF<G,>,2&:60R$^6  <_\<?!&@Z)_P4,_9O\
M%%AI%K9ZUKT?B&+4KZ/A[W[-IO[KS.W[OS6^?J1@'B.,5TO_ #E,_P"Z-_\
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MYI],ORS&6T:6*2&4*?22.49CZ<1DC,<9'@O[0W_)]7[(_P#W-W_IKBJS\/\
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MJ_\ SE,_[HW_ .YJN@^%_A/]HV\\<:3JGQ+\5^ M%\-:<93+X?\  NG74O\
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M>]^S:;^Z\SM^[\UOGZD8!XCC%=!XB_9W^(?P]^,'C/XD_ K7?"UG<>-/LO\
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MR&[NE\&Z9>WMSJ<4<O[RR?[9^[BBEC,G[V/]X"L>.": .0_:Z\"Z!\2?VO\
M]EKP_P"*M,MM7T2Z?Q-++8W2YBE,5E;2QB0'[_[R./Y._?BOLVO"OB?\'=?\
M:?M&?!'Q_8S6$6C>!_[<_M&*YE?SY?MUK'#&(ALZ@@DY(]*]UH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M":?\0/AQXW\82>*?^$EM=7CTVYT;[;*!=)-;RD_:?*\N,@1]1W)D\N/[$HH
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M76?LV[43:FY\H17,4P(C\R//,6.O>O7: /G'X2_"#QA\ _V=_%4&GR:?XO\
MBSJIU3Q+?W.PPVNK>(+E?-4 >;&(XLB*+CRAB/S,1UZ-\"-4^(6M_"O1;[XH
MZ+8>'?'DOG?VEI>F2*]K#B:3RO+(EEZQ>63^\/)/3I7I%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !129HH 6BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M+\.]3O#HGBN6Q(TRY>3%O9WUV]K+:EO,S*(C%YL1DZ$1^9YAC)D /V(HHHH
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MS#%&8\2DBXZ%X^8^M?4U?E9_P7*_YHK_ -QK_P!L*TKS_@KIXUT_08/&5[\
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ML_:MX ^&U]+;I?>)(]>CU*72A+GRI+FSCB$L8\PQA_,P1G&#)B-NF_X*B?\
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M<CUC0(=-G_>ZC?27+PI:$&+RXHA'#)+)=22 1QQ2<$CD ]H^*WQ0\-_!_P
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MS0!%^RA_R:S\&O\ L3-&_P#2&*O*_P!@K[W[1G_99?$?_MM7T#\//!UC\.?
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M#W6BBB@#X\^#MKIND_\ !1C]HB'5;!(?$.KZ1H-_HL]S9$2S:=%;1174D4I
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MEJG]H:@D1BBB*(Q41@^7&5W[/,P[IYFPXH YW_G*9_W1O_W-4O[>OWOV<_\
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MO\/_  S?^%(+6/PQ=:9:W&DQ6EO]FA%G)$IB\N+ \L"/&$QQ@#BN6^$?[/\
MX7^#?P3T_P"%FGFXUSPS:Q7-MY.O^5<&YCN)99I8Y0(Q'("9)!C9@C@]Z\2_
MX=H^ ?[)_L#_ (3WXE_\(%]M^T_\(%_PDA_L7ROM/VG[-Y7E^9Y?F<Y\SS,\
M^9O^>@"Q_P %(=<L?$/[!/C[5=-NK?4--O(=+N;:ZMI/-CGCDU"U\N2-QQC&
M#Q7M/[2VE7NM?LZ_%'2].LY]1O\ 4/"VJ6EI:VL?F2SS26LJQQQQ]SD@8J]J
MGP;\(:M\)X/AK?>'H+[P3%IL.E#29YI''V>*(1QJ),^9E-D>),EP1GKS7-?L
M^_LW67[/>EW]AIOC+QEXKTZ:&UMK:S\6:J+Z+38K;?Y4=J@BC$2D2<C_ *91
M8Z4 ?.G[./P?^.OBWX _#S5/"?[4L&F:&^A68MK"U\#:;?"R\N((;7SO,S)Y
M1S$2><Q>M>V_LY?LW>)O@WXX^(OC#QA\1!\1_$?C,:;]KO!H<6E[#91RQ1_N
MXI#'_JY(^F/]63R3FN9U+]@GP?#?7=SX*\9_$;X1V=_/)=3:)X"\226%C-<R
M'YYO),<@B/\ JX\1XC$<,6!Q7LGP8^"7ASX#^&+O1O#YU"X:^O9-5U#4-4O9
M+JZU"^D2-);F620G]Y(8QG'&>>,T >!_\$N5TW2_V4=.T2+3UTW7]'UG4[#Q
M%;2V1M;B+41<YV39 _>BWDMAWP $X\L@6K/6+'4/^"IFHPV=W;W5Q8?"7[)=
MQQ2AS;R_VO%*(Y /N'RY8GP1TD!YKI_&'[$?@[Q/XJU/Q+X?\1^-OA9K>M2?
M:M<E\!^()--_M:8G(>YCQ)'\I,F"@&3+(3DUJ_"O]C7X9? WX@1^+/ NE3Z#
M<1Z#)X>&FQR>9:R1R71NO-D+CS9)M_[OS))?]6!'C@8 /H"BBL?6-<L/#FEW
M>I:C>6]CIMG%)<W%U<R"**"./_62.YX  ]?2@#YK_P"<IG_=&_\ W-5D?!VU
MTW2?^"C'[1$.JV"0^(=7TC0;_19[FR(EFTZ*VBBNI(I2 #']H%NAP>7B_P"F
M1Q0^'?Q!\._%K_@H]K_B+P=JL/BK0=$^&$6CWNM:2WVFQBO)=3^TQPBY4&,D
MQG(P3S')WCDQZU\=/V1_ G[0%YI^L^(DU'3/%FEM&VF>*?#]V;'5+#9*)<12
MXP0"#CS!)Y?F2>7Y9)- 'GW_  4ZU)9/V0_$/AVWBGO-:\3ZEINCZ1I]K;O+
M+>WOVV*80H$[F.VFX[X Z\&]^T-_R?5^R/\ ]S=_Z:XJO^!_V$? /A'XA:?X
MZ\0ZQXJ^*'BS2S$-+U3QYJ[:E+I@C,A!B^YDYD,@WAQ')B2,1G)/I_C#X)Z/
MXR^*WP^^(%[>7\.M>"?MYTR&V=!;R?;81#-Y@\O)X Z$>M 'D/[0W_)]7[(_
M_<W?^FN*E_X*B?\ )B_Q,^NE_P#ITM*]=\8?!/1_&7Q6^'WQ O;R_AUKP3]O
M.F0VSH+>3[;"(9O,'EY/ '0CUIWQZ^"VD?M!?"W6/ 7B&\O[/1M6\K[5-ICQ
MQW'[J6.4>7YD<@',0[?X@ \@_P""HG_)B_Q,^NE_^G2TKZJKEO'/@;0?B9X3
MU+PSXFTFWUC1=0B\NXLK@'#^GN.?XP:\^_9]_9NLOV>]+O[#3?&7C+Q7ITT-
MK;6UGXLU47T6FQ6V_P J.U011B)2).1_TRBQTH ^=_V0OA'I?QV_X)@^&O 6
MKR>5::W9:G!#= %OLL_]J74D4V!)'YGE21QR^7D9\O!ZUQ-[\7KK]J+]F'X.
M_!>^BOX_&_BCQ);^#_&&GZDTAU."+2#%<:G=&6YC""Y$45K,1)YA_P!(DCQ)
M)&<?;OP%^"VD?L^_"W1_ 7AZ\O[S1M)\W[+-J;QR7'[V624^9Y<<8/,I[?XG
MYE_91\&>&?BM^T]\:_C5H$]M<^%K+Q#-H?AJWA,4MM%J!M;4:KJ<4<8,>;GR
MXL7$<F^6.23S ,T ?<M%%% 'E'[5_P#R:S\9?^Q,UG_TAEK-_8[U:SUC]EGX
M27-A>07MO%X6TZU,ELXD'F0V\<4J$^J21R)[8KO_ (A^#K'XC> _$GA'4I9H
M;+7],NM,N7MC^\2*6(Q2%./1Z^:[?_@G;X*T"\,GA#QO\1/AN/[/LM.O/^$(
MUY-.&H_98?+CN;H"'F7'7'!)+]9)"0"[^S?,M]^V!^U;K=N1<Z3-J'A[3XK^
M%O-MWN;:PDCN81+T,D1($D?6,D9ZBO(?!WQ8T_\ 8=TG]HSX9S37$%KX0BD\
M8^"?[6BOI;6:SOO)CBM(AR?)BOI8X3*)?WDDTLG[ORY"/L_X1_!SPA\$_!T7
MASP3H,/AO25=[@V\4LDI>1\Y>220F20]OG/8>@KY5^.G@KP[^T9^W;\.? ZR
M0F;PQH%SKGC>W5HO^)AI_P!JMI;#2[D 2>:!<I%+);R@1^5+YD9S)0![_P#L
ME?"X_ W]G'P%X+NTGM[[3].$M_;W,L<WV>]E8W%S%YD?R$1S22@'T P3UKVN
MBB@ KY4_8*^]^T9_V67Q'_[;5]5UYG\(O@KI'P97QF^D75_>?\)5XDO?%%]]
MO>.0QW5UY?FQQ[(QB/,8X.2/4]@#\U_VD+:]_9I^"GQY^ VJQW*>"=2>U\2?
M#N\NI#Y+V_\ :ED;O3HI)99"3;F08B'SG%S+( )8Z^LO^"C^GZC=?#SX57FF
MZHWAO^S/B3HUW=>))K?S;;0X\RQB^E\W]T(XY)8O]:=AR!WKU/\ :*_9@\%?
MM1>$;70O&=C<236=QYUEJMG+&E[9YP)!%(5QB0#$D>,'&>J1D>C>.? V@_$S
MPGJ7AGQ-I-OK&BZA%Y=Q97 .']/<<_Q@T ?/O_#._P"TY_T=Q_YC;3/_ (Y7
MD_[3OP/;]FW_ ()4^*/ARVL_\) NC?90NH"U^S><)==AF),7F28YEQU/3\*]
M1_X8!\,[?L'_  M/XN_\(3G[/_PAO_"72_V-]@SC[!Y7E^9]F\O]SCS,^7_R
MTSS7OW_"K?#?_"J?^%=?V:?^$0_L?^P?[/\ M,G_ !X^5Y/E>9GS/]5QUS[T
M :7_  E6B_\ ",?\))_:]A_PC/V/[?\ VO\ :D^R?9O+\WS_ #?]7Y6S]YYF
M<8YZ5\[_ /!+O_DQ?X9_75/_ $Z7=9NC_P#!.'X;:7J6B0W.M^,M=\$:/J,F
MI6'@'6-<^T>';>3=(5!MO*Z(9I.#(?,Q^\,GF29]Q^ OP6TC]GWX6Z/X"\/7
ME_>:-I/F_99M3>.2X_>RR2GS/+CC!YE/;_$@'D'_  2[_P"3%_AG]=4_].EW
M6-\';73=)_X*,?M$0ZK8)#XAU?2-!O\ 19[FR(EFTZ*VBBNI(I2 #']H%NAP
M>7B_Z9''O'P%^"VD?L^_"W1_ 7AZ\O[S1M)\W[+-J;QR7'[V624^9Y<<8/,I
M[?XGDOCI^R/X$_: O-/UGQ$FHZ9XLTMHVTSQ3X?NS8ZI8;)1+B*7&" 0<>8)
M/+\R3R_+))H \^_X*=:DLG[(?B'P[;Q3WFM>)]2TW1](T^UMWEEO;W[;%,(4
M"=S';3<=\ =>#3\51Z?I_P#P5$\':AK=B -3^'%SIN@W=Y9%T?48KV666.&4
MC$<@MC+G_IG+C_EK@]3X'_81\ ^$?B%I_CKQ#K'BKXH>+-+,0TO5/'FKMJ4N
MF",R$&+[F3F0R#>'$<F)(Q&<D]S^T!^SSX7_ &AM)TRRU\:A9:IH]_%?Z1KV
MBW'V74])F!!\ZWEP<9V#.<@X! \R.,@ ]+OM<L=/OM+MKN\AMIK^?[-:1R2;
M/M$WE22F./(^<^5'*^!VC)[''S7_ ,Y3/^Z-_P#N:K;^%W[$_A#X=_$RR^(5
M]XD\8_$#QI8(8-.UOQEK<E]/8PE)8Y(HL",8(N)1B7S,=L&O1_\ A2&C_P#"
M^/\ A;'VO4/^$@_X1S_A%_LF^/[)]D^T_:=^/+\SS?-[^9C';O0!X_\ \%1/
M^3%_B9]=+_\ 3I:4G[>OWOV<_P#LLOAS_P!N:]@^/7P6TC]H+X6ZQX"\0WE_
M9Z-JWE?:IM,>..X_=2QRCR_,CD YB';_ !"?%WX*Z1\9E\&/J]U?V?\ PBOB
M2R\46/V!XXS)=6OF>5')OC.8\R'@8)]1W *G[5__ ":S\9?^Q,UG_P!(9:^8
MOCUH^H:U_P $A])M=/M9[Z9/ OAJY:.WBWXBB^PRRR?2..*1R>!@5]E?$/P=
M8_$;P'XD\(ZE+-#9:_IEUIER]L?WB12Q&*0IQZ/5+PG\-=#\,?"G1_ +6QU;
MP[IND0:&+?54CE^T6L<0B"R\;'!C'(QCK0!\\Z+\%_VBO$.DVVHZ?^U[!?Z=
M>11W%M=6OP\TR2*>.0?NY(W\WD$8(KTG]E_X!ZE^SSX9\6V6K^+?^$WU;Q)X
MENO$][JBZ:+',]Q'$)1Y22R=XL\$?ZRN A_X)]Z!HZ-9>#_BI\6OA[X9B8_9
MO#7AGQ;+!860_P"6GDQRI+)^\D\R0YDZR'%>^_"GX7^&_@_X!TOP?X0TTZ3X
M=T[SOLUG]IDF\KS)9)9!YDA,A_>22=3W[4 =M1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44
M %)2T4 %%%% !117E7_#5WP1_P"BQ> /_"GL?_CM 'JM%8^CZY8>(]+M-2TZ
M\M[[3;R*.YM[JVD$L4\<G^KD1QP01Z>M5--\6:'J_B#5=#L-6T^ZUO1S%_:-
MA:W4;W-GYH\R/S8^J>8 2,]>WJ #HZ*** "BBB@ HHK \3>)]#\&Z)<ZSKVK
M:?H6CVY_TB_U2ZCMK9>=@$DDA '/'/M0!OT444 %%%% !1110 4444 %%%%
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MO"WCGPAX.U/4OLGB'Q2+O^R+/[)+)]J^RQ>;<?O /+3$?/[PCKQF@#N:***
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M+//3CK0!VM%%% !16!XF\3Z'X-T2YUG7M6T_0M'MS_I%_JEU';6R\[ )))"
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M_K>.N?:M+_A*M%_X2?\ X1O^U[#_ (2;[']O_LC[4GVO[-YGE>?Y7^L\K?\
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M('A_6OA_9^-(=5MX/#%WIL6L1ZM=DVT/V*2(2B:3S,>6/+YS)C&.<<U\WO\
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MPZ=JLL<<,;RPW1E/FF0R"4$\R1[C7E'[-G_*''5O^Q*\6?\ HW4*^J?V4/\
MDUGX-?\ 8F:-_P"D,5 'FGC;]N/PMX3^(NO^#= \&^/OBKJF@&)-5D\ Z+_:
M<&FRR>9_H\L@D'[S,1R.@Z?ZR.0#U3X+_&?PI\?_  #I_C#P;J1OM/N"(Y(9
M2/M-G-_RTMYHO^6;CZ]P1E,9^;_!/QF^//QLCO\ 7_@=X*^&OA_X62WMU_9&
MK>*[BZW:W)]NN1->Q16VR2$221^8\<T8D,DI.^3)"[O_  3E_MK_ (1GXX?\
M)#_9W_"2_P#"UM<_M+^R?,^R?:O*M?/\KS/G\OS<XSSC% &GJ7[>G@>VU3Q)
MH>B^'?&GB[Q3HOB"^T&Z\,^&=)2_U$?961);_P M)3Y=J998HA))C>Y.(^'Q
MWWC[]JCP=\,?!?A;Q!XG36-+O/$T:?V/X3&F22ZY?73Q!Q:+;1D_O<ND1S^[
M$LD8,G(KS/\ 8+T6SAUO]HW4UM($U"X^+>NVLMUY8\V2*+RS%'OZXC,TN/\
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M>ZU^SK\+M4U&\GU&_P!0\+:7=W=U=2>9+/-):Q-))))W.23F@"7XT?&?PI\
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M>&+_ ):.?KV).$SCYH^-_P"VCH?BKX&_$OP_KGP^^(OPT?5?"VKV>G:GXZT
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M$@Z?GZU^T[H]GI?[-?QTN;2SAMIK[POK%W=R0Q[#<3#3)(A))S\Y\N.).?\
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M(_\ W-W_ *:XJ\HU3_A=O_#<7[,__"X/^$#W9\3?V;_P@_V[_H&#SO.^T_\
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M^(K?4=)M=(<1^*L6XBBFL8O.Q>QQ',V<?)'('%=-^W1X\_X6=_P3A\=>)?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_6<XQT-=9\5O B_$GX6^,/!PNOL+>(-(O=+^U>7YGV?[3%)%YFSOCS#7:44
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M]X0M-$UG4-4TF33]2@U?3]4T&[^RWUC>1 B*6*3'##S9.3_?XP<&O'Q^S/\
M&W7B^G^,_P!J77KGPY</MN8?#GAFQT._<]8S%?1^9)%^\$><#D93O7UG10!\
M>?\ !1GPSIOC+PK\#O#NL6_VO1=8^*^AZ?>6Q<H)(98[J.2/*<C@FH[G]BWX
MCZEH.H>"/$/[2WBW6OACJ#3P7&EOIUL-8DM9&DD$4FK2;Y).H$G[O$B Q[4C
M.!])?$+X7^'/B=_PCJ>(]/;4/[ U:VU[3AY\D7V>^MR?*E^0]O,/'3GI7:T
M<7_PJWPW_P *I_X5U_9I_P"$0_L?^P?[/^TR?\>/E>3Y7F9\S_5<=<^]>3_L
MX_ ;QU\!]0DT>\^,&H^-OAIIMI+8Z+X=U31X8[FR0R*T.^]'[R411DQ8P$]!
M&(Q'7T910!\<>'_V*_&_PV6_\-?#[X\^(/!7PFO+Z25/"L>CQ7-W8PR\W45K
MJ,LAEMP?WGEN!^[)W_O)<R/Z1^R+^S#:_LF^!=<\)Z7KL^NZ;J6O7.LV\EY;
MB*:WCDCABCADP3YI A.9,1Y)_P!6*]_HH \?^ _P5_X4JWQ#SK1UD^+?&6I>
M+,?9OL_V7[5Y6;?_ %A\PIY?^LXSGH*S?CQ^SO:?&VZ\,ZW9^(=6\%>.?"-S
M<7/A_P 2:/-O-M-+$$DCDADS'+"Y2+S(CC>$,?F 229]RHH ^7_"_P"SI\8)
M/$FCWGCG]HW7O%>BZ7?1:DFEZ#H%KH)N)HI!^ZN98BYEMR/,$D)_UF>O JS\
M1O@'\6=<^)6L>*/A]\?]7\$:=K"6XNM#U'1;?6K6UEBC\K%L)9 +=7Q^\\KK
M(2<G@)]+T4 >&_ ?]G>T^"5UXFUN\\0ZMXU\<^+KFWN?$'B36)MAN9HHBD<<
M<,>(XH4+R^7$,[ XC\PB./'N5%% 'S#\2OV5O$VI_%S5_B;\*/BEJGPI\4:_
M9QV?B"+^R(]7M-3\GRUMI?(FD\N.6.,&/([=-F93)TO[1?[-.F_M 6.B7J>(
M]<\$^,_#QNFT/Q+X<N6CN+*2XA\F7C_EI&3Y>_'ER?N^)(P3GWFB@#XYUK]A
M_P =?%BZMK7XR_'[7?B!X0@Q)+X<TO1XM M[Z031R 77V>3$L7[L<8#C.8Y(
M^_V-110!X7^T5^SS_P +O_X1/6M'\6:AX&\=^$;W[7X?\36,8N7MS)Y8N89+
M<XCECECC4$'Z']WYD<GD6H?L)^+O'7CKX?\ C?XC?'#5_&GBKP7K]OJ=@6T2
MVLM/^QQ31RR0"UA_U<TDD8_TCS#\@0>6?+&/M&B@#RSX\? G0?C]X0M-$UG4
M-4TF33]2@U?3]4T&[^RWUC>1 B*6*3'##S9.3_?XP<&O"O%/[%?C7XP>%]:T
M?XM?'W7?&]D]I+%I^GZ;I,6C:='-)&?+FN[:UD_TWRY1;2QQF2/!B/7S#7V1
M10!Q?PI\"+\-OA;X/\'&Z^W-X?TBRTO[5Y?E_:/LT4<7F;.V?+%>+_LU_L96
M/[.WQ \0>(H]=&LV7V&31O#.GK9FV_L#2Y+^XOI+0R&:3[3F6:/][)^\_=>A
MQ7TY10!X7^T5^SS_ ,+O_P"$3UK1_%FH>!O'?A&]^U^'_$UC&+E[<R>6+F&2
MW.(Y8Y8XU!!^A_=^9')Y%J'["?B[QUXZ^'_C?XC?'#5_&GBKP7K]OJ=@6T2V
MLM/^QQ31RR0"UA_U<TDD8_TCS#\@0>6?+&/M&B@#Q[QY\#9/'7QN^$OQ%;7/
ML#^ _P"U\Z<UKYGV[[=:B$_O?,'E>7@GI)GIQUJ3]J/X'O\ M)? WQ#\.EUG
M_A'UUG[-NU$VIN?*$5S%,"(_,CSS%CKWKUVB@#QO]H;]G_3?VAO C>'K[4]2
MT#4K.^BUC1-<TV8PW.EZC%N$5S%@\X\P\9Z$X,<@$@\OTS]E'XE^(_%_AO5O
MB7^T-KWC32="O8=3MM TS1;?1+>YNHKF&YC-R(C)]IB!M\^41P?]7)&,@_6E
M% 'AOQX_9WM/C;=>&=;L_$.K>"O'/A&YN+GP_P")-'FWFVFEB"21R0R9CEA<
MI%YD1QO"&/S )),\CX7_ &=/C!)XDT>\\<_M&Z]XKT72[Z+4DTO0= M=!-Q-
M%(/W5S+$7,MN1Y@DA/\ K,]>!7U!10 5\2_MK?#O3?BM^U1^S!X9U6ZU"R@O
M3XFDCO-+N#;75K+%8PRQ7,4O!CEBECCD'O&.#T/VU7#>*OA=X>\4^.?"'C'4
M]-^U^(?"PNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\] >G&* /G6W_ &+_ !QXTT*R
M\+?%WX^Z]\1/ M@;=CH5OI$6DRWSP^7Y8NKM)));F/ R>?,,ACD\WS(Z]C^/
M'P5_X74WP\QK1T8^$O&6F^+,?9OM'VK[+YN+?_6#RR_F?ZSG&.AKV"B@ KY
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M'_Q9U7XC:YXO\:Z%_:']JWVNCSO[3^TVS1K%;QB18[&VBEEN98X8XY/];C.
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%?._A?\
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MQ%KNG0S7-S%9VUQY(ACDCC>2.Y\ORI1YDL7^KD.=P(Z&@#V>BOF[QY_P4"^
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '%_%;P(OQ)^%OC#P<+K["WB#2+W2_M7E^9]G^TQ21>9L[X\PU\N_"SQ
MY?\ [,/@GPG\+OC=\,K'0_">E_8[:Q\?>'XA>>&Y)XI8Y([J]#J)+!_M,EMB
M:4?O+CS9?W8&:^DOB]HGC#7/AKK=E\/_ !%'X4\8S1[M-U*>VCNHXI!*)"'C
MEXQ(,Q]#L\W(!Q7S9X^^!/[1W[2?AFX\!_%?Q'\/?#/@:YGM[G4?^$"L[Z>^
MOO+ECD^S9N_W<2GF3S1DB2.+@@R4 =;_ ,%1/^3%_B9]=+_].EI7U57E?[27
MP4LOVA?@MXG\ :CJ$VE0:U'%_IMO'YABDCEBEC.S(WC?$G'IQ63^SW9_''2]
M-O[;XRW_ (-UB:VBMHM/OO"WVGSKEOWGG277F1QQCCRL>5&!_K.!P* //_\
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M\66M\=8B:UQ:QW$4/E[_ "I8XQG9)G]UVBCQJZ#X=^(G[&OQ"^)WB2+X=?\
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MK:2*/?[9D&:/@GX+N_AW\'/ 7A746AEU'0?#]AI5S+!_JY)(;:.*39[9C.*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /*OBA\!]!^+WC+P!K_B"^U/RO!NI_P!KV6FV
MMWY=E/>Y7RI;B/'[QHB/W9!&/-E!R)#7JM%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF/Q8^/'@+X-V^A-XV\4Z=X9&M7OV"S-XS RR9Y) '[N,<;Y9,1QY&\C->G4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?W>99(TBS^\X!\J\#_M\?M:>*O!NE^/=,^!^E>+? MQJ*V/F:'IMZ]U<[/\
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M_B2V_3[SP;J]R=.T^\E#7-U#I[RYM9<210^=8F20R2Q9_=1 \Q^60#TO1_\
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MB/RSYC?^":_Q\^'&B_L?^&]%U3QYH.C:IX=:^_M:TU.^CM9;..2^D:.23S2
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M0_"6GZGY<<]Y8YA^R><<177FR7,D4EJ/^6A!_=_O.<Q&.O+OV4OB9X4^%?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!O\ ;0T7XW>,-/TCPQX!^(4N@:C)<):^-+CP\8M!E$7FYD^U>9T<Q&,?N_\
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M^.'PST'QSX:DF.D:Q&TD2W$?ERQ^7*8Y(W]T>.1./3OUKOZ "BBB@ HKQ?\
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M5K.*^L[CRRF^&6,21R8?V(/XUT% !1110 4444 %%%% !1110 4444 %%%%
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MGP[BM7T:X\2?$:_^'GFR2?\ "N[CQ7)_80#R&01>5%B3$<O[W_6Y\Q 27YR
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M9^(WQ0\7>#;:*.T;P?KGBN0Z4T48Q%&8H8XSB(B.2, CF*/M7TS_ ,(KHO\
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M'[0W_)]7[(__ '-W_IKBI?\ @J)_R8O\3/KI?_ITM*]=\8?!/1_&7Q6^'WQ
MO;R_AUKP3]O.F0VSH+>3[;"(9O,'EY/ '0CUIWQZ^"VD?M!?"W6/ 7B&\O[/
M1M6\K[5-ICQQW'[J6.4>7YD<@',0[?X@ ]+HHHH *^5?^"HG_)B_Q,^NE_\
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M\*0T?_A?'_"V/M>H?\)!_P (Y_PB_P!DWQ_9/LGVG[3OQY?F>;YO?S,8[=Z
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M\9:W)?3V,)26.2*+ C&"+B48E\S';!KT3P?\$]'\&_%;X@_$"RO+^;6O&WV
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M#[PGX7TQ[*1[C7-+TZUTRYTV)#O-U'=!!Y7E8R2?W>.) 8R179_M#?L\:/\
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M/4FG_'C2[*W_ &]OV6-2CM+=-1N8?$UI-=)&/-EBBL,QQE^O[LRRG&?^6DE
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M^^*NJ: 8DU63P#HO]IP:;+)YG^CRR"0?O,Q'(Z#I_K(Y /5/@O\ &?PI\?\
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MH7PQ^-OAG2]%\5Z]%<RZ!KWA:\DN=+UPVT8FN8HXI/W]LT4<D?,O$ACEP?\
M5^8 ?25%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?(5E^Q9XJ^'<)\,?#3XX>)_ GPLN9
M9);CPO\ V?;ZA=6GFR$RQV%])^]M5\LXC_UACD!ES)))FOKVB@#YT_9K_91L
M/V<?'GQ'UC2_$5_KEIXP_LZ62'5/WEXDUM'();F:Y\P^=)<RS22D^7& <\5A
M>(OV2/%6@^,_$>O_  >^,FK?"Y?%&HS:KK>EW6D6VMV,U[+C,UO'/C[.7/F>
M9R?,/EC@1H*^J** /(/@K\+?$7PW_MJ_\7_$W7_B7XBUEH5NY]1CCM;"V\KS
M!']DLHOW=MF.2/S,']X8_,]:X+]I3]C*Q_:)^('A_P 12:Z-&LOL,>C>)M/:
MS-S_ &_I<=_;WT=H)!-']FQ+#)^]C_>?O?08KZ<HH *^0--_8]\??"F Z+\%
M_COJWP]\"_:)9X_#.J:!:ZX+&660NZ6\LI$D<6"N(N>?,D\PF0U]?T4 >8_!
MKX::I\,_"E[9ZSXW\0>/-=U&_DU&]U37I0<321Q"6.VBCP+:VRA,<(SY?F$#
M-4/V7/@>_P"S;\#?#WPZ;6?^$@71OM.W41:FV\T2W,LQ)C\R3',N.O:O7:*
M/CG1?V'_ !U\)[JYM?@U\?M=^'_A"?,D7AS5-'BU^WL9#-)(1:_:),11?O#Q
M@N<9DDD[>F_LZ?LTZ;^S_8ZW>OXCUSQMXS\0FU;7/$OB.Y:2XO9+>'R8N/\
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MQ&USQ?XUT+^T/[5OM='G?VG]IMFC6*WC$BQV-M%++<RQPQQR?ZW&< 5]9T4
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MJ[ZQ:Q(UQ>R31227,1CP(H1]GBCCML'RP"!(>!7I'_"D1_PU%_PN/^W&V?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &45R_BCPWJ7B!;<6?B
MG6/#'E]3I4=I)YO^_P#:;:7],5D?\*Y\0_\ 15/%O_@+H_\ \@4^3^\9^T.]
MS_LT9_V:X'_A6OB+_HJ?BS_P%T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y J^6/\
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M_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\
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M?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\
MLUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AW
MV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L
M?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#
M:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1
M?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\
M_(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4
M\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/
M_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\
M9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y
M_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\
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M_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\
MN'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!
M1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G
M_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK
M7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H
M_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_
MT53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S
M7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9
M_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_
MF#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H
M_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_
MT53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\
M@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q
M9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\
M*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!F
MC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_
M +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\
M@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q
M9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\
M*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#
M:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1
M?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\
MLUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AW
MV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L
M?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#
M:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/_"M?$7_15/%G_@-H_P#\@4?\*U\1
M?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\ 9HS_ +-<#_PK7Q%_T53Q9_X#:/\
M_(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y_P"X=]G_ &:,_P"S7 _\*U\1?]%4
M\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\ _(%'+'^8.?\ N'?9_P!FC/\ LUP/
M_"M?$7_15/%G_@-H_P#\@4?\*U\1?]%4\6?^ VC_ /R!1RQ_F#G_ +AWV?\
M9HS_ +-<#_PK7Q%_T53Q9_X#:/\ _(%'_"M?$7_15/%G_@-H_P#\@4<L?Y@Y
M_P"X=]G_ &:,_P"S7 _\*U\1?]%4\6?^ VC_ /R!1_PK7Q%_T53Q9_X#:/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
G"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_3a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_3a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
M/D/K5;_GZ=W_ ,+V^)7_ $47Q9_X/+K_ ..T?\+V^)7_ $47Q9_X/+K_ ..U
MPE%'U/"?\^0^M5O^?IW7_"]?B3_T47Q9_P"#RZ_^.T?\+Z^)W_11?%G_ (/+
MK_X[7"T4?4L/_P ^4'UJM_S].^_X7S\3/^BD>*__  =W7_QVC_A?/Q,_Z*1X
MK_\ !W=?_':X&BM/J6'_ .?*,OK5;_GZ=]_POGXF?]%(\5_^#NZ_^.T?\+Y^
M)G_12/%?_@[NO_CM<#11]2P__/E!]:K?\_3OO^%\_$S_ **1XK_\'=U_\=H_
MX7S\3/\ HI'BO_P=W7_QVN!HH^I8?_GR@^M5O^?IWW_"^?B9_P!%(\5_^#NZ
M_P#CM'_"^?B9_P!%(\5_^#NZ_P#CM<#11]2P_P#SY0?6JW_/T[[_ (7S\3/^
MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
MGZ=]_P +Y^)G_12/%?\ X.[K_P".T?\ "^?B9_T4CQ7_ .#NZ_\ CM<#11]2
MP_\ SY0?6JW_ #].^_X7S\3?^BB>+/\ P>77_P =H_X7S\3/^BD>*_\ P=W7
M_P =K@:*R^I8?_GRA?6JW_/T[G_A?'Q,_P"BB>+/_!Y=?_':/^%[?$G_ **!
MXH_\'EU_\=KAJ*V^IX?_ )\H/K=;N=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7X
MD_\ 10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'
M_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_
M ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K'=?\+U^)/_10/%G_
M (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<+11]3P__ #Y0?6ZQW7_"]?B3_P!%
M \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ_P#CM<+11]3P_P#SY0?6ZQW7_"]?
MB3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_ (/+K_X[7"T4?4\/_P ^4'UNL=U_
MPO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\ 10/%G_@\NO\ X[7"T4?4\/\ \^4'
MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
M<X<5YAXH_9[\'>)(3MTI-+G$7EB733]GV?2,?)^8-?D69<!\T_:X&I;R/U?+
M..I17LL?3OYH^(UH-?3.I?L>V<TF=+\0SVMOY>/+O(!<.?R,=&F_L>V<,F=4
M\0SW5OY>/+LX!;N/S,E?&_ZEYSSV]F?4_P"N64^S^-_<?,W [YKOOAC\&-;^
M)%P952;3M(\KC4FB_=RY_P">7_/0>]?3_A?]GOP;X;A&=*35)S%Y9EU(_:/,
M^L9_=_D!7IQBVJ F$%?995P)RS]KF,[^1\EF?',I4_98&G;S.:\#^!],\!Z'
M#IFEVZPP1]6QF21^[N>YKJ?X:3CO3^,>U?KE*E3HTU3I;'Y74J3JS=2H]6+1
M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
MRU_^1J/]:,%V8?ZOXWN?FC17Z7?\.R_AK_T'?%?_ (&6O_R-1_P[+^&O_0=\
M5_\ @9:__(U'^M&"[,/]7\;W/S1HK]+O^'9?PU_Z#OBO_P #+7_Y&H_X=E_#
M7_H.^*__  ,M?_D:C_6C!=F'^K^-[GYHT5^EW_#LOX:_]!WQ7_X&6O\ \C4?
M\.R_AK_T'?%?_@9:_P#R-1_K1@NS#_5_&]S\T:*_2[_AV7\-?^@[XK_\#+7_
M .1J/^'9?PU_Z#OBO_P,M?\ Y&H_UHP79A_J_C>Y^:-%?I=_P[+^&O\ T'?%
M?_@9:_\ R-1_P[+^&O\ T'?%?_@9:_\ R-1_K1@NS#_5_&]S\T:*_2[_ (=E
M_#7_ *#OBO\ \#+7_P"1J/\ AV7\-?\ H.^*_P#P,M?_ )&H_P!9\%_*P_U?
MQO<_-&BOTN_X=E_#7_H.^*__  ,M?_D:C_AV7\-?^@[XK_\  RU_^1J/]:,%
MV8?ZOXWN?FC17Z7?\.R_AK_T'?%?_@9:_P#R-1_P[+^&O_0=\5?^!EM_\C4?
MZT8+^5A_J_C>Y^:-%?I=_P .R_AI_P!![Q5_X&6W_P C55_X=L_#'_H.^+/_
M  (M?_D6I_UJR[LS3_5_&GYMT5^D?_#MKX:_]!WQ7_X$VO\ \BT?\.VOAK_T
M'?%?_@3:_P#R+1_K3E_8/]7,:?FY17Z1_P##MKX:_P#0=\5_^!-K_P#(M'_#
MMKX:_P#0=\5_^!-K_P#(M'^M.7=@_P!7,8?FY17Z1_\ #MKX:_\ 0=\5_P#@
M3:__ "+1_P .VOAK_P!!WQ7_ .!-K_\ (M'^M.7=@_U;QA^;E%?I'_P[:^&O
M_0=\5_\ @3:__(M'_#MKX:_]!WQ7_P"!-K_\BT?ZTY=V#_5O&'YN45^D?_#M
MKX:_]!WQ7_X$VO\ \BT?\.VOAK_T'?%?_@3:_P#R+1_K3EW8?^KF,/S<HK](
M_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\ Y%H_UIR[L'^KF,/S
M<HK](_\ AVU\-?\ H.^*_P#P)M?_ )%H_P"';7PU_P"@[XK_ / FU_\ D6C_
M %IR[L'^KF,/S<HK](_^';7PU_Z#OBO_ ,";7_Y%H_X=M?#7_H.^*_\ P)M?
M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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MOX/^ =4\8>+]2.D^'=.\G[3>?9I)O*\R6.*,^7&#(?WDD?0=^U ';445YE\
MOB%KGQ8^$^C>*/$/@[4O &LWQF^T>&]6W_:;79-)&#)OBB/[P1B3_5CB3\:
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M444AA1110 45QWPM^)GASXP>!]/\6>$]2_M;P[J7F_9KO[+)%YOERR12?NI
M)/\ 61R=J[&@5PHHKC/$WQ.\/>%?&_A7PEJ>I-9^(O% NCI-F+667[5]FB\V
M7]YCRXR(N?WF/QH!L[.BBB@84444 %%%% !1110 4444 %%<=\4OB9X<^#_@
M?4/%GBS4O[)\.Z;Y7VF[^RR2^5YDL<4?[J,&3_621]J[&@5PHHHH&%%%% !1
M110 4444 %%%% $EK_K*T:IV/W:O"NJF<E3<;114-U,85^3K6QD-DN/[G-4J
M\7_;"^,FN?L_?L^^*?'^@6]G>:QHYM=D&I1R2VS>;=118D$<D?\ SU]:]HKD
MJ'2@HHHK(W"N?NX?)NJZ"LG5H?WM:TS*H5:AJ:BMC$**** "BBB@ HHHH **
M** "BH:* "IJAHH MPWG_/2K=9-6X9O^65:TZAE4IENI:*BKK,B6BO%_^%OZ
MY_PV!_PJ?R;'_A'O^$#_ .$J^T>5+]K^T_;OLOE9\SRO*\OG_5YS7M%( HHH
MI@%%%% !117)^ ?B9X;^)G]O?\(]J!O_ .P-7N="U+-K+%]GOHO];%^]_P"N
MM(#K**\7_P"%OZY_PV!_PJ?R;'_A'O\ A _^$J^T>5+]K^T_;OLOE9\SRO*\
MOG_5YS7L= $M13310Q43310Q5B33234S$)II)JBHHK4R"BO-?VD_C(?V??@S
MKWQ!&D?VX-'-J3I_VG[-YHENHHO];Y4O_/6O2J "BO-? OQC_P"$T^,_Q.^'
M_P#9/V3_ (0C^R_]/^TF7[;]NM?-_P!5Y/[KRJ]*H **** "BLKQ)XBT[PEX
M>U37]8N#:Z7I-M+?WMT(O-,<<47FRRT>&_$6G>+?#VEZ_H]P;K2]6MHK^RNC
M%Y1DCEB\V*6@#5HHKQ+XG_M":YX?\=3^!_AW\/;OXF^+M.@BO=4A@U2UL;'3
M8I/,\N.2XE/_ !\_N_-$1C&8Y3)V- 'MM%>:?!GXC^,O'1UNU\>?#&^^'&J6
M/E2Q13:E%JEI=12^;_JKJ+_EK^ZE\V+_ *Y?\]:]+H **** "BBN;_X6-X;_
M .%D?\(!_:)_X2[^R/[>^P>3+C[#YOE>;YO^J_UM '240S2P_P"KKFOB-\1O
M#?PB\$ZAXN\5:D=)T"Q\HW5V(I9?*\R7RHOW47[W_6RUTM &W9WGG5+7/PS2
MP_ZNOGWQ/^U=\2I/C)XX\ _#_P""7_"??\(B;$7U^/%5MI?_ !\VOFQ9CEB]
MY.G_ #RK$V/J>BO!OAA^T=KOB#QU#X#^)'PXO/A;XNU*TN;[1XIM8M+ZQU&*
M+R_,CCN(CS<Y>60Q",_NXQ)WKWF@U"BBBF 45Q7QF\7WGPZ^#_CCQ1IZ6\FH
M:)H=]JMM%<C,<LD5K++%Y@_[95P4OQT\2V7[)^@_%*P\&W/C7Q1?:'I>J_\
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MQ%\.?$;^WO\ A']0:_\ [$U>ZT'4MT,L/EWT7^MB_>_]=:Z6@ HHHH ****
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ME_$O2O@[X3B<VVC:;8Z';ZY<WD,<LL?VJYDF $1E CD2*-N(Y0"!)')OZ?\
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M(?P?\ ZII7Q$TGX1^%+3PKI%GI.DV&D6VMW-U%':X^UW+R@>6TN(I1%&>(Y
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M#\;]:^#_ ,%[?_A._P!GSQAI5K\4+W5+&UL_!O@34X;FP\0S>9''Y-UIEL9
M!Y1N3&8_*Q)+U\WR\@'W[1110!PWQV\1:EX+^!_Q$\0:-<?9=4TCP]?W]C="
M/S/+EBM998I:E^!/B/4?&GP.^'?B#6;C[5JFK^'K"_OKKR_*\R66UBEEEH^.
MWAS4?&GP.^(GA_1K;[5JFK^'K^PL;7S/*\R66UEBBBKYV_9R_;8^#VB_LM^#
M)]8\:66B7'AW1[+1M0TZ^/\ IRRPQQ0_NK6/][+'DB7S8O\ VG)Y8!Z?^RO\
M1/$?Q$7XNCQ!J1U$:'\1M8T#3,QQQ_9K&+RO*BS&/^FM>"_LUZ[^TY^TQ\+?
M#?B23XC:9X"T5HM0A?6ETFUU*_UJ[^U_Z[[+Y<<5O#$!Y0P1)F.3J)(]GH?_
M  3YUH^)O"WQEU<V-]I/]J?$_6+S[!JT7E75OYL5K+Y4D7_+.4=/J#Z5;_X)
MK_\ )E/PZ_[BG_I?=4 =!^RQ\3O'.J>-/B?\+OB1J=KXG\0> [NQ\OQ+I\?V
M7^TK6]BDFA\VV&(XI(X^OE\< <^69).#\"^*OC3^UUJ_BGQI\/?B;;?"OX:0
MZA)I?A^'_A%HM2FUI(O];?-]J$?^M]LX\N6,\Q%Y.B^ /_)ZW[4O_<K_ /IK
MEKC_ -B7XS^%O@?\*[_X-?$?Q'H/@?QA\/\ 5KFP>/6M4^RQ:G!+++<Q7</V
MD1@QR>9+V_U8BDX\V.NFF95!_P 'AX^L_P#@H1<Z=\0S8W6NZ;\+#:QZ]88A
MCUJU.JQ^5?>5_P NTI#^7)%DXDCD\O\ =F,#T'Q]\1_B5\4/C;K7PJ^$^MZ3
MX4L_#VG6UUXI\9:A8_;KG3[FY_>6MK:VTA$<AEBBR9#YD8BE_P"6<D8$GG?P
M9^-7AWX[?\%"+OQ)X3>^N] A^%IM;75+RREM8K_9JD7F30B4"3RO,>2+_KK%
M)UQFN0^+7PE^"]O^VEXWF_:#LK8Z9XUL+&^\*:U=7]U8Z?&;6V^S7UM+<1R1
M1>;^[CDY)X\KI)*(BS(]1;QY\:OV8?B=X)L/B5XKM?BYX$\;ZI;>';?5[;2+
M;1[_ $C4Y99/*'E1?ZR*0 \_],O^66/WMCXQ?$KXR7W[7%G\*?A]J5I9Z=J/
M@,:C+<7L$,L>C2_VA)%+J8C(\RYD$<7E1VWF>7OEC\SY!)7,> _@Q^Q;8_%[
MP58>#1H.J^-Y-0-_H<>B>)+[4_+FM0+D22^7<RQ1@"+I+_K,<=Z[?_G)U_W1
M_P#]S- 'L?P<\(^-_!?AF[L?'GQ _P"%D:Y)?&6+5O[&BTORHO*B_=>5%_VU
M_>_]-:]"HHK4#DOB;X?\2>+/!=_IOA'Q0O@KQ!<>2;;6FTR*_P#LO[Z+S3Y4
MO[N7]V)8O^VE?%G[%/PQ^+EQXH^)5Y;?&?[)HND?%+4HO$.E'PI;2?V[+')"
M;J;S?^7;SA_RSB_U><U^@%?&O[(OQ.\)>!?B)\=O GBC7['PQXQOOBEJ=[8:
M-K;_ &6ZOH;TQ?99(O,_UGF^7D>5SS'_ ,]8JR POC@GQ';]O VGPFM=)B\6
M:A\*?LL>IZO(([;2HSJ<I^U>68Y/-^:.*../!_>31$YCCD!WM?U[XX?LP^._
MAA>^+_BE9?%SPCXL\06WA*_T^Z\/V^CS6DUT?W5S%)%GS"/*F_UIQC_KIYD?
M2?\ .3K_ +H__P"YFJO[>,WG?\,_Q_\ 56]!_P#:M &Q\<OBUXUU#XI^'?A/
M\,Y](L_$^K:9+K&K:QJR23?V'IH_=BZBAX2:0R']W'GCROWD?ER>9'YC\0O%
M7QQ_9*MK#X@>+?'UM\8_AW;3?9?$&G_V):Z-=6,,LT<45U;&/_6_O<?N_P#I
MI_VUBYW]K/X=_#R;]JKP/XI^-FF?:_AMKOA\^&K74?,N+6&QU**Z,L4MW+%Y
M7EQ2Q228]_-_Y9Q>;5>;X%?L,Q:GHVG6S^'=4OM8U&+2K*VT?Q/?7LLMQ*<1
M?NXKJ7RN>/-E_=5J9GW51116Q@?-7_!2'_DR_P"(?UT__P!.%K1_PVX?^B _
M'#_PBQ_\=H_X*0_\F7_$/ZZ?_P"G"UKZ5H-NA\B?LB^-F^(_[3G[1^OMH.M>
M&OMJ>'0-)\2V7V;4(?*LIHL2Q=N8B?Q%>J_&#2?C-XS\6:9HWP_U[2O 'AN.
M/[3J/BBZ@BU*ZN)?WO\ HUM:RCRB(_*A\R60C_61^7_JY/,Y#X#?\GI?M2?]
MRO\ ^D$M>7?&)/ /Q8_:V\7>$OCUXHF\.>#_  ]I^F77AS0=2U:;3-,U@2Q2
M_:;F0YP\L4USY8,,L1Q"P_>^5+6(SU3X*^.?B=X2_:(\0?!SXC^)++XA"7P_
M%XMTWQ)!8QV$L,7FQ6LMK+;1?NO];TYSP?\ GK^ZYF\\<?&SXB_M+_&#X=>"
M_$=GX8\-Z'_8TD?B2\L;:[DT:.6Q\TQ0VN!]IDN9,9EE)CBBCE]8L>9_LH0?
M"BQ_;R\4Z9\%[8P>%]-\#RVUQ+%<R74%S>_;[4R2Q/+++YD6&BC]#Y><?\M:
M]O\ @-_R>E^U)_W*_P#Z02T 9G[27PS^*L/[+NN1S_&3SKG2/#VLR^(;H>%;
M;_BH(O+EEBB_Z=OW.8O-BK7_ &,/ GQ%T'X;>!=:\1_%(>)_"5YX2L?[-\-C
MP_;VO]G>;##)%_I4?[V7RH@8_P :]2_:&TV]U[X _$[3-/MKC4+^Z\-:I:VU
MK:Q&62666UE\J**(5YC^S'XZ^&_QJ_9J\)^ D\0Z/K<\O@RVTO6/#T-^([F*
M**UBM;KS(A^\C'_345J(^C:^4/B3IOQ _9^_:)\1?%;PMX/U3X@^"?&.G6$/
MB72M+E1]0LKFVECBBNH8O)\R0?9O^649_BD\WRAY9'6>&?V _@3X/\0:7K^B
M>!FLM4TFYBO[&[&LW\OERQ2B6*7_ %OL/RKI+/\ :K^%\?B+Q!X?UKQ=9^#]
M=\/7,EK>V/BN7^S)/]9)Y4D1E_=2QRQ1B6/RO^6<T5 &G\"_VB/ W[1/A]]7
M\%:L+D6_E_;M/EB\NZLI98_,$<D?3KD>;_JLQ2^E>27GQ&^)W[1GQ4\>>&/A
MGXIL_ASX.\%7<6GW7BJ30O[3NM2U,?\ 'U:Q1W7E1>7%SYO!D_=1=8Y<#+^$
M&O:1\7OVZO&7Q#\!V?VWP7IOA0^%]4\30Q1Q6NHZI]KBDQ'+_P O7[KRH_-_
MZ9Q?\LC%YD'P+^)FA?L_?&CXX?#OXB:MI/A*XU3Q/=>,M(U35+[[-;:I:WV/
M]5)+'''^Z\N(?ZP?O1+C_55D,]8\!ZM\2/A?IOC*7XM^(M)\2>&- TR+5;+Q
M=9Z6;:YN8<W,MW]JMHB>8O+BXBB_U0_YZ]/+_AW+^T)^TKX-L/B';?$NP^$&
ME:OYTNF^&K3PI'J<GV7S2(9I);KGS)>#^[ C\KRI/^6M=_>_%CPI^U1X+^,G
MP_\ ASKEOJ^HV^B2:7)JC"1-/%U=1W4,0\P?ZWF+_6Q_NOWL7E^;7$_LG_M:
M?#?_ (4KX<\,>*_$NE^!/%WA+38M&U?1?$-T+*6&6VS;#)N?*\PXB\WRH_\
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M^&=]JUG'=R^%;'P3;W,>F_NQ^Z\RZE,OF=?,$O\ JY3*.E>3?#'X>ZU\5?\
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M>5%_J^M>C_%CXC?%F\_:RM_A=\/=1M+32M0\$B]DNKZ**2/29#?312ZAY?\
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M>UMHQ%%!''_JXT0<  >GI6Q10!YI_P ,^_"__A*?^$D_X5MX1_X2/[=_:/\
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MCZ/K6K:O9:18VFK:OY7V_4(;:**6^\K]U%YLO_+7RJUJ* ,G6_"ND>(_[/\
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MV;2-#LWO)\.F]\?=B3S&4&20XCC&>7D [U\.^*/A#KWP9_9$\%?&*6QU"_\
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M%[%Y<<D4L0D_>1?ZWR_+EY)B,G205G8TN>D45XI^S;\8M<^,:_%$ZU;6=O\
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M_EG6MA7/LVBN;^'WC*Q^(O@7PWXMT^*>*RUS3;74[:.Y_P!9'%+%YL?F<_\
M32NDK$V045\T_%C]HKQ9)\9O^%-_"'0M#UGQ^NDG6-2U;Q#J'E:;HL7FQX\R
M*'][))(#GRQY9_>PR?O(R<;OPE\8?&J+QM_PC'Q5\+>&O)DTZ;5(/%?@NXN3
M8?NY(8A82QW,?FI-^^DE\SS.W _=R8=A<Q[S6?J%G_RUCKYIUS]H;XA_$3XN
M>,_AO\#-#\+WD_@_[+_;OBKQ=J<K6(FE,G^A0Q6Q\SS.O[S(\LQ31F,?NR6^
M&/CI\8?AQ\6O#O@[XZ^'_"D.B^+?]$T/Q;X+DN4L(M0_>D6%T+DY,DN!Y? Y
M_P">O[PQZF=SZ"HKYF^/'[17Q*\"?M$3?"[P!X%M?&=_?>#1K&FQMF+RK[[7
M+"9KJ626...U$4?(QF23RH_,_>USGBO]HKXZ_L[ZOX9O?C#X1\+>)/">O7/]
MCQ?\*T:ZFU-+^16-M%Y5S+^]\WRI !'GZ_\ +.74R/L*BOC+QC^T1^T7\&O#
M:?$KXD_#_P 'VGPXCU,1:EH&DW\LNNZ9:R2^5%)YOF?9I3_JO]5_K?-_Y9=8
MO6OVLOCUJ_[//A?P-K&C:1_PD*ZMXNL='O["&UFNKJ2UEBEEE^RQ"6+_ $G,
M0$7UH ]SKR_]I+XU-^SS\%?$?Q &DCQ"-'-KNT_[1]F\T2W447^M\J7_ )ZU
MXMJ7Q'_:ZTGPU>^,YOAY\/YM*M)9;EO!%O=W5SX@-J)L>5'+&?LTDOE=XLY_
MYY>;^[K,_;)^)VB?&K_@G-XK\;>''N7TG5H["6$7,>R6+_B:6L<D<GKY<D4D
M?I]>M 'V917FGQW^,EG\!_AO<^))=*N-<O?.CL=)T2UE NM3OY9#'%:P\=<X
M_P!5YG[J.7]WVKQSQ!XZ_:U\/Z3<>*_^$"^'-[I=OF_D\(Z?=7TNNFVZRVOF
M_P"J>ZBB/_++T_=QR?ZJ@#ZBU?4[#P_I=UJ>I75MIVGV,<MU<W=W+Y44447^
MMEEEHTC4[#Q!I=KJ>FW5MJ.GWT<5U;7=I+YL4L4O^JEBEKY3^/GQ0\7?&S]D
MN^\;_".3PZ? ^K^&M:FU\>*([J._2V\HQ216OE?N_-C\JZC_ 'G[O_5=:VOV
M)_\ A<G_  K?P/\ \)=_P@G_  @/_"(V/]D?V%]N_M3_ %4/E?:O-_=?ZKS?
M-\K_ ):XH ^GJ*^6X?CE\:?C=JFL7'P4\-^$].\&:/J,NFQ>)?&EW<R1>(3'
M^[DEL([8',,4D<G[W]YYN8^F)(QTWP!_: \1^)_&GB+X6_$WP_;^%_BEH<9O
MQ_9<,O\ 9>L:9YOE1W=K))[F*+][_P#'8H@#WZBOC_P#\>/V@_CEI<GQ#^'?
M@_P0WPVDN)#I&BZ_=W,6NZI:VV(Y?WL9^S12RR1R1?O?]7SG?'^\D^P* "O+
M_P#A<W_&37_"HO[(_P"90_X2G^UOM7_3U]E\KRO*_P"VOF^;7J%?$?QT\:^+
MO!?[=@?X?^$KCQGXNOOA:MAING;TCMDE.JR2>;=2R21B.(>5_P!M)#''_P M
M: /N&TJW7QOKW[0'QQ_9RU#0M;^-NA>$+[X<7,OV#4-:^'\=]++H4DF/*EN8
MY>L1.>(AQQR?W44GK?P[^+?B.;]I;XB?##Q<VF116>G6VO\ A22QMI(I+W2Y
M99(II9?WLL?[J7RHN?*\S_6^7V'539E4/<J*\7^)?QBUK0_CW\,_AKX;M;.\
MNM>-UJFMW3I)<RZ;IMM$,'RHY(_+%S+^ZCEE_=>8"/+D->T5J9!7R;X;_P""
MANA^--!M=:\/?!/XS:SI%R2([[2_"D=S;28'E_ZV.Y_"OK*OEW_@F?\ \F0?
M#3Z:G_Z=+J@#T'X%?M,>"_C]:W%OHEU=:7XCLYKE=3\*:R([76K#RI@DIEM@
M>F9(QOYZX_U@(KUR:;R:^7?VK&'P\^+WP&^(VCOY?B&Z\7V_@>[S_JKW3+_S
M#+%-@>9+Y4L?F1 _NXY.?+)KJ_CY\<];\#>)O#7PY\ ^&8/%WQ \1I-<Q175
MT(;72;6+!^WWW_+3RO-(_P"NGE2Q^9YE(#U?_EM17R=XA^/'QL_9YU'1M:^-
MF@^$+_X<74OV34-:^'\=]++H4D@'DRW4<O6,G/$0XXY/[J*3T'X]_'W4_A]X
MV\'_  \\#Z+9^)_B3XM-U]AM-1U#[-:Z;%'%_P ?5T/];Y7_ $R_Y:^3+_RU
MK8R/<**\#\"^,OC]H/CK0=(^(_ACPCJV@:S-+"=:\$S78_LDQVLD@%S%<@^:
M)?+$<9Z#!_YZ19=\4OC;XVN/B8_PN^$GAK2=;\46NG1ZAK&N^(;F6+3-#\S_
M %,=UY7[R226.*0^5^[_ -9')^\C\T@,K'O5%?,>C_'CXJ?"OXI>'/#'QOT'
MP]'HGB^2+3]#\2^"XKJ2UBU/)Q:W7FDR?O0?W?\ 7$OE'QN_:.^)/@WX_?\
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ML#D]6U+X??$[X;W6I:G>^'/%G@"2.2ZNKR[DMKW2IHXI 9)9)/\ 5$121_\
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MYLW-E+';",I+%G?'^\BDP3]_:<9% &)\,_VAOB/\:/AQXR\/:'X?TGPA\?\
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M@WQ]\&]+\+:/K^M3/]JL?'3736D4<;S13"-[4YD/FQ#8> 8\G Z5])U\J_\
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MBQ?>*?'TTJ6M]<M'#((;&*W?S2(TEP92/+,@ECR#%F2Y^S)\=/%GQ"U_XA^
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MTU\:/^$9^Q?;_P"UO^$\C^R_9O)\SSO-\KR_*\OGS,XKH-:^&WACX0_\$_\
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M &:/CAXK^(6N?$'P)\0M#LM%^(/@>^MXM2?1)2VF7L5T));:6V\PF0?NX_\
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M5K^]BDB'[N3_ ):]JX/7O@_9>+/V\OBKHNM_$GQC\,]3\2Z9I&IZ!9^$-?\
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MTKW7]G?X3^'/A1\'?#7AOPCJ\^O>&;:*:YL=2GN(KC[3%<2RW'F>;'%Y<O\
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M4445D:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/ OQN^$OPZ;0_M[^//[7SJ+77E_8?L-J)C^Z\L^;YF2.L>.O/2@#V&F5\_\
MQF_:3?X<^/=.^'7@[P1K/Q)^)>J:<=9M]#L9([*UMK(2^7YES>RGRX5)$@0X
MDS(@3Y/,CSS/@G]L#5;;XL:;\/?C%\-[CX-:WXBA$OANXNM;CU.QU:8/B2V^
MTQ1B.*7/E_NSG/F#H9(O, /IN[A_Y:55K3FC\Q<5F5R5#KI'&^&?B=X>\5>.
M/%7A+3-2:\\1>%Q:G5K,VLL7V7[3%YL7[S'ER$Q<_N\_A795XI\+?'FC^(OV
MB/C3X9L_!ECH.M>'5T,:EX@@:(W.M?:;626(3 1 _NN8AF23VQ7D8_;LU_Q5
MXP\5>#_ /P>U3QWXS\/^*+[0KFQM=0^SV$-I;9,5]=7TD7E1&62*41Q$_P#+
M*3]Y]SS,[$GV/17@/P1_:6U+X@_$37OA]XV\ 7GPW^(FF646IQZ)/?"^M[RP
M8QQ?:H;F./RR!))Y9 _^."/WZD;!16%XJU+4=,\*ZS?Z'I/_  D&LVUG-+9:
M7]K%J;R81GRH?-DXC\P\>97P#\(?B]\;-+_:?^/VIZ7^S^-6\1:FWAW^UM!_
MX36QA_LKRK&00_Z08_+N/.C_ 'O[O'E]*V,KGVMXN^,VC^#?BE\/_ %[9WLV
ML>-?MPTZ:&./[+%]AB\Z7S?WGIZ5Z+7QG^VA\1-.^%/[4G[,GB?5+6]OK:R_
MX2:*.STJW-S=74LMC#%%;11\^9++))'&/>0=.M3WG[:'Q!\!Z7H7B7XH? '5
M/ /P\O9(X[[Q)#K,>I2Z5YN3%)<V4<0EC_>&,2>9@@\8,F(R"/L6BO-OCK\<
MM"^ /A.TUW6K'5-6EU+4K?2--TK0;,7%]>W4@)BBBC)&2?+EP._;G%>&ZQ^U
M]\2/A6FGZ[\7O@)>^ O SWT5M>^(K#Q+:ZQ_9WFD^5++;6T6\1>9@9)[_P#+
M23RXY,K&O,?7=%9NCZU8>(]*M-2TZ]M]0TZ]BCN;>ZM9?-BECE_U4D<E:5(:
M=SR;X]_M!>%?V?=(TN]U_P"W7NK:O?Q6.D:#HEO]JU/59B0/*MXLCIY@ZXZ@
M9\R6,'4^#?Q9/Q>\,W6M_P#"&^*_ XM[^2T&G^,=--A=R'RHI/-CC\W_ %7[
MSK_TSDKX[_:(^*'Q<3]LCX*2V_P4,\VBWWB:'PW:KXKM?^*EA^S>7)+G_EU\
MN,>;Y4O/[PQ]J^JM4^/$WPY_9[NOB7\5O"UQX"GT^.26^T"VOHM1DBS="*&.
M.6/$<GF_NO3_ %G:MS ]?HKY+U3]I3X\PZ1>:QIW[+.KW>@)#+>6_P!J\764
M.HRV^!+&)+$1R2Q2F(_\>P\R0$^6,]_4;3]HK0_$W[,FH?&;P];7&M:-:Z+?
M:S'878^RRRBUCE\RVDZ^6?-BDBS^\'&?W@K*QMS'L=%<C\*?&@^)7PQ\(^+3
M9?8/^$@TBUU3[-YGF?9_M,44OE^9_P!M*YCX%?&P_&<_$'_B3_V2?"?B^_\
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M-U<OY<5O%$+DR2/(>  /6OJ+6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./\
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M _V?/%'BK5O!5C<:5!XCBTV*;3/-3[-;"SB,<7DX7S"TF\O+)))(9'R2<GD
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MK8&7]UFY6(]?,SC_ ): 5^@&L:Y8>'-+N]2U&\M['3;.*2YN+JYD$44$<?\
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M+XR;2+J\O?\ A*O$E]XHOOM[QN8[JY\OS8X_+B_U7[L=>1ZFLS4\@_YR>_\
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MM$*[[_A3>B_\+T_X6M]KOO[>_P"$<_X1C[)YT?V3[+]I^T^;_J_,\WS?^FE
M'H%15+16P'Q%\<O"/C?6OV^M B\(_$!?A?>ZA\.Y;2UUJ?1H;]-1ECOI)9+&
M*.3Y#((WBE_=YD$<?O6I\2_V./C?\6_!.H>$O%_[2PUC0-3$8N;7_A [&'S?
M+DCDB_>Q3>;_ *R.*O=OC)\!/!WQXT[3;?Q-8W:WFC3?:-'UO3[J2UO])N2!
MB:VECYR#Y<G_ #R_=19'[KC@O"_[$WAS2?$VF:QXA\?_ !)^(R:3>QZGIMAX
MN\2RW5M;7\<GF174<48B_>Q GKQ^]EK$#,_;JZ?L^?\ 97_#G\[JO3_VHO\
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M[%_X4/\ MC?\)%]O_P"$?_X3WQC_ &C_ &5Y7VO[+]FC\[R?,_=>;Y>:^O/
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M,>7&*DIE/K(U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[S1['4/^"IFG37EI;W5Q8?"7[7:22Q!S;R_VO+$9(R?N'RY94R#TD(YKZ\H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI<5I[,R=0CAM1%4U/HKK.493Z** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ J*:&.7[XS4M% &--IW_/.JOD^36_NJ&6UCFZBME4,C!HK4ETD?\LSB
MJ$L,L/\ RRDI 15+45%; 2T5%4M $5%%% !4M144 2U%4ODRS?\ +.2K,.DR
M?\M#FE<"M5JUT^23_6U?CM8X>@J;=[5DZ@"0PQQ?<&*=3Z*R-0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *93Z* *%QIR3#Y>#67-9RPUT%)+")!6BJ
M <W4M:DFG1_P#%4)=-DBIF1%1116P!1145 $M%%% !145% $M%'DU+%ILDM(
M"K5J&SEFK0ATV.(?/S5NLO:B]F5+738X?>K=/HK(V"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 E%+10 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445YYI?QJ^'
MFK^,'\*Z;X[\-:AXI226T.AVVKV\E_YD1;S8S#YGF Q^7(2"..?2@#T.BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK \3>)]#\&Z)<ZSKVK:?H6
MCVY_TB_U2ZCMK9>=@$DDA '/'/M5/P3\0O"GQ&TN;4O"OB32?$UC'+]FEN]%
MOHKJ%)0!^[\R,GGYQ^= '5T444 %%%% !1110 4444 %%%% !117.^)/%FB>
M%_L":SJ^GZ.VIWD>GV7]H720FYN9"1'%$'_UDIQQ&.?RH Z*BBB@ HHHH **
MYS4O%FAZ1X@TK0[_ %;3[76]8,O]G6%U=1I<WGE#S)/*CZOY8()QT[^IZ.@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BN=_X2K1?^$G_ .$;_M>P_P"$F^Q_;_[(^U)]K^S>9Y7G^5_K/*W_ +OS
M,8SQUKHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MN=\-^+-$\4?;TT;5]/UAM,O)-/O?[/NDF-M<QD"2*4)_JY1GF,\_G0!T5%%%
M !1110 4444 %%%% !117.^&_%FB>*/MZ:-J^GZPVF7DFGWO]GW23&VN8R!)
M%*$_U<HSS&>?SH Z*BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /B7]M;X7^&_C!^U-^S!X.\7Z8=6\/:D/$XN;+[1)%YOEV,,L
M?[V,B0?O(XSP>W>N$_:Y_9W^&W[&OP1U+XF_"*?4?A9X[T^\L8M.O+'7[HG4
M2;F+?92Q7,LD=S%Y8:4PXY^S9.8Q(#WG[:'@7_A9G[4W[,7AD>(]<\*_;O\
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MP>'K>^G:&RC,,US+*R@%R(XHWD( /,F, O&,_/SZY7R#\:/BEIGAS]I&WMO
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ML>_KB0PQ9_ZYQ^@-5/VU/$VG> _C'^SSXM\2W+W/@_1M8U2[U#053[7<>8+
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M<^8.I- '7:/KEAXCTNTU+3KRWOM-O(H[FWNK:02Q3QR?ZN1''!!'IZU\_?\
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M$CRW4MSXZ\)6(N1+;RR_O#K.G8\W$=M'(99@98Q$(HOWAZ]M^WU?1?$+X/\
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M>7D8SZ\]^Q/X%T/P'^RS\,HM TN'3$U30;#5[TQ!O](O;BUBDFEDXY)X[XP
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MT[R?M-Y]FDF\KS)8XHSY<8,A_>21]!W[5^=G[9GQ$^*'C3]CV[L?$?[,5O\
M#SP7;1Z9/8ZG-XDLIO["7S8HX_+L/*CDB/ER&WV8C,8E/O7T_P#\%1/^3%_B
M9]=+_P#3I:4 ;/CS_@H%\!/AKXNU3PUXA^(D-EK&FR?9[N&WTF^N1%)_<\R*
M%TSP<C->\Z/KEAXCTNTU+3KRWOM-O(H[FWNK:02Q3QR?ZN1''!!'IZUR/@OX
M,^!OASX$E\#Z'X6TS3?"UQ#Y-UIL5G'Y5Z#$(I#<@K^^,D<061Y<^8.I-? O
MAGQ5J7@__@B.][I=Q]GN9;*ZT^60INS!<Z]+;3)^,4L@_&@#ZG_X>)?L[?\
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M->\1S74VIWZMB2[,5]<PQ!CGD1Q1\1]!F3O(Y(!['_9/P_\ ^&R/[8_M^_\
M^%J?\()]C_L79_HO]C_VAN^TY\K_ %OVC]WCS>G_ "S[UH_%O]I[X6_L_P#V
M9/'WC:PT&\N@C1:?MDN;PQGS,2?9HA)+Y7[J0>;CR\C&?7S3_G*9_P!T;_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?!GC_P !?$#P^G-K??$JVO8=7MXR0D=M+)9?N[G$<<9^TR 222/+TX%?6U%
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M*HO$?B2\BTS1K1=,G>6RL=(L(O*M88A)#$8S^^N#)C.>'_UAD)^KJ* /"O\
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M  =U_P :?M&?!'Q_8S6$6C>!_P"W/[1BN97\^7[=:QPQB(;.H().2/2O=:*
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MKXNT>S\1QPK:_P!FV\)L;6^F,ADC'FQ&+9)("2#TDCCDC^K?V:_AA\+/AO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7/F^8900#F3?YF,2>8"<_6W[%UYXWU+]F7P/+\1XM7C\9QV]Q!?CQ!#)%?\
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M'&EZ=XS_ &>U\"^'KGS?M7B!O&MC?FVQ$YC_ -'BC$DF7\N+CH9,T >#Z?\
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MF87I_<C'2,8]"_85^&7B3X-_LL^"?!_C#3?['\0Z;]N-Q9B>.;RO,OKB6/\
M>1$QD^7(AX/>L3P3\+_'?A/X^?M.>+],T[3K<^*;/1#X6N]3N/,M;JZMM.EB
M_?1Q'S8XEF\L'@'&?+S0!\R?"/P/\,_@CX<N? '[4?PJM;?Q!K6IW/G_ !2U
MJU_M.RUR6YD81G^TCF:RF*"23#^5Y<</G2&.24U[]_P4>\87^A_!71M MUUF
M73O&'B?3/#.KP^&\_P!J2V$QEDFBL><&67R1%B0%'$A0]:P/%'B;]J7XT?#3
M6/AYJGP-T'P9>^)M)ETR_P#$]]XL@FTZW$L)CF<6UOYDN7!D$8!D\LO%O\P
MUZ%\1/V8+[Q!^S#X.^'^AZ[;6WC/P*NDW/AKQ)<VI$$>IZ;%''!-)%D@"0!X
MR/WGE^;G$AC H ^9_$=O\"_%7P_G\(-^Q?\ %[2;9K/[)%JFE?#N*'4X @_=
MRI<^;YAE! .9-_F8Q)Y@)S[)X7OO&VH_\$Q?$T_Q'CU:/QG%X%\007__  D%
MO)'??NX[J.(RB3Y\F*.,[SS)]\]:WO\ A;W[4_\ R!O^&?-#_M'/V/\ X2K_
M (3BW_L?SL^7]M^R^7]I^S9_>>3GS?+X_P!97I_Q1\->,/&O[+_BWP[>V^GW
MGCS5O!][826VER%+274I;&2,QQ>81^[,A('F'IC/3@ L?LH?\FL_!K_L3-&_
M](8JYG]LSX>^&?%W[//Q'U/6_#ND:YJ.B>%M8NM,N=1LHKB:PF^R2'S8I)/]
M6<QQG(Q_JQUQ79_L_P#AO4?!OP!^''AO6;?[+J^D>&]-T^^M=P?RI8K6*.1,
MIUP0:UOBMX$7XD_"WQAX.%U]A;Q!I%[I?VKR_,^S_:8I(O,V=\>8: /*OV-_
MA5X,\(_ /X9>)-&\(Z'H_B#4O!NF->:MIVFQ175UYMK#+*))8QODS)^\Y/7%
M>+?L.?!7PI\>OA9JGQK^)GAW0?'?C+XB:Q>:E+)K&E"]BTR"*:6VBM;?[2TF
M(X_*?&.=ABC.1%'7J?[)$OQH\*Z#HOPV^(?PZL-%T7PKHPTJQ\9:7K\5S;:G
M]F,<5MLM1F6/S(1O\R3O$?W<?F!!YUX)\!?'C]D74-7\+_#?P#I'Q8^$UYJ%
MY?:)I_\ PD)T[4=#WF(BV,MW(\?E9$N!&)"\ADDD,?F;* -&Z\ Z'^S=^W!\
M+(?A]IT'AC3_ (H6&L:?X@T>P'DV!_LVVCN;:YAM8R(HY?\ EEG!_=R2<"25
MWK[3KX_^$_P@^+?Q&_:"TWXU?&?3]*\-2:)IMUIWA?P;I5]+<_V69I91+=74
MOF&(S>01&3%D2"2,D1>5BOL"@#Y6^,7[).OZW\1-7^)_PB^)&K_#3XD:A%$+
MY-OGZ/JQAMI8HOM-K(#\V)(AYF)!&$R(C)EZWOV9/CIXL^(6O_$/P'\1=#L=
M$^(?@>^MXM3DT.4OIE[%="26UFMC(3*/W<?*2=,@\9,<?-1_$#]J7X:_\2._
M^$VA_&0Q$BV\4Z%XE@T/[1$,H/M-K<CBY/E^9)Y7[H>: G0UTO[,GP+\6?#W
M7_B'X\^(NN6.M_$/QQ?6\NIQZ'$4TRRBM1)%:PVPD E/[N3EY.N .<&20 \8
M_8<^"OA3X]?"S5/C7\3/#N@^._&7Q$UB\U*636-*%[%ID$4TMM%:V_VEI,1Q
M^4^,<[#%&<B*.M^Z\ Z'^S=^W!\+(?A]IT'AC3_BA8:QI_B#1[ >38'^S;:.
MYMKF&UC(BCE_Y99P?W<DG DE=ZSO!/@+X\?LBZAJ_A?X;^ =(^+'PFO-0O+[
M1-/_ .$A.G:CH>\Q$6QENY'C\K(EP(Q(7D,DDAC\S972?"?X0?%OXC?M!:;\
M:OC/I^E>&I-$TVZT[POX-TJ^EN?[+,TLHENKJ7S#$9O((C)BR)!)&2(O*Q0!
MY+/X<\*_ 7XO?%?Q)^T9\*U\6^'_ !/XGEU.P^)EYIG_  D6G66G8'V:UN(\
M22V7E^;##&?+_>&3R_\ 5PI)7N7[57C*'X#?L*^(]7^&+PQ:;IVA6.F:%=6E
MW+,([&62*VBEAN8Y?,S'%+YD4OF==AY[YFF_%K]JU8IM#U/X"^&+C65EGM1X
MOM?%<4>C!MY\F[^Q?O+KRA^[<QY$K@G_ %9X&CX"_8Y6S_8;B^ WBS5+6_ED
MT^XA?4K6.0QV][+=2W,4L8+QF012O&1GR_,\LYP),  ^>?#EO\"_"OP_@\(+
M^Q?\7M6MEL_LDNJ:K\.XIM3G#C]Y*]SYOF"4DDYCV>7G$?E@#'5_!M?%EA_P
M3T^.FA^)+'QAIVF:/IWB.R\+V7CBQ^SZE%HJZ;_HD<O )(\QP.P_U<9\N, >
MF:;\4?VIO UC:Z#K'P-TWXEZI8QQPW'BK1O&5IIEMJ.0/WOV:2+S(R./,X ,
M@D,8\L@#T7Q;X7^)/C+]D[QGX>\66F@WOQ'U3PYJ^GBU\-M)'I\LTL4T=LD7
MV@CJ&B&9.AS0!N_LH?\ )K/P:_[$S1O_ $ABKRS_ (*B?\F+_$SZZ7_Z=+2O
M8/V?_#>H^#?@#\./#>LV_P!EU?2/#>FZ??6NX/Y4L5K%'(F4ZX(-<-^W5\,O
M$GQD_99\;>#_  ?IO]L>(=2^PFWLS/'#YOEWUO+)^\E(C!\N-SR>U '+_P##
M._[3G_1W'_F-M,_^.5R/[%OAWQ/X4_:H_:=TKQCXM_X3?Q%;?\(P+G7%T^*P
M%QFQF9/]&C_=QXC,<?'7RR>]?;-?//P9^&/B3PK^U)^T#XPU/3?LWA[Q6/#Y
MTF\\Z-_M0MK&2*X_=AB\6)#C]X!GM0!\P_&#QMH?BC]M_P <Q?$/X6^-OC%I
MW@#3M-L- T?PCH7]L:?:F\MOM5U<7UM+)Y?FR^9Y49Z&.'IYD4<@S;J2SO/C
M[\)O%/P8^ 'Q0^#^MP>(+72/$,C>#!IFCWVAS3#[4MS%%YD?&1B4@<#.<QQ&
M/Z+^)GPW^*'PK^/&M_%OX2Z#I/BVT\1Z7:VGBKP7?ZA]@NM3N;<F*UNK:ZD\
MQ(S'')AXSY<>R,_ZR20&/H_A?X^^/WCCQ]IA\4_"C0/AEX-M3+_:;W_B./5]
M1O\ ,<GD_93; 1Q"*4+YGG=1)^[Y!H \7^-WP4\.?'K_ (*+67AOQ<+^[\.K
M\*H[NYTNTOY;6/4/+U>3RX;GRR)#$)'CEQD?O(8SSC%._;O^"/@SX+?!&?XM
M_#7P[I_PZ\?^!;ZVN]*U;PG8Q:?YAEN8K:2*ZC2/RY8S'*>)..H_U<DD<E3X
M\-\2V_;Z^W_".YTEO%FG_";[7'I>L0;[;58AJDL9M/,,D?E9:2.1),CYXHP<
M1R2&NJ\8>%_CM^UQ'I?A'X@?#S2?A)\,4U.UO/$EK>:]%JU]KMM%-YL=I;&V
MQY \R-!)(7CD^>,QD['20 J?MZ?"OP9=>)/@KKTOA'0Y-9UKXK>'M.U._ETV
M(W-_;$2QF&:7!,D1$<0\N3C$?M7T)KO@WP3\*?@[XPL]/M;;X9>&&TV]N]2O
MO!]I'8RV7^CXENH?)BXECCC!$GED_NX^N,5R'[8?PF\5_%+X?>'+KP,=.G\9
M>"_$MGXOTRQU9#]FOYK7S<6SR;P(]XDX).,@ ^6"9(^;^)?@GXE_M<?LK^//
M!WBSP?%\(?%&H3116%I<ZM%J\4OV>6VN8I7EM_\ 5+))&8R.3&,R8DX% 'R5
MX^\2_LZ:U^SAXOTWX??LS^-+_1(M+U(:1X\M_"(DM1+$93'='5)9?M/DQRQ\
M^8<B,&-X_P#EG7UQJNI7NN?\$U;W4]0O)M0U#4/A'+=75S=2&26>:31]TDDD
MAZG))S7G'Q2U;]K/XX?!GQ!X&7X/:+\/]0OM)DAU'6+KQ/:W,6I1F(136MK;
M(9/(DFR<&60I&AD'F"3RY1[3_P *Q\1?\,&_\*[_ +,/_"9?\*V_L#^SO-C_
M ./[^S/)\KS,^7_K.,YQWZ4 <?\ L:_LS_#?3/@A\-/%%WX6T[Q1XKU#1]*U
MM]>UZUBOK^WF^RQ&(132 F&.$111Q1QX$0C7'<U\YZ3\0?"?B[]H3XW>+/B'
M\#?'OQEUNS\2W?A+3CHGA7^W=%TO3++$<<4<<LF(KF0YED./^6N8_+\V3/WM
M^S_X;U'P;\ ?AQX;UFW^RZOI'AO3=/OK7<'\J6*UBCD3*=<$&O#=6\$_&#]F
MOXD>.]>^%W@[2?B1X%\9:I_;,GA9=6.EZAIVK2H?M5V+FX$D<L4AC7]V3]^2
M,1QQB-S( >2_!N46_P"VAX-USX4_"#XG?!WP;X@L;VS\:Z;K7A8Z;HUP8K5W
ML)8XT\R*&429!/[OMC_72^9N?%OP+8?#K]JKQI\3/C!\*+GXG_"_5=*TRQTO
MQ%';_P!MQ>%8HD)N_M-A+S%%F.6XDN(T/EC@9>XD%?0WP<\8_&[QMXHNM1\>
M?#W0?AQX4CM'@BTE=;_M36'OA)'^^\V$?9Q;&)I!Y?\ K/,CST-<3X@^+'[3
M7@_QEXCL(O@+I?CS1H]3D_L76M&\66^FA[$E/*$L5P9)#+QB0C8F>G WD ]=
M^!,?@9OA9HMU\+O[-/@6\\V]TT:3D6H:6>2641QGF+]Y))^ZX\L@QXC\O ]-
MKY^_9/\ @KXK^"_@_P 7/XTU+2[[Q3XN\57WBO4H?#T4GV"UEN?+S'&91YC@
M>5GGG]YCG&\Z_P"S+XD^,?BGP#J5S\:/#&E>$?%L>I216VGZ/*LD3V8BB\N4
MD7$OS&0R_P#+3H.@H ]JHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!Y#_P *1'_#47_"X_[<;9_PAW_"(_V)]EY_X_?M
M7VGSO,]?W?E^7[Y[5Z]110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !116??7UKI5I+=7=Q':VMO'YDDTC^7'&GJ?RH T**P_
M#OBC1O%%I+<Z)J]GJ]K&_E^=8W$<T>_TS&:W* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ***S-'UK3_$FGQ7^EWMOJ%A,,Q7%M*)8W_$4 :=
M%9FCZUI_B33XK_2[VWU"PF&8KBVE$L;_ (BM.@ HHHH **** "BBL^^OK72K
M26ZN[B.UM;>/S))I'\N.-/4_E0!H45GV-]:ZK:175I<1W5K<1^9'-&_F1R)Z
MC\ZT* "BBB@ HHHH **** "BLS1]:T_Q)I\5_I=[;ZA83#,5Q;2B6-_Q%:=
M!1110 4444 %%%% !1110 4444 %%%% !17/^(O&GA[PG'"=<U_3=#^T?ZLZ
MA=1VWF>W[PBN@H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-4MO)ECL9(3+'Q]9)*[S]F?X?Z)X(^%.@W6DVVRYU:PMK^]NGY>622,2G/\
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MMXA+G]WQPY\PY^M:WCC1[;1OVHOAGJ5C$+6]UN#4K74I(2(OML<-J#%YN/\
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MX=NM:UJY.GZ5:E/.G$<D@CS($Y$8)ZD=*\^_:4Z_"O\ ['W2_P#VK2_M??\
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M!-(^24BN98X__'0*P=!^,7@?P79OI/@3P7KGB#1K60PR7GA#1OM5J9HP(_\
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M?]@&0XK&^".CVOA?XR_&'0=+B^P:+:W6F7%M8QD>3')+:^9+Y47_ "SR<<4
M>^4445F:!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&>E>PT5-S4\1^,6C>(_#_C;1?'OA/0F\17-I8W6FZO817 CFN+4CS(O+R/\
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MN(=.OSHXM;J6+$5SY=J1+Y9_CQTKV.BLRPHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(_*D!ED$?[M^Y'\!QN>.?'.@_#/PGJ7B;Q-JUOH^BZ?%YEQ>W!.$]/<\_P
M% '4T5S_ (7\5Z=XW\*Z/XBT>X-UH^K6<5]9W'EE-\,L8DCDP_L0?QKF=6^+
MWA#P_P#$[PW\.;_7(+7QAXABENM.T?RY'EFABCDD>0X&(Q^[EYDQO,;@9.<
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M]X:\%>)?$\%CXH\4RQ1Z5I!BFEFE,LODQY$<9\I3+C#R$<B3GY#@ ]:HHHH
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M;H'@WQ]\5=4T Q)JLG@'1?[3@TV63S/]'ED$@_>9B.1T'3_61R  'U%1110
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M[4/%WA?Q/\:O$-A<:9XH^*6HKJDEK<IY?V/3;;-MIMKV$N(1YHF$<?F>=R.
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MS?;HO+CE^T@1Q;O+C_U@/!KSGQ1^RK^T'XT\+ZMX?UK]J?[=HVJV<UC>VO\
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M,UX-^SG\$]#_ &>_VYM%\%^'K:W1+#X,J+Z\AA,/]H7G]L#S;F0')W28]6V
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M)]6TCQ3\2)?#/@K5M6O)9!?V<MS#')=2RQ']Y*?W4L4D4AC)\R3/H?JOPO\
M"CPGX)^'=MX"TG0+&S\&V]D;'^Q3");>2.0_O(I/,SY@D)?S/,&9/,Y.2:\
M_P""BE])X5^&OPY\;364U_HG@7XB:)XDU9K79YR643RQG8'D&]O,FBCQG_EI
MGH"1],_\)5HO_",?\))_:]A_PC/V/[?_ &O]J3[)]F\OS?/\W_5^5L_>>9G&
M.>E 'R?^Q;X"T'QC\"?'OPEUO2;;7/!?@/XAZIX=L;;4%$IO[>UO8[V'[6HQ
M'(?,E.1@1D8'E^OT;XTTKP/HOPCU6V\5:%I"_#K1=-\ZYTVZT]+BQM[&VC\S
MBU$9XC$?$83CRQ@<5X3_ ,$Z[Z3Q5\-?B-XVALIK#1/'7Q$UOQ)I+76SSGLI
M7BC&\)(=C>9#+'C/_+//0@FSXIC_ .&XKZ[\,Z<3_P ,_6M^!K.N1G,GBZZM
MY XM;"0?ZNQBEB7S;J/F62/RXCCS)* -O_@G3_;?_#&/PS_X2#[?]M^Q7'E_
MVAYGF?9?M,OV7'F<^7]G\KR^WE^7CC%>5_M+?!;PY\'(_@4VC+J&HZOJWQ>\
M*_VMX@UJ[DOM3U.2*.:.*6YN9/F.  !&/W:9_=QIDU]UU\J?MZ_>_9S_ .RR
M^'/_ &YH ^JZ*** "OAG7/BGI/[-_P"WWXRU'XH75OINA^/M TR+PGXHO_-E
MCTQ;<K%=:;YAB\N$22R-<R?O!%'^ZDDYDX^YJX[5=+\+_%+PO=:;J-EI?BOP
M_-,]M<V=]#%?6LDMO,1)'+&08\QS0XP>CQ^U %S0?[%UQHO$^F?V==_VQ9VQ
MBU2S9)/MEJ/,DAQ*,^9%^^DD3!Q^\)[FO"_B-^U5JVF_$+5OAQ\+_AKK'Q4\
M:>'8K6ZUL+>0Z/IVG1S(9(D-S/P92#&1$!S&9#OS%(!YG^S_ .$=!^ O[=7B
MOX2?#S4)K?P'<^#(?$>H^%_M_P!LATW6/M,40*^9F6,FW,3G)Y\U,\>4$W_V
M&(M.LOB-^T_HT]G]A\6Q_$>]U"\$UD8;E].N?WEB_F$9DB.+F2/K_K#)@>;R
M =1\-?VJ?$VI_%S2/AE\5_A;JGPI\4:_9R7GA^7^UX]7M-3\GS&N8O/AC\N.
M6.,"3![==F8A(?$K]JGQ-IGQ<U?X9?"CX6ZI\5O%&@6<=YX@E_M>/2+33/.\
MMK:+SYH_+DEDC)DP.W3?B41X/[<FK0W7C3]FWPO8I-=ZY>?$[3-92QM89)";
M*Q#FZE.!@",3QD^W^YQTWQ'_ &8_$-K\2M:^)OPD\<77@KQ[JT=LNKZ?JD?V
M_0M=^SQGRHKF,XDA)VPQ^=$<QQ^9LCS)(2 >N?"WQ5J7C3P+I>LZWX9U/P?K
M,QECOM&U(B2:UFCE>&0"2/B:(F/,4O\ RTC,4F.:^>M-_;"\??%: ZU\%_@1
MJWQ"\"_:)8(_$VJ:_:Z&+Z6*0H[V\4H,DD6 N)>.?,C\L&,U:7XI:W^T!^R+
M\;--GT$#QUH%IXA\&ZOI^CB6YM;W4K>V>-C8\>8\<IEC\N.0>9D[.<>8?/\
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MP^^&^I?L]ZGX/\$>&/#&H3_%OP[:RW6CZ/;VLLD69CY9DCC!(W1J<9[5O_\
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M/_VB+7Q9\./%OBKQ3X?UCX>/X*DN+?Q+I^K()FLY;>VBN9Y(C%DW$/ER#RY
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M\0> [JR^WZ?J&H>)+6QO[R+8"7%@%DEYP?+\OS#*/+,>?,%=/_P4FT>_UO\
M8L^)MOIUM<7LBP65R8K>/S"(HKZVEEDX[1QQ2.>V!6'HOP7_ &BO$.DVVHZ?
M^U[!?Z=>11W%M=6OP\TR2*>.0?NY(W\WD$8(H ]O^"_QG\*?'_P#I_C#P;J1
MOM/N"(Y(92/M-G-_RTMYHO\ EFX^O<$93&?F?X;_ +?GC'XZ>%-'N?A9\!=7
M\::A+%<OKO\ Q/8M/L-,FCE$:6XOYX1%<3&,QRF/@B.2/_6?O/+]R_9?^ >I
M?L\^&?%MEJ_BW_A-]6\2>);KQ/>ZHNFBQS/<1Q"4>4DLG>+/!'^LKB?^"7?_
M "8O\,_KJG_ITNZ .V_9U_:&_P"%W_\ "6:+K'A/4/ WCOPC>_9/$'AF^D%R
MUN9/,-M-'<#$<L<L<;$$?4?N_+DDXOQ%^UOXJU[QGXCT#X/?!O5OBBOA?49M
M*UO5+K5[;1+&&]BP##;R3Y^T%#YGF<#RSY9Y$B&F?L\_\GU?M<?]RC_Z:Y:Q
M/^"7*Z;I?[*.G:)%IZZ;K^CZSJ=AXBMI;(VMQ%J(N<[)L@?O1;R6P[X "<>6
M0 #UKX?_ +1%KXL^''BWQ5XI\/ZQ\/'\%27%OXET_5D$S6<MO;17,\D1BR;B
M'RY!Y<@ ,@Y$?2O(W_;"^+?B;PVWC+P-^S-K_B#P'=67V_3]0U#Q):V-_>1;
M 2XL LDO.#Y?E^891Y9CSY@K7_X*+3#Q3^QC\7-/T<G6+_3?L37EG8MYTUL(
MKJTNI?-5/]7BW(E(.,1XDZ&J>B_!?]HKQ#I-MJ.G_M>P7^G7D4=Q;75K\/-,
MDBGCD'[N2-_-Y!&"* /;_@O\9_"GQ_\  .G^,/!NI&^T^X(CDAE(^TV<W_+2
MWFB_Y9N/KW!&4QGTZO"_V7_@'J7[//AGQ;9:OXM_X3?5O$GB6Z\3WNJ+IHL<
MSW$<0E'E)+)WBSP1_K*]TH ^5_$7[6_BK7O&?B/0/@]\&]6^**^%]1FTK6]4
MNM7MM$L8;V+ ,-O)/G[04/F>9P/+/EGD2(:].^!'Q>F^,7A_6'U'PGJW@S7-
M"U0Z/J^BZSY;&WODBAFE$4L9*S1?Z2GER\>8,.!S7B?_  2Y73=+_91T[1(M
M/73=?T?6=3L/$5M+9&UN(M1%SG9-D#]Z+>2V'?  3CRR!]%^-OB3H_@OP7XW
M\13SM?VWA&RN;O4;>Q>.:XA,-J+DQ8)XD,1CD D_YZQGO0!\YR?ME?%#Q%;Z
M[XA^'/[.'B#QAX!L_P!Y8:_?ZS'I5SJT7E+)]IMK&2(RR12Y!B,8/F^GF$QC
MM?B+\6-"^-W["?Q$\<>&O.?2=8\$:U)']HB\N6,I:W,;Q2#U22.1./UZUY9X
M+TG]I/XJ_#:U^)VO_M >&?A3I&IZ;%K$.FZ/X6MM0L+*P>TBF\V:XO</&?\
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MV32;+XB>/[G4H;'5/$$#R6-C;6MI)-++^[R?-!DA\O,4D?$GF"OG7]HSX?\
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M/^$<_P"$7^R;X_LGV3[3]IWX\OS/-\WOYF,=N]-^+OP5TCXS+X,?5[J_L_\
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M[UKZEX3T/5_$&E:Y?Z3I]UK>CF7^SK^ZM8WN;/S1Y<GE2=4\P  XZ]_0='0
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M:G->W^H^5YGV7S9&/E_NXY#&/+C'&.N*]BHH \S^$7P5TCX,KXS?2+J_O/\
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M\0Z]H/Q1^*7P_37]1EU>^TKPAXG%C8_;93F67R_*)W2''.>WI@5]2T4 >?\
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MB0$ D1^6-@'T3X&\#:#\,_">F^&?#.DV^CZ+I\7EV]E;@X3U]SS_ !DUU-%
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MT74(O+N+*X!P_I[CG^,&OG;_ (8!\,[?L'_"T_B[_P (3G[/_P (;_PETO\
M8WV#./L'E>7YGV;R_P!SCS,^7_RTSS7UE10!\]_%#]D?P9\3- ^'NEV.J>*/
M \G@:-K3P[JGA+5GMKVQMO)6VDA$LGF<&..+K^\_=]>9 7_";]D7P;\+O%T7
MC&YU7Q1X_P#'-C%);6OB?QQJLFI7]K;2 _N8<XCC',G(C\S][*,XDQ7T#10
M5CZQH=AXCTN[TW4;.WOM-O(I+:XM;F,2Q3QR?ZR-T/!!'KZUL44 >/\ [/?[
M/FB_LV^$+KPUH6M:YKEM<W:W1NO$5TES<1E;:&UCCRD<>(HXK6)$ ]^V,8/P
M%_8[^'W[.7COQKXJ\)V]Q_:/BJ4RO#=16_E:='YLDIMK'RHHS#"3(!Y>2,11
M?\\Z]^HH \R\8?!/1_&7Q6^'WQ O;R_AUKP3]O.F0VSH+>3[;"(9O,'EY/ '
M0CUI_P#PI#1_^%\?\+8^UZA_PD'_  CG_"+_ &3?']D^R?:?M._'E^9YOF]_
M,QCMWKTJB@#S7_A2&C_\+X_X6Q]KU#_A(/\ A'/^$7^R;X_LGV3[3]IWX\OS
M/-\WOYF,=N]>E444 >9>,/@GH_C+XK?#[X@7MY?PZUX)^WG3(;9T%O)]MA$,
MWF#R\G@#H1ZT[X]?!;2/V@OA;K'@+Q#>7]GHVK>5]JFTQXX[C]U+'*/+\R.0
M#F(=O\1Z710!Y_\ %SX.>$/C9X.E\.>-M!A\2:2SI<"WEEDB*2)C#QR1D21G
MM\A[GU-?/=G_ ,$V_ <T.BZ-XF\<?$SQUX1TM=MMX7\1^)3)I:".$PQ 1111
M&,QASY?ED8^G%?8E% 'A?QA_9;\+_%RU\'6\>I:]X#NO!XEBT/4_!%\-,NK.
M*6,1R6T1\LH(O+CC' SB,#@9S2^$W[(O@WX7>+HO&-SJOBCQ_P".;&*2VM?$
M_CC59-2O[6VD!_<PYQ'&.9.1'YG[V49Q)BOH&B@#QS]H#]GGPO\ M#:3IEEK
MXU"RU31[^*_TC7M%N/LNIZ3,"#YUO+@XSL&<Y!P"!YD<9'6?"WP"/ACX#TWP
MT?$&N>*_L;2G^UO$MY]LO[@R2O)^]E/WB-_E@X'"@5V]% &/K&AV'B/2[O3=
M1L[>^TV\BDMKBUN8Q+%/')_K(W0\$$>OK7ROIG_!.3X=Q6KZ-<>)/B-?_#SS
M9)/^%=W'BN3^P@'D,@B\J+$F(Y?WO^MSYB DOSG[ HH \T^ OP6TC]GWX6Z/
MX"\/7E_>:-I/F_99M3>.2X_>RR2GS/+CC!YE/;_$^ET44 ?+OC;]ASPMXL^(
MNO\ C+P_XR\??"K5=?,3ZK'X!UK^S(-2EC\S_2)8Q&?WF93D]#U_UDDA/>_!
M[]F;P#\!_A;<^ /#.CLWAZ^$K:E#J<GVO^TY9(HX)I)5DS&?,CC&8P!'_P!,
M^U>RT4 ?'=Y_P3;\!PPZUHWAGQQ\3/ OA'5%VW/A?PYXE,>EN)(1#*#%+%*9
M#($'F>83GZ<5]"?"/X.>$/@GX.B\.>"=!A\-Z2KO<&WBEDE+R/G+R22$R2'M
M\Y[#T%>@44 >:? 7X+:1^S[\+='\!>'KR_O-&TGS?LLVIO')<?O99)3YGEQQ
M@\RGM_B6^#_@GH_@WXK?$'X@65Y?S:UXV^P'4X;ET-O']BA,,/ECR\C@GJ3Z
MUZ;10!YEX/\ @GH_@WXK?$'X@65Y?S:UXV^P'4X;ET-O']BA,,/ECR\C@GJ3
MZU1^-'[/WA#X_:?I<'B>RNUOM%G^T:/K6FW4EK?Z9<$#$UO/& 00?+DQS'OB
MBR#Y8QZW10!\P^%?V&/#FE>)-*U?Q+\0OB7\2ETF]CU33;'QGXIENK6SOXWW
MQ74<<8C_ 'L?S#G(Q(_!KU'QA\$]'\9?%;X??$"]O+^'6O!/V\Z9#;.@MY/M
ML(AF\P>7D\ ="/6O3:* ,?6-#L/$>EW>FZC9V]]IMY%);7%K<QB6*>.3_61N
MAX((]?6OF2'_ ()]Z!HZ-9>#_BI\6OA[X9B8_9O#7AGQ;+!860_Y:>3'*DLG
M[R3S)#F3K(<5]9T4 <3\*?A?X;^#_@'2_!_A#33I/AW3O.^S6?VF2;RO,EDE
MD'F2$R']Y))U/?M65\!?@MI'[/OPMT?P%X>O+^\T;2?-^RS:F\<EQ^]EDE/F
M>7'&#S*>W^)]+HH \R\'_!/1_!OQ6^(/Q LKR_FUKQM]@.IPW+H;>/[%"88?
M+'EY'!/4GUKRKQM^PYX6\6?$77_&7A_QEX^^%6JZ^8GU6/P#K7]F0:E+'YG^
MD2QB,_O,RG)Z'K_K))"?J*B@#QKX/?LS> ?@/\+;GP!X9T=F\/7PE;4H=3D^
MU_VG+)%'!-)*LF8SYD<8S& (_P#IGVKS&'_@GWH&CHUEX/\ BI\6OA[X9B8_
M9O#7AGQ;+!860_Y:>3'*DLG[R3S)#F3K(<5]9T4 <3\*?A?X;^#_ (!TOP?X
M0TTZ3X=T[SOLUG]IDF\KS)9)9!YDA,A_>22=3W[5VU%% 'R[XV_8<\+>+/B+
MK_C+P_XR\??"K5=?,3ZK'X!UK^S(-2EC\S_2)8Q&?WF93D]#U_UDDA/>_![]
MF;P#\!_A;<^ /#.CLWAZ^$K:E#J<GVO^TY9(HX)I)5DS&?,CC&8P!'_TS[5[
M+10!\?Z9_P $Y/AW%:OHUQXD^(U_\//-DD_X5W<>*Y/[" >0R"+RHL28CE_>
M_P"MSYB DOSGU;P;^R_X9\"_LVW'P4TW4-7E\*3:=?:6;JZDB-_Y=XTIE(D\
MKR\_Z1)C]WQGI7M5% 'FO_"D-'_X4/\ \*G^UZA_PC__  CG_"+_ &O?']K^
MR?9OLV_/E^7YOE=_+QGMVKH/AYX.L?ASX#\-^$=-EFFLM TRUTRV>Y/[QXHH
MA%&7X]$KJJ* ,?6-#L/$>EW>FZC9V]]IMY%);7%K<QB6*>.3_61NAX((]?6O
ME?3/^"<GP[BM7T:X\2?$:_\ AYYLDG_"N[CQ7)_80#R&01>5%B3$<O[W_6Y\
MQ 27YS]@44 >*^#?V7_#/@7]FVX^"FFZAJ\OA2;3K[2S=74D1O\ R[QI3*1)
MY7EY_P!(DQ^[XSTKT#X>>#K'X<^ _#?A'399IK+0-,M=,MGN3^\>**(11E^/
M1*ZJB@#S/X1?!72/@ROC-](NK^\_X2KQ)>^*+[[>\<ACNKKR_-CCV1C$>8QP
M<D>I[>;>,/V(_!WB?Q5J?B7P_P"(_&WPLUO6I/M6N2^ _$$FF_VM,3D/<QXD
MC^4F3!0#)ED)R:^E:* /G_X5_L:_#+X&_$"/Q9X%TJ?0;B/09/#PTV.3S+62
M.2Z-UYLA<>;)-O\ W?F22_ZL"/' Q] 444 >8_'#X,Z1\=/ _P#PC>M7-]I?
MD7UMJ%EJND-'%J&GW44HDBGMI7CD\N7@Q^8.<2R=,U5OO@'X:U;X")\'-0-U
M?>%(]!B\/)-=&*6X\J*(1QR_ZORQ-'LCD$GEX$@''&*]8HH \F_9X^ ?AC]F
MOX;V7@?PD+E]-MI9+A[N^\LW5U-+*299GCBB$A'$><?ZN*(5R_Q9_9%\&_%'
MQ=+XQMM5\4> /'-]%';77B?P/JLFFW]U;1@?N9L9CD'$?)C\S]U$,XCQ7T#1
M0!X5\'_V5?#GPA\57?BD>(?%_C3QE<6<FECQ+XSUR2_O$L"\<OV1<XC$?FQ^
M8/W>?WC\X.*Q?C1^Q3\//V@O%U]XB\8C4KN\N?#G_".QQ)+'LM(Q=&ZCN8LI
MYD=R)"<'/E^63&8R#S]'T4 ?-7@_]B/P=X8\5:9XE\0>(_&WQ3UO19/M6AR^
M//$$FI?V3,#DO;1XCC^8B/)<'!BC(P:](\8?!/1_&7Q6^'WQ O;R_AUKP3]O
M.F0VSH+>3[;"(9O,'EY/ '0CUKTVB@#S7_A2&C_\+X_X6Q]KU#_A(/\ A'/^
M$7^R;X_LGV3[3]IWX\OS/-\WOYF,=N]-^+OP5TCXS+X,?5[J_L_^$5\267BB
MQ^P/'&9+JU\SRHY-\9S'F0\#!/J._IE% 'CG[0'[//A?]H;2=,LM?&H66J:/
M?Q7^D:]HMQ]EU/29@0?.MY<'&=@SG(. 0/,CC(\VM?\ @GCX#?Q)X5\5:SXI
M\>^*_&GAO5[;5+'Q'XB\0&^NO+MY/,BL3YD?E_9O-S)Q'YF2<28.*^K** /,
M_B[\%=(^,R^#'U>ZO[/_ (17Q)9>*+'[ \<9DNK7S/*CDWQG,>9#P,$^H[^F
M444 %>9_"+X*Z1\&5\9OI%U?WG_"5>)+WQ1??;WCD,=U=>7YL<>R,8CS&.#D
MCU/;TRB@#P?XZ?LC^!/V@+S3]9\1)J.F>+-+:-M,\4^'[LV.J6&R42XBEQ@@
M$''F"3R_,D\ORR2:YOP/^PCX!\(_$+3_ !UXAUCQ5\4/%FEF(:7JGCS5VU*7
M3!&9"#%]S)S(9!O#B.3$D8C.2?IRB@#S/XN_!72/C,O@Q]7NK^S_ .$5\267
MBBQ^P/'&9+JU\SRHY-\9S'F0\#!/J._IE%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 <3\5OBAX;^#_@'5/&'B_4
MCI/AW3O)^TWGV:2;RO,ECBC/EQ@R']Y)'T'?M7;5\J_\%1/^3%_B9]=+_P#3
MI:5[I\5OB)IWPI\!ZGXFU2#4+VWL3#&ECI=L;F[NI99HXHK:*+GS))99(XP/
M60<CK0!VU%?%]U^VI\1?A]IOAWQ-\5?V?M6\ ?#:^EMTOO$D>O1ZE+I0ESY4
MES9QQ"6,>88P_F8(SC!DQ&WN?[4?QP?]FWX&^(?B*NC?\) NC?9MVG&Z-MYH
MEN8H0!)Y<F.9<].U 'KM%?'$G[97Q0\16^N^(?AS^SAX@\8> ;/]Y8:_?ZS'
MI5SJT7E+)]IMK&2(RR12Y!B,8/F^GF$QCU[P#^TUX"^)GP7D^*VD:R7\&VME
M+<:G)+$3=::8HO,FBFBCR1)&.<#.?^6?F"1"0#VFBOC'5/VTOBOH?AF[\9:K
M^S'XHT[X:V,DDMSJUWK=M%JL%A'*8Y+F33/+\P$1CS"F=@ SYGE_O*^@?%'Q
M<TS2_@'K/Q0T-!KVC6OAN7Q-9(6-J;^%;8W,>=\>8C*!U,>1G.,\4 >FT5\7
M>$/VVOB%\8--T[6/A1^SUJOC306TRUGNM7O]=CTBU^V2Y\VVM);F("Y$,B21
M22)C]Y&>,;#)[;^SS^T!IO[0W@1?$-CIFI:!J5G?2Z/K>AZE"8;G2]1BVF6V
MER.<>8.<=",B.0&, 'LE%?(&F_MA>/OBM =:^"_P(U;XA>!?M$L$?B;5-?M=
M#%]+%(4=[>*4&22+ 7$O'/F1^6#&:[SX*_M<>%?BU\*_$7BZ]%QX2N_",3GQ
M5H.HB0ZAH,T4<AF66+;YD@Q&_EXC^?8>!()(XP#Z#HKY/^&?[6'Q)^)EYH.L
M+^S_ *]IWPQUR_B@LO$B:S;/>BVEE\NVNY-.QYHC.8I),$^7%F0&6,<^N_'C
MX[:#\ ?"%IK>LZ?JFK2:AJ4&D:?I>@VGVJ^OKR4$Q111YY8^5)P?[G&3@4 >
MIT5\<ZY^V1\2_A7'IVM_&+X ZAX"\#-?1VNH>([#Q1:ZS_9WFDB.66VMHMXC
M\S"DD]\#S)#'&_U=H^N6'B/2[34M.O+>^TV\BCN;>ZMI!+%/')_JY$<<$$>G
MK0!L5Q?_  M+PW_PM;_A77]I'_A+_P"Q_P"WO[/^S2?\>/F^3YOF8\O_ %O'
M7/M7:5X7_P +'T;_ (;,_P"$%_X0NP_X2;_A _[;_P"$NW1_:_LO]H>5]@_U
M7F>5O_>_ZS&?^6?>@#W2BOE3X]?MG#X+?%__ (5Q'X'U7QIK4_A4:_I5OH?F
M3W6I7WVB6(6*PQQ'8-D4LTDV3B..3]V> 8=&_:]\=:!\1/"/AOXN_!34OAAI
MOBN^72=*UVVUZ+7+?^TB1Y5M-]FC'E>9\P!)Y*]-@D>, ^L:*\=\*_&M_$GQ
MZ^(?PPN='.BW?AJQL=1TVZN[PB36;>XC/FS10F,?NHI<1&0&0;R1P>*/CE\:
MW^%'_"':3IVD-XH\:^+-8BT;2=%6X^SB7^*XN9"(Y)8[:&/]Y++'')L_=YX.
M: /8J*^?/C-^TF_PY\>Z=\.O!W@C6?B3\2]4TXZS;Z'8R1V5K;60E\OS+F]E
M/EPJ2) AQ)F1 GR>9'GF?!/[8&JVWQ8TWX>_&+X;W'P:UOQ%")?#=Q=:W'J=
MCJTP?$EM]IBC$<4N?+_=G.?,'0R1>8 ?5-%?,/Q*_:I\3:9\7-7^&7PH^%NJ
M?%;Q1H%G'>>()?[7CTBTTSSO+:VB\^:/RY)9(R9,#MTWXE$?>K\3/'>I? W_
M (2W2_A;J-QX_P ^2_@;4-4BL)?.CNO*F471S%Y0"RRQR=)8_+/_ "TX /8:
M*_.C]B7XF_%VU\4_$RTL_@D;S1M8^*VI2^(M3/BVUB_X1^:22V%U%Y)&;K[.
M.?,CP)>@Q7TI\9OVDW^'/CW3OAUX.\$:S\2?B7JFG'6;?0[&2.RM;:R$OE^9
M<WLI\N%21($.),R($^3S(\@'T'17R=HW[7OCK0/B)X1\-_%WX*:E\,--\5WR
MZ3I6NVVO1:Y;_P!I$CRK:;[-&/*\SY@"3R5Z;!(\?3?M*?M76'[./CSX<:/J
MGAV_URT\8?VC%'-I?[R\2:VCC,5M#;>6?.DN99HX@/,C ..: /HNBO"_AY\:
M/&[>&?%_B3XN?"^3X1Z/X?L_MXG_ .$@AUH7,4<<LES)MMH\Q^4L0_ZZ>9P.
M.>#^&?[6'Q)^)EYH.L+^S_KVG?#'7+^*"R\2)K-L]Z+:67R[:[DT['FB,YBD
MDP3Y<69 98QR ?6%%%% !17S7\4/VDO&FE_$F[\$?##X-ZM\3+_28C)KFI'4
MH]'L+&0QPRQVHNIX_+EF\JYCD\L'A)$//[P1]!^SK^T-_P +O_X2S1=8\)ZA
MX&\=^$;W[)X@\,WT@N6MS)YAMIH[@8CECECC8@CZC]WY<D@![I17YJ?\+D^.
M/_#>7]M_\,[O_P )M_PK;^S_ /A%/^$WL?\ CP_M/S/MWVKR_+_UO[OR^O?I
MQ7Z#^$]2U'4O"NCWNNZ2?#NLW-E%+>Z7]J%T;.8QCS8?-3B38W'F=#UXS0!T
ME>:?%[X]?#_X(:&FJ^.?%5CX;AE4_9TN,R7%SC8&\J*/,DN-Z9\L'&:]+KXP
M_:<US4?@7^U-X*^-?BW1I]<^$5KH+^&[F_M=UPWA:^N+O/\ :0MQD@2Q&.V,
ML7SX!!R?*BE /4/A3^VQ\%_CEXK3PSX,\<PZMKLD32Q6$EC=VN_8"7V&6*/S
M#CG8.< GM7O]?$?QLUK3OVJ_B_\ !JQ^&%KI_C2T\$^,8_$6M>.;,'[!IL-M
M]GE>PBO1$8II;CSH_P!U%*>88_,&/WD?M_QJ^,WBKX9>._AOH&B_#/5_'6F^
M*=3^PZGK6G^;Y>@0^;;1_:9O+AD!&)9'Y,0_==>IH ZWXN?&/PA\$_!TOB/Q
MMKT/AO25=+<7$L4DI>1\82..,&20]_D'8^AKA_A'^V+\&OCGK1T;P5X]L-7U
MC(\NQNHIK*ZNOOR8ACN8XS-@1R$^6#Y>.< BO,=-\-:=\>/V]O&&H^(+?[39
M?![2-+M-(TN\D,UN-3O@]W_:21G]W%)'&/*Y$F3'%)D&./%C_@H[HMMH_P "
M;3XGPVD,OB;X;Z_I?B+17GC#9E^W0QF&0_ZPPR>828XY(^8XN?EQ0!]*^.?'
M.@_#/PGJ7B;Q-JUOH^BZ?%YEQ>W!.$]/<\_P 5Y'\-OVY?@7\6O$T'AWPW\1
M-/FUN<[;>UU"VN+'SY"XC$49N8XQ)(2X_=+ESGH1S7G7QZT'3_CG^VE\./AC
MXHM1>^$O"/ARY\>WFEW#F6UUF:2Z%A;0RPY _=',F3Y@D$DD9CPYSZ!^W;\-
M-%^)'[*/Q$L]9MA,-'TFYUVRE5(_,M[FUBDFC:/>O'"-&<8S')(,\T ?15%<
M#\$_&EW\1/@YX"\5:BL,6HZ]X?L-5N8H/]7')-;1RR;/;,AQ7?4 %%>(_'WX
MZ:A\'8=$TSP[X'UCXD^-M>G,>FZ#I?[O,4<L22W%Q<^64MH8OM,0,DG&9(LX
M!DDCX_X:_M4^)M3^+FD?#+XK_"W5/A3XHU^SDO/#\O\ :\>KVFI^3YC7,7GP
MQ^7'+'&!)@]NNS,0D /IZBBOE3X]?MG#X+?%_P#X5Q'X'U7QIK4_A4:_I5OH
M?F3W6I7WVB6(6*PQQ'8-D4LTDV3B..3]V> 0#ZKHKXWU#]N#Q-\']:TH?'?X
M/:C\(?"^LM-';^)+/6X==M8[J,"00S);1$Q^:!)SR21TP)'CCO/VYO&/A.QL
M?%GQ!_9_\4>!OA3<ZC]BE\5ZC>QR7UA"99(X;FZTP1^;$/,$>1T_>?N_-/EB
M0 ^S**** .*^(7Q0\.?#'_A'7\1Z@VG_ -OZM;:#IQ\B27[1?7!/E1?(._EG
MGIQUKM:^5/V]?O?LY_\ 99?#G_MS7I_QZ^+\7P1\!_VT-!U?Q=KUQ/\ 8=&\
M/Z):R7%UJ5[Y4LJQ@1@B,"..6220CB.*3@G"$ ]<HKY.T;]KWQUH'Q$\(^&_
MB[\%-2^&&F^*[Y=)TK7;;7HM<M_[2)'E6TWV:,>5YGS $GDKTV"1X^\_:C_:
M8T[]F#PSX2\1ZSI_VK2-8\26N@WUT9S'_9\,D<TDEUA(Y#)Y8A/[L#GUH ]U
MHKXQU3]M+XKZ'X9N_&6J_LQ^*-.^&MC))+<ZM=ZW;1:K!81RF.2YDTSR_,!$
M8\PIG8 ,^9Y?[RO<[_\ :!\'P_"$?%#3;FY\3^%9X8I[%O#]M)<W-]+-*(8;
M6*$<F:25XXO+.,2'$GE\X /6Z*^+[K]M3XB_#[3?#OB;XJ_L_:MX ^&U]+;I
M?>)(]>CU*72A+GRI+FSCB$L8\PQA_,P1G&#)B-O<_P!J/XX/^S;\#?$/Q%71
MO^$@71OLV[3C=&V\T2W,4( D\N3',N>G:@#UVBOCB3]LKXH>(K?7?$/PY_9P
M\0>,/ -G^\L-?O\ 68]*N=6B\I9/M-M8R1&62*7(,1C!\WT\PF,?1'P;^*NA
M_'#X9Z#XY\-23'2-8C:2);B/RY8_+E,<D;^Z/'(G'IWZT =_7#?$KXK>$_A'
MX;G\0>-?$6G^&-%BR/M-_)Y?F2;&<11 \RRD12GRX\N<<"NYKXZ_;BUB\^'?
MC7X%?%'5[0ZK\./"?B24>)+-VE>*UDN8A%:ZG)&D4@/V4^:03A_,DCCCYES0
M!Z-\*?VV/@O\<O%:>&?!GCF'5M=DB:6*PDL;NUW[ 2^PRQ1^8<<[!S@$]J]_
MKSKP3XZ\"?''P_I/BCPUJND^,-/MY#+;W]F$D^Q7)A Q_?@F\NXY0XD EQQD
MU\@?\% OB%\3(/''PMTVP^%!U#PWI/Q'T*_T/Q ?$=M$=;OA%*8[+[-C?;9D
M>6/S9./W.3U% 'Z"45Y#X'^+'B9?ACXA\9?%;P,?A2^B?:+FYLO[8BUC%A%$
M)6NO,MD_ZZ#R\$_N_>O#]4_;2^*^A^&;OQEJO[,?BC3OAK8R22W.K7>MVT6J
MP6$<ICDN9-,\OS 1&/,*9V #/F>7^\H ^SJ*\R\4?%S3-+^ >L_%#0T&O:-:
M^&Y?$UDA8VIOX5MC<QYWQYB,H'4QY&<XSQ7SWX0_;:^(7Q@TW3M8^%'[/6J^
M--!;3+6>ZU>_UV/2+7[9+GS;:TEN8@+D0R))%)(F/WD9XQL,@!]HT5XW^SS^
MT!IO[0W@1?$-CIFI:!J5G?2Z/K>AZE"8;G2]1BVF6VER.<>8.<=",B.0&,>.
MZ'^V1\2_BI'J.M_!WX ZAX]\#+?26NG^([_Q1:Z-_:/E$"26*VN8MYC\S*@@
M]L'RY!)&@![SX/\ C9H_C+XK?$'X?V5G?PZUX)^P#4YKE$%O)]MA,T/EGS,G
M@'J!Z5Z;7Q+^Q3\1--^*W[5'[3_B;2K74+*"]/AF.2SU2W-M=6LL5C-%+;2Q
M<&.6*6.2,^\9Y/4]9XD_:D^(^J>/M?T+X4? ;5_B'H>AS&QNO$>H:Y'H5I->
MQ32Q316OVF,BY$4L3QR21GB0$=!')( ?5U%>-_L\_M :;^T-X$7Q#8Z9J6@:
ME9WTNCZWH>I0F&YTO48MIEMI<CG'F#G'0C(CD!C'C-G^W%XB\<>*/''A/X=_
M!W4/&?C7PEXCOM&OK&WUF.SMH[*WD\J&[ENYHA'')+)YOEVP\PXAE.>* /LJ
MO-/CU\:=(_9]^%NL>/?$-G?WFC:3Y7VJ'3$CDN/WLL<0\OS)(P>91W_P/GWQ
M@_:9U3X3^&_AY:GX?:EX@^+'C?9#IO@33[T'RY@D4EVLE]Y?E>5;"0YEQCOQ
M'YDD?S!^W7^T#XYU3]ECQOX7^*?P=O\ X7W>MBQB\/WBZS#K=K>S17MO++;R
M36P_T>7RXS)'YG$HCE[QX(!^E=%%% 'RI_P]$_9C_P"BEC_P0ZI_\BT?\/1/
MV8_^BEC_ ,$.J?\ R+7JG[5__)K/QE_[$S6?_2&6C]E#_DUGX-?]B9HW_I#%
M0!T?_"TO#?\ PM;_ (5U_:1_X2_^Q_[>_L_[-)_QX^;Y/F^9CR_];QUS[5VE
M>%_\+'T;_ALS_A!?^$+L/^$F_P"$#_MO_A+MT?VO[+_:'E?8/]5YGE;_ -[_
M *S&?^6?>O-/B!^W%=>&?C1XZ^%OACX8:OXZ\=Z)/IT>G:9I-P0+^*ZCCDEN
MKF7RO+L8;;S($\R3S,F6/[@\TH ?7]%?'L7[>&I> O$Z>'OC9\(]>^&FK:I9
M?:/#=KIER/$ UZ;S?+-E$;:/BYR8L1GC]Y^\\O,?F/\ "?[9WC2S\8^!]-^*
MWP2UCX6:)XVN(].T36FU>/4O]-E\LPVMQ$D226IDW#_68DR/]7A97C /K^BO
M+/CQ\=M!^ /A"TUO6=/U35I-0U*#2-/TO0;3[5?7UY*"8HHH\\L?*DX/]SC)
MP*\,US]LCXE_"N/3M;^,7P!U#P%X&:^CM=0\1V'BBUUG^SO-)$<LMM;1;Q'Y
MF%))[X'F2&.-P#[&HK'T?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B.."
M"/3UK8H *^5/^'HG[,?_ $4L?^"'5/\ Y%KZKKRC]J__ )-9^,O_ &)FL_\
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M.:?\<?@Y=?!_P]KT[V%CXJ/B.VU:PAO< I'<F*,"W$@,F))#_"3]P221_7M
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MKXZZ%\./@:WQ2\4:?J>BZ3!IUMJ$NGWMF5OHC*$\NVDB_P"6<OF21QD$\/\
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MEP<9V#.<@X! \R.,@ ^0?VC/A_\ $_P+\0?V>X/B)\>K?XBK??$W1&L_#_\
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MF0FW'VHR#_EE$?+C\KR\ #S/,H H_M#?\GU?LC_]S=_Z:XJ3_G*9_P!T;_\
M<U7K_C#X)Z/XR^*WP^^(%[>7\.M>"?MYTR&V=!;R?;81#-Y@\O)X Z$>M/\
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MADQ)))(-[9/:OJ.L?1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**"./_ %<:(.
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MC'F2S+%%'T/+R/''[DBN)^-'P8\*?'_P#J'@_P 9::;[3[@F2.:(#[39S?\
M+.XAE_Y9N/IW(.4SGR;PO^P=X/L?'?A_Q9XL\:?$3XF:CH%P+K2(_&?B&2]B
MTVZ\R.3SH?+CC(YBCX),?'(.!0!A_!VUTW2?^"C'[1$.JV"0^(=7TC0;_19[
MFR(EFTZ*VBBNI(I2 #']H%NAP>7B_P"F1Q]4W&LV,.M0Z7)>6R:A<0R74-J9
M!YLD<1B$LFSK\AFB[''F)ZBO(_C;^R7X4^.FOZ%XDO-2U[PAXPT4R)9>*O"-
M\+'5(XI!()+?S?+/[K]X2.,\R8(\R7S(/@=^R/X/^!OB[4?&5IJGBCQ;XWU6
M#[)=^)O%FJ27M]):GRCY)X2,@?9H^3&9!C&<<4 ?,WP#^&OQ?\1?$;X_V/@_
MXU_\*K>W^)6JW=UX:F\)6NIW,D5SY4EM?'[0PDBCEB \OC8?*R.]>T>$?V3?
MB<OQO\"?$+XB?'+_ (6&?!IOOL.GGPA;:7Q=6QAE_>0R^\9Y!_U?UKK?BS^R
M+X-^*/BZ7QC;:KXH\ >.;Z*.VNO$_@?59--O[JVC _<S8S'(.(^3'YG[J(9Q
M'BKGP?\ V5?#GPA\57?BD>(?%_C3QE<6<FECQ+XSUR2_O$L"\<OV1<XC$?FQ
M^8/W>?WC\X.* .+\1?LV>/?ACXP\3^,O@-XVMM'N?$6IR:SK/@OQ=')>Z%?7
MLJ_O)HWC N+4\R2GRC)YD@B3$<<>*V_#=UX2_;\_91M;W7-+U'2?#7C+3_+N
M+!;M?M-K/%=%2T<H'/EW%L'C)X< >9%UCKE]-_X)V^$-'M?[&T[XA_$_3_ I
MDDSX'M?%,D>BFVDE,DUJ8O+\SRY/,D!_>&0Y/[S)S7?^.OV2_ ?C+X0^'OAU
M91W_ (1T#PW?6M]H=SX:N3;WFF7$);RYHI.?WO[V3]Y()"3(9,^9^\ !YR/%
MGQ+_ &3_ !MX*T;QAXHC^*/PU\3Z]:>%]+U2^MS#XBL+NY\Q;9)B/W-U#&D"
M^9*=DTCS2/SL\L\?\>/"7CG7O^"@V@)X0^(C?"N\O_AS+:V.MWFBP:E'J,L>
MI22RV,4<Y"&01M'*=F9!''R,$UZQX/\ V(_!WACQ5IGB7Q!XC\;?%/6]%D^U
M:'+X\\02:E_9,P.2]M'B./YB(\EP<&*,C!KNOC1^S]X0^/VGZ7!XGLKM;[19
M_M&CZUIMU):W^F7! Q-;SQ@$$'RY,<Q[XHL@^6, '@/Q2_8O^.7Q>\"ZKX/\
M9_M.C6?#>I"(7-D?A_8P^:8Y8Y(\213"08DCC/7G%:GBJ/3]/_X*B>#M0UNQ
M &I_#BYTW0;N\LBZ/J,5[+++'#*1B.06QES_ -,Y<?\ +7!Z?PK^PQX<TKQ)
MI6K^)?B%\2_B4NDWL>J:;8^,_%,MU:V=_&^^*ZCCC$?[V/YASD8D?@UZ'\:/
MV?O"'Q^T_2X/$]E=K?:+/]HT?6M-NI+6_P!,N"!B:WGC ((/ER8YCWQ19!\L
M8 /'?^"IFL65C^Q+XZM[NZAMY+Z;3K>U22389Y1>VTICCSC>?+BE?CM&?0U]
M>U\BZS_P3D^&GC#P[K%CXNU_QMXS\07T$5I'XO\ $FL_;]5L;9)8I1#:R/%Y
M48\R-AGRC)B689Q)7UU0 5\AWFL6.G_\%3-.AO+NWM;B_P#A+]DM(Y90AN)?
M[7EE,<8/WSY<4KX Z1D\5]>5\X?&C]BGX>?M!>+K[Q%XQ&I7=Y<^'/\ A'8X
MDECV6D8NC=1W,64\R.Y$A.#GR_+)C,9!Y .:_P""ETAOOV.O%^AP$S:SK=[I
M=AI=C$0]U?7/V^VD\F&/_EK+B*0^7'DD(:ROVQOLOP/^,'PJ_:)VZDECH]]_
MPB?BQK3[2(CH]T)?*N;CR_,'E6UP?,\OROWLDD0R"(Z[3P?^Q'X.\,>*M,\2
M^(/$?C;XIZWHLGVK0Y?'GB"34O[)F!R7MH\1Q_,1'DN#@Q1D8-'[?/C+PUX1
M_9$^(TGBG[/<V^IZ9)IEG;7"1.9K^52+;RHY",F.7$N1EXQ"9 /W= &%\%G?
MXK?ME_&3XF@O-HOA*RMOAUI-S:#RTN98Y1=:FDL;_/YD5R8HQ)^[C,9_Y:?Z
MP?65>.?LR_!F3X%_"'2?#ES>G5/$,QEO]=U>:;S)=1U.8^9=3R2F-))<R'RQ
M)(/,\N*('FO8Z "OD/\ 8+UJSFUO]HW3%NX'U"W^+>NW4MKY@\V.*7RQ%)LZ
MXD,,N/\ KG)Z$5]>5^=?P'_97\*_'_Q!\9?$E[J&N>#O&&@_%_Q)!9>*O!M]
M]AU-(I!&)+<RF,_N_P!X3TX)DQ@22>8 >Q_'16U;]NO]FBSL UU=Z/9^)M1U
M&&W!DDL[66RBACEEP?W<<DG[L2'@OQG-3?L\_P#)]7[7'_<H_P#IKEKO?@[^
MR_X1^".I:GKVF3ZMXE\9:O"+/5/&'B?4I;[5+R)"?+CDF8X&/W28C$>1#'G/
MEBNA\'_!/1_!OQ6^(/Q LKR_FUKQM]@.IPW+H;>/[%"88?+'EY'!/4GUH ^<
M/VW/#GB?4OVBOV99?#/BP_#Z[^WZWIL7C";38[ZVLKFZM8A%"4F/EF2X$4L4
M<9.3DX]*V?%'[*O[0?C3POJWA_6OVI_MVC:K9S6-[:_\*[L$\V&6,Q2(3',#
MT)''K7T'\7/@YX0^-G@Z7PYXVT&'Q)I+.EP+>662(I(F,/')&1)&>WR'N?4U
MX9-_P3[T#6$6R\8?%3XM?$+PS*P^T^&O$WBV6>PO1_RS\Z.)(I/W<GER#$G6
M,9H ZS6?@/\ $[3_ (9_#CP?\//C(/ '_"*:-%I-[>?\(M;:G_:WEQ0Q1R>7
M+)B+'E2'@G/F'TKJ/@9\/OB5X%N-;/Q%^*__  M(W(A%B?\ A&K71S8X,GFC
M]R3YOF9BZ]/+]Z]?HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_G7144 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7._\(KH
MO_"3_P#"2?V18?\ "3?8_L']K_94^U_9O,\WR/-_UGE;_P!YY><9YZUT5% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5SOB3PGHGBC[ ^LZ1I^L-IEY'J%E_:%JDQMKF,DQRQ%_P#5RC/$
M@Y_.NBHH **** "N=\-^$]$\+_;WT;2-/T=M3O)-0O?[/M4A-S<R$&264I_K
M)3CF0\_E7144 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7S?\;/\ BN/V7_V+O^$C(U_^V/&7@PZG_:8^T_;O.L9?.\WS,^9YFXYSUR:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% "44M% "44M% !1110 E%+10 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 445SOB3Q9HGA?[ FLZOI^CMJ=Y'I]E_:%TD)N;F0D1Q
M1!_]9*<<1CG\J .BHHHH **** "BBB@ HHHH **** "BBN=\2>+-$\+_ &!-
M9U?3]';4[R/3[+^T+I(3<W,A(CBB#_ZR4XXC'/Y4 =%1110 4444 %%%% !1
M110 445SFI>+-#TCQ!I6AW^K:?:ZWK!E_LZPNKJ-+F\\H>9)Y4?5_+!!..G?
MU(!T=%%% !1110 4444 %%%% !1110 445@>)O$^A^#=$N=9U[5M/T+1[<_Z
M1?ZI=1VULO.P"220@#GCGVH WZ*Y3P3\0O"GQ&TN;4O"OB32?$UC'+]FEN]%
MOHKJ%)0!^[\R,GGYQ^==70 445@>&?$^A^,M$MM9T'5M/UW1[@_Z/?Z7=1W-
MLW.PB.2,D'GCCWH WZ*** "BBB@ HHHH **** "BBB@ HK@?&/QH^'?P\U-=
M-\7^.O#/AC4I(_M"V>M:O;6DCQ]I!')("1\G7VKOJ "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHKG-2\6:'I'B#2M#O\ 5M/M=;U@R_V=875U&ES>
M>4/,D\J/J_E@@G'3OZD Z.BN<U+Q9H>D>(-*T._U;3[76]8,O]G6%U=1I<WG
ME#S)/*CZOY8()QT[^IZ.@ HHHH **** "BN=\-^+-$\4?;TT;5]/UAM,O)-/
MO?[/NDF-M<QD"2*4)_JY1GF,\_G3_#/B?0_&6B6VLZ#JVGZ[H]P?]'O]+NH[
MFV;G81')&2#SQQ[T ;]%8'B;Q/H?@W1+G6=>U;3]"T>W/^D7^J74=M;+SL D
MDD( YXY]JWZ "BBB@ HHHH **** "BBB@ HHHH **YWQ)XLT3PO]@36=7T_1
MVU.\CT^R_M"Z2$W-S(2(XH@_^LE..(QS^5=%0 445SFI>+-#TCQ!I6AW^K:?
M:ZWK!E_LZPNKJ-+F\\H>9)Y4?5_+!!..G?U(!T=%%<[XD\6:)X7^P)K.KZ?H
M[:G>1Z?9?VA=)";FYD)$<40?_62G'$8Y_*@#HJ*** "BBB@ HHHH ***Q]8U
MRP\.:7=ZEJ-Y;V.FV<4ES<75S((HH(X_]9([G@ #U]* -BBL?1]<L/$>EVFI
M:=>6]]IMY%'<V]U;2"6*>.3_ %<B..""/3UK8H **** "BBB@ HHHH ****
M"BBB@ HKG?#?BS1/%'V]-&U?3]8;3+R33[W^S[I)C;7,9 DBE"?ZN49YC//Y
MUT5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445@>)O$^A^#=$
MN=9U[5M/T+1[<_Z1?ZI=1VULO.P"220@#GCGVH WZ*** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&?A#;_&+6?"6F:-I&DW$^OVND/H%M<6LEQ*L1E!\PRR2RDR?ZR,9C!\N3%
M'T]\&OVLOA7^T!JFIZ9\/_%T6OZAIL'VJ> VES;3>42!YHCEBC,@W=?+SC>F
M<>8*]KK\_/B%X9^-WQJ^-GP>\5WG[.[?#O6?"_B6QFOO%]KXVLKNZ_L<S$W=
MH\<7EF6(B7/\>!YJ@?O9,_H'0!XI\9?VLOA7^S_JFF:9\0/%T6@:AJ4'VJ"
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MO N@?$G]K_\ 9:\/^*M,MM7T2Z?Q-++8W2YBE,5E;2QB0'[_ .\CC^3OWXH
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M ='K7[?OP#\-^&_#>MZE\0[:'3->AEN],9=.OI)9HHI987D,0A\R/]['*F9
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MT1;/Q!_PD]CJ\H:6;+VJQQ1^8@E$8D)Z?Z.G&0*]V_:&_P"3ZOV1_P#N;O\
MTUQ4 '[0W_)]7[(__<W?^FN*OJNOE3]H;_D^K]D?_N;O_37%7U70!P/PP^,7
MA?XR:;J=_P"$[^XOK?2-1DT>_2ZL;BREM;V,1F2&2*XCCD#*)5SD>W7(%?P+
M\8_!OQ&\8>+O#'AOQ%!JNJ^$Y8;76+6WCE!LI93)B,RD!)#^ZE'[L_NRA!]*
M\!^$4VG? +]L3XZ^%;ZZ_L[P[XJTNW^)-NTE\38Z?&'DMM3FG,I_=2RW.).,
MQ^6@R8_+$=>(?LQZA>_!_P"-'P@\?>(Y(-$O_P!H/3-<O-9TN&\\JQ74#?\
MVZQNAF642-+%=0VT47WX_-/6220$ ^]+_P")V@:?\0M+\ SZCN\5ZC937]MI
MMK;RRR1VD?\ R\2B/(MX\GRP\IC$DGR)SQ7&?LUZ3X TB7XK?\(!KU]K8NO'
M>J77B!=0BQ]BUAO)^TVT?[J/,<?[O!'F#G_6&O/OV>HS\6/VH_CI\5;G?<VF
M@WT?P[T-9F\JYM4LB)=0B\N/]W)%)<RQR1R2$R8R/W8P*L?L%?>_:,_[++XC
M_P#;:@ _8*^]^T9_V67Q'_[;4O\ P2[_ .3%_AG]=4_].EW2?L%?>_:,_P"R
MR^(__;:E_P""7?\ R8O\,_KJG_ITNZ #_@J)_P F+_$SZZ7_ .G2TK9\>?\
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M\N<<"O.?A3^VQ\%_CEXK3PSX,\<PZMKLD32Q6$EC=VN_8"7V&6*/S#CG8.<
MGM7@_P"TMKGBR^_;T\$V6A_#./XN3>&/!$OB'2-!NM6M=-.FWTE^8I+_ ,R7
M_68$5O&(SD XDC *9KG/VH-+_: _:8\#6MB/V8)/#?C#2KZ+4/#_ (NM_'UB
MUWH\T<L1>2+9Y1_>"/&/,ZA).L49 !^C5<-\2OBMX3^$?AN?Q!XU\1:?X8T6
M+(^TW\GE^9)L9Q%$#S+*1%*?+CRYQP*[FOCGQYX<A^(7_!2'P+I6O8O]'\%>
M YO%FD:?)!$T7]I2Z@+8RR?NBW \J48_U<D,;@C!H [7P'_P4"^ GQ*\7:7X
M:\/?$2&]UC4I/L]I#<:3?6PED_N>9+"B9Y&!FO7/B%\4/#GPQ_X1U_$>H-I_
M]OZM;:#IQ\B27[1?7!/E1?(._EGGIQUKS+]MCP+H?CS]EGXFQ:_I<.III>@W
M^KV1E#?Z/>V]K+)#+'QP1SWQ@E#UKY__ &G?^+U?LP_LD'QE_P 3G_A,/&7A
M'^V<GR!=_:K&7[3_ *K'E^9YDG^KQC/&* /:?^'B7[.W_"6?V#_PL_3_ +?]
MM^P>9]CNOLOF>;LW?:?*\GR_^FOF>7CG.*]"_:O_ .36?C+_ -B9K/\ Z0RU
MR_[2'P_\+Z#^QW\4_#NG^&M)TWP[8>%]4NK;2K2PCCM+>6.*2YBDCA $>1,!
M+_O\UR7_ #BS_P"Z-_\ N%H Q]:TGP!K?_!,_P &6?Q3UO4?#GP_D\&^'!J.
MIZ7'YEQ%\MH8MG[J0_ZT1#B,]?R^C_B%\4/#GPQ_X1U_$>H-I_\ ;^K6V@Z<
M?(DE^T7UP3Y47R#OY9YZ<=:^-/VD_P#E#CI/_8E>$_\ T;I]=[_P49\,Z;XR
M\*_ [P[K%O\ :]%UCXKZ'I]Y;%R@DAECNHY(\IR.": .J_X>)?L[?\)9_8/_
M  L_3_M_VW[!YGV.Z^R^9YNS=]I\KR?+_P"FOF>7CG.*^F:\ _:0^'_A?0?V
M._BGX=T_PUI.F^';#POJEU;:5:6$<=I;RQQ27,4D<( CR)@)?]_FO$?C9XJU
M#P?_ ,$C=,O=*N/LUU+X!\/:?(Y0.#!<QVEM,G_?N63\Z /3_$G_  4<_9S\
M)ZU<:3>_$^PDN(,;I=*M+J^M\$?P2V\4D;X^M?0VCZY8>(]+M-2TZ\M[[3;R
M*.YM[JVD$L4\<G^KD1QP01Z>M?'/AOQ-\:_ _P /;;P%HW[&6GVW@N"T:P&B
MGX@:9)!)#)_K(Y!)$?,$F7\SS,F0R')).3VO[ OPT\9?"/X5^*]#\5>&[CP=
M;/XKOKW0O#<VK1ZDNF:;*D4D=M%+'))P)/-/."26DQF3D [G]L?2? .M?LY^
M+K/XJZUJ'AOP#(+7^T]2TN/S+B+_ $J(Q;/W4I_UHB'$9ZUW?Q"^*'ASX8_\
M(Z_B/4&T_P#M_5K;0=./D22_:+ZX)\J+Y!W\L\]..M>%?\%1/^3%_B9]=+_]
M.EI6-_P49\,Z;XR\*_ [P[K%O]KT76/BOH>GWEL7*"2&6.ZCDCRG(X)H ZK_
M (>)?L[?\)9_8/\ PL_3_M_VW[!YGV.Z^R^9YNS=]I\KR?+_ .FOF>7CG.*^
MF:\ _:0^'_A?0?V._BGX=T_PUI.F^';#POJEU;:5:6$<=I;RQQ27,4D<( CR
M)@)?]_FNH_90_P"36?@U_P!B9HW_ *0Q4 <A^V-^TYX:_9Q^%VJQW_B5O#GC
M/5]'U+_A%F^PRW7G7\40\KI')&,220_ZW Y^M9?[(O[7W@7]H7PKX;\-6?B_
M_A(OB3;>'+:_\0V_]G2VV)@D4=S("8HXC^^E_P"67KQ7H?[5_P#R:S\9?^Q,
MUG_TAEH_90_Y-9^#7_8F:-_Z0Q4 ?+GP!_:"^'7[.-C\;=1^('BF#08-3^,W
MB6.RC:.:YFE*BVWGRH8Y), 8R^,#S(\D>8*^GO@O^T9\._VAK'5;[P#XG@\0
MV]C.L-[&(9K:6)F!*$QRQI( 0.),8)209^3CP/\ 8;^&GA6Z^('Q_P#'5WH&
MGWGBVS^*NO6-KK5U )+JUB0_ZN+C]W_Q]2Y\OE_,P>@QN6>CV.G_ /!4S49K
M.TM[6XO_ (2_:[N2*((;B7^UXHA)(1]\^7%$F2>D8'% 'K?Q;_:>^%O[/_V9
M/'WC:PT&\N@C1:?MDN;PQGS,2?9HA)+Y7[J0>;CR\C&?67X+_M&?#O\ :&L=
M5OO /B>#Q#;V,ZPWL8AFMI8F8$H3'+&D@! XDQ@E)!GY./CSX+^.OBC9_'#]
MH'QMX5^!5O\ %+6Y/&U_X<E\7GQ-8Z/+:65D8XX; 12)R$1(B91_K<Q^9DQB
MNP\*>#OB[XY_;2\ _%#5/@2/A1;VUC?6/BG5K+Q9:WQUB)K7%K'<10^7O\J6
M.,9V29_==HH\ 'W?7RI^P5][]HS_ +++XC_]MJ^JZ^5/V"OO?M&?]EE\1_\
MMM0!U/C+]MKX+?#_ $W4+_6O'%O81:?KUUX9N%>TN7D;4+4+]IA$8B,D@C\R
M+,@'E?O(_GYKIO@O^T9\._VAK'5;[P#XG@\0V]C.L-[&(9K:6)F!*$QRQI(
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M\O6+:*3]W(!(/WD<G4?XUV'[0W_)]7[(_P#W-W_IKBI?^"HG_)B_Q,^NE_\
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M\9=1U[X<GX4>$O$E_I]]HGA.WUF/4K6WE$4POI8O*.(O,_<G'EQ\".,?ZL8
M/L>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO\1R>%O$/PQ\3>&;C4WN=);Q5:WMO?65K+C%KBV'ED19($AWR2<D]HQ]3T4
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M\3_L]ZA\,?B9XFN/'LFKPWT&HZ])9QQ2S-<7,LL<L41\V.(Q>9&8L9$7E1X
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M-/VC/@CX_L9K"+1O _\ ;G]HQ7,K^?+]NM8X8Q$-G4$$G)'I7NM% 'A7Q/\
M@[K_ (T_:,^"/C^QFL(M&\#_ -N?VC%<ROY\OVZUCAC$0V=002<D>E>ZT44
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M^#.N_M#?L\>*OA_H$]A::OK'V;R)]2DDCME\JZBF/F&..0_\LL=.XZ5[C10
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MPK=/\2?%6G^*?$=]>2WH_LFP%C::=%(D?^A0C)DDBCD\S$LN)""-PXKTNB@
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M5\Q_ OQ5K>L?MC_M,:'>:MJ%UI&C'PS_ &;875S)+;V7G6$DDWE1DXB\P\G
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M6KZ*UA>4@_N_,D(Y^0_E1X)^(7A3XC:7-J7A7Q)I/B:QCE^S2W>BWT5U"DH
M_=^9&3S\X_.@#JZ*Y'4_B+X7T34;O3M2\3:5I][8Z9)K%U:W=[%%-;V,9Q)=
M21Y!$0.<R'Y,_J_P3\0O"GQ&TN;4O"OB32?$UC'+]FEN]%OHKJ%)0!^[\R,G
MGYQ^= '5T5YI_P -!?"__A*?^$;_ .%D^$?^$C^W?V=_9/\ ;MM]K^U^9Y?E
M>3YGF>9YO[OR^N>/:NSUC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>
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M !17FWAW]H#X6^,M:MM&\._$CPAK^L7!)@T_3-=M;FXFP-_R1QR9Z#]*])H
M**Y+Q+\1O"OA/5M'TS7?$NDZ+?:U+]ETVUO[V.WFOI,Q@Q0QR8\ULR1C R1Y
M@]:O>)O$^A^#=$N=9U[5M/T+1[<_Z1?ZI=1VULO.P"220@#GCGVH WZ**P/#
M/B?0_&6B6VLZ#JVGZ[H]P?\ 1[_2[J.YMFYV$1R1D@\\<>] &_17FWAW]H#X
M6^,M:MM&\._$CPAK^L7!)@T_3-=M;FXFP-_R1QR9Z#]*\>_X*B?\F+_$SZZ7
M_P"G2TH ^JJ*\V\1?M ?"WP;K5SHWB+XD>$- UBW(,^GZGKMK;7$.1O^>.23
M/0_K7I- !17GFJ?&KX>:1XP3PKJ7COPUI_BEY(K0:'<ZO;QW_F2E?*C$/F>8
M3)YD9  YX]:ZO6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_ %DCN>  /7TH
M V**X'P=\:/AW\0]3;3?"'CKPSXGU*./[0UGHNKVUW(D?>0QQR$@?/U]ZW_$
MWB?0_!NB7.LZ]JVGZ%H]N?\ 2+_5+J.VMEYV 222$ <\<^U &_17*>"?B%X4
M^(VES:EX5\2:3XFL8Y?LTMWHM]%=0I* /W?F1D\_./SKYZ_X;H\$?\-.?\(9
M_P )_P" O^%<?\(=_;'_  D']KPY_M/[=Y7V;[1YWE?ZK]YY>/,[]* /K"BL
M?1]<L/$>EVFI:=>6]]IMY%'<V]U;2"6*>.3_ %<B..""/3UK*\2_$;PKX3U;
M1],UWQ+I.BWVM2_9=-M;^]CMYKZ3,8,4,<F/-;,D8P,D>8/6@#K:*P/$WB?0
M_!NB7.LZ]JVGZ%H]N?\ 2+_5+J.VMEYV 222$ <\<^U;] !17A?QVU#1/BM^
MSKKEUX?^,=C\/-(OS"+?X@:;J48MK,1W4>=EPDT0_>>68N)1_K".>E<1^WK]
M[]G/_LLOAS_VYH ^JZ*^5/VAO^3ZOV1_^YN_]-<5?5= !17RI^WK][]G/_LL
MOAS_ -N:]@_X:"^%_P#PE/\ PC?_  LGPC_PD?V[^SO[)_MVV^U_:_,\ORO)
M\SS/,\W]WY?7/'M0!Z7117FG_#07PO\ ^$I_X1O_ (63X1_X2/[=_9W]D_V[
M;?:_M?F>7Y7D^9YGF>;^[\OKGCVH ]+HHHH **\T_P"&@OA?_P )3_PC?_"R
M?"/_  D?V[^SO[)_MVV^U_:_,\ORO)\SS/,\W]WY?7/'M74^)/%FB>%_L":S
MJ^GZ.VIWD>GV7]H720FYN9"1'%$'_P!9*<<1CG\J .BHHKG?#?BS1/%'V]-&
MU?3]8;3+R33[W^S[I)C;7,9 DBE"?ZN49YC//YT =%17FWAW]H#X6^,M:MM&
M\._$CPAK^L7!)@T_3-=M;FXFP-_R1QR9Z#]*R?CQH*:U)\/2OQ+'PW^R>,=,
MNSMN/*_X2#RS-_Q)_P#6Q[_.Y_=_O,^7_JS0!Z_17RI^WK][]G/_ +++X<_]
MN:^C/$WB?0_!NB7.LZ]JVGZ%H]N?](O]4NH[:V7G8!))(0!SQS[4 ;]%<3X#
M^+?@SXG27X\'>,M!\6_81']J_L/48KX6_F9\OS#$3C/ER=?0UX5^T-_R?5^R
M/_W-W_IKBH ^JZ*\V\._M ?"WQEK5MHWAWXD>$-?UBX),&GZ9KMK<W$V!O\
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M0(X\2#]YYO4,,57ME[/VE/;D_G_]L,_8OVO[Q_\ DAD?&#_D[#]G[_=\0?\
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M*UA>4@?O/+C Y^0?E5SQ-X8T/QEHESHVO:3I^NZ/<'_2+#5+6.YMFYW@R1R
M@\\\^U;]% 'PY^PS\&_A]?:E\:M3G\#^&7U#0?BWK=KH]T^D6WFZ9'$;;RH[
M9_+S$(SR@C( /3%4OC=\%/#GQZ_X*+67AOQ<+^[\.K\*H[NYTNTOY;6/4/+U
M>3RX;GRR)#$)'CEQD?O(8SSC%=9\,?"7QC_9W^-_CG0]*\":?\0/AQXW\82>
M*?\ A);75X]-N=&^VR@7236\I/VGRO+C($?4=R9/+C] _P"%8^(O^&\O^%B?
MV8?^$-_X5M_8']H^;'_Q_?VGYWE>7GS/]7SG&.W6@#QW]K+X.>!_A#XR_9U\
M5>!O"FE^"M?'Q+T?1Y+OP["FG/+97/F_:89?*V"02",#]YG@R 8$D@*?\%$/
M$S2^(O@S\/-?T'Q1XK\$>)=3U'4M<T'P5#))JNI+91QR0VL<0D421;YA)*.N
M(1)&8S'7L'[7?PS\2_$AO@S_ ,(WIIOQX>^)&C^(-2;SXT^SV5MYWFR?.1DC
MS!P.:D_:2^#'BKXD2>"/%_P[U'2=&^)_@;4Y+K2;K7HI9+"ZMKB+RKZVD$7(
M66,C]X(S)^ZPGE[_ #  ?(OQJO\ X:^/?ASJ5KX-_9*^*_@+QO8K]O\ #^O^
M'O $>D7=IJ48)MG$EO)YAC$F/,ZXX(Q((R/O[X,:EKNM_!_P)J?BI9[?Q1=:
M%8RZM%>6_P!GE%Z]O%YPDCP/+;S"<Q@#![5X7+\8?VI/%!&F:?\ L]:%X*OY
MQ^ZU[Q'XWM;^PM2.?WMO;1^=)D?N_P!WW<5]9T ?*7_!0SP?J^O?LXWGB?PX
M\Z>)? .IVOC/29H6B_=RV1/F2R"48<1Q232>7W,0Z_ZL\-^V9H*?M=:+\&OA
MWX=@N;K2/&R:GXMLM>C,D<=J+;2I/L4MPAAS'#+-J%MYA(!'^KQOD%?9VL:'
M8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M?'G[&'[-7C7X6_$_5M
M0\?6NHA?"GAH>!O#6M/J44\>M::=4N[K[285DDEMO+C^PQQQ&3]VF>O_ "S
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M[6OVM/ G@[QKX&\7_$SP7H/AL^+H_"O@[2S?R7FHR71MHY+^W$GERVT,<7'
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MTUO/C?[197/D^5)\A."?+/!YH ^AZ*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH XOXK>!%^)/PM\8>#A=?86\0:1>Z7]J\OS/L_VF*2+S-G?'F&CX4^
M!%^&WPM\'^#C=?;F\/Z19:7]J\OR_M'V:*.+S-G;/EBNTHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#D_'^BZUX@\*WEEX<U\^%M8EV"WU7[%'=>0=X_Y92<-QZUY&WP;^.1Z_M
MJ?\ N2[+_P".5]#<4O6M8590Z'-4H0J'SW_PI_XY_P#1P?\ Y95E_P#':/\
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M (Y_]'!_^659?_':]^\A?;\C1Y"^WY&CZY5[+_P"'^0?4Z?G_P"!S_S/ ?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ&/-Z^:<??'A?PIIW@CPKH_AW1[<VNCZ39Q6-G;^87V0Q1B../+_ .R /PH
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M\D,I,ADP4EBC*?NHS7N?[&^BK\*?CA^T!\'M#U+49/ OA&\TB\T+3;Z4W/\
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M9_#/XHQ:G]M\)7\LMU'IM[8V/F_:K6623S 9?D$F<\#DG]T(@#[CHK\_-,^
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MU[XGZ]<^)/+U",FYL]/,ABL;4SR8DFBBBB$D1^1/+G_=KW(!]6T444 %%%%
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MXZ\#Z)_;$KZ5<>7Y=A++^[DB$/V:,>5O/3H$$<DG3_L8Z=\4[W]HK]HCQ?\
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M3K\,ZOX+_8[^'VB>(=+U#0]7M6OQ<6.IVTEK<0DW]S(/,CD&1D$'IT-?3=%
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MN/%?B/QE;Q:5<M9QRR2R6UM;2QRF0DQPD2QYQ(%60"(DGUSXZ>%=;UC]L?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9/\ @GO\)_AW\#?'?C73G\2O\2-!TV^\3V_CJ\U^Y_M5[Z(R7<<LG/EDF2,
MD1^9CG/F?O*[O]I'X0ZCHW@;]F?PGX2TS6->TWPC\0_#,<K1VYN9K:QM8I8V
MNKDQQ@ 8QYDF!&#Z9KVW]I;2KW6OV=?BCI>G6<^HW^H>%M4M+2UM8_,EGFDM
M95CCCC[G) Q0!\U_M$?M'>(?"?["_P *==OO$MUX<UKQ]%H6FZEXULXR9-(%
MS;"YN[](HXQYA\N*4>7%Y9'F?NR"E?/GBAOV#M5TN6[T?XE:]HWQ$P+NW\?B
M+7+C4X]2!\S[?+^["22F7]Y)CR^_E^6>1]3>*_@KXM\7?L7?!>UT#31#\1_
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY8CU&U2Z,<<HE\J0_P"MCWC@[#E,^QKA?B=_R<1\%_IK7_I+%6%\!9/^%?\
MQ$\=?#1WE72[&6/5]"@G60_Z++_K(XI)"08HY#%'USYAD_!_8#[9Z]XP\8:=
MX&\,ZGKVJ2F*PT^W,TIS]_ /R#GE^,?C7D?[.GCKQQXL\6>-K'QO=0_:[&/3
M+F+3H+81?8/M,4LIB_YZ_P#/,?O?^>9J[\;;5/B5XX\)?#5&D^QRR#7-;:.>
M2/\ T.(D11;1Q+YLN.AS'Y?F=A5[X8_\G$?&CZ:+_P"DLM'V!GLE%>-_\W@?
M]R'_ .Y"C]K[_DW?Q9_VZ_\ I5#2Y0N>R45XO^T[J&H:9X#L)[75;W1],_M>
MS37-0L'\JXM; R@22Q$?O,[S"/W?.">V:3X>_ _X>^'=:TOQCX%E>V6..:$2
M:1JDEQ;:A%@Q8DRTGF^7@D<_ZP<T#/::*\$\6Z>?C?\ %#6?!.H7%S;^#O#E
MO:RZI9VLODS:G=RCS8XI>N;;RA_TS/F_2MOP?\!-!^&?C"WU?PA=7?AVWFB$
M6HZ3YIN+:^C'F?\ /4F3S?-D0^9GD C_ ):&@1[!17DOQ4^'^C>,)/[3\7^(
MKBT\&VUO'%+H[WWV'3Y9#-S+<R<&7D0^6#@ Q]_,KSGP?)X/^'_QN\&Z-\,]
M;M;O0]>M]0AU+2K+6#>VL4D<44L5SY7FGRY<1^5Z>7]*KE"Y]045\W_M*:)K
MGB3XI?"?3?#^KC0=5N?[7CCU$#/V=/*A\TC_ *:>5YF/QKT7P+\$_"OP\UJ7
M6]-LYY=:N8#;WFJ7-Y)+-=Y82/)+DD&0R(,X_P#K5(S9^&=GXGT[PC9VWC'4
M+;5/$<9E^TW=GCRI/WA\LC$<?/E^7V'.>O6NRKQO]D'_ )-W\)_]O7_I5-7C
MW[-OP/A^(7PMTN]\:ZE<:WX>/F1:1X?CN)(K6W FD\V23RR,RF5I0#T$9_"-
M\HC[%KC_ +)XI_X61]N_M*U_X0K^RO*^P[1YOV[S<^;_ *O_ %?E\?ZSKVKR
M_P"&6AW/PL^->H?#G3M0FN_"$VC_ /"065G=9>739#<^488I/^>6#T/\_,,F
MY_S>%_W(?_N0H ]DI:\#\6Z>?C?\4-9\$ZA<7-OX.\.6]K+JEG:R^3-J=W*/
M-CBEZYMO*'_3,^;]*V_!WP$T'X9^,+?5_"-U=^';>:,1:EI/FFXMKZ,>9G_6
MDR>;YLB'S,\@$?\ +0TAW/8O6O!_'FH>-O$7QZ@\&^&O&?\ PB=A'X9_M64_
MV9%?&23[5Y7_ "U]J]XKYP^(&O:_X=_:DBNO#7A<^++^3P7Y<MF+^*Q\N+[?
M_K/,DZ_3VH@34#Q1KWQ0^ JKX@U_7+7XA>#8Y(4U.3[$EAJ%N';R]\:1?NY.
M3%P>O3]V,R5]&U\KZGXF\2_&[QPOPO\ &FG6?P_L=EM?W6BW,ANKO64CE\WR
MX;F/RXQ%^[_Y9_O?W1_Z:B+U/X_>/+KX;^!XIM,O+73M5U:_BTJROM0 ^RVL
MLN29I?2....0GZ4QGJ^11FOES_A7/P-<"_N_'EM?^(QA?^$EN_%N;_S03Y<H
M?S?+\R,#C]W_ ,LQQ5[P;\;+KPO\ _%FNW5Y_P )%/X4OKG1K;5.)!J3><B6
MTN,\H?.BSB3L>:/9B]H?2=%?/J?LG^%O$.E7.H>.'OM>\7:E$9;[6#?RGRYO
M+P!%M$<7EQ'/E>9'Q74^+O$UU\#?@OJ^HZAJ5QXENM)M_)M;J^4M),7E6*V\
MT_\ +3!EC\R3V)I6'<];R*,U\K6O@CX/>)K*WO\ Q]X[TOQCXHEC7[3?W/BG
M$<,A/[R*U\N6+RHO,\SRQCCFNQ^ 'BR2[U+QKX27Q+-XQL=!N8)K+7Y[M;AY
M8;F/S1#YHXD,920>9WS_  8Q1R"YSWC-&:^1OAG\*9OB9XN^(S:_J=S)X+C\
M5:E#_P ([;W4D,=[<^9&3)-Y>/W>!'@>OMDR='J'@FW_ &=_B%X-OO#%[J-I
MX0\0:L-&O]!^U>=#]IEB_P!&EBBD'7S(LR2&3S#[C.'R![0]<^)'Q#/@#_A%
MU%D;\ZWK=KHV?,V>7YV?WGX8KN*^8?VEO@[X1N/$/@O6I]($^I:YXLTS3-2G
M-S*#-;&,Q^5@2 ?\LXO_ *]=EK7AWPG^R[\-?%OB/POHOV.7[-'F%9I;GS)<
M^7"/WLOW/,E'<=30,]LHKP73_P!EG1O$.GQWGQ%N+KQIXKER]QJ$E]<Q0Q=/
MW<4<<D>(_:I?A&VI_#CQYJ/PKOM2DU>PMM/CUG0;R2',L.G^:8C:R_\ 7,X$
M9]/^_80SW6BOE4_#W4_B%^TI\3[&77+K3?"L1TR35["V8PR:G_H.(8?,_P">
M7^M\SUX_[9^R0?#NV^&7PU\2Z9\/=-73[^2WN;JQA\PR@WODXC_UF>\<?7CC
M\: /2:*^3_A5\&_AU\7O ^DZRFN:CJ?CF2"VO-3\00ZK+_:MI='T$G^J \HQ
MQYC_ -7'QV>OK"H+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV5OI]A",16]M$(HT_ <4FCZ+I_AO3XK#2[*WT^PA&(K>VB$4:?@.*T(/+?\
MF\+_ +D/_P!R%'_-X7_<A_\ N0KT[^P]-_MC^U_L%K_:?V;[-]M\D>;Y6=VS
MS,9V9H_L/3?[8_M?[!:_VG]F^S?;?)'F^5G=L\S&=F:0CPN^\5:/\(_VB?$T
MGB"Y6STOQG8V-S;:C<(\4,=S;XMOLW .>,2^9P(\\^M>BZ;\8O".M>,-/\.:
M-K$?B+4[B/SLZ7_I<5O$!)^\DDB_=Q#(\ODYS)'ZUV>L:+I_B33Y;#5+*WU"
MPF&);>YB$L;_ ('BJ7AWP7X>\)QS#0] TW0_M'^L&GVL=MYGO^[ I@=%7C/_
M #>%_P!R%_[D*]FK(_L/3?[8_M?[!:_VE]F^S?;?)'F^7G=L\S&=F:S-#R3]
MI329;7P_I/C:P@NIM4\'7\5\D-J'\RXM3+']KAZ?(AB&3)V\NIOC]H$OCCP#
MI>JZ3:0^)TTG4K37HM)B\N6/58H^)(N>,&.1N?GZ 8->MWUC:ZK:2VMW;QW5
MK<)Y<D,B>9'(GH?SHL;&UTJTBM;2WCM;6WC\N.&-/+CC3T'Y5ISF9XKHNL?L
M]ZUIT-Y"OP_590<&ZM;6VE_[]R 25'XR\.>&_B9^S3XFC^'EK;VNF:C!)?6\
M>DZ:(_M4MO+T$7[H^9(;81<XKTF[^$_@F\NIKJ^\&Z!=W%Q)YLL\VFPRR/)Z
MDF/)^M=G1S@>.^%_VEOA_P"(/!\.MW'B73M*N%MC+=6-Q/\ OXY?*$DD<<?W
MY< _\L\YQQZ4[XBZ=_POKX"ZU%H,5U"=4M?-LOM-OY<EQY4HEB!$@_U<OECK
MVDKL]6^%WA#Q!?27VJ>%M%U&_D&)+F\TZ*623\2,UUM 'SSX3USX%ZSI$<FH
MZ'X'\/ZG'^ZO=+U2QM;66TN1@RPGSHXR3'TR!7HGPHNO >I6FJW7@2UTJ*TC
MNOL-Y-I=D+:.2:,=#@ 28\SKSUZUJZM\+O"'B"^DOM4\+:+J-_(,27-YIT4L
MDGXD9K?L;&UTFTBM;2WCM;6WC\N.&-/+CC3T'Y4 ?,?P<^,&C^#/'GQ"\,^(
M%&B6M[XKU2ZL=8NYO*LY9?-Q+%YG'ER#,9_[:^N#)T7C+Q98?'#XC>$?"OA0
MMJUEX9U:U\1ZOKEJX>TMQ'YGE6V<G?))GG'X9_>>7N?!SP3YUE\3;#Q+H9DL
M]2\97]U';:M:YCN8#Y7ERXD_UD?'!]J]1\.^&-'\+VDEMHFD6>D6LC^88;&W
MCACW^N$% 'E7[4=U#I.A^!M6NUD_LW2?%VFZA>SK&\GV>&/S,R<=AQ^=6?BE
M-H_QX^&?B_POX2UJSU;5H[6&X7^SY8YHR_F^;%'YG,?[PV^.>F<FO6;ZQM=6
MM);6[MX[JUN(_+DAD3S(Y$]#^=9WAWP7X>\)QS#0] TW0_M'^L&GVL=MYGN?
M+ H X3P7^T7X-\5:"+K5-8L_"6K12-:WNCZW<Q6MS;31_P"LC(D(S7-_"^_;
MXK?&+5?B1IUK<6WAJUTK_A'=*DO(S_Q,L7)FENH^?DC!S&..<#N-@]1U;X7>
M$/$%])?:IX6T74;^08DN;S3HI9)/Q(S76T >.?#'_DXGXT?31?\ TEEKT'QA
MXRTGP/X=NM:UJY.GZ5:E/.F$<D@CS($Y\L$]2*N6N@:;97U_?06=O%?7OE_:
M;J.("2?RQ^[WD<O@9_E5F^L;75;26UN[>.ZM;B/RY(9$\R.1/0_G69H?-7Q\
MOOA!XD\,ZIXBBU_1X_&EA;&YT[4]'U&/[>UR/+$6/+/[SF*'DY\L?\\^M?0'
M@O\ MG_A#M#_ +<_Y#WV*+[?G9C[1Y8\W&SC'F9Z54TGX7^$/#]]'?:7X6T7
M3K^,8CN;/3HHI(_Q S76UH9CZ***S- HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M01ZU](?$/P=8_$;P'XD\(ZE+-#9:_IEUIER]L?WB12Q&*0IQZ/0!\_\ P_\
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M\/?A-X(T'Q?\5+C29-0FU3Q%/]GM= TR2^MHI)I.%>6.5XSF.*3S ;:-]DN
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MQ]%_P4&\%77C;]C/XHZ78201RP:?'J?^D'CR[.>*ZD'U,=O)BNPAOM%_:N^
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M9_W1O_W-4 ?17B[Q&OA/PQK.N'3K_5FTVSEN?[/TV(S75QY<9?RHH\_O)#C
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MM/N"(Y(92/M-G-_RTMYHO^6;CZ]P1E,9].KY4_8*^]^T9_V67Q'_ .VU?5=
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M1_!OQ6^'WP_O;._FUKQM]O&F36R(;>/[%")IO,/F9'!'0'TKR#_G*9_W1O\
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MQHM?C=X3N]2AL+G0]<T?4KC0->T6[?S?[.U*W_X^+;S8QY<V,@B6/@@CO\@
M-?XX7FAZ7\%_'=UXJL;C5_"MMH5[-J]C9_++<6(MY#/%&?,CY,>?^6@^H.#7
M WWQP\!? O\ 9)\._$RVT;58OA[I^@Z3-8:3:^7+?1V4WV>*V0^;+R8Q-%G,
MGKR>_5?M7_\ )K/QE_[$S6?_ $AEKY6_:3_Y0XZ3_P!B5X3_ /1NGT >CZ]_
MP42\"6T_B>30/!?Q!\?>&/#CRQWOB[PGH27NC%H8_-D NO-'^K!'S\#_ ):
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M.M>PT4 <7\5O B_$GX6^,/!PNOL+>(-(O=+^U>7YGV?[3%)%YFSOCS#7*_\
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M]@_VA]ID_P"/'S?.\KR\^7_K>>F?>NTH \>\>? V3QU\;OA+\16US[ _@/\
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M\77-O<^(/$FL3;#<S11%(XXX8\1Q0H7E\N(9V!Q'YA$<>.\^%/PO\-_!_P
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M6\%>.?"-S<7/A_Q)H\V\VTTL022.2&3,<L+E(O,B.-X0Q^8!))GW*B@#Y?\
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MNK:U^,OQ^UWX@>$(,22^'-+T>+0+>^D$T<@%U]GDQ+%^['& XSF.2/O]C44
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M%/@1?AM\+?!_@XW7VYO#^D66E_:O+\O[1]FBCB\S9VSY8KM** /'_@/\%?\
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MAU#P3^TEK7AW1-4U.34X=&UCPY;:T+)I>9(HII9,^2#_ *N+ $8P.3F0^K?
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MW*BL#Q-XGT/P;HESK.O:MI^A:/;G_2+_ %2ZCMK9>=@$DDA '/'/M7SOI/\
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M *U^W[\ _#?AOPWK>I?$.VATS7H9;O3&73KZ26:**66%Y#$(?,C_ 'L<J9D
M\SRWQGF@#Z8HHKEO'/CG0?AGX3U+Q-XFU:WT?1=/B\RXO;@G">GN>?X * .I
MHKQ3X-?M9?"O]H#5-3TSX?\ BZ+7]0TV#[5/ ;2YMIO*) \T1RQ1F0;NOEYQ
MO3./,%=;\,/C%X7^,FFZG?\ A._N+ZWTC49-'OTNK&XLI;6]C$9DADBN(XY
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M!^&_#?AO6]2^(=M#IFO0RW>F,NG7TDLT44LL+R&(0^9'^]CE3,@'F>6^,\T
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M>]?M'?%:+X'_  1\:^-Y)+>.?2=-EFLA<P/+%)>,/+MHY!'SB262*/\ '.:
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MG&:_0+X1_$?1_C%\.O#OC30KG[3I&N6:7D&73>F?O1/Y;,!)&<QR#/#QD=J
M.ZHKX#_X*2:M>_$.%/A'IMY<0Z9I_A77/B!XHM[.0Q31VUE;2_V:)"?W<L,M
M\0)(@))/W44G[O&^OHGX!_VS_P ,9_#;_A%_[/\ ^$F_X032O[,_M7S/LGVC
M[!%Y7G;/WGE;^N.<9Q0![G17P3XD^#]Q\/\ ]NS]G;Q#XB\37/C'QMX@G\4_
M;-2\O[+:0VL5A_H]K:6OF2>5%")I#@F222266220]OO:@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[.4BS%;QR>6(XLB3,8R?,>0>80#F?V;/^4..K?\ 8E>+/_1NH5ZI_P XL_\
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MP-HW@^RL_P"QK+QEI>FWO_"1QV40/V<I%F*WCD\L1Q9$F8QD^8\@\P@'8?\
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M^TN;[)<RV5MI\KE X,-S=16TR?C'+(/QKI?^%/ZY_P -G?\ "W//TW_A&?\
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M:U&?,D6+?)'YLO,D9BR,B0N <Q^SS_R?5^UQ_P!RC_Z:Y:/VAO\ D^K]D?\
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MZ,LN9)+G!\KRI(Q&(R2)8S))D [?]H;_ )/J_9'_ .YN_P#37%7U77A7Q/\
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M7[3_ .U%>Z_X'A^'>LW4GAZYO?#EOJ$5]]GEDM;J0R>=$/+D,I/FY'>6M_\
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MRQNCLOXH1&1';6T-X-L46(S^]D/[P'?7=_\ "G]<_P"&SO\ A;GGZ;_PC/\
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M-+_9QU#X@06=K'XO\"ZIIVL>&]::+=)IUR;^VC)&<AA@\QR#RSB/(/EC%/\
M:Z\"Z!\2?VO_ -EKP_XJTRVU?1+I_$TLMC=+F*4Q65M+&) ?O_O(X_D[]^*B
MU+]F?XS_ +0WBKPU/\?/$W@Z3P5X;U6VU>/P5X-TR2XM=3NH3,-US+>Q^8BX
MF"&/]Y')'D8B/[P^N_$_X.Z_XT_:,^"/C^QFL(M&\#_VY_:,5S*_GR_;K6.&
M,1#9U!!)R1Z4 >6_\%,/"^B6?["OB^&#2-.CL]$_LS^RX8K6/R[#_3;6(&(
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M\8OAUXB\%Z[;?:=(URS>SGPB;TS]V1/,5@)(SB2,XX>,'M7D_P"QG^S[XG^
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MABU'7O#]_I5M+/\ ZN.2:VDBCW^V9!F@#Y0^-GBK4/!__!(W3+W2KC[-=2^
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M/RO!NI_VO9:;:W?EV4][E?*EN(\?O&B(_=D$8\V4'(D->JT4 %%%% !1110
M4444 %%%% !7-?\ "+Z<_C#^WWMFEU;[ +**ZDE+B&+S?,DCC4\1^81&9#&/
MWGDQ;\^5'72T4 %%%% !1110 4444 %%%% !7S]\6?V1?!OQ1\72^,;;5?%'
M@#QS?11VUUXG\#ZK)IM_=6T8'[F;&8Y!Q'R8_,_=1#.(\5] T4 ?-WPN_8G\
M(?#OXF67Q"OO$GC'X@>-+!#!IVM^,M;DOI[&$I+')%%@1C!%Q*,2^9CM@U](
MT44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=&\1?$CPAH&L6Y!GT_4]=M;:XAR-_P \<DF>A_6ODC]I/_E#CI/_ &)7A/\
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MU/7;6VN(<C?\\<DF>A_6O2:^<O#_ .PO\$--\-W^E7W@BP\67.HO--J>N>)
M;W6+Z>6,1RW!O),RQR.07S$8QYA+H$-9?_!-G6+_ %O]BSX97.HW-Q>R+!>V
MPEN)/,(BBOKF**/GM''%&@[8% 'U#1110 5Y#\/-":T^.7Q7U#_A9G_"3-?'
M1\>"OM)D_P"$6$=L1_JO./EFZ'[W_5Q9Q_RTZUZ]7RI^SS_R?5^UQ_W*/_IK
MEH ]M\8_&CX=_#S4UTWQ?XZ\,^&-2DC^T+9ZUJ]M:2/'VD$<D@)'R=?:N^K\
MY9_#GA7X"_%[XK^)/VC/A6OBWP_XG\3RZG8?$R\TS_A(M.LM.P/LUK<1XDEL
MO+\V&&,^7^\,GE_ZN%)*^[/AWIWA_2/A_P"&;#PI/:R>&+73+6WTF6UN/M,)
MLXXE6+RY<GS 8\8?/.0>: .NHHHH *X'QC\:/AW\/-373?%_CKPSX8U*2/[0
MMGK6KVUI(\?:01R2 D?)U]J[ZOSTUSQO^SI8_&+XAVUC\&/&7[0'C3^TI?\
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MS##_ ,2?_6R;/)X_=_N\>9_JQ7F?[//_ "?5^UQ_W*/_ *:Y:/V"OO?M&?\
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M#WPSXN_9Y^(^IZWX=TC7-1T3PMK%UIESJ-E%<36$WV20^;%))_JSF.,Y&/\
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MS/E^88B<9\N3KZ&M?Q-XGT/P;HESK.O:MI^A:/;G_2+_ %2ZCMK9>=@$DDA
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M_9T5L4FB,<SZI',99/,C/RNYD#R21/\ ZS#C[3_X*B?\F+_$SZZ7_P"G2TH
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M1++)')((O+@D,9(R8B#D&O>:* /B/PGXV_:^\*^!]'\"+\'-#U;Q-IYBTO\
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M;SXW^T65SY/E2?(3@GRSP>:?_P *Q\1?\-Y?\+$_LP_\(;_PK;^P/[1\V/\
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M&6EZ_%<VVI_9C'%;;+49EC\R$;_,D[Q']W'Y@0>=>"? 7QX_9%U#5_"_PW\
MZ1\6/A->:A>7VB:?_P )"=.U'0]YB(MC+=R/'Y61+@1B0O(9))#'YFRON2B@
M#X_^$_P@^+?Q&_:"TWXU?&?3]*\-2:)IMUIWA?P;I5]+<_V69I91+=74OF&(
MS>01&3%D2"2,D1>5BOL"BB@ HHHH \5_:S^"][^T%^SYXQ\ 6&H6^EW^KI U
MM<7"AXO,BNHKB,/[.8@GMGOTJ/\ 9\\??&#QCINHK\5?AE:_#O4+&.V\I[76
MK;4(M1D(D\[RXXB3;X(CXDD?_6 =B:]NHH ^?/V%?AEXD^#?[+/@GP?XPTW^
MQ_$.F_;C<68GCF\KS+ZXEC_>1$QD^7(AX/>N7^)GPW^*'PK^/&M_%OX2Z#I/
MBVT\1Z7:VGBKP7?ZA]@NM3N;<F*UNK:ZD\Q(S'')AXSY<>R,_P"LDD!C^JZ*
M /G?X7^/OC]XX\?:8?%/PHT#X9>#;4R_VF]_XCCU?4;_ #')Y/V4VP$<0BE"
M^9YW42?N^0:Y3XY^ ?BIX0_:6T'XU_#+PII_Q#CD\-R>#]7\+W>H)IMRD7VF
M2ZCN8KB0^7_K?*!!!.!P#YGF1?6=% 'PYI/@W]H7XE?M=?"#XD^-_!VC^&/!
M6A1ZJB:'9ZO#>W>D-+930M+<RC'F_:93%L$/F".., B,B0R>C?M4_#'Q]J'C
MWX4_%;X9Z3I_BCQ'X!O[XR>%[V?[)_:=M>Q1VLWEW!(CCDCC&1Y@QU//E^7)
M].T4 ?)W[4'A+XG?M'?L,^)M#'@ >'_B/K+6H'A7^U[:Y,7E:G#)_P ?68XC
MF*+S.O?')KKOVZOAEXD^,G[+/C;P?X/TW^V/$.I?83;V9GCA\WR[ZWED_>2D
M1@^7&YY/:OH.B@ K\WO%WPMUKX=_\$NO#?P?\:6L^A^/=>U2/0=*TFV,5T;G
M4I=6ENK6V,HD\I!*D0S(9 (P?4",_I#7EGQX^!.@_'[PA::)K.H:II,FGZE!
MJ^GZIH-W]EOK&\B!$4L4F.&'FR<G^_Q@X- 'S#HOPK_:I^&?V_Q+HW@_]GC4
M?&,MG(;_ %6QTR]M]8UJ4_O9/-EC6*/S)I8A(<F./S#GCK7T[^S;\:[+]H7X
M+>&/'^G:?-I4&M1R_P"A7$GF&*2.66*0;\#>-\3\^G->,ZG^RW\?/%4*:?XC
M_:LU6XTB22,WD.A^$;+1[Z2-'WCR[N&3S(C[CWXYKZ ^$?PXT?X._#KP[X+T
M*V^S:1H=FEG!E$WOC[TC^6J@R2',DAQR\A/>@#NJ*** "OBW4? _Q@_9E^.W
MCWQ#\*? L/Q,\ _$"7^U[G03KW]FR:3JY.)9Q)<2&-UN-SR'8 <B./\ =B*/
MS/M*B@#YS^$6A?%SXJZ3X^B^/&@Z'X>\+^)[+^S++P7I=[YUS:VI^U17(N;F
M(_O))8I+8>9%(/\ 5\1Q'.?*/A;;?M/_ +,/AFV^'D/PWTKXX^%-)C\K0]<L
M?$\>E7<=OYTV(KI+K?R(_*\N.(>7%&!'YDG;[CHH ^0/@G\-_&?P_P#$WQ$_
M:+^.^JZ-9^)[G08H#9:(]U<V_A[2;:(37404RR<F2/S)(X_,_>12&.0^::^?
M?V7_ -GOXX:;\+_!^K>'?#_P4\1:/;C^T_".J?$71YCKMC8RS275M^\M?,\K
MF4W(C\V0Q_:2/,XP/TA\4>%-.\;^%=8\.ZQ;FZT?5K.6QO+?S"F^&6,QR1Y3
M_9)'XU\PZ/\ LF_&+X?Z9%X<^'G[3&L^&_!NF1QVNF:7KGA*PU>Y@C"C$?VJ
M0H9%!XCX'EQ[(_\ EF#0!V?[,GQT\6?$+7_B'X#^(NAV.B?$/P/?6\6IR:'*
M7TR]BNA)+:S6QD)E'[N/E).F0>,F..3]D3X9^)?ANWQF_P"$DTTV \0_$C6/
M$&FMY\;_ &BRN?)\J3Y"<$^6>#S6W^SM^SO9_ +0=55_$.K>.?%&N2Q7.M^*
M=>F$M]>RQPQPB/S.9/*C\L^5'))(8_,<>8:]LH ^>_\ A6/B+_AO+_A8G]F'
M_A#?^%;?V!_:/FQ_\?W]I^=Y7EY\S_5\YQCMUIOP9^&/B3PK^U)^T#XPU/3?
MLWA[Q6/#YTF\\Z-_M0MK&2*X_=AB\6)#C]X!GM7T-10!\F?'/P#\5/"'[2V@
M_&OX9>%-/^(<<GAN3P?J_A>[U!--N4B^TR74=S%<2'R_];Y0(()P. ?,\R+9
M_:$\ >./C!X;^ .H6WAAK+6-'\=>'_$WB#2QJ44HTR**.4W(\S($OE-(!^[_
M -9R0*^FJ* / OVR_@E?_'7X':CI>ARW%OXTTB>+7O#=U:S&.:'4[;+0B.02
M1^69!YD0D)Q&9?,_Y9BJ'[+OPW\3>%_^$]^(OQ!TTZ7\0_'^L'4;_2UN(YFT
MZPM\PZ?8B6(^5+Y40_UH"$^;^\Y%?1E% 'RI\3/AO\4/A7\>-;^+?PET'2?%
MMIXCTNUM/%7@N_U#[!=:G<VY,5K=6UU)YB1F..3#QGRX]D9_UDD@,?1_"_Q]
M\?O''C[3#XI^%&@?#+P;:F7^TWO_ !''J^HW^8Y/)^RFV CB$4H7S/.ZB3]W
MR#7T110 4444 %?/7[8?PF\5_%+X?>'+KP,=.G\9>"_$MGXOTRQU9#]FOYK7
MS<6SR;P(]XDX).,@ ^6"9(_H6B@#\[_VH]#_ &JOVH?@OK7A*V^$^E^ -,,M
MM)?:7?>*+74K[60)@8HK>0 11+$\8DD,DD9DVQ[/^6D<GT;^W5\,O$GQD_99
M\;>#_!^F_P!L>(=2^PFWLS/'#YOEWUO+)^\E(C!\N-SR>U?0=% !7QQ\$?V5
M=1UG_@GS9?!/XBV7_"/:W<V5]#<P^8+H6,IOIKFTD_=2XD\LF*3RQ)SC!K['
MHH ^-O"OB#]K7PGX;T?X=#X:^$=3U_3K2*T'Q0U/Q5)-I5T8X\^9-:^6+V20
MQ@Q$]Y<R?ZNNK_8D^$/CSX.^&_B98>/YOM>LZQX]U+68M7Q%&-4AECMO]*\J
M*0B+S3'(1'UCZ=J^GJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **YS4O%FAZ1X@TK0[_5M/M=;U@R_V=875U&ES
M>>4/,D\J/J_E@@G'3OZGF?#O[0'PM\9:U;:-X=^)'A#7]8N"3!I^F:[:W-Q-
M@;_DCCDST'Z4 >DT45YMX=_: ^%OC+6K;1O#OQ(\(:_K%P28-/TS7;6YN)L#
M?\D<<F>@_2@#TFBN=\2>+-$\+_8$UG5]/T=M3O(]/LO[0NDA-S<R$B.*(/\
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M(M'U2ZT[4_BEX,TR_LY)+>XL[S7[6*6"2,XDCDC,H((P>#TH ]4HKRC]J_\
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M6G6MO5/C5\/-(\8)X5U+QWX:T_Q2\D5H-#N=7MX[_P R4KY48A\SS"9/,C(
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M_ G4-$^%/[.NAW7B#XQV/Q#TBP,PN/B!J6I1FVO!)=28WW#S2C]WY@BYE/\
MJP..E 'NE%>5?\-7?!'_ *+%X _\*>Q_^.UWNL:Y8>'-+N]2U&\M['3;.*2Y
MN+JYD$44$<?^LD=SP !Z^E &Q17FWAW]H#X6^,M:MM&\._$CPAK^L7!)@T_3
M-=M;FXFP-_R1QR9Z#]*Z?Q)XLT3PO]@36=7T_1VU.\CT^R_M"Z2$W-S(2(XH
M@_\ K)3CB,<_E0!T5%>:?\-!?"__ (2G_A&_^%D^$?\ A(_MW]G?V3_;MM]K
M^U^9Y?E>3YGF>9YO[OR^N>/:J?[5_P#R:S\9?^Q,UG_TAEH ]7HKYO\ @/\
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M (2#RS-_Q)_];'O\[G]W^\SY?^K- 'K]%8'B;Q/H?@W1+G6=>U;3]"T>W/\
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M(OB1X0T#6+<@SZ?J>NVMM<0Y&_YXY),]#^M>DT %%%% !1110 4444 %%%%
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M+3SN@R3%)UX\K>,R",56_9IU_P"!'C#Q]>2>!? -O\,OB7H^GO%J?AJ^\/\
M]@ZI;65Q+%(/-MH_W<HS%:R>8#)Y8DCSY?FXKN?CEXP^,/@^^\+7WPT\!Z7\
M0+(-<QZ[HMWJ7]G7N-G^C26TTA\H#S,^9N$G6, 8S(/+?!O@;XP?&S]H3X=?
M$KXA^#=+^$VB> 4U2.RT%=6&K:AJ5Q>VPBDD,L7[J.$1XQ_RT\R)\C]Z#& >
M._&#QMH?BC]M_P <Q?$/X6^-OC%IW@#3M-L- T?PCH7]L:?:F\MOM5U<7UM+
M)Y?FR^9Y49Z&.'IYD4<@S;J2SO/C[\)O%/P8^ 'Q0^#^MP>(+72/$,C>#!IF
MCWVAS3#[4MS%%YD?&1B4@<#.<QQ&/Z+^)GPW^*'PK^/&M_%OX2Z#I/BVT\1Z
M7:VGBKP7?ZA]@NM3N;<F*UNK:ZD\Q(S'')AXSY<>R,_ZR20&/H_A?X^^/WCC
MQ]IA\4_"C0/AEX-M3+_:;W_B./5]1O\ ,<GD_93; 1Q"*4+YGG=1)^[Y!H \
M-^+?@6P^'7[57C3XF?&#X47/Q/\ A?JNE:98Z7XBCM_[;B\*Q1(3=_:;"7F*
M+,<MQ)<1H?+' R]Q(*^K?@3'X&;X6:+=?"[^S3X%O/-O=-&DY%J&EGDEE$<9
MYB_>22?NN/+(,>(_+P/(O$'Q8_::\'^,O$=A%\!=+\>:-'J<G]BZUHWBRWTT
M/8DIY0EBN#)(9>,2$;$STX&\[O[,OPHUCX ^ ?&NJ_$?7M"&L^(/$FI>--:N
M=+66'2].\WR_,"2S<^6!%YOF28P">OE^90!]&T5XU^R?\3?$WQ@_9]\'^,?&
M&E6VB^(-8BFN9K6SMY+>$Q_:)!%+&DA+XEB$<@)//F U[+0 5\J?M#?\GU?L
MC_\ <W?^FN*OJNOGGXS?#'Q)XJ_:D_9^\8:9IOVGP]X4'B ZM>>=&GV47-C'
M%;_NRP>7,@Q^[!QWH \5^-WP4\.?'K_@HM9>&_%PO[OPZOPJCN[G2[2_EM8]
M0\O5Y/+AN?+(D,0D>.7&1^\AC/.,5:_:R^#G@?X0^,OV=?%7@;PII?@K7Q\2
M]'T>2[\.PIISRV5SYOVF&7RM@D$@C _>9X,@&!)(#[%_PK'Q%_PWE_PL3^S#
M_P (;_PK;^P/[1\V/_C^_M/SO*\O/F?ZOG.,=NM,_:[^&?B7XD-\&?\ A&]-
M-^/#WQ(T?Q!J3>?&GV>RMO.\V3YR,D>8.!S0!Y_^V[HMU\5OBO\  +X+W5P+
M?P9XPU:_U/7X(FF62_BTV&.Y^RDQRQ_NY=YSW$@BD'^KY]*UW]D'X.ZA?:#>
MV?P_T/PUK&@ZS9:]87WAO3+>QN8Y+:<2 &2.,>9&<%7C.>N1A_+>L7]L#X'^
M+/B)IWA#QI\.YH5^)_P_U,ZMHD=U/)'#?0E<W-C(4DCP+@11 D\'RQ'F-)))
M*Q-,\?\ [5/Q(\=>'+(?"G0OA-X4M;Z&YUS4-4\1VVL7%W;)<0F6VM3;C]W)
M)%YP_>1X_P"FD9Q0!-_SE,_[HW_[FJ7]GG_D^K]KC_N4?_37+73_ /"L?$7_
M  WE_P +$_LP_P#"&_\ "MO[ _M'S8_^/[^T_.\KR\^9_J^<XQVZUY]\1/AS
M\8O@O^TGXB^+/PF\.6'Q$\/^,K+3[?Q)X1O-7BT^Z-U;12Q0W-O-+'LCBC01
M<&23)EE_=_ZN2( VOVAO^3ZOV1_^YN_]-<5<Q\</"O\ PO\ _;J^'OPS\4-%
M=^!/"_AB7QU)H\D,LD6JWGVDVB17(\P1%8_W<@S&>&EC.1+QF:/\/_V@_B)^
MT]\&OBA\0O#VD^'] T237XSX9TN>&5M#MY;:6.WDN;GS3]IEF)0'ROW:"*(X
MB,K@>C?M#? _QN_Q:\%_&GX6+I]UXS\.V5SIFK>']0OIK6/7]-D!D%J) ?+C
MD64R&/S(S&9)8Y)/]4!0!XM_P4B_9M^'?A7]EOQ5XH\*^&-,\%ZOI(MD/_"*
MVL>F1W\,M_:1R6]U'$H%Q%N\N0 \I)#&0>H/KO[>OWOV<_\ LLOAS_VYKR;]
MIKP=^U/^U/\  SQ)HC> -"^'6E.;8?\ "+?VO;ZGK.L317,4G-W^[MK>VY\S
M_GKYEKC_ %<M>^_M=_#/Q+\2&^#/_"-Z:;\>'OB1H_B#4F\^-/L]E;>=YLGS
MD9(\P<#F@#RG]M#X<Z;\6OVIOV8_"6K7&H6^E:G_ ,)/'>?8+EK:6YA^PP/+
M;&2,9\N4 Q2 =8Y)!GG-<[^WE^SC\-?A#^R+K?B?P9X*TGPEXD\*3:5/HVO:
M-;FTO[607MO$)/M,9\R0[)#S)G]Y^\_U@!'O/QF^&/B3Q5^U)^S]XPTS3?M/
MA[PH/$!U:\\Z-/LHN;&.*W_=E@\N9!C]V#CO3_VZOAEXD^,G[+/C;P?X/TW^
MV/$.I?83;V9GCA\WR[ZWED_>2D1@^7&YY/:@#E/^"BO_ "0OP_\ VMG_ (5S
M_P )EHW_  G6[_H!?:OWN<?O<^;]F_U/[ST[UX;\?O /[.7Q-^)?P(T+X2Z3
M\.]=\43^-;:6^T_PK]B,4FC1(9=0^U+%^ZD C2(B.7]X<2>5G]YGU;_@H#I>
MJ^.;?X1>"O!>L2:;\4K_ ,80:SX76:V66T\RPCEDEN99)/W<<<,<OF])7DP(
MQ%)R8^,NM+_:*_9@\(>(?&FG?#/X!P:!IUO'?:W8>!K6]TN^O;*VPTN)7 CS
M'&92/,S@ X20_NR ?<NCZ'8>'-+M--TZSM['3;.*.VM[6VC$44$<?^KC1!P
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MYP_CCQ7HFD6MK=2WR']WH]K<QQ9XQ%+<^5)Y@CD,9DBD_=R=9\</"O\ PO\
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MI;Q 6T_R28BCEN&,?F2 @D8'->\4 %<#\;/&EW\._@YX]\5:<L,NHZ#X?O\
M5;:*?_5R20VTDL>_VS&,UWU<_P"*/"FG>-_"NL>'=8MS=:/JUG+8WEOYA3?#
M+&8Y(\I_LDC\: /E3]CS]E#X;WGP \'Z[XP\(^'_ !]XM\562>)-6\0^)=(C
MO;NXFO?](P9+DRDE!*D>0?G*^9@&0UF_L7_#G3?A+^U-^TYX2TFXU"XTK3/^
M$8CL_M]RUS+;0_89WBMA)(,^7$"(HP>D<<8SQFI?AG8_M-_LW^"].^%6E>!_
M#OQ,TZR$EKH?CJZ\2FUAL;5Y7%J+ZUD!E?R003';''E>7'&28\GIOV5_A'\4
M? /QL^-WBCXF_P!GW]UXM_L)[?4M+$4=K++%;2^='%'YOFB*V\Q(0\H$DHB$
MG4F@#Y1_9I^)G@GQEH.M?$7XA_LX?$/XN^-/&6I7%]J.OP^#8];TQ )I8XK6
MQDN)3Y<4486/ YR/+)(CCQ[3^QW'?Z+^T]XUC\$?#CXB?#+X.ZYX?DUB;P_X
MNT(V-E#K@N8H\VHZ1 PEOW8D['CRXHO+ZCP?X7^.W[(\>J>$?A_\/-)^+?PQ
M?4[J\\-VMGKT6DWVA6TLWFR6ER;G/GCS)'$<@>23Y)#(1O1(_:_@GXB^+7B7
M^V-0^(WA70? UG<"'^R/#^GZD+_4+;'F"Y^UW 'DR9Q%)'Y7:0B3F@#YB_94
M_9G^'WQ9\?\ QR\6>-]$;Q1=:3\5O$%IINE:O,;G3+7F,RR_9O\ 5O)+YL8D
M,N__ (]H<8,>:I>(OV7?AUKW[>VI?#U=(GT+X?:Q\/(O$6L>%=!O9=-TS5KV
M*_-M#]HBA(XCXD'E[/WD8DZF3S/H?]D3X9^)?ANWQF_X23338#Q#\2-8\0::
MWGQO]HLKGR?*D^0G!/EG@\T__A6/B+_AO+_A8G]F'_A#?^%;?V!_:/FQ_P#'
M]_:?G>5Y>?,_U?.<8[=: /)_&GPO\)_!O]O#]G.;P)H6G>##XCLO$5CJ\&@Q
M?8;>_AM[$3112Q1?NSB67S,XR=L6?]5'CD_VQO&^G:U^UIX$\'>-? WB_P")
MG@O0?#9\71^%?!VEF_DO-1DNC;1R7]N)/+EMH8XN.!^\FP=\<ICKZ"^,WPQ\
M2>*OVI/V?O&&F:;]I\/>%!X@.K7GG1I]E%S8QQ6_[LL'ES(,?NP<=ZH?'3X2
M^/(?BQX9^,?PMATF\\5Z/IMSI&MZ+K,[Q?\ "0:29#<+:0S',=M*LPS')@ F
M4>9)Y<9CD /D3X_:UHFK:%IFN_!C]F;XL?"OXJ>'KZ*[T/6])\ Q:;:KDJ)H
M;I8O,$L9B$G!C/)Q_JY)1)[G^VA\.=-^+7[4W[,?A+5KC4+?2M3_ .$GCO/L
M%RUM+<P_88'EMC)&,^7* 8I .L<D@SSFN]\*?%#]I+QQXGTBRO?@EH/PVTB&
M^BGU;5/$/BR+5/,L?- EBMH;4 BYQDQR2_N_W9SUK:^,WPQ\2>*OVI/V?O&&
MF:;]I\/>%!X@.K7GG1I]E%S8QQ6_[LL'ES(,?NP<=Z /!OV\OV<?AK\(?V1=
M;\3^#/!6D^$O$GA2;2I]&U[1K<VE_:R"]MXA)]IC/F2'9(>9,_O/WG^L (^@
MOVS/A[X9\7?L\_$?4];\.Z1KFHZ)X6UBZTRYU&RBN)K";[)(?-BDD_U9S'&<
MC'^K'7%0_MU?#+Q)\9/V6?&W@_P?IO\ ;'B'4OL)M[,SQP^;Y=];RR?O)2(P
M?+C<\GM7I_Q6\"+\2?A;XP\'"Z^PMX@TB]TO[5Y?F?9_M,4D7F;.^/,- 'E7
M[&_PJ\&>$?@'\,O$FC>$=#T?Q!J7@W3&O-6T[38HKJZ\VUAEE$DL8WR9D_><
MGKBN=_8*^]^T9_V67Q'_ .VU7/V2)?C1X5T'1?AM\0_AU8:+HOA71AI5CXRT
MO7XKFVU/[,8XK;9:C,L?F0C?YDG>(_NX_,"#,^#O[//B=?A;^TIX*\20_P#"
M,+\0/&'B:YTV\;R[HM8WT21177EQR<G_ *9DQGCG&: /G_PSXF_9DO\ P]K>
MG^$O@#\0?CIIUS-(FJ>/K/PG)K%UJ5[)!&;F0WUQ+'<Q3$R>8?+$6)&,D>,Y
M/TC_ ,$V=8O];_8L^&5SJ-S<7LBP7ML);B3S"(HKZYBBCY[1QQ1H.V!7G'@F
MZ_:Q\)_"W1_A3I?PQ\-:!JNC:;_8-E\29_$D4VEQQ6\8BAN?L!CDN#F.*,#/
M'FD221B/,=>R_L*_#+Q)\&_V6?!/@_QAIO\ 8_B'3?MQN+,3QS>5YE]<2Q_O
M(B8R?+D0\'O0!]!T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >0_\*1'_  U%_P +
MC_MQMG_"'?\ "(_V)]EY_P"/W[5]I\[S/7]WY?E^^>U>O444 %%%% 'BGBSX
M%R^-OVD/ ?Q-O?$UPNG>#]/O;;3/#L=A&1]KN08IKE[G[_,7E#RS_P \@<\R
M!O:Z** "BBB@ HHHH **** "BBB@ KY TW]CWQ]\*8#HOP7^.^K?#WP+]HEG
MC\,ZIH%KK@L999"[I;RRD21Q8*XBYY\R3S"9#7U_10!\_P#P)_9EF^#NO>(O
M&?B;QEJWQ/\ B+K</V>XUS5XHXA;6XEEF^SV,?)M8B9<F$2&/,4>!'7T!110
M 4444 %%%% !1110 4444 %>*?LV? >?X#>#=;TZ_P#$EQXNU_Q!K]YXCUC7
M);..R6XO;G'FF.*+/EC]VG&>I.,#Y![710 4444 %%%% 'D7[+GP/?\ 9M^!
MOA[X=-K/_"0+HWVG;J(M3;>:);F68DQ^9)CF7'7M7KM%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %<!\9/A5H?QP^&>O>!O$L<QTC6(UCE:WD\N6/RY1)'(GNCQQOSZ=^E=_10!
M\B:E^S#^T!)I%]HEE^U5K%IX?:&6QM3=>$[*;4HK?&R/S+X21RRRB,$?:!Y<
MAD_>#%>V_ _X,Z1\"_ __"-Z+<WVJ>??7.H7NJZNT<NH:A=2RF26>YE2./S)
M>1'YAYQ%'UQ7IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5Q/Q$\%V/Q"\*:IX>U::ZBT;583:7T-L=IGM9#B:$D D+*A>(D
M 2 2$QF.3$@[:B@#'T?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_ -7&B#@
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M-\68^S?:/M7V7S<6_P#K!Y9?S/\ 6<XQT->P44 %%%% !1110 4444 %%%%
M!1110 4444 <'IOPTT6Q^(6J>-I(6O/%%U;1::-0NH4,EM8QMY@MHB ,1F4O
M*>N9).21'$D?>444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXDZE\)]!&@I$1=6\2WDUR(K^Y>&R6YS<&7/E_NI/+Z'RL'J30!]:45^2K/\
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MT/3+>^\3_"[7K+Q98)+IQN3+''*!+$3&1+'#S'+*1QBU&<8\R, ^NZ*^&_\
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M (IMJ7C>T5;V/P]HTE[-9VFAPB^N?.$7V:6/S999?WDDLG./*C&/*H ^CO\
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M3:OXT_8[^'VM^(=4U#7-7NFOS<7VIW,EU<3$7]S&/,DD.3@ #KT%?3=?*O\
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MP@\4>#OAGH<>NII^I:U9&.^\R:RDBE:^B223[*/,CBCC$N/,Y<$B0"/[ZHH
M^7_VX/!?BWQ5X"\&:_X-\/-XJU'P%XTT[QD=!BE,-QJ<5MYADBA_=G,G[WIC
MH#CS),1E?'%G_P -Q?LN^/O#T?A3Q?\ #RYO\V=E:>-M,_LNZ:ZA\JZMI<9D
MS;F7RXR1SA91UQ7T_10!\@:+^V/XM\):/!H_CS]G;XJ-XQMHD_M'_A$= 35M
M+>;;]ZWNHY\$$8./^69S&<F/)[3XF> _$?[5G[)OB#PGXH\.GX<^+]>LY4&E
M?VK%>QVEW%<F2U$ES#&0T<C10R2;$)\N1AUYKZ+HH ^./#'[4/Q>TKPQI/A#
M6OV>O'GB'XMVME%%>O\ Z);:!?3",&68ZHA-O'YD8,GE^7@2GRNN#6Q^P-X4
M\9^%_#?Q?;Q]I!TCQ+J?Q(UC4)Q%:S0VESYB6V9K4R@226QD\SRY.X'UKZOH
MH *Y_P 4>%-.\;^%=8\.ZQ;FZT?5K.6QO+?S"F^&6,QR1Y3_ &21^-=!10!\
M(?L1^!OB19_$N(>/4\16?_"MO!Z^!+?[=IDUMIFI2?VI<2&ZL)#L$D7V:RL(
MC)Y7F2_NS)]T>9QOP9^!?C?0_P!H"U^#6H>";@?!OP)XXOOB!H^LW4U^]KY1
MMO\ B5V-C-(/+)BFN?-E0R?O)/-_YYR>;^D-% 'S%^VQX8UGQ8WP*71])U35
M6T[XJZ'J%Y_9]K)+]FM8S,)9I=@_=QC(S(>!D>M=#^VO\(M;^.?[,7C;P7X6
M2VEUS48[=[:*X?8)?*NHK@IOSP7\K'7'->^44 >*?L]_'S4_CEI5^^H_#3QG
M\.K[38[87-OXMTTVL<LDGF;Q:R_\MO+\LY)CC^_'P-W''_\ !.OPSJ_@O]CO
MX?:)XATO4-#U>U:_%Q8ZG;26MQ"3?W,@\R.09&00>G0U]-T4 ?,?P+\*ZWH_
M[8_[3&MWFDZA:Z1K)\,_V;?W5M)%;WODV$D<WE2$8E\L\'!ZG\:^G*** /F+
M]K#POK?Q4\<?!CX>0Z+J5WX.U3Q*=8\27\=O)<V M=.B\Z.POHR/+,5U*R8,
MAP#$/W<A''I'_#*/P1_Z([X _P#"8L?_ (U7JM% 'RK\+?A]??L__M3>,=#T
MGPW<P?##Q_I]KJFF_P!CV!BTK1=3M4$-S:F*%3'";B+RIO.D\H2&(1_O)!69
M^S=#XG^%?@?]I;7[CP9K%UJ$?Q#\3:_I&BRVTL,NL1>7')%]F_=YD$OE%(Y(
MQ)DG@'I7U[10!^<O[-_QNN/A.WBKQ3XF^"'QXU[XD>-[Q=3\27\?@Z86D<J^
M88K6U22Z)^S6XD\J/=^\/? \N./VC]JJSUGXH>%_V<-8T;PSKX(^)/AS7K[3
MY=.D^VZ9;&*:20W429\HQ;P)"3^[.:^LJ* /+/VEM*O=:_9U^*.EZ=9SZC?Z
MAX6U2TM+6UC\R6>:2UE6.../N<D#%>'>*_@KXM\7?L7?!>UT#31#\1_ 5EX?
M\0Z1HFL,;>*;4[&VC'V6ZR!_"98\$Q?O/+_>1@$U]B44 ?*'_#:'BC=_9'_#
M-_Q>_P"$R_X]?LO]D1?V/]OSL\O^T_-\O[-YG'VKR\>7^\QBO1/C9;:_XX_9
M-\=K<^&KFR\5ZMX'OO-\.6DQO9HKV6Q?-I&\7^M/F'R\QC]X>@YKVNB@#X:^
M/W@#Q1K'_!+'3/">G^&M6O/%*^%?#-J=#M+&62]$L,UB98_* \S,?ER<5]RT
M44 ?,G_!.OPSJ_@O]COX?:)XATO4-#U>U:_%Q8ZG;26MQ"3?W,@\R.09&00>
MG0US7[-WPAU'6? W[3'A/Q;IFL:#IOB[XA^)HXFDMS;37-C=111K=6QDC((Q
MGRY,&,GUQ7V!10!\3?"_X[^._P!G/X?>'_AS\1_@3X\UK6?#EC%I=IK7P\T<
M:QIE[8VP\JVE\SS<QRD1Y\N3!'$A$?F>6GT5\%?'GB#XC>%[K5?$G@/4OA\C
MWK_V9IVL7D4]W<6/EQR0W,T<>?LTI\Q@;8DF,QGVKT^B@#YB_8G\,:SX3;XZ
MKK&DZII3:C\5=<U"S_M"UDB^TVLAA$4T6\?O(S@XD'!P?2OIVBB@#YI^)7[4
MWB'X5_$[5_#^I? WXC^)-%MX[>XT?7?!>G?VK#?*\9\WS4!3R#&XV>62Y.-Y
M RF<#]C7X>>*/#_C/XI^+Y?!@^%G@'Q9?:=<>'/!,CQI+9Q16OE274MK$?+M
M9;C$7F1_ZSS(R)/]6#)]:T4 %?./[9_P;\1_&+X4VP\#736WC_PMJUGXI\.F
M6:**)[VV+X1Q+&8SF.27 .!YAB\P^7FOHZB@#Y/C_:C^*WC$OX:\)?L_^,-+
M\>D^3>77C0QV/AS3'P8Y)8[U"?MT44VP[(@LDL6]X^E:O_!.OPSJ_@O]COX?
M:)XATO4-#U>U:_%Q8ZG;26MQ"3?W,@\R.09&00>G0U]-T4 ?#7[,_B;Q]^S3
M^P9\.'/PG\3>)M7M=1N+?5O#MK;20ZI8V<M]<DW,=K)'YDISY?[O@XF\S(C%
M0>*-4\2?M6?%SX8:SX2^#'C#X=:GX3\26.H:QXV\:Z=%HEV-+C\[S+"$Y>6Y
MCE$DP,2'RP3'YG$F1]V44 ?*WQS\+^+_ (:_'WPO\<?!'A.[\>)!H4_AKQ3H
M-O<Q_;X]*\XW4=S8QG'FS"7S1Y7F$R8BCCC!S+'-X6_:R\1_$SQ-HNB^&_@#
M\3K.2:^B&IZEXQTV+0K6QL3((Y;B.6663SI8MX/V<8,@\STKZCHH ^1/VU_"
MNO7WBSX4^,XO MU\6? /A;4[[_A)O!4$?VN6\^TPBVAN8K%QY=R;;=*<$9'F
M]@9)(_+_ (U_$3XE_M'>//@>=#^"?C/P[\/=%^(FE7NIZGXDTPVU_'<1RG'^
MC1R221VL<,LF;D_NS(<9C\O]Y^A=% 'S3\2OVIO$/PK^)VK^']2^!OQ'\2:+
M;QV]QH^N^"]._M6&^5XSYOFH"GD&-QL\LER<;R!E,X'[&OP\\4>'_&?Q3\7R
M^#!\+/ /BR^TZX\.>"9'C26SBBM?*DNI;6(^7:RW&(O,C_UGF1D2?ZL&3ZUH
MH ^%OA7XO\9?L0^&[SX8ZO\ "7QGXV\&:=J=XWA'Q%X(LDUB2YLI)FN M]&)
M(_)EC,V,^7&DA\SRQ^[\R3Z)^!OQ7\0?%;^V=1U'X9:W\/?#,9B.D3>))HXK
M[4F/F"Y\RR_UEMY<D?'F']X)1(*]@K&UR/56TJ\&F7-I;:@T<GV::ZM3-$DG
M&S?$)(S)]/,CSZCJ #SCX#_&K_A=3?$/.BG1CX2\9:EX3S]I^T?:OLOE9N/]
M6/++^9_J^<8ZFO8*X#X-_"K0_@?\,]!\#>&HYAI&CQM'$UQ)YDLGF2F221_=
MWDD?CU[=*[^@#RS]I;2KW6OV=?BCI>G6<^HW^H>%M4M+2UM8_,EGFDM95CCC
MC[G) Q1^S3I5[HO[.OPNTO4;.?3K_3_"VEVEW:W4?ERP31VL2R1R1]CD$8KU
M.B@#A_BQH>K^+/A;XOT3PUJ/]E^(]0TF\M--OA-)";6[DBD2*7S(_GCQ)@[A
MR,<5\:_!/XQ>.?A#\%-+^%G@_P#9@\6:9\4;*R^Q22RZ1#;>'+W4X8Q%)?2Z
MCYD:2^9'")2?^6AQ&)>1+7Z!44 ?,G_!.OPSJ_@O]COX?:)XATO4-#U>U:_%
MQ8ZG;26MQ"3?W,@\R.09&00>G0T?\$Z_#.K^"_V._A]HGB'2]0T/5[5K\7%C
MJ=M):W$)-_<R#S(Y!D9!!Z=#7TW10!\KZG\.[S6OV_KV_P!3\-7&H>"[_P"$
MDNCW-W=6!ET^XDDU7,EK+(1Y9;RN?*.24SQ4O[/^F^,_@7\1M5^%NLIJ6O?#
MBYWW/@/6+6QGN8](M@29-(O[DEVC\I3%]G>7B2,$>9GRX8_J.B@#YB_8G\,:
MSX3;XZKK&DZII3:C\5=<U"S_ +0M9(OM-K(81%-%O'[R,X.)!P<'TH_8G\,:
MSX3;XZKK&DZII3:C\5=<U"S_ +0M9(OM-K(81%-%O'[R,X.)!P<'TKZ=HH ^
M8?\ A%=<_P"'C'_"2?V+J7_"/_\ "J?[/_MC[/)]D^U?VQYGD^=M\OS?+_>>
M7UQ7%ZO^U1K?CGP[>>$/%_[*7Q$U+7+J5[.;0+O18K_P[+=I,!$)-0EQ"83)
M'&_VCRS&F?,^<#)^TJ* /CGP[^RGXK\6?\$\;3X*^,KTIXR;1_(61KXRI:S)
M<FZL;>6;8^8HC';12"//[N(B,_<K+\/_ +97Q6\#>#?[%^(O[.GQ,UGXBZ58
MI#)<>&].BU'3-5F%O$1*;JW'EQ>9+G>D4<HBSW(,8^VJ* /F#]D_X4^-] \0
M?$[XE_$JR;1O'/Q U:.8Z1!?Q7<6FZ=:@Q64)DBB$9<1O(#("<QB(\2&6I/^
M"=?AG5_!?['?P^T3Q#I>H:'J]JU^+BQU.VDM;B$F_N9!YD<@R,@@].AKZ;HH
M ^8_@7X5UO1_VQ_VF-;O-)U"UTC63X9_LV_NK:2*WO?)L)(YO*D(Q+Y9X.#U
M/XU].444 ?%NK_M4:WXY\.WGA#Q?^RE\1-2URZE>SFT"[T6*_P##LMVDP$0D
MU"7$)A,D<;_:/+,:9\SYP,GU[]COX<^*O@_^SGX"\)^-[B27Q-IMDT5QNN?M
M7V>,RRO%;>;_ -,HC%%P?+'E 1DC!KW2B@ KY0_:&\$^.? O[17@GXZ^!-"O
MO%MM8Z5<^'/%WANRDB-U-I>3<QRVL;QYDDCE+.8TD#R&*&-!\\I'U?10!^='
M[97Q0^*_[37[._BO0_!OP)\6:'X8+6OVRZ\4VAM]8NY8KJ*3[+8Z;$99).L,
MGV@_NQ'%<CJ*]\_X**>&=7\:?L=_$'1/#VEZAKFKW36 M['3+:2ZN)B+^VD/
MEQQC)P 3TZ"OINB@#Y^^,G[1&O\ P9^(6E::_P '_&?CCPM>:<;F/7/!=M_:
M4JWV_:;62UX\L>7^\\TR<Y  /SD><?L\^'_$_C3]I_Q3\5;#X<ZE\)?AUJOA
MQ; Z;JJ1V%_K>I_;I)I;^YL8_P#5R#-S%OE/F$21R#(D(C^R** /B^"Z\8?L
M??$[XD@?#+Q1\0_A=XQ\02>*;+5/!2IJ.JVNIW*+]JMKBU!C/E9A)20 [,Q@
MR222?N_6O@[\=O%'QB\67#'X1>,?!7@ZVMI#_;7C1(]/NI+W?&/LT=ADR&+R
MY/,%R3C,<D>,C->[44 ? OA3Q1X@_9?^-WQ<N?%OP5\:?$#5?$>OW>L:'XZ\
M#Z)_;$KZ5<>7Y=A++^[DB$/V:,>5O/3H$$<DG3_L8Z=\4[W]HK]HCQ?\2O \
M_@#4-?ET(PV8'G6K1Q6US'$(KH'R[@QQ>5YIC/\ K">(_P#5C[3HH ^+=7_:
MHUOQSX=O/"'B_P#92^(FI:Y=2O9S:!=Z+%?^'9;M)@(A)J$N(3"9(XW^T>68
MTSYGS@9-SP[^RGXK\6?\$\;3X*^,KTIXR;1_(61KXRI:S)<FZL;>6;8^8HC'
M;12"//[N(B,_<K[&HH ^0-%_;'\6^$M'@T?QY^SM\5&\8VT2?VC_ ,(CH":M
MI;S;?O6]U'/@@C!Q_P LSF,Y,>3Z[)\6_$_AW]GC7?B!XR\$CPMXCT72K_5;
MKPLNKQ77E"V\V2.'[5$GEYDCCC.0./,QVKV*O*_CI\)=.^.7@$^%/$99_#-[
M>V\FJV42MYM[#%+YJQ12AP8LR10DR8/[L2@>67$L8!T'PI\=K\2?A;X/\8FU
M^PMX@TBRU3[+YGF?9_M,4<OE[^^/,%=I110!\B?MK^%=>OO%GPI\9Q>!;KXL
M^ ?"VIWW_"3>"H(_M<MY]IA%M#<Q6+CR[DVVZ4X(R/-[ R21^7_&OXB?$O\
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MVT4DQCC[#&<1]C@=J\T_8S^*OB&Y\*Z!\+?%'PK\9^!->\(:$EC=ZIJFG?\
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M^G:* /F3_@HIX9U?QI^QW\0=$\/:7J&N:O=-8"WL=,MI+JXF(O[:0^7'&,G
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MXC2>,]6TZ6&R_P"$JT".UTG3;Z2VEC-RE]<D;#$))3%)Y<;R$!,1F3C[XHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHKY\_;J^)OB3X-_LL^-O&'@_4O['\1:;]A%M>&".;RO,OK>*3]W*#&3Y<CC
MD=Z /H.BBB@ HHHH **** "BOGGXS?$[Q)X5_:D_9^\'Z9J7V;P]XK'B :M9
M^3&_VH6UC'+;_O"I>+$AS^[(SWKZ&H **** "BBB@ HHHH **** "BBB@ HH
MKY[_ .%G>(O^&\O^%=_VF?\ A#?^%;?V_P#V=Y4?_']_:?D^;YF/,_U?&,X[
M]: /H2BO,O!^L?$&\^*OQ"L/$&A:=8>!+$V'_"+ZI9R*;F^\R(F^,O[TX\N7
M _U<?MYG6O3: "BBO-_@1JGQ"UOX5Z+??%'1;#P[X\E\[^TM+TR17M8<32>5
MY9$LO6+RR?WAY)Z=* /2**** "BBB@ HHHH **Y7XA^,;'X<^ _$GB[4HIIK
M+0-,NM3N4MA^\>**(RR!.?1*/AYXQL?B-X#\-^+M-BFALM?TRUU.V2Y'[Q(I
M8A+&'Y]'H ZJBOGC]D3XF>)?B0WQF_X2343?CP]\2-8\/Z:OD1I]GLK;R?*C
M^0#)'F'D\U]#T %%%% !17FO_"[]'_X7Q_PJ?[)J'_"0?\(Y_P )1]KV1_9/
MLGVG[-LSYGF>;YO;R\8[]J]*H **** "BBB@ HKYY^#/Q.\2>*OVI/V@?!^I
MZE]I\/>%!X?&DV?DQI]E%S8R2W'[P*'ES(,_O"<=J^AJ "BBB@ HHKS/X1?&
MK2/C,OC--(M;^S_X17Q)>^%[[[>D<9DNK7R_-DCV2',>9!R<$^@[@'IE%>;?
M\)!\0/\ A?/]C_V/IO\ PJW_ (1K[3_;OFC[7_;'VK'V;'FY\O[-^\_U77_E
MIVKTF@ HHHH ***^>/V1/B9XE^)#?&;_ (2343?CP]\2-8\/Z:OD1I]GLK;R
M?*C^0#)'F'D\T ?0]%%% !117FGP%^-.D?M!?"W1_'OAZSO[/1M6\W[+#J:1
MQW'[J62(^9Y<D@',1[_X  ]+HHHH **** "BBB@ HHKS3X]?&G2/V??A;K'C
MWQ#9W]YHVD^5]JATQ(Y+C][+'$/+\R2,'F4=_P# @'I=%%% !17PQ^P?^VQX
M[_:*\87?A_X@>'-*TN>]T+_A(] N- CDCBGLXKZ6QN3+YES(?]=@(,#_ %<A
M_P">>?N>@ HKXOM_VS_$/B?]M+2_A?HNCZ2OPSNM2U/P[+KTOFM>W&J:=8BX
MNXXQOC\KRI);>+_5R"3DI(<CR_M"@ HKXB\(_MI>*O'W[6GA/PCH7AFPB^#O
MB&]U;3=/\47C&2?5YM-M99+FYM)(Y?+%OYOE1B39()!YG[P']W%]NT %%%%
M!1110 4444 %%?/G["OQ-\2?&3]EGP3XP\8:E_;'B+4OMPN;P01P^;Y=]<11
M_NX@(P?+C0<#M7HOQL\:7?P[^#GCWQ5IRPRZCH/A^_U6VBG_ -7))#;22Q[_
M &S&,T =]17R5^PW^U%XN_:&TWQ19>/]#T_1/%NBMIM]_P 2>+%I)IVI6PN;
M%\F:0F3:)"1V#Q=_,KZUH **^+/V:?VS/$_Q^_:6\0>%?[&TJR^&<^@WNO\
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M\*EXL2'/[LC/>OH:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MSG[3&I>(/V>_VFO#'Q\A\.ZSXN\$?\(O=^%_%-MHNG_:+G3;>.62]ANE'FH
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M".HV/@75['0/%%QY<5IJFHVWVF&RC,L8FF$./WDL49E,49_=F0)YG!->(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_99\;>#_  ?IO]L>(=2^PFWLS/'#YOEWUO+)^\E(C!\N-SR>U?0=% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$WQ7I_Q#CD\-Q^,-(\46FGIIMRD7VF.UDMI;>,>7_K?-(().!R3YGEQ 'O\
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MZA:IF2)/)>7S1B7]V#C_ *:)Z\'[1'[3(^,WB7X!:&?A9\3?!7V?XK>'KO\
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M)=&VB$9^TQ(?*C^T9$9?S/+\P1Y/U97RI^T-_P GU?LC_P#<W?\ IKBKZKH
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MHZ;X9TO3[VQTR/1[6ZM+***:WL8SF.UCDP"(@<8C'R9_4 ^4OB_\2M%^ /\
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MGPD\&?$Z2P/C'P;H/BW[ )/LO]N:=%?"W\S'F>6)0<9\N/IZ"M7_ (171?\
MA)_^$D_LBP_X2;[']@_M?[*GVO[-YGF^1YO^L\K?^\\O.,\]: .BKRC]J_\
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MT5B+CR\^7Y@B SCS).OJ: /"_P!O7[W[.?\ V67PY_[<U]5USOB3PGHGBC[
M^LZ1I^L-IEY'J%E_:%JDQMKF,DQRQ%_]7*,\2#G\ZZ*@ KY3_P"<IG_=&_\
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MQ3QR?ZR-T/!!'KZT >.? _QQH/PR_8S^&'B7Q+JMOHNBZ?X(T>2XO+G/[O\
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M4M'^%'@CPZV@+I7@_0].?0#<_P!D"STV&+^S?M))N?LQ"_NA)D[_ "\9R<T
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M>K^(-*UR_P!)T^ZUO1S+_9U_=6L;W-GYH\N3RI.J>8  <=>_H #YX_X*B?\
M)B_Q,^NE_P#ITM*/^"HG_)B_Q,^NE_\ ITM*^B_$WAC0_&6B7.C:]I.GZ[H]
MP?\ 2+#5+6.YMFYW@R1R @\\\^U'B;PQH?C+1+G1M>TG3]=T>X/^D6&J6L=S
M;-SO!DCD!!YYY]J /$/VU_AMKOQ"^!.HZAX/MS/XY\)7=KXJ\-R>7)+*M]92
M>:?+B D$LIB\Z*.*2,@R2>^1YG^S=XX'[77[2%[\7I['[+X<\)^$-.TG2K-I
M?MUK'J>HQ)>WTMO<<1Q7-O'Y=K*(U\P@C?Y?$=?1WQZ\::U\-?@[XH\1>&O#
ME]XL\16-F6TW2M/L'O);BZ<^7%^ZB(D,8D</)CGRQ)7*?L=_!2U_9[_9Y\)>
M$Q8'3=8^QQWVM+(8GE.I3#S+@22QX$AC.(P>?W<48R<4 >[UQ/Q6^*'AOX/^
M =4\8>+]2.D^'=.\G[3>?9I)O*\R6.*,^7&#(?WDD?0=^U=M6/K&AV'B/2[O
M3=1L[>^TV\BDMKBUN8Q+%/')_K(W0\$$>OK0!^>WQW\1?!CX)PMX_P#V</&V
MDV7Q1NM3L;:V\#^ ]7BO=+\32F6.,0W6F6QD 40FY\LQB+$DN=WFR)GN?^"A
MG@+POJ?B;X+>-_B7I$^L_"GPYJ5[8>)K>W-QYMJ+Z&*.VNI&BQ^YCF@CWGS,
M\Q@"3S,5]5>#O@O\._AYJ;:EX0\"^&?#&I21^0]WHND6UI(\?>,R1Q@D?)T]
MJ[Z@#\Y_$GP4_P"">'A'1IM4O+_P?<6MN?G33/&M[>W/_ (;>ZDD?\!Q7J?[
M8OA73O _A?\ 9A\.:3;&WT72?BQX8L;*W$GF&*&**:../YSS@ ?E7OGAW]G_
M .%O@W6K;6?#OPW\(:!K%OD0:AIFA6MM<0Y&SY)(X\]#^M=/XD\)Z)XH^P/K
M.D:?K#:9>1ZA9?VA:I,;:YC),<L1?_5RC/$@Y_.@#X9_;$^%_P -YOVMO GB
MKXWZ8MU\+_$/AQ_"UMJ1N+FWM=-U>&[>YAEN98RGE1RQ221H3(>DI($<?F"O
M=?L^?L"1ZKH.F6TOAO4]2US4;;2;*UT/Q7?ZA))=3$B(%+>ZD\L9_P"6DF(Q
MW/-??&L:'8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M<SX.^"_P[
M^'FIMJ7A#P+X9\,:E)'Y#W>BZ1;6DCQ]XS)'&"1\G3VH ^=OVW=:NOA5\5_@
M%\:+JW%QX,\'ZM?Z9K\\2S-)81:E#';?:B(XI/W<6PY[F0Q1_P#+3CT76?VT
MO@_IOB+PQH=KX_TGQ-K?B74[?2M.L/#=U'J1$LL\<*M+)"?+B'[U9/WI&0DO
ME^81BO:M8T.P\1Z7=Z;J-G;WVFWD4EM<6MS&)8IXY/\ 61NAX((]?6N9\'?!
M?X=_#S4VU+PAX%\,^&-2DC\A[O1=(MK21X^\9DCC!(^3I[4 ?/'[7'BNP^'O
M[4W[+_C'Q)-_9'A33[[Q#8WNLW$1%K;RW5@D=LDDI7$?F8;K_<D/2,X/^"B?
MBK1O&G_!/_XB:UX>U33_ !!I-P-/%O?:;<QW5L^-4M4/ER1G!QS_ "KZF\3>
M&-#\9:)<Z-KVDZ?KNCW!_P!(L-4M8[FV;G>#)'("#SSS[5D_\*D\%_\ ""?\
M(5_PAV@_\(=G_D7?[-B_L_\ UOG?\>V/+QYO[SIU]^: /)OVU_AMKOQ"^!.H
MZAX/MS/XY\)7=KXJ\-R>7)+*M]92>:?+B D$LIB\Z*.*2,@R2>^1YC\#?'!_
M:\_:3T#XH0VA@\&^!/!UM':IYOF0VWB'5(HIKN.VN8@/M/E6VRVECEQY<A'[
MH$YK[<KE/!/P]\*?#G2YM-\*^&])\,V,DOVF6TT6QBM87E('[SRXP.?D'Y4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 445Q7Q"^*'ASX8_\(Z_B/4&T_\ M_5K;0=./D22_:+ZX)\J+Y!W\L\]..M
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M:?+EE382D8X\P@_ZJ3T_]H;_ )/J_9'_ .YN_P#37%2_\%1/^3%_B9]=+_\
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M%IMK?#_EW^RB+$1DE_U,F#GS: /MROSG_:.^&'Q=?]L_X)1V_P ;6@GUR_\
M$\OAJY7PA:?\4U"+;?)#C/\ I6^(I%YDO(V&2OT8KXZ_:X\5V'P]_:F_9?\
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M(OA#XHU":66_N[;28M7BE^SRW-M+$D5Q_JEDDC$@/)C&(\R<FO)O^"8?P_\
MB8/@9\-?%#?%G_BV^=2'_" _\(S:_P#/S=1_\?\ GS?];^^Z?],^E>L?\$N_
M^3%_AG]=4_\ 3I=UQ_\ P31^)WA32_V=_"'PSO=9L-,^(FD7NIV-[X6U&06V
MIQ2B[N;DQ_9Y<2'$4F>.F)?^>;T ?;5?+'[2GQ?\<R_%SP+\$?A3J$6D^,O$
MT4FM:SXBN+*2]7P]I,3X\X1&(Q/YLD<D0$AP"!'^[\Z.2/ZGKXM^.'BK_A0'
M[=7P]^)GBA8K3P)XH\,2^!9-8DFECBTJ\^TF[26Y/EF(+)^[C&9!PLLAP(N0
M#R#]NCPM\=/AU^R[XW@\7_$&Q^,/A/6!8Q:A-/HEOH=WH4D=];RPS1K$2+F*
M4J8I(R1)&9(I!QYE?4G[57Q^\1_"=O GA3P#IEAK'Q(\<ZQ_9VD6>KQW4MK#
M'&!]INI?)&1'$#'GD?ZWS.1&]?/W_!1W]J;X;^*?V;_&7@+PEXDA\::_>P6%
MY)_PC9%_:V5LFH1%IKJYCS'$/,C$0&[S/,FAXQ(#7H_[;NM77PJ^*_P"^-%U
M;BX\&>#]6O\ 3-?GB69I+"+4H8[;[41'%)^[BV'/<R&*/_EIP 2>(OA#^UEX
M2T.YUC0OV@[+QYK.F@7EOX;U+P78:?;ZD8R";62YCDS'YH)';!Q^\C_U@]U^
M 'Q:TSX\?"3PUX]T=##:ZY9B>:UW$_99\B.6'=Y<?F>5)')%YF!GR\CK7EWQ
M*_;_ /@IX#^&4_BO3OB#H/B6[DLFN--T>RO_ #+JYE\HRQ0RQ1K)+;;\>67E
MC'EDC?SQ6Q^PK\.M8^$?[)_PW\-Z]#]GUA+&6ZN;;RY$DMFN9Y;KRI!)@QR1
MB7RY%QPX^E 'T/7YW?LU>)/VJOVI?A3X7\2#XFZ9\/M$2*\B?7H]"M-3O]=N
M?M/^L^R^7'%;PQ(&AX(D\R*0D2"1/+_1&OE7_@EW_P F+_#/ZZI_Z=+N@"[^
MRM\3?'VH>/?BM\*?B9JVG^*/$?@&_L1'XHLH/LG]IVU[%)=0^9;@"..2.,8/
MEG'0<^7YDG!^ O&_QJ_;&/B#Q7\._B)8?"'X;6.L7.F>'[J/PP=2N_$,49 ^
MUR?:_*"1Y \L1#J98Y<F,9Z[]GG_ )/J_:X_[E'_ --<M>8_L.?'[P?\!O -
MU\"/B=X@TOP+XW\":E?6<W]L7,EI:ZA;?:/.BNHI+B**/$OVD^7'GS)(XQ+T
M/ !Z+\*O''Q6^$OQ^L/A3\8/%%AX]LO%MG=:AX2\76VGQV,]S-;1QFZL);6(
M;(\1EI0Y..G[R0R>7%X1_P *;^./_#>7]B?\-$/_ ,)M_P *V_M#_A*_^$(L
M?^/#^T_+^P_9?,\O_6_O/,Z]NG->BVOQ,T;]JK]NKX=7/P[NX/$?A7X5Z;J]
MUK7B&-93;27%]&;(6L9\H1R$>4L@D$GERQ^:8R?*YU/B)\0?#OPE_P""CV@>
M(O&.JP^%=!UOX82Z/9:UJS?9K&6\BU/[3)";E@(P1&,G)',D?>2/(!]7>$]-
MU'3?"NCV6NZL?$6LVUE%%>ZI]E%J;R81CS9O*3B/>W/E]!TYQ1XLU+4=-\*Z
MQ>Z%I)\1:S;64LMEI?VH6IO)A&?*A\U^(][<>9T'7G%7-'URP\1Z7::EIUY;
MWVFWD4=S;W5M()8IXY/]7(CC@@CT]:\;_;:\:>*/ ?[*_P 2==\(1W3:Y;Z<
M$CGL_-\ZVB>2*.>YC\L[T,44DLOF _N_*W]!0!XI\1?#/[5_PW^&OB3XEZC\
M</#<VHZ%#<ZY=>"K7PM#_9;VL3M-);)?8%SC[-&>WF9X\W_EK7I'Q@_:NN/
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M\&/B'\(O".K:EX\\;_&WX>^*OBKXAC$.IZO!XEM!::;:@[X]-L(S+F.UC/\
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MCA!CDBDC:,<G.>?W?EGS=K]GG_D^K]KC_N4?_37+1^T-_P GU?LC_P#<W?\
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M&T8Y.<\_N_+/F[7[0W_)]7[(_P#W-W_IKBH_:&_Y/J_9'_[F[_TUQ4?M#?\
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M0EBNO)\L\$1W&\_O(\1QRGS!BO)/^%(_\$\O^$;_ +=^W^$?[/\ L?V[R?\
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M)/,%>[_\$J;WPYJGP;^)5WX0LY]*\*W/Q#U*72;&ZR9;>S-K:&&*3]Y)R(\
MDN>1U- 'O'[*OQ:F^-/P1\/ZSJ%Q<-XJLT.E>([:]BCM[FVU:V/EW4<L,9_=
M'>/,$9 _=RQ\#.*\>;]J+4-('[1'Q1U>_D;X;?#J_D\)Z1X:6,12WNJ6WE?:
M)+F412R 2W$L,,4@D\L1G,L0(S7GWQ*^).N_L??%CX\Z#I-A<1:=\0K ^*?
MHL$%U._B:=X;&XABBEC_ -)EDN)HKEX8Y)!%%",1_O3&.X^+W[+NK:-_P3?O
M_A%X=L;>XUW2M"M9YK.SDN;D7M[#<QWUT(.#(YEE2?RX\9S+&/W8X !9_P"%
M8_M;^,O#0U^Y^-NA^ _%-Y8F=?!NG>%+6[L;"?R_W<)OI3+)C/\ K)!YN"9/
M+\P 5ZM^RG\=-4^.7@'5KS7]#_X1_P 8>'=9NO#?B#38YA+;QZC;"/S?)D!/
M[O\ >#@DX.X9DP))/E#P%\'/^">OC[PII^OQOX7T..\CWC3M>\;7-E>P?[$L
M4E]P?TKZP_9+\-_!_0?@_;7GP-MC#X$UJ]FOXG$EU^^E!%M+)_I1\T?\>V,'
M_GG0![E1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 <IXV^'OA3XC:7#IOBKPWI/B:QCE^TQ6FM6,5U"DH!_>>7(#S\Y_
M.J6C_"CP1X=;0%TKP?H>G/H!N?[(%GIL,7]F_:23<_9B%_="3)W^7C.3FNXH
MH ^&_"OB;QM^RC\3_BY<>*_A+XQ\>Q>,O%5QK6E^*_!%DFL2RZ?LB$-C<_O(
MY+<6L1\N(2'9^\E\OB/,ESP6GB7]IS]K'P)\59?A5K_PP\+^ +/4K5-7\4VL
M=OJFMRW-O%%';2VW^LACB^TW,J29EC.)/]69#C[8HH P/$WAC0_&6B7.C:]I
M.GZ[H]P?](L-4M8[FV;G>#)'("#SSS[5C^ _A)X,^&,E^?!W@W0?"7V\1_:O
M[#TZ*Q%QY>?+\P1 9QYDG7U-=O10!SFI>$]#U?Q!I6N7^DZ?=:WHYE_LZ_NK
M6-[FS\T>7)Y4G5/,  ..O?T$GB;PQH?C+1+G1M>TG3]=T>X/^D6&J6L=S;-S
MO!DCD!!YYY]JWZ* ,#Q-X8T/QEHESHVO:3I^NZ/<'_2+#5+6.YMFYW@R1R @
M\\\^U8_CSX2>#/B=)8'QCX-T'Q;]@$GV7^W-.BOA;^9CS/+$H.,^7'T]!7;T
M4 8'AGPQH?@W1+;1M!TG3]"T>W/^CV&EVL=M;+SO)CCC  YYX]ZI^-OA[X4^
M(VEPZ;XJ\-Z3XFL8Y?M,5IK5C%=0I* ?WGER \_.?SKJZ* //]<^"GP]\7Z?
MHVG:YX%\-ZWINBP&UTRTU'2K>YBL82(QY<4<B8C&(X^ /^68]*Z'PSX8T/P;
MHEMHV@Z3I^A:/;G_ $>PTNUCMK9>=Y,<<8 '//'O6_10 5@>)O#&A^,M$N=&
MU[2=/UW1[@_Z18:I:QW-LW.\&2.0$'GGGVK?HH XK_A4G@O_ (03_A"O^$.T
M'_A#L_\ (N_V;%_9_P#K?._X]L>7CS?WG3K[\UVM%% &!X9\,:'X-T2VT;0=
M)T_0M'MS_H]AI=K';6R\[R8XXP .>>/>N;TOX*_#S2/&#^*M-\">&M/\4O)+
M=G7+;2+>._\ ,E+>;(9O+\PF3S) 23SSZUZ'10!@>&?#&A^#=$MM&T'2=/T+
M1[<_Z/8:7:QVULO.\F.., #GGCWK)_X5)X+_ .$[_P"$U_X0[0?^$QS_ ,C%
M_9L7]H?ZKR?^/G'F8\K]WUZ>W%=K10 5CZQH=AXCTN[TW4;.WOM-O(I+:XM;
MF,2Q3QR?ZR-T/!!'KZUL44 >?6GP5^'>F^$=0\)V'@7PU9^%+Z47-YHD.CV\
M>GW,O[O]Y)"(_+<_NXN<?\LQZ<>@T44 >;>'?V?_ (6^#=:MM9\._#?PAH&L
M6^1!J&F:%:VUQ#D;/DDCCST/ZUZ3110 5@>&?#&A^#=$MM&T'2=/T+1[<_Z/
M8:7:QVULO.\F.., #GGCWK?HH YS3?">AZ1X@U77+#2=/M=;U@Q?VC?VMK&E
MS>>4/+C\V3J_E@D#/3MZ'+\>?"3P9\3I+ ^,?!N@^+?L D^R_P!N:=%?"W\S
M'F>6)0<9\N/IZ"NWHH P/#/AC0_!NB6VC:#I.GZ%H]N?]'L-+M8[:V7G>3''
M& !SSQ[U3\;?#WPI\1M+ATWQ5X;TGQ-8QR_:8K36K&*ZA24 _O/+D!Y^<_G7
M5T4 8^CZ'8>'-+M--TZSM['3;.*.VM[6VC$44$<?^KC1!P !Z>E;%%% 'FNA
M_L_?"_PK'J(T/X<>$=)74K*6POET_0K:'[5:R?ZV&3RX_P!Y&<#]V>#BNRT?
M0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_P!7&B#@ #T]*V** /-O#O[/_P +
M?!NM6VL^'?AOX0T#6+?(@U#3-"M;:XAR-GR21QYZ']:['6-#L/$>EW>FZC9V
M]]IMY%);7%K<QB6*>.3_ %D;H>""/7UK8HH X7P_\(_!'AWPOJ/A[1?!VA:/
MX=U/S/MND:?IL4%K<>9'Y4@EBC 1\Q@1G(.0.]=%H^AV'AS2[33=.L[>QTVS
MBCMK>UMHQ%%!''_JXT0<  >GI6Q10!R7AKX<^%?">K:QJ>A>&M)T6^UJ7[5J
M5U864=O-?29D(EFDCQYK9DD.3DCS#ZU>\3>&-#\9:)<Z-KVDZ?KNCW!_TBPU
M2UCN;9N=X,D<@(////M6_10!Y]I7P4^'^@Z99:;I_@7PWI^FV6HQ:S;6EKI-
MM'';7T8_=W4:"/B8#($O^L'8^GH-%% '$> _A)X,^&,E^?!W@W0?"7V\1_:O
M[#TZ*Q%QY>?+\P1 9QYDG7U-0>,?@O\ #OXAZFNI>+_ OAGQ/J4<?D)=ZUI%
MM=R)'VC$DD9('S]/>N^HH Q]'T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_\
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MR)'VC$DD9('S]/>NFT?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_ -7&B#@
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M) ST[>AZ.B@#G-2\)Z'J_B#2M<O])T^ZUO1S+_9U_=6L;W-GYH\N3RI.J>8
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?'SPUI/P$3XQZ@+JQ\*2:#%XA2&Z$45QY4L0DCB_UGEF:3?'&(_,P9".><T
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M2/V6?'&A?%WPWX3U/1];%E%::Y\/#=>3ILT5[;RXOH[KD1R@$1R1])(Q&?\
M6QD?7?[8WQFUW]GG]GCQ5\0- @L+O5]'^S>1!J4<DELWFW44)\P1R1G_ ):Y
MZ]AUH ]QHKPS]I;]H>V^ &A>'H].TA?%OC'Q5K$&B:%X<35(;&6^FD..99#F
M.,=/, .))(@?]9FN)T?Q?^U'X*\2:%<>._"/P_\ %?A[4M1MM*N1X%N+^._T
MX3S1Q_;I!<1E9(8Q_K$C .").$CDH ^J:*^?/CGXT^,T?BS1?!_P=\$Z3>R2
M1_;=6\5>,))(]&LHSYPBMD\J032S%XP3Y8(BS%D8ES'B? [XY_$34/C=K_P=
M^+6A:):^-+?2$\3Z=JWA*6;^RKW3O-CA/$K&5)!,2.1@XDZ8'F 'H'_"[A_P
MU%_PIS^PVV?\(=_PEW]M_:O^GW[+]F\GR_7]YYGF>V.]>O5\I_\ .4S_ +HW
M_P"YJOJR@ HKXO\ %7[4'QIO_C]\3/A/\-_ ND>);_09]$^P:[J(EAL-.MKB
MWCENI=0D\W,AS(!%%$!(8Q-)B3RL/N> /CM\8O OQX\+?#+XU^'_  A.?&EG
M<RZ!K?@>:Y^SI-;1M+<PW,=T?,/[KRSY@&!D#Y\R>4 ?6E%?-GQ<^.WCF^^*
M<_PH^#WAG2=?\6VVG1:IK.NZ_=RQZ/H"R2'R8KF.'][)+,D;XBS&<21R8DC\
MPQ\MH?[0GQ=^$/Q:\-^%?C_X<\-IH?C*6+3M \6>!(KJ6RBU)I#_ *#="7YP
M91@QG _[:?O#" ?7E%?/GQU^/'B7P?XY\+?#?X<^%X/%WQ%\1PW-S'#=WPCL
M=$LT_=_;[XI^\$0DD'&/WACECC?S, ^9^(/VAOCQ^S=JVB^(?COX>\&W_P +
MKV4V6J:]\.XKYY-#FD\L0W%U'<_,T).8_P!V.IZF3RXI0#[/KR+]J/XX/^S;
M\#?$/Q%71O\ A(%T;[-NTXW1MO-$MS%" )/+DQS+GIVKA_VE?VBM?^'OC#P/
M\,/AOIFE:Y\6/&4TOV&'6+HQV.FV<7[R:ZNHTD\P@I%)Y>!SY4I',?E2?-'[
M<GBOX^Z1^RSXXT+XN^&_">IZ/K8LHK37/AX;KR=-FBO;>7%]'=<B.4 B.2/I
M)&(S_K8R #]+**\,_:L^.FJ? WP#I-YH&A_\)!XP\1:S:^&_#^FR3"*WDU&Y
M$GE>=(2/W?[L\ C)VC,>3)'%\'=4^/K>*)['XM:1X&?2)+-Y[75/!%Y<C[/+
M'+$#%-%<\R>8)"0\>/+^S2 \RQT >\445\Z?LQ?'3Q-\4/$7Q3\)^-8M/A\9
M> _$DFF2IIVF7%A%+IL@)M+ORYI9?]=Y4L@ D/[ORSW!< ^BZ*^5/V?_ -JC
M6/C!^T3\6_AQKVCQ>'8?#]Q*?#FR.X,VIV-K=S6-W=&4_NY +F&, <8W21_O
M#'(1V_\ PN;7=>_:N'PPT6UL6\.:+X=.M^(]4V27,D5S--Y-I89CD$=K(8\W
M/[SS#)'TCC_UE '4?"+XU:1\9E\9II%K?V?_  BOB2]\+WWV](XS)=6OE^;)
M'LD.8\R#DX)]!WZG3?%FAZOX@U70[#5M/NM;T<Q?VC86MU&]S9^:/,C\V/JG
MF $C/7MZCQKX+?&CQM\9/#?QI2RM]"MO$?A?QAKOAC0/,CFCM)/LL<1MI+H>
M89"#)(/,,>/8"OESX.?\-0_\-4_M#_V+_P *E_X3+_BG?^$C_M#^U/[._P"/
M*3[)]D\O]Y_J\^9YO?&.* /LKQY\<I/ OQN^$OPZ;0_M[^//[7SJ+77E_8?L
M-J)C^Z\L^;YF2.L>.O/2O8:^(_VT/%VI^"?VJ/V8]8T3PWJ7C#6%'B:&RT73
M2(IKJ:2RABB4R2<11@N#+*>(HQ))CBH?%G[0/[3?P#\&Z9\1OBYX3\ 7O@&U
MFMCKMCX3FNAK&FQS_NPW[R4V\GERRQJ1&T@/';,J 'W%7C_QX^-7_"E6^'F-
M%.LGQ;XRTWPGG[3]G^R_:O-Q<?ZL^84\O_5\9SU%>P5\??\ !1O6CX;\-_!#
M6AI^H:L=+^*VAWAT_2X3-=7'E174GE11Y^>0XP!W)H ^P:\B_:C^.#_LV_ W
MQ#\15T;_ (2!=&^S;M.-T;;S1+<Q0@"3RY,<RYZ=J\)U#XF?MDZ-X;O/&<WP
MV^'9TNVFENI? UI=W5UXC%E'+@PQRQR?9I9?*YS'G.1B(R'RJS?VV/BMH?QL
M_P""9_BSQUX:,LFCZS'ITD2SQ^7)%LU6VCDCD]TDCD0XXX[]: /N6BO'OVDO
MV@M$_9L^$.L^.M85+];=XX+334N8XY+RZD($<<?F=3UD. <1QR28.,5Y+J^O
M?MF2:;=ZMIWAWX/0QO')=6GAN[GU.74(R5,D=K),/+MY)L8C\S,<1DYR!0!]
M=T5\_>%_VL/#>L_LXZQ\7]4AF\-QZ%%<QZYH-])%]MTZ^MCY<M@P<QGSC)Q'
M')Y<DGG1<1^9@>;^%?BW^U5\2/#>A?$3PWX%^&T/A'5;&'4[7PKJ&JWCZU<V
MQ02>5]J2,6L<DPYB,@Q'YB"3D24 >T_'CXU?\*5;X>8T4ZR?%OC+3?">?M/V
M?[+]J\W%Q_JSYA3R_P#5\9SU%>P5\9?M9:Y>^*O ?[*>MZCI-QH5_J7Q0\*7
MMSI-P2)+*66.:22"0$ YCSLY Z=*]97XS:WX\^,!\'?#F"QO?#_AV],?C/Q5
M?122VMK)S_Q++3RW3S;TYS(_^KMA_K/,D_=T :?CSXY2>!?C=\)?ATVA_;W\
M>?VOG46NO+^P_8;43']UY9\WS,D=8\=>>E>PU\1_MH>+M3\$_M4?LQZQHGAO
M4O&&L*/$T-EHNFD1374TEE#%$IDDXBC!<&64\11B23'%.USXT?M4_!GPS9>/
MOB7X*\!ZWX-MS%<>(-(\&_;CK.FVI0^9+^\E\E_)/,GEF08!Y$>98P#[:HKY
MV^,W[2ESX1\._!+Q'X-%CJ^B_$#Q?H>B_:[ZVE"G3;Z.20S1#,;1RE1'CS.G
M.8Z]+^-GC2[^'?P<\>^*M.6&74=!\/W^JVT4_P#JY)(;:26/?[9C&: .^HKY
M7^(G[4OB'P;^R[\+_'%AX<@U_P"('Q!BT>PTC38'$-C_ &M?6WFQB0R29$((
M?@OS@ R)GS!V'P=U3X^MXHGL?BUI'@9](DLWGM=4\$7ER/L\L<L0,4T5SS)Y
M@D)#QX\O[-(#S+'0!ZKJ7BS0](\0:5H=_JVGVNMZP9?[.L+JZC2YO/*'F2>5
M'U?RP03CIW]3T=?G1^T9_P -#_\ #:7P2^R?\*Q_M#[;XE_X0;S_ .TO+^R_
M91YW]I_]-/L_E8\GCS,]J^DO&'QJ\4_ ']GNV\2_$K3M'\2>/O--C#HG@R>4
M1ZM?2W)CM+6T%Q^]8E/*\SAW&R4B.3&" ?0M%?&WB/X@?M@^$=!F\5CP!\-=
M0TBV8:@_@O2;J^GUXVH.9+1)O^/>2Y2/(S&""8SY<<G$9]0N/VC=,\8?LHZW
M\9/ FZ:RM?#M]K%A#JMNT)::VBE/DS1YY_?0^6?+///ER=#0![S17R!\%_B]
M^T+\=++P)XNTOPGX-\+?#_4([!]4C\4&^75;U2(C=75C%&3%%"?W@M_-)+B,
M2'B08^OZ "BOB_Q5^U!\:;_X_?$SX3_#?P+I'B6_T&?1/L&NZB)8;#3K:XMX
MY;J74)/-S(<R 111 2&,328D\K#ZFA_M"?%WX0_%KPWX5^/_ (<\-IH?C*6+
M3M \6>!(KJ6RBU)I#_H-T)?G!E&#&<#_ +:?O#" ?7E%?+_Q;_:.\5M\:O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>G[&?[*?PI_:(_8W^$VK^/O"5OX@OM.AU2UMKB.XN+27R3JEV?++PR1;QNY
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M%8:?]O\ MOV_R_MEU]E\SS=^W[-YOD^7_P!,O+\O'&,4 >/?M7?#7PQ\'_\
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M/%7PN\/>*?'/A#QCJ>F_:_$/A877]D7GVN6/[+]JB\JX_=@^6^8_^>@/3C%
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M,)(',4D4F(V&_'G2 ;,D>B2?L8^#=(^(G@*+Q/\ ';XF^(=8L]8BU[P_X?\
M%GBZ&Y2^N;(^:3%;R19E,8SO\H B.0\C.:]\^+WP%\ ?'#0TTKQSX5L?$D,2
MG[.]QF.XML["WE2QXDBSL3/ED9Q7)?"/]CKX-? S6CK/@KP%8:1K&1Y=]=2S
M7MU:_?CS#)<R2&'(DD!\LCS,\Y % 'SU^T9\.K+6/V]/ T?B7X@^*/ACIGB;
MP1+H&B:YX9UC^SKN_P!1BU'S?L)EP^ 8KF(_O,"23RPOSX%='\2/V#_!=QH=
MMHGCG]H+XLSZ+KEY%I\6G^)/&T1M;^Z)WQ1>7+#B27]WE(^N8L]:^H?B5\*?
M"?Q<\-S^'_&OAW3_ !/HLN3]FOX_,\N38R"6(GF*4"64>9'AQG@UYG\-OV&O
M@7\)?$T'B+PW\/-/AUN [K>ZU"YN+[R) XD$L8N9)!'("@_>KAQCJ!Q0!Y]X
M\\1P?#W_ (*0>!=5U[%AH_C7P'-X3TC4))XEB_M*+4!<F*3]Z&Y'E1#'^LDF
MC0 Y-9?_  5-^*'A/2OV5_%_@V^U_3H_%NL_8#I^C22C[7)&+Z*0R>7G(CQ;
M2_O#\F8\>U?4/Q*^%/A/XN>&Y_#_ (U\.Z?XGT67)^S7\?F>7)L9!+$3S%*!
M+*/,CPXSP:\OTG]A+X$:%X'UOP=I_P .M.M]&UK:+]A<7'VJ6,212"+[5YGV
MD1>;;12>6)-A,>: .O\ CAX"^&WQ<T[3/A]\2DTO4X]9F^UZ=H][?"VN;N6W
MQ)(]K^\$N8XR?,,?2.0\X)!\0\*^(O$O[-O[3'@7X/3_ !)U'XG:!XTL[ZXL
M;7Q-)')K>AFVB,_FS72?/=17,GVI!YD8,8BQ&<1.#[;\:/V<_AW^T-8Z58^/
MO#$'B&WL9VFLI#--;2Q,P <"2*1) "!S'G!*1G'R<1?"3]F'X6_L_P#VE_ /
M@FPT&\N@ZRZANDN;PQGR\Q_:93)+Y7[J,^5GR\C./4 ]AKXE^,'CW_AEG]KK
M5O&\-B+G0OB#X%U*]N-*MI2);W5]#MC<B6620'[/']B'DCRLYDYDCX$E?;5>
M:?&?X$>!OV@_#-IX<\?:&?$>CVEZE_'9B[FMOWOER1B4F*2,YQ+)W[]* /B*
MR\'-^R#X7_8V\=2A=$L+=3X8\6#7KG^SKP?VO$;KRKEO+&;:UN3<R>5+_JS%
M'W\R0?0/[%ENOC2/XI?&#[7#JTGQ"\47,^FZO")(VETBRDDLM/BDB,<?E^6L
M4G('F$2 R'->X_%;X7^&_C!X!U3P?XOTTZMX=U'R?M-G]IDA\WRY8Y8QYD9$
M@_>1Q]#V[UK>%_"FG>"/"NC^'='MS:Z/I-G%8V=OYA?9#%&(XX\O_L@#\* /
MG3]@K[W[1G_99?$?_MM5'X#ZI96_[>W[4^FR7=NFHW,/AF[AM7D'FRQ16&))
M G7]V98AG'_+2.OH3X>_"_PY\,?^$B3PYI[:?_;^K7.O:B//DE^T7UP1YLOS
MGOY8XZ<=*XGXR_LF_"O]H#5-,U/X@>$8M?U#38/LL$XN[FVF\HDGRC)%+&9!
MNZ>9G&]\8\PT >?_ +0W_)]7[(__ '-W_IKBI?\ @J)_R8O\3/KI?_ITM*]Q
M\5?"[P]XI\<^$/&.IZ;]K\0^%A=?V1>?:Y8_LOVJ+RKC]V#Y;YC_ .>@/3C%
M/^*WPO\ #?Q@\ ZIX/\ %^FG5O#NH^3]IL_M,D/F^7+'+&/,C(D'[R./H>W>
M@#MJ^//^"C/B;3?!OA7X'>(M8N/LFBZ/\5]#U"\N2A<1PQ1W4DDF$Y/ K[#K
MBOB%\+_#GQ._X1U/$>GMJ']@:M;:]IP\^2+[/?6Y/E2_(>WF'CISTH SM8^-
M'@?0OAC=?$&?Q9I,G@FSCDE?7[2\2YM65)/+^22,_O"9,1^7'DF0^6.>*^!?
M$WA74O!__!$=++5+?[/<RV5KJ$48?=F"YUZ*YA?\8I8S^-?5>E_L!_L]Z7XN
MD\1P_"S27U&:22;R;AYI;(&3<,?8I)/LX #\1^5A.P'%>O\ Q6^%_AOXP> =
M4\'^+]-.K>'=1\G[39_:9(?-\N6.6,>9&1(/WD<?0]N] 'SU_P %%+Z3PK\-
M?ASXVFLIK_1/ OQ$T3Q)JS6NSSDLHGEC.P/(-[>9-%'C/_+3/0$CZ&_X6WX+
M_P"$$_X37_A,=!_X0[/_ ",7]I1?V?\ ZWR?^/G/EX\W]WUZ^_%;NL:'8>(]
M+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M?/W_#NW]G;_A+/[>_X5AI_
MV_[;]O\ +^V77V7S/-W[?LWF^3Y?_3+R_+QQC% 'R;)X>UKXK?\ !.G]I/Q=
MHNDW2:;XR\:ZIXQT>&XFABD_LV*_M))9) ),(8Q:W64)S^ZXSE"?O[PW\=/!
MOBGX0Z/\3AKUAI7@[4K.*[&H:I?0PI;>8=GE32>88HI!*?*/[SB0%,YKM='T
M.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_]7&B#@ #T]*^?O\ AW;^SM_PEG]O
M?\*PT_[?]M^W^7]LNOLOF>;OV_9O-\GR_P#IEY?EXXQB@#B_VT=5TOXG^ _V
M;=3TS4+FY\/^(?B?X;NK:\MY);.66UN8IMCQR QRQ'RY,CI(#CIC-;/P)\4)
M^S;\0M$_9MUZ$3Z5/:2WO@/Q%9Z>(DO[6,R2S65V(HQ']MA&93+'_K8Y$DD\
MN5\2^Y>)?@[X1\5Z9X1T[4O#MO\ V=X5U2TUC1;2UDDMH;"XM@1;&..(@8C'
M'E?ZOV-6?B%\+_#GQ8T2TTGQ5I9U"WM+R.^MKB.XEM;BWNHCF.>*:(QR12 ]
M'C((YH ^:_VNO'6@?#;]K_\ 9:\0>*M3MM(T2U?Q-%+?738BB,ME;11F0G[G
M[R2/Y^W?BO0/VPOBOX1T']D7XB:U=^(--CTS7?#US8:3=)*9(=3FN;23[-'!
MY?\ K?,R#E21Y>9#B,$UZ5XZ^#G@[XA>*/#NO^)=!M]=U'08;^UL?M<DAB2*
M]A\FZC>'/ER"2+]WB4'K[UY[\-OV&O@7\)?$T'B+PW\/-/AUN [K>ZU"YN+[
MR) XD$L8N9)!'("@_>KAQCJ!Q0!X9^T/IMY\*_V5_P!EF;Q58W&F0^ _%/A"
M\\23+'YXTZ*UM3%-+)Y6_@28C!&<D@#->R?MB?&'P/X5_98\:3:EXMTA3XI\
M*WZ:&3=))_:WFV^R,VP0YE!-Q#\\? $F_I7NOB;PQH?C+1+G1M>TG3]=T>X/
M^D6&J6L=S;-SO!DCD!!YYY]J\'\)_P#!/_X"^!;S49M&^'D,$FI:9<Z/<O)J
M5Y<'[-<1>7,$,LQ,9,>8_,BQ)B0\CG(!D^!? ?PT^+G[)OP,^'WQ'CTS5(=:
M\*Z/=Z;H]]?BVN;J2WL89)'MAYHES'&3YACZ1R'G!(.'X5\1>)?V;?VF/ OP
M>G^).H_$[0/&EG?7%C:^)I(Y-;T,VT1G\V:Z3Y[J*YD^U(/,C!C$6(SB)P?6
M_'7[)?PF^)W@KPMX0\3>$8=2T'PO'';Z1;&YN(Y+*)(UC$8N(Y/-QY<<><R<
M^7'G/%7?A)^S#\+?V?\ [2_@'P38:#>70=9=0W27-X8SY>8_M,IDE\K]U&?*
MSY>1G'J >2_M/:S8Z+^VQ^R7<ZC=PV<,DWB6W22YD$8\V6QABBC^LDDD:=.N
M*I?\%*-)DU3X1> ]4O=1U#0/#OA_QUI.IZWKVE7 CNM)LOWEM)=Q8S(9(Y+J
M/'EB0YY]:^B/BY\'/"'QL\'2^'/&V@P^)-)9TN!;RRR1%)$QAXY(R)(SV^0]
MSZFH_!?P;\(_#GX8P_#O0]!MXO!<<5Q;#1;QWNHGBEDDDECD\TR&02&20G.>
M#CVH ^?_ /ACW1/^$6_X23_AJ#XV?\(U]D^W_P!L_P#"P$^R_9?*\SS_ #?)
M\ORO+_>>9G&.<UO:Y\-?"WP=_P"">WCGPKX+U6XUSPM:^"-=N=.U.YN([@W4
M5Q;75SYGF1@1R@F4X(&",'I5W_AW;^SM_P )9_;W_"L-/^W_ &W[?Y?VRZ^R
M^9YN_;]F\WR?+_Z9>7Y>.,8KVO5/A_X?UKX?WG@N;2K>#PQ=Z;+H\FDV@-M"
M+*2(Q&&/R\>6/+XQ'C&.,<4 <M^RA_R:S\&O^Q,T;_TABKU>N?\ "_A33O!'
MA71_#NCVYM='TFSBL;.W\POLABC$<<>7_P!D ?A704 ?$GPC^*7A3P;_ ,%!
M/VC=!U_7K#1M8\1_\(RND6U_,L1O98[ 1F.+./WF;B+$8^<YXR :W/VRM7L/
M%WQ+_9W\!:9<Q7'C4?$/3?% T/S!YR:98K<R7-R<X &-V,\R&.01B0H:YKPU
M\'_"'QN_:T_:U\-^./#\'B/2=WA"X6&662$I(FF2X>.2,B1#VRASSCO7T'\)
M/V8?A;^S_P#:7\ ^";#0;RZ#K+J&Z2YO#&?+S']IE,DOE?NHSY6?+R,X]0#P
M_P"'?CK2OA3_ ,%!_C3H/BR:WT2;Q_IGA_4_#EQ>75M%'??9HOL/E19DW&66
M60B./&3Y4G3N[_@I7XUTW4O@/-\)K&ZM[WXA>/-2TS2](\/QW-O'<,9+Y)8Y
M9(Y) 8XC]FDB\W&/-(Z=OH3XO? 7P!\<-#32O'/A6Q\20Q*?L[W&8[BVSL+>
M5+'B2+.Q,^61G%<E\(_V.O@U\#-:.L^"O 5AI&L9'EWUU+->W5K]^/,,ES)(
M8<B20'RR/,SSD 4 >>_\%!M6LM$TOX"ZE?WD%AIEC\6]"N[FZN7\N*WBB%R9
M)'D/  'K70?\%&O"NH^+_P!BWXFV.EP_:[F*RMM0E0N$ AMKJ*YF?\(XI#^%
M>X^.? V@_$SPGJ7AGQ-I-OK&BZA%Y=Q97 .']/<<_P 8-<[\&/@1X&_9\\,W
M?ASP#H9\.:/=WKW\EF;N:Y_>^7'&9099)#G$4??MTH ^?/ _[)>A_$SPCIOB
M;PS^T]\=-8T34(O,@O+;QMG>?^_.1_N=:]9_91^$_@[X2_#W47\#>,=1^(&C
M^(]6N==F\1:AJ<6IO=W#B.*5OM,2 2',63U)D\S)].6\2?\ !./]G/Q9K5QJ
MU[\,+".XGQNBTJ[NK&WP!_!%;RQQIGZ5[_X9\,:'X-T2VT;0=)T_0M'MS_H]
MAI=K';6R\[R8XXP .>>/>@#YT_X)=_\ )B_PS^NJ?^G2[I/V>?\ D^K]KC_N
M4?\ TURU[K\*?A?X;^#_ (!TOP?X0TTZ3X=T[SOLUG]IDF\KS)9)9!YDA,A_
M>22=3W[4SPK\+O#WA;QSXO\ &.F:;]D\0^*1:_VO>?:Y9/M7V6+RK?\ =D^6
MF(_^>8'7G- 'S_\  ?5+*W_;V_:GTV2[MTU&YA\,W<-J\@\V6**PQ)($Z_NS
M+$,X_P"6D=7OVAO^3ZOV1_\ N;O_ $UQ5Z!\9?V3?A7^T!JFF:G\0/",6OZA
MIL'V6"<7=S;3>423Y1DBEC,@W=/,SC>^,>8:[+Q5\+O#WBGQSX0\8ZGIOVOQ
M#X6%U_9%Y]KEC^R_:HO*N/W8/EOF/_GH#TXQ0!\P>-'\2_M.?M8^._A5%\5=
M?^&'A?P!9Z;=/I'A:ZCM]4UN6YMY99+F*Y_UD,<7VFVB>/$L9Q'_ *LR#'%?
MLXZ+H'A#_@HUXHT#0OB-XF^)+Z3\.Y;34=0\6ZP-3O+.\&J6_FVJS! ,1_NS
MY>#B223H<BOJ+XR_LF_"O]H#5-,U/X@>$8M?U#38/LL$XN[FVF\HDGRC)%+&
M9!NZ>9G&]\8\PU;^'/[+OPO^#_B*#7O!/@G3_#6JQZ1_87VG3S)&9+3S!+^]
MY_>RDQ1DRR#S#C'F&@#S/_G*9_W1O_W-5] 6'Q"\*ZMXTO?"5KXDTJ[\46,)
MN;G0X+^.2]MHL1_O)8<^9&,2Q\D?\M1ZBJ__  JWPW_PM;_A8O\ 9I_X2_\
ML?\ L'^T/M,G_'CYOG>5Y>?+_P!;STS[UD:/\!_ N@_&36_B?I^B_9_'FM67
MV&^U87DQ,\0$0\LQ&3R_^7>+D1Y_=]>M 'I=%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445F:/K6G^)-/BO]+O
M;?4+"89BN+:42QO^(H TZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BLS6-:T_PWI\M_
MJE[;Z?80C,MQ<RB*-/Q-:= !1110 4444 %%%% !1110 445C:5K6G:L;Q;&
M^MKT6EQ):W"VLH?RY!C,<G/#].#0!LT5C:5K6G:L;Q;&^MKT6EQ):W"VLH?R
MY!C,<G/#].#6S0 445C6NOZ;>WU_8P7EO+?67E_:;6.4&2#S!F/>!RF1G^=
M&S1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MVC_AOX9AL9=2\3V\*WT*74,4<,LDJQR1QR1F6*.,F(&.2,CS,<$5%KG]H?\
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M8;&74O$]O"M]"EU#%'#+)*L<D<<D9EBCC)B!CDC(\S'!%=1XX^)'AKX:Z?\
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M1QB(3G][*1QB.,?O).7Z#.*H^ OB]X.^)/F?\(WKUOJ4T'W[4$Q3;>/WOE2
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M%QS^\C'_ #T%8/[8'_)N_BS_ +=?_2J&O8XZ7V!?;'4M)2U!J%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ%&<&3.,YYKTKP!XQU;QQ_:%Q=^$=3\-:6GDBSEU>1(KJZR3YOF6PYBPWO\
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#XN_:(_;*\6_!O\
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M^'4?[9WPST*QM[;PPDL<L,.Z226 6'B:VMK6/>7/ CNI,YZX3GK0!]+^+/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,21[L/4_;>^(WPO^.?QZ^'-Q^SG /^$]OKTBYUO2;:32?MNI374?V7F3RL7
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 45YEXP^-FC^#?BM\/OA_>V=_-K7C;[>-,FMD0V\?
MV*$33>8?,R.".@/I7IM !17SM8_M?:-KWP#\._%SPYX \>>*M(UZ]EM(-'\/
MZ.E]JD7ER31F:6*.7 CS;=?,/^LC]>.$OO\ @HSH>EZWINC7_P $/C5::WJQ
MF_LW3KKPG''<WGE#S)/)B-SF3RQ@G .,T ?8E%>%_!W]IC_A<WBB?11\+/B9
MX*^SV<EV=0\9>'_[/M9,21Q^3')YIS+^]SCTCD]*ZGX"_&G2/V@OA;H_CWP]
M9W]GHVK>;]EAU-(X[C]U+)$?,\N20#F(]_\   'I=%%% !17R[XV_;C\+>$_
MB+K_ (-T#P;X^^*NJ: 8DU63P#HO]IP:;+)YG^CRR"0?O,Q'(Z#I_K(Y /1_
M@O\ M ^$/C]I^J3^&+V[6^T6?[/K&BZE:R6M_IEPP.8;B"0@@@^9'GF/?%+@
MGRS@ ];HKYW^+/[8_A7X4_$!? EKX;\6_$3QC#9?VA>:)X'TL:G=:=%^Z"/<
M 2#R]XE&!R<$$X\R,R;7P=_:@\(_&[4M3T'3(-6\->,M(A%YJG@_Q/ILMCJE
MG$Y/ER20L,'/[I\QF3 FCSCS!0![=17GWQ=^+6@_!GPBVO:]+<SI)+'9V6FZ
M=%YM]J5[(?W5K;19'FRR8.(QZ?C57X"_&G2/V@OA;H_CWP]9W]GHVK>;]EAU
M-(X[C]U+)$?,\N20#F(]_P#  'I=%>?_ !<^,?A#X)^#I?$?C;7H?#>DJZ6X
MN)8I)2\CXPD<<8,DA[_(.Q]#7D/AG]MC3_$7B/1-(U7X0?%KP5!J5]!8IK?B
M;PG]DT^&::410QRRB23R_,EDCB&1UD'(H ^GJ*\U^,_QM\.? ?PQ::SX@&H7
M#7U['I6GZ?I=E)=76H7TB2/%;11Q@_O)#&<9XSQQFO%;;]OSPIINM:+8^,?A
MY\3?A=INK7HM(=?\:^'1IFEQ2E28XY)?-XR(S^1SA,X /K2BO(/C=\=I/@B=
M&8_#OQ]X]&I><<^!M#_M(VQB,7^N_>#RQ)YGR^OE2?6O)M2_X*!V.BZ;=W^H
M_ 3XY:;IMI&]Q/=W?@\0Q6\<8)DDDD-SC  )R?2@#ZXHKSS1_BYH.H?!FS^*
M,\EUI/A6XT*/Q'(]S%NFMK$VWVC,L<9DY$9R1'D^F:\'U+_@H=X?TK3KO7(/
MA'\8]5\*V\4EY%XEM_"+?V==66TR"YCEDECQ$8P)!)(!\@R>IH ^NZ*Y;P-X
MYT'XF>$]-\3>&=6M]8T74(O,M[VW)P_K[CG^ BNIH **\)_91^-&N_M!_"N?
MQ_?6MA9:-K&L7_\ PC\%K#)%<KI<4_DQF[!DD'VG]W*3Y9V?<Q6G;_'W2KWX
MO^,O!.T0V?@G2H]2\3^);J6.UM=,>4"6UA/F']YFW\Z627B./RUSS(1& >QT
M5Y3X%^,UAK_P+A^*>NZ?<>%]!FTVZUU8KN;[7+'IH,LT5S)Y9(_>6PCF\H9,
M?F>7R17C6I?\%#O#^E:==ZY!\(_C'JOA6WBDO(O$MOX1;^SKJRVF07,<LDL>
M(C&!()) /D&3U- 'UW17D]U\>M"_X4JOQ/\ "]AJWQ"T*XABFM+/P?9F_OK@
M/,(B(H]P^:,D^9'P8_+DR,C%>6?\-[G_ *-U^/W_ (0Y_P#CU 'U717DG[//
M[0^C_M%>&=;UG1]#UWP^-'U>70KRQ\16T=M<I<Q1QR2#RXY).@E'4YZUYYXJ
M_;G\.:5XDU72/#7P]^)?Q*72;V32]2OO!GA:6ZM;._C?9+:R22&/]['\IXR,
M2)R: /IZBO'/V?\ ]H;PO^T-I.IWN@'4++5-'OY;#5]!UJW^RZGI,P)'DW$6
M3C.PXQD'!!/F1R <WJO[4K:=X@_:+TL^&/-/PCTFUU7S%O\ ']KB6PEO?+_U
M7[G'E>7_ ,M.N?:@#Z'HKPOQ%\4O&OB+]DVW^)O@'0+&;QG?^'+7Q'9:#J!F
MNHG\R*.XDM\0B.223RS)''C&9/+SWKM/@G\2+/XS?"7PCXULC!&FNZ=%?&&W
MN1<"WE=,RP>8 .8Y?,CZ=8^W2@#T"BBO,_A%\:M(^,R^,TTBUO[/_A%?$E[X
M7OOMZ1QF2ZM?+\V2/9(<QYD')P3Z#N >F4444 %%%% !1110 4444 %%%% !
M1110 445X]X#^.4GCKXW?%KX=+H?V!_ ?]D8U%;KS/MWVZU,P_=>6/*\O '6
M3/7CI0![#1110 45YG\(OC5I'QF7QFFD6M_9_P#"*^)+WPO??;TCC,EU:^7Y
MLD>R0YCS(.3@GT'?TR@ HHHH **** "BBB@ HK'UC7+#PYI=WJ6HWEO8Z;9Q
M27-Q=7,@BB@CC_UDCN>  /7THT?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_
MU<B..""/3UH V**\S^$7QJTCXS+XS32+6_L_^$5\27OA>^^WI'&9+JU\OS9(
M]DAS'F0<G!/H._IE !1110 445@>&?$^A^,M$MM9T'5M/UW1[@_Z/?Z7=1W-
MLW.PB.2,D'GCCWH WZ*\R\'_ !LT?QE\5OB#\/[*SOX=:\$_8!J<URB"WD^V
MPF:'RSYF3P#U ]*]-H **** "BBB@ HHKQ[QY\<I/ OQN^$OPZ;0_M[^//[7
MSJ+77E_8?L-J)C^Z\L^;YF2.L>.O/2@#V&BBOFCXX?MN?#S]G[XQ>&OAYXM@
MU2'4?$$=K<PZQ%%;#3K9)KB6W\RYEDEC,8C\K,AP<)^5 'TO117CG[1W[1_A
M;]E_X?CQAXP74);.6ZCLK:WTZ 2W$\S_ /+./.(\^7'++^\D'^KQUP* /8Z*
MY7X>>,;'XC> _#?B[38IH;+7],M=3MDN1^\2*6(2QA^?1Z\Z_:*_:?\ !7[+
MWA&UUWQG?7$<UY<>39:59Q1O>WF,&0Q1EL8C!S))G SCJ\8(![?17*_#SQC8
M_$;P'X;\7:;%-#9:_IEKJ=LER/WB12Q"6,/SZ/754 %%%% !117C_P >/C5_
MPI5OAYC13K)\6^,M-\)Y^T_9_LOVKS<7'^K/F%/+_P!7QG/44 >P4444 %%%
M% !17.:EXLT/2/$&E:'?ZMI]KK>L&7^SK"ZNHTN;SRAYDGE1]7\L$$XZ=_4\
MO\>OC3I'[/OPMUCQ[XAL[^\T;2?*^U0Z8D<EQ^]ECB'E^9)&#S*._P#@0#TN
MBBB@ HHHH **** "BBB@ HHHH **** "BBO-/CU\:=(_9]^%NL>/?$-G?WFC
M:3Y7VJ'3$CDN/WLL<0\OS)(P>91W_P " >ET444 %%<YJ7BS0](\0:5H=_JV
MGVNMZP9?[.L+JZC2YO/*'F2>5'U?RP03CIW]3T= !16!XF\3Z'X-T2YUG7M6
MT_0M'MS_ *1?ZI=1VULO.P"220@#GCGVK?H **\B_9<^.#_M)? WP]\16T;_
M (1]=9^T[=.%T;GRA%<RPD&3RX\\Q9Z=Z]=H **** "BN=_X2K1?^$G_ .$;
M_M>P_P"$F^Q_;_[(^U)]K^S>9Y7G^5_K/*W_ +OS,8SQUKHJ "BO'O'GQRD\
M"_&[X2_#IM#^WOX\_M?.HM=>7]A^PVHF/[KRSYOF9(ZQXZ\]*]AH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BO'_CQ\:O^%*M\/,:*=9/BWQEIOA/
M/VG[/]E^U>;BX_U9\PIY?^KXSGJ*]@H ***P/$WB?0_!NB7.LZ]JVGZ%H]N?
M](O]4NH[:V7G8!))(0!SQS[4 ;]%%% !1110 45X]X#^.4GCKXW?%KX=+H?V
M!_ ?]D8U%;KS/MWVZU,P_=>6/*\O '63/7CI7L- !1110 4444 %%%>/_'CX
MU?\ "E6^'F-%.LGQ;XRTWPGG[3]G^R_:O-Q<?ZL^84\O_5\9SU% 'L%%<[XD
M\6:)X7^P)K.KZ?H[:G>1Z?9?VA=)";FYD)$<40?_ %DIQQ&.?RJO\0_&-C\.
M? ?B3Q=J44TUEH&F76IW*6P_>/%%$99 G/HE '545ROP\\8V/Q&\!^&_%VFQ
M30V6OZ9:ZG;)<C]XD4L0EC#\^CUU5 !117D7[+GQP?\ :2^!OA[XBMHW_"/K
MK/VG;IPNC<^4(KF6$@R>7'GF+/3O0!Z[1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Q+^VM\4/#?P?_:F_9@\8
M^+]3.D^'M-'B<W-[]GDE\KS+&&*/]U&#(?WDD8X'?M77_P##T3]F/_HI8_\
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M:Z&L:;'/^[#?O)3;R>7++&I$;2 \=LRIV_[0W_)]7[(__<W?^FN*E_X*B?\
M)B_Q,^NE_P#ITM* /JJO#/VEOVA[;X :%X>CT[2%\6^,?%6L0:)H7AQ-4AL9
M;Z:0XYED.8XQT\P XDDB!_UF:]SKX[_:]\0Q?"_]HK]F;XC:\PM/!FDZQJVB
M7VJ&:&..VFU&T2*W\TRRC$0\J6220?<CC/?&0!/%'BG]LKP+HMSXAO\ PO\
M";Q?I^F;;FYT'PL=3_M2]B!_>1VWF_)YNS)!P>^(Y#B,^KZ[\>K/6?V6=9^,
M?@L0W\$?A:Z\1:>EV^]?-AMI)1#-Y4G6.2,QRQK)P5E&:Z#XC?&[P5\+?A?=
M>/\ 6/$%C_PCC6!N[*>&^B/]ICR6FBCM3)((Y998XR8P#^\^E?,'P3\*ZAX/
M_P""1NIV6JV_V:ZE\ ^(=0C0.'!@N8[NYA?_ +]RQ_G0!UWP7^+W[0OQTLO
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M$^A2QYBBED!,5S;R8(>*81,Z<G'_ $T0QR2>1?#G]H+]H[X\:7<_$WX<>!_
M9^&4UY.=(T?Q#?7,.NZM:P'RY )8B;:*662.2-#+Q&0<^9&/,D]&_9U^$?P^
M^!-[\3?%6F?$O5O&L][)';^*=<\5>(+:_P#L$FGQR9BFF6./RC'%-^\$I^0"
M,<<UYS\4/@[HO[._P[USXR_!#X@+\.]$@M9-=N/#ZRQW_A;Q 9/WJI';22 0
MR7)%K%'+;2#$>(XHQYG(!W_[>7_"T/\ A0OC#_A ?^$0_P"$<_X1G6/^$H_X
M2#[3]L^R_93C[#Y7[OS/+\[_ %O'^K]ZROV%/^%U?\*Q\ _\)I_P@7_"M_\
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M#1OA-X)M?$OBK5IOFU37)/+T?2K:*6(2371$@DD)\U=D469,"5QGR_+D\_\
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MX57]@T_^U_MGVK^VOM7]IQX^S8_<^7G[+GS.<>9[5](?!+_A=F-:_P"%P?\
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M(\N3GB/I0!]&T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]7#C'4#BOH6B@#G_ !1X4T[QOX5UCP[K%N;K1]6LY;&\M_,*;X98S')'E/\
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M\P^&_P#@G'^SGX3UJWU:R^&%A)<09VQ:K=W5];X(_CBN)9(WQ]*]I^(7PO\
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MFBV_V/2-)\":G865N9"XCBBL)(XH\ODG@ ?A7D/PQ_8G^"WQS^!_PE\3^,_
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MPB2VF(/^D1Q^8_E21G]Y^YED'$B5\=?!S_AJ'_AJG]H?^Q?^%2_\)E_Q3O\
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M:?:ZWK!E_LZPNKJ-+F\\H>9)Y4?5_+!!..G?U/EOQ/\ C%K_ (+_ &C/@CX
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 ?$O[:WPO\-_&#]J;]F#P=XOTPZMX>U(>)
MQ<V7VB2+S?+L898_WL9$@_>1QG@]N]>Q?"/]CKX-? S6CK/@KP%8:1K&1Y=]
M=2S7MU:_?CS#)<R2&'(DD!\LCS,\Y %=_P"*OA=X>\4^.?"'C'4]-^U^(?"P
MNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\ /0'IQBNYH ^5/V]?O?LY_P#99?#G_MS7
MJG[5_P#R:S\9?^Q,UG_TAEKHOB%\+_#GQ._X1U/$>GMJ']@:M;:]IP\^2+[/
M?6Y/E2_(>WF'CISTK5\4>%-.\;^%=8\.ZQ;FZT?5K.6QO+?S"F^&6,QR1Y3_
M &21^- 'QWXN^,.L?!_]AG]GQM UZW\'WOBF'PKX=3Q1<I%+%H44MI'+-=2Q
M2_NY0(HI<@^7Q(.1BO%/V[O@-8_ O]FN:/Q%\?/B5XN\6:K]E@L_#_B#Q(9+
M'59(IHI+B06AC)\N/F3F0^6?+'F$XW_H5JGP;\(:M\)X/AK?>'H+[P3%IL.E
M#29YI''V>*(1QJ),^9E-D>),EP1GKS7DFF?\$[OV=K'P]J>E1_"O3I;74HX?
MM#W-[<R7,7EMD>5-))YMN3GDQ%/,QB3- 'HWQP\!?#;XN:=IGP^^)2:7J<>L
MS?:].T>]OA;7-W+;XDD>U_>"7,<9/F&/I'(><$@^(>%?$7B7]FW]ICP+\'I_
MB3J/Q.T#QI9WUQ8VOB:2.36]#-M$9_-FND^>ZBN9/M2#S(P8Q%B,XB<'VWXT
M?LY_#O\ :&L=*L?'WAB#Q#;V,[364AFFMI8F8 .!)%(D@! YCS@E(SCY.(OA
M)^S#\+?V?_M+^ ?!-AH-Y=!UEU#=)<WAC/EYC^TRF27ROW49\K/EY&<>H!\J
MZ[\';/QE^WW\6M"UOXF>,OACJOB;3M'U7PY:>#_$ TU]=MH;62"Y,F$D#F*2
M*3$;#?CSI -F2/1)/V,?!ND?$3P%%XG^.WQ-\0ZQ9ZQ%KWA_P_XL\70W*7US
M9'S28K>2+,IC&=_E $1R'D9S7OGQ>^ O@#XX:&FE>.?"MCXDAB4_9WN,QW%M
MG86\J6/$D6=B9\LC.*Y+X1_L=?!KX&:T=9\%> K#2-8R/+OKJ6:]NK7[\>89
M+F20PY$D@/ED>9GG( H ]XHHHH *^5/VAO\ D^K]D?\ [F[_ --<5?1?BCPI
MIWC?PKK'AW6+<W6CZM9RV-Y;^84WPRQF.2/*?[)(_&OG3_AUW^S'_P!$T'_@
M^U3_ .2J /JNBO-/@Q\"/ W[/GAF[\.> =#/AS1[N]>_DLS=S7/[WRXXS*#+
M)(<XBC[]NE>ET %> ?%CX%_#7]H+Q@[RZQ=:;\2_"<$5K_PD'@[6OL.OZ+'<
M?O-CF,_*)8Q+@2Q_ZN64Q_?)KW^O /BM^Q/\%_CEXK?Q-XS\#0ZMKLD2Q2W\
M=]=VN_8 $WB*6/S#CC>>< #M0!SW[*OQ<\0^*O'OQ2^&7BKQ19?$+5?AY?6$
M#^,+"TBLCJ!N8Y9)(I;:(F.-[>6*2(X/\/($@.<;X#ZI96_[>W[4^FR7=NFH
MW,/AF[AM7D'FRQ16&)) G7]V98AG'_+2.OH#X:_"GPG\(_#<'A_P5X=T_P ,
M:+%@_9K"/R_,DV*AEE(YEE(BB'F29<XY-<;\9?V3?A7^T!JFF:G\0/",6OZA
MIL'V6"<7=S;3>423Y1DBEC,@W=/,SC>^,>8: /)?VN/%=A\/?VIOV7_&/B2;
M^R/"FGWWB&QO=9N(B+6WENK!([9))2N(_,PW7^Y(>D9QE?\ !4WXH>$]*_97
M\7^#;[7].C\6ZS]@.GZ-)*/M<D8OHI#)Y><B/%M+^\/R9CQ[5]0_$KX4^$_B
MYX;G\/\ C7P[I_B?19<G[-?Q^9Y<FQD$L1/,4H$LH\R/#C/!KR#1?V O@'X;
M\-^)-$TWX>6T.F:]#%::FK:C?22S112Q3)&)3-YD?[V.)\1D>9Y:9SQ0!R?[
M7OB&+X7_ +17[,WQ&UYA:>#-)UC5M$OM4,T,<=M-J-HD5OYIEE&(AY4LDD@^
MY'&>^,]S^VY\2_"?P]_9O^(-GXB\0:;I>H:]X:U2PTRSO)L7-[+);&,)%%G?
M)^\ECR1]S<,X%>V>)O#&A^,M$N=&U[2=/UW1[@_Z18:I:QW-LW.\&2.0$'GG
MGVKQ3P9^PK\"/ -EK5OH?PZT^)M8L)+"ZENI[BXNE@FBDAF2&:64R6_F12RQ
MDQ&/J?84 >$_M)_\H<=)_P"Q*\)_^C=/KN/^"E&DR:I\(O >J7NHZAH'AWP_
MXZTG4];U[2K@1W6DV7[RVDNXL9D,D<EU'CRQ(<\^M>^^)/@/X'\5?!V+X6ZO
MHQN_ L5E:V":0MW,F(;<QF&(2B3S./*CY\S)P,FNSUC0[#Q'I=WINHV=O?:;
M>126UQ:W,8EBGCD_UD;H>""/7UH ^4_^&/=$_P"$6_X23_AJ#XV?\(U]D^W_
M -L_\+ 3[+]E\KS//\WR?+\KR_WGF9QCG-='X?\ V<_@;'\!/ ?P4U;4=/\
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MX@^RZ%KMS<Q226MO%8QB0>3*&&8XI#'Y8D<>7&/DZ#]I/_E#CI/_ &)7A/\
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MV.O@U\#-:.L^"O 5AI&L9'EWUU+->W5K]^/,,ES)(8<B20'RR/,SSD 5[Q0
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MNXT.VT3QS^T%\69]%UR\BT^+3_$GC:(VM_=$[XHO+EAQ)+^[RD?7,6>M=?\
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MEL;RW\PIOAEC,<D>4_V21^- 'P_^TG_RAQTG_L2O"?\ Z-T^OT KS3Q)\!_
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M*@^+GP<\(?&SP=+X<\;:##XDTEG2X%O++)$4D3&'CDC(DC/;Y#W/J: /%?\
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M'I[:A_8&K6VO:<//DB^SWUN3Y4OR'MYAXZ<]* .=_:O_ .36?C+_ -B9K/\
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ML^"O 5AI&L9'EWUU+->W5K]^/,,ES)(8<B20'RR/,SSD 4 >\4444 %?G_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M>7*4\N4$Q2?/$7''N*]6H **** "BBB@ HHKE?B'XQL?ASX#\2>+M2BFFLM
MTRZU.Y2V'[QXHHC+($Y]$H ZJBN5^'GC&Q^(W@/PWXNTV*:&RU_3+74[9+D?
MO$BEB$L8?GT>NJH **** "BBB@ HHHH **** "BN*^(7Q0\.?#'_ (1U_$>H
M-I_]OZM;:#IQ\B27[1?7!/E1?(._EGGIQUKM: "BBB@ HHHH **** "BBB@
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M!K_L3-&_](8J\K_8*^]^T9_V67Q'_P"VU '1?LT_%.U\?_LFZ3X\\!?#C3M
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MCDF^LGE^6),<,G[:'BKX?^+_  YI_P <?@Y=?!_P]KT[V%CXJ/B.VU:PAO<
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M^9'Y8,9KVS]I;2KW6OV=?BCI>G6<^HW^H>%M4M+2UM8_,EGFDM95CCCC[G)
MQ7*?L/ZEH6L?LD?"J7P];VL=A'H%O!(MK;>4#>1'RKHXQU-Q%*3)SO.7R>I
M+7[.O[0W_"[_ /A+-%UCPGJ'@;QWX1O?LGB#PS?2"Y:W,GF&VFCN!B.6.6.-
MB"/J/W?ER2>4V?[<7B+QQXH\<>$_AW\'=0\9^-?"7B.^T:^L;?68[.VCLK>3
MRH;N6[FB$<<DLGF^7;#S#B&4YXJYX?U*/7O^"G7B:33X+B[B\-_#.'1M4NUM
MI!%:WLVH1744)DQC,D,@D'KMD_N28T_V"OO?M&?]EE\1_P#MM0!XA^VQ\4/B
MW=WWP62]^"?V&TM_'WAG5;&Z_P"$OM9OMNJ?93)_9? S%B626+[2?W?[G?\
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M;"WD.CZ=IT<R&2)#<S\&4@QD1 <QF0[\Q2 9G_.4S_NC?_N:KQ7X!_#7XO\
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M=4_].EW1_P $N_\ DQ?X9_75/_3I=T?\$N_^3%_AG]=4_P#3I=T ?55?G/\
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M[+NI?&GPW;3ZWHUMH=]K45C=?Z+++]E24R6TGWO+(DADBR/,'&1O%>=?#/\
M:\\<?&]/!^L>"?@OJ&I^ ]3^QQ:KXHNO$$-DEE/)L^W+;0RQ^9>QVID\OS8Q
M'YDD4J1CC)\F^#VJ0^(?V,?VPO$]H)WT'Q-KWC36=(O9H)(_MUE+8_NY8_,
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M#\9:)<Z-KVDZ?KNCW!_TBPU2UCN;9N=X,D<@(////M6_0!Y;-\$?"L/P/O\
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M^#LWPYUO6->\;:)=6MU8WM]XEU$W&H7L5P9/-BEN(_+)/[PQ@\'  ]Z].HH
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M#1_^%\?\+8^UZA_PD'_".?\ "+_9-\?V3[)]I^T[\>7YGF^;W\S&.W>O2J*
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M_%GP[U+QOXR\9:7XFCNK6YU3Q7JRWM_;QW%L+:2.*4Q@ =6 P?GD;UQ7MU%
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MQIXRN+.32QXE\9ZY)?WB6!>.7[(N<1B/S8_,'[O/[Q^<'%>ZT44 >4?M7_\
M)K/QE_[$S6?_ $AEKYE^!O[#OA;Q1\*? /B_P_XV\>_"[5-?\'Z$^JI\/]<_
MLVWU22.QC_TF6/RC^\S+R1P?O8\R20G[9UC0[#Q'I=WINHV=O?:;>126UQ:W
M,8EBGCD_UD;H>""/7UHT?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_U<:(.
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MV\/)>P/%Y5M++YF)KB265!'#&(B9),G''![>)_\ #R[P#_9/]O\ _"!?$O\
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M)'CQQ=>%I(]%-M)*(X;H2^9YGER>9&1^[,AR/W>3B@#ZVHKG?^$JT7_A&/\
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M7UU0 45XC\8OVH/"/P1U+3-!U.#5O$OC+5X3>:7X/\,:;+?:I>1(1YDD<*C
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M_621@^Q?%SXQ^$/@GX.E\1^-M>A\-Z2KI;BXEBDE+R/C"1QQ@R2'O\@['T-
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M@O3]/LM;/AGQ)HNK6>O:'KWV;[5_9U];S!HY?LWF1QRY3S8L29'[S.#BM/X
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MZMI6&(I4BDCMY!&-YCDCR<$(>IO?V5_#^K?LCP_ NY>&&QCT!-+&H6MF8O\
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M8Z++?VO^BRR_94B$=S'][RR)(8Y<'S!Q@[Q7D_\ PQ]\9OLG_",?\-7^,O\
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MM^//@;)XZ^-WPE^(K:Y]@?P'_:^=.:U\S[=]NM1"?WOF#RO+P3TDSTXZT_\
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M=-^"WB2YGUO1K;0['19;^U_T667[*D0CN8_O>61)#'+@^8.,'>* /;:^1/\
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M"/WOF'S?,R#TCQTYZT >PU\J?M#?\GU?LC_]S=_Z:XJ^JZ\+_:*_9Y_X7?\
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MJ-[JFO2@XFDCB$L=M%'@6UME"8X1GR_,(&:H?LN? ]_V;?@;X>^'3:S_ ,)
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M[_@J)_R8O\3/KI?_ *=+2OI+1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**"./\
MU<:(.  /3TKSK]J/X'O^TE\#?$/PZ76?^$?76?LV[43:FY\H17,4P(C\R//,
M6.O>O7: /S__ &;/^4..K?\ 8E>+/_1NH5ZI_P XL_\ NC?_ +A:Z/X=?LKO
M\/?V/;KX$KXH_M#[1I&J:2=?6P\LC[;+<GS?LWFG_5BYZ>9SY?:NK_X4B/\
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MB/,$@,>?2/% 'G?B"X;]M;XSW7@^"YU.V^$WPRUA3XJAEM?]%\4ZQ%*)(].
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M2=/\9>'8/$>GZ=J46KV]I=R/Y7VB,2B,R1Y'FKB60>5)F,YY%>AT44 %%%%
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M+S.<8\M9.,<?<>L:'8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M
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M3(>:S?V"]%LX=;_:-U-;2!-0N/BWKMK+=>6/-DBB\LQ1[^N(S-+C_KI)ZDT
M>C?!+]K3PI\=-?UWPW9Z;KWA#QAHIC>]\*^+K$6.J1Q2",QW'E>8?W7[P \Y
MYCR!YD7F5/BS^UUX-^%WBZ7P=;Z5XH\?^.;&*.YNO#'@?2I-2O[6VD _?38Q
M'&.8^#)YG[V(XQ)FN4_YRF?]T;_]S5>+? MOVA=2^(7[0>N?#$_#.[M9/B3J
MVG7NH^.AJ,FJ/]F\N.*$2VW_ "[11,@BC/\ J\R 8% 'T_\ !+]K3PI\=-?U
MWPW9Z;KWA#QAHIC>]\*^+K$6.J1Q2",QW'E>8?W7[P \YYCR!YD7F8WQH_;6
M^'G[/OBZ^\.^,3J5I>6WAS_A(HY4BCV7<9NC:QVT67\R2Y,@.!CR_+!D,@ X
M\\\-_ /X[^+OVH/AA\5/B:GPOLXO"*:A:RS>$3?K>W,5Q:210QN;B,^8(Y)"
M0/,&/-D[FM:\T>QU#_@J9ITUY:6]U<6'PE^UVDDL0<V\O]KRQ&2,G[A\N65,
M@])".: -KP3^W'X6\6?$70/!NO\ @WQ]\*M4U\RII4GC[1?[,@U*6/R_]'BD
M,A_>9E&!T/3_ %DD8/U%7RI^WK][]G/_ +++X<_]N:^JZ "O$?C%^U!X1^".
MI:9H.IP:MXE\9:O";S2_!_AC39;[5+R)"/,DCA48&/WKYD,>1#)C/EFO;J^/
M/@[=:;JW_!1C]HB;5;])O$.D:1H-AHL%S>DRPZ=+;12W4<41) C^T&W<X'#R
M_P#34Y /3O@_^U5X<^+WBJ[\+#P_XO\ !?C*WLY-4'AKQGH<EA>/8!XXOM:Y
MS&8_-D\L?O,_NWXP,US_ (P_;<\'>&/%6I^&O#_ASQM\4];T63[+KD7@/P_)
MJ7]DS X"7,F8X_F(DP$)P8I <&O>[C1K&;6H=4DL[9]0MX9+6&[,8\V..4Q&
M6/?U^<PQ=QGRT]!7RG_P2Y?3=4_91T[6XM074M?UC6=3O_$5S+>FZN)=1-SC
M?-DG]Z;>.V/;((?GS"2 >H?!+]K3PI\=-?UWPW9Z;KWA#QAHIC>]\*^+K$6.
MJ1Q2",QW'E>8?W7[P \YYCR!YD7F8WQH_;6^'G[/OBZ^\.^,3J5I>6WAS_A(
MHY4BCV7<9NC:QVT67\R2Y,@.!CR_+!D,@ XY#XZ:G:V'[?W[.-MIM];6FNWF
MF>(;;5HK.81W=U8"U\RUBN .9(O-BEDC$G[OS(I2.<X=>:/8ZA_P5,TZ:\M+
M>ZN+#X2_:[226(.;>7^UY8C)&3]P^7+*F0>DA'- &KH/[?'@B;QAIV@^-?#'
MC+X/MJL,\MEJ'Q)TF+1[.X,0'F1B5IB,_O <$8YZY>,'*T?_ (*/?#;5-2T2
M:YT3QEH7@C6-2DTRP\?:QH?V?P[<2;I I-SYN<.89.3&/+S^\$?ER8=_P4&T
MFRUO2_@+IM_9P7^F7WQ;T*TN;6Y3S(KB*47(DC>,\$$>M:'_  5$_P"3%_B9
M]=+_ /3I:4 >I?&S]H#PO^S[I'AC4?%;W$6GZ[KUMX>2]@>+RK:67S,37$DL
MJ".&,1$R29...#V\3_X>7> ?[)_M_P#X0+XE_P#"!?;?LW_">_\ "-G^Q?*^
MT_9OM/F^9YGE^9QCR_,SQY>_Y*M?\%!M)LM;TOX"Z;?V<%_IE]\6]"M+FUN4
M\R*XBE%R)(WC/!!'K7U%K&AV'B/2[O3=1L[>^TV\BDMKBUN8Q+%/')_K(W0\
M$$>OK0!S?BCXK^$_!/P[N?'NK:_8V?@VWLA??VT)A+;R1R']W+'Y>?,$A*>7
MY9S)YG R17@6@_\ !1+P)<S^&)-?\%_$'P#X8\1O%'9>+O%FA)9:,&FC\V,&
MZ\T_ZP _/R/^6A(C!D'E?[,GQ8L?A;_P3>^$5U-X7A\9:OK6O-I.@>'I[CR!
M>ZI)KES);+YKQR1PF,QF822# ,(Y!Q7*_MH7W[4NI_L@>*KOXDZ?\,-*\*7*
M:=+J6GZ7]N&J6[?;[<)$"9)+;(E\O?\ O",>9@G@T ?=GQZ^-.D?L^_"W6/'
MOB&SO[S1M)\K[5#IB1R7'[V6.(>7YDD8/,H[_P"!XGP'^U=H?Q(^)$7A/PMX
M/\::UH5S/<10^/K31_\ BFY!%'(9/+OA)\_SQR1;P,&4XSWKEO\ @J)_R8O\
M3/KI?_ITM*^DM'T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_]7&B#@ #T]* /
M O&'[;G@[PQXJU/PUX?\.>-OBGK>BR?9=<B\!^'Y-2_LF8' 2YDS''\Q$F A
M.#%(#@UV7[/_ .T-X7_:&TG4[W0#J%EJFCW\MAJ^@ZU;_9=3TF8$CR;B+)QG
M8<8R#@@GS(Y /CC]A]OVG[K]G3P_K7@3_A4L^BZY=WU]+?\ BQM3;6+^Y-U+
M'+-=RQ<22GR\;^3Y<<?H:]M^!?P(^+FF_M4:M\8_B;_PKVVFO/"I\/2Q^!Q=
MHUU+]IBECEE^TQ#>?+C$>_S.D<0QQ0!M^-OVX_"WA/XBZ_X-T#P;X^^*NJ:
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M&\\'_%Z'1;^WN_"MG\3M;MM"BT^7S+&UL"8I8HK81GRHX<R&0>5^[_>G'7@
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MN8K.+*B3RTDS@B,F3)C\P>97TY10!Y#_ ,*1'_#47_"X_P"W&V?\(=_PB/\
M8GV7G_C]^U?:?.\SU_=^7Y?OGM7-?&;]FQ_B-X]T[XB^#O&^L_#;XEZ7IQT>
MWURQCCO;6YLC+YGEW-E*/+F4$R%!F/$CA_G\N/'T'10!\<7O["%_XL\5>!?&
M7C3XMZ]XW\=^'?$MCKQO]0M1%8K%;2?O+6UL8I1%:^;Y=KYDG[PDVP/&\UV'
MQ&^ ?Q9USXE:QXH^'WQ_U?P1IVL);BZT/4=%M]:M;66*/RL6PED MU?'[SRN
MLA)R> GTO10!X;\!_P!G>T^"5UXFUN\\0ZMXU\<^+KFWN?$'B36)MAN9HHBD
M<<<,>(XH4+R^7$,[ XC\PB./'N5%% !7R]IO[*WB7P+\;]6\7?#KXIZCX+\*
M>(M9CUWQ'X,O-*BU.VOKCS?]*,4TLN;;[4",^6,@^T<<<?U#10!Y#_PI$?\
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M=)C/F$'[$\4>%-.\;^%=8\.ZQ;FZT?5K.6QO+?S"F^&6,QR1Y3_9)'XUT%%
M'SG^SC\!O'7P'U"31[SXP:CXV^&FFVDMCHOAW5-'ACN;)#(K0[[T?O)1%&3%
MC 3T$8C$==9\!_@K_P *5;XAYUHZR?%OC+4O%F/LWV?[+]J\K-O_ *P^84\O
M_6<9ST%>P44 ?,'CC]C+3_&'[2^F?$^37/LVAF\TW6-8\,_8F<ZCJMC%<16-
MW]I\W,7E"YC_ ':)Y;^2?,!SFO:_BMX$7XD_"WQAX.%U]A;Q!I%[I?VKR_,^
MS_:8I(O,V=\>8:[2B@#S+PO\(],TOX!Z-\+]<<:]HUKX;B\,WKA3:F_A6V%M
M)C9)F(R@=!)D9QG/-<!^SC\!O'7P'U"31[SXP:CXV^&FFVDMCHOAW5-'ACN;
M)#(K0[[T?O)1%&3%C 3T$8C$=?1E% 'PG^U9\';#X]?M@?#;P-:3N'OO#<L_
MC]'!+7/AZVU"VN;2'F2/'FWL4L?F6Q$J>9D_(,'[LKSG2?A#X0\/_$[Q)\1K
M#0X+7QAXBBBM=1UCS)'EFABCCC2,9.(Q^[BXCQO,:$Y.,>C4 %%%% 'S5\/?
MV0[3P%^T5KOQ*BUR&^T6^DO=1T_PU<::&.F:G>"U%]?1W+R&3,OV7& ,#S3C
M@<Y?CC]B/2?&G[5ND_%^7Q!<6NGVLUCJ6I>%?+F,6IZE91S1V-\91<8C,0DB
M 'E'_52?\]I,_5-% 'D7[4?P/?\ :2^!OB'X=+K/_"/KK/V;=J)M3<^4(KF*
M8$1^9'GF+'7O7>^*/"FG>-_"NL>'=8MS=:/JUG+8WEOYA3?#+&8Y(\I_LDC\
M:Z"B@#YS_9Q^ WCKX#ZA)H]Y\8-1\;?#33;26QT7P[JFCPQW-DAD5H=]Z/WD
MHBC)BQ@)Z",1B.NL^ _P5_X4JWQ#SK1UD^+?&6I>+,?9OL_V7[5Y6;?_ %A\
MPIY?^LXSGH*]@HH \A_X4B/^&HO^%Q_VXVS_ (0[_A$?[$^R\_\ '[]J^T^=
MYGK^[\OR_?/:O7J** "OCCP_^Q7XW^&RW_AKX??'GQ!X*^$UY?22IX5CT>*Y
MN[&&7FZBM=1ED,MN#^\\MP/W9._]Y+F1_L>B@#P#]D7]F&U_9-\"ZYX3TO79
M]=TW4M>N=9MY+RW$4UO')'#%'#)@GS2!"<R8CR3_ *L5QNL_LA>.M ^(GB[Q
M)\(OC7J7PPTWQ7?-JVJZ%<Z#%KEO_:1)\VYA^TR#RO,^4D <E>NP1I']8T4
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M=M[KQK9Z=_9-MK$LDCM;V_F22%4CSY:$^9)^\ WX?&<'%>B4 >/_  '^"O\
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MBN+_ .%6^&_^%K?\+%_LT_\ "7_V/_8/]H?:9/\ CQ\WSO*\O/E_ZWGIGWH
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MA<OBC49M5UO2[K2+;6[&:]EQF:WCGQ]G+GS/,Y/F'RQP(T%3_!G]C'3?@O\
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M)*\G[V4_>(W^6#@<*!7;T4 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?NI3_K1$.(SUH ]PHK'UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>
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M^S1"27ROW4@\W'EY&,^H![#17BGP:_:R^%?[0&J:GIGP_P#%T6OZAIL'VJ>
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MD?:D^U_9O,\KS_*_UGE;_P!WYF,9XZUT5?*?_.4S_NC?_N:KT'XR_M9?"O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO&G@/Q/\-[?SI-,L?'ME<V]UIWF74TCQ>99#][GS<F5SUZ1Q@8(!M>"=,L/
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M@_8Y^#.N_L\_L\>%?A_K\]A=ZOH_VGSY]-DDDMF\VZEF'EF2.,_\M<=.QZT
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MV9_&=]\8(/C-\&_$>F>$OB,VG1:3J.GZ[ID<NGZU;+=1R[;F2.,RQ?NXPAD
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M\,_&G@7QKX,T_(TR;XB6U\FIV$))$5CYEH3'-''&J8D.,9P(XXXT  %_8?\
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MB*1\==GJ: .XHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?#SP=8_#GP'X;\(Z;+--9:!IEKIEL]R?WCQ11"*,OQZ)7544 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7F?Q=^"ND?&9?!CZO=7]G_P (
MKXDLO%%C]@>.,R75KYGE1R;XSF/,AX&"?4=_3** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?"'CKPSXGU*./[0UGHNKVUW(D?>0QQR$@?/U]Z^-?VQO&^G:U^UIX$\'>-?
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M6>!(M-\#:1XX\9:;X-D;2;(PQ6-K>R2RS>5%$8A^\9,21YQ(DL@/^LS7JO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SS\9OAC
MXD\5?M2?L_>,-,TW[3X>\*#Q =6O/.C3[*+FQCBM_P!V6#RYD&/W8..]/_;J
M^&7B3XR?LL^-O!_@_3?[8\0ZE]A-O9F>.'S?+OK>63]Y*1&#Y<;GD]J^@Z*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\
MY H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P
M&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[-&?]FN!_X5KXB_Z*
MIXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:
M^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:
MX'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[
M-&?]FN!_X5KXB_Z*IXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]
MP[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC
M_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\
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M6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\
MY H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P
M&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[-&?]FN!_X5KXB_Z*
MIXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:
M^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:
MX'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[
M-&?]FN!_X5KXB_Z*IXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]
MP[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC
M_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_4a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_4a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
M6OA+^$FC*:BJJK57_/PTS^G4I5,/3J?\^X'Z&_\ !/ZUCB^#.I3[/WDNM3$O
MZ_NHJ[K]JK0Y=>^#.MB \VUM/=/]!;2BN+_X)_\ _)$;W_L-W'_HN.OH?5+&
M+5K.[L+J/S+:XB>*0?[)&/Y5\+C*CAF52KYGZSE>'6(R6G2[P/QD^\U?6'[!
M'C_3?#?BO7- O/W=WK;VWV:3S(^?+BE_PKQCXX_!K4/@OXPETJ?,UG-%'+:W
M1D,AD_ _]M:\\MY);:>&2,_OH_WM??5(4\QPGLTS\9P]2IDV.]H_L'[1R-NP
M01CZU\,?\%"/%=C=:MX8T:VDCENH(KB2X\N3F)9)(OZQFO#+/]I;XE:=HD6B
MVWB3R=+B'DQQ_8+7I_WZKS>:9[J:667F63]Z:\3+LEJ87$JI5Z'U.<<5T\?A
MOJ].GN1*V(R.]>H?%WPO<Z!HOP^NKG_5:EH\4L7_ 'ZBK!^$OPHU?XN>*XM)
MT:..41>5+<RR2>68XO-\OS0.]?>_[3?P'LO'GPHCM]*MW.K:!:;=,07'E 1Y
MB$H)_P"N<>*]''9E3PN)ITT>-EN35<=@L15IGYK2+SFOU3_9O\;67CKX4Z7J
M%F!$'>9)(M_^K(EDXK\MK_3KK2=4N["^C\F[M9?*EB_Z:UU/P[^+/BOX3W$U
MQX9U)+-9O];%);QR>9^,E:9E@O[0I+V1ED.:?V/B?WJT/UVVC(Y /I7QY_P4
M+&WPOHW_ %_Q?^B;JOGOQ=^UA\3O&>B36%_JUM#:2_NI8HK&(^97OW[?AW^#
MM!_["$7\KFOF,-E]3 8JFJI]YF.<8?.,MQ'LOL'P_P#\L_QK]7/V:]/BTSX,
MZ%:P)Y44;7( ]/\ 29:_*/\ Y9_C7ZR_L\_\DET;_?N?_2B2O4XD_P!WI'A<
M#_[Q4/0/X?PK\R_VUO\ DX;Q%_USM?\ TFBK]-N>?I7YD_MK?\G$>)_^N=M_
MZ315XW#_ /OB]/\ (^FXR_Y%O_;Z_4\<\/\ _(<TG_KZB_\ 1M>Y_M:?Z[X?
M_P#8J:=_.:O#/#__ ",6D_\ 7U%_Z-KW/]K _O?A]_V*FG?SEK[&O_O=+YGY
MK@_^1=B/D?/W_+/\:_6WX$?\D5\"?]@.P_\ 1$=?DE_RS_&OUN^!'_)%? G_
M & [#_T1'7B\2?!3/I>!_P"/4/)/V[O^22S_ .ZO_I5;5^=;?=%?HI^W=_R2
M6?\ W5_]*K:OSK;[HKMR#_<CS>,/^1B23P20I%))_P M(_-BJQHMG'J6KZ=8
MRW/V2&YN8HI)O^>=>Q6WP=O/&?[-NF^+K".-9]%DOOMD4TOWH_-CR/P EKQ'
M[RBO9I5E7ND]CYFOAJF%]FZJT/M5?^"<<VT8^(B_^"0__)--;_@G),O7XB+_
M ."4_P#R37G/@/\ ;<\:>%=+BTW4(['4+>/S/](:V!E]>B21C]*Y+XO_ +3'
MB?XP0Q6%X;.UTNVN1+&EM;["<>N3+7SE.CF[J>R]J?:3Q7#OLN>&'U/<F_X)
MQRXP/B(A^NBD?^W->^?L\_!>3X#^#;S0FUK^W#=7KWOVA;;R #Y<4?EX,DG3
MRASG^5?FCH,6M>+-4ATS3%^U:A)_JH<Q1U^J7PK\%Q?#_P "Z1I*(7NDMX?M
M(,A?,HBC1SGOTKR<V^LTHJE6J^T/?X:^IXFNZN&PWL_^WSOATI:0=*6OEC](
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *2EHH @V_*0>]>!_&;]GL>*IY-9T00VE]^\DN$.__ $GV.*^@#3-H]:\C
M,LNP^:8?ZOB3T,OS#$9955;#,_-W5-)O=(NOLVH6-S:2_P#/*ZB\JJH ]<5^
MC^IZ%9:M;F&ZA$D9KA9OV?\ P1--YKZ2QD]?M5Q_\<K\GQ/A_63_ -FJGZEA
MN.Z-O]JHZ^1\0:?IUQJ-U%;6-M)=W4O^JBBB\VOHOX-?LZF%HM;\4QQR0RQQ
MR6]C)'()H9-Y/[S/X5]":'X5TS0;7RK"V%N@Z#<6_G6R%4<=J^BR;@O#X"I[
M7$_O&?/9MQAB<93]EAOW:(K.WAL;:.""-(H8QL2-.@QVJ:GTE?IB26B/S[U/
MG']J;]E?3?CQI)O+%+6P\56]N(;:_F23# 2"3RY/+(./];^,IK\U?B?\'O%/
MPGUB:QUS3KA%C\SR[L6TODR_O?+_ '4LD5?MFW"]*J:AI=KJ]A-:7,8DMI4\
MMXSW%?39;GU?+U[/>F?/8W)J6*?M.I^#M2PP^=_J_P!]7[ :U^QU\)/$E])?
M:CX3-W=22>89FU&ZSG_O[75>"?@?X*^&+>9X8T+^SY#_ -/,LI_\B2&OJ*G%
MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** &_PU\J?M?_\ (6\/_2Y_]I5]5]J^5/VO_P#D+>'_ *7/_M*OB.,O
M^1/5/L>$?^1O2.S_ &7M)M+KX<&2>,2O]KEZ^N:]?_X1ZP4L?('3^\:\J_94
MY^&1'_3W+_.O:&S\P]J[\AHTGE6&NOL'GYY6J?VEB->IY/\ M :)9VGPGUR2
M.+]YY<?\?_36.O&/V2?^2F7?_8*D_P#1L5>[?M$?\DA\0?[D?_HV.O"?V1N?
MB9=_]@F3_P!&Q5\=G%*-'B;!<J/J,KJ.7#>+N^O^1[G^TH/^+,:[_OVO_I3'
M7S)^SSI]OJWQ2TNVO(O.BDCE_P#15?3G[2O_ "1G7?\ ?M?_ $IBKY)^%/C.
MW\ ^-+77+B.26&UCDS%%_P!<J\[BJ<*>?8:I6^#W/_2]3U>%Z=6ID.*IT=_?
M_P#2$?;/_"N/#O\ T"__ "))_C1_PK7P[_T"_P#R*_\ C7D7_#7&C_\ 0,O_
M /OQ'_\ ':/^&N-'_P"@9?\ _?B/_P".U]?_ &WD%_L?A_D?(_V/Q!;_ )>?
MB?0>T0PU\1?M)_\ )8-<_P!RW_\ 1<=?4_PY^)%M\1=->\MX)8HFY E3!ZN/
M_9*^6?VDS_Q>#7/]RW_]%QUXW&.(IXK)Z=6EMSK]3U>#Z%7#9O5I5=_9O]#W
M+P'\!? VL>"="O;O2//N[G3[:6:3[7<#?)Y0Y_UE=KHOP;\)^'I/,T_2C%)[
M7$O_ ,75GX5X/PW\)^7C=_9-KG/_ %R2NNY'3:&K[# Y;@OJ].?LH?<?(8O,
ML:ZE2#K3MZL=# L,02, 8I].HKZ-)+1'D^IY#^TQ_P DBUC_ 'H?_2B*O"/V
M7_\ DIEA]9/_ $5+7N_[3'_)(M8_WH?_ $HBKPC]E_\ Y*98?63_ -%RU^0<
M0?\ )3X;_MS_ -+/U7(_^2;Q?_;_ .2/M#CI7R#^U+XQDU+QC_8$<O\ HME'
M'-)^[SB7]YD?]^Y*^IO%.N0^&=!U#49CA+:WDFS[(F3_ "KX)T^UU+XC>,HK
M;]W+J%]Q_P \O]7%_P#:J]3C7&3]A3P%+XZC/.X-P2=6ICZW\.D:'@'XGZK\
M-9)9-*@LY99?^6MU%+)_G_5UU>N?M+^*]>TB]TZYMM)^RW<<EK)BUE_Y:#'_
M #U]Z^@U_9O\ 101H=$<@?\ 3[<?_'*1?V;/A\>FBL?^WVX_^.5X^'X:SW#T
M_8TL2E3[?U$]*MQ)D.)J^VJX5NI\O\SXOT_4I--U*UU.W_=36TOVJ*OT"\%^
M)+7Q=X>M=5LR_P!FN-Y3S$P?OX_I7RU^T7\*M*\ _P!EWNCV_P!FT^Y>2.6/
M<7ZF/L?^VE=O^R?XZBDTF7PO*?\ 2K>26XB&S'[K]U_\=K'AEU<BS6IEF)^V
M:\2>RSG+:6:89'*_M=?\CQ9?]>47_HR6MO\ 9Q^'6B>,/ ]_/J5H+J3[;)&9
M-\D?_+*/WK&_:Z'_ !7%C_UY1?\ HR6O0/V0S_Q;[45[_P!HR?\ HN*GAZ-*
MMQ55IU5=$XJK5H\+49TG;4^?_BMX+E^'WCN^BMX_*M3<^999D\SG_6GC_MK7
MU#\ ?'EKXQ\&VMJ7!U+3K>*.Y79C'4(?_'#6=^TG\.6\7^$XM0M,+>:5YEQN
M,F,Q^7^\'_D..OG3X/\ CZ3X<>,/-E_X]KGR[6X/E^9B/S,?UK.*_P!5<]U_
M@5#?_DILD7_/VD?=8P8W;U7^E?GUX#M8[KXC:%;7'[V*34HXY/\ O[7Z"1\V
MY_W<_I7YX^'=4BT#Q=IFJRQ^;#9WL=S+_P!LY:]/C9TO:X)U-KO_ -M/.X+4
MO8XY4M[?_)GW5_PK?P[_ - S/OYDG^-'_"M?#O\ T"__ "*_^->1#]KC1P!_
MQ++_ /[\1_\ QVC_ (:YT?\ Z!E__P!^(_\ X[7O+.L@M]C\#P?['X@_Z>?B
M>]:3I=KI-H+:SB\F%.D8J[QCIFO,?AI\9;7XD7$\5I;W$)C3S/WT8':,_P!\
M_P#/05Y3\7OVBM1L=<FTOPT3;/;2F&2:>WSB1/,R/T%>K6SO+\%@UB5_#\CS
M,/DF-Q6*^K?\O#Z#\3>$=*\7V#VNJ6_G0,-A!=T_E7S!\?\ X*Z5\/\ 3;76
M-%+QP7%SY<L<CEPG[KW]HW_.O0-"_:QT.6QB_M:"[BN\?O-EN/+'_CYKS+XX
M?'"W^)=K:Z=ID;Q:;;W/FGS(L22?NNP_[^_E7Q7$.89)C\%4J1LZG3N?69!E
M^=X''TZ;35/KV-']E/Q-<6GC>31<?Z#/;R3#]WC][^Z'\HS7U^&^4FOE_P#9
M/\ RQW$GBNX_U<L<EM'^\SQ^Z_J)*^H,=J^GX1IU:>54_:GA\55*57,ZCH[#
MZ***^U/D0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!E%%% 'F%_X+EM_C
M!HVN6UL[6LD<IN90>(Y/*\L?I5WXR:'>>)/#VGV-FGF327R<>WERUZ!GI1C&
M:XO80]G.FNIK[0RO"_ANV\+:/#IUEO\ )BZ>;S6P124XFNJR@K&0M%,I]6 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
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MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
M\6?^#RZ_^.UPM%'U/#_\^4'UNL=U_P +U^)/_10/%G_@\NO_ ([1_P +U^)/
M_10/%G_@\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]
M?B3_ -% \6?^#RZ_^.UPM%'U/#_\^4'UNL=S_P +V^)/_10/%'_@\NO_ ([1
M'\=/B1']SXB>+#_W'+K_ ..UPU%'U/#_ //E!];K=SOO^%\_$S_HI'BO_P '
M=U_\=H_X7S\3/^BD>*__  =W7_QVN!HI?4L/_P ^4'UJM_S].^_X7S\3/^BD
M>*__  =W7_QVC_A?/Q,_Z*1XK_\ !W=?_':X&BCZEA_^?*#ZU6_Y^G??\+X^
M)@Z?$?Q7_P"#NY_^.UZ%X _;@^+'P_AAMI-9C\2VD4<L<46NQFXY\S?YIE'[
MV7CCF6OG^BLJF78.JK5**-J>+Q5+^'5/U%^$/[>G@#XE-;V.NR'P/K& #'JT
MH%I+S)S'<\=HO^6OE_ZSC?7U("-OJ*_!:OL[]C7]LP^#FL/ 7CV\SH/^JTG6
MKJ7_ (\_^F4O_3+K^\Z1?]<O]5\#G'#CH4_;8+5=C['+<^]M^ZQ.Y^D%%(IR
M!2U\*?9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112'
MH: .=\:>*+'P7X=OM:OS(+:WBW/Y29>O@+Q%K]WXJUJ^U.^8//>2!W5>@ [5
M](?M;>(Y;'P]HNCJTQBU&>6226-\<1_\L_\ R)G_ +9U\N]*_ ^.\RG6Q:P2
MV@?MO!.6^SP;Q[_Y>:"4445^4GZ<%%%%( HHHI@:?AWQ!=^%=:L=4L7"7%G(
M9$5NA![5^@?A;Q)8^+M!L=5T^7S;:\B$D;>HK\Z:^I/V2?$4M]X?UK1G:41:
M=/')'+(^>)/^6?\ Y#S_ -M*_5N \R='%O!/:9^8<;Y;[3#K'K_EWI]Y]'4M
M(**_?#\3,3Q+KUAX5\/ZCK6HRBULM/MI+RYFV[_+BC&^0_D/TK\6OBK\0;SX
ML?$77O%=]%Y,FI7/G>5W2/\ U<<9]XX_*C-?H7_P44\;'P_\"8M%22U\SQ!J
M45M+%,<2BWCS*9(P.I$D<(_[:5^8]?I7"N!Y(/%OT/@>(L5[ZPP4445]\?&:
MA1110 4444 %%%% !1110 4444P"BBOKG]HCXP:;\)_B]XA\*Z-\*?AK<V6F
M&W"3:AX<CDES);Q2D?NY!_ST]!7FXO&U:%94*-*[=W]UO\SMHT56I^UJGR-1
M7OGC?PKX1^*OPHU+XE>#K"+P?K6A/'%XI\.0^;]F<W,H\JYMO^>>9,_N^V/^
MF?[V;]GNXT[PU\&_B_XKN?"_A_Q+>Z'_ &1]BB\1Z=%<11^;<RQ2CU]^".E<
MSS3]PZR6J:5O-V_S-?JO[WV9\^TH7/>OH7PW^T1X0\3:Q#I?CWX2>!8O#UY)
M'%<76@Z;+IMS9 RQ'S#)$9)#TXCBYD]<9SYI\;OAR/A'\6/$?A5;DW4.FW1%
MM(9#+BVDC\R,2_\ 37RY(ZNCCG*K[&M2L]S.KA+4_:TZAPE%?5GQ,^)FF_!O
M2/AM8:;\,/ .K-J'@O3-4N+G6=#CDN7N91)Y@\P8_P">6><\DUY1XX_: _X3
MCPKJ&B_\*Y\ :!]I$7_$PT;1/LUU'^]$O[J7S?;]:FACJ^(UC1T]32IA:5+_
M )>GE5%>\>%[?PY\&O@]X>\=:IX6T_QAXL\37ER-'M];4OIEE;6_[N0R6^1Y
MDDLDAY'',<G4'S(-:^,_@#X@^%-2TWQ/\,M)T#6X[:7^RM9\$1_8C#<XB\F*
MXMO^6L>8_P#6G/\ TRBX\VCZ_6D_W-&ZV_S#ZHK7J53PZBO:?A7H'ASPC\*?
M$'Q,\3:%'XIN(]5AT/0=+O'86OVPQ_:99;B,8\V/RA'^[!^?]Y'CD2UL:=\?
M/A[XRM[O2OB!\)/#^G64I!35? UG_9M_9R^5+^\P>).L7^LD$7_77%%3'U6V
MJ%&]MP^J+>I4/GZBBBO8O97/.MJ%.4 M@G%?7?[1GQBTSX3_ !@\0^%=&^$_
MPTN;'2S;".6_\-QR2YDMHI2,1R#O)Z"N)\<:?X.^-7P3UOXD^'_#%AX)\6^&
M+VUAUK3M+E?['<VTD4<<<L,7E;(SYG_++I@2>9YG[NO#IYE7G"G4K4;4JG4]
M>>!2]I3IU#YXHKZ#_9YNM-\,?!SXO^*[KPOX>\2WVB_V1]BB\2:;%<Q1^;<R
MQ2CU[YX]!5!OVJMW_-'?A,/IX7_^VUJ\=7]M5HT*-[>?DG^IC]4I*E[6K5/"
MZ*]!^&\UMXR^/OAB2\TK3H+75O%%M++I<-L!:B*6ZB_=>6>/+_Z9&J/QFT^W
MTGXQ>.[*SACM[6VU^^BBMX8_*B2+[5+^[KHCB&ZZH-:VN<GL?W7M3C***^N?
MVB/C!IOPG^+WB'PKH_PI^&MS9:8;<)-J'AR.27,EO%*1^[D'_/3T%3C,;5H5
ME0HTKMW_  M_F;4:*K4_:U3Y&HKT7XB?&C_A8VAQ::? G@KPMY=P+G[7X=TG
M[-=28\W]WYOF_P"K/FUF?!GP%)\4OBIX9\*)%+/#J%[''="&2..:.U_ULLO[
MSG_5>;TJ_K$HT'7Q"M87L4ZOLJ1QM%?4'[7WA?PEKGA_0_B%X%TW2['1O[2O
MO#M[#H4EJ+82VMS)]EE'E ?O)8O-E_ZYF/Z2?.GA'P[<^,O%6C:!:2QPW6K7
MT5A'-+_JO,EE\JIP>-6,H>W>EM_(,3A?95?9&517T?XY^+'A/X/>+]9\&^#O
MA=X5U33]$N9+&XO_ !C9_P!IWU[<Q?NI9?-\W]W%^[/[OZ=#)Y=>;?&3Q1X!
M\:7.EZKX,\*7G@R_N!<G5M+%WYMAYID_=26O_P"[CC_U?E],GGHXZM7:_<Z/
MJ;U,'3I?\O#SFBOI^3QIIGPC_9T^$>IP_#WP5XEO]>&K_;;KQ'H\=Q)^ZNCY
M7[P?]=>]<)X@_:0.O:+?:>/A9\--/^VP2VYN=/T#RKFW\T$>9')YO^LYS]12
MHXZO7?[FCI=K?L["J86E27[RJ>-T445[1YH4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
M:A1110&H4444!J%%%% :A1110&H4444 %%%% !1110 4444;Z#U6I^IG[#/Q
MTN?BQ\,9[+6KR34/$>@RK;75Y*Q>6YBDR;>4X&!TDCZY;RO,/$E?3N1T-?DW
M^P;XS_X1']HW0[9WM([76[>XTN62Y;'_ $TC\OUD\R../'_37UK]92N[!K\4
MSW!+!XYQAL?JF3XEXK#)S)**2EKPCW HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#X\_:W_P"2F:=_V"H__1LM>(?Q5[E^UU97$?CW2[MT
M!MI]/$44@[21R2>9_P"C8J\-_BK^6^*/^1OB+G]*<,_\B?#6\_S$HHHKY ^G
M"BBB@ HHHH 7^*O;_P!DC_DIFH_]@J3_ -&Q5XA_%7N7[(ME<2>/=4NT0"V@
MT\Q2R'O)))'Y?_HJ6OK^%_\ D;X<^8XF_P"1/B+^7Z'V!1117]2'\UGP%_P5
M,_UGPS^FI_\ MK7P=7Z"_P#!3SP_<7?AWP-KL<L8M;*[N;!X?^6AEN(XY(\?
M^ TGYBOSZK]CX=_Y%M->;_,_*\[_ -]J!1117TIX6H4444!J%%%% :A1110&
MH4444!J%%%% ]0K[)_:I_95^)OQ$^/7BKQ)X>\,"_P!'O?LK07 O;:,N8[6*
M,\22#O'Z5\;5[O\ MR-N_:E\:G_:L?\ TAM:\/&*L\525!V?O[J_\GFCU\*Z
M7U:I[7^OC)O%L.G_  )^"VN^!/[9M-9\=>*[FU;7M.MI$N+;1;6VDD,=L9(Q
M@W/FX\SKCGH?+DDU_P!FW3='UCX!?'>QU[6SX9T>;^PQ<ZH+-[G[,/M,Q_U4
M?7D <>M?-=>]?"+'_#+O[0G_ '+O_I?+7/6P;H85ZZNI#7_MZQ6&K*K4O_<F
M=1X%_9U^'.LZ?>^(=#\4ZA\8ETZ-Y?\ A%="LHM)NY/+(D\R47$OF?9O^67[
MJ/S/WO[K/2O /B-X\U7XI^-M3\5:W)'+J>HOYD@BC,<40'[J*+_OU5GX6>/K
MSX4_$30O%5C%YLFG7/FB/N\?^KDC'O)'YD8]ZZ?]I;PCIWA7XK:A<Z!$L'AK
M7K>/7-&57B3?;W,7F_NH\#RHO,\R/RL?\LZ=&C5P^-M7=[K1_FM-.W](=2I3
MJX;]V>U?&3P/\//$>A_">Y\5_$]O!NH1^!M'B335T&XO_,BV2'S?-CZ9/F#'
M_3/-?/\ \3/"?@OPQ_9?_"'>/?\ A.OM)F%S_P 222Q^S<Q^5_K/];_RU_[]
M5W/[5V?^+/Y_Z)UH_P#[5KPFL\IHU/9*M[:RUTT_RN3CJD/:>R]D>Y?#3XK^
M"]:\"6_PV^+%G>S>';*X\W0]=T9(_MVDF23]YSSYD7T$O_;7]WY<7C;]F/5=
M(\+GQ?X)UFQ^(?@I83-)JFFJ8I;7$44I%U;?ZR,_O#QG]V!F3RQS7!>*/A;X
ML\$Z'HVLZQH%Y::-JUM%=65__K+62*7]Y%^]C_Y:_P#3+_65ZC^QSI,^G^/+
MKQIK#'3?AWI.G7L>OW]]'*-/NHI(_+^R$X,4CF62.0Q^_K162P=-XS!UOEW?
M^95.]7_9\13.<^#_ ,6M#\/^&=7\">/M'FUKP)JLGVX'3HXOM^F7QC$<=U:R
M?A_G]Y')T?B3]E5M>TV^\1?![Q)9_$K0;<^9)8V_RZI8Q_O<>;;2<R?ZOT\R
M3_EG'7EMU\*O%EKX!L/&LF@7G_"+W@D,>J0GS8OW<OE9E\K_ %7[W_GKZ5V?
M[*OAO6]8^,_AW5=)D?3]+T2]COM7UHB5+2RM8_-DE\V3_EGYL44L7[VC%6H^
MUQF#K6[]G_P0IOVGL\-5I'CM%=%\2KS3-2^(?BN^T(0P:)=:M<RZ>($\N'[/
MYLOEXCP/+_=^U<[7T5-\U.[['F5%:5D?:G[37PK^&_BW]HS7Y==^,">&->OI
M+))-*ET&YD2W_P!%CCA'VGS!%SQ+^/->9?'+3S\!?!,/@+PYINHC1_%45O>:
MEXIOIHI8M<%N0839"*26.*WX\W_GK^]B\W_IKG_MQ+_QE+XT ];+_P!(;:K?
M@W44^+7[,_B?P7<6_P!J\0^!?^*BT22(1Q_Z%YH^W19\OB*+S/-_UGFRGRO^
M>=?&T:-:EA\-6JU;TKPT[?\ #'T5>I2J5ZM)?Q#0_9JTO1=:^ ?QTL_$&N'P
MOH\HT,7.J"S>Y^RC[3*<^5'UY ''K7(^(/AG\(].T.\N-*^-;:M?P6\LD%C_
M ,(E>Q>?)@F*/S?^6?.!^-:/P@S_ ,,O_M >F/#W_I?)7A@QM;/7M7J0I5*V
M+JM5K:^6ON0\CSZE2G3I4U[*_P#^V=S\"_\ DMWPZ_[&/3/_ $IBH^.G_);O
MB+_V,>I_^E,M'P+_ .2W?#K_ +&/3/\ TIBH^.G_ "6[XB_]C'J?_I3+7;=+
M,?\ N&9[X3YG"5]E?M5_#_X8:Y\>?%-_XA^+[>%M:D%M]HTE?#EQ=F "VB /
MG18'(P?QKXUKW;]N/G]J3QI_O6/_ *0VU88RFZV)I)5;?'K_ . =[EX6I[+#
M5+K^O?/-_B/X=\+^&=;AM_"?C ^-+&6U\V6_.FR6/E2_O?W7E2?]LO\ O[7J
M/[.MV_PQ\"_$?XKL(X[[2K&+1M %U'%_Q_7/_+6.27_EI%%^\\K_ )Y2UX!7
MU7XK^*G_  S[\.? GPVC\(>%_$UR-/CUW6X?$NFB1[>]NA)Y,3V_F QR11?N
M_P![_P L_+&8P*C,?:^RI8.+]HW^2W_R^887V?M'69RO[._G?%3X=^.OA 1:
M_;+ZV_MSP\;H1&4:G;"/S8H_-_Y:2Q?NO];^[CBD_P"FE>':#K=[X9URPUK3
M'%K?:;<Q75M(8O-$<D7[V*O=_"O[95QX2UZPU2T^%GPXL)+>3'G:5HGV6[\K
M_EKY4OF_N_W7K6-\7/@AJ-Y^T7J?A3P78)J,6MR_VGH@@,5K:W-M)']I_P!&
M/^J\J/\ >Q_]LZYZ%5T:U:.(7LHU5_P_]>I=:G[:G3=)ZG2ZI<?"[]IJ:35K
MO68/A=\2;I#)?I>Q;="U"X\J3S)=Y_X]_-_=Y,A'L)9?WE>5_%OX*^*_@IKD
M.G^*-.%I]I\TVMU%)YEK<Q1_\M(Y.Q]C^]_>Q5R&M:)J/AG4I-.UC3;S2KZW
M&9+6_MI8I8_^V4M>W?$+29?!/[+/A/P[XL8VGC";Q'<ZEI^DW\3_ &[3M-,4
ML<O[N7F*.2YB\WTEW=^U?[C6HJC5O2;V_KH+_>:53VJ_>([74O"?@GQ-^RW\
M$_\ A,/'G_""-;G7/LX&B27QN@;_ !*?W7^JZ1_]_*\2^(W@KX?>&="2Y\)_
M$UO&=])=")]/.@7-CLBQ(?-\V3W\L?\ ;2NR^,'_ ":W^S[GICQ%_P"G".O"
M.-H]:O T:M_;*MI[2>FG\_I<G&U*=O9>R_D_]($HHHKZ,\;4**** U"BBB@-
M0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HH
MHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#
M4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**
M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"DI:* /!_P!J+P;)X@\%Q:M;0">ZTN0OEMX/V=_]:./^ '_MG7R+][I7Z1:A
M8PZA9RV]Q&LT$B;'CD V-FOA+XK?#NX^&?BB6S_?RZ9)^\M+B5L[D[J?I7XC
MQUE-2%59C3^9^P<$YORP> J^J.)HHHK\;/UL****0!1113 =C;UKZY_9=\&R
M>'_!<NK7$ @NM4D#Y7>3]G3_ %0Y_P"!G_MI7SU\*?AW<?$OQ1'9_OXM,C_>
M7=Q&V-J=E'UK[MT^QAT^SBM[=%A@C38D<8&Q<5^R<"Y34E5>8U/D?DG&V;\T
M%@*7JR_112U^W'X^>,?M/?"M_C!\&/$/A^RMXI-::+[3IWF0QR$7,1\P",R<
M1F3F(R=A*37X\5^]7#*1CBOS6_;R_9K?P3X@F^(6@V]W-HVL7,LVK1H#)#8W
M4G67K_JY2#_VU..?,CCK[GAC,EAZOU:J]'^9\;GV!=5?6:>Y\?4445^GGP&H
M4444#U"BBB@6H4444!J%%%% :A1110&H5O>./&VL_$;Q1?>(=?O!?:O>>4+B
MY$440D\J+RO^67_7*L&BIY5=2MJ;WTL%;VE^-]9T/PMKOAVTNQ'H^O?9CJ-J
M8HLW'ER^9%BL&BG**DK-!ML%;VJ>-M8UOPOH7AV[NUDT?0?M)TZU$46;?S)?
M,ES6#10XJ33:V#T/9]!_;&^+OAC0[#1=*\5_9+#3;6.TMHO[,L9?+BCQ%'_R
MR]A5#QU^U1\3_B=X6OO#GB+Q,NI:/>"/[1;M86L9D\N7S>L<7_3*O)Z*X%EV
M#57VJHK[C;Z[B?X?M#TCX?\ [1?Q*^%>FR:=X:\6WMAIXZ6LL<=U%%STBBE\
MWRA^\Z154^(_QO\ ''Q?\L>*_$5WJ<-O_J[11%#:GB0>;Y47[KS<22#S?:N"
MHJOJ>$]K[;V0?6JOL_9^T.]^&_QO\<?"#S!X4\17>F0W!_>6C"*:T'$8\WRI
M?W7FXCC'F^]6_B!^T5\2OBGIL>G>)?%EY?Z>>MK%'':Q2\])8HO*\T?N^DM>
M;T4?4\)[7VWLM0^M5?9^S]H%%%%=QQZF_P"./&^M?$CQ5?>(O$%X+[6+WRA<
MW0BBB$GE1>5_RR_ZY4>!_&^M?#?Q58^(O#]X+'6++S1;71BBF$?FQ>5_RU_Z
MZU@45S^QH^Q]A;3L:^TJ^U]J=]\,?CAXT^"[:FW@W61I;:D(Q<DVL4OF>7YG
ME?ZV+_II)7<_\-T?&P_\SM_Y2+'_ .-5X116%7+L'6?MJM%7-H8K$T_W=.H;
M_P#PG&L_\)S_ ,)A]M'_  D7]I?VQ]J\J+'VGS?-\WRO]5_K:]7'[='QK'_,
M[?\ E(L?_C5>$T45<'@ZUO:T5H%/$U:?\.H==\2/BEXG^+^N1:UXKU!=4O[:
MV^RQRK:Q0_NOWLG_ "R_ZZ25Z1_PW/\ &O\ Z';_ ,I%C_\ &J\)HHGE^#J6
MI5*2TV#ZSB:6U0]2\<?M,?$;XCV-C9^*->BUFTL[Z*_CLY-,M?)\V+V\K]Y_
MK?\ 52UP/B?Q7JGC77KW7-:NWU/5[MP\]PXP' Z #TK+HK>CA:-#^#2L8U*U
M6K_$"NDUCXC>(O$%[X<O+K5)!<^'[*VL=-NH?]%EMH[<YC_U7_/,D_O:YNBM
M94(RUD@55H]OT_\ ;/\ C3IMG;V<7C22:*"/RD$UC;2R'W\R6+S)37D&LZWJ
M/B;4I-1UC4;S5;ZX&)+J_N9999!_UUEK/HKCHX.A0;=*DC:IB:M7^)4/6/ O
M[57Q0^&?A6Q\.>'?$XT[1[,2_9K86-K*8_,E\WK)%_TUJ_KW[8WQ=\4:'?Z-
MJOBL7=AJ5K):7,?]F6,?F129BD_Y9>YKQBBE_9V#=7VKHH/KN)_A^T"BBBO0
M./4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4
M**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH'J%%%% M0HHHH#4**** U"BB
MB@-0HHHH'J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&
MH4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H44
M44!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!
MJ%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% @HHKL?A+\+=4^,7CO2_
M#.D1R8N)0+FZBC$ALK<G$ES)D]8R0![D5C6JTJ%+VM4WI4O;/V5(^H_^";/P
MKEU3Q7K/C^[CC%K8Q'3K/S(XI0;F012R21]XO+C_ '?'47#?2OT67O7%_"_X
M=Z3\*/!.D^$]&A>/2]+0QPF63S)'YWO(?<R,?Q-=KTK\0S'&/'8F59GZQE^&
M^JX=4Q]%%%>8>D%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 ,_AKE?''@?3/'FAS:9JENLT$@X;&)(W[.A[&NLXQ[4SCM6%6E3K4_9U%H:
M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
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M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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MP!X \.:#X@;6=&MKR*'4K*YN;B2YENKF+RXO*FCR#Y4?')S7GG@7_@JAX_\
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MEK*9;:^B'E)-<PDC]U^]F'[J3. \>))/WGE@'V/1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /R6_X*->)-,\%_\
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M_2[X:_"GPG\(_#<'A_P5X=T_PQHL6#]FL(_+\R38J&64CF64B*(>9)ESCDT
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M(XR?+CD&)/+K?!O_ )0X_'3_ +'.U_\ 1NC5]^_\$N_^3%_AG]=4_P#3I=T
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M44 %3444 0U-14- &A:3?\LJFK/K0AF\Z&NNG4.6H2T5%4M:B"BBB@84444
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MG@_Q?IIU;P[J/D_:;/[3)#YOERQRQCS(R)!^\CCZ'MWKEO'7[,GPU^)7PO\
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M4$<?^KC1!P !Z>E;%% %6ZCW151K5K/EA\J6N2H;4R*BBBLCJ"BBB@ HHHH
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ML7V&V$W^K\K]YYF<=1_*O5:^";SQ9\2=2_;<_9LT#XH>&[/3/$NE'Q-,NL:
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M?MWV[Q-_PA?G?;_+^R_9AYW]I_\ 33[-Y7^J_P"6F>U<U34Z#[%^._QET?\
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MIW[07[%/Q<U^RTV^T'4K+PYKNE:YH.I0F*XTN_BL)/,MFSU&9!^!Y$<@,8U
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M?^$(_LO_ (F N3)]M^W6OF_ZKROW7E5S/[-WQL\3^/M9^('@GXAZ'9Z+X_\
M!-W%'J<NBR&32[V*Y$DMM+%R9/\ 51?ZJ3],^5%ROP&_Y/6_:J^OAC_T@EH
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MDBS%+%=#][YOFD^9%T\J7_GK$:FX'L]I9^=^]DK0HHK,05+7@/[6'QRU_P"
M.A>#_%=DMDWA1O$EKIGBJ2^TVYNI;*PE.)+N*6&7]UY6/+YCDS)+&.O$E+]M
MCX^>)OV;_@[;Z_X6T&W\1^(KW4Q90PW$<KPVL8MI;J6:6.+F01Q6TN>8^/WG
M_+,Y1L?1=>4_'#XU-\%_^%>DZ1_:P\7>+[#PM_Q\F+[-]J,O^E?ZK]Z?W?\
MJJM>-OC=H/A?X":E\5+:YMKW0UT/^W;$W4ILA>F6+S+6+]X/W?F_NHNG_+7I
M7S)^U5XX\2P_ G]FWQAXQTF>[\4'X@>']:O=#T;3I8KOS/*NI?LD5M++))YV
M"(@#)S*.D?2L@/N>O/?CE\9=&_9^^&&K^.O$%I>7NB:281/%I<<<ET/-ECB&
M/-DBR<RBOG?Q3\7/VMO!/@G5OB'K7@7X;6OAK23+JE[X4&IW,FM16,4N9?\
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M\5R/P\^-U_XX^(GQ4E+:1I7PR\$S'1Y=:NCY<D^IQ1>9?22RRR#RH[4#R_\
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M* "BBB@ HHHH **** "OE7_@EW_R8O\ #/ZZI_Z=+NOJJN)^%/PO\-_!_P
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M3_AWG^SS_P )9_;O_"L[+[=]L^W>7]MNOLOF>;YF/LWF^5Y?;RO+\O''2MC
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MV)'<US'2>*?\%-?^3(?B5]-,_P#3I:T?\%-?^3(?B5]-,_\ 3I:UZG_PS/\
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MY=<UZ2ZG\V6*UL=.TZ+S;O4[J7_56MK%_P M99:!G8?ZZM6UL_)_ZZUP_P
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M**\8^%?[2-C\0/V9V^,]_HEUI6GPZ=J&IW&E6US]HFCBM9I?-\N4^5YG^JH
M]GHK%\"^+K+X@>"M \4:?'<16&MZ9:ZI;171S+%%+%YL7FUM4 %%>:_LV_&0
M_M _!G0?B"=(_L,:P;HC3_M/VGRA%=2Q?ZWRHO\ GE7I5 !1165X9\5:1XNT
M>UU;0M7LM;TNX.(]0T^YBNHI/^67^MBH U:*** "BBB@ HKA/C=\7M*^!7PS
MU?QWKEI>WNE:28A-%I\<<LP\V6*+CS)8L\RBN[H *M6EGYW[V2IK33?^6LE:
M%!J%2T45D;!1110 4444 %%%% $5:FE_=K+K4TO[M8@:E%%%9&H4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU@:G>6=X-4M_-M5F" 8C_=GR\'$DDG0Y%>Q?L\_\GU?M<?\ <H_^FN6@"_\
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M8,A'/.:7]J__ )-9^,O_ &)FL_\ I#+7S3\;/"NH>,/^"1NF66E6_P!INHO
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M:6J?\)AYGV_[7]J\VV^W_8/^6?E>7_JO-Y_YZ5^C=?(W[!>M6<VM_M&Z8MW
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M''TR6R\0:P+B/3+"&6T,MT;Z2.3S)99)3'%%%%&"<22'B(UZ!X\^-?C+X)_
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MB7[-)')(1Y83S-YCZ@ T_''Q9_:A^!^EP>,/B%X7^'_BGX?Z;-G7+7X?"_\
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MN/:%Q)]ATQ(_+TJUS%^[D\NVQ)YGEQR?O?W@S&:?F29O_!,G_DQ_X:_34_\
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MRR$<R'_ZU '<_L%?>_:+_P"RR>(__;:OJ"^_U5?!G_!/W_A=W_">?%#^TO\
MA _^$._X61KW_"4_8_MWV_\ M3RH_-^PY_=_9O-\G'F_O,>;WQ7WK=?ZNE4"
M&Y\Y?M@?'S7/V=_"_@?6-'T7_A(?[7\76.@7]A#;2W5W):2Q2RR_98HY8_\
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M_O/WDAC\N/(CS'7CWQ?_ .&FO^&H/V??[6_X51_PF&?$7_"/?V?_ &I_9_\
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MB[XN>"? O@N#QCKGBG2K#P[-'YEIJLES&8KLF+S8O)_YZ_NO^>7^MH$>-_\
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M$XS1\7O@+X ^.&AII7CGPK8^)(8E/V=[C,=Q;9V%O*ECQ)%G8F?+(SBO2Z*
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M^*'PH\)?&;PK+X=\:Z+!K>C2/'<^3(98O+DC&#)%+%^\BXKTF:SBFJK-H_\
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M?PB\$Z?X1\*Z:=)T"Q\T6MH999?*\R7S9?WLO[W_ %LM<?I?[+?POT7XP?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY+SP_+_:\>KVFI^3YC7,7GPQ^7'+'&!)@]NNS,0DI?'K]LX?!;XO_P#"N(_
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M\7OCAJG[,?CDZK^SRVCC4-'UNQU@'QM8RC2+$6$8%\/W?[[/FW/[J/D?9?\
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M->LM-U#0-2L[Z72M<T+4(3#<Z7?Q >9;-GD_ZP?@>D<@,8RL.YK?';XRZ/\
M #X8ZOX]U^RO;[1M),(NXM+CCDNAYLL<0QYDD>3F4<?_ *J]$KY;_P""FO\
MR9#\2OIIG_ITM:];^.OQRT+X ^$[37=:LM4U:74M2M](TW2M!LQ<7U[=2 F*
M**,D9)\N7 []N<46T--CTFBOD36/VOOB1\*TT_7?B]\!+WP%X&>^BMKWQ%8>
M);76/[.\TGRI9;:VBWB+S,#)/?\ Y:2>7')ZRGQ^L[CX]Z#\/8+2!])\1^%Y
M/$6B^+!?9MM2E\T9MK;M+^Z_TG]W+_J\<8HL',>Q5#Y$?_/*.O,OV@/C-9_
MGX<7GBB?3KC7KGSXK/2_#MJ^+S5K^639#:0C&<YZB,2'RTE/ER8Q6)\7/VAO
M^%-0^#](D\,ZAXJ^(OC RV^E>%_#\@FB>ZAB#RC[5((O+MHS)&#,8\B,^9Y>
M/,P6"Y['_9L5']CQ_P#32OEE?VR/$_@/Q?H%E\;OA#=?"/PYKTTEA9>*&\06
MVK6$-U@;(KDQQ@6XD!EQ+)Z'_EF))(^P_:._:IT[]G#QM\/-'U70+O6[3Q;_
M &E%%-I?[V\CFMHX_*MHK;R_WTES++%$!YD?.*U,KGO=KI$4DF3YE7_[+B]7
M_.O*/@+X^^)?C:XUH?$7X3CX8FU$)L1_PDMMK'V[)E\W_5?ZH1XCZ]?,]J\>
ME_;*^)_B*WUWQ#\.?V<?$'C#P%9_O+#7[_68]*N=6A\I9/M-M8R1&62*7(,1
MC!\T=A(3&.FF<U0^N/[*B]9/SJ7^SXO2O._AG\;O"/Q,^$.E_$G2=2:S\)WE
MG)?/=ZF1;BUBB,@F,I)PGEF*7)SL_=G![U\Z^)/VZ/B79_#JY^)>@_LV^(=5
M^&"V?]H0ZYJ>OVUC>R6V,&=["..61(N_F9(\K$N?+YI@?:?DQ_\ /-/RIU>'
M?!WX^:EXV^!=U\5/'_A'_A6>CQV4FL0PG41J?FZ6+6*Z^UYBC!!PTO[HQ^9^
M[Z<UY6_[87Q;\3>&V\9>!OV9M?\ $'@.ZLOM^GZAJ'B2UL;^\BV EQ8!9)><
M'R_+\PRCRS'GS!0!]D5YC\;OCMX&^ /A6S\0>/M;/AW1[R]2PCN_LDMS^^\N
M201D11R'.(I.W;K1\%_C/X4^/_@'3_&'@W4C?:?<$1R0RD?:;.;_ ):6\T7_
M "S<?7N",IC/B?\ P4&TFRUO2_@+IM_9P7^F7WQ;T*TN;6Y3S(KB*47(DC>,
M\$$>M 'O_A;Q-IWC3POI?B#1;C[5H^K6<5]971B\LR12Q^;%+^\]JM:QJMAX
M=TFZU/4;VWT[3K&*6YN;JZE\J*..+_6RRRU\K?L2ZY!X!U+X@?L\70^R:G\.
MM8N9M'CN98WN[W1[F4W-M<R^7)^]D'F@R8BC$8FAZ29%;O[;FKWWBKPSX9^#
M&AZC<67BGXFZB=+BN;5]GV/3(B);ZZQG$O[K]T8C)'YOG?@=3(]9^#_QP\$_
MM >&+OQ!X%UHZYHMI??8);S[++:YE\J*0Q#S8HO^>L54/C'^T-\/?V?K*QN_
M'OB6W\/P:E+Y5K^ZEN992HR3Y<4<LF,?\M<?\M(Z\C_8$TVQT'2_COIVGV=O
MI^GV/Q7URTMK6V3RXXHH?LHBBBB[=.G;%<7^WK\%O#WA']E_XP^+L7FI^*-8
M^Q12ZWK=])=W,-J^L17(M(A)G[/;1F7B*(#_ %<6?,- 'W!1116P!17R9-^V
M#\3O$MOKFO\ P]_9V\0>+O =K^\L/$%YJT>FW.IQ>4)?M5M8R1>:\4O_ "R\
MH'S>/^6A,8]\^#_Q4T+XU?#G0?&WAZ2X?2-8C\R);E-DD8\TQR1R?]<Y(Y(_
M\>M8@=O17Q;\//V\/%_QN\-:1>_#'X'ZOXQU)H[F77-NM1V%CILL<OE16POY
MH?+N93$8I?+["6/_ %G[SR_;/V?OV@Q\:D\5:/K'A>\\#>//"%]]DUWPU?2>
M:UL9/,-M+'<?ZN6*6.,X/?\ ZY^7))J![-7G_P#PN31O^%Z?\*I^R7O]O?\
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M2XE/7!X$HDCC\[_X)G_\F0?#3Z:G_P"G2ZH ^HJ*^3M._:[\>_%"VEUOX._
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M)[N6(/:B*26,?:,1='Z^9@CJ ?>]1>1'_P \HZ\J_9Q^-#?'SX76GB>?1_\
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M7U[)JNH:AJE[)=76H7TB1I+<RR2$_O)#&,XXSSQFO'_^"HG_ "8O\3/KI?\
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M''[16E_L]_$;7_B+^T-H>E:>^DZE)?>%M+\+6QTZ2*3S$BL8K^7RI1YOF1Q
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MK7Q:^#WA#XV>#Y?#GC?0(?$FDLZ7(@DFEBV21_QQR1D21Y''[OL3ZFF,^?\
MQ3^RU\?_ !IX:U;0M:_:B^V:-JEG+8WMI_PK^QC\V*6,Q2QYBE!Z<<53_:8^
M&]_\'_V;OAEXDT=)]9UWX)7&DWQFL+?R;K4K"V2*UOHO-CWR6L4L7[V7_6 1
M1?O!CIO2?L"^']85;7Q7\4/BQ\0?#4A'VKPWXF\6S36-V/\ EGYT4:12?NY/
M*E&).#$/I7TOK&BV'B32;K3=1LK?4-.O8I+:XM;J+S8I8Y?];')'0(^5?$7B
MC3OVI/VGOAAH.F77]K_#WP?I-K\1KFX@B_=7%]+@:7'+Q');21QRFZ\N0_O8
M^L7>N:^.WA'QMKG[?VA1^$_B /A?>ZA\/);2UUNXT.'4DU&:.^DEEL88Y\(9
M!&T<I\O,@CC/8U[_ /LY_LU^&/V:]#U33/#M[JVLRZC+%)<:GX@DCN;XQ111
MPVUMYL<49\J**+]W'TC\R3'%7OC1^S_X-^/FFZ=;^);&[6\T:;[1HVN6%S):
MW^DW) Q-;2Q\Y!\M\?ZO,<>1^[& #P7XF?L:_&WXO>"=1\)>+_VF?[9\.:D(
MA<VO_"!V,/F^7)')'^]BF$G^LCB_+O76_'B/S/VY/V2QZ_\ "6_^FN*K?A;]
MB'PYI7B;2=6\2^/_ (D?$5=+OH]4TRP\7^*9;FVMKZ.3S(KJ..,19EC^;KQB
M63@UZSXL^"&C^,OBI\/O'][>7\&L^"3?G38;5X_LTOVV+RIO,'EY/'ICUYHA
MN.9T_P 0_&-C\-O ?B7Q=J4,TUEH&F76IW,=L/WCQ11&601\^B5\C>"])_:3
M^*OPVM?B=K_[0'AGX4Z1J>FQ:Q#INC^%K;4+"RL'M(IO-FN+W#QG_6-)EY(^
M.),<#[-UC0[#Q'I=WINHV=O?:;>126UQ:W,8EBGCD_UD;H>""/7UKY7TS_@G
M)\.XK5]&N/$GQ&O_ (>>;))_PKNX\5R?V$ \AD$7E18DQ'+^]_UN?,0$E^<]
M)S'(?LD?V%_PZ?\ ^*A_M+_A'?\ A'/$G]I?V3Y?VO[)]JO_ #O*\S]WYGE[
ML9[UR_PGUWX^?%[]D?0?AEX?^''A6;P_KW@Z/0X/B)_PED;:?';&T\HB2RCC
M-R+F*/\ T63' N8\X\L$5ZU\9O!)_9 _8#\6>&?AS:W?B6#0]*FCB37;2/4L
MP7%UFYEEA\L12+''<RR',?EXB/F C.?&M/\ @3_P3YTWP+9:G-KWAG4X(+".
MYFO+KQA<?VC.JQAC)):Q7$<GFMMP8HX@=[8$8QB@#UW]N+X;-X3_ ."=/B?P
M5H-OJ&J0:!H^DV5O&5$LYM[.ZM299-@'2*$R.<   GBK&B_!?]HKQ#I-MJ.G
M_M>P7^G7D4=Q;75K\/-,DBGCD'[N2-_-Y!&"*=^P'9W'BK]FW6]+U"^N/&7P
M[DUW4M*\)3:]Y<WVSPU'BVBCEC\L9'R7,9CE0?=Q@1^75B'_ ()]Z!HZ-9>#
M_BI\6OA[X9B8_9O#7AGQ;+!860_Y:>3'*DLG[R3S)#F3K(<4 =_^R_\  /4O
MV>?#/BVRU?Q;_P )OJWB3Q+=>)[W5%TT6.9[B.(2CRDED[Q9X(_UE<1^WK][
M]G/_ +++X<_]N:]U^%/PO\-_!_P#I?@_PAIITGP[IWG?9K/[3)-Y7F2R2R#S
M)"9#^\DDZGOVK)^+OP5TCXS+X,?5[J_L_P#A%?$EEXHL?L#QQF2ZM?,\J.3?
M&<QYD/ P3ZCN >$_M3?VE\%_CC\(OC':16D>AM+_ ,(5XRNI)#"(M-NI8OLL
M\DAC,<45O<^9(9?W1)>*/.)*7X#:K?\ QK^/7C;XN17MT_@W28G\$>%(87)M
M;V*.6.6_OQ_K(I1+<Q0QQ312<Q0GS!^Z%?0?Q<^'.C_&+X=>)/!FNVOVK2-<
MLWLY\1H73/W98_,5@)(SB2,XX>//:LKX4_"/1/@;\-]!\$^'(KB/1='C\N-K
MA_,=_P!\9)'D]Y))))../ITK6!F>&?L*]/V@_P#LK_B/^=K2_P#!2_\ Y,@^
M)?TTS_TZ6M>P_"OX-Z5\'_\ A+O[(NKR['BKQ)?>)[[[<\3F*ZN?*\V*+$7^
MJ_=_7WKQGXI?L):+\7KKQ /$7Q9^*\VD:W?274GA\^)8_P"RH?WQE$45M+#_
M *J+_EGUQY7TH$?4]<]X\\76/PY\"^)?%.H1W$MCH>F76J7,=K_K9(HHO-E\
MK_OW7G7P?_9K_P"%1>*+C6Q\4?B3XU%Q8_9#8>,/$'V^U3]['+YT<?E?Z[]U
MCZ22UZQK&E6'B+2KK3-1LK?4-.OHI;:YM;J+S8I(Y?\ 6Q2Q5H!\=>"=,_:-
M^)OPZM_B;KWQ\\._#+1-6TZ/6X=+TOPO;7]E9:?):QR^;+-=8DC/,IDS)(!_
MST].Q_X)H?\ )D'PT^FI_P#ITNJIZ?\ \$\?A[;VKZ))XI^(-_X!$TK_ /"O
M[KQ+*N@XDD,GE>3%^\_=R_O?];S+%GN:]L^!OP:T;]G[X7Z1X%\/W=Y>Z)I)
MF,$NJ21R78\V624Y\J.+/,I_SS68'C__  30_P"3(/AI]-3_ /3I=4? /_D]
MW]JW_N4__37+7L'P-^#6C?L_?"_2/ OA^[O+W1-),Q@EU22.2['FRR2G/E1Q
M9YE/^>:/!_P9T;P;\4O'GCNRN[V;6/&WV$ZE#-)']EB^PQ>5%Y7[J@#PS_@F
M*=-T_P#96T_28;,:?KNCZQJ>GZ_;26)M;F.^^T_ZJ7('[WRI+8=^ (_^6=36
M6I6&I?\ !3[4K>UO;>[FL?A1]DNX8Y?,^S2?VI%*(Y/^>?[J6*3_ +:=\UT_
MC#]BOP?XE\6:IXFT+Q'XT^&&MZN_VK6)? .NR:<-6F.<27,>)(_ES+@Q=?-D
M)R:U?A7^Q[\./@C\0$\6^!M.GT"9-%DT'[!%();5XI+K[3YLGFCS9)1_J_,\
MW_5@4 >YU\-?LK_"I/C7_P $O=*\$O'!++JVF:I#9&YFEBACNO[3NI+:27R^
MT<L<<E?<M>>_ WX-:-^S]\,-(\"^'[N\O=$TDS&"75)(Y+H>;+)*<^5'%DYE
M-:@?(Z_&K7OVJO@S\,_A&+N;3_'OBZ:73_B#]DF\J^T73;&;R]0EN1'_ ,>4
MMUY<4<<4L/E?Z5+$>HKUCX^?\GN_LI?]S9_Z:XJ]$\%_LS^"O /QP\8_%31[
M2>W\5^*(O+N,2I':1\1^:8HHQUEECCDEDD\S]YSW-;GC#X,Z-XR^*7@/QW>W
M=[#K'@G[<=-AADC^RR_;HO*E\W]U60'SQ\7+?XUVO[5$/C*S^#/_  L7P]X5
ML/LW@^X@\4V.CQ037%M%]NN9!)^]ED/,6#Y<8CB_U?/F5YE\6/BY\:M7_:<^
M &I:K\ 6TK7]-_X2,:/H@\:6,W]K>;8QB8^<(_+A\F/$G[S/FYQQ7Z+5Y[XP
M^#.C>,OBEX#\=WMW>PZQX)^W'3889(_LLOVZ+RI?-_=4 =/X5U/4M4\*Z5?Z
MYI0T#6;FRAEO=+^UBZ-E,8QYL/FQ_P"M\L\>;[UXG\0/V:_$-K\1-9^)WPF\
M<WG@[QYJJVZ:MINHQ_VAHNM_9X_W<=S#_K(L_NHO-BYCB$GEQ_O37T/7S/KG
M[#>@W_B_Q'K>B?$_XG^ XO$&HRZQ?:5X3\2"TL/M,IS++Y?E=9?7VQTXK2P%
M1?B;J_Q\_9-^-&GRZ(K>-=%LO$7A#4[#1#+/:7VJ6]J8C]B!_>21RF6+RPP\
MS_EGSU/GO[._PD^./BSX#_#[5?"W[3]OI^AR:-9_9["T\#Z;??8?+C\K[+YI
MDS*8CF+)_P">=?5OPH^$/A#X)>#X_#7@K18?#^D1O)<FWCFEE\R208$DDDI\
MR3_]7I7C6J?L*^#K?4KJZ\%>,/B%\*+*_FDGFT/P+XADL+&2YD/[V;RO+E$?
M'EQ_NOW>(HACBLP.C_9V_9S\2_"/QI\0O%WBWXB?\+!\0>,5T\75W_8D6F>6
M;6*6*/\ =QR^5_JY8_\ OW7B7[+]C>ZY_P $HKK3;"RN+^_OO"WB:TM[6W0R
MRRS2S7XCCCC'K7U/\'?@QX>^"/A>ZT/07O;AKV^.J:CJ&JWLMS=:C>RQQQRW
M,DDI_P!;+Y?;C)/3--^!OP:T;]G[X8:1X%\/W=Y>Z)I)F,$NJ21R70\V624Y
M\J.+)S*:T ^7/V=_A)\<?%GP'^'VJ^%OVG[?3]#DT:S^SV%IX'TV^^P^7'Y7
MV7S3)F4Q',63_P \ZZF?]F7QA\//AE^TCK>L^-;GXG^-/B!X7DM-]MH$=E.\
MEM87,444<44LOF^9YL<>  ?W??BM_5/V%?!UOJ5U=>"O&'Q"^%%E?S23S:'X
M%\0R6%C)<R'][-Y7ERB/CRX_W7[O$40QQ7KOP=^#/A_X&>%[G1]!>]N&O;XZ
MIJ.H:M>RW-UJ-[+'''+<R22G_6R^7VXR2>,UF!QO[$^I:!JG[*/PMF\.I;Q6
M,>BVT4OV6W,6;J+,5T3[FYBE)D_Y:'UZUI_M&7]MK_[+GQBN]/N8[JWB\*Z]
M!)-;2^9'YL5K=12Q_P#;*6*2.O,M8_X)Y^"M3NO$MKX?\:?$/P+X=\02R/>>
M%?"NM?9-$'F1>7*3;>5R)!_RS.1V_P!7@5]#^"?@QX/^&OPQB^'6B:##'X+C
MAN+8:1=^9=120RR222Q2>:9#(KF23.<\$CVH&9'[)=K&/V8?@_)W/@_1O_2"
M&O,OV!_O?M%_]ED\1_\ MM76? /]E'1?V>=>N[OPKXJ\92>'7AGAMO".IZT;
MC1M.\V43;K: QY5@?X_,/^LDSR37:?"+X*Z1\&5\9OI%U?WG_"5>)+WQ1??;
MWCD,=U=>7YL<>R,8CS&.#DCU/;(T/EGP#\7M-_9#UC]HWX>Z]&8]/\+M<>/O
M"MK-NT_3[G3KI(R+"UQ'Y4,45ZZ6P\LGS);F3$61(*Z#0?AOJ?P[_P""=_Q/
MN-?^T2>+_%?A37?%GB6:ZM/LDTNJ7UC)--YEN>(C&"L6 (_]3_JU)KUWXS?L
MI^"OCEXU\,^(_$$NH6]WHH\J6UL3"+?7+47,-T+*^$D3FXMO-M]_E9_Y:/W-
M>E_$/P=8_$;P'XD\(ZE+-#9:_IEUIER]L?WB12Q&*0IQZ/0!R7[*'_)K/P:_
M[$S1O_2&*O)_^"7T,<W["OPSWIG_ )"G_ITNJ^A?AYX.L?ASX#\-^$=-EFFL
MM TRUTRV>Y/[QXHHA%&7X]$KQ[P!^Q]X5^#?Q1F\8>#O$?BSPMI=U?R7TW@C
M3]4\OPX\TT7E22?8A'W_ -8/WF(]B8Q&@C !Y%I/B#0_V1OVNOB-I.MW&I:=
MX&^(FCS>.K&[FBNI+6VO[6.6758HAB3S))(HOM,G,? AC\OF*NT_8.T#4['X
M'/XMUNV:VUKXA:Q?^-=0MTD_=1/?2#RO*&3B,VT<<O[PF3]Y^%<O^W7H.C?&
M;XD?!#X/PZC_ &;XSUS6+RZNKZSEBCN[+0OL-Q'J$(D ,D?VF,F./,?ERF$B
M3_5U];V?ARQ\-Z39V&EV<&GZ?9Q1VUO:VT?EQQ1Q?ZN*.,<?_JK4S/+?VHO^
M39OB_P#]BAK/_I!+1^R[_P FS?"#_L4-&_\ 2"*O1M8T6P\1:5=:9J-E;ZCI
MU]%+:W-K=1>;%+%+_K8I8J\;^ O[*6B_L^ZU<W7AKQ9XRFT)X;B"U\+:EK!N
M-%T_S91*6MH3%P<Y'F9/$DF3DFM1'GG_  3%.FZ?^RMI^DPV8T_7='UC4]/U
M^VDL3:W,=]]I_P!5+D#][Y4EL._ $?\ RSJQ\9]477/V]OV==$L(KB[U#1M-
M\1:OJ<$5M)FUM;BV^S132R?ZO!EBDB_ ?\](ZZ#QQ^PWX"\5_$"\\;Z!JOBC
MX:>*-3,@U/5/ ^KG39=2\PQG,G,G/[OS/DV"23,D@D.".D^"'[*/@3X!7&H:
MOH4-_J7BK5F<ZGXJUV[^U:G>B28S$22$8Y).1%CS/+C,GF&L@/2/'GBZQ^'/
M@7Q+XIU".XEL=#TRZU2YCM?];)%%%YLOE?\ ?NODWP3IG[1OQ-^'5O\ $W7O
MCYX=^&6B:MIT>MPZ7I?A>VO[*RT^2UCE\V6:ZQ)&>93)F20#_GIZ?8NL:58>
M(M*NM,U&RM]0TZ^BEMKFUNHO-BDCE_UL4L5?+VG_ /!/'X>V]J^B2>*?B#?^
M 1-*_P#PK^Z\2RKH.'D,GE>3%^\_=R_O?];S+%GN:T X?]E_3;W7/^"45SIU
MA97%_J%_X6\36EO:VZ&666:6:_$<<<8]37NO[$^I:!JG[*/PMF\.I;Q6,>BV
MT4OV6W,6;J+,5T3[FYBE)D_Y:'UZUV'P-^#6C?L_?"_2/ OA^[O+W1-),Q@E
MU22.2['FRR2G/E1Q9YE/^>:\FU;]@_X>3:I=QZ%K7C3P1X4U262;5?!?ACQ#
M+8:/J9DSYPFM@.DL6(O+B\O]U%68&7^S;JEAK/[9W[5=SIM[#<Q1S>&K4O:R
M>:!-%8RQ2QC_ *YR121U#_P3%.FZ?^RMI^DPV8T_7='UC4]/U^VDL3:W,=]]
MI_U4N0/WOE26P[\ 1_\ +.O5/@K^S+X)^ 'B;Q/J7@FRN-(CU^*QCETSS$%M
M;BRB,<7E<;R9/,\R22220R2<GKSS'C#]BOP?XE\6:IXFT+Q'XT^&&MZN_P!J
MUB7P#KLFG#5ICG$ES'B2/Y<RX,77S9"<F@#F++4K#4O^"GVI6]K>V]W-8_"C
M[)=PQR^9]FD_M2*41R?\\_W4L4G_ &T[YJ[\ _\ D]W]JW_N4_\ TURUU_PK
M_8]^''P2^(">+? VG3Z!,FBR:#]@CD$MJ\4EU]I\V3S1YLDH_P!7YGF_ZL"N
MQ\'_  9T;P;\4O'GCNRN[V;6/&WV$ZE#-)']EB^PQ>5%Y7[JM /$/^"B6GZC
M>> OA;>Z;J@\-G3?B-H]U+XCFMO-M=#C_>Q_;I?-_=B*.66+_6?NSG'>KW_"
M@OVDO^CJS_X;C2__ ([7T'XX\#Z#\2/".I^&/$^G6^L:'J$>R>VN<@N1T(/K
M_P!-:^>_^&"_#>W[%_PM/XJ_\(?_ *C_ (1#_A+Y?[+^P?=_L_RO*\S[+Y7[
MK_69\OO68%OPS^Q/H6G_ +,OA+X/ZUXEU6XE\+ZB=7TWQ)HN--OK>Z-S++%+
M'_K?+/\ I,L?_+3U'(X/!?Q'^(_PA^,'@WX7_%'7-+^(*^,(K\Z!XKTJR&GW
MWFVT7VFY%]:_ZJ/B7RXS$?\ EE^\'[S,?1_$[]DOP9\1]%^'^FP:IXE\$OX%
MC-MX=U7PKJTEK?6%KY0AEA\V7S.#%%'_ --?W?7_ %E/^%?[)O@WX9^,8O&$
M^I^)/B#XVL8Y+6V\3>-M4DU+4+.VD!/DQ$_NXQ\TO2/S/WLHS^\Q0!E_$#]F
MOQ#:_$36?B=\)O'-YX.\>:JENFK:;J,?]H:+K?V>/]W'<P_ZR+/[J+S8N8XA
M)Y<?[VNH_9O^,NH?&+PEK9UK3K?3_$_A77;KPOKD.FRB6PEOK;_6RVOF?O/*
ME\T?ZWGC_MI7#:Y^PWH-_P",/$>MZ)\3_B?X"B\0:C+K%]I7A/Q(+2P^TRG,
MLOE>5UE]?;'3BO8/A1\(?"'P2\'Q^&O!6BP^'](C>2Y-O'-++YDD@P))))3Y
MDG_ZO2@#N****V **** (JEJ*I: (JEM(?.DJ*MG3[40Q[^YK$"W&/+C%24R
MGUD:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !117/^*/%>G>"/"NL>(M
M8N#:Z/I-G+?7EQY9?9#%&9)),)[ G\* .@HKG_"_BO3O&_A71_$6CW!NM'U:
MSBOK.X\LIOAEC$D<F']B#^-=!0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !17#>*OBCX>\+>.?"'@[4]2^R>(?%(N_P"R
M+/[)+)]J^RQ>;<?O /+3$?/[PCKQFNYH **\C^-'[1GP[_9YL=*OO'WB>#P]
M;WT[0V49AFN9964 N1'%&\A !YDQ@%XQGY^>F^%/Q0\-_&#P#I?C#PAJ1U;P
M[J/G?9KS[-)#YOERR12'RY )!^\CDZCMWH [:BBB@ HHHH **** "BBB@ HH
MKG?$GBS1/"_V!-9U?3]';4[R/3[+^T+I(3<W,A(CBB#_ .LE..(QS^5 '144
M44 %%%% !6!XF\,:'XRT2YT;7M)T_7='N#_I%AJEK'<VS<[P9(Y 0>>>?:M^
MB@ HHHH **** "N4\;?#WPI\1M+ATWQ5X;TGQ-8QR_:8K36K&*ZA24 _O/+D
M!Y^<_G75T4 <1X#^$G@SX8R7Y\'>#=!\)?;Q']J_L/3HK$7'EY\OS!$!G'F2
M=?4UV]<MXY\<Z#\,_">I>)O$VK6^CZ+I\7F7%[<$X3T]SS_ !7&? []I[X9_
MM(-K/_"N_$I\1'1Q#]N86%S;>3YOF>4#YT<><^5)T]* /7**^?\ P-^VM\%?
MB1\28/A_X7\=6VN^*+F6XCAM;2SN3%(8HGDD,=SY8B<>7'(?,$F#CC.<5] 4
M %%%% !17.:EXLT/2/$&E:'?ZMI]KK>L&7^SK"ZNHTN;SRAYDGE1]7\L$$XZ
M=_4]'0 4444 %%%% !17G_Q<^,?A#X)^#I?$?C;7H?#>DJZ6XN)8I)2\CXPD
M<<8,DA[_ "#L?0U4^#'QX\#?M!^&;OQ'X!UP^(]'M+U["2\-I-;?O?+CD,0$
ML<9SB6/MWZT >ET444 %%%% !1110 4444 4;N'_ ):54K6JI=1"/FL:E.YM
M3J%6BBBN4Z@HHHH ***X[X6_$SPW\8/ ^G^+/">I?VMX=U+S?LUW]EDB\WRY
M9(I/W4@$G^LCD[4"N=C1110,**** ,3PSX6T3P;HMMH_A_2;+1-(MSFWL-+M
MH[:UC/\ K.(XZVZS=8UJP\.:3=ZEJ-[;Z?IUE%)<W%U=2^5%%'%_K9))*-'U
MJP\1Z5::EIU[;ZAIU[%'<V]U:R^;%+'+_JI(Y*9"9I4444BPHHHH **** "B
MBN.^*7Q,\.?!_P #ZAXL\6:E_9/AW3?*^TW?V627RO,ECBC_ '48,G^LDC[4
M"N=C114D<?FT ]B:TA_Y:R5;HHKT#@'T444 %>5ZI^S+\(M8U2ZU'4_A;X,U
M._O))+BXO+S0+666>20YDDDD,1))R>3UKU2B@ HHK \3>)]#\&Z)<ZSKVK:?
MH6CVY_TB_P!4NH[:V7G8!))(0!SQS[4 ;]%,I] !4<T?G1XK$\,^)]#\9:);
M:SH.K:?KNCW!_P!'O]+NH[FV;G81')&2#SQQ[UN4 <_-#Y,OE245L75KY\?_
M $T]:QY?W-:F045%16P$M%15+0 445R/B;XF^'?"OC;PKX2U/4C::_XH%T=)
MLQ:RR_:A;1>;+^\_U<>(O^>E(#KJ***8!1110 4444 %%%<GX!^)GAOXF?V]
M_P (]J!O_P"P-7N="U+-K+%]GOHO];%^]_ZZT@.LHHHI@15+7(^&?B;X=\5>
M-O%7A+3-2-WK_A<6IU:S-K+%]E%S%YL7[S_5R9B_YYUJ>'_%FA^*!?+HVL66
MKG3+V6POO[/NHY3:W,6/-BE\O_5R_P#3.E<#:HHHI@15+_KJ*T[&S\K]Y)_K
M:3=@)[.U%I'BIJ?17*:A1110 4444 %%%% '._\ "*Z+_P )/_PDG]D6'_"3
M?8_L']K_ &5/M?V;S/-\CS?]9Y6_]YY><9YZUOT^B@#&U"S\G]['5"NBDC\P
M<UCW5G]DD_Z95M3,B*BHJ*U EHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "HJEJ*@ HHJU:V?G2?],J0%O3[/\ Y:R5H44^N4U"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#X0_;E_:BUWP3XZ^'OAO1_"/Q,LGTGQU
MI$M[J^BZ=+%8:_:F(ROIMK*DH%S+)Y@C\D]X91VY]0^(WQ<_X6_^QS\:];'@
MOQAX)2'P[KEG_9_C/3/L%Y+_ ,2\R>:D?F']U^\P#_TSD'UI_MZ_>_9S_P"R
MR^'/_;FO5/VK_P#DUGXR_P#8F:S_ .D,M 'S+\#?VXO"WA?X4^ ?"'A_P3X]
M^*.J:!X/T)-5?X?Z'_:5OI<DEC'_ *-+)YH_>9BY X'W<^9'(!]1_!?XS^%/
MC_X!T_QAX-U(WVGW!$<D,I'VFSF_Y:6\T7_+-Q]>X(RF,XG['>DV>C_LL_"2
MVL+."RMY?"VG71CMD$8\R:WCEE<CU>221_?-?-_PEU:^T/\ 9U_;;U33KVXT
M^_L?'/C6[M;JVD,4L$T=K&8Y(Y.Q! YH ]+U+]O;P?-?7=MX*\&?$;XN6=A/
M):S:WX"\-R7]C#<QGYX?.,D8E/\ JY,QYC,<T6#S7L'P7^,_A3X_^ =/\8>#
M=2-]I]P1')#*1]ILYO\ EI;S1?\ +-Q]>X(RF,_*O[-6D_M7:-^S[\-[;P-9
M_ ZP\+/H%G<Z?#?1ZM%<&.6(2B281#899/,\R0C@R,YKT[]DSX"_$#X6_$OX
MN^-/B G@RWU'QQ)IEP;7P2+E+6.6WBF$LOES1 YD,OF$Y),AD]: /JJO-/@+
M\:=(_:"^%NC^/?#UG?V>C:MYOV6'4TCCN/W4LD1\SRY) .8CW_P'I=?*O_!+
MO_DQ?X9_75/_ $Z7= 'KO@_XV:/XR^*WQ!^']E9W\.M>"?L U.:Y1!;R?;83
M-#Y9\S)X!Z@>E>.:]_P40^'6E:]JGAZPT/Q;XE\9V7B*^\/?\(KX?TY+S4[A
M[,9ENHXA+_Q[8_[:$B0^7B.0B7]GG_D^K]KC_N4?_37+6=^P7HMG#K?[1NIK
M:0)J%Q\6]=M9;KRQYLD47EF*/?UQ&9I<?]=)/4F@#T;X)?M:>%/CIK^N^&[/
M3=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#^Z_> 'G/,>0/,B\S&^-'[:WP\_9
M]\77WAWQB=2M+RV\.?\ "11RI%'LNXS=&UCMHLOYDER9 <#'E^6#(9 !QA?\
MY3/^Z-_^YJL^\T>QU#_@J9ITUY:6]U<6'PE^UVDDL0<V\O\ :\L1DC)^X?+E
ME3(/20CF@#5T']OCP1-XPT[0?&OACQE\'VU6&>6RU#XDZ3%H]G<&(#S(Q*TQ
M&?W@.",<]<O&#E:/_P %'OAMJFI:)-<Z)XRT+P1K&I2:98>/M8T/[/X=N)-T
M@4FY\W.',,G)C'EY_>"/RY,._P""@VDV6MZ7\!=-O[."_P!,OOBWH5I<VMRG
MF17$4HN1)&\9X((]:T/^"HG_ "8O\3/KI?\ Z=+2@#VKXN?&/PA\$_!TOB/Q
MMKT/AO25=+<7$L4DI>1\82..,&20]_D'8^AKPNV_;\\*:;K6BV/C'X>?$WX7
M:;JUZ+2'7_&OAT:9I<4I4F..27S>,B,_D<X3..=_;<F\9:I^T7^S3HW@0:'>
M:U)>:_?6NG^+'EDT>2ZM;2*2*66*+DRQ9E,4@YCD-,^*'PW_ &N/C)\/]=\%
M^)H?@3+H>N6;VEV88=8>6/.-LD0E! DC.)(R1P\8/:@"/_@I9^T)K?PS^"OB
M3PSH&A^/--UBZL[*\MO'&@VLD6F:;_I\?[J6]CD!BE(B,>/^FT?:2O?O@C\=
MI/C<=98?#OQ]X"&F^2<^.=#_ +--R93+_J?WA\P1^7\WIYL?UKY[_;1\&W?P
MY_X);ZAX4U%HI-1T'P_X=TJYFM_]7))#=V,4FSVS&:^XZ "OC72?^"E7P]\6
M:;H$WA/PMX[\>ZSJ5G/?RZ'X6TB*]U'3H8KK[-YEU%'+^[\SJ.>AC)\OS(\_
M95?(7_!+/1[*Q_8E\"W%I:PV\E]-J-Q=/''L,\HO;F(228QO/EQ1)SVC'H*
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M%_:OLGV7^UX\;_M/[SS?,\WIQC9[T <K_P -M:W_ ,-D_;O^%9?&K_A'/^$
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MI!YE_+*2< "+I_K!Y?:OIC]E#_DUGX-?]B9HW_I#%7EG_!+O_DQ?X9_75/\
MTZ7= %CQM^W'X6\)_$77_!N@>#?'WQ5U30#$FJR> =%_M.#399/,_P!'ED$@
M_>9B.1T'3_61R ?07A?Q7IWC?PKH_B+1[@W6CZM9Q7UG<>64WPRQB2.3#^Q!
M_&OF%_A'\6_V;?%/CWQ)\,(=+^)OA#Q=X@NO$>H>!]8D&FZI;WUQY8D-E>@"
M/!?,A\[I';QI'F1S(??_ (-_%70_CA\,]!\<^&I)CI&L1M)$MQ'Y<L?ERF.2
M-_='CD3CT[]: *'QH^,_A3X > =0\8>,M2-CI]N3''#$1]IO)O\ EG;PQ?\
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MP1^7\WIYL?UKS3_@J)_R8O\ $SZZ7_Z=+2OJJ@#Y+^"/[0'PH^&_[.'P>O/
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M$LDQN4E_U40(Y$?8F,2#!/T#XY\<:#\-_"VI^)_$^HV^CZ)I\6^>^N<DH3T
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MOX@^ ?#'B-XH[+Q=XLT)++1@TT?FQ@W7FG_6 'Y^1_RT)$8,@]K^-'QG\*?
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MO=Z* .+^%/@1?AM\+?!_@XW7VYO#^D66E_:O+\O[1]FBCB\S9VSY8KD_@/\
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MY9\>/@3H/Q^\(6FB:SJ&J:3)I^I0:OI^J:#=_9;ZQO(@1%+%)CAAYLG)_O\
M&#@UX^/V9_C;KQ?3_&?[4NO7/ARX?;<P^'/#-CH=^YZQF*^C\R2+]X(\X'(R
MG>OK.B@#Q_X\?!7_ (74WP\QK1T8^$O&6F^+,?9OM'VK[+YN+?\ U@\LOYG^
MLYQCH:ZSXK>!%^)/PM\8>#A=?86\0:1>Z7]J\OS/L_VF*2+S-G?'F&NTHH X
MOX4^!%^&WPM\'^#C=?;F\/Z19:7]J\OR_M'V:*.+S-G;/EBO%O@G^RKXC_9_
M\;"+P=\4]1A^#]OJ%U=Q?#R^TM+G[,)83F&*^ED,B1B8^:./S,DDC_3M% 'Q
MYI?[*?QLTZUDT"']J3Q3/X+EGDC:RO/#]K+K0LI)B2G]IRR&7S1')Q-CY"!B
M/&(Q]"?!OX5:'\#_ (9Z#X&\-1S#2-'C:.)KB3S)9/,E,DDC^[O)(_'KVZ5W
M]% 'B'QW^$'C#XEWGAS4O!/Q1U?X8:UH<ERX:TM4OK*\BE3RF%S:2'RY2, Q
MF0_N\R$#)!CY7X<_LJZMIOQ"TGXC_%#XE:Q\5/&GAV*ZM=$+6<.CZ=IT<R".
M5Q;0<&4@R RD\QF,;,Q1D?3-% 'SG^T)^RW;_&[Q+X4\=Z#XIU#X;?$?PVI&
MD^)-+MX9CLEEC)BN8S@W,8Q*!$9!'_I,N1()"#YPO[!.O>*/&'A+QIX\^,NJ
M>/O&?A_Q38Z[;7EYIOV:P@LK8#S;&VL8IO*MS-)'$9)@/^6*?N\^9YGVG10!
MX_\ 'CX*_P#"ZF^'F-:.C'PEXRTWQ9C[-]H^U?9?-Q;_ .L'EE_,_P!9SC'0
MUUGQ6\"+\2?A;XP\'"Z^PMX@TB]TO[5Y?F?9_M,4D7F;.^/,-=I10!Q?PI\"
M+\-OA;X/\'&Z^W-X?TBRTO[5Y?E_:/LT4<7F;.V?+%>%^(OV2/%6@^,_$>O_
M  >^,FK?"Y?%&HS:KK>EW6D6VMV,U[+C,UO'/C[.7/F>9R?,/EC@1H*^J**
M/(/@K\+?$7PW_MJ_\7_$W7_B7XBUEH5NY]1CCM;"V\KS!']DLHOW=MF.2/S,
M']X8_,]:3X#_  5_X4JWQ#SK1UD^+?&6I>+,?9OL_P!E^U>5FW_UA\PIY?\
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MB@#Y,\/_ +'?BG7/'?A_QA\7?C-X@^*$_AV^M=0T;1+>PCT73(KB(S;)9;:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3*?10!'Y0J
M/[''5BB@"G]AC]*9_9X]:O8HQ6/LS3G91_L\>M']GCUJ]BC%'LQ^T91_L\>M
M3?98_2IJ*?LC/VC$\E/2EI]%:B"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** &44^B@"M+9Q3=8ZA_LJ+UD_.K]% &7
M_9(]:B_LF3_IG6QBC%:>T8&/_9,G_3.C^R9/45L8HQ1[1@9O]CQ?\]9*LPZ?
M##TC%6J*S 93Z** &4^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *93Z* (I(4D^\F:K?V;%5ZB@#+_LC_II47]D2>M;&?:C
M/M1[1@8_]DR>D=']CR?\]*UJ*T]HR>0S_P"R/>I8M-BJ[2UF41>3''T2G4^B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$HI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M&QU?6=.\-W,-U%%<RK%:QRRFW^TW'F21#/\ K#D9DK!_;0^)5G\8O^"7NO\
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M'QYTS1X?BSIBQS2_$.[ETV%=92XEEEDN=:T_;Q;C%S)&]M'Y<8BCQ)OR;B(
M^DOV)?!?BCP'^RO\-M"\7R71URWTTO)!>>;YUM$\DLD%M)Y@WH8HI(HO+(_=
M^5LZ"O(?VUOA?X;^,'[4W[,'@[Q?IAU;P]J0\3BYLOM$D7F^78PRQ_O8R)!^
M\CC/![=ZVM5^-$7Q>_:H_9]B^''BZ[UCPK_8.N>*==M=,NI8[:;3Y8_LUI--
M&<>:1="2+RB#)%(.8X\5J_M#?\GU?LC_ /<W?^FN*@#+F_X)Q?"CP_)I^M?#
M"+5/A-XZTJ?S].\3:/J$]VT4_ER1^7)%<R2I)"=_[R/CS!^[\P M7HW[*/Q?
MU+XP?!^S?Q.BP>._#E_+X8\5VI'^JU2U/ES?-&@B_>#RY?W68_WOE@\5[S7R
M;^P6_P!JT/XV:Q"?-T?6_BMXAU#3=0A<?9KZV)BC66&7I)'F.0"2,]8SZ$4
M?65>1_&C]HSX=_L\V.E7WC[Q/!X>M[Z=H;*,PS7,LK* 7(CBC>0@ \R8P"\8
MS\_/KE?(/QH^*6F>'/VD;>V\ ?!&X^,7QCL=/LXKC5XKBWMX-#LI/MTD<4M[
M+YHLI9!)-^[*1>;',O[P_NXZ /8O@O\ M&?#O]H:QU6^\ ^)X/$-O8SK#>QB
M&:VEB9@2A,<L:2 $#B3&"4D&?DXD\:?M&?#GX;Z[J.@^)_$UMHNJZ?H'_"3W
M,=U#*!'8^?\ 9O-W^7L)\W]V(Q^\)Z)7S!\"=;\7^)?^"C>M:SXV^&,'PNU^
MZ^&;>=IT>KVVIF\ U."..Y>6'')$8BQU'DCU%;_Q"^&/A+XH_P#!3#3K+QAH
M-AXCT[3_ (4C4+>UU2+SK83#5)HO,DC.4D'ERR##\=.X!H ]9^%/[;'P7^.7
MBM/#/@SQS#JVNR1-+%826-W:[]@)?898H_,..=@YP">U=_\ %SXQ^$/@GX.E
M\1^-M>A\-Z2KI;BXEBDE+R/C"1QQ@R2'O\@['T->!_MZ:+9S:W^SEJ;6D#ZA
M;_%O0K6*Z\L>;'%+YAECW]<2&&+/_7./T!JKX\\.0_$+_@I#X%TK7L7^C^"O
M <WBS2-/D@B:+^TI=0%L99/W1;@>5*,?ZN2&-P1@T >=?MF?M6?"G]HC]C?X
MLZ1X!\76_B"_TZ'2[JYMY+>XM)?).J6@\P)-'%O&[@F/."\><>8*_0NOBK_@
MJAX!T#Q)^R#XFU[4-)M[O7O#DUK-IE^S9DM#+?6T,H4YX$D4G,?0XC[QH1]J
MT %>#_%S]L7X-? S6AHWC7Q[8:1K&3YEC:Q37MU:_<DQ-';1R&'(DC(\P#S,
M\9 ->\5\<_\ !,OPU#-^SJOQ)NP+[QG\0-7O]<U[59(X8Y9I!=2PX7RHQB/]
MT9!'VDEEZ9Q0!]&_#7XK>$_BYX;@\0>"O$6G^)]%EP/M-A)YGER;%<Q2@<Q2
M@2Q'RY,.,\BO&O$G_!1S]G/PGK5QI-[\3["2X@QNETJTNKZWP1_!+;Q21OCZ
MUSW[=>BV7P;_ &-_C7K/@RUM]#U'Q!.ESJYM(L+=2WLMM8W4AC.5!EA)!(')
MS)_K"7KZ%^$?PXT?X._#KP[X+T*V^S:1H=FEG!E$WOC[TC^6J@R2',DAQR\A
M/>@#1\#>.=!^)GA/3?$WAG5K?6-%U"+S+>]MR</Z^XY_@(KQ#6OV_?@'X;\-
M^&];U+XAVT.F:]#+=Z8RZ=?22S112RPO(8A#YD?[V.5,R >9Y;XSS7.?LFZ3
M:^ ?VD/VEOA]X:LX-!\':/JVAZQ9:'9HJ0VEQ?6!>Y,?'20Q1_NL^7%@", 5
M@?\ !++X7>$]*_97\(>,K'0-.C\6ZS]O&H:S'$/M<D8OI8Q'YF,B/%M%^['R
M9CS[T >S_P##8OP;_P"%-_\ "SO^%@V'_""?;?[._M+RYO/^T_\ /'[-Y7G>
M;_RT\OR\^7^]_P!7S6O\%_VC/AW^T-8ZK?> ?$\'B&WL9UAO8Q#-;2Q,P)0F
M.6-) "!Q)C!*2#/R<?.?P1^#7@;Q%_P4$_:2UJ_\':5=W^@S^'[K3)Y8(_\
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MZ7::EIUY;WVFWD4=S;W5M()8IXY/]7(CC@@CT]:V*^5?^"7?_)B_PS^NJ?\
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MG&)(K?[#& 8<)%@'H(Q'C(,DGVE10!\T:'\$?B5=?LT_$;P?XX^(5OXY\?\
MC'3KR,:A<6OV:PL9KC3H[9;:,1@D0QR1&3S(XX\^:7\H$G.=\1/V6?$/C+]E
MWX7^![#Q'!H'Q ^'T6CW^D:E @FL?[6L;;RHS()(\F$DOR4XR"8WQY9^J**
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M'QH\3>&1?^#H[^WT;PWX(LI%L5^TQ>5-<RW-S^])*''E 8_=1D'_ %@/:_\
M"G]<_P"&SO\ A;GGZ;_PC/\ P@?_  BWV?S)/M?VG[?]J\W'E^7Y>SC_ %F<
M]J]UHH \+_:6^#.N?&)?A6NBW-A;GPKX[TOQ5>?;II(S+;6WF^9'%Y<9_>'S
M.,X'!R:3XG_!W7_&G[1GP1\?V,UA%HW@?^W/[1BN97\^7[=:QPQB(;.H().2
M/2O=:* /@7]H'P7XT\:?\% C#\//&-YX)\:Z?\)%OM+U"...2VED_M62+[/=
MQ21N)87\T]<^7((Y,$Q@'NIO@7\<?CQJF@V7QQ\3>#],\$Z3J<&IR^%O UG<
MRQ^(6B_>)%?O>D_N4DCB/E['\T&3(!2.0>[?\*0T?_A?'_"V/M>H?\)!_P (
MY_PB_P!DWQ_9/LGVG[3OQY?F>;YO?S,8[=Z]*H *X'XV>"[OXB?!SQ[X5TYH
M8M1U[P_?Z5;2S_ZN.2:VDBCW^V9!FN^HH ^5_BM^S5XJ^('[!MC\$M/O-)A\
M4V^@Z)I1O+F>3[!YME+:F4^8(_,P1;28_=YY' KZHHHH \._8Y^#.N_L\_L\
M>%?A_K\]A=ZOH_VGSY]-DDDMF\VZEF'EF2.,_P#+7'3L>M>XT44 ?&_QZ^#_
M .T%XZ^.VG^*O#-W\--6\'>'3%<>'-#\7/J*QPWWEGS+Z2*VCQ+=(3+'$2Y$
M<8R(Q(?,KK?#7_#7O_"5Z1_PDG_"E?\ A'/MD/\ :7]D_P!K_;/LOF#S?)\W
M]WYFS=C=7TW10!\N_M#_ +.GC;Q%\2/#/Q9^$GBC3_#7Q'\/V7]ERVVM1S26
M.MV)FCD^RW/E-^[C&ZY/$1)+Q_ZLQQR1XNA_L]_%WXO?%KPWXJ^/_B/PV^A^
M#98M1T#PGX$ENHK*74ED/^G71E^<F(8$8R?^V?[P3?7E% 'D7QM_X79C1?\
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MI?$S1K64W(T/Q?XH>ZLGD\J2,2?)''("/,/,<@ZX/'% &[\4_ .I?MB?LU^
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M6M6VC>'?B1X0U_6+@DP:?IFNVMS<38&_Y(XY,]!^E>/?\$N_^3%_AG]=4_\
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M7^PK*RM;$?9H@"(C<RDR>;)-+&,N4$<<8CY /N&BBB@ HHHH **** "BBB@
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M=\43^-;:6^T_PK]B,4FC1(9=0^U+%^ZD C2(B.7]X<2>5G]YG>_:$\#^)6^
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M\*U\6^'_ !/XGEU.P^)EYIG_  D6G66G8'V:UN(\22V7E^;##&?+_>&3R_\
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M]6\96/@C4K'1X18V%]IM\)?,\ZVA\L/)&T:O&?41F02>7'LLZA\-OC+^S?\
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M?[<\>O8>5I%M]HAMC'-*1&)O](_=_NMQF\N3B3RC'WJ']FWX*67[/7P6\,>
M-.U";58-%CE_TVXC\LRR22RRR'9D[!OE?CTXH Y']K/QUX9T3P+:>#==\$S?
M$S4?'DDFCZ;X+M)(XY[^41&7S7\QQY44/EQ&2[&3;YCDKY8D_96^.WPE^%'A
M<>+]2T_X_P#@_P )64IN_A7;WUS:QNL<L<EMY,PC_P")EY?E1R?9[J,I&D?E
M1Q2$ICZ>_:;^!?BSXA:_\//'GPZURQT3XA^![ZXETR/7(B^F7L5T(XKJ&Y$8
M,H_=Q\/'TR1QD21\CJ7Q1_:F\<V-UH.C_ W3?AIJE]')#;^*M9\96FIVVG8!
M_>_9HXO,D)Y\O@@2&,R#RP00#WKX-_%70_CA\,]!\<^&I)CI&L1M)$MQ'Y<L
M?ERF.2-_='CD3CT[]:\H_;>U;X5Z7\%[>Y^--SJ\7@P:EN;1M+EG0:W<BVN)
M(K.3RB"1\AE&9(X_-BC)DXP?0OV;?@I9?L]?!;PQX T[4)M5@T6.7_3;B/RS
M+))+++(=F3L&^5^/3BO-OVJ?ACX^U#Q[\*?BM\,])T_Q1XC\ W]\9/"][/\
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M%K_BZYU^VU2.6WD_=W4=K8Q;S'+)YKD>9(<1B1?,\SRY!WW[1'P)U+5?#GP
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M\$?#_P"&4/Q8^%T^I2ZQX:D7Q1'ILVB12DB73V%T\I=4*Y_=C&9))"2\ICC
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M&0 F_;0^'.F_%K]J;]F/PEJUQJ%OI6I_\)/'>?8+EK:6YA^PP/+;&2,9\N4
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M-JT4>LZMXMU;P+'K1U2\N8A++-%<RR?-$2W[OID'><O)(Y^L?V0?@/JGA/\
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MGA?1_B3X5N?BUXBM-5\(WES%IE]:W /RW5M?2GR\2>9"DD<@DQY2>7_K)#&
M>D:S\,]#_9T_;L^#S?#F)/!^C?$BRU>T\3>']*CCCTNZ-A8^;;2QVP&(I09.
M3'C_ ,B2^;D_\,__  M_X>,?\(U_PKGPC_PCW_"J?[1_L?\ L&U^R?:O[8\O
MSO)V>7YOE_N_,ZXX]J]%^&?PW^*'Q4^/&B?%OXM:#I/A*T\.:7=6GA7P78:A
M]ONM,N;@B*ZNKFZC\M)#)''A(QYD>R0?ZN2,F2O\<_ /Q4\(?M+:#\:_AEX4
MT_XAQR>&Y/!^K^%[O4$TVY2+[3)=1W,5Q(?+_P!;Y0(()P. ?,\R( T_VQYO
M@UX/^ ND6?Q2.H:=\.[*ZBAA\,Z 9K6+4I8[68VNGF.WQB+]T9(QYD<8EMH<
MR "OE?XE>+? \WQ2^ >I>!_@#XR^"6O0?$32K2;7]0\))X<MKNRN)#'<VN^*
M3]Z9!C]VX_U?G#H7S])_M ^ ?BIXBU3X(_&7PAX6TZX\=>"5N+C4? 6H:C'^
M^2_MXH;J&*^&(O-B^<"0_NS_ *SMY4GG/Q4\-_M+?M!^.O@[K>K?#S2? WA#
MPOXWTW4[[PV-?M[^_<PRF3[>90!'Y4<+/%Y49\TR&0^7(/+\L [K_@HWHQ\2
M>&_@AHHU#4-).J?%;0[,ZAI<QANK?S8KJ/S8I,?)(,Y![$5WVO?#7P/^RW\%
M_&GC#X=>!?#&BZYX;\+7\UM<QZ=&)YQ;VYDCCN9EQ+*N^)-^9,G&<YY$?[7?
MPS\2_$AO@S_PC>FF_'A[XD:/X@U)O/C3[/96WG>;)\Y&2/,' YKV?Q1X4T[Q
MOX5UCP[K%N;K1]6LY;&\M_,*;X98S')'E/\ 9)'XT ?FG^S]K_PLT+X5>'YO
M$7[+?Q3^)_B;5HH]9U;Q;JW@6/6CJEY<Q"66:*YED^:(EOW?3(.\Y>21SZ/^
MR3X8\9S>#OVB/ G@?2?'7PU\'75D!\/;7Q_;SZ?<Z3<75O=?:O*EP9!'%<F(
MCRWD,>1(<R2.7[3P&W[2W[./A'3_   GPNTWXV:=HJ?9M)\2Z5XFMM#Q8Q_N
MK6&YMKB/B6*.,$F/,>&CYDD#R'U*#7/V@F^!_B?5V\.^#[;XGM*;O0/#;74T
MUJEJ!$XMKJ7=&'NN;B/S(S'$9/+/$>30!\X_LTZ#\%OAG#\._AC\4O@Y!\,/
MBU9SV)TW5]9L8Y1K6I12BZ\RRU>+/F$2"+,7FX!N([;]Y_JZ_0VOA[XKZ'^T
M)^UQX%U+X9ZW\(]'^$6A:M-;RZGXAU/Q5%J^+:*YAD$5O;6P_P!=F-3^\Q&1
M'(,@R C[AH ^5/V]?O?LY_\ 99?#G_MS7&_MH?#G3?BU^U-^S'X2U:XU"WTK
M4_\ A)X[S[!<M;2W,/V&!Y;8R1C/ER@&*0#K')(,\YKU;]KOX9^)?B0WP9_X
M1O33?CP]\2-'\0:DWGQI]GLK;SO-D^<C)'F#@<TOQF^&/B3Q5^U)^S]XPTS3
M?M/A[PH/$!U:\\Z-/LHN;&.*W_=E@\N9!C]V#CO0!X-^WE^SC\-?A#^R+K?B
M?P9X*TGPEXD\*3:5/HVO:-;FTO[607MO$)/M,9\R0[)#S)G]Y^\_U@!'W_7S
MY^W5\,O$GQD_99\;>#_!^F_VQXAU+[";>S,\</F^7?6\LG[R4B,'RXW/)[5]
M!T ?(G[3VLV.B_ML?LEW.HW<-G#)-XEMTDN9!&/-EL88HH_K)))&G3KBOKNO
M$_VFOV?U_:*^&H\.QZY<^$]:L]4MM7TCQ!:I+++IE[%(,2QHDL63Y9FCZX'F
M^9U&:\XB^,/[4GA<G3-0_9ZT+QK?P#][KWASQO:V%A=$\_NK>YC\Z/ _=_O.
MZ&@"Q^T-_P GU?LC_P#<W?\ IKBKZKKX#TG5OBO\ /VA->^+WQZ\'VWB72]0
MT&WT.#Q9\-$ENK+PW9QRRS7,5S:OBX\G,9N9+DB7R_+$<9/F>6GT1\0_C1XW
M7PSX0\2?"/X7R?%S1_$%G]O,_P#PD$.BBVBDCBDMI-MS'F3S5E/_ %S\OD<\
M '$?L%?>_:,_[++XC_\ ;:OJNOS_ /@3JO[2WP3;XA8_9H&MGQ;XQU+Q9C_A
M/-,MOLOVKRO]&[^84\O_ %O&<\ 5^@% !7Q_'9V_[7WQ^\,^*8FNKGX)_#B5
MKG1[U9Y+:+7_ !*DO_'Q$!G[3:VHB($O[O,OF@&6/S!4O[9EK\:_'&K:1X-\
M$_#FZ\7?#.>/[1XGFL?$MKI-SJBGS/\ B6>9(1)%"?D\TQ#,L<AB$D8\PENB
M_&C]HKP]I-MIVG_LA06&G6<4=O;6MK\0],CB@CC'[N.-/*X & * -'_G*9_W
M1O\ ]S5>J_M7_P#)K/QE_P"Q,UG_ -(9:\I_:T^ _C+Q'XD\ _%?X3II<'Q6
M\$2W'DIJGEK'J5C)%+YMK*?+RW7RX\RQI']JF/F1G#UQ?Q,\*_'S]LJWT_X<
M>-OAY!\%/AG<S+=^);_^W[+6;[4HXI8I(K2W$8_=?O,'S"#Q'GMY4H!]%?LH
M?\FL_!K_ +$S1O\ TABKS#]IW5+_ ..^J?\ "@/!M[<_VAJ$MM+XYU.QF,2Z
M)H1(DDA-P#A+JZ \N*(QR>9'YIDC$?[RNM_:*G^)W@/X*M8? ;P=8ZAXF5H=
M,LK-9K:TM=(MA$!YL4<OEQR",1QQQQYX,@."$*'Q7X1^)_CM\&/"":#H'[)5
MS<)+-)=WVHZA\3=-EOM1O)/];=7,OE#S99"!F3O[4 ?8?A?PIIW@CPKH_AW1
M[<VNCZ39Q6-G;^87V0Q1B../+_[( _"OG3]H;_D^K]D?_N;O_37%7KWAOQ;X
MXU+X/R^(=5^'QT7Q\MA=31>"?[=AN&DFC:3R8?MP_=CS<1?O,8C\WGI7R5X^
MOOVF?'7QT^$_Q#_X9K:R_P"$!.K_ .@GQWIDAO\ [=;"'_6<>5Y>,]'SG% '
MZ!45YE\&?%WCKQEX9N=0\?\ P]_X5KKBWSQ0Z3_;<.J>=#Y<9$WFQ<<DR#R\
M?\L_>L+]F7Q)\8_%/@'4KGXT>&-*\(^+8]2DBMM/T>59(GLQ%%Y<I(N)?F,A
ME_Y:=!T% 'M5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'X
ML?\ !*_]I[X9_LWK\3F^(GB9?#G]L?V8+#%C<W)E\K[5YO\ J8I,?ZV/K7Z:
M_!?]L3X1?M!^)KOP]\/_ !8WB#6;>RDOIK<:;=6Q$(DCC\PF:*//,L?3U]JW
M?^&4?@C_ -$=\ ?^$Q8__&JU_!WP7^'?P\U-M2\(>!?#/AC4I(_(>[T72+:T
MD>/O&9(XP2/DZ>U 'YU?\$-?^:U?]P7_ -OZ^:/^"AGP)OOV<_C=K.F:0ES8
M_#OQ;,OB#3;1%,5IYG[P2P^6(HXLVTDLOEQC)CBN8N<RFOVS\!_"3P9\,9+\
M^#O!N@^$OMXC^U?V'IT5B+CR\^7Y@B SCS).OJ:N>-OA[X4^(VEPZ;XJ\-Z3
MXFL8Y?M,5IK5C%=0I* ?WGER \_.?SH _-/]O7_E%G^SE]?#G_IDN:] \$_\
M%-_@Y\'?V7_A]I=KJ6I>*/%^D>&;'2Y-"L+&2W\JZBL0,27,L:Q^6)8?++Q>
M8?F!$<@K[=\0?"/P1XB\+Z=X>UKP=H6L>'=,\O[%I&H:;%/:V_EQ^5&(HI 4
M3$9,8P!@'M6)_P ,H_!'_HCO@#_PF+'_ .-4 ?GW^R%I/COXM_&#XI_M?:]X
M'N-8M[?3M4N/"^CB:2.ZO;R.+RH;6V$47[T1VT<MKYOEG,DHP))!)Y?HW@7_
M (+*?#N^T6_G\9>$->\.ZM;J)H-/TF6+4DN4_=@A)#Y6)?WDDF) (_+A)$AD
M(CK]$Z\KU3]F7X1:QJEUJ.I_"WP9J=_>227%Q>7F@6LLL\DAS)))(8B23D\G
MK0!^>?\ P2G\,W_CO]H;XM?%S3M"@\*^#+B&ZT^UL8(2(K62ZNHKF*VML1",
MB&./!Z8\R+]WB3C]8*P/#/AC0_!NB6VC:#I.GZ%H]N?]'L-+M8[:V7G>3''&
M !SSQ[UOT %%%% ' ^,?@O\ #OXAZFNI>+_ OAGQ/J4<?D)=ZUI%M=R)'VC$
MDD9('S]/>LC_ (91^"/_ $1WP!_X3%C_ /&J]5HH X'P=\%_AW\/-3;4O"'@
M7PSX8U*2/R'N]%TBVM)'C[QF2.,$CY.GM7?444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBE\/H/ GBCPS8WWA.VD@%MIL8-M%:K#Q"(3$8S#@'R_W>/DRG0F@#R;XB_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ8D<EQ^]ECB'E^9)&#S*._\ @0#TNBBB@ HHHH **** "BBB@ HHHH ****
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M0?\ ".?\)1]KV1_9/LGVG[-LSYGF>;YO;R\8[]J /2J*** "BBB@ HKQ_P"
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MZ/\ 9I^,VN?&)?BHVM6UA;GPKX[U3PK9_889(S+;6WE>7)+YDA_>'S.<8''
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M_P#D!?\ "'Q_\)C_ &1YO]G_ /"0_;_^6W_++[3Y7F=.<_:?^6GG5UO[//\
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M7G'[!>M6<VM_M&Z8MW ^H6_Q;UVZEM?,'FQQ2^6(I-G7$AAEQ_USD]"*T/\
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M6+RY>4SD."9)#0!]8UCZQKEAX<TN[U+4;RWL=-LXI+FXNKF01101Q_ZR1W/
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M6WX+_P"$$_X37_A,=!_X0[/_ ",7]I1?V?\ ZWR?^/G/EX\W]WUZ^_%?//\
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M9O-\GR_^F7E^7CC&*^F:* ,?1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**"./\
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M_#'X/^$/@W8ZMI_@WP[!X<T_4=2EU>XM+21_*^T2"(2&./)\I<11CRH\1C'
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M6?!7@*PTC6,CR[ZZEFO;JU^_'F&2YDD,.1)(#Y9'F9YR *]XHH \T^+WP%\
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M*^@='T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_\ 5QH@X  ]/2MBB@ HHHH
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M/TWPI?-I.JZ[<Z]%H=O_ &D"?-MH?M,9\WR_E!(/!;IL,;R 'L__  N_1_\
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M]C_V]_9_V:3_ (\?-\GS?,QY?^MXZY]J[2O"_P#A8^C?\-F?\(+_ ,(78?\
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M<TCX9?%?X6ZI\*?%&OV<EYX?E_M>/5[34_)\QKF+SX8_+CECC DP>W79F(2
M'T]17@'QL_:&U_X?^,M'\%> _ACJWQ1\9WD?V^ZM+:X^P6&FV),XAFN;^6,Q
M1-(]M*(XSU\N3GB,20?!#]IK4OB'\1-=^'7CGX?7WPR^(^E6<>K1Z'=7PU*"
M\TUC'$;J&ZBC$1 E<QD#\\B01@'T-17R!\0/VXKKPS\:/'7PM\,?##5_'7CO
M1)].CT[3-)N"!?Q74<<DMU<R^5Y=C#;>9 GF2>9DRQ_<'FE.A^&O[5/B;4_B
MYI'PR^*_PMU3X4^*-?LY+SP_+_:\>KVFI^3YC7,7GPQ^7'+'&!)@]NNS,0D
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MWKQ/XI?M"67P9^%OAGQ7X\\.:K::SK<EGIJ>$]$4:G>R:G<)DV,1C(CE8$2
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M\%W'PH^)L,'VZQ\.W^HI>Q:M9%,^;;7,8$4Q7$N^,9QY9()\N7RP#Z4HHHH
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MO8J /CSX.VNFZ3_P48_:(AU6P2'Q#J^D:#?Z+/<V1$LVG16T45U)%*0 8_M
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M_M"_MC?M,6FOQ:EI^K:1?^$-0TGQ%HUR+74],E%@?WMO+SC_ %8R/QQYD<9
M!ZG^V],NK>(/V<-%L#]KU>7XJZ3?I80'S;E[>V6:2YF$0Y,<0(,DG2,=>M2?
M\Y3/^Z-_^YJNK^$W[(O@WX7>+HO&-SJOBCQ_XYL8I+:U\3^.-5DU*_M;:0']
MS#G$<8YDY$?F?O91G$F*[?\ X4AH_P#POC_A;'VO4/\ A(/^$<_X1?[)OC^R
M?9/M/VG?CR_,\WS>_F8QV[T ?&?P#^&OQ?\ $7Q&^/\ 8^#_ (U_\*K>W^)6
MJW=UX:F\)6NIW,D5SY4EM?'[0PDBCEB \OC8?*R.]>T>$?V3?B<OQO\  GQ"
M^(GQR_X6&?!IOOL.GGPA;:7Q=6QAE_>0R^\9Y!_U?UKK?BS^R+X-^*/BZ7QC
M;:KXH\ >.;Z*.VNO$_@?59--O[JVC _<S8S'(.(^3'YG[J(9Q'BKGP?_ &5?
M#GPA\57?BD>(?%_C3QE<6<FECQ+XSUR2_O$L"\<OV1<XC$?FQ^8/W>?WC\X.
M* /=:*** "OR_N-2_P"$+_9[\9_LLRZE?Z#JT?Q*LO >CW]JI>YATC5[K[;:
MW5W)')%')YMM]N!CCQD>7')''DD_J!7BM[^S/X9U3]H#3/B]%>:IINO6*".;
M3K.6.*QU*6.VN[6*YN8O*#RS1Q7<L<<ADXC"@<9R ?.,GQ3G_93^,W[56D"&
M'2=*N- _X6AX7AU!XWL9KUXA;W1EE\T2YN;_ ,J)(21GRR(Q'F/?W=G\*W^"
M'_!-+Q%X)NH9H-0L?AYJ\E[!<21S&&]FM;FXN8?,C^0B.:2501G@#FN_^/7[
M'?P^_:-\=^"O%7BRWN/[1\*RB5(;6*W\K48_-CE%M?>;%(9H08R/+R!B67_G
MI7JGQ#\'6/Q&\!^)/".I2S0V6OZ9=:9<O;']XD4L1BD*<>CT ?/O_.+/_NC?
M_N%KU7]E#_DUGX-?]B9HW_I#%70>$_AKH?ACX4Z/X!:V.K>'=-TB#0Q;ZJD<
MOVBUCB$067C8X,8Y&,=:\U^ ?[*.B_L]:]<W?A;Q7XSD\./#/#;>$=3UHW&C
M:=YLHFW6T!BRK9_C\P_ZR3/)- '*_L%?>_:,_P"RR^(__;:D_P"<IG_=&_\
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MS_PMC_A$/^$A_P"%4O\ 9_\ A"_M7V3[+_:\>-_VG]YYOF>;TXQL]Z /1/\
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MCD([KX)?M:>%/CIK^N^&[/3=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#^Z_>
M'G/,>0/,B\SSG]@O1;.'6_VC=36T@34+CXMZ[:RW7ECS9(HO+,4>_KB,S2X_
MZZ2>I-:'_.4S_NC?_N:H [;XV_M:>%/@7K^A>&[S3=>\7^,-:,CV7A7PC8B^
MU22*,2&2X\KS!^Z_=D#G/$F ?+E\OYH^/W[26B?&35_@7H8T+Q1X'\5VGQ:\
M,WLOAOQMIO\ 9U_)9'[0GVJ&(D[X?,S'Y@Z2#''[NO2O@[=:;JW_  48_:(F
MU6_2;Q#I&D:#8:+!<WI,L.G2VT4MU'%$20(_M!MW.!P\O_34YG_;TT6SFUO]
MG+4VM('U"W^+>A6L5UY8\V.*7S#+'OZXD,,6?^N<?H#0!]>4444 %>9>#_C9
MH_C+XK?$'X?V5G?PZUX)^P#4YKE$%O)]MA,T/EGS,G@'J!Z5Z;7RI^SS_P G
MU?M<?]RC_P"FN6@#U[QA\;-'\&_%;X??#^]L[^;6O&WV\:9-;(AMX_L4(FF\
MP^9D<$= ?2N>^-W[47@/]GSQ1X5TGQK?7&E0>(XM2FAU/RD^S6PLXA)+YV3Y
MA:3>$BCCCD,CX &3SP7[0W_)]7[(_P#W-W_IKBK/_:>T:QUK]MC]DNVU&TAO
M(8YO$MPD=S&)!YL5C#+%)]8Y(XWZ]<4 .T'_ (*)>!+F?PQ)K_@OX@^ ?#'B
M-XH[+Q=XLT)++1@TT?FQ@W7FG_6 'Y^1_P M"1&#(/:_C1\9_"GP \ ZAXP\
M9:D;'3[<F..&(C[3>3?\L[>&+_EHY^O8DX3./(_^"HG_ "8O\3/KI?\ Z=+2
ML7]K&2POOVKOV3M%\17_ )6@3ZUJ]^;6XO3:VTNHVUO";"0C=S*+B0"+GDR;
M,'S"" <]\;_VT=#\5? WXE^']<^'WQ%^&CZKX6U>ST[4_'6@'2[&\O#8R^7:
MQR&4YEE^?RX^I\L]\ ^U? _QQH/PR_8S^&'B7Q+JMOHNBZ?X(T>2XO+G/[O_
M $&'''<Y_@%:7[8FDV>L?LL_%NVO[."]MXO"VHW0CN4$@\R&WDEB<#U22.-_
M;%?*?QVDUR\_8<_9+T30UTZXN-<UCP?IS6&M^8=+O\V!DCAOHH\^9;>;%$9$
MQ_RS!["@#U_4O^"B7A#1[7^V=1^'GQ/T_P "F2/'CBZ\+21Z*;:241PW0E\S
MS/+D\R,C]V9#D?N\G%>_^+/B5H?ACX4ZQX^6Y.K>'=-TB?7#<:4\<OVBUCB,
MI:+G8X,8X.<=*^>M6T+]LCQ%I-UIFI6G[/NH:?=Q26]Q:W4>LO#/'(,21R(>
M"#WJMHOP:UO]GO\ X)J>./A]XBN+&YU72?!OB(3W&F222VS>:MW-E/,CC[2]
MQU'>@#JO"/[<7A7XCZSX6L_!O@[QWXML]8:RCN-=T70_M.EZ--<B*0V]]<"7
MRXY(HYHC+L,GEY/<8KZ;KQ;]CO2;/1_V6?A);6%G!96\OA;3KHQVR",>9-;Q
MRRN1ZO))(_OFO//^,W?^J _^5R@#TG]H#]H;PO\ L\Z3IE[KYU"]U36+^*PT
MC0=%M_M6IZM,2!Y-O%D9QO&<X R #YDD8/-?";]L?PK\5OB W@2Z\-^+?AWX
MQFLO[0L]$\<:6-,NM1B_>AWMP9#YFP1'(X. 2,^7(8\KX^_&7Q=HWQ:\/?#W
MX3>"-!\7_%2XTF34)M4\13_9[70-,DOK:*2:3A7ECE>,YCBD\P&VC?9+@ ^-
M:I_PNW_AN+]F?_A<'_"![L^)O[-_X0?[=_T#!YWG?:?^V./+_P"FF: /I_\
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M0_X*B>#M/UN_!&F?#BYU+0;2\O2B)J,M[+%+)#$3B20VPES_ -,XL_\ ++(
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M\B0CS)(X5&!C]Z^9#'D0R8SY9K@OVAO^3ZOV1_\ N;O_ $UQ5C_!VZTW5O\
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M17$4HN1)&\9X((]: *O_  \N\ _V3_;_ /P@7Q+_ .$"^V_9O^$]_P"$;/\
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MZ+;P_P#&S1Q9FTN7C7;KNFB&*'E@/+CDMY?+C D<R2S=,>7@ ]VO/C5HEO\
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M!GB;]GCP)XUTOQ7_ ,(Q;:GKWBF\\0QV?A$RC3[2.:*'$,<<L<?EA#&0(P"
M@3F@#Z8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#??#+XCZ59R:3)KEK8C4H+S36,DHM9K6601$"5Q("?RR(S'7^"O[.'B;X?\
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M$O[+NF_!;Q)<SZWHUMH=CHLM_:_Z+++]E2(1W,?WO+(DACEP?,'&#O%>VT4
M?)W_  S'\=?^01_PU+XA_P"$.S]C^R_\(O9?VQ]@SY7E_P!IY\S[3Y7_ "]>
M7GS/WF*^C_"/AQ?"?AC1M#&HW^K-IMG%;?VAJ4IFNKCRXPGFRR8_>2'&2>Y.
M:Z*B@ HHHH \+_:*_9Y_X7?_ ,(GK6C^+-0\#>._"-[]K\/^)K&,7+VYD\L7
M,,EN<1RQRQQJ"#]#^[\R.3R+4/V$_%WCKQU\/_&_Q&^.&K^-/%7@O7[?4[ M
MHEM9:?\ 8XIHY9(!:P_ZN:22,?Z1YA^0(/+/EC'VC10!X]X\^!LGCKXW?"7X
MBMKGV!_ ?]KYTYK7S/MWVZU$)_>^8/*\O!/23/3CK4G[4?P/?]I+X&^(?ATN
ML_\ "/KK/V;=J)M3<^4(KF*8$1^9'GF+'7O7KM% ' ?&3X5:'\</AGKW@;Q+
M',=(UB-8Y6MY/+EC\N421R)[H\<;\^G?I7A0_8]\<^*M^@_$#]H'Q?XP^',?
M[N/PW;VL6F7=W"I\H6]_?Q#SKN*2$R1R_P"J\PGS.#7UI10!Y%^RY\#W_9M^
M!OA[X=-K/_"0+HWVG;J(M3;>:);F68DQ^9)CF7'7M7KM%% !7QY_P49\,Z;X
MR\*_ [P[K%O]KT76/BOH>GWEL7*"2&6.ZCDCRG(X)K[#KBOB%\+_  Y\3O\
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M^+-_M"?%CX)@_8?#L@C\;>#]- W;+&Z.R_BA$9$=M;0W@VQ18C/[V0_O =]
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MCD/% '7_ /"5:+_PD_\ PC?]KV'_  DWV/[?_9'VI/M?V;S/*\_RO]9Y6_\
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M;<\'>&/%6I^&O#_ASQM\4];T63[+KD7@/P_)J7]DS X"7,F8X_F(DP$)P8I
M<&@#Z5HKPGX)?M:>%/CIK^N^&[/3=>\(>,-%,;WOA7Q=8BQU2.*01F.X\KS#
M^Z_> 'G/,>0/,B\SF_B9^W9\/?A9XV\6>$=7M]:O/%^A7FFV$&BZ5:QW-UK4
MM['YD<=C$)0SF-2/,,@C&3&!DR1@@'TU7%_\+2\-_P#"UO\ A77]I'_A+_['
M_M[^S_LTG_'CYOD^;YF/+_UO'7/M7E?PF_;'\*_%;X@-X$NO#?BWX=^,9K+^
MT+/1/'&EC3+K48OWH=[<&0^9L$1R.#@$C/ER&.3_ (5CXB_X;R_X6)_9A_X0
MW_A6W]@?VCYL?_']_:?G>5Y>?,_U?.<8[=: /H2BOG?XL_MC^%?A3\0%\"6O
MAOQ;\1/&,-E_:%YHG@?2QJ=UIT7[H(]P!(/+WB48')P03CS(S)ZE\*?B)IWQ
M6\!Z9XFTN#4+*WOC-&]CJEL;:[M98II(I;:6+CRY(I8Y(R/6,\GK0!VU%%%
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MCFTT-O#EQHOBBT>72M0LC<"0;Y8P)82CN\GR9\PQQ#Y!YGF6OA;\ ?B9H/Q
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MG?VG]IMFC6*WC$BQV-M%++<RQPQQR?ZW&< 4 9=WJ$'P%_;\L]3O]=%MX?\
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MQ_ZN-$'  'IZ5L44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCD,LP,L8B$47[P]0#[BUC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>
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M-H^E6?AB_O;GRR_EPQ:1-)))A!S@ GBN!\ _\%._AG_PO+XL#Q3\2V_X5O\
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M_D^K]D?_ +F[_P!-<5 ''_MT?$[PY\9/^";WC?Q?X1U+^V?#NI&Q^RWGV>2
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ME=(Y(QB22'_6X'/UK+_9%_:^\"_M"^%?#?AJS\7_ /"1?$FV\.6U_P"(;?\
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MP$5XOX\_X*!? 3X:^+M4\->(?B)#9:QILGV>[AM])OKD12?W/,BA=,\'(S7
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /F
M_P#:$_9QU?XA>./!WQ+\#ZY8^&?B=X):X-A=:AI?VFTU.&2+FQNNDGE9+ 21
MY,7G2F-/,.1X_P#'+]E_]H[]IOX5ZYI?C?XC>$='NU,(LO"?A6UN(-'NI8YH
MY/M-]=2QR7+_ +LS#[,$\OS(K:3J#7WA10!X7^TM\&=<^,2_"M=%N;"W/A7Q
MWI?BJ\^W321F6VMO-\R.+RXS^\/F<9P.#DUA?$G0OVFM-^)6N:A\,O$GP_U;
MP?J26YMM+\:VUTDNCR1QB.4126W,HD/[S,F<= !C,GTC10!\]_L\? 7Q%\/?
M%7CKQWXZ\20^(O'?CB:RNM5_LVQ^R6%C]FB,<5M:C/F2+%ODC\V7F2,Q9&1(
M7X.'X%_''X#ZIKUE\#O$W@_4_!.K:G/J<7A;QS9W,4?AYI?WCQ6#V1'[EY))
M3Y>Q/* CP"7DD/V!10!X]\$- ^+.G-KFI?%GQ9H6JW^H>3]E\/\ AW3?(L-(
M\OS1(8;B3][<>;^[DQ+@QD$#.:\:MO@7\>?@G\0/']U\%]=\"7_A#Q?K$WB:
MXT[X@I=+=66H3?\ 'SY4EJ/WD9Q%@R'MC&09)?L:B@#Y!_9__99^)WPA\1?'
M35];^)EOXCU_QU':G3?%WV'_ $NWNHX;G][+8RYB BDEB$40D,?EQ_\ +,<5
MD:I\+?VM?BEX'F^'_CGQE\,-)\/ZKITFF:MXET.POKO5)4\ORY,12>7;9E^Y
M)CR\"24Q@8%?:M% '@_C[]F'1_&7[/>D_"RQU34])70;.QAT'Q)'Y<FHZ=<6
M/EBUNHY/EQ+B+DQ^7\LD@!CS7$?\(_\ MD;O["_X2OX2_P!C[_L/_"6?V9?_
M -L>3]S[=]E_X]OM&/WOE?ZKS.,^77U?10!X1\>/'FI_ 3]E/Q7XBU;Q49O%
M>D>'&C7Q*-/4"XU3R1%#+]F DCC\RY:/]W_JQYGI7H?PF_X2?_A5?A'_ (33
M/_"9_P!DV7]N?ZK'V[RD^T_ZK]U_K?,_U?'IVJWX@\)Z9X@_LHZE:O?0V%]'
M?10RR-Y7FQ@F*25"V)/+8B0>9G$D<<@_>1QD=30!X9^T%\ 9OC1IGAZYT7Q-
M>> ?''A;4_[2T+Q19V<5Y-;$@QS1/&Q!EAEC)$D7F 28B\P.!Y9\_D\/_MB^
M)6_LW5O%/PC\&V5U_K-?\.:=?7U_:]#^ZM[H^5)TV?O.S^M?6=% 'A?[2WP9
MUSXQ+\*UT6YL+<^%?'>E^*KS[=-)&9;:V\WS(XO+C/[P^9QG X.37;?&SP7=
M_$3X.>/?"NG-#%J.O>'[_2K:6?\ U<<DUM)%'O\ ;,@S7?44 >(Z%\!;/6OV
M6=&^#GC0PW\$?A:U\.Z@]HF]?-AMHXC-#YL?6.2,212-'P5B.*\E\+?!;]J/
MP5X9T7X::-\3O =IX+TFTALK'QH?#\KZ]!#%$/+C^Q/+]E.,?9^2?W7[PGS*
M^R** /FO]EO]F:_^!?@7XD^%O%E[;^,;'Q-XIU/5(SJ$IOY;VQN8HHO].\R*
M,2S2",^:,&,^9UKSKX?_ +/G[2'[-.GCPC\)O&G@/Q/\-[?SI-,L?'ME<V]U
MIWF74TCQ>99#][GS<F5SUZ1Q@8/VS10!\T_LS_LSZS\*?$_B7Q]\0_%-MX[^
M*_BR"V34M<ATV*UBM88HHH_LUOY:#C*<R?N_-\J(F(&/-=%^S3\&=<^#J_%1
M=:N;"X/BKQWJGBJS^PS22&*VN?*\N.7S(Q^\'E\XR.1@U[I10!X5_P *?US_
M (;._P"%N>?IO_",_P#"!_\ "+?9_,D^U_:?M_VKS<>7Y?E[./\ 69SVH^)_
MP=U_QI^T9\$?']C-81:-X'_MS^T8KF5_/E^W6L<,8B&SJ""3DCTKW6B@#Y\^
M.OP'\2^,/'/A;XD?#GQ1!X1^(OAR&YMHYKNQ$ECK=F_[S[!?!/WAB,D8YS^[
M,DLD:>9@C$\)>'OVJ_$GBK23XX\6?#;PIX>LKR&[NE\&Z9>WMSJ<4<O[RR?[
M9^[BBEC,G[V/]X"L>.":^GJ* /"_VK/@7JGQR\ Z39:!KG_"/>,/#NLVOB3P
M_J4D(EMX]1MA)Y7G1D']W^\/(!P=IQ)@QR5/^$*^+GQ&_9V^)'A'XEGPA'XR
MU_3M2TO3IO"WVI=/CBFM/*B\TS?O ?-DDS@8V8[YKW^B@#@?@GX+N_AW\'/
M7A746AEU'0?#]AI5S+!_JY)(;:.*39[9C.*XC_A3^N?\-G?\+<\_3?\ A&?^
M$#_X1;[/YDGVO[3]O^U>;CR_+\O9Q_K,Y[5[K10!\@^-?V8_BA\/OC3XF^)7
MP'\3^&-&F\6SV\OB'PCXITX_V9?21Q31_:?-MH_-C/F2^:8QC?))+))(1^[H
M\%?LQ_%#X@_&GPS\2OCQXG\,:S-X2GN)?#WA'PMIQ_LRQDDBAC^T^;<Q^;(?
M,B\T1G.R2.*2.0#]W7U]10!\L>)?#_[6GA_Q?XCD\+>(?ACXF\,W&IO<Z2WB
MJUO;>^LK67&+7%L/+(BR0)#ODDY)[1CO/V;/@//\!O!NMZ=?^)+CQ=K_ (@U
M^\\1ZQKDMG'9+<7MSCS3'%%GRQ^[3C/4G&!\@]KHH ^6/A'^SY\3?A#^Q;I_
MPP\-^+-'\/\ Q'TN*X^P:];PB]LHYY+^6YZ2Q#B2*3R\F(F/S"0),#/'^/O@
M3^T=^TGX9N/ ?Q7\1_#WPSX&N9[>YU'_ (0*SOI[Z^\N6.3[-F[_ '<2GF3S
M1DB2.+@@R5]KT4 %%%% 'SS^TQ\4/$OA;Q]\$/!_@O4C:^(O%/C&+[;9_9XY
M/M6B6T3RZF?,E'EIB/RSP1(<_N\U]#5S7_"+Z<_C#^WWMFEU;[ +**ZDE+B&
M+S?,DCC4\1^81&9#&/WGDQ;\^5'72T ?.O[5/P!UWXU6OA;7O!7BE?!GQ+\&
M7DM_HFK[))8@982LEK)@\1RE8?,RDO[N,CRR)"*\/^.'[,/[3G[2G@'Q%H/C
MGQ_X+T>!H[4Z7X;\)BYBTV]NDN@\DM_+)$]Q@1GB*/,9D$4AV&+,GWU10!Y7
M^TE\%++]H7X+>)_ &HZA-I4&M1Q?Z;;Q^88I(Y8I8SLR-XWQ)QZ<5SGP1T'X
MR7'A?7-#^//_  @OBBVELH+&W&@PW+_;T:.2.Z^WQRH(_P!Y^[XBC$?,O&,"
MO=Z* /C?PS\'?VD?V?\ 1K7P?\,_&G@7QKX,T_(TR;XB6U\FIV$))$5CYEH3
M'-''&J8D.,9P(XXXT ]]^"_A_P"(6A^%;I_B3XJT_P 4^([Z\EO1_9-@+&TT
MZ*1(_P#0H1DR211R>9B67$A!&X<5Z710!X7^S3\&=<^#J_%1=:N;"X/BKQWJ
MGBJS^PS22&*VN?*\N.7S(Q^\'E\XR.1@TGQ/^#NO^-/VC/@CX_L9K"+1O _]
MN?VC%<ROY\OVZUCAC$0V=002<D>E>ZT4 >%?\*?US_AL[_A;GGZ;_P (S_P@
M?_"+?9_,D^U_:?M_VKS<>7Y?E[./]9G/:E_:6^#.N?&)?A6NBW-A;GPKX[TO
MQ5>?;II(S+;6WF^9'%Y<9_>'S.,X'!R:]THH \,_:"^ ,WQHTSP]<Z+XFO/
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M'8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M;%% 'P[X3_9^_:;^
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M;_9C=-)<R2X$7F2",1K((PF?^6?0#@>;?M-_ OQ9\0M?^'GCSX=:Y8Z)\0_
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MT_7=,CET_6K9;J.7;<R1QF6+]W&$,@!D,<448,?)KF=2_9G^,_[0WBKPU/\
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M\4I)+:'0[;5[>2_\R(MYL9A\SS 8_+D)!''/I0!Z'17D/Q#T)KOXY?"C4/\
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MFB>%_L":SJ^GZ.VIWD>GV7]H720FYN9"1'%$'_UDIQQ&.?RKEO\ AH+X7_\
M"4_\(W_PLGPC_P )']N_L[^R?[=MOM?VOS/+\KR?,\SS/-_=^7USQ[4 >ET4
M5YI_PT%\+_\ A*?^$;_X63X1_P"$C^W?V=_9/]NVWVO[7YGE^5Y/F>9YGF_N
M_+ZYX]J /2Z**\\TOXU?#S5_&#^%=-\=^&M0\4I)+:'0[;5[>2_\R(MYL9A\
MSS 8_+D)!''/I0!Z'17D'QXT%-:D^'I7XECX;_9/&.F79VW'E?\ "0>69O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@/JGA/\ 8GT'X5_$G26M;R2RU.PU?2Q=>9F&YN[DF/S+>3O%(/\ 5R9&>H-
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MD2"2,D1>5BK'Q4^%OQ(^$_[24_QG^$GAN+QS'XCTV/2?%?@V35?[/-U-$/\
M1;Z.663R@8TCBA_U? S@'SI)(@#U3PA^S#\./AW\4(O''A+PU8^%-:&E3:)-
M'H5M%9VMQ#)-%,/-BB7!E!B'[S@D2'.<1^7\S_LC_L_^!_B-X]_:#\4^,M&M
M_&,EO\3_ !#IUCI.OQ)>6%D#-%)++%;2#RQ-)F/S).I2&( CFO;O@;X@^/\
MXS^)%]K?Q'\):#\-_ T=G-;V7AJWU--2U26Y)M"+J6>/]T8QBYQY?ED>80\;
M_NY*G_9$^&?B7X;M\9O^$DTTV \0_$C6/$&FMY\;_:+*Y\GRI/D)P3Y9X/-
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M/!QCO3+KXA?MA:_H=WX37X5>$O#/BN3[1:1_$-?$*2:/#\\GEW,=AMEN>8@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O
M$OA%\"W^&_Q-^)WCS4O$]QXDU?Q[J<-S(AT^.V2SLK6.2.TM0J9\PQQR%#,3
MF3$?&<E_;:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KA/%_PTT;QWKGA:^UV%KV/P[>MJ=E8S1)]G6]!
MV17/(SYD0:41\XS-OP9(XWC[NB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q_X\?!7_
M (74WP\QK1T8^$O&6F^+,?9OM'VK[+YN+?\ U@\LOYG^LYQCH:]@HHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** .?\4>%-.\;^%=8\.ZQ;FZT?5K.6QO+?S"F^&6,QR1Y3_9)'XU\PZ/\
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MGP#\5/C1KT>B2ZY+-I,E];Z?-+]HN4EN8XSY4,<G,D=L9"<!,],#&?2/@O\
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M/7-0^(EUK_C_ ,=:YNGOO%U]J4MM<),8EC#6MM$1%%%&03'#)')Y?$9,D8
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MEGD>E?&+XN:_\<_^"/\ JGC3Q))!+K^I16T=S):IL\SRM=BMQ)LXY<19].:
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MJ?QKZ<HH ^8_CIX5UO6/VQ_V9];L])U"ZTC1CXF_M*_M;:26WLO.L(XX?-D
MQ%YAX&3U'XTG[;'AC6?%C? I='TG5-5;3OBKH>H7G]GVLDOV:UC,PEFEV#]W
M&,C,AX&1ZU].T4 ?-/Q*_:F\0_"OXG:OX?U+X&_$?Q)HMO';W&CZ[X+T[^U8
M;Y7C/F^:@*>08W&SRR7)QO(&4S@?L:_#SQ1X?\9_%/Q?+X,'PL\ ^++[3KCP
MYX)D>-);.**U\J2ZEM8CY=K+<8B\R/\ UGF1D2?ZL&3ZUHH **** /F3_@HI
MX9U?QI^QW\0=$\/:7J&N:O=-8"WL=,MI+JXF(O[:0^7'&,G !/3H*/\ @HIX
M9U?QI^QW\0=$\/:7J&N:O=-8"WL=,MI+JXF(O[:0^7'&,G !/3H*^FZ* "OF
M3_@G7X9U?P7^QW\/M$\0Z7J&AZO:M?BXL=3MI+6XA)O[F0>9'(,C((/3H:^F
MZ* /S;^$/[/OCO3/B5X2^!&J:3K!^&OPT\;W7CK3O%%U9/'#<V4<44NEV4-W
MY0CEF^T7MR;F,Q]I!')^[Q7T+^UA\*?&^O\ B#X8_$OX:V3:SXY^'^K23#2)
M[^*TBU+3KH"*]A$DL1C#F-(P)"1B,RGF015]/T4 ?$OB#]LKXK>.?!O]B_#K
M]G3XF:-\1=5L7ACN/$FG1:=IFE3&WE)E%U<#RY?+EQL26.(2X[$B,]?#\ +O
MX,?\$_=<^%U@;O7=9M?!6K6[6UFS7!NKZYMKF:6*'$8,@\Z5Q&!'O(\L'J:^
MJZ* /#/A5\-E\5_L:>#O ?B.#4-,;4/ =EH6I0[1%=6^^PCAF7$@^209/!'!
M%?-_[)WPZ^)'B'XF_#BQ^(^CZEI=O\"-*U'0;#59-.EM8=:O;J::UC-M+)&$
MN+**PMH0),1R>88R?,\SG] Z* /F+]MCPQK/BQO@4NCZ3JFJMIWQ5T/4+S^S
M[627[-:QF82S2[!^[C&1F0\#(]:7XZ>%=;UC]L?]F?6[/2=0NM(T8^)O[2O[
M6VDEM[+SK"..'S9 ,1>8>!D]1^-?3E% 'S)_P44\,ZOXT_8[^(.B>'M+U#7-
M7NFL!;V.F6TEU<3$7]M(?+CC&3@ GIT%>2?\% =-UWQ[\4O@SX7\-Z!8_%"Z
MMO[3OM9^&=U>2Q"]L981;?;I7XCMO+S<QQ7,L@,<TL?E>9^\%?>U?-?QE^!/
MCVX^,VG_ !C^%GB72]-\<VFAMX<N-%\46CRZ5J%D;@2#?+&!+"4=WD^3/F&.
M(?(/,\P ^?\ X8^++7]B=8M:\0_LFGX3>$+N]2RU?QGIWB2+Q!=623 ?ZT@2
M7'V;S8H<@2>7GH#(1&_Z*5\6>*?@)^T9^T5<6'A?XQ>)/A]H_P ,C+%<:MHO
M@VQO)9=;6*ZMY1;32W!$EN#Y/^MAE!Y^[(.GVG0 4444 ?''QT;QA\&_VO-!
M^,EIX U[Q[X+O/!\G@R^M/"=O]JU.RE%U)=QS?9>!)&>(P<\?O"?^68DU?VJ
MK/6?BAX7_9PUC1O#.O@CXD^'->OM/ETZ3[;IEL8II)#=1)GRC%O D)/[LYKZ
MRHH \L_:6TJ]UK]G7XHZ7IUG/J-_J'A;5+2TM;6/S)9YI+658XXX^YR0,5X=
MXK^"OBWQ=^Q=\%[70--$/Q'\!67A_P 0Z1HFL,;>*;4[&VC'V6ZR!_"98\$Q
M?O/+_>1@$U]B44 ?*'_#:'BC=_9'_#-_Q>_X3+_CU^R_V1%_8_V_.SR_[3\W
MR_LWF<?:O+QY?[S&*^B_">I:CJ7A71[W7=)/AW6;FRBEO=+^U"Z-G,8QYL/F
MIQ)L;CS.AZ\9KI** "BBB@#YC^.GA76]8_;'_9GUNSTG4+K2-&/B;^TK^UMI
M);>R\ZPCCA\V0#$7F'@9/4?C3?\ A%=<_P"'C'_"2?V+J7_"/_\ "J?[/_MC
M[/)]D^U?VQYGD^=M\OS?+_>>7UQ7T]10!\Q?ML>&-9\6-\"ET?2=4U5M.^*N
MAZA>?V?:R2_9K6,S"6:78/W<8R,R'@9'K3/VX/!?BWQ5X"\&:_X-\/-XJU'P
M%XTT[QD=!BE,-QJ<5MYADBA_=G,G[WICH#CS),1GZ@HH ^8/'%G_ ,-Q?LN^
M/O#T?A3Q?\/+F_S9V5IXVTS^R[IKJ'RKJVEQF3-N9?+C)'.%E'7%<_HO[8_B
MWPEH\&C^//V=OBHWC&VB3^T?^$1T!-6TMYMOWK>ZCGP01@X_Y9G,9R8\GZ_H
MH X?X5^)O$OBSP/IFI^,/"B^"?$MQYGVK0DU&+4/LH$L@C'VB+]W(3$$DXZ;
M_45XY_P3K\,ZOX+_ &._A]HGB'2]0T/5[5K\7%CJ=M):W$)-_<R#S(Y!D9!!
MZ=#7TW10!\6_$>/QA^S/^U-KGQ:T/PGXH^(?P^^(%A:V.OZ9X5MTOM1L-4M8
MC%;7"6WE[_*,*>7_ *P#S))3(>(D/HWP1^/'C[XS?$G49;CX2^(?A[\-[:RE
M6+4_&"BVU.\O@;7RXA9$YBCVR71,@\P2$1_/&08S]&44 ? _PF\3?$?]AE;W
MX9ZQ\+/&OQ%^&]KJ.H7'A3Q'X-MXM5N5LY)8Y8[:YMHHXC&09)B99,9D++&#
M$ 1T?PVLOB-^TI^T]X?^+OBSP;JWPU\!>"--OK?PQHNKS1)J%[>W4LEM+=SV
M_E>9$#; 9BD(PZ1&,R R5]JT4 ?,/_"*ZY_P\8_X23^Q=2_X1_\ X53_ &?_
M &Q]GD^R?:O[8\SR?.V^7YOE_O/+ZXI?VV/#&L^+&^!2Z/I.J:JVG?%70]0O
M/[/M9)?LUK&9A+-+L'[N,9&9#P,CUKZ=HH ^8_CIX5UO6/VQ_P!F?6[/2=0N
MM(T8^)O[2O[6VDEM[+SK"..'S9 ,1>8>!D]1^-+_ ,%%/#.K^-/V._B#HGA[
M2]0US5[IK 6]CIEM)=7$Q%_;2'RXXQDX )Z=!7TW10!\S?M2?#WQ=JGB7X:?
M%'X>:1;^*_&?@#4[C9X>OKY+.+4+"^A\B["22  2C]V8R9 @ DXD.(SBM^V?
MXD\1*=.\)_LV?%C4/$DC;[6'Q-I,6B:>Y',@DOI99$B.SS,9') CX)KZSHH
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M,_B!JRRS:/(EU'<V6G640M;.&:.4#][^[FD,@'[SS0>!B./R3PIXH\0?LO\
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MH ]=HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\T^$>B_$#1W\9_\
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M#;W,?V^/2O.-U'<V,9QYLPE\T>5YA,F(HXXP<RQS>%OVLO$?Q,\3:+HOAOX
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M6, ^(?B5\5?V9/@7'8?$7]E_QM/X?^).B2+YNB&VU>YL/$-G)+$)K6Z^U
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MUKX/Z#?:'=Z5X?O[Z;%F+N$WTL,<J$2^6)8XSS)QCUDD,GJO_!.OPSJ_@O\
M8[^'VB>(=+U#0]7M6OQ<6.IVTEK<0DW]S(/,CD&1D$'IT-)\"_"NMZ/^V/\
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M+?@IJEE\%?$'A'X=Z7\2=$U%KC6HV.LS%)9#)/+819^PVT)%SYDDW,@DMG!
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M=\">'_&7P2\:^)["+PKH]QH>O?#K3'U6TOK*2V_=B6,E/(FCC\I)(\OF3>X
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7BFV\+ZWX7\2^+K;Q"&LKJ0#[5&L;9A\ORS^\QP9(\X'F1R^P_\ !1K^VO\
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M]8_;'_:8T.\U;4+K2-&/AG^S;"ZN9);>R\ZPDDF\J,G$7F'DX'4?A7SKX/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MV32+&/X>ZKJVFR7^E&..*47]L\4*R>;)]HNG?]]%)Y?RG,>8M_Z,44 ?G/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/%?Q6_9PU>^\8Z]J/B74=-\27&GV]WJ<QEN%A%M;2^7))]]_WDTO,A/4=@*
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M4Z,?"7C+4O">?M/VC[5]E\K-Q_JQY9?S/]7SC'4U[!0 4444 %%%% !1110
M445X_P# ?XU?\+J;XAYT4Z,?"7C+4O">?M/VC[5]E\K-Q_JQY9?S/]7SC'4T
M >P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1IMKJL>?E%D;F*.81R=QC.).YP>]>/\ P7^+W[0OQTLO GB[2_"?@WPM\/\
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MB1JTEIK6HR^;=7T?DVGEW$I< F60?O"2.IYYKKO^"7?_ "8O\,_KJG_ITNZ
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MK'_A&O\ A:VJ?\)EY_\ :7VO[7YMO]N^P8^3R_+QY7F\_P#/2OJ+_A<&N?\
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M\ 'T-^T-_P GU?LC_P#<W?\ IKBKZKKY4_:&_P"3ZOV1_P#N;O\ TUQ5]5T
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M((Q-Y4EQ^\CMA)QYA!'[R'S/]9FL']@K[W[1G_99?$?_ +;5C?M>^(8OA?\
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M--I=IJD?F6]S+']F80N#+%CS,>7YAD_=^8#T!%?;M?*G[!7WOVC/^RR^(_\
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MO_9-^%?CCXM:9\2M<\)07/C739;>ZMM5AN;BWVRV\@DBE>..01R$$#_6 YV
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MG?PU;ZB+/X7:?(;ZREL7^WWEU=%(W_YYF663RI,# EBQ(,\'FO9O^%6^&_\
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M/1IM&^'.FVE]I>K0ZY9W_P!IN7NH;F(#RO\ 2'D\TQ@@'R23$3R8\\U]"T4
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M"FG>"/"NC^'='MS:Z/I-G%8V=OYA?9#%&(XX\O\ [( _"O%O^&"?@#_PG/\
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M_P##W]EG4/C7X32W\;>'X4MIK6*UO#;"X\V[CMCF7RY/+,9D.4*$@Q[#0!]
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M_94E^-_@+3+?QQH=A);I?:?>:A]AN;)I)8XO)DQ#*!-')-%F,\&,^8)#F/S
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MM?#X5_'BV^%UCX,U'Q7XDU7PY'K&@0Z;/^]U&^DN7A2T(,7EQ1".&262ZDD
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MM0:./[3#:W1FB23G?LE,<9D^OEQY]!T'RAXK\.Z;^UQ^UOJ'@WQ';-J?P_\
M@_966HWNCWDA$6K:Y?1F2VDEAYBN+:*VC/!\L^9+(,212'(!N_\ #T3]F/\
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M.C>"O'MAJ^L9'EV-U%-975U]^3$,=S'&9L".0GRP?+QS@$5Y5XV\?^&/AO\
M\%*H]4\5>(])\,Z9)\(Q:QWFLWL=K"\QUDD1&60@9Q&WOP:H_';XDZ-\=/B_
M\"=(^$=S_P )SXD\.>,+/6-7\3>%72ZM-%T<^;'<Q7-_'^[B^TQQ-_HP/[WR
M<$']T) #[;HHKS+XS>+O'7@WPS;:AX ^'O\ PLK7&ODBFTG^VX=+\F'RY"9O
M-EXX(C'EX_Y:>U 'IM%?G[_P3#^('Q,/P,^&OA=OA-_Q;?.I'_A/O^$FM?\
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M!UKX+_ C5OB%X%^T2P1^)M4U^UT,7TL4A1WMXI09)(L!<2\<^9'Y8,9KTO\
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M*UOA%\%=(^#*^,WTBZO[S_A*O$E[XHOOM[QR&.ZNO+\V./9&,1YC'!R1ZGL
M>/\ _.4S_NC?_N:H_P"<IG_=&_\ W-5[%_PI#1_^%\?\+8^UZA_PD'_".?\
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M>5&#)&#PTF>F3CR^*P8?^"?>@:.C67@_XJ?%KX>^&8F/V;PUX9\6RP6%D/\
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M]N=6N4T+5O&?@7POJTDL^K^"?"WB*6PT+5&DSYRS6PS@2Q8B*1&,>7& -AH
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MTF^T3]G7]B32]1LKC3[^Q\<^"K2ZM;F,Q2P2QVL@DCDC[$8/'M7H>F_\$\_
MFI>(M,USQSXG\>?%E]+3-EI_C[Q"=1MK>4R1R&0((DSD1@&.3,<@_P!9&>*]
MJ^+OP5TCXS+X,?5[J_L_^$5\267BBQ^P/'&9+JU\SRHY-\9S'F0\#!/J.X!Z
M97PC\$O[&_X4'^VG_P ))_:/]@?\)]XS_M3^R?+^U_9/LT?G>5YG[OS/+W8S
MWK[NKY _:!\"S?LO_LI?'?6_AW:W6OZEX@U*^\0ZA:ZW:QZE$GVZ2**^/E",
M*T,4/F2?O1(!Y?[SS(P10!Y/\)]=^/GQ>_9'T'X9>'_AQX5F\/Z]X.CT.#XB
M?\)9&VGQVQM/*(DLHXS<BYBC_P!%DQP+F/./+!%?37QJ\&V/PY_8@\?>$=.F
MFFL= ^'-_IEN\Y_>/##IDL2%^.N$KY:T_P"!/_!/G3? MEJ<VO>&=3@@L([F
M:\NO&%Q_:,ZK&&,DEK%<1R>:VW!BCB!WM@1C&*]3_8I\)3?$S]DOQEX/U/Q!
MJFL_#G4M2UOP_P"$-7N)(OMTOAS'V:$_ZOJ")\>;'D8 \ORQ&* .C_YQ9_\
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M[/6UBGA:6] $T0C\L?NL(!LD![Y)KQ;3/^"<GP[BM7T:X\2?$:_^'GFR2?\
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M; KW/X=ZCX?U?X?^&;_PI!:Q^&+K3+6XTF*TM_LT(LY(E,7EQ8'E@1XPF.,
M<5K:QH=AXCTN[TW4;.WOM-O(I+:XM;F,2Q3QR?ZR-T/!!'KZU\IWG_!-OP'#
M#K6C>&?''Q,\"^$=47;<^%_#GB4QZ6XDA$,H,4L4ID,@0>9YA.?IQ0!/^RWJ
MB>+/VOOVJO$.G17,NBS:GH6BKJ!M9$BDO;&QEBNHAO'6.3&>F,Q]0X)T_P#@
MEW_R8O\ #/ZZI_Z=+NO:OA'\'/"'P3\'1>'/!.@P^&])5WN#;Q2R2EY'SEY)
M)"9)#V^<]AZ"JGP%^"VD?L^_"W1_ 7AZ\O[S1M)\W[+-J;QR7'[V624^9Y<<
M8/,I[?XD \?_ &>?^3ZOVN/^Y1_]-<M)_P Y3/\ NC?_ +FJ]?\ !_P3T?P;
M\5OB#\0+*\OYM:\;?8#J<-RZ&WC^Q0F&'RQY>1P3U)]:?_PI#1_^%\?\+8^U
MZA_PD'_".?\ "+_9-\?V3[)]I^T[\>7YGF^;W\S&.W>@#TJOCG_@ERNFZ7^R
MCIVB1:>NFZ_H^LZG8>(K:6R-K<1:B+G.R;('[T6\EL.^  G'ED#[&KYC\<?L
M(^ ?%WQ"U#QUX>UCQ5\+_%FJ&4:IJG@/5VTV74Q(8R3+]_!S&)#L""23,D@D
M." # ^-FH+X@_P""@7[-VBV,=Q>ZAH&F>(=7U.*.UE_T&SN;;[/%-(^/+VR2
MPO%UZ^\D=.^ ^J65O^WM^U/ILEW;IJ-S#X9NX;5Y!YLL45AB20)U_=F6(9Q_
MRTCKT'X%_LC^!/V?[S4-9\.IJ.I^+-4:1M3\4^(+LWVJ7^^4RXEEQ@ DC/EB
M/S/+C\SS" :B^./[(_@_XY>+M.\97>J>*/"7C?2H/LEIXF\)ZI)97T=J/-/D
MCAXP#]IDY$8D.<9QQ0!P?QXU2RN/V]OV6--CN[=]1MH?$UW-:I(/-BBEL,1R
M%.O[PQ2C./\ EG)5W_G*9_W1O_W-5I?#/]A/X>_"SQMX3\7:1<:U>>+]"O-2
MOY]:U6ZCN;K6I;V/RY)+Z4Q!G,:D^6(S&,F0G)DD)]0_X4AH_P#POC_A;'VO
M4/\ A(/^$<_X1?[)OC^R?9/M/VG?CR_,\WS>_F8QV[T >E5\J_\ !43_ ),7
M^)GUTO\ ].EI7U57RK_P5$_Y,7^)GUTO_P!.EI0!]):/KEAXCTNTU+3KRWOM
M-O(H[FWNK:02Q3QR?ZN1''!!'IZU\+?#$FY_9'_;)UB'$VCZYXF\<ZCIVH1G
M=:WUJ;7RUEAD'$L1,<GSQGGRC7I]Y_P3]\!_V]K,FD^)?'7A;PAKEZ+K4O _
MAW7#8Z#<"11'-";9$XCE48?$@(!(C\L; /8)O@CX5A^!]_\ "O1--?0O!MUI
M-UH@M=+8"2**6.1)/+:0$>9EW??)G+G)SF@"+]E#_DUGX-?]B9HW_I#%7B'[
M#$6G67Q&_:?T:>S^P^+8_B/>ZA>":R,-R^G7/[RQ?S",R1'%S)'U_P!89,#S
M>?ISX>>#K'X<^ _#?A'399IK+0-,M=,MGN3^\>**(11E^/1*\?\ C)^Q=X&^
M,'CFU\<K-KO@OQ_;LJGQ3X-U3^S]0>(12Q!'8*8R?+D"[]GF81$\S8,4 <;^
MW)JT-UXT_9M\+V*37>N7GQ.TS64L;6&20FRL0YNI3@8 C$\9/M_N<%YK%CI_
M_!4S3H;R[M[6XO\ X2_9+2.64(;B7^UY93'&#]\^7%*^ .D9/%=E\&_V+O W
MP?\ '-UXY:;7?&GC^X9E'BGQEJG]H:@D1BBB*(Q41@^7&5W[/,P[IYFPXKQO
MXS_!CPM\?_V^-2\'^,M/:_TRY^$/F1R1$?:+&<:R?+N8GQA)!G&?J#E": .Z
M_P""ETAOOV.O%^AP$S:SK=[I=AI=C$0]U?7/V^VD\F&/_EK+B*0^7'DD(:L_
MMZ_>_9S_ .RR^'/_ &YK6\'_ +$?@[PQXJTSQ+X@\1^-OBGK>BR?:M#E\>>(
M)-2_LF8')>VCQ''\Q$>2X.#%&1@UZ3\7?@KI'QF7P8^KW5_9_P#"*^)++Q18
M_8'CC,EU:^9Y4<F^,YCS(>!@GU'< ],KX'_9;TR_UK_@DC<Z786EQ?:AJ'A7
MQ-:VMI;QF22>:2:_$<<:#J22.*^^*\T^ OP6TC]GWX6Z/X"\/7E_>:-I/F_9
M9M3>.2X_>RR2GS/+CC!YE/;_ !(!\J_LX_!_XZ^+?@#\/-4\)_M2P:9H;Z%9
MBVL+7P-IM\++RX@AM?.\S,GE',1)YS%ZU[;^SE^S=XF^#?CCXB^,/&'Q$'Q'
M\1^,QIOVN\&AQ:7L-E'+%'^[BD,?^KDCZ8_U9/).:YG4OV"?!\-]=W/@KQG\
M1OA'9W\\EU-HG@+Q))86,US(?GF\DQR"(_ZN/$>(Q'#%@<5[)\&/@EX<^ _A
MB[T;P^=0N&OKV35=0U#5+V2ZNM0OI$C26YEDD)_>2&,9QQGGC- 'CW[!7WOV
MC/\ LLOB/_VVK,\<^./C!\:OV@/$OPT^$WC#3?AQHO@>'3)-?U^_TK[??O=7
M=O<31Q6T4I,4D/E^5YAE\N02#@XZ]G<?L?>%G^-UU\2_#GB#QAX#U*]O[74-
M7T?PQJGV'3M:GAD\SS+NW,?[SS-Q\P @-F3_ ):22$O^+/[''A7XK?$!?'=K
MXD\6_#OQC-9?V?>:WX'U0:9=:C%^Z*)<$1GS-@B&#P<  Y\N,1@'B'P)T3Q?
MX:_X*-ZUHWC;XG0?%'7[7X9MYVHQZ1;:8;,'4X)([9XH<\@2"7/4^</05Z7_
M ,Y3/^Z-_P#N:KH/@[^Q;X#^!?Q0NO'_ (8N_$#>);[1WTO4KG5-1-U_:,DL
MT<TM]-YH+_:99(AD@^7G.(Q7H7_"D-'_ .%\?\+8^UZA_P )!_PCG_"+_9-\
M?V3[)]I^T[\>7YGF^;W\S&.W>@#S_P#;5^$=Q\6_V>_$$.CM?6OBWPZ?^$F\
M.W6E+*;J+4[8&2+RA&X_>2 R19YP9?,'(%>,:G\8-/\ VS/B)^S%I&CI_P 2
MU2_Q,UZ&'<+O39;)GM;6,2R1QK+%]N,UO)LCWD1!QY:$2'[9UC7+#PYI=WJ6
MHWEO8Z;9Q27-Q=7,@BB@CC_UDCN>  /7TKX\_P""<_PWT2^\/>+?C'I4"V]I
MXNUC4D\+:;)'&/[$T&._N7BL8X@,6V;F2:22**3RCB'N": /MNOCG3?$NG?
M?]O;QAIWB"X^S67QATC2[O2-4O(S#;G4[$/:?V:DA_=RR21GS>3'@R11X)DC
MS]C5Y_\ %SX.>$/C9X.E\.>-M!A\2:2SI<"WEEDB*2)C#QR1D21GM\A[GU-
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M!K^Y3P#?^+IGT2. ?ZBV\O D\N+$7E_O<@QQY)[@&[_P3[\<>(?B5^R+\/\
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M/V:?"GBSPW\,M!:74-(T?X>ZMI>L:):Z?<#:LEC&8[>*4RB0R1;2 <GS./\
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M[>^T_3A+?V]S+'-]GO96-Q<Q>9'\A$<TDH!] ,$]:\ ^.G@KP[^T9^W;\.?
MZR0F;PQH%SKGC>W5HO\ B8:?]JMI;#2[D 2>:!<I%+);R@1^5+YD9S)7W50
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%<K\0_&-C\.? ?B3Q=J44TUEH&F76IW*6P_>/%%$99 G/
MHE '545ROP\\8V/Q&\!^&_%VFQ30V6OZ9:ZG;)<C]XD4L0EC#\^CUU5 !111
M0 5SOB3PGHGBC[ ^LZ1I^L-IEY'J%E_:%JDQMKF,DQRQ%_\ 5RC/$@Y_.NBH
MH **** "BBB@ HHHH **** "BBB@ HHHH ***\S^$7QJTCXS+XS32+6_L_\
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MO,_A%\:M(^,R^,TTBUO[/_A%?$E[X7OOMZ1QF2ZM?+\V2/9(<QYD')P3Z#N
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M3_\ "2?V18?\)-]C^P?VO]E3[7]F\SS?(\W_ %GE;_WGEYQGGK7144 %%%%
M!17G?C[XR>&?ACJGAFQ\2:A<:>_B75(M&TAA87,L<U[+Q%"9(XC''G.?WA&<
M/_SS->B4 %%>>?#'XP>$/C)8ZMJ'@WQ%!XCT_3M2ETBXN[2-_*^T1B(R".3
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MZY:>,/[1BCFTO]Y>)-;1QF*VAMO+/G27,LT<0'F1@''-<_\ L\_\GU?M<?\
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M/_!1C]HB'5;!(?$.KZ1H-_HL]S9$2S:=%;1174D4I !C^T"W0X/+Q?\ 3(X
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M2/,<@$D9ZQGT(H ^LJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-XP\'>(_%GA;2[J_DOIO!&GZIY?AQYIHO*DD^Q"/O_K!^\Q'L3&(T$8^BZ*
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M1>?\$_? ?]O:S)I/B7QUX6\(:Y>BZU+P/X=UPV.@W D41S0FV1.(Y5&'Q("
M2(_+&P#ZRHH \@_9]_9K\)_LQ^&]5T'P2]];:/J6K3:NUG?7'G+;R2)#'Y41
MZ^6!"@'F&23DY<UY=KW_  3O^'6JZ]JGB&PUSQ;X:\9WOB*^\0_\)5X?U%+/
M4[=[P8EM8Y1%_P >V/\ MH"9!YF)) ?K"B@#Q'X._LO^$?@CJ6IZ]ID^K>)?
M&6KPBSU3QAXGU*6^U2\B0GRXY)F.!C]TF(Q'D0QYSY8KH?!_P3T?P;\5OB#\
M0+*\OYM:\;?8#J<-RZ&WC^Q0F&'RQY>1P3U)]:]-HH \R\'_  3T?P;\5OB#
M\0+*\OYM:\;?8#J<-RZ&WC^Q0F&'RQY>1P3U)]:7X1?!72/@ROC-](NK^\_X
M2KQ)>^*+[[>\<ACNKKR_-CCV1C$>8QP<D>I[>F44 ?.EQ^Q]X6?XW77Q+\.>
M(/&'@/4KV_M=0U?1_#&J?8=.UJ>&3S/,N[<Q_O/,W'S " V9/^6DDA/H/_"D
M-'_X7Q_PMC[7J'_"0?\ ".?\(O\ 9-\?V3[)]I^T[\>7YGF^;W\S&.W>O2J*
M /$?C%^R_P"$?C=J6F:]J<^K>&O&6D0FSTOQAX8U*6QU2SB<CS(XYE.#G]ZF
M)!)@328QYAK"^&W['>@_#SQIIWC#5/&7CSXC^(=',@T>[\;^(I;\Z9YL4D5S
MY,8$:?O8WP3()/\ 5QD8Q7T710!\M:_^P=H5]XP\0Z]H/Q1^*7P_37]1EU>^
MTKPAXG%C8_;93F67R_*)W2''.>WI@5[+\(_@YX0^"?@Z+PYX)T&'PWI*N]P;
M>*624O(^<O))(3)(>WSGL/05Z!10!XU^S+^S%X9_93\!ZCX2\):EJM_IE[J,
MFJ/+K4L4LPFDBBB/,<48QB)>WXU[+110 5X9H_[)_@O2OVE]<^.7F:E?>,-6
MLOLAAO3%):V8$,4/FVV(A)%+Y<7EY\SI+*,<U[G10!POQ<^'&C_&+X=>(O!>
MNVWVG2-<LWLY\(F],_=D3S%8"2,XDC..'C![5@?L\? /PQ^S7\-[+P/X2%R^
MFVTLEP]W?>6;JZFEE),LSQQ1"0CB/./]7%$*]9HH \1^,7[+_A'XW:EIFO:G
M/JWAKQEI$)L]+\8>&-2EL=4LXG(\R..93@Y_>IB028$TF,>8:POAM^QWH/P\
M\::=XPU3QEX\^(_B'1S(-'N_&_B*6_.F>;%)%<^3&!&G[V-\$R"3_5QD8Q7T
M710 4444 ?+OC;]ASPMXL^(NO^,O#_C+Q]\*M5U\Q/JL?@'6O[,@U*6/S/\
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MWX'U0:9=:C%^Z*)<$1GS-@B&#P<  Y\N,1_1%% 'SG\'?V+? ?P+^*%UX_\
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M_O <$8YZY>,'*T?_ (*/?#;5-2T2:YT3QEH7@C6-2DTRP\?:QH?V?P[<2;I
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M#_CW8_'"76;<>%_%O@G5]),$L^B^,](.FW?E2F7RKF,<[XY##+'G(.89./4
M]BHHKYW^+/[8_A7X4_$!? EKX;\6_$3QC#9?VA>:)X'TL:G=:=%^Z"/< 2#R
M]XE&!R<$$X\R,R 'T117CG[/_P"T-X7_ &AM)U.]T ZA9:IH]_+8:OH.M6_V
M74])F!(\FXBR<9V'&,@X()\R.0#!^+/[77@WX7>+I?!UOI7BCQ_XYL8H[FZ\
M,>!]*DU*_M;:0#]]-C$<8YCX,GF?O8CC$F: /H&BO'?@7^T5X?\ CJNM6&EV
M.N^'/$VAB,:OX=\3:9-97^G>;YGV7S8V'E_O(XS(/+D/&.F:\C\/?\%%O _C
M+POI&K>#?!'Q#\>7%W%))>Z5X7T%-0NM)'FRQQ"^$<Q2(R^5(\:>9R@SQQ0!
M]?45XC\8OVH/"/P1U+3-!U.#5O$OC+5X3>:7X/\ #&FRWVJ7D2$>9)'"HP,?
MO7S(8\B&3&?+-<7X)_;C\+>+/B+H'@W7_!OC[X5:IKYE32I/'VB_V9!J4L?E
M_P"CQ2&0_O,RC Z'I_K)(P0#ZBHKQS]H#]H;PO\ L\Z3IE[KYU"]U36+^*PT
MC0=%M_M6IZM,2!Y-O%D9QO&<X R #YDD8*_ _P"/=C\<)=9MQX7\6^"=7TDP
M2SZ+XST@Z;=^5*9?*N8QSOCD,,L><@YADX]0#V*BOEWQM^W'X6\)_$77_!N@
M>#?'WQ5U30#$FJR> =%_M.#399/,_P!'ED$@_>9B.1T'3_61R ?07A?Q7IWC
M?PKH_B+1[@W6CZM9Q7UG<>64WPRQB2.3#^Q!_&@#H**Y7XA^,;'X<^ _$GB[
M4HIIK+0-,NM3N4MA^\>**(RR!.?1*^:[?_@HEX*U^\,?A#P1\1/B0/[/LM1O
M/^$(T%-1&G?:H?,CMKHB;B7'7' (*=8Y  #Z^HKY0F_X*,?">Z\-^$=1\-Q^
M(?'>O>*6D^R>#_"]@+[6K?RHC)*;BV$O[L1@>O[S_61^9&#(/3/V?_VAO"_[
M0VDZG>Z =0LM4T>_EL-7T'6K?[+J>DS D>3<19.,[#C&0<$$^9'(  >QT5YG
M\(OC5I'QF7QFFD6M_9_\(KXDO?"]]]O2.,R75KY?FR1[)#F/,@Y."?0=W?\
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M,>0/,B\RQ\8OVH/"/P1U+3-!U.#5O$OC+5X3>:7X/\,:;+?:I>1(1YDD<*C
MQ^]?,ACR(9,9\LT >W45\[_";]L?PK\5OB W@2Z\-^+?AWXQFLO[0L]$\<:6
M-,NM1B_>AWMP9#YFP1'(X. 2,^7(8^^_X7?H_P#POC_A4_V34/\ A(/^$<_X
M2C[7LC^R?9/M/V;9GS/,\WS>WEXQW[4 >E45YG\7?C5I'P97P8FKVM_>?\)5
MXDLO"]C]@2.0QW5UYGE22;Y!B/,9Y&2/0]N=^-W[47@/]GSQ1X5TGQK?7&E0
M>(XM2FAU/RD^S6PLXA)+YV3YA:3>$BCCCD,CX &3R >W45XE\*/VDK#XJ:7X
MDU*_\%>-OAIIGA^&.XN[SX@Z1_9$4D9\PR/'(9",1>63(20!D>M><P_\%!-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)8M/T_3=)BT;3HYI(SY<UW;6LG^F^7*+:6.,R1X,1Z^8: -S_G%G_P!T;_\
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MD@_ZN+ $8P.3F0@'I_P-^-%K\;O"=WJ4-A<Z'KFCZE<:!KVBW;^;_9VI6_\
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MSX9(X8X[7+R2&3RQ"/WA//I7F]E^Q9XJ^'<)\,?#3XX>)_ GPLN99);CPO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6\!_!?P;\,=6\4:GX:\/PZ9?>*-3EU?6+A9))9+VZ?)WF20D]9)"(Q\@,DF
M,FNPT?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B..""/3UK8H Q[[0['4
M+[2[F[LX;F:PG^TVDDD>_P"SS>5)$9(\GY#Y4DJ9':0CN<[%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >:?%[X
M]?#_ ."&AIJOCGQ58^&X95/V=+C,EQ<XV!O*BCS)+C>F?+!QFO+O#/\ P44_
M9^\:>(])\.:+\0&O-9U2\BL+*T71+^+SI991'''F2V &20.<5Y_\??B9X<^"
M'[;7A/QEX]U$3>%8? =['#%!!)?2>'+K[=$#J<L*#-O'<K)':B6,9ED!B/%3
M_L_7FD_&[]LCQ3\9_ UA=0^!%\&0>'U\1W6F2V/_  D%Y)?>9YUN9(AYPBCM
M1;2R2?O!Y<0 Q@T >\_&C]HSX=_L\V.E7WC[Q/!X>M[Z=H;*,PS7,LK* 7(C
MBC>0@ \R8P"\8S\_)\%_VC/AW^T-8ZK?> ?$\'B&WL9UAO8Q#-;2Q,P)0F.6
M-) "!Q)C!*2#/R<>._&CXI:9X<_:1M[;P!\$;CXQ?&.QT^SBN-7BN+>W@T.R
MD^W21Q2WLOFBRED$DW[LI%YL<R_O#^[CKAO@3K?B_P 2_P#!1O6M9\;?#&#X
M7:_=?#-O.TZ/5[;4S> :G!''<O+#CDB,18ZCR1ZB@#Z,^,O[67PK_9_U33-,
M^('BZ+0-0U*#[5! +2YN9O*!(\TQQ12&,;NGF8SL?&?+-7[O]H;X=Z+\&4^+
M5SXI@E^'CQ1R'6K>*>;"R3>4/W<:-+GS91'Y>/D[XP<>*>,/AW\0/@!^TGXZ
M^-'A?P99?%/P[XLM;&#4[*PF%OXDTJ.VB\N0VP?]W<P^7"&\D$22R>2.!%YA
M]W^!OQ$\+_%#P0=:\(6@TRW&H7*:CI<EM]FN]-U$S>9=6UW;8_=7/F22&3/)
M+F3)$F2 ?,/[,/\ P43\#^,O$GB_PYXM\?F]UC5/'EW8>#K,:+-$9=*EDBBL
M(\Q6V 2Q?F7]YS^\QQ7TMXT_:,^'/PWUW4=!\3^)K;1=5T_0/^$GN8[J&4".
MQ\_[-YN_R]A/F_NQ&/WA/1*\L_8*^]^T9_V67Q'_ .VU<KXK\%:%XX_X*AZ%
M+K^EP:H^A?#*/6=-%R&/D7L6LR1Q2_6/S'QVXW]0, 'OOPO_ &C/AS\9O NJ
M>-?"/B>WO?"FD320W^L7D,UE%;-'''+)O^TI'@".0'S.@!Z]:\PU;_@I#^SG
MH^IW.GW?Q-M[B:VD>*26TTJ_N8/DZF.6*$QR=\/&2,8K+_X**6,GBKX:_#GP
M3->S6&B>.OB)HGAO5EM=GG/92O+(=A>,[&\R&*3./^6>.A(/TS_PBNB_\(Q_
MPC?]D6'_  C/V/[!_9'V5/LGV;R_*\CRO]7Y6S]WY>,8XZ4 6M'URP\1Z7::
MEIUY;WVFWD4=S;W5M()8IXY/]7(CC@@CT]:\2^)/[<OP+^$OB:?P[XD^(FGP
MZW =MQ:Z?;7%]Y$@<QF*0VT<@CD!0_NFPXQT YKQ3]GWQ)JGPO\ V4?VF;3P
MM>'3;/X:^)O&%CX6A""5=.AMHC<PQ_O 3+B660YE\S.><XK _94\;?%_X4_
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M0PB(D\OR\^W(KY6\ _\ !3OX9_\ "\OBP/%/Q+;_ (5O_P 2?_A#<:'<@_\
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M)E^&H9OV=5^)-V!?>,_B!J]_KFO:K)'#'+-(+J6'"^5&,1_NC((^TDLO3.*
M/:O@O^T9\._VAK'5;[P#XG@\0V]C.L-[&(9K:6)F!*$QRQI( 0.),8)209^3
MC#^+G[8OP:^!FM#1O&OCVPTC6,GS+&UBFO;JU^Y)B:.VCD,.1)&1Y@'F9XR
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M21Q20_O)8P?WHA\OG((Q?VL?%&G?'FS^!GPTT63^TO#WQ3U6+6;QYT,5K?\
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M\:+IEJ/$UM\3M"T4:J,B<V<DTDI@)X\P>9$",Y*9DQCS),])^T-_R?5^R/\
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M/CO0OAE_P45U+Q+XFU6'1]#L/@OYMQ?7&<)_Q/./?.?X!],5T?[!7WOVC/\
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MP'X;\(Z;+--9:!IEKIEL]R?WCQ11"*,OQZ)7D/['/Q0\3_&/P'XS\9ZSJ?\
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MYCC<?:/Q#\'6/Q&\!^)/".I2S0V6OZ9=:9<O;']XD4L1BD*<>CUU5% 'S/\
MLL^ ?C9\*[.V\%^-=;\&^(_A[X?TLZ;HVI:7%<1:Q)Y4L8M?M41'E#;;Y!$>
M3Q'^\DYDKA=-_9G^,_[//BKQ+/\  /Q-X.C\%>)-5N=7D\%>,M,DM[73+J8P
MC=;2V4?F.N(2@C_=QQQX&)3^\'VE10!\I_!7]F?QG8_&"?XS?&3Q'IGBWXC+
MITNDZ=I^A:9'%I^BVS74DNVVDDC$LO[N0H)"!((Y98R9.#7;_##X.Z_X+_:,
M^-WC^^FL)=&\<?V'_9T5M*_GQ?8;62&02C9U)((P3Z5[K10!CZQH=AXCTN[T
MW4;.WOM-O(I+:XM;F,2Q3QR?ZR-T/!!'KZU\+?\ !.GX,-9>*/%OC*TN_M/A
M#PVNI_#[P1J,4@D&JZ8FL7-])?R2"/RY<RR11QRQ$)^ZF'EY -?;_B[PXOBS
MPQK.AG4;_26U*SEMO[0TV4PW5OYD93S8I,?NY!G(/8C-87P;^%6A_ _X9Z#X
M&\-1S#2-'C:.)KB3S)9/,E,DDC^[O)(_'KVZ4 =_7R_\6_V<?%:_&K_A='P@
MUW0]'\?OI)T74M)\2:?YNFZU"98\&66']]')&!_K!YA/E11_)&#GZ@HH ^(_
M%O[+GQT^+'BKX<>+?'WQ&T.ZU'PWXRTW7Y/"6CV\MKHEE;6\I\XQ2%));JX<
M1PF/S?+$?FW(Z25[/\3_ (.Z_P"-/VC/@CX_L9K"+1O _P#;G]HQ7,K^?+]N
MM8X8Q$-G4$$G)'I7NM% 'RQXE\/_ +6GA_Q?XCD\+>(?ACXF\,W&IO<Z2WBJ
MUO;>^LK67&+7%L/+(BR0)#ODDY)[1CKO@%^SM;_!WX>^)_#GB#6!\0=0\6:Q
M>ZUXBO=1TV&WM[V6Z CF'V89C$1C1<QY(_UG8[![S10!\;^&?@[^TC^S_HUK
MX/\ AGXT\"^-?!FGY&F3?$2VODU.PA)(BL?,M"8YHXXU3$AQC.!'''&@'OOP
M7\/_ !"T/PK=/\2?%6G^*?$=]>2WH_LFP%C::=%(D?\ H4(R9)(HY/,Q++B0
M@C<.*]+HH ^(_AS^S[^T=\!]+N?AE\./''@,?#&&\G&D:QXAL;F;7=)M9SYD
MA$40%M++%)(\B"7B0DY\N,^7'K? _P#9;^+7P5_9[^)?A#2?B/IY^(FN>);O
M7]*\7S6[7!E\S[, ;N.XBDQ),(91+_K?+\[(,A%?8U% 'Q1X^^!/[1W[2?AF
MX\!_%?Q'\/?#/@:YGM[G4?\ A K.^GOK[RY8Y/LV;O\ =Q*>9/-&2)(XN"#)
M7LG[07P!F^-&F>'KG1?$UYX!\<>%M3_M+0O%%G9Q7DUL2#'-$\;$&6&6,D21
M>8!)B+S X'EGW.B@#Y,D\/\ [8OB5O[-U;Q3\(_!ME=?ZS7_  YIU]?7]KT/
M[JWNCY4G39^\[/ZUZ7\>-&^,UU<^&M2^$'B+PSILME-.NK:+XKM)9;+4HY8B
M(B9(_P!ZABDVG$9&_P PY)$?ER>T44 ?*O@?X$_%OQC\:O!7Q0^-'B;PR+_P
M='?V^C>&_!%E(MBOVF+RIKF6YN?WI)0X\H#'[J,@_P"L![_Q)X9^,=S^T9X5
MUG1?%&E6_P '8-,>+7?#LB@7UU>XN0)8I/LQ(&9+;_EK'GRCQZ^UT4 %?+/[
M<G[,?BG]HCPGX:?P)?:7I/C#2+B]MOMVLRR1Q?V;>V4UM?18CCDRT@,7\'8]
M*^IJ* .5^'G@ZQ^'/@/PWX1TV6::RT#3+73+9[D_O'BBB$49?CT2OE;X=_L5
M^(/"/[96J_$>Z\16MW\/[?4]7\2Z%I,4@^W1:MJ<4,-\9LVP!BQ')Y8$N1Y4
M/K)G[3HH X7XN?#C1_C%\.O$7@O7;;[3I&N6;V<^$3>F?NR)YBL!)&<21G'#
MQ@]J^=]+\"_M=_#FSM?#FA^,/AEX\T[38HXH/$'B^#4X-5O%Q_R\QPR21YY,
M>_)+A/,D/F9)^PJ* .'^%?AGQ+X3\#Z9IGC#Q6OC;Q+;^9]JUU-.BT_[4#+(
M8S]GB_=QD1%(^.NSU-<-^V-\&==_:&_9X\5?#_0)["TU?6/LWD3ZE))';+Y5
MU%,?,,<<A_Y98Z=QTKW&B@ KY"\'?L;ZA)^P;'^S_P"--=MK*]DAN%DU316,
MT<4G]H/>P8\V./S,802#$9/SC(^_7U[10!\-^.O@?^UG\:?AAJO@3QA\0OA]
MX?LKK3/+?4_#=K?M?:O*$ ^S71<11PQ3')EDBC[>7Y7ER-'7U-\$_!=W\._@
MYX"\*ZBT,NHZ#X?L-*N98/\ 5R20VT<4FSVS&<5WU% 'Q=\-OV'[WP+^T1/J
M<DVEI\&M+U^^\8^'_#MM(3*FLW-M;1*9;7R1;^5:^5<_9O+_ 'D68^3S7KW[
M07P!F^-&F>'KG1?$UYX!\<>%M3_M+0O%%G9Q7DUL2#'-$\;$&6&6,D21>8!)
MB+S X'EGW.B@#Y,D\/\ [8OB5O[-U;Q3\(_!ME=?ZS7_  YIU]?7]KT/[JWN
MCY4G39^\[/ZU]9T44 ?/GQU^ _B7QAXY\+?$CX<^*(/"/Q%\.0W-M'-=V(DL
M=;LW_>?8+X)^\,1DC'.?W9DEDC3S,$8GA+P]^U7XD\5:2?''BSX;>%/#UE>0
MW=TO@W3+V]N=3BCE_>63_;/W<44L9D_>Q_O 5CQP37T]10!\W?$G0OVFM-^)
M6N:A\,O$GP_U;P?J26YMM+\:VUTDNCR1QB.4126W,HD/[S,F<= !C,EW]GCX
M"^(OA[XJ\=>._'7B2'Q%X[\<365UJO\ 9MC]DL+'[-$8XK:U&?,D6+?)'YLO
M,D9BR,B0O]"44 ?)?C_X$_&+P+\>/%/Q-^"GB#PA.?&EG;1:_HGCB&Y^SI-;
M1K%;36TEJ/,/[KS!Y9.!DGY\Q^5K?''X&?$34/C=H'QB^$NNZ):^-+?2'\,:
MCI/BV*;^RKW3O-DF',2F5)!,0>#@XCZ8/F?3U% 'Q;X=_9K^.&O?M/\ PU^,
M7Q$\;>%M7BT-;^.[\,Z)%<QV6EB6UEAC-@9<F5I?,$DLDGEG@#]X(XZ[']IC
M]FOQA\;?BQ\(?$OA?QDW@AO!HU:>35;9B;Z*6YAB%LT<)C,<L?FQ8EBD,?F1
M&1.YKZAHH ^+=8^!?[3/QR\*V_@3XI^/_!GAWP?/%''JFK>![:Z.LZQ& HFM
MI#,(H8A*GF%Y(XQSA/+,;RI7J'Q[^ -W\0].^$.G^$%TG1M.\%>-M'U^:UD4
MVT4=A9"4>5;1QQGYAO C3B/CJ*^@J* /"OB?\'=?\:?M&?!'Q_8S6$6C>!_[
M<_M&*YE?SY?MUK'#&(ALZ@@DY(]*P_B3H7[36F_$K7-0^&7B3X?ZMX/U)+<V
MVE^-;:Z271Y(XQ'*(I+;F42']YF3..@ QF3Z1HH ^>_V>/@+XB^'OBKQUX[\
M=>)(?$7COQQ-976J_P!FV/V2PL?LT1CBMK49\R18M\D?FR\R1F+(R)"^A^S3
M\&=<^#J_%1=:N;"X/BKQWJGBJS^PS22&*VN?*\N.7S(Q^\'E\XR.1@U[I10!
MX5_PI_7/^&SO^%N>?IO_  C/_"!_\(M]G\R3[7]I^W_:O-QY?E^7LX_UF<]J
MXGQA\!_BG\-_B5XH\<_ SQ1X:MXO%4T4^K>"_&%G-_9<5[Y>V6_MI+;YTFD\
MN+S%V_O/,EDDD)$7E_5=% 'A'P=\.?'>/Q1=:U\6/%?A$V+64EC;>%O!>GR_
M9?-\R.07SW5S^^$N!+%Y6/*QY9ZYKA?$7[._Q#^'OQ@\9_$GX%:[X6L[CQI]
ME_X2#PKXNTV5;$SPF3_389;;$GF<G,>,2&:60R$^6!]8T4 ?&WA[]EWXM7G[
M1WPI^+'COXC67BBZT'^U#J6EVML;.QTV.YM?+CM]/A\MO,Q)+)YES-())(XX
M>,QU]DT44 ?GFO@GXH:_^VM^TEKGPG\9VOAGQ3I<_A3=IFN0^9H^KVLE@#)%
M=8B,D9'E@)+%^\&94X\SS$]A\'_ ?XI_$CXE>%_'/QS\4>&KB+PK-+/I/@OP
M?9S?V7+>^7MBO[F2Y^=YH_,E\M=O[ORXI(Y 3+YGKW@_X)Z/X-^*WQ!^(%E>
M7\VM>-OL!U.&Y=#;Q_8H3##Y8\O(X)ZD^M>FT ?)?C_X$_&+P+\>/%/Q-^"G
MB#PA.?&EG;1:_HGCB&Y^SI-;1K%;36TEJ/,/[KS!Y9.!DGY\Q^57^!_[-GQ7
M\*_M1ZC\6?B+XZT?Q7-KGA@Z9-:Z=;2VO]F3FXBE^RVJ/UM(_)P)"?,D,F9(
M\DN?KRB@#PK_ (4_KG_#9W_"W//TW_A&?^$#_P"$6^S^9)]K^T_;_M7FX\OR
M_+V<?ZS.>U>E_$/P=8_$;P'XD\(ZE+-#9:_IEUIER]L?WB12Q&*0IQZ/7544
M ?,_[+/@'XV?"NSMO!?C76_!OB/X>^']+.FZ-J6EQ7$6L2>5+&+7[5$1Y0VV
M^01'D\1_O).9*Z3]FGX,ZY\'5^*BZU<V%P?%7CO5/%5G]AFDD,5M<^5Y<<OF
M1C]X/+YQD<C!KW2B@#PK_A3^N?\ #9W_  MSS]-_X1G_ (0/_A%OL_F2?:_M
M/V_[5YN/+\OR]G'^LSGM6#\7/@3XYL?BG/\ %?X/>)M)T#Q;<Z=%I>LZ%K]I
M+)H^OK'(?)EN9(?WL<L*2/B7$AQ'''F./S!)])T4 ?.?PO\ "?[1MYXXTG5/
MB7XK\!:+X:TXRF7P_P"!=.NI?[8:6-Q^^N+K]Y;^5*(I!Y6?,S)YE:__  I_
M7/\ AL[_ (6YY^F_\(S_ ,('_P (M]G\R3[7]I^W_:O-QY?E^7LX_P!9G/:O
M=:* /(_CKHGQ0UWPI:I\*/$.F^'O%-EJ5O=;/$%L9K#4[4$^;:RL 9(@1@^9
M&/,S'@>7YGF#Q^+X$_&WXW^+O ^H_&KQ+X-T70O!GB"W\26.B^!;"Y=M1OH?
M,,1N9KHGRQ&3_P LA^\$L@."(I!]>44 >%?$_P"#NO\ C3]HSX(^/[&:PBT;
MP/\ VY_:,5S*_GR_;K6.&,1#9U!!)R1Z5)^V-\&==_:&_9X\5?#_ $">PM-7
MUC[-Y$^I221VR^5=13'S#''(?^66.G<=*]QHH \+_:6^#.N?&)?A6NBW-A;G
MPKX[TOQ5>?;II(S+;6WF^9'%Y<9_>'S.,X'!R:\R_P""C>C'Q)X;^"&BC4-0
MTDZI\5M#LSJ&ES&&ZM_-BNH_-BDQ\D@SD'L17V#7F?Q=^"ND?&9?!CZO=7]G
M_P (KXDLO%%C]@>.,R75KYGE1R;XSF/,AX&"?4=P#P23X<?M<:WH6H>!]8^)
M_@2'0KK[5:'QYI.FW2^(Q%E]DJ6R>7;128,<>(SF,$D2&0>8>Q\4_"+XF_#'
MP#\.?#/[/NM>'=$T_P *1/87>C>+[/-KK$?EX^TS2VL7FB82@RGRA&)9)I#(
M>/+?Z6HH ^5? _P)^+?C'XU>"OBA\:/$WAD7_@Z._M]&\-^"+*1;%?M,7E37
M,MS<_O22AQY0&/W49!_U@/U5110!\@?M/?LBZU\<OB]X;\0V$NF7N@ZAIEKX
M;\86>L74\(FTF'5;;41]A\F/_7.8I8V\R0<&/&#^\K6_;-_9Q\=?&@^"=>^%
M_B:'PMX[\,3:A':ZE>W;PPK9WUKY%UY1BBEE$O\ JO+<8V9D(.1'CZIHH Y7
MX>>#K'X<^ _#?A'399IK+0-,M=,MGN3^\>**(11E^/1*\U_9I^#.N?!U?BHN
MM7-A<'Q5X[U3Q59_89I)#%;7/E>7'+YD8_>#R^<9'(P:]THH ^3_  =\"_B[
M\%?C;XFU#X=ZWX1U+X8>,O$?_"3:W8^*8;D:I8RS2#[>+62W&R0M&!Y?FG P
M@QQ)))W?_"G]<_X;._X6YY^F_P#",_\ "!_\(M]G\R3[7]I^W_:O-QY?E^7L
MX_UF<]J]UHH \+_:6^#.N?&)?A6NBW-A;GPKX[TOQ5>?;II(S+;6WF^9'%Y<
M9_>'S.,X'!R:]THHH ^6/$OA_P#:T\/^+_$<GA;Q#\,?$WAFXU-[G26\56M[
M;WUE:RXQ:XMAY9$62!(=\DG)/:,==\ OV=K?X._#WQ/X<\0:P/B#J'BS6+W6
MO$5[J.FPV]O>RW0$<P^S#,8B,:+F/)'^L['8/>:* /B;X?\ [/G[2'[-.GCP
MC\)O&G@/Q/\ #>W\Z33+'Q[97-O=:=YEU-(\7F60_>Y\W)E<]>D<8&#Z'^S/
M^S/K/PI\3^)?'WQ#\4VWCOXK^+(+9-2UR'38K6*UABBBC^S6_EH.,IS)^[\W
MRHB8@8\U]+44 >%_LT_!G7/@ZOQ476KFPN#XJ\=ZIXJL_L,TDABMKGRO+CE\
MR,?O!Y?.,CD8-)_PI_7/^&SO^%N>?IO_  C/_"!_\(M]G\R3[7]I^W_:O-QY
M?E^7LX_UF<]J]UHH \*^)_P=U_QI^T9\$?']C-81:-X'_MS^T8KF5_/E^W6L
M<,8B&SJ""3DCTK!^+GP)\<V/Q3G^*_P>\3:3H'BVYTZ+2]9T+7[2631]?6.0
M^3+<R0_O8Y84D?$N)#B../,<?F"3Z3HH ^<_A?X3_:-O/'&DZI\2_%?@+1?#
M6G&4R^'_  +IUU+_ &PTL;C]]<77[RW\J412#RL^9F3S*^C*** /D'QK^S'\
M4/A]\:?$WQ*^ _B?PQHTWBV>WE\0^$?%.G'^S+Z2.*:/[3YMM'YL9\R7S3&,
M;Y))9))"/W='@K]F/XH?$'XT^&?B5\>/$_AC69O"4]Q+X>\(^%M./]F6,DD4
M,?VGS;F/S9#YD7FB,YV21Q21R ?NZ^OJ* /"O^%/ZY_PV=_PMSS]-_X1G_A
M_P#A%OL_F2?:_M/V_P"U>;CR_+\O9Q_K,Y[5[K110!X7^U9\"]4^.7@'2;+0
M-<_X1[QAX=UFU\2>']2DA$MO'J-L)/*\Z,@_N_WAY .#M.),&.2I_P (5\7/
MB-^SM\2/"/Q+/A"/QEK^G:EI>G3>%OM2Z?'%-:>5%YIF_> ^;))G QLQWS7O
M]% ' _!/P7=_#OX.> O"NHM#+J.@^'[#2KF6#_5R20VT<4FSVS&<5YW\!/@#
M=_#S3OB]I_B]=)UG3O&OC;6-?AM8U-S%)87HB'E7,<D8^8[")$YCYZFOH*B@
M#XW\,_!W]I']G_1K7P?\,_&G@7QKX,T_(TR;XB6U\FIV$))$5CYEH3'-''&J
M8D.,9P(XXXT ]]^"_A_XA:'X5NG^)/BK3_%/B.^O);T?V38"QM-.BD2/_0H1
MDR211R>9B67$A!&X<5Z710 4444 %%%% !1110 4444 %%%% !1110 4444
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MWQ9H>K^(-5T.PU;3[K6]',7]HV%K=1O<V?FCS(_-CZIY@!(SU[>H\1\>?\%
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M\-S^(/&OB+3_  QHL61]IOY/+\R38SB*('F64B*4^7'ESC@5YS\*?VV/@O\
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MC(JK\*?VV/@O\<O%:>&?!GCF'5M=DB:6*PDL;NUW[ 2^PRQ1^8<<[!S@$]J
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M/X5:UJ'B3P#&+K^S-2U2/R[B7_2I3+O_ '41_P!:91S&.E 'N%%?,^M?M^_
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MSQ7ETW[:OP8_X2[PGX6'CBV?7/%<5E-I-E'974IE%Z ;8R8B_=&02Q'9+Y9
MD&: /?Z*\>^+?[3WPM_9_P#LR>/O&UAH-Y=!&BT_;)<WAC/F8D^S1"27ROW4
M@\W'EY&,^O,_#7]NSX(?&;QUI?@WP=XW_M?Q%J1D%K9?V1?1;_*CDED/FRPB
M,#RXY._/:@#Z'HKPKX8:/X"L_P!HSXWWWA[6M0U#Q]?'0SXKTN>/%O8^7:R"
MQ\HF(#]Y%ECB20YQ_J^E6?&_[6WPG^&][XLA\1^+[;3)O"<UG:ZO'/:7&Z&2
M\B,MM''B+]]YD<4DF(MY 0YH ]LHKQ3X-?M9?"O]H#5-3TSX?^+HM?U#38/M
M4\!M+FVF\HD#S1'+%&9!NZ^7G&],X\P5:^+?[3WPM_9_^S)X^\;6&@WET$:+
M3]LES>&,^9B3[-$))?*_=2#S<>7D8SZ@'L-%?/'PU_;L^"'QF\=:7X-\'>-_
M[7\1:D9!:V7]D7T6_P J.260^;+"(P/+CD[\]J^AZ "BBOGG]L;]ISPU^SC\
M+M5CO_$K>'/&>KZ/J7_"+-]AENO.OXHAY72.2,8DDA_UN!S]: /H:BOF7]D7
M]K[P+^T+X5\-^&K/Q?\ \)%\2;;PY;7_ (AM_P"SI;;$P2*.YD!,4<1_?2_\
MLO7BNB^+G[8OP:^!FM#1O&OCVPTC6,GS+&UBFO;JU^Y)B:.VCD,.1)&1Y@'F
M9XR : />**\_^$?QC\(?&SP=%XC\$Z]#XDTEG>W-Q%%)$4D3.4DCD DC/?YQ
MW'J*Y[XM_M/?"W]G_P"S)X^\;6&@WET$:+3]LES>&,^9B3[-$))?*_=2#S<>
M7D8SZ@'L-8'AGQ/H?C+1+;6=!U;3]=T>X/\ H]_I=U'<VS<["(Y(R0>>./>N
M3^$/QZ^'_P ;]#?5? WBJQ\20Q*/M"6^8[BVSO"^;%)B2+.Q\>8!G%?'_P"Q
MG^U9\*?V=_V-_A-I'C[Q=;^'[_48=4NK:WCM[B[E\D:I=CS"D,<NP;N 9,9*
M28SY9H _0NBO/_A'\8_"'QL\'1>(_!.O0^)-)9WMS<1121%)$SE)(Y )(SW^
M<=QZBO/?&7[;7P6^'^FZA?ZUXXM["+3]>NO#-PKVER\C:A:A?M,(C$1DD$?F
M19D \K]Y'\_- 'T%17D?P7_:,^'?[0UCJM]X!\3P>(;>QG6&]C$,UM+$S E"
M8Y8TD ('$F,$I(,_)QH_%[X]?#_X(:&FJ^.?%5CX;AE4_9TN,R7%SC8&\J*/
M,DN-Z9\L'&: /2ZYS4O%FAZ1X@TK0[_5M/M=;U@R_P!G6%U=1I<WGE#S)/*C
MZOY8()QT[^I\C^%/[;'P7^.7BM/#/@SQS#JVNR1-+%826-W:[]@)?898H_,.
M.=@YP">U<G^T-_R?5^R/_P!S=_Z:XJ /JNBO-/B]\>OA_P#!#0TU7QSXJL?#
M<,JG[.EQF2XN<; WE11YDEQO3/E@XS7%_"G]MCX+_'+Q6GAGP9XYAU;79(FE
MBL)+&[M=^P$OL,L4?F''.P<X!/:@#W^BO-/B]\>OA_\ !#0TU7QSXJL?#<,J
MG[.EQF2XN<; WE11YDEQO3/E@XS7EWAG_@HI^S]XT\1Z3X<T7X@->:SJEY%8
M65HNB7\7G2RRB../,EL ,D@<XH ^G**\\\$?&#PO\0?%7BKPSHM_<2>(/"\D
M,.MV4]E<VQMC+YIB8&6-!)O\MR'CR.G8C,_B[XI>&O!>M^%M%U74S#K/B74?
M[/TG3X;:2XNKF0#S)B(X@3Y4:\R3?ZN,$>810!WE%%% !16/K&N6'AS2[O4M
M1O+>QTVSBDN;BZN9!%%!''_K)'<\  >OI7@6E_M^?L]ZIXND\-P_%/24U&&2
M2#SKA)HK(F/<<_;9(_LY!"<2>;A^Q/% 'TK16!XF\3Z'X-T2YUG7M6T_0M'M
MS_I%_JEU';6R\[ )))" .>.?:OG?2?\ @I#^SGK&IVVGVGQ-M[>:YD2*.6[T
MJ_MH/GZ&266$1Q]LO(0,9H ^IZ*XGXK?%#PW\'_ .J>,/%^I'2?#NG>3]IO/
MLTDWE>9+'%&?+C!D/[R2/H._:O)/'G_!0+X"?#7Q=JGAKQ#\1(;+6--D^SW<
M-OI-]<B*3^YYD4+IG@Y&: /I&BO"OB=^V=\'/@NVA+XL\=65F=;LO[0TW[*L
MM_\ :;4D^7,/LT<F(G',<G23!QG!KTSP-XYT'XF>$]-\3>&=6M]8T74(O,M[
MVW)P_K[CG^ B@#J:*^9]:_;]^ ?AOPWX;UO4OB';0Z9KT,MWIC+IU])+-%%+
M+"\AB$/F1_O8Y4S(!YGEOC/->L?"/XQ^$/C9X.B\1^"=>A\2:2SO;FXBBDB*
M2)G*21R 21GO\X[CU% 'H%%>*?&7]K+X5_L_ZIIFF?$#Q=%H&H:E!]J@@%I<
MW,WE D>:8XHI#&-W3S,9V/C/EFNK^$?QC\(?&SP=%XC\$Z]#XDTEG>W-Q%%)
M$4D3.4DCD DC/?YQW'J* /0**\3\;_M;?"?X;WOBR'Q'XOMM,F\)S6=KJ\<]
MI<;H9+R(RVT<>(OWWF1Q228BWD!#FE^#7[67PK_: U34],^'_BZ+7]0TV#[5
M/ ;2YMIO*) \T1RQ1F0;NOEYQO3./,% 'M=%>&_V3\/_ /ALC^V/[?O_ /A:
MG_""?8_[%V?Z+_8_]H;OM.?*_P!;]H_=X\WI_P L^]:/Q;_:>^%O[/\ ]F3Q
M]XVL-!O+H(T6G[9+F\,9\S$GV:(22^5^ZD'FX\O(QGU /8:*\C^"_P"T9\._
MVAK'5;[P#XG@\0V]C.L-[&(9K:6)F!*$QRQI( 0.),8)209^3CG/BM^VQ\%_
M@;XK?PSXS\<PZ3KL<2RRV$=C=W6S> 4WF**3RSCG8><$'O0![_16/H^N6'B/
M2[34M.O+>^TV\BCN;>ZMI!+%/')_JY$<<$$>GK6Q0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R'^TKIP^'7[5'[/
MGQ9,D\$6IZG+\/M5BL[F027HO8Y381/&#Y1BBN1)))GG/ED"0QC'@O[4VH7T
MWQ4^)W[05H8&A^#.O>&-&T:[TB_,3:G&DA.L:9)(DI\L^9J<<<DAB/$?E8_U
MM?:W[4/P<;X^_ CQEX"BN%M+G5K(?9)MVR,744B2VOF?NY#Y1FBB\S SY>?P
MY+X1_LVSZ;\"/'/@_P <'3X/$GQ N]9OO%-UX5NI3;R3:C-,&DMOM(/E[;=H
MHQF/_EESOY) .0^*FL67Q[_:V^"'@FQO(=6\+>']-F^)UYB4?9[_  WV;2Y;
M::/F0QRR2RXXCDC//F=*A^&OAVV\?_\ !1#XU^*-:VZAJO@+1]$T30(Y(HS%
M907ML]S+C]WO$N_S0)<Y\NYECY& -3]BG]G7QY\!?#>O3_$GQ5%XC\27D6F:
M-:+ID[RV5CI%A%Y5K#$)(8C&?WUP9,9SP_\ K#(2[XU?LS^,[[XP0?&;X-^(
M],\)?$9M.BTG4=/UW3(Y=/UJV6ZCEVW,D<9EB_=QA#( 9#'%%&#'R: ,K_@I
M-H]AI?[..H?$""SM8_%_@75-.UCPWK31;I-.N3?VT9(SD,,'F.0>6<1Y!\L8
MI_M=>!= ^)/[7_[+7A_Q5IEMJ^B73^)I9;&Z7,4IBLK:6,2 _?\ WD<?R=^_
M%1:E^S/\9_VAO%7AJ?X^>)O!TG@KPWJMMJ\?@KP;IDEQ:ZG=0F8;KF6]C\Q%
MQ,$,?[R.2/(Q$?WA]=^)_P '=?\ &G[1GP1\?V,UA%HW@?\ MS^T8KF5_/E^
MW6L<,8B&SJ""3DCTH ]UK\O_  SXJU+P?_P1'>]TNX^SW,ME=:?+(4W9@N=>
MEMID_&*60?C7Z@5\Q?!/]E$^'_V*;/X&>/Y-/U,R6=]:7TND_OH4\V[EFCEA
M\Z(?O8_,CD!,?$L>>>I /5_!/PC\,_#WX4Z1\-M/TZWG\)V&FKIGV6[MXI!>
M1^7B7SHQ&(Y#,"YDX^<RR&O O^"<WAG3?!OA7XX^'='M_LFBZ/\ %?7-/L[8
M.7$<,4=K'''E^3P!47A;X+?M1^"O#.B_#31OB=X#M/!>DVD-E8^-#X?E?7H(
M8HAY<?V)Y?LIQC[/R3^Z_>$^97??L<_L_P"N?LZ^%_'FD:QK1\1#6/&%]K]A
M?374MU=R6DL<4<1NI9(X\W7[HF3&1D]>: /5OBMX$7XD_"WQAX.%U]A;Q!I%
M[I?VKR_,^S_:8I(O,V=\>8:^7?A9X\O_ -F'P3X3^%WQN^&5CH?A/2_L=M8^
M/O#\0O/#<D\4L<D=U>AU$E@_VF2VQ-*/WEQYLO[L#-?27Q>T3QAKGPUUNR^'
M_B*/PIXQFCW:;J4]M'=1Q2"42$/'+QB09CZ'9YN0#BOFSQ]\"?VCOVD_#-QX
M#^*_B/X>^&? US/;W.H_\(%9WT]]?>7+')]FS=_NXE/,GFC)$D<7!!DH ^UZ
M*** "OA+X(>)-2\&_ /]M'Q'HLYLM7T?Q[XTU"RN=@<QRQ6D<D;X?W ^M?=M
M?/OP$^ -W\/-.^+VG^+UTG6=.\:^-M8U^&UC4W,4EA>B(>5<QR1CYCL(D3F/
MGJ: /G+]E3QM\7_A3\!O!NB^!/V4[:^T:;3;74FU>W\=6-H=6EEACD-[)')&
M9,R\$;S^[&(^!&!7I'[#_P +?'/P[\=_&74=>^')^%'A+Q)?Z??:)X3M]9CU
M*UMY1%,+Z6+RCB+S/W)QY<? CC'^K&$\,_!W]I']G_1K7P?\,_&G@7QKX,T_
M(TR;XB6U\FIV$))$5CYEH3'-''&J8D.,9P(XXXT ]]^"_A_XA:'X5NG^)/BK
M3_%/B.^O);T?V38"QM-.BD2/_0H1DR211R>9B67$A!&X<4 ?,_@SXX:G;^+O
M&=U^S[^S)-XMT2ZU*XDU;QK)K=EH\&NWQO;KS);>YD$GVZ(2F4QR"0^7YGE^
M7$ ,\Q^R?X@UKX=_LG_M4Z]I^CV_@77=%\5^*KZWTFU,5S#H]S%8121VZ8'E
M2"&3$? \L^5TQ77?#G]GW]H[X#Z7<_#+X<>./ 8^&,-Y.-(UCQ#8W,VNZ3:S
MGS)"(H@+:66*21Y$$O$A)SY<9\N/OOV1/V8M<^ _PR\?^#_'^L:?X[7Q)XCO
MM3FNYQ),-2MKF&*(_:HY0?WLOER&2/\ > ^9_K'H U/V$OAIHOPW_91^'=GH
MUL(1K&DVVNWLK)'YEQ<W44<TC2;%YX=8QG.(XXQGBO//V1? N@?#;]K_ /:E
M\/\ A73+;2-$M7\,RQ6-JN(HC+97,L@C ^Y^\DD^3MVXIG@']G;]H'X">&X/
MAM\,?'W@Z[^')EN?LFJ^*-,D.N:%%<2R22"..+_1[HQ;Q(#+@22.01''@#K_
M -F?]FOQA\$OBQ\7O$OBCQDWC=O&0TF>/5;EB+Z66VAE%RTD(C$<4?FRXBBC
M,GEQ"-.PH J_L\_\GU?M<?\ <H_^FN6N2_8;^&GA6Z^('Q_\=7>@:?>>+;/X
MJZ]8VNM74 DNK6)#_JXN/W?_ !]2Y\OE_,P>@Q['\,/@[K_@O]HSXW>/[Z:P
MET;QQ_8?]G16TK^?%]AM9(9!*-G4D@C!/I2_LT_!G7/@ZOQ476KFPN#XJ\=Z
MIXJL_L,TDABMKGRO+CE\R,?O!Y?.,CD8- 'F]GH]CI__  5,U&:SM+>UN+_X
M2_:[N2*((;B7^UXHA)(1]\^7%$F2>D8'%>;?"K]ISX;?LU_%'X_0?$OQ$]OK
M&K^/+B>U\40V5SJ,%];"*%H],^TQ12?O+$2>5)"<"+SL)GFOI#_A3^N?\-G?
M\+<\_3?^$9_X0/\ X1;[/YDGVO[3]O\ M7FX\OR_+V<?ZS.>U?+O[-?PF^)7
MQ4L_&/Q:^%/QHOOA3X,^(OB74-:M/#M_HMMKDI_TF2.2>7S-D4,DDD<O[N+?
M^[$0,LICS0![A^P3\.KCP;\-?&>HW'AFX\%V/BOQKK'B#2/#E]8&PN]-L))8
MXH89[; \HXMQB-"8_+\OGFOJ>ODSX&>/_BIX0_:6U[X*?$WQ7I_Q#CD\-Q^,
M-(\46FGIIMRD7VF.UDMI;>,>7_K?-(().!R3YGEQ?6= !7RK_P %1/\ DQ?X
MF?72_P#TZ6E?55?*O_!43_DQ?XF?72__ $Z6E 'LG@OX,^!OASX$E\#Z'X6T
MS3?"UQ#Y-UIL5G'Y5Z#$(I#<@K^^,D<061Y<^8.I-?'7P>TN'P]^QC^V%X9M
M#.F@^&=>\::-I%E-/))]ALHK']W%'YA.!^\<^I,F2:]/T_X=_M4^$[C4/">A
M_$[P7KWA.:<0:;XG\7V-S-XCL+(Q1I_JHXTM[F:+.1)*3YL@S(1YGEQ]AI?[
M-#^"?V3_ !=\*=%U0ZOXEUW2M4AO?$FK_)-JFIWL4OFW5U(@WG,D@&?WD@BC
M09DQR +^Q'\-/"?P]_9O^'UYX=\/Z;I>H:]X:TN_U.\LX<7-[+);"0O++C?)
M^\EDP#]S<<8%<-^PD^B^ _#/[161IWAWPWI'Q6\0]/*M;6QM8H[89[1QQQQC
MZ #M7T-\$_!=W\._@YX"\*ZBT,NHZ#X?L-*N98/]7))#;1Q2;/;,9Q7E/PG_
M &9;[1/!?QZ\)^+-0@?3?B5XIUW58Y=%D/FP6-_%'%@^;'Q,!G/$D?3W% 'C
M?PI^+WB.^^&\NB_!S]CJZF^$M["D<9US5['1#J\4EK$'DDM9HW^TK)'M'G&2
M7S0.9#T'IW_!+O\ Y,7^&?UU3_TZ7=<?H'P1_:FT?X;P?":'XC>!M&\'V5G_
M &-9>,M+TV]_X2..RB!^SE(LQ6\<GEB.+(DS&,GS'D'F'VG]CGX,Z[^SS^SQ
MX5^'^OSV%WJ^C_:?/GTV222V;S;J68>69(XS_P M<=.QZT >-_\ !*_P#H'A
MO]D'PSKVGZ3;VFO>(YKJ;4[]6Q)=F*^N88@QSR(XH^(^@S)WD<EGQ"^&/A+X
MH_\ !3#3K+QAH-AXCT[3_A2-0M[75(O.MA,-4FB\R2,Y20>7+(,/QT[@&O9_
MV.?@SKO[//[/'A7X?Z_/87>KZ/\ :?/GTV222V;S;J68>69(XS_RUQT['K4?
M_"G]<_X;._X6YY^F_P#",_\ "!_\(M]G\R3[7]I^W_:O-QY?E^7LX_UF<]J
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M%\1/&WA;5XM#6_CN_#.B17,=EI8EM988S8&7)E:7S!)+))Y9X _>"..O7?\
MA3^N?\-G?\+<\_3?^$9_X0/_ (1;[/YDGVO[3]O^U>;CR_+\O9Q_K,Y[4 ><
M?MZ:+9S:W^SEJ;6D#ZA;_%O0K6*Z\L>;'%+YAECW]<2&&+/_ %SC] :T?V]?
MO?LY_P#99?#G_MS7;_M+?!G7/C$OPK71;FPMSX5\=Z7XJO/MTTD9EMK;S?,C
MB\N,_O#YG&<#@Y-'[2WP9USXQ+\*UT6YL+<^%?'>E^*KS[=-)&9;:V\WS(XO
M+C/[P^9QG X.30!\^?M+:YXLOOV]/!-EH?PSC^+DWACP1+XATC0;K5K733IM
M])?F*2_\R7_68$5O&(SD XDC *9KG/VH-+_: _:8\#6MB/V8)/#?C#2KZ+4/
M#_BZW\?6+7>CS1RQ%Y(MGE']X(\8\SJ$DZQ1D?2_QU^ _B7QAXY\+?$CX<^*
M(/"/Q%\.0W-M'-=V(DL=;LW_ 'GV"^"?O#$9(QSG]V9)9(T\S!&)X2\/?M5^
M)/%6DGQQXL^&WA3P]97D-W=+X-TR]O;G4XHY?WED_P!L_=Q12QF3]['^\!6/
M'!- &1\<_@WX^T?]H_P]\>/ ?AC0?B)<:9X<D\.S^%=0NUT^]!-R\@N+&[DS
M'')B:42>9C]V)8QYGF_)ZA\"?C-X5^,%KXBN=%T;4/"'B."_B.OZ%X@TP6&K
MV\QBC$4EU#G/[VWBB\N0]8XP,_NR!R?Q)T+]IK3?B5KFH?#+Q)\/]6\'ZDEN
M;;2_&MM=)+H\D<8CE$4EMS*)#^\S)G'0 8S)=_9X^ OB+X>^*O'7COQUXDA\
M1>._'$UE=:K_ &;8_9+"Q^S1&.*VM1GS)%BWR1^;+S)&8LC(D+@'T)1110!\
MT_MD>-/ WA7PIX7M/%_@"X^,&OS:C++X=\$V=O%>2WU]'8W.Z62V.3)#'%(1
M)((Y?*,L3B/.,?.G[1GQ ^)_CKX@_L]S_$3X"V_PZ2Q^)NB+9^(/^$GL=7E#
M2S9>U6.*/S$$HC$A/3_1TXR!7TM^TW\"_%GQ"U_X>>//AUKECHGQ#\#WUQ+I
MD>N1%],O8KH1Q74-R(P91^[CX>/IDCC(DC\H\9_LU_M$_&;Q[\+_ !=\0_''
M@VV@\'^)[+4SX2\,Q7L6GRV\<H>2Z,LN9)+G!\KRI(Q&(R2)8S))D W_ /@H
MSX9TWQEX5^!WAW6+?[7HNL?%?0]/O+8N4$D,L=U')'E.1P37HG[2'P_\+Z#^
MQW\4_#NG^&M)TWP[8>%]4NK;2K2PCCM+>6.*2YBDCA $>1,!+_O\U;_:6^#.
MN?&)?A6NBW-A;GPKX[TOQ5>?;II(S+;6WF^9'%Y<9_>'S.,X'!R:[;XV>"[O
MXB?!SQ[X5TYH8M1U[P_?Z5;2S_ZN.2:VDBCW^V9!F@#XP^-FGR>*/V%OV6?
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M_P#^"B'QK\4:UMU#5? 6CZ)HF@1R11F*R@O;9[F7'[O>)=_F@2YSY=S+'R,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OE'4OV
M"?!\-]=W/@KQG\1OA'9W\\EU-HG@+Q))86,US(?GF\DQR"(_ZN/$>(Q'#%@<
M5]744 >,? ?]F/P?^SJFOW/AEM5U/6_$#BYUO7-;OY+F\U.8222"27I'D&XE
MYCC&=W.3S7L]%% !7FGQZ^"VD?M!?"W6/ 7B&\O[/1M6\K[5-ICQQW'[J6.4
M>7YD<@',0[?XCTNB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O,O!_P3T?P;
M\5OB#\0+*\OYM:\;?8#J<-RZ&WC^Q0F&'RQY>1P3U)]:]-HH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHKG-2\6:'I'B#2M#O\ 5M/M=;U@R_V=875U&ES>>4/,D\J/J_E@@G'3
MOZD Y?X"_!;2/V??A;H_@+P]>7]YHVD^;]EFU-XY+C][+)*?,\N.,'F4]O\
M$^ET44 %%%% !1110 4444 %%%% !16!XF\3Z'X-T2YUG7M6T_0M'MS_ *1?
MZI=1VULO.P"220@#GCGVK?H **** "BBB@#YJ\8?L1^#O$_BK4_$OA_Q'XV^
M%FMZU)]JUR7P'X@DTW^UIB<A[F/$D?RDR8* 9,LA.36Q\#OV1_!_P-\7:CXR
MM-4\4>+?&^JP?9+OQ-XLU22]OI+4^4?)/"1D#[-'R8S(,8SCBO?:* "BBB@
MKYJ\8?L1^#O$_BK4_$OA_P 1^-OA9K>M2?:M<E\!^()--_M:8G(>YCQ)'\I,
MF"@&3+(3DU]*T4 >!? []D?P?\#?%VH^,K35/%'BWQOJL'V2[\3>+-4DO;Z2
MU/E'R3PD9 ^S1\F,R#&,XXKWVBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /G[XL_LB^#?BCXNE\8VVJ^*/ 'CF^BCMKKQ/X'U633;^ZMHP/
MW,V,QR#B/DQ^9^ZB&<1XK/\ A=^Q/X0^'?Q,LOB%?>)/&/Q \:6"&#3M;\9:
MW)?3V,)26.2*+ C&"+B48E\S';!KZ1HH \I^/'P%T/\ :&\(6_AGQ)=ZG!H:
M:G!?W5EI=WY U%8P<6]S@?-&20<9!S'&0<BO5J** "BBB@ HHHH **** "BB
MB@ HHHH \T^ OP6TC]GWX6Z/X"\/7E_>:-I/F_99M3>.2X_>RR2GS/+CC!YE
M/;_$^ET44 %%%% !1110 4444 %%%% '+>(/">F>(/[*.I6KWT-A?1WT4,LC
M>5YL8)BDE0MB3RV(D'F9Q)''(/WD<9'4T44 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!Y#\0]":[^.7PHU#_A9G_"
M,M8G6,^"OM)C_P"$I$EL!_JO.'F&U'[W_5RXS_RSZUV&I_$7POHFHW>G:EXF
MTK3[VQTR36+JUN[V**:WL8SB2ZDCR"(@<YD/R9_7P+]H;_D^K]D?_N;O_37%
M7G7QN^"GASX]?\%%K+PWXN%_=^'5^%4=W<Z7:7\MK'J'EZO)Y<-SY9$AB$CQ
MRXR/WD,9YQB@#ZR\'?&CX=_$/4VTWPAXZ\,^)]2CC^T-9Z+J]M=R)'WD,<<A
M('S]?>NFUC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_UDCN>  /7TKXQ_:R^
M#G@?X0^,OV=?%7@;PII?@K7Q\2]'T>2[\.PIISRV5SYOVF&7RM@D$@C _>9X
M,@&!)(#J?'#PK_PO_P#;J^'OPS\4-%=^!/"_AB7QU)H\D,LD6JWGVDVB17(\
MP1%8_P!W(,QGAI8SD2\ 'TYX#^+?@SXG27X\'>,M!\6_81']J_L/48KX6_F9
M\OS#$3C/ER=?0UX3_P Y3/\ NC?_ +FJ[RU_9/\ A9I/Q"\*^-M!\':3X7UK
MP[/<7%JWA^QAL1,+BVEMY8KE(H_WJXD!&>08^H'F"3@_^<IG_=&__<U0!]$Z
M;XLT/5_$&JZ'8:MI]UK>CF+^T;"UNHWN;/S1YD?FQ]4\P D9Z]O4&I>+-#TC
MQ!I6AW^K:?:ZWK!E_LZPNKJ-+F\\H>9)Y4?5_+!!..G?U/SO^SS_ ,GU?M<?
M]RC_ .FN6C]H;_D^K]D?_N;O_37%0!] >-OB%X4^'.EPZEXJ\2:3X9L9)?LT
M5WK5]%:PO*0?W?F2$<_(?RKY:_:^^('ACXE:;^SWJ7A'Q'I7B>PA^-/AVWFO
M-%OHKJ&.0"8F/S(SCHX_.J]KX!T_]H[]O;XF?\)W9:?XB\,?"[2M,TS1_#FI
M6OVFUDEU*V^TR74D4LGEF3B2/_5\@P]X<GF_VN/V?_ _PY\>_L^>*?!NC6_@
MZ2X^)_A[3K[2= B2SL+T":62*66VC'EF:/$GER=0DTH)/% 'T[\>-!36I/AZ
M5^)8^&_V3QCIEV=MQY7_  D'EF;_ (D_^MCW^=S^[_>9\O\ U9KO-2\6:'I'
MB#2M#O\ 5M/M=;U@R_V=875U&ES>>4/,D\J/J_E@@G'3OZGYW_;U^]^SG_V6
M7PY_[<UQO[:'PYTWXM?M3?LQ^$M6N-0M]*U/_A)X[S[!<M;2W,/V&!Y;8R1C
M/ER@&*0#K')(,\YH ^E/#O[0'PM\9:U;:-X=^)'A#7]8N"3!I^F:[:W-Q-@;
M_DCCDST'Z5V.L:Y8>'-+N]2U&\M['3;.*2YN+JYD$44$<?\ K)'<\  >OI7P
MQ^WE^SC\-?A#^R+K?B?P9X*TGPEXD\*3:5/HVO:-;FTO[607MO$)/M,9\R0[
M)#S)G]Y^\_U@!'>?MP_V+_PLW]GK_A9/]G?\*;_X2.\_X2+^T_+^R_VE]@E_
MLKS?^6GE[_M6?^66,^;QB@#V[_AJ[X(_]%B\ ?\ A3V/_P =KU6OSG\1?"_X
M _%G]MKX/V/PO\/^!/$VE:;I.L:AXPL_#T=I-IGV41".QDEBC_T=Y/M,AX ,
MG,?F?)Y=?HQ0 445\Q?\%!?CE<_ C]E[Q3J^FZ@VF^(]6\O0])F42B7SKC/F
M&*2+!CDCMQ/)'(3@/&.O0@'B/@7XZ^*+SXT>'OC?%K6JS?"/XA^-+GP#IF@S
M:G+<VQMC#%%8:E:6N(Q;-)=6-V9O-_>1QR8$9SYA_0NOS>^+W[3W[+OC;]D>
M_P#@KIOQ6NK:&W\/VVFZ3=7VDZD"9++ROLC32"Q^Z9+>(R>7'T\S Z5]@_LO
M?&-OC[\"/!OCV6W6TN=6LC]KAV[(Q=12/%=>7^\D/E&:*7R\G/EX_  \$_X)
M^?%KP7\+_P!A_P"$Z^,/&6@>$_MXU<VAUO4H;(7 CU2Y\SRS*1G'F1Y YY%?
M7GAGQ/H?C+1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]Z^$/^"<7[+/P
MW\4_LW^#?'OBWPW#XTU^]@O[./\ X20"_M;*V34)0L-K;29CB'F1F4G;YGF3
M3<XD(KO/@_X%L?@3^WSXG^'O@F:YTCP%XB\$_P#":W'AK@6%MJGV_P"R^9;1
M@9B!C!_=C@\=HXA& ._9!^('ACX:Z;^T)J7B[Q'I7ABPF^-/B*WAO-:OHK6&
M20B$B/S)#CHA_*OJ7P3\0O"GQ&TN;4O"OB32?$UC'+]FEN]%OHKJ%)0!^[\R
M,GGYQ^=?%/[*G[,_P^^+/C_XY>+/&^B-XHNM)^*WB"TTW2M7F-SIEKS&99?L
MW^K>27S8Q(9=_P#Q[0XP8\UT^L_#/0_V=/V[/@\WPYB3P?HWQ(LM7M/$WA_2
MHXX]+NC86/FVTL=L!B*4&3DQX_\ (DOF@'5?LS>)=0\ _'SXO?!7Q%J_B'6;
MNQO4\6^&K[7KJZNY)M'N8XXS;127!DS':RE8O,\TF6223@>7+7HO[6OQ1/P-
M_9Q\>^-+1Y[>^T_3C%87%M%'-]GO96%O;2^7)\A$<TD1(] <@]*\A_;&^R_
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MF$DHZXA$D9C,= 'T]X=_: ^%OC+6K;1O#OQ(\(:_K%P28-/TS7;6YN)L#?\
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M;I3&L<D8_P"6?EF,G]Y'))'CG(^D_P#AC#X&?\([_8'_  J;PE]A^Q_8?/\
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M7X*U\?$O1]'DN_#L*:<\ME<^;]IAE\K8)!((P/WF>#(!@22 ZGQP\*_\+_\
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MI\)?'D/Q8\,_&/X6PZ3>>*]'TVYTC6]%UF=XO^$@TDR&X6TAF.8[:59AF.3
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M_P#A%\8O OQI^.GBSXM)I5QJ7BN729;;4]"E!LKD0Q7(\N.,_O8Q"DD,?[U
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M_P"6D<GWAXH\*:=XW\*ZQX=UBW-UH^K6<MC>6_F%-\,L9CDCRG^R2/QKH**
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MX[USPM?:["U['X=O6U.RL9HD^SK>@[(KGD9\R(-*(^<9FWX,D<;Q@'=T444
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MOVN_AGXE^)#?!G_A&]--^/#WQ(T?Q!J3>?&GV>RMO.\V3YR,D>8.!S7T/10
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M#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_U<:(.  /3TH V**** "BBB@ HHHH
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MVVGV\6K7]LH,5Q>","62/]W&,&3)'[L<$<5UU !1110 4444 %%%% !1110
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M117SQ^R)\3/$OQ(;XS?\))J)OQX>^)&L>']-7R(T^SV5MY/E1_(!DCS#R>:
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MO]J'XB7>N:=IW_"26NHR^(8SX<U"XXFCCBL0/*\JYD/E11>9)'^]C'[T?NY
M#[ZHKA_A/KFK^+/A;X0UOQ+IW]E^(]0TFSN]2L3#)";6[DBC>6+RY/GCQ)D;
M3R,<U\Y_&+6OB_XV_;'M/A?X ^*B_#31D\!Q^)YY#X?M=4,DPOI;8\2C(R#%
M_'_RSZ4 ?8E%?%7C*+]I+]F>QOO'NI?$#2?CEX2TC3;F[UKPW?:5;^'[B.&,
M!_.M98HY=[1_O'?S#S&A $DDD9C^M?"_BO3O&_A71_$6CW!NM'U:SBOK.X\L
MIOAEC$D<F']B#^- '04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ML?MC_LSZW9Z3J%UI&C'Q-_:5_:VTDMO9>=81QP^;(!B+S#P,GJ/QH \W\<>
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MX2:[XV\ S^6=(UOP.@OKZ.4QQYMKFQ.'&)$N)/M,9\O$EO']_.. \*6'C_\
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M6-\"ET?2=4U5M.^*NAZA>?V?:R2_9K6,S"6:78/W<8R,R'@9'K7T[0!\??\
M!.7^VO\ A&?CA_PD/]G?\)+_ ,+6US^TO[)\S[)]J\JU\_RO,^?R_-SC/.,5
M\Z?$#XV?!'XL_'7XH)^T;XVU2'0O#_B&;0] ^'7_ !,FT^ 668FU,O91CS)9
M9#<8W\Q(9$_>CRS']7_L3^&-9\)M\=5UC2=4TIM1^*NN:A9_VA:R1?:;60PB
M*:+>/WD9P<2#@X/I7&077C#]C[XG?$D#X9>*/B'\+O&/B"3Q39:IX*5-1U6U
MU.Y1?M5M<6H,9\K,)*2 '9F,&2223]V >-_LS?%/X6>!?VMO"7@S]G3QE<:Q
M\-_'*7S:WX1O[6]\K2+VVL3+%<VLMUB0&;RL/_K/]7SG]T(NG_X9WL/VC_VU
M/VC=$\3^(M6L_!5O/X6NM4\-Z;)]F&MS+9;X8KJ4?O/)C\N8^7&03YL<F\>3
M'7TO\'?CMXH^,7BRX8_"+QCX*\'6UM(?[:\:)'I]U)>[XQ]FCL,F0Q>7)Y@N
M2<9CDCQD9KYE_P"%D>//A'^VM^TAK_AKP)=?$;PX+CPK!K]AH3R?VU;J]BOE
M7%K%C%R(QY@DB."?,BYCC$I !L>./@CI/[$'Q6^%'BOX-SW'AC1/&/BG3?!/
MB/PK=3RWUC?Q7,DIBNAYLGF1S1#S .>I'3][YN#^T;^QS\(KS]M?X*Z?-X5:
M2U^(5YXGU#Q-%_:5S_I\T=H+F-_];^Z'FR2']ULZUZ-/=>,/VP?B=\-@?AEX
MH^'GPN\'>((_%-[JGC54T[5;K4[9&^RVUO:DR'RLS O(0-^) )(Y(_WFY^UY
MH?BWPW\6/@G\8/#OA+4_'.E>!;W5(=6T70PTNJ&&_BCMO.MXP")?*P28^"<C
M_EGYDD8!W7BGX5^%?A!^SK=^"O"WBG_A3W@VR(A_MX7^U],AFNM]UY5U=2_N
MY)?-DCCD)/E22@C. *_.#XL^(OV3?A5\,;#Q%\ ?&.IZ?\:_#<UI+H^JPC41
M-?'S1%<?:OM$(MB)(9)9)(]L><>7_JR8C]F_M/\ _"7_ !\_9M\*>+_"O@'Q
M%,FG>([77]7^''B:V-G?:MIMG/+YME+;8E$GF%(I1$V0X (#R>7$?)/VL/BM
MX]^.G[->H^ ?AE^S?X^T/PQ:FPCU-->T+[!+!:QS1FVAL+*.0R2_O(@'\H$1
M1Q],2"2, ]]_X*B?\F+_ !,^NE_^G2TKH/A;^QOX'\$^.M/^(^LO?^,/B];F
M62^\9ZE>S)+<S21212-]F27[/'$(I/+BB$?[J/RQR1FL[_@HIX9U?QI^QW\0
M=$\/:7J&N:O=-8"WL=,MI+JXF(O[:0^7'&,G !/3H*^FZ /R,\'_ !J_9I_:
M"CU3QM^TGXXU;5O$>I:C=W.F^$+IM7:P\*V)D,<=O;&RCCCD,D4<7F2?\M,1
MY D$A?VG]A'XJ>%+7]HKQ;\*?A'XVN?%_P %Y- D\3Z99ZA:7,<N@7IO(XY;
M**2X"R/$1+YGMD=9/-DDZ'X5^+_&7[$/AN\^&.K_  E\9^-O!FG:G>-X1\1>
M"+)-8DN;*29K@+?1B2/R98S-C/EQI(?,\L?N_,D^B?@;\5_$'Q6_MG4=1^&6
MM_#WPS&8CI$WB2:.*^U)CY@N?,LO]9;>7)'QYA_>"42"@#XHU3P/\*/$W[1O
MQ*C_ &L8=5L?$6I>(+FT\$ZEXGO;FPT)]!B!EACM+FV>*$$1RCS1+)_K)8NL
MLDP/Z*^$?#B^$_#&C:&-1O\ 5FTVSBMO[0U*4S75QY<83S99,?O)#C)/<G-?
M)^K_ +5&M^.?#MYX0\7_ +*7Q$U+7+J5[.;0+O18K_P[+=I,!$)-0EQ"83)'
M&_VCRS&F?,^<#)]>_8[^'/BKX/\ [.?@+PGXWN))?$VFV317&ZY^U?9XS+*\
M5MYO_3*(Q1<'RQY0$9(P: /=*^5/V>?^3ZOVN/\ N4?_ $URU]5U\Q_ OPKK
M>C_MC_M,:W>:3J%KI&LGPS_9M_=6TD5O>^3821S>5(1B7RSP<'J?QH ^9-4\
M#_"CQ-^T;\2H_P!K&'5;'Q%J7B"YM/!.I>)[VYL-"?08@988[2YMGBA!$<H\
MT2R?ZR6+K+),#^BOA'PXOA/PQHVAC4;_ %9M-LXK;^T-2E,UU<>7&$\V63'[
MR0XR3W)S7R?J_P"U1K?CGP[>>$/%_P"RE\1-2URZE>SFT"[T6*_\.RW:3 1"
M34)<0F$R1QO]H\LQIGS/G R?7OV._ASXJ^#_ .SGX"\)^-[B27Q-IMDT5QNN
M?M7V>,RRO%;>;_TRB,47!\L>4!&2,&@#W2OSR_X9WL/VC_VU/VC=$\3^(M6L
M_!5O/X6NM4\-Z;)]F&MS+9;X8KJ4?O/)C\N8^7&03YL<F\>3'7Z&U\Q_ OPK
MK>C_ +8_[3&MWFDZA:Z1K)\,_P!FW]U;216][Y-A)'-Y4A&)?+/!P>I_&@#R
MZ+X*^'?V2OVT?@MI7PK.I>&_#GCZPURSU_05OI+FUN?L-K]IMI?WOF2"0/+U
M!Z# _P!9+YE;]MCXV>$]/^/WA#X7_$KQQJOP_P#A>V@3:_KG]DFY)\2&:62V
MCTR7[/&98XO+CN#)SB0.1B.01R#UKXZ>%=;UC]L?]F?6[/2=0NM(T8^)O[2O
M[6VDEM[+SK"..'S9 ,1>8>!D]1^-4OCGX7\7_#7X^^%_CCX(\)W?CQ(-"G\-
M>*=!M[F/[?'I7G&ZCN;&,X\V82^:/*\PF3$4<<8.98P#XA^)7Q5_9D^!<=A\
M1?V7_&T_A_XDZ)(OFZ(;;5[FP\0V<DL0FM;K[4   /W@Q(/]6?\ EIY4D7V[
M^V]IOPTU#PSHT'QC^)=QX,^'J2?:KOPU:S".;Q),DMMY22",&XEBBR?,CB'_
M "UBE\R/RLU/X6_:R\1_$SQ-HNB^&_@#\3K.2:^B&IZEXQTV+0K6QL3((Y;B
M.6663SI8MX/V<8,@\STKDOVF=+U_P/\ M2>"_BGJ?PXU;XN_#VUT&718M+T2
MT_M&^T+5OM9N8]0BLY!@&0111>;&0?W?)'[M) #P_P" OC3X(>&?VT/A?I'[
M-/B34(_#/B>QU2T\6Z!B^^R2?9;:6YL91]MB\SS/,\SF,G C[>9)YGMG[2VC
MW/[1?[4W@GX"7]U/9?#JWT*3QIXJMH+TVYUN,7/V:VM"(X\XCFCC/,@!$F>)
M(HR>9M?%WQ0^-W[:WP)\6W?P@\4>#OAGH<>NII^I:U9&.^\R:RDBE:^B223[
M*/,CBCC$N/,Y<$B0"/TO]H;P3XY\"_M%>"?CKX$T*^\6VUCI5SX<\7>&[*2(
MW4VEY-S'+:QO'F22.4LYC20/(8H8T'SRD '@7[='[&W@?X"?LL^-M?\ A8VI
M>"+1ELH_$.C1WLUY::Y";ZV\D2_:99/*EBE_>1RQ\X\V,Y\VO;_VX-0U_P <
M^)_A!\"M%U&X\/V/Q(U.^77=5MKD12_V391"2ZM8_P!U)S+'(<=OW?ER9CED
MQY+^V5\4/BO^TU^SOXKT/P;\"?%FA^&"UK]LNO%-H;?6+N6*ZBD^RV.FQ&62
M3K#)]H/[L1Q7(ZBO;_VR/ 7C.XNOAQ\7?AYIEUJ_B_X::E-J!\/Q319U+3+B
M(1W]M'^ZE/FF.( 8YPTGEB27RQ0!YU\?/V$?AI\)?@3\1?%'PHM-0^''B6S\
M.:B]U=6NHW%]%J-C]GD^TV%S%<R21F*6/N,&.012C_5X.9^TG_RAQTG_ +$K
MPG_Z-T^KOQ\_:2\>_%_X#_$JP\'?!#Q;X:L/^$;U)=<\0?$BV_LB*RM?LTID
M^S6X>22YD>))HQY9 BD,)E^0UU>O?"'4OCM_P3/\,>"=%*R:W?> ]$FL8QR+
MF2VAM;F.+]X\8 E:)8_,R/+\PGG!! /LBOE7_@EW_P F+_#/ZZI_Z=+NN8T?
M]K'XS>)-*TKPC;_L[^*=.^*]U/)I]]JFL6TEKX3LI(S(/MHO@93+$"D<GE#_
M %@RD<LA\LR:'[(OPS\::?\ \$ZM/\$QVVI>"_'MQH^N6UF=3CFT^YL;F6ZN
MS;2N,>9&<R1R<"@#YL\7:-^Q!)J'B"/XK?%J\^)/Q&U,^?J7C*.2^FQ-);1C
M_1?L47V411XS'$?-\O'E'(C\L>W_  I\=>(OB5_P2C\1>(/%6HW&KZQ<^"/$
M<<M]=DM-*(Q>Q1F0_P ?[N./Y^_7UK"^"?QB\<_"'X*:7\+/!_[,'BS3/BC9
M67V*2672(;;PY>ZG#&(I+Z74?,C27S(X1*3_ ,M#B,2\B6MWX ^ /%&C_P#!
M+'4_">H>&M6L_%+>%?$UJ-#N[&6.],LTU\8H_*(\S,GF1\4 3_LL_L;^!_$7
MPO\ A'\2?',>I>.O'EKH^CZII&JW5[+;1Z5#'#%+86MK;Q2"/RX>,^8#YLGF
MR2?ZS X?]HW]CGX17G[:_P %=/F\*M):_$*\\3ZAXFB_M*Y_T^:.T%S&_P#K
M?W0\V20_NMG6OL/]FG2KW1?V=?A=I>HV<^G7^G^%M+M+NUNH_+E@FCM8EDCD
MC['((Q7CW[7FA^+?#?Q8^"?Q@\.^$M3\<Z5X%O=4AU;1=##2ZH8;^*.V\ZWC
M (E\K!)CX)R/^6?F21@&!^UEK&E?L<?LMZ!X,\!WUQ\.O#VKZ[;>'H?$-I--
M=2Z!;W$LMS=W4>_S)93Y:38 DWCS,QD&,"OFCQ0W[!VJZ7+=Z/\ $K7M&^(F
M!=V_C\1:Y<:G'J0/F?;Y?W8224R_O),>7W\ORSR/L3XX:'KW[3_[/GA?QAX-
M\+:MX>\;^'?$%MXJT'PYXVM_[-FDO;*XDC\JZB)X$L8D\O\ >1\R1$R1C-5O
M^&T/%&[^R/\ AF_XO?\ "9?\>OV7^R(O['^WYV>7_:?F^7]F\SC[5Y>/+_>8
MQ0!X=\8OBYK_ ,<_^"/^J>-/$DD$NOZE%;1W,EJFSS/*UV*W$FSCEQ%GTYKZ
M6^%O[&_@?P3XZT_XCZR]_P",/B];F62^\9ZE>S)+<S21212-]F27[/'$(I/+
MBB$?[J/RQR1FN:_;ET7Q;\2OV%?%%G:^$]1'C74;+2)Y_#.EYU*YMIA>VLLL
M,?E B;ROWG[Q!@B//05]7T ?EG\0/C9\$?BS\=?B@G[1OC;5(="\/^(9M#T#
MX=?\3)M/@%EF)M3+V48\R660W&-_,2&1/WH\LQ['[,WQ3^%G@7]K;PEX,_9T
M\97&L?#?QRE\VM^$;^UO?*TB]MK$RQ7-K+=8D!F\K#_ZS_5\Y_="+V2"Z\8?
ML??$[XD@?#+Q1\0_A=XQ\02>*;+5/!2IJ.JVNIW*+]JMKBU!C/E9A)20 [,Q
M@R222?N_6O@[\=O%'QB\67#'X1>,?!7@ZVMI#_;7C1(]/NI+W?&/LT=ADR&+
MRY/,%R3C,<D>,C- '@'A?X,Z7^VY\=OB]XJ^*UM<:WX-\&Z[=>"_"WA==7EC
MCMI+81?;;HB'RSF4B(_ZP_ZR2.3/E1$4=3^ &G_ /]N#]FG1_"^J7T/@6X/B
M6?3?"]W*T\>CS'3?])-M*Y\TQS'RI/*)/ER"63/[W ZK2;CQ[^QM\8/BE>MX
M"\6_$?X5^-=7'B+3I/!UK#J.H:;JESEKN*:U_=R^7)Y9Q+DQQB.$9,DLF,R;
M6/BS\8?VP?V?_&NN?"K4O!?@/3#X@6Q^U*]S?PQRV'%SJ'ECR[+S<P1QV[DR
M"2.<$_<P ?=E>4?M7_\ )K/QE_[$S6?_ $AEKU>O+/VEM*O=:_9U^*.EZ=9S
MZC?ZAX6U2TM+6UC\R6>:2UE6.../N<D#% 'RE^TG_P H<=)_[$KPG_Z-T^NW
MF_X)I_##QI9ZYJ'Q$NM?\?\ CK7-T]]XNOM2EMKA)C$L8:UMHB(HHHR"8X9(
MY/+XC)DC  P_C]X \4:Q_P $L=,\)Z?X:U:\\4KX5\,VIT.TL99+T2PS6)EC
M\H#S,Q^7)Q7W+0!\V?\ !/OQQXA^)7[(OP_\0^*=1N-7UJY2[CFOKLEII1%?
M2Q1ES_&?+CC_ 'G7CZU])U\R?\$Z_#.K^"_V._A]HGB'2]0T/5[5K\7%CJ=M
M):W$)-_<R#S(Y!D9!!Z=#7TW0!Y1^U?_ ,FL_&7_ +$S6?\ TAEH_90_Y-9^
M#7_8F:-_Z0Q5)^TMI5[K7[.OQ1TO3K.?4;_4/"VJ6EI:VL?F2SS26LJQQQQ]
MSD@8H_9ITJ]T7]G7X7:7J-G/IU_I_A;2[2[M;J/RY8)H[6)9(Y(^QR",4 ?.
MWC#PC/\ M:?M>?$#X?\ BR[U%_A#\/M)L8;[PM9:O+;1:WJ=[$+J*:Y6(1EX
MXA'@1^;\DD,3CB645R_QZ_9K\#?L.^%8/CK\);/4/".I^$;RW&J:/:ZA/<6N
MOZ;<74,,ME,;F27R^H(D P",^69/+>/K_B39?$;]FO\ :>\0?%WPGX-U;XE>
M O&^FV-OXGT72)HGU"RO;66.VBNX+?RO,E MB<11DY=Y3(8P(ZYSXL^)OB/^
MW,ME\,]'^%GC7X=?#>ZU'3[CQ7XC\96\6E7+6<<LDLEM;6TL<ID),<)$L><2
M!5D B)) .\_X*"WL>EZ7\!]0=)Y$M?BUH<[1VUO)<RGRQ=$^7%'^\E/'$<8)
M)Z"M/X,Z7<_M6:KX>^,?BR:VD\&6DWVWP+X1AGCNHK8QYC.IWYCS&]\3GRXN
M1:CC_6^81<_;8\,:SXL;X%+H^DZIJK:=\5=#U"\_L^UDE^S6L9F$LTNP?NXQ
MD9D/ R/6J/C3P7XH_9[^-D/Q%\$6-]??#'Q3.$\;^%-%TZ2YNHKYR1%K%K;1
M\DD^5%<^5'YACC,ACFD_>1@&#^S3:P_ 7]J+XP?!&QT/^S?#^IF/XB^&WMXX
M1"8+CRK6[A_=D>5''<!8XH_+R$CDSQY9.M\/]OQE_;F\?>*SNG\/_#/2XO">
ME,P-W:R:G<_O[^XMY/\ 5VUS%'LM98X\R8(\PK_JZK_MU6]SX!@^'7QWM;Z>
MT_X5AK\4VHPQ+'(USI%]+%:WT<,;IS,1Y8&9(\!I><^7CK?V*/AMKOP]^!.G
M:AXPMS!XY\6W=UXJ\22>7)%*U]>R>:/,B(C$4HB\F*2*., 21^V2 >/>$?AC
M9_MO?&#XS:K\59-3U?X>^$_$TOA+P[X+AUFYBM([FRW"XOI8XA%^]D\P^7(7
M.!-+&<B.(T[Q7\$?#7[#_P 6OA7XM^$T=_H'ASQEXCLO!'B'PA)>RS6E_P#:
M1-]EOC)*9)(Y(9!T'7( ,>9/-?'<?$G]C'XT?$>;3_AOXF^)GPB\=Z__ ,)'
M%=>%?+OM2TF^N8I?M0-L(HY)!)+%$,^8(XHUC^<R2$$DN/B3^V=\:/AQ-J'P
MW\3?#/X1>!-?_P"$CENO%7EV.I:M?6T47V4"V,4DD8CEEE&?,,<L;2?.)(P
M ?=5%>0_\+N'_#47_"G/[#;9_P (=_PEW]M_:O\ I]^R_9O)\OU_>>9YGMCO
M7KU !7RI^P5][]HS_LLOB/\ ]MJ]*^.'QHU3X-S:)>Q?#GQ=X_TB],\%Q)X+
ML_MUS9S 1M#YEKD$QR 3?O0?W?EH/^6HQP'[#_@OQ;X5\!>,]?\ &7AYO"NH
M^/?&FH^,AH,LIFN-,BN?+,<4W[L8D_==,=",^7)F, 'SW\<M/_9$M_C!XJO?
MCS\3KCQ_XUNI)(H;4R7LMIX?MH[FY\JQBCTWB/RL^7)'+(9"\1DVQ^:<^O\
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M\$_&?AWX>Z+\1-*O=3U/Q)IAMK^.XCE./]&CDDDCM8X99,W)_=F0XS'Y?[P
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M2T'PC/\ 9_#FIM'D"[=Y9?M-Q=1R>9B+RXQ''92G]Y'+)GUO_A%=<_X>,?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!\E_M>:YXM\2?%CX)_!_P .^+=3\#:5XZO=
M4FU;6M#+1:H(;"*.Y\FWD! B\W)!DY(P/^6?F1R>T?!SX0GX0>&[S1%\8>+O
M' FOWO/[0\:ZE]ONX\Q11^4DIC'[O]WG'_360U\:_M&_L<_"*\_;7^"NGS>%
M6DM?B%>>)]0\31?VE<_Z?-':"YC?_6_NAYLDA_=;.M?3GBGX5^%?A!^SK=^"
MO"WBG_A3W@VR(A_MX7^U],AFNM]UY5U=2_NY)?-DCCD)/E22@C. * />J*_&
M;XL^(OV3?A5\,;#Q%\ ?&.IZ?\:_#<UI+H^JPC41-?'S1%<?:OM$(MB)(9)9
M)(]L><>7_JR8C]R_MF:YXLU[Q[\&/A#X3U[4O"#^/-7NYM1UO2]0-K<Q:=8Q
M1W-S%%((I"DD@DX<=XA&?W<LE 'UI7F7C#1_B#>?%7X>W_A_7=.L/ EB;_\
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M^$"UG3]"6U\26-UX@-]&K"]T<&3[7:QYBDQ))^[Q_J^G^L%?$/\ PPG\#_\
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MWG_3AO\ WTN9))8DSBWB CD_0Z@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3[-;AY)+F1XDFC'ED".0PF3]V:\_\<7'B7X$_M@^+?B)XE^$7B3XL:'KVF6
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MLGPS_9M_=6TD5O>^3821S>5(1B7RSP<'J?QKS'X/^(?&W[#&A:U\,O$'PO\
M'OQ"\$VFKW,O@S6?!-E%J\QTV1C,8;J.(1/%)')(3YDG^L>67R_W<0)^ZJ*
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M\#ZGX@\6_#76/A?J-MJ4EDFC:UYGFR1"**07'[R&(X/F%.G_ "S/TKVFBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@7X$^,/VA/VLO"MW\6O"OQ>\,^#]/DU*X_L[X?C1HM3M8C;'$=K?7N!<1&7
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M%EM#XC\'3>';;3HIXY)1"_V>]BB\T^7+*FPE(QQYA!_U4GN_[=7Q-\2?!O\
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M_:>^&?[-[:-_PL3Q*?#IU@3?86-A<W/G>5Y?F@>3')C'FQ]?6CX'?M/?#/\
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M%YI_Q!\66/C?5[>\D^Q>(+/3182W5L8XC_I%O'F..42^=&!'QY:1_P#+0R4
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M)XA\4B[_ +(L_LDLGVK[+%YMQ^\ \M,1\_O".O&:[FOSG_:.^&'Q=?\ ;/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.., #GGCWH ^<O\ G*9_W1O_ -S5'[?WCS6/ ?P7T*:UU?6?"^@W_BG2]/\
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M]KC_ +E'_P!-<M>[?\*D\%_\)W_PFO\ PAV@_P#"8Y_Y&+^S8O[0_P!5Y/\
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M*4_UDIQS(>?RI-2\)Z'J_B#2M<O])T^ZUO1S+_9U_=6L;W-GYH\N3RI.J>8
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M?%OV 2?9?[<TZ*^%OYF/,\L2@XSY<?3T%;'AGPQH?@W1+;1M!TG3]"T>W/\
MH]AI=K';6R\[R8XXP .>>/>@#Y?^,'B+]EGX^ZMJL7BSQKX=T7QGX5U*32X=
M:EU7^PM=TF^MBX_T:63RY)!#+(TD?^LB,F3@XK,_9YU[Q3^TY^Q_\4] &M76
MLVES)KOA+PAXJ\01R1R:QIOEF*TN[J3RLR-^\,<DHBS^Z.1YOF5]$^(OV?\
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M]9&Z'@@CU]:J_P#"*Z+_ ,(Q_P (W_9%A_PC/V/[!_9'V5/LGV;R_*\CRO\
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M5HKG?#?BS1/%'V]-&U?3]8;3+R33[W^S[I)C;7,9 DBE"?ZN49YC//YUR_\
MPN_1_P#A?'_"I_LFH?\ "0?\(Y_PE'VO9']D^R?:?LVS/F>9YOF]O+QCOVH
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MXTZ1^T%\+='\>^'K._L]&U;S?LL.II''<?NI9(CYGER2 <Q'O_@ #TNBBB@
MHKS3X"_&G2/V@OA;H_CWP]9W]GHVK>;]EAU-(X[C]U+)$?,\N20#F(]_\ WQ
MA\;-'\&_%;X??#^]L[^;6O&WV\:9-;(AMX_L4(FF\P^9D<$= ?2@#TVBBB@
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M23R_,EDCB&1UD'(KW_Q-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV 222$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\7_L6_$VQTN'[7<Q65MJ$J%P@$-M=17,S_A'%(?PKTSX<_&[P5\4OA?:^/\
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MPY^*<T5QJ_PV\<Z!X=B\5RO;2W-_H-^-/CCM[T3 &26PP/+-M(?W,CQ_9O\
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M/\2>%]-LC#%JVF7'FV]Y-YKFXEC;S)!^\N?-)C\P^7G9VQ7B/_!-3QKINF_
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M3-&_](8J\K_8*^]^T9_V67Q'_P"VU '0?LR?'3Q9\0M?^(?@/XBZ'8Z)\0_
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MCKX-? S6CK/@KP%8:1K&1Y=]=2S7MU:_?CS#)<R2&'(DD!\LCS,\Y %>B?\
M"K?#?_"UO^%B_P!FG_A+_P"Q_P"P?[0^TR?\>/F^=Y7EY\O_ %O/3/O7:44
M<5\0OA?X<^)W_".IXCT]M0_L#5K;7M.'GR1?9[ZW)\J7Y#V\P\=.>E<Q\:/V
M<_AW^T-8Z58^/O#$'B&WL9VFLI#--;2Q,P <"2*1) "!S'G!*1G'R<>N44 >
M$^ OV/?@U\+-;\)ZWX6^'VG:'K/AP7(TZ^M9I?M7^D@QRF:0R9N<+(<>=YGE
MY(CQ7>^*OA=X>\4^.?"'C'4]-^U^(?"PNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\
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M#X7\-Z9+/)#:P'R;*SMXB<1Q1@\1QQ8\N,=L =*ZZB@#Y,_X)W:-K3? J_\
M'&OHUKJ_Q%\3:EXSN;%;"2WCM_M4BH!%O8EXI!"LT;G_ )9S <_ZP^T:/\!_
M N@_&36_B?I^B_9_'FM67V&^U87DQ,\0$0\LQ&3R_P#EWBY$>?W?7K7I=% !
M7@_Q<_8Z^#7QSUH:SXU\!6&KZQD^9?6LLUE=77W(\S26TD9FP(XP/,)\O'&
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MH7@?6_!VG_#K3K?1M:VB_87%Q]JEC$D4@B^U>9]I$7FVT4GEB383'FOHFB@
MKAOB5\*?"?Q<\-S^'_&OAW3_ !/HLN3]FOX_,\N38R"6(GF*4"64>9'AQG@U
MW-% '@_PC_8Z^#7P,UHZSX*\!6&D:QD>7?74LU[=6OWX\PR7,DAAR)) ?+(\
MS/.0!7L&L:'8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^M;%% 'D?
MP._9A^&?[-[:S_PKOPT?#IU<0_;E%_<W/G>5YGE$^=))C'FR=/6N&TO]@/\
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M^\\SS/,SCC'E^] '5^*/%>G>"/"NL>(M8N#:Z/I-G+?7EQY9?9#%&9)),)[
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\7?%'QKI?P
M=_X**>#_ !1XTO;?0_"WB?X>W'AVSUK4+J"&UCOK:_-W()&DD'EKY8B />26
M,<\X[[]NOXP>&/A5^S3\0K77-4MX-2UW0;W2]-TUKB+[5>/-&+8F**20&7RO
MM,<DA&2(^<&O6OB5\*?"?Q<\-S^'_&OAW3_$^BRY/V:_C\SRY-C()8B>8I0)
M91YD>'&>#7F?PV_8:^!?PE\30>(O#?P\T^'6X#NM[K4+FXOO(D#B02QBYDD$
M<@*#]ZN'&.H'% 'BWQO\-ZEX-^ ?[%WAS6H#9:OH_CWP7I][;;PYCEBM)(Y$
MRGN#]:^[JXKXA?"_PY\3O^$=3Q'I[:A_8&K6VO:<//DB^SWUN3Y4OR'MYAXZ
M<]*[6@#A_B)\4O"/PMM=*N_&'B"Q\.6.HWAL+>ZU23RK7S?*DE\N27_5Q_NX
MI#ER!QZUX=_P40TOX:2?LU^+-1^(EII;75KIEU:^'+N_C_TJ/4I8LV\5M*!Y
MF9)8HRXC(!2,^;^[$AKZ*\3>&-#\9:)<Z-KVDZ?KNCW!_P!(L-4M8[FV;G>#
M)'("#SSS[5XS\-OV&O@7\)?$T'B+PW\/-/AUN [K>ZU"YN+[R) XD$L8N9)!
M'("@_>KAQCJ!Q0!X7^TU=>(?"/[(7[./C?Q59ZIJ,_@;Q%X4\1>*OM/_ !_(
M(8"D[2>;(#)*994C(SDN^>.<?8G_  MOP7_P@G_":_\ "8Z#_P (=G_D8O[2
MB_L__6^3_P ?.?+QYO[OKU]^*W=8T.P\1Z7=Z;J-G;WVFWD4EM<6MS&)8IXY
M/]9&Z'@@CU]:^?O^'=O[.W_"6?V]_P *PT_[?]M^W^7]LNOLOF>;OV_9O-\G
MR_\ IEY?EXXQB@#RC]D6'P7\3?@)\1]0^(5CIUKX$^,'Q(U>YT2P\0W<4+ZC
M%<R1I#'\LI_TKS;:0(J'S=\6]#T>M/7&U7]B'QW\+=+T'QS?^(/ GC3Q-:^%
M[?X>^)9Q<W.EQS?NQ=6-T3YWV:U'V6+[,1)'^\YD$DHD'T;\0OV?_ 7Q2^'T
M'@3Q1X9L;[PG;20"VTV,&VBM5AXA$)B,9AP#Y?[O'R93H37+_"/]CKX-? S6
MCK/@KP%8:1K&1Y=]=2S7MU:_?CS#)<R2&'(DD!\LCS,\Y % 'SU^T9\.K+6/
MV]/ T?B7X@^*/ACIGB;P1+H&B:YX9UC^SKN_U&+4?-^PF7#X!BN8C^\P))/+
M"_/@5T?Q(_8/\%W&AVVB>.?V@OBS/HNN7D6GQ:?XD\;1&UO[HG?%%Y<L.))?
MW>4CZYBSUKZA^)7PI\)_%SPW/X?\:^'=/\3Z++D_9K^/S/+DV,@EB)YBE EE
M'F1X<9X->9_#;]AKX%_"7Q-!XB\-_#S3X=;@.ZWNM0N;B^\B0.)!+&+F201R
M H/WJX<8Z@<4 <S^T-_R?5^R/_W-W_IKBKZKKAO%7PN\/>*?'/A#QCJ>F_:_
M$/A877]D7GVN6/[+]JB\JX_=@^6^8_\ GH#TXQ7<T ?%_BSQE8_LI_MF:MXL
M\1I<Z9\.?BUI]A:77BF\(DM;'7+(RQ10R29'V:)[;',F?WG<1QR>7[AXF^%?
MP8\86MU\0=?\&^!-=M[JR%_<^*M2TZQN(GM!$")7NI <QB+!\PG'EBO0?$WA
MC0_&6B7.C:]I.GZ[H]P?](L-4M8[FV;G>#)'("#SSS[5X+_P[M_9V_X2S^WO
M^%8:?]O^V_;_ "_MEU]E\SS=^W[-YOD^7_TR\OR\<8Q0!G?\$N_^3%_AG]=4
M_P#3I=T?\$N_^3%_AG]=4_\ 3I=U]%^&?#&A^#=$MM&T'2=/T+1[<_Z/8:7:
MQVULO.\F.., #GGCWK(^%/PO\-_!_P  Z7X/\(::=)\.Z=YWV:S^TR3>5YDL
MDL@\R0F0_O)).I[]J /F3XH^-=+^#O\ P44\'^*/&E[;Z'X6\3_#VX\.V>M:
MA=00VL=];7YNY!(TD@\M?+$0![R2QCGG'??MU_&#PQ\*OV:?B%:ZYJEO!J6N
MZ#>Z7INFM<1?:KQYHQ;$Q122 R^5]ICDD(R1'S@UZU\2OA3X3^+GAN?P_P"-
M?#NG^)]%ER?LU_'YGER;&02Q$\Q2@2RCS(\.,\&O,_AM^PU\"_A+XF@\1>&_
MAYI\.MP'=;W6H7-Q?>1('$@EC%S)((Y 4'[U<.,=0.* /#/VA]-O/A7^RO\
MLLS>*K&XTR'P'XI\(7GB298_/&G16MJ8II9/*W\"3$8(SDD 9KV3]L3XP^!_
M"O[+'C2;4O%ND*?%/A6_30R;I)/[6\VWV1FV"',H)N(?GCX DW]*]U\3>&-#
M\9:)<Z-KVDZ?KNCW!_TBPU2UCN;9N=X,D<@(////M7@_A/\ X)__  %\"WFH
MS:-\/(8)-2TRYT>Y>34KRX/V:XB\N8(99B8R8\Q^9%B3$AY'.0#Q;]I/_E#C
MI/\ V)7A/_T;I]?77@OXS>!OB-X$E\<:'XITS4O"UO#YUUJ45Y'Y5D!$)9!<
MDM^Y,<<H:1)<>6.H%>!_\%#/">F^"?\ @GKXS\.Z-;?9-)TFST>QLK?>9/+B
MBO[2.)/G[  #/M7=>*/V&?@7XR^($OC;6_AYIU[XDN+W^T+B1IKD6T\V1EY;
M82^5)D_ZP%,2')D!R: .5_X)[R?VKX)^*/C"VS)X=\9?$G7-?T2\V$?;;&69
M(HY=A_>1_O(9!B0 C'3FMC_@HUX5U'Q?^Q;\3;'2X?M=S%96VH2H7" 0VUU%
M<S/^$<4A_"OH+1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**"./_ %<:(.  /3TK
M8H \R\-_'3P;XI^$.C_$X:]8:5X.U*SBNQJ&J7T,*6WF'9Y4TGF&**02GRC^
M\XD!3.:^?OVX_&&G7WP.^$'Q?TJ*;5_!?AOQOX?\97EQ:ILE.E@2>5)&DGED
MDFXA C.#^\YP 37:_P##NW]G;_A+/[>_X5AI_P!O^V_;_+^V77V7S/-W[?LW
MF^3Y?_3+R_+QQC%>[_\ "*Z+_P (Q_PC?]D6'_",_8_L']D?94^R?9O+\KR/
M*_U?E;/W?EXQCCI0!F?\+;\%_P#""?\ ":_\)CH/_"'9_P"1B_M*+^S_ /6^
M3_Q\Y\O'F_N^O7WXKXG^">H2>*/V%OVIO'$%A+9Z+XYU+QGXETC[=L\Q[*6T
M\L>8$D.P^9#+'C/_ "S)Z8)]T_X=V_L[?\)9_;W_  K#3_M_VW[?Y?VRZ^R^
M9YN_;]F\WR?+_P"F7E^7CC&*]KU3X?\ A_6OA_>>"YM*MX/#%WILNCR:3: V
MT(LI(C$88_+QY8\OC$>,8XQQ0!RW[*'_ ":S\&O^Q,T;_P!(8J\K_8*^]^T9
M_P!EE\1_^VU?1?A?PIIW@CPKH_AW1[<VNCZ39Q6-G;^87V0Q1B../+_[( _"
MLKX>_"_PY\,?^$B3PYI[:?\ V_JUSKVHCSY)?M%]<$>;+\Y[^6..G'2@#PG]
MGG_D^K]KC_N4?_37+7)?L-_$OPK:_$#X_P#@6[U_3[/Q;>?%77KZUT6ZG$=U
M=1.?]9%S^\_X]9<^7RGEY/49^G_"OPN\/>%O'/B_QCIFF_9/$/BD6O\ :]Y]
MKED^U?98O*M_W9/EIB/_ )Y@=><U\?? ']GWX=?M'6/QMT[X@>%H->@TSXS>
M)9+*1I)K::(L+;>/-ADCDP1C*9P?+CR#Y8H ] ^*6IV?C?\ X* _ _1M$O+;
M5]5\#V'B#5?$-I#*H;2K>ZM(;>V,OJ9))(_W?,@$BR8\L@U@^-'\2_M.?M8^
M._A5%\5=?^&'A?P!9Z;=/I'A:ZCM]4UN6YMY99+F*Y_UD,<7VFVB>/$L9Q'_
M *LR#'T;\(?@+X ^!^AOI7@;PK8^&X95'VA[?,EQ<XWE?-EDS)+C>^/,)QFN
M?^,O[)OPK_: U33-3^('A&+7]0TV#[+!.+NYMIO*))\HR12QF0;NGF9QO?&/
M,- 'R[^SCHN@>$/^"C7BC0-"^(WB;XDOI/P[EM-1U#Q;K U.\L[P:I;^;:K,
M$ Q'^[/EX.))).AR*]B_9Y_Y/J_:X_[E'_TURUZ7\.?V7?A?\'_$4&O>"?!.
MG^&M5CTC^POM.GF2,R6GF"7][S^]E)BC)ED'F'&/,-=/X5^%WA[PMXY\7^,=
M,TW[)XA\4BU_M>\^URR?:OLL7E6_[LGRTQ'_ ,\P.O.: /#?VAO^3ZOV1_\
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M]\^+WP%\ ?'#0TTKQSX5L?$D,2G[.]QF.XML["WE2QXDBSL3/ED9Q7)?"/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%)2T %%%% !1110 4444 %%%% !1244 +1110 4444 %
M%%% !1110 44E+0 4444 %%%% !1110 44E+0 444F: %HHHH **** "BBDH
M 6BDI: "BBB@ HHHH **** "BBDH 6BDI: "BDS2T %%%% !124M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,>?7?@O\9_"GQ_\  .G^,/!NI&^T^X(CDAE(^TV<W_+2WFB_Y9N/KW!&4QD
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M^([Z'S;+P_H=H;J_N8SG,@BSP.)#F3'^JD]*Y[PK^U3H&N^+M*\.:SX:\5^
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M1CZ67^E%:$*<8(5.I[2<R2BBBL3J"BBB@ HHHH **** "BBB@ HHHH ****
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M["[U?1_M/GSZ;)));-YMU+,/+,D<9_Y:XZ=CUKS_ /X9C^.O_((_X:E\0_\
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MD6/V:)HI!]B'E>6=QV1^7$4'!CXR>T_X)=_\F+_#/ZZI_P"G2[KE[/\ 8?\
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MXU*F(J?S_P#R:9Y,,/.$,.OY/_D#A/@VVW]JS]H'_N7O_2&2G?M<<)\'>_\
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M])MM/^ /P\2WM8K6,^'[*4PQ)L'F20QR2/CW<DU=;X7C_A07_"M_[0_YEO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?"7[7:22Q!S;R_VO+$9(R?N'RY94R#TD(YK1_;U^]^SG_P!EE\.?^W- '?\
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M@/3FK>B?'32K_P !ZIXNUG2]:\":3ILVRX'BRQ-C+TC.]$R=X)E\O/\ ST!
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M%);7%K<QB6*>.3_61NAX((]?6OBW_@HE\!/A?X%_8]^(.O>&_AQX2T#6;?[
M(-0TK1+:UN8LW]M&0DD<889!(QGH:^ZJ^5?^"HG_ "8O\3/KI?\ Z=+2@#U;
M2_V9?A%H^J6NHZ9\+?!FF7]G)'<6]Y9Z!:Q2P21G,<D<@B!!&!R.E.^"?QRT
MKXXZ5XGO-/T?5-'E\-Z[=>'=1L-7%N)8KVW$9E ,,LL9&9<9$AZ'ZUZE7Q9I
M5_H/[+?[:7Q:NM6BM]&\+>/O"L?C+^TC;_9XH;C3%E6^MXHXP?M4QCEEO9?+
M_><Y\LY\R@#V_P"%O[2/ACXP>/OB3X0\,'4KF^\ W<5EJ5S=6XAMI)I#-^[C
M_P"6A,;V\L1R@' (\S.:T[SXU:);_&G3?A:MKJE]XHNM)EURX-M$@MK*QBE,
M2RRO)(,B67]V!'YA!'SB,<U\+_ ^WNO@;\0_V:?BEKZ0S:I\7M.U32O%>MV=
M@?L\MUJ-U_:FF?ZN*/R[J:2:*(^8#'Y<1 _=Q>97T?\ LMZ3?>/?C9\=OBMK
M=G>6EQ-K_P#PAFAQ:@A<V]AIA$<LEM<8 $5S<^9))%&-@EB.3(>: .D^"WC+
MX?Z3X7^-6M> ?">O0G1?&&MOX@T^)#=7>KZQ%'%)<R6L?FR9,N(Q''^[Y_Y9
MI7SA\+OVW=:M?VB_CA=7WPP^-6OZ+.VA_P!G>%;70)+BYT#%M)YIEM3+BV^T
M'$HQ_K,9/3->U?L%?>_:,_[++XC_ /;:C]GG_D^K]KC_ +E'_P!-<M 'G?[<
MO[4.N>"?'7P]\-Z/X1^)ED^D^.M(EO=7T73I8K#7[4Q&5]-M94E N99/,$?D
MGO#*.W/TQ\,?C=:_$;P%JGBO4O"WBCX9:=I<DT=U#X\L/[+F2*.*.62YP9<>
M3B3_ %I/6*2O*_V]?O?LY_\ 99?#G_MS5K_@I-K%_HG[%GQ-N=.N;BRD:"RM
MC+;R>63%+?6T4L?':2.61#VP: ,74_\ @HGX/&DW7B#1OAS\4/%W@VVBDNU\
M8:'X4D.E-%&,RR"6:2,XB(DCD) YBD[5[3+\;O"LOP/O_BIHFI-KO@VUTFZU
ML76EJ#)+%%'(\GEK(0/,S&Z;),8<8.,5XKI.A?MD>'=)M=,TVT_9]T_3[2*.
MWM[6UCUE(8(XQB..-!P .U<GX1^!?B7]GK]B?]I'2?%O_",0:CK\/B3Q"EEX
M0\T6%I%-IH ABCECC\L)Y9Q& 0$"<T >F^$?VXO"OQ'UGPM9^#?!WCOQ;9ZP
MUE'<:[HNA_:=+T::Y$4AM[ZX$OEQR11S1&789/+R>XQ79>'/VH/#'BC]H[Q1
M\%;33M5C\5^'=-CU.\NIHXOL+Q2+;$"*02^83_I47_+,#KZ<G['>DV>C_LL_
M"2VL+."RMY?"VG71CMD$8\R:WCEE<CU>221_?->TT -]J\2_: ^(WB3PS%H'
MA/P2MA+XZ\674MII,E\Q\JVCBC,EU=,._E#'[LGOTDQY9]L/RU\WZO!'KG[=
M&B0WDCS0Z)X$FU/3X/-?9!=2WIMI91'G&3%\F?3-;X>*YW.1S8C^&><_V#\'
M?@7X@;PIJ'@K5OC'\0+BV^W:S<VNE#6+IN.99HY93Y7FF3MG_EEYIYCDDF\,
M>$_@E^U;INM1^!-#G\&>(?#L=K<V_B#2[&+3IH+J0"2+"Q2#S?*>$QGS..IB
MD_Y:5J_"WXL>#_!/CKXY7_CW7K3P_P"*?^$ED#KJ6;:2?2XHP+#RH?\ EJ?+
M\S'EYDD_=D_ZR.N5^"'Q[\%_#/PC\:_%6HM9Z7XDNO%FIWL&BZA+%;:K<@^5
M]FMI8^9!B222/D$1DR>AKVTZ[]^'/SZ?UZ'@VA]ODY#Z!_9_^*I^(OP!\/>,
MO$L\-A*MC+_:%W/)''$IMI9(I+EN?+C!,)EQ_P LP<=JP_"W[7/AWQMK6G06
M7ACQE%H=]?"QM_%$VBD:7)(9O)CQ-SQ)+B,<=7'3J)?@/\(/[-_95T?P%K3Z
MA"^J:+-%>J\?V>[MOMOF221?/G#Q^<8^>FS..U<KI?B;QO\ LMZ'I6G^-$L?
M%'PTTE;?3O\ A*K!?L]]IT/[N*(W5KR)/WDD<>8>D<?F'GBO/Y*,YU.3N=_M
M*].%/VA[?\1OBAX=^$^@S:[XKU:/1].WI&DTBF3?(>D<<<8\R0^V#^6:\HOO
MVR-)T.'[;KGPV^)'AK21)%'/JFK^'_)M;;S)1&'E/F9 SCG!ZU1_:(GL;W]H
MCX!:?K$[0:.^I:E<?9Y[CRH)+Z**+[(V"1F42']WC^^1_P M*]\\4?V2="OA
MK8M?[(6WD^VF_P#+^S^1M/F>;YG'EXZYXQUXK/V=.G"#G#X_Z_0W]K.I.IR?
M8*.O>/O#_AWP>_BN_P!5LX_#L=M]I.I++YD31GE"A&=^?:O.?AA^TUI7Q(U[
M2=/3PCXR\.Q:K'YFFZCX@TL0VMZ3"91'%*)),GRXY),<<1G\?//@7X%_X7O^
MPOI'A/6=4U!/[2M98$U#=OEB,5](8, \&./RXQY?_/,8KL=(^)7CCX7^)-&\
M.?$RTT^_TG6+V/2=,\::,QC2XN9!B*&YM?\ 612R&*0^9'F(&2,<<XMT84^>
MG]M,S]O4J.G4^P=_\4OC%X?^$MKI[:W/*;G4IOLNG:791>?=:A+C/E0Q Y)Y
M ]/G3D=*XWPQ^U5X>UWQ=I?A[5_#/BSP'J&KETTV3Q=IGV"*]D&,Q0GS#F3]
MX.*\_P#BTOCF\_;$TFT\%MX>N-3TWP4UW;6_BA;F2U@\V^,<LL7E#]W*<1(?
M^F>?I5;XL_"#X^?'#P3<^&/$"?"]+69XIHKRU:^-S;RQDGS8O,C(C.!Y?'.)
M9*TAAZ/+#G,YUZ_M)^S/9/'U[X3M_C1\+K;5]%NKWQ5<#5!X?U".0>3:L+7-
MSYG[P9WQXQ^[DZ=NM>4_%3XI:!\'_P!KR\\2^([QK;3H/AN8HXT.9+B3^TN(
MXQGF3IQ[UV/Q>_Y.P_9]_P!WQ#_Z0QU0NM)AU#]O6SEFACE>V^'QN()9(QE)
M/MYCWQGMA)9!_P!M*JDJ<;.?\G_MS%7]I_R[_G-KPQ^U1H&O>,-*\.:QX:\6
M> K[5RZ:;)XOTS[!'>R#&8H3YAS)^\'%>@?$;XF^'?A-X?GUSQ5JT>D:=O2-
M)I 9-\AZ1QQQCS)#[8KS/]K1<2?!S_LI.C?^U:Y;]JQO$U]\8_@?IWA9],DU
M"2XU:ZM[77O,;3OM,5M&8I94CS^\C!E\OT<]NM8TZ,*LX&U2O4IPF=+'^V1X
M?MM4TZV\1>#?''@6RO9_LT>L>*=%%C8QR$<"24RX&<5Z!\3/B]H7P?L]"O/$
M!FCM]7U:'1DO%\M8K::428DE,D@V1?NCSSCBO%_'O@G]H7XA^$-5\,ZXGPFD
MT_4X)+64K_:),88$"5-_\<>/,^H'UJ+XZ>"3X?\ A/\ L]^%-92TU'[#XM\/
M:9?1*OFVT_EPR12C$HYCXSSS6GL:,YPN9>WQ$*<S9'[;GA?R?[8/A7QS_P (
M?Y_D_P#"5?V*/[+\KSO+\_S?,SY>>/N;_:MS]H[XV-X-^%5_<Z)IGB#5EUO1
MKUK+Q!X6MS<VUB?)S%=2RQO^[C_>>8)0>D9/I7M6J:7::IIUQ97MK#=6D\7E
MRV\L8>.1",%".E?*GP5 _P"'<=]QS_PC6N_^C+NLZ2H3_>*&TOZ_()^W@N3V
MAWW[,/QHO/B!X3\/:-?>%_&5O=6F@VLLOB+7].\JUOW$<:>9'<;SYIDSYGJ1
MS5GQ/^U5H.@^+M5\.:1X9\5^/+[2"B:E)X1TS[?'92'.(ICY@Q)^[/&,UVO[
M/;+_ ,*%^''_ &+>FY_\!HZ\3\,_$GXL_$^VN=5^%_AOP3H_@+[5<?8KW7YK
MDG5U^TS>9<Q);\Q>81NV2QYS)G,G2GRTZE2<^0'.I3IP_>'N_P +/BGX>^,7
M@^S\1>';T7-A-\CQN0)8).,Q2#/#C/2O-K[]KCPK#J6L:?IVD>)O$.NZ3K%U
MI-QHFBZ?]IO#]GVB6Z$4<G%MYDD<?F28Y/3O65^Q5_:']@_%'^V/LO\ ;'_"
M?:I]O_L_S?LWVC$7F>5YO.S_ .O4_P"R7I<$>J?&K4%BC6[D^(>IPR7&P>8T
M<?EF-">^/,D_[^&BI1HTYU+_ &=C6GB*E2%,[KQE\>/#W@;PGH&KZY#J.GWF
MO1QMI^@M9&35+B4Q&7[*+8'/G?\ +/;G_6$"N<\,_M4^']<\7:7X>U?PSXL\
M!W^KETTV3Q=IGV&.]D&,Q0GS#F3]X.*X'XL)XYO/VQ=)M/!;>'KC4]-\%-=V
MUOXH6YDM8/-OC'++%Y0_=RG$2'_IGGZ55^+?P@^/GQO\$W/ACQ GPO2UF>*:
M*\M&OC<V\J$GS8O,C(C.!Y?'.)9/I5PHT7R<YE4KXB\_9GO'Q<^-GA_X,Z78
MS:LMYJ.H:E<):Z=H^EQ>?>WLI_ABBR,TWX6?&&Q^*/\ :21:%XA\-:CIOE23
M:;XET\V-SY4ID$4FTDYC)BE'_;,_CB?&/X2ZEXVUOPAXF\*Z['H_BWPA+=2V
M/]H6HN+6X$T0CDAE!Q(H<)_K(SD /US3_A?\6M5U;Q9?>!O&NA1>'O&ME9#4
M!#8W!NK34;7S!%]JAD_Y9CS,_NI,2 ,AYKFE"'L?W?Q'2JE15OW@OQ"_:*\-
M>!?$4WABVL==\7>*8XDN+C1?"^G&^NX(\ B64 A(Q]SJ0?WD?&#FM7X4_&C1
M?BHVJ6EC::GHVM:3Y;:AHNM6+VMW9B4R>495(X\P1EQ@GC%>9?LI"SU/QI\;
M=1FE^U>(6\;7-O<_:+GS9ULHABU&S/$6/-\O\1SY=>F_&V,Z)\*?B'KU@QL=
M77PY>_\ $PM\17"^5#+)#B3MY9=R/<FJG3A"?L3.%2I.G[<XK5/VN/#C:A<K
MX7\,^,?']C:3?9Y]5\(Z(;RT20#_ %?FY'F'I_J]W^L%=U\(?C;H'QFTV^FT
M=+S3]0TVX>TU'1]4B\B]L90?NRQ9.*Q_V5;#2M-_9[\ QZ/Y7V9M+BED\F3S
M +B3]Y<<^OFM)^-<7H^HPP_MT:S8:==(BR>!HI=5L[5U^>XBO?W4DNW_ ):B
M*6,#S.?+D':KG3HWG3A#X!4ZL_W<Y_;/I:OE7]O7[W[.?_99?#G_ +<U]5U\
MJ?MZ_>_9S_[++X<_]N:\X]4^JZX7XN?#C1_C%\._$7@O7;7[3I&N6;V<^$3>
MF?NR)YBL!)&<21G'#Q@]J[JB@#XC_99_:&/PH_9Y\?\ A;XJ-]D\0_! '2]2
MV+L^V64:G^S);82Q0Q_O8X_*B'63RXY"?WM>D_LI^$+SX=?"K6_B3\27@TGQ
MMXTFE\5^*+S4/W']FQ>7F&U9YL2116ML !'*3Y691GK7BW[57P+\,>*?VZ?@
M)=W*7:1>.(KZT\2:=:I#]FU>/24AOK:.ZC\O]Z'D2*.02Y!C@B \ORZ];_X*
M3:Q?Z)^Q9\3;G3KFXLI&@LK8RV\GEDQ2WUM%+'QVDCED0]L&@#-A_P""@>@:
MQ&U[X/\ A7\6?B%X9E8_9O$OAGPE+/87H_Y:>3)*\4G[N3S(S^[ZQG%>R_!?
MXS^%/C_X!T_QAX-U(WVGW!$<D,I'VFSF_P"6EO-%_P LW'U[@C*8ST'P[T[P
M_I'P_P##-AX4GM9/#%KIEK;Z3+:W'VF$V<<2K%Y<N3Y@,>,/GG(/-?.G[+NI
M6<W[7G[5-CH5]!)H%OJFAW!LM/F'V6.^DLI!?2^4G[L2R2Q$2D?O#)%^\Y%
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MWRC(?W?./,]Z^D8^57Z5G6C!PA.)5"<_:3A,EHHHKF.T**** "BBB@ HHHH
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M>N6N=+U>UC$@BW\2QR1'B6.4#';I@\>8DG/?\,CLO3XR?%K_ ,*G_P"U4?\
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M(N)HW!_?21?.\7'^JR.W.4K0_P"&1!_T6+XM?^%1_P#:J7_AD51_S63XM?\
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M:>S_ /)RSXX_9[UV^^(U]XV\!?$&^^'VMZM;1VVKPBPCU"UO1%D0R^5+Q'(
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M?,'E>7@GI)GIQUKT'Q1X4T[QOX5UCP[K%N;K1]6LY;&\M_,*;X98S')'E/\
M9)'XUT%% 'QA'^Q?\6_!?AW4/"7@#]IOQ/H7@B2,6UG8:QHEMJ=_91>3'$8X
MKXRQ21@;/W8B$0BXQS^\/OGP'^!.@_ 'PA=Z)HVH:IJTFH:E/J^H:IKUW]JO
MKZ\E $LLLF.6/E1\C^YSDY->IT4 ?(_BC]CGQ!9_%WQ!\1_A'\5]1^$NL^+
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M*^?5_9%7M\9?BQ_X5'_VJG_\,C,/^:R_%K'_ &-/_P!JK*I[&?P3-:3KP^.
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "44M% "4M%% !1
M110 4E+10 E%+10 4444 %%%% "4M%% "44M% !1110 E%+10 4444 %%%%
M!1110 E%+10 E+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M"4M%% "44M% !24M% "44M% !1110 E+110 4444 %%%% !24M% "44M% "4
M4M% !24M% !1110 4444 %%%% "4M%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 E%+10 E+110 4444 )12T4 %%%% !1110
M4E+10 E%+10 E%+10 E%+10 F!Z44M% !1110 4E+10 4444 )12T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 RBN7\4>&]2\0+;BS\4ZQX8\OJ=*CM)/-_W_M-M+^F*R/\
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M6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\
MY H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P
M&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[-&?]FN!_X5KXB_Z*
MIXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:
M^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:
MX'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[
M-&?]FN!_X5KXB_Z*IXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]
MP[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC
M_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\
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M6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\
MY H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P
M&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[-&?]FN!_X5KXB_Z*
MIXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]P[[/^S1G_9K@?^%:
M^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC_,'/_<.^S_LT9_V:
MX'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\ Y HY8_S!S_W#OL_[
M-&?]FN!_X5KXB_Z*IXL_\!M'_P#D"C_A6OB+_HJGBS_P&T?_ .0*.6/\P<_]
MP[[/^S1G_9K@?^%:^(O^BJ>+/_ ;1_\ Y H_X5KXB_Z*IXL_\!M'_P#D"CEC
M_,'/_<.^S_LT9_V:X'_A6OB+_HJGBS_P&T?_ .0*/^%:^(O^BJ>+/_ ;1_\
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M4<G]\7._Y#MZ***1L%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_5a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_5a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0'X:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X])^^[OR<@:60])U<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"<_/@T*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(^/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R
M9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX\<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB=75I9#IF868U8F1D-2UB83-D+3$Q9&$M860S,2UD,S-D
M-S4Q.#)F,6(B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(^/&1C.G)I9VAT<SX\<F1F.D%L="!X;6QN<SIR9&8](FAT=' Z
M+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/CQR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^/"]R9&8Z;&D^/"]R9&8Z06QT/@T*
M"0D)/"]D8SIR:6=H=',^/"]R9&8Z1&5S8W)I<'1I;VX^/"]R9&8Z4D1&/CPO
M>#IX;7!M971A/@T*/#]X<&%C:V5T(&5N9#TG=R<_/O_A ")%>&EF  !-30 J
M    "  !@I@  @    $          /_; $,  P(" P(" P,# P0# P0%" 4%
M! 0%"@<'!@@,"@P,"PH+"PT.$A -#A$."PL0%A 1$Q05%14,#Q<8%A08$A05
M%/_; $,! P0$!00%"04%"10-"PT4%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!04%/_  !$("2,&=0,!(@ "$0$#$0'_
MQ  ?   !!0$! 0$! 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#
M!04$!    7T! @, !!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*"
M"0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS
M='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$
MQ<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$!
M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
M:O[,LH;+S=NSS/*C$><=NE9WPM^+/A?XR>&H_$/A+4AJVD-((Q=>1)%R8DDZ
M2 'I)'V_E7;;M_0XK'$8S$XK^,[G5@\JP6 ]_#4['F?QR^#L?QI\)MHTFJ2Z
M3NQF:&,2'B6*7O\ ]<A^=?/O_#N:V'_,\7 '_8/'_P =K[/_ !I6QWYIX?,,
M3A:?LJ50QQF38+'U/:XBG=GF?P/^#L/P;\"#PVNHMK$8GEF\Z6 1$^8<XP#7
MG_Q9_8S\*_$C6'U:VO+CP[J$DGF2FTAC,4GUCQ7T0R\<G%*?E S\PK&GB\13
MJ>T3U-JF6X.KA_JU2G[A^?NN?L"^*K&81Z?JW]JQ?\]3;11?^U:O>&_^"?.N
MZDY.K^(I-+C]!912_P I:^]FX'% Z<UZO]MXRVYXG^JN5\]_9GD7P;_9W\,_
M!FT9=(@-[?Y<C4+N*(SX)^YY@0'%>O?PTO%+QBO%J5:E:?/49]-AL-2PM/V=
M)60M%%%9G6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% #*?110 4444 %%%% #**** 'TRGT4 %%,I] !
M113* 'TRGT4 )@>E%+10 444E #::S!1R<4B]!7S?^T]XVUGPWJ&CQ:5J%Q8
M>9Y@E,5S)%D?N_3\:\C-,QIY7AWB*FR/3R[+ZF9XE8:ENSZ,7$F'4U)MV[J\
MD_9OU_4/$7P_^U:C<R75U]HD3S9)/,Z&O6U;()-;8/%+&X:GB:>TSEQ>&>#Q
M$\,]T*Q"Y)/%1QLC9VMFN!^.>L7.A_"W6[VSN'M+J)(S%+')Y9'[R/O7C7[,
M_CC7/$?Q O+75-4NKZV33I)5CEN))<'S(QFO)QF<T\+F-++6M:AZ>'R>KB<%
M5QZVIGU-PH]![T"3/1@?QKS7X^:Q>Z/\,=5O]/N'M+J+R_+DCD\L@^:@ZU\G
M6GQ2\9WDWEVVL:I+-_SRAN)/_CM<.<<34LGQ"P]2%[G;E/#M;.,.\12FE8^_
M-K>WY4WYJ^%_^$^^(_\ S^:]_P!_+JD_X3CXC_\ /[KW_?RZKR/]=Z'_ $#5
M#V_]2\3_ ,_H?>?<YQ@9^8=L&G;@/O$#VKA_A'?7MYX!TNYU+SGOIFE\W[3_
M *S_ %C]:^>?CM\1/$6@_$[4[*PU2[MK2..,^5%<R1_\LZ^CS'/J668*GC:D
M/C/F<OR:KF&-J8&E/6%_P/KSS/1EHR3C.W\Z^&8_&7Q'FAC=&U^6*7]Y')%)
M<U/8?&SQSX3N/]+EN)/^F>J"Y_\ CM?-_P"NV%BKU*-1?(]__4[%/2G439]O
MK\V#TYI3A=V&&[W->,_!WX\1^/GET_4X;>QU6% 0L<N1/ZD?@8_SKQ_XE>+O
M&UIXVU!--DUC[)&8_+\E[GRO]7&3^N:]S$<2X>C@J>,I+G4SR</P]B:N)GA:
MO[MKN?9/F>Z_G3?,'JOYU\'77Q"\=V<6^>_UB&+_ )ZRW%S5:U^*?C2\D\JW
MUC5)I?\ IE<25\[_ *^89.SI,]U<$8MJZJH^^@R+W&?K2Y!'K^-?"?\ PG?Q
M$_Y^M<S_ +]S7U3\#+_4M0^&^D7>JR7$E])YGF_:O]9GS9.M?0Y1Q%3SBNZ<
M*=K'@YID=7*Z:J5:B=^QZ$4PHR< 4BS!MQ7G%>5_M ^/'\$^"9#97'E:E<21
MQQ?/^\R>_P#XX:\"^%/QDUZW\=Z1#JFJ3W5A<7/ER?:KB3K)^['ZT9AQ)AL#
MCH8*IU*P?#N*QV"J8ZELC[6HJ.&X2>&.1'\R-^AJ2OL4[JY\OY$0D"J"YVGM
M0K!<[F&#[U\S?M,>.-9\,^++.VTW4+BVCDLXY3''<21$_O)!GCZ?I7E&G^/?
M'^J0[[.[URYA_P">L4ES+7Y]C>+L/@<3/"^S;:/LL'PM6Q>%ABU423[GWDK?
M[H'UIW';FOA9?B5\0="_>W;:I%%_U$)+FO1_AO\ M37-U?6^G>);>TBCE\M(
MKZ'S.OF8_>9Z5I@^,<%6J>RK+V?J5B.$L=2I>UI?O%Y'U RAFY'--W*QP6'Y
MTQI#Y) /S%=U?!/_  M;Q=-=%(M<OY9C+^[B^V2?_':]3.<^I9)[-U(7YSSL
MFR2MG+J*C-+V?<^_,/\ Y%&UO\BOA7_A/OB/_P _FO?]_+FD_P"$X^)'_/[K
MW_?RZKYS_7BA_P! U0^A_P!2\5_S^A]Y]U)GGY<4O"UX]^S?JNN:SX/O;C6W
MO);I;]T'VSS/,\ORX\?ZSFK_ ,9/C!:_#/3 +86]YK,A1H[6:7'[LY_>'_O@
MU]A#-<.L%]>J^Y ^.EE>(>-^HT5SU+V/2PX7)(5![FA9B_W64_C7PI>>-/'G
MQ"OI9K275+K/_+KI<ES)%'5"ZO?'?A%H[B]F\1:8/^>DOVF,5\9/C:G?VE/#
M3=/N?8?ZFU%^YJ8E*IV/T!W<4[K7C7P%\?>)/&FF[M:TL069\SRKWS,^;R/Z
M[_TKV)?NFOO\%C:>.PZQ%/J?#8S"5,#B'AZG0FHI*6O1.4**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@!JUA^,/"]OXNT.?3;EBD4@^\.U;G2DK.=-5%9C/B_5M-
MN='OY;&YCDAEB_=?OJBKV_XY>!OM=L=>M%CB-K'_ *0(X^91Y@KQ"O@,5AOJ
MM3V9]7A:OM:9K?##PK#J7QM\(ZXS^7)8?:8_^NOF6TM>F_M4>%X/%G@?1K>=
MRL=MJ\5R?^FF(I>/UKC_ (-_\E(T;_MK_P"BI:]0_: S_P (;:9_Y_D_]%R5
M]%@\;4IX+VG_ #[/"Q."P]3$^RY-*A\^445O?#_PC)XSUR*W0XAB_>2_]<J^
M8ITW7?LSZ+2@O0].^!?@4VD)U^?S89I/,CCBECQW_P!9^->SG.VH+.TAL[?R
MK>*.*)?^6<=6:^[PN'6&I>S1\G5J.K4]H/HHHKM,@HHHH **** "BBB@ I#2
MTE &9J>G6VL6,]G>11SVUS&8Y(Y$R'^M?#&G_ &_^#/[2_A[['%>77AN2*46
MU_(F<2_993Y7_D.OO1@I5>PK.U'0[+5S$MY;1W)AD$L7F#.QQW%=V#QM3"\Z
M6S/#S#*J>.=.K_R\IFHO04M%/KA/</ ?VU;Q;/\ 9[U.X>]M+)8];\/RB\OU
M#6MN1K%D1+*/,CS&" 3^\'&>17E'['FN+JGQD\>W/VO3?$GG1Q2GQ3X?C\K2
M),6FF1_9HXO,EQ)@?\]>W^K%?6'B_P %Z#XZT&ZT?Q#I%GK.D7)B,UA?0"6&
M3RY!)&3&>N) #SZ"H?!/PW\)_#FQFL_"OAG2?"]I-)YDL&DV45JLDGJ1&!S0
M!U%?._QQ_P"3I?@G_P!@W6?_ $NT6OHNL#4O"NDZMK&GZS>:9:7&K6$<L5K=
MRQ"22W\WRS+Y9/3)BBS_ -<Q0!N5\=?\%%-/N+S2_@_>7MC<WO@O2_'%CJ/B
M;RXC+!'8QD^;)<Q@<Q"/S:^R*Q_$7AO3/%>DS:9K5A;ZII]S'Y<MK=1"2.0>
M^: /B;XL>)O!?Q*_:V_9_OOA;?Z3XDU+2+J^&K:EX5FBNH[6VE\H#[3-%D8,
M<=SC]Y_SUXK[NKS_ , ? ?X=_"BXFN?"'@?0_#ES*/WDVGV$<<I^LE>@4 >'
M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH 9114,UT(Q\G- $DDWEU6EO/\ GG57SO.HKD]H=:I!
M11161J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!:BO/^>E68YO
M,K,H\[R:U]H8ND;%%5H[K^_Q4U=9RCZ*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *93Z90 ^BBF4 /IE%9]UJ7_/.@"S+=1P]367+J4DO2
MHJ*V]F9$5%2U%6@$M%%%, J*I:* (JEHHH **** "BBB@ HHHH **** "BBH
MJ0%^+4I(O];5^*ZCFZ&L&I89O)_U=9^S Z"GUF6NI?\ /2M"L34?1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4456NKR.$<G)H ?
M)(L74U0N=5"\1\U1FO)9O]916WLS()IO._UE%%%: %%%%, HHHH **** "BB
MB@ HHHH BHJ6B@"*BI:* "BBB@ AFEA_U=:EOJ*3+\QP:RZBK$#I:?6#:ZC)
M'UK9CF2;I61J2T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 1#K3J;P@JC--YU9>T'3ICY+GS/N57HHKE.Y)(****0PHHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *L)=>7_K#BJ]%,QM<TU-/(
MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
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MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
M![=?_':/^%]?$[_HHOBS_P 'EU_\=KA:*/J6'_Y\H/K5;_GZ=]_POGXF?]%(
M\5_^#NZ_^.T?\+Y^)G_12/%?_@[NO_CM<#12^I8?_GRA_6JW_/T[[_A?/Q,_
MZ*1XK_\ !W=?_':/^%\_$S_HI'BO_P '=U_\=K@:*/J6'_Y\H/K5;_GZ=]_P
MOGXF?]%(\5_^#NZ_^.T?\+Y^)G_12/%?_@[NO_CM<#11]2P__/E!]:K?\_3O
MO^%\_$S_ **1XK_\'=U_\=H_X7S\3/\ HI'BO_P=W7_QVN!HH^I8?_GR@^M5
MO^?IWW_"^?B9_P!%(\5_^#NZ_P#CM'_"^?B9_P!%(\5_^#NZ_P#CM<#11]2P
M_P#SY0?6JW_/T[[_ (7S\3/^BD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U
M_P#':X&BCZEA_P#GR@^M5O\ GZ=]_P +Y^)G_12/%?\ X.[K_P".U'_PO7XD
M_P#11/%G_@\NO_CM<+13^I8?_GRA?6JW_/T[K_A>OQ)_Z*!XL_\ !Y=?_':/
M^%Z_$G_HH'BS_P 'EU_\=KA:*/J>'_Y\H/K=;N=U_P +U^)/_10/%G_@\NO_
M ([1_P +U^)/_10/%G_@\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G
M_@\NO_CM'_"]?B3_ -% \6?^#RZ_^.UPM%'U/#_\^4'UNL=U_P +U^)/_10/
M%G_@\NO_ ([1_P +U^)/_10/%G_@\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD
M_P#10/%G_@\NO_CM'_"]?B3_ -% \6?^#RZ_^.UPM%'U/#_\^4'UNL=U_P +
MU^)/_10/%G_@\NO_ ([1_P +U^)/_10/%G_@\NO_ ([7"T4?4\/_ ,^4'UNL
M=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -% \6?^#RZ_^.UPM%'U/#_\^4'U
MNL=U_P +U^)/_10/%G_@\NO_ ([1_P +U^)/_10/%G_@\NO_ ([7"T4?4\/_
M ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -% \6?^#RZ_^.UPM%'U
M/#_\^4'UNL=U_P +U^)/_10/%G_@\NO_ ([1_P +U^)/_10/%G_@\NO_ ([7
M"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -% \6?^#RZ_
M^.UPM%'U/#_\^4'UNL=U_P +U^)/_10/%G_@\NO_ ([1_P +U^)/_10/%G_@
M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
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M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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MQC,>""?GA.?WD1XDQC/2@"C\/]3^)Q\075EXVTG0?[--MYMMJV@2R^69=_\
MJGBE/F X/4<=:]./:O#O#/C;QGX5^)FC>"?'$=AJT6M6\W]D^(=(0Q>?);C,
MOVF(\1R>61_JN.O_ &S]Q/:LIF@M%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ J.0>9&:DHH QZ*?<1^7)FF5YYWK8****!A1110 4444 %%%% !1110
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M:QR')\N*+_EKQCS?^>9Q[UZS110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% %6ZCW151K5K/EA\J6N2H;4R*BBBLCJ"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBK5W9RPU5K4R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "K5I9^=^]DJ:TTW_ ):R5H4&H5+1161L%%%% !1110 4
M444 15J:7]VLNM32_NUB!J4445D:A1110 4444 %%%% !1110 4444 %%%%
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M/C<_\%3O^!?^X*N(^$_PE\,_&3]M#XHZ1XHM&U'2K&_UB_%G#+Y7FR"^\O\
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M^(__ &+>I?\ I+)7R#_P3?\ $&J1^(?&>FZ?H^JKX.OV^TV]S=2236]M<1D
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MY^=/P&^#?Q>@_:RT;Q5\0M(OO/V7-]?ZM)+'+%\]O)#&!+#^[#9$0\H<A/\
MIF*]$_9W^$_C'PG^V!\5_$&JZ!?Z=H=R;W[-J,R@QW7VJ^BEB\LCB3]U%V_U
M723DBOM;:/3%&WBM\3G-:MIR+X%#Y(SHY72I'R?^V=^S[XE^*7_".>)_! BA
M\6:#-\L<,GV:ZNHC)&T>RY/W?)D!DP>/WDG/.)/%O$WBK]J?XO>'[_X?S^"9
M]/Q%Y6I7T=H;$WL49\N6+[3++]GD\W/2+B3VBS7Z+KN[T<'@8!^E<U'-)T::
MIS@I\FURJV7^UJ>TY['QCXD_8KN;/]D]/ ^EW:77B^WO!KC212^7!>WV/+DC
MS)Q_JB8H_P#5?ZN+)C&^O-[#6OVL(_"MG\+M+\,RZ4-)L3;#58X(HY9;=4\N
M)/MOF?9LA)(O]5^]S%_UTK]&NU0MG/WP/PJX9I-7]I34^NO1F=3+8;TIN!\;
M?'#X<>,IO%7[+T3V.H>);S0;ZUCUO5+6.:[BCECDL/-FED[9\F8^9)[]\U]%
M_&ZPN=4^#/CZSM+=KJZNM OH8K6-=[RR&VD C'J2<#\:]";;N&1FER.>*XY8
MISY-/@_SN=U/#JG[37XSX;_X5]XJ_P"'<?\ PC?_  C&J?\ "29S_8OV.;[5
MC^V/,SY7^LSY?[SUQ7T_\$-/N=*^#/@2SN[=[2ZMO#UC!+:R+L>*06T8,9'8
M@\?A7H94$9 HX  %5B<7+%4_9O\ GYR*&$5*5S\\?V3_ -F7Q'XI^$_Q4\.>
M*],U3PA::^;"*"XO+4Q3;[:663(BD'^K_P!5]1FH_ K_ +3_ .SC::?X-L/!
MMIXFT>2>6STX_9?M=M%B7/F^9%+&8HY/,S_I'H/]7B2OT.?,F"AP*?Z^H[UW
M5<WJ5JE1U()\_P"9QT\KITX05.>QX#^RW8_&B.QUVX^,%Q&T\KPQ:;;@6OFQ
M@&0R.QMOW?.Z/_OV:]!^.-C<:M\%_'EG:6[75U=:!?016L2[Y)9#;2@1^Y)(
M'XUWXQV%.XVUY<JW-6]I8]&&']G2]G<_-KX,_%K]HKX:^#]$\">'_A5)+:6L
MDL<$NJZ!>Q[?,E,F99?-BB'^L/Y5[#^R#^SMXT\$^-/$_P 1/'K+#XDU^*1#
M:I.CD&:X\VX>41CRP<QP^7Y;G SD5]?QHL?:AAMZG ]J]2MFCJQJ*E34.?<\
M^CE_)[/GJ7Y#\_/V0_V;]<U[X5?%KP_XT\/ZCX;L?$4-E;6<NJ12PRF6(2R"
M3R?W4A\J62/DD>9CZUB>#;;]I[]FW39O ^C^'&URPU">6'3;N&$W\-E(3CS(
MI/-_T:/+^9BZ_=_G)7Z-R!I&4J>*D7!8\<^M*IFU2K4J.I!/G_02RR%.$%3G
M:Q\'_"?]FSXS>"=(^(/CL7EEI_Q4UNU/V*/S;:3$KW0ENO-_=>49)/+_ '?/
MECS?^6?..-\?V_[3GQD\/R?#;Q+X$2^DM)(KZ;5)K"VB$Q]8[KS?LP($F/W7
M[WMVDK](/^!"EPW^R:=/-ZD:CJSIP^[8?]ET_9^SA,^'/BA^Q5KVI?L\>!?#
M&FWUI>>)_"/VERKR&&UNOM/[V6*+C[_F^7'$9#& ,DXKE?[6_:Z^*%D?"CV-
M[X<-E<BTOM>$<>ER2YF/[WS.DD<9C/\ QZ]8_P#GKY@K]#54_P!_-*RCCD5*
MS:I%>_34][76U]Q2RN%_<G8^#?B]\%_&EU^U!\%5M;'5?$UKHVG:1%JGB:>W
MD,,QMKF5Y)99,'$O DQYG_+3H>[?BA\!?BO\$_C-K7Q)^$\3>(K+5A<WVHVT
MR)+.G[W[3+:^5UECD/\ JS%^]'$?_73[XVCTHVCTJ5F=1672UA_V739\3^ /
M%7[4GQ&\<>%]8U/2K'P7X2DN8EU*WDMHK<RVT<F93Y,QDN8I).8\<8_=XQ_K
M:%^%/B\_\%#!XQ_L#4!X9\C[3_:FP_9O+_LW[+CS/^>GF_\ +/[^.>E?:2_>
M'':E4GCYJRCFEN?V=-*Z<#7^S[:SF?&'_!03X6>+?B=)\/E\*:!?:VUO<7-O
M(MJO^KEE\H1&4_\ +.+]U)F0_(._45%^T_\ LS>.=2^*FD?%/X4#/B0^4E]#
M'=)'+YT:&(2@S2^68O+_ '<D8QTX$GFR"OM;Y>.*<V,$8Z5<,RJ4X4Z<%I3O
M^.]Q3R^G4J5*G\Y\%^$[_P#:7^.OQ)\(:WK6E7O@7PKI.IQ->VD+R:;%)'%*
M)9/,BDD\V;S8\1]X^?\ KI6!J'P;^,?[)WQ,\1>(?A?I/_"0^$+C,C:?"K7
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MQP]JU]F9^U*ODRU)':_\]*N8IV*U]F8^T;&>4*6GT5L9!1110 4444 %%%%
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MW109'/T5M36<4U59M'_YYUM[0#/HJ6:SEA_Y9U%^\I&04444 %%%% !1110
M444>3)_SSH **M0V<LU30Z/_ ,]* ,^K4.FRS5K0PQ0_\LJEI^T-?9E2'38H
M:FHHK$ J6BB@V"BBB@ HHHH **** "BBB@"*I:BJ6@"*MK2?^/6L6NBM8_+M
MT7T%8U!4R:BBBLC8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*^9?%'[%2^)/
M%&K:T/CO\:M(;4;V6Z.GZ/XM\BTM?-D,ACAB$)\N,= ,\"O!_P!CW]G?7/VB
M/V<_"7C[7OC_ /&RTUG5OM7VB+3?&<D5L/*NI81L$D<A_P"67KZT ?HE2UR.
MFVMI\-? -G!J>M7%Q9^']*2.YUS7KT>;)'#%B2YNIR0,X3S))#CN:Q/#O[0'
MPM\9:U;:-X=^)'A#7]8N"3!I^F:[:W-Q-@;_ )(XY,]!^E 'I%%<]XD\6:)X
M7^P)K.KZ?H[:G>1Z?9?VA=)";FYD)$<40?\ UDIQQ&.?RKEO^&@OA?\ \)3_
M ,(W_P +)\(_\)']N_L[^R?[=MOM?VOS/+\KR?,\SS/-_=^7USQ[4 >E4M<G
M?_$+PKI/C2R\)77B32K3Q1?0BYMM#GOXX[VYBQ)^\BASYD@Q%)R!_P LCZ&M
M36-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_ %DCN>  /7TH V*2LC1]<L/$
M>EVFI:=>6]]IMY%'<V]U;2"6*>.3_5R(XX((]/6N$_:6U6]T7]G7XHZIIUY/
MIU_I_A;5+NTNK63RY8)H[65HY(Y.QR <T >ITF!Z5Y;^S3JM[K7[.OPNU34;
MR?4;_4/"VEW=W=74GF2SS26L32222=SDDYJUXB_: ^%O@W6KG1O$7Q(\(:!K
M%N09]/U/7;6VN(<C?\\<DF>A_6@#TBEKE/&WQ"\*?#G2X=2\5>)-)\,V,DOV
M:*[UJ^BM87E(/[OS)".?D/Y5IZQKEAX<TN[U+4;RWL=-LXI+FXNKF01101Q_
MZR1W/  'KZ4 ;%%8^CZY8>(]+M-2TZ\M[[3;R*.YM[JVD$L4\<G^KD1QP01Z
M>M5?#?BS1/%'V]-&U?3]8;3+R33[W^S[I)C;7,9 DBE"?ZN49YC//YT =#17
MF_B+]H#X6^#=:N=&\1?$CPAH&L6Y!GT_4]=M;:XAR-_SQR29Z']:H_M7_P#)
MK/QE_P"Q,UG_ -(9: /5Z*_/_P#:3_Y0XZ3_ -B5X3_]&Z?7Z 4 )12T4 )1
M2U\R?\%%/$VK^"_V._B#K?A[5-0T/5[5K V]]IES):W$)-_;1GRY(SD9!(Z]
M#0!]-45\L_L3>*/%EC8_$/X3>/M=N?$7C/X<Z^]J=6O'EDNKW3;D?:;&ZED>
M63)E'F_)YF8TCC0C/)]G^-GQ(L_@S\)?%WC6],$B:%ITM\(;BY%N+B5$S%!Y
MA!YDE\N/IUD[]* ._I:^$_\ @GCJWQ$E\?\ QET;XD>+==\2:Y:V/AO4WM=8
M62'^S);^QFNYK>.V_P"7?RS*8O+C\O\ U0_=Q]!]@^-OB%X4^'.EPZEXJ\2:
M3X9L9)?LT5WK5]%:PO*0?W?F2$<_(?RH ZNBN4\$_$+PI\1M+FU+PKXDTGQ-
M8QR_9I;O1;Z*ZA24 ?N_,C)Y^<?G53QY\6_!GPQDL!XQ\9:#X2^W"3[+_;FH
MQ6(N/+QYGEF4C./,CZ>HH [6BOCOXL>*M%\:_MD?LC:UH&L6&N:/<?\ "7^1
M?:9=1W-O)C3XH\1RQ\'FO9_[#'_#3_\ ;'_"S7_Y$[[)_P *U^T_-_Q_;O[7
M\KS?3_1_,\KIQYO:@#UVEKE/&WQ"\*?#G2X=2\5>)-)\,V,DOV:*[UJ^BM87
ME(/[OS)".?D/Y4>"?B%X4^(VES:EX5\2:3XFL8Y?LTMWHM]%=0I* /W?F1D\
M_./SH ZJBEHH 2BEHH **** "BBB@ HHHH **** &44^B@!E)Y*>E24R@!/)
MC_N?I4?V..K%% %;[+'Z4?98_2IJ*R]F/G9%]CCJ3R4]*DIE:B$\E/2EHI]
M!3*?10 RGT44 %%%% !1110 4444 %%%% !3*?3* *EW#_RTJK6G-'YBXK,K
MDJ'7284445D:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVJ7'B'4)]=T3X+QZA\,]%O+^0W/VF\^WRRS7T,1D)LC':FUML#.8R!YN(_+
M!^B->4?M7_\ )K/QE_[$S6?_ $AEKU>ODK]J*Z^/WBRS\9?#;PE\.-#UGPSX
MMM!I=MXQFU]+:+3+:XACANOM5J?WDDB?Z3('B./+EB/ER&.1" <Y\0OB-K'P
ME_X)8Z/XET";[/K"^ ="M;>YWR1R6QN8+6U\V,QD&.2/S?,C(/#BO)_#EO\
M OPK\/X/""_L7_%[5K9;/[)+JFJ_#N*;4YPX_>2O<^;Y@E)).8]GEYQ'Y8 Q
M]=^)/V:=-\6?LEV_P.U74?MEO#X<M=!35?(V_O;:*,0W7E"3M)%%+Y?F<XQF
MO.]-^*/[4W@:QM=!UCX&Z;\2]4L8XX;CQ5HWC*TTRVU'('[W[-)%YD9''F<
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M+0!%4MI#YTE15LZ?:B&/?W-8@6XQY<8J2F4^LC4**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH YOQ9INHZEX5UBRT+5CX=UFYLI8K+5
M/LHNC9S&,^5-Y3\2;&Y\OH>G&:X_]FWX*67[/7P6\,> -.U";58-%CE_TVXC
M\LRR22RRR'9D[!OE?CTXKU2B@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHI* %HHHH **** "BBDH 6BBB@ HH
MHH ***3- "T4E+0 4444 %%%% !1110 44E% "T44E "T444 %%)FC- "T44
M4 %%%% !1110 4444 %%%)0 M%)FEH HW</_ "TJI6M52ZB$?-8U*=S:G4*M
M%%%<IU!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !114D<
M?FT">Q-:0_\ +62K=%%>@< ^BBB@ HHHH **** "BF4^@ J.:/SH\5)3* .?
MFA\F7RI**V+JU\^/_IIZUCR_N:U,@HJ*BM@):*BJ6@ HHHH **** "BBB@ H
MHHH **** "BBB@"*I:** "BBB@"*I?\ 745IV-GY7[R3_6TF[ 3V=J+2/%34
M^BN4U"BBB@ HHHH **** "F4^B@#&U"S\G]['5"NBDC\P<UCW5G]DD_Z95M3
M,B*BHJ*U EHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "HJEJ*@
MHHJU:V?G2?\ 3*D!;T^S_P"6LE:%%/KE-0HHHH **** "BBB@ HHHH ****
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M))) ,@"O3?V//BSXK^*7P^\1VOCD:=/XR\%^);SPAJ=]I+G[-?S6OE9N4CV
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MBB@ HHJQ';?WZ8G)(CAA\VK\,/ET**>373"G8Y)U+B44^BMC,**** "BBB@
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M_>8<^J_#N@V'A7P_IVB:;$+73].MH[.VBW[O+BC 2,?D!^5>/_LOZ#JN@_\
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M G+VD/MGFGQ#\;?$3XU^)OAY<6?PTU[0O!NE^.M,N)9M8LI(M3D(P/.^S?\
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M9DZA'#:B*IJ?176<HRGT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12T4 )1
M2T4 %%%% !1110 4444 )12T4 %%%% !24M% !1110 E+110 4444 %%%% "
M4M%% !24M% "44M% !1110 E%+10 4444 %%%% "44M% "44M% !1110 444
M4 %%%% !3*?10!'Y0J/[''5BB@"G]AC]*9_9X]:O8HQ6/LS3G91_L\>M']GC
MUJ]BC%'LQ^T91_L\>M3?98_2IJ*?LC/VC$\E/2EI]%:B"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &44^B@"M+9Q3
M=8ZA_LJ+UD_.K]% &7_9(]:B_LF3_IG6QBC%:>T8&/\ V3)_TSH_LF3U%;&*
M,4>T8&;_ &/%_P ]9*LPZ?##TC%6J*S 93Z** &4^BB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *93Z* (I(4D^\F:K?V;%5Z
MB@#+_LC_ *:5%_9$GK6QGVHS[4>T8&/_ &3)Z1T?V/)_STK6HK3VC)Y#/_LC
MWJ6+38JNTM9E$7DQQ]$IU/HH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@!**6B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM\1M=UKPA$^M7.B_$#7)-3TK4K.*)Y+BVDA$<9R8\X/J/^61Q+& ?=5>:_M
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M6_M#>)=<\+ZA;ZO;_$OQ!J-[X:TO%]=QRB&VEDM(C'Q<2;OW8QCS#]:^VJ*
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M2X(H=0_M.VO%B\L&XAN8XTBEB\PR1^9%OC_='$AKSSQY^W1I.G^/O!6B^"-
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MCA\5_ACX'\!ZC;>(YM)\2V_B/5KZSDEDM;.VMX_,7][%$8W\SS>OF8#XC/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKX-CN(@XZ2 228_&OI_:/:C:/:G[:'\@OJ]3^<^8/#/Q_P!$\$V<ECH'[/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@!**6B@ HHHH **** "BBB@ HHHH **** "BBB@!*6B
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2B@!:*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBDH CW8YQQ1NSS7SO\ ';]L+P9\!=4_L>\COM;\
M3&W^T'3K!HRMKD#REN9#_JA)ZX<^W,><OX!_MM>$OC9XET[PS+I6I>'O$M]'
M)+'!*1<6<K1#S/+BEZD^5B3F./BNWZAB?9?6/9^YW.'ZYA_:>SY]3ZAHI,BB
MN([A:*2EH ***0MP: &%O6EZUXE^SK^T=H/[0UIK<^C0W=G/IER([BRNE 98
MG,GDRCL1((\^V#U&)']&^(7BL>!O ?B/Q&+<WAT?3;G4/LV_89/*B,FS/N!6
M\Z,Z=3V<]S&%>%2G[2!U''K1QZUYM\!_BI_PN;X5Z)XP_L[^RQJ7G9M?/\WR
M_+FDB^^.O^K_ %KG?$GQ\;0?VD/#?PJ;0_.&M::]^-6^TX$>!<GR_*\KG_CV
MZ^8/]9TXJ51J>TG2MK CV\/9^T/;:*0'@45D=(M)110 W;MHV[JX;XF_%CPK
M\'="AUCQ5J7]D:=<7/V5)_L\DO[W;))@B,$](Y#7<AMU-PDK2%SH=2TE&:0Q
M:*2B@!:*2C- "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%(WW30!^;7[05_/\#_VXK7X@^*?#IU+P]=26UU:[
M!'_I"QVT44DD63S+#)^\\ON1&>/]8/K_ .#?Q!^&GQ>NK[QEX.@TZ?Q!)'':
MZA>?88X=3BW)%B&<X\S_ )9 ?W/W/?RZ3_A<'PF^(NK:IX&U#6M%U*_MKX:7
M=:/K48B^T70D/[N..X $W[R/_EGY@R!7QAX-T;2?AC^VUX<TWX/ZW%XBTB[F
M_P!(2&[\V*WM9/WMS;>:)?\ 21%%^]C_ .V?^MDBKZE1_M"A[.JO9SIP^3L?
M)\_U&I[2G[\*DSV+XU?MB>+].^,D?PY^%V@:?XFU:*0V]T]Q^^\VYQS%%Y<J
M>6(NLDDG_37_ %?E<\QH_P"V!\6O@SXFT?P[\9_"\<-C=GRVUD1>5)S+&9)?
M,B,D=SY<<O\ JHHP>.M87P+\5:1\,_VX_BA+XONX?#45[)J<5K)JO^C0CS;J
M*YC_ 'LA'^MBC,M:G_!1CXG>"_$FE:)X4TS4+/5_$MAJ)N+E[7RY/L$0\R*2
M.27_ )9R>9Y?[O\ Z9#S,?N\]E'#8=UZ6#=#W&M^OJ8U,14Y*F(50[']H']J
MOQUIOQ>/PK^&>@QWGB%HA;R7-Y'YD@FEA$L9B_>",>7'F0O+P>>/W9$O?? C
MXX?$+5].\?WWQ=\,P>$K'PY%'/#=P:=<1QRQH)3<R#]Y*)1'Y<?,?K[\>1_%
M#X$^$O'J:#?6_P 7='TCXP:!I,5KJ<T>J0N;BYLHG\Z:1N+B*021G_2>3''$
M?W?%<O\ "OX_>+/%_@3XS?#7Q3JMGXJ&D>$]6EMM>M9&E#Q0Q"W'[T?\?,<F
M[S/-R'Y/7.(^-X:A5PZA2I[6OWW.CZQ4IU_WE0Z:S_:R^-WQHUC4T^%?@.SF
M\-6UR3;7NHH1-Y47EYCFEDE$0DES_J^)!'*.G$M>I?LL?M4:A\:M7USPQXHT
M5- \6:/#YTUM$)8_-Q*8Y<12#,?E_NL_O#GS:^4OV:_ *^,/!<KZ9\?KWX:W
M,,]S+<Z"9S;<QQ^9)<C_ $F+S8O*!S*8QCRI/^>?'T?^RC\ M&\"_$C7O&6E
M_%G3OB9<75C+:W[69226.266.3S9)1<R\YB?@XZ^U=&/P^"HPJ4E:ZV^._XZ
M&.%JXRK.%0S/^"?_ ,3]2^(]KX]L+NQT71+6RO+>_M[71--BL8HQ<^:/+Q'P
M<"W3KF3GF0\8^C/VA/\ D@OQ'_[%O4O_ $FDKY(_X):MB;XE?]PS^5U7US^T
M)_R07XC_ /8MZE_Z2R5YF94Z=',W3I[:?H>C@*CJY??U/F3]E/\ :M^%GPQ_
M9_\ #'ASQ#XH_L_6[+[4US:"QN93&9+J67_EG%C_ ):"LRU^*7ACXQ?M_?#/
M6O"6IC5].M]$N+623[-+%AQ#?2$?O /^>D?YUWW['GP>\!>+OV:_"&I:UX*\
M/ZKJ4ZW1DO+[2;>:63_2I>KO'DUR^N>#]$\$_P#!0CX8V/A_1=/T6RE\/S2R
M6FF6L=K&9/+O_P!X1&!]*[_]G^LXE13Y_?\ 0X_W_L,/S_![ATO[27[7.L_#
MSQ]!X#^'WA\>*O%T7[V\CEM9;A85\H2^5'%$1))+Y7[STQ]3Y?$Q_M>?%GX/
M^-M)TKXR^#].T_1M6E9UOK7/^C1FY_UGF1F2*3RHO^60_>']WWYD\T^-FCVN
MO?MV>)K:Y\;2?#N39:FW\11_N_LTO]FQ$F27S8O+\R+S8Q]*Z3Q1^RMIGC74
MM,L/$'[3UAX@U3;&+&TU62.ZE(N/+\D11R7Q/[W,7;][F/\ 'IAA<#1ITHU;
M:PN_CO?Y:&%3$XRI5J*D>@_M6?M8>+O@)\7M,TO2[:QU'19- ENGM+J,J7N9
M99(XI/.[B(PC]V,9$LF<_NS'Q_B3]J_]H+X3VFFZ_P"./ VF6.A:S<)+#'-'
M(C0Q>7%FV&R0^5)_K9?WO[S_ %G'[KRJI_MIZW8^&/VROA?K>J2"TL-.MM,N
MKF;R_,\N**_EDD_3%>A_MS?&#X>>)O@)?:3IWB/1?$NL75_:QV4.E7MK=2VT
MGF>9YI_>?NAY4<L?F]O,]ZBAAZ:AAH?5[^TZ_,N56J_K%3VG\,\4_;5\5?$C
MQSI=AKUT&3X0:M-IU_HD,GV;SO-DL?-_Y9_O?^?FOI#X+^*/C7X'\"?$GQ+\
M8;9KO^R=._M'2+;?8Q^9Y45S)+&#;=L"(9D^OK7@7QYTG4=)_8(^$=MJ=]_:
M5U)J%K=)*7DDVVTMM=20Q>I\N*2.+T^6OI[]HSX]6W@OX+^*=7\':QIU_KMK
M':I&;3_31;?:<&.63RB?*!B/F1R2XC.(^H/.%=^UH4L+3IKXWK]W7\_D&'3I
MSJ8FI4/GOQ!^US\?[7PS_P )^G@73]*\#M(883=6<LA$<HBDAEDQ+YDF,>6)
M1Y44GFY_YYU[;XT_:,O=0_9#OOBMX5MUTK4KBV3RH[[$QMY#=BWEQS\^#YGE
M\<_+F,G]W7R9)I>LWWP<U#Q+XC_:6::\NM-=T\)V^LRWLLZO'S:RQ^;^[E)E
M$<G[J7R^M>IDC_AUD/7=_P"YVNBMA,/^Z_=_\O$NNWSW,J&(Q#=3]Y]@Y;P;
M^U'^TCX[T6'7_#OAVSUW2= Q;WHLM,\Q=1E<8_>Q>;YDDF,2_P"C>4,RCS/W
M=>B_$#]KOXD^+/BIXA^'?PC\*1W&HZ:UU:S:AJ#;W'EXB,T6?W47E2B7_6^9
MYF8_^N=>M_L)HK?LL^#\C/S7_P#Z77-?"OP#\%W%MXJ\7>'=4^,$GP;U;3IO
M+NX_M/E17DD4DL<D?F17449\H@=/^>M5"EAJM7$OV?\ #V6O>VM@J5,32I4O
MWG\0^G?@C^U9XXB^*MG\-OB_X>CT75KR/[/8W_E_9C),AER9"9?+D$OE8CDB
MXWC '[S$?.>,OVH/C;XP^)'C30?AMX;LWT[P?J<QN6A@^T2W,=O,4\J3S,#]
M[Y9_=Q?O<#]V3UH\+?LPZ;??&CPY?ZI^T)9^-/%>A:G#(=)NECN+X"WE,LEM
M\US))'_RTR.U<_\ 'SX&:')J7BWXO_"?XHZ3;S6/FZEJB6NL F.602>88KF*
M3]W)+S%'&<<R2_O,'RZRIPP,L1==5V?)?TWL;5*N,^K[GV5\"?%GB7QQ\*]$
MUSQCI/\ PC_B2Z,S76GBUEMO*Q-(D?[N7]X,QB,\^M>D_P 1KYQ_8C^+GB'X
MR_">[U7Q5=1W^J66JRV*W$,2QB1!%%("XC_=YQ+VXKZ._B%?+8JFZ5>=-GT>
M&J>UH4ZA)1117.=84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'[./CSX<:/JGAV_URT\8?VC%'-I?[R\2:VCC,5M#;>6?.DN99HX@/,C ..:
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MAJEYH'C'QUX@T_PAHFK0N8A:75U+CS)9!F2,>4DW[R,%P2I KT;X+_!CPI\
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M_ACJ?A?3_$W[,EWI\OB;5(]&TI_^$TM98I+V4 10^;';%(R<_P#+3'1STC-
M'W'17S[XA_:"\0^#_'WP<\/^+_!$/A_3O'T;6UUJCZV7&BZM]G,HT^3$/E2F
M23$<1$H,I$F(_P!WSUW[27QKLOV>O@MXG\?ZCI\VJP:+'%_H5O)Y9EDDEBBC
M&_!V#?*G/IS0!ZI16-H<FJMI5F=3MK2VU!HX_M,-K=&:)).=^R4QQF3Z^7'G
MT'0;- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MR/%GQ+_9/\;>"M&\8>*(_BC\-?$^O6GA?2]4OK<P^(K"[N?,6V28C]S=0QI
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MD_0_C)\0M/\ &@\6^-? ?BFTTPZ,^J^#-9^P2W-GYAF$4A\M\@2'.!CWSA,
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M&[O/&%X;^^N \QE!EDVCYHR1Y<G!C\N/!R,T >6_\,[_ +3G_1W'_F-M,_\
MCE>G?LN? ]_V;?@;X>^'3:S_ ,) NC?:=NHBU-MYHEN99B3'YDF.9<=>U>5?
M\, ^&=OV#_A:?Q=_X0G/V?\ X0W_ (2Z7^QOL&<?8/*\OS/LWE_N<>9GR_\
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MIX98;N\\87AO[ZX#S&4&63:/FC)'ER<&/RX\'(S7DW_# /AG;]@_X6G\7?\
MA"<_9_\ A#?^$NE_L;[!G'V#RO+\S[-Y?[G'F9\O_EIGF@#R+X]_"?3_ -EG
M]D+X,^$I_$\&H>(?#?Q$TVZ\/:]JD/\ 9^E"_DO;FY#ZEF21X[6.*2Y#F.3S
M,QQG(&:])O/"?QG_ &G/&?P\/Q ^&-A\)?"7@OQ-:^*92_B>+5+_ %&ZMXY?
MLT5N(8O+2)9#B42X)$@\L\'/._MHZ+X-\+K^S[\*/%EE;:'\![K4VLM5U*:&
M1UL39VR#3+4WLGF?9Q*<QR2Y$IBCE_>QQ^::\9_:!^&?[%7PV^&/B#6_!?BC
M2=(\;V<3R>%M0\(>+KG4K^'4HXS-:XCBFE\L&6/9YL@ &?\ 61GR\ 'V)^VK
M\([CXM_L]^((=':^M?%OAT_\)-X=NM*64W46IVP,D7E"-Q^\D!DBSS@R^8.0
M*\8U/XP:?^V9\1/V8M(T=/\ B6J7^)FO0P[A=Z;+9,]K:QB62.-98OMQFMY-
MD>\B(./+0B0_5G@/5=7\/_!KPQJ?Q)OX=.\06.@VMQXDO+F>&*.VN8[8&[DD
MDC/E8$@E)(_=\<5\T_\ !.?X;Z)?>'O%OQCTJ!;>T\7:QJ2>%M-DCC']B:#'
M?W+Q6,<0&+;-S)-))%%)Y1Q#W!- 'VW1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+%/')_K(W0\$$>OK1H^AV'AS2[33=.L[>QTVSBCMK>UMHQ%%!''_ *N-$'
M'IZ5L44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.FV6J:MINK7LMG:RZ[?RD6GVKS?W,L,=M$,<C]Y=>7^\$DD=?:-?!OAOX#>
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M.=]8?E,\[$>T]O3]GY_^VGKOQ?D#_M6?L^^F/$7_ *0QUTGQUU+PIIZ> /\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_$.K>"O'/A&YN+GP_P")-'FWFVFEB"21R0R9CEA<I%YD1QO"&/S )),^Y44
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M_>]ZXG_AA'X'?]"5_P"5:^_^/4O_  PA\#_^A)_\JU]_\>HG4PE1WG4G_P"
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M97!?\,'_  2_Z$K_ ,JU[_\ 'J/^&#_@E_T)1_\ !M>__'JVJ5J-2').J_\
MP"/_ ,D<T,/4IU/:4Z?_ ).</X8U/5_V2/$VK^'=4T+5=9^$=W<S:GH^M:+;
MRWG]@1' EMKE!GRX8P/-\SW<_O"\GE7-)_:._9QTK3=5TSPK:Z;++J\?V:71
M-%\,2QOK':.V,?DB.0R>:8P'QGS>HS78?\,(_ __ *$<?^#>^_\ CU'_  PA
M\#_^A(Q_W%[[_P"/5M&M@)+]\YW\DO\ -F3H8V'\-0/2?AKI&@:3X3LIM \,
M6_@ZTU&-+Z32X;&.REB>1 <2QQC DQP?<=>*YKXF?!W4/&&OP^)/#/B[5?!7
MB:"V:T%[:G[1:W$>9-HN;20>7+Y?FRF//0R'VKF1^PC\#O\ H2O_ "K7W_QZ
MC_AA#X(?]"5_Y5K[_P"/5Q^TPD9\_M)_^ ?_ &YU<F)]GR>S_P#)_P#[4F\*
M?LZ7'_"9:1XM^(OC&\^(OB+1O,_LDW5E'96-E_TT6VC&/-R2?-]H^/W<9'<_
M%SX3Z1\9O#MMI6J7.H6!LKZ'4K._TJY-M=6US%GRY(Y,<$9-<#_PPA\#_P#H
M2O\ RK7W_P >H_X80^!__0D_^5:^_P#CU5[;#<ZFJD]/[B_^3#V=;D]G[/\
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M^"7_ $)7_E6O?_CU-RPS=_:O_P  C_\ )C]G5_Y]_P#DYWG_  J\_P#"^/\
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MAIOF":2(1R Q#RY8S@EP>O\ RS%<A_PP?\$O^A*_\JU[_P#'J/\ A@_X)?\
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M]2!Z52T45S'H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %)2T4 %%%% "44M% "4M%% !1110 4444 )12T4 %%%%
M!1110 4444 %%%% "44M% "4M%% !1110 E+110 E%+10 E+110 E%+10 E%
M+10 E%+10 E%+10 4444 )12T4 %%%% !1110 4444 %%%% "4M%% "44M%
M!1110 E%+10 4444 %%%% !1110 E+110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 45SO\ PE6B_P#"3_\ "-_VO8?\)-]C^W_V
M1]J3[7]F\SRO/\K_ %GE;_W?F8QGCK714 %%%% !1110 4444 %%<YIOBS0]
M7\0:KH=AJVGW6MZ.8O[1L+6ZC>YL_-'F1^;'U3S "1GKV]1T= !1110 4444
M %%%% !1110 4444 %%%<[X;\6:)XH^WIHVKZ?K#:9>2:?>_V?=),;:YC($D
M4H3_ %<HSS&>?SH Z*BBB@ HHK'UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@C
MC_UDCN>  /7TH V**Q]'URP\1Z7::EIUY;WVFWD4=S;W5M()8IXY/]7(CC@@
MCT]:V* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HKG?^$JT7_A)_\ A&_[7L/^$F^Q
M_;_[(^U)]K^S>9Y7G^5_K/*W_N_,QC/'6NBH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ***YW_A*M%_X2?_ (1O^U[#_A)OL?V_^R/M
M2?:_LWF>5Y_E?ZSRM_[OS,8SQUH Z*BBB@ HHKE/&WQ"\*?#G2X=2\5>)-)\
M,V,DOV:*[UJ^BM87E(/[OS)".?D/Y4 =716!X9\3Z'XRT2VUG0=6T_7='N#_
M */?Z7=1W-LW.PB.2,D'GCCWK?H **** "BBB@ HHHH **** "BL#PSXGT/Q
MEHEMK.@ZMI^NZ/<'_1[_ $NZCN;9N=A$<D9(//''O6_0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%<YJ7BS0](\0:5H=_JVGVNMZP9?[.L+JZC2Y
MO/*'F2>5'U?RP03CIW]2 ='1110 4444 %%%% !1110 4444 %%%% !1110
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M9^-WQJ^-GP>\5WG[.[?#O6?"_B6QFOO%]KXVLKNZ_L<S$W=H\<7EF6(B7/\
M'@>:H'[V3(!ZO_SE,_[HW_[FJ]0^-'[1GP[_ &>;'2K[Q]XG@\/6]].T-E&8
M9KF65E +D1Q1O(0 >9,8!>,9^?GR_P#YRF?]T;_]S59OQH^*6F>'/VD;>V\
M?!&X^,7QCL=/LXKC5XKBWMX-#LI/MTD<4M[+YHLI9!)-^[*1>;',O[P_NXZ
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M_P :-3-\MU9KI,D1E,<MS*A\R*$6PQ;1(>#V]37T'^RA_P FL_!K_L3-&_\
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MXP6OB*YT71M0\(>(X+^(Z_H7B#3!8:O;S&*,1274.<_O;>*+RY#UCC S^[(
M!V'P]^*'ASXG?\)$_AS4&U#^P-6N=!U$^1)%]GOK<CS8OG';S!STYZTO_"TO
M#?\ PM;_ (5U_:1_X2_^Q_[>_L_[-)_QX^;Y/F^9CR_];QUS[5X1^P5][]HS
M_LLOB/\ ]MJ3_G*9_P!T;_\ <U0!ZIXT_:,^'/PWUW4=!\3^)K;1=5T_0/\
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M01ZV=*\8R?;].NX[:XNHX;*YDA,G[G[/+$-H!^2,18C',8!]&_!K]K+X5_M
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M,H'?_6>7"8_IZB@#PK_A3^N?\-G?\+<\_3?^$9_X0/\ X1;[/YDGVO[3]O\
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MOAA\'=?\%_M&?&[Q_?36$NC>./[#_LZ*VE?SXOL-K)#()1LZDD$8)]*/B?\
M!W7_ !I^T9\$?']C-81:-X'_ +<_M&*YE?SY?MUK'#&(ALZ@@DY(]*]UHH \
M*^)_P=U_QI^T9\$?']C-81:-X'_MS^T8KF5_/E^W6L<,8B&SJ""3DCTH_P"%
M/ZY_PV=_PMSS]-_X1G_A _\ A%OL_F2?:_M/V_[5YN/+\OR]G'^LSGM7NM%
M'CW[27[/NB?M)_"'6? NL,E@MP\<]IJ26T<DEG=1D&.2/S.AZQG!&8Y)(\C.
M:\:_X0W]M'['_P (S_PL?X9_8OMNS_A./[(N/[:^R_:L^9]D\K[%YOE?N_*Z
M=O-S^]K[&HH \>_9M_9]T3]FSX0Z-X%T=DOUMWDGN]2>VCCDO+J0DR22>7U/
M2,9)Q''''DXS71_&SP7=_$3X.>/?"NG-#%J.O>'[_2K:6?\ U<<DUM)%'O\
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M.?@SKO[//[/'A7X?Z_/87>KZ/]I\^?39))+9O-NI9AY9DCC/_+7'3L>M>?\
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M9+B.6ZTS4[9[RXDDM7D,7FQ I*A\R-/,S'Y8P#Y@^O:* /D.+X$_&WXW^+O
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M/U5110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M MO*Z']SC]Y^\$G[S\.,5G'#\\.>;'4Q'LZGLX'UCO$>%S2]-U?(&NZ#XO\
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M\%$OC/XDCU33I;+P+X<TWP;;16<?F>9]HE^U3&67S"!)%<PSQ>7@=0.#&?,
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MI? 5_IEIXAMKGS/*UE));.ZCVO'Y<OEGS$&7$F4[Q8Z&L\7B(5:C=/K)_P#
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M &%/M6S&W/VG_6;\<^9YF_/.<\UYU\"+7Q!KWP3^)7@72=7FMKSPSJ^L>$=
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M?^.?_1P?_EE67_QVC_A4'QS/_-P?_EE67_QVO?O(7V_(T>0OM^1H^N5>R_\
M (?Y!]3I^?\ X'/_ #/ ?^%/_'/_ *.#_P#+*LO_ ([1_P *?^.?_1P?_EE6
M7_QVO?O(7V_(T>0OM^1H^N5>R_\  (?Y!]3I^?\ X'/_ #/ /^%/_'/_ *.#
M_P#+*L?_ ([2_P#"G_CG_P!'!_\ EE67_P =KW[R%]OR-'D+[?D:/KE7LO\
MP"'^0?4Z?G_X'/\ S/ /^%/_ !S_ .C@_P#RRK'_ ..TO_"G_CG_ -'!_P#E
ME67_ ,=KW[R%]OR-'D+[?D:/KE7LO_ (?Y!]3I^?_@<_\SP'_A3_ ,<_^C@_
M_+*LO_CM'_"H/CG_ -'!_P#EE67_ ,=KW[R%]OR-'D+[?D:/KE7LO_ (?Y!]
M3I^?_@<_\SP'_A3_ ,<_^C@__+*LO_CM'_"G_CG_ -'!_P#EE67_ ,=KW[R%
M]OR-'D+[?K1]<J]E_P" 0_R#ZG3\_P#P.?\ F> _\*?^.?\ T<'_ .659?\
MQVN=\*?LQ?%/P*NL?V)\<_L)U;4IM8O?^*0M9-]U+CS9,O*<9P*^H/(7VH\A
M?:CZ_66B2_\  (?Y!]3I^?\ X'+_ #/ ?^%/_'/_ *.#_P#+*LO_ ([1_P *
M?^.?_1P?_EE67_QVO?O(7V_6CR%]OR-'URKV7_@$/\@^IT_/_P #G_F> _\
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M !VC_A3_ ,<_^C@__+*LO_CM>_>0OM^1H\A?;\C1]<J]E_X!#_(/J=/S_P#
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4E+10 4444 %%%% "4M%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "44M
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 44F:6@ HHHH **** "BBB@ HHHH
M**2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDS10 M%)1F@!:**
M* "BBB@ HI,T4 +1110 4444 %%)2T %%)FEH **** "BBB@ HHHH **** "
MBBB@ HHHH **2EH **2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***2@!OUXJ)F?/ !_&OE/]KG]IS7?A%J&@^$?!=K#J7B_6
MXS(1);R2O;1R'RH?*BQ^\EDESQSCRO\ 5GS :\[7P#^U^UK_ ,)4/%=K_;/D
M_9/^$?\ M5MO\OS/^>7E_9=__+3S?-\SR_?]U7IT\ME5IJI4J*%]K]3R:V/]
MG4]G3IN9][=J7BOBK_A+OV@/B-^SCI<VBZ%J/AWXB6OB"&UO/.BCL9+VUBB\
MP7(CNO*&/-,0D P)/*DP/+;RZ]9_:V^/&I_ 3X:VFO:-86>H7MSJ,=BBZ@9/
M*3,4LOF$1\OCRN@]:Q^J3]HJ2U9O]<I^S]HSWPD4 BO)=2\3>)O&WP)B\3>#
ME&D^)M6T&/4-.AD(N1%++")5BQ+Y:'G \R3'4Y%3_L[V?C'3/@_X>M?B&TDG
MBZ".6.^:6>.9^)9/+_>1\.?+\OI_.L/8^[S'3[1.?(>J44W>OJ/SI=P]:Q-;
MH3BAL4S<,<'FO,?VAOB?<?!WX0^(?%UG9Q7UYIJ1>7!,^(S))+'$!G_MIFKI
MP<YJ$3*I45.'.>I+2$5S'P]\6#QSX#\.>(S;_8SK&FVVH?9MX<Q^;$)-F?8&
MNG+CID5#CR:&MTQ10U1QD\UQ'Q@UN_\ "?PG\:ZWIDH@U+3]$OKNWEV;]DD4
M,DD9QWZ=*J,>>?(*;Y%<[-2S-DIGW%2]1UK\V?@_\/\ ]I'QGX%TOXA^%/B3
M-<VUQ'=206.IZ[<SRR&,R1>7Y<L<EODLG63OZ5Z1^SI^UCXO'Q57X6?%RSBM
M-;,AM8;^:*.VE6['[P12C(BD$F4$;Q?],A^\\SS*]BME,Z?M/95%/V>]CQJ6
M9PG[/VD.3G/N&EI-P'4XHW#U%>*>T+12;AG&1FC<.F: %HI-P'>C</44!<6B
MDW#UI&/RGZ4 ,9@HZ?K3=Q(Z<5^9<UW\8/CE^TA\0_"OA;XB:EH7]FW]_+%!
M)JUU9VL5O;W1MHXXXX?^V9)[\^M=[\/?CM\7O@S\<M ^&WQ5N8];LM6DMK6V
MO/W4LNR262V@FBDC$?\ K)0#)YH,GH*]NIE,_9^Y47/:]NIXT,S@_L'W[2TW
M< !DXI=P]17B'LW0M%)N ZFDWKZC\Z NAU%)D>M&X>M Q:*3<!U(%)O7^\/S
MH%=#J*0,#T(-&X#J10%T+12;AZC\Z-P')- 70M)2;U_O#\Z7/R\<T!=,R=4U
M2UTBQN+V]NHK6TMXS)+<32!(T0 DN34.@Z]I?BC2H]2T;4[35["X&8[RPN4E
MBD^DB9!_"OEK_@HQ\0$T#X,V?AF.6'[7XDO4C>&9'+?9K<B622/'I(+9?^VE
M:VO+J_[+?[$]O_9A-IXDTO3+82+="*<6UW<W49FP>(SY<ES)Y8Y'RCB3OZ$,
MNYZ%.HGK4GI^!Y<\<J<ZD/\ GV?4ZD-TY_&FG'397Y]_LU_![XI?$*Q\'?%%
M/BCJ,BS:O$;W2[K4KC_2--MKB7S(I)>?,/F&;$6/+Q(?WF*_07GINQ48O#0P
MM1TE4YS7"8GZS3]IR6):6D# ]#FDW*.XS]:XCON@SFDH'-?&7[7_ .T1\0/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%S#)Y4?E_O8S^[S)_K.G[NOIW]L#X3^%/B!\&V^.5O-K46JR:3ITUG:R70:
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M!(\OAV_,4C&2,1QVUR!'YG/4^;';?]]G\/"? _P'?Q!^POXL\4G3&.M?VO\
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M?S^;%YD<N8\2<BMJ3K\U'VM/GJZ^MOZV)J*C^\]G4_=G7_LC^'/AO\(/#?Q
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M*.YU^X:TE?RY0?-_>^7S+^Z\J2*.+_EHX\S_ *9W?VLA_P 9W?![_:_L8_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[U[SG;3^*1L45JD\15]I/J%.FJ5/V<!U+24M0;!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\?&_^$2\*^+/"_\ :7C+]N[4K3XB7=E_I,OAOQU8Z?HL%UY>(C%8Q^5F*/\
M=Y(,7FX,G[LR< 'Z+45\->!?VW-?TO\ 8P^(7Q&\1_V/XC\3?#_4KCPL=6T6
M3[38:S>Q^3';WR@"/]U))<Q&01D9C$CQ[<B,:'@G]COXFWWA/3?$WB;X^_%/
M3?BG<0_VI<V=KK$4FCV.H2?O?)^PC,4L,4A\LQ>9Y<GE\;(S@ 'IW[(GQ,\2
M_$AOC-_PDFHF_'A[XD:QX?TU?(C3[/96WD^5'\@&2/,/)YKO_@1JGQ"UOX5Z
M+??%'1;#P[X\E\[^TM+TR17M8<32>5Y9$LO6+RR?WAY)Z=*\&_X)R_VU_P (
MS\</^$A_L[_A)?\ A:VN?VE_9/F?9/M7E6OG^5YGS^7YN<9YQBNF_P""=?B;
M5_&G['?P^UOQ#JFH:YJ]TU^;B^U.YDNKB8B_N8QYDDAR<  =>@H ^FZ*_/WQ
ME\.;?[9XGF^*7[9M[X+^*MY^]DT7PWXMAT;2-&DDM8_*B6QDF$DL<?42$Q22
MQD$XDS(?H;]BCXNZW\<_V8O!/C3Q2]M+KFHQW"7,MNFP2^5=2VX?9C@OY6>F
M.: /?**** "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH *
M*** "DI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1?AU\2]=BUWQSX%U_P"QRWL.GQVWV[3;F/S;"ZD2+]T#+'YG[N/F/ROWG/4
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M\<<@![?17R!J7[87C[X4P#6OC1\"-6^'O@7[1%!)XFTO7[77!8RRR!$>XBB
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M7TFUOY8XO]6))8HY./H35\GN\YE[3W^0[.BDI:@U"BDS1F@!:*** "BDR**
M%HI** %HI*6@ HI,T4 +129'K2T %%)D>M% "T4E% "T4F:6@ HI*,T +124
M4 +12;AZT9'K0 M%)FB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^\/!Y[1RF/@/^"DW[1WP4\;?LPZYX7T_QGX9\4^*KV6WN=$ATFZCU+RYHKF
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MD /I/X)^"[OX=_!SP%X5U%H9=1T'P_8:5<RP?ZN22&VCBDV>V8SBOF'XD_\
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M[(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?\-;O_T1OXM?^$M_]MKB]-^)W@;0S<_V7^S5XXTT7T$EG<_9/ EO#]HMY/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **2B@!:*2B@!:*2B@!:*2EH **3-&: %HI** %HHI* %HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BDI: "BBB@ HHHH **** "BBB@ HI
M** %HHHH **** "BBDS0 M%%% !1110 4444 %%)10 M%%% !1110 4444 %
M%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !112&@!@ /2EZYKY<_:6_;-;]GOQS8^&T\(?V^;G3(
M[\71U'[,H)EEC\O_ %4F?]5G\:^A_#6O67BKP_8:WITHN;'4;:*[MIMNWS(I
M 'C/Y$?G6]3"5:5.%6HM)['+3Q%.I4]G#=&V2%7FCAE]J\?_ &DOCM:_L\^
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M:3)]*^)/ _\ P4M\+ZQ>+:>)_#6H^'89)4ACN[2X%]'&.=\DG$<F!_TR$O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3?%K3='\5Q?:K'4=9O;3P;&TME$9(9)8HP#Y?/>V_P!;ZU]#>&_C-\3O@/\
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M/-DCB'ERG@R1H)9,#@!Y!&.@^</C-X)^%^M?VM\6/A5\6[/0O%$PN-3.EOJ
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MUKV\3ALOHT?9I]/^?>O_ ('_ , \[#XC&5*OM/\ V_\ ]L.L^-'[17Q<T/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ]I=_JDFM>(&G^U17<L9MHS+*)9/+ C!',8[GI7M0Q2\41J3IZ0ZA.G"IN>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-HKQSPW\?M'\0?LSP?&22!CHQ\-MXAO;33+F.ZE3R[<R7-M'(#&'DC,<D?\
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M(G[9^DZ%^RO9_'KP=H?_  E7AZ012RV.H7S:9<PQR7(MI 0(I098[AA'C[A
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M#6QDDEN=6N];MHM5@L(Y3')<R:9Y?F B,>84SL &?,\O]Y1_P4 \<:#\3?\
M@GAXW\3>&=5M]:T74(],>WO+?/[S_B9VN>#[Y^0B@#[.HKRSX\?';0?@#X0M
M-;UG3]4U:34-2@TC3]+T&T^U7U]>2@F***//+'RI.#_<XR<"O#-<_;(^)?PK
MCT[6_C%\ =0\!>!FOH[74/$=AXHM=9_L[S21'++;6T6\1^9A22>^!YDACC<
M^QJ2LC1]<L/$>EVFI:=>6]]IMY%'<V]U;2"6*>.3_5R(XX((]/6MB@#S3XS_
M !W\#?L^>&;3Q'X^UP^'-'N[U+".\%I-<_O?+DD$1$4<ASB*3MVZUX__ ,/1
M/V8_^BEC_P $.J?_ "+5#_@H-JUEHFE_ 74K^\@L-,L?BWH5W<W5R_EQ6\40
MN3)(\AX  ]:]FTO]IKX1:QJEKIVF?%+P9J=_>21V]O9V>OVLLL\DAQ'''&)2
M23D<#K0!8^+OQJTCX,KX,35[6_O/^$J\267A>Q^P)'(8[JZ\SRI)-\@Q'F,\
MC)'H>WI=?*O[>OWOV<_^RR^'/_;FO6/CQ\=M!^ /A"TUO6=/U35I-0U*#2-/
MTO0;3[5?7UY*"8HHH\\L?*DX/]SC)P* /4J6OCG7/VR/B7\*X].UOXQ? '4/
M 7@9KZ.UU#Q'8>*+76?[.\TD1RRVUM%O$?F84DGO@>9(8XW]@^,'Q]L/A3\,
M[7Q7I6EZE\0[K5O+BT#2O#,?VR76Y989)HO)\H2?NO)BEE,O_/.//SG@@'LU
M)7R?HW[7OCK0/B)X1\-_%WX*:E\,--\5WRZ3I6NVVO1:Y;_VD2/*MIOLT8\K
MS/F )/)7IL$CQ]Y^U'^TQIW[,'AGPEXCUG3_ +5I&L>)+70;ZZ,YC_L^&2.:
M22ZPD<AD\L0G]V!SZT >Z4M?&.J?MI?%?0_#-WXRU7]F/Q1IWPUL9));G5KO
M6[:+58+".4QR7,FF>7Y@(C'F%,[ !GS/+_>5[GXW_:&\'^ _@;-\6[^\N[CP
M2NG6^J6\UK;2>==17!06P2,X(,ADBP),8,H\SRP#@ ]:HKY%U+]I[]H"/2+[
M6[+]E76+OP^L,M]:BZ\664.I2V^-\?F6(CDEBE,9)^SCS)!)^[&:]\^#?Q5T
M/XX?#/0?'/AJ28Z1K$;21+<1^7+'Y<ICDC?W1XY$X]._6@#OZ*^)/A?^WCXZ
M^/'@K2];^%GP(O\ QA>(98_$"/XBATVTTV;S6\FVCN;F(&ZE\H"601H/+$L7
M7S./MN@#PWXT?MB?"+]GSQ-:>'OB!XL;P_K-Q91WT-N=-NKDF$R21^8##%)C
MF*3KZ>]3?!K]K+X5_M :IJ>E_#_Q=%K^H:; +J> VES;3>42!YHCEBC,@W=?
M+SC>F<>8*\__ .<IG_=&_P#W-5A?MH>&=+?XS?LV^(=#M?+^(I\>V6GK=Z?*
M8K^31AYDFH1$1G,MO&"/,)R(Q))T$LF0#[)I*\.^/'[1%I\$[KPSHEGX>U;Q
MKXY\77-Q;>'_  WH\.PW,T40>222:3$<4*%XO,E.=@<R>61')CS1/VT/%7P_
M\7^'-/\ CC\'+KX/^'M>G>PL?%1\1VVK6$-[@%([DQ1@6XD!DQ)(?X2?N"22
M, ^O*6OG3]I3]JZP_9Q\>?#C1]4\.W^N6GC#^T8HYM+_ 'EXDUM'&8K:&V\L
M^=)<RS1Q >9& <<UUGP,^(/Q*\=7&MCXB_"C_A5IMA";$?\ "2VNL&^R9/-/
M[D#RO+Q%UZ^9[4 :GP%^-.C_ +07PMT?Q]X>L[^ST;5O-^RPZFD<=Q^ZEDB/
MF>7)(!S$>_\ @-7XK?%#PW\'_ .J>,/&&I?V5X=T[R?M-Y]FDF\KS)8XHSY<
M8,A_>21]!W[5\H?L1_%O0?@S_P $[_AMK^OO<2I++?6EEING1^=?ZE>R:I=>
M5:VT6?WLLF#B,5ZA^T-\5I? ?[(NL^.OB=\+]+UB:&.SFU+P/>:C%>VI,M]'
M%'%)<-;F.3R_-CD_U9 =."<"0@'TI2UX5^U'^TQIW[,'AGPEXCUG3_M6D:QX
MDM=!OKHSF/\ L^&2.:22ZPD<AD\L0G]V!SZUY-JG[:7Q7T/PS=^,M5_9C\4:
M=\-;&226YU:[UNVBU6"PCE,<ES)IGE^8"(QYA3.P 9\SR_WE 'V;2US_ (7\
M5Z=XW\*Z/XBT>X-UH^K6<5]9W'EE-\,L8DCDP_L0?QKH* "DI:* .?\ %'BO
M3O!'A76/$6L7!M='TFSEOKRX\LOLABC,DDF$]@3^%'A?Q7IWC?PKH_B+1[@W
M6CZM9Q7UG<>64WPRQB2.3#^Q!_&N(_:O_P"36?C+_P!B9K/_ *0RUQ_PK\;+
M\,_V"_!WC 60U ^'_AK8ZM]E\SR_/^SZ7'+LW^_EF@#Z'HKXN\(?MM?$+XP:
M;IVL?"C]GK5?&F@MIEK/=:O?Z['I%K]LESYMM:2W,0%R(9$DBDD3'[R,\8V&
M3T7P'^TWJOQD^!>I>-/ 7P\U#6?&VDW_ /9&I>!-3OAI=U:ZC'(@N+9[F6/R
MQY22&3)'((!$<F4 !]&45^='[$OQ-^+MKXI^)EI9_!(WFC:Q\5M2E\1:F?%M
MK%_PC\TDEL+J+R2,W7V<<^9'@2]!BOI3XS?M)O\ #GQ[IWPZ\'>"-9^)/Q+U
M33CK-OH=C)'96MM9"7R_,N;V4^7"I(D"'$F9$"?)YD>0#Z#HKY6\$_M@:K;?
M%C3?A[\8OAO<?!K6_$4(E\-W%UK<>IV.K3!\26WVF*,1Q2Y\O]V<Y\P=#)%Y
MF]^TI^U=8?LX^//AQH^J>';_ %RT\8?VC%'-I?[R\2:VCC,5M#;>6?.DN99H
MX@/,C ..: /HNBOGC1OCQ\3M/^&?Q'\8?$/X-CP!_P (IHTNK65G_P )3;:G
M_:WEQ32R1^9%'B+'E1CD'/F#TKS7PA^VU\0OC!ING:Q\*/V>M5\::"VF6L]U
MJ]_KL>D6OVR7/FVUI+<Q 7(AD22*21,?O(SQC89 #[1HKQO]GG]H#3?VAO B
M^(;'3-2T#4K.^ET?6]#U*$PW.EZC%M,MM+D<X\P<XZ$9$<@,8\U\2?M2?$?5
M/'VOZ%\*/@-J_P 0]#T.8V-UXCU#7(]"M)KV*:6*:*U^TQD7(BEB>.22,\2
MCH(Y) #ZNHKYS\!_M-ZK\9/@7J7C3P%\/-0UGQMI-_\ V1J7@34[X:7=6NHQ
MR(+BV>YEC\L>4DADR1R" 1')E!\Z?L2_$WXNVOBGXF6EG\$C>:-K'Q6U*7Q%
MJ9\6VL7_  C\TDEL+J+R2,W7V<<^9'@2]!B@#[C_ .%I>&_^%K?\*Z_M(_\
M"7_V/_;W]G_9I/\ CQ\WR?-\S'E_ZWCKGVKM*\+_ .%CZ-_PV9_P@O\ PA=A
M_P )-_P@?]M_\)=NC^U_9?[0\K[!_JO,\K?^]_UF,_\ +/O5#XS?M)O\.?'N
MG?#KP=X(UGXD_$O5-..LV^AV,D=E:VUD)?+\RYO93Y<*DB0(<29D0)\GF1Y
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF.3[:^'G@ZQ^'/@/PWX1TV6::RT#3+73+9[D_O'BBB$49?CT2N?_ .%(:/\
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M/;G5KE-"U;QGX%\+ZM)+/J_@GPMXBEL-"U1I,^<LUL,X$L6(BD1C'EQ@#8:
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MB*7QL_9_\+_M!:1X8T[Q6EQ+I^A:];>(4LH$B\JYEB\S$-Q'+$XDAD$I$D>
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MG]V/+$GF?-Z^5']*]>S10!Y3^U?_ ,FL_&7_ +$S6?\ TAEKRK_G%G_W1O\
M]PM?07Q#\'6/Q&\!^)/".I2S0V6OZ9=:9<O;']XD4L1BD*<>CUS_ /PI#1_^
M%#_\*G^UZA_PC_\ PCG_  B_VO?']K^R?9OLV_/E^7YOE=_+QGMVH I?LH?\
MFL_!K_L3-&_](8J\K_8*^]^T9_V67Q'_ .VU?0/P\\'6/PY\!^&_".FRS366
M@:9:Z9;/<G]X\440BC+\>B5SOPB^"ND?!E?&;Z1=7]Y_PE7B2]\47WV]XY#'
M=77E^;''LC&(\QC@Y(]3V /(/V"OO?M&?]EE\1_^VU>3Q> _B9XF_;N^/]GX
M+^+#?":XO;/P_J$<-QX=MM2DUFVCLA#YT0N<?NHI1)&9(\CS),'I7O%Q^Q]X
M6?XW77Q+\.>(/&'@/4KV_M=0U?1_#&J?8=.UJ>&3S/,N[<Q_O/,W'S " V9/
M^6DDA.[\8OV7_"/QNU+3->U.?5O#7C+2(39Z7XP\,:E+8ZI9Q.1YD<<RG!S^
M]3$@DP)I,8\PT >5:E^R'\8/&GB;P1>>//VB1XUTCPKXEL?$T>EGP3:Z>))K
M:7(_>PRY''F#H?O5L?M#?\GU?LC_ /<W?^FN*N@^&W['>@_#SQIIWC#5/&7C
MSXC^(=',@T>[\;^(I;\Z9YL4D5SY,8$:?O8WP3()/]7&1C%=]XP^">C^,OBM
M\/OB!>WE_#K7@G[>=,AMG06\GVV$0S>8/+R> .A'K0!5_:O_ .36?C+_ -B9
MK/\ Z0RT?LH?\FL_!K_L3-&_](8JZWXA^#K'XC> _$GA'4I9H;+7],NM,N7M
MC^\2*6(Q2%./1Z/AYX.L?ASX#\-^$=-EFFLM TRUTRV>Y/[QXHHA%&7X]$H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;BRCOH;<Z;=7),)DDC\P&&*3',4G7T]Z /<J*^5/^'HG[,?_ $4L?^"'5/\
MY%KZ3UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_ -9([G@ #U]* -BBOF;_
M (>)?L[?\)9_8/\ PL_3_M_VW[!YGV.Z^R^9YNS=]I\KR?+_ .FOF>7CG.*^
M@=8URP\.:7=ZEJ-Y;V.FV<4ES<75S((HH(X_]9([G@ #U]* -BBOEC2?^"D/
M[.>L:G;:?:?$VWMYKF1(HY;O2K^V@^?H9)981''VR\A QFOJ>@ HKYA\2?\
M!1S]G/PGK5QI-[\3["2X@QNETJTNKZWP1_!+;Q21OCZU[KX&\<Z#\3/">F^)
MO#.K6^L:+J$7F6][;DX?U]QS_ 10!U-%8^L:Y8>'-+N]2U&\M['3;.*2YN+J
MYD$44$<?^LD=SP !Z^E?.&D_\%(?V<]8U.VT^T^)MO;S7,B11RW>E7]M!\_0
MR2RPB./MEY"!C- 'U/117RI_P]$_9C_Z*6/_  0ZI_\ (M 'U717FGP8^/'@
M;]H/PS=^(_ .N'Q'H]I>O827AM)K;][Y<<AB ECC.<2Q]N_6O'_^'HG[,?\
MT4L?^"'5/_D6@#ZKHKPWX+_MB?"+]H/Q-=^'OA_XL;Q!K-O927TUN--NK8B$
M21Q^83-%'GF6/IZ^U=E\7/C'X0^"?@Z7Q'XVUZ'PWI*NEN+B6*24O(^,)''&
M#)(>_P @['T- 'H%%<_X7\5Z=XW\*Z/XBT>X-UH^K6<5]9W'EE-\,L8DCDP_
ML0?QKH* "BO(OVH_C@_[-OP-\0_$5=&_X2!=&^S;M.-T;;S1+<Q0@"3RY,<R
MYZ=J]=H *9QFE+87->)^./VL/A5\/]>ET36O%]E!JD7^NM[2.6[\ILB/RY/*
MCD\N3/\ RS.#Q[U<*<ZGP&52I"G\9[=16%X1\8:3X\\-V&OZ#?0ZIHU]%YMM
M=0G(D'M6Y4&HM%%% !129HS0 G%'%<I\0?'FB?#7PK>>(_$5Y_9^C61C^T71
MCD?RO,D$8)" GK(.@[T?$#QYHGPU\*WGB/Q%>?V?HUD8_M%T8Y'\KS)!&"0@
M)ZR#H.]5RR,_:0.MHI,URVD>/-#\0>*M?\-V%X)M9T#[-_:5KY;_ +CS8_-A
M]N1S4FAU5%)10 M%)2T %%)FB@!:*2B@!:*2C- "T4E% "T45SGBCQIH'@RP
MCO?$.N:=H=G(_EQW6J74=M&TAZ1@R$<\4 ;_ #Z4W/M7@ _;P^"&?^1UQ_W"
MK[_XS7JW@3X@>'OB)HL>L^&M3M=6T^<C$UK,'V'"OY<F.4D'F#]VW(S6LZ-:
MG\<#FA7IU/@F==2TE%9'2+1110 4E%+0 RBEKAO#/Q.T[Q5X^\8^$8(;J/4O
M"ILA>RR(@BD^TQ&6+RSGG@?G5*-Q<QW0&*0BN7\&^/=#\=KK']C7_P!M.DZC
M+I%[F)T\NZBQYL7SCG&1T_.NI+5%N48M%)FC-,!:*** "BDS1F@!:*2EH **
M** "BBDH 6BDHS0 M%)D49% "T4E+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MRG\N"ZEO?M,41DQC)B^?'H165J'PW\6?LTZ-JFN?#CQ"NH^ ],2YU2[\#^)
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M_P"UI(K-\&_^RDZ*?_1M=Q\>?B<OP=^$OB7Q8(OM,EC;@6L6TOFYE?RX@_\
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MA\H#ID@_(:ZS]GWY?@/\-AUW>'--[?\ 3M'7S=\)O OQ UCQI\7[3PY\3Y/
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MRL^8WECA!4VPOMOE_?Y2N;%\A[9X>U[^WM!L-3-E>:9]LMH[G[)J$7DW,&\
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M"\'Z7=2:=X@DMI;:+4KZZ/E21Q^8,RQ1QQOG XE3G_EF:ZN11I\\J?)\=_\
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M&[X.L._Q(T8?^C:^@X_NK]*\VMR.$)P1V4/:>TG"H/I:**YSO"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP^T_+( 8Y!CF.20=Z]!HH Q]'T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_\
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MFJZ[_P 2]X8_]5&8HDCX3$>.?^68K1_X80^!_P#T) _\&U]_\>H_X80^!_\
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MC_QCXNMYKJ34O%1LOML4C*8H_LT1BB\L8XX)S[UYS_PPA\#_ /H2?_*M??\
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M*E<F2VV"/S/*Y/'F=ZO_ /#"7P._Z$C_ ,JU]_\ 'J/^&$O@=_T)'_E6OO\
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M_P"/4O\ PPC\#S_S)'_E6OO_ (]1*M0J34YU9Z?W%_\ )BA3JTX>SA3A]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%+10 E%+10 E%+10
M E%+10 4444 )12T4 %%%% !1110 4444 )12T4 %%%% !1110 E&!Z4M% "
M4M%% "44M% "44M% "44M% "44M% !24M% "44M% !1110 E%+10 E+110 4
ME+10 4444 %)2T4 )12T4 )2T44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P# ;1__ ) H_P"%:^(O^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\
MA6OB+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_
M[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\ D"CE
MC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__ ) H_P"%:^(O^BJ>+/\
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M#OL_[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\
MD"CEC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__ ) H_P"%:^(O^BJ>
M+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\ D"C_
M (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_[-&?]FN!_P"%:^(O^BJ>+/\
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M^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\
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M\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P#
M;1__ ) HY8_S!S_W#OL_[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB
M+_HJGBS_ ,!M'_\ D"CEC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__
M ) H_P"%:^(O^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJ
MGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_[-&?]FN!
M_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\ D"CEC_,'/_<.
M^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__ ) H_P"%:^(O^BJ>+/\ P&T?_P"0
M*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL
M_P# ;1__ ) HY8_S!S_W#OL_[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\
MA6OB+_HJGBS_ ,!M'_\ D"CEC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P#
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M_P# ;1__ ) H_P"%:^(O^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\
MA6OB+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_
M[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\ D"CE
MC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__ ) H_P"%:^(O^BJ>+/\
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M#OL_[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\
MD"CEC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P# ;1__ ) H_P"%:^(O^BJ>
M+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\ D"C_
M (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_[-&?]FN!_P"%:^(O^BJ>+/\
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M^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\
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M\P<_]P[[/^S1G_9K@?\ A6OB+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P#
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M_P# ;1__ ) HY8_S!S_W#OL_[-&?]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\
MA6OB+_HJGBS_ ,!M'_\ D"CEC_,'/_<.^S_LT9_V:X'_ (5KXB_Z*IXL_P#
M;1__ ) H_P"%:^(O^BJ>+/\ P&T?_P"0*.6/\P<_]P[[/^S1G_9K@?\ A6OB
M+_HJGBS_ ,!M'_\ D"C_ (5KXB_Z*IXL_P# ;1__ ) HY8_S!S_W#OL_[-&?
M]FN!_P"%:^(O^BJ>+/\ P&T?_P"0*/\ A6OB+_HJGBS_ ,!M'_\ D"CEC_,'
M/_<.^Y_N_K2\_P!W]:X#_A6OB/\ Z*IXL_\  ;1__D"KGAWPCJ^@WDUQ>>--
M<\11F+8+74XK".-/]L?9[6)\_C^%1R?WQ<[_ )#MZ***1L%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_6a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_6a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
M/D/K5;_GZ=W_ ,+V^)7_ $47Q9_X/+K_ ..T?\+V^)7_ $47Q9_X/+K_ ..U
MPE%'U/"?\^0^M5O^?IW7_"]?B3_T47Q9_P"#RZ_^.T?\+Z^)W_11?%G_ (/+
MK_X[7"T4?4L/_P ^4'UJM_S].^_X7S\3/^BD>*__  =W7_QVC_A?/Q,_Z*1X
MK_\ !W=?_':X&BM/J6'_ .?*,OK5;_GZ=]_POGXF?]%(\5_^#NZ_^.T?\+Y^
M)G_12/%?_@[NO_CM<#11]2P__/E!]:K?\_3OO^%\_$S_ **1XK_\'=U_\=H_
MX7S\3/\ HI'BO_P=W7_QVN!HH^I8?_GR@^M5O^?IWW_"^?B9_P!%(\5_^#NZ
M_P#CM'_"^?B9_P!%(\5_^#NZ_P#CM<#11]2P_P#SY0?6JW_/T[[_ (7S\3/^
MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
M\6?^#RZ_^.UPM%'U/#_\^4'UNL=U_P +U^)/_10/%G_@\NO_ ([1_P +U^)/
M_10/%G_@\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]
M?B3_ -% \6?^#RZ_^.UPM%'U/#_\^4'UNL=S_P +V^)/_10/%'_@\NO_ ([1
M'\=/B1']SXB>+#_W'+K_ ..UPU%'U/#_ //E!];K=SOO^%\_$S_HI'BO_P '
M=U_\=H_X7S\3/^BD>*__  =W7_QVN!HI?4L/_P ^4'UJM_S].^_X7S\3/^BD
M>*__  =W7_QVC_A?/Q,_Z*1XK_\ !W=?_':X&BCZEA_^?*#ZU6_Y^G??\+X^
M)@Z?$?Q7_P"#NY_^.UZ%X _;@^+'P_AAMI-9C\2VD4<L<46NQFXY\S?YIE'[
MV7CCF6OG^BLJF78.JK5**-J>+Q5+^'5/U%^$/[>G@#XE-;V.NR'P/K& #'JT
MH%I+S)S'<\=HO^6OE_ZSC?7U("-OJ*_!:OL[]C7]LP^#FL/ 7CV\SH/^JTG6
MKJ7_ (\_^F4O_3+K^\Z1?]<O]5\#G'#CH4_;8+5=C['+<^]M^ZQ.Y^D%%(IR
M!2U\*?9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112'
MH: .=\:>*+'P7X=OM:OS(+:WBW/Y29>O@+Q%K]WXJUJ^U.^8//>2!W5>@ [5
M](?M;>(Y;'P]HNCJTQBU&>6226-\<1_\L_\ R)G_ +9U\N]*_ ^.\RG6Q:P2
MV@?MO!.6^SP;Q[_Y>:"4445^4GZ<%%%%( HHHI@:?AWQ!=^%=:L=4L7"7%G(
M9$5NA![5^@?A;Q)8^+M!L=5T^7S;:\B$D;>HK\Z:^I/V2?$4M]X?UK1G:41:
M=/')'+(^>)/^6?\ Y#S_ -M*_5N \R='%O!/:9^8<;Y;[3#K'K_EWI]Y]'4M
M(**_?#\3,3Q+KUAX5\/ZCK6HRBULM/MI+RYFV[_+BC&^0_D/TK\6OBK\0;SX
ML?$77O%=]%Y,FI7/G>5W2/\ U<<9]XX_*C-?H7_P44\;'P_\"8M%22U\SQ!J
M45M+%,<2BWCS*9(P.I$D<(_[:5^8]?I7"N!Y(/%OT/@>(L5[ZPP4445]\?&:
MA1110 4444 %%%% !1110 4444P"BBOKG]HCXP:;\)_B]XA\*Z-\*?AK<V6F
M&W"3:AX<CDES);Q2D?NY!_ST]!7FXO&U:%94*-*[=W]UO\SMHT56I^UJGR-1
M7OGC?PKX1^*OPHU+XE>#K"+P?K6A/'%XI\.0^;]F<W,H\JYMO^>>9,_N^V/^
MF?[V;]GNXT[PU\&_B_XKN?"_A_Q+>Z'_ &1]BB\1Z=%<11^;<RQ2CU]^".E<
MSS3]PZR6J:5O-V_S-?JO[WV9\^TH7/>OH7PW^T1X0\3:Q#I?CWX2>!8O#UY)
M'%<76@Z;+IMS9 RQ'S#)$9)#TXCBYD]<9SYI\;OAR/A'\6/$?A5;DW4.FW1%
MM(9#+BVDC\R,2_\ 37RY(ZNCCG*K[&M2L]S.KA+4_:TZAPE%?5GQ,^)FF_!O
M2/AM8:;\,/ .K-J'@O3-4N+G6=#CDN7N91)Y@\P8_P">6><\DUY1XX_: _X3
MCPKJ&B_\*Y\ :!]I$7_$PT;1/LUU'^]$O[J7S?;]:FACJ^(UC1T]32IA:5+_
M )>GE5%>\>%[?PY\&O@]X>\=:IX6T_QAXL\37ER-'M];4OIEE;6_[N0R6^1Y
MDDLDAY'',<G4'S(-:^,_@#X@^%-2TWQ/\,M)T#6X[:7^RM9\$1_8C#<XB\F*
MXMO^6L>8_P#6G/\ TRBX\VCZ_6D_W-&ZV_S#ZHK7J53PZBO:?A7H'ASPC\*?
M$'Q,\3:%'XIN(]5AT/0=+O'86OVPQ_:99;B,8\V/RA'^[!^?]Y'CD2UL:=\?
M/A[XRM[O2OB!\)/#^G64I!35? UG_9M_9R^5+^\P>).L7^LD$7_77%%3'U6V
MJ%&]MP^J+>I4/GZBBBO8O97/.MJ%.4 M@G%?7?[1GQBTSX3_ !@\0^%=&^$_
MPTN;'2S;".6_\-QR2YDMHI2,1R#O)Z"N)\<:?X.^-7P3UOXD^'_#%AX)\6^&
M+VUAUK3M+E?['<VTD4<<<L,7E;(SYG_++I@2>9YG[NO#IYE7G"G4K4;4JG4]
M>>!2]I3IU#YXHKZ#_9YNM-\,?!SXO^*[KPOX>\2WVB_V1]BB\2:;%<Q1^;<R
MQ2CU[YX]!5!OVJMW_-'?A,/IX7_^VUJ\=7]M5HT*-[>?DG^IC]4I*E[6K5/"
MZ*]!^&\UMXR^/OAB2\TK3H+75O%%M++I<-L!:B*6ZB_=>6>/+_Z9&J/QFT^W
MTGXQ>.[*SACM[6VU^^BBMX8_*B2+[5+^[KHCB&ZZH-:VN<GL?W7M3C***^N?
MVB/C!IOPG^+WB'PKH_PI^&MS9:8;<)-J'AR.27,EO%*1^[D'_/3T%3C,;5H5
ME0HTKMW_  M_F;4:*K4_:U3Y&HKT7XB?&C_A8VAQ::? G@KPMY=P+G[7X=TG
M[-=28\W]WYOF_P"K/FUF?!GP%)\4OBIX9\*)%+/#J%[''="&2..:.U_ULLO[
MSG_5>;TJ_K$HT'7Q"M87L4ZOLJ1QM%?4'[7WA?PEKGA_0_B%X%TW2['1O[2O
MO#M[#H4EJ+82VMS)]EE'E ?O)8O-E_ZYF/Z2?.GA'P[<^,O%6C:!:2QPW6K7
MT5A'-+_JO,EE\JIP>-6,H>W>EM_(,3A?95?9&517T?XY^+'A/X/>+]9\&^#O
MA=X5U33]$N9+&XO_ !C9_P!IWU[<Q?NI9?-\W]W%^[/[OZ=#)Y=>;?&3Q1X!
M\:7.EZKX,\*7G@R_N!<G5M+%WYMAYID_=26O_P"[CC_U?E],GGHXZM7:_<Z/
MJ;U,'3I?\O#SFBOI^3QIIGPC_9T^$>IP_#WP5XEO]>&K_;;KQ'H\=Q)^ZNCY
M7[P?]=>]<)X@_:0.O:+?:>/A9\--/^VP2VYN=/T#RKFW\T$>9')YO^LYS]12
MHXZO7?[FCI=K?L["J86E27[RJ>-T445[1YH4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
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M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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M>UT5R?@+XD:)\2+6[DTJYD^UV,OE7VGW4?E7=C+_ ,\I8JE_X3JP_P"%D?\
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M];\1Z7%;S7]EY(ACNE/EDR31Q=O^NE87[1W_  F7_"N-:_X1O^QO[*_LJ_\
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M7E?]^ZJ^.OB-JFG>)+;P=X4TF/6_%-U;?;S]KF\JVL;7S/*^U2G_ ):_O/\
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MC=F;Y'ZU=KGX9O)E_=UM6LWG1YK!FQ9HIE/K,U"BBB@ HHHH **** "BBB@
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MS1X3^'I\._$/QIXH^V^<?$@L2UIY6/LYMH?*_P!9UDSUYKO:* .%^)'P\/Q
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MYDAD.>I-;_@OPV/"G@W0=#^T"Z_LNRAL?.V;/-\J,1YQVZ5T-% ' W'P[/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *K74/G"K-,H RJ*LW$?EC-5J\\ZD%%%%!L%%%% !1110 4444 %%%%
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MHHH-@HHHH **** "HJEJ*@ JI=V?G?ZNK=%!B<_16KJ%G_RUCK*K4R"BBB@
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M@C_T1WP!_P"$Q8__ !JC_AE'X(_]$=\ ?^$Q8_\ QJO5:* /*O\ AE'X(_\
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M6?@K_P!$>\ _^$S8_P#QJC_AEGX*_P#1'O /_A,V/_QJO4**+L+'P_\ L:?
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MWGQ&F^"'BA/&UEX*M_$FD2:K<>!9(X+BYUWS;..58HII#')_HOF"4^5&<YY
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MXO\ 5+F.VM8S_J^9)*>H'%?\,L_!7_HCW@'_ ,)FQ_\ C5'_  RS\%?^B/>
M?_"9L?\ XU70_P#"U/!O_"<?\(;_ ,)?H/\ PEW_ $+W]I1?VA_JO-_X]?\
M6X\K][77TM1JS/);K]E/X,R?ZKX1^!1]/#-A_P#&JRO^&8/@]_T2/P+_ .$S
M8?\ QJNV\)?&CP!\0M2?3?"GCGPSXGU*.(W#6NC:M;74L<8ZRF.*0X'[SK2_
M$#XE>"?ARUK_ ,)=XLT'PG)>>9Y']M:E%8?:/+_UOE^;_K?]:/S%:ZF1Q/\
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MP_\ C5>JT4&IY5_PRO\ !G_HD?@7_P )FP_^-4?\,K_!G_HD?@7_ ,)FP_\
MC5>JT4 >5?\ #*_P9_Z)'X%_\)FP_P#C5'_#*_P9_P"B1^!?_"9L/_C5>JT4
M >5?\,K_  9_Z)'X%_\ "9L/_C5'_#*_P9_Z)'X%_P#"9L/_ (U7JM% 'E7_
M  RO\&?^B1^!?_"9L/\ XU1_PRO\&?\ HD?@7_PF;#_XU7JM% 'E7_#*_P &
M?^B1^!?_  F;#_XU1_PRO\&?^B1^!?\ PF;#_P"-5ZK10!Y5_P ,K_!G_HD?
M@7_PF;#_ .-4?\,K_!G_ *)'X%_\)FP_^-5ZK10!Y5_PRO\ !G_HD?@7_P )
MFP_^-4?\,K_!G_HD?@7_ ,)FP_\ C5>JT4 >5?\ #+'P9_Z)'X%_\)FP_P#C
M595U^RS\'H?^:3^!?_"9M?\ XU7M5130Q314&1XK_P ,R_![_HD_@7_PGK#_
M .-4?\,R_![_ *)/X%_\)ZP_^-5ZI=V<L-5:U,KL\U_X9E^#W_1)_ O_ (3U
MA_\ &J/^&9?@]_T2?P+_ .$]8?\ QJO2J* NSS7_ (9E^#W_ $2?P+_X3UA_
M\:H_X9E^#W_1)_ O_A/6'_QJO2J* NSS7_AF7X/?]$G\"_\ A/6'_P :H_X9
ME^#W_1)_ O\ X3UA_P#&J]*HH"[/-?\ AF7X/?\ 1)_ O_A/6'_QJC_AF7X/
M?]$G\"_^$]8?_&J]*HH"[/-?^&9?@]_T2?P+_P"$]8?_ !JC_AF7X/?]$G\"
M_P#A/6'_ ,:KTJB@+L\U_P"&9?@]_P!$G\"_^$]8?_&J/^&9?@]_T2?P+_X3
MUA_\:KTJB@+L\U_X9E^#W_1)_ O_ (3UA_\ &J/^&9?@]_T2?P+_ .$]8?\
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M=!O-+&I:-J4WE2(]S]F$D4L5RY,1>2&:,2>3^]CD)S0!G_MU?$76/A'^R?\
M$CQ)H,WV?6$L8K6VN?,D22V:YGBM?-C,>#')&)?,C;/#CZUW'_"A_A]_PI7_
M (59_P (E8?\(#]A^Q?V%SY7EYSG.?,\WS/WGF_ZSS/WF?,YK)O/@L_C[0]7
MT_XHZR_CZSUBS:RN-%@LC8Z/%'NZQ6WF22"3,<4GFRS2RQR1DQ-$)#'7._\
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M^)? <A'AN[@L1<65O;2IY-S:R6GF1@Q2PA8_W9CDCP/+D'(H \0\=>,M:O\
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M6W=UXJ\22>7)%*U]>R>:/,B(C$4HB\F*2*., 21^V3A_\%1/^3%_B9]=+_\
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MUS]H'X>_%CQ/\0[K5M5\+I?02Z';:<;?2?\ 2+>2/-K'YDDEMS(&DDEDF,A
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M.1I&F>+- NM3NM(M3C%K%<QW\/FQ1D'RO,C,D<9$?F'R\@ N?L@^%_&O@_\
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M\3I?B#X[UV'QIXKMH?L>AO;::;"PT2VDC F^RVQEE_>RG_6W)D\PC$8,<0Y
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MD\7?]$+^('_@=X>_^6M'_"Y/%W_1"_B!_P"!WA[_ .6M>K44 >4_\+D\7?\
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M][]AT3P]HRI+?:E(,>9Y<;R1H(XHR9)99'2., 9.2 0"O_PN3Q=_T0OX@?\
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MG_A<GB[_ *(7\0/_  .\/?\ RUH_X7)XN_Z(7\0/_ [P]_\ +6O5J* /*?\
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M  BOB.^\,7WV](T,EU;>7YLD?ER?ZK]X.O)]!6]8_$'PMJW@^;Q=8>)-+O\
MPK#%+<'6K6]CEL1'$<2R^</W?[KRY/RI_(DYC_A;WBW_ *(CX^_\#O#W_P M
M*/\ A;WBW_HB/C[_ ,#O#W_RTI?A)\:A\88X=2TOPCXFT_PO>1376F^)-6BM
MK:UU*+S1'%)%%YQN1YH_>1F6*(&/!],^G4AH\P_X6]XM_P"B(^/O_ [P]_\
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MM:/^%P>*O^B'^.__  /T+_Y:UZM10!Y3_P +@\5?]$/\=_\ @?H7_P M:/\
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M_'?_ ('Z%_\ +6C_ (7!XJ_Z(?X[_P# _0O_ ):UZM10!Y3_ ,+@\5?]$/\
M'?\ X'Z%_P#+6E_X6UXJ_P"B'^.O_ [0?_EK7JM% CR&;XF>*9O]7\$O'/\
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MK1[O0[J?Q=&9M+U.2VDNH,:%I8 /V:22/D#/$IX/KQ7L=>5_"/\ Y*!\;O\
ML;[7_P!,.C4 >J4444 15+452T 15M:3_P >M8M=%:Q^7;HOH*QJ"IDU%%%9
M&P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7F^-VM^)OB%K/A'X7^%;+Q=%X<W0:[KVJ:R^G:79ZAN!^PQS1VUR;BY )DD
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M^-VM^)OB%K/A'X7^%;+Q=%X<W0:[KVJ:R^G:79ZAN!^PQS1VUR;BY )DD C
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M-%\+ZA_:_AW3=)L[33M1\Z.7[3:QQ)'%+YL?[N3,8!R.O6@#N:*** "BBB@
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M#W_RJH_X4WXN_P"BZ?$#_P  ?#W_ ,JJ /5J*\I_X4WXN_Z+I\0/_ 'P]_\
M*JC_ (4WXN_Z+I\0/_ 'P]_\JJ /5J*\I_X4WXN_Z+I\0/\ P!\/?_*JC_A3
M?B[_ *+I\0/_  !\/?\ RJH ]6KG?#?A/1/"_P!O?1M(T_1VU.\DU"]_L^U2
M$W-S(09)92G^LE..9#S^5<7_ ,*;\7?]%T^('_@#X>_^55'_  IOQ=_T73X@
M?^ /A[_Y54 =GJ7A/0]7\0:5KE_I.GW6MZ.9?[.O[JUC>YL_-'ER>5)U3S
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MJ>8  <=>_H.,_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ _P# 'P]_\JJ
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MGQ _\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/?_*J@#U:BO*?^%-^+O\ HNGQ _\
M 'P]_P#*JC_A3?B[_HNGQ _\ ?#W_P JJ /*OV"OO?M&?]EE\1_^VU?5=?"7
M[%OPWU_5_P#A>WV+XK^+M#-K\5]=MYOL-KI!-[(/)_TJ7S;&0>8^1GRQ''P,
M1CO]+_\ "F_%W_1=/B!_X ^'O_E50!O^//A)X,^)TE@?&/@W0?%OV 2?9?[<
MTZ*^%OYF/,\L2@XSY<?3T%;'AGPQH?@W1+;1M!TG3]"T>W/^CV&EVL=M;+SO
M)CCC  YYX]ZXC_A3?B[_ *+I\0/_  !\/?\ RJH_X4WXN_Z+I\0/_ 'P]_\
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MJC_A3?B[_HNGQ _\ ?#W_P JJ /2[V'SHCC[_:L*N-_X4WXN_P"BY^/_ /P
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M9^TQI^E?$_Q%:'6(C_PFWV&Q\.74L(,-JFD"]6&2*V/EYCN/,\TK+YG^L(H
M^\:*_/WXB_M#>+OB-_P2C?XG6FJ7_A_QG)8V44^K:7=_9KGS8M7BMIIHY(O+
M">;Y4A\N/H)?+[5V'[46E>+/V;_@!??%JS^(7B?Q%\1?"TUA<7-U?7LL6E:O
MYES%;2Q3:2DGV:.$Q3$XBCCD!2-Q+Y@D=P#Z'^/7QITC]GWX6ZQX]\0V=_>:
M-I/E?:H=,2.2X_>RQQ#R_,DC!YE'?_ ^EU\:_P#!3[P[:ZI^QSXRUB>?5(;G
M3Q9-!'!J5S';.9M0M01+!'((KCCIYHD\OK'@\U[A-\,_#G@WP;XBV>)_$FBZ
M9<)')J>IZQXLOYS:VL)\R;R[F]ED-J#$)=\L1C<9R)(WC22, ]:KS/XN_&K2
M/@RO@Q-7M;^\_P"$J\267A>Q^P)'(8[JZ\SRI)-\@Q'F,\C)'H>WRWX[^+O@
MKX9_$7X07/PD^+B^*K_7?&5CX7UKP_-XZF\16]QIM\2)+CR9;F5XI(I(XO+F
MC,?,A$GF"3!W/V_?!>F:MJGP#U*:YU>*:[^)^@:7-';:Y?6L(BD^TDO'''*(
MXI<D_P"D1@2CH)!0!]/?$'Q)XG\._P#".GPSX3;Q2+S5[:RU,C48[/\ LVQD
MSYU]B0'S?*X_=#DYXZ5VU?(O[3]O>?!JQ^!VF^$M>\3:;;:O\6M"M+V6Z\1W
MU])=6\GFB2VDEN)I)#$?+&8L^7WQG-=+\3-6\0?#/]K;X;ZY>:O,?AWXNT^?
MP>]A<:C]EL+#5\R7MK<^49/WL]SY4EOQ&.@'F'S!&0#Z5HKXX_:$^,FN+\?+
MG3M(GU >%OA1X/OO'_B.UTF_DBBU6\$;_8M+NY(O^/;(CDN?+D\P2QX_=$"N
M5^&7Q \ ^./AG#XQ\6?M,:?I7Q/\16AUB(_\)M]AL?#EU+"##:II O5ADBMC
MY>8[CS/-*R^9_K"* /O&BO"/V./BWJ7QX_9K\#>--9.=;O[)H;Z92#]HEMII
M;628>7'&!YK1-+Y>/W?F <X!/N] !1110 4444 %%%% !1110 4444 %%%%
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M"RYUC4M8\.>"[_2[K1KG6;F2[U".+4;62XEMI;F3]Y)'')_JC)^\ X,DF!@
M^H:\3?XZ7OBSQEXB\,?#7PY;^+M3\/3+;:QJ^I:DVFZ/;7&<264=S'#<R2W4
M8\HR1QQ&.,2'S)8Y,1GVROEG_@G+J$WBK]E'PYXKU&.WDU[Q)J.K:QJM_';Q
MQF\O9-2N0\KA.,XCC&0!Q&!V% 'J?ASQ[XMD\3)H'BSP,=&NGLI=1AU30]1_
MM/1O+CDCC,4EQ)#;2QW.9,^68O+,8)$AQ((_4Z** .?\4>*].\$>%=8\1:Q<
M&UT?2;.6^O+CRR^R&*,R2283V!/X5X[X/^,'Q,^+6AV?B?PO\,M,TWPQJ<,-
MQI,GBOQ<;*_OK:6**83&VM;6ZCB'[P@ R^9^[.1'G%<?_P %"(_[5\$_"[P?
M<YD\.^,OB3H>@:W9[R/MMC+,\LD6\?O(_P!Y#&<QD$8Z\U[YXVU#QQ8269\(
M:#X?UO?Y@N!K6MS:9Y8X\OR_*M+GS"?WG7R\8'X &?\ "OQQK7CC0WN_$/@W
M6O FN6,T=M?Z3JAAE1I##'*7MKF*0QW$0,GE^;QDQ.-D?(KT:OG?X9_M3_\
M"6?"_P"+?C#Q)X8&B_\ "MM8U?2]1L=-OOMWVG^SHHY9I8WDCBSG) !':N>^
M$?PENOC1\&M,\9>,O'WC.?Q9XTTJ'6OM'AOQ)?:-;:,+JWC,5M8V\4WE8BC\
MO!F\TR2 R29\S% 'U317Q?X-^+_B_P 3_L=_M!G6]?N-1\:?#Z3Q5X=?Q3;1
M)8RWLUK%+)%=1QQ8%L<21< \>5G-=?\ L@?#/4!\)_ /COQ?XY\7>-/%NL:/
M:ZHMQ?:W=1644<MC&(H191R_9Y/+CQF26.2627?*3G&T ^D[N'_EI52OCO\
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MOLNA/J,6G_:@9HQ(/M$GR1D1[Y/?R_4U\S?M^^"],U;5/@'J4USJ\4UW\3]
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M;6]MI9)(X[JQE'E27,.8XQ(?*C\N23R^N0.,MO&GBWXO_M&?$7P-I'BZ_P#
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ML_.D_P"F5("WI]G_ ,M9*T**?7*:A1110 4444 %%%% !1110 4444 %%%%
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M^9C$A&3UW_#2WA+_ * _C_\ \-SXA_\ D"C_ (:6\)?] ?Q__P"&Y\0__(%
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M?>%([>^U[P3XKLO&%GH\TOV?^U6M1*/LHF/$1D,AQ(01Q[[ZZO\ X:6\)?\
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M]E%S8QQ6_P"[+!Y<R#'[L''>NP_X:6\)?] ?Q_\ ^&Y\0_\ R!1_PTMX2_Z
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M)?._M+2],D5[6'$TGE>61++UB\LG]X>2>G2J/_#2WA+_ * _C_\ \-SXA_\
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MQ(1G_6=*Z_\ X:'\*_\ 0%\>?^&Z\0__ "!3XOVBO"O_ "TTCQZ?I\.?$/\
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MO]1TV*ZOY"!SYD5S+#'&,Y)\WS,1R?NR0@DK_P##2WA+_H#^/_\ PW/B'_Y
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M_P#AN?$/_P @4 >K45Y3_P -+>$O^@/X_P#_  W/B'_Y H_X:6\)?] ?Q_\
M^&Y\0_\ R!0!ZM17E/\ PTMX2_Z _C__ ,-SXA_^0*/^&EO"7_0'\?\ _AN?
M$/\ \@4 >K45Y3_PTMX2_P"@/X__ /#<^(?_ ) H_P"&EO"7_0'\?_\ AN?$
M/_R!0!ZM44D(E'SUY=_PTMX2_P"@/X__ /#<^(?_ ) H_P"&EO"7_0'\?_\
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M?^2=ZM_V.?BS_P!2+4*]9KR;]FW_ ))WJW_8Y^+/_4BU"O6: "BBB@ HHHH
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M\:>,M&\<^,O#.L>']-EU/3KZ\\=:I<P"^BQ);0R17MU+;RB67RHC%)&?,\W
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M= D<I_>(8_\ 6<5Z5K&N6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_ *R1W/
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MN+^.(VT9'FQB3S)1Y9.),5Y__P $N_\ DQ?X9_75/_3I=T ?55%%% !1110
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M?B#1XIK::ZL[B2XA$?VB0Q11O( ^(HC'& 1QY8%>=?\ !43_ ),7^)GUTO\
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M?'?B[PAJ%O:26,T.AW5O):W$1<2;I+6YAFB\S(($L<8D_>8SCBJG@?X#>&?
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M&H7%E;6!\S ,DL5E;6XG.!A!)Y@C,A( )S7K- 'RI^T-_P GU?LC_P#<W?\
MIKBJ3X-:C+XH_;C_ &BI=2AM[F;PWIOAG2-)O1;Q>;;V<MO-=2PB0 $B263S
M",_PIG_5QX]:\8?!/1_&7Q6^'WQ O;R_AUKP3]O.F0VSH+>3[;"(9O,'EY/
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M8WQFUW]GG]GCQ5\0- @L+O5]'^S>1!J4<DELWFW44)\P1R1G_EKGKV'6O<:
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M?%GAC1M<&G7^DMJ5G%<_V?J41ANK?S(P_E2QY_=R#.".Q%=%0 4444 %%%%
M!117A?[-/QFUSXQ+\5&UJVL+<^%?'>J>%;/[##)&9;:V\KRY)?,D/[P^9SC
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M9X-\4:C\8O@OX7\1:+=MX0U'Q5I5AJPD2'[;)8)<1I)*$W@1EQ&SA'DC\OS
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M=<_X>,?\))_8NI?\(_\ \*I_L_\ MC[/)]D^U?VQYGD^=M\OS?+_ 'GE]<4
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MGN-2CEACNKFYE(DQF6XACCDCEQY7F$P^9C/4>/;3XV?"[X(^)?B'/\2(=?\
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M2(RZ7<116\LUN8I#YD;\Q2B20_NY 8Z /:/@!\7/$/BCX@?%CX;^+9(;_7?
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M% 'DW[-O_).]6_['/Q9_ZD6H5ZS7DW[-O_).]6_['/Q9_P"I%J%>LT %%%%
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MY9YZ<=:[6@ HHHH **** "BBB@ HKAO%7Q1\/>%O'/A#P=J>I?9/$/BD7?\
M9%G]DED^U?98O-N/W@'EIB/G]X1UXS7<T %%%% 'C7Q@^!\GQ'UWP?XIT76?
M^$:\=>#;V:YT76I+;[;;>7,!%=VTML9(Q)'+%F/[\<D9.8Y!SG#\;? /Q1\<
M/#<OA'XI>,=,U?P7=26]S>:;X7\/R:9+?&*9)DCEN9;JY/E9B&1#Y4GW?WO_
M #T^@:* .#TWX::+8_$+5/&TD+7GBBZMHM-&H74*&2VL8V\P6T1 &(S*7E/7
M,DG)(CB2/O*** "BBB@ HHHH **** "BBB@ KR+]J/X'O^TE\#?$/PZ76?\
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M_DG>K?\ 8Y^+/_4BU"O6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^5/V"OO?M&?]EE\1_\
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M^BVUI+I\_E8\Z6UC-R+FZCB;S(\VT,GF&.01>;WH?&+PS\4;SX$?%2TUK7M
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M)JUGH_[+/Q;N;^\@LK>7PMJ-J)+EQ&/,FMY(HD!]7DDC3WS0!H_&S]H#PO\
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M ."C&A0:C?75GI%]\,KNWT>&XD,=M<WW]IQ2745L&.))O)CBDD$?[P1QQ$\
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M7QYX@^'EI]IF/B328-,\N:&&22*6ZCMI+T7 CRCG]Y$,(-YP!5SXJ?$3X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD\0^*1:_VO>?:Y9/M7V6+RK?]V3Y:8C_ .>8'7G-/^%/PO\ #?P?\ Z7X/\
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MAC5?#FO7GQ,UN6RUJSFO=#OKS3I3"T0CNH)(Y9;620&3RQ)Y9D!.,@5]I44
M<MX&\#:#\,_">F^&?#.DV^CZ+I\7EV]E;@X3U]SS_&37$7'[-G@>36-<U>SB
M\0:#<ZY>G4-0A\-^)=2TB"YNC_K93#;7,4?FN$7?)C+[<DY.:]@HH X/PO\
M"CPGX)^'=MX"TG0+&S\&V]D;'^Q3");>2.0_O(I/,SY@D)?S/,&9/,Y.2:X_
M0_V3_ASH$WAGR-.U:\M?#<L5SH>GZQXDU+4;*QEBC,44L5M<W,L0:.-L1GR_
MW?48XQ[910!\K?MQ^ +_ .(FE_!?3+;PW<>)M/7XFZ'=:O91Z?\ :X8[#_2A
M-+<Q@?ZK#@2&3]WSSU->I>'_ -GGP'X7\86'B.PT6X&J:/'+::,;O4[JYMM+
MAEV"6.QMI99(K4;(Q'B&./\ =CRQB/BO5Z* .*^(7PO\.?$[_A'4\1Z>VH?V
M!JUMKVG#SY(OL]];D^5+\A[>8>.G/2L_Q]\'O"WQ3O-'O/$-G<RZIHCRRZ9J
M=AJ%S87M@9(_+D\JYMWBE021_?0/@C&0<"O1:* /,O!OP+\'_#[Q)?>)["SU
M&\\275DEC)JNLZQ?:M=?98Y#*(8Y+J:5XX_,)D\M#@G!ZXKTVBB@#S36/@/X
M%U[XR:)\3]0T7[1X\T6R^PV.K&\F!@B(E'EB(2>7_P O$O)CS^\Z]*-8^ _@
M77OC)HGQ/U#1?M'CS1;+[#8ZL;R8&"(B4>6(A)Y?_+Q+R8\_O.O2O2Z* .&\
M5?"[P]XI\<^$/&.IZ;]K\0^%A=?V1>?:Y8_LOVJ+RKC]V#Y;YC_YZ ].,4?$
M+X7^'/BQHEII/BK2SJ%O:7D=];7$=Q+:W%O=1',<\4T1CDBD!Z/&01S7<T4
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MK\0^%A=?V1>?:Y8_LOVJ+RKC]V#Y;YC_ .>@/3C%/^*WPO\ #?Q@\ ZIX/\
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M /P>\+?"R\UB\\/6=S%JFMO%+J>IW^H7-_>WYCC\N/S;FX>65Q'']Q"^ ,X
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MJ]>4?!W_ )*-\=/^QTMO_4=T:@#U>BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /)OV;?\ DG>K?]CGXL_]2+4*]9KR;]FW_DG>K?\
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MP+\5:WK'[8_[3&AWFK:A=:1HQ\,_V;875S)+;V7G6$DDWE1DXB\P\G ZC\*
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M((/%NH>&/%.I>'#XKMXXHXM<CB<2PW<447[J(&.6' !?_5GDYH ^E**^9/\
M@G7XFU?QI^QW\/M;\0ZIJ&N:O=-?FXOM3N9+JXF(O[F,>9)(<G  '7H*\V^
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MM >';_QYXEM/ >A1Z&'\+Z=?R6B2S3V(D#17,4@EM!OC>1Q;&,S&3]X2 8W
M/M:BOE[]F?Q-J]C\<_CG\++G6-2UCPYX+O\ 2[K1KG6;F2[U".+4;62XEMI;
MF3]Y)'')_JC)^\ X,DF!C$^%MUKO[5?Q4^*NK>(]6U?0_!'@GQ!<^#]$T'PU
MXAOM,-S<V\O^DWMW):F*24N/)\L>9LC!E!C)'F2 ';?!GXG>)/%7[4G[0/@_
M4]2^T^'O"@\/C2;/R8T^RBYL9);C]X%#RYD&?WA..U?0U?$O[%/A/4_ _P"U
M+^T_H&J>*-2\7W5@?#4,>L:LH%W-%]CG\GSO^>LD<7E1F4C,OE^8?]97T/\
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M1K?XM^(3%I.@ZE<:5+)=9AW2RW5O+'+(OEX$<0V1\R&3S3Y7D^J?L2>-M?\
M%7A'X@Z#XAUBZU^3P-XXU3P?9:KJ#&6^O;*U\KRI;F3_ ):2GS#F3 SU[F@#
MU[X?>)/$_B+_ (2(^)O";>%A9ZO<V6F$ZC'>?VE8QX\F^Q&!Y7F\_NCR,<]:
M[:OE3]D7Q!XD\=:3^T#;WWB/5IFM?B?X@TO3;Z2Y^T3:;;1^4(DMEF$L8$>[
M*1^7Y8]#R*\C_:1^,'PZ^#?PQN?'7PC^-?\ ;/C?0;JTNK31)OB1<Z[;:G')
M-'%-;S65Q=2B2/RI9'S'LDC\L2"08H ^N_B[\:M(^#*^#$U>UO[S_A*O$EEX
M7L?L"1R&.ZNO,\J23?(,1YC/(R1Z'MZ97Q7^W[X+TS5M4^ >I37.KQ37?Q/T
M#2YH[;7+ZUA$4GVDEXXXY1'%+DG_ $B,"4=!(*V/VV+>Y^!7[%7Q&O/!NO>)
MM*U2"6QFCU:7Q%?7=_"9+ZUBE$=S/-)*@*<;!)C!/% 'UY7#_"OQ-XE\6>!]
M,U/QAX47P3XEN/,^U:$FHQ:A]E ED$8^T1?NY"8@DG'3?ZBL'X3_  =N?AY'
M!?:GXO\ $WC+Q1/%*FIZIKFK7)M;J2202R&*P$OV:V&[B/RH\QQCR\]<_(_P
MA^/WCK0_V#_@E<VFO7&H>,_'_BK_ (0^'Q5KDTE[+IIN;^]077ER'-T8HXB(
MXI),$^7G('ED _0ZBO$-'^ #^";;2+CPOXZ\;6^K:?-:?;;S7-=N=;&K6\<D
M9NHI;:ZD>&(S1H1YMM'%)&3F/Y,QR>WT %?//P9^)WB3Q5^U)^T#X/U/4OM/
MA[PH/#XTFS\F-/LHN;&26X_>!0\N9!G]X3CM7$_"VZUW]JOXJ?%75O$>K:OH
M?@CP3X@N?!^B:#X:\0WVF&YN;>7_ $F]NY+4Q22EQY/ECS-D8,H,9(\R3!_8
MI\)ZGX'_ &I?VG] U3Q1J7B^ZL#X:ACUC5E NYHOL<_D^=_SUDCB\J,RD9E\
MOS#_ *R@#ZD^'WB3Q/XB_P"$B/B;PFWA86>KW-EIA.HQWG]I6,>/)OL1@>5Y
MO/[H\C'/6NVKX1\%_$KXL3? 7]J74_!$VH^+?'6A_$C7K'0K2^<W\EM;QR6O
M[NVBE/6*$RR1PC(\Q<".3/EGTO\ 9KU3X:>(I-&E\*?$3Q=J?BBSM7_MCPWX
MP\4W5[K">5^YECO]-N99?L\L=P(R7BCB_>!1&_E2&.0 ^HZ*^4_ \C_M/?$_
MXCZQJ/B/Q18>$_!_B&[\':5X9T74;K1E>ZMD@>[OKJ:TN1)<,96\N($B...,
M_N_,E.'_  MUWQ#\.?VKO$GP9O/$>J>,O"]YX4C\9:&VM7 N;K25-_+#+:&X
M(\VY!DD!2663,<<,<?)_>4 ?5-%?$/A'P[XD^,7[;WQUTO5_'_BZQ\$^&/[#
MEB\*:3K%S91237.F'GSHI(Y88P?.D,<1C\R0Q/)GR@#UWQ*USQ+XK_:0\$?L
M_P"A:G?^'O"%GX<3Q7XAU:UUBZBUF^M8KDVT-E'=#,HS+'$99?,\V6,R?O8S
MGS0#JOC-\3O$GA7]J3]G[P?IFI?9O#WBL>(!JUGY,;_:A;6,<MO^\*EXL2'/
M[LC/>OH:O@WQG\,IOA_^WY^SK):>*]>UGPWJ)\1R6.D:]?RZE+ILT>E".4Q7
M-Q(\QCE_=?NI#^[DCD(/[W WO'/QH\.>-?VIO%W@+QY\3(?A?X,^'L-E+'IT
M7B5M$N?$EY?6QE,LMRDL4HBMD(_<Q'EY!)))C$8 /M2BOD;X#_&BSE_:D\4_
M"WPWX\A^(?@6;PO;>(M'NX]6_M+^QI8[C[-<VCW1DEFNC+))'-F67]V/W8&*
MY/\ 9E\#Z[\9/B!\<=7\8_$;QIJ/A[1?B'KFAZ1X=T_7[W3XK7$T,AD\ZVFC
ME<",QQQPD^7&!*0#YO !]RT5\-VWCJSO/CI\2].^/OBGQ-\-GBU&6'P?YOB.
M]\.>'+S1XMOERVMQ;744=S=$S>9<"21I/WD001^7)&GV3H=G=Z7IEM;76H76
MMSP(D;ZA="(2W'?S)!%'''G_ *YH![4 ;=%%% !1110 5Y1\'?\ DHWQT_['
M2V_]1W1J]7KRCX._\E&^.G_8Z6W_ *CNC4 >KT444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!Y-^S;_R3O5O^QS\6?\ J1:A7K->3?LV
M_P#).]6_['/Q9_ZD6H5ZS0!\E>'6?X7_ /!1#QA8;/*TSXG>#[35?M&H9'VC
M5--?[-]EM#QN M9/-DC_ 'D@XDR$XKUC6/V;? ^K>-M>\8?9=?TKQ'KXMO[3
MO-$\5:GIAO/)B\J(2QVUU&A\N,8''KZ\R_%#X%:#\4O&?@+Q)?W&KZ5K7@O4
MS?:;?Z/=FWW"3!FMI>IDBE\N,2#'(&,X,E>L4 ?'OP>_99NO"7[47QA\3:E'
MXFMO#U[/H<GAN_D\8W\OV\V]JPN/M6+HR7 CEQA+K(QQ'\F:?^U+!??$C]H[
M]G/X::?=P/!:^()?'>JRV]J;BYL(=,'^BF3$G[N*:266'S9./-QC/,9^OZ\H
MT'X$Z'HOQX\0?%?[9JNH^)=8TZ+2(UO=0+VVFV<9C+0VT6T;!))&)7R3^\/&
M-\F0#U>BBB@ HHHH **** "BBB@ HHHH *^;OV9?@[JGA'3OC?IOC70;9]/\
M6?$+7-9M;.[:&XBO=-NO+6/S(\D8D_>#RY/Q%?2-% 'R'^S7^S/XL^'/CQSX
M\NX]>\-> 4N=!^&[221W5U]BN9A++=7$GE"19%B%I9#R_+2..&:,1>61))IZ
M#\#?&-S\;OVI]1>2X\*6'C[3=(L/#GB2VN(Y)HY8=-EM9;F...7S(VBEE!&?
M+]CWKZIHH ^)(_#/Q4T/]D)_@;HOP2\G6X_#-]X9N-4BU[3K;1Y_]%N(C?0D
M2?:));F0QR".6WB_>7)\V1,&2M;XT_ WQOXP_P""<%A\+=)T(W'CV+PUX?TY
M])>YBB_>VLMIYL9E\SRN!#+SYF*^Q:* /GGXS?#'Q)XJ_:D_9^\8:9IOVGP]
MX4'B ZM>>=&GV47-C'%;_NRP>7,@Q^[!QWH^,WPQ\2>*OVI/V?O&&F:;]I\/
M>%!X@.K7GG1I]E%S8QQ6_P"[+!Y<R#'[L''>OH:B@ KY:\:>$_&_AK]M^+XH
MZ;X#U;Q?X6;X>?\ ",E]&O-.BG2]_M(W/^KNKJ'@1X.?4]^:^I:* /E/Q_X.
M^(/[0?Q0^&R:QX,NO 7PY\&Z]:^*[NYUG4;635=1OH8I1:PV\=K)<QB*.0Q^
M;YL@>02_N\>7RJ>!/'OP7_:J\?\ Q!T3PO=>/?!OQ TVR-W9Z3-:P:AIM[8I
M';Q#-S=0QR12122R9!+[QC"8S+]5T4 ?*?[-OPW^)_AC]H+X_P#C/XA:-I6F
M1^+9M%_LR;1;DW5K+#;V\T6,R$2YCC,8D,D<>^3S#&,8J+XWV?CSXZ?!_7_
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MXPU/3?LWA[Q6/#YTF\\Z-_M0MK&2*X_=AB\6)#C]X!GM1\&?ACXD\*_M2?M
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MH^#O_)1OCI_V.EM_ZCNC5ZO7E'P=_P"2C?'3_L=+;_U'=&H ]7HHHH ****
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MVPBN)([VUN3:R_9[F5[:;R?-D$=R(_\ 52CJ,4 ?H;17AO[2FK> -(E^%/\
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MY<L=O<S2VS>7G/G1QX(\LD2&-"SQK\<-+\#>+M$\'6FC:UXO\9:O#+=P>'=
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M 4444 %%%% !1110 4444 %%%% !7E'P=_Y*-\=/^QTMO_4=T:O5Z\H^#O\
MR4;XZ?\ 8Z6W_J.Z-0!ZO1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'DW[-O\ R3O5O^QS\6?^I%J%>LUY-^S;_P D[U;_ +'/Q9_Z
MD6H5ZS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[6=]*3<PV,D5L+&7RY/W@BDABQ$?N&.+]WP*]U_X5;X;_P"%K?\ "Q?[-/\
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MY8^G)!'''()KZ \%_"?1? ^I2:EI]YXHNI)(_+\K6?%>J:G%C_KE=7,L>?\
M;QFIO%7PN\/>*?'/A#QCJ>F_:_$/A877]D7GVN6/[+]JB\JX_=@^6^8_^>@/
M3C%=S0!\J?L%?>_:,_[++XC_ /;:H/'S'XE?MZ?"BST(_:&^&6D:OJ_B2[W9
MAMSJ=NMM:6N4SMN#Y?F^7)Y?[KYP37I-M^RS\/M,U+7]2TV+Q-H\^M:E<ZQJ
M*:+XQU?3X[F]F.9I3%#=1QY)'7';VKM_!?@70OA_I,NF^'M+325N)A=W4T8'
MG7UT0/,N;F7[\TLGE@22R9>3'))H ^5_A#J'C/XJ?M"?$WXU^#M!T'Q/X?\
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M#RC_ ()\ZM9:WI?QZU*PO(+_ $R^^+>NW=M=6S^9%<12BV,<B2#@@CTKV/\
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M?=7Z6G@ZTMM)NY_/N?#<-Q<QZ%<2&../S)=+\S[%(0(X3DQ'YXQ)GS!D7?\
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MV._B#K?A[5-0T/5[5K V]]IES):W$)-_;1GRY(SD9!(Z]#0!]-T444 %%%%
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M\=ZIXJL_L,TDABMKGRO+CE\R,?O!Y?.,CD8- 'SC\.?^37?V[?\ L=/'G_I
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M$^+-8UC]BG]J+PWK&J:CKY\$WGC'PO9ZMK$\ES?7EM%;2R127,LG,D@\[R^
M!B-.*]8\%^$/C=\(/ ,O@#PJG@WQAIFDQ_8?"VO>(M5N;&ZAL1&/LL5];6]C
M)'+Y6/+,D4D7FQHO^JD)JU:_LSOX5_9N^)/@33=976?%7C6RU6XU;7M5'DQW
MVL7UMY<MS+'&"+:(Y3$40_=QI_RT.20#QCQMXV\8>&/V(?V;=!\(>(6\)ZGX
M^;PMX.?7HX3+<:9'<V($DL(\P8ES%^1./+DQ(.=_X*%_LI_#/X=_LA^(->\'
M>'(_"%_X?BL;5&T)3:_VA;27MI'Y%\1S=#(BES+F3S84?/\ K-_T%KO[,=_X
MN_9?^&W@&Y\0VWAOQIX*AT.YTSQ%:VXOH;+4[".*/SHHI#'YH.V1 )/^>G(R
M,5Q'[1GP-^/O[2GP&N?!%_J/@7P;=R_9&O8;"ZNKZUUN6.1'(\V2V22QB$B"
M48%R[D1Q^9&/,,@!O_MD>$_&VOS?#G4-.\,3_$;X<:+J5Q?^,_ ]E<1Q76JQ
MQQ^9:RB(X^U"*1'D^RY_>R>4/+/6/L_V=?$OP=\0-XFA^#T6FZ5_9M^NGZ_H
M6GZ7+I!LKE/,YEL98XC%*<F,R^7F3R?+)_<XC[/Q[)\2K2XT6?P5:^%]1ACD
MD_M73->N+BU:6/R_W7V>ZBBE\LI)R?,@D\P$X,>*X'X?_!_Q/<_'C6/C'XWD
MTFSUJ3P_%X3TK1-$NI;NUBL!-]IDEN+B2&(RS/-G'EQ1QQQC'[PG( /6O%GV
M&V\*ZR^LZI_96E"RE^W:@U\;$6\0C/F2_:4*&+ &?-!!3&1CM\"_M0>*O@YX
M5_9_G^(_P9\%3^"O&.DO8ZSX;\8:-\/[[1H<27,47_'R;6**2*6VFE'E2DQ2
MB4<'BOL[]I+X*67[0OP6\3^ -1U";2H-:CB_TVWC\PQ21RQ2QG9D;QOB3CTX
MKPS]H;X1_M#?M'? S4OAWJ,/PQ\,-?V5O]NNK;4M2NOMUU%<VLO[K-K']EB_
M=RGG[2>8X^,F4 %7]KSPF/&_[7'[+&CRZCJ>FK-+XEE>XT>_DLKLB.RM9?*$
MT7[R,2>7Y<GEX/ER28(SD6O$/A?0_@1^VE\#=/\ A[I6G^"-*\<6FN6/B+2]
M%MDMK74H[*U%S;&2&,"(212R2?O0!)AS'GRSBO4OB?\ !W7_ !I^T9\$?']C
M-81:-X'_ +<_M&*YE?SY?MUK'#&(ALZ@@DY(]*/B?\'=?\:?M&?!'Q_8S6$6
MC>!_[<_M&*YE?SY?MUK'#&(ALZ@@DY(]* /-_BY!??&O]L_PE\(M>DMYOAQI
M7A7_ (3;4]!\ABNMW$=\;:&&Y_> &&*7RIO+(,<AC_>>9\GE\5XW^"?A3X1_
MM]?LXWO@[3!H%CKI\22W&@:>ODZ9%+'I8B^T0VZXCBDDC\L2% /,\F,XSDGV
M_P"+7P7\4WGQB\+_ !=^'&I:9:>+=-TM]$U+2]:BE^S:YIDMS'*+8W,?F?93
M$?-D22.*0[RGF9C&*Y;5/@?\4_&W[3GPI^*_B;4O#UAH'A&+5$E\+V+33&T^
MU6LD7FQ73Q1_:3(63>)(K?RQ& !)S(X!]64444 %%%% !1110 4444 %%%%
M!7E'P=_Y*-\=/^QTMO\ U'=&KU>O*/@[_P E&^.G_8Z6W_J.Z-0!ZO1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DW[-O_ "3O5O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O*/@[_R4;XZ?]CI;?\ J.Z-7J]>4?!W_DHWQT_['2V_]1W1J /5Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \F_9M_Y)WJW_ &.?
MBS_U(M0KUFO)OV;?^2=ZM_V.?BS_ -2+4*]9H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y4_
M8*^]^T9_V67Q'_[;5]5U\J?L%?>_:,_[++XC_P#;:OJN@#P[QE\;-0M?B9:_
M#KX?>'+?QIXLM8Q>ZW]HU1K/3] MWC)B-U="&4B64_ZJVCC,ACS(?+C )Y?X
MW^,/$&L_L\_'72?%/A2[\-:GIO@G4)GN+2X^VZ3>^=:W07[+=;(Y9#'Y7[R.
M6*+R_-Z/&T<AQ_AE_P 4'^WA\;+;Q /[(?Q]9:'?^%WNSB+5H[&RDAO1#)T\
MV(MDQD^9L_> >7S78?M+>/- UCX)_'WPO8ZQ!>:YH/@J^FU"QA&39FYL;DPB
M4C@&01.0G7&"?OQY /.M+^(>A_#S]F']DU]:\&:?XO&MW7A/1K'[=Y>=-NIK
M']W?1;XI/WL0CR,>6>?]8*]#^//[2\OP1^)7PL\'P^"=6\9W'CB:^@C31)4^
MU0?9DA(Q'+B.0'S?WDDDL8BCCD<G KP#XC?\FN_L)?\ 8Z> _P#T@->K_M#?
M\GU?LC_]S=_Z:XJ .TT7XZ:WHOQ>T'X>_$3PMI_AG5_%%I<W7AJ_T;5)-4M+
MZ6W'FW5N_F6]O+#)'$8I.8_+<9'F>8-A?_PL?1O^&S/^$%_X0NP_X2;_ (0/
M^V_^$NW1_:_LO]H>5]@_U7F>5O\ WO\ K,9_Y9]ZXC]H;_D^K]D?_N;O_37%
M2?\ .4S_ +HW_P"YJ@#J/#7QZ\3_ !8UC6;GX7>$=,\4>$-/D^PQ>*M=UZ;3
M+35KA&D$WV$16MSYL4141FYS'')(9/+\P1YKM[7QUXF\1>#;35]"\!ZE!KEU
M>36AT7Q5<QZ:+,Q2R1RS7$L7VC]V?*/E&$3>9YL1&(R9(_&/^"=C?\(C^SU8
M?#35MVG>.? ]]?66OZ%,,75E)+=W%S%GM)%)%)')'+'F.09P3@U;^+7[0UUX
MBUKX0:7\.?%5OI7A7Q_KU[I4WQ$MHXKF*U^QD_Z+;&5/LS2W4D,D44DGF?\
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M_1M/^RFX\.ZGY?V:Z\RZBCQ)YD4O^K,@E_U9_P!7V[<S^S#\2/&GB?Q)\3O
M?BK6X?'<_@/5+>Q@\?65HEC%JLDD7G36DD468XYK63$4GEG.#'YD8.?,S/\
M@J)_R8O\3/KI?_ITM* .G^//[2\OP1^)7PL\'P^"=6\9W'CB:^@C31)4^U0?
M9DA(Q'+B.0'S?WDDDL8BCCD<G JYHOQTUO1?B]H/P]^(GA;3_#.K^*+2YNO#
M5_HVJ2:I:7TMN/-NK=_,M[>6&2.(Q2<Q^6XR/,\P;#Q?[0W_ "?5^R/_ -S=
M_P"FN*C]H;_D^K]D?_N;O_37%0!]5U\R6O[4'B/6OVA/B'\(?#GPXFU;4O"L
M5C,FN7.HFWTO=<P12DW4WE226I_>E(DCCN#*0>(HXY''TW7RI^SS_P GU?M<
M?]RC_P"FN6@#7\+_ +4'B'Q;XLUKX?6'PXN'^*'A^1SK%DVI?\2*PA/E2VL\
MNI>3OQ<PR9BC%L9=\<@DBC2,RUU_P?\ CA)\1]=\8>%M:T;_ (1KQUX-O8;;
M6M%CN?MMMY<P,MI<Q7(CC$D<L6)/N1R1DXDC'&?.?V>?^3ZOVN/^Y1_]-<M'
M[//_ "?5^UQ_W*/_ *:Y: /2O ?QRD\=?&[XM?#I=#^P/X#_ +(QJ*W7F?;O
MMUJ9A^Z\L>5Y> .LF>O'2CP'\<I/'7QN^+7PZ70_L#^ _P"R,:BMUYGV[[=:
MF8?NO+'E>7@#K)GKQTKR7X)Z@OA__@H%^TCHM]'<66H:_IGA[5],BDM9?].L
M[:V^SRS1OCR]L<LR1=>OO')6;^R+XZT#XD_M?_M2^(/"NIVVKZ)=/X9BBOK5
MLQ2F*RN8I#&1]_\ >1R?/W[<4 6?V,9M:L=#_:/D\/6%CJFL?\+A\1?9[74[
MV2SMW_X]O]9)'#*4./\ IF:RO^"9-]XX?]E7X:V\>@: ?!8;43_:W]N3?V@<
M7MUG_0OLGE_ZT8_X^>GS]?W===^P5][]HS_LLOB/_P!MJK?\$T9#8_L=>$-#
MG)AUG1+W5+#5+&4A+JQN?M]S)Y,T?_+*7$L9\N3! <4 :GP[^/NC6WPN_:"\
M9Z+X L/#9\">(_$,5]9V$T<?]MW5C$LLMU-(D(\N67N2)",]9*L:7^T+\1O&
MGP9L?B/X0^%<.H:-+H$>L+8:IK=Q:ZA=2?9O.DALK>*PE,PSF*.23RO-D7*1
MF(QR2>*_#G_DUW]NW_L=/'G_ *0"O8/V8OCQX#TO]B3P5XPF\7Z?!X>\+^&[
M+3]6O9<XL;JVMHHIH9(L>9Y@DV@1\F3S(C'N\R/(!P'[<7Q*TCXO?\$U/%'C
M;0+LW&DZW9Z3>0,70O'G4[7,<GELP$L9S'(,\/&1VKZ)^-7QJM/A':Z;;6FG
MW'B?QEKTIL_#GA6Q<"ZU>YP2P!)Q%%& ));B3$<48SR2 ?A_QUX'\0?#;_@C
M#=>'_%.FW&DZU;1V\LUC=Y\V(2Z]%+&) ?N'RY(_W9Y'YU[?^V/H-WH_QP_9
M[\;W.O:EX+\'>';[6-/UCQG9I;S?V1)?6T,5J9?.BECBBEE!B\V6/RX_,Y,>
M8S0!ZI=?'36O!?CKP;X;^)?A>Q\.GQ=?36.DZGHNL2:C8174<1D$5U-<6UKY
M4DH 2&.,2&4^;TQ7NM?-OQ(^!.C:AJGP^NOB3\9?$VI0Z1XHL-3T6QUB71;&
M*ZUB(G[-$/*L8I)&DS)^[$F3Z9 (^DJ /AS6-3^(,?\ P4FO7T[PSX:N-33X
M82PVL=QXCNHHI; ZQ^[FED%C(8IL]8O+DC':4U-KWB[7]'_X*)V$D/A][WQ/
M>?"".WCTJQN)'M$O#JY,AENO*'EVT8$A\Z2/)V_NXI)9(XI.JU0-HO\ P4QT
MJXNL6=OK/PKET[3I)_W<=Y<Q:IYTL4>?];)'%^\,8R1'SP.:G_YRF?\ =&__
M '-4 >@> ?CU>:I\5-5^%WB[PW'X;\<V>G1Z[;V^GZB=2L=0TQY!$;F*Y,41
M3RY=T<D<L<9Z&/S!47C+XV:A:_$RU^'7P^\.6_C3Q9:QB]UO[1JC6>GZ!;O&
M3$;JZ$,I$LI_U5M'&9#'F0^7& 3PG_.4S_NC?_N:KB]%\&ZMI/[>/Q<@O?'6
MN?#63QU9Z1>>'/[+BL)(]?BL['RKORY;JUN%\VW8\Q#RY-DOF8\O! !]!?#C
MXU#Q7\1O$/P^US1_^$7\<>'[.WU&XM8[KS[*_MIB0)K"62.*2YBC($4LGDQB
M.4^7SU/F7@+]J3Q_\8O'WCWPWX+^%,#P^#=?OM!O=>U_Q ]EI\C6\JQPB*6.
MTFDDF?$KR1>7B)#%F0^:*Z[P7\(O#7AC]HR3Q1J?Q-U;QA\3F\+G2SINM7.F
MQ2II'VH2B3[-:VT)P)A_K,=\5R/[!7WOVC/^RR^(_P#VVH ]>\1>*OB2VM7E
MOX6\%:#?Z3;;8_M^O>)9=/DN)",DQ1Q6-SF,9"9<QOYB2#R]FR22E\#?C1:_
M&[PG=ZE#87.AZYH^I7&@:]HMV_F_V=J5O_Q\6WFQCRYL9!$L?!!'?Y!Y3X1^
M('BGXQ>.OC1<ZQ\1K[X3:/X U:72%T*PM],$L5C%$91JUW-?6TI$=T#YD9Q'
M&(X3_K.9*R_^"<%Y;WGA/XV7-KK:^([>3XIZY(FMK)%(+Y#':_Z1NB C/FY\
MS,8V<\8% '1? G]ICQQ^T9\*M*\9^#?AMI]I'>-,+V/Q'XAFL;6)XYY4\NVE
MCLI3<\1[Y)?*CC'FB,/))'*(NN^'_P"U'X5\:? 6Y^)VO3-X$L]*,UOXAT_4
M90;K0[Z&3RY;69 -_F>9@1QF,22"6+]V#)Y=>*_\$P/BEX4D_8NT6R'B"PBG
M\)?;AX@CN)O*_LN.2YN;F.68R8Q%Y1SYO^KXDYS')CS*^^%OBSXC_L*?M(3^
M'/#^IZA'XZ\<7WB[PU'%$8[C5---]92Q7,<4F)<R1VTCQQD;Y  0#YD>0#Z7
MU#]HKQUX/^%MW\2O%'PDGTGP-;)-J$EC#J\MQXDAL3,?+EEL/LWE1D(8Y98C
M=?NHO-SS%Y==/^T3^T-8_ W]GC5_BMIFG0>,M-LH;*ZMX+>_$,-[#<W,44<B
M7'ER _ZT2# /Z@UQ?_"':9\:O@GJFL2?M#>+M5^&FO:1<_;-0\K0+:V-B\<D
M=R9)3I:&/ $GF$E#&<YP17'?MI>$;&Q_X)MZ[X;\&33^)M$TO0='ATRZMB+G
M[396UQ:L+G?%PX$,9E,@_=X&: /=?VH_C@_[-OP-\0_$5=&_X2!=&^S;M.-T
M;;S1+<Q0@"3RY,<RYZ=J\4_X*A/K]K^QWXT6VT_3KK1)!9?VE<W%])'<VQ^W
MVOEF*+R9!+DDYS+'Y?4>9TKG?^"D7Q@\':M^P[J(MM=@>3QU#IL_AN+9+'+J
M48N;6Y,HB*^8!Y6"3)T.S."^*])_X*3:/?ZW^Q9\3;?3K:XO9%@LKDQ6\?F$
M117UM++)QVCCBD<]L"@#MO&7C/Q/H/P:^(VO_$/P'X:ELM)\/7=__8VGZZ^H
MQZE'%;RR2VTQEL8A&"!LZ2@^8>/7 7]H31?!'P1^&^J:-X7-SXC\9:39?\(C
M\.]#DC#W4DEK'+]FB.T)%;6\;#S+D@111C/]R,]!^TEKEEXB_9*^*FJ:7=P7
MVG7G@?5+FVNK:021SQR6$ICDCDZ$$=_>OF5&'A71_P!A7XEZL5T_P-X:\.O8
MZYX@N?\ CTTR2^T>UMK7S<?ZN.27$?FG$<9/[PC- 'U9H_CSQ[9^(-+TGQ9X
M M[:+5)3%!JGA?5Y=8M+,I%+*?MOFV]K)"'$>R.2-)09" _E_N_,]8KCM4\>
M:#X>\3>'/#VI:I!;:UXEGF@TRP*L);MHHI)I2H](XXAF3IS&"<R1@V/'VO7_
M (7\">(M:TW2+C7;W3--N;VVTJV_UM[+'&9([>/ /,A&S@'KTH \F\=?&3XD
M?#OP=JGC#4?A;IC^&-'B_M"^M;?Q5_Q.+:P0_O9/LQM?LS2Q1^9(81=&/]W^
M[EDR#5WXV_M*:5\*?V8;WXR:+I[^+=%6SL;^QMS*;$W<5S-#'#)F2(F/B82<
MQ]NE?.?C?Q-JGC+]A77/B/XM^/EQ;R>+?"U_/'HMA'H]KI<UU-;32_V1#YEM
M)<2&,[K8C[093Y3G@YI?VD_^4..D_P#8E>$__1NGT ?1.A?';6]-\$ZA\0OB
M5X8L?A3X M[5[Y)=:U>236(XA,/)%U9BV\N&22,\Q)++)YDL<6/,Z86H?M%>
M.O!_PMN_B5XH^$D^D^!K9)M0DL8=7EN/$D-B9CY<LMA]F\J,A#'++$;K]U%Y
MN>8O+I?^"@G@?Q#\2OV1?B!X>\+:=<:OK5REI)#8VF6FE$5]%+($'\9\N.3]
MWU_2J/\ PAVF?&KX)ZIK$G[0WB[5?AIKVD7/VS4/*T"VMC8O')'<F24Z6ACP
M!)YA)0QG.<$4 >VZAXDFNO",6M>%+:'Q6]\D4NFM#?1QVUT)<>7+]I.<0XDW
MF2,2'RP3''(<1GS/5?CCXL^&/BCP?IGQ'\(Z1H.A^*]270=.UO0/$$NJB'4I
M?^/:WN(I+6UDQ+B0"6,28,?[S8/WE<E\9/'5S^SS^S#\/=/^'.K1+HES-H_A
M2U\=ZALO+70],D3RH]8EP!%*!&(L$F.(R31]OW9\U_:\L6\->//V?-$U/XM:
MIXOUR3XG>'KP>&M;_LB.:*U$TT?VOR;6UAE_U@\OS.8^2.O- 'T!K7QTUO6O
MB]KWP]^'?A;3_$VK^%[2VNO$M_K.J2:7:6,MP/-M;=/+M[B6:22(2R<1^6@P
M/,\P[!Z9X7UC5M1TBVEU;2&T?5,F.ZL/M"W$<<@8C=')QYD9V^8G$;^6PWQQ
MR9C'C_CKX&^#/B%\4M<\5^!O%+>"OC9HUC%97VL>&[J"YN$CDBD^S1:G92>9
M'+&0(Y/WL8D(MXO+E'E+BG^SA^T)>^)_@GXO\6^-[ZVNK#P;J.I:?)XUL;4B
MS\0:?8GG5(8H\Y$@$PQ#YD?F12>7U$8 /I>BN?\ "_BO3O&_A71_$6CW!NM'
MU:SBOK.X\LIOAEC$D<F']B#^-=!0 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %>4?!W_DHWQT_['2V_]1W1J]7KRCX._P#)1OCI_P!CI;?^H[HU
M 'J]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >3?LV
M_P#).]6_['/Q9_ZD6H5ZS7S)\%_@IH/C#PWK^K7VJ>+XKJX\8^)PT.D^,=7L
M+7"Z[?CY(;:ZBB0G')QDGKDFO1?^&:?"7_08\?\ _AQO$/\ \GT >K45Y3_P
MS3X2_P"@QX__ /#C>(?_ )/H_P"&:?"7_08\?_\ AQO$/_R?0!ZM17E/_#-/
MA+_H,>/_ /PXWB'_ .3Z/^&:?"7_ $&/'_\ X<;Q#_\ )] 'JU%>4_\ #-/A
M+_H,>/\ _P .-XA_^3Z/^&:?"7_08\?_ /AQO$/_ ,GT >K45Y3_ ,,T^$O^
M@QX__P##C>(?_D^C_AFGPE_T&/'_ /X<;Q#_ /)] 'JU%>4_\,T^$O\ H,>/
M_P#PXWB'_P"3Z/\ AFGPE_T&/'__ (<;Q#_\GT >K45Y3_PS3X2_Z#'C_P#\
M.-XA_P#D^C_AFGPE_P!!CQ__ .'&\0__ "?0!ZM17E/_  S3X2_Z#'C_ /\
M#C>(?_D^C_AFGPE_T&/'_P#X<;Q#_P#)] 'JU%>4_P##-/A+_H,>/_\ PXWB
M'_Y/H_X9I\)?]!CQ_P#^'&\0_P#R?0!ZM17E/_#-/A+_ *#'C_\ \.-XA_\
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M_P ,T^$O^@QX_P#_  XWB'_Y/H_X9I\)?]!CQ_\ ^'&\0_\ R?0!ZM17E/\
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MWR/-_P!9Y6_]YY><9YZU6\;?#WPI\1M+ATWQ5X;TGQ-8QR_:8K36K&*ZA24
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M_AFGPE_T&/'_ /X<;Q#_ /)] 'JU%>4_\,T^$O\ H,>/_P#PXWB'_P"3Z/\
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M0_\ R?0!ZM17E/\ PS3X2_Z#'C__ ,.-XA_^3Z/^&:?"7_08\?\ _AQO$/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN?BWXA\3^+3I_B:[NDT/P_HVM7^A6NE:=:W<UM%YB65T/-N9=ADEEDD?M'&
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M9NQ^[MN>LN(Q^B^BZ7%HNEV5A&UR\=O%'&LEY<2W4IV?WY9"9)#P?WCDYZT
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MVTD,-Q+']JP/+'EL\9F CD'S21F*0"0?-_COXN^"OAG\1?A!<_"3XN+XJO\
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MO.*Y_6?B+/X3^"M[XV\6:%-H\^DZ!)K6K:+;R1W$EL8K<S36T<G$<A&#&""
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M&?\ A&]1-@/$/Q(T?P_J2^1&_P!HLKGSO-C^<'!/ECD<TWXW?%#Q'\)?CO\
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M/B+6;:RBBO=4^RBU-Y,(QYLWE)Q'O;GR^@Z<XK-\;:AXXL)+,^$-!\/ZWO\
M,%P-:UN;3/+''E^7Y5I<^83^\Z^7C _  Y#X/_'"3XCZ[XP\+:UHW_"->.O!
MM[#;:UHL=S]MMO+F!EM+F*Y$<8DCEBQ)]R.2,G$D8XSP?Q^_:SU;X/\ @7QG
MXGTSX9Z]JVB^$[Y+6\U76)1H]K>^9+'$19>8)+B7$EQ'B3RDAD$4I27B,2<S
M^QO-J>B_&+XSZ7\2%^S?'#6+VTUC6)UB%O8W>EQB2VL!IH\P_:+:(1\RE(Y
M;D1RYDCK=_X*B?\ )B_Q,^NE_P#ITM* /JJBBB@#C/&WB&X\&^'I=8M=$U;Q
M+)!-!$NDZ/''+=R"66.(;?-DCC &_P QY)' 2,2$G&37DWQ(^/GC/X&Z+;>+
M?B-X$T*Q\#6]Y#;ZOK/AWQ5-J5QIJ2'RX[DV\MA;>9&)3%&XC<R8D)$<F,5]
M&5\<_M[3:M\6[7PO^SUX6A>[\0^/+R&ZU>ZCB6Y&B:';74<LM](OG1^7^]$0
MCSQ+Y<D0/F>70![9\<OC1:_!'PG::E-87.N:YK&I6^@:#HMH_E?VCJ5Q_P >
M]MYL@\N'."3+)P #W^0\SJOQQ\6?#'Q1X/TSXC^$=(T'0_%>I+H.G:WH'B"7
M51#J4O\ Q[6]Q%):VLF)<2 2QB3!C_>;!^\KF?V@-6O8?VT/V6M,CNYHM.NY
M_$UU-:^8?+DEBTK;%(4SUC$LF,\_O'J/_@J)_P F+_$SZZ7_ .G2TH ]7\1^
M/?%L?B9] \)^!CK-TEE%J,VJ:YJ/]F:-Y<DDD8BCN(X;F62YS'GRQ%Y8C()D
M&8Q)C> ?CU>:I\5-5^%WB[PW'X;\<V>G1Z[;V^GZB=2L=0TQY!$;F*Y,413R
MY=T<D<L<9Z&/S!7ME?'O[/LVH_'']K;X@_&JVC%OX%TS2!X$\-7RH&CUN..Z
M,MU<QR"4AXX[B)_+D0>7)'*.DD<HH ]+UKXZ:WK7Q>U[X>_#OPMI_B;5_"]I
M;77B6_UG5)-+M+&6X'FVMNGEV]Q+-))$)9.(_+08'F>8=@TO@_\ '"3XCZ[X
MP\+:UHW_  C7CKP;>PVVM:+'<_;;;RY@9;2YBN1'&)(Y8L2?<CDC)Q)&.,\%
M^Q#K%]K5[^T)/J%U/?2Q?%G7+3SKB3?^ZBBM(HH_7$<4<<8]A57_ )RF?]T;
M_P#<U0!]645C:Y'JK:5>#3+FTMM0:.3[--=6IFB23C9OB$D9D^GF1Y]1U' _
M\(S\;O\ HH?@#_PA;[_Y<T >KT5S/@NU\5V>ER1^+-5TG6;_ ,S*2Z-I,FG1
M>7Z&.2YN,GWWCZ5TU !1110 4444 %%%% !1110 4444 %%%% !7E'P=_P"2
MC?'3_L=+;_U'=&KU>O*/@[_R4;XZ?]CI;?\ J.Z-0!ZO1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% 'DW[-O_).]6_['/Q9_P"I%J%>
MLUY-^S;_ ,D[U;_L<_%G_J1:A7K- 'B7Q=^.C_#?XF_#'P'IOABX\2:OX]U.
M:VC<:A';)9V5K'')=W19\^88XY XA S)B3G. ^YXR_:$\%>!/'T?@G4KO5KO
MQ0^FC61I>C:!J.IS?8C*8O.Q:PR\>9QGM^5>._#WS/'G_!0[XK:V0;%_ ?@W
M2?"30J?,-[]ND;4OM(SCR_+(\OR_GSUR.E7O&GA/QOX:_;?B^*.F^ ]6\7^%
MF^'G_",E]&O-.BG2]_M(W/\ J[JZAX$>#GU/?F@#W'P/\2='\?+>KI=EKUH+
M3RP_]M>'[_2?OY'[LW4,7F=#G9GMZBN+TOXRO-^TMJGPBU/16MKI/#,'BJPU
M.VN_-BN+;[3]FECEC,<?E2"4< &421DDF,_NZD^&'[17A/XK>*=<\)6OV_P]
MX]T$%M7\)Z_;BVO[-/,*B48,D<L9!CD$L,DD>)8N1YHKR[]L)3X1^+'[,_CV
MQ99];L_'D?AF*.48M_LNK0RQ74A'_/0+$OEG/7.1)0!]:T444 %%%% !1110
M 4444 %%%% !7G?C3XR>%O NI1Z+J%W=W6O21_:QI&C:?<:G?BW)V_:_LEK'
M++Y/F?N_-\O9YG'6O1*^4_V!KFS\<_";4OBZUO=+KWQ(UO4M:OOM=P+F2WBB
MNIK6VLDFV!S%%%#^[&.,R=!Q0![1X+^,GA;QUJ4FBZ?=W=KKT<?VLZ1K.GW&
MF7YMP=OVO[)=1Q2^3YG[OS?+V>9QUKT2N6U[3)&+:MINFZ?J/B2SL[B&PDO7
M\K'F>63%Y@CDDCBD>*+S, _ZH'!Q7AGQL^*_Q-_9H\#-\0_%6J^$?%_@W2+N
MVCUJQT?0+K3;\V\LHA\VWEDOKF-Y$EEB/E2!-X$G[V/@D ^G**\"_:B^.6N_
M [2?AM=^'=+MM;G\1^-M-\.3Z?/DRRV]P)C(MOF6.,3'RP(S+)Y?K7-_&;XM
M_%#]GGP[H_CWQ7-X4U/P''JMK9^);+2].NHKG1+&Y;ROM*79N3]K\J5XA^[M
M8S*#D1Q9_=@'M'BKXH^'O"WCGPAX.U/4OLGB'Q2+O^R+/[)+)]J^RQ>;<?O
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MHK=>9]N^W6IF'[KRQY7EX ZR9Z\=*]AKY4_9Y_Y/J_:X_P"Y1_\ 37+7U70
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MX9>)/@W^RSX)\'^,--_L?Q#IOVXW%F)XYO*\R^N)8_WD1,9/ER(>#WKZ#HH
M^?/V%?AEXD^#?[+/@GP?XPTW^Q_$.F_;C<68GCF\KS+ZXEC_ 'D1,9/ER(>#
MWKTCXD:IXMT709M0\%:38>(-:L]TXT._N#:#4T$;9BCN<%;>7/ED221NAQY9
M,?F&6/NZ* /D3]I#PG\5/VK/AT_PNL? <_P[T+5IH9=:\2^+;ZRD,-M#<0R"
M.UMK&ZF,TI()_>F./$6,_O08^R_: ^&/B/4OBI\'OBEX8TUO$MU\/[R_CN?#
MD5Q';75];W\,=O+)#+*1%YD0_>>7(8Q)S^]C(&?HFB@#Y?\ %G@7QH/BIX5^
M/?ACPCJ-QXA72#X3U_P-JUW917[:8;TR_:;2:.4VPN8Y/WOER2F.2+C,4@I?
M&7@WQG^TI\1/ 9U[PMJ7P[\"^"]9M?%@DU>XLY]2U75(3(+>VBCM9I8HK:,$
MO))*?,D+QI&$YDKZ?HH ^:=3^'OBWX+?M">)_B5X4T"Y\>Z)X^6Q@\1:39W5
MO;:EI\]G;R1VEQ;?:)8HI87C_=2QR2"3S&$B$C,8]1\%ZSXV\3:IK&H:WX>A
M\(Z#)#;IIEC=W4<^J"4&47+70B,EN@_U7E"*67C)D()\N/T6B@#X/^&7[&_C
M@?L8_#/0)-1/PY^-7@2\O=3T75$>.X%M-)=71^S2R)YF;:XBE02)'G_EGYB2
M!#&WU_\ #W6M=\2>$]+U+Q'X>N/">LW$)-]HUW<Q7+6LA ^7S8B8Y.G!'8CA
M#E*[&B@#@?C9X+N_B)\'/'OA73FABU'7O#]_I5M+/_JXY)K:2*/?[9D&:/@G
MX+N_AW\'/ 7A746AEU'0?#]AI5S+!_JY)(;:.*39[9C.*[ZB@#D?B)?>(]-^
M'_B.\\(6-OJ?BFVT^XETFPN6!BN+P1DQ1R?O(Q@R8!_>#@GFO%O@3^Q_\/\
M1?A/X93QUX T#Q'XYN+3[=K^J>)M-LM2OY=1N29;I9;DQGS<2R21@Y.0!R>M
M?2]% 'RO-^SI;_"3]IKP5\0OA1X)TNST.[TZX\+>*]+T>WM;+[-;22_:+>^A
MCS%&Q$T8$QS))Y0B$<1/2/P!X.^(/[/GQ0^)*:/X,NO'OPY\9:]=>*[2YT;4
M;6/5=.OIHHA=0W$=U);1F*202>5Y4A>,1?O,^9Q]644 ?*?[-OPW^)_AC]H+
MX_\ C/XA:-I6F1^+9M%_LR;1;DW5K+#;V\T6,R$2YCC,8D,D<>^3S#&,8JK^
MS_X3^)W[,GAF^^%,'@'_ (3'PQIM]<OX0\2:=JUM&@MKFZFDC35#*8Y(I(_,
M!DDM89?W<G[N,F/]Y];44 ?$GPB^!GQ5TG]F?]I7P]XNT'3T\>>.-7\27MC:
MZ7<Q?8[U[RPCBAEA,DG[N.27S !-B3&/,P<UUWC/]FWQ%\3/V ])^#T]U;^'
MO%(\+:1I\QO6\V&&\M1;2>7(8L\>9;^5YD?F8SD"3&#]6T4 ?/OC:Z\;_&/]
MG/XD^'+[X;ZOX/\ $^H>%;RPM+'4-1TV>&ZO;BUEC\J*6&YDX\P@>9+Y6?,^
MN.%O/V?O&FD_##]G_P 6Z%:0W'Q,^$VA0VZ>$[VYCCM=0\RPBM;ZT^T1G$<N
M(SY<N3&)/]8"ARGUY10!\I_&_P ->-/VJO"]O\+K_P !ZM\/?!6JSQ77B77]
M<O--DNOL]O-'-%;6,-K=7/[V66,9EF CCCCDXD) KI?VN_AGXE^)#?!G_A&]
M--^/#WQ(T?Q!J3>?&GV>RMO.\V3YR,D>8.!S7T/10!\\?M=_#/Q+\2&^#/\
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M%6[\6ZP_B+2O$&G:E86TQ1XQ%#I=VUU-')%':^5B.2/S8_+FR(XR/+KZUHH
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MC?'3_L=+;_U'=&H ]7HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\+:3H(T7PCHT4<DLMM)*8WN[Z0R'RXILAXOW7,D1 ./+_> 'T%1110 4444
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M?$G5BNG^!O#%_K=CKGB"Y/\ HNF27UK%;6OFX.8XY)<1^:?W<9/[PC-?65%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG_:&J^ /A]X1T/Q*]E);Q3Z?IL6F_:,8/E2R11;Q$9(XR>'^AH \D_::^/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI\0/_ 'P]_\ *JC_ (4WXN_Z+I\0/_ 'P]_\JJ]6HH \I_X4WXN_Z+I\0/\
MP!\/?_*JC_A3?B[_ *+I\0/_  !\/?\ RJKU:B@#RG_A3?B[_HNGQ _\ ?#W
M_P JJ/\ A3?B[_HNGQ _\ ?#W_RJKU:B@#RG_A3?B[_HNGQ _P# 'P]_\JJ/
M^%-^+O\ HNGQ _\  'P]_P#*JO5J^;OAU^T%\1/C!JWCY?"'@#PR;'PEXHO_
M  G+/K7BVYM9+B:U(S((X],FPI$@/^LZY^M '=_\*;\7?]%T^('_ ( ^'O\
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MQ_P#/O0!R7_"F_%W_1=/B!_X ^'O_E51_P *;\7?]%T^('_@#X>_^55>K44
M>4_\*;\7?]%T^('_ ( ^'O\ Y54?\*;\7?\ 1=/B!_X ^'O_ )55ZM7FGQZ^
M-.D?L^_"W6/'OB&SO[S1M)\K[5#IB1R7'[V6.(>7YDD8/,H[_P"! *G_  IO
MQ=_T73X@?^ /A[_Y54?\*;\7?]%T^('_ ( ^'O\ Y55ZM10!Y3_PIOQ=_P!%
MT^('_@#X>_\ E51_PIOQ=_T73X@?^ /A[_Y55Q_QF^)WB3PK^U)^S]X/TS4O
MLWA[Q6/$ U:S\F-_M0MK&.6W_>%2\6)#G]V1GO7T-0!Y3_PIOQ=_T73X@?\
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MQ7(CC$D<L6)/N1R1DXDC'&0"_P#\*;\7?]%T^('_ ( ^'O\ Y54?\*;\7?\
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MG_A3?B[_ *+I\0/_  !\/?\ RJH_X4WXN_Z+I\0/_ 'P]_\ *JO5J* /*?\
MA3?B[_HNGQ _\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/?_*JO5J* /*?^%-^+O\
MHNGQ _\  'P]_P#*JC_A3?B[_HNGQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?
M$#_P!\/?_*JC_A3?B[_HNGQ _P# 'P]_\JJ]6HH \I_X4WXN_P"BZ?$#_P
M?#W_ ,JJ/^%-^+O^BZ?$#_P!\/?_ "JKU:B@#RG_ (4WXN_Z+I\0/_ 'P]_\
MJJ/^%-^+O^BZ?$#_ , ?#W_RJKU:B@#RG_A3?B[_ *+I\0/_  !\/?\ RJH_
MX4WXN_Z+I\0/_ 'P]_\ *JO5J* /*?\ A3?B[_HNGQ _\ ?#W_RJH_X4WXN_
MZ+I\0/\ P!\/?_*JO5J* /*?^%-^+O\ HNGQ _\  'P]_P#*JC_A3?B[_HNG
MQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ _P#
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MP]_\JJ/^%-^+O^BZ?$#_ , ?#W_RJKU:B@#RG_A3?B[_ *+I\0/_  !\/?\
MRJH_X4WXN_Z+I\0/_ 'P]_\ *JO5J* /*?\ A3?B[_HNGQ _\ ?#W_RJH_X4
MWXN_Z+I\0/\ P!\/?_*JO5J* /*?^%-^+O\ HNGQ _\  'P]_P#*JC_A3?B[
M_HNGQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ
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M#W_RJKU:B@#RG_A3?B[_ *+I\0/_  !\/?\ RJH_X4WXN_Z+I\0/_ 'P]_\
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M_P!EGP3X/\8:;_8_B'3?MQN+,3QS>5YE]<2Q_O(B8R?+D0\'O7"? CX*>(O
MWP.OOV;_ !;X8UJY\-K%J^CP^/M%N[);6[T^Z\V7S#%++]HMY<W!C\ORI4$D
M8/F/&: .,^&7Q \ ^./AG#XQ\6?M,:?I7Q/\16AUB(_\)M]AL?#EU+"##:II
M O5ADBMCY>8[CS/-*R^9_K"*]Z_8X^+>I?'C]FOP-XTUDYUN_LFAOIE(/VB6
MVFEM9)AY<<8'FM$TOEX_=^8!S@$\W\(=6^)'P8\#:7X UOX8ZOXMB\*QPZ-I
MVO\ A2[TV*TU*RCBC2VE>*]OXI(IO+_=RQ?O(_,CS')C 'M?@#5/$FL^$M)U
M#Q5H4/A[79XGDN])M[W[;]D)/$1E\N,2$#J0,9X!<#?0!Y)^TYXTU2Y\8?#'
MX0:'K^H^%-2^(U[?1SZ]I\ :YL]/L;1KBZ%M(7_=7$F8HXY=DGE[Y),>9''7
M _M/Z7J?[+7PW_X7!X)\7>+8?^$7OK5M7\.:KK]UJUIK>GS7UM'+:G[=)<_9
MI1Q_I,7(S*,'S 8_2?VAOA/XA\2>*_ WQ/\ !26^J>.?AW-?7%EH%^_D6FL6
M]U#Y5S;"4_ZJ8Q?ZJ7_5B0#S 1S'R?QO\->-/VJO"]O\+K_P'JWP]\%:K/%=
M>)=?UR\TV2Z^SV\T<T5M8PVMU<_O998QF68"....3B0D"@#E_P!OWP7IFK:I
M\ ]2FN=7BFN_B?H&ES1VVN7UK"(I/M)+QQQRB.*7)/\ I$8$HZ"05]5>#?!M
MAX%TM['39]7NK=I/-+ZSK=]J<WT$EU+)(./X,XKR+]KOX9^)?B0WP9_X1O33
M?CP]\2-'\0:DWGQI]GLK;SO-D^<C)'F#@<U]#T ?(/Q^^,UE/^T?X>^$GB;Q
MS#\+?!Y\/_\ "6:OKYU?^RKK5MMUY,.F17)DB-LI,9EDDC/FR1Q&,&,>83F>
M$_C9H'A/]JOX>>"?A]\3(?B)X,\9:=J<5WI(\2G79-(O[>-;F.]-U+-<7!66
M)#"+?S$C^623&<UZ%\4/A?XJ\/?'30?C9X.TQO%&KPZ2/"6M^%I;J*WEN=+D
MN!-]ILI9#'$+B*4Y\J8^7+&,9BDP3VOA_P"('CKQ+XPL],_X5AJGA;03#-)>
M:UX@U73LQ'@11V\-K-<F7S"3_K#$(PF<R?ZN@#YUMO'5G>?'3XEZ=\??%/B;
MX;/%J,L/@_S?$=[X<\.7FCQ;?+EM;BVNHH[FZ)F\RX$DC2?O(@@C\N2--;_@
MI9X-AM_V*?$]Y>:GJVIW^A0V,4=T^H26ZW9DOK2.22ZM[?R[>4XYP8L1DDQB
M.O3_ (A>)O&6O6/BOPSKG[/<_CO3O.D_L](M7TJYTG5H@(Y;<W"WLL4D1\T8
M<?9Y/*,>8S+P:X34/V0_%FL?L"0_ >^\7VM_XHBTN.$:U=+++:^=%=?:8[;.
M?,$,8CCMA)CB,9\K@1T >P3?#/PYX-\&^(MGB?Q)HNF7"1R:GJ>L>++^<VMK
M"?,F\NYO99#:@Q"7?+$8W&<B2-XTDC^:?'?Q=\%?#/XB_""Y^$GQ<7Q5?Z[X
MRL?"^M>'YO'4WB*WN--OB1)<>3+<RO%)%)'%Y<T9CYD(D\P28/>_&KPKX_\
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MQ*\::AXZUC3KBUG\6R^(+V,PWTLGF"YM[**YCM[98Y?*\N*+9^['E$D/)O\
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MS&*+,AS':F23RQ^[&:L_L]_!>\^%=CX@UKQ)>Q^(/B'XRU%M:\0:M:H1"LN
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/8__ !VO5:* /*O^&KO@C_T6+P!_X4]C_P#':/\ AJ[X(_\ 18O '_A3V/\
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M>_:,_P"RR^(__;:OJN@#RK_AJ[X(_P#18O '_A3V/_QVC_AJ[X(_]%B\ ?\
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MZ+%X _\ "GL?_CM>JT4 >5?\-7?!'_HL7@#_ ,*>Q_\ CM'_  U=\$?^BQ>
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MKT/B326=[<W$44D121,Y22.0"2,]_G'<>HH RO\ AJ[X(_\ 18O '_A3V/\
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M@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QVO5:* /*O\ AJ[X(_\
M18O '_A3V/\ \=H_X:N^"/\ T6+P!_X4]C_\=KU6B@#RK_AJ[X(_]%B\ ?\
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M/8__ !VO5:* /*O^&KO@C_T6+P!_X4]C_P#':/\ AJ[X(_\ 18O '_A3V/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M36?@U_V)FC?^D,5'[5__ ":S\9?^Q,UG_P!(9: #]E#_ )-9^#7_ &)FC?\
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M^+W^V^(M*U:YTNZU(B*(WS 1S1R"**.../$=S'$ .OE9[F@#T;XR_M9?"O\
M9_U33-,^('BZ+0-0U*#[5! +2YN9O*!(\TQQ12&,;NGF8SL?&?+-'P:_:R^%
M?[0&J:GIGP_\71:_J&FP?:IX#:7-M-Y1('FB.6*,R#=U\O.-Z9QY@KX:_9QT
MW3?C9_P5>^+NL^*])TW4+KPZ^H3Z="T9*6TUC=VUC;7'EGK((AGG.)/W@ Q'
MC*_:O\,Z9\*O^"IGP=O/"<"^&[KQ#>Z/?ZC-IK^2UQ-<ZG+;7#\'I+&,2_\
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M,&,G[,9!V\N2/GG% 'VC7E'P=_Y*-\=/^QTMO_4=T:O5Z\H^#O\ R4;XZ?\
M8Z6W_J.Z-0!ZO1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'DW[-O\ R3O5O^QS\6?^I%J%>LUY-^S;_P D[U;_ +'/Q9_ZD6H5ZS0
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MJ* /GC]GC]E4_ 'XI_&/QG_PD_\ ;C_$76?[5-G]@^S?8 );J4Q^9YLGF_\
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MA!?^(6EGU./3(9I99)I)3)-Y<L=U%)Y4LGER>5R!)D]/+CC^[Z* /SZ^!?\
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M3#F+RI9929I7E818BC&<( >"?+\O[2HH ^4?^&&V_P"&YO\ AHK_ (34;O\
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M **** /)OV;?^2=ZM_V.?BS_ -2+4*]9KR;]FW_DG>K?]CGXL_\ 4BU"O6:
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ^5/V"OO?M&?\ 99?$?_MM7U77RI^P5][]HS_LLOB/
M_P!MJ^JZ /GK]L[]J<_LB_"_2O&/_"+CQ6M]JT>E?9/M_P!B$9DBFE\SS/*D
M_P">6,8[UZW\//&-C\1O ?AOQ=IL4T-EK^F6NIVR7(_>)%+$)8P_/H]?%?\
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M][-]GF-R!%@2&,QS1R/V\L _6&BOQR\+ZA\=/CU^V]\6OAEX<^,?B_PSH/\
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M_P#).]6_['/Q9_ZD6H5ZS0 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ,'P>\/7QEM]#T^"*74)[7,9E\T^;%^\N1%%&<2XB'^K,A&9/V*_X:N^"/\
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M4_'CX8ZAX$TE[2[T;1SXNCENXY;:WB$<?^MCCBC%SYMU@22 GK'^]DQ]I_\
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M6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QV@#U6BO*O\ AJ[X(_\ 18O
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M +$RY_\ 16LU]5_\-7?!'_HL7@#_ ,*>Q_\ CM'_  U=\$?^BQ> /_"GL?\
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M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DW[-O_ "3O5O\
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MTW[?=1V-J;NX2,W-S(?W<48/^LD.. /\:R-/^+'@C4O$Q\/6?C'0KGQ)'))
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M'&*Q:M#HN@3:5?ZQ#Y8W137/VJ011RG)D\J*/(S&#'DT >8_%O7]0\8?!_\
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MB#X)>(M-LQJ]O;2>)[?Q+I[2$:[;22^7+=7/G2R2_:C*<')[8&(XXC+UNE_
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MQE:>.?#$NJ>+?L'VZ*;PK<^3%]FA\J+R_P#B8>_>@#W^O*/VK_\ DUGXR_\
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MQXLOO%#:OK5SJEM]L\S_ (E]O*1Y=I%F1_W<>..G4\=* /F.3XM>!_$OP/\
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M=F.@#OOV?_B=XCU+XJ?&'X6^)]2;Q+=?#^\L)+;Q'+;QVUU?6]_#)<11S11
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M^M?MGC2[D^S7,?\ JY8\Z-^[D!/!'^-;?_"2_&[_ *)YX _\+J^_^4U>KT4
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MZ0Q5ZO0!Y1_PDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\ "ZOO_E-7J]%
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MB>> /_"ZOO\ Y35ZO10!Y1_PDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\
M"ZOO_E-7J]% 'E'_  DOQN_Z)YX _P#"ZOO_ )34?\)+\;O^B>> /_"ZOO\
MY35ZO10!Y1_PDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\ "ZOO_E-7J]%
M'E'_  DOQN_Z)YX _P#"ZOO_ )34?\)+\;O^B>> /_"ZOO\ Y35ZO10!Y1_P
MDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\ "ZOO_E-7J]% 'E'_  DOQN_Z
M)YX _P#"ZOO_ )34?\)+\;O^B>> /_"ZOO\ Y35ZO7(^+OB1X2\ +:CQ-XFT
M;PZ;K?\ 9O[6OHK7S"G7R_,(!Q0!RW_"2_&[_HGG@#_PNK[_ .4U'_"2_&[_
M *)YX _\+J^_^4U=WX<\1:-XNT>/5=!U2SUS3;D9BU#3[F.6&7Z21DBMR@#R
MC_A)?C=_T3SP!_X75]_\IJ/^$E^-W_1// '_ (75]_\ *:N[\1^(M&\(Z/)J
MNO:I9Z'IML,RZAJ%S'%#%]9)"!5C2]3M=:TZWO\ 3KB*\L;F..6WN+>02121
MD9#IC/8_RH \\_X27XW?]$\\ ?\ A=7W_P IJ/\ A)?C=_T3SP!_X75]_P#*
M:ND\5_%OP5X%OX=/\1^,=!\.WTL7G16^K:G#;.\8XWXD(-:_ASQ%HWB[1X]5
MT'5+/7--N1F+4-/N8Y89?I)&2* .$_X27XW?]$\\ ?\ A=7W_P IJQOV>9-9
MN_$_QHEU^QLM,UAO&$/VFUTN\DO+>,_V#I&-DLD41?@ \QCDX]S[A7E'P=_Y
M*-\=/^QTMO\ U'=&H ]7HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#R;]FW_DG>K?]CGXL_P#4BU"O6:\F_9M_Y)WJW_8Y^+/_ %(M
M0KUF@#Q+XN_ M_B1\3?ACX\TWQ/<>&]7\!:G-<QH-/CN4O+*ZCCCN[4J^/+,
MD<803 YCS)QG!3VVBB@ KQ;1O@1<6O[2WB+XPW_B:YU.YO-"@\/:7HRVT<<&
MGV0ECEE!EQF;?)'YG;9YD@_>9CV>TT4 %%%% !1110 4444 %%%% !1110 5
MY%^RY\#W_9M^!OA[X=-K/_"0+HWVG;J(M3;>:);F68DQ^9)CF7'7M7KM8'AG
MQ/H?C+1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]Z -^BBB@ HKG?$GB
MS1/"_P!@36=7T_1VU.\CT^R_M"Z2$W-S(2(XH@_^LE..(QS^5=%0 45SOB3Q
M9HGA?[ FLZOI^CMJ=Y'I]E_:%TD)N;F0D1Q1!_\ 62G'$8Y_*NBH **** "B
MBB@ KG_%'A33O&_A76/#NL6YNM'U:SEL;RW\PIOAEC,<D>4_V21^-=!10!\^
M> OA'\5OA5X1TOPAH7Q)\-77A[1U^Q:;+X@\&RW-]'9I_P >T<LEOJ$,<OEQ
M^7'Y@BCSY><9-=O\'O@IH_P6T36;72K[4K^XUS5KG7]7U+4GC^T7U]<G,TKB
M*.../_EF,11QX\L<=<^F44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3?\ "$_$WX,>.M)4P:Y=>*K;PA=Y)2.ZL;X2>9%-CE_*DC$L6?D$F*]5\;^
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M\L9QD\5Q7_#-/A+_ *#'C_\ \.-XA_\ D^C_ (9I\)?]!CQ__P"'&\0__)]
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MYGF>5YG7R]_.WUYZ\UQ'_#-/A+_H,>/_ /PXWB'_ .3Z/^&:?"7_ $&/'_\
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M?_\ AQO$/_R?1_PS3X2_Z#'C_P#\.-XA_P#D^@#U:BO*?^&:?"7_ $&/'_\
MX<;Q#_\ )]'_  S3X2_Z#'C_ /\ #C>(?_D^@#U:BO*?^&:?"7_08\?_ /AQ
MO$/_ ,GT?\,T^$O^@QX__P##C>(?_D^@#U:BO*?^&:?"7_08\?\ _AQO$/\
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M^[\V2*+/MT?%8/\ PS3X2_Z#'C__ ,.-XA_^3Z/^&:?"7_08\?\ _AQO$/\
M\GT :'PJ^'*_#/PJVD_:_P"UM2NKR;5-6UA;:.UDU&^GE\V::2.+ SG  /2,
M1Q\XJ_I_PG\$:;XF/B&S\':%;>)))))SJT.FQ1WADDSYLGFX\SG><\]ZP/\
MAFGPE_T&/'__ (<;Q#_\GT?\,T^$O^@QX_\ _#C>(?\ Y/H ]6K#\.>'=&\(
MZ/'I6@Z79Z'IML,1:?I]M'%#%](XP!7"_P##-/A+_H,>/_\ PXWB'_Y/H_X9
MI\)?]!CQ_P#^'&\0_P#R?0!ZM7/77AG1]0UC3=7NM,LKG5=-\S[#?36T<DUM
MYF/,\J3K'Y@QG!YKBO\ AFGPE_T&/'__ (<;Q#_\GT?\,T^$O^@QX_\ _#C>
M(?\ Y/H ]6KRC]J__DUGXR_]B9K/_I#+2_\ #-/A+_H,>/\ _P .-XA_^3Z\
MN_:2^ OA?2/V=_BEJ,&H^,YI+7PKJDR)=^.=<NH<1VLI_>12W9CD]XY 0>:
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MK_3TMC+J=U*ML?-M8Y0(XXI1'YHCE/24Q]8Q0!]F45X1_P ,[WW_  A_D_\
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M28$L5 '6^!_C5XV^)6H>-$\,>"=!>T\->(;[PY)<:MXEFM9+F2V(S((X["7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>3?LV_\ ).]6_P"QS\6?^I%J%>LUY-^S;_R3O5O^QS\6?^I%J%>LT %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!\J?L%?>_:,_[++XC_\ ;:OJNOA[]D/XK:+X%U#]H'3M1L_$
MUU)-\7/$4HET7PMJ>JQXS$#F6UMI8PW!_=GGD''(KZ+_ .&EO"7_ $!_'_\
MX;GQ#_\ (% '*_&[PKXHO/CK\&O&6@^&;[Q+IGAG^V?[2AT^XM8I8S=6L<47
M_'S-$#T/ K)^-'A_QY^T9X?3P#_PA-YX.\+ZE<VLVOZIX@OK$2I:17$4OE62
M6LMUFY)'64>5^Z_Z:5Z!_P -+>$O^@/X_P#_  W/B'_Y H_X:6\)?] ?Q_\
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M<_;Q*8I(CR?W63_SSZU+\ _!OB[X+_VCX"U6:]\3>#K B3PWXEO+F/S8K4Y
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M'QU\2]/MO#C>+O#_ (IU^;Q+I6K6D]M;16UQ<@B6&^,DOF"./RX<2112D@G
MS^['H'_#2WA+_H#^/_\ PW/B'_Y H_X:6\)?] ?Q_P#^&Y\0_P#R!0!R7[)?
MP^\:?#_1/'Y\=6%G8:WK?C+4-9_XELHDM)(Y8X#YD1^]Y9D$N/-_><<]J;\*
M?"/BCX-^./&^COX;O_$6@^*?%<OB.W\0:1/:Q1VHN2/-BNH998Y!Y7E@^9'Y
MOF ]O]577_\ #2WA+_H#^/\ _P -SXA_^0*/^&EO"7_0'\?_ /AN?$/_ ,@4
M <7H_P $]3UKXJ?M#S^(;2>W\*>.[#3+"RO+:>+S98Q82VUR8QR8R"_'F=SD
M4O@C4/B5\(O L?@VX^'%]XQO/#ENNF:+JNBWUE;6&I6T<6VVDE%S=>;;/P(Y
M?W4F#DQ^:*[/_AI;PE_T!_'_ /X;GQ#_ /(%'_#2WA+_ * _C_\ \-SXA_\
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M-SXA_P#D"C_AI;PE_P! ?Q__ .&Y\0__ "!0!ZM17E/_  TMX2_Z _C_ /\
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M^$;L?#_VR*[NWB^W23?:;F2/]W&<>7B*&27_ %AS)V/2_P##2WA+_H#^/_\
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MC_AI;PE_T!_'_P#X;GQ#_P#(%'_#2WA+_H#^/_\ PW/B'_Y H Q_CQ\+]?\
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M_P#_  W/B'_Y H ]6HKRG_AI;PE_T!_'_P#X;GQ#_P#(%'_#2WA+_H#^/_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%J%>LUY-^S;_ ,D[U;_L<_%G_J1:A7K- !1110 4444 %%%% !1110 4444
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MH/SKOJ /F/\ 8YTN"'4OCMJ*P1?;I/B7K$,MQY8\UXXC$8T/_?R3_OX:TO\
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MZ*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^
M/_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO
M_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?
M\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O
M^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@
M#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[
M_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO
M10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4
M?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_
MZ*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^
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M_P"BA^ /_"%OO_ES7J]% 'E'_",_&[_HH?@#_P (6^_^7-'_  C/QN_Z*'X
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MS\;O^BA^ /\ PA;[_P"7-'_",_&[_HH?@#_PA;[_ .7->KT4 >4?\(S\;O\
MHH?@#_PA;[_Y<T?\(S\;O^BA^ /_  A;[_Y<UZO10!Y1_P (S\;O^BA^ /\
MPA;[_P"7-'_",_&[_HH?@#_PA;[_ .7->KT4 >4?\(S\;O\ HH?@#_PA;[_Y
M<T?\(S\;O^BA^ /_  A;[_Y<UZO10!Y1_P (S\;O^BA^ /\ PA;[_P"7-'_"
M,_&[_HH?@#_PA;[_ .7->KT4 >4?\(S\;O\ HH?@#_PA;[_Y<T?\(S\;O^BA
M^ /_  A;[_Y<UZO10!Y1_P (S\;O^BA^ /\ PA;[_P"7-'_",_&[_HH?@#_P
MA;[_ .7->KT4 >4?\(S\;O\ HH?@#_PA;[_Y<T?\(S\;O^BA^ /_  A;[_Y<
MUZO10!Y1_P (S\;O^BA^ /\ PA;[_P"7-'_",_&[_HH?@#_PA;[_ .7->KT4
M >4?\(S\;O\ HH?@#_PA;[_Y<T?\(S\;O^BA^ /_  A;[_Y<UZO10!Y1_P (
MS\;O^BA^ /\ PA;[_P"7-'_",_&[_HH?@#_PA;[_ .7->KT4 >4?\(S\;O\
MHH?@#_PA;[_Y<T?\(S\;O^BA^ /_  A;[_Y<UZO10!Y1_P (S\;O^BA^ /\
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M[.?_ &67PY_[<T ?5=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>4?LH?\FL_!K_L3-&_](8J]7KRC]E#_DUGX-?]
MB9HW_I#%0!ZO7P/^T%\&M/\ C[^WA=>%[B_F\.ZF/A1'>Z5K]E$'N]*OHM<W
MPW,+?PL&ZE#'(8Y)1YD><U]\5\I_\Y3/^Z-_^YJ@#S+]K3XIW'Q9_P"":7Q
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M4 %>4?!W_DHWQT_['2V_]1W1J]7KRCX._P#)1OCI_P!CI;?^H[HU 'J]%%%
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M4<#T[?QM\0O"GPYTN'4O%7B32?#-C)+]FBN]:OHK6%Y2#^[\R0CGY#^5?/\
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MTG+V7VG3?WOE]OWGE+\_4#('$D@H ^LO#/B?0_&6B6VLZ#JVGZ[H]P?]'O\
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MBKQ9/JNEZ=J-EIEU)I$.M3B*&]OH[>:6&W'[Q#*TABQY49WGG\/!O@!)-/\
MLOZ)H<OP+\9:]IOC3P['=>(=1M]0T@-K]Q?6H^UW4DDFJ1W!,QDSYDF),$?<
MQ6AH/A?QQX-_X)D>)/#OQ#MOL?BS2? >NV%Q:B2)_)BBAN4M8P8B8R!;B$<'
MTH ],^!O[2W@;XI?#'P_KEYXW\(MXE_X1JVU[Q!86.K1'^S?W,<ETTD9E,D,
M43R$?O?]7D FO5_#/B?0_&6B6VLZ#JVGZ[H]P?\ 1[_2[J.YMFYV$1R1D@\\
M<>]</^RA_P FL_!K_L3-&_\ 2&*OCS2]1N_@_P#LA_&?X%6T-C>^(M&\2W7P
M_P#"^A76L6T=_?VNM2 V$TF/D\R2.^EEX\L$6TH(C\N0@ ^^_#/B?0_&6B6V
MLZ#JVGZ[H]P?]'O]+NH[FV;G81')&2#SQQ[UD_\ "V_!?_""?\)K_P )CH/_
M  AV?^1B_M*+^S_];Y/_ !\Y\O'F_N^O7WXKXGN/$R?"3]G'X\_ '3+/2[O7
M](\02>$O"WA^UOY+8R67B#,MA']IN?\ 6S1B[N^.XM.?^>IW=<TN?P9^UO\
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MQ8__ !J@#U6BO*O^&4?@C_T1WP!_X3%C_P#&J/\ AE'X(_\ 1'? '_A,6/\
M\:H ]5HKRK_AE'X(_P#1'? '_A,6/_QJC_AE'X(_]$=\ ?\ A,6/_P :H ]5
MHKRK_AE'X(_]$=\ ?^$Q8_\ QJC_ (91^"/_ $1WP!_X3%C_ /&J /5:\H_9
M0_Y-9^#7_8F:-_Z0Q4[_ (91^"/_ $1WP!_X3%C_ /&J\N_9K_9K^$6O?LZ_
M"W5=3^%?@O4]0U#PKIEU<W=WX?M999Y9;2(R2/(8N222: /J:BO*O^&4?@C_
M -$=\ ?^$Q8__&J/^&4?@C_T1WP!_P"$Q8__ !J@#U6BO*O^&4?@C_T1WP!_
MX3%C_P#&J/\ AE'X(_\ 1'? '_A,6/\ \:H ]5HKRK_AE'X(_P#1'? '_A,6
M/_QJC_AE'X(_]$=\ ?\ A,6/_P :H ]5HKRK_AE'X(_]$=\ ?^$Q8_\ QJC_
M (91^"/_ $1WP!_X3%C_ /&J /5:*\J_X91^"/\ T1WP!_X3%C_\:H_X91^"
M/_1'? '_ (3%C_\ &J /5:*\J_X91^"/_1'? '_A,6/_ ,:H_P"&4?@C_P!$
M=\ ?^$Q8_P#QJ@#U6BO*O^&4?@C_ -$=\ ?^$Q8__&J/^&4?@C_T1WP!_P"$
MQ8__ !J@#U6BO*O^&4?@C_T1WP!_X3%C_P#&J/\ AE'X(_\ 1'? '_A,6/\
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M !J@#U6BO*O^&4?@C_T1WP!_X3%C_P#&J/\ AE'X(_\ 1'? '_A,6/\ \:H
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MX(_]$=\ ?^$Q8_\ QJC_ (91^"/_ $1WP!_X3%C_ /&J /5:*\J_X91^"/\
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M%^-WQ:^(JZY]O?QY_9&-.6U\O[#]AM3"/WOF'S?,R#TCQTYZU[#10!XYX?\
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M'\"/VTO@;I_P]TK3_!&E>.+37+'Q%I>BVR6UKJ4=E:BYMC)#&!$)(I9)/WH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.:ILDMI);F&;R;NPS)(8[J01XN?W?EF./K')_K*\M_9[\5:?\6OVOOB)XO\
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M[NZA#VEA:I<B6../RR\KRF*0DPF/]WP\@!U'_"X-<_X;._X5'Y&F_P#",_\
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M5+:X\TQR=3'-'Y@'2*M/_A<GB[_HA?Q _P# [P]_\M:/^%R>+O\ HA?Q _\
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M_P"6M 'JU%>4_P#"Y/%W_1"_B!_X'>'O_EK1_P +D\7?]$+^('_@=X>_^6M
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MQO=$\JY M(AYD?G:E&^#U^>,'V]0#ZEKPK_A3^N?\-G?\+<\_3?^$9_X0/\
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M?Q _\#O#W_RUH_X7)XN_Z(7\0/\ P.\/?_+6@#U:BO*?^%R>+O\ HA?Q _\
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M3[BS_9BU"ZUJ\^S"'0/^%2R6UTCR&-=DMQ<6T=K&8S)^\D:Y$8$9/F$=7?\
M!1C5-1TOPM\#[S1-,.O:S;_%70Y;'2_M0MC>3".Z,4/FOQ'YA&WS#P,Y[5]B
M5X_\>/@K_P +J;X>8UHZ,?"7C+3?%F/LWVC[5]E\W%O_ *P>67\S_6<XQT-
M'D?[2C:O^U5X!D^#'A_PKXFT.]\120G7]=\0:/<6=AX?MK:XAED)E<>5>S%X
MQ''%:RR1R?O)/-$8\P]1^VUX*U_Q5X1^'VO>'M'NM?D\#>.-+\87NE:>IEOK
MVRM?-\V*VC_Y:2GS!B/(ST[BOI2B@#Y9_:9O]<^,_P $5G\&Z?XHOM @UZU/
MBSPZ=)O='U;6="B)-]:VL-Q%%+(98Y(Q^[,?F 21B0Y,9\8^,G@GPCXI\<_!
MI?A/\!=5T271_B)H.HZKXELO ,FB10VOFR^;&_F017! \N.5Y/+,2#R\R9(K
M]#:* /F'_A%=<_X>,?\ "2?V+J7_  C_ /PJG^S_ .V/L\GV3[5_;'F>3YVW
MR_-\O]YY?7%9W[7/P7G\;>)/AO\ $;_A%+?XE:7\/[C4)=6\$7%K'<RZK8W<
M4<<LMM%+F.26'RA)'"?]85P'$F ?J^B@#Y6\/Z7\#;?Q9X;3PM\ KB?6WU*'
M[/J47PP?1O[-,>9/M<ES?6UM'&(O+'^K<RY(\N,GIZ1\6O&_ARUO5\&>-_ .
MO>+/#NJV?VJ2XM?#$NN:6[QS1XMI8K=)9$D^Y*/-B\LXXDR,5[#10!\K?L9>
M ];\"WOQ#BTK2M9\+?!F74(E\#^'?$'GQ7UJ(XC'?W'E7.98HKFY_>QQRD'[
M[^7'YG[S>_;/\->+O%'PCM[;PS!J.JZ0NMVMQXLT31SMO]:T",G[=8VP&"9)
M!M_=AXS(!)'D^9L?Z+HH _/+XR>"?"/BGQS\&E^$_P !=5T271_B)H.HZKXE
MLO ,FB10VOFR^;&_F017! \N.5Y/+,2#R\R9(KV__A%=<_X>,?\ "2?V+J7_
M  C_ /PJG^S_ .V/L\GV3[5_;'F>3YVWR_-\O]YY?7%?3U% 'S#_ ,(KKG_#
MQC_A)/[%U+_A'_\ A5/]G_VQ]GD^R?:O[8\SR?.V^7YOE_O/+ZXK);3]?^ O
M[6OQ&\8:AX5U[Q#X!^(UEI ?7O#VGRW\ND7UE;S1"WEM;?S;J2.2)-_V@1XC
M>2./N7'UI10!\<> _P#A)_&__!0+5_&5_P" O$7AKP<OPY_LO2]9U.WQ'?C^
MTHYO-<_\NLIWR_Z+*1,(X\R1QD^6/L>BB@ HHHH **** "BBB@ HHHH ^5/V
M"OO?M&?]EE\1_P#MM7U77RI^P5][]HS_ +++XC_]MJ^JZ "BOCS]JCPOHOC#
M]L7]EC1->TRPUO1[O_A+/M.GZG:QW-M)C3X9 )(Y 0>0#SZ"N?\ CYH_@/X)
M_'#X$:=\)](TCP;\2]7\3VT%[8>$]+CAFNO#<F?M_P!JBBC\N2',<<GF2C,?
MDR21']U(0 ?<=%>9>#_C9H_C+XK?$'X?V5G?PZUX)^P#4YKE$%O)]MA,T/EG
MS,G@'J!Z4>#_ (V:/XR^*WQ!^']E9W\.M>"?L U.:Y1!;R?;83-#Y9\S)X!Z
M@>E 'IM%>*7'[1%OK'B[7] \(>#O$WQ"F\.2I9:OJ/APV,5C;7YY-KYMS=Q;
MY8^/,2/S/*\Q!)@\5D_'KQ5\.&TKX1:EXWT+6-6M]5\<:0/#,2P36LECK$GF
MM:7-Q$\D4B",;_,CD!P>#%D$  ^@:*\(\>?M5>%OA[\:M*^%VH:7X@O_ !GJ
MND_VKI=KI=C]H2^)EFC%LA$O[J4^3))YDHCACC&9)8P*VO!7QPTOQSXNUOP=
M=Z-K7A#QEI$,5W/X=U];9+J>RE_U=W;O#-)%/#YG[HR12GRY!B3!QD ]=HKR
M+QK\<-+\#>+M$\'6FC:UXO\ &6KPRW<'AW0%MGNH+*+_ %EW</--'%!#YG[H
M22RCS)#B/)SB]\-_C#H?Q)USQ)X<BM=1T/Q;X:%L-:T'4EC-UIGVD-+;%Y8I
M)()/-CC\S]U))@$"3!XH ]/HKP?P[^TY8^,EO=1\,^"O%WBSPA9WTMH?%^BV
MUI+I\_E8\Z6UC-R+FZCB;S(\VT,GF&.01>;WV_&OQPTOP-XNT3P=::-K7B_Q
MEJ\,MW!X=T!;9[J"RB_UEW</--'%!#YG[H22RCS)#B/)S@ ]=HKBO!OBB?Q/
MI\]U/X>UGPY?6\XAGTO6XHO.1N.?,BDDBE!CDC/F12R#JA_>1R1CM: "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KRC]E#_ )-9
M^#7_ &)FC?\ I#%7J]>4?LH?\FL_!K_L3-&_](8J /5Z**_.;]J7P#XO\;?M
MZ6.I?#V?RO'OA/X;6WB/1+6>Y-K;7TL6L2Q2VLIXS%+;RW,>/,CR9.9!'F@#
M]&:*^'OVXOB5I'Q>_P"":GBCQMH%V;C2=;L])O(&+H7CSJ=KF.3RV8"6,YCD
M&>'C([5]0?%WXM:#\&?"+:]KTMS.DDL=G9:;IT7FWVI7LA_=6MM%D>;+)@XC
M'I^- 'H-%>&3_M.6/ASQ)X=TCQSX)\7?#[_A)+Y-+TC4=6MK:YMKF\>6..*T
M,EC<W(BED\PD>;Y8(BD.?D-3_&C]J+PA^S_XR\">'_%<6K?:/&$]S:Z9-ING
M27JQR1&(>7)%%F8F22:..,112$GT!S0![917C7ASX^6^K?$*S\!:[X8U[X>^
M*+ZT:]TBW\2-:LNK11_Z[[-+;7,T4DL7WI(?,$@C</TSBQXU^.&E^!O%VB>#
MK31M:\7^,M7AENX/#N@+;/=0647^LN[AYIHXH(?,_="264>9(<1Y.< 'KM%>
M8?#?XPZ'\2=<\2>'(K74=#\6^&A;#6M!U)8S=:9]I#2VQ>6*22"3S8X_,_=2
M28! DP>*]/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS;4-;MKNSN+:_P!,@"22^9<V,D0N(OW44DD8DB_>#!3((H ]0HKQWX;?M+^
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M_P!C_P!@_P!H?:9/^/'S?.\KR\^7_K>>F?>C_A5OAO\ X6M_PL7^S3_PE_\
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M6CN1:7]D)<2C$LG^KEC(D?S/,)CCQTO_  Q_\*?[/_LG^P-2_P"$=^V_;_\
MA&_^$AU/^P_.^U?:<?V;]I^R^5YW[SRO*\OVQ73>,O@7X/\ B#XDL?$]_9ZC
M9^)+6R>QCU71M8OM)NOLLD@E,,DEK-$\D?F 2>6YP#D]<T <3^SY\:O%/Q \
M3>.OAWX_T_3++Q[X$GLAJMWX;>633+N.\B^T6I@\X>:,1@QR;_3(/[S"?0=<
M-\/?A?X<^$^B7>D^%=+.GV]W>27US<27$MU<7%U*<R3RS2F2260GJ\A)/%=S
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>4?L
MH?\ )K/P:_[$S1O_ $ABKU>O*/V4/^36?@U_V)FC?^D,5 'J]?*?_.4S_NC?
M_N:KZLKB_P#A5OAO_A:W_"Q?[-/_  E_]C_V#_:'VF3_ (\?-\[RO+SY?^MY
MZ9]Z /SM_P""A&K:A\"_"WQ;\!7UY,_@OXF0VOB'PK#+)O%CJ\.IVSZG:Q_Z
MR0^;YGVHEO+B0_NXQDFOIW]I#4[_ $G]J[]ER:6\NM-\+2:IKEO<SO/Y-B;^
M33/+L8I#DQ^=)YDT<0/[PYE$?4U[3\7/@YX0^-G@Z7PYXVT&'Q)I+.EP+>66
M2(I(F,/')&1)&>WR'N?4UK^.? V@_$SPGJ7AGQ-I-OK&BZA%Y=Q97 .']/<<
M_P 8- 'SI_P4ND-]^QUXOT. F;6=;O=+L-+L8B'NKZY^WVTGDPQ_\M9<12'R
MX\DA#5G]H;_D^K]D?_N;O_37%7J'AW]GWP1X?\667BB"TU;6->T^*6.QO?$.
MOZEJ[67FX\W[/]KFD\KS @S(F"<?A71>*OA=X>\4^.?"'C'4]-^U^(?"PNO[
M(O/M<L?V7[5%Y5Q^[!\M\Q_\] >G&* /#?VAO^3ZOV1_^YN_]-<5<AX'TWQM
M;_MV?M%VOA_7O#_A>^U2Q\/7\,/B30Y[Z74[:*R,1GM0EW;?NHY/W4D@,HWD
M#]V>#]0^*OA=X>\4^.?"'C'4]-^U^(?"PNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\
M] >G&*I^/O@]X6^*=YH]YXAL[F75-$>673-3L-0N;"]L#)'Y<GE7-N\4J"2/
M[Z!\$8R#@4 <1X-^ GBFS_:,F^+OBKQCI.LZF?"I\)1V.C:#+IL(B^UBZ$G[
MR[N23GCK^5>^5YEX-^!?@_X?>)+[Q/86>HWGB2ZLDL9-5UG6+[5KK[+'(91#
M')=32O''YA,GEH<$X/7%>FT %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=*^+,N@:A=7>H:#XBT"]^W:)XAT9DBOM-D./,\N1XY(S'+&#'+%(CQR C(R
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MA?W1$<D8&,&,<C ->D?#OX"^%?A_I_CS2[9+C6].\;:]?>(M7L];6*>%I;T
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MTMM<S122Q?>DA\P2"-P_3. "_P#\*;\7?]%T^('_ ( ^'O\ Y54?\*;\7?\
M1=/B!_X ^'O_ )55ZM10!Y3_ ,*;\7?]%T^('_@#X>_^55'_  IOQ=_T73X@
M?^ /A[_Y55@_LT_&;7/C$OQ4;6K:PMSX5\=ZIX5L_L,,D9EMK;RO+DE\R0_O
M#YG.,#C@5[I0!Y3_ ,*;\7?]%T^('_@#X>_^55'_  IOQ=_T73X@?^ /A[_Y
M55T'Q6^*'AOX/^ =4\8>+]2.D^'=.\G[3>?9I)O*\R6.*,^7&#(?WDD?0=^U
M=M0!Y3_PIOQ=_P!%T^('_@#X>_\ E51_PIOQ=_T73X@?^ /A[_Y55ZM10!Y3
M_P *;\7?]%T^('_@#X>_^55'_"F_%W_1=/B!_P" /A[_ .558G[8WQFUW]GG
M]GCQ5\0- @L+O5]'^S>1!J4<DELWFW44)\P1R1G_ ):YZ]AUKW&@#RG_ (4W
MXN_Z+I\0/_ 'P]_\JJ/^%-^+O^BZ?$#_ , ?#W_RJKU:B@#RG_A3?B[_ *+I
M\0/_  !\/?\ RJH_X4WXN_Z+I\0/_ 'P]_\ *JO5J* /*?\ A3?B[_HNGQ _
M\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/?_*JO5JXO_A:7AO_ (6M_P *Z_M(_P#"
M7_V/_;W]G_9I/^/'S?)\WS,>7_K>.N?:@#G?^%-^+O\ HNGQ _\  'P]_P#*
MJC_A3?B[_HNGQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?
MB[_HNGQ _P# 'P]_\JJ]6HH \I_X4WXN_P"BZ?$#_P  ?#W_ ,JJ/^%-^+O^
MBZ?$#_P!\/?_ "JKHO\ A:7AO_A:W_"NO[2/_"7_ -C_ -O?V?\ 9I/^/'S?
M)\WS,>7_ *WCKGVKM* /*?\ A3?B[_HNGQ _\ ?#W_RJH_X4WXN_Z+I\0/\
MP!\/?_*JO5JX;PK\4?#WBGQSXO\ !VF:E]K\0^%A:?VO9_9)8_LOVJ+S;?\
M>$>6^8^?W9/3G% &%_PIOQ=_T73X@?\ @#X>_P#E51_PIOQ=_P!%T^('_@#X
M>_\ E57JU% 'E/\ PIOQ=_T73X@?^ /A[_Y54?\ "F_%W_1=/B!_X ^'O_E5
M7JU% 'E/_"F_%W_1=/B!_P" /A[_ .55'_"F_%W_ $73X@?^ /A[_P"55>K4
M4 >4_P#"F_%W_1=/B!_X ^'O_E51_P *;\7?]%T^('_@#X>_^55>K44 >4_\
M*;\7?]%T^('_ ( ^'O\ Y55YA^S9\+/%>H?L[_"FZM?B]XTTFWF\*Z9(MA8V
M6B>5; VD1\N/SM-D? Z?/(3[^GU+7E'[*'_)K/P:_P"Q,T;_ -(8J %_X4WX
MN_Z+I\0/_ 'P]_\ *JC_ (4WXN_Z+I\0/_ 'P]_\JJ]6KP#XH_M?>"?A?\?O
M"7P>\06VKP:_XJBMI;+4(8(I+("662*.*0^9Y@+RQ&/B+'[P<]2 #J?^%-^+
MO^BZ?$#_ , ?#W_RJH_X4WXN_P"BZ?$#_P  ?#W_ ,JJM_'KXTZ1^S[\+=8\
M>^(;._O-&TGROM4.F)')<?O98XAY?F21@\RCO_@?2Z /*?\ A3?B[_HNGQ _
M\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/?_*JO5J* /*?^%-^+O\ HNGQ _\  'P]
M_P#*JC_A3?B[_HNGQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?$#_P!\/?_*JC
M_A3?B[_HNGQ _P# 'P]_\JJ]6HH \I_X4WXN_P"BZ?$#_P  ?#W_ ,JJ/^%-
M^+O^BZ?$#_P!\/?_ "JKU:B@#RG_ (4WXN_Z+I\0/_ 'P]_\JJ/^%-^+O^BZ
M?$#_ , ?#W_RJKU:B@#RG_A3?B[_ *+I\0/_  !\/?\ RJH_X4WXN_Z+I\0/
M_ 'P]_\ *JO5J* /*?\ A3?B[_HNGQ _\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/
M?_*JO5J* /*?^%-^+O\ HNGQ _\  'P]_P#*JC_A3?B[_HNGQ _\ ?#W_P J
MJ]6HH \I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ _P# 'P]_\JJ]6HH
M\I_X4WXN_P"BZ?$#_P  ?#W_ ,JJ/^%-^+O^BZ?$#_P!\/?_ "JKU:B@#RG_
M (4WXN_Z+I\0/_ 'P]_\JJ/^%-^+O^BZ?$#_ , ?#W_RJKU:B@#RG_A3?B[_
M *+I\0/_  !\/?\ RJH_X4WXN_Z+I\0/_ 'P]_\ *JO5J* /*?\ A3?B[_HN
MGQ _\ ?#W_RJH_X4WXN_Z+I\0/\ P!\/?_*JO5J* /*?^%-^+O\ HNGQ _\
M 'P]_P#*JC_A3?B[_HNGQ _\ ?#W_P JJ]6HH \I_P"%-^+O^BZ?$#_P!\/?
M_*JC_A3?B[_HNGQ _P# 'P]_\JJ]6HH \I_X4WXN_P"BZ?$#_P  ?#W_ ,JJ
M/^%-^+O^BZ?$#_P!\/?_ "JKU:B@#RG_ (4WXN_Z+I\0/_ 'P]_\JJ/^%-^+
MO^BZ?$#_ , ?#W_RJKU:B@#RG_A3?B[_ *+I\0/_  !\/?\ RJH_X4WXN_Z+
MI\0/_ 'P]_\ *JO5J* /*?\ A3?B[_HNGQ _\ ?#W_RJH_X4WXN_Z+I\0/\
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M-2CMX[B<_P!@Z0<R"WCBBR,XXC' &>>3[=7E'P=_Y*-\=/\ L=+;_P!1W1J
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M":MXOU#X@>'OB)9:I'"-6M;*WNM)N+&$W'FQR6L,4<L<L<GEF*2/(,8<2?\
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M?'3_ +'2V_\ 4=T:O5Z\H^#O_)1OCI_V.EM_ZCNC4 >KT444 %%%% !1110
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M_P#18O '_A3V/_QVO5:* /*O^&KO@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\
M?^%/8_\ QVO5:* /*O\ AJ[X(_\ 18O '_A3V/\ \=H_X:N^"/\ T6+P!_X4
M]C_\=KU6B@#RK_AJ[X(_]%B\ ?\ A3V/_P =H_X:N^"/_18O '_A3V/_ ,=K
MU6B@#RK_ (:N^"/_ $6+P!_X4]C_ /':/^&KO@C_ -%B\ ?^%/8__':]5HH
M\J_X:N^"/_18O '_ (4]C_\ ':/^&KO@C_T6+P!_X4]C_P#':]5HH \J_P"&
MKO@C_P!%B\ ?^%/8_P#QVC_AJ[X(_P#18O '_A3V/_QVO5:* /*O^&KO@C_T
M6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QVO5:* /*O\ AJ[X(_\ 18O
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M_"GL?_CM'_#5WP1_Z+%X _\ "GL?_CM>JT4 >5?\-7?!'_HL7@#_ ,*>Q_\
MCM'_  U=\$?^BQ> /_"GL?\ X[7JM% 'R9^T9XY^"O[0W@G3/"%[\=? 6D^'
M9=6L[W6[<:Y8RC5K&&42R6'F"YCDA$LD<9\Z,Y'E=\FO7O\ AJ[X(_\ 18O
M'_A3V/\ \=KU6B@#RK_AJ[X(_P#18O '_A3V/_QVC_AJ[X(_]%B\ ?\ A3V/
M_P =KU6B@#RK_AJ[X(_]%B\ ?^%/8_\ QVC_ (:N^"/_ $6+P!_X4]C_ /':
M]5HH \J_X:N^"/\ T6+P!_X4]C_\=H_X:N^"/_18O '_ (4]C_\ ':]5HH \
MJ_X:N^"/_18O '_A3V/_ ,=H_P"&KO@C_P!%B\ ?^%/8_P#QVO5:* /*O^&K
MO@C_ -%B\ ?^%/8__':/^&KO@C_T6+P!_P"%/8__ !VO5:* /*O^&KO@C_T6
M+P!_X4]C_P#':/\ AJ[X(_\ 18O '_A3V/\ \=KU6B@#RK_AJ[X(_P#18O '
M_A3V/_QVC_AJ[X(_]%B\ ?\ A3V/_P =KU6B@#RK_AJ[X(_]%B\ ?^%/8_\
MQVO+OV:_VE/A%H/[.OPMTK4_BIX+TS4-/\*Z9:W-I=^(+6*6"6*TB$D;QF7@
M@@BOJ:B@#RK_ (:N^"/_ $6+P!_X4]C_ /':/^&KO@C_ -%B\ ?^%/8__':]
M5HH \J_X:N^"/_18O '_ (4]C_\ ':/^&KO@C_T6+P!_X4]C_P#':]5HH \J
M_P"&KO@C_P!%B\ ?^%/8_P#QVC_AJ[X(_P#18O '_A3V/_QVO5:* /*O^&KO
M@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QVO5:* /*O\ AJ[X(_\
M18O '_A3V/\ \=H_X:N^"/\ T6+P!_X4]C_\=KU6B@#RK_AJ[X(_]%B\ ?\
MA3V/_P =H_X:N^"/_18O '_A3V/_ ,=KU6B@#RK_ (:N^"/_ $6+P!_X4]C_
M /':/^&KO@C_ -%B\ ?^%/8__':]5HH \J_X:N^"/_18O '_ (4]C_\ ':/^
M&KO@C_T6+P!_X4]C_P#':]5HH \J_P"&KO@C_P!%B\ ?^%/8_P#QVC_AJ[X(
M_P#18O '_A3V/_QVO5:* /*O^&KO@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\
M?^%/8_\ QVO5:* /*O\ AJ[X(_\ 18O '_A3V/\ \=H_X:N^"/\ T6+P!_X4
M]C_\=KU6B@#RK_AJ[X(_]%B\ ?\ A3V/_P =H_X:N^"/_18O '_A3V/_ ,=K
MU6B@#RK_ (:N^"/_ $6+P!_X4]C_ /':/^&KO@C_ -%B\ ?^%/8__':]5HH
M\J_X:N^"/_18O '_ (4]C_\ ':/^&KO@C_T6+P!_X4]C_P#':]5HH \J_P"&
MKO@C_P!%B\ ?^%/8_P#QVC_AJ[X(_P#18O '_A3V/_QVO5:* /*O^&KO@C_T
M6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QVO5:* /*O\ AJ[X(_\ 18O
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M_A3V/_QVO5:* /*O^&KO@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\
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M\R*:7B.0VUN ^8OWG^LKK_V]?O?LY_\ 99?#G_MS0!]5T444 %%%% !1110
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MW>NZ%9V^CW_@'5-'UCPW]FB5(=+N8KV&&$QQ#]V1'%+)&(R"G/3@8TOVAO\
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M\/-7\8/X5TWQWX:U#Q2DDMH=#MM7MY+_ ,R(MYL9A\SS 8_+D)!''/I7S/\
M&CXG^*?!_P#P2YT[QMI7B#4K;Q>_@[P^TFM-.SW1DN?LD,LOF9SYA$K_ +P?
M/GG.<&M/XF?#^?Q-^S%X@^$'AG]G7Q;HVE2Z+-9:/9?VIHD=K;W"?O;:25DU
M0N2+E8I9&/F&0Y,GF9- 'V17RI^T-_R?5^R/_P!S=_Z:XJ]W^$W_  D__"J_
M"/\ PFF?^$S_ +)LO[<_U6/MWE)]I_U7[K_6^9_J^/3M7A'[0W_)]7[(_P#W
M-W_IKBH ]M\8_&CX=_#S4UTWQ?XZ\,^&-2DC^T+9ZUJ]M:2/'VD$<D@)'R=?
M:NFT?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B..""/3UKQ^+XY:=)XY\
M6:-X"\ :]XYNM)U!$\1:MX733HK7^T/*\O[-+<75U;B:ZCBB@$@C\SRE\N-R
M",5X[^QEHNH>./@I^T!X5TJYO_ >WQ[XETC0X(?]9X9CDBB*10Q12^7'Y4DD
MDGEQ2",2$X/.: /I?2_C5\/-7\8/X5TWQWX:U#Q2DDMH=#MM7MY+_P R(MYL
M9A\SS 8_+D)!''/I7DOQF_; T?X4_M&?"_P#<>)?"5GI.K?VI_PE,FIWT<5S
MH_EVL<UB)"90MOYAD_Y:C]X,;.O/$_"_QM)^R[\-?!WPP^-?P]ATC0],FM[*
MU\<:%;1W/A4>5)%);75U(<2V4IN9(LRRQ8-P/-$F"3'U'[0W_)]7[(__ '-W
M_IKBH ^C/#/B?0_&6B6VLZ#JVGZ[H]P?]'O]+NH[FV;G81')&2#SQQ[UX#\9
MOVP-'^%/[1GPO\ W'B7PE9Z3JW]J?\)3)J=]'%<Z/Y=K'-8B0F4+;^89/^6H
M_>#&SKS].U\J?M#?\GU?LC_]S=_Z:XJ ,7XL>*M%\:_MD?LC:UH&L6&N:/<?
M\)?Y%]IEU'<V\F-/BCQ'+'P>:^C_  '\6_!GQ.DOQX.\9:#XM^PB/[5_8>HQ
M7PM_,SY?F&(G&?+DZ^AKYL_:N\+:=XN_; _9=T?5K9;O3+P^*#<VDDCB.>/[
M!$?+?!S)&>1)%_JY(R8Y 8\UL?'1FTG]NO\ 9HO+ M:W>L6?B;3M1FMR8Y+R
MUBLHIHXI<#]Y'')^\$9X#\XS0!] ^)/B-X7\&W%I;>(_$>DZ+/>17-U;1:I?
M16YDCMD\VXEC$F"5BC_>2'I&!D\55\/_ !<\$>(O"^H^(=%\8Z%K'AW3/,^V
MZOI^I13VMOY<?FR&66,E$Q&1(<D8![5\V?M=>!= ^)/[7_[+7A_Q5IEMJ^B7
M3^)I9;&Z7,4IBLK:6,2 _?\ WD<?R=^_%2?MCZ]=ZQ\</V>_!%SH.I>-/!WB
M*^UC4-8\&6;V\/\ :\EC;0RVHE\Z6*.6**4F7RI9/+D\OD28C% 'TGX#^+?@
MSXG27X\'>,M!\6_81']J_L/48KX6_F9\OS#$3C/ER=?0UK^)O$^A^#=$N=9U
M[5M/T+1[<_Z1?ZI=1VULO.P"220@#GCGVKYC^-&F_$'XH_$[X*^)O#?PH\3>
M&=<\)^*(I;O6M9OM(,4>CW*>3JD7EQ7TOF&2/R_^6?F#RSY9R:Q_BMXHO]<_
M;L\(>';OPEK/C_1O#G@K_A+=,\-::UE"+76#?FV%_*+FYBCD,48\N,DR&,S;
MXP#F0 'U1X)^(7A3XC:7-J7A7Q)I/B:QCE^S2W>BWT5U"DH _=^9&3S\X_.M
M/6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_ %DCN>  /7TKYBN/#_CKQ9^U
MM\,?B'I'PVU_P?I5MI&IZ%XKU#7+[3)/M%B4\ZQBCCM[V7I= \H ?WG/R5]:
MT 8'AGQ/H?C+1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]ZHS?$'PM;S
M^)+=O$6EQ3>'(TN=:B:]C0Z7$\9D$ER#_J@8@9,R=1STYKYC_9S\0?\ #,GA
MGXZ^ ]:LKZ'PY\-;ZZ\3Z'%;0'RO^$=N4ENK>&UEEVR7,L;Q74<AD./,_=^:
M0#CPNS\&^)/"=G^S?X-\=^'K_P 67?Q,U?Q!X[\=>#K#R[>37=3\N*ZM?M,=
MU);11^2#"9+8F.(R0D>7(0,@'Z#^ _BWX,^)TE^/!WC+0?%OV$1_:O[#U&*^
M%OYF?+\PQ$XSY<G7T-6_&WQ"\*?#G2X=2\5>)-)\,V,DOV:*[UJ^BM87E(/[
MOS)".?D/Y5\W_&C3?B#\4?B=\%?$WAOX4>)O#.N>$_%$4MWK6LWVD&*/1[E/
M)U2+RXKZ7S#)'Y?_ "S\P>6?+.37JGQ(^+&@^"OB-X;\/6_A_4O&OQ(O+&Y>
MTTSP_;V\FH6NFD@S7,DMQ+%%;VQDBBCS)(/-D$0 D,? !WG@GXA>%/B-I<VI
M>%?$FD^)K&.7[-+=Z+?174*2@#]WYD9//SC\ZYK6OVA/ACX=:3^U?B1X0TCR
M[RYL91>:W;1>7=PF/S8#F4?O8O,B\R/J/-&>O/S]\/=>OKS_ (*,:JTGA75O
M T>I?#2.[OM,OY[,G4;F+5!%%=RBUN)8Y"(V,,<DA\S&1P,9=^PCX%T*W^(W
M[1GC1M,M3XFN?B=KNBG53DSBSCFCE$ //ECS)23C!?$><^7'@ ^F?'GQ;\&?
M#&2P'C'QEH/A+[<)/LO]N:C%8BX\O'F>692,X\R/IZBM[1]<L/$>EVFI:=>6
M]]IMY%'<V]U;2"6*>.3_ %<B..""/3UKYF\4>$?B%\&OVEO&'QB@\./\4/"&
MO:3;64NG:2!_PD.@16T4DGE6$<L@CFMI9(O,DACD$DDDT>(B8SYGL/P-^(GA
M?XH>"#K7A"T&F6XU"Y34=+DMOLUWINHF;S+JVN[;'[JY\R20R9Y)<R9(DR0#
MU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLG]C9D\L9QGIV]" >[T5Y1_PDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\
M"ZOO_E-0!ZO17E'_  DOQN_Z)YX _P#"ZOO_ )34?\)+\;O^B>> /_"ZOO\
MY34 >KT5Y1_PDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\ "ZOO_E-0!ZO1
M7E'_  DOQN_Z)YX _P#"ZOO_ )34?\)+\;O^B>> /_"ZOO\ Y34 >KT5Y1_P
MDOQN_P"B>> /_"ZOO_E-1_PDOQN_Z)YX _\ "ZOO_E-0!ZO7C_P'^"O_  I5
MOB'G6CK)\6^,M2\68^S?9_LOVKRLV_\ K#YA3R_]9QG/059_X27XW?\ 1//
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M>*],\4R:A>V<4LNI&R$O[J01>5'$9#)GS(X\#_GGCI[;7E'_  DOQN_Z)YX
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M5O%GC^WN8M+E,L&E^%](ET>TO"\4L1^V^;<74DP02;XXXWB D +^9^[\M?\
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M]^.2,G,<@YS>_P"$E^-W_1// '_A=7W_ ,IJ/^$E^-W_ $3SP!_X75]_\IJ
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M5Y1_PDOQN_Z)YX _\+J^_P#E-1_PDOQN_P"B>> /_"ZOO_E-0!ZO17@GP_\
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M_P!$\\ ?^%U??_*:C_A)?C=_T3SP!_X75]_\IJ /5Z*\H_X27XW?]$\\ ?\
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M3SP!_P"%U??_ "FH_P"$E^-W_1// '_A=7W_ ,IJ /5Z*\H_X27XW?\ 1//
M'_A=7W_RFH_X27XW?]$\\ ?^%U??_*:@#U>BO*/^$E^-W_1// '_ (75]_\
M*:C_ (27XW?]$\\ ?^%U??\ RFH ]7KRCX._\E&^.G_8Z6W_ *CNC4?\)+\;
MO^B>> /_  NK[_Y35C?L\R:S=^)_C1+K]C9:9K#>,(?M-KI=Y)>6\9_L'2,;
M)9(HB_ !YC')Q[D ]PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#R;]FW_ ))WJW_8Y^+/_4BU"O6:\F_9M_Y)WJW_ &.?BS_U(M0K
MUF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** /)OV;?^2=ZM_V.?BS_ -2+4*]9KR;]FW_DG>K?
M]CGXL_\ 4BU"O6: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MP/#/B?0_&6B6VLZ#JVGZ[H]P?]'O]+NH[FV;G81')&2#SQQ[UOU\*^#?$WA[
M]@;XQ_%_PWXBN!H_PY\16<GC[PK;1QV]K;B9,QW^F6Y/E*]SG[*(K:/?B(1]
M,\@'V/IOBS0]7\0:KH=AJVGW6MZ.8O[1L+6ZC>YL_-'F1^;'U3S "1GKV]1T
M=?%OPMUV_P#V>OA;9^+/%6D7?B;X^_%[59=8C\*VI,=]=W,D?^C6'[X>;;VM
ME;&+S/.\R.US+R<Q@^NW7QTUKP7XZ\&^&_B7X7L?#I\77TUCI.IZ+K$FHV$5
MU'$9!%=37%M:^5)* $ACC$AE/F],4 >ZT5YSXUUWQ]:ZM!:>$O!FFZS;+");
MC4-=UY]-A&3Q%%Y5K<R2$>7\_F1QC$L>PR?O/+P/@_\ '"3XCZ[XP\+:UHW_
M  C7CKP;>PVVM:+'<_;;;RY@9;2YBN1'&)(Y8L2?<CDC)Q)&.,@'LM%?*G@+
M]J3Q_P#&+Q]X]\-^"_A3 \/@W7[[0;W7M?\ $#V6GR-;RK'"(I8[2:229\2O
M)%Y>(D,69#YHKZKH **^>_#7QZ\3_%C6-9N?A=X1TSQ1X0T^3[#%XJUW7IM,
MM-6N$:03?81%:W/FQ1%1&;G,<<DAD\OS!'FNV^!_QFTCXZ>!_P#A)=%MK[2_
M(OKG3[W2M76.+4-/NHI3'+!<Q)))Y<O D\L\XECZ9H ].HKY-^#'[6WQ!_:(
M^$L7CKP5\'<!%N ]EKOB46,5])&2%BL)A;2?:.P>25+:-)/W?F2;9"GLGPS^
M-WA'XF?"'2_B3I.I-9^$[RSDOGN]3(MQ:Q1&03&4DX3RS%+DYV?NS@]Z /3J
M\T^ OQITC]H+X6Z/X]\/6=_9Z-JWF_98=32..X_=2R1'S/+DD YB/?\ P'EW
MA_\ :@\7?$;P/J7Q(\"?#+_A*OAO;7DL6GW4.M&+6=6MHI/*N+JUTW[,0?F\
M[RXI;B*601#B/S #YM^Q'\6]!^#/_!._X;:_K[W$J2RWUI9:;IT?G7^I7LFJ
M77E6MM%G][+)@XC% 'W+17SEK7[07BWX5:%H&N_%3P+8>%/#FK7MGITUWHWB
M$ZG+HDMR1^\U!I;6WBAMXSQ)*)9,.8P!)OR._P#C1\9_"GP \ ZAXP\9:D;'
M3[<F..&(C[3>3?\ +.WAB_Y:.?KV).$S@ ?\>OC3I'[/OPMUCQ[XAL[^\T;2
M?*^U0Z8D<EQ^]ECB'E^9)&#S*._^!]+K\[O^"AGQ*^)<W[(VOV'C/X7VNB:?
MXA@L@]]H7B+^V#I-TE_:S>5?1FVB$8P)8O-BDEC\T)'G]XAK]$: "O*/V4/^
M36?@U_V)FC?^D,5>KUY1^RA_R:S\&O\ L3-&_P#2&*@#U>BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *Q]8URP\.:7=ZEJ-Y;V.FV<4ES<75S((
MHH(X_P#62.YX  ]?2MBL?6-#L/$>EW>FZC9V]]IMY%);7%K<QB6*>.3_ %D;
MH>""/7UH -'URP\1Z7::EIUY;WVFWD4=S;W5M()8IXY/]7(CC@@CT]:J^&_%
MFB>*/MZ:-J^GZPVF7DFGWO\ 9]TDQMKF,@212A/]7*,\QGG\Z^$OAS\4I/V'
M?AS\7/A'=S7&M>*O"^H>9\.M)NUCEFUNQU&3-A'#$/*DO3'<F;[28A\G[P1D
MXKUGX?W#?LK^"_!/PCT'3S\1OC-X@<ZSJT?V[RO-FDF!O]6O[WRO,2V$F8HY
M98I)9?+BB D/0 ^MJ*\0\._&[4(_BAIOPT\;^'+?PIXLUC3)]5TF\T_43?:9
M>QQR@26\5Q+%;22748/FO$D9Q$!)YG-=%XB\5?$EM:O+?PMX*T&_TFVVQ_;]
M>\2RZ?)<2$9)BCBL;G,8R$RYC?S$D'E[-DD@!Z;17DOP-^-%K\;O"=WJ4-A<
MZ'KFCZE<:!KVBW;^;_9VI6__ !\6WFQCRYL9!$L?!!'?Y!Y=^S3^U+X]_:<\
M,Z7XHT;X5P:#X7DF\BXU37O$+QF7]\XE^PQQ6DGVD11B+,DAB'F&2(?ZN1P
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M@F738=5&K3PR(/L\L0DC81X\S+[X\1X#DG'7BOF;X\?M ?$+QA^R-XR\7?\
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MDQQQ@ <\\>]'AGPQH?@W1+;1M!TG3]"T>W/^CV&EVL=M;+SO)CCC  YYX]Z
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M]7&B#@ #T]* -BO*/@[_ ,E&^.G_ &.EM_ZCNC5ZO7E'P=_Y*-\=/^QTMO\
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M^+?L(C^U?V'J,5\+?S,^7YAB)QGRY.OH: .VHKGO%W]O?\(KK/\ PC7]G_\
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M'\2KNXT6#P5=>%].ADDD_M34]>M[BZ:*/R_W7V>UBEB\PO)P?,GC\L X$F:
M/1**^;_V.?B+XJ\=Z;\6;;Q9X@G\1R>%?B'J_AJQOKJWMH9OL=JL(C,HMXXH
M\Y+$D1CD^F,?2% !117A,?PQ^*WB;PR]QJWQBU+PQXUGM/WMIX:T?39=$L[G
MR\ Q1W5M)<R1 C)\RY!DY/[K(CC /=J*^7OAS^UH_B;]B>'X\Z_IUCIMW:Z3
M>W=UIJWQBMKJZMI98?*AED!V>=+$!&/WF/-$?[P@$W/^$&^/7_"H_P#A*?\
MA9>I_P#"T/LG]K_\(A_96D?V+]I_UW]E_P"J\[R_^7;S?MN?^6OF=J /I6BO
M$? OQ@U?XZ_LZZ3X_P#AA:Z6-?UK3?.LK/7KJX33[6\R8I8Y9(XO,D$4HEZ1
MCS/*X,?F"0<+X+\>?$#1?VV9_AQXE\86_B#1IOA[_P )$]O8Z3'8VD-X-2%K
M^Y&9;C'E#GS+B3]Y)(1@%(XP#ZHHKY__ &AOBQXA\-^*_ WPP\%/;Z7XY^(D
MU];V6OWZ>?::/;VL/FW-R(C_ *V81?ZJ+_5F0CS"!Q)ROQD\5>,_V78?#WQ
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M\++U/_A:'V3^U_\ A$/[*TC^Q?M/^N_LO_5>=Y?_ "[>;]MS_P M?,[5Z/\
M #XM:9\>/A)X:\>Z.AAM=<LQ/-:[B?LL^1'+#N\N/S/*DCDB\S SY>1UH ].
MKRCX._\ )1OCI_V.EM_ZCNC5ZO7E'P=_Y*-\=/\ L=+;_P!1W1J /5Z*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \F_9M_Y)WJW_8Y
M^+/_ %(M0KUFO)OV;?\ DG>K?]CGXL_]2+4*]9H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\)R>'--^,.DW$:PR6MEKFN^$9+[6HX_F\IY9A?QQ7,T2&,>8;?$IC_>(3D4
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M4PDSF+RACRO]7S)QF23-K_@FKX!T'4/V.=$UC4M)AUC4/%D-Q:ZU<:A_I/\
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ME/L>LW'A7PY_9>J:I$(F79)<R7,T48ED(DE$=N!(,Q\1N00#VWX>>,;'XC>
M_#?B[38IH;+7],M=3MDN1^\2*6(2QA^?1Z^?OV"OO?M&?]EE\1_^VU>T^(/"
MWB>TTO1=/^'FI^&_"5AI\7V?['J/AZ2^A$0V>4D4<-U;>4(P/?C' KRWX(?
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M /"D1_PR[_PIS^W&W_\ "'?\(C_;?V7C_CR^R_:?)\ST_>>7YGMGO0!X5:>
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M^UP[=D8NHI'BNO+_ 'DA\HS12^7DY\O'X>9_\Y3/^Z-_^YJO7O#OPN_X5/\
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MM_V.?BS_ -2+4*]9H \I_P"%R>+O^B%_$#_P.\/?_+6C_A<GB[_HA?Q _P#
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MP]_\M:]6HH \I_X7)XN_Z(7\0/\ P.\/?_+6C_A<GB[_ *(7\0/_  .\/?\
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MOA/K7@JRURSU*.U\6:NF@6FI6Z1O!!>RY^RQR#S?,_>X8 QQN!C,AC% %?\
MX7)XN_Z(7\0/_ [P]_\ +6C_ (7)XN_Z(7\0/_ [P]_\M:]6HH \I_X7)XN_
MZ(7\0/\ P.\/?_+6C_A<GB[_ *(7\0/_  .\/?\ RUKU:B@#RG_A<GB[_HA?
MQ _\#O#W_P M:/\ A<GB[_HA?Q _\#O#W_RUKU:B@#RG_A<GB[_HA?Q _P#
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M:]6HH \I_P"%R>+O^B%_$#_P.\/?_+6C_A<GB[_HA?Q _P# [P]_\M:]6HH
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M _\  [P]_P#+6MCQC\:/AW\/-373?%_CKPSX8U*2/[0MGK6KVUI(\?:01R2
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M'(,'!/EGTH Y;_A<GB[_ *(7\0/_  .\/?\ RUH_X7)XN_Z(7\0/_ [P]_\
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M/_ [P]_\M:/^%R>+O^B%_$#_ ,#O#W_RUJW_ ,-!?"__ (2G_A&_^%D^$?\
MA(_MW]G?V3_;MM]K^U^9Y?E>3YGF>9YO[OR^N>/:O2Z /*?^%R>+O^B%_$#_
M ,#O#W_RUK'_ &>=6NM9\4?&6]N]&OO#UU/XPB:33-2DMY+B _V#I Q(;>26
M+)QGB0\$9YX'MU>4?!W_ )*-\=/^QTMO_4=T:@#U>BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7B^*NK7[V$Y\JY2WN5ADMIC$>1'* 3')TD'3I7)^./!'AOX#_!_Q?\7OV?\
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M=K$LD<D?8Y!&*]3H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]LBLIM0CMOMVFW,?E7]K&\O[H&6/R_WDG,?E?N^>O?\ _"F_%W_1=/B!_P"
M/A[_ .55'_"F_%W_ $73X@?^ /A[_P"55 'JU>>:7\%?AYI'C!_%6F^!/#6G
M^*7DENSKEMI%O'?^9*6\V0S>7YA,GF2 DGGGUK,_X4WXN_Z+I\0/_ 'P]_\
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M_HNGQ _\ ?#W_P JJ/\ A3?B[_HNGQ _\ ?#W_RJH ]6HKRG_A3?B[_HNGQ
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M_HNGQ _\ ?#W_P JJ /5J*\I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ
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M\7?]%T^('_@#X>_^55'_  IOQ=_T73X@?^ /A[_Y54 >K5Y1^RA_R:S\&O\
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MGQ _\ ?#W_RJH ]6HKRG_A3?B[_HNGQ _P# 'P]_\JJ/^%-^+O\ HNGQ _\
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MDD>>@_2O2:\I_P"%-^+O^BZ?$#_P!\/?_*JC_A3?B[_HNGQ _P# 'P]_\JJ
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M51_PIOQ=_P!%T^('_@#X>_\ E50!ZM17E/\ PIOQ=_T73X@?^ /A[_Y54?\
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M:.YA$HY$<H $D?20=>E 'UA1110 4444 %%%% !1110 4444 %%%% !1110
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M_P!I+X&^'OB*VC?\(^NL_:=NG"Z-SY0BN982#)Y<>>8L].]>NU\J_P#!+O\
MY,7^&?UU3_TZ7=?55 'D^L>//'MYX@U32?"?@"WN8M+E$4^J>*-7ET>TO"\4
M4H^Q>5;W4DP02;)))$B D!">9^\\MOP-^-%K\;O"=WJ4-A<Z'KFCZE<:!KVB
MW;^;_9VI6_\ Q\6WFQCRYL9!$L?!!'?Y!H_$K4/BE!Y]MX T'P?J#261,5]X
MDUJZMO*N>1_Q[Q6LGF1_ZO\ Y:QGD_6OD[X+ZW<>#_V.?VB+!IM6T7XQZ)#K
MVK^,[FZ\NPOAK%S8/="]ABAED\N(_NHXIH_+CE^S&2,<T >R>"?VC?'?Q?\
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MB?\ )B_Q,^NE_P#ITM* /JJBBB@#RC]E#_DUGX-?]B9HW_I#%7J]>4?LH?\
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MB[^WO^$5UG_A&O[/_P"$H^R2?V;_ &IO^R?:=A\KSO+^?RM_7'.,X[5\[?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MGQV\/?%A?C5X8T_Q)H^FRZ3(MCXULDMM2LY"Y$-S%O.]8Y)#*F"/W@YSLCP
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M /\ PI['_P".T?\ #5WP1_Z+%X _\*>Q_P#CM '(?\*Q\1?\-Y?\+$_LP_\
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M$?\ HL7@#_PI['_X[0!ZK17E7_#5WP1_Z+%X _\ "GL?_CM'_#5WP1_Z+%X
M_P#"GL?_ ([0!ZK17E7_  U=\$?^BQ> /_"GL?\ X[1_PU=\$?\ HL7@#_PI
M['_X[0!ZK17E7_#5WP1_Z+%X _\ "GL?_CM'_#5WP1_Z+%X _P#"GL?_ ([0
M!ZK17E7_  U=\$?^BQ> /_"GL?\ X[1_PU=\$?\ HL7@#_PI['_X[0!ZK17E
M7_#5WP1_Z+%X _\ "GL?_CM'_#5WP1_Z+%X _P#"GL?_ ([0!ZK17E7_  U=
M\$?^BQ> /_"GL?\ X[1_PU=\$?\ HL7@#_PI['_X[0!ZK17E7_#5WP1_Z+%X
M _\ "GL?_CM'_#5WP1_Z+%X _P#"GL?_ ([0!ZK17E7_  U=\$?^BQ> /_"G
ML?\ X[1_PU=\$?\ HL7@#_PI['_X[0!ZK17E7_#5WP1_Z+%X _\ "GL?_CM'
M_#5WP1_Z+%X _P#"GL?_ ([0!ZK17E7_  U=\$?^BQ> /_"GL?\ X[1_PU=\
M$?\ HL7@#_PI['_X[0!ZK17E7_#5WP1_Z+%X _\ "GL?_CM'_#5WP1_Z+%X
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MR6(DECDQ#Y<0C\PR2')/E\[(_3_^&KO@C_T6+P!_X4]C_P#':/\ AJ[X(_\
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MBO*O^&KO@C_T6+P!_P"%/8__ !VC_AJ[X(_]%B\ ?^%/8_\ QV@#U6BO*O\
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M/%]C;Z9XIN=/MY=6L+9@(K>\,8,L<?[R08$F0/WAX YKF/\ AJ[X(_\ 18O
M'_A3V/\ \=H_X:N^"/\ T6+P!_X4]C_\=H Y?P/X)\7:Y^T[XT^(OBA+C1M#
MTW3QX7\)Z:UXCBYMB\5Q>WTL<<DD:&66.(1D&.0QQ#S8L@5[[7E7_#5WP1_Z
M+%X _P#"GL?_ ([1_P -7?!'_HL7@#_PI['_ ..T >JUY1\'?^2C?'3_ +'2
MV_\ 4=T:G?\ #5WP1_Z+%X _\*>Q_P#CM8?[._B;1?&7B;XS:WH6IV&MZ/=>
M,83;:AIEU'<VTF-"TB,F.6,D=01QZ&@#W&BBB@ HHHH **** "BBB@ HHHH
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M6H5ZS0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%?(GB^WU?XQ_MS1^"3XN\4VW@7PMX+_M34[#POJUSI
M</\ :US=;(8KV:U,<G-MB6.,R@_N<C@R^8 ?7=%<7X'^&VC^ 5O6TN]UZ[%W
MY9?^VO$%_JWW,G]V+J:7R^ISLQV]!7:4 %%>2:M\(V\7:G<WGBOQAXGU!'GD
M^P:=H6K7>AVMA'D_\^4L4LW[L1^8US))^\#F(1"3RZ^5/A+^T=XN^$W[.'C"
M2+4]3^)^OW?Q&OO!WPRNO$=T95U^.2:**UD-[Q]HBS]JD\TR",^28A)'^[P
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M&*O5Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.Z-0!ZO1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC3PD? FL?$#0M \ O8R:7>Z?X&\'C3+F2Q:UEA^RQ2W-U<Q118DB/[N'/[O
M,?->=_M]^%;?0?V4_"_P<\*VD%G;^+=?T3P/I!N[B0Q::/-$L+R-B220?Z*(
M_7$F><8/N=G\&-3FU;3+_4_BMXXUZ#3;P7\>G336-C;7$H!$8E^Q6MM))%EL
M^49/+<C]X''%:'QA^"FC_&G1-&M=5OM2L+C0]6MM?TC4M->/[18WUL<PRH)8
MY(Y/^6@Q+')GS#QTP >F5\G_ !*W?%#]N_X8>"+T>5I'@?P_>>/&MG_>VVI7
M$LOV"V+1'B.6V.9HY?WA_>$ 1]3])>&=$N]!T>WM+S7-1\1W29WZEJB6\=Q)
MZ;Q;Q11\>T=<!XU^!VE^.O%VB>,;36=:\(>,M(AEM(/$6@-;)=3V4O\ K+2X
M2:&2*>'S/WHCEB/ER#,>#G(!XQ^V)K3^,OC]^S7\*M-FT\ZO<>,(_%]RTE[^
M\M;738I9"#%M)_?*;G9)P-]MCU,?8?&?X3^/-,^,FF?&OX7Q:3K'BRUT ^&M
M0\,^()GMX;[31="[_P!%FC_U5UY@,8\W,>) 3CR_WG0>%/V5_"OA/XP1_$I]
M2U[7?$\=E-%*=9O5N8C<RB*.6_CB\O\ T:YEBMXH3]G\N/RHQ&(P!6I?_!.Y
MDUK5[BU^)OCRPT+5KYKNYT"'4+>6VS( )8HKB2VDNK:*3!($-Q'Y?F'RO*XP
M <%_Q*/^"BW[%_\ S$/!^G^,['_IG/-8W-M<_E-$+FV_Z9F2,?\ +(GBS\&O
MCMX]N/C-J'P<^*?AK2]-\<VFAKXCM]:\+W;RZ5J%D;@QG9%(1+"4=TC^?/F&
M.4_(/+\SKY_V?M'T?P]X1T'P3K?B#X9Z?X8:1--7PQ<Q1Q/')$1(EQ#<1RPW
M.3^\\R:.202?O X)DSK^ _@QHGA/Q1?>+KB\U+Q'XYO+--/N_$>LR1RW4MK'
M)YL<"(D:16\8)YC@CB$A&^022?O* /GSX.GQK\9OCM\9_B)HFO>&-!NM)U^7
MX=VEKKGAJ35);>RTT^8XCN8KJU(%Q-<22R1D2=(N3Y0Q[1\-_@'/X=^(VH_$
M;Q;XHN/&GQ!O=-.BB_%E'865C8_:I+D6UK;1G(&7C^>:2:3]W_K!D@MN/V=[
M?1_%VOZ_X0\8^)OA[-XCE2]U?3O#@L9;&YOQP;KRKFTEV2R<>8\?E^;Y:&3)
MYKL/ASX(/P\T6[LSXFU_Q9=7-W+?3ZAXCOOM%P\LC'Y5 "1Q1=DBBCCC&W@#
M- '@/_!-^YN?$GP7\7_$.XMH;"+XA^-=7\6VUC%<^<UK'+*(C%))Y:9(EMI1
MG'(QZD5S?CK4/%7[!%]X]\<VVG6/C#X-^(_$K>(]:@^V?9M>TF]OI8HII(P?
MW-U; QCRXQY<N90"<1F2O:_A3^S?IGPD\,W'A3P]XI\3+X'*74=GX:>Z@B@T
MX7$K2N+:ZBABO0<R2[)#<$C/7(!J*#]F&TU30K'P[XS\;^+OB/X9LUM_+T7Q
M1+:&WFDMS'Y<EP;:UBDN?N<I<R21R$YD1S@@ ]WKXM_:,\#Z#^T!^W!\'/ F
MLZ1;:S8>$="U/QEK%IJH_P!&N;666*UMHX\<R$7,0DDCD_=F/C]Y_JZ^TJ^'
M? WPJT_]HC]J+XZ^,Y-6U>"+PSKVD:+X7\5:5<+%>Z1>V-I(-3MK82B3]T9;
MDB2*2,PR^:>)* .N_;- \0>./V:/"6G$W'B.Z^)-CKT5G(NW?8Z?%++?3%_]
M7F..6,XSDY_=@XK"^#I\:_&;X[?&?XB:)KWAC0;K2=?E^'=I:ZYX:DU26WLM
M-/F.([F*ZM2!<37$DLD9$G2+D^4,>Z>"O@=I?@7Q=K?C&[UG6O%_C+5X8K2?
MQ%K[6SW4%E%_J[2W2&&.*"'S/WICBB'F2',F3C%&X_9WM]'\7:_K_A#QCXF^
M'LWB.5+W5].\."QEL;F_'!NO*N;279+)QYCQ^7YOEH9,GF@#D[SP!<? ^'QY
M\>_%VMS_ !%^(.F>%;Z,JT,6F6,-A;RS7PL;:&,2&(9$0\R:2XD/E9SU%5?^
M"<_PF3X4_LD>"T$5N+WQ%!_PD5W):N[K,;G]Y$</T(MA;1G_ *Y]^M=IK7[.
M]KXJ^#/B3X;ZSXY\9:A'XDEFDU77I=6_XF;^;,)'BB/E^3%$8P8O)BB2/RR1
MY?SFO5='T.P\.:7::;IUG;V.FV<4=M;VMM&(HH(X_P#5QH@X  ]/2@#8KXA\
M!ZIXJ_81O/ OPPU+3;'Q3\'-8\3#PYX:\16,YBUC39[R669(KZ%P(YMTDI D
MB* 1PR28S)'%7UOX]\(KX^\)ZCH4FJ:MH<5Y'Y?]H:#?265] ?[\4L?(/Z5P
M=G^S[9:AKVC:KXR\4>(OB)<:)>C4-(C\2&U2WLKO&//$-G;6\<DHR/+DF$GE
M'F+RR3D \0_:,\#Z#^T!^W!\'/ FLZ1;:S8>$="U/QEK%IJH_P!&N;666*UM
MHX\<R$7,0DDCD_=F/C]Y_JZZ7XG*/&7_  4$^".BV;!+GP5X;USQ-J,ESRCV
MU[Y=C%'$<??$HZ''R>O2O7_#OP;T?0_C!XM^)WVN_P!2\1>(+.UT\?;I4ECT
M^TML_N+7]V)(HY'(EECR091G%'AWX-Z/H?Q@\6_$[[7?ZEXB\06=KIX^W2I+
M'I]I;9_<6O[L211R.1++'D@RC.* /&?V6K@_$S]H+]H3XG7IVWUMXC'@+3K6
MX7SY=.MM-0";RI<?NXKF642F(  2)DF0UG_"W7#\4/\ @HO\4-?TQM._LGP+
MX1LO!]U/'>^;+<W-Q=&]R %Q'Y6RYADCSD21<]Q'ZM<?LZ:59^+O$.L^'?$_
MB7P9:^(IX[K7M%\/W-M!8:E=8(DNAYD,DMM-*G^LEM989#Y:29\P"2HOAI^R
MIX4^$/@OQOX=\+W^OZ</%&^.765O]^J:="+86MM;6UUY?F"*UBQ]G\TR&/UH
M \D_X)O>&XM6\ ^./C'+IUOI][\4/%.H:V(XKF20V]C'<R1Q6TF?DS'(;HC
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M/V8['PYXD\1:OX&\;>+OA]_PDE\^J:OIVDW-M<VUS>/+))+=B.^MKD12R>8
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MBK_A7$^F1V7BC4>;^^L[ZV,T4=SVDEBP4,O'F]?+!S7/?\$W[FY\2?!?Q?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5YMXB_9_^%OC+6KG6?$7PW\(:_K%Q@3ZAJ>A6MS<38&SYY)(\]!^E==K6EQ:
MUI=[82-<I'<121M)9W$MK*-_]R6,B2,\C]XA&.M>0^*/V9G\7:/=^'-8^*7C
MJZ\)79$-QH+W5GY5S:ALBUENA:B]DC*#RI&-SYLD>=\AR<@''_L%ZEJ-]\,_
M&UE#>7%[X'T7QKJNC^"[AYOM4+:%%+&ML+>Y.XW$4?[R..3>^-GECB, ?5-<
M1XL^&NA^)_A3K'@%;8Z3X=U+2)]#-OI21Q?9[62(Q%8N-B 1G@8QTK/T?X4^
M'](^%NE?#^6&>\T'2=-M-,B>ZG\NXVVJQK#*)(BABF3RHY1+%Y9CD4/'@XP
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M)FC?^D,5>KUY1^RA_P FL_!K_L3-&_\ 2&*@#U>BBB@ HHHH **** "BBB@
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MO7E'P=_Y*-\=/^QTMO\ U'=&H ]7HHHH **** "BBB@ HHHH **** "BBB@
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M?C?H/A37+C2KW2O&+W-O@--I?@W6+^V((_@EM[62-\?6@"C_ ,)+\;O^B>>
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M=(L(O^NES=6L<4?_ &TD% $O_"2_&[_HGG@#_P +J^_^4U'_  DOQN_Z)YX
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M?_*:C_A)?C=_T3SP!_X75]_\IJ]7HH \H_X27XW?]$\\ ?\ A=7W_P IJ/\
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MB>> /_"ZOO\ Y34?\)+\;O\ HGG@#_PNK[_Y35ZO10!Y1_PDOQN_Z)YX _\
M"ZOO_E-1_P )+\;O^B>> /\ PNK[_P"4U>KT4 >4?\)+\;O^B>> /_"ZOO\
MY34?\)+\;O\ HGG@#_PNK[_Y35ZO10!Y1_PDOQN_Z)YX _\ "ZOO_E-1_P )
M+\;O^B>> /\ PNK[_P"4U>KT4 >4?\)+\;O^B>> /_"ZOO\ Y34?\)+\;O\
MHGG@#_PNK[_Y35ZO10!Y1_PDOQN_Z)YX _\ "ZOO_E-1_P )+\;O^B>> /\
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M_1// '_A=7W_ ,IJ[CQ-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV 222$
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MM]1M[27*QQZEI]Q8W'N7AN(XY$_$5OT >4?\)+\;O^B>> /_  NK[_Y34?\
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M-'H;WUK:R2ZCJFLAH_M44?[V,1".22&W \ORY'E$GFB,$#"_:Q^)_P#PRO\
M%[0_C+-!J6I>&-6\-WWA34K?^U1#:&^MO,O]+'E".20R2R?;K;S""(A-G*#/
MF9_BC]E+Q/<?\$[]7^&FBVYE^)>MV5MK&K2:I<Q&YO\ 6#<Q7EV);D#$DN8V
MACDD/2.(&7'[P '=>-/B/\=?AI\']9^*/B'1_"4[Z792ZI>> +"&5;NVM@<F
M+^UWNO*DEAB_>2%+7$AB>./K&]-_:2_:;U_X=_#'X4>+_AEI-AXU_P"$X\1Z
M7IEC:WS2VWVVUO899HA$[F,0RR^7&!)*"(]_,9KA9O&W[+WB;P!J%SXD^(_B
M#2+62RN8M6\+>*_B1K<>I0! \=U8W6G27YD\X$2QF+8Y?_EGY@()M_M6Z7HN
MC>!?V5--\-V5U8:!8_%#PK:Z;9W231RVUM'%*L4;QS#S01&.DG[S/6@#O/&7
MQA^(7P/\9?#R7QP/#.K>&/&VOP>&&M=!M+F*^TF^NB3:_OI9C'?1#RY8I)/+
MMGYCD$?6*N@^)_QBU_P7^T9\$? %C#82Z-XX_MS^T9;F)_/B^PVL<T9B._J2
M2#D'UKB?V]?O?LY_]EE\.?\ MS6=^UE<2^ ?VA/V<_BEJEM=1^"?#6IZGI>M
MZK&8_*TS^TK>*UM9;@R2#RX1(Q\R4\ #GGRP0#T?XG_&+7_!?[1GP1\ 6,-A
M+HWCC^W/[1EN8G\^+[#:QS1F([^I)(.0?6F?%;XP:];?%70?A+\/H+"?QYJ5
MJ/$%]>:U'(UCHVCQSB)[ITCEC>XDDD'EQPQR=>9#''R?$?B!\6M ^*'[=W[,
MR>&9KK5-/LT\2RP^)+6 2:7?>98$-%:W7^KN3%Y6)?*)$?FA,^8)!'K?M%>$
M;'PI^UAX;^*GCF\U;2OAI?>%QX.N-<T/6KS3/[(OS?\ FQ2WTUM+%)':2>88
MQ)DQ"4Q^8(_W<E 'IVD_%[Q5X'^.7AOX8_$!=+O'\66%Y?:)XDT&UDLX;F[M
MC$9K$VIEN9 8XBTIN9)(XR#Y8CR,G!\!_&SQK\?/B1\2])\":SX1\*Z-X%UG
M_A'GMM>TB;4]4N+F)I/.NFBBO;;[/;$GRXLF0R>3*?W?^K%7P+#^SSKGQF\)
M3^&?&%S\0_'VG07MQH\T7C'4_$@TV/RUCN9),W4T5NLB21QYEV>8>!DBN?\
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MH \9_P""?/C6Z\;?L9_"[5+^.".6#3Y-,_T<<>79SRVL9^ICMX\U](5\R_\
M!.7PKJ/A#]BWX96.J0_9+F6RN=0B0.'!AN;J6YA?\8Y8S^-?35 !1110 444
M4 %%%% !1110 4444 %%%% 'DW[-O_).]6_['/Q9_P"I%J%>LUY-^S;_ ,D[
MU;_L<_%G_J1:A7K- !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7SK^T5=O\ $SQ-X3^!UC>;1XESJOBQ;>?RY+;P
M];21^?%^[N8I8_M<IBM<@29CENC_ ,LZ^BJ^==)^!OQ0\,?$;QWXKT[XDZ%J
M%QXHO8Y!_;GABZN9K"QB,GV6PB\K4XHA%$)93GR@9))99),DT <?_P $^=)L
MM$TOX]:;86<%AIEC\6]=M+:UMD\N*WBB%L(XTC'  'I5?X*CQU^S>WQIDUKX
M3>+/$&G:UX^UOQ98WWANXTRX$EC-Y7E'RI+Z.;S,1G]V(R>F.<UE?L"V?C)=
M>^-LLVN:+)HT?Q6\0)J5K'HDR7-S=8BW2PR?:B+>//E_NI(Y2 /]8<\>Q7'[
M9'P1M="O]2O?B5H.DC3_ #Q=Z9J5Q]FU2*2$R1R1RV,F+H2 QD>68_,X''.*
M .F^'?Q*\"?M)?#^XUGPSJ%AXQ\*W@ETZ[1X"8IAR)89H90,9!!\N0?ZN0=G
M%>)?&O0]/\._MG?L@Z;IUE;V6GV47BNWMK6UC$<<$4>EQ!$C0<  8Z5O?LA^
M&M2^&OP_^)7B_P 8VC^$=-\6>+]7\<"#69!:W&F:?<^5L^VC.R*01PM)(-_[
MO(SW \Q^.GQ^^&.L?MA_LS:[9_$GPC=Z+HY\3?VEJ%MKMK+;6?FV$<</FRB3
M$7F'@9/7\Z /NRL>^T.QU"^TNYN[.&YFL)_M-I))'O\ L\WE21&2/)^0^5)*
MF1VD([G/G/Q*_:3\&?#'X&ZI\6&O!XK\'V/E;KKPS-%>_:3)<QVW[H^8(S^\
MD_YZ=CZ8IG[27[06B?LV?"'6?'6L*E^MN\<%IIJ7,<<EY=2$"../S.IZR' .
M(XY),'&* /&OVS/$D/BSXN?LW?#32@VH>+7\>V/BU[198P+?3K(3&663+@]#
M(4X^?[-*!R,'[&KY"^#'Q#^$7A'5M2\>>-_C;\/?%7Q5\0QB'4]7@\2V@M--
MM0=\>FV$9ES':QG_ +:2R9EDR2 GU[0 5Y1^RA_R:S\&O^Q,T;_TABKU>O*/
MV4/^36?@U_V)FC?^D,5 'J]%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% '/^*/%>G>"/"NL>(M8N#:Z/I-G+?7
MEQY9?9#%&9)),)[ G\*\)_8K\/7-Y\-;WXFZOI4]AXF^)VHS>*;[[9=1WLL-
MG+(?[+M8[@ $Q1VOE>7&?]697_U>?+&3^UU>6WQ(U[P)\ [:R@UMO&&JP:MX
MDAE,N++P_93I<322O%()8#+*D<4,I'ED^8F4(!KWCXL_\)/_ ,*K\7?\(7G_
M (3/^R;W^P_]5C[=Y3_9O];^Z_UOE_ZSCU[T ?%WPA^+]S^PK\,_$OPI\4Z5
M_P );<^#;V4:5JGA^:VCT^6.]EADLX]3F,Q_LN226]E_>74<47E1'RY)C'^\
M]D^!?[.TNA_L*V?PB3Q;IFJIJOAJ_L_^$BTN+[3;$WS32>;",CSHHQ<\'(\S
MK^[S@><?LP_%OX%?"?\ 9;MO"/BR32/ASJ&F::8?%W@[Q?&MIJ5S=FUB-U))
M92@RW(F0YCP'\R*2*+&1Y2<GH?PK^(OAG]@?X]>%_ VB:_ FH>(]6_X0_0M0
MAE^TCP_)<Q120QVMT/-BWPB\/ER 2YD\P#S) 2 13_'RZ\)_LGW'P,\4Z7I]
MKXQ2SE^&Q\2KJ-O%X3B_=7-L99M2\R00R16UL)9+641W4CR((X0),Q_<OPI\
M"+\-OA;X/\'&Z^W-X?TBRTO[5Y?E_:/LT4<7F;.V?+%?.>E_%O\ 9CU3]GNS
M^'TKZ7H_A6>*/1)/AK<Q.=>M[G[3Y)M9--C\RZ^U"Y.3(@,GF?O1(3B2JW[-
M/CW4_P!FC]E'X$:'\4])UV#Q'K^L6WA:TMYPLMU:O=7%R;(2^9)^ZCCMQ&/+
MY>, 1^6.@ /J?Q)X3T3Q1]@?6=(T_6&TR\CU"R_M"U28VUS&28Y8B_\ JY1G
MB0<_G7SM^SS_ ,GU?M<?]RC_ .FN6OH#QM\0O"GPYTN'4O%7B32?#-C)+]FB
MN]:OHK6%Y2#^[\R0CGY#^5?'WP+^/WPQT?\ ;#_:9UV\^)/A&TT76#X9_LW4
M+G7;6*VO/*L)(YO*E,F)?+/!P>OYT ?=E%%% 'E'[*'_ ":S\&O^Q,T;_P!(
M8J]7KRC]E#_DUGX-?]B9HW_I#%7J] !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 <[XD\)Z)XH^P/K.D:?K#:9>1ZA9?VA:
MI,;:YC),<L1?_5RC/$@Y_.OG;]GG_D^K]KC_ +E'_P!-<M?0'C;XA>%/ASI<
M.I>*O$FD^&;&27[-%=ZU?16L+RD']WYDA'/R'\J^/O@7\?OACH_[8?[3.NWG
MQ)\(VFBZP?#/]FZA<Z[:Q6UYY5A)'-Y4IDQ+Y9X.#U_.@#[LKY5^%EY;^,/V
M\/CK?:AI\*ZCX.\/^'_#VFWT1ES]BN4EOYA(#)LYE\L9QTC&/^6F?7OB[\:M
M(^#*^#$U>UO[S_A*O$EEX7L?L"1R&.ZNO,\J23?(,1YC/(R1Z'MX9_:UC^S?
M^V-X[\2^,[F+2? _Q3TW3Y+7Q1J,HMK"QU+3HI(_[/ED.0#+$6FCEE,0/E^7
M&),< %OXO*?"_P"WQ^S[J6EA8;WQ7I'B+0=6E)\S[396MM'>V\?(_=[;C,G[
MO!/KVKJOVBKM_B9XF\)_ ZQO-H\2YU7Q8MO/Y<EMX>MI(_/B_=W,4L?VN4Q6
MN0),QRW1_P"6=<G*%_:(_; ^&?BSPJ3>^ _AWI6I7Q\86[^=8:M>WZ&U^P6L
MO$<GEQQ&1Y83* ?W4GER"NLTGX&_%#PQ\1O'?BO3OB3H6H7'BB]CD']N>&+J
MYFL+&(R?9;"+RM3BB$40EE.?*!DDEEDDR30!Q_\ P3YTFRT32_CUIMA9P6&F
M6/Q;UVTMK6V3RXK>*(6PCC2,<  >E5_@J/'7[-[?&F36OA-XL\0:=K7C[6_%
MEC?>&[C3+@26,WE>4?*DOHYO,Q&?W8C)Z8YS65^P+9^,EU[XVRS:YHLFC1_%
M;Q FI6L>B3)<W-UB+=+#)]J(MX\^7^ZDCE( _P!8<\>Q7'[9'P1M="O]2O?B
M5H.DC3_/%WIFI7'V;5(I(3)')'+8R8NA(#&1Y9C\S@<<XH [7X1_&/PA\;/!
MT7B/P3KT/B326=[<W$44D121,Y22.0"2,]_G'<>HKS#]OW2M:UC]COXHV_AU
MY[>^32TGD^R3^2?L<4T<MT.2.#;I*"F?W@)3G-<Y^S4NH_ [X,_&+XD>+M!U
M+2M.UOQ)KOQ&CTB2,?VE;:;)$)$BEB)$<=SY<7^J\SC."1@U[)#\9O"-G\(=
M"^)6I:HWA[PAJUE8WT5[JAVK;QWIB\KS3DB/F:,$YV)ZX% &5%XF^$_C3]G$
M7LFK:#!\'-3TC^S_ +5]K.FV$=C)_HPA+9C^SC!\KR_W9C/[O@BN(_X)R^*M
M1\7_ +%OPROM4F^UW,5E<Z?$X0(!#;74MM"GX1Q1C\*Y[Q9\4/@?H^K:CJ_P
M;\.>#/B+\;[Z*ZNM);PCI%MJ=TU]+B+[3?75OC[-%YES^]EEECS&TN":];_9
M>^#C? +X$>#? 4MPMW<Z39'[7-NWQFZED>6Z\O\ =QGRA-++Y>1GR\?B >P5
MY1\'?^2C?'3_ +'2V_\ 4=T:O5Z\H^#O_)1OCI_V.EM_ZCNC4 >KT444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y-^S;_R3O5O^QS\6
M?^I%J%>LU\R?!?X*:#XP\-Z_JU]JGB^*ZN/&/B<-#I/C'5["UPNNWX^2&VNH
MHD)QR<9)ZY)KT7_AFGPE_P!!CQ__ .'&\0__ "?0!ZM17E/_  S3X2_Z#'C_
M /\ #C>(?_D^C_AFGPE_T&/'_P#X<;Q#_P#)] 'JU%>4_P##-/A+_H,>/_\
MPXWB'_Y/H_X9I\)?]!CQ_P#^'&\0_P#R?0!ZM17E/_#-/A+_ *#'C_\ \.-X
MA_\ D^C_ (9I\)?]!CQ__P"'&\0__)] 'JU%>4_\,T^$O^@QX_\ _#C>(?\
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M /PXWB'_ .3Z/^&:?"7_ $&/'_\ X<;Q#_\ )] 'JU%>4_\ #-/A+_H,>/\
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M/_\ PXWB'_Y/H ]6HKRG_AFGPE_T&/'_ /X<;Q#_ /)]'_#-/A+_ *#'C_\
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M]'_#-/A+_H,>/_\ PXWB'_Y/H ]6KRC]E#_DUGX-?]B9HW_I#%2_\,T^$O\
MH,>/_P#PXWB'_P"3Z\N_9M^ OA?5_P!G?X6ZC/J/C.&2Z\*Z7,Z6GCG7+6'$
MEK$?W<45V(X_:., #B@#ZGHKRG_AFGPE_P!!CQ__ .'&\0__ "?1_P ,T^$O
M^@QX_P#_  XWB'_Y/H ]6HKRG_AFGPE_T&/'_P#X<;Q#_P#)]'_#-/A+_H,>
M/_\ PXWB'_Y/H ]6HKRG_AFGPE_T&/'_ /X<;Q#_ /)]'_#-/A+_ *#'C_\
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M44 %%%% !1110 4444 >3?LV_P#).]6_['/Q9_ZD6H5ZS7DW[-O_ "3O5O\
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MW0!]54444 %%%% !1110 4444 >3?LV_\D[U;_L<_%G_ *D6H5ZS7DW[-O\
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M8R3^:=2O9+FYNKF^ANI+B2620=!%C!XD/[P@'V1X+M?%=GI<D?BS5=)UF_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^W_:O-QY?E^7LX_UF<]JW_\ AI;PE_T!_'__ (;GQ#_\@4?\-+>$O^@/X_\
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MDADFC!RF8CS'C,?\8XKU3_AI;PE_T!_'_P#X;GQ#_P#(%'_#2WA+_H#^/_\
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ME_T!_'__ (;GQ#_\@4 >K45Y3_PTMX2_Z _C_P#\-SXA_P#D"C_AI;PE_P!
M?Q__ .&Y\0__ "!0!ZM17E/_  TMX2_Z _C_ /\ #<^(?_D"C_AI;PE_T!_'
M_P#X;GQ#_P#(% 'JU%>4_P##2WA+_H#^/_\ PW/B'_Y H_X:6\)?] ?Q_P#^
M&Y\0_P#R!0!ZM17E/_#2WA+_ * _C_\ \-SXA_\ D"C_ (:6\)?] ?Q__P"&
MY\0__(% 'JU%>4_\-+>$O^@/X_\ _#<^(?\ Y H_X:6\)?\ 0'\?_P#AN?$/
M_P @4 >K45Y3_P -+>$O^@/X_P#_  W/B'_Y H_X:6\)?] ?Q_\ ^&Y\0_\
MR!0!ZM17E/\ PTMX2_Z _C__ ,-SXA_^0*/^&EO"7_0'\?\ _AN?$/\ \@4
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M>'Y9LFZLH1#:7,7V7S/WD2H(C&99?]9]^N__ .&EO"7_ $!_'_\ X;GQ#_\
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M?_\ AN?$/_R!1_PTMX2_Z _C_P#\-SXA_P#D"@#U:BO*?^&EO"7_ $!_'_\
MX;GQ#_\ (%'_  TMX2_Z _C_ /\ #<^(?_D"@#U:BO*?^&EO"7_0'\?_ /AN
M?$/_ ,@4?\-+>$O^@/X__P##<^(?_D"@#U:BO*?^&EO"7_0'\?\ _AN?$/\
M\@4?\-+>$O\ H#^/_P#PW/B'_P"0* /5J*\I_P"&EO"7_0'\?_\ AN?$/_R!
M1_PTMX2_Z _C_P#\-SXA_P#D"@#U:BO*?^&EO"7_ $!_'_\ X;GQ#_\ (%'_
M  TMX2_Z _C_ /\ #<^(?_D"@#U:BO*?^&EO"7_0'\?_ /AN?$/_ ,@4?\-+
M>$O^@/X__P##<^(?_D"@#U:BO*?^&EO"7_0'\?\ _AN?$/\ \@4?\-+>$O\
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M_#2WA+_H#^/_ /PW/B'_ .0*/^&EO"7_ $!_'_\ X;GQ#_\ (% 'JU%>4_\
M#2WA+_H#^/\ _P -SXA_^0*/^&EO"7_0'\?_ /AN?$/_ ,@4 >K45Y3_ ,-+
M>$O^@/X__P##<^(?_D"C_AI;PE_T!_'_ /X;GQ#_ /(% 'JU%>4_\-+>$O\
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MV)FC?^D,5 'J]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!Y5_PU=\$?^BQ> /\ PI['_P".UU7@GXA>
M%/B-I<VI>%?$FD^)K&.7[-+=Z+?174*2@#]WYD9//SC\Z\V\7?L^_ 'P7X7U
MCQ'K7PG\!VND:39RWU[=#PI:/Y<,49DDD^2+/"@GCTKSW]BWX./:?LFW:23M
MX8O_ (F_:O$]Q_PB+FUBT?\ M&/]RFG_ +K_ $?RK<0@ ^9Y<@)!(Q0!];45
M\F?M.? GX4>!?V>O'_BE?"GA_P /^(-)T>ZO]/\ %;HMMK":I'^\M)O[1)^T
MR7#7/E?O#*9)9.OF>80?:?V?_$FH^,O@#\./$FLW'VK5]8\-Z;J%]=;0GFRR
MVL4DCX3IDDT >E45Q_C[PG_PG'A:31Y=1U?3$FFMY7N='OI+*Y/ERQR^5YL7
M[R,2",QOY>#Y<DG(SFOE+XU>%?!?PG^/?P+T7X1:-H7@[XFZEXEB%_8>&[6&
MPEN_#(25]3^U11@1R1'R8S'Y@\SS(CY/SQL: /MVBBB@#RC]E#_DUGX-?]B9
MHW_I#%7J]>4?LH?\FL_!K_L3-&_](8J]7H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\O\9_"&P^(_B>RU/7]
M7UZ\T:VLI+4^%(=0:WT>Z\V0&22ZCCQ]I)4>68IGDA\LN/*_>'(!ZA17RK_P
M2[_Y,7^&?UU3_P!.EW6#\7/&OA/XB_M%:IX+^(/C'P_I/PC\"V6FW.NZ3K=Y
M]ABU;Q!=&::RMKDS#R[FWCMK?[1Y0."_E^9YHC*Q@'V117BWP7T7X#7FJ:EJ
M/PCL?AU->VL MKR\\%0V/F11RG(CEDMNGF&+.#_SS]J?XX^!OP\U?4/$/B[Q
M_8:=XF@S]O;_ (31H[ZPT6".UCCE^RQW'[NTC/E>;*1C>23(2!&(P#V:BOE;
M]@'6+_6/@WKMQ;WUQ>^ 5\5:C;^ Y;ERY'A^*58K6,>8/- CDCFCQ-^\P/3R
MZ[[]K7XHGX&_LX^/?&EH\]O?:?IQBL+BVBCF^SWLK"WMI?+D^0B.:2(D>@.0
M>E 'M=%?,7_##/@#_A3O_"-_V5I__"?_ &/?_P +-^P'^V_[8_UW]J_:?-^T
M^9]J_>^7YW_3+/EUTW[''Q;U+X\?LU^!O&FLG.MW]DT-],I!^T2VTTMK),/+
MCC \UHFE\O'[OS .< D ]WKRCX._\E&^.G_8Z6W_ *CNC5ZO7E'P=_Y*-\=/
M^QTMO_4=T:@#U>BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQQX>M=&\K2/'-Y>WWB*V%U*1>RWD?E7,F3)F+S!Q^[(]L=@#QW_G%G_W1O\
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MR?:OLL7E6_[LGRTQ'_SS Z\YH \-_9Y_Y/J_:X_[E'_TURT?L\_\GU?M<?\
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M-$DLLG&99,R' YXX[;PSX8T/P;HEMHV@Z3I^A:/;G_1[#2[6.VMEYWDQQQ@
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M'2V_]1W1J /5Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXB?!SP%XJU%88M1U[P_8:K<Q0?ZN.2:VCEDV>V9#BN^H \H_X1GXW?\ 10_
M'_A"WW_RYH_X1GXW?]%#\ ?^$+??_+FO5ZXO_A:7AO\ X6M_PKK^TC_PE_\
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MZ*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^
M/_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO
M_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?
M\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O
M^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@
M#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[
M_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO
M10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4
M?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_
MZ*'X _\ "%OO_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^
M/_"%OO\ Y<T?\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO
M_ES1_P (S\;O^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?
M\(S\;O\ HH?@#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES1_P (S\;O
M^BA^ /\ PA;[_P"7->KT4 >4?\(S\;O^BA^ /_"%OO\ Y<T?\(S\;O\ HH?@
M#_PA;[_Y<UZO10!Y1_PC/QN_Z*'X _\ "%OO_ES7FG[-.A_%V3]G?X72:?XY
M\%VNFMX5TO[-'=>#[J>9(_LL?EB24:G%YG'<1QY]!W^HJ\H_90_Y-9^#7_8F
M:-_Z0Q4 '_",_&[_ **'X _\(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >
M4?\ ",_&[_HH?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#ES7J]% 'E'_",
M_&[_ **'X _\(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >4?\ ",_&[_HH
M?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#ES7J]% 'E'_",_&[_ **'X _\
M(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >4?\ ",_&[_HH?@#_ ,(6^_\
MES1_PC/QN_Z*'X _\(6^_P#ES7J]% 'E'_",_&[_ **'X _\(6^_^7-'_",_
M&[_HH?@#_P (6^_^7->KT4 >4?\ ",_&[_HH?@#_ ,(6^_\ ES1_PC/QN_Z*
M'X _\(6^_P#ES7J]% 'E'_",_&[_ **'X _\(6^_^7-'_",_&[_HH?@#_P (
M6^_^7->KT4 >4?\ ",_&[_HH?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#E
MS7J]% 'E'_",_&[_ **'X _\(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >
M4?\ ",_&[_HH?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#ES7J]% 'E'_",
M_&[_ **'X _\(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >4?\ ",_&[_HH
M?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#ES7J]% 'E'_",_&[_ **'X _\
M(6^_^7-'_",_&[_HH?@#_P (6^_^7->KT4 >4?\ ",_&[_HH?@#_ ,(6^_\
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M5B?.%M')'%='4HK:Z,<4ID'E$^=Y8DR?+(/6O5O^&HM0_P"$*^T?\*F\??\
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M_P"36?@U_P!B9HW_ *0Q5ZO7E'[*'_)K/P:_[$S1O_2&*O5Z "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6?@U_P!B9HW_ *0Q5ZO7E'[*'_)K/P:_[$S1O_2&*@#U>BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^
M;/B/\6O@'^S3X3\?:;K6I>&8EN);K5-=\(0W$-UJFJ75\WF2B6UDDWRF42C_
M %G[L1D9\N*/C7_8E\%^*/ ?[*_PVT+Q?)='7+?32\D%YYOG6T3R2R06TGF#
M>ABBDBB\LC]WY6SH*[#PY\2OAM\7_A;?^(]/U_0_$W@*2PE74KJ6>)[2.$Q+
M+-%=B0XC_=29DCE (!Q)BO'?^"=7_)"_$']DY_X5S_PF6L_\(+M_Z 7VK]UC
M/[W/F_:?]=^\]>U 'HW[57Q:F^"WP1\0:SI]Q<+XJO$&E>'+:RBCN+FYU:Y/
MEVL<4,A_>G>?,,8!_=Q2<'&*VO@!\)=,^ _PD\-> M'<S6NAV8@FNMI'VJ?(
MDEFV^9)Y?FR222^7DX\S Z5Y-K:V7QP_;1T;P^]M<7FA_"*P_MS5%:YW6K:Y
M>B,6"36TD?[PPVPN;B*:/_5R28S&1B3W'XK?%#PW\'_ .J>,/%^I'2?#NG>3
M]IO/LTDWE>9+'%&?+C!D/[R2/H._:@#PG]JJ:U\=?%KX!_"/6XKBXT+Q5X@O
M-7U+RK@>3=Q:3:FYCL[B$QF.6&6:2,R#I^Y]<%&_\%#4;P5\$K?XN:8QA\8?
M#C6++6M(NL[=YDNHK6XM93Q(;:6*7]Y'')'YA2/FH_VL(YO OQR_9Z^+6JL(
M?!WA?5]2TC6+LGFP_M.U^S6]U*3^[BMDD $DLD@QYL?7.!)_P4-=O&OP2M_A
M)IBF;QA\1]8LM%TBUQNV&.ZBNKBZE',@MHHHOWDD<<GEEX^* /JZBBB@#RC]
ME#_DUGX-?]B9HW_I#%7J]>4?LH?\FL_!K_L3-&_](8J]7H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\>_:*\>:
MUX-^'OV3PC&1X^\3W47A[PVQB>1(]0N0<7,F(I?W=M%'-<R>9'CR[9AQ7L-?
M-7BKX>_%34/VE4\?PZ3X+\3:!H>G-8>%+&^U::QGT_[0L7VZYE_T"YS+*8EC
MC,<B 1 C&9)* /,?V&?A+H?P/_:8_:5\$^&TG_L?28_"L,7VF3S9'WV$TDDC
MG_;DDD?C'7H.E=Q^S#/:_$;XS?'WXD3VUPNMVWBN3P);QW5R+D6=CIT<2D6Y
M,>8A---+-)&#Y>1'UP9#Q7[/NJ>/Q^VQ^T<6\.>'3/<2^%?[>0>(K@"QC^PR
M!?LQ^P_Z43&6.)!;<J!DY,@ZS]D]C\-?B]\?OAIK49C\2W'C&Y\=6F.(K_3-
M1$?E36P?$DGE2Q^5,0/+CD./,- ">!=_PV_;W\=>"M%58/#_ (P\&P^.[RPP
M1':ZHEV;&66VCCPD?G1_O)209))0"9,<#Z=UC7+#PYI=WJ6HWEO8Z;9Q27-Q
M=7,@BB@CC_UDCN>  /7TKYB\"[_B3^WOXZ\:Z*RS^'_!_@V'P)>7^28[K5'N
MS?2Q6TD>4D$,?[N4$B2.4@&/')T_VSM;_P"$DTCPC\&;*341J_Q3U:+2I/[*
MO?LMS;:/;M'<ZK,DA!C)%M^[\H_ZP3'B3!C( ?L8Z)_PDFD>+OC->QZB-7^*
M>K2ZK'_:ME]EN;;1[=I+;2H7C!,9(MOWGFC_ %@F',F!(?J*N1U;5-!^%'P_
MO-2F2WT'POX;TR6>2&U@/DV5G;Q$XCBC!XCCBQY<8[8 Z5#_ ,+2\-_\*I_X
M6+_:1_X1#^Q_[>_M#[-)_P >/E>=YOEX\S_5<],^U 'RM^TM\2_@=\-_V7?%
M'P;\+2Z'K-[<6$GA71/ ?AR6'4K^'4Y?,CB'V7=YOFQW'[UY9/WGF@GF4@'Z
ME^$^AZOX3^%OA#1/$NH_VIXCT_2;.TU*^,TDQNKN.*-)9?,D^>3,F3N/)SS7
M,?%+Q/\ "'QI\!-?UKQIJ>A:_P#"R\LI6O[];D75C+$)!'F*6(G,HE $?E?O
M/- \O]Y7)_L&?\))_P ,@_"+_A,-W]J_V,OD_P"JQ]A\S_0/]7_TZ_9O?KYG
MSYH ^BZ\H^#O_)1OCI_V.EM_ZCNC5ZO7E'P=_P"2C?'3_L=+;_U'=&H ]7HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R;]FW_ ))W
MJW_8Y^+/_4BU"O6:\F_9M_Y)WJW_ &.?BS_U(M0KUF@ HHHH **** "N&^(7
MQ0\.?"?1+35O%6J'3[>[O([&VMX[>6ZN+BZE.(X(H8A))+(3T2,$GFNYKY8U
M;5)-5_X*.^'-$U)8;JRT+X9W6L:;%-#$38WMSJ<=M+-'*?GS)%$D1QVR!_K)
M,@'J7AS]HCX?>+/&"^$X=;N]+\4RPBY@T'Q!IMWH]]=1-Y@\RWAO(HI)1^ZE
MYC!QY9Z5H6OQ?\+7GQ:O?AO#?W*>,K33O[8DTV>QNHO]!\Q(_.CFDC\J0&60
M1_NW[D?P''BG[;T*Z3X@_9PUJP'V35XOBKI-@E_ /*N4M[E9H[F$2CD1R@ 2
M1])!UZ4_XUVL7PX_:L^"/Q2&H0Z79:U-<_#C7V;S)9KTW,<ESIL(C\LB,?:H
MN9 4/[V/)\O. #VFQ^,W@_5/BU?_  VLO$5O=>-;/3O[6N='BCD=K>W\R.,,
M\F/+0GS(_P!V3OP^<8YJIK7QT\$^'=2\4Z7J&M%=2\)Z7_;>O_9[66YBTZWQ
MYA,LD<902&-#((N)3'^\$9'-?'/@OQ>]O\5_!7[1D-_IS:-\1_B1JG@^(:-I
MQ^TZGHUS#%8Z8;B2X_>1&.YT:*8QC_GYDQY?[R(]-X?:U^('[,/[5WQIB_L^
MY'Q$L=>;3=0TY;F/S=(TVQEL;'S(I?\ 5RGR9I3@9_?<X_U<8![M:_M>?"23
MPSI^N0>+_MGAZ[:W#>(+72KF72[.25HXXX;JZCB,-C)^\CS'<R1R1B6/>!FO
M>:^0])TJTT7_ ();W%OI]I;V<$GPCGN]EJ@C'FRZ0TLKD>KR22.?<UP_QZUC
M4-%_X)#Z3=:?=3V,S^!?#5LTEO+LS%+]ABEC^DD<LB'J,&@#Z&TO]J;X8:A;
M3W\/B*Z'A^.22 ^*KC2;Z+0OW<S1[AJ<T?V/'F+Y?F>;AY, <D"NK^)WQ@\(
M?!NQTG4/&7B*#PYI^HZE%I%O=W<;^5]HD$IC$DF#Y2XBD/FR8C&.37D?Q+\
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M3>?J.K7EKX;EEMM<U#1_#>I:C96,L48EEBEN;:VEB#1QMF0>9^[Z''..B_:
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MGW4D7VFUD,QEAEV']Y&<#,9X.!Z5E_ M6TG]NO\ :7L[\-:W>L6?AG4=.AN
M8Y+RUBLI89)8LG]Y'')^[,@X#\9S4W[>OWOV<_\ LLOAS_VYH G_ &H/%FMM
M\5_@EX#&LZEX5\!^+=8NH->UK3;B2QN3-;PB:PL8[X8\K[5)^[(CQ++Y9CCD
M'SUZ]X0^%-CX!UJ2ZTG7?%$D%Q;E)K'6M>O=7BE;(\N3-Z\LD13,G$4D8/F?
MO ^(O+W?'/@;0?B9X3U+PSXFTFWUC1=0B\NXLK@'#^GN.?XP:^:?"\%W^R?^
MT%\//A?HNO:UXF^'/Q"CU,6&EZ_>-=2^&9;&W$@BM+@_O#:^48HA;2 ^7Y8D
M$O,@(!6\"Z#+\6/VQOVCM%U_Q+XN.C^&QX<_LG3]+\5:EIMM:_:+ R3"..UN
M8QF1H\__ *ZZGQ-XFUO]F?XP?#W3+G5M2USX3>-+W_A'(?[;N9;Z\\/ZR1))
M;>7<N9+FYCNLR1D3>8(C&#YL<>(ZI_L\_P#)]7[7'_<H_P#IKEJM^V:!X@\<
M?LT>$M.)N/$=U\2;'7HK.1=N^QT^*66^F+_ZO,<<L9QG)S^[!Q0!ZUXN_:)^
M'/@#QY;^#?$?B.+2/%LVF#5;;1Y$D,UY$9O)2.VPG[Z:22+$=M$3+)@XC-0Z
M9^T[\-;ZUU29O$2Z==:;>QV%QI.K6=S9:G]JEB\VWACL;B*.YDEFC&8HXXR9
M/F$8D(->1WFCV.H?\%3-.FO+2WNKBP^$OVNTDEB#FWE_M>6(R1D_</ERRID'
MI(1S1>:/8ZA_P5,TZ:\M+>ZN+#X2_:[226(.;>7^UY8C)&3]P^7+*F0>DA'-
M 'N_@'XP^%OBE>:Q9^'KRYEU31'BBU/3+_3[FPO; R1^9'YMM<)%*@DC_P!6
M^S!&<$X->)?&EW^%/[9?P;^)I+PZ+XMLKGX=:M<W8\Q+:624W6F)%&GS^9+<
MB6,R?O(Q&/\ EG_K#-_SE,_[HW_[FJ7]O7[W[.?_ &67PY_[<T ?5=%%% !1
M110!Y-^S;_R3O5O^QS\6?^I%J%>LUY-^S;_R3O5O^QS\6?\ J1:A7K- !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!YMXB_9_\ A;XRUJYUGQ%\-_"&OZQ<8$^H:GH5K<W$V!L^>22/
M/0?I7I-%% '.^&_">B>%_M[Z-I&GZ.VIWDFH7O\ 9]JD)N;F0@R2RE/]9*<<
MR'G\J?XF\,:'XRT2YT;7M)T_7='N#_I%AJEK'<VS<[P9(Y 0>>>?:M^B@#'U
MC0[#Q'I=WINHV=O?:;>126UQ:W,8EBGCD_UD;H>""/7UK \!_"3P9\,9+\^#
MO!N@^$OMXC^U?V'IT5B+CR\^7Y@B SCS).OJ:[>B@ HHHH \H_90_P"36?@U
M_P!B9HW_ *0Q5ZO7E'[*'_)K/P:_[$S1O_2&*O5Z "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G--\)Z'I'
MB#5=<L-)T^UUO6#%_:-_:VL:7-YY0\N/S9.K^6"0,].WH<OQY\)/!GQ.DL#X
MQ\&Z#XM^P"3[+_;FG17PM_,QYGEB4'&?+CZ>@KMZ* ,?1]#L/#FEVFFZ=9V]
MCIMG%';6]K;1B**"./\ U<:(.  /3TJK_P (KHO_  D__"2?V18?\)-]C^P?
MVO\ 94^U_9O,\WR/-_UGE;_WGEYQGGK7144 8^L:'8>(]+N]-U&SM[[3;R*2
MVN+6YC$L4\<G^LC=#P01Z^M&CZ'8>'-+M--TZSM['3;.*.VM[6VC$44$<?\
MJXT0<  >GI6Q10!YI_PS[\+_ /A*?^$D_P"%;>$?^$C^W?VC_:W]A6WVO[7Y
MGF>;YWE^9YGF_O/,ZYY]Z]+HHH *\H^#O_)1OCI_V.EM_P"H[HU>KUY1\'?^
M2C?'3_L=+;_U'=&H ]7HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX0M]_P#+FC_A&?C=_P!%#\ ?^$+??_+F@#DM-_9FNO#7A"3PCX=^+OQ%\/\
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M",&23RP,XKU3P%X17P#X3T[0H]4U;7(K./R_[0UZ^DO;Z<_WY99.2?TKC_\
MA&?C=_T4/P!_X0M]_P#+FC_A&?C=_P!%#\ ?^$+??_+F@#P;]KKP/I'Q%_:]
M_99T/78;N:QFE\27.;6]DM9(98K*VFBDCEBDCEC:.2*.3@]OPKVOPY\ [?2?
MB%9^/==\3Z]\0O%%C:-9:1<>)%M5728I/]=]FBMK:&*.67[LDWEF0QH$Z9S>
M_P"$9^-W_10_ '_A"WW_ ,N:/^$9^-W_ $4/P!_X0M]_\N: (?&OP.TOQUXN
MT3QC::SK7A#QEI$,MI!XBT!K9+J>RE_UEI<)-#)%/#YG[T1RQ'RY!F/!SG#^
M'O[,FA^ _BQ=?$@^*O%OBGQA=:3-HMU=>)-1CN$DCDO3='$8BC$6&(CCCB\N
M+8!B/.7/1?\ ",_&[_HH?@#_ ,(6^_\ ES1_PC/QN_Z*'X _\(6^_P#ES0!;
M^$7P5TCX,KXS?2+J_O/^$J\27OBB^^WO'(8[JZ\OS8X]D8Q'F,<')'J>V=XU
M^!VE^.O%VB>,;36=:\(>,M(AEM(/$6@-;)=3V4O^LM+A)H9(IX?,_>B.6(^7
M(,QX.<S?\(S\;O\ HH?@#_PA;[_Y<T?\(S\;O^BA^ /_  A;[_Y<T 3^!?A3
M=^&_%5_X@U;QWXN\7ZA<6D=C##KEU;QVMO$',FZ.UMH88O,R0#+)&9/W>,XX
MJ3X1?!72/@ROC-](NK^\_P"$J\27OBB^^WO'(8[JZ\OS8X]D8Q'F,<')'J>U
M3_A&?C=_T4/P!_X0M]_\N:/^$9^-W_10_ '_ (0M]_\ +F@"W\(O@KI'P97Q
MF^D75_>?\)5XDO?%%]]O>.0QW5UY?FQQ[(QB/,8X.2/4]L;2?@19^'_B-JWB
MSPGXGU_P;!KE]%?:WX?TM;5M-U&[C_ULLD<MM+Y4LHPDLEO)$9-@S^\'F5>_
MX1GXW?\ 10_ '_A"WW_RYH_X1GXW?]%#\ ?^$+??_+F@#U>OD7PW=1_";_@H
M%XSTG4(KAH/B]H-CJ>E:C);R)&E[IL,L4MCT(E(B!N#(3'Y8,4>/WD>?8_\
MA&?C=_T4/P!_X0M]_P#+FC_A&?C=_P!%#\ ?^$+??_+F@"SX\^#&B>+/%%CX
MNM[S4O#GCFSLWT^T\1Z-)'%=16LDGFR0.CQO%<1DCB.>.41D[XQ')^\JEX9^
M FD:7XPTSQ=KNLZQXY\6:5%-::9K'B#[,6T^*4#S8X(;>&*WC/!'FB+S2"8S
M(8\()/\ A&?C=_T4/P!_X0M]_P#+FC_A&?C=_P!%#\ ?^$+??_+F@"7X@?"%
M/&'B#2=>L/$6O>#/$ED/*?5?#EW%'+=0_O0+>YBEAEAN8AYTLD8EC)C<YC,9
MDDSB>#_V9O"OA7XI3_$?6+[6?'7Q"$8MH/$OB.2.26RMC'Y?DVT4,<5M".)2
M?+B\S]]+D_O2*UO^$9^-W_10_ '_ (0M]_\ +FC_ (1GXW?]%#\ ?^$+??\
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M$+??_+F@#U>BO*/^$9^-W_10_ '_ (0M]_\ +FC_ (1GXW?]%#\ ?^$+??\
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M4/P!_P"$+??_ "YH_P"$9^-W_10_ '_A"WW_ ,N: /5Z*\H_X1GXW?\ 10_
M'_A"WW_RYH_X1GXW?]%#\ ?^$+??_+F@#U>BO*/^$9^-W_10_ '_ (0M]_\
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M_P!%#\ ?^$+??_+FC_A&?C=_T4/P!_X0M]_\N: /5Z*\H_X1GXW?]%#\ ?\
MA"WW_P N:/\ A&?C=_T4/P!_X0M]_P#+F@#U>O*/@[_R4;XZ?]CI;?\ J.Z-
M1_PC/QN_Z*'X _\ "%OO_ES6-^SS'K-GXG^-$6OWUEJ>L+XPA^TW6EV<EG;2
M'^P=(QLBDEE*<$#F0\C/L #W"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)FC?^D,5>KUY1^RA_P FL_!K_L3-&_\ 2&*@#U>BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /*/V4/^36?@U_V)FC?^D,5>KUY1^RA_P FL_!K_L3-&_\
M2&*O5Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\H^#O_)1OCI_V.EM_ZCNC
M5ZO7E'P=_P"2C?'3_L=+;_U'=&H ]7HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'[F'PUX3U[1-6^(FF1RM?1"PC,ESJC7$0,GVF+[1)YCQQB1!@D?NX\C[VHH
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M<9),GS&\P',@)R>] '?UY1^RA_R:S\&O^Q,T;_TABKU>O*/V4/\ DUGX-?\
M8F:-_P"D,5 'J]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 45\@?LYZ!:?M=>&]7^*_C^VA\6^&O$&I
M72>$O"^L1^=I^EZ;;32112264F8C?R.)O,FS)B,^7')'&3'3/A_HEG\+?V\]
M7\ >#K*W\+>!]3^'L7BBYT'3HQ'8C5([_P"R"ZCB&/*/DXCD$?EB3 ,@)P:
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MKQ +F.\TG29)?+AMI8I?]4<QR28!<?O?,R3(: /JRO*/@[_R4;XZ?]CI;?\
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M"./ CC2,7N  !P*Z7Q5\%_"GCKPEI?ASQ%I]WJFGZ7-;7=C--J-R;ZVN;?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS=2^28XY(S'$8C()>9.F #D/V3XYO'7QR_:%^+6E,)O!WBC5]-TC1[L'F_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%U??_*:O5Z* /*/^$E^-W_1// '_ (75]_\ *:C_ (27XW?]$\\ ?^%U??\
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M_P"B>> /_"ZOO_E-7J]% 'E'_"2_&[_HGG@#_P +J^_^4U'_  DOQN_Z)YX
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M% 'E'_"2_&[_ *)YX _\+J^_^4U'_"2_&[_HGG@#_P +J^_^4U>KT4 >4?\
M"2_&[_HGG@#_ ,+J^_\ E-1_PDOQN_Z)YX _\+J^_P#E-7J]% 'E'_"2_&[_
M *)YX _\+J^_^4U'_"2_&[_HGG@#_P +J^_^4U>KT4 >4?\ "2_&[_HGG@#_
M ,+J^_\ E-1_PDOQN_Z)YX _\+J^_P#E-7J]% 'E'_"2_&[_ *)YX _\+J^_
M^4U'_"2_&[_HGG@#_P +J^_^4U>KT4 >4?\ "2_&[_HGG@#_ ,+J^_\ E-1_
MPDOQN_Z)YX _\+J^_P#E-7J]% 'E'_"2_&[_ *)YX _\+J^_^4U'_"2_&[_H
MGG@#_P +J^_^4U>KT4 >4?\ "2_&[_HGG@#_ ,+J^_\ E-1_PDOQN_Z)YX _
M\+J^_P#E-7J]% 'E'_"2_&[_ *)YX _\+J^_^4U'_"2_&[_HGG@#_P +J^_^
M4U>KT4 >4?\ "2_&[_HGG@#_ ,+J^_\ E-1_PDOQN_Z)YX _\+J^_P#E-7J]
M% 'E'_"2_&[_ *)YX _\+J^_^4U'_"2_&[_HGG@#_P +J^_^4U>KT4 >4?\
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MM-MM)U*>41+<FYDBN \UM#*1%'Y%S+Y@B)DCB'R;Y!'7M_@;4O'>K:FTVO\
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M/96^1)-)YDD7 SCS1D@<@ \:_97QX3_:'_:)^&VDA=/\#>&+_1+[0_#]L/\
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M_P!(8J]7KRC]E#_DUGX-?]B9HW_I#%0!ZO1110 4444 %%%% !1110 4444
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M?_\ AQO$/_R?1_PS3X2_Z#'C_P#\.-XA_P#D^@#U:BO*?^&:?"7_ $&/'_\
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MB'(V?))''GH?UJE_PS3X2_Z#'C__ ,.-XA_^3Z/^&:?"7_08\?\ _AQO$/\
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M^U_9O,\WR/-_UGE;_P!YY><9YZUT5>4_\,T^$O\ H,>/_P#PXWB'_P"3Z/\
MAFGPE_T&/'__ (<;Q#_\GT ;_CSX2>#/B=)8'QCX-T'Q;]@$GV7^W-.BOA;^
M9CS/+$H.,^7'T]!6K_PBNB_\(Q_PC?\ 9%A_PC/V/[!_9'V5/LGV;R_*\CRO
M]7Y6S]WY>,8XZ5Q?_#-/A+_H,>/_ /PXWB'_ .3Z/^&:?"7_ $&/'_\ X<;Q
M#_\ )] ':?\ "*Z+_P (Q_PC?]D6'_",_8_L']D?94^R?9O+\KR/*_U?E;/W
M?EXQCCI5K1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**"./_ %<:(.  /3TK@?\
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M0T#6+?(@U#3-"M;:XAR-GR21QYZ']:I?\,T^$O\ H,>/_P#PXWB'_P"3Z/\
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MW1[<VNCZ39Q6-G;^87V0Q1B../+_ .R /PKB?^&:?"7_ $&/'_\ X<;Q#_\
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M_#-/A+_H,>/_ /PXWB'_ .3Z/^&:?"7_ $&/'_\ X<;Q#_\ )] 'JU%>4_\
M#-/A+_H,>/\ _P .-XA_^3Z/^&:?"7_08\?_ /AQO$/_ ,GT >K45Y3_ ,,T
M^$O^@QX__P##C>(?_D^C_AFGPE_T&/'_ /X<;Q#_ /)] 'JU%>4_\,T^$O\
MH,>/_P#PXWB'_P"3Z/\ AFGPE_T&/'__ (<;Q#_\GT >K45Y3_PS3X2_Z#'C
M_P#\.-XA_P#D^C_AFGPE_P!!CQ__ .'&\0__ "?0!ZM17E/_  S3X2_Z#'C_
M /\ #C>(?_D^C_AFGPE_T&/'_P#X<;Q#_P#)] 'JU%>4_P##-/A+_H,>/_\
MPXWB'_Y/H_X9I\)?]!CQ_P#^'&\0_P#R?0!ZM17E/_#-/A+_ *#'C_\ \.-X
MA_\ D^C_ (9I\)?]!CQ__P"'&\0__)] 'JU%>4_\,T^$O^@QX_\ _#C>(?\
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M/_R?1_PS3X2_Z#'C_P#\.-XA_P#D^@#U:BO*?^&:?"7_ $&/'_\ X<;Q#_\
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MEGX^UV&&"./ CC2,7N  !P*T?^&:?"7_ $&/'_\ X<;Q#_\ )] 'JU%>4_\
M#-/A+_H,>/\ _P .-XA_^3Z/^&:?"7_08\?_ /AQO$/_ ,GT >K45Y3_ ,,T
M^$O^@QX__P##C>(?_D^C_AFGPE_T&/'_ /X<;Q#_ /)] 'JU%>4_\,T^$O\
MH,>/_P#PXWB'_P"3Z/\ AFGPE_T&/'__ (<;Q#_\GT >K45Y3_PS3X2_Z#'C
M_P#\.-XA_P#D^C_AFGPE_P!!CQ__ .'&\0__ "?0!ZM17E/_  S3X2_Z#'C_
M /\ #C>(?_D^C_AFGPE_T&/'_P#X<;Q#_P#)] 'JU%>4_P##-/A+_H,>/_\
MPXWB'_Y/H_X9I\)?]!CQ_P#^'&\0_P#R?0!ZM17E/_#-/A+_ *#'C_\ \.-X
MA_\ D^C_ (9I\)?]!CQ__P"'&\0__)] 'JU%>4_\,T^$O^@QX_\ _#C>(?\
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M\5^&8IK;9?2QQ?9K6ZL)999(O,D%UB:*60?)'Y@B'-<[^P5][]HS_LLOB/\
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M7'_<H_\ IKEKR_\ 8$^ OASXG?L5>"+_ ,0)-J&J7$6J0Z3JC"+[3X<_TZZ
METPF/_19A*/.\X?O/,$>9"D4*1@'WW17PU^RG\+;7]J[]DKP7XI^)6LZKXG\
M47<<L%AXCGG\K4=$^RWDD5M-82Q@&&;=;1222DF65P/-DDCCCC7CU_:.\;:I
M_P $[OA!J,FM:AI'BGQQJ]KX)F\2Z4DUY?VJ?:[B&2^CC DEN;F2&U_Y9D2&
M25I(R" * /T5HKX1^+-YX.\!VNE^._@U\./'L/Q-T*[MI=NF^"M;LIO$EK)<
MPB_L]2N;BP)N?-B$DOG3&202QB0'S/O]C\7(+[XU_MG^$OA%KTEO-\.-*\*_
M\)MJ>@^0Q76[B.^-M##<_O ##%+Y4WED&.0Q_O/,^3RP#M_C-\3O$GA7]J3]
MG[P?IFI?9O#WBL>(!JUGY,;_ &H6UC'+;_O"I>+$AS^[(SWKZ&KX;\:?"7P_
M\(?VTOV7].\*)<:9X?FD\6W2:$C^996<LE@99GMHSDQ"4R_ZF,^4/+S''&3)
MO^S-8T.P\1Z7=Z;J-G;WVFWD4EM<6MS&)8IXY/\ 61NAX((]?6@#B_A%\:M(
M^,R^,TTBUO[/_A%?$E[X7OOMZ1QF2ZM?+\V2/9(<QYD')P3Z#OZ97PY^PS\&
M_A]?:E\:M3G\#^&7U#0?BWK=KH]T^D6WFZ9'$;;RH[9_+S$(SR@C( /3%=#^
MRWX=\+?M7_":W^*GQ$\.0^,-4\4ZA?WMIIOBN./5;30[:.[EMHK2QCDB$<0\
MNVC\UXXQ)+)\\F?W8 !]A45\O_LO^)-=TCXM?&WX4ZGK%]XDMO!6KVE_I>J:
MI<RS745CJ<1N8K&220R22_9OWH$LLDAD\P?ZL1@"K_P5$_Y,7^)GUTO_ -.E
MI0!]545\_7W@+0_V??!/B'XKWFD6WBGXBZ#X7OYM6\2[S:W>N-'"ES+YK#S,
M+)):Q^7&1(+>/$<6(QY=?/7POTWX=_%+X">']5^)UMXZ\5_$K6["/6I/'L'@
M36_[2TVXED-U%_9E[':R"WBMFDB\L6Q%N?+,@CQ+(" ?0?[=7Q-\2?!O]EGQ
MMXP\'ZE_8_B+3?L(MKPP1S>5YE];Q2?NY08R?+D<<CO7T'7Y^?M-^,/%_CO_
M ()1ZOK?CS1+[P_XQFL]-BU.SU:V\BZ\V+6+:+SI(_+C\OS?+,OEB/ $@QTK
MZ:^/NK?"JQAT.+XJ7EK(EU*;;3?#MU/<7"ZQ)+)%$8_[,CS]O82218!AE\LD
M2#9UH ]IKS+P?\;-'\9?%;X@_#^RL[^'6O!/V :G-<H@MY/ML)FA\L^9D\ ]
M0/2OF7]GK5=+\+_MK^)/ /P_N?$VD?#34_!7_"2#PEKFEWMA:Z;??VIY<GV"
MVNHXI+:(^;(^(AY?F2R?\\T2.+X%_ 'X8ZQ^V'^TSH5Y\-O"-WHNCGPS_9NG
MW.A6LMM9^;8223>5$8\1>8>3@=?RH ^[**^#O"GQ#\,?&?XP?&;4OBEH?B#Q
MEH.@^)W\)^'_  B/">I^(-(TX6'RS7>;>VDMC<W,DS']XGG11CR_,,<E>I_L
MCWEYI]Y\0? MIHWBRT^&_AR_M9/!VI>++*ZM97L+BV^>QC6YACE>*UE21(S*
M9&\N2)#Q&"0#W3XA^,;'X<^ _$GB[4HIIK+0-,NM3N4MA^\>**(RR!.?1*/A
MYXQL?B-X#\-^+M-BFALM?TRUU.V2Y'[Q(I8A+&'Y]'KSC]LCPCH?BK]F7XF'
M6-(T[5SIOAO4[^R;4K:.7[+<QV4WERQF0'RY1GB3J.?6O A>>&_V8?\ @GGI
M7Q8\$>"_#^F^/CX"TF-M;L--MK>Z>:\BM(_.ED\H^;B:6.4QR?ZPQ<^M 'W=
M17S[JG[(WA*X\"SV&EI<6?CN33I;6'XG7<DDWB:.Y\HQQW4E\#'<R,#C,8D2
M,Q@Q8$6(ZM_L<?%O4OCQ^S7X&\::R<ZW?V30WTRD'[1+;32VLDP\N.,#S6B:
M7R\?N_, YP"0#=^.7QHM?@CX3M-2FL+G7-<UC4K?0-!T6T?RO[1U*X_X][;S
M9!Y<.<$F63@ 'O\ (>9U"Z_:)T733KR6'P^\0SPS7,LO@NQ-[:R-;#SC#'#J
MTLACDF_X]Q^\M8HSF3_5XKE/VAO^3ZOV1_\ N;O_ $UQ5]5T <!\&_BKH?QP
M^&>@^.?#4DQTC6(VDB6XC\N6/RY3')&_NCQR)QZ=^M=_7Y6^-,_\.Y_VH/[-
M_P"1,_X67=_\(K]F_P"0;_9?]KV/E?8?^67V;S?.QY7[O/F=\U]$?M(Z._[*
MO[._BWXMZ#%8:C\8['2H=+O/'5W8 7%_)=7-I%<SRQYP<,OF112&2*$)%'&/
M*_=D ^@/V@/$FH^#?@#\1_$FC7'V75]'\-ZEJ%C=;0_E2Q6LLD;X?K@@5ROA
M+Q1\2?&7[)W@SQ#X3N]!O?B/JGAS2-0-UXD62/3Y9I8H9+EY?LX'4-*<1]#B
MO'_BQ^R=X.^&?[+OCJ^T^.YC\=Z3X)U@:EXSM9'AU#799;<RWYOC*T@N1<R1
M$XE\TQB3]T8R(Y*Y/]I/_E#CI/\ V)7A/_T;I] 'Z 45\=?M2Z.GB+]K[]ES
M33?ZCID5R?%7FWFER>1<B,V$7F1)*.8O,!$?F1XD&_,<D<F'J;Q!H]C\!OVP
M_@OH/@:QA\.^%O'>GZY8:OX9TR$6FEQR6D,5U%?16T0CC^TG CDE<.3$!'Z4
M ?7]%?+GQD_X4#XI\=:OX7\=Z>WCSQ9>6;^?X?M[&_\ $-UI$.R*,RQ6UN)3
MIAD66',D0A\PF.3)(R/'OA?XPU?Q-^PS^T]IFK^)/$7BNV\-WOBW0](OO$ZR
MG4UL8K$R1"Z,D<<OF?O),^: 1GR\  1@ _02BODO]E;]GOP?K/[/OPC\0^,M
M)LO&GB;_ (1RU>#5-1M098K&YL#%'8 9(^S1VMP8C%_JY'\R4Q^:^:P/V>?B
M=?\ P,^#GQM\$ZLMQKU[\$9;]]-L-1NC]KGT/[-)=Z6TUS@QYDB$L8\L?NHX
MHQY0[@'VG7/^*/%>G>"/"NL>(M8N#:Z/I-G+?7EQY9?9#%&9)),)[ G\*\T_
M9*^%Q^!O[./@+P7=I/;WVGZ<);^WN98YOL][*QN+F+S(_D(CFDE /H!@GK7G
M_P"W=XTTFU^&_A[P'>^((/#T'CW7[71K[4&\06^CRVFDB3SM0N0\WRR 11^4
M?4W,8/F;_+E .I_94_:$OOC]X9U?4-9M--T/7K*6TF&DZ9>M=>797ME%?6,L
MH>.-\^5=>43C8\EM*8^.!]!5\>Z5\8/ <?[<V@OX)\9:!XGM?B5X<N=*U*S\
M+2V-T(]2TTFYM;NZECE\WFUENH1_USC'(QY>[I[67[0'[47Q1\'^+8IM6\)?
M#W3=(M8O#-U*)-)U*ZOTEN9+JZMO+Q,8Q'!'''*9(XS&90/,(,8!]2UYI\!?
MC3I'[07PMT?Q[X>L[^ST;5O-^RPZFD<=Q^ZEDB/F>7)(!S$>_P#@(],^"7A:
MST?5O#DU@VJ^#-0$9_X1/6@+_3+8QGC[-%-YGDQ<1@6P/DQB&/RXXSYGF?.O
M_!,7X3^"W_97^&WC;_A#M!'C$G4S_P )#_9L7]H?\?UU%_Q\X\S'E?N^O3VH
M ^I?A7_PF_\ P@FF_P#"Q?[#_P"$QS-]N_X1GS?[/_ULGE>3YO[S'E>7G=SG
M-=I7Y?\ PO\ ">HQ_P#!+WX9_$SPI$S^.OAG=W_BC2IED$7[J+4[D7UM+(")
M#;2VWFF2*.1/,\J,>Q^@OVK-;TS]H7P-\*?A?H6M6QTSXP:E:W8N)HI8Y7T*
MUB_M&ZEM6,?[N;$5L(_-C_Y:].IC /HK_BM?^%I?\P'_ (5K_8__ $V_MG^U
M//\ ^_7V;R?^VGF>U8W@_P"-FC^,OBM\0?A_96=_#K7@G[ -3FN406\GVV$S
M0^6?,R> >H'I7D'_ #E,_P"Z-_\ N:KS_P"!?P!^&.L?MA_M,Z%>?#;PC=Z+
MHY\,_P!FZ?<Z%:RVUGYMA))-Y41CQ%YAY.!U_*@#ZW\/_P#"<?\ "<>+O[=_
ML+_A"MUK_P (W_9_G?VA_JO])^U^9^[_ -;CR_+[=:[6OB?PGXX'PU_:2_;D
M\8?8?[0'A_2?#NJBV\SR_/-OHTTIC\SM_J_UKD?A?IOP[^*7P$\/ZK\3K;QU
MXK^)6MV$>M2>/8/ FM_VEIMQ+(;J+^S+V.UD%O%;-)%Y8MB+<^69!'B60$ _
M0:BOB+QK>?%[XV?L4>!=1UKPYKEMJ[7EJWC[PI#$;76-:T>WDEBOX(8O+B*2
M7/EQ2^4GE924Q@D?ZSU+]E/7O@YX@M_%EY\([#_A&+IKV+_A)/"!ADL9-)OD
MB$?ERZ<?W=M)^Z,<CQ1XE>(_O)/+X /HNBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MV?O,<'%4/VQO@SKO[0W[/'BKX?Z!/86FKZQ]F\B?4I)([9?*NHICYACCD/\
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M-)A\4V^@Z)I1O+F>3[!YME+:F4^8(_,P1;28_=YY' KZHHH \*^)_P '=?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ***Y#5OBCX/\/WTECJGBG1=.OXQF2VO-1BBDC_ G- '7T5GV-]:ZK:1
M75I<1W5K<1^9'-&_F1R)ZC\ZT* "BBB@ HHKG-+\8Z7K/B+6]#L[GS=4T4PB
M^A,;_N_-C\R+\QS0!T=%%% !1110 45DZYKEIX;TB^U/4)!!865O+<SS?W(X
MQD_IFC0]<M/$FD6.IZ?()["]MXKF";^_'(,C],4 :U%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&/\ R<1\:/IHO_I++77_  3_ .2.^!O^P%8?^DT=<A\,?^3B/C1]-%_])9:
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M3X1Z+\0-'?QG_P )[K.GZZMUXDOKKP^;&-5%EHY,?V2UDQ%'F2/]YG_6=?\
M6&O2Z "BBB@ HHHH **** "BODO]KS7/%OB3XL?!/X/^'?%NI^!M*\=7NJ3:
MMK6AEHM4$-A%'<^3;R @1>;D@R<D8'_+/S(Y/:/@Y\(3\(/#=YHB^,/%WC@3
M7[WG]H>-=2^WW<>8HH_*24QC]W^[SC_IK(: /3**\B_:C^.#_LV_ WQ#\15T
M;_A(%T;[-NTXW1MO-$MS%" )/+DQS+GIVKUV@ HKYD_X)U^)M7\:?L=_#[6_
M$.J:AKFKW37YN+[4[F2ZN)B+^YC'F22')P !UZ"OIN@ HHHH **** "BBB@
MHHKY+_:\USQ;XD^+'P3^#_AWQ;J?@;2O'5[JDVK:UH9:+5!#811W/DV\@($7
MFY(,G)&!_P L_,CD /K2BO,_@Y\(3\(/#=YHB^,/%WC@37[WG]H>-=2^WW<>
M8HH_*24QC]W^[SC_ *:R&O3* "BBB@ HHHH **\?^/'QJ_X4JWP\QHIUD^+?
M&6F^$\_:?L_V7[5YN+C_ %9\PIY?^KXSGJ*]@H **** "BBB@ HHHH ****
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M#>FZA?76T)YLLMK%)(^$Z9)->E4 %%%% !1110 4444 %%%% !1110 4444
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M6NOWWVU=8<F62[BDR$)CE),<DD6?W4?F>82<^L_''X6:A^TE^S#KG@W6+/\
MX1GQ-XCTB&7^S_MHECL=00Q3Q122QQD21QW*11R21Q\IG&.H\P\,?M0_%[2O
M#&D^$-:_9Z\>>(?BW:V445Z_^B6V@7TPC!EF.J(3;Q^9&#)Y?EX$I\KK@T /
M_P""<^EZCI?A;XX6>MZF=>UFW^*NN17VJ?91;&\F$=J)9O)3B/S"-WEC@9QV
MKZ.^*WPO\-_&#P#JG@_Q?IIU;P[J/D_:;/[3)#YOERQRQCS(R)!^\CCZ'MWK
MP;]@;PIXS\+^&_B^WC[2#I'B74_B1K&H3B*UFAM+GS$MLS6IE DDMC)YGER=
MP/K7U?0!^=7[$?['GPDUKQ1\3/$5[X4\W6? OQ6U.P\/W(U*Z'V&&R>VDM8_
M];^]$9'_ "USGOGK7M/_ #E,_P"Z-_\ N:KD?@WKWBO]FOXT?$?P-K_PN\8:
M_IOCCQY<>)]'\7>&+ W^FQ1ZC+''_I<OR?9O)\H&3)/5SC8(WD[S_A%=<_X>
M,?\ "2?V+J7_  C_ /PJG^S_ .V/L\GV3[5_;'F>3YVWR_-\O]YY?7% 'B'_
M  SO8?M'_MJ?M&Z)XG\1:M9^"K>?PM=:IX;TV3[,-;F6RWPQ74H_>>3'Y<Q\
MN,@GS8Y-X\F.JOCC]FO2_@1^TY\)_!7P6\0Z]\)]&^*5GJ^F>)(M)OOM@EAL
M8OM(DB-SYOE7.))8_-!S%D>6!^\\SWOX%^%=;T?]L?\ :8UN\TG4+72-9/AG
M^S;^ZMI(K>]\FPDCF\J0C$OEG@X/4_C1\=/"NMZQ^V/^S/K=GI.H76D:,?$W
M]I7]K;22V]EYUA''#YL@&(O,/ R>H_&@#PWXH_LQ^$/V-O%GP"\3?"1]8\/Z
MSJ'C;2_!NLS'4)+C^V[&YYE^TI)\F3]F!Q$(XP7R -D>SV/]H;_D^K]D?_N;
MO_37%5[]MCPQK/BQO@4NCZ3JFJMIWQ5T/4+S^S[627[-:QF82S2[!^[C&1F0
M\#(]:7XZ>%=;UC]L?]F?6[/2=0NM(T8^)O[2O[6VDEM[+SK"..'S9 ,1>8>!
MD]1^- ' _MK>$]3\<?M2_LP:!I?BC4O"%U?GQ+#)K&DJ#=PQ?8X/.\G_ )Y2
M21>;&)0,Q>9Y@_U=>:_M0?L>_#S]D?\ 9[N?BI\*HM4\*?$/P5-836/B"'49
MI9;LR7$=M+]ICD_=?O(YG,B1QH.V/+)C/T1\=/"NMZQ^V/\ LSZW9Z3J%UI&
MC'Q-_:5_:VTDMO9>=81QP^;(!B+S#P,GJ/QI?^"BGAG5_&G['?Q!T3P]I>H:
MYJ]TU@+>QTRVDNKB8B_MI#Y<<8R< $].@H Q_P!L*YN/$OQ&^!_P[UBYU#0_
MAUXQUB_MO$5]I][)8_:I8[$FUTN6YC8#R[LR2QF+_62^7B,@BOGWXF?L'_!C
M3?VQ/@[X5T'PG<SZ#JVF:Q=>*?#\.IW4IM[6*'%I=R-YOG0B2XE\KS/,\MS#
M@?\ +3/?_P#!0'3==\>_%+X,^%_#>@6/Q0NK;^T[[6?AG=7DL0O;&6$6WVZ5
M^([;R\W,<5S+(#'-+'Y7F?O!6#\,?%EK^Q.L6M>(?V33\)O"%W>I9:OXST[Q
M)%X@NK))@/\ 6D"2X^S>;%#D"3R\] 9"(W /T4KXU_:.37/CA^U;X*^!IU74
M=)\ 6OAJY\7>+(M-U*2TFURTDE-E'8$QQ^9Y7F?ZR/S )(YI.DD<9K[*KX[_
M &F_"'Q'^'/QX\+_ !X^&7AN?QU-IFA77A_Q'X2@OXX)KS3\O<PFV\R&0D^<
M<D1$ROY<4<<?,AH Y;XV?L'_  T^"OPQU[XF?".VU+X9>/O!=C<>)-/UK3[^
MZNS(+6&1Y;62.XEDC,<L>8S]>1)'OCDY;]OSX?\ @7XT?L8Q_M!:IX8^R>/)
M/#6ARV-PNHRRBR@N;J"0P\8BDQ]KF'F&/)SVKJ?C5\<?BI^T[X)U7X8?"WX)
M^.O"<_B*S>PU/Q)X\LH](M-.M9)8XY2/,\T7.^*20$1D2QC+QB7MV?[:'P?U
M'3?^"?\ KOPV\$Z=JGB:;3--T?3-.MK>W:ZO;B*UN[4#]W%'\Y$463@=C0!Z
M]\#OV8?AG^S>VL_\*[\-'PZ=7$/VY1?W-SYWE>9Y1/G228QYLG3UKHOBY\.-
M'^,7PZ\1>"]=MOM.D:Y9O9SX1-Z9^[(GF*P$D9Q)&<</&#VKNJ\Q^,_B+Q[X
M:\,6>H?#[PG8^-]7M[R/[;X?O-2%A+=6QCE'^CW$F8XY1+Y,A,G'EI)_RT,=
M 'RW#KG[07[#7ANULM?T^Q^.'P:T"SCB&L:(B:9K6BV,,5M%^]M<^7+%%'YQ
MP#(2%\R66(#%=;^V=XDTKXA_#W]GRXTZZ75O"/C+XD>&?M,5Q$1;:IILHEF$
M4T4@^>(D1R>7(#T]N,OXH?'?QW^T9\/O$'PY^''P)\>:+K/B.QETN[UKXAZ.
M-'TRRL;D>5<R^9YN9)0),^7'DGF0"3R_+?UCQE^S':^//V1;;X'7FNW21V^@
MV.CIK%M:@$269B\J;RB<8\RWC)C\SID;_P".@#M/C-XN\=>#?#-MJ'@#X>_\
M+*UQKY(IM)_MN'2_)A\N0F;S9>."(QY>/^6GM7EOP8_:?\=^-/CU<_"SQ[\(
ME^&NLQ>&I/$RS-XEAU3S81<QVP_U40 R3)_RTS^[Z<Y',^'_ -H[XS_";0;7
M1/C)\$_&7BK6K7-M!XF^&MO'J]OK'E,=UQ+;1R1FUS^Y(#X\S,G[N$?NPWX.
M0^.?BQ^V1>?&/4/AKXA\!^!)? TGAJRF\1RQ6^H7$O\ :$<I,EGYAEMNDN!T
M(C$F?WH% &M\"V;5OVZ_VE[R_+75WH]GX9T[3IK@F22SM9;*6:2*+(_=QR2?
MO#&."_.,U]8U\G?'SX)^._"?QLTOX]_!G3+#6?&<=G'H7B3PC<M#:QZ_IQF7
MF.YX\NYCQ'^\D./+BB[1&*5K?MG^)/$2G3O"?[-GQ8U#Q)(V^UA\3:3%HFGN
M1S()+Z661(CL\S&1R0(^": /IFWT:QAUJ;5([.V34+B&.UFNQ&/-DCB,IBCW
M]?D,TO<X\Q_4U\F_\% ]*O=6NOAA;>([3Q-J'P'74KJY^(,/AV(OB***.6UE
MNO*_>BVCDCEDE\OC X_>^57U7X1_M[_A%=&_X27^S_\ A*/LD?\ :7]E[_LG
MVG8/-\GS/G\K?TSSC&>]>/\ QD_:(U_X,_$+2M-?X/\ C/QQX6O-.-S'KG@N
MV_M*5;[?M-K):\>6/+_>>:9.<@ 'YR "E^R/\._@[X3\,:CK'P*UEKKP;K3V
MK2Z?:ZM+?6MO<1Q&0R>7*YDM[B2.:(2QR8.(H@8Q@Y^CJ^-_V>?#_B?QI^T_
MXI^*MA\.=2^$OPZU7PXM@=-U5(["_P!;U/[=)-+?W-C'_JY!FYBWRGS")(Y!
MD2$1_9% 'Y^:9\ -/^/G[<'[2VC^*-4OIO MN?#4^I>%[25H(]8F&F_Z,;F5
M#YHCA/FR>4"/,D,4F?W6#8_:WUKPE^RSX5^#?P<T+Q5K'P9^&NM:C?7.H>(M
M GN;F]L+.V/VB6VB.)9LW-Q=1_O0?W>#D21DH/7_ (%^%=;T?]L?]IC6[S2=
M0M=(UD^&?[-O[JVDBM[WR;"2.;RI",2^6>#@]3^-/_:D^'OB[5/$OPT^*/P\
MTBW\5^,_ &IW&SP]?7R6<6H6%]#Y%V$DD  E'[LQDR! !)Q(<1D ^&OB1XD_
M8U\(^&;GQ/\  GQW??#_ .*NA'^T_#^I65KK%R;F>*,_Z++'=QF/RI@3$>PW
M<YC\R-_K+]H#XW^/-8_8[^%UWX6N+3P_X]^+$NAZ''JUK<26D.F7.I0^;)+%
MQ+(!D21#'[R/S/,!S'SLM^V?XD\1*=.\)_LV?%C4/$DC;[6'Q-I,6B:>Y',@
MDOI99$B.SS,9') CX)KI?VS_ (-^(_C%\*;8>!KIK;Q_X6U:S\4^'3+-%%$]
M[;%\(XEC,9S')+@' \PQ>8?+S0!QNK?\$W_AK%8W6H^&+SQ)X2^)CQ2>3\1(
M/$%]/JOVQP1)=2_OA'(9<OYH C\P2R >7D$5?VCDUSXX?M6^"O@:=5U'2? %
MKX:N?%WBR+3=2DM)M<M))391V!,<?F>5YG^LC\P"2.:3I)'&:KR?MK?$_P 4
M:+9:7X(_9H^(<?CO4(6S#XLT\Z9HUC-Y,DFXW3_ZT"4  .+?S!CF,G%7OVF_
M"'Q'^'/QX\+_ !X^&7AN?QU-IFA77A_Q'X2@OXX)KS3\O<PFV\R&0D^<<D1$
MROY<4<<?,AH Y;XV?L'_  T^"OPQU[XF?".VU+X9>/O!=C<>)-/UK3[^ZNS(
M+6&1Y;62.XEDC,<L>8S]>1)'OCDT?CAXVN/CI'^S#INL-J7A+X;?%)9-0\1M
M8:G-;!Y)-+$MKHTMTGEB6.Z,LD9C(\R7RQY?ED5G?&KXX_%3]IWP3JOPP^%O
MP3\=>$Y_$5F]AJ?B3QY91Z1::=:R2QQRD>9YHN=\4D@(C(EC&7C$O;F_VP?A
MM>6NM?L\_"CP3H<7Q4@\-Z?=QWGP[U:]9)+_ $N.UCLHK^XE'EQ6QCC$T<5Q
M(8RMQ,/*$G[P4 <W\3/V#_@QIO[8GP=\*Z#X3N9]!U;3-8NO%/A^'4[J4V]K
M%#BTNY&\WSH1)<2^5YGF>6YAP/\ EIGW'_@HQI>HZIX6^!]GHFIG0=9N/BKH
M<5CJGV47)LYC'="*;R7XD\LG=Y9X.,=Z\O\ ACXLM?V)UBUKQ#^R:?A-X0N[
MU++5_&>G>)(O$%U9),!_K2!)<?9O-BAR!)Y>>@,A$;^[_ML>&-9\6-\"ET?2
M=4U5M.^*NAZA>?V?:R2_9K6,S"6:78/W<8R,R'@9'K0!Y#\9/^">_P )_AW\
M#?'?C73G\2O\2-!TV^\3V_CJ\U^Y_M5[Z(R7<<LG/EDF2, D1^9CG/F?O*O_
M +6WB34_&?\ P2C/B36+@W6L:QX;\-:A>W7E[/,FEN;"220A.G)[=,5],_M+
M:5>ZU^SK\4=+TZSGU&_U#PMJEI:6MK'YDL\TEK*L<<<?<Y(&*^;?C]X \4:Q
M_P $L=,\)Z?X:U:\\4KX5\,VIT.TL99+T2PS6)EC\H#S,Q^7)Q0!Z/\ MU?
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M([$5X+\=/"NMZQ^V/^S/K=GI.H76D:,?$W]I7]K;22V]EYUA''#YL@&(O,/
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M "?5^UQ_W*/_ *:Y:^@O'/CG0?AGX3U+Q-XFU:WT?1=/B\RXO;@G">GN>?X
M*\1_8_\ @?XL^'>G>+_&GQ$FA;XG_$#4QJVMQVL\DD-C"%S;6,9>23(MQ+*
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
M_P#"M?$7_15/%G_@-H__ ,@4?\*U\1?]%4\6?^ VC_\ R!1RQ_F#G_N'?9_V
M:,_[-<#_ ,*U\1?]%4\6?^ VC_\ R!1_PK7Q%_T53Q9_X#:/_P#(%'+'^8.?
M^X=]G_9HS_LUP/\ PK7Q%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4
M<L?Y@Y_[AWV?]FC/^S7 _P#"M?$7_15/%G_@-H__ ,@4?\*U\1?]%4\6?^ V
MC_\ R!1RQ_F#G_N'?9_V:,_[-<#_ ,*U\1?]%4\6?^ VC_\ R!1_PK7Q%_T5
M3Q9_X#:/_P#(%'+'^8.?^X=]G_9HS_LUP/\ PK7Q%_T53Q9_X#:/_P#(%'_"
MM?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7 _P#"M?$7_15/%G_@-H__
M ,@4?\*U\1?]%4\6?^ VC_\ R!1RQ_F#G_N'?9_V:,_[-<#_ ,*U\1?]%4\6
M?^ VC_\ R!1_PK7Q%_T53Q9_X#:/_P#(%'+'^8.?^X=]G_9HS_LUP/\ PK7Q
M%_T53Q9_X#:/_P#(%'_"M?$7_15/%G_@-H__ ,@4<L?Y@Y_[AWV?]FC/^S7
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MHY/[XN=_R';T444C8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
7 **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_7a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_7a.jpg
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
M 0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B<M$*%B0TX27Q%Q@9
M&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U=G=X>7J"
M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2
MT]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$  A$#$0 _ /U3HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HIE/H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M3-&: %HI*6@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI* %HI*6@ HHI* %HHHH **** "BBB@ HHI* %HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%(>E '/>-/$</A'PSJ6KR\BSMVE(^@KX(\<>++CQGXJO\ 59^!<28B_=_\
MLJ^F?VK/$<EIX2@TU/\ 5ZBK[_\ MG)%_C7R0IK\%XZS*=7$K K:!^T<$Y;"
MGAWCY+X]$)4M15+7Y0S]3"K6BZM<^'=2MM1LY/*N;>2*2.JM%;T:SHNZ,)45
M75I;'W?\(?'0\?>#+"_E?-_Y0%P/+\O]YT/'_ *[P@;3SP:^5OV0-29=>US3
MS_JY+>.0?]LY#_\ ':]'_:T\:W'P_P#@/XCUNR_X^[<VIB/E>9S]IB[?C7]5
M\,XB>;X+#M_&]/T/YDXBPU/*\=6I+X$?F_\ M2_'B]^.GCZ6=9$.B:7++:Z9
MFW,9\KS?];D_]LJ\6J6BOZ:PM&G@Z7LJ1_/E:K4K5?:5 J*BI:[3 *^_/V1_
MVU-+;P[;>%/'^H?9=2CDAM--FALOW<L0C,8\SR^.L9KX#J*O&QV I9A3]G4W
M/1P6-JX&I[2F?LYXR_:-\!^!]'74]7UJ2"TD_P!68K*:3S/IB.OS'_:6^/-Q
M\?/'DVI*/)T6.**.RM9HO*FCXZGU_>22UXW4M>=EN1TL!5]J]3LQN;U,=3]F
M%15+17U1X6H44446OHQZK4_3?]A3]H63XF>%Y/#&O7/VOQ59FYNO-%MY4<EM
MYD8R/?S):^L=PZ&OR6_80\1?\([^TIH SB*_M;JUD_[]2R_^TJ_6G:&P:_%L
M^PM/"XYJGL?J>38EXK#)S'-VK\U/^"B7Q2N=>\>1>!-H73]$F,LN(_\ 6R26
ML4@_222OTK;M7YC_ /!1'X:WOAOXJ?\ "8N@^Q>()/*23S>GEVL472M>'?9?
M7U[4SSWVGU-^R-[]DO\ 8O\ #?Q8^'-OXQ\72WKQWLDD=K:VUSY8,4>8B)/W
M?7S!+^E>F?$3_@G+X,U/1YI?!MQ>Z=J?_+**ZOO]%'SYY!BE->*_LJ_MH6_P
M;\-VWA/Q18R3>'+42RVLNGVWF7*>9^]P?WOO+7W%\+_VC_ /Q:=XO#&LRWUP
M/OP26<T93\XZ]#,JF;8;%5*FOL_+8\W+J>78G#JF_P"(<W^R[^S;IGP%\-2!
M_,FUV_\ *EOI&N#)&)1&<I&#VS))^=;G[2'QNL/@3\/+G6K@M]ONO,M--Q%Y
M@^U>3++'YF.D?[JO7,],=*_.S_@I=XP;4?$7AS0(A\NGO<O,?+SQ)';$?^A&
MO(P-.IFF.2J=3U\;4_LW!?NCYIT?2?&7[27Q.,$!BU7Q3J47FYF\JU_U47_V
MJOMCX<_\$X?"ECHL4OC2\O=2UH;S+#87O^BD9_=]8A)T]ZC_ .";_P ,]-L_
M M]XYDBD_MJZNKJQBF,AQ]ES%QY?;]Y$:^T!SEF/%>QG.<UJ=;ZKAOW:IGFY
M7E=.K3^LXG5L^1_&7_!.CX?7^CW!\/MJNG:KY9^SA[_,7F>LA,4G\J^&/BI\
M(_$GP!\<BTU3RXI+>Y\VPNXY#)%+Y7E2]#_UUBK]I.,9'2OE_P#;W^%\?CCX
M3QZG$F+G0))M0\[S,8B%M+Y@_P#'(_RKGRC.L1]85+$NZ968Y525/VM+1HD_
M8W_:4N/CMI-[IFNA?^$CTV/SKF2.W,44B22R8Q^ CKG?^"B7Q(G\,_"F#PW9
M2>7-J5_:_:3LS^Z_>R?^C(HJ^3_V(?'<G@GX[6'ER9_M@1:7+^[_ .>MU%7U
M+_P4A\#7&I_#2V\46R[X["ZM8KKY\>7#F4 _]_9(JZZF#H83-Z<7_#>IC3QE
M7%954?4^;OV/_P!F&Q_: O=5OM9N98M TV6*&2*TN?*ED_=2_P#3+_KE7U/K
MG_!.CX7ZAI<B::VL65]L_=S+>]7QUD_=FOCS]EO]IJ^_9[U:XM9[:.[\.:G/
M')>QPVWFW7[OS?\ 59EC'YU]^_#7]L'X9_$BXM[;3-8N;;47"#['>64OF'/O
M&"GZUOG7]I4L2ZE*_L^EC#*UEU7#JG5_B'!?LT_L4V7PA\3:GX@\0RQWURDA
M_LUHKISY,?F^9OE_=Q?-F*+U'!KZOU'4H--M)+B>01Q1CEC4D<R7$<<D9RC]
M*^>/V[_%-QX6_9ZU3[/)Y4][>VMK&=F<'S1)_P"TZ^2=2KF.)2J[MGT_)3P.
M&?LCX%^/GQH\0?M,?$JUBB\N6TCNI;'0[3R_*_=2R_NO-_Z:_P"JKZ.^ '_!
M/.PO-'@U7XE"2:>3RI8+&PO@83'Y>-LO[O(/_7*3%?+7[,_B+POX1^-'AS7_
M !=>C3]&TVY^TRRQQRR_O/*E\K_5 _\ +7RJ_1AOV\?@BV/^*ND_\%MU_P#&
MJ^VS:IB<+3IX3 TFE;='Q^7T\/B?]IQM0IZE^P+\%KRSV0^'+VUD_P">T6JW
M7F_^1)37PU^T]^S+>_ '7#+:2F[\)W)BAM;N>XBEE\WRI?W4G^J_YY2<U]YG
M]O+X(L/^1PD'_<+NO_C5>&?M@_M*?"?XO?!B[T?P[X@DU'6HKRUN;6(V%S$<
MYY/[R+_GE))7F97B,VIXA1K*HZ9Z.84\NGA_W/)<[7]AW]IRY^*5A_PAOB&0
M3>(--MO,MY8K7RHC:Q>7$,_]-,FO8OVL%V_LW^/O^P9-7YS_ +%'B >&?VCO
M#5Q+_P >DL=S')^%K*:_1G]K/_DW'Q__ -@R7^589E@Z>$S.FJ>S:_,Z,OQ%
M3%9=4=4_/W]@K_DNT?\ UZG_ -*K6OUB6OR=_8*_Y+M'_P!>I_\ 2JUK]8EJ
M.)O]]-,A_P!V'4445\H?2A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4RGT4 ?+_ ,8/!H\)Z]');#%K>^;*?*B_U7[P'^M<
MCI^L7VCW7VFSN9+27_GK%+7U5XV\/+XH\,W]B0/,DC/EGT?L:^5=6TV32-4N
MK*XYEMI?*EKX?,L,\+4]K2/H<%5]K3LSUWP5\<A^YL==BEDFDDP+H&,#\A7I
M]]I^C>.=)3[3##J-G)B2//(^M?(=9OB#Q]XH^&.FG7_"TMO]JC_=7,5U&9(I
M(OJ/^V5>AEV-J5JE/#53S\QHT\+AZF)-#XU?LM^.-#74-:\&^)[JZT^*.63^
MRO-N3=?ZS/E1?ZWS/QKY8U3Q1XSTG4)K&]UG5K*[M9/*DBFEEBECK] O@[^U
MCX2^*S6VCR3W.F^(Y1'$8)K;$<DICR3$09,#_KH:[;XL? /PG\9;2&+7[6?S
M8O\ 575I<&*2/Z&OTO#5Z>%J>SQM*Y^6XW+7FD/K.6XD_+Z3Q]XE0X'B+4C_
M -O,M-_X3SQ-_P!##J7_ (%2UZ?\9_V7/$_PC\V_\J/4?#XC\PW<5U_JOK_J
MZ\S\%_#_ %CXC:U_9'A[3_MM_P#\\FECB_\ 1E?74Z> J4O:TZ5,_.:E3-L/
M4^KS<_:#?^$^\3_]##J(_P"WJ6O5O@[\*OBG\8',UMK>IZ5I7E^;_:%_]I\J
M7_KE_P ]:][^#?["^B:'8Q7WCO=JNK?O/]%M+Z0VO/I^ZBDKZ"\>?$7PW\*-
M#COM=NWT^Q#>6@CC>0MA,XXSZ?I7SN,QF&E^ZPE(^TR_*<=&G]9S+$^SI^IE
M_"_X(Z7\.]*BBNI#K>IG?YFH7!F.[/\ TSEEDQ^=:GC3XHZ;X+\J/_D(7,O_
M "QAECS']:^5-7_:FU_XR>+Y=&\,YTKPGY/F3336\1NOR_>C_6F+M5NOSW.*
MM3 S]G_R\/U7)E3Q]/VE/^&=3XJ\?ZUXHFF\^\D6U/6T$G[JL&TLY=2NHK:W
M_P!;++Y4515Z[\"O!<5W=2Z_<<FWE\JU_>9X\L9_G7Q].G5Q=74^KJ^RPM(]
M.^'?AD>&?"=E:-'BYV^9+_UT/6NHD7I3J<U?>4:?LJ:IGR<W[34*6BBMQ'R9
M_P %#O\ DENA?]A<?^B9:^ F'R#BOOW_ (*'?\DMT+_L+C_T3+7P$WW!7Z9D
M"3P1^#\7-_VCIV/L+]BS]H26SNQX)\0WK_9/*CBTJ6:2/Y'\S_58]?WH_P"_
M5?<K8>/@\,.*_%R&8QS12Q_ZZ.OTG_99^/Z_%SPJ+;5+A?\ A)[;S3<PQP&)
M"@D&)%_"2.O$SK+?9/ZS3V/J.%\[]LG@L1OT/S>U8?\ $PO#CGS9:]&_9C'_
M !>[PN<<_P"E_P#I++7G6K?\?]Y_UUEKT7]F?_DM_A?_ +>O_266OJZZ_P!E
MJ'YSA'_M]/\ Q_J?H9\;_C/IOP/\+Q:OJ,3W<T\GDVUK'(B&6383C)^E?G%X
M]^.WC?XC74TFJ^)=1DM)?+_T.&3R8O\ OW%7K'[=GC+_ (2CXG:?IT)S::38
MR1\I_P M3++YO_HJ*OF=5,C8'6O)R7!4H4?;/^(?2<2YK5Q&)GAJ=3]W UM$
M\*ZUXHF\O1-'OM7E_P"H?:RRTFK>'-6\+W_V;5M,OM(N_P#GE=6TL4M?6?PK
M_:\^'7PM\)VFC:?X?\01%8HOM$ODPR^;*(HXC+_Q\Y_Y9_I5;XV?M9_#WXN^
M![K0+S0_$ _>1RQR>5%%Y<L9SG_6_P"<UM]=Q7M?X/[LX_J&7_5O:?6?WAYU
M\ OVHO$7@#Q/866OZK>:KX=EDBBD6ZN?,,4?^KZR?7U_Y9U];?M(:_:^)/@#
M-JUFWF6U]:&YB^DEK)C^=?FE]Z(^U?5O@[QN_B+]DO4]&<8FT6WN(F_=]?-B
MO<?RKES' TU5I8FDCT<GS:I5PU7!5'T/E"(9<9&:_3C]B[_DW/PK_P!O7_I5
M+7YCP_ZP5^G'[%W_ ";GX5_[>O\ TJEJ>(K>P7]=S7@U_P#"C4_P?Y$G[9G_
M ";9XO\ I:_^E45?F'(,/C%?IY^V9_R;9XO^EK_Z515^8<G^LI<-_P "7]=$
M+C-_\*%/_!_F?6&D_P#*/'6O^PE_[=Q5\FC[IKZSTG_E'CK7_82_]NXJ^31]
MUJ]3+5_%_P"OAXF=-_[-_P!>X'K?A7]H+5O WP<D\(>'I+G2M1DU+[>^JVL@
MXC_YY#_OW7F&IZM>ZM<?:=2OKG49_P#GM=2>;+7I_P"SO\"I_C5XJ6WFE-IH
MMNDKW%U#)Y<Q/M_W\CKZ)^+/[)/PO^'GP[US58X]3-_:V,WV:66Z,A\T0R>7
M_P"BZYZN*PN$Q/LDOWC-Z6 S+,L-[6_[NF8OQV_:YG\/Z</"7@Z=TU&$Q3/K
M<<D4L0X,GE?D8_SKY*\0>)]8\477VG6M7O=5E_YZWEU++67&P4YKU+]GKX*7
M?QJ\9I9O^ZT6UEB_M&2.7RI?+/FX$7XQ5V0P^%R^DZS..MC,;G.(5&YY8N.]
M:&B^(M3\.:A%=:1J5SIUU'_RUM)?*K]&X?V*?A-#9QP2:!=2S!?]=+J5R7S_
M -_-F?PKXZ_:8^!(^!?BZQBL99)=&U&.5X!-+YLH,<@./R,58X;-L-CZOLFC
MJQ_#V.RRE]9J,]=_9K_;$OH-4M/#?CFXN+^.Z,5M;:M-)'\DOF_\M??]Z.?^
MF5?8?CKQE8^ _".J^(-0XL]/MS-(!CYP/X1^GYU^/;'='GN*^F/VE/C%?>+?
MAS\/M+AFS]LTF.;4LQ_ZR7]T?YQG\Z\C'912J8FG[+9[GT64\1U*>"J+$;PV
M.,^,O[3_ (N^)VO7W]GZQJ&E>'?,_P!&L89/)S'W\WRS^\_.O&GC5/XLFF'*
M^U?;?[*7[+7AW4O!MOXF\66,MYJ]Q<2&WB%])Y<449,0QY9'H:]VK4PN4X8^
M5PU#&Y_B;>T/BFTO)+.ZBEMI9(98O^6L,E?;O[?W_(EZ)_U_1?\ HJZKV3Q=
M^RO\/?'%JJ7VES1-%_JYK6\E$L?T.:\B_P""@L(C\(Z'&.AOXC_Y"NJ^=_M"
MGC\72=-;'UM3)\1E&6XCVC/A;K7KOC#]H;Q'J^@V&A:!J&HZ'I%O'F5(Y?*F
MDE\V23K'T_U@_P"_5>1KQS7TI^S'^RK%\7-%'B3Q%=2PZ!,9(8H;2Y\N5Y8S
MC/\ J^G^MKZC'3PM*FJN)1\5EL,=BJGU?!,\B^#<CS?&;P#+++YLIU^QS_X%
M15V_[:!S^T'XE/\ TSMO_2:*OKO0_P!B_P"'?A_7-(UBPBU"*[TVYANH#]L)
M_>1R^8,COSFOD?\ ;47;^T-XB'I';?\ I-%7CX7&4LPQ]Z72!]'F&68G+,H]
MGB'K[3]#QWP__P C%I/_ %]1?^C:]S_:PYF^'P_ZE33OYRUX9X?_ .1BTG_K
MZB_]&U[G^UI_KOA]_P!BIIW\YJ[\5_O='YGB81O^SL1\CP"2(#H:Z_Q?\6/$
M/BO2-+T2;4)[?1M.MHK6WL%?]T?*BCC_ )QD_B:XS!QGM7Z'?LN?L]>%]*^'
M&@^);NR>[UC5K&&XEF^U2&,QDB6+'/IY?Y5698BCA*:J5%J1DV Q.:5'AZ52
MQ^>8PW&,&NH\!?$CQ)\--8BU#1-5N+%?-B\V".3,,L0_Y98KZ8_;6^".D>%]
M/T_Q+HMB;3 D^W,;F20RGS8O+_UA/_/67\Z^/VDW+6^'KTLPPOM+'-C<)B,E
MQ/LV]3].?%_[3.AZ)\'3XVMX\S7<4OV*T\^,232))Y6!S@\U\!?$+XR^+/B=
MJ5W<:GK.H-ITLLDL6G+<8BB_Z95@ZYXHEU?P[X:T@_\ 'IH\4OE?NO\ EK++
MYO\ \:K'@:+[3 +CS/)\S]YY5<>"RREA7S/5GJ9IGV)S)4Z6QIZ%X+U_Q1SH
MNA:EJ_\ V#[&27_T75:ZTW5O#.J>5>VM[HVHQ?\ +*:.2*6.OM/PK^VY\./!
M>B6VEZ-X>U^UL;9=L47DPR\?^!5>>?M%?M)^!/C?X5MK-='UJ'4[.666VFFB
MBBBSY9_Z:_\ 7.LJ>-Q-2K^\H_NRJ^ R^GAO:4L3>H0?L[?M::UX/UZ'3O&6
MK7NM:$\<A$UU<QR2QR^\LF,].\O_ "UK[!^+V@WNN0Z7?6"^?#:"7S?*C\Z4
M+)Y?^KC_ .6G2ORG+;XO<5^H7[*7CI_&WP=TJ1U^?3HX=//[OR^8[>+M^->/
MG6%AA6L32V/J.&<RJ8^G4P.(9J_!W0]0T^P6XNQ<6L.R2*6UNB_F22^9GS>?
M;Y/PKU->]*%"]*#7Q]2I[2=S]/H4O94U3'T4E+69L%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2'H:6B@#YM_:ZT66ZTK0K
MZ-',5J+A9,?]-#&*^7Z^\_C%X97Q9\/]8L8X!)=FW,EMG_GH#O _-!7PA?Z?
M<Z3>7-E>1R175M+Y4D4M?SSQQ@:E',/K/2H?NG!..53+_JG_ #[(J***_,S]
M&(JEHHAA\Z7]W3W'>VI[W^R#9R?\)AK-R?\ 51V0A'XRX_\ :==G^W1H]QK7
M[,_BF&TCDFG1[1Q''U.+J*MC]FKP2GAGP6FI3V_E:EJ:^9*'Z^7YDAC_ $/Z
MUZIK6BV7B+3Y].U&VCN[28?/%(,@U_57!=*IE>#PSJ;_ !G\Q<65:>98W$^S
MV9^%515U/Q*\ :M\-?&%]H&J6=Q;/;R2F%I(_+$T/F^5YW_D*N6K^J*-7VR]
MJC^=JW[EV"I:BJ6MS'4***^@OV9?V3-:^-UT^IWGVC2?#EK<Q1_:)+4DW7[K
MS>@EC/\ SR_[^UQ8K%4L'2]K6.O#8:KBZGLZ1\\5+7Z)>-O^"<OA^\\/ ^'M
M5&G:C$A?<+>:8W+>7C!$ES7P/XT\#:U\.O$,FB^(-.DTK4XQ%-):R'((KCP.
M:87,':EN;8C+<3@-:A@45+17LGG:D5%2T4!J>U?L8:3)KG[2'A6WC_Z>I99?
M^>7^BRU^O^.E?GW_ ,$X_@[<+J=U\1;RVD-MY=S86$DT>/\ GE^]B_\ (T?X
M5^@O>OR#B+$JOCG;H?I^0TO9887/RUS_ (L\(Z/XWT632]9TRWU.UD&#%<PQ
MS!/?#@UOXKQ[XM?M)>$/@W+ID&MZE:Q7=U<"*2U:0F6VC[RR",2' _=]1SFO
MFJ5.K4J+V6Y[=6I3IT_WNQ\Z^.?^"9^DS137'A;Q1J4,H\OR[6_MHING_30>
M57QU\4/@?XW^#=]%%XFT2YTZ*3S?LUW^ZEBD_P"VL5?L=X;\:^'_ !G8B]T'
M6]/U6V_YZV%U'*/S!KY*_P""A7Q \&W?@+_A'S>:??>)9"!:^7()9;?_ $F'
MS3_TS_U>/PK[7*<TQU3$+"U=4?)YCEF"I8=U:6A5_8%_:$U'Q5#>>"O$=]]J
MNXI8CILUU</+++'Y4GFH<^GDY_[:5Y5_P4;T&YL_BE9ZG+%(+6^$OERC_IE%
M:UG?\$^?#=]J7QLM-7MK>1[#3"_VJ;_EE'YMM<^57TO_ ,% OA!J'Q$^'6E:
MMHNFR7^H:)=23RB%/WOV8Q$RX_&*.MJCI9?GFFQG3]IBLI)/^"=>N6]]\!([
M%'3[18ZC<PR1Y_>9_=R]/^VH_.OJA.A!K\C?V2?V@)/@CX^B&JW\G_"*W44O
MVFU_Y9"7_GK_ *K_ *915^HG@OXJ>$_B%;QW'A[Q#IVKQD?\NMT"_P#W[ZUX
MF?8.K1Q52I;1GJY-C*=7#JFWJCL>BBO#_P!L'Q=8>$_@9XB6]ECB_M*TN=/B
M$G1Y)+6; KU#Q)XVT#P;I\M[KFMV6DVL2>9)->7,<6!^-?FM^VO^TA:_%[6X
M?#GA^X^T^'=)N993=PR#RKV3RXR)/]7VS**YLFP57%8JGH:YKC*>&P[75GG/
M[+.@7.O?'7PB+:.27[#J5K=2F/\ YY1745?L/<6<5Y#Y4\<<T1_Y9R1YKX*_
MX)S_  5U33=:UGQEKFCR6EK-8QVNFRW4>#(/,/FD?C$/SK[&^)_Q7\._!_P^
MVK^)-2M].M=Z1H9&^>0GMBN_/JGUK'<E'H<N34_JV"]I5ZGSK\4/^"=/A+Q?
M?7.I^']:O/#EW,9)#:Q6T4EKD_\ 3$>7_.OCKXR?LG^/?@Z]U=7.CW.H:#%+
M+LU6&*/_ %?_ #UEBCEE\NOU$^&/QG\'?%31K:^T'7;&[DD1#+:Q3#S(I"F?
M+,?48KE_VGOB+X2\+?"SQ/9:[J>GI<7VEW=M9VLTH\R64VTG&/IFM,%FV94:
MBP]2[786,R_!5:7M:9\0?L5?M':MX#\>6?A?5;N6^T+5I+;3[6.ZN)#'8R&7
MD19'3][)^0KZE_X**V+WW[/#W$7_ "ZZM;2/]#YD7_M2OSZ^#&DW'B+XV>%4
MT^VDE URUF/E?\LHOM45?KE\6_AKI_Q7\!ZIX8U(I]FOA%NS_P!,Y1)_[+79
MG*I87,J6(1P94ZN*P56D?D;\"OA1;?&CXB:7X2DUN/1);WS?*E^R^=_RREE_
MYZQ?\\J^K_\ AUO-_P!%)_\ *'_]U5\?^&]4U[X)_%+3M5:WN+'6-%O<R1R'
MRY"(Y?*EB_\ 1L5?J%\%_P!J[P/\4?#=@)M?TW2O$+1QQ2:=>7/E2><8\GR_
M,$?F]_\ 5BO5SO$9EA[5L*_W1R97A\%4_=8G^(?/?_#K.;_HI7_E"/\ \E4?
M\.LY?^BE_P#E"/\ \E5]S2^(M)BM?M,FIV45H/\ EJ;B/R_SS7R7^U/^VMIG
MA/1O[)^'?B"SU'7I7BDDU#3Y8[F.&(]3GRI8Y.L7_?P5\UA\RS?$U/9TJC/;
MQ&79;AH>TJ%#X<_\$[9OAYXUL/$/_"=C43:>;F'^R#$)/,B\KK]J]*]\_:R8
M']G'Q]C_ *!DO\JH_L^_M):/\=-"A^S+Y&L1QYN;0"24+@1F0^;Y4<9.9 ./
M6KW[62[?V</'P_ZADU<,\1B:V-I?6G=IK\SJA3P]+!5/JVQ^?O[!7_)=H_\
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M9:]'$_[M5/)R_7&TO\9M_M>Z!=>'OC)>"Y_Y?5DNHO\ KE)<RUXGMZFOOO\
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MH&H*/[>U72)EG/F<>;()3'S_ -M:YL8L5@W3]O5NNUCKRNE@\P57ZKAO9_\
M;Y^;':OTH_8EUBVNO@'HEE&^9K?S?,^LEU,17YNW5G):74UK+^ZEBD\J2NY^
M%OQJ\4_!RZOY/#5Q'$+[RC<QRVT<GF>6,?U->YF6#_M##*G2W/E\BS"GE6-=
M2J?=_P"VMJ,%O\ _$%H\N)[G[/Y8]TNH2:_-'L*[WXH_&CQ1\9KFQE\1SVT@
MLT*V\5I;>5Y9/4UP\<$EW=0VL7^MED\J*GE.#_L_#>SJBS[,*>:8Q5*)]7:3
M_P H]]:7_J)?^W<5?)@^ZU?=WQ,^'\WPK_8;U#PY=<W5I)%)+Y;F3_6WX/\
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MU#V=J5(\/_5NI_S\/SR^ /[#OBCXJP_VGX@/_"+Z5'*!Y&H6,OFW.8^)8O\
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MH3Y<?4YEB%98?$5<-/VE)V9OC<%A\?3]EB4>1Z9_P3MMK&^MKIO'%PYAD\T
MZ<.?_(M=K\5/V.;?XG2:*7\426']EZ7;Z:/]#\WS?*\S$G,@P?WO3GZU],>O
M>O/?BU\:O!_P#\)_\)-X[U3^QM%%Q';?;!:RW $DG08BC)['G':NO^U,:ZBJ
M^TU1Y]/(<NIT_9*GH?-__#N*T;KXZN/_  7C_P".U]5>!O"Z^"_!NA:#'/\
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M?M=^ /!'Q2^"^H^&O'WBZ+P3H%[<VK'69KJ*U\J2.7S1^\E_=]C^M<Y^R/\
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MGDW47E_ZV+/[J6Y_Y:5]#UQGCSX3>#_BA;Q6WBOPSIVO01/YL0O;<2;#S_\
M')/SH \P_8\^.6H?'KX;ZUK.H:+9Z'=Z=K<VER2Z:0;6^,<44GVN+KB.3S.G
MF2_]=#7T)7.>$/ 7A[X>Z-#I/AG1+#P]I472TTZVCAB_(5TE "4M%% !24M%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3S?_ +;7UYGFOU?AK,/[1RZG-[H_+^(<O_L_,:M+H?)'[71W>.=-Q_SYQ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %,I]% $0%>9_%#X.:9\3IK22^N[NW-J7$?V9
MD'7'J#_<KT_&*2N+$8:EC*7LJZT.FAB*F&J>TI.S..^&OP[M/AMX?73+*XN+
MB .7WW3;G.?6NQ7H<T;?4T=L=*UI4H8>FJ=/9&52I/$5'4J/5G,^-O!UMXY\
M-7>CWDLD,%PNUWA.'KC_ (:_ O1?A?KDNJ65[>75Q);_ &;%S(AX&/8?\\Q7
MJ2\=#D4[L<<5R5,!AJN(ABJD/WB.BGC,13P[PU.I^[?0YCQOX-MO'WAF\T6[
M>2&WN2A=X3A^) ^/TKRC_AC_ ,.+UU?6 /\ KK%_\;KWY<C^+-#X[UCC<GP6
M.J>TQ-/G9O@\SQN!A[/#56CP/_AD#PO_ -!K6/\ OY%_\;H_X9 \,?\ 0:UC
M_OY%_P#&Z]\H_*O/_P!6<H_Z!T=G^L.;?]!+.+^'/PYL/AOIK6%C<7%TF>/M
M#9/4G_V>N4\=_LYZ)X^\13ZW=ZEJ,-U<",&.WDC$6!]8\_K7KYSZX%(WR@9Y
MKTJF5X.KA_JLZ?N'##,,93KO$PJ?O'U,OPYH<7A[0]/TN!WDBLK>.V1Y.I$8
MP,_E6HXSBI.U%>A2IJDO9K8\^=ZCNQ:;3Z2MQ''^// UEX^\,76C7DLT-O<%
M"\ENV).) _\ /^=<E\/_ -G_ $7X>ZTFI:?J&H33H,".Y>,COZ1Y_P"6AKUB
M/'.#FG'A?2O,J9=@\1B%B:E/]XNIVT\?B*6'>'IU+4WT.1^(GP]M_B+H\=A=
MWEU9Q1R"0_99-I?V-<G\/_V=]"^'VO)K-I?7EU=QQ/$#<^6>"?:,&O68\=CF
MG<?2LJF5X.MB%BJE/]X53S#$T\/]6IU/W;Z!3J6DKV#@.3\=^ ]-\?Z+_9VH
MEEBW[PT9KS[PS^S'HGA76;;4K'5M4\ZWD23YI(L.1Z_NZ]HZ+_>%*N"O' KR
M*^58/$55BJE/]YW/1H9CC,/2]C3J6I]CS#XF?!#1_B=J4-W>WEW;311^4/L[
M(..?4'_GI6S\.?AQ8?#719=*L;BXNDDG^T9N#D@G'_Q%=NF"IQR*&X7^[6E/
M+\+3Q'UI4_WG<BIF&)J8?ZJZG[OL0;/M$95QQ7C'B+]EOPWK^O7^JO?7]O->
MOYDL4/E"(_AY=>V*K?WLTK''4T\;E^%QR4,33YQ8/&8C N^'J6.:\(>&8_!?
MAVVTA+NYU".,-F:[D,DIY]:\GF_9#\.S71<ZMK 7U\R+_P"-U[]P<<9%.XZ5
MAB,JP6*A3IU:=U#8UP^9XW"U*E2E5:<]SP#_ (9 \,?]!K6/^_D7_P ;H_X9
M \,?]!K6/^_D7_QNO?/RH_*O/_U9RG_H'1V_ZPYM_P!!+/-OAE\&=*^%]Q*]
MC>W=T\D?E8N"A]/;_IG5_P ?_"G0_B-:[;ZV6*8C_CZ@1!+^#XKNVPHY.*12
M,=<UZO\ 9N#AAOJOL_W?8\_^T,3]8^L^T_>=SYIN_P!CF'?FV\2311^DEKYO
M_M2M_P *?LIZ'H=U#=:A?SZI)'_RR>.,1_EBO>-OO2%<]:\>GPSE-.I[18?4
M]:IQ)FU2G[-UG;Y?Y#+.TBLXA%!''%&O\,8Q5BDI:^K225D?-W;U84444Q!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #*?110 444
M4 %%%% !1110 4444 ,I]%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %)2T4 %%%% "44M
M% !1110 4444 )2T44 )2T44 %%%% "44M% !1110 4E+10 4444 %%%% !2
M4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R@!
M]%%,H ?13** 'T4RGT %%,I] !13*?0 444R@!]%,I] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%,I/.C_O_K0!)147G1_\]$_.CSH_^>B?G0!+14?G1_W_
M -:6@!]%,HH ?13** 'T44R@!]%,I] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113* 'T4
MRD\Y/6@"2BHO.C_YZ)^='G1_\]$_.@"6BHO.C_YZ)^=.H ?13*?0 4444 %%
M,I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MK-AF\JK\4WF5TPJ7,9TVB6BBBMC,**** "BBB@ HHHH **** "BBB@ HHHH
M**** "F4^F4 %-FFCB^^<5'=7<<,?-8LLTMY_K* );J\DFJK14M=1D%%%%,
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M4**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **2B@!:*** "BBB@
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MNENH\]*Q:871;HJ/</6G[AZUD:W%HI-P]:-P]: N+12;AZT4#%HHHH ****
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M47Q9_P"#RZ_^.T?\+V^)7_11?%G_ (/+K_X[7"44?4\)_P ^0^M5O^?IW?\
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M_GZ=W_PO;XE?]%%\6?\ @\NO_CM'_"]OB5_T47Q9_P"#RZ_^.UPE%'U/"?\
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MBD>*_P#P=W7_ ,=H_P"%\_$S_HI'BO\ \'=U_P#':X&BCZEA_P#GR@^M5O\
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MUNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?B3_T4#Q9_P"#RZ_^.UPM%'U/#_\
M/E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T?\+U^)/_ $4#Q9_X/+K_ ..UPM%'
MU/#_ //E!];K'=?\+U^)/_10/%G_ (/+K_X[1_PO7XD_]% \6?\ @\NO_CM<
M+11]3P__ #Y0?6ZQW7_"]?B3_P!% \6?^#RZ_P#CM'_"]?B3_P!% \6?^#RZ
M_P#CM<+11]3P_P#SY0?6ZQW7_"]?B3_T4#Q9_P"#RZ_^.T?\+U^)/_10/%G_
M (/+K_X[7"T4?4\/_P ^4'UNL=U_PO7XD_\ 10/%G_@\NO\ X[1_PO7XD_\
M10/%G_@\NO\ X[7"T4?4\/\ \^4'UNL=U_PO7XD_]% \6?\ @\NO_CM'_"]?
MB3_T4#Q9_P"#RZ_^.UPM%'U/#_\ /E!];K'=?\+U^)/_ $4#Q9_X/+K_ ..T
M?\+U^)/_ $4#Q9_X/+K_ ..UPM%'U/#_ //E!];K=SNO^%[_ !)_Z*!XH_\
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M\NO_ ([7"T4?4\/_ ,^4'UNL=U_PO7XD_P#10/%G_@\NO_CM'_"]?B3_ -%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110&H4444!J%%%% :A1110&H4444!J%%%% :A
M1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A111
M0&H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110&H4444!J%%
M%% :A1110&H4444!J%%%% :A1110&H4444!J%%%% :A1110&H4444!J%%%%
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M** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4****
MU"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"B
MBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@-0HHHH#4**** U"BBB@
M-0HHHH#4**** U"BBB@-0HHHH#4****!G>_ C_DN'PY_[&33/_2J*OVM7K^%
M?C+^R_H,_BG]H3P#9VLT<$D>L0WH\WO';G[3(/J8XP*_9I>OX5^5\6?[W#T/
MT/AW^%/U)****^+/K0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4ZDZ4U4IO4^#_B)\&=>^',GFW$)OM,_Y_K:+$4?[S/[S_GF.>HK@>*_2O:)
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M11700%9NI:7:ZMI]Q8WMK%=VEQ&8YK>:,/&\>""F.E:5)36FJ%ZGYS_M#?\
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M_K1@NS#_ %?QO<_-&BOTN_X=E_#7_H.^*_\ P,M?_D:C_AV7\-?^@[XK_P#
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M_D6C_6G+NP?ZN8P_-RBOTC_X=M?#7_H.^*__  )M?_D6C_AVU\-?^@[XK_\
M FU_^1:/]:<N[!_JYC#\W**_2/\ X=M?#7_H.^*__ FU_P#D6C_AVU\-?^@[
MXK_\";7_ .1:/]:<N[!_JYC#\W**_2/_ (=M?#7_ *#OBO\ \";7_P"1:/\
MAVU\-?\ H.^*_P#P)M?_ )%H_P!:<N[!_JYC#\W**_2/_AVU\-?^@[XK_P#
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MIR[L'^KF,/S<HK](_P#AVU\-?^@[XK_\";7_ .1:/^';7PU_Z#OBO_P)M?\
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M:_\ R+1_P[?^&_\ T'?%G_@3:_\ R+1_K+@NS#^Q,:?G+17Z-?\ #M_X;_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M)12T4 %%%% !1110 4444 %%%% "44M% !1110 E%+10 E%+10 E%+10 E%+
M10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+
M10!%+_JS696G+]PUF5R5#JI!11161L%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %:<7W!696G%]T5I3,:I+11178<HE%+10 E%+10!6O_ /CUDK%K5U;_
M (]:Q:VIF-0EHHJ*M1DM%144 2T5%10!+1110 4444&04444&H4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !452U%0 5+45
M% $M%144 %2U%4M !1112 ****8!1110 4444 %%%% !1110 4444 15+452
MT %%%% !1110 4444 %%%% !1145 $M%%% $5%%%( HJ6HJ8!1110!+1110
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M4T5Q^@^/]-\1>,O%7ANV2XCOO#QM1<RR)^Z?[3%YD9C.>:["F 4444 %%%%
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M_GI5NLFK<,W_ "RK6G4,JE,MU+145=9D2T444 %%%% !1110 4444 %%%14
M2U%--%#%1--%#%6)--)-08A--)-45%%:F04444 %%%% !1110 4444 %%%%
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M &;_ ()W-W;26=K8>+K6_NIKF(11VUL;JZQ+*3Q%'^\B_>?]-!1\8'IO]O\
MQ[_Y#G_"*>%?)\[_ )%W[;+]O\KS?]7YOF_9O-\K_EIG'?'_ "SKI?B]\3M0
M\'_!/4/&VEZ?Y6H1VUM,FGZLA4QF62(>5+&#D2?O,8]:]6KQS]K[_DW?Q9_V
MZ_\ I5#0!4\&^-/B3\3)-*\0:/H6CZ!X.GN.8]>>4ZI<VHDXN8A%^[C\V(Y
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MI_R;[XJ_[=?_ $JBKL/A;XYM_B9X%TKQ-;6TEI%?1\VLW6.2*4Q2C\XZX_\
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M#Q.WA?9=>((;#5)M.CN?LMK8R?\ +;S)9?W1_P!9_P!_8JN?#/\ Y."^,O\
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MM1U;XD0?9O[,NI;G0[;08O*_U7[VUBF_UGE_\L_,ZUZK\'/^22^"?^P'8?\
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MZKF?%GP.\>>,=%N]#UGXJ_;-/N?*\V+_ (1Z*+_IK_SUK1^/W_-.O^QUTO\
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M[&[,WR/UJ[7/PS>3+^[K:M9O.CS6#-BS13*?69J%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 <%XL^'I\1?$/P7XH^V^2?#8OBMIY6?M!N8?*_UG6/'7BN
MMOK&UU6TEM;NWCNK6XC\N2&1/,CD3T/YUH44 >._!;X"6_P7UKQ=<Z;J1N]/
MURXBEMK(6WE_88X_,Q%YGF'S1^\/)QTK:^)'PJ/C!K;5M'UN\\+>*[)1':ZQ
M8<GRA()/)EC_ .6L7'^K/K7H^?:C/M2YP/']%^%?C0ZY97'B?XIZEK5A8S17
M4=GI^F0Z9YLD?:62(_O(CWBKHOBO\)]+^*^B06US-+INJ6,GVG3-9L\?:;";
M_GK$?6N^S[49]J.<#YZ\0?LYZY\0M-GLO'7Q!U#Q0\23G388]-BL;6WEDBDB
M$DD<9Q*8P1C)'?\ YZ5Z7_PKYO\ A3O_  @OVSG^PO[%^W>4,_\ 'MY7F[/Z
M5W.:,T_:"Y# \%^&QX4\&Z#H?V@77]EV4-CYVS9YOE1B/..W2L+XL?"?2_BQ
MHD%M<S2Z;JMC)]ITS6K/'VJPF_YZQ'UKOJ*!GAEW\ _$GC*-=-\>_$:^\4>'
MMT4TFFVFFQ:;]IEC/_+62(Y,9/\ RS_6N^\7?#O0_&G@>Z\(7EL(-%N+=+41
MVO[ORQ&08Q&>QC,8('M7:9]J,^U+G \$_P"%$^//LG]B_P#"Y=9_X1W[1GR/
ML$7]H>3YGF>5]N\SS?-[>;U]J['XA?">#QK\)9O FG7/]C:>8+:T@F,7V@PQ
M121D #>,\1@<FO2**TYV+E'UP7A/X>GP[\0_&GBC[;YQ\2"Q+6GE8^SFVA\K
M_6=9,]>:[REJ!G!>$_AZ?#OQ#\:>*/MOG'Q(+$M:>5C[.;:'RO\ 6=9,]>:?
M\2/AX?B!_P (N1>FP.B:W:ZSCR_,\SRL_N_QS7=44 <KXV\%:=X_T,Z;JJ3+
MMD\ZVNK.4QW-M*AS'+%)_P LY!V-><6/P9^)D4$6GWGQIU&;3-GE2K#HMM'<
MR18Q_P ?.?,$N/\ EI^.,U[C10!C:%IATK2;&R-W=:@;:WCB^TWLOF2RX _>
M2''+\9S5?QIX;'BOP;KVA_:!:_VI936/G;-_E>;&8\X[]:Z&B@#P;0O@O\3_
M  UH]CIFG_&-(+"SMHK6WA_X16U_=QQ# _Y:>E=G\,_A7!X#DUC4Y-7OM=U[
M6WCEU/4KYL>;)&,8BC'$4?+_ +L=,UZ)FC-'.+D.$\)_#T^'?B'XT\4?;?./
MB06):T\K'V<VT/E?ZSK)GKS7/>/O@M-XA\5V_B[PQXAE\%^+8XO(N-1M;2*X
MCO8?^>4T1_UF.W?\1&8_7J*!GCF@_ ^>3Q7IWB+QQXHNO'>N:80=/::UBMK2
MV!_Y:"VCX\W/_+7VBX_=@UO?$KP'X@\6OI-[X<\87OA*_P!-DD8B&(7-M=(_
M:6$\2= 1SZUZ)GVHS[4N<#QO0?@UKK>(]*U7QMXXN_&BZ3<"YTVQ_LZVLK6*
M;R]IEEBC_P!;(.L9_P"6?O5OXD?!^;QKK=KXFT7Q'J7A?Q38VWV:'4;$[XY8
M?-\WRI8NDD?'3\]_2O6,T9I^T%R(\B\'?"77]/\ &$'B#QAX[OO&5SIZ?\2Z
MV-J+&UM9")8_-\J(^6\OE3/'R.GYCHO"?P]/AWXA^-/%'VWSCXD%B6M/*Q]G
M-M#Y7^LZR9Z\UWM% SR#QQ\(K[7/$4/B3PMXIN_!?B1AY=[=6MJ+B"]C"'RC
M-;$^7)*F1B3GCC_GGY<GA#X:>*M-\16FJ>*OB3J7B9[+>+6Q@L8K"VD\Q,2&
M:.,'S>>1G_5UZUGVHS[4<X' >,OAU_PD7Q \%^*#>^2?#0OR+3RL_:#<P^5_
MK.L>/:M#QEH \4^$];T,7/V0ZG8RVGG>7YGE>;%Y5=::SY8?*DK*H:TSD]+\
M$VUG\.=/\(WO_$QL(M,BTJYX\O[3%Y7E5Y?'^S[XRT6QFT7P_P#%O6-/T%XO
M*BM;^RCN;FVC\KROW=QG]W[>7Y>*]WHK'VAM[,XZU^&NB1^!?^$0O+>75=&D
M23[2=0D\V6YDDE\V6663_GKYF9,UP]I\(?B7I$;6FG_&2^73HI)/*;4-#BO[
MHQ'M)++S+7M-%'M ]D<KH_@?^R_ TGAL:UK5R7AEA_M6ZNO-O_WG_+3S<?ZR
MO/['X/\ Q*BM8K&X^,E_+I^SR91%HD45U)%C'_'UGS/,_P"FM>U44>T#V9B^
M#O"-AX*\,Z9HFEQ^58647E1]/W@_YZ=/]9_C6/\ %KX??\+2^'VK>&OMW]G?
M;O*_TKRO-\ORI8I?]5_VRKLJ*8K!5:\L;75+66VN8H[NTN(_+DBEC\V*2.K-
M%8FIXCIOP)\5>#_M-AX(^)5QX?\ #?F^;;:5=:/%?BU\S_EE%++_ ,LJ[WX;
M_"O0_AC8W4>E&YN[N^E^U7VJZA+YMU=2_P#366NQHK7VAG[,XOPK\/O^$<\?
M>-/$PO?-_P"$B^P$VGDX^S?9HO*_UG_+2NTHHK,T2/)_AE\"+3X8^)-2U*+4
MFU"'ROL6E6:P&,:=:?:9KGR?]8?-/FR_ZR3G@5)\1O@?%X\\=:3X@&K_ &6*
M&.*TU+3Y[&.ZBO[6*ZBNO*R?]5^]BKU/;1MK3VE0R]G Y_QOX)TSXA>$K_P_
MJL<G]G7T7E2^3+Y4L=>;S? WQ3JTEKIVO?$W6-6\'Q2?O=(%M%:W5U$/^64M
MU%^]E_Z:_P#/6O::*/:#]F<;\)?A_P#\*M^'VD^&A??VC]A\W_2O*\KS/-EE
ME_U7_;6CX2_#_P#X5;\/M)\-"^_M'[#YO^E>5Y7F>;+++_JO^VM=E11[0/9G
M(_$KX<:;\3-!BT[4;F\M&MKF*_M;K3Y?)NK::+I+$:\^C^ >O^)=/M-(\;_$
MC4O$WAR+RB=-BL(K W!CY(FE'[R6/FO;Z*/:![,XSX2_#[_A5OP^TGPU]N_M
M'[#YO^E>5Y7F>;+++_JO^VM=G1161H<;_P *]/\ PMO_ (3?[<?^0%_8WV#R
MO^FOF^;YM9/Q,^$=OXXOM,UG3M0G\->+]'DS8:Y:0^;)'$?^64L?_+6+V_QD
MKTBBM?:&?LSQJ/X#ZEXDU"P?XA^,[KQO;:=+]KMM+^P16-J)?^FL40_>]?\
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M%N[U**'_ %=9\TTDU145H9!1110 4444 %%%% !1110 4444 %%%% !1110
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M2ZL/$_AE$^&?A^WTNU.N>&;FYAL9=2+7*2VT(OA^]-M%Y4EUYD61^[\D@YH
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MNK_?));6-M=22R21Q2F6&8R2"3RA%C&3^Z._\4?B]\3/@!8:?XV\:1^&-=\
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M-MH_-NA'Y4O%SCR_*ZQ4!8]>HKR']ICXN:M\(?!N@'PW;65YXL\2^(;#PYI
MU5)'L([FYE_UESY<OF^7Y44O^JSUBXKD]0^/7C;Q)^TQXC^%?@OPU!<V6AZ;
M;?VEKNJ6\OV73I;F*247,LD<H\W]W]E\NV\N.260R_O8HXO,(%CZ*HKYL\)?
MM!?$#7/B?XE^$R>%+/5/''A^[4ZKXHL_,@T"UL)8C+:W,D9F,IN<211?8?,_
M>>7+_I/E<Q]G\%?B]K/BWQU\0OA_XIM+(>*_!-Q;1W.HZ*DL=C>VUU%YMI)%
M%)+YL4GE9\V/]YT'[WF@+'2^$_B_I'C#XH>/_ =E:WT.J^"_L'VZ::*+RI?M
M47FQ>5^]KNZ^-OV9[WQMXXT3XJ>-_A_/H\DGBKQ=J>J6/BKQ/87,L=[:Q'R;
M"PQ^ZE\J(12_O?GCBCE\N.*67S8[;T2Q_; T?5/V=?"7Q-MM O9]5\7W<>BZ
M'X;\Z/S+K5))98?LHN3^[BB\V*7]Y*/]5_WZHN:GT+17@_BOXL>./A;\1/AU
MIGB<>'_$-AXRU272X]%\-VUS_:NFR>7YHE\R67_3;:(?ZV7R[;ROW4OE?\LJ
M;\2_CEXFTW]H[PE\)O"&FVDNH:GH=UK-]J&H6,EU;6T7F^5#+YL4T7E\Q2_]
M=93:Q>;%YOFQ!E8]ZHK*\,PZO9Z/:Q:]?66HZK_RTN]/L9;6*7_ME+++_P"C
M:\VU/XO:OXJ^*^M?#?P%:6?]J>'[>.Y\0:_K4<LEKIDMS^]M;6*VBECDNI)8
MO,_Y:Q1Q?\]9/]53 ]>KSWQU\:M.\%^+]&\(VFD:MXL\7:G'+=0^'_#XB^UP
MVL7_ "]R^;-%%'%YO[K][+^]E/[JN9^&?Q@\27?Q=\1?"_QWI^EVOB?3=+CU
MC3K_ $::3[+K>FRW,D1F\J02_91$?+BDBEEE_>9\O,8S7D_[-^G>./'?[0GQ
M>\?/XE\/7D-CK</@R6:\T"Y-ULL>;N*P_P!/_P!!BEEE\S_6R>9(!(8H\>69
M-3ZI\+^(!XF\-Z5K LKW21?6T5U_9^K1^5=6OFQ>;Y4L7_+*6M>L7QUXNLOA
M_P""M?\ %&H1W$MAHFF76J7,5J<2RQ11>;+Y5>6?LX^/OB1\8O ?A+QMK;:+
MHNCZE;^:^EG0KF&[NAVFCDDNR(H_^>7[N7S8HO-_=>;Y45&)Z1X>^(_AOQ)X
MV\4^$M.U+[7K_AL6IU>T,4L7V;[5%YL7[W_52_NO^>5=+7S#J7[7MWX;\(_'
MCQW?:)!=^#/ 6M_\(WI5I;_N[^YOX_*BN3<GS?+\K[3=1>7)'SY?F_NNU>P>
M'H?BI%XJTZ77[GPA=>'KB.;[=:Z?%<VUSILG'DB*6666.^_Y;1Y\JVSQ)@?Z
MND.P_P 6?%_2/!_Q0\ > [VUOIM5\:?;_L,T,47E1?98O-E\W][7=U\C^/?B
M#X:T']L+7/%>K7XU;3O OA2QT"VT&..2YOSKVI7,DL,-A;$8DN9;6/RR8C_R
MT&< 2^7WWBGXW^-OA?\ #OPIJ7C?PWI3>,_%WB6UT'3/#^GW4L5IIIN9?W4-
MU= 2^;Y<<4OFRQ1?ZW_5Q?\ +6@U/>J*X3PG#\2;?Q!<1>*+WPIK/A^:VBDA
MO]%L[JRNH[KS/WL<EM)+<QR1&+!\SS8\?\\SUKNZ9B%%%% !1110!+:0^=)6
MW4-I#Y,535D:A4M144&Q+452T4 2Z?+Y5UBMNN?A_P!=6]'^\B0UC4"F2T44
M5D:A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 ?(D5O%\3O^"CEU?QR7&IZ;\-/!
M45N\;S211:7K-]*[#$61YAEL@<R /'Q&"=Z1UH_L0ZM)X^T7XI_%":"UNH_&
M?C>\ET37%@CCFU#1[8):V)8#$@$8BF CEQ(#YAQ^\Y^JJ* /DK]@.-_&W@?Q
MW\6V)D_X6-XQU+6]-N[D[M0738Y3:VMI<\_\L?*F$<8>2.,2C%7/V]--U&^^
M&?@F]FL[B]\#Z+XUTK6/&END/VJ%M"BED:Y-Q;#<;B*/]W))'L?&SS#Q&2/J
MFB@#X;_;D^.%K\4O@O:^ _A;J]MXCF\>^(-/\'_\)7I.IC^R]-EN9LB*2XB\
MSS3)'&\<D462(Y29,>9$DNUX\CT/X1_MJ^!/$7C+[!X1^%5GX$ET#PS?:AL@
MTC3-8%SYCQ1GB*RDDL8B@)\L21QF,$X\NOLJB@#X1\?^,IOVD/VX_@OX2T[1
M+^]\!>$[2Z\>2:B]^([34L$Q65[%$) 98HKJ.-8I>?,$TAC!MSYDN_\  7Q]
MH'P5^)GQUT[XCZM'HOCS7/&]SJM@NICS-0U;1I(PFF1V9R9+U0(IH8[:+S)(
MG_=>4#P?L^B@#X._9E\8KXL^.G[27QX\;Z1J/AG1_# 'A:TGO]0-[)IUI81&
M74H/*ADD YAM;DB/S/WDLGER29D)U/V?_"GB[2_^">'BSQ'!;:A#\3O&VD:Y
MXMFNM)ES=WVHWL4DEK<Q+%_JY9(A:XCBQ@@<"3-?;M% 'PW\-?C)X$^#_P#P
M3C;4?!?BW2(=6\,>!XWF2QN$U&;3-8OHLQ>;'^\\LRWTI_=RCRQSTCC..>N/
MA6W[-9_8VUG6].'AGPIX'L]3L_%&I37)EMM)U/4K**/]]*"_EQ2WKRCS?]5'
MYG)C&ROT%HH ^0OC_K5I^UQ!X,^&GP_O+?QAX1U'Q!:7_C?5]-F$VC1Z1;.)
M)K%[Z/.+J60VQCBB/F_+F3RXSDZ=AK#_ !#_ ."@U]!#%;:QH/PY\&_9Y#<0
M(&TG5]1N$DS&7'F%I;&(#S(_W87*9!<@_55% 'R5X=5_BA_P40\87^_S=,^&
M/@^TTG[/J&3]GU34G^T_:K0<[0;6/RI)/W<AXCP4YKZUHHH ^+/V/]8T#1?C
M9\?[;Q'K-O:?%+7_ (BW\,6F:OJ1_M.]TFVB\RP,=K+)YGD)#+*8Y(T_U>.J
M1C$'[#_Q0\)_ G]G;0/AEX[\0V'AKXC^%KZ^T_4O"][*/[3$TEW+<11VUM_K
M+HRQ31>5]F$@E,@\OS#7VU10!\W?LD^!=?MKOXC_ !-\9Z/=:/XE^(FO?VA;
M6]^/*O;;1XHA%IMK=1)^[BEBCWY_Y:?O0)/W@P,']N)CXT;X1?!V!A?/X[\8
MVPU?1?N&]T.R_P!*O_WI_P!7Y6+>3]W)'*<?N^]?5]% 'RO^V5:Q_$+Q-\#/
MABE_!YWB+QM!J=_H]ZLIM-3TC3HY;F]BF C,<@XMSY4G!D\OT+#,U74H_'G[
M?%YJ$\-QJWASX1>"6N98[6VEEETS6M2/_+.*(>;<F6PBQY<8DC';$IKZ[HH
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M##H<=M;_ /"+W,=K_P (]%<B*VM9)<8^RF/S(_*B_P!;F/\ U8\J66+[ HH
M^-?VD?ASK/PD_P"":6L>#M$ADM]3T/PW8VE\OAN-Q'(HFMO[0ES&!E)1]JEE
M.,&.60R#FOI+X1:QX)U#P3IVG?#W6]+USPSH4<6C6QT;48[^*V\N./RH3-YD
MO/E^7QU_.NXHK4#Y<_;6D?QLWPF^$\>+L^./%MK_ &QHN/+%]H5D#=7X,O\
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M6FH:GK?B[5X](T[3=)CCFNNF^6Z>,R _9H0/WL@!\L'/?-'QP^,VD? OP/\
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M+P%=_M*?"O0]2T>^UOXD6MCJ=_HU]9,3#H=OY(BEFNXA*-D4O^JBDDCD'F#
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MN.M_X7IX!_X4_P#\+/\ ^$KLO^$#^Q?;O[<Q^Z\K_P!&>;YG[KR_]9YO[O\
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ME_>RW47E^5_JOWOER^:)?*\WRI?* /8**\'^.7Q&^&O@GXJ^$-0\1:!JNO\
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M^R:MK^IWGV2WCEAEBAM9);DR6T7F6UOF.(QB3R8LY$>![S0!\A>.+:\\:_\
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M?[_FCV_=YK-B\1:;\9OV^='L=/N3J>E?"GP_?7,FHZ>@,,.L7TOV66TNI?\
M5D_9AGRXNDL4O_/.2*O</&7P3\(^./%%OXEU"RO[3Q!;VTE@FJZ/K%UIEU]F
MED\SRI9+:6*22+S/^64G?)ZU/X-^#_A'X>^)/$&N>'=#MM(O]<BL+6^^R2R^
M5+%:Q>5:Q11?ZJ+RHO\ GE0!XI\.UU#QI_P4"^+VL7%[;10>#/#>E^&;6S@A
MR9X[[_3S+++YO'ER12?7S1Z?O.?_ &>/"&K_ !0^*'[0'CRV\<ZUX1U23QS+
MX8NK;0(K*6"YMM,BBBM9/]*M;G][B23I7T)=?!?PK>?$";QNME>Z?XDN#:BY
MN])U:ZL(K\6Q_<_:HHIHXKGK_P M?,_=_NZ@\0? ;P;XB\6:AXHDMM5TK7]3
MBCBOKKP_X@OM(^V^7_JC)]FEB\PQ>9UEH Y[Q1X;TW]GGX5_%/QOX?MO[0\7
M+H]SK]]JVM2?:9M3NK6VS%YOK%^Z_P!5%Y447_+***O+_@#'8_LK_P#!.^+Q
M19W6EKJ$?A67Q1]INH?LL5Q?W,(EM8I?WO[S_66UM_TU\N+VKW?Q-\$_!/C3
MX:7OP^UC0VN_"5UD7-@;J99991+]I\V63S?-DD\T>;)+YOF2R?ZRMWXB?#3P
MY\8O >J^$O%NF'5] U/RA=6@NI8O-$<OFQ_O8OWO^LBBK6F95#P+X-Z6G['/
M_!/]=5EBM-*UO3?#MQKMU_:=J+(OJ4L7FQ6UU'D2>:))8K7J)#Y,0XKR:W^&
M,FC^%OV*O@Q+/JOARWU"6]\67%UY4<6K:7J=M8_;Q"!-$8P!<W4G[N2,\11Y
MK[?^*'PS\-_%SP1J'A/Q;IIU;0=2\H7-H+J6+S?+EBDC_>Q?O?\ 61Q4WXC?
M#'PW\4]!CTGQ+IG]HP6M['?VDT5Q+;7-M=1?ZJ6*6(^9'+_TUB]ZU,CEK3X
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M?F?\LI.AR:M^!_A#X-^'7B3Q#K7AG1+?1+[7(K"VOEM99?*DBL8?*M8HXO\
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MM$L]1L]5UR/0]<@\1Z;_ &UXAOK^:VOHN(I?-EEDE_[9?ZOK0!X[^T)X3O\
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M9_%&+P?I45DM^DL5W]KDENI+F2_NXK6[N999)#+)+Y4O^MED_P">56/VD/\
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M0?O>:[+XO>+KSP!\)/&?BFP2WDOM#T2^U2VCN1F.22*UEEB\T=ZT?!O@O0_
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M3?&CX?VVL6FER^.O#2:C<:C+H\5JVK6P>6_B,8DM@GF?ZZ,RPYB&9!YD?KR
M>AT5RGC;XA>%/ASI<.I>*O$FD^&;&27[-%=ZU?16L+RD']WYDA'/R'\JL_\
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M\S/E^88B<9\N3KZ&M?Q-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV 222$
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MYX:^'.FQ:CXJ\2Z3X9L9)/LT=UK5]%:Q22?\\O-E^AK6D953H**QO^$JT/\
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M2?$]A'+]EENM%OHKJ*.7_GEYL7_76J6K?%+P?H/_  D!U3Q;H%@?#_V4:O\
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MMY[G2- ^(FHW\WB">WDQ]JTRQMUN+FP(CQ(!<B3RS)'(A'/$@D(KHO#OP/\
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M&%UHGB33[KP=XI\37OB;4-+U#1Y'U%;JYBB\U(KV.Y$8B$L><&W)P"F23Y@
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MS&1K&:+S #'*?+)\SS,>6#Y9XH EM_@K:^//V=]#^&GQ80>+P=*L;37'&H7
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M/X>>$=-\.Z=/<7D%C'Y<MS>*'NKR4DM+<W,@ \R660R222?\M)))#U->"_\
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MW4/'GQ)N/$OQSTGPQX;\72^,-3O5T/5/$OB:YL+_ $W1(KJ2*VTSR8[&YBB
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M._V:]<^%>DW?@CPYXX;3?A6;V:2VT2WTYX]6L+65_-DM8=3%P,(9#)^]\HW
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M  4T_P#:+_::\1?M(+J=U)\.;O4HIO#>C21#_B;W5E:_81?RQ9/E^5+]I,7
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M#X+2:=^T)XI^*^J:R=3O-1TBVT+1[+[-Y0TBRC_>30F3S?WOFRXE_>1_N\4
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MSH?A6'Q[HKOX>M+"RTBXA\+/'&\,,?E&*^C-^3)N'E2?NI;8^9'_ ,M8\Q4
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MKWXV?!SQ%X&T[Q#/X6DUN*.U.K6\?F"&+S(_,C\KS(L^;'YD6/\ IK5'XQ?
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MKUC!<>'3IG@WP_JKP1WUJ8X[?[5J=A+;1RQR.1<2Q29\R.2.2(1^9Y<<L1T
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MV^'L?C.SM]7B\:ZAHFJ7BWO^B77A^QFLHY+;R8O];%+++LD\PS=)"-GE]\T
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M[$8'E>;S^Z/(QSUK>UC7+#PYI=WJ6HWEO8Z;9Q27-Q=7,@BB@CC_ -9([G@
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MRS2_NZ+6S\Z3RZW8H4BX08K$"O#IL<0^?FK=%/K(U"BBB@ J*2%)/O)FI:*
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M]%_I.IWQBMOLLEN?WN([:.63S.F9!R/+P_*?"OPMXV_9S\9_%#3H? .K>/\
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M3SQW,,-S8Z1'-YMS<PF0X,H,<(QB0G/^K/- 'D?[;GC*XF_8*3QQXM%QX?\
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MT_\ X)^ZI\"_ 5\/$>M6UA$]O<:C(MNMY,M_'?2K@<1&1O-$8)P/W?F2]9*
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M_ OX%^&_A3+X"N8==T9[ZT/BNXO;*?0/WM]+*+K8EU]ME'ER9$/E1EY,1DQ
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MDE'F>9QYF#'7I7PI\%CX:_#'PCX2-[]O_P"$?TBUTLW/E^7]H^S111>9Y?\
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MB4QRR'S)(OWOFUZ3\4O&P^&?PQ\7^+?L8OSX?T>ZU7[*9?*^T^5%++Y7F_\
M;*O,/$'[3QT/X9_!#Q<?#@D7XE:OH>EFT:^Q_9G]I1>;YOF^5^],7/\ SRI
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MJOVNG^;_ *RE<"*UL_._ZY5M11>70L8CZ5)7*:A1110 4444 %%%% !1110
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M",Y'&;?Q(T75?C'^U1\#3:Z/JQ\%>&].O_&&I3ZQIEU!I\UQ+$+:PC\N6/\
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M=_HTFE7%_+^\Q;Q17WE29 $?[R01Q9E&)>)1& >'^!?B5XU_:<UWXO:?X?\
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M];2S/"9(B2D<I(CD_=^9%'^\(DD(!]S5\'> OAMXC\<?MT?%FY3XI>+[/4?
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M^]&!))$3Y<6 *\ZO#>> ?V,?VGOBEXWT?5=,U#XB:CJ\MM:ZI9&+6+6QN?\
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MUC5/"L4^IKIUG96$.I_VF8HHXI1]EEXABN1'F(Q&7RCTZQ]SXR\1:A^P_P#
MGPOI;^++KQC?WTFF>$-%N/$PM+#1=+N?*DB^T2R6T4<L5M''$99!))+)^[B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"WN/AW::E;:K'X;L-.,4U[);L'%M?2RRRPW5H9 28?LT1_U7[S,?[SVRBB@
MHHHH ***P/#/B?0_&6B6VLZ#JVGZ[H]P?]'O]+NH[FV;G81')&2#SQQ[T ;]
M%<[XD\6:)X7^P)K.KZ?H[:G>1Z?9?VA=)";FYD)$<40?_62G'$8Y_*K6L:Y8
M>'-+N]2U&\M['3;.*2YN+JYD$44$<?\ K)'<\  >OI0!JT5E:/KEAXCTNTU+
M3KRWOM-O(H[FWNK:02Q3QR?ZN1''!!'IZUL4 5I;.*;K'4/]E1>LGYU?HH R
M_P"R1ZU%_9,G_3.MC%&*OVC Q_[)D_Z9T?V3)ZBMC%&*?M&!F_V/%_SUDKD/
MBQX7U7QA\/?$&@^']?/A/6M2LWM+?6D@DDELO-X,D7ERQ'S1G,9\P8DP><8K
MT*BLP."^#_PXT?X._#GP[X.T&U^S:1HEFEI!F--[XZR2>6J@R2',DAQR\A-;
MWB2#6[W1;B/P_?V.EZN5S;W.J64EY;IZ[XXYHB__ '\%;]% 'D?P?^"UA\)[
MGQ=JLFHW.O\ BGQ9J0U76M:F0!I9?+$8MHADR1VL6#Y44LLGE"0CS#7KE8'A
MGQ/H?C+1+;6=!U;3]=T>X/\ H]_I=U'<VS<["(Y(R0>>./>M^@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *93Z* (I(4D^\F:K
M?V;%5ZB@#+_LC_II47]D2>M;&?:N'\5?%'P]X6\<^$/!VIZE]D\0^*!=?V19
M_9)9/M7V6+S;C]X!Y:8CY_>$=>,T>T8'0?V3)Z1T?V/)_P ]*UJ*T]HR>0S_
M .R/>I8M-BJ[2UF41>3''T2G4^B@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /DK]O3XC_ !'\&_"TZ5X#_L^QU3Q=
M?67A[1M7BU6:TU(ZG<S%?)BB-L8@3#')B:2YB\O)(^>./S,G]K[Q%XM\'_L3
M>+])U+^P_"/B75Q:>&-,7_A*#J4=U%<2112+->W\41\S[,;KS)),XCC,IE!R
M8[O[5EB_C3]J#]ECP5=:A-;:+<Z]J?B*6*U"?-?:9;17-J=Y3./WDH([^8?:
MK7[23-\3/VF/V>?APF;NRL]9NO'&JFQ7_3+$Z;#BPED!SY=K+<R2QDN/WAP(
MY : -RR^,$?P=E^&WAJ_\%7'A3X7:Y<6_A/PGJ<U[+)?6]QY2I8PWEC)%YMN
MLJ12B.0RR2)^[^TQQ.7$?;>*/C,S?$2;X>^"M'/C#QO8V@O]16:\-KI>CQ2'
M,8OKL1RF.28"3RHHHI9#@DB.+,E>=_'O1W^)7[5?P \%+=6NH:/H<^I>.-:T
ME;B-9K<VJ10Z;='GS /M-R0,<.1)U\LXXW]G'X=Z7\4OBK^T1JWBZ\UZT\=V
MOCNXL)(M*\07VB7/]D1PQ#3#+%:31>9%Y0D\J60?O 7Y.": /<_@_P#'"3XC
MZ[XP\+:UHW_"->.O!M[#;:UHL=S]MMO+F!EM+F*Y$<8DCEBQ)]R.2,G$D8XS
MG?M=?%[6?@K^S[XM\8Z!_9MO>6MC)''>W]Q)%]CDE'E12QQBVF\V7[3)"HBD
M"1G.9)(P#7>?#7P]X3\-Z!-;^#K2Q@LIKV0WLU@XEDN[Z,^5<S7,V?,EN/,C
M\N624F4R1GS"2#7SW^W_ &LWC[P=\,_A5:WMU!#X^\;Z?I&K:?8[);Z728S)
M+=31 I)@0F*.5Y<$1_+YG#8H M?!C5;K]CS]EWPWI?Q"\+:?X:CTRSL[+3=+
MT'6)M8U/6-4N#))+;16WDQ@W,MR_$,4LD?[U_P!X(HLUTOCC]I/Q/\)KC1=2
M\?\ P_\ [$\!ZM>QV U[3=:BO9M$DEEBBB_M2,QQ16T>9#YDL4MS'')&8]TG
MF1D\Y^U#_P G5?LL_P!KY_X1'^V-7^U?VAG^S_[4^P?\2SS,_NOM/F>;Y/\
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MF+X7C6P,MS;7*QH!;W,47ER<>;#DR".:0@>9QE]J"_$+_@H)HVFG3[?4=/\
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M//%%C8:T=X2YMM'MY/M-_?1=HA;"&-I)908XTSYG:IOVX-WQ2TSPK\"=+?\
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M9XUU?1[3Q%'K4\=K?Z?;2W0O]0EC\S'E_9[ADB/FH1'O DYYH ]1^$_Q6?\
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M_P#!0+XV7/B)UBUG2_#6B6/AA;@&&1M(E$DM\88P1]IC^VX!D/F>7)B/('%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^&])\,V,DOVF6TT6QBM87E('[SRXP.?D'Y5U=% '%?\ "I/!?_"=_P#":_\
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M .=\2>$]$\4?8'UG2-/UAM,O(]0LO[0M4F-M<QDF.6(O_JY1GB0<_G71444
M<[X;\)Z)X7^WOHVD:?H[:G>2:A>_V?:I";FYD(,DLI3_ %DIQS(>?RH_X171
M?^$G_P"$D_LBP_X2;[']@_M?[*GVO[-YGF^1YO\ K/*W_O/+SC//6NBHH Y3
MQM\/?"GQ&TN'3?%7AO2?$UC'+]IBM-:L8KJ%)0#^\\N0'GYS^=8]MX1TGX/^
M -<3X<>!=)LYU2?4+3P]HT5OI<-]>^5B./>!Y<9E\N*(R$<<'M7H=% 'S?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU]\4?%UEXDM?"NL1:_I&F^'=(?2+=[Z,2"*6Y\RYN9)/*\P&/RY(AG/F"7@
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MZ;\6/ NG?L;_ /!-KQAH-GH5@;V/PS'IFK#3G*PW6HWPBL;J[,KQF23]Y-O
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M7/G-:QRRB(Q22>6F2);:49QR,>I% 'T+_P +2\-_\+6_X5U_:1_X2_\ L?\
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M<#R\VTL4<D>^*X\N09 QGBO&_"^K66N?M\_&CQ=J-U!H=A\-_!&E^';B6YG
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M+)YDIDDD?W=Y)'X]>W2N_H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;T?0_C!XM^)WVN_U+Q%X@L[73Q]NE26/3[2VS^XM?W8DBCD<B66/)!E&<4?
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M'Q(T;3_$'C37M6NO$]K=:IHL4,ME)+<M(+J(8P)92%N/M$8CDDC^S1Y\NVA
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MXTU/4O$NN3W$/E&^N;BZ?;<^7TC$D,=N0(P(\<@4 ?4]%?F;>ZMJWCC]EO\
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M7\L6RUCD$?FQDBYDBCX,D7N8\FOGK]M;X7^ KB/]GOX8Z=X,TV^O]4\3:9H
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MA2:GXA\>_:]^O:'(8O/NTL+JVS]FABW3".VMOW6S(,<OFRB3Q_PKI6E>#_\
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M TCQI#XFGA0Q:G:ZQIEO:_V?)<$VT,NF>7%P([F:*3RKK[3YD<>/-!YEY?\
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M)H-?T*Z\5)XMTSQ'=6Z1:LDVDVTUQ<6UU%$([:02"6$1RQ1Q>6 ?,BD/[R0
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M/M:@:MJ%AY5AJ?VB+S/]%E_Y:^5_JY.F#ZU3\&^&/%OA?59!J'CR[\8Z"T1
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M@<_$[1/$O_" >%KV\N&\,Z/9:;%=SW4,4OD[]7\U3O\ ,EBD/E6LEOY<9/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.UCR\D:21+)+'&9)(PV0),9'V;10!\,?M0VOC3]I;XF? KPUIGP]NKKX8?\
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M-QH.DW%[9:E;WPC$47VE!Y5M+&\)CD%R8HXS)$_F&/\ >55_8_\ !7CF^_:
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M;6]K;1B**"./_5QH@X  ]/2MBB@#Y$^!]S<_LT^,OC+HGC#PYXFF3Q!XXO\
MQ=I.K>'O#E[J]C<V-Z(\1^9;12&.6+R3YD<@3_EGY?F YKI_VK_ WB']IG]D
M?QGX:\+:3=:=K&KQ1R6%AK2_8Y91;7T<@!!/[HRQPYC27RR/-3S?*/F>7]*4
M4 >2^!_C)+\2KK28](\(>*-+2:,7.K2>*=(N-';3OW64AVRP_P"DRF0@?NB8
M@(I29O\ 51R^2:+!>_!#]K#XP^*==T+7;WPM\0K71[C2M5\,Z%=ZNEO)86IM
MIK6ZCMHI)(I#YHDC/E^6Z9_>9!0?6M% 'S?X1\!^(OB7^T[+\7=>TRYT3PQH
MF@'0O"FCZP-]S))-*);C5Q"3_H+21XMO+(^T&,?O1#Q'2?L:Z/XFF\'>/?%G
MBVRU?2I?&GC;5/$-EI>O1S0:G9V),5M:Q74<G^K(CM0 @)01^5@XXKZ1HH _
M/'1O@#XY^+G[!WQ?MH-#N-"\;?$WQ3?>+X_"^M126TUFWV^*3[,9)0.9([+,
M4LD<0S*F<#]Y7O/C[XOZY\7OA-JVA?#3PGXUTOQQKVF_9(EU[2+[P^-!^T)Y
M4ES+=S1K'NM_,#^7;&61S'^[#<R)]*T4 ?$WQD_9WDA\)_LQ?!/2O#IU[1]$
M\2V&IZKJO]C;=&%KIUM)]K%T!YGER71F/EQR9$DDCYD[UV'[7'P]O/C)\1/@
M/X!F\.7-_P"&)?%;^(M<U;[";NPMX[&WEE%I<QX\L"Z\XQ R<=>).E?5-% '
MS#^U!X1UOXC_ !2_9Y\,VND:C_9=OXO_ .$IU3Q-;VDDUOIPTR%I8K>7 Q']
MJ,OEB0R#!CX$G0+8>&-;\:_MY:MXFU'2=1A\'^"?",.D:;-K-JXMI=3O)C-)
M<Z:<>7Q;XMY91B3($>".:^G:* /CG]DV\\1_ 7X'Z=\'-2\$^(;KQ_X>O;VQ
MC$.G7$>C:CYEU)<Q7<6I^5]GCMO+F!)DQ*/*DC$,DGEQR?8U%% 'R5HL%[\$
M/VL/C#XIUW0M=O?"WQ"M='N-*U7PSH5WJZ6\EA:FVFM;J.VBDDBD/FB2,^7Y
M;IG]YD%!6^#/ASQYXT_;?^(OQ#\:>';GPC8:+X6L/"^C6LEM(XOK:ZE^W-)]
MJR8Y)H9!Y<L<.^.,R!/,D\OS)?KZB@#YN_8UT?Q--X.\>^+/%MEJ^E2^-/&V
MJ>(;+2]>CF@U.SL28K:UBNHY/]61':@! 2@C\K!QQ7@6C? 'QS\7/V#OB_;0
M:'<:%XV^)OBF^\7Q^%]:BDMIK-OM\4GV8R2@<R1V68I9(XAF5,X'[ROT.HH
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MGJNFZ#?ZEIOA[0[77()8IVBTZUD$TL2$;#:R37,DD3QG#DRG S7TG10!\E_
MNQUS0_BE^T=\6-<\,:]8IJ/B2UT:VT>#3Y9+F>TTR'[-_:<7^K-S%*)I)?*B
MC)Q$1'YTG%5O&GA^7XF?&CX>>./A%X6U;PQXHM/$$9\7>*M6T"YT/[1H?E 3
MVERMU%%)>^;Y4 BQ%+Y1B_UEOP3]>T4 >3Z3\6KC6/V@/$/PXT[2(+G3="T.
MVU34=<AU",FQOKF:00V,EMC?F2*)YO,..,<?O$-=MXN\1KX3\,:SKATZ_P!6
M;3;.6Y_L_38C-=7'EQE_*BCS^\D., =R:POAO\.=*^%NDWFGZ;&S&]O9M5U*
M_DCC^U:A?S?/-<R^6 "\ASG  '"((XTC0=_0!\[?L-_#/6OAK^S5X4M?%-JZ
M^+]6,^O:Y)<I)]JN+NZDDE+71E D-R(Y(HY#)DYC([5RGPLM=:TOX[_'[XM>
M(_#6O76G&\L?"^B1W6F22ZI'8V2 7TMK$?OV,LTGVD"W),WE28B,NR,_6E%
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M(^@[]JYKXB?&NT\(^-M)\#:-I5QXI\?:XDEU::-:2^6MK:I@&^OI3_Q[6HD
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MX"U+3=0TS5DA"37$9NA;/8W,HQ+):R1W4WF1"1,\9/4'Z]H *YW_ (2K1?\
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MEU';6R\[ )))" .>.?:CPW/K=[HMO)X@L+'2]7*XN+;2[V2\MT]-DDD,1?\
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M_=^]N8HS#:^:(^\DL47F>7QG.* /=:*\3UWX]2Z1<>$O"<OABZNOBKXET_\
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M.BEN[7RI3+%Y4KCS(\2?O!@]<T 9O[0G]L_\*#^)'_",_P!H_P!O?\(YJ/\
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MO&M_G,:6LMO?6YABV?O))99C#S((QYB$F/RSGZGT?X4>"/#K: NE>#]#TY]
M-S_9 L]-AB_LW[22;G[,0O[H29._R\9R<UY#:_!G5?BY^T;?_$#XCZ!''X;\
M&R+9_#[2IIHW8R2+&;O5)A$9.3)'%]GS(/+$7F&*.3$E &G^RS\)O$7@+P?K
M'B+Q^MN/BAXXU276_$4EO)]H%J6R+:RCEP9##;1;(UC,D@C)E\N0IBN-_;\D
M?QMX'\"?"109#\1O&.FZ)J5I;#=J"Z;'*+JZN[;C_ECY4)DD*21QB4YKZUKG
M-2\)Z'J_B#2M<O\ 2=/NM;T<R_V=?W5K&]S9^:/+D\J3JGF  ''7OZ  ^>/V
MAM0C\<?M/?L\_#EK"VUZRMM3O?&NH11M*;G338VTD=A=2^6^8X3<S$9DXDDC
M$?J#7^/3'XD?M=_ CX<QL=1TSP_]N\?:_8R'RC;&WC\G2[OS<C.+J20>5&3D
M$>9&8Z^D/^$5T7_A)_\ A)/[(L/^$F^Q_8/[7^RI]K^S>9YOD>;_ *SRM_[S
MR\XSSUH_X171?^$G_P"$D_LBP_X2;[']@_M?[*GVO[-YGF^1YO\ K/*W_O/+
MSC//6@"UK&N6'AS2[O4M1O+>QTVSBDN;BZN9!%%!''_K)'<\  >OI7R1^Q)X
M[T#P-^RKXC^+/C;5(-"G\0>(M2\8>*$D/EQ:=<W<@\J.*+F0+);FTECC)DDD
M%S&4WB2.O<?VIM)\0Z_^SKX_T/P?H7_"3:_K>DSZ3;::U[':>9]J_<R.)9"(
MQY<<DDO)Y\O'>I/#O[.?@#0]+\&6UQX1TK7[SPAIMEI>EZSK6G6US?P0VJ_N
ML3>5PP/[S,>/WA)&* /C[5H_%7PE_P"">?Q"U/6M%>P^*?Q<U:]O)_"]S!F2
M2]U>Y6U:UM+<'S/-^Q?O1$3)(CK)Y@.#'7HND^#[3P=^VU\%_!>H2SR>%O!W
MPQN(?!DNJD1%]3CDCMKKRY!Y8N9OL,:;XN0F/,\N/K7UIXD\)Z)XH^P/K.D:
M?K#:9>1ZA9?VA:I,;:YC),<L1?\ U<HSQ(.?SJMXV^'OA3XC:7#IOBKPWI/B
M:QCE^TQ6FM6,5U"DH!_>>7(#S\Y_.@#Y9^+WC2S^.W[:7P?^&>CV]QKF@^"K
MB[\9>("0(K47-OFVL98I<B28VUYYL<D<7[L2-Y<F3%*(M/\ 9)UBS\/^)_VG
M=5\47MOI^OV/Q%U*ZU*ZU:41W=OH\<,1T^29Y?W@MO*\WRB3Y8C\SR^,U](:
M9\.O"^B:C::CIOAG2]/O;'3(]'M;JTLHHIK>QC.8[6.3 (B!QB,?)G]:NN?"
MGP9XN\2:;XCUGPAHFL>(=-\IK+5M0TZ*6[M?*E,L7E2N/,CQ)^\&#US0!\]?
MMX7D/B#X.?#M;_[1%\/=?\;Z%%XL>_MY;,1:/)-YC_:C,$DLAY@MP7/ER1DA
M.,D'UFW^"W@#0=?T:XU/^T]6O_MP_L>W\7>([[5XTO8@9HYK6&]N98Q<QQQ2
MR"2,"41K+S_K!7IFL:'8>(]+N]-U&SM[[3;R*2VN+6YC$L4\<G^LC=#P01Z^
MM<SX.^"_P[^'FIMJ7A#P+X9\,:E)'Y#W>BZ1;6DCQ]XS)'&"1\G3VH [ZOC[
M_@GOK%MX?_8^@U/Q#?6^G>(+/4]9N?&-UJ,@BNX-0COI6FDU*23#K,(1%YAF
M_>"/R^V*^P:\\U3X*_#S5_&">*M2\">&M0\4I)%=C7+G2+>2_P#,B*^5()O+
M\P&/RXP"#QQZ4 ?+/P[\9:CX-^'/[3'[3=U'!I-QXCFDN_#?]K!K;3]2TVPM
MC#I$IBE(ES=/(1UC,N8O+$?F<^[?L;_#5OA#^R[\,_#4L%_:7$.DI=7EMJ49
MCN+>YN2;F>.0$ Q[))94QU&!WKU3Q-X8T/QEHESHVO:3I^NZ/<'_ $BPU2UC
MN;9N=X,D<@(////M6_0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%?-_[7G[3D7[-GPO\ $VN66DZA
MJGB.WLXY+&"32K[^RQ++,(LS7T<7DQX.9/*,L<CX &/-C-<W^U5\:8[/]AOX
MG:^;;5-1O?['_L.[74-$OO#XDENO)M)9HK:^B\P1 W/F ?O,X,?FDC( /K2B
MO"?@[X_\#> ;;P3\%H/%)U#Q'HVEC1[6>;3IK:WU633HXHKK[-,0899(SGS(
MHY9)(B)!)S%)CN?&7Q1\.?#]K1=:U+9>7S2?8-,LX);N_O3'CS?L]K"))I?+
M#@R>7&=@Z\4 =[17DNE?M$?#C5_$7AGP_9>*+>YUKQ)<7UI96$=O*T_VBTBB
MFNK:X'EYMI8HY(]\5QY<@R!C/%>3ZA^VBLW[2&E>!;'1]>MO#4/AR37]3N+G
MP1K<NJ74GVG[/#%#;+"DD40/SFX,4D;_ .J_=D9H ^LJ**\3\0_M6_#'0--U
MR:?Q!<>=HL]W'?V5OI=[<75O':S2175UY4<)D^RQRQ2Q&Z ^SB2,Q^9GB@#V
MRBO*O&/[1GPY\$:7'J&H>*H;F!],&N>5H\4VI3?V7@_\3#R[6.63[+Q_Q\8\
MK_II79_\)5HO_",?\))_:]A_PC/V/[?_ &O]J3[)]F\OS?/\W_5^5L_>>9G&
M.>E '145XW+^TW\-;.UO+N?Q"=-M+:SNM1234+"YMXM3M;:*2:6:P+Q@7T<<
M41D,EKYH\LQGI)'G8\,_'?P1XT\2:+X<T77/M>M:KX<A\7V-H+.:-I]*ED$<
M=R#)&,<G_5G$GJ.] 'IE%<7_ ,+2\-_\+6_X5U_:1_X2_P#L?^WO[/\ LTG_
M !X^;Y/F^9CR_P#6\=<^U'Q6\=K\-OA;XP\8BU^W-X?TB]U3[+YGE_:/LT4D
MOE[^V?+- ':45\<_L;^/_!'P;_9\^"W@+5O%!N-:U2RA>.>33IH[47NI))J4
M5A)= &WCN?*FXBDD$D@\IQ'^\CS]*>-/'6A?#_28M2\0ZHFDK<3&TM89"/.O
MKH@^7;6T7WYI9/+)CBBR\F. 30!V5%>=> ?C#X6^*5YK%GX>O+F75-$>*+4]
M,O\ 3[FPO; R1^9'YMM<)%*@DC_U;[,$9P3@UZ+0 45X7J'[8?PCT]?%<?\
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M>,=.\/Z1XEM]0U'589I=,FAAF-AJ2P_ZW[#?>7]GNFB\S]Y'%)(8\29QY3T
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M&M7!U36(Y;O1Q=Z7=6UMJD,6PRR6-S+$D5T-D@DS#))^[/F#,?->KT %%%%
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MJ_%C]E7X4V5K;:%IZ^*3XCMKBS7]W;1:':F6.UCMAC E$OEYS^[V=).!5O\
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MKSQ[H7B?7OA[XHOK1;+5[CPVMJRZM%'_ *G[3%<VTT4DL7W8YO+$@C<ITQ@
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M,8[=Z]*H ^0O ]S>>-?^"D7Q0U<VUO9V/@?P1I?A29C<EY+B2]F%_'*(_+P
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M_P #W-YXU_X*1?%#5S;6]G8^!_!&E^%)F-R7DN)+V87\<HC\O  'FQXSGA,
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M;3Q=\1O!'BNYU75()/"37MQ;:9;SA+"YEN+?[-YEQ'C]XT<;RB,Y&/-D]2*
M.^KY+_9/4_$KXO?'[XEZU(9/$MOXQN? MICF*PTS3A'Y4-L7S)'YLLGFS 'R
MY)!GRQ7UI7BEQ^SO;Z/XNU_7_"'C'Q-\/9O$<J7NKZ=X<%C+8W-^.#=>5<VD
MNR63CS'C\OS?+0R9/- 'F_@&,>(_^"BGQ7OM"9].TSP[X1T?2/$EIN,(U+4[
MB3[3:W.(^)O+M5\KS)<..8Q^[YK)_P"">'A?3-8\)?$;XQ6-L8A\3O&.I:S9
M&27;=)IL=U+';0S1Y\M)1*;O_5YXE'[PX 'OVB_ _P .^#O 7B#PGX6.H>&;
M76_MLUSJ6GWTAU,W5QGS;TW4OF2R7/S B64R']W'V&*T?A'\.-'^#OPZ\.^"
M]"MOLVD:'9I9P91-[X^](_EJH,DAS)(<<O(3WH \&_X)^L/&7PS\1_&"[8RZ
MO\3O$5_K$IF&^XL;6.9[:VT\W)/[Z.$1'RSB/ E("#G/SE;_ !./A7X>?MO?
M&[P=!IUKHNKZO;^%])N/#^H^5+]IC_T:34XYHHL?O#?QW0,?)D\SG_EH?LC1
MOV6?#OAEK_3=,UOQ!9?#V^O9;R;X=QR6W]C+Y@)DBC B-Q%;22_O#;1S"(^9
M)&8_+EDC*_#G]D7X<_#OX!77P=MM);6O!]\93>MJRQFZO)))/,,DSQ1Q_O(\
M1B.4?O$\J/!!C!H Y7PO^S'XKT7X)6_P@N_'.BV_P_.C_P!@W3>&_"1L-3N(
M7C\J5O-ENKB%9)2299/LQSYDI'EO^\'"?MC?"_PUXPN/V:?V?K325CTF^\3)
M=0V<EU+]F_L?2;&3[7;&;/FB0Q2A(_UDCZU[QX;^"^KZ VA0W/Q6\>^*=(TT
MP@66J2V :?RL;#-<V]I%=2<A2?WO[WD2^;')(#KWWP9T;4OC?I7Q/U&XU&\U
MK2])ET?3=.NI$EL;(RR>9)=0QF,F*XD'[HR"3F,[,4 <G^U)\%M<^,_ACPBO
MAG6+'2O$OA#Q-:>+-,_M.UDN+2ZNK:.416\QCD5XXI'DYD&2 #@$XK4^#_QP
MD^(^N^,/"VM:-_PC7CKP;>PVVM:+'<_;;;RY@9;2YBN1'&)(Y8L2?<CDC)Q)
M&.,[_C7P!?\ BG6$U+2/'/B?P?<+#Y4R:(UG-%<@$F+]S>VUQ%&?WDF9(A&7
MR Y<1Q^6[X>_!W0/AQ/KE_9175[KOB":.XUK7=0F,M_J4L<8C6264= !]R&,
M1Q19Q%'&,B@#QG]O+5+N?X:^"_!<%[=6-A\1?&ND>#M7NK"4Q7<=A<R2F40O
MG@RB,Q_O!)&4D<;3FM+]MZ?PY\/_ -BWXB07^@VTOA^V\/'2;/2[:UB,-I+*
M8[:Q,<6!'&(I9(9 1S'Y>8P<"O5_B[\)=!^,WA%M!UZ*Y@2.6.\LM2TZ7RK[
M3;V,_NKJVEP?*ECR<2#U_"N=L_V?;+4->T;5?&7BCQ%\1+C1+T:AI$?B0VJ6
M]E=XQYXAL[:WCDE&1Y<DPD\H\Q>62<@'B'[6?AN]C_8X\ ?"+QCK-S=>)_&6
MI>&O!=UX@B8WW^G>;#)+=2>:8WE!^RRXZ22$KGJ<:7[?&G64W[//A7X6:;96
MVE:5X\\5:%X(MI[6,1Q:1";@2QR1VP_U@C%L(_*!CZ]0!BO<?B!\%]&^)7CK
MP)XDUFYU&7_A#[V?4+/259#87-U)"(HYKB)T/F2P_P"LBD&#&<D=>7>,/@GH
M_C+XK?#[X@7MY?PZUX)^WG3(;9T%O)]MA$,WF#R\G@#H1ZT >FU\H_\ !/)&
M\:_!*X^+FIL9O&'Q'UB]UK5[K.[88[J6UM[6(\R"VBBB_=QR22>67DYKZNKP
M?P[^S'8^#5O=.\,^-?%WA/PA>7TMT?"&BW-I%I\'FX\Z*UD-L;FUCE;S),6T
MT?EF20Q>5V /'?@SXV3PCX@_;+^*FE6>[P9I.MS"V\/F7[+OU33+#_B9S&(9
MCC^TR^4?-YDDQF0<"N\_83T3_A4?[$OPZ&NZA96MG;Z/)KMQ?>=Y=M;6UU++
M?9EDDP$$<<O[PG@8//>O6=+^#?A#2?A//\-;'P]!8^"9=-FTHZ3!-(@^SRQ&
M.13)GS,OODS)D.2<]>:\YF_9!TB^^%Z_#K7O&_BSQ-X*CTK^QK/1[[^S8H[2
M,0F*&4>5:1F66+CR_-\R,2".3R_,CCD0 ^-KE_\ A8'[ NL&V)MM6_:'^*Y?
M3+6;FWT>ZN=4&(IIAGS(Q_9LF98X\_O1^[K]-/"_A33O!'A71_#NCVYM='TF
MSBL;.W\POLABC$<<>7_V0!^%>9Q_LS>%V7X/VES?:I>:?\+XA'HVF7,D4EM=
M2QVRVT-S=1^5B2:(#S(Y(_+\N1B1Z#VR@#Y4_P""@VI7Z_L\KX(T6[N;+7?B
M)KVF^#-,N8IRD$,ES<?O/M#K^\\J2*.6.3 D/[P#!R:Y_P#;P\)6&D_LMV?P
MMT.-K>;Q]XFTCPQI$L\IDBCO9KX71N;J4YD?S/)FDDEQ++)++DY))KVCXT?L
MZ^'OCMKW@Z\\3ZAX@^Q>%KZ6_M=+TG5I+&WGNB (II#'B7S8N3')'(AC+2<X
MXIOASX!V^D_$*S\>Z[XGU[XA>*+&T:RTBX\2+:JNDQ2?Z[[-%;6T,4<LOW9)
MO+,AC0)TSD \I^)S:AXX_P""BWP;\/V]K;Q1>!_"VL>*[BZEN3F>*])L5CCC
M\LY:.2*)\D_\M#WC&\_:PU>P\;?M#?LW?"M+R&TU*X\4'QI/*)_.FMX=,MYI
M8HC;@YQ<DS1B7/'DR8$G0>K^-_@#9^+OBM8_$+3O$_B#P?XQMM(;07U'1_LD
MOVFQ\T3>7+%=6TJ<2#/[L _.?:LSP_\ LJ^$M%^)VI>/O[0UZ^\2ZSX=D\.:
MC>RW?E37L<DOFR7<LL4<<L=QD! 8GC2*-(HXHXQ%$% /+HTUO]AF[\=>*O$1
MTWQ)\)/%'C&7Q'J>M68EMM4\-SWTICS);?O!=VZXL8\QO'+^\D/E2#II_MA,
M?%WQ8_9G\!6*K!K=YX\C\3122G-O]ETF&66ZC)_YZ%95\L8ZYR8Z])U+]G6S
M\91I8?$'QCXH^)>A0RQ7?]A:]]BCT^22.59(WDCLK:V-P 5!\F8R1>L9PA&_
M??!G1M2^-^E?$_4;C4;S6M+TF71]-TZZD26QLC+)YDEU#&8R8KB0?NC().8S
MLQ0!XWX3T;2/B5_P4.\>>)!"#J/PW\(:9X=$=U9)(1<WTEQ=?:;>7=F/%M^Z
MZ#/GRCI_K.5U3QV--_:^_:(^)GV(22?"+X;6ND_V891MU;S4EU?S!+_RQ(\L
MQ8\N3_GID?<KZ-^&OP4T7X8^(/&VM6-WJ&IZWXNU>35]1U+5I(YKKILBM4D$
M8/V:$#]U&2?+!QWQ5;X=_ 7PK\/]/\>:7;)<:WIWC;7K[Q%J]GK:Q3PM+>@"
M:(1^6/W6$ V2 ]\DT >'_L@_"KXE:+^SWX,EL?B%H45KXHLHO$6I:BWA:676
M9)KX?:999+V2^,4MR/,$8FDMI/\ 5Q>9'(!@[GC_ /8W2'X)_#?P+\,=6@T.
M3X<Z]:>)M(_MZ*2\CO+ZV$L@BNC'(AC$LTWF2/'TRWEQ\@5V7A?]F9_".CVG
MAS1_BEXZM?"5H3#;Z"EU9^5;6I;)M8KHVIO8XPA\J-A<^;''C9(,#'9^-? %
M_P"*=834M(\<^)_!]PL/E3)HC6<T5R 28OW-[;7$49_>29DB$9?(#EQ''Y8!
M@?!_XX2?$?7?&'A;6M&_X1KQUX-O8;;6M%CN?MMMY<P,MI<Q7(CC$D<L6)/N
M1R1DXDC'&?'/@Y)K/[#NC_#WX2^,UL=?\!:IK+Z%X>\9Z69(KA;^Z;[3':WU
ME\YC\R62Z$<T4D@Q'%Y@CR7KW#0?@/H6@6/B5M,O]6MO$?B*:&ZU;Q<+TC5+
MNZB$8CE:3!CQ'Y0(MA']EYDC$0CDDC-2S_9]LM0U[1M5\9>*/$7Q$N-$O1J&
MD1^)#:I;V5WC'GB&SMK>.249'ER3"3RCS%Y9)R >QU\H_P#!/)&\:_!*X^+F
MIL9O&'Q'UB]UK5[K.[88[J6UM[6(\R"VBBB_=QR22>67DYKZNKP?P[^S'8^#
M5O=.\,^-?%WA/PA>7TMT?"&BW-I%I\'FX\Z*UD-L;FUCE;S),6TT?EF20Q>5
MV /(O@/XQL_!_C3]K[XH1PW%O\.]'U]T_L:V/E2_VAI=C_Q-+F.'/E;KF381
M)OWRD RXXJU^QCX6T_\ 9M_87TCQGK$'VF<>&9?%&I2Z?.]Q-)8_O[Z*WB\T
MC8(XIO\ 4\1"628]99)'N?M?>$=,\!_LBV_P?\!-#X(;Q-J6E^#?#\,?GQ1-
M+<WL8DCDEC!?;)$+DRR29,N9,[S)SZ/K/[+/AWQ,UAINIZWX@O?A[8WL5Y#\
M.Y)+;^QF\L QQ2 Q"XEMHY?W@MI)C$/+CC$?EQ1Q@ ^.?"?@O79/V=?V._@:
M]U867_"8WE]XMN+J2*2_L)K2V674XK&ZLB8OM,<OVN(21^8,&'CS.#7V5J/[
M/VN_$C7?"U]\4?%UEXDM?"NL1:_I&F^'=(?2+=[Z,2"*6Y\RYN9)/*\P&/RY
M(AG/F"7@#I?BM\&=*^+,N@:A=7>H:#XBT"]^W:)XAT9DBOM-D./,\N1XY(S'
M+&#'+%(CQR C(R 19\%> +_PMK#ZEJ_CGQ/XPN&A\J%-;:SABM@2#+^YLK:W
MBD/[N/$DHD*8(0H))/, /G_2_#>G?%/_ (*4>(O$WV0NWPK\(6.BMY\ABE&I
M7YN+F.:+8<21?9998B)>0\G$9_U@U_"+?\+._P""@OCS4KS)MOAAX<LM#TVQ
MNA]I076I*UW+J$73[-(8HQ;' )DC_P"6F/W=>P_#7X*:+\,?$'C;6K&[U#4]
M;\7:O)J^HZEJTD<UUTV16J2",'[-"!^ZC)/E@X[XK(\1_ .WU;XA7GCW0O$^
MO?#WQ1?6BV6KW'AM;5EU:*/_ %/VF*YMIHI)8ONQS>6)!&Y3IC !Y!XKM]%^
M(7_!2[P#IUBUA#K?P^\(W^MZAJ%L(IKFY^U?Z)'8S8P8O*%S]I&<\7/^K D\
MRI_ ]S>>-?\ @I%\4-7-M;V=CX'\$:7X4F8W)>2XDO9A?QRB/R\  >;'C.>$
MP#YA\OUOX5_LY^%/@SXX\:^)_#?]I6]UXP:R-[;7-QYD8DM8I8_,!(\V667S
M9))999)'DD)D)S3HO@'8:;\7-7^(.@^)M<\.ZKXA-A_;UEIYM9;75S9 QP^;
M]HMI9(OW1\L^3)'QTQ)F2@#S+XG*/&7_  4$^".BV;!+GP5X;USQ-J,ESRCV
MU[Y=C%'$<??$HZ''R>O2D_X)Y(WC7X)7'Q<U-C-XP^(^L7NM:O=9W;#'=2VM
MO:Q'F06T447[N.223RR\G->P>'?@WH^A_&#Q;\3OM=_J7B+Q!9VNGC[=*DL>
MGVEMG]Q:_NQ)%'(Y$LL>2#*,XKE?#O[,=CX-6]T[PSXU\7>$_"%Y?2W1\(:+
M<VD6GP>;CSHK60VQN;6.5O,DQ;31^69)#%Y78 \B^ _C&S\'^-/VOOBA'#<6
M_P .]'U]T_L:V/E2_P!H:78_\32YCASY6ZYDV$2;]\I ,N.*U?V5])L/V7_^
M"?6D>)+"RCU:2U\,7'C6[6*#[$;Z:2U:^\J23]YR(O)M_-.>(1QTCKUSQ%^S
M?X1UCX 7GP;T?^TO!?@ZXM?L'_%,W'V>ZC@\WS9(_-D$F1*"ZRF3/F"63.?,
M)J[\7/V?_"_QD^">H?"S4#<:'X9NHK:V\G0/*MS;1V\L4T4<0,9CC ,<8QLP
M!P.U 'S-\+_V7]9\7?L.? '2?#7B;3X/$GAF]L/B#I<FJ6#O:7-S(+B]BMIO
M+E$D<0EN]AEY/[DGR\D5]%_!_P".$GQ'UWQAX6UK1O\ A&O'7@V]AMM:T6.Y
M^VVWES RVES%<B.,21RQ8D^Y')&3B2,<9W_&O@"_\4ZPFI:1XY\3^#[A8?*F
M31&LYHKD DQ?N;VVN(HS^\DS)$(R^0'+B./RW?#WX.Z!\.)]<O[**ZO==\03
M1W&M:[J$QEO]2ECC$:R2RCH /N0QB.*+.(HXQD4 >._M^:M>3?!G0? =A=W&
MDO\ $CQ3I?@@ZI _-C'=2;Y9?*ZR@QPR1>7F//F]>*C_ &^/$'A?X4_L8>-]
M.NM$TG^SKC38M"TG1F>*WB,KD10"VC92,VR_Z3'''R!;<>7C(]I^+OPET'XS
M>$6T'7HKF!(Y8[RRU+3I?*OM-O8S^ZNK:7!\J6/)Q(/7\*\_\2_LGZ+X]UCP
M?JWBWQ-XF\6ZYX8\0VNO:9K-])8QRQ_9CYBVWEQ6T44<4DIS)Y<?F2^7%YDA
M$40C /)/CM\+=#9?V2O@!J]T=32WU6VNGN[K3HY;2_M=$TUS-%-$9./M!ECC
MQ^\ $DG7 $G5?M;^=XQ^.G[,?P\?_0VOO&<OBU=1QYHC_LBV,WV;RNYF\W'F
M9_=XSA\U[+??!G1M2^-^E?$_4;C4;S6M+TF71]-TZZD26QLC+)YDEU#&8R8K
MB0?NC().8SLQ3_\ A2&C_P#"^/\ A;'VO4/^$@_X1S_A%_LF^/[)]D^T_:=^
M/+\SS?-[^9C';O0!XK^RU<'XF?M!?M"?$Z].V^MO$8\!:=:W"^?+IUMIJ 3>
M5+C]W%<RRB4Q  "1,DR&L+X5367Q!_X*.?&/Q)X=BTFULO"7A6R\)ZE>6<ZS
M3:C?RRBX\V39'UB%M+:R R%P;:,>T?L=Q^SII5GXN\0ZSX=\3^)?!EKXBGCN
MM>T7P_<VT%AJ5U@B2Z'F0R2VTTJ?ZR6UEAD/EI)GS )*N_ ?]FWP5^SNWBY?
M!UF;-O$VKRZQ=*T$4?D^9_J[6+RHH\6\7[SRXSGR_-DYYH ZWXK>.U^&WPM\
M8>,1:_;F\/Z1>ZI]E\SR_M'V:*27R]_;/EFO _V0XS^SS_P3Z\)ZSKVZ\LM)
M\.77B>X33!YDAM93+?B.,.8_WGE2 $$@>9GG%?2'BCPIIWC?PKK'AW6+<W6C
MZM9RV-Y;^84WPRQF.2/*?[)(_&O'V_97MV^!6J?"B\^(WC2X\+W.F6FC6[_:
M+&WN;&QM^##%)%:1\2Q#RI/-$F8QCC)R >=?LJVES\"/V'T^(>LI_P )#XNF
M\.W7C#5;V;4)I9M1C8W%]#$;B4'RP1,2>#&)9;F7]X9)))/#/#_@6XG_ &?_
M -CGX%V6KVOE>,)I_&-U>:A9_:K*:.VA?5!I]U8^;&+F*22ZCC(\P?\ 'MG'
M/R?=/Q2^#&B_$CX0ZI\,OM%]X3\.7UK'8[O#3QV4EO:H4Q#%^[,:Q[(_*,>,
M>5D?0^*WP9TKXLRZ!J%U=ZAH/B+0+W[=HGB'1F2*^TV0X\SRY'CDC,<L8,<L
M4B/'(",C(! !S6H_L_:[\2-=\+7WQ1\767B2U\*ZQ%K^D:;X=TA](MWOHQ((
MI;GS+FYDD\KS 8_+DB&<^8)> /=*\Y\%> +_ ,+:P^I:OXY\3^,+AH?*A36V
MLX8K8$@R_N;*VMXI#^[CQ)*)"F"$*"23S/1J "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HKYY_;;^)WB7X9?!&3_A!;]M.^(WB#5]-T'PTWD1R">^N+J+]T/-'
ME F*.;F7CBOH:@ HHHH ***XO_BM?^%I?\P'_A6O]C_]-O[9_M3S_P#OU]F\
MG_MIYGM0!VE%%% !1110 4444 %%%% !1110 4444 %%%% !117F.A?&31_$
MWQ>\6?#[3K>]O=3\+6=K=:U?>5&MM:2W(,EM;<R>;)(8OWF8XS'C/[P2?)0!
MZ=17%>'_ /A./^$X\7?V[_87_"%;K7_A&_[/\[^T/]5_I/VOS/W?^MQY?E]N
MM=K0 4444 %%%% !1110 45\Y_&3XG>)]7^.7@OX->!-4;1=:U*SE\0^(]>B
MMXI;C2-'BE$<9ACN 8I)+F7,&2)#%_K#$>#7KG@C0]8\-^%X=,U_Q#<>)]36
M2=FU>XM4MY'0S2/$KQQ 1_NXRD6X8\SR\D<T =A17EUY\:M$M_C3IOPM6UU2
M^\476DRZY<&VB06UE8Q2F)997DD&1++^[ C\P@CYQ&.:X;XD?%/Q&/VO/A9\
M/?"^JM_97]CZMKOC'3HX(L_8?+$-A-YDH_Y^LC$1S_ST^2@#Z*HHHH ***X#
MXR?%70_@?\,]>\<^)9)AI&CQK)*MO'YDLGF2B..-/=WDC3GU[=: ._HKQ/\
M:+^+,GPE_9@\;^.)6NO"FHV^A2368NXX[F:ROY8MEK'((_-C)%S)%'P9(O<Q
MY-=Q\)O^$G_X57X1_P"$TS_PF?\ 9-E_;G^JQ]N\I/M/^J_=?ZWS/]7QZ=J
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MC3Y9;"PUX_N[>]*$Q177V:20%1)CS#%(> <$]:T/"/\ ;W_"*Z-_PDO]G_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+6UYX9F^*'Q(U'5]3U>21[C^Q();^;RIQ;_NA, +4#R_,W_O>YCH \\_9F^
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M)YN3QY8<_P#+.0CZ0\+^%-.\$>%='\.Z/;FUT?2;.*QL[?S"^R&*,1QQY?\
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MO/BG6(=9\5698F)?#ME)YLHN'C_>VWFRB*.*1=F^2(Q^8.:R/$G@73OV6O\
M@GC<?#+5KU[G6KCPY>^'["&WS<OJ>MWT<V+6UCCC#R^9<2R>6/+SY0S)T<UT
M'[$?[.?B'X+^"=/U?XDR0:Q\3+O3+72C<*HE_L32+:**.VTN.4$Q@1E/,D,0
M DE<DF7RQ(0#USQA\$]'\9?%;X??$"]O+^'6O!/V\Z9#;.@MY/ML(AF\P>7D
M\ ="/6NC^(?C&Q^'/@/Q)XNU**::RT#3+K4[E+8?O'BBB,L@3GT2O-OV>/&G
MB+XH7_C/QS=ZCJ ^'>N7UNG@K2]1TZ.VE%G%;@2WP(_>&.ZE,DD8FP?+CC?
M\W%>D_$/P=8_$;P'XD\(ZE+-#9:_IEUIER]L?WB12Q&*0IQZ/0!\\?!/X+:;
M\>O@GIWC'XWZ;9?$+Q)XWLO[4\JX+36.C6MS$##;:9&1FR M_*\R2/\ >22Y
M)EEQ&1Y]\-_CSKOP_P#V(?C/XFO_ !+J>H6_A'6?$&D>#?&FIF34KG5(A(8[
M"ZDFQ)'<C[5-Y7F >5B(# $9KUSP#X!^-?@_X6Z7\,[&]\&Z;%I.FKH]AXZM
M[BZNKF&WAC,5M<C2)(?+\WRXHP5-WY8DS)^\'[HUOBM^R#IFH_L8ZI\"/!&H
M-HEN+&*"QO-7<W1DECNX[G,V.@EE!R8Q^[\S,<? CH WOV<]'TG]GS]C?P1_
M:]I=>&;'0/"T>L:S#=13>;9R^2;J^\R/_69$LDQ\O''3':OBWX7^ _$?CK_A
ME[PO?WPM=<\:ZQKGQ7\;M:QQ7,SF3_CROB(S_H/FV\AABFB\KRI9!)'^^B&/
MJG]HGX7_ !L_:$^"OBOPC9WWASX=W]]#%"O]EZW<WPU$&:/S8KBX-C%)##Y7
MFYCCB<RF2,>9'&)(YM_X;_LYW'@_]H75?&I^PVGAG1O"&G>"/"&FZ9<2R2QZ
M=$3+,+OS5/[SS1&(S'+_ *O_ %G- 'L'@GX>^%/ASI<VF^%?#>D^&;&27[3+
M::+8Q6L+RD#]YY<8'/R#\J^6?^"@VDZ!X\UCX%?#Z^T>#6M4\4^-;6.:R736
MENO['B(DU/RKD1^9;#'V4R21R1OY8S]P25]HU\E>(F?XH?\ !1#P?8;/-TSX
M8^#[O5?M&GY/V?5-2?[-]ENSSM!M8_-CC_=R'F3)3B@#E?VO_"GA3P]I7PA^
M"OA3PKIVCZ9\0O'ED-:\,>'=+%M'J.EV_ER7\I^SQ#R_+_T4R2YCDV1'_EF'
MQZ%_P4"\4:CH_P"S;JOA_P /3;?%GC>^M/"6BV9C7_39KV81R6^9!Y<9DM_M
M/[R0@#GD'%;OQU^#_BKQ9\7_ (1?$;PFVE75]X#;5!)H^M7,EE%>1WUJ(2?M
M$44IC,>P'_5G/\^9\>?L_?$#XM_&#X1>+O&6J:7%X6\+:G=:K>^#['4[F6WB
MNHT'V"YBE\F(W4PEW.YE$4<<1\N.,_O9)@#ROXU_!KX8ZM^UU^SY\,-,\"Z3
MJ=CI>F7.K>(+1-&$\IL;6R%KI!NKXIYDD0EA,7ERRE),1B4',8/3_&/0]$D_
M:J_9R^#?AO1[:V\+:%+J7C74?#>CZ;]FMK Q12C3+LO'&/+'VHW/0X,D@WC]
MY'GTGQI\)/&^F_M.6OQ@\(1:#K>?!S^$KG1];U.;33#B]%U'<QRQ6USYF29(
M_+,:8P"">@/&GPD\;Z;^TY:_&#PA%H.MY\'/X2N='UO4YM-,.+T74=S'+%;7
M/F9)DC\LQIC ()Z  YK]N)CXT;X1?!V!A?/X[\8VPU?1?N&]T.R_TJ__ 'I_
MU?E8MY/W<D<IQ^[[URO@/P':_'_]M7XWZMXH:P\8^ _"UEIGA>QLK[3(KBRN
M9O*^T36SS#_6_9;B24R6L@DQ+-;R28DM[?9W6A_ 'QMX@_:R\/\ Q9\<:W8:
MKI>D>';FUTS1+6YF\K1-3FE*2FVC\M!+$;4F*2:0^9)+\_E11^5'%U7[+?P7
MUSX-^"M?'BJYT^Y\8^+/$NI>*-<&CR226$5U=2_<MO,02"/RXXAA\G._DT >
M$V>MWGQ<^,?CW2F^'^J^/O@MX%EB\&Z'X7\-MIMGHOVZ**,W@O["]NK?[089
M?*BM^##&(LQCS/WE>U?LS?"G7_AI)XV>6*+PWX+UW4UOO#G@6UD%R/#T;Q9N
M1YG^KB\V4F0VT6^WB((BDD$F:RO!?PD^(7P-\8?$!/!.G^&_%7AKQEK\WBLI
MX@UNYTN^LK^YP;N+,5I<QS0GRHC&<1R)^\!\S&\^X^&'\0_V3;'7_P"S3JTA
M:6YBTL2FV@4DXBC>3F0H-J>81'YA!D\N//E@ ^9_^"EVJ6<7[+&HZ0;"#4O$
MVNZC9:/X;MY=(%_+)?2S;2+9/*D$<QM?M7ER#$@Z1GS",]C\0O"?@W]DK]FK
MXB:Y\/=+T+X?W6E^')S;:C!9Q1/+<Q6\D=AYLDF?M,OFR #S3(9))>YDKE_V
MDF;XF?M,?L\_#A,W=E9ZS=>.-5-BO^F6)TV'%A+(#GR[66YDEC)<?O#@1R U
MWW[5WP7UW]H/X5P> +&ZL++1M8UBP_X2">ZFDBN5TN*?SI!:$1R#[3^[B \P
M;/OYH ^9O'/PCFF_8Y_9M^ ^GPW/AZ3QIJ&DQ^(/#_F10ZB;-87U+6)0+K)C
M\J;$O S&_EQX_>".N^^-O@+2/A7\9_V?X_AY!=6'Q1\0>)_L]]J$]]+<W^J^
M'XXO,U6*]N;B1_M0B3[,8Q-))(@CC\G'EUZ]XN^#&N>-/VH/A[\0+V?3H?"G
M@K2;]M,BMY)1J#ZI>GRIA*#'Y9MOLP&"")!)ZBFZW\&]<\5?M5^%/B%J\^GW
M?@_PKX<N;;1[ RR)=6NKW$HCN;GB/$D;6O[O]Y(1D9$8/[R@#S[P:K_M1_'K
MXK#Q&/\ A(?A/X'OH_"VDZ'/_P @N^U14$FI27UJ_P#Q]26TGDQQF4>4/]9&
M#)^\KF/ ?PWT[4/V]M1T[2)[_5O!GPX\."[M]/O+IA;^&=8U(11?9;2/ (MI
M+&WR(E\RWB,DGE^4<(/2/!OP>^(7P/\ &7Q#B\#GPSJWACQMK\_B=;K7KNYB
MOM)OKH@77[F*$QWT0\N*6./S+9^9(S)TEJC\"_@#XX^#MG\;O$$VM6/BGXE>
M,-9N+G2M:U:ZDE2:VABVZ7'?!$B$90R2^8+:,#RSB/I&  <3^S%\$=%^-'BC
MXP_%;QLJ^,-.\5^,+VTTF%[U)=&U/2+%_LUE));1-Y5T 4D -R)/]3%+& 3Y
MDG _#OXU>+_ 7[*-U;^!]2\VW\6?$B7P3\(]3U;%U:V.ERW7E6LDOF9E\N$1
M7(C\X22?NXOW1B&*^F?A#\#]?^"'[).G?#KPMJMM;^,M-T&ZCM=4N_WMK%JT
MWFR^9_JR3#'<RG!,?^KQP<8KB+C]C^[L_P!F'X7>!-!O[#2_&/P]OK#Q-IK3
M-+<:7=:[:EY9O.)Q+]EEFEEXC\LQ^8"!QY1 /4_!O[-O@CPA-IUY'9ZC?>)K
M!HQ+XNO-1E_MO4_+"X%[>QN)+J(D)_H\I,7[J,>7B.,#QKQUXEL;K]N\:SK]
MR+WPA\)OAO=:[-=VZ%XM$U&ZGQ,96B!)EDT^,D0R=4'F1IWKWWPG_P )]>:K
M-J/BV'2M"@MX/(M]#T*_>_AE8G<;F6YEMH9,C CCBCC  ,ID,OF1^3YMX2_9
MAO=1US]HC4?'6HPK<_%:4Z6?^$?E.+;1HK3[+:_ZV+Y+KRY)/,_UD>1'COD
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MK'1=,W^:UC$20;D^<3))<R@%\#RXHA^[KP7]D2U^,-G^S[=>./#F@^&9M?\
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MC:_X;T7P!H,>I7^F^/;];F\U72K+Y[F1IM,$7EW4L4CR@2":*,CRY#"<&*0
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M,;?[+WP<;X!? CP;X"EN%N[G2;(_:YMV^,W4LCRW7E_NXSY0FEE\O(SY>/Q
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MB3Q9HGA?[ FLZOI^CMJ=Y'I]E_:%TD)N;F0D1Q1!_P#62G'$8Y_*@#HJ***
M"BL#PSXGT/QEHEMK.@ZMI^NZ/<'_ $>_TNZCN;9N=A$<D9(//''O4^L:Y8>'
M-+N]2U&\M['3;.*2YN+JYD$44$<?^LD=SP !Z^E &Q16/H^N6'B/2[34M.O+
M>^TV\BCN;>ZMI!+%/')_JY$<<$$>GK6Q0 4444 %%%% !1110 4444 %%%%
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M=ZEJ-Y;V.FV<4ES<75S((HH(X_\ 62.YX  ]?2@#YXT+]K#5?B1\7OB)\/\
MP-X#_MVX\+7QL%\0R:P+:R$T0C^TK>CRC<6P$N8HMD4PN3%)Y?[N*62/L_AE
M^T1H7C;X4^(_&VJ17'A1_!\][9>+;&ZS<_V3>V40:ZB\R,'[2L8/$D7^L '0
M_(/'/V)/'>@>!OV5?$?Q9\;:I!H4_B#Q%J7C#Q0DA\N+3KF[D'E1Q1<R!9+<
MVDL<9,DD@N8RF\21UYGJT?BKX2_\$\_B%J>M:*]A\4_BYJU[>3^%[F#,DE[J
M]RMJUK:6X/F>;]B_>B(F21'63S <&.@#Z>_9S^.OB?X_>#_#'C'3O">EZ;X/
MU595FNY-=EDN(WC,@_<P_9!YH$@\F0RR18DBE\L2Q^7+-%;_ +06N?$+3M?U
MGX0^![7QUHFDRW%I'J^IZX=(MM;EBP#'ID@@F%R/-\R(S2^5%YG^KDD'F&/6
M\=>"]0^'?[)OB3PKX*DU:75- \$76E:+):;CJ#RPZ>8K;RC&,^;E(_\ 5X^?
MH*Y7]F[QMX"^&_[#?PY\3W^JZ1HWA+3?"]G->WUNR"&.Y$8^TY\K[TOVDR@H
M!YAE)&/,.* .L\(_M1>"/%'P=U+XG7M_=>$= T>>Y@UBSU^..*_TFXMYC%);
M74,9D,<I/EXB_P!9B2/C,@%9&H?M#^(/"/@Z+Q]XH^&6JZ)\/#%'<RS-<>;K
MVFPR$>9<7VF)'B..(>9)+Y4TLL:8/E?ZT1?*'BKP-K^@?LC^#9OB#I$^@P?%
M+XLVGB'XEZ5=((+6QL+V]+,))!^\LHAY%D29)1+'(^PR#F.O;?\ @H[\;AX$
M^!.L^!?#IU&_\=>,C;:%96.EV7VR7R[J4QN)!SL\Z.*ZBB_Y:2/YGE#]U(\8
M!R'P-^(VH_L\?L6^%/&NI>&F\0?%'XH>)%OH]+6^^R'7=4U:Z_=2><!)%;>9
M:K')C]W&/+Q^[D-?4GQ_^+6F? ?X2>)?'NL(9K70[,SPVNXC[5/DQQ0[O+D\
MOS9)(XO,P<>9D]*^<OC?X!ATGXQ?L:_!V#4-0_X1#2;RYU!%+Q&XN)M%L8Y+
M!WD\H>DHD$8&1*>A\O%W]MCQE:?$KQA\,O@!I4%QKESXI\56LGB?3K=A':'1
M[01W=U:R7)P8IO+^S7'E1'S/+ Z>=%YH!ZO_ ,- ZEJVO6?@S1/!_P#:'Q,B
MT>VU77]%EU1?[,\-22A#]FOK^*.3$D@\T1)%#*\GEB0QQQGS:[*T\2>-=4\'
M7MW!X-@TWQ1;S_98],UG5XX[&Z ,?F2PW5O'-)Y6/,\LR0QRGR_WD46>/!OV
M2=8L_#_B?]IW5?%%[;Z?K]C\1=2NM2NM6E$=W;Z/'#$=/DF>7]X+;RO-\HD^
M6(_,\OC->S?&KQM>Z/\ LX^/?&'ANYNM-U&P\+7^K:=-=V1AEMY([662/S()
MH\C! _=R1]CD9H \4_8I\<?$_P"*DOB[XA:Y;:?K'@_Q1XFO7TW5)/$MTXM=
M-MQY-M'8V#6HC$8ECD'FR?9I9?\ 621DB//T%\7?BUH/P9\(MKVO2W,Z22QV
M=EING1>;?:E>R']U:VT61YLLF#B,>GXUP_[$7@^Q\"_LB?"C3[&2::&YT"UU
M0FX.3YMZ/M4OX>9</CVQ7#?M0_\ )U7[+/\ :^?^$1_MC5_M7]H9_L_^U/L'
M_$L\S/[K[3YGF^3_ ,M,Y\OG- 'L7AGQCXXU#Q!;6WB+X>R:1IUZQ:VO;/7(
MKJ2S0<_Z?#^[\J0@1H!:_:DWF3,@C D?#?XZ7OBSQEXB\,?#7PY;^+M3\/3+
M;:QJ^I:DVFZ/;7&<264=S'#<R2W48\HR1QQ&.,2'S)8Y,1GT/3?%FG:QXAU3
M1[2Z:[N],:'[8L,1,<$DA\Q(S)CR_,\LK(8_]8(Y8I" )(R?E[]A'Q9IWA7]
MEF^\4>*9OLOB[4/$^K7WC,,K?:_[<EOVA\J6V09BN' M8Q;1)DF2+$>9.0#T
MGX4_M*S_ !:^,7B7P19^"=6T*'POIT<VN7FMO''=Z?J,MS)'#9&V4R"1988C
M=1W,4LD1C,?KSROPK_:H\8_'#P;XD\2?#WX2W>M:18ZE?0Z+JFI:Y'IEAK]O
M;\1RVQDC\Y999"?W<D0B7$@>YWQ^77F7P%^*TVF?L_?M$_M.WMM;VE[XHU+4
MM1T&ZUR6*$76GV41MM)MI8HI?+!$OG6^,B60XYDS&:[VPU"/]E7_ ()R6^I6
MD5UX.U/1?!$;1)>6LDDUMK%S$<>9'+YG6^N?N2#8F3G$8X /0X?VK_A_?? C
M1OBS;W.I2Z!KA$6FZ9#:DZKJ%]YC1C3X;8?ZRY\V.2/"$C]V7\SRP9!Q7[0O
M[1/C+X+_  ?\6^)/$7@V^\*"YTZZCT+7-*NTU?\ LV^-O*;4:G#Y?EV_F2^3
M%^Z^U0^:2))0/+DD\IF^&+?"F;]A_P"'/B/3VT3PC97UUJ&L6DUR/LT7B6*Q
M-Q:+]ISQ(;V6Z\N(2%)<8Q(.F]^W]XYM?B?JWPZ_9YTR75KF[\9^*+*U\2)I
M-B)!#IL+137,?G%)!%-&);:ZP,F..,228CEC\T Z'PGI^A_L\_#3]F/X/77P
M]L?$'C'5+ZUE31=0N$D_LJYAA-SJFJ12RB6/S;:621Q'%("?-_='%>L/\=+W
MQ9XR\1>&/AKX<M_%VI^'IEMM8U?4M2;3='MKC.)+*.YCAN9);J,>49(XXC'&
M)#YDL<F(SYMXB9_BA_P40\'V&SS=,^&/@^[U7[1I^3]GU34G^S?9;L\[0;6/
MS8X_W<AYDR4XK*_81\6:=X5_99OO%'BF;[+XNU#Q/JU]XS#*WVO^W);]H?*E
MMD&8KAP+6,6T29)DBQ'F3D R]#\?6_QE_;5D\4:SI^I^&O#'PA\'7'VZU\2>
M782^']8NKN2.224Q2&.6.6PMO,$GF26XCQ)P37KNG_M#^(/%W@Z7Q]X7^&6J
MZW\/!%)<Q3+<>5KVI0QD^7<6.F/'B2.4>7)%YLT4LB9/E?ZH2_%L/B+Q+\0O
MV2?VMOCEH=OKL>J>/]8&GVAO--0@^';9X[7(CCC(/EVUS=1RR R "W)SYD3O
M7UE^T%\;?"/[+W[*37W@[4GAM8_#BVWA :8?[2 B\J*WM;H&0R VT1EM<S2$
MQ_O8Q^\DECCD +GA?]J;5O'WP.\1_%/0O">F0^%]-U+4S9ZAK>M7%O#?:/9>
M9YFI$16,LT9+Q28MC%YG[OZ5QG[)?Q*\:>#?V;8?B'\<+W3['0=0LYO$][XG
MU#Q)-=W+FXE5[<?8?)\JVC,4D?EPVTO78!$))"!R_P </"^H?LZ?\$K;KPQI
MMJ?#FM67AO3[#4[?S!<K'/>W4,>IIEO,&9#<W(R.GF?N\8&-_P#;,\(V/@;]
MG+X3?#HW%U)\-(?%/AOPYXHN;XA570HF4&2ZN !]G'F16V908\$XS@T =[XL
M_:;\0^!?"6G_ !'\5?#F?PU\,+B6W^V7FI:F!KNCPW $:7%SIBPF,?OI(E,<
M=S)*$DSY7F"2(=AX^^.;:#\4+'X:^%-";Q5X]NM*DU_[%=79T^RLK))A!YUS
M<F.23YY,QH(HI22/G$<?[RBW^"W@#0=?T:XU/^T]6O\ [</['M_%WB.^U>-+
MV(&:.:UAO;F6,7,<<4L@DC E$:R\_P"L%8/Q4^$/AGQMJUW\5=#\<W'P_P#%
MVBZ;=:9_PFNF7\4UM;6]N;GS[:^MI<VTL$5QYLD@.)!)%_K(_+X /2OA[XD\
M4>(-'NW\5^$6\):U;W<ML+:/4X[ZVN8T(,=Q%+& ?*D!X\R**3@YC'%97P"^
M(6N?%CX3Z-XH\0^#M2\ :S?&;[1X;U;?]IM=DTD8,F^*(_O!&)/]6.)/QK@?
MAC^U)!-^RCX>^-7Q1MO^$&T^YLEGU)1;7$L:>9="VAFCB\LRB*7,<L8&?W<P
MYDQYA^BZ /!_V@/VD].^ _B'X?:.]@-9U[QKK!TFQT\S&*62,8\SRY#$8S)Y
MDEM#''(\:&2Z&^2...21#XL?%B\^&O[/OCWQC\5?"F@16MA8R12Z)9:G+J=K
MJ*2+Y<=M+)+918\V2418,4D>&Y[BN"\1,_Q0_P""B'@^PV>;IGPQ\'W>J_:-
M/R?L^J:D_P!F^RW9YV@VL?FQQ_NY#S)DIQ1^WY(_C;P/X$^$B@R'XC>,=-T3
M4K2V&[4%TV.475U=VW'_ "Q\J$R2%)(XQ*<T =M#\9IM"U/P9\+O#_@:WMOB
M'<^&(==;PJM]'9Z5X?LHS'"8I;J..3($F^*(6T,O,72./]Y7<^%?'&KMX0U+
M5?'GARW^'TND27'VEI-8CN;#[+&3_I<=P/+(A,8S^]CBDCP<ICKP?Q4^$/AG
MQMJUW\5=#\<W'P_\7:+IMUIG_":Z9?Q36UM;VYN?/MKZVES;2P17'FR2 XD$
MD7^LC\OCQWXK?M$>*/B!_P $W7\97_AZUT?QUX\TV/0K3P^\4I^VRWMP;7_1
M8O\ 62F6V,MS%&/,X(_UH'(!5_93^)6J?#;X)^"-*A\-KXK^.'Q2O+KQMJ&D
M17HM8FANKG)UF^FC62.RMC;"WP(X\R2$11Q>9YF/H/5OCQ?:U\2_%/@'P!X<
MM_$WB7PK'8SZU-K&I_V;86/VN-WAC$HBEEDEV#S,)%Y8C!_>^9^[/C'[.?A&
MS_8]^/6I?">[EN-2T?QU!#>^#O$6H,MQJMY]@L8X[G3;J8"/8MM'LDMXS'Y8
MCDD DW_NZW?VA/"NC_#KPUXR_:,^'OC+_A%]?ET>+5KN^-U'?:)XHCBBB^QP
M7$4I\O\ >QQ_9HI;62*0?:L@R>9@@'T)\/=:UWQ)X3TO4O$?AZX\)ZS<0DWV
MC7=S%<M:R$#Y?-B)CDZ<$=B.$.4KY[_;T^(_Q'\&_"TZ5X#_ +/L=4\77UEX
M>T;5XM5FM-2.IW,Q7R8HC;&($PQR8FDN8O+R2/GCC\SZ,\ Z]?\ BCP)X=UK
M4M(N-"O=3TVVO;G2KG_6V4LD8DDMY,@<QD[.0.G2OFK]JRQ?QI^U!^RQX*NM
M0FMM%N=>U/Q%+%:A/FOM,MHKFU.\IG'[R4$=_,/M0!2_:^\1>+?!_P"Q-XOT
MG4O[#\(^)=7%IX8TQ?\ A*#J4=U%<2112+->W\41\S[,;KS)),XCC,IE!R8^
MSLOC!'\'9?AMX:O_  5<>%/A=KEQ;^$_">IS7LLE];W'E*EC#>6,D7FVZRI%
M*(Y#+)(G[O[3'$Y<1X?[23-\3/VF/V>?APF;NRL]9NO'&JFQ7_3+$Z;#BPED
M!SY=K+<R2QDN/WAP(Y :O?'O1W^)7[5?P \%+=6NH:/H<^I>.-:TE;B-9K<V
MJ10Z;='GS /M-R0,<.1)U\LX /1/%'QF9OB)-\/?!6CGQAXWL;07^HK->&UT
MO1XI#F,7UV(Y3'),!)Y4444LAP21'%F2N9T7]IW5=6^.VB?"F3P!?:=XC6SN
MK[Q!/=7O^BV%I$D(AO;1]@^W6\UQ-Y(/[J2,QR>;%'@BN(_90URQTWQ[^T]X
MI\9W\6E^+;?QS/!JLM^_V9H=$MK6,:7))#P(X?)\XQS8'F@$^9)C-5?V6]>F
M^-_[4GQN^+/]G:@VBZ0UMX%\.W6J0FRN8([8&6_MI+;/FKFY\F7,T?F#S0/W
M>)(P 95C\0?C;X\_;(U32;32="GTOP%X=AAU'0K3QE?6NEQ:G>R>9%+-(-/$
MEU*;4<1F*6&+_6>;'+Q7V]7Q_P#L2V$^O?$S]I;QQ?WUQ>ZO>?$6Z\,NK>7'
M$MGID92UQL0<B.YV$G.?*C[Y)]V_:$_MG_A0?Q(_X1G^T?[>_P"$<U'^S/[)
M\S[7]K^S2>3Y/E_O/,\W;C'.: .0T/X]:E\4%U*^^&?@]_%GA73;N6UG\17&
MI?88=6,6/-.CGRY!=8/FQ>9*]M$9!^[ED'F2)P?[:%M<?$SPO\(/AO\ 8V@_
MX3WQCIYUSPO>7%LEU+I,$<E[?QYCDX\KRXM\EM)P< 2'S!OZK]E/Q1X5\+_L
MF?!+^S[S3[>UU'3-,L+:'2HQ*+K49(A]KC$</642BZDE/_+/RYI)<".0CE?$
M3/\ %#_@HAX/L-GFZ9\,?!]WJOVC3\G[/JFI/]F^RW9YV@VL?FQQ_NY#S)DI
MQ0!WV@_$31_%_P"U9XL\,:/X/L+[5/#'ANVBUCQKF..[M'NI?.MM+P8Q+)$8
MQ]I\R.0Q@\$;ZP?"O[3WB#XD?$[XC^%O GPYN-;L/!^I)HJ>*+_4C8Z5-?>6
M3=12^9$9HVBD'E?N8[GK&2(XY1)7+_LFZQ9ZYXD_:)^-6JWD&GV.O>*IK"#5
M _EZ3<:+I$7V:VOXI2<$$>=YLHD\O,9XC -6_P!C?Q!:^&?V2KCXL>+]._X1
MBZ\17>L>.?$KQP7(C'FW$LGVF*(^9)Y?V6.'9LSF, \DY(!Z-\,OVB-"\;?"
MGQ'XVU2*X\*/X/GO;+Q;8W6;G^R;VRB#747F1@_:5C!XDB_U@ Z'Y!QGPV^/
M_AOPG\!OA=JB_#QO">J^-1_Q37PU\(?9[JZN$F<R^;%CR8O+\J3[5+++Y4<7
MG?O"),9^>X;SQ!\//^"7WB#6YK"WN/B9\6YKFYNK.3][+K=[K5T8M]K#$^/.
MDL9(Y(XHA_RRSY7^L%>K>&O!=G\.?VY_A=X3NWED\.Z!\)/[,\)RZU@F2_AN
M8XKDVI(\LW7V*-/-\K$GE$9_=T >^^'/&OB73#?_ /"P/#%CX5L+&QDOI-?L
M=>CO-(BABP#'+++';2QR8,DA_P!'\KRP#YN?W8X[3_VA_$'B[P=+X^\+_#+5
M=;^'@BDN8IEN/*U[4H8R?+N+'3'CQ)'*/+DB\V:*61,GRO\ 5"7E/VW?'&IZ
MA^QU\8;OP5+-JE]:1?V->S65F9AY0EBCU#!,6'6.&2YCEDCR(C'*,QR12>7;
M_:"^-OA']E[]E)K[P=J3PVL?AQ;;P@-,/]I 1>5%;VMT#(9 ;:(RVN9I"8_W
ML8_>22QQR '<? _X_6'Q@^&>M_$&:RM?#/@NVU._BTW6;N^_<WNFVLIC.H2^
M9'%]F!,<O[N3F/R^37%_\$_?"^HZ/^S;I7B#Q##M\6>-[Z[\6ZU>"1?]-FO9
MC)'<8C/EQF2W^S?NXP .. <UYM\4_#]]^S=_P31M/!>FZ7#9^*M1T*U\,IH$
MTOVF6ZU/4I/+OXK94D_>RDW-U)&(\C]WGF,8KZ\^'G@ZQ^'/@/PWX1TV6::R
MT#3+73+9[D_O'BBB$49?CT2@#A_%'QF9OB)-\/?!6CGQAXWL;07^HK->&UTO
M1XI#F,7UV(Y3'),!)Y4444LAP21'%F2O!_B+XJU/X[_M:?!?X<ZIX=U#16\%
M7E]XO\2:3=8:V+V]O"FF:C:W/'VFV^U7$D8QY<F0_FQ1XP-O]E#7+'3?'O[3
MWBGQG?Q:7XMM_',\&JRW[_9FAT2VM8QI<DD/ CA\GSC'-@>: 3YDF,UY9X%\
M::_\7OC-^U5\8/!]KXHAU#PIX6E\&^#(KC1?+)N8XIIIHOL[PF2247L4<@CD
M_>?Z2!)'R$C /I"W_:"USXA:=K^L_"'P/:^.M$TF6XM(]7U/7#I%MK<L6 8]
M,D$$PN1YOF1&:7RHO,_U<D@\PQYNI?MB:'/\-/A#XY\,:3/K^C?$CQ78>%XC
M=2_8Y;(W$DT<DD@V2!S%)"T?E@X/_/3O7&?LN_!;X5I^RC\.O$-QJ6HMX;/A
MJVO]8BD\8ZD-$$OEB2_%S:_:OLOE>:;CS8GC\OB42#J*L?\ !0;1;/X?_LPV
M'BS1K6WL9?ACX@T3Q#H6E)%LL5EM[J*VBBDBCQB'R[@_NX_+Z#!XH ];^+'Q
MN'P\\:_"[PCI^CMXC\2>-]7DL([-KC[+Y%C#$9+Z_+F,QR>2GEGRL@R;\1]#
M5=_CI>^+/&7B+PQ\-?#EOXNU/P],MMK&KZEJ3:;H]M<9Q)91W,<-S)+=1CRC
M)''$8XQ(?,ECDQ&?+_V=[R']I[XX:_\ ';;=2>"=$A;PSX"2[MY(O,&0;_4X
MXY0<&63]S'+&8R8HY8Y8P0:Y7]A3X2Z1\1O@+_PDGB2^\36OQ#U+Q!J\WBZ'
M3?%.J:1LU@WTPD%S96MS%%#-Y8A)3RD./+SUH ^A?@W\?M)^*'PWUSQ-J$7_
M  BMYX;OKO3/$^G:E<QF/1;RUQ]JBDN<B*2./[_F@X\O!XZ5X-^RMX_M?@K^
MS;X%UOQ=IVH:Q\4?BEJUSKXT71##+J&NW=[+YGVJ*+S8X8HOLOV:60YCBB'^
MLQ(>>G_:\U[1_AO^Q)X@LOAEIN@Q6?B2SBT+PYH^CP(+;4O[2F".+&*VQYLD
ML4LTJ"+K]\YYK%\->"[/X<_MS_"[PG=O+)X=T#X2?V9X3EUK!,E_#<QQ7)M2
M1Y9NOL4:>;Y6)/*(S^[H ]-?]H#Q'X-^)7A?PA\2_ UOX8B\3S?8]%\2:%KG
M]HZ6;T+*_P!DN998;:2&:01Q^7&(Y/.\TX_U<F*?QD_:GMOA7\;O!WPQT[PG
MJ7C37==LI+ZZL](O(XK^UA\P16TD,5QY<=SYDGF^9B0&*.&663]W&37+?M 7
M!^-G[2WP@^'>DI)JFF>"=97QMXMNM/&)=(EMXC_94<DA_=C[1)))F+'F^7^\
M'EI^\J'X5:QI_P 0OV^OB[XB:ZC,OA;0;+P;HSVDH:&]C#"ZU,29SYDMM=36
ML<GED>5YL0D&7H ]/\ _'J\U3XJ:K\+O%WAN/PWXYL].CUVWM]/U$ZE8ZAIC
MR"(W,5R8HBGER[HY(Y8XST,?F"N)\/?M;7?Q*^,'Q#^'GP_\'_\ "2ZKX7OC
M92ZK+?SV6GQ21B(3_;I#:GR/WHEAB$0N9)3:RG$<>):P?A/K%A\2OVG/BG\=
MVNK5/A_X;T"'PKX=\2"3R=-OK6*22YU2Z,D@_>"&Y!C%Q&1"4$G^L/-5?V")
M'^'W[)%]\3_'.H:E9W7B>\U;QYXDO;ZV\K'F2%C<1PQQ\1RV]O'*-H.=_P"[
MX(  .L^'?[7W_"XM0N?#'A#P-J%Q\1M($D7B31]0NQ!IGAR[BF,<D-UJ4:2B
M02-')Y/V:*4R>6?,6(>9Y?4>"_VIO"WB+X1Z]X[\2RMX'B\)7MUI'BNSU*7S
M?[(U*WXFMA+$,77S21B,Q?ZSS$ 'F'RQYM^P[;77PM_9'N_B1X[N[F._\47%
M_P#$/Q-=S>5(%$H,IFBCMD'$EO%#+Y7)S(1C_EF/GR?PQJ%E^PK\+[KQI;F.
MQ^)OQ&T_Q%\2;NY<+:W.FWM[)+]JFEC/EV<4D<>G\Q&+R^.A)H ^KO%G[3?B
M'P+X2T_XC^*OAS/X:^&%Q+;_ &R\U+4P-=T>&X C2XN=,6$QC]])$ICCN9)0
MDF?*\P21#;^/W[1Q^"^O?#_P[8^%M1\;^*?%^JFP@T;2Y/*N#:QC-U<QD_NL
MQ9BXEDB&)<^8!')C5M_@MX T'7]&N-3_ +3U:_\ MP_L>W\7>([[5XTO8@9H
MYK6&]N98Q<QQQ2R"2,"41K+S_K!7G%]J"_$+_@H)HVFG3[?4=/\ AWX*N]3C
MU"T$A.G:MJ-U%#Y-QY<FP&2RB,D<<@!(EDDYP-@!V=A\?M3L?B_HO@;QQX,;
MP=>^*[&YNO"UPFIB^%XUL#+<VURL: 6]S%%Y<G'FPY,@CFD('F>1_&#X@?%S
MQ-^UM\./A[X<TS2X;+2(K_Q9J>DVGBVZL?MMDG^C6,M]*EB#&!,?^/6+[3'(
M>)!Y8$E=)^\^+'_!0[MJFC?"CP;_ -<1IFO:G)^#2B2PB_Z:1)CM)5#X1Z;/
MXP_X*&?'?Q!?:C//-X2T'0_#FF6JB-(H[&\B^VRY_=Y<^=%D$GCS9?1, 'U-
MH<FJMI5F=3MK2VU!HX_M,-K=&:)).=^R4QQF3Z^7'GT'0>6/\=+WQ9XR\1>&
M/AKX<M_%VI^'IEMM8U?4M2;3='MKC.)+*.YCAN9);J,>49(XXC'&)#YDL<F(
MS[97QK^PCXLT[PK^RS?>*/%,WV7Q=J'B?5K[QF&5OM?]N2W[0^5+;(,Q7#@6
ML8MHDR3)%B/,G(!Z#X _:PMOB!\4/&'AJX\*W_A#2/!ND?;_ !-JGB:ZBM)-
M(NO/E$=M+%S&\<EM#)="YBFDB\O'/(-:>@?'3Q1X\T.S\7^$?AMJ&K^ [HYM
MI[C4H[+6=2B)_=7-K92@1&VDS'()+JYMY#&9#Y7^K\WXMUB\UWXC_L._M/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M..9#S^5<_;_!GX?VNHZ[J=OX&\,IJ.NQ7%MJ]Y#I-N)=1CE;,T=R_E9E$O\
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MYY]JI^"?A[X4^'.ES:;X5\-Z3X9L9)?M,MIHMC%:PO*0/WGEQ@<_(/RKJZ*
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M^&;&27[3+::+8Q6L+RD#]YY<8'/R#\JZNB@#B/'GPD\&?$Z2P/C'P;H/BW[
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MB#5=<L-)T^UUO6#%_:-_:VL:7-YY0\N/S9.K^6"0,].WH<W_ (5)X+_X3O\
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M\S'E?N^O3VXKM:* ,#PSX8T/P;HEMHV@Z3I^A:/;G_1[#2[6.VMEYWDQQQ@
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MH/BW[ )/LO\ ;FG17PM_,QYGEB4'&?+CZ>@JS8_#_P ,:+X/E\(V'AO2M/\
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M+B66267)R230!L?\%$-_B+X%Z#\.V!@3XD^,]&\(C46Y;3C+<B;[28_^6O\
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M&OQ6\)_%SPW!X@\%>(M/\3Z++@?:;"3S/+DV*YBE YBE EB/ER8<9Y%>%?\
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MO=6T@EBGCD_U<B..""/3UJ#Q-XGT/P;HESK.O:MI^A:/;G_2+_5+J.VMEYV
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MQ_J]UJFCP:;<^(](UJYD32O#4?V61XY+7S(Q'$)8\RRD22<KSC&*XK_@G/\
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MO[9\LUX'^R'&?V>?^"?7A/6=>W7EEI/ARZ\3W":8/,D-K*9;\1QAS'^\\J0
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MT[:CX0\*-8_$[6-<A3RRKF/_ (D]MDY\J67S3+)#+''(80#&1S7V30 4444
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M<<D@ \TR>7'CJOA[\'= ^'$^N7]E%=7NN^()H[C6M=U"8RW^I2QQB-9)91T
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MDL80&263&8Q'7O=% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+]$T?Q#J7E+9:3J&HQ17=UYLIBB\J)SYDF9/W8P.N:[BOB+X!Z+!\&/!.C_
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M?Q^9FDT?Q/?1:'X3:Z!FD31K(F%Y(9) )(8KFY\R4VOEQXDBR?,SFMO_ (*
M75UJ'[.][X.TG5O['\0>.-6TOPOIDN^6**22ZNHQ+'+)%R(C;1W/F<<QY'?!
M /8;7XJ>#-0\1Z+HD/B_0I]9UBS&H:981:G$US?6Q#.)88@<RQD1RGS$XQ'U
MXXZ'6-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./\ UDCN>  /7TKX]_;,^&/A
M+X7_ +-'AKX;_#SP_8^#]9\0>,=#T?PM?:?&(O[.U<RQ^7>RW _?"3R;:2,W
M(\R7D=>:ZK28U^.'[;7C#2O$3-<^&/A#9Z9-I>A7#F:VN=9OHY+G^TR,@"2&
M(>5%')YGEY,D9C- 'T+X)^(7A3XC:7-J7A7Q)I/B:QCE^S2W>BWT5U"DH _=
M^9&3S\X_.O%?BE^VO\/_ (=?$KP=X*M_$OAC4K_5-3NK;6+FX\16]K;:!#;1
MYE-U)^\,<Q.(XXI!'YDF1YD>.>6\::+8Z?\ \%&?AK/X.L8+;Q'?>%M4NO'D
MD:>6UQI'[F.PDD,G$A^U1!/W7[W]V/,_=8%)H]Y/\2/^"D/B&9;>[N='^'/@
MJ'3)&OFC:&SU:^ECN/-MH_,)!DM3Y<DF ?W1C)QY>0#ZGT?7+#Q'I=IJ6G7E
MO?:;>11W-O=6T@EBGCD_U<B..""/3UKYN^*7C:Y;]LSX;^'+?Q-=>'O#_A/P
MMK/C'Q8+J_-M8W-A+_HML9.=DABF\R7][B.-,GK7U37QS\)= M_C?^UO\:O'
MVK.FL^&/"5_IOA+05FBCCBBNK)3/>Q2#RQ+)Y-U()1YA\HR>7(/,-M;21 'U
M/X9\3Z'XRT2VUG0=6T_7='N#_H]_I=U'<VS<["(Y(R0>>./>L;7/BMX,\(^)
M--\.:SXOT31_$.I>4MEI.H:C%%=W7FRF*+RHG/F29D_=C ZYKXJO/BY-\'8_
MVWOB9X7DN;/PO9ZI8Z9HTEE#%Y,'B06HM;Z86LG&1=W-K)+*8_WN"?WN,5Z1
MX>_9L\?3_L]ZC\'=2\->!]'M]?M)1KOC"75[S7+J^U&0 RZI):RVL/FW,LH$
M@,MS^Z_=8\P1"*@#[%KE/&WQ"\*?#G2X=2\5>)-)\,V,DOV:*[UJ^BM87E(/
M[OS)".?D/Y59\(^'%\)^&-&T,:C?ZLVFV<5M_:&I2F:ZN/+C">;+)C]Y(<9)
M[DYKYE\1P>(OV<OVB_B;\8/%GAZX\3_#K7-.T^TMM>T23[7?^$;*V$8N?-M9
M,2"UDEEDN9?LIE_X]C))'DY !]-?\)5HO_",?\))_:]A_P (S]C^W_VO]J3[
M)]F\OS?/\W_5^5L_>>9G&.>E6M'URP\1Z7::EIUY;WVFWD4=S;W5M()8IXY/
M]7(CC@@CT]:^1_VWKK2=#_8]M?!'PMLK6SC\>ZA8^'?#D/A)[:TLI3>2_:64
M.DD<7E7,4<HXXD\[!XD./3?VLO'5E\#_ -DCX@:AI45QH5OIN@MI6D_V"!;?
M8))0+2T,6WR_*$<DL7^KYC"<=,4 >JV/Q \,:UX/E\76'B32M0\*Q0RW!UJU
MO8Y;$11G][+YP)CQ'Y;Y.<#::O\ AGQ/H?C+1+;6=!U;3]=T>X/^CW^EW4=S
M;-SL(CDC)!YXX]Z^+?V;?AH^K?'6+X<>(K?3SH/P%\.Z%#!H5JF[3[SQ#>VI
MN)=7 Q'^\C_>)'YL<A!D,H,<A->Q_M9^.+3]G?\ 9_\ BC\5/"NA:?:^,)[*
M""35[>UBANI)GECM;6::0QGS?L_FY$<H.?+\OC.: /8K_P"(7A72?&EEX2NO
M$FE6GBB^A%S;:'/?QQWMS%B3]Y%#GS)!B*3D#_ED?0U=\3>)]#\&Z)<ZSKVK
M:?H6CVY_TB_U2ZCMK9>=@$DDA '/'/M7G7P^_9T\*^"_@_!X!U;2[#Q5;70^
MTZ]/K%JMP==U,[7EO[H2F7S)))8Q)^\\PC$8'^K%>"?#F\\;?%[]I;XH_$;1
MM!T/QAIG@W69? _AJU\5:Y/IDNA3V\40U26VCAM+F,BYED_UI/F^5%Y?"?NZ
M /L#PSXGT/QEHEMK.@ZMI^NZ/<'_ $>_TNZCN;9N=A$<D9(//''O63_PMOP7
M_P )W_PA7_"8Z#_PF.?^1=_M*+^T/]5YW_'MGS,>5^\Z=/;FO'=&_9[\4:#X
M7^.E[IWB.UT?QE\1XY+BVL-)>6UTO0]0-AY4<L4@'F&;S2));L1QR2F..3RH
M\8K"_9]'AWPOX?\ AS\"_B%X!T_POXQ\-6D5_H1O+6VNM,UNYLFD234M,E'_
M "\X'VF1)(XKF/[420>9* /HGQM\0O"GPYTN'4O%7B32?#-C)+]FBN]:OHK6
M%Y2#^[\R0CGY#^5<Y\1OC=X*^%OPONO'^L>(+'_A'&L#=V4\-]$?[3'DM-%'
M:F201RRRQQDQ@']Y]*\1\1P>(OV<OVB_B;\8/%GAZX\3_#K7-.T^TMM>T23[
M7?\ A&RMA&+GS;63$@M9)99+F7[*9?\ CV,DD>3D9?[;UUI.A_L>VO@CX6V5
MK9Q^/=0L?#OAR'PD]M:64IO)?M+*'22.+RKF*.4<<2>=@\2' !:_99\2:7\1
MO".F_%[Q;\8_[1\8QF3Q#XATW1/%C'0=%M9[:6.WL;FQW^5;Q10_O#YH\P7$
M,I,LF#GZNT?7+#Q'I=IJ6G7EO?:;>11W-O=6T@EBGCD_U<B..""/3UKY<_X*
M"WDGA/\ 97D\ ^#;&[L-3\9:IIW@G0+#1_*M(8VED&+;EXQ'!)%#+%QQB3!_
M=Y([C]K+QU9? _\ 9(^(&H:5%<:%;Z;H+:5I/]@@6WV"24"TM#%M\ORA')+%
M_J^8PG'3% '&_ME?%?\ X2+]G?1K;X9^,/+UOX@>)=,\+^&O%'AS4]L$-S+=
M9>1KJWR1'_HTT<GE[R.F*^M:^'='\$OX7^+'[*OP/@M-+U"#P+X?N?%7BK2;
M.VC%K!=16HM;74(S)&#*3?276/+_ 'GF2>;(. :^KOBMX[7X;?"WQAXQ%K]N
M;P_I%[JGV7S/+^T?9HI)?+W]L^6: &^//BWX,^&,E@/&/C+0?"7VX2?9?[<U
M&*Q%QY>/,\LRD9QYD?3U%=M7S/\ LF?#>T'P#TWQ)XK$'C+Q/\3-/AUWQ5J]
M]:+_ ,33[5$9([:5&)'DPPRBWCB&(L XC3S"*\&^$/CI/AO_ ,$]?C5KVD:M
M<:)\/[?5?$D7P[U"V,J2PZ?-*8;$QM_Q\(?MLLOSR_O1P3@8P ?9^C?&[X>>
M)]4TC3=%\<^&M7U#5HI;C3+.PU:WEEOHT,GF20H),R &.7) X\J3G@UU6L:Y
M8>'-+N]2U&\M['3;.*2YN+JYD$44$<?^LD=SP !Z^E>4_LF_"H_!3X!>#_#F
MH177]NPZ=;2:Q->.DDIO?+B$D1EC&)!$!';1\G$5M#'DB,5PW_!135+P_LT:
MQX7TF\N(?%'C34M-\-:'!;S>4;ZYN+I-UMYG2,20QW )D(CQP30![=X=^+'@
MOQEX@_L;0_%^@Z]JPLH]0:QL=2BN+E;>3RWCF\I#GRB)8B),8^>,YY%+KGQ6
M\&>$?$FF^'-9\7Z)H_B'4O*6RTG4-1BBN[KS93%%Y43GS),R?NQ@=<UY5\<O
M$UG^R7^R'XIU+1+S4OMV@Z0(+/5)EBN;R34;B3RH[VY$@$<LDES-YLLA'[PM
M*>3Q7#^'OV;/'T_[/>H_!W4O#7@?1[?7[24:[XPEU>\URZOM1D ,NJ26LMK#
MYMS+*!(#+<_NOW6/,$0BH ^IO$WB?0_!NB7.LZ]JVGZ%H]N?](O]4NH[:V7G
M8!))(0!SQS[52L/B%X5U;QI>^$K7Q)I5WXHL83<W.AP7\<E[;18C_>2PY\R,
M8ECY(_Y:CU%?+'[8WA6YU;P_\ /@A8Z_K&K:AK?BJQ6Z-Z\5S<:GI.FPF6^N
M+HRQFWN3&/)D,4T9$DB@B*3I3OVB/ OAWX>^)/V5_ ?PXTF#0-9L?&\$FDVN
MGYBFAT:WAEEUC_2#SB2.2(RH9-]QGGS3F@#L_P!J7Q)K,GQ9_9^\!>%]6U#0
MM8U_QB=8NI(+F6WMKK2].A,M];3&,Y?S1*F(\>6Y'SXP#7J?A"[NI?BG\0(Y
M?B+I_B.WA^P^3X1M;:WCN?#@:+)\UT)E?[3GS1YH&,?N^*\@L-8?XA_\%!KZ
M"&*VUC0?ASX-^SR&X@0-I.KZC<))F,N/,+2V,0'F1_NPN4R"Y!^=M%\<:ZWP
M<\7^*/"^JW&FZE\=OC,_AKP_X^B8-?6^C2S?9[>8>9^] BCMKJ**)S$\7FYC
M\O@T ?H/8?$+PKJWC2]\)6OB32KOQ18PFYN=#@OXY+VVBQ'^\EASYD8Q+'R1
M_P M1ZBKOB;Q/H?@W1+G6=>U;3]"T>W/^D7^J74=M;+SL DDD( YXY]JYSP_
M\&?!'A7PKX9\,Z?X1TI-!\/3QW6E6,UO'-]AN8\^7<Q>9G$H+R'S?]9E^N37
MAG[/]N?C9^TM\7_B)JSR:IIG@G66\$^$K74#B72);>(?VK)'&/W8^T221XES
MYOE_NSY:?NZ /HB'X@^%KB?PW;KXBTN6;Q'&]SHL2WL;G5(DC$ADM@/]:!$1
M)F/H.>G->$ZA^W5\,K;XX:/X%LO&/A&[T:71YM9U3Q5=^*+6.PMF\T1Q6T)&
M\27!8$F,R1>7&3)^\Z5R7PW\#:'K'_!1CXDZKH.F16%AX-T& ZE;2+Q_PD&I
MM'))?VL1S''YEE;I#+)^ZDD(/$F3)6A^S)?7'Q"_:L_:0\>M9W<^EV.JV/@G
M2;_4/+EEMS91N+^UBPY,4)F:*8] _F _ZS. #Z5\;?$+PI\.=+AU+Q5XDTGP
MS8R2_9HKO6KZ*UA>4@_N_,D(Y^0_E6GH^N6'B/2[34M.O+>^TV\BCN;>ZMI!
M+%/')_JY$<<$$>GK7Q;^RWK'Q&^)2^)_COI/AKPWXH/C;5+R/1-4\1>)+G3]
M1TW0K>ZDAMM-^SQ6%S%$ \4DA\J3]Z\@,F\CGZ*_9W^";_ +P-?:"=975%O-
M9O-7\BUM?L-A8FXE,GV6QMO,D^S6T?:/S'Y\P]\4 >@^)O$^A^#=$N=9U[5M
M/T+1[<_Z1?ZI=1VULO.P"220@#GCGVJE8?$+PKJWC2]\)6OB32KOQ18PFYN=
M#@OXY+VVBQ'^\EASYD8Q+'R1_P M1ZBOFW]NRSF\?7?P5^$^GWES%?\ BSQM
M;75S91K&1<Z39QR37\D@FC-O((@8I/)E$@D./W<F,5F?M$>!?#OP]\2?LK^
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MOKCXA?M6?M(>/6L[N?2['5;'P3I-_J'ERRVYLHW%_:Q8<F*$S-%,>@?S ?\
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MC?MW? SP)!97=_IGA73]2\::U;711;(K)$;2PN?*+YDEBN@>?+S'YV0?]9@
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MA37_ (D^++?Q?\0Y=!37;;19M;$FJ:G'>W4DEJ/])/FD1QRQQR2@2>6(I?\
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M X!]D6'Q"\*ZMXTO?"5KXDTJ[\46,)N;G0X+^.2]MHL1_O)8<^9&,2Q\D?\
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M4/#,&J:+KN@ZV8SY=[)X=U6/4K:WN?+R\?G1^F_/1#C![U\]?MQ7=QXN\9?
M3X3V5G<ZM)XH\;6VJ:GI[;/L-[I.G?OKZ*X\R0"0 21R"+!SY)[B/-KXQ8^-
MW[6_@_X-:N G@;2O#LOCO6=*D/FVWB&7[4+6TMI8QC]U#*HN2"9(Y#@21<9H
M ]_\!_%OP9\3I+\>#O&6@^+?L(C^U?V'J,5\+?S,^7YAB)QGRY.OH:[:OD7]
MJW1[2W_:&_9NU3PO9V\?Q4NO%/V-;KRQYLGAZ*"5M5C\R3]V1''*"/\ EH/,
MD\KDR5]=4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XYH/P1-C^T1XI^+
M&JZY_:=[J.D6NA:/:+;^5_8UC'E[F'S!)_I(EN")<R(#&1@<&E\*_!1_#?QZ
M^(?Q/N=8.M7?B6QL=.TVUN[,F31K>WC/FPQ3&0_NI9<2F,",;P3R>:]BHH \
M'C_9MT[4OBQ\5_%?BK4SXFL/'6D6OAV/2KF$Q2:5IJ12Q7-I%<^;YGE7,DOF
MD1>7AP#R>:YAOV7_ !;J'P2U/X0:A\3VF\%Q:5<Z/IIM=%-KJ<<!CDBM(KJY
MCN1'<111F/,<4=L9?*C$A\MY8I?I^B@#YJU[]D6RU_\ 9R\!_!J/68=.\+:+
M-IO]OQVNFA5\0VMLWF7,6V.0&U-S+MF,D;F0$D<\Y['X\?!-OCQH/AG1+K6?
M[.T?3/$EAK.I:?-:"YM=<M;9C(UC-%Y@!CE/ED^9YF/+!\L\5[)10!XC\8/@
M??\ Q#^(WPW\?:#XEMM"\4>")+\63:AIYOK"XCO;;R9?-BCFB?/"%,2CIT.:
MYO6/V6;OQQ\:?AI\1O&?BNW\2ZOX/EOI9-*&D>7IA\V(1VQMK:2YD^S&*2/S
MO-)EEDDQ^\2..*.+Z2KE/&WP]\*?$;2X=-\5>&])\36,<OVF*TUJQBNH4E /
M[SRY >?G/YT ?/?[#JGQHWQ=^,4ZB_?QWXQN3I&M?<-[H=E_HMA^Z'^K\K%Q
M'^\CCE./WG:NXUKX%:WHOQ>U[XA?#OQ3I_AG5_%%I;6OB6PUG2Y-4M+Z6W'E
M6MRGEW%O+#)'$98^)/+<8/E^8-Y]WHH ^?\ X._LOVOPJ^,_Q+^(\VMW'B35
MO%<-A +K5+99+^V6"+;/_I /(GD$4OE1QQ1Q^5'''&$CC J_#K]FK7/A7I-W
MX(\.>.&TWX5->S26VB6VG/'J]A:ROYLEK%J8N1A#(9/WOE&X$<I E$GERQ_1
M5% 'CGQ]^",GQMT3PHMOK?\ PC^L>%?$UAXITV>6T-U;?:K7.V.:/S(C)&1)
M)GRY(^W/','Q@^!=]\>_V?\ Q#\./%_B.V@N]7B&[7=#T_[/&DL=SYT9^S22
MR\9CC$@\WY_WF/+R,>U44 ?+OQV_9G\<?M&?"K5?!GC+XDZ?:1WC0FRD\.>'
MIK&UB>.>)_,N8I+V4W/$>R.+S8XQYID*221Q&+M;O]GFSN_CIX)\<F^M[?P_
MX*T*?2O#WA>TL1;1:;<2E8Y;F.6.3&/L\?D^3Y7EX&1S7MM% 'CWQ7^")^*G
MC#X9W^IZX8?#7@[5Y-<ET%K?<=2OHXR+&7[2)!)&;=S))CD2YQ(,"FZ#\$38
M_M$>*?BQJNN?VG>ZCI%KH6CVBV_E?V-8QY>YA\P2?Z2);@B7,B QD8'!KV.B
M@#QWPK\%'\-_'KXA_$^YU@ZU=^);&QT[3;6[LR9-&M[>,^;#%,9#^ZEEQ*8P
M(QO!/)YKPZ/P;I/P3_9P\5WWA7XTV]E^S]:Q7][92>&(;>76+*&0DR65AJYN
M?*+&Z\R./S(I)1YOEB7S!')']IUYI_PS[\+_ /A*?^$D_P"%;>$?^$C^W?VC
M_:W]A6WVO[7YGF>;YWE^9YGF_O/,ZYY]Z /E+X&_#7Q/\!?V(?#OPV\-:-<P
M?&'XC0W<GDVEY+92:3+<Q8.IW)D'F6PL;?[)'(8H_P#CX\J,9DE$A^UO"/AQ
M?"?AC1M#&HW^K-IMG%;?VAJ4IFNKCRXPGFRR8_>2'&2>Y.:Z*B@#Q/Q]\!;S
M5/BII7Q1\(^)(_#?CFSTZ30KBXU#3CJ5CJ&F/(91;2VPEB*>7+MDCDBDC/42
M>8*M>%_@RS?$2'XA>-=8/C#QO8VAL-.:&S-KI>CQ2'$AL;0R2F.28"/S9999
M9#@ &.+$=>Q44 >-_"?X(CX>>-?BCXNU#6&\1^)/&^KQW\EXMO\ 9?(L88A'
M8V 02&.3R4\P>;@&3?F3H*]DHHH ^?\ 2O@=XL^&/BCQAJ?PX\7:1H.A^*]2
M;7M1T37_  _+JHAU*7_CYN+>6.ZM9,2XC)BD,F#'^[V#]W78_"GX,Z5\)I=?
MU"UN]0U[Q%K][]NUOQ#K+)+?:E(,^7YDB1QQB.*,B.**-$CC .!DDGT^B@#P
MGX2_ W7/A!XT\876B>)-/NO!WBGQ->^)M0TO4-'D?45NKF*+S4BO8[D1B(2Q
MYP;<G *9)/F#5_9U^!8^!G@O4-/O=;/B;Q)K6K7FO:YKWV;[+_:-]<3%I)?L
MWF21Q83RHL1X'[O.!FO8:* /G/1?V2]&O/V>]>^%?C?5E\42>)+Z^U7Q!KMC
M81:;<7]]<W1N1<F.+($D9\G!.1B&,8\O]W75>$_!GQ<LYM%MO$OQ*T35[&W:
M-;VZTWPF;&_O?*YR97O9(8_-*XDV6W223R_*/ER1^Q44 >.>(/@K_P )-^T)
MX1^).K:T);/PGI-W8:1H/D[1:WUU@7%]]H\P>9FVS%Y4D9'!<8->QT44 >.>
M(/@K_P )-^T)X1^).K:T);/PGI-W8:1H/D[1:WUU@7%]]H\P>9FVS%Y4D9'!
M<8--^,'P/D^(^N^#_%.BZS_PC7CKP;>S7.BZU);?;;;RY@(KNVEMC)&)(Y8L
MQ_?CDC)S'(.<^RT4 ><^"M"\?6NK3W?BWQGINLVRPF*WT_0M!?381D\RR^;=
M7,DA'E_)Y<D8Q+)O$G[OR^"TG]GWQ!\/_&/C2^^'GC:+PUX=\7:E_;&J:5=Z
M&+^YMM0D&+NZL;HS#RS(!$=D\5S'')'D1F,F*OH.B@#YT^"W[+7_  H[2_B3
M'X<\3,/$'BGQ'<:Y!K=U8FXN+:,LDD-E=/+)))=1#:_F2&1))!<RD-%(?,&O
MJ/[/VN_$C7?"U]\4?%UEXDM?"NL1:_I&F^'=(?2+=[Z,2"*6Y\RYN9)/*\P&
M/RY(AG/F"7@#W2B@#PC6O@5K>B_%[7OB%\._%.G^&=7\46EM:^);#6=+DU2T
MOI;<>5:W*>7<6\L,D<1ECXD\MQ@^7Y@WG<^'?P4M/"/C;5O'.LZK<>*?'VN)
M':W>LW<7EK:VJ9(L;&(?\>UJ) 9/+S(Y)S++*0)*];HH \>_9U^!8^!G@O4-
M/O=;/B;Q)K6K7FO:YKWV;[+_ &C?7$Q:27[-YDD<6$\J+$>!^[S@9K+^"_P&
MU3X,?!3_ (0[3?%_VSQ?)=S:G>>+)M+7S-1OI+GS3-=1/(YF+ 1Q2$R^88Q^
M[DB/EE/=:* /GWQ-\&[_ ,57&@>(/C%XTTN^T+P3J*>*;.#1]._L2PBN[>.3
M%Q>R37-S(1%DR#RY8HQB3S!*, 6_V?;;Q9KFK>-_'WBM/$'AY?%][:SZ-X0U
MB_:4:3IEO;B*,FVQBVN;@B666('@-&#^\C>O=Z* /-?V@OA[J'Q>^#OBCP7I
M7B'_ (1>[UVT^PR:F+(7OE0N1YR>42 1)%YD?7_EIQSBL#XN? ./QQ^SC>?"
M;PKKEQX(TYM.M='M+ZW5[O[+9Q-'^ZYEC>0211F$_O.DASFO::* /'OCA\%3
M\7/@'J_PQ\/:R?A[9WMG%I]O=Z7:?N[6VCDC_<I%%+&/*>*,Q>6#CRY,>U4_
MB=^SO!XOO/ FL>%;Z#P+XE\!R$>&[N"Q%Q96]M*GDW-K):>9&#%+"%C_ '9C
MDCP/+D'(KVVB@#YMUC]EF[\<?&GX:?$;QGXKM_$NK^#Y;Z632AI'EZ8?-B$=
ML;:VDN9/LQBDC\[S2999),?O$CCBCB\C_:H^$O\ PV9^TEX5\ Z%K^H>&[#X
M;VMR_C35+5C'*D.J0Q>78VQ_Y:2RV\4OF<>4D<O/F',1^[JYWPWX3T3PO]O?
M1M(T_1VU.\DU"]_L^U2$W-S(09)92G^LE..9#S^5 %K1]#L/#FEVFFZ=9V]C
MIMG%';6]K;1B**"./_5QH@X  ]/2O-OBO\$3\5/&'PSO]3UPP^&O!VKR:Y+H
M+6^XZE?1QD6,OVD2"2,V[F23'(ESB08%>PT4 >-_$[X*R?%#XL?"SQ-=ZOY6
MC^![V^U!_#LUOYMMJ-U)%Y5K,1YF(Y;8DRQR&-R-YQY=9FM? K6]%^+VO?$+
MX=^*=/\ #.K^*+2VM?$MAK.ER:I:7TMN/*M;E/+N+>6&2.(RQ\2>6XP?+\P;
MS[O10!Y)\._@I:>$?&VK>.=9U6X\4^/M<2.UN]9NXO+6UM4R18V,0_X]K42
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MK2^'?$ECK!TNP\/R1Z-=VL?F>;;26LMU+ODE\S!EDDD\N.,".*/S9?-^H**
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M_P ,ZOXHM+:U\2V&LZ7)JEI?2VX\JUN4\NXMY89(XC+'Q)Y;C!\OS!O/N]%
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M5\)>*]-T3Q"GAI_"]S;:QH\FIVLMJ;D7*21B.YMI(Y?,$F3O<$$<#&:]ZHH
M\<T'X(FQ_:(\4_%C5=<_M.]U'2+70M'M%M_*_L:QCR]S#Y@D_P!)$MP1+F1
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MDU".;2_'WAQ$:.(SP:EX5EN!'=",)(;?R[^(QPG'F>5+YLG[R0>=C8(_6**
M/E3Q=X!F^"?PI\0^ /A>=8\0?$;XF:KJEPNK76I1VMREY=1#[5K5T\4<8MX;
M7,0_T:(?O/LT8 DFS7T3X1\.+X3\,:-H8U&_U9M-LXK;^T-2E,UU<>7&$\V6
M3'[R0XR3W)S7144 >.>(/@K_ ,)-^T)X1^).K:T);/PGI-W8:1H/D[1:WUU@
M7%]]H\P>9FVS%Y4D9'!<8-%]\%&UK]I;2OBG>ZU]LL]'\.3:-8:%/:"2.RNI
M;GS)+Z*0R?NY)(OW)Q'DQC_68XKV.B@#QR^^"C:U^TMI7Q3O=:^V6>C^')M&
ML-"GM!)'974MSYDE]%(9/W<DD7[DXCR8Q_K,<5S'PZ_9JUSX5Z3=^"/#GCAM
M-^%37LTEMHEMISQZO86LK^;):Q:F+D80R&3][Y1N!'*0)1)Y<L?T510!\^?
M/X2^'OV*?V<7T:_U2&\L?#\-]J^L:]!IQMC<@&262:6*,RNYCA,<?60XB7T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\7:+^SA\=[Z\U-O$NJ_"?6?$>AZ5J6LJ9;B^ATZV,MO]NDC,?FR= \O[O?\
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M6HZY?C-C87?F<2B2&/,1CC_=RR 9)/ET ?:5%?!UUK'C/XB?!U=4_M/XL/\
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M[=>*;#P7+KD>I:7IT]M'>D7MB(HY(_M$L41 DCP^9 ?WF<'FOI*B@#Y?\9>
MO%VD?M(^%?C=HWA+4?$5M>>#F\)ZOX8AN;*WU33";C[:ER#)-]FN/WF89$$H
MP2)(S*.![)X'\4:_XJCO9[[P;J?A*UC,45O%JU_:27DKY/FGR[:26..(#R\'
MS?,)\T&./RXS)WE% !7R=^R;X7^(?P _9[A^'&I_#N_U#Q#X6LM7GLKJ'5;&
M+3-;F^US36\,,GG&:/S/,C DFMX]G.??ZQHH ^=_V9/A=XG_ &<_V/\ PSX6
M.F_V_P",M&TFXOSHOVB.V\V^D>6Z^P^=F2,?O9/)\W)&!YE>61_LF>*/"O['
M_P $_#/A^U,WB[X<ZMIGC:7P_J%U'C4;Z-Y;BZL!=1_NXLRW,J1R8D'[N,'O
M)7VW10!\<_M4>!_BQ^U!X'T'P?8^%-1\)^"M4\1Z7:^*K.^N=._M>731*99[
MF-XYI88HXC%#@ R2RR9_=QQQ?Z1Z5^VO\(M;^.?[,7C;P7X62VEUS48[=[:*
MX?8)?*NHK@IOSP7\K'7'->^44 <MX/\ $NJ^)-(FO+_PIJWA&XC?8+'69+*2
M63I^\_T:XE3'_ \^U>*^/OA[XK\'_M1:3\9O#?AVZ\:Z==^%Y/"&J:)I]S;6
M]_98NC=17<)N98XI5,G[J2/S8\9$@\SD#Z3HH ^<_P#A6OB/XL?'CP7\4/%>
MDGP?H_@BRO8]!\/M/%/JEQ=7T?DW4E\T326T<8CC'EQ122$^9YDDD?\ JAA>
M&O"?C;X2_M/_ !J\:1> =6\::!X[BT-[*;0+[3E-J;*UEMI8[A+JYM\')R/+
M\P8Z\\5]4T4 ?'_@OX9_%G3?VD?B[\7_ !9H<>M:M;>%[;1_!FE:3?P6UC?1
M;3=3V!ED'FCR[J..,7,PB\SS))/*$9$<7I/[''PCU+X#_LU^!O!>LC&MV%DT
MU]"H ^SRW,TMU)"/+DD!\II6B\S/[SRP>,@#W>B@#B_BMX[7X;?"WQAXQ%K]
MN;P_I%[JGV7S/+^T?9HI)?+W]L^6:^6OV6_^%E?"G]D+X?>&/!?@/_A*=6OM
M(M]3TCQ!=:A;V^D0?;Y/M)-[&9?M(^S&XES'%')YL<41$D<DIBB^F/C+\,[/
MXR?#/6_!-]J>I:3INLJMO=7.BS^1<^4)09(P^T_+( 8Y!CF.20=Z]!H ^+?B
M=^R+K6E?L5^'_P!GKP:UQXA34-2L;+5=>NI(X_[,M?MXO;N^\DD"0"0<6XD\
MS$N/,D\O)]H_:S^"][^T%^SYXQ\ 6&H6^EW^KI UM<7"AXO,BNHKB,/[.8@G
MMGOTKVJB@#YG^(6I?%#X]_"O4?!"?#:X^'=_XDTXZ=JFJ^(]0LK^QL;>XC$5
MV;7[%<R2W,JI))Y7F);1G&7D3'ER4?B!\ -6\&ZS^SYXH\#6-UXJM_A'!-HX
MT":XCM[_ %*QN;2*Q,L<K^7%YL21>88W\N.3G]Y'W^IJ* /CKXR_#CXM_'SX
MP?!"]FT;_A$/ASX?\1?\)%J.GW?V:XOX)K+$EK)<>5<D?OLRQ1Q6QE\L'S)2
M3)Y473>-_!_C+PC^V-IOQ:TSPIJ'BSPW<^!'\,2VFD75E'=6]R+X76^074T,
M?EE#CY),YCKZ?HH ^2(_A7\2OB+^V%X+^(7C33_[)\!>%O#E[>:)8VMS;F2R
MU.ZE^S2VUR09))9#;8F/E?NHY!'%')((S+,[]F[P+\2_V?/A?9_!^W\*F_;1
M;ZZBTSQ[+<6IT:2VEFDN/M,UKYXNDD3SI(S;1Q_.\2_Z0D<GFQ_6M% '@?[:
M_P (M;^.?[,7C;P7X62VEUS48[=[:*X?8)?*NHK@IOSP7\K'7'->I^#_ !+J
MOB32)KR_\*:MX1N(WV"QUF2RDEDZ?O/]&N)4Q_P//M74T4 ?.W[0'PQ\1ZE\
M5/@]\4O#&FMXENOA_>7\=SX<BN([:ZOK>_ACMY9(992(O,B'[SRY#&).?WL9
M SU'B+0O$WQK^&/CS0-;L?\ A!+'Q%I5QHUC;7@CN[^W\Z&:&6XNO*E,760>
M7%%(>(LF7][Y<7L-% 'R5X;7XW>'?V:[3X<^'? K^'_'GAGPV=*L_$EY>V5[
MIEW+:VYAMI;2/SA*9+CRXR!<Q11Q>;(9#+Y7E2\9XD_9=\6C]@7P1\!M"T:X
M>[U273+;Q#/<7=O(?#XDN_M]]<CF-+H0RAHQ'')R",$X.?NBB@#YT_;/^%GB
M?XV?"_1_ &AZ>U_H?B#Q'I=IXGGCN88;FQTB.;S;FYA,AP908X1C$A.?]6>:
MK^/OA[XK\'_M1:3\9O#?AVZ\:Z==^%Y/"&J:)I]S;6]_98NC=17<)N98XI5,
MG[J2/S8\9$@\SD#Z3HH ^0+KX:_%OXH?ME> OB)XEM(?#OP\\(Z%?7.F6$?V
M:2:VO+H26LMM<2B7>93%Y4TDD0,49C\F,R<W$ESPO^SSXF\7:U^U1J/B5?\
MA$/^%FE?#NFQ_NKXQV-M8R64.I'RY.?-\WS/)/EF/RL$\YKZSHH ^2O#:_&[
MP[^S7:?#GP[X%?P_X\\,^&SI5GXDO+VRO=,NY;6W,-M+:1^<)3)<>7&0+F**
M.+S9#(9?*\J7CM,_9+\;>$_V/_@IX9L8H-3\8_#O7;'QJVB7,RVWVZ[CEGNI
M=-^T R1Q8^TR1";F,F(=!(3']S44 ?'/[5'@?XL?M0>!]!\'V/A34?"?@K5/
M$>EVOBJSOKG3O[7ETT2F6>YC>.:6&*.(Q0X ,DLLF?W<<<7^D=[^US\,?$_Q
M+T;X77OA;3#K<W@_QYI'BF\T^&XBAN;BWM3)YD</FF./S")<@221C@\U]$T4
M ?-/[17PY\7?&KX<^"->T+09K#Q3X0\567C*V\*ZS=V\<FHFQDE'V4W,4LL4
M1ECDS'+\XSY8DV9)C]&\/>.O$_B;7;2SN?AGXB\+60+/=7^O:EIRQB, \1QV
MEU<R2R&3RQAQ'&(Q(?,X$<OJ%% 'CGB7QAXEU)M7\+S?!_4O$EO<":P^T7&I
M:<='NH9"1&+GS91<"/8?WN+67&)1&+CY3(?LO_"[6_@C\#/!G@3Q'K?_  D6
MK:%9F"XU'S)/+YD>18H]_)BB!$,? _=Q#B/[@]CHH ^9+/P7XQ^#?[2OQ(\=
MZ3X0U#X@>'OB)9:7),=)NK*WNM)N+&$6_E21W4T4<L<L<GF"6.3(,90Q_P#+
M0T?@U\)?B+<?M9_$;XH?$:""!?[#L?#GAC^S'B:Q^Q2'[5=18XFE\JX  FD\
MOS=\C>5&#''%]4T4 ?/'[/WPR\2Z+\</CQ\0_$6E'0SXNUBQLM.LVGBN3-8Z
M?:^3#?>9&>/M DSY14&/9@YK+L_!?C'X-_M*_$CQWI/A#4/B!X>^(EEI<DQT
MFZLK>ZTFXL81;^5)'=311RQRQR>8)8Y,@QE#'_RT/TW10!QW@K5M;UW3Y]0U
M+PW=^&)I)#]FTW4KZ.:Y"<?Z[RFDBC)D\WB.20>6(CD$^7'4\<>*-?\ "L=E
M/8^#=3\6VLAEBN(M)O[2.\B?(\H^7<R11R1$>9D^;Y@/E 1R>9(8^\HH ^=O
MAK\+?$MU^TKXG^+]]8#P/H^L>';;1W\*O<127M]=17!?[??_ &<FW$D<>(HL
M27!\N3F2+F.N3_9N\"_$O]GSX7V?P?M_"IOVT6^NHM,\>RW%J=&DMI9I+C[3
M-:^>+I)$\Z2,VT<?SO$O^D)')YL?UK10!^>=_P"&_%/[-?\ P3;^+NK^/K&Z
MN/B!XPEU.^\26LES;[4OM4N!8F5/LP,>/*DAF\L'D\?N\XC^KO\ A2(_X9=_
MX4Y_;C;_ /A#O^$1_MO[+Q_QY?9?M/D^9Z?O/+\SVSWJ;Q=\"=*^(?C31];\
M4ZKK&N:=H^I6NM:3X=E-O%8Z9?V_^JN8Y(H8[B0@[_W<LTD?[YOW>-FSUB@#
MYK^#>L?$OX<_"GPGX"OOA%JUQJWAW2X="_M:VUG3?['NVMHQ;Q7'G&Y%S'#*
M(XY#_HIECR1Y<A'/TI110!\R6?@OQC\&_P!I7XD>.])\(:A\0/#WQ$LM+DF.
MDW5E;W6DW%C"+?RI([J:*.6.6.3S!+')D&,H8_\ EH:/P:^$OQ%N/VL_B-\4
M/B-!! O]AV/ASPQ_9CQ-8_8I#]JNHL<32^5<  32>7YN^1O*C!CCB^J:* /G
MG]CCX;^(OA[X#\8ZKXLTS^P/$OC7QCJ_BR[T#[3%=?V8;F3$=O\ :(B4E_=Q
M1OYG'^LQ@5Y!HW[(_C3XD?L7?$;P=XF^R^#OB7\0M>OO%>KVLCI=6%E?M?I+
M'%%Y1D(BDCM8<GS)7C\PGG_5U]RT4 ?('[0UY\=OC?\ LZ>)=!\)_#BZ\#^(
M[_3X;>^MM;U33KK[;YQCCN+6Q>.Y\O'ER7!-Q-Y?$:".+S)?,M_HOX4^!%^&
MWPM\'^#C=?;F\/Z19:7]J\OR_M'V:*.+S-G;/EBNTHH ^9+/P7XQ^#?[2OQ(
M\=Z3X0U#X@>'OB)9:7),=)NK*WNM)N+&$6_E21W4T4<L<L<GF"6.3(,90Q_\
MM#Z!KWQ8UCPQ\(/&GQ!UCP9=:--H>FZAJ5MH>I7\1NI8;:W,A662(2Q1&22*
M3'ER2_N_+<G),<?K=>3?%_X%Z9\;K6;1_%.L:O=>#[B.**_\*1FWBL;[RY/-
MCDDE$7VH'S/*/[NXC'[H#'^LW@')_L%^"_\ A _V//A5IWVG[:9](CU3S/+\
MO'VV0WFP<GA/M&SWV=NE<C_P3OW^(O@7KWQ$5C GQ)\9ZSXN.G+RVG&6Y,/V
M82?\M?\ CVSYF(_]9TXY]N^*/PW7XH::=(O=<U>QT*XCFM-6TFP6W\K5;:4>
M5+%+))$\L8\OS1_H\D4G[P\YQCI?"_A33O!'A71_#NCVYM='TFSBL;.W\POL
MABC$<<>7_P!D ?A0!\V?LW:)XY_9>^%UO\+[KX7Z]XRM_#]]=1:=XC\,W^F0
MVNI6LL\EU%+Y-U>PRQ2CS3')'B0?NL^9(#75?M+?"KQ?\4/ 7@C4=)L-.NO&
MO@SQ)IOC/_A'9+W-MJ,MLL@DL8KJ2,>7O,DGERR1XR%R(\DQ_1-% 'G/@OQ!
MXN\4:C)-J/A6Z\':+#%Y7V/6);>74+FY)'[S-M<RQ1PQH/\ GI))(\O_ "Q$
M/[[R;QOX/\9>$?VQM-^+6F>%-0\6>&[GP(_AB6TTBZLH[JWN1?"ZWR"ZFAC\
MLH<?))G,=?3]% 'SKX9^%_B74OVT?%_Q-U#2UT/P[I_@VT\*Z1(9XY?[6:2Y
M-[<W/!WV_DN?*\N2/]YGS >U?/\ \3?V8_BI\3OVM/'NFW.AP6GP*\>:EH5W
MXEU03V\DUY;Z;9+(+4(+@31B6Y_=%XQO7$9SY>1)^A5% 'SM^T!\,?$>I?%3
MX/?%+PQIK>);KX?WE_'<^'(KB.VNKZWOX8[>62&64B+S(A^\\N0QB3G][&0,
M^A>"_&'B;Q5JQ2_\ :QX.TV&#!FU[4+*2:60G">5%:S7 /\ RT\PR21D?N\"
M3,GE^CUB:UI<6M:7>V$C7*1W$4D;26=Q+:RC?_<EC(DC/(_>(1CK0!YC\"_B
MUJ_QF\2>/]7LI-+O?AG8ZC%IOA;5+&.Y6743'$/M\IE<^5-$+@^5%+%P?*E]
MC2?M9_!>]_:"_9\\8^ +#4+?2[_5T@:VN+A0\7F1745Q&']G,03VSWZ5ZEH^
MAV'AS2[33=.L[>QTVSBCMK>UMHQ%%!''_JXT0<  >GI6Q0!\S_$+4OBA\>_A
M7J/@A/AM<?#N_P#$FG'3M4U7Q'J%E?V-C;W$8BNS:_8KF26YE5))/*\Q+:,X
MR\B8\N3/^*G[/>L:HG[-OP_\-:?.W@KP+XAL-8O?$EU<Q/-:QZ3:E+6&6$&/
MS6N20AEC_P!61DQXZ?5%% !7SO\ M.?#?Q'\5O'7P3TO3M,/_"-Z'XPB\5ZM
MKZW,7^@FRBD-M;_9V(DD^TR2E/,CSY6W.#FOHBB@#YU_:"^%OB;XK?%/X%:?
M'8?:?!&@^)9/%&NZM#<10W-M=64&;! '/[R*66602".,G ZQ]2?M!?"WQ-\5
MOBG\"M/CL/M/@C0?$LGBC7=6AN(H;FVNK*#-@@#G]Y%+++()!'&3@=8^I^BJ
M* /F2S\%^,?@W^TK\2/'>D^$-0^('A[XB66ER3'2;JRM[K2;BQA%OY4D=U-%
M'+'+')Y@ECDR#&4,?_+0T?@U\)?B+<?M9_$;XH?$:""!?[#L?#GAC^S'B:Q^
MQ2'[5=18XFE\JX  FD\OS=\C>5&#''%]4UB:Y9W>J:9<VUKJ%UHD\Z/&FH6H
MB,MOW\R,2QR1Y_ZZ(1[4 ? <WP]\7_M+?M??&_P@MU]J_9]N]7TF3Q3+%=?N
M[F_L;"$&PMW_ (9#<10_:?+\N7R[:,>;'^[$GZ+UP'P;^%6A_ _X9Z#X&\-1
MS#2-'C:.)KB3S)9/,E,DDC^[O)(_'KVZ5W] 'SKX9^%_B74OVT?%_P 3=0TM
M=#\.Z?X-M/"ND2&>.7^UFDN3>W-SP=]OY+GRO+DC_>9\P'M3/!GPQ\3WG[97
MQ#^)7B/3OL.DV/AVQ\+^%+RVFB,=]:R2M=7LLL0)D$L=R!&"?*'E]I#\]?1M
M% 'R7^S9X7^(7[,OPKM_A/)\/KWQ2=#N[F+2/%-CJ=C;:9?PW$\MS'-<QR2_
M:;;!F\N6..&YQY1,?F]*]%_9F^#>H_!OP;K;:SJ%MJOB;Q1XAO/%FN2:;'Y=
MC'?W9'FPVWF?O/*B\L?ZS,AP3_L#V^B@#YD_8=\"^,_@C\&] ^%GBSPE?Z?=
M>'_MZMXAANK*;2[[S+Z66(P^7-]HYCE'^MBCZ'VKO?VIM)\0Z_\ LZ^/]#\'
MZ%_PDVOZWI,^DVVFM>QVGF?:OW,CB60B,>7'))+R>?+QWKUZB@#X_D\&_%FX
M_9WTCX$V?@BUL;B3P[;^$=6\</J=O=Z-;V(M3#-=6T?F17LLWEC$<4D,:"63
MF0Q1[Y-KX@? #5O!NL_L^>*/ UC=>*K?X1P3:.- FN([>_U*QN;2*Q,L<K^7
M%YL21>88W\N.3G]Y'W^IJ* /./!?C#Q-XJU8I?\ @#6/!VFPP8,VO:A9232R
M$X3RHK6:X!_Y:>89)(R/W>!)F3R]/XK>.U^&WPM\8>,1:_;F\/Z1>ZI]E\SR
M_M'V:*27R]_;/EFNTKS[XR_#.S^,GPSUOP3?:GJ6DZ;K*K;W5SHL_D7/E"4&
M2,/M/RR &.08YCDD'>@#YG_9;_X65\*?V0OA]X8\%^ _^$IU:^TBWU/2/$%U
MJ%O;Z1!]OD^TDWL9E^TC[,;B7,<4<GFQQ1$21R2F**?XG?LBZUI7[%?A_P#9
MZ\&M<>(4U#4K&RU77KJ2./\ LRU^WB]N[[R20) )!Q;B3S,2X\R3R\G[2HH
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MU^*&FG2+W7-7L="N(YK35M)L%M_*U6VE'E2Q2R21/+&/+\T?Z/)%)^\/.<8
M/$?^"=^_Q%\"]>^(BL8$^)/C/6?%QTY>6TXRW)A^S"3_ ):_\>V?,Q'_ *SI
MQS]'^+-2U'3?"NL7NA:2?$6LVUE++9:7]J%J;R81GRH?-?B/>W'F=!UYQ4GA
M?PIIW@CPKH_AW1[<VNCZ39Q6-G;^87V0Q1B../+_ .R /PKH* /"/V./A'J7
MP'_9K\#>"]9&-;L+)IKZ%0!]GEN9I;J2$>7)(#Y32M%YF?WGE@\9 '!_LW:)
MXY_9>^%UO\+[KX7Z]XRM_#]]=1:=XC\,W^F0VNI6LL\EU%+Y-U>PRQ2CS3')
M'B0?NL^9(#7UG10!\[?M+?"KQ?\ %#P%X(U'2;#3KKQKX,\2:;XS_P"$=DO<
MVVHRVRR"2QBNI(QY>\R2>7+)'C(7(CR3'P7[5'@?XL?M0>!]!\'V/A34?"?@
MK5/$>EVOBJSOKG3O[7ETT2F6>YC>.:6&*.(Q0X ,DLLF?W<<<7^D?8U% 'SM
MXY^%WBCQQ^UW\+/%(TXV?@_P)I&L7_\ ;1N8Y3?7]]&+7[#Y.1)'Y<:^=YN)
M <^7@=:^B:** /B;]OKX'?%/XQ>+OAA<?#K0[/5_L]CXAT;4;K4[F**UL(M3
MMHK$S2?.)"!#+-)^Z$AS$/W9Z'SSX_?L;_%+Q!\7/#'A7X;7/]D_#V3X;:?\
M/=7\6ZE>Q_:;*RCOC+(!%')')+))%!%&0(_+D$TB'RQDQ_HY10!\T?M$?L]W
MFI?"KX=Z=X L[=W^&>O:1XDT;P[<7!B&HQZ>K1QV'VF3/E$Q8 ED\SD?/UWB
MK\9O"/C#]K3P/_P@5YX4U#X=>"=0O;67Q#J/B"YLI;^:UBE\T16$-K+<Q^89
M8H_,DN3&(P>(Y23Y?U#10!\[>.?A=XH\<?M=_"SQ2-.-GX/\":1K%_\ VT;F
M.4WU_?1BU^P^3D21^7&OG>;B0'/EX'6I/VUOA?X@^-/P5/P]\.Z9]M_X235]
M-LM2O_M$49TFPCNXII;PQR$?:1&8@/*!!/FY[5]"T4 ?,EGX+\8_!O\ :5^)
M'CO2?"&H?$#P]\1++2Y)CI-U96]UI-Q8PBW\J2.ZFBCECECD\P2QR9!C*&/_
M ):'%^$?PE^*1_;(\>?%?XBO9PZ;#X<M/#WAZUTE(Y+:6&62.YFB1_,$I-M,
MDD?F2Q1^;YID B0",?6M% '-^+-2U'3?"NL7NA:2?$6LVUE++9:7]J%J;R81
MGRH?-?B/>W'F=!UYQ7EG[''PCU+X#_LU^!O!>LC&MV%DTU]"H ^SRW,TMU)"
M/+DD!\II6B\S/[SRP>,@#W>B@#Y,_9NT3QS^R]\+K?X7W7POU[QE;^'[ZZBT
M[Q'X9O\ 3(;74K66>2ZBE\FZO898I1YICDCQ(/W6?,D!KW'Q!XH\6^'=+TB[
M3P%<^([J:)AJ.G^']5MC-;7!V?ZLW1MHY8?];^\+QR<1?NCYDGE>A44 ?.WP
MU^%OB6Z_:5\3_%^^L!X'T?6/#MMH[^%7N(I+V^NHK@O]OO\ [.3;B2./$46)
M+@^7)S)%S'7,_!7PQ\1?@)K'Q;TN/X>W_B9_%7C_ %/Q/I6M6.IV,6F""]$/
ME_:3+*+F/RR")/*MI3QF,2]#]7T4 ?"5G\!_BU:_"_\ :GUO6M&'BSXJ?$"^
MET73K:WNK6PM+G38HC:V=W$!))Y7EQ7,LGE2RF0BVC!_>$R/Z-\?OV;]=\2_
ML+W/P9\,SV^N:UIN@Z9I]K)='[,+TV,EL_3/R&3[,1@G&9!\_&:^IZ* /(KK
MXC>+8]-L=23X1^)I(OM$MK+I<FIZ2-1C.(C%,H^V&W,1/F*<W(D#I'^Z<2&2
M/D_AK\+?$MU^TKXG^+]]8#P/H^L>';;1W\*O<127M]=17!?[??\ V<FW$D<>
M(HL27!\N3F2+F.OHFB@#Q7]K/X+WO[07[/GC'P!8:A;Z7?ZND#6UQ<*'B\R*
MZBN(P_LYB">V>_2N1^(6I?%#X]_"O4?!"?#:X^'=_P")-..G:IJOB/4+*_L;
M&WN(Q%=FU^Q7,DMS*J22>5YB6T9QEY$QY<GTQ10!\K_%3]GO6-43]FWX?^&M
M/G;P5X%\0V&L7OB2ZN8GFM8])M2EK#+"#'YK7)(0RQ_ZLC)CQT^J*** /G;]
MH#X8^(]2^*GP>^*7AC36\2W7P_O+^.Y\.17$=M=7UO?PQV\LD,LI$7F1#]YY
M<AC$G/[V,@9K>+OA[XO_ &C/&'P_N]>T&Y^'W@WP;KL7B62UU*XMIM9U'4[;
M_CUCC%M+-;16O[V3S)/,,DA_=^7$!YI^DJP?$VB7>O:/<6EGKFH^'+I\;-2T
MM+>2XC]=@N(I8^?>.@#YJ^'OF>//^"AWQ6UL@V+^ _!ND^$FA4^8;W[=(VI?
M:1G'E^61Y?E_/GKD=*^LZ\Z^&/P?T+X3Z=JUIHHN_.UO49M9U6^NI \M]?RB
M/SKJ3&(XS(8Q\D21QCH(P.*]%H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **^=?VE/VA-:^$7CKX3^#_#&B
M#6/$/C75I;5(YK:2:+[+;Q R[GCE$D7[R6#,HCE\J(7$IBEV".2YXL^,'B;X
M17/A7PMJKZ7X_P#B9XRU22UT'3],M9M"L?L\444ES)<R2RW7EB&,R29&9),H
MD<7!- 'OU%?.^D?%GQQX1_:$T+X8>+FT'Q>?$VDW6IV^H^%].FL9-)^SG$C7
M]K)<W.+>7*1Q7(D_UH,7E]Q1T'XN?$7XT7GQ);X8MX<\-0>#-?O?#*-XML[B
M_.KWUM''Y@Q;RQ?9(?,< 29N)) Q)CC\O8X!]+45\_\ [1WQJ\4?"7X;^$)]
M'T[28?B'XL\0Z5X6TZWO9);G2[>]N9,N)I<12F(1QS 2"/?GR_W?) Z#]J'X
MQM\ O@1XR\>Q6ZW=SI-D/LD.W?&;J61(K7S/WD9\H32Q>9@Y\O/X@&I\7?C5
MI'P97P8FKVM_>?\ "5>)++PO8_8$CD,=U=>9Y4DF^08CS&>1DCT/;TROCWQI
M8ZS\0OVK/V>?#'B.^TJXUSPGH=_XV\4Z';FY%A+<F.*UM+FV$D>',=U)*8_,
M/F1I')T)Q)R6AZ9\4/B9^W9XNN1XQ\)R7OPP\-6NF^;J/A:Z:UM[G4LW/F6M
MM_:61(;>/RY+GS8\@>7Y1'[R@#[OHKYIT'XN?$7XT7GQ);X8MX<\-0>#-?O?
M#*-XML[B_.KWUM''Y@Q;RQ?9(?,< 29N)) Q)CC\O8_ONAR:JVE69U.VM+;4
M&CC^TPVMT9HDDYW[)3'&9/KY<>?0=  <_P"*OBCX>\+>.?"'@[4]2^R>(?%(
MN_[(L_LDLGVK[+%YMQ^\ \M,1\_O".O&:[FO"/$'QLUI_P!K3PK\)M"LK%K
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M_#&^,2WVL22R6\=K]I_U<47F12_OI,8C&<>9^ZH ^GZ*\U\.P_%*/7+=]?\
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M-+TK0O"6IG1=0\5>(+>2]6YU*+)NK&WL8I;:3$(DBS<R2@$C$<4F?-$?P/\
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MV<?A'X7TC35\(:KXR\0>(],\'>%8K/0IM,T;3_.P(H[F(74D@BCBBEP8CWC
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R?\
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M,_G^$_ ]C;>$K#6O+/\ H4=C%]JUBW$,8\V01W/E2>88SGGRB16G^R7K=_\
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M_5FOTCHH ^3/V\D?1/V;;'X<>%D7P]J'C?6=)\":&=/_ -&M+,S2C]U,(_\
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M$5UG_A&O[/\ ^$H^R2?V;_:F_P"R?:=A\KSO+^?RM_7'.,X[4 ?&'[,GQV\
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M=VGAFWU"?Q#=>=+>ZKKMZ@2[U;4)9!)-=3'/+9R 7,DGEI$/,DVYH ^)M-\
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M6GC/XU>#_ _@_2_$NJZ_ VBZO-;VNEW6G0RWYU&6YQ]F2VBMED>X,F<CR\Y
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M?M^A+XBM8[6/6[53^\:V E.)(ALDDMIA%<1QR9\H8. #V6BO$_$'[2&B:/\
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M6/!-_P"+YKK4--\/0^)IO"^GW<UJ;D:_="7RHI=,CMS+)>Q2R;Q'Y0R?+FX
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MMFCZY8>(]+M-2TZ\M[[3;R*.YM[JVD$L4\<G^KD1QP01Z>M %7Q)XLT3PO\
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M)-:T[6-=U?0-5\%Z/I:&YCU?Q(UM:Q7%H2\AF\OSO-M\1J,BZCADC\SD9\S
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MYDN8[6.7@_NA<&0_ZR,21?O*[[P%XN7Q]X3T[78]+U;0XKR/S/[/UZQDLKZ
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MU..;R9+"XDS_ *5#':OYLEH.#UE$D?% 'U517G7AWP7X0^#.EZS?:;';^$]
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MY<^;=:Y)+<QRVL=CY<L?G$D"7]W)DQQ$\C(H ^@:*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#Y+^$*GQ1^WQ^T%J6J!9KWPII'AW0=)E!\O[-975M)>W$?
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M#0_&FAZU;:!X7EN3YMU>F*Z_T&REACDN-DEKF3S9,1"42'(!Y=IN[X@?L/\
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M2&MO$=OHYT)-0DNI999+:2Z-RZR;Y,2227!DDDFD!EDDD),A)-2>,O@7X/\
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M&/\ PD2>'-/;3_[?U:YU[41Y\DOVB^N"/-E^<]_+''3CI7!V/[)_PRL]*O\
M2X= N(]%OX;Z'^Q!JEZ-.M3<^8MR+6V,OE6GF)--'OMHXSY<LH!Q)B@#Y.T7
MQ#J7@O\ X)A?%;XCZKH$P\1?$N35]:U.PD_T:&&;5;H6,<EL&!?RO)DBFC!,
MGF#/[P>8"/;_ -KKS/@-^P_JG@KPGMU6ZFT>Q\#:-I^HYFN]3\X1V/E1)%L,
MMR;?S9 (QUCSY> 17M.H? OP1J?AOP/X>NM&\W2/ UY97WAVV-U*!92V<?E6
MTF1)F7RQQ^\)]\]]7XA?"_PY\3O^$=3Q'I[:A_8&K6VO:<//DB^SWUN3Y4OR
M'MYAXZ<]* /F.Q\&V6G?MN?![X<)/</HWPH^&-SJFA3G;]HFDEDBTLBY.,2#
MRHMW[L1_O/;BJO[4WC;3OB3^UE^SY\%=,UVQ.H6/B?\ X3'6XXXS-<V+V5L;
MFUB/SA(_.C-SQ]]?W4G3'F?2WC[X/>%OBG>:/>>(;.YEU31'EETS4[#4+FPO
M; R1^7)Y5S;O%*@DC^^@?!&,@X%4_#?P-\%> _&4'BO1-(:V\1V^CG0DU"2Z
MEEEDMI+HW+K)ODQ)))<&222:0&6220DR$DT >HU\D?\ !-O[9KW[/VJ>/KZX
M@EO_ (A>*-6\57-O:VYBBLYI+@VTL<>9)"1FV,@S_P ]<<XS7=?M8:SJVK_"
MOQG\/O"OAG5_%'C'Q'H,]A8V<5I/%9$7"O%)+)J#1_98C''YLGE22(9/+$>,
MRQUZ3\*? B_#;X6^#_!QNOMS>'](LM+^U>7Y?VC[-%'%YFSMGRQ0!X#_ ,$U
M(_[:_9?TWQC>$S>(O&>LZMKVMW>['VV]DOYHI)O*'[N/]W%$,1X''3UY7X*>
M/A:R_M7?M&VUD+G1[N]DBTZPCFS:ZG;:%8RQ"[BN\8DCN3YGW(SY?E?\M*][
MO/V:?AY=^(-:O_[)U"T.M7K7^KZ9I^LWUMI>I32*(Y)+FPBF%O-YHC'FB2,B
M7GS-^36[XT^#?A'XC?#&;X=ZYH-O+X+DBM[8Z+9N]K$D44D<D4<?E&,QB,QQ
MD8QP,>U 'F'_  3_ /AQ:?"_]D7X<VEL())M5TV+7+FXBMO+:62\ N1YG_/0
MQQR11>9GI$.G0/\ ^"@WC6Z\$_L9_%'5+"."26?3X],_T@<>7>3Q6LA^HCN)
M,5](5CZQH=AXCTN[TW4;.WOM-O(I+:XM;F,2Q3QR?ZR-T/!!'KZT >(_%GQQ
MH?[%_P"RY.\.JPP0>&-"CTGP_P#VUF3[=>QVWEVD,@CV>89#'F01@<"1_P!V
M 2-/]C?X:M\(?V7?AGX:E@O[2XATE+J\MM2C,=Q;W-R3<SQR @&/9)+*F.HP
M.]0S_LC_  MNO!<W@R[T#4=1\-W%C%8?9-6U_4[S[);QRPRQ0VLDMR9+:+S+
M:WS'$8Q)Y,6<B/ ]YH ^/_BII-A\5/\ @H1\)?#>HV< A\ ^&-2\9CSX/M2W
M<MU<Q6,4?ED#RC%)%'<"7GD=!CS*T?%R_P#"SO\ @H+X#TVSR;;X8>'+W7-2
MOK4_:4%UJ2K:1:?+T^S2&*,W(R29(_\ EGC]Y47PN^#4/Q"^+_[0?CCQ#I.N
M:9!K/B2QT[2;>YAN='O8_P"S;!;;[?:W<4HE$<WVBXC$D1&8A(,_O9(Q[W\/
M?A?X<^$^B7>D^%=+.GV]W>27US<27$MU<7%U*<R3RS2F2260GJ\A)/% 'S[^
MR?I%AXV_:&_:1^*CV<-IJ5QXH'@N"(P>=-;PZ9;PQ2RBX(SBY)AD,6./)CR9
M.HG_ &,B/$/CC]I?Q;J(-QXCNOB1?:#+>1MMWV.GQ116,(3_ %>8XY9!G&3G
M]X3BO?OA3\+_  W\'_ .E^#_  AIITGP[IWG?9K/[3)-Y7F2R2R#S)"9#^\D
MDZGOVKFO$7[/O@CQ!XLO?%$]IJVCZ]J$44=]>^'M?U+2&O?*SY7VC[)-'YOE
MASB1\D9_"@#YUUKQE?3?M&?M$?&'0XH)5^%OPZE\,6KS#[58:E?QK)J4R^;&
M8]C6T@CAEAR9/WF<QGBO1?V7+KPA^SO^P[\/]8UC6O[(\*6GARVUV^U+4G \
MN2[Q=2*/+'.9+GRXXP/,.$3]X3S] ^&?#&A^#=$MM&T'2=/T+1[<_P"CV&EV
ML=M;+SO)CCC  YYX]Z\ML?V3_AE9Z5?Z7#H%Q'HM_#?0_P!B#5+T:=:FY\Q;
MD6ML9?*M/,2::/?;1QGRY90#B3% 'QEX<\6:[X?_ ."6_P 9/BE))IUYK'Q+
MU35-5O;7R'2VL!?WL>G7,49$F6X\V6/)X,@!\S!W_6'Q#\<67[&/[)UJ+[Q%
MI\NH>$O#<6DZ1)?PF.+5=1BM!':Q>3')YA\R2,GRU/$:R$G$9<>DZI\&_"&K
M?">#X:WWAZ"^\$Q:;#I0TF>:1Q]GBB$<:B3/F939'B3)<$9Z\URVO?LM_#SQ
M9X;UG0/$>FZGXGTK5TBM)UUSQ'J=_*D,<T4OEQ32W,DL(,L$4D@B,8D\J+S,
M^70!\I?LM_#5O!_Q^^!/@;5(;_'@_P"#TWBZQT_4H_*NM.UC4K_R[X. (R2!
M))%Y<GW /^>F9*_0.QURQU"^U2VM+R&YFL)_LUW'')O^SS>5'*(Y,#Y#Y4D3
MX/:0'N,\EX^^#WA;XIWFCWGB&SN9=4T1Y9=,U.PU"YL+VP,D?ER>5<V[Q2H)
M(_OH'P1C(.!6WX/\+V/@_0['1]+@:VL[4GAW\R1I'(DDD>5SYDCR2%Y))),R
M222%R2230!\V_L;PWWB[XU?M._$*_N(/-O/&O_"*?8K:W,?EQZ3$8HY0_F=9
M(YH\\=8^^>.B_P""C7BK4?"'[%OQ-OM+F^R7,ME;:?*Y0.##<W45M,GXQRR#
M\:]*\/\ P-\)^%?&^H^+](T[4-)U74K^6_OH=/UF^AL+FXEB$<DTMC'*+>20
MXY<Q9S^\)WC-=QK&AV'B/2[O3=1L[>^TV\BDMKBUN8Q+%/')_K(W0\$$>OK0
M!E>'K70?AOH?AGPI8O!HVFVL,6CZ587%R?F$41\N&,R?/(1%&_?.(C[FOG_X
M8L/&7_!03XW:U>*$N?!7AO0_#.G1VW*/;7OF7TLDHS]\2CMCY/7K7L/P\^!O
MA#X7&)?#VGZA"EO9KI]K_:>KWVH_8K4 $0VOVF63[-&?*BS'%Y8/E19SY<>$
M\9? OP?\0?$ECXGO[/4;/Q):V3V,>JZ-K%]I-U]EDD$IADDM9HGDC\P"3RW.
M <GKF@#P./Q)IWQR_P""ANB:=IET=7TGX0^'+VYFO]-C/DVNMWL@M9;&ZFYC
M)^S 'RXR#YL4G/[N2,=)^R:;7QE\7/VD/B!%!-8ZC?>-QX6GM?M'F1>7I-G%
M;12#]WP9/-ED(/3]V/4U[%X%^#G@[X>^*/$6O^&M!M]"U'7H;"UOOLDD@B>*
MRA\FUC2'/EQB.+]WB(#I[5=^%/PO\-_!_P  Z7X/\(::=)\.Z=YWV:S^TR3>
M5YDLDL@\R0F0_O)).I[]J /@#QEXRO?^&=?VR/C5:+#=R>+]?/A*RG53)IE[
MH]LT.F0W=L1CS,QW-U^]$AB,D8XX(KZO^+/CC0_V+_V7)WAU6&"#PQH4>D^'
M_P"VLR?;KV.V\NTAD$>SS#(8\R",#@2/^[ )'H7@OX-^$?AS\,8?AWH>@V\7
M@N.*XMAHMX[W43Q2R222QR>:9#()#)(3G/!Q[5Q4_P"R/\+;KP7-X,N] U'4
M?#=Q8Q6'V35M?U.\^R6\<L,L4-K)+<F2VB\RVM\QQ&,2>3%G(CP #Y)\1^!Y
M- _X)F_ ?X3_ &SS(OB;J^AZ5_:QBYTTZE=C4Q+Y6?WOE\QXWQYX.>U?07PQ
M8>,O^"@GQNUJ\4)<^"O#>A^&=.CMN4>VO?,OI9)1G[XE';'R>O6O=/%7PN\/
M>*?'/A#QCJ>F_:_$/A877]D7GVN6/[+]JB\JX_=@^6^8_P#GH#TXQ67XR^!?
M@_X@^)+'Q/?V>HV?B2ULGL8]5T;6+[2;K[+)()3#)):S1/)'Y@$GEN< Y/7-
M 'SAJGC>Q^-W_!2CP=HFB:_IUY9?"CPWJFI7:VT?F2RZC=>78W-K)('\L>5'
M+;/D XD66,\Y\K?_ ."?.LV:_LP:A\4]:O+73)/'&OZYXQUR61O*L+*;[7+%
M*8S)_JH?+ME.9)..>:]Z\"_!SP=\/?%'B+7_  UH-OH6HZ]#86M]]DDD$3Q6
M4/DVL:0Y\N,1Q?N\1 =/:LRS_9Y\#:;XNOO$EGH5S:ZA?:I_;%W8PZE=)IMU
M?_N\74MCYOV:27,44OFF+?YD0DSY@S0!XM^P_?K\5/%'QL^,R+<+'XU\4_8-
M*F2WDMK2]TC38_LUK=11RCS,R"67S.<>9&1B/D5QO[(WC#6O!O[#?Q*^-PDT
M^]\2^)K[Q-\0/[/6"2.TMKF-94,)'F[Y(O,M0>H/[S';S#]=_"GX7^&_@_X!
MTOP?X0TTZ3X=T[SOLUG]IDF\KS)9)9!YDA,A_>22=3W[5F?#?X'>#?A+///X
M3L;[1;6;SBFE0ZK>/IEMYDOG2>39/*;>W'F9/[J-,9.,9- '@_[)7[/\^F_L
MM_#:VLOB?XTTS0[[0+;4I=%M)--BA#74?VFYBCN%LA=1J9)I"'2;S8P1Y<BD
M CW[0-)\"_ OPEX:\,:?)I'@W0XYH=(TJQFNHXA-=2$^5#$9&_>2R?O/620Y
M/)KE]._91^'6BPRV&F:=JNG:%+--,?#]OXCU)-% EE,DL(TP7/V;RI#))F+R
MO+YQLQP6>+OAGJWQ.^,_A_4_$'DQ^ /!<R:CI6DRP12R:EK!BFC^VRREI/+A
MMHY<1#]W(;CS9#Q%%Y@![=7Q_P#%32;#XJ?\%"/A+X;U&S@$/@'PQJ7C,>?!
M]J6[ENKF*QBC\L@>48I(H[@2\\CH,>97V!7#>%?A=X>\+>.?%_C'3--^R>(?
M%(M?[7O/M<LGVK[+%Y5O^[)\M,1_\\P.O.: /!?^"B&_Q%\"]!^'; P)\2?&
M>C>$1J+<MIQEN1-]I,?_ "U_X]L>7F/_ %G7CGM?BK\"->U#XK6WQ;^'7B:'
M1/B'9Z%)X?\ L6O6'VK1M2LQ)+*(IA&8YH2;B6*3SHY.D7^KDZ5Z+XJ^%WA[
MQ3XY\(>,=3TW[7XA\+"Z_LB\^URQ_9?M47E7'[L'RWS'_P ] >G&*Y_6?V?/
M!>L:S>7MY9ZK);7DLEQ<Z1'X@U*/2[EG;,WF6"2BV?S<N98S'B7S)?,$GFOD
M ^6OVA?C1:_M5?L2_#F.RL+O0X_C!XKTCPIYUW()3H\AO\R284 7($EBX7_5
MDB3)\L_NZ])_8Y9O!_B/XF^#_&SL_P 9%U>35-7UJ\ %WXJTSS,6.I1CE([8
M1G[-]GBD>.W,6,1F0@^XW'P<\&W7B7P-KRZ!;QW_ (+AN;30#:R26\6FQ31B
M*6..*,B/_5QB/!& !VXJ6_\ ACH&H?$+2_'T^G;?%>G64UA;:E:W$L4DEI)_
MR[RF/ N(\CS DHD$<GSISS0!XI\8_A[X@^ ?B+XE_'GP+JL-_+>:='J'BCPM
MK\!-KJ-MIT46W[+=1 2VLJVT=T/WGG1R22C,8'(^@/AYXQL?B-X#\-^+M-BF
MALM?TRUU.V2Y'[Q(I8A+&'Y]'KAH_P!F3X?74C6MUI%_?Z,C?\BUJ.M7MUHO
ME9/EQ?V;+,;7RH\#RX_*V1>7'Y8'EBO8Z /D+]L"*_\ &'[0G[+W@);B"RL+
MWQ7<^+'N/(,DOG:1;+<1Q ;P,2"65">WR8Z8+/VT-.TWXF?%;]G/X5ZG9PR6
M.L^*[CQ)=2W,'VJ%XM)MI)9+62V/^M%P)C&3VP>),@5[WX^^#WA;XIWFCWGB
M&SN9=4T1Y9=,U.PU"YL+VP,D?ER>5<V[Q2H)(_OH'P1C(.!3M*^#?A71O&]M
MXUM+.Y?Q7;: GAF+5+J_NKF4V,<IE$<GFRGS3Y@!,LF9#SF3F@#Q7]IS3=0\
M=?M"?LX>"6M+J70HM>OO&=_>6<69X)-)@C^REW'[M(I);GRY,CGS(P"A/-?]
MCU3XN^+'[3'CV^98-;O/'DGAF6.(9M_LNDPQ16L@'_/0K*WF'/7&!'7T#_PJ
MWPW_ ,+6_P"%B_V:?^$O_L?^P?[0^TR?\>/F^=Y7EY\O_6\],^]<YX@_9Y\!
M^*/&%_XCO]%N#JFL1Q6FLFTU.ZMK;5(8MXBCOK:*6.*Z&R0QXFCD_=GRSF/B
M@#Q#]GGQ5I_Q\_;,^+OQ,TN]34- \,:18^"M#U738F-CJ$/F275[^]/^MECN
M/+&8SY?E/&<2>9')5K]C>&^\7?&K]IWXA7]Q!YMYXU_X13[%;6YC\N/28C%'
M*'\SK)'-'GCK'WSQ]#_#WX7^'/AC_P )$GAS3VT_^W]6N=>U$>?)+]HOK@CS
M9?G/?RQQTXZ5B>'_ (&^$_"OC?4?%^D:=J&DZKJ5_+?WT.GZS?0V%S<2Q".2
M:6QCE%O)(<<N8LY_>$[QF@#U"OD/]C>&^\7?&K]IWXA7]Q!YMYXU_P"$4^Q6
MUN8_+CTF(Q1RA_,ZR1S1YXZQ]\\?7E>7^'_@;X3\*^-]1\7Z1IVH:3JNI7\M
M_?0Z?K-]#87-Q+$(Y)I;&.46\DAQRYBSG]X3O&: /%/V3](L/&W[0W[2/Q4>
MSAM-2N/% \%P1&#SIK>'3+>&*647!&<7),,ABQQY,>3)U'AGQ0U[6]#^ ?[:
MGQ9FTWR-8\4>)I/!$<=U#(MC+IEK)'I,=S%DY\S;/= R>9Y?FQ]!@QU]\?"G
MX7^&_@_X!TOP?X0TTZ3X=T[SOLUG]IDF\KS)9)9!YDA,A_>22=3W[51\%_!O
MPC\.?AC#\.]#T&WB\%QQ7%L-%O'>ZB>*62226.3S3(9!(9)"<YX./:@#@M,_
M97MK7P?!X#U3X@^--?\  L.FII/_  C=U+8VL,MDD?EQQ2W%K:Q7.!QTE'F
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M'PO>OIKQ5\+O#WBGQSX0\8ZGIOVOQ#X6%U_9%Y]KEC^R_:HO*N/W8/EOF/\
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MWP-J4NJZ?_:]YJ$MO]F^V:_K-[J]Q''D&2.*2ZEE,0D,47F",CS/*BSGRXR
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MR=1U[]BWP3;>(+.;2Y?VA?BU;77B:)4\K[-'?WTDOF6'F?ZL&.QM9(S+YO\
MK.^17Z*?\*M\-_\ "J?^%=?V:?\ A$/['_L'^S_M,G_'CY7D^5YF?,_U7'7/
MO6=JGP;\(:M\)X/AK?>'H+[P3%IL.E#29YI''V>*(1QJ),^9E-D>),EP1GKS
M0!S&I?LZV?C*-+#X@^,?%'Q+T*&6*[_L+7OL4>GR21RK)&\D=E;6QN "H/DS
M&2+UC.$(X/QK>6GC;_@H+\-= O[:X2?P/X*U3Q5:7<-P )Y+VYBL!')&8_\
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MV@/&WBOQS;>'/A_;^*[7PAHMMXHU?[)%;7UC:_Z>L22R>4BRR'S $(DDV,9
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MLO.P"220@#GCGVH WZ*^5_VEO'U_XB^('[-GA;P)XDNK63Q1XKAU[^T]*O\
M98:AH]C;&XNHI)(B3()8Y(_+CP8Y.,D#%>N^$+NZE^*?Q CE^(NG^([>'[#Y
M/A&UMK>.Y\.!HLGS70F5_M.?-'F@8Q^[XH ]+HKD[#XA>%=6\:7OA*U\2:5=
M^*+&$W-SH<%_')>VT6(_WDL.?,C&)8^2/^6H]17AW["/BC7/B3\*/$WC[5-9
MU'5M)\7>,=7UC0(]3NY9+C3]-\\116K@DB+RS!+B*,F,9X/- 'T[17GUI\:O
MAWJ7A'4/%EAXZ\-7GA2QE%M>:W#K%O)I]M+^[_=R3"3RT/[R+C/_ "T'KSYK
M^T9^V%X,^ :Z=I#ZOH&J>,KO6+'2/[%N-=AL?L;7&#]JOCB22VMHXOWAE\I^
ML?KF@#Z+HKD;'X@>&-:\'R^+K#Q)I6H>%8H9;@ZU:WL<MB(HS^]E\X$QXC\M
M\G.!M-/\$_$+PI\1M+FU+PKXDTGQ-8QR_9I;O1;Z*ZA24 ?N_,C)Y^<?G0!U
M=%</KGQ6\&>$?$FF^'-9\7Z)H_B'4O*6RTG4-1BBN[KS93%%Y43GS),R?NQ@
M=<UW% !17(ZG\1?"^B:C=Z=J7B;2M/O;'3)-8NK6[O8HIK>QC.)+J2/((B!S
MF0_)G]2Q^('AC6O!\OBZP\2:5J'A6*&6X.M6M['+8B*,_O9?.!,>(_+?)S@;
M30!UU%8'AGQ/H?C+1+;6=!U;3]=T>X/^CW^EW4=S;-SL(CDC)!YXX]ZI7_Q"
M\*Z3XTLO"5UXDTJT\47T(N;;0Y[^..]N8L2?O(H<^9(,12<@?\LCZ&@#K**X
MS_A:W@C_ *'+0_\ D,_\(W_R%(O^0I_SX?>_X^?^F/\ K/:M'Q)XLT3PO]@3
M6=7T_1VU.\CT^R_M"Z2$W-S(2(XH@_\ K)3CB,<_E0!T5%%?(/P6^,VGK\6?
MV@/&WBOQS;>'/A_;^*[7PAHMMXHU?[)%;7UC:_Z>L22R>4BRR'S $(DDV,9
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MJUM'';7T8_>6LCF3B8#!,7^L'<>@!Z#117S%^WSXBUS1_@GIOASPEJM]X?\
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M[QC%<ZAI,DUS;1:GH]A;R75]#))$/3R<<C]X8NGEF2/+_:0\+:)H/Q0_9:\
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MYLDDDOEY./,P.E '7>*/%>G>"/"NL>(M8N#:Z/I-G+?7EQY9?9#%&9)),)[
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M]I/[/OB#X?\ C'QI??#SQM%X:\.^+M2_MC5-*N]#%_<VVH2#%W=6-T9AY9D
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M:^%=8BU_2--\.Z0^D6[WT8D$4MSYES<R2>5Y@,?ER1#.?,$O 'NE 'PW\$_
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M8U3)DNK_ .SK;QR2%B=L<?/EQC=Y:<R/Y:C?)))F0@'5T444 %%%% !1110
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MQ!\*-%\-6^GZKK'B_P 96ND7.F744DUR--Q+)?7,*1R _N@(R9"#''N'F<=
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M2TU;Q5JAT^WN[R.QMK>.WENKBXNI3B."*&(222R$]$C!)YH [FBBB@ HHHH
M**** "BO!_B'\;M<\/\ [2GPI^&>A6UCJ-GK]IJM_P"(V\J66ZTVTMX@+:?Y
M),11RW#&/S) 02,#FO>* "N4\$_#WPI\.=+FTWPKX;TGPS8R2_:9;31;&*UA
M>4@?O/+C Y^0?E75T4 %%%% !1110 4444 %%%% !1110 445P%_\3M T_XA
M:7X!GU'=XKU&RFO[;3;6WEEDCM(_^7B41Y%O'D^6'E,8DD^1.>* ._HKB_\
MA(O$W_"UO[!_X11O^$,_LC[;_P )5_:,7_'_ .;Y?V'[-CS?]5^]\WIVKM*
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M1%))B09'F@@9]K\%^,/$WBK5BE_X UCP=IL,&#-KVH64DTLA.$\J*UFN ?\
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M3]=-Q'),3#8Z?<BUC^UWL7_/))$\R/S 8S+;( DA CKZI^#?PJT/X'_#/0?
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M2=2N?%NGZU?R:B+-;:/S+74TCZ6/G7$DD)\H1VQXCCB!C&.%\5?#GPW\3O\
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MKNK&[UC7K_4](L=)\2:C%:VL7VJ0>7)%YO[P"2+RA;R&2W$4,6(Q+)<F7,\
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MISZ!^R1\,K3QGXXT;4-9BN?$OBWQ%.\USK5L;>&&YEMKKS3L\DS7WV?9<QR
M?Z,"),&.3MOVJ/ _Q8_:@\#Z#X/L?"FH^$_!6J>(]+M?%5G?7.G?VO+IHE,L
M]S&\<TL,4<1BAP 9)99,_NXXXO\ 2.\\,_"_Q+J7[:/B_P")NH:6NA^'=/\
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MZQIMKI%M+\EKY5]%%%;74LH$<WVF]D-L#(,"*/S0?J+X"_\ "?\ _"H?"O\
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M)&1(:^GO!?B#Q=XHU&2;4?"MUX.T6&+ROL>L2V\NH7-R2/WF;:YEBCAC0?\
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M]U?Z]J6G+&(P#Q'':75S)+(9/+&'$<8C$A\S@1R@'E'[4TWCGQ=\:?@1\/\
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ML^+CIR\MIQEN3#]F$G_+7_CVSYF(_P#6=..0#ZSHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** //_
M (>_#&U^&5QXKN+75=4U>?Q-X@N?$-U-JUQYIBDF2*,11D#B*..**..,] H'
M88] HHH ***X;PK\4?#WBGQSXO\ !VF:E]K\0^%A:?VO9_9)8_LOVJ+S;?\
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MKG0=1/D21?9[ZW(\V+YQV\P<].>M=K0 4444 %<U_P (OIS^,/[?>V:75OL
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M(\1R?Z421CZRKY'_ &R(W\:^//@)\)8R)D\5>,H]8U&VO.;"^TW3(C<W=K=
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MP^;/PKI%SX[CLM8T2:XLX=Q%C#))&+L?:[F.X\R2/BV^SB0XDE/%>N7OQ?\
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M5X;CTZ^U&RT^Y^'>GB2YUTFY/EB*ROO.$5[<A\2>2+:,%(Y0)/W?F/\ ._\
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MXC(,#'FQ^H-87[4GQ-7X._LZ_$'QA%??V;>Z=I-Q]@NA#YFR]D'E6IV$'/\
MI$D74?6@#Q32_P!LS7#^Q?XY^/M]I>GFP-[?_P#"(V-K;2>9]E-T+&Q^WQF;
M'F_:?];Y4F/+'[OGBM3Q]\=/C+\%?@_IGQ-\?Z#X1L='TL62>*?#.DRW-U?A
M)=D4EQ:W)Q"DD<LL>;7RY(\1R?Z421CSKQ5X#;X=? W]E?\ 9]ATF&+4=?\
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MFUUQM9L=\.E>(-.TU)KK4+"ZL9))9(RF;79'(\L4I(D\R/\ U<>MX-U7PY\
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MDGE1DO(<[_+#U]'4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB?XS:_<Z5IU_X_U_5O%>M7ODBVALHX[F:,QF:20_N8_*EE7S#^[\V3W)L_\
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M!>"KW6=+TJ*SBM="MYK@Q6(U2_,?2*(GF6:022>6"7))ZT >L5P?C;X>Z?\
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M: /6/$WQ[TC2_&&I^$="T;6/'/BS2HH;O4]'\/\ V8MI\4H/E23S7$T5O&>
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MAX:TO08XMVHV\D::G?2R27$D<8-L\MMF0RQ1QBXACP99HO,Z#X:[OBA^W?\
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M+]BLGC[]EOP1JMZ<>&?CS\>X[S6M _YY6%S?R"2Q^T#$A_>:?%)YL8B/./J
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M2#]YDB0XDYXX^\AOO@/_ ,$?8TT^ZM]5:^\*1_O+NW,81-7N09!@2'F.*^D
M/<IDC'R4 ?0^L?M<>&;?PQ=>*M%\/^)/%?P]TV>2&^\9Z+91R:?:F*8Q3R[9
M)8[BYBBP9))K:*6+8),2'RY /;-'URP\1Z7::EIUY;WVFWD4=S;W5M()8IXY
M/]7(CC@@CT]:\6TS]E>VM?!\'@/5/B#XTU_P+#IJ:3_PC=U+8VL,MDD?EQQ2
MW%K:Q7.!QTE'F 8D$@,@/M.CZ'8>'-+M--TZSM['3;.*.VM[6VC$44$<?^KC
M1!P !Z>E 'SW^VO\=O&'P7^%^H2>#/#.HW/BK4Q;:?H6MJUE);"^N)A&(8[6
M2Y^T7%SY:R.D<=O*#D9!'FXR?VH_&7C.W_8D\?)%X6UZ'Q-=6=OX96Q\0QV=
MQ?ZD+V6WLGF$>FRR1>;)]HDV"/'[S_EEC -3]L"*_P#&'[0G[+W@);B"RL+W
MQ7<^+'N/(,DOG:1;+<1Q ;P,2"65">WR8Z8+/VT-.TWXF?%;]G/X5ZG9PR6.
ML^*[CQ)=2W,'VJ%XM)MI)9+62V/^M%P)C&3VP>),@4 =G\/?C%X*^'MO\./A
M[!#KUMX3N+*'0?"OC;44B_LS67M88XHHHYHI,^9*,^49(HH[GRR83(#'O[_Q
MY\9]$\)^*+'PC;V>I>(_'-Y9OJ%IX<T:..6ZEM8Y/*DG=WD2*WC!/$D\D0D(
MV1F23]W7D'[3FFZAXZ_:$_9P\$M:74NA1:]?>,[^\LXLSP2:3!']E+N/W:12
M2W/ER9'/F1@%">>3_9Q\(ZQ\5OBM^T1X\M?'.O\ @C69/'5QX8G@\-P6+VUU
M;:;#'#;2$7MK<XDQ))O\L@9/0=P#Z+^%/QFTKXLRZ_I]K::AH/B+0+W[#K?A
M[652*^TV0Y\OS(TDD0QRQ@212QN\<@)P<@@>G5YW\/?@[H'PXGUR_LHKJ]UW
MQ!-'<:UKNH3&6_U*6.,1K)+*.@ ^Y#&(XHLXBCC&17HE !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>7_V0!^%8WQ"^%_ASXL:)::3XJTLZA;VEY'?6UQ'<2VMQ;W41S'/%-$8Y(I
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M'M!C!C_=F-,=!7MM% 'SS\#?V79_V>?$%U8>$?'6L/\ "^1+B2W\$ZK%'/\
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M(Q(7R(XXP#A!74^%_"FG>"/"NC^'='MS:Z/I-G%8V=OYA?9#%&(XX\O_ +(
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M7>'O"WCGQ?XQTS3?LGB'Q2+7^U[S[7+)]J^RQ>5;_NR?+3$?_/,#KSFNYHH
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MATGXM^&;[X_:^KWOB_QU?7B69N/G?0M'BN98K?3(I#QY0,9E+QQQ^9(^9,D
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M\46,)N;G0X+^.2]MHL1_O)8<^9&,2Q\D?\M1ZBOE#XGQ^)?@'^PS\,_AOX:
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M8+#Q7JVLP>)-2DM-;U"^D,?]IZ#8QFXU"Q\V+][")(I(HXHXS_JH_*,N ?,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !17,^,/&VB>!=(DU'7-0M]-LHSCS+F;;YA^;]W'
M_??C[@YKF_ OQV\"_$34#9:!XBMKR^'"V\D<EM+)UYC$H'F?</3/2@#TJBBB
M@ HHHH **** "BN:\8>,M)\#^';K6M:N3I^E6I3SIA')((\R!.?+!/4BNEH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)YD<B>A_.@"C=>)M,T_PW+K\EW&-&BMS>O>1CS$\D1^89?DZC'/O7D<?Q_\
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MXX>)[:+4]-T3PAX9M;B+S(]*\0R74E]%_P!=?*XS]*M_L@_\F[^$_P#MZ_\
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MA[X(TK7/$6F7D5_?2VUJFC6 ^U7374HXMH\8\T_ZS\C7.?#'_DXCXT?31?\
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M0ZS ?&VH>')],L['RA_88E\ZZN<1?O9?,CX'$O\ J_\ GI7K%% 'SGI?PO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** .!\8_&CX=_#S4UTWQ?XZ\,^&-2DC^T+9ZUJ]M:2/'VD$<D@)
M'R=?:LC_ (:N^"/_ $6+P!_X4]C_ /':]5KY-_8.;_A,/#_Q4^))S?V_CCQW
MJ5_I'B"0YN+[2(B+:U'.)8XH_*F2.&7'E<X'- 'LV@_'KX?^,/&MIX4T#Q58
M:_K5SHYU^U72_P#2;>6Q%P;8RQW$?[K/F@QX\S.1TZUZ77Q1X'\6:CXH_;8^
M.&M:%86/C7Q!I-GI?A+0)5U3[+9:;;1Q&YU**ZEACE,7^E-A/,BDDDD$D<?[
MN&Y,/MGPR_:(T+QM\*?$?C;5(KCPH_@^>]LO%MC=9N?[)O;*(-=1>9&#]I6,
M'B2+_6 #H?D !Z;X9\3Z'XRT2VUG0=6T_7='N#_H]_I=U'<VS<["(Y(R0>>.
M/>M^OE3X8_M!:7X=^%7P8TW2?AM#X6\2_$B&ZN?#/@;2+JWCL+:'9)=&YDN(
MXXHXH?*>.63RXVE'GG$4L@P?9O GBKQMK4^JVOB[P/;^%I[*:);:YT[68]2L
M=0C>/)\N0QQ2HT;Y1Q+#'T_=F3/ !Z+17F/Q_P#BUIGP'^$GB7Q[K"&:UT.S
M,\-KN(^U3Y,<4.[RY/+\V22.+S,''F9/2O)+K]KS5]!^&.A?$[Q)\.+GP]\.
MI)K:VUK5)];BN+FQ\V;ROMMM;Q))'>67G>4(YHY?-DCD\R.'R]AD /JFBO!_
MV@/VD].^ _B'X?:.]@-9U[QKK!TFQT\S&*62,8\SRY#$8S)YDEM#''(\:&2Z
M&^2...21-3Q!\8I_@_\ #^\\1?$K1['1+LW:V>F:/X4OI=8NM7N)3^YM;426
MUM))<RR>8/*\O&/G,F ^P ]DHKY\U;]H+Q!\/_&/@NQ^(?@F+PUX=\7:E_8^
MEZK::X+^YMM0D&;2UOK40CRS(!*-\$MS'')'@R&,B6MC5OCQ?:U\2_%/@'P!
MX<M_$WB7PK'8SZU-K&I_V;86/VN-WAC$HBEEDEV#S,)%Y8C!_>^9^[(![517
MA&I?M$7^@Q_#K1-7\$:GIWQ,\<&ZBLO"<U];/':S00F6X>:]C)B^S1C8?-C\
MR4QN,0F3,0[/P)XJ\;:U/JMKXN\#V_A:>RFB6VN=.UF/4K'4(WCR?+D,<4J-
M&^4<2PQ]/W9DSP >BT5YC\?_ (M:9\!_A)XE\>ZPAFM=#LS/#:[B/M4^3'%#
MN\N3R_-DDCB\S!QYF3TK+^&?Q<UWQ;X;@\9Z[HFA^&OA[<:0-4AUJ;Q!))*T
M>Q9/-DBDM8HXK;RS)()9)!)Y8B\V**0R1Q 'L-8'BCQ7IW@CPKK'B+6+@VNC
MZ39RWUY<>67V0Q1F223"?[()_"O"]7_:B\03_#6Z^*/ASX<W&I_#6SB:^EN=
M3U,:=JM]8129EOK*QDB(DB\K,L7G36\D@S^[&8C)D_MI>-I?%W[']^W@/6(9
MK[XA1Z=H_AU96CA_M3^TYHD$$0N,#,MM++UYC +_ +ORR0 ?17A?Q7IWC?PK
MH_B+1[@W6CZM9Q7UG<>64WPRQB2.3#^Q!_&N@KPJ/XB:3X)UZQ^#GPO\._\
M"1:YX;TBV62S:_:'3=!M8UCCM8[Z]Q+)')+&K>5$(Y99!'EPD>9:L?#']HB#
MQ=>>.]'\56,'@7Q+X#E!\26D]\+BRMK:5/.MKJ.[\N,&*6$-)^\$<D>#YD8X
M- 'MM%?/VG_M#^(/%W@Z7Q]X7^&6JZW\/!%)<Q3+<>5KVI0QD^7<6.F/'B2.
M4>7)%YLT4LB9/E?ZH2X'AK]L[1M6^$EG\0;G0=2.D>(/&;>%?!L&E31W5SXD
MS.8H9T$GDK;>88K@^7<&/R_*//*9 /J"BO,?!/B?X@:AXIO-,\8^ ].T2PAL
MX[NVUG1=>&I6SR>81);2"2*WFCEP(Y!B-XR"?WF>*XNW_:"USXA:=K^L_"'P
M/:^.M$TF6XM(]7U/7#I%MK<L6 8],D$$PN1YOF1&:7RHO,_U<D@\PQ@'T%17
M ?!OXJZ'\</AGH/CGPU),=(UB-I(EN(_+EC\N4QR1O[H\<B<>G?K6'\1/C7:
M>$?&VD^!M&TJX\4^/M<22ZM-&M)?+6UM4P#?7TI_X]K42 1^9B1R3B**4@QT
M >MT5YSX=\8:M::5K-SXZT.+P7%HT7VNXU$ZO#<Z5)$?,D>2*YQ%)B)%S(9H
M8L<X,@_>5YU_PT5XQ\2>!S\0O!'PKO\ Q'X$SYT/VF^-EK.IVGFD27=C8>3)
MYD9C_>Q"66WEE' CYC,@!]%T5X1XH_:H\):#^R_=_&ZSD-]X<_LC^U+6W\P!
MY)I,1Q6DAB$@CD^T$0R$9\N0'/0URVM?M8>)/ OP]T#Q_P".OA7J'@GP-,MD
MGB"74=7BDU31_M. )Q91QGS;82RQ1']Y'=<R'[*/+P0#Z@HKY*_;T^(_Q'\&
M_"TZ5X#_ +/L=4\77UEX>T;5XM5FM-2.IW,Q7R8HC;&($PQR8FDN8O+R2/GC
MC\SOKKXL3_!OPYX=TCQ?X?$GC+6+V/2?#_ACPOK4FO7^IQQ11YD\V[BMC^[7
M>\LDO[N,8=Y<R4 >[USFI>+-#TCQ!I6AW^K:?:ZWK!E_LZPNKJ-+F\\H>9)Y
M4?5_+!!..G?U/@7Q;_:I\7?!.UTVP\0?#'[5XN\07=O9>'K/1M<:YTC4KJ6Y
MBB%B]_+:Q?9;G#S2XDA\LQQ'$N<B/J?&'Q&T:3]J'P!X A\%:?XD\4VVDZAK
MD^O7ACCNO#EB0+<30F2,F07,O[DB*0$?\M!B@#W>BOFKPK^T]X@^)'Q.^(_A
M;P)\.;C6[#P?J2:*GBB_U(V.E37WEDW44OF1&:-HI!Y7[F.YZQDB..425U/P
MR_:(T+QM\*?$?C;5(KCPH_@^>]LO%MC=9N?[)O;*(-=1>9&#]I6,'B2+_6 #
MH?D ![917A/A'XV>./']GX+\4:/\,&D\ >(_(GCNI=>ACU>SM98O,CNIK+R_
M)\K)C.(KJ27RY ?+\S,0]VH \Z\??&#PM\+;S1[/Q#>7,6J:V\L6F:98:?<W
M][?F./S)/*MK=)97$<?WWV8 QDC(KI?"_BO3O&_A71_$6CW!NM'U:SBOK.X\
MLIOAEC$D<F'_ -D@_C7QQ^SSJ'Q ^)7[6?Q3^(MQX6\,:EI^AS6WP]CO?^$C
MN4_LB.V99M2M[9#81F[82R>9F6.(9_=QRF/D>RV_[06N?$+3M?UGX0^![7QU
MHFDRW%I'J^IZX=(MM;EBP#'ID@@F%R/-\R(S2^5%YG^KDD'F&, ^@:*\=^'7
M[1GA3X@?!_4_B0PU+0-&T5K_ /MW3]6M@M_I#V)D^T175M$9#%* GF^7_K")
M(^.0*Q?V<_CKXG^/W@_PQXQT[PGI>F^#]5659KN3799+B-XS(/W,/V0>:!(/
M)D,LD6)(I?+$L?ERS 'OM%?*NG_MJ6DG[%4G[0FH^%9K6V$,A3P_:7OFN91?
MFR13,T<?'F"/+>7E 3]_')I_[:EI)^Q5)^T)J/A6:UMA#(4\/VE[YKF47YLD
M4S-''QY@CRWEY0$_?QR ?55%>)Z[\>I=(N/"7A.7PQ=77Q5\2Z?_ &@/"%A?
M1R_V2/*S++?76/+BMHY?W7G 2&0_ZJ*4_NZY?Q!^T_XD\*?$KP5\.=5^'5U%
MXW\3ZG%'']FU,2Z6]B(II;N\M;R2*/SC;111^;;R16\A,O[OS 0Y /I2BOG7
M6/VH)KW]H+7O@_X,\/:?XE\4:'I5MJ-T=1U66PCMY)3DB0_99/W21/;_ +R+
MS7,ES#'Y6/-EBW-1^.U[/XRA\">'O#$7B3XCVVFQW^M64.HF/1]$,F"([J_\
MDR R@3&*-+9Y)!$)#%%&?,H [GXA?%#PY\,?^$=?Q'J#:?\ V_JUMH.G'R))
M?M%]<$^5%\@[^6>>G'6NUKXE^(OBK4_CO^UI\%_ASJGAW4-%;P5>7WB_Q)I-
MUAK8O;V\*:9J-K<\?:;;[5<21C'ER9#^;%'C ^VJ .&\5?%'P]X6\<^$/!VI
MZE]D\0^*1=_V19_9)9/M7V6+S;C]X!Y:8CY_>$=>,UW-?)_B2[M_%'[=AUG4
MK_3I?!_PM\"O?2W4U[%%%H>I7\L@DEFY#9DL;:0XD/EQQXDX,@)Z7_AHKQCX
MD\#GXA>"/A7?^(_ F?.A^TWQLM9U.T\TB2[L;#R9/,C,?[V(2RV\LHX$?,9D
M /HJBO$IOVHO R_ _0/BDUS<7VC:]#;'2;"Q5+J_OKV48CL88HR1)=>8&C\K
M/$D<F<;"1SWCC]I/Q/\ ":XT74O'_P /_P"Q/ >K7L=@->TW6HKV;1))98HH
MO[4C,<45M'F0^9+%+<QQR1F/=)YD9(!ZS\5OBAX;^#_@'5/&'B_4CI/AW3O)
M^TWGV:2;RO,ECBC/EQ@R']Y)'T'?M7;5\J_MO:3)X^T7X6?"^&>UNH_&?C>R
MBUO0VGCCFU#1[8/=7P4G$@$8BA)DBQ(#Y8S^\Y]&^%/QF7XV>)/$(\/:,+_X
M>::RVUOXUDN<1ZO?1RGS([&+R_WMM%@C[5Y@!DR(Q( 9* /0O#?BS1/%']H)
MHVKZ?K#:9>2:?>_V?=),;:YC($D4H3_5RC/,9Y_.NAKY1\(_M.>$_#?[-7Q,
M^-]EX*TWPWX2CU74KS3)-.81_P#"3R>:MO%>RF*+S(I;JYQ$?-C\R/;E^.:O
MZU^UAXD\"_#W0/'_ (Z^%>H>"? TRV2>()=1U>*35-'^TX G%E'&?-MA++%$
M?WD=US(?LH\O! /J"BO,?BM\9M*^$TN@:?=6FH:]XBU^]^PZ)X>T94EOM2D&
M/,\N-Y(T$<49,DLLCI'& ,G) /EOQ;_:I\7?!.UTVP\0?#'[5XN\07=O9>'K
M/1M<:YTC4KJ6YBB%B]_+:Q?9;G#S2XDA\LQQ'$N<B, ^H***^=O#7[1OB7XJ
M>%8/&WPU^';^+_ 4EV;>&]N-:ATW5+]([IK>6XM+62(QF/"N1]IN+:0^7)F-
M/D,@!]$T5\E?MZ?$?XC^#?A:=*\!_P!GV.J>+KZR\/:-J\6JS6FI'4[F8KY,
M41MC$"88Y,327,7EY)'SQQ^9WUU\6)_@WX<\.Z1XO\/B3QEK%['I/A_PQX7U
MJ37K_4XXHH\R>;=Q6Q_=KO>627]W&,.\N9* /=Z*^7_BW^U3XN^"=KIMAX@^
M&/VKQ=X@N[>R\/6>C:XUSI&I74MS%$+%[^6UB^RW.'FEQ)#Y9CB.)<Y$?,?M
MA^-?B@_C_P"&?PY\*V^GVC>,/$4,D?\ 9WB6ZL-0U+3;*+[3?1RO':C[%&"8
M\RPW,DQ4?NXY/,DC !]CT5XMK7QOOO#&L>&_"-_X9M]5^*NLQ37,7AKP_J+7
M=M9VR,X^W7-U)#%Y-KQ'&9##O,DGEQQRD<L\ _'J\U3XJ:K\+O%WAN/PWXYL
M].CUVWM]/U$ZE8ZAICR"(W,5R8HBGER[HY(Y8XST,?F"@#VRBOEWP]^UM=_$
MKXP?$/X>?#_P?_PDNJ^%[XV4NJRW\]EI\4D8B$_VZ0VI\C]Z)88A$+F24VLI
MQ''B6I/AW^U]_P +BU"Y\,>$/ VH7'Q&T@21>)-'U"[$&F>'+N*8QR0W6I1I
M*)!(T<GD_9HI3)Y9\Q8AYGE@'T]17A/@O]J;PMXB^$>O>._$LK>!XO"5[=:1
MXKL]2E\W^R-2M^)K82Q#%U\TD8C,7^L\Q !YA\L8/BS]IOQ#X%\):?\ $?Q5
M\.9_#7PPN);?[9>:EJ8&NZ/#< 1I<7.F+"8Q^^DB4QQW,DH23/E>8)(@ ?2E
M%>#?'[]HX_!?7OA_X=L?"VH^-_%/B_5380:-I<GE7!M8QFZN8R?W68LQ<2R1
M#$N?, CDPMA\?M3L?B_HO@;QQX,;P=>^*[&YNO"UPFIB^%XUL#+<VURL: 6]
MS%%Y<G'FPY,@CFD('F 'O%%?%?Q@^('Q<\3?M;?#CX>^'-,TN&RTB*_\6:GI
M-IXMNK'[;9)_HUC+?2I8@Q@3'_CUB^TQR'B0>6!)7KLGQR\0>)?'VM> O!_A
M:PUCQMX7LK"Z\3'4-8DLM'TZ6ZB,D=M%<_9I)KB7 W@BV$?E\F2.3]V0#W>B
MN.^'NM:[XD\)Z7J7B/P]<>$]9N(2;[1KNYBN6M9"!\OFQ$QR=.".Q'"'*5V-
M '.:EXLT/2/$&E:'?ZMI]KK>L&7^SK"ZNHTN;SRAYDGE1]7\L$$XZ=_4]'7A
M'C#XC:-)^U#X \ 0^"M/\2>*;;2=0UR?7KPQQW7ARQ(%N)H3)&3(+F7]R1%(
M"/\ EH,5@^%?VGO$'Q(^)WQ'\+>!/AS<:W8>#]2314\47^I&QTJ:^\LFZBE\
MR(S1M%(/*_<QW/6,D1QRB2@#Z5HKPGP7^U-X6\1?"/7O'?B65O \7A*]NM(\
M5V>I2^;_ &1J5OQ-;"6(8NOFDC$9B_UGF( /,/EC3\+?%3QWXF71]5_X5=J&
MF>&]4,12&[U*%-<LQ)C,E]8R^7%#$/WG^JN99?\ 5?NLF1(@#KOB%\4/#GPQ
M_P"$=?Q'J#:?_;^K6V@Z<?(DE^T7UP3Y47R#OY9YZ<=:[6OEGX]Z._Q*_:K^
M '@I;JUU#1]#GU+QQK6DK<1K-;FU2*'3;H\^8!]IN2!CAR).OEG'HOPH^-Q^
M*GC#XF6&F:&8?#7@[5X]#BUY;C<=2OHXP;Z+[,8Q)&;=S''GD2YS&<"@#V&B
MO -?_:NT3PG\4/B#X=U-+?3_  CX T&UU3Q'XLN;O8MG>W,F;:P^S>49)#)#
MB02QF3D^7CS*;J'[0_B#PCX.B\?>*/AEJNB?#PQ1W,LS7'FZ]IL,A'F7%]IB
M1XCCB'F22^5-++&F#Y7^M$0!VND_'KP!JV@^*=;C\3V-EH_AK5I="UK4-3_T
M*WL;Z(QI)%))-Y8X,L8ST]#T%>F5^?GPQUR#X5_L*Z!KGC7P-I_CWQI\7/$T
M6HR^&=6FA^S>(]3U.^\VUDD)BEMK<&VBBEYCC0>4,[)*^@OBE^TC-X#^.7@S
MX7Z!X(U;Q[KVJ:=<:QJ4.DRQQ2:;8Q'RHIO])\NW(EE$D7,L>,#O+&" ?0-%
M>)^ ?CU>:I\5-5^%WB[PW'X;\<V>G1Z[;V^GZB=2L=0TQY!$;F*Y,413RY=T
M<D<L<9Z&/S!5+0_CUJ7Q074K[X9^#W\6>%=-NY;6?Q%<:E]AAU8Q8\TZ.?+D
M%U@^;%YDKVT1D'[N60>9(@![S17@_P  ?VD)?V@[OQO<6'A'4-#\,^'KVWTQ
M+W4Y=EY/?&W$E]:RVN!);2VTDD<1YD#D_N\@5UGQA^->C_!;1-&NM5L=2O[C
M7-6MM TC3=-2/[1?7UR<0Q(99(XX_P#EH<RR1X\L\],@'IE%>8^"?$_Q U#Q
M3>:9XQ\!Z=HEA#9QW=MK.BZ\-2MGD\PB2VD$D5O-'+@1R#$;QD$_O,\5\WV/
MQ!^-OCS]LC5-)M-)T*?2_ 7AV&'4="M/&5]:Z7%J=[)YD4LT@T\274IM1Q&8
MI88O]9YL<O% 'V]17@VA_'K4OB@NI7WPS\'OXL\*Z;=RVL_B*XU+[##JQBQY
MIT<^7(+K!\V+S)7MHC(/W<L@\R1*WP-_:2U+]H*'X@W/A?P9<:?I_AR6+3+&
M7Q!<&SEN=3^S"2YLKFV\HR6IM9)4BD/[T'DQ^9B@#Z"HKXQ_9Y\>?%OXE?M&
M?%/79],TK4?"6BZG:^#HK;_A+KI+#29+8 ZE]EM_L,?VN;S)!^]FBBZ>5'*8
MJ],M_P!H+7/B%IVOZS\(? ]KXZT329;BTCU?4]<.D6VMRQ8!CTR003"Y'F^9
M$9I?*B\S_5R2#S#& ?05%?/^H?M9^%(?V4;WXZV#3W/AN/3I;NUMKE7AFEN/
M--O%:R$"01L;C$)D DC!_>9*#-<O<?MC7^B_#7P_\4M;\ 7%C\*KJXMX-3UZ
M;4/])MHYI3%%?V]DT"R7%B93#Y<I\JX>.42"VP 2 ?5%%?+^O?M??\([X)LO
MB>_@G4+3X,SWT5O>>)M0N?(OXK>64PQZG#IOEEY+.21H/^6D=QB3S!;$8,GH
MOQ$^-=IX1\;:3X&T;2KCQ3X^UQ)+JTT:TE\M;6U3 -]?2G_CVM1(!'YF)').
M(HI2#'0!ZW17B?@'X]7FJ?%35?A=XN\-Q^&_'-GIT>NV]OI^HG4K'4-,>01&
MYBN3%$4\N7=')'+'&>AC\P5RWA7]I[Q!\2/B=\1_"W@3X<W&MV'@_4DT5/%%
M_J1L=*FOO+)NHI?,B,T;12#ROW,=SUC)$<<HDH ^E:*\1^'/QPN?C'\,=7UG
MPYX;AMO&FB:I)H&L>'-8U(016&I6TL8N;8W444H< ',<D<9\S]WGRR3L\2_9
M3^,GCS7_  S\1_C#XV%C<_#34]5U+4XM<;Q'?2'3]'LH72,6.G?9 /*!BES(
M?L]Q+S))&?W>0#[;HKPGPC\;/''C^S\%^*-'^&#2> /$?D3QW4NO0QZO9VLL
M7F1W4UEY?D^5DQG$5U)+Y<@/E^9F(>[4 %%>#:'\>M2^*"ZE??#/P>_BSPKI
MMW+:S^(KC4OL,.K&+'FG1SY<@NL'S8O,E>VB,@_=RR#S)$J_ O\ :<T[XT?\
M+%U:30KOPOX+\)S1V[ZUXCN?LT@N5M5EOX;FWD ^RFU,@20DE,Y(.!P >G?#
MWXH>'/B=_P )$_AS4&U#^P-6N=!U$^1)%]GOK<CS8OG';S!STYZUVM?GU^RG
M\4=?^&O[*<GQ'7P)_P )DUY>ZAXR\=ZTNJ16SW$DMR9)9[&/RS#<2Q6D<<DL
M0>WC22/R@?M FBC^HO%7[1GA3P[X:\#ZMIKZEXFO/&YA/AK1M%@!O]822)9O
M-CBF,8CCCB<2222F..(']X02* /8Z*^?W_: \1^#?B5X7\(?$OP-;^&(O$\W
MV/1?$FA:Y_:.EF]"RO\ 9+F66&VDAFD$<?EQB.3SO-./]7)C=U[XW&Q_:(\+
M?"?2M#_M.]U'2+K7=8NVN/*_L:QCPEM-Y9C_ -)$MP3%B-P8R,G@T >QT5XW
M\6/C</AYXU^%WA'3]';Q'XD\;ZO)81V;7'V7R+&&(R7U^7,9CD\E/+/E9!DW
MXCZ&O!;'X@_&WQY^V1JFDVFDZ%/I?@+P[##J.A6GC*^M=+BU.]D\R*6:0:>)
M+J4VHXC,4L,7^L\V.7B@#[>HHKXAL?B#\;?'G[9&J:3::3H4^E^ O#L,.HZ%
M:>,KZUTN+4[V3S(I9I!IXDNI3:CB,Q2PQ?ZSS8Y>* /J7Q5\4?#WA;QSX0\'
M:GJ7V3Q#XI%W_9%G]DED^U?98O-N/W@'EIB/G]X1UXS7<U\5>//$UUK/_!0;
M0[.S2W\:WG@?P5++I&CV]W%%_9VL7UP8I)+DQYDCA^PQYDDD21(Q)%Y<9FN+
M>.7VCX8_M$0>+KSQWH_BJQ@\"^)? <H/B2TGOA<65M;2IYUM=1W?EQ@Q2PAI
M/W@CDCP?,C'!H ]MHKYKU?\ :B\03_#6Z^*/ASX<W&I_#6SB:^EN=3U,:=JM
M]8129EOK*QDB(DB\K,L7G36\D@S^[&8C)[IX7\5Z=XW\*Z/XBT>X-UH^K6<5
M]9W'EE-\,L8DCDP_L0?QH Z"N*^(7Q0\.?#'_A'7\1Z@VG_V_JUMH.G'R))?
MM%]<$^5%\@[^6>>G'6N2\4?&9F^(DWP]\%:.?&'C>QM!?ZBLUX;72]'BD.8Q
M?78CE,<DP$GE1112R'!)$<69*\'^(OBK4_CO^UI\%_ASJGAW4-%;P5>7WB_Q
M)I-UAK8O;V\*:9J-K<\?:;;[5<21C'ER9#^;%'C  /K?3?%FAZOX@U70[#5M
M/NM;T<Q?VC86MU&]S9^:/,C\V/JGF $C/7MZCHZ^=OA[\:O"FI>+OCUXKC\-
M:=X=\.^#+[^SM8\<VT6;G5Y;*V\R[CEB$0F_T4?N@?WGF9S'6GX1^-GCCQ_9
M^"_%&C_#!I/ 'B/R)X[J77H8]7L[66+S([J:R\OR?*R8SB*ZDE\N0'R_,S$
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MJ_"[Q=X;C\-^.;/3H]=M[?3]1.I6.H:8\@B-S%<F*(IY<NZ.2.6.,]#'Y@H
M]LHKYJ\*_M/>(/B1\3OB/X6\"?#FXUNP\'ZDFBIXHO\ 4C8Z5-?>63=12^9$
M9HVBD'E?N8[GK&2(XY1)73_#GXX7/QC^&.KZSX<\-PVWC31-4DT#6/#FL:D(
M(K#4K:6,7-L;J**4. #F.2.,^9^[SY9)V 'MU%?'G[%/CCXG_%27Q=\0M<MM
M/UCP?XH\37KZ;JDGB6Z<6NFVX\FVCL;!K41B,2QR#S9/LTLO^LDC)$>?L.@
MHKS'XK?&;2OA-+H&GW5IJ&O>(M?O?L.B>'M&5);[4I!CS/+C>2-!'%&3)++(
MZ1Q@#)R0#Y;\6_VJ?%WP3M=-L/$'PQ^U>+O$%W;V7AZST;7&N=(U*ZEN8HA8
MO?RVL7V6YP\TN)(?+,<1Q+G(C /J"BOG[XI?M(S> _CEX,^%^@>"-6\>Z]JF
MG7&L:E#I,L<4FFV,1\J*;_2?+MR)91)%S+'C [RQ@ZO@'X]7FJ?%35?A=XN\
M-Q^&_'-GIT>NV]OI^HG4K'4-,>01&YBN3%$4\N7=')'+'&>AC\P4 >V5Q?\
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M\0_$UW-Y4@42@RF:*.V0<26\4,OE<G,A&/\ EF/IW_A%=%_X1C_A&_[(L/\
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M?WPC(/F>9LCXSDG[3T?0[#PYI=IING6=O8Z;9Q1VUO:VT8BB@CC_ -7&B#@
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MTV;PWI%QI^@36]SI-HUC$8M.EAXADMX]N(C&!A/+Z=!0!\W?M%ZC8^!?V/\
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M&T%G-&T^E2R"..Y!DC&.3_JSB3U'>@#TRBN+_P"%I>&_^%K?\*Z_M(_\)?\
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M(8MAEDL;F6)(KH;)!)F&23]V?,&8^:]7H **\L\8?'3P5X3UN?2;[6RNH6C
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MKYH ],HKAOA[\4/#GQ8T2[U;PKJAU"WM+R2QN;>2WEM;BWNHCB2"6&41R12
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MQ"O/'NA>)]>^'OBB^M%LM7N/#:VK+JT4?^I^TQ7-M-%)+%]V.;RQ((W*=,8
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M>7/@7P;;6\\?VS[/;7EU;6T<7DQS2+P)90(XSY?60#&2!7RGX*T"[\.? _\
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MU[O^S[\-5^$'P1\$^"FM[&*XT72;>WN_[/CQ;R7.S-Q(G _UDIEDZ#_6=.:
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MXA7GCW0O$^O?#WQ1?6BV6KW'AM;5EU:*/_4_:8KFVFBDEB^['-Y8D$;E.F,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU]#4 %%%?._['/Q0\3_&/P'XS\9ZSJ?]L>'-0\8:L?"-XMM'$'T..7RK?$:
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M^!OP9UWX=_$#XM^,?$]S8:CXB\;>)6N+6ZL9).-'MXA%I]M+'Y<<8DB3S1D
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MW@'E7?@9\4M1\%_L*_%_QA8^(3:>$](O_$ ^&NJ:A,LOEZ7"#%ID0^T$R?\
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M/SO*ZV_F8C ,J'P-\(O _P #=;$6D:3/\(I+>X\3W%I)&=4TO[/_ ,?,DMO
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MQ:;_ * #?6'VJ60QB*Q\I!Y76')\PDGCSK]CK]GOPQX]_9DU'XA?&J+^U_\
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M#_LV_ WQ#\15T;_A(%T;[-NTXW1MO-$MS%" )/+DQS+GIVH ]=HHHH ****
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M%/VA/C1>?"NQ\/Z+X;LH_$'Q#\9:BNB^'])NG(A67!:6^N!'^\^RVT8\R4Q
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MTT#5KZ^F\-SVEO9:G?!O.FC2.0R0"/[%$/+C\J2/[3++%))YT49CCK2_9_\
MB?\ &7]KSX.IXR_M6Q^#^C7-FT.EW6BVT6IW=_?1M)%+=2)<B2.*R\W@6N/.
M/ED_:43'F:GQ,\!ZU\&?^"=^J^!/#WA9?$OB.W\(1>'9=-\-VS@3W5RB6EW<
MQ(D7F2#S)9K@_NP9,'.,YJW\7OA]J'P-_8$\0_#_ ,(^&Y_%E[8^%O\ A'(;
M'1++RYKY[E1;377DQB3G=-+<R#G.),GGS  <IJO[9'B;4/\ @G+>_':'2X='
M\43Z;+;Q16D@,-O>F^^P"YC$D4GR^83*(I,]!&2?]94WQ4^(WQI^ W[.]O\
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ML0,49\F3S#Y?N_@7QY;_ ! EOY;+1->LM/MMBI<ZWI%QIOFR9),4<5PD<IV
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MN]/CN!?7QMWAM91*3F(VQDED&,Y)!X,8->L5Q7Q"^*'ASX8_\(Z_B/4&T_\
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M_P#;W]G_ &:3_CQ\WR?-\S'E_P"MXZY]JU?#/B?0_&6B6VLZ#JVGZ[H]P?\
M1[_2[J.YMFYV$1R1D@\\<>] &_1110 4444 %%%% !1110 445PWBKXH^'O"
MWCGPAX.U/4OLGB'Q2+O^R+/[)+)]J^RQ>;<?O /+3$?/[PCKQF@#N:*** "B
MBB@ HHHH **** "BBB@ HHKB_P#A:7AO_A:W_"NO[2/_  E_]C_V]_9_V:3_
M (\?-\GS?,QY?^MXZY]J .THHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ?@I\,;6S:#P9X LK"\^($$T@$=U);!X=+L<2#%S%<FU^TRQ&(QB/8/-\P4
M?H+X3U+4=2\*Z/>Z[I)\.ZS<V44M[I?VH71LYC&/-A\U.)-C<>9T/7C-?-W[
M>GQ'^(_@WX6G2O ?]GV.J>+KZR\/:-J\6JS6FI'4[F8KY,41MC$"88Y,327,
M7EY)'SQQ^9]:U\@_M66+^-/VH/V6/!5UJ$UMHMSKVI^(I8K4)\U]IEM%<VIW
ME,X_>2@COYA]J *7[7WB+Q;X/_8F\7Z3J7]A^$?$NKBT\,:8O_"4'4H[J*XD
MBBD6:]OXHCYGV8W7F229Q'&93*#DQ]G9?&"/X.R_#;PU?^"KCPI\+M<N+?PG
MX3U.:]EDOK>X\I4L8;RQDB\VW65(I1'(99)$_=_:8XG+B/#_ &DF;XF?M,?L
M\_#A,W=E9ZS=>.-5-BO^F6)TV'%A+(#GR[66YDEC)<?O#@1R U>^/>CO\2OV
MJ_@!X*6ZM=0T?0Y]2\<:UI*W$:S6YM4BATVZ//F ?:;D@8X<B3KY9P =?XP^
M(VC2?M0^ / $/@K3_$GBFVTG4-<GUZ\,<=UX<L2!;B:$R1DR"YE_<D12 C_E
MH,5@^#_VF]8^)WQ,^(G@OX<>'=-\1/X'U-+*^U#6-<N-.A.8SY@D_P!!D((F
M$L<8C$HD%K+)))$/)^T<O\.=<LO%'[9WQQ^(VKWEO;>'_ .AZ?X-LM<BDV6)
MB;_3M2%S,3L\VVG"B0 IY:'$@[UI?\$^=-OU_9Y;QOK5I<V6N_$37M2\9ZG;
M2P%((9+FX_=_9T;]YY4D4<4D>3(?WA.3D4 =^_QTO?%GC+Q%X8^&OARW\7:G
MX>F6VUC5]2U)M-T>VN,XDLH[F.&YDENHQY1DCCB,<8D/F2QR8C/B_@GQ'/\
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M=9\:>.OAQ/9:((I#I\VEZF+WRI3&[V]OJ>R+_0VDD\J+S(?M40DDP90/+,G
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MW4?Q"\3?'/XG/80>=XB\;3Z98:Q9-*;34](TZ.*VLI829#'(.+@>;'P9/,]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 <1X\^$G@SXG26!\8^#=!\6_8!)]E_MS3HKX6_F8
M\SRQ*#C/EQ]/05OZQH=AXCTN[TW4;.WOM-O(I+:XM;F,2Q3QR?ZR-T/!!'KZ
MUL44 <1X#^$G@SX8R7Y\'>#=!\)?;Q']J_L/3HK$7'EY\OS!$!G'F2=?4UJ_
M\(KHO_"3_P#"2?V18?\ "3?8_L']K_94^U_9O,\WR/-_UGE;_P!YY><9YZUT
M5% '._\ "*Z+_P )/_PDG]D6'_"3?8_L']K_ &5/M?V;S/-\CS?]9Y6_]YY>
M<9YZUE>//A)X,^)TE@?&/@W0?%OV 2?9?[<TZ*^%OYF/,\L2@XSY<?3T%=O1
M0!SFF^$]#TCQ!JNN6&DZ?:ZWK!B_M&_M;6-+F\\H>7'YLG5_+!(&>G;T,GB;
MPQH?C+1+G1M>TG3]=T>X/^D6&J6L=S;-SO!DCD!!YYY]JWZ* .4\$_#WPI\.
M=+FTWPKX;TGPS8R2_:9;31;&*UA>4@?O/+C Y^0?E5C3?">AZ1X@U77+#2=/
MM=;U@Q?VC?VMK&ES>>4/+C\V3J_E@D#/3MZ'HZ* ,#PSX8T/P;HEMHV@Z3I^
MA:/;G_1[#2[6.VMEYWDQQQ@ <\\>]<KX=_9_^%O@W6K;6?#OPW\(:!K%OD0:
MAIFA6MM<0Y&SY)(X\]#^M>DT4 <IXV^'OA3XC:7#IOBKPWI/B:QCE^TQ6FM6
M,5U"DH!_>>7(#S\Y_.F:9\.O"^B:C::CIOAG2]/O;'3(]'M;JTLHHIK>QC.8
M[6.3 (B!QB,?)G]>NHH *\TOOV?_ (7ZMHNF:+>?#KPE?:-I1D_L[3;G0[66
MULO-/F2^5$8\1>8>3CV_'TNB@#R7]H*X^)$/PYOK3X56,,WCC5)H;"RO+UHO
MLFEB20"6]F\R0<11[V CCE)D,?[N09%7/@O\&/"GP \ Z?X/\&Z:;'3[<B22
M:4#[3>3?\M+B:7_EHY^G8 83&/3J* "N4\;?#WPI\1M+ATWQ5X;TGQ-8QR_:
M8K36K&*ZA24 _O/+D!Y^<_G75T4 <CIGPZ\+Z)J-IJ.F^&=+T^]L=,CT>UNK
M2RBBFM[&,YCM8Y, B('&(Q\F?UN?\(KHO_"3_P#"2?V18?\ "3?8_L']K_94
M^U_9O,\WR/-_UGE;_P!YY><9YZUT5% ''VOP^\+VNDZ]IL/AO2+?3]?FN+G5
MK1;&(1:C+-Q-)<1[<2F0'#^9UZ&MC1]#L/#FEVFFZ=9V]CIMG%';6]K;1B**
M"./_ %<:(.  /3TK8HH XK_A4G@O_A._^$U_X0[0?^$QS_R,7]FQ?VA_JO)_
MX^<>9CROW?7I[<5K>&?#&A^#=$MM&T'2=/T+1[<_Z/8:7:QVULO.\F.., #G
MGCWK?HH ^?OV@OASJWQ5^(7P5L(M!NKKPOHWBL^+=5UJ"^CB-A-96T@L8?*D
M!,BS32C/E@X$9SCS/,'I.A_"GP9X1\2:EXCT;PAHFC^(=2\UKW5M/TZ**[NO
M-E$LOFRH/,DS)^\.3UQ7<44 8'B;PQH?C+1+G1M>TG3]=T>X/^D6&J6L=S;-
MSO!DCD!!YYY]JQM'^%'@CPZV@+I7@_0].?0#<_V0+/388O[-^TDFY^S$+^Z$
MF3O\O&<G-=Q10!SFF^$]#TCQ!JNN6&DZ?:ZWK!B_M&_M;6-+F\\H>7'YLG5_
M+!(&>G;T,GB;PQH?C+1+G1M>TG3]=T>X/^D6&J6L=S;-SO!DCD!!YYY]JWZ*
M .'T?X4>"/#K: NE>#]#TY] -S_9 L]-AB_LW[22;G[,0O[H29._R\9R<TOC
MSX2>#/B=)8'QCX-T'Q;]@$GV7^W-.BOA;^9CS/+$H.,^7'T]!7;T4 <C8_#_
M ,,:+X/E\(V'AO2M/\*RPRVYT6ULHXK$Q2'][%Y( CQ)YCY&,'<:K> _A)X,
M^&,E^?!W@W0?"7V\1_:O[#TZ*Q%QY>?+\P1 9QYDG7U-=O10!Y+\)?A7?^%-
M8\2>*_$>L76M>,/$[Q27TGVCS+6QMXFF-MI]L"(\0VXF<>9Y<<DLDDDKX,GE
MQ^M444 </KGPI\&>+O$FF^(]9\(:)K'B'3?*:RU;4-.BEN[7RI3+%Y4KCS(\
M2?O!@]<UK>&_">B>%_M[Z-I&GZ.VIWDFH7O]GVJ0FYN9"#)+*4_UDIQS(>?R
MKHJ* /-/^&??A?\ \)3_ ,))_P *V\(_\)']N_M'^UO["MOM?VOS/,\WSO+\
MSS/-_>>9USS[UQ?C3X=:QXT_:X^&OB:ZT.>'PKX'T/4[JTUJ*^B_TG4[XQ6W
MV62W/[W$=M'+)YG3,@Y'EX?W^B@#B/ ?PD\&?#&2_/@[P;H/A+[>(_M7]AZ=
M%8BX\O/E^8(@,X\R3KZFCQY\)/!GQ.DL#XQ\&Z#XM^P"3[+_ &YIT5\+?S,>
M9Y8E!QGRX^GH*[>B@#D;'X?^&-%\'R^$;#PWI6G^%989;<Z+:V4<5B8I#^]B
M\D 1XD\Q\C&#N-7/^$5T7_A&/^$;_LBP_P"$9^Q_8/[(^RI]D^S>7Y7D>5_J
M_*V?N_+QC''2NBHH YW_ (171?\ A&/^$;_LBP_X1G[']@_LC[*GV3[-Y?E>
M1Y7^K\K9^[\O&,<=*P-*^"GP_P!!TRRTW3_ OAO3]-LM1BUFVM+72;:..VOH
MQ^[NHT$?$P&0)?\ 6#L?3T&B@#E/&WP]\*?$;2X=-\5>&])\36,<OVF*TUJQ
MBNH4E /[SRY >?G/YT>"?A[X4^'.ES:;X5\-Z3X9L9)?M,MIHMC%:PO*0/WG
MEQ@<_(/RKJZ* ,#PSX8T/P;HEMHV@Z3I^A:/;G_1[#2[6.VMEYWDQQQ@ <\\
M>]'AGPQH?@W1+;1M!TG3]"T>W/\ H]AI=K';6R\[R8XXP .>>/>M^B@#B/ ?
MPD\&?#&2_/@[P;H/A+[>(_M7]AZ=%8BX\O/E^8(@,X\R3KZFH/&/P7^'?Q#U
M-=2\7^!?#/B?4HX_(2[UK2+:[D2/M&))(R0/GZ>]=]10!CZ/H=AX<TNTTW3K
M.WL=-LXH[:WM;:,1101Q_P"KC1!P !Z>E;%%% 'FNA_L_?"_PK'J(T/X<>$=
M)74K*6POET_0K:'[5:R?ZV&3RX_WD9P/W9X.*\\\1?"2[U7]J+X5:A#X9_LO
MP)\._#FHOI>H:;<VT%L=0NA':BQ^RX\R.**UCED!CXR8QQY>'^C:* .(\!_"
M3P9\,9+\^#O!N@^$OMXC^U?V'IT5B+CR\^7Y@B SCS).OJ:/'GPD\&?$Z2P/
MC'P;H/BW[ )/LO\ ;FG17PM_,QYGEB4'&?+CZ>@KMZ* ,?1]#L/#FEVFFZ=9
MV]CIMG%';6]K;1B**"./_5QH@X  ]/2H/#/AC0_!NB6VC:#I.GZ%H]N?]'L-
M+M8[:V7G>3''& !SSQ[UOT4 8'AGPQH?@W1+;1M!TG3]"T>W/^CV&EVL=M;+
MSO)CCC  YYX]ZI^-OA[X4^(VEPZ;XJ\-Z3XFL8Y?M,5IK5C%=0I* ?WGER \
M_.?SKJZ* ,#PSX8T/P;HEMHV@Z3I^A:/;G_1[#2[6.VMEYWDQQQ@ <\\>]9/
M_"I/!?\ PG?_  FO_"':#_PF.?\ D8O[-B_M#_5>3_Q\X\S'E?N^O3VXKM:*
M .=\-^$]$\+_ &]]&TC3]';4[R34+W^S[5(3<W,A!DEE*?ZR4XYD//Y5E>//
MA)X,^)TE@?&/@W0?%OV 2?9?[<TZ*^%OYF/,\L2@XSY<?3T%=O10!SFF^$]#
MTCQ!JNN6&DZ?:ZWK!B_M&_M;6-+F\\H>7'YLG5_+!(&>G;T.5KGPI\&>+O$F
MF^(]9\(:)K'B'3?*:RU;4-.BEN[7RI3+%Y4KCS(\2?O!@]<UW%% ' ^,?@O\
M._B'J:ZEXO\  OAGQ/J4<?D)=ZUI%M=R)'VC$DD9('S]/>CQ%)JO@7X?W<?@
M/PE8:M>Z7:"+3/#OVH:7:R1Q?=MHY/+D2(>6 L8(\O. ?+&2.^HH ^+_ !9\
M _\ A;4>E^ =#^"5O\'/A[JFHVVH>-[R2#2+<ZQ96<@DBTV.+3;F63,DIR9M
M\7E",X,GF>6?JW4O">AZOX@TK7+_ $G3[K6]',O]G7]U:QO<V?FCRY/*DZIY
M@ !QU[^@Z.B@#B/'GPD\&?$Z2P/C'P;H/BW[ )/LO]N:=%?"W\S'F>6)0<9\
MN/IZ"NWHHH Q]8T.P\1Z7=Z;J-G;WVFWD4EM<6MS&)8IXY/]9&Z'@@CU]:Y;
M2O@I\/\ 0=,LM-T_P+X;T_3;+48M9MK2UTFVCCMKZ,?N[J-!'Q,!D"7_ %@[
M'T]!HH YW_A%=%_X2?\ X23^R+#_ (2;[']@_M?[*GVO[-YGF^1YO^L\K?\
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MTZ**[NO-E$LOFRH/,DS)^\.3UQ6M_P (KHO_  D__"2?V18?\)-]C^P?VO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD9'[V,QR]\U^F&CZ'8>'-+M--TZSM['3;.*.VM[6VC$44$<?^KC1!P !Z>E
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MA_'#X9Z#XY\-23'2-8C:2);B/RY8_+E,<D;^Z/'(G'IWZT =_7G?C3XR>%O
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MH>'_ !!X?T:\L?$<G@*"#Q%HDNL2VUOIJ1Y^RR1W=MY,=S)+YLD/3S .2>:
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M >\>#?CIX/\ B#XDOO#%A>:C9^)+6R2^DTK6='OM)NOLLDAB$T<=U#$\D?F
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M'7%?M#?".'6O!?[(?[..O);ZE?3:I8RZG)'-*EA<66CZ<?M\0D&),R1RXB(
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MKP6=S=:7IUSYOE^3=7\<9MK642&,&.:2,Q^8F<<9\Y_:&\4:#^SK^P=XFO\
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M<?\ +*+TKO=8T.P\1Z7=Z;J-G;WVFWD4EM<6MS&)8IXY/]9&Z'@@CU]:V**
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MC>BW-]JGGWUSJ%[JNKM'+J&H74LIDEGN94CC\R7D1^8><11]<5P=U\%_A=\
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M7Q)_:1UW5O'%A<:!--_9WB:.0V^C:7;";%W%#&-\MU)$/-%_@W!CEC$<G4R
M'WY17YZZ?\7OBO\ \,F_L^>#9=3U;4OBC\2)'AN)["ZMQK,WA^+S;F2YM;F6
M06\=U]A-MB263S,R_P#/7]Y'Z3IOP-U35_B=X%\3^ OA]/\ !6_T/4_-\1^(
MM7N;.34/$-A)&?.LI4M;BY^VF:2.,R7%[*)8I,2Q^;(7P ?8-%?'/C[P"WQT
M_;PTNRN=6U"3PG\-_!WVJ2/0=7^PW-CJ^IS21B*66WDCN5\RUA$N!(.(X^@E
MQ+<^#NDV?@_]MKXC^%/AS9VNA?#C2_"MC<^(]#TR(6MC:^(I9O\ 1I8HL#RS
M)91?.;<>6?+'FYD% 'M-Y\:M$M_C3IOPM6UU2^\476DRZY<&VB06UE8Q2F)9
M97DD&1++^[ C\P@CYQ&.:]1KX$^ /P1^%OQ0_:F^/^HCX:>&;_PKX6FT[PQH
ML?\ PC$,.GI<)'+_ &E%Y1B$<LPN,$R',@0Q@/Y4G/WW0!\__M,?%+Q%X3D\
M$?#_ ,&7%O%X_P#'VI2:9IMU=1^:NF64,7F7VI^7(!'*UO'R(7D'F%Q_K,&,
M^D> ?"VO>$[/5;77?&%_XU#W_G65UJ=A;VT]O$8HAY3FVBBCDQ*)9/,\L?ZW
M!_U>:^5-8^&O@?XT?\%'-8T[5?!VD>)],\*^"5EUAKC1$,4>L7$T8A%U(8\7
M1^P^7Y23>8B"(F/#QOCI_A9I-I^T9\3/B(-2M+8_"'P!J1\!Z!X%:W$>FRW5
MJD7VNXO;$#R[@(_DBV#$QQQQD^5'( ] 'UY17R%\#]-B^%?[9GCOX:>#3<2?
M#W_A%K?7KG2UNI9M/\,ZM+>S#[);1 ^79"YBD>Y\DC)ZQXC %<I^RS\,=,_:
M!\9?'+XD>/+#3/'?A_5_&MW;>'X;[1[>6PNK*R'V6&ZCEQY5UB(1Q12$'RS%
M<^7(#<W.0#[HHHKX;TS2?#VM?$OXB>&/VF_"EU?WGBOQ3<VG@G4?$%M]JTM]
M,FC>*UM;"YBS%8W12VE8QYAN)"8C^\DZ 'W)17QS^V\UIJ.C_!7X*VSZCJUE
MXQ\8:9I^I:,WVBZN-0T.R(EOC)<G,O[O_1Y'E\T2'!.3B0UU/_!0+Q1J.C_L
MVZKX?\/3;?%GC>^M/"6BV9C7_39KV81R6^9!Y<9DM_M/[R0@#GD'% &O^TQ\
M4/$OA;Q]\$/!_@O4C:^(O%/C&+[;9_9XY/M6B6T3RZF?,E'EIB/RSP1(<_N\
MU]#5\1:UX!M_'7[97@?X<>'I#I?@[X3^!9'6\T>2Z^VZ=->21VOV#[2)?]&D
MDLK8;"_[WRI99(R)/*N(M[X9:?8_#_\ ;L\7^"OA[80Z1\/O^$,M=8US1='C
M L++7#=>3"?*'[NUFELH\^6@C\V.,28? - 'U_7 ?&3XJZ'\#_AGKWCGQ+),
M-(T>-9)5MX_,ED\R41QQI[N\D:<^O;K7R?\ L_>$?#OC6QTCP3^T7X;U"+]H
M&XO+B^_M?7S+'=W317,=]'_8^IV\GEQQ0QR0_P"CVDL?EF.;]UCS"=3]OSPA
MX0\:>*_@GX0NO#&GZQXH\8^,+&PNPND^;?S>'[9_-OHHKL1^9;1Q^9%(3%)&
M<&4]/,R ?8&AWEWJFF6US=:?=:)//&DCZ?=&(RV_;RY#%))'G_KFY'O6W7R'
M\0-)L]-^-GPY^ 7PULK;P-X=U2*Z\9>-X_!D8TB[%G$8X[41W$(CP+FYC\F3
MROWWEQ#F./)/%_M;? _PE9^*OA'\.O!VE/H5IX[\2)::UX&T0+8:1J^CVLD=
M[?7,L48$<=Q$+:V(FB,=Q)&QB!DP!& ?>%%?'/C[P"WQT_;PTNRN=6U"3PG\
M-_!WVJ2/0=7^PW-CJ^IS21B*66WDCN5\RUA$N!(.(X^@EQ+<^#NDV?@_]MKX
MC^%/AS9VNA?#C2_"MC<^(]#TR(6MC:^(I9O]&EBBP/+,EE%\YMQY9\L>;F04
M >TWGQJT2W^-.F_"U;75+[Q1=:3+KEP;:)!;65C%*8EEE>209$LO[L"/S""/
MG$8YK=_XK7_A:7_,!_X5K_8__3;^V?[4\_\ []?9O)_[:>9[5\<? 'X(_"WX
MH?M3?'_41\-/#-_X5\+3:=X8T6/_ (1B&'3TN$CE_M*+RC$(Y9A<8)D.9 AC
M ?RI.7^(/BPG@?XU?M;?&J^DAO$\!:#I7A3POJLL,LMA'<21>;-IY,)Q+_I\
MEKYO/F1>9C,8- 'WQ7/^*/%>G>"/"NL>(M8N#:Z/I-G+?7EQY9?9#%&9)),)
M[ G\*^==+^!OA[2/@#+XG^+5[JUM\18-"DU/Q#X]^U[]>T.0Q>?=I875MG[-
M#%NF$=M;?NMF08Y?-E$G@T-YX@^'G_!+[Q!K<UA;W'Q,^+<US<W5G)^]EUN]
MUJZ,6^UAB?'G26,D<D<40_Y99\K_ %@H ^LOV./%/C;QA^S/X"\1?$:[%UXK
MU>SEO[F[6.)/.BEEDDM9,1 1C-MY/;ZUT?Q_^+6F? ?X2>)?'NL(9K70[,SP
MVNXC[5/DQQ0[O+D\OS9)(XO,P<>9D]*Z[POX4T[P1X5T?P[H]N;71])LXK&S
MM_,+[(8HQ'''E_\ 9 'X5\G?\%!M)T#QYK'P*^'U]H\&M:IXI\:VL<UDNFM+
M=?V/$1)J?E7(C\RV&/LIDDCDC?RQG[@DH ]F^"_A?XHVL>C:]\0_'<^H:CJ6
MG22ZKX173+&.QTR^EDBFCBM98@9<6T?F0_O)9?-_UF01BO:Z^(/VO_"GA3P]
MI7PA^"OA3PKIVCZ9\0O'ED-:\,>'=+%M'J.EV_ER7\I^SQ#R_+_T4R2YCDV1
M'_EF'QZ%_P % O%&HZ/^S;JOA_P]-M\6>-[ZT\):+9F-?]-FO9A');YD'EQF
M2W^T_O)" .>0<4 ?3M%?$FJ?!W3_ (B?MF>$_"5G>ZC9?#CX1> XHK6ST#7#
M;76EZC?226T5O+<QR"[!DLK<2?ZP<1Q$G][B6YX-NO#_ ,&_VL/C!9>%H[?P
MS\'O"_@BUUCQCI.FVIBL;#6,F6.6*V'0R6$69/LT?EOY8\S,@% 'V?7SMX=^
M)WB;Q-^VIXO\'Z7JOVWP%X7\'VQUBS6VBC^R:W=7/FVP\P@2R9LLG]V3&,<_
MO.*Y;]FGX:I\>_A#I'Q,^+^F-X@\<>)R^L6WVN=FBT"VD(^R_P!C;#FQ_P!'
M%M+YL1%P9,&24R1CR_&?V=?&2>%?V8_VE?C7:^(=0N-4FN[^UT#QSXD $NK6
M6G626NC3'SHXXYI#*3'DQYDERLF9!B@#[D^%?_";_P#"":;_ ,+%_L/_ (3'
M,WV[_A&?-_L__6R>5Y/F_O,>5Y>=W.<UVE?GAXY^$<TW['/[-OP'T^&Y\/2>
M--0TF/Q!X?\ ,BAU$V:POJ6L2@763'Y4V)>!F-_+CQ^\$==]\;? 6D?"OXS_
M +/\?P\@NK#XH^(/$_V>^U">^EN;_5?#\<7F:K%>W-Q(_P!J$2?9C&)I))$$
M<?DX\N@#[1HKY5\0:[?_ !X_:TU#X;2W=U-\-/ ^@Q:AXDTVTE-L+[5KTD6U
MA?\ >YM?LOF2^3'^ZD)Q*9/]77 ?$;X2^'_^&T_@SX \*+<V_A;2XY?'6L^"
MK.7[/I6E-9&6+3+ZUB^["9+JXE$L5N<2%!)+%R9* /NFO,/'GQFTCX?^// ?
MA"YM+^_\2>-;Z6TTNUL(4YCMXA+=W4LDDD:"**/&>?,.?W<<E>GU\(77PR^'
M'Q8_X*(ZSI,G@/0-:T+PKX--_JRKH,<=O_PD%Y=!Q)=2^4!<R26LGF1^89!_
MK'CQ()#0!]WT5\A_"S2;3]HSXF?$0:E:6Q^$/@#4CX#T#P*UN(]-ENK5(OM=
MQ>V('EW 1_)%L&)CCCC)\J.0!Z3X'Z;%\*_VS/'?PT\&FXD^'O\ PBUOKUSI
M:W4LVG^&=6EO9A]DMH@?+LA<Q2/<^21D]8\1@"@#Z]HKE?B'XQL?ASX#\2>+
MM2BFFLM TRZU.Y2V'[QXHHC+($Y]$KY\^ /PC7XR_"70/B-\58K?Q?XT\61+
MK]O/-++Y7AZ*X3S+6'1_^6EB8XC%F2(B4RCS#+)Y<9 !]6T5\H_%36M6\4?'
MSX?_  #T'7=9T+0++0!XK\3WUM?W,6J7>GPRBVM;:*^#F;,ER/\ 29/W<C1D
M8FYD%<U\</ ^A?L__&CX(ZS\)]'A\+Z_XB\4V^@:MX6\.K]EL-8TGR[G[3=7
M%A;X$IM/-,OG8(C\T>;TCP ?:=%?'/C[P"WQT_;PTNRN=6U"3PG\-_!WVJ2/
M0=7^PW-CJ^IS21B*66WDCN5\RUA$N!(.(X^@EQ+6\&W7A_X-_M8?&"R\+1V_
MAGX/>%_!%KK'C'2=-M3%8V&L9,L<L5L.ADL(LR?9H_+?RQYF9 * /L^OG;P[
M\3O$WB;]M3Q?X/TO5?MO@+POX/MCK%FMM%']DUNZN?-MAYA EDS99/[LF,8Y
M_><5RW[-/PU3X]_"'2/B9\7],;Q!XX\3E]8MOM<[-%H%M(1]E_L;8<V/^CBV
ME\V(BX,F#)*9(QY?A_P%^(,7PZ_97_:3^.,?B#5)[^]U&YT[PYXXUJVDEN=5
MLK*UBL=$EDC,7ERD2R^7)*8AF0R>;S&< 'Z145\_?LYZ/I/[/G[&_@C^U[2Z
M\,V.@>%H]8UF&ZBF\VSE\DW5]YD?^LR)9)CY>..F.U?*/[,MUXN\7+\,_AM/
M=:AX6U7QK8WOQA^(>J:9?&TOM:AN;X16*6MQ;M_HYEQ;F6.,18BX$D<GF @'
MZ7UY=>?&K1+?XTZ;\+5M=4OO%%UI,NN7!MHD%M96,4IB665Y)!D2R_NP(_,(
M(^<1CFK?@OX-^$OAQJDE_P"%-"MO#!F3R9;#16DM=.=<@F7[#$WV?SB(U7SO
M+\W8 F_'%?)7P!^"/PM^*'[4WQ_U$?#3PS?^%?"TVG>&-%C_ .$8AAT]+A(Y
M?[2B\HQ".687&"9#F0(8P'\J3D ^^Z**^)O ?@.U^/\ ^VK\;]6\4-8>,? ?
MA:RTSPO8V5]ID5Q97,WE?:)K9YA_K?LMQ)*9+6028EFMY),26]OL /MFBOA2
MSUN\^+GQC\>Z4WP_U7Q]\%O LL7@W0_"_AMM-L]%^W111F\%_87MU;_:##+Y
M45OP88Q%F,>9^\KT#X<_"WXC?"_X9_&F3PG''X9AUN.ZOO /@.V>*X'AVZ>V
M?GS'_=1>;='S#;1[[:(@^5)*)": /JNBOC?]G/PI\-?%4G@W2_%7AG4M)_:%
M\)VEKJ>KWOB W-MK]S=1B6UENOMV\R7]C)()8QB66V,<D49 'EQC+;Q9K/Q\
M^//Q).H>"M?^)_PM\'7:^%[#0=%GL8=+N-4CCCEU!]2MKZZA^U212^5'%D21
M)@R1CS/WM 'VY17QI&NL_L<_!7XV?$&[33_"/A1<ZGX1\!YEO[;1+B6+ AD,
M7$7VJ]E3S+:$_9X2?W4I!,E=#I?P-\/:1\ 9?$_Q:O=6MOB+!H4FI^(?'OVO
M?KVAR&+S[M+"ZML_9H8MTPCMK;]ULR#'+YLHD /JJBOS6N?^$D\$_P#!+?6=
M2DS:?%#XKWIOKA8=DT^NW&K7J_ZJ(9C\V:PZ11 $8Z"3->_?$"Q\,_L2_LX^
M(/B'9^'=*U7QSHOA^.PEU]=(BBFO;J3RHHA)^\!CM?.\G_1XI!'%%$(HAB.*
M.@#ZKKYY_:8^*'B7PMX^^"'@_P %ZD;7Q%XI\8Q?;;/[/')]JT2VB>74SYDH
M\M,1^6>")#G]WFG^!/V7]+7P?I]Y\09[KQ5\2Y(1)?\ C3^T98M3AN9#YDL5
MA>Q>5+:VPDDDCCAA\J/RR08_WDGF>=?$729_C9^WIX=\-K<M:Z'\/O!]SJEU
MJ>B&7[9:WFHS"*2U-S'(/LTLUK%E 1YGE2S21[)/*EA /LBBOD7X.Z39^#_V
MVOB/X4^'-G:Z%\.-+\*V-SXCT/3(A:V-KXBEF_T:6*+ \LR647SFW'EGRQYN
M9!7UU0 45\A? #1;3]KB#QG\2_B!9V_C#PCJ/B"[L/!&D:E")M&CTBV<Q0WR
M6,F<74LAN1)+*/-^7$?EQG!P?V9]%TZ#]HCX]^-KO7-0U;PEX,*>#M)\4>)-
M2,DMC!$9;[5;26:0B22**XFBQ+<^81''_K2 : /MNBO@']F;X!>"[W]DW4_B
M-\<;*?7I/%L.I^-O$RZK/+<6$*7 >3[=:VEO^ZBE-MLD$L4?VF/S9(Q(@_=B
M/P[\3/BIJW[+/[-W@F\UW48?B;\3[P07VJ0S1#5$\.Q>9+<WT-R?W:7(L3:X
MDDS+^])QYHR #[B\4>*].\$>%=8\1:Q<&UT?2;.6^O+CRR^R&*,R2283V!/X
M5Y=^QQXI\;>,/V9_ 7B+XC78NO%>KV<M_<W:QQ)YT4LLDEK)B(",9MO)[?6O
M OV]OAGX;^$W[/&I3^ H=1\-^-=>O8_#ULF@+)+/XKDO5DBFM;\8<W\IMY+J
M2.2XS*)<&.3S)#O^SO"_A33O!'A71_#NCVYM='TFSBL;.W\POLABC$<<>7_V
M0!^% '05\\_MM_$[Q+\,O@C)_P (+?MIWQ&\0:OIN@^&F\B.03WUQ=1?NAYH
M\H$Q1S<R\<5S?B#7;_X\?M::A\-I;NZF^&G@?08M0\2:;:2FV%]JUZ2+:PO^
M]S:_9?,E\F/]U(3B4R?ZNO.OB9\,?#5C^VM\#OAWX;@U&/PU&)O&&L>#+".1
M-'TB2RBN1IM_#'&!':^9<RRB1(B(Y9%B,D>Z3,@!]WT5\(?"_P 17O[0TWBS
MXA>+_A?K_P 9?!&I:S<VW@ZWCDTEM CTNVFEABN1I]]=Q2"]ED\WS)9(O, P
MD?EQYC.;^T-\'?&GPV_X)P_$[PMK5Q_;3VU_%?:3H^ERS7T>BZ-'J5M+'81W
M,L:RW$5M#%*_FRQC9'Q_JXQD _0&BOC_ /:PU#3OCIJWPH^#7ARZ@US3?&FI
M6_B/7UM9Q-:2^%[8B:4R2Q$R1"YE\H0RQ_ZR2,CS!6&WBS6?CY\>?B2=0\%:
M_P#$_P"%O@Z[7PO8:#HL]C#I=QJD<<<NH/J5M?74/VJ2*7RHXLB2),&2,>9^
M]H ^W*^>?@%\4/$OQ,^-WQW,NI-J'PYT'6;'0M "V\47V:^M[;_B:0GCS3B5
MX^9..?W?>H/@#\/]3^"%M\0=7UR:P\$_#:_O1K&B^$1=>9;>%[?R3+=O)<9$
M</F2!Y9+>(FVA.?+DD#DGYM^$_C7Q1??!/X/^%]#BF\!>/OC_P"*]<\3:]J4
M/G6WV:Q\V66ZELC(9&@EDM?LWV8^7(F,R9!Q+0!^C]%?$O[8?PS\-_ 'X?6/
MQ(^&^ER:#\4=)U2QBTIM)N98[GQ9/->V_FV%_P"6WFZEYOE^;(')ED,>?,_U
MF;'[97A^^^-'[07P&^%FGZO=6=F\NJ>)M:&EDB[TW[-;B*QO_,C(DMB)998X
MI3^Z\TC?'+Y?ET ?:5%?&VK>%]/^$O[;WPAT7X?6ITEO$ND:Q)XYL]/E,\M]
M:0Q#[!?W^>?-^U22C[;)^]DDEDC\V3I7->!/!O\ PTU^VM\9_$NJZGJ%[X"\
M&-8^$K73X;$VUKJ<D:2F[T^XN/+$DUM%<R2R2VQ)CE,EL9/,BCC! /NZBO@C
MX!_#F#XA?M!?&3PIHVK:M8?L^^#]=2*U\&6L,EOI-[JDEL1J5K))@'[-%-YQ
M>P'^C2&XC.SR\>8SP9\6H_V??#O[6FO>&&@M/A1X-U)+7PGITR226-EKHA_T
M^U2+(DBB-]/;#RQLB'F,8L?O#0!]]45\(R? _P 3^/OA"-)\2?"SQ!??&N\L
M_M"_$_Q;K6FH=)U+/F^;;75C<RW-M;139\JVMHA'T$@C\V66NG_;*\(^(?''
MPR^#WP5O?$ZZOK7C3Q+IVF>(IK86ME<ZCIMM#)<ZA<PQ."(_+,44O[OH?+3G
MS C@'V/7F?QA^->C_!;1-&NM5L=2O[C7-6MM TC3=-2/[1?7UR<0Q(99(XX_
M^6AS+)'CRSSTS\]?&WP%I'PK^,_[/\?P\@NK#XH^(/$_V>^U">^EN;_5?#\<
M7F:K%>W-Q(_VH1)]F,8FDDD01Q^3CRZS?VD/AWX%^)7[<'P3\(7/@W1M=N+F
M+4/$WBQO["B::6VAMO)TV2ZN?+S)%YL4D?EF3RS^[$B']W0!]QT5@>&?#&A^
M#=$MM&T'2=/T+1[<_P"CV&EVL=M;+SO)CCC  YYX]Z^>_CIXFU_QM^T+\-O@
MIH6M:AI>F7EE=>*/&$NBW$EE?Q:9$?+M$CN1@I%+=?NY!$?.P!_JH\D@'U'1
M7P?^UM\#_"5GXJ^$?PZ\':4^A6GCOQ(EIK7@;1 MAI&KZ/:R1WM]<RQ1@1QW
M$0MK8B:(QW$D;&(&3 $?5>/O +?'3]O#2[*YU;4)/"?PW\'?:I(]!U?[#<V.
MKZG-)&(I9;>2.Y7S+6$2X$@XCCZ"7$H!]C45\8>#;KP_\&_VL/C!9>%H[?PS
M\'O"_@BUUCQCI.FVIBL;#6,F6.6*V'0R6$69/LT?EOY8\S,@%;O[-/PU3X]_
M"'2/B9\7],;Q!XX\3E]8MOM<[-%H%M(1]E_L;8<V/^CBVE\V(BX,F#)*9(QY
M8!U/AWXG>)O$W[:GB_P?I>J_;? 7A?P?;'6+-;:*/[)K=U<^;;#S"!+)FRR?
MW9,8QS^\XKZ)KXL_X)S:=#KGAOXH>/OM6K>()=?\42:?IWBK6#(+G7-'TZ*.
MWL)I!Y<>\C]Z))/+#R2&3S>1BOIWXJ6OA.7X<^(;CQQ9Z??^$;&R>^U&+5K(
M7MMY5OB;S)8B#Y@C,6_&.WK0!C_#/XV:-\6-:\:V6AV>I26OA/5WT"[U*X2-
M()[V+'VJ.,>;YG[K*@F2- <YC,@KTZOS=^ L?AK]G']@$_M ZC\.M&7XEM#>
MZQ%J4^B1QSFXNKJ6UM3&/W1M[7RY+;]W;^5&8B?+SYG/T%_PROX1N/A0)_BY
MJ9U/QY%8C5-6^(ESJ&V_TBZ1OM,DMA>M'&;&VMY09(HXQ'%&%^:/]Y)Y@!]0
M45X'^Q+XT\4>//V5_AMKOB^.Z77+C3BDD]YYOG7,222QP7,GF'>YEBCBE\PG
M]YYN_H:/VQOBMX@^%?P9,O@NYB_X6#XAU*R\.^%[>YB#K/?W4OE@<CRP1%YL
M@\W]WF+G/2@#WRBOB;5OV=]5\6:-HMIX/^'^O?#[XFZ3?65[#\7_ !UJ5A?Z
MP!&5CFDEEM;FYEOI9(C)']FF\NV\L]8Q'%&6?M>>-HOV7_C]\._C)NTW6+S7
M='NO M[X?O\ 4HK.29/^/JUFA>0QQQ1_:O+CN;F4F.*.6+]WDT ?;E%?)<GA
M/5/V4_V4_B?XSU_Q-87GQ=OM)O-:UKQI(G%[J@B<642&7@Q1,8K>&' CQTB3
MS#&?(;']G+PE\(?^"?E[X@\6P75GXMTWPM_;FDR:Q=7%M+X8U?[.DD4=@)9O
M,L93>B)I1$4,MQ(00(_*BC /T2HKXMN/'7CWXH>*/V>?A1?ZMK&CZKJWA:/Q
MA\1VL?,TC5(HHHHO*C\P>681-?&2*6.WQ+@?\LH\YP?VMO@?X2L_%7PC^'7@
M[2GT*T\=^)$M-:\#:(%L-(U?1[62.]OKF6*,"..XB%M;$31&.XDC8Q R8 C
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\8?@3XBU/]DN[^$?PUUB'3M0_L"U\/65]X@*\V41BBE$QCB/,EL)4XCZR?\
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M%'+:6L<1E\LCS3YN,?ZI\Y3Z7HH ^?\ XZ_!_P 5>+/B_P#"+XC>$VTJZOO
M;:H)-'UJYDLHKR.^M1"3]HBBE,9CV _ZLY_GS/CS]G[X@?%OXP?"+Q=XRU32
MXO"WA;4[K5;WP?8ZG<RV\5U&@^P7,4ODQ&ZF$NYW,HBCCB/EQQG][)-]344
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M2RM2([:(V4L'EVQECCB$LGG2_P#+81",R1RQ?0%% 'S[\0/@_P")[;X\:/\
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MDYW\FO=:* /"OV4_@?K/P5^%<]AXKNK/4?'>NZO?:[XDU329G^S7U[<RMF5
M8X_+_=>4"(XT&8_Q/G'A_P#8TO-?_9"\5?##Q[K<</C/QQJ5UK>O>(=$!DBN
M-4DO!<Q7 BDCC 7$-L)(DCBXC?IG?7UY10!X]X5OOC=<0Z/:^(]!\!::^^+^
MT]6TG6[V]#<CS?*LGM8L;QD#-S^[W[SYNS9)F^+O@QKGC3]J#X>_$"]GTZ'P
MIX*TF_;3(K>24:@^J7I\J82@Q^6;;[,!@@B02>HKW.B@#PK6_@WKGBK]JOPI
M\0M7GT^[\'^%?#ES;:/8&61+JUU>XE$=S<\1XDC:U_=_O)",C(C!_>5E>-/A
M)XWTW]IRU^,'A"+0=;SX.?PE<Z/K>IS::8<7HNH[F.6*VN?,R3)'Y9C3& 03
MT'T510 5\^_$#X/^)[;X\:/\8_!$FDWFM1^'Y?">JZ)K=U+:6LM@9OM,<MO<
M1PRF*9)L9\R*2.2,X_=D9/T%10!\P:'\ ?&WB#]K+P_\6?'&MV&JZ7I'AVYM
M=,T2UN9O*T34YI2DIMH_+02Q&U)BDFD/F22_/Y44?E1Q=1\%?@OKG@WXK_&+
MQ[XEN+"76O&VL6_V>'2I9#;1Z98Q>38F021Y6Y(W^:03'T,>.E>[T4 ?-G@;
M]F74?+_:%E\<7EM?:C\4M3NK;[=H\I\Q-"^R_9;&$^9&(XY8HY)1]Q\YY,E9
M.C_"OXWV?P!D^%MIKGAOPX^E:#<:)H_C'1[VYBOKKR(S!8;K9[;_ $+($)EE
MCEN"!YHB ,D<L7U310!X_P#LO?!QO@%\"/!O@*6X6[N=)LC]KFW;XS=2R/+=
M>7^[C/E":67R\C/EX_'K/BMX$7XD_"WQAX.%U]A;Q!I%[I?VKR_,^S_:8I(O
M,V=\>8:[2B@#Y4D_9U\3_$W]DNY^"'CM-,\/P6^@:7HMCJ_AO4I=3+R6IB F
MEAEM8A'^\MXB8Q)(2#(/,CP)#TGB?P9\8?C%X!G\#>-&\(^"[/5K06FMZUX6
MO;G4Y[V%QY=U;6UM<6T26QEC,F)9)+GRO^>;G$B?0]% '/\ A?PIIW@CPKH_
MAW1[<VNCZ39Q6-G;^87V0Q1B../+_P"R /PKS#]IGX-ZC\9/!NB-HVH6VE>)
MO"_B&S\6:')J4?F6,E_:$^5#<^7^\\J7S#_J\2#(/^P?;Z* /-/#^K_%2^UJ
MQ7Q!X=\(:!I"9EN9=,UV[U2XGX(\J.-[.V$9R1)YA,G$9C\O]YYD?D&I_LGW
MOQ6M_B?XC^*$^ER>-_&6@W'AFSBTY#=Z;X<TWS#);Q1"01&YE$HBN7ED\L^:
M,1>4!D_55% 'Q?\ M2:#XZ\4_LZ?"WX8^,8[35/$7CGQ5H?AGQ7=:#YMR3;Q
M^9<W-[;?NHA$2+$2G,7EQ@R\$#S*[SXD?!_XC?'Z*S\&?$1_#>G_  Q27[3K
M8\/W%Q+?>)!#+');0B.2(&PB,B>;)Y4LLG$<4<O62O6_%7PN\/>*?'/A#QCJ
M>F_:_$/A877]D7GVN6/[+]JB\JX_=@^6^8_^>@/3C%=S0!\^_$#X/^)[;X\:
M/\8_!$FDWFM1^'Y?">JZ)K=U+:6LM@9OM,<MO<1PRF*9)L9\R*2.2,X_=D9.
M%H?P!\;>(/VLO#_Q9\<:W8:KI>D>';FUTS1+6YF\K1-3FE*2FVC\M!+$;4F*
M2:0^9)+\_E11^5'%]/T4 >$?!7X+ZYX-^*_QB\>^);BPEUKQMK%O]GATJ60V
MT>F6,7DV)D$D>5N2-_FD$Q]#'CI6'X&_9EU'R_VA9?'%Y;7VH_%+4[JV^W:/
M*?,30OLOV6QA/F1B..6*.24?<?.>3)7TG10!\K:/\*_C?9_ &3X6VFN>&_#C
MZ5H-QHFC^,='O;F*^NO(C,%ANMGMO]"R!"998Y;@@>:(@#)'+%Z3^R]\'&^
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MB/V?O Z^-M<TJ#7/$L_B.V^SQ6$MOI,FD6OG#R8C;>9)++YG6662.,YS%(.
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M31]9T2ZBL!<V-J8I)!<QQF*Z$DD7[J*UEDDE\V+_ %<9EEB\YN?@[XX\)_\
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M9I\9?&71/&'ASQ-,GB#QQ?\ B[2=6\/>'+W5[&YL;T1XC\RVBD,<L7DGS(Y
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M'N-*U7PSH5WJZ6\EA:FVFM;J.VBDDBD/FB2,^7Y;IG]YD%!ZA\5]'\2?$O\
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M8:OJUYHUQIECX:TRWDB$T22?ZF],L8^SQPVLCQ2)YI\P1#)]H^)_PKD^(GQ
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>60^6=@!<1X_[;=UI?B"]^"_@;4M:L=.M=:\9Q:YJ]IK4S)87VAZ7;S7M_\
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M:^ ]GX&^'T=CH/BWQWXGOWL/#&BZ%I\GA[2[:QMHHS-),9);GRHK>/)_=\R
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M8H ^D:*^?_AIXQ^+OQ)T#P'X]M;;P;9>%_$4-M?W/AR7[6^H65C<0^9YD>I
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M_&_C:#PKKWP\:[M[;Q!!I<=S;7?AJ*YN8HX[D2L\G]HQ1"22,^7;V\LA\L[
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M\.Z9<>*==^(?BH3Z'=6O,FIZ'IE];QVGEVXY'E1PW0\LQB63'_+0F.OTSHH
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MUQ+:>$-)U/QYJVGZB=UE/O/V&PDACY#W,5QOE!D \L',<F3@X/Q9U30O"_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ?A'0M&UCQSXLTJ*&[U/1_#_ -F+:?%*#Y4D\UQ-%;QG@'RC+YI!\P1F/+@
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M];^(/AS7[34-<-SK,.IW%M8VNE1V\DQ-M;VL4<OVKRO*Q()+B,E_G_>R Q9
M/J.BN&^(7Q0\.?"?1+35O%6J'3[>[O([&VMX[>6ZN+BZE.(X(H8A))+(3T2,
M$GFN+TG]HS3;OXH:1X!\2^%_$O@+Q5K<3S:+9^(+>WEBU,1)+)-Y-Q93W$6Z
M*.+,B221G$D7!\R@#U76-<L/#FEW>I:C>6]CIMG%)<W%U<R"**"./_62.YX
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M<XZ72?CUH/B;XZ>)OA79V.J7.K^&[""^U2_^PG[!:--Y9BMFEYS+)%)Y@[;
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MPOX$B\7:=IESXQT5X?MGVS1;VRBA2R\LR_:O.NKJ&+RO+Y\SS.^>E>!?LO\
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MS(DDD9Q)%P?,KSC]K7X\>.?!.N>"O!/@_P -Z_!K'B/Q-;64>KZ>=-N9[JQ
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M?9I;:YFBDEB^])#Y@D$;A^F<>RT %%%% !1110 4444 %%%% !1110 4444
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M>*OA=X>\4^.?"'C'4]-^U^(?"PNO[(O/M<L?V7[5%Y5Q^[!\M\Q_\] >G&*
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M@ID=9_PJWPW_ ,+6_P"%B_V:?^$O_L?^P?[0^TR?\>/F^=Y7EY\O_6\],^]
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MVFK:/KVH111WU[X>U_4M(:]\K/E?:/LDT?F^6'.)'R1G\*Z&;X5>#X_AQ?\
M@*VT#3]/\'WUC<V,FC::GV*U\JY\SS8XQ%@Q^9YLG^KYY- 'SS_P3MTJPUKX
M3^)_BQ%:6]G?_%#Q3J_B.2 H/-L8OM<T4=J;CCSA&8Y'!^3_ %TG'K'^QWHK
M^,OC]^TI\5=2AT\ZO<>,)/"%LL=E^\M;738HHP1+N)_?*;;?'P-]MGT$?U)X
M7\*:=X(\*Z/X=T>W-KH^DV<5C9V_F%]D,48CCCR_^R /PK)^%/PO\-_!_P
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M7/B'_HJGBW_P%T?_ .0*?)_>,_:'>Y_V:,_[-<#_ ,*U\1?]%3\6?^ NC_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>nbix-20211231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nbix-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ E@"6  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" +#!M,# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJWL_4^ESCA9Y;@E4B[SCK+LT^WI_F>[4445J?G04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\33-&NIR)I[2>846/_2!^[$>T3;LA=@"XV] .<\UW<$$=K#'#$BQQ1J$1%&
MJ@8 %2451^;5L56Q"2JRO8****#E"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[*9K7_M&@#Z HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU_\ CE3_ !@^%^F_&#X?ZKX8U-0$NDW038R8)EY20?0]?4$CO7X[^-/!^I>
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M,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\+[\=_\ 0=_\DX/_ (W1]7D'^L>$_EE]R_S/L"BOC_\ X7WX[_Z#O_DG!_\
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M_#TC]H?_ *&Z#_P"2@#]]:*_ K_AZ1^T/_T-T'_@$E'_  ](_:'_ .AN@_\
M )* /WUHKY1_X)M_''Q?\?O@%-XD\:ZBNI:LNIS6XF6(1_(N,# JO_P4T^.W
MC']GG]G_ $GQ+X(U%=,U>?Q%;V$DSQ"0&%K>Y=EP?]J-.?:@#ZVHK\"O^'I'
M[0__ $-T'_@$E'_#TC]H?_H;H/\ P"2@#]]:*_ K_AZ1^T/_ -#=!_X!)0/^
M"I'[0Y(_XJZ#_P  DH _?6BN-^#'B"^\6?"#P1K>IRB?4=2T2RO+F0+@/+)
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MCNK>9>CQNH93^1%:%?#--.S/H-]4%%5[Z_MM,M9+F\N(;2VC&7FG<(BCU)/
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M4+R. $#J1O(]#^5-1<G9(3:6K-FBN*L/C=\.M4G$-EX^\+WDQP!';ZS;.W/
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M'M;26<?54+?TKX29B[%F)9B<DGJ:ZJ$;MR9\=Q%BI4Z<*$7\6K^0E%%%=Q\
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M9K>]LY5GAE7JK*00:^J/C=I-E\;OAEIOQ7T*%5U.V1;;7K6/JC#CS,>W'/\
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M;K_T6:_FITK_ )"EG_UV3_T(5_2M^TA_R0/X@?\ 8%NO_19K^:G2O^0I9_\
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M.UK_ ,&LO^->Z?\ #8GP3_Z*9X?_ / H4?\ #8GP3_Z*9X?_ / H4 :O[/\
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MK9/_  "@#YM^+7PMUWX+_$'5O!OB2!;?6=,9%G13E<M&KC![\,*_<C_@F?\
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M[C4M/M[B/9)]CSM@D93R"Z -@],U[+110 4444 %%%% !1110 4444 %%%%
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M_@IM_P D&T'_ +&6W_\ 26ZKSS_@E[XTG^U>-O"4LK-;%(=4MXL\(P)BE/\
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MOV@/#\GB;3$TK4(()K=88XF1618Y_F&YFW DL-P.#CBLO]J#_D?M/_[!D?\
MZ-EKS?\ X3#6?^$F_P"$A_M&;^V?-\[[7D;MV,8QTVX^7;C&.,8XKL/%WQXU
M_P :>';O1KVSTV*UN=F][>*0.-KJXP2Y'51VJ^1J2:.%XVC5PE6C.3NY<R;5
M[Z;/[CUCQQ_R;/;?]@S3O_0H:\?^ G_)6-"_[;_^B)*CU7XR:UK'@9/"LUK8
M+IZ00VXDCC<2[8BI4Y+XS\@SQZ]*YOPCXHN_!?B*TUFRCAENK;?L2X4E#N1D
M.0"#T8]Z(P:C)=PQ..HU<70K1V@HW^3NSWCXAZY:^'/VAO"E]>OY=JMBL3R$
M@!/,:>,,Q) "@L"3V -<_P#M2:'=Q^(-)UG9NL9;7[)O4$[)%=WPQQ@9#\<Y
M.UO2O,_'GCS4/B)K$.HZE#;03Q0+;JMJK*NT,S9.YCSECW]*Z3PU^T!XN\.6
MAMFN8=7C_@;4E:1TY)/SA@QSG^(G& !BDH2C9KH;5,PP^(]M0J-J,Y<R=KV>
MFZNNQZQ\$_\ B@/@_=ZSK'[BUDEDU!4^ZYCVHBC#8&YRGR\X.]>>:\S^$M[\
M0O#^F7][X;TE]0TEU\QX[I"8F89!>(;E+O\ (5(3.> 03MQS?C3XL>)/'>Z/
M4+WR;%O^7&T!CA_A/(R2_*AOF)P<XQ4?@;XH:_\ #UW&EW"-:2-ODL[A-\3M
MM(SC(*GIRI&=JYR!BCD=F^K(ECZ#J481E*,*::NK7N^O73R/H#P3\0=(^.-O
M?:3J?AIU2%3*WFXF@4$;5(DPI20[GQ@ X4D-Z<W\+?#4'A#X]>)]*M3FUAL7
M>)<'Y$=X'5.22=H8+DGG&>]<?J'[3'BZ\M)(88M-L9&QBXM[=BZX(/ =V7GI
MR#U_&N/\%_$35? _B"[UFU$-[?743Q2O?;Y-VYU=F)# EB5')/<U*IRL[:'7
M/,\/*I1E-\THN[ERVTUTL=I\1[?7YOCYJ3^&HKF35H6MWC:U7)3]S$N6[!/F
M );Y<'!X-=Q;_';7_#>O1:)XO\*O'?RL"G]EG<S*PP@1"6$A+<9#^HQE2#X?
MJWQ U?5/&C>*4D33]6+(ZO: JJE4"<!B<@@<@Y!R1T.*[BW_ &G/%D-O%&]K
MI5PZ*%::2"0,Y ^\=L@&3UX 'L*<H-I)JYST,PI4ZM6<:LH<TF]DTU?MW-S]
MHOX=:-X?TNQUS2K.'3I)+K[-/#;H523,9*L%!VKCRSPJ\[\GISX/70>,O'>L
M^/-06ZU>Z\[R]PAA10L<*DY(51^ R<D@#).!7/UK"+C&S/(S"O1Q&(E4H1Y8
MO^KA1116AYP4444 %%%% !1176_#7X=WOQ#UY+6%6BL8B&NKK'$:^G^\>@'X
M] :3:2NS6E2G6FJ=-7;.W\"_ ZX\4>%+#5&,4?VE68+(<' =@#T[@ _C17TK
M8V<.FV<%I;1K#;P(L<<:]%4# 'Y45Y[K2N?IE/)<+&$5-7:6I/1116![X5^9
M/[=W[/\ _P *W\='Q9H]ML\/:[(TCK&ORV]R>77CH&^\.W)':OTVKDOBI\.=
M,^+'@35?#.K1AK>\CPDF 3%(.4D7W!IIV/LN%,_GP]F4<1_R[EI-=X]_5;K[
MNI^*4<C1LKH2K*<@CJ#7V6^S]L#]G4E0)OB;X)AW;1S)?6H'('&22!T ^\%'
M\5?*?C_P/J?PW\8ZKX;U>(PW^GS&)^,!QU5Q[,""/8UT/P/^+.H?!?XC:7XE
MLMTD4+[+NV!XG@;AT],XZ'L0#1(_K'.,'+,L+3QF DO;4_?IOH]-8_X9K1_)
M]#AL%<@C!!KZ0_8_^*.G6.I:I\,_%C>=X/\ %R?9BLA&VWNB,(XSTW<#_>"'
ML:A_:^^$NG^']=L?'_A,+/X,\5K]LA>$?)!,PW,F!]T'.X#MDCM7SS'(T;*Z
M,5=3D,IP0:P>A?\ LW%.4Z72FO\ MZ$T_P )0DOP['=?&+X6ZC\'?B%J?AK4
M%)\A]UO/CB>$GY''U'Z@TSX:^.-1^'/C#2_$.ERF.[LI1(!V=>ZL.X(R*^D+
MI5_:\_9X6\CQ-\2?!<6)$7_67UL!V'<D#/ ^\,?Q5\FV^00#P:\W%7BDT3E6
M,>:82I@\?%>VI^Y4CT>GQ?X9K5?-=#ZI_:>\%Z;XMTG1OC!X4C!T;756/4H4
MZVMUC^(=LX(/&,J#_$*\!M>U>V_LD_$BPCN-4^&OBEA+X5\4(85$AX@N3PK+
MG@;N.?[RH:X#XF?#J_\ A9XXU'P]?KEK=\Q2XP)8C]UQ[$?UKY;,HJ<?;QZ[
M^3_X)Y&3U)X"K/),0[NFKTV_M4^GSA\+\K,^@_A_=1?M&?!67P?>NK>,?#4?
MG:7-(WSSP@8V>_&%/7HIKY\^S2V=U);S(T4T3%'1A@JP.""/6I_ASXTO_A_X
MJT[7=.D*7%K(&*YX=?XE/L17N7[1'@^PURQTKXG>&XP='UI0+R-/^6%QCN.V
M<$'W7WKY;'1^O85U5_$I[^<>C^6S\K'GT_\ A%S%X5Z4*[;AVC4WE'TE\4?.
MZ*/[-/Q7/PY\8);7LNW1-2817.X_+&W\,GX'K[9K[U5@R@@Y!Y!%?E?;?UK[
M@_9=^*G_  F'A0:%J$V[5M+0(C,>98.BGW*_=^@'K7=PAG/)4>6UGH]8>O5?
MJOF?G/B%D/,EFV'6JTGZ=)?H_D>XT445^N'X0%?$O_!7S_DS^\_[#%E_Z$:^
MVJ^)?^"OG_)G]Y_V&++_ -"- 'Y._L2_\G=?"'_L9;+_ -&BOZ/*_G#_ &)?
M^3NOA#_V,ME_Z-%?T>4 ?F-_P6\_Y$KX:?\ 80N/_18KYR_X(]_\G;)_V!;O
M^0KZ-_X+>?\ (E?#3_L(7'_HL5\Y?\$>_P#D[9/^P+=_R% 'Z!?\%)/V/$_:
M6^%?]N:#:J?'OAJ-YK(JOS7EOC=);'N3QN7WR,?-7XS? 'XV>)/V:?B]I'C'
M1?,BO=-G\N\L9"4%S#G$L$@[9&1R.#@]17]+M?CA_P %8/V-3\//%#_%[PG8
M[?#>LSA-9MX%^6SNVX67 Z))T] V/[U 'Z+>,?BMX?\ C=^Q[XD\:>&;M;O2
M-5\/7$L9!!:-O+(>-P.CJV5([$&OYVM*_P"0I9_]=D_]"%?3/[(/[7$_P7\+
M>.OA_KL\LO@[Q3IEQ%$N2197C1E4D [*W ;Z U\S:5_R%+/_ *[)_P"A"@#^
MH7P7_P B?H7_ %X0?^BUK\P/^"WUC*+CX8WFX>0RW4(7/.X%3G'T(K]/_!?_
M ")^A?\ 7A!_Z+6OAK_@LI\.9_%7[.^B>)K=7D/AO50\B("?W<RA&8^P*K^=
M 'PM_P $H;Z&S_;,\-I+)L:XL;R&(8/S-Y6['Y*3^%?O/7\SO[.GQ7E^!_QP
M\&>.8]Q31]026<*,L8&!CF 'J8W<#WK^DOPCXLTKQUX9TSQ!H=Y%J&DZE MS
M;7,+!E=&&0<C_.10!KU\W_M8?MT>"_V0=4\.V/BK1->U:76XIIH&T>*!U01%
M P?S)4Y.\8QGH:^D*_)'_@N%_P CC\*?^O'4/_0X* /M']E/]O[P/^USXNUC
MP]X6T'Q!I5WI=C]OEEUB*!(V3S%3:OERN<Y8=1C -?3M?C?_ ,$2?^2Z>/O^
MQ;'_ *515^R% '\R'QX_Y+A\0_\ L8M1_P#2F2OV0_X)WZIJ.A_\$\8=0TA#
M)JEK%J<UJHC,A,JLQ4;1UY XK\;_ (\?\EP^(?\ V,6H_P#I3)7[9?\ !*D!
MOV,/"X(R#=WF1_VU- 'XX_%C]K3XM_&Q'@\7>-]4U"R+$_88Y/)@&>VQ,9'L
M<UW?['_["'CC]K74/M]@T.B>"K6Y\B_UVX<':PVEHXHP=SR;6!Z!1W85ZM_P
M5+_8Z_X4A\1V^(/A>Q:/P5XFG:2>.)?W=A?,273C[J/RR^Y8#@"O-O\ @GW^
MU[<_LK_%V(:G-(_@77F2UUFWR2(>?W=RH_O1DG/JK,.N* /W!^!/P+\*?L[_
M  [T_P '>$;+[-I]L-TL\F#-=2G[TLC=V/Y#H*]"JOI^H6VK6%O>V<Z7-I<1
MK+%-&V5=&&0P/H15B@#^<_\ ;N_Y.]^*7_87;_T!*\BTGP/XCU^T^U:9H&J:
MC:Y*^=:6<DJ9'4;E4C->N_MW?\G>_%+_ +"[?^@)7ZH?\$@X8Y/V1+4LBL?[
M7O.H']^@#\7O^%6^-/\ H4==_P#!;-_\31_PJWQI_P!"CKO_ (+9O_B:_I\^
MS0_\\D_[Y%'V:'_GDG_?(H ^=O\ @GCIMWI'[(/P]M+ZUFLKJ.T8/!<1F-U.
M]NJD9%?1U(JA5PH 'H*6@ K\>O\ @J=^W,GC_5KKX0^!=0\SPYI\NW6]1MG^
M6]G4_P"H5AUC0]3T8CN #7TA_P %.OVX!\#?",GP[\&WX7QWKD!%S=0/\^EV
MK#!88Z2.,A?09/7%?E+^S+^SSXB_:?\ BUIOA#1%9%F;SM0U%U)2TMP?GD8^
MOH.I- 'O7_!-?]BJ7]I#X@?\)9XEM77X>^'9U:8.O&HW(PRVZ^JCAG]BH_BX
M_=&WMXK2WB@@C6*&)0B1H,*J@8  [ "N4^$OPL\/_!7X=Z)X,\,6BV>CZ5 (
M8U &Z1NKR.>[LQ+$^IKKZ "BBB@#.\1>(=-\)Z%?ZUK%[#INE6$#W-U=W#A(
MXHU!+,Q/0 "OP#_;P_;$U']K#XHR36;S6O@;2':#1;%\J67.#<2+_??K_LC
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MOA7K/P9\?:GX7UN%DGM7)@GVX2YA).R5/56 _ @@\@U]Q?L9_MI:1J7AW3_
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MND:K;7\N.JH1)#G\YA^&37T.+:CG--OR/-HIO RMYGS%_P $T_\ DO\ J?\
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M_P!!#1_^_P!+_P#&J/\ AE[Q5_T$-'_[_2__ !JOJ"BCV\P_L#!=G]Y\O_\
M#+WBK_H(:/\ ]_I?_C5'_#+WBK_H(:/_ -_I?_C5?4%%'MYA_8&"[/[SY?\
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MU7U!11[>8?V!@NS^\^7_ /AE[Q5_T$-'_P"_TO\ \:H_X9>\5?\ 00T?_O\
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M7Y^A\3X@9\L+AUEE!^_4^+RCV_[>_+U+5%%%?M)_/ 5\2_\ !7S_ ),_O/\
ML,67_H1K[:KP']MS]G/5OVH_@A/X(T75+/2+V2^@NQ<WP<Q[8R21\H)R<^E
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M]#_X7_[YN?\ XW1_PY)^(O\ T/\ X7_[YN?_ (W0![=_P^P^'7_0B>(/^_\
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MY@5+9B&$9#J#D,7/T;VH ]THHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1L/P(S5C1/#>K^);D6^D:5>ZK<$X$5C;O,^3TX4$U^[E%?1_ZRNW\+7U_P"
M>7_92O\ '^'_  3\\OV1/V'_ !%'XOTKQKX_L3HUAILJW5GH]P ;BXF4Y1I%
M_P"6:JV&PWS$C! '7]#:**^9QF-JXZI[2K\EV/6H4(8>/+ ****X#H"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^?_P!D/_FM7_93-:_]HU]
M5\__ +(?_-:O^RF:U_[1H ^@**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXT>$_@G\!];B\,W<]S\3?$"_9YKC[.R+8PG(PCGJ0.>/XB#VK.1^K9I/$8+
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MO^Z0>W/2G*,'!5(JVIIB<-@:F CF%&DX)3Y7'FO=6ON<[_P\N^'/_0N^*/\
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M4(/"6L#3=^//9XA+M]=F[&?;=7FF@^%])\8?\%$]7TS6]/M]4T^34+QWM;I
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M3&X[%XF+E&FU[J=KM^9[U\'?V[/!_P 4O%4'AN]TZ^\-:K<OY=O]LVM#(_\
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M>M:7BKQYHO@NYTB#6+O[(^JW(M+4E&*M(<8!(&%'(Y/%?+_Q7\,Z=\'?VBO
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO*QM"G1Y>16O<^GR?&5\7[3VTKVMT7GV/EGPO_R>]KOF9W>4^W_P&CQ^E/\
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M=E:V^ZW/G#XN_"/1OA)\4O MIH\][<+>7$4TTE]*LCEA.HSE57^5>C?MT?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!\F^#_P!E[Q7\-_VK+KQ=X6FM;/P1>%YKF.63DK)R\"QCGAN58\#
MKZRHHK2<W.USOQF-JXZ495MXI*_>W?NPHHHK,X!*6BB@ HHHH 3 '04M%% !
M2  =!BEHH **** "BBB@ HHHH **** "BBB@ HHHH *0 #H,4M% 'S[^V5\)
M_&_QB\!Z?HGA&6V-NMT)KZUFD\MIE'W2">,*><=3Q7JGPG^'=E\*?AWH?A:P
M"F+3[<))(HQYLI^:23_@3EC^-==15N;<5#H=\\;5GAH81_!%M^K??OY!1114
M' )@=<<TM%% "8QT%+110!^??P]_Y24:I_U^W_\ Z225^@> .@KB]-^#/@K1
M_'5UXSM/#]M%XGN9&EDU(L[2%F7:Q&6(7*DC@"NUK:K451IKHCVLTQT,=.E*
MFFN6$8Z]U<*3 ZXYI:*Q/%"DQGJ*6B@ HHHH **** $ QP!@4M%% "  =!BE
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "D90RD$9!Z@TM% %672[*;/F6D$G;YHE/\ 2JTGAG1Y&R^D
MV+GIEK9#_2M.BJ4I+9F;IPEO%&._@_0I&R=(LP?]F!1_(5KCC@=*6BARE+=A
M&G"'PI(^6OVNK:;PCXZ\!^/+9"QM)EAD(]8I!*BG_>#2?E7T_9WD.H6<%U;N
M)8)XUEC=>C*PR#^1J:BNVOBO;T*5)QUA=7[IN_X'+1PWL:U2JGI.SMV:7ZG"
M^(/@;X"\47S7NH^%[&6Z<DO+&IA+D]2VPC<?<U=\)_"?P?X&N#<:'X>LK"YZ
M?:%3?* >H#L2P'L#76T5B\57E#V;J/E[7=ON-EAZ*ESJ"OWLKG/?$3_DG_B?
M_L%W7_HIJ\"_8^\,Z3XL^$FN66LZ;:ZG:'6'/E740< ^3%R,]#[BOIZBNBCC
M'1PT\/%:R:=[[6_KN85<(JN(A7D](IJUM[GG5K^SO\.+2[%RGA*P:0'.V7?(
MG_?#,5_2O0;>WBL[>."")(((U")'&H554=  .@J2BN6I7JUK>UFY6[MLZ:=&
ME1_AQ2]%8Q/%?@K0O'.GBQU[2[?5+93N59UR4/JK#E3[@BM+3=/M](T^UL;2
M(0VEK$L$,8)(1% 51SZ "K-%9N<W%0;T73H7R14G-+5]3A_$/P0\!^*KU[S4
MO"]A-=2-N>:-#$SGU8H1N/N:7P_\$O GA>Z2YTWPMI\-RC;DFDC\UT(Z%2Y)
M4^XKMZ*W^M8CEY/:.W:[L8_5J'-S^S5^]D5-4TJRUNQFLM0M(;ZSF&V2WN(Q
M(CCT*G@UP:_LZ?#=+K[0/"5CYF=VTERG_?);;CVQ7H]%13Q%:BFJ<VK]FT54
MH4JKO4@GZI,Q)O!/A^?3+'3GT6Q-A8RK/:VHMU$<,BYVLJ@8!&3R/6OG[]NC
M_D5/#'_7[)_Z+KZ<HKIP>,EA<1"O)<W+?2_?[SGQ>$CB:$J*]WFZV['#ZG\)
M_!_C:RLKC6_#UC?7)@C!N&CV2D;1P77#'\35GPK\(?!O@FZ%UHOAVQLKH?=N
M-F^5?7:[$D?@:Z^BL'B:[CR<[Y>UW;[C=8>CS<_(N;O97"L7Q1X+T+QK9"TU
MW2;75(%R5%S$&*$]2K=5/N"*VJ*PC*4'S1=F;2C&:Y9*Z/-[7]G+X;6=PDT?
MA.S9T.0)6DD7\59B#^(KT*UM(+"VBM[:&.WMXE"QQ1(%1 .@ ' %345K4KU:
MW\6;EZMLSIT:5'^'%+T5C$O/!.@7_B"#7;G1[.?68,"*^>$&9,9QANHQD_G6
MW1164I2E92=[&D8QC>RW,76O!>@^(M1L[_5-(L[^]LR#;W%Q"'>(@[@5)Z<C
M-;5%%#E*22;T0*,8MM+<X7Q!\#? 7BB]>\U'PO82W3DL\L:&%G)ZEMA&3[FG
M:#\$/ 7AJX$^G^%=-28<K)-%YS*?52^<'Z5W%%='UO$<O)[25NUW8P^JT.;G
M]FK][(\P_:2\5+X2^#7B&4/LGO(O[/A'3)E^5L?1-Y_"J/[*WA=O#/P7T<R)
MLGU)GU!Q[.<(?QC5#^->NT5K]:MA/JJCO+F;^5DK&7U:^*^LN6T;)?.]PKA-
M4^!7@#6+YKRZ\)Z:UPQW,T<7EACCJ0I /Y=>:[NBN6G6J47>G)KT=CIJ4J=5
M6J13]5<R?#OA/1?"-H;71-*L]*@;&Y+2%8]V.[$#D^YK.\6_#/PKXZDCEU[0
MK/4IHUV+-+'B0+Z;QAL>V:Z>BA5JD9^T4GS=[Z_>#I4Y0Y'%6[6T.?T7X?>&
M?#NEW6G:;H&G6EC=)Y=Q!';)MG7&,2<?.,$CYL]:\V_:NM8;'X!ZG;6T,=O;
MPR6L<<,2A411*@"J!P  ,8%>TT5O0Q4Z5>%>7O<K3WWL8UL/&K1E1C[MTUMM
M<\M\&_#7PMXX^%?@F37=!LM2F70K)%FFB'F!?(3@.,-C\:[3PMX$\/>"89(M
M!T:STI9/]8UO$%9_3<W4_B>*WJ*FKB:M2Z<GRMWM?0JGAZ=.SY5S)6O;4H:S
MH.F^(K%K/5=/M=2M&.3!=PK*F?7# C-<:O[/_P .DN_M \(:;YF<[3&2G7/W
M,[?TKT&BHIXBM25J<VEY-HN=&E4=YQ3]40VMI!86T5O;0QV]O$H6.*) J(!T
M  X K*\4>"= \:V\<&NZ19ZK'$28_M408H3UVGJ/PK;HK.,Y1ES1=F7*$91Y
M9*Z.9\*_#7PKX(D,FA:#8Z;,5V&>&$>:5]"Y^;'XUMZ7I%CH=BEGIME;Z?9H
M25M[6)8HU)))(50 ,DD_4U;HISJ3J-N<F[]Q1IPIJT(I&)I?@O0M$UR^UC3]
M+MK+4KX8N;B!-AEYSE@."<\YZT[Q-X-T+QI:+;:[I-IJL*'*"ZB#E#ZJ>JGZ
M5LT4_:U.93YG==;A[.'*X<JL^APND_ OP!HMPD]IX2TP3(<JTL/FX.<Y&_//
M\J["^TRSU2Q>RO;2"[LY!M>WGC5XV'H5(P:M44YUJM1J4Y-M=V*%&G37+"*2
M\D>?S_L__#JXN//?PAIH?TCC*+_WR"!^E=II.CV&@V,=EIME;Z?9Q\);VL2Q
MHOT4#%7**=2O5JI*I-M+NVQ0HTJ;O"*3\D%%%%8&P4444 %%%% !1110 5\_
M_LA_\UJ_[*9K7_M&OH"OG_\ 9#_YK5_V4S6O_:- 'T!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !116-XJ\9:%X'TTZAX@U>S
MT>SS@37DRQACC.U<GYC[#)JHQ<G:*NR93C3BY3=DC9HKYXU[]N[X5Z+.T=M=
M:IK0'_+2PLB%_P#(K)6(?^"A_P .,_\ (%\4'_MTMO\ Y(KT(Y;C)*ZI,\.6
M?97!V>(C]]_R/J*BOEW_ (>'_#C_ * OBC_P$MO_ )(H_P"'A_PX_P"@+XH_
M\!+;_P"2*K^R\;_SZ9/^L&5?\_XGU%17R[_P\/\ AQ_T!?%'_@);?_)%'_#P
M_P"''_0%\4?^ EM_\D4?V7C?^?3#_6#*O^?\3ZBHKY=_X>'_  X_Z OBC_P$
MMO\ Y(H_X>'_  X_Z OBC_P$MO\ Y(H_LO&_\^F'^L&5?\_XGU%17R[_ ,/#
M_AQ_T!?%'_@);?\ R11_P\/^''_0%\4?^ EM_P#)%']EXW_GTP_U@RK_ )_Q
M/J*BOEW_ (>'_#C_ * OBC_P$MO_ )(H_P"'A_PX_P"@+XH_\!+;_P"2*/[+
MQO\ SZ8?ZP95_P _XGU%17R[_P /#_AQ_P! 7Q1_X"6W_P D4?\ #P_X<?\
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M?+O_  \/^''_ $!?%'_@);?_ "11_P /#_AQ_P! 7Q1_X"6W_P D4?V7C?\
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M9>-_Y],/]8,J_P"?\3ZBHKY=_P"'A_PX_P"@+XH_\!+;_P"2*/\ AX?\./\
MH"^*/_ 2V_\ DBC^R\;_ ,^F'^L&5?\ /^)]145\N_\ #P_X<?\ 0%\4?^ E
MM_\ )%'_  \/^''_ $!?%'_@);?_ "11_9>-_P"?3#_6#*O^?\3ZBHKY=_X>
M'_#C_H"^*/\ P$MO_DBC_AX?\./^@+XH_P# 2V_^2*/[+QO_ #Z8?ZP95_S_
M (GU%17R[_P\/^''_0%\4?\ @);?_)%'_#P_X<?] 7Q1_P" EM_\D4?V7C?^
M?3#_ %@RK_G_ !/J*BOEW_AX?\./^@+XH_\  2V_^2*/^'A_PX_Z OBC_P !
M+;_Y(H_LO&_\^F'^L&5?\_XGU%17R[_P\/\ AQ_T!?%'_@);?_)%'_#P_P"'
M'_0%\4?^ EM_\D4?V7C?^?3#_6#*O^?\3ZBHKY=_X>'_  X_Z OBC_P$MO\
MY(H_X>'_  X_Z OBC_P$MO\ Y(H_LO&_\^F'^L&5?\_XGU%17R\O_!0[X<,P
M!T;Q0H]3:6^!_P"1Z[#PI^VA\*?%4R0'7I-&G8@*NK6[0KUQRXR@_%A42R[%
MP5W2?W&M//,MJRY85XW];?F>XT57L-0M=5LXKNRN8;RUF7='/;R!T<>H8<$?
M2K%>=L>TFFKH****!A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\./^@+XH_P# 2V_^2*/^'A_PX_Z OBC_ ,!+;_Y(H_LO&_\ /IA_K!E7_/\
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MP:VJ\^47%VDK,]N,XU(J4'=,****DL**** "BBB@ HHHH **** "OG_]D/\
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ME>WE^1VRP6(CAEC'']VWRWNM^UM^G8XFBBBNDX@HHHH **** "BBB@ HHHH
M]$^#_P >?%GP5U9;C0[YI-/=PUSI5P2UO./<?PMS]Y<'ZCBOTO\ @S\9-"^-
MGA&+6M&D\J9,1WNGR,#+:2X^ZWJ#U5NA'H00/R,KU/\ 9O\ C)<_!?XEV&I-
M*PT2[=;75( 3M: G&_'=D)W#OP1T8U\]FF60Q=-U*:M-?CY/]#[3AW/ZN6UH
MT*TKT7IK]GS7ZK]3]7:*16#*&4Y!Y!%+7YJ?O(4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%-9EC4LQ"JHR6)P * .'^,7Q@T/X*^$)=<UES(S'R[6
MRC8"6ZEQD*N>@[EN@'X _FA\8?CYXM^-6J-/K=\8M-1]UOI-L2MM".QV_P 3
M?[39/)Q@<5H?M+?&*?XR_$Z_U".9FT2R9K33(LG:(5/^LQ_><_,?; ["O**_
M2LJRR&%IJI45YO\ #R/P?B+/ZN8UI4*,K4EII]KS?EV7ZA1117T)\4%%%% !
M1110 45ZC^SO\$?^%]^-;WP__;7]A?9M/>_^T?9?M&[;)$FS;O3'^LSG/;IS
M7T/_ ,.V?^JB_P#E#_\ NBO,Q&987"S]G5G9^C_1'NX/(\PS"E[?#4^:.U[Q
M7YM'Q/17U1\3/V ?$_A#P_+JGAO6XO%S6T;RSV"V;6URP!7 A4.XD."Y*Y4_
M* H<L!7RO71A\51Q4>:C*Z./&Y?BLNFJ>*ARM[=;^C5T%%%%=9YP4444 %%?
M0_@_]D?_ (2O]G^?XF_\)7]E\K3[Z_\ [+_L[?G[,THV>;YH^]Y77;QNZ''/
MSQ7-2Q%*NY1IN[B[/U.W$8+$82-.=:-E-<T=5JGUT_4**V_ _AO_ (3/QKX?
M\/\ VG['_:VH6]A]HV;_ "O-D5-^W(W8W9QD9QU%>H_M)_LV?\,]?\([_P 5
M%_;_ /:_VG_EQ^S>5Y7E?]-'W9\WVQM[YX)8BE"K&C)^]+9>@4\%B*N'GBH1
MO"%DW=:7VTW^X\3HHHKI.(**** "BBB@ HHHH **** "BBO;/V;/V;/^&A?^
M$B_XJ+^P/[(^S?\ +C]I\WS?-_Z:)MQY7OG=VQSA6K4\/3=6J[11UX7"UL;6
MCA\/&\WLM%LK];+9'B=%;?CCPW_PAGC7Q!X?^T_;/[)U"XL/M&S9YOE2,F_;
MD[<[<XR<9ZFL2M8R4DI+9G-.,J<G"6Z"BBBJ)"BO;/V;/V;/^&A?^$B_XJ+^
MP/[(^S?\N/VGS?-\W_IHFW'E>^=W;'/MG_#MG_JHO_E#_P#NBO+K9GA,/4=*
MK.TEY/\ R/H,+D&98VC'$8>E>#V=XK9VZM/='Q/17T;\;/V)?$_PI\/SZ_I>
MI1>*]&M(Q)>&&W:"Y@&6W2&+<X:-0%)8-D;B2H52U>&^!_#?_"9^-?#_ (?^
MT_8_[6U"WL/M&S?Y7FR*F_;D;L;LXR,XZBNFCBJ->FZM*5XHX,3E^*P=98>O
M#ED]EWOV>WXF)17MG[2?[-G_  SU_P ([_Q47]O_ -K_ &G_ )<?LWE>5Y7_
M $T?=GS?;&WOGCQ.M*-:GB*:JTG>+,<5A:V"K2P^(C::W6CW5^EULPHHHK<Y
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -OP?XVUWX?ZU#J_A[
M5+C2=0BZ30-U'HRGAA[,"*_1;]F/]J>P^-EG_8^KK#IGC"W3<T"'$5X@',D6
M>A'\2<D=1D9V_F=6GX9\2ZCX.\06&MZ1<M9ZE8S+-!,G56'KZ@C((Z$$@UY.
M89?3QU-IJTNC_KH?1Y-G=?*:R<7>F]X_JNS_ *9^SM%<E\)_B#;?%/X=Z'XH
MM4\I=0MP\D(.?*E4E9$SW"NK 'N #WKK:_+9QE3DX26J/Z&I5(5H1J4W>,E=
M>C"BBBH- HHHH **** "BBB@ KY__9#_ .:U?]E,UK_VC7T!7S_^R'_S6K_L
MIFM?^T: /H"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *^3/^"B7B:33_AWX;T2-BHU+4&GDQ_$L*=#_P "E4_@*^LZ^-/^"D&GR2:+
MX%OAGR8;B[A;KC<ZQ$?I&U>QE"4L=33\_P F?,\2RE'*:[CO9?BTG^!\-444
M5^IG\\!1110 4444 %%%% !1110![9^Q?_R<MX._[?/_ $CGKMO^"A__ "6K
M1?\ L7X/_2FYKB?V+_\ DY;P=_V^?^D<]=M_P4/_ .2U:+_V+\'_ *4W-?.U
M/^1O#_!^K/MJ/_),U?\ K[^D3YCL;&YU2]M[.SMY;N\N)%AAMX$+R2NQ 554
M<DDD  <DFOL3PU^Q;X%\*^$M,N/BSXV_X1GQ#J&Z1;2/5+6UBC4!<QAI5;S7
M7<-S*=H+ #( 9ODGPK9ZKJ'BC1[706E37)[R&*P:";R9!<,X$15\C8=Y7#9&
M#SD5]>^//V:O$7B"RT9OC+\<=&TJ\M8VM-+BNBLD;PJ$W.'E> O(20'8JS$!
M"SG@#?,:KC*$/:\B=[V3<GZ63T[G+DF'C4A5JO#^UDK6NTH+O=MK7L8GQL_8
MBL?#7@6?QEX \02ZWI5K9B^FM;Z2*1I;<*SO/#.@5& 3:P3;R Q#$E5/(?LC
M_L[^'/CW_P )7_PD%[JEG_9/V3R/[-EC3=YOG;MV^-\_ZM<8QU/6OJ_3=/\
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MVNM:AHNH6^IW>FSZA;7K3017$)8J8 ICP-W)5@S,@RG6J7_!2;_FG7_<1_\
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M@AAM+%)/D4+S>_9O_9*U7XW0G7-4NI=!\)QR!$N5BW37Q#@2)""<  !@92"
MV %?#A?H[_@H?_R171?^Q@@_])KFNHAT_P *6?[&^A6OB+4[KPIX8N/#^G_;
MKW1E*2KYPB+X"(^?-D<A_E.X2/GJ37&LSQ#P--I^_*7+>UW]W<]-Y#@HYM7B
MU^ZIPY^5NRO;9RZ+KY>AY/;_ +&/P>\;0W.G^"_B;+>ZXL8F7R]1L]06- ZA
MF>&)48CG;G< "R]>A^4/'GPG\3_#KQT_A'5M,E;66D5+:.U1I5O0[;8W@P,N
M'/ P,YRI 8$#Z.\$Z?\ LS?#_P 6Z3XCTCXH>*(M0TVX6XBS!,%?!Y1]MF"4
M895@",JQ'>J/[6'Q\\&^*_&OPY\5> [VUUC5] N)+B>2:QFASY<D,ENDA=49
MTW++P#QN;INY[,+6Q4:_L_>E!IZRBU9^O9GF9CA<OJ8-U[TZ=2+6D)J7-%M)
MZ7W5[^GX=?8_L*^ ?!?A>WO/B/X]ET^\FD5#<07=O8VBN4!\E6G1C(05D(;Y
M2RC[@P:R_B#^PUX<O/A_/XF^&7BJZU[[/;S7"02/'?)J&P\I!) HPXVR*!M?
M<^U?EY->HW7Q@_9__:7TVPM/%-S:V\]IYEU%;:_(^G2V_P VP@7"N$.X;6\M
M93D!21E/EY#QM^Q7)_PK*>#X8>.]9O--NH_MQT.]OTDL=5)\MHV5H]D8)5 0
MS*P8B/YD W5Y=/%XB,U]9JRA*_6/NV_K^NI[]?+<%4I2^HX:%6GRZ.,_?OY_
MY:ORZ/YX_95^#.B_'+XA:AH.O75_:6=OI<E\CZ=(B2%UFA0 ET88Q(W;.0.:
MYW]H+X=Z;\*/B]KWA72)[JXT^P^S^5)>NK2G?;QR'<551U<XP!QBO7_^">'_
M "6K6O\ L7Y__2FVKB?VT/\ DY;QC_VY_P#I'!7T$*U1YG.BW[JC>WG='QM7
M"T8Y#3Q*C[[J6OUM9Z'I7PS_ &,_#]IX%B\1_%_Q'+X+:_D1;.S:\@LVB!5F
M F:96'F, 2(Q@J%.[DE4V_&7[!WA_7/!HUSX6^*Y=<E6.1XH;NX@N(+\JP&R
M*>((J$;9!R&!; )0 FC7/V=?B!XB\"Z5;_&3XQ6'AW1K617L8=1G%RWVB179
MTGED>(/(@W!?GEP-X4A1S[S^RKX9\&>$/A[J&E^"?$<OBFS@U21+_4'3;&UZ
ML,*RB+Y0#'A492"XPW#MUKP,1CJU-.O"MS.^R3Y+>MOU_P S[' Y3A<1)82M
MA.2+C\4I+VE^KLG??R2MTMH?EK1117W1^1!1110 4444 %%%% !1110!^LO[
M-?B.3Q7\"?!6H2R&67^SUMGD;.6:$F$D^IS'U[UZ77CW[(>GRZ;^SEX+AE!#
M-!-,-W]V2XE=?T85[#7X_BTHXBHH[<S_ #/Z<RV4IX&A*>[A&_W(****Y#T0
MHHHH **** "BBB@ HHHH **** "BBB@ KSC]HSQ-)X1^!OC34X6,<RZ>\$;C
MJK2D1*1[@N#7H]>0?M<:?)J7[.OC2&+.Y;>*8[<_=CGC=OT4UU81*6(IJ6W,
MOS//S&4H8*M*&ZC*WK9GY74445^PG\Q!1110 4444 %%%% 'U%_P3P_Y+5K7
M_8OS_P#I3;5Q/[:'_)RWC'_MS_\ 2."NV_X)X?\ ):M:_P"Q?G_]*;:O;/C1
M\=_@KX,^)>L:/XM^'G]N^(;;R?M6H?V)97'F[H4=/WDCAVPC*O(XQ@< 5\G4
MK3HYI.4(.3Y=EZH_1J&&IXKAZG"K55->T;N]MGI_78Q/^"=.M:]?>$O%=A>S
M74WAZQN+<:<LJDQ12N)6G2-R/^N3% < ONP"Y)^3_'7@F]\0_'SQ5X7\+Z3Y
M]U+X@OK6QTZRC5%55GD 50,*B*HY/"JJDG %?0_C#]O32-$\,RZ#\+_!W]A0
M?9RMK=W4<,"64K.Q<I:QAD;@E@2P&]B64@$-\R?"/P_XG\5?$;1=)\'7LNF^
M([J1TMKR&Z:V:$>6QD<R*=P C#D[<DC( ).#TX2E6A5KXRI%04EHGY+=V_'Y
MG#F6(PU7#X3+*,W6<'JTN[^&-]^RZ:+Y?5,/[&?PG\&Z;IUE\0/B/_9?B>2W
M$]Q"FK6EG$<LPS$DT9<H""NX_>*DX7[HX+]I3]C:3X/^'YO%7AS59=5\.02(
MEU;WP1;FT#%$5]XPLH,C$'"J5W)PPW,.O^(G[.T6I:U!K_QL^-^EV^O+;K-=
M:=#%&)#:(S +; LA^8*V-D!_>%OE<YW>L?M%6^E6G[$]S!H-S+>Z'%I>DI87
M,X(DEMQ/;")V&U<$IM)^4<GH.E>9#&5J=:BXUG/F=GI[NKZ-I?(]ZIEF%K87
M$J>&5/V<7*/O)ST3^))OYW_/4^>/V<?V5=%^.7PC\0:]+J%_:>([>\N+&P1)
MT2T+K;Q/$91Y3/C?)\VTYVC@9KK_ (T?L7>"OA/\&=8\3?V]KUUJ^G6\/S[8
M&MY9VD2/_5;5949G_P">A* Y^?;M;T3_ ()X?\D5UK_L8)__ $FMJ^!?%'BC
M5?&GB"^US7+Z74M5O9/-GN9C\S'&  !P    H "@    "NZB\5B<;5@JMH0:
MT[^7X,\K$QR_ 95AZDL.I5*L6KWM:W7S>J_S1]]?"#_E'_?_ /8OZY_Z,NZ\
M%_9I_93TWXJ>$M4\8^,]6NM!\,6_F);M RP-)Y8#2SM+*A00J-RY&<LKY*[,
M-]1?LEZ+9^)/V3_#VD:C#]HT^_M]0M;F'<R[XGNKA77*D$9!(R"#4'[4&DCQ
MQ^R_JG_"":C82Z'91QW)BTOR9+:XLK9OGBC<':@CV!_DY_<; /FQ7CQQ<Z5>
MKAZ;Y7.I\797?XGTU3+:6(P>&QM:/.J=%-0_F?*OP7S_ $?PU)X8\#>)OCAH
M7AKPE/K,GA.]U2UTTWVH2Q_:9Q),J/+&!$HC!#?*&4G@%L9V+WO[7'[._ASX
M"?\ "*?\(_>ZI>?VM]K\_P#M*6-]OE>3MV[(TQ_K&SG/0=*\N^!__):O '_8
MP:?_ .E,=?47_!2;_FG7_<1_]M:^BJU*E+'4*"D^5IW\[)[GQ&'H4<1D^,Q<
MH+G4HVMTNUHCEOAC^QGIOQ7_ &?--\5:1JEU;^,;_P WRH[VX5=/&R[>,[@L
M+2?ZM#C!/S8[5VVE_L1_"?7/M>A:=\1;K4/%UG;NMS%:WUI)Y$Z81W>V53(J
M+(0"A?(R%WYYKK_@C?7.E_L&SWEG<2VEY;Z'K4T-Q Y22)UENBK*PY!! ((Y
M!%?+O[$]]<VG[2'AB*"XEABNH[R&=(W*K*@M97"N!]X;T1L'C*J>H%>9[3%U
MEB9QJM*FY67IT]-#Z#V.789X"E/#*3KQ@F[O2]M4N[;U?D<'\9/A7J7P9^(&
MH^&-1D^U>1MDMKU8FC2Z@89210WXJV"0'5UW';FOI3X??L->'+/X?P>)OB;X
MJNM!^T6\-P\$;QV*:?O/"3R3J<N=T:D;4VON7YN#7+_\%#_^2U:+_P!B_!_Z
M4W->V:'^T=\'?VAO!6G^'/B%):V.H2^6US9ZHCVMN+B.,.\L-PKD1)GS%4M(
MKD94CYL-MB,5BZF$HU:=[/XG%79R8++\MHYEBL/6Y;QTIJ;M&[[OK;1=?O./
MOOV%? /C3PO<7GPX\>RZA>0R,@N)[NWOK1G"$^2S0(IC)+1DM\Q53]PY%?)/
M@OX:Z]XZ^(%GX,L+3[/KUQ</;-!?$P>0R!C+Y@(RNP(Y(P6^4@ G K[8OOV.
M=!U7PEJ]Y\)OB'JFE6NM>9NA@U(7.EWD0$JBW8Q89D#,4W,TI4;P58DUR_\
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M>I6<<L5I9P:G!?2>8\; E8[=%P2F] TA$8+\D':1R'_!0'QQX<\9_P#"!_\
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MES'91?:%\R.67HNPHYY)(C*%F))->B?\% ?''ASQG_P@?_"/^(-+UW[-]O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^&+_ (R?]"=_Y4[/_P"/5^HE%'^L6*_EC]S_ ,P_U)R[_GY/[X__ ")^7?\
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M3L__ (]7ZB44?ZQ8K^6/W/\ S#_4G+O^?D_OC_\ (GY=_P##%_QD_P"A._\
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MK%BOY8_<_P#,/]2<N_Y^3^^/_P B?EW_ ,,7_&3_ *$[_P J=G_\>H_X8O\
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MU)R[_GY/[X__ ")^7?\ PQ?\9/\ H3O_ "IV?_QZC_AB_P",G_0G?^5.S_\
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M=G_\>H_X8O\ C)_T)W_E3L__ (]7ZB44?ZQ8K^6/W/\ S#_4G+O^?D_OC_\
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M=_\ #%_QD_Z$[_RIV?\ \>H_X8O^,G_0G?\ E3L__CU?J)11_K%BOY8_<_\
M,/\ 4G+O^?D_OC_\B?EW_P ,7_&3_H3O_*G9_P#QZC_AB_XR?]"=_P"5.S_^
M/5^HE%'^L6*_EC]S_P P_P!2<N_Y^3^^/_R)^7?_  Q?\9/^A._\J=G_ /'J
M/^&+_C)_T)W_ )4[/_X]7ZB44?ZQ8K^6/W/_ ##_ %)R[_GY/[X__(GY=_\
M#%_QD_Z$[_RIV?\ \>H_X8O^,G_0G?\ E3L__CU?J)11_K%BOY8_<_\ ,/\
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MWM;(_H+*$_JJ<NH4445Q'MA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *^?_P!D/_FM7_93-:_]HU] 5\__ +(?_-:O
M^RF:U_[1H ^@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MD2$L3+URIK.2<9<K6IT0G&I!5(.Z>J9[91112+"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M000>017=45Y#;D^9GVD(QIQ4(*R04444B@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&78I4<LBX:TFN;;3W;?U8]@HHHKPS[\^4_@;_P G4>/OI<_^C4KZLKQ_X?\
MP-O?!OQ>\1^,9M5M[FVU3S=EJD3*\>]PW))P<8KV"O1QU2%6I%P=U9'S'#^%
MK8/"SA7CRMSF_DWH%%%%><?3A1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MEUN&%+5$(EB"3;0V[.#G'(Q70WOQ \16J^*-3$=B=(T2YEMQ$0WFSD8"\]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ KY_P#V0_\ FM7_ &4S6O\ VC7T!7S_ /LA
M_P#-:O\ LIFM?^T: /H"BBB@ HHHH **** "BBB@ HHHH **** /-OC%;VSW
M7A2>_>2'3(]0(N+B-RGEAD(!+#D#/>L'6X?#>AW'AJ[TB\6:Q.N![NZ:<R@2
M>5M&YR3VQ7L=Q;Q74+131)-$W#)(H93]0:@72+%;7[,+*W%OG=Y(B79GUQC%
M5<FQX,;[3]0M]+N[V5KCQ0_B%1,'=BT48E( VYPJ[=N..]%QK5MIW@BZT"?S
M$U5-?5GMRARJFY!#$],8[^]>]?V79^<\OV2#S7P6?RUW''3)QVKBM:\+Z[XJ
MOS87^HZ8FEI<I<2+;(WVED5MR*V>!R!S5<PK'$:MJ5M8^%O'VC3S+'JMSJ3>
M1:-_K)=[*5*CN#4&L7$=O:^+M.D<)?'5;"00'[Q7]T-P'ID5[I)IMI+<I<O:
MPO<)]V9HP77Z'&:8MK87S&Y$-O.S?*9=BL3@],^QI<P^4\DNM0E7XB1>,U53
MI,5V-#)V<E",&7/IYG'TK7^)VLVGBOX?7<]H)I+6TU&..Y8*590D@#D=\#U%
M>E?8[?R?)\B/RLY\O8-N<YSCZU5TO1+72;6>"%,I-*\TFX [F<Y-*X6//DE\
M"Z'97UY!*VKP7:16EZ_GM<^7$Q.TOD\*"?PKD[^]\GP5J.GQW;7^BZ3K5JMI
M?,=P\G<&*ENX3.,U[<NGZ9I\+1BVM;:*8[641JJN3V(QS3K>WT^2WELX(K9K
M=#LDMXU78IZX*]*=PL</:WBW?Q6N[JR=;A'T-'B=.5?YVQ@UY]I]UI]\W@^Z
M>5[KQ+-J;F^,CLTB'#C:1T4= !BOH"&S@MRIB@CC*KL!1 ,+Z?2F+IMG',TJ
MVD"RLV]G$:ABWJ3CK2Y@L>$VNN64W@GP7I,<P?48-:B\ZW4'=%MD;.X=NHJ3
M2KB/2]?T74;MQ;V,.O:BDEP_"(6'RY/;->XKIEFDCR+:0+([!F81J"Q'0DXY
M-.DT^TFA>&2UA>%SN:-HP58^I&.33YA<IX:^HVPUZ+6C*%TJ3Q2SI=GB-E\G
M;NSZ9XS7;?$:\MSXE\-6NJW!@\/3^<\S;RD<D@4%%=AVY)QWKNVTVT:U6V:U
MA-NN-L)C&P8Z8&,4E]#9R6ZK>QP/"&&%G4%<]NO>E<=CQ+P/Y!OO"YM%*VO]
MN:CY:X/"[>.M%W=1:;XQFOKEO)M(/%),LS#Y4!@P"3V&:]Q6SMT92L$:E6+
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*Y'Q6P/C#5SG(_M[3!_Y#I-9476D>/+"./S=0OM>6WLE4X8384JP/;&"<T6
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M:UXJTSP[';-J5RML;C(B4@DN0,D #J:S;/XG>&]0N+.&#4E=[I_+C^5@-_\
M=)QPWL:H>+5#>,/ VY0<33D9'0^4.:XVS55\-@A0"?%F3QU_>FILAW/1G^(G
MA^/5CIS:@HNO.^SA=IVF3^X#C!(J+6M0OYO%,>FV-S]F5+"2X=]@<;B=J$CV
MP:\]A>/_ (1O358KYO\ PEK[0<9_UCYKO-%_T[Q9XIO>JQ".S0_[J;F_\>8T
M6#<=\/\ Q!/?> ;35=6N1)*L;O//MVC"DY.!["D7XK>&&+A=35R$\Q0J,3(O
MJG'S?A6'X3_Y(A<?]>-U_)ZK^&X47Q1X'PBC;H<FWCI]WI3L@N=?<?$+0+6Q
ML;M[]6@O5+P%%+%E'4X X [U#KWBR*;P//JVCW*RB952VF09RS.$!&?<_I7
M> 6CCU/PV7*JO]E7WWL8_P!=S5KPOB\\$^!].4 K<7IE;']R,LW\]M%@N6-:
MUC7KRY\53V^L26"^'XD\J&.-669Q&'8R9Z@],#I6]XJ\07Y\$Z3>6ES_ &?=
MWTUM&TRJ&V!\;B >*YRZ8+_PM7) ^3//_7"N@;^P=0\%Z!8:VRR12?9D6+<?
M]:5R@..F:!'2>';.YL;.076KMK)9]PF9%7:,=/EXK)'Q4\+F54&J1Y;<%;:V
MUF'50<<M[=:S_ -G!I7B/Q?862^580W$;1PJ?DC9HP6 ].>U<CX=B3_A'?A^
M-BX.M2L>._[SFBPST<?$30&T==3%\#:M,;<?(V\R#JFW&<UH:)XETWQ%9RW6
MGW27$$3F-W' 5AU!SZ5Y;:E5\769; _XJB[Y/_7.NB\ 7%O#I?C*9E$MJFI7
M;LJ=&4#) I6"YT.G_$'0=4EN([>_5VAB:=LJ0&C7[S*2/F ]J-*^(6@:U=/!
M::C'(ZPFXS@A3&.K D8('M7F+37%S_9-PZVUO:2^'K][6TMU/[B,H, L3\QQ
MBI-018]*T-54*!X6NL #'\"T^4+G8:?\0(/$/CW3+'2KWSK![.>6:/RR,L&4
M*P)'3D].*I^-+KQ-I!U371J!L[.RGA2UL5562YC+*K[N^26./3%1Z'L_X3'P
M5C;O_L*3IUV_N\?A2_$V2QU72[W5+6\F:]\/W$>ZU+'R6?>IVNAX;AN#1U%T
M*>NZ]KUT/%FK6VK/8QZ%*L<%DD:F.3"*S;R>3G=CCI1JFO:]K'_"3ZC:ZL^F
MIHD"20VL<:LDK>4)&WYY(/3CI52[E$GA?XH.WREKDL5/;,24MJP70_B2&(4B
MU7.?^O44P/16\666G>'=/U35+B.SCN4C^9NF]ER /UK.7XK>&&53_:2C,ODL
M&1@4;.!NX^7)]:PO%*AO!G@E67(_M"QR&'^R:Q_$,:C2/B4P4!FO;?)QR?\
M5U*2'<[_ %3XB>']&U"2SN]02*>/:'^4E5+?=4D# )STKHU8,H8<@C(KQ;7G
MB7PYX]#E QU2WP&QG/[K%>S6_P#Q[Q?[H_E28T24444AA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\_P#[(?\ S6K_
M +*9K7_M&OH"OG_]D/\ YK5_V4S6O_:- 'T!1110 4444 %%%% !1110 444
M4 %%%% &3XB\+Z?XJM8H-0B9Q%()8I(W*/&P[JPY%4+/X=Z#IXA$%EL$5U]L
M7YV/[W;MW<GDXKI:*=P.?U3P'HNLKJ NK3>;YXY)F#D-O081@0>"!Z5)X?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ/\ A87BK_H9M8_\#Y?_ (JN?HHY5V#V];^=_>SH/^%A>*O^AFUC_P #Y?\
MXJC_ (6%XJ_Z&;6/_ ^7_P"*KGZ]D^,GP;T7X=^&+74M-NK^>>6\6W9;J1&7
M:4=LC:@.<J._K4/EBTFMSKHQQ5:G.K"3M#?7N>=_\+"\5?\ 0S:Q_P"!\O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"OQ%Y@^R1)O\O*CS$E5%PRL1E2,'(^\"P'0:WH=WXC_9YM;"R3S+IM'LY4C
M)+^6L<A50 26(4@#N2*\[_9=T>];Q/J>JBW?^STLVMC<'A?-+QL$'J<*2<=.
M,XR,X)+DD[ZGNU9S^MX>CR)PE%7TO??KY?KJ'PB\ V^E_%S7O#^M65MJ:65G
M(4%U"DBL/,B*2!3N )1@>N1N(]:W/'VH?#SX<_VMH?\ PCL.HZM=12W(<V\4
MB0R2[MD98,KQ*HVX5,$*5(Y.3H>"]0@U+]I'Q?-;2>9&MB82V"/GC-NCCGT9
M6'X<5Y/\>_\ DK&N_P#;#_T1'6BO.>O8\ZK*&"P+E1BG[\HIM7TU_P CM/AG
M\+]!TGP,WC7Q;;O.D:M<PVDK[8S&I7RR48+N=R"%4L58.O'-7/!VK^!OC#=W
M&@77A&S\/71B,UM-9.B.[ $$!E1"6 ;<%(8':21\O/0'_BX7[.8M='_?74-C
M# T/WG\RW*%DVKD[F$>5'4[UZ9KR_P#9TT.[U+XCVU_"G^BZ=%)+/(P./G1H
MU4$#&XELX..%;TH^)2DWJB[*A5PV'HP3A-*^B?-??7R6I<\+_#Z+PU\?+3P_
MJ%JE[I^Z9X5NXQ(DT)AD:,G<H#$8 ) P&4XZ5H?%WP#;ZI\7-!\/Z+96VF)>
MV<9<6L*1JH\R4O(5&T$A%)ZY.T#TKI-0URUUK]I[1([5_,^P6LEI*X(*F013
MNP!!/3>%.<$%6':K'C34(--_:1\(37,GEQM8B$-@GYY#<(@X]691^/-'-+F3
M\A_5J'L)TU\/M4K^6G4K^.M0\#?!RTTS1D\)V>NWYB\P_:XDW^7EAYCRLC99
MF!PH&!@_= 4'J+7^QC\"=4;P_P"<-(DTR^D@2XSOCW"4LAS_ '6++U/W>K=3
MYG^U%H]ZOB?3-5-N_P#9[V:VPN!ROFAY&*'T.&!&>O.,X./0/#NCWN@_L[7=
MEJ%N]I=II-\[0R<,H?S77(['##@\CH<&H:7+%WU.RE4G]<KT>1*,8NVEK;=?
M/]-#@_V??A=HWBK3[K7=7B^W>1=?9X;-\B,,H1R[8/SYW ;3QC.0<C%QO'?P
M]O-3O=%\2>!$\-Q;@$F-H(Y0O+ R"-5DC) 3A=V=W)QR>7^$M[\0O#^F7][X
M;TE]0TEU\QX[I"8F89!>(;E+O\A4A,YX!!.W'K'@GX@Z1\<;>^TG4_#3JD*F
M5O-Q- H(VJ1)A2DAW/C !PI(;TN=^9MZKUV./!>SG0I4::4)N_Q0NI_/L?+^
ML+IZZG<#2GN9-/W9@-XBK+M]&"DC(Z9'7&<#.!3KJ/B=X:@\(>/-8TJU.;6&
M4/$N#\B.JNJ<DD[0P7)/.,]ZY>NI.ZN?'UH2IU)0DK--H****9B%%%% !111
M0!WOACXN:IX9T.VTVW<B&#=M^<CJQ;T]Z*['P'\#V\1^$=.U*9O*>Y1G"M_=
MW':?Q&#^-%<SE3OJ?64<-FCIQ<&[65O0^DJ***X#]$"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1-8AU'4H;:">*!;=5M595VAF;)W,><L>_I7>?\,O>*O^@AH__?Z7_P"-4?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OG_\ 9#_Y
MK5_V4S6O_:-?0%?/_P"R'_S6K_LIFM?^T: /H"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFL:-J6IZONUVX66^GMI[%(F5U8&T7-W*Y2S\A6.U2#&H2BX'ME%?/=GXDO\
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MVPEC2;Y)#$6+(#)YI>3>7 ^A-1OH]+T^ZO9EF>&WB:9UMX'GE*J"2$C0%W;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>nbix-20211231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nbix-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$!2@%*  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" @X#+0# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[_\ CM>QT4 >.?\ #(/PD_Z%/_RI7?\ \=H_X9!^$G_0I_\ E2N__CM>QT4
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M[_\ CM>QT4 >.?\ #(/PD_Z%/_RI7?\ \=H_X9!^$G_0I_\ E2N__CM>QT4
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MXY_PR#\)/^A3_P#*E=__ !VC_AD'X2?]"G_Y4KO_ ..U['10!XY_PR#\)/\
MH4__ "I7?_QVC_AD'X2?]"G_ .5*[_\ CM>QT4 >.?\ #(/PD_Z%/_RI7?\
M\=H_X9!^$G_0I_\ E2N__CM>QT4 >.?\,@_"3_H4_P#RI7?_ ,=H_P"&0?A)
M_P!"G_Y4KO\ ^.U['10!XY_PR#\)/^A3_P#*E=__ !VC_AD'X2?]"G_Y4KO_
M ..U['10!XY_PR#\)/\ H4__ "I7?_QVC_AD'X2?]"G_ .5*[_\ CM>QT4 >
M.?\ #(/PD_Z%/_RI7?\ \=H_X9!^$G_0I_\ E2N__CM>QT4 >.?\,@_"3_H4
M_P#RI7?_ ,=H_P"&0?A)_P!"G_Y4KO\ ^.U['10!XY_PR#\)/^A3_P#*E=__
M !VC_AD'X2?]"G_Y4KO_ ..U['10!XY_PR#\)/\ H4__ "I7?_QVC_AD'X2?
M]"G_ .5*[_\ CM>QT4 >.?\ #(/PD_Z%/_RI7?\ \=H_X9!^$G_0I_\ E2N_
M_CM>QT4 >.?\,@_"3_H4_P#RI7?_ ,=H_P"&0?A)_P!"G_Y4KO\ ^.U['10!
MXY_PR#\)/^A3_P#*E=__ !VC_AD'X2?]"G_Y4KO_ ..U['10!XY_PR#\)/\
MH4__ "I7?_QVC_AD'X2?]"G_ .5*[_\ CM>QT4 >.?\ #(/PD_Z%/_RI7?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KQS_F\+_N1/\ W(5['7CG_-X7_<B?^Y"@#V.BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#QS]F[_FJ7_8]ZI_[2KV.O'/V;O\ FJ7_ &/>J?\ M*O8
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "O'/V0?^3=_"?_ &]_^E<U>QUXY^R#_P F
M[^$_^WO_ -*YJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_:^_Y-W\6?]NG_I7#
M7L=>.?M??\F[^+/^W3_TKAH ]CHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<^)W
M_)Q'P4_[C?\ Z2)7L=>.?$[_ ).(^"G_ '&__21*]CH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS_F\+_N1/\ W(5['7CG
M_-X7_<B?^Y"@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\F?\
M@N-_R,GPA_Z]-3_]#MJSE/E<5W=OP;_0N,>92?;_ #2_4_6:BOYA? _P?\>?
M$Z"[G\'>"?$7BR&T94N)-#TFXO5A9@2H<Q(VTD X!ZX-;&M?L_\ Q<\#:?/J
M^K_#;QIX?L;="\M]>Z%=VT4:]RTC1@ ?4UH_=W(7O;'],5%?SY?LP_\ !0#X
MI?L[>++&27Q#J7BKP@9%6^\/ZM=/<1M%GYC SDF%P,D%< G&X$5^^?@KQAI?
MQ \(:+XFT2X^UZ1K%G%?6DV,;XI$#*2.QP>1VK5P]WG6J,U/WN5[FU17\PGQ
M,_Y*SXK_ .PW=_\ H]Z_ITLO^/.#_KFO\JRI?O<-#$;<W3Y)_J:U/W=9TNU_
MP=B>BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%?&G[?G[?/A[]
MF_P?JGA;PWJ,.I_%"_@:&WM;=@XTH.,?:)ST5@#E8SR3M)&WFORE_8$D>;]L
M_P"%4DC,\C:R&9F.224?))I4?WU54UM=*_\ 7;_@!6_<TG4>Z3=OZ[_\'L?T
M2T444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QS]F[_FJ7_8]ZI_[
M2KV.O'/V;O\ FJ7_ &/>J?\ M*O8Z "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HK^?S_@IW_R>]\1_]^R_](H*\;\,_L[_ !6\::':ZSX>^&7C'7='
MN@3;ZAIF@7=Q;S $J2DB1E6P01P>H-13DZD%.VYI4C[.?)<_IGHK^9+Q!\.O
MB=\&3;ZAK?ACQ;X%+R;8;K4-/NM/RX&<*SJOS8STYK[8_P"">O\ P4<\9>&_
MB/HGP\^)FO77B?PIK5PEC9ZGJDK37>G7#MMBS,V6>)F(4AR=N000 0=Z<?:/
MEB]?ZT.><G37,UH?LK17A?[<_P#R9_\ %O\ [%ZY_P#0:_&;_@FG_P GN?#'
M_KYNO_2.>LZ/[VLZ.VB?WW_R-*G[NE[7U_"W^9_0;1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%?G1_P %-/\ @H'KWP-UB+X8_#:[CL/%,MLM
MSJVM;%DDL8W&8X8@P($C+\Q8@[59<<G*_EM;>%?B_P#M#75YKEMHWC;XE3PM
MLN=1AM;S56C;&</( ^#CL36<)^TNXK1&DH\EN9ZL_I@HK^<[X(_M??&']F'Q
M5$-'\1:FMI8S&*[\+ZU)))9O@X>-X'/[MN,;EVL,=>U?OA\ OC1HW[0?PC\.
M>/=#5HK+5[?>]M(<O;S*2DL3'N5=67/? />NCDO#GB[K^OZ_I'/S6ER25G_7
M]?TST&BBBLS0**** "BBB@ HHHH **** "BBB@ HHHH *\<_9!_Y-W\)_P#;
MW_Z5S5['7CG[(/\ R;OX3_[>_P#TKFH ]CHHHH **** "BBB@ HHHH ****
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M !1110!XY\3O^3B/@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN?-D"[0_[QV"G  ^4#.!GH*_$G_@I5\4+SXF_M@>.!-<-+8:#.NAV46<K$D
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M %>.?M??\F[^+/\ MT_]*X:]CKQS]K[_ )-W\6?]NG_I7#0!['1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %?DS_P %QO\ D9/A#_UZ:G_Z';5^
MLU?DS_P7&_Y&3X0_]>FI_P#H=M7/5^.GZ_\ MK-Z?PS]/U1U_P#P0]_Y$;XJ
M_P#81L?_ $5+7Z;,H=2K ,K#!!&0:_FT^!_[67Q5_9OL=5L_AUXI_P"$=MM4
MDCFO$_LZTNO-9 0IS/$Y& QZ8ZUV_B;_ (*/_M(>+M(N--O_ (HW\5K<(4<Z
M=8V=C+@^DL$*.OU# UVUI^T=XKHE]R2.*C!TXVEW;^]MG/\ [<>A^%O#?[67
MQ+TWP;';PZ!!JA$<%F (893&AGC0#@!9C(N!P,8 P*_9C_@FE->S_L2?#-KX
M,)!;W2Q[O^>0NYA'_P".A:_%K]FG]E?Q[^U5XZM]*\-:=<?V9YX_M3Q%<1L;
M2Q0D%F=SPSX.1&#N;Z9(_H3\'_#'2_ ?PJTOP%HDUQI^E:;I:Z5;7$++Y\:B
M/9Y@)!&_^+)!&>QI0BZ&$Y'J]+>=D_\ ,NI)5L3SK1:W^?\ 5W\C\[/VR/\
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MD8(D:NH$_4C!,I.?RK]Q+0S&UA-R$%QL7S!'G;NQSC/;-?+_ (3_ ."9_P
M_ ?BSPIXE\/^&+S3=:\.WD5]#<?VI<3BYDC!V^:DKLN-V'^0)RH[9!^IJVO%
M4U%;IO[M+?KN<_O.;D]K?CK?]-@HHHK,T"BBB@ HHHH **** "BBB@ HHHH
M**** /'/B=_R<1\%/^XW_P"DB5['7CGQ._Y.(^"G_<;_ /21*]CH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.?LW?\U2_P"Q[U3_ -I5['7CG[-W_-4O^Q[U3_VE7L= !1110 4444 %%%%
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MQ3\+O$&I7&K:=H]E'J.CO=.7>UB#B.2 ,>?+^:,JO1?FQP<#X!_;:T6Z\/\
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M;^+==ZG?1KM%S=R8,C#OM&%1<\[47->RTZK]_>]K+[E;^NY-)6CM:]W][O\
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MRQ-63W:?_I#'B8J&"IQ6RDOS@?O#1114%!1110 4444 %%%% !1110 4444
M%%%% !1110!XY\3O^3B/@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'/V;O\
MFJ7_ &/>J?\ M*O8Z\<_9N_YJE_V/>J?^TJ]CH **** "BBB@ HHHH ****
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M9\(Y=6.J/\+/!3ZF7\TWK>'K,S%^N[?Y>[/OFO1(84MXTCB18XT&U408  [
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M?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\
M@A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G
M_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T
M5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)
M_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^
MH7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W
M_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^
M0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?
M_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J
M%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_
M\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E
M%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;
M'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_4
M5_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /
M^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%'
M]G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z
M]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%
M?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\
M@A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G
M_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T
M5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)
M_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^
MH7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W
M_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^
M0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?
M_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J
M%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_
M\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E
M%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;
M'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_4
M5_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /
M^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%'
M]G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z
M]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%
M?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\
M@A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G
M_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T
M5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)
M_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^
MH7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W
M_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?_;'Z]T5^
M0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J%_U%?^2?
M_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_\/\ @A_J
M%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]T5^0E%']G_P!_
M\/\ @A_J%_U%?^2?_;'Z]T5^0E%']G_W_P /^"'^H7_45_Y)_P#;'Z]UXY_S
M>%_W(G_N0K\YZ*/[/_O_ (?\$/\ 4+_J*_\ )/\ [8_7NBOR$HH_L_\ O_A_
MP0_U"_ZBO_)/_MC]>Z*_(2BC^S_[_P"'_!#_ %"_ZBO_ "3_ .V/U[HK\A**
M/[/_ +_X?\$/]0O^HK_R3_[8_7NBOR$HH_L_^_\ A_P0_P!0O^HK_P D_P#M
MC]>Z*_(2BC^S_P"_^'_!#_4+_J*_\D_^V/U[HK\A**/[/_O_ (?\$/\ 4+_J
M*_\ )/\ [8_7NBOR$HH_L_\ O_A_P0_U"_ZBO_)/_MC]>Z*_(2BC^S_[_P"'
M_!#_ %"_ZBO_ "3_ .V/U[HK\A**/[/_ +_X?\$/]0O^HK_R3_[8_7NBOR$H
MH_L_^_\ A_P0_P!0O^HK_P D_P#MC]>Z*_(2BC^S_P"_^'_!#_4+_J*_\D_^
MV/U[HK\A**/[/_O_ (?\$/\ 4+_J*_\ )/\ [8_7NBOR$HH_L_\ O_A_P0_U
M"_ZBO_)/_MC]>Z*_(2BC^S_[_P"'_!#_ %"_ZBO_ "3_ .V/U[HK\A**/[/_
M +_X?\$/]0O^HK_R3_[8_7NBOR$HH_L_^_\ A_P0_P!0O^HK_P D_P#MC]>Z
M*_(2BC^S_P"_^'_!#_4+_J*_\D_^V/U[HK\A**/[/_O_ (?\$/\ 4+_J*_\
M)/\ [8_7NBOR$HH_L_\ O_A_P0_U"_ZBO_)/_MC]>Z*_(2BC^S_[_P"'_!#_
M %"_ZBO_ "3_ .V/U[HK\A**/[/_ +_X?\$/]0O^HK_R3_[8_7NBOR$HH_L_
M^_\ A_P0_P!0O^HK_P D_P#MC]>Z*_(2BC^S_P"_^'_!#_4+_J*_\D_^V/U[
MHK\A**/[/_O_ (?\$/\ 4+_J*_\ )/\ [8_7NBOR$HH_L_\ O_A_P0_U"_ZB
MO_)/_MC]>Z*_(2BC^S_[_P"'_!#_ %"_ZBO_ "3_ .V/U[HK\A**/[/_ +_X
M?\$/]0O^HK_R3_[8_7NBOR$HH_L_^_\ A_P0_P!0O^HK_P D_P#MC]&/V;O^
M:I?]CWJG_M*O8Z_(2BC^S_[_ .'_  0_U"_ZBO\ R3_[8_7NBOR$HH_L_P#O
M_A_P0_U"_P"HK_R3_P"V/U[HK\A**/[/_O\ X?\ !#_4+_J*_P#)/_MC]>Z*
M_(2BC^S_ ._^'_!#_4+_ *BO_)/_ +8_7NBOR$HH_L_^_P#A_P $/]0O^HK_
M ,D_^V/U[HK\A**/[/\ [_X?\$/]0O\ J*_\D_\ MC]>Z*_(2BC^S_[_ .'_
M  0_U"_ZBO\ R3_[8_7NBOR$HH_L_P#O_A_P0_U"_P"HK_R3_P"V/U[HK\A*
M*/[/_O\ X?\ !#_4+_J*_P#)/_MC]>Z*_(2BC^S_ ._^'_!#_4+_ *BO_)/_
M +8_7NBOR$HH_L_^_P#A_P $/]0O^HK_ ,D_^V/U[HK\A**/[/\ [_X?\$/]
M0O\ J*_\D_\ MC]>Z*_(2BC^S_[_ .'_  0_U"_ZBO\ R3_[8_7NBOR$HH_L
M_P#O_A_P0_U"_P"HK_R3_P"V/U[HK\A**/[/_O\ X?\ !#_4+_J*_P#)/_MC
M]>Z*_(2BC^S_ ._^'_!#_4+_ *BO_)/_ +8_7NBOR$HH_L_^_P#A_P $/]0O
M^HK_ ,D_^V/U[HK\A**/[/\ [_X?\$/]0O\ J*_\D_\ MC]>Z*_(2BC^S_[_
M .'_  0_U"_ZBO\ R3_[8_7NBOR$HH_L_P#O_A_P0_U"_P"HK_R3_P"V/U[H
MK\A**/[/_O\ X?\ !#_4+_J*_P#)/_MC]>Z*_(2BC^S_ ._^'_!#_4+_ *BO
M_)/_ +8_7NBOR$HH_L_^_P#A_P $/]0O^HK_ ,D_^V/U[HK\A**/[/\ [_X?
M\$/]0O\ J*_\D_\ MC]>Z*_(2BC^S_[_ .'_  0_U"_ZBO\ R3_[8_7NBOR$
MHH_L_P#O_A_P0_U"_P"HK_R3_P"V/U[HK\A**/[/_O\ X?\ !#_4+_J*_P#)
M/_MC]>Z*_(2BC^S_ ._^'_!#_4+_ *BO_)/_ +8_7NO'/V0?^3=_"?\ V]_^
ME<U?G/11_9_]_P##_@A_J%_U%?\ DG_VQ^O=%?D)11_9_P#?_#_@A_J%_P!1
M7_DG_P!L?KW17Y"44?V?_?\ P_X(?ZA?]17_ ))_]L?KW17Y"44?V?\ W_P_
MX(?ZA?\ 45_Y)_\ ;'Z]T5^0E%']G_W_ ,/^"'^H7_45_P"2?_;'Z]T5^0E%
M']G_ -_\/^"'^H7_ %%?^2?_ &Q^O=%?D)11_9_]_P##_@A_J%_U%?\ DG_V
MQ^O=%?D)11_9_P#?_#_@A_J%_P!17_DG_P!L?KW17Y"44?V?_?\ P_X(?ZA?
M]17_ ))_]L?KW17Y"44?V?\ W_P_X(?ZA?\ 45_Y)_\ ;'Z]T5^0E%']G_W_
M ,/^"'^H7_45_P"2?_;'Z]T5^0E%']G_ -_\/^"'^H7_ %%?^2?_ &Q^O=%?
MD)11_9_]_P##_@A_J%_U%?\ DG_VQ^O=%?D)11_9_P#?_#_@A_J%_P!17_DG
M_P!L?KW17Y"44?V?_?\ P_X(?ZA?]17_ ))_]L?KW17Y"44?V?\ W_P_X(?Z
MA?\ 45_Y)_\ ;'Z]T5^0E%']G_W_ ,/^"'^H7_45_P"2?_;'Z]T5^0E%']G_
M -_\/^"'^H7_ %%?^2?_ &Q^O=%?D)11_9_]_P##_@A_J%_U%?\ DG_VQ^O=
M%?D)11_9_P#?_#_@A_J%_P!17_DG_P!L?KW17Y"44?V?_?\ P_X(?ZA?]17_
M ))_]L?KW17Y"44?V?\ W_P_X(?ZA?\ 45_Y)_\ ;'Z]T5^0E%']G_W_ ,/^
M"'^H7_45_P"2?_;'Z]T5^0E%']G_ -_\/^"'^H7_ %%?^2?_ &Q^O=%?D)11
M_9_]_P##_@A_J%_U%?\ DG_VQ^O=%?D)11_9_P#?_#_@A_J%_P!17_DG_P!L
M?KW17Y"44?V?_?\ P_X(?ZA?]17_ ))_]L?KW17Y"44?V?\ W_P_X(?ZA?\
M45_Y)_\ ;'Z]UXY^U]_R;OXL_P"W3_TKAK\YZ*/[/_O_ (?\$/\ 4+_J*_\
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MBC^S_P"_^'_!#_4+_J*_\D_^V/U[HK\A**/[/_O_ (?\$/\ 4+_J*_\ )/\
M[8_7NBOR$HH_L_\ O_A_P0_U"_ZBO_)/_MC]>Z*_(2BC^S_[_P"'_!#_ %"_
MZBO_ "3_ .V/U[HK\A**/[/_ +_X?\$/]0O^HK_R3_[8_7NBOR$HH_L_^_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/_? 89]2*3X#?!=?A?XJ\?7QB"17VH^78<  6NT2#;[9DV'WBKYV_;<\=?\
M"0?$JUT""0-;:';[7 S_ *^7#/\ 7"B,?7-8U)+%5X16UK_K_DCD]I'B#B&G
M*&M*FD_NU_\ 2FD_0^=****]H_7 HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ^\?V%VE;X/ZB),[%UJ81Y&/E\F
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*[E)2V9]K3JTZJYJ<DUY.XVBBBF:A1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM*\C\2S;-\1F]?VM;1+9=$O\^["BBBL#Q HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ KQS_F\+_N1/_<A7L=>.?\ -X7_ '(G_N0H ]CHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_FJ7_8]ZI_
M[2KV.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MX*?]QO\ ])$KV.O'/B=_R<1\%/\ N-_^DB5['0 4444 %%%% !1110 4444
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MG_Y%_P#K4?\ "9?].?\ Y%_^M1RL/J]7L=-17,_\)E_TY_\ D7_ZU'_"9?\
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M-16!#XPMV.)(9(_<8:M>UU"WO@3!,LF.H'4?A4M-&4J<X?$BQ1112,PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/^;P
MO^Y$_P#<A7L=>.?\WA?]R)_[D* /8Z*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'
M/V;O^:I?]CWJG_M*O8Z\<_9N_P":I?\ 8]ZI_P"TJ]CH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW$V83JIVI1TOY=EYO?R/<^L4>&<OA2:O5EK;S\_);>9Z=\?OV^->\837.C^
M3-X>T3E&U(\7EP/53_RR4^WS>XZ5\HC[=KVI@#[1J&H74@ ^])+*[' ]2Q)_
M&H[&QN-3O(+2TADN;J=UCBAB4LSL3@* .I)K]+?V2OV1;3X1V,'B;Q1!%>>,
MITW1QL Z:<I'W5]9,=6'3H.Y/V6(K8'AS#?NXZO9=9/S?]>1\9AZ..XCQ-ZD
MM%N^D5Y+]/O.'_9H_8/M=+AM?$GQ*MUN[Y@)(- 8YCA[@SX^\W^QT'?/0?:5
MO;Q6=O'!!$D$$:A4CC4*JJ.@ '05'J&I6FDV<MW?74-G:Q#<\]Q($11ZECP*
M\8\6?MH?"/PE*\+^*%U6=>#'I4+W /T<#8?^^J_+:];'YU5<W%S\DG9?Y'ZG
MAZ. R6BH*2AYMJ[_ ,SW"BODN^_X*1?#V&3;:Z%XAN5S]YHH4_3S#7<_#O\
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M@BNXT'4CJ-B"YS,AVO[^AK"4;:H\O$45#WX[&E11169PA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5XY_S>%_W(G_N0KV.O'/\
MF\+_ +D3_P!R% 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CG[-W_ #5+_L>]
M4_\ :5>QUXY^S=_S5+_L>]4_]I5['0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY^R
M#_R;OX3_ .WO_P!*YJ]CKQS]D'_DW?PG_P!O?_I7-0!['1110 4444 %%%%
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY\3O\ DXCX*?\
M<;_])$KV.O'/B=_R<1\%/^XW_P"DB5['0 4444 %%%% !1110 4444 %%%%
M!1110!1UNZ-GI<[C[Q&T?4\5P5=AXN8KIB =Y0#^1KCZWAL>MA5:%PHHHK0[
M0HHHH **** "BBB@ KE?&7Q6\$_#JXMH/%?C'0/#$UTI>"/6=4@M&E4'!*B1
MEW $CD>M=57Q_P#\%//@G_PL_P#9[F\165OYNM>$)3J*%1EFM2 MPOT"[9/^
MV58U9NG'F^_T_P"!N.S=TM_Z_,^K?#?B?1_&6C6^KZ!JUCKFDW&[R;[3;E+B
M"3#%3MD0E3@@@X/4$5!XL\;>'? .EC4_$^O:7X<TTR"(7FK7D=K"7()"[Y&
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ML?/E8LSQPSR1QY)ZD(JC\**;56$I+=/_ #%&K4C5]E46_8_+7X _\GX>&/\
ML=&_]*&K[Y_X*X?\FSZ/_P!C-;?^D]S7P-\ ?^3\/#'_ &.C?^E#5]\_\%</
M^39]'_[&:V_])[FN"'_(KH^J_P#; H_[WB?1_E,\_P#^"6/C_P -_#7]GOQ]
MK?BK7+'0-)BU]0UU?SK$FXVT>%&?O,<<*,D]A7U5X#_;<^!WQ*UZ/1=!^(>G
MRZG*PCBAO89[+S6)P%1IXT5V)Z!22>U?F1^PS^QO-^U9_;$VOZ_J&C^!=%G
M:&P8>9<7<B#(CWAD0A%3<Y4DC:,=QM?MS?L"V?[,OAW3?%WA+6;_ %CPQ/<K
M974&J[&N;:5@2C[XU561MI'W05..N[CNJU'!QE46CLOP2_$YL/*I[']TKVO?
M[VW;T/V.KC?B9\9/!'P;TE-1\:^)].\.VTF?*^V2XDFQC(CC&7D(R.%!ZU\S
M?\$Z_P!HR]\>?LS:Q-XKO9+V]\$-)!/>3-NEDLUB\V)G/=@H=,GDA!G)R:^
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M#O7AO['O_!-30/C=\([+QSXX\0ZOIZ:N7;3K'17BC*1*[)OE:2-\EF4X4 8
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MD8MA0V5%?JK^RGX=^+'A?X:S6?QAU2UUGQ.]_-<1W5O<^<PA?#!'PBJI5MX
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M,I<>)=5N]28L,'8K"W3\,0$_\"K.FN>=1MZ12^]O_).QI4?)"%EK*37R2O\
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M# .:^,_$7[5OQ6_:R^."^ _V:-2C\/>"]!GQX@^(EQI\-W _4%85F1E9>NT
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M91R:M8Z=S;V]P5R\:'S),A3QD.P.,@D5\J_\%"_VB/B!\+?%GP;\#_#+7O[
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M_P#CG_UZ?NCM1[DW_"16W]R7\A_C2?\ "26W_/.;\A_C47_"-?\ 3S_XY_\
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M .HG_P"2_P#]E2'X7Y_YB?\ Y+__ &5/]V/EP/\ -^?^1?\ ^%F:7_SPN_\
MOA?_ (JF_P#"SM+_ .?>\_[X3_XJJ7_"K?\ J)_^2_\ ]E33\*_^HI_Y+_\
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M^%\:!_SYZE_WZC_^+I/^%]>'_P#GSU+_ +]1_P#Q=9'_  S[_P!1_P#\D_\
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M )(__;*+4.X>SR7^=_\ DW^1M_\ #1GAO_GQU7_OU%_\<I/^&CO#7_/CJO\
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MVTG_  RU_P!3/_Y(?_;:+8?N/V>1?SO_ ,F_R-[_ (::\+C_ )<-7_[\Q?\
MQRD_X:<\+_\ /AJ__?F+_P".5@G]EC/_ #,__E/_ /MM)_PRO_U-'_E/_P#M
MM.V'[_F/V>0_SO\ \F_R-_\ X:<\+?\ /AJ__?F+_P".4W_AI[PL/^7#6/\
MOS%_\=K"_P"&5O\ J:/_ "G_ /VVFG]E//\ S-'_ )3_ /[;1;#]_P Q^SR'
M^=_^3?Y&_P#\-/\ A;_GPUC_ +\Q?_':\S_9O^/&@>"_@OX=T>]L]2ENK;[1
MO>WBC*'=<RN,$N#T8=JZS_AE/_J:/_*?_P#;:\[_ &?_ -GW_A./A%H.M_V]
M]B^U?:/W'V/S-NVXD3[WF#.=N>G>IM0OOH8NGDGM8I3?+9W^+>ZMT]3V+_AJ
M+PK_ - _6/\ OS%_\=I/^&I/"G_0/UC_ +\Q?_':Y_\ X9/_ .II_P#*=_\
M;:3_ (9-_P"IJ_\ *=_]MJK8?O\ F='L\@_Y^/\ \F_R.A_X:D\*?] _6/\
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M+_AK;PA_T#=;_P"_$/\ \=H_X:V\(?\ 0-UO_OQ#_P#':YO_ (8Z_P"IN_\
M*9_]NI/^&.?^IN_\IG_VZBV%[_F/V7#G_/Q_^3?_ ")TG_#7'@\?\PW7/^_$
M/_QVF_\ #77@_P#Z!NN?]^(?_CM<X?V.,_\ ,W_^4S_[=33^QKG_ )F__P I
MG_VZBV%[_F/V7#?_ #\?_DW_ ,B=+_PUYX._Z!NN?]^(?_CM)_PUYX._Z!NN
M?]^(?_CM<U_PQI_U.'_E,_\ MU!_8SS_ ,SA_P"4S_[=1;"]_P Q^RX;_P"?
MC_\ )O\ Y$Z3_AK[P=_T#=<_[\0__':3_AL#P;_T#-<_[\0__':YK_AC'_J<
M/_*9_P#;J0_L7Y_YG'_RF?\ VZGRX7O^8_9<-?\ /Q_^3?\ R)TW_#8'@W_H
M&:[_ -^(?_CM)_PV%X-_Z!FN_P#@/#_\>KF?^&+_ /J<?_*7_P#;J3_ABW_J
M<?\ RE__ &ZCEPO?\Q^RX:_Y^/\ \F_^1.F_X;$\&?\ 0,UW_P !X?\ X]2?
M\-B>#/\ H&:[_P" \/\ \>KF?^&*_P#J<O\ RE__ &ZD/[%>?^9R_P#*7_\
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M3O\ ^4G_ .WT<N$[_F/V/"O_ #]E_P"3_P#R)U7_  VUX&_Z!7B#_P !X/\
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MWQ[^(FN1:=H&JW%W?RGY+33-,A8_7&P\>YKZD^%_P]_:/U%8KWQ;\2+708V
M8V2Z?;WDP]CA0BGZ,U>V_"_X/^%/@[H2Z7X8TJ.R0@>=<L-T]PP_BD?JQ]N@
M[ 5V=?'8_.*%1N&#P\(Q[N,6_P K+\3[' 9-7II5,9B)SEV4I)?G=_@4]'M;
MJQTV""]OFU*Z1<273QK&9#Z[5&!^%7***^5;N[GU:5E8****0PHHHH ****
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MCDP.Z8JW^S_X=NOVSOVY)-;U:-I]+FU.7Q!J"2<A;.%QY4)]C^YB^A-?6O\
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MSOT_/H?D_P#M_?\ )YGQ$_Z_+7_TD@K]S++_ (\X/^N:_P J_*C]K_\ 8?\
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MEYCQ--RJ*JE=6LUZ:?I^?D=LO_!)_P ,OX@N=!7]H+26URVV^?I@T:+[3%N
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M2BKM6BO1))OSZ_TCK=:L_P!NZY\/7FK:GXP^%O@2PM;5KFZDA@DFEMXT!=V
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?\WA?]R)_
M[D*]CKQS_F\+_N1/_<A0!['1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY^S=_S5
M+_L>]4_]I5['7CG[-W_-4O\ L>]4_P#:5>QT %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %>.?L@_\F[^$_\ M[_]*YJ]CKQS]D'_ )-W\)_]O?\ Z5S4 >QT444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]M_A1<.:/<K459_LN\_Y])_^_;?X4?V7>?\ /I/_ -^V_P *+AS1[E:BK/\
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MR<I.[?\ 2^2"BBBI&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG_-X7_<
MB?\ N0KV.O'/^;PO^Y$_]R% 'L=%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CG[-
MW_-4O^Q[U3_VE7L=>.?LW?\ -4O^Q[U3_P!I5['0 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5XY^R#_ ,F[^$_^WO\ ]*YJ]CKQS]D'_DW?PG_V]_\ I7-0!['1110
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MS+("JL<8!]SD8]<UI:=J5KJ]E%>65Q'=6LHRDT3!E;G'!^M %FBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /'/B=_R<1\%/^XW_P"DB5['
M7CGQ._Y.(^"G_<;_ /21*]CH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^_\ R$_^%'_"8:1_S]_^0G_PH VJ*Q?^$PTC_G[_ /(3_P"%'_"8:1_S]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>.?LW?\ -4O^Q[U3_P!I5['7CG[-W_-4O^Q[U3_VE7L= !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7CG[(/_)N_A/\ [>__ $KFKV.O'/V0?^3=_"?_ &]_^E<U 'L=
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %>.?M??\ )N_BS_MT_P#2N&O8Z\<_:^_Y-W\6
M?]NG_I7#0!['163-XJTNWFDBDNMLD;%67RW."#@]JC_X3#2/^?O_ ,A/_A0!
MM45B_P#"8:1_S]_^0G_PH_X3#2/^?O\ \A/_ (4 ;5%8O_"8:1_S]_\ D)_\
M*/\ A,-(_P"?O_R$_P#A0!M45B_\)AI'_/W_ .0G_P */^$PTC_G[_\ (3_X
M4 ;5%8O_  F&D?\ /W_Y"?\ PH_X3#2/^?O_ ,A/_A0!M45B_P#"8:1_S]_^
M0G_PH_X3#2/^?O\ \A/_ (4 ;5%8O_"8:1_S]_\ D)_\*/\ A,-(_P"?O_R$
M_P#A0!M45B_\)AI'_/W_ .0G_P */^$PTC_G[_\ (3_X4 ;5%8O_  F&D?\
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MIT>FV5U%K&EV=A]J:X \AHX?+=F4C+*,[ACG([9S7HG_  F&D?\ /W_Y"?\
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MY$=N?[3TN"R@,AQ\R-*6!XX'SK71?\)AI'_/W_Y"?_"C_A,-(_Y^_P#R$_\
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M_P#"8:1_S]_^0G_PH_X3#2/^?O\ \A/_ (4 ;5%8O_"8:1_S]_\ D)_\*/\
MA,-(_P"?O_R$_P#A0!M45B_\)AI'_/W_ .0G_P */^$PTC_G[_\ (3_X4 ;5
M%8O_  F&D?\ /W_Y"?\ PH_X3#2/^?O_ ,A/_A0!M45B_P#"8:1_S]_^0G_P
MH_X3#2/^?O\ \A/_ (4 >;?$[_DXCX*?]QO_ -)$KV.O&?'$JZY\=OA!J%B?
M/L[.75H9Y/N['DLB4&#@G(BDZ#C;SU&?9J "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HJO=WT%C'NGD5!V'<_05@7?C!MQ%M" .S2?X"J46]C6%*=3
MX4=/17$-XFU!NDP7Z(O^%)_PDFH_\_'_ (XO^%5R,Z/JD^Z.XHKA_P#A)-1_
MY^/_ !Q?\*/^$DU'_GX_\<7_  HY&'U2?='<45P__"2:C_S\?^.+_A1_PDFH
M_P#/Q_XXO^%'(P^J3[H[BBN'_P"$DU'_ )^/_'%_PH_X234?^?C_ ,<7_"CD
M8?5)]T=Q17#_ /"2:C_S\?\ CB_X4?\ "2:C_P _'_CB_P"%'(P^J3[H[BBN
M'_X234?^?C_QQ?\ "C_A)-1_Y^/_ !Q?\*.1A]4GW1W%%</_ ,))J/\ S\?^
M.+_A1_PDFH_\_'_CB_X4<C#ZI/NCN**X?_A)-1_Y^/\ QQ?\*/\ A)-1_P"?
MC_QQ?\*.1A]4GW1W%%</_P ))J/_ #\?^.+_ (4?\))J/_/Q_P".+_A1R,/J
MD^Z.XHKA_P#A)-1_Y^/_ !Q?\*/^$DU'_GX_\<7_  HY&'U2?='<45P__"2:
MC_S\?^.+_A1_PDFH_P#/Q_XXO^%'(P^J3[H[BBN'_P"$DU'_ )^/_'%_PH_X
M234?^?C_ ,<7_"CD8?5)]T=Q17#_ /"2:C_S\?\ CB_X4?\ "2:C_P _'_CB
M_P"%'(P^J3[H[BBN'_X234?^?C_QQ?\ "C_A)-1_Y^/_ !Q?\*.1A]4GW1W%
M%</_ ,))J/\ S\?^.+_A1_PDFH_\_'_CB_X4<C#ZI/NCN**X?_A)-1_Y^/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5XY^R#_P F[^$_^WO_ -*YJ]CKQS]D'_DW?PG_
M -O?_I7-0!['1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1161XM\5:;X(\.7VN:O/]FTZS3?+)C)Y(  '<EB
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/'/B=_R<1\%/^XW_ .DB5['7CGQ._P"3B/@I_P!QO_TD2O8Z "BBB@ HHHH
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MW_@0_P#C1[%]Q_V3/^='O]%?/K>)M8_Z"U]_X$O_ (TG_"3ZQ_T%K[_P)?\
MQH]B^X_[(G_.CZ#HKY[;Q1K/_06OO_ E_P#&HV\4:SS_ ,3>^_\  E_\:/8O
MN/\ L>I_.CZ(HKYU_P"$IUK_ *"]_P#^!+_XTA\4ZUC_ )"]_P#^!+_XT_8O
MN/\ L>I_.CZ+HKYR;Q5K7_08O_\ P)?_ !J/_A*];_Z#&H?^!3_XT>P?</[&
MJ?SH^D:*^;O^$KUO_H,:A_X%/_C33XLUOG_B<ZA_X%/_ (T>P?<?]BU/YT?2
M=%?-/_"6:Y_T&=0_\"I/\:;_ ,);KG_09U#_ ,"I/\:/8/N/^Q:G\Z/IBBOF
M9O%VN_\ 0:U#_P "I/\ &F_\)=KO_0:U#_P*D_QI^P?<?]B5/YT?3=%?,7_"
M7:[_ -!K4?\ P*D_QIK>+]>Y_P")WJ/_ (%R?XT?5WW'_8=3^='T_17R]_PF
M&O?]!O4?_ N3_&FGQAKV?^0WJ7_@7)_C3^KON5_853^='U'17RTWC'7_ /H.
M:E_X%R?XTG_"9:__ -!S4O\ P+D_QH^KON']@U/YT?4U%?*__"9:_P#]!S4O
M_ N3_&FGQEX@S_R'-2_\"Y/\:/J[[C_L&I_.CZJHKY3;QGX@_P"@[J7_ (%R
M?XTP^-/$.?\ D.ZG_P"!DG_Q5'U=]Q_V#5_G1]7T5\GMXT\0_P#0=U/_ ,#)
M/_BJ;_PFOB'_ *#VI_\ @9)_\53^K/N/^P*O_/Q'UE17R7_PFWB+_H/:G_X&
M2?\ Q5-/C;Q%G_D/:I_X&2?_ !5'U9]Q_P"K]7_GXCZVHKY(;QMXB_Z#^J?^
M!DG_ ,53#XX\1Y_Y#^J?^!DG_P 51]6?<?\ J_5_Y^(^NJ*^1/\ A./$?_0?
MU3_P-D_^*II\<>(\_P#(P:I_X&R?_%4?5GW'_J[5_P"?B/KVBOCYO'/B3_H8
M-4_\#9?_ (JD_P"$Z\2?]#!JO_@;+_\ %4?5GW#_ %=J_P#/Q'V%17QXWCKQ
M)_T,.J_^!LO_ ,53#X[\2Y_Y&'5?_ V7_P"*H^K/N/\ U=J_\_%]S/L:BOCC
M_A._$O\ T,.J_P#@;+_\52-X\\2_]#%JW_@;+_\ %4_JK[C_ -7*O_/Q?<S[
M(HKXS;QYXF_Z&+5O_ Z7_P"*IO\ PGOB;_H8M6_\#I?_ (JCZJ^X_P#5NK_S
M\7W,^SJ*^,?^$]\3?]#%JW_@=+_\53&\?>)_^ACU;_P.E_\ BJ/JLNX_]6JW
M_/Q?<S[1HKXL_P"$^\3_ /0QZM_X'2__ !5-_P"$_P#%'_0R:O\ ^!TO_P 5
M1]5EW'_JS6_Y^+[F?:M%?%#?$#Q1S_Q4FK_^!TO_ ,53?^%@>*?^ADU?_P #
MY?\ XJG]5EW'_JS6_P"?B^YGVS17Q+_PL#Q3_P!#)J__ ('R_P#Q5,;XA>*?
M^AEUC_P/E_\ BJ/JLNX_]6:W_/Q?<S[=KQS]D'_DW?PG_P!O?_I7-7@G_"PO
M%/\ T,NL?^!\O_Q5<G\+?&6OZ3X#TNULM<U*SM8_-V0V]W(B+F5R<*#@<DG\
M:GZL[VN8OAVJJL:7M%JF]GT:7ZGZ%45\.M\1/%7/_%3:Q_X'R_\ Q5,_X6)X
MK_Z&;6/_  /E_P#BJKZI+N='^J];_GXON9]RT5\-?\+$\5_]#-K'_@?+_P#%
M4QOB+XK_ .AGUG_P82__ !5/ZI+N/_5:M_S]7W,^Z**^%?\ A8WBS_H9]9_\
M&$O_ ,53?^%C>+/^AHUG_P &$W_Q5'U27<?^JM;_ )^K[F?=E%?")^(WBS/_
M "-&M?\ @PF_^*I&^(_BW_H:-:_\&$W_ ,51]4EW#_56M_S]7W,^[Z*^#3\2
M/%N?^1IUK_P83?\ Q5-;XD>+O^AIUK_P83?_ !5'U27<?^JE;_GZON9]Z45\
M%?\ "R?%W_0TZU_X,)O_ (JF?\+*\7?]#3K7_@QF_P#BJ/J<NX_]5*__ #]7
MW,^^**^!C\2O%^?^1JUO_P &,W_Q5-;XE>+_ /H:M;_\&,W_ ,53^IR[C_U3
MK_\ /U?<S[[HKX!/Q,\7Y_Y&O6__  8S?_%4G_"S/&'_ $->M_\ @QF_^*H^
MIR[C_P!4J_\ S]7W,^_Z*_/]OB9XP_Z&O7/_  8S?_%5&WQ.\8_]#9KG_@QF
M_P#BJ/J<NX_]4:__ #]7W,_02BOSY_X6=XQ_Z&S7/_!E-_\ %4C?$[QC_P!#
M9KG_ (,IO_BJ/J<NX_\ 5&O_ ,_5]S/T'HK\]F^)_C+_ *&S7/\ P93?_%4U
MOBAXR_Z&W7/_  93?_%4_J<NX_\ 5"O_ ,_5]S/T+HK\\O\ A:'C+_H;==_\
M&4W_ ,53?^%H>,_^AMUW_P &4W_Q5'U*7<?^I]?_ )^K[F?H?17YWM\4?&?_
M $-VN_\ @RF_^*II^*7C/'_(W:[_ .#*;_XJG]2EW#_4^O\ \_5]S/T2HK\Z
MF^*7C3_H;M>_\&<W_P 52?\ "TO&G_0WZ]_X,Y__ (JCZE+N5_J=7_Y^K[F?
MHM17YT-\4_&G_0WZ]_X,Y_\ XJHS\5/&N/\ D;]>_P#!G/\ _%4?4I=Q_P"I
MM?\ Y_+[F?HW17YQ?\+4\:_]#AKW_@SG_P#BJ0_%7QKC_D<->_\ !G/_ /%4
M?49?S!_J;B/^?R^YGZ/45^;S?%;QM_T.&O\ _@SG_P#BJ3_A:WC;_H<=?_\
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MA[B-RL2"5ED9B7!DWX.<'MQBOJ?2_P#@CU\1IM=6+4O&WA>UT;?AKNU^TS7
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M_B;]F'X4:OX8\4WVDW]_>:S)J$<FCS2R1"-H84 )DC0[LQMVQ@CFOFKXU?\
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M-BHP?.YN'+V[_P!?UZE%%%2=H4444 %%%% !1110 5J^&K8W&JQMCY8P7/\
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M (*C?"?X>WD:WN@^%M-74K^W;YDW#S+EE8>C!+92.X:NP_X)V_#7Q>WQV_:
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MQMU,3]K2/_A;W_!2K]GOX?8:6R\.PGQ!<J.5#!WG(/X6<8_X'7LW_!3KQZ?
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MN./E<:="D^B<GZZ1_1L^"OVZF/Q?_;[_ &<OA="?,ATV9=:O$'(VM-YC@_\
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MMY;]KM&BUIU(4]?>C:_5+?UUV[V3-'_A3?\ P4,_Z+M\/_\ P!A_^55>D?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#]F'P)+XX^,&B9C8V.F2KJ%S)Y991Y9W(IQP-SA1SVSUZ'Z]_:^_Y-W\6?\
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M?]]-_A1_PB%Y_P ]8/\ OIO\*.9![:G_ #&'16Y_PB%Y_P ]8/\ OIO\*/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG_-X7_<B?^Y"O8Z\
M<_YO"_[D3_W(4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >.?LW?\U2_['O5/
M_:5>QUXY^S=_S5+_ +'O5/\ VE7L= !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[(
M/_)N_A/_ +>__2N:O8Z\<_9!_P"3=_"?_;W_ .E<U 'L=%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;X
M@\.:7XJTR73M8T^WU.QD^]!=1AUSV(!Z$=B.1VKQ/Q!^Q3\/M6G,MB^J:)P
M(;6Z$D?;G]ZKMZ_Q=Z]^HK6%6=/X78]'"YCC,#_NU5Q]'I]VQ\YZ/^PUX(L9
MDDOM2UC4@NW,1ECB1L'G.U-V#['O^->T^"_AUX:^'=BUIX=T>VTN)OOM&"TC
M_P"](Q+-^)-='13G6J5-),TQ6:X[&KEQ%5R7:^GW;!7CG[7W_)N_BS_MT_\
M2N&O8Z\<_:^_Y-W\6?\ ;I_Z5PUB>4>QT444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M >.?$[_DXCX*?]QO_P!)$KV.O'/B=_R<1\%/^XW_ .DB5['0 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG_ #>%_P!R)_[D
M*]CKQS_F\+_N1/\ W(4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >.?LW?\U2
M_P"Q[U3_ -I5['7CG[-W_-4O^Q[U3_VE7L= !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7CG[(/_ ";OX3_[>_\ TKFKV.O'/V0?^3=_"?\ V]_^E<U 'L=%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %>.?M??\F[^+/^W3_TKAKV.O'/VOO^3=_%G_;I_P"E<- '
ML=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKSW^U+S_ )^Y_P#OXW^-']J7G_/W/_W\;_&CV;#ZI+N>A45Y[_:EY_S]S_\
M?QO\:/[4O/\ G[G_ ._C?XT>S8?5)=ST*BN#AUZ_A((N6;V?YOYULZ?XM5L)
M>)M/_/1!Q^(_PJ7!F<L-..JU.CHID4J31K)&P=&&0P[T^H.0**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS_F\+_N1/\
MW(5['7CG_-X7_<B?^Y"@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QS]F[_FJ
M7_8]ZI_[2KV.O'/V;O\ FJ7_ &/>J?\ M*O8Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "O'/V0?^3=_"?_ &]_^E<U>QUXY^R#_P F[^$_^WO_ -*YJ /8Z*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BHKBYAM4#S2I"I. TC!1GTYI+6\M[Z$2VT\=Q$>CQ.&4\9ZCZT#L[7)J**
M*!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !7CG[7W_)N_BS_ +=/_2N&O8Z\<_:^_P"3=_%G_;I_Z5PT >QT444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#QS]F[_ )JE_P!CWJG_ +2KV.O'/V;O^:I?]CWJ
MG_M*O8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O'/V0?^3=_"?_;W_P"E<U>QUXY^
MR#_R;OX3_P"WO_TKFH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@"*YN8K.WEN+B5(((D,DDLC!510,EB3P !WKX
MR^-W[8>HZQ<S:3X$G;3]+'ROJQC*W$_7/EY_U:GU(W\?P]*Z?]M;XJW&GV]E
MX(TZ?RC=(+N_DBD(8QY8+"P QAB-QYS\J\8//QVU>QA,,FO:31^L\+\/4ITE
MCL7'FO\ "GM;N^_E_5K>K:UJ.O73W6IW]UJ-TYRTUW,TKDX R68D]A^55['4
MKS2;I;FQNIK*Y7[LUO(8W'T(.:BJ-J]>W0_4U&*CRI:'T3\'?VP_$/A2]M=.
M\73/K^ADA&NI!F\MQ_>W_P#+0#G(;+'LW&#]P:/K%EX@TNUU'3KJ.]L;E!)#
M<0MN5U/0@U^2C5]3?L/_ !0DL->O/ ][,S6U\K75@K$D),BDR(/0,@+?5#ZU
MY>+PT>5U(*UC\UXHX=HNA+'82/+*.LDMFNKMT:W?='VC1117B'XZ%%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY^U]_R;
MOXL_[=/_ $KAKV.O'/VOO^3=_%G_ &Z?^E<- 'L=%%% !1110 4444 %%%%
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MQ>;PG\7==^'M_*8K3Q';>?:QR'&V\@!)4 ]"T9DS_P!<UKD?^"AGQ#OOC_\
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M':H9SM  9V!<@=V/)ZT4Y)58QW3W_ Y:DJD8.7M%S=EK_7]:G[2?M>?M/?\
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M7?G6W EDAB#NQ\^3A0?G;ZUO3BI3<.EF[^:U_'\#*;:BI];K3I9_Y?B>-?\
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MAO\ MR?%C]B_3]!^'W[0_P *KZ'PYIL,6FZ?XHT6-<&*--J#()@G(51G8Z,
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX^W^-'_"/Z?_ ,^__C[?XT7CV*]I0_E,0^++S_GG#_WR?\::?%UY_P \X/\
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MP1^)&IZ/_P )_P"3!:-]J\6ZA=/YB,<,WEY PPXXKT@_&+6O^?6P_P"_;_\
MQ=87[/G@C1=2_P"%E?:;+S/L_C;4X(_WKC:B^7@<-SUZGFO6/^%:>&_^@;_Y
M'E_^*H4J?5$4\1@8Q2G3;?\ 7F<'_P +BUK_ )];#_OV_P#\733\9-:'_+K8
M?]^W_P#BZ[W_ (5GX;_Z!O\ Y'E_^*H_X5EX:_Z!O_D>7_XJGS4^QK]:R_\
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M (ND/QXU_P#Y\]-_[]2?_%UZ1_PJ3PG_ - K_P F9?\ XNC_ (5'X3_Z!/\
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M1WB7_GQTK_OS+_\ '*3_ (:.\2_\^.E?]^9?_CE>J_\ "D_!?_0&_P#)J?\
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M'_Y-S_\ Q=)_PH7P)_T O_)N?_XY1[2A_*/Z_DO_ $#O[E_\D>0']J#Q4/\
MF'Z/_P!^9?\ X[3#^U%XJ'_,/T?_ +\R_P#QVO8O^%"^!/\ H!?^3<__ ,<I
M/^%!^ _^@%_Y.3__ !RCVE#^4?\ :&2_] [^Y?\ R1XY_P -2>*_^@?H_P#W
MYE_^.TA_:E\5_P#0/T;_ +\R_P#QVO8_^% ^ _\ H!?^3EQ_\<H_X4#X"_Z
M/_DY<?\ QRG[2A_*/^T,D_Z!W]R_^2/&O^&J/%G_ $#]&_[\2_\ QVD_X:I\
M6?\ 0/T;_OQ-_P#':]E_X9_\ _\ 0!_\G+C_ ..4G_#/O@'_ * /_DY<?_'*
M/:4/Y1_VADG_ $#O[E_\D>,G]JKQ9_T#]%_[\3?_ !VD/[5GBW_H':+_ -^)
MO_CM>S_\,^^ /^@!_P"3EQ_\<I/^&>_ '_0 _P#)RX_^.4>TH?RC_M#(_P#H
M'?W+_P"2/%O^&KO%O_0.T7_OQ-_\=I/^&L/%W_0.T7_OQ-_\=KVG_AGGX?\
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M:?\ 0M_^3]S_ /'*3_AF/X:?]"U_Y/W/_P <H]KAOY/Z^\?]J</?] K^Y?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QSXG?\G$?!3_N-_P#I(E>Q
MUXY\3O\ DXCX*?\ <;_])$KV.@ HHHH **** "BBB@ HHHH **** "BBB@"E
MK-K]LTV>,?>V[A]1S7 UZ77&>(M)^P7/FQK^XD/'^RWI6L'T/0PM1*\&8]%%
M%;'IA1110 4444 %%%% !1110!^+7[8'A#5/V1_VS1XK\-Q+;6UQ>1^)=)R#
MY9+.3-"<?P^8)%('\+CUKK/^"7_PMNOBQ^T1J_Q%UM&O+?P\KWK7$G234+@L
M$/N0/-?V(4U^A_[2W[)/@G]JBQT2W\6SZI83:/)(]M=Z/-%%-M< .C&2.0%2
M54XQG*CGKG8_9W_9S\*?LR^"9_#'A.2_N;6XNWO9[K5)(Y+B61E5?F9$1< *
M  %_G66%C['27V;\OSM^2_%(X:]!U*W,OA;3?R_S?X-G$?\ !035-=T?]DCQ
M[<>'GGBNS!#%/);YWK;//&LYXZ#RRP)]":_,_P#8/\=_ GP/XJ\03_&K2+:\
M\R"+^R[S4M.?4+2$@MYBM J/\[93#%#C:>5SS^V&I:;::QI]S87]M#>V5S&T
M,]O<('CE1AAE93P002"#7R%XJ_X)3_!'Q)KTNI6I\1^'H9'WG3M*U"/[,#G)
M $L4C@>P; [8J8QE3JRFK._X?U_GW-<13=51<?L].G]?\ ^&OV_?VCO /QQU
MWPIH_P -M,%IX9\-Q3HMU'9BSBN'E,?^KBP"J*(QRP4DD\  $_H)_P $RY%D
M_8]\)!6!*W-\K8['[5(<?J*V?$7[ /P@UOX0K\.K+2;KP]I'VV/47OM+G7[=
M+.BLH9YI4DW##N,$8&?E KN/V=/V<]!_9E\&W?ACPUK&MZII5Q=M>JFM30RM
M"[*JL$,<4>%.T'!SSGU-;45[-5(OKU[NZ?\ G]QE[.HZL*CMYVZ:-?Y?>?D#
M\ ?^3\/#'_8Z-_Z4-7WS_P %</\ DV?1_P#L9K;_ -)[FNL\(?\ !-GX9^"_
MBU8?$.QUSQ9+K5GJAU:."XN[4VQE+E]I46X;;D]-V?>O7?VBOV=?#?[37@:V
M\*>*+W5+#3K>^CU!9=(ECCE,B(Z $R1N-N)&[9X'-<L:<E@:=!_%%J__ )+_
M ),UIP<<16J/:2:7_DW^:/S%_P""=O[9F@?LXWFN^&?&PN+?PMK,J7<>I6\+
M3&SN%7:Q=%!9D=0HRH)!4<$$D=K_ ,%#OVZ/!GQJ\!V'@+X=W<^KZ?+=QWNH
MZK);26\9"9V0HDJJY.XAB2H VJ!G)Q];Z3_P3C^#=C\+QX'O[#4M=LXKV6^M
MM4O[E%O[:21$5@DL,<8V?(IV,I&>2#@8Q?A]_P $N?@CX$\01ZK<6VM>+&A<
M216?B"\CDME8'()CBBCWC_9?<I[@UO4BZUHSV5M?3_+]#GITZU&FXQMK?Y7_
M ,SC?^"<'P!N[/\ 9/\ %8UVW:S/C_SQ$DBD-]C,!AC<@]F+2,/52I[U\"_!
M?5M&_9C_ &CKBP^+/@JS\2:7I\DVEZMI>H6$5WY62,3Q1RC:Q!"L#QE6.#S7
M[QPPQV\*11(L44:A41!A5 &  .PKQSX[_LA_##]HMX[KQ?H.=8BC\J+6-/E-
MO=JO8%APX'8.& R<=33J7]M[:"Z6L^RT7Z]M^EC3ZM_L\:-]4VT_-N[_ !]=
MO,^3?B=^UM^QWX3\.PW?A'X6>$O'>K22*O\ 9T7A.*P6)3]YGEFM0.!T"ALG
M X'(^AOV+?B)\-_B]X<UCQ/\/OA/#\.8DD6RN+N'2;2T6\8#<422#!D"$C.X
M  L,<YQPOAO_ ()._!#0M46[O)O%'B&!3G[%J6I1K"?J8(HG_P#'J^N/#/A?
M2/!>@V6B:#IMKI&D6:>7;V5G$(XHE] H]\GW))JX>ZFWN]O+^OUW",*KFG*R
M2_'^OTVZGX@_M_?\GF?$3_K\M?\ TD@K]S++_CS@_P"N:_RKY6^,'_!-OX9_
M&KXF:SXYUS7/%EKJVJRQRSPZ?=VJ0*4C2,;5>W9@,(.K'G-?5L48AC1!R% 4
M9]J5'W,-"D]U_DO\B_9R^LSJ]'?\S\*M4_Y/^F_[*/\ ^Y*OK?\ X+':IKL.
MB_#?3X7G3PW<3WDMRJ9\M[E!$(@WN%:7 /JU>WW'_!-?X97'Q?;XCMKOBP:X
MVM_V\;<7EK]F\_S_ #MNW[/NV;N,;LX[]Z^A?B?\*?"GQE\)W'AKQCHT&MZ/
M,0YAFRK1N,X='4AD89/S*0>2.YKG]F_JE.EUB[^6R_R^^Q2IOVU:72>WWO\
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M** "BBB@ HHHH **** "BBB@ HHHH *\<_YO"_[D3_W(5['7CG_-X7_<B?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% 'CGQ._Y.(^"G_<;_P#21*]CKQSXG?\ )Q'P4_[C
M?_I(E>QT %%%% !1110 4444 %%%% !1110 4444 %17%O'=0M%*H=&&"#4M
M% ]M4<7JGAV>Q9GA5IX.N1RP^H_K617I=4KK1K.\8M+ N\]67@_7BM5/N=]/
M%-:31P-%=@WA&R9LAYE]@P_PI/\ A$+/_GK/_P!]+_A5<Z.CZU3.0HKK_P#A
M$+/_ )ZS_P#?2_X4?\(A9_\ /6?_ +Z7_"CG0?6J9R%%=?\ \(A9_P#/6?\
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M%'_"(6?_ #UG_P"^E_PHYT'UJF<A177_ /"(6?\ SUG_ .^E_P */^$0L_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YWQK\.?"?Q*
MT^&Q\7>%]&\4V4$GG16VM:?%>1QOC&Y5D5@&P2,CGFNBHH J:5I-CH6FVVGZ
M;9V^GV%L@B@M;6)8HHD'1510 H'H!5NBBGOJPV"BBBD 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY_S>%_
MW(G_ +D*]CKQS_F\+_N1/_<A0!['1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY^
MS=_S5+_L>]4_]I5['7CG[-W_ #5+_L>]4_\ :5>QT %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %>.?L@_P#)N_A/_M[_ /2N:O8Z\<_9!_Y-W\)_]O?_ *5S4 >QT444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5XY^U]_R;OXL_P"W3_TKAKV.O'/VOO\ DW?Q9_VZ
M?^E<- 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'CGQ._Y.(^"G_<;_P#21*]C
MKQSXG?\ )Q'P4_[C?_I(E>QT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !163-X5TNXFDEDM=TDC%F;S'&23D]ZC_X0
M_2/^?3_R*_\ C0!M45B_\(?I'_/I_P"17_QH_P"$/TC_ )]/_(K_ .- &U16
M+_PA^D?\^G_D5_\ &C_A#](_Y]/_ "*_^- &U16+_P (?I'_ #Z?^17_ ,:/
M^$/TC_GT_P#(K_XT ;5%8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T ;5%8
MO_"'Z1_SZ?\ D5_\:/\ A#](_P"?3_R*_P#C0!M45B_\(?I'_/I_Y%?_ !H_
MX0_2/^?3_P BO_C0!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\ R*_^- &U
M16+_ ,(?I'_/I_Y%?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_ )%?_&C_
M (0_2/\ GT_\BO\ XT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\ (K_XT ;5
M%8O_  A^D?\ /I_Y%?\ QH_X0_2/^?3_ ,BO_C0!M45B_P#"'Z1_SZ?^17_Q
MH_X0_2/^?3_R*_\ C0!M45B_\(?I'_/I_P"17_QH_P"$/TC_ )]/_(K_ .-
M&U16+_PA^D?\^G_D5_\ &C_A#](_Y]/_ "*_^- &U16+_P (?I'_ #Z?^17_
M ,:/^$/TC_GT_P#(K_XT ;5%8O\ PA^D?\^G_D5_\:/^$/TC_GT_\BO_ (T
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MY%?_ !H_X0_2/^?3_P BO_C0!M45B_\ "'Z1_P ^G_D5_P#&C_A#](_Y]/\
MR*_^- &U16+_ ,(?I'_/I_Y%?_&C_A#](_Y]/_(K_P"- &U16+_PA^D?\^G_
M )%?_&C_ (0_2/\ GT_\BO\ XT ;5%8O_"'Z1_SZ?^17_P :/^$/TC_GT_\
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M?]R)_P"Y"@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QS]F[_ )JE_P!CWJG_
M +2KV.O'/V;O^:I?]CWJG_M*O8Z "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\
MS_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
MA0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\
M*/[%T_\ Y\+7_ORO^% !_;6G_P#/_:_]_E_QH_MK3_\ G_M?^_R_XT?V+I__
M #X6O_?E?\*/[%T__GPM?^_*_P"% !_;6G_\_P#:_P#?Y?\ &C^VM/\ ^?\
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M_P#Y_P"U_P"_R_XT?V+I_P#SX6O_ 'Y7_"C^Q=/_ .?"U_[\K_A0 ?VUI_\
MS_VO_?Y?\:/[:T__ )_[7_O\O^-']BZ?_P ^%K_WY7_"C^Q=/_Y\+7_ORO\
MA0 ?VUI__/\ VO\ W^7_ !H_MK3_ /G_ +7_ +_+_C1_8NG_ //A:_\ ?E?\
M*/[%T_\ Y\+7_ORO^% 'D?Q&OK>\_:(^"WD3Q3[?[:W>6X;&;1>N*]IKQ;XC
M65O9_M$?!;R((H-W]M;O+0+G%HO7%>TT %%%% !1110 4444 %%%% !1110
M4444 %%%)TY- "TA8*,DX%<_JWBA8=T5IB1^AEZJ/IZUS=Q>SW;9FE>3_>/%
M:*#9V4\-*:N]#O6U"U3[US"OUD%-_M2S_P"?N#_OXO\ C7GU%5[,W^IQ[GH/
M]J6?_/W!_P!_%_QH_M2S_P"?N#_OXO\ C7GU%'LQ_5(]ST'^U+/_ )^X/^_B
M_P"-']J6?_/W!_W\7_&O/J*/9A]4CW/0?[4L_P#G[@_[^+_C1_:EG_S]P?\
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M]J6?_/W!_P!_%_QKSZBCV8?5(]ST'^U+/_G[@_[^+_C1_:EG_P _<'_?Q?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %>.?\WA?]R)_P"Y"O8Z\<_YO"_[D3_W(4 >QT444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 >.?LW?\U2_['O5/_:5>QUXY^S=_P U2_['O5/_ &E7
ML= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7CG[(/\ R;OX3_[>_P#TKFKV.O'/V0?^
M3=_"?_;W_P"E<U 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %>.?M??\F[^+/\ MT_]
M*X:]CKQS]K[_ )-W\6?]NG_I7#0!['1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X
MY\3O^3B/@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1110 4444 %%%
M% !1110 4444 %%%% !7,>)]8.YK*$D8_P!8P[_[/^-;^H70L;.:<C.Q<@>I
M[?K7GTDC22,[G<S'))[FM(*^IW86GS/F?0;1116YZH4444 %%%% !1110 44
M44 %%%?)O_!33QKXA\!?LW)J?AG7M3\.ZE_;5K%]LTF\DM9MA63*[XV!P<#C
M/:LJE14X\S[I?>[#2O?R3?W*Y]945^0O[!/[;_BGPO\ &.W\/?$;Q?J_B'PW
MXC*6:W6N:A+=&PN<XB=6D8[48G8V,#YE8_=K]>JWY?=4ELSEHUXUKI:-!17X
M]?#OXZ?$F^_;ZM?#UQ\0?%5QH#>.I[0Z5+K5RUJ8!=NHB\HOMV  #;C&!BOO
MW_@H!XHUGP;^REXRU?P_J]]H6K0-9^3?:;<O;SQ[KJ)6VR(0PR"0<'H36'M%
M]7CB.C_X'^9=.HJE:=%?9_X/^1]$45^&?P;UC]J/]H"\U.U\ ^.O'.O3Z;&D
MMVG_  F$EMY:N2%.9KA <E3TSTKTN^^!_P"W7H=G-?RZEX^DCMU,C+#XV2Y<
M@#)Q&EVS.?8 D^E-RLKM:&$<0Y_#%L_8&BORX_8@_P""@WCBX^*.E?#OXH:@
MVN6.K7 L+34KR)8[NSNB=L:2$ ;U9OE.X%@S YQQ7VO^VUXBU7PI^RU\0-6T
M34[S1]5M;.-H+[3[AX)XB9HQE70AE."1P>].K)4Z7MEJC>A45>7(M&>X45^9
M7_!*GXN>.OB)\5O&5IXK\:>(?$UI;Z*LL,&L:K/=QQOYZ#<JR.0#@D9'K7Z:
MUJXVC&7=7_%K]"*-95E*RM9V_!/]0HHK\S_V]/V^/&WAOXGWOPQ^&-VVBG36
M2WU#5+>)9;JYN'4'R8MP.P+N RHW%AP0!SA*HHM1W;-Y24(N<MD?IA17XQ>)
MK7]M#X*>'4\?:[K7CJQT>(K(\]YKHOXX0W0S6QEDV+D@?O$ !(!Q7W9_P3__
M &P+_P#:<\'ZKIOB>*&/QCX?\K[3<6Z!([V%\A)M@X5LJ0P'&<$8!P-8>_=+
M=;HYHXA<R4DU?8^L:*^%_P#@H-^W9K/P%U2U\!^ 3;Q>*[BV%U?:I/$LPL8V
MR(UC1LJ9&P6RP("XX.[(^3M-T/\ ;6\9^$U^(=CJWCZXT6:$WT<D&O&'S(P-
MV]+,3*S*1R L>&&, C%8*JI)R2]U;LTJ55"2II7EV1^S-%?G!^P+_P %!/%'
MQ!\>6?PV^)=U'JMUJ(9=*USREBF\U5+>1,% 5@R@[6P#D8.[=D+_ ,%%O^%^
M_P#"[-*_X5=_PLC_ (1_^Q(?._X1'^T/LOG^=-NW?9_EW[=F<\XV^U:U'[-1
M:U4A4ZT:D)36\>GS1^CU%?AS_P 9C?\ 5<O_ "LUQ_A_XU?'_P 0>,;3PQ8?
M$+XB76OSW8LTTQ=>OO/,V[!0H9,@@@YSC&#G&*=-^TG&GU9A+%J*YG'0_?:B
MH[<.MO$'SO"@-DYYQS7Q)^WM^W9HOPO\)ZMX$\":T+WQ]>HUM/>:;-QHZ'AV
M,BGB?&0J@Y0_,<8 .=2HJ:[L[8R7+SRT1]OT5^=7_!)WXI>-/B-K'Q(3Q9XN
MU[Q0EI!8FW76=3FNQ"6:?<4\QFVYP,XZX%?H!XJ\3:=X+\,ZKK^KSBUTO2[6
M2\NIC_!'&I9C^0-;5+4XJ4GI:YG1J>W7NKK8U:*_'3Q3^UE^T/\ MB?%"ZT'
MX67.L:-8?/+9:-X?N5LI(H%./,N+K<IR<KG<X3)  R>5\'_M>?M!?L?_ !2@
M\._%2?6-;L5V27NC^(+D7<SPN?\ 6V]UN8DC#8P[(2"",CC*$N:W-[M]KF,L
M3&-^5-I;M'[%45F^&?$5AXN\.Z9KFE7"W6F:E;1W=M.O1XI%#*WX@BK6H:A;
M:3I]S?7L\=K9VT;333S,%2-%!+,Q/0  G-:2]R_-I8ZXM32<=;EBBOQ+_:E_
M;L\>?%+XN:G?^"?&7B'PIX1M#]DTVUTC4I[(31J3^_D6-ER[G)YY"[1V.?V(
M^$=[<:E\*?!=W=SRW5W<:+92S3S.7DD=H$+,S'DDDDDGKFE2?M*;J;:K\;_Y
M'/[>+K>Q6NCU]+?YG64444SI"BBB@ HHHH **** )[.\DL;A)HCAE/3L1Z&N
M]L;Q+ZU2:/HPZ>A]*\[K?\(WACNI+<GY9!N ]Q_];^59S5U<XL334H\RW1UE
M%%%8'DA1110 4444 %%%?G=^UI^T-\=M7_;6\/? _P"!_C&Q\,SW&DI+<M?V
M-O/ MP4EG9Y'DMYG4"%8^%'4CCFIO[T8):O_ ";_ $*M[LI-Z+7\4OU/T1HK
MX _X4W_P4,_Z+M\/_P#P!A_^55<WJW[37[37[&'Q \'6O[0-UX;\=> _$5X+
M237]&A6)[0Y ;#)%" R@[]KQ'<H8!@0<:17-)1OJ]%Z]").R<K;:GZ1T4BL&
M4,IR",@BEJ1A1110 4444 %%%% !117YP?M ?M!?M!_$+]NC4/@I\#?&^G>%
MH--TR.2X.IV%M+;K*(1/+(\CVTT@XEC0 #&0.!DFIO[R@E=N_P""NV.WNN3>
MB_5V/T?HK\_V^#?_  4, )_X7KX /L+&'_Y55)^S9^UY\8/"'[30^ /[0MKI
MMSK]]"9=)\0:;$D8N&VLZY$85&C=4<*P1&5EVL"3\ND5S2Y4]7MY_P#!)D^6
M+DUHM_+_ (!]^4445(PHHHH **^=_P!OKXX:S^SY^S#XF\5^&KY=-\2^;;6>
MFW+11R[)9)E!8)(K*Q$8D."".*U/V8_$7Q#\<_LC^%?$&OZQ#JOQ"UK1)+^*
M_O(([:+S9@[VV](8PJJJM$#A"< G!/6;WA.:5^6R^;5[+Y%6M*$7]J_W+2[/
M=**\F_9I\,_%OPK\/);7XT>+M-\9>,)+V25;W28$BMXK<J@2,!8(<D$,Q)3/
MS8R0!7K-:27*[7N9Q=UL%%%>"?ML?M-O^RA\#KOQE::;;ZOJ\UW%IVGV=U(R
M1--(&.Y]O)551F*@C.,9&<UE.2@KO^KZ&L8N;LCWNBN4^$]]KNJ?#'PI?>)W
MC?Q'=Z7;W.H^3&(T%P\:M(JKV4,2 .>!R3UKJZVG%TY.#W1C"2G%26S"BO./
MV@M'^)GB#X7:E8?"+7=*\->.)9(?LNJ:PH:"",2*9?E,,P)* J,H?O9XQ71_
M#?3O$FD> /#MEXPU6'7/%<%A"FJZE;QK'%<700>:Z*J( I;.,*O&.!4+5-]O
MQ]"WI;S.DHHHH ***^.?^"GG[3'B[]FWX-^';KP'JZZ+XIUG65MH[DVT-P1;
MI$[R829'7EO+&<9&:B4N6VF[2^]V+C%S=EYO[E<^QJ*_/FQ^$O\ P4,OK&WN
M?^%X^ X/.C63RIK" .F0#M;&E$9&><$U/_PIO_@H9_T7;X?_ /@##_\ *JM&
MFG9F::DKH^_Z*YKX:Z;XET?X?>';+QEJL.N>+(+"%-5U*VC6.*XN@@\UT540
M!2V<?(O&.!72TY+E;5[A%W28445XK^T;X6^-_BFY\'Q?![QAHG@ZTAO6D\07
M&J0K+-/;90!(5>VF7=CS#R4YV\XSB>J7=_T_1#Z-]CVJBOB__@I#^T7X]^"]
MG\+O#7PRUS^P_%OBW6S:BX^QP71:%0D979,CJ,R3Q'(&?EZ]:^R[6.2&VB26
M4SRJ@5Y" "[ <G &.?:B/O1<UM>WW)-_G]X2]UJ+ZJ_XM?HR6BBB@ HHHH *
M*** "BBB@ HHHH **** "BOG?]OKXX:S^SY^S#XF\5^&KY=-\2^;;6>FW+11
MR[)9)E!8)(K*Q$8D."".*^8OAGX9_;_^*GP]\.^,=-^-?@NQT[7;&'4+:WU#
M3K=)TBD4,F]4TQE!P0>&/7K4Q?-S66D;)^K5_P BI+E4;O>_X'Z2T5\ ?\*;
M_P""AG_1=OA__P" ,/\ \JJ^I/A=)X^^%?P!EO\ XR>)[#Q1XOTFUO+_ %35
M-.B2*V,:%Y$"!88AA8PH)* YSUZTY24(2J2>B%%.4E"*NV>MT5^4?[-/C_\
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M.NT@&OKO]E_]I#P[^U-\)[#QKX?1K1F<VVH:;*X:2QNE +Q,0!N&&5E; RK
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MX*?]QO\ ])$KV.O'/B=_R<1\%/\ N-_^DB5['0 4444 %%%% !1110 4444
M%%%% !1110!C>*Y-FE8Y^>15_F?Z5QM=EXKCWZ5G^[(I_F/ZUQM;PV/7PO\
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MY[)ORNNA\U^+/CY\:/VU?C)XD^'WP UR#P)\//#,WV36?'+)NFN9,E2(6P2
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M7\00>.I]&L/M]AXB48GV!8757; +ADF!._+*P(W,""/ ?^"CWP3\9>+OVK?
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MX7#>+VV/C-_P6.G?F6P^'F@X'==X@ _ B6]/_?%.\%1#XA?\%D_&<VK@2?\
M")>'A_9D<H^Y_H]NN5_\"IF_X$:*=ZT::E]MSFVM+Q6UNWPKY/N.5J3FX+X%
M"*O_ #/>_>W-^%BQK'[%/[5TN@S>+V_:CUB7QW'%]J'AVU,\6F/,!GR@RRK%
M@].;?:3U&.:]M_X)W_M0:Y^T[\%;J\\6Q1IXP\/W[:5J<L,8C6Y(562;8.%8
M@D,!@;D8@ $ ?0?Q"^(7A[X4^"]5\6>*]3CT?P]I<7G7=[(CN(UR%'RH"S$D
M@!5!))  IGPY^(OA_P"+7@K2_%OA6]?4O#^J1F6SNY+:6W,J!BN[9*JN!E3C
M*C(Y'!!JHR^-+;33^5_\%75O\B)+X6]^_=6V^5T_^'.EK\J?^"J'Q"\/W7[6
MGP/\+^)M06P\+:#Y.JZO<-$\JQPS72B3*(K,Q\NVZ $_-7ZK5^6_@'PKHO[4
M7_!6+XEW/B/2+#Q-X7\*6,UM]AU.V2YM6>%(K4*T;@JW[QY7&1U7/:LX7>)I
M<N\;R_\  4_U:-)65"HY;.T?_ G;\KGT[_P]&_9B' ^)G_E U3_Y&KI/AW_P
M4#^ ?Q8\::5X2\*>.VU?Q#JDAAM+-=%U",R,%+'YWMU50 I.6('%=E_PR=\$
M/^B-_#__ ,)>Q_\ C5:OA;]GOX6>!M<M]:\-_#7P?X?UBWW>3J&EZ#:VUQ%N
M4JVV1(PPRI(.#R"16D;7][8SE>WN[GR3_P %=?CCXC^%/PM\#Z/X0\1:MX;U
MS6]9:1KG1+R6UN6MX8B'0/&P;!>:+C/.!3/$'[-O[4W[07AV#Q7J/QON_A'?
M- )=*\$Z(;@);Q[!Y:7EY%*CO*<#>Q20 DX'\(YS]JBZT_XK?\%1/@+X"U$+
M/I>@VO\ :4D+<J;@^;<!2/?[-!^!K]&+BXBM+>2>:18H8U+O(YPJJ!DDGL *
MRII>P=23U<I?)1]V_P"'7;7N:U&_:QIKI%?/FN_Z[GQA_P $Z/VFO'/Q2;QY
M\,OBF?M/C_P'=_9I[\JJM<Q;WC(?: "R/&1O &Y64]<D\W=?$CQ=\1_^"L%O
MX-TGQ7K5EX,\'Z'Y^IZ+::A-'97,GD%MTD*L$<[[N$?,#_JQZ"N9_P"":<P^
M)W[3/[2'Q=LXMOAW4M3:TL+DY"RJ\\DO'N(TA8^F\>M/_P""9BM\4?VC/VCO
MB[+^^AO]6.GV,YY_=/-)(5!]D2W_ $K:FW.=*=16?(Y2];66GGS)^NIE42A&
MM"&JYU%>E[O[K->@G[0G_%Y/^"KGP<\'@?:-.\'V":K<KU$<JB2ZR?KLMA^(
MKT+]K']JOXAZA\9M._9^^ -O:R_$2[A%QJ^O7:J\.C0E0W1@RA@A5F9E; 95
M56=AM\\_8GQ\7O\ @HA^T7\2FS+;:0S:):R=5P91"A!_ZYV1_P"^J\*_9]_9
MY\;?M5?M*?'_ ,2:'\9M9^%7B'2]?FM[B;1XIFGN89;B8!"T=S"RHOV=!M.1
MP.F*QI)RIT86]UQE4:]9:+TUCMNO4UJ-1J59]4XP7;1;_G_2/?O$7[&/[5'@
M/0;SQGX?_:CUWQ)XOLXFO/\ A'[Q9_L$S ;FC02321'H0H:!5)QG;U'T?^PS
M^TY)^U7\";/Q3J%I%8>(K&Y?2]7M[<$1?:$56WH#R%=71L'H21DXS7SEXB_8
M!^+'A?0[S5=>_;B\9Z1H]K&7NKW49+N"WB3H2[OJ851SU)QS7KO['_P9\/\
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(3BEI,9H
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M=.;_ );77_?:_P#Q-/W"N;!]OS_S*!^)7_4._P#(_P#]C3/^%F?]0W_R/_\
M8UH?\*[TW_GO=?\ ?:__ !--_P"%<Z;_ ,][K_OM?_B:/W97-@OY?S_S,_\
MX6A_U#/_ "/_ /8TA^*6/^89_P"3'_V-:'_"M=,_Y[W?_?:__$TG_"L]+/\
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M_#*_A/\ Z"&L_P#?^+_XU5WPW;\SI]IP_P#\^W_Y-_F<X?VN/^I4_P#*C_\
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M_P#*I_\ :::?VT_^I._\JG_VFNH_X8_\&_\ 03UW_O\ P_\ QJF_\,>>#/\
MH)Z[_P"!$/\ \9I\V%[?F5[7AK_GV_\ R;_Y(Y9OVUMO_,F_^53_ .TTG_#;
M'_4F?^53_P"TUU+?L<^#&_YB>O?^!$/_ ,9IO_#&_@O_ *">O?\ @1!_\9I\
MV%[?F5[;AC_GV_\ R;_Y(Y4_MN8_YDO_ ,JO_P!IIK?MO;?^9+_\JO\ ]IKJ
MO^&,_!7_ $%->_\  B#_ .,TA_8Q\%'_ )BFO_\ @1!_\9HYL)V_,?MN&/\
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M@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7CG_-X7_<B?^Y"O8Z\<_YO"_[D3_W(4 >QT444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 >.?LW?\U2_['O5/_:5>QUXY^S=_S5+_ +'O5/\ VE7L= !1110
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M_AYK.MZA<:KJUYIHEN+RZ<O+*V]AEF/4\"O9*!!1110 4444 %%%% !1110
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MT@_[]K_A1_9=G_SZ0?\ ?M?\*/:!];CV//J*]!_LNS_Y](/^_:_X4?V79_\
M/I!_W[7_  H]H'UN/8\^HKT'^R[/_GT@_P"_:_X4?V79_P#/I!_W[7_"CV@?
M6X]CS\ L< 9-:FG^';N\<;T,$7=G&#^ KLH[>*'_ %<2)_NJ!4E)U.QE+%M_
M"BII^FP:;#LA7D_><_>;ZU;HHK(X6W)W84444""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KQS_ )O"_P"Y$_\ <A7L=>.?\WA?
M]R)_[D* /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** /'/V;O^:I?]CWJG_M*O8Z
M\<_9N_YJE_V/>J?^TJ]CH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_9!_P"3=_"?
M_;W_ .E<U>QUXY^R#_R;OX3_ .WO_P!*YJ /8Z*** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *\<_:^_Y-W\6?\ ;I_Z5PU['7CG[7W_ ";OXL_[=/\ TKAH ]CHHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** /-_CC\&K3XR>&X;-KC[#J5FYDM+
MHKN521AE8?W3@=.F!]#\V:/^Q/XPN-66+4=1TNTT]6^>XAD>1BO^RFT<_4BO
MK?XCV'B;5/ VM6G@W4[71O%$UN5T^_O(A+#!+QAF4JV1U[&OE_\ X57^V=_T
M6CP9_P""6/\ ^1J\?%95A<74]K5CKZ[^I]9EO$^995AWAL--<O2ZO:_;^FCZ
ML\(^%K'P3X:T_0].5EL[*(1)N.6;N6/N3DGZUL5^>7Q_U3]LOX!?#F^\:7?Q
M)\-Z_I.GE3>)IVDP"6%&8*'VO;C<H+#.#D9STS7SG\./^"JWQFT'Q383>*;W
M3?$^AF91=VDFGQ6\GEY^8H\2KAL=,@CVKUHQ4(J,59(^7J3G5FZDW=O5OS9^
MS-%<UXJ\>6'A7X<ZKXRF#3:98:9)JI5>&>-(C)@>A('ZU^//BO\ X*H_';7-
M9N+G2M5TOPY8NY,-C:Z9#,(USP"\JLS''?CZ"J,S]A?B=_R37Q9_V"+O_P!$
MO7\W5?K#'8_M>>-/V:;KQY/\3=#*:AHLNH'PZ=$MA-+:-$6(\T18$C1\@#U
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M., \<"OG[]O7]MKXN_ O]HF^\+^#O$5OI^APV%K.MM+IUO-\[J2QW.A;D^]
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M:-)M=4PK*RJPX (..U?I)0(**** "BBB@ HHHH **** "BBB@ HHHH ****
M/'/B=_R<1\%/^XW_ .DB5['7CGQ._P"3B/@I_P!QO_TD2O8Z "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_YO"_[D3_ -R%
M>QUXY_S>%_W(G_N0H ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V
M/>J?^TJ]CKQS]F[_ )JE_P!CWJG_ +2KV.@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKQS]D'_DW?PG_P!O?_I7-7L=>.?L@_\ )N_A/_M[_P#2N:@#V.BBB@ HHHH
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MGZ&?\$<_^2(^-O\ L8?_ &VBKXF_X*-0R0?MB>/A(A0M):NN>X-M%@U]L_\
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MT/38-(LY[>==6EF1F9W5@5\N)\C /4BOE+_@D#_R<)XB_P"Q?E_]'15]*_\
M!3G]JSQG\!]/\*>&O ]__8NH:XD]S=:I&BO,D4950D>X$*26)+8S\O&* ZF%
M^Q?_ ,$\?'_[./QRLO&GB'7?#E_ID-E<6S0Z;/.TQ:1,*0'A48]>:P/^"SG_
M " ?A;_U\W__ *!!7SO^S'\5OCW^TG\9M'\$P_&/Q)I,5V))[F]^ULYBAC4L
MY5,C+'& ,@9-;/\ P4F^#OCKX2ZGX-7Q%\2=9^(F@7R7!L6UIOWMG,GE^8N
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M (2^S_YY3_\ ?*_XT?\ "7V?_/*?_OE?\:Y"BCD0?5:9U_\ PE]G_P \I_\
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M.1!]5IG7_P#"7V?_ #RG_P"^5_QH_P"$OL_^>4__ 'RO^-<A11R(/JM,Z_\
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M_P#X2^S_ .>4_P#WRO\ C1_PE]G_ ,\I_P#OE?\ &N0HHY$'U6F=K#XHL)2
M7:+/]]?\*TH;B.XC#Q.LB'^)3FO.*FM;R:SDWP2-&WMW^H[TG#L9RPD?LL]%
MHK'T7Q FH8AE^2XQ^#_3W]JV*R:L>=*+@[2"BBBD0%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !7CG_-X7_<B?\ N0KV.O'/^;PO
M^Y$_]R% 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CG[-W_-4O^Q[U3_VE7L=
M>.?LW?\ -4O^Q[U3_P!I5['0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !137=8U9F8*JC)9C@ >M>/^,/VL/A[X0N);;^
MT+C6KF)]CQ:5")0#D@_.Q5#C'9CU%7&$INT5<[,-@\1C)<F'IN3\D>Q45\UP
M_MU>$#-B70=;2''WT6%FSSV,@]N_<^G/K/P]^-_@WXG/Y.A:NDE\ Q-C<*8I
M\#J0K?>&,'*YZ_6M)4:D%>43LQ.3YAA(>TK46H]]U\[;'=T445@>.%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7CG[(/_)N_A/_ +>__2N:O8Z\<_9!_P"3=_"?_;W_ .E<U 'L=%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6WN[)[A5^5)2R.JD]B5W$?[IH%U/%?\ @E9_R=QI?_8*OO\ T77T-_P6<_Y
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M-]Y-.LYQFFK2CT^?_#_<?4?_  T]\'/^BL^!O_"DL_\ X[2C]ISX.L0!\6/
MY/\ V,=G_P#'*_,;5/\ @DO\5]#TV[U'4/%W@&SL;2)IY[B;4;Q4BC4$LS$V
MG  !.:^<_@9\!]?^/'Q:L_!7AB2&[<RL\^J*K_9H+=&^:X.Y0P7&, @$EE&
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MNO8)>[\6FWX[??T/8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH=(NOE(YW$CT Q@DC]#/V^?^30_B3_UXQ_\ H^.OR9_:<\(VO[-'[5GB'3?
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ML=/>JP[E*G4B_B<K_)<S_)D*5.GB8RC\-N7YOE7Z'V51110>R%%%% !1110
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MVLWYUA&"JTJ%)W7//\+K7Y\K.AS=*K5J;\D/QU_%.2/N#X$^!E^&?P5\"^%
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M"G3KO/\ QZS?]^S_ (5&VFWG_/K-_P!^S_A7?44^8KZU+L>?-IEY_P ^D_\
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M^+O^A5UO_P %TW_Q-??-%/ZY+L7_ *V5_P#GTOO9\ M\-/%__0J:W_X+IO\
MXFF-\,_&'_0J:Y_X+IO_ (FOT!HH^N2[#_UMK_\ /I?>S\^O^%8^,?\ H4]<
M_P#!;-_\34;?#'QC_P!"GKG_ (+9O_B:_0FBG]<EV*_UNK_\^E][/SR/PO\
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MT)GB#_P5S_\ Q%?I=11]>E_*5_KKB/\ GROO9^9K?"7QSS_Q1GB'_P %4_\
M\16-KW@[7_"RPOK6AZEI"3$B)K^TD@#D8R%W 9QD=/6OU+KQ?]K#P!)XV^%L
MUU:1"2_T63[<F%RS1!2)5'_ 2&]_+%:T\:Y349+1GH8#C">(Q5.C6IJ,9.U[
MO2^WXGP"]1MUJ1ZC;K7K'ZDB)JC>I&J-Z:-41M7Z8_LZ^=_PI'P=YY)?[ N-
MP(^7)V]?]G%?G%X8\-7_ (R\1:?HFF1K+?WTHAA5W"+N/J3T%?JKH>CV_A_1
M=/TNS4K:6-O';0JW4(BA5'Y 5Y6827+&)^8\=8B"HT</]IMOY)6_&_X%ZBBB
MO%/Q\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\<_9!_Y-W\)_\ ;W_Z5S5['7CG[(/_ ";OX3_[>_\ TKFH ]CH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_VZ?^E<->QUXY^U]_R;OXL_[=
M/_2N&@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*DD[W=_P2_0*_-']N/\ X)V^*O$GQ"U'XB_"NV75&U24W6HZ&LRPSQ7!Y::
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MEJ>7_'G]FGX=?M*^'[?2?'_A^/5DM69[.\CD:&ZM68#)CE0A@#@94Y4[1D'
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY^S=_S5+_L>
M]4_]I5['7CG[-W_-4O\ L>]4_P#:5>QT %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MQS_F\+_N1/\ W(5['7CG_-X7_<B?^Y"@#V.BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#QS]F[_FJ7_8]ZI_[2KV.O'/V;O\ FJ7_ &/>J?\ M*O8Z "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "O'/V0?^3=_"?_ &]_^E<U>QUXY^R#_P F[^$_^WO_ -*Y
MJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\<_:^_Y-W\6?]NG_I7#7L=>.?M??\F[
M^+/^W3_TKAH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<^)W_)Q'P4_[C?\
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M_DHG^-;5% &+_9>K_P#0<_\ )1/\:/[+U?\ Z#G_ )*)_C6U10!B_P!EZO\
M]!S_ ,E$_P :/[+U?_H.?^2B?XUM44 8O]EZO_T'/_)1/\:/[+U?_H.?^2B?
MXUM44 8O]EZO_P!!S_R43_&C^R]7_P"@Y_Y*)_C6U10!B_V7J_\ T'/_ "43
M_&C^R]7_ .@Y_P"2B?XUM44 8O\ 9>K_ /0<_P#)1/\ &C^R]7_Z#G_DHG^-
M;5% &+_9>K_]!S_R43_&C^R]7_Z#G_DHG^-;5% &+_9>K_\ 0<_\E$_QH_LO
M5_\ H.?^2B?XUM44 8O]EZO_ -!S_P E$_QH_LO5_P#H.?\ DHG^-;5% &+_
M &7J_P#T'/\ R43_ !H_LO5_^@Y_Y*)_C6U10!B_V7J__0<_\E$_QH_LO5_^
M@Y_Y*)_C6U10!B_V7J__ $'/_)1/\:/[+U?_ *#G_DHG^-;5% &+_9>K_P#0
M<_\ )1/\:/[+U?\ Z#G_ )*)_C6U10!B_P!EZO\ ]!S_ ,E$_P :/[+U?_H.
M?^2B?XUM44 8O]EZO_T'/_)1/\:/[+U?_H.?^2B?XUM44 8O]EZO_P!!S_R4
M3_&C^R]7_P"@Y_Y*)_C6U10!B_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XU
MM44 8O\ 9>K_ /0<_P#)1/\ &C^R]7_Z#G_DHG^-;5% &+_9>K_]!S_R43_&
MC^R]7_Z#G_DHG^-;5% &+_9>K_\ 0<_\E$_QH_LO5_\ H.?^2B?XUM44 8O]
MEZO_ -!S_P E$_QH_LO5_P#H.?\ DHG^-;5% &+_ &7J_P#T'/\ R43_ !H_
MLO5_^@Y_Y*)_C6U10!B_V7J__0<_\E$_QH_LO5_^@Y_Y*)_C6U10!B_V7J__
M $'/_)1/\:/[+U?_ *#G_DHG^-;5% &+_9>K_P#0<_\ )1/\:/[+U?\ Z#G_
M )*)_C6U10!B_P!EZO\ ]!S_ ,E$_P :/[+U?_H.?^2B?XUM44 8O]EZO_T'
M/_)1/\:/[+U?_H.?^2B?XUM44 8O]EZO_P!!S_R43_&C^R]7_P"@Y_Y*)_C6
MU10!B_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XUM44 8O\ 9>K_ /0<_P#)
M1/\ &C^R]7_Z#G_DHG^-;5% %/3K:[ME<75[]L)/RGR@FW\NM7*** "BBB@
MHHHH **** "O'/\ F\+_ +D3_P!R%>QUXY_S>%_W(G_N0H ]CHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_FJ7_8]ZI_[2KV.@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KQS]D'_ )-W\)_]O?\ Z5S5['7CG[(/_)N_
MA/\ [>__ $KFH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_P!NG_I7
M#7L=>.?M??\ )N_BS_MT_P#2N&@#TV;3=4DFD:/6/*C9B5C^RH=HSP,YYJ/^
MR]7_ .@Y_P"2B?XUM44 8O\ 9>K_ /0<_P#)1/\ &C^R]7_Z#G_DHG^-;5%
M&+_9>K_]!S_R43_&C^R]7_Z#G_DHG^-;5% &+_9>K_\ 0<_\E$_QH_LO5_\
MH.?^2B?XUM44 8O]EZO_ -!S_P E$_QH_LO5_P#H.?\ DHG^-;5% &+_ &7J
M_P#T'/\ R43_ !H_LO5_^@Y_Y*)_C6U10!B_V7J__0<_\E$_QH_LO5_^@Y_Y
M*)_C6U10!B_V7J__ $'/_)1/\:/[+U?_ *#G_DHG^-;5% &+_9>K_P#0<_\
M)1/\:/[+U?\ Z#G_ )*)_C6U10!B_P!EZO\ ]!S_ ,E$_P :/[+U?_H.?^2B
M?XUM44 8O]EZO_T'/_)1/\:/[+U?_H.?^2B?XUM44 8O]EZO_P!!S_R43_&C
M^R]7_P"@Y_Y*)_C6U10!B_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XUM44
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MB_V7J_\ T'/_ "43_&C^R]7_ .@Y_P"2B?XUM44 8O\ 9>K_ /0<_P#)1/\
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M4Y4W9A1112,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5XY^U]_R;OXL_P"W3_TKAKV.O'/VOO\ DW?Q9_VZ
M?^E<- 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4;-B./.0"L2$#C&[D@Y.>5RE*K"C#>7_  %^ITUJBHTG5:O;_@_Y'Z$^%O\
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MK;J/HKRY?VG/AA_PL3Q5X'D\6VMMXD\*V7]H:U#=0S006-OB,[WN700])8^
MY//3@XYGX??MT? CXI>,E\*>&OB/IM]KTDGE0VTT4]LMP^<!(I)HT25B>@1B
M3VS2C[UN76^J\UW'+W;MZ6/=Z**^?/B#^W_^S]\+_$4^A>(/B7IT6J6[F.:&
MPMKF_$3@X9':WBD56!!!4D$8Y%*ZO8=G:Y]!T5QOPN^,G@CXU^'SK7@;Q/IW
MB;358+))8S!FA8C(61#AHVQSM< ^U9O@O]H+P!\0OB1XH\!:!K_V[Q;X9/\
MQ-M-:SN(6M_F"Y#R1JCC)'*,PY'K56?-R==[>2)NN7FZ;'HE%4M:UJQ\.:/?
M:KJ=U'8Z;8P/<W-U,VU(HD4LSL>P !/X5PGP]_:(^'WQ4^&>H_$'PSKSWW@[
M3Q.UQJLUA<VR*L*[I6"S1HSJHSDJ",@CJ"*FZLWVU?DN[*L]%WT7F^R/2**\
M^^"OQ\\"_M#^&;KQ#\/];;7]'MKIK*6Z-C<6H$P56*@3QH3@.O(!'/6O0:II
MQT:)33V"N.\9_&7P!\.+J.V\6^.?#?A>XD&Y(=:U>WM'8>H$CJ37BW_!1;XW
M>(/@+^RWK^O^%II+/7;RX@TNWOXURUIYK$/*/1@JL%/9F4UXY^S?_P $P_@S
MXC^%/AWQ7\0+?4/B-XG\26,&L7FI7>KW,48DGC60B/R9$+#YOO.69CDY&<"(
M7J<[6T6D_5J]ONZE2M#E3WE=KT6E_O/M[P?X_P##'Q"T]K[PMXDTCQ+9*<&Y
MT>^BNXP?3=&Q%;]?FE^TY_P3_E_9RL;+XK_LQ?\ "3:/XNTF[A27PYI<D^H?
M:H7D"G8IW2, 2I='+(4!R!CG[7U3X[6W@#]G&+XI>/=/G\-M;:)#J.HZ5.A2
M>&X>-<VP5L'>9&$8![D9JG*/LY5-N5V?W7T[_P!(2C)SC"U^;;[[:]CTW4-2
MM-(LIKR^NH;*TA7?+<7$@CC11U+,3@#ZUQ&@_M"_"OQ5K":3HOQ+\'ZQJCMM
M6QL->M9YV/H$20L3^%?GA\'?@?X__P""GFMS_%+XR:]J.@_"J*Z>/0?">E2F
M-)@A()3<-H4'*M,07<A@"@48^B/%G_!)G]G77?#5SI^E>&+_ ,-ZD\96+5[/
M6+N::-^S;)I'C;GJ-OTQUH:G!7FM>W7_ ""\9.T'\^G^9]CURWCGXJ>"OAA'
M9OXQ\8:#X22\++;-KFIP60G*XW!#*R[L;ESCID>M?%?_  3K^+GC?P?\4?B!
M^S7\1]3EUO5O!@:?1]2N&9I)+1712FYB24VR0O&#DJKLO10!YE_P4=\-R?M)
M_MM?"?X+VUP\2QZ1/.\D9YCEF$LA)^B6L9^C5-1V]FZ>JGJGY6;V^5O^ 5!?
MQ/::.&_X?YW/U$L[R#4+2&ZM9H[FVG198IH7#I(C#*LK#@@@@@BJGB#Q%I7A
M/1;O6-<U.ST;2;1/,N;_ %"X2""%<XW/(Y"J.1R37RE_P2_^+]U\0_V;X/"^
MM%T\3^ [M_#U]#-_K%CC_P!02.V$_=\]XFK)_P""N?CO_A$?V/\ 4-,20I/X
MCU6TTU=IP2JL;A_PQ!C\:>):HZPU3M;TE:S_ !3%ATZKM/1J]_E>_P"3/K[P
MOXLT/QQH=MK7AS6=/\0:-<[O(U#2[J.YMY=K%6VR(2K88$'!X((K,\;?%3P5
M\-4@?Q?XOT'PJD_^J;6]3@LQ)C^[YC+G\*\2\%W%S^RM_P $_P#3;^VL%N-3
M\+>"_P"T#:D':UUY!E<-CMYC$GVS7RY^Q3^Q!X/_ &J/AV?C;\;[S4?B'XD\
M675Q*MO-J,T$-O''*T0R875MV4;"A@BKM4*,5K4@XUITX[0W?S:7WV9G3FI4
MH5);RV7RN?I%X7\8:#XXTE-4\.:WIWB#3)#A+W2[N.YA8^@="0?SK7K\M?&G
MPQTW]@_]O+X/67P@OKZRT'Q]/'8ZQX5DNWN(UA,RP[SO)8KB0NI<DJT3X;!(
M'ZE5*M*FJL=FVOFMQN\9NG+=)/Y,P_&'CKPW\.]'_M;Q5XATKPSI7F+%]NUB
M]BM(-[9VKOD8+DX.!GM4OA7Q?H7CK0X-:\-:UIWB'1[@L(=0TJ[CN;>0JQ5@
MLD9*G# @X/!!%?FG^T_J%[^WY^UY#\'/#]Q))\/?A[;W-[K5U;L?+FO40JPR
M.X<I O<9F(XKU7_@CAXL.M?LLZAHDAQ-H/B"ZM]A/(21(YA_X\[_ )5-'][&
M4GII=>:ORW^;O;R*K?NY1BM=;/R=F[?=;YGW=1110!@^,O'WAGX<Z2NJ^+/$
M>D^&-+:581>ZS?16D)D()";Y&5=Q .!G/!KB/^&L?@A_T63X?_\ A46/_P =
MKXO_ ."Q.LW'BJ3X,?"K3VS>>(M;:Y*@]&!2WBR/0FXD_P"^:]V@_P""6G[,
ML=O&DGPW:614"M*=>U,%CCDX%SC]*F%Y1<^EVE\K7_%V*G:,E#K:[\KMV^]*
MY],>&/%VA>-M+74O#NM:=KVG,2JWFEW<=S"2.H#H2/UK7K\H/VK/V>[S_@F_
MXJ\-_&OX':IJ.G>&YM0CL-9\.7-T\T# @LJ,6R7A<*Z_.69'*E6R1M_370?B
M-I7B#X7V'CNWEQHMYI":RDC'I"T(ER?HIJG*'LI54](Z/RTO^*U)Y9*HJ;6L
ME=>>MOP>AS^K?M-?![P_JEWIFJ?%?P/INI6<K07-G=^([.*:"13AD=&D!5@0
M001D$54_X:Q^"'_19/A__P"%18__ !VOS@_X)R_LJ> /VO+?XJ?$?XJ>&V\1
M&\U\K9J;^ZM1%*X:><Y@D3=GSHOO9QCC&37V5_PZX_9B_P"B9_\ E?U3_P"2
M:?+**CS[M)_>K@Y1<I<FR;7W.Q[IX+^.'PY^)&J2:9X1\?\ A?Q3J4<1N'L]
M%UFVO)EC! +E(W8A0649QC+#UI/&GQQ^''PWU5-+\6_$#PMX7U*2(3I9ZUK5
MM9S-&20'"2.I*DJPSC'!]*Y+X)?L?_"+]G/7;_6?AYX07P_J=];_ &2XN#J%
MW=%XMP;:!/*X7YE!X /%?!.K?#?P[^V7_P %6?&^A^+;!M<\&^%],:">T6XE
MA#^1%'%M,D3*PQ<3.W##.T^]+XJD:<-VFWZ)-Z?@'PPE.>R:2^;2_P _N/T%
M_P"&L?@A_P!%D^'_ /X5%C_\=JYHW[3'P@\1:M::7I/Q6\$ZGJ=Y*L%M96?B
M*SFFGD8X5$19"68G@ #)KQ[_ (=<?LQ?]$S_ /*_JG_R36_X!_X)Z?L_?##Q
MEI/BKPU\/UT[7M)G%S9W3:Q?SB*0 X;9).R$C/<&JC:ZYMB97L^7<^BZ***D
MH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW_Z5S5['7CG[(/\ R;OX3_[>_P#TKFH ]CHHHH **** "BBB@ HHHH ****
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MU>^(_P!L+X>:MJ,YNM0O_$T5U<SL #)*\I9V(''))/'K7ZH?\%)/^3.?'/\
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M9TTDZN=7T#5&B+6[Y<R?9W(_B7)1ER"5Y'!K[,_9Z_X)@_\ "A_C%X<\=_\
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M=S:;H/A_XB>"9Y7*6ECIFFZW9LS'A4BBC1^>P"J/85Z179*S245[JV_/[_\
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M(P2B$6Z?A^Y8_P# JFDFZTYIVY8_^E.S7W(JHTJ,8M7YI?\ I*O^;/,_%/\
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MDO90E5C\23MY:=NY=.*JRC2F[1;5_O[]OZ9^3/PF^.OP,_: ^./BSXL?M/\
MBMBT=T(/#7@ZXL+ZZM+>U!W*7$$3J54$#82 S>8S*<BNN_;,^)'[%OQ ^#6H
M3?"NXT;0/B1IC17&C2>'?#-YI32N)4WH["WCC/R;B&<Y4@$'L?4O^"6OA/X'
M?%CX"#P_XB\"^"];^(6A7MRFHQZYHMI<7\D32%XY,R(79 &V?[)0CCBNN^/G
MC_\ 9V^&/Q+\,?#7P'^S]\._BM\0]9O!:RZ+INE6$":>I_BFF6UE"MW*$950
MS,5&-VM2E;DH0?:UOOOZ]V_GH9PJ.3G5DMKWOM9:6]+;+]39\>?M@:[\-_\
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M ):&ONZA1=.GR37O2UE^D?DM_-L'+GJ<T7[L=%^K^;V\DC"\'>!?#7P[T?\
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M^\?SIC2/_?;\ZT**=R^;R,HS29^^WYFF-/)_ST;_ +Z-;%%%Q\Z[&&;B7/\
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MZ"5W_P!_W_QKVJBG[1=BO[0A_P ^U_7R/$#XAU7'_(2O/^_[_P"-,;Q%JO\
MT$[S_P "'_QKW*BCVB[#_M"'_/I?U\CPEO$>K9_Y"E[_ .!#_P"-1MXDU?G_
M (FE[_X$/_C7O5%/VJ[%?VE#_GTOO_X!X$WB75_^@K>_^!#_ .-1MXFUC_H+
M7W_@2_\ C7T#11[5=BO[3A_SZ7W_ / /GMO$^L_]!:^_\"7_ ,:B;Q1K7_07
MO_\ P)?_ !KZ)HH]JNQ7]J4_^?*^_P#X!\YMXJUK_H+W_P#X$O\ XU%_PE>M
M_P#08U#_ ,"G_P :^D:*?ME_*5_:M/\ Y\K[_P#@'S6WBS7,_P#(9U#_ ,"G
M_P :C;Q=KG/_ !.=0_\  J3_ !KZ8HH]LOY1_P!K4_\ GROO_P" ?,C>+M=_
MZ#6H_P#@5)_C43>,->_Z#>H_^!<G^-?4%%/VR_E*6;T_^?"^_P#X!\N-XPU[
MG_B=ZE_X%R?XU&WC+7_^@YJ7_@7)_C7U/13]LOY2O[8I_P#/A??_ , ^53XR
M\09_Y#FI?^!<G^-1'QIXAS_R'=3_ / R3_XJOJ^BCVZ_E'_;5/\ Y\+[_P#@
M'R8WC7Q#_P!![4__  ,D_P#BJ:WC;Q%_T'M4_P# R3_XJOK6BG[=?RE_VW2_
MZ!U]_P#]J?(K>./$?_0?U3_P,D_^*IC>./$?_0P:I_X&R?\ Q5?7M%'UA?RC
M_MRE_P! Z^__ .U/CW_A.O$G_0P:K_X&R_\ Q5,;QUXE_P"AAU7_ ,#9?_BJ
M^Q:*/K"_E*_MVE_T#K[U_P#(GQNWCSQ+_P!#%JW_ (&R_P#Q51'Q[XFS_P C
M%JW_ ('2_P#Q5?9M%/ZPOY2O[>I?] Z^]?\ R)\7OX^\3_\ 0QZM_P"!TO\
M\54;>/\ Q1_T,>K_ /@=+_\ %5]J44?6%_*5_;]'_H&7WK_Y$^)V^('BC_H9
M-7_\#Y?_ (JF-\0?%/\ T,NL?^!\O_Q5?;=%/ZS'^4?^L%'_ *!E]Z_^1/SU
M\ ^,M?T\>)/LNN:E;>?K5S/+Y-W(GF2-MW.V#RQP,D\UTS?$3Q5_T,VL?^!\
MO_Q5?0/[-W_-4O\ L>]4_P#:5>QTHXA15N4RH9[2HTU!X=.WFO\ Y$^&6^(G
MBO\ Z&?6?_ ^7_XJHF^(WBS_ *&?6?\ P82__%5]UT57UF/\G]?<=/\ K%1_
MZ!5]Z_\ D3X1;XC>+.?^*HUK_P &$W_Q51GXD>+<_P#(TZU_X,)O_BJ^\J*/
MK4?Y/Z^X?^LE'_H%7WK_ .1/@EOB3XN_Z&G6O_!C-_\ %4QOB5XN_P"AJUO_
M ,&,W_Q5??-%/ZU'^3^ON+_UEH?] J^]?_(GP"WQ,\7_ /0UZW_X,9O_ (JF
M-\3/&'_0UZY_X,9O_BJ_0&BCZU'^3^ON'_K-0_Z!%]Z_^1/SZ_X6=XQ_Z&S7
M/_!E-_\ %5&WQ.\8_P#0V:Y_X,IO_BJ_0FBG]:C_ "?U]Q7^L]#_ *!%]Z_^
M1/SR/Q0\9<_\5;KO_@RF_P#BJ8WQ1\9_]#=KO_@RF_\ BJ_1"BCZW'^3^ON*
M_P!:*'_0(OO7_P B?G6WQ2\:9_Y&[7O_  9S?_%4QOBGXTQ_R-^O?^#.?_XJ
MOT7HI_6X_P G]?<5_K30_P"@-?>O_D3\XS\5/&N?^1PU[_P9S_\ Q51M\5O&
MW_0X:_\ ^#.?_P"*K](**/KD?Y/Z^X?^M5#_ * U]Z_^1/S<;XK>-O\ H<=?
M_P#!I/\ _%5&WQ8\;\_\5CX@_P#!I/\ _%U^D]%/ZY'^3^ON*_UKP_\ T!K[
MU_\ ('YJM\6/''_0Y>(/_!I/_P#%U&WQ:\<?]#GX@_\ !I/_ /%U^EU%'UR/
M\G]?<5_K;A_^@)?>O_D#\S6^+?CGG_BL_$/_ (-9_P#XNL;7O&.O^*5A36M<
MU+5TA),2W]W).$)QDKN)QG Z>E?J77@W[8W@B7Q/\,HM5M8S)<Z)<?:' )SY
M##;)@>QV-GL%-:T\7&4TN2U_Z['I9=Q1AL1BZ=)X90YG;FNM+_\ ;J]-SX2>
MHVZU(]1MUKUC]01$U1O4C5&]-&J(VK],?V=9I;CX(^#FEQN%@J#']U20O8=@
M/_K]:_-G2='O=?U2UT[3K62\OKEQ%#!"N6=CT %?JOX5\/P>$_#.DZ+;'=!I
MUI%:HV,;@B!=Q'J<9_&O*S"2Y8Q/S/CJM!4*-'[3;?R2M^IJT445XI^.A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7CG[(/_ ";OX3_[>_\ TKFKV.O'/V0?^3=_"?\ V]_^E<U 'L=%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %>.?M??\F[^+/^W3_TKAKV.O'/VOO^3=_%G_;I_P"E<- '
ML=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWXW\!V'CCX>ZWX-EFN-)TO5=.ETMY-+*12P0R1F,^5E652%/&5('I7$_!?\
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MMXHSYC*SLPE@D)8[%'! P.E?1=%3)<[4I:M!'W5:.A\ ?\.5/@A_T-/Q _\
M!C8__(='_#E3X(?]#3\0/_!C8_\ R'7W_13 \4^*W[)GA#XN? '2/@_J&H:U
MI/A/38[.&)M)GACN7CME"QJ[/$ZD<*3A1D@=*^:_^'*GP0_Z&GX@?^#&Q_\
MD.OO^BAZRE-[R=WZ@M(J*V6B/@#_ (<J?!#_ *&GX@?^#&Q_^0Z^JOV;/V;_
M  K^RS\.?^$,\(SZE=Z<UY+?27.K2QR7$DKA02S1QHN $4#"]!WKU6BJ4G%-
M+J2XIM-] HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "O'/^;PO^Y$_P#<A7L=>.?\WA?]R)_[D* /8Z*** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_P!NG_I7#7L=>.?M??\ )N_BS_MT
M_P#2N&@#V.BBB@ HHHH **** "BBB@ HHHH **** "BFO(L8R[!1ZL<4JL&
M(.1ZB@!:*3..3Q3%GC9MHD4MZ!AF@"2BBB@ HIID4,%+#<>V>:56##*D$>U
MA:**:TB+]Y@/J:!CJ*16##(((]J6@ HIC2HO!=1]31YR$$A@0.ISQ0*Z'T4S
MSD.<,#CK@YI5D5B0&!(ZB@+H=1136=5^\P7ZF@8ZBD5@W(((]J6@ HIK,J\L
M0H]S0KJ_W6#?0T .HHHH **0G')X%1FZB&,N.>E.S9+DH[LEHIJR*_W6!^AI
MU(H***3..M "T4Q948X#J3[&GT %%)31*C-@.I/UH$/HHHH&%%%% !1110 4
M444 %%%% 'CGQ._Y.(^"G_<;_P#21*]CKQSXG?\ )Q'P4_[C?_I(E>QT %%%
M% !1110 4444 %%%% !1110 4444 %%%% %>\L8-0B\N=-XZCL1]*Y^Z\'L.
M;:<$?W9./U%=115*36QK"K.G\+.(;PSJ"](0WT=?ZFD_X1O4?^??_P ?7_&N
MXHJN=G1];GV1P_\ PC>H_P#/O_X^O^-'_"-ZC_S[_P#CZ_XUW%%'.P^MS[(X
M?_A&]1_Y]_\ Q]?\:/\ A&]1_P"??_Q]?\:[BBCG8?6Y]D</_P (WJ/_ #[_
M /CZ_P"-'_"-ZC_S[_\ CZ_XUW%%'.P^MS[(X?\ X1O4?^??_P ?7_&C_A&]
M1_Y]_P#Q]?\ &NXHHYV'UN?9'#_\(WJ/_/O_ ./K_C1_PC>H_P#/O_X^O^-=
MQ11SL/K<^R.'_P"$;U'_ )]__'U_QH_X1O4?^??_ ,?7_&NXHHYV'UN?9'#_
M /"-ZC_S[_\ CZ_XT?\ "-ZC_P ^_P#X^O\ C7<44<[#ZW/LCA_^$;U'_GW_
M /'U_P :/^$;U'_GW_\ 'U_QKN**.=A];GV1P_\ PC>H_P#/O_X^O^-'_"-Z
MC_S[_P#CZ_XUW%%'.P^MS[(X?_A&]1_Y]_\ Q]?\:/\ A&]1_P"??_Q]?\:[
MBBCG8?6Y]D</_P (WJ/_ #[_ /CZ_P"-'_"-ZC_S[_\ CZ_XUW%%'.P^MS[(
MX?\ X1O4?^??_P ?7_&C_A&]1_Y]_P#Q]?\ &NXHHYV'UN?9'#_\(WJ/_/O_
M ./K_C1_PC>H_P#/O_X^O^-=Q11SL/K<^R.'_P"$;U'_ )]__'U_QH_X1O4?
M^??_ ,?7_&NXHHYV'UN?9'#_ /"-ZC_S[_\ CZ_XT?\ "-ZC_P ^_P#X^O\
MC7<44<[#ZW/LCA_^$;U'_GW_ /'U_P :/^$;U'_GW_\ 'U_QKN**.=A];GV1
MP_\ PC>H_P#/O_X^O^-'_"-ZC_S[_P#CZ_XUW%%'.P^MS[(X?_A&]1_Y]_\
MQ]?\:/\ A&]1_P"??_Q]?\:[BBCG8?6Y]D</_P (WJ/_ #[_ /CZ_P"-'_"-
MZC_S[_\ CZ_XUW%%'.P^MS[(X?\ X1O4?^??_P ?7_&C_A&]1_Y]_P#Q]?\
M&NXHHYV'UN?9'#_\(WJ/_/O_ ./K_C1_PC>H_P#/O_X^O^-=Q11SL/K<^R.'
M_P"$;U'_ )]__'U_QH_X1O4?^??_ ,?7_&NXHHYV'UN?9''0>%+V1OWACB7N
M2V3^E;.G^&;6SPT@^T2>K#Y1^%;%%)R;,I8BI+2XG3@4M%%0<X4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG_-X7_<B?
M^Y"O8Z\<_P";PO\ N1/_ '(4 >QT444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >.?L
MW?\ -4O^Q[U3_P!I5['7CG[-W_-4O^Q[U3_VE7L= !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7CG[(/_)N_A/\ [>__ $KFKV.O'/V0?^3=_"?_ &]_^E<U 'L=%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KQS_ )O"_P"Y$_\ <A7L=>.?\WA?]R)_[D*
M/8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /'/V;O^:I?]CWJG_M*O8Z\<_9N_YJ
ME_V/>J?^TJ]CH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_9!_P"3=_"?_;W_ .E<
MU>QUXY^R#_R;OX3_ .WO_P!*YJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_:^_
MY-W\6?\ ;I_Z5PU['7CG[7W_ ";OXL_[=/\ TKAH ]CHHHH **** "BBB@ H
MHHH **** "BBB@#D/BEXJN?!_A-[ZR\LW3311()&"CYF )S@^OI7'VD?Q+US
M0U?S;-!<Q'YEN4XS_P!L_P"M>;?MP:+X[UVTT"U\&V]Y=1D2-=QVJ%A@,FS.
M!G.[^E=[^RG#XHM?AZ8?%<<T5]&R*J3JRD +R.?>F SP=X(^(_A"TO($NK6Y
M-U.;AW,ZK@D 8QY9]!6K\*_'VOZSXVUOP[KRP>=8VRSJ\,H?.9&7'"C^[7H'
MB[^T/^$?O?[,S]L\IO+V]=V#C]<?A7A_AOPS<:7K4.IZ3:W\'B&Z=C=2S+((
M9=N[&,C&W<3[?2C<#Z)HID._R4\S_6;1NQZXYI]("*YN([2!YI75(T&2S' %
M?''[2'QJG\9:N?"?AYFFAW[)'BY$C D<8KU[]HCQ'XL&DG2?"^EW5U).I$UQ
M#&Q\L'(QP.XKC_V<?V>[G1;AM?\ $L/^GL24MYDY7/4G/0\U[>$C3P\/K%1W
M?1'YYGE;%YEB%EF%BU%_%(\+\3?!OQ1\,=/L/$&UQG#Y ^9.AY%?5G[/?QJM
MOB)X?CM;IUBU6W0+)'GJ!QFO4]=\/V7B#29M/NX$EMY$V%6'!'I^E?&?B#X/
M^,?A/\0QJ/A:QN;ZS5PX\F-F4C@E3@<^E=7MX9E!PJZ26QXW]FXCA7$QKX.\
MZ4M)+<^WZ*YWP)K5[KGA^WGU"SELKO8GF13 A@2H)Z_6NBKYR47%N+/U>E45
M:FJBV9\"?M6*#\5E7J&6,$#W/->^>#_V6_AYJ'AZRNKK2_/GFB5V+RN,$CV:
MO*OVD_AGXH\1_$1K[2M'N;RV"(/,BB8@,.<9QUJ#3O%'QPTJU2UM],O(XHP
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M %%%% !1110 4444 %%%% !1110 5XY^U]_R;OXL_P"W3_TKAKV.O'/VOO\
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MBBB@ HHHH **** &2R"&-Y&^ZH+'Z"O/;RZ>^N9)I#EF.<>@]*[#Q-,8M)D
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M&>_@YKGCS^QO[?\ [,, _L_[5]F\SS)DC_UFQ\8WY^Z<XQ7Y'_#'_E(]9_\
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M/AC_ ,*Y^!.J^"_A59Q:-<6^F7-OHD,]U(R03R!RK&20NV [ELDFO@']D_\
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M<@C8'JK8(]*5U>P[.USWRBN5^&WQ4\(_&#PS%XA\%>(;#Q)H\AV?:K"4.$?
M)1U^\C@$95@",C(JA\5OCAX!^!VCQZGX\\5Z;X9M)=WDB]FQ+/MQN$40R\A&
M1D(I/-.7N?%H*/O?#J=S17@7PU_;S^ ?Q;\0PZ%X9^).G7&K3L(X+6^@N+!I
MG)P$C-Q'&'8GHJDD^E>\W%Q':V\L\K!(HU+NQZ  9)HE[L>:6P+WGRK<P-'^
M)7A'Q!XHU+PUI?BG1=2\1Z8"U]H]GJ,,MY: $ F6%6+IR0/F ZBNCK\Z/^"4
M,#_$+QU\?OB_< N?$7B#[/;.W4*7DN'7/IB:$?\  :_1>G9J$'+=I-^5U?\
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M'%>NWEY!I]K-=74T=M;0H9)9IG"(B@9+,3P !W-.2<5>6@E[SLB:BOF[6/\
M@HU^SAH?B Z+<_%/3)+P.$\RTMKJYMLG_IXBB:+'OOQ7OWAOQ-I'C+0[/6M!
MU.TUG2+R,2VU]83K-#,I[JZD@CZ4+5<RV&]'RO<O75W!86LUS<S1V]O"ADDF
ME8*B*!DLQ/  '<T^.19HU=&5T8;E93D$'H0:_*+_ (*(?MC_  ^^+7C[X:>
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M %%%% !1110 4444 %%%% !1110 5XY^U]_R;OXL_P"W3_TKAKV.O'/VOO\
MDW?Q9_VZ?^E<- 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CGQ._Y.(^"G_<;
M_P#21*]CKQSXG?\ )Q'P4_[C?_I(E>QT %%%% !1110 4444 %%%% !1110
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M &UO@Q\'_&5[X4\7>,O[)U^R$;3VG]EWLVP.BNOSQPLIRK*>#WKX-_X(\_\
M)8O'/_8!7_THCKZZ^.'_  3G^&WQ^^)6J>./$.M^*K/5M16%98=,N[9(%\N)
M8UVA[=V'"#.6/.:[:G/R4N7:S_\ 2F<^"OR5>7>^GW1.R^'O[</P3^*OC'3O
M"OA;QK_:FO:BS):VG]E7L/F%49R-\D*J/E5CR1TK\[/VQOV3?'W[//QJO/B3
MX%L;ZZ\-3:B=9LM2TR$S/I4^_P QDE4 [55\[6(VE< G.17VS\&_^";/PS^"
M'Q*T7QOH6N>++O5=)=W@AU"[M7@8M&T9W!+=6/#GHPYQ7DGQF_X*7>+?A!^T
M->^!-4\&:58:#I>KQV][?2O-/<2V+,K>=& 5 8Q,& PPSQS7/*,74I\LK3U]
M-U_P'_3.F=W1G]87NZ;=]?Z_I'SIXL_:W_:%_:[^'>J^$+?1K%/#]M:M<ZYJ
M6CV$D"M;PJ9&-S.\C)&OR9PNS<1M .=IH_\ !+-9F_:VTLQ$!%TJ^,N?[OE@
M<?\  BM?:/[;'[:'PVM?V<_$.E>$_&.D^)M>\36;:=;6NDW:7#PQRC$LDH4G
MRL(6P&P2Q QUQX/_ ,$@_A/>W7C+Q9\1KFW9--L[/^Q[.5E^66:1DDEVG_85
M$!_ZZ"KP_P#'F[:).[\[-?JOFSCQ$+JE'GYGS+[DT_T=_(_4JOST_;^_X* V
MWA.SU7X9_#:_6XU^57M=8URW;*6*D8>&%AUEZAF'"<@?-]S7_P""E/[95]\*
M=/3X9^"[UK3Q/JEMYNIZE"Q$EC;/D+'&1]V1QD[NJKR.6!'RG^Q&W[.?@>Z3
MQK\8/&$-QXC@F)T[P])I-[<06I4\3S%(&21R>57)51@G+8"X:8AN-[16_GY?
MUOY+?OK5W1:A#XG^']?UJ?0'_!,?]CC4_#=]%\7O&=B]C</ R:!IUPFV0*ZX
M:Z8'E<J2J \D,S="IK]$[[1=.U2YL[B]L+6[N+*0RVLL\*N\#D8+(2,J<'&1
MVKPKPG^WQ\!_''B;2_#VA^.OMNKZG<):6EM_9%_'YDKD*J[G@"C)(Y) KZ"K
MND^9*R]U:+\_OUO_ $B,/"%.+C%W?7^OR/@'_@L/_P D?\"_]AU__2=ZZ?\
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ML,:2_A.*WG\9>%= LC<P74)G79&B"X 4$9**68?[G0TN95,')UMD[?)W_P"
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MW21>JC*Y!( *D$<&OCO]NSXG6W[:WQQ^'W[.WPSO4UZPM=4%_P"(-7L&$MM
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MXUA+WL).,=?:327W*+M_X%\VO0UC[N*@W]B+;^^Z_)^FAWG_  2P\!?\(/\
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M?VR/A[^RWX3O;S7=7M;[Q-Y1-AX:M9U:\NI"#MW*,F./(YD8   XR< _.?\
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ML<@X[ZZ?UEN&KII)I]FN6_?>._3YG%2DOJZ4M%-MJWD[V^Y[=?D>1>(OV/\
MX(?M7_\ ")?$;]GSQ9X?^'NL:%>QW1U/PII:LAVX=(YK-)(?)E#8.6 ;!(((
MQCS3_@IU^T'I_B#XS>#O@/K/B^;P;X  AU#QCJUK#+*[*V62'9$KLV$4,%VD
M%I8R1A*Q-,^'_AC]G?\ X*B^!/#GP+U%SI>K6Y'B/0;2[:Y@LD*RF6)VRQ "
M(DH1R2K;>0"H&C\0-*\$^"_^"LVL'XP:)HNH>$O&&CPKI<OB.TBN+)9C!#'&
M["4%%/F6\L>[L7'0&L8I5?8J/PMR=GUDEMYIV37=K;J]FW3]KS?%&,=5VD]_
M57?>R.FT/XL_\$Y-!\'KX;BMO#5W9^286N[[PEJ-Q?/D<L;I[4RAN^588[8X
MJO\ \$G_ !QI\/Q4^-W@'P=K-QK7PPL[M=3\/-<K(ICB:5TR%D 8;D\O.X Y
M3.,DU]&_'/PG^RQ^SSX%N_%'C#X;?#6R@CB9[6S_ .$<T\W-_)C*Q01^5EV)
MQT& .20 35[]B+4O#_C;X4CXB:7\$O#WP5&M,1!;Z3% LM[9IRDTC1V\)"EB
M^U2#P P.&%5"2YYU'LDT^VNU_--7MVOT,ZD7[.,%U::[Z;_>G9L^3M!^#?@#
MXK_\%7O$FA0>!O#J>#O!NAF2\TF+2;<6-U<F) 7EA";'?S+LG+ G,0]./TN\
M-^&-'\&Z):Z-X?TFQT/2+4%;?3]-MDM[>$$DD)&@"J"23P.I-? G_!+6:'XB
M_$[]HOXJO,LTNN>(_L]ON/SI"9)IAQU (DB _P!SVK]#J4;QH4H/?E3?J[R_
M6WEL7/WJ]279V7HK+\T_S"OD7]LC]A%_C]XFTOXC> /%$O@#XKZ/&$M]6B=T
MBNE4'8LC1_/&RY($BACM)4JPQM][^/\ H7B'Q-\$?'6E^$K^\TSQ1<Z-=)IE
MU83M!/'<^63%LD4@J2P R".M?*7_  3!_:PT[XA_"1/ WC;QC<7/Q-T>]N$F
MB\2:@\E]>Q-(71D:9BTFS)0J"2NP9 !%1&/M)M+1Q2DN_5:>GY%2E[."D]5)
MM/\ /7U_,\Y@_;<_:3_9!NH--_:)^&[^*_#*R")?%VC*B,P+$!O,C'D.Q ^6
M-Q"YZDU]U?!S]H3P+\=_AJ/'/A'64O-#17^U>:OES6;HNYXYD/*,HY]""""0
M03>^,WQ!\!_#OX?ZQJ'Q%U+2[+PRUM)'=0ZHR%;I"IS"L;?ZUF&0$ )/3%?G
M3_P2\^'6M^)/A'^T7J.BV5SIOA/Q1'+IWA^WN6.#((KD<$]=JS0H6'4@C^&E
M*I)TZNEW&+:?W:->=^GX#4(J5-WLI22M^J]#RKP?^T!\$_VEOVCO%?Q*_:3\
M72P>'=-G^S^$O!\EE>SV_P!GW$JT@MXG&  I921O=FW J #W7[77Q(_8>^(_
MP1URW^'TFA:'X\LH?M&B3>'_  M>:9)+.I!$;LMM&C*PRO[PX&<@@BNN_P""
M5?A/X+_$3X4ZSX,\9^!/"&J_$G0M5N#=6_B'1K6>_>W;;M8&5"Y5&#H0/ND#
M.-PSZ/\ M*>//V<?@KXM\/>!O"'P"^'GQ2^).L7R6B^&-+TBPA>V##[TT@MI
M C9VX0@'!+' &3=2FHQA1B]TK6W;>M_-WW?Z$PFY3G5:V;O?9)=/)6V7ZGJ?
M[.WQXU*X_P""?>C_ !.\2W+W>IZ9X8N[FYNI&W/.UJ)45V)ZLWE*2>Y)KS'_
M () ^ 5L_P!EW6O$.I0K=3>+M;NIY3,H830QJ(=K _>!<3=?[QKH?^"D&M:=
M\&_V#=;T+1M*T_PM%JK6FC6VEZ3&D5M!YDHEFCC5%5<;$FZ*,Y)P,UWGP9UW
MPW^R'^PUX*U/Q?<KI6FZ+X>@NKM>/,DN9E\UHD7^*1I)"H'J>U7*I!SQ-=_#
MI'[VY/\ 1>9G&$HPP]%;ZR^Y**_-^GS.:_:JTG]FS]E7X4WOBW7/@[\/;J^?
M,&E:2OAJQ62_NB,J@_=<*.K-_"H[D@'Q?_@G7^Q7=7GB63]H/XFZ)8:=KFK2
M-?>'?#EK9I;6^GH_*W'DJ J':0(T_A7YC\Q&W,_9S^#OBO\ X* _&5?C_P#&
M*TDM?AYILY7PGX3G!,$Z*V5)!^]$" 6;'[UQCA%VU^F8 4  8 Z"BFI4OWDO
MC>R_E7_R3Z]O74<W&I^[CK%;O^9_Y+\?30_.3_@I*Q^+W[47[.OP9A;S8+K4
M1JFHV_4&%YE3<?I'#<_G7Z,221VL#.Y$<4:DD]  !7YP>"[VV^)7_!9/Q7<:
MI/%'_P (AH;0:7#,P!=UMX4(4'J?]*G? [ GM7MG_!0+]L#PY\"?@[XFT#2]
M6@OOB%JUC):6FF6<@DFLDD'EM=3!<^4JAOEW8W-@#/)',YNG@XR6KES27G=V
MBONBO1>AOR>TQ3CTBHQ].K_%_P!:'D'_  2UA?XF_%K]H/XRS_O4US7#964K
M#D1F22=E'L%:W'X5YS\&/A"W[9G[=?QZUC7;JX;X:Z=JBVFJ6,$AC75C;R&*
MUMG<8;RO]'\UE!&2B>Q'T/\ \$_=)@^ O_!/6V\4WR"W>:QU'Q1<L1U7#F,_
MC%%'^=,_X)'^#YM'_99E\37FY]0\6ZY>:I+*X^9PK"$?K$Y_X%76J:IUN1;4
MH)?-V7INI/\ X!S2FZE)S?\ R]FW\E=_ER_\.0_MX>//#/[#W[.=^/A7X9T/
MP/XH\77":3;W.@Z=#9R*JHS/.QC52S(FY58Y*M(#7S[^S1XP_80^$_@&P'C+
M7M(\=^.+V%9]9U/Q%X7U#4%^T,-SI$LMJR*JL2-P&YL9)/;TK_@L+HTEG8?!
M7QI>Z;_:OA?0/$$B:K;-&)$=)#"X1U/!5EMY%YX.X#O7TII/PI_9=UKX?P>.
M;;P%\*SX1FMQ=#6)-"TY+98\9)9S& I'0@X(((/-<]-OEJ59=[>:22LO1WO_
M ,,;5$KTZ:[7]7=K[U9?>? _A'XH?"#PQ_P44^&.K?LWZLJ>&/%.-*\0Z39V
M5S9V@>1F7"QS1IA?]6X5!M5H^,9Q7T9_P5X\%^-/%7P,\.7?A[3[W6O#6D:N
M+WQ#IE@6WR0!#LD8+R8U.[)P=NX-T7(TOV4_'OPB^.?QQ\4)\-?V?/".E^$O
M"+C[)\2+73+6V>>Z^4*L$0M592<R-N$F0JJ2!O K0T?]N;5-#_;J\5?!3X@Q
MZ!X:\*QP+_8&J2)+!/=3ND+QI)*\IC(</*!A5RRJO4X-<O/"E16^LE?LFI)6
M^^R?1DWY:E2J]K*+MWLTW?T:N^Z/.O@;XH_8B_:F\'P^"K+P+X7\&^(+JW%J
MNEZGIT-EJ>_& 8+U?FF?/(Q(7.,LHSBOIC]C?]F74?V4/AC=^";KQO+XUL/[
M0DO+&273_LGV-'5=T*KYLF06#/U'+MQS7SW_ ,%-/V:_@@OP4\2?$&]LM+\(
M>.X$\[3=0TYEMI-4N2P/E/$N!.S\_/@NN,[@ :^A/V%/$/B?Q5^R3\--4\82
M3S:Y/IGS3W1+2S0K(ZP2.3R2T0C;)Y.<Y.<UK"7,JDUH]$^J=[M?/37K\B)1
MY.2+U6K7=6T_7T^9[S7YR_$HCXT?\%>O VA#]_IW@'1EO+B,\JDPC><-_P!]
MSVP_X#7Z-5^<G_!/#/Q8_;(_:3^*\@\V 7QTFQGZ@Q/.V #[1VL/YUG2UQ,'
M_*I2^:5E^,BZFF'FOYG&/R;N_P $SE?^"CMGKWQV_;<^"GPE\*ZC+I>K6=O]
MN7482=UB\LI=YQ@@[HXK4..0<XP17U9)^Q'\ ?AC\'];M;_X?Z+J]O:Z;<7%
M_KNMVR76I2D1LTDYN7!D1S@ME"H!^Z!7S]^S(?\ A<G_  5)^.'CD_O]/\*6
MC:-;.>1'*#';#:>V1!<'_@1KZ$_X*.?$#_A7?[&_Q$NDDV7.I6BZ/#S@DW+K
M$^/I&TA_"N:;Y, N7>:;\_>;LOR_JQT1][&.+V@XK[DFW^?]-GC'_!&"VU*/
M]F?Q'-<R2'3)O$T_V&*0Y"J(( Y7V+9_$'UK[]KYX_X)]_#W_A6O['_PUTUX
MS'<W>G#59PPPV^Y9I\'W"R*O_ :^AZ]+$Z57'M9?<K?H>?0=Z?-WN_O=SR3]
MJC]H#3/V9_@CXA\<7_ES75M'Y&FV;MC[5>/D11_3/S-CHJL>U?.7_!+CX":C
MX?\  NL?&CQGNN_'?Q$E:^^TW _>1V3.74^QE8^8<?PB/TKQW]H!KK_@HW^V
MM9_!_2;^ZM_A=X"\V36M2L& +3#"S.A8,N_?MA3(.,2-@C(KTO\ X<J?!#_H
M:?B!_P"#&Q_^0ZY*+:BZUOC5H_X>K_[>?X*UCJJV;5%?9U?KT7_;J_$YS]EF
M1?AK_P %4_CUX0&(K;7K674HUZ9D9X+D8_">7\J[_P#X*@_&SQ-X?\+^#/@_
MX$GDMO%OQ(OO[/,\#E'CM=Z1E PY7S'D52?[@D'>OFW1O@+H7["__!3+X0:%
MX:U#5KSPYKMGM^T:S+%),TEPMQ;E-T<<:X#B(@;<\\FO4_\ @H+KUM\*_P!N
M;]G#X@^(@8?"5JWD37; E(62?]XY]-JS(_KA3Z41C"=/"TGK"_(^GPMM_?I]
M]A2E.G4Q-5+W[<Z^:5OU?W'T7\(_^">?P1^&GPUL_#.H> ]"\6WY@"W^M:U8
M1W%U<3%<.Z.X+0C/W5C(VC'?)/P=\#_@B^C_ /!52R\ Q7]UJGA?X=M<7.EQ
M7DAE-G9")KB"$,>2$FNU&37ZE?$WX[>!OA'\-Y_'7B+Q%8VWAU8/.M[F.=9/
MMF5RB0 ']ZS=@N<]>G-? O\ P2NU&\^./[1/QW^-FJ6QAGU!X[6W!.?*6>5I
M#$#WV)! OY5K2E*6+<W]F,F_)[1T\GMV]&95(J.%Y5]II+S7VOPW_P" ;G_!
M25C\7OVHOV=?@S"WFP76HC5-1M^H,+S*FX_2.&Y_.OT8DDCM8&=R(XHU))Z
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M1=3AGU+0=!MQ$HL423;MAC !C20HQ51Q@-C"DCG?^"1L<?C*S^-WQ0F8-?\
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M '[;_"HVTN]_Y\[C_OTW^%>BT4_:,KZY+L>;MI-]_P ^=Q_WZ;_"HO[)OO\
MGRN/^_3?X5Z;11[1C^NR['ES:/?_ //C<?\ ?IO\*8=&U#G_ $&Y_P"_+?X5
MZI11[1E?7I?RGD[:+J'_ #X77_?EO\*C;1-1S_QX77_?EO\ "O7**?M&5_:$
ME]D\?;0]2Y_XE]U_WY;_  IC:#J?_0.NO^_#?X5['11[1]BO[1G_ "GC']@Z
MG_T#KO\ [\-_A3&\/ZI_T#;O_OP_^%>U44_:OL5_:4_Y4>('P_JN/^09>?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%UKPEX@MA=:3JULUM,G=<_==3V96PP/8@&NEHJII5%RRVM;]"*<5124-+?\
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M)P #D#FO7Z*AI-)/96M\MONL4FXMR6[O^.Y1TW1K/2]%M=)@A46%M;K:QPL
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MO^:I?]CWJG_M*O8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *\<_:^_Y-W\6?]NG_I7#7L=>.?M??\F[^+/^W3_TKAH ]CHHHH ****
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M6*O<YG_A#?\ I\_\A?\ UZ/^$-_Z?/\ R%_]>NFHHYF'UBKW.9_X0W_I\_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *\<_YO"_[D3_ -R%>QUXY_S>%_W(G_N0H ]C
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_ )JE
M_P!CWJG_ +2KV.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]D'_DW?PG_P!O?_I7
M-7L=>.?L@_\ )N_A/_M[_P#2N:@#V.BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/VOO
M^3=_%G_;I_Z5PU['7CG[7W_)N_BS_MT_]*X: /8Z*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** /'/B=_R<1\%/^XW_ .DB5['7CGQ._P"3B/@I_P!QO_TD2O8Z "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_YO"_
M[D3_ -R%>QUXY_S>%_W(G_N0H ]CHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<_
M9N_YJE_V/>J?^TJ]CKQS]F[_ )JE_P!CWJG_ +2KV.@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ KQS]D'_DW?PG_P!O?_I7-7L=>.?L@_\ )N_A/_M[_P#2N:@#V.BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "O'/VOO^3=_%G_;I_Z5PU['7CG[7W_)N_BS_MT_
M]*X: /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@?+_P#%4?\ "P/%/_0R:O\ ^!\O_P 56!11]<Q/_/R7WL/JN'_Y]K[D;_\
MPL#Q3_T,FK_^!\O_ ,51_P + \4_]#)J_P#X'R__ !58%%'US$_\_)?>P^JX
M?_GVON1O_P#"P/%/_0R:O_X'R_\ Q5'_  L#Q3_T,FK_ /@?+_\ %5@44?7,
M3_S\E][#ZKA_^?:^Y&__ ,+ \4_]#)J__@?+_P#%4?\ "P/%/_0R:O\ ^!\O
M_P 56!11]<Q/_/R7WL/JN'_Y]K[D;_\ PL#Q3_T,FK_^!\O_ ,51_P + \4_
M]#)J_P#X'R__ !58%%'US$_\_)?>P^JX?_GVON1O_P#"P/%/_0R:O_X'R_\
MQ5'_  L#Q3_T,FK_ /@?+_\ %5@44?7,3_S\E][#ZKA_^?:^Y&__ ,+ \4_]
M#)J__@?+_P#%4?\ "P/%/_0R:O\ ^!\O_P 56!11]<Q/_/R7WL/JN'_Y]K[D
M;_\ PL#Q3_T,FK_^!\O_ ,51_P + \4_]#)J_P#X'R__ !58%%'US$_\_)?>
MP^JX?_GVON1O_P#"P/%/_0R:O_X'R_\ Q5'_  L#Q3_T,FK_ /@?+_\ %5@4
M4?7,3_S\E][#ZKA_^?:^Y&__ ,+ \4_]#)J__@?+_P#%4?\ "P/%/_0R:O\
M^!\O_P 56!11]<Q/_/R7WL/JN'_Y]K[D;_\ PL#Q3_T,FK_^!\O_ ,51_P +
M \4_]#)J_P#X'R__ !58%%'US$_\_)?>P^JX?_GVON1O_P#"P/%/_0R:O_X'
MR_\ Q5'_  L#Q3_T,FK_ /@?+_\ %5@44?7,3_S\E][#ZKA_^?:^Y&__ ,+
M\4_]#)J__@?+_P#%4?\ "P/%/_0R:O\ ^!\O_P 56!11]<Q/_/R7WL/JN'_Y
M]K[D;_\ PL#Q3_T,FK_^!\O_ ,51_P + \4_]#)J_P#X'R__ !58%%'US$_\
M_)?>P^JX?_GVON1I:;XGUC1OM7]GZM?6/VN=[JX^S7+Q^=,V-TC[2-SG RQY
M.*N_\+ \4_\ 0R:O_P"!\O\ \56!11]<Q/\ S\E][#ZKA_\ GVON1O\ _"P/
M%/\ T,FK_P#@?+_\51_PL#Q3_P!#)J__ ('R_P#Q58%%'US$_P#/R7WL/JN'
M_P"?:^Y&_P#\+ \4_P#0R:O_ .!\O_Q5'_"P/%/_ $,FK_\ @?+_ /%5@44?
M7,3_ ,_)?>P^JX?_ )]K[D;_ /PL#Q3_ -#)J_\ X'R__%4?\+ \4_\ 0R:O
M_P"!\O\ \56!11]<Q/\ S\E][#ZKA_\ GVON1O\ _"P/%/\ T,FK_P#@?+_\
M51_PL#Q3_P!#)J__ ('R_P#Q58%%'US$_P#/R7WL/JN'_P"?:^Y&_P#\+ \4
M_P#0R:O_ .!\O_Q5'_"P/%/_ $,FK_\ @?+_ /%5@44?7,3_ ,_)?>P^JX?_
M )]K[D;_ /PL#Q3_ -#)J_\ X'R__%4?\+ \4_\ 0R:O_P"!\O\ \56!11]<
MQ/\ S\E][#ZKA_\ GVON1O\ _"P/%/\ T,FK_P#@?+_\51_PL#Q3_P!#)J__
M ('R_P#Q58%%'US$_P#/R7WL/JN'_P"?:^Y&_P#\+ \4_P#0R:O_ .!\O_Q5
M'_"P/%/_ $,FK_\ @?+_ /%5@44?7,3_ ,_)?>P^JX?_ )]K[D;_ /PL#Q3_
M -#)J_\ X'R__%4?\+ \4_\ 0R:O_P"!\O\ \56!11]<Q/\ S\E][#ZKA_\
MGVON1O\ _"P/%/\ T,FK_P#@?+_\51_PL#Q3_P!#)J__ ('R_P#Q58%%'US$
M_P#/R7WL/JN'_P"?:^Y&_P#\+ \4_P#0R:O_ .!\O_Q5'_"P/%/_ $,FK_\
M@?+_ /%5@44?7,3_ ,_)?>P^JX?_ )]K[D;_ /PL#Q3_ -#)J_\ X'R__%4?
M\+ \4_\ 0R:O_P"!\O\ \56!11]<Q/\ S\E][#ZKA_\ GVON1O\ _"P/%/\
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M[D;_ /PL#Q3_ -#)J_\ X'R__%4?\+ \4_\ 0R:O_P"!\O\ \56!11]<Q/\
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M?>P^JX?_ )]K[D;_ /PL#Q3_ -#)J_\ X'R__%4?\+ \4_\ 0R:O_P"!\O\
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M_P #Y?\ XJC_ (6!XI_Z&35__ ^7_P"*K HH^N8G_GY+[V'U7#_\^U]R-_\
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M_ ^7_P"*K HH^N8G_GY+[V'U7#_\^U]R-_\ X6!XI_Z&35__  /E_P#BJ/\
MA8'BG_H9-7_\#Y?_ (JL"BCZYB?^?DOO8?5</_S[7W(W_P#A8'BG_H9-7_\
M ^7_ .*H_P"%@>*?^ADU?_P/E_\ BJP**/KF)_Y^2^]A]5P__/M?<C?_ .%@
M>*?^ADU?_P #Y?\ XJC_ (6!XI_Z&35__ ^7_P"*K HH^N8G_GY+[V'U7#_\
M^U]R-_\ X6!XI_Z&35__  /E_P#BJ/\ A8'BG_H9-7_\#Y?_ (JL"BCZYB?^
M?DOO8?5</_S[7W(W_P#A8'BG_H9-7_\  ^7_ .*H_P"%@>*?^ADU?_P/E_\
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M!6;11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:
M^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R
M7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\
M56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:
M^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R
M7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\
M56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:
M^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R
M7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\
M56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:
M^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R
M7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\
M56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:
M^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R
M7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\ T,FK_P#@?+_\
M56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__ !5'_"P/%/\
MT,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_]#)J_P#X'R__
M !5'_"P/%/\ T,FK_P#@?+_\56!11]<Q/_/R7WL/JN'_ .?:^Y&__P + \4_
M]#)J_P#X'R__ !5:6G_&#QCILH>/7KJ3!^[<8E!_!@:XZBKAF&,IN\*TD_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>[G]-4::HTHTH[127W!1116!L%%%% !1110!\F_\%%O^29^&?^PO_P"T9*^
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MXL?7"% /3+>M=)^RC^R'X=\<>"8?%_C6";4(;\N++34F>%!&K%?,=D(8DD'
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M/,YJ8)TL/@TI5*FWHW9?>]NA],6W_!2*U:[5;CP#-%:YYDCU8.X'KM,(&?\
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MB6"KOE<-P0W&,<USGPE_8:D^&'Q2T#Q+/XFM]>L-/,DS0-9&W<3;"(R!O<$
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MY?\ @G__ ,ETN/\ L#W'_HR*OH;]N;XMW7@#X<VN@Z7.UMJ?B%WA>5#ADMD
M\W![%BRK]"U>AQ/@ZF89]3PM+>48KTWN_DM3@X9Q,,'D]7$5-HR;_".GS>A<
M^*7[<'@3X>ZA<:9IJ7'BK4X"5D^P,JVR./X3,>I_W%8?C7G^B_\ !1_2Y[U5
MU;P-=V5IWEL]16XD'_ &CC!_[ZKQ7]D_]F^'XY:U?WVM336_AK2RBS+;G;)<
MRMR(PV/E&!ECUY '7(^G?B)^PG\/];\,W$7A6RF\.ZW&A:WG%W--'(X'"R+(
MS?*?5<$=>>AWQ&#X:RJJL#BE*<]+RN]+][->NB9EA\7G^:TWB\*XPAK9::V\
MVGZ7NM3VGX;?%3PQ\6M"_M7PSJ:7T"D+-$04F@8_PR(>5/7V.."176U^3'P;
M^)&K? ;XJVU^?,@2VN#9ZK99XDB#;9$([E<$CW45^BW[1OQ'E^'/P3U_Q!IT
MNV]>!8+*5>TDK!%<?[H8M_P&OG\ZX=EE^,I4<.^:%5VBWWNE9_>M>Q[>39XL
M=AZDL2N6=+67IKK^#NO\SD/C+^V=X.^%&J7&C6L$_B;7+<[9K>S=4AA8=4>4
MY^;V4-CH<&N,\"_\%#/#.NZI':>)/#MUX:AD8*MY#<B\B3/>3Y$8#Z!J^2?@
M+\)Y_CA\3;/0'NI+>U97N[ZZ7YG2%<;B,_Q$LJ@GNV>:^X?$'["OPOU+PY)8
MZ;87>D:GY>(M42\EE?>!PS([%",]0%'L17T6.R[A[)E#"8Q2E4DKN2Z>=KV^
M5FSP\)F&>9Q*>(P;C"G%VL^OE>S=^[ND6/B!^VQX"^'?BBYT.[LM:U*6&.*4
M7>F102V\J21K(C(QF4D;6'.*[?Q9\=]$\(_"?3?B'<Z;JUUH=]%;SB.UBB:>
M%)E!0NK2!1R54X8\L.O6ORO\7>'K[PCXGU30]2_X_M-N'M)>21E&*\9[<<>U
M?I[X&\'VOQ _9;\.^'+P#R-2\,6UN6(SL8P+M?ZJV&'N*Y,ZR/+LJH8:M&\E
M*2YG?=6NVNU^AUY1G&.S+%5\/.T7&+LK;2O;7O9F=\(_VN/!?QF\7#PYH]GK
M%CJ#0//&=2AA1) N,JI25B6P2<8Z*:]MK\AO ?B"_P#@S\7M+U&Y1H+O0]2\
MN[B')VJQ29/Q7>/QK];FU2U32VU(SI]A$/V@SY^7R]N[=GTQS7E<3Y-1RNK2
MEA;^SFM.NJ_X#1W\.YM6S&-6EBOXD'VMH_\ )IW^1XQ\5OVP/!/P@\8S^&M6
MLM9OM0@B225M-@A>--XW!27E4[L8/3N*])^&?Q"LOBGX+L/$VFV5]86%]O,,
M>HQHDI56*[L*S#!(..>E?EAXBU#4/C;\8KNXMPSWOB+5MENK#.T22!8U/LJ[
M1]!7ZR>%O#MIX1\-Z7HEBFRST^VCM8E_V44*#]>*US_*,)E&#P\4G[:>LM=-
M%KIZO3T,\GS7$YGC:]FO8PVTUU>FOHF_N-2BBBOA#[0**** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@#Y-_X*+?\ ),_#/_87_P#:,E<[_P $WO\ CW\>?[UG_*:NB_X*+?\
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MP9Z[AN)Q_P !#5X%_P $\8;AOB[KDJ9^S)HKB7TW&:+;_)JX;]I3]I*]^/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5T^0[O+F!!1L$!D88*L,GD$'DUT%%>1"<J<E.#LULUN>K*,9Q<9*Z9\V6_[
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M] /_ ,FY_P#XNC_47,O^?D/OE_\ (A_KEE_\D_NC_P#)'R+17UU_PHCP-_T
M_P#R;G_^+H_X41X&_P"@'_Y-S_\ Q='^HN9?\_(??+_Y$/\ 7++_ .2?W1_^
M2/D6BOKK_A1'@;_H!_\ DW/_ /%T?\*(\#?] /\ \FY__BZ/]1<R_P"?D/OE
M_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\ 0#_\FY__ (NC_A1'@;_H!_\
MDW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\ DCY%HKZZ_P"%$>!O^@'_ .3<
M_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^^7_R(?ZY9?\ R3^Z/_R1\BT5
M]=?\*(\#?] /_P FY_\ XNC_ (41X&_Z ?\ Y-S_ /Q='^HN9?\ /R'WR_\
MD0_URR_^2?W1_P#DCY%HKZZ_X41X&_Z ?_DW/_\ %T?\*(\#?] /_P FY_\
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M&_Z ?_DW/_\ %T?ZBYE_S\A]\O\ Y$/]<LO_ ))_='_Y(^1:*^NO^%$>!O\
MH!_^3<__ ,71_P *(\#?] /_ ,FY_P#XNC_47,O^?D/OE_\ (A_KEE_\D_NC
M_P#)'R+17UU_PHCP-_T _P#R;G_^+H_X41X&_P"@'_Y-S_\ Q='^HN9?\_(?
M?+_Y$/\ 7++_ .2?W1_^2/D6BOKK_A1'@;_H!_\ DW/_ /%T?\*(\#?] /\
M\FY__BZ/]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\ 0#_\
MFY__ (NC_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\ DCY%
MHKZZ_P"%$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^^7_R
M(?ZY9?\ R3^Z/_R1\BT5]=?\*(\#?] /_P FY_\ XNC_ (41X&_Z ?\ Y-S_
M /Q='^HN9?\ /R'WR_\ D0_URR_^2?W1_P#DCY%HKZZ_X41X&_Z ?_DW/_\
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MH_X41X&_Z ?_ )-S_P#Q='^HN9?\_(??+_Y$/]<LO_DG]T?_ )(^1:*^NO\
MA1'@;_H!_P#DW/\ _%T?\*(\#?\ 0#_\FY__ (NC_47,O^?D/OE_\B'^N67_
M ,D_NC_\D?(M%?77_"B/ W_0#_\ )N?_ .+H_P"%$>!O^@'_ .3<_P#\71_J
M+F7_ #\A]\O_ )$/]<LO_DG]T?\ Y(^1:*^NO^%$>!O^@'_Y-S__ !='_"B/
M W_0#_\ )N?_ .+H_P!1<R_Y^0^^7_R(?ZY9?_)/[H__ "1\BT5]=?\ "B/
MW_0#_P#)N?\ ^+H_X41X&_Z ?_DW/_\ %T?ZBYE_S\A]\O\ Y$/]<LO_ ))_
M='_Y(^1:*^NO^%$>!O\ H!_^3<__ ,71_P *(\#?] /_ ,FY_P#XNC_47,O^
M?D/OE_\ (A_KEE_\D_NC_P#)'R+17UU_PHCP-_T _P#R;G_^+H_X41X&_P"@
M'_Y-S_\ Q='^HN9?\_(??+_Y$/\ 7++_ .2?W1_^2/D6BOKK_A1'@;_H!_\
MDW/_ /%T?\*(\#?] /\ \FY__BZ/]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R
M1\BT5]=?\*(\#?\ 0#_\FY__ (NC_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O
M_D0_URR_^2?W1_\ DCY%HKZZ_P"%$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;
MG_\ BZ/]1<R_Y^0^^7_R(?ZY9?\ R3^Z/_R1\BT5]=?\*(\#?] /_P FY_\
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MB/ W_0#_ /)N?_XNC_A1'@;_ * ?_DW/_P#%T?ZBYE_S\A]\O_D0_P!<LO\
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M ";G_P#BZ/\ 47,O^?D/OE_\B'^N67_R3^Z/_P D?(M%?77_  HCP-_T _\
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M] /_ ,FY_P#XNC_47,O^?D/OE_\ (A_KEE_\D_NC_P#)'R+17UU_PHCP-_T
M_P#R;G_^+H_X41X&_P"@'_Y-S_\ Q='^HN9?\_(??+_Y$/\ 7++_ .2?W1_^
M2/D6BOKK_A1'@;_H!_\ DW/_ /%T?\*(\#?] /\ \FY__BZ/]1<R_P"?D/OE
M_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\ 0#_\FY__ (NO-?\ A6_AS_AI
M'_A%O[._XD/_  B?]I_9//D_X^/MGE[]^[=]SC&<=\9H_P!1<R_Y^0^^7_R(
M?ZY9?_)/[H__ "1X?17UU_PHCP-_T __ ";G_P#BZ/\ A1'@;_H!_P#DW/\
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M_(??+_Y$/]<LO_DG]T?_ )(^1:*^NO\ A1'@;_H!_P#DW/\ _%T?\*(\#?\
M0#_\FY__ (NC_47,O^?D/OE_\B'^N67_ ,D_NC_\D?(M%?77_"B/ W_0#_\
M)N?_ .+H_P"%$>!O^@'_ .3<_P#\71_J+F7_ #\A]\O_ )$/]<LO_DG]T?\
MY(^1:*^NO^%$>!O^@'_Y-S__ !='_"B/ W_0#_\ )N?_ .+H_P!1<R_Y^0^^
M7_R(?ZY9?_)/[H__ "1\BT5]=?\ "B/ W_0#_P#)N?\ ^+H_X41X&_Z ?_DW
M/_\ %T?ZBYE_S\A]\O\ Y$/]<LO_ ))_='_Y(^1:*^NO^%$>!O\ H!_^3<__
M ,71_P *(\#?] /_ ,FY_P#XNC_47,O^?D/OE_\ (A_KEE_\D_NC_P#)'R+1
M7UU_PHCP-_T _P#R;G_^+H_X41X&_P"@'_Y-S_\ Q='^HN9?\_(??+_Y$/\
M7++_ .2?W1_^2/D6BOKK_A1'@;_H!_\ DW/_ /%T?\*(\#?] /\ \FY__BZ/
M]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\ 0#_\FY__ (NC
M_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\ DCY%HKZZ_P"%
M$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^^7_R(?ZY9?\
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M^HN9?\_(??+_ .1#_7++_P"2?W1_^2/D6BOKK_A1'@;_ * ?_DW/_P#%T?\
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M_P#)N?\ ^+H_U%S+_GY#[Y?_ "(?ZY9?_)/[H_\ R1\BT5]=?\*(\#?] /\
M\FY__BZ/^%$>!O\ H!_^3<__ ,71_J+F7_/R'WR_^1#_ %RR_P#DG]T?_DCY
M%HKZZ_X41X&_Z ?_ )-S_P#Q='_"B/ W_0#_ /)N?_XNC_47,O\ GY#[Y?\
MR(?ZY9?_ "3^Z/\ \D?(M%?77_"B/ W_ $ __)N?_P"+H_X41X&_Z ?_ )-S
M_P#Q='^HN9?\_(??+_Y$/]<LO_DG]T?_ )(^1:*^NO\ A1'@;_H!_P#DW/\
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M /\ \FY__BZ/]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\
M0#_\FY__ (NC_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\
MDCY%HKZZ_P"%$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^
M^7_R(?ZY9?\ R3^Z/_R1\BT5]=?\*(\#?] /_P FY_\ XNC_ (41X&_Z ?\
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M /\ \FY__BZ/]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\
M0#_\FY__ (NC_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\
MDCY%HKZZ_P"%$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^
M^7_R(?ZY9?\ R3^Z/_R1\BT5]=?\*(\#?] /_P FY_\ XNC_ (41X&_Z ?\
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M_DW/_P#%T?\ "B/ W_0#_P#)N?\ ^+H_U%S+_GY#[Y?_ "(?ZY9?_)/[H_\
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M_"B/ W_0#_\ )N?_ .+H_P!1<R_Y^0^^7_R(?ZY9?_)/[H__ "1\BT5]=?\
M"B/ W_0#_P#)N?\ ^+H_X41X&_Z ?_DW/_\ %T?ZBYE_S\A]\O\ Y$/]<LO_
M ))_='_Y(^1:*^NO^%$>!O\ H!_^3<__ ,71_P *(\#?] /_ ,FY_P#XNC_4
M7,O^?D/OE_\ (A_KEE_\D_NC_P#)'R+17UU_PHCP-_T _P#R;G_^+H_X41X&
M_P"@'_Y-S_\ Q='^HN9?\_(??+_Y$/\ 7++_ .2?W1_^2/D6BOKK_A1'@;_H
M!_\ DW/_ /%T?\*(\#?] /\ \FY__BZ/]1<R_P"?D/OE_P#(A_KEE_\ )/[H
M_P#R1\BT5]=?\*(\#?\ 0#_\FY__ (NO-?VCOAOX<\!?!GQ#KNA:=]AU6T^S
M^3<>?))MW7,2-\KL5.59AR.]'^HN9?\ /R'WR_\ D0_URR_^2?W1_P#DCP^B
MOKK_ (41X&_Z ?\ Y-S_ /Q='_"B/ W_ $ __)N?_P"+H_U%S+_GY#[Y?_(A
M_KEE_P#)/[H__)'R+17UU_PHCP-_T __ ";G_P#BZ/\ A1'@;_H!_P#DW/\
M_%T?ZBYE_P _(??+_P"1#_7++_Y)_='_ .2/D6BOKK_A1'@;_H!_^3<__P 7
M1_PHCP-_T __ ";G_P#BZ/\ 47,O^?D/OE_\B'^N67_R3^Z/_P D?(M%?77_
M  HCP-_T _\ R;G_ /BZ/^%$>!O^@'_Y-S__ !='^HN9?\_(??+_ .1#_7++
M_P"2?W1_^2/D6BOKK_A1'@;_ * ?_DW/_P#%T?\ "B/ W_0#_P#)N?\ ^+H_
MU%S+_GY#[Y?_ "(?ZY9?_)/[H_\ R1\BT5]=?\*(\#?] /\ \FY__BZ/^%$>
M!O\ H!_^3<__ ,71_J+F7_/R'WR_^1#_ %RR_P#DG]T?_DCY%HKZZ_X41X&_
MZ ?_ )-S_P#Q='_"B/ W_0#_ /)N?_XNC_47,O\ GY#[Y?\ R(?ZY9?_ "3^
MZ/\ \D?(M%?77_"B/ W_ $ __)N?_P"+H_X41X&_Z ?_ )-S_P#Q='^HN9?\
M_(??+_Y$/]<LO_DG]T?_ )(^1:*^NO\ A1'@;_H!_P#DW/\ _%T?\*(\#?\
M0#_\FY__ (NC_47,O^?D/OE_\B'^N67_ ,D_NC_\D?(M%?77_"B/ W_0#_\
M)N?_ .+H_P"%$>!O^@'_ .3<_P#\71_J+F7_ #\A]\O_ )$/]<LO_DG]T?\
MY(^1:*^NO^%$>!O^@'_Y-S__ !='_"B/ W_0#_\ )N?_ .+H_P!1<R_Y^0^^
M7_R(?ZY9?_)/[H__ "1\BT5]=?\ "B/ W_0#_P#)N?\ ^+H_X41X&_Z ?_DW
M/_\ %T?ZBYE_S\A]\O\ Y$/]<LO_ ))_='_Y(^1:*^NO^%$>!O\ H!_^3<__
M ,71_P *(\#?] /_ ,FY_P#XNC_47,O^?D/OE_\ (A_KEE_\D_NC_P#)'R+1
M7UU_PHCP-_T _P#R;G_^+H_X41X&_P"@'_Y-S_\ Q='^HN9?\_(??+_Y$/\
M7++_ .2?W1_^2/D6BOKK_A1'@;_H!_\ DW/_ /%T?\*(\#?] /\ \FY__BZ/
M]1<R_P"?D/OE_P#(A_KEE_\ )/[H_P#R1\BT5]=?\*(\#?\ 0#_\FY__ (NC
M_A1'@;_H!_\ DW/_ /%T?ZBYE_S\A]\O_D0_URR_^2?W1_\ DCY%HKZZ_P"%
M$>!O^@'_ .3<_P#\71_PHCP-_P! /_R;G_\ BZ/]1<R_Y^0^^7_R(?ZY9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O'/^;PO^Y$_P#<A7L=>.?\WA?]R)_[D* /8Z*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** /'/V;O^:I?]CWJG_M*O8Z\<_9N_P":I?\ 8]ZI_P"TJ]CH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *\<_9!_Y-W\)_\ ;W_Z5S5['7CG[(/_ ";OX3_[
M>_\ TKFH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_VZ?^E<->QUXY
M^U]_R;OXL_[=/_2N&@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QSXG?\G$?!
M3_N-_P#I(E>QUXY\3O\ DXCX*?\ <;_])$KV.@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *\<_YO"_[D3_ -R%>QUXY_S>%_W(G_N0
MH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_
M )JE_P!CWJG_ +2KV.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]D'_DW?PG_P!O
M?_I7-7L=>.?L@_\ )N_A/_M[_P#2N:@#V.BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HILDBQ*6=E11U9C@4
MR"ZAN@3#-'*%.#Y;!L?E]#2NKV'9VN2T444Q!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[7W_ ";OXL_[=/\
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MD]R2  .22 ,DU\9ZQ_P6,^ 6F^(#IUO#XLU6T#A?[6L]*C6V(_O;99DEP/\
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MS5^SE_P46^#_ .TSXJ'AG0+K5="\1R!FMM,\0VR027849;RFCDD1B!D[=P;
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M @\B+/![C<01Z=C70_'[QQ+X9\-QZ;9R>7>ZEN4R(Y#QQJ1N(QZYV_B<>WS
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M]LY.>M=A7*WL)@NI4QCYN/I7G8Q:19WX5ZM$-%%%>6>B%%%% !1110 4444
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M "7W'X,?MO\ _)\7CW_L-6__ **AK]7OV_/^3,_B1_V#HO\ T?%7Y0_MO_\
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M/$FA^)OAAK%V]W#HL2:CI!E;+10,^R6(?[*N48#MO;MBO=?^"C7QV\-_"_\
M9Q\5^'[O4K<^)?$UD^F6&EJX,SK)\LDI7J$5"QW'C.T=2*^5?^",_P /M1E\
M8>//&[Q/'I,%C'H\4I'RRS/(LK@'N55$S_UT%&%E*I3K*H[QM^/_  ]OO:%B
MHJ$Z3@K2O^&GZ7^ZY\S_ +=EQ=VO[:WQ$GL)98+Z/5H7MY8&*R)((8BK*1R&
M!P01WK]%O /_  2I^#EK\-[:Q\56.I:[XMNK8/>:]_:4T4D5PZY8Q1JPCVJQ
M.-ZN3CDFOSO_ &W_ /D^+Q[_ -AJW_\ 14-?O';_ .HC_P!T?RI)N&7T''JO
MRC'_ #'92QM5/HW^;/P)_9[COO@[^V]X1TFSNVDN-*\9+HCSI\OFQFY-M)QZ
M,K-Q[U]Y?\%6/V:O#&K_  ]UCXT37VK+XITNWL=+ALXYHA9-$;K:2R&/>6Q,
MW(<#@<=<_#.B_P#*0RU_[*>/_3K7ZB_\%.[<W'[&/C7! \N>P<Y]KR&G6G)X
M?#5&];[^O)?\W]XZ,%[>O!+2W_R5OT/SS_X)Z_L=^#/VLI/'2^+M3UW3AH0L
MC;?V+<0Q;_.\_=O\R&3./*7&,=3U[?M7I>GQZ3IEI8PLS0VL*0(TA!8JJA03
M@=<"OS"_X(NW]M;7?Q<CFN(HI#%IDH1W .Q3<AFP>P++D]LCUK]1599%#*0R
ML,A@<@BKS!M5.1;6B_G;_AR,'%-.76]OR'4445Y9Z(4444 %%%% !1110!TF
MDY_L^'/O_,U<J&SC\FUB0]0HS]:FKZ*FK02/"F[R;"BBBK("BBB@#@/V@O$-
MUX2^ _Q%UNR++>Z?X=U"Z@9!DB1+=V4_@0*^1?\ @C+X9L],_9AUK68T!OM5
M\17 GDQSMBBB5%SZ#+'ZL:^X?&7A>T\;>$-<\.WXS8ZM8SV$X_Z9RQLC?HQK
M\OOV'?C_  _L(>.O&'P"^-AD\,VIU(WVE:Y,C&U+.%3)8 XBE5$=9.BD.&P<
MX*#2JU(O>44EYM2N_P /O"M[U*FU]F3;]'&R_'[C]6:*\#^('[>'P%^'?AFX
MUJZ^*'AS65C3*6.@:C%J-W,V.$6*%F()/&6VJ.Y YKYH_9'^'_BK]K+]IW4/
MVHO'FC3Z'X9LXOLG@K2;Q<,T85E2;'=55W;=C#22DJ<)3@G.?+T6[[?\%]%\
MQ2:C#FZO9=_^ NK,?]HJPG_;6_X*%:-\$-0NKA?AQX%M!JNLV<$K(+J7RT=R
M2#U/G0P@]5#2$$$U^@EK\,?"%GX)_P"$.@\,:3%X4\C[,=%6RC^R&/&"IBQM
M(^HK\[;[Q]8_L>_\%2/&7B#XA;M*\'_$#3%2QUQD)@B+"#YG(Z*LD+(W]W<K
M'"\U])?M"?\ !1;X/?!WX>W^J:'XST/QQXDDA9=,T?0+^.],LQ'R^:T181("
M026(. 0 3@5E&48X2#WNFY+^]=W7RT21I)2EB9+:UDO\-EK\]6SPK_@FE9)\
M-?VGOVDOACHEP[^$-)U/S;*W9RX@9+B6( ')YV;5)ZGRQGI7G7A'X/Z9^VQ_
MP4T^*FJ>(D:_\#>#YU@NK/<?+NVM]MO#;MZHTD,DA'<(1WS7MO\ P3M^$^N?
M KX&_$3XS?$:*6S\4>+?.U^[CO%*2Q6D2R2AI%.-K2,\LA']TIG!X%+_ (([
M^&[JZ^$OQ ^(6I)_Q,O%OB21VF/61(ER3]/,FF_*MZ<7&I%3=Y4J>O\ B;27
MW:KY&522E"<H:1J3T_PK5_)V3^=STS_@I'#X9\$_L,^-; :-I\%BL5K9:990
MVZ)%;RM/&J&)0 $*C<1@=!7E6H?%C6?V4?\ @D_X-U.TNI(?%.HZ1;V6F3L?
MGMY+QGE5E]#'"S,ON@J/_@KYK%QXGT3X0?"C3I"-0\6^)%?:O<)MA3(]-]R#
M_P !KM?^"HWP?O?$'[%/V#PY:23P^#[NSU VL";F%K#$\#$#T1)-Y] A-<<[
M_5ZLW]J<5\E\7_I3U_R.F$5[>E%=(R?S?PKY\NW^9V/_  3[_9=T+X%_!'0-
M<N=.BN/'WB2SCU/5]8N4WW69E$@@#MRJJ& ('5@S'DU\@_\ !33]GS0+G]J[
MX/6GARQ33;KXA7:6FL6MBHCCN)$N8D%PR+QO*SOEL?P9ZY-?7WP/_;\^"?B/
MX&:!K^L?$'0?#>H6>FQ1ZCH^H7JQ7D,T<8$BI ?WDHR#M**VX$8YXKY%^&'Q
M@_X;8_X*C^&?$5I:7$'A#PC833Z7#=QE':WCB8I<,I^Z9)IT<=]NP=J]&:3Q
M\.5:1;?_ &ZD_P#@6[[G#!N.#FV_>DK>?,VOZOT.M_X+ ?'9/#L7@/X/QWMW
MIV@:H4U3Q%_9JJ9VLDD"11(I*JW*2OM) +1ID@4OPL_X*C?LN_!?P;:^%_!_
MPV\9Z-I$,81HX=)L-]P< %YG^V9D<XY9B2:T?V^;VX^ /[;GP1^.^J6,]UX*
MMX1I%_<01E_LS!IPV<?Q&.X+J.K>4P'2OI_QM^W[\ _!/@F3Q*_Q+T'68O)\
MR'3=%O$N[^9B,J@MT.]&/3]X% _B(KDINU&4V]Y2OWTVO\K6[^9U5(KVL816
MBBK=M=[>CW[;'P]^PO\ %SPEXZ_X*/>*M4^%6D7_ (7\">)="FEGT6[@B@"S
M1K$S.(HG=%'F!B,'CS&Z9Q6W^VWX+E_:P_X*,_#OX1QW4UOH^CZ2DNJ36S8>
M"-R]Q<8/\+-$(5!]77K7U[^Q5\:OBE^T)X+U;QQX\\-:3X4\-ZA<Y\,65K!,
MEW-:98^=.TDK!@04"E53=M9@-I6OG+]AG/Q>_;\_:.^*#KYMMITIT2SEZJ5,
MWEH0?^N=FO\ WW[UK&%JU&E):4XREKKM>R?SFE;Y&4I/V=:HGK-QC^2;7_@+
M=_GZ_7_C+P;X"^!_[./B[3K#PSI>F>#=)T&[EGTN*V40RQI Q8.,?.S8Y9LE
MB<DDU\U?\$<M NM _9-U'5+R5A:ZIX@N[NW5C\JQI'%$Q'_ XG_*NY_X*F_$
M+_A _P!C;Q7!'-Y5WK\]MHT//+"20/(/QBCDJ'283^R__P $R0<"SU#3/!+S
M$=-M]=1EOS\Z>L?:RA#$U]W:,?GK+_(U]FI2P]#:[;^6D?SO]QY)_P $M5;X
MF_&#]H;XPS@R+K6N?8[*5AR(VEDF90?0*;<?@*G_ &&XQ\6OV]/VD_B@Z&6W
MT^X_L&RFZJ5\WRP1[[+-/^^_>NK_ ."=.EI\$?\ @GG/XOFMV6>Z@U3Q-,H7
MYG6,.J?7,=NA'UKD_P#@CSXM\&:?\&M5TZX\6Z,WC_Q%X@NKV719+^(:@Z)$
M@#"$MYC+A9'W $<GG@UU1@J=?V<?^75-+[[)_E(PE/VE)U'_ ,O*E_E&[7_M
MOJ>T_M^:+\$_$7@WPY;?&_XAZGX1\.VM]]MBTC2[E5;59%P,/"L,LLBJ"1^[
MV[?,))!P1YW#_P %./V6_!OAF'POX9L-1O\ 1DA%M#HNB^'"D3J?E\L1R>6I
MR.QZY]:\9^,5YX&MO^"KEX_Q]6V/@I=&@'A_^WD#::&,*;#(&^3RO,^U<O\
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M"RW-Q)"3$7):QGPN0P #]B<<\_2G_"F_^"AG_1=OA_\ ^ ,/_P JJ^F_V.?
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MUO?\3Y@_X)+^-M*USXZ?'BT\%V][I?P\O98M5TS2;Q55K0--($7:K,JG8VW
M)X1>3BH8_A3;?M@?\%1/B-_;;27G@3P7:V]IJ%FK$17OE",):28/*&X$DC*>
M#Y1'>OMG]F#X@_$SQE\$8/&/QAT?2/#&M7@DO8M,TNVFM_LUF%!0S+++(1(0
M&8C(P"H(!!KYV_X)-Z?)XF\(_%KXI7416[\:>+KB8.WWFB3,@_ /<2#\*Z8Q
MY:T8O7V4'YZW48W\TFUUV.:4N:G.2?\ $DO+3=V]>7IW/I_]HKQ5;?!_]FWQ
M]K6GQ0Z=%HWA^Z-E# @CCC<1%8551@ ;BH %?)/_  27_95T/PG\'[+XK:[I
M<%]XK\0222Z9/=1AVT^S4F,&+.=KR%68L,$J5'KGM?\ @KGXX_X1?]D.]TB-
MV%SXDU:STU%4\LJL;AOPQ!C\:M_L<_M6?##PA^S[X:\%>-?%VD> ?&/@VS71
M=8T/Q)>1V%Q%-!E"460CS P 8%-WWL=:RHR]ZM4ZZ1^2U;_\F2?KKN:5H^[2
MIVTU?Y)+\&_DCQO_ (*N>$]+\"_$CX(?$KP[9PZ?XW;7U@>YM0L<EV(VB>,R
M$<L5/R@GL^#QBNJ_X+%>);JY^$/P^\ :>?\ B9^*_$<86!3S(L2%=OT\R:+\
MJXJ36Y/^"D'[<'A74O#EO-/\%_A?*MR^K31M''?7.]9,*& /[QXXE"D9$<;,
M<;@*W_VI$_X7)_P5"^!/@0#SK#PO:KK5RHY"2!I+D@_46\ _X$*5.FI1HTIK
M251RMVBK._SY&^^I4Y\DJM2+NXPMZR=U;Y<R7RMZ?37[1?@GX=:5^RTW@OQ_
MXVO/A]X%M[&UTVXU#3;J.WGEBB50($+QR;]X3!15+, 1T)KY\^&G[?W[(7[.
M?@2Q\)^!;O4)=-M(Q&\EEH4JSWCA0#-,\B1^9(V.6/Y  8X__@J%/I</[3GP
M!/Q(6Z;X/K([:@$5S 9/.7SMX7D_)Y60/FV;MM?1_B+]KW]F']GWP!)J'A[Q
M+X+>W@B)M-#\%M;37$SX)6-8K?[A)XW/M49Y(HC4<X3KR?Q2:??3OZ]$3[-0
ME"C%7Y4K=M>WI;5GR5^QKXY\._&G_@IYXP\9^ O#UUX5\,R^'YIYK&YMDMI'
M8K;H\DD4;%5+RG?U.?O'DFO7?^"G7P-\?^+/$OPP^)_@[PNGQ!L/!<[R7_A5
MX3<><IECD#>0.94;R]CJN2!M."-Q'#?\$C]2O?BK\7/C[\4]8B$>J:M>0*5Y
M/E>=+/,\8/H-L:C_ '176?!W]N?7_AK^UG\5?AG^T'XK32-*%^Q\+W>HV4%I
M:VT ED:-6FCC7*R0O$1)*2/W9!8$\WRN/U>"]V<8\RZZZNWGI+;[N@N9-UYO
MWHM\OJK)7\M5J_O-'P3^W!\ _P!M+PC=_"CXDZ2W@36M2C.G_P!DZVD?E1W!
M!4&UN2NU)4;&WS%C;=@ -7I?Q$\$Z+^Q!^P7X\T3PUJ^K7VG:5I-ZFGW&M3Q
MR3QS73%$4-'&BX$LV0-O?O7S7_P5*\<?L^?%#X96LGA?5O#?B_XN7-];PZ7=
M>%9XKRZ:/> Z3R0$[DVDA5<D[BNT=:V?^"BWB+Q+X/\ ^"?_ ,+/!'B"22X\
M9:\^E6&I(S;I))(+<22Y_O'S5C!/<FL:B=6A4Y59RE&#\^;JO2_WZ&U/]W6I
MW=TDY>ENGS/8/^";G@FU^'?[!^C7>I:A_P (XNM1WVLWFJ>8D1MDD9E2?>X*
MKMBCC8%@0,<@BO)/@O\ M'?L7_L>'7+?POXNU3Q?XAN[J26]\17FFRWM_<,2
M,QK<B"-&3(+?+P22223FNB_X*.>#];^&W_!.SP]X4\.K.NG:.VDZ=JWD9_X]
M(XBN7Q_"9EAS[D9KM/V=/C1^R1\+/@CX?U'P]XE\"^'!%IL3WB7$ENFL/*J#
MS/.C_P!?))NW=FS_  Y&*ZJDE*M6J1=E%J/RM=?*UCEIQY:-*+5W*\O)._YZ
M_<?'_P"T;^T?X _:V_:N_9_N/AGX?U+3]6M?$-O'=ZY?6"6KWJ&ZMS'M97+.
ML>R4Y;&-QQU-?L;7Y*?#/XTV7[97_!53PGXFTN&:/PGX=LIUTD7,91Y88()B
M)BO\.Z:4L >0 H.#7ZUU,5RX>"M:[D_DW;Y;;%RES5Y6=TE%?/5OUM?<R_%7
MB"V\)^&-7UN\8)::;9S7DS$XPD:%V/Y*:^#/^"/>ASZA\-OB;\2]33;J/BOQ
M)(9)F_C2)?,8Y]/,N)?RKW;_ (*+>//^%>_L;_$B\5]D]_8KI,6#@DW,BPMC
MZ([G\*\V^"K?\,U_\$L8=9'^CW\7A*ZUA6?@_:+L/)"#[YFC7\*Y^=TXUZ^_
M+%)>K?,_PBOP-G#VCHTMN:3;]$K+\9/^D?./[$?P,T3]L#]JKXO?&#QE9)K?
MA33]=E>PTVZ4/;7=P\CF+S%/#K%"%^4C!+KG@$'W7_@L/=:'HO[)^FZ=)I]J
M;VZUVUM],VQ*#;;4D=S'Q\HV(5..S5U7_!)GP#_PA?['>B7\D7E7/B+4+O57
MR.2N_P E#]"D*G\:\L_X*)?\7@_; _9R^$$9\VW-Z-6U"#L8GF4$GZ16T_\
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M[GC'_!/O'QD_;4_:+^+\@\VVANCH^GS=5,3S$+@^HBM(OP>O:_\ @J-\0?\
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MOR/^--_X22Z_YYP_D?\ &M?^Q+(_\L?_ !]O\:3^P[+_ )X_^/M_C4^QQ/\
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M[BT_[X;_ .*KK?\ A!M$_P"?+_R*_P#\51_P@NA_\^7_ )%?_P"*J?J>9_\
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M_KF5_P#/E_<O\SB/^%N:QQ_HUC_W[?\ ^+I/^%N:Q_S[6/\ W[?_ .+KM_\
MA7/AW_H'_P#D>3_XJC_A7/AW_H'_ /D>3_XJE]1S?_G^OO?_ ,B'US*_^?+^
MY?YG#_\ "W=8_P"?:Q_[]O\ _%TG_"WM8_Y]K'_OV_\ \77<_P#"M_#O_0._
M\CR?_%4G_"M_#G_0._\ (\G_ ,54_4<X_P"?Z^]__(E?7,J_Y\O[E_F<-_PM
M_6?^?:Q_[]O_ /%TG_"X-9_Y]K'_ +]O_P#%UW7_  K;PY_T#O\ R/)_\52?
M\*U\.?\ 0._\CR?_ !5'U'./^?Z^]_\ R(?7<J_Y\O[E_F<*?C%K/_/M8_\
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M_BZ[_P#X5?X9_P"@9_Y'E_\ BJ/^%7^&/^@9_P"3$O\ \52_L_._^@A?>_\
MY$?U[)_^?#^Y?_)'G_\ PNK7.?\ 1=/_ ._;_P#Q=)_PNO7/^?73_P#OW)_\
M77H/_"KO#'_0,_\ )B7_ .*I/^%6^&/^@9_Y,2__ !5+^S\[_P"@A?>__D0^
MO9/_ ,^']R_^2//O^%V:YQ_HNG_]^Y/_ (NC_A=FN?\ /KI__?N3_P"+KT'_
M (59X7_Z!G_DQ+_\51_PJSPO_P! S_R8E_\ BJ7]GYY_T$+[W_\ (C^O9/\
M\^']R_\ DCSW_A=VN\_Z)I__ '[D_P#BZ;_PN[7?^?33_P#OW)_\77H?_"J_
M"_\ T"__ "8E_P#BJ/\ A5?A;_H%_P#DQ+_\52_L[//^@A?>_P#Y$?U_)O\
MGP_N7_R1YW_PO#7?^?33O^_<G_Q=-_X7EKW_ #Z:=_W[D_\ BZ]%_P"%4^%O
M^@7_ .3$O_Q5)_PJCPK_ - O_P F)?\ XNI_L[/?^@E?>_\ Y$?U_)O^?#^Y
M?_)'G7_"\]>Y_P!$T[_OW)_\71_PO37O^?33O^_4G_Q=>B_\*G\*_P#0*_\
M)B7_ .+H_P"%3^%/^@5_Y,2__%TO[-SW_H)7WO\ ^1'_ &ADO_0._N7_ ,D>
M<GXZ:]_SZ:;_ -^I/_BZ3_A>VO\ _/IIO_?J3_XNO1O^%3>%/^@5_P"3$O\
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MI_PC_P! G_R9F_\ BZYO[,X@_P"@E?>__D3H_M'(_P#H'?W+_P"2/,O^%_\
MB'_GSTS_ +]2?_'*3_AH#Q#_ ,^>F?\ ?J3_ ..5Z;_PI[PA_P! C_R9F_\
MBZ/^%.^$/^@1_P"3,W_Q=+^R^(?^@I?>_P#Y$?\ :.1?] [^Y?\ R1YC_P -
M!>(O^?+3/^_4G_QRD_X:"\1?\^6E_P#?J3_XY7IW_"G/!_\ T"/_ "9F_P#B
MZ/\ A3?@_P#Z!'_DS-_\74_V7Q#_ -!2^]__ "(_[1R+_H&?W+_Y(\O_ .&A
M/$7/^A:7_P!^I/\ XY0?VA/$7_/EI?\ WZD_^.5Z?_PIKP?_ - ?_P F9O\
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M .DB5['7CGQ._P"3B/@I_P!QO_TD2O8Z "BBB@ HHHH **** "BBB@ HHHH
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M(-HA$GE'B63DH3\V>H&/1Z4$HTE%[\TG?UM;[DD.3;J.4=N5+[KM_BS!\$>
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MOX3_ .WO_P!*YJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-Q_?C_,_X4?V#<?WX_S/^%;U%'U6F'UFH8/]@W']^/\ ,_X4?V#<?WX_S/\
MA6]11]5IA]9J&#_8-Q_?C_,_X4?V#<?WX_S/^%;U%'U6F'UFH8/]@W']^/\
M,_X4?V#<?WX_S/\ A6]11]5IA]9J&#_8-Q_?C_,_X4?V#<?WX_S/^%;U%'U6
MF'UFH8/]@W']^/\ ,_X4?V#<?WX_S/\ A6]11]5IA]9J&#_8-Q_?C_,_X4?V
M#<?WX_S/^%;U%'U6F'UFH8/]@W']^/\ ,_X4?V#<?WX_S/\ A6]11]5IA]9J
M&#_8-Q_?C_,_X4?V#<?WX_S/^%;U%'U6F'UFH8/]@W']^/\ ,_X4?V#<?WX_
MS/\ A6]11]5IA]9J&#_8-Q_?C_,_X4?V#<?WX_S/^%;U%'U6F'UFH8/]@W']
M^/\ ,_X4?V#<?WX_S/\ A6]11]5IA]9J&#_8-Q_?C_,_X4?V#<?WX_S/^%;U
M%'U6F'UFH8/]@W']^/\ ,_X4?V#<?WX_S/\ A6]11]5IA]9J&#_8-Q_?C_,_
MX4?V#<?WX_S/^%;U%'U6F'UFH82Z#-_%(@^F35J#0X8\&1FD/IT%:=%7'#TX
M]"95ZDNHU56-0J@*HZ 4ZBBNDYPHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "O'/^;PO^Y$_P#<A7L=>.?\WA?]R)_[D* /
M8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /'/V;O^:I?]CWJG_M*O8Z\<_9N_P":
MI?\ 8]ZI_P"TJ]CH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_9!_Y-W\)_\ ;W_Z
M5S5['7CG[(/_ ";OX3_[>_\ TKFH ]CHHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]K
M[_DW?Q9_VZ?^E<->QUXY^U]_R;OXL_[=/_2N&@#V.BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@#QSXG?\G$?!3_N-_P#I(E>QUXY\3O\ DXCX*?\ <;_])$KV.@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/^;P
MO^Y$_P#<A7L=>.?\WA?]R)_[D* /8Z*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'
M/V;O^:I?]CWJG_M*O8Z\<_9N_P":I?\ 8]ZI_P"TJ]CH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *\<_9!_Y-W\)_\ ;W_Z5S5['7CG[(/_ ";OX3_[>_\ TKFH ]CH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_VZ?^E<->QUXY^U]_R;OXL_[=
M/_2N&@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QSXG?\G$?!3_N-_P#I(E>Q
MUXY\3O\ DXCX*?\ <;_])$KV.@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHJ*ZN4M83(YX[#U/I2;25V-)MV1(S!023@>IJC-K-M%P"9#_ +(K(O-0EO&.
M3MC[(.E5:\RIBW>T#T(85;S-EO$ [0$_5O\ ZU)_PD'_ $[_ /C_ /\ 6K'H
MKG^LU>YO]7I]C8_X2#_IW_\ '_\ ZU'_  D'_3O_ ./_ /UJQZ*/K-7O^0?5
MZ?8V/^$@_P"G?_Q__P"M1_PD'_3O_P"/_P#UJQZ*/K-7O^0?5Z?8V/\ A(/^
MG?\ \?\ _K4?\)!_T[_^/_\ UJQZ*/K-7O\ D'U>GV-C_A(/^G?_ ,?_ /K4
M?\)!_P!._P#X_P#_ %JQZ*/K-7O^0?5Z?8V/^$@_Z=__ !__ .M1_P )!_T[
M_P#C_P#]:L>BCZS5[_D'U>GV-C_A(/\ IW_\?_\ K4?\)!_T[_\ C_\ ]:L>
MBCZS5[_D'U>GV-C_ (2#_IW_ /'_ /ZU'_"0?].__C__ -:L>BCZS5[_ )!]
M7I]C8_X2#_IW_P#'_P#ZU'_"0?\ 3O\ ^/\ _P!:L>BCZS5[_D'U>GV-C_A(
M/^G?_P ?_P#K4?\ "0?]._\ X_\ _6K'HH^LU>_Y!]7I]C8_X2#_ *=__'__
M *U'_"0?].__ (__ /6K'HH^LU>_Y!]7I]C8_P"$@_Z=_P#Q_P#^M1_PD'_3
MO_X__P#6K'HH^LU>_P"0?5Z?8V/^$@_Z=_\ Q_\ ^M1_PD'_ $[_ /C_ /\
M6K'HH^LU>_Y!]7I]C8_X2#_IW_\ '_\ ZU'_  D'_3O_ ./_ /UJQZ*/K-7O
M^0?5Z?8V/^$@_P"G?_Q__P"M1_PD'_3O_P"/_P#UJQZ*/K-7O^0?5Z?8V/\
MA(/^G?\ \?\ _K4?\)!_T[_^/_\ UJQZ*/K-7O\ D'U>GV-C_A(/^G?_ ,?_
M /K4?\)!_P!._P#X_P#_ %JQZ*/K-7O^0?5Z?8V/^$@_Z=__ !__ .M1_P )
M!_T[_P#C_P#]:L>BCZS5[_D'U>GV-C_A(/\ IW_\?_\ K4?\)!_T[_\ C_\
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M#_X=^)_$]RVV#1M,N=0<GTBB9_\ V6JKUOCK2\W^I-&D[1I1\E^A^=_['_\
MQ>;_ (*??'+X@L/.LO#Z7&GVTAY 82):1D?6."7\Z_32OQ/_ ."?W[0WQ(^
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MG_M-?"+4[CX&WEK;>(DMM]IJ5KK=W+);W&T^6MW;SN[1HS#YAY:MC)7M7O\
MX=E^('[,_P"P[KTGQ/UZP\0^+?"VAWQ35+&XEG6=55_LH:26-&9QE$)*\X!R
M3FE5E[*G.36L5?U] IQ=2<(QVD[>GJ7O@+\%OA'%\<OB%\8O GCK_A.?$OB
MM::HUOJ]G?6MAN9'\I! @:/_ %:##LQPH^M>U^,OB-X3^'-E'>>+/$^C>%[2
M1MJ7&LZA%:1L?0-(R@FOC_\ X)-^!+SPC^QJ=:LH8I-9\2ZC?:E"+QV2-V3_
M $>(.P!8(3#DD G#$@&N>\(_\$]= \0^(O$/CO\ :O\ %FG^-_&6I7#.EK:Z
MW/::;9VV045&/DR<$D!>$48&">:UJ0=.2HK:,5\O)?-OT(C)34JO64G_ )7?
MR2]3[A\&_$7PI\1K&2]\)^)]&\46<;;'N-&U"*[C5O0M&S &NBK\@_C5X+^&
M/[+O[6_P1OOV<O%,5OJ&L:NFG:WHFDZW_:,4<+7$";),R.X$JR2 H[$?("N"
M,U^OE)6E352/5M?=;_,;O&?(^R?WW_R"BBBI&%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5XY_S>%_W(G_ +D*]CKQS_F\+_N1/_<A0!['1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!XY^S=_S5+_L>]4_]I5['7CG[-W_ #5+_L>]4_\ :5>QT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %>.?L@_P#)N_A/_M[_ /2N:O8Z\<_9!_Y-W\)_
M]O?_ *5S4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5XY^U]_R;OXL_P"W3_TKAKV.
MO'/VOO\ DW?Q9_VZ?^E<- 'L=%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CGQ._Y
M.(^"G_<;_P#21*]CKQSXG?\ )Q'P4_[C?_I(E>QT %%%% !1110 4444 %%%
M% !1110 4444 %<UJ5X;NX;!S&IPH_K6UJDWDV,A!P2-H_&N:KS<94V@CT,+
M#>;"BBBO,/0"BBB@ HHHH **** "BBB@ HILDBPQL[LJ(HW,S'  '4DU\_>+
M/V_OV??!6K/INI?$S39+I#AO[-M[B_C!]/,MXW3/XTTG)V6XFU%79]!T5Q?P
MQ^-'@;XSZ3)J/@CQ1IOB2UCQYOV*8&2'/021G#H3Z,!6MXQ\?>&/AWIL6H>*
M_$>D^&+"6401W6L7T5I$\A!(0/(P!;"DXSG -$HN+M)681DI*\7<WJQ_&'B[
M2? /A75O$FO7?V#1=*MI+R\NO+>3RHD4LS;4!9L '@ GVKB_$W[3'PJ\(^ S
MXUU#Q_H+^%OM!M%U.PO%O8Y)P,F*,0;R[@<E5!('.,5@2?%+X1_M3?!'QG#I
MOCFTG\'W.GS6>L:C#.+.73X9(V#/(+A!Y/R[B&D3'!/.*)1GRR:6W]:@I0ND
MWO\ UH3_  =_; ^$?Q]\37'A[P'XM_MW6+>U:]DM_P"S;NWVPJR(6W31(I^9
MU& <\].M>R5\<?L>?LV_L^_!_P")FH:S\*OBG_PFWB&;2I+6;3_^$AT^_P!E
MN98F:3R[>-7&&2,;B<?-CJ17TQXS^,'@/X<WL%GXL\;>'/"]W<1^;#;ZUJUO
M:22)DC<JR.I(R",CTK>M&$7%4[ZKKWN]OE^IE3E.2;G;3M\CKZ*\Z^(7[17P
MT^%?A>P\1>*/&ND:;H^HQ">QN%G$YO8R 0\"1[FE7!!R@(P0:Q_A+^UM\(?C
MEJ1T[P5XYT_5M3Y*V$J2VES( ,DI%.B.X ZE0<5DH2E>RV-'*,;7>YZ[117D
M_P 6OVK?A+\#;P67C;QSINCZCP38()+JZ0$9!:&%7=01T)4 U&[LBNESUBBO
M*OA-^U-\*/CE=&T\$^.--UF_VEA8$O;W14=6$,RI(0.Y"X%>JU4HRCI)6)C*
M,M8NX45QWQ*^,'@GX.Z.NI^-?$^F^&[-\^4U].%>8@9(C3[TA [*":\J\,?\
M%!/V>_%VKIIMA\3-/BN7.%;4;6YL8B?^NL\2)_X]1&,I_"KA*48_$['T-13(
M9DN(DEB=9(W 970Y# ]"#W%<U\0_BAX2^$V@G6?&/B+3O#>F[MBSZA.L?F-@
MG8@/+M@$[5!/'2IVW*6NQU%%?/GA7_@H!^S[XRUA=,T[XF:;'=,=JG4;>YL8
MB<XP)9XD3_QZOH&.1)HUDC971@&5E.00>A!JY0E'62L1&<9:)W'45Q/BOXX_
M#CP'K#:3XF^('A?P[JJHLAL=6UJVM9PK?=8I(X;![''-<I\4/VOO@]\&?$5K
MH/C#QU8:5J]RBR+:I%-<LBM@JTAB1Q&""""Y&1STJ5%RM9;E-I7OT/6KZ_MM
M+LI[R]N(K2TMXVEFN)W"1QHHRS,QX  &237SSJ7_  40_9WTO69-+F^)ED]R
MC[#);6-W/!GVFCA,9'N&Q7C/_!3/]H'PAK'[+]YH?A3QWH.IZGJUY8^=I^FZ
MM#+<O9L/.#^6C[MC 1G.,$,/6OB;]C#]GCX*?&;0_$E]\6?B?%X&N;.YB@T^
MR_MFRT]YU*DM)_I"L7&<#Y0,8/)SQTX>C[13E.Z4=/-[?YG/7K>SY(PU<ONZ
M_P"1^W/AGQ-I7C+0;'6]#OX-4TB^B$]M>6S[XYD/1E/<5IUS/P]\&Z7\+?AW
MH'AC3IF_LC0M.ALH9[AEW&*) H=R !D@9)X')KR+Q9^W]^S[X*U9M.U+XF:;
M+<J<-_9MO<7\8/3'F6\;IG\:QE%.;C3U73O8UC)\BE/1]>Q]!T5Q/PP^-?@3
MXT:;)?>"/%6F>)((@IF6RG!EAW9V^9&</'G!QN Z5U&M:YIWAK2;O5-7U"UT
MK3+2,RW%[>S+##"@ZL[L0J@>I-1*+@[25BXR4M8NY>HKC?#/QG^'_C:'49?#
MOCKPUKT6G1>?>OI>KV]RMK'S\\I1SL7@\M@<&O*YO^"@G[/4/B(Z(WQ.TTWO
MF>5YJV]RUKGU^TB+R<?[6_'O34)2?*EJ)RBES-Z'T-5/6-9L/#NEW6IZK>V^
MFZ=:1M-<7=W*L44* 9+,S$!0/4TW3=<T[6M'@U;3[^UOM+N(A/#?6TRR0R1D
M9#JX."N.<@XK\=_^"IWQ\/Q%^+6EZ!X6\=VWB/P'!I,%Q]ET748[FQ^V&24.
MSF)BK2!0GWB2H/&-QR1A*4U36_Y?U8)2C&#F]OS/V%\.^(-.\6:#IVM:1=)?
M:5J-O'=6EU'G;+$ZAD<9YP00?QK1KP+]C[XL>"/$7P/^&?AG2?&7A_4_$EGX
M7L%N='L]4@FO(3';QK('A5RZ[3P<C@\&O?:UQ%/V-64%LF_S,Z-3VE.,NK2"
MBBBL#8**** "BBB@ KH]+O?M<&&/[Q.#[^]<Y5[1YO+O5'9QM-=.'J.$TNC.
M>O!2@WV.BHHHKW#QPHHHH **** .2^+O@UOB)\*?&7A6-E236M'O-.1FQA6E
MA= ?P+"O@_\ X(\_%;3M*\$>+?@UK;KI/C71=9N+Q=-NODEEC9424 'JT<D;
M!@.0&7WK]':^4?VEO^"<_P /OVA/%H\:V6HZGX \>@JYUW0F \Z10-DDL9QE
MUP/G1D8X&2<#$P;IU)2M=25G\G=-?/<<DJD(Q;LXNZ^:L[_+8^I=2U*TT?3[
MF_O[J&RL;:-II[FXD$<<2*,LS,>   22:^(/@K^TU\1/VJOVS-;C^'^OM9?
M+PC$(;Z1;"W==6N-K!=LKQF1=[DL-C#]W"#P7K*A_P""6?B#Q<T=C\4OVDO'
MOQ"\,HRO_8[R2PHS*01DS7%PN..R ^A%?:'PM^%/A3X+^#++PKX+T6WT+0[0
M?);VX)+L>KNQRSN<#+,23ZUI%*,N>3O;9>?=^G1=]63)MQY(K?=^79>O?[CX
M,^">IV7AO_@K]\7[;Q#(MKJ>K:3Y6D-<G;YW[NTD"1YZDQ1L1CLC5][?%#XF
M>'O@]X#UCQ?XIU"/3=$TN!IYII" 6Q]U$'\3L<*JCDD@5XU^U7^PSX)_:FN]
M-UR\OM0\)^-]*0)8>)-'8"90K%D613]]58EA@JP/1@"0?%M)_P""5,GBK6+&
M?XQ_'3QI\6=)L)!);:5>2RP1@]U9I+B=@I'!\LHV.C"LH\SHPH[.*M?RNW?U
MU+ERJK*KNI.]O.R37IH8/_!+?3=4\27OQL_:$\20/86OB[4Y7M1)G'E1R2S3
MLI/5%+K&#ZQ,.U2?\$C]/?QK=?&[XN7<;?:O%'B-HHW<<A07N' /UN4'_ !7
MVKXL^$UE??!/6?AQX4DM_!EA=:--HUC+9VH>.P22)HPRQ!EW;0Q.-P)/>N8_
M9+_9RMOV5_@MIO@&WUC_ (2"2WN;BZGU3[)]E^T22R%L^7O?;A=B_>.=N>.@
MVCRQG+ETC&"C'[U?\%^/J9SYI13EK*4W*7W.WXO\$SYJ_P""Q7B^YM_@/X3\
M#Z?^\U'Q9XAAA6W7[TL<*EL#_MJ\%9G_  5$^'DO@G]@/PAX=TJ-O[/\,ZAI
M5K/LX ACMY( 3[&1H_Q(KW_]H3]C\?M!?&_X6>.M0\6?V?I/@6Y6[701IOF_
M;9!,DI)F\Y=@/E1C&QONGUXZ?]I[XE?"#PKX1M_"/QBU&&TT/QF7TN&UN+2X
MF6Y;Y<C="C>45+(0[%<'!!&,CF<6Z#@OBE-.W^&RC]^OGKL="FHUHR?PQ@U?
M_%=R^Y6_S[=?\#]>T;Q-\&_!&J>'I8I=$N-&M&M&AQM6,0J N.Q7&TCL017Y
M^_$_XC:3^U)_P5,^%7A70KB+5?#WP_:6:>ZA(>-KN)6N)2IZ$*\4$>1_$K?6
MNTTW_@E+-X3FO=*TG]H7QSH?PMG9Y+KPM:2M#YD9'SAY5F$)R.I,'3K7G'_!
M,/X<^'=8_:V^,GC?P9IHL_ 6@Q-H6B,K,Z2*\JA9 [$EF:.WWL<Y_?9[UV1D
MJN+57:W-/T=M+OU=EW?;KQN+I85TEK?EC?R;Z>=E\O,M?M[^#_#'B7_@HM\%
M;+XFVIN/AYK.DII\HFN9+>)Y#+<J%\R-E9<220$D,.&&>*^C=6_X)G?LJ:#I
M=WJ6I?#Z#3]/M(FGN+JY\1ZE'%#&HRSLQNL   DDUZI^TU^RQX'_ &K?!,/A
M[QC;W$<EI(9[#5;!E2ZLI",,49@058 !E8$' /4*1\N0_P#!*76/$"V^C>._
MVC/'/B_P-;LIB\.,9(T55^XH,MQ-&,<=(A[8KFIIJG[.UG=N_DW?7KI^/D=5
M27--5+Z62MZ:>FOX>9U'[!_@_P#9J\5>+O$OC3X)?#77?#TV@2OI \1ZI=W#
MVM[OY<6ZR7<NX;51B616 D7H217 ?LW[?C-_P50^-7C9O](T_P (6;:1:LPR
M(YE\NU^7ZB*Y/_ C7WI\.?AKX;^$?@G3?"?A#2H-$T+3HO+M[6$$@=RS$G+L
M3DEF)))))KQO]D/]D%?V6YO'M]=^*_\ A,=:\7ZF-1NK_P#LW[%L +L$V^;)
MN^:61LY'WNE;)I5E+I&+2OU;LOEO)_@8-7I2C:SE)/Y+7Y[11#_P45^('_"N
MOV.?B/>(^RXU"R72(><$FY=86Q]$=S^%<;^S):I^S5_P37T[6YE\JZM/"]WX
MDDW##&69)+B,'WP\:_@*]"_;0_96N?VN_AQI7@]/&!\'V=KJB:E<2KIWVPW&
MR-T6/'G1[1F0G.3R!Q72?'WX!M\9/V>=5^%>D:__ ,(E;7MI;V"Z@ME]J\J"
M)XR4$?F1YW+'M^\, ]^E<LHR=&M%?%*R7HD_U?X>ATQE'VM&_P ,;M^MU^B_
M$^9O^"3^A0_#;]C+6?&^HML75M1O]8FF?C]Q @BY/IF&0_B:B_X(_P"@W&H?
M"GXA_$74$!U/Q?XGFE>;'+I&N[/_ '\FFKZG^&7[/VC_  __ &<],^$%S<-J
MNCP:+)HUY=1Q_9VNEE1EFD"AFV%B[G&XXSU->'?LM?\ !/S5?V7OB,NJZ=\9
MO$FM>"83</;^#)8Y(+3S)%VB27;.8Y'4<Y\I<D \8KN<HO$5']GE44_1K\U%
M'':7L(?S<SDUZWZ^3DSQ#]H*QUC]LW_@H%>_ /7_ !=J/A?X;^'-,6\ETW3)
MA&^I2>3%*QPP*L^9EQN5@JQ,0,DFO0/BM^P7^RE^S;\)=<\:^)/"<E]'H]JT
ML3ZIKEV'N[@+^ZB")*B,SN -NW')XQ7I7[5?[ /A[]H_QCIOCK1_%6J?#CXB
M6$:Q1^(-(7?YBK]PN@=&WJ"0'5U.#@Y 7'G5A_P2LLO$\-S/\6OC!XO^+6JI
M:3V^FR:Q/,MM8R2(567RVGD=BIVL%$JJ=O(-</*_8.$=):W?5[ZKSZ).R1V.
M4764GK'33MHKI^5[NZU=S"_X(U^&8?#/[-OC'Q==(MNNJZY*QDZ 06\* ?@&
M:6JW_!).RE\<:Q\=/BY=(QE\3^(C#$S#D -)<2 ?^!$?_?-?0WP1_9'O_@K^
MRKKGP;M?&ZWUS?PZA#;^(ETGR3;?:E(W&#SVWE"Q/^L&>!QBNH_9'_9NMOV5
M/@Q8^ X-9_X2&6&ZN+R?5/L?V7SWD?(/E[WQA0B_>.=N>.E=SDG6E/\ N12]
M=.;\$<B4O9*#ZS;?IJX_BSV>O@S_ (*D?'K5+#PSH7P)\#;[OQS\0)8[:>&W
M;]Y'9-($">WG/\F3QL63-?>=?+'P]_8=;0_VL-=^._C+QN?&VN70D72M/.E?
M9(M+##8@5C-)OV0YC'"_>9CR:Y>55)QC/X-WYVZ?/;M:]SH4G3C*4/BZ?/K\
MM^]['@O@/_@E3\4/A]X>BTSPY^U5XG\)6;'SY=-T*QNK>V69@-Y COT#'@#=
MM!.!7S]^VU^S3X__ &4[WX8_$?Q3\9]>^+K6FNQI;MK<4P:Q:,K. C2W4W#^
M4<@;?NCK7[15X3^V3^RS;?M=?":'P9-K_P#PC,UOJ4.HP:E]B^U[&170KY?F
M1YRLC#.[CWJI3G&4:D%JFG\DU??R^9,80E%PGLT_R?;S/GC_ (+'27&K?LG^
M&[ZR#RZ<WB.TGG:/[OEM;S["?;<R_B17VG\+M<T?Q!\,_"VJZ%/#-H=SI=M+
M:2PD>7Y)B7;CTP.,=L5SNJ_ C1/&WP%M/A;XX8>*-,_LFWTR\NO+,#3O$BJ)
MT&YC&^Y X^8X..37R3X:_P""4%[X=>?0(OV@_'47PPF=_-\(6+O;++&WWD=Q
M,8FS_$?(&>>!5Z0E5IQV<KI^BMKU\R+N<:4Y[Q5FO5WTZ>1YKKWQ%TG]K?\
MX*N^ K3P_<1ZMX4\"Q.1>0D/#-+;K),\J$<%?.:) >AV9'!%>G_MB0I\6O\
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M@!1R20!R:](_:L_8I\$?M7VVEW>L7%]X>\5Z0"-.\1:2RK<1#.X(X(PZ!OF
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MP,A63.,'(XKUG]K;]CM/VJG^'UI-XJ7PWH'A?4#?3Z6FF?:5OQ^[ CW>:@B
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M 4444 %>.?\ -X7_ '(G_N0KV.O'/^;PO^Y$_P#<A0!['1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#I@#E-<_X(WZ9X9TFYU36/CK::3IELN^>\OO#JPPQ+D#+.UZ HR0.3WKV_\
M8G_8+TS]G;XBS^/-(^*MIX\L[K3)=/$-CIJPQD.\;[_-6YE!QY?3'?KQ2A4A
MRU(U)\R:[;/6WX_J.5.5X.$+-/OTTO\ A?\ #L?%'_!5PE?VO-1(Z_V18_\
MH!KT3X._\$Q?%G[27@K3OB?XU^)!TC4_$V-2%J^F&\FE@?E'>3SD"%EP0H4A
M5*_0>=?\%7O^3O-1_P"P18_^@&OU\^!<*6_P3^'T<:[47P]IX"CM_HT=98>;
MIX-3CNI/\7*_Y(JLE4Q?LY;<M_N45^I^9O\ P4G_ &*['X9Z?>?%C3/$:KIL
MT^GZ-;>&DTW8+:*.U6%2)_-.[ @''EC[W7CGR7]BW]@__AKCPWX@UK_A./\
MA%/[&O8[7R/[(^V>=N3?NW>?'M],8-?=_P#P5N_Y-13_ +#]G_Z#+7 ?\$8_
M^27_ !%_[#$'_HBKPE>HJ-6I?6#5O_)?OW>X8JG&-:C%+22U_P#)O\D<5_P5
MG_:4UC3M7TSX-Z#?R6>G+91WNN/ Q5KDOGRH&(/W J[RO0EU]*F_9O\ ^"2N
M@^-OA;I'B7XC^)-<L-7UBV2]@TW1##"+2)UW(LK2QR%W*D$@!<$XYQFO"O\
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MB@ HKPO]K/\ :\\'?LC^!TUCQ!OU+6K[<FDZ#:N%GO9% R22#LC7(W.0<9
M8D _,.@:]^WO^T5IL7B70;CPC\%]#N1YME8ZI:J9YH3RK.LL%RX..[+'GJ%
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MN5L9OL5O:B.UCVQ[=L,: _O%E.2"?RKZJKJDI4[Q;WM?\]?ZW,(N,_>72_\
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MO_LJ7-F'\J_#_,?+@?YOS_R+/_";6/\ SRN/^^5_^*H_X3BQ_P">5Q_WRO\
M\557_A!?^G[_ ,A?_94G_"!_]/W_ )!_^RJ>;,?Y5^'^8^7 ?S/\?\BU_P )
MQ8?\\;C_ +Y7_P"*I/\ A.K#_GC<_P#?*_\ Q55?^$!_Z?O_ "#_ /94G_"
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MZ9_SPN_^^%_^*JB?A?G_ )B?_DO_ /94G_"KO^HG_P"2_P#]E4\^;_R+\/\
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MB_\ )?\ ,?L\D_G?_DW^1I_\+ET7_GUO_P#OVG_Q='_"YM$_Y];_ /[]I_\
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M'_SZZA_W[C_^+K*_X45T_P")W_Y*?_9T?\**_P"HW_Y*?_9TO:\0_P#/M?\
MDO\ F/V>1?SO_P F_P C4_X7=H?_ #Z:A_W[C_\ BZ/^%W:%_P ^FH?]^X__
M (NLK_A1/7_B>?\ DI_]G2?\*'_ZCG_DI_\ 9TO:\1?\^U_Y+_F/V>0_SO\
M\F_R-7_A>&A?\^FH_P#?N/\ ^+I/^%Y:#_SZ:C_W[C_^+K)_X4+_ -1W_P E
M/_LZ3_A0G_4=_P#)/_[94^UXB_Y]K_R7_,?L\A_G?_DW^1K?\+ST'_GTU'_O
MW'_\71_PO30?^?34?^_4?_Q=9'_"@^O_ !/?_)/_ .V4?\*"_P"H[_Y)_P#V
MRE[7B/\ Y]K_ ,E_S'[/(/YW_P"3?Y&M_P +TT'_ )]-2_[]1_\ Q='_  O;
M0?\ GTU+_OU'_P#%UD'X _\ 4>_\D_\ [92?\* _ZCW_ ))__;*7M>)/^?:_
M\E_^2'[/(/YW_P"3?Y&O_P +VT#_ )]-2_[]1_\ Q=)_POC0/^?/4O\ OU'_
M /%UD?\ #/\ _P!1[_R3_P#ME)_PS[_U'O\ R3_^V4O:\2?\^U_Y+_\ )#]G
MP_\ \_'_ .3?Y&O_ ,+YT#_GSU+_ +]1_P#Q='_"^O#_ /SYZE_WZC_^.5C_
M /#/G_4?_P#)/_[92?\ #/?_ %'_ /R3_P#ME+VO$O\ S[7_ )+_ /)#]EP_
M_P _'_Y-_D;'_"^_#_\ SYZE_P!^H_\ XY7EW[,OQ>T?PO\ !#PWIEU;7TEQ
M!]IW-#&A4[KF5A@EP>A':NY_X9Z_ZC__ ))?_;*\S_9Q^#/_  E?P9\/:K_;
M'V7[1]H_<_9=^W;<RKUWC/W<].];JKQ#[&3=-<]U;X=K2OU[\IC*GD7M8I3?
M+9W^+>ZMT[7/8_\ A?GA_P#Y\]2_[]1__'*/^%_>'O\ GSU/_OU'_P#'*Q_^
M&>.G_%0?^27_ -LI/^&=_P#J8/\ R2_^V5S>VXF_Y]K_ ,E_^2.CV7#W_/Q_
M^3?Y&Q_PO_P]_P ^>I_]^H__ (Y2?\- >'O^?/4_^_4?_P <K'_X9U_ZF#_R
M2_\ ME)_PSI_U,/_ ))?_;*7MN)_^?:_\E_^2'[+AW_GX_\ R;_(V/\ AH+P
M[_SY:G_WZC_^.4?\-!>'?^?+5/\ OU'_ /'*QO\ AG/_ *F'_P DO_ME)_PS
ME_U,/_DE_P#;*GVW%'_/M?\ DG_R0_9<.?\ /Q_^3?Y&S_PT)X=_Y\M4_P"_
M4?\ \<H_X:$\._\ /EJG_?J/_P".5B_\,X_]3#_Y)?\ VR@_LX9_YF'_ ,DO
M_ME+VW%'_/I?^2?_ "0_9<.?\_'_ .3?Y&S_ ,-#>'/^?+5/^_4?_P <I/\
MAH;PY_SY:I_WZC_^.5B_\,W_ /4Q?^2/_P!LH_X9M_ZF+_R1_P#ME+VW%/\
MSZ7_ ))_\D/V7#?_ #\?_DW_ ,B;7_#1'AS_ )\M4_[]1_\ QRD/[1/AL?\
M+EJG_?J/_P".5B_\,V?]3%_Y(_\ VRD/[->?^9C_ /)'_P"V4O;<5?\ /I?^
M2?\ R0_9<-_\_'_Y-_\ (FU_PT5X;_Y\M5_[]1?_ !RC_AHOPW_SY:K_ -^H
MO_CE8A_9IS_S,?\ Y(__ &RD_P"&:?\ J8__ "1_^V4O;<5?\^H_^2?_ "0_
M9<-?\_'_ .3?_(FW_P -&>&_^?'5?^_47_QRD_X:.\-?\^.J_P#?F+_XY6)_
MPS/QC_A)/_)'_P"V4G_#,W_4R?\ DC_]LI>VXK_Y]1_\D_\ DA^QX9_Y^/\
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MW_DA_P#;:7MN+?\ GU'_ ,D_^2'['AC_ )^/_P F_P#D3=_X:4\,?\^.K?\
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ML+P2%)%*L.QIM>+MHSU]PHHHH **** "BBB@ HHHH \1_:R_97\/_M6?#M=
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M, 8%>EA:+O[21P8BJK<D1:***],\X**** "BBB@".XN([6WEGE8)%&I=V/0
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MR"!(Q&!A8R3P17@'_!6*67XB^+_@)\'K9V#^)?$'GW CY*+OCMT;'IB:8_\
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M.G:[?JWVVTN"Z)N9G9WX>6/<K2.-K94@@BO8O^"HOQAU;X/?LJZA<^'M9OM
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M]4T/]G[QYJ<-]K/BG2DMK?0[JRN&6^@PZ!O-1#'&287(RZL"H(YP:^2/&?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'CG[-W_-4O\ L>]4_P#:5>QUXY^S=_S5+_L>]4_]I5['
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MU/LCF_[(N_\ GE_X\/\ &C^R+O\ YY?^/#_&NDHH^IT^[#ZU/LCF_P"R+O\
MYY?^/#_&C^R+O_GE_P"/#_&NDHH^IT^[#ZU/LCF_[(N_^>7_ (\/\:/[(N_^
M>7_CP_QKI**/J=/NP^M3[(YO^R+O_GE_X\/\:/[(N_\ GE_X\/\ &NDHH^IT
M^[#ZU/LCF_[(N_\ GE_X\/\ &C^R+O\ YY?^/#_&NDHH^IT^[#ZU/LCF_P"R
M+O\ YY?^/#_&C^R+O_GE_P"/#_&NDHH^IT^[#ZU/LCF_[(N_^>7_ (\/\:/[
M(N_^>7_CP_QKI**/J=/NP^M3[(YO^R+O_GE_X\/\:/[(N_\ GE_X\/\ &NDH
MH^IT^[#ZU/LCF_[(N_\ GE_X\/\ &C^R+O\ YY?^/#_&NDHH^IT^[#ZU/LCF
M_P"R+O\ YY?^/#_&C^R+O_GE_P"/#_&NDHH^IT^[#ZU/LCF_[(N_^>7_ (\/
M\:/[(N_^>7_CP_QKI**/J=/NP^M3[(YO^R+O_GE_X\/\:/[(N_\ GE_X\/\
M&NDHH^IT^[#ZU/LCF_[(N_\ GE_X\/\ &C^R+O\ YY?^/#_&NDHH^IT^[#ZU
M/LCF_P"R+O\ YY?^/#_&C^R+O_GE_P"/#_&NDHH^IT^[#ZU/LCF_[(N_^>7_
M (\/\:/[(N_^>7_CP_QKI**/J=/NP^M3[(YO^R+O_GE_X\/\:/[(N_\ GE_X
M\/\ &NDHH^IT^[#ZU/LCF_[(N_\ GE_X\/\ &C^R+O\ YY?^/#_&NDHH^IT^
M[#ZU/LCF_P"R+O\ YY?^/#_&C^R+O_GE_P"/#_&NDHH^IT^[#ZU/LCGX]#N6
M/S;4'N:OVNBQ0L&<^:P]1Q6C16L</3CK:YG+$3EI<2EHHKI.<**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_YO"_[D3_
M -R%>QUXY_S>%_W(G_N0H ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<_9N_Y
MJE_V/>J?^TJ]CKQS]F[_ )JE_P!CWJG_ +2KV.@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ KQS]D'_DW?PG_P!O?_I7-7L=>.?L@_\ )N_A/_M[_P#2N:@#V.BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "O'/VOO^3=_%G_;I_Z5PU['7CG[7W_)N_BS_MT_]*X:
M /8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /'/B=_R<1\%/^XW_ .DB5['7CGQ.
M_P"3B/@I_P!QO_TD2O8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\<_YO"_[D3_ -R%>QUXY_S>%_W(G_N0H ]CHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_ )JE_P!CWJG_
M +2KV.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KQS]D'_DW?PG_P!O?_I7-7L=>.?L
M@_\ )N_A/_M[_P#2N:@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/VOO^3=_%G_;
MI_Z5PU['7CG[7W_)N_BS_MT_]*X: /8Z*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M/'/B=_R<1\%/^XW_ .DB5['7CGQ._P"3B/@I_P!QO_TD2O8Z "BBB@ HHHH
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M /\ R6/_ ,B?;/\ P\H_ZIU_Y7/_ +GH_P"'E'_5.O\ RN?_ '/7Q-11_8N
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MGH_X>4?]4Z_\KG_W/7Q-11_8N _Y]_C+_,/]:LX_Y_\ _DL?_D3[9_X>4?\
M5.O_ "N?_<]'_#RC_JG7_E<_^YZ^)J*/[%P'_/O\9?YA_K5G'_/_ /\ )8__
M ")]L_\ #RC_ *IU_P"5S_[GH_X>4?\ 5.O_ "N?_<]?$U%']BX#_GW^,O\
M,/\ 6K./^?\ _P"2Q_\ D3[9_P"'E'_5.O\ RN?_ '/1_P /*/\ JG7_ )7/
M_N>OB:BC^Q<!_P ^_P 9?YA_K5G'_/\ _P#)8_\ R)]L_P##RC_JG7_E<_\
MN>C_ (>4?]4Z_P#*Y_\ <]?$U%']BX#_ )]_C+_,/]:LX_Y__P#DL?\ Y$^V
M?^'E'_5.O_*Y_P#<]'_#RC_JG7_E<_\ N>OB:BC^Q<!_S[_&7^8?ZU9Q_P _
M_P#R6/\ \B?;/_#RC_JG7_E<_P#N>C_AY1_U3K_RN?\ W/7Q-11_8N _Y]_C
M+_,/]:LX_P"?_P#Y+'_Y$^V?^'E'_5.O_*Y_]ST?\/*/^J=?^5S_ .YZ^)J*
M/[%P'_/O\9?YA_K5G'_/_P#\EC_\B?;/_#RC_JG7_E<_^YZ/^'E'_5.O_*Y_
M]SU\344?V+@/^??XR_S#_6K./^?_ /Y+'_Y$^V?^'E'_ %3K_P KG_W/1_P\
MH_ZIU_Y7/_N>OB:BC^Q<!_S[_&7^8?ZU9Q_S_P#_ "6/_P B?;/_  \H_P"J
M=?\ E<_^YZ/^'E'_ %3K_P KG_W/7Q-11_8N _Y]_C+_ ##_ %JSC_G_ /\
MDL?_ )$^V?\ AY1_U3K_ ,KG_P!ST?\ #RC_ *IU_P"5S_[GKXFHH_L7 ?\
M/O\ &7^8?ZU9Q_S_ /\ R6/_ ,B?;/\ P\H_ZIU_Y7/_ +GH_P"'E'_5.O\
MRN?_ '/7Q-11_8N _P"??XR_S#_6K./^?_\ Y+'_ .1/MG_AY1_U3K_RN?\
MW/1_P\H_ZIU_Y7/_ +GKXFHH_L7 ?\^_QE_F'^M6<?\ /_\ \EC_ /(GVS_P
M\H_ZIU_Y7/\ [GH_X>4?]4Z_\KG_ -SU\344?V+@/^??XR_S#_6K./\ G_\
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M]L_\/*/^J=?^5S_[GH_X>4?]4Z_\KG_W/7Q-11_8N _Y]_C+_,/]:LX_Y_\
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MS[_&7^8?ZU9Q_P __P#R6/\ \B?;/_#RC_JG7_E<_P#N>C_AY1_U3K_RN?\
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MMG_AY1_U3K_RN?\ W/1_P\H_ZIU_Y7/_ +GKXFHH_L7 ?\^_QE_F'^M6<?\
M/_\ \EC_ /(GVS_P\H_ZIU_Y7/\ [GH_X>4?]4Z_\KG_ -SU\344?V+@/^??
MXR_S#_6K./\ G_\ ^2Q_^1/MG_AY1_U3K_RN?_<]'_#RC_JG7_E<_P#N>OB:
MBC^Q<!_S[_&7^8?ZU9Q_S_\ _)8__(GVS_P\H_ZIU_Y7/_N>C_AY1_U3K_RN
M?_<]?$U%']BX#_GW^,O\P_UJSC_G_P#^2Q_^1/MG_AY1_P!4Z_\ *Y_]ST?\
M/*/^J=?^5S_[GKXFHH_L7 ?\^_QE_F'^M6<?\_\ _P EC_\ (GVS_P /*/\
MJG7_ )7/_N>C_AY1_P!4Z_\ *Y_]SU\344?V+@/^??XR_P P_P!:LX_Y_P#_
M )+'_P"1/MG_ (>4?]4Z_P#*Y_\ <]'_  \H_P"J=?\ E<_^YZ^)J*/[%P'_
M #[_ !E_F'^M6<?\_P#_ ,EC_P#(GVS_ ,/*/^J=?^5S_P"YZ/\ AY1_U3K_
M ,KG_P!SU\344?V+@/\ GW^,O\P_UJSC_G__ .2Q_P#D3[9_X>4?]4Z_\KG_
M -ST?\/*/^J=?^5S_P"YZ^)J*/[%P'_/O\9?YA_K5G'_ #__ /)8_P#R)]L_
M\/*/^J=?^5S_ .YZ/^'E'_5.O_*Y_P#<]?$U%']BX#_GW^,O\P_UJSC_ )__
M /DL?_D3[9_X>4?]4Z_\KG_W/1_P\H_ZIU_Y7/\ [GKXFHH_L7 ?\^_QE_F'
M^M6<?\__ /R6/_R)]L_\/*/^J=?^5S_[GH_X>4?]4Z_\KG_W/7Q-11_8N _Y
M]_C+_,/]:LX_Y_\ _DL?_D3[9_X>4?\ 5.O_ "N?_<]'_#RC_JG7_E<_^YZ^
M)J*/[%P'_/O\9?YA_K5G'_/_ /\ )8__ ")]L_\ #RC_ *IU_P"5S_[GH_X>
M4?\ 5.O_ "N?_<]?$U%']BX#_GW^,O\ ,/\ 6K./^?\ _P"2Q_\ D3[9_P"'
ME'_5.O\ RN?_ '/1_P /*/\ JG7_ )7/_N>OB:BC^Q<!_P ^_P 9?YA_K5G'
M_/\ _P#)8_\ R)]L_P##RC_JG7_E<_\ N>C_ (>4?]4Z_P#*Y_\ <]?$U%']
MBX#_ )]_C+_,/]:LX_Y__P#DL?\ Y$^V?^'E'_5.O_*Y_P#<]'_#RC_JG7_E
M<_\ N>OB:BC^Q<!_S[_&7^8?ZU9Q_P __P#R6/\ \B?;/_#RC_JG7_E<_P#N
M>C_AY1_U3K_RN?\ W/7Q-11_8N _Y]_C+_,/]:LX_P"?_P#Y+'_Y$^V?^'E'
M_5.O_*Y_]ST?\/*/^J=?^5S_ .YZ^)J*/[%P'_/O\9?YA_K5G'_/_P#\EC_\
MB?;/_#RC_JG7_E<_^YZ/^'E'_5.O_*Y_]SU\344?V+@/^??XR_S#_6K./^?_
M /Y+'_Y$^V?^'E'_ %3K_P KG_W/1_P\H_ZIU_Y7/_N>OB:BC^Q<!_S[_&7^
M8?ZU9Q_S_P#_ "6/_P B?;/_  \H_P"J=?\ E<_^YZ/^'E'_ %3K_P KG_W/
M7Q-11_8N _Y]_C+_ ##_ %JSC_G_ /\ DL?_ )$^V?\ AY1_U3K_ ,KG_P!S
MT?\ #RC_ *IU_P"5S_[GKXFHH_L7 ?\ /O\ &7^8?ZU9Q_S_ /\ R6/_ ,B?
M;/\ P\H_ZIU_Y7/_ +GH_P"'E'_5.O\ RN?_ '/7Q-11_8N _P"??XR_S#_6
MK./^?_\ Y+'_ .1/MG_AY1_U3K_RN?\ W/1_P\H_ZIU_Y7/_ +GKXFHH_L7
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M_<]'_#RC_JG7_E<_^YZ^)J*/[%P'_/O\9?YA_K5G'_/_ /\ )8__ ")]L_\
M#RC_ *IU_P"5S_[GH_X>4?\ 5.O_ "N?_<]?$U%']BX#_GW^,O\ ,/\ 6K./
M^?\ _P"2Q_\ D3[9_P"'E'_5.O\ RN?_ '/1_P /*/\ JG7_ )7/_N>OB:BC
M^Q<!_P ^_P 9?YA_K5G'_/\ _P#)8_\ R)]L_P##RC_JG7_E<_\ N>C_ (>4
M?]4Z_P#*Y_\ <]?$U%']BX#_ )]_C+_,/]:LX_Y__P#DL?\ Y$^V?^'E'_5.
MO_*Y_P#<]'_#RC_JG7_E<_\ N>OB:BC^Q<!_S[_&7^8?ZU9Q_P __P#R6/\
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MG_AY1_U3K_RN?_<]'_#RC_JG7_E<_P#N>OB:BC^Q<!_S[_&7^8?ZU9Q_S_\
M_)8__(GVS_P\H_ZIU_Y7/_N>C_AY1_U3K_RN?_<]?$U%']BX#_GW^,O\P_UJ
MSC_G_P#^2Q_^1/MG_AY1_P!4Z_\ *Y_]ST?\/*/^J=?^5S_[GKXFHH_L7 ?\
M^_QE_F'^M6<?\_\ _P EC_\ (GVS_P /*/\ JG7_ )7/_N>C_AY1_P!4Z_\
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M_GW^,O\ ,/\ 6K./^?\ _P"2Q_\ D3[9_P"'E'_5.O\ RN?_ '/1_P /*/\
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M_AY1_P!4Z_\ *Y_]ST?\/*/^J=?^5S_[GKXFHH_L7 ?\^_QE_F'^M6<?\_\
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MMG_AY1_U3K_RN?\ W/1_P\H_ZIU_Y7/_ +GKXFHH_L7 ?\^_QE_F'^M6<?\
M/_\ \EC_ /(GVS_P\H_ZIU_Y7/\ [GH_X>4?]4Z_\KG_ -SU\344?V+@/^??
MXR_S#_6K./\ G_\ ^2Q_^1/MG_AY1_U3K_RN?_<]'_#RC_JG7_E<_P#N>OB:
MBC^Q<!_S[_&7^8?ZU9Q_S_\ _)8__(GVS_P\H_ZIU_Y7/_N>C_AY1_U3K_RN
M?_<]?$U%']BX#_GW^,O\P_UJSC_G_P#^2Q_^1/MG_AY1_P!4Z_\ *Y_]ST?\
M/*/^J=?^5S_[GKXFHH_L7 ?\^_QE_F'^M6<?\_\ _P EC_\ (GVS_P /*/\
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MD6&&-2[R2,%55 R22>@ K\S_ -JG]IB^^,?B&XT72IS!X-L)V6WCC)'VYE)
MG?H<'JJGH#SS7T5^WI\8YO!_@VR\&Z9+Y>H:\KM>-M!V68^4KR."['&1V1O4
M5^>U?<Y#EZY?K=1:_9_S/R+C#.I.?]G4'9+XO/LO3O\ \ ****^T/RP****
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M--5:3O%_UU-<9@Z^ K.AB8\LETNGOZ704445N<04444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MZ\NZ^73R:-S_ (*1?\>_@/\ W[S^4-?$-?;W_!2+_CW\!_[]Y_*&L/\ 8/\
M@/8>)IKKQ]KUJEW;V,_V?3+>9<H9E 9IB#P=N5"^^3U KIRS$0PF5*M/97_]
M*9R9_@:N9<0/"TMY*/R7+J_N/$?"_P"RW\5/&6FI?Z9X-O#:R#*/>216A<=B
M!,ZD@^H&#6/X]^!/C[X8VPN?$OAB\T^SZ&Z7;/ I)P TD995))X!(S7Z ?M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\N)9YF+RRN7=CU+$Y)K]<O@9X^M?B=\*/#VMP2K+)):)#=JO_+.=%"R*1_O
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MN4__ *425\5?M#16<_[7VKQZAM^P/J]DMQYGW?+*0[\^V,T\O_Y'6(_[?_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY^T;1\TEHQ^;Z[&PWL"]?G?7[7SP1W4,D,T:S0R*4>.10RLI&""#U!%?F?\
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M_P!;<V]GR>T7K97_ *^1I^)O$NI^,->OM:UF\DO]3O9#+/<2GEF/Z  8  X
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M79E#'8R-&C*\*:MIM=[_ *+Y,****^D/A HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#_\ NBC_ (=K_P#51?\ RA__ '15_P!M8#_GY^$O\C+_ %5SC_GQ_P"31_\
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M^?A+_(/]5<X_Y\?^31_^2/B:BOMG_AVO_P!5%_\ *'_]T4?\.U_^JB_^4/\
M^Z*/[:P'_/S\)?Y!_JKG'_/C_P FC_\ )'Q-17VS_P .U_\ JHO_ )0__NBC
M_AVO_P!5%_\ *'_]T4?VU@/^?GX2_P @_P!5<X_Y\?\ DT?_ )(^)J*^V?\
MAVO_ -5%_P#*'_\ =%'_  [7_P"JB_\ E#_^Z*/[:P'_ #\_"7^0?ZJYQ_SX
M_P#)H_\ R1\345]L_P##M?\ ZJ+_ .4/_P"Z*/\ AVO_ -5%_P#*'_\ =%']
MM8#_ )^?A+_(/]5<X_Y\?^31_P#DCXFHK[9_X=K_ /51?_*'_P#=%'_#M?\
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M "A__=%']M8#_GY^$O\ (/\ 57./^?'_ )-'_P"2/B:BOMG_ (=K_P#51?\
MRA__ '11_P .U_\ JHO_ )0__NBC^VL!_P _/PE_D'^JN<?\^/\ R:/_ ,D?
M$U%?;/\ P[7_ .JB_P#E#_\ NBC_ (=K_P#51?\ RA__ '11_;6 _P"?GX2_
MR#_57./^?'_DT?\ Y(^)J*^V?^':_P#U47_RA_\ W11_P[7_ .JB_P#E#_\
MNBC^VL!_S\_"7^0?ZJYQ_P ^/_)H_P#R1\345]L_\.U_^JB_^4/_ .Z*/^':
M_P#U47_RA_\ W11_;6 _Y^?A+_(/]5<X_P"?'_DT?_DCXFHK[9_X=K_]5%_\
MH?\ ]T4?\.U_^JB_^4/_ .Z*/[:P'_/S\)?Y!_JKG'_/C_R:/_R1\345]L_\
M.U_^JB_^4/\ ^Z*/^':__51?_*'_ /=%']M8#_GY^$O\@_U5SC_GQ_Y-'_Y(
M^)J*^V?^':__ %47_P H?_W11_P[7_ZJ+_Y0_P#[HH_MK ?\_/PE_D'^JN<?
M\^/_ ":/_P D?$U%?;/_  [7_P"JB_\ E#_^Z*/^':__ %47_P H?_W11_;6
M _Y^?A+_ "#_ %5SC_GQ_P"31_\ DCXFHK[9_P"':_\ U47_ ,H?_P!T4?\
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M_P!5%_\ *'_]T4?\.U_^JB_^4/\ ^Z*/[:P'_/S\)?Y!_JKG'_/C_P FC_\
M)'Q-17VS_P .U_\ JHO_ )0__NBC_AVO_P!5%_\ *'_]T4?VU@/^?GX2_P @
M_P!5<X_Y\?\ DT?_ )(^)J*^V?\ AVO_ -5%_P#*'_\ =%'_  [7_P"JB_\
ME#_^Z*/[:P'_ #\_"7^0?ZJYQ_SX_P#)H_\ R1\345]L_P##M?\ ZJ+_ .4/
M_P"Z*/\ AVO_ -5%_P#*'_\ =%']M8#_ )^?A+_(/]5<X_Y\?^31_P#DCXFH
MK[9_X=K_ /51?_*'_P#=%'_#M?\ ZJ+_ .4/_P"Z*/[:P'_/S\)?Y!_JKG'_
M #X_\FC_ /)'Q-17VS_P[7_ZJ+_Y0_\ [HH_X=K_ /51?_*'_P#=%']M8#_G
MY^$O\@_U5SC_ )\?^31_^2/B:BOMG_AVO_U47_RA_P#W11_P[7_ZJ+_Y0_\
M[HH_MK ?\_/PE_D'^JN<?\^/_)H__)'Q-17VS_P[7_ZJ+_Y0_P#[HH_X=K_]
M5%_\H?\ ]T4?VU@/^?GX2_R#_57./^?'_DT?_DCXFHK[9_X=K_\ 51?_ "A_
M_=%'_#M?_JHO_E#_ /NBC^VL!_S\_"7^0?ZJYQ_SX_\ )H__ "1\345]L_\
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M+_Y0_P#[HH_MK ?\_/PE_D'^JN<?\^/_ ":/_P D?$U%?;/_  [7_P"JB_\
ME#_^Z*/^':__ %47_P H?_W11_;6 _Y^?A+_ "#_ %5SC_GQ_P"31_\ DCXF
MHK[9_P"':_\ U47_ ,H?_P!T4?\ #M?_ *J+_P"4/_[HH_MK ?\ /S\)?Y!_
MJKG'_/C_ ,FC_P#)'Q-17VS_ ,.U_P#JHO\ Y0__ +HH_P"':_\ U47_ ,H?
M_P!T4?VU@/\ GY^$O\@_U5SC_GQ_Y-'_ .2/B:BOMG_AVO\ ]5%_\H?_ -T4
M?\.U_P#JHO\ Y0__ +HH_MK ?\_/PE_D'^JN<?\ /C_R:/\ \D?$U%?;/_#M
M?_JHO_E#_P#NBC_AVO\ ]5%_\H?_ -T4?VU@/^?GX2_R#_57./\ GQ_Y-'_Y
M(^)J*^V?^':__51?_*'_ /=%'_#M?_JHO_E#_P#NBC^VL!_S\_"7^0?ZJYQ_
MSX_\FC_\D?$U%?;/_#M?_JHO_E#_ /NBC_AVO_U47_RA_P#W11_;6 _Y^?A+
M_(/]5<X_Y\?^31_^2/B:BOMG_AVO_P!5%_\ *'_]T4?\.U_^JB_^4/\ ^Z*/
M[:P'_/S\)?Y!_JKG'_/C_P FC_\ )'Q-17VS_P .U_\ JHO_ )0__NBC_AVO
M_P!5%_\ *'_]T4?VU@/^?GX2_P @_P!5<X_Y\?\ DT?_ )(^)J*^V?\ AVO_
M -5%_P#*'_\ =%'_  [7_P"JB_\ E#_^Z*/[:P'_ #\_"7^0?ZJYQ_SX_P#)
MH_\ R1\345]L_P##M?\ ZJ+_ .4/_P"Z*/\ AVO_ -5%_P#*'_\ =%']M8#_
M )^?A+_(/]5<X_Y\?^31_P#DCXFHK[9_X=K_ /51?_*'_P#=%'_#M?\ ZJ+_
M .4/_P"Z*/[:P'_/S\)?Y!_JKG'_ #X_\FC_ /)'Q-17VS_P[7_ZJ+_Y0_\
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M47_RA_\ W11_;6 _Y^?A+_(/]5<X_P"?'_DT?_DCXFHK[9_X=K_]5%_\H?\
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M_P#*'_\ =%'_  [7_P"JB_\ E#_^Z*/[:P'_ #\_"7^0?ZJYQ_SX_P#)H_\
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MMG_AVO\ ]5%_\H?_ -T4?\.U_P#JHO\ Y0__ +HH_MK ?\_/PE_D'^JN<?\
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MU_\ JHO_ )0__NBC_AVO_P!5%_\ *'_]T4?VU@/^?GX2_P @_P!5<X_Y\?\
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M %47_P H?_W11_;6 _Y^?A+_ "#_ %5SC_GQ_P"31_\ DCXFHK[9_P"':_\
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M_MK ?\_/PE_D'^JN<?\ /C_R:/\ \D?$U%?;/_#M?_JHO_E#_P#NBC_AVO\
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M_P"JB_\ E#_^Z*/[:P'_ #\_"7^0?ZJYQ_SX_P#)H_\ R1\345]L_P##M?\
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MHH_X=K_]5%_\H?\ ]T4?VU@/^?GX2_R#_57./^?'_DT?_DCXFHK[9_X=K_\
M51?_ "A__=%'_#M?_JHO_E#_ /NBC^VL!_S\_"7^0?ZJYQ_SX_\ )H__ "1\
M345]L_\ #M?_ *J+_P"4/_[HH_X=K_\ 51?_ "A__=%']M8#_GY^$O\ (/\
M57./^?'_ )-'_P"2/B:BOMG_ (=K_P#51?\ RA__ '11_P .U_\ JHO_ )0_
M_NBC^VL!_P _/PE_D'^JN<?\^/\ R:/_ ,D?$U%?;/\ P[7_ .JB_P#E#_\
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M1_\ DCXFHK[9_P"':_\ U47_ ,H?_P!T4?\ #M?_ *J+_P"4/_[HH_MK ?\
M/S\)?Y!_JKG'_/C_ ,FC_P#)'Q-17VS_ ,.U_P#JHO\ Y0__ +HH_P"':_\
MU47_ ,H?_P!T4?VU@/\ GY^$O\@_U5SC_GQ_Y-'_ .2/B:BOMG_AVO\ ]5%_
M\H?_ -T4?\.U_P#JHO\ Y0__ +HH_MK ?\_/PE_D'^JN<?\ /C_R:/\ \D?$
MU%?;/_#M?_JHO_E#_P#NBC_AVO\ ]5%_\H?_ -T4?VU@/^?GX2_R#_57./\
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M "1\345]L_\ #M?_ *J+_P"4/_[HH_X=K_\ 51?_ "A__=%']M8#_GY^$O\
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M<_YO"_[D3_W(5['7CG_-X7_<B?\ N0H ]CHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH \<_9N_P":I?\ 8]ZI_P"TJ]CKQS]F[_FJ7_8]ZI_[2KV.@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KQS]D'_DW?PG_V]_\ I7-7L=>.?L@_\F[^$_\ M[_]*YJ
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "O'/\ F\+_ +D3_P!R%>QU
MXY_S>%_W(G_N0H ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V/>J
M?^TJ]CKQS]F[_FJ7_8]ZI_[2KV.@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]D'_
M )-W\)_]O?\ Z5S5['7CG[(/_)N_A/\ [>__ $KFH ]CHHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ"^OK;3;26
MZO+B*UM85+R33N$1%'4ECP!]:!-V5V3T5X_XB_:W^%'ANZ:WF\6P7DRMM/\
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MXW_Z2)7L=>.?$[_DXCX*?]QO_P!)$KV.@ HHHH **** "BBB@ HHHH ****
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MN_YJE_V/>J?^TJ]CKQS]F[_FJ7_8]ZI_[2KV.@ HHHH **** "BBB@ HHHH
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MBBZ\%[\=?5'W/"^=5<'B882I*].;MZ-[6^>_WGZ0T445^;G[F%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5XY^U]_R;OXL
M_P"W3_TKAKV.O'/VOO\ DW?Q9_VZ?^E<- 'L=%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0O ^F6R6D%\8;.6ZOO*0([XN20XRIP(D.#E=S$5YK_P5J_Y.0T3_ +%NW_\
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M%_\ @&GU>"QDZ?V8J_XM?Y?B3^&_V@/VV?C7H\_CCP5IBQ>%@S%(+'3K%89
MGWA$MSNGE&01E"W(('(Q7O\ ^Q/^WA<?'[7KKP-XXTRWT3QS;1O)"UJC1PWB
MH<2)Y;DM'*O4KD@@,1MQBOGCX7_M9_M3^"_AQX8T+PW\#OMV@:?IT%M8W?\
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MC^!FB?M@?M5?%[XP>,K)-;\*:?KLKV&FW2A[:[N'D<Q>8IX=8H0ORD8)=<\
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MOEMWQC6_X+%?'R7PWHW@SX4P7]U8:=X@?^T?$$EB T[6*2!4C525#;F#M@L
M3$H)P32E>E&$9?')1]$VDVWWTN[=O,J-JDYN/PQ;U[I-JR^=E?OY'J'C_P#X
M*[_ +P/X@DTNSF\1>+UB8I)?>']/C:V# X.'GEB+C_:0%3U!-?1'P#_:2^'_
M .TMX7EUWP%K:ZG#;LL=W:31F&ZM'(R%EC;D9P<,,J<'!.#7PK\(_P#@I]^R
MY\#?!=KX7\&_#?QII&F0QA)/+TJP\VZ;&#),_P!LS(Y[LV?RP*XW]C/XR>#_
M (@?\%+M1UGX3Z-J'A;P7XGT2X^W:/>6\5N/.2)7=Q%"[HH,D88<]7;INK:$
M4Y^SWT>OHK[=G:W?8QG+EAS[:K3U:6_=7OVW/T*_:&_:B\*_LV2>#X?$6GZQ
MJMYXJU(:7IUIHL,4LIE.T;F$DL8"Y=!D$G+#BO(_C)_P5.^!?P;\43>'WU#5
MO%^HV\ABNCX7M8[B&W<=5:626-&([^66P<@X((KYZ_X*(>&;G]I;]N;X-?!>
MRNI;6WM[(W=Y<P-\]NDSM).PXP&$-J"N>["OO>R^'/P_^ WP7U;2-)\.:;I/
M@_2]+GEN[-8%*3Q)$3(TQ(S(S*#N9LD]S7+S.-!UY='+3NHZ?==/7SMT.CE7
MME1CJVH_>_STMITMYE[X)_'#P?\ M"> ;3QAX)U/^TM'N':)M\9CE@E7&Z*1
M#RKC(XZ$$$$@@GRZ'XT_"+XB?M@W/PTE\"_VQ\3?"=D+Q?$UYH]I+'8QA(Y-
ML5RSF9"#<*,*@&YCSWKP;_@C!H=S8?L]^,=:F#0V.I^))#;1$_(%C@B#,/Q)
M7_@%9O\ P3/S\5/VD/VCOB_*OFPWVJ_V=83GG]TTTDA4'VCCMOTKLE%+$*/1
M1YO1V5OQE_6IS\W[F3O=\W+ZJ[O^$3ZZ_:$_:O\ AG^S#I=M=>/-?%E=WBLU
MGI=K$T]Y<@=2D:]%[;W*KGC.:\#\"_\ !7WX!^,O$$.EWA\2^$TE8(FH:[I\
M2VVXG RT,TK*/]IE '<BN<^+7C#]DKX0_M5ZQ\1/B'X]O/%GQ$6-8$T6[A_M
M2RT8IM"B*.&WVQ2)M. \A8%F;&XYKR3]N?\ X*#? []H#X >(/"/A[0M8\0:
MY(86T_4KK25B@TZ02J?,\QGWH2@=1M7G=@\$UR1G:"G\5^B]>_?\#IY+SY/A
M7=_Y=OQ/U2LKVWU*S@N[2>.ZM;B-989X7#I(C#*LK#@@@@@CUJ>O$OV)M-N]
M)_9)^$MO?,S7'_".VDGSDY"N@=!SZ*RC\*]MKJJP]G4E#LVCEI2=2G&;ZI!1
M1161J%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C4M% #"3BO&
M\G_AK[K_ ,R)_P"Y"O9Z\<_YO"_[D3_W(4Q'K3,WJ?SIGF-_>/YU<HHN*Q1\
MQ_[S?G36E?GYV_.M"BG<7+YF6TTG]]OS--::3_GHWYFM:BGS"Y?,QS/+C_6-
M_P!]&F_:)?\ GH__ 'T:VJ*.;R%R/N8+7,W_ #U?_OHTS[5-_P ]9/\ OHUT
M-%/F\A>S?<YS[5/_ ,]I/^^C33=SY_UTG_?1KI:*?/Y"]F^YS#7D_P#SVD_[
M[-1M>W'_ #WD_P"^S75T4<_D+V3[G)&^N,?Z^7_OLTW[=<_\_$O_ 'V:Z^BG
M[1=A>Q?\QQK7]S_S\2_]]FFG4+K'_'S-_P!]FNTHH]HNPO8O^8XAM0NO^?F;
M_OX::VHW?_/U-_W\/^-=S13]HNPO8/\ F.#;4KO_ )^IO^_A_P :9_:5Y_S]
M3_\ ?P_XUW]%/VJ["^KO^8\^;5+S_G[G_P"_C?XTS^U+W_G[G_[^M_C7HE%'
MM5V%]7E_,><_VK>_\_EQ_P!_6_QIC:M?<_Z9<?\ ?UO\:])HI^V7\I/U:7\_
M]?>>9MJU]_S^W'_?UO\ &FMK%_\ \_MQ_P!_6_QKTZBG[9?RA]5E_/\ U]YY
M;_;%_P#\_P!<_P#?UO\ &FG6=0S_ ,?US_W^;_&O5**/;+^47U67\_\ 7WGE
M+:UJ'_/]<_\ ?YO\:C;6]1_Y_P"Z_P"_S?XUZU13]NOY1?5)?S_U]YY&VN:C
M_P _]U_W^;_&FG7-2Q_R$+K_ +_-_C7KU%/VZ_E)^IR_G_K[SQ_^W-2_Z"%U
M_P!_F_QIC:]J?_01N_\ O^W^->QT4?6%_*+ZG+^?^OO/&/[>U/\ Z"-W_P!_
MV_QIIU_5,_\ (1N_^_[?XU[313^L+^47U*7_ #\_K[SQ1O$&J?\ 02O/^_[_
M .-,_P"$@U7_ *"5Y_W_ '_QKVZBG]9C_*+ZC+_GY_7WGAS>(M5_Z"=Y_P"!
M#_XTW_A(M5_Z"=Y_X$/_ (U[G11]9C_*+ZC/_GY_7WGA7_"1ZM_T%+S_ ,"'
M_P :8WB35O\ H*7O_@0_^->\44_K4?Y/Z^X7U"?_ #\_K[SP1O$FK_\ 04O?
M_ A_\:8?$VKY_P"0K??^!#_XU[]11]:C_)_7W"_L^?\ S]?]?,^?V\3:Q_T%
M;[_P)?\ QIK>)M8_Z"U]_P"!+_XU]!44_K4?Y/Z^X7]GS_Y^O^OF?/+>*-9Y
M_P")M??^!+_XTW_A*-9_Z"]]_P"!+_XU]$44_K4?Y/Z^X7]G3_Y^O[O^"?.O
M_"4ZU_T%[_\ \"7_ ,:;_P )5K7_ $%[_P#\"7_QKZ,HI_6X_P G]?<+^S9_
M\_7]W_!/G ^*M;Y_XG%__P"!3_XTQO%FM_\ 08U#_P "G_QKZ2HH^N1_D_K[
MA?V;/_GZ_N_X)\UMXLUS_H,ZA_X%/_C33XLUS'_(9U#_ ,"I/\:^EJ*?UR/\
MG]?<+^S)_P#/U_=_P3XI^$_B+5K/_A,O(U.\A\WQ)>RR>7<.N]SLRQP>2?6N
MZ;Q=KO\ T&M1_P# J3_&NY_9N_YJE_V/>J?^TJ]CJ8XN,5;D_K[BZF73G+F5
M5KY?\$^7V\8:]_T&]1_\"Y/\::?&&O8_Y#>H_P#@7)_C7U%15_7(_P#/O^ON
M,O[+J?\ /Y_=_P $^6_^$PU__H-ZE_X%R?XTQO&6O_\ 0<U+_P "Y/\ &OJ>
MBG]=C_S[_K[A?V54_P"?S^[_ ()\K-XR\0?]!S4O_ N3_&H_^$T\0?\ 0=U+
M_P #)/\ &OJVBCZ['_GW_7W"_LFI_P _G]W_  3Y1;QIXA_Z#NI_^!DG_P 5
M36\:>(?^@]J?_@9)_P#%5]844_KT?^??]?<+^R:G_/Y_=_P3Y,;QKXA_Z#VI
M_P#@9)_\54;>-O$7/_$_U3_P,D_^*KZWHI_7H_\ /O\ K[B?[(J?\_W]W_!/
MD;_A-_$?_0?U3_P,D_\ BJ;_ ,)QXC_Z#^J?^!LG_P 57UW11]?A_P ^_P"O
MN%_8]3_G^_N_X)\@MXX\1_\ 0P:I_P"!LG_Q5,/CKQ)G_D8-5_\  V7_ .*K
M[!HI_7X?\^_Z^X7]CU/^?[^[_@GQXWCKQ)_T,.J_^!LO_P 536\=>)?^AAU7
M_P #9?\ XJOL6BG_ &A#_GW_ %]PO[&J?\_W]W_!/C=O'GB7_H8=5_\  V7_
M .*IC>//$W/_ !46K?\ @=+_ /%5]ET4_P"T(?\ /I?U\A?V+5_Y_O[O^"?&
M/_">^)O^ABU;_P #I?\ XJF_\)]XG_Z&/5O_  .E_P#BJ^T**/[0A_SZ7]?(
M7]BU?^?[^[_[8^+?^$^\3_\ 0QZM_P"!TO\ \53&\?\ BCG_ (J35_\ P.E_
M^*K[5HI_VC#_ )]+^OD+^Q*O_00_N_\ MCXG;X@>*/\ H9-7_P# ^7_XJFM\
M0?%/_0RZQ_X'R_\ Q5?;5%']HP_Y]+[_ /@"_L.K_P!!#^[_ .V/B)OB%XI_
MZ&76/_ ^7_XJF'XA>*L_\C+K'_@?+_\ %5]P44_[2A_SZ7W_ / %_8=7_H(?
MW?\ VQ\.M\0_%7_0S:Q_X'R__%5&WQ$\5_\ 0SZS_P"!\O\ \57W-13_ +2A
M_P ^E]__  !?V%5_Z"']S_\ DCX7;XB^*_\ H9]9_P#!A+_\533\1O%F/^1G
MUG_P82__ !5?=5%']I0_Y]+[_P#@"_L&K_T$/[G_ /)'PG_PL;Q9_P!#1K/_
M (,)O_BJ8WQ'\6_]#1K7_@PF_P#BJ^[Z*?\ :</^?2^__@"_L&K_ -!+^Y__
M "1\&GXD>+<_\C3K7_@PF_\ BJ:WQ(\7?]#3K7_@PF_^*K[THH_M.'_/I??_
M , 7]@5O^@E_<_\ Y(^"6^)7B[_H:=:_\&,W_P 54?\ PLKQ?_T-6M_^#&;_
M .*K[ZHJO[4A_P ^5]__  !?ZOUO^@E_<_\ Y(^ V^)?B_G_ (JK6_\ P8S?
M_%4S_A9GC#_H:];_ /!C-_\ %5]_T4?VI3_Y\K[_ /@"_P!7ZW_02_N?_P D
M?G]_PLSQA_T->N?^#&;_ .*IC?$WQAS_ ,59KG_@QF_^*K]!**?]J4_^?*^_
M_@"_U>K?]!+^Y_\ R1^?!^)WC'/_ "-FN?\ @RF_^*IK?$_QE_T-FN?^#*;_
M .*K]":*?]JT_P#GROO_ . +_5VM_P!!+^Y__)'YZ-\4/&7_ $-NN?\ @RF_
M^*II^*'C+'_(VZ[_ .#*;_XJOT-HH_M6G_SY7W_\ 7^KM;_H*?W/_P"2/SN;
MXH^,^?\ BKM=_P#!E-_\53/^%I>,_P#H;M>_\&<W_P 57Z*44_[6I_\ /E??
M_P  7^KM;_H*?W/_ .2/SI_X6EXT_P"AOU[_ ,&<_P#\53&^*GC3G_BK]>_\
M&<__ ,57Z,T4?VM3_P"?*^__ ( O]7*W_04_N?\ \D?G)_PM3QK_ -#?KW_@
MSG_^*IC?%7QK_P!#AK__ (,Y_P#XJOT>HI_VO3_Y\K[_ /@"_P!6ZW_04_N?
M_P D?F^WQ6\;?]#AK_\ X,Y__BJ:?BMXVQ_R..O_ /@SG_\ BJ_2*BG_ &O3
M_P"?*^__ ( O]6J__04_N?\ \D?FR?BQXWS_ ,CCX@_\&D__ ,72-\6/&_\
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M<E^?Z'Z<T445^.G].A1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTW[8GQ"^+/[3/A#3/B3KW@"7P9\/-%F%GI\<S,7DDN "TNYU1I5/EH-ZH%'
MY.:_9.BL94I2A&$I7Y=OZ^;^9T+$J-1U(QLWO_7]::'RQ_P3Q\3V7B+]C?P[
M!:RJT^EB]L;J,-DQR":1P#Z921&_X%7PM_P2]_Y.VA_[!5]_):_9"BNE^]7]
MN^UOP>OXG,IVHRHI;M/[G>Q^1/\ P5I&[]I'0QZ^&[<?^3%Q7;^&_P!M?XM?
ML<^"+3X>>/\ X:'69-+B^RZ/KLMU);02VX7]UAA$RSJHP 59#M 5L,":_3^B
MN>-*4(N,9;MO\;_>K[G1/$1J<O-#9)?<DOTV/R;_ &1OV=_'_P"TO^T-'\8_
M'^GW-AH,6HC6I+JY@:%;^X5@T,4"MR8E(3YN5"IMSDU]*_\ !1_]D_6OCQX7
MTCQ5X/M3J'BG0$>&33D(#WEJQ#$)GJZ,"0N>0S 9. ?L^BJE1A*E&E'11V]?
MZT]#..(FJKK/5O\ +^M?4_*GX>?\%+_'WP1\!V'@'Q7\-GU'Q%H]NMC;76H7
M,MC,$10L8F@:)F=@  2&7('KS7T/^Q)\4_VD_BUK$NI_$/3K+3O RJ\BW6H:
M2;2[N68?(ENJLGR#()D9&! P"221]GT5K'FYG.;N_P"NG<SE*'+R0C9'Y8?\
M%@O^2F?#_P#[!$W_ *.K]!/V9?\ DW+X7?\ 8L:;_P"DT=>ET5-"/L:<X;\S
MO^,O\RJU3VO+I;E5OR_R/QF^ ?\ RDLB_P"QPU;^=S7M_P#P58^ 'B[Q+XJT
M'XBZ%I=YK>CV^F?V=?I90M*]F4DDD61E7)$;"0Y;& 5Y(R*_2JBL%A[4(4;_
M  N]_DEL;_6G[>59+=6M\[GY=_#W_@H!\5_B3\-;'X:> OA6-1\71Z?'I0UJ
MRE>2&%0HC$K0>6%B(7^)Y-@/)&.*\O\ V!$D^#_[;MIX:\3*MEJ:&^T.12XV
MK<A3A0>X9H]H]=PK]E**Z(I^V]M)W;O?SO\ ENS"52/L71C&RZ>7^>R/Q'_X
M*#_&#7_B;^T;XCTK4YMFD^&+J72M-LHR?+C56^>0CN[D9)] HZ**]%_9[_X*
M,>'OV<_AK8^$M ^#YFV'SKW4)/$866]N" 'E8?9#C.  N3M4 9.,G]<Z*PHT
MIT8<JEOOIO\ T]3>KB(56KPT6VNQ\R?L=_MI?\-9W7BJ#_A#O^$5_L..W?=_
M:GVSSO-,@Q_J8]N/+]\Y[8KX"_8#_P"3ZM-_Z[:I_P"B9J_9BBMXQY:T:O9-
M>M^I@ZG[JI22TDT_2WYGY=_\%A_^1V^&W_8/O/\ T9'7W=^RC_R;/\+O^Q<L
M?_1*UZM12HQ]C"4-[N_Y_P"8JM3VG+ILK?E_D?C-\+O^4F@_['G4/_1LU?;_
M /P42_95U7]H;P%I6L>%81=>+?#K2&&RW!3>6\FWS(U)(&\%59<GGYAU(KZZ
MHK%4%]7C0;VUO\DOT_$VEB&\2\0ENK6^_P#S/RB^%/\ P49\??LY^ ]/^'7C
M'X:3:CJNC0BSLI-0N)=.N(X5&(TEB:%B^T84$%<@ =>3] ?L6_&']I?XR^+)
M-2\:Z98Z=\/BTD[7>HZ0UK-(&YCAM,,A902/WC!QA2"Q:OMVBNB/-S<\W=F,
MY0<>6$;?U^ 4444S$**** "BBB@ HHHH **** "NA\%V+3:@UR1\D*X!_P!H
MC'\LUA6]O)=3I#$NZ1S@"O1]'TU=)L4@4[F^\[8ZL?\ /Z5C5ERQMW.O#4^:
M?-T1=HHHK@/8"BBB@ HHHH ^:/\ @H%^TZO[,?P!U+4=/N%C\7ZWNTS0X^"R
M3,OSSX](ERW3&XH#]ZO"_P!D[_@ES\,;SX(Z%J_Q@\*3>(?'6L*=2NVFU2\M
MC:K+AHX"L,R L%P6+ G<S#. *^MOBE^R[\,?C7XR\/\ BGQMX:_X2#6=!*G3
MGGU"Z2&#;()/]0DHB;+ 9W(=P !R !7JM*FE%2E+XG^"73U;U?W7:'-N7+&/
MPK\6_P!$M%]^A\2?&3_@F'^S_8?"/QI=>%_A\;#Q);Z->3:;<C6M1E\NY6%F
MC;8]P5;Y@.""/8US/_!,Z^F^*G_!/GQ%X.MI5%[:2:OH<6[HIGC\U"?;-P?R
MK[]GA2ZADAE4/%(I1E/0@C!%>>?!/]G?X??LZ:/J6E?#S0#X>T_4;@7=S!]M
MN+D/*%"[AYTCE> !A<#BIY>:-6G-^[.*7H[ZO[M!\W*Z<H[QE?\ #_,^%O\
M@EM^U!X#^%_PEUOX5_$/Q#IW@+Q/H&L74GE^(;E+*.5'(#+OD(42)(KJ4)SC
M!&><>:?\%,OVN]+_ &CK[PO\)/AE<MK>A-K$8O-;MU/V6]O>(XH(7Z2*GF[F
M89!+)C(&3^AGQ8_8G^"/QO\ $W_"0^,OA]I^J:VQ!DOH)I[.6<@  RF"1/-(
M  R^>!CI2>+/V6/@;IUEX6UW6?".E:+IOP]+ZEI<L5S+8V>FE665YG2.1(W^
M:)69I V=O.>:TDU4E3E7V5KI;.W_  VW?KT)BG34HT>M[7Z7O_G]W3JO%_\
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M%L9-JP^9Y0^5W&=F?F)ZUJ?%CX.>"_CEX3D\->.O#UKXCT9I!*+>YW*T<@!
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M%9-HR>-V.:XWP-_P3Z_9Y^'6JIJ6C?"[2FO(V#H^J37&HA&'(95N9)%!!Y!
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M1110 5XY^R#_ ,F[^$_^WO\ ]*YJ]CKQS]D'_DW?PG_V]_\ I7-0!['1110
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M172_^?7_ ,B/_C1[>(?5)]T>>T5Z%_PBNE_\^O\ Y$?_ !H_X172_P#GU_\
M(C_XT>WB'U2?='GM%>A?\(KI?_/K_P"1'_QH_P"$5TO_ )]?_(C_ .-'MXA]
M4GW1Y[17H7_"*Z7_ ,^O_D1_\:/^$5TO_GU_\B/_ (T>WB'U2?='GM%>A?\
M"*Z7_P ^O_D1_P#&C_A%=+_Y]?\ R(_^-'MXA]4GW1Y[17H7_"*Z7_SZ_P#D
M1_\ &C_A%=+_ .?7_P B/_C1[>(?5)]T>>T5Z%_PBNE_\^O_ )$?_&C_ (17
M2_\ GU_\B/\ XT>WB'U2?='GM%>A?\(KI?\ SZ_^1'_QH_X172_^?7_R(_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "O'/\ F\+_ +D3_P!R%>QUXY_S>%_W(G_N0H ]CHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_FJ7_8]ZI_[2KV.@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KQS]D'_ )-W\)_]O?\ Z5S5['7CG[(/_)N_
MA/\ [>__ $KFH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]K[_DW?Q9_P!NG_I7
M#7L=>.?M??\ )N_BS_MT_P#2N&@#V.BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q
MSXG?\G$?!3_N-_\ I(E>QUXY\3O^3B/@I_W&_P#TD2O8Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HK%_X1K_ *BN
MI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"H
MKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_
MX1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ
M/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]
M:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG
M_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BN
MI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A
M&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_
MX1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ
M -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_
M ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG
M_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:
M_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A
M&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H
MVJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\
M@1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_
M ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_
M *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:
M_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:
MHK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!
M'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\
M@1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\
MJ*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_
M *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JB
ML7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?
M_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!
M'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"H
MKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]:C_A&O\
MJ*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?_6H VJ*Q
M?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BNI_\ @1_]
M:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"HKJ?_ ($?
M_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_X1K_ *BN
MI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ/^$:_P"H
MKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]:@#:HK%_
MX1K_ *BNI_\ @1_]:C_A&O\ J*ZG_P"!'_UJ -JBL7_A&O\ J*ZG_P"!'_UJ
M/^$:_P"HKJ?_ ($?_6H VJ*Q?^$:_P"HKJ?_ ($?_6H_X1K_ *BNI_\ @1_]
M:@#:HJM8V?V&#RO/FN.<[YWW-],U9H **** "BBB@ HHHH *\<_YO"_[D3_W
M(5['7CG_ #>%_P!R)_[D* /8Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /'/V;O^
M:I?]CWJG_M*O8Z\<_9N_YJE_V/>J?^TJ]CH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\<_9!_Y-W\)_P#;W_Z5S5['7CG[(/\ R;OX3_[>_P#TKFH ]CHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ KQS]K[_DW?Q9_VZ?\ I7#7L=>.?M??\F[^+/\ MT_]*X:
M/8Z*R9O[=\Z3R?[/\K<=F_S-VW/&<=\5'_Q4/_4,_P#(E &U16+_ ,5#_P!0
MS_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#
M_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_
M ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U
M16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(
ME &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,
M_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4
M/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)
M1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0
MS_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#
M_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_
M ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U
M16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(
ME &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,
M_P#(E &U16+_ ,5#_P!0S_R)1_Q4/_4,_P#(E &U16+_ ,5#_P!0S_R)1_Q4
M/_4,_P#(E 'FWQ._Y.(^"G_<;_\ 21*]CKP_Q]_:/_#1'P8^W_9?^8UL^S[O
M^?1<YS^%>X4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5XY_S>%_W(G_N0KV.O'/^;PO^Y$_]R% 'L=%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'CG[-W_-4O^Q[U3_VE7L=>.?LW?\U2_P"Q[U3_ -I5['0 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5XY^R#_R;OX3_P"WO_TKFKV.O'/V0?\ DW?PG_V]
M_P#I7-0!['1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !7CG[7W_)N_BS_MT_\ 2N&O8Z\<
M_:^_Y-W\6?\ ;I_Z5PT >QT444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >.?$[_DXC
MX*?]QO\ ])$KV.O'/B=_R<1\%/\ N-_^DB5['0 4444 %%%% !1110 4444
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M]S61]UT5R_Q(^)GAGX1^"-3\7>+-6@T?P_I\7FSW<Q)'/"JH&2S,2 JJ"22
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M444 %%%% !1110 4444 %>.?\WA?]R)_[D*]CKQS_F\+_N1/_<A0!['1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOTU\TSR[X:?M9?&C]@#0M%^'WQR^%=SJ/@32E6QT_P 4:" =L(+; )!^YF.
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M '(4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#_R;OX3_ .WO_P!*YJ]CKQS]D'_DW?PG_P!O?_I7-0!['1110 4444 %%%%
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MI"OT)\QQ[2"OE[_@IS\:/%&O_'J;X</JUQI'@_3(+4-;([+#<22HLC3RJO\
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M!%N4\L?,2WW>IS70Z3I-CH.EVFF:996^G:=9Q+;VUG:1+%#!&H"JB(H 50
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MY 5)! (R."*NZ1I%CX?TNSTS2[*WTW3;.);>VL[.)8H8(U "HB* %4    8
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M04444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M #\9\,M\._%?_0L:S_X+Y?\ XFHS\.?%F/\ D6-9_P#!?+_\37W513_M:?\
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MQ;$_<;YR3]T>@KV'XD?%CP=\'_#YUOQKXETWPSI>[8MQJ-PL?F/@G9&IY=L
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M2_!_@=%1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ KQS_F\+_N1/\ W(5['7CG_-X7_<B?^Y"@#V.BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#QS]F[_FJ7_8]ZI_[2KV.O'/V;O\ FJ7_ &/>J?\
MM*O8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1110 4444 %%%% !1110
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M1/$5T=T^L>'KC[)-,<Y+.A#1.Q[NR%CZU,;PG)VNI)+TL[W7ZE2M**6S3O\
M>K6?Z'KWQF^(/@/X=_#_ %C4/B+J6EV7AEK:2.ZAU1D*W2%3F%8V_P!:S#("
M $GIBO@#_@D9X,U>\\(?''Q!I5I=:3X.UZY6TT&&X)/SH+C)&>#L66)2PZD$
M?PUZWX*_X(^_ 'PGJB7E^OB;Q8B$,+36M300Y'J+>*$D>Q.*^S?#OAW2O".A
MV6C:)IUKI&DV40AMK&RA6*&%!T544  ?2GR1M.[^*/+\G^;[=KBYI>ZDMG?[
MNW;S[GY]?\$:_%6CZ/\ #'QU\/+V:'3_ !OIOB*:ZN]+G<+<-%Y446\*>2%>
M)U./NG&<;AGU/XY?MKZW;_M%>!O@S\%8= \6^)M0NB/$5S>QRW5OI4 (W<PR
MH!(JB1F!8[<*,9:MG]H#_@FG\%_VAO%D_B?5;+5?#6OW3;[R^\-W,=N;MO[T
MB21R)N]6"ACW)KT']G/]C_X8?LMV-PG@?1&CU.Z01W>M:A+]HO;A00=I<@!5
MR =J!5) .,\UKSNI*$ZO1*Z76RLO1::]3.45!2C3ZWLWTN_Q?;H?*'_!1C/Q
M7_:T_9M^$J$302:C_:M_;]0T+3("2/:.WG_.OT3N)X[.WDFD81PQ(79CT50,
MD_E7C>J?LG^$=:_::TOXY7NH:U/XKTRQ^P6EBT\/V"*/RY$R$\KS-V)9#GS,
M9;IVKU3Q5X?C\6>%]7T.:ZN;*'4K.:S>YLV59HED0H7C+*P# '()!&0.#6'O
M1P_)'XKR?W[?@E^70UTE6YGI&T5]VK_%L_/S_@E/;O\ $;XB_M ?&&X'F#Q!
MKQM;25AR$,DEPZ@^FV2 ?\!%,_9/_P"+P_\ !3KX]^/B?.LO#<#:+;,>0KAT
MME(^JVLW_?5?8O[-O[-WA7]EKX<'P7X1N-2N].:\EOI+G5I8Y+B260*"6:.-
M%P B@87H.]9?[.'[)WA']F)O%TWAK4=:U:\\47JW^H7FN3PRRF0;R ICBC 7
M,CGD$Y;K6L>6G.#C\,(<J]6DO_DG?_,SES5(3O\ %.:;]$V_TBO^&/EK]M?]
MHCQ7\>OB5'^S%\#96N-8O6,7BO7K9CY-E!P)8#(OW54']ZP]1&,LS+7UM^S+
M^S?X9_9=^%EAX.\.1B9U_?:CJ;H%FO[D@!Y7ZX'&%7)VJ .>I^9M4_X(V_!O
M6=4O]0NO%_Q">YOIGGN&_M*R^=V8LQ/^A^IS5+_ARK\$/^AI^(!_[B-C_P#(
M=12O&G9_$_B?Z>B[?-W9I5M*>C]U;?Y^K_X&Q/\ \%E_#6IZQ^S-H.IV5N]Q
M9Z-XC@N;[8,B.)H9HE=O;>Z+]6%?7/PE^,7@_P"*7PKTGQGX>UJQF\/S6:2R
M3"956T(0;XY>?W;(<@AL8Q71W'@G0[_P;_PBE]IMOJ'A]K,:?)I]W$LD4D 0
M)L92,$8'I7QOK_\ P1U^ 6M>(6U*UD\5Z):,X;^R=/U2,VP_V0989)<'_KI3
M5X\]-:INZ?;1+5?)?UO+]]0D]'%6:]7?<\>^+WC6V_X*!_MU_#SP5X(D_MCX
M<_#Z?^TM5UF#YK:=ED1Y65NC(QCBA0CJ6=AE>:9_P4H^*EAIG[;?P$L-1W2:
M)X0DM=>U,JA=8(I+U#)(P'98[8,?8^]?H3\&?@-X#_9]\+G0/ /ARUT#3W;S
M)C&6DFN'_O2RN2\AY.-Q.!P,#BOA_P""6D6'Q_\ ^"GWQYUC5K:#6?#N@Z._
MA\VUS&)(FR(K9XR#P0?+N<CON-.G[M6C3I[P<IZ]6E^5[)>03=X5*D]%)1AI
MT3?YVYGVO]Y]U^+/C-X(\$_#N;QUJ_B?3+?PFEO]I355N4>&=2,J(F!/F,W1
M57)8D 9KX@_X)T:#K/QS_: ^+'[3>MZ?-IVFZ]*^E:!'.,%X R!B.Q")##'N
M'!;S!V-=Y:_\$A?V?;;QH=<:T\17%AYGF#P]+JO^@+_LY""<K]937V'I?AO3
M?#_AVWT+1K2'1=+M;<6MK;:?&L26T87"B-0-JX'3C%$;0;JKXK-)=K[W[M["
ME>25/I=-OO;;T74_/O\ X)_K_P +9_;8_:3^*LBB6&"\.C6,_4&-IF48/_7.
MTB_[ZKV+_@J7\0/^$%_8U\6Q1S>3=Z]-;:/#SRWF2!Y%_&*.2O4?V8?V5?"/
M[)_A36-!\)7NL:E#JM^=1N;K6YHI9S(45-H,<48V@+D#&<LW/HG[3G[*OA3]
MK#PWHFA>,-3UNQTW2K_^T4BT:XBB\Z0(4 D,D3Y4!F^[@\GFLJE-2HTZ">D5
M%/TTYOU-:<^6M.L^KDU_[;^2/'K>(_LS_P#!+DC T^_L?!#,>Q2]O(R?S\ZX
M_.NN_P"";W@(?#_]C7X=V[1[+C4[5]8F.,%C<2-(A/\ VS,8_"O3?CY\ = _
M:(^$]Y\/->O]4TG0;IX&D?198HIML3JZ(#)&Z[<JN?E[5VWA+PS8^"O"NC>'
MM,1DT[2;.&QME<@L(HD"+G '.%':NF4^:I6J;.35O1<S_-K[CFC%QITJ;^RG
M?U=E^2?WGYS_ /!2NUTCPA^UQ^S_ ..O'&DV^J_#D,=/U-+VV%Q; +/N<2HP
M*L-DH?:0<B-N#BOJWQ#\)OV7?"?@<^,M7\"?"FQ\*^2+A=7ET+3OL\B$94HX
MCP^[C 7).0!G->I?%;X1^$?C=X+N_"GC;1+?7M#NB&:WF+*4<?=='4AD<9.&
M4@\GU-?)>B_\$=O@#I?B+^TKA_%6KV>\O_9%[JJ"UQ_=S%$DN!_UTS[USTTX
MTW2\VT_75IKUV.B=I357R2:]-K?+<W_V'_&7P\^.6N^*/%_@C]G[PS\//#VB
MW;V&C>,+2QMH+K5,EE<HB6T;1#9MW?.WW]O)!QY5\*O^+T?\%=OB#X@91<:;
MX#T=K"VDZB.81QVY7V.Z6Z_(U^@OACPOI'@KP_8:%H.FVNCZ/81""UL;.(1Q
M0H.BJHX%>5? ?]D_PC^SYXT\?^*=!U#6M4UCQK>_;M2FUB>&0(_F2R;8O+B3
M:NZ9N#N/"\\5M%I5HRZ1C)>=VK7\MV]-.AD[NE)=9->ED[M=^B_X;0SOV[OB
M%_PK/]D?XFZPLODW$FDOIUNRG!$MR1;J1[@RY_"O*/V+[*/]G/\ X)OVGB>Z
M013KHFH>*9SC!<NLDL7X^6L0KWS]I+]G3P_^U%\.?^$)\3ZKK.E:.UY%>2/H
MDT44LC1AMJ,98I!MRV[  .5'/K;\=? 7P_X\^!-Q\)9;O4M(\,S:9!I/G:9+
M&ETEO$$ 56>-EY5 IRIX)Z5S2C)TJR7Q2LEZ)/\ ]N?X&Z<?:4>;6,6V_5V7
MY)_>?(G_  2I\.:AX+_8S\7^-H8C=:UKNH:AJ5ON4L9O(B\N,'N<R))_WU7E
MW_!-/X"?"G]IS0_%WQ#^*/D_$/XER:S(UW9ZQ=,_V>(JK+*T&X!PY9_F8%1L
M"J!M-?I!\%_A'H?P)^&&@> _#CW4NC:-"T,$E\ZO/)N=G9G*JJEBS$G"@<]*
M^:_BQ_P2@^!GQ6\:7GB5H]?\*W5[*T]U:^'KV**VFD8Y9_+EADV9/9"H]JZ9
MR7MY3BKIQ45Y6MK\TM3GBFZ2C)V?,Y/SO?1^E]/ZO\I_\%1/$GP-\"^$M-^&
M'PM\+>#;/Q==7R3:O=>'=-MDELX(P=L$DT:Y#NY4[,Y 3D#<,_J=\+O"</@/
MX:>$_#<"A8=(TJUL% ](XE3_ -EKYGUW_@E9\"-4\ Z=X6T_3M6\.&SOEU!]
M<TRZC.IW,BHR!9)YHI/W?S;MB!5W $ <Y^O((_)ACCWM)L4+N;&3@=3CO1&T
M*<HWNW*[^2LK?C^8Y^].$K6237WN^O\ 7D25^='[($(\0?\ !3K]I/6[DJ;F
MQADLHMS98)Y\*#''3; H]LCK7Z+U^?7PLM9/A3_P5P^)&EW06&T\<>'!J%B6
M&/-8"!VQ_P "AN?RJ*.F*C+IRS7SY;_DF.KKAY);\T'\N:WZH^VOBQX(7XF?
M"_Q=X2>7R!KFDW6F^;_<,L3(&_ MG\*_/?\ X):?M :7\([/Q+^S_P#$BXB\
M(>+])UB:2QAU1A DY?:LD =B 9 Z[E'\:R#;G%?IG7@_[0W[$?PC_:;N%O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#QS]F[_ )JE_P!CWJG_ +2KV.O'/V;O^:I?]CWJ
MG_M*O8Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O'/V0?^3=_"?_;W_P"E<U>QUXY^
MR#_R;OX3_P"WO_TKFH ]CHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]K[_ )-W\6?]
MNG_I7#7L=>.?M??\F[^+/^W3_P!*X: /8Z*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /'/B=_R<1\%/\ N-_^DB5['7CGQ._Y.(^"G_<;_P#21*]CH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *\6_9^_9/\(_LX^(?'6N>'M1UK5=4\97HO]2N-:GAE(D#ROB/RXH\+
MNF<X.>W->TT4+1W7:WRT?Z('JK/U"BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %>.?\WA?]R)_[D*]CKQS_ )O"_P"Y$_\ <A0!['1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!XY^S=_P U2_['O5/_ &E7L=>.?LW?\U2_['O5/_:5
M>QT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>.?L@_\F[^$_P#M[_\ 2N:O8Z\<_9!_
MY-W\)_\ ;W_Z5S4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M )&_^QH_X3S_ *<?_(W_ -C1[*?8/K%+N=917)_\)Y_TX_\ D;_[&C_A//\
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M )&_^QH_X3S_ *<?_(W_ -C1[*?8/K%+N=917)_\)Y_TX_\ D;_[&C_A//\
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M )&_^QH_X3S_ *<?_(W_ -C1[*?8/K%+N=917)_\)Y_TX_\ D;_[&C_A//\
MIQ_\C?\ V-'LI]@^L4NYUE%<G_PGG_3C_P"1O_L:/^$\_P"G'_R-_P#8T>RG
MV#ZQ2[G645S4'CBV8@2V\D?J5(;'\JVK'5+74H]UO*K^J]&'U%2X2CNC2-2$
M_A9;HHHJ#4**** "BBB@ HHHH ***_,O]H@?\+L_X*T_"CP>,W&G^$;6WO+B
M,<K')&)+UB?J! /RHC[U6%/^9_<K-M_*P2]VG.I_*K^NJ5OQ/TTHKGO%'Q$\
M*>![[2K/Q'XGT;0+S5IOL^G6^J:A%;27LF5&R%78&1LN@PN3\P]15#QA\8O
M/P\U"WL?%7CCPWX9OK@9AMM8U:WM))03C*K(X)Y]*!G845';W$5U!'-#(DT,
MBATDC8,K*1D$$=0169XH\8:#X'TE]4\1ZWIV@:9&</>:I=QVT*D] 7<@#\Z'
MIN):[&O17)^"?BYX&^)33KX0\9^'O%30#,JZ)JL%X8_][RW;'XUUE,045R'B
MWXP> _ .J6VF^)_&WASPYJ-R 8+/5M6M[6:4$X&U)'!;)]!7Q'_P6<\=-9_
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M 4444 %%%% !1110 5XY_P WA?\ <B?^Y"O8Z\<_YO"_[D3_ -R% 'L=%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% 'CG[-W_-4O\ L>]4_P#:5>QUXY^S=_S5+_L>
M]4_]I5['0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5XY^R#_P F[^$_^WO_ -*YJ]CK
MQS]D'_DW?PG_ -O?_I7-0!['1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[7W_)N_BS
M_MT_]*X:]CKQS]K[_DW?Q9_VZ?\ I7#0!['1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%(6"\DX%<=XT^,'@WX>PF3Q!XA
ML=-XR%ED^9O8 5$IQIKFF[(Z</AJ^+J*EAX.<GT2;?W([*BOE;Q%^W_X5%TU
MCX5T75/$=_G:ABA'E,?J#FH+7XI?M#?$< Z-X'M/"D#CY+C4BP!'KWKS?[2P
M[?+3;F_[J;_X!]I'@G-Z<%5QL8X>+ZU9QA^#?-^!]845\RV_P?\ CEXE4?\
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M9J^O7.K.0Y\N#/$2GC\?4UFT45WI**LCQ92<G=A1113)"BBB@ HHHH ****
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M7_9!_P""5=CKNAPB'Q':^'H]0C:1 WDW-].K"0J<@F/[0#@\?( >*\Y_9/\
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M[#_P3G\"Q?#_ /8U^'%L-OFZA9-J\SCNUR[2C/T1D7_@-?)GQN^)FC_M<?\
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MG/'IG[!O[%/[-_[0/[,OA?Q/K7@U-<\4 SVNL3C6K^)EN4E; :.*=53,9C8
M*,A@>]:7QF_9Z_8J^"_Q,\(_#V[^%&K^)O&?B:=8;;1_#NLWUQ/;AF"K).'O
MD\M#DD'GA&.,#-:SINE.%&GHTU:W5_KS;Z]&1"I[2,JLU=-.]^B[>5MO4^[O
MA!XW?XF?"CP;XND@%M)KNCVFIO"O1&FA20J/8%JZB\LXM0LY[6=2T$\;12*K
M%2588.""".#U!S5#PKX7TSP3X9TGP]HEJ+'1]*M(K&SM0[.(H8T"(FYB6.%
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M3=_"?_;W_P"E<U 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M4:U/$04Z4KH_ <QRS&93B)87'4G":Z/].Z\T+1116YY84444 %%%% !1110
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M\Y?LN_L/>#/V9=4U/Q)'J>I^,O'FJH4O_$^NR!YV4D%UC'\"LP!.2S' RQ
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MY=FYMNYBS8R<9ZGK7<T57,_>_O6;^2LO^&0K+3RO^._Y(^<? O['X\*?M?\
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M*FME9_=_P_ZGRU^UA^P/X<_:8\3Z7XST[Q-J?P]^(6F1K%!XATE=Y95.4\Q
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M;_Z ]_\ ^ K_ .%0MX3USG_B3:A_X"O_ (4_J<?Y_P"OO%_:4_\ GT_O_P"
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MM7_H'?WO_P"1/NJBOA)OASXL_P"A7UK_ ,%\W_Q-0M\-_%O/_%+:U_X+YO\
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MLF_^)I_V33_Y_+[O^"+_ %CK?] K^]__ ")^BM%?G,WPK\:?]"AKW_@LG_\
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MQ17YAM\(?'?/_%%>(O\ P53_ /Q%1-\(/'G_ $)/B+_P4S__ !%/^QJ?_/\
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M@GO7Y?O7WY_P3ICG'PS\3NR@6S:OA&P<EA#'N'IT*?G]*^=SZG&6#YGNFO\
M(^WX-K3IYG[-;2B[_+4^LJ***_-S]T"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "O'/V0?^3=_"?_ &]_^E<U>QUX
MY^R#_P F[^$_^WO_ -*YJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_:^_Y-W\6
M?]NG_I7#7L=>.?M??\F[^+/^W3_TKAH ]CHHHH **** "BBB@ HHHH ****
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M10 4444 %%%% !1110 4444 %%%% 'CGQ._Y.(^"G_<;_P#21*]CKQSXG?\
M)Q'P4_[C?_I(E>QT %%%% !1110 4444 %%%% !1110 4444 8_BNW-QHLQ
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MZ#\4O!.J^$_$=BM]HFI0^3/!G:0,@JRD?=92 P(Z$"OS6\>?\$@_&%OK4O\
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MWTJE\0?^"=^AZE?1WWA76)]+N$(<BZ)D+..=V1COS6__ ,/#?AS_ ,\-3_\
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M_P#D1/\ &C_A%=4_Y]?_ "(G^-'/'N'LY_RLR:*UO^$5U3_GU_\ (B?XT?\
M"*ZI_P ^O_D1/\:.>/</9S_E9DT5K?\ "*ZI_P ^O_D1/\:/^$5U3_GU_P#(
MB?XT<\>X>SG_ "LR:*UO^$5U3_GU_P#(B?XT?\(KJG_/K_Y$3_&CGCW#V<_Y
M69-%:W_"*ZI_SZ_^1$_QH_X175/^?7_R(G^-'/'N'LY_RLR:*UO^$5U3_GU_
M\B)_C1_PBNJ?\^O_ )$3_&CGCW#V<_Y69-%:W_"*ZI_SZ_\ D1/\:/\ A%=4
M_P"?7_R(G^-'/'N'LY_RLR:*UO\ A%=4_P"?7_R(G^-'_"*ZI_SZ_P#D1/\
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MVA=+?P9XCL/"/PB\/W0\C4-<TNX1KBX@/#JOEW$[@D9.%\K/0L 37V#^SO\
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ML15+X5PG]NO]N_5_B1<@W?PK^%3_ -GZ K?-!>7X.?-&>#\P,N1SA;?-:_\
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M)^FY]=JH50JC '  I:**S+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KQS_F\+_N1/_<A7L=>.?\ -X7_ '(G_N0H ]CH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \<_9N_YJE_V/>J?^TJ]CKQS]F[_FJ7_8
M]ZI_[2KV.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KQS]D'_DW?PG_ -O?_I7-7L=>
M.?L@_P#)N_A/_M[_ /2N:@#V.BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %>.?\WA?]R)_P"Y"O8Z\<_YO"_[D3_W(4 >QT444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >.?LW?\U2_['O5/_:5>QUXY^S=_P U2_['O5/_ &E7L= !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !7CG[(/\ R;OX3_[>_P#TKFKV.O'/V0?^3=_"?_;W_P"E
M<U 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>.?M??\F[^+/\ MT_]*X:]CKQS]K[_
M )-W\6?]NG_I7#0!['1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M91ED79-;R#[T4JY.UUR..00002""2+4US1'.$J;M)':T444S,**** "BBB@
MHHHH W?#_B233Y$@G8O:$XYZQ^X]O:NZ5@R@@Y!Y!%>45VG@W5&N;=[20Y:$
M90_[/I^%<M:'VD>CAJSOR2.DHHHKD/2"BBB@ HHHH **** "BO@OQ1_P5<T3
M2?VD$^&FD>!)-;T :_;^'Y/%JZOY40F>18Y66'[.P8(Q?'[P;@F1@&OO2B/O
M051;/_@/]4$O=FX/=?U^@4444 %%%?./@W]L#_A-_P!L3Q9\#-/\);K?PW8?
M;+OQ+_:606"0DQBW\KCYYPN?,_A)QVHC[TN1;V;^2W!Z1<GMI^.B/HZBBB@
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M '(4 >QT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>QUXY^R#_P F[^$_^WO_ -*YJ /8Z*** "BBB@ HHHH **** "BBB@ HHHH
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MV4:2"6;<O(XWI@X[UYE_P6 TW6;CX=^ ;VV61]!MM2N%O=N2JS/&OD%OP68
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MDD"OP^_:(\=>,/VGM=\5_%^\M7M_"FGWL&DV<<K';;(^]H8$[,^U6=\=VSW
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MU=F*ES8BA&UU9/YJ,5;\68T%RJL[V>ORNV[_ ('Z*>-_V8?V:7^'\GPFCO\
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M\U+QI\6/VM/A/\)O!^@V_BF[T^R&NP:!?3)':ZA.7D9EFW21J4$5JPY=3AW
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MD5PH)"MC!^YO&WCJQ\'_  WUWQB9HY]-TW2IM5$JG*21I$9 01U! _6OE_\
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MZ'Z9UY'^UC\:KC]GG]GSQCX^LH;6XU+2K9/L4%\K-#)<22)'&'"LK%=SC(#
MX!Y%>N5\ _\ !8SQ5<K\$_!7@33VSJ'BSQ%%&(!UECB4G'_?V2#]*Y:O-)*$
M-Y-+[VD=-/EYN:>R3?W*_P"A[O\ #_\ :&\23_L3)\9O&=CI=KKW_".W6O-9
MZ?%)':D!9'MU"O(S?,HCS\_)8XQV^=/@[_P4;^*OQN^&=E:>!/A;:^/_ (K2
MF:34(],22PT31X=[+ )Y9Y3NE<+NV"100?O9!%=A_P %)=6@^"/[ :^#[!_L
M_P!K73?#5LJ=XXPK./H8[=A^->Y?L7?!*P^ G[-_@SPY;6<=MJ,UC'J&JR*H
M#S7DR!Y2Q[[20@ST5%':NIJ-2I7G%^XFDOQ?W6MY]#F3E&E14E[S3;]-%^=]
M/^&/"OV>?VY/B?>?M%P?!3X]_#[3?!7BW4K=KC3+C1W;R7PC.%8&697#*DF)
M$DP&3:1GI]RU^<.?^%R?\%D%:(>99?#W0<.PY&X0$?F);['_  "OT>J4^>C3
MJ-:N_P U=I/YI?TRY+EJS@GHK??9-KY%?4+Z+3;&YO+AQ'!;QM+(QZ!5!)/Y
M"OP#OM-OO&GP%^*WQR\O-Y/\2["XCF<<IE;N5P#C^]<P]^U?LE^W!X\_X5M^
MR;\3]:67R9_[&ELH'!Y$MQB!"/<-*#^%?#GAOX,_8_\ @B_K9>WVWVH;O%#<
M<_)>IM;_ +\0K^=<W.Z;J5U]A1L_/G4G_P"2Q_JYT)*2IT7KSN2?RBTOQDOP
M/U$\.:Q'X@\/:7JD)S#?6L5RASGY70,/T-?F]^VE\3;3]H;]HB3P"Q:\^%7P
MCL9_%/C)HV_=7=U#&62U)Z'YBL.,YS++_<KUVX_:LC^"7_!-?P/\05D2Y\07
M'ANQTK2HI.?.O_*\H$CN$,;R$=PA'>OF7XR?#.Z_92_X)IZF-?:0_$GXJ:O:
M3:Y<S',^78W/DLW4[4C;=_MRR>M;8J*C5J..T'9?XF[1_P# ?B?HC'"^]2IJ
M6\UK_A2O)_/X5ZL^E/\ @DWH,UG^S3J_CC561;_QAX@OM7N+@@(NQ6$7T"AH
MY3Z#-8FO?M]_%?XS>,-<T/\ 9B^$T'CO2]%G-O<>*M<G\JQG<=1&#+"N.A4F
M7<P.=@%>P>!=8\(?LE_L*^%)O'JQQ:#I/ARV34;,P"8W4\Z R0+&>'9Y)&7!
MXY.<#)'@?PG_ &NOBOXA\-LGP&_9!CT;P7-(T]A.US#I=I<;C_KE0111DL!S
ML=N1C<<5M62^L2@MH::>6BN_1?/T,J+?L8U'O-MZ^>KLOF=!\/?V^_B?X!^+
MWAKX<_M(_"VW\"WWB69;?3-;T64O:-(S*B*1YLRL-S*&9924W+E<'(^B?VQO
MCQ>?LV_L\^*/'NF6]G>:O8""*QM[]7:"2:69(P'",K$ ,3@,/N]:_.CXX>+?
MC9\<?VR_V??!?Q<\(:+X)O;35H=3LM*T>[6YE%LUPC2232+-(N=MHV -O .1
MS7OW_!7O6)]>\%?"GX8V,I6^\7^*(P(UZLD8$8!_X'<QG_@-8R4JE&'+92E/
MET]4OOLW]QM'EA6DI;1CS:^C?W.R/IOPK\?HO#G[+>@?%CXJW%AX?:;1+?5M
M26RB=(D>5 R111N[L6.Y5"[B2QKY5T?]N+]J'X_0S^(/@;\!--F\%)(\<&H>
M*+D"2[56(W(3<6ZD\8*IY@4@C<<50_X*3:;+XU^)W[.'P M)6M/#>KZC$UY'
M&VW,:/';QX_W8S/@>I%?HCH.AV'AG1;#2-*M(K#3+"!+:UM8%"QQ1(H544#H
M  !6GNU.>O'X>9J*]-[_ 'V2^9E%N"A2E\7*G+Y[)?=>_P CY8_9)_;JF^.'
MCK6?AC\0O"$WP[^*FCH7ETJ5F,5VJ@%VCW ,C $-L);*$,K,,XO?MI_M@7O[
M,?BKX4Z38G1(8/$^J.NK7FMQRNEGI\1C\Z5!'(GSXDXSNSMQM)->%?&Q[>]_
MX+#?""/1%!U&VT0?VHT Y'[J]/SX_P"F13KV*^U+\?/!UE^TO_P5,\">"=2C
MCO\ PYX(T%-5U*TDY1F#-,$8=PS26H(/5<BHBW5]B]KR=_2%VW;L[;>JN:32
MI>U6]HIK_MZR2]4WOZ'KGP]_:$_:.^-/Q.\.7_AKX1:;X3^"6H3AI->\52 Z
MG):#)\Y;=;F-XS(  @,;@;@Q)6OL"D "@ # '04M5I917_!^?_#(G5OF?_ _
MKYGPQ_P6&\??\(M^RE'H,;D3^)M9MK,JIP3%%NG8_3=%&/\ @5?37[,G@'_A
M5W[/7P[\+,BQSZ;H=K'.%&!YQC#2G\79C^-?#'_!20GXQ?MD?L]_"&+,]O\
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M]L3]LZY_9G^*GPJ\.1-HMOH^O2W%WX@OM6BED>UL(2A)@$<B_O6'FA<ALL%
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M>B^9?^/W[?U_X?\ BI/\)?@IX%G^*OQ'MP5O?*<K8Z<XX*R,OWBI(#Y9%4L
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M#_B^/_!7;XC^*3FYTWP5:3VMN[<K')$D=E@?5FG8?C7Z:5G2TPM/^]S2_P#
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M!I]IK=U8^8< X>18P/8RY'U-8RJ<M.LVO@2DOG=6_"]S7V=Y4K/XVX_@G?\
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M ,<[:^<?@?XJ_:&^(?[47Q8^-7PF^'.@^/M3;4I]+-QXBN8D&FQ%L11Q*UW
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MU_\ B:=Z'8GEQ??\C.;XG;?^8;_Y'_\ L::?BCC_ )AG_DQ_]C6BWPWTQO\
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M+7/^_P##_P#&J3_AC_P;_P!!/7?^_P##_P#&JUY\K_E?X_YG-[//_P#GXO\
MR7_(Y9OVU-O_ #)O_E4_^TTT_MKX_P"9-_\ *I_]IKJ6_8[\&-_S$]=_\"(?
M_C--_P"&.?!9_P"8GKW_ ($0_P#QFGSY7_*_Q_S%[+B'_GXO_)?\CE6_;:Q_
MS)G_ )5/_M--;]M['_,E_P#E5_\ M-=4?V-?!9_YBFO?^!$'_P 9II_8R\%'
M_F*:]_X$0?\ QFGSY5_*_P ?\R?9<0_\_%_Y+_D<J?VX,?\ ,E?^57_[33/^
M&Y/^I*_\JO\ ]HKK/^&+_!)_YBFO_P#@1!_\9IO_  Q;X(_Z"GB#_P "(/\
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MP?\ QFF']AGP&?\ F+>(O_ F#_XQ3Y\G_D?X_P"9/L>)O^?B_P#)?_D3C_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM5UVL-DLS*<@]Q7M-%*,5%WBK?\ !W)E.4E:3N@K\9?V6O\ E(Y9?]C'J_\
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M5U8S.F>1B'D=#SNK._9CD_X6Y_P5*^.OC4$36'ABR.BP-U"2*T5OQ]1;S_\
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MDK>1/VG+JW=GPC^S?^RS\0?BM\=V_:(_:"MHK#Q#%@>&_!Z,'32XQGRVD&2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7CG[7W
M_)N_BS_MT_\ 2N&O8Z\<_:^_Y-W\6?\ ;I_Z5PT >QT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDZ*ZS_A _P#I^_\ (/\ ]E1_P@?_ $_?^0?_ +*CVL.X?5ZO8Y.BNL_X0/\
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MKV.3HKK/^$#_ .G[_P @_P#V5'_"!_\ 3]_Y!_\ LJ/:P[A]7J]CDZ*ZS_A
M_P#I^_\ (/\ ]E1_P@?_ $_?^0?_ +*CVL.X?5ZO8Y.BNL_X0/\ Z?O_ "#_
M /94?\('_P!/W_D'_P"RH]K#N'U>KV.3HKK/^$#_ .G[_P @_P#V5'_"!_\
M3]_Y!_\ LJ/:P[A]7J]CDZ*ZS_A _P#I^_\ (/\ ]E1_P@?_ $_?^0?_ +*C
MVL.X?5ZO8Y.G11/-(L<:EW8X"J,DUV,/@>V5LRW$D@]% 7_&MJQTFTT[_CW@
M5&Z%NI_.HE6BMC2.%F_BT,3P_P"%?LKI=7>#*.4B[*?4^]=-117)*3D[L]*$
M(TU:(4445)H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7CG_-X7_<B?^Y"O8Z\<_P";PO\ N1/_ '(4 >QT444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 >.?LW?\ -4O^Q[U3_P!I5['7CG[-W_-4O^Q[U3_VE7L= !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !7CG[(/_)N_A/\ [>__ $KFKV.O'/V0?^3=_"?_
M &]_^E<U 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %>.?M??\ )N_BS_MT_P#2N&O8
MZ\<_:^_Y-W\6?]NG_I7#0!['1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY\3O\
MDXCX*?\ <;_])$KV.O'/B=_R<1\%/^XW_P"DB5['0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9^H?VKYR_8?L?E;
M>?M&_=NR?3MC%5?^*A_ZAG_D2@#:HK%_XJ'_ *AG_D2C_BH?^H9_Y$H VJ*Q
M?^*A_P"H9_Y$H_XJ'_J&?^1* -JBL7_BH?\ J&?^1*/^*A_ZAG_D2@#:HK%_
MXJ'_ *AG_D2C_BH?^H9_Y$H VJ*Q?^*A_P"H9_Y$H_XJ'_J&?^1* -JBL7_B
MH?\ J&?^1*/^*A_ZAG_D2@#:HK%_XJ'_ *AG_D2C_BH?^H9_Y$H VJ*Q?^*A
M_P"H9_Y$H_XJ'_J&?^1* -JBL7_BH?\ J&?^1*/^*A_ZAG_D2@#:HK%_XJ'_
M *AG_D2C_BH?^H9_Y$H VJ*Q?^*A_P"H9_Y$H_XJ'_J&?^1* -JBL7_BH?\
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M -JBL7_BH?\ J&?^1*/^*A_ZAG_D2@#:HK%_XJ'_ *AG_D2C_BH?^H9_Y$H
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M_M*O8Z\<_9N_YJE_V/>J?^TJ]CH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\<_9!_Y
M-W\)_P#;W_Z5S5['7CG[(/\ R;OX3_[>_P#TKFH ]CHHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )Y6_P#WRW_Q5'_";WW_ #RM_P#OEO\ XJCV,P^M4SMZ*XC_ (3>^_YY6_\
MWRW_ ,51_P )O??\\K?_ +Y;_P"*H]C,/K5,[>BN(_X3>^_YY6__ 'RW_P 5
M1_PF]]_SRM_^^6_^*H]C,/K5,[>BN(_X3>^_YY6__?+?_%4?\)O??\\K?_OE
MO_BJ/8S#ZU3.WHKB/^$WOO\ GE;_ /?+?_%4?\)O??\ /*W_ .^6_P#BJ/8S
M#ZU3.WHKB/\ A-[[_GE;_P#?+?\ Q5'_  F]]_SRM_\ OEO_ (JCV,P^M4SM
MZ*X^#QU*"/.M48=S&Q'\\UNZ9XBL]4PJ2>7,?^6<G!_#UJ)4Y1W1I&M">B9I
MT445F;A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %>.?\WA?]R)_P"Y"O8Z\<_YO"_[D3_W(4 >QT444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >.?LW?\U2_['O5/_:5>QUXY^S=_P U2_['O5/_ &E7L= !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !7CG[(/\ R;OX3_[>_P#TKFKV.O'/V0?^3=_"?_;W
M_P"E<U 'L=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %>.?M??\F[^+/\ MT_]*X:]CKQS
M]K[_ )-W\6?]NG_I7#0!['1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!XY\3O^3B/
M@I_W&_\ TD2O8Z\<^)W_ "<1\%/^XW_Z2)7L= !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEMD/_ Y$5?UKY5_9?_8Q7XU:/_PL/XF:C?W<&J2-+;6:S$370S@S2R')P3G
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MF8CB0K]Q@>N  /3%>T?"?X6^'O@+\.X-!TC<EC9HT]U>3GYYY,9>5_3IT'
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MA5EO))_>%%%%<ITA1110 4444 %%%% !1110 4444 %%%% !1110!XY\3O\
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M&5K<_$QIF\5^(+-=8F%Y/YMRJN[HHF_NO^[^Z"=H*C@@J/WA^&__ "3OPO\
M]@JU_P#1*U^5?_!6K_DY#1/^Q;M__2BXK]5/AO\ \D[\+_\ 8*M?_1*U.%M[
M*HDK)2M]W,C;&W]I2;W<6_OY6?%G[;/[6'Q5T7XK-\&/A5HCC6+RTAD.IV,;
M7%\PE&2(EQMB &<N=V <@IC-? VF_#_Q!\+_ -J?PUX:\5.C^(K/Q#ICWQ28
MS?O))(92"_\ $P\P GD9!P2.3^\<&CV%KJ-UJ$-E;PW]T%6>ZCB599@HPH=@
M,L .F>E?CE^TK_RDDN_^QITC_P!!M:RIQ<,33YG=MO7RYE9?),U]HI4*BBK)
M+\;.[/V9K\V/VHOVE/C7\9/C%XE^!GPLT26PM[.Y-C>7FF%FN9X\?,TLYPMO
M$<C.,'C&\YVU^D]4[#1[#2I+I[*RM[-[J4SW#6\2H9I#U=\#YF/J>:UG3]I)
M<S]W6Z[[?\$Y:=3V:;2][H^Q^)O[&WARZ\'_ +<G@_0+YHGO=+UJ[L9VA8M&
M9(HID8J2 2,J<9 K]G/B)X'L/B9X#U_PGJDMQ!IVM64MC<2V;*LRQR*58H65
M@&P>,@CVK\B/@'_RDLB_['#5OYW-?LS2P_[W!QY^M[_-1-<7>GBWR]$OSD?$
M/_#HOX/?]#)XX_\  ZS_ /D2OB74_P!FGPI\1/VKH?A1\(M0UC4=%MI3!J.M
MZM-%/L\LG[3,GEQQC8GW%S]YL<X85^F_[<_QO?X%?L\Z]JEC/Y&NZIC2=,93
M\RS2@[I![I&)&'NHKQ+_ ()0_!F/PS\*]6^(E[ #J?B2X:VM)&'S+9PL5./3
M?*'SZ^6M33A&I7>GNPU?FWLOU?EZ&DJDZ=#G;UD[+R[O_+T\S[$\%^#=!^#G
MP[L/#^B6XL-!T.S*QH6)(1069F)ZL3N8GN2:_&3]FWX8^%?VFOCCXNN_B)K\
MWACPWY%WK=[J<=Y#:[)'N%"J99E9 "93U&3BOV5^,6BZUXE^%'C#2/#GE#7M
M0TFYM+(S2;$$LD3(I+8. "<U^7WPM_X)/_$OQ5?7R^--5L/ ME =L,L834I;
MD_WE2.10J=>6<-G^'O2FI3Q+G*-[+\7>_P"28490IX=QYK-M>ME_G=GNW@__
M ()F?L\>.[=[SPO\1_$/B2VA<!YM)US3KI%;T+1VQ ->T_M_?%V^^"_[,^LW
M6CW3V>L:K+%HUG<1L0\1D!,CJ1R&$228(Z$@U^:_Q5^&?Q!_X)Y_'#1KS2/$
M2W$LD7VNPU2U1HH[V$-B2&>(D\9 #)EA@J0<]/JC_@IAXX@^)'[)?PK\56:-
M#:ZUJ5M?K$3]SS+*5MI]P21^%16DIX5N&UTFO5V?WV:\C2$''%0YW?1M/Y7_
M ,CS?_@G9^Q;X,^.?A'7?&WQ!LI]8TZ.\.G6&FK<RV\9945Y)F>-E<_?50 0
M.&SGC'J6A_\ !-+Q+\-_VD++QO\ #_Q5INB>%--U*&]L;2[DGFO%B^7SK=OD
MP5(,B ER2I&<G-?)_P"SS\ ?C1^U/\/I_#GAC6X-.\!Z'<N3%JEY);V3W4F'
M8;8D=I9,$'+*=H(&1G!Z#X,_&CXF_L*_'J/P/XOO+AO#L%U';:IHTEP9K402
M$$7-MGA3M8."N-V-K#/3I@X^VIJW*]+>;TW]7^'D934Y0J6ES;W79>7RT?GY
MGU#_ ,%>M4UBU^$G@RRM6E31;O5W-Z4)"M(D1,*MZCF1@#W7/:NC_8Q_9=^#
M_BS]E'PYJ&K>$M%\0WNN6DLVHZK?6Z2W*2%W1ECE(W0[-NT;"N"N>I)KL_\
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MJ/\ Y*=\</\ LCC_ /I5/5U%;#TTG>T9Z]_<FR=7B*C:M[T-/^WX'UM\-_\
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M_-'H_A/QAH/CS0[?6O#>LV&OZ1<#,5]IMREQ"_KAT)&1Z=J\#\&_L5Z;\/\
M]KK7/C;X>\0_V3:ZU9O;WOA:UT\)#+(ZKOE,HDZM(BR$;/O9YYS7S7\0/^"9
MOCKX"WU[XT_9A^).L:)J,2F=_#6H7 Q=!=S"-9 /+E'0+'.A![O7M'["O[;5
M]^T5\'?%M_XOL(;'QCX)!&K+;*8X[B/RW9)@A_U;'RI%9>@*9& =H?-!*59:
M.";?>ST?DU_7I+C+2F]5)K;NM5Z>7_!UM_M-?MW'X6_$:T^%?PR\'7'Q0^*M
MTH9]+M)"L%@"NY3,R@DMC#%?E 4[F=>,^/:O^WM^T9^SOJVDZA^T+\%-+T?P
M1J5P+;^TO#4^^2W8\Y8BYG1FV@D1L8RV#@\&I_\ @D;X9;QII?Q0^-NO1BY\
M5>*M?FM?M<@RR1 +-($/8-)* 1_TR7TK[@^*_P )/"?QP\$WGA'QMI"ZWX>O
M'CDFLVGE@W,CAT(>)E<$,H/##TZ57+.BHMZR=FT]M=;*WD]^X<T*CDE\*NDU
MOII?[^G8\0_;\^*MEH'[#WCKQ#I=VES;:[I45E8W$3<31WC)&&4_]<Y&;\*^
M7/V4?CY\2/#/[,7@[P%^SM\*W^(NN:?;/=:WXBU:06FD6MW/(9FME9Y(A/*B
MR*K!9%VX'WL\;_\ P57TRU\._!OX*_ [P= ;.'5M:AL]/L?.>3;!;QK!%&7=
MBS -<1\L2?E]J^^/A;\.='^$?P[\/^#M MDM=*T:SCM8408W;1\SMZLS98GN
M6)H@HOVLTWRN22[M15]?1RUMN^N@2<E[*#W2;?:[=OR6GS\CYB_9!_;8\8_%
MCXM>)OA#\6_!-MX*^).B6[7C1Z>S?9YHP4W+M9WVD"1&#"1E=6R,8YUOVI/V
ML/%_PG_:,^#7PL\%:;HNHW/C&Z7^U&U2":62WMFG2,/%Y<J ':)VRP8?(..N
M?%?V06/Q>_X*7?M!_$)&:2PT*%M$A8'@L)([=#]"MG(?QHT5O^%S?\%B]4N2
M/.T_X>:"8XSU4.(50CZB6]D_[X]J=-^TEAI-?$N:2\DF_P =/O%47LUB(K[+
MY5ZOE^_=GOW[4'Q!_:C\+^-M.L_@=\,O#?B_PVU@LEWJ&N7<4;BY+N#&BF]@
M.T($.2IR6Z\5\H_&[]OC]L#]G'3=-O?B+\-?AOX<74I6ALX3*US-,5&681PZ
MB[;1D L0 "RCN*_0KX[?'+PK^SO\-M3\:>+KT6VGVB[8H$(,UW.02D$2_P 3
ML1]  2< $CX6_9+^!?B7]M#XN2?M+?&JS(T191_PB'AF;)@$<;$QR;3UB0Y(
MR/WC[G(QC=E3BY3Y4]%JWV\O-OHNVK-*C48\[6KT2[OOZ=6^^Q]??LW_ !0\
M>>(?@!;^//C78:)X,U&:*749+>SCEMHK.P"AD><2R.4?:&<@MP"H(!!%?,<G
M_!0;XS_'[Q%J]I^S-\&H?%/A_2YS!)XC\2R&*"X(Q]U3+ L9(.0IE9]I!*KG
M%=!_P5_\?:GX9_9ITSPWI4C12>+-<@TZX*G:6@57E*9]W2,'VR*^K?@;\*=(
M^"/PE\+^"M%@2"STFRCA9D4 S2XS+*WJSN68GU-::57.IM%-)+N[)M_)->K9
MG_#4(;R:;;[*]K?/7Y(^7O@+^WWXLN/C19_![X^?#]?AOXZU #^SKNT=C97K
MMG:B@L^ V"%=9'5F!7@UZ?\ MY_M.:K^RE\"3XNT"UTV^U^YU*WTZRM]5CDD
MMV+[G<LL;HQQ'&^,,.<=>E?./_!4Z2UN?C;^S+9:<N[Q6WB'= 8?]:L1N;4*
M/H7Z?[K5+_P5(L_^%O?&']GKX,1SF.+7M8:ZO=A^9(F>.$./<(;C'TK/WJ\*
M:CI*4^7R=FG^5T_0T]VE.;E\*AS>FZ_-)KU[&_=?MG?M&?%;PGI^M_ WX+6/
MB?1;>UC_ +0\2:T3;VU_<B,>>+&V>XBE:)7W*K;G)QC&1SZQ^Q-^VM;?M5Z7
MKVDZSH+>$/B#X;D$>K:(Y;&,E?,0. RX=65D;E#@$G(-?2&@:#I_A?0]/T;2
MK2.QTS3[>.UM;6%=J11(H55 ]  !7YX?LNI'JW_!5_X_ZEHA T6WTV6WNFA4
M>6;C?:*X./XO-CF.>N0WO71%QEB'26S4FNZY=?NZ6_-F$E*-!5&]4XKRUT^_
MS_30P/\ @J5\0=!D_:=^ GA7Q)J"V/AK19?[?UAV5G @:X0$;5!+,4MI   2
M2X ZUZ!\1/VQ/VJI-(O/&_@;]GB#3_AM90O=-+XJESJDULF29?LR7$<D>5&=
MHCDP.<L*XCPOX3L_VE/^"N'C'5-3MTU'0/AW:1^5'( T?VB!(XXU(/=9Y)9!
M[QU]E_MH>/1\-/V5_B=KWF^3-'HD]K _<33CR(\?\#D6N/F=/!*JM6^::^;T
MOWV6GY].M153%^SZ+EB_+J[?-O\ K>W^RG^T5IW[4GP7TGQYI^GOI$EQ)):W
MFG22>9]FN(SAT#X&Y<%6!P.&&0#D5\P:%_P4@\5:]\1OBCX1T+P79^-M>L->
M?1/!WA_1%DCNKI8FD6>[O9GD9(X$VQ_.%0$OCH"R]5_P3]LD^!7_  3RLO$^
MHCR=UCJ7B>?<?X/G9#^,<49_&N6_X) _"&#1?@IK'Q1U&%9O$GC/49R+QQEQ
M:Q2%=H)Z;IA*QQUPN>@KMJ07UBI#91CKZMK1?=)==-3CIR?L(R>KE+3T5]_E
MROS9Z]\/_P!H+XE_#/X->+OB#^U#H_AWX?P:;<*EAIN@GSIIDV\ L+F97=W8
M*JJ5(VL6X.1XEIO[:'[5_P ;K7_A)?@W^S]IH\$.2;6Z\4706>\C!XDCW7-N
M""/[@D .0&;%<5_P5?U3Q;\3/CI\'O@YX3TE-?NYHVUM-%N)EB@U"<NZ(DC,
MZ  )!,#\Z\2'!!Q7=V?Q9_X*"Z?:PVMM\ _AY;VT*+'%#%>0JB*!@* -5X
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MK%_-6.().<'$1W%DZ XQV_0']D7PI+X(_9?^%NBW"E+BW\/6;2JW57>(.P_
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M(8_^>D:1>;^6&S]#7UG^T[^R5HG[14%K?B];1/$]E$88-06/>DD>21'*N02
M22"#D9/7I7D?[%/[*^O^'_$\WQ/^(,4D6N3B1[&QNN9U>3.^XE]&() 4\_,2
M<<5M_M/?M9>//@3\5-*M[?PCN\%QIF:ZN%)&I%AR(Y1D1E.P/)()(QBNVO.K
M5Q='#Y?-.5*-KW6K6Z\SCHQIT\+5KXZ%HU)7M;:^WH?/GB/P'^T%^QO;#5+#
M6IY_"\,@S-8W!N;)<G@20./DSTSMQSC-?6GPY^-T_P"T=^RYXNU6&T6S\11Z
M7?:?<VT&=OVC[.Q5DSSAMRD \@Y'.,U\X_'3]O+_ (71X O/!/A7P=>6]WK0
M6WFDN)!,^W<"4B1!EF) &3^5?2O[$OP5U/X._!PV_B"#[/K.L7+7UQ9MR8%*
MA4C;_:VKDCMNQVJ\QYE@XU\;34:REI;=KSL1@.5XJ5'!S<J+CK?9/RN?!7[*
MOP]^(OQ#UG7[/X=>+E\+7T%O'+= WDMNUQ'N(&-BG(4GO_>%?1O_  S#^T]_
MT5K_ ,K-U_\ $5P?QD^#/CW]D;XNS?$/X>P2W'AF25YDDAB,J6Z.<O;W"#_E
MGGHW3 '(85W6F_\ !42T_L<?VAX#F.J!<'[-?@0,WKRFX#VYKT\54QF+:Q&
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M 4444 >.?$[_ ).(^"G_ '&__21*]CKQSXG?\G$?!3_N-_\ I(E>QT %%%%
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M<1@\'8 JQH<$C<J X)&<&O>Z7L%["5)/5N]_.]U^+U^XIXC]]&<5I%6]>C_
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M.,G['HJN6/+)-?$K/TWLOU)O*\==$[_/N_3H?D_\ ?V@M9_X)?R>*_A9\7O
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9L_\IO\ ]MKZ*HI_VAB?Y_P7^0O[%P'_ #[_ !E_F?.+?L?[O^9M_P#*;_\
M;:C;]CG=_P S=_Y3/_MU?25%/^TL5_/^"_R)_L/+_P#GW^,O\SYI;]C3<?\
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M/_)N_A/_ +>__2N:O8Z\<_9!_P"3=_"?_;W_ .E<U 'L=%%% !1110 4444
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M_$T?\(1??\];?_OIO_B:/:0[A[&I_*<]170_\(1??\];?_OIO_B:/^$(OO\
MGK;_ /?3?_$T>TAW#V-3^4YZBNA_X0B^_P">MO\ ]]-_\31_PA%]_P ];?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5XY_S>%_W(G_N0KV.O'/^;PO^Y$_]R% 'L=%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"O'/V0?^3=_"?_;W_P"E<U>QUXY^R#_R;OX3_P"WO_TKFH ]CHHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ KQS]K[_ )-W\6?]NG_I7#7L=>.?M??\F[^+/^W3_P!*X: /
M8Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#TD2O8Z\<^)W_)Q'P4_P"XW_Z2)7L= !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %>.?\WA?]R)_[D*]CKQS_F\+_N1/_<A0
M!['1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!XY^S=_S5+_L>]4_]I5['7CG[-W_-
M4O\ L>]4_P#:5>QT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC#_\50!TM%<U_P +-\'_ /0UZ'_X,8?_ (JC_A9O@_\ Z&O0_P#P8P__ !5
M'2T5S7_"S?!__0UZ'_X,8?\ XJC_ (6;X/\ ^AKT/_P8P_\ Q5 '2T5S7_"S
M?!__ $->A_\ @QA_^*H_X6;X/_Z&O0__  8P_P#Q5 '2T5S7_"S?!_\ T->A
M_P#@QA_^*H_X6;X/_P"AKT/_ ,&,/_Q5 '2T5S7_  LWP?\ ]#7H?_@QA_\
MBJ/^%F^#_P#H:]#_ /!C#_\ %4 =+17-?\+-\'_]#7H?_@QA_P#BJ/\ A9O@
M_P#Z&O0__!C#_P#%4 =+17-?\+-\'_\ 0UZ'_P"#&'_XJC_A9O@__H:]#_\
M!C#_ /%4 =+17-?\+-\'_P#0UZ'_ .#&'_XJC_A9O@__ *&O0_\ P8P__%4
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M;X?_ /0]>&O_  ;V_P#\71_PN;X?_P#0]>&O_!O;_P#Q= '945QO_"YOA_\
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M&]O_ /%T =E17&_\+F^'_P#T/7AK_P &]O\ _%T?\+F^'_\ T/7AK_P;V_\
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MSX<?]#OH?_@:G^- '?45P/\ POSX<?\ 0[Z'_P"!J?XT?\+\^''_ $.^A_\
M@:G^- '?45P/_"_/AQ_T.^A_^!J?XT?\+\^''_0[Z'_X&I_C0!WU%<#_ ,+\
M^''_ $.^A_\ @:G^-'_"_/AQ_P!#OH?_ (&I_C0!WU%<#_POSX<?]#OH?_@:
MG^-'_"_/AQ_T.^A_^!J?XT =]17 _P#"_/AQ_P!#OH?_ (&I_C1_POSX<?\
M0[Z'_P"!J?XT =]17 _\+\^''_0[Z'_X&I_C1_POSX<?]#OH?_@:G^- '?45
MP/\ POSX<?\ 0[Z'_P"!J?XT?\+\^''_ $.^A_\ @:G^- '?45P/_"_/AQ_T
M.^A_^!J?XT?\+\^''_0[Z'_X&I_C0!WU%<#_ ,+\^''_ $.^A_\ @:G^-'_"
M_/AQ_P!#OH?_ (&I_C0!WU%<#_POSX<?]#OH?_@:G^-'_"_/AQ_T.^A_^!J?
MXT =]17 _P#"_/AQ_P!#OH?_ (&I_C1_POSX<?\ 0[Z'_P"!J?XT =]17 _\
M+\^''_0[Z'_X&I_C1_POSX<?]#OH?_@:G^- '?45P/\ POSX<?\ 0[Z'_P"!
MJ?XT?\+\^''_ $.^A_\ @:G^- '?45Y_)\?_ (;QHS'QMHI"C)VWB$_@ >:J
M?\-)_#'_ *'/3?\ OIO\* /2Z*\T_P"&D_AC_P!#GIO_ 'TW^%'_  TG\,?^
MASTW_OIO\* /2Z*\T_X:3^&/_0YZ;_WTW^%'_#2?PQ_Z'/3?^^F_PH ]+HKS
M3_AI/X8_]#GIO_?3?X4?\-)_#'_H<]-_[Z;_  H ]+HKS3_AI/X8_P#0YZ;_
M -]-_A1_PTG\,?\ H<]-_P"^F_PH ]+HKS3_ (:3^&/_ $.>F_\ ?3?X4?\
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MPQ_Z'/3?^^F_PH ]+HKS3_AI/X8_]#GIO_?3?X4?\-)_#'_H<]-_[Z;_  H
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M#A;?]^)__B*/^&J/A7_T.%M_WXG_ /B* /5Z*\H_X:H^%?\ T.%M_P!^)_\
MXBH;C]K+X3VNW?XNC;=T\NRN7_/;&<4 >NT5XY_PU]\)/^AL_P#*;=__ !JC
M_AK[X2?]#9_Y3;O_ .-4 >QT5XY_PU]\)/\ H;/_ "FW?_QJC_AK[X2?]#9_
MY3;O_P"-4 >QT5XY_P -??"3_H;/_*;=_P#QJC_AK[X2?]#9_P"4V[_^-4 >
MQT5XY_PU]\)/^AL_\IMW_P#&J/\ AK[X2?\ 0V?^4V[_ /C5 'L=%>.?\-??
M"3_H;/\ RFW?_P :H_X:^^$G_0V?^4V[_P#C5 'L=%>.?\-??"3_ *&S_P I
MMW_\:H_X:^^$G_0V?^4V[_\ C5 'L=%>.?\ #7WPD_Z&S_RFW?\ \:H_X:^^
M$G_0V?\ E-N__C5 'L=%>.?\-??"3_H;/_*;=_\ QJC_ (:^^$G_ $-G_E-N
M_P#XU0!['17CG_#7WPD_Z&S_ ,IMW_\ &J/^&OOA)_T-G_E-N_\ XU0 ?LW?
M\U2_['O5/_:5>QU\I?!+]H[X=^$?^$^_M;Q#]D_M3Q9?ZG:?Z%<OYMO)Y>Q_
MEC.,[3P<$8Y%>E?\-??"3_H;/_*;=_\ QJ@#V.BO'/\ AK[X2?\ 0V?^4V[_
M /C5'_#7WPD_Z&S_ ,IMW_\ &J /8Z*\<_X:^^$G_0V?^4V[_P#C5'_#7WPD
M_P"AL_\ *;=__&J /8Z*\<_X:^^$G_0V?^4V[_\ C5'_  U]\)/^AL_\IMW_
M /&J /8Z*\<_X:^^$G_0V?\ E-N__C5'_#7WPD_Z&S_RFW?_ ,:H ]CHKQS_
M (:^^$G_ $-G_E-N_P#XU1_PU]\)/^AL_P#*;=__ !J@#V.BO'/^&OOA)_T-
MG_E-N_\ XU1_PU]\)/\ H;/_ "FW?_QJ@#V.BO'/^&OOA)_T-G_E-N__ (U1
M_P -??"3_H;/_*;=_P#QJ@#V.BO'/^&OOA)_T-G_ )3;O_XU1_PU]\)/^AL_
M\IMW_P#&J /8Z*\<_P"&OOA)_P!#9_Y3;O\ ^-4?\-??"3_H;/\ RFW?_P :
MH ]CHKQS_AK[X2?]#9_Y3;O_ .-4?\-??"3_ *&S_P IMW_\:H ]CHKQS_AK
M[X2?]#9_Y3;O_P"-4?\ #7'POE_X]==N;['WOL^EW1V^F<QCKS^5 'L=%>.?
M\-9?#O\ Y_=2_P#!3<__ !%'_#67P[_Y_=2_\%-S_P#$4 >QT5XY_P -9?#O
M_G]U+_P4W/\ \11_PUE\._\ G]U+_P %-S_\10!['17CG_#67P[_ .?W4O\
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M_P %-S_\10!['17CG_#67P[_ .?W4O\ P4W/_P 11_PUE\._^?W4O_!3<_\
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MM],Y4=>?RH ]CHKQO_AJCPC_ - SQ+_X)IO\*/\ AJCPC_T#/$O_ ()IO\*
M/9**\;_X:H\(_P#0,\2_^":;_"C_ (:H\(_] SQ+_P"":;_"@#V2BO&_^&J/
M"/\ T#/$O_@FF_PH_P"&J/"/_0,\2_\ @FF_PH ]DHKQO_AJCPC_ - SQ+_X
M)IO\*/\ AJCPC_T#/$O_ ()IO\* /9**\;_X:H\(_P#0,\2_^":;_"C_ (:H
M\(_] SQ+_P"":;_"@#V2BO&_^&J/"/\ T#/$O_@FF_PH_P"&J/"/_0,\2_\
M@FF_PH ]DHKQO_AJCPC_ - SQ+_X)IO\*/\ AJCPC_T#/$O_ ()IO\* /9**
M\;_X:H\(_P#0,\2_^":;_"C_ (:H\(_] SQ+_P"":;_"@#V2BO&_^&J/"/\
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MO_@FF_PH_P"&J/"/_0,\2_\ @FF_PH ]DHKQO_AJCPC_ - SQ+_X)IO\*/\
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MCC_P1/\ _%4 >QT5XY_PTYI'_0F^./\ P1/_ /%4?\-.:1_T)OCC_P $3_\
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MVDO_ !Z_#WX@WV/O?9] )V^F<N.O/Y4 >QT5XY_PTC_U2WXE?^$]_P#;*/\
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M_P" 2?X5WU% ' _\*#^''_0D:'_X!)_A1_PH/X<?]"1H?_@$G^%=]10!P/\
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M_P#]"+X:_P#!1;__ !%'_"F?A_\ ]"+X:_\ !1;_ /Q%=E10!QO_  IGX?\
M_0B^&O\ P46__P 11_PIGX?_ /0B^&O_  46_P#\17944 <;_P *9^'_ /T(
MOAK_ ,%%O_\ $4?\*9^'_P#T(OAK_P %%O\ _$5V5% '&_\ "F?A_P#]"+X:
M_P#!1;__ !%'_"F?A_\ ]"+X:_\ !1;_ /Q%=E10!QO_  IGX?\ _0B^&O\
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M_P#@NA_^)H_X5EX/_P"A3T/_ ,%T/_Q-=+10!S7_  K+P?\ ]"GH?_@NA_\
MB:/^%9>#_P#H4]#_ /!=#_\ $UTM% '-?\*R\'_]"GH?_@NA_P#B:/\ A67@
M_P#Z%/0__!=#_P#$UTM% '-?\*R\'_\ 0IZ'_P""Z'_XFC_A67@__H4]#_\
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MNT4 4O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"KM% %+^Q=/_Y\+;_ORO\
MA1_8NG_\^%M_WY7_  J[10!2_L73_P#GPMO^_*_X4?V+I_\ SX6W_?E?\*NT
M4 4O[%T__GPMO^_*_P"%']BZ?_SX6W_?E?\ "KM% %+^Q=/_ .?"V_[\K_A1
M_8NG_P#/A;?]^5_PJ[10!2_L73_^?"V_[\K_ (4?V+I__/A;?]^5_P *NT4
M4O[%T_\ Y\+;_ORO^%']BZ?_ ,^%M_WY7_"KM% %+^Q=/_Y\+;_ORO\ A4]O
M9V]GN\B".#=][RT"Y^N*FHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXML-7U'3+G4(]-2+188I9A(Z2."1))&-N(FYSG)'%?*G_!.7XW:]\-?%VO\
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MEU^;_P"S7_REV^//_8%F_P#0]/J*:=2NJ5].63_\!LRI6C2<_.*^^YU6F_\
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MS^9(&(.))(UV_(<_-GIQ7IFE:C'K&EV=_"K+#=0I.BR !@K*& .#UP:^(_\
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M\0>,_#NMMHNB:+HEVUU<:X4><2S%5@_<(@A4G'F']X., FKE>,N5[VO\M/\
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M()5T0X.1D X^+?\ @H?\;/&%S^V)\)Q)\*]6@'@K7]VAEII/^*I(N+5P+?\
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M( D/SCL"0WXX?ME6Z?LKV'C[XH_LX-,6\4)H_P#PAGC1H\))Y$CB[0S6K$@
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M>$+2"_NX?'SRR&SN93<EO(5/)"ALNR_ZT_ZL\>GH7CW_ (*4;O'&M^%_@_\
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MO8^J**\6_:>_:U\"?LH^%[34_%L]S=ZAJ#F/3M$TU%DO+QAC<54D!47(RS$
M9 &20#\XK_P5 \2^%?)U?XB_LV>._!'@>1E7_A(7$DH0,0$+));Q* <C_EID
M]LTHM2=E_P #[]AM.*N_Z^1][T5@> _'F@_$[P?I7BGPQJ<.L:#JD(N+2\@)
MVR*>.AY4@@@J0"""" 16_52BXMIK4E-25T%%?(7Q-_X*.>%O@[\>?'7PY\4^
M';F*/P[86MQ8W>GW7VB[UBYG2%DM8;7RUP_[X_,9"/DR<9XX*^_X*F:QX#U:
MQF^)_P"SQXV^'OA"]F$,&NWGF,Q)Y&8I+>)<X!8JLA; . :F+4DFMG_7]+?[
MRI)QNGT_RO\ DS[ZHK'L?&&BZEX1@\4V^IVS>'9[)=134FD"PFV*>8)2QZ+L
M^;)Z"OBO6/\ @J%/XJU[4;/X+?!#QA\8=+TV0PW6L6*RV]ON[%-D$S$$<C>$
M)]*'[LG![K\/7L"]Z/.MC[LKF?&OQ*\*_#E=,/B;7['17U2[CL+"*ZF"R7=P
M[!5CB3[SL2PX4' Y.!S7AW[,/[=W@[]H_P 07_A"XTC5/ 7Q#T]6:Z\+Z\FR
M8[?O^4V 7V]U948==N!FOB7_ (*4?&?Q==?M4?"VTD^%^JP6_@W7O-T2Z:63
M;XG8R6DA2#]S\I#(J?*9.7'T-;5*<'M)[[Z=6N_]=F)6E&<E]F_WVT3['ZXT
M5X[\-OV@IM5^ \_Q+^)WA6Z^$$=F+B2_TO6I7>2UBC<JKDM%&S;Q@JH3)+ #
M)(KYJ'_!4+Q#XRFN-1^&'[.'CKX@>#H)&C;7XA)$'*GYMJ1V\RG YP7!Z9 I
M/27+UW^_OV!:QYNFWS/O>BO$_P!F']KCP-^U7X>OKWPM)=6&K:8XBU/0=4C$
M=Y9L20"R@D,I*G#*3TP<'('-?M3?MQ^$_P!F?5M+\,)H^I>./B#JZAK#POH:
M[IF#$A#(V"4#$$*%5V)'"XYHE[C2?7;S].X1]Z[73?R]3V#XP?%'2O@K\,_$
M/CC7+>\NM)T.V-U<PZ>B/.Z@@80.RJ3SW84[X1?$_2_C1\-?#WCC1+>\M=)U
MRU6[MH=01$G1"2,.$9E!X[,:_/W]HS]O"?Q]^SG\1/!'Q*^%'B?X->)M:T>4
M:*FN1R/:ZBRLC-&DSPQ$28R=NS'&-V2 ?K/]@?\ Y,W^$W_8$C_]":B*=YWV
M7+;Y\]_R1,I*\$NO-?Y<MOS9[]11104%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD7C3_K[T[_TMAKRO]F'_ )2M?M#_ /8+_P#9K.O5/^"KG_)D7C3_ *^]._\
M2V&O/G_N.%_PQ_\ 2SKI_P"]5_67_I)PO[6W_*)FP_[%OP]_Z':5]$?L2^%]
M/\(_LE_"BSTVWCMX9O#UG?2"-<;YIXEFD<^I+NQS7SO^UM_RB9L/^Q;\/?\
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M_@J]IMO'XD_9WUE$\O4H/%JV\=PO#!&>!R,]?O(I%3?\$9_^2&_$#_L;IO\
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M9O\ T-*X,1IET6OY&_G>1WT_]\^</_28DW[!<KS?L<_"9I'9V_L.)<L<G +
M#\  /PKWNO ?V!_^3-_A-_V!(_\ T)J]^KTL1_&GZO\ ,\O#?P(>B_(_-K_@
MG-X?L[K]M7]J76Y(E:_L]7GM(9".426^N&D /;)A3\J['_@LU_R:SH'_ &-E
MI_Z3758/_!-[_D[+]K/_ +&#_P!O+VM[_@LU_P FLZ!_V-EI_P"DUU7*_P"#
MAEY4_P#TI,]2G_O>(]9_^DG)_P#!2Z8^,/%G[+GPUOG9?#GB+6X6U!-Q5)/G
MM80"?9)Y?^^J_1>RTVTTW38-/M;6&WL((E@BMHD"QI&HVA HX"@#&/2OC[]O
MK]G#Q)\;/@MX*\3^ X3/X_\  LT.K:9;IC?<)M0R1IG@OF.-U'?R]HY:N)\/
M_P#!6O2+G2X?#VH?"3QT_P 6Q'Y+^%K+3U99+H#[H);S50GKF(LOHV,G5R5J
ME/[7/)OS3M;UM:QP13Y:4^G(EZ--W^^Z?_#'._L-^!=*^&O_  47_:,\.Z';
MI9Z3:VA>VMHU"I"LD\,OEJ!T52Y4#L *E^"/A+3?$'_!7[XT:G?VT5S/HVDI
M<V9D0-Y4S064?F+GHP1W7/\ MFN:_P"":;>,=0_;:^/.I>.[2.R\5S67FZI:
MQ2*RVT\MRCB$$$\(/EX)QMQFN_\ V>/^4LG[0G_8#@_] L*>%5GAD]6J4_U)
MKN_UAKK5C^AZO_P5$TNUU+]B+X@R7,*RO:&QN(&8<QR"]A7</0[68?0FJ%C*
M\W_!*]7D=G;_ (5<PW,<GC3R*V?^"FW_ "8]\3/^N5E_Z76],^'?A6_\=?\
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M*]3UKN?@K_RF"^-?_8JQ_P#H.FUT8:+BL+%[JE/\.8BI9_66MG./W/E/:?\
M@I9I%KK'[%'Q)%U$LGV>WM[F)B 2DB741!&>G<?0FO+?$4CS?\$>XF=F=O\
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MA/ >C_$SX(^-_#FNVT=UIUYI-P&$B@^6ZQEDD7/1D8*P/8J*^/?^";_BJ_\
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M2.GXO[S\UOCE^T)<_$7_ ();> UL+AKCQ-XX;3_"1"GYY+B.79/G_>^S,/\
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MJJ2H=2<CC+&ONBOG[]B#X<_$SX=_ ^SB^+?B;5/$?C349VO9X]4O6NWT^-@
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MGAB*BFG3]I"3LVT[=URJS7?KIYDRM4]G..J2:OV?,[I_UT.)_9TU;XE>+O\
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M$TKQY^Q[\1TU."*232M.;5K.:0#=#/!\ZLI[$@,GN'([UI?L#_\ )F_PF_[
MD?\ Z$U?%G[6'_!0*;]J3X ^+/"_P=\!^*GTDVAG\2>(M6M8X+>PLXR'= R2
M.I9]NWE@2,A0Q/'V5^PS>?V=^Q-\,;O9YGD>'Q+LSC=M+G&>W2LX_NX59RT7
MNO\ ">OZ>=@E[]2E".KM+\X:?K;S\SZ'HKYR_8D_; _X;&\#:_XB_P"$2_X1
M'^RM1&G_ &;^TOMOFYB63?N\J/;][&,'IUKZ-K247%V8HR4E=!1114E!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?*W[:7
MA#XZPZUX)^(/P1U.ZO[GP]*PU;P9]N,5OJT!96!,994<@!U(R&PPVG( KRK4
M_P!N/]I#QMIMSX>\)_LH>*- \4W4;0PZIK4LRV-M(1CS-TMM%&V.HS(HZ=:^
M_J*A17*X/6+O^.^N_P#6A3EJI+?_ "\CYP_8/_9AO_V7/@N^CZ_>QZAXMUJ^
MDU?6)H&+QK,ZJHC5B/F"JHRW=BQ'&*^CZ**VE+F=_P"M-$9QCRK>_P#F]6%%
M%%04%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?._[;/P[^+7C?X;Z;?\ P7\2WFA^,]"OUOEL;>]-M'JD.TAK
M=\D(QSM8"3Y>",C.:\.C_;R_:)6U717_ &1?%3>*MOD&]$EP--,V,>9N^S;=
MF><>;C'\?>OOFBI4;75]'K^%M&-N]G;5?\/J?)/[!?[,_C+X1_\ "=_$/XGS
M6[?$CQ]?"^U"SM75X[*,,[B/<I*EBTC9"DJ $ )P:^MJ**T;O9)625DNR1*3
MNVW=MW;\PHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MAAU4E2=K#(RIP1W%=%5--:,E-/5!1112&%%%% !1110 4444 %%%% !1110
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MWC\V&1 Z/M<!ERK X8 C/(I+5-KH&UK]36HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %?G9_P42TOXD6?C)=#\*_%^^FO?B;''X>TSX71:*DT$L!01W,SW
M#RL(5^=F,BQJW('12P_1.JMUI=E?75G<W-G!<7-F[26TTL2L\#,I1F0D94E6
M921V)'>HE!2:OMU\UU7S]&7&3BG;?]>C^3]#X(_X)RK\0_$VO74OBSXOZA=7
MG@6V?PMJOPPN]%CM8].*;5@D62.4+( (<+*8RQ&\9&<G] :JV>EV6GSW<UK:
M06TUY)YUS)#$J--(%"[W('S-M51D\X4#M5JMY3<[-[]?7=_>[[W,8Q4+I;?I
MT7R78_GU30]5\,_$'XK?&;0S(=1^'7Q"M+IT5L+Y,UY=Y)]O,AA3Z2&OWU\*
M>);'QGX7TC7]+F%QINJ6D5[;2J<AHY$#J?R85^7/[#OPQMOC->?MJ^";L+LU
MN]^RQNPR(Y3/J!B?ZJX5OPKZ,_X)B_%\ZO\ LHSZ+XDE-IJGPZN[K1]1%P<-
M##%F1"WH%0LG_;(UE2DHX=0EHHPA/Y.*4OQ2?S-*T;XARCUDX_/XH_G+[CY^
M_P""GUU/\=/C#J/@FSG?^Q/ACX,OO%&JF(\?:Y540QMVR,P'_==Z]S_95O\
MPMI?_!+/3KSQOIMUK'@^#P[JDFK:?9,5FN+43W!DC0AT(8KD#YU^HKQ/X?:7
M=>/?V-OVKOCOJT++?_$0W[6/F?>33[<LD2CTPQ=/^V2UZ-\(_P#E#?J7_8G:
MU_Z-N:AWI86K%K7EA)^LO:/\%:/R*TJ8FFT].:45Z1Y5^+N_F='XA_:7^%GP
M9_8 T?Q!X$\,^*-%\%>(+6]T;0+"W FO+&:07.))6>Y8J@D1VW"1R,C [#RW
M_@D?^U%X;7P5HWP4?2M>;Q1-=:AJ/]I?9HCI^S_68,GF[]V >-G7O7K7[)W_
M "BQMO\ L5=:_P#0[JI?^"1/_)F>E_\ 88O_ /T8*ZVN3&8E/6R7_I32_'6_
M7;S.5OFPV':TO)_EK]ZT\M_(ZWX\?\%)/@U\ _%MQX6U"\U;Q1XDM7\N[TWP
MS9K<O;-C)5W=XX]P[J&+#N!6]^SG^WE\)/VG-6;1/"^J7FF^)EC:7^PM<MOL
MUTR+]XIAFC<@<D*Y( )( KX>^&?QBU[_ ()I_%[XEV?Q1^&&K:UHOB?6Y+V#
MQSIL2F2XC9G9%61P$D#;MQC\Q&1BV0<\>_\ P[\=_LN_MC?M$>#/B/X>\37V
MB_%318]UOI,BC3I[W )VRAD*W#*N\8BD)VDYR ,88?\ >1@WK=:VWCIV\GH_
MT-Z_N.26EMNSU[]+K;]3Z%^(G[57A/X9_'?P/\)M4T_69_$?BZ/S+"ZM((6M
M(QN=?WK-*KCE#]U&[5ZSK&J1:+I-]J,ZN\%I ]Q(L8!8JBEB!DCG ]:_/W]K
M7_E)]^S7_P!>O_M6>ON_X@?\B'XD_P"P;<_^BFKGE-K!RK?:3G_Y+L:\J^M*
MCTM!_P#@6YP/[-?[3'AC]JKX<W7C'PG8:MIVF0WLNGM%K4,44QD1$8D".21=
MN)!_%G@\5^>/_!/?]KSX;_LL_L]>-)_&NISMJ5]XMN#9:+I</GWUT!;P E4R
M JYXW.R@G@'/%>[_ /!&S_DTW5_^QEN__1%O7"_\$<?@QX??PSXX^)MYI\%W
MXC.MRZ1974R!VM84C1W,9(^4N9L$CDA .F<][I\M>I&.B]G%OYN+_/[D84ZG
M-A[RU?/;[E-?D?3'[.__  4*^$/[27B0>&]"OM2T'Q.^XPZ+XBM5MI[@*,MY
M91WC8@9.T/NP"<8!-5?V^?$WP:\,> O"$WQI\)ZQXNT6;Q!%%IMOHTK1O#>&
M*0K(Y6XARH4.,;FZCY>X\2_X*[> M/\ #7@;P7\9=#ABTOQYX=\06L,>JVZ[
M)98R'= Y'WMDD:%<] 6 ZU6_X*PZTWB3]G/X-:LR>6U_XFL;HI_=+V<K8_6L
MJ;51Q:T:G&+^;BTU\G\FO0<TZ;:>SA*2^2::?S^]'VW\7OC9X*^ ?@A_%7CC
M6X="T5&6%'D5I))I""5CCC4%G8@$X / ). ":^6-'_X+"? C4M9BM+RS\8:)
M82.576+_ $A#:D#^+$4SR$?1,^U5O^"GOPC\;^,M'^%?C?PGX:D\=67@G5C?
M:GX6CB,_VR-C"P8Q*"9%_=,C  D+*3C&ZN5_X>:?L^?'SP1JOP\^+'AW6_ L
M&HVK65]!?6(N[>V<C;^[>-6D5T/*LT*[2H/&*RBV^9K5IO3;336_GY?,NR48
M7T36K^;TMY(^MOCSXETKQE^R;\1M<T/4+?5='U#P=J5Q:WMK('BFC:SD(92.
MHKXC_8W_ &Z/A5^S#^QIX"TCQ/J%]JOB6:6_E70-!MQ<W@C-Y-AW!940$<@.
MX)'(!%?2\/@'P-\-/^"?OC;0_AMK\WB7P6GA/69M/U&:]2[\Q9()W?$B*JX#
MEN !@Y%><?\ !(3X3^'O#7[,=KXU@TZW/B7Q%>W7VK460&;R8IFB2$-C(0;"
MV!U+$GMC:,;5:T8Z*T?7>6G]=F*4KX>BWJ^:7I\*U/9?V:_V[OA3^U-J-QI/
MA2_OM-\101M,VAZY;"WNFC4X+IM9T<#/(5R1U( K$_:*\3?!K2?VG/@CI_CK
MPEK&M?$*]NF'A75K&5EMK"3S4!,RBXC!&XJ>8Y.GX5X9^TQX9T_P?_P5(_9]
MU_1K>/3M2UZ%TU&2W4+]H*B6+<^.K&-]A)[*OI6G^V]_R?U^R?\ ]?\ )_Z/
MBJ:,E5J8>:5KS<7ZQOJGT_X<QKWIPKQ>MH*7W]'W/T!KE_''PM\&?$Z&TA\8
M^$=!\616C,]O'KFF0WJPLP 8H)5;:2 ,XZX%=114VON;7ML?FE_P5K^!_P .
M/AO^S3H^J>$OA_X6\+:G)XFMH'O-%T6VLYFC-O<DH7C125)53C.,J/2OK3X:
M_LL_!>^^'7A:YN?A#X#N+F;2K626:7PS9,[L85)9B8LDDG))KP'_ (+/_P#)
MJFA_]C7:_P#I-=5]G?"O_DF'A#_L#V?_ *(2BC\%;_%'_P!)"OI4H6_DE_Z4
M9OCOX@> ?V;_ (;C5O$%[IO@SP?I4:6T$<4/EQ1@#"0PPQKDG X1%/ Z8%?)
M]Y_P6/\ @=:WS1QZ+XXN[ 2>6-4ATJ 6[<_>&ZX5\?\  <^U>I?MQ?#WX*^)
MO#/A;Q)\</$]UH/AOPWJ(NK:TCN (;^8[287@$;O/E4(VH-P4O@@$FO+KG_@
MJ-\*O$UK=>&/ 7PS\<?$E1";:/3M'T!&M)8\8\LH7+A".,>4>.U2I.3DV[OM
M_F_,IQ226R[_ .1]9?!SXU^#/C[X)@\5^!=:BUO1I9&A:14:.2&5<;HY(V 9
M&&0<$<@@C(()\4U#_@H]\'-!M?'TVNWFJ:"W@_67T*:"\MHVFU&Z4N"+2..1
MV=?W9RSA ,KG&:^>_P#@C?J$LUS\=K8:9)H%HNMV\T>B29_T!F-P##@@'*A5
M0\#[@X%4/^"?OPMT#Q7^VY^TGXNU;3K?4-1\.Z_/%IK7,8?[-)/>71>5 1P^
M(0H8<@,WK6[AS5%%:)PYN]OA?SWM\[]#)2M3E-ZN,N7U^)?+HW\T>]?"'_@J
M1\$_BYXVM?"HDU[PAJUY*MO9_P#"36,<$5S(QPJ*\<L@4DXQOV@D@#DXKZG\
M5>*M'\#^'=0U_7]2M](T;3X6GNKZ[D"10H.K$G_)Z5\)_P#!9?P?IEU^SSX?
M\6"UBC\0:1K]O#;:@J 3+%)'+NC#]0I94;'J@KZ!_:0\ ^ _BY^S)':?%?Q1
M>>&/""V]IJ&H:G:WB6I+JJE0S.CALN1A-I);;@9Q6#GS4IRCHXM)WVU2:?YW
M1KR\M6$9:J2OYZ.UOGT/'/$7_!87X%:/J4\&G:?XR\2V<)PVI:5I,:V_U_?S
M1./Q45]$_L\_M2_#K]J#P_=:IX#UEKU[(HM]I]U"T%U:,P)42(>QP<,I925(
M!)!KYG\._P#!3+X ^ -)TOP)\,/"WB_QA9Z=;K:6-GX9T(;&51@?+*\;DG&2
M=A)))KR#_@GWXJE\1?\ !1?XO7L7@R\^&UMJF@RWDGA6\A,,MJWG69!>,HFU
MFWM)C:,>;WZGHIQ4ZCIK56DT]OAUV\_P,9MQAS[.Z5O7S\OQ.G\3_%'PM\&_
M^"KOCOQ9XRUF#0]!L?!:&:ZGR<DQ6P5$506=R> J@D]A7K/@W_@K;\!O%GBJ
M'1KN3Q%X7AN'\N#5]=TY([*3+8#;XY79%/\ >=5 ')(KR3Q!\&] ^,W_  5^
MUFU\36,.J:3HGAZWUEK&Y0/%/(D,,<8=3PRAI0V#P=HSQFOL/]K[X,^'?C1^
MSOXRT/6]/MYVM=+N+S3KAXQOLKF*)FCEC/5<%0#CJI*G@D5QQG['"PJSU24G
M;R4I=>^_E]^G3*'M,0Z:TORZ^?)'IVV_I:^RP7$5U!'-#(LT,BATDC8,K*1D
M$$=017R1\7?^"I'P0^$OBJX\.)=:UXUU6UD:*Z3PK9)<1P.O53)))&C$=]A;
M!!!P17SI\-?VB/$FB_\ !'S7=9BO9EUG26D\+6E]O(D2&2XCB0J1R"D4^U3V
MV+7+_L6_M]?L[_LM?!?2?#[>&_$Q\6SQ^=KNJ6>EVSFZN"2=HD,ZLT: [5!
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MM0>&?'GPE\-_"2QTC7;?7_"^C27%Y?7=M$MC,OVDC$4@E+,?WJ]47H?Q[O\
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M-'^+/_!6_P"&&@^(+.'4=&'AZ&]N+.X7='-Y'VV549>C*71,J>",@^E>]_\
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M+PG'I$MB-+6!?),?ED<KCDGKD\YYZU^<_P"Q'\6-7^&W_!+OXQ>(-/N6AO\
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M8Y(5#<JH^@  _"JK+FPU5M6LOONI=/EZ&E"7+BJ*3W?Y-?YD_P"P7>:#I_\
MP3'^U>*K*?4O#$.FZ[)JEE:L5EGM!+<&:-"&3#,FX#YEY/4=:[OX+_'KX0?"
M?]B6#XD^ O"7B/2?AAILDQAT,*+C40S7IA<@27+@YE<MS+]WTZ5Y/^R/_P H
MD/$'_8N^)?YW5>F?\$J?^3(_!/\ U\ZA_P"EDU=M9.5:LD[64/S9SPM&C2D]
M4YS_ *7;U.&_X?(?"'_H1OB5_P""BS_^2Z]%_9[_ ."C_P .OVE/BE!X"\->
M&?&6G:S);2W33:Q86T4$4<:[B7,=P[+G( ^7!+#UJW^W!^UP_P"S_P"&]/\
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M$U+\"_A/X<^$OP?\.>$M!TNUL]-M]/B29(XE'VF0QCS))./G9SDDGKFOB_\
M8#\.VGP]_;B_:>\)Z)&MCX?M[B.6"P@79%%^_=D55[!1*R@#M6B2C6>'D[NT
MG?\ PVOIVUTZG.Y-T576BO%6_P 6VO?N?HG7BOQR_:V\#_L\^._ _A?Q>NH6
M\OBQIA;:E$D(L[18B@=[AWE4HH\P'*JW ->U5^:'_!53PI:>._VCOV8_#=^N
M^QU?5)+"X7UCEN[-&'Y,:SBG*M2IK[4K?@S5V5*I/LK_ (H^C?@A_P %$OA9
M^T)\5&\!>%+/Q,]_)'--;:A>:8([.ZCB!+.C"0NJX'!D1.2!U(%'[ 'B;X,^
M*/AOXHG^"GA+6/"&@Q:[)%?VNM2M))+=^5&6D4M<3X4J4'WAT/R]S]*VFDV6
MDZ=;VEE:06EK:0B&WAAC")#&%P%0#[H  &!Z5^9O_!.'QS/\,OV'_C[XLM<?
M:]%U+4[Z#(R/,CL8F3/_  ("CGC#VLE]F%_7WE^G3OJ7"$IQ2OO-+R5XR_J_
M8^F?CU_P4C^#?P \72^%M1N]6\4^([=_+N].\,6B7+VK?W9'>2--P[J&+#'(
M%9)_X*D?!&?P/H_B33[C6M5;4-6AT:71[:TB6_L9I%9D::.25!Y9"$;XV<9X
MZ@XY;_@DO\)]'TC]G>/XE7%LM]XR\87UY/>ZQ< /<&-+AXA&'/(4M&SGU9LG
M.!CR/_@K5\%?#NB^./A3\2M,L8-/US4]<CTO5'@3;]LP5>*1\<%U"NN[J05!
M^Z,:J#IU:=*KK=Q3MT;:T_3UUV.:<^:G4J4].52M?K9/?[K_ ('H'_!9!@OP
M<^&C,0%'C* DGH/]'GKM/B)_P5@^!?PY\03Z+!)X@\8?8V$5UJ'ANQCFLX7!
MP1YLLL8?G^)-RGL37!?\%HK0ZA\"_A_:J0K3>+8HP3T&;6<?UK[8^&?PI\+_
M  M^&^E^"_#^CVEEH%G:+;FU6(%9LKAVDR/G9SDL6R22<UG#F]G)]%)_/W8?
M=;]?(UGR^TAW<?N]Y_U\C#^&G[2'@/XQ?"N^^('@W5CKNA6,,TES'#$4N87B
M3>\3Q/M*OCH#@'(()!!K\L/AI^WUX/\ #?[>_P 1/C#J6B^,+WPUKNC#3+#3
MHK2&2_MO^/0X>-IPB)F&0_*Y^^..3CZ*_P""9NCV_@K]I+]J?PGI*_9= TS7
MTCM+).(XE6YO$4*.V% 7Z >E'P!_Y3 ?'7_L71_Z#IM:44I8F$X[2IN7I[NJ
M^>R[>=PJWITYTY;QFD_/73[NO<^L_CQ^UA\-OV;O"NG:WXYUIM/.IH6L--@A
M,UY=84,0D:] ,@%F(4$@%LD9\.\!_P#!6OX$^,O$5OI.H-XD\%&Y94AO?$FG
M)%;,6( R\,LNQ>?O.%4=217G?[>WAGQS\+?VK?AS^T!IO@.?XG>#] TTV=UI
M,*-)]BE4SGS6"HYC&)0ZRE2H:/G!VYA\6_MR?LK_ +;O@5O 7Q)FUKP,;B>%
MX+G5+5$>VG# [H;I!,D0(!5FD" JS XS64'S+F6KN_=VLKV^;:U6A4H\K46]
M++WO.VOHEL?HQ#,EQ$DL3K)&ZAE=#D,#R"#W%.;[ISTKG/AKX<TKP?\ #WPW
MH>A7TFI:)I^GP6MA>37 G::W2,"-C(.'RH'S#K71/]UOI3JVCS);*YG!N44V
M?,/["/B;X->)/#'CR7X-^$]8\)Z?;^()(M6BUB5I&N+P(I:1-UQ-A2,#&5Z?
M=K)_X>??!2W^'VH>*]0N-9TL6VL7&B0:-<6D;ZA>SPI&SM#%'*X\O$JC>[(,
M\'!(SYI_P2$_Y)_\8/\ L<I__125Q_\ P2(^%>@7NL_%OQ_>:?;WFOVVOOI=
ME<S1AWM(P&DD,9(^4OYB@D<X7'KF87DXQO9>SB__ $G;[[>2]+&M2T>=VN_:
M-?C/?[K^;]3Z(^ O_!2CX-_'_P 90>$].GUGPQXCNG\NST_Q+9I;M=/C.U'C
MDD3=Z*S*3T -?5-?G3_P5J\,V&CZM\#_ !W86\5GXGMO$\5FNHPH%F:,%94#
M-W"NF1G.-S8QDY_1:KBU*GS6LTVG\E%W^Z1D_=J<M]+)_>VOT"BBBD4?G!_P
M3A_Y/,_:M_[#,G_I==5]0_M$_MR?"7]F.^CTKQ=K<]QXBDB$R:'I%N;F[*'H
MS#(1,]M[*3VS7R]_P3A_Y/,_:M_[#,G_ *775=K\0/'/[+_[&O[1GC#XA>)/
M$^HZU\5->0/<:;L&HRV"L =L06,"W++L&)),[ N."<YP?[C#INRY/GULE_GT
M[&E1?O\ $-*[Y_\ +4U_ ?\ P5M^!7C+Q-;Z+J(\3>"9+AE2.[\2:='%;[F(
M #/#++L&3]Y@%'4D"OIOXS?%[1?@?\+-=\?:W!>7VBZ/ MQ-'IB))/(K.J#8
M'=5/+CJPXK\QOV]_VSO#W[3W[/-U:^'?@]XR_LZWO()X_&FO:4L%KIY\U0=D
MB&09D!\O!=<[^^,5](?'2^GU+_@DG%=7,K37$W@;1WDD8Y+,5MB2:=5N.&J5
M4K.+2];J_P M@I14L13IMW4OPU2.@^(7_!4[X*?#VP\/R2?\)!KVHZMIEOJK
MZ3HME%/<Z?#-$LJ+<EIEC5]K#**[$=^""?8_V=_VK/AQ^U%H=SJ'@366NI[/
M;]MTN\B,%Y:;ON[XSU!YPREE)!&<@UY[_P $Y_@AX?\ A#^R[X+O].T^%-<\
M3:;!K&J:CL'G7#3+YD:,W78B,JJO08)QEB3\^?&3PSI_[.'_  5"^$7B/PE;
M1Z19?$&)[+6+&S0)%/*[F)W*#IDM!(<#EHRW4FNJ45#$K#O[3:7D];+TTM??
MKY',I.5!UMN57]5I^/6WR/LC]H#]JCX:_LQZ3:7GC[Q NG37N[['I]O$T]U<
M[>I2-0< <#<V%R0,Y-?.FB_\%B/@9J&L6]GJ&F>-/#MK,>-2U/28C;@?WB(9
MY)"/HAK=_::'[.'P5_:$T/XR?%?Q-=-XWM[$0:5H#G[9&$7<%F2U2(LA!,A5
MV8)N)/W@,>,?M)_\%"/!G[1'P#\<^'/"/P=\<^,K*?3IE?6+W1T6PT\A"1=F
M1&E*^5]\$A?N]1UKB4VH.>[5].GW]^_8ZN2\E#9.VOKY=OS/T.'C[1+CP _C
M/3KQ-7\/_P!G-JD5U8,L@N(!&9-T9R <J.,D?A7S%J'_  5,^".E_#/0/%]Q
M+KOVC7!,UEX9BLXI=5*1S-$SNB2F.-2R-M+2#< <9P0.?_8-O)KS_@F9!YTC
M2^5I6N1)N.<*);G ^@S7,_\ !&WX5:!H_P"S[?\ CH:?;R^)=8U6XMFU!HP9
MH[:((JPJV,JI;<Q ZDC/08Z90_VBM23TBHM=]6U_E^)SJ=J5.;6LI-?<O^'/
M=?V;_P!O[X2_M/:\_A_PW>ZCH_B8*\B:)K]JMO<3(G+&,H[QL0.2H?=@$XP"
M:^D*_.?]MKPW8^$?^"@O[,7BG1[>/3M9UO4A:W]S;H$>X5)X8P7(^\2D[ID\
M[<#H!C]&*4;3HQJI6NY+_P !>_SN.5XU73WT3^_I\BOJ&H6NDV%S?7US%9V5
MM&TT]Q.X2.)%&69F/   ))/3%?&'C/\ X*Z? CPOK$]AIB>*/&:0$B2\\/Z6
MC0+@D'YIY8B1QU (/8FOI;X_>!_#/Q(^#OBGP[XSUFX\/^%+RT/]IZC;W:6K
M0P*0[$RN"JK\O.1@C(/!KX\^'_\ P4$_9G_9S\(Z-\-OAE8^*?&EIIL?D1?\
M(_HP>6ZES\TLC2F'S'=LDLJX.>.,"LD[R:;[675[_@:M6BG;^O\ ,^D/V;?V
MT/A=^U0MW#X*U:X36+.(3W.BZI!]GO(HR=N_&2KKD@$HS ;ESC(S)\1OVPOA
M]\)_C-;_  Y\52WND7LFB2:_)K,Z1+IT%LGF9#N9-^\F(@*L9R2H!R:^"O@?
M\2)/B%_P5<T3Q%;_  ]U7X6IK&D7(FTG5[8VUS>+]EE/VF2/:N-Y13QG)3.X
MFNT_:N^&^C?%G_@JS\&_#7B"SBU#1I]"CN;FSG7='.L!O9PC@\,I,8!!X()'
M>MN5R=*RMSWOUM;FU^7+>V_30SNDJS;OR6?JO=NOQ:OMU/4X_P#@L!\!6\2)
MITD?BR#3))#&OB"32%^Q, <;P!(9L?\ ;+/M7V7X:\2:7XQ\/Z=KFB7\&J:1
MJ$"7-I>6SAXYHV&593Z$5YG^U/\ #_0O&7[,OQ"T'4--M9=/B\/WDMM$T"E+
M>6*!VA=%_A*,JD8QC%?(O[+?Q*UCP%_P2/UOQ)8W4@U/2=/U>*PFSEH&-Q(L
M;#_=:3</I6$JD8PJOK!*7JM5]]T:<DG*GKI-N/H]']Q['\9O^"GWP3^#/C*Y
M\+2W&M>+]9LY6@O8O"]DEPEK(OWE>222-6(Y!"%L$$'!!%?-W[1GQ_\  _[1
MG[3O[(7BCP+K*ZKI_P#;\D,\3H8Y[67[39DQRQGE6Y^A'()'-?0/_!*_X1:#
MX#_95\.^)K2RA;Q%XK\Z_P!2U(KF:4":1(HRQYVJJCY>FXL>I->,?MI_!G0/
M _[?7[./C31-/ATVX\4:_%'J2VZ!$FG@N(")B /OLLV&/?8#US773A['&4(3
MU:FM?/7\/^ <\Y*MA:TJ>SB[>:WO^OH?I;39)%C1G=@B*,EF. !ZFG5\E_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M  2%FU:#QO\ M"V/B:V_L[Q6-8M9M2T]N&AF,EWYBXR>C[AU/:NB_P"";?\
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M7I^E]O,\>_X)]WL%_P#L9_"F2WE65%T@1,5/1TD=6'U# C\*^A*Q_"?@W0/
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M3^_'YBG:W Y&#4+2-%?R<GSY6G^-C:M^\E6DOM\WRYE8T/$W_(MZK_UZ2_\
MH!K\T/\ @FO\+Q\:O^">WQ<\#^<MM)KFLWUI#.PRL<ILK0QL?8.%)]A7Z?21
MI-&\<B+)&X*LK#((/4$>E87@KX>>%?AKI<NF^$?#.C^%=.EF-Q)9Z+816<+R
M$!2Y2-5!8A5&<9PH]*E15JT9;3BH_C<KF:]FX[QE?\+'YY_L7?MP>&?V:? /
M_"DOCP+[X?\ BGPA-+;6\]Y8S317$#.SJ,Q(Q!&XX;&QDV$,<UU6L?MP>,/V
MF/VC_!G@;]FN]FD\)6,HG\5>)KK20;=K<LI8 3Q[HPJJX4X4N[ #@9/VWXV^
M%_@SXE0P0^+_  CH7BJ* YBCUO38;Q8SZJ)%;'X5>\*>"_#W@/2ETSPUH6F>
M'=-4[EL])LX[6$'U"1J!^E:\[E-5*FK6ODWY_JNICRJ,7"GHG^'I^G8^!O\
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MWFMIR3);I)-))'$WH4C=%([8QVKW=_NM]*=16U:3K2E+O<RIQ]G%1['Y_?\
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MSZUI%O>.@]%:1&('TKI='T;3_#^FV^G:78VVFZ?;KLAM+.%8HHU'0*B@ #V
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M]@>S_P#1"5\2_L\?\I9/VA/^P'!_Z!85]_6MK!8VL-M;0QV]M"BQQ0Q*%1%
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M#X;_ +3G[,/CGQ#)+%X:TG46-_J2P,XC\NXMW<E4!YVY;:N20IP.*^]?A?\
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M/%?[)?P@\4^%]7T9OAKX1L1J%I+:_:K/0K6*:'>A7?&ZQ@JPSD$'((%?%/\
MP3'\<>*?"6E?&7]G:XU"'3_&WA::[N="DNDWHDF6BD^0]8UF$4F.XF:OTSKE
MK/X5>"M/\:7'C"T\'Z#;>+;@$3:]#ID"7\H*A2&G"^8<@ <MT %**:E+7246
MG^::]&$G>,=-8R37Z_>CX:_9]_X*.:!I_AW7OA_^U+=OX=^(&DWLUM>?VEHK
M/;7D18E5,<$3*I4';RNUEV,&;<:\I\(P?#[X]?\ !17X>Z_^S?X:&F>%?#*+
M=^)-:TO3WT^QD_UF<1%4VEU/E?=4N6/!"EJ_3?QK\(_ OQ*DAD\7>"_#OBIX
M1B)M:TJ"\*#T4R(V/PK7\,>$="\$Z3'I?AW1=/T#3(R2EEI=K';0J3UPB */
MRJX.U2-62]Z/;1-VMK^=B9KFA.DMI=^EW?3\KGPIKW_*93PY_P!B:_\ Z)GK
MR3Q-XX\+_L[_ /!4CQKXK^.FG2G0=4L@_AW6KJR>[@M1LA$4J(JL<*J21;D!
M*L3QR2/T\D^'OA67QE'XO?PSH[^+(X?LR:\UA$;Y8L$>6)]N\+@D;<XY-.\8
M^ ?#'Q$TU=.\5>'-)\3:>K;Q::Q8Q7<0;UV2*1GWQ6<+TW3E'>*DO_ I-_>K
MZ/U!I2]HI;2<7_X"DON=CX/_ &N/V]?!OQF^#/B[X=_!*'4?B/XAUC2KA;^>
MQTZ>*VTRP5"UQ-(TJ)D^6"%P",GDYPK=#^Q;=PW/_!*V9(I%=H="\0QR ?PM
MYMVV#^# _C7V7X8^''A+P3HL^C>'?"^BZ#I$X(ET_2]/AMK>0$8(:-%"G()'
M(IGASX9^#_!_AJZ\.Z#X4T/1/#]UYGVC2=-TZ&WM)MZ[7WQ(H5MR@ Y'(X-3
M.'-2JTE]M+7S5_PU];FL9\LZ4VO@E?\ KS_ ^7_^"3/_ "93X8_["&H?^E+U
MP?[;W_)_7[)__7_)_P"CXJ^Z/"7@SP_X!T6+1O#&A:;X<TB)F>/3])LX[6W1
MF.6(CC 4$DDGCDU!KGP]\*^)O$&DZ[K'AG1]6UO2&WZ=J5]8137-DV0<PR,I
M:,Y /RD=*Z'*]>E6Z0:?W*QR^S?L*E'^9-?>[G05\W?\%&/^3*_BE_UX1?\
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M<J%.C_+R_A*YTJHE7JUOYG+\58^5OVPOV38?CY^RWX<_X16S2P\;^$-.@O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%SER(]JHKY?_ ."?_P"T%9?&+X!>%(];\>:9XE^)$EO=7FK6/]H0/J$:_:Y
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MO3)O]5>Z=<I<0O\ [KH2I_ U1NOB)X5L?%L?A6Y\3:/;^)Y+<WB:++?Q+>M
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MR*>C*RD@CW%):JZ'L[,LT44V2188V=V"(HRS,<  =R: '45YP_[2?PCCU?\
MLI_BGX*75/,\K["WB&S$^_.-NSS-V?;%>BQR++&KHP=&&593D$>HHZ7#K8=1
M7,:;\4?!FL6>MW=AXNT*^M=#F:WU6>VU*&1-/E7.Y)V#$1,,'(?!&*A\%?%[
MP+\2IKB'PCXU\.^*9K89GCT758+QHO\ >$;MM_&A:[ =;117&/\ &GX>Q^+A
MX4?QWX97Q09/*&B-K%N+TO\ W?(W[\^V*-W8.ESLZ*_/[]EG_E*!^TK_ ->$
M/_H5M7Z T1]ZE3J_SJ_IJ_\ (F_[RI3_ )7;UT3_ %"BOE3]I+_@G#\-?VI/
MB1_PFOBO7/%>GZK]CBL?)T>[MHH-D98J<26\C9^8Y^;'3BOSY_:8_8'^'_P9
M_:B^#'PVT36/$MUH?C2XBBU"XO[JW>YB#7(B/DLD"JIVG^)6Y_*I@W*<*;6L
MG9?C;\$7*T82GTBKL_;&BOA#PY_P1P^"_ACQ#I>L6OB?QY)=:?=17<237]D4
M9XW#J& M <9 S@BLOX@?\ID/AS_V)S_^BKZM8I2E&-]7?\(N7XVL9R;C&4K:
M*WXM+]3] Z*X>U^.?PWOO%/_  C-M\0?"MQXD\PP_P!CQ:U;->;QU7R0^_/M
MC-=Q4=+E];!17(^-/B]X$^&\D4?B[QKX=\+23#,::UJL%F7'J!(ZYK1\'^//
M#/Q"TTZCX6\1:3XET\-L-WH]]%=Q!O3?&Q&?QH6NP/3<W:*^6_VLO@CX4^*'
MQH^!>OZ_\4-'\"ZEX8UH7FFZ+J0B,VN2>?;/Y,.^>,[LQHORJYS(..@/B'_!
M1S_D\']D;_L8E_\ 2ZQJZ4?:3I0>CG+E]//S].@Y^[&<E]F-_P =O^"?HG13
M)94@C>21UCC0%F=C@ #J2:\[7]I3X1MJPTH?%/P4=4,GE"R'B&S\[?G&W9YF
M[/MBHW=D+I<]'HIJLLBAE(96&0P.017,:=\5/!6L:7K&I6'C#0;W3M&F:WU.
M\M]3@DAL95^]'.X;$;#N&((I;;@=317)^"?BUX'^)3W">$/&?A_Q4]O_ *Y=
M$U2"\,7^]Y;MC\:ZRJ **XQ/C5\/9/%W_"*)X[\,MXHW^7_8BZQ;F]W_ -WR
M-^_/MBOC/]CO_E(O^U+_ +T/_HP5$'S58T^ZD[_X;?G<*GN4W/LXJW^)GW_1
M115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5X!^U9^S-X6^+/PJ^(=QI
MOPY\-:Y\2-2T6X@T_5+C3+07SW/DE(<74B@JPPH#%QMP.1BO?Z*B<5.+B^I<
M9.#31Y'\!?V??!?PI\)>%KNS^'WAKPWXQ@T:VM-0U#3=*M8KLR^4@F5IXER^
M74Y.XAB,\UZY116U2;J2<GU,*<%3BH+H?GW_ ,%J/^3:?"W_ &-,/_I+<UZ/
M^W]_RCI\6_\ 8*TK_P!*K6O./^"U'_)M/A;_ +&F'_TEN:]'_;^_Y1T^+?\
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MH0^"Z=_YFMO1+IU>^VA^=O\ P35)U3]J;]K+4[@YN_\ A(A%\W)VF\OL\_\
M %KZD_;>LXK[]D3XNQRC*KX;O)1P/O)&77]5%?*/P#UNP_9G_P""E?QC\&>)
MKB/2+#XA[-5T6[NF$<5Q*\C2I&K'C):6=!ZM'M')&?8O^"GWQFT?X;_LM^)/
M#DEY"WB;Q=&NE:;IBL&GF5W7SG"#G:J;OFQC<RCJ17)6]_!4U%;P44O/X6O6
M^_:YU0_WVHV_M7OY63OZ6-?_ ()CWTVH?L0_#9YCEHX[V%>OW4O9U7K[ 5]
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M0_(6,7Z #_OHO$GXW)K)_P""S/\ R*/P?_[&.3_T6M>@?\%3_ -]?? ?P_\
M$K0DV^(_AUK%MK%O,JY982ZJ_P" <0N?:,UG2DJ7[V6RJ-/_  RA33^Z]_D5
M4BZC]DMW#3U4Y-?BK?,N?\%-?$%[X@\!^!/@SHDS)K?Q+\0V^FL$^\EG'(CS
M.?8,8L^VZO+=(\/V7A+_ (*^>&M#TR%;?3M-\%QV=M"HP$CCL611^  K?^ /
MC:U_;,_;HE^)UEB?P=\/O"MI;Z;W4:A>Q;Y#Z;E#SQMZ&-:I7W_*9[3O^Q5/
M_I')6L(NG.FI;R<V_3V<XQ_!<W_;QA6DJD)-;14%\W.$G^:7_;I^AU?F_P#
M[_E,9\9O^P$?_1.GU^D%?F_\#O\ E,9\9O\ L!'_ -$Z?10_WI?X)_DC6I_
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MV?/%]S%J=K?M<>(=<T.02V\*\*R.>8Y$B3S&=6!7>47[PP/T/C4QQHK.9"H
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MMO+^W(%\MA&3]X[$BD4=65\C(!Q[C_P4W^-GAWX9?LM^+- O=0MSXC\4VO\
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ML5>:2/R;J.VE\N0;&7)&X\'(YZ5[57"_'>-YO@A\0D16=V\/:@%51DD_9I.
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MC\!/$7PZ\0?\%9HQ\*]/TFP\&V&DW6GV_P#8EM'!:3R1VC"62,( &!<L-_\
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MA[:'U5_S?^22O)_=RS^]&\I^QG]97\O_ )-&RC]]X_<SUKXG>(-4_P"">_\
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M\2M6&FS7D+%76V#QQF/(Y =YT!QU56'\5;>F_P#!)_X":?X!@T8:/J0\1Q0
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M# 'U!]:_:^T7Q-X;_P"";WBS2O&>JP:YXIL=!M;;4=2MMQ2ZF2>%3+\P!);
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M&:%4W#D&1<&E+6BHR>GM+?)J&GHV]?)G791JQE%:N$G\US6$^'?[&W[%6@>
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MMGLKT67A:RU2[N+;3H[8.Q3,D17RP8O)==S*C&1R<L17ONG_ +"/AO2_B_\
M#[XL?LN>+=&\/Z/97.-<M[?69K^SU"VWJ6CB93+G>N]65F"CY",$5M:7XO\
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M7*2WRR.3WRP)SWS7Z$:M\2O"NA^!9?&E[X@TZ#PG':_;3K!N5-L82,AU<'#
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M!&L? >Z\1^ OAA<?"W1-7U.1Q87&L3ZG]L:-5C,Z23'(7*E, #F-N.YRI/\
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MNK:MX9T&^AA93<6_BZ:;487Q]\0^>Y9AG.TQL/\ 9[5<_P"".7CC4O$'P/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI!E5&W<H4D8!S@8[3Q7^R7X3\9?%+X9^/]1U;7FUSP!;+;::J7$(AN0!C=<
MPEF8]3L9![5[;14Q7);EZ.Z]==?Q8Y>_?FUNK?+33\$>/?%/]E[PK\7/B]\/
M?B-K&H:Q;:WX(F,VG6]C-$EM*Q=7Q,K1,S#*C[K+7KMQ"MU;RPL2%D4H2O7!
M&*DHHLN3V?37\=_O#[7/UT_#8\5_9[_9K\/?LB_#/7_#_@>76-?BN;N?6!#K
M5S$TLEP8401*\<2!5/E*.5)!)//2OAS3=+_9-_;LOM5\7>,[I_@/\2H+UX=6
MT]?$-O83W##CS?\ 2(_+D)^8,517R#N[$_J;7AOQ6_8A^!OQKUV76O%_P[TW
M4-7F;=-?6LLUC-.W]Z1[>2,R'@<MD\4I7E/FEKHDO*W;Y:-,N_NM)VUN_._?
MYZGYS?$[X1_!34?C-\$_@Q^SVMOXMOH]>35_$WB*VN5U O$ACR9+D?(P6-96
M*IA%)'&YC7[%UYQ\'_V=/AK\ [.:V\ >#M-\-^>H2:XMT,ES,H.0KSR%I' /
M0,Q KT>M;^[RWN[MM^ME]R221C;WN:UM$ONN_ONV9^OZ#IOBK0[_ $;6+&#4
MM*OX'MKJSN4#Q31."K(RG@@@D5\7WW_!'WX#W'B*74;:Y\7:9I\KAGT2TU9/
ML94?P$O$TVW_ +:9]Z^X**SLK\W4TN[<O0^:K[_@GS\)(]8^&NH^'+/4/!,W
M@&\:^TU= FB7[3(SQN3=--'(\V3$HR6#8)&>F/5?C9\!_!'[0_@M_"_CO18]
M8TOS!/$=[1S6\H! DBD4AD;!(X.""0002*] HIR]Z/++57O\^_X"C[KYEOM\
MOZ9\>?"O_@E7\#OA;XLM-?:'7O%T]E)YMG9^);V.>UMGSD,L4<48;'H^X< X
MSS7M'[.7[,_A?]F'P_K^C^%K[5K^VUK59-7N&U>:*1TF=54JACC0!,(, @GK
MS7K=%/F?Z?BG^B^X5E_7S_S?WGRC\0/^":OPG\>?&;_A9T-[XE\+>(WO8]2G
M30;Z*.WGN5D$AE9)(9""S %@I4'DXR2:]-N_V7O"MY^TQ9?'%]0U@>++33#I
M26:S1?83$5==Q3RM^[#GGS,=.*]AHI1]U1C'97MY75G^&@27.W*6K=K_ "=U
M^.ISOQ$\#V'Q,\ ^(O".J2W$&FZY83Z=<RV;*LR1RH48H65@& 8XR",]C6!\
M!?@GH?[._P *M%\ >'+K4+W1M)\[R)]4DCDN&\V9Y6W,B(I^:0@84< =>M>@
MT4T[7MUM^%[?FQO5)/H?)'QC_P""7_P1^,/BRX\2FTUGP9K-W*TUW/X5O$ME
MN)&^\QCDCD12>2=BKDDDY))KT']G/]BGX4_LNF6Z\&:'))KD\?DS:[JLWVF]
M=,Y*AL!8P>,B-5!P,YP*]VHI0_=JT= E[[O+4\8^-7[*?A+X[?$CX<^-M?U'
M6K/5? MZ+[38=-GA2":02Q2XF#Q.S+NA4?*RG!//0CV.XA6ZMY86)"R*4)7K
M@C%244OL>SZ:Z>N_WCO[W/UT_#8^9?"__!/_ .'OA+]G7Q?\&++6O%#^%_$^
MH#4;R\FN[<WJ2 P';&X@"!?]'3AD8\MSR,>31_\ !&WX010QPIXX^)*0Q@A(
MUU:S"H"22 /LG'))_&OO.BF]7S/?3\%9?@/F=K=+M_-[GQ5X"_X)0?"SX>>.
M/#_BG3_&7Q NK[1-0@U&WAO-4M7@DDBD615D46H)4E0" 0<9Y%=_^T;_ ,$]
M_A'^TUXD'B3Q#9ZGH?B<A$FUGP]=+;SSJ@PHD#H\;$# W;-V !G  'TM10_>
M23Z:HE>ZVUU/E/X??\$S?@=\//#NO:?!I&H:UJ6LZ?<:9/K^M70N;Z**:,QN
M83L$4;[6.'6//8Y&17LOP)^!>B?L_P#PHT[X>Z+J&J:SH5AYPA?7)(I9MDKL
M[(3'&BE<NV!MZ'%>CT4VVTT]GI]U_P#-_>*VWEJ?*?PQ_P"";?PJ^#?QLL_B
M7X/U#Q/HU]:3RS0Z+'?Q/IH\R-XV38T)D*X=L R<<<]J],^%/[+WA7X/_%KX
MA_$/1M0UBYUKQQ.L^HP7TT3VT3!V<"%5B5E&7/WF;M7L%%):6:Z)I>CW0Y>]
M>_6S^:V_,\%_:._8C^%'[4<L-[XQT::#7H8O)BU[2)_L]XL8.0I."D@';S%;
M&3C&37#_  8_X)B_!'X,^*K?Q(ECJWC+6[659K6Z\57B7(MW'1ECCCCC8C@@
MNK$$ C!&:^LJ*(?NW>&@2]]6EJ>>_'SX(Z'^T5\*]8\ ^)+O4++1]4,)FGTN
M2..X7RY5E7:SHZCYD&<J>,_6NA^'G@FQ^&G@+PYX1TR6XGTW0M.M],MI;ME:
M9XX8UC4N5506(49( &>PKH:*:]U-+KJ_D#UM?I^IX_8_LO>%=/\ VEM0^.$>
MH:PWBR^TP:5)9M-%]A$05%W!/*W[L1KR9".3Q7L%%%2M$HK9?\/^8/5MO^M+
M?DCR[]H[]GGPY^T]\-)O _BF]U2PTF6ZANVFT>6..??&25 ,D;KCGGY:[SPG
MX;MO!_A71M LGEEL]+LH;&%YR#(T<2!%+$  MA1G  SV%:M%./NJ275W?K:W
MY _>:;W6B]'J?(?Q=_X);_ _XM>*KCQ&EKK7@K5;J1I;I_"MZEO'.[=6,<D<
MB(3WV!<DDG)->E_LZ_L8_"O]EV.:;P5H3?VS<1>3<:YJ4IN+V5,Y*[R J*2!
ME8U4' R#@5[C11#]VN6&B"7ON\M3QGXO?LJ^$_C1\6/A[\0=;U'6K76O!%Q]
MHTZ#3YX4MY6\Q),3*\3,PR@^ZR\9KV:BBA>['D6UV_F]P>LN9[Z+[M@KFOB5
M\/M)^*_P_P#$/@[7DD?1]<LI;&Y\DA9%1U(W(2" R]02#@@<&NEHJ914DXRV
M949.+4ENCR7]F?\ 9E\(?LI_#^;PCX.DU"ZLKB\DOY[O5I8Y+F:5@J_,T<:+
M@*B@ *.!4_[07[,_P_\ VG/"L&A^/-'-_':NTMG>6\IANK-V&"T<@Z9 &5(*
MG R#@5ZG153_ 'GQZ_\  V)A^[^'3_@[GQI\.?\ @DY\"/ .N6VIWL'B#QL;
M5P]O9^)[])K6)@<C]U#%$KCCE7W*>X->R?!K]E/PA\"?B9X^\:>%[W5XKCQI
M.+G4-*GEA-C%('=P846)63!DDP"[##'VQ[/15<S6J\U]^_Y(5DU9^7X;'C'P
M3_93\)? ;XA_$/QEH&HZU>:GXXO/MVI0ZE/"\,3^;+)B$)$C*,S-]YF. .?7
MSW6/^":_P<\37_Q(O-=@UC6KCQQJ8UBYDNKJ-7TZY#S-NLVCB5D'[]P5<N"
MN<XY^J:*BRLEV5OEH_S2^XOF=V[[N[]3Y2^!O_!,_P""_P "_%\/BFUM=7\6
MZ_:R++9WGBB[2Y^R.O1T2..--PXPS*Q4@$$&OJ34M-M-9T^YL+^UAOK&ZC:&
M>VN(Q)'+&PPR,IX(()!!ZYJS152;DN5[$)<KYEN?$_C+_@D3\"/%&O3ZEIS^
M*/"$,Y)ETW0=31;5LG)&V:*5@#_=# #L!7T/\ _V:?AY^S3X;FT?P%H*:6ER
M5:\O97,UU=LN<&65N3C)PHPHR< 9->HT41;BN6.PY>\[L\?L?V7O"NG_ +2V
MH?'"/4-8;Q9?:8-*DLVFB^PB(*B[@GE;]V(UY,A')XKM/BM\-],^,'PW\1>"
MM9GN[;2M=LWL;F:Q=4G1'&"4+*R@_52/:NLHJ'%.'LVM/\]_S*YFI<_73\-%
M^1YQ\//@'X4^'OP0L/A0D$VO^$;6RDT]H=;V3/<PNS,RR[453]\]%';ZU\RW
M'_!'OX#R>();^"Z\7V6G22!VT.WU=/L94?P$M$9BOUDS[U]PT53]Z;J/=D17
M+!4ULCYON/V OA1:^*/AKKGANUU#P3<> 9VGTV'0)8D2Y+.C-]J,L<CS9VX+
M;@Q#,,],<A\9?^"87PR^-WQ8U[XAZQXH\;Z7KNLLIG32-0M884"PK#M0-;,P
M!5!D%CG)[<5]?T4?\'\=_OL/;;R_#;\SX-_X<W_"'_H>?B5_X-[/_P"1*]@T
M_P#8-\!Z?^S1K'P/_MWQ3<>%=4O1?37]Q>0-J"N)(Y-JR>1L"YB7@QDX)Y]/
MI*BCHX]'_G?\T&TE+JMOR/'?''[+?A3Q]^S?:?!/4-0UB'PK;:?9:<EY;31+
M?&.U,9C)=HBFX^4N[Y,')P!V]!^'G@FQ^&G@+PYX1TR6XGTW0M.M],MI;ME:
M9XX8UC4N5506(49( &>PKH:*MSDW)M_$[OS8K))+MM_7R/'[']E[PKI_[2VH
M?'"/4-8;Q9?:8-*DLVFB^PB(*B[@GE;]V(UY,A')XK2^/'[-GP\_:3\.PZ/X
M^\/Q:O';,SVEVCM#<VK$8)CE0AAG RO*G R#BO3J*RY5RJ-M%_G?\R^9J3EU
M?^5ORT/B3PC_ ,$A?@1X9UZVU&_F\5>*[>W;=%I>N:G&;48.0,0PQL1[%B#W
M!K[1TS3+/1=-M=/T^UAL;"UB6"WM;>,1QQ1J %15'"J   !TQ5JBM.9VY>A%
ME?FZA7C&D_LI^$M&_:;UGXYPZCK3>+=5L!ITUG)/";!8Q'%'E4$0D#8A7K(1
MDGCICV>BI6CYEO\ YE=&NC_SO^:.-^+'P?\ !WQQ\'7/A;QQH5MK^B3,'\B?
M*M&X! DC=2&C<9.&4@X)'0FOD_3/^"/7P'L=<2]N+KQ?JFG)(9!HEWJR"TY_
MAS'"LN/^VF?>ON*BDDHOF6X-MKE9B^$/!NA_#_PS8>'?#>E6NB:)8Q^5;6-E
M&(XHEZ\ =R223U)))Y->:?LV_LK^$_V7;+Q/:^%=0UG4(_$.H?VE='6)XI2D
MF",1^7%'A>>AR?>O9:*J[YG)[O\ SO\ FB;+E45LO^"OR;"HKJUAOK6:VN(E
MGMYD:.2*095U(P01W!!J6BI:4E9E7MJCY5^$?_!-_P"%OP-^,UK\1O!NI>*-
M+O+5YGBT4ZA%)IP62-HV0JT)E*@.2,R$@@<UZ1\'?V6_"GP1^)7Q&\<:%J&L
M7>K>.[W[=J4.H31/!#)YDLF(0D2LJYF;[S,< <^OL5%4I-6\E;Y/H)ZWOU:;
M]5L>7?M'?L\^'/VGOAI-X'\4WNJ6&DRW4-VTVCRQQS[XR2H!DC=<<\_+7<V/
MA/3;7PC;^&IH%U'2(K%=/>"^195GA$8CVR+C:V5'(Q@Y/%;%%2HI*26TM7YZ
M6_(-VI=5M^9\3^,O^"1/P(\4:]/J6G/XH\(0SDF73=!U-%M6R<D;9HI6 /\
M=# #L!7T/\ _V:?AY^S3X;FT?P%H*:6ER5:\O97,UU=LN<&65N3C)PHPHR<
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M*>"""00:^,/&_P#P2-^!'B[Q!<:IIY\3>#4N"3+I_A[4HTMFR<D!9HI2H/\
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MWP!_9>\*_LY:EXXOO#6H:Q?2^+]3.JWZZK-%(L<I9SMB\N),+F1N&W'@<T?
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M*A8M@NX*.KCRFVY-?5M8OC'P5H'Q"\/76@^)]%L=?T6Z $UAJ5NL\+X.02K
MC((!!Z@@$5DU[JBE=7O9[/N:J6MWVM?MO;\6?G!!^RK^PK\/&?QK?_%6W\1Z
M%:YO8O#L_BNUNK=B/F");PJ)Y#QC868GHP/-=U_P23\)7$V@?%KXE#2&T;1O
M&GB)I=)MVB$8^S1/*WR <;%:<H,<9C8#I7M.E_\ !-W]FW1]<35H/A;8272O
MO$=U?7EQ;Y]X))FB(]BN*^C=.TVTT>PM[&PM8;*RMXUBAMK>,1QQ(HPJJH&
M . !6T9<J>NZM;YIOU>B,91YFO6_X.R\EK<^2_B__P $M?@G\7?&UWXK*:_X
M/U:]E:XO#X9OHX(KB5N6<I+%(%)Y)V;0223R2:T'_P""97P,C^$>K> ;'1K[
M3(M5D@EN_$$-RLFJR-$X=<32HZJI(Y54"G)XSS7U;162BE'D6QHVW+F>Y\._
M\%./#,?@O_@G_<>'X;V[U&'2YM)LH[N_96GF6.5$#2%%52Q &2% SVJCI_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$+X)_P#"+?8?^$2L4O?[<_M#S/M6X0';Y'E#9CS^N]ON].>/H*OR?O/CM>?
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MS;^U/I/[5WPGU/7_  A!_8OBFP#VE[HNKJ9#I][L)02!2ADB)Z,"I(##Y6!
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MMHI+5,+ZN+W05G^(-5_L+0=2U+RO/^QVTEQY6[;OV(6VYP<9QUQ6A6!\0/\
MD0_$G_8-N?\ T4U<V(DX49RCND_R-Z45*I&+V;1X[^Q7^U=_PV!\,-4\8?\
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M?(?[-7[:NM?%CPG\9OB7XLLM)TCX4>$;V>+1KRPMIA>74$(=W>0O*RNWEF'
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M5"*2UC.;^3;6GI^3.P_X*C:#I[^//V;-:9$&K1^,X;-'Q\S0M+"[#/H&1?\
MOH^])_P6._Y([\,_^QSM_P#TGGKQ'X^:;^TA^TM\7O@]\0?$OPEU;PKX0TWQ
M%:PZ=X=M89KV\LX_/BDGN[L)&#&IV*-TBQX"#"]6/T=_P5<^'OBKXB_"KX>V
MGA3PSK'B>[M?%D%S/!HUA+=O%$()@9'6-254$@;CQR*PHQ<>3FT_>IV[:T_S
MW^9O.2E*5M?W;7K\?_#%;_@L)_R9_;?]C!8_^BYJ]T^)7_)COB?_ +)Y<_\
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MG]R?ZGP1_P %G_\ DU30_P#L:[7_ -)KJN<_;PT6\\ ?#/\ 9V^/6BPNVH^
MY].CO/+X+VDL<9VL?3<FS_MN:]"_X*U_#_Q1\2/V:='TOPEX;U?Q3J<?B:VG
M>ST6PEO)EC%O<@N4C5B%!91G&,L/6O;_ (A?"#_A;_[)-Y\/[^W:"[U+PO%:
MI'<(5:"Z6!3$64\@K*JG!]*QC*5.G5JQ6L9QDOE']=OF;5%&I5HTY?#*$HOY
MR_3?Y'S_ /MT:];?M!>,_@'\%-$NA=:=XUU.+Q'JC0MD'2H$W@G'\+@R$>\0
MKD_VD(4M_P#@K'^SS%$BQQ1Z$JJBC  #7X %4/\ @F#\&_B1/X_U7Q[\5_#>
ML:!>>&?#UIX0\/0ZWI\MI)]F4EG9%D4%@JJJ[AP?,85VO[0?PX\6ZU_P4\^!
MOBK3_"^M7_AC3M(\J]UJVT^:2RM7W7ORR3*I1#\Z<,1]Y?45UJ,:=:C&/6;E
M]Z:C_P"2J/S;.?FE.A7YMU34?G=.7_DS:^1]WU^<7B+_ )32^'?^Q>/_ *03
M5^CM? NO?#7Q?-_P5PT'QC'X5UM_",>A&%]?73IC8*_V*9=IN-OEAMQ QNSD
M@5C#^/3?^+_TW,=3^#47DO\ TJ)]]5^1?Q$^#_B7XW?\%5/B5X<\*?$;5OA=
MJHTR*Z_MW1A*9S&MI:!HOW<T3;6W GYL?*.#7ZZ5\"?#GX:^+['_ (*S_$+Q
M?<^%=;M_"5UH?DP:]+ITRV$K_9K,;4G*[&.588!SE3Z&E!)UXW[2_(T;:HSM
MWC_Z4B)O^";7QDNE,-]^V1X_N[-_EE@*7OSKW'.HD?F#7T#^RO\ L4^ /V3+
M/49?#7VW5_$.J*%OM>U:17N95!SY:[5"HF[G &2<;BV!CW^BM(R<;VZF3BI;
MGYK^ 8U^&/\ P64\96VJGR$\7:,[Z;))TE+P028'XVTR_5<5^E%?)_[<G['>
MJ?M )X=\<?#_ %9/#7Q8\).)M*U!F,:W*!MXA=P#M(;+(Q!&68$88D>8:;^V
M_P#M,?#S3XM%\>?LJ>(_$WB*W3;)JGAEY7M+@CH?W,$Z*3QDK(1G. .E9TY)
M4HTGHX:+S5VU;[[,N<7[251;2U]':SOY=4?5G[0_[27@O]F#P?8>)?&\]U#I
MMY?QZ=$+*$32F1E9MVS()551B<9/L:]%T+6K;Q'HFGZM9&0V=];QW4!EC:-R
MCJ&7<C ,IP1P0".]?G=I?[//QK_;L^,7AWQM\>M C^'OPR\.R?:--\%^9OGN
MR2&VRKG<-VU1(\@0D+M5%W%A^CJJL:JJJ%51@*!@ 5HHN,+S^)O;LO/S;^XE
MM.:4-DM?-^7E;[SR?]K?_DUOXM?]BMJ7_I,]>1?\$J],MM/_ &(_ \L$2QR7
MD^H7$[  %W^V3)D^ORHH_ 5[1^U!I%_X@_9P^)^F:797&I:E>>&]0@MK.SB:
M6:>1K=PJ(B@EF)(  &237F__  3A\)ZYX'_8Y\!Z+XDT;4/#^LVQOO/T[5+6
M2VN(MU[.R[HW 9<JP(R.00>].EHJK_P?G/\ X!=76G2_Q2_])1XE^TW;QQ_\
M%3_V<IE15EDTR57<#E@/M> ?ID_G7IG[7?[47A'X*_%+P=H.D?#"'XI_&J_C
M\S1K.&WB%Q91,60/]H,;NF[$F%0=%<L5')Y;]HKX>^*M<_X*0? #Q-IWAG6+
M_P -Z9I\R7VL6MA+)9VC'[3@2S*I1#\R\,1]X>M<U^V-\'/BQ\-_VMO"G[1_
MPP\*-\0H-/L5LM2T&WRUP $DB;8@RY#QR<%%8JRY*D'!YJ+M1IJ3LO:3N^RU
MMZ7=E?LRZMW6J.*N^2%O-V_K0U=7\6?MU_$;0M6A_P"$-^'GPLTU[:0FZU"Z
M-W=)'M.<>7+.F<?WHQ6'_P $;]*M]>_9*\;:9>)YEI>>);RVF3.,H]E:JP_(
MFMC4OCM^TS^U9X=N_!?A3X'ZA\%[35$-IJ?BWQ==2*UG;N")/(@>&%V<KD!E
M#=?X?O"+_@F5\&_$7A?]GGXI_#+QUX<U[PQ/<:W=Q>?>V,]F+B":VC@\VWD9
M5WX,3$,A.,J>XK>*M&O&4?B@K+O:2O\ G^9FVFZ3YMI:^5T[?E^1P'AOX'_M
M>_L*MJ>D?"./1?BI\-FNI;NVTR\"&> -C):,O%('( &V)W4D9V@DBO2OV=_V
MY/#OQ.^/NF^$_BK\&V^%_P 8KBW^RZ?J>H6(,LZ@,PB$DL230AOWFU<LIY&[
M) /GGPA\8?M(?L!Z;J7PXU/X,ZQ\9_!\5]-<:+KGAMY'D"2,6;<(XIF 9CNV
MNJE69^6&*Z3X?_#/XP_M>_M8>"?C/\1O +?";P;X+B#:7H]]+OO[N4,S ,"J
M./G(8ET0;5 4,26JZ;YIP5^:/5O1I6_-;6,ZBY83:5I:V2V;O^3W;Z'Z'5\N
M?MU?LE:Y^TIH?A'6?!.OP>'/B#X-OS?Z/=W980L248JS*K%&#11LK;6&5P1A
MLCZCKY#_ &^OV>_B'\2/^$%^(GPFN=_COP-??;(=(EG$<5_'N5@,,P0NK+T8
MC<KN,YP#SRT<6[JS6JW7FO0WC?WK;V>CV>FWS/$=1_:N_:Z^ VDW%M\9_@79
M_$'PM';O'>:II$8/FPX(>2=X/.A5"N<AXHQ@\XKVD_&3X=_'#_@GS\3=?^&F
MDP>'M#C\.ZK;3Z+#:1VIL;A;9B\;1Q_)DAE8%>"&!ZY \^OOVX_VC_$VBW'A
MK2_V3/$UAXNNH6M5U*^:==-BE*E?-R]NB%<G.#,!_M'OZ-^Q_P#L6WWP?_9)
M\3?#?Q?>1MKGC-+R35A:D21V9N+<0"-#T8HJ@DCC<3C( )JI%SHUDU]G1K2[
M[>EM;V["I2C3K4I=I:K>R[_?IYC_ /@E3_R9'X)_Z^=0_P#2R:O*?VM'4_\
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MQY1!\.Y?V<_@O^R/\;)MT%X_B:6\UJXQS)#>2+(A8_\ 7O"X_P"!5]5ZFO\
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MM'_X*<?'/Q3?^&=8LO#&HZ/#%9:U<6$L=E=.%LLK',5V.?D?A2?NGT->K?\
M!1#PKK7C;]COXAZ+X=T>_P!>UBZBLQ!I^EVKW-Q-MO8&;9&@+-A5).!T!-<5
M7_<J"6_*O_2F=N'?^W3;VY_T1U/[&W_)I_PB_P"Q7T__ -$+7L4C+&C,Y"HH
MR2W0"O*OV3]%U#PY^S+\+M+U:PN=+U.S\.6,%S97D+0S02+"H9'1@&5@>"",
MBO3-7TY-8TF]L)69([J!X&9>H#*5)'OS79C&_:U7#5W=CCPZ7LX*6FB/@+1?
MVRO$WC3Q=XNT+]D[]G[3-?T^SO"-1\3S-!IME=W'(\PJIB#D@9!:7>5YVBOG
MG_@HP_[36L?![PUJ_P :5\%:'X<;6HX[?0/#>][A;HPRE9)&8R# 02#Y92,L
M.#U'>?L_W_Q^_P""<\WBCX?2? O6?BOX6O\ 4VU#3]8\,B5]Q*+'O9HHIL!E
MCC^1PC*0W)!K+_;8\#_M.?M7?#*#QEK?PYG\)^'=#NX3I7P_TW?J>K7;2_*]
MU*L2Y^0'&"BE0S94#+'G]U*G*+NKQNWTU5]/P2MYG7%M3DI:?%9+KOU_%O0]
M?_X*^?\ )F?A#_L8;#_TCN:^XOAKIMOHWPW\*V%G$(K6UTFUAAC7HJK"H4?D
M*^,/^"F7@WQ7\7/V-/ ]OX5\(>(-:U:35M.O)=(LM*GFO;=/L<^[S8%0NFUF
M56W 8)P>:^W/!T$EKX1T.&:-H9H[&!'CD4JRL(U!!!Z$&MM5]87]]?\ I)RO
M6.&?]Q_^E'X]_L=^,_VB--^*7QL\3?"+X;:#X\U/4M<=-:O-<OHH9;5_.G=8
MTWW4)PQ9B< CY!TQ7MWQRF_;?_: ^%>O> O$7P"\(PZ5J\:I)-::Q:B:)E=7
M5T+:@P#!E!Y!K<\;?!?XR_L7_M'>+OBM\&?"0^)'P_\ &#&ZUSPG;2[+J&8L
M7)C498_.[LC(KX$CJR8 8XGQ<^(W[2O[=GAV/X9Z#\$]8^#GAN_GC.MZ[XHD
MEB)A5@X5?,AB;;N4$A%=FP!\HSGEC'GH4Z:5VDDT]+6T>O;JG^ITRERUIU&[
M)MM-:WZK3OTL?8O[&O@WQ?\ #S]F7P#X8\=V1T[Q/I-B;.YM3/'.8D21Q$N^
M-F0XB$?0FNZ^,&I7>C_"7QK?V!9;ZUT2]G@*@DB18'*D8]P*=\*/AY9_"7X;
M>&_!UA<3WEKHMC%9K=73;I9RJX:1SZL<L?K737EI#?VDUM<1K+;S(T<D;#(9
M2,$'Z@UMC$Z_M5%ZRO\ B985JC[-R6UM/T/B'_@CSH]A8_LD-?6T:?;=0UZ\
MDO)!@LS*(T4$^RA>#ZY[U]3_ !(^!/@3XO:QX:U7Q?X=@UK4?#=P;O2;B261
M&M925)8;&&>40X;(RH-?"'@GPK\=O^";_B[Q7I'A#X;7WQG^#NLWS7^GP:-(
MQOK&1N-K*B229"*JM^[*-M0AE)9:TY/#/QS_ &^_B_X#U;QI\/K_ .#'PI\(
MWPU%['4IW74-0F!!V[62-^0H7)1556?YF.!6SDJ\X2C_ ';W^S9*[]5TMOI8
MR471C.,G?XK?WKMV7SOK?;4MWW_*9[3O^Q5/_I')7U-^VDP7]DGXOEB /^$7
MOQS[PM7S?^V-\&/BO\/_ -J+PC^T=\)/#?\ PFTNFV T_6/#T)_?R1@2(2JC
MYG#QR;?D#,K(IVL,BN8^,GQ._:._;*^#OBKPKI?P1U;X2^&QITUSJM[KK32W
M^H")#*EE:6YABD9I714R%8$$C(Z'@DG+"NFMUSI^5Y2=_2S.NFN7$\[V;BU\
MHQ5O6Z]#IOV5_P#E$3J/_8J^)?\ T9>UU7_!(W3;>Q_8QT6>&,)+>:K?S3L/
MXW$WE@G_ ("BC\*J?LU_#_Q3H7_!+B_\*:EX:U?3O%+>&O$$"Z'=6$L5Z9))
M+LQH(&4/N<,NT8R=PQUKK?\ @F+X,\0> ?V1/#NC>)]"U+PYJ\5]?/)I^K6<
MEK<(K7#E28Y & (((XY%>G5?^UXEKJE_Z4<O_,/17:<_R/$?VIM-M]5_X*P?
ML]0748EB728I@K?WXYKV1#^#*I_"OH__ (*(:Q?:'^Q?\4[C3BRW#Z<ENQ0X
M/E2SQQR_^..]>.?M!_#CQ;K7_!3SX&^*M/\ "^M7_AC3M(\J]UJVT^:2RM7W
M7ORR3*I1#\Z<,1]Y?45]D_$SX?Z7\5OA]XB\'ZVC/I6MV,MC<;.&574C<OHP
M."/<"O.E&4\$X+?FGI\U^9V\T8XY3>RC3_!'YI?LC>.OVO\ P/\ L\^#]-^&
MGP1\(:UX,:W>YL=4NM3@CFNQ)(SM)(#?(0Q8D<J", 8XI/C5\-OVROVB_B!\
M-/$/B7X,:#X>O/!NJI>VM_HVLV8D"F6)V#[[Y\@&($ #/7UKIOA/XD_:4_X)
M^Z/<_#F^^$&H_&KP';7,CZ%J_AAY&FBC=B[!DCCE=5+,3L=%VL7PSKBM?PW\
M-?C?^V_^T/X,^(?Q-\(W?PC^&G@Z3[3I_A^ZN&%]=R[E=E<%5?YF2/>SH@V*
M%4$EFKN4E.O"K%W2:=WTZZ[:]++<X'%PHRIRT=FM.M]--]][O8G_ ."F.F6V
MM?M*?LGZ?>1+-:77B4PRQL 0R-=V(((/8@U^ALBAHW4C*D$$&OAW]OCX=^*_
M&/[27[+FIZ!X8UC7--T?Q*)]2O--L);B&QC^U6;;YG12(UPCG+$#"D]C7W(W
MW3]*P27U.W]Z?_MITU/XJ:_EC^<C\_/^"/%O'9_#GXLV\*[(8O&$J(N<X40H
M /RJC_P3[_Y/@_:U_P"PV_\ Z775=G_P2Q^'OBKX>^"OBG!XJ\,ZQX:GO/%L
MUS;1ZQ82VC3Q&- )$$BC<N0?F'%>3Z+_ ,+8_8Q_;*^+WB"T^"WB7XD^%?'U
M^+NWU+P_%+,MO&\[2EF,4,F"IE=2C!3\H()!R2E=UZ-^M.WS<8Z!6UI5DO\
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M*_V@/C6!HWBC7(?LNF^&+>;<EE"0JAI%#$*51%15R3RY;#&LSX6_#CQ;I_\
MP5<^*'BZZ\+ZU;>%+SP^L-MKLVGS)8SR>58C8DY78S91Q@'/RMZ&MZ7NU*46
MK6A/3M>[M?Y]/3H.5I0JM.]W#YV<5=?=^%S[PIK_ '6^E.I&^Z?I6$OA92/S
MI_X(\Z9;1V/QOU%8P+N;Q*EN\G<H@D91^<C?G7*_\%1KSQ7J'[6?[/\ I'AO
M1K7Q'J-N/MNE:-J$JQVUY>&Z7]W(6=%P?*C!RPX.,UZM_P $K/ASXL^'F@_%
MR/Q5X8UGPS)?>)O/M5UC3YK0W$>QOGC$BC<ON,BN]_;Z_9/U[]H7PUX9\3>
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MM&,G<,=:]"_X)I^#]>\!_L?^$-&\2Z)J/AW6(+B^,NGZM:26MQ&&NY64M'(
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M+M@;?(BF90CGY6^Z3T/I7CGA'0OCC_P3U^.WQ+O-#^$.J?%_P%XSOS>V]QH
MD>XCQ)(\>[RHY60J)F5E=,,0"K=<\U*WL<-&3LO9O[[Z+ROK]QH[^TQ$HJ[Y
MU]UE=^=C"_;HO/VM/%'[,NN:I\5K'P)X.\%0W-K]KT316>6^N&-P@B&\M,N%
M<JQVR+P#UZ5^A7[)O_)KGPB_[%/2_P#TDCKX4_:LL_VG/VS_ (*ZO<R_"^X^
M&?@O1HTU*+PQ+*][K6O7"N%"")45U5%+.$,:DL!C?QM^PO@SK'B?P?\ L-^&
M[RP\-:A#XRT'P2J0:!JFG3I<-?6UH46%[?"R'=)& %&"P88/(-;1E[.A6YE;
MWHNW6W++^ON!Q]I5I*+OHU\[K_/?U['T!17AW['?Q3^)7Q@^$!U_XK>$/^$)
M\4_VC/;_ -E_V9<Z?^X4(4D\JX9GY+-SG!QQ7N-$HN+L_P"KZD1DI*Z\_P -
M HHHJ2PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC%02B@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M110 444F<<G@4 +15;3]2M-6LXKRQNH;VTE&Z.XMY!)&XZ9# X-6: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MD^I>(;.6WN=<68-9*E];AD3S;B;AB03@KT[UM02>+P]W]M?DR:E_85=/LO\
M0_7+X@?$/PW\*_".H>*/%NL6VA:#8)ON+VZ;"KS@  <LQ. %4$DD  FOC_\
MX?"? ?\ M[[%]E\7_P!F>=Y7]O?V0GV+_>QYOG8]O+W>U>,?\%;/BCI4/QR^
M#O@?Q>]\_P /;3;K^MV.G#,MTC3M%@ LH+!(I5'(QYK<UW*?\%8/V98_!_\
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M5Z!^T!^U-X/_ &;=4\$6?BRWU)AXLU'^S;2ZLDA,-L^4!DG:25-D8\P$L-V
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M[>G<]HHHHK,T"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH _.'_@L-_KO@/_ -C#-_.WKU7_ (*U_P#)EOB+_L):
M?_Z4+7U+XQ^&OA#XB&P/BKPKHGB8Z?(9K/\ MC3H;O[,YQEH_,4[&X'(P>!5
MOQ=X+\/>/]%DT?Q1H.F>)-(D97?3]7LX[JW9E.5)CD4J2#R#CBL94W*E[/\
MO\W_ *3_ /(EJ5JG/_=Y?QE_\D8'P+_Y(C\/?^Q=T_\ ])HZ^,?@K_RF"^-?
M_8JQ_P#H.FU]_P!C8VVEV-O965O%:6=O&L,-O @2.)% "HJC@*   !P *Q;'
MX=^%--\87OBVS\,:/:^*KZ+R+K7(+")+ZXC^7Y))PN]E^1."2/D7T%=LJB>)
M=?H^?_R9'/2A[/#JB]_=_P#)6G^ARNJ?LQ_!W7-3N]1U+X3^!]0U"[E:>XN[
MKPY9RRS2,26=W:,EF)))).237A7_  4#\ ^&/AS^P3\3]+\)^'-)\+Z8WV.=
MK+1;&*TA,AOK8%RD:JNX@ 9QG@5]@5E^)_"NB^-M#NM%\1:/8:]H]T%$^GZI
M:I<V\VU@R[XW!5L,H(R.H!KCJ1<H."T_X<ZZ4^2K&I+6SN?"7CC_ )0W6O\
MV)NG_P#HV&K.L_ G4OVA_P#@E-X)\,:'$+CQ#;^'=/U/38"0/.FA ;RP3P"Z
M%U&>,L*^V)_A[X5NO!H\(S>&='F\)B%;8:#)81-8B)2"L?D%=FT$#"XP,"M+
M0]"TWPQH]GI.CZ=:Z3I5G&(;:QL8%A@@C' 1$4!54>@&*NM%5957_.TUY6N_
MS:^XQHMTHTE_*FO6ZBOT?WGPM^S3_P %-/A7H_PCT7PW\5=7O/ OCKPW:II.
MI6&H:9=2-*\"B/S%,<;8)VC*-A@VX8( )V?V=/VBO'W[8G[0'C6]T-;FQ_9S
ML].?3H?MVGQQR:C=,NPLDA7>"<NQ7<=JA 0"V*^JO&'P3^'?Q"U*/4/%7@+P
MQXFOXP%2ZUC1[>[E4#H \B$@?C75Z;IMGHUA!8Z?:06-E;H(X;:VC$<<:CHJ
MJ  !["M)-5I2G55V[Z=-=&_\EWUZ(F,?9Q4*;LE;UTUM_P 'MZGY>_LG_'2T
M_P""<_C#QE\$?C5%?:'H$FIR:GH/B9;.2:WN(V 3=B-68JZI&05#;6WJV,5Z
M!^T!_P %%+OXI:QX8^'?[*E_/XE\<:I?(USJRZ2QMK6W'#*5N(^F2I:3;M15
M/.3Q]X>+/!/AWQ]I1TSQ/H&E^(]-8[C9ZM9QW4)/KLD4C/X54\%?#'P=\-;>
M:W\(^$]#\*P3'=+%HNFPV:N?5A&J@_C23<N7VKORVVTO;:_Y.VY3M'F=-6O?
MY7WM^:OL?&/_  5NM[ZT_8ITJ#5+M;_4X]:T]+JZ2,1K-*(I0[A1PH+9..V:
M^V? _P#R)7A__L'V_P#Z+6F^,O ?AKXB:0-*\5^'=)\3Z6)%F^PZS8Q7<'F#
M.'V2*5W#)P<9Y-;,$$=K#'##&L,,:A$CC4*JJ!@  = !2A[OM+_:DG]RL$O>
M]G;[,6OO=SX"_99_Y2@?M*_]>$/_ *%;5+:_MR^(?V<_VGO'W@3]HJ]EM?!M
M[(+CPGKEOI/^CI:[FP&\E"\FY616;YMKQD$ 'C[<TKX>^%="\4:GXETWPSH^
MG^(]44)?ZQ:V$45W=J,8$LRJ'<?*OWB>@]*E\6^!_#GC[2_[-\3^']+\1Z=N
MW?8]6LH[J'/KLD4C/X5,+PITH+7DCROL];W\FNGS7432E.K)_:ES+NM$K>CZ
MGY,?MQ>,O@=^U)JW@SPM^SQX=MM?^*NH:PLDNKZ!HTEAB'8VX3.T<?F'<4?>
M00@C8EEZ'WW_ (*&?#/QIX"\3?"#]H'PMI\WB34/A[Y<.NVT(+.]LI#F4]3L
MYF5VP=HD#= 2/MWP3\+?!?PUCGC\(>$-!\*QS_ZU=$TR&S$F.FX1JN?QKJ*I
M>XH^SW4N:_G:VW:U_6Y3?.W[173CRV[IN^K[WV[6/CVW_P""KW[.LW@H:X_B
MF^AU'[/YI\/MI-R;P2;<^3N">46SQN\S9_M5-^PK\1/C#^T1X=\;^-/B<@L/
M VNW#Q^%]%ELHX95M'+EFWJBM)&$9$5VR6VLW3!/OLW[/OPMN/$!UZ7X:^$)
M=<,GFG4WT&U-R7Z[O-,>[/OG-=\H"@ # '  HM&2ES+=6MT5]_7MKL3[RLHO
M9WOUT_+]3\N?V5?C5I__  3C\?\ CKX)_&1;W0O#5SJ;ZMX>\2?9)9[>XB8*
MF3Y:LQ5E2,Y4':X<-BN _P""FO[:WA3]HSPCH'A+X:F\U[PQI6JQ7^J^(392
MPVPN#'*D$"^8JMD@S-D@9VC;NPV/UI\8> _#/Q"TL:;XJ\.Z3XETX-O%GK%C
M%=P[O79(I&??%8L_P-^&]UX3@\+S?#[PM-X9MYQ=0Z+)HMLUG', 0)%A*; ^
M&8;@,\GUJH2?-3E5=^1Q^?+:U_.RZ;M>IHFH2DX*W-?Y7WMY/\$_0["R_P"/
M.#_KFO\ *IZ15"J !@#@ 4M)ZNYC"/+%1['YX_\ !)+_ )#'[0W_ &-2_P#H
M5Q4?PB_Y3'?%O_L6E_\ 1-A7WAX1^'/A/X?OJ+^%_"^C>&WU&7S[UM(T^&U-
MU)S\\OEJ-[?,>6R>3ZTEG\./"6G^,KOQ=:^%]%MO%=Y%Y-SKL.GPI?3QX4;'
MG"[V7"(,$X^5?04J/[N5-O[,.7_R11O^!;^&I'^:7-_Y/S'@7_!1K]GO5_VB
M_P!FG4M(\.0F[\2:/=QZSI]HIP;EHU=7B'^TT<C[1W8*.]>:_ +_ (*D?":3
MX8Z9I_Q1UFZ\#>.]'@6QU73;W3+J3S)HE"-(ABB;&XC)1L,IR,$ $_=5<3XN
M^"/PZ^(&J)J?BCP!X7\2:D@"K>:OHUM=3*!T >1"1^=3&\.9+:5G\TK77RZ%
M2M/E;WC=+T>MOO/@7X6ZMJ?[?/[>>A?%O1]%OM/^$GP\@,%CJ.H0F,7UPOF%
M=@_OF20.0,E4C7=M9@*ZWX@?\ID/AS_V)S_^BKZOOO3]/M=)LH;.RMH;.T@4
M)%;V\82.-1T55' 'L*QKCX=^%;OQE;>+I_#.CS>++:'[/!KTEA$U]%%AAY:S
ME=ZKAV^4''S'U-:P<:;@H[1YOFY*2;^]_<C*:=13<MY)+T46FE^'XGS]_P %
M-O\ DQ[XF?\ 7*R_]+K>NR_8?_Y-#^$7_8N6G_H KUSQ/X5T7QMH=UHOB+1[
M#7M'N@HGT_5+5+FWFVL&7?&X*MAE!&1U -3:'H6F^&-'L])T?3K72=*LXQ#;
M6-C L,$$8X"(B@*JCT Q40]U37\S3^Y-?J:R?,H+MS?CR_Y'Y_\ [(/_ "DV
M_:9_ZX'_ -'PU^AU<[H_PY\)^'O$VI^)-*\+Z-IGB+5!B_U>ST^&*[NQD'$L
MRJ'?D _,3T%=%2I^Y0I4OY(I?B_\R&KU:E3^:5_P2_0_/G]O[P)X_P#A'\?/
M ?[3'@'2+CQ-:^'8/LFO:3 68K /,!D*J"0C132(S@'855B,5Z!X1_X*S?LY
M^(M!AOM4\3ZCX7O67,FF:CHUU+*A]-UO')&1Z'=^5?8U>>^(/V=_A5XLU234
MM<^&7@[6=1D;<]YJ&@6D\S'U+O&23^-*/-&/)NKMKNKZOY7^XJ5I2Y^MDO6V
MW]=3\^?B5\2#_P %+_VD_AAHOPST#4A\/_ NI?VEJ_BV_MC"A!>)F5 ?NY6(
M!5/SL7)*A4)KT;_@HEX(\6?"[XU?#']IGPEH\WB"W\'@6>O6, )=;4,Y\S@'
M"E)ID9_X24)&,U]Z:+H>F^&]-AT[2=/M=+T^ ;8K2RA6&*,>BHH  ^@JZ0&!
M!&0:KX%#V>CB^:[ZM[W\K:6"_,Y<^TERV7;?\W<^/+[_ (*P?L[6W@EM<@\3
MWUWJ7D>8OA]-*N%O#)MSY)8H(@<\;O,V_P"T:X3_ ()T_"OQWKU]\7OCOXGL
M6\+Z_P#$661M$M[N$EX(69Y!*58 F/<T07(&Y8L]&!/V%:_ 'X867B,>(+?X
M<>$H->\SSO[4BT.U6ZW]=WFB/=GWSFN]HM'WI?:::]$][>;)=[*'1-/U:VOZ
M;GYX? 3_ (**6GA,>+/AS^U9=MX>\<:7J$L1N+G1F:TN[=ONIL@B(P,$ABNU
MT92&)KR#4/\ A6W[1'[>WPDO?V9_#B6-CX=NH]1\3Z[H^F/IUB\23*YS&53:
M=BR(6*CS#*!\V,U^HOC;X5>"?B4L*^+O!^@>*E@_U0UO3(+P1_[OF*V/PJ_X
M3\%>'O 6E+IGAG0=,\.Z:IW"STFSCM803WV1J!G\*JG+EJ0JRWA;;K96U_-]
MPJ+FA.G':7?6UW?3\D?GM^TZ=;_8O_;DLOVB?[$O=:^''B:Q32_$$MC'O>S?
M8D1SG 7/E0.NX@,0ZY!Q7IWQ4_X*N?!#0?AWJ-_X*\1S>+?%DL#)IFCP:9=1
M,UPPPGF-+$JJH8@GDD@':#7VA<VT-Y;R07$23P2*4>*10RNIX((/!%<3X=^
MGPR\'ZV-9T'X=>$]$UA26&H:=H=K;W )ZGS$C#?K62B_9JE)Z*]FMTGK;\[/
MI\C1R]_VB6NGIHK7_*_<\C_9KU#XNZY^R?J.M?&F[\WQ=J=C>7,=J]C%:2VM
MJ82(DECC50)#@L1@$!E! (->:?\ !';_ )-!/_8Q7O\ Z##7V]<6\5W;RP3Q
M)-!*I22.10RNI&""#U!':L;P=X%\-?#O1_[)\*>'M*\,Z5YC3?8='LHK2#>V
M-S[(U"[C@9.,G K922J5)VLI12]+._\ 7F<\H.4:<;_#)O[U8W:_.+Q%_P I
MI?#O_8O'_P!()J_1VN;D^&OA&;QI'XQD\*Z(_BZ./R4U]M.A-^J;2NT7&WS
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,H **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>nbix-20211231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 nbix-20211231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[?XQ^,'C']G[]CP_&'XP:0^I>*- \$V]QKFG:7"7^V:MY"*\,8C!X>Y;;D#
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M%0?$S_H3;S_OD?XT <W172?\*@^)G_0FWG_?(_QH_P"%0?$S_H3;S_OD?XT
M<W172?\ "H/B9_T)MY_WR/\ &C_A4'Q,_P"A-O/^^1_C0!S=%=)_PJ#XF?\
M0FWG_?(_QH_X5!\3/^A-O/\ OD?XT <W172?\*@^)G_0FWG_ 'R/\:/^%0?$
MS_H3;S_OD?XT <W172?\*@^)G_0FWG_?(_QH_P"%0?$S_H3;S_OD?XT <W17
M2?\ "H/B9_T)MY_WR/\ &C_A4'Q,_P"A-O/^^1_C0!S=%=)_PJ#XF?\ 0FWG
M_?(_QH_X5!\3/^A-O/\ OD?XT <W172?\*@^)G_0FWG_ 'R/\:/^%0?$S_H3
M;S_OD?XT <W172?\*@^)G_0FWG_?(_QH_P"%0?$S_H3;S_OD?XT <W172?\
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M*@^)G_0FWG_?(_QH_P"%0?$S_H3;S_OD?XT <W172?\ "H/B9_T)MY_WR/\
M&C_A4'Q,_P"A-O/^^1_C0!S=%=)_PJ#XF?\ 0FWG_?(_QH_X5!\3/^A-O/\
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M'4HT3(1M9"I(*D8(.* /DO\ X+.Z3<_$_P#91\.?!SPFZW6I_$#XCZ+I.BI
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M&(5YR3PF!S@?E6!_PD.O_P#0<O/_  )?_&ND_;!_Y/5U_P#[%;3_ /V:N/H
MN?\ "0Z__P!!R\_\"7_QH_X2'7_^@Y>?^!+_ .-4Z* +G_"0Z_\ ]!R\_P#
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M$O\ XU3HH N?\)#K_P#T'+S_ ,"7_P :/^$AU_\ Z#EY_P"!+_XU3HH N?\
M"0Z__P!!R\_\"7_QH_X2'7_^@Y>?^!+_ .-4Z* +G_"0Z_\ ]!R\_P# E_\
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MX2'7_P#H.7G_ ($O_C5.B@"Y_P )#K__ $'+S_P)?_&C_A(=?_Z#EY_X$O\
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MZ* +G_"0Z_\ ]!R\_P# E_\ &C_A(=?_ .@Y>?\ @2_^-4Z* +G_  D.O_\
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MS_P)?_&C_A(=?_Z#EY_X$O\ XU3HH N?\)#K_P#T'+S_ ,"7_P :/^$AU_\
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M_P#T'+S_ ,"7_P :/^$AU_\ Z#EY_P"!+_XU3HH Y_XY?'+7_@Q\+=4^)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHK)\*>//!OCG[;_PB'B6TU'^SKMK6]^R
MRAO)E7JI_P >AYP>*M0G*+DD[+=]K]S.5:E"I&G*24I7LKZNV]EUMU-:BBBH
M- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"FG52I4Y1A!\O+&#M)*-Y*[N_DVO6?V&_P#DZ7PO_P!OO_I#<5ZS_P .O/\
MJN/_ );/_P!TUUOP-_8-_P"%,?%+2_B7_P +5_M+^S?/_P!"_L/R?,\R"2+[
M_GMC&_/0YQCOFNG'\0Y16P-6G"K=RC)+W9;M-+H?3<>?2"\(<ZX&S3+\'F7/
M6K8:O3A'V.(7-.=*48J\J22NVE=M)=6D?0M%%%?F9_F<%%%% !1110 4444
M%?27_!/;_F;_ /N'_P#MS7S;7TE_P3V_YF__ +A__MS0!])4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!\%_M@_P#)ZNO_ /8K:?\ ^S5Q
M]=A^V#_R>KK_ /V*VG_^S5Q] !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML_'O]IS]K;4YO"?P.\.SZ%H6_P NYO8I2A"G_GM<X&SCG9'\V,CYJZGX1_L
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M ?!?[8/_ ">KK_\ V*VG_P#LU<?78?M@_P#)ZNO_ /8K:?\ ^S5Q] !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\1_:R_:VTWX*V#>"_!;QWOBR[C CC WI8*W220=W/\
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MVG'%>(&+O7M=8'#R4JS[*M43Y:2[I/F:UC*ZL>7_ /&67[;L_P#T+?@^1_\
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M.I>(8/!;7MQ:6EH?-U2=7>*V8(@X,^(7)4;1YI. HH ^E:*_/[]A+P3^RO\
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M*@^)G_0FWG_?(_QH_P"%0?$S_H3;S_OD?XT <W172?\ "H/B9_T)MY_WR/\
M&C_A4'Q,_P"A-O/^^1_C0!S=%=)_PJ#XF?\ 0FWG_?(_QH_X5!\3/^A-O/\
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M(_QKPVW)W9^'5*E2M4=2HVY-W;>K;>[;ZMG-T5TG_"H/B9_T)MY_WR/\:/\
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M^-4Z* +G_"0Z_P#]!R\_\"7_ ,:/^$AU_P#Z#EY_X$O_ (U3HH N?\)#K_\
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M_P "7_QH_P"$AU__ *#EY_X$O_C5.B@"Y_PD.O\ _0<O/_ E_P#&C_A(=?\
M^@Y>?^!+_P"-4Z* +G_"0Z__ -!R\_\  E_\:/\ A(=?_P"@Y>?^!+_XU3HH
M N?\)#K_ /T'+S_P)?\ QH_X2'7_ /H.7G_@2_\ C5.B@"Y_PD.O_P#0<O/_
M  )?_&C_ (2'7_\ H.7G_@2_^-4Z* +G_"0Z_P#]!R\_\"7_ ,:/^$AU_P#Z
M#EY_X$O_ (U3HH N?\)#K_\ T'+S_P "7_QH_P"$AU__ *#EY_X$O_C5.B@"
MY_PD.O\ _0<O/_ E_P#&C_A(=?\ ^@Y>?^!+_P"-4Z* +G_"0Z__ -!R\_\
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M .Q6T_\ ]FKCZ[#]L'_D]77_ /L5M/\ _9JX^@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ KYW_:T_:YN/"%TWP<^#3M>^*+
MMQ;W-U:+YALF;@1Q@9W3G.,#[N?[W C_ &L_VN+SPY?-\%O@E(][XFNY!;7=
MY9+YC6;-QY46/O3G../N?[WW=C]DO]D>S^#]JOC_ .(")>^++M"Q+MO73PW5
M5/\ %(<_,_U XR6^MR_+L+E6%CF.91O?^'3ZS?\ -+M%?CZ63_-\YSO,>(LP
MGD>13Y>72O76U-=80?6H]M/A\G=QC_9*_9&M_A1"OQ'^)"+>^++M2X$C^8NG
MANH!YW2G)W/VR0.,EO>***\#,<QQ6:8IXC$2O)_<ET271+^M3[+),DR[A_+X
MX/!PY8+[Y/K*3ZM]7\E9)(****X3U@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHKC_C+\<? /P-\-GQ!XTU/$D@
M(L=.@PT]VX_A1?3U8X49Y/(!TI4JE>HJ=-7D]DCT,JRK,L\S"G@<OHRJUJCM
M&$4W)OR2^]O9+5Z'Q)^W)_R=+XH_[<O_ $AMZ\FKI_C-\3;WXQ_$S5?B1J&F
M164FI21D6L+EA&B1)$@R>IVHN3QDY.!TKF*_9L!2G0P-*G/>,8I^J21_LMP+
ME>,R3@C*\NQ<>6K0P]"G-73M*%*,9*ZT=FGJM&%?H7^PW_R:UX7_ .WW_P!+
MKBOSTK]"_P!AO_DUKPO_ -OO_I=<5\]QC_R+(?XU_P"DR/Y[^F%_R;/"?]AE
M/_TSB#UFBBBOS8_S=*NL:'HOB&Q?2]?T>UOK:3[]O>6ZRQM]58$&O)/'W["'
M[/7C;?<6/AV?0KE\GSM%N/+7/_7-PT8'LJBO9:*[<)F./P$N;#U90]&U]ZV?
MS/+S+),GSB')CJ$*B_O13:]'NODSY(O?V&?C]\*;I]6^ GQE9@#N-L;B2RD?
M_9(!:.3_ ($5'M48_:D_;)^!Q$'QI^%IU2SB.)+V:S\K..PN+?,/YJ37UW00
M&!5@"".0:]U<4U,2N7,</"LN[7+/_P "C_D?'OP]HX!\V28RKA7_ "J7/3^<
M)WO]YX)X"_X*(_ WQ1LMO%<6H^'KAN&-W!Y\&?0/%D_B545[+X3\>>"?'=E_
M:'@OQ9IVJPXRSV%XDNW_ '@IRI]C@URGCW]EGX"_$??+XA^'%A'<ODF\TY#;
M2Y_O%HMNX_[V:\;\6?\ !-TZ9>_VW\&OBO>:=<QG=!%J2G<I]IX=K+_WP33]
MCPGC_P"'4GAY=I+GC\FM?FQ?6O$?)_XU&EC8+K!^RJ>K4O=^43ZEHKY#_MO_
M (*&_ /C4M/E\5Z;#_&\8U%6 ZDLF+@#W; KH/!/_!2GPO).-+^*?P[U#2;A
M&V2SZ>XF16[EHWV.@]AN-9U>$\R<'4PDHUX]X23?S6COY:FU#Q&R*-54<RA4
MPE1]*T'%/TDKQMYMH^G**XSP%^T-\%?B9LC\'?$;3;B>3[MG+-Y,Y/H(I-KG
M\!79U\]7P^(PT^2M!Q?9II_B?;83&X/'TE5PU2-2+ZQ:DOO5T%%%%8G2%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5])?\$]O^9O\ ^X?_ .W-
M?-M?27_!/;_F;_\ N'_^W- 'TE1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'P7^V#_ ,GJZ_\ ]BMI_P#[-7'UV'[8/_)ZNO\ _8K:?_[-
M7'T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\W?M
M8_M;:AI>HM\#_@8\E[XCO)/LU[?6(WM:NQQY,6.LQZ$C[G^]]V/]J[]K35(=
M5;X$_ 5Y;WQ!>2_9;Z_L!O:W<\&"''67L6'W.@^;)7J?V3OV2]+^".G+XO\
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MYKYMKZ2_X)[?\S?_ -P__P!N: /I*BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /@O]L'_D]77_ /L5M/\ _9JX^NP_;!_Y/5U__L5M/_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH *^DO^">W_ #-__</_ /;FOFVOI+_@GM_S-_\
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M%4='[8/_ ">KK_\ V*VG_P#LU<?0!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P!
MW1__  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A
M_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\
M!5'1_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#=
M'_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=<?10!V'_
M  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\ 0-T?_P %
M4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?
M_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\
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M=_T:SNMP_P"V)$A_'F@?MX_M#>"ACXG_ +/PC"??8VEU8Y]\R!Q1_JCCZO\
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M*HZ/^%V^+/\ H&Z/_P""J.N/I))$B1I97"JH)9F. !ZF@#L&^-_BI%+OIVC
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M48&&$PD%"G!627YONWNV]6]6=A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\
M\%4=<?17,=QV'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\
M"[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51
MT?\ "[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__
M  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +
MM\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1
M_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\
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M110 4444 %%%% !1110!\%_M@_\ )ZNO_P#8K:?_ .S5Q]=A^V#_ ,GJZ_\
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MJ? Y+X;\.Y'GM3,Z,;MZPB_AIOKR_I?X5H@HHHKY<_0 HHHH **** "BBB@
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M110 4444 %%%% !1110!\%_M@_\ )ZNO_P#8K:?_ .S5Q]=A^V#_ ,GJZ_\
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M>"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1Y/8O1.*E%M<DDXR5[).%MSASAT\'453V,9*75K6_P#7ZGIO_"OO@!_T._\
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M21@/0&C_ (AYX[QU7&]_7+<-^DP^MY7_ - W_D\CU-OV8;@#Y?&:$]@; _\
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MV A"KUJRO.J[[WJ3YIZ[M)I>1R8C'8K%?Q)77;9?<%%%%?H9R!1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5])?\$]O^9O\ ^X?_ .W-?-M?27_!
M/;_F;_\ N'_^W- 'TE1110 4444 %%%% !1110!Y_P#&SPO\%?CEH&O_ +/W
MQ4\/:?KJ-H*:E=Z-J$!(\EVFCCGC;@JZO$^'0AD.TY&X9^1_^"?<'Q@_90^.
MG@#]EV/XBWOB[X=?$;X6+XJT6RU4[[KPM<I%$TT2N/\ EU=WVJ, ;G7 #*YD
M^N?BM^S3\,/BYXGM/'^MPZKI_B73M.EL-.\0Z%KMW87,5O(=S0L8)4$T1;#&
M.0,N1G&>:J?L]_LM?#?]GO2K6?1HKC5/$8T"STK4O%.JW4UQ=74%O&%2)#-)
M)]F@W L+>,B-2<X)^8@'C?\ P47('Q^_9@R?^:RQ?^B#7U7/<V]JJO<W"1AG
M5%,C@98G  SW)X KSSXO?LH? _X[>+="\<?%#0=7OM3\,WRWOA^:V\7:G9I8
M7*[<31QVUS&BO\H^;;GKZFKOQQ_9Q^$7[1OPQ_X5#\8/#<VK:(LT$T2-J4\<
M\4T/^KF6='$HD'/S;B3D[LY.0#Q#]M;X!>&9/VE?@;\>/A=I<&G?$5?B?9V-
M]>:>@2;5-#,,SZ@LX7!D6.WC;YVSM#E<_.!63\'_  ]>?#K_ (+*_%LZ[&8T
M^(7PVTK6-!E?[LT=F+>RF13W973<5ZA2#C%?0OPF_9T^%OP9E_M#PI8ZG>:E
M]D^R_P!M>)/$%YJU\+?(/DK/>2R/'%E5/EH53*@[<@&KOQ,^"?P]^+-WI.L>
M*].N8]4T">2;0M;TK4)K.^L&D39((YX65PCK\KQDE' &Y3@8 /FWX.>'K_QE
M_P %E?BW\3].1GTOPE\,=+\-WEPH^0WMTUO>",'H2L<39 Z9&<9%?7U<Y\,?
MA-X!^#N@3>'/A_H7V.&ZO9;W4)YKB2XN;ZZD(,EQ<3RLTD\K8&7=F;  S@ #
MHZ "O$M4_8(^#6KZG<ZM<^*O&ZR74[S2+%XON54,S%B  >!D\#M7MM% 'Y\?
M$/PIIO[.'[7&O^'O L]U>0?\(O9G?X@N&OI/G;<?FDYZJ,>@SZUI_P#"[?%G
M_0-T?_P51T?M@_\ )ZNO_P#8K:?_ .S5Q] '8?\ "[?%G_0-T?\ \%4='_"[
M?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=
M<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\
M0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\
M6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ
M]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P!
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M?10!V'_"[?%G_0-T?_P51T?\+M\6?] W1_\ P51UQ]% '8?\+M\6?] W1_\
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M,_'>(.)N(.*\>\;G&*G7JOK.3=EVBMHKRBDEV"BBBL#P@HHHH **** "BB@
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M\.K6;C'WY?XIN\Y?]O29YU?%8C$RO5DW_7;8****^O.<**** "BBB@ HHHH
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M,/HU<%\2<"\!U\#G='V-:>(G44>:,FHRI48J_*Y)-N+]UNZ5KI7"O6?V&_\
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ME_X1W_@IMI)_T/7/M6.G^E::^?\ OZ!Z_I1_8M&7PXJE\Y6_0/\ B#&45_\
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MX(^+.'^/)J[](\W_ *2V>[45X[:?MY?LR7/^N\<7-O\ ]=M'N3_Z#&:U+/\
M;+_9FOL>3\5K1<_\]K.XC_\ 0XQ6$LKS*.]&?_@+_P CQ:_AAXDX7^+DV*7G
M]7JV^_DL>G45PMI^TY^SY>X\GXPZ N?^>VH+'_Z%BM2T^-?P;OR!8_%KPS,3
MT$6O6[']'K&6$Q4/BIR7R9XM?A/BG"_QL!6CZTIK\XG345F6GC3P=?\ -AXL
MTR?/3R;^-OY&M&.6*9/,AD5U/1E.16,HRCNK'CUL-B<.[58./JFOS'445^>G
M[<G_ "=+XH_[<O\ TAMZ]3)\K_M;%.CS\ME>]K]4NZ[GZAX/>&'_ !%CB:ME
M'UOZM[.C*KS>S]I?EG3AR\O/3M?VE[W>UK:W7Z%T5^3=%?2?ZE?]/_\ R7_[
M8_I'_B2W_J??^6O_ -\'ZR5S7Q&^+_PV^$VG?VE\0/%UIIZLI,4#ONFE_P!R
M-<NWX# [U\<_!KXU?M-:_P##33/@;\ _"KHNGB9;K6+:'=)^]GDEYEDQ' /W
MF.?FXR".E>E_#G_@GM-JVH_\)=^T+XYN=7OIF#SV-G<NV\^DMP_SOZ$*%QCA
MC7D5<EPN J2^NUDDF[*.LFNCMM&_G<_(\R\%^%N \QK/C3.8TZ<)R4*-!*>*
MK04FHR<+RC0]I&TESN25^5M-%+QG^WA\1?B3J[>"_P!FCX=7<D\F0M_<VOGS
MXZ;UB7*1@?WG+#'4"F>$?V%OBE\4]73QI^TQ\1KHRORUA;W(GN /[AD.8XA_
MLH&'TKZ9\&> O!GP[TA="\$>&;/2[48S%:0A=Y_O,>KGW8DUKUE+.H8:+A@*
M:IK^9ZS?S>WHOD>9B?&;"<-4)8+@++H9?!JSKRM5Q4UYU)74$_Y8IV?PR1R_
MPU^#'PR^$5A]@\ >$;6Q++MEN@N^>7_?E;+-ZXS@=@*ZBBBO$J5*E:;G-MM]
M7JS\3S#,LPS?&3Q>.K2JU9:RG.3E)OS;;;"BBBH.(**** "BG0PS7$HA@B9W
M8X5$7)/X"NET/X._$/7=KP^'Y+>,_P#+2\(B _ _,?P%>#GO%/#7"^']OG&,
MI8>'>I.,+^G,U=^2NS6E0K5W:G%OT1S%%>IZ=^SG:6$/VWQEXOB@C7[ZVX"J
M/^!O_P#$U9^V?L\>!_\ 46Z:I<)W"FX)_%L1_E7X]B/I$\(XZM+#\+X3%9K5
M6G^S4)NFG_>J34(I?WDI(]!917BKUY1@O-Z_<CR_2?#^N:[+Y.BZ1<W39Y\B
M%FQ]2!Q77Z'^SWX[U/$FI"VT]#U\Z7<^/]U,_J16IJW[2-U'%]D\*>%X+:-1
MA&N6W8'LBX _,UR.N?%7Q_X@W)?>))TC;_EE;'REQZ?+C/XYK'^TOI&<6?[K
M@L)E%)]:TWB:Z7>,:=J5_*>VP^3**'Q2E4?DN5?CJ=ROP=^%OA!1+XW\8^;(
MHR86F6(-_P  &7/X&E_X6O\ "'P8-G@SPG]HE7[LR0!,_P# WR_Z5Y*S,[%W
M8DDY))ZTE'_$!:N?^]QGGV+S&^]-3^KX=_\ <&E^DUH']J*E_N]*,//=_>SO
MM<_:(\;:CF/28;;3T/0QQ^8_YMQ^E<U%X@OO%6N6T?C;Q1=&S:8&XEF=W")U
M.U5S@]A@=36-17Z+D?A;P'PM@YT<CP%/"S<7%5:<(NM&ZMS*I-3DY1W7,Y*^
MZ>J..KC<57E>K)R\GM]R/H&W^-/PHM8$M;;Q&$CC0+&BV,^%4#  ^2G_ /"\
M?A=_T-'_ ))3_P#Q%?/=%?@,_H5^%U2;E+&XUMZMNI0NW_X3GJ_ZQXU?9C]S
M_P STKXV^*OAYXUTZVU#0-=$NH6K[=GV65?,B/4990.#R.>YKS6BBOZ(\/N!
M<O\ #CABGD6 Q%6M1IN3@ZTH2E%2?,XIPA!<J;;2:;5VKVLEY.+Q4\96=622
M;[?\.PHHHK[8Y@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_/&_N8__ $"45F7G[!/[,]SGR?!UW;Y_YXZQ<''_ 'V[5[)16\<TS..U:?\
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M_P"!W@GYO%'B3[9,OWH7N,G/^Y%\P_$FO.]<\>^,O$>X:QXCNI4;K$)-J?\
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M 4444 %%%% !1110 4444 %%%% 'P7^V#_R>KK__ &*VG_\ LU<?78?M@_\
M)ZNO_P#8K:?_ .S5Q] !1110 4444 %%%% !1110 4444 %%%>._M8_M3:5\
M!O#W]B:"\5UXHU"(_8;4_,MJAX\^0>G]U?XB/0&NO X'$YCBHX?#QO*7]7?9
M+J>;F^;8#(\OGC<9/EIP6OGV275O9(S_ -KW]JZW^#>FGP'X%F2Y\67\8"!
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M2[&2R$,7W;6S("*?]RW4 ?C5P_&KX9>&1L\'^!]SKTD$$<(;_@7+'\17R_\
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M@8 /FWX.>'K_ ,9?\%E?BW\3].1GTOPE\,=+\-WEPH^0WMTUO>",'H2L<39
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M<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\
M0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\
M6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ
M]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P!
MW1__  51T?\ "[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9
M_P! W1__  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T
M4 =A_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#=
M'_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_
M $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=<?10
M!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\ 0-T?
M_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\6?\
M0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '
M8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__
M  51T?\ "[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P!
MW1__  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A
M_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\
M!5'1_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#=
M'_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=<?10!V'_
M  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\ 0-T?_P %
M4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?
M_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\
M"[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51
MT?\ "[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__
M  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +
MM\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1
M_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\
M!5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=<?10!V'_  NW
MQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\ 0-T?_P %4='_
M  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?_P %
M4=<?10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\ "[?%
MG_0-T?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\
M"[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51
MUQ]% '8?\+M\6?\ 0-T?_P %4='_  NWQ9_T#='_ /!5'7'T4 =A_P +M\6?
M] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?10!V'_"[?%G_ $#='_\ !5'1_P +
MM\6?] W1_P#P51UQ]% '8?\ "[?%G_0-T?\ \%4='_"[?%G_ $#='_\ !5'7
M'T4 =A_PNWQ9_P! W1__  51T?\ "[?%G_0-T?\ \%4=<?10!V'_  NWQ9_T
M#='_ /!5'1_PNWQ9_P! W1__  51UQ]% '8?\+M\6?\ 0-T?_P %4='_  NW
MQ9_T#='_ /!5'7'T4 =A_P +M\6?] W1_P#P51T?\+M\6?\ 0-T?_P %4=<?
M10!V'_"[?%G_ $#='_\ !5'1_P +M\6?] W1_P#P51UQ]% '8?\ "[?%G_0-
MT?\ \%4='_"[?%G_ $#='_\ !5'7'T4 =A_PNWQ9_P! W1__  51T?\ "[?%
MG_0-T?\ \%4=<?10!V'_  NWQ9_T#='_ /!5'1_PNWQ9_P! W1__  51UQ]%
M '8?\+M\6?\ 0-T?_P %4=>\_L1^,]5\92>)I-5MK2,VJV8C^R6JQ [_ #\Y
MQU^Z,>G/K7RM7TE_P3V_YF__ +A__MS0!])4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!\%_M@_P#)ZNO_ /8K:?\ ^S5Q]=A^V#_R>KK_
M /V*VG_^S5Q] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7TE_P3V_YF_P#[A_\ [<U\VU])?\$]O^9O_P"X?_[<T ?25%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 ?!?[8/\ R>KK_P#V*VG_
M /LU<?78?M@_\GJZ_P#]BMI__LU<?0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5])?\$]O^9O\ ^X?_ .W-?-M?27_!/;_F;_\
MN'_^W- 'TE1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'P7
M^V#_ ,GJZ_\ ]BMI_P#[-7'UV'[8/_)ZNO\ _8K:?_[-7'T %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %?27_!/;_F;_ /N'_P#M
MS7S;7TE_P3V_YF__ +A__MS0!])4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!\%_M@_P#)ZNO_ /8K:?\ ^S5Q]=A^V#_R>KK_ /V*VG_^
MS5Q] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7T
ME_P3V_YF_P#[A_\ [<U\VU])?\$]O^9O_P"X?_[<T ?25%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OI+_@GM_S-_\ W#__ &YKYMKZ2_X)[?\ ,W_]P_\
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M;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\  MJ/^$'TC_GYO?\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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M"HN#<3W<"D@@/9PLP(3;0![U17P5^TE^SGXK_8-\?_"_X[?LS_&[Q]?W>O\
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MZ517R[_P1X\3>+?&'[#>C>(/'7BO4=<U6;Q%K(N]5U6\>>XN&6_F7<[N2S'
M[FLW]EJXT+]O/6/C#X\^,-SJ5U;Z%\2]0\(^&-'MM8N+6/1K&SBAVW$2PNI2
MZE>1Y&G^^,*JL%7% 'UI17S9_P $T_CEX^^)7@;QU\(/BMXBFUOQ#\)OB'J/
MA.?7KHYFU2VMY"(+B4C[TI4,K-U;RPQRS$U])T %%%% !1110 4444 %%%%
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MMKR.0QZA*9W;-U#)"7\X8=P[(Q*D ?6U !1110 4444 %%%% !1110 4444
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M'=?"[]C;]GG5?"/@%UO9O!/AQ[\Z9)<B2]U"ZG:0QR3D8)FN[K>-QQOD9L8
MXYKXE_\ !+O]A_XP^/M4^*'Q*^$>H:MKVM7)GU+4)O&^LJTK=  J7@5$4854
M4!54!5   KH/A3^P;^RQ\#?"EQX(^$WPS.C:9>^(['7;^W76+NY-W>V<J36[
M2/<2R.RI)&CA,[=RYQR<@'6?!SP99? GX&:/X7\3Z[;@Z)H_G>(-8N95CCEN
MB#->7;LV H>9I96)P!N)KB]-T>P^-7C[3OVFOB5C3/!W@R&>Y\!V6K?N \CQ
ME)=<N1)CR_W19+='P4C>25L-*JQ=W\;O@9\,_P!HOX?7/PL^+VBW6I:!>R(]
MYI]MK-W9"XV'*J[VLL;NF<'825) )!(&/$[;_@CQ_P $Y[6]M]0'[/3RR6MP
MDT*W7C'6)DWJ<@E)+PJPSV8$$<$$4 <M/I+^"_\ @M+HGQ#O,MI7Q'^"%Q8:
M#>,"%EN[:ZBGEB7/\0@C23'H_P!:DUWP]?\ Q$_X+8:/KVB1L]C\/?@H3K=P
MOW8;F\NKE8H&/9FCD\P ]0C'M7TO\4/@[\/_ (PZ?867CG1Y)9=)OUOM'U"S
MO);6[TZZ4$":">%EDB;:S*=K896*L"I(*?#+X.?#_P"$4.H_\(7I,JW>LWGV
MO6]5O[V6[O=1G"A0\]Q,S22;5 506VHH"J%4 4 ?//[;A _;U_90R?\ F9?$
MO_INBK(_X+.>&UU?X1_"_7?$=H)_"6B_&K0[GQFDJ;H8[!C+"TDH/'EYD"'/
M&917OOQ-_9+^!OQA^(^A_%KX@Z%K-WK_ (9F>;P]?6_C'5+5=.=U57:&*"Y2
M-"RHH;"_-CG/-=GXL\#^$O'G@Z]^'_C;0+?5M&U*R:TU#3]13SH[B%A@J^[)
M;CN><\YSS0!\B_\ !3_X-Z%X/B^"WQ9^!7A:QT3QUHOQ;T?2?#LVB6:6[W%K
M<>8)+,B,#=$1&"5.5""08 9L_9]>?^"/V9/A1X$U;1]:L;35]2N/#EN\'AMO
M$/B&[U$:3&R;"+<7,CA&V?)YG,FS*;MI(KT"@ HHHH **** "BBB@ HHHH *
M*** "OE'_@JF1_QCMS_S<]X5_P#;FOJZO._C;^RM\$?VBM0T;4OB]H&JZE)X
M>U*+4=%6V\5ZE91V=Y%GR[A([6XC42KDXDQN&>M '=:WK>C^&M'NO$/B'5;>
MQL+&W>>]O;N98XH(D!9G=F("J "23P *\ATG2+#XF^/K7]K'XN8T;PSX0L+E
MO =AK/\ H_V:.5-MQK-T),>5))$-D4;X:*%G9\23,D78?&3]G+X2?M ?#)?@
M[\7-%U'5O#OF1/+8_P#"1W]NUP8\[!-+#.DLP!^;;(S L%8@LH(\BTG_ ()!
M_P#!._1=:L?$%E^SZ[7.G7D=U:&Z\8:Q.BRQL&4F.2[9'&0/E8$$<$$$B@#O
MY)$^)7[6MLD?[S3?AQX7-R<CY6U74R43KT>&S@ER/[NHC\-OXO?$G7-+N8?A
M;\*TM[OQMK-LSV*3H7@TFVSM;4;L C$*'(2/(:>0"-2!O>/HO"O@/PYX-U'7
M-7T2WD%SXCU?^TM7GEE+M-<>1#;J>>BK%!$@4< (/>O'?BK_ ,$QOV)_C=\0
M=2^*?Q3^$U_J^OZM('O]0F\;:RA? PJJD=VJ1HHX5% 51P !0!G?'#]G7PMI
M'["OC_\ 9(^$FH-?^()_ VHWAAFF62_U2]F\R5KJ?;R9+FY#_,0 6+!1A,#B
MO"'Q/\.P_P#!#U/&:WD:P6?P$GTPDM@?:XM/>Q\L_P"T;A=F/4U[M^SA^Q]^
MSE^R19:O8?L^?#A= 37KB*;5V.J7=V]R\88(2]S+(P"AWP 0,L3C)-1R_L=?
ML_S:K+>2>$;DV%QKG]LW'AK^V;K^QY=1WB3[2UAYGV=G\P"0@IL,@\PKO^:@
M#'_X)W_#;7_A'^Q#\,_ /BJTDM]2M/"L$M[:S*0\$D^9S$P/1E\W:1V*FO./
M^"+9!_8*T3!_YF77/_3C/7U#XAT&Q\3Z-/H6I3WL<%PH61]/U*>TF R#\LT#
MI(AXZJP...AKC_@#^S)\&/V7_"[^"O@AX<OM'TAYGE&FS^(K^]AC=SN=D6ZG
MD$98\G;C))S0!S7[=_C/7O#/[-VK>%O!5UY7B3QQ=6WA+PRR_>6\U*46PE'I
MY4;RSD]A"37IG@+P5H/PV\#:-\._"MKY&F:#I5OI^G0_W((8UC0?@JBJ7C+X
M5^#O'WBGPQXO\46<MQ=>$-3EU'1(_/811W3V\EOYK(.'98YI N?NER1S@UT=
M !1110 4444 %%%% !1110 4444 %%%0:EI\&JV$VFW4DZQSQE':VN7AD /]
MV2,JZ'W4@CL: /EC_@E80?\ AHC!_P";GO%7_MM7M_Q?^(GB*.\3X0?"*6&3
MQIJUH9([B6/S(-!M&)0ZC<KW4$,(H<AIY%VC"++)'%\$?V5O@E^SK?ZSJ7PA
MT#5=-D\0ZE+J&M+<^*]2O8[R\E(,EP\=U<2(96P,R8W''6N#^)?_  2[_8?^
M,/C[5/BA\2OA'J&K:]K5R9]2U";QOK*M*W0 *EX%1%&%5% 55 50  * .ECN
MOA=^QM^SSJOA'P"ZWLW@GPX]^=,DN1)>ZA=3M(8Y)R,$S7=UO&XXWR,V, <=
M/\'/!EE\"?@9H_A?Q/KMN#HFC^=X@UBYE6..6Z(,UY=NS8"AYFEE8G &XFN3
M^%/[!O[+'P-\*7'@CX3?#,Z-IE[XCL==O[==8N[DW=[9RI-;M(]Q+([*DD:.
M$SMW+G')SV?QN^!GPS_:+^'US\+/B]HMUJ6@7LB/>:?;:S=V0N-ARJN]K+&[
MIG!V$E20"02!@ X33='L/C5X^T[]IKXE8TSP=X,AGN? =EJW[@/(\9277+D2
M8\O]T62W1\%(WDE;#2JL7DL^DOX+_P""TNB?$.\RVE?$?X(7%AH-XP(66[MK
MJ*>6)<_Q""-),>C_ %KJ;;_@CQ_P3GM;VWU ?L]/+):W"30K=>,=8F3>IR"4
MDO"K#/9@01P017N7Q0^#OP_^,.GV%EXYT>2672;];[1]0L[R6UN].NE! F@G
MA99(FVLRG:V&5BK J2" ?-&N^'K_ .(G_!;#1]>T2-GL?A[\%"=;N%^[#<WE
MU<K% Q[,T<GF 'J$8]JT/VW"!^WK^RAD_P#,R^)?_3=%7T-\,O@Y\/\ X10Z
MC_PA>DRK=ZS>?:];U6_O9;N]U&<*%#SW$S-))M4!5!;:B@*H50!7/_$W]DOX
M&_&'XCZ'\6OB#H6LW>O^&9GF\/7UOXQU2U73G=55VAB@N4C0LJ*&POS8YSS0
M!SG[>WQM\3_!/X(6C>#+>V75/%_BO3/"MIJ-_:K/;:9]OF\E[N6-OE=43=A6
M^4N4# C(/SWJG[->L_\ !,#]HOP#X_\ V6M;O9?AQ\2_&>F>%/'/@34)_-$=
MW<YCBU*W./E(VL[@8Q@@?NV"Q_:7C_X9^!/BGX%O?AI\1O#-OK.AZC;B&\T^
M_P R+*H(*DL3N#AE5@X.X,H8$$ UA^'OV=_AUH.N:5XCO)-;UJ\T$-_8,GB3
MQ%=ZB-/9D,9DC6>1AYNQF3SF!EVLR[\,P(!W-%%% !1110 4444 %%%% !11
M10 4444 ?*/_  53(_XQVY_YN>\*_P#MS7U)K>MZ/X:T>Z\0^(=5M[&PL;=Y
M[V]NYECB@B0%F=V8@*H ))/  KA?C;^RM\$?VBM0T;4OB]H&JZE)X>U*+4=%
M6V\5ZE91V=Y%GR[A([6XC42KDXDQN&>M7/C)^SE\)/V@/ADOP=^+FBZCJWAW
MS(GEL?\ A([^W:X,>=@FEAG268 _-MD9@6"L064$ ''Z3I%A\3?'UK^UC\7,
M:-X9\(6%RW@.PUG_ $?[-'*FVXUFZ$F/*DDB&R*-\-%"SL^))F2+2DD7XE?M
M:VR)^\TSX<>%S<G(.UM6U,E$Z]'ALX)<C^[J(]>. TG_ ()!_P#!._1=:L?$
M%E^SZ[7.G7D=U:&Z\8:Q.BRQL&4F.2[9'&0/E8$$<$$$BO?/"O@/PYX-U'7-
M7T2WD%SXCU?^TM7GEE+M-<>1#;J>>BK%!$@4< (/>@#G?B]\2=<TNYA^%OPK
M2WN_&VLVS/8I.A>#2;;.UM1NP",0H<A(\AIY (U(&]X_+OCA^SKX6TC]A7Q_
M^R1\)-0:_P#$$_@;4;PPS3+)?ZI>S>9*UU/MY,ES<A_F( +%@HPF!H_%7_@F
M-^Q/\;OB#J7Q3^*?PFO]7U_5I ]_J$WC;64+X&%54CNU2-%'"HH"J.  *[#]
MG#]C[]G+]DBRU>P_9\^'"Z FO7$4VKL=4N[M[EXPP0E[F61@%#O@ @98G&2:
M /"?"'Q/\.P_\$/4\9K>1K!9_ 2?3"2V!]KBT]['RS_M&X79CU->M?\ !._X
M;:_\(_V(?AGX!\56DEOJ5IX5@EO;692'@DGS.8F!Z,OF[2.Q4UL2_L=?L_S:
MK+>2>$;DV%QKG]LW'AK^V;K^QY=1WB3[2UAYGV=G\P"0@IL,@\PKO^:O0O$.
M@V/B?1I]"U*>]C@N%"R/I^I3VDP&0?EF@=)$/'56!QQT- 'R]_P1;(/[!6B8
M/_,RZY_Z<9ZM?$C]GCPM^QUXD^(O[7?@3]H_5O 'AKQ"&U;QUX=CTBTOH;N^
M!/[ZS^T*?)N97<J%Q('DD VD;5'L_P  ?V9/@Q^R_P"%W\%?!#PY?:/I#S/*
M--G\17][#&[G<[(MU/((RQY.W&23FK&I_ 'X=>)/&EKX]\;6U]X@OM.O3=Z/
M#K>HR3VFG39)62"U)$"2)DA9=AD4='ZT >*_\$H_@!\0O@[\ -6^(/QDM;FW
M\8_$_P 5W?BO7+6^Q]HM?M!!BBEPJ@2;09&&U2K3%2 5P/I^BB@ HHHH ***
M* "BBB@ HHHH **** "OE'_@E80?^&B,'_FY[Q5_[;5]3ZEI\&JV$VFW4DZQ
MSQE':VN7AD /]V2,JZ'W4@CL:X+X(_LK?!+]G6_UG4OA#H&JZ;)XAU*74-:6
MY\5ZE>QWEY*09+AX[JXD0RM@9DQN..M $OQ?^(GB*.\3X0?"*6&3QIJUH9([
MB6/S(-!M&)0ZC<KW4$,(H<AIY%VC"++)'AQW7PN_8V_9YU7PCX!=;V;P3X<>
M_.F27(DO=0NIVD,<DY&"9KNZWC<<;Y&;& ..:^)?_!+O]A_XP^/M4^*'Q*^$
M>H:MKVM7)GU+4)O&^LJTK=  J7@5$48544!54!5   KH/A3^P;^RQ\#?"EQX
M(^$WPS.C:9>^(['7;^W76+NY-W>V<J36[2/<2R.RI)&CA,[=RYQR<@'6?!SP
M99? GX&:/X7\3Z[;@Z)H_G>(-8N95CCENB#->7;LV H>9I96)P!N)KB]-T>P
M^-7C[3OVFOB5C3/!W@R&>Y\!V6K?N \CQE)=<N1)CR_W19+='P4C>25L-*JQ
M=W\;O@9\,_VB_A]<_"SXO:+=:EH%[(CWFGVVLW=D+C8<JKO:RQNZ9P=A)4D
MD$@8\3MO^"/'_!.>UO;?4!^ST\LEK<)-"MUXQUB9-ZG()22\*L,]F!!'!!%
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M17[%/[-O[6&H:9J7Q]\"WNNOHT;IID:>)]2LXK?>?F816MQ&A<\ N5+$ #.
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /A_\
M;Q^-W_!6'P)^T!<>'_V0?A%_;/@Q=+MG@O?[ BN,W#*?-7>S@\''&.*^&O\
M@H/\4O\ @JY\1OAC8I^V)X!UG0?!UM?J3'::(MK92W)_U9G:(MN(YV!SMSG
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M\1:I)?W?@^?PG;:C)I;R',BV4LY*Q9'"G9\H"EA(5S0!S?QJ\+>/O /Q[_9
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MM@>)?VQ/#'[2WA*/5O$V@P:/<Z-?_#"YFM8;2+R=NPIJ\;^9F$$L6Q\Q^7&
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MQ:NO'OP:^)'A^S\/W?ABPTAO!>M>'I98(&M6G\NYAGBN$,9V3!#'L(98UY!
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M"OXQ?\(OX+\)0W$&O^#(='CF368#"L=O&)6.Z$1;>,9Z^HH ])HHHH ****
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MV5Y>IW07%Q>2_9E89#>6GF8/R2QL U8OQZ_8UB\>?%'P1^T'\%/&%MX+\=>
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M@T;XF?#6^6]\,>-M+T$K;^9A5EAELWG<O!*J('3SLY&0P!*G:T3]G7QAXO\
MC/X;^/?[0OB[1]7U?P987=OX2TGP[I$MI96,UTJI<W;F::62:9HT$:\JL:EL
M!F.^@#PWPC?_  X\7?M7?M ^#?V[9-'3[*+1_!,7BV9([:#PT8) 9]/:4@(?
M,!::6(AQ+MW$%5QC_L=?L?\ B7X_?\$V+KPW\;M4\6P^+/%EO=2:)KWB3Q+J
M4]W9K%--_9MVD4\S"T^1EW+"L?FQ%0X;-2^ /"/QZ_:9^*_Q(^./[)G[<.C:
M5I-[XS:S.@>(_!%GJ]S9M81K;;@SNLEM$765HHBH^1Q(3NE>O8OV>OC=\3/
M\?C#0?VP/C=X U*R\,WMA!:>/]-=-+LYKFY$N_3YQ*_EI<Q;(6(1N5NHAC=F
M@#Q?X,?$RQ^/O[!/A3]E*]\/PZ7XZN/%*?#WQ9ID2!9M,N;$F74=0XY67['#
M+,)>/](F4;LGG[>T#0=&\+:+:^'/#NF0V=C90+#:6MNFU(HU& H%?.7[,_P9
M^$WB?]M+XJ_MB_#CR[FPU".UT"RO;6X$EI>7\<:-J-W!M^4@E;6W+KUDM[@9
M.37TQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^'$TY(K2 QMN0QI&%$9!)Y7'4^ISV]% &?X3\)>%_ GANR\'>"O#MEI.DZ=
ML%AING6RPP6\8Z(B* %'L!6A110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
I110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358028056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 07, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-22705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">NEUROCRINE BIOSCIENCES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0525145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12780 El Camino Real,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San&#160;Diego,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">617-7600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">NBIX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,105,256,378<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,242,683<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement relating to the registrant&#8217;s annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days following the end of the registrant&#8217;s fiscal year ended December 31, 2021 are incorporated by reference into Part III of this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000914475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364870680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst&#160;& Young LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358083128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 340.8<span></span>
</td>
<td class="nump">$ 187.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Debt securities available-for-sale (amortized cost was $370.6 and $612.4 as of December&#160;31, 2021 and 2020, respectively)</a></td>
<td class="nump">370.5<span></span>
</td>
<td class="nump">613.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">185.5<span></span>
</td>
<td class="nump">157.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">30.5<span></span>
</td>
<td class="nump">28.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">45.5<span></span>
</td>
<td class="nump">30.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">972.8<span></span>
</td>
<td class="nump">1,016.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">315.1<span></span>
</td>
<td class="nump">319.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Debt securities available-for-sale (amortized cost was $563.2 and $226.7 as of December&#160;31, 2021 and 2020, respectively)</a></td>
<td class="nump">560.7<span></span>
</td>
<td class="nump">227.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">97.2<span></span>
</td>
<td class="nump">82.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities</a></td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">58.6<span></span>
</td>
<td class="nump">44.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">2,072.5<span></span>
</td>
<td class="nump">1,734.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">225.8<span></span>
</td>
<td class="nump">168.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">245.8<span></span>
</td>
<td class="nump">186.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes</a></td>
<td class="nump">335.1<span></span>
</td>
<td class="nump">317.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">94.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">698.5<span></span>
</td>
<td class="nump">608.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding as of December&#160;31, 2021 and 2020</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 220.0 shares authorized; 94.9 and 93.5 shares issued and outstanding as of December&#160;31, 2021 and 2020, respectively</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,011.4<span></span>
</td>
<td class="nump">1,849.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(635.8)<span></span>
</td>
<td class="num">(725.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">1,374.0<span></span>
</td>
<td class="nump">1,126.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 2,072.5<span></span>
</td>
<td class="nump">$ 1,734.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344357072104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">220,000,000.0<span></span>
</td>
<td class="nump">220,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">94,900,000<span></span>
</td>
<td class="nump">93,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">94,900,000<span></span>
</td>
<td class="nump">93,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 370.6<span></span>
</td>
<td class="nump">$ 612.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 563.2<span></span>
</td>
<td class="nump">$ 226.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344356981512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Income and Comprehensive Income - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,133.5<span></span>
</td>
<td class="nump">$ 1,045.9<span></span>
</td>
<td class="nump">$ 788.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_CostOfSales', window );">Cost of sales</a></td>
<td class="nump">14.3<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Research and development</a></td>
<td class="nump">328.1<span></span>
</td>
<td class="nump">275.0<span></span>
</td>
<td class="nump">200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">164.5<span></span>
</td>
<td class="nump">154.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">583.3<span></span>
</td>
<td class="nump">433.3<span></span>
</td>
<td class="nump">354.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,031.0<span></span>
</td>
<td class="nump">882.9<span></span>
</td>
<td class="nump">715.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">102.5<span></span>
</td>
<td class="nump">163.0<span></span>
</td>
<td class="nump">72.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other (expense) income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(25.8)<span></span>
</td>
<td class="num">(32.8)<span></span>
</td>
<td class="num">(32.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) on equity securities</a></td>
<td class="nump">20.9<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of convertible senior notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_InvestmentIncomeAndOtherNet', window );">Investment income and other, net</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expense, net</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(56.3)<span></span>
</td>
<td class="num">(25.8)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for (benefit from) income taxes</a></td>
<td class="nump">101.4<span></span>
</td>
<td class="nump">106.7<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="num">(300.6)<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">89.6<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized (loss) gain on debt securities available-for-sale</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 86.1<span></span>
</td>
<td class="nump">$ 407.7<span></span>
</td>
<td class="nump">$ 40.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in USD per share)</a></td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 4.38<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in USD per share)</a></td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding, basic (in shares)</a></td>
<td class="nump">94.6<span></span>
</td>
<td class="nump">93.1<span></span>
</td>
<td class="nump">91.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">97.9<span></span>
</td>
<td class="nump">97.8<span></span>
</td>
<td class="nump">95.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductMember', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,090.1<span></span>
</td>
<td class="nump">$ 994.1<span></span>
</td>
<td class="nump">$ 752.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=nbix_CollaborationRevenueMember', window );">Collaboration revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 43.4<span></span>
</td>
<td class="nump">$ 51.8<span></span>
</td>
<td class="nump">$ 35.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_InvestmentIncomeAndOtherNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment income and other net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_InvestmentIncomeAndOtherNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding the write-off for research and development assets that were acquired in a transaction other than a business combination during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=nbix_CollaborationRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=nbix_CollaborationRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344361843416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 480.8<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 1,660.4<span></span>
</td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="num">$ (1,177.7)<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on debt securities available-for sale</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">75.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under stock plans</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">636.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,768.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(1,132.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">407.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">407.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on debt securities available-for sale</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under stock plans</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Equity component of repurchased convertible senior notes, net</a></td>
<td class="num">(47.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">1,126.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">1,849.7<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="num">(725.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">89.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss', window );">Unrealized gain (loss) on debt securities available-for sale</a></td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 134.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuances of common stock under stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuances of common stock under stock plans</a></td>
<td class="nump">$ 27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 1,374.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 2,011.4<span></span>
</td>
<td class="num">$ (1.7)<span></span>
</td>
<td class="num">$ (635.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344356986040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 89.6<span></span>
</td>
<td class="nump">$ 407.3<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Reconciliation of net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">134.2<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="nump">75.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">16.2<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">18.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Change in fair value of equity securities</a></td>
<td class="num">(20.9)<span></span>
</td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="nump">4.3<span></span>
</td>
<td class="num">(310.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of convertible senior notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(28.4)<span></span>
</td>
<td class="num">(30.5)<span></span>
</td>
<td class="num">(69.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(10.7)<span></span>
</td>
<td class="num">(6.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">56.8<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
<td class="nump">54.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet', window );">Other assets and liabilities, net</a></td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(23.6)<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">256.5<span></span>
</td>
<td class="nump">228.5<span></span>
</td>
<td class="nump">147.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of debt securities available-for-sale</a></td>
<td class="num">(800.1)<span></span>
</td>
<td class="num">(735.5)<span></span>
</td>
<td class="num">(797.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Sales and maturities of debt securities available-for-sale</a></td>
<td class="nump">697.9<span></span>
</td>
<td class="nump">750.5<span></span>
</td>
<td class="nump">669.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Purchases of equity securities</a></td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(68.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(23.4)<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(130.2)<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(211.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuances of common stock under benefit plans</a></td>
<td class="nump">27.5<span></span>
</td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Partial repurchase of convertible senior notes</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(186.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">27.4<span></span>
</td>
<td class="num">(157.8)<span></span>
</td>
<td class="nump">32.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents and restricted cash</a></td>
<td class="nump">153.7<span></span>
</td>
<td class="nump">74.8<span></span>
</td>
<td class="num">(31.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at beginning of period</a></td>
<td class="nump">190.3<span></span>
</td>
<td class="nump">115.5<span></span>
</td>
<td class="nump">147.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash at end of period</a></td>
<td class="nump">344.0<span></span>
</td>
<td class="nump">190.3<span></span>
</td>
<td class="nump">115.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Non-cash capital expenditures</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets acquired through operating leases</a></td>
<td class="nump">23.4<span></span>
</td>
<td class="nump">12.8<span></span>
</td>
<td class="nump">77.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">11.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364070104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Summary of Significant Accounting Policies</a></td>
<td class="text">Organization and Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc., or Neurocrine Biosciences, the Company, we, our or us, was incorporated in California in 1992 and reincorporated in Delaware in 1996. Neurocrine Continental, Inc., is a Delaware corporation and a wholly owned subsidiary of Neurocrine Biosciences. We also have two wholly-owned Irish subsidiaries, Neurocrine Therapeutics, Ltd. and Neurocrine Europe, Ltd. both of which were formed in December 2014 and are inactive.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Neurocrine Biosciences as well as our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry Segment and Geographic Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a single industry segment&#160;&#8211; the discovery, development and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. We had no foreign-based operations during any of the years presented.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments that are readily convertible into cash without penalty and have an original maturity of three months or less at the time of purchase to be cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of customer allowances for prompt payment discounts, chargebacks and any allowance for doubtful accounts. We estimate the allowance for doubtful accounts based on existing contractual payment terms, actual payment patterns of our customers and individual customer circumstances. To date, an allowance for doubtful accounts has not been material.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of investments in certificates of deposit, corporate debt securities and securities of government-sponsored entities. We classify debt securities as available-for-sale. Debt securities available-for-sale are recorded at fair value, with unrealized gains and losses included in other comprehensive income or loss, net of tax. We exclude accrued interest from both the fair value and amortized cost basis of debt securities. A debt security is placed on nonaccrual status at the time any principal or interest payments become 90 days delinquent. Interest accrued but not received for a debt security placed on nonaccrual status is reversed against interest income.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income includes amortization of purchase premium or discount. Premiums and discounts on debt securities are amortized using the effective interest rate method. Gains and losses on sales of debt securities are recorded on the trade date in investment income and other, net, and determined using the specific identification method.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For debt securities available-for-sale in an unrealized loss position, we first assess whether we intend to sell, or it is more likely than not that we will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivables on debt securities available-for-sale totaled $2.2 million as of December&#160;31, 2021 and $3.7 million as of December&#160;31, 2020. We do not measure an allowance for credit losses for accrued interest receivables. For the purposes of identifying and measuring an impairment, accrued interest is excluded from both the fair value and amortized cost basis of the debt security. Uncollectible accrued interest receivables associated with an impaired debt security are reversed against interest income upon identification of the impairment. No accrued interest receivables were written off during 2021, 2020 or 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record cash equivalents, debt securities available-for-sale and equity security investments at fair value based on a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). The fair value hierarchy consists of the following three levels:</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Unobservable inputs that reflect our own assumptions about the assumptions that market participants would use in pricing the asset or liability when there is little, if any, market activity for the asset or liability at the measurement date.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities available-for-sale are classified as Level 2 and carried at fair value. We estimate the fair value of debt securities available-for-sale by utilizing third-party pricing services. These pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Such inputs include market pricing based on real-time trade data for similar instruments, issuer credit spreads, benchmark yields, broker/dealer quotes and other observable inputs. We validate valuations obtained from third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing data in certain instances.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities of certain companies that are subject to holding period restrictions longer than one year are classified as Level 3 and carried at fair value using an option pricing valuation model. The most significant assumptions within the option pricing valuation model are the stock price volatility, which is based on the historical volatility of similar companies and the discount for lack of marketability related to the term of the restrictions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deem transfers between levels of the fair value hierarchy to have occurred at the end of the reporting period during which the event or change in circumstances that caused the transfer occurred.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value. We determine the cost of inventory using the standard-cost method, which approximates actual cost based on the first-in, first-out method. We assess the valuation of our inventory on a quarterly basis and adjust the value for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand. Inventory costs resulting from these adjustments are recognized as cost of sales in the period in which they are incurred. When future commercialization is considered probable and the future economic benefit is expected to be realized, based on management&#8217;s judgment, we capitalize pre-launch inventory costs prior to regulatory approval.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated over the estimated useful lives of the assets using the straight-line method. Equipment is depreciated over an average estimated useful life of 3 to 7 years. Leasehold improvements are depreciated over the shorter of their estimated useful lives or the remaining lease term. Depreciation expense was $10.9 million for 2021, $8.6 million for 2020 and $7.4 million for 2019.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows. If&#160;the carrying amount is not recoverable, we measure the amount of any impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized using a five-step model: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Product Sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the United States, we sell INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (valbenazine) primarily to specialty pharmacy providers and distributors and ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (opicapone) primarily to wholesale distributors. We recognize net product sales when the customer obtains control of our product, which occurs at a point in time, typically upon delivery of our product to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. Such estimates are based on information received from external sources (such as written or oral information obtained from our customers with respect to their period-end inventory levels and sales to end-users during the reporting period), as supplemented by management&#8217;s judgement. Our process for estimating reserves established for these variable consideration components does not differ materially from historical practices. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant categories of sales discounts and allowances are as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Discounts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Product discounts are based on payment terms extended to our customers at the time of sale, which include incentives offered for prompt payment. We maintain a reserve for product discounts based on our historical experience, including the timing of customer payments. To date, actual product discounts have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period. Such estimates are based on actual historical rebates by state, estimated payor mix, state and federal regulations and relevant contractual terms, as supplemented by management&#8217;s judgement. Our rebate accrual calculations require us to project the magnitude of our sales that will be subject to these rebates. There is a significant time-lag in our receiving rebate notices from each state (generally, several months or longer after a sale is recognized). Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The difference between the list price, or the price at which we sell our products to our customers, and the contracted price, or the price at which our customers sell our products to qualified healthcare professionals, is charged back to us by our customers. In addition to actual chargebacks received, we maintain a reserve for chargebacks based on estimated contractual discounts on product inventory levels on-hand in our distribution channel. To date, actual chargebacks have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payor and Pharmacy Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates as a percentage of sales under payor and pharmacy contracts. We estimate these rebates based on actual historical rebates, contractual rebate percentages, sales made through the payor channel and purchases made by pharmacies. To date, actual payor and pharmacy rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient Financial Assistance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To help patients afford our products, we offer financial assistance to qualified patients with prescription drug co-payments required by insurance as well as free trial vouchers to qualifying new patients. We accrue for patient financial assistance based on estimated claims and the cost per claim we expect to receive associated with inventory that remains in the distribution channel at period end. To date, actual copay assistance and free trial vouchers have not differed materially from our estimates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributor and Other Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In connection with the sales of our products, we pay distributor and other fees, which are generally recorded as a reduction of revenue, to certain customers that provide us with inventory management, data and distribution services. To the extent we can demonstrate a separable benefit and fair value for these services, we classify the associated costs in selling, general and administrative expenses. These costs are typically known at the time of sale, resulting in minimal adjustments subsequent to the period of sale.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We offer our customers product return rights primarily limited to errors in shipment, damaged product and expiring product, provided it is within a specified period of the product expiration date, as set forth in the associated distribution agreement. Where actual returns history is not available, we estimate a returns allowance based on benchmarking data for similar products and industry experience. We record this estimate as a reduction of revenue in the period the related sale is recognized. Once product is returned, it is destroyed. To date, actual product returns have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into collaboration and licensing agreements under which we out-license certain rights to our product candidates to third parties. The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees; development, regulatory and/or commercial milestone payments; and royalties on net sales of licensed products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses of Intellectual Property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, we assess the nature of the combined performance obligation to determine whether it is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Milestones.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At the inception of each arrangement that includes developmental, regulatory or commercial milestones, we evaluate whether achieving the milestones is considered probable and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. Amounts for milestones that are not within our control, such as where achievement of the specified event is dependent on the development activities of a third party or approvals from regulators, are not considered probable of being achieved until the specified event occurs. Revenue is recognized from the satisfaction of performance obligations in the amount billable to the customer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For arrangements that include sales-based royalties, and under which the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). Each quarterly period, sales-based royalties are recorded based on estimated quarterly net sales of the associated collaboration products. Differences between actual results and estimated amounts are adjusted for in the period in which they become known, which typically follows the quarterly period in which the estimate was made. To date, actual royalties received have not differed materially from our estimates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and debt securities available-for-sale. We have established guidelines to limit our exposure to credit risk by diversifying our investment portfolio and by placing investments with high credit quality financial institutions and maturities that maintain safety and liquidity. To date, we have not experienced any credit losses and do not believe we are exposed to any significant credit risk in relation to these financial instruments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to credit risk from our accounts receivable related to our product sales. Our two largest customers represented approximately 82% of our total product revenues for 2021 and approximately 86% for both 2020 and 2019, as well as the significant majority of our accounts receivable balances at December&#160;31, 2021 and 2020. To date, we have not experienced any significant losses with respect to the collection of these accounts receivable.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes third-party manufacturing, transportation, freight and indirect overhead costs associated with the manufacture and distribution of INGREZZA and ONGENTYS, royalty fees on net sales of ORILISSA and ORIAHNN, and adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, or R&amp;D, expenses consist primarily of salaries, payroll taxes, employee benefits and share-based compensation charges for those individuals involved in ongoing R&amp;D efforts; as well as scientific consulting fees, preclinical and clinical trial costs, R&amp;D facilities costs, laboratory supply costs and depreciation of scientific equipment. All such costs are expensed as R&amp;D when incurred. These expenses result from our independent R&amp;D efforts, as well as efforts associated with collaborations, in-licenses and third-party funded research arrangements, including event-based milestones.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Acquisitions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of an asset that does not (or a group of assets that do not) meet the definition of a business using the cost accumulation method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the asset (or assets) acquired on the basis of its (or their) relative fair value(s) on the measurement date. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in R&amp;D activities which have no alternative future use are expensed as in-process research and development, or IPR&amp;D, on the acquisition date. Future costs to develop these assets are expensed as R&amp;D when incurred.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed when services are performed or goods are delivered and are included in selling, general and administrative expense in our consolidated statements of income. We incurred advertising costs related to INGREZZA and ONGENTYS of $139.8 million for 2021, $64.8 million for 2020 and $40.6 million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant stock options to purchase our common stock to eligible employees and directors and also grant certain employees restricted stock units, or RSUs, and performance-based restricted stock units, or PRSUs. Additionally, we allow employees to participate in an employee stock purchase plan, or ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock options and shares to be issued under the ESPP using the Black-Scholes option-pricing model on the date of grant. RSUs are valued based on the closing price of our common stock on the date of grant. The fair value of equity instruments expected to vest is recognized and amortized on a straight-line basis over the requisite service period of the award, which is generally 3 to 4 years; however, certain provisions in our equity compensation plans provide for shorter vesting periods under certain circumstances. The fair value of shares to be issued under the ESPP is recognized and amortized on a straight-line basis over the purchase period, which is generally 6 months. PRSUs vest upon the achievement of certain predefined company-specific performance-based criteria. Expense related to PRSUs is generally recognized ratably over the expected performance period once the predefined performance-based criteria for vesting becomes probable.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our income tax provision (benefit) is computed under the asset and liability method. Significant estimates are required in determining our income tax provision (benefit). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. Refer to Note 9 to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities based on the technical merits of the position. An adverse resolution of one or more of these uncertain tax positions in any period could have a material impact on the results of operations for that period.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the treasury stock method and reflect the weighted average number of common and potentially dilutive shares outstanding during the period, excluding those which effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt instruments that may be settled entirely or partly in cash may, in certain circumstances where the borrower has the ability and intent to settle in cash, be accounted for under the treasury stock method. In December 2021, we entered into the First Supplemental Indenture, dated as of May 2, 2017, by and between the Company and U.S. Bank National Association, as Trustee, or the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes, in cash upon conversion and to settle any conversion premium in either cash or shares of our common stock. As a result, and consistent with historical practice, only the shares required to settle any conversion premium would be considered dilutive under the treasury stock method. Further, PRSUs for which the performance condition has not been achieved are excluded from the calculation of diluted earnings per share.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, we adopted Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, using the modified retrospective transition method. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application of Topic 740. The adoption of ASU 2019-12 did not result in a cumulative-effect adjustment to retained earnings. The comparative prior period information continues to be reported under the accounting standards in effect during those periods. The impact of the adoption is expected to be immaterial to our financial position, results of operations and cash flows on an ongoing basis.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements.</span></div>ASU 2020-06. In August 2020, the FASB issued ASU 2020-06,&#160;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity's own equity. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Instead, entities will account for convertible debt instruments wholly as debt, unless certain other conditions are met. The adoption of ASU 2020-06 is expected to prospectively reduce reported interest expense and increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders&#8217; equity to liabilities as it relates to the 2024 Notes. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We will adopt <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d">ASU 2020-06</span> on January 1, 2022 using the modified retrospective transition method, which allows for a cumulative-effect adjustment in the period of adoption and does not require restatement of prior period amounts. Under this transition method, the cumulative effect of the accounting change is expected to increase the carrying amount of the 2024 Notes by $42.2&#160;million, reduce deferred tax liabilities by $10.0&#160;million, reduce the accumulated deficit by $74.6&#160;million, reduce additional paid-in capital by $106.8&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344374419496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text">Collaboration and License Agreements<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Heptares Therapeutics Limited, or Heptares.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We entered into a collaboration and license agreement with Heptares, which became effective in December 2021, to develop and commercialize certain compounds containing sub-type selective muscarinic M1, M4, or dual M1/M4 receptor agonists, which compounds we have the exclusive rights to develop, manufacture and commercialize worldwide, excluding in Japan, where Heptares retains the rights to develop, manufacture, and commercialize all compounds comprised of M1 receptor agonists, subject to certain exceptions. We are responsible for all development, manufacturing, and commercialization costs. With respect to such rights retained by Heptares, we retain the rights to opt in to profit sharing arrangements, pursuant to which we and Heptares will equally share in the operating profits and losses for such compounds in Japan. Subject to specified conditions, we may elect to exercise such opt-in rights with respect to each such compound either before initiation of the first proof of concept Phase II clinical trial for such compound or following our receipt from Heptares of the top-line data from such clinical trial for such compound. In addition, we have entered into a 2-year research collaboration with Heptares that, unless extended by the parties, is scheduled to expire in December 2023.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Heptares $100.0&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;D in 2021. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Heptares may be entitled to receive potential future payments of up to $2.6&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which the royalty term for such licensed product has expired in such country. On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a licensed product and terminate on the later of (i) the expiration of the last patent covering such licensed product in such country, (ii) a number of years from the first commercial sale of such licensed product in such country and (iii) the expiration of regulatory exclusivity for such licensed product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement in its entirety or with respect to one or more targets upon 180 days&#8217; written notice to Heptares during the research collaboration term and upon 90 days&#8217; written notice to Heptares following the expiration of the research collaboration term. Following the expiration of the research collaboration term, Heptares may terminate the agreement on a target-by-target basis in the event that we do not conduct any material development activities outside of Japan with respect to a certain compound or licensed product within the applicable target class for a continuous period of not less than 365 days and do not commence any such activities within 120 days of receiving written notice. Either party may terminate the agreement, subject to specified conditions, (i) in the event of material breach by the other party, subject to a cure period, (ii) if the other party challenges the validity or enforceability of certain intellectual property rights, subject to a cure period, or (iii) if the other party becomes insolvent or takes certain actions related to insolvency.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Takeda Pharmaceutical Company Limited, or Takeda.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we entered into an exclusive license agreement with Takeda, pursuant to which we acquired the exclusive rights to develop and commercialize certain early to mid-stage psychiatry compounds, including luvadaxistat, NBI-1065845, NBI-1065846 and four non-clinical stage compounds. Luvadaxistat and the 4 non-clinical stage compounds have each been designated as a royalty-bearing product. NBI-1065845 and NBI-1065846 are currently each designated as a profit-share product. We are responsible for all manufacturing, development and commercialization costs of any royalty-bearing product. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Takeda $120.0&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Takeda may be entitled to receive potential future payments of up to $1.9&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any royalty-bearing product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to NBI-1065845 and NBI-1065846, we and Takeda will equally share in the operating profits and losses. Takeda retains the rights to opt-out of the profit-sharing arrangements, pursuant to which Takeda would be entitled to receive potential future payments upon the achievement of certain event-based milestones with respect to such compounds and receive royalties on the future net sales of such compounds (in lieu of equally sharing in the operating profits and losses). Takeda may elect to exercise such opt-out right for such compound immediately following the completion of a second Phase II clinical trial for such compound, or, under certain circumstances related to the development and commercialization activities to be performed by us, before the initiation of a Phase III clinical trial for such compound.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which, (i) for any royalty-bearing product, the royalty term has expired in such country; and (ii) for any profit-share product, for so long as we continue to develop, manufacture, or commercialize such licensed product.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a royalty-bearing product and terminate on the later of (i) the expiration of the last patent covering such royalty-bearing product in such country, (ii) a number of years from the first commercial sale of such royalty-bearing product in such country and (iii) the expiration of regulatory exclusivity for such royalty-bearing product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement in its entirety or in one or more (but not all) of the United States, Japan, the European Union and the United Kingdom, or, collectively, the major markets, upon 6 months&#8217; written notice to Takeda (i) with respect to all licensed products prior to the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes, as defined in the agreement, prior to the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. We may terminate the agreement in its entirety or in one or more (but not all) of the major markets upon 12 months&#8217; written notice to Takeda (i) with respect to all licensed products following the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes following the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. Takeda may terminate the agreement, subject to specified conditions, (i) if we challenge the validity or enforceability of certain Takeda intellectual property rights or (ii) on a target class-by-target class basis, in the event that we do not conduct any material development or commercialization activities with respect to any licensed product within such target class for a specified continuous period. Subject to a cure period, either party may terminate the agreement in the event of any material breach, solely with respect to the target class of a licensed product to which such material breach relates, or in its entirety in the event of any material breach that relates to all licensed products.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Idorsia Pharmaceuticals Ltd, or Idorsia.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, we entered into a collaboration and license agreement with Idorsia, pursuant to which we acquired the global rights to NBI-827104, a potent, selective, orally active and brain penetrating T-type calcium channel blocker in clinical development for the treatment of a rare pediatric epilepsy and other potential indications, including essential tremor. We are responsible for all manufacturing, development and commercialization costs of any collaboration product. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Idorsia $45.0&#160;million upfront, which was expensed as IPR&amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Idorsia may be entitled to receive potential future payments of up to $1.7&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement, in its entirety or with respect to a particular compound or development candidate, upon 90 days&#8217; written notice to Idorsia. Further, in the event a party commits a material breach and fails to cure such material breach within 90 days after receiving written notice thereof, the non-breaching party may terminate the agreement in its entirety immediately upon written notice to the breaching party.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Xenon Pharmaceuticals Inc., or Xenon. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we entered into a collaboration and license agreement with Xenon to identify, research and develop sodium channel inhibitors, including NBI-921352 and three preclinical candidates, which compounds we have the exclusive rights to develop and commercialize. We are responsible for all development and manufacturing costs of any collaboration product, subject to certain exceptions.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Xenon may be entitled to receive potential future payments of up to $1.7&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product. Xenon retains the right to elect to co-develop one product in a major indication, pursuant to which Xenon would receive a mid-single digit percentage increase in royalties earned on the future net sales of such product in the United States and we and Xenon would equally share in the development costs of such product in the applicable indication, except where such development costs relate solely to the regulatory approval of such product outside the United States. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Xenon $30.0&#160;million upfront and purchased approximately 1.4&#160;million shares of Xenon common stock (at $14.196 per share) for $20.0&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $14.1&#160;million after considering Xenon&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $36.2&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;D in 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the European Union&#8217;s approval for the clinical trial application for NBI-921352 for the treatment of focal onset seizures in adults in September 2021, we paid Xenon a regulatory milestone of $10.0&#160;million, including a purchase of approximately 0.3&#160;million shares of Xenon common stock (at $19.9755 per share). The purchased shares were recorded at a fair value of $4.6&#160;million after considering Xenon&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $5.4&#160;million of the milestone payment was expensed as R&amp;D.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the expiration of the royalty term for such product in such country. Upon the expiration of the royalty term for a particular licensed product and country, the license obtained by us with respect to such product and country will become fully paid, royalty free, perpetual and irrevocable. We may terminate the agreement upon 90 days&#8217; written notice to Xenon, provided that such unilateral termination will not be effective for certain products until we have used commercially reasonable efforts to complete certain specified clinical studies. Either party may terminate the agreement in the event of a material breach in whole or in part, subject to specified conditions.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voyager Therapeutics, Inc., or Voyager.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we entered into a collaboration and license agreement with Voyager, pursuant to which we acquired certain rights to develop and commercialize the NBIb-1817 for Parkinson&#8217;s disease program, Friedreich&#8217;s ataxia program and two undisclosed programs. We are responsible for all development costs of any collaboration product, subject to certain co-development and co-commercialization rights retained by Voyager. In February 2021, we notified Voyager of our termination of the NBIb-1817 for Parkinson&#8217;s disease program, which became effective August 2, 2021. The termination did not apply to any program other than the NBIb-1817 for Parkinson&#8217;s disease program.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the agreement, Voyager may be entitled to receive potential future payments of up to $1.3&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the agreement, we paid Voyager $115.0&#160;million upfront and purchased approximately 4.2&#160;million shares of Voyager common stock (at $11.9625 per share) for $50.0&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $54.7&#160;million after considering Voyager&#8217;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $113.1&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;D in 2019. In addition, we paid Voyager $5.0&#160;million upfront, which was expensed as IPR&amp;D in 2019, to acquire the rights outside the United States to the Friedreich&#8217;s ataxia program. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless terminated earlier, the agreement will continue in effect until the expiration of the last to expire royalty term with respect to any collaboration product or the last expiration or termination of any exercised co-development and co-commercialization rights by Voyager as provided for in the agreement. We may terminate the agreement upon 180 days&#8217; written notice to Voyager prior to the first commercial sale of any collaboration product or upon 1 year after the date of notice if such notice is provided after the first commercial sale of any collaboration product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BIAL &#8211; Portela &amp; Ca, S.A., or BIAL.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We acquired the United States and Canada rights to ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(opicapone) from BIAL in 2017, and launched ONGENTYS in the United States in September 2020 as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. We are responsible for all commercialization costs of ONGENTYS in the United States and Canada and rely on BIAL for the commercial supply of ONGENTYS.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, BIAL may be entitled to receive potential future payments of up to $75.0&#160;million upon the achievement of certain event-based milestones. In addition, with respect to ONGENTYS, in the event we fail to meet certain minimum sales requirements for a particular year in comparison to our annual sales forecast for such year, we would be obligated to pay BIAL an amount equal to the difference between the actual net </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sales and minimum sales requirements for such year. Further, upon our written request to BIAL 12 months prior to the estimated expiration of the term of a licensed product, we will negotiate the continuation of BIAL&#8217;s supply of such licensed product after the term. After the term, and if BIAL is no longer supplying such licensed product, BIAL would be entitled to receive a low double-digit royalty on our future quarterly net sales of such licensed product.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the FDA&#8217;s approval for ONGENTYS for Parkinson&#8217;s disease in April 2020, we paid BIAL a regulatory milestone of $20.0&#160;million, which was expensed as R&amp;D in 2020. In connection with the FDA&#8217;s acceptance of the NDA for opicapone for Parkinson&#8217;s disease in 2019, we paid BIAL a regulatory milestone of $10.0&#160;million, which was expensed as R&amp;D in 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until a generic product with respect to such licensed product is sold in a country and sales of such generic product are greater than a specified percentage of total sales of such licensed product in such country.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may terminate the agreement upon 9 months&#8217; written notice to BIAL. BIAL may terminate the agreement in the event we fail to meet the minimum sales requirements for any 2 years, or under certain circumstances involving a change of control of Neurocrine Biosciences. Under certain circumstances where BIAL elects to terminate the agreement in connection with a change of control of Neurocrine Biosciences, BIAL would be obligated to pay us a termination fee. Either party may terminate the agreement if the other party materially breaches the agreement and does not cure the breach within a specified notice period, or upon the other party&#8217;s insolvency.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mitsubishi Tanabe Pharma Corporation, or MTPC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We out-licensed the rights to valbenazine in Japan and other select Asian markets to MTPC in 2015. MTPC is responsible for all development, manufacturing and commercialization costs of valbenazine in such markets.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $55.0&#160;million upon the achievement of certain event-based milestones and would be entitled to receive royalties at tiered percentage rates on MTPC&#8217;s future net sales of valbenazine for the longer of 10 years or the life of the related patent rights. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with MTPC&#8217;s submission of a filing for marketing authorization for valbenazine for the treatment of tardive dyskinesia in Japan in April 2021, we received a regulatory milestone of $15.0&#160;million, which was recognized as collaboration revenue in 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently conducting the KINECT-HD study, a placebo-controlled Phase III study of valbenazine in adult Huntington disease patients with chorea. In connection with our performance of the study, we recognized non-cash collaboration revenue of $5.7&#160;million for 2021, $2.6&#160;million for 2020 and $0.9&#160;million for 2019. As of December&#160;31, 2021, $1.0&#160;million of revenue is being deferred in connection with our continuing performance obligations under the collaboration and will be recognized as non-cash collaboration revenue over the remaining study period using an input method according to costs incurred to-date relative to estimated total costs associated with the study.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MTPC may terminate the agreement upon 180 days&#8217; written notice to us. In such event, all out-licensed product rights would revert to us.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AbbVie Inc., or AbbVie. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We out-licensed the global rights to elagolix to AbbVie in 2010. AbbVie is responsible for all development and commercialization costs of elagolix. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $366.0&#160;million upon the achievement of certain event-based milestones and will continue to receive royalties at tiered percentage rates on AbbVie&#8217;s quarterly net sales of elagolix for the longer of 10 years or the life of the related patent rights.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie launched ORILISSA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix tablets) in the United States in August 2018 as an FDA-approved oral medication for the management of moderate to severe endometriosis pain in women. In June 2020, AbbVie launched ORIAHNN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(elagolix, estradiol and norethindrone acetate capsules and elagolix capsules) in the United States as an FDA-approved oral medication for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. We recognized elagolix royalty revenue of $22.3 million for 2021, $19.2&#160;million for 2020 and $14.3&#160;million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the FDA&#8217;s approval for AbbVie&#8217;s ORIAHNN for uterine fibroids in May 2020, we received a regulatory milestone of $30.0&#160;million, which was recognized as collaboration revenue in 2020. In connection with the FDA&#8217;s acceptance of AbbVie&#8217;s NDA for ORIAHNN for uterine fibroids in 2019, we received a regulatory milestone of $20.0&#160;million, which was recognized as collaboration revenue in 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AbbVie may terminate the agreement upon 180 days&#8217; written notice to us. In such event, all out-licensed product rights would revert to us.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Collaboration and License Agreements</a></td>
<td class="text">Under the terms of our existing collaboration and license agreements, we may be required to make potential future payments of up to $10.9 billion upon the achievement of certain event-based milestones. Such contingent payments are recorded when paid or payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364070104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Securities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Debt Securities</a></td>
<td class="text">Debt Securities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, unrealized gain and loss recognized in accumulated other comprehensive income (loss) and fair value of debt securities available-for-sale at December&#160;31, 2021, aggregated by major security type and contractual maturity:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.075%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contractual<br/>Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">612.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">563.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, our security portfolio consisted of 164 debt securities available-for-sale, including 136 such securities that were in an unrealized loss position but of high credit quality. Unrealized losses on these investments were primarily due to changes in interest rates. We do not intend to sell these investments and it is not more likely than not that we will be required to sell these investments before recovery of their amortized cost basis. We did not recognize an allowance for credit losses as of December&#160;31, 2021 or 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes debt securities available-for-sale in an unrealized loss position for less than 12 months, aggregated by major security type. There were no debt securities available-for-sale in an unrealized loss position for longer than 12 months as of December&#160;31, 2021 or 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">659.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344360958792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments, which were measured at fair value on a recurring basis, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities&#8211;biotechnology industry</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">396.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">931.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,069.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of equity security investments, which were measured at fair value on a recurring basis using significant unobservable inputs (Level 3):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) In September 2021, we purchased 0.3&#160;million shares of Xenon's common stock, valued at $4.6&#160;million on the date of purchase, in connection with the European Union&#8217;s approval of the clinical trial application for NBI-921352.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) In the fourth quarter of 2021, our equity security investment in Xenon was transferred from Level 3 to Level 1 as the associated holding period restriction expired.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the discount for lack of marketability used in the valuation analysis of our Voyager equity security investment was 2.5%. Unrealized gains and losses on equity security investments are included in other income (expense), net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364068232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Convertible Senior Notes</a></td>
<td class="text">Convertible Senior NotesOn May&#160;2, 2017, we completed a private placement of&#160;$517.5 million&#160;in aggregate principal amount of&#160;the 2024 Notes and entered into the 2017 Indenture with respect to the 2024 Notes. The net proceeds from the issuance of the 2024 Notes were approximately $502.8 million, after deducting commissions and the offering expenses payable by us. The 2024 Notes accrue interest at a fixed rate of&#160;2.25%&#160;per year, payable semiannually in arrears on May&#160;15 and November&#160;15 of each year, and mature on May 15, 2024.<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $136.2&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $186.9&#160;million in cash. We accounted for the partial repurchase of the 2024 Notes as a debt extinguishment. As a result, we attributed $130.7&#160;million of the aggregate repurchase price to the liability component based on the fair value of the liability component immediately before extinguishment. The fair value of the liability component was calculated at settlement using a discounted cash flow analysis with a discount rate of 3.37%, which was the market rate for similar notes that have no conversion rights. The difference of $56.3&#160;million between the fair value of the aggregate consideration remitted to certain holders of the 2024 Notes and the fair value of the liability component was attributed to the reacquisition of the equity component and recognized as a reduction to additional paid-in capital. The carrying amount of the liability of $112.4&#160;million at settlement was recognized as a reduction to the 2024 Notes and resulted in an $18.4&#160;million loss on extinguishment.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may redeem for cash all or part of the 2024 Notes if the last reported sale price (as defined in the 2024 Indenture) of our common stock has been at least 130% of the conversion price then in effect (equal to $98.70 as of December&#160;31, 2021) for at least&#160;20&#160;trading days (whether or not consecutive) during any&#160;30&#160;consecutive trading-day period ending on, and including, the trading day immediately before the date which we provide notice of redemption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the 2024 Notes may convert the 2024 Notes at any time prior to the close of business on the business day immediately preceding May&#160;15, 2024, only under the following circumstances:</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt">during any calendar quarter (and only during such calendar quarter), if the last reported sale price of our common stock for at least&#160;20&#160;trading days (whether or not consecutive) during a period of&#160;30&#160;consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than&#160;130%&#160;of the conversion price (equal to $98.70 as of December&#160;31, 2021) on each applicable trading day;</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt">during the&#160;5&#160;business-day period immediately after any&#160;5&#160;consecutive trading-day period (the measurement period) in which the trading price (as defined in the 2024 Indenture) per&#160;$1,000&#160;principal amount of the 2024 Notes for each trading day of the measurement period was less than&#160;98%&#160;of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;</span></div><div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt">upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of our assets; or</span></div><div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt">if we call the 2024 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On or after January&#160;15, 2024, until the close of business on the scheduled trading day immediately preceding May&#160;15, 2024, holders may convert their 2024 Notes at any time.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, we entered into the First Supplemental Indenture to the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2024 Notes in cash upon conversion and to settle any conversion premium, calculated based on the per share volume-weighted average price for each of the&#160;30&#160;consecutive trading days during the observation period (as more fully described in the 2024 Indenture), in either cash or shares of our common stock. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest, and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2024 Notes will be paid pursuant to the terms of the 2024 Indenture.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial conversion rate for the 2024 Notes is&#160;13.1711&#160;shares of common stock per&#160;$1,000&#160;principal amount, which is equivalent to an initial conversion price of&#160;approximately $75.92&#160;per share of our common stock. At the initial conversion rate, settlement of the 2024 Notes for shares of our common stock would approximate 5.0 million shares. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2024 Notes represented a premium of approximately&#160;42.5%&#160;to the closing sale price of&#160;$53.28&#160;per share of our common stock on the Nasdaq Global Select Market on April&#160;26, 2017, the date that we priced the private offering of the 2024 Notes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we undergo a fundamental change, as defined in the 2024 Indenture, subject to certain conditions, holders of the 2024 Notes may require us to repurchase for cash all or part of their 2024 Notes at a repurchase price equal to&#160;100%&#160;of the principal amount of the 2024 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#8216;&#8216;make-whole fundamental change&#8217;&#8217; (as defined in the 2024 Indenture) occurs prior to January&#160;15, 2024, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert their notes in connection with the make-whole fundamental change.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes are our general unsecured obligations that rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the 2024 Notes, and equal in right of payment to our unsecured indebtedness.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the 2024 Notes were classified as a long-term liability as of December&#160;31, 2021, the future convertibility and associated balance sheet classification will be monitored at each quarterly reporting date and analyzed dependent upon market prices of our common stock during the prescribed measurement periods. In the event that we have the election to redeem the 2024 Notes or the holders of the 2024 Notes have the election to convert the 2024 Notes at any time during the prescribed measurement period, the 2024 Notes would then be considered a current obligation and classified as such.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to separately account for the liability and equity components of the 2024 Notes. The liability component of the instrument was valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $368.3 million&#160;was calculated using a&#160;7.5%&#160;assumed borrowing rate. The equity component of $149.2 million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2024 Notes and recorded in additional paid-in capital on the consolidated balance sheet on the issuance date. The equity component is treated as a discount on the liability component of the 2024 Notes, which is currently being amortized over the 7-year term of the 2024 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. As of December&#160;31, 2021, the remaining period over which the discount on the liability component will be amortized was approximately 2.4 years. We plan to adopt ASU 2020-06 on January 1, 2022 using the modified retrospective transition method. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Refer to Note 1 to the consolidated financial statements for more information.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocated the total transaction costs of approximately&#160;$14.7 million&#160;related to the issuance of the 2024 Notes to the liability and equity components of the 2024 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the&#160;7-year term of the 2024 Notes, and transaction costs attributable to the equity component are netted with the equity component in stockholders&#8217; equity.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by us. The 2024 Indenture contains customary events of default with respect to the 2024 Notes, including that upon certain events of default,&#160;100%&#160;of the principal and accrued and unpaid interest on the 2024 Notes will automatically become due and payable.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes, net of discounts and deferred financing costs, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">335.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes were recorded at the estimated value of a similar non-convertible instrument on the date of issuance and accretes to the face value of the 2024 Notes over their 7-year term. The fair value of the 2024 Notes, which was estimated utilizing market quotations from an over-the-counter trading market (Level 2), was $464.7 million as of December&#160;31, 2021 and $514.3 million as of December&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344369849000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Details<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Other Balance Sheet Details</a></td>
<td class="text">Other Balance Sheet Details<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scientific equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee related costs </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue-related reserves for discounts and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other balance sheet details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363679224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">Per Share<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share were calculated as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income - basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive were 4.1 million for 2021, 2.5 million for 2020 and 2.1 million for 2019.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363613384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May&#160;2011, we adopted the 2011 Equity Incentive Plan, as amended, or the 2011 Plan. The 2011 Plan authorized 21 million shares of common stock for issuance and allowed for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, or RSUs, performance stock awards, performance-based restricted stock units, or PRSUs, and certain other awards. During 2020, the 2011 Plan was merged into the 2020 Plan (defined below). As a result, there were no shares of common stock remaining available for future grant under the 2011 Plan.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, we adopted the 2018 Employee Stock Purchase Plan, or ESPP, pursuant to which 0.3 million shares of common stock are authorized for issuance. As of December 31, 2021, 0.1&#160;million shares of common stock remain available for future grant under the 2018 ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we adopted the 2020 Equity Incentive Plan, or the 2020 Plan. The 2020 Plan authorized 3.3&#160;million shares of common stock for issuance and allows for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, performance stock awards, PRSUs and certain other awards. The 2011 Plan was merged into the 2020 Plan and, as a result, all remaining shares in the 2011 Plan were transferred into the 2020 Plan. As of December 31, 2021, 5.4&#160;million shares of common stock remain available for future grant under the 2020 Plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of share-based compensation expense on our consolidated statements of income and comprehensive income by line-item follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by award-type follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized share-based compensation expense by award-type and the weighted-average period over which such expense is expected to be recognized, as applicable, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Recognition Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 years</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Typically, stock options have a 10-year term and vest over a 3 to 4-year period. The exercise price of stock options granted is equal to the closing price of our common stock on the date of grant. We estimate the fair value of stock options using the Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various and highly sensitive assumptions including expected volatility, term and interest rates. The weighted-average grant-date fair values of stock options granted were $45.02 for 2021, $45.67 for 2020 and $41.74 for 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 years</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average valuation assumptions were determined as follows:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected volatility of common stock is estimated based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of our stock options.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The expected option term is estimated based on historical experience as well as the status of the employee. For example, directors and officers have a longer expected option term than all other employees. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The risk-free interest rate for periods within the contractual life of a stock option is based upon observed interest rates appropriate for the expected term of our employee stock options. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have not historically declared or paid dividends and do not intend to do so in the foreseeable future. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised was $58.0 million for 2021, $40.2 million for 2020 and $64.3 million for 2019. Cash received from stock option exercises was $20.7 million for 2021, $23.5 million for 2020 and $27.3 million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs typically vest over a 4-year period. The fair value of RSUs is based on the closing sale price of our common stock on the date of issuance. RSUs may be subject to a deferred delivery arrangement at the election of eligible employees.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to RSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2021, our board of directors approved an equity grant of approximately 0.5&#160;million RSUs, which will vest over a 2-year period, to our full-time employees other than our executive officers.</span></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs that vested was $64.3 million for 2021, $49.7 million for 2020 and $36.1 million for 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRSUs vest based on the achievement of certain predefined Company-specific performance criteria and expire 3 to 4 years from the grant date. The fair value of PRSUs is estimated based on the closing sale price of our common stock on the date of grant.&#160;Expense recognition for PRSUs commences when attainment of the performance-based criteria is determined to be probable. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to PRSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>PRSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized share-based compensation expense for PRSUs was $32.0 million. The total fair value of PRSUs that vested was $13.5&#160;million for 2020. No PRSUs vested during 2021 or 2019.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the ESPP, eligible employees may purchase shares of our common stock at a discount semi-annually based on a percentage of their annual compensation. The discounted purchase price is equal to the lower of 85% of (i) the market value per share of the common stock on the first day of the offering period or (ii) the market value per share of common stock on the purchase date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363611224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of income tax expense (benefit) for continuing operations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income taxes at 21%</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets as of December 31, 2021 and 2020 are listed below. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net of deferred tax assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, our deferred tax assets were primarily the result of federal net operating loss carry forwards, capitalized research costs, acquired intangible assets and tax credit carryforwards. As of December 31, 2021 and 2020, we recorded a valuation allowance of $54.8 million and $49.8 million, respectively, against our gross deferred tax asset balance.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of each reporting date, management considers new evidence, both positive and negative, that could affect its assessment of the future realizability of our deferred tax assets. As of December 31, 2021, management determined there was sufficient positive evidence to conclude that it is more likely than not deferred tax assets of $315.1 million are realizable. The recorded valuation allowance of $54.8 million consisted primarily of state net operating loss and credit carryforwards for which management could not conclude it is more likely than not to be realized.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had federal and state income tax net operating loss carryforwards of $421.1 million and $329.9 million, respectively. The federal net operating losses will begin to expire in 2028, unless previously utilized.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California net operating losses will begin to expire in 2031 unless previously utilized and the net operating losses related to other states will begin to expire in 2026.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had federal and state R&amp;D tax credit carryforwards of $107.3 million and $66.3 million, respectively. A portion of the federal R&amp;D tax credit carryforwards expired in 2021. The remaining federal R&amp;D tax credits will continue to expire beginning in 2022, unless previously utilized. The California R&amp;D tax credits carry forward indefinitely and the R&amp;D tax credits related to other states will begin to expire in 2022, unless previously utilized.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the future utilization of our net operating loss and R&amp;D tax credit carryforwards to offset future taxable income may be subject to an annual limitation, pursuant to Internal Revenue Code Sections 382 and 383, as a result of ownership changes that could occur in the future. No ownership changes have occurred through December&#160;31, 2021.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to recognize interest or penalties related to income tax matters in income tax expense. Interest and penalties related to income tax matters were not material for 2021, 2020 or 2019.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxation in the United States and various state jurisdictions. Our tax years for 2001 for federal and since inception for California and forward are subject to examination by federal and state tax authorities due to the carryforward of unutilized net operating losses and R&amp;D tax credits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to unrecognized tax benefits follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded those deferred tax assets that are not more-likely-than-not to be sustained under the technical merits of the tax position. Such unrecognized tax benefits totaled $4.9 million for current year tax positions, as reflected in the table above.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we had $57.4 million of unrecognized tax benefits that, if recognized and realized, would affect the effective tax rate, subject to the valuation allowance. We do not expect a significant change in our unrecognized tax benefits in the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363613384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesOur corporate headquarters, for which we have operating leases with terms that expire beginning 2024 through 2031, are located in San Diego, California, and consist of office space and research and development laboratories. Certain of these lease agreements contain clauses for renewal at our option. As we were not reasonably certain to exercise any such options at commencement of these leases, no such options were recognized as part of the associated lease liabilities or right-of-use assets. <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present supplemental operating lease information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash related to letters of credit issued in lieu of cash security deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximate future minimum lease payments under operating leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accreted interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab">Less current operating lease liabilities included in other current liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364061848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plan</a></td>
<td class="text">Retirement PlanWe have a 401(k) defined contribution savings plan, or the 401(k)&#160;Plan. The 401(k) Plan is for the benefit of all qualifying employees and permits voluntary contributions by employees up to 60% of base salary limited by the IRS-imposed maximum. Employer contributions were $8.1 million for 2021, $6.7 million for 2020 and $4.9 million for 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363613384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 8, 2022, we entered into a lease agreement for a four-building campus facility to be constructed in San Diego, California, pursuant to which we also secured a 6-year option for the construction of a fifth building and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the lease, on a building-by-building basis, base rent will be subject to a 10-month rent abatement period following the respective lease commencement date, which dates will be determined in the future based upon achievement of substantial completion of construction with respect to each such building in the condition suitable for the installation of our furniture, fixtures and equipment, and on which date we will record a lease liability, corresponding right-of-use asset, and begin lease expense recognition with respect to each such building. After the rent abatement period, monthly base rent will be $6 per square foot, subject to annual escalations of 3% during the initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODc5_2f705c83-17a2-4b52-a632-b67c9ccf6649">13.6-year</span> lease term, which term we have the option to renew for two additional terms of 5 years each.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358225688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_BusinessDescriptionPolicyPolicyTextBlock', window );">Business Activities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Activities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neurocrine Biosciences, Inc., or Neurocrine Biosciences, the Company, we, our or us, was incorporated in California in 1992 and reincorporated in Delaware in 1996. Neurocrine Continental, Inc., is a Delaware corporation and a wholly owned subsidiary of Neurocrine Biosciences. We also have two wholly-owned Irish subsidiaries, Neurocrine Therapeutics, Ltd. and Neurocrine Europe, Ltd. both of which were formed in December 2014 and are inactive.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of Neurocrine Biosciences as well as our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Industry Segment and Geographic Information</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Industry Segment and Geographic Information. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a single industry segment&#160;&#8211; the discovery, development and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. We had no foreign-based operations during any of the years presented.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider all highly liquid investments that are readily convertible into cash without penalty and have an original maturity of three months or less at the time of purchase to be cash equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of customer allowances for prompt payment discounts, chargebacks and any allowance for doubtful accounts. We estimate the allowance for doubtful accounts based on existing contractual payment terms, actual payment patterns of our customers and individual customer circumstances. To date, an allowance for doubtful accounts has not been material.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Debt Securities</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities consist of investments in certificates of deposit, corporate debt securities and securities of government-sponsored entities. We classify debt securities as available-for-sale. Debt securities available-for-sale are recorded at fair value, with unrealized gains and losses included in other comprehensive income or loss, net of tax. We exclude accrued interest from both the fair value and amortized cost basis of debt securities. A debt security is placed on nonaccrual status at the time any principal or interest payments become 90 days delinquent. Interest accrued but not received for a debt security placed on nonaccrual status is reversed against interest income.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income includes amortization of purchase premium or discount. Premiums and discounts on debt securities are amortized using the effective interest rate method. Gains and losses on sales of debt securities are recorded on the trade date in investment income and other, net, and determined using the specific identification method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts', window );">Allowance for Credit Losses</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Allowance for Credit Losses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For debt securities available-for-sale in an unrealized loss position, we first assess whether we intend to sell, or it is more likely than not that we will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#8217;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.</span>Accrued interest receivables on debt securities available-for-sale totaled $2.2 million as of December&#160;31, 2021 and $3.7 million as of December&#160;31, 2020. We do not measure an allowance for credit losses for accrued interest receivables. For the purposes of identifying and measuring an impairment, accrued interest is excluded from both the fair value and amortized cost basis of the debt security. Uncollectible accrued interest receivables associated with an impaired debt security are reversed against interest income upon identification of the impairment. No accrued interest receivables were written off during 2021, 2020 or 2019.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record cash equivalents, debt securities available-for-sale and equity security investments at fair value based on a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). The fair value hierarchy consists of the following three levels:</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Unobservable inputs that reflect our own assumptions about the assumptions that market participants would use in pricing the asset or liability when there is little, if any, market activity for the asset or liability at the measurement date.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in debt securities available-for-sale are classified as Level 2 and carried at fair value. We estimate the fair value of debt securities available-for-sale by utilizing third-party pricing services. These pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Such inputs include market pricing based on real-time trade data for similar instruments, issuer credit spreads, benchmark yields, broker/dealer quotes and other observable inputs. We validate valuations obtained from third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing data in certain instances.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in equity securities of certain companies that are subject to holding period restrictions longer than one year are classified as Level 3 and carried at fair value using an option pricing valuation model. The most significant assumptions within the option pricing valuation model are the stock price volatility, which is based on the historical volatility of similar companies and the discount for lack of marketability related to the term of the restrictions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deem transfers between levels of the fair value hierarchy to have occurred at the end of the reporting period during which the event or change in circumstances that caused the transfer occurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value. We determine the cost of inventory using the standard-cost method, which approximates actual cost based on the first-in, first-out method. We assess the valuation of our inventory on a quarterly basis and adjust the value for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand. Inventory costs resulting from these adjustments are recognized as cost of sales in the period in which they are incurred. When future commercialization is considered probable and the future economic benefit is expected to be realized, based on management&#8217;s judgment, we capitalize pre-launch inventory costs prior to regulatory approval.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost and depreciated over the estimated useful lives of the assets using the straight-line method. Equipment is depreciated over an average estimated useful life of 3 to 7 years. Leasehold improvements are depreciated over the shorter of their estimated useful lives or the remaining lease term. Depreciation expense was $10.9 million for 2021, $8.6 million for 2020 and $7.4 million for 2019.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows. If&#160;the carrying amount is not recoverable, we measure the amount of any impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized using a five-step model: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Product Sales.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the United States, we sell INGREZZA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (valbenazine) primarily to specialty pharmacy providers and distributors and ONGENTYS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (opicapone) primarily to wholesale distributors. We recognize net product sales when the customer obtains control of our product, which occurs at a point in time, typically upon delivery of our product to the customer.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. Such estimates are based on information received from external sources (such as written or oral information obtained from our customers with respect to their period-end inventory levels and sales to end-users during the reporting period), as supplemented by management&#8217;s judgement. Our process for estimating reserves established for these variable consideration components does not differ materially from historical practices. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant categories of sales discounts and allowances are as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Discounts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Product discounts are based on payment terms extended to our customers at the time of sale, which include incentives offered for prompt payment. We maintain a reserve for product discounts based on our historical experience, including the timing of customer payments. To date, actual product discounts have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period. Such estimates are based on actual historical rebates by state, estimated payor mix, state and federal regulations and relevant contractual terms, as supplemented by management&#8217;s judgement. Our rebate accrual calculations require us to project the magnitude of our sales that will be subject to these rebates. There is a significant time-lag in our receiving rebate notices from each state (generally, several months or longer after a sale is recognized). Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The difference between the list price, or the price at which we sell our products to our customers, and the contracted price, or the price at which our customers sell our products to qualified healthcare professionals, is charged back to us by our customers. In addition to actual chargebacks received, we maintain a reserve for chargebacks based on estimated contractual discounts on product inventory levels on-hand in our distribution channel. To date, actual chargebacks have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payor and Pharmacy Rebates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are obligated to pay rebates as a percentage of sales under payor and pharmacy contracts. We estimate these rebates based on actual historical rebates, contractual rebate percentages, sales made through the payor channel and purchases made by pharmacies. To date, actual payor and pharmacy rebates have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Patient Financial Assistance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To help patients afford our products, we offer financial assistance to qualified patients with prescription drug co-payments required by insurance as well as free trial vouchers to qualifying new patients. We accrue for patient financial assistance based on estimated claims and the cost per claim we expect to receive associated with inventory that remains in the distribution channel at period end. To date, actual copay assistance and free trial vouchers have not differed materially from our estimates.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distributor and Other Fees.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In connection with the sales of our products, we pay distributor and other fees, which are generally recorded as a reduction of revenue, to certain customers that provide us with inventory management, data and distribution services. To the extent we can demonstrate a separable benefit and fair value for these services, we classify the associated costs in selling, general and administrative expenses. These costs are typically known at the time of sale, resulting in minimal adjustments subsequent to the period of sale.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We offer our customers product return rights primarily limited to errors in shipment, damaged product and expiring product, provided it is within a specified period of the product expiration date, as set forth in the associated distribution agreement. Where actual returns history is not available, we estimate a returns allowance based on benchmarking data for similar products and industry experience. We record this estimate as a reduction of revenue in the period the related sale is recognized. Once product is returned, it is destroyed. To date, actual product returns have not differed materially from our estimates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Revenues. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into collaboration and licensing agreements under which we out-license certain rights to our product candidates to third parties. The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees; development, regulatory and/or commercial milestone payments; and royalties on net sales of licensed products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licenses of Intellectual Property.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, we assess the nature of the combined performance obligation to determine whether it is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Milestones.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At the inception of each arrangement that includes developmental, regulatory or commercial milestones, we evaluate whether achieving the milestones is considered probable and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. Amounts for milestones that are not within our control, such as where achievement of the specified event is dependent on the development activities of a third party or approvals from regulators, are not considered probable of being achieved until the specified event occurs. Revenue is recognized from the satisfaction of performance obligations in the amount billable to the customer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Royalties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For arrangements that include sales-based royalties, and under which the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). Each quarterly period, sales-based royalties are recorded based on estimated quarterly net sales of the associated collaboration products. Differences between actual results and estimated amounts are adjusted for in the period in which they become known, which typically follows the quarterly period in which the estimate was made. To date, actual royalties received have not differed materially from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and debt securities available-for-sale. We have established guidelines to limit our exposure to credit risk by diversifying our investment portfolio and by placing investments with high credit quality financial institutions and maturities that maintain safety and liquidity. To date, we have not experienced any credit losses and do not believe we are exposed to any significant credit risk in relation to these financial instruments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to credit risk from our accounts receivable related to our product sales. Our two largest customers represented approximately 82% of our total product revenues for 2021 and approximately 86% for both 2020 and 2019, as well as the significant majority of our accounts receivable balances at December&#160;31, 2021 and 2020. To date, we have not experienced any significant losses with respect to the collection of these accounts receivable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Sales. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes third-party manufacturing, transportation, freight and indirect overhead costs associated with the manufacture and distribution of INGREZZA and ONGENTYS, royalty fees on net sales of ORILISSA and ORIAHNN, and adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Expenses</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development, or R&amp;D, expenses consist primarily of salaries, payroll taxes, employee benefits and share-based compensation charges for those individuals involved in ongoing R&amp;D efforts; as well as scientific consulting fees, preclinical and clinical trial costs, R&amp;D facilities costs, laboratory supply costs and depreciation of scientific equipment. All such costs are expensed as R&amp;D when incurred. These expenses result from our independent R&amp;D efforts, as well as efforts associated with collaborations, in-licenses and third-party funded research arrangements, including event-based milestones.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Asset Acquisitions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Asset Acquisitions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for acquisitions of an asset that does not (or a group of assets that do not) meet the definition of a business using the cost accumulation method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the asset (or assets) acquired on the basis of its (or their) relative fair value(s) on the measurement date. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in R&amp;D activities which have no alternative future use are expensed as in-process research and development, or IPR&amp;D, on the acquisition date. Future costs to develop these assets are expensed as R&amp;D when incurred.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed when services are performed or goods are delivered and are included in selling, general and administrative expense in our consolidated statements of income. We incurred advertising costs related to INGREZZA and ONGENTYS of $139.8 million for 2021, $64.8 million for 2020 and $40.6 million for 2019.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grant stock options to purchase our common stock to eligible employees and directors and also grant certain employees restricted stock units, or RSUs, and performance-based restricted stock units, or PRSUs. Additionally, we allow employees to participate in an employee stock purchase plan, or ESPP.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of stock options and shares to be issued under the ESPP using the Black-Scholes option-pricing model on the date of grant. RSUs are valued based on the closing price of our common stock on the date of grant. The fair value of equity instruments expected to vest is recognized and amortized on a straight-line basis over the requisite service period of the award, which is generally 3 to 4 years; however, certain provisions in our equity compensation plans provide for shorter vesting periods under certain circumstances. The fair value of shares to be issued under the ESPP is recognized and amortized on a straight-line basis over the purchase period, which is generally 6 months. PRSUs vest upon the achievement of certain predefined company-specific performance-based criteria. Expense related to PRSUs is generally recognized ratably over the expected performance period once the predefined performance-based criteria for vesting becomes probable.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our income tax provision (benefit) is computed under the asset and liability method. Significant estimates are required in determining our income tax provision (benefit). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to </span><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. Refer to Note 9 to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities based on the technical merits of the position. An adverse resolution of one or more of these uncertain tax positions in any period could have a material impact on the results of operations for that period.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Share.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the treasury stock method and reflect the weighted average number of common and potentially dilutive shares outstanding during the period, excluding those which effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt instruments that may be settled entirely or partly in cash may, in certain circumstances where the borrower has the ability and intent to settle in cash, be accounted for under the treasury stock method. In December 2021, we entered into the First Supplemental Indenture, dated as of May 2, 2017, by and between the Company and U.S. Bank National Association, as Trustee, or the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes, in cash upon conversion and to settle any conversion premium in either cash or shares of our common stock. As a result, and consistent with historical practice, only the shares required to settle any conversion premium would be considered dilutive under the treasury stock method. Further, PRSUs for which the performance condition has not been achieved are excluded from the calculation of diluted earnings per share.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted and Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASU 2019-12.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, we adopted Accounting Standards Update, or ASU, 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, using the modified retrospective transition method. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application of Topic 740. The adoption of ASU 2019-12 did not result in a cumulative-effect adjustment to retained earnings. The comparative prior period information continues to be reported under the accounting standards in effect during those periods. The impact of the adoption is expected to be immaterial to our financial position, results of operations and cash flows on an ongoing basis.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements.</span></div>ASU 2020-06. In August 2020, the FASB issued ASU 2020-06,&#160;Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#8211; Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity's own equity. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Instead, entities will account for convertible debt instruments wholly as debt, unless certain other conditions are met. The adoption of ASU 2020-06 is expected to prospectively reduce reported interest expense and increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders&#8217; equity to liabilities as it relates to the 2024 Notes. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We will adopt <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d">ASU 2020-06</span> on January 1, 2022 using the modified retrospective transition method, which allows for a cumulative-effect adjustment in the period of adoption and does not require restatement of prior period amounts. Under this transition method, the cumulative effect of the accounting change is expected to increase the carrying amount of the 2024 Notes by $42.2&#160;million, reduce deferred tax liabilities by $10.0&#160;million, reduce the accumulated deficit by $74.6&#160;million, reduce additional paid-in capital by $106.8&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_BusinessDescriptionPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Description Policy [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_BusinessDescriptionPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (a,b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344388332984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Amortized cost, gross unrealized gain (loss) positions and estimated fair value for available-for-sale debt securities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the amortized cost, unrealized gain and loss recognized in accumulated other comprehensive income (loss) and fair value of debt securities available-for-sale at December&#160;31, 2021, aggregated by major security type and contractual maturity:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.073%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.075%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Contractual<br/>Maturity</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Gain</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Unrealized Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">300.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0 to 1 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">230.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">370.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">612.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">613.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">358.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1 to 3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">563.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">560.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">226.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">227.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Gross unrealized losses and fair value available-for-sale investments in unrealized loss position</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes debt securities available-for-sale in an unrealized loss position for less than 12 months, aggregated by major security type. There were no debt securities available-for-sale in an unrealized loss position for longer than 12 months as of December&#160;31, 2021 or 2020.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Loss</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Corporate Debt Securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">428.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">659.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364500952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Investments measured at fair value on recurring basis</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments, which were measured at fair value on a recurring basis, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.393%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.398%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair <br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt securities available-for-sale:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">204.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">485.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">445.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Securities of government-sponsored entities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">240.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">312.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Equity securities&#8211;biotechnology industry</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,338.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">396.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">931.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,069.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">841.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of equity securities measured at fair value on recurring basis using significant unobservable inputs</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of equity security investments, which were measured at fair value on a recurring basis using significant unobservable inputs (Level 3):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">68.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gain (loss) included in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transfers out of Level 3 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) In September 2021, we purchased 0.3&#160;million shares of Xenon's common stock, valued at $4.6&#160;million on the date of purchase, in connection with the European Union&#8217;s approval of the clinical trial application for NBI-921352.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) In the fourth quarter of 2021, our equity security investment in Xenon was transferred from Level 3 to Level 1 as the associated holding period restriction expired.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364076504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Convertible senior notes net of discounts and deferred financing costs</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 Notes, net of discounts and deferred financing costs, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">381.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt discount, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(59.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net carrying amount</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">335.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">317.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364111032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Details (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Scientific equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities consisted of the following:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued employee related costs </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue-related reserves for discounts and allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">225.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">168.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock', window );">Reconciliation of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">344.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other balance sheet details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of reconciliation of cash cash equivalents and restricted cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344360980072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of net income (loss) per share</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share were calculated as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income - basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">407.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">37.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">94.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">91.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024 Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">97.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363846744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share based compensation</a></td>
<td class="text">The effect of share-based compensation expense on our consolidated statements of income and comprehensive income by line-item follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by award-type follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">PRSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, unrecognized share-based compensation expense by award-type and the weighted-average period over which such expense is expected to be recognized, as applicable, were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.726%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.729%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(dollars in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Recognition Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RSUs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.2 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-average assumptions for stock option grants using black-scholes option-pricing model</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected volatility of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">45.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.0&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expected option term</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.3 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.4 years</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary and changes in stock options outstanding</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to stock options follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.98&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110.74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Outstanding at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">136.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercisable at December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary and changes in restricted stock units outstanding</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to RSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>RSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.60&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Released</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82.22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Canceled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.3 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">174.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%">_________________________</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2021, our board of directors approved an equity grant of approximately 0.5&#160;million RSUs, which will vest over a 2-year period, to our full-time employees other than our executive officers.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to PRSUs follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.880%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.808%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>PRSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Grant Date <br/>Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">102.90&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unvested at December 31, 2021</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364511992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Components of income tax expense for continuing operations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of income tax expense (benefit) for continuing operations were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(287.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(310.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Provision for income taxes on earnings subject to income taxes differs from statutory federal rate</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for (benefit from) income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Federal income taxes at 21%</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Branded prescription drug fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Officer compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expired tax attributes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(22.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(296.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(300.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Components of deferred tax assets</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets as of December 31, 2021 and 2020 are listed below. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">111.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">109.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capitalized research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">413.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">411.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Convertible senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(19.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(43.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(42.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net of deferred tax assets and liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">369.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">315.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">319.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Activity related to unrecognized tax benefits</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of activity related to unrecognized tax benefits follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase related to current year tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Settlements related to prior year tax positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">64.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364492600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of supplemental operating lease information</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present supplemental operating lease information.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of operating lease liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions, except weighted average data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average remaining lease term</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.8 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted cash related to letters of credit issued in lieu of cash security deposits</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of minimum lease payments for operating lease liabilities</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximate future minimum lease payments under operating leases were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2022</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ending December 31, 2026</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less accreted interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab">Less current operating lease liabilities included in other current liabilities</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344362395816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>subsidiary</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>May 02, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_NumberOfIrishSubsidiaries', window );">Number of wholly owned Irish subsidiaries | subsidiary</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff', window );">Accrued interest receivables write-off threshold period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Accrued interest receivables</a></td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff', window );">Accrued interest receivables write-off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">10,900,000<span></span>
</td>
<td class="nump">8,600,000<span></span>
</td>
<td class="nump">$ 7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="nump">$ 139,800,000<span></span>
</td>
<td class="nump">64,800,000<span></span>
</td>
<td class="nump">$ 40,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible List]</a></td>
<td class="text">Accounting Standards Update 2020-06 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes</a></td>
<td class="nump">$ 335,100,000<span></span>
</td>
<td class="nump">317,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(635,800,000)<span></span>
</td>
<td class="num">$ (725,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember', window );">2.25% Convertible senior notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ProFormaMember', window );">Pro Forma | Cumulative Effect, Period of Adoption, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebtNoncurrent', window );">Convertible senior notes</a></td>
<td class="nump">42,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liabilities</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">74,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid in capital</a></td>
<td class="nump">$ 106,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_ESPPPurchasePeriod', window );">ESPP purchase period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share-based compensation arrangement by share-based payment award, award requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Share-based compensation arrangement by share-based payment award, award requisite service period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">Revenue, Product and Service Benchmark | Customer Concentration Risk | Largest two customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="nump">86.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_ESPPPurchasePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ESPP Purchase Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_ESPPPurchasePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_NumberOfIrishSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Irish Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_NumberOfIrishSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Organization and summary of significant accounting policies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period when accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), is considered uncollectible and written off, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3C<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267859-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of writeoff of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized by reversing interest income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3D<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267862-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ProFormaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ProFormaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=nbix_LargestTwoCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=nbix_LargestTwoCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358800152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration and License Agreements - Additional Information (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105.3<span></span>
</td>
<td class="nump">$ 164.5<span></span>
</td>
<td class="nump">$ 154.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,133.5<span></span>
</td>
<td class="nump">1,045.9<span></span>
</td>
<td class="nump">788.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty | AbbVie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
<td class="nump">19.2<span></span>
</td>
<td class="nump">14.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Heptares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Takeda</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">120.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Idorsia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Xenon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_UpfrontPaymentsMade', window );">Upfront payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities number of shares (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in USD per share)</a></td>
<td class="nump">$ 19.9755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14.196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_MilestoneEquityPurchasePayment', window );">Milestone equity purchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities fair value amount</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_MilestonePayment', window );">Milestone payment</a></td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Voyager</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff', window );">Acquired in-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="nump">$ 113.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_UpfrontPaymentsMade', window );">Upfront payments made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.9625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_MilestoneEquityPurchasePayment', window );">Milestone equity purchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities fair value amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | B I A L</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePayments', window );">Potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.0<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | MTPC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePaymentReceipts', window );">Potential milestone payment receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Deferred revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | AbbVie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PotentialMilestonePaymentReceipts', window );">Potential milestone payment receipts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 366.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.0<span></span>
</td>
<td class="nump">$ 20.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Patents | Minimum | MTPC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PatentTerm', window );">Patent term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Patents | Minimum | AbbVie</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PatentTerm', window );">Patent term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Common Stock | Xenon</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities number of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember', window );">Collaborative Arrangement | Common Stock | Voyager</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities number of shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_MilestoneEquityPurchasePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone Equity Purchase Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_MilestoneEquityPurchasePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_MilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments made for milestones under a collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_MilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_PatentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of the patent, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_PatentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_PotentialMilestonePaymentReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Potential later stage milestone payments and royalties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_PotentialMilestonePaymentReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_PotentialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of potential milestone payments to be paid under a license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_PotentialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_UpfrontPaymentsMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront payments made under a collaboration agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_UpfrontPaymentsMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_AbbvieIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_AbbvieIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_HeptaresTherapeuticsLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_HeptaresTherapeuticsLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_TakedaPharmaceuticalCompanyLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_TakedaPharmaceuticalCompanyLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_IdorsiaPharmaceuticalsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_IdorsiaPharmaceuticalsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_XenonPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_XenonPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_VoyagerTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_VoyagerTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_BIALMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_BIALMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_MitsubishiTanabePharmaCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_MitsubishiTanabePharmaCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344361731704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">$ 370.6<span></span>
</td>
<td class="nump">$ 612.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">370.5<span></span>
</td>
<td class="nump">613.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">128.2<span></span>
</td>
<td class="nump">299.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">128.1<span></span>
</td>
<td class="nump">300.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments | Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">37.6<span></span>
</td>
<td class="nump">230.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">37.6<span></span>
</td>
<td class="nump">231.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember', window );">Short-term investments | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">204.8<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">204.8<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember', window );">Long-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">563.2<span></span>
</td>
<td class="nump">226.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(2.5)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">560.7<span></span>
</td>
<td class="nump">227.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember', window );">Long-term investments | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">358.9<span></span>
</td>
<td class="nump">144.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">357.4<span></span>
</td>
<td class="nump">145.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember', window );">Long-term investments | Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost, Total</a></td>
<td class="nump">204.3<span></span>
</td>
<td class="nump">81.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 203.3<span></span>
</td>
<td class="nump">$ 81.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ShortTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=nbix_LongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358033928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">$ 659.1<span></span>
</td>
<td class="nump">$ 95.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Unrealized Losses</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">428.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Unrealized Losses</a></td>
<td class="num">(1.6)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less Than 12 Months, Fair Value</a></td>
<td class="nump">230.5<span></span>
</td>
<td class="nump">95.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less Than 12 Months, Unrealized Losses</a></td>
<td class="num">$ (1.0)<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363607464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt Securities - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>security</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions', window );">Debt securities available for sale position number of positions</a></td>
<td class="nump">164<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Number of debt securities available-for-sale in an unrealized loss position</a></td>
<td class="nump">136<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt securities available for sale position number of positions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344362491992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details) - Fair value measurements recurring - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">$ 1,338.9<span></span>
</td>
<td class="nump">$ 1,069.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">485.5<span></span>
</td>
<td class="nump">445.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">240.9<span></span>
</td>
<td class="nump">312.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember', window );">Equity securities&#8211;biotechnology industry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=nbix_CashAndMoneyMarketFundMember', window );">Cash and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">340.8<span></span>
</td>
<td class="nump">187.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Fair value</a></td>
<td class="nump">204.8<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">396.7<span></span>
</td>
<td class="nump">190.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Equity securities&#8211;biotechnology industry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">52.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Cash and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">340.8<span></span>
</td>
<td class="nump">187.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">931.2<span></span>
</td>
<td class="nump">841.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">485.5<span></span>
</td>
<td class="nump">445.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">240.9<span></span>
</td>
<td class="nump">312.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Equity securities&#8211;biotechnology industry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Cash and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">204.8<span></span>
</td>
<td class="nump">82.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Securities of government-sponsored entities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Equity securities&#8211;biotechnology industry</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Cash and money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of assets on recurring basis</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=nbix_CashAndMoneyMarketFundMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=nbix_CashAndMoneyMarketFundMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358672456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Purchases to acquire equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 68.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) included in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=nbix_XenonPharmaceuticalsIncMember', window );">Xenon | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Purchases to acquire equity securities</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, ending balance</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedBalanceShares', window );">Equity securities number of shares (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value measurements recurring | Equity securities&#8211;biotechnology industry | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.2<span></span>
</td>
<td class="nump">55.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRestrictedInvestments', window );">Purchases to acquire equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">68.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized gain (loss) included in earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.9<span></span>
</td>
<td class="num">(17.7)<span></span>
</td>
<td class="num">(13.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Transfers out of Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(52.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRestricted', window );">Equity securities, ending balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.0<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
<td class="nump">$ 55.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRestricted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of restricted investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=109249958&amp;loc=SL6224234-111729<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRestricted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123583765&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedBalanceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Balance held at close of period in number of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=122147990&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedBalanceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRestrictedInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRestrictedInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_XenonPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_XenonPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363639640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=nbix_VoyagerTherapeuticsMember', window );">Voyager | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DiscountForMarketabilityUsedInValuationAnalysis', window );">Discount for marketability in valuation analysis</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DiscountForMarketabilityUsedInValuationAnalysis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount For Marketability Used In Valuation Analysis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DiscountForMarketabilityUsedInValuationAnalysis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=nbix_VoyagerTherapeuticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=nbix_VoyagerTherapeuticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358577960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Convertible Senior Notes - Additional Information (Details)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 02, 2017 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 381,200,000<span></span>
</td>
<td class="nump">$ 381,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Equity component of repurchased convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember', window );">2.25% Convertible senior notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="nump">$ 517,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance</a></td>
<td class="nump">$ 502,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Aggregate principal amount repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 136,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Aggregate repurchase price paid in cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment', window );">Fair value of the liability component immediately before extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments', window );">Equity component of repurchased convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_CarryingAmountOfLiabilityComponentAtSettlement', window );">Carrying amount of the liability component at settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of common stock price trigger</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleStockPriceTrigger', window );">Common stock price trigger (in USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold common stock trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive common stock trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PrincipalAmountOnConversionRate', window );">Principal amount on conversion rate</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_TradingDaysDuringObservationPeriod', window );">Trading days during observation period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">0.00131711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in USD per share) | $ / shares</a></td>
<td class="nump">$ 75.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Shares issued to settle notes at initial conversion rate (in shares) | shares</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DebtInstrumentConvertibleConversionPremium', window );">Conversion premium</a></td>
<td class="nump">42.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Market price of common stock (in USD per share) | $ / shares</a></td>
<td class="nump">$ 53.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Redemption rate</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_CarryingAmountOfLiabilityComponentUponIssuance', window );">Carrying amount of the liability component upon issuance</a></td>
<td class="nump">$ 368,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Assumed borrowing rate</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent', window );">Carrying amount of the equity component upon issuance</a></td>
<td class="nump">$ 149,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1', window );">Remaining discount amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Transaction cost related to issuance of convertible senior note</a></td>
<td class="nump">$ 14,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault', window );">Events of default percentage of principal and accrued and unpaid interest due and payable upon default</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 464,700,000<span></span>
</td>
<td class="nump">$ 514,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember', window );">2.25% Convertible senior notes due 2024 | Conversion Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Threshold percentage of common stock price trigger</a></td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold common stock trading days | d</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive common stock trading days | d</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember', window );">2.25% Convertible senior notes due 2024 | Conversion Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Threshold common stock trading days | d</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Threshold consecutive common stock trading days | d</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_PrincipalAmountOnConversionRate', window );">Principal amount on conversion rate</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice', window );">Minimum percentage of common stock price trigger</a></td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember', window );">2.25% Convertible senior notes due 2024 | Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_CarryingAmountOfLiabilityComponentAtSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the liability component at settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_CarryingAmountOfLiabilityComponentAtSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_CarryingAmountOfLiabilityComponentUponIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the liability component upon issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_CarryingAmountOfLiabilityComponentUponIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DebtInstrumentConvertibleConversionPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of excess of the price paid for the convertible note over the closing stock price on the closing date of the convertible note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DebtInstrumentConvertibleConversionPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Events of default percentage of principal and accrued and unpaid interest due and payable upon default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the liability component immediately before extinguishment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum percentage of the product of the common stock trading price multiplied by the conversion rate during the measurement period as compared to the principal note amount that triggers a conversion option on the notes, if it falls below this percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_PrincipalAmountOnConversionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Principal amount on conversion rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_PrincipalAmountOnConversionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_TradingDaysDuringObservationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading days during observation period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_TradingDaysDuringObservationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467658&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DebtInstrumentConversionAxis=nbix_ConversionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DebtInstrumentConversionAxis=nbix_ConversionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DebtInstrumentConversionAxis=nbix_ConversionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DebtInstrumentConversionAxis=nbix_ConversionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364453880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal</a></td>
<td class="nump">$ 381.2<span></span>
</td>
<td class="nump">$ 381.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="num">(4.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount, net</a></td>
<td class="num">(43.2)<span></span>
</td>
<td class="num">(59.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleDebt', window );">Net carrying amount</a></td>
<td class="nump">$ 335.1<span></span>
</td>
<td class="nump">$ 317.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363976200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Details - Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="nump">$ 16.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">3.6<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 30.5<span></span>
</td>
<td class="nump">$ 28.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other balance sheet details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358586808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Details - Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 110.5<span></span>
</td>
<td class="nump">$ 86.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less accumulated depreciation</a></td>
<td class="num">(51.9)<span></span>
</td>
<td class="num">(41.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">58.6<span></span>
</td>
<td class="nump">44.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">34.9<span></span>
</td>
<td class="nump">29.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nbix_ScientificEquipmentMember', window );">Scientific equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">51.6<span></span>
</td>
<td class="nump">39.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=nbix_ScientificEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=nbix_ScientificEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358016168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued employee related costs</a></td>
<td class="nump">$ 50.6<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_RevenueRelatedReservesForDiscountsAndAllowances', window );">Revenue-related reserves for discounts and allowances</a></td>
<td class="nump">62.7<span></span>
</td>
<td class="nump">34.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_AccruedResearchAndDevelopmentExpenseCurrent', window );">Accrued development costs</a></td>
<td class="nump">32.4<span></span>
</td>
<td class="nump">32.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_AccruedBrandedPrescriptionDrugFee', window );">Current branded prescription drug fee</a></td>
<td class="nump">28.6<span></span>
</td>
<td class="nump">23.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other accrued liabilities</a></td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">39.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 225.8<span></span>
</td>
<td class="nump">$ 168.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_AccruedBrandedPrescriptionDrugFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Branded Prescription Drug Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_AccruedBrandedPrescriptionDrugFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_AccruedResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_AccruedResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other balance sheet details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_RevenueRelatedReservesForDiscountsAndAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue-related reserves for discounts and allowances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_RevenueRelatedReservesForDiscountsAndAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364782536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_OtherBalanceSheetDetailsAbstract', window );"><strong>Other Balance Sheet Details [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 340.8<span></span>
</td>
<td class="nump">$ 187.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash related to letters of credit issued in lieu of cash security deposits</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 344.0<span></span>
</td>
<td class="nump">$ 190.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_OtherBalanceSheetDetailsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other balance sheet details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_OtherBalanceSheetDetailsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363873880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 89.6<span></span>
</td>
<td class="nump">$ 407.3<span></span>
</td>
<td class="nump">$ 37.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">94.6<span></span>
</td>
<td class="nump">93.1<span></span>
</td>
<td class="nump">91.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">97.9<span></span>
</td>
<td class="nump">97.8<span></span>
</td>
<td class="nump">95.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in USD per share)</a></td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 4.38<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in USD per share)</a></td>
<td class="nump">$ 0.92<span></span>
</td>
<td class="nump">$ 4.16<span></span>
</td>
<td class="nump">$ 0.39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=nbix_A225ConvertibleSeniorNotesMember', window );">2.25% Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities', window );">2024 Notes (in shares)</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract', window );"><strong>Effect of dilutive securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of dilutive securities (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=nbix_A225ConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=nbix_A225ConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358019640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember', window );">Stock options restricted stock and convertible senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Anti-dilutive shares excluded from diluted per share amounts (in shares)</a></td>
<td class="nump">4.1<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344360071720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>May 31, 2018</div></th>
<th class="th"><div>May 31, 2011</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair values of stock options granted (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.02<span></span>
</td>
<td class="nump">$ 45.67<span></span>
</td>
<td class="nump">$ 41.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Stock options exercised in period intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,000,000<span></span>
</td>
<td class="nump">$ 40,200,000<span></span>
</td>
<td class="nump">$ 64,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Cash received from stock option exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,700,000<span></span>
</td>
<td class="nump">23,500,000<span></span>
</td>
<td class="nump">27,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Total intrinsic value vested in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,300,000<span></span>
</td>
<td class="nump">49,700,000<span></span>
</td>
<td class="nump">36,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember', window );">PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of PRSUs vested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,500,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember', window );">PRSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember', window );">PRSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Discounted purchase price percentage of common stock authorized for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nbix_TwoThousandAndElevenPlanMember', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=nbix_A2020EquityIncentivePlanMember', window );">2020 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of common stock authorized for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nbix_TwoThousandAndElevenPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nbix_TwoThousandAndElevenPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=nbix_A2020EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=nbix_A2020EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358236024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 134.2<span></span>
</td>
<td class="nump">$ 100.0<span></span>
</td>
<td class="nump">$ 75.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">85.8<span></span>
</td>
<td class="nump">66.3<span></span>
</td>
<td class="nump">49.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 48.4<span></span>
</td>
<td class="nump">$ 33.7<span></span>
</td>
<td class="nump">$ 25.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358553000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 134,200,000<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
<td class="nump">$ 75,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">60,500,000<span></span>
</td>
<td class="nump">47,500,000<span></span>
</td>
<td class="nump">36,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">62,500,000<span></span>
</td>
<td class="nump">44,200,000<span></span>
</td>
<td class="nump">30,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember', window );">PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="nump">5,300,000<span></span>
</td>
<td class="nump">5,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 3,600,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">$ 2,700,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364467496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 101.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Recognition Period</a></td>
<td class="text">2 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized Expense</a></td>
<td class="nump">$ 150.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-Average Recognition Period</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344357054328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of common stock</a></td>
<td class="nump">45.90%<span></span>
</td>
<td class="nump">48.50%<span></span>
</td>
<td class="nump">54.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344357708904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary of Activity Related to Stock Options (Details)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance, Outstanding (in shares) | shares</a></td>
<td class="nump">6,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(700)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares) | shares</a></td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance, Outstanding (in shares) | shares</a></td>
<td class="nump">7,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Exercisable (in shares) | shares</a></td>
<td class="nump">5,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance, Outstanding (in USD per share) | $ / shares</a></td>
<td class="nump">$ 62.98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in USD per share) | $ / shares</a></td>
<td class="nump">110.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in USD per share) | $ / shares</a></td>
<td class="nump">28.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (in USD per share) | $ / shares</a></td>
<td class="nump">103.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance, Outstanding (in USD per share) | $ / shares</a></td>
<td class="nump">76.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (in USD per share) | $ / shares</a></td>
<td class="nump">$ 63.53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Term, Outstanding</a></td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Term, Exercisable</a></td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding | $</a></td>
<td class="nump">$ 136.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate Intrinsic Value, Exercisable | $</a></td>
<td class="nump">$ 134.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358632728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance, Unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Released (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Canceled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance, Unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance, Unvested (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 89.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Released (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82.22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Canceled (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance, Unvested (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Unvested, weighted average remaining contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Unvested, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember', window );">PRSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning Balance, Unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending Balance, Unvested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning Balance, Unvested (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending Balance, Unvested (in USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 109.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Unvested, weighted average remaining contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Unvested, aggregate intrinsic value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=nbix_PerformanceBasedRestrictedStockUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344359985704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Components of Income Tax Expense for Continuing Operations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current taxes</a></td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="num">(287.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(23.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred taxes</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="num">(310.7)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="num">$ (300.6)<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363994056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income taxes, rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal income taxes at 21%</a></td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="nump">$ 22.4<span></span>
</td>
<td class="nump">$ 9.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefit</a></td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">5.5<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Non-deductible expenses</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee', window );">Branded prescription drug fee</a></td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation expense</a></td>
<td class="num">(11.3)<span></span>
</td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(12.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost', window );">Officer compensation</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in tax rate</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxReconciliationExpirationOfTaxCredits', window );">Expired tax attributes</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research credits</a></td>
<td class="num">(22.0)<span></span>
</td>
<td class="num">(39.0)<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="num">(296.3)<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">$ 11.8<span></span>
</td>
<td class="num">$ (300.6)<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_IncomeTaxReconciliationExpirationOfTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation, expiration of tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_IncomeTaxReconciliationExpirationOfTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense branded prescription drug fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax reconciliation nondeductible expense officer compensation cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32059-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344388353576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Components of Deferred Tax Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 90.3<span></span>
</td>
<td class="nump">$ 111.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development credits</a></td>
<td class="nump">129.7<span></span>
</td>
<td class="nump">109.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment', window );">Capitalized research and development</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="nump">24.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Share-based compensation expense</a></td>
<td class="nump">38.9<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DeferredTaxAssetsOperatingLeasesAssets', window );">Operating lease assets</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">86.1<span></span>
</td>
<td class="nump">86.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">21.6<span></span>
</td>
<td class="nump">23.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">413.8<span></span>
</td>
<td class="nump">411.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes', window );">Convertible senior notes</a></td>
<td class="num">(9.9)<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(23.3)<span></span>
</td>
<td class="num">(19.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(10.7)<span></span>
</td>
<td class="num">(8.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(43.9)<span></span>
</td>
<td class="num">(42.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_DeferredTaxAssetsLiabilitiesGross', window );">Net of deferred tax assets and liabilities</a></td>
<td class="nump">369.9<span></span>
</td>
<td class="nump">369.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(54.8)<span></span>
</td>
<td class="num">(49.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 315.1<span></span>
</td>
<td class="nump">$ 319.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research and development costs capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DeferredTaxAssetsLiabilitiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets (liabilities) gross.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DeferredTaxAssetsLiabilitiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DeferredTaxAssetsOperatingLeasesAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets operating leases assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DeferredTaxAssetsOperatingLeasesAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities convertible senior notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities operating leases liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344358695848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets, valuation allowance</a></td>
<td class="nump">$ 54.8<span></span>
</td>
<td class="nump">$ 49.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred Tax Assets, Net</a></td>
<td class="nump">315.1<span></span>
</td>
<td class="nump">319.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carry forwards</a></td>
<td class="nump">129.7<span></span>
</td>
<td class="nump">109.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would affect effective tax rate</a></td>
<td class="nump">57.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward, net</a></td>
<td class="nump">421.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carry forwards</a></td>
<td class="nump">107.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and local jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_IncomeTaxesLineItems', window );"><strong>Income Taxes [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carry forward, net</a></td>
<td class="nump">329.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carry forwards</a></td>
<td class="nump">$ 66.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_IncomeTaxesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Taxes [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_IncomeTaxesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344364329256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 60.8<span></span>
</td>
<td class="nump">$ 63.9<span></span>
</td>
<td class="nump">$ 54.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase related to prior year tax positions</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">(Decrease) related to prior year tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase related to current year tax positions</a></td>
<td class="nump">4.9<span></span>
</td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements related to prior year tax positions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations for the assessment of taxes</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 64.6<span></span>
</td>
<td class="nump">$ 60.8<span></span>
</td>
<td class="nump">$ 63.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344357840536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 15.3<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
<td class="nump">$ 8.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in the measurement of operating lease liabilities</a></td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="nump">$ 7.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
<td class="text">10 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">5.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash related to letters of credit issued in lieu of cash security deposits</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Leases [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Restricted cash related to letters of credit issued in lieu of cash security deposits</a></td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344357840312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">Year ending December 31, 2022</a></td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">Year ending December 31, 2023</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">Year ending December 31, 2024</a></td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">Year ending December 31, 2025</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">Year ending December 31, 2026</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">70.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total operating lease payments</a></td>
<td class="nump">154.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less accreted interest</a></td>
<td class="nump">32.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">121.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current operating lease liabilities included in other current liabilities</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent operating lease liabilities</a></td>
<td class="nump">$ 105.3<span></span>
</td>
<td class="nump">$ 94.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344369871288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plan - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Defined contribution plan, maximum employee contribution percentage</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, employer contribution amount</a></td>
<td class="nump">$ 8.1<span></span>
</td>
<td class="nump">$ 6.7<span></span>
</td>
<td class="nump">$ 4.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140344363861368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event<br></strong></div></th>
<th class="th">
<div>Feb. 08, 2022 </div>
<div>USD ($) </div>
<div>renewalOption</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term</a></td>
<td class="text">13 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot', window );">Monthly base rent per square foot | $</a></td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_AnnualRentEscalationPercentage', window );">Annual rent escalation percentage</a></td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_RentAbatementPeriod', window );">Rent abatement period</a></td>
<td class="text">10 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_NumberOfRenewalOptions', window );">Number of lease renewal options | renewalOption</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding', window );">Lessee option term for construction of fifth building</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_AnnualRentEscalationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>AnnualRentEscalationPercentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_AnnualRentEscalationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Monthly Base Rent Per Square Foot</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of term of lessee's option for the construction of a fifth building under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_NumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of renewal options under the terms of the lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_NumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_nbix_RentAbatementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rent Abatement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">nbix_RentAbatementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>nbix_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>nbix-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nbix="http://www.neurocrine.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nbix-20211231.xsd" xlink:type="simple"/>
    <context id="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic58f0d332b1740bcbfe3ae799b6c76f1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i524e39f5a339434b949a0ca71590d62a_I20220207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2022-02-07</instant>
        </period>
    </context>
    <context id="i410ba3ab0060406a970171c67adc140c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3444b3f24cee47b19a83d7b209ba18d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i70a090e172d54a3390fc3154fe0c83e2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i235dcd3608564d60b4d0f9676da9af24_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id34e6de166964d63af8e67b2f42daf09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a39bd69114b41f3a7575046b42fd208_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i670cc6e75e624e85a72e5224f486c622_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88608bd64b9d491d965911eb2f10d0ba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f4ab3853b3242c7858dcf9b3a67bb47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i798a316339674cf592518cb98cd4340d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57e3f974b4374e128e00062b09a226b8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">nbix:CollaborationRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98bc001f820e4a76842b22423643fd00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i37c451fdb8934177af07aab2f9815261_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i850a1c2e6bbe421b9e53c336f81ae194_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if8328f9cd2d94115acc9db87f97b7e95_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib8c5963bd49a44d8ab23a5f66be2f6e7_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ief1e07453fb8400290d05177cdbc914a_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="id623863c89314565b0c613c6e4844cd9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b1e1efe40c742aa916cca25579067f4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6f25e6030cba44eeaeb535268d2aec62_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ieebdcec5b54b4ac6bdd2c1d5c2eba719_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i15f9746d0c4c45cbbdbb3cee1e0be1d3_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9be0134c1cf94658b1ea4f2a9d3aabd0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5e5a9db50e334fceb17223af88813a25_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i57f40d95bd5147f493ce76a1d0d54aa9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5d3840166f542059e79068112c8351f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iee36651c7ea24ee1aa1a126bc3592f0f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i50270a33ffaf46e699671aaa2d154c06_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if2f0e73949934202a967b64bd1dbcc51_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8e86243316844136bf4f9112f308abd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5e59d7192ea042ceb2f48ae50260ec53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff0345a87ec74fc2a1683ba954ad2eea_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icecbc009167140a6a443a748af98ebb3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id963b79121954d3ea702db8ac5aaec24_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia21b050c801745578a610cadda27dda1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic234985e15bc4a1d876dca26f6503d8e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2e85c7f4bf3e4e8a9b237b4341c4b9a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i534bd413a5404e2da06b975889c1c349_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f297dfb69c64f82a416c17120802d81_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8a1c966228ae4eef899ad097142a3675_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0ee2ff30f3694c999d1bfea3cac16df0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i48483359c04e4e06bd637a90f9af6854_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f748abc48034713a36960dffd357755_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b8d7ede3b7d42c98a7b4985db5ee059_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d2cb1ed67a045fab2a95fa6a800c0a0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic8d3727d3ea944fea7f664879d4c85b0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">nbix:LargestTwoCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i945a7d74da95458e8a3fe747ece465cd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7a0c5ec3d79147229881155f9e94893d_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ProFormaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43c71899173f405dbe3d33122d8cc5f3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:HeptaresTherapeuticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79c18d17c4d449729c00a0ccd9f18346_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:HeptaresTherapeuticsLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia23be7e269184e22820e45d5995df04f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia5e99701bd3641d5a09bb0c7b27a6b9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:TakedaPharmaceuticalCompanyLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a59621400074ae78191449ef71bd45d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:IdorsiaPharmaceuticalsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i456ae801af6b4bcc85cf441dbbfd2d07_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:IdorsiaPharmaceuticalsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib237ea6839b14af68a00881661bda1d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10dced8bd21b43fc85950bc06dc71600_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic6d6f5ca848240c5ac2c7ad24cd32191_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i43094c3fedcd4655bb4323ec7e023ff3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i24b0e316d5b94182bbf5816c348e19d7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:XenonPharmaceuticalsIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2d30d0be95cb415b8e4d465eff571719_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9e86bc6f5114de09a4f88e130139396_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if4c4fe5c60424af0bcadedd757afff96_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e054e20087341ada5c247008d55c3b7_D20190101-20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-03-31</endDate>
        </period>
    </context>
    <context id="i7f5841fc889c4d08846ef46e8a70311f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:VoyagerTherapeuticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i86636d6fafc9428a9d7466bfe935ab09_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if3045b62535f464b86c604c3234e0d9c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibad5cee165ce4cf8891c0de774e460a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:BIALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebafbee9477a4c18a360adb95c24c539_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i13f8068eb08a4699b20184347a6e696a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76d0ccd9a2e24853bab0ecd66739a001_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:MitsubishiTanabePharmaCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i451e907724df41c5908356a4f2323922_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3ef358c546644634864929f3c2061c03_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f9ae86c7e9144a1bae39b561ed9746c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i454f573ac4474e279abf38d39ec2838c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3fddadf6fcb24a699f2fa1cbf8dd90f5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0db30671c08348dab7eba8e85cf822e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i16b9930a1b5945c1bdf18b24ad954df4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">nbix:AbbvieIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f71aac91af1491f9facb5b304bc26ab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6fbe0b4e8d8444179db90d05853c145d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91d81c1abc6d4b73ad93fc98b7974149_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ShortTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8ff02291a68451db9fb0056413edd22_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia9e005455b14444cac5e10f4c73e0446_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">nbix:LongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib0735a600c0d40f49b4766b4bceeb49c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic01bd7b047c1401a899b33800d0940b5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i24cc646be8f346209fda92f0f7069e29_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie25af8b80ac74893a5e4045458ebe3d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i76a49edc4ee149f98fe61f36a1419ed3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if35fcf69010c43dba3cbbf868e2b0935_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccfdb59917c64d368e0d64701f53126a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i04d318b9ca2d49ba84b1a9cb4b48b0ec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib1fc4ae0f5aa4acab5c143236c0015b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8aba8816099b49f2b953b15fdf4c39b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadfb23126df048dbb4bac68dde154ace_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c1c4f4456c9492990b2e5c6e5a0abd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">nbix:CashAndMoneyMarketFundMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc5ff81f5ac24f46bf859c4b7eee092a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6ff788d8c75a4d8b9999c533dabd5da6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9d4d41477f874a44b2eba85537a90148_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaeb2651610fa4d00b5e2ac296d947a60_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8dceb0bae28a43219d613b3ec3a546bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0b4b9585d44440bfaf6270349255857e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10fea06938594614aa8b26da5cf66581_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic56519559b60412eb627bc0dd14040fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0f374dbf03747a2a83ac15d4ac0a895_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0ada51f1409498abba0c3063df43360_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i876dd799b2e4471c969a5ee5b51f6040_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0efb41a1a6274a0fa1294d81a1e66e3e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa7306db60774a77859d10b85a4592ba_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i43241c1d857141b3a9d4aa8134c3faa9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib50a2b7c2c194c41a768ce0f89919060_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18d11505b7354bdb8dd782858dcfdce3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadb175bdb8bf48208387a96572f64706_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if70c342cd44742ebb040c59491a90fca_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifb7c841968874564a68757c7554e2071_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic77011f1e4f6476984258b7755256168_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0def021d29df4ec18dc8a7252ae17d0a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10f1318702cc48bd9a8576b930cc668f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84e3b1a6faf84f6db9b5b5a39c51c46c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7057cb4559b6490ab7be7846300e2a22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a4cc70d0fde4bd498a8a0983c081d59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9f1618b76d04cb19552c0380c3a41a8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i43e9f130272d4e318928d9dafd608b88_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cf0666db5964cb0b1c6c44c2bb1140a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifbeb38fcafcd44cf92ecbae65ec65d39_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5d7321b1fe734028a54ac2f80b9681ed_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35e8c83d4e9e4b538a866c7908923299_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0302646986a64378a658c9ee1c53404a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7c29b15534a34aa1bd91898138b443d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2f3cf54d0e5248aeb00d32bbd4fe0441_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia476ce9b48f74567b16e1107fc4d5f58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i342378a3e6bf401686eecb77ea0a41b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib96e57d5b9fc4cb2a73243bdd55f6767_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf7b779b22d24eb6b77769f385e8229f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4bd4b276a5774cf7bb670de6b43ee0b4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i47234201a06341db8895b8958db19f97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6692ce12fc644c68b73fb3a2340f8955_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i55302882586a46d2ad57cdca3f162199_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d5b407bace949d5a87fb8d9069a7e54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17791cc67ea8442dae07024c287c5a9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f43889d0d9d4bfab3fb6c31e2cfe848_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia17bbaa87ba6441bae1e26b9009ae2e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02ed2ad514134c8abd326f4aa918a949_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ide17712ce808468da6c2d67ca2751e47_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadbe113298b847b29bf4f91e55934f46_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3bb2904499f043418ddda2535a27e40f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i011bbd35393d4e94b37558ebd5a2d436_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie56afca00a6145f1a8cb8913d7007d6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CollateralAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-02</startDate>
            <endDate>2017-05-02</endDate>
        </period>
    </context>
    <context id="i80a878a1eb5a45cca632daa2d96abd21_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i88996bf4af1e44edb618cc379576a171_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-02</startDate>
            <endDate>2017-05-02</endDate>
        </period>
    </context>
    <context id="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-02</startDate>
            <endDate>2017-05-02</endDate>
        </period>
    </context>
    <context id="ib1c20b9ca378493e9004243174a5bb6c_I20170502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="nbix:DebtInstrumentConversionAxis">nbix:ConversionPeriodTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-02</instant>
        </period>
    </context>
    <context id="i4255ef0f065341c38adf6ce89cc06fa5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d16c122f0c14c3992a051928c9d5bfd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4babbf9b0ae54bd68b403bf9135804ce_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1cd1bce8a314e4b8d4f01b7b48efb31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i514d273d4829444bb2f094cc035cbd85_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nbix:ScientificEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8949e231305a4303b6a93baa2c50ef7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">nbix:ScientificEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i018745fbe176486d9a40f767eb4cddfb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89da8fd5abc84ebc90ff0e08c8e74ae0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idc1e7a31965e41d398a354180cf8e854_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id096d2e9e4db408388a0546974b8a714_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5697c0bc55240d2a8a8a2235b016776_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i36e1a597b4cd4605869672a9be81b61a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6121635642d44cadaead83be87d2fe62_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d2ef4094777484ab20a42ddbdcf479d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5766d218ac54177beed97641411133f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia4461a18f4b94ca1b02b8be10c79cda1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d90a3769ad6449da089e4e3f18d3d7a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icfdf32908a434e5d91386e010cdf2b9b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i861174ad0c8446e0ab825a068912a989_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">nbix:A225ConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27b3593b7e0f4137b9d9cb95a340d296_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie926624338174ce3a9a95588da6b7482_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">nbix:StockOptionsRestrictedStockAndConvertibleSeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if55c2dd5020b439ab20a6854804adfb2_I20110531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:TwoThousandAndElevenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2011-05-31</instant>
        </period>
    </context>
    <context id="i131a19b02d4549ae975f25ad4ec218e0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:TwoThousandAndElevenPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66b8b371eafd4e9bb87813ab1ee9b7f3_I20180531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-31</instant>
        </period>
    </context>
    <context id="if9a1371b813245e8b49ad33c120478c5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7daa1d827ed84d04bc8d829d69e3b5a5_I20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:A2020EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="i21a8268dccfc48f59cd4814f44c54a4f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">nbix:A2020EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d2e9814a27b4d21828b870c0c7bba39_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6383419676f5414c97631fba30d073e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i563c70f91f7d45baadb5b41baf1f5dee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i086d3bf04898438689679b7c70886c50_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f20287d2f5d47629aa5cb895c7b9e67_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21700785bb0c4daa8be1c905aeeb15f6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if784e79b6b9e442a9b259642b8723999_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibc56f68087124b8b8cfe42e19151218a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1e84a209c2b443968257a0960b35e6f0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2ca72bf2007745ac9be527c3a44edef0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if9dd80ab56044cb5b1502c3c0b0084c6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib439fe7fca70420e85d14235298d0807_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c44c1a195de478c824a69cb855d11ea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0bc4f833719d407fb605d6e3f05afc23_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i360e7030403c47f48b0818bcce72318e_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i8d20c96869ad45d18f300e0ed27f7ee7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i670a859ff8a84b0ba0c51a248450c900_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib60edb8359ba4965aa27229d88b89dff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9700de8000ff49f19b9b94d8714b9b95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">nbix:PerformanceBasedRestrictedStockUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i94ec3a34a5c1464a98687009bb85c0ee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib009e76fc516405f817eb74aed96c1cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia69ac08c927f48ea9cf1305bd5fc5f9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib860e40dbf6b4206ac8fb74ce9822840_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-08</startDate>
            <endDate>2022-02-08</endDate>
        </period>
    </context>
    <context id="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000914475</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-08</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="subsidiary">
        <measure>nbix:subsidiary</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>nbix:segment</measure>
    </unit>
    <unit id="security">
        <measure>nbix:security</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="renewaloption">
        <measure>nbix:renewalOption</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl8zLTEtMS0xLTI0NTg3_fcf41756-5594-4146-8e59-8e66e3b4ee86">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl80LTEtMS0xLTI0NTg3_7c7b7da4-a5db-48a5-a475-675dbe366472">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl81LTEtMS0xLTI0NTg3_1a7bb336-11fa-4d7f-87d7-3ff629678fe5">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl80L2ZyYWc6ZDYwMTBiYmRmZWFiNDg4NzlhODliNjUyODFlZTdmMDAvdGFibGU6Zjk4ZjcxMjJmZjNmNGYzNzhjMjQxYWE2MDEyN2U1MWIvdGFibGVyYW5nZTpmOThmNzEyMmZmM2Y0ZjM3OGMyNDFhYTYwMTI3ZTUxYl82LTEtMS0xLTI0NTg3_ba39c8e7-8bdb-4c30-9bff-59b2ec767722">0000914475</dei:EntityCentralIndexKey>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i6f25e6030cba44eeaeb535268d2aec62_D20180101-20181231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMC0xLTEtMjk1OTY_5ea9ac00-e603-441e-9579-bb39249f3899">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate202006Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDIvZnJhZzo2ZjhiNGM1YzA1OGY0ZDAxOTE0MDdhMWViNmM5MmQ1Mi90ZXh0cmVnaW9uOjZmOGI0YzVjMDU4ZjRkMDE5MTQwN2ExZWI2YzkyZDUyXzQ3_90039d47-18bb-4eca-aafa-a3cc047cdbac"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDIvZnJhZzo2ZjhiNGM1YzA1OGY0ZDAxOTE0MDdhMWViNmM5MmQ1Mi90ZXh0cmVnaW9uOjZmOGI0YzVjMDU4ZjRkMDE5MTQwN2ExZWI2YzkyZDUyXzQ3_cf39e409-b35d-4e9a-a30d-6d99d9f6d438"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTcvZnJhZzphZTg3YzAzMWVmZDA0NmUyOTkzYTlhYWRjMzdhYWIzYi90YWJsZTphYzdmY2Y2ODc2NWE0ZGNjOWVjMDg2NzZhYzA2MDYzOS90YWJsZXJhbmdlOmFjN2ZjZjY4NzY1YTRkY2M5ZWMwODY3NmFjMDYwNjM5XzItMS0xLTEtMjQ1ODc_e1a0ec94-c327-499f-9f0a-07625453b571"
      unitRef="number">0.00131711</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODc5_2f705c83-17a2-4b52-a632-b67c9ccf6649">P13Y7M6D</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcz_6e79ae72-890f-421c-8dad-7d7731f5387f">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6YmM4NjY3MmEwOWEwNGM5MjliMzI5MmNhZTdhMzE1MTEvdGFibGVyYW5nZTpiYzg2NjcyYTA5YTA0YzkyOWIzMjkyY2FlN2EzMTUxMV8wLTAtMS0xLTI0NTg3_f48233f2-b764-4ea1-80e5-ef74a0136ae3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY4_ba0142b6-c67f-4212-b6bd-fb37cf9be636">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY4_8837d1b6-0895-4464-bf1f-1a60f084c666">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6Y2EwOGI2NmVjNTQ2NGQ1Mjg4MDU3MzE0OTc3YWQ2NjEvdGFibGVyYW5nZTpjYTA4YjY2ZWM1NDY0ZDUyODgwNTczMTQ5NzdhZDY2MV8wLTAtMS0xLTI0NTg3_aceaa6de-175f-436c-8d7f-9b2f2c30cc03">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjYx_4b74c1e8-dac9-447f-9cc9-4de8fb55bc0e">0-22705</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY5_4283ab91-9600-495b-929a-1658cd2835d7">NEUROCRINE BIOSCIENCES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8wLTAtMS0xLTI0NTg3_85ece88c-0d3a-4e7f-9e92-510b601fd43d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8wLTQtMS0xLTI0NTg3_23047807-9f1e-44b8-b334-78b16c26f56c">33-0525145</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTAtMS0xLTI0NTg3_4b0aef7a-e7d3-4fd1-a648-14cf90672330">12780 El Camino Real,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTEtMS0xLTI0NTg3_bc928ad0-cd95-4b09-bf2e-5e887e13bf54">San&#160;Diego,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTItMS0xLTI0NTg3_43efce9a-f69e-4ef2-ae7e-aa9976f2d60a">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NmZjOTMyNDUyODJmNDg5YjkzMTVhOTA1MjlmOTZlZTIvdGFibGVyYW5nZTo2ZmM5MzI0NTI4MmY0ODliOTMxNWE5MDUyOWY5NmVlMl8zLTQtMS0xLTI0NTg3_687ff7ab-08d0-4da7-a367-3ec6124debeb">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY0_f7828515-77cf-435d-aa60-89850b7c115a">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcw_168a3f83-ece1-4a14-b8bb-783a90444657">617-7600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTAtMS0xLTI0NTg3_9704f5b6-8521-4bc7-b539-5ba9ece8902f">Common Stock, $0.001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTItMS0xLTI0NTg3_c6977152-44ad-4f86-87e8-4d89986d4930">NBIX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6ZGI0YzY3NTIwOTRmNGM0M2IwZTg4ZjU1ZmVhODRiNTkvdGFibGVyYW5nZTpkYjRjNjc1MjA5NGY0YzQzYjBlODhmNTVmZWE4NGI1OV8wLTQtMS0xLTI0NTg3_06b6b43f-a00f-473c-a968-c19f5b2377dc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjYy_47ef7c5f-0917-449a-8796-a13c1f80683c">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY1_d6d29554-c8fd-4d5e-a748-f9ba8a82d59a">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcx_f5a20e8c-8425-42f4-99c3-9d283a002bbc">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjcy_704b81fb-ee15-4a27-8351-5f145c901793">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTAtMS0xLTI0NTg3_604e96c1-4fcc-4f85-8538-f94ae915330c">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTEwLTEtMS0yNDU4Nw_3b714b55-0d72-45f5-b150-112f367a4a60">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGFibGU6NzZmMjg2MmRmMjM2NDg0Y2JjODdhNDY5ZWZjZmNhNGIvdGFibGVyYW5nZTo3NmYyODYyZGYyMzY0ODRjYmM4N2E0NjllZmNmY2E0Yl8wLTEzLTEtMS0yNDU4Nw_fa527ea9-5d6b-40c8-a6b5-72d0bcb81207">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY2_ef0ca1fe-f1fc-460c-9640-8564141e8ff0">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjY3_4df4a362-0603-4e2f-b422-16e0b590dcb0">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ic58f0d332b1740bcbfe3ae799b6c76f1_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8yODQ0_57d16aca-7a28-400f-80d6-7faa87b3c198"
      unitRef="usd">9105256378</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i524e39f5a339434b949a0ca71590d62a_I20220207"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8yODU4_aa85fc6d-2787-4936-a7f9-74a85a215c55"
      unitRef="shares">95242683</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xL2ZyYWc6NzczODAxNjEwYjg5NGNjZGJlOTNkYmZiNDA1ODQyMDEvdGV4dHJlZ2lvbjo3NzM4MDE2MTBiODk0Y2NkYmU5M2RiZmI0MDU4NDIwMV8zMjc0_0712e898-9ccf-4632-9f9d-6910df8e0f72">Portions of the registrant&#x2019;s definitive proxy statement relating to the registrant&#x2019;s annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days following the end of the registrant&#x2019;s fiscal year ended December 31, 2021 are incorporated by reference into Part III of this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMTgvZnJhZzo5NWQyOTQxN2I1MmU0YWFmYWMyYWEzMzRlZDM0YjFlOC90YWJsZTpmOWNiMjNlZDgwNzM0NTg5OTQyYzA1NjZmMzY1MTRmZS90YWJsZXJhbmdlOmY5Y2IyM2VkODA3MzQ1ODk5NDJjMDU2NmYzNjUxNGZlXzEtMC0xLTEtNDk4ODAvdGV4dHJlZ2lvbjplYzQwZGU2ODc4ZTk0YTJiYjE4NGVhNDkyYjhkMWZlOF8xMDk5NTExNjI4NTE0_869b256b-081f-479d-bc18-f0d08a1e7b9e">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjEvZnJhZzpiNWY2MThkMDQzYmY0NjZhOWRmNTAzYWNkMWQ2MWQ2ZC90ZXh0cmVnaW9uOmI1ZjYxOGQwNDNiZjQ2NmE5ZGY1MDNhY2QxZDYxZDZkXzM4NDgyOTA3MDExMzA_bb00d961-0421-463d-ba58-5a5910781ddd">Ernst&#160;&amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjEvZnJhZzpiNWY2MThkMDQzYmY0NjZhOWRmNTAzYWNkMWQ2MWQ2ZC90ZXh0cmVnaW9uOmI1ZjYxOGQwNDNiZjQ2NmE5ZGY1MDNhY2QxZDYxZDZkXzM4NDgyOTA3MDExNTA_e4520900-59b5-4d5a-ba86-4fc5e84ae3b2">San Diego, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzQtMS0xLTEtMjQ1ODc_f3dfbbaf-7c31-4d71-8cf6-b64999b95777"
      unitRef="usd">340800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzQtMy0xLTEtMjQ1ODc_f0e339fe-da5e-4f6c-ad07-06d1e141989a"
      unitRef="usd">187100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjo2ZTM3OTIyOTRhNDc0NDlhYmY2NWQxZTNjYjdhYTU5ZV81NQ_faf4b98f-3f16-4d1f-aff4-32a98cccf41e"
      unitRef="usd">370600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjo2ZTM3OTIyOTRhNDc0NDlhYmY2NWQxZTNjYjdhYTU5ZV82OA_119f84fe-2d21-449e-9d49-e66d9bba2ea3"
      unitRef="usd">612400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMS0xLTEtMjQ1ODc_f22f4ce1-f5f4-4ec7-922e-c13e8d452bb1"
      unitRef="usd">370500000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzUtMy0xLTEtMjQ1ODc_67360c6c-7955-4602-adb5-b15cbd967606"
      unitRef="usd">613900000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzYtMS0xLTEtMjQ1ODc_e12d6166-9fcd-432f-bdee-b486d062b8b2"
      unitRef="usd">185500000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzYtMy0xLTEtMjQ1ODc_3417264f-30d3-47f6-a86f-f861465961b0"
      unitRef="usd">157100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzctMS0xLTEtMjQ1ODc_87fbab69-3882-4953-a4bc-22da83d7faaf"
      unitRef="usd">30500000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzctMy0xLTEtMjQ1ODc_3780a988-6cd3-4671-8d4e-e83057ef11e5"
      unitRef="usd">28000000.0</us-gaap:InventoryNet>
    <us-gaap:OtherAssetsCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzgtMS0xLTEtMjQ1ODc_a9694c7a-f019-4b53-837f-2dd8ad4acd1d"
      unitRef="usd">45500000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzgtMy0xLTEtMjQ1ODc_4e8a9c34-5486-45ab-a4a1-26940fbc25c7"
      unitRef="usd">30100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzktMS0xLTEtMjQ1ODc_cffd50b6-51f2-4dd8-806b-4375ee1bc3ab"
      unitRef="usd">972800000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzktMy0xLTEtMjQ1ODc_3d42ecec-c4e0-49cf-8c34-3ecb6c13ac50"
      unitRef="usd">1016200000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTEtMS0xLTI5ODY3_d946a499-2a0a-4f97-a94e-abcd8e4c803d"
      unitRef="usd">315100000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTMtMS0xLTI5ODY3_9d07ccf1-03f0-4a7c-a5c7-c36b5cac64a8"
      unitRef="usd">319400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTAtMS0xLTI0NTg3L3RleHRyZWdpb246ZTZmMGU4ODczYWNjNGNlNmFiYzk2MTFkMGM4ZTRjZjZfNTU_ceed7519-013e-461a-a29f-f4c9f81e0742"
      unitRef="usd">563200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTAtMS0xLTI0NTg3L3RleHRyZWdpb246ZTZmMGU4ODczYWNjNGNlNmFiYzk2MTFkMGM4ZTRjZjZfNjg_3b82adf3-0455-4437-91fa-ad3d3d0dbfcb"
      unitRef="usd">226700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTEtMS0xLTI0NTg3_443ebc73-15c6-413c-8ba9-f742d9db2d69"
      unitRef="usd">560700000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEwLTMtMS0xLTI0NTg3_8de8cb2f-7248-46b3-9c1c-03da00c1935b"
      unitRef="usd">227100000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzExLTEtMS0xLTI0NTg3_357a2e9c-c54a-42d1-bd73-5c019b757850"
      unitRef="usd">97200000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzExLTMtMS0xLTI0NTg3_277d7815-eb33-4734-8347-905b42c8a9e0"
      unitRef="usd">82800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEyLTEtMS0xLTI0NTg3_1998ade6-66c7-4dfb-a3ae-f991fbe98c61"
      unitRef="usd">63700000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEyLTMtMS0xLTI0NTg3_41956496-2f97-40bc-84a2-274101e85deb"
      unitRef="usd">38200000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEzLTEtMS0xLTI0NTg3_1a5a9fb5-b7e5-41c0-876a-4a05e297f90f"
      unitRef="usd">58600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzEzLTMtMS0xLTI0NTg3_e35f9779-724c-4da9-a7c9-72614aa91ebd"
      unitRef="usd">44600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE2LTEtMS0xLTI0NTg3_ae3e8dc3-40e1-43bd-ae8d-8d43fd8b2fbf"
      unitRef="usd">4400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE2LTMtMS0xLTI0NTg3_9d8b8400-b3c3-4afd-9e78-a828b01e8901"
      unitRef="usd">6400000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE3LTEtMS0xLTI0NTg3_88879b85-f95d-4337-87e6-b17d339e6a06"
      unitRef="usd">2072500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzE3LTMtMS0xLTI0NTg3_6a014be4-64e4-4f4c-865a-349bbe8a80e0"
      unitRef="usd">1734700000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIxLTEtMS0xLTI0NTg3_e6aab7c8-9d40-45aa-ba95-29f04f7bab83"
      unitRef="usd">225800000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIxLTMtMS0xLTI0NTg3_e3baa3d4-5c47-4364-8e2c-f116ea29ac49"
      unitRef="usd">168700000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIzLTEtMS0xLTI0NTg3_5cf8b5a9-3b52-4605-938c-d3d3881b8666"
      unitRef="usd">20000000.0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzIzLTMtMS0xLTI0NTg3_e4d57e3c-8d51-4086-b5e3-77aaa165f712"
      unitRef="usd">17800000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI0LTEtMS0xLTI0NTg3_6f4dfa15-0a76-477f-8c73-b7c54661db62"
      unitRef="usd">245800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI0LTMtMS0xLTI0NTg3_49a62fbc-bedc-4999-bdc3-f9aa223a11c4"
      unitRef="usd">186500000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI1LTEtMS0xLTI0NTg3_8c8b6f1f-f7ec-470b-8906-09b2cde0bad7"
      unitRef="usd">335100000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI1LTMtMS0xLTI0NTg3_50a9ac35-a2a5-4c0e-b27c-d95180f195bd"
      unitRef="usd">317900000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI2LTEtMS0xLTI0NTg3_cf994635-bf9c-43a7-97cb-226d898f8213"
      unitRef="usd">105300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI2LTMtMS0xLTI0NTg3_142b46b0-de8e-4cd0-9283-b662fb6e4ab4"
      unitRef="usd">94400000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI3LTEtMS0xLTI0NTg3_05046822-fd9e-42f4-a8e5-820828f8bb0c"
      unitRef="usd">12300000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI3LTMtMS0xLTI0NTg3_995e2e74-6239-4c0b-ae00-54fa81e192cf"
      unitRef="usd">9700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI4LTEtMS0xLTI0NTg3_3307d2f8-35a9-4374-b650-20de58ecfdab"
      unitRef="usd">698500000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzI4LTMtMS0xLTI0NTg3_78d2d9b4-e58a-44f5-9164-94b4e023836c"
      unitRef="usd">608500000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMjI_1e77621e-51b3-4084-9dce-e2feff2473f4"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMjI_ee35ee6f-144e-4e0c-8fc3-8270f9299695"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMzY_6587f058-e16f-4227-a8a6-2547c3e8b4cf"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfMzY_74e9a6fb-d15a-4a0c-aa2a-1d6db7900bd3"
      unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_37a3c994-d378-4412-ab29-984dd1fca032"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_663f95c2-acfd-4ba1-80af-c84521d0bbbf"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_a37e5174-c8f8-4a9a-bc91-1f3101d83199"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTAtMS0xLTI0NTg3L3RleHRyZWdpb246YWU1MGQzZTg4OTgwNDI5M2E1MjE4OWExYjk4MDk1OWNfNTg_a7702628-22a7-4526-86a9-47ff3a187408"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTEtMS0xLTI0NTg3_c10bded1-cff2-41e1-b5d3-93ec530643af"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMxLTMtMS0xLTI0NTg3_558e3bc1-121b-4c0d-80da-711588fed0fb"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMTk_19548e99-3e54-4b4b-a55a-c7b218e080b6"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMTk_1fee38cf-1c4d-4705-ad62-12b187006aac"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMzM_14973553-4e26-460d-b64c-03b841b41929"
      unitRef="shares">220000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfMzM_a4038097-8a89-4658-9658-438e7f85ead3"
      unitRef="shares">220000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTA_dcb47ef6-3956-4567-9226-6def6ceda60a"
      unitRef="shares">94900000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTA_f253a4ef-75eb-409e-81fb-e3398b3bddf7"
      unitRef="shares">94900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTc_301c7b47-f135-470e-a4d9-2eaa389841dc"
      unitRef="shares">93500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTAtMS0xLTI0NTg3L3RleHRyZWdpb246OTQ5NzU4NzQ3NWU0NGMyYTg3MWQ0MzM4ZGVlZDIwZTBfOTc_bf0a7149-212b-4419-b955-dfeab2768655"
      unitRef="shares">93500000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTEtMS0xLTI0NTg3_e1fd48e5-099f-42b7-9a1c-27d72a7931b7"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMyLTMtMS0xLTI0NTg3_300dadf8-91ae-4643-a59a-65fae93f134b"
      unitRef="usd">100000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMzLTEtMS0xLTI0NTg3_855c5e52-ba8f-45f0-b991-3c8647612bff"
      unitRef="usd">2011400000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzMzLTMtMS0xLTI0NTg3_b936cf3d-0da5-4ea7-828b-e7b878a1ce97"
      unitRef="usd">1849700000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM0LTEtMS0xLTI0NTg3_8b612672-e930-45ad-9b84-c25c4a2b4726"
      unitRef="usd">-1700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM0LTMtMS0xLTI0NTg3_a3da2d1f-9370-4023-85f4-cd1b7fdd2599"
      unitRef="usd">1800000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM1LTEtMS0xLTI0NTg3_73cdbfbc-0c8a-4af2-a26b-68a3ffa1dfaa"
      unitRef="usd">-635800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM1LTMtMS0xLTI0NTg3_46ced0c5-ac4b-4978-a3f9-b033b7d652df"
      unitRef="usd">-725400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM2LTEtMS0xLTI0NTg3_efdbc9bf-3ea9-4013-9ab3-5a7f91505abc"
      unitRef="usd">1374000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM2LTMtMS0xLTI0NTg3_596e3974-338b-4f75-b4ce-827cc123e830"
      unitRef="usd">1126200000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM3LTEtMS0xLTI0NTg3_0e385d8b-87ab-4436-9110-9d8402bc8e24"
      unitRef="usd">2072500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjQvZnJhZzo0NGRiOWEzNzUxNTE0ZjJmYTM4YzViNGRiMzNkZjdkNS90YWJsZTo5YTU1ODkzMzQyMWQ0OTNlYjBiMjBmNWIwMDUxOGRmYS90YWJsZXJhbmdlOjlhNTU4OTMzNDIxZDQ5M2ViMGIyMGY1YjAwNTE4ZGZhXzM3LTMtMS0xLTI0NTg3_a8bbc1f2-7311-4601-8a17-0792465a41e3"
      unitRef="usd">1734700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a39bd69114b41f3a7575046b42fd208_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtMS0xLTEtMjQ1ODc_18c04a74-4cb7-4968-a69e-f74444527924"
      unitRef="usd">1090100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i670cc6e75e624e85a72e5224f486c622_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtMy0xLTEtMjQ1ODc_6295e660-3198-4c8a-a75a-047131786099"
      unitRef="usd">994100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88608bd64b9d491d965911eb2f10d0ba_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzMtNS0xLTEtMjQ1ODc_a7598c33-4fa3-4b03-84b3-d07943966ebd"
      unitRef="usd">752900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f4ab3853b3242c7858dcf9b3a67bb47_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtMS0xLTEtMjQ1ODc_a47822d9-c154-4010-99b4-cdf0c44046ec"
      unitRef="usd">43400000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i798a316339674cf592518cb98cd4340d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtMy0xLTEtMjQ1ODc_3053f708-eaed-46bb-8bee-f8c04ea77e78"
      unitRef="usd">51800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57e3f974b4374e128e00062b09a226b8_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzQtNS0xLTEtMjQ1ODc_33cd8d28-dfe1-41c3-9b1d-967ea00fbace"
      unitRef="usd">35200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtMS0xLTEtMjQ1ODc_19555290-9856-4be4-8e76-e6a9573786d7"
      unitRef="usd">1133500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtMy0xLTEtMjQ1ODc_f28043f1-69a6-48df-959b-5f0cad6eb65f"
      unitRef="usd">1045900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzUtNS0xLTEtMjQ1ODc_297ae999-d394-4924-a5a5-fb3af2781680"
      unitRef="usd">788100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <nbix:CostOfSales
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctMS0xLTEtMjQ1ODc_b46b2614-3858-41a5-b558-241884d80a77"
      unitRef="usd">14300000</nbix:CostOfSales>
    <nbix:CostOfSales
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctMy0xLTEtMjQ1ODc_9b8a2ae5-9ed2-455d-ac8d-c1e7a1dfc810"
      unitRef="usd">10100000</nbix:CostOfSales>
    <nbix:CostOfSales
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzctNS0xLTEtMjQ1ODc_93bceb4e-e5e7-4ebb-8e88-33d5bb2e6b60"
      unitRef="usd">7400000</nbix:CostOfSales>
    <nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtMS0xLTEtMjQ1ODc_e102d360-da7f-4dd6-a21c-05610ec7fcad"
      unitRef="usd">328100000</nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtMy0xLTEtMjQ1ODc_2b8cf6d1-d586-4219-99a9-c39920472f3b"
      unitRef="usd">275000000.0</nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzgtNS0xLTEtMjQ1ODc_da7ccb26-4853-4492-8a57-c122fe45b1e6"
      unitRef="usd">200000000.0</nbix:ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktMS0xLTEtMjQ1ODc_e341f22b-8b26-46a1-be1b-7cf0ceb65f9f"
      unitRef="usd">105300000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktMy0xLTEtMjQ1ODc_a131dbbc-2b8e-4360-b3bb-c536d588f518"
      unitRef="usd">164500000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzktNS0xLTEtMjQ1ODc_9ed4e7de-01f0-4b46-8e73-bc86c0169b9e"
      unitRef="usd">154300000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTEtMS0xLTI0NTg3_686a8c52-e3c3-48ad-b6fd-599ca5b0ca66"
      unitRef="usd">583300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTMtMS0xLTI0NTg3_c04399c9-340c-4fa1-9f37-4164ab4e925b"
      unitRef="usd">433300000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEwLTUtMS0xLTI0NTg3_fd0105bd-1d7e-4d60-b8e8-6aaa688f7a44"
      unitRef="usd">354100000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTEtMS0xLTI0NTg3_39671fad-98bc-43b3-be12-89af4ccde43b"
      unitRef="usd">1031000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTMtMS0xLTI0NTg3_bc526b00-a251-4b8c-b51e-685fe1ca90ec"
      unitRef="usd">882900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzExLTUtMS0xLTI0NTg3_bd9407a5-d523-4c32-a496-99ff365799a8"
      unitRef="usd">715800000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTEtMS0xLTI0NTg3_d11de969-05bf-4e75-baf6-6300813dc31c"
      unitRef="usd">102500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTMtMS0xLTI0NTg3_570bdeaf-7390-4f15-a462-f847a3129325"
      unitRef="usd">163000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzEyLTUtMS0xLTI0NTg3_e7fb7352-167c-421f-a2a7-679b579b2074"
      unitRef="usd">72300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTEtMS0xLTI0NTg3_227bcf03-8053-4e8d-be99-906b41a83188"
      unitRef="usd">25800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTMtMS0xLTI0NTg3_d06ff8b4-9441-4755-9cc2-0e96e74d71cd"
      unitRef="usd">32800000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE0LTUtMS0xLTI0NTg3_4d2939bb-7536-4dcd-b6ce-7e52e7ac2b25"
      unitRef="usd">32000000.0</us-gaap:InterestExpense>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTEtMS0xLTI0NTg3_86a4b6d4-5342-4fb9-8b3d-6dc813cbf4fc"
      unitRef="usd">20900000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTMtMS0xLTI0NTg3_fc0eb855-f743-4cb5-86bb-939ac3a2f68a"
      unitRef="usd">-17700000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE1LTUtMS0xLTI0NTg3_bfdea611-21bc-4d4c-93e5-c3c08e0b4d5f"
      unitRef="usd">-13000000.0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTEtMS0xLTI0NTg3_0533937a-ea44-4ccc-81f6-d318459ace00"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTMtMS0xLTI0NTg3_7db8f832-acc9-4558-bda0-9dc99b930a69"
      unitRef="usd">-18400000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE2LTUtMS0xLTI0NTg3_9631fc78-28d5-45b8-85df-5b051730acd8"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <nbix:InvestmentIncomeAndOtherNet
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTEtMS0xLTI0NTg3_d0370d93-15f6-4f36-a6b0-88b99063f631"
      unitRef="usd">3800000</nbix:InvestmentIncomeAndOtherNet>
    <nbix:InvestmentIncomeAndOtherNet
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTMtMS0xLTI0NTg3_81c7dd3f-125d-41ce-b209-4b7fa6094dfa"
      unitRef="usd">12600000</nbix:InvestmentIncomeAndOtherNet>
    <nbix:InvestmentIncomeAndOtherNet
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE3LTUtMS0xLTI0NTg3_d3e4f2a8-07d1-40f9-a0d4-d950154a8a1f"
      unitRef="usd">19200000</nbix:InvestmentIncomeAndOtherNet>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTEtMS0xLTI0NTg3_010a7e0e-94d3-4e9e-8267-e458076a99c6"
      unitRef="usd">-1100000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTMtMS0xLTI0NTg3_4afa24a2-f871-4ee0-a736-5349a1c4caa4"
      unitRef="usd">-56300000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE4LTUtMS0xLTI0NTg3_8ee542ca-1760-449b-a007-3de12e18d167"
      unitRef="usd">-25800000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTEtMS0xLTI0NTg3_9d5242f6-ccca-4616-af8e-749533ac1c28"
      unitRef="usd">101400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTMtMS0xLTI0NTg3_859b172c-43c5-418a-ac28-adcda70d48ce"
      unitRef="usd">106700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzE5LTUtMS0xLTI0NTg3_48611f97-c52e-48c2-b8ae-67ec864e623e"
      unitRef="usd">46500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTEtMS0xLTI0NTg3_acd24d25-76a7-4c0e-8688-a46f3da66c9b"
      unitRef="usd">11800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTMtMS0xLTI0NTg3_23c53463-ee7b-4d01-8392-2b22a4c460c5"
      unitRef="usd">-300600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIwLTUtMS0xLTI0NTg3_05c9972c-508a-47ce-9aba-14f44529c29b"
      unitRef="usd">9500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTEtMS0xLTI0NTg3_862a06a8-4997-401c-95f3-ca3b75fbc30b"
      unitRef="usd">89600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTMtMS0xLTI0NTg3_82c70a43-cf11-4a51-b665-1d025b591028"
      unitRef="usd">407300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIxLTUtMS0xLTI0NTg3_d9bc9324-3c3d-49b5-bef3-68fbca79b36f"
      unitRef="usd">37000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTEtMS0xLTI0NTg3_615c1446-8552-4154-9140-06938688ae50"
      unitRef="usd">-3500000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTMtMS0xLTI0NTg3_5756b379-68a3-49c1-a058-a2325b839e51"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIyLTUtMS0xLTI0NTg3_99f58f3b-eba2-4137-b197-1abc287be816"
      unitRef="usd">3400000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTEtMS0xLTI0NTg3_bda6617f-9d30-461f-8d83-b1b3b2049e8d"
      unitRef="usd">86100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTMtMS0xLTI0NTg3_442c35f6-5495-4b76-b426-6e58bd867d8c"
      unitRef="usd">407700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzIzLTUtMS0xLTI0NTg3_7f990035-e50d-474e-9ab8-73707aaa0f61"
      unitRef="usd">40400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTEtMS0xLTI0NTg3_bcb4c70a-d336-4700-b313-64f214ee7903"
      unitRef="usdPerShare">0.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTMtMS0xLTI0NTg3_aa723d57-159d-4c16-bed6-1216d474ddca"
      unitRef="usdPerShare">4.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI0LTUtMS0xLTI0NTg3_b8601815-977c-43c4-81a1-f30182f7b4d9"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTEtMS0xLTI0NTg3_204827d5-a524-4d49-b3c6-4f0f9d2fa867"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTMtMS0xLTI0NTg3_8f81895b-35b7-4772-a005-3ce531c080ae"
      unitRef="usdPerShare">4.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI1LTUtMS0xLTI0NTg3_292c7c1b-7c38-4c61-80bb-734e2811c12b"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTEtMS0xLTI0NTg3_4d0dd282-f4b6-4cc6-99ce-4b96245b3b1d"
      unitRef="shares">94600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTMtMS0xLTI0NTg3_82bde8d4-4bb7-403f-9f24-52b11fe669ae"
      unitRef="shares">93100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI2LTUtMS0xLTI0NTg3_a5f133ad-1796-4daf-91ab-ac6c13e78050"
      unitRef="shares">91600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTEtMS0xLTI0NTg3_7bd7717a-7f22-4cf6-ada0-97fbf4984c60"
      unitRef="shares">97900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTMtMS0xLTI0NTg3_96752df4-831e-4f51-9151-05385bb6c1b2"
      unitRef="shares">97800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMjcvZnJhZzo2NGMzNGRkMGMyZjM0M2QxYTUyNzI3ODlkNzM0YmE1MC90YWJsZTo2ZmQ0OTFhNWUzY2M0MWQwOWJkMzAyZTcyYjdjYWQwOS90YWJsZXJhbmdlOjZmZDQ5MWE1ZTNjYzQxZDA5YmQzMDJlNzJiN2NhZDA5XzI3LTUtMS0xLTI0NTg3_17fdc62c-5f56-4064-8263-ef02d61dceb5"
      unitRef="shares">95700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i37c451fdb8934177af07aab2f9815261_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMS0xLTEtMjQ1ODc_28953c28-0159-401f-b160-28db70ab6752"
      unitRef="shares">90800000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i37c451fdb8934177af07aab2f9815261_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMy0xLTEtMjQ1ODc_e8c78128-d265-426e-971b-c2757f88654e"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i850a1c2e6bbe421b9e53c336f81ae194_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItNS0xLTEtMjQ1ODc_7e997c8c-c6ab-40b6-82dc-5c54f74fba99"
      unitRef="usd">1660400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if8328f9cd2d94115acc9db87f97b7e95_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItNy0xLTEtMjQ1ODc_4b5b6d26-d2fc-4839-b33f-b3e642d0db1c"
      unitRef="usd">-2000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib8c5963bd49a44d8ab23a5f66be2f6e7_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItOS0xLTEtMjQ1ODc_bdf8bf34-379d-4d10-a3d3-5e0c53b132d1"
      unitRef="usd">-1177700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzItMTEtMS0xLTI0NTg3_b7b57e18-306c-4871-b233-c60e0ed6a170"
      unitRef="usd">480800000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="id623863c89314565b0c613c6e4844cd9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzMtOS0xLTEtMjQ1ODc_5057e45b-8cc4-4761-a198-7e6f4f8c1604"
      unitRef="usd">37000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzMtMTEtMS0xLTI0NTg3_1f10d57a-2d67-4c70-b4ae-f41dcd3f7bf9"
      unitRef="usd">37000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i2b1e1efe40c742aa916cca25579067f4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzQtNy0xLTEtMjQ1ODc_cca85ee9-cb98-44df-9dad-438a3265292a"
      unitRef="usd">3400000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzQtMTEtMS0xLTI0NTg3_b89521d9-7d01-4346-bdd2-7e01c05a7dfb"
      unitRef="usd">3400000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzUtNS0xLTEtMjQ1ODc_a65959f8-d5f0-43f8-976b-b27b4cbe5d17"
      unitRef="usd">75300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzUtMTEtMS0xLTI0NTg3_43e5b4dc-5145-4038-b205-79b24e99e472"
      unitRef="usd">75300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquity
      contextRef="ieebdcec5b54b4ac6bdd2c1d5c2eba719_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtOS0xLTEtMjk2MDk_41554713-e6af-422a-8e40-8546effa6147"
      unitRef="usd">8000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i15f9746d0c4c45cbbdbb3cee1e0be1d3_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMTEtMS0xLTI5NjE1_7cac3641-a296-46ff-84ee-76c978c024f9"
      unitRef="usd">8000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i9be0134c1cf94658b1ea4f2a9d3aabd0_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMS0xLTEtMjQ1ODc_bb8899f5-95cf-44a8-bc32-9fc473f180d4"
      unitRef="shares">1500000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2c600dc3982c4e169a8f21ee341cc156_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtNS0xLTEtMjQ1ODc_4671fc34-da3d-40b4-b320-a84992a33dbc"
      unitRef="usd">32400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzYtMTEtMS0xLTI0NTg3_d786fb72-a1ff-4cf2-8d96-30ed72ba455c"
      unitRef="usd">32400000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i5e5a9db50e334fceb17223af88813a25_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMS0xLTEtMjQ1ODc_5db91718-56b3-4c27-9a0b-7bdf4e6448c4"
      unitRef="shares">92300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i5e5a9db50e334fceb17223af88813a25_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMy0xLTEtMjQ1ODc_59bf0cfa-9b48-451b-b162-7a70f59f4b06"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i57f40d95bd5147f493ce76a1d0d54aa9_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtNS0xLTEtMjQ1ODc_7fef4c44-4578-4fcb-a209-e9f9b1bb7610"
      unitRef="usd">1768100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia5d3840166f542059e79068112c8351f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtNy0xLTEtMjQ1ODc_071d8dee-474c-4587-90cf-5f6024d5207d"
      unitRef="usd">1400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iee36651c7ea24ee1aa1a126bc3592f0f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtOS0xLTEtMjQ1ODc_0bcf6220-6fb3-497d-a478-88bb22dd62c7"
      unitRef="usd">-1132700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzgtMTEtMS0xLTI0NTg3_b86fce5f-3e55-4e85-bf85-64b3a2c7f6ea"
      unitRef="usd">636900000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="if2f0e73949934202a967b64bd1dbcc51_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzktOS0xLTEtMjQ1ODc_858abf42-99f8-4390-a70e-6d7e170fef4a"
      unitRef="usd">407300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzktMTEtMS0xLTI0NTg3_c752109a-61df-46a6-afcf-ee997e900fc1"
      unitRef="usd">407300000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i8e86243316844136bf4f9112f308abd5_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEwLTctMS0xLTI0NTg3_aa7a12e2-fccf-4869-ba98-5cea132c4167"
      unitRef="usd">400000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEwLTExLTEtMS0yNDU4Nw_e4963091-58d0-48f6-9087-cc7829cb3a95"
      unitRef="usd">400000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzExLTUtMS0xLTI0NTg3_8653031b-2f05-450b-98e7-bb7aec51b918"
      unitRef="usd">100000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzExLTExLTEtMS0yNDU4Nw_d8bbab90-1138-4d4c-894d-c651cdf152f7"
      unitRef="usd">100000000.0</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTUtMS0xLTI5Njgz_ed9d620f-fc27-4451-a93e-8f6e24ae20e3"
      unitRef="usd">47500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTExLTEtMS0yOTY4OQ_ce4e63ec-9893-4404-9d4b-6be5ff89e7ef"
      unitRef="usd">47500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i5e59d7192ea042ceb2f48ae50260ec53_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTEtMS0xLTI0NTg3_cf7d8ba0-cbeb-4b2b-96d0-fa0454cbeb2c"
      unitRef="shares">1200000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4b9718ae8cd548828ff2a6f5cb8b582d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTUtMS0xLTI0NTg3_46d898a0-a698-4ee1-8693-440e6ea490f0"
      unitRef="usd">29100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzEzLTExLTEtMS0yNDU4Nw_600ed36a-e63d-405c-a1ed-175d5d04a6f1"
      unitRef="usd">29100000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="iff0345a87ec74fc2a1683ba954ad2eea_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTEtMS0xLTI0NTg3_2082b4f8-d8e9-49c6-844a-efe543da7380"
      unitRef="shares">93500000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="iff0345a87ec74fc2a1683ba954ad2eea_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTMtMS0xLTI0NTg3_f51006d2-1f7d-47c7-9889-e1a8dd339083"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icecbc009167140a6a443a748af98ebb3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTUtMS0xLTI0NTg3_04ff6dd9-5757-4e67-9b5b-a89307611cd3"
      unitRef="usd">1849700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id963b79121954d3ea702db8ac5aaec24_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTctMS0xLTI0NTg3_8820e443-f9c9-4710-abd3-f4be6cbd0eb3"
      unitRef="usd">1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia21b050c801745578a610cadda27dda1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTktMS0xLTI0NTg3_d79d0737-003c-408d-9f93-6ba8ada5633a"
      unitRef="usd">-725400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE2LTExLTEtMS0yNDU4Nw_f16fdc53-9b3d-4329-9632-f2d71220c501"
      unitRef="usd">1126200000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ic234985e15bc4a1d876dca26f6503d8e_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE3LTktMS0xLTI0NTg3_429c2a8a-734b-44ab-a594-233020f15460"
      unitRef="usd">89600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE3LTExLTEtMS0yNDU4Nw_40cebac8-bdcf-4b18-8101-452678c9b70b"
      unitRef="usd">89600000</us-gaap:NetIncomeLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i2e85c7f4bf3e4e8a9b237b4341c4b9a7_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE4LTctMS0xLTI0NTg3_1765d70f-11f9-4897-8c22-4181ee264f50"
      unitRef="usd">-3500000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:MarketableSecuritiesUnrealizedGainLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE4LTExLTEtMS0yNDU4Nw_3231adc2-16d5-4cf3-a4ba-175eda7c68c7"
      unitRef="usd">-3500000</us-gaap:MarketableSecuritiesUnrealizedGainLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i534bd413a5404e2da06b975889c1c349_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE5LTUtMS0xLTI0NTg3_015e071d-5a90-42c1-96bc-aa73ee04ddd5"
      unitRef="usd">134200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzE5LTExLTEtMS0yNDU4Nw_ca9095ea-14da-4aba-9345-e66a54ed9f9a"
      unitRef="usd">134200000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i2f297dfb69c64f82a416c17120802d81_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTEtMS0xLTI0NTg3_296074c0-47fe-4dac-9d55-12f8130d1c45"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i534bd413a5404e2da06b975889c1c349_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTUtMS0xLTI0NTg3_d44079a8-76d8-478e-95a2-eb9c625a2df5"
      unitRef="usd">27500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzIxLTExLTEtMS0yNDU4Nw_4e2abfc5-a0bf-4a05-a67a-ff53b59395f2"
      unitRef="usd">27500000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i8a1c966228ae4eef899ad097142a3675_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTEtMS0xLTI0NTg3_dd1bde34-59a9-4b74-a9b5-5496669eb33f"
      unitRef="shares">94900000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8a1c966228ae4eef899ad097142a3675_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTMtMS0xLTI0NTg3_236f9299-86d9-4255-ad2b-4714784696b8"
      unitRef="usd">100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0ee2ff30f3694c999d1bfea3cac16df0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTUtMS0xLTI0NTg3_15d92c5c-61a9-4723-b3a0-f8d06053b828"
      unitRef="usd">2011400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i48483359c04e4e06bd637a90f9af6854_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTctMS0xLTI0NTg3_d2fa9997-655b-4c72-9c32-0e44d5c5877b"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1f748abc48034713a36960dffd357755_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTktMS0xLTI0NTg3_ec1c81d3-c6ea-4c84-bab5-d2f2c8a74e2a"
      unitRef="usd">-635800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzAvZnJhZzpjODE0MWU0ZmMzOTM0MjBiYWU0YWFmOWM5YTlhMTg5NC90YWJsZTozNWZiMjgyMWIxYzI0MzllYWRiOGJmNjllMjk4NjRlNC90YWJsZXJhbmdlOjM1ZmIyODIxYjFjMjQzOWVhZGI4YmY2OWUyOTg2NGU0XzI0LTExLTEtMS0yNDU4Nw_fac19c74-1f6b-471b-8cab-099380f440a1"
      unitRef="usd">1374000000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtMS0xLTEtMjQ1ODc_332ef259-e0dd-48d2-8649-c6a8bde69f6d"
      unitRef="usd">89600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtMy0xLTEtMjQ1ODc_87461311-4f6b-413c-a81e-b90f0c66f573"
      unitRef="usd">407300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMtNS0xLTEtMjQ1ODc_0df320de-5ed5-4ad0-ac02-249e8a398608"
      unitRef="usd">37000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtMS0xLTEtMjQ1ODc_789c990e-4749-4e2e-920c-fe5b500a164c"
      unitRef="usd">134200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtMy0xLTEtMjQ1ODc_e3a99296-d6a6-4d6b-b371-970cc18a787b"
      unitRef="usd">100000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzUtNS0xLTEtMjQ1ODc_9cdf98df-3668-40a9-a8fa-1447d3dc85c9"
      unitRef="usd">75300000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtMS0xLTEtMjQ1ODc_29a33b50-a492-40e8-8e45-3a39487d381d"
      unitRef="usd">10900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtMy0xLTEtMjQ1ODc_0279f45d-572a-4bbf-8a21-f53ac04f83b1"
      unitRef="usd">8600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzYtNS0xLTEtMjQ1ODc_c35c2161-5f57-478e-9902-4531b24f3205"
      unitRef="usd">7400000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctMS0xLTEtMjQ1ODc_6593cd24-036c-4416-95a5-886ceca0b22f"
      unitRef="usd">16200000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctMy0xLTEtMjQ1ODc_ba3a5309-2961-4dd3-9ccf-b828d40538a4"
      unitRef="usd">20000000.0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzctNS0xLTEtMjQ1ODc_89ec5265-139e-454b-bb11-2a8e56497e04"
      unitRef="usd">18900000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtMS0xLTEtMjQ1ODc_b4211be7-109a-4689-b92a-7dc0adf1f76f"
      unitRef="usd">1100000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtMy0xLTEtMjQ1ODc_5cacce82-a23b-4a0c-92d4-4fffb1ae239c"
      unitRef="usd">1400000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzgtNS0xLTEtMjQ1ODc_9d1e3976-786f-4709-b9f7-0b03f55e0e6e"
      unitRef="usd">1400000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktMS0xLTEtMjQ1ODc_93111576-80d3-4b26-af9b-7d35e9c2c081"
      unitRef="usd">20900000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktMy0xLTEtMjQ1ODc_0b9d814c-f13f-4e43-aba9-620bcda13d52"
      unitRef="usd">-17700000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzktNS0xLTEtMjQ1ODc_b23a2963-6741-48a0-9272-2ef3eb6ce639"
      unitRef="usd">-13000000.0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTEtMS0xLTI0NTg3_146f6ad3-30f0-4b58-8dd6-8fcece58f75e"
      unitRef="usd">4300000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTMtMS0xLTI0NTg3_3490b1f9-b99d-40e1-bdc1-6cb49d862cf1"
      unitRef="usd">-310700000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEwLTUtMS0xLTI0NTg3_5e466e6e-c1cb-4326-b6a7-75e0300d0214"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTEtMS0xLTI0NTg3_398ae897-83bc-44e2-9514-222b15028b3d"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTMtMS0xLTI0NTg3_128b1fc9-2c5d-41c8-b78f-f77fad051e95"
      unitRef="usd">-18400000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzExLTUtMS0xLTI0NTg3_e7c989c3-528f-449c-8a40-100d786e73e3"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTEtMS0xLTI0NTg3_5a705233-5f6e-419a-bc4c-09514c9a72b5"
      unitRef="usd">4400000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTMtMS0xLTI0NTg3_c650faed-76f2-401b-bbf2-32301f8ecce5"
      unitRef="usd">3700000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzEyLTUtMS0xLTI0NTg3_5103a015-0990-4b30-9bb4-b5ef4ba6567e"
      unitRef="usd">-1200000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTEtMS0xLTI0NTg3_dcd30494-674e-4961-80b4-7cd967673a86"
      unitRef="usd">28400000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTMtMS0xLTI0NTg3_166a22f4-8f56-4e2c-988d-a54dbc4456fb"
      unitRef="usd">30500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE0LTUtMS0xLTI0NTg3_8846d880-de51-4089-be1d-051c726a0dfc"
      unitRef="usd">69200000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTEtMS0xLTI0NTg3_5d81e187-9cb0-4ba3-b9e9-9ca67810f9e0"
      unitRef="usd">2500000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTMtMS0xLTI0NTg3_2461a53a-f1dc-4b0b-940c-987d61f8ee40"
      unitRef="usd">10700000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE1LTUtMS0xLTI0NTg3_40134bda-3a91-4213-9edb-62322780e6d6"
      unitRef="usd">6400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTEtMS0xLTI0NTg3_f7ea7f93-06a4-429e-9b0b-8a9965590eba"
      unitRef="usd">56800000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTMtMS0xLTI0NTg3_89dac54d-0a58-40c3-bcfb-f8b444d4a999"
      unitRef="usd">26900000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE2LTUtMS0xLTI0NTg3_322da7b8-e3e7-4810-add0-9fb5e9c3320e"
      unitRef="usd">54000000.0</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTEtMS0xLTI0NTg3_71f0b9f6-49c7-4342-8f8f-cdab133f5fa2"
      unitRef="usd">9200000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTMtMS0xLTI0NTg3_658f27c0-8d85-4dea-b263-769baa752106"
      unitRef="usd">23600000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE3LTUtMS0xLTI0NTg3_d2bb89f8-1a16-4c54-b4ec-0e4e92be9e8a"
      unitRef="usd">-16800000</us-gaap:IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTEtMS0xLTI0NTg3_851def7e-a3aa-4dc9-9869-63d7f624bf26"
      unitRef="usd">256500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTMtMS0xLTI0NTg3_c010fbd0-f092-4033-812b-eb2725ad661f"
      unitRef="usd">228500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzE4LTUtMS0xLTI0NTg3_67562569-3f8d-4ecd-8238-dce43cc5e51c"
      unitRef="usd">147000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTEtMS0xLTI0NTg3_8f094152-c3c6-4875-ae6f-5c8127f46a84"
      unitRef="usd">800100000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTMtMS0xLTI0NTg3_bf78ee2c-b143-43ae-bd47-5610d2d7df6e"
      unitRef="usd">735500000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIxLTUtMS0xLTI0NTg3_4ae937d8-a30a-4a52-b37e-4b0249198ab6"
      unitRef="usd">797200000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTEtMS0xLTI0NTg3_38c1e75f-ed74-4325-95bb-41e0d3ce9abe"
      unitRef="usd">697900000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTMtMS0xLTI0NTg3_57ed0760-3b2d-403f-b543-927ebd3bee60"
      unitRef="usd">750500000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIyLTUtMS0xLTI0NTg3_fe049e50-196d-443d-afc3-9056757a73cb"
      unitRef="usd">669700000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTEtMS0xLTI0NTg3_f7b832fd-abde-4fc3-b330-64abd79e6a02"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTMtMS0xLTI0NTg3_e9be5a6e-d456-4296-90dd-44e24c271746"
      unitRef="usd">0</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzIzLTUtMS0xLTI0NTg3_8d3a90ad-a195-4f5c-840b-abbab6fe73b0"
      unitRef="usd">68900000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTEtMS0xLTI0NTg3_914bcc76-34b5-444f-950b-0e77caf711a2"
      unitRef="usd">23400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTMtMS0xLTI0NTg3_55343d1d-e286-42ec-98b3-bab4dad2e794"
      unitRef="usd">10900000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI0LTUtMS0xLTI0NTg3_eaecffaf-5f64-412a-82c5-971324dee7c3"
      unitRef="usd">14700000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTEtMS0xLTI0NTg3_5b2602fb-5399-4955-913c-eb4497ebd8a5"
      unitRef="usd">-130200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTMtMS0xLTI0NTg3_e102a1be-3563-458f-a84a-f7893d7951f5"
      unitRef="usd">4100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI1LTUtMS0xLTI0NTg3_19770768-574a-416b-9c39-c0ee1564af56"
      unitRef="usd">-211100000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTEtMS0xLTI0NTg3_d44b4cc3-8361-4b4c-bc0a-5416083d34b9"
      unitRef="usd">27500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTMtMS0xLTI0NTg3_86026f8d-4608-4294-9c52-d4e0ec5fa1a7"
      unitRef="usd">29100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI4LTUtMS0xLTI0NTg3_cc512d38-8f5e-407f-8ad6-a6fb722244bd"
      unitRef="usd">32400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTEtMS0xLTI0NTg3_931993df-75c1-4cdc-b19f-2d7b1183e03e"
      unitRef="usd">100000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTMtMS0xLTI0NTg3_7bbac2b7-7ea1-4911-9049-f9e855d0c012"
      unitRef="usd">186900000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzI5LTUtMS0xLTI0NTg3_fbcfd2a2-47ce-487a-ad58-42bba7a906fb"
      unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTEtMS0xLTI0NTg3_a7e47558-9153-4660-a10f-b36bc08e8a4e"
      unitRef="usd">27400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTMtMS0xLTI0NTg3_2fe7d080-4050-413c-b044-9b87ef992405"
      unitRef="usd">-157800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMwLTUtMS0xLTI0NTg3_a6618147-cd5c-471a-a4c1-e4ac8c323e4a"
      unitRef="usd">32400000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTEtMS0xLTI0NTg3_9d35fcb4-78d1-4068-a467-011a658c14cc"
      unitRef="usd">153700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTMtMS0xLTI0NTg3_6f564330-7bdc-4ca0-ace6-b37ac51f7258"
      unitRef="usd">74800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMxLTUtMS0xLTI0NTg3_c5181db4-7e91-4ed8-9c92-f1a2129ded24"
      unitRef="usd">-31700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTEtMS0xLTI0NTg3_b68b9fc0-65b6-49a2-a9ba-403722bb7aa7"
      unitRef="usd">190300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTMtMS0xLTI0NTg3_564ab491-488c-4efd-9437-5a8801d2e2b9"
      unitRef="usd">115500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMyLTUtMS0xLTI0NTg3_ae9a4ddd-c139-488c-ade8-d533f6c05c00"
      unitRef="usd">147200000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTEtMS0xLTI0NTg3_2ad9a86e-ad98-4b2b-be4b-6a25f4b333f1"
      unitRef="usd">344000000.0</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTMtMS0xLTI0NTg3_25c80f40-a3ad-4678-a65b-0ca77ed144bb"
      unitRef="usd">190300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzMzLTUtMS0xLTI0NTg3_365b3843-5538-4d87-8696-af1d0395c228"
      unitRef="usd">115500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTEtMS0xLTI0NTg3_2b3ccb64-b2df-4f6a-9994-be643b792836"
      unitRef="usd">1900000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTMtMS0xLTI0NTg3_d257a107-220b-48e7-aca1-8e4c332c9570"
      unitRef="usd">1400000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM2LTUtMS0xLTI0NTg3_449bd881-cc7e-4de6-83e0-ddb21c171525"
      unitRef="usd">1000000.0</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTEtMS0xLTI0NTg3_f7c2edbd-f7f3-42ec-9a07-03eb624594d2"
      unitRef="usd">23400000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTMtMS0xLTI0NTg3_ba48bfbf-528a-4b3d-b690-c2ad022cf700"
      unitRef="usd">12800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM3LTUtMS0xLTQwOTg2_5e252e05-1e33-4ed2-81ee-f9c76cc6ad6a"
      unitRef="usd">77100000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:InterestPaidNet
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTEtMS0xLTI0NTg3_94fe2b53-6c16-4d1c-bb8a-370c4ca16b22"
      unitRef="usd">8600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTMtMS0xLTI0NTg3_8141cfb2-8e70-4261-a252-4fe7d744cc12"
      unitRef="usd">11600000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM4LTUtMS0xLTI0NTg3_31cdb921-3b0f-4149-8586-28390a1e440b"
      unitRef="usd">11600000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTEtMS0xLTI0NTg3_6246f11a-97a4-42b0-b37e-7ada0bb58275"
      unitRef="usd">5100000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTMtMS0xLTI0NTg3_02c29b64-e881-4e07-81c0-a47aa0c9195f"
      unitRef="usd">15300000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzMvZnJhZzo2NGU0NWIxNzQ3ZmY0OGE1OWQ3MDgyYTdkMWUxZDFkNS90YWJsZToyMGVmZTExNTgyMGM0M2VkYjNkZTkxYzE2Mjg0NjNmMy90YWJsZXJhbmdlOjIwZWZlMTE1ODIwYzQzZWRiM2RlOTFjMTYyODQ2M2YzXzM5LTUtMS0xLTI0NTg3_314e523f-75a6-4dfb-91c7-47fc3a938524"
      unitRef="usd">500000</us-gaap:IncomeTaxesPaid>
    <us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg0_bafcb067-7d33-4c3e-8b94-29f42a158ced">Organization and Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Neurocrine Biosciences, Inc., or Neurocrine Biosciences, the Company, we, our or us, was incorporated in California in 1992 and reincorporated in Delaware in 1996. Neurocrine Continental, Inc., is a Delaware corporation and a wholly owned subsidiary of Neurocrine Biosciences. We also have two wholly-owned Irish subsidiaries, Neurocrine Therapeutics, Ltd. and Neurocrine Europe, Ltd. both of which were formed in December 2014 and are inactive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Neurocrine Biosciences as well as our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Industry Segment and Geographic Information. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a single industry segment&#160;&#x2013; the discovery, development and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. We had no foreign-based operations during any of the years presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments that are readily convertible into cash without penalty and have an original maturity of three months or less at the time of purchase to be cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of customer allowances for prompt payment discounts, chargebacks and any allowance for doubtful accounts. We estimate the allowance for doubtful accounts based on existing contractual payment terms, actual payment patterns of our customers and individual customer circumstances. To date, an allowance for doubtful accounts has not been material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist of investments in certificates of deposit, corporate debt securities and securities of government-sponsored entities. We classify debt securities as available-for-sale. Debt securities available-for-sale are recorded at fair value, with unrealized gains and losses included in other comprehensive income or loss, net of tax. We exclude accrued interest from both the fair value and amortized cost basis of debt securities. A debt security is placed on nonaccrual status at the time any principal or interest payments become 90 days delinquent. Interest accrued but not received for a debt security placed on nonaccrual status is reversed against interest income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income includes amortization of purchase premium or discount. Premiums and discounts on debt securities are amortized using the effective interest rate method. Gains and losses on sales of debt securities are recorded on the trade date in investment income and other, net, and determined using the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For debt securities available-for-sale in an unrealized loss position, we first assess whether we intend to sell, or it is more likely than not that we will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued interest receivables on debt securities available-for-sale totaled $2.2 million as of December&#160;31, 2021 and $3.7 million as of December&#160;31, 2020. We do not measure an allowance for credit losses for accrued interest receivables. For the purposes of identifying and measuring an impairment, accrued interest is excluded from both the fair value and amortized cost basis of the debt security. Uncollectible accrued interest receivables associated with an impaired debt security are reversed against interest income upon identification of the impairment. No accrued interest receivables were written off during 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record cash equivalents, debt securities available-for-sale and equity security investments at fair value based on a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). The fair value hierarchy consists of the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Unobservable inputs that reflect our own assumptions about the assumptions that market participants would use in pricing the asset or liability when there is little, if any, market activity for the asset or liability at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities available-for-sale are classified as Level 2 and carried at fair value. We estimate the fair value of debt securities available-for-sale by utilizing third-party pricing services. These pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Such inputs include market pricing based on real-time trade data for similar instruments, issuer credit spreads, benchmark yields, broker/dealer quotes and other observable inputs. We validate valuations obtained from third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing data in certain instances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities of certain companies that are subject to holding period restrictions longer than one year are classified as Level 3 and carried at fair value using an option pricing valuation model. The most significant assumptions within the option pricing valuation model are the stock price volatility, which is based on the historical volatility of similar companies and the discount for lack of marketability related to the term of the restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We deem transfers between levels of the fair value hierarchy to have occurred at the end of the reporting period during which the event or change in circumstances that caused the transfer occurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value. We determine the cost of inventory using the standard-cost method, which approximates actual cost based on the first-in, first-out method. We assess the valuation of our inventory on a quarterly basis and adjust the value for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand. Inventory costs resulting from these adjustments are recognized as cost of sales in the period in which they are incurred. When future commercialization is considered probable and the future economic benefit is expected to be realized, based on management&#x2019;s judgment, we capitalize pre-launch inventory costs prior to regulatory approval.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and depreciated over the estimated useful lives of the assets using the straight-line method. Equipment is depreciated over an average estimated useful life of 3 to 7 years. Leasehold improvements are depreciated over the shorter of their estimated useful lives or the remaining lease term. Depreciation expense was $10.9 million for 2021, $8.6 million for 2020 and $7.4 million for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows. If&#160;the carrying amount is not recoverable, we measure the amount of any impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized using a five-step model: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Product Sales.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the United States, we sell INGREZZA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (valbenazine) primarily to specialty pharmacy providers and distributors and ONGENTYS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (opicapone) primarily to wholesale distributors. We recognize net product sales when the customer obtains control of our product, which occurs at a point in time, typically upon delivery of our product to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. Such estimates are based on information received from external sources (such as written or oral information obtained from our customers with respect to their period-end inventory levels and sales to end-users during the reporting period), as supplemented by management&#x2019;s judgement. Our process for estimating reserves established for these variable consideration components does not differ materially from historical practices. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our significant categories of sales discounts and allowances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Discounts.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Product discounts are based on payment terms extended to our customers at the time of sale, which include incentives offered for prompt payment. We maintain a reserve for product discounts based on our historical experience, including the timing of customer payments. To date, actual product discounts have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Rebates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period. Such estimates are based on actual historical rebates by state, estimated payor mix, state and federal regulations and relevant contractual terms, as supplemented by management&#x2019;s judgement. Our rebate accrual calculations require us to project the magnitude of our sales that will be subject to these rebates. There is a significant time-lag in our receiving rebate notices from each state (generally, several months or longer after a sale is recognized). Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The difference between the list price, or the price at which we sell our products to our customers, and the contracted price, or the price at which our customers sell our products to qualified healthcare professionals, is charged back to us by our customers. In addition to actual chargebacks received, we maintain a reserve for chargebacks based on estimated contractual discounts on product inventory levels on-hand in our distribution channel. To date, actual chargebacks have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payor and Pharmacy Rebates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We are obligated to pay rebates as a percentage of sales under payor and pharmacy contracts. We estimate these rebates based on actual historical rebates, contractual rebate percentages, sales made through the payor channel and purchases made by pharmacies. To date, actual payor and pharmacy rebates have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient Financial Assistance.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; To help patients afford our products, we offer financial assistance to qualified patients with prescription drug co-payments required by insurance as well as free trial vouchers to qualifying new patients. We accrue for patient financial assistance based on estimated claims and the cost per claim we expect to receive associated with inventory that remains in the distribution channel at period end. To date, actual copay assistance and free trial vouchers have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distributor and Other Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In connection with the sales of our products, we pay distributor and other fees, which are generally recorded as a reduction of revenue, to certain customers that provide us with inventory management, data and distribution services. To the extent we can demonstrate a separable benefit and fair value for these services, we classify the associated costs in selling, general and administrative expenses. These costs are typically known at the time of sale, resulting in minimal adjustments subsequent to the period of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We offer our customers product return rights primarily limited to errors in shipment, damaged product and expiring product, provided it is within a specified period of the product expiration date, as set forth in the associated distribution agreement. Where actual returns history is not available, we estimate a returns allowance based on benchmarking data for similar products and industry experience. We record this estimate as a reduction of revenue in the period the related sale is recognized. Once product is returned, it is destroyed. To date, actual product returns have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into collaboration and licensing agreements under which we out-license certain rights to our product candidates to third parties. The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees; development, regulatory and/or commercial milestone payments; and royalties on net sales of licensed products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Licenses of Intellectual Property.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, we assess the nature of the combined performance obligation to determine whether it is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Milestones.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At the inception of each arrangement that includes developmental, regulatory or commercial milestones, we evaluate whether achieving the milestones is considered probable and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. Amounts for milestones that are not within our control, such as where achievement of the specified event is dependent on the development activities of a third party or approvals from regulators, are not considered probable of being achieved until the specified event occurs. Revenue is recognized from the satisfaction of performance obligations in the amount billable to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For arrangements that include sales-based royalties, and under which the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). Each quarterly period, sales-based royalties are recorded based on estimated quarterly net sales of the associated collaboration products. Differences between actual results and estimated amounts are adjusted for in the period in which they become known, which typically follows the quarterly period in which the estimate was made. To date, actual royalties received have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and debt securities available-for-sale. We have established guidelines to limit our exposure to credit risk by diversifying our investment portfolio and by placing investments with high credit quality financial institutions and maturities that maintain safety and liquidity. To date, we have not experienced any credit losses and do not believe we are exposed to any significant credit risk in relation to these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also subject to credit risk from our accounts receivable related to our product sales. Our two largest customers represented approximately 82% of our total product revenues for 2021 and approximately 86% for both 2020 and 2019, as well as the significant majority of our accounts receivable balances at December&#160;31, 2021 and 2020. To date, we have not experienced any significant losses with respect to the collection of these accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Sales. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales includes third-party manufacturing, transportation, freight and indirect overhead costs associated with the manufacture and distribution of INGREZZA and ONGENTYS, royalty fees on net sales of ORILISSA and ORIAHNN, and adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development, or R&amp;amp;D, expenses consist primarily of salaries, payroll taxes, employee benefits and share-based compensation charges for those individuals involved in ongoing R&amp;amp;D efforts; as well as scientific consulting fees, preclinical and clinical trial costs, R&amp;amp;D facilities costs, laboratory supply costs and depreciation of scientific equipment. All such costs are expensed as R&amp;amp;D when incurred. These expenses result from our independent R&amp;amp;D efforts, as well as efforts associated with collaborations, in-licenses and third-party funded research arrangements, including event-based milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Asset Acquisitions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for acquisitions of an asset that does not (or a group of assets that do not) meet the definition of a business using the cost accumulation method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the asset (or assets) acquired on the basis of its (or their) relative fair value(s) on the measurement date. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in R&amp;amp;D activities which have no alternative future use are expensed as in-process research and development, or IPR&amp;amp;D, on the acquisition date. Future costs to develop these assets are expensed as R&amp;amp;D when incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Expense. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are expensed when services are performed or goods are delivered and are included in selling, general and administrative expense in our consolidated statements of income. We incurred advertising costs related to INGREZZA and ONGENTYS of $139.8 million for 2021, $64.8 million for 2020 and $40.6 million for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant stock options to purchase our common stock to eligible employees and directors and also grant certain employees restricted stock units, or RSUs, and performance-based restricted stock units, or PRSUs. Additionally, we allow employees to participate in an employee stock purchase plan, or ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of stock options and shares to be issued under the ESPP using the Black-Scholes option-pricing model on the date of grant. RSUs are valued based on the closing price of our common stock on the date of grant. The fair value of equity instruments expected to vest is recognized and amortized on a straight-line basis over the requisite service period of the award, which is generally 3 to 4 years; however, certain provisions in our equity compensation plans provide for shorter vesting periods under certain circumstances. The fair value of shares to be issued under the ESPP is recognized and amortized on a straight-line basis over the purchase period, which is generally 6 months. PRSUs vest upon the achievement of certain predefined company-specific performance-based criteria. Expense related to PRSUs is generally recognized ratably over the expected performance period once the predefined performance-based criteria for vesting becomes probable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our income tax provision (benefit) is computed under the asset and liability method. Significant estimates are required in determining our income tax provision (benefit). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. Refer to Note 9 to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities based on the technical merits of the position. An adverse resolution of one or more of these uncertain tax positions in any period could have a material impact on the results of operations for that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the treasury stock method and reflect the weighted average number of common and potentially dilutive shares outstanding during the period, excluding those which effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible debt instruments that may be settled entirely or partly in cash may, in certain circumstances where the borrower has the ability and intent to settle in cash, be accounted for under the treasury stock method. In December 2021, we entered into the First Supplemental Indenture, dated as of May 2, 2017, by and between the Company and U.S. Bank National Association, as Trustee, or the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes, in cash upon conversion and to settle any conversion premium in either cash or shares of our common stock. As a result, and consistent with historical practice, only the shares required to settle any conversion premium would be considered dilutive under the treasury stock method. Further, PRSUs for which the performance condition has not been achieved are excluded from the calculation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASU 2019-12.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, we adopted Accounting Standards Update, or ASU, 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, using the modified retrospective transition method. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application of Topic 740. The adoption of ASU 2019-12 did not result in a cumulative-effect adjustment to retained earnings. The comparative prior period information continues to be reported under the accounting standards in effect during those periods. The impact of the adoption is expected to be immaterial to our financial position, results of operations and cash flows on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;ASU 2020-06. In August 2020, the FASB issued ASU 2020-06,&#160;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity's own equity. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Instead, entities will account for convertible debt instruments wholly as debt, unless certain other conditions are met. The adoption of ASU 2020-06 is expected to prospectively reduce reported interest expense and increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders&#x2019; equity to liabilities as it relates to the 2024 Notes. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We will adopt &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d"&gt;ASU 2020-06&lt;/span&gt; on January 1, 2022 using the modified retrospective transition method, which allows for a cumulative-effect adjustment in the period of adoption and does not require restatement of prior period amounts. Under this transition method, the cumulative effect of the accounting change is expected to increase the carrying amount of the 2024 Notes by $42.2&#160;million, reduce deferred tax liabilities by $10.0&#160;million, reduce the accumulated deficit by $74.6&#160;million, reduce additional paid-in capital by $106.8&#160;million.</us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock>
    <nbix:BusinessDescriptionPolicyPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc3_a5f1a908-d64f-4fde-ad9b-de11eea87c34">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Activities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Neurocrine Biosciences, Inc., or Neurocrine Biosciences, the Company, we, our or us, was incorporated in California in 1992 and reincorporated in Delaware in 1996. Neurocrine Continental, Inc., is a Delaware corporation and a wholly owned subsidiary of Neurocrine Biosciences. We also have two wholly-owned Irish subsidiaries, Neurocrine Therapeutics, Ltd. and Neurocrine Europe, Ltd. both of which were formed in December 2014 and are inactive.&lt;/span&gt;</nbix:BusinessDescriptionPolicyPolicyTextBlock>
    <nbix:NumberOfIrishSubsidiaries
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM2Nw_440a340e-835d-4c94-a6d9-13c64b95c0d2"
      unitRef="subsidiary">2</nbix:NumberOfIrishSubsidiaries>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk0_0cb85d09-4cdd-42ed-9438-af218172979b">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Principles of Consolidation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of Neurocrine Biosciences as well as our wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg3_bb42aabf-ed9a-4841-8079-7e21ca06cbb8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America, or GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc4_462220c7-96db-4231-a11d-5f298636e4df">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Industry Segment and Geographic Information. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate in a single industry segment&#160;&#x2013; the discovery, development and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. We had no foreign-based operations during any of the years presented.&lt;/span&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg5_36e08d7f-e883-4485-b062-9f78f78f5af0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider all highly liquid investments that are readily convertible into cash without penalty and have an original maturity of three months or less at the time of purchase to be cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkw_da860ec9-3921-4f99-ba6b-87027f59dcd0">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded net of customer allowances for prompt payment discounts, chargebacks and any allowance for doubtful accounts. We estimate the allowance for doubtful accounts based on existing contractual payment terms, actual payment patterns of our customers and individual customer circumstances. To date, an allowance for doubtful accounts has not been material.&lt;/span&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkx_69acd660-2a65-4898-a896-edb590734fc1">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities consist of investments in certificates of deposit, corporate debt securities and securities of government-sponsored entities. We classify debt securities as available-for-sale. Debt securities available-for-sale are recorded at fair value, with unrealized gains and losses included in other comprehensive income or loss, net of tax. We exclude accrued interest from both the fair value and amortized cost basis of debt securities. A debt security is placed on nonaccrual status at the time any principal or interest payments become 90 days delinquent. Interest accrued but not received for a debt security placed on nonaccrual status is reversed against interest income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest income includes amortization of purchase premium or discount. Premiums and discounts on debt securities are amortized using the effective interest rate method. Gains and losses on sales of debt securities are recorded on the trade date in investment income and other, net, and determined using the specific identification method.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM0Mjc_44d8b549-2579-4d8f-8e2e-08f41d252f91">P90D</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff>
    <us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc5_ef7034ee-dbe0-4411-852c-bd38fefafaec">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Allowance for Credit Losses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For debt securities available-for-sale in an unrealized loss position, we first assess whether we intend to sell, or it is more likely than not that we will be required to sell, the security before recovery of its amortized cost basis. If either of the criteria regarding intent or requirement to sell is met, the security&#x2019;s amortized cost basis is written down to fair value through earnings. For debt securities available-for-sale that do not meet the aforementioned criteria, we evaluate whether the decline in fair value has resulted from credit losses or other factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, any changes in interest rates, and any changes to the rating of the security by a rating agency, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the security is compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive income or loss, as applicable.&lt;/span&gt;Accrued interest receivables on debt securities available-for-sale totaled $2.2 million as of December&#160;31, 2021 and $3.7 million as of December&#160;31, 2020. We do not measure an allowance for credit losses for accrued interest receivables. For the purposes of identifying and measuring an impairment, accrued interest is excluded from both the fair value and amortized cost basis of the debt security. Uncollectible accrued interest receivables associated with an impaired debt security are reversed against interest income upon identification of the impairment. No accrued interest receivables were written off during 2021, 2020 or 2019.</us-gaap:FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts>
    <us-gaap:InterestReceivableCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzUzODI_ea5f2e36-ff60-4b59-a7db-1e6cfbd12e41"
      unitRef="usd">2200000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NjcwMTk_14672360-094d-476f-b36f-1dbcc900bd20"
      unitRef="usd">3700000</us-gaap:InterestReceivableCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzU3OTg_2442c281-65dd-4011-9cd9-a87d1974bbca"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzU3OTg_89431985-01c5-4dfb-b5c2-016ec9563883"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestWriteoff>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgw_f62eaabb-31a7-4e97-8b4c-d5588cd818fb">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record cash equivalents, debt securities available-for-sale and equity security investments at fair value based on a fair value hierarchy that distinguishes between assumptions based on market data (observable inputs) and our own assumptions (unobservable inputs). The fair value hierarchy consists of the following three levels:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 1 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or inputs that are observable, either directly or indirectly, for substantially the full term of the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Unobservable inputs that reflect our own assumptions about the assumptions that market participants would use in pricing the asset or liability when there is little, if any, market activity for the asset or liability at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in debt securities available-for-sale are classified as Level 2 and carried at fair value. We estimate the fair value of debt securities available-for-sale by utilizing third-party pricing services. These pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. Such inputs include market pricing based on real-time trade data for similar instruments, issuer credit spreads, benchmark yields, broker/dealer quotes and other observable inputs. We validate valuations obtained from third-party pricing services by understanding the models used, obtaining market values from other pricing sources and analyzing data in certain instances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments in equity securities of certain companies that are subject to holding period restrictions longer than one year are classified as Level 3 and carried at fair value using an option pricing valuation model. The most significant assumptions within the option pricing valuation model are the stock price volatility, which is based on the historical volatility of similar companies and the discount for lack of marketability related to the term of the restrictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We deem transfers between levels of the fair value hierarchy to have occurred at the end of the reporting period during which the event or change in circumstances that caused the transfer occurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc2_9ebb2f77-115e-4d00-a6fe-9841cd9666e9">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value. We determine the cost of inventory using the standard-cost method, which approximates actual cost based on the first-in, first-out method. We assess the valuation of our inventory on a quarterly basis and adjust the value for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand. Inventory costs resulting from these adjustments are recognized as cost of sales in the period in which they are incurred. When future commercialization is considered probable and the future economic benefit is expected to be realized, based on management&#x2019;s judgment, we capitalize pre-launch inventory costs prior to regulatory approval.&lt;/span&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgx_b860cc0d-0747-4ac4-b4c8-6293b2cf2e7f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost and depreciated over the estimated useful lives of the assets using the straight-line method. Equipment is depreciated over an average estimated useful life of 3 to 7 years. Leasehold improvements are depreciated over the shorter of their estimated useful lives or the remaining lease term. Depreciation expense was $10.9 million for 2021, $8.6 million for 2020 and $7.4 million for 2019.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzkzODk_ebc2fc8e-f0c8-4895-a829-be44c7404a9b">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzkzOTU_7f4611e1-7d5e-40ff-bc14-175dcc6a1732">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:Depreciation
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NDE_6a526d7a-518f-4b88-aaf7-bb5d8ed0cc1d"
      unitRef="usd">10900000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NTI_9191b79a-05ed-4700-beb2-51b0edcdb120"
      unitRef="usd">8600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzk1NjY_504fa41c-5703-4024-936f-5d0f86cc5234"
      unitRef="usd">7400000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg2_8037018c-f1f2-44a7-9f37-3129bd7e5dc6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. If indicators of impairment exist, we assess the recoverability of the affected long-lived assets by determining whether the carrying value of such assets can be recovered through undiscounted future operating cash flows. If&#160;the carrying amount is not recoverable, we measure the amount of any impairment by comparing the carrying value of the asset to the present value of the expected future cash flows associated with the use of the asset.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjcz_8509862d-44c5-4354-b1ff-657c19eceb9e">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize revenue when the customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. Revenue is recognized using a five-step model: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation. We only apply the five-step model to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services we transfer to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Product Sales.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In the United States, we sell INGREZZA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (valbenazine) primarily to specialty pharmacy providers and distributors and ONGENTYS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (opicapone) primarily to wholesale distributors. We recognize net product sales when the customer obtains control of our product, which occurs at a point in time, typically upon delivery of our product to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from product sales are recorded net of reserves established for applicable discounts and allowances that are offered within contracts with our customers, payors and other third parties. Such estimates are based on information received from external sources (such as written or oral information obtained from our customers with respect to their period-end inventory levels and sales to end-users during the reporting period), as supplemented by management&#x2019;s judgement. Our process for estimating reserves established for these variable consideration components does not differ materially from historical practices. The transaction price, which includes variable consideration reflecting the impact of discounts and allowances, may be subject to constraint and is included in the net sales price only to the extent that it is probable that a significant reversal of the amount of the cumulative revenue recognized will not occur in a future period. Actual amounts may ultimately differ from our estimates. If actual results vary, we adjust these estimates, which could have an effect on earnings in the period of adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our significant categories of sales discounts and allowances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Discounts.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Product discounts are based on payment terms extended to our customers at the time of sale, which include incentives offered for prompt payment. We maintain a reserve for product discounts based on our historical experience, including the timing of customer payments. To date, actual product discounts have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Government Rebates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We are obligated to pay rebates for mandated discounts under the Medicaid Drug Rebate Program. The liability for such rebates consists of invoices received for claims from prior quarters that remain unpaid, or for which an invoice has not been received, and estimated rebates for the current applicable reporting period. Such estimates are based on actual historical rebates by state, estimated payor mix, state and federal regulations and relevant contractual terms, as supplemented by management&#x2019;s judgement. Our rebate accrual calculations require us to project the magnitude of our sales that will be subject to these rebates. There is a significant time-lag in our receiving rebate notices from each state (generally, several months or longer after a sale is recognized). Estimated rebates are recorded as a reduction of revenue in the period the related sale is recognized. To date, actual government rebates have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The difference between the list price, or the price at which we sell our products to our customers, and the contracted price, or the price at which our customers sell our products to qualified healthcare professionals, is charged back to us by our customers. In addition to actual chargebacks received, we maintain a reserve for chargebacks based on estimated contractual discounts on product inventory levels on-hand in our distribution channel. To date, actual chargebacks have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Payor and Pharmacy Rebates.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We are obligated to pay rebates as a percentage of sales under payor and pharmacy contracts. We estimate these rebates based on actual historical rebates, contractual rebate percentages, sales made through the payor channel and purchases made by pharmacies. To date, actual payor and pharmacy rebates have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Patient Financial Assistance.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; To help patients afford our products, we offer financial assistance to qualified patients with prescription drug co-payments required by insurance as well as free trial vouchers to qualifying new patients. We accrue for patient financial assistance based on estimated claims and the cost per claim we expect to receive associated with inventory that remains in the distribution channel at period end. To date, actual copay assistance and free trial vouchers have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distributor and Other Fees.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In connection with the sales of our products, we pay distributor and other fees, which are generally recorded as a reduction of revenue, to certain customers that provide us with inventory management, data and distribution services. To the extent we can demonstrate a separable benefit and fair value for these services, we classify the associated costs in selling, general and administrative expenses. These costs are typically known at the time of sale, resulting in minimal adjustments subsequent to the period of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We offer our customers product return rights primarily limited to errors in shipment, damaged product and expiring product, provided it is within a specified period of the product expiration date, as set forth in the associated distribution agreement. Where actual returns history is not available, we estimate a returns allowance based on benchmarking data for similar products and industry experience. We record this estimate as a reduction of revenue in the period the related sale is recognized. Once product is returned, it is destroyed. To date, actual product returns have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Revenues. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into collaboration and licensing agreements under which we out-license certain rights to our product candidates to third parties. The terms of these arrangements typically include payment to us of one or more of the following: non-refundable, up-front license fees; development, regulatory and/or commercial milestone payments; and royalties on net sales of licensed products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Licenses of Intellectual Property.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; If the license to our intellectual property is determined to be distinct from the other performance obligations identified in the arrangement, we recognize revenue from non-refundable, up-front fees allocated to the license when the license is transferred to the customer and the customer is able to use and benefit from the license. For licenses that are bundled with other promises, we assess the nature of the combined performance obligation to determine whether it is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue from non-refundable, up-front fees. We evaluate the measure of progress each reporting period and, if necessary, adjust the measure of performance and related revenue recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Milestones.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; At the inception of each arrangement that includes developmental, regulatory or commercial milestones, we evaluate whether achieving the milestones is considered probable and estimate the amount to be included in the transaction price using the most likely amount method. If it is probable that a significant revenue reversal would not occur, the value of the associated milestone is included in the transaction price. Amounts for milestones that are not within our control, such as where achievement of the specified event is dependent on the development activities of a third party or approvals from regulators, are not considered probable of being achieved until the specified event occurs. Revenue is recognized from the satisfaction of performance obligations in the amount billable to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Royalties.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For arrangements that include sales-based royalties, and under which the license is deemed to be the predominant item to which the royalties relate, we recognize revenue at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied (or partially satisfied). Each quarterly period, sales-based royalties are recorded based on estimated quarterly net sales of the associated collaboration products. Differences between actual results and estimated amounts are adjusted for in the period in which they become known, which typically follows the quarterly period in which the estimate was made. To date, actual royalties received have not differed materially from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjky_0cf087f5-d7cf-4323-999d-95dc57db6129">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents and debt securities available-for-sale. We have established guidelines to limit our exposure to credit risk by diversifying our investment portfolio and by placing investments with high credit quality financial institutions and maturities that maintain safety and liquidity. To date, we have not experienced any credit losses and do not believe we are exposed to any significant credit risk in relation to these financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are also subject to credit risk from our accounts receivable related to our product sales. Our two largest customers represented approximately 82% of our total product revenues for 2021 and approximately 86% for both 2020 and 2019, as well as the significant majority of our accounts receivable balances at December&#160;31, 2021 and 2020. To date, we have not experienced any significant losses with respect to the collection of these accounts receivable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5b8d7ede3b7d42c98a7b4985db5ee059_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwMzkw_c272af31-b289-4ada-b52f-3d8a6e263e8b"
      unitRef="number">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d2cb1ed67a045fab2a95fa6a800c0a0_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwNDQ4_00f6873e-5743-42bf-9fa1-2c5ad361b64b"
      unitRef="number">0.86</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic8d3727d3ea944fea7f664879d4c85b0_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIwNDQ4_3c8e3c91-8209-4611-b52e-376b9e8eaf88"
      unitRef="number">0.86</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjkz_31909535-0a7f-4ecf-9133-5c797578c9b7">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Sales. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales includes third-party manufacturing, transportation, freight and indirect overhead costs associated with the manufacture and distribution of INGREZZA and ONGENTYS, royalty fees on net sales of ORILISSA and ORIAHNN, and adjustments for excess and obsolete inventory to the extent management determines that the cost cannot be recovered based on estimates about future demand.&lt;/span&gt;</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk3_a5546a3c-2626-4ef5-a7e9-d036a60dae31">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expenses. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development, or R&amp;amp;D, expenses consist primarily of salaries, payroll taxes, employee benefits and share-based compensation charges for those individuals involved in ongoing R&amp;amp;D efforts; as well as scientific consulting fees, preclinical and clinical trial costs, R&amp;amp;D facilities costs, laboratory supply costs and depreciation of scientific equipment. All such costs are expensed as R&amp;amp;D when incurred. These expenses result from our independent R&amp;amp;D efforts, as well as efforts associated with collaborations, in-licenses and third-party funded research arrangements, including event-based milestones.&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjc0_36cf9e89-a811-4285-866b-0eac15f8a783">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Asset Acquisitions. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for acquisitions of an asset that does not (or a group of assets that do not) meet the definition of a business using the cost accumulation method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the asset (or assets) acquired on the basis of its (or their) relative fair value(s) on the measurement date. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in R&amp;amp;D activities which have no alternative future use are expensed as in-process research and development, or IPR&amp;amp;D, on the acquisition date. Future costs to develop these assets are expensed as R&amp;amp;D when incurred.&lt;/span&gt;</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgy_df99036e-3456-4ff0-9542-6a6bc922afea">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Expense. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are expensed when services are performed or goods are delivered and are included in selling, general and administrative expense in our consolidated statements of income. We incurred advertising costs related to INGREZZA and ONGENTYS of $139.8 million for 2021, $64.8 million for 2020 and $40.6 million for 2019.&lt;/span&gt;</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjAz_6bd647af-cb20-48c7-866d-a0bba854f2f0"
      unitRef="usd">139800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjE0_95cb1a9d-9ac3-423b-ad7b-985ce6628515"
      unitRef="usd">64800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIyNjI4_65569162-7212-4e72-b9c5-6730f11714a2"
      unitRef="usd">40600000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk1_dedb8135-abed-4ed5-94bf-a72080e17544">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We grant stock options to purchase our common stock to eligible employees and directors and also grant certain employees restricted stock units, or RSUs, and performance-based restricted stock units, or PRSUs. Additionally, we allow employees to participate in an employee stock purchase plan, or ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of stock options and shares to be issued under the ESPP using the Black-Scholes option-pricing model on the date of grant. RSUs are valued based on the closing price of our common stock on the date of grant. The fair value of equity instruments expected to vest is recognized and amortized on a straight-line basis over the requisite service period of the award, which is generally 3 to 4 years; however, certain provisions in our equity compensation plans provide for shorter vesting periods under certain circumstances. The fair value of shares to be issued under the ESPP is recognized and amortized on a straight-line basis over the purchase period, which is generally 6 months. PRSUs vest upon the achievement of certain predefined company-specific performance-based criteria. Expense related to PRSUs is generally recognized ratably over the expected performance period once the predefined performance-based criteria for vesting becomes probable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="i004bb05a2f87453f8d8921366e44fd6d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzMzc3_a2c4fe6e-400d-4fea-9071-fdcee7729735">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
      contextRef="ia286733a78f243579b66afc10b8ae4c6_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzMzgz_c6200ab0-e1e5-40d1-bead-b312ef2b362d">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <nbix:ESPPPurchasePeriod
      contextRef="i945a7d74da95458e8a3fe747ece465cd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzIzNjY0_a810f6a9-3db5-46b0-b51e-913244946f6f">P6M</nbix:ESPPPurchasePeriod>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjk2_be42f50f-116d-4efb-b31c-2436e07b957f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Our income tax provision (benefit) is computed under the asset and liability method. Significant estimates are required in determining our income tax provision (benefit). Some of these estimates are based on interpretations of existing tax laws or regulations. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (temporary differences) at enacted tax rates in effect for the years in which the differences are expected to reverse. A valuation allowance is established for deferred tax assets for which it is more likely than not that some portion or all of the deferred tax assets, including net operating losses and tax credits, will not be realized. We periodically re-assess the need for a valuation allowance against our deferred tax assets based on various factors including our historical earnings experience by taxing jurisdiction, and forecasts of future operating results and utilization of net operating losses and tax credits prior to their expiration. Significant judgment is required in making this assessment and, to the extent that a reversal of any portion of our valuation allowance against our deferred tax assets is deemed appropriate, a tax benefit will be recognized against our income tax provision in the period of such reversal. Prior to 2020, we recorded a valuation allowance that fully offset our deferred tax assets. On December 31, 2020, based on our evaluation of various factors, such as our achievement of a cumulative three-year income position as of December 31, 2020, as well as our consideration of forecasts of future operating results and utilization of net operating losses and tax credits prior to &lt;/span&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;their expiration, we released substantially all of our valuation allowance against our deferred tax assets and recorded a corresponding income tax benefit. Refer to Note 9 to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities based on the technical merits of the position. An adverse resolution of one or more of these uncertain tax positions in any period could have a material impact on the results of operations for that period.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjgz_42a16674-b50f-4e97-b08c-68238dc3c4c9">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Share.&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic earnings per share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per share are computed using the treasury stock method and reflect the weighted average number of common and potentially dilutive shares outstanding during the period, excluding those which effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible debt instruments that may be settled entirely or partly in cash may, in certain circumstances where the borrower has the ability and intent to settle in cash, be accounted for under the treasury stock method. In December 2021, we entered into the First Supplemental Indenture, dated as of May 2, 2017, by and between the Company and U.S. Bank National Association, as Trustee, or the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2.25% convertible senior notes due May 15, 2024, or the 2024 Notes, in cash upon conversion and to settle any conversion premium in either cash or shares of our common stock. As a result, and consistent with historical practice, only the shares required to settle any conversion premium would be considered dilutive under the treasury stock method. Further, PRSUs for which the performance condition has not been achieved are excluded from the calculation of diluted earnings per share.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NjQyMjk_54aba427-4e3b-4372-9405-689de6a6703a"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjg1_986ddd08-c7d5-457a-9b50-f1a29ed0df4d">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASU 2019-12.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, we adopted Accounting Standards Update, or ASU, 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, using the modified retrospective transition method. ASU 2019-12 simplifies the accounting for income taxes by removing certain exceptions to the general principles in Topic 740 and amends existing guidance to improve consistent application of Topic 740. The adoption of ASU 2019-12 did not result in a cumulative-effect adjustment to retained earnings. The comparative prior period information continues to be reported under the accounting standards in effect during those periods. The impact of the adoption is expected to be immaterial to our financial position, results of operations and cash flows on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;ASU 2020-06. In August 2020, the FASB issued ASU 2020-06,&#160;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging &#x2013; Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity, which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts in an entity's own equity. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Instead, entities will account for convertible debt instruments wholly as debt, unless certain other conditions are met. The adoption of ASU 2020-06 is expected to prospectively reduce reported interest expense and increase reported net income, and result in a reclassification of certain conversion feature balance sheet amounts from stockholders&#x2019; equity to liabilities as it relates to the 2024 Notes. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We will adopt &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzM4NDgyOTA3MzM1Njg_0b6cd44f-393b-43dc-93c9-f2e86ce8324d"&gt;ASU 2020-06&lt;/span&gt; on January 1, 2022 using the modified retrospective transition method, which allows for a cumulative-effect adjustment in the period of adoption and does not require restatement of prior period amounts. Under this transition method, the cumulative effect of the accounting change is expected to increase the carrying amount of the 2024 Notes by $42.2&#160;million, reduce deferred tax liabilities by $10.0&#160;million, reduce the accumulated deficit by $74.6&#160;million, reduce additional paid-in capital by $106.8&#160;million.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConvertibleDebtNoncurrent
      contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMTg5_f9177336-a3f1-4fb3-be0d-b8233e66258e"
      unitRef="usd">42200000</us-gaap:ConvertibleDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzEwOTk1MTE2NzI5MzA_62682cdf-122a-46ab-9bd9-1945af0a5966"
      unitRef="usd">-10000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjI3_5c2ac297-9ccb-4508-9499-9cfc0bb38a0c"
      unitRef="usd">74600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i01acd1d73cf84c3a9091a8cc6fb8bffc_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xMzkvZnJhZzphODMyZWIwY2E0ZWI0NTI4OGI1MDZiYjhiMDkyMDI5Yy90ZXh0cmVnaW9uOmE4MzJlYjBjYTRlYjQ1Mjg4YjUwNmJiOGIwOTIwMjljXzMwMjcx_4059bee6-32db-455a-aec7-fe514a3840b1"
      unitRef="usd">-106800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEzMjE3_c6062e8f-3370-4d5d-be9d-09c50ef2cd94">Collaboration and License Agreements&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Heptares Therapeutics Limited, or Heptares.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We entered into a collaboration and license agreement with Heptares, which became effective in December 2021, to develop and commercialize certain compounds containing sub-type selective muscarinic M1, M4, or dual M1/M4 receptor agonists, which compounds we have the exclusive rights to develop, manufacture and commercialize worldwide, excluding in Japan, where Heptares retains the rights to develop, manufacture, and commercialize all compounds comprised of M1 receptor agonists, subject to certain exceptions. We are responsible for all development, manufacturing, and commercialization costs. With respect to such rights retained by Heptares, we retain the rights to opt in to profit sharing arrangements, pursuant to which we and Heptares will equally share in the operating profits and losses for such compounds in Japan. Subject to specified conditions, we may elect to exercise such opt-in rights with respect to each such compound either before initiation of the first proof of concept Phase II clinical trial for such compound or following our receipt from Heptares of the top-line data from such clinical trial for such compound. In addition, we have entered into a 2-year research collaboration with Heptares that, unless extended by the parties, is scheduled to expire in December 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the agreement, we paid Heptares $100.0&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;amp;D in 2021. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Heptares may be entitled to receive potential future payments of up to $2.6&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which the royalty term for such licensed product has expired in such country. On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a licensed product and terminate on the later of (i) the expiration of the last patent covering such licensed product in such country, (ii) a number of years from the first commercial sale of such licensed product in such country and (iii) the expiration of regulatory exclusivity for such licensed product in such country.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may terminate the agreement in its entirety or with respect to one or more targets upon 180 days&#x2019; written notice to Heptares during the research collaboration term and upon 90 days&#x2019; written notice to Heptares following the expiration of the research collaboration term. Following the expiration of the research collaboration term, Heptares may terminate the agreement on a target-by-target basis in the event that we do not conduct any material development activities outside of Japan with respect to a certain compound or licensed product within the applicable target class for a continuous period of not less than 365 days and do not commence any such activities within 120 days of receiving written notice. Either party may terminate the agreement, subject to specified conditions, (i) in the event of material breach by the other party, subject to a cure period, (ii) if the other party challenges the validity or enforceability of certain intellectual property rights, subject to a cure period, or (iii) if the other party becomes insolvent or takes certain actions related to insolvency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Takeda Pharmaceutical Company Limited, or Takeda.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we entered into an exclusive license agreement with Takeda, pursuant to which we acquired the exclusive rights to develop and commercialize certain early to mid-stage psychiatry compounds, including luvadaxistat, NBI-1065845, NBI-1065846 and four non-clinical stage compounds. Luvadaxistat and the 4 non-clinical stage compounds have each been designated as a royalty-bearing product. NBI-1065845 and NBI-1065846 are currently each designated as a profit-share product. We are responsible for all manufacturing, development and commercialization costs of any royalty-bearing product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the agreement, we paid Takeda $120.0&#160;million upfront, which, including certain transaction-related costs, was expensed as IPR&amp;amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Takeda may be entitled to receive potential future payments of up to $1.9&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any royalty-bearing product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;With respect to NBI-1065845 and NBI-1065846, we and Takeda will equally share in the operating profits and losses. Takeda retains the rights to opt-out of the profit-sharing arrangements, pursuant to which Takeda would be entitled to receive potential future payments upon the achievement of certain event-based milestones with respect to such compounds and receive royalties on the future net sales of such compounds (in lieu of equally sharing in the operating profits and losses). Takeda may elect to exercise such opt-out right for such compound immediately following the completion of a second Phase II clinical trial for such compound, or, under certain circumstances related to the development and commercialization activities to be performed by us, before the initiation of a Phase III clinical trial for such compound.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the date on which, (i) for any royalty-bearing product, the royalty term has expired in such country; and (ii) for any profit-share product, for so long as we continue to develop, manufacture, or commercialize such licensed product.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a licensed product-by-licensed product and country-by-country basis, royalty payments would commence on the first commercial sale of a royalty-bearing product and terminate on the later of (i) the expiration of the last patent covering such royalty-bearing product in such country, (ii) a number of years from the first commercial sale of such royalty-bearing product in such country and (iii) the expiration of regulatory exclusivity for such royalty-bearing product in such country.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may terminate the agreement in its entirety or in one or more (but not all) of the United States, Japan, the European Union and the United Kingdom, or, collectively, the major markets, upon 6 months&#x2019; written notice to Takeda (i) with respect to all licensed products prior to the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes, as defined in the agreement, prior to the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. We may terminate the agreement in its entirety or in one or more (but not all) of the major markets upon 12 months&#x2019; written notice to Takeda (i) with respect to all licensed products following the first commercial sale of the first licensed product for which first commercial sale occurs, or (ii) with respect to all licensed products in one or more given target classes following the first commercial sale of the first licensed product in such target class for which first commercial sale occurs. Takeda may terminate the agreement, subject to specified conditions, (i) if we challenge the validity or enforceability of certain Takeda intellectual property rights or (ii) on a target class-by-target class basis, in the event that we do not conduct any material development or commercialization activities with respect to any licensed product within such target class for a specified continuous period. Subject to a cure period, either party may terminate the agreement in the event of any material breach, solely with respect to the target class of a licensed product to which such material breach relates, or in its entirety in the event of any material breach that relates to all licensed products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Idorsia Pharmaceuticals Ltd, or Idorsia.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, we entered into a collaboration and license agreement with Idorsia, pursuant to which we acquired the global rights to NBI-827104, a potent, selective, orally active and brain penetrating T-type calcium channel blocker in clinical development for the treatment of a rare pediatric epilepsy and other potential indications, including essential tremor. We are responsible for all manufacturing, development and commercialization costs of any collaboration product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the agreement, we paid Idorsia $45.0&#160;million upfront, which was expensed as IPR&amp;amp;D in 2020. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. Under the terms of the agreement, Idorsia may be entitled to receive potential future payments of up to $1.7&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may terminate the agreement, in its entirety or with respect to a particular compound or development candidate, upon 90 days&#x2019; written notice to Idorsia. Further, in the event a party commits a material breach and fails to cure such material breach within 90 days after receiving written notice thereof, the non-breaching party may terminate the agreement in its entirety immediately upon written notice to the breaching party.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Xenon Pharmaceuticals Inc., or Xenon. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we entered into a collaboration and license agreement with Xenon to identify, research and develop sodium channel inhibitors, including NBI-921352 and three preclinical candidates, which compounds we have the exclusive rights to develop and commercialize. We are responsible for all development and manufacturing costs of any collaboration product, subject to certain exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreement, Xenon may be entitled to receive potential future payments of up to $1.7&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product. Xenon retains the right to elect to co-develop one product in a major indication, pursuant to which Xenon would receive a mid-single digit percentage increase in royalties earned on the future net sales of such product in the United States and we and Xenon would equally share in the development costs of such product in the applicable indication, except where such development costs relate solely to the regulatory approval of such product outside the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the agreement, we paid Xenon $30.0&#160;million upfront and purchased approximately 1.4&#160;million shares of Xenon common stock (at $14.196 per share) for $20.0&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $14.1&#160;million after considering Xenon&#x2019;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $36.2&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;amp;D in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the European Union&#x2019;s approval for the clinical trial application for NBI-921352 for the treatment of focal onset seizures in adults in September 2021, we paid Xenon a regulatory milestone of $10.0&#160;million, including a purchase of approximately 0.3&#160;million shares of Xenon common stock (at $19.9755 per share). The purchased shares were recorded at a fair value of $4.6&#160;million after considering Xenon&#x2019;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $5.4&#160;million of the milestone payment was expensed as R&amp;amp;D.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until the expiration of the royalty term for such product in such country. Upon the expiration of the royalty term for a particular licensed product and country, the license obtained by us with respect to such product and country will become fully paid, royalty free, perpetual and irrevocable. We may terminate the agreement upon 90 days&#x2019; written notice to Xenon, provided that such unilateral termination will not be effective for certain products until we have used commercially reasonable efforts to complete certain specified clinical studies. Either party may terminate the agreement in the event of a material breach in whole or in part, subject to specified conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Voyager Therapeutics, Inc., or Voyager.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2019, we entered into a collaboration and license agreement with Voyager, pursuant to which we acquired certain rights to develop and commercialize the NBIb-1817 for Parkinson&#x2019;s disease program, Friedreich&#x2019;s ataxia program and two undisclosed programs. We are responsible for all development costs of any collaboration product, subject to certain co-development and co-commercialization rights retained by Voyager. In February 2021, we notified Voyager of our termination of the NBIb-1817 for Parkinson&#x2019;s disease program, which became effective August 2, 2021. The termination did not apply to any program other than the NBIb-1817 for Parkinson&#x2019;s disease program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the agreement, Voyager may be entitled to receive potential future payments of up to $1.3&#160;billion upon the achievement of certain event-based milestones and would be entitled to receive royalties on the future net sales of any collaboration product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the agreement, we paid Voyager $115.0&#160;million upfront and purchased approximately 4.2&#160;million shares of Voyager common stock (at $11.9625 per share) for $50.0&#160;million. We accounted for the transaction as an asset acquisition as the set of acquired assets did not constitute a business. The purchased shares were recorded at a fair value of $54.7&#160;million after considering Voyager&#x2019;s stock price on the measurement date and certain transfer restrictions applicable to the shares. The remaining $113.1&#160;million of the purchase price, which includes certain transaction-related costs, was expensed as IPR&amp;amp;D in 2019. In addition, we paid Voyager $5.0&#160;million upfront, which was expensed as IPR&amp;amp;D in 2019, to acquire the rights outside the United States to the Friedreich&#x2019;s ataxia program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless terminated earlier, the agreement will continue in effect until the expiration of the last to expire royalty term with respect to any collaboration product or the last expiration or termination of any exercised co-development and co-commercialization rights by Voyager as provided for in the agreement. We may terminate the agreement upon 180 days&#x2019; written notice to Voyager prior to the first commercial sale of any collaboration product or upon 1 year after the date of notice if such notice is provided after the first commercial sale of any collaboration product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;BIAL &#x2013; Portela &amp;amp; Ca, S.A., or BIAL.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; We acquired the United States and Canada rights to ONGENTYS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(opicapone) from BIAL in 2017, and launched ONGENTYS in the United States in September 2020 as an FDA-approved add-on treatment to levodopa/carbidopa in patients with Parkinson's disease experiencing motor fluctuations. We are responsible for all commercialization costs of ONGENTYS in the United States and Canada and rely on BIAL for the commercial supply of ONGENTYS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the license agreement, BIAL may be entitled to receive potential future payments of up to $75.0&#160;million upon the achievement of certain event-based milestones. In addition, with respect to ONGENTYS, in the event we fail to meet certain minimum sales requirements for a particular year in comparison to our annual sales forecast for such year, we would be obligated to pay BIAL an amount equal to the difference between the actual net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;sales and minimum sales requirements for such year. Further, upon our written request to BIAL 12 months prior to the estimated expiration of the term of a licensed product, we will negotiate the continuation of BIAL&#x2019;s supply of such licensed product after the term. After the term, and if BIAL is no longer supplying such licensed product, BIAL would be entitled to receive a low double-digit royalty on our future quarterly net sales of such licensed product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the FDA&#x2019;s approval for ONGENTYS for Parkinson&#x2019;s disease in April 2020, we paid BIAL a regulatory milestone of $20.0&#160;million, which was expensed as R&amp;amp;D in 2020. In connection with the FDA&#x2019;s acceptance of the NDA for opicapone for Parkinson&#x2019;s disease in 2019, we paid BIAL a regulatory milestone of $10.0&#160;million, which was expensed as R&amp;amp;D in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement will continue on a licensed product-by-licensed product and country-by-country basis until a generic product with respect to such licensed product is sold in a country and sales of such generic product are greater than a specified percentage of total sales of such licensed product in such country.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may terminate the agreement upon 9 months&#x2019; written notice to BIAL. BIAL may terminate the agreement in the event we fail to meet the minimum sales requirements for any 2 years, or under certain circumstances involving a change of control of Neurocrine Biosciences. Under certain circumstances where BIAL elects to terminate the agreement in connection with a change of control of Neurocrine Biosciences, BIAL would be obligated to pay us a termination fee. Either party may terminate the agreement if the other party materially breaches the agreement and does not cure the breach within a specified notice period, or upon the other party&#x2019;s insolvency.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mitsubishi Tanabe Pharma Corporation, or MTPC&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We out-licensed the rights to valbenazine in Japan and other select Asian markets to MTPC in 2015. MTPC is responsible for all development, manufacturing and commercialization costs of valbenazine in such markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $55.0&#160;million upon the achievement of certain event-based milestones and would be entitled to receive royalties at tiered percentage rates on MTPC&#x2019;s future net sales of valbenazine for the longer of 10 years or the life of the related patent rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with MTPC&#x2019;s submission of a filing for marketing authorization for valbenazine for the treatment of tardive dyskinesia in Japan in April 2021, we received a regulatory milestone of $15.0&#160;million, which was recognized as collaboration revenue in 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are currently conducting the KINECT-HD study, a placebo-controlled Phase III study of valbenazine in adult Huntington disease patients with chorea. In connection with our performance of the study, we recognized non-cash collaboration revenue of $5.7&#160;million for 2021, $2.6&#160;million for 2020 and $0.9&#160;million for 2019. As of December&#160;31, 2021, $1.0&#160;million of revenue is being deferred in connection with our continuing performance obligations under the collaboration and will be recognized as non-cash collaboration revenue over the remaining study period using an input method according to costs incurred to-date relative to estimated total costs associated with the study.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MTPC may terminate the agreement upon 180 days&#x2019; written notice to us. In such event, all out-licensed product rights would revert to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AbbVie Inc., or AbbVie. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We out-licensed the global rights to elagolix to AbbVie in 2010. AbbVie is responsible for all development and commercialization costs of elagolix. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the license agreement, we may be entitled to receive potential future payments of up to $366.0&#160;million upon the achievement of certain event-based milestones and will continue to receive royalties at tiered percentage rates on AbbVie&#x2019;s quarterly net sales of elagolix for the longer of 10 years or the life of the related patent rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AbbVie launched ORILISSA&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(elagolix tablets) in the United States in August 2018 as an FDA-approved oral medication for the management of moderate to severe endometriosis pain in women. In June 2020, AbbVie launched ORIAHNN&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(elagolix, estradiol and norethindrone acetate capsules and elagolix capsules) in the United States as an FDA-approved oral medication for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. We recognized elagolix royalty revenue of $22.3 million for 2021, $19.2&#160;million for 2020 and $14.3&#160;million for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the FDA&#x2019;s approval for AbbVie&#x2019;s ORIAHNN for uterine fibroids in May 2020, we received a regulatory milestone of $30.0&#160;million, which was recognized as collaboration revenue in 2020. In connection with the FDA&#x2019;s acceptance of AbbVie&#x2019;s NDA for ORIAHNN for uterine fibroids in 2019, we received a regulatory milestone of $20.0&#160;million, which was recognized as collaboration revenue in 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;AbbVie may terminate the agreement upon 180 days&#x2019; written notice to us. In such event, all out-licensed product rights would revert to us.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEzMjE5_f31de7d7-d85b-4477-a487-210c7243dfc4">Under the terms of our existing collaboration and license agreements, we may be required to make potential future payments of up to $10.9 billion upon the achievement of certain event-based milestones. Such contingent payments are recorded when paid or payable.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <nbix:PotentialMilestonePayments
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzIzNw_a5c20507-5cd2-434c-a9cc-cc96b69faff1"
      unitRef="usd">10900000000</nbix:PotentialMilestonePayments>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i43c71899173f405dbe3d33122d8cc5f3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzEzNTI_e80d4795-dec9-4e3a-ae38-5dd5674c0b86"
      unitRef="usd">100000000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:PotentialMilestonePayments
      contextRef="i79c18d17c4d449729c00a0ccd9f18346_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzEzMzc_8c78db92-4238-4641-b482-4b9b064b9059"
      unitRef="usd">2600000000</nbix:PotentialMilestonePayments>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="ia23be7e269184e22820e45d5995df04f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NjUzMDA_28023171-2d86-42f0-8506-c8e951fc728b"
      unitRef="usd">120000000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:PotentialMilestonePayments
      contextRef="ia5e99701bd3641d5a09bb0c7b27a6b9f_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzE5Mzk_4f50175d-e470-4354-8071-52fda6e9c1ae"
      unitRef="usd">1900000000</nbix:PotentialMilestonePayments>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i7a59621400074ae78191449ef71bd45d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzI2NzI_ab809a79-58d7-478b-a717-ad177926c3aa"
      unitRef="usd">45000000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:PotentialMilestonePayments
      contextRef="i456ae801af6b4bcc85cf441dbbfd2d07_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MzIzOTE_b96c6242-1898-4317-a276-4c6057e5d530"
      unitRef="usd">1700000000</nbix:PotentialMilestonePayments>
    <nbix:PotentialMilestonePayments
      contextRef="ib237ea6839b14af68a00881661bda1d9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODI3MTU_46371734-a868-4e04-b6c1-16ade31983c7"
      unitRef="usd">1700000000</nbix:PotentialMilestonePayments>
    <nbix:UpfrontPaymentsMade
      contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQxNjI_316b318b-0f4f-4f11-8ffb-642567c52e87"
      unitRef="usd">30000000</nbix:UpfrontPaymentsMade>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="ic6d6f5ca848240c5ac2c7ad24cd32191_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg0MjI_389c0357-a229-4fbc-8df6-5c632bfb0c9f"
      unitRef="shares">1400000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:SharePrice
      contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQyMTc_c0b16d79-052d-4298-891b-b8de87edbbf9"
      unitRef="usdPerShare">14.196</us-gaap:SharePrice>
    <nbix:MilestoneEquityPurchasePayment
      contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg0MzU_a8535cd4-3aca-4cc3-ad86-075fad74f93a"
      unitRef="usd">20000000</nbix:MilestoneEquityPurchasePayment>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i10dced8bd21b43fc85950bc06dc71600_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQ2OTk_528e262e-1497-4756-8354-8dd49768bb9c"
      unitRef="usd">14100000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i43094c3fedcd4655bb4323ec7e023ff3_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzQ4NTQ_c83793f3-016c-4fa5-a60e-45ef050e6421"
      unitRef="usd">36200000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:MilestonePayment
      contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg1ODE_28c664ce-fdad-40d7-9340-b29fd5c85a08"
      unitRef="usd">10000000</nbix:MilestonePayment>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2MTA_183bbdb9-97be-4eab-8ce1-327e1154c83b"
      unitRef="shares">300000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:SharePrice
      contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2MjM_e846157f-750e-48e8-b38b-cac64f549d8d"
      unitRef="usdPerShare">19.9755</us-gaap:SharePrice>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTg2NDc_f34b4a82-664b-416e-bc1f-a000a9a2f957"
      unitRef="usd">4600000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzM4NDgyOTA4NjQ2NDI_ae5ca332-ae63-4069-adcf-c8ecdc0ea0af"
      unitRef="usd">5400000</us-gaap:ResearchAndDevelopmentExpense>
    <nbix:PotentialMilestonePayments
      contextRef="i2d30d0be95cb415b8e4d465eff571719_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODE1MDc_379c8e2b-b36f-421b-83a6-f2f7ad3f241f"
      unitRef="usd">1300000000</nbix:PotentialMilestonePayments>
    <nbix:UpfrontPaymentsMade
      contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzU0NTI_4aa1d42a-468b-4d0f-9ff8-00ae24cfc125"
      unitRef="usd">115000000</nbix:UpfrontPaymentsMade>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="if4c4fe5c60424af0bcadedd757afff96_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTgxNjM_f1db092f-8b38-495c-aec3-e63bc400dfac"
      unitRef="shares">4200000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:SharePrice
      contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzU1MDk_74fcdf86-e984-4117-9485-679be96345cc"
      unitRef="usdPerShare">11.9625</us-gaap:SharePrice>
    <nbix:MilestoneEquityPurchasePayment
      contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTgxODA_3fb70e52-28b8-4cbc-9fbb-add95a0981c1"
      unitRef="usd">50000000</nbix:MilestoneEquityPurchasePayment>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="id9e86bc6f5114de09a4f88e130139396_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzYzOTg_ce287ac1-c02d-41d9-a4d6-db5463548983"
      unitRef="usd">54700000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i4e054e20087341ada5c247008d55c3b7_D20190101-20190331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzY1NTU_c72f5cf3-ced9-44e1-938f-2b6fb52f579e"
      unitRef="usd">113100000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff
      contextRef="i7f5841fc889c4d08846ef46e8a70311f_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1Mjc1NDQ_418aef47-9b67-4c38-9678-0c039e76faf6"
      unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff>
    <nbix:PotentialMilestonePayments
      contextRef="i86636d6fafc9428a9d7466bfe935ab09_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc0OTE3MzE_a3d0ee67-335f-4044-9f5b-0d03e93faafb"
      unitRef="usd">75000000</nbix:PotentialMilestonePayments>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if3045b62535f464b86c604c3234e0d9c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjUwNjg_e56fd045-2672-4ae5-8750-d986623b4cb9"
      unitRef="usd">20000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ibad5cee165ce4cf8891c0de774e460a5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjUyNDU_8f434cf6-de33-4f5d-8d57-f848fb0a2579"
      unitRef="usd">10000000</us-gaap:ResearchAndDevelopmentExpense>
    <nbix:PotentialMilestonePaymentReceipts
      contextRef="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NTUxNzM_6765f4c8-b396-40c1-9340-5f2bbee43ab6"
      unitRef="usd">55000000</nbix:PotentialMilestonePaymentReceipts>
    <nbix:PatentTerm
      contextRef="iebafbee9477a4c18a360adb95c24c539_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE2NjIyNjA_8fe84203-7fab-4fad-a5cb-217e4232c6b0">P10Y</nbix:PatentTerm>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDA1Njc_a93f2608-a055-47f1-a494-20f2f643ce0c"
      unitRef="usd">15000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i397d24f8c00a428f9678e93c11f8b36f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3NDI_3ed9f2f3-27f3-4c84-874a-5ea30f97e24f"
      unitRef="usd">5700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i13f8068eb08a4699b20184347a6e696a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3MTk_9c412aae-0aa7-4147-9e5d-d2289dc32e9d"
      unitRef="usd">2600000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i76d0ccd9a2e24853bab0ecd66739a001_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MDE3MzQ_05c33722-9aa4-447b-a795-be504071d5fe"
      unitRef="usd">900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:DeferredRevenue
      contextRef="i86eb8905a37c4c41a9c7f5c8e0f19765_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODk0NDU_9fd7abe2-7acb-4094-9b99-b6c969b217b9"
      unitRef="usd">1000000</us-gaap:DeferredRevenue>
    <nbix:PotentialMilestonePaymentReceipts
      contextRef="i451e907724df41c5908356a4f2323922_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3MjA4NjQ_006ff27f-3d4c-4aad-8e10-7b5ce335620b"
      unitRef="usd">366000000</nbix:PotentialMilestonePaymentReceipts>
    <nbix:PatentTerm
      contextRef="i3ef358c546644634864929f3c2061c03_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE4MDMxMjM_c531b906-b680-49f3-b9c4-c307fcb0a55d">P10Y</nbix:PatentTerm>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f9ae86c7e9144a1bae39b561ed9746c_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3ODk0NjA_69ae7616-9562-43fc-912d-1dd46d122b31"
      unitRef="usd">22300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i454f573ac4474e279abf38d39ec2838c_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3NDE3NjY_b12e171c-1e0f-4fe5-8ee5-e20f2fdb6a35"
      unitRef="usd">19200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fddadf6fcb24a699f2fa1cbf8dd90f5_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzEwOTk1MTE3NDE3ODQ_2ffa49da-d7cc-4345-ae86-7a50ceca06ac"
      unitRef="usd">14300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0db30671c08348dab7eba8e85cf822e8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MTIyNTQ_1eda00a2-e898-4823-ba99-16d0ab7a2212"
      unitRef="usd">30000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16b9930a1b5945c1bdf18b24ad954df4_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDUvZnJhZzozOGYxYzE2YjQ5Yjc0YjM1OTVhNzE4YWFmY2E5N2EyZi90ZXh0cmVnaW9uOjM4ZjFjMTZiNDliNzRiMzU5NWE3MThhYWZjYTk3YTJmXzE2NDkyNjc1MTIyNzE_5ab6bbe0-bc93-4b72-ad43-9ffc83694ae3"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2MDI_74f67843-064b-4649-92c1-31d759327961">Debt Securities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amortized cost, unrealized gain and loss recognized in accumulated other comprehensive income (loss) and fair value of debt securities available-for-sale at December&#160;31, 2021, aggregated by major security type and contractual maturity:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Contractual&lt;br/&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;612.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;613.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1 to 3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;358.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;357.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1 to 3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;563.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;227.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, our security portfolio consisted of 164 debt securities available-for-sale, including 136 such securities that were in an unrealized loss position but of high credit quality. Unrealized losses on these investments were primarily due to changes in interest rates. We do not intend to sell these investments and it is not more likely than not that we will be required to sell these investments before recovery of their amortized cost basis. We did not recognize an allowance for credit losses as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes debt securities available-for-sale in an unrealized loss position for less than 12 months, aggregated by major security type. There were no debt securities available-for-sale in an unrealized loss position for longer than 12 months as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;659.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2MDM_13bf591f-e8ba-4d18-ab13-c9acf72065d5">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the amortized cost, unrealized gain and loss recognized in accumulated other comprehensive income (loss) and fair value of debt securities available-for-sale at December&#160;31, 2021, aggregated by major security type and contractual maturity:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.073%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Contractual&lt;br/&gt;Maturity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;128.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;299.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;300.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0 to 1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;230.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;231.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;370.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;612.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;613.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1 to 3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;358.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;357.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;144.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;145.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1 to 3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;81.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;563.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;560.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;226.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;227.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMy0xLTEtMjg4NjU_182a94db-b476-4662-a63b-75bf97f16277"
      unitRef="usd">204800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItNS0xLTEtMjg4NjU_35456a31-bc2b-4f5d-90e3-8c100de6d952"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItNy0xLTEtMjg4NjU_29377ffb-4c1b-412c-a7e7-59613ac32e80"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f71aac91af1491f9facb5b304bc26ab_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItOS0xLTEtMjg4NjU_b01e24f8-1637-45cf-8a48-fe87e997a0bc"
      unitRef="usd">204800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTEtMS0xLTI4ODY1_087f7080-0783-422e-bd19-7d1ad61d68fb"
      unitRef="usd">82200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTMtMS0xLTI4ODY1_29d71f03-af00-45a6-a561-a54390752115"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTUtMS0xLTI4ODY1_33d39b3c-7a63-4e9a-8dd4-bccb71b4e7ce"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6fbe0b4e8d8444179db90d05853c145d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzItMTctMS0xLTI4ODY1_adfa77ba-be5e-4290-8b32-91af5c57e2e1"
      unitRef="usd">82200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMy0xLTEtMjg4NjU_cdb6fb71-09a1-42bd-b141-6b6265a6cd1d"
      unitRef="usd">128200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtNS0xLTEtMjg4NjU_0e4e4aa1-4030-4ba0-90b9-7e7c9fd4474b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtNy0xLTEtMjg4NjU_6e4cf324-024a-4004-8692-929f0f43bc92"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia354000cd50b4ec1ae22e67d8c5238ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtOS0xLTEtMjg4NjU_9cff80b4-bf4f-4e1e-9041-0c68c76d5967"
      unitRef="usd">128100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTEtMS0xLTI4ODY1_1e0d79cb-d6ad-4d56-8bdd-2fbf35e5c490"
      unitRef="usd">299300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTMtMS0xLTI4ODY1_28fa6f7f-7644-4f1d-ad4e-454e0d4d091b"
      unitRef="usd">1400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTUtMS0xLTI4ODY1_0ba16bfa-937c-4761-8242-40d1ef423b11"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i91d81c1abc6d4b73ad93fc98b7974149_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzMtMTctMS0xLTI4ODY1_582d6171-b3a3-4aa1-b0d9-8aeecdb03afd"
      unitRef="usd">300700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMy0xLTEtMjg4NjU_7222385a-218f-4c1a-b2c8-f884e8fc8b76"
      unitRef="usd">37600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtNS0xLTEtMjg4NjU_b0e50a4b-b202-44d1-9a09-09319366d1c0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtNy0xLTEtMjg4NjU_fe021baf-a8c6-47ee-afde-99927cb08ab1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i89e3a3c1bde5450ab96dc17e9a050b11_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtOS0xLTEtMjg4NjU_5f1b8134-2757-4faa-86f5-8a39b893b142"
      unitRef="usd">37600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTEtMS0xLTI4ODY1_571e59c3-6453-49bc-875c-28f69fe6eaf3"
      unitRef="usd">230900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTMtMS0xLTI4ODY1_73edbacf-1f35-425c-9b4e-00fb9d230b31"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTUtMS0xLTI4ODY1_255324c4-bd13-4a5c-89f6-09b70714e617"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i191cc2bc5c2e43e695b94c121c9e2cfe_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzQtMTctMS0xLTI4ODY1_b583e27c-05d3-4883-8e78-b1d6ab12eddc"
      unitRef="usd">231000000.0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMy0xLTEtMjg4NjU_faf4b98f-3f16-4d1f-aff4-32a98cccf41e"
      unitRef="usd">370600000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtNS0xLTEtMjg4NjU_5542f171-ee1a-49dc-87fa-2892875e08c4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtNy0xLTEtMjg4NjU_76634ecc-f2da-4869-a27c-e29101e97663"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3444b3f24cee47b19a83d7b209ba18d2_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtOS0xLTEtMjg4NjU_3295d1da-884a-4f07-a6c8-e4828689d706"
      unitRef="usd">370500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTEtMS0xLTI4ODY1_119f84fe-2d21-449e-9d49-e66d9bba2ea3"
      unitRef="usd">612400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTMtMS0xLTI4ODY1_9a6b078e-81cb-463e-a655-4c19f8e61896"
      unitRef="usd">1500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTUtMS0xLTI4ODY1_53809edc-60f2-4174-aa71-b174bd37eb96"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i70a090e172d54a3390fc3154fe0c83e2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzUtMTctMS0xLTI4ODY1_2011c1d9-5cf5-49c3-bc0c-cd9facee318a"
      unitRef="usd">613900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMy0xLTEtMjg4NjU_201c46a6-bcab-448b-9189-2500cb119c00"
      unitRef="usd">358900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctNS0xLTEtMjg4NjU_b42e4212-a679-4fcf-98bc-d31cdeb8c806"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctNy0xLTEtMjg4NjU_20b94b80-1bbe-471e-bddf-29e23534bbd0"
      unitRef="usd">1500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic8ff02291a68451db9fb0056413edd22_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctOS0xLTEtMjg4NjU_dde04c60-935f-428f-9978-efbddf722236"
      unitRef="usd">357400000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTEtMS0xLTI4ODY1_cf46199b-4f72-4e97-8b69-882ff7adc50a"
      unitRef="usd">144800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTMtMS0xLTI4ODY1_354048e9-f173-4dd9-a2ba-2dfaf9389562"
      unitRef="usd">400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTUtMS0xLTI4ODY1_9e5409a6-9816-4c88-8a30-608f3a31e973"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f395cb9d20e4731af7c9ee3668a9dfa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzctMTctMS0xLTI4ODY1_e23127e4-cef6-4527-b94d-7050c27c64ff"
      unitRef="usd">145200000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMy0xLTEtMjg4NjU_cca5c3f0-00c4-4295-802a-eae934c740ac"
      unitRef="usd">204300000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtNS0xLTEtMjg4NjU_26a42a33-c458-4233-91dd-8337ec73a01b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtNy0xLTEtMjg4NjU_e0c04d7b-8797-4aad-8dd9-dd302083fb67"
      unitRef="usd">1000000.0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i08d125aaa55c4e49aa9e111cf119eeb7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtOS0xLTEtMjg4NjU_4bada154-e57d-479a-8126-03c17083f6a1"
      unitRef="usd">203300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTEtMS0xLTI4ODY1_b5ab03c9-22a9-4129-9451-4bf118878063"
      unitRef="usd">81900000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTMtMS0xLTI4ODY1_ef24b79e-b6be-4524-b3e1-a126cb9e4fb0"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTUtMS0xLTI4ODY1_0af0c9c0-bed0-41a9-84a6-e6123a068c43"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9e005455b14444cac5e10f4c73e0446_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzgtMTctMS0xLTI4ODY1_542b6e5d-3d56-49e0-9af4-97848b37ad0b"
      unitRef="usd">81900000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMy0xLTEtMjg4NjU_ceed7519-013e-461a-a29f-f4c9f81e0742"
      unitRef="usd">563200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktNS0xLTEtMjg4NjU_fbc91e8e-e2db-4027-911c-886de80b3250"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktNy0xLTEtMjg4NjU_c9641ac6-7be0-4ffd-840f-4a434e4ddc33"
      unitRef="usd">2500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i235dcd3608564d60b4d0f9676da9af24_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktOS0xLTEtMjg4NjU_343993c1-36a0-4b58-b227-fdcb69e18f70"
      unitRef="usd">560700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTEtMS0xLTI4ODY1_3b82adf3-0455-4437-91fa-ad3d3d0dbfcb"
      unitRef="usd">226700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTMtMS0xLTI4ODY1_087e51c6-8ba8-4e08-99df-adb4618ccc79"
      unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTUtMS0xLTI4ODY1_4caa3933-c980-4e33-882b-5c2f3b630a00"
      unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id34e6de166964d63af8e67b2f42daf09_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZTpkNWQ0ODcyNzIzMTQ0NGRkYjgwOTVjMTY5ODg0MDliNS90YWJsZXJhbmdlOmQ1ZDQ4NzI3MjMxNDQ0ZGRiODA5NWMxNjk4ODQwOWI1XzktMTctMS0xLTI4ODY1_e7a6bc83-c4f8-46e6-b1dc-6d08259ca413"
      unitRef="usd">227100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <nbix:DebtSecuritiesAvailableForSalePositionNumberOfPositions
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2NDkyNjc0NDM2MjY_c609ea2e-35c6-4292-9ca1-8e4adc88beee"
      unitRef="security">164</nbix:DebtSecuritiesAvailableForSalePositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzE2NDkyNjc0NDM3MTI_e2f4d8d2-4006-45be-8b2e-35e5c892ab62"
      unitRef="security">136</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90ZXh0cmVnaW9uOmI0MThhYTlkZGNkNzQ2ZjY5NGE3MGM1MzcyNDQ4Y2RjXzM4NDgyOTA3MDIwMTE_531b6cfb-ce8c-4a5b-9161-1942d60c8bc2">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes debt securities available-for-sale in an unrealized loss position for less than 12 months, aggregated by major security type. There were no debt securities available-for-sale in an unrealized loss position for longer than 12 months as of December&#160;31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Corporate Debt Securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;428.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;230.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;659.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib0735a600c0d40f49b4766b4bceeb49c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMS0xLTEtMjg4ODI_b6c3c3d3-4b82-4d00-b5d3-ba3aa3756827"
      unitRef="usd">428600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib0735a600c0d40f49b4766b4bceeb49c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMy0xLTEtMjg4ODI_26c23268-0170-4bd5-9310-89f1dd7446b1"
      unitRef="usd">1600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ic01bd7b047c1401a899b33800d0940b5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMTItMS0xLTQxMDg3_b1f41b17-4dd7-4ca5-aa33-128c312bb7f1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ic01bd7b047c1401a899b33800d0940b5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzItMTQtMS0xLTQxMDg4_6d15009e-371d-4512-9fe0-1f5846e40798"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i24cc646be8f346209fda92f0f7069e29_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMS0xLTEtMjg4ODI_063de587-682c-49dc-afaa-ceb60f115fb6"
      unitRef="usd">230500000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i24cc646be8f346209fda92f0f7069e29_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMy0xLTEtMjg4ODI_dc798081-cd23-42a6-a84d-9760674692b6"
      unitRef="usd">1000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie25af8b80ac74893a5e4045458ebe3d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMTItMS0xLTI4ODgy_d71a3a37-8399-4c5d-a121-794fd34f788a"
      unitRef="usd">95000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie25af8b80ac74893a5e4045458ebe3d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzMtMTQtMS0xLTI4ODgy_6f8e95ea-0615-4609-9fc8-5137c7a2fef6"
      unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMS0xLTEtMjg4ODI_100cec30-1ae7-4451-8365-4e482f10f951"
      unitRef="usd">659100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMy0xLTEtMjg4ODI_9894a680-16ae-4104-a720-db04b6dd300f"
      unitRef="usd">2600000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMTItMS0xLTI4ODgy_076d75da-76be-48eb-b2ac-6501a4d6affb"
      unitRef="usd">95000000.0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNDgvZnJhZzpiNDE4YWE5ZGRjZDc0NmY2OTRhNzBjNTM3MjQ0OGNkYy90YWJsZToxYTgzMWI0Yjc4NDE0MWU0YWRlNmJiYWY0YTJjNDM0ZS90YWJsZXJhbmdlOjFhODMxYjRiNzg0MTQxZTRhZGU2YmJhZjRhMmM0MzRlXzQtMTQtMS0xLTI4ODgy_1512f75c-782b-4b93-8fc7-99d8cc2cb32b"
      unitRef="usd">100000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzk1MA_598e38bb-87d4-4cf2-9801-ac283e7c449d">Fair Value Measurements&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments, which were measured at fair value on a recurring basis, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities&#x2013;biotechnology industry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;396.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;931.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,069.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of equity security investments, which were measured at fair value on a recurring basis using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gain (loss) included in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"&gt;_________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) In September 2021, we purchased 0.3&#160;million shares of Xenon's common stock, valued at $4.6&#160;million on the date of purchase, in connection with the European Union&#x2019;s approval of the clinical trial application for NBI-921352.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) In the fourth quarter of 2021, our equity security investment in Xenon was transferred from Level 3 to Level 1 as the associated holding period restriction expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the discount for lack of marketability used in the valuation analysis of our Voyager equity security investment was 2.5%. Unrealized gains and losses on equity security investments are included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDYwOTY_c1a77f5b-d66c-4b05-81e3-e74f512e7fff">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investments, which were measured at fair value on a recurring basis, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.398%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Cash and money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Debt securities available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;204.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;82.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;485.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;445.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Securities of government-sponsored entities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;240.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;312.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Equity securities&#x2013;biotechnology industry&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,338.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;396.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;931.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,069.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;841.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:Investments
      contextRef="i76a49edc4ee149f98fe61f36a1419ed3_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMS0xLTEtMjg5MTY_873bf537-ebe3-4f9d-b0d9-1d31e0c1b0d3"
      unitRef="usd">340800000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if35fcf69010c43dba3cbbf868e2b0935_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMy0xLTEtMjg5MTY_93da4f3e-2279-4373-8271-68a1f9c74625"
      unitRef="usd">340800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iccfdb59917c64d368e0d64701f53126a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtNS0xLTEtMjg5MTY_f449602a-c50e-457a-80c9-6c3bce1870c9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i04d318b9ca2d49ba84b1a9cb4b48b0ec_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtNy0xLTEtMjg5MTY_7f03096b-1663-47b1-a697-f6a14c63f93a"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="ib1fc4ae0f5aa4acab5c143236c0015b6_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtOS0xLTEtMjg5MTY_8752e761-985d-4cfd-b8f3-fa986d4ff5f5"
      unitRef="usd">187100000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8aba8816099b49f2b953b15fdf4c39b2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTEtMS0xLTI4OTE2_02166528-e22e-450b-aee8-4e37750ab35b"
      unitRef="usd">187100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iadfb23126df048dbb4bac68dde154ace_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTMtMS0xLTI4OTE2_74b62d21-5b6a-4bcc-a949-faa3c24a649e"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1c1c4f4456c9492990b2e5c6e5a0abd1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzQtMTUtMS0xLTI4OTE2_f4144249-47c1-4717-99d5-8689634e7268"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="ibc5ff81f5ac24f46bf859c4b7eee092a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMS0xLTEtMjg5MTY_5d213410-b087-447a-84c2-3fb3cd284e25"
      unitRef="usd">3200000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i6ff788d8c75a4d8b9999c533dabd5da6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMy0xLTEtMjg5MTY_bb1be795-421a-4cff-939b-168cb8a1df93"
      unitRef="usd">3200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9d4d41477f874a44b2eba85537a90148_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctNS0xLTEtMjg5MTY_07204e7a-e1b5-4d70-939f-7097566d00df"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iaeb2651610fa4d00b5e2ac296d947a60_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctNy0xLTEtMjg5MTY_b40a0c77-a92e-413f-9a9a-803d3665b74c"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i8dceb0bae28a43219d613b3ec3a546bd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctOS0xLTEtMjg5MTY_c73d3e46-a061-4bf7-bee3-60d5f75e1eaf"
      unitRef="usd">3200000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0b4b9585d44440bfaf6270349255857e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTEtMS0xLTI4OTE2_429178af-66a9-473d-bfe8-69c9018b4eba"
      unitRef="usd">3200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i10fea06938594614aa8b26da5cf66581_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTMtMS0xLTI4OTE2_4120c452-5c99-469f-a3b0-8d24ad34a948"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic56519559b60412eb627bc0dd14040fa_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzctMTUtMS0xLTI4OTE2_1fb43291-2150-4d58-9aba-491706aec387"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="if0f374dbf03747a2a83ac15d4ac0a895_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTEtMS0xLTI4OTE2_dde6c9c2-87fa-4663-bc24-2421075042dc"
      unitRef="usd">204800000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if0ada51f1409498abba0c3063df43360_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTMtMS0xLTI4OTE2_e685641e-4aa4-48c1-bca1-d6d85e52b346"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i876dd799b2e4471c969a5ee5b51f6040_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTUtMS0xLTI4OTE2_3da4daef-c705-4897-8baf-e2eca74d967e"
      unitRef="usd">204800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0efb41a1a6274a0fa1294d81a1e66e3e_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTctMS0xLTI4OTE2_e5854d6d-1100-4ee8-8b63-4123ab8ea6e9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="iaa7306db60774a77859d10b85a4592ba_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTktMS0xLTI4OTE2_40ce6777-46c4-4eec-8b64-444ece1d783c"
      unitRef="usd">82200000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i43241c1d857141b3a9d4aa8134c3faa9_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTExLTEtMS0yODkxNg_c2c59977-153b-4b5a-a9f9-ffe58b479638"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib50a2b7c2c194c41a768ce0f89919060_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTEzLTEtMS0yODkxNg_f412a700-baaa-4046-8cef-7b3c07a6d240"
      unitRef="usd">82200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i18d11505b7354bdb8dd782858dcfdce3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEwLTE1LTEtMS0yODkxNg_212267b7-5efc-4dc8-a226-f335c5d51875"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="iadb175bdb8bf48208387a96572f64706_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTEtMS0xLTI4OTE2_85fa14b8-e65f-4496-a957-128cda08c027"
      unitRef="usd">485500000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if70c342cd44742ebb040c59491a90fca_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTMtMS0xLTI4OTE2_62902703-18c8-4399-ba11-f470b57ebbb9"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifb7c841968874564a68757c7554e2071_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTUtMS0xLTI4OTE2_b7b170d0-f182-4cea-85fd-86a548c81384"
      unitRef="usd">485500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic77011f1e4f6476984258b7755256168_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTctMS0xLTI4OTE2_feea1827-4696-484b-8e43-1de913af9ef4"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i0def021d29df4ec18dc8a7252ae17d0a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTktMS0xLTI4OTE2_88cc39b6-3dce-4ae9-90b0-33bdd297396b"
      unitRef="usd">445900000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i10f1318702cc48bd9a8576b930cc668f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTExLTEtMS0yODkxNg_97d16ef1-89df-4481-9134-cf0e0c3a7098"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i84e3b1a6faf84f6db9b5b5a39c51c46c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTEzLTEtMS0yODkxNg_ee3f6001-48cd-4d1d-8ba6-b799f8f677df"
      unitRef="usd">445900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7057cb4559b6490ab7be7846300e2a22_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzExLTE1LTEtMS0yODkxNg_f67a1e97-46f7-4432-8da1-b5c902a0f3bc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i1a4cc70d0fde4bd498a8a0983c081d59_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTEtMS0xLTI4OTE2_7b657bf1-556e-427f-9a7b-fff2915f7cb4"
      unitRef="usd">240900000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib9f1618b76d04cb19552c0380c3a41a8_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTMtMS0xLTI4OTE2_98eb4594-52ff-4f02-a848-a240015ae034"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i43e9f130272d4e318928d9dafd608b88_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTUtMS0xLTI4OTE2_a755ed8e-028e-4ce5-91df-cface838cf58"
      unitRef="usd">240900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1cf0666db5964cb0b1c6c44c2bb1140a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTctMS0xLTI4OTE2_96887993-334f-458d-862f-04c01166efd5"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="ifbeb38fcafcd44cf92ecbae65ec65d39_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTktMS0xLTI4OTE2_121110ee-aa86-4bb1-aef7-b7f288992078"
      unitRef="usd">312900000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5d7321b1fe734028a54ac2f80b9681ed_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTExLTEtMS0yODkxNg_06206161-c6fe-4048-98ec-f7adf9a51a6f"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i35e8c83d4e9e4b538a866c7908923299_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTEzLTEtMS0yODkxNg_836a49bc-8c51-4540-b894-ad633ef8e07e"
      unitRef="usd">312900000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0302646986a64378a658c9ee1c53404a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzEyLTE1LTEtMS0yODkxNg_fb312975-e9c6-4f26-b971-4196a73b0acf"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i7c29b15534a34aa1bd91898138b443d9_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTEtMS0xLTI4OTE2_0f9c4359-a55f-4c0b-a660-dc4f8fe85e78"
      unitRef="usd">63700000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i2f3cf54d0e5248aeb00d32bbd4fe0441_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTMtMS0xLTI4OTE2_2bedffd1-5d8e-42fa-8d19-12b7af671369"
      unitRef="usd">52700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia476ce9b48f74567b16e1107fc4d5f58_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTUtMS0xLTI4OTE2_2d039ef2-3ea1-4b09-a771-d91bd10e7c29"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i342378a3e6bf401686eecb77ea0a41b6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTctMS0xLTI4OTE2_0a5d32a0-4d7b-4a8f-a47c-3b347f4cdae4"
      unitRef="usd">11000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="ib96e57d5b9fc4cb2a73243bdd55f6767_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTktMS0xLTI4OTE2_eb20f98f-3f2d-4a6d-bb0f-1b148cad5024"
      unitRef="usd">38200000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icf7b779b22d24eb6b77769f385e8229f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTExLTEtMS0yODkxNg_aceddd29-6e4d-47eb-9b40-62f1e1a1e2f1"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4bd4b276a5774cf7bb670de6b43ee0b4_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTEzLTEtMS0yODkxNg_a7b6720c-d38e-419e-b1b3-6d7114f194d0"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i47234201a06341db8895b8958db19f97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE1LTE1LTEtMS0yODkxNg_bba5122c-86cc-40e5-902b-635255b36971"
      unitRef="usd">38200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i6692ce12fc644c68b73fb3a2340f8955_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTEtMS0xLTI4OTE2_8bd662e0-1403-4c7b-a5a8-7e0919a1ee3e"
      unitRef="usd">1338900000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i55302882586a46d2ad57cdca3f162199_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTMtMS0xLTI4OTE2_9a767faf-cf13-4b29-9631-0554784b29a5"
      unitRef="usd">396700000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3d5b407bace949d5a87fb8d9069a7e54_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTUtMS0xLTI4OTE2_379d7633-5396-4ed3-9947-a24addf86338"
      unitRef="usd">931200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i17791cc67ea8442dae07024c287c5a9b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTctMS0xLTI4OTE2_a01e4819-6110-423a-a68c-2c5f116cdcff"
      unitRef="usd">11000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:Investments
      contextRef="i7f43889d0d9d4bfab3fb6c31e2cfe848_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTktMS0xLTI4OTE2_03dbe89c-56fd-4a9d-99be-c0bca7ad84b7"
      unitRef="usd">1069500000</us-gaap:Investments>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia17bbaa87ba6441bae1e26b9009ae2e3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTExLTEtMS0yODkxNg_674407b1-0105-4415-9b4e-a129f5b0698f"
      unitRef="usd">190300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i02ed2ad514134c8abd326f4aa918a949_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTEzLTEtMS0yODkxNg_328d3490-f024-49e4-a181-725a22dc4ce4"
      unitRef="usd">841000000.0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ide17712ce808468da6c2d67ca2751e47_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTplODYzYjgzMTNhOGY0OGEyYWY4ZDJlMDNiOTg4Njc1NS90YWJsZXJhbmdlOmU4NjNiODMxM2E4ZjQ4YTJhZjhkMmUwM2I5ODg2NzU1XzE3LTE1LTEtMS0yODkxNg_6256fe3d-f547-47af-9527-76f7712c5b7a"
      unitRef="usd">38200000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDYwOTc_d95b91aa-c490-447a-ad71-e8f04417751e">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents a reconciliation of equity security investments, which were measured at fair value on a recurring basis using significant unobservable inputs (Level 3):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Purchases &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;68.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unrealized gain (loss) included in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Transfers out of Level 3 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(52.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"&gt;_________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1) In September 2021, we purchased 0.3&#160;million shares of Xenon's common stock, valued at $4.6&#160;million on the date of purchase, in connection with the European Union&#x2019;s approval of the clinical trial application for NBI-921352.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2) In the fourth quarter of 2021, our equity security investment in Xenon was transferred from Level 3 to Level 1 as the associated holding period restriction expired.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="iadbe113298b847b29bf4f91e55934f46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItMy0xLTEtMjg5MTY_cdd7fbb5-e615-4dd8-8b60-5736a653190c"
      unitRef="usd">38200000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i3bb2904499f043418ddda2535a27e40f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItNS0xLTEtMjg5MTY_fb0b2d1b-1e06-46b5-9d04-606a6097ed48"
      unitRef="usd">55900000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i011bbd35393d4e94b37558ebd5a2d436_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzItNy0xLTEtMjg5MTY_e6407dc9-7f76-43ee-94e8-8e8745ac9a74"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtMy0xLTEtMjg5MTY_85fe138c-9cb0-487a-b42b-ddace29fe2f2"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtNS0xLTEtMjg5MTY_ba3dd606-337b-4e6c-a840-3613747aae31"
      unitRef="usd">0</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzMtNy0xLTEtMjg5MTY_08702635-5195-4a4e-a6ae-353b3b87494e"
      unitRef="usd">68900000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtMy0xLTEtMjg5MTY_eac55f12-ab81-4bd6-b6c4-4fe5dd9a4b92"
      unitRef="usd">20900000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtNS0xLTEtMjg5MTY_1c637ce7-aadc-4dcb-b39f-a3dd91a53ec5"
      unitRef="usd">-17700000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzQtNy0xLTEtMjg5MTY_30d074bc-ef07-4b16-ae9b-63e9b05635d2"
      unitRef="usd">-13000000.0</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i25d189e116b649b7a6fc5e8bc7058b47_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMS0xLTEtNDA4Mzg_65ca84ab-6838-4fa5-ab9d-59a112757bc3"
      unitRef="usd">52700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i66c2827fe9474a1f8f6e9f76b8c03a96_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMy0xLTEtNDA4MzI_1b98eddf-ce71-4baa-8745-1158def4dc71"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="i5fb1097ab9d9476cb60b259987b8c5b9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNS0xLTEtNDA4MjY_9399b0aa-102b-44f0-9d9d-e639af4fd89b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="ie56afca00a6145f1a8cb8913d7007d6a_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtMy0xLTEtMjg5MTY_139ebcd7-62c2-40df-bcaf-d447385c9045"
      unitRef="usd">11000000.0</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="iadbe113298b847b29bf4f91e55934f46_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNS0xLTEtMjg5MTY_009d1e33-0d36-41bb-b040-5f47d07ceb2c"
      unitRef="usd">38200000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:EquitySecuritiesFvNiRestricted
      contextRef="i3bb2904499f043418ddda2535a27e40f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90YWJsZTowNmIwOGRiOGZiYTk0NmE1YmY5YTBiYjkxM2MwYTlmOS90YWJsZXJhbmdlOjA2YjA4ZGI4ZmJhOTQ2YTViZjlhMGJiOTEzYzBhOWY5XzUtNy0xLTEtMjg5MTY_be208228-dae8-45a5-b330-25c2feec31e7"
      unitRef="usd">55900000</us-gaap:EquitySecuritiesFvNiRestricted>
    <us-gaap:InvestmentOwnedBalanceShares
      contextRef="i24b0e316d5b94182bbf5816c348e19d7_I20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzE2NDkyNjc0NDI5NjU_3c4a9069-eeb1-4c5e-a0ba-8df518e14267"
      unitRef="shares">300000</us-gaap:InvestmentOwnedBalanceShares>
    <us-gaap:PaymentsToAcquireRestrictedInvestments
      contextRef="i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzE2NDkyNjc0NDMwMTE_e6604194-c77a-4d4c-9d0b-baa5e0340304"
      unitRef="usd">4600000</us-gaap:PaymentsToAcquireRestrictedInvestments>
    <nbix:DiscountForMarketabilityUsedInValuationAnalysis
      contextRef="i2d30d0be95cb415b8e4d465eff571719_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTEvZnJhZzpmZWI5NzczYjVmYjY0ZTM5OTFjYTI2YTE2ZTdlMDRkYi90ZXh0cmVnaW9uOmZlYjk3NzNiNWZiNjRlMzk5MWNhMjZhMTZlN2UwNGRiXzM4NDgyOTA3MDc4OTk_b02a059a-835d-4f8a-aae6-4be635066b3c"
      unitRef="number">0.025</nbix:DiscountForMarketabilityUsedInValuationAnalysis>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU0_791c5066-fe07-459f-9b1f-619bcd586812">Convertible Senior NotesOn May&#160;2, 2017, we completed a private placement of&#160;$517.5 million&#160;in aggregate principal amount of&#160;the 2024 Notes and entered into the 2017 Indenture with respect to the 2024 Notes. The net proceeds from the issuance of the 2024 Notes were approximately $502.8 million, after deducting commissions and the offering expenses payable by us. The 2024 Notes accrue interest at a fixed rate of&#160;2.25%&#160;per year, payable semiannually in arrears on May&#160;15 and November&#160;15 of each year, and mature on May 15, 2024.&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, we entered into separate, privately negotiated transactions with certain holders of the 2024 Notes to repurchase $136.2&#160;million aggregate principal amount of the 2024 Notes for an aggregate repurchase price of $186.9&#160;million in cash. We accounted for the partial repurchase of the 2024 Notes as a debt extinguishment. As a result, we attributed $130.7&#160;million of the aggregate repurchase price to the liability component based on the fair value of the liability component immediately before extinguishment. The fair value of the liability component was calculated at settlement using a discounted cash flow analysis with a discount rate of 3.37%, which was the market rate for similar notes that have no conversion rights. The difference of $56.3&#160;million between the fair value of the aggregate consideration remitted to certain holders of the 2024 Notes and the fair value of the liability component was attributed to the reacquisition of the equity component and recognized as a reduction to additional paid-in capital. The carrying amount of the liability of $112.4&#160;million at settlement was recognized as a reduction to the 2024 Notes and resulted in an $18.4&#160;million loss on extinguishment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may redeem for cash all or part of the 2024 Notes if the last reported sale price (as defined in the 2024 Indenture) of our common stock has been at least 130% of the conversion price then in effect (equal to $98.70 as of December&#160;31, 2021) for at least&#160;20&#160;trading days (whether or not consecutive) during any&#160;30&#160;consecutive trading-day period ending on, and including, the trading day immediately before the date which we provide notice of redemption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the 2024 Notes may convert the 2024 Notes at any time prior to the close of business on the business day immediately preceding May&#160;15, 2024, only under the following circumstances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.57pt"&gt;during any calendar quarter (and only during such calendar quarter), if the last reported sale price of our common stock for at least&#160;20&#160;trading days (whether or not consecutive) during a period of&#160;30&#160;consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than&#160;130%&#160;of the conversion price (equal to $98.70 as of December&#160;31, 2021) on each applicable trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.8pt"&gt;during the&#160;5&#160;business-day period immediately after any&#160;5&#160;consecutive trading-day period (the measurement period) in which the trading price (as defined in the 2024 Indenture) per&#160;$1,000&#160;principal amount of the 2024 Notes for each trading day of the measurement period was less than&#160;98%&#160;of the product of the last reported sale price of our common stock and the conversion rate on each such trading day;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.03pt"&gt;upon the occurrence of specified corporate events, including a merger or a sale of all or substantially all of our assets; or&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:22.5pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.57pt"&gt;if we call the 2024 Notes for redemption, until the close of business on the business day immediately preceding the redemption date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On or after January&#160;15, 2024, until the close of business on the scheduled trading day immediately preceding May&#160;15, 2024, holders may convert their 2024 Notes at any time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, we entered into the First Supplemental Indenture to the 2017 Indenture, pursuant to which we irrevocably elected to settle the principal amount of the 2024 Notes in cash upon conversion and to settle any conversion premium, calculated based on the per share volume-weighted average price for each of the&#160;30&#160;consecutive trading days during the observation period (as more fully described in the 2024 Indenture), in either cash or shares of our common stock. In the event of conversion, holders would forgo all future interest payments, any unpaid accrued interest, and the possibility of further stock price appreciation. Upon the receipt of conversion requests, the settlement of the 2024 Notes will be paid pursuant to the terms of the 2024 Indenture.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial conversion rate for the 2024 Notes is&#160;13.1711&#160;shares of common stock per&#160;$1,000&#160;principal amount, which is equivalent to an initial conversion price of&#160;approximately $75.92&#160;per share of our common stock. At the initial conversion rate, settlement of the 2024 Notes for shares of our common stock would approximate 5.0 million shares. The conversion rate will be subject to adjustment in some events but will not be adjusted for any accrued and unpaid interest. The initial conversion price of the 2024 Notes represented a premium of approximately&#160;42.5%&#160;to the closing sale price of&#160;$53.28&#160;per share of our common stock on the Nasdaq Global Select Market on April&#160;26, 2017, the date that we priced the private offering of the 2024 Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If we undergo a fundamental change, as defined in the 2024 Indenture, subject to certain conditions, holders of the 2024 Notes may require us to repurchase for cash all or part of their 2024 Notes at a repurchase price equal to&#160;100%&#160;of the principal amount of the 2024 Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a &#x2018;&#x2018;make-whole fundamental change&#x2019;&#x2019; (as defined in the 2024 Indenture) occurs prior to January&#160;15, 2024, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert their notes in connection with the make-whole fundamental change.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Notes are our general unsecured obligations that rank senior in right of payment to all of our indebtedness that is expressly subordinated in right of payment to the 2024 Notes, and equal in right of payment to our unsecured indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While the 2024 Notes were classified as a long-term liability as of December&#160;31, 2021, the future convertibility and associated balance sheet classification will be monitored at each quarterly reporting date and analyzed dependent upon market prices of our common stock during the prescribed measurement periods. In the event that we have the election to redeem the 2024 Notes or the holders of the 2024 Notes have the election to convert the 2024 Notes at any time during the prescribed measurement period, the 2024 Notes would then be considered a current obligation and classified as such.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are required to separately account for the liability and equity components of the 2024 Notes. The liability component of the instrument was valued in a manner that reflects the market interest rate for a similar nonconvertible instrument at the date of issuance. The initial carrying value of the liability component of $368.3 million&#160;was calculated using a&#160;7.5%&#160;assumed borrowing rate. The equity component of $149.2 million, representing the conversion option, was determined by deducting the fair value of the liability component from the par value of the 2024 Notes and recorded in additional paid-in capital on the consolidated balance sheet on the issuance date. The equity component is treated as a discount on the liability component of the 2024 Notes, which is currently being amortized over the 7-year term of the 2024 Notes using the effective interest rate method. The equity component is not re-measured as long as it continues to meet the conditions for equity classification. As of December&#160;31, 2021, the remaining period over which the discount on the liability component will be amortized was approximately 2.4 years. We plan to adopt ASU 2020-06 on January 1, 2022 using the modified retrospective transition method. Among other changes, ASU 2020-06 removes the separation models for convertible instruments with cash or beneficial conversion features. Refer to Note 1 to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We allocated the total transaction costs of approximately&#160;$14.7 million&#160;related to the issuance of the 2024 Notes to the liability and equity components of the 2024 Notes based on their relative values. Transaction costs attributable to the liability component are amortized to interest expense over the&#160;7-year term of the 2024 Notes, and transaction costs attributable to the equity component are netted with the equity component in stockholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Notes do not contain any financial or operating covenants or any restrictions on the payment of dividends, the issuance of other indebtedness or the issuance or repurchase of securities by us. The 2024 Indenture contains customary events of default with respect to the 2024 Notes, including that upon certain events of default,&#160;100%&#160;of the principal and accrued and unpaid interest on the 2024 Notes will automatically become due and payable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Notes, net of discounts and deferred financing costs, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;335.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Notes were recorded at the estimated value of a similar non-convertible instrument on the date of issuance and accretes to the face value of the 2024 Notes over their 7-year term. The fair value of the 2024 Notes, which was estimated utilizing market quotations from an over-the-counter trading market (Level 2), was $464.7 million as of December&#160;31, 2021 and $514.3 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzg1_58479f0f-bf69-4f2b-a6e1-c150a7987366"
      unitRef="usd">517500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQzNDk_d48765d0-a981-4b1a-b544-466cf79e073f"
      unitRef="usd">502800000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQ2MjM_ccdffc29-9212-49a1-9429-c00abe7aa2dd"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i80a878a1eb5a45cca632daa2d96abd21_I20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMwNTY_680d2d70-dc2e-4a58-b50d-39bd2359cfa7"
      unitRef="usd">136200000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:RepaymentsOfDebt
      contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMxNDI_dbcc2ca6-db4d-4aaf-a576-abfc4bb8b2b8"
      unitRef="usd">186900000</us-gaap:RepaymentsOfDebt>
    <nbix:FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment
      contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTMyNjY_8277488a-5574-4784-9d7d-2fde366bf1ed"
      unitRef="usd">130700000</nbix:FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="i88996bf4af1e44edb618cc379576a171_I20201130"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM1NTA_808638cf-3159-45a9-8337-a299eac4ae0e"
      unitRef="number">0.0337</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments
      contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM2NDk_66ce2875-ccbe-4dd3-98c9-b6472f3ed0f8"
      unitRef="usd">56300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments>
    <nbix:CarryingAmountOfLiabilityComponentAtSettlement
      contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTM5NjA_6f2adba8-d809-4b66-b134-59795280aa0a"
      unitRef="usd">112400000</nbix:CarryingAmountOfLiabilityComponentAtSettlement>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i9e2859fa47144d648b50e73b3100e6ef_D20201101-20201130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTQwNTU_261036a0-88c6-46a1-a82f-312771d2a384"
      unitRef="usd">-18400000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNTI_704c9fea-3744-489c-abf6-81299eb1bc3a"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleStockPriceTrigger
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNTg_889f09f1-cf86-40f1-8853-d45df6d9fcf1"
      unitRef="usdPerShare">98.70</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNzA_1ad8dc82-d683-4baf-a0b0-a932aa6e884f"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzNjY_f26a82fd-5f36-4ac9-9ff4-9dbbc979ee9e"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzk0Mg_e74d5714-7f11-4863-a40b-2e1dff307a0c"
      unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDY_8a16ca51-3bd2-449d-9b4e-04b9b64bcb9e"
      unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i1eb75f3b62224e1990a0457e6a66510f_D20170502-20170502"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzExMjc_bf50b03b-c43d-4475-b26d-6c133cdcd33b"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleStockPriceTrigger
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NTUzODU_889f09f1-cf86-40f1-8853-d45df6d9fcf1"
      unitRef="usdPerShare">98.70</us-gaap:DebtInstrumentConvertibleStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzExOTc_32c6d42e-d672-49c8-84d4-14197868738b"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEyNDI_b01ed4a7-8f53-478e-b7a1-799d703a67eb"
      unitRef="d">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <nbix:PrincipalAmountOnConversionRate
      contextRef="ib1c20b9ca378493e9004243174a5bb6c_I20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEzNjc_e57c80f1-f196-466e-888b-37e1489cf60b"
      unitRef="usd">1000</nbix:PrincipalAmountOnConversionRate>
    <nbix:MinimumPercentageOfTradingPriceToLastReportedSalePrice
      contextRef="i396ca69150e8439ea762b4f790ff47b6_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE0NjY_a592879e-5db5-4fe8-9a37-fea0cd22c4e9"
      unitRef="number">0.98</nbix:MinimumPercentageOfTradingPriceToLastReportedSalePrice>
    <nbix:TradingDaysDuringObservationPeriod
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzIyMTA_3de684eb-3704-4c4d-aabc-4535651d0942">P30D</nbix:TradingDaysDuringObservationPeriod>
    <nbix:PrincipalAmountOnConversionRate
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM1MDY_374c26bb-0ca6-459f-90b9-353d231c6e8c"
      unitRef="usd">1000</nbix:PrincipalAmountOnConversionRate>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM1OTU_934f5195-e7f0-42b4-89dd-64cb7f27bb52"
      unitRef="usdPerShare">75.92</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM3Mzk_67275a95-f73b-42c5-aa71-48e12293e447"
      unitRef="shares">5000000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <nbix:DebtInstrumentConvertibleConversionPremium
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM5NjM_2b0b4d0d-1e36-45c5-ba1e-2d8117a4758b"
      unitRef="number">0.425</nbix:DebtInstrumentConvertibleConversionPremium>
    <us-gaap:SharePrice
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM5OTU_138da351-f8fc-4ee6-88db-620a47a74ea4"
      unitRef="usdPerShare">53.28</us-gaap:SharePrice>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzU2NTY_ab373912-633a-4fe4-9d0e-4cd9132d7695"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <nbix:CarryingAmountOfLiabilityComponentUponIssuance
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY3OTI_8d3abc53-ecc4-4188-be51-de955adf32fd"
      unitRef="usd">368300000</nbix:CarryingAmountOfLiabilityComponentUponIssuance>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY4MTg_01847326-130b-47d6-bba5-171070e65644"
      unitRef="number">0.075</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzY4Njk_98d48c62-be44-4a80-866a-ffbb76f5ab5c"
      unitRef="usd">149200000</us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent>
    <us-gaap:DebtInstrumentTerm
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU2_554e44fb-3594-4cda-8720-6ec41a6fe74c">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
      contextRef="ie27106cccd3a41c2bdfd69a9f8e7b839_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzc1NDI_c944be01-1df3-4c4e-8290-311018e72b64">P2Y4M24D</us-gaap:DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i7a0c5ec3d79147229881155f9e94893d_I20170502"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzc2MDQ_21c1ab7d-b6f8-4650-9660-d1eec5e9e1fb"
      unitRef="usd">14700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentTerm
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzM4NDgyOTA3MjEzNTE_9079522c-14bc-4e69-b176-c9ea1c78db8a">P7Y</us-gaap:DebtInstrumentTerm>
    <nbix:EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzgzMzI_4ed1246e-cdbf-4234-add4-59068e6552f4"
      unitRef="number">1</nbix:EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU3_a256c976-d068-425f-8859-efee36121f26">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2024 Notes, net of discounts and deferred financing costs, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;381.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Debt discount, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(59.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net carrying amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;335.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;317.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzItMS0xLTEtMjQ1ODc_1a578a0f-f584-4f93-9610-50bb1066c940"
      unitRef="usd">381200000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzItMy0xLTEtMjQ1ODc_110bcadf-62d7-456d-8d4a-9850ce109288"
      unitRef="usd">381300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzMtMS0xLTEtMjQ1ODc_3d674c0a-03d7-4374-b498-660459803fa2"
      unitRef="usd">2900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzMtMy0xLTEtMjQ1ODc_1ebdad9e-af62-46e6-b2ca-da194a7a4d48"
      unitRef="usd">4000000.0</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzQtMS0xLTEtMjQ1ODc_aabcd9ee-5ad0-47ca-8fb8-642050864ef2"
      unitRef="usd">43200000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzQtMy0xLTEtMjQ1ODc_9146a284-b33c-419f-a324-c24bf66141b4"
      unitRef="usd">59400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ConvertibleDebt
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzUtMS0xLTEtMjQ1ODc_37d5431b-85b8-4c49-ba21-e6f9b824dfcb"
      unitRef="usd">335100000</us-gaap:ConvertibleDebt>
    <us-gaap:ConvertibleDebt
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90YWJsZTpjOTYzNDllZGM1NWM0NmM1ODU4Nzk4ZjNiMjQ5YzliMy90YWJsZXJhbmdlOmM5NjM0OWVkYzU1YzQ2YzU4NTg3OThmM2IyNDljOWIzXzUtMy0xLTEtMjQ1ODc_e4c19f79-bd43-4976-824f-839e53e88cce"
      unitRef="usd">317900000</us-gaap:ConvertibleDebt>
    <us-gaap:DebtInstrumentTerm
      contextRef="i17d305f965a642e6b5f85a15f7395229_D20170502-20170502"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzEwMDU4_ee8b3334-76b1-4714-8c35-e912c8396f81">P7Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4255ef0f065341c38adf6ce89cc06fa5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NjIyMjg_cfb1fe46-8e57-4701-bcb4-307260bfd510"
      unitRef="usd">464700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3d16c122f0c14c3992a051928c9d5bfd_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNTQvZnJhZzo2MzRkNzJkZGNkMGM0ZTVkODFlY2I3ZGNjOTVhZDk3ZS90ZXh0cmVnaW9uOjYzNGQ3MmRkY2QwYzRlNWQ4MWVjYjdkY2M5NWFkOTdlXzE2NDkyNjc0NjIyMzI_96f480ab-8907-4b9d-be3d-e9837fb3dfee"
      unitRef="usd">514300000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1MA_b4f0fa78-2ab2-4475-b405-8ebfe8392046">Other Balance Sheet Details&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tenant improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scientific equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued employee related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue-related reserves for discounts and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current branded prescription drug fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1MQ_1dbe8d02-c962-42f1-af8a-d0299ad2df81">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzItMS0xLTEtMjQ1ODc_f5be87af-1bb9-4be7-aae5-3929cdcb6299"
      unitRef="usd">11200000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzItMy0xLTEtMjQ1ODc_4899a7c1-f563-45c7-87ea-0ebb64c9ebd3"
      unitRef="usd">16600000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzMtMS0xLTEtMjQ1ODc_f8acf7ee-be85-4c8f-ba67-c15403eecab6"
      unitRef="usd">3600000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzMtMy0xLTEtMjQ1ODc_5d9fa296-af7b-434e-aa0e-987b43310f90"
      unitRef="usd">2400000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzQtMS0xLTEtMjQ1ODc_256cf462-6bfd-42d8-bcd5-37e6f9b365d8"
      unitRef="usd">15700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzQtMy0xLTEtMjQ1ODc_87be39e2-9a00-45a2-ad90-759d859f793a"
      unitRef="usd">9000000.0</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzUtMS0xLTEtMjQ1ODc_507cd53b-a099-4fa8-8662-ae9f4288414e"
      unitRef="usd">30500000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxZWQ4M2RiNTMxNmY0NzEzOWVkYjczZjZhMWY0ZGFjZi90YWJsZXJhbmdlOjFlZDgzZGI1MzE2ZjQ3MTM5ZWRiNzNmNmExZjRkYWNmXzUtMy0xLTEtMjQ1ODc_45d95c82-ada3-4199-8a8f-2ada4b4f28c6"
      unitRef="usd">28000000.0</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1Mg_e895a3da-fbb7-4f58-b261-32a76935474a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Tenant improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Scientific equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(41.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4babbf9b0ae54bd68b403bf9135804ce_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzItMS0xLTEtMjQ1ODc_9ab5ddc5-689c-47d8-acef-fe21bffe218e"
      unitRef="usd">34900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia1cd1bce8a314e4b8d4f01b7b48efb31_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzItMy0xLTEtMjQ1ODc_9f57f737-7378-471b-acb8-d35c282d6137"
      unitRef="usd">29500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i514d273d4829444bb2f094cc035cbd85_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzMtMS0xLTEtMjQ1ODc_29839064-e933-43c3-ab0f-fc45f431506b"
      unitRef="usd">51600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i8949e231305a4303b6a93baa2c50ef7c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzMtMy0xLTEtMjQ1ODc_21c7d81b-939a-4cfd-adfd-d89e23b3388c"
      unitRef="usd">39200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i018745fbe176486d9a40f767eb4cddfb_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzQtMS0xLTEtMjQ1ODc_ffcbc0c4-f83c-4337-bd80-af09615674fa"
      unitRef="usd">18100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i89da8fd5abc84ebc90ff0e08c8e74ae0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzQtMy0xLTEtMjQ1ODc_fd08014f-bd72-404f-893a-ccd344a31972"
      unitRef="usd">13900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idc1e7a31965e41d398a354180cf8e854_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzUtMS0xLTEtMjQ1ODc_d9ce409b-3e57-483b-816c-ed9d615ebeb4"
      unitRef="usd">5900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id096d2e9e4db408388a0546974b8a714_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzUtMy0xLTEtMjQ1ODc_63c8c5c2-1a0f-4365-8e3a-a289b5b010bd"
      unitRef="usd">3700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzYtMS0xLTEtMjQ1ODc_6918dd60-2a05-4621-84c3-a4f6c09821bb"
      unitRef="usd">110500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzYtMy0xLTEtMjQ1ODc_762570c3-6861-4808-b28b-04a703ef4606"
      unitRef="usd">86300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzctMS0xLTEtMjQ1ODc_e51ad6ca-d537-41fa-9cac-73f4c50747f3"
      unitRef="usd">51900000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzctMy0xLTEtMjQ1ODc_ace918ff-dd46-4cff-bf0e-e483d4dc3043"
      unitRef="usd">41700000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzgtMS0xLTEtMjQ1ODc_e25dad5a-f4df-441c-ade0-6c0c795454f3"
      unitRef="usd">58600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZToxYTJjZTQ4ZTk4YjA0MzU1YWViNmVhODhmYTYwYzEyYS90YWJsZXJhbmdlOjFhMmNlNDhlOThiMDQzNTVhZWI2ZWE4OGZhNjBjMTJhXzgtMy0xLTEtMjQ1ODc_3ca14496-4aef-4dd0-ac4f-cfa8ca62bbd7"
      unitRef="usd">44600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1Mw_9f642e81-41de-4488-a32f-b2f22485a7bc">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued employee related costs &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;50.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Revenue-related reserves for discounts and allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accrued development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current branded prescription drug fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Accounts payable and other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;225.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;168.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzItMS0xLTEtMjQ1ODc_1c08d906-e1a3-4bd9-ab98-12d33460f8c8"
      unitRef="usd">50600000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzItMy0xLTEtMjQ1ODc_81b898e9-49d7-4f86-9d39-dc8c33cb9fdd"
      unitRef="usd">38200000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <nbix:RevenueRelatedReservesForDiscountsAndAllowances
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzMtMS0xLTEtMjQ1ODc_b8916128-d4b6-461c-b6fa-8abec1fdeda3"
      unitRef="usd">62700000</nbix:RevenueRelatedReservesForDiscountsAndAllowances>
    <nbix:RevenueRelatedReservesForDiscountsAndAllowances
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzMtMy0xLTEtMjQ1ODc_f26e044d-e11a-403c-905d-d1cc9ed4ea1f"
      unitRef="usd">34600000</nbix:RevenueRelatedReservesForDiscountsAndAllowances>
    <nbix:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzQtMS0xLTEtMjQ1ODc_5ee27bb8-b314-4a5b-ae4a-95868ce4f523"
      unitRef="usd">32400000</nbix:AccruedResearchAndDevelopmentExpenseCurrent>
    <nbix:AccruedResearchAndDevelopmentExpenseCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzQtMy0xLTEtMjQ1ODc_7a0af7f6-d43f-407b-beb5-80d0c350e3a9"
      unitRef="usd">32900000</nbix:AccruedResearchAndDevelopmentExpenseCurrent>
    <nbix:AccruedBrandedPrescriptionDrugFee
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzUtMS0xLTEtMjQ1ODc_e2d92c11-6cf4-40b6-b89c-d25d1647021e"
      unitRef="usd">28600000</nbix:AccruedBrandedPrescriptionDrugFee>
    <nbix:AccruedBrandedPrescriptionDrugFee
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzUtMy0xLTEtMjQ1ODc_3a18815f-c86e-4bac-8346-95eefcc2cfcf"
      unitRef="usd">23600000</nbix:AccruedBrandedPrescriptionDrugFee>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzYtMS0xLTEtMjQ1ODc_e2e8fb52-acbe-43a3-bb5b-a0ec61837ebe"
      unitRef="usd">51500000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzYtMy0xLTEtMjQ1ODc_a4696a0e-24d3-4fbd-839a-78864be272e3"
      unitRef="usd">39400000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzctMS0xLTEtMjQ1ODc_43be0b5c-235e-4fcc-b801-ff6047ba1d35"
      unitRef="usd">225800000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTo0Njk4ODhmYzVlNjA0MTg2YjhkNjBmM2U3Y2FiYzhhMC90YWJsZXJhbmdlOjQ2OTg4OGZjNWU2MDQxODZiOGQ2MGYzZTdjYWJjOGEwXzctMy0xLTEtMjQ1ODc_6e37478b-0899-481c-b015-1cb39fd25e4b"
      unitRef="usd">168700000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <nbix:SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90ZXh0cmVnaW9uOjNlZDA1NGJiMjYzNzRiYWViNzdmNDM4ZGRhNDNmM2JiXzQ1NA_1783d46f-0767-46d1-a3f6-45acf9ebce36">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;340.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;187.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total cash, cash equivalents and restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;344.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;190.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</nbix:SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzItMS0xLTEtMjQ1ODc_8af4e3b0-0004-438a-9922-1fe81c4f63de"
      unitRef="usd">340800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzItMy0xLTEtMjQ1ODc_eab1fb26-7b91-42e6-8163-a778a8b75265"
      unitRef="usd">187100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzMtMS0xLTEtMjQ1ODc_69706941-bc24-493d-a23c-d4d1ea101139"
      unitRef="usd">3200000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzMtMy0xLTEtMjQ1ODc_e9bbc091-0624-424d-8bf3-7620c1a626de"
      unitRef="usd">3200000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzQtMS0xLTEtMjQ1ODc_84fccf05-c0b7-4123-8396-b938cb3c6449"
      unitRef="usd">344000000.0</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjAvZnJhZzozZWQwNTRiYjI2Mzc0YmFlYjc3ZjQzOGRkYTQzZjNiYi90YWJsZTpjMjZjYWYzNjQ5YmM0MzVjODU1ZWI1N2YyYTM2NDdmNS90YWJsZXJhbmdlOmMyNmNhZjM2NDliYzQzNWM4NTVlYjU3ZjJhMzY0N2Y1XzQtMy0xLTEtMjQ1ODc_d6073e43-ded5-47b8-a80e-6829b1036b76"
      unitRef="usd">190300000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzI0MA_f1108e8d-265a-4062-84c9-1ea3d954c760">Per Share&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share were calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares which have been excluded from diluted per share amounts because their effect would have been anti-dilutive were 4.1 million for 2021, 2.5 million for 2020 and 2.1 million for 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzI0MQ_db26e447-0343-415a-83ee-8fc6e718df82">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Earnings per share were calculated as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net income - basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;407.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;37.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted-average common shares outstanding:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;94.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;91.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;97.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;95.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Earnings per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItMS0xLTEtMjQ1ODc_12f8c320-66fb-4e50-886f-16b09c08411f"
      unitRef="usd">89600000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItMy0xLTEtMjQ1ODc_cead22be-894b-4cfd-b149-81f819937830"
      unitRef="usd">407300000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzItNS0xLTEtMjQ1ODc_8a9dfac8-4f6b-4c19-9c24-926d4b68c572"
      unitRef="usd">37000000.0</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtMS0xLTEtMjQ1ODc_f919ff0a-ac5c-4544-85ee-68eb430fb03c"
      unitRef="shares">94600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtMy0xLTEtMjQ1ODc_d6d3f806-83a4-48d1-95f0-f670f2f9977c"
      unitRef="shares">93100000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzQtNS0xLTEtMjQ1ODc_35c3e44b-8fb7-44d9-91cb-0e8dcd86cc8b"
      unitRef="shares">91600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib5697c0bc55240d2a8a8a2235b016776_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctMS0xLTEtMjQ1ODc_df06fc50-5ed3-43f2-bd49-effb1fa0ebf1"
      unitRef="shares">1800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i36e1a597b4cd4605869672a9be81b61a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctMy0xLTEtMjQ1ODc_2a17da17-da36-4a54-982d-f3dd89cf5ba3"
      unitRef="shares">2400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i6121635642d44cadaead83be87d2fe62_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzctNS0xLTEtMjQ1ODc_4ddbfe3b-4ed2-4694-82f0-73760871b623"
      unitRef="shares">2600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1d2ef4094777484ab20a42ddbdcf479d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtMS0xLTEtMjQ1ODc_e7e1637a-9a4a-41ef-a2f1-855dfc2d0a4e"
      unitRef="shares">300000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if5766d218ac54177beed97641411133f_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtMy0xLTEtMjQ1ODc_944b3d3d-8ae3-4be9-a650-63551794c7c2"
      unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia4461a18f4b94ca1b02b8be10c79cda1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzgtNS0xLTEtMjQ1ODc_32241e3d-b825-46ce-a112-3b10a6c8e4e4"
      unitRef="shares">400000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
      contextRef="i1d90a3769ad6449da089e4e3f18d3d7a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktMS0xLTEtMjQ1ODc_1b9b4268-7a8a-47d6-afd2-8d518dd1be77"
      unitRef="shares">1100000</nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities>
    <nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
      contextRef="icfdf32908a434e5d91386e010cdf2b9b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktMy0xLTEtMjQ1ODc_d159452c-5555-460c-8c09-8e7fac367ab9"
      unitRef="shares">1800000</nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities>
    <nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities
      contextRef="i861174ad0c8446e0ab825a068912a989_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzktNS0xLTEtMjQ1ODc_1e1ad727-1eb6-4bf8-8302-973024efd752"
      unitRef="shares">1100000</nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTEtMS0xLTI0NTg3_b8a6597a-1bdd-4c50-9042-8f172eeb48c1"
      unitRef="shares">97900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTMtMS0xLTI0NTg3_3c99aa39-c231-4b34-aa73-ceb9545c98b9"
      unitRef="shares">97800000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEwLTUtMS0xLTI0NTg3_10d37733-68ba-490f-99db-758f80fdc6dd"
      unitRef="shares">95700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTEtMS0xLTI0NTg3_3e6cdd70-3185-4933-b06e-bb16caf07cfe"
      unitRef="usdPerShare">0.95</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTMtMS0xLTI0NTg3_d923ee6b-409c-4bd3-9222-02e5e1127818"
      unitRef="usdPerShare">4.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEyLTUtMS0xLTI0NTg3_c39d3006-e438-46f4-802f-c60053d79859"
      unitRef="usdPerShare">0.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTEtMS0xLTI0NTg3_329f17fa-ddbc-4dfd-90dd-6502bbe19f9a"
      unitRef="usdPerShare">0.92</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTMtMS0xLTI0NTg3_be003758-4678-41c6-b260-fb49b80281f5"
      unitRef="usdPerShare">4.16</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90YWJsZTo1OWQwZDcxMjg0ZGM0MTg0OTQwZmU5ZTE0M2MxMmRhYi90YWJsZXJhbmdlOjU5ZDBkNzEyODRkYzQxODQ5NDBmZTllMTQzYzEyZGFiXzEzLTUtMS0xLTI0NTg3_3b4190ec-4410-4106-a238-e5e6eb7d2594"
      unitRef="usdPerShare">0.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzE5NQ_55575638-a842-4e25-8375-89d72d9d4789"
      unitRef="shares">4100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27b3593b7e0f4137b9d9cb95a340d296_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzE5OQ_0fa0d4c9-f33d-4906-a568-db7b061d0351"
      unitRef="shares">2500000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie926624338174ce3a9a95588da6b7482_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjMvZnJhZzo2Y2FhYTkzODY3M2Y0YmI2OTc0MzNkNzQ2MWQxYmZjYS90ZXh0cmVnaW9uOjZjYWFhOTM4NjczZjRiYjY5NzQzM2Q3NDYxZDFiZmNhXzIwNg_3643a475-20fc-422d-a0fb-9f970b04d609"
      unitRef="shares">2100000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTY_95393ee4-3801-47e1-b5dd-2b7c17088885">Share-Based Compensation&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May&#160;2011, we adopted the 2011 Equity Incentive Plan, as amended, or the 2011 Plan. The 2011 Plan authorized 21 million shares of common stock for issuance and allowed for the grant of stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, or RSUs, performance stock awards, performance-based restricted stock units, or PRSUs, and certain other awards. During 2020, the 2011 Plan was merged into the 2020 Plan (defined below). As a result, there were no shares of common stock remaining available for future grant under the 2011 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2018, we adopted the 2018 Employee Stock Purchase Plan, or ESPP, pursuant to which 0.3 million shares of common stock are authorized for issuance. As of December 31, 2021, 0.1&#160;million shares of common stock remain available for future grant under the 2018 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2020, we adopted the 2020 Equity Incentive Plan, or the 2020 Plan. The 2020 Plan authorized 3.3&#160;million shares of common stock for issuance and allows for the grant of stock options, stock appreciation rights, restricted stock awards, RSUs, performance stock awards, PRSUs and certain other awards. The 2011 Plan was merged into the 2020 Plan and, as a result, all remaining shares in the 2011 Plan were transferred into the 2020 Plan. As of December 31, 2021, 5.4&#160;million shares of common stock remain available for future grant under the 2020 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Expense. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of share-based compensation expense on our consolidated statements of income and comprehensive income by line-item follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by award-type follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, unrecognized share-based compensation expense by award-type and the weighted-average period over which such expense is expected to be recognized, as applicable, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Recognition Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Typically, stock options have a 10-year term and vest over a 3 to 4-year period. The exercise price of stock options granted is equal to the closing price of our common stock on the date of grant. We estimate the fair value of stock options using the Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various and highly sensitive assumptions including expected volatility, term and interest rates. The weighted-average grant-date fair values of stock options granted were $45.02 for 2021, $45.67 for 2020 and $41.74 for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average valuation assumptions were determined as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The expected volatility of common stock is estimated based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of our stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The expected option term is estimated based on historical experience as well as the status of the employee. For example, directors and officers have a longer expected option term than all other employees. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;The risk-free interest rate for periods within the contractual life of a stock option is based upon observed interest rates appropriate for the expected term of our employee stock options. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;We have not historically declared or paid dividends and do not intend to do so in the foreseeable future. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to stock options follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised was $58.0 million for 2021, $40.2 million for 2020 and $64.3 million for 2019. Cash received from stock option exercises was $20.7 million for 2021, $23.5 million for 2020 and $27.3 million for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs typically vest over a 4-year period. The fair value of RSUs is based on the closing sale price of our common stock on the date of issuance. RSUs may be subject to a deferred delivery arrangement at the election of eligible employees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to RSUs follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"&gt;_________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2021, our board of directors approved an equity grant of approximately 0.5&#160;million RSUs, which will vest over a 2-year period, to our full-time employees other than our executive officers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RSUs that vested was $64.3 million for 2021, $49.7 million for 2020 and $36.1 million for 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based Restricted Stock Units. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRSUs vest based on the achievement of certain predefined Company-specific performance criteria and expire 3 to 4 years from the grant date. The fair value of PRSUs is estimated based on the closing sale price of our common stock on the date of grant.&#160;Expense recognition for PRSUs commences when attainment of the performance-based criteria is determined to be probable. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to PRSUs follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, unrecognized share-based compensation expense for PRSUs was $32.0 million. The total fair value of PRSUs that vested was $13.5&#160;million for 2020. No PRSUs vested during 2021 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the ESPP, eligible employees may purchase shares of our common stock at a discount semi-annually based on a percentage of their annual compensation. The discounted purchase price is equal to the lower of 85% of (i) the market value per share of the common stock on the first day of the offering period or (ii) the market value per share of common stock on the purchase date.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="if55c2dd5020b439ab20a6854804adfb2_I20110531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE0OQ_b140beb4-55cc-4cfb-8521-2d32c9962a96"
      unitRef="shares">21000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i131a19b02d4549ae975f25ad4ec218e0_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUyNQ_71d06868-d0a5-4ea0-aa72-85b60acec262"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i66b8b371eafd4e9bb87813ab1ee9b7f3_I20180531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzY5OQ_c920123e-ad10-4904-bee7-dc6c264ffa84"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="if9a1371b813245e8b49ad33c120478c5_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2Xzc3Ng_256e33fb-ab50-437d-8d09-73aefca59a32"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i7daa1d827ed84d04bc8d829d69e3b5a5_I20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2Xzk1Ng_35794b89-9f51-4761-a525-57bb2240f96f"
      unitRef="shares">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i21a8268dccfc48f59cd4814f44c54a4f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzEzMTQ_5b7a19f0-2f10-491e-843b-a0207ee73ac7"
      unitRef="shares">5400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUxMDA_a15a91ba-2da7-44cb-9264-d04e43ad5d5d">The effect of share-based compensation expense on our consolidated statements of income and comprehensive income by line-item follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;66.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;33.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by award-type follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;47.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;44.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;75.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, unrecognized share-based compensation expense by award-type and the weighted-average period over which such expense is expected to be recognized, as applicable, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.726%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.729%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Recognition Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;150.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8d2e9814a27b4d21828b870c0c7bba39_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItMS0xLTEtMjQ1ODc_7efd0e8a-399c-4ebf-b141-487321468b0e"
      unitRef="usd">85800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6383419676f5414c97631fba30d073e1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItMy0xLTEtMjQ1ODc_e7e458e8-34a6-4408-b36d-72852d40fe99"
      unitRef="usd">66300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i563c70f91f7d45baadb5b41baf1f5dee_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzItNS0xLTEtMjQ1ODc_a9b59505-69de-4910-8e5f-ff32b4d0c11b"
      unitRef="usd">49500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i086d3bf04898438689679b7c70886c50_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtMS0xLTEtMjQ1ODc_8e260c32-829b-4d82-b3fe-97046849893e"
      unitRef="usd">48400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4f20287d2f5d47629aa5cb895c7b9e67_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtMy0xLTEtMjQ1ODc_9b4e2def-dd20-4202-bbbd-3419d730acbd"
      unitRef="usd">33700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i21700785bb0c4daa8be1c905aeeb15f6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzMtNS0xLTEtMjQ1ODc_e7a0c6d5-6fe7-4b27-b748-cd8889c62685"
      unitRef="usd">25800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtMS0xLTEtMjQ1ODc_cbe7b4d7-e345-4257-9592-8bdf23df8b55"
      unitRef="usd">134200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtMy0xLTEtMjQ1ODc_03fab4eb-4b90-48a7-ba8d-fe9b1209eee3"
      unitRef="usd">100000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTozYzllZWE0ODYzNjU0YTg1YmM3ZDc3MzRmYjkzNzE5OC90YWJsZXJhbmdlOjNjOWVlYTQ4NjM2NTRhODViYzdkNzczNGZiOTM3MTk4XzQtNS0xLTEtMjQ1ODc_0749d824-ccef-4171-b7eb-5876e90f7efe"
      unitRef="usd">75300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItMS0xLTEtMjQ1ODc_464e619b-7b17-43b4-acc8-91bfeb91c4c4"
      unitRef="usd">60500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItMy0xLTEtMjQ1ODc_efe2a319-73b4-45c8-b75d-880540f51da6"
      unitRef="usd">47500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzItNS0xLTEtMjQ1ODc_b8ce35f0-91b4-4130-add8-be5dc952f3a8"
      unitRef="usd">36500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtMS0xLTEtMjQ1ODc_af95b5cf-4998-4ce5-b72a-5ba35af2bdc7"
      unitRef="usd">62500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtMy0xLTEtMjQ1ODc_0f56fa96-8e7e-4dcd-88d6-8987eb146ea6"
      unitRef="usd">44200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzMtNS0xLTEtMjQ1ODc_55ca4ad6-eb97-45c6-bc69-138de0a35738"
      unitRef="usd">30500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtMS0xLTEtMjQ1ODc_4a860a49-9ce3-4b90-b9df-6fccc16ae15a"
      unitRef="usd">7600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtMy0xLTEtMjQ1ODc_d76e8124-0ccd-4c68-8ed6-133f2d2c1f19"
      unitRef="usd">5300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzQtNS0xLTEtMjQ1ODc_802db124-f077-4353-9042-d1b74c7eecb3"
      unitRef="usd">5600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibc56f68087124b8b8cfe42e19151218a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtMS0xLTEtMjQ1ODc_b496d491-2c76-4611-a187-0f5d93d1e741"
      unitRef="usd">3600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1e84a209c2b443968257a0960b35e6f0_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtMy0xLTEtMjQ1ODc_a0981a3b-7068-4b56-b1bd-5b77e804aebf"
      unitRef="usd">3000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2ca72bf2007745ac9be527c3a44edef0_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzUtNS0xLTEtMjQ1ODc_202f0ac7-37af-4565-92df-f82c7854a9ba"
      unitRef="usd">2700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtMS0xLTEtMjQ1ODc_14317e6d-2c66-4c16-b3d6-b58488c7ed71"
      unitRef="usd">134200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtMy0xLTEtMjQ1ODc_e143bce2-f5e0-4131-b5bf-a8cade1f0a59"
      unitRef="usd">100000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTowZjM2MjE3NjQyMDI0MDZlODBlZGQwZDZhNGI4MjAyZi90YWJsZXJhbmdlOjBmMzYyMTc2NDIwMjQwNmU4MGVkZDBkNmE0YjgyMDJmXzYtNS0xLTEtMjQ1ODc_173dc8f3-7740-4ef6-a3a2-00c77cad27f3"
      unitRef="usd">75300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="if9dd80ab56044cb5b1502c3c0b0084c6_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzEtMS0xLTEtMjQ1ODc_595bb3cf-5b6c-4c73-acdb-0d7180eeb0fb"
      unitRef="usd">101700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzEtMy0xLTEtMjQ1ODc_0429462b-8c53-4ce4-b4ea-6512e5778b8b">P2Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzItMS0xLTEtMjQ1ODc_27696b72-7a9f-4a0c-9b43-066c270d862d"
      unitRef="usd">150500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTo2NGUyNmU4ODQ2ZmE0OGQzOGJlYWIxNDU1Y2M0NjY2Yy90YWJsZXJhbmdlOjY0ZTI2ZTg4NDZmYTQ4ZDM4YmVhYjE0NTVjYzQ2NjZjXzItMy0xLTEtMjQ1ODc_4519995e-f7ab-4d42-93da-33b352f19de8">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTc_34036960-a7d9-45ae-bad4-478e22f3902f">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ib439fe7fca70420e85d14235298d0807_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE4OTA_aeedf41a-eda8-4018-9479-392104de06b2">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3c44c1a195de478c824a69cb855d11ea_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTI_03211a20-db1d-4875-87ef-d253b5536851">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNjI_af31b7ce-bb62-4f7d-ae11-3684d982e0d0"
      unitRef="usdPerShare">45.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNjY_4297b3b6-6b9a-4689-b46c-b2fea1aac9d3"
      unitRef="usdPerShare">45.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzIzNzM_bb84998f-863f-43b6-8bc0-9ac7f519d21e"
      unitRef="usdPerShare">41.74</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTg_d5af3960-6fa6-4926-8820-b4710dc7905d">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each stock option granted was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted-average assumptions: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected volatility of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;45.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;48.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expected option term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItMS0xLTEtMjQ1ODc_6f14a732-c0b0-4308-ad1c-a790554ce27c"
      unitRef="number">0.006</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItMy0xLTEtMjQ1ODc_9249cedb-e3de-46dd-b17d-c4c4bab2928b"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzItNS0xLTEtMjQ1ODc_c0017734-6c39-479a-903d-01f0d8c362db"
      unitRef="number">0.024</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtMS0xLTEtMjQ1ODc_b93617d9-ad9c-4e8f-9396-6506d416f7cb"
      unitRef="number">0.459</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtMy0xLTEtMjQ1ODc_b67e1a29-fb3f-4271-a781-0f348fd8f3e1"
      unitRef="number">0.485</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzMtNS0xLTEtMjQ1ODc_770edc5a-f5b8-47fd-8a30-a99333ad73c4"
      unitRef="number">0.548</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtMS0xLTEtMjQ1ODc_fa19cdf8-d52e-42b0-b6f7-62e2d860a4cb"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtMy0xLTEtMjQ1ODc_4da788be-aa63-49e3-a2c4-006cc6992faa"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzQtNS0xLTEtMjQ1ODc_b04bf89b-3aa2-463f-88ec-475de27e0444"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtMS0xLTEtMjQ1ODc_561ba715-2514-47af-9ff7-dd19bdc802a8">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i63f678c41c724186809ce1140e5eb23b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtMy0xLTEtMjQ1ODc_004b2a00-4665-4432-a349-8c882454a275">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if784e79b6b9e442a9b259642b8723999_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpiMTllMTE0NjQzMmI0YTg2YTI3Zjg0NDE5NjJlYzVhNy90YWJsZXJhbmdlOmIxOWUxMTQ2NDMyYjRhODZhMjdmODQ0MTk2MmVjNWE3XzUtNS0xLTEtMjQ1ODc_4e50781a-5468-4390-b84d-01a0bc454a25">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTM_6fbb40e5-26ee-4e7d-855c-8e409b3a1327">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to stock options follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;62.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;110.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;28.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;76.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;136.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;134.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzEtMS0xLTEtMjQ1ODc_de02bdd0-4538-48bb-9577-db4729545f11"
      unitRef="shares">6800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzEtMy0xLTEtMjQ1ODc_cce10cec-a2e1-46b7-950e-2be29bde357c"
      unitRef="usdPerShare">62.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzItMS0xLTEtMjQ1ODc_d73ddb06-b59e-4f9b-a81c-af6862b97016"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzItMy0xLTEtMjQ1ODc_39c6a082-e5e1-408d-b024-0ec27ac94c75"
      unitRef="usdPerShare">110.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzMtMS0xLTEtMjQ1ODc_a5e8ae2d-64d2-4320-bd4e-6fdb42e90245"
      unitRef="shares">700000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzMtMy0xLTEtMjQ1ODc_c88de8e3-9f0e-4a8f-b41d-f9597353ce65"
      unitRef="usdPerShare">28.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzQtMS0xLTEtMjQ1ODc_53350fa7-6428-4e1b-bbfa-76fbdbfcd0dd"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzQtMy0xLTEtMjQ1ODc_98291adc-599f-45c8-b8ae-4ad15f73c264"
      unitRef="usdPerShare">103.30</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtMS0xLTEtMjQ1ODc_69995397-b8c4-4add-9629-ce9a9ebe2f4d"
      unitRef="shares">7700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtMy0xLTEtMjQ1ODc_cb4a919a-b7a6-43bf-afc7-6cabe93d7d58"
      unitRef="usdPerShare">76.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtNS0xLTEtMjQ1ODc_7cd0127e-409b-4d3d-acc6-c7f25581857d">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzUtNy0xLTEtMjQ1ODc_38e2e023-b3cc-4919-8859-a8d5e606052e"
      unitRef="usd">136400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtMS0xLTEtMjQ1ODc_8fe59d90-4b77-40f1-add4-440a817a332e"
      unitRef="shares">5200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtMy0xLTEtMjQ1ODc_914709a1-f30f-417e-aefb-ea4ff287481b"
      unitRef="usdPerShare">63.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtNS0xLTEtMjQ1ODc_8e3befa4-a1f7-4ec7-9216-b9b93b3c36b9">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpjZDQzNzc5ZDJkMzQ0YjIzYjBhYWM0Yjg3MGU0YjhiNC90YWJsZXJhbmdlOmNkNDM3NzlkMmQzNDRiMjNiMGFhYzRiODcwZTRiOGI0XzYtNy0xLTEtMjQ1ODc_eebd177a-f9c8-4775-84ad-ecaf6e081505"
      unitRef="usd">134700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MDk_bffd0a58-e5d4-49a5-ade6-e8e3afa7457c"
      unitRef="usd">58000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MTM_a42f1ba5-c213-4f92-b72c-d9ccdbe03fa7"
      unitRef="usd">40200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM1MjA_4db1d484-1912-4320-abd4-8cb640f3e379"
      unitRef="usd">64300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MDU_061dd5a2-1371-4f8b-82f3-ba667eba5806"
      unitRef="usd">20700000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MDk_4caed97a-3b61-4209-9f4a-539686320ac4"
      unitRef="usd">23500000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzM2MTY_f9c294de-9dd0-455b-9911-1ca0c75abe59"
      unitRef="usd">27300000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTQ_3a6299da-21fe-47f9-9682-265a0611a29b">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzUwOTU_38657800-38f1-44d3-b130-0c19d7e06a98">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to RSUs follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;89.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;104.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Released&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;82.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;101.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;99.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;174.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"&gt;_________________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2021, our board of directors approved an equity grant of approximately 0.5&#160;million RSUs, which will vest over a 2-year period, to our full-time employees other than our executive officers.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to PRSUs follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.808%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;PRSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Grant Date &lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;102.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0bc4f833719d407fb605d6e3f05afc23_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzEtMS0xLTEtMjQ1ODc_ae3b21e4-187c-4fde-91f5-0570695c2ca4"
      unitRef="shares">1500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0bc4f833719d407fb605d6e3f05afc23_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzEtMy0xLTEtMjQ1ODc_6a6783af-812a-4ca5-abe4-b198c979f1c0"
      unitRef="usdPerShare">89.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzItMS0xLTEtMjQ1ODc_256d9d91-8bea-4290-9538-572b4ebe2d38"
      unitRef="shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzItMy0xLTEtMjQ1ODc_2b030a9d-7871-4cb5-ac6c-51fa6996d66c"
      unitRef="usdPerShare">104.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzMtMS0xLTEtMjQ1ODc_40628e1f-90b8-40d6-859d-c3422f5e1cb0"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzMtMy0xLTEtMjQ1ODc_35fe08e4-4a80-48a5-bf55-cd0b18576309"
      unitRef="usdPerShare">82.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzQtMS0xLTEtMjQ1ODc_c6330966-70f3-48b2-a6f7-5f41acf92e91"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzQtMy0xLTEtMjQ1ODc_e756b439-2dc2-42df-8b05-d67220232ae6"
      unitRef="usdPerShare">101.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtMS0xLTEtMjQ1ODc_8bf9e5da-e29b-4498-a895-883455105018"
      unitRef="shares">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtMy0xLTEtMjQ1ODc_2b1de87f-ec28-4dab-9729-e5c9ec5f2a4b"
      unitRef="usdPerShare">99.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtNS0xLTEtMjQ1ODc_215cebd0-72ee-4db7-b45f-7377b663e238">P1Y3M18D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="ifd0b6fb331fe4c9dbc89908fb3a4e7f7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpmOWRiMWM1NWU1NWU0MGZhYjEwM2QxOGVhNDdkMzEwMS90YWJsZXJhbmdlOmY5ZGIxYzU1ZTU1ZTQwZmFiMTAzZDE4ZWE0N2QzMTAxXzUtNy0xLTEtMjQ1ODc_a51bc306-c07b-48e6-881f-cdf371116b18"
      unitRef="usd">174100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i360e7030403c47f48b0818bcce72318e_D20210801-20210831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzE2NDkyNjc0NDcyMTg_c15c57ff-6a8b-4b2c-9caf-cb25c1a56830"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i360e7030403c47f48b0818bcce72318e_D20210801-20210831"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzYwNDczMTM5NTg1MzY_26e39ff0-2828-478a-8281-5eef8422e363">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i3bb097c88a9d4f6c836ac47d60fd2298_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMTQ_5a4974f3-208c-4ef5-9097-7cc92a81a877"
      unitRef="usd">64300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i27166c017561418eb9f1c2c65eda78a8_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMTg_8b5b5094-de84-40ff-b482-6c1fc2d8dd99"
      unitRef="usd">49700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
      contextRef="i088597e053a44c6fb2edd6094ae38ef9_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQwMjU_2603bd40-42db-48f9-8eff-6a500181d5bd"
      unitRef="usd">36100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8d20c96869ad45d18f300e0ed27f7ee7_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQxOTI_fc645662-ac50-46b2-9389-3ad384684bf0">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i670a859ff8a84b0ba0c51a248450c900_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQxOTg_d0225239-ef2f-4af3-af05-c3c0b898c765">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib60edb8359ba4965aa27229d88b89dff_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzEtMS0xLTEtMjQ1ODc_460c773e-4381-4798-af1e-88fd70275479"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib60edb8359ba4965aa27229d88b89dff_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzEtMy0xLTEtMjQ1ODc_fd2c8fb5-e5b3-4ff0-8b3f-ae258639563a"
      unitRef="usdPerShare">102.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzItMS0xLTEtMjQ1ODc_36596665-59d5-46db-87b5-84d89649f9f2"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzItMy0xLTEtMjQ1ODc_d6804c96-b5c1-48f8-a970-360bdb3905ec"
      unitRef="usdPerShare">114.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtMS0xLTEtMjQ1ODc_f6b26d14-5191-4277-9fb9-e1be8b19bc00"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtMy0xLTEtMjQ1ODc_ae129ece-af0e-4acc-b857-7f8a80d66abf"
      unitRef="usdPerShare">109.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtNS0xLTEtMjQ1ODc_d4b1b2f1-afd7-4ff5-b26b-81c8bbac0f6d">P1Y2M12D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested
      contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90YWJsZTpkMWUzYWYxODM5ZTc0MmJkYmU1M2I5YzJhNWJiZWIyNS90YWJsZXJhbmdlOmQxZTNhZjE4MzllNzQyYmRiZTUzYjljMmE1YmJlYjI1XzUtNy0xLTEtMjQ1ODc_62ae6186-4954-4c21-a21e-f21868c1c72b"
      unitRef="usd">30900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9700de8000ff49f19b9b94d8714b9b95_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ1NzQ_3a03f973-f682-4fbb-8c44-dc78ecddf734"
      unitRef="usd">32000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i77badcffcb4d49e99067110d2749b48d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NDE_ae907993-f206-4ce5-9d7e-f0dc38b91aed"
      unitRef="usd">13500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ic7a6ae4784b0418e9f221e7d5fbd5c7d_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NTU_c15052fa-6e79-45bb-a729-60872348f172"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i6291d1c18a684b5b8660bc9530c4d244_D20210101-20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ2NTU_d13cd016-00e4-4f00-9c4d-5c5858d66752"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i94ec3a34a5c1464a98687009bb85c0ee_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjYvZnJhZzpmZDI5ZmNhMTdkYmE0YzFhODcwZjdmZDA4YTJlMDFhNi90ZXh0cmVnaW9uOmZkMjlmY2ExN2RiYTRjMWE4NzBmN2ZkMDhhMmUwMWE2XzQ5MjQ_9bd2f149-a9fc-4778-96b1-0410af658101"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTY_e83a333c-fc54-46bb-8c01-c408b25a8fd1">Income Taxes&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of income tax expense (benefit) for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(287.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for (benefit from) income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal income taxes at 21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Branded prescription drug fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expired tax attributes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets as of December 31, 2021 and 2020 are listed below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;411.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, our deferred tax assets were primarily the result of federal net operating loss carry forwards, capitalized research costs, acquired intangible assets and tax credit carryforwards. As of December 31, 2021 and 2020, we recorded a valuation allowance of $54.8 million and $49.8 million, respectively, against our gross deferred tax asset balance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of each reporting date, management considers new evidence, both positive and negative, that could affect its assessment of the future realizability of our deferred tax assets. As of December 31, 2021, management determined there was sufficient positive evidence to conclude that it is more likely than not deferred tax assets of $315.1 million are realizable. The recorded valuation allowance of $54.8 million consisted primarily of state net operating loss and credit carryforwards for which management could not conclude it is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we had federal and state income tax net operating loss carryforwards of $421.1 million and $329.9 million, respectively. The federal net operating losses will begin to expire in 2028, unless previously utilized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California net operating losses will begin to expire in 2031 unless previously utilized and the net operating losses related to other states will begin to expire in 2026.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, we had federal and state R&amp;amp;D tax credit carryforwards of $107.3 million and $66.3 million, respectively. A portion of the federal R&amp;amp;D tax credit carryforwards expired in 2021. The remaining federal R&amp;amp;D tax credits will continue to expire beginning in 2022, unless previously utilized. The California R&amp;amp;D tax credits carry forward indefinitely and the R&amp;amp;D tax credits related to other states will begin to expire in 2022, unless previously utilized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, the future utilization of our net operating loss and R&amp;amp;D tax credit carryforwards to offset future taxable income may be subject to an annual limitation, pursuant to Internal Revenue Code Sections 382 and 383, as a result of ownership changes that could occur in the future. No ownership changes have occurred through December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The impact of an uncertain income tax position on the income tax return must be recognized at the largest amount that is more-likely-than-not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our policy is to recognize interest or penalties related to income tax matters in income tax expense. Interest and penalties related to income tax matters were not material for 2021, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to taxation in the United States and various state jurisdictions. Our tax years for 2001 for federal and since inception for California and forward are subject to examination by federal and state tax authorities due to the carryforward of unutilized net operating losses and R&amp;amp;D tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to unrecognized tax benefits follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We excluded those deferred tax assets that are not more-likely-than-not to be sustained under the technical merits of the tax position. Such unrecognized tax benefits totaled $4.9 million for current year tax positions, as reflected in the table above.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2021, we had $57.4 million of unrecognized tax benefits that, if recognized and realized, would affect the effective tax rate, subject to the valuation allowance. We do not expect a significant change in our unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTc_e35b498f-7cf2-46e2-a8b7-7dfe48b82911">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of income tax expense (benefit) for continuing operations were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(287.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(310.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtMS0xLTEtMjQ1ODc_af7b0b0f-1b28-4da8-9d8a-b8fb1768d1bd"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtMy0xLTEtMjQ1ODc_d8afa970-726f-41cd-ad38-696143f79d78"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzMtNS0xLTEtMjQ1ODc_41c63556-355b-41b6-9d06-77f524c137f8"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtMS0xLTEtMjQ1ODc_63608f58-81a4-4961-a2eb-c38827d100fb"
      unitRef="usd">6300000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtMy0xLTEtMjQ1ODc_b7935488-470a-4a03-ae89-fa454603c6c2"
      unitRef="usd">10100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzQtNS0xLTEtMjQ1ODc_7bdf8870-6d61-43b7-bb58-f4461f4e084d"
      unitRef="usd">9500000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtMS0xLTEtMjQ1ODc_807d2207-21c9-4da7-8f0f-3915b6064aeb"
      unitRef="usd">6300000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtMy0xLTEtMjQ1ODc_fd533f29-8b9b-4cd6-ae69-64aa26982909"
      unitRef="usd">10100000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzUtNS0xLTEtMjQ1ODc_200f0329-2d7f-4b99-bed4-ec538ec9386c"
      unitRef="usd">9500000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctMS0xLTEtMjQ1ODc_3b5ef156-25a4-41b2-be25-8528a30c6869"
      unitRef="usd">5900000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctMy0xLTEtMjQ1ODc_c7500877-2b27-4959-ba41-5cc8dc95bd60"
      unitRef="usd">-287500000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzctNS0xLTEtMjQ1ODc_9e3de00b-ef12-41ee-997b-b0d9792d560d"
      unitRef="usd">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtMS0xLTEtMjQ1ODc_c8422fac-9c22-4263-b615-40cc1ea1fa1d"
      unitRef="usd">-400000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtMy0xLTEtMjQ1ODc_03af3481-c430-40fe-893b-c047ca209342"
      unitRef="usd">-23200000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzgtNS0xLTEtMjQ1ODc_e4be7cfd-d105-44f0-a9d6-0c4707a8e220"
      unitRef="usd">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktMS0xLTEtMjQ1ODc_5303b765-7e45-416c-b53c-8878a1ae9bae"
      unitRef="usd">5500000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktMy0xLTEtMjQ1ODc_e4721dda-5e95-4352-8170-8c9c736faabb"
      unitRef="usd">-310700000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzktNS0xLTEtMjQ1ODc_59ec356b-3624-4390-8159-5e119b15e09d"
      unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTEtMS0xLTI0NTg3_12435662-c3b7-438d-95ce-6058263f336a"
      unitRef="usd">11800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTMtMS0xLTI0NTg3_826407f2-5214-4212-a6a2-7f7f09457e2e"
      unitRef="usd">-300600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTozOWE3NGE2YzZlNjY0YmE4OWE3OGNkYTc3NTViNDM0Yi90YWJsZXJhbmdlOjM5YTc0YTZjNmU2NjRiYTg5YTc4Y2RhNzc1NWI0MzRiXzEwLTUtMS0xLTI0NTg3_07409906-89f3-4f39-a899-2aebbfc887b0"
      unitRef="usd">9500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTg_b7e7134d-04c5-4354-9c23-a58c5a3f4020">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for (benefit from) income taxes on earnings subject to income taxes differs from the statutory federal rate due to the following: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Federal income taxes at 21%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Branded prescription drug fee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(11.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Officer compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expired tax attributes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(296.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(300.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_048f3b20-81e8-4c9d-a660-d43362c4c2d9"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_56e3098e-f0d8-49ce-af7b-d98b6d2e610c"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMC0xLTEtMjQ1ODcvdGV4dHJlZ2lvbjoyZDBmNmQ4MDJmNDM0NGI5OWE2MWEzMTFkMGJkOTU0ZF8yOA_b123720f-408b-4187-bca4-0081f9a9e90a"
      unitRef="number">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMS0xLTEtMjQ1ODc_ac9999df-5672-4c5e-80f9-0b856275f4fe"
      unitRef="usd">21300000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItMy0xLTEtMjQ1ODc_37ac6e29-528c-46ab-8429-183219d32826"
      unitRef="usd">22400000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzItNS0xLTEtMjQ1ODc_4dcd294a-52ac-4fe1-a392-a9957fdae03a"
      unitRef="usd">9800000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtMS0xLTEtMjQ1ODc_7ef7d024-730f-4caf-adc8-ef4abcb39e16"
      unitRef="usd">6200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtMy0xLTEtMjQ1ODc_6d44822e-f541-48b5-af8e-b4723f46d1ef"
      unitRef="usd">5500000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzMtNS0xLTEtMjQ1ODc_354914e8-aa8e-47f4-91a4-ed3ee6edc2e6"
      unitRef="usd">4000000.0</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtMS0xLTEtMjQ1ODc_657f7f86-18d9-4649-a81b-f8a78d11e609"
      unitRef="usd">200000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtMy0xLTEtMjQ1ODc_d1943e54-151e-4131-bd32-f988a8246528"
      unitRef="usd">600000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzQtNS0xLTEtMjQ1ODc_0fbd67dc-849e-496d-ab9d-9a7fc933911a"
      unitRef="usd">800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtMS0xLTEtMjQ1ODc_163d61fe-3c81-47c5-9aae-331a051644e1"
      unitRef="usd">4800000</nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtMy0xLTEtMjQ1ODc_77981c0c-97b6-490b-8156-5311fc8842c0"
      unitRef="usd">4900000</nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzUtNS0xLTEtMjQ1ODc_bcc1bb55-ca99-49f5-9f97-d9b538f85d78"
      unitRef="usd">3700000</nbix:IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtMS0xLTEtMjQ1ODc_7c0671c1-3ac9-4398-9895-96bc8e35212a"
      unitRef="usd">-11300000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtMy0xLTEtMjQ1ODc_95379f57-0a5e-4edd-9cf8-fdcc33f28d4f"
      unitRef="usd">-6700000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzYtNS0xLTEtMjQ1ODc_2d4bce55-69ab-42df-943e-6c546b20d491"
      unitRef="usd">-12800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctMS0xLTEtMjQ1ODc_e0fc976c-d1f3-4566-a2fb-c5c63ef79987"
      unitRef="usd">7000000.0</nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctMy0xLTEtMjQ1ODc_2cd6dc6e-3060-4421-9400-edceeb265883"
      unitRef="usd">3700000</nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost>
    <nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzctNS0xLTEtMjQ1ODc_2fe2100a-011d-4897-a3a9-4a89bd83bc64"
      unitRef="usd">3100000</nbix:IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtMS0xLTEtMjQ1ODc_44ec2278-5b94-432d-b11d-dc902fc2dce9"
      unitRef="usd">200000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtMy0xLTEtMjQ1ODc_d133959c-9b15-4ba7-8dcf-eb1e96c15db2"
      unitRef="usd">3300000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzgtNS0xLTEtMjQ1ODc_0494357a-8a4a-4baa-b233-3ed8e5f60696"
      unitRef="usd">-4100000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <nbix:IncomeTaxReconciliationExpirationOfTaxCredits
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktMS0xLTEtMjQ1ODc_53d138fe-7285-4566-8982-2e36f65d5329"
      unitRef="usd">600000</nbix:IncomeTaxReconciliationExpirationOfTaxCredits>
    <nbix:IncomeTaxReconciliationExpirationOfTaxCredits
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktMy0xLTEtMjQ1ODc_97b116a2-526b-4a23-88db-e0d23a2224e7"
      unitRef="usd">1100000</nbix:IncomeTaxReconciliationExpirationOfTaxCredits>
    <nbix:IncomeTaxReconciliationExpirationOfTaxCredits
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzktNS0xLTEtMjQ1ODc_e257c9a7-df80-448c-b0bc-2a77b8ac316e"
      unitRef="usd">1200000</nbix:IncomeTaxReconciliationExpirationOfTaxCredits>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTEtMS0xLTI0NTg3_91ad187c-0781-4efa-8add-9c3141352195"
      unitRef="usd">22000000.0</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTMtMS0xLTI0NTg3_c9a9e705-d202-4957-83d2-725f1d74c58d"
      unitRef="usd">39000000.0</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEwLTUtMS0xLTI0NTg3_340a34ed-8e6d-40cf-a422-741fddaf3aec"
      unitRef="usd">10400000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTEtMS0xLTI0NTg3_7cb4d8af-9353-4ed4-9264-c3ba4d3a9683"
      unitRef="usd">5000000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTMtMS0xLTI0NTg3_ace9b9c1-cdc4-44c2-8b78-dc785cc962e8"
      unitRef="usd">-296300000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzExLTUtMS0xLTI0NTg3_b9568a70-2073-4585-89cf-059b3681aba7"
      unitRef="usd">13900000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTEtMS0xLTI0NTg3_96bb2cbf-bbc6-4735-bc9f-e8d8340bc3c2"
      unitRef="usd">-200000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTMtMS0xLTI0NTg3_c3b76735-953e-42a0-8f99-d3ddb341391f"
      unitRef="usd">-100000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEyLTUtMS0xLTI0NTg3_e99d4b99-8f1a-44da-91c3-18dcfb6137cc"
      unitRef="usd">300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTEtMS0xLTI0NTg3_2a4173c4-6416-4b18-ae0e-31e25107aed8"
      unitRef="usd">11800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTMtMS0xLTI0NTg3_bcecc749-9379-4a2f-ab00-b74719620e95"
      unitRef="usd">-300600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZTphOWI4ZmM4MWQzOWU0N2Y5Yjk4YzNiNTU1YjY0ODE2My90YWJsZXJhbmdlOmE5YjhmYzgxZDM5ZTQ3ZjliOThjM2I1NTViNjQ4MTYzXzEzLTUtMS0xLTI0NTg3_3084687b-4b5d-48eb-b8f6-cd39168a40a1"
      unitRef="usd">9500000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTQ_0c4014ef-f5b5-480d-a778-602faac3de2d">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets as of December 31, 2021 and 2020 are listed below. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.214%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;90.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;111.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;109.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Capitalized research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;86.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;23.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;413.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;411.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Convertible senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(19.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(43.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(42.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net of deferred tax assets and liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;369.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(54.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(49.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;315.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;319.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzMtMS0xLTEtMjQ1ODc_8a7990be-39f3-487f-b309-d31e0925a05e"
      unitRef="usd">90300000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzMtMy0xLTEtMjQ1ODc_7533008a-1aff-4086-95a2-e4f12ab32c3c"
      unitRef="usd">111400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzQtMS0xLTEtMjQ1ODc_d048ce51-89e2-4f08-8a3a-b7359b5107d0"
      unitRef="usd">129700000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzQtMy0xLTEtMjQ1ODc_166bcde1-ebab-48cb-9f01-426f6c17725c"
      unitRef="usd">109600000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzUtMS0xLTEtMjQ1ODc_8f15ae06-566d-4712-a8ab-14b3f82277e4"
      unitRef="usd">17900000</nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzUtMy0xLTEtMjQ1ODc_ef4993ed-5fe0-43dc-8c7e-65dcb8ed8fcd"
      unitRef="usd">24700000</nbix:DeferredTaxAssetsCapitalizedResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzYtMS0xLTEtMjQ1ODc_a34ca331-7c29-40d5-8f92-b1c05055b11a"
      unitRef="usd">38900000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzYtMy0xLTEtMjQ1ODc_da5ff208-5521-48db-8ce6-509f85a7d492"
      unitRef="usd">29800000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <nbix:DeferredTaxAssetsOperatingLeasesAssets
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzctMS0xLTEtMjQ1ODc_33cc466e-7bda-4518-9198-6a1befe307b0"
      unitRef="usd">29300000</nbix:DeferredTaxAssetsOperatingLeasesAssets>
    <nbix:DeferredTaxAssetsOperatingLeasesAssets
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzctMy0xLTEtMjQ1ODc_cf42561a-cf57-4f8c-ad44-12a2e7f6de50"
      unitRef="usd">25200000</nbix:DeferredTaxAssetsOperatingLeasesAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzgtMS0xLTEtMjQ1ODc_7dceca8b-a12b-47eb-aaa7-845f7f535d40"
      unitRef="usd">86100000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzgtMy0xLTEtMjQ1ODc_17c0a64a-7221-4b38-b945-4f9d78c5c9a1"
      unitRef="usd">86700000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzktMS0xLTEtMjQ1ODc_7367f931-9119-4f51-8262-3e654c85e4e7"
      unitRef="usd">21600000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzktMy0xLTEtMjQ1ODc_a19872f5-11e4-4ddc-a5a8-094f9af91e92"
      unitRef="usd">23900000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEwLTEtMS0xLTI0NTg3_6cf84c3f-2165-4abd-a697-0343c205ae73"
      unitRef="usd">413800000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEwLTMtMS0xLTI0NTg3_11a37eba-933d-4684-a0a2-d1e092e5945b"
      unitRef="usd">411300000</us-gaap:DeferredTaxAssetsGross>
    <nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEyLTEtMS0xLTI0NTg3_ecd2b928-0fdc-4ab2-92fe-27b0c318229e"
      unitRef="usd">9900000</nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes>
    <nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEyLTMtMS0xLTI0NTg3_479292d1-cf75-4d9d-bfa1-62ecda846d13"
      unitRef="usd">13800000</nbix:DeferredTaxLiabilitiesConvertibleSeniorNotes>
    <nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEzLTEtMS0xLTI0NTg3_57e75f60-871f-4d74-bee1-c16b5af9189e"
      unitRef="usd">23300000</nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities>
    <nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzEzLTMtMS0xLTI0NTg3_7b36df67-34ad-481d-a46c-3c21c0089588"
      unitRef="usd">19900000</nbix:DeferredTaxLiabilitiesOperatingLeasesLiabilities>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE0LTEtMS0xLTI0NTg3_12793934-568a-4e64-a95f-5d679dddd6a6"
      unitRef="usd">10700000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE0LTMtMS0xLTI0NTg3_edca93d7-d9a6-444e-86cf-30fff6ba0c5c"
      unitRef="usd">8400000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE1LTEtMS0xLTI0NTg3_9bb2ea4d-c244-4d75-8541-31d72ed6cedb"
      unitRef="usd">43900000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE1LTMtMS0xLTI0NTg3_cca91c09-45e7-47fa-899d-b465d0ab1aa6"
      unitRef="usd">42100000</us-gaap:DeferredIncomeTaxLiabilities>
    <nbix:DeferredTaxAssetsLiabilitiesGross
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE2LTEtMS0xLTI0NTg3_35b4eb2d-93ec-4c23-a6e3-ff366e10dd0c"
      unitRef="usd">369900000</nbix:DeferredTaxAssetsLiabilitiesGross>
    <nbix:DeferredTaxAssetsLiabilitiesGross
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE2LTMtMS0xLTI0NTg3_d7cedbfe-b4c8-41ed-9ecb-b05cd1262dcc"
      unitRef="usd">369200000</nbix:DeferredTaxAssetsLiabilitiesGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE3LTEtMS0xLTI0NTg3_e68267f5-2544-4543-9dfd-76da6508ea30"
      unitRef="usd">54800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE3LTMtMS0xLTI0NTg3_24f0dfdb-c39c-47d0-a98a-87996a71cf9d"
      unitRef="usd">49800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE4LTEtMS0xLTI0NTg3_936aeec7-9e3d-4d99-acc6-d8db0e9a055d"
      unitRef="usd">315100000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyYWRlODBmODI3ZWQ0MzBkOWNjYzQxZjM2ZjA2YTY0MS90YWJsZXJhbmdlOjJhZGU4MGY4MjdlZDQzMGQ5Y2NjNDFmMzZmMDZhNjQxXzE4LTMtMS0xLTI0NTg3_df746360-9a62-44e2-9417-fd808259ddc8"
      unitRef="usd">319400000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzYyMg_e68267f5-2544-4543-9dfd-76da6508ea30"
      unitRef="usd">54800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzYyOQ_24f0dfdb-c39c-47d0-a98a-87996a71cf9d"
      unitRef="usd">49800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzIxOTkwMjMyNTk2NjU_936aeec7-9e3d-4d99-acc6-d8db0e9a055d"
      unitRef="usd">315100000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzIxOTkwMjMyNTk4MjU_e68267f5-2544-4543-9dfd-76da6508ea30"
      unitRef="usd">54800000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib009e76fc516405f817eb74aed96c1cd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE1OTM_2a5bbce6-8421-4568-881c-977e4291bcd2"
      unitRef="usd">421100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE2MDA_60554a58-066f-4aa3-8829-abd9c953cefe"
      unitRef="usd">329900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ib009e76fc516405f817eb74aed96c1cd_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE5NTA_fa81a3ac-a474-4ec3-a162-46f7cf82a379"
      unitRef="usd">107300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i1fbda367aa42435fb1d611c87e2f5bc4_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzE5NTc_176bf114-3f94-4276-a8a7-ae4762f1deaf"
      unitRef="usd">66300000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM4OTU_4aa982d4-48e5-402e-80e0-3d8edd5f64fd">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of activity related to unrecognized tax benefits follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Increase related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Settlements related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;64.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;60.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItMS0xLTEtMjQ1ODc_46fae3b2-665d-4b7e-a108-8293dbeea0a5"
      unitRef="usd">60800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItMy0xLTEtMjQ1ODc_b19d0b81-5478-4439-b00d-dbd58710b3f2"
      unitRef="usd">63900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ief1e07453fb8400290d05177cdbc914a_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzItNS0xLTEtMjQ1ODc_4f907dc3-eabb-408a-80c0-ce0fbc977720"
      unitRef="usd">54800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtMS0xLTEtMjQ1ODc_31ca0272-bed7-4c71-925a-92386394417d"
      unitRef="usd">600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtMy0xLTEtMjQ1ODc_74d3af92-2758-4613-ad82-3b408c86653e"
      unitRef="usd">5700000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzMtNS0xLTEtMjQ1ODc_67006df6-f13c-469f-b5cf-87b8be947355"
      unitRef="usd">300000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtMS0xLTEtMjQ1ODc_cc243fc6-f9ce-45bd-85ce-409ca1e1fba2"
      unitRef="usd">4900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtMy0xLTEtMjQ1ODc_9bbeaeb4-87bd-4a9a-8c41-145e2bb7e078"
      unitRef="usd">3900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzQtNS0xLTEtMjQ1ODc_2d9d52cc-508e-4ab4-9d85-56a6eb2063c8"
      unitRef="usd">9500000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtMS0xLTEtMjQ1ODc_e6993d64-95d7-4759-a20b-6795a8eb5a64"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtMy0xLTEtMjQ1ODc_ee4eec18-646a-40cc-9fa3-bf780c4e9a30"
      unitRef="usd">200000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzUtNS0xLTEtMjQ1ODc_7aa1b70e-9d62-4294-9734-0104825d64de"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtMS0xLTEtMjQ1ODc_e79a7a70-75c3-42f0-b6e8-082a451c4807"
      unitRef="usd">1700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtMy0xLTEtMjQ1ODc_16877886-2a21-4372-a730-74dede1cd3aa"
      unitRef="usd">1100000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzYtNS0xLTEtMjQ1ODc_e03f2bb0-0e4e-468e-b7c6-8d8f2b047fea"
      unitRef="usd">700000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctMS0xLTEtMjQ1ODc_9ad483f3-7123-4ea1-bb7d-adac7a7ee6ec"
      unitRef="usd">64600000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctMy0xLTEtMjQ1ODc_bdeb00c1-b12b-4ee6-9acc-d0dd13e81358"
      unitRef="usd">60800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i50270a33ffaf46e699671aaa2d154c06_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90YWJsZToyNjZhMWYyZTIyNTQ0NThhOGFkNWRkOGZiNzg4NmFkYy90YWJsZXJhbmdlOjI2NmExZjJlMjI1NDQ1OGE4YWQ1ZGQ4ZmI3ODg2YWRjXzctNS0xLTEtMjQ1ODc_2dfcf9c2-62e6-4c72-9cd6-ad5c13685bde"
      unitRef="usd">63900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM1NzQ_9a5da594-5fdd-4840-adf7-60a176ecbc02"
      unitRef="usd">4900000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNjkvZnJhZzpiZTI0YTA0ZmU3YmU0NDRjYTM4MDRlZjJmNzYzOGNhNC90ZXh0cmVnaW9uOmJlMjRhMDRmZTdiZTQ0NGNhMzgwNGVmMmY3NjM4Y2E0XzM2NTk_ed0839f6-1364-4989-ac5b-aabbabb635c4"
      unitRef="usd">57400000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzE0Mjg_639d778e-e62f-4d94-b7dd-da00df61306f">LeasesOur corporate headquarters, for which we have operating leases with terms that expire beginning 2024 through 2031, are located in San Diego, California, and consist of office space and research and development laboratories. Certain of these lease agreements contain clauses for renewal at our option. As we were not reasonably certain to exercise any such options at commencement of these leases, no such options were recognized as part of the associated lease liabilities or right-of-use assets. &lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present supplemental operating lease information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash related to letters of credit issued in lieu of cash security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximate future minimum lease payments under operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accreted interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab"&gt;Less current operating lease liabilities included in other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzYwNDczMTM5NjY2OTI_a2bb1291-31ae-4bc2-a3f6-6731ca9bf1b7">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present supplemental operating lease information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions, except weighted average data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8.8 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10.3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Restricted cash related to letters of credit issued in lieu of cash security deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItMS0xLTEtMjkzOTY_aa7836ed-3fae-454d-9464-a0598545cb11"
      unitRef="usd">15300000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItMy0xLTEtMjkzOTY_d159e1bb-bfcb-4cd1-8068-a78b46df0838"
      unitRef="usd">10100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzItNS0xLTEtMjk0NzU_626d5441-58be-4f82-bf25-0857f60181bf"
      unitRef="usd">8100000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtMS0xLTEtMjkzOTY_9e783b67-e54b-4d21-a548-0543ea8d08f3"
      unitRef="usd">12600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtMy0xLTEtMjkzOTY_1624e383-af72-4990-92a0-c4a791b61e6e"
      unitRef="usd">8600000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzMtNS0xLTEtMjk0ODE_da7c3c0e-9d16-4af8-baea-b22e37b13039"
      unitRef="usd">7700000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzYtMy0xLTEtMjkzOTY_1d587ebd-5e1b-4d0e-9990-89361de9b102">P8Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzYtNS0xLTEtMjk0MzE_74b05f7e-0a9d-4a59-92a2-ac258d13b274">P10Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzctMy0xLTEtMjkzOTY_2f5c09ea-abfe-478c-869b-f55311590100"
      unitRef="number">0.052</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzctNS0xLTEtMjk0MzE_b9dab1a3-5d31-46e4-a2e9-b6b5406dee7a"
      unitRef="number">0.056</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="ia69ac08c927f48ea9cf1305bd5fc5f9f_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzktMy0xLTEtNDEwNjU_620174e1-ebf4-460b-a8da-c9372d9e0db1"
      unitRef="usd">3200000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="ib860e40dbf6b4206ac8fb74ce9822840_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZToyZmEyODQ3NThlZDA0Y2EyYmJjYzJlZWIzMThhNDE1OC90YWJsZXJhbmdlOjJmYTI4NDc1OGVkMDRjYTJiYmNjMmVlYjMxOGE0MTU4XzktNS0xLTEtNDEwNjM_f80e620c-a64d-47ce-a873-52afaf236721"
      unitRef="usd">3200000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90ZXh0cmVnaW9uOjMxYmFkYzA4MmQzZDQ0YmE5N2VmNzZlYTdhMzEyNjhmXzE0Mjk_3f370887-b390-4b1e-8c88-d0e6cf0d29af">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximate future minimum lease payments under operating leases were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Year ending December 31, 2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;70.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;154.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Less accreted interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;32.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTAtMS0xLTI0NTg3_8d27f727-7f2d-4742-a56a-65571f08d9ab"&gt;Less current operating lease liabilities included in other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Noncurrent operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;105.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEtMS0xLTEtMjQ1ODc_6762052b-d95d-4280-bcde-23423c864622"
      unitRef="usd">17000000.0</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzItMS0xLTEtMjQ1ODc_0e75688b-c0b6-45d1-90c9-f25882e93466"
      unitRef="usd">17900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzMtMS0xLTEtMjQ1ODc_2bf4f80a-53be-47cd-8066-9676d18dd48d"
      unitRef="usd">17400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzQtMS0xLTEtMjQ1ODc_6a10bf77-ba4e-4bf1-80a7-1b66b96e4ab7"
      unitRef="usd">15900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzUtMS0xLTEtMjQ1ODc_81c8dba2-d316-419c-a12f-b3d55ba3d506"
      unitRef="usd">15700000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzYtMS0xLTEtMjQ1ODc_596273ac-3822-493d-9baa-c5e171c54f4a"
      unitRef="usd">70400000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzctMS0xLTEtMjQ1ODc_8e87d889-81a8-40e9-bbd1-bfb0be27b181"
      unitRef="usd">154300000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzgtMS0xLTEtMjQ1ODc_53a95c06-f4a3-4119-b377-318e7aaf19b8"
      unitRef="usd">32500000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzktMS0xLTEtMjQ1ODc_aa286543-969a-4751-bf2f-0016facfe11a"
      unitRef="usd">121800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzEwLTEtMS0xLTI0NTg3_4988b776-058b-44b7-bd5e-c7dc943ac462"
      unitRef="usd">16500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i410ba3ab0060406a970171c67adc140c_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzIvZnJhZzozMWJhZGMwODJkM2Q0NGJhOTdlZjc2ZWE3YTMxMjY4Zi90YWJsZTpkNTA5YWQyNzFhYzc0ZGQ3YjhmZDZkYTYxZGEyMjFjNC90YWJsZXJhbmdlOmQ1MDlhZDI3MWFjNzRkZDdiOGZkNmRhNjFkYTIyMWM0XzExLTEtMS0xLTI0NTg3_3fc60ec6-4340-4bf2-8e67-26a4e6338263"
      unitRef="usd">105300000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzM0OA_f20a0880-117b-4080-8de7-f9f21a39775b">Retirement PlanWe have a 401(k) defined contribution savings plan, or the 401(k)&#160;Plan. The 401(k) Plan is for the benefit of all qualifying employees and permits voluntary contributions by employees up to 60% of base salary limited by the IRS-imposed maximum. Employer contributions were $8.1 million for 2021, $6.7 million for 2020 and $4.9 million for 2019.</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzIyMA_8d105992-3cd1-4c36-93d0-b60fe60f6bbc"
      unitRef="number">0.60</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMwMg_927ef71d-ee6d-4b8e-a394-0e8bbe169123"
      unitRef="usd">8100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i09822ae4fa6649b8888440c439e02ccb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMwNg_c5a180e0-4bc1-4b2c-b198-5260b5dc6faf"
      unitRef="usd">6700000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i98bc001f820e4a76842b22423643fd00_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzUvZnJhZzpjMTZmNmMwNmJkMzA0ZTA4OGE0ZjBiNTI2MTU4OWYwOC90ZXh0cmVnaW9uOmMxNmY2YzA2YmQzMDRlMDg4YTRmMGI1MjYxNTg5ZjA4XzMxNA_35ca2d90-5df6-486d-b042-d3e9153386e1"
      unitRef="usd">4900000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODYx_0558dcc9-1d2b-418f-90cb-afbeb818cd3b">Subsequent Events&lt;div style="margin-bottom:3pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 8, 2022, we entered into a lease agreement for a four-building campus facility to be constructed in San Diego, California, pursuant to which we also secured a 6-year option for the construction of a fifth building and an option to purchase the entire campus facility, which will consist of office space and research and development laboratories, in the future. Upon completion of construction, we expect to utilize the campus facility as our new corporate headquarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the lease, on a building-by-building basis, base rent will be subject to a 10-month rent abatement period following the respective lease commencement date, which dates will be determined in the future based upon achievement of substantial completion of construction with respect to each such building in the condition suitable for the installation of our furniture, fixtures and equipment, and on which date we will record a lease liability, corresponding right-of-use asset, and begin lease expense recognition with respect to each such building. After the rent abatement period, monthly base rent will be $6 per square foot, subject to annual escalations of 3% during the initial &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODc5_2f705c83-17a2-4b52-a632-b67c9ccf6649"&gt;13.6-year&lt;/span&gt; lease term, which term we have the option to renew for two additional terms of 5 years each.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <nbix:LesseeOperatingLeaseOptionTermToConstructFifthBuilding
      contextRef="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF8zODQ4MjkwNzAxMzY5_1a1ef4d8-481e-41cd-b80e-682a5aaf85af">P6Y</nbix:LesseeOperatingLeaseOptionTermToConstructFifthBuilding>
    <nbix:RentAbatementPeriod
      contextRef="id4edc38f1baa466499b53bf11d3bbbdf_D20220208-20220208"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF8zODQ4MjkwNzAxMzYx_84a4673c-8462-4431-b1e1-24b2bfc8262d">P10M</nbix:RentAbatementPeriod>
    <nbix:LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot
      contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODYz_e9a9ce7f-d2dd-4cb9-9268-d5a015fd36bc"
      unitRef="usd">6</nbix:LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot>
    <nbix:AnnualRentEscalationPercentage
      contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODY3_ec47246e-e5ee-43e3-a500-29f126bafaab"
      unitRef="number">0.03</nbix:AnnualRentEscalationPercentage>
    <nbix:NumberOfRenewalOptions
      contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODgw_389ebea1-6104-43b0-9431-86a2eb967cf8"
      unitRef="renewaloption">2</nbix:NumberOfRenewalOptions>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208"
      id="id3VybDovL2RvY3MudjEvZG9jOmMzNWU5ZDEyZDkyMTQ1NWFhNDVmMzBkMWQ0MTMwMjAyL3NlYzpjMzVlOWQxMmQ5MjE0NTVhYTQ1ZjMwZDFkNDEzMDIwMl8xNzg3L2ZyYWc6ODA4MTY0ODJiZTE3NGZjNzliY2M0ODc0OWRjYWRmYmQvdGV4dHJlZ2lvbjo4MDgxNjQ4MmJlMTc0ZmM3OWJjYzQ4NzQ5ZGNhZGZiZF82MDQ3MzEzOTU2ODgx_ea0c10e5-61b5-4ea8-8d41-be18c26afa46">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>87
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MH>K)]C:Z?=%BTUSH+H36HFP>UXP">&, WZ\$-#[[%W-'?/B?P,V_4$L#!!0
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MET@#@/.Y$'J[,(-4-3B/_P-02P,$%     @ 98E+5%]ZR_QA!@  DAH  !@
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M]GM_PZ;";F*L @LJ],:*=M<C$7>/!!*;'C>J/KVQ=$?G;KM.A2Q^^=2-='T
M<?<!KG.WQO3\1"TVSHY6%EP<!\81DP46A?V=\_DA9*?TU*WT*Y&!X@F]+:Y>
M E2$7,>;G>Q2_,M333M-HVY-<TTUM:@--5I&"RHT^JZU!45#H^6?]0[K<U;N
MJI<>$I;IL5#U@7;[:_MBY6/U.F'P^QV^7M>O1SHW]=N:STFYXX5$&=N"2]^+
MH.Z4]0N0^D*)0_5*X$DH)?+JZYXE*2LU .YO!>SYF@O]@/8UU.U_4$L#!!0
M   ( &6)2U0+R-PXQ04  '49   8    >&PO=V]R:W-H965T<R]S:&5E=#8N
M>&ULK5G;;MLX$/T5PBBP+1#+(G4O' -U8CL!FMV@V>P^%'U@)-KF5A)=D4[2
M?OV2LFK=:-IIDX=$LL\,SPQGYE#*^(D57_F:$ &>LS3GYX.U$)OWHQ&/UR3#
MW&(;DLMOEJS(L)"WQ6K$-P7!26F4I2-DV_XHPS0?3,;E9[?%9,RV(J4YN2T
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M*+-(:$#R(:7W(##7X(:P*R4+'<IW/*O[+F74>#VL_B%Q@XL5E:6=DJ4TM*U
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M.(@T!X#?#PKD2_/!/:#]#P W_P%02P,$%     @ 98E+5%?RPAC8)   'G(
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MM'<XX9@K.U:A,5BW[HH3JZN=,@K!D)?,FJ?8;L&NTG*2$ %(>,C:S5=/6VX
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M5(S\P8"_]>Y2V]7NWH3&E(1QPQHW/C4V6O1Z'1U, P%'-OC10\K].!+7.<7
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MPU%9:N.X]VLJB49<K VE]E;P!";PHT _8N0^FR2Q!P@!UXE2#MQ&&&-Y%XO
M^*IBT&6^.T2<$M4M)0ZT-GE5J*L-3VZ( D&&7-0ITZ1H5.P4Z':PRLR<LNM
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M2PW0+QOZXZ!V G1?*PKH?N,>F/YAZU]02P,$%     @ 98E+5!G)!G;0"@
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M<*'BQ,O6)2;ZH" )5JVH.T(<AA?SK:#B<:XQ!U9PW'PG_J:D]35Y'Z!7,#I
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MFP<#5O]BA&@;A6?QE=>_C[N2E#\=/3LU2(O&85DOR%_K)E+F,]UCOM%NY4.
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M')R)VTQ:]8;2;@JT%\2+4;X+"+@K!C"FY.Y!& 6S$_%QN=2)LOL$9Y"-.,8
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M0]PW4BXU,$9?7\R93;9Q]ZKT!M][F9U*LE(G@'&!</5--K_O&"@0MS7ZVL/
M<K0#5K1IVK6._O#UH+^X_EBUI"\/OBWQJ_+.;V'NU,OM[_'D#/O9=CF.J8,"
MPD)#RK?=*E&FVUX;/+N[*!)%\2WM7]KSK^%>KL*4G@T&I[74L"<HD6*R1,;I
M'"UM#[NH=S@L<6.04MUCN8W*(4?!7Q&"OM/XT\['#?AQQ9]P*BK>I?/?.;9O
MMU^)+OW'D=UT_XGI-U1-;&Y1DI8@!6(G1\+ZSS;^P9DU?RK!QM29@F\S)8$G
MFH#QI3&N?: %MM_.+OX'4$L#!!0    ( &6)2U3URM"V?00  %D*   9
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M:F&EZ]C02$M9&-O!#/CP5382CI@C&.WY:^[3@80V)GO0(0JXJVM=,H5.X2O
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MMFY+5V>-7?QP[_GYMR\NOL8+_,0_2KMMDW]G.,K<N4_XXVWQP[TS[,A6-N\
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MD4.2KZ>G:4.DB5M"0%\565'22DVV:-R:7G1MLK-CE_PT7/+3HU?TMBY(-Y/
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M+)_MV1E1_X[4"]F%]1\]?75*&E8?]@>;D[0%V8MT@9U+(,W>]H[MK81D(NH
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M$FXYP\XA'8&K75)*S6VQ:L<,R7*L.]19,*[(BHD*"/8A82O&A3VG&Y1N-!.
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MN&%:T'\4:)F SF>&X+E=L(#U_R@7_P)02P,$%     @ 98E+5'H&-UB4 @
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M&BUOH/65,7XW8 -MLW[U+U!+ P04    " !EB4M4<9#7%OP"   ]!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6R-56U/VS 0_BNG:!] @KR7-E5;
MB0+3]@&$Z#8T3?O@)I?6PK$SVZ'LW^_LE-!I@/8AML^^>^[%?BZSG=(/9HMH
MX:D1TLR#K;7M-(I,N<6&F5"U*.FD5KIAED2]B4RKD57>J!%1&L=G4<.X#!8S
MOW>K%S/56<$EWFHP7=,P_7N)0NWF01(\;]SQS=:ZC6@Q:]D&5VB_MK>:I&A
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M2BJ4,<?0DE/CG+Y6VG>!'3>GIF4ES@,BGT']B,%+-@,P[)"&DHFR$\QB!<Q
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M2!X[5-45I?7Z1&>E9<*;N4HQ.Y21CHO#&6DNI(:UR$IDM*!@QWTA!-EW0_Y
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M ^#^4D"36YR8!Y2[:*-_ 5!+ P04    " !EB4M4<WW?TTT'  !^*@  &0
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M ["D*_*<RJ]L_RLM)S32\18L%<5_L"]M@P%8/ O)LM)9(<B2_/!)?I0+47.
M88<#*AU07P=<.A0KYQ^0%=.Z(Y+,IISM =?6*IK^4JQ-X:UFD^0ZC7/)U:^)
M\I.S._HDP9PNGGDB$RK $+S/&)?)/W0);IF0U^ 39T* QUQMDK2X_4EM#G!U
MK^Z^!0],)#H= I!\"7X1,E$KJVP^DH2#;R1]ID!M-?!^1Y*4/*5TJ-9^."<I
M!<<#7]U1J8Q4S"%XG-^!JS=OP1N@1OJ2I*D>8>I+-5^-VE^4<_MPF!OJG-O"
M QA> Q0@V.)^V]\]:+K[:I6KI4;54J,B7M@1;[Y1"SN4E&=J6CLJI&*#%([
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M7!NHWU>,R9<+_6ZJ>A<Y^P]02P,$%     @ 98E+5 3EE)SX @  " H  !D
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MV"0RDNM[P]FE65'4O64L<&7AP'T4"P.(,3E#KB*YJH1+A]XCN5JB# _) ;D
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MH3LWYH#9C#P)KC'V9ZW#()S]/PAW%%Z)E#1)%2J(&-22?PU(U&K ,:U!DHC
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M"&.@[\\Y5YN-.:(51_+17U!+ P04    " !EB4M4Z0ACN^T"   ["   &0
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M!WRC>!7$N$-R$MG%,V2$KF_)B T9\%0?1TQ'#=.15=>']5I9O9Z%*<D*;?9
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MXFRMBHFX+P&5 /%^00C?5F0'S0UL] ]02P,$%     @ 98E+5$BMOA6[ @
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M^M^*\&R78K>(GZG:,:$1:XL:T6",G5;5NZYZ8.3!;5PVTN VR)WN<:<*RD[
M^ULIS?/ [H7:O>_B/U!+ P04    " !EB4M4&4*^IX<"  "1!@  &0   'AL
M+W=O<FMS:&5E=',O<VAE970U.2YX;6R=5=MNVS ,_17!Z( 6Z'R+DUZ0!$B:
M#>M#@*!%MX=A#XI-QT)U\22E:?]^E.QX:9MDQ5YLB>(Y/!1I>KA1^M%4 )8\
M"R[-**BLK:^CR.05"&I"58/$DU)I02UN]2HRM09:>)#@41K'@TA0)H/QT-L6
M>CQ4:\N9A(4F9BT$U2]3X&HS"I)@:[ACJ\HZ0S0>UG0%]V ?ZH7&7=2Q%$R
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !EB4M4JS "F>X    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !E
MB4M4F5R<(Q &  "<)P  $P              @ ', 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( &6)2U2Y!01?A@8   (:   8
M  " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !E
MB4M4Z/$.)R<"  !W!0  &               @(')#@  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ 98E+5*;M57#_!0  'Q@  !@
M         ("!)A$  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( &6)2U1T]M>!"P,  $0+   8              " @5L7  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !EB4M47WK+_&$&  "2&@
M&               @(&<&@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ 98E+5 O(W#C%!0  =1D  !@              ("!,R$  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( &6)2U105C[M<@<
M  P@   8              " @2XG  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " !EB4M45_+"&-@D   ><@  &               @('6
M+@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 98E+5$,@
M]3:\%0  VEH  !@              ("!Y%,  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( &6)2U3M8]P5WP0  +$,   9
M  " @=9I  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M98E+5$B"L4Q5!0  G@P  !D              ("![&X  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " !EB4M48@P^7C<.  !M*@  &0
M            @(%X=   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( &6)2U2Y(6J#)00  ,,)   9              " @>:"  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 98E+5.RP/=(B P
MSP8  !D              ("!0H<  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " !EB4M4&<D&=M *  "X(   &0              @(&;
MB@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( &6)2U3#
M\HKV_PD  $<;   9              " @:*5  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ 98E+5/7*T+9]!   60H  !D
M     ("!V)\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M" !EB4M4U0@+/)$"  "J!0  &0              @(&,I   >&PO=V]R:W-H
M965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &6)2U1FIN[W]0,  /H(   9
M              " @52G  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L!
M A0#%     @ 98E+5*HF1J7%)0  \7H  !D              ("!@*L  'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !EB4M4L,E(7V4$
M  #7"P  &0              @(%\T0  >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;%!+ 0(4 Q0    ( &6)2U1VT,!&* 4  *\,   9              "
M@1C6  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ 98E+
M5'H&-UB4 @  G 4  !D              ("!=]L  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " !EB4M4Q?6M#(8$  "X"P  &0
M        @(%"W@  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( &6)2U1QD-<6_ (  #T&   9              " @?_B  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 98E+5/%C^]%1!@  4Q$
M !D              ("!,N8  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " !EB4M4&6!N2O %    $   &0              @(&Z[
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( &6)2U3D5Q4!
MLP,  &0)   9              " @>'R  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ 98E+5,=ZCEXN!@  41L  !D
M ("!R_8  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !E
MB4M4<WW?TTT'  !^*@  &0              @($P_0  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &6)2U3T(>YA2 4  )<<   9
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M970S-2YX;6Q02P$"% ,4    " !EB4M4,_ 6Z"$"  "-!   &0
M    @(%Q&P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M &6)2U3*V[]((P<  -TA   9              " @<D= 0!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ 98E+5$\3.0&% @  <08  !D
M             ("!(R4! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " !EB4M4O8Q@:6D"  !'!@  &0              @('?)P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( &6)2U3I/#5@*P,
M )X+   9              " @7\J 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ 98E+5.D(8[OM @  .P@  !D              ("!
MX2T! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " !EB4M4
MP,E)L8L"  !7!@  &0              @($%,0$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( &6)2U3#D8I'&P0  $4/   9
M      " @<<S 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ 98E+5'LRN^BW @  T08  !D              ("!&3@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !EB4M4'\&Y_:4%  #.'0
M&0              @($'.P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( &6)2U279Z_?!@,  /\)   9              " @>-  0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 98E+5'3:/+8[
M P  C0T  !D              ("!($0! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " !EB4M42*V^%;L"  #E!P  &0
M@(&21P$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( &6)
M2U3TSO_&' ,  )T)   9              " @81* 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ 98E+5(%P007T P  V X  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( &6)2U2\P,69LP,  $(,   9
M  " @=YB 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M98E+5*NFCQR3 P  ^@H  !D              ("!R&8! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " !EB4M4QQA7?64#  #<"@  &0
M            @(&2:@$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( &6)2U0'7!MP4P,   <+   9              " @2YN 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 98E+5!E"OJ>' @
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M96QS+RYR96QS4$L! A0#%     @ 98E+5.(D^,S"!   V"<   \
M     ( !S7L! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( &6)2U28&UJ>
M^P$  ,LC   :              "  ;R  0!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( &6)2U1TTL9BW@$  %HC   3
M  "  >^" 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !$ $0 DQ(  /Z$
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>238</ContextCount>
  <ElementCount>452</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Statements Income and Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome</Role>
      <ShortName>Consolidated Statements Income and Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Collaboration and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/CollaborationandLicenseAgreements</Role>
      <ShortName>Collaboration and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Debt Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/DebtSecurities</Role>
      <ShortName>Debt Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Convertible Senior Notes</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.neurocrine.com/role/ConvertibleSeniorNotes</Role>
      <ShortName>Convertible Senior Notes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Other Balance Sheet Details</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetails</Role>
      <ShortName>Other Balance Sheet Details</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2139109 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2146110 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2150111 - Disclosure - Retirement Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/RetirementPlan</Role>
      <ShortName>Retirement Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2152112 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2307301 - Disclosure - Debt Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/DebtSecuritiesTables</Role>
      <ShortName>Debt Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/DebtSecurities</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/FairValueMeasurements</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Convertible Senior Notes (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.neurocrine.com/role/ConvertibleSeniorNotesTables</Role>
      <ShortName>Convertible Senior Notes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/ConvertibleSeniorNotes</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Other Balance Sheet Details (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables</Role>
      <ShortName>Other Balance Sheet Details (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/OtherBalanceSheetDetails</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/EarningsPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/ShareBasedCompensation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2340307 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/IncomeTaxes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2347308 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Organization and Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Collaboration and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Collaboration and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2408403 - Disclosure - Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails</Role>
      <ShortName>Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails</Role>
      <ShortName>Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2410405 - Disclosure - Debt Securities - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails</Role>
      <ShortName>Debt Securities - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2413406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2414407 - Disclosure - Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415408 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Convertible Senior Notes - Additional Information (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails</Role>
      <ShortName>Convertible Senior Notes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails</Role>
      <ShortName>Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - Other Balance Sheet Details - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails</Role>
      <ShortName>Other Balance Sheet Details - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - Other Balance Sheet Details - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails</Role>
      <ShortName>Other Balance Sheet Details - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails</Role>
      <ShortName>Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - Share-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Share-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails</Role>
      <ShortName>Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails</Role>
      <ShortName>Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Share-Based Compensation - Summary of Activity Related to Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Summary of Activity Related to Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails</Role>
      <ShortName>Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - Income Taxes - Components of Income Tax Expense for Continuing Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails</Role>
      <ShortName>Income Taxes - Components of Income Tax Expense for Continuing Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails</Role>
      <ShortName>Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Components of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445428 - Disclosure - Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - Leases - Supplemental Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/LeasesSupplementalInformationDetails</Role>
      <ShortName>Leases - Supplemental Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Retirement Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails</Role>
      <ShortName>Retirement Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="nbix-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453432 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.neurocrine.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.neurocrine.com/role/SubsequentEvents</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="nbix-20211231.htm">nbix-20211231.htm</File>
    <File>nbix-20211231.xsd</File>
    <File>nbix-20211231_cal.xml</File>
    <File>nbix-20211231_def.xml</File>
    <File>nbix-20211231_lab.xml</File>
    <File>nbix-20211231_pre.xml</File>
    <File>nbix-20211231exhibit1010.htm</File>
    <File>nbix-20211231exhibit1017.htm</File>
    <File>nbix-20211231exhibit211.htm</File>
    <File>nbix-20211231exhibit231.htm</File>
    <File>nbix-20211231exhibit311.htm</File>
    <File>nbix-20211231exhibit312.htm</File>
    <File>nbix-20211231exhibit32.htm</File>
    <File>nbix-20211231exhibit43.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>nbix-20211231_g1.jpg</File>
    <File>nbix-20211231_g2.jpg</File>
    <File>nbix-20211231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="860">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>93
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "nbix-20211231.htm": {
   "axisCustom": 1,
   "axisStandard": 28,
   "contextCount": 238,
   "dts": {
    "calculationLink": {
     "local": [
      "nbix-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "nbix-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "nbix-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "nbix-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "nbix-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "nbix-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 562,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 7,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 11
   },
   "keyCustom": 40,
   "keyStandard": 412,
   "memberCustom": 21,
   "memberStandard": 38,
   "nsprefix": "nbix",
   "nsuri": "http://www.neurocrine.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.neurocrine.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Debt Securities",
     "role": "http://www.neurocrine.com/role/DebtSecurities",
     "shortName": "Debt Securities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Fair Value Measurements",
     "role": "http://www.neurocrine.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Convertible Senior Notes",
     "role": "http://www.neurocrine.com/role/ConvertibleSeniorNotes",
     "shortName": "Convertible Senior Notes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Other Balance Sheet Details",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetails",
     "shortName": "Other Balance Sheet Details",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Earnings Per Share",
     "role": "http://www.neurocrine.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - Share-Based Compensation",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensation",
     "shortName": "Share-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139109 - Disclosure - Income Taxes",
     "role": "http://www.neurocrine.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146110 - Disclosure - Leases",
     "role": "http://www.neurocrine.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2150111 - Disclosure - Retirement Plan",
     "role": "http://www.neurocrine.com/role/RetirementPlan",
     "shortName": "Retirement Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152112 - Disclosure - Subsequent Events",
     "role": "http://www.neurocrine.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.neurocrine.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nbix:BusinessDescriptionPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "nbix:BusinessDescriptionPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307301 - Disclosure - Debt Securities (Tables)",
     "role": "http://www.neurocrine.com/role/DebtSecuritiesTables",
     "shortName": "Debt Securities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.neurocrine.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Convertible Senior Notes (Tables)",
     "role": "http://www.neurocrine.com/role/ConvertibleSeniorNotesTables",
     "shortName": "Convertible Senior Notes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Other Balance Sheet Details (Tables)",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables",
     "shortName": "Other Balance Sheet Details (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.neurocrine.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - Share-Based Compensation (Tables)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationTables",
     "shortName": "Share-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340307 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347308 - Disclosure - Leases (Tables)",
     "role": "http://www.neurocrine.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "nbix:BusinessDescriptionPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:NumberOfIrishSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "subsidiary",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Organization and Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "nbix:BusinessDescriptionPolicyPolicyTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:NumberOfIrishSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "subsidiary",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Balance Sheets",
     "role": "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "nbix:PotentialMilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Collaboration and License Agreements - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
     "shortName": "Collaboration and License Agreements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "nbix:PotentialMilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i3444b3f24cee47b19a83d7b209ba18d2_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408403 - Disclosure - Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details)",
     "role": "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
     "shortName": "Debt Securities - Amortized Cost, Gross Unrealized Gain (Loss) Positions and Estimated Fair Value for Available-For-Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i3444b3f24cee47b19a83d7b209ba18d2_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details)",
     "role": "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails",
     "shortName": "Debt Securities - Gross Unrealized Losses and Fair Value Available-For-Sale Debt securities in Unrealized Loss Position (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:DebtSecuritiesAvailableForSalePositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410405 - Disclosure - Debt Securities - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails",
     "shortName": "Debt Securities - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:DebtSecuritiesAvailableForSalePositionNumberOfPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "security",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i6692ce12fc644c68b73fb3a2340f8955_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413406 - Disclosure - Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Assets Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i6692ce12fc644c68b73fb3a2340f8955_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiRestricted",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414407 - Disclosure - Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Reconciliation of Equity Securities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i03e016c2fc1943a8826660c3671c43fc_D20210901-20210930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireRestrictedInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i2d30d0be95cb415b8e4d465eff571719_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:DiscountForMarketabilityUsedInValuationAnalysis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415408 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i2d30d0be95cb415b8e4d465eff571719_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "nbix:DiscountForMarketabilityUsedInValuationAnalysis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Convertible Senior Notes - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
     "shortName": "Convertible Senior Notes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i7a0c5ec3d79147229881155f9e94893d_I20170502",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details)",
     "role": "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails",
     "shortName": "Convertible Senior Notes, Net of Discounts and Deferred Financing Costs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - Other Balance Sheet Details - Inventories (Details)",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails",
     "shortName": "Other Balance Sheet Details - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - Other Balance Sheet Details - Property and Equipment (Details)",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails",
     "shortName": "Other Balance Sheet Details - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails",
     "shortName": "Other Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "Other Balance Sheet Details - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "nbix:SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details)",
     "role": "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails",
     "shortName": "Earnings Per Share - Schedule of Net Income (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i1d90a3769ad6449da089e4e3f18d3d7a_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "nbix:IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details)",
     "role": "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails",
     "shortName": "Earnings Per Share - Schedule of Anti-Dilutive Shares Excluded from Diluted Per Share Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i36b21327e06c4819b35f65220e76ae7d_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - Share-Based Compensation - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
     "shortName": "Share-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails",
     "shortName": "Share-Based Compensation - Compensation Cost Related to Share-Based Compensation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i8d2e9814a27b4d21828b870c0c7bba39_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
     "shortName": "Share-Based Compensation - Schedule of Share-based Compensation Expense by Award-type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "if9dd80ab56044cb5b1502c3c0b0084c6_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
     "shortName": "Share-Based Compensation - Schedule of Share-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails",
     "shortName": "Share-Based Compensation - Weighted-Average Assumptions for Stock Option Grants using Black-Scholes Option-Pricing Model (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "ie232c0b3cab944b19607d9113626ebbd_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Statements Income and Comprehensive Income",
     "role": "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
     "shortName": "Consolidated Statements Income and Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "nbix:CostOfSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Share-Based Compensation - Summary of Activity Related to Stock Options (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails",
     "shortName": "Share-Based Compensation - Summary of Activity Related to Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0bc4f833719d407fb605d6e3f05afc23_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details)",
     "role": "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
     "shortName": "Share-Based Compensation - Summary and Changes in Restricted Stock Units Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0bc4f833719d407fb605d6e3f05afc23_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - Income Taxes - Components of Income Tax Expense for Continuing Operations (Details)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails",
     "shortName": "Income Taxes - Components of Income Tax Expense for Continuing Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails",
     "shortName": "Income Taxes - Provision for Income Taxes on Earnings Subject to Income Taxes Differs from Statutory Federal Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Income Taxes - Components of Deferred Tax Assets (Details)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Components of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i9af8d124121d413aaa8ef3e63a0e5b6a_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445428 - Disclosure - Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details)",
     "role": "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of Activity Related to Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "ief1e07453fb8400290d05177cdbc914a_I20181231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - Leases - Supplemental Information (Details)",
     "role": "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails",
     "shortName": "Leases - Supplemental Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)",
     "role": "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails",
     "shortName": "Leases - Summary of Future Minimum Lease Payments Under Operating Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i410ba3ab0060406a970171c67adc140c_I20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Retirement Plan - Additional Information (Details)",
     "role": "http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails",
     "shortName": "Retirement Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i37c451fdb8934177af07aab2f9815261_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i37c451fdb8934177af07aab2f9815261_I20181231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "nbix:LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453432 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.neurocrine.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i333cd8d56d1c42f6b4b6e805cd612f0a_I20220208",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "nbix:LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization and Summary of Significant Accounting Policies",
     "role": "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies",
     "shortName": "Organization and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Collaboration and License Agreements",
     "role": "http://www.neurocrine.com/role/CollaborationandLicenseAgreements",
     "shortName": "Collaboration and License Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "nbix-20211231.htm",
      "contextRef": "i0586c87c3dad482f8fbb655a4137c5ce_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 62,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r692"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r701"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r702"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r689",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.neurocrine.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "nbix_A2020EquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Equity Incentive Plan",
        "label": "2020 Equity Incentive Plan [Member]",
        "terseLabel": "2020 Plan"
       }
      }
     },
     "localname": "A2020EquityIncentivePlanMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_A225ConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.25% Convertible Senior Notes.",
        "label": "2.25% Convertible Senior Notes [Member]",
        "terseLabel": "2.25% Convertible Senior Notes"
       }
      }
     },
     "localname": "A225ConvertibleSeniorNotesMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_AbbvieIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to AbbVie Inc., an entity with which Neurocrine has a collaboration agreement.",
        "label": "Abbvie Inc [Member]",
        "terseLabel": "AbbVie"
       }
      }
     },
     "localname": "AbbvieIncMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_AccruedBrandedPrescriptionDrugFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Branded Prescription Drug Fee",
        "label": "Accrued Branded Prescription Drug Fee",
        "terseLabel": "Current branded prescription drug fee"
       }
      }
     },
     "localname": "AccruedBrandedPrescriptionDrugFee",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_AccruedResearchAndDevelopmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expense current.",
        "label": "Accrued Research And Development Expense Current",
        "terseLabel": "Accrued development costs"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpenseCurrent",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_AnnualRentEscalationPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AnnualRentEscalationPercentage",
        "label": "AnnualRentEscalationPercentage",
        "terseLabel": "Annual rent escalation percentage"
       }
      }
     },
     "localname": "AnnualRentEscalationPercentage",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nbix_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.neurocrine.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nbix_BIALMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to BIAL, an entity with which Neurocrine has a license agreement.",
        "label": "B I A L [Member]",
        "terseLabel": "B I A L"
       }
      }
     },
     "localname": "BIALMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_BusinessDescriptionPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Description Policy [Text Block]",
        "label": "Business Description Policy [Policy Text Block]",
        "terseLabel": "Business Activities"
       }
      }
     },
     "localname": "BusinessDescriptionPolicyPolicyTextBlock",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nbix_CarryingAmountOfLiabilityComponentAtSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of the liability component at settlement.",
        "label": "Carrying Amount Of Liability Component At Settlement",
        "terseLabel": "Carrying amount of the liability component at settlement"
       }
      }
     },
     "localname": "CarryingAmountOfLiabilityComponentAtSettlement",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_CarryingAmountOfLiabilityComponentUponIssuance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the liability component upon issuance.",
        "label": "Carrying Amount Of Liability Component Upon Issuance",
        "terseLabel": "Carrying amount of the liability component upon issuance"
       }
      }
     },
     "localname": "CarryingAmountOfLiabilityComponentUponIssuance",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_CashAndMoneyMarketFundMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions, and funds that invest in short-term money-market instruments, for example, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Cash And Money Market Fund [Member]",
        "terseLabel": "Cash and money market funds"
       }
      }
     },
     "localname": "CashAndMoneyMarketFundMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_CollaborationRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration revenue.",
        "label": "Collaboration Revenue [Member]",
        "terseLabel": "Collaboration revenue"
       }
      }
     },
     "localname": "CollaborationRevenueMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_ConversionPeriodOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Period One",
        "label": "Conversion Period One [Member]",
        "terseLabel": "Conversion Period One"
       }
      }
     },
     "localname": "ConversionPeriodOneMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_ConversionPeriodTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Period Two",
        "label": "Conversion Period Two [Member]",
        "terseLabel": "Conversion Period Two"
       }
      }
     },
     "localname": "ConversionPeriodTwoMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_CostOfSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of costs relating to expenses directly or indirectly attributed to the goods or services sold, which may include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, unallocated production overheads and abnormal amounts of production costs of inventories.",
        "label": "Cost Of Sales",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DebtInstrumentConversionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Conversion",
        "label": "Debt Instrument, Conversion [Axis]",
        "terseLabel": "Debt Instrument, Conversion [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentConversionAxis",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nbix_DebtInstrumentConversionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Conversion",
        "label": "Debt Instrument, Conversion [Domain]",
        "terseLabel": "Debt Instrument, Conversion [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentConversionDomain",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_DebtInstrumentConvertibleConversionPremium": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of excess of the price paid for the convertible note over the closing stock price on the closing date of the convertible note.",
        "label": "Debt Instrument Convertible Conversion Premium",
        "terseLabel": "Conversion premium"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPremium",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nbix_DebtSecuritiesAvailableForSalePositionNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities available for sale position number of positions.",
        "label": "Debt Securities Available For Sale Position Number Of Positions",
        "terseLabel": "Debt securities available for sale position number of positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSalePositionNumberOfPositions",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nbix_DeferredTaxAssetsCapitalizedResearchAndDevelopment": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from research and development costs capitalized.",
        "label": "Deferred Tax Assets Capitalized Research And Development",
        "terseLabel": "Capitalized research and development"
       }
      }
     },
     "localname": "DeferredTaxAssetsCapitalizedResearchAndDevelopment",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DeferredTaxAssetsLiabilitiesGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets (liabilities) gross.",
        "label": "Deferred Tax Assets Liabilities Gross",
        "totalLabel": "Net of deferred tax assets and liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesGross",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DeferredTaxAssetsOperatingLeasesAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets operating leases assets.",
        "label": "Deferred Tax Assets Operating Leases Assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeasesAssets",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DeferredTaxLiabilitiesConvertibleSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities convertible senior notes.",
        "label": "Deferred Tax Liabilities Convertible Senior Notes",
        "negatedTerseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesConvertibleSeniorNotes",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DeferredTaxLiabilitiesOperatingLeasesLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities operating leases liabilities.",
        "label": "Deferred Tax Liabilities Operating Leases Liabilities",
        "negatedTerseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingLeasesLiabilities",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_DiscountForMarketabilityUsedInValuationAnalysis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discount For Marketability Used In Valuation Analysis",
        "label": "Discount For Marketability Used In Valuation Analysis",
        "terseLabel": "Discount for marketability in valuation analysis"
       }
      }
     },
     "localname": "DiscountForMarketabilityUsedInValuationAnalysis",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nbix_ESPPPurchasePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ESPP Purchase Period",
        "label": "ESPP Purchase Period",
        "terseLabel": "ESPP purchase period"
       }
      }
     },
     "localname": "ESPPPurchasePeriod",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nbix_EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Events of default percentage of principal and accrued and unpaid interest due and payable upon default.",
        "label": "Events Of Default Percentage Of Principal And Accrued And Unpaid Interest Due And Payable Upon Default",
        "terseLabel": "Events of default percentage of principal and accrued and unpaid interest due and payable upon default"
       }
      }
     },
     "localname": "EventsOfDefaultPercentageOfPrincipalAndAccruedAndUnpaidInterestDueAndPayableUponDefault",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nbix_FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the liability component immediately before extinguishment.",
        "label": "Fair Value Of Liability Component Immediately Before Extinguishment",
        "terseLabel": "Fair value of the liability component immediately before extinguishment"
       }
      }
     },
     "localname": "FairValueOfLiabilityComponentImmediatelyBeforeExtinguishment",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_HeptaresTherapeuticsLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Heptares Therapeutics Limited",
        "label": "Heptares Therapeutics Limited [Member]",
        "terseLabel": "Heptares"
       }
      }
     },
     "localname": "HeptaresTherapeuticsLimitedMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_IdorsiaPharmaceuticalsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Idorsia Pharmaceuticals Ltd",
        "label": "Idorsia Pharmaceuticals Ltd [Member]",
        "terseLabel": "Idorsia"
       }
      }
     },
     "localname": "IdorsiaPharmaceuticalsLtdMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_IncomeTaxReconciliationExpirationOfTaxCredits": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation, expiration of tax credits.",
        "label": "Income Tax Reconciliation Expiration Of Tax Credits",
        "terseLabel": "Expired tax attributes"
       }
      }
     },
     "localname": "IncomeTaxReconciliationExpirationOfTaxCredits",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation nondeductible expense branded prescription drug fee.",
        "label": "Income Tax Reconciliation Nondeductible Expense Branded Prescription Drug Fee",
        "terseLabel": "Branded prescription drug fee"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseBrandedPrescriptionDrugFee",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax reconciliation nondeductible expense officer compensation cost.",
        "label": "Income Tax Reconciliation Nondeductible Expense Officer Compensation Cost",
        "terseLabel": "Officer compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOfficerCompensationCost",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_IncomeTaxesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Line Items]",
        "label": "Income Taxes [Line Items]",
        "terseLabel": "Income Taxes [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesLineItems",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nbix_IncomeTaxesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Taxes [Table]",
        "label": "Income Taxes [Table]",
        "terseLabel": "Income Taxes [Table]"
       }
      }
     },
     "localname": "IncomeTaxesTable",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nbix_IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the treasury stock method.",
        "label": "Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities",
        "terseLabel": "2024 Notes (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecurities",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "nbix_InvestmentIncomeAndOtherNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment income and other net.",
        "label": "Investment Income And Other Net",
        "terseLabel": "Investment income and other, net"
       }
      }
     },
     "localname": "InvestmentIncomeAndOtherNet",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_LargestTwoCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Largest Two Customers",
        "label": "Largest Two Customers [Member]",
        "terseLabel": "Largest two customers"
       }
      }
     },
     "localname": "LargestTwoCustomersMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Monthly Base Rent Per Square Foot",
        "label": "LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot",
        "terseLabel": "Monthly base rent per square foot"
       }
      }
     },
     "localname": "LesseeOperatingLeaseMonthlyBaseRentPerSquareFoot",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_LesseeOperatingLeaseOptionTermToConstructFifthBuilding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of term of lessee's option for the construction of a fifth building under operating lease.",
        "label": "LesseeOperatingLeaseOptionTermToConstructFifthBuilding",
        "terseLabel": "Lessee option term for construction of fifth building"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionTermToConstructFifthBuilding",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nbix_LongTermInvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are intended be sold or mature more than one year from the balance sheet date or operating cycle, if longer.",
        "label": "Long Term Investments [Member]",
        "terseLabel": "Long-term investments"
       }
      }
     },
     "localname": "LongTermInvestmentsMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_MilestoneEquityPurchasePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Equity Purchase Payment",
        "label": "Milestone Equity Purchase Payment",
        "terseLabel": "Milestone equity purchase payment"
       }
      }
     },
     "localname": "MilestoneEquityPurchasePayment",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_MilestonePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments made for milestones under a collaboration agreement.",
        "label": "Milestone Payment",
        "terseLabel": "Milestone payment"
       }
      }
     },
     "localname": "MilestonePayment",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_MinimumPercentageOfTradingPriceToLastReportedSalePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum percentage of the product of the common stock trading price multiplied by the conversion rate during the measurement period as compared to the principal note amount that triggers a conversion option on the notes, if it falls below this percentage.",
        "label": "Minimum Percentage Of Trading Price To Last Reported Sale Price",
        "terseLabel": "Minimum percentage of common stock price trigger"
       }
      }
     },
     "localname": "MinimumPercentageOfTradingPriceToLastReportedSalePrice",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "nbix_MitsubishiTanabePharmaCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the Mitsubishi Tanabe Pharma Corporation.",
        "label": "Mitsubishi Tanabe Pharma Corporation [Member]",
        "terseLabel": "MTPC"
       }
      }
     },
     "localname": "MitsubishiTanabePharmaCorporationMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_NumberOfIrishSubsidiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Irish Subsidiaries",
        "label": "Number Of Irish Subsidiaries",
        "terseLabel": "Number of wholly owned Irish subsidiaries"
       }
      }
     },
     "localname": "NumberOfIrishSubsidiaries",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nbix_NumberOfRenewalOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of renewal options under the terms of the lease.",
        "label": "NumberOfRenewalOptions",
        "terseLabel": "Number of lease renewal options"
       }
      }
     },
     "localname": "NumberOfRenewalOptions",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization and summary of significant accounting policies.",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nbix_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "nbix_OtherBalanceSheetDetailsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other balance sheet details.",
        "label": "Other Balance Sheet Details [Abstract]",
        "terseLabel": "Other Balance Sheet Details [Abstract]"
       }
      }
     },
     "localname": "OtherBalanceSheetDetailsAbstract",
     "nsuri": "http://www.neurocrine.com/20211231",
     "xbrltype": "stringItemType"
    },
    "nbix_PatentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of the patent, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Patent term",
        "terseLabel": "Patent term"
       }
      }
     },
     "localname": "PatentTerm",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nbix_PerformanceBasedRestrictedStockUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted stock units which are awarded to employees after certain performance targets are met.",
        "label": "Performance Based Restricted Stock Unit [Member]",
        "terseLabel": "PRSUs"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_PotentialMilestonePaymentReceipts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Potential later stage milestone payments and royalties.",
        "label": "Potential Milestone Payment Receipts",
        "terseLabel": "Potential milestone payment receipts"
       }
      }
     },
     "localname": "PotentialMilestonePaymentReceipts",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_PotentialMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of potential milestone payments to be paid under a license agreement.",
        "label": "Potential Milestone Payments",
        "terseLabel": "Potential milestone payments"
       }
      }
     },
     "localname": "PotentialMilestonePayments",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_PrincipalAmountOnConversionRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Principal amount on conversion rate.",
        "label": "Principal Amount On Conversion Rate",
        "terseLabel": "Principal amount on conversion rate"
       }
      }
     },
     "localname": "PrincipalAmountOnConversionRate",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_RentAbatementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent Abatement Period",
        "label": "Rent Abatement Period",
        "terseLabel": "Rent abatement period"
       }
      }
     },
     "localname": "RentAbatementPeriod",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nbix_ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding the write-off for research and development assets that were acquired in a transaction other than a business combination during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research And Development Expense Excluding Research And Development Asset Acquired Other Than Through Business Combination Written Off",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_RevenueRelatedReservesForDiscountsAndAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue-related reserves for discounts and allowances.",
        "label": "Revenue Related Reserves For Discounts And Allowances",
        "terseLabel": "Revenue-related reserves for discounts and allowances"
       }
      }
     },
     "localname": "RevenueRelatedReservesForDiscountsAndAllowances",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_ScientificEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scientific equipment.",
        "label": "Scientific Equipment [Member]",
        "terseLabel": "Scientific equipment"
       }
      }
     },
     "localname": "ScientificEquipmentMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information related to the 2.25% Convertible Senior Notes Due in May 2024.",
        "label": "Senior Convertible Notes Two Point Two Five Percent Due In May Two Thousand Twenty Four [Member]",
        "terseLabel": "2.25% Convertible senior notes due 2024"
       }
      }
     },
     "localname": "SeniorConvertibleNotesTwoPointTwoFivePercentDueInMayTwoThousandTwentyFourMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_StockOptionsRestrictedStockAndConvertibleSeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock options, restricted stock and convertible senior notes.",
        "label": "Stock Options Restricted Stock And Convertible Senior Notes [Member]",
        "terseLabel": "Stock options restricted stock and convertible senior notes"
       }
      }
     },
     "localname": "StockOptionsRestrictedStockAndConvertibleSeniorNotesMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of reconciliation of cash cash equivalents and restricted cash.",
        "label": "Summary Of Reconciliation Of Cash Cash Equivalents And Restricted Cash [Table Text Block]",
        "terseLabel": "Reconciliation of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "SummaryOfReconciliationOfCashCashEquivalentsAndRestrictedCashTableTextBlock",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "nbix_TakedaPharmaceuticalCompanyLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Takeda Pharmaceutical Company Limited",
        "label": "Takeda Pharmaceutical Company Limited [Member]",
        "terseLabel": "Takeda"
       }
      }
     },
     "localname": "TakedaPharmaceuticalCompanyLimitedMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_TradingDaysDuringObservationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading days during observation period.",
        "label": "Trading Days During Observation Period",
        "terseLabel": "Trading days during observation period"
       }
      }
     },
     "localname": "TradingDaysDuringObservationPeriod",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "nbix_TwoThousandAndElevenPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand and Eleven Plan [Member].",
        "label": "Two Thousand And Eleven Plan [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "localname": "TwoThousandAndElevenPlanMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_UpfrontPaymentsMade": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront payments made under a collaboration agreement.",
        "label": "Upfront Payments Made",
        "terseLabel": "Upfront payments made"
       }
      }
     },
     "localname": "UpfrontPaymentsMade",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "nbix_VoyagerTherapeuticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Voyager therapeutics.",
        "label": "Voyager Therapeutics [Member]",
        "terseLabel": "Voyager"
       }
      }
     },
     "localname": "VoyagerTherapeuticsMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "nbix_XenonPharmaceuticalsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Xenon Pharmaceuticals Inc",
        "label": "Xenon Pharmaceuticals Inc [Member]",
        "terseLabel": "Xenon"
       }
      }
     },
     "localname": "XenonPharmaceuticalsIncMember",
     "nsuri": "http://www.neurocrine.com/20211231",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r63",
      "r65",
      "r123",
      "r124",
      "r293",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r2",
      "r130",
      "r137",
      "r143",
      "r235",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r490",
      "r493",
      "r495",
      "r496",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r2",
      "r130",
      "r137",
      "r143",
      "r235",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r490",
      "r493",
      "r495",
      "r496",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r2",
      "r130",
      "r137",
      "r143",
      "r235",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r490",
      "r493",
      "r495",
      "r496",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r199",
      "r347",
      "r350",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r292",
      "r328",
      "r372",
      "r374",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r591",
      "r639",
      "r642",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r292",
      "r328",
      "r372",
      "r374",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r591",
      "r639",
      "r642",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r199",
      "r347",
      "r350",
      "r641"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProFormaMember": {
     "auth_ref": [
      "r143",
      "r274",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pro Forma [Member]",
        "terseLabel": "Pro Forma"
       }
      }
     },
     "localname": "ProFormaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r197",
      "r347",
      "r349",
      "r594",
      "r638",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r197",
      "r347",
      "r349",
      "r594",
      "r638",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r292",
      "r328",
      "r353",
      "r372",
      "r374",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r591",
      "r639",
      "r642",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r292",
      "r328",
      "r353",
      "r372",
      "r374",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r591",
      "r639",
      "r642",
      "r682",
      "r683"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r64",
      "r65",
      "r123",
      "r124",
      "r293",
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r138",
      "r143",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r138",
      "r143",
      "r274",
      "r373",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r131",
      "r132",
      "r133",
      "r134",
      "r208",
      "r209",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r277",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r461",
      "r462",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r552",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible List]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and other accrued liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r8",
      "r29",
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r47",
      "r266"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r32",
      "r69",
      "r70",
      "r71",
      "r627",
      "r650",
      "r654"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r68",
      "r71",
      "r78",
      "r79",
      "r80",
      "r127",
      "r128",
      "r129",
      "r483",
      "r645",
      "r646",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r30",
      "r420",
      "r555"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "negatedTerseLabel": "Additional paid in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r417",
      "r418",
      "r419",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of subsequent adjustments to additional paid in capital for convertible financial instruments where a component of equity and a component of debt are recognized.",
        "label": "Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt, Subsequent Adjustments",
        "negatedTerseLabel": "Equity component of repurchased convertible senior notes, net",
        "verboseLabel": "Equity component of repurchased convertible senior notes"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r376",
      "r378",
      "r423",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Reconciliation of net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Expense"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r378",
      "r409",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "auth_ref": [
      "r90",
      "r105",
      "r312",
      "r532"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.",
        "label": "Amortization of Debt Discount (Premium)",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfDebtDiscountPremium",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r87",
      "r105",
      "r312",
      "r534"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "verboseLabel": "Anti-dilutive shares excluded from diluted per share amounts (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r119",
      "r180",
      "r189",
      "r195",
      "r231",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r480",
      "r484",
      "r514",
      "r553",
      "r555",
      "r600",
      "r624"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r62",
      "r119",
      "r231",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r480",
      "r484",
      "r514",
      "r553",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r498"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Fair value of assets on recurring basis"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r212",
      "r244"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Debt Securities, Available-for-sale, Amortized Cost, Total",
        "verboseLabel": "Amortized cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r210",
      "r213",
      "r244",
      "r605"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "verboseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r380",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Asset Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r126",
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and accounting policies concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Business Description and Accounting Policies [Text Block]",
        "terseLabel": "Organization and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r110",
      "r111",
      "r112"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Non-cash capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r43",
      "r107"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r100",
      "r107",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash at end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r100",
      "r523"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r476",
      "r477",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration and License Agreements"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaborative Arrangement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralAxis": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Axis]",
        "terseLabel": "Collateral Held [Axis]"
       }
      }
     },
     "localname": "CollateralAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollateralDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Category of collateral or no collateral, from lender's perspective.",
        "label": "Collateral Held [Domain]",
        "terseLabel": "Collateral Held [Domain]"
       }
      }
     },
     "localname": "CollateralDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r271",
      "r272",
      "r273",
      "r275",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "verboseLabel": "Collaboration and License Agreements"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r127",
      "r128",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in USD per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r28",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r28",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 220.0 shares authorized; 94.9 and 93.5 shares issued and outstanding as of December\u00a031, 2021 and 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r76",
      "r84",
      "r608",
      "r633"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r199",
      "r512",
      "r513",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r199",
      "r512",
      "r513",
      "r656",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r199",
      "r512",
      "r513",
      "r656",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r164",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r169",
      "r170",
      "r199",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r199",
      "r512",
      "r513",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r114",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Deferred revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebt": {
     "auth_ref": [
      "r24",
      "r603",
      "r625"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.",
        "label": "Convertible Debt",
        "totalLabel": "Net carrying amount"
       }
      }
     },
     "localname": "ConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertibleDebtNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.",
        "label": "Convertible Debt, Noncurrent",
        "terseLabel": "Convertible senior notes"
       }
      }
     },
     "localname": "ConvertibleDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r354",
      "r368",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r457",
      "r465"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r457",
      "r465",
      "r467"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current taxes"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r457",
      "r465"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r167",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Shares issued to settle notes at initial conversion rate (in shares)"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r117",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r306",
      "r313",
      "r314",
      "r316",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r23",
      "r24",
      "r118",
      "r125",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r320",
      "r321",
      "r322",
      "r323",
      "r535",
      "r601",
      "r603",
      "r622"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.",
        "label": "Debt Instrument, Convertible, Carrying Amount of Equity Component",
        "terseLabel": "Carrying amount of the equity component upon issuance"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r291",
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r55",
      "r291",
      "r332",
      "r333",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining amortization period for discount on the liability component of convertible debt which may be settled in cash upon conversion, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Convertible, Remaining Discount Amortization Period",
        "terseLabel": "Remaining discount amortization period"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentConvertibleStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of the entity's common stock which would be required to be attained for the conversion feature embedded in the debt instrument to become effective.",
        "label": "Debt Instrument, Convertible, Stock Price Trigger",
        "terseLabel": "Common stock price trigger (in USD per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive common stock trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Threshold percentage of common stock price trigger"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Threshold common stock trading days"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r289",
      "r320",
      "r321",
      "r533",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ConvertibleDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r511"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r54",
      "r309",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Debt Instrument, Interest Rate During Period",
        "terseLabel": "Assumed borrowing rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r54",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.",
        "label": "Debt Instrument, Measurement Input",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DebtInstrumentMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r56",
      "r118",
      "r125",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r320",
      "r321",
      "r322",
      "r323",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of principal amount of debt redeemed.",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "terseLabel": "Redemption rate"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Aggregate principal amount repurchased"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r56",
      "r118",
      "r125",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r296",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r315",
      "r320",
      "r321",
      "r322",
      "r323",
      "r332",
      "r334",
      "r335",
      "r336",
      "r532",
      "r533",
      "r535",
      "r536",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r302",
      "r532",
      "r536"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_ConvertibleDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Debt discount, net"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period when accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), is considered uncollectible and written off, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, Threshold Period, Writeoff",
        "terseLabel": "Accrued interest receivables write-off threshold period"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestThresholdPeriodWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestWriteoff": {
     "auth_ref": [
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of writeoff of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized by reversing interest income.",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest Writeoff",
        "terseLabel": "Accrued interest receivables write-off"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r223",
      "r249",
      "r252"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less Than 12 Months, Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r223",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedLabel": "Less Than 12 Months, Unrealized Losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r220",
      "r248",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Gross unrealized losses and fair value available-for-sale investments in unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r221",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Number of debt securities available-for-sale in an unrealized loss position"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r458",
      "r465"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r534"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Transaction cost related to issuance of convertible senior note"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r48",
      "r302",
      "r534"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ConvertibleDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesNetofDiscountsandDeferredFinancingCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r105",
      "r120",
      "r458",
      "r465",
      "r466",
      "r467"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r25",
      "r26",
      "r448",
      "r602",
      "r621"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "nbix_DeferredTaxAssetsLiabilitiesGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r433",
      "r434"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r120",
      "r458",
      "r465"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r449"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "nbix_DeferredTaxAssetsLiabilitiesGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Gross [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsGrossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "terseLabel": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r454",
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development credits",
        "verboseLabel": "Research and development tax credit carry forwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r450"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Valuation allowance",
        "terseLabel": "Deferred tax assets, valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r455",
      "r456"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r371"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Defined contribution plan, employer contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Defined contribution plan, maximum employee contribution percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/RetirementPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r105",
      "r264"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r85",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r144",
      "r146",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r496",
      "r497",
      "r609",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in USD per share)",
        "verboseLabel": "Basic (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r85",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r146",
      "r151",
      "r152",
      "r153",
      "r157",
      "r158",
      "r496",
      "r497",
      "r609",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in USD per share)",
        "verboseLabel": "Diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r121",
      "r436",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income taxes, rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued employee related costs"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r410"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized Expense",
        "verboseLabel": "Unrecognized expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-Average Recognition Period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r78",
      "r79",
      "r80",
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r161",
      "r235",
      "r331",
      "r337",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r495",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r645",
      "r646",
      "r647",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRestricted": {
     "auth_ref": [
      "r574",
      "r675",
      "r677"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of restricted investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Restricted",
        "periodEndLabel": "Equity securities, ending balance",
        "periodStartLabel": "Equity securities, beginning balance",
        "terseLabel": "Equity securities",
        "verboseLabel": "Equity securities fair value amount"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRestricted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r230",
      "r635"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "negatedLabel": "Change in fair value of equity securities",
        "terseLabel": "Unrealized gain (loss) on equity securities",
        "verboseLabel": "Unrealized gain (loss) included in earnings"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r17",
      "r22",
      "r226",
      "r623",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity securities\u2013biotechnology industry"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r498",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Investments measured at fair value on recurring basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r504",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of equity securities measured at fair value on recurring basis using significant unobservable inputs"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r354",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r368",
      "r499",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r498",
      "r499",
      "r502",
      "r503",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r304",
      "r354",
      "r356",
      "r361",
      "r368",
      "r499",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r354",
      "r356",
      "r361",
      "r368",
      "r499",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r354",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r368",
      "r499",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r505"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "negatedTerseLabel": "Transfers out of Level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r354",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r368",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r506",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair value measurements recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r509",
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r227",
      "r228",
      "r229",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r248",
      "r250",
      "r251",
      "r252",
      "r315",
      "r330",
      "r486",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for charging off uncollectible financing receivables, including, but not limited to, factors and methodologies used in estimating the allowance for credit loss.",
        "label": "Financing Receivable, Allowance for Credit Losses, Policy for Uncollectible Amounts [Policy Text Block]",
        "terseLabel": "Allowance for Credit Losses"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r257",
      "r259",
      "r261",
      "r262",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r257",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r105",
      "r324",
      "r325"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedTerseLabel": "Loss on extinguishment of convertible senior notes",
        "terseLabel": "Loss on extinguishment of convertible senior notes"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r263",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r82",
      "r180",
      "r188",
      "r191",
      "r194",
      "r196",
      "r597",
      "r606",
      "r611",
      "r636"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r268",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r121",
      "r437",
      "r446",
      "r453",
      "r463",
      "r469",
      "r471",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r122",
      "r141",
      "r142",
      "r179",
      "r435",
      "r464",
      "r470",
      "r637"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for (benefit from) income taxes",
        "totalLabel": "Provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/IncomeTaxesComponentsofIncomeTaxExpenseforContinuingOperationsDetails",
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r77",
      "r431",
      "r432",
      "r446",
      "r447",
      "r452",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "auth_ref": [
      "r430",
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "terseLabel": "Change in tax rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal income taxes at 21%"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Non-deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedLabel": "Research credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesProvisionforIncomeTaxesonEarningsSubjecttoIncomeTaxesDiffersfromStatutoryFederalRateDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r102",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current operating assets after deduction of current operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssetsAndLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r153"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Effect of dilutive securities (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r81",
      "r178",
      "r531",
      "r534",
      "r610"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r99",
      "r101",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable, Current",
        "terseLabel": "Accrued interest receivables"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r37",
      "r255"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r7",
      "r59",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r60",
      "r115",
      "r160",
      "r253",
      "r254",
      "r256",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r39",
      "r255"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r38",
      "r255"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentOwnedBalanceShares": {
     "auth_ref": [
      "r657",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance held at close of period in number of shares.",
        "label": "Investment Owned, Balance, Shares",
        "terseLabel": "Equity securities number of shares (in shares)"
       }
      }
     },
     "localname": "InvestmentOwnedBalanceShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r658",
      "r659",
      "r660",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r631"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "verboseLabel": "Fair value"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r226",
      "r598",
      "r616",
      "r674",
      "r700"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecurities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of supplemental operating lease information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Tenant improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Leases [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Leases [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of minimum lease payments for operating lease liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total operating lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "Year ending December 31, 2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "Year ending December 31, 2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "Year ending December 31, 2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "Year ending December 31, 2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "Year ending December 31, 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r549"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "verboseLabel": "Less accreted interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r50",
      "r119",
      "r190",
      "r231",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r481",
      "r484",
      "r485",
      "r514",
      "r553",
      "r554"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r35",
      "r119",
      "r231",
      "r514",
      "r555",
      "r604",
      "r629"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r53",
      "r119",
      "r231",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r481",
      "r484",
      "r485",
      "r514",
      "r553",
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r9",
      "r51"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Debt securities available-for-sale (amortized cost was $370.6 and $612.4 as of December\u00a031, 2021 and 2020, respectively)"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "terseLabel": "Debt securities available-for-sale (amortized cost was $563.2 and $226.7 as of December\u00a031, 2021 and 2020, respectively)"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Debt Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketableSecuritiesUnrealizedGainLoss": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in marketable security.",
        "label": "Marketable Securities, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized gain (loss) on debt securities available-for sale"
       }
      }
     },
     "localname": "MarketableSecuritiesUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r100",
      "r103",
      "r106"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r72",
      "r74",
      "r80",
      "r83",
      "r106",
      "r119",
      "r131",
      "r135",
      "r136",
      "r137",
      "r138",
      "r141",
      "r142",
      "r150",
      "r180",
      "r188",
      "r191",
      "r194",
      "r196",
      "r231",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r497",
      "r514",
      "r607",
      "r632"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income (loss)",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted and Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other (expense) income:"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r180",
      "r188",
      "r191",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r543",
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Less current operating lease liabilities included in other current liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r538"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Noncurrent operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/LeasesSummaryofFutureMinimumLeasePaymentsUnderOperatingLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r540",
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in the measurement of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r547",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r546",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carry forward, net"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r61",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r67",
      "r69"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized (loss) gain on debt securities available-for-sale"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r52",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r91",
      "r93",
      "r211"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedLabel": "Purchases of debt securities available-for-sale"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireRestrictedInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire investments (not to include restricted cash) that are pledged or subject to withdrawal restrictions.",
        "label": "Payments to Acquire Restricted Investments",
        "negatedLabel": "Purchases of equity securities",
        "terseLabel": "Purchases to acquire equity securities"
       }
      }
     },
     "localname": "PaymentsToAcquireRestrictedInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r353",
      "r355",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/RetirementPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r380",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r27",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r27",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r27",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding as of December\u00a031, 2021 and 2020"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "verboseLabel": "Proceeds from issuance"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Issuances of common stock under benefit plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r91",
      "r92",
      "r211"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-sale",
        "terseLabel": "Sales and maturities of debt securities available-for-sale"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r96",
      "r412"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Cash received from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Product sales, net"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r47",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r46",
      "r265"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r267",
      "r555",
      "r617",
      "r630"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r45",
      "r267",
      "r680",
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r265"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment, useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r203",
      "r205",
      "r206",
      "r207"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Repayments of Convertible Debt",
        "negatedTerseLabel": "Partial repurchase of convertible senior notes"
       }
      }
     },
     "localname": "RepaymentsOfConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Aggregate repurchase price paid in cash"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff": {
     "auth_ref": [
      "r258"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the write-off for research and development assets that were acquired in a transaction other than a business combination.",
        "label": "Research and Development Asset Acquired Other than Through Business Combination, Written-off",
        "terseLabel": "Acquired in-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r428",
      "r593",
      "r684"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r16",
      "r107",
      "r113",
      "r599",
      "r626"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r12",
      "r20",
      "r107",
      "r113",
      "r676"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_RestrictedCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash related to letters of credit issued in lieu of cash security deposits"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/LeasesSupplementalInformationDetails",
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsReconciliationofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "verboseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r31",
      "r337",
      "r420",
      "r555",
      "r628",
      "r649",
      "r654"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r235",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r495",
      "r645",
      "r647"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r176",
      "r177",
      "r187",
      "r192",
      "r193",
      "r197",
      "r198",
      "r199",
      "r346",
      "r347",
      "r594"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r116",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r545",
      "r550"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets acquired through operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueProductLineMember": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from specified product or service, when it serves as benchmark in concentration of risk calculation. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service Benchmark [Member]",
        "terseLabel": "Revenue, Product and Service Benchmark"
       }
      }
     },
     "localname": "SalesRevenueProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofAntiDilutiveSharesExcludedfromDilutedPerShareAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Amortized cost, gross unrealized gain (loss) positions and estimated fair value for available-for-sale debt securities"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r216",
      "r217",
      "r222",
      "r223",
      "r224",
      "r225",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Components of income tax expense for continuing operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r56",
      "r125",
      "r320",
      "r322",
      "r332",
      "r334",
      "r335",
      "r336",
      "r532",
      "r533",
      "r536",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Convertible senior notes net of discounts and deferred financing costs"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Components of deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of net income (loss) per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Provision for income taxes on earnings subject to income taxes differs from statutory federal rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r378",
      "r408",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r378",
      "r408",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share based compensation"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r15",
      "r40",
      "r41",
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r47",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetailsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r380",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary and changes in restricted stock units outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r386",
      "r396",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary and changes in stock options outstanding"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-average assumptions for stock option grants using black-scholes option-pricing model"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r445",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Activity related to unrecognized tax benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Industry Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative expense"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationCompensationCostRelatedtoShareBasedCompensationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, award requisite service period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Canceled (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Restricted stock units granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "verboseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending Balance, Unvested (in shares)",
        "periodStartLabel": "Beginning Balance, Unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Units"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending Balance, Unvested (in USD per share)",
        "periodStartLabel": "Beginning Balance, Unvested (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Unvested, weighted average remaining contractual term (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Released (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "verboseLabel": "Total fair value of PRSUs vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Released (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of common stock authorized for issuance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted-Average Remaining Contractual Life and Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r398"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Stock options exercised in period intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair values of stock options granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r388",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance, Outstanding (in shares)",
        "periodStartLabel": "Beginning Balance, Outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Stock Options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance, Outstanding (in USD per share)",
        "periodStartLabel": "Beginning Balance, Outstanding (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r401"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r399"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r377",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpenseDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationScheduleofSharebasedCompensationExpensebyAwardtypeDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails",
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Canceled (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r380",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in USD per share)",
        "verboseLabel": "Market price of common stock (in USD per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConvertibleSeniorNotesAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "terseLabel": "Unvested, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryandChangesinRestrictedStockUnitsOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "terseLabel": "Total intrinsic value vested in period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Contractual term of stock options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r403",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected option term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationWeightedAverageAssumptionsforStockOptionGrantsusingBlackScholesOptionPricingModelDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Term, Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-Average Remaining Contractual Term, Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Discounted purchase price percentage of common stock authorized for issuance"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestmentsMember": {
     "auth_ref": [
      "r670",
      "r671",
      "r672",
      "r673"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments which are not otherwise included in another category or item that the entity has the intent to sell or dispose of within one year from the date of the balance sheet.",
        "label": "Short-term Investments [Member]",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and local jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r58",
      "r78",
      "r79",
      "r80",
      "r127",
      "r128",
      "r129",
      "r132",
      "r140",
      "r142",
      "r161",
      "r235",
      "r331",
      "r337",
      "r417",
      "r418",
      "r419",
      "r461",
      "r462",
      "r495",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r645",
      "r646",
      "r647",
      "r707"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r161",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r331",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuances of common stock under stock plans (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r28",
      "r331",
      "r337",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ShareBasedCompensationSummaryofActivityRelatedtoStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r27",
      "r28",
      "r337",
      "r379",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuances of common stock under stock plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r28",
      "r33",
      "r34",
      "r119",
      "r204",
      "r231",
      "r514",
      "r555"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets",
      "http://www.neurocrine.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r530",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r530",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r530",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r530",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r556",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Other Balance Sheet Details"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OtherBalanceSheetDetails"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental Disclosure:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r227",
      "r228",
      "r229",
      "r315",
      "r330",
      "r486",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/CollaborationandLicenseAgreementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsReconciliationofEquitySecuritiesMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r354",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "terseLabel": "Securities of government-sponsored entities"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/DebtSecuritiesAmortizedCostGrossUnrealizedGainLossPositionsandEstimatedFairValueforAvailableForSaleDebtSecuritiesDetails",
      "http://www.neurocrine.com/role/DebtSecuritiesGrossUnrealizedLossesandFairValueAvailableForSaleDebtsecuritiesinUnrealizedLossPositionDetails",
      "http://www.neurocrine.com/role/FairValueMeasurementsAssetsMeasuredatFairValueonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r429",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "(Decrease) related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails",
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r440"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Expiration of the statute of limitations for the assessment of taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesSummaryofActivityRelatedtoUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Unrecognized tax benefits that would affect effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/IncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r162",
      "r163",
      "r165",
      "r166",
      "r171",
      "r172",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/OrganizationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]",
        "terseLabel": "Effect of dilutive securities:"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r145",
      "r153"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted average common shares outstanding, diluted (in shares)",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r144",
      "r153"
     ],
     "calculation": {
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average common shares outstanding, basic (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.neurocrine.com/role/ConsolidatedStatementsIncomeandComprehensiveIncome",
      "http://www.neurocrine.com/role/EarningsPerShareScheduleofNetIncomeLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a,b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27337-111563"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117546-209714"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267859-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267862-210455"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12317-112629"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123467658&loc=d3e12355-112629"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32059-109318"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62586-112803"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(c)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r685": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r686": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r687": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r688": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r689": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r690": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r691": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r692": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r693": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r694": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r695": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r696": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r697": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r698": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r699": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r700": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r701": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r702": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>94
<FILENAME>0000914475-22-000013-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000914475-22-000013-xbrl.zip
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MN+^^19L?X?CYSO'^N@=!L7_<ZNX<MHXVX?HMT*U-T)<;IV_;:]>]"U#Z,DI
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MDX-B^.)=T?<C-]PN=D/Q.7<W^'MZ=/Y 7+S7)B1R3@3)@P"/0W$C2>"$L,C
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M[/5OG?Q(4'W1'4T3ZM_LBJ;W@%^_NQ<BGCB+@Q?2(,:CL<1H^"&,0L@A4X5
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MF2L!:CII!L7TQO<#:B5]&<.#3ION6$\%PYX;I*U%3EHBC; Z+B_AU&CZ-9O
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M3H_!OQKOS/K5-CSH50> \+3:6EHI@SXAB4E06J6=JV.#"4H:.FK?$!HC'U5
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MH(4:QB-%'GMHJM!CDD]R97;-X<7^$2?F(#1L$<PQJ&)XZ O3.05[K3R_3E+
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M[;\.5Q57[V%.3H(ITIA-WIOLA[TVV>E[)YSTBR%\98;EMMJ]_K#<F?MDL@'
M^)M/3Q?=O  ^YP6\S> DN'+:?KI_^.IU<KB]U7:YO_1"-MK^U>8F\]C3.VUE
MNFR;>HL'X&_R+?>UK-(K;N=MG-VS0NG*-U^0+NP%-_O%J2E\XVV_?YR:\F5:
MA'ON5?X0MKD?W-NW*:??R^"%+H) &_\N^Y!$)?GEXB3XW<U""GT&'!> O^P8
MN"7"[T!#H -[Y1Q9G%9.9UHY@\N<$26YY;W/:9^DS&2]4=<"60)/%?G@>#*
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M'[7-]#__4DV*CV,2FH.#PZ.#_W=^L/?K\OPO(U+WV_X4G\S#AX?+C\_BK1Z
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M\*MF/;JR_57>7' '45<"VV0%*BZ0 0?@;B[&JPBB9E2^N34ZG7Y(SZWZQ#=
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MV^V5]V-.,.,EWCD'QF>0+'$DGMISZ.?GP6Z<^+#V)J5-^,*0+2\6FF5V6^C
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M+)1BR'"GB9;!V+MB'%H0^) 1W"2RRC^.XU\"5. @P?QSV+[::D$6=#NB'++
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M.69.+8,Z"$CPA0UEXS<:?2&L<-,F*,*R3D,_B&0!B\8;S& HHXN]'>&]&Y'
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M8)V8?J V4FH@E0JI3W<56+4K?VGEJ/"8.F=#G-=S(62N,U8E-KLMXXQ:8XT
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M+>L17@]L2E+G]!Q#408)$9N>EYC?X]0G[F,+/*QZ[30<[A\=./XCJ7RL<H#
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M/NT1%?#,]LIX"JS1^2TBSN=DHXL@YR"8-K/!>MFU38O54C#<'+6X/H,5V,H
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M_WS--8,I"8MCXI^41FMRUN]LAX.]U*/A!7BAS;Q.>H=$5H\C&"GR.!VZ>3I
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MBL-?PV1],5SAX2[#%00.?I(N(7*[ %CXW - TO=BL2SK=1[LT9W#"'(*!AR
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M&+>]*]H/HQ]2+M3N0MCYR5*W+^T6@=0R/QBR 7-0*W\ ,0R7GH-!<#*M@>?
M&1MVRWW](+N50>G :S?2#*_A"88-Z: U\13I'B@HC\NZ_B#M-/0=I<]6U!2?
M00[FM@F[-\;:PHO;7,H@3(R;T[LC'X(V.I[P>"JS.=56!@5N>MU67PGHCRDI
MX"2*N9!,RM$YR^5P?F?FR[7434@A@VR&)$!DT2;,/;H 6[Q71GI/G'& A 4B
M*_.C010NQ+ V <B#:+,<$_H6MLA)0*OB9_2Y0%&?>1A;>TVM\&"7M<)91TM!
M8<FM.H%*QV121\(+1FEF*6.C'Q!(QR*X4.$5! E\ATF^KEU.@_G6OE&JJ+\=
M.Y@8.JV":8J)K6[;UE.9NL))X^AX*.KQ#M?R#:MR-J1>ATKK/.DPA:9)O%E7
M<B;8H(68'NW'NGMR QV"%G,AA:QC//XX7XMO;6CT3PW#O=OPK[7A9&/[P&$C
MK<AJEH,(B3KE82".F0CTI?(I_4NT\9Q@!.*TQXGF9J5RP\O*<_LFYA'@M\SO
M@4Q=,*J<*<*Z.XGXEA+Q8\14.32F6P8.ZEQ*O\%;)H*HI6LM11'RH0D76CBW
M^Z\;4\![E&>1@RO?#S6+2HCUL90\9[U59]8&'G-]\TZ(OJ$0O0D-M_.KTXS+
M&[U9R-RLR?]N_<16QWO*<I(O"_E'?[31P" AX]KA2=A,1<)14#B4.BO:IEN&
MY)G>]=:9/D[B(PQYXK'ECEXR0LNSWCMY]T9^<$R)&!H*9R?7@KNVAC!Z_4X.
MOZT_P\Z[,:Y&O$><N)EQ*;W!*#GO[DBKG+-+VJ.)B78\L;>OD70@K7!;9'<;
M^@TW]/M@!&74L[+=P6Q#$MZ4QZ>M4FECRO)SS1;&5+P^PEM'/@D[O^*?!L0>
M5SJXMT8:/C-CO*/R </CR%K:59<)'0R?3W8'M&4:,V96:Z^DI0@@:MOFO_H!
MEB)O^AWNS(-+BEDS6_<]-D1*;BNT]2&EL;@H B0:8!.^-=)S&V7EEUQA<.::
M&N<1YM:G$Z3QX>P:H42?8#L,?AUQ;S =[#J<VQ(8K;E]3NCH471"Y<#W;=NS
MV!A*?8Z-9\@=>?[M5T:W49Q^]IS/FVWU+$.U_T0L8MY#[B7 ,,7'.\>->= C
MUB9WV_F-M0/7-MS82QVUH?UVN+QM9A@">-9^.]-A L6N<>4E&$\&K<##*5@C
MH%J#5"F'$#(*!RV.!F 3>&LO]ND%6_Q!*P#AKE=5&^[$Z"LFV#8"#(52ZWSN
MIBM60>._[^D/.^\=F!I$^K/0Y?R0@X2C*GARIN*U6AFQ(G+7CN9"-.DO)"R8
M$".4KGA4GKDBC(<,+)TEZX3 /U4Y&K1]F_E?2_]N6*(A?O([,?RVVLR7)5FO
M576/)A$M]IP:8WJBTRO2(%=O]O90S#O6%W6<V.7"KYP'&^BA]30,2LT;]<P+
MP]R3[N)*.-,*M!;3@:=2"L']N0FA^U4@'^DF4\:Q01* CEN-[#$ XPZ/Z/&(
MA[< CWBG(WZOCO"142II=M+5GDPL5 UMA]DEQN W*NO6FF.0=K4_\OGE4\:V
MA XC&4,A5V5?")];AXH%G_+E)/%I K0*8S&'7)R@?>D:M<KP+G<&Z-L*5UE,
M.0G+L]A<'-3DT;@@*=Q@H%!_-%641V<#A;E*^2SEP9]5:'M(MI1=S48E2_"E
M3R#">%'4I:5V'%.^2*W_W&5NI:9:H50-7E1GFM;M-1Z>;C4!?*F92CRPA*^5
M+DA!WGG>?[3GK:.X>2-1$R@QE;H3LF?0#:V3C3EDLOUATD4JV3ZVCSIJV/&^
MR&7ZC>=O5][K+16$.SGXAG+PTK=CVGQ5FP\91%@2YD=35</VKRMB:JMSWFWB
M-\[K8W4FY(=4-A&T+%S $@$"F+\^;>>C&=B=@IX)/78^]9& 9@Q:O)-V#D:A
M!0"#*S<\&421:A1SEV:YD6Q=BF0'EU P"KSF$7]&I3A=12DX;N6D7\/0NR0_
M_9<<@%S$A3/PKO=R !BGT)([8,D?6]^C52<7LE'R220(JI7T7.AX*%;SN0Z=
MEW DC1 @=@G>5."6ODB3WQ&_?+%;!AIX.DM-R@2/'F<_Z[@MVU7=)WU@1@ED
MQO4J_\B(TOFD6*"=ARR8XL-M2WU],?CTAD#U[]AFO?,H=":-9![F]2YT-G]F
M=\XM1R#?8!=LD/B0MPRR' X6B3GL9"!=_E_LHH7*Y:I BB7@A]&H)KCV9VZ%
MSL69\ISV+/]G)R&W3Q_U:$?>J%46WF/L@P<.RZ7*DBG(^VA3"\;R<TQ<QKO9
M([AY?&Y&,[-H'CQ&@);S>&9ZGCSS@&7A7F"_P12(_IG"NU533+K U8O&W >*
M)"""M@:0*L=RH07FZL4+P0@<+PH6P(\N,G?'T]VL(BZ8F/:WJ&9-2L_=<?Y>
MDA3A>PRIOR5]8?1@M,[39@-UR?S";4!/RK,)*,I:1PS#.HT6-ZSJCDE7]>*2
MROFG-&7C(N TE90>1G462PB):GOI>Y,D80XWN_>]0UJ-.09\&'$(17=(4SKV
M#[CB*0#MO&*!;'V68#F+Q'C"J!X;= "YJBP>5P:^*_60Z1]ZL+JR82CQQB3>
M?8%^@OZKZM$YO2T]?IZ[_C+K?#7EN !0+;5]LQLDHQ83]1:0PZ9!2[+T[!F;
MLMOP2"@_6]'";[[RHU]4"^SIWYV@,_M4.Y-G2XK:EN8IE%)>.:Q/N,3?!!1M
M3% ;X&@F=8+6M53GB/$%8&-GH9-S+Y]%6<U1RYQC0$5N%>!$,KCSNF7R8D9%
M+Q8@[EJ/M&] GY?.BDF9S[3(WS@=$_P]7!4^J,NZ1'%0PW$)[-.(\UE:#YI<
M.S)3'7TH\TQ*+&=:D!J(CYQK;Q&I#9^1ZQ=M<&=F.RD^8&]P-*2O?Z-150<R
M+HRYC#L8SMF@GC>8ZYY;,]N*"V+]R7/<)QAPABD+ ?X(+29A;58O6<7D96YK
MBRJ*CF7AF9KI5%,:/NNH%7OLJUEPW?AM]^-EH0 YY[Y?-17I><69[HU9V'NC
M'[H&FYJ,,O&DMX#R>=R]H)]<NU'X,IAL60AULH%L(IQD0IH@+^5HI%5L@,+V
MD7[O"/;JW#6T1.,PT<BB%2O(EN'K(&S!@RD=I7(]Q&Z0D*"A#, \ :.+HNTT
MO)"79 H=,.,(1&+[CBAOGHQ#")9_<\AYPOQNO-*U'Q2#[NW\,F\BZ4956[<N
MT[69Y4UC([)LYHRL@;E^#N0QV[:57M= ;DLR7]K3);I*%NJ27I5+)[)(<=8,
MFJ5@%D&'LQ8+[&':WJ^14V?E'D,0.)/G#4\XU<(W)5WEG@WV#2VX8PB]\7<U
M?U_S/[H=-?^=B6*_45OEKG15WB 91CC-Q(^ &"KGBY^L. 9NNV*MRRO*P"'6
M<3!L'J7=,LC?(/ZR?N:.F5_AG9UP7W>"P?*3JZ>ERW@1!A?/0Y(#KS2<)Z=\
M(X%!N.O,_X9I4PZ;R5$!XG<FHS^6;*:#*%;3&U+-")*J.BT0#LZSNSWZMGNT
MI4F(0RM5,W=[\(WWP%K/>TTX=^O^C===*^TNK DB?8ZWXE#-98,W^_WO3LL?
MM&O+;D(.+5(D< B$!?P<8;Z&=\XS4A=2"V]W>_*MK8AW;?./A838'I06.*Q9
MQC.+M0]H!<K#E;H$VG0&+O:<?JW.'CCU+V2H II1.V3#@RL^P]&\*W]_V]U%
M;\'8Q1=5[@#3GPT(O,&$]VPX*$I\I"OA$1/&; ]ZXRY9&S ,+RH)0U@GJ,H1
M$R_AK0IQ/S.5L/-\/-(95K?]E/T?2M&S&W7W4+ZWE,.C2MFUBV=)E,PH*F6?
MK;0<N]+9"-;_>6TO*TI^<+I42YE^(KFK-AJ,4A+&^JIAYHET6"_7/B"JNDK<
MIMX8+-J48ECK8K=1"Z(LO%(](',W;0KQ58"T;XVF=W21DH+H6H![JS9,MDOC
MJPB=J_'PTR@RP+V!8;V#)EVYLY5>=>2FUD:V^D>NH'S;<"3';=MQCH'>IY[P
M+CEIXG<>G<-BN;/,.:&-799ZCX!@A8(U%#WZ"/^W8?1-"/8Q4:T;Q<R3K\((
MO[%^1S6+LS"S@NDX-9T%!F\4%O9&;^T#E_-Z)"4N%IL)9EWD+AGB8@TG[GZJ
MCP/TMJXLC[Y#O8X !2S!FZC-*7DX[.9 8B_Z;B4$&]*$4V+U!/0I *(;!W(?
MO*7T./A*I;'^.NFD/PH1EVYET5K)*1NHDA1M@-2IY5OVO#&,\O]G[UV;W#B.
M+N&_@MBPWY4B>L:\6!>O(S9B3$D6O:+$%>G5[GYKH N#%AO=<%]F"/WZM_)D
M9E56=V,NM$#.K/'$$Q9G!NA+7;+R<O(<8OB5*AP*ST-_UJS/=LV*DHST.N,0
M_'SQ0I_![[*R"RV8-DT;FC>11/$3T5 ]6AL\90T49;?.K_P3D>0W6F[B7B10
M#U3;$_0.M'X=NPY 6>0[G(W^U2 Y+2(L9'4JOQZ*O>5Z;]%C2NSAZ(Y;^L?:
M6C)X#ILJ<>7\$PCUUQA79B .:Z4,CCRH-'.S0[0,BTB/7].B\E]3)BK6A6+3
MEVS>#^PX^42FZ._F*!FHQCK&$<SL,!IJ0\PDQ63_3U(L:W8$#2]9O&3K)Z@I
M.JX?PR&JHG37BG'%':%^@!'(,0-P9=B%,@<L$A];PE%P8G9\RIK9-:;'5,YK
MOV'K$GTI<*""X0N7N*G"3;6B9/4C7B39B ;E^,D8R8GTSQHMG6]Z\,+0J<B@
MZ>Q^=R.<DE")I\1&*+USUH=[WIH6*F>YG N9F+RPU*D%3ROE_O*J%-6LB;<_
M!]+B#&BNK2*V:(8@VL ?YC.:O!4].+BI0T7IA%AA33N>OAU8H@8(SX7#8(@L
M+9%SLEFX?+61%^J<'U'@)#.VT7X*O=D>6E14Q/F]W0<+GA5:9 N#S637D ]@
M T8M6\#[.E1N1B@2"<#"R39"/D# !ZWP,<%C'2TY>VX*&\@UDAZ+VEU*BY1X
M6*(FU7O+SQY3!HH:PM9B XV>3L)!@S<=VZM)V!%MX>,S9=A<T38O1VR4W!1-
M#C$F?&)AIGO0GWG5/AXJ[ <WK2WT9+)%Y#J"I<>IJ.W<?J$*9G!H*7[CH>48
M H17M-/+;O;P:O@$\MM &JO\^]8)@UFTV>>+5_[O]"1^553E92D!TRVFK6B<
MJ&ILJ34<VRKGA]*= Q'%-5X<#LHJ[QB A8\*<9ONQB[R.E@4BQ)Y)N*2F26\
M8#S)!#9[OOA6EC@<$9&?//@Z))LPP*3EO>QKK.2:_=W&X'O-/)B88X8>CM!
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MNB9K2:<M6:\W>_8C[WWJJ1,*Q)\BE1*ILH@3+0VW:E98IKMA29J,\[N.NH:
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MI"-;@N<O0)I!B'^_I93VI"3V3Z0.R^V2X/DXH%!WR L_J$3%ET+/Z!6XWLH
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MB,-=JOG>).((AGD4"A]99F3L<!O^4?I6MS#_HW9*A[?>^346I6RD"2T=T31
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M1>DJI!EH@JY\C+1UQAYE',_W^T JYE>'_BI ^H3*B:9_U.'>;9J6)0C\?69
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MBNTC2(5>0/><9QOZY;K^EF43.JGV 2O%$$F\'H*XJ[(8*/I#'SV;EL"J)Z,
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M9_Z1;^(*N<QWC$P:(E<M E[M.+&G$WR8F@!Q!*B*"^\K[YSL&A]FGC7K,^+
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MXT=^C)&%"@AB +_]V9'60Q=_BY&8'>?@QYSI6QK<BGA;U!;4*='TCGRX0'U
M";QF2UL'4'AQ/$.W8F+$.$8+;9V:/%(7;^X=M^2MPIRH(L?BV5<JQD%#"Y)?
M<=#-H*H(A#?*17?PZM/9@%_+9PEN<7 -1,L[,Q%2Z_#NX[;!M+Y0,AF.Z'L;
M:7^+$=QGH0Y"'K\/9?K2KPL+8L[++6^IJ?>$QY:F!J0K\,QA]4P>L+&'PE]T
M/+V!M2?*BZ3'ZS7905HX/LZ$K^5?ZWLBKP?>[37#!*2YNB>OLU--E,K%\V+D
M'/ A0\PLQ!"6@T_ <>-S!&#;9%*:9E6_3TEF60B'PBY>B(+:C<]Q[G=HXNI1
M?B@EIM?FBYC!BT=.<IQ/KYUTA85G*R,[%EIG["A0=PCM324]._%&QY+5TU/)
MZH;A&>76QUGZZXV3B,6QC]Z5_B$HX3OQI4.9("QMCK%L"4 B!@V5$"_H-D)J
M7RA*#%/]+D=QV6XVZ>,(-['R#";F"GV9\PVSRN,UB;0L$T#)_3 :0Z6Q4>B2
MH>)- *=D031(&PW#$2EWRF/2BLMK(:0=28$D0:%.4<;)\D1I)4O>VW^\&5#R
ML0XW?#:V#I$$ &,Q5.^TT8WZ%A]\YN&726,OMT,9?Y#?\X8:4DAI4O^O5%.2
MQ3IFGT"4WI:734M=;J&H%K"<-)+<]IPLDDPZ_1(EJN:ZOL[;8K8?5WR.:X>D
M!)TDRDO&M$6Q.Q '1>1W0)9JRA@5;YL64M."PJ),S_W9,@7+C20UA71#<"U$
MO<6@^!QO?$;P&V>PKB,1J6!>DIM$?Q.!EFCN<7_ZH;@&VTD:UR61H=7#]M#J
MX,=1EHU![K=T.&&%@X.E:% _\Y\:* KIL;D[3@OSR_E (K"/60(\O\A#G]B8
MG"/6\K;YKX&W!9Q04N616]*DD1- 2P%/J&F0F;8@:\W"Q-"*U"SJPV_)_&7,
M&V7)V.DM_&89K?219Q;/ATCI9A6]3*^@--1+PZ#8!\WVI319Z*KU]Y6Z84AL
MCG.#8S<Q*/;<X7DE",.I.-(SX(7/-(,K++- :]:L^0Z1N0 7Y24^EF?(B8(H
MM#8%(;UX]C%2(N5H7_A3CZK+HBO)6!=X>=R(FBB,6O)(K:-IE6_,,3L58X[<
M-FPQ)!=[+];[A\1WPB8T)G"E-)/NW;4FH9E 010A8Q<[J#T-[:7_P:]8[PZT
MW>(SJ?TFW:>?'Z+W8*6S6M);D5!43 Y::GF]1VH2(X\MUF2.54/0(EF2UB+8
M'O^4@6)NDC\WXT"T1*K0E8HPL$X7DGG8&L1;)!2(D/FB7B>\"K8!:WA=.U[Z
MC%\ #:_?//YF)?.0U""0&J+L2):*D9 /2>^"(&\3S'QGA\A[S#5HH["4!_+Z
M*F7D@U,X!+UJ7M5&;^0A+.5;!1S"&H@/SGB4N"3$9L9I'LUZ*B((RH!;5X$]
MQ90&/!;ILW&CN7QG[;>/4WID_E61]SD[$*N]Y P@Q[N7OQL/,O&]P9 5:2N"
M0Q)\">\$;@&3\?9W< GQ1KJS&1=@51?5!Q*=49BZ3;DD=)I_V<)[&CD0M>NY
M'6A&)I+O8FBD[!1!T(E@>I9P/F0Q^-$P!C_$Z$2L+J6AZ..L=PPQ0ABJ:'^F
MU6Q+XQ3?P.1B)X/!%=+YDEEBG.*JPVX_8"E5Y(<AY[+^TLF>,7=X13,$60@"
M5\U9*.[[M^_ZH*SH IV#OOO#=Z_>J(E4(,>)E.#(^NQJ[B[\-CG['^7J'3&,
MHI!%^*/ Q0,;T,WO F]].[6]H5<&L0"14'/B1,]E/A@[)#QY(:-Y2XK*%&+B
M0&I-/:]UVZ$6 W_X_!:I:V$P?E=25H+;4H5%I'44Y<H)X'_R^PJIWU#PXF(V
MH5S8:\UMNR)_4OQ%Y>')!"R,J[,$5Z%^8@;?FN2RD*CBDA_#<F109=?*$;4E
M1F\NQ.4WQ%!3Z)*-GTY]81]IMZS\LF 78=62$T8+9'K ITC0]+O?X>,O^.-,
MT$.P,?SM55,S;^9K]0D7/[#;B)4CK#'ASG@,?#'XD('UQC;<,B&H;$]:SG.;
M.6Y9: #)V4MY@UP8:>%/RQ\=[S+[>C&_DNEHH)XJRSUP _!X47TT$D6!'I>I
MR^3O\, 4X0CR[BR&B,P-M'(8 T.HQHBR/<E^NOWAYSOMEB/O%D$^O SH_]>4
M_S7*D"1UXMT[_16V 6$B7KZ^N$A7>S>WW",WP<'E+$5"K*ANM:%>%S 3JY.^
MMS96J^YJ:^-R'"W&5(/=7$%8KT\KZX@K2U;'03ZSEX:.\&WD(24C]*W4]=G6
M:J.F?"\888JC$_S"C#8N]P?)TC14CM;H<RL@P7AM0$^<V!V*U=KGK4;9?E>K
M-'/Q6A98PH!:BK1D^!A*9?X2/BY%+<9&D>A&BF&/BC"%/A=M:7< 2>E3([\S
MYNDFA,OE8+@>)9#-8A0;BD82ES'SMYY'1-D@_(S(I(16H3![AW?1?U[=^-GC
MJ!N?K-F_XU6^#NCKUYK3>3-07K86#D<E;P*8K@M&8L(=*Q6=P@G.,$"0N<R+
M:*'R6YS(+P3'D@8EQ'][E9<5=F;*0Y%-6O9>;,JJ: TR9WKN:RL!YT&9P6XE
M_4QL-M' 0O5AX<EC1D_@S!)ZV0A7G:2]E!W6I+X05=&'8]_&9_[P+VLE+>)N
MD:(1*P>#U$%@94<9I+[EGW9-X0TE?F#_8U,2O3T;Q\^S:0TO29LO/M.H+>+K
M-5DC%ZRI;"E0<U#TD:X!#"@I/R6-1'Q(&>*2$5MO^D?J=M^9@GI*N73#L$?B
M7:X9A[XUX,L<C<3&53A\S>C&@Z3<0FBZ)T^?]I)?=@3,.DE4'I\?,/>;G5+9
M\%>S1=4HT$19L9%AR^LB]6QTD7+6FRB)S]YI0@C?GD:X41&:EMR>'8.*Z]HF
M7VNQKM@^? V_J)KJ*K: <[V3D]<A9]+%LCX66]W49PEX((IQ:1UIA)I!@1XM
MR%A^@O>A(1! )<SI&)@3>>M#C2<*.!T0C@P6T+\7Q36MUH!@!0F][AA$J.U)
M!$R\RNM^_+%<%$&V0W69&W+YF2#VX/L DS=!?LMNO\VHQBSYC%5-#6K\Z)RS
MFJX$*#059:_8!XL;O.%-(A );3;E*L"R'"3OKPP9N7)^TP#[NVR:JN@2, [W
M AH)ORH?:A\:AA9Q/,9?PS8H9 --GXMG\#+B9Z>T[;P;_*!SOH3!:=-K"[86
MPT$0F 5M.L7.SNW6OYKZU&1G\^H8.>9IA2FR]MN5$&!<9;L:MEQ+0-F!)4!Y
MMQ<EZ+:0X(6\H12=:K _@X[<+VAT8&!I>$^T1L:'!5V<=)'X%2V17+\!AFDK
M:C^ GX7=( (1#[\B^:TH60![@+4:1)EF"TU:IHZ&Q9S:HY*CZ**1M713Y:'S
MQ2\;4D>C6^%P5K3O+;7\:"0!M-CYN,&U<X4R^]CQF&"!N#K4[:21D\M2IA85
MT3\1?1P:XHL9ZZK5-U[R;)O4*,[CRB;2(:*YQ64Q[L&5RAQ# [1)>#Q!L==/
M%8CLLVEACI*64I?C.@G*\Q'VB6PIOP5/B%_U?!#&&1Y7B>> 8 %SD%;G :])
M80]KHC22U"PIV'E_/UBDJ-_+P\IR;4M"P\-R"@QHC(Y#(V)\)\[;ZB$_1 W3
MA(HCFZV(6[N S%V69O-&8'6#A CHAZVFQ,EW9X#KI?=D!=485H./*$C,4P&F
ML:UXQ#I@@IBXS&]$KAF %!^AG!@RC/&X$ 0;J464A3A%C-7 #(@:L"7BAIZ5
MG2_;1$;7HIKC+UG; +N?NDN";,@:WI"QEJ,M] "@)-DB.3QNT$8R@"Y167_X
M]>I4CY; =.S])G*=BX:9;PSNDF1\^ZX4HH(9L1SD%T790E?/  NK)STM/>^.
MN3H2J$U.#5<KW3OM]#1#;CV&!W&ZWA.Z]HM J%C$/)8""%.YL.KP8O[W48^P
M"ZAFV>/2T*3RG-GBIQ___NV/;__/FV <TPDUP@GB$ (<W2UF5.FYYBL.7K->
MGT&W1GT[RM$^_&5^(='0W@KS^4%S-[X77IPL22)$0;CM1?@\:"_*SC)@1/T>
MQIHC9RQ(%B:M8I7->(ZIBBQ_+01AWWUS<19@ZGRW674JZ='$(X<6P$0XBN]K
M'5^6H@Q7E_#,G.]V)0A-V'E,\'$!@+XBASZZ* 3PS:\5E3OHX9(!HS%4[6OM
MH(['V,R=50Y4_D0B8R& "\.UVC0E:V1S&!(X:I!$TS&>?,WHBX?,XJ]#<<DG
M<T^J/443(64!M\4A]G:H@\0G!C:&W8W2I\&FLHKU1"TT&1:.#LVH:7HBM+50
M;00')348TXC &^5.5J/X'A\"LM80O_"'7+]9#^RQT%>W9><O!__9QE"Z1*.T
M$1KE.JB3I@)5=J4NTI7*DEUAV^E%@Y\'5UHV83':3E1FZ8-"T]1)2_RQ8#B3
MZM,4WN#-!^\%R(2RF,]<9F3B$J7]1^L[+MA965A=.E,Y[/CH:L-Q?37CC$:\
M#O*F&([6$,O1 P4/?/YYZ%!FPFDY.P+8E[UMIXE/^\(CNH,YE_G&PO:H_9)>
M.LK)AN5#1>>:NX]5'TLEOGBMU 4(%!3K3RZD_U.($CC(,.-P(![ :(0V.Z2Q
MTDA+)*@$>S*(<DW 3/>I0EB^.'+J]*!',7_*^86[Z//M)U6L[@8?WR[!MM#3
MJ9+'#J.*>OO\$40GQ])M\FJMV\E";KB S5TYXNX48<F&E:J(/F$V2+M/DGV6
MV-.A#E:*B\N*8Q\;&)NBP(IN3EW IIK[_!%4<S^=MQDA=?#5*4V,R'61$X+3
M)J;"H1224E#Z(\X>PHA)HOW&@+M+V"+984 T:N#<,RO<QU$-F%F4S F%U:8F
MV6W92I(%'$?GQD><2^QR6R->1U(=\M;A>(HO;?JQJ*+(0;6V@$F'5N@,U!Q7
M9I1\_5X6"FY^"DT+/,9X4-)DB2L6T3\=F-YD,?4Y'#3O'SJ9(&_Q2N@3!8-&
ME8JVA#*[#BQW BAG%V!AY+$R9VRXR*U-$,@(ML,NY$Q'V;TDOZH8)>]1(&<K
ME3,UZ&0>5AND$UKM)PGT0 DLB=(\>K,XT5)+7E1-!^<L-FXUXG<_B*5PEY;,
MI$\_AB1-?=N2X/*V96E-0%S-DG+KX7M(2\84U:@+4G2EH:+'U3_4]<5?C5L0
MRPPBFMD"8I0!3I5QN)&%NELT=P@F0&0/<I!ZS;4N[54B2A/D3QU=M_6V:)6\
MNAB$VO7$]JSO'5>.4)$*?6-:%D*^_ #\7\L.>)V!K<H.:CW*5$?T)S0:YII,
M0I.\1/*LTFL<.C>U<T:$;YVA>.3V@RF@;.9ZSIOB9N\BLX2*9O8S^Y#9"*0P
M@.2TN]QKR%!VAX99J1E1:N/B7 GF5J2(-$G/?^6V65KLVF^ZJ]Q[TVQ]\]+5
M,6B4.C0V5'JC7S2MQ%'7&V^FL.0X&1S'CNK46X[Y:0F@SY_*J)2+>.?8%.D^
ML6)+5T-%+1G2 0DGA7@$Z&O4V4'@ Z*B'+@=*U0=Q5Q1"MHO[F9[C0:&OL]7
M[ZBPU AUO#<KCGEEXM\(J[0_6VV@&Z&_C9[ :K]T[9G\X7SQ\^3R"P;X^B'F
M@-V2>O@S$HE4V4<$@/0STR!0N@*$I1?*81R;65PELO>2A+I2:B(/.7X.U*\D
M!MRAVT0'$0/N'526Z R5^!"ZRI>&FD)1:9*)3:B%=[J;Q6?FZ%E;+L%R/?$[
MDM;N+O;Y<;.VW/WS\\4;KD9PMR3J/\DD)"0IG(M;MZRUO(_CB?P">H!"#'[)
MLM<N1.&*XB@E#4<U27O#$&\C9V-.;<X4J42TI+J$;8'.\:HA @32@W)KUALA
M4ZPZA=,6=%ZEV(*0^9&S6DW$O8\3Q<E]P!?7HW'!$].H$(;C0,_N[WL&/[M;
MW/HI@V;A9R1.%*ST6;J0B)H<! =#.0K.A1+/8L\B")QF5(*VN\TVFT[A&V)1
M!=D,;=F](U<.="WC,XA%%^!">OOL']T'$L(-+&>T:8;O0L&($U^.5OYCJ!PD
M$N8U$2M1);+L\HYYSW<LF:6(=IDM;E;:E?+#0;LV.]6?9P2R;WT@UA'D-&\%
M2%FY).',0 $<XG"QUWE9 9>4TL!([$F;7[=Q]-^%*#8O6V7[?.=-D($3P%D3
MJD\F'>P8']#$2ZP/^D'6$9UUL;+$OS(LZ''1P@D3%\G^X3QIE A'-"U9,>HF
M31SU%=G$"T4Q2.29%(?$EZ*H@'^JJER["(LBR)7UH8,'$B_;-;L-Z:28V3%!
M.*PQD*N.L]*.8IK5.Z;"E.E.@&ND=MK22XOQM(.IQ<](W\/VU8"J .VE'/S(
M>^'F5(9419P%R[BXO(!QL8"UEJP)AC%XHJW2^G1&*N5.;JSF "3*PV3$/Z\D
M'^ CO7&81\<ER@/CG+VA._B3\N7JF_IS-#YX2%:8PK$M0F>C.K7M?FE;5D*3
M#'$6$'3\47(0UGN)"/!9IG5@KY3(VW&<I\!$1$/I+6,1F"'K<_D5GBD9O[@Q
MZ$:9B>S+VJQ,H*S /B-ALB15$N<H[N[U*&SG R)4MRHGFL>:0Z+U4'FGB.Z4
MQOL3YP1$KL$]FJDV*UZ.5_+L!I;(JNN[1#4"ZP7)7G9WZ:'/%ZG]]K]?]S$V
MF8OYN'7[9I.D;\5KP":+$WPHGF[KBOT\[XI28W&0,@XQ9K=IEQ)[=_Z7W1H[
M?<^W*ID,7*CM1@&A*:[ )Z1\D?BT*!,.* _'-1)W7\RXX:^SI:_8NZL"<T0L
M"VKYEFJ-F&'_1OEHUX]*1 S^":,0;U76Y@IJ=XBJ%2^T7A/U5\_-D;W3&)$*
M05ASBPBMW0NP=(NW)ILGK12R6]C^L!O6[W=N##@[7[SR%J1!H97/"@V_Y*4E
MY2+=*X(\6TVS'J,4A<"!>R;F?Q>"VIGHTV*1] 62_7OP//;Q<X'HO74)X\K<
M7D#Q#X$IH,AYWR6L1 YP3EL4#"S9]%?LA*14FT#0.K\X5PI.CQ?%6;/G5N\-
MDLY2*.W% EOF.4R;<I,XL93:M4%37\YY"!K[DZ4M4RP"!TC40EZYPCM-MDH:
M$ZJ\K/QE7<OCNV)RZ$FT5:!]X9J?C*ZL68T(),4B\[ZN@UG"8(<'U0MW01L(
M_J>PHRAGH]O:,50LK3ZY9?8,%XZ\C4TX24(:+6E_O"U_ ]L5+A?!-<:RG<IF
MH6SVYU/9[(;A88^2?))H,N)^ZNZ64D1N)!RA8PNZ,@6GN('G"T]S]::HBBW(
M$'_D\(,]+.JQ^Y>>KAWBQZB#R'TO92W_WGECS+@JYL8=^?/&#Q (\Y70&G!#
MQD'\H7!0*1,[R,1Y7\>R)1W([L[<FI^ND&/\&""E:^KG FPJ%K4RSE$3_P_8
M>[;B:\T.W\@\!RA#J+#-3PL%?9.1'@$]#\TH.U1,(P&//Z?2@<NW%8 8UM^3
M0HYI38KL\*8[2:Y& (RJ C=+</;/%R^4AS3C \X^2A#>8OQ;,C*S.$A:;5])
M3*_A^;<#.3/^I?Q'17'DZ1.-^RU64S"<Z[+M-(>L!-,*&0DJUS)X$=<I-:>9
M!RT:!Z!>1A)7#,[;2:<7LSL%]* 6I?):*B(1 (APAF:*-"FU^QB1MHY7!)%&
MV&Y-_@C=OHPGLMS$>[6QSYKGV9)7\=*(4]%90E1M,Z/H-=\Z^PY&:H9NM\#Y
M!6H;L]JH-5M&U.CGT&X-2I55H&=FR!7=!M]5PE/\)AKC,H*_M#>FB]@X2MWH
MG34^!2H=:H1!6%B>,6#>6QP1F-!N0T4VH@U<^8/D89CXVRS1=/%G^HIV?0;/
MG?4A_5A\&7='6'=ULR#1=X W*.0L)4YIVO(22)?$A"B)-]J($)\A#/3187/)
M!/AR;=-AF^@,4L\CB-6!A>FX[:0C49,B64I2$M*C2 HS4G1Q-7QZ^F#&],*N
MCI>1KP)IHY+#V"I=6"L"#9]9,@H2#RM'1L$\V_EAO_>A^%M\ZDNYB7VBPN\_
M3B>.CBW&<">0U7XCX8NZ[*$8S2#L**=\X'2C$C19B4OH&+7 Y6H$ ; 20F9"
M+,=+'3BVND#K;BTJ,.FX!4,X<46R.HEY-[T0D>7VX'WH =51(F(#?WF#?J8C
M[5NY83YS!C,C\(&CE]/VS%)O=H8FQ@2VC]N%*JP^2LRP'7+;[,@/._)@PT%A
M%8I"\G7.)7L0AN^>OBT!%)+$_34W:H04I#"9IC1#TD* P!Q?Z5!HD3[6-=7V
M^6SBG8(#4L"I6C\(*<26GJ8+M5"1?.:$_<,O@/T2"MXYJROLFV&NXHWZH7S,
M.SAJ0F[.,(6Q9 40QH9%^/5"C$X*HQE#ZY/9':3 $UW1V+?S$IN2GRNY,4#+
MP-(I<OF69X 7/_MP(<>*0BP.U*YO=L@-(0\I'.W""&Q(A)DR@J$1TZ=?!-Y!
MC)+2O\A*S"V)A.ELF1OR('1'901@;2Y;T+@<&F]9O^B:=4PN-I\M?%D+EC"?
M8*MM9E#B2T%":=>U[J+YG8,UQ'4#,):.LH9338@XZZ$IYCHY7C0++T]#9T=X
MHO"TPF<: KD;GC#=#61?5T0.Q+<1RK26JNO>DXB'Q'2T@>KDQ3AZQ#@/2!K>
M=<(UI2Y?%X>/^F[U2' B/+OT2T%" ',  +D6JGS!^SZP!OY9]24E5BBBLZ ?
M0S9O9BK)#4S7/,ZR/?LF]%U4?^QW9AG44VF[N?W.AB9-HS-LJMK'$S"@(A_A
MJ7>(7I[K/+;F6)3=CAD U/P22C&_)IN8$.0L'8INPH5,2LYGT$S8*J,YCZ-F
MU>1SL5-:867^R0R 6Y,]#SN?=C-\!XY9R<R<K' =5CZZYX7X N?2C<.==+(<
M6-\3G2*Y%[J(Y9J&$(?WZ]KUXQ[@+CMP/@@%:"9 '^F@E-_U^?OX@TGRF->*
MHHK*;(_6@N#0!HH*?X?ZJFP;[<X*US5HCU^'%HU]2L06E*(87>'-M*P?U%Y0
M"OK_V?O6KK:19MV_HI4S9Y]D+\LCR?)%R7ZS%@&287: 3""3-_DRJR6U0(DM
M^95LP/GUIZJZ6Q=;!AL,R*!SUMY[@FVI+U75U75Y'LR0Z&H%Y#-%4X(<I%QZ
MRH>+A:<%%!UGU[>GL4M<::+^FB^'%IZAAT5_A?@U9<%D7R[+*1K)&P@P4TRZ
M<\W02AG:N8,4(8++G27D0DPF0YXARRT".. #)K+%%W-EO%1'6(EL,%=4G*NO
MU-@YXN?+>8XA'IVQ,R'_BJ6B6O8*/*1RYS)/K!1;S ZF@J2KQLFV]AG+4NE/
M$S[2.FWM(S]#=$(,6'*?<"""JGH_Q"Q"N+G(UZ7M".C_O7DH2R)B3EAKYV,5
M\Q 97PNDHB(GG68HO?6_/'S,][-LDU*>F8S'/%S0!9/ )'[!YU\L24 *1Q&V
MQ<2HPIWUQ5VDR)Y;2LGG-0475, QE*'K.5ZHY?OX_%*DW2U(D=;-T<LJ<ELE
M,(,2_/&*O%?YB8XN1J3P.%7= JJJ,.8HQB-DMXE4M%Q>\T?"F%>SZE3"_13"
M@UA'Y6<]DL56_/K;.MG&!2=^G.:^EZKD47LD<;.R]<K7L*T=YNL)5[&\SEH4
M8BS9V R9=1,;3'?4TKNS1J;%WPE;IR!HL^KCN?I,#(Z64#I%4A,S>WBMG,J^
MUD)./\ZCG'//*L=+<F%1Q2XP;2:)QQ=^>RTM5C7E58XVF9\I<]6L5%Z@IB%I
MV++PZWR'6*$O:J$,BZ[TY3\N7?F6K'V25;ITO9;Y$UZJ.::0S<*%89Z+J5!C
M5PWT)Z=2Q#A5G(XL*?N65Q-)3"XYD"8"X+Y0[4A+W=(4,"M*,!\&N@\/+X\%
M=T(07\G[0EO;5TJT7".*1DEZM(1T+[$')X+>5)@HA36R%-*]NI*]&B.N)!BN
M)"_-A$!U42[TPQ9#$'D0OV@2LVYIT8PDW.?J;EAQS9E#L8CO_82(\\*V((N#
M%^!2%![B_"QO#ZL79""TN)EA*NZ0M0@5K(\")M@3YZ-?A6)P.E*F1#E#,*4(
M.YX6ZJ'F+\?U/RM/"VA9!72RQ0@@LF+-JXPJ[4 [IIXPS^:\"J0..3-T6B^4
MWXLXBJ+2DU&5$>$B*JJKC,?+G0D-&169+>8)+Y9B,RM'(,UB_^7H]5>>027-
M245%4$0E:>>K\%5IR C):G#)?K.[;0,F!&_$0ALLG_?$=5UR[Y6_H'Y_=H:L
MC1,^=S^Z7&&,"R$IL7>56W,/X\V2 &6-4?F #*%;)D%*:6@L+0\S%,O"%U7.
M.0ORR X+D63,2^J+!>,5NQ:F2_IZQ7,I/E\( LWE+S)OHRI(-J%0.,-H&G[=
MD]7X1+"=34LL<ZD8>)K'7>2$9&]4@;&(BL-@]HN@LO/BEQ4/%?23&I/R#/^B
MZ)#2M22.NFR@4G'[BBR=R%[GS%K31-#I87XWN<B 5/!+LCEACIL9D2DI-5/J
MQA0LI4-I;E&HR(O!H!4X )Y,1;#EXZ?<4?6'Q>%3 %(-WN<CV:<DD%QN8=MD
M6'"^BZK2P\B/^[R_J-SA(D,S8/!@A50.3&"S%5K#T#N@I9WK'LI ;*60H??D
M)^P22P_R 64-/2(PFE>6(*)<%F!IE;<XIXW'-M85 K@DM?0-96JW/<M3</>5
MDWO.?H'0QB16(EZ6SH>1A\+!518L[QNCMG-TP;+N4(S!;T6EPG&IG&-Q6>1U
M;)(@<(FO_(^*Q:)35Q8]\"$YI+*L0]WFX<9'%P51$EZQ8+.L7$>$:]6##XB6
M4_U<UA.V"%1YFH@\!!:_H4E8ND49#'*>FRNT3%9%.<GVD6I.LSP^*_6MC25J
M@[IT%DUGN4!(-)B+YZ2<_RQV]<AK<G2VC<HDXS=%%+@)I8PEKH9WSB)A-7)8
MHJ);L\"&7=5\U-:DSM()DA1@563\9#YL(:K1"F]<IX6A:/JO;V>(EXA.+39R
ME5+751"+;@T]5.)CJ6A%;ZV.3;0H91'>' K$[:WK:6\D9R]=Q?UYX/Y"KS">
M[!D32X%L7;'<S8%MM2K%-<<H$DLG$=*KUX!JK:?(D206U0,QRH'396R412*$
MHK2I1&$O (H+1 /YK#(:@AR5W5>'&6Q.CE K$)Z(EI..+5(X-5DUA\+I0-P_
M&"(JET6(&-1RAOL2-IF*P69AL2PTV<J[^+-94$M_U3/'Q"K-"ZCWQ?[7HA$H
MD$94; ^-&JZE4XD!-5LL3B+=( S.)OF4)Y]ZSSWY='TR5X1T95?!O=D4>DB!
M::6$ 9!P?"#WY74NKP"D2KVS6'YAKB!AL1<BNQI\X!&E!?;PK9_R>O?/F57-
MH$_VOV@?]CY]S@-0LOOH?V$&?CS*'TE?DC_Z\K_RWY+T6J*(EU"F W&A4HM1
MQ(03JU$*4J=T,%#SOBR"!76D<KL0$>W*D\T(8W= 8&E0^_L[RV90&+0 =I,S
MSK\N)I.U9E\#V%B<E,*^RYQOP<4UAUVQ#")GP=T2]5&OBTLFHVX%8-7L1,>'
MORET$"B U?*:OI'!.I&CG,B 0''1<W%??IB\H1V)15F/<@G5N4*@8G#'?8,$
M646*W*Q]FCI4*+TJQ"!'P\L7\HT -9EE Y&/GSO[\]Y7U0S[1H7+<UK@#+.Q
M%/NA\%Q15RM26*6MNUY6E-P7+ALB>A]4=>H6A*FH(EF>1+033<>"2&0J'6BQ
MG6?#V*6:)(H)H"Q;>4B0@T:HQV D$*-NLO%$(D6@#X!31?<EP]6AHEEQXQ,2
M'LVM^CJS*"U4J[1*!2! =(Q$P5@5S-U\[0F%I(0Z^B55##+YRKK]RDJ1NRTP
MHN(K<O:U*AB8?*2%?*!X7CEH)*%Z:#K+2*HP8"IK97(,\ I(=I&>HATI%-O$
MY5J['("D$%C+PWZ;Z/K>WFO2KA2&,BV(R)I'C)"8:'OITJ'Z\#+\(0^4)X5)
M4.U]^6S*Z14%VU?IX 77CS:Q -Q2,#I9$<0<75_AL-7.Q/E,1[\X.U.5*Q?H
ML@NN UV@I?>?@\Z)X"T=?DKL%QJ(6X5VV^P$W8U'BOY;]?(*0@S9AI#5,D1Y
M^]P0>SP61Y:KIP($DD&F'-&'(4-EZ!=!MT<<=2A,1V1K5MF)<DUP7H26Y1$I
MD9%#+WG9-6;>1HL[RX]IEH)6Q9@%URUGV$Q*]^,<-$HZC"@8PY1?GG,%' L:
MEG-FB>[!Q<U<[/.FS$K)+<1Q1D0K=C%7#5A105V\S;LSD<17T>#">+(J@K(1
M+ 46U=0$$I^<VYMK'JDZ/63ID[J1%>[ F>#EAG;^3,G/!;2T^!YA:TL 60NB
MIS;,8^,,^Z8\A=^+.X3)HXI*YOI;.KJF/$# @R(:Y#549^^P4B+/198E&-86
MUDE8FL7")#(?%5>873 -\/HH9&"51,89KBPBD$#TZO"#W=U/.UG 5K)=Q^J,
M@[%8AF6HRTA:\JV1E4,JBR@=$@\)!6LBA5)$.KSX(UG]55T2D[O4&6-Z#BPH
M8!?EZ(7+C5$=1'^CGQ0F"U^6.$C*I9&]3.6D<IC,7RGR(D+2]7QV!7VCA85%
MDR9(VN$%WSQ;1#+P58.3][\YQ1,C%>:.7L,0!$/XC8)\,U:DD/2W*(X*MO^E
M\'1_Z[>ZAD%Y[ZRXYM5<$EYPIJ#U)KY(19HR)S=*7#Z+!=P1.,]"*.3E;_?3
M9Y @,5GT%?]DT10#JV8+O]=IB4Y/$<K+5J]*6N$YA8H\[,I")(:*P12NW3N"
MH:>T%V1<A4N8[]9+;/,:4779JW(5568%2PF;*J*?MG8L+HM"*86#B I=\HB4
MC KWIO;F#\.=JV8H<JL'I@S4Q/LIP*I%GH.Z(LLV+<^(!"P]E\ G\S9AD2%J
MG;ANJ>&L(K);=F!%,0->V^"QDS:($H<S52*D:ADF/5V7"]RBY04JX2K[_ *Q
ME(M'7PY6]_*&(L#\SI"U,:CUSQ[R:MF:19Q.'#H"U"WP.LANBA07<9SS>Q4K
MPNH+_K4%%&Z5#9D+-95BPU70C//#)H"%RDO??!,;H5+7/X^<P0%>XMW(Y^PB
M3N;3<@R1 G) ^A7S!-(M1[-, R;TAI?4I54F6"!3%% 'T*L,';]81N3S=!Q*
M]@Z)F-HJN'T1'PISKD)(U!J/J ^*2H%:78L($G)V"_E&P=PGF6-47[ \GL")
MF! +1 X@)KJ<D^7SH1)IV0HG@*3S55U]&0O,J:4J4@SN$79_[JX4_Z:Z](3/
M@L0$BM>]2'!S4RBB6(ZR$JTR.M89LS*\EPEWJ^!CEI607'_*\@F+!&8W)DQ,
M'"DF[^?B;SL90W8J"Y3JDR=^?EFD_O(L$@XW]/_U(O0Z7>[XIN4[EFEWNXS9
MW:!C^*9OFQUPQJQ_>OT7SR+U-$_/L 2@$!LYS7?M>Z)IL&Y9,O(ERIH'X6(7
M!!0L0NVK_1EW%$=55_G59+-OO*BYK B,':MN\O))]#G#8;P5UXB<=_"<,_\_
M< L4'=E(SRY2D.A\G\#@]D)^!@=G?K>C0A>D >87$GE2EK7GQ%IX1H[%P0H/
MS..\A,*DJIK17X!WG,6QKTX;D<,KP+"FJI]=H0-F38G!#16>C[.T>]3;G?5O
M#$5P%GP9&913=R#561=?LQ4B/8<W)'H<UG2#1S1FGD+#5N606!\KD(=HR3/
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MS-)WZM?,<A\BMIK6?MKY?"JT]N#@MG9I8-7=+FG=VIDD(CPA3^PS7'J05Z*
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M/9N"_0*+-I@S19\/=OXX.FK6_R[KWT+"A02N9[% H(]BN(*?AY&?8*4H\[@
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MQ$K+.6_L2Q9<A$2\XCA%RE-1S>)E-8_ZJ <M#%AF(%Q)!UMV/D2;E? ]_BB
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M0ME"3>-PRF7;+&CJDPY(KC?Y>L<;[Z%,M$Y5 HT /WD!OBN@42/ ==G*YRG
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M[1>MV_=:.'F&X7:]%O4/Z:_1$+&F.*RQULO0U;*MA]?\Y @R557178_P+[5
M:/NJQ^:(5_1U-/'=[0N9;M5@GW)\MSI6T<1WF_CN4XJ\-?'=)KZ[U?'=6E-"
M'>!6@(/91':?:USLI=5M#Q9.E.<=$FN$=UN$MV,UPMO$<[<YGHLB;&Q.A#<:
MRGT.I)A?HH3#&'XA,@^"N+P<QFGZ"B-S_#_3<#+34NY-$T+V>&94F9;1=AH:
MQGKOT4NSW^ZO;CV:_7GP_>FL8]WK1Y%9?P/^$>PUF>LKS(=,P_1<]0AY<42C
MI P#CQ!*.8HGM[3CV\NN3?",UIN&!+W>V_32'+3MM1W!9G^>C1H]&Y?\H)CS
M]N(1S^GJ6UK$)\_,#^^T!XT;7N\M,JUVK]FCFN^1T[8:QOI[6U[!6$]&.@?6
MK3#6*T:V&F+A9T\L_-)LF[<-C#8$W(V>/!L]Z?;:G491&D5I%.4>2QT:DOJ-
MME4HXC.L:E]T&ELE7C;X@S:=2]-)]AXG:T=(N!>?1?0%>!'2R:2BUT*F\?)"
M>N*+47@X.=X-_"I@(3$Y3V$43!+9(EJ]@)]W)_,Q9DD/03PY@P)M!#S_*+[(
MV)*,2N(<6!0B8DWX>)IX1+HJ&SR6Q:T%/5J!,:Y<NX5(0@B@#X,E<A.F#>-+
M7GX<S<)E0^+HD=2]\70BX;GDD(:S)0QU\GTR*)-.^&B4O4V\:Q;RH4_A>)P(
MO4WF3TL[</]="QMO]J@2TFH:P1I(RHUM-O=E&V[;+/(IB2_"5)%#O91<1R19
MKQ!X"N7M%/F#FAZ2I]"6L56#?<H]) U&4--#\O2K^YL>DJ:'Y/Z7['EC!,UY
M<&[)@Y,W!F* ;%I,GEN5OFFNG<%^%I7ZC0!OB0"_[,"=K]?TF3SCZ/C6![^=
MC5-S-.%M"IIBA [6B4OR<G:E)<@O?<E2&1.=G,/P NYG&-CI!+^@OID6PHC^
ME&,$DE\1IR=^(V?+G@L,+F?.AC<DB@T4'^$EW$?><.T=AW6+,&(;"G+J($S2
MB?:?*4O F<:88L;2X/(S)F+JB>1%'I?\NZ)#ITT);@B^7[$,; P_O J1J14C
MQ0NK@/][.HF36;X>;6U/+ ,.D;G$Y4K0]B(FC5P!XP0#>%=9>2"F!& F\.>+
M,)ZFL))RW9!G5KX3LPCQF"=B)-CE@XA+49Q]@0",\*FX=1E-;2BX*^I/&J%B
MV:T2JR[%YDN[50Q5_V8YO0+MAOI151 ZX4,N(\_IU(5MBV2J /Z7"D=CZD0*
MX1!DGY(,:F]$/B#@M*BXRO 2/J%403$80U-H(TU!E30%*EY_@2SSOI@=CFY1
MC!:UR@,]/","^66#;0DA"62P'X0%=@7#]VX<__P=G^R',*B$PW=!=@K*I9T1
MQCVM*LAV.!HS3[ U%-Z*WQ^RRZUA!5=ID&M4/Q<FGDY0R^4"D/+ P@DE+_[D
MAKTUG2W?6VV'/IJ3:<D1<LY0ZX(IJ,Q-NH*CK=(7XJ_&3*ADMH%_3R/)0-]P
M<F02W+4;3HZ*93D"J3K(:^KW0MQ,7]MG"?H%*:J%=H*>19-G>PJIJZT:[%/.
MLS58;<\TS]:BRQS<C-&RTIU-\]F$->FW)I?4I-^V(/U6WX8;=.7$Q:K)J#VW
MA,3 6;O?\%GD)!H!WA(!MHU^P\;12/ 62W"GWS;J*, ;0HFHK]^C8E:\&+.B
MF]5=^KJ?FJI53;'>"F6TG4?LS]\0AD(C<MLD<G;;W'[8CD;DMDGDC';G$4$U
MM[K49H5.THB7(*/\I:["DM:]FM9#%!F[:DLJ1KGQJF'*G#R_ MG!G( '6XP2
MJN'( _!^X^K.T_QAV>!P?\=)[$\]\)O9<*$E]N#39Z+DVBOTQ-+NBI(?K,::
MCH,$1 [>.!/-P%AW0&NO,>\_TU DNK>F1F.EWM4GJA9S(K=<2JKE*X[.8I0+
MI4,H"#B%@A[E.I(]G+[%$A]K5_Q9^A/V)0T9#07>>9;PE"IE5(-N)NOAF.,>
M5LA5Z/_K1>AUNMSQ3<MW+-/N=AFSNT''\$W?-CLP5>L?I__B4831NBG\3L+X
M,035\;%0#Q=BEXTQ6:9]YBDL@E?H^7CXXKG5QG\BQHG;EDVE]A;@*Y;Y#4..
M553G3*(=7(7I1!AJL0>)VH.6%H!34:QF<G&WP%D(Q_3/&ZQLN(#*> GV $8
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MOF[0:SM%Y1:9A2K?:_,[NQK.O&GT7CR*WJP&U'X(:TO'$EF$SP4$\=JK_($
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M.J>K1YS0-9\<81J7H/1M%2DB,^L6D;J*5199+]RD89QB&7!;.X[H"(ATD::
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MM& @U-55M-!6Q89+3AYYX<K\H)LX NLDK(A:A#@)N( ^H+EF+J!8J>P2)F[
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M.K*.D/4-9C@&-_N6W[49F"<C />H:P?<\ 8=;JUZ@C1"MCU"9AWO_&.:3C"
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MG^F!83JZ[8(3,.CT ]WR_0'S;>;YIO_BK=U$ IZR?F[*"6CT\^[Z.><*V'S
M'*]CZUT;>[6[S 4GG9FZ!6IK!*YG=;T^.>E/\/I?Y_/_-$88Q V<_W+J*W=,
M/3GCL[&,06-W;FUW?B[X!5X0^%W#[>E=,[!T&[P!?6#T7-WN]+N<FZX'._;B
MK=.W[EZ#OJX&;%'HX/EJ]<:2"V6M1EPK-H'G7TU>1].1[L?$]8L_;U1^796?
MCSKXML4][NF>S0W==KQ 'Z#GT>&>V_-@#[TNIAI:A@G7\VU1^B?5KKNLP%M1
M?[*K)A+Q,,Z&6O,#XH,]95?"3C7!SW7-T/XEF2#R/@ZZQWO?.O_XCMUCMN/H
M%C.8;@=.7V>.S77F>OZ V][ Z/APY3&[M;KS-#&)>CH0C:9N4%,/RYKJ^$;?
M\P)3-SH!> RL[^FLZ_5UK]-SNQ[S>C8;H*8Z%:7YSR<ZL:Q-;/#,NL2L3M?W
M_$[/&'1[MM\S7-LW JQP]1DHNV4W76*UT?,=I><PG[/.Q\[G(?_C\^S[5W_L
M6G;O^^GWT>$'>-Z>AXB5/XX^' V/1N_#;[]^6H>G[W\>?CBTOY]^_O']Q_<
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MS*E'BPH&+AQ6.*PYSST#AVF!+?$T2N<BI\29")L_8S)I8B,Q?!X.2]W>F1W
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MP4EM:2553C/*+)59>M)MG3NCB+91^R"XUE2G1*U,PCOMA*9AYFV]M-YHED$
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MQ&-2@@!,2?(&42] 2A"OD5,ZH:14L@$+$HVHXY;G#F4H"&XL@A<N)\JN_'B
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M<C;37%7:R\' [#47?KGHQ]"J.O^X4WVANDZ"F;/ZPFA8[DTM6W'.6H!>N*>
MS#VIF-?92R45\V?):TI+&$<EILDAP8Q!W C@+<(\BHYSD\,5M!5 7@PO(E+R
M85!Y1G[)5<)^ RLO%,0O O'CQPX$4TM<1$Q(AKC0"5G-+4I*&Q:4$22)?(PX
MF:'T<T<.!?0-!OTCBY2RX3\^_,?4"C%*89@\)!2 GA/ID/',((]C)$)RFT2N
MND3((E(4EXO]A=1<> X9Y*MTC=51GP^KN?"ZZMB.7T3-A>=04:,IUUCUD\Z]
M?O\"EM7PI--WS\ZZ^0ZZ_C-LX,"X+1<[,56#UGD;/F.]SCR;DD)U-46'::>>
MGZ,\/<5^F<U^F:P:&3AWW'N&-),$Y>\1F*46"3!EL&:!<9<;WJB26['*P%UF
MKE0![F* .]ZI2F(JZWIO@-,<[LA!> B* H\X>I$LL0J :^9W/!3@-A:X2TV*
M*L!=#'#'/ ;>"T(#TT@G$1''*B%M@T16)J<HS!YW86.+T2FQ127[:6FACA;N
MP[9;O7@^"GH<*H%.?8.YP6T_=JINK]7I#DHVU"-*@+?Q?!1[D6GH>CI*79?9
MJ4A,ACDR8@P+"2GAP?CW(5=I,@G1H!PAFD7,XL96J:ZVLFA=M-U?T+I(M(Y9
M_,K!,J5.(14MH-40@@SF!B43M1 !>YB@C2VBIS6G+7AM*EZ?TMK_6[B6/,4%
MP7B\_('S*5!+$5<^YJ*F%MF0FTU3P+>R!H,.:&*>XJJ? 4SM+743\YBN#YZ6
MW&5JM3GLL5I,79\3EF"'GZ2N_:\3>L&JR)4 KC)$,,2EQ,@2G)!C$G8F';7E
ML3XL6)3KHAG!3H_18>89HOZ1E<9LP4X%_XO _Y@"H2FJ@#5&' OXD@.;'>8<
MP82JF(RA\'M0($)-:8HY<VY&P7Z#L=_ UE(%\8M _)A8 ;HFFG"%?! >% L!
ML<(]03"37GM&&7RST,.*1PEQ7-ECC)U3VSF)H%>&2B:7:JB_R?4:O@ 20.G7
MO^Q=%S"I7R_Y6D^O8S*EY?_?O9FJFS(S^87M3KC[BUM_^08>MQLF.X7[]D6>
M@MUOOEX8;^T@[J84??'&SLB,D[UI3& B><>1TH& 020U,*-4"!-BI="><)^;
M[@DV?Q7+DOFQ6M2QZ%.70AT-IXXQ&263 -N78:1< */*6XRLCS+WU+!>D*2H
MT!M;BD]1484Y5HXYFI$S5CBDX1PR'D4F0)>%;'Y$ ^9'#!H9;RA*Q%)"#>AB
MRD&8D;FJ9#QFVMG*GBOMS*+$6G;0<O&DZG3R25,NNU=#JZ2<W$>(-H'Y33FA
M)(#TLM;JF%B4S.(HG+0?]Q[!A"IL-AN;3;;L<5([DSQ&$B8-<6,ILL;9W.Q#
M4>J<LCF8'7:V3=:@H-@2S;Y8, M,%;:,Y>I/7$9IC%0$($T#$=QCF<'\$ =Q
M ?/C@GF\_%ZNH,^S5:(UR)N8 C*<*22LUI@$&FE.*2-D6L?/ N95 7-,)&+%
M!4M.P\6HP0$+HI0/SAO"ZYT93-@"YH:!>?P *!K+0X"E2Y@9(MJ&J%$0P-/2
M8P%Z-%?CF];ZLZ2K-$931/CUO6KBI_7?@QPNTP;N*3GL_R[O\5>%NSG!SC+K
M,):88VF-PD01+Y4-GG#L:U6U[#.MPMVS<?=DAR-J@[%:1F!LHQ%WU"$7N4/2
M4I&X8\#@9&.+<;Z)E^UH;IBON3!>8;SB1UH!QAL/4!1>X\0Q@MTK5T90&EDI
M',+>*A4#X=RY!?F1"N,5QGO.C%><;<^3\<;T.0-Z8YHS) 0#&R]HA;0T$ME$
M F9&>$KU@IQMC\5X3:M#>>N!&3Q2Z%[D>A#C3_S4U2%7]BY7QY<SO<+ET<7Y
M>3OF+%S;;KVJ^K[=[5_T8BEJN>QKK'K@P4&W@VK_G[?G55Y<\=MY[(1J *MK
M(G5U[K.*YVL"3GO"5;'REA"F7J^EW5M+::_C+WJ]&'Z[&!QT!Q_BX(VM0K'L
M9K/LZ*3WSC'OG>3(T9 03](B8PS\&"5G3AFJF03+;DJQCV=_B%K(:#7):/&!
M[X6,ED1&8XZU0(6R!"M$*7:(ZZB0]98@';EGC'HC5#X&;E3-PD)&A8P>,2VY
MD-'2R&C,Y\5A\PA:$^2]BHB'*%&N58A"<)1XHHB@N0S!_*>:)2+EP<A[F[]'
MW80N^K%E^_V88U&&O5)#:W *CW9RVLH]4VW=*[*=$T0>+D(?6MWM^5+MM"=<
M%:I=?%'8?!^'Z5T_;N>5=N@&%NXO['6N,HU>=WN'5VOMC[S4_JBLJ]K5X+*P
M[VSLRR9T:5*>QN "2BJQ47=M"Y8A9M%)RH7A@6YL43:_+;C XG6/=(I:"*HY
MC_:D=7 +03TB08UI56>Y=LDE)*BVB#L6D),&(T]MP)3ZI.J09;JP].I"4(6@
MGIE8+03UF 1UI5___'IX?$(_BD@%C5@@$AG+N=L4:1(C2L8KZ;VT0=J-+:46
MUC.XI&D_,*7BW%8A%[YN50"^G$;1*N>D:^$-7+A$W1LMH.SQ.XBEX,6,I#G9
MJ-#P%*D3#$E/).*!>.0<V'=,@:'N+9&P(6YLZ4W9(*=?.8$HG/.(JK-PSKR<
M,]YCD7#BDP/S+"J,.)4$63#=$,]UD!7GWM<=5T@AG4(ZSX1T%JXD"^G,2SKC
M$?W$!V<H0<SAA#CA!FFP3A'5S&!+(NP1KG&DL^K'F^/JT'?/8FM@OY4SS#7Q
MP"U!(.8U=)R74(D*F9TW)YM92LIE(L0BHRS/W;1P+J@:D;+!8N>$IDIL;(E&
M.=6*U[]PSJ,*Q,(Y\W'.F$"$:: FQ^C''([&(U9($X^1Y<I:[ TQ(N4B\ M+
M-R^D4TCGV0G$0CKSD<Z$0.114):[=MOL"4\.&>(5XBIY9@W3(I=^Q@M+^%Z8
M/OSGP+IVA']#]67K7_#EZJ//;.^DZJ#A6^I,[]N7]S&[&!8-'()_A!Q:9^?&
MV+(>5C!\]F6.7.UT!W#U03>CILY]M[G.VJ@[J&W#_<$OZIZZF]<#/?Z\HT]0
M^4'/N_TJ3\[+7FS;0?4E_OJU"H/3*^#>>M=H>/#-6ZR#.[@8W/^6IHRB%'?'
MXO;7?+LU$7@FH@F$!D,)!VEEN4@,A[H@#Y@W]"/)"6^C=YU>UP<XMR<1N5ZT
MGY%-\(@O;?NKO>QO_//N$H/U=7O8QT=L."Y;_W(]>-^4>[UWM<HG6:P3J>3U
M,!_LOGM[N/-V[V"W]=O>X='.WN[!SN[1B];>P<[]B['!CW-XO'LTY*SCP];Q
M_^RV=@X/C@[_V'NU?;S[JO5Z[V#[8&=O^X_6T3'\8G_WX/AH\BD?NK3,Q@_'
MAM7VSV)'@CYH),CFB+J'A'YP<0;7\0OP4-S=JG^[Z,-']_NO8M_WJO/,,=N=
ML WT=]')@4!O@.]\%?O'\*&_M;O^\Y-OX9]'6_CYZ>&K_<N_WL-V2G<Q_ OO
MV^.'O^^1_5=_51\^G5;[^?-?[8D/L!W_];^GV)_]IV/?FXO#LUV^__W?[0^?
M?OOTX?@M_/LG@:V;?_CT[NO!V;\KN,;7PV/XO$_M3[E%7M[6/SJ;O,-2(15R
M!(]G$6EG.*(F<6J)T#Z.[*JJ<Q'#=FZC+GW2BKC@+=4\>6N=]AS3%&1DC#FP
MQ&'4[7EF[=Y%W-@Z[)W83O7=U@9;+NMY='$&Z_$RU_$\ FQ6"7;;SJ!U,SVM
MJ_FYVOA'ZV2,T."UT9T-KUU/X8_O[N[3>&/!"-0"# [)M77.":4HU0%& /Z?
M;?P]QUR;I(M>RAT'UYVRCNNAN1Q^7>_EZ]E'*Q*!Z=,H2)Y3RT-=(M*A$ F)
MT>:1Y^/+<5D[0'W%ESESKO(/8,*KJ6W==/G<O [2>@K3YB!>]+JPRCJQ]5O5
M[0/\.C[V8<_M^,T7K6ZO==\?#$YC:V=H5[YH?8WPMQ>]_/<7\-I7VZ\/&7KG
MW5YM7U:=U@Z,4.KV.I7-/Q%CZ*C8[_@?O@)#\JOMQ=&?R<W;M[!3H[@N-G-U
MCU6_96_>='6M*]:QK:^GW78;:.=K!Z[?OW#]*E0C'IK^;)NM]V TM_O=UJG]
M$EOWBL^;:RW6V;YW\/H.'0#'N-@[3'N]JG]Z=/6A=7]8&- SF_D,+)Y^]"\[
M%V=?N[W0CYUKG8K7CR7HP=>/G&/+.(:-C8D 6QSL;E8&@PCSDCLC/,YI/H.O
MW0F5.5HP:+A@ZD&_63957OJWELWQ:>P!RUR =(07_AB$S7K5W?J+7?CN/(Y>
M@QWD-"^\KZ>5/P74P(+-4WBU\'W,,]VBF/#AXJU1D._K2[RQ@,<WQQ]:Q$O;
MK:YSAZ^UY/56M=Z;U&?\$7NG1< &UEX(.<^L;B.A0>11HHFB1AG7T$WJ#2Q<
M7YVWX3-@K=Z9W*?=K !M/_9;Y)VG?1%BO4/9H779OY_M6[!7?8WM=OXW;V'3
MMXMZG]Z&OZHCJT?^E-:@!P\SI(UAZ7IGV[:^:+USN!@[K=BN0+Q?;6[^SF V
M&-+O^O$P[?8'L"<-\DZSAB#.N5@.])!U"<5@+.*:$Z2Q,DA%2KS%TCNG&PIB
MF,"\Z*^G\.F1>]Z+YW9DFL&=W8/=O)+SGE@-+EM?*]@N[8U /+\AII/8@9TW
M(Q5>C^<C>&7(OP/[#'XZRA>M<;]=(\36UNSOV]MO7H#166?V]UOP7/:D_NCL
M$CVSGR-,YFC ACMPOW]Q=CX$^.#4#EJV;@ YY):S(;7 8W5[MVY@ZH/EBUT1
MTEUG[&;6 A?PUW!#%VWX4WC<=FB%"CZIUTJ][AF\L=N_=6=-YHVC>)(?^&T]
M)E<^ER)<LW#E'[FDE&*OD)'!@4W "+*$!"02-5HR&7E(#:63O4ZXZ ] -HTF
MN%[0O\?N"9B_8,R"%AMJD2>W$4"[#>MTU +2MD!OG[3S]Z/[[P_O?^B0_'__
M1\,R_K5&9JCZOOLE]D#.AO@EMKOGU\\),/H<!U<M+4\M/*BO;7[0:W5$77[_
MH!?MH'X+_%$GVQKM[DG^DQ>Y?<W(\,A7.^]?^M/*YI+2R-E^S%COUP5%ZI?A
MA[K*[%"'GMH -)$_!!ZR,_K[42&23$KAHI?O*ULC\+'Y/BZC[?4SV?:S\SLT
MF2Q&];7'V_$6LOAT(CX"'6 =5,K!&0QQK@5R6%)DDM+Y?\(FW%"RJ,--;\WH
MDS-"-KLKP%0++(;6*;P&=D.[@AO,F_87V%B'F_1PAP?1#5 .<"/Y??6YL*L9
M))^:YB?+9DGW8M ZCQW;!C,EH[8V^.'9NKT*0 2[.7 A0',P@F4OQM89W.EI
M/ULA[>P!M$,K O;TVE [O^CY4T!W-D1<G.B,M>0!O'>"IP]IDTGE;?011@VF
MK#!)=D5\_1BLECAZ@UB.R^?)&-A'I$-:8:J2,,&'IC+)]I5^OYG5IR63ZQOJ
M7=_0B#%\WK5ALXZU >#!VNB>#1FG^W7H%,B6PCG8\^= '?:R-A5JHR-?[T4+
MT-\[B3F,920]8$N_?G/]WEQN?I NVM=>C=I"N)(%0WGQ]V]HC>R'3BM^J_JU
M19/AEUV?68%<W=4@]L[@CL9^>VX'\$*GUE394W+UB,/;!0.K^E*%_(;K9_=5
MSU^<@0H:NM6/NZWLMGF1>?)'-PI4F.71T(>2'Z\'@NH'M+-<7MFOC< \X4?1
M9VJOK@AF/7GEVT=IK ]28D2M%(AKHY'51J(8G#!8,9X\F>"51PU/^%G:>17=
MH'4SS4]+.?7-]*]O9FC,]&N6N6V\9-=)ME7RN?K(\Q%B'6OUXOI4#%3.V,4R
M=&_]"&\ZR2*HDZ^)^N?979E+(,)/HY'(UE3;]OM5NIR\&/SOBZW:&20(<(WZ
M-O/U^ -,_LU="@7+*-FJUP+3YP+8HO8"773 )FO#J(76B:U&[M9VMY]5T\CA
M6SM@NL""0#Q LKUX&F&@OL2K?*=L>,$;7EQ1],!^&Q+HMZ&_&+@'EFBX*9Y1
M^U[J(YO:K7-]2T-Z/LL.CGP_O@M_"\1:C<;\SL-NMK;O_.HRGU>>MT$_UC0,
M?%5_[,A9=''7+,Q;P,CG!7]PNZ['B).!T&/];'_'?;.TP[Q+>7GB;E"P?35M
MK[N](YBT[>%X7650'H.1VS_MML.;NDOK>WA3[*8T>4@)DC78-21-O/_)?^0\
M:">X050HDQL>):0CC0CKQ$F@@B9#-K8,'M_B8.>\!+4?@1[^>P$SO]FZ&O?K
M=>M DN0M<VB9Q&&NGQU;?7^W]*ILU0#XLXE@:Y0-;E;<$$0SQ.$]4:SFWMT;
MOB*'_A5@K_W/UX(+F.*LNCC+^+HRQS9;;X:_O';)7!TC=29)KQ=OD4&.[SBI
M$1QK3_&0?T:W5#/P603U&#9;OX_3&%P[<^$T%KG+C]W.R.%D@;7"R--ULQ5<
M/7F^=$V'->.]&#Y)S+9=KI5UZT[_?_;>O3F.&]D3_2H=NGMW[0B" U2A'K#C
M*H*69 _/FI1L4<?K^8>!)]52LYO;#TG4I[^9>%15O\BF1(DMJR;.F1');A0*
M2"3R\<M?SJZLQFL#3B3J>7^!X"+%F:[@25=,KUON\R]KD_T:0NWCB]8].$J&
M)6BI)W!U#>>_^^4-IAK\\A6LSFB$6X.?#C'\[T\984"Z.+>NHCFWEAAE*>&<
M,5(7F2;*Y+6S3CII]1IT+M,\+UUE5(UH02-UIG)>Z@(^:V"_]M637'(X@F0,
M@F@\K'GW*^J=VRTD#&:/NV80:HU!PM(C!&O@AE.\#O"59H/WKZTWA=X'_8/I
MIPD\8C3R>3!X=]#VH+7L8#1\:T?7&/L:^^O#!\'@6^^'HQ%&HF*RK/-]KS/2
MA:(LQJ:]<L+@N;=*Y[.-YA'<66Y@AWY:,5BMT4H UPZ^?R&G6*<19CO'2<8G
MI_0</MS/&I59=PX^BE_]O/FA^(WW\"D8%-S,]V,<J6/*)6YO*Z=C>#K,<<?]
M\,MD)G[)+JV-*4%<"YPO; G.(KZ=WQV+#T1EG7;&)QVL1HG W>U,"IW?D W$
M6QRM4!WD-=T4TVCG.G#1)Y@I.$8G^6U0Z B(\S* $_&/;L*?_E[Z,(\+&E!(
MG>?"-WUHTLO"\F(>>&,TD"O.PGW3N=1F!TW((GT$QL>G1<+TN-VMU%R#91+_
M)B_L6%\?X /QDRLOYE;?R$<:@HL3XK7=Q0EQC0A/C#F0^'(8E,&@J@,],//-
MQ+"C9PJWABLA+??27(<S[T_(> 9BZG>C\=_]7IS[)TYC:2NV/?)@X\O'K5@)
ML2Q+D#?U@CEQ,$"$"CY377?RVF%Q5QR?G68%+@_(P1!6;#@-9Q='6@KH-*9,
M.GZ[3?=B[!^UHYN'WNC5%=P./FIX<^CH7RNH\N^\WJG<7N_TM2N7-L+];X7O
MK]@LLC;*@9NE<EIR55E1J$)GDDM-%;,\NQWN_Q#;L.7=;[._'A^M!C+:6/5F
M#V;#[38!NPJ&^!]W*+V]2YQA%TJFUJ9_@FUHQO.E4 )BG8F9S$D<:H\*<[^V
M,?_JX_.GQ^=6%BZS>4F<*\&65X4@$H2$,%MJIPS++&>/'F>'V3KB&61WY 'S
M_A)+..0 D<C9P0#WS=\J=Q$'(5T-3^4L\W5J4LK:NMR6N:2V4*7TXG '6L!>
M''84AV?P[[?LY.Q9=OI&OS\Y>WO.>%EE.4@%%=P07I6.*% AA!FEM:!4F0S4
M1GY8?9)H4!]%;4QAB>U_;[O0?6CJ!C45S'!O/2VF<(&&J$B,3UP'Q(N)#PL_
M=0R.@_6AA[,4YC6?%M8-QGHGDG8X6 HDW/@V:+U.]-"#@ .F,4T7P3]+\;D0
MZ+DY"#=87/G+8"E8$^?8KL+A]LJ5>^>'ZI2L?%+L>&.P^"<W_& -^6BGD^_X
M-+_*GY]=G&><9SJK&2D+K":@C!&A#6CXNC),5%PI+;\F.4^_X5]XPVO!<R;J
M@E"FB\"2@28K_%A:+8HRK^L<>V2O:>QU%7ZC9O(U2"D^ AN2 (5XRH-V1X<*
MJ5(.-SA)JX6Y7S+4"VKMOU%-/W>_)H#U,2C'Z>*R!0U^=\+BL8+OSUV960EN
M$,F9K BWHB*UXIJ8HJAK;6H&"[Y[)OZ+>CQW#-OBM@_^.T5.FIT?=+;^P=&%
M(9JQ!MD[V,710IL#OS._[@2<.EG]I5QX"]^12^'"H9W*J7Y]'8.2 =FS&,Y>
M6TP0S]]CR*5;R= ,$X#-F$.2@Q\F"I8@()J&XZO%?/9C2"%A7>_[Y0%^6(S7
M/WV(U9";YQ4A"XTEY29H&X9P)4(C1PBXGOVT8W+Q89 BF[?_=YSY@#VH""84
M^Q^+"5J85Z!^K=\C:=XL9O"K'WWV("0CPY8'"SR8D'#1II:7&#N+C7*&]@8&
MH'W?CVP/]P,7?#:$Q\GIYN5>WZ2#P?]=&Z+=LUW&2[O=()O11XL/\7@2/+GM
M7]M#?9 2-0:<%#W'BLBIC[R'GP["ZRP4@OOF0U^(Y0_V8C3R\,%TTOW,NA.[
MW@L(P2=)5;X74O5J7?6&#9Q:A][H1H4M%0+6XX8L5[3%.^!*(O_9$%X,QGOO
M2]"P%R[($ I?@@JL;R>FLWPN8!K2 V!)HO0,W< S0\319:"[N&ZJ938,%-,-
M,8(0X+'@,N^%%KH%<K*$PMOEUI\V*+HA^OFS0=);>.-J.9T.5W%PZUC?SDV[
M"3&R_E1U/5C,8:T_QCSAU!#<]>MFAU&LA@&J"Z:#7?M]_'JWF@J.OY%@_(3D
MID>-3 S<Y0<1>(-?][&6#B@ER$2L99)75].)U*\QAXC"$9*26*<QZ[ $13F_
MHXZ:3]H5ZZ[DRX5^G89,U>+I&,17;DPDS+<3C\9K\#9R29</6TL4R4AF"]L$
MNV976$@"OU9VK%_C$P;70SOROYE.WMKIOPR,#I_W:G[6(G8&:T?<;S],WQ>^
MMZL-.C_VODN)R^V[ZO=_C)5EN&GI1(?MPK-N#N)@^*>X''[!9F'L,+-F5% S
M.E7)CN7HVDN57YV(1)4^2YS0W]_:*5XVRB,V-KU6J.$=VL[5"7?A&U\9/!D@
M"-*7*WL@)&;RL=8O;-=H,K[PB7BL%1J':KVMZB#?K@XB? M'\<J\V9>5@QB,
M\DN,97;/4_<6P(AD+%V^>2P_3Y_BGD_TVV"4#-Y-, ^*"OP@GMUAQ\' 3[\&
MRW\R]29+^V%<S72"VM5,5=()<.</VDC"P^#CEQ& '[[O\Z]M1KYK<W07?"^L
MC=L<2&/M92"3<%A.D5RVX!4U/M-&AR^2%$VTQJ2(29<HXGV:U8BEV$D>8X0G
M;);_\+L(N G8#7]^NY4;0<BU1!V1D(=^JLUC/Q4C^#7JP?!<CT$ ^R)TQ/QE
MY\(JE;FJ(HP5EG!#*9&ELT34G&DCRK*T8D\Q?,U6/FS(IYD&JCI_(IMS-YJ\
M#^ VGSV"(X6U!@&RYR_SUI1KD+@!!S=I"SK"T!UX;K2QB/]0 .4F7>NMIP^)
ML"+4:Z7$5:N!/3"0#,<'\5_H"R08\E\V(0;QDZW&CT5>[81\U.G_+L"TL%,P
MM4)FS-_^/LK0?#VD^^P'[8M<40\A[,5ZE'(:*RKM"$7KL' TJS)K\4?^?>#6
M"NBAA#1$O%)3S-9R=G@_QRWFF(,T%D8V"(Y+S\6A$K0.ES>!O<#6#6\1@VX1
MT!CQ1G+6[$\ :,?;,NI3^*G1I=>1LRNJQ<%?Z!S%Z< U!QH.HY<)A3Z<-= \
M[^1/5*@GC+=@_!Y,9#RY!,T(5J1UPYC,7,*-)5#H03>TEQ:U@4>^69B+%A,H
MK_RY^^@!:F0D%V-O%"\O%=SQZ+!-$)^Y@ L7_^)E[MVMU7@/JO1?(.D:&,$O
M1F#M'(T-%J-[/H?^$H"_?3A7=4FUIH;0BE>$2\V)XKHF929RE6F7V6I?F4C2
MUOICTNSKP]X(2W.R:4[!+YA[,Q4-*-0AH0@#3ER$ Z J"[HPZC ?=L%2V-'P
MG9TMA=%F2Y?"5.($B(</)V7>+ ?JB+7'("8#_A?4PJ:G.1]&N/%<4JX4+22<
MR(H7N:M-+3*6@\' N3.E^9QS^<I/XW>8Q<:",723OKNS^O;C\Z=OSZW2F=.U
M)8[" >6U*(BL,T$4K+JN..52J$>/\[6",5#:-VVFS.JRRG-9U2[C>5$)59;2
M:495+2W79;^9][Z99Z_.*\=+QBPCE4'CFSI'E&:<L*HP6I>257GVZ'&UMIF>
MU.=P\#O2!&%X 7$^< G;UE[9J%1FKY&9+%5;@/^X3<M,HZMX&<,_(^NI2, 6
MP_+=./+0\P9<V3'\"2E^[X(&O/<&=-U9]4C +3+'X/GGI2RRTE22%*QVA*NZ
M)E*ZBBA5F-H:L .8>?28T4.Q'?[G/ @$(2%WVO3[[@#6;_I.FWYV?"Z88*H2
MDM#"(N03O'QE508RH*@UVBB&D,]-_>97]YS>'?E[WSV8^FW?:=O?_'U>4#AL
MG&E25#2'^R7C1"#2MS#4@0+6199SN%\.^6W;[O%>>^O>'3<HU^?3I\/9U03\
M\N?N]\GXXG>L?#_RUG+OZL'?LO.:YA5EM2:.N8QP.)!$N+PB.<N$,I4%PZ/<
M4U>OW6:T8'![B=_?0=C@/0!^O1O"8)C3(2,_L>BG>:!&.WE,D2.F.T3:9VVH
M?;8>:T_5C9WXEYQ.KU,ZQCMI<ASSYY?R>K <%@L,6<<NC3.9!N1\.QE?).A#
M0)VX7_/M)CD3REE=B#*MOZ&Z;F)U(9G0UK2NSW>&^=;X10V37XKBI1+ Q3AE
M?3"9&4)?D>@2::J:FDE\NU!_L/2P6+4XG"4.C+0:_E5364*GOM&OXU*=HKJ.
MA9[)R5Y_DQ:Z$$.8:\6=(:X9HW,I\M<6?*Y6 N#'%[/EL?M:Q;O4*E9[7JMX
M:^WA2JUB);DR5A7PN@4OG1-6PI>%RD5>F5R47X% $;34POXZG5P^B>1P?X&H
M/HFL;OVU>O)&?SRO"_!NR@QL:XX _;S@1#%PY\NBTDQ8#5MF5[>VYCDWLF*9
MK347E,(_*]@@Z8RQE:W7J3/V#!RW^9:.\H(4C9@QV0L*Z"9[XXNI<'8)IM:R
M$P:PRRPP($Y&GA,(9'Z("92+R<3X>SJ!9PXB 4>W.#X"[F8Q2Q42.>'DIP8O
M\2H(&11/R^2Q)1]BICV@X9#<?>V!AX.TKLO%[Q'W,7 P%NR4O0K8C)\&/PQ_
M; KD&E;''V8_QHJSYKU_AD]V/QHS6=ZKPF*]B0*E'L%%,=&51O-?A>\NYRX[
M73 ")@0_]NY'7_^G$UAM[4/-!;KKH]$+_0&&7=O:6=C;'["D$%_7#F8PQNS&
M5_-YS\EXY+-9";NZO**Q2:I_>GQ$R+TU>;HEII18"[A)%@+>SU/HC4+*;ET&
M-D@ ?K%!6L352INX%W"J.^J)4[":7DPG9@&KA"5A+3;G(90$4J:LM8OPMJ+G
MF3D^_>W/9__YS]$7F6)Y6.PPQPWVVWQR]1/)_;=7^Q7+&7+#6<0)LXK__*!+
M^P-8P\J.Y4?XTX]XW$$HD4X;27R0:\RS9D<>?<0I3M[A:6FXUN;3H5IXSP5_
M\?STMV>G9W^_['?B4W9B<@53NYJL[0.V.;(>%=Q=<*\66P4[]H#8<&(#\F&G
M6Q1Q(_%K":?B@6*^FDD.KB9#C^CU')<'@_DU3A$+"'Q9,U(<)B*ISD![J0!O
M7/L_T^WD02;+R[B),1H=R2DF8^P,68:Q>BM2.#8D-ATB0@^\::FEVPH.[!H3
MG<O03"==8&@%+-$V'R"+:#IED^B^#Z<FE *@!>)QTAUPS;13@39L&WYT&"?Q
M51'5,T4*_ 01_B'Z_VV=*7:*E*.E,99QS,O\TG[NL#[)E JYK "_(79L.K"5
MB)GTM+9^J1$#/C8$?.QITRUC$RSR1T\8-%O 8ONL6N!#VH*BL0%R\#S(IT<Z
M>=!36"H<=.MN!K31.SB(?D>7304,/TS&/D9D)C:$,F(CH,2!#>?$KU '57OE
M8[@)M[]N:C7 W$2%N>7IT9Y-*X21$>U%<YO8'?@ E%H"/^.0B$V(K5.&R_2\
M."[*>]B;8 AZ,VP9$>;%>9.U)9=0S($H08Z:Z$D3V0FJXG(1M'7C!'3L:&^T
MX?IZU11ZQ<1P31"(IB]3ZO.$[XJX,=P)F'&W01.*:]N>"<-O<KFG$ZSX=8BY
M-6"Y;D>GM$.A]5/J)1$81#W +;+3K2#/,(35P-;V'^F,QZ6[?>@<7$RF$5L?
M1&*KAO,TJ[-8.;ISJ>@^%9$EV_=I>L6'M7_3=#HKWM7O2[T PKDTP7E9X?Y?
M;F."N[BB;_!_T?D)<*9P/:VW0O"F!\(/?(&%3 HT?7)EJLTT<3(=58CN]M0W
M=NP6(,4)1B+"QG1))-K=S@2QY<': _V9;-6Q-6L*>5D'?(/R^5M#_#[XTZJE
MMW@0 ?W+QGHO[[0'V8,M \GPD_.2@0!?_[=VIWR)D]_R$XLID*$9/)TN+N([
MH=A?3.5EN"K;XL-0SJI?-Z-W2];!O)AXCWR)6EN/Y/"R,>\0)QO1T4T])HHS
MS.<*YN!95SOU;>,TZ!HQHG] X--LT3K==PYWFZ? ZMJ&JP;-S>9;%/3.T4F/
M4-<!LWC0>;PW% >7PP\'X6]^=LZBY3!*T."F"2KX2/:=U^^3MK5(:BGR*296
MF-D@L97#9'7SP,@1.UAX2P_.[9L4A+F4&(Q$_1,]B6@/^J!-Y+;MV"WA1HZ+
MX*4C%+0N6QRHYLA(7G@.2C\UW*]@\/E)PDZ&4FUO"4O8@+!@/S0-*V$)T6S!
M%E&3IB%4J KSJ0E\HB?\[8;]?CQL.GFVPK#<-&'FE2:JK0C?3T;/LLT0;-]0
M.[7^G'55V+:#:)[['>C")VTSGH=5@F>^&LXO,T8P4VF8KS7!)B#1P$]D:=Z@
M1@%/\6<?S.KXT;.U&_R@J3=(YS41#FP;=MD V/@$T(2C4,SXVLK1_+5&684/
M.'"50#RE+Q">Q9Y'6,FAW^+7%E[]+(WON8VE,3[^@I])52Z==DFMUGR_U8;H
M?GZM<,0LZ:HENO]D"JRYF),Q>1T:'_D)-V$4[\?!7\:^^'+E-'5G\1T<HQ?^
MWL!5>I&B?=^$:>&5*2A,M%L1+M^X)\&XN&I>JPEB-H&6M3K]]E;9X?8]6!+$
M>*>T$X&_AWE<2M-RE_LCZJ<4Y2Y,+?:WB!]63<1U:#=9O.NO]!VI^Q=@3> -
MU_)+'<W0^D/7\X'U_P0TZ.@*FZ\- ];;.22;ZBI<K_8F(1K1O(!L7F!9'S<#
M^: :PE?T=!C*O@V:R7I"FN9"#?6_0E*JV6+JA\- 'NI\],:1O&F.HC!X-P%K
MT]N^Z6FAQ36L0WID*#;T;'3!K8NKOG'2FW1T,+C;ZPKO/QL-\<W)UE6X3:<$
ML371F[#*)AV.UUXTG>QX@WVD)Z@X.A/WIO&&=?F\8[0&!>I!0%T04+WG(*!;
M03TK2)'24BM$7="Z8IP50I0R-[)@C,LJ,S7;1@Y^*\)D[W+%6WK>M4FID 3T
MZ8E?[4,;#L<^I3*VP<EJ$'Q-WZ8UM8S*P:R\3&QQ8=NX+QHCC8.X@T_GJ6T:
M,I+&%/<Z+:93T99>47FMIWT0B%J6\JWXA X!T%(\WM<+8V[N,D3WT1N'#U])
MC[!L"I.]ZFMI*MIT1XNB>=]I'Q@!CTE!AXKCX=A[%'!W'*0EB57F"#7U#T?%
M'NN0&JJB\&5/4-+D$]^./0W6I@!E6P*.)&DP\"4^IE,"CM1FUG=:ZP!58LS=
M=S7\%JV<Z,K\:>>+Z?CA3?!@LBQ[D\G=FOHY#J;XE5DG=9UZE6!:;SK%["4*
MS.M0=XAB?2DO0BV]'\9'T3Y<#7W:K\E)QR-B8HHIYDIE:H2&WV\V._B_830_
M4M"VT09 ]]>SU/B#MBK12V=+7H!1$"/=/KC4&/E^-Z(S<)T0S U_5V@>E!P*
MV7R^I5=O3*6&9JJA8NH2537^>6S7&QB\VHAYD_R?HGTUG'4>>D^QI><XV\:A
MGL570;]]&"N684J3ZTUAJ&6Y^(<Y)9OQ4D\F(Q" 212X!"=X<&BE7WEO[ 5.
MZ8F'OK43]1T-0=F/ U Q27WRG9O(U&2!Q>O:5Y.FJRP>]QBB2GNND:[,A(Y/
MDU6,PEDD?TJE\DCE,9TBLBX\M;T.4CJJR6SY>!->VF-/ANF[H:T2U/Z$?3+)
MU#J8?3B-BRL"\@7?3Y/'B_QGD-UW=C2):JC+EC$V_YI,.^0?6&@%<HD/38Y6
M #>"Y,M18!H;=Y+D,*/XI$:M[;DX;^'0#"_A7PAIX#U<$H]V*B-_8,O.Q:!J
MV-0H@L/N1*\2RX-754TCS4#!$EB7];QM(!;Y\K;A6V/[AA87T1%;K_/7,<Q^
MZ*WRB'+8@&X;8K3T0@UR*_T"7B*A2SN=S=J^]<G+3K_ 7(C'84Q\P0K^/=E]
MS2O'L4/WCE':\ :<I&#2H^2*)SI!C[B>K18DC64H (I0CLFE\FN]>35Q3BTF
M.=4BA3LE8(&'357\,+0(6T>BX1MYWM+F<Z&+G*>[ 0.D[=WJR>B:UB-7F%!,
M"*!NMY*T?R$[M.L.AOAAZA78(42-^/3P+)]96F-V2V\ _@E\R$-..N1,W7$Z
MRQA3=C&SM(23\4CI;U#5G"0-^\ V[E%8>,0_7"7+R>]<YZA'K%."9G6N$3E:
MNDBV7"*SS<TEX2E#^ZXA^6P^?1/GU!*[;"IT\,IM%<*UCN9OF6D\UV1L*AH'
M2?0T6):X$Z@KR& $=P4RX@:J==!A&FNKYI+)W5ZN&Y!G:],^',0&P %,T*[2
M$E]V] ^\HQ)0K@>#!M(837E<;9LJ57U(H/$E KUB(.1!$,UXGGC9.IN=&)(C
M&$IVS!R_]8ET*V:6&[G ]%V<YJ9MA:&4]798F*$!*VP^'&V<8<#H;JL[:?MB
M>H4J&U?@E@*.* )J.!JEZ^-3<+S[I%[^3(;:PVH7O&.73=V.)@G&8^18;BS+
MD.OM&N(K%@$RD38F3:QO-7!#CST)\QQI2B>=;[8F:[A!MM@MB1Q11BX:+%5J
M[)&NPSA+1QQ>S5<I-9_:?O&'V<QBZT\DCD[$IWYRUQY@X\$UK6W4_*JU#G[P
M"8EIY+)O?H_ "]38+?%AN&L/-B_P,B9C0PZC'6?)PE\+A74]JL;J'SQMD "=
MQA[+2--EW%#"KGKT9.P&$:K3;Z P5-93=?OP68I0MFY41&#ZKZ^NRM) [7V"
M9$&8A%QWZ[L"%*%5GY\G6<Z+?-EBV2<3#VX,._7G</8V=!;'?WV7E;%OK\^I
M=K2N7$%,I1WA>983(80AHC"ZJ(PJ6;9.,+MG68EM$9G.9N.QC6WD<;<?N(E\
MDT+MT-''?, $0_A1K46\6T#+Z=77B;3U4WB=A'_LA%Y3Y^K 2;[<ZRCR&M[6
M@L [-R& U"F+N%@,C2^9\K/R$=YPQC^ +^59&R9+4T/N":P1FL4<<^*I#;'[
M 3I%H*2&D^"C@FX:21U"_2W#NW=!7\,*II%]SAJ!H$LK.9PO6F#C)?JDX=5B
MYXR(-)I)9R/YXV@(BV)\?\A&U[VWK5)KPZVQ7?I26TR_BI,(!QVAP=94C^):
MA)L9O[8$H^\L#<;0[*BY&T,\S&T2CKTPO&Z+-?IK:S2;+!68=%ZWN0ZDCHBM
MMK==ER&^&TWT=VX EL[?@[@A( L)AIL4Q-1&4H_4G>)#*OG8RH$U7F!7U!4:
MK$+5IK+&YJHR/-.BEI7BHBZ,*JREA;B%\BZ[]:IYT>""6$-\1;+O[MJ!__WX
M]OVYSJI,NIP1E=6"<&DD447F2&YJ6=JLS&VM'CVNU]L?_[\I<>N;7G<R#:E^
M+W+?A33D9PA$9C*MF#5E)2DOG%29%/ _I:PIU53>QHO6"\3. G'Z] ]^3JDK
MZRJWI*AX3GBF'!%.PMKJ0IJ\9*KDZH:>J1NW4-<FK[+*Y%8*SIV5E2M+7E?"
M<%T7BM[":-AOX=VV,->US;5@I,XHG.F2,3S3EN15J82MK71U#6=ZG<1PPR''
M8^P[$36<AGC(#KIP-A_>Z-RLE_+-9!KYL+;=,DJ.8H':_*;.Z:%/]DXF07<&
MT2[84 ";""?:WL\SNVF"/8[L+C@RL><XLEMQ86N,0U9990P<'\F-@J,DF=-E
MH;)<28/$T0]+Y/AD,IL_=YX-I.>5 N_YXWD.%H H\H)0N%L(M^!""Y;GI-"5
MJ(JJUD)5>TK7^"0VR0CD+@_J#S]9Z=<1LRO=]FCPC 6&L7T6[R#D!M!U]*?M
M "&\.%X"R_B><CXU^-K*A%7;1.;7#FO7\768^H[$,DO<)@=-L-(G<5?S_\__
M//[]^.7+^)T_CX_^?7IZT.F]$ES:/6N[LL?TL7_"78G]LX[&YFF;@GD6((7?
M<2?QM_FY+ H.=XHF69F5H'Y<061E!3$T+V5)C;2XG'NI?M*N>NGO[.O@68,5
M?4B5M#2]);00G-L__Z>\O/KYZ4&#:]T<?P.-(*<^CW,EKZ<3[+4K/^"/]O)J
M-+FV#10W,J"\EE,;4Q1(+0(CRU3;@%&/#O\<JKAW0[/ #"-6)H_>A;3I9'PQ
MP=A9G"!R4H".1,12:S;/]#!@6?Q);7HK>7PS$G?#6H0FTQ@X3#^$Z@BO1P^:
MT4%QIN;%\2\Q#8+:RQ<.I\9$2WU4HFKMS,.V?6&.L)7HPI-K)(AP7&0/L$Z/
M#@1O3>.F@"IN=B-D5]IX$RQ7D\Q=69HECR+^;NVF6$KP>')!TL!E O*FO:@0
M*.*Q&4E^.CF_+LN!S^+&W;Y<1T#LH1[^!5$#<%\]\?">L!;?L?K5]#POM0/'
M5A!9@Z_+L[H@=5DJ0JW4K'"UK.I\3]6OY^0>'&DX><'M>WBH:G2' XM69V)+
M'-K>X&G8ECR+Y.!B.EE<^4\%TNKX&?S$CX-+:^<1ON&& 205(!LJBG,'#!-Z
M/NE$181]V9K^?6!,J>OV4RD+W,ZS>[@30K8+88DJ<K@!]1=>+5!BXAO\&,:=
MMCT!0_\^)+> ]_LA5&H,IS\.DGO?*>1 $M'XK;7FW(/3B6>N](P*RXB12)CJ
M9])Y*RSHGH,"&WK845C?9G);ON-W,+8C3^JV Y@)*><84('%\/QCX26"2>H!
MBRN*'U1=XNZ:WG0U'[]H+N>X"-V)A47X-77XFP7T<APC167B2^YT\^RQNCXR
MGNH0A1O]J]YCQP8+U^?&"0'6L24Y+\!D=HX24?",@+VLM,@RZ:S<5YW=[FBR
MDA]6:7<GM,%>\T>EX<>5TP87A'IM&BET0S<LSR+I(ZHF]>1LL(!W*# ;M, _
M<*>'@6S(4[H$I]NS R%<QJ>VTRF&P5;?HY.-W!@"P)$>M*%69^FC*/2M=K8D
M)ZY/WQQ]/"^5*7DE'=$JHX37ND);S1!)E9)UP5WFZ*/'+!>']=XWUNHW_RZ;
M_XR>BT(K)A'5)#4F%W-%I*D4$36<O;($PYT5CQZ7?(>]WX,&6_WVWV7[C_DY
M:-I2L#(C5<8RPFV5$25T0<HJIXZQBG&9/7K,Z>W]U6YMM/5E;;J7&"+Z!6,&
M3SH!HN>^7.%H;(X3=2/V^/R>??.W[!R,!U6SO"!284L]:PHBN')$5AFMJ655
MP?FWB6OT0D"\% RZ8O#@#OS%%)/@LSEX%X/)5?#=D:HI4AM%R^SR$JD+_(>P
M+'PT#+YEBHDF7GG,X"2Z:P\J"Z,GS[K]^!3+D(<Z6'HX*JKB68C3OGP50?0=
M0'H"@6__V@O\WN'@*-*8!1I 1/8AE+KS9$]#A6SRPROI,S>>!CC%=L.HS<M?
MP9'THS][^>+%-P'G6RHPZA!%8.QV:8^;X/4L%2#-9@MK.MR>^,Z=.,LO(ZG?
MDI?:L]K'80B6^. '0CN/5'.#SX<'^LT_]!OJ_0,_DTYRR\=E1I-9*/'S/-5N
M7=XV#WJV]GH8CYY?+X%SFR9A\(:(2UV)GG@IO<3ZOH^1,VREYW<,X*16OYZK
M:3:<-V0;*QP&\KV<FH:9=]:A&_G"+;\WWS!';1#[E^OV(R]"1?013M;_UY_I
MM5Z&MWKA7XKU?:4;@^3CR4>=G\M,<V=+["E-X7)R5A)!*T:<T=9652:JO'B8
M+N']_G_Q_;_X>*Y+\/>DHL0R6X 0&$:4E8:HG&7692HO,P,&Z>;&XC\/7D_>
M8[GE07,;>HJ462KD\VC\H,*6\HAX!<T:QB%/-A([CJ-&:RN3$_E#0UG4;7FY
M25_NH/P_3UVVMV@LY[JC8A2\D)6IN)&BX$5M:YD[6_'*:LO+0M^D&,<*QL57
M>!'G$&1ZHTA[BN#O4*9/W_Q-SV7-J"NE(+E1(-,E2+<JF$4\5,:YX*4K'?C8
M:S(=>)4/@]45[E;?6B;$[I<J=5MQMSZ;$Q/E<GQ-8GFLWF#IZ>G05Z0=IJ!I
M-[H7GKHD2!TYG4JL>[EN!;$Q [H5CNGJ]NR-L0HS3F_[;/SY2^<NU/"UE=:W
MP$!O<5.^<#=G'T ]DQ_ZA (XFMFYLCQS!76$L1(=3:=0C6L"-W!I::5$4;FU
MKJ$U*Y33>%<S#MJH+JF%90?5!/\KY+XFC</6#\X0Q?*PU=3//:K#SV8N/[3W
MW^"'"*GY,5 G7%XMYDN744Q6^MJOU$T@$1Z\[$"YEXGX&VK5X7BID?+DUFG
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MR\A9TM53E_)MB+<,9Y&J*3"7(.O0AOY=<JD_%U:V--(0(BF?L@4M1T6'E^D
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MS4OKX/]K6=&<,1>EER?I+3\M^=E+[[W;#-DIO,?I&\U.X/]/G_YQSEDM8>_
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M+!9LJZ?DY69QDW_FRZT4SC,1#>!$,)1P(:SE(C$<*LP ?*!9P%Z-/[4_N.C
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MJWKNK7:T^:E7O5EG(6=2:J?@IUZ<&[_YH5NKGDO0V^$PCH;-[83-WJ=LU@>
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MK')2* =T6 @)OBQ5N26J<@BDD1HB4L;Z5V\HQ_<WYRN<4O725=.91"313LF
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ME4,AUJ*<@((($3K$!$Z5*MLK+P 0EKZ]4@#A:0#"QB0S.-C>-<R ZP4P0/(
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M^3 /@);-10O6&/Z$M[OP:W4J6.'6QB\?D*&$";HVI_GHH\ MK>!V5/5O/1[
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M9?PAT\W:DH]F/*X<,SAMC>!"LH7/VR;]ICRC7V^6N!SEC375SF^<_S[]6(_
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M6:F/[<T3OK'[5Y_L%BV9KMBU>J"F.!,AT OQJD(%+SGDV2:;6Y]W\U@308Q
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M1!V^ WGXI5Z!/R<68!V>_V\Q%O"Y%?C,]M.)-!CJ"4%Y/#N CY/(Y8D&@8I
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MKE_KIDOYJR%B&7E3R]'_&^#S7O3=PPX<,-R9N!I3O<L=N 9'L38\?0S( N[
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M1?7LGXT0QO7L*1$^NH"1HC$"(3B%'!<)*::4DY)%.JS:9*4_8G%''J5G/]>
M["&]->ZDHUMT["_=DQ*AS4HV8]Z'%<1YAB7R6$&$IJ.$X(PDY$-BBA B78[0
MB.)35BM>N$'B34'[7PG8SQN([%ZB10>W_;FGL.+3*^_+]3LWY]!?;<ZY[]Z<
MEY",JFUW:N].#T_[@Y'(;1;+<UT@G2QQ$IJ]Z ?=7K]F3TYZW2R7#)<8*SJJ
M'592'UEI*K_V$VAO$%MGM1E7@"6."C/,,0/G+G'ML";: 0@4\*F^4$;3(R\/
MZ\79=5,45J?IK&W1!MQ'X]CCQJ:'^SD\\."H"942DE8#=SKJD?$6N--1X8D5
M4K.J0O&V.O,+Q=4LM?.F]N.HZ8]J/^!W]]<(?8B-%8W09S&7O1]@)C#MUD5C
M]Y#4S_<.J(S,I(01U3G05]HB^(8@ =.BYI1&)MG:!OV57NB;K'67B2R=MEIH
M 'QY)<-9ZV98UP: Z^HM\6?TIYFM@<E2T\?>-*'.A[2 40O0 F:*9"K<^* V
M6MV95=[^:<IUGM,C_FOD#A?NG@;&3S_@'@Z$Y4;QQ& ,M4<\)H$,##M2WAMJ
M-;%:J?LU6YA5-)\J(J7'1 E).!"SR]("U$L1@P4>T _K!%/L:Y'LZ_! .^$$
M-AP>B.:Y^W)"CFN*I"?)TZ!#,&9M@YM[-&6878H?Y[[V*F(!L3OW$-73&("_
M#+>1Z9C,PYK#%!-;(!,[_@(^!&8N<)PK;7*XG@R"P<T>J #ZT"0(%]8VF)P2
MK:^$P#]XFI5Y='Q$E4M:6T3)_X^50U)Y\3=4W*T_:L;O0VEU<%O )QO89J=V
MTHLA)CA*J&6HV<X9ZI^ P8/7EOV^BQNN^5YS !=D*VZ(/T\@AOUE>* #Q3YW
M 3$V<!&(3@SCB&.@*JD8U2*T$%CB=8)'8/GGSN[V0?*2"RDILEX H*6CR#!M
M$+.!:2XU=PG"Q\DL/X0 OQIUJ;"%J2 E\"NXP\YB+XBE7',!UC#LR5)&_85&
M_? @8$H%90;%1!/B%MQ1F[! GGGLM-%>20%.PO2UG6%/KTPEPQQ5;O0PK8?$
MQXLF$GDHVI5(^AS:253G7!_F+G+GV4X_YFYCW<-.E1ZL)I;AF?-1(E!6O_;C
M*'9J=I!Y[H+V\B&OT1H:7MDEN<%5APC?MBM"!&-W^1*[+B=[KVC]%QT-[I2U
M7V0A^X]%R7[5]-;+Q18E^X<32U&R?ZR2_<<B95^D[&=_2D7*ODC9%RG[%]LL
MXB2.P6DFC+/<2&$M592:H#5$22&E(F7_1*5(</XOYWM?]W[N;-;%_J[']?8?
M\-DOI$ZWQ=[Y'T>-KW\T][]NGS4F2I$^_=S?;1SM'V_Q^GFKU3C_=+;7_MS<
MWX7C';>.Z^TMLM?^H[5WO$VF2=ESB;U2+"+.-$%<Y<TBB42D=0H*4R5X[H4]
MK;7Z:FLQ/_@^7D%9YCWO?3EY\?;](P\CQ[)_9"5H<ZR",P7J=7("1>$8XKG
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M8&LDX_)G['UO^CC=1;D$;@7__FZ60KG^^N_=_J#1'>Q%N+B+FR_[Z6_9C4D
M[ ?,8I:,8BA)3<%;<. H>,Y1\$I''T)2C . IRF47^RN&>Z_G"9+\_'1NC1*
M.1M\2M[QP$TT!DM%" Y4<>.X#@_3#7F&?H&5:5X+<XL-3K5!"N>'&-9@90S8
M(,4PD_@HD D*)A$</-/.$!NSQ\KNU!&[T Y9OUVJ;M+$O++21J[R7O$L36,2
MA1E,!9%<$%Z%.W1#\"):6&K^C &=QUYWZ1,LCS*NW2]9HPX+FBR241G$!1"<
MS>KB$FM%&=>)*#J3U_O(RHMB+XMM+X$P'S"1"./<BS1AC P,+!)>:*&#E$J
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M@#M!&$$N,(J2T=IJRJ6@.J-X<O=X0?&JH/BY8H*"XGFA>#PHP,D%J8)'FAM
ML9$!66<",E8E;Q@SA-B,XGDM*I1U@WMA\+>>K78\G?1BW_>:)Q400^_TL);B
MPSJYO(84Q=Q"@XZ#D\[ 1:/A^GAMM#9AL-['LNHY&T%]F0@6B&1!DA01\YH@
M#N,(W&3A1T8L%D1R'DG.6CR:H$KJ<7%Q/:]@H>#ZY7 ]%CXH933QV".CG 3'
M [LLQBJ18(1D<15./<ZX+MU<5Q?7<PL?"JY?#-?C 87SGC@G!/+6&,!U@ODZ
M&86"<8+II$50>FV#31%8+ZL,3UF(=&1[$3G;C_D6VQD%0[&@T7K#ZUIN6(SN
MD#,05C5\O^71^_W:X/W>[:^*SMMS$=;>9(&2QU(13Q"SWF15>(V,-L!:TGD=
MF:"$#F6#)S?:E'YS*P'PI]>N+0!_3H"/11I&, 5NB$+8BHAX# $9GS1*P7O&
M$M6!IUR!^)B6+P7?BXOO.409!=\+A._QB(,&[GR$B$,:ZQ"G(:&\,HFD%UPZ
MB@,W!"9P.B5%^"( ?P7+%SLI-7WLW8@TRJK%HJU:C$:I$-*C",E/1!01)V^4
M]"B0+!PMI$26)H=@,"6+21FCU=J&6JA"RY+:7)$EBP+J.8%Z+(J@/LC@940,
M2XPXIP2\#(Q1#. 9."J%UFS1\IH%U"NR7E% /1]03X0.*8)GA2W"A 3$M5'(
M,FL0M]JXH)GSDF=03^IXE<6*)X3D[T>V<YBW3><MTY56^^M:GEC W1##(=GN
M;'7@FF(HF@X/(:##B5"!\^@I51H)9W)+6AJ0RU04O,$T>0K.1=D*L>H0?J:M
M$ 7"\X'PQ#X(QHPP'N46TH@[JY ./J'H2#32$Q$<S3[$O'3Z"H3+&D,!\YS
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M=KD7[=UB$&L B4'E\4J@RAZ3X@_&+WF:]T1$8 JX P:9%PDOV]INU3%,PF0
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M\V@2>G>_FH=[:>?[WH%U^ U^_WWRZ_L>2XX_??]UU#WI'/T$K'1V<'/X[=
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MNK3L5T=9,NH?*%NN=6]08/PUIH0C]@,@*@8@M-(%Z(<"H-@-_L)[ A*.K$>
M:_#H7CH"($+Z(FC.L:Q;#I9$PF="ZNDN='-IL<Z@TC'Q\JWEUFR9P.9F_;>Z
MZ:^,7E^;?SR-4;;(Z\?7Q6U;-JZ#1"73_W[AA3!Y*HX1)A#/:J I#9"RMFB:
M),DXW)<*JP#A*Y("&A(T*> CL&$JCK[0& '"+:4;5FXY]@NL-%I9PPAQ6EN^
MVXS=)R]G]V\3-6+3QW>OX$.;%&%=;2&(2#F9 K20G'FT1!G".!@-3WK]*I@
MS_994D478#P$QYN[%&8H[*H9[Z4#$$I@3<_!UA7!5N*[6C7X;C,(U=H,0AWI
M1" ^C(456UF,O 1]/@RZ&V3UC@L* _--2B(PQ$ UY453.HT+)TET0)(IJW/O
ML/EJ@;0M-?_08IE!\^MOSBX.LB*:97E_B%-JJV2>CV+6(T8^"F#2B(JUCX4_
M(<FP"+6H-P/B1+H,VMKB@T-/U1#X57KK,D_Q39T!+!)L,.!VC+*JO5@]P%#U
MGW!W(VQ#]+<5XFKHY1#Q1&A\L/Q*^)W*02K>&Q=YMWH#*,%4N##N,6P1*8P.
M( PX3HIHT$5"EE@2.^T.RHJHDRXZQ/B8D,*G%K 58#F/%E/X\!J+V$+:!*$H
M%JA(RE]R=88TW$W*AHCNTAL--SGD-5.A15Y4S"2M<UISF APQ)$FB\ZWK?TS
MOX+'%F)4)9^Y[4*&_\I@H;684RG6*_?!K"6L-EWDLP( R3'8#!02C&SH:X(]
MK9P9(BJ\:2.4-.87 RK0#H8+L &ZPT!4#"XZ8B4XCBR3?DCAK( E;&LC"TPZ
M;#$83;Y+@.D20^.2LE,C\=K%+/YF_+\#C'-;>-4:H<1=D! WZR]4&LO3 < P
M*+FT1N*"=OE57OS20+3BM/J=VD,M9RO"G?LI7#YIQNKXQ85PF6H?AX]Y30S3
MDKIB^.PJR;DW$%LP2B[=S;M 8WTNV.04-RP7T3K'Q07-*B@PI+0S8'9V!=P@
M[BH%&\Y\6:LB59CF[O'IL3#E*D<?G^U;0]UR#XYI>,60AT$IE:7T_W7'5WF&
MNVMQ$D-/;\/I)09:-R:14ZZZDYAM;;_(RGZEIFFW]TX[!\!VT=(^?_[2JE[+
M.&(RZ32_2$J9DB%V)&H"O#C!*!X</"SQ0'C&-72:E_WZ!*7V:MQO-K>-OXX:
M2AI5SU!R)-GZ\Y40<6*]0LXS/&.H3I"2^ZY0%:DF8&]>BK,-D1Z38."15@7G
M2T+"U]7J H%ZY>X0+A4A_"ILAMG<OU O]//IZUOW)'OE5!TZ5?VE.%4#8QE.
M5<?>6*=J[4&-0?6,Q-?)2'Q]D>*K$2_Q$<37@C(#I[HJH2$1SVD_CWYU\I2A
MI[1V#WZH?95[M;&+?QSQ < C$!!P09*748*X&9#D01:MDXR<O8_'/<!9J#%F
MN,+SE^H*'Q9^&3!1+^.V'1J>"3Q47VHC51G6X />)23Z"-O*X(+))18O)^]F
M@K5*QR\5CFE-)/9:/!=0V'"X?X@@ %0]N22+UJU+5SU!PNP_AK =E1TZD=)T
M9#=5B2-PXP@V+7/!IZ8RBOA97U'SK<I];=)J:Y;_31S"]$$*"<NKVN1*P%;+
MWQ2T>(15XGLJ@?7ZKTRPP2E:KN4?VNLONSO''_YH#1,NL>::H+Z0IN*M0*_H
MS*G>5+]BSC8(\8A1OJWZN$4\:^S!#:,971@9V&8CUT+!.U@S3) $_M""RT?2
M5_"(^TYD06$ZD[B+EATM3O,K("AA0F(R4C7:/G;HK8)=*VNI2BQ#)<5FD5$M
MW^NA@R5;G;Q(]ZE0=7(B=19U%< @'T'0JUJ(T"/$Y(-,EH 2P0R5?!5NA3Q;
MF"Q7IQ$^"#\%KFJM&]9HR'.!?DVD0W'>O=7GT'0Q/$@BR7@PX8P;&9ES T06
M?W"SM#0^"D6!F!C^N)R3[+9V+*BZ6A%Y,)H(CTY%QC+!>@@,^C.6=_$9#66T
M\!*CE&MK*/D*= [/-G*;9O!0  JA)=._Q0G+6+1@TX:>S%1LBK YPO6O]FE;
MBSG#TQ59BD 6^D[IU0C]C4)F&T&!,-)!.JY]3T?WXQ7#N,6&,JX?*>:T5C)A
MKJ;"7%99WF&XCXNK*CG-,W&R/?JUVD-I-U]Q48&O+I2'495RU<6;,'0R%&>P
M,P\W:(A!8U<=+B(%'L+05\)LKP',7/RR**!?(:HX;FQ/)4ODTDFY)>,ZQ"8(
ME\8]A%.K$G7#P(JA?[QQRG,%YK$0>_P:6!@=ZH"!YT643L7,-<7Q7.$YAOKD
MD.!O'$VK23[X,.'?K^)'QH+MKB3R29@0,J,SVCIS6YPNX"I%>$3Q#8])4\P5
M'WD+Y1I7YSOE>-!H.-2A#3"]_L:@J,,E3_5P'3\W3AF$H;\IH5([]=G  ]39
MV-%9,ZY]@R*2VMJC5FCQ2";MM?D'LNN"T36MF>$UK67$U]2B9&3U5 OP#BSG
M/V[?W'6/ 9D?_S$^U0>%@XB'S(L%F5I+_/6U=<=Z+BU4H34C5J$QG"%M+R5V
MX04X'#[<'470N@>CU\??U2Z-3K['C\E!FJ1E+M)S?O)H2#-(<*,8?_QF7/,#
MIU056Z3Y+KFJ$7@P#D&& >HXJI +!P.,N3X^;@101%7"7Y*-"K245>7G*GZ=
M<<P"E)5?AJ$/HU2#6J+E8Z@"7RRJSB2B;M,]U/UT^!,0B*P7,SR1$57R,<@!
MPRW>UA_>(76G].9MDHGM%C>]&W^!TYNJD"].$>3/U?F$1=J&8^(11=4UI7IQ
M=7K1%J<7$T7_Y6^!WPZ,^3\;;7/XVQU=61[:?&5V9<G5\)E8B3?E&WGLJS5.
M?/' =^*\9TY[@C5$3#/K^4T1^&K&-MLE=]>1J#B;VXXCT6 Y1Z+6^N69K$5V
M\8=URRX6?3? 7!MFIJY]7O'#RI,.NS5\EL4%A8+^Q+N,@N+<0;,"T<,741SR
M  -N=H>Q8?))B$(P=?8ZZ4KKP;&<%LQ4NRARC':K"E5QWJ@6V1K5@KRIBE%&
M22K*\XLZDL-!?2DXP" $XB(*T'3:'M%I-*I.F>8R+1@P!S9.TO;9!;_*<Z9]
MP!3 W7Q0P QG"EX-F-0R&F]"[PF>C=0>AQHX26L \>LP44?.HC(/&E.113#Q
M 7.+8$I_ISPB 2PE@PB'\VQ4WDL3F;*(U2[E(<P5F#VX#V5K!*/JFD_#!U25
M.2NW%-Y3EY83OPU]6/!<T<EW<O>(;<S>/;%2D@X:ISWEJ#AP;VE#".804&,(
M1/J_AR=_XS68P#Z3Z4""XONY'G*]65QWO!SJL+*IL%JJ$4Z,R23FO#%-H&E9
M]&<JV%"P5UL['5T<52;["#_/N:LU+/!;652B_*"T=PL12!4/2BPW-%''M2;I
MA:VJU<FNL\Z,FI2"D2J*0Y>1+/]:U0! ;X4F35HJ>F9IAX+?B!1]UHBQJP?L
M-A^_)Z)K:R*^[<UD@3</Q:Z$38[D:;%WDJ'EOF5#;A7EPZ;HWK2J$U<<ER?K
M/):M>G2"G;*[IC3(4F'WB;*=0LC $]-$)%[+]<#24()Y)-\ =TJ^J<ZN^KQ:
M%+P. R=B%'B-LD>:" ^5A2>;Q\;UH$0UCFKI:FDFBEC*PS[3J"8V4:)T[IS&
M'CACQJ/:IBE0^L>QA\XHB]J08:+MT' N/7HS+"Y:#V986--M ^]C+/PX_XOJ
MBT@'8_OX/V;;'G8$$ 'T..%:RM N^IGDHT&S%()*8)VMOXEK1;JZ\!:,-FOA
M29%6?50_/=!;ISK:*C3UTV%:ZQT/DGZN'DW8$!342S=42'61#W0\";H3;Q+B
M3""3$2X1I2O070!J+^F/1C)Z'QN,BK\.7]"H@)A2$(=BM6LO5<UQ<B'A_]9>
M%(I"V)<TD@<Y"$3J#J6W(!%<99-X/@"@%# .\'ZNG7":WH%]KN3I7B8$6XDM
M!:O-JHII)R^A.L99LW0#GB9$1=)K>BJ'#LBQ8MI2/(-P'\69@-)%EYZL?]Z_
M0:X4:=XBAZ=BB7B0XH.N^V// 5T"<KHG3B(:9=)#='.FTGV-U3BN.TF85%6X
M&\@)KA''IS6H.]W?5='(P_T-C.68WN[ZF=ZK:]SR9>?D3)K>!P<'#RY>%@0O
MHWB9::R;>V%O5*AAJOZ#!("[P]X%GQ .B+.\M5=>![-JD=5%=Q+8CZ%<K,RL
M46FR^MS\4A@NUS<RTG+8004O$5&"LJZT=@BV5V5A-L/,6U4LDQ2[S58I)\,@
MHXHF[)TQB5N7-8.)R L8"(+;<I).9Y0NP]C+:MOJ%)\Q+;+^VG08]LUR>2X*
M.\6$EX?#\D1U/3H,X^)E78UM3B&3UNU53&21M3H_30:8Y!4+M)JE3,8[@(+(
M%@=BTF8<&QO&%5S2))5GH?TJ:FV:CS \K8D0#K)+7HJS5E0(=9S=%0]!5XH'
M75U=M;-A%'<;3#(!94?@J:ZT5WN-*! ND^?/_5S8"%<4'3JE2-]M#8U_<89;
M-@M43$RICM )8?##$56D&HO:+X,R$6=]@E['C2IAR]89NL,AC4;3;CHX\7&B
M,X(T:2(\;9>YK)T"<U-;8XL"2RV.+:E(8&G5.<WXW1@3(+JO\E@KSAU%6W[$
M^#33T/_UX/*9\+\7HH',==- (V[%N$Z>E??Q<J^R>(#2,/?4,(NRTF(]V%?/
M2F3=6*D*5K[1CJ\RH)"J[N1N)>)ENW:I_L3O0E8>CD?[G%1' @U*@TO0([)H
M05O%DAO(DOX+84EKW5BR9KZ31C'8<HS3SAJQAJVJ<+E$G(ULW(5-+L5]F\=]
MIOE"N,]>-^[[,O14-U/7:P/N% MA1@M7:E>L]8)8:VN=U.8RG-3PM7)2CSNI
MM8-_/UR SVR<+CJB =E@QZ:WLL?!S;MUDNH8YK1F GU?GER!0!KY\D82[33J
M<(;9G&LDT6?/XS6M2G7MY=&@2ORI#^@J5Y;6+!"_]@YWD-R?JT;,,W:F\I*.
MG()XAM_,CAZ!"']BZHO61U[=U)^V>L[JYK7;K/GPH2HF<2J+2=Q696Q80N)E
MS?!TK*K%P:BJQ>Y858OJASKZHPI(&BM&,5ET#=>B6A0S>,F+<CI9R<-[I^V+
M2A[;N1Z[6+GD(U8NV>#Y'XGZ*</2"XW%F"7HUWXZ9*2H\-!O%HPH:QB!R6[I
MZ$^AM7)1N8D-<]!@562N93;6B&T8YCBTUR9LFK*#I3.K\-I9*XD/D+5K1+F9
M?K[^9[;6:&UKH#9FKXZTO&N8>-6D]7BJ_PLL0"X; &FOPPHDA1QX;'KZ*X)N
MX1_#V3T5/+Y/P%D-J7B]XB(^<@),RHJ533-Z+*:L<3BZ(.K"I#QG!:F-8$>V
M#6E+WC>WT6L3RUHHM?%^OP$M/^C.6_,PVZ[EO9"Q>GZ;$'\%.:- @\L6=,%=
M(@!(3PZ+844 (;K>BB(L>-70/AUR3[4@M\S5P)F^6NC2]5F6V9FR4EBKN6\2
ML:M=57-_N10]>V96V]S.+=T;Y22\78,5N W"Q_%3+<-MZOL?=*9SOH+6[U8]
M/JT#D/W_O>KT^[WR[9LW& P*PVQ?Y)=O=HJH@\UEWG!V08LW8*#3-X%IVY[S
M!D9K.J[M!(;I&\3U;?M-%B;7,#O+_!&8[4Z_*^,4DECT-J[=7])4$.5W,&VD
M*YP:_WA#)T]M-D@R;+.\/ZFMP740#2N8_\%<Z[B?UP:_!JICHI#RL.[45]DX
M(KV9$5C\M3+(X:NC_%)6+';0$6CZLQ3LQ.FU=)8M;2/6Z](-D1Q6FVPGVRA,
ML:68PI ?B8F?+5=B"CS@,"S+K&9G_2 27GRXP>K+CP,/3R.,UIV_E%I>2"V3
M";7\?Q96R(?T1NIB8FZBL;O-D%;-?1,IVE;N&P6UM@MJ^8%O6X8>N+J! ,MO
M]Z]A1X4RPS"4O-L%12:B<[2&(T?Y:C95$BA0> LHG.6<D=&858'V4:1/C0A/
M=5-[/7;-4=[6+,O2#<OTR!^;J$:WF7_4W#>1HFWE@U/ <*N H6D&EDD<TS,=
MVPR"-\P*#-<T&+^VJW.] Y&-,"AXJ^IY*"/W#VE589V(4PBOA5H40Y)#WK_"
M_MICK2+A>]%4[0/-?FE'8O284EF6>92,3@C/BD'9YPIU;JR84:AS 5>D/?^$
M<+>JGSGACO3U?XU[(RN>5">#&R$Q[+:UG>RB4(E)UAN5W#Z^"I4,S_5,,CS7
MLRV)+CZ*NN^G@UXO%08UH((Y@&/8J)F08;]OA3@4XE!SWT8[W=[.+54:4=GI
M$W9Z4 ?@UH<YF&Z+27C8N"<;-E>>-"5(FSA_PVQ<L;&8@"?3=+$Q 6A76ZG$
M394AR@A?P @/ F6%*RM\'',XV\DO"G-L*^:0.3\$/EJ>9]4Y/[;]P[,EY-@;
M;U$S%D8R+CQ5X*Y2U$_D+;?GZ>GY5?I'>GK8\,YKC5><VB#-M<U@5\U]$RF:
MF"J"5X&Q%PS&9AV)P!\259T.PC)A"2VP+]$R8=2Z$[<2UFKNFT711%4*48IJ
MXQ2559?\R+-2!,'?NW"QTF*;R?5J[INHQ2QE;BDMMFE:S#*G"E?5;NS9/6#'
MN]9@.>>Z91C535M$G)D.PX^](N\.T@OAMQ1CD;UL9&\]-.KVKZ,.S2XX*$:A
M/<W 4@?N&RM$U-PW5"FJ9#&E%#=-*9);E>)4__.7IA1E:[6U826E&M3<-TPM
MDK___>_;N:E*+VZN7IRE%LO;C$71]VL!G6GZ4A9@LM(NMJZ)&JU0+<>0I9-9
MWNM/]$T=NS(PW/JD\)06(<UXJ1]?I_RF5J;$,(BR,#=5\JBY;Z(J-0VS?7!T
MNIW;NF;*= 4K<" :76G_^7#R63O(RK[HGEEW>VUK(LS1?"=D?E+_S*J?X0.,
MHVHHQVE1MXD[0.L'="YJJCW:IZ"<4C[L1(>]O\3K^O1"=@'#C%N&G0BK)MSR
M&:-QU>]K3_/?&]&AZ_UT_Z]GZZ@]LSWRVK39)A.JN/'OZAMFJ^9LJCG;%C1G
M4VA*S7U;D.3I[C^W<UL5DFPBMC-ZG6=Y]T;;O^YC0W+,UXHZO$M'T'(3.4#)
M-37WS:)HE.F[.Y^W<UN53+]#IN_2-*H:HVN?D^Q72$NN)/RF$H.:^R92-$KX
MO?V/V[FM2L+?(>'W>)QDB1+P6T$+:NZ;2-$HX#_O?-C.;54"_@X!_YF&/%6R
M?>/)0,U]$RD:9?N7D_WMW%8EV^^0[5]D<5;EG]D.:E!SWT2*-@U5A7Q+Q?MN
M#B/1OM"+>2%UK^.\Z-)^U;ZBJ0TPD@ZC\E*8!X96]6OMP(?:(<GDW?@Y@K%0
MN)EA"%]=]!# Q0(=)4WGH>LJ8[+NR"%XY/J*![Y-^O#&Z,X5ORVK8!>#T,+J
M!Q%W_SF)8"6YMG-1<-%5I*P7:PVF\NK]B&?N",)W7QQ?W%O1;=R$MKQ*MFFT
M397_M19J4>5_/5MW=?F1F/C9<M\,,\@,:YA!AOZ JFA64UT-5535Z^K/ > $
MTQ&= XRI#E<[(6IF"3FRNJ?5Y\$U[X;YH+C03MNT7;33MKAIK!U6J=$NEN<2
M18]W!A>#LB]%FV6*=YDJ.6Q3Q9(J([Y &7'46Q.U5O]/J7T=T )8+;V9443\
MZWBS#T<VI=M$.W>;F4?-?1,I&KB=*)2J4*I"J5,HE33[LNX@9A3H%%3E GX6
M=("!2I3X4JNAY=P&K;? V2::5=!T4V61@J:+05.BH*EB'C7W+8&FEH*F"IHJ
M:#H%3:U9#M39.%0Z4P\IO'7,S>D,L>AATB\'85)V$NV,9C3DVI<.+;H45*S4
MR/7#5?>=+9 \"H@N!D0M!405\ZBY;PD0M14054!4 =$I(%IUOYX'.^N>PE5I
M5@$\O2'P_'"P\[FNW?<%]"5/J;SP?VFW]T[;W6EII^V=J2-\A3TW5=@H[+D8
M]ISL\ZVPIV(>-?=-Q9Z.@I[KH \4]'PNZ&DZKNT$AAD8!K&(+Z$GOS8-YX=/
MR'U=GW_2#"&H1GP!/X,A_/QW?D,O>*&==7A!>WP 6UZV--#!"G%NC8Q1B',Q
MQ.E,($YAMGGO2FTG ^Y*9X#.?XU 9VT%:I[DP$W4T]O,1&KNFTC1P/7N=NZI
M IX*>(X#3_>'72<MG?;SZ)?V90 /H@IM*F6AT.;RT::KT*9B(C7W+4.;WG;N
MJ4*;"FV.HTT/T*8AT>9!!K?W\T+A3*4F%,Y<-L[T%,Y43*3FOF4XT]_./54X
M<^MQ)G%=@XQPIOG#JYR:H^SVH[RMF8OFN#<+-=GK@T-E-^.U8;QM5B0*B3ZL
MXM(0B2X8U_GG *X@P7PD6L^[&ITE.UH_2?W&E5^Z.5 E4&DG"JQL%5BITTX$
M?9G^,.W$,%S+F,Q_WK^.TD&)Y:9OQR9$1+P;0VQR1G]Q1JLTYTA@$[#VZWH\
MGY-N(JI5+Q.F/(W86W<V5NK_8<G$]U7_=9DI2>=*_V^*_C<-!0"V%0"89+T!
MP.WCJP# ,&O4),WZS\9]@_B/\DO>#7FA$:G+1Y7T_LE[?5K A)J.AF7H\"WI
M&;'_WT'2O]&^I/ ZL5PG/)6E"U]XRXB7)_.VV5&DYO[DIRU/*(WNQ#'FD\@0
MI^T[B]BIO;P4[:'?%BC;P%Y\!ROR5K?:)MX^*;UIR:5H_+\S1,W6$*4"8%OJ
M@3'-P#*)8WJF;[J>\899KN7[A/'K(*B.BX[XH,B!.C*N?4CR,DK0I*U/=T2=
MXPI5P!< (-!!@_BBU6B^H8*/-E5P*)_/ CZ?()A_Y+,[* JT?"8\/GXS^ CK
M>%B&..[Q-S%,8YL92,U]$0>FL?$>S#=][(I9JT?X9V()/ )+.@UMKQ+6[U3+
MV;Q+>B7>&J-;:%CFZ: __Y8Q8%,.NEU:W$P'6BR;4DSC+E(A.-# FL /C7\[
MQ6AY+[@>%IS^TFD,@WU+TRMZ4[YZ,S;1;I+IS56=7! YP_?_"(LWDZAE<G-@
MC2[@:6A@.))$16_3X284 -#T"!U?O9*_K3^\8TG92^G-VT3T1]7%3>^J9U4[
M-\-6$7LA?QZ-N6W(<5=:H'IS]7-;_%33X]AO7IM8UMQ?P8A[X&^N\; [;QMK
MT'8M[X6,U?/;A/@+/7;3S'ZBS/X7IH"5V;_E9K]#C,!PK#<LL.S <)MFOS!#
MP&B1*?#'@DBT3P458:.P=UR<'U3?CTYPXKS0!B77Q""%Q?-P_P$\OQ[%"2_[
M11*AE24']%<&AM74<&9?]@2C4QZ-396)RJ/Q#!X-&:DE6U,HC\9F$9":^T8?
M[ED*Y;\PHE0H?\M1OF_8Q OL-PS@ON=X3*2#>0N<[AUD;!!)Y*R.]+9%7"@
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MF$GO38B)YK]ASF[@/YU^-WW__P-02P,$%     @ 98E+5,GX)N$@$P  U;X
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M!ILM:V^C,CL6'*>3"W;L6$CJ1G'E&A-Q]2A3_QX=&86M9@?5KGGU/S66GG%
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M-#=0R^35R'RF"2TA(RHKMMH\F;(0X,OG%=IL5)'1C3F,Z84-& TE_'M-G\F
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M".)U37$8@\>D$*=E9$V8?VY9.!X2/DUM<(F1LA T 7BY&'UY72.^9:!ZB%]
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MQE>V*3]"K>#2$H_K+1R;XYL5J/<;4R%5Y.KU_#B2W"!"VQ+WIH+*&GB;*V5
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M!5.3@8YSBET"J3<E9(K":&7['+RX#=60>DH^"'?V$-*A#T]KBR9IZR"I>IN
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M 8$N@>8ERLM[.[MIJ.L?N^,%[M\-1SH+H+?>.8-U>M)^Q(+S/F5.H 2!DDH
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M^C@9QG_B%'P_FDDD_=U?3.$#C#Z>X[3L,<>D9A2(C!QM/:K0UO-H]4%V- 7
M^<YM$P)UP_?D:=- #??)PNJ2909I?#:=G ]'A=,]%J+TCG,2-4>((("X4+[(
M:(4QPNNR2S0GR2JN9T:.O<1^GQ2\!2G>CL=31.8%."M191X4(]*:2())0*S)
MD4+4P$(X&"'FF)XE&780]WTBB!9$>#^=% >ZG$GTP ON. .BC7$(3^-.%W"G
M\URQ9&24.;8QP!X!]BPIL:O@[_-"[LN+U\/+R^'@X8U-*JZ"\(90HQ$BN$""
M+1 5$P Y)69E$VYT /?D^5%; ?<YHBIRY-[^)E*B"KPD5"(JJ4,FCDM#@L*U
MCL<81.*MN?'L;(I: K_/!5V="XOM+7%&M9::9.L++.IQHQ.1H =%K:#14]G&
MFM@ Z/EQ8 =!W]>_J:[_VWN9!:>]3Y0H)REZ0$R0XC\3ZT7,*G+MK3@,"9Z3
M!5%-Y/?I8/>EP_50/Y5CE1[WGNID+&'2*2*9*KP4FD3OG5#.4,BL[3'>#$=%
ME=^Z@6FNZ#V$N>X\X8?Y>?I?XL5P#.FO/TY&4[AY<3B8P+?)+Q>S!_[UQS%\
M+M_LRX>W@Z\PGLS&@']Q]JT_[N6<T(K%#<NATT,D-Y)8FP.A(F6T:R03S#7A
MQ'TL%7GQP"W8 SS90;'#J@)N<.YT%]%K'.GG8JK,KE9_G:V4G1#V5F[F&E)A
M'<::N\2FR\;[Q-A7FP^2HYHJCD.: ,;JH +)P>)*:D,Y-&.6))MLSIK3F-I<
MBQR++'=N>D^!*]MHH %'/J++,_D$H\L;J.,%,A==<C%%$L!G(KU6Q"J5B84H
M C5E-6USX[$9T^'-S-H:7+5&ZHB_XK58N7[OO1L./J]'%=$K<A3W46 !!ZMS
M(L%135*0Z!-KD71:.<*\?Y__\".>C8XK2G+CQ/_WGU:DA$;R/^O$<%S;4^.W
M WP#H"^$3M*7$9R7M?0KS%_=-YZCXU.JQW;L,KJ5. \F$W-:0'*<RLBIE9[S
M\@*JCF9F>CL\KWK,AV5:JVP54>@FX>ZE@%CF$S&29H\^%.6VL;/XKE;,Q^_P
M%093&)^%\63DXZ3GE*/,.]R/M4LX@]#$M]IP@@9_L JT%K:-\;**Y"1./[;1
M].HVM)=H&\1D+/"\P7'C))I!^D=_<OYZ.I[@+!G]\BU>3,O)S-EX#/C_],E_
MZPGF&4(4)"K$+5U&R(I3PA*W5B7.I&QS][X#V,,39C\-KZ=+,_4TL'/??X$1
M;NB#S[]\^X(K[BU!**,#$\H1#<P3R0R0P'"3-Y'QJ+CE(M$FO-D(Z<DO)W6$
M79$%,U.L1)R]SR4D;=SSX(2S5I#,I"8R4C2^%)IWRAKO,V,A4=W)C+WUH8=7
M6R4Y#RL(J;:R?H<QX*>=GPW2S[C:7 R_%'HNQGF]P*Q_5UEV)F?Q?Z;]$:3W
MDW,8?3KW@T_GH^'T\_FKZ1@Y/AZC]17Z@YF-_X]1?X*6W?N<>YY!\!+7)N&"
M0]:S2- /8\1+21/*#KB6G7AQ'/S/@H)/0/4-@LBJCT<;R[.,FN0D#9'>>.(L
M!>)9<"G@SD]I&\O_.ZDW64U'U'"#:+>/<(&_^OPW&*"T+G!49^D255,D-4&/
M=B&['C7>HK5G" 5GB139HR&A&='1>\B.L]3HOKH;ON?"K@;::! )=V_L/:LE
MT*PT$4#1^^!H:5B%RHPF@4XB^>C;+%/WH#P7)NPGXP:A;=> YH=<[X;C<8\R
M9Y5&-,DP1:32.$"O-5$4)'J$+K#0)A1V#9CGXV_M*. &YLQOP\'P+JH%&Z\I
M'K..RBLTL+011.9$23!!DJQM4)8KFFD;O_M1:$^>#W6%W\!T>#N8P C&2Z.^
M%SQ#(-818\L=:W::!(DVC14I<I.,THULA!4@A]=\957=NW_>7<X-#N%^02MW
M<G63#/CFZV_]/P8C\!<EZO9O**_9TI6H@.15R=U0L[(*DGCTP$CF60!P'[-I
MPX9N^)X;21IHI<&&4G","Q 8OQ_\\JV(8MH?GY=%\WTN.:8] RXQPP.)/J,#
M;Y(O5^<H"&4=8@P&8AO:/ KMN3&FKBXJ[B^S\Z.;J_;YR-$7FOG5O\&DY[U*
MSDA+(J.I)'DX]):U0]-(1B2WR]*OQ+1L.-][X"'/1=M5A=G E]PXZE[*(8@0
M+$&#B:'MZP3QKA2-H3HQ%Z5BO,W%\$9(SX43=67?P->\\8"6MY/]P11!+ERD
MX6#\"O)PM(BW^.2_P1@7L)''Y_<'?G0U,[YQ="5T&\5],1O?W(CJ"2V3R>B*
M"Z.0[\$K')H-Z)D;X2&;D%=CGZI9J<T&]>1]G5-1>(,%[AKR8FZ]@@'J9])C
M4K*DT79'1( 3EW'B@$;B3&)>TG(OUR;280.@9\*A_03=8"W#/?;6@8ZPB5K0
MF61:;F,%8X@#&('(G7!:>Z':')3>@?'D=;V[4!LD>LY,J35Q@#?NUW\.+\IM
MY](+>S^X54IGU!_CKW[&'P>?/\"H/TPXN/>Y1-O8@,Z]]:P$E^+*)3,N6MHH
M@H/-R&6C</UJ<[S::$1/GG<GH>HVN:JK0[J&%H31.@-.+!UEN7>0Q&F?"94V
M964\];[-1O4 J"=/I%H";Y"H^HL?#9"@XV5-A5+?*_9P3"YPX8BCP2,R;TE0
MU!'M70S4)R-R&Q:LA?/D];^_D.]KWM76_,_]B^D$4L\HGI27"BUH7I(<;"8^
M>D-R<"*+2%-V;2I7; #T[+2_BZ#7G.SO';']#RAUDB&=?46WZS/\-BU2>9_O
MY=+/V:IRHB9I3HH;57+J- E4)/2NLM+<4[#,-*'%5C"?/%G:*64-A?:^'=J
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M[,D3]*14WR!R]"S&X;1$PG[^6(PM/TKC/[X4[^"7XEB,^S@SW_7'DYZ)QB)
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M7?H]6^*DLH2:+%0I5>P;G2<]CNWE\*BRGM90:>_#Z0WY>#TN! U1!)*,1X^
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M4)\R#@.];B9P@ G]Y6"!:!6T<B$!Y_6.ZN\^^[!'#964,:PBR<J[>Z?^) %
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MF]ZO:^$<.OK]5"@RK*VJ!D'0]X7AUX]_64JT ]RF(?-; CY.)'T%5:\V9CR
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M#*03@$9H0.<CXAA==I+8P)U@G%N<50<8Z VBPZ]P-3BPNI)5D7<#9^\#3G&
M-'Z#4K@UV0K<'OJ<%%0$HB-#:#A!2Z=0(#RB/V)X4-RU<?D> /4\V%!+Z@W,
MH+O#?5N./& \^=U/X.,$OZ0/Z"SC+_QGZ!E0.4LOB2XUQ*6GZ+F&J)"Z3%/&
MC5"I35Q7=XS/@RZ-=-+ X[^+].84+=U:\4)TN+@921)E"%'04I:91P)>Q6B3
MIHH>@C9KP3U'ONROA0:9X@AJ43O^?9XM>TPZG4!1="U]"<(.@5AE)<F,4R,Y
M"D&TL3M6D3P/"NPEWXKY<+.C[NM3T_=Y>5QZ]7IX^64X*,O9Y26D/BYC%U>O
M *UY^.7;I#_X/.V/SPO^GD]&91: &(%?).,)!6!P"![=N^"I!Z<?<Y?V1O&T
M27%8)31(:+@KC%MAB;/$X%Z02.W,-&$ '#%Y1@((2;A'M,Q:(5.;2O@/XWK:
MI&D@^P8UK\_2?T\7;48^#6_.!3[X?GH[>.V_]"?^8EZ5YYKK[_.*R?UQ&L:S
MFH"36Y_6,S2&H"(G04 D$ITTW"!C((Q*'I@P0MLV0:/-AO0\^'@:&K]/9;/7
M%OG:CT97Y<)P9IVM6Z+/)A]A,ID'EO4<#4;$H E50A!I$B<>4:(Q9U2PL=2;
ME)TVQ>V>^[09U%K0]SEA]UW>2B^;<6EF ^/W@[M[\L*N TJ32S$2-.UQ_4U.
ME][Q"#6+1"T$EV.;AA&/0GO:9&FC@?L4<75MHUL+W2=4]_A\>''K>.!]_C@9
MQG]^&/4C?!KU/W\NY6F3= DB(UFE6:J9(%Z)1!Q/4F=KHSS(@>_6P)\'O0ZI
MO36GA7N?'V_$?Q^J$ ;*7"DUHPS.#I913!'%Y*)1U&L939OV"]TQ/G-.[:>3
M-?2I?-J\COZ?1C[AFONSOQKWM  3M#:$>9!HH*%D'$A)@HZ@0D !'>02[A&8
MSYQ$>VMF#8\JGSNO0XNOC2%.2R#!+>"L%Q2ZK(FAO:\2(U)F($&AO:>U<S@@
M8?EJY.K!.+4!\DOA5PV-K>':SD?7,_<!5\]!['_Q%PO_83!'7D*LRGU,SQLN
MA1*9"'"N=-C-Z"\82C0$)3FUTN5N57@>>=#3)D%U4:[1\WY'UK^B/"^GE[>-
MKP4)Y_OG\)T?EYN5X6@"Z:._@-G+/9\X@D,R&L"M5+I2,1PU2Y*1W',$S58[
M9&]0_V[/?P:L.(#@UY!EYQ/J&>9;R]//TQ+G_7[>A["('@?2'Z8>AS+N;$E,
M)B ^)8DKV2'2H;EN,]CL12=B//ZL9T""R@)=H_"]#YXW[E]W5K'^D/644(XZ
M)HA6"%>F4OT](#5U$"(X_&0:VM15[PSQ:3.FK4;6<&?GD]XMD,Y6-=8#EST3
M6A A"[>]4,3%B.Y:Y#%!:6O%V^2X=X;X8KBS@T;6<&?O$^&"] ;4 FDI_K $
M/^]%^W8\GD)"JN,RZ64 DE$Z*)027NA3:7@K5 *1$I5M<AZVP_E\6-1(-VNH
MM//)\;R22!?&PV5_>ME+"-*)Z(A23A 9,R?6ES8X-"BK79:,=8O Z/[,I\V'
ME@)>$[2W]R'NC)9S.SHG277*FOA4"L98BW:TATA,$#QG2KFV;6X#;C \;=WO
M*=,UZJU\R/H[)+C\,EGN:+<=K16/O+P3+B'UM,(E24@<?4:2RB@LL3PQ_#'+
MD)34!@YQ1K8]\N=!I8/J;PT!=SZ=[7CA_@?^4_9$/\#)$D3,-#I-(K>V3!9'
M LX2DJ./(4:$O<JUG2,;;C_W:3.EM:#7D&+O".#-0>USEW_AYT<E@$;A2);<
M('>])S:8\B/5'NEKDVR3=]D-W]/F34-=K*',SB>RCWMI*]3_= XK(6 ] 3)[
MHW7)A,CHM[&R&EK<A*617 -5*+8#>]*/@GZ.Y&JGM36,JQQX_ E&ESTK/)/)
M<4)M"?>1,I' !"69@X$(6M!&3:#N8WF._-A:QFO4WNYP]W<H8BI'TXM"G,A=
M_,W_WCJ99CUOL^!<421M+@VI$A#+1*E_*),'")R: R\U76 _1S*UU-P:WE4X
M&,XP&D%ZTQ\4&^WU<#P9_VTT'(][7.ODI3+$.X_6FM(<9P2:\%8E-'M#U)2U
MBM+; .FY\*6&Q-=P8>>#WIDM_\O79>K6K(C.>B=OD,YB'$TAX7=_#+[, N#G
MEMO/4\#7/OBK4E>J6/V+S^FQ@#(20A%@J9PT44V\D(:@X$!J'<"P;C6<&P%\
MVJ0Z&=6MX6/E../K;+(>#5)EBEY LJ5JF9:..$4%X4IQ!YE;;0\1UGD-Z&E3
MJ*:TUZ3M5H[WG=>M$]0(6\+>A0,@$E2>UZT#RWV(-H8HVW3770/F4/6S#V (
M;RW;8U>K7C^.61TQFYF2@3KB@RCM@P/2UCA+-,_)4N]2S/0 %#EFZ<B]M?L@
M6[:6<O/2(;=JI';!U;2NXR9DQRG@N*_F'B3"GF(_)"V<1FUI7FKEEA NL!*7
M29IP+Y,F"*^L38>X5CI2#>E#LV$;:=<N'#VOW7;+&Y^5<?OTY_##$ 6'_[[I
M?UW>9/U<VGW_ZJ_PU4_GP^G8#]*G/_'UJS?#Z6A1^(\I:[A%6YC-@G!$BL27
M=%VO+17,V.QEMVC*RL".;7ONJN[AB>BJ08&SU8(%I<[I;))))EC0,1"0%@7$
M2D$4FA/)BM*D-$K,L2:KSR9$S\4PJ2+Q!K6IUN%:%G'O@*RI@;(9VW%,E#HZ
M[$",/130P%1Y &&*I3N>PDU84DZDX9DXL"7E5FJ+T)D.;:Y]#DV-1\R50S-C
M&[D?@!'+VX-R-[[8X(R5+N522DL;263VG'B5+#&0A%#.<KYZIMJ(&?>Q'=X>
MJ:7)1PBRIQHJVAD;8SW+;)I/#&DC[IN&>%..[ !-(6MS(,9I%H,0I;7#SN&S
MRZ<\=>.AKA@K%BQ\$-AR]^H ;;WYL*6FCV$25-9,%WWO(=;:GNLC$$U*U)1R
M9\Z6_@A:X::G12!4XFK$E E:/5K+_6@:W[#3'T_AVTBSMJ)O1>7/@@'>#Y8;
MBS/4&2\IB31$(GF0Q*>82>3>^8!^MA&LDXXW/N)PVW1U+0RKB[#VWKR*ZM.?
MPP4JS;/,@!N3!UI*HGI' FA;#BJD=\Y;0;M-WHV/>*:*W4V$&V=LY0X<[R?G
M,'KE+TH\Q\=S@,FB,\2'T1 -F\F5'Z029OBER&B/%AR[/*9*#XZ]Q[?2A,.Z
MP&V*R3$.4@;G'#  5*N*60FG>[L\<.^N!+-/_H#/G)S=^OAWUQ>M,4G#LDN$
M>S_KM(A+BH5$I!,L9FHR?FH3K^MQ;!5Z,JQ_PCPP264 IPT0F_AL,17$EY[>
M4@-+P7)TI=I4_'L8U^%]S<HL6=.DH98:&IQKG\4XO9Q>E/+_/\.7$<3^H@L.
M+EWS%O#I3H3CIL'T7+1):AI),@K'(14GEC)-8A9<H27'([292+5&\.R(=Q35
M-C@[VPCL-YCTO$S,9:=)UE'AI F4.,XB&B-.N8B[4Y1M*AL\A.K94:F:"AK<
MQWR,YY"F%[.XR THY^=)-*!I$G#L1E%#2CT?$DQI5:&3CU:#<*Y-A&%7A(<*
M.FM,EB8*.96@M(U#>G5U?87!M5,0,X[+&H?"\XG8 ($(FDI3N@2T$=$Z@#O6
M 6\;4G1=IG94SB$WLULW'%T@-KU&[@#R./?)U17<E4![:N=(1'+:*AVY+AG9
MY2X+IZKU/I!$@P$GI370IM#MT0CTR*WS*?!G&Z4TX,T[\&,H=5'?7GX9#;_.
M&_ NCN$D2%,66.)C:>Y$2P\+@T8 >.71RA=)I3;AU0^ .B%;>E<E#MMHH/8)
M]\?81R3]W(_7(UZ@XC&C-2@ET4$B*BL,<2XZ8H6((5GI15[)1-T4)[GI$<]'
MRQ5%V6#VEY3XZ01&J["29-QY5E*C2SLN&C0I+4L(% \_J^"%;#/S-P!Z/GRH
M*?D&WO.;Z0@E.QV5;,$W_6_EN^5:!$% ":;!,>82?Y$M07Y:$IS(EN<H?6X3
M5[\9T_.C127Y;XQ4J7PI]HL?E>3W\0<8S2J3+=VZ8?X-)F\'^#XH36Z6O][C
M7FS')U6Y&JLQRI7;,>U\EL;FJ*F5H=2Y25X:XQEGU 7'>SL^<\^SLVD8]U/?
MCZY*">Q%8YB;4R .GJ;(D'<T(K$YVL-!!$NB<!"!2_S2J(K?@[CV7?/N"+3'
MT**WJ1A:7*C2P5815 @:_30E8P&<"&U.:^[ ./S*5E'WJXO:[@)N<,/U#^A_
M/I] .OL*(_\9?IL6L>!P9S54WT\GXXD?E"KA9V$\&?DXZ6F:F!&:DJ1+L2"1
M*?'4 <F1<C Q69_:U+K=%NFSXDQ3-36PI+OB?>7'_=C3T9NH@B3448LF@N'$
M9NX(,YIR'JRAC3SKK6 >GE!MM;XCQ;97V:'X]7/_8EKZ5=P3SW7[T6M!<1$2
MI;K$9C%<=9VUQ&N-7X*1DB>:?&J33K G\.>_J#528@/G$#?Q>;*$OT#W]7(X
MF&,^FTQ&_3"=E/N:3\/9:SAEH%2;F:$?C?S@\_Q8JR<83\I9(-$['$'"25LN
M> @US#GO(^>J34_M_;&?R&K8BB[#H^JZ=MQU)_@S4?:_PB\Y0[QNYUQN#N8]
M6#]"G(Y0QS#NY10M-PJWF-*F5U(6T&@MUY Y*6&M1L^>/^;"M@#V,DAY=)4V
M6$PW6!^;)-FCJASX>T:X-"BW: VQ(3%B)(-L2X[:84W&34!?!B,/H<6*Z69+
MN*NG2C/3]FR0%GBO16(%PF0T$2>\(])S08)%K#R!HPI_":Q-[:V. )^55=A"
M*8?B3L_0<D&>.#'*,B)5-#AOD-\6J+'.",M$FYB"M7 .SXLFRNM"D*TDW\ A
M706U&' O@*6(*Q,^ZSICDT>KCP)NJP[7-HJ_SFT"OS< >AF4V$7Z+8)OKU?)
M]Z-YT?5?87(^3&_1"AM/ &ZMG:^N[K]Y^;9YZ!\(+SAE@M!0VO(R \1SGG$L
M-M*0?$Z-NM35',6A@G@;[D]'4^JI!/F>#28XI+EC<>- _/(M7DP3I#>HB_EM
M_BQOXGV^-_^OUG_ ++PL.R%1-X88D1(ZR1&(2S$2%VUI.9I1)&WVSX:#.EI0
M\=&(NIIJ<R*$:;#MKT=VJT)<%WQ-HY4?0WB<4.63H40GJNZISV/PKIS=*&$"
M,<QS(C5'?SZB286H9?#@.15M\E>/P[='(IN?+-VV46,+K^;RR\7P"K>*LDF\
MG_7#6X1?"2F3B)029B..&E(@07--5*1"62NELFW" #9".KQG4U=[JRY-%=$W
MB!CY':V"43^6\[P";5FC(E!J@TJ$B]+HSF5TOY/2Q#LF>;9@ W5-^+ 6SC/C
MPOXB;UYQ>K84:IV$HU02:U%1TGK\C@M/DN/&H+L=(V_5/^=4"M"?C-&]IWH:
MG(9LK*+<!=?+KER_E>:ZUBK?1>R'K%P?("B;C"99V1(XCC:55SX0KJCQ1ID
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ME7@:F1 5&$-"UB)E&I)>+3F^L>+!0\]YNJJM*+\6V1XSZV+9--M9QJQUFN2
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M>]&JTO>[S3E(06W?LWQW"N7%,!:!1P1@,G)1>JM>3!8/JOO(P</%+O;Q;>Q
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MOXB=ZK-D?A^V8A31D@8U6M@+.BQQ6N2)Y!C9%MKC5/LQ6+S.],E@7PE.,]1
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M<W]$N49[]J(B7QS3#0_HC72-^]!>5'0\V))^6..283(39DQ.)_9K+RQ,+R'
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MTKHI%[SL;0G6F<?3]V"3XI1'$+RZ@1@5*&,%1 [44W=.\@]3I?^3J4)S"$#
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MRWE+AZC^ $>O+0A=:8P.>_GJHSEH-^+>Z+8H[<$Y<!]J?8H%G HC6S&;UUG
M!\5PMM]Q[C,BD,+,W[B*;5DU<G3V9\C7_>BV,KCS8K2N_%WDU5!\!ZXFB)ZU
MT:9.XZUA1J3MR[,O^L[(@1Q#Z# RO"K1(L&#EK]VSA>Z7/)2/S5VW!X1A38]
M)YO, @1B&1C<DDP):G8$1LYERH!H4-0O(R>VH8IQ<Z[++(#_)<F6&>?^SVR7
MDMV__KQZ&+O& FA&5 N*)^GQM 3IOM[5Y:>358-GIEJN3$Q@3]6(XA'G2)"W
M9)6FT/[HJL_)VR5.4R5/["6/&)BOQDA'V2-4B+W@#BG^+S4?/,]ZCEL/;$1N
MCM58'-\Y7+7$0413_:%K#!9P;AW.CB$I+" 13%I"C=&8S\;Q3'ZV4TC17/-7
M,Q=B8_SA4\XW:V-:K,NC2]742J7ES*02*C1,@(,14!.D,:K)!/< .[9(2,+.
M>0N/K]J-CGZ1JW%QLM5<N2?0>=4]W6V/+WMX#R3V5CV>?BL3%:O]-M/+?,TT
M;_F56.8%ES+I.]F.WSFF&^(8#=#'B1:44NJ'.=MTN#>P5$I:&E%(_D.!%W %
M(7Q 4[<%:E_2;)D\5K2C+*!9)6\"X4ZNBM&)_X:FRX^'-]\9;YT\]H6+.GI?
M+?2@C>9Y .R(;,%41./7FD@@2]*7@L":T/D^_#@ZW4_ZNF6DF^FD^E0_0M@E
M8YV'9A1L2LDD66.C$7#^H7WK*GIH MS#YU?-^Y=RRHJAB>4X\.7M?:5_5UKY
M?ZFTNAG*,^H& 3O63X@IF;,5OOVXNO)"-27?XEV0 5CA$L]\ZAY?)D#_S:B#
M/H".U5"N4!]+==L.JR."BE7,<I<W/<O/7@FGO12'^OIU%!TU?-@@S, P#U'1
ME'CJYUSJJ18-U.?I3C[\4V4-IPL&(1B9U_?G"O0Y2FY1V\AN[; JVW8X3G"E
MV<L*-E(J--)A&Y%QM-WYL>YOT'G,XY2>D),X+^@=Z.B?#LI-ZIUR3T$S:-+.
MMP$7US7@BGSA1,YJ5=A^=M@18/]48[9P5".2A\0>>B5Y*7\F++Y&V29YG /)
MM4E]>-@A><*O[<EO,^ I3A1R8AG'PY0.3FTWK!4=W';FP3[@W7TCES[>\"DY
MPL0:I2.K1!:K(J.(]I^+IU,#L,&I-\)>:M"O]ROKRTZ\XQC'W8+.5H!E)EJ@
M_/[@&,. ]N[^H[V4J?,.V+%[CPM3)_S?(7.L$7[L,5?SST0Q;SPE<[!*I1ME
M9$KZA!K/<,Y0>M!URZZAA)V @ ^@=\@SB#-X)"_]_'#=,>(EL1G'04DQ_^MI
MW>:E9\-(S;BGT-FW+  ,)00C>\:-'6H@2!SAO8?XPCN_KW:T HG]<M O?!>.
MY.3][$+_#1*Z+0O"I_B+V3(L&>I]X%/-8]#5DYR8BZ*$&=)E6[0I07W]!)PP
M=6&^+8=:?_C=\8=[UQ8-GI4-*G[]ONT),.XQ<KS1$76^I!FB]:2F%6'](+P7
MZI"IK4XQ"FM[P9M^%;)B?(1GA3/[+3;+V(3$SY2A._UFZMD6+&5^3L2]##"J
M_:9>-0PW<E%;4>#-G[B_;IEZ=S).<V5TY5#XCK:R+V_;:=5DP[3[OFEW@H\G
M$>N8>$H0U<4MWRS,F[3;<G;25"E;+O/&B7NOI&/-)JJ<Y8TBN(Q_<1G1M%J"
MBAXQ3Y,3VXI'=!M.C_S5.0.9)IJDA*.-[B2_WN3]P!\UJ+-6^;];GWJ1A@C>
MM.5D]OVHJA/2=G!:;W6ZIBE]M"0CE:31OLH"#F)S58A8ZFF^0?66_D.M1;28
MX?ONWN9'7^5NGMES*$B_?E/C=2Z;CZ?GG52ST3Z)=R/ GD,X4"]9@'"=%N'F
MPXO#ZKF1CL(;"HX]"2;-AZ'1R'$/*>LO49\=EW^$_W :'6M.IY#,SY:UQXG>
M" , [$_0J)S2)T:!\<G[4$VST-^TFC%%<&<FPQ/K_F+%$A^M]A*V@2()2)>J
MC/T,?R)B9X9(7DM,T4G_CV**?,6:W":)2"WF( O@NTLU);>T,F4J$CJ^J#:O
MM(5Q*]K)Y5-<VJ"SHC0=V!L4Z=K21_0<)?TW)ML6Y%R)V0C9Y=@[A,TGK*0D
M*;?DPI+G_]C9Q&7<Z/^(FGW78(02I LW_#J5G(T"K8"D[[PG\L2^P5!90-;>
MD>W^\51*0CDCBWZX9E7$@2DW)/EA8$U10>4KAS\V*?"XO/Y\NEWR>W0F"YA-
M][.FH%_:'7BCN]QCF_MP'M3COHE5_"=;!P]X"R-_B^\[OLT>/%\9^5.)!3S7
M.OZV4_9[*B<+*#<YY&_,IR%9M]Q-<-VB9:STI,O=(-FES+BU(8\C[,BHMG4?
M6/ [Q_J1#1DRGZ:&1L<WQF@N^#3Z@>C#F5E8Z[O:&]^C"!MQ7VH")BLL/DZ6
M"ZYP7[G7P X9D8%TT( V*N8WX@*N+&;5=?A/VN/2D^=ZX=['WI#>THK[DJP$
M+HT;!M"D:C4<YWW29(Z(#.?F>7^7L.N>>G0Z3;$(RJ>=!6^=X:-?5/.GU5NU
M&$Z5-3UZNYYG^U!:6G:6!-_.I9QAE#RD$MQ]"6@1;0UJB^WSRQF"$?'Y%\Y*
M4I(XXRY-<G$%GI-^-H[$8SC\40E@GJK:EZH?V?U/O521LF7=<+,U)_?:'[FI
MX4:5J$8%V8\X3:@[1JJ?M#L7%+GS[>&C:S(V$J5'=B/-!7]"10)+;N<O!EOV
MIP^B=W /+U]OM+^\&P]]5,5_8<)R\*\WUCUII&_D9*;'@E>!E)+BF^Q&P)8
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M:-#&K+OJDEZ75SB+Q-ZHB3>6/WCO-0MH?!;+W,.:LB/_.U37X5^HM0<U+&#
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MA//7<9=U2&W?Y "0-QRR5R\O+K_>O*UZ5U0G,/W3MIW9G3 "["VT)FB-!;"
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M0^<O4]EL[BXOFB&FLJA.E9^A9Y6C1L4V]H[LZS%Y0UB G$.++8W[-FJI#&:
M:I)E ?/KJ<S&&E3G5:XE<;I(*L78=MR9 */\B?+,ZVB02OQ3?AJGL]"@9_DX
M++5]8;>SHQ>6, ,@=8-3*1[4^D_!'69;<O6#[IL;JO<5#_48M'Z]9'3__E-]
M?1,SE%45E< "#MUA)-JV](M VS9X1M=)TQ7ZU@^G#^T]_CL1G<'QT7+PERZT
M_ASXX[0&M81]=N),V<9+8P_"NZK: 1T8Z+:5)*=88EVYK!Y';M&#2VOGL8OP
M_WEURR"T'+3N"VU"\0:O$IBUQN54HS;#!ZUV:I9B#HF2-UX)_)P\O,\!T_*
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MU6H7:UB.^XR&9'$/E9SV2T/WVU(=F$IL\.#MP (:)5'43"@!1LUE1M?#6 #
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MQV%-J,1JP_;O\N=S79TM\UQNGT[?O/FS_#M'"L?'1>FY4]EI^UT$S+'@L/9
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MU62F_5XF<CRNS8QW4*9'PMPI>XUSU>5<:A[N!NBI/.N8GUCH21J&2V7'A2"
M_55O.VIW)K5GDBRB4@-<DB*/?D$VR?G>UBR BY@0E?:J)AX^IE+TOGU#A&A,
M?09M=7"ACE?$TJ-?)#R8MO>Y[.@*6W1@T_#=36[8?DA"BOPF*;'KF"[W_M?U
MN@S.[.RU\ 0%*%^!UQD,V!OWZI85>[ZK?G5)C:L)X'<W\\^ 3*;62"X/S'V
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MFCYNI[,S/JH[GO+'I7(1$+O(G--]9D4^=C-Q'3R+PL@3KV3C9(G4PT0[5)@
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MSOMM,=KZ-S+TN2F.:G@2$YH\!IL44SD'=.'\[R,_VEV[R_%]X6K7F5G*B)N
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MQG!Z176TASJ,ISSV_L'8KV]*?QDYENF $FH8L(GKO4O%M5W"CV. JB,= $
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M=?)SZMV1N,*"IZC$\X) 9? X(\-)&N;@Z/F?]Q9_-*7Y8KQ'UQE;>\>6F^D
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MV!Y:(DH\S,X]9>S][\53TVSR''!/U,^6C'A%M;3WU@-DD/.YP[C8T=8CU?Y
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MXT KY(Z\68"HY28=:;O<:X$)M PGP,D=OG\!O1UANWMY0UV<H%W^W%G9M;S
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M$<P*0FA]_9;\V1 1&7P)XR)>F5*(FIJ(Y_O<HL0KKW\< E44B^6U(I-)JUB
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M3+##K2(6$!(318OZZB]*XM BIXY;V6\\"1RR=Q?L^KNUS^?H*=2 2MJY1[#
M:-QDY.^Q[M*'K>,ZMGNV=0?7@U87*?DO\RV/]R?9C8:AHA<R6$WUT>-[QGQJ
M@;N^=K,[W21*R4IQ]F[,)#& SJV7Q<B3/8Q.Z-(5(#1);NUKD9ZMF^.&0\LI
MG>N0D7PQ+^]=C3^*1"3P1PX*".BJG(/*7=J/"9SG.;:,#8(<K7P)X.[LG%[?
M>C;([WUI IQ\%58%8]J*YVHH3\#WM2@1#+QL-N-@5:,06/?34M3C8'Y8T[7.
MLLL73L?WFRDB_3W&I!YS?ZS=6PITHV+6@+(FYKZYEJV[KL^6/CKDR\&J(BL
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MT_\55"%7@@KW.E6BDTPR^]5NX=\PR.Q"0,)XFPRD?"*.?:'4]_8-WJ]M-?[
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M<]@5H$XO[/K_?RO1Z'M@OPX/ZG/:X;*I],A-36JJ/IHYU4R;M6UN>F@]3X7
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MWD$1^C%[52@';?P;TS.TM9A@18]A+(H_=?O, S3!JJ1*'["EA!J=VX560MF
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M3MTXT'!IPIL!0=/1U-[RE/*D?!%.&E9@"8H6!?E@9,X9&8JS6)\:9&LFENY
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MC6C0G+OW5=J#3:DW<BXO$3R*QZD%&/R^4U)M]@'WP*OG.Q =[%K*OJ0J7#0
M0I*WIVOX5)] ,K@]-X\KVCLQI#T\%3?X3(O\/4U/A"B#I>&+29X#K(_[:D;6
MN HBT)+XK&5KKBI'DFD9%EN"((V/8YC5*/H:WD;AZ23UIP]-Q4U36T'I0=8S
M\Q%>Z8FN9L[V=ODG.^2>?T ?3648IM7?1-@5@J21$N#AKNL88E&BJ/Y8>\EV
M$!\?P1+4$(U)T_+O,E=IC*R4KW\E#(_56)+0'9.T[31S>[AWDM6TGWQO9H9I
M5*?D&%D]H,_P#+ )RS3%GM%2G-+%R;..2Z"S*E0QYY=_^:J?$#?X_+5%LXHA
M*!]NVTSEL;%V44VVW>+O7 +FMIK/3BXI=70EG/2?JZFA"W?WIT'AUNM<J8UZ
M]YM .;\+)WVHQ"-@?:9#5&!\?68KZDYGK'.9=O)RC\W&_HC#'K*&99+5PS.&
MEDP:%E2G;1YIR,_&NK9(C+0WS[(-D?_8]-0XR6%JW6?PE,X*^#>E1T!@D\L>
M2HTS 1$(:PJA_$>"O-BVC'W+DW )>[282&!**$VFU18,D^EX('W2+>IRLDKN
MCBRP]FH^<ELS:TZ?]R8(C9_Z6J6_U+_%B@@R@<IRYLNQ_Q4$(G/PV$> YFES
M]-I-#HSC._6=6N<K?S-+XG#; @.=66M[,$83HN8=5P]>BJL/:&?PB)2UGQ%G
M%O&B?H8VI'N>KQ:8-\:[9F9K>P\1A6Q^N/5-ZUZ!+M(H\!FN2P]^8VDQ%E:Q
MK*4*0OW.R@X4]\[L$3U2'9[&F%N=[3#E!O;AVW5/U$&V25!I+5Z;6D@W.JN>
M*M1$BEER$/3X%H#Y$MP>B,>T%ZR$4F_]D[=/-.9/V!KH\BRQGZ.B^;3K:!<2
M[!0C0/Y%'D8RIXAQ>&(GSGW!.II8115&5_5D2?$A+S\T:/E![Q>I2:A"?3/=
M^;9;1((9?@C@%B_L9N #%%:=^=LC7**V9K($ OSK X6-8RY*>",BB'KOO7>*
M96T%B[R-@^W'VX*S?72F-'VOS-^7MQ0@:!NK$J4F#VT? 35'N1/V0]#AQ'7Y
M-F_W/-G1+J; 173Z<XU8]5_X/-F>=_Q,XA3&E%.$V\E;*4\4<ST*LN8K?:=:
M.>;B2ZXTF14N,UG"<V.1ONT].Y>3C IZ^6>>?1*3F*O.85/:9*0Q^:0SG?:T
M-, .H<)7E*NO;7WM/I\;*5A>7Q_;?3R]+& (=D?A4W-:=H_]S,9*\EQ@H%V<
MJD;*Y[K0P'H^XWM5-/)38DL4SULENT<M2-Z900YRCH:^GF[6+$M.W.]T#&R%
M"B3:.#8_ @1]-M+6#;BNI4[]NR&*"YW+]#BK'%7\(6_B].I<H"[C;*4U@_(G
MC8/G>*I'N>\+<374*\H=,^3&C 0]CD5D[O@W3L)ZOE_"2QL966O(*(O)LD?G
M=>2)0LR<2-HCBKBJBDG_I R&?PND,FTVCXZ&*LBL^F46&NZ15><4#SVU1,66
MTL62%G_>32W^:NG>#L8$;;J7"IUW6=6O,K%11O'>Y;1>][.T(Q@]UZEQX"<=
MG.Q!&VQ<*]KU"0M:];#TID^NA&-$E8.E]ICN%21YYS34#=61-&?+GTTZ'7^5
M-^)39:VMS%VW/G :X1[<)H8U2GQ:.Q+=49WB!95HTK?45G[=BIJ;74 W 36#
M,*7"7W-YYFPNZ^-D\I+O7C2)[E^9):W5A.:ZUGS=^5D8("L[2NS6NJ9.Q/@%
M?;UX)A2A.JZW%O)43F@_P,QSD,0"H> #;RP9C=JFYB@/XT= = ,X--<J1LN+
MI41'@D3')Y=C>Q>A7-L PXD@[JAVFW^HG;YZM52=\GL_1"IL')2=+&#'8:_J
ML6V9TA<OZ;;W1IQB&-;?#?A-%53LT2 _"D4NJT\P\:4/FLZAA#055P[0$6W3
M)\68:+*VCKQ"XQHTVD)%)><]PX:NV[_B^'H,)1^8@_#>L[2)O3KZ5%O3'&ME
M&YF; \9\QJZC"2+C#7['X$#GU+"P33<#01B>BF1\;Q2WR-Y++@VU 6JMXRR'
M%@,5"G3UYK1;3V7<G6)DA-HKF.7)NO_P+?&45V8QIO;KXY@4[R'$/]FO8[!A
M@Z[V$Q,JE]M0NH77@M9 >FY\D1!'M#9!83@J*I7>QBY#(^Q%7B!/KX]\:6Y:
MSD(_SSV+7N+'.V[9LZX70P]_[#2WM1=Z8SYTTG_:&CRC*QZU7?,CVR.F8H?'
MG=[>=6KI_IBJ.L AG+>!SI22T>M1NHVCT5I@4<\3,! NJR\)2%I](R1A1QU/
M=KWPRLT >[\<_+$H64FS^/Y4CO#+:Z =4I;Q63$24AL I@EN12 56HL*G?JW
M^6/M)U?G7"F V\06O-*V((CIZQEG<:K40HA3!+V&>:,G119+I?27Z@X:$5_5
M \U)A%2V!^,#'J7YQ,>)1K=YQ@4V>P,..QN<$/KF,X:,$U$J(U909X-)Y/7-
MP [>JB^ZE&?>%YN%]D< @8_6FK?\D=R!5/58%421!&H@MZ$<SYCN^T%06\'A
MA&&\NLPGI3H@^PL&)V.W+/LEF\E:=9Q]T;ZN2'7>NB!;J9%<'=_9"& <BJZ+
MM_&CV,10"S,;15I&PQ79B\!]K"]?P93H$P^G##?W^W6:$GU !6YY"F>U.E[_
MRP2 4)QY(X?A3*D?WI*/IB_-_MGM2H<H<N74(9LKY,/VO>@H_32=N7N"=$P-
M29:F\#D45_R9%IG03*#Y*7_T ^F0R;H_WI*_-7ABP;ILGZRJYI51QB'D@_(1
M/F7,9]EKM%7M/WW4#:+ZAMK<DXW"ZQ@X1![^'V=X"AZF<O;=R@WGE<KC!H,E
ML2.A7S[%&SN\IP6&\7"\TO9([M9KXO.O6NAQ=38]*4_$%Q=NXUK[(L8:([23
MN?!#]O7,L#\.@F\9^S[##]^C8D!_9FMZ.[Q]>M!BZA@K+\;5T<R6CJ97H'K^
M=5*6VI8="1X1U[:$29LHH&GB@7SX%A5!5Y^3 A_0-3!1J(31]R\OS77D[ZM(
M)DPH. 60(G<OZU":A>9H9R^/$\UOM=YJ%LGX4B0'3HN;XTL0.'/S8-,P;[5B
MO"$GK20W$V?]76",5 !T;Q<> +D8*':OW/G-V_(A%O3W_.@:B6N\7"(Q5;\K
MM,8^(2EZT%=N.9F,2J= W)YVA#&,")+KWPZ[H\KSM+I/.]U?OAWHK76YXVU[
MF!T<6T7$4C-S)#GXNZ4BL@!4>_JE_S)$TJ+\[X<BZ#"BF4[B# H?['3RR8LE
M!KB'LSX'7U$>R!<W^DA(49U&"1TK+<]M_1W:O/,/M$,?%A@C"!:<21\?E-MB
MS^-(&F[=3#G) Z\.0$%.?"4=5-&QA>I(*M!*YZK1/N2[[O\"+M9%-A+NH_(;
MA!496.-HI WWVR8IGA986@;]N=,O%?I"</@A,L@8G?7E34GT(P"=(\2/SN/E
MQAUW9[U( K10*7??"5[4N7VU?1F<YNDD-]M!-^T@;1K C_=AC.NGY31]:+.Q
MQ6A\VMK*4^Q4=MR:U^4H74$XU*!A3[PU(MV4Z[6+;3$29A%2P#/23:TP#T90
MP_BE K$<+-5/8!PA523%GN1=S/\]8MX0ZF%K%NL*#65/.R(,5-.7A'58][Y1
M1Q%95KL4JS@.LLU\&&G!>1ABV\RP&76YZQ.=\Q69GO&6K: ]-VBLA:_SS(</
M$YB.HF9Z?.LDHB(>9YR\%'P8L< >U::5/1YL4^61>I$=LQ1/2$#D9J:!_ ,K
M\N]Y_58+H>O"P@FUAY[D$WDN\,BE)%*'H92:Y?99YX%93V>S0UUY..N3IG4Z
M6(1EZ ,MC-FC&J^#<F 4*S@^"JM%E"RJIP_0[)4N7_OL 5=D+?M,?2/@GV74
M (O@I<9?)ZR9&$(_[X!*]8M<-H!KX8/=BUU-'4T+S02!]P&H237"A?^MG>^*
M:FJ!MHV*% $1I-=#[Z&#=$%I(J(@G=!["$@/TA2D-P$)$J07Z1AZ"2!=NG0(
M/=)K0 VA^L(9XXWQ?MY[Y]R?>\<=]V/]Y6/MM=>:<ZZY]@B_P)OW.5^$NB$&
M@V)W2&C!FRWQMN=$*LB)VI\_1,A=DL!+],E!;-WP/NR[H_F%W7N=#MIO/5XM
MF>\RCTFJVP#>7>TK=([O05&*&GVLDM.UBW*#EC/SVC!!S>'$* ?,05K1@%6,
M/V<3?,F]=E2P -'H$ZKY08$O3YJ.ZAZ%:Z4,VJAG^4X@%^)+TY%2C6-14/,.
MDQG4#9@7HR4S2JW+$<WBQ6SAB8R30-QPMPFD/[K]!Q"K1 &E,Y]R/#<L*=F2
MIFOPVGOYDR=YD67>Y4V^4/<*@!!*,QK\_3VT\F?GF0(K_??RWT@P2JWG:V,;
MC(3SN$Y>ZWEIGSMPZ\I07%9P/2^MZP>$!?"KXO__GBS_D1E2QNB=YNF,K0HA
MD)X9ILJ(@FQ(J#%_9$IE+J5[[GF+1D]#7N/):KNCY:G,<H0R5G [Y$R+1HPE
M,3)0Q1H]2K$-WTA51M6V/IL6G-?"BON___9VK/X+F7CY76("QR13J9]T7]O)
M&Q(D_P#N.,,3FJKFM^J5R0,%O5@S"EU.:"D9UND&)NC>CNO,VQA\?54N"C(N
ML)=C(]Z!)\95*BBOM&H83J9I^0<^GS W71Z^_6O,N1GIZ_N^;EPTPRG!'KC:
M72W)WZ9.+O"M4@+UJ_V>,5@&U5KXZ<JG-\6[WJ@$D3;PL8-ZU?,A^7D3VK52
M8SAN[9XD>(,'.:5 6@(MZX*;S%P\8D4<W50$AE1;/&ZN,:4@GU\X]3 ?YGHH
M2KO-D+X\<GSRY?V(H2FB#,S*6_/=9Y1B/IL*)SX@K(]GR+EC%U1/!;8&@FVU
MMF[JCO7P'+[QDDEIHMU+L3-PC"^>].VO"D?G?V1R&&&JWNTA63[WVULK75L,
MZ;$NS177%@/@:S):BQE('9BS3\3+P)5EMIIXD;!,I[SG%/8'\+397HQEZ!^0
MJ5??DMP4D@Y-$8NJ^+3L=/45PPVKLK?U'IGN7+4TLNFY1=&^UDU?0O#N11:A
M7"9O!P+':S$!Y#CR+11"?:BZO5[?6JPX.\5]7/">GM./!"+PP5]Z/J]G/5HE
MEI1)]<U!<=5'),4/=UH7%$4H\E6@(KI%QZR;:EO/A3&AI-(X_J9V0).U"97@
MH\# 0A*^8X5&P]5,=BH&LA02(1=&^YU 6ES2CU,%';0)4B-O$9JW^\1]O^7C
M?OE5?U  %GHUS%2NKU[$+>^H)7ZWZ^,4I]X/I=0\I A:@>Z,+5I!JPJ7P,;
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M]L'K48'4 "R2W$(%UAQ&@/_IZO]_TZE_:?675O_K:$5+(;GHWRGD&$%I7B1
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M13ZG58<NJS-6L#V$0JJI0-< O?ON^A&Z R88"._^R=(7%I+C.&D@>" G;@B
M;MF! Q[SM522+]V$#&1L=E"!XP AGZ@56-5M$GJE.+"T_82!_3;'.L;<6\@
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M48V0,2[*23DL+7Z="<':0O-H.D>)J&63F<Y&UD>]WCXM5<?;-?3]V>G8X3<
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MR7M:[Y'-B!LMGT4^TX2_?>3;D#UTT)F9*?!CQ>)*>8W>T[G;SB&_6/7:9T^
M)6@N/GZ=7)"R:@H_:R 1-/!B@OWM!Z*+?53/ N31V&\63>$D2>.6$Q8\0^;9
M.BGL0_*ZF+!\0KE<)Y^]GDR5@U>"E9KGA9.G/IWRSMQ')T'J.38;\@E\5MB*
MIOD6OBZ\FJK%Y4;52$]ROG"LY9,27'$DTX* 7S<=3Q_"U2R3-+Q%#M $;<L\
MSG<[T+Z%%_G=-5]'\K>><4=PZ$JO:885E)>"DPN@C18UETQ4I\IN=7X=<Q5[
MLGJYUVI,J;%UE%Q(.;>./@X'"#,]@B(M;T?+<\:$2MW\& +"QQ3CU0VMQ;._
MRAZND9$5F3T+!QTA<0]< INO%30_#(YW-(HE+Y/1Z,5^^ 7$F !Z3[G\4LI2
MVY<RW[1\@L3P_L@ .^JYY73)!@Y&2HK294&T/="V*8(&3\UP*8-9)E;]-:\>
M6']85:V_Y.CD=,(@ZKB[O,0-_LK>R4\6(38Q S3'>I-SEG%-&[Q'=0FB+X=^
M)74@QD^UO'+J18/<P!!EX2-?5!8<")7^2%C!Y;91Z.N1F]$.(^)U*;.LK^XM
MY3_22C-XS/A8%H_1HWG%@3*0+3"BK5+LWLK7&F'U?5MNVWKGFD50PD)GVY-L
M#8%<F4ZV-LZP#^KE#;J""6OUATVAM/)4\_4NR7*42 522*"-[Z0@<C$:BN*'
M8YS$ON\G\;LWBF;YY-FUY#'GM"D;?QYHSCC==T9:]YD-C'B)MO576\4I7RAT
M66VM7(/:<D7NJ3.]1<H3_?E?JYE%;AJ?T(K!>(F#.K+-53;0V-OF44X<A/LX
MI3DR*H(DG4.PF-@PSK:=^[ZW^G#(ANN.4IEI3HRP"X:61]JDX"=(ZH0$HM*Z
M)BI.%T2P[SS*#(Q=YFD9];6'-J1?8F40"^)\=4[BC:MPYALABV=+(J=;, CX
MP'9P6LR!ZW$=^]KFEDF*'>@N91@BX(>* %4K/*><=4NOX[.;SBCL"&!KS1%J
MJ=;J%7SQ);',4'CO[D0K"QE) [/*1DKM/!L<%J?I&N6+9G<_TL:DXPCP;W,*
M,/G.Y LWC):G--^VC66?.)9B#&#&9K WC8= 8\CY9]XE>=!"_9*2BP ?YQTZ
M2!RXTKR-K+10OZ4S:WYBP[MY0G)I>"#L].E6EXN=N\HNB9<1"G?%&9=G(VP'
M6Q[^,5MC342%P>U)<6^+YW(U/(8#=NOED> 1_/9S6KJS24JD7,3<1[;73[@^
MJ4GSW[FP24-EB?%LAJHI\5\P/TO1']N@R@ 23VIGJSPA\GV@T/Q^*]+O!$K3
MUI:0WLWI*1' [O_N8P)<OZS+YC'#Y)L7AL9DB1^MG 0E.T* ]ZP6DG4-@8VY
M]M"3/4FD1++1*!XH.L&=^"[^U&7Q3(I'Z,V\WEEPS$3K:YAL6:-JJ4K-X]-J
M]*Q=>@OQI-I\9KU[XOKVX"]X>'JC5-Y]S>MYCGGH_(UZYZ-(5#]X4HUR\OL,
MF[9C4:#T'$\4LLQ#,S0!5D1C4=;I$QHO7PRV"59MRP3*]WCIT=WV@=A1QL"\
M"KH\E,_3FK@HI)+=.C0WIESJUJZ!3IOQS;9]ZY=J<Y 81*5Y1"CC FI"JT,5
MS57[5M8(>[\R_8ARS0NO91^2),<B(2<1G\M.U!-8].))B2^Q\47=IZ4-4*_L
MX<_0C;=7V$OM?MG#06^WQJ$[>V$@RLD&HLE:9I63 ^%;CW6]]90OL9^]_^Y=
M\M"]YQ(]@VT'J"'P&(1R4O8]Y<>.R5Q8R/7H=BIPJOR=$CF%F<5NG;-(:/%)
M_=?\X%=C*8QG7IV87'52(^00Y4E7"6%^LPD!\QSM1#2K.0Q_MS#IE/N:L&S\
M^1AFL']?F[4#CQAG+$D.BX[-P@>3<\O]T&SKI<5Z<Q#.2[4C%Y9M3^],G_^2
M4A$-E:A\JLC.A B>CL^5^1*?GN1Z1-'R@T19B2L\6.]:;T1 AL!AX(<*\1.8
M32)1@]#10Q&I_= RJNQ;[R;V0SQ(;O)K0ZS4=-%JS]*+Y"CA\#W4P$P$&FN+
MY'&Z-E^*>B[(&'6OZL.@2\/0YIXL])6\@A^'JD3LZ9V!L\\F=I1$&NB8!;HY
M,+23:%%:M(V^"XZIOUBW^J#N0[+0CVM;#8P[*C1S+Y+X8!-\"ST1)#I\1E7]
MCU]??CITGR"4+QBF/W# -=U35>HV+G/K]BG71"A<4SOT@FGHJP>.[L)^R-LX
MK\ZPTH+>&N$N%S#O%V>[;J>;PYX;)-*"CA(RBK'C37XJX;'.0#9N4TQ%?D%[
MR[%VCW(]/N7P$'+1Z&U3Y3>E294=&LC3HO<U%0!(C/,#)P,S.BC\S<-^*/9I
M@S"V'GQ^Y_RR<=OD<EY%7\(8XH6TC)8+J+@4VG7KIGT!94ONZ)</\9N7.12N
M.;,W=NZ?3?+A!I[/['B#CH-_J5&!O.>_!_EP6I3KXK.%9!J5V4N6_1=/T/^O
M*BAA*I!%B\(&+BKPF&?3;P&Y&P@Y.(OXI?]$)_$?#A#2!"V%F/TXLZ,8>H8*
MH*Z94X$K=:A1C_\\H]VP3O(E(_"C,/,Y9.%Z).UC31K[ G5NGR"9(;MUF;';
M<5(UZ&JS()5^J>G]'.M$BS;6HDD],1?VCSQ'"JZTZ!<8=K4MU^4D\([>7S3A
MB"I+CF(W.JM@1["G,-&*D;-J71 B$XT^K19#]Z9;A U3K;= 9$E1?]!MK8,,
MRLLO>,&PB@QWD?*T&E7_RH1BMN:[G(SO;GXJY;[IT'.3U![Z!PVQJ^?11+:?
MM#4.4&M#?13M62I0 265'L81:/9(NG8A\$)-5&!P&S*<GT$*:J,"#IA#"YK7
M/M=%[^/O:9L3I]!;VU])9C3K^A"]$VNTNEMVG+8<,9.(H3#3^+G4K;DD(I,'
MZ,AB'VM#XK6G7,?07%;I1*,N1E.8:336)!MQ#\G*<13S^YV]N^ (ZVG$D:TZ
M:G[X$+'&N$2CR6U$6\(P_A6AMV*-N7C::+9)Q-",#72Y[D49>_$9@[3OWA(5
MAIMU_K\^?>+92VI'$\["8O83Y&G!U#-SJEQ;QUO,5FK(-XX^Z.QY8%-)Z7UI
M8O3)=:;9Y/[0-*([_)NN%#E+5Q.*MTM(^QK,0][#-$J5<1_:7-3*N($:_OI'
MY/UUI@']/*(";0-G2Y$U\/*YM^ V0;G6A#+HKF&==6.9X-5ZP9J!^/,G)2YI
M(_&?5SZJ\#M!2KN_[&YL4 *FES]F$0/*<U _AY>\>K[-U"+:=4"SX"WF!1"=
MFQK&+CWMO3DKIR-$4_F;'=// VXKARA_?OIX9Y0*<8YXMCL=7%78?A'"I'V^
MH.&!>K=G+G@430]V-X] G**P$8Z8X-(G=&5PQU.@P[T2%-]XUX I"7C4Y2]M
M3R3HIS";R$W,.T( OH:V.3X$U[:#X0=?=CL6]!J2X:ZU#77D"75&0EINXF6.
MA_XJ+1JFZAJH6)/2HWP)6N%X?D?[CV"#F5_^4.S((MH-.<:(#R'GZ8HYM2;-
M;X!H!WB$(4-Q<C4 ORM4N+YK=L_>1S0__KZBR043#=0+N"2B34!7(1"R92/*
MB0D%+T"-N^]%]T-9>L.:&^ABX$HVW[)U"1!< )Z+T.\<Y,>V$JWR4WXI?\B/
M:"GG'I@K[GO=<)SGY5RNUZ.Q^P)=(5U4@,1KL]"_'"WYS X1\; B4^&"A_^1
MR_*<$/\T_91R2-/.LQ!KSAMX]V&$PL;.]]'KH5N6$/ &XM8R*!+,T^Q'E"'=
MN08Q;&C\OD_FQ97[R6F\*;DNGGIZ\GINE(7E4_9'E\49Z"'%(.SMR*RNF:J
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MZS ZU#@?'SIF&I2<P@RD6%\5FWU;'J6Q%!M7>L[2H=R3'/Q39=@G!'U?8#C
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MA=XO=9^NZ0=7^L\=0207W='I*S)NI@*PM7NDOG%M E\'Z3.D3>0(^_YX#]Y
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MJF^W54X\]RWG'\I@D2G1,9\-\U'V=T)O$VX;AKZP4*V31IDK&5Q#V35\=OI
MG#_#NY<+Y: ,S'$I2/XH]=9HK.%*S(P+RGN>[E(:G>'R1Q_Q-84)0P4LK=.T
M)T?#@_TZLZC *>QH0.!7;=M'6J\P5^;6K#?5!=YB+=XO3-E'P9B\X1H-S@C[
M+ <[UHZBF$4[L-EYS$9+[A_GC-7 &I1<+HQT=<?G-H0I-/*8[!DG_6L8'M??
M5L?:Z%#@A76V^E^A E5SE-B;?IS_?(H<7??%4=NY=X(%1H6[XG0#$93ZVQ,E
M&6P:JAFZX<M3[1JD>\%DFXZ];"K0;$L%M&"'+%2@0/]G#P5A6#RD8]9'N@79
M6Z$",;"C8=A??$)%@#Y_9--]V%"<"IQ+)!^?&HL02CD(^QDV!*<H4X$-G9\M
MZ_M^G!),W7_5LLI?M/>JZ*C>HD-3V0W\%V)_V1S'=X7?O?C=B__,7@321PB-
MHU5MHJ<M\RW&GE0VG&H2ZXQ*]0"%:&BRJ7]!X6ZT7=%1[?ZOU#O_'3C6=<M8
MY-9#*C =\JLB 6F6A?P#3OSP;\M/]A_RKNYO,@/6_:/<@:O_I:\/_]WU&OX3
MILIQ^YB6,,.F<BCQ+7_'2B"P8U)22ID![Q6R_Y]Q$G$Y#;2\;+/,Z;2"YV,"
M]MGCS4-]XGOZ.G'["D'54HC.[4E9?/@H1<&[>.7S8BD6DU^R-FGDDB"QM@P^
MR+0<QJ]*(3)@\QD@-G:)(06.M:'X:68J\'3<-_K0FH'T/H:"0KR3DTV%>.=;
M#.T%B)VN&1;)T?"^KM@E>PD@]4 +6J3-^)X<D6VWY1$#7H<4E462=I)6/>R;
M#G1]=@;BDKBR&F!\K'R/"#=2!'$>?5'[IJZWDM.JHMK,7&].L,UL%ZN"#2#J
MY!,XE?"[\#]6#7U[*V%TR=DFV8>%]B_XH[5?^0+2O(%FL-<D\51H+_+TYJ9P
M(;IL<,]426)_EY2V2!Q4#= 0E>+T/0%)AI=U8(3R2?XX<?Z["0I,I1_>T\I*
M];G<TS;DQNHT;FF_V_>=UORDE>>9Q2FR-.%33XIVV[CB;2\2<@MA8#+5U]?I
MM.SKU;$]M6"!"QZ3 ;]^/,LU(/UH.)HED69$FU2BA]GUBXK?>4OTK,]]K3#P
M[3F++J"P%_MS\Z6\QF48>U1[^X)>W9O!039AYQR/*#XKW>Y-K9.O96(=]RKQ
MZN08)P6&\2:TRQ5%II6(',V!]D89AY\J,Q!CT9$PK:!JL.W;@D!4M^360OZ$
M1]PN;"P&]\E7:HN[=3:SS+0AQD)CC]@+PC\C!V'<JYS\U7#\,\[;G\Y=ZV==
MEO(+4E#8A17W>_4IXN/KZPP\<4VGU$XQ?'L:)7$^+R,5<&?B2LLU<;CW:F;.
M7,G>\=+T[K0JPQ7?!+GSN&AFZ"3H+.FF0#.%S]S 8[XCZ\$!0.:@#:,<(;H<
M1SM6],VFS4BQGI!%:$Y8QNO.9]]N\_E4%%*![H/S HNUQ_R,I67<9LHQS3MT
MR>T@B4]O;Y?6"TQ'!1SY*+<P<<H$IP79_'M2+#&3+8NPN?9XPQT))C%_#U:W
MX<S!W1*R1LZ7/P6T)X;R,DG';2K-KN;A);5]["_NF&H\VQ%>.$7TRBF>5.WK
M3RJV>#3)U7YT3+Y4+?^%&\MGHOY1\.P_JESZ3Q,W)2\OSLA:30$G95)?46Y^
MV%BY4J[%I9P#!E*>>-/Q8^'R(GP^U[-;C!JL2CX=71G^$O$)A6%/ 8-,>M/#
M5\?Q&4Q,-L?L3>S-/\G8L0AZRC3X%$EGH0MRVB%%@JC]SMD%5II>3/E9KSEV
M-7QSMC^8XXV8*=?^G+\986A^+E"!+:Q507H45K3WKM"@1UBA2Z+=UM9.?^JR
MK/LCZ7:I#;T>+GW9U:,]2OG#W%O3>B,N2QL'XI7I5?1!2"[_"[B#1PTC_F<*
M8<[C1M,!"6B7$FV7$LVT"K3- ^]KBR<%D'DCS@RQL77FOZXFI/[O#]/YACO^
M'EAPH_SY/F/<<B4Y)'O6C!Q[KJ%3OOU0O10S=5X:Q%_<R8K.*N<TXL0PM?A?
M)\S,(Z(5.*K'ZBX4P)P=#,8T;84Z)NPKI\3RJLU+;X@>FFO=[Y#W'7,S&#*-
M8[LMT/8K4ZCR_S\-3"LF*IAS\[1^Z-DL;'N'N4.=:\ZCP1D'F&4U1.AD/N-R
MF95X2QHJ>A:AG%FNKF$GD#UI?O=X9>BQ_O*GZ&7$H&+,6?-S?UA.)BN?E,'0
MM][8O63V@9?"LGIU:L.T?#DU_EK0&X&J?@_N;^-O5L2O3U(HH44?G?+DZI29
MZ*&R[$]UE.U>_I_X=?_'X'\QA5_&^E]4E+UR8M/]7Y&]\S\2QWIYA@I(:% Z
MZO6H@(/A+^NX9V[W*7+3;P2,C_^7#*7_8# MP$OH2<G(8"J V:8"ZLM_Y\WX
M*RKQKR@"\>^&81^D?*7=P?\"JHHDFJ5N/>KQR:A+SB6LHG+FC4HM:IBKR0CK
M:J*7O:ZFS!5*\X>A:&L+K8H/]$+^(:._-;GP+CALS&V-_>(%-.=SP<PHGK;R
MVC>*!I9==[CC(<15+H%ELA^^BI#\?5:NV-'5X4GQ*5.CR4<,WIMFXI07CAVY
M!:,-H2G,\1+E<Y^)%32A.YM7+KL/+XUT0K"^(C&;[&<P+CA)I<_LFL[R!DP=
M6Q(7C":TN?/Y#%=%#VI32&,#<V=@+VAI.KPN.5APJY)DOW>&1#VRQAM/Q^WD
M@ZI<*[>YU!JEVZ&TV94F_)8.3TU-^[][T2Z-KSOY29SS"J]$E1["$7];BJ-0
M Z] F!&)+).6N_F]=\A1QDP1D_,AHN_%G520P>/ E$R&:49S%TS +X*'[B.Z
M'Q.\*L>5=3WWS 5N;$0+C:%0:Q>MJ0>A,'KYU^P9<[W\5[EFS9 1%#YO#=2B
M@OT[.>6<9X=L1ELY.MRP&K@WY62=BSZYH8'!H9*60R8AZ]MKUV63<:GC)1R
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M,N2QNF@$T:@==4JO,?SS?.Z[+W>LV%Z*QL5L&(&88<]=0L TB(QB'")2T#U
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MSQ\]7+GUMMZR=2Y-;LK]1?DQO;Z1EW>81!IL#S(WV:<GE+:=>@#N>WJ5ND:
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M1H#9/L]3<M5 ?6U^00#K.(R29\JF4 28(QUX1;8 DQ:+_KW(82H]"![> 6P
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M8@#NE09[7,3/_6;0&&1A;BEM]@^T*%1Z:2EU5N3WL(""V&,7GD'33Q=)$IT
MK<0S^-=@L2,$N-3^C4N#IRYT!_ZQ^>V_Z%>7_#WNTX9X?@5D!*3&!2 @=E$
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M)A(WL[97+5Q0;6N5T_</>#!4M[P^^YV!_.>4\T$&FK:SJA1$ <?8QHJJ.MW
MVLXV.JPF+%-(NY=;T;IS_=+/8?8Q^A</'#^W2W-,\56A;[C%53[-2*E]D-*-
M/YIX-^/,R_[^GBE"PA1,Q<6FC^*9QJ++QBQ')A)80Z[]\N/N#:^Z/.:'K'8O
MJ:8<W$H)I5["W_;S82QG7:PKE8IX(%[Z'G]T6VY13 -C^_F6O[9U.$0L#YK8
MTF.^:9AZ#17F;?M&6L[3:.1)TC\_O<[0U=Z<4AK9KZ\9::[3^23JQZ&E-Q7[
M:%VOT57PVW%;S1:B$S-DNG[CPJ6B^+\_QD],+1N<W-EURK7+ZN$;<^<?QS^M
MS8R1Z[)DO<=[YJ+P<Y2B%ABF5F3E+<"(?]2'[E'['OE!=U7S6W*GPML.[WP6
MFM8>%WX[AOEZ?]GM*3^,_$-,@WQ[(RT+FL [<?>/RVYMOR[ W'/W[6^WS GY
M+NRJX]JH7G"!VW9CJ9,NS1)Y/\#>Q,\D*1LYO_1MF^;G?/3N$>G=Q;+L[3[B
M$9HAG[WOT,#=*7P2^;WY!"4)K05[[5#CF[?4W-SZ(\<^M*I=BJB;^2ZR9_L@
M(TSOT&:%'1'$-;OW6M6YT72@+V?N.AY*,:[[RH=T@T%WL7B$K<)3ECA*589G
M(U?SOP!OCS@$C<<),'MX:7R* &,GP(21-U"=*9N1[')98;29B;ZX1MB1.\+.
M?&Q[,;/H>+5#E*+(@7>#:Z,7LJZ$;7FSJUPD;0DVT!C;4UJF B,KNZ/Y;B\S
MDZG#I(UCY&FX&>XT$&"^1Y. #Y8:0"ZBZTE?2>N8:$3?R$F5]<C]5W*FD3NB
M)AX>>[?_V(6S'S=O^$L/LV+@D-SPR:D.GX&KM-S9$G7<<J?R-0-XAD< _[4]
M:*:HKC/$^D1@C(*O/1\_VFN;=X F3V/B-BW7_/8L92+A".TDZU+0M*&=6A]A
MN\-#E:<B@7I[5OVS[>8AQ>8HZQK#"\['W!)?9V9BQYN&*D^.'[J_]Z-N?-T"
M-^)AR5*TDJ3)?X_*.B="R!U6E%G\26JBZ0JR7$W:"0EYAZO9M6+B!5:K)=[M
M;W[.461'(RZ@)0!-V19MHSZ:R)58J:I'+W$2A;TVQR/D#(>V15LD90PY[/VP
M-.R#]AW\$422+<G/)*IY0,&J+A^GA'YH>&)S<"[]N;>K3H5*^CY__-$! [5&
MA;?:#QCPQ*K[\7>G5%>2L%V& [F1GW1?^[;'Y+EL&6;75D4=#\MV^R*3]?FB
MQ\,5;QO3-Y=:ZA2"WH2D("F?8I2Z<:AG89:+#I)>('7]P<$E:W@["1N1I+FK
MU\-TJS2\^XHRW[F&JS5\F7#'S*DA[2R-?BQH5'=),I8X.[TZ?U++2,[JQ\+A
M_$G5;NO;#7)+;E5)&8J:WCRT.IF!ZX[J$ZW"=4G3H5*ND5#90<,WSGE--11G
M!;.<,.6W(J?W3#<OBXJ.77[R@GBSVG3^'?@BMHM&[ZFOK Y4578JEY3<)9=H
M(UWI[1VQY\[#-_:%RV_JA(G/L\0>M_;'YW-X HR<97CJN\!#RDU4^.C<4K85
M_PE/D[N/J//@:),902W^^?NQKO+G8KVGA% MJ<% XT]1-?+D9W#?._STD:(M
M(%>#KGE4:6ZFFG>P@4$38/3P,@(,'0;M\L[V9G)>\ 2'93!@,)'/_%ANJ1ZF
M<4_;,:7>29VRI2K%[;V0E4*XN;/C8Z6P80WY_0J:(YF;PJ^T/"M,W:)-X2A*
M-45'I6Q2+< /<3X^A$NWP8,]VH9@06T!9N&D*WXEJ14_34P$VT56(L1??9B_
M2X"Y[<%;SZ)\(MQ>Z+TSD"G)%34K:'<L#J$Q3EN[!3Z_M=0ML,?@2^@^8]_1
MII)3B ##%25>9>4SS/OQFWZ4K.82@E746HINSW//U>HP@XY8V9^2N:XMT9![
M'<='[R[(OUU0N<,C?_=H2]6(,8[#Q4T94PDO%JCX0+P(:/S1ZQ%<; ,:*\5O
MI=0(,$O1<JJT*MPU;LS*'+E=1!8I[Y_)T)EG9SZXV,W0QQV\\(3:,^+VG7OI
M?<HK]=#>.LI7!=O#!Q*ESH0L?K%73T:4O!]<PSY I<>XJ[)CJB:_Z1X2D[]7
M(3XI0]+_0.D$-4_6*[21O.IZA+0S;:-<<^\4T<?RRH_MWME/-P7=)S-.1H7N
MJPT-$I)I']5@*'.U?D YU>72E%7C)L6/:_M'<"U)?S<XN3\/=!?M-5EUSCKT
M]@VA923G_ DAKBE1LDUE&Q*09EWOZNX^W[N1M:OY;NVJ[F&ER+).]J (T^A:
M<TAJ_2K]>1]<:P\*QSYAJ7[/V)-N8UGOY[Q (AE<I3(7?X^AWMM[78+_/">F
M73F/LW"A,8E[RNJF8X]DM\]>O64.GBLI3;1@=*.N$%,AF'BH/?CT8?T$P@6W
M+_[:4WO4C+B>WB-N'E&A<VJ<+*8PNHHP@%OGVT^KQ$IY;=KV[CS:?BW%P)>@
M0AC\>J)^UPXS"_ZPR(2^05U"^=S:39&]\B&J%@/'5J<E+_F[#Z.8IQ&FA0]H
M3^5I[0R5U(H++%1!" \7=B6]G/HOM?:W;]L.7FGKNV[Z 5VJ1K;!W7TC=6BP
MT -4W7L<O"?AAI13"8\"G3WULI.20A2?,/_US4;1:W8&BXXX<C5XQUE[#(>L
M+7Z8Z_?,-#F%OL0CW$R_3.(MT!2=RF+!("4[QI-%D(/E4K00+V6"66Y^8OO1
MYN&BR$-R.[V]+:+OV31N'V3%2-3?,SZ;(M&.H^+*1O2Q)[*B1BD]Z4#*LMM,
M4=YVZ/VIPU_NY\%B8_.60<=+I[]E%HJ^L@.)^B]**JI-=/Y&=:(&2BW^2Z;!
M<$G\RPKI":9]_8?H)_(>.WWKM';5]#DIW#I+O00'3S$I[ #D!EWSA?J\G^U]
MES5?'+VCGU5)68=7?W%ZBV=W(,)I:!,^.^(^3SS9NMHE$S=DT_'TJUSD90<Q
MI:O^0EWF/A<_L=]^N?XR!7)JQD4VH6Y=G.RH%5&AU@OC\^,$ZM'AJ6 !1H;J
M2NC2,GA0*2O"-+^EO;R/;ZC-V#M2(:I8+Z_D3BG/UDBS7ZWXU\IEZ_&'2:TD
M662N/Z)+O"^XG!"*JC&G[K]J4XOW?QV +=_(W?;^?NKQ. -[$;?*QR=#)Y?:
MVV?ZFY?AN^K8"8AYGXTX/?$%5]EE :6^Z*I.L1KWR&EC[\W:=?QIYP7?^-62
M2MG+#\E?_$#^BRB)\ . 438BSJRE ]B@R:E>]L:2Q/&C67$#)QLE/Q<<=Y5U
M-)5QE-DMYW]MJ]:3/*.R_19Q;E*E)^8#7#,XH_S+NZ]IZQ@'*-3.VJBD]C07
M3&*9YLJ7AF?ZR+=)LJ.A4$Z18_\#JTW]Z/16!0%&7U6-C2LG_S5*%B$N!?O7
MJLO?,DN>)G64V_^UJ[HV1-)C7EX,YVE(>23 .#=@?)/[&Q@LKFZG0I#: \HR
M7[.=;12UW'>/1UG6CB__<69/B!:V86,U.=69 ?D634T/ AQWHH:[*#7\X6CH
M@00O"__ %0T>P?+$JW&X^P),G@)#@:5UOO)KMGU&7I1#D^>%P)&G[CK[M^3L
MTKFU97P<WZU1T>5SE^H(A;0O)"=9:003E#<<-ZA7:E3=OZO!<_)Y@,N Z'JB
M#D+C"I&:44W6?#D^.)^\ 97V[:6_?3L;ML-F<ONCA,&5YU1OR%WN&>SB;EFM
M*UH_[TOM-AE@)_,S=-=W7<FGK9XC+/?55?QQKKWT\%7Q,;]<7J4U/VG(/E35
M0W_#S2WBPXX<JVVQB3[I@:G&.MN3>(D-4SY7>KA7KA^=]TUO@>N_%"U0C-X(
M, U':=2^)PM&^:7DCKU35;%U@RD3<;'WWFY&^"U[[(5&\[JA,$=0^LCP#GHI
ME%*W(-PSR^=4))!P@QO=;]+%;EM!<TWG7Q<C]#Z"V.(OS+==\F_R%.D,<UO6
M'N12W5&TODDII:# *;;N9,ST@,GW%8^CPA6;0)T&!VG@5\*.HL&V,BU*3LU>
MQYK13G\7+_%CJ@>_,@XFO\:8/:[)N?.Y.[SU1SV*%N4;Z@M/48<V?9\9X*U6
M?.V&FQ1@-+6PZJ1Z)?(:T)RDT7(4@C8)^]M<,[9QUG#??/_V17CZDBDBE<XT
M_HY^!P66.I5UA65$*\<&$?BQ])<>3]PH2^1/%8>OO=1P)AX^,;#XF!)U38G*
M*)R;RI,78%83MU#&P_JI0G"9CE?ZJ"6Q^>C5IJ*'-24.)EGO(NJTGH2Z=_:7
MS/"?H,M&J=EP*;3&5]*X4SYOWXW8]A/[V: :>!7[PVJK4U+@EM?QHBF'K\'3
MC$,46V=%7G+^LZ+PD(6O'OAIUBN^YD7&3*QQ#9E,SF,'LX0'J+P-+J6V*Y@[
M*2F7%Z:"9B_G;I$=L))F;$OP^5Z4<LKD=K7#A;]"(>\"BKD $Z@!P@YLETD,
MI@ CP"R6OT-FKF@W+1NJ>*I[T%>#?1M16':8'$[4%.OJ_1%U@-)]P091+'BL
M;F(HY_5]4[I-ZO:"+2[L7'ZFKKJSIZ_!)VKVJ]=,FG4A?OM 1<G6&^>$'>76
MR.O[VAVS:Y&I]:5;]&>G>IV,/%RCZ3S6C<O-=%F0-$6>32.6X24A;5/%Z,Q;
M_D/8GAHJP C#SI2-1!NDH+]!Q)=LTC[K\R[1=?V@6,W^2)J+*GPI2.WT0_NA
MJ?##<=S((FFV!C]Z5H#I/$G'LU<6HYVLO:E0]UR]]0A_YV"HW;6OE3(BTYY?
MW"W:B]I/]3QVSDS*3*5Q\NRV$#1::0L<[ K@H@[:?D0-KLIHK\Q]*MQOY+9R
M\Y+!\M4Y7^"IW'LDM;G@B9D^"#$#:1TDC2,?'9NNGSSI_*'*<;W*$UA2"99"
M%-'5+UX0_V;E5V,#U_OZT(-#>/YTBL@Q?KIOG&[T-9WBBDCKW;XBC15CF>][
M]/H>R@NM^/@$>$TR7KHS6I*MPF+6?/H2^YP$=Q:=V^!0_)B[^+O7)_,]W+E+
MN4G\EUKZT((IM2^3+S<)2?N6GT0"Z&N<*KIZ:L^/2AF]C,TW+?ADT7@26QTN
MY'F,1 3Z[" J9"#-E?A-)9IC>9G.D@_4#)4GS+)GW)Z./+O3<U3[A&C&O@D7
M7%7O$OY+F#!ZG2%<U2L5T:=12E?R.1R4.)\T;M:2]^RNW&K?K78.QUL-O_\3
M^#?6BZ>%^#_G[68:1]!51"QV/GWAK#[NZG+U&=W Q'#H2:1%UF"DX;BEZ8.[
M*>>LNFJ\<=Y\[Y,C+]2DGMD;:]E.#;VWC:<-$C7HGQO*04UE?N]%0RRH)5:O
M*IM='K.I!K)I(W!:9)?@$+>&[L4#&9MW%R%&S+#ZF%#IX=M<TYZH70,B&BI/
M'Y(FW&&_(@$&75ULWX\7!KOBRB*#OG->+%+Q2UO$N\7JT<C&AT_^MO6]F/]V
MJ;<VFU)$=<3?/ Q/-#.URA.%WG<J]^38DE*\[Z"Z!/ER(X5F:,](4D9XRSL!
MICP0-&Q[.<E86V<7 <:M<G3XVSC/\U4)39'T+&,<[769/%7+3RI:RLQF/_^6
MB[VCNXNE&U>RS3WN[F'7Q&1,Z]4$R=WN[\2LI"U&%&^_#;B&WWA%5Y3_AMJ7
M4/A/8>(=2C?1'CGZ\A7GC8I$G)6BHW#,=,?3"V:;JQ]/ZR<KU87,1G2+LSV0
MCW2HRTJ/GTQ:V=&-1%EFYUK9F);/[!/=\\9ULZ-)W;!<E7>TB8R$R?.1H4^L
M6(8CUYA(9+IE]8F*D.H*I^[DVEQI,M(-(.!C''*#=F]X&5H24+1R;5/'CF[9
ML*:L"$@Q6B6L=SPYK\%&J367-JE/B7VJ3RE]56PV;S/E/XHZM8+\)<!<P:_E
M6?&?IB#E=AOB2 F$5STVO>>_[W/*C>FQJ-ML-__.]$Z5GM#20Y3/V,[N3]@M
MJ"91',ERZO.')QI6CQUH>.,;817E>?*-X893HZG_?'*LN>3M:*OK470KD%!,
M=.5J(V0VV!MN7T+NT"E!UWN.5I$.MKR8)FS_II12>.-2X=/EI6'K3SX^GK^W
M?\61VQ[/S+_1LG#EFJ@86DM=2]P/V^\EIU6F*%?.I50XRH?T>S:?"'_I<" G
M\+AVZ,6\=.,#"<X&+KO>MOL0ZE\VS34-JX[L*HN,;&.4L"U5]$'ZQ\K50WTQ
M)%#2A$(.*FM*7XSF^1E-1J@6>F<NCUM^P&:;4 -IZ&58\D6<IX&>K0X71&,E
MJ!9N)Q"7,3%?VG2E;WF]?BP3Z#[E^2G"*_<N_"G0&:W!KR$Z<E70[_@-1>N%
M[GJ-(&;]>:Y'3[71FR^YJG>=%FE\\40EYLGY'7<'[SP.]9%XP=7BJ;%\0JA]
M*=C-)0I(5%E7;]CSCB[UV*3>L<+K;<R>"Y5_%:T=6YI^7/YJNO9Q4;]&7/?%
M7>W=!I!^4BN5J1Q[448G3*HEO_68GV$J_)$2\!6/KG8$K HGLV/XB;K";T+9
MA8$S^+%]R1<X!TX\BEFX1_]0W=+^(\[ D=ZSQ6370';SFPME53?W'!-3P:S]
MM(NO2+<1I:<^(&T#*<0\-T+&15>B[0T12U<6G5@PSKZ16B^1\"7Q2'7>[O-'
M-'NNN9-,2/192BKL8H2S:5I\C\"]!GJ8XIFV(CW=,)V$L)@HEQWU=74'."=,
M#I7:YY,&;GTR\3>7BTJ],QQ1P4F9_W@,BN09)YJ92M2RK;-FQU4J4:%J,O.$
M5WRU["[^\Y*#ULG[6"L*&_4^IBU)*7@$[WZ!#23.<3<3(7Y*R4$0H&*H$F\K
M:R20IY#F(M725EC4-7M2K>+M<?(50O:S/:*JUQ43DK<R)!96@7*=CAQ-(V[A
M1Q8IOQR/,ZN*>#LF9CUF&1@VL4:$5?3^G=FC32O.K5>Z</N XG"""GWQ,1-$
M 5?9($4C'D:\O%@^=-'[;TLZ-\:F:,5_U%QU\7Z>:N0_#B*GWX6UMFRK?72K
M<5=9F*/PZ";/U,[7>,)P^\B8_>83N;N-NVJ)#<U6.O[.(X2CK]H%&*>I;FZE
MU,;DY"NP-(K]/EH8F!,3>SH@4G5F^Z,3A9,VN]9'RSNL<_D..Q""3G+7H5_:
M2%N0Y'Z:B+,^S>1#C,WI,=UC-P_JVNLIEU7.K#N\3G,TCM-=*2O+3Z;V)<7%
M/*73-OGN'.C#E]YS$QLWS2N^A#:6[-);WW_,P#[1?/_VW9S[GAFY<RH,'>X>
M"^)E?LPD*N[KRN#IYIUK*_]G9LGT5O^K-XXC-1UF)S:6RGF['R^]?\TT=7?*
MZ_?YMF>GX&D;XELM_9<#&V?-28:Y!,2;V,V21E?-#)#_0KK/(*^YBKR3 LQ=
MSP$+J$N4SG'"7BP4+=0;.K[TF)+KQ]TR:6?=OC+WAPLP;$U^OK8=2[P_YC43
M/Z!QM[T,WG#]@Y1C9(_W4;^T)1=,E238Z^B/0@X/OOV&T3W#S&<_XZ<!!R,O
M'\6O)=IP5<<%F'5[52W$JJK/?QM\FNQR?8F]F.$RR?4%F"4?/666/'H6U8O6
M83'H'N(__#0U0A<TH![LTM?-SE*7D@RR<Y\NWQRJ+VLMGK\^9I/]A^RL/3=W
M'6X."2W8.F6D0#72Z?8J9GB-=X2$FT2H1F?8N+:;^<_F4M)KB/KVK%AT-;\O
M;)T&.=572-^J8$ [X\3V2'>:S4QW!+*2<HK_"G)MD/;U'[B.78:N\-W>70VM
MKQ"^!JLG#9[O2#_-M1"*2 A]<_ZEF<T/W8ONFH2.8'K^@URH6Y$=B+SN!YEW
MW%8VA#V4PY=R=3*.:V>HUVO9)<UL(/RE=5E3AEA6T!!!7H,>('W!YY&RN'\3
MU9BJ LP&HDZ_BT1VJZK_!J?"X,% J7U900\=2J7?A(0+?7DCM(QN7)NPLKY3
M=1 D,<6<8EGR;?7$7,43>QB6BHWR\3/C?+G,-E#.NXV316VO=)%#=3<B8F5M
MK6_=7@:MVAG3J[J\Y^9EQR-';FM>]4#:%4$L.39.>>&6$$U9:+JBS17;[:S5
ME6K-:2N<0@XJ4C%K;4<+/9ZU.57A0K"Y,.,&,[6B:\4MINTX73*PV_A#U-DH
MRSAG-66]]<(!D;T'13S%]ZZ^\(^/DW2+F&@Q7+I/6_@-48L?>=U(H4(6VZI]
M,%. N4PS\K%_8U'CK#O\A'$Q$M.Q2UQ(IC\O^?I8@:)_1L]<)+6FFSF[_[63
ME+,6]RL_YT'^]P#[8QO.;OS??-OM_\7;;V=\\?,_GQ,,+[J&$H31P<6'!(6R
M&O]W3\5:,D#.]N&UJG!EYW#\E)\OR]> ZTT$F*RILP),E]G$]?_5,[K,PTF?
MH6DW5!RT552^8MS/\PWT%O_CA4GF%PLPH]8M_]^_.%EB1I1!9H;8P(9WJKH<
ME)5[XR4?P5*/ZM\IE9WRV?/E&FW-C]S9.;5&!WV#T[7ERRT<UH]:-J6-&AG)
M)EI%I,?TO[B?4CC:XV4P&*96V-X);8;L-ZFYI.<2_BI2%_OL8YC\Q6/5Q?*=
M&I#[A:B<0>]-FR1FS._I"B-3Y0</7Y$5;TU>]:Q.(MM(<K, $W,_>L)_=B0E
M8(OVL<,AHV2J(Z=7:-_MZ#WW=1OT2_!#+\J;K3*]%U1*\;+([;ZCCO0U=O<;
M&M3BRS=]^BK\8;5HEMJL3ZD TY&@Y)8YAY>U-KANNK90^;6CAO>, [H5*BR2
MU;UX8)7I>N.XCX[VV44K\$:UF?_0'%_#*C/?LKAB//FHD\V3O&OI>GDN@^I=
M5SYH6ESCUNR#BX[<#)#XJ.9G\-_> ]RQ+4C+UV17LD52V)&7ES%FI_=AECZG
M8/D4ZF /[SS((>0%\S5$AF7XF^^=R%JG)V?K]YM6GFWB[JU+0@L3JX]M.*?P
M^']J)&(-]RKIZP&>-?,-2?Z;,J]!XG(C]OMS#D5YX4GUZ]UU*F\M?"0X4?($
MD3"9D,]CWN_?E2[S5N,FX_>2FO!9LE&LBV,C%;8;X[8(58HYCH3_?2QSP"]O
MQ9F&^9M;YS</EP@PP3,(??N[)_F3UP.*R+%#H_DC/+WRZ<J:?N8#VMA'#@5J
M:(>_0L)(_!DFX5X._]KQ A>C$V6.B:MB,]Y!:3HK)U=)+-"YNKSK327:OF(T
MBYS=A(RRC<HG<6MB\N-E!EJEEZ7/#J2I<5Q8XGUPN*Y$CZ'D?6VM&_9BSX1S
M([[DPU[1GJDS]>:(&<NJ K^"=YY 0?Q^E+J3E=[IGC)?/Q]^;%)T6%1N14F^
M1MUN)PNOPV+6XTZ-'&C\Z."!T*]Y)^^Y4R0_H_+SMBX-,Y!33YO:I4NK,PZ<
M#\?(YLZ0JU2Z?$Y?\Z!3[EJJM8<13W6&&.E7?:]WO.@G9KWF[<!XCH_"IDS\
M;5KNR$WTH'/C^9X>O><N33MK<A).'!/>IKU>_)G2S07WWM;)F#9F5UF65:7,
M_ET<$[75R3^6DTS2BPISLQY;17;J2#84SCJ-[TWZDI9ZY\UC6\85U(:<H;N,
M*3JQ?$!4UL43[-/B<\VIQ=^#_.]M?6AM^Z4ZJH#S#ZBN2FZ7?$&<F' 9)#1[
MS9X>L'V+YB;2PB"ON3Y\^O@-R/C..XG7 Y LXD^??+A OC?G;[.]QL_PVM;E
M#?-G_++]=^TLT45J6-?Z\QD2,J@48D=?XV+,?)E:1S[WX6ZW3G]B-VWU(_+?
MG@:VX[;4O"\'JZ]DGWY)972HS) L$Z&LNFDUO]/7,@08QBAUVM:/6 OG@FLR
ME9$HA 3 T[QO8WX]!>,MJOLT9CQF97-9^G?H?%RE96Y)_$L+ZRM^@>570[K:
M#LJ'!]RDO"_9#)=J>$FGAHQ7^_'.[9MSA0SY@ZF=*7:YN&\:;27E0$NG4MK*
MZ[3WOOA_[N"47C@6R@54T*8^D^QG1W\H_HCQB!G,T:7<LFVRP>MS\]L'B0,U
MV4ICU+;]#9W526.Q#H7$.=WS_ 0!YL*FZ^UY[>C.E9-O5\@'_WU_7C\U;:;#
MO9H?.-"2&,TNSGRC?HYEU5TIL^Z?%W(A.U:G/;^ $<*(GH@)092\[>Y]N>)_
M8IKJV.@G-\74],;N39U@LO)]6A<6SQ>LU]GZ/SZ=YK^?ON4[4C'%^3_8>\^H
MIM9M83@J"A9$Z46("HB"B-*E92O21$100&I41#J1)B A41!06@0$MBA$>B?2
MJXGT)B"]$YKTDE!"(.U=;/>Y9^]]OW/N^XWOCG/?;[SG1\;(2N9\9GUF2=9Z
MIB+*'[TM ,2(&QCK?WR'8:'G&*>#*PQU]&E  &URWM$LQ'XPLZ5F0[@]-7PR
M,K(W)ZOF[O 'R]6TE)%%1TK#D)@])RL>E9GOME0;]W3CI'D@25E_QM%&I-,L
M\2R[V?PW,_$1>X6LFN(/A.O(& 7*I0VZGQ@#A'.F<WEI:<GZQF3F0(:\T!L+
M$!H%1DCYP_><%O"N5>-DH.JQ&4=VINX]+XBK12U7=>YLHNFT,K+!TUF46PF7
M[1]1D'\ #0W^YZM?31G-TS"EMU4S0&@=!FAM!!D(_CML\F2[T \'\4Z2Y1QU
M5Y\!0HQ0S_\)EN>XW;:$@3&R< TRUXVDD/"36G^$+7?7JC +*:+%^3! :M$,
M$+YT[V'"OP-KU,6KMO8:H?\@SY]A+YWZM_3_9TMO=L*.9Z/T8-7IU<<[&L[V
M=(X(%=61G7 &2&4@D$KI=M-N-4IB'8I.ML-DM0K6F-M 9)Y3CJQ8AS\*-SC4
M9_!"%92LV"]R3^-(]F5.#\[%6L-9E>P22Q/$2Z L_O7_]0P%'ZT526) /5#Y
M(P3%7E>+$>:,R$G9 H-Y$<$I.UAD;$VH+J7<QNG2=[55M8?-&)/D=)V2E (#
M>U6CSB#($U0 ^"16"?%]&U)LTH@_KO!JMJ"4PO-*Y<S3^I:,)O]CW1= 0?O0
M OX%MD^&D^Z8C&X:F,GGIG ]QF5LP(R;^UI:;Z\P0+HS_B'GLWC_YR?,_E?5
M+;)]$CGZA@&J.+)W^/G?QHK^(M3T+SZOA/DOHS_^TVR0[__2TU/^T^#0/>T,
M,=/U\+5(TC8#E.;^+^Z,3/XR./2W/N2/=][+_N^V(1:S%=/FS@<:^+G#79E>
M+8[;Z<8T-K^77V&E$Q\P8U7M#J0D5TA:3W&5OI]2_L)UALT5EMZ2J>,JFZS(
M8<\;CF>V/Q/ $7&([7EBSY1"\&I^B3>D^-.;S5*C"MNG7&X\2:O2-8CJ.\QZ
M&K9FW@%ZV# =F.^QS(<43:.FW>K(JH6W6A..A\!OXA6H(@K#-GTK>9]>FY=4
M=]\&E;.G3VA]FI?!R^[KU^'7$Q!YG1]VV2CH&E4B< "['ZY(E T_ES:1<'S*
M>.ETX0UW!FC_'58/!:'+/1[X8D%-4G>[X<Q(NBU3 4ON-=Z)R8I3$P^VLRN1
MJ,V</)?MF^55I278H+7ES[4]K!M/9)]^]5T]?9SBG6??EZ4S_C%^\YETEF:"
MC4.DGD_.1TYT 0-4LW"J@*#ZJQBEJ"-EG=W$;P(3K,1<5Z590J"E]LO76[<X
M5J1K@)??"/K3>7-(N_7;\2K;STJ_CXT*-[]A4CB=\\ZM'!]VH$FXH#E7D&U*
ML;JHXDM?+L_UGLE$\VNNKL]0E78SCQ^#V(R<P-?,[S5,.6K%INGH/',NXO=6
MD>-S[\[@Q2Z(>&SS7T)[^@ENDKB+K!JKV*>TC5*--H]I_I)3$N [W7E\H:M&
MM*/,^HC%#;$W\9YUC>[!IVCC;*KB[4TAQ;YZAJQ*SC>')19(.W=D7\BL4LIW
M25OYYF45O5'F_,4F5R8QK_E-7MM0I(97)GNI"U,4GH_'T%61<1E91ZL$7^:I
M2M7OWJYP=X5E+,H/1(\P0+D1? >X9L*((Z?#=D/4Y<[GR]1#3Z*"M_1N<J2V
MNUNGJQ_;+HML?5$?Q5W#XN-T4&1Z*V<<3)R-R\-;V,\NC@O>E,@)?6@[Z[_R
M0[OMX_.W507S=@?2D@O.$$M?*HU+.W([E5I[UOE\91E0;"%U\BW<*:N7.H:)
MK++\#%55UZKT%'@7=<#O,)-M&LA#UEA$3?Z[B^S0VE1?GDC1RWJW;X7[LYMX
MF4=GK ?DTC(<C"N_O#.)-3DY9M8J'7VC)J:BB7GI%VZ[_ZUAQG^9_F#UUV&N
M_]I1AO_T5?B$:!P'DXW4\2S5'LR1BIUC.B74!Z:>X]>BTAB@&2"]'P$-)Q<@
M)R]W0^;6&* S$/+>3,Z@2 8(@MPYS #5OI#/S(62;\FB=B@,4+,^4#;4/DQ%
M=N+IUY&$3ZS9$CQT#E9A.H(!6N?8.SB"\*L]> .(?6_1U/,''$(:&*!7==I
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M@9KFR%5>/T._KE$#"PA5)!Y%I2*G0_?J$YW,O2.+Z(JX22UAMFS]2N40B6!
MG=$&>T?I4%V1@')TY,![)\TT\5#/SSS<TMG6<M5XR@#]@?Z>UY]+V3L]ACP%
MZ.A4F%J6VOSJ^7SP'^E#_LA89'"?V)A@ U<=H.D_</ 'SMPN[Z924LJ3RY%_
MI/\GSB(TP??0'EZ<)FQ_I@_^(VO-=?_6S/]UFIF'F_KR[=2[H3R;UO,^L'$,
MCU_6V5?F_G6L&1(NQAV6%IPEZ.1DH,'%K/@__3O_O_]'^/?_"/_=_R/\=_:
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MAM$T)A? VRA[S._^_0+R^'<H#:XI'.&M WJ3O0JPY I=MI%X* L@*-%)H3-
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M<L@6A<>5QI4],*G0>:@:X<<&[LC:K!X[]+%9J56<&5C4+!F^<GLT!BQGSYT
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M%D.T&ITG_!BHR@EY]K3!*B=!0*7:B-]^YP@ U C[AM*G1L&=P'^N@S'%:LM
MK49%QYOE2!^OU#L_NSBAMR&\,*MM&7!!9TKEX_7BY!2_E_ PP;)5UL;] '>[
M/KLJ*:6/O2FV/;8S:</P]&@$;7A*#HUCH\>R'LD$3]Q6_OH3*O>AO!#NA5'T
M$G'IDV'78WY2$,@&AE/N$5X#S\ $2:6=JF)RS?&%O];8=N,DH/"%&D+T1@9^
MN+-A'W= V)FG Q2YLA45AH"TO%\>4]"QP9DV%^NQV[:ZQ[HSW*)EDF.9/@Z@
MZ).K!\=*-5%3*.#\(-7KHQ2#\G5C[R+QW'@GN5\TL]ZRJSR)UI';HZW7NK]K
M0=(+%UZ\=,I/\1[L1Y. F8.,A0FIZ8/N(1\+X2/;"B31HHAR/WKZ6^B 76X^
M@=*TF&?>U!Q;%WLFW8TDDQZCOD*ZCP#.P*A*R@5J)NP<R7)I\)/W!GVG:*I+
M9FD*5$2HN#P(9C00C4 :$EEVKYRU..=4_:1YT?OG0MZO]P-RBX'[C;2B)02%
MMW+;.P;#W<P !5;YHFU'M0?5%<2"*[L]N9TFE/8.39Q<SR)=O2''3\V%*\<I
M"Q__V )\A>I%3E7NS"=ET'TL\)F444CA(A1U@,X$J;"&VIW:4"JMJ6M\R-"\
MF^/YVUYVN.(;DX3FLY%0WCH*C]5"VDS;#61%-(+WUYR :U,B_*SGM6.DK,6\
M\<]&I:^S=P?U\>"Q#WNIQ%E#*06'11+R'FST",#_"<9(&VA6)H3]_IAJY[ZM
MXR)T3J#\M^FK=WM]GR6% 9(UT#(ZKQO&)W9O[)#/!*'FY1N%[+0_U>6*W7KU
M(/ZV'(%3E(J2FPB)MG49WY@DE!*72"_R(6C@AAQ-&"H_^)BLBWA>36[5ZE\X
M H0$<[QB9G+WN0E@*9&8']T$U_U ED_"NK4OXY>?-RE_7!=,W*MI1K@7NJEP
MV7][I113>2).7.Q\S+75%YVN]PUS!"O)OH92 5;#2],'<OT7^DS++E'?--9A
M:,?!2=V1]"@1Q^T> 8[1OCM>(:7-SUCVZ=>-[QV4>_E[FF+/1SZ*D7V8:W7A
M^HZMH\&:QWX7<D*%W)VKC5Q T>W64V )0MKV+V0;51YZ%7QO:2SLT(@:ES82
ME8W!46<A(]J\L#[T-!AO8LPWM_FIRHWO$!75-A.,3Q;/^=WQ2WCEJ4_*Y]ZW
MP-=Q!U5SW9W>4]%$87P"^#14!\]D3BI^OYIRNT&O&%O\^)7LG8T.@0M13SY8
MIYU);HB(F#A3TBO=E%?]U$"WO-:^#,8\[?UEN>#W2K%6<+:/2?\,J//#$>#[
M+G(RFSA)0N93GGTF<9)O!3EJB79E)!\!.JH<JRUN?;W *N5_P^D!&<AUZ\:F
MD"'#VZ ,G/$[BC&)2@^D:V VJ,;8;B)K1R[S(&YS-[LL*#C]<[+@W6W&R]]/
M9Y?K*49O,B2_<*S!9\\= ;H4IK*)G_#=W2;QL#/QV**H)DGONIOXC4KOILQ6
MGZCKUQ_6_*IW-0=)G[A;9@>J5=U8)-QL!U4K1(/<!L+/<D)FQ8=QG1^JL*O\
M,HZW2GKJ=5QV&/0"%".^>-YX]W9!M>#C2&F^\>R,DH=B ,5TTL/>W^*AB?E0
MS6%CD3C*6 EM!OKO,/!A6B>\4K(3'8X\UWP>:DA"S2/8@A!F!-V8./==_=30
M_J7\J@:AH/MZW"1]K#U[+,C]"$#/33%#XGC7%R!7JAE6%[=-S=KOF!5-=QN;
M4N$/C/P0SE%P>CO/DF$S<4)Y3W\#299?05=B6M]H\CGY^,N0/T"^@LUE:LHW
M<VY4':-( UCR!WV"Q;(02FHEXB7&"AI;*TWDW8L>5^]'A)G!+$=#&G<WH*.2
MN%9"'S&1E#POS$"$X$_&AF$=3OZ>G"&A.H94TV2<GZ\PQO#>969A3+*"<-1W
M!F-PJ<_(#X) Q!""8P5!J'OVV+"FI"_7ZKZM2;1G9CGJ1/NGQR?<Y6CW:]ZD
MH-[*^'B@VA1(;NPD2?;8)J>Y&=6YVF)"=,M4<\'XH5?^.]G"GBD>C:;+W^^]
M/B6HQO'P=9J83S!\VDR76HKV0$?5YEX8:^9W"+)K/82]!TYH<A9V*]/*GHGF
MLU?WGW.S?BF4L61-6 H;WB_-<E>_OSA&;(0%--3-II!WU5,7RV16'^.\^CSA
MJD7I15/@"JWNJ.9CM'8TZS(A %T8!#9IK.!#A)8Y=KHSIVSJ?S''B$IO2E-.
M$U%G"/L4[O%YOC8,_QJ8"^WB'<O4/E"B.@UN5^4^YJY>N\S*_6K0,-,[6<*X
M].U!CLPLW$UA,LID2H9X90@FO)H"?[ VUO 8^>R#_'ON6Q>_A/.R\O0E]J3)
M1H>;OYU;X-U!MX.G2HGYU%RH4"%4BP#?Z)\'BH!7:@D34Q!;V53^@A<\8C#G
M5SK/A#X#7"+DKPL ?N?VXHPX+:VJ4_>AXV"YPP"U2S/W/I3YC2["$(>A^UJN
MQ*O4.DT+@MV\=CT^='XKDJ\-Q%-]6_#Q-D^!JD=D(/1E[?C4RERIHGI*WXOG
M,*,J?!&=KTQQT\$"H:@3R-QD\2[(KE.$LRGU3M).QR4)ZS*+K%%+7HC["-?%
M1W=_ZNT,?(>LHB85B#!2_@+[E%4'O#JPRT%DN,VV?R]C0LF;S:ZA*9W 8XZ1
M8)ZZ!:ECW!3_]>HY(!B>"&:D7:;U(6LLZP@+<^@H$!:$WXK- ^%?D1Q/=K;X
M5O?4,'V?SKD5]ZW<(CZ\,>3W;JFAO]*^<TZ# :XNG5H^F#>6<]ML?#81-2I'
M]9_^FJH$QQK_*: &6FF$@HX +?SP PM'^I["2*:F4@+)\JM(#G:$?PZ[S:BF
M<;$N3/SG8MJP=*6W0C/_9R.0+O\"'L5-Z.Z 3Q41YX; 6%HB/FYGSC6B!K0;
M%FI+$.HC1GC!#B6S>60MHG2L%\0KC_F;CNZKMJ C;-DWZ"0#=1TO&35(Y^!^
M;P*"AQ:^?TF+=:<#!.[ZQ]?F7!F>2R\$%1N4@G5GQXT/Y?A0WV)M[TI!/*'I
MB0I6I;N;@=7W=74>_F>IUO\XI5K!W+3IV9/9QH3RG/F81Z!'([BQ67?%NY*(
M:P,?S+R8R&S@)U97"$ L,8.@T6:5=>93]+<W7DDN9+SAL>F+Y/ 0/]'S>$A>
MI(G+?:/W6\[!&41'=?Y8J 9(GV9'0?1Y0*Q<"!I8QT9\48?B:E9G5; =8G(K
MV235)R?3;GPT)&[!MCE+T=1*?]=!<(3 8>%N2 A5TK\]4E.&!3-[S%X;+_,+
MX^HUHM[ ?J[H4C^]_3U$.FDCB&?:P"&K]UD1DUJC^,@N^V1T2PII8>%D[)N)
MB=64\O>^DNDV^NF!%]\^5;UV?^#)W@KL*Q6%_CU#L3D"_$WYWIURC"3GBO=M
M)4Q7ZLNC@TH.$Z>X6M^XGBI ?*EOV5/36K_Z]U5:=]Z4]-88E253R!WUGWSO
M0-(4PEGZ!AH/:)9_:J^67_W=]C_4G_@_V]C_L4HX/8JYT;_GM5G@O[R/  9<
M7Y/^[>*MQ<7N@QZ62U+7M"RB+92]XDYFQS=HDN\-NPX_EI(6KC^P9T]K3K/\
M*N(F6I]0\+'R NVLP"<[U*GIGN]<2I(_*6VU9ILA?H3['L-JTC+!34!_RM4;
M^O6BAV9P+$<3G4)]AF.,:;S0;RO$$?(;/\MERD4^Y,X8.WD5W88@W5( +7\"
M[@_#(\]]TZH!+5U>*1OX2R<0'^,('[ &;7WXHXWP*M0#_OWAH!WRK[V@OSR%
MQ_<\<>0(\*8]K^[ONN%M%^AD3NO!$: YFW)I20=7? 2X$JWK]??]1X"7-W9H
M(:U'@#!5TOWO$=-F-*<S<;_^OOL(<"IRF;(703OTQN=G,M464;J$>>O_KI?&
MR3IPL,Y$W<5@]179/4T.$M1E?/_:^1</)#F+3"%W^/_3+?]QW"(<Q#O8.K<\
M0UZ/9%WE[P'E/%D]E"O/B1#T2J6%@"2/ &6F2PF+L2\#1K[]A*K?E.L?FO._
MC=@!81V4>2SE:H/]I0WS&^D+-_G-_W%!A#9T=0X2=P%O0LP%QX/89?U1<? S
M"K*6K!B&UA+C1=MOHM83W1[,@ K=5P;GO'R<3Y_T@:WE?1C(--"Z;U!ZK2;_
M"*!!BUZ"=YHD &O8<158(724HPB)J9@B/ECC\QDB.!Z[E'59;O^XA:WUA8.[
MEUNY]$3/'^L/P^"9YF8SR" *$-_]W"_V-+%!ZV/LIDU =NR;C'13#:^ Q]U/
M%FI"V'CS/*X\B\/ -3RW'9J^3_FXU]5BM&@P.C@Q?_W/5&GX-_3R=H+ ^Q?A
MFS?^"$G0O%EIOTVHW_[)FA;T=NP? (SC/R*<?UM!XO\CE8UOH&TO&O<1H Y-
ME<GZF\J&SI],BD=2OQX!5NU'_CDR&X])$>U9X+CJ'C^<DTG=R(8S^:>#GK#O
MQ/,0SHDD?0\"B /6"6*O<?]>JU#B]A9PH::!2W\:.5M:AR($HF!Y-9$VPR0'
MA#[KFX7+H,U1^S 19$#WCQ#0AO)<O$"*$<[(>B0<]UW/>EZO=5G#+("]8HLT
M7DU2P(Y'-0M/U!1%^X5ZRDN0<?QRHD> KZ)<_:14!V&>9=M"8['^*S;E&H+U
MSWCM,R"K^T_H@52S3\E&QX-PPT< 0^S?=!?_#JL\"M;_=PBJ?\ 33?]8[_WG
MOXOLPW^T]I_<Z?_?W.GOY^KO[M_\N;XR1:898SJ1Q-4C0.'3G_\>N>'_Y3)V
M70L9;7[SQ;?9<1 %[AZJGT;Q.AK3/GUBI7WKH?2;QKOJJG,7ETQL?$2!/&WW
M&F;Z26H\&)S1P,&_%$P8):MX[QD$:K'$[?RE=Y!:3$=6H#\E$[K^5I: O<2H
M?L7<*O<(X$'';G10M4] =R'^\@<;$V&F#@,W\IKVR:8[--CR$0"=2%."_W7T
MX_:UE,T07MYE]%0&<F<?1*5X$_+_.CI4!6B>X?OS(TJ+-D)'?T@Z7-U:@"<"
M_S)\\O-A06-NI&[P%K%PF4(=. + A2AN?S=<I#]Z5/S7KK3,P%]K0?QU./&)
M]K\4A@C]^]<$_65\U</_],I_(*]$1#NB7X;+VWQ%+M'\JXI(-7;,0=DFE%V=
M[GE06V%K9A_;M;4:=76I9,-4O4J]UL&HFV=V#R->_5OR*?^W-)F_I+,_>G7_
M59O[';M37MPEP#^Q,72#'F\=E(")6FM(LN'?,*O7$2"K\ C@-/OGBDGIQ,H_
MTQS /][%_YN:W]]ENX\,$RO_.V[_6"[_L.;ZCN&KXFMLHB<$=I=2QK9G#SGE
MJ@F_;H5HWA4P$5C3KC[S8UR";@;'_P;X_[]+8@\4HXS:(#5]O*W*=@1(8@>7
M>=C?2<<WE3^-417<6>\K:FI(<27_\-W=Y7V6^*-)2\%=YFLR=^/MSISX*VJR
MW6)#]W7]1%K^AUX#9\-/P^<*,-R:[G^[!\BN4*W W)DW&_1R5='$V]U/_M8-
MT^P(H?#&S^JX[IJ_W0,<=!2C9L(XK(-0;41;!UK^LT\WBZIMFTQ[.!+GTWJ.
MJW%L?H=@SN7*B)O*)T!0478PX%+"@K+4CZQ9=70W)7/7F'>';X./;!)41"S
ML\?L#?!:NQV&S687QU\RTX^RSG?>3MYN,W 66T3<T$[;Q3T93CH"C';>+?#H
MSM* I[_0Y3%5_N\?+J(RZ>&J,.74":S<:O=DZ-#F_3RDS#IST_(L5_>GF[+)
M,=\5M<WUQ5P#[OF+.6F:W_5@V3IL#E_!.*W&R2RS3Y@07Q%4<5KX?"L"*.Z)
M7S8K6>NQL?:UW2"7)%'!=M;P6REJ,YE"S9>9>'?#()>^:( D]TN3Z6;I9VG0
M :&IV[_,N#T*T2Q-NHE]$F+?+$_@C8Z^,%(.ZX&HY%^*4\UP]RP<Z&V26HP1
M/NFC>R$XQX)W&Q$)ARAPK8%J51-I@A!6;",[( ANJ%ZY?DO3-UA/)L J.,OI
M[*\?P5/7& K#^.9 ,;F"I/?O<B!M6?WE7PMB?]>27;*]$GJ$/)^R0T46PB_K
MG%^*(0^:.EC0K.J6]-67GFW@2&"3Y$$Z].O_K^>W;,) Z]0[;XX;V54<#!\B
M0C9%DQ\G.@CY7/XF^C6XQH_&-2(P9J2OQJ(J^7E31JJ[N#6V(&M9WT"7QU(R
M_5]C&WP9-HS!WQN(PE1&)WV"2L[W*W1D?2CU?Y 50VNOJ4N_MN#J=V_)9N%"
M;&(20-,I*T,LRZ384.[#^,W50YDY(SA)3K5E]<,M.!N)>,(I0BS+/]-B7\.K
MAQ(9!L9?);XB!9+U23!/<(N(:(1MW*^2&=LT-R]/Z^7CUF]/VL]A*ZKGYMY:
MQLF5YJN*Y62NOKZO:Z#S-\C(NP2NML*=P"(G4[&)F"2HU9GW_H73OVX^D:O^
MLI"R9"/F6<+I[&>69+T8S1*R^S?5Q2&?09%LW8=![)UC1P .3>YWI-RAH<VV
M89N*Z'M18U1>UR2U>^J?7MB\5N%W/BDZ6P<QT&V[JSC#*2 E+E[%(M.IS4P;
M<^0D'1!$Y]DC-)6+(/=G@R16)M=4]W_>2$_I6>KAV+9Q>?S@SEV]14<FK..X
MV:!1_BC/;FK\C-N_'MO/:U^&>N#!+=Y,??/P<^NUAV=3RB_J9<B);;^ZG71I
MY&SR-T;<O2#&MP!C?\O#:C.WP34?V?3/RE_J7=X"",4.'9<9GU]?'_ P+GB;
MV_=L<D:>S.>&$J"^@7N@6.C6\8U!=;!L"G;#NS/RE-4!B1K&*P+.I\KOP.PK
MG0'KXTRY:1NCQM<V;],WA2B>^XZ<!#+Q%TF'K#PC#.K2O@3&;2E\=V"_$UN.
MNI*0V(N6#69"7,G0*K%_'2BEV^<TLX**UA0] IR((9V8=W@HB\HG6$5BG1!U
M:X?VGH!E].126C=U!^P>%-@18A5?K2$,N3GBZ>]Y\5 \=^SPAT6ZP*M=%Y=K
M%ZL7 Y96]!6_-F0IW=>]_:^>H3OX*NR/@X&$F]@CP'/E1%6[44V=!;L7GD7E
MJ8R*^LR*!3I+"M*\#@-O/WIQ?EE(AEQJ]9K)R&8JL,_MLPQU^"MMXYU'T\/#
M"0N<S"6WUFJ+#>^5V1X!.C/*'A;9KKRZ*1O9JBO>D=(=^?WC-;'?NRAWZB7;
MTK):6C,^1 ,$'J"\J3:]>L*T8^Y8"F3NJQV-50U_TV!401:-%2:,8B8_!,$&
MO1\Z/TJ%<-8S-S(6=^E=OZ8E'9QV$)+6B^O_21Z+(W%-TUB-\>JA+Q,I:@M]
M?DX1LO\M\%^@*IHY*,YX>#>"<8I4U2KXW78V]FD_,%NP4M-47E7_XN7328K7
M1-\S.G/<?5M6FJ_MG),Y-:C+*WZ"-W%!@7<BB+U-'1.K;.D\K!0JA=K,NLP:
M?/]"0(O8\:=%Y^*P:%?V*:'KU*)FP<X%Q.G5K*Z,_#Y_N8+[Z_<Z>7XXG;]Z
M[%P*6SU]<_0IBN-KFG)0AK\"^4L<KGP-U#+\)WY:.OZO9YE_-/W^5=P80%3_
M)\H+_HO$X#^"L/5_@&G_5'-8_D&^^(][_OZL\_F?3X'_2]X^5>[UJ*HN?7[>
M//S4JQZQRLL6N@SBL9H IA!2WT(@+OKC.M]5=VW&G&JJ+!15RM_[RV1<VQ$^
M6KPG"@>V#S7 I^WFR[J0WBYSB>KP2S/G&]$I4J><1*QE90%=_(G=;RFE7>P@
MX9I0_CN*D"ECX"<\FMTT1SRILSOK", 2:M>XM4BUG2TK\U#?&Y[Q"-RW31Q^
M6SWNJU1^%]#S6(P(3+.J&$$I91?65S1D]2["-L:V^7^%G5+[6**"<IQA'QEY
ME-^;'CT(8H(_ 7&03(GC=PE^ Z@5YY>0XI/><MW[=4> ONMJWYY4;/QZ0&W-
M7S_K>'X(YR^LOJ8Q+?2:Z^8S5B\KLY\1X)1$L!FL_0C (_9Y'*7)'GI5N6:[
M9C2\0DSL6\&WB)^*QS'FVC6+\_C!1?_S94X[CI>P4_(O*R9N;_>J]\AEK>$&
MRS!^8?FZ/%8Q,/7_Q1/\_\G!Z[_'$1M!@W97=*Z(2B>[N\E_3ORT)>$]'5">
M(\ 7#"U%/%3XWWP?9U*>T]F4N7/!"7R']/>9+_U,\-@<^GD$"+@'OR&#*,-6
MK&/A]-RBZQ;P=X^%8LE.L'%!Q$9V$2G0#'P<WF93X#'4X[7O9$D&3GZX)W /
M<?'.ID/'.<07R,HA86!J?:X!&DQBF$>R=G/UE 0#GPSS[]E]:0YJT:I[\)[H
M:[^W>$GGAY;R@3]%94?ZRM*^Y9:W(YV[N,"G5$VH'[5Y.Q=8M53)7(M>A55-
M0[01>;;J&!V&[Q/9$:*B88/[%=/*D>0'L+&LP(WL.:J01;:NB/C(GEV[IW=A
M/*8R)2ZR( .>3E'X=J6N- F"!9'$T)U+>&3G3" 61_D@8\(Y'4RL^/:L=AM@
M<(_]QF#FU2. _5@]D'3)M4-C"W$$J"G09OUIC=')Z^.+_G0AL;+240-Q#7%S
MZ7+"$6#\@NU88]JUP=D BBK%[R#77_:FN:1Z8]?Z$I&<CI: O:;U@:K#QG%\
M^ _KW5G(R-166UO[OM/''8QP-]SR[B_=L>[DMV"K#Z6V@X%0.I8/;W)8I5UL
M&F[F)YF9?!TN*[SRH0)572[_?,%'1^B"A>1[5[$$9ZGYYE4\LA5X)LAUSCBZ
MC1QSFG8N^C:MK]$\[=W5? F)1RLWI7P<8AG#%L#G2) N3,7XAM,"SML6/U83
MB"(EYI'5IZQ/CHS]/!YX2D*:X^I3(<74[84D'\NZVD73:M.#.LSR8=6MM1).
MSRF3T-WM UAT5I HC95MP<[3$D2ZH\G^;DT=<IF=&K4S=2<^USJXTI#_1:ZV
M_6%2S:$K'C-_-I%@U]*@$ _5TK!?.:QI^#7=6#X.P%M$/S9E29Z( ">@ZZQP
M!G-'@*GXSES@J*8<UNXK6_6$>-3"O1%& ]^@3[WW;9QD 7=4%)>W<NFT2P\]
ME[G93Q8F7;O*=39T3C&$O::OTX$/)]73XX&<>\B2DNA_0MOY"'!U!_0_K:""
M5VT!'H#83\,G5C"']T;W!RB\[31CI/X1H")K^@A@L D9B*;$K1RBJ)^G$.19
MR4&:F?8-:C+<<T:&:$J2G/=483MKPD%"F8]I#WJZ;3ZLB[IP7"%3[(T8I>5Y
M?$]KCR/SKLFQ(T#K0ZC32320(I'+_'/+3^\!D,S8[^G+M9PN\B1%YA4H>G'@
M8WD=C9D=CVB?2HJ8'XA1)7* (;53X:OI5TWX?=W"Q0/=MK4MO2\?U[]F'ZBV
M^:>B"A,45 KEBYAG# G[BHZMCB?)S=*46,6(VRE1JJ);@$YKUZ)^1)/OI*-I
M?I^:!B;#Q$[\$+S\V_<AUM0/+%II/S#67P?OPN"7)\%G8!?=0+P4[@(2JEVU
M[Z-;P]N+;A*.IY9/?P)%IKTP+7K/:/4-71--X>G3(XG.QV.8@A3THSMSQ2LE
M9-8;BS-E/RT"MP=8=PP72,^E>0A?7EW? 9,DX!W]1NW@RH$N]YM*%:0'QB63
MQ6I378._/A)G3H%,(?.(R=)YU1<45D)E7Q>0ISI'OU/=&)7MY^GY, F[U*29
M_ZWR6UP+UW>?D!>M>>4UHV(X(0F:QRHLK,&S.*^C;ZVB)*-I&NQ;!<^ %8UJ
M_]'7; \:PE@C:-Q 1C?UJ-??&8X #ZO'JO+^YN12CK\Y>1U<< 1@ILD$^2Y8
M/=\=X NRW,<UZ&ZG%$9-7GS6KG_Q",!:/(?H.Q\!S@;5+.,&\"!B"@D$QZY[
MGPK*9>?6J700,OTZC..P_2;@PUK6?EGOGOES]OO=#,(*%,Z^KHQ$R0YOYAX9
MY9>/QLW#10?%Q/-?(3YRPC'*?BZX<\4U):/:U", >#45YZ#6C5DRT5^DNH44
M=8%)4E 0$PVT!F?S@@(RTHE\8V,I$!](WLR-WN3Z5UV>$Y?N2]+A0O1'W!)8
M&#U7?G6%)MDPU'PVR-=X5(EL<]K5=KQI/&F=,?Q1E.H-[L',2AUR7K,YW2,O
M4)ED9ZB>8W8Y+IIFJ .N1+/"3I-,L$5M.(W6!LOH1UG7JFY[82%^#X,Z <E+
MWZ@+(#6YMTN?"XJLV 7+U@\:%1HPQ=5%JK'%>@I&Z!23/2I[&MS9Y(^]YS0]
M'\XAA%;.-@,))]\96J\)/DGPE'<!(*62>]PF7FSG?&=>2+JZ5]2E$-\L0A+
M[U@0,F(W183E6YDVL<<*<_6NW<XWU;-) OP^\_LY,ZH#QZ=;BP?A.IT*5M:)
M=G)7YQD#QBI0E*I$94 )^OH[%NHK:@'M+%295(C'S9&*90.:!8;%R>Z-V::A
MEW"_6>ZI/>TMP'X[5JD8\KC:Q_]R11F;$)UET,B@&Y^WLTI-$V8.X'.H1A.S
MG>E.#-[:&SCC,:0:2>'&?E6]\X-+R_Z7XQW]8K??,>P?9K6,0X M0)+,35)I
MY]3C%P3)-J+Z'<&7ZUX-L_%B\:?/=$AG7GA5,9G:Q[1 _E!-$Z%- "L'-J*Q
M&@@V*"C5@? @:][ RVMC@\'D:LI3L:R'IYSO1SJ\2SCS.P6NJ:U-T1NDR4%=
M"9+QNVR,0:Y&HU[I0=5SO8;")0(_?@)<']B_F$%(EO'\3K/N]MNGG+%-*>97
M"]7MGX10X;;(:B0]*+6. *=+\5MW"+?Q&(HXT',DU82L,$WKJ?+ST:;2[#./
M %8)3FA'F=\F).@R]?X1@%)_!" GH764@<=)WO,*+ZNS%7A)H88$K11]GG7O
M3Y.Z@8(]54)MWPI.MG/F-B%M27PTEA,$X%QW"U7:^WB0*!;Y_#=A;Q>\JIH<
M%-"#KIA_V Z<@9<_@-VGG-\$M;]=5[O_.C5P7)<:MOSD;<D-Y8L'%C6TYM^6
M8)+LV!(#C0X[S! ' FAR4G,9]1,<PDYR.0)$-0L3O"D7,?A4.&2V$#E!A^;:
M/8M>D8LSZ-[4 !4G?F'?W-&#!3* UKY#"1Y[3ZA+\!2+QFXB53??08M'E\R^
M>_@F<R7OJ/JH) 7R'D)H+%3!FWBAUF==[T7!G'DE'UL M@//90SW"W5!U5/D
M;'!F?W2Q9=[KW[L&5"*5_1W:66'*ER98A?U1.(\BZ:&Q?&21CX?>D]H8XE?R
MHSAC,N4+ :G*WXW?6VHRFF>B\$R-8Y=QS&'X(7++,[FT] J1#%",Q/A+@W-/
M>@4#$J9?'8\22Z0VQ,73F%GI*69UWH0LL'P$&++S(+$3.X9_H,@N4)T*]L7L
M,OBWF=7&1\M[I:5!\ZNF44-Q 9LX]IU'_H7GN,LD2T(/0C&_$:7:2O!61W]6
M$-<O:XH"OCD[L&#ZFY,@*L;22O7!.:_;3D&]4KCZ6%$!EB"4'37I"#"73T17
M\\7CFCCG<2SL9T@?UE0@,J7,-F4* N95^C7;@[4_;Y]X<TY$IP5D%J0_MQ71
MQ(=? C*L-HL,S^.'IL/2(0Q>B<)M:5.X2Z++CW]7J1A(9E',24)%W5C@='3;
MH5>6K1"$OB6\U?P=,[;2=6P G!%G[M?1?69FI($R1+U7P5UFF#&F /&C>)*
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M2Y"0U\>=2%IE$*[5%3F%?-I/CO<'!LEY$_ 8AHJ;;^RAF2?1;J#'P"C0&9H
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M><-!!?EWL9QS$V0BQ#5\\=)>N+A%[8U@1G\:0]LR:#HY0HTQ;<1N]'GM2I1
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M4O\<FP-G;/ 7NBP*\#5&9A7;:4*AX66:;YP2+U;U.B3&%7A[M1)UPW3XL^%
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M[OD:9CE/W6_U6"=DW4IL]44PT)+HWW@^ICS*A\S5!!TM;4ZU;V&*.![Z/LU
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M5MA_\?9G")IE7!?29[(OQ/6&O\)*#6E+ HA\;>.]-P<S^]?I!ZD:C(3/$T(
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M-<%UE:HU56C9JJU"/M90$F(:<CM^KNMF%.]=K>;0RY^[CM7?Y[C4/<IQC10
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MN9"\0Q#(O7U6.OBY=TEQJ/R*3OC\FK3=L,.:5.2P33T#9^3Q)W\J]@U. /<
M,6;8"..LE_$G,"51VN26EP,WR<=(R I;.SZS@Z-=,+S_4.+'MA$+BP,*F#XW
M^G QXX6G!'5[RA_E0;/OF<&>IGHRCSWH;:I>2MDZ%*/&[7RR7>[3NEY1\=%O
MUR]];VQ%OQL>J;OX7:-S;75Q%QMWNER_LZ"@GHE#1^G=R[/Z %$PVMN*1GF$
M>9H%(0;3=% ."3Z_E+M&K6\'B-IMRW2R]VNXA/\:^8,O:X\-!]7EZ/8T-$)G
MQ]NU6F3PF_#,=IM",5?KJ/X,(@7W#4\_!6V E?FM@)!#I;6EXB-\B#JFM=\-
M_7W<\UT^KXLE=!V]D;3.W=IO[!WE&-$6B9[T-B1$XT@2R YTW3&I\=]M\D1#
M%L3 D@'D8PK3SY#EX@A:<D%PNR&9,@^5"<Z>@*]VXB?:,G*='T"@=Q$I#EQD
M)5A%#IU7Z#89&Y*XBCI"HG28&CG=>;VJ62S7=(1-].' I3O/,YWRAWV@5#%X
M@P?TCF%DG7Z;S5\I+P_YK2NG52@7A/S'U^\[+,X@P[7Y&>\!)]CK8<Q1'T[$
M49T<*G"G+M2#3;%L^3$UR8 _.:ZM;^.R!,>A)Y*W;L72=(8:59(_5B)_/(TL
M9/XLFR]!=BY_WD!$:FNC7!CE(#@F$+8;CGEQ[4=IDKKQ#X=17AW5[BD*9J]M
M#[RX5=$H.GQ658#G$F\WW8KJ3+N-;D+SP7@V<3&[F%8\EVO"#=\ZKI:^[H:F
MG[GON'M@ O<XQ<3DV>/B')QH1YG-(.YI2Z/8OI&30W N>&Z48ND05DZ[[_/"
MDS^'AZTR+R.?1:R?Z3;G^9M]]<S#D1R4%>,%W?(+U9R(OL#\\[PG-JQ<XG0A
M5Z1XDH9&-FU:H73IOC"]IF)CVWNLZ$XB3P;?FFO^\-IZZ<IM)\$2SUOD$=T^
M6=6U^3\T!^28<],S6.EMJ.#:I"'\:,>7]OP=F6O)<AD>52L/Y6XX5BQ1*PDX
MD':XKHW3C-.F94=:(T%NA#[P'639!&A_K7;\3NF-PLI _MG0CPJ7Z_4U7C_X
MFA^1 9;>&9)]>P/L-Q?!N=E0RV6)8K%;5X1Y^K5 ^VK-S:GT.^-L*OON%4:W
MK\:X;_HU: L-U I-(;E<;&X8'$_.7B39V&0Z<HC='+*$ON#UO/QN:7 AJXMW
MO09=G8EE/G*[&ZU^)[##'M>$3_M%]V54USJ1(T:,2;B5<?*%71CO<K'[L]VD
MQ.D:WY,LB/MH)_; ?K-V;IGH<PD=5_Y6J*J.XT@F,*@#<^_FKJ:Z\ZNMP-[C
M2UBYCY]<*ZN=FL?_7"\FI#E^/OH]YI!="-UA:QI?IC2&;(=3I:%-B".CCVO#
MFTZ3>K^6B#1>>-7U_ YEZO"U[0?22";'RQZRQDS.RC+II3Q>-]_]'&7W9._J
MF OAJ/ZG:T]W!#LEA[.,CXV9NP4M*B7LM!H._1DS5LJ_!3SZ(+\PYH&E'\E_
M]FM79:9=5!D4K/Q4;[/(ZV2^5J[7SW9%/ES_R>_I*UU3LR-FVGOY3C__4.1I
MQ]$GQV]B,9HPFCAS"!!1TH#S^6]0XD:T!9?YR)&OZ:H$6L"7F!Y^3ZM9*\\S
MYD^.'S[[HUW&V+T?\%@;RV^'':U%3B%#,.R;RX:Q;[0OV?^:1%ST+[@G\Z,H
M#R_YP%2OR\G<4<WB1]O!V)4TFI4_!JY/1A M=F7']SN%7_W5U^>EUIQ;":,N
MY'F9.ZEWN(Q7.GD0P;F1>W=?M\[4<G6MG 6YX8QN8T&$ZV7]]2D9Y/"563*B
MY83_4I!@,Y$B>L[D#>5@Z)#]-\XP@V"-]<Z&Z.[#8@W 5 ;^ -UI>FVLLL'A
M>/)T3&'A;_KUH21;^6-=PK@'I,U[[?N[A/6\8IZE6"5:=8RQ()-%R<PC 02U
M<NPX^XQ?A%PM_*O_U,(=E5CHZRT#08.U[3\>UBDI[]>3/AS](,FF:?G9 $J7
MDZ?*7/HC: L-UQ9B'[H1)AS[&1\$T@ES7:F$9H.E,4][N43\)%$$1?]M4/VT
M14]JV%7^PH[EQ+--^LISZ!M-L6G\[PR*)+4T$$NW'6&*^8>OE!KD+(\5).@K
M)W0)/R/I'PZ8E:[0F^3X-EM]]%&M(\67A".>HCF@>R=/1[1/MWTGU30.J_0(
MD&76E"DUTT*]EU-=;]=[W4Q::&EY_Y;[Q-^3+^H_@E7D33XX@.ZM%R+I?=Q8
MTE8@*Z=_B&/KREL%R:W>84"=QD58>[FB+4SE:I[D[9\^L;BK_.KTB8O\.XY7
M/S&,%8)Z;L/\\XR#9GAPS4)X.%G>?ELG^?L*X7@_<HZ(;*07)<8&PQYK(=J8
M;.21%1"YFS G41:^ALN9]NYVX9;?(V@F45T\CZPSK56_P1:/E97N>\%^S:&/
MYHT>$5QKH)!PS;UAU6[NF-.U3F="#%_J<I__\'C\0'<FX7W%]; =M.4CPI-)
M>8_8*#S):A&?\EA;U.6*R(C_"ZZ&-T@X@VQ,,M.9YJ.?AK=YNTT9L""'D\/#
M*0^]8K\S8SV_(^@<*;@IO0B_0D$WA,=/CT)YWO(:E/1?6HQ%YMQ4_<'#H'92
MG&00>ZA6Q07H5EBY3_7127GD6*Q5<OO35LIGPOA=31O'[D.H3UU2K2$#:4&9
M6_QS=95[VQ;><<>4K37:YO>>;A7T;V[>)F:Y>37S1WO>-'^8=H]@]5)G7_!W
M_A?[($'L9,YIOO!Z'JJ\.=DY8NO*)L#E^C1@Q*]$K"K:BP?UE?.R^ O>:^)O
M(=DH-6KDWN[N#AS]=%N"[<A@+2Q/SZFT)G[,UEOJD'3-P[RB0V8S4@IJPB?<
M,N2C9<L&=A!T7E_D^CE# A+-&*K8L8=1O;.PG1BJ5'B+/-<$>AC#1I>?]KCV
M6%/VTXYZ$?9)GV:^L*+]Q82+$=WM714+^V#*Z'S+6=P+E/07YB""9"'_QD];
MK%]&TX@ <%CU>%!$C$?E/*P)-PNOEWER5*Z)6@J(6&KE7[&?=O5:$^IB0?;!
MMUSZ+<RDU!X3H?0CX^O?-]?H6D*4!\)<;S [5X=@.X+5\'" = ?V CBMZ9KE
M;]B4KN&!:%'/#!,R5.[S/=P=Q5.\,SEA?I7#V"JX]1F"U($_ %N(IH,BN\FA
MG06)ML"&XIQQH>F'1F2WL,?HRB0@?"LR:-+X<]:"2L7(24_3PHH;49<ZXX]S
MG8FST1O9KE!,)*ZNHL#,/NA+G9F&A<(X45P95)T6F\JPK1ZDM:O@_(W:I.'9
M0L+K\*OD;X_Y4N44?QY4;(&6(HE&M&O^S[AXEV!"J\R3>*7]]M*-ZF>KCB!%
M&V>S9O^:9M3FL 7RO-UOS$Z*\:9\K1Y@2@.-)MK[J9PFG-K)GT 0<37@],J>
MVJG<=W.;I@0-QO9%1KXNE/V;[GKZHJ/IFM@'J:\"XND-')VI#HV#"4.=B//0
M9RQ(N'WYJKL)SEW0/=.R-W5M=Q4%ZM0#"XSL6F^R06T J6LZA0:/I;/[45S7
M.O/*NVTG%: ND!+-ATB(I\7=$?$-/P2WICT9RN1H1$Y-2+0^'TH.T81^WME-
MCW3]:B22V)U^S:/_>L')G[0J_6ZNW>(%Z90]NMJM+8$>@)6%MXY?J:#ZF0Z.
M]3?]_2N3M]$A+SJM%!J;35Z&@Y<]DD:9,#)@+FN1)<Q=(8;5(D4Q'?#9,#A[
M)RA.E@6Y-9;F_5%RT (58[I5GI2.ZMA=<C*YJ%=V-F_>Q"&YAE8P\@E3)D%W
M@%.EYAM[V8,IT1J-E"-Y?[ FPGGBU1V[*Q70U]CKC + #??Z>7B;AP8%365#
MNLNW&%;IMF&Q]GFUZDKG=7SN=?*?M7CD]/B0N;GS_<I>V ,4R@%T[C6Z#^!.
M4QAW/3IVON"CY2$3CA/ \L<X%J0^OPGGC!^=;\.76Q(E]]Y?FPIM\W F6+[V
MJ4.[![XI\\]V7;V?-'WO1)G?I9(OC(^'!N(:%B/:XKUR]$YOVSF98*U=ZI1C
MQK%W;:+ULJRWC"_9E]DR@7XM6@NB.)9H,J5U:*,-#65\W<)S^]?_O%"[]^IY
MLC/M0/>AN>@#"08G%ZZ'!9M]<$::; (KBC1C YHY_4@IV?BS*V_XZP)/A.$0
MD=AX,N@SK^USMA^6EGJ-"P8"5WI0L]/RO]FGVT,W-7HL'1A5M<Z9+I3BY.JZ
MP8<U+R?%%PQKENZ;>0]^\':HH4'I B069,67ID1MOMM??_8W_=:O1X&XDT4U
M.0UQMB7ZGGF=61<2$8<.=1U:>AHC#7<5]%GJ##SO4Z/!!$7H4^$8KU>.9%6D
M.7*C<A)5,X6+08B@%9A_,(*:JJ2:%CZ,HX)1UKB].U]_3P;UV:2 8X1A2YEX
MV\#E5Z^$ ERMTE7-\;'H8XQLW'W.0&BD"EZX'!XI*AQ#N5)>*&]C8,IC+0PY
MP"635UR\H]IF\JYDZMZ'YW#Z2=RURBJJQ P@!*\( EH<SK]WL'.<EQ9VZ<QD
M0>J4"ED0MJ(<)L?L# ,&BHH2\^WP;%^/NZV"B86)B56SXUV)SG$-F_LO:1?5
ME_/RD,H6=5$&U_SJB#DS&\N_J[P>2)DAISP1TO8($C,]!^<?.<.(2:-=FD0]
M'%@1KR]&' 4111?YH"?LR;T-"Y4SPEY7)82]W GR+UB0HX +UWAI0\YT-)YX
M+=>?UW-U/HR+BVKN9+4R)/PUQBQL^D1XU(OQWY\M9+P1%OZP=AP7\ @DL(A#
M];PHTT'"0#G\A,NS:G%U^YZH[<L.MQ]$J'WVBJO.6WLON<$1F_9+V!_6(D\]
M__,[J;?%3UN9D:HMYN:P?^3:QJ'0 "\6Y-&[0\=F99HEG*%+<];7M*PXA@L<
M.;9$L)QEJ<,]JH"]C)-1I\\9K*O+Q&:U.]S(\^<\Y199E<A+&IFI*">%3&_5
MY\Y@.75=/)5B7W/FW/)8SRLH[O#])GW:M.$-?W7UC/?^8TYT#FKD-!'$B*?D
M9,)<Y;2'NQEIMNV=LI:TT:#R$>>*<HF5_NG#$Q%MEY5"9MF"8X9^ XW:(.U%
M\#)_J0-1M5 RU"@<3GTSE995-IA9J1LM=\WY>BM/HC7OM*\'3K(SL>V)YOC,
M?E@SGBH=V^3A8:7C/(WA,G#4$&6K;O=Z+['T#?U.5KJ_!IYB@,BHM86/W'@U
MM##4_Z=0XUFI ;:U1G2+%H#N6Z.IT@\.EA^3'*UU*H)1]((/./J$+5W53^7Q
M71^176W4)YOC1UF0*7P,78(FHTM GO3?L*NF1A:XEAKZ3<LZK ?I!:FO^I.^
MP!3N_ Z7VI]_42:TZH_[/#3\*68<2UD:1 6J1_:^8D&.(%8$+Z!=D.4R?[LU
MA"]M*&CHLQ>BPX:?1B]4RBZA3RYNT^V)CM8&>;GZ*\"B/9I8XS ?A^[&':#K
MDR0:5&WX(NK/NP,\6^Z1\S7JPU4; B<YSA5<+.F1-!<R('PS/!6Q-78Q_]V'
MCZ,?'GPIB.V1I\J&QXA5DN2;80?2@O<O/2\8^]C\X>V; P\NM1R-5WS2'DQ7
M)D[R@I"6P.QR.$6JC_MB@[IUQ#5[M-F9(YKM+D3<Y:0^/?#Y/@<VFL'B,Z!,
ME<[K1\"]*.>\J1S$UOSL1,=7JS]M)0TTQZ1UW3C^$YT-39DG0SY83D#_ZWKJ
MX_G5&U9Y@;GF"S."*2Q;#YLPK;#TM$E@Q%T4^9D%:32$.7.=<G^.CLM&W7"O
M,[Q3%3,\/*$D<EO Z1E'A*)'5-(9[V4+V%1&NB8+$@K0!.GZU?JC3[]:9\?Q
M71'_\Z-8!39U=)Z$->P''B%")J%#LLI:\@3]X,V)6S_-T\?6!YJ3GAH=B+AF
MJ6_5:'%@_V&U Y9M,))U+P_<F[1&R&E>/B0/3,OZ_SELF?_Z;I<)M:Z3:<Z;
M03R3JS^=8/AW#)'8<[$K/B-7(O,NX(5$R$;%_I:@_&:D[^%]>-/D*;)$[(@Q
M6:JN=2[K<;7<9[F.K)3?DO[$4:M7ZVW7Q")V^9BBT;3+0-]M%J3S4"X+\F-H
MP4& $</D6$@7ZB];9')3!7<##6\6_JW^3IKX$-_=&6Q84_:PE%O!0$U\&$-7
M\&ODVA4#]K[LFUS,@LR8#UG8#0FIN<I9R2\'64]0Y=L$X2WR1Q9%+_R22]V^
M,53H6%ORW>7AJR[.KP^#XJ5*_IYXTB#J[E;+3GE/YFKG"D>+D,IC5[9(R\W,
MBT[RQV8K<L0MAH=5R%\.FXJKJE!_WMSG!;E][ZF#+FE\.IG85X"ZNO>M3S27
M/Y\.Z</VK^S\7-L)??$*2E9[ZD)^[G<9OBM-E5>F-K]&YQFUJ4N/(Y;)2GZO
M>++RRS>O@,K3+[8<>\* 5#/E'%YTE$];97 FL*DP>NG"S<*9^Q.WB^QH+>7;
M$HUKH>I<C="P:JZ7*%6WBFJ+A,??L@\)6BZM?U]=;7V/N8O P$@FD:](JL1Q
MFBIUP#*QD X3'BXV>#*__31 M3'+<3$TY<C\)^R [[W.PVKL;W6-N+8]T24?
ML"R(YZA\@R\N)J-/3V5G M=B(&;M^-#W:-0E\[!KHHG3F%)@)6YJ;=1MN75M
M:D+')JFWI=(U0 63"S^:1(G*(GV3NA%JR>VQ$RE\;J.QUXBF@WK2AW-&O-(^
M2YZK..VO].-(9<D&*KNVRO-<L"W[P=_!'X2/?K@G2*AEIQF[U\LPXGVYHOU8
M$"Z,7E6D0<WP8[HJX^NCP#3_N%05Q0#.TFX.*U1TJ%3 3ZF =V9+@-3(0"":
MKX)Q:];K;_B&EI8E70L[[SC'-<[5!)P G-;&EKHHZ:38,'%R9>BJ$MD9^[NY
MJBZOX-R%1U+\;:$G^6_RY)6<^/UC8E.^ 4J]F-,('X.,6UOYQZ$N3TN^OO:9
M&NM1T/UW2@:9()R9'A%C.Z3[#%8B3SR/I%G0!<K(?VRD_)\9R,O)S/4/TXAA
MAZ*_*4HD0V6R;(7TV(Z7-Z/[,"1C( 17=KZ0.+YPB:K?ZGWHX4C9X6%VA70_
MHQ.,/Z,P_V^3>D^6AS]FZ4IY61J:3TA@<Q!QJM'.O7S.I<1L3%8LHIZ!J8<N
M(?@+T%)_J,_4-(.</"B&08Y$Q4,W*]0]UIMWG&<3VV[-I]<>1<G2[N7V 5-Y
ML-*VK*:LH?)W0A^B'D[8?88$":,O5'-1Q?&M& $W6;(B036BW(]\#!OL.5,Y
M4,[^MFLV)T4)SO%]-J/[[%O1%V^O- C@2'=^@.L[F WP4;@YQZ>>?!U/:W*4
M+%U@>^I6$,ZF/Q5AW;2NT=JAO#  I#,?]E2&M[3=ZI]UI:<N+P1*T'EJ*/')
M4_"&@#(M#F=1%7*:2EQ6.S)!Z>FW_0'OCGOQOI047HN#NU%5*2^IA_ E=&@Q
M!0,(/UTNGJ@;+FI\ 75Q'W<=Y02*YW@F%A(W)9J,CL/'0Y@<7-/ F^H7JKAC
M:/[N:L\(;+<JGTF\F/1H>,J<,1RQ=89L!DR560TX4T4*[U]VSG58_=$EZF&'
MAIY=F\S@<OD9;8U4:]W5-^?=P"ENZ25^69)Z)T9Q/+\L;<\8GJ7UYN"F/D/+
M_.B*L2N+!?C%;5'+B/+N14&%W)UA5YZU]\"(TI^&S8EO?E]Q4^G04H"NB%E9
MSAQ;4IF$1VI>BT98R\'\X]5CY4ZQ('8#;G&,Z?DZU(R?JSQQ!!0Z@B=N9R\3
MDIL.WI42O5]5QQ6/L_QXZ?G+I)SA^GH&%N=Z!.>$""GUI\ASJD8ZOMSE-'@<
MNOV[2>95\-F$KH2,@_SC/U?++\5G&0RE;X&<_L5D'PO2D%YOPV$XUG,WYM<0
M"_(F'_?==7X)I:CZFNX(BI,&1K:VF'^"#<EW+1)]TI_)@A!QXS8NC-E\ :>X
M$\4[-R*<XS0KI6OO)U:=JU^AGJ+=1YUG9)Q]@^*;7C:,-D_P7DC.61E9#$YB
M=$U5"<PF>-%&/$CX-D&@#?EJ4HBL^+O!9XW;566[UU&,\_70HS?67QZ8L;,]
MO9LHT'ZMO_XRHPSD !^@1XO04"IF&O9"-KP9X*.B.ST>*&9V4 (%NH_,W6M]
M^ZWB!-&E M(NKJRF&A9;6E#T.6LW$\>.K'UJ>%+N.=QZ^>\X';L-=?#GI*!)
M[,U<POXY;:+\I)7GEJ_I<&EX/OY\=[]0CK,"M_F?/'HWO)/=9E-]QY)Y)(>,
M:\&)L"!.$XH69(^6U+#R+#P\T^!KS_9J_Z6H>+75\8<<MKG2"1W*6^;NII@2
M-Q%NB\T)]*-+F#+C(%N_K5'F-5T>BT?!_W<?-KUI+.EZ.17BFB"2WT;'4[OH
M,\R'=L#L];KD>\HS:"L6)*RA';9^SID%D>+ATAD96T:2F&4# ;%3##<=SYSO
MV8Q$+9OTT,!,_3LL2#90*.9F"\QBF%HLR'"N=C,T'_W@[2*YDJPZ!VN*YM@^
M;)S/@MS&D=>8Y4K+_"Q($HRZS8+89#.[(FF].[&D3&8'2*-.,1WID@N6JS^$
M;,99$!G@G\M_@Y=#J2P(>'V.NJ8LW10-7H7[_00ZD[ !)>B%.B0_X*+>A"WB
M61 H"[)\%T809T%R #K @A1: -\\6!"<!.A%&@MR>*MR>Y;>3KW[*[]OQ1)Y
M"OQ3,I+^!G0Y&V@R9T&,<3NG]AJE-2?UT+WVG,&1HD =WFN N\SD"<RH.]YZ
M=[H;Z,(R;^QU!(^ZS(+(8?YI@R.<!M,H/0' Z] E88139;#U?B1M 0B%^>03
M:&@GG1D9H O#U-UK:-M6!?8,HT>R(+^'<-0;CWOI9?_:A#0;PVX-W7'_9Q/2
M*G/2!$XAPW\&NC[+@L2!U,B9+H'9G %_Q]$$JU%\#X'9PG;P4KJ1*O-$)'1G
M^>G>IJQ@&.%_H"I\E7.F2.C>"*'T:+"? 8!PCP49"&?J@3K/C4Q2#@;#.@+=
MVS"5K(2G7MUD07:(WO\VH%]EJ7*J<LX$=A*V!/VG/W>4'C@GE];HL7M.KU&O
M^OSW#6[BN7SF]@PBML?V##*:OG\+PL$V+D+?(+:.@[2(!6%$*S)/.S-T@'60
M/#K:0$E%F_B=-5_0 +B0GS("R9]W-ACJ0"R-"%!38<\L53AW -B&(@M"< $&
MP?_$6!"*4OAT$FQ.@ 5)@#*B78"F\@'8?!V>00%C($&7UI)A0;H"<?\R -1(
MI['1L:!85U1EGL8RKK,@ZR#6%&=C(L'\>V_)O U0>/<VE&TW9$$PD;TT(HR:
MBJ1+$2^"-EKG&10,W0A: U5AVT',,!^YHVSW1H^EIX#1D\R9IL#FP%E/@#%"
M7:&ASPV!_[20H$M%G]DSL+9WJ*LQL&*I@OC'"T4F'SOC.FP=+*AOV95M1KB-
MPRQ(!X;9!*8-X:XK=&,C$(Q%#@MR\B;ZY,(\TP&)6YL&R#Q@>G\OP<\"L3LI
M .D[;@GDB@D(1NCE>F5'YCW\CC(X'198NI0(E(G^=XL!DI\>;'TCB 4!0"=?
M?]FLX>U- J3I0'<G,OH].'A5IA% X>FE.D"W#H(^X)A-Y;V-=3R@WR X,^AP
MYCFP6#@08))C"G683 G0)^/-&BZ,--,2K,.4MWCA"A:D^]2_'F"C<;A2B;$[
M8#;]!0OPOLW\5-%K_/K65P#?PH),@Y5@L.#,=-CBHNV B712=X$BC9'ZQTP,
M6A,8Y/JW$7<4:B_ \O0/(/C[@E280P><,4P=V+T^"])B"@VN/@+F<IW^/\=W
MZT1;O6=AG6#);UR.;5_;#0;^SH/Z$LR@YJLLR" ["R(!H]D_!F5*Y"]@?LT4
M! '0*)D'3[VSRTYGNB&V*3#FN8][[EQDZN^Y$P6XP'=?_-L,= P*W0 3^^\:
M>%2(H]ZI![W']!@RF>U[O<,;8%R8'=0@"[*V M ](_M68*X)8(:"(6Z!E5G
MYA!@6/',$2-8V2/8G,,_![884B]3%+:^ \H$/ AJU E5IL!V<PX3X0NGT4#[
M0CG/12(H*:KK,'H:O5N%D0G"B\(:TQC,^VIW=#\(R2D@W93 T>P]H:/+S>'_
M9\-,6&E[.!>]?@FS-RQ5W85GTF,/<6#1K2,W+@&$+-R2'>C#&G/D)KZL#;^3
M!/X!3+;RX36Z(C:,!9G?-M^+#T"NUJ&I^;N >4 !X1IX  H2'X?P!W79!GM5
M#\Z3X@'F &)O4?^[!\=[80*865@Z!IPS<QP+<I1 P.XPAX"U303=$TRAH^,$
M#'B,^]?Q1Q(CG*@ ^POLJ.Z\/T:[0P2' ]8"F%PT<R7F(&9+YM]FW8I>,'O0
M_,@=]+];[EGJ)<3NL"!@>O[K3"2!QD=4D/^7K0\T]!!8T2E@<4M!&7FI^'(P
M_I:@' O_QU1W/1]LG04!!X1?P%$GSC+>U\H (*""X<3U >0\OV8*O9VH /V7
ML715DA_E)0ORRI)Y*I;ZEI%/,VSE&XNEHQ^OTWLP$KNE'SR6V[S[Z_;AW(_A
M-J2!61TPC);R)/TI[>#I6"J\?B@@5Y^!F9[0@4=V)%VNOD*ORRH)G_L[SR\Z
MM"A!L2>!<_\^#,Q$X,N>VKOL(YNG\/FNN-E(><C<WC?:N^?A1*?8G41@/8,%
M&<L-IX"%EGL7'!F,D5<-HSIA.8!?.O_Q'$E7P(&KYL+9 G!L5!QUR!Y<,!1S
MQIZP('3:OT)#8!3!ELS 6(#3YY:-&=N ;DBR(+.&>TX;@%'-)\!V#[LCMIE0
MIC*(P&$FI&3& 5\L#10U+(C@%ZHG_CT#RP7T5H*8 Z3T8,9HH '@7^WOPHDA
ML3OO<.L@AHZY@_^$P4G@2OH^IAP<' $<G!F>^A!_&+/S>AGXEWUCT%J*PT@X
M,#^^ASG=<[:4EG9Z)VP'K$VB4C3-T9'I!*6#\:&D+L)7$@AL+,AE623(!9M9
MD+9<KI78J8V],][_/O.U'ESA+,L)O3N4O31GWIR#$4IP2R 9Z033T36[DIA6
MR7P(1N(?BR#&QFF"+.O:?S, F@R9FOF_,HG[CTDP2PAEL"6P #MS]FQBQN',
MS#5Z'D!)78(18NE"H#TMO__8PY':TX^R()_2:UB0X!,@V*2B?COL#3D,]\^0
M=\22D..V2#KXF]G>F#&D<>C6!6 6G-^R$5-\<6^($//!\VWF 3"IVEQQI#8F
MYYZYNCUSP'^LC8?!_F,M$58Q!YL#)Z,3^\^(Z\ 1X^AY>P->PA&BZ+R@?T9@
MH>\'EZ09I7#*99().$/9N'\;5/OV$7>9Y@D6#P;YK_+^&W.'^6</9J3!C,,Q
MLE,!S]M =R(+DHA@]MDCZ)>!EW!Z*[CBT ^'L"!1_4#S:2IHNOMN"Y1Z$H1<
M@9R>5\2=1&(5@AD$VT.%>#5%FC?(*S'T?( 2<9]1C5NZ";H+II-+4263/Z<1
MNLE+9F<>N/;/@%N8H)%/V-<PTCDNIJ+^'@6QK" @]K;27 >8-__V$D=C=^)A
MZX5@RDF'45MIYH;DNXUW_9_!CG\4D4A5$W_O=LBC,_Q9?[T-"W+B;@>QORZ!
MR9_0@ =[X?JG%_=>M#JZ<Y>K&1?NEW[V%]+7-C]2S7$CHSY5!2&9=O^,S"TO
M@63<[>%WLZ'S=OF(%'QP83/")OO;YMC'(6P/SF@B-GGRBUOBT@6L'</H9.7S
MZ#R]-9-R);?7J;@;L(=:7A[N4YYO2W\.=#C)#*=X'3&W[)3_)7U1@$B,H*^Y
M,?@9[S0U8.':AQ;V3RD8!<TA'M^/DHFYY?C[DP4X)Y8?8RM+''(:R*7A%!^>
MRGD+6LKRIHFNOP2!\+]WDOG_UTXR^QR8OQVL>[BV!X-_JA%W1])+WCTHN-3Y
M1/>YN;?VQ;Z?1G^E,3L+GX"9H4RH3@WGW<1U[1QE4*;-Y_V7YX?(&#IO"-/H
M$8S&90,L*(R,)D9/]Q[T#VRO1E"<WY2)*+;8(-^?IXD6.HL,:K0]&1<W55 (
M:'_>5*YJJIE?#7C?=AV%*8U,IFH+LR O-<%)%R*W,\)!'6\P4Y3!Y'"FR6,B
M<4?;8\J$8*JM:+[0=+,W7MO/V&3/!98YR]6/-_R-V!UIQ'.A9$FK/P-A'%1W
M?5)/YGI Z;6,W[JNPK$O5!7:/IUZ<0B>A51XPY,/Z6P^</*MKNOKV(KHI&B;
MR5S;W74UTB8C$>:L95&Y T*?@_.4_M[+&B7NDBJ9S</X75YT$0O2: #[^Q/E
MS=Q*9B;I.-1D,'OQG+6P_'&W:D0S\O!B=5;!2Q?Y@DUIJYR(:S]\?*,4*JO4
MBK MZ7Q]M4X9O9G^(3>+1WQ2*#O#ZHDE=M<N] OXZ4WE-D*B8CZ9F&IN\LIK
M,!%_G<.^D+;.JZSY),\SG:?95Y TD'DUBR^+7@ 1[Q6<R8TC?CT3TL7LIT$3
M9DLKO&<-:C08Q1&[+V>8G,K2UZ>AKPR$,U&%$F\X+VIG<E[#=%O^P9.Z8>RP
MA01_,$..U,# 52R6\H@*.QI!IE\D75=?%T"I/0)I_ \?[4?O;/L$FD)O^=V)
MH[9^]D=.0XD3-!U[O&Q*U9!R?M7L(%;V\WW7[/$7)RZ+?_SZ^M-%"1FSXP;8
M(6#<\48%J7=%?\9#M/ND:\X"9?AMF)J&6!*O'1-BB5O0%NI'2>=<P'Q9?&:C
M]0KP&FZ:./,&'?%BGR&6&GB+[!#KG;G\W"F].,M>;G3%E],G_<C5,X2X1@L!
MR+J&F5EVN@B! "[.V&9ZS\)=G^7 YS'K3!QL'2:-FXJ%K5O5@@+N'KA,]+]>
MW@K[#F-'B9'DFVLZ5NF24S@N_T>KTS IU\T@*4X#\=LAY:E*!Z)>/ F2+BA*
MN46."I1&RS*S_9_+121.K*Y1S^\>1,NAQS 0E!--@?DK&3CA8^C:'HXL!XAU
MTM:5467/*H_)I_W]\334"34E*O TBMZ [AOT4_DU:=MQL,5 DUO2,D;W: '7
MG6M+TNDF*'(NGZO\\J:^[DV]0E5C6\5UG>ED.J]W*W!2FWM)^U0YR2DFI, M
MR<,IL% 'O5[4;E_"?__BT8<OKU[0;PM,=^\#IA*AI?*OE;2>@RJD_7793EG-
MD0*;+MVP60X#+W$IAR<Y;]/,I##3DS>G'C+FL^EL5,<O2QUYKBS(<92$8V[;
M>#]E7*<\Q@EY9YG_'B"XNGS+];IQSMAS !&H]O%(3ZM9XJ O8J0#&@LEF<'&
M3MVAAI)3D>$42WEH&.IBEU!#U+,_#B5LXE$:*\=FHS9!?O"\=H3BSZBBV](4
MJ!8SNJ3P5[50L8E;CVH&MX0T4N3EX!HZU7\NCGTBF%UD2QB,!QXJ(T=G"!9U
MN1-N-IAF&+N;>O2?0N76B<E@5YG2F^TRJT0!F99U S7ENTR!\*EY!C>2#2"H
M@H2Z+9_CSL<K8[MU],Y"/7,IV@W*> >4C7X21(<,E#DUD1S26,\S2(=-496(
MSN:5Q55)_9U$)ZN_;Z5Y9+T:5+@$#@1:+H9'E <3UHZZ[>8'C0NI%<'I^SB!
M6W_+,*/S!(N0W+$E&V?0I<6QZ()(Y;J)[&!7GF\_<J06EOFE&C;/S-7D+PL%
M&?\,U.CR+R+*B;ED5WYD:S]WJ5E:<NKED0.BWPOS)*3D3O;;+"\EUL_<UG0V
MSE'6]\W&8";1"B!0*)8](K<3W]S/QZMBM$(_4@I6_B3%)7?UCBC.X5S<8TBQ
MC9AP)F1(R)34'HQ2)M3I9EPJGXO+M!WK=A3G#IVY^BQ^7]O3AJ(VK.[A:T&)
MR-8XO7>YWV\9KX(L[H5E-X9D"M]1Q(!86><$+H-O1P9\4Z;AG N3"GWS_9K7
M,JV6JV_34,LBMT;ESB2X'JW)>&(V]4)/_XZTX#=*W"QB..<A0OK[#DA #H 0
M]Q;?*K^[/0 NL-(1C -4 JEI? ;6A."A2A&'>89E'";5WC_4E9^,N.TWME1(
MM0@/09^FRA.ZD^$$V&$7;;[ ;U\(91X*0CJ7[(A<LWFK;<:* Q>J(X9+S#]]
MHI3'/%96#5\>G@>Y=",B"GH"-I4.$U >%_%K*GPR<H*1=J>O:/:2;&?^*1Y2
M-V\P9+7Y1:?.I>4?VI=05E10C1\\21W_;+50+T"3UN$;]6%<&-;[*#/SZ)#U
MW/L\\@?/H#R(.7\O8@QVVI^K65N[U!!VBNIG0!;Y(M*%S+=J]17$W"F1A/01
M8/NH[@TJ<&<"YOBBMG"9]_?"S33^0D?')0ME-N4/#V:[B+ZSX[L[[PVYQ+,X
M3,N<<%OKFB UBJ^5G>X=Q=Z@*N8Y+*F,G<8@W84F%I'"=SO$Q2^CJM6CUY)@
M\F1+4'LV?V(>!WYUS6#H7*4@ [U%BXGX?E[REH?;Q&C?ROTN?MN;^?(ZI#3*
M-".=KD%3I#M5D)+#Y'T-&2I&%S@WY IEO(SF-.-S!6*4A)[R$]/ARKON-%[F
M#^WC5*Z,1:;J+V59KPUS\H40=TJ5KR3!_U2WU1Q21OQF\]R44RST8R F$GV4
M#B-3OE9CWM Y"=B32X;\KQS<QG3K!ILN&1RIOR'A(O[!63AU::6@<'/\BJSL
MF8CA_DGE"/ZS5^/:(B[EY5V!0"!LV1<SGC]-W$8"LCZT5%J4J*!<)6R4.)^-
M"[GP)4+RX^?_GIK9,KF+%>SJ^J#BCFXT4 DN ^KMI:7QNX2SKYW>;ZVPYQ:M
MM_4HT<Q>:E_?UC+8*IC;+&Y]D]LE:EXC8Z++&_SW/[O0B7+1GOJKMK$@)W&/
MH(+^EH35M[[84^XF.DXB7[^'X;=E09: *HID%EQI"^BQ8D2@CR_!]K$@CV!L
M5%7KLM/JQ*S\GJ_C;[CA<M/6#I;V"[<J^FE>1Z#RA^J:(L16O6V)MJ3Z]%3\
MX/DU+_P*GKQ,M8KQ%ZM^>=-)-UZ2)R/C:)CII6O8E\ #8#1C.F<EBW:;;M W
MTHQ4;?1 &X@/;#D->EA=[RL.]+J_@<)7K9T221&77%!$!)G<".K8*.H)T&!!
MDHT;Y9\+QU8#?CM;VONI-)H<_2GU/NV.&T(4YIP]H#Q.?#[AL15[S&U _(%.
M.6_QG*9;'T9*=?J&[[VG;Y_:X5J1+X$*)-&#M&P[H'VVEX -KU8Z[=7+]XJN
MOK#AKNI2\RG,X.BZU.<G:JY-(2_O3)W<-=35/_?7;#+78W9QL7];/F6#IHM#
MP! .%:7:AHP$YBGZ#>IY&GO'% UW5#FY)=!0Q&K<]=SN*'T\13R%R(*@2OC#
M_/0[T)=_2G_>>[,R_<@(SAD[FJQ+ZHW8G.VOO:L\.T3)<BMM5^D0-3W!%YUB
MM6, O1XDO:@N[:<RK[85;[ KOTS2T\Q/NLRTP/>P(#:BBC0;=,]S.-&<A#0A
M663X,M("YF3GTG(/X"F&F0?$$E<S%:6/UUC-L!^JOTWJP=%YN BQ82M,4==J
M]A!-P_N.ATO*R1^'_I@:"E_UT-N9C\;<:^@:+[XR[XN.ZK/ZNE[ID;XP5.^.
MR&[OQ!>OK3@'D?3M1M!B*#WR"7)O&]?)E\K''&5^C;7=O'#1$')3PU*V7(_7
MW-S,>\N(QR+&LF14EGLE:M##;V@5U0M"R@GJ4U P1[(@I=J%4[WAZJ?<=X>Q
M0>XBK=63USQ*1L4WK+N,SDGN9.@VJ.U4/W'OQSV"A=U%"3$PJ'U3XU46H!(Q
MZ#\3MJY\K]'SUEI:HCAT4G']R*$Z]8CW@1%/$:XYV]*\\@&MN))4V@23H3V5
M][PMP17KJEK]Z/-^>RN'!LKVB9L*)7I+YN]H)V[FOS-]9Y80.1JMRN>#?DQU
MI'@Q\H '(MZ( 6VV9A SWP#'MVS;JLO[?1?[U0K>OU"]$O!IAQ)J:GI=R.6\
M&4F=!0D'BGM;\;&8TV6(-T#YZ?(<N/OG*Q@]DFA,8Z'L[!\A!6*GQT&SMX)Z
MJ(O._P=[[QW5U->NBRY%18I$*=*$*$64JA3IQ$(5,8("4J.B5*4(2,]24) :
MZ0I*E"HUTCN1)B(JO7<0Z9!00B#)RHW?/7N<;^_?/?L[]YQ]OS'NV?N/.09C
ML=;*G.]<[_,\[UQSO>](+7)BR[3INHS!TL"/-?Q4$<;K6EQB3[=FS_+D^@KF
M**T889^*',%-Q61-Y<IQ&?8-W&KH6?]UN?U@WYT78\SJ_!9=LZ\$1<7N-5B2
M'V6@)],$"',YS7*?R/*]!B5A*\<AK;XBT>JJB(."QJ_$6M_F/>5N=XM_5EN-
MZ[XJI=*JTU%6:0-'?LW5NE];B'63N[)92Q*DA5&#",JD$N)Z=*#3D8$/F84)
M S4.+\O9.OQR^G.2;G^O%.<T]]UYZ!E^SN,DLX32A NJ%-\"/P$V7E/$1%BV
MA?W -V/9%QB(T.NM6U]Y5V/B2M1A[5#3EF3.C1NP<4H$Q2RBVP!G3P=B%1M\
M!@?-[UGBRR"(#H1B0RNKB=C5'Q1Q,F7&)X9ZC!@P!>4_LB-*-+'-Z3@%G-2N
M?:Z@=L#^(-,A/^[\:8O[JG=C?',5L:.5I&>]8H2<B,(Z. %UJ08E<6.@+,=B
M/>O9,X[BPVL.S4<#^# 9K+1]Z:51)I$A \JNG8]\*!T);U.2>LIQ@T8-:V$M
M<,(UM^&P-D2I<"I1^1JQXJD7OG+)_4)J$*G6Z<5JG8MDZ"AWC-V2("QDDR(P
MA9J26T40Y$AMY&>SZZ$3)PB#466P$Q/V03?-JR^1!,U>:_7R5X4:$9]ADGWO
M9."9MIXPADS1-_6ORO?/%\<5EI='59N7)HJ7O:,)C?;V[-G.?P7+X9]!H4!'
M6G[#/N<+-? 1M)"OUI*1N6G?R-H![:J)HO!?9<&ZJL'G$TT0?H,A&-R9]&RM
M581]12VH3'.TKE_<W!7? 9N7 LTI1Z"?=.!H(!-Q=!;7@GNYQTP2VHE4DE[4
M'ZS8D1[XH=%3>>XK15?C66CCKK^IVT@ER8#\&B^LV(F9W*<DQ08*6UG)%.6D
M.TL7M^:*%#6&/CPKG6J<^"U*I.33791K]TT726>UQV+)XVYM5GN) =\>^V_6
MXI>_?9L(FS]=3=&"^K$511E9CG1 :/(*&468^#8G*U>&Y/@>9_0Q495O6'%6
MLV3CH,F5 _>DMJ2:T4*]=:+3-.4KW:NBGWK*1AU7963N\NFGZ[!&:#X%S*)Y
M<I0ROB4FK?_8 7-<0Y_45:?5:QX3:L$(U>&X[9UX#&XW L5M3!(Q0<L;R"FY
M)L2H%<F3.(C1,)_&A:"%^[V1?-:T=)*1CUG)ZS;*L)@(0NH&AM_INB>VIEX=
MJC*VR'+:+%QUPX-UW;7-L86RV/%B C-5%ODG+=A1[)^T8$(P.B#C,H"W!X6A
M?DB2_$(3]P47"G$1W)Z+%L=IU_5(6+B*5X\]$]WGEO.Y\;'!M<!Z79<ER\)<
M(\T&K+=,P:'?BR+V$4<;K\7LDZP6VQ?_K)TII0BM/>?"<!"<;<O&IH5MVQPL
M#.)VP98/KK93+OLV-Z6))S<+2Q",6HZ2W<PH78T!!X(/<,IR+(P_RC$YY_OJ
M76$4W(2("0%=L2,*AM5DSYE11H"E3$B<W-/*G3$Z_<!/KK!A.2^O4VHZ]'K7
MJS5*5@*G5"]B*@5?BH^!#I&59PYE$>7T!.0BJ<8XP>&[%&M>\0^'6:M];0;?
MB*=&S<>\'1Q6E'1^I^:5EJMCX^4Z"/ZB*0FF)EKTQ22[=N89ZFST+)=O:2@W
MX?>]I[T%'XS;?<:R>0WV*47:B*P,[\:U<8_$I!//<7Y=,[VBL+IT^2/@#N N
M,'@-1'="YVEOZ, #FYL&@U[P$O(&:8-R,TC:IO&LTY/#4Y@?>N>I'9SP^F?X
MMYXHFVYMG(1Q94$_-MVGR[CLEDA2K,]V345])P8_Q;A'*28*[X!_#IV!']WZ
MD$G&HP;%ZM/@Y5<>3^A''Y>WE?!6M3M+&=[-?TZNI8A2[<E2E,LN> '0?K1>
M<@]U-#3(K7&O+O*$N7SQV)R/O*@48ETU[H*93.BIEW"T\75DBD=*=]8C=<N!
MW:R/>OK?Y/N5?= []1 )[;4T6=JY:DYQ0"WNF;=%KO).8YI=_'I<UCG(SO?]
M<-]./$M(NH/&G66]>)=?I#Z91.Y3Q#VE Y\<(LM0,,NVK,79ZY6$-:P3C.W$
MXQKM6^"HYKSF]2-!=BA&Y-!X38LY4)^6KG6"K-#8L*]KU+3\D;>;MQ\TZN9:
MT97Y,$(_25ON>\&0-39^T<(T\AW"3H@[!?\C<Q1MN*:;D!*-=)$@Y+C%U<=M
M@A=\DS^O,WZWS'RED^#6V"!!/J0('K<@Y^N4]I5/'B2_:7KI]BO\]MC%56F5
M@Q?RY5ZK&C=[5.+)IA0AJAEYFIBA1ZZG7%]2<QESO*\5-A4D'C(RHO*H,5/2
MPIWOT(CPY5^R\TVK"*]%@8=JLO$/<D9E.P+T.2>4A!*YS\!?Y7OWG\4Y+^G5
MEN\]J4SO?F)UXE.D5X)X=@2$QN/0.=_QE>8K3T 7Y+[%8XL"3;X!7]*$J@+J
MX3=2W<,\#TYRO[CTX$#ZT246DZ=3&U+-6Y-<8..5K6@M!)MRB 8LCZ]WI?F+
MLO*%WV8KC&@O@5-MTZW36VF/1\?SBT:EH4-A'1U QG9-*J6..VV,[::21&FQ
MZZ!]$%O+"#ZB?(B*)/*V[@33 9N^J?%?:P>']/A/'A?,C(WDL4Y: '@V]:C'
MV?3[BNKN$N1!%EL-M%I577VO%\5*N;4OS>=57OL8T.8:A(J@Y)!"!AK$R>"T
M:U8  7.QM\YH]N.OYQ:+-64121NG8@-[6K-?NJ>^W&U364:IHG\B2N&M,/Y
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MEO+JG\R3C,;T;XHTU/VEC,/"/UEET5Z!#.J6H -NX)ZYTM\*?X;\H>YI!"6
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M7/[])WG$Q>"&:XQS J@FA/4FQ(CGI8&ZF^@4,XQ2?6O\Q(\6][+85U'S)6L
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MK! Z23:;1;F$."I^+,^WKU$(E;RW$;(V<5C452$V8C'08"9:L+%&8P__4BE
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MVX26U]<(+^MX@*R0@J_HK$]83/44BLL).MUK&FP@GO#&]W;4BSB%L.CBGX-
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MZH1SKW/*3C/NR))_PFJ-5779 G58L/\U>_&.TF+?#>8HL)F/>H0AM2VFL53
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M/E]66$D.2QKKWAOB#"^\&2GNAX$TKT"1DFH"DQ*5KIX_.#J@;:HBZQS/M(Y
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MG(E;K0'#P?4_L4'EXJ^>4TVX( D2^B'69O!':L$_:+'2^XDYE1=:]CX".FY
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M!<COB+?\S6H;U -^8,KA%(J$&"&,(?(50SU&2]'?+<-CX5:AL=9S.B3.S9E
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M9ODWRW\^RVF:5F5]%35;BSVTA+R6@:ZJHLTYC-->U"P-:X29KW/_NUK7_P\
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MN(@1T1&5537?+V%O#D&>QG:[;[Y5O43?"FF?L]^D<LR1,B'L5"_)9MQ9^X!
M]C=/<;EZ2H_<T<0$^<S0^R &""Z_%Q?D1SVW1-?%Q4/6-+ 'QL)P($ RB]'2
MQ<G"Q,=@$;(;;SFA+TK.L+FRP7+MQBNUJ2-@[ZNL,9MUK.[<@U+!#F7)9+$D
MY$OJ0<#7^CX.KJE[RFXM^!BDGQ*U9E_USQR"CP'JT@%PW]H7.^3RD_<'6H?#
M UI>)_911J 'UFP(2WJ7P/#F&P;HF7QD>E7V]9HA>:HA]W#/&DA1?RO%][QG
MIQAQ%5H(_G>"(<68".B)!B #OKUQY27I0V&Y_0/ V1.ZH&-Y'3C!NI,%L#(J
M3^7(-X_G%Z)\+F2[&!1>B57BVRO2E&A*^G.-?VF@/KL56<&RCO7,FFHKM"%O
MM;?-.:7X4_FJ8F/B==_+<B?'SX:(5/[%$;0W]X4T)!B@T?!4>FP*]OZ&W,7*
M\,7TNQ%B@NEZ?-+YNV([)7G&>Y[N&U@+I_"P='>]DL! 46(R_60W?C/<@9<\
MZYY/O9-QWYBW3R'R;GW-*6_RT[?NLC*<M;V/V\S?C*MR!#2!LX%MT$=-YVU%
M'1 !I70ZH$G(JMSJ60].Q!#BQA#\G'A]>Y2G?[CD]Z8(5VH.IQZ_PPE7S4\M
M$6*)'Q>Q#[ PY2%'VBOXW?3JMRO=LQ/G A9I#)":M\C3X+VGU:L&XS-"ZS"9
MX-4#[,^_S8@EGK^;)9O;MD"3L,E])OJ);09(/*8#0CH"I5V*Q^K##8F#LYC0
MW;2=A+/4VX1OX46WN+H?%:Q:C&QW5&O*_9UJ80T]\7/^+&S;]M_Z-H32OF)G
MTL&$?C"_"E8$V=P!Q$0D1>\A= UP DC%/L).BO>@KR+7JQSB[7AMJ<1WZ.7]
MKUT5Y8"#I_6%8L4M,-AESA5C=G@@V0F__GA"]W?#17]CF^'G>E:7O6G/1_ !
MNLQOK/J[KX(D0WX+4%_3<C7.D?M(2K1<EECE#&=#L94ER]\JVF\J:Q=Z4,XO
M(5$O35+/OY]_ 5OK&UNEGP2 _RGP'&^DNA\#=%J&XD41T1.C]]&;*)",!LD$
M$>=QZ'/5I8W,]Q[X42J75Q-"F%P=1"AOQ;'+R560?<P'*FU[W?RUBCWYCZ91
MLQ(6=2HBFR82E^VVHDGO%D[:Y%911E?=C=)3/_$7WZGPIB$-4"K4)P ^3?2?
M("618<&$[184^Z!NW;![FH],D0&F/LG VWX[P',?MB WK)86,^OGO7*=G2S^
M;K"#8N-:=+;GI:MED?RUYC46XG[HZ!2N<J26@"7YT-+4G]!Y^ZE*L[V:;8%>
MRREG_UI8D/K@3^W#&Z.T=\V>/IZZ)I(-N81LNH 0FEK!\M29S%F&1V3DN$8T
MB9^?_2;I<XVE^J2@\^#+@^'9]=VH?4F_)>>\A6V$LX0$9Z6XE/VV3*!$Y?[J
M'KC8AXA=GZ)XNV*/>*OACI/U5V08H#>IWS^,93_LS!%EWRU##MH)907S_VB$
M00GWP1/7L<X0UI;9A--Z@F2*34BFE"VK\L1+_?T%8TNQLZ^([\66G@OBH7_Z
M9I MD"B!(=S9AJM ,=];65 3\/BW"O+L1%M ?F^MK.SO *9BI_(M5%J?Y.D]
MXNC92<X*B\T=Z.C*Z!<;3*F;PHBQA[PJ#=FT8TP6WUPK+R1'MO?#'8GB%6]=
M:OP^*#]Z<0(VD<MLXYF9_^K[U%0?V'MT62>A@<M?$Y^T[(K?9+<B1PLKSDS9
M-.7K+#8GO9?YT8ZPF$'5G2B&L%']R5I^5S,^DY%XR5#G]UTV5LOISS%/>SK"
M=;/BP)F-T@F/'!+MD\KUM(**//HV&:!7SG?2\W@R:H,8(/N$/AQ99K?" LE,
M/<)<IW?L'.Q9%)<;MXE6[2N0$$BF"' &/2 /EZU 20IV#-#?#S(?@$<MA_R4
M!'E:)!3(.],U2+(8BIHA=WC'F;N/'A5:V@SW1Z72_SB]&>34.5@670_<]R)1
M"1[M[&#X30(ICN#O5E30D#7HINAJ4^BZ3O+DO*23^#56,<5S:W[)92YZBE8)
M<?4XB^C&LE>@.?XV\&*(7*I^N,<_DE;\XF3U[OQLO20>YOYHR"O!)H_"01\]
MBQC2.%+[8QAG, AWSIO434TWC'IR5&A1RL1^+/KM"R//:F,CZ>L6%_1/4J]B
M9X 03]=YLJ*=<3]YQ!8AN=BQUH2'GJ)W(2M44XE%C35)L!'>4XG3QE=D<G0#
M[8)1'ILU&QPLUUA>%@D)T)Z3:9]7H1P-1_RQV@3'\:F5FHUD\<K8)",.7NMW
M4N[46*['MP\L%YRIW((=TT)$W+J4@+_O!NZ^NZ1>I!&VIO+AW^<\UO;)+V;>
MGRD,/B&:KW+ [#6WR4WO88"^8\+KM,"1H]!1=<AGU^Z /+NN_@^_LT23;DGN
M/0H1[3>^F*I8$I9<D&4T[NMG255=V[N>CR["3]T(7$:J%;F2)T8=9_O"L00]
M;#1"9FACL#TPXM.,H093U?46B6S9IEU=_%M0P]<I8^-WHR<IAHB?]*NT-RH,
MT!G_# .BJ=M5I5\6'=#!;)C4^H;9\S^=]55)U><CSK]JG,-.8DLA5*YS#)!+
M'R\L4X"8(R 9X1.K(Q?CX?(+!8-F]"1XQ_O]Q%XX\D)WTK.I@P7(F?[DO%D2
M@25"G8EYMW[TS829O5&0U0>EB3N)NJ\:-):?OGTH\D5O7;]R69LS(FY\.IB^
M[CO>[KU\O\#(HW*/JL$ #1TXDB3)-"^*-IQYH$ZG  C'KT,'+ =]- 7"+7_$
M2FV#A-C^_B0+'6T]PQSD4/W-E<[?OZEB;T-B4[U7'I5775OS5H?+)+_SJ6,C
MR+(#2M!'G7#P5R,YUH_X:%U-.1A!:WPYDK$ =M:=B^E9*G7!H6ZGD[=)8[32
M7>AX4$?,#/24V[EE%'O)IL4TSX]J Y=*_C!W7LZ?K=*M[-)\KUAZ)FG3L??2
M\[\8!O7*OQ_ S@TN3!6U#)NT2+\7B6: ;MICSV 5(.X>XRVFM.\-YUTUCA-X
M4'X^L[9JO>D^%9Z<GH530I\_Y)G;<9PS/L_1&_H"FP,IC5Q;98!8!PGZ+2V8
M.*'I"_7O*]D<7.)-U\^ _N359!5^"WIK'$B$C#$U@LOSUEJR.O(GX5:$,_5S
M$_FE <78-\](C2<6!1\^V><<;MC>:VQ.0%,%B:+-T'-?:C*:$5+]<&/N(FEC
MB;A\3=_OY4?-KL=EN)X7<A[X>#&_K5UN?8,!0J\^J;#I55X9,B^L#Y3#C>YC
MODT)<YGH[OP/*%KB:DT?K "P)'11NL35WW=RTNTWL=FI#X!BHVV2I9]T7*K\
ME$VT7F;^Z]QNYQ,KQP#AT*S0GH[/3 7H-O!8#"F1B EG@%R-8R&\ZI($TU8<
MG_$;C^>R2>[\<D?_:(DWO9-1]AUD?:?[RA1S1(U$LZ85J_LC^!&]4(XZW:03
M>>6_-\)KDV/O_76,88# /NA#:L&WB$.F&F.2-F9X6C&9G&Q9.W12]%C6N>>H
MR TK!JBQT%5BU<AU(@5R8%H.?2F=K1_[>'@?"%HY1?1GVQ N!JC)3CU@YM.#
M%GTB.Q 3V,^LI,<$^%JD-Z!O5F!8=4':2592"%VAP.C2;'H?6!CKOAGGP$WL
MZXCC&)W=;$&S]LCMX$YTG _8,%H(_E8;(^5>*!9P]:,<]W$],!0Q@BK?2*48
MP-F(O&'H1PF4V[.P3Q+KH[*PP%<?/HI\YMRJNE%T91.J@6R2 C9:KRD^M=G=
M$C!IC&2Z,:\_CU.YHZ\Q2CSMLB@NTT#[)Q'E=&\+IB]['>.!$$ ;HE=0W]+3
MAFN G)N2,$I%=>(T^['/^\("C=N-CY/]C(B1;:ORX5AV615FE%55K15>H(%?
M7Y,4)1GGV,@>4DE_7!+V_=16KT$KE&#<QT*^]3>Y@S"RV*SF(=;KGG>:,I#C
MWC<N&K<D3__M/K4]79?0YL!#Z%B_>?CO)J)'*%W)[:7>+);=ZD3=S=GEC>D1
MP;RMSQZR^F4?OR?IZ3[@KXK7_R8S@83)@DDNM$3ZF56_%U0(@1L;NU":Q,9B
M'"P]'K0L9WVUX])T[JTWND_?9BJ,BC'U+'1'F@<:F]4T1$%N7OWK?6G;@@3S
M'X-FK>[!L*: ZX1>G>)7!L>^7>:TPX0^)AYSUHZ8C?ISJC,YK#_V,1ONMITR
MA/4Y -.A9"F_M@FU3T8K$[/T2'>>Y&\E'W.OUF$BNZ#?-\&*EY-;U]ITU4S:
MM6$3D)FD<;:\5]C'8W4&+^]ZKJ1_HA>I1U:\"&&?/\:*% BCGY3,,2ZF*I$3
MB7)TV9K(.+BEE_>3FP[*\U[+BP97J#)5)@9GDT?'!FWWW!0LM\E8KE^ZG923
M*MD?Q_<EI=2"NP>]OM'0ZEHSZ#\ZI!=$EC<- OZ0E@9VHA%ZP24P^%=R[FT/
M4?W9-TG:YCV9-I?C59<6F6X:PE,IE\C=I$ODH!E;>T=\:E2Q>@!1R1I:!?-S
M$"-L?"D0X]3U4]9%/R,FY5 'X#V]/S::0$$8*H]MBTW$5PJ$;&"/J8!-J6D2
MA4RAG_E/"R7>D%&EB'>AA]N"$EIP$=@R!J@5&G[@EZ",BD2RBA&&V[(F.X,E
M0O)R?!D@.7LG1_#/GR_YKIXXOUB]C'&K%!S[^K<8A9_ YCFZ1<D[&\H.(KZ1
MJ!P6&D>(?FWH4!%^6I4&JW\+R7EHMD*@*D_D/=Y0QG!PHX*BQ%6N=?:HE*/6
MD7Z<=)B+2^)WP60*/Y05SD3<:Y*/ U?DHF<3(L#E2Z$>Z@JS]S$/J+H5 VLS
MNM_>A?%A;L-2/*[ OXGQG_AUC0GB-=*M?R6AR"$A[^L@IH#=I@P1=8 >Z842
MI6 VQ0(\"<$%]M?B1WZ=E!-W_'U1ZBGDK0H916%'3&4>I672S\,MB'D)%>AS
M*S5+L6@+O$2_K/NBU=MNY;)(Q3[^8Q4QC2P;H\NX]?VY3;(% U0*F&?*1&QK
M0TZY:O#"^9G-:B?,S[VC=Y"GYB$SJ8BC&LRT6*K 5MN"/<S#L]B@X[+XNS=]
M<QPZ5@.&0P4/#K3$MY-KH2^AJ0]6)L::P;T2=!,;2#T#9*'>AITIQ;'7:7*E
M9)XDNQ*9VD3..T&<!^/>USW663NMI=S#\D-SIQ@ZYC73T2K/#W])A*Q#B91[
M'B<KP]\-_!UG&U T<#[5;/:S'],KH,-#X";T]/RZ->?WMS=@<YUM-EBS'7<$
M<9&,U(OM+5A!@+$5E;$^ 0XLYM#6MQ"!]"32_?=65#VU ->):F]\89=R[CK/
M,)U.P^8B[E$ER*L$)=(K\AR^+P9<P0!%_ZGPN\/.YG\#WWRP,C ])-QE=YNS
MP/P8V^M7O8M*4C^_U9)ZR(D4'NHMLDJ^(>';G/9O#3'7..[V.,E(N%+ 5^5O
MXH9_UV3G8JD9;YRO/SC"4KHK3Q9'OZ:SP*W()]0A>/FC9'E;<O@7A\G<;)'J
MK'$[:">GKL-UI8N\3XY4(<ONQU_[5CNW!!2:SAX1$ ZJ F&T$5F^UX*-QIW=
MS6B"R<7D+EN<E<C,(^>FN3N=FNHZ]_Y^3YNV*NS!^^I+MTF5#92#/8^E+Q^E
MKU\?3AK?:QBQL1V8D!\:(RZMAWRCJ@+!Y)F_+=Z][6=&QXW%!%B>]91>J,.!
MUB5G4;[+/-?%.^Y8 MGA3QZ)F: :B>!RG;Y,1LW&L(O [Q#OR12N6(I<JK)E
M@,KW<756[\59:QN?U;ZU*GWN^0HHC6260BQU:<EP09&0;)OEP#,A>$%'V8B,
M4VT>KIRWE=VXN>\4LCB9 (#BVF)#-X&]O>^8/W:&GD8\VM)ZXYD&1Q!7=1+=
M]G6\X'TN#SV]:]J:[YVNG0^5KLZ6=, XP )EH$0/0E7KRRZ%+P:4DH/:B:WE
M;8@4\KG'&-J0 %UW)VS/(D-;:YQ#U3V0S@7@,[:E%)5/\\D9KO-1D)![;GE,
M(3]GF)E6(.3+DM$H'=I'JL),G(J7']X]<'I8=K"H[53J. O-^XIE'%627.!$
M<44VF5?T<2\?620DA.V,_<H0>V/6?>S$WW)N];C!R4W03 CFO-#H9_HX'QEP
M<&8!VJ<&P6].E?V^JWZZU\&K-L['D-5/L7O#SD9".X0=9](2DN)S4_[O%P\Q
MV .[2AGSR#_AV/7%2LIDLN_D01!^M"DJ@V00,]N02CR*FWWZR2E[?#DU4S1S
MRLGJ&3[N@7FWP5G#V1=V&!#FFTX?CMT;^P<R@PQYYBVX[CR+CMD\_T9VNK3P
M]O$2+Y]+)@WWUE,?2KZ->G7C#"P16.]DZ.VYOO'!&;]FG.!J\E_P*95CME-W
MS#\TL0Y6#%PXL[1P[%@<$[AZ26%.90<2HW&$W@DLL$[+OL_F.7_VQ@/?&->3
M_HLC)1<;,N?#Q<2T@S=E,$['D@W&KVO[I[GV2J"0?CNC=^O]>,OG7[24V#U
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MORX\6WGB2U2['B9=(;-882CZDOBUV3E9L^H5V'!M)>^>I,>%X3IQZPX=;KY
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MXRQX1_K!J('K#L7Z1JPZGD\7LMO>C[T1#<O@9 YZ6:!/=[5&7*YNL.$,PJ5
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MH+$\:R*V'<)%#K,A2F2SCJ^W 2CGY,:95)C0O>43>E;[]VXY.X$<7YCNR71
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MJR]CY1_(;#O2A5F("?0(*!-R)ABHPB]:K@YS?>3*7=Q[FIPGD&@2)+^Z [F
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M)/C_;^VOGLH?5?4WMSVR_>^H1K@U1P7(:E-0C894@+W)G^OY^A?VGB"W_,?
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MR31E/MO])OX^ZS?RI K#>%/5PR<_L![YWQ?B")Z71SI?^83[S&J_,YZ>W)W
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MZ)R"$Q#FYL)<+:Q2UYX <T#APAPM.BQ?G5J>R)6(C#Z^^7^#8NE0("%8=WL
M&Q50LT")%_P#8O_AV/O?Q.2GM:^&RL4U;02CUL0&720SCG]K92N\4D!]W2]I
M:Q_AJO@"V%B1VH2O6^HXG1K=Q\8-_8FF&-W_5Z]JL,7_(&<BEY(I'%*1R"4@
M%? N60X[28[ (%\0EZ(Q%(O]F1$7:.76& Y.8@^AZ+P"$YG,86O2$W>NN[V3
MXMO$V;.S>TH)"AW>Z(=-\5#.,6521D&W1@,DO)<0A/N>-<64D9>,&Y#7%F.0
M@[=ZB7SC^B'5#/RNE$L0\XF]]XM@;D?(!>5GF83R>S7^$B;:=1819LU*WOGT
M^0<&%R_[AUX]0"P@@B"7]V$Q"^<JP-QV6X6\^Z:UE7-)E376@A\;Q\I#9IG]
MN+>,TT$OZQ;V81,;OCZO'^0(Z69-Y![!(-_VA$+!BSD+V'CH$)8D0@6\=\7#
M;K=+VX&GJ8"9U-*R5Q']N] ^1<S '!F7<; ?@Q'$%5(N[RS^KET>W'+!4 %;
M;0#*(-%DJF%0^D4,^16J4VYU.VV9_0B(15$,5&RI@)?GEJD ;0'$L!1!1(CT
M93 :-E]&F[PNQY@,B,%[EXH%*H"?\GHM2T&/W3BMR@*VLK 2DT(%+.W!#S2H
M@%V:L=M6#(!AS;+M 0E+C*+>+W&2RT>!L3#%1=CB)^ %DB".IP/"O(2S?5\!
MN=3A^/(5'K>I&"#GR"@3?UI8P'A:DTY^G_U8K #: SEUH /RUZ*P$>[(OU*-
MQ$_S5K "U,^:L=")'-*S6#R\K6_0M'G@N*^PUE/\8CJQ"%/:1NF#5^NUT12J
M&UX'^,@"R43X+M^7JS&*W_YR]RB%T^!!D#=0[(WNK+MU*FX/C20)[[P#">(&
M\1#\!%Z&46X2-(2'*4F+VO1-SD#QT/5U2"3LS+X7%H'I_FH/HJM-VAYOZX2_
M^%'SL?JR!.M*%FO;CLB[.WJN"9!"^)\22<!_*9%D-IX? !P769NC @2H ,-"
M1I&>BCRCB41$/^(GC;\VR)DV"C>JT_QW"!5P!DRZOC"5=)*( 4XOO-Z[??W[
M7-,#'^+4@)YNXL%[J!ZLA0^V4NJS2FD6H^D]EHG-"YX](JI,=63SFZU&Z48@
M;W\EZ%G*-X@*= 12==BV,Q6J63%G5>(Y>&D0F,KW,0<C?9W9JV&@7=S!%66L
MHAJ7 %&]U9H >0\Z.\)/SD$Z;3KJ<>D(=B ^!.C<:C04,?A9J'3F_L6[D\&W
MHN]VWK*,ZO'\IBHY.P?]=9PNN^'/+5F,<"& 5P+#EEP(XK P1&5B6#OX@B<O
MO[9-B'?N1KZ_Z-YH^]"#6_NP@28<P1]WJ0W)WL"?2X"WUF4K=GX,2%VJ?0?_
M9FS8\T.9_2JS^AE$(A7@!)D\7+*@#(!$QF6D&.SFV<<#%)X>1^7@XUXEE5 >
MSP[U_F"Z*1T,"HC5O#HQ",1J2H6;)(% .)>V]5SO$5E&(,;1QY14.GCIN@)=
MZ0O/0;([>Z6(:$*B4)V)-6P,OC]@KUM\]E[_G+:>!EDFD$R\2QF>/TU.";A]
M$;',<V2@_?U%V<CK+-:YN;+('P\$SI^/+&?.NFHK0(=+7"5Q6.CHZ&=5$@P]
M[Z0C3Z*=/&T^(_(C+7XPS,"6C< NP,G5Y3 4,IHSX\9/F4(5V[;8Z9:7WYOK
MTF[VLCG4IY7U])R0OIUQ=A&1"S3Q@>!Y"%+? F0JL3D+03(Z#XH_!Z\:U95'
M[:RX(97A]JC/1;J:T\U2KT^8:DP_O)@U4D9!%@=\:=0P, I,D['Z4[5#=75K
M@OC<AP[_M;(VILU]UGX:D^*;K,CWO2!9^ OJ<ZIIT<?XTT]67C@SQL'=$'\B
ME24=8TY29N8OE6+[5Y*-APCA.K=>&5,!,1&J@SP<*'JNW?DTNFFD'M@9,1UB
M04YNXK$W1X151*@8&H]+Z;R3AMSFP@PF#39D+M8N YR!,0_'C:YM\5N]WJ_.
M@*</I7/'NZ<KIJ(02<B5?N3T,KYJ"/P2R&#J8&+N1PBQ''6FOV-^?9[1-I%!
M^B'$!F/$M6K?_9)W5Y+2#:Y()LD*M8G!.6&M2K1%@$K(ZWV&!U<'(I18>*!4
M@"2H'A?IM0F)6> C,>(23'^^;I(@F5C\4B0O3&[-&(.,^H+XY45.,R2> 2P^
MT^@[%WS1<=^"<E:("KC1FP^;[* Y]9E/"]IRI1P*G)/F*F/6J(!+(L^O%!H^
M'I;"#6T2H Q3W/C&7!^(6M/8@6.7!T:ZDZ.FMK[F36D'=V3Y+17 R:9S!)JW
M>"H8"PTKUK)?8CJY 1(MBPKG(6[^&DEZ!&SD]G4K-:3\--PX%:A&-"&QC,/L
M7$(FYL\.-6@!0\WQ:!%)9\$J^R2[V.W=#^=S[KT)4R;/VJ3@8J8@E+.KBSO!
M39?&7Q"^9/O8=AX?=/0F-C94$W4J&[_J_Q#5#>)?]7U%I_RV_F29Y>ZGDJWD
M93(T<K-H=;LS9<%[YIAL\F6$T@?#/G8!4(:Y^Z"\1(F)=R2+ZYQACT8%S/CK
MF@7?W3[O\O2T5UE^IR8# U#?9+$ZLJ)1<@2/RD MXO:*^'$/Q+ZF<DH+?194
M5:[:#M:95([ZZJ8A2TQ?UF-56]PYM9ER,"+:EC.IY\]_Z>V'95MP3^&TVE*2
M8*%+;J;>@71;3_;F().$>553,>(G00FM06+O7&A&,BMK+=7KA0*G\<?J6:Y/
MDZD ;*POV&XW^\5"^59QM:![%&K3<I4$<J?D40$42RJ C(+P4WK\8&UZEP/L
MFD9!LI#IMB6NK9)*QE)O3YG3O]UZ6)ZTMJH[#7-,I\7F1KYJVB388L/P%PDM
MQ3?BEDQEB!@#]1GV] %$X53O;3_U\I[W@V6_OZ<Y[&I\F=>!-9//\]J/IJ4)
M?'+)H>QMNDRMHJD DA0B9)X7MX#7PP/Q=9JT!4(%V!,U$LM,8OA>M<^E?R%F
M%?L ,:=H,R]#\,2:M)O,\PS+$ >O..(EG]=97#9FU!1@N,"CV_+QV<+SFPQ7
M8^_1S;N N*B UEK"I0*"U))1FKEL1],7=Y?,^RJCD;%Z5]V*7L36/U5*ZK[1
M=(*<0 4LIE!$ARBWJ0"[@!?8CIS5]T5.UNA3G-C9>[[>M2?%/Q0WY)V:#'U\
M]O'%>RW#WOE6G?!Z7BI !<R4:K?VJ6 DBX<XX@=N@VR6*R'IJ("6YP%B!1M#
M,X3"I>V<I1G.I\C7(P=LHW=>D'_?OZ)!ES^3L'8A\-?BPF4[.'.#5*Y/1%O*
M)^ZJB+P'-ZH:JE\7YI/O,5P-"3YS-4@M@)'VS<KD=.AE'ZG%I'3TX$6"K08V
MJ=ZIX+X]UQ"&OT*[9L5$/.K*4S&6ZC>O7SBI?"P>)/!3:O,7 GAP2>EN.S>2
M;8I%RF>US@RK?E>#W(LMCC$&5>C'YQ6H%=M0 72DB8/\A$1SV6]GZ_-I=-,6
M:B!.C<V(]^_P@97)NP,F:<X*]SVA/KCN\A[%LV<\]*U"B'$U?Q;ONT"?_/BZ
MF\5\/C)_H(4[W[]L/)EP+KM$P2]2N#<>K\]+X79"E<7R=)@SQ*Q<3*O+$Y<%
M\CRU>+4L"\^_C0Q9M\J!&OGL+6V'$)_3R#"519PC9'1M@BYB2V)6YLTEVF,_
M<@AS_EJX)"8IZ:RA#O3F&Q/=S>=VG9LCQ=>30;L5D8(*'M7S<_'@N_^ZY''Q
MSBF2&\$5QV\<*-4*85:60$?I7+]=F1%1;&']J#3XA%M</?/7LLCE*S'FV$&"
M)^I/_?H'-+0O=IQ+\Q0FLD@LY%@0"W3 ;_Y;(4D9&^P#,T!6<U1SGJ9LK*=<
M;:F* 9E,2Y]0<DT[OU_,[TCL=,;_Q"N*]3;=@HX"SU$ 'R90\W(CRF#WZQ]9
M.Z9RZU\HG.AH>#C,W@6^,^LZ7A# 0RX&,5-^<L:;$1A1YEZU>>HY QF]@L5#
M^F-)EQ,%7O).BM"-?P<=''F6&AQ")9@L,\.QX(_@ZIAF\+LZ4HK01ZB@?:Q#
MZ:UH1\<SMJ/<G RG!(@R;F<F^0HF^8<3Q[:4E"P/>\02"4XXPU8PE_)MS@\!
M[&@>)E:[75ZXPX]/\AK-@KS077GZEZ8GI:5%PSI<HOE.$'BS4/F$O0X_EU G
MP;F5B*E2<:)KC1IS;Y>ZNJJ(\DAR+<Y.F+AP,===S8>S#3(SN CL0#*W??.Q
M1>NFNQ;JMLI+N'RM^6&?ED8?.:O!Y264F2]P;-(P:ZGAZ"*^^T,SRV ;]17P
M(D5P&Y5B<?(0+CK;/$01]-%HYQ,>;9#-(>2JC39H?#\Y,:V2D76^.BF(^6P2
M^_/U;KK?='DET4A%\.*GF^!V*=X * 'YAA'.XA.RA1^84TV.7YH ?4YAH0).
M((;\O!R8W>:R%Q+'J(!K<CO]$@GVOC-Z TM&LD[6J'LCJ\C1':?]32[.@&H3
MMR)]]::BOKMTFY8:J(6H%,ZM/2P<@EO]$*$2FLQA,'U=N??+Y_?A;(>OKMK^
MZ%:F@\ AIV"OX$!8BX94,GH5A6!Q,+<-LOT";Z.P#.?<[,2%\ON%=D6#"I&G
MM124/IVZP>_;W:DB%\AYA)2<3L)PY6N7]!92 6]_0]_Y>..#"19HC)5,,2/:
MY)ULL?[ 6.E(Y:;9JLT:BX"XWI(5.>#E<@Q! +%UB-8[/VMJ!P6.*O,7E$%7
M34K'G$L$-%"GLC(TU"T/ "<U5!4G,B@M,)X&7VSU,NHC#3?LA-=EIVQ_RRKL
M72(_7^KM%M#,O,?Q6^D+-P?K#;?'8I)O %;7[+M'B,8NXS/D>?\XL4YELI2+
M-H;L ;Z_A@ 1$+B]9AC=*G:+3W8"5KJ*N["*AR:S3@VZ3=S^I=Y\+:KK5W)2
M\XJ[)4UJ9EP682U@%EZ&3C#S/D;)S+#*@L?.MC&)KJ6]T(7GR);^"DAQU%V2
M @&O9Q91 9#-;=L:?=,,1ES56QQ/VQV^Z]A.A'W)FG?W;PN(:8] ^+VT*RP_
M:3IP]\S5Q7 T2)HR"CY'!=@N7(->]9G0Q1[T;0B$=U</>JQI\;2SB'577XV:
M<8T;3VM$V=,DLP<W>B JA@(Q02<AIRDJ&[:/L'(Q'AB;)RUBN3WQTY9=@&X1
MMK7HQ1/Q3ZZ8E,Q;W\N=[O?TE/$:__DMWNS[FP_AI[5O*0,8W'6U.JS-S_H/
M=*6$']6;4@'!4= !;N"'BQ'N.+U'\5AY/>GAZ8W?,T*4C.L?,U%-)!.DCTO[
MM$9DA9**X[U1C&SZ]=U;$I4'[S9E;HMLEV0'@SY)F$A/NFCT'$I96;4\<Y3M
M[QN:F6D-U;J1&)PI?%F\'0O@[0<I<-B-#24.A?YZJ4#/]XZ;E$D;^ -TD@I@
M:I+P(2[E!E5(\?11SH\TW$5U]E^H7'E3H*:L73K2>]KS<?G-R2LO1'@+]U%+
M>AUZC %V6$DX>N?4AH8)=@X7Y^1RH6(<K2<Q?:?U8?CB:>,KT;,&N<0>Z)B3
M?T#%Q.I((V)-;S8E9'XANLZOT.HXW5/#U94]FU5/.?_\K7S;>/5S!0P&6FNB
M#TD_R=D2GN 9?LHY.N 6&>&3H(]=;8MALB^$N>=.:EX/?.@B>$.BZUKJ8=Z)
MIRW&<E=?)!@6??_&.T?1$JLR#I=.JX(4:DDUPMTUB-JDJZE/N%_#V -8CS_"
MQ,VE/A3U=2#KR_L& DNMHZ[DR]@+.)>I+TJ7I04SJ5X(2/"F NASR2DE'LD5
M,<V'7M7G4T^1%'_AONB"L!=NQ8"?H"I]45LQV$$T8BN5^,01?F8YICU#C,#K
M;S?A9UT=Z,AO8;^;*"UZ5+,[]I&)IV#Q-IM3@:Z8YK3!BO_F>B:RMVO )-+W
MV'ZS)&SM%'LW29-0NK@30@$J+D0%:'\GV&K/E=J..G. ;_W0[1K=Q03ICM'C
MAAOJEY"8=2P3>N+C-RP5$ H5L)]0;-_F#Y[&SZ/;!U86!9Q<KSALZ:D9:&V)
MVNR 3#=ZH!N__?F(EK-@U@9^UV6M!E[.\ HS9:OS4(^ZDPXW4_=C[)PP+O5]
MC)6?5DINWMNQ$@R8P1K#II;10BBI#S!6*% .#V_7D865!V@5R>'#B^YOOS:"
M,V=(N'Y^NZ2X5*M5XN2E54WVJA_;!^K(U4$FTJM \9E-1BX$4;FM]J)[A-2N
MY2@&0S#1R<0#3!"QW5I ZSCJ#<LL?"CVS%N8U7!T.KFF^%GZX18[VZ77@%YF
MA8,"K>ZI2T(]J7ZFQU[A>SM1$* R U&)X# "(80@I,+V4PMSRH)A98-NUL^+
MEE15HQ<\N5:YEA'7Z^O%NBH9Y26_"G[-D$VZ\U+TX8\N >8SB_O\,DGYE3]=
MM(5&4\+W8I@H0T"F!B-<B"7!*L<G!).A.'25J/LM)R>QF0,7(Y5P*_(!;!S5
M[.8VN?7F"&FG%U:%O"2+ .BA324:C#+7X3.*B478WBO&23X&+^.78E6S+N:>
MV@M),UB#JY<T3'C^RB*&V7K5PR %Q,$'F0W)2TP8"RQB>>)C911=,Y\HA'5#
M\0'4:6>J2#+IS(37SP<[K)U3*G=*N^@C@W1>DDS)E90S <SCJ1JXF'85.=VQ
M+*67/RJC'=>7Y <$H^<$[ ;.R+]1'/$S)WOML8[CUVLQHR9GL<G+N4%0)3LW
M!\I)G#$<[2C\P:RI:T7[A$)STHT3RT(,)S[9LH\28MKK]$+VE?IMK48Q,D[7
M!VY+]!^0-L_?S*/<\+IZXD!&>Y90<89F:;\GLN^I(4ELJ?C7=1.GX^%L1<9K
MW;]\XTVM!9O<(X\P9R)<B!:E.Q"UM>..L \>]3IZVHW5HQ4S->.._KU:QJ:O
MHD*-AD9CFZ/?<7MY_5X3VW3.Z6G%)<<HRV)W-"CC.,@'#\1Y>^CS-CSF%5Y,
M4Z[*J^2(2W(YY&T:UM&KR8=<A&@Z0?B^W *Y +W3X_P;=S$[WLY<%68G4EM'
MKYK=^/W.'FAA_B;D<T;[Q[%*KNTYY%+#EGE5B07_&B//II-!S_SN %JL7NG#
MN)WSU3>XGL@3QL97F._1L[2<SD7($>)PR*75+2+3>X]!]DVQKS?*WZ081SGQ
MIG=TI]QE-Y9EX8^+ZI*>O!+MF$PH)CJ1F A":/ZO!!2:+SW74=2KU\;I_&%9
MLX]\HM,R3'PQ) QE[JR/K-MO1")4]%D,JAL;$61?J]NSPD5ZIP@S=PE12ZE,
M+#XV)A43'DHK>Q*(HI>L:E<'+IY9NT?/[$O/_$;-:<2^8RK8OO!K$9*5D*6.
MM0[S+"*$F)3^K/!_S+W\>+3$8'Z>6?.QM<8U$X&WW1MJ#B:KG)BY93$J8!J.
MC\:"MVJ7>+Y<_,(^ZP>/V"[N;M?,@B6UNQ)K/@;P,78S;XC*ND7)N]!0\<6%
M>//DS,A<B7CDD93Q/HB,A;1+,09H#J^,DOC15L .Q==NG_EH\QZ^RQX+>,@9
M]?GTB4_+"BU\E3]-5B$D5LEU92%?W,)2M7" $MH)U]F>4/'EJ4H@J ^9#OTX
M'CT>F56N15Z_+>O?(SUWIVF5?,LQ U?=#CD7(#OR;#0 @@[D::T+&/YPO6[\
MX$P1VO>,P/6&R*]5;&ET:73KUO?1\)EE/!1K&PE>XAJ#"MNS.* A@N-S-VJ"
MA0;.=;NRRNC'^BBEV5Q!-SV@&2B$XT^2)>YPBXA%J36%4D;:3=#$@8K8A_$"
MNVKTK(4BUSX5/KIWA<6L<.!Q)&@TW@I9:#FBF:^PWI,*FRB..[:W]3W]S?;4
M6!%N=GH@0MRP=6GXP;/$E\]:Z)GO\;H;FJ0%6!*6L8=X6ZQS:@%ATQ)R8<U
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MB8$JP5.S2YJ[3YRA7S-T6U (_9_KNA>S1TT,D73ODI0NZ5VX<"4=V4^*VYO
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M_JGB& )D(+WT7]+C].DE"D'*6"KP\"GO\M<7PS?W4(PB/6493'X$.<J9/2I
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MJZ 1R7U5)/$V8G6'!EQ$[*W0@+?*5"1XFXN>[E<[BB\]VXNH^V5'/8LYA-.
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M&P%C?4G1%.8''%QI-!QIN.QCZSAKKJCL*@#$7HB["]LNV %/@'!NX8O)E;"
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M24J(W=!]>$<@7AE5CEIX3 9<1. 0$PI'H,5%3*;5":$ZH/=>ND^'P[\30$C
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M*+OAGO6A%V:]US/W!Z! U,+1&,MBJ,TXD-*BAOW*>_W=IQ&Y?2S0-_^MO=K
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MB@U0#,K6P$4^"SSFP1SHH=9:ZR25#O5F7UE*65I\VF(L7IUWJ5;Z ^%&OO9
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M0?H4W+692^P:<!;\WMP'U@Z&J\# 4E59^M%F_AQTTA8W1W"9,/U>KCN:@?P
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M:C:!6%:,U,<;XXK2V"EJ*)5Y&DH-Z\%^W[O/!)P\-?;!)%K3IL$G@>-]O-=
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MF@XYWG.L/^\MCLFWGP#^',Z-=Z9I$[4[^0##7M'Z"[!,5FT'KYOG 7Y?/7T
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M"Z@GN0SN,! N/UC5GR(XY N;5/6VPN]J=878\@<OF;?_XH^>-DV ]8/*QEN
M4>@:CHX!QIH0Q9T0RF6]'Y-K8@76@!K8*]6&?E:_XCT5#S=+Q%_>9[-"CKY9
MZ/!J>R*W*3615F@;K;&J-\3O/L2XFOG&V./AS(U)NPB9 "4+M1$761?1W3NR
M50=1&S*L'?X*"G%%^2,\IL BRN^,2] ')<J1A5 M;.B7(H$CE_Q9I[$?TV)
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M\G9GZ]5Q*:>K^=[,-HGK\QJ_O(W%R@ O0\V8'JN(S'I\%L"_2@F4G*D\DK+
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M.YN>N_,.=0[)W([KF>?HD#KKNT%AS6 AO*O*^S9VW)1V4!RZK+[[Z>'[[!.
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MWS0:-@K_,1 $=W1JDK=L1(XH"B\$WCK[W#=>_<5-_2*SJZJ@0./PET%%3&J
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MUFC:_'-G6B=G=Y;:Z[M\)#%5!N&O3<ZJKFJR_X3U$6'2\.9GRK*^$Z@AF1/
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M"(E5Y/,KOAF2+$ST"I]C.F.UJ@**CT-2YOT 3U$SL@;)"RI\^&52?2+(/77
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M?[Y3XQ>[H6>SX\KU8*HX/\3MG.$4:=F',V._Q7G2E*NZVZ6>D9EIB?V#](A
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MYVYSN3O:L70:I7\GQ<E?[FZUT$2DVB7B@2K9\'DAZ3"M"^QW%?S3R'P495<
M>5#&,M%7Y9GSLKB<Z27)5W);(D^<_#7=MSF,^]JPO2!+B<7#030FKS7B']6!
M7X:85RBJZ3Q3HUD7JA1"K6[(2/"M%F\2MOO>,^@-6*.$M-5=,QY-1I8ZH"KZ
M_2QZV4?8*<"=&5(@*N\G:??=:'.;3I5XU$>N3=SN'D\%::3;=)QW7S#8SGX*
MV+Y&.2,%?#)K$E5HAU*=DZ<6E084*6/F%14EL>[(H0M[>3=\>1W][.=6]8AE
M#H(RD#3H2*(:<A#<UZR2/#J</30RJ,I/O\L) ?,90A4'V<^!FX/*]+(BVCZ
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MZM"6\&^GC!Z_>11,0P\4C!:' 78<1!^7?N<L3F\O(\+U!"%5W%EA_PL#]X*
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MQT.O6<)^"_^4EH*_0OK(012O&@<$L8GML?-<<SM8'OA0YF4Z@RVVL(?T$>A
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M2L1$C!KJ\R];#!8W3>:*.W4!9#AD=ZZM ]!-/:5?+6I=R,01OP>[?G7+\=4
M85'#W/+PP/Z1J(99J8*5< 6HJNX@3@;VL*FP2(PYB$!7#N(R$GP &P?,%!PU
MT\.A,S /F8JXCC6MW"[[@EU$U8,A1&J>"HE)AH,Y3@GF6!>4-U2#?*P!$L^:
M3I089L3E7?""2'8TDIH-3$O"ND7!]L',_6T?,1S$FG+7Z!&&@V&B\-_TU'4
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MTZEY02,J 58-:<P1J/H%S^ZYQ$$0X;JU%EY]ZM_C;@QXF(-8@TC[TP/4H!2
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MF9ODZZ8"M 8-U&#-)T!CI90E W]KU^4QG^D]17J\D,<VUZ+':?($S_E&OOG
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M:DQ;EA38EFN:;C;>R.+C]F54=M._>%>V,#/S89'>54N&&+$+[86_Z<\*(Y+
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M$@+/MP"<FL9IX/-YMD]] 4/QYZ .6?)A9T.,AB3M'B3C18[]S_7$AFB'VOF
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M?@)7*0"R+@_Y/L&1S&U( 9AL4B,Y.&E0^Y_:-]_*@?W[#3TG5SGR[/\YJ2\
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M[2NB2L/[LO@Q/)&-[!^ $2K*14[.KQZ\KQ)E<^L(M>7U_?I36BE@V,^CI5D
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MH4TR9HZ)E /F"Q2/X4C2GCSDXGNLZ7"W!=/?8_<\@SN<1O%&%-X UXBG]<"
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M//653EE"F9$>//1$-6S0^+N\M6OXI"V'V]:SM&4>C+6*]K ESR7.D,Q<ON"
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M"ZO7:GC9*VL^GBWQXB>X[NZTF./:)/<B31,D@/B"%$_TFN>Y;MV>L\8>'G'
M]L76WO=+RP0=GR"OG<FYI+?S";<#0FS.:QHI/M5TD9O-VT8F[1[#;3LK71Q8
M5>1%+W([B3;)#3^4]SD&:A10 ,'@#87K% ![%>V#R>9!KSR]%<3+XO@DP?4$
M(/N1 5[(-$:!Y_R;HI0;>A[%G<LGF4,/+Y!!21H$9O)/I<&VL=%&0W3Z<]MB
M5)NX6['N>3_>&;;H#P_H.B3[1\^M)KYKH6H(#37!*1>6-)YWQ5\L\\L_;+ 0
M],$U(F;\:@3+WS MT)/Z_3A)Q8(MKF,WG\8JZ/*&/F-&^1Q;R6&5HYJK(++)
MKO)P8L1X^$\M4^#>?0_DE@R0'!W52$^^1.\KB^(0N^%[B_6-DX_@\U1[?C)P
MN&F??)&*#K\6@=PN0U6ZM45 W&]2IC<\LO\+'M&&0TZQ5\-/5=67W3N;J%%;
M7FZW9U(!;GK@?H=5:KOPU\]\D;A^UY..D8VJ,K#HI3?,RZZ3WI5P(K"_#NO1
MRG%\@(JQN5A;[:-C;EGY%/%J^-MWHCH?%C$J";M>9@-FPHX:,UO\C/;Q5;A[
M_Y$Z\0(S%K151)#$-Q/0#HEH2<8U\[0KD;D_)<H*[_W25>G]X1+__?+;:9T7
M4N]B5IJS265@?X]Y^#NE X.;T;//@17B.8(I^XJ)>S!_8I/+_K</'2^^#N?L
M2DK*%SNVC;H\*]\R!3_R?T%8+_<E;H$3"1SD(7:/UB8/HR&BUBY]>)6#CMKX
M-]!6A= -J<?2IN]:^?C=;*32"$1H&R_62IV&72&ZTOF*UGWS#XQ J?CC*+P@
M[CDI&2R'G6Y72*.*?Y2'N/O+'3H6=K>,"PC6&TQ!6U:\8=!0SSR?(C@;T [)
M1N3"<K(CVH';VU8/G<)/-$/S$?.)N<)7W[\H"+X$>QQ@M_UIJ!5=!OY6( #2
MDQ^IKK[CJ6+F^+;?5%O=-+NDF+2I4!IU8G.DY[L6)+AH\!NVX!'-:%XU7*IR
MQY=W=G5=@2Y7+<MJYZYJDB98FZ .^1DPT:+J,*5<]''LC=4VRG8T)^8+6JJ.
M2]KG]N"C#]HW#L]L[$Y>VE_T_EGFV:RB]]C/3-G,(J[IJBX"Z+D]W7C1PM9'
MUPXB"\<87C;JXGG_Y#I<5'A40LX^^6S/#//-#\JV(ZN&%,!IYH'W'2^^^_U^
M;F\^I7F,(K//QA';SZ2L^)L^ @LIR42Y67O.S>EJ9?7N>OVD,F46D('<BK[L
MVZH@C1;%4P"58J-9*J.G[ QWC)VIZM2A7A(OE-(^XEW@Y]HE_WTG^>*5U#<]
M=0)6D@QJK2&PHBAJDP5X;*D:)_6#.E:\&GWB/?RHK\E&96&$?/9]^"*HI+X:
MED-\B&G*L;X)6E?0\X"R> ?%)72A'GTC,P^E(;XNKML:#>WN#5$ 2PW^N='A
M>14O<YI-%7:U+8B'H#?)S?K=0(QK*P8L@%?X[,QR3IP"J-A2(4S8ON5_9I<:
M>4!GA6$^?HW5[;X&?HB/1^ 3/'^/2K(_&*O/N[L="SU["7B)=(542;X);;N(
MT3"J#@91]>S3UU\TXAI8KPF?O*23V6A#2KF^#+Y2\K!V(]I2&8(X(,1!;I?0
MJ8JIF6H2ONL@$Y9AFT?PRN3O7^#9&DQG7FB\9 9LG9Z'BA!!=;4)>VC+E1=[
M?<NS,*..I322)YYM<1,4B;JDHEK2*M+/GQQY>0I!K,AD$HO2)K3 LVF:P.>P
M13A#[& (V/]K=P[>Z_%$I7)12D+7YJ,:UQBM;EY^VH3W7L%6@,6;M7N6W;11
M)5H-E7#HK=WCK'"FH<)/]K^?ZE^7>&R5C^A(JMYV:'8,,<[]Q\9=+K3"8ZLP
M%^^X\"&Z>XYEN$H5<N)3%R_IEINF:]%SJ8RFE>_]S*N ,L0'H(LH_04GY/]@
M[[W#FOJ^=/%@ 04!:=*)"@A21+H@$!L@HB*]"1&1WJ1)3Q1%E!9! 44@2E5:
MI(8>D XBTDN $'H+))002+MQYLZ=^7SGF3LS]_G=[SR_N?ZQ_N$Y9Y^SU[O6
M>M>[<S9;L%)>MCDT0//)A_P7R RO>1?]FB,?CDUV"$B<8P9(!R/ROCL'E KT
M%9K>02.NSRI^8!8__/2E9D72(OG"J@T=T#3:236<-#6<Y&!M2:0#PD=GAULW
M WTE!JKV)1ZN=]1(28SBA/]Y;2^6;SM=G3!*!R"AQ+GU8"S*\05XEO()\A'2
M$F=+#.QGTF#S#V!!;J8U7J,BWRG@^!$S3._E#9K6R"\0") #8E_=2YC66(+:
M\;?LA"-9*.GV#8S&E(@Z.'-^!C7O;TF;IO3GN3!*9R60'$ V_7=6N"*FR&(,
M1JTA7:;5&-$!N=R6;> *%0M_VNA$?>A+S#<=Q".DF,O45O=UE,Y8KQ:*IF\%
M(T,9(^D)8BAO!13(T71 WOP3X%&H@ZA+1YI\2MULL7&]1KZ=3 ][G&)(JHF>
MWG5%*<\0 ?$S,*UGX.LD?Z(TR6"F6G?DLZ-OT7NC#\1X]YWU^Z$%GM>TWPOM
MB4*$]\.UO[1E&_(UYHV4R:<GG<@R_/9"(I2Y#>)L'WZ8A":(M_<ZEKC6XJ8_
M2:#/91==_N@ZE&EUN_6S<3KV.)$EU]^X;5;9H"\-51:S4@6/[C/M;UT8DXM,
M5G!Y$?RZQW"S)/..[([%2LV!?XZ^XZFWSFD/D':J#E<]Y7T7CD7&?U0C( 7:
M+[5!3%W7A8GORT_/ _G/'(&.SB"&-H\M@_ Q)".]_AN-4&+@.[5,;T74PZ-3
ML'#+!>]HP5)J]KKX>]Q%4C'?=KMB,%/^&_2::M%&,2HB2"HVO?'K"W^8[**E
M705Z'I(2'LX0"L"Y33*3/8/:4A&=:=1H4N7GJ>"/C-I9$2N0YM&#.[<Z+3 J
M&.3Z7EIP+DD78A2<CX7'4#CSQZ=)T2U[!Y(-\S!>X,3)]W;C /D7GFHZ#C\O
M^MN):)APQ=]$%GKL7JJ>C;<>RC91])*4;41[0]Y#NJ!;WHVL= #"&K03D(Q/
MQ<47]15!^L5D>6[^3(&Q%\ET;)S]GL[IU0:; S^A_<W5G#A;.D"*?0YZ0 %3
M>9,U@B@)#)F#I@,.3$[YGZNV/9)J;D@'W"GOK0>5V)%<[ 8KPP2U"M'"KS8<
MH/IZ)T#&X)(#K\5D @P;KHSC7M$Y.WAQ.4RN%/N.')>XRT?:!D-__R!%8W3,
M7L'\%OB('S4U_?EDW3+X_MZ[I"L'!G4T,M_R$LG'XZ5Y=CUP9H_**?[<MX<S
M(=B-HLK7Z&%.L@M9#ME<U\='+AF1L+.Q#28BJ!>M*5>2Q:F2X]F3VE5R\+U?
M)4LT5E$"#UGYNPWPN5=NZT1Z.Q%GMCW?_O@I3,\?3G8!F[HV\@V&@[ZL68[<
M.U:B&O8YZ D&\^9&XG/<=\[6M],H1LUT![V"X\L:U8*?WXL!JWT?,%HG*P^%
M&#OY:7] (BFL]7&2!LXU<3*];L?RM\'4\MHMG53E; [1+G?L5U1H4=J^.J,2
M2, _:F7&2",:0"+_Y<K^C_VQ_Y 5VEBD!I6XIX1ZO6 /C A1LD4W Z>3]!\4
M9$\FL<Q=?S(<+R7U"))+Z]*T=67T)HC(3^$+N)SJ_0;)3 -]AW$Z@!KABM##
M!T4[X*-?[-AQ3)D[#'IB*^Y]:.<ZM)09%K080W'A,IT8R= =1NZ5'\!8=+'X
MH2^H<M[&!<<E(W0/EI\B20=PSA B7ES>->)<P@GK]TIF S^NE7Z;;FJ !(WB
MPO'Z@2?>] KUGH@QGDN\+GM>X/3S(2[P!SJ@4G^]+PSO 4ZU'CB3M-2,'%@\
MKO_#<ZIFZU'3C,MEV^HFK01(SYD?XCV[MV#V\'D(N%U#A:&7*UQE\PDA3Z#9
M6O_XJ;'L/WE#^SG1E_H)A8579CRD \B'R6%DO:G36[1QHH^"A_?/<&3?BB4=
MX*8P84L3XM8^"L**T)IH/<HBU#J<CL^'<MJ'/,5R3'%P%%^;G.AQ2ZM48$1@
MW0[:<3@_S?$\5O+9"SH@8,_"OFZ"#GAE.?![R<5+VV@&$ZG_$A$.H@..RQ=Q
MEX]W,EH(%U=Q[]O05?CCJ21-1XF =AW/K,I6AY6'G]?7]):7FN=\!2/,P>P7
MK+V@8#O.WQ\;N_F07&_N\-(!+_P9;RWWPY^X6;'?Z-QWX/R^O0]2N01FAYSS
M8#RAWMQGEI-C*B)SZTSIW!OOF. NX>S$L*]->P)'3EY1[>Z_E2 4SVK_/3UB
M*@ 3L:? \_ZA;S"LV")CU:TDUJNJJF.:)L#0I''!#[VT.5_5*Q1:8S@$W+SX
M6N]LL-4_BM#H^%H@ILFX(-;-(Z\>PH'O74_=R)%OKS"Y-*N=T#D>2U67#U?0
M#0&/!8MY>X.3IV"?Z0!;?Q^7+AQ_<3*#E!+S9WVX5R$71Q&5Q<Y;AM2[Q.MR
M>]R9UK!E@ "  P#@.!KJLKY-OND! NQZP,^.!WJQDIX'Y76=N?UMQD#X >[!
MI>6K(F)/8:>S&E[WYYO 2]]%3!6%]\J9AZJ.G$N?2 M"V=*0:Q$'\$][0+RQ
MT2'Y6!4=,0)OZD>_4@,1-D&?:[,F5_;0),OX,<ATICB01X)P(3=+<C%1]%W*
MDS2^!FSD)<-:Q>0<Z6E'K-J2ZPR>16/?+V9KY=&8C*4[?V-:^;('0<\#G+(K
M[Q+!/16TN5*Z :V(QFG0 >PL+I\93/M=E?J,FBHQX$V&3H1/8?5 PWF*2$RQ
M.M&;F@?%9N)VEU%881J&-N1J"_(FJR<O1 .W>[<S:%.R+5]*.F<>$UKJ96#5
M!W9[C7N-2ZE::&%3?I'P @CQ\N4+O5X>GICKXR@WX(0"(SBWKU8S@B&,$0P7
M--[ZH"&#B_M1'-#A?XS/7EZ+'6G3%E.SK[*ZD-K=2Z7!M6.K ZT/)7O5/1I.
M=?=XR">N8(Z@7(UX*6Q#"V_UDBXW7%AX;N<69'VQ)T']A!\L09W3,Y)9=DV;
MG\8J/U-3Y.AEVV*SF[&H$UST0IWK^3I.XA$=@#F+ GTID;.PC6HWS"P*W*C0
MOH_2Z5CX1@R0VB"&(E)]$HFPUDV2=$#J1, (Y.BOO&^99A.JVE:?@\NGSIAT
M&WUV%J>^!0NOVB1/EWZYCP'?-P@*\1<W5&W]83WOYV?U=NBM^9?BQ]5" BK#
M A/4T/3]EUYQO4+!7Z?D4[K"479]_3"25!\E47B3?**/#LB:+:(#$C"5:J5X
MX%R96]GXA7+LQV*E:3=/9(A?VYD0IB3UYOFG2OG/G^V%J'X@LX<;X&$O()S3
MUAZ9Y_L#;-N'\][8K@J]N'C3K.,D>^68R".QB/C@(%S;; 2P#2Y8O!F@;=-A
M729TF^MCO,Z"5-S%$ .[SIN=G7.3ECWU2HB//U4=@E%;H*L'E&_AZGK!H>F5
M9T=ZP;,1H!\'AXU_9TRPF+:.Y3?\TJL+/I&+E[RYCSUTWKD@X<?2.+B#@$%4
MP[T)G!U 'G9+F\"7$R=->HR>PF7&C\^?V'5\EJ*5_@3 M%1AV>_@5W^!&S*0
M'KBQJR,%;!5\Z60T-@JO&Y<%CQZ4CE/.DVIF0<\AY^P\6I"&(G%U4I7O3T4N
M:.(2_92TCYU.:+4<FQ;YA^RV">-E9'%49:SPS[A:#UU_P;VC$THZ[^>&1IN&
M+-X7H=CCW(83&HC.&I# A.[!!*$GL<N[8+R./@9RYA_N-YEN2XC"1C@?;)-,
M[[D69Q^DZ+^A"5 \YF"Q0'ZMZX34-LYBTDNL_95&NX:BTT5J_4N7N?R@W 92
M-2478N(N6$<U]V2^8TQ"Y8?R.L2%T^G5[SDHP!\CAH'C@I4OJ?!P*6I%KO/)
M:N3D18SS]/1=Z(Q 1Y5L#]2IC\%'6!BLD2O8MK4V_Z5\(+M7^'"FP05)F8VW
MFO$$EK'@PY'U,42?6)1H_1F\88MI5TB$^\2[>[BR?J\<L*9%^TE/H.^EA5<
MIK6G$)]+[46FP4+WO&^!DT<R\Z?P[:9R-7*C/.;2MT3)X^31P;O=!W!A" 9\
M$H4]1RKUPHY)3+E@R0\2LO,G))DF:6P+L"^JVZ*NI%AP/<$"]65-,RXS<)?:
M,OF35K)N-8<^5UZXBK>"%F"Q^F6CHXA9B'_:G+UC?.'K%:G\K'X(R]=P-NIG
MBB%>W"+ECEPN+3&@N62G,.6LQLTYO\1NG4N3RNC3,Y8C:3X47LNFLO'VB>CH
M\.M> ?I]HA6/;S\]8%'Z+$X[)+N]&-/"E^+@F[14*!I6S%'_CREHQDA!][6%
M,3+_+(;"R[UY?Z!$I>_0\O9R>^#81,FG;I<K5UEZX@W,O>&*CIBXF=&.8N4N
MQ10]-PGGR1\=D@E^!CH5W;+9QY]G/P-7Q]<?I']XZ1';*Y$;DX$K&U=()&9#
MFV^JVPB L/90YEX,&C+61PD;;0LP-F2/;)F9S#B&_AAABQ[>?WE9M=WY%E>;
MT8=KQ'Y9^]'Q"YT'/C,^N%PZ@!6,G4J-0F$Y:&-DK;(>(@IG)/YD3SX^T]!1
ML,-F"Y@ Y$5A_</U4 1+H@L1-)$= RJ+R.Y#EQYR@0S_],U,;C:^<=$J-##S
MK.+>],8F32!0V=/+4^ZQ:<9*H;5U -H63-#))X'(OHRBG$_RSR99TDXB<.#U
MW4 RF(AXN^B="-\(D8<U).3G!NNW85Z!\94ZXA[VLF06(ICX[K74N-;FY1ZT
M4)XZ[CYU<D?4 Y85$RS#6]C#=6S"KV$*8QFT4*.Z?=M9G.V$J/5TNKR34VYR
M2E7CU#A1O1F*7B:YM%35JB<$%/::C;>?C38;C%$9. U@.GM96HZ%\'*I^J?!
M,B6$#CC*-X J>P1KSA1IC+AUQ=Q;];.([_<PM<XI!I$J[""BOI3(?-#AR-6W
MN#>\OQPZ%)RM\OGJO:@[W&5>YVATP+9.#1Y(X96UQ(]&X51P02WLLUYWS[WI
M*5#+D_^!SGCO=$2.F8FMN4.4Y=9^RRQ_O ,ANO6.;9NF<_H$)[J$-E%5Z+LD
MX"2A?))LJ1&.O!HW5^E78>DDP@'D-!_)%38X., A9T*"B]#"\9]%U,[FJXA7
M#C3&H"<V[ZZ3RYN@>&-Y]@"VX'H'+/6>.T':0&K XOS#]*=*9+M?GZ5($)_B
M$ 6<+?F>*TA,Q4OX=K^*U[4NN0LV\U/NS*J.[V2_G3U%U)A"Y^?W5EC*:V4?
MOUN&.#9>'/1K1];WG..K[_62UM/RULL('_"H_RKJ!0II1)'!1(=*,0+F.&V0
MUOLZFX$B,GG1:;R\O-,S8CU06[9)1S9XFW8JJ%7;IPWH0.NE#;R_0S2ZW+N%
M+ZC&5/H/_@HLN1NSEA_9TE\L=T/<K7LO*,(.8^L=4EG^&T6CHQ9!^6S6UFY.
M3L4(Y!.^'<YUI< H$AV01P<XE7C=R6T:,@!*(]$8VL0QPF;,(N.O/FRDH':,
M8$4#6]LI17<A\QU^KO=.R=G[K4[O7EJ8</:,[2'Z^Y@IZGC^)NJY+3N>N]_P
M4V_C]]3][_J9^6_WRIZ:T)BI8O;HZ2T7<'"0NQSKEQZ *^[?N:^>--PQE*"F
M;!RE4;@9(2^O:3T]BO)+Q;$3V&A\L.9-;H_$KH7IXAIDA;817*HS6JP-&<$[
M.O]!8BM$=9<35TB^X8;A534$LI&<UW!IS*GB=[3GH:L;)1?-/'=O''WJ_:*T
M \"SM:NG^SQ%F&/5S.(='2")7*4YI]M]N"X:%R^D5'^^T*URFL&H^Q>S8F17
M.%_\UVN8/_;'_@-VX$_D(UU6CZ.=1<1N.M !KZ6BQRJ\JB'$[<,]]UTNW4-O
MKQ9H="$$2?IXF#VI=W8Y0)N#4[^V_@U09D1N:P/Z9M7H$,J\48BB/4 [19(R
MQ(\DGC2TE8ZLKWL\V 7+_"T-/TH<N!Q^>C3\9^![.6VI:YR8U!E8 _9^BM7D
MK;9A<-WSVNVD\5!YS&3 CK$NY#%DD4__?K^<ED&.W4IH;H[E1,2D\WG<HEW7
MV<Q/,0VZ*A-!U]Z9O;UCI[R]-S>ZKE!(NE,2" =0L^W[DX,:4_:3B.)OCL5)
M4Y?G$]MGF'6\\Q<$9Y)&W,ZDJ;UT'<ON.)OL].#Q59;/S"A/V5>D9WC+9B"O
M0P!!*EH.L>@)S9,)L10_?)CG'%#TTD\.YJN(DF;"D97<$[<6[4;H +Q1K__=
M$[GV=TN8[\/V[3%2M12C3DW9'6 K&'^7#CCBSJ.5IE=7Y,;TM-5$8$/<-,XW
MF7V4)667V"$E1>%QN!UG.GO&K*];^$;7X4GJ)^?&2(U%YEL;3_9! TMM0UBY
M:8[^O-P5:5HQD-L8_'N;=B4=L)I%!RQPT@&UTG1 -$.L#NO2 =U AF0V9^CD
M!Z"E):S"EA(=8.X/VR?0 6_UZ8 DG7-9C>-_<S6CF^9@2.B"6#K@'8BVG$WV
M8.AL$.@X] VTH*:#PJC97=D, _+\^P\VIE;^WA\.?X'J! W?GZ.%0^=__XP#
M>_T%407%,E3\KC%T*YH.F.*%_G4<VD03M*_O.W@>N%K"Z#!T0%NN=,"6?NN0
M)1J$QT$/OJ#VK],!&S&@OP[R3[/DW+7\O;$?N*\"W1>?=9?%P4E/4%0S,(4A
ME_=T@7\9H>H;<'L;G[K/<E"8#NV#4=) E$2"*A^QCW(93"M0H-VC \A9L+_<
MC[;BW-\G&5*>4\U_@I8Z:'> M)NDM!BR"TT4P? O/QT@#:7VZ_]E %P1"X5"
MD:1=I14L ;?GZ(!S,#I (OR.[N^]_7_Q]U\'(8X<ID$@W'3 Z3_(_4'N#W)_
MD/N#W!_D_B#W![D_R/U![@]R?Y#[@]P?Y/X@]P>Y_U/DYE#8EW3 +![ZG8T.
M.(ZD-$&KZ( *4!EJ9:YKJQX%HAVM"ZJZW/]OO$;R\I\ ^G\\@/X@]P>Y/\C]
M/XS<0386M:Y.!["QT;CAI.+&9FHTPLX5OL6ZK;4IY;,)'8VO0T9,^R;DU0'_
M!,)_YT#X@]P?Y/X@]P>Y_RARL@FDJV1V.N#[""DHAY1/X_%91R'W,<OP<?LG
MO6^UH-"^^TO.H1S5_^:8LOU_HN&_333\0>X/<G^0^X/<OT;.%\-PBP/J]^%S
MNSZ\#+[P^GWZG!25ARS;A6E\!-O<Q\7Y]%T?_#?&6PC]$PG_32+A#W)_D/N#
MW!_D_MG?Q;VRM.,=V$YG*1/"RZ]!G *&MJXSWO5;:'*86<_E)LF<S2WH_/U@
M(_6WY;D^Y%!0MDNS^0:8&?0(+!QN55U95U/^MJ51Y,W+B%O[K.7Y1<8BRDNE
MV(BUE=<@E\TCX=(D'![2<WT@J'C.'>$ON?,2F^=:S-O>JM[-6BJG]BS2?P56
MX-':1N#Q2&43#D%MT1HXBWJJ)?5N!>]CR*54\'[$DB ^'ZL0W<@1;"_/TS+2
M:/)XC]_$7W7H?7.(< U1A.,IZ_IR5J.:?[*!1N]4^2ZKV==?D;FWU&+&3V?%
MR+!?BY'^=.B/_=^Q>G^:#QMMWHC::5DZF@#MQ4(G7],!-:P HN;?^<MZ+7^B
M-QV0EDL'.$Y_I0,J"L?6.D#.F_L%8*+V*IQ\JR'A[_NA/Z%OG(5V!_,=2MRC
M W+]?[L'T@G:\J;QT %(%%4V[:EVPM\7*6(CHP0'$5RHM="5^ZKK@7/PRCW*
M1U0L"#=(!]S"?N)T_)\GG_R]['"'CA2TJS6<T8Y68VA)DF&BP4NMF_N78)'P
M/6$Z8. &PO'?F5?K2+TQ\\=:Z5+MSAD$'C'$F,>"@I;N%_L(\DM=VCI4FBKK
M.O"N4L/]X1D6K_'E(<MW%?%2<C\Z)A<_VI YE3E+H &[,;)=R]EC(=&CH#I2
M9JENB#9O&.?%@Z4]*,^(-$(J"^:P"+Q/VYP-;>.;WS%>UVI9@T]1C*RRZC-C
MM*/?1_B34:_7>"W?]NM_VV8,%T30?ABS%2I-%'/8[=N@2149VQOIBK7\T*FA
M8EK_?_ZH984-KU>*]PW$-+W\9(-N$]+Q#@H\?4:;" [0YR_)@O+QXC$O*I)*
M)XSO64]?AWJ77\'VHXP<-TU'-<8R=J_J\MZ[^'>.K[^K(43H@(_?&;6/D=]^
M?+^S:SL8O'<6NG'M[YSH#.,4H7Y$+7Z%CNT50'$R1$U&+:JCN:=28:'YM(%_
M-ZG^OR\\5W\7'CR<VD 'K-P?_NV;,DY&Y7E!!^ V&2F[^']4>B(/#M!W*E)6
MMV9E;:W,ZM_>Q7+Q!DK" !&N/$\L'^U8PDBQ1"3)&%N7A_S8]LW^=G$%'>#2
M(MD=\/-ZUCOQQ%]T@/@]5U 5_W>O4*M9,)]\7!^%GUA^C>5NB>F#->K&\/BN
MG)&">EER@^ BU'V&=U\T&$PQI/2Y9!6LA!:GU.0W0_/M;5=/*9>02KR<K,\F
M1IB_>Z,_4&PI7MN?F>9^:UDZ*^;Z?Y(Q)L@,QFB#$U<8C/%X]#=CC&(8C"''
M8 PCJNS+_XI (F70 5)<>%/:'/3@9O)OZ'A0\[,ZK-!)'SK @/M_QZJ+]98(
M87.U)YNOT51'3JS RJXJ*B2@RJ+LYYRL4$K3)L[>T??QGB7WG3,]G6VP.3M>
MAQ\;/[7NZ!_;*AX7Y36VRW_SOSV9S(Q_0$5-G?M,2XYG=\0Q9I0:ZL$F^O#L
M4CMTXJS"B>".-A1:2-AMS_0C>!U]22?@L-L4[ZU)EY%<@UOYY6L>-.B\QSJF
M/##T7.HT),48G([!&W-.#,ZBFE#Q:?;/9J!\T(=NRJYOI@U\J!ENOA]LW-Y5
MK3Q\LARCF.X+AI*D[E4/4X0_8>RZ%J?LK&S[5#Y>VW@2;YT :.J2RN6=+V@W
ML1-%@;98*Z;X^10J$/O0#Y6ZO.:"1WF-K_QKB[YT:0TL%,[0/"_KZ8"H-2\Z
M@$V=9M!(1JC3K@*#'/>!JZ"(O:H 2MC W>U[6]Y4%6H8?\^&!L8[ Z(__LY8
M5^F?,=N/)CZEEE'$L792L]'/=X"G6CY1[N")'R2J/,)87RVD7RM[QG932$.$
MF6T!*?F,Z:ZR%; <BD-AO2R;4"<J.$6")^2ALT&OX=UIER\'TP&!$F]OGN41
M2'[X"K<UZC/=)2CRUO2X3$+_%C)CTR-B(JT[_;.8<QVEZ&T=N0_AFA63??I?
M).FAC;<%ACE3<J7I^?IW?\CV%WL[UB,37!.6)Q\);76OAO-\X4NQ5?=)?KG#
M,EH-7*KT'XD:5;K\;5C$J9/H M;EM>1:C?J7CN*;M5>@5C2>".:<K0"Q!Z*$
MK[O-67M[X9C?I_";/G0C[M\<Z.#1R]D$U[<("K:%>;%9;<L_6]ZWQS*XATDW
M!-:B,&&)1;6#!(/AWS,Y"$#B2!WVJY"\Q92G]T-;9VLA):TN<3-HAE5XG'^D
MOL@0$52AWX(SFM/=^^X!/AE"!YR4\Z*-^N=()C=O98W!JGL7]L%/;ES"P-]S
MU-]K6+,M*>P-8LG='(0JF/8O9\4 I/^E%9TB+$5'Q_-\%[<NA_)49H/I@$<Y
MGTNXIZS-NI<U;DPV'1H[@E=^?A_5#IL0QM(!ZWOY*^J-((9*^U:\:PLO'><K
MJZYURVU_$A6I[M#AI]BYE'8Y!+>'WAX< B%&M[2%8G0?K H$B(O'F?P2_E]>
MX[,U&?*JB-!<I6V91PZ,G,MTL\TZ&_FC8YE)=6N/HBU,?$@'9'U@J$!V4SH@
M\:N_+/K+.LY_M4!V 4P*55]OHP-TE1G24BB?42PM'?!PXBKI#*&G?:21&Z\?
M;WN?<'3(SY O;7D/[V1LJ*$@QQH#8"GDO)OW54J>6[)2U'K3S%CWS#]#:,'>
MET#1=IEC [$:%EG#N*=M&R8U;W4++7PR:CA_M?O3)>$$YIN"?;PA3 W_@-C?
MFH,-::UE=/IB/;ZXI-3-?U;VLE-=[:##.ZT1@B*3S16=Q5G(O3'Y2+TKEZ:R
M<UN*(_\A(60S2,\(/"U@5HILV"R8W\," OQ5U*1L/]U5RB_%I/_D83 KDP2>
M*6<BID[H3IUX5E:]Z<PF#H[WF-M[G8/?>UKO<:JN6)_GKB>M.<B39C/GSZDI
M<>1$0G0UPJ.@W/9M )%5-H. :?5A"U?X!;8E0%\%8-C=I-'LBU\#WNA9[=RS
MBO_Q^'&VQ(%EI"T=T'P;Y/RQ^(XGSVS4EPSX@Q"5NIU8T.[PIV,LC>MF>1_+
M)O,#2H@Z&5EE6K*S.,X.&_82)+;W88=]_\:SB^ 5Y'$M[@<SN  )$9'GR[H>
MPRJ#Y>?VAH_RFJFG/EXAOIVZ?_,L,DK(0,([YM.CMSN'<BOY@DH-U-9??T%H
MDV0)Y"9HA?[+354Z('H"2V!.='LRHFP7$3,[)M?,U\VDXGJ7;VC^D,::?939
M8$(\=UK84;XVBAVI:V;SF=B)CVV9FB.6UWZ=2;LDMH[N 6V*8,TD;O[TBV 1
MO1.@(T X!Y]38%^Q(29>OK]BDUMD6?56Q8@K2?"DIJ(^4ZK,U1: _N/S"B%J
MM:[M.VXZ>1E_J7Z63(3LN8YG4!<$FRT)-LM<WPCLW[B0TBW[W$.[.>2#=>2+
M*-%:<9$YD<"<"=MX*7DN3+]YQ=0U=ENCRL9*YS"/]RFN'Q+?O'O FE3$),+5
M#(@I-QN,+9=4E0S@_4OT6::'7Z%FZ0##+Q"6HL+Y9WU.0EU(\#9N.1N]S!1+
MGLH>?BY8FO3X/>\'2@OZIK^XCQ8:VS;PO_=,S^S<"?W/J[_]>@5R(FCOC'V'
MO08=H![%Z JE://2A\?^56GXOVQ_T_PA_J8W_+N^BVP'Z!%P7QUZG Y 8VC)
MO;^=0SY-!W35D8QHTW3 3HG[?W[EX*)6X%P&$-L1M5E)?;)LLT)\7;V#$8>>
M<#V^_P$&L%P$=W!. %LQPKO.8?NV=W[->:)=J[85HQ33E7>V)9I!BH>_-AV.
MV=U$;\_JMA?.A7$RVTZJ$Y^DLMI-?A>\5=D3:?9&XZBC0QQ\3BL()#6ZK'$!
MS&J6<M9]*V7:D':<A.1S,?<5>/W [;+I2UCO+BII H-G5K?Q,/U8K%JX"NL3
MG H7)TW-PB(/=BP/^';@CB[,:X;)756U]DJ"H<Q-3;[;G/<? 0=1+Z"G D!Q
MC9S(T1T-CG8=N]XB^)I\'N!4/.KBU>6KS*@S-HT)U"B:E.$,)C:1%!H2N6(O
M?MU[%1=E^\+"U2KL;8WB9*>V[))R>J- S(5Z?I1HA/&>ED*&>?.LPXNOLH,?
MD=EAMDNH:<B;?EV^_1KR^_]Y1,%_R"S_IA%M2/B;U005IO6 O_.IM/]JJ0#Q
MM[UJP+\U'Z;H.<'Z!K[42]NBE@<,_3&S5DO(<=IY[+LG:4$]1JO\/AH(?+&E
M"&YE1!?RTO>_Z8F/^9Q)FOT9_#FCV#G R:#_NHJGWF% 4^35I3?Z?/OE9"W:
M&!UP:@<\L1RN2*J<C1JN6&JH[F?MRK>Q>5'+<O*6D'3B*[_/5Z2.W.+,A:18
M+NA3^-2Q$:,MJ'@Q05)N%G.%4/>GE%FNYWS4J@%89EOV%H$.N)]6LP!RM.&3
MQ#< ^Q!+VZ[KV4=MTE<B"NU 1JNTU_#/X I$6P[I#![4-JW(+6-O-5XV%@UX
M6?OV^+'F5?6R)&TFQ(??!]2"A'04PR%U!)=7X2&SR.%ZY;RB)Q95=,!XU9,U
MR<'P=736:]OY*_4NP :Q9"P*?V]S(I(S%L1"XW8],/NL5_,@4WP(&T?MNNAP
M$S9PU;>#+..Q@1C;P\I!#T%=0&RN0:Y5$\]MH6[N<22!ZG<A"0*,YH4U+^*D
M^6#M5YN<S,0]2X^UH/VU^==?77_E\S:L>"QYJ5 :B>%1!%/B :F2X#$GN=32
M]U3HOO"93,.PL%UDS.PBOOUF2+GBEF-L AO'>\F7N.PX@B4NBFP-^6$O,WB6
M]-7+(XQ]]</#\J&B(LK7.9/#KY;*FTXH@5[-/9:\*:[S=FZ3)$V,56]%?P0^
MAQYW(*2^[NYR\4%4EJKSGQ;Y%B/MJ&S -2&<:O+XN'',?BQQ@+#78?0JA79R
M6.=BL WP^,JZMQ[,B1TQWNBIN\0-$^_FT$(T7MG9O._N%R<N786Q(.Z+-YC&
M+6*E)8JSUJC0EGT@ L1.$Q\/MR==SP[NN1N%PZD6J^,,C\0)9CW,4>+63'[0
MDTE"=$-)DIN4C H0D;619@C^!/P&I7R /J,#UMI_"^)SB#XZX%]>8;<5DZ!I
M;&O-$,P=<.9I9DN:*\VYC\)72+M[_08=4.J-8=QU07:@F YP59BHFY.*W*&:
MSG0\AU_#ZWSP3'D#%O!<J&W<>B/>>,& 0RG_D,0E#;L?NB&(?S7"+O],^T?'
M;,H9_)V4]Z_%X!RQSF_D(M3VSS\G[5(\/G*RR)B+XC8A9;2BP(<%,OZY&WG[
MH<0*GP/W<%NR$+3Y>OW5N;Y7%G0 >Z/L1+-/B=W-D2J;BB=T@+._7[W A;/D
M@OE(IGNHBZR6Z;]/*D;BC+-I/?: 6//J*CO+5J'8"B&+Y$7/[72 C;[V#==C
M72))9APUP#1H96\M"4QCY?K:FR73\;AV,34T4A&V\S)A6N^2:$^248TJFM%;
MV:D:UM"T@^V_6_B4VI)")*,4VY>JWU_F]"_5IQPQNUN1^S)?.U?*9<N2#GA&
MVC![C+?ZH+_^Y:OMZ %J)D"3LP.&#IN%1<^3GF$CE,5XO ;UO5SRK([EZ*XM
MZ*MY2]H?ZT[I.G(8K$=K!2/U*2K);9M1X>;YMLN-&J6O2P#E)ZKVOGUE^L#W
M^E&@A+?)7?_$2<X,"A?9'C),.X7WCLIV11TZ4JL'=SQ:G!Z+9;=^_CVQ(-O)
MB=7OD\A3ICZ^)50YZ&FCP@1MW%Z8L(C HUJGQ9X;CYZK'I(08E^H3"Z[OQ\)
M3M.]["CF0/X1>B)M-=_)SB1^TCYM ZY/<U&]F7_-7"(I:?3NE/&.$84WEOB9
M]!'/V6'/.4@Y/NNS+GN9JF:]X4@^6MR^QXUC4;XQ[SMV4O;=6^(G:F&C%DE-
M- @+?"$Q6*^:C\[Q7[OCY;H7^J(_3RK X&?[T1:',_&OM!YELBC0 4<CZ8"D
M#W@Z@-;, UU>)2\1308=!E#.L"B\;5:.2TN*TIOLP_[?2SI6K5__CA9!\UR3
MNT8&JJ1NC+P:0T+8_%3)4,NJ!&=1PNF '_L*Q%-4%,6.8#IKCFJ!OS[N$?8%
MK*\PIOI*OJV^W76H3E?%_9!?P9A,863UZ8W.O4VT+;$RFFB)EW]!5+OH/BT[
M\BBX FV8<I;W&%-(#NM5F;IW7D>XK?PNWH$$T?I*<T!XD[#@N7N)^;&[YN;&
M3P'JE_@.I,@/(4.00]3,>E47E]F&XUH.!>[=BX,M.!'/I+/X/ME+3C>ZV#**
M#+3.-[>%@=U>1%GLVPZ.NAR@%WQO);V4'XSS+H;V0E)U+I>3>LC^I)9F_=E3
MB2=*@^_>%"(J>N6MA#<I!4DHG:]V:NH\S:TOKNTQ"7T 1Q?:4;.TKGX)EFU/
M47.;9;-5CO#X:G7F]05'"_/ )*TW(OPLLD_U(,8)X;6<$V1B"JD-FU))LL-[
MC[8T\B7]:/,(K>)6,;Y6B.2Z?\L1>9KIZ2'?A.19.@!O:+2OB0:1#S,Z)\EB
M5Q3FDD>/2R,9M'6NPO+;DIO_N:I=_5%P12I%S9)R0=Z'QJ= >17V@,Q">5:[
M?WZ1#NCHVX2.^) QT0*(%,@%VC"\<K,IPWWP)J$C]G-_X.4OD'[1@@E7I%)(
M2)/SR78RT^FY)\K/XV9&5X)PD@Q6NDY-U^%?%9,=[NX+8$G,=T,3&W!=+(\<
M?_G6P)R.'!S>5\3S8SECZ0!O.F""TW@X_&J(LK7!I2&MJX5'SCQ\E2['13S1
MY*E+XS,)88M9,GY7(*."?C+5"!^A9>81WD6\+;0X+Y^<0AP\V.C[Q2B'4M V
MQ&N@D [7FKT$Z?67.P4W)[*OYTT;.!XMZ#K4_JSJ6/:5)H-Z[^9YKDQ%L!:D
M$UHEU;89 ZR,@CT/-YK=Q('8NR0/&E*)7NG67&WB4GTB,A0^8-M/#40_Y@3)
MQ1 /?KE#9;M1&GMG((!T:GIDY.AW?:$X *CCJU8:)9SZE Z8/ZC '. *H,L?
M"HM5"(DQZ!1P)&;T:P]O)G?1Q,C:0M@R["MT)@=3L=2*>FHOC=?-?THQH$;Y
M?+6>[ F /ZBJWA84/93>*YSXU.BV)9\/V9@VC )J\7@4A$O@8R=<T[R*?.T]
M!FPG5']^]DM\=KG];:+P(>RW-^VM 3_O]D<SLH]AB6@LDOI\$[3S*' /N!Z1
MUYQ#ZT&=.(W435#[Y95W1D]IX/03D,D/H[G[I.#N7,WXKA6I_7]*OK)X!><A
MBT(*"@C:UKE+98PV\TE'F11/T!O$HEI;D8T-0T=*Q]W[)XHKUGR%R@7RX@&W
M3Q8QF9L<:_X9?( DYE%S=XS&H=B6X&CCIZLVN4-PYX&=BHCX0#4EO['+QOIR
M8SNB-Q$_8%&*$B"\Z9$$U6.Q<[%XW@!@0UJ#.HWMZ%>[+H)RDQJ'[?K%%1XC
MH9FY'R%5-0>S*E^20PS9[H9I7(;PTP%/W7:#Y1ZM4-\7TN2AJ;-&6-3$8>(X
M:32[;PYVU"V6/^JYXDVY@#6^EU?@P3>0E_/?/>)Z)]]YVD_1G@X@\]"F^8'
MRC7$X>"YV\A^+7\OX2XVFVQ]]MG/K:\7:N1%"H=*;IY6%/:-V9_#0G$N9%.2
M K;CI8H".X6#_.19_LHO6ZLI.N"[9$'7TO?2ITG\!M=*'5Y.?CJ<'K.->:'#
M3NJ/(#\,=IQ5*\3GM]8>28M^_;!NR ;3,EI%?+*B]='%L[.X5*TNR;HNTZ,@
M\WW4+<VVE9*5'6AQG+ONK;B\ 1.;PL MG7AJ7>-1^&L07[C4#(8E_%Q%Q3#%
M-' )$W[5BC7KP>*]:5NFZM-R[<8I(J>ETK+) K1>18H"B3 '/$SJPWHA7NM%
M*X'=,K6JJZ:$SI_Y)/SHX<?W["T]1Q.3GW7.0U[WWTI6-=A6 +6/[%16(#/V
M%+_:F)_II*!F#C T 88$&UKZBWSZA:>TB[K_>AY7;=]8#[7I*ZP5@3B7.C-U
M;)K1]$$#[ZJ<6F;U<QF280%^Y9\Z;[X%:,5F1[$LT9,D.ZL@ZA[FE/130>9[
M?P+[,)IPXOKJ9'J N>-$@PE*"N5A%)O)3RU&>?FP4\Z/:CG\/CE#*O*"O9?+
MO>% Z:*9^IK;(<L(\2_.*X>>=?XH4I+5D#(QSN9WN="0:KD%CH\_.\13*!DH
MEH'1W::4,#B#H#"#>E7/3[Y(,B3&$:X;@&!:=G,!PVFSOM&V%@G6#CX^BG-N
M%T$O.E; M38<Q1P-GU<F,NJ8(XD3E]^/!<BL"@ [1YM1>!.C&#J A786TF%_
M^E>]/$&X6;,J/Z_/T3_?S>9NG9M6J[[2&:M9@^.7XC%/+P$.+/N!90JM81$N
M1!52X&S=^-Y5%^S[QE$%Z([5#S]@R4-W=*9,LK5-_XMD5$MG*@V]-]G<?C=7
MJCXG@[+0"Z7673<EQE!+((*0GEJO>IK&Z G^/5?[0?W25WUA?BR!<0]DYKD:
MNDOTE#-E>W5XH<VW()P43P;)QN3_\E$5%;;^M5-8;+:B<QIY4RI-0/S"IJ!^
M@"=3]\NIN/0'//8L=,"139(7$&=,N-Z!JD"UADGO?MRO="[#4Y-7CSN4'2M
M#]]L5LS6%1)KLVLD'MOQ(<G"6XH/FU#?([1<B:6VP=G7ZI$Q?28OCF1\SKQZ
M9&2A0UY8XD7RRA;5([,L61-</VT 1=>C0RL#,-BO#3K60^["NE1*W8&\$!C2
M(<AXN@.^:#M<G?26<(C"CR)PU%:U/UF=Y=T6H"GX89(C),EJ%%O2'0)YEK,5
MQ$T2;XK-):5>:Z1U#&N9!N;87-7)&A<_[BM<D73NS/5MW%S/W+=MS+B."C6=
M49W2:GU>.8O=)]*$&@BR;YM=WAEH75^K:$<E.T";I2N.0<0@[>HZ\D,?>^Q<
M3% C)><@C696T5+HO1-0H?6BN;O%-W;BI26W^R'&*?!Y?]/%C$M&028^N] B
MJ#A&1XPVHL-%^D @MT./J]BIVT8$??=524O(E3L9#SJ3;?)JUF0!:1#'"_3=
MGW$I)PT3PJZ3./$H>\+2ZU.K=X3UHIPR+TM89M[Y^>7+LP]FI<[WE)K\1QHE
MZ8#(&RO*I$;.. Q_X+$Q>U)YJQ=WRCIOQ=:#@U,UAVE,=BR44\+MED+0=1R6
M#F ><[YSO2WS-++*BG_30.1*YQ7@[F 7,-[?W#1*TQ?9..2S)@NQU#R_=:L(
M#9GU0^9 L9GY@Z&<.%%L0Q QP">>N<5BL%ZF]L;!Z+B/PVN?._4.?9/6@NH7
M;W_!/*_QT_<Y-\1P8Q[X: 7P12@G3-6CU_:VT*KAA0QL5W%VA(WK@&7L#T5]
M\;/B*EZ5&4,BC_W;?$'X>[:=.@!&.WW9$6_W+I(_;?0VOE7X+MM1UD>4N<C;
M5(]*QB0AD,YI4=)AO$]+[=3&VZ-]K:+N[;)3^F:UK[3;JA,/RQ=YAMS0G<CA
M*#JN_70\]_S(/&3=QI  C:EJK!5HOZNRXH\(-4"N9%$V\Y8,R8JT:3@;U!UG
M0KZ)3S_(2T5,M'IS)):@)?BYKQUCOJ'8=?;BD;BGZ)>ACFE$H]= 'BUY?/1W
M]6EI0@+2 TME_N'LT5-U^M&.^3VVRYG=GTJU !XSHN?:!]M0>.NUE0H![I\@
M#E>O"P7$[I/W;WI^5];13)]LS8%O<-[RZ;#E(;O^/F</^OP@9ZL7OX2EOAG:
MM=.0D!6=)'-AGFC?_G4C+(K[0?PPVUY!ZKD$-Y3$VZ#4W&2:$T/A#"T-ZV'4
M!LIVZVA%?5?I@.AVRB$ZX,4[MTRC6$C;XCX4#1XWIKZY *%A+O]$8Z@6$873
M-#G:*)Q3AYO"5DY":B]TO-8"1D@H6O=\DO,W]'.2 ,2*?^J<0#\_:>EQ2$G1
MKB.FD9-TO0W#KA!^- 2+4PFV6.PO:O\@6B!W,F_R?#R Z1;>K.38::Z8_?+O
M()9-Z P<4ZK02CX>[CY]P9#-D&ITMR:I91WL'/+ [.:U_;)'@GKK\WY+,=U%
M^^?-4K<*\S&U6X.(1;>[6KNG41_&2Z8R#M9^D3:)@M0R+7$7,IBB3SA5ETV*
M-AZE27D\'G,U=/0Z$CDBZ UFTW!+=04T<321N.!7X2@=Q7 WDFX@^68PY\QH
M7/CO+?#PN$H!5$5 X<=BL0'BZ-V^]X:I'_9:QY!RM\Y@+?&SJ)EW($XZ 'N<
MFA"N'29Q3AC!93_EOK4A\DTIQ!C^.8%7?,W>&*^-POI#FVUT9()SGU8/AO/D
MJ7WPI-XPE>GPO'+P-@"JN38?)S/P'?$-/B4P/5U@%YH^^3-@=18XX18^CX/J
MBT6/0(Y2"[4DYS8G>-K!S.L[./>>-L@I)-E\<O37]ZIR_?<O'9R2,U"C>I!'
M]NRAR%?U5_-)1BT'*<A".WVGW)61 ;NI^]V/2V_$6(_!KS"IXL6*!4A>C#;L
MS8"S\<+U.2C;FZ5RI:8URGH*DI%EN7!N5;C0?9("T0NO@JZWGB-_09NX]E'"
MW%;W>^;>%'7^P*Q?FVOP#QO(-DP,VQJD39MX; S0HG6SA<J7!A3+Z0#D?5/*
MCKU+/QU0'H33P&(FPIJ"&I7P&[$(UTP@LC;,K)9PY"0Z-O(I?S"EYE'WA<=6
M<V_T'6%<OY>]CKJ26/ 8<*I!5<,(Q4WN0G^O+_:C] )2C^7(<><4R3?02L$'
M$1[MO]\3<K&"F@QU@C'ZOT,4'I4TN\Q2'AN[7A;NACBFV^/-0)6!3C;_;?89
M?'NI#A.C#AB G%#C?4U/Q 3QL!:,\,2QS^9U0Z R3YU!J#10I=R ^*-42DN,
M5P0 .(28>I<S0QVK4]#9[(+4!HA/QSG^K$QIC,W:AN8U&-6A7* 3Y=@.G.[G
M*7>Q(R-IJV':**^!S;,7[6V\R75SVE>73N2^>Z/GQQZZ"[E".4$BST!CP'@S
M3F92-I8C^FNPX0T"7WQ;)M(AS(,=.9&_)95DH%7]*+!9L6E^2?)7J> \#661
MH#/OXF%_$'HY8LI8O6)2(<R60 V2716**"EV]'>,\&)?2/[A=8(XRO5:/$7M
MB))2IN!-B9/!IT<32(5$;Q(7%L2V)C2%:<9$=[GEC?>&* /9QF8D7.U@!X@K
M'A.%BYLD:20,A+6G,5S)K<!'-((^K+UM=4EBLO-;E<ZK#2CK7*NZD(GO]$3H
M#N5NVOE;.8[R"%(@A?,-:B8)6KX729,)EIH%)6BYS?APD&(NX]SDUKUVO<ZR
MO?>ZX>KTYEK2F6/',UBZ628/5T)>NH*8(:<HDFEKK8UB)"C6B'7:!GW3:2@@
M@GMDP.D%^T^MSOZ[ _R)Z;[VV@P:[L,+XCG776:DYV%./XM%)EKK'8/@LBJ/
MZ "T@L)623EQE?"+%$@6I]P;;FV\W9?=Y<#&D668)#\JMI\*B@IT!'\S,=N+
M0?;*0J A?5%@JR1_L@FJ"[5%3F!=H['ZXCWND)3SPO6'/MX?]-RU?8W;F>((
ML[(U:]CZZ-B9*/$C\N*X\-20T\VUIQ&.S? *!D=0C/%"@[.T@M%,%KS7CSN/
MDT@9#Y$?>SB,;3W];G)LZ>@>*7=ZK,$W@\'?!H]##4FV>-F63(T1N9&]]NFS
M9?R*4U/LF_EC-WLEU'XQ!*1%D?"/!]63 R)+AQJM?_^'?T@_Y!1!'Y>(_1W&
M5X1Z][Y#CP@L#@?$GSB3=D"8W>9DEW 4<,V6>BR39U=?J=EE6KCNLZF^93%-
MI0/Z="?-X!7/"XD6C=YD232E,@*6JP"=*<4 <.&ZU(^\8O+UY=N'H)[7<_7D
M?:E4A%(OC.P"=R<?9N@DU(EP>[PW?!;%LG;J8.,9I.Y3/5**A>6H]<T3<9Q'
MK0YQ'F$E<8_26+O(2F,D%=(M#!86\QE?\Q0M*J@BKV(C\*KY.O\$\8V^ISDG
M2;POMEC5YU1XT*"66NH3R!':('*H(D)S6QAG8EEMSO[R@7!/@N0E*:K5_)P*
M5LS;E6B)ZG6E48^>F^,#J:3MXK8GR8;$%]1"FB#MAZ9=Y2A,E> 4%%PT$FI7
M=$=[H5/TEEX#?]6>3,V<!N(P7H'"MS<#C*N_RI$:'&Z(54F.//>Y9.7W>8*/
ME7[URDK3 6[OF"9CEG3D@UN(MTC7R>9K0"Z=,R3B=AN<ZY3J,Q7;:FBE7,7#
MC]=>9;_$>)J<&WRZ=>KHA]+JQ?JWQ"4&),_#.:B?= #!S[_KB/VJA)WT2!*P
M-1HJJ4B.8=>\*@-7_N$R_>)3H+!EQI@6S_W^C$_Y!'#6[B8&KZFAH&,4%01=
M0!- UR&:D%^9?%0X[>1T^,W1^)%\[!JT?%WH8H*;]Y&?7P5C_0LN7FYQ>2Q\
M56MT ;G^E>P9?($3#9N5:M4.TB6(4O=@);/]]9>/QE=P2G 9:KD)]=4&LC[I
M .RS[?AX4E?P^JVC0$;+/).A(T00R\(1X_F;X!.&]>D$SX$;]61>X_M "C=_
M4S$6/JX=N-+?.#H;[[QF[.+;<Y;K$$WP=1^%M3:;TRFV$/JM>#5GWV:WOX[&
M(I>+NUAQH%&YEQMVX%ZQ-DED=.[@RH[G.MSAGGB7[U,V/59U!&",(P_ZCB/O
MN9$1^?4\P^B0>UDP^;%DBZ9K'AWAYHSZ[4UBPD)%@)R2Q)IBVYS&V[4;R?E%
MM>&/1'AJ<JQ%]?>RXY^)E'@LP5]!3S XR!-.DJFJP4[=<F.P*!?^R0=>FS?(
MY&SE9A&/1HS?FRM)'BEZS5UVNSL*%-X^(SR\!3QFU*K)E_"<06L*OHZ..6-H
M6PECVYZE;.]X,T"1N &'?F-HVOS2X\^L Z,?ENOR9176-DN'.W/MS;++;FV6
M5V)V!W_LH!* R/QFQ--,L?[=.SZM\(F!-36W+VZUWE$"M36U58]9;S&;&Q_3
M$A2\VMS^V!T\'DV<)3F2K>]\&0_6G#/^-E)!HNSO1+A//:C9\N/OM4M8[JE^
M^J147/ST(Y=81OP$TWIT@"1E/.C[]+G&P8<-!&)#_O6(D$+[TTFST^>Y;&2M
M/I0YQHN/L7Z=CS1ZH*5 M"NM(D13^,+FX*\J#(.]*KS$NL,TXLN.ZE5/^;"Y
MB#CEQ#A+U1PY&'4YFW#F5^B*U$K/8%\?7E\!I'K4.BAF=Y%2AV@E]\SNM:..
M4)CQ<9F2!,PK^7!03F&(FP0ZS2!'_,S9^*LAPH!T:2E YM.T?7T#QENVAQ\:
MJM>K?80GE=\N5_*DC=4-S*E]@@:_6@SQ90"SC0.+44*H!3JBP6O$G9%*>)RF
M=^4LXB7M>)*7[ W\1O()TS;5UKM<F8]2K(:R;Y9IS&^@N=^8<=D3YE DF?SU
M7@(;=OKS3 ,8BXK=H( "W4=Z'ARH99YYY?7]W:'->9G'9@B9*^*Y?GIW!LQ3
MD,,*%U(CQH>E<TW'M>7KMK?L$@^TL1@N-\B%7YZJQ3SWD,,!L22+V1'BP%4)
M4[T6F>Z6R&.(DT,@K\V7:5+M/L+AFL-+C?TE6J+Y);F%:Z,K)T+OW_S.7?I:
M"Z.8<R[@7J.]P9$3!#@S8]HJI!0ZP(SZ/G!-N.>UY. .G&OR^B-)T&J6JT/R
MFS"?()]"(0+G&&S&^37Y 608S-]X,;B[2Q7%ZG:PCG#(FY(.\ZB+3OQA_S!3
M].$+A6Z]XX%]@.>#TK9<ZZ,MW0LK <7[^W;$BW$HO\6]1>/=80S>_HG-FN,R
M59W&NH<_;$*HL.&$SUZV/7]N*[657_-A;K04$VQ3:P'L?[(CW+(6,@BL='D.
M=8)&3_C$:9ERY!:XU2:O6DVT?>[@'>CL$^X4"$DZNSX1G3'5P=S(0"FR9<HU
M5&$=GK<RX$;,(Z[952('U5H_H;T,1'^$AV<_Y+NT/KP,!P86(IZ!\'>H=V77
M4FE#I7CSDE?.3_9[6[_I>Z0?;+R!?Z_)5R"&OK5MSJ7)*^SMK-54B(?NS!#3
M? 9MH<W[0"%HLR+*'<7FAA+5\G4H6M'<I0,2&L\'/W.J2NL^9C\R?=$YN7[4
MS?PIL[Z4N_HQS1W$:,'^1]KQAAD@R1)5BFBI"V)0>;[[0>OD@]+JQ)SK= #D
MAR,>D>=15F1^V81FIS.?NH(R34G/T%M%52*F,2M>FIX.I-'V \X6.-NJF#A!
MI]CC\_(3KGVD^FC2D035GRS:71( %HDW (G1]C0DY=3E&;&,6>;!8AS%KL"&
MY3BUV"U7KZH5&N;Y5J*:#J@*(9:P$>MM-R<VB6MXH_4M'Q<D7BH:-VI-.*&V
MQ:<,2EVL\L7TN&:;4LX%J>Y-/\<CFVF"^%NDRX;X]F07K/E3=(;8Y1MDY7:]
M8P'BG)D+97<--$I<[>\1&S:=IG^.0N[@?$RS+.(:X+:RC:/#DEO3U&[4<8AB
M,&@N-1)7;SD3[X>Q[Y=R!,*/.;G."TR)O&I2NM2Y;W4XDO,:.^0VM%D/Y=UW
MF#; TB)VY-<ZY:K7IV6=,RD13\)>G3:J*'+IMJA"*_OLVSQ47U_-).W!QX &
M2)(^.1CR"W-"2PT'?.X PWVSWI!+V2CKJ+2D#E<'[)[AUY:QC0MW9D1(QY6G
M^R,@3I43B<-!KXY3)1N!,8/&YOG7C$G.->L'?FN(,%6/P-KJFHQ+([&DK'V?
MZ8/PDER4H?*RT5C)]@RL#<B<W^KS@@Y@*Z:PB2A<>)6:*J2=FSR_'*D67L]!
M'LK(]E<S/', SY/.JGA7PVC@$:"&51>!K4(H>!C6@WD]#>R'NL%(,LFC+9A8
M=27UY_7:N5]_59POL3GFXW3Q^GGCR.,7'B7^'& [9FYTF(^X\9DL2#DV5/%!
M99PA&>7EI[3*B >2]<J. IT?3M[DK/8DCXJ2[6C?(6S4HJRRX0N("^&R<Q%J
MH L=K6FAS(\_)7U5>A3RJBCHA-(WC1; 39 <F-$#]%"?XVR66GUM*;XDET=L
MAM!%[;:V"G&)U%2@ZRN<H/S9'J$$9:OF=I7D\RL>:_U3TYM]!WJ#)LGZ)D*X
M?',G#P6%E4P$^0*M&WH2Y&0T,=A^"L)760T=IP/N5RKK$AOTSK,WC+0]8A.$
M7DSV(FS*=O--6I5X+/]>\/U*<B,KK:CM96H36-WV^!WB,S_Z"!N%!";DGK6_
M1IQ&FW$S/;AC2DVC ]S[F&F#&#8G B(ZT^-(J?RIK_GV,W<<9$J(%N(O35!*
MU3.P:ZRP>#K@ >K(!&0,+JHC">FW!Y7?"66SLR0KM]A /F59>2;K[9X17OCA
M6W$5.A'DT_#<9JNWR]@'&X_&&*ZL3JW#'SU*U[!S(F8DH6T]EI-+*'V.)%L&
M:3\B<1% ;2D3A_L0P7IA7X]8[$$DRF-DK47293Z<3;ORH6\ZHG!5-W0/5SJ'
MQ:.)]T@9)473M^=TTP:FKX1P3S(=>01MRF7!%\"K6-;??H*,8$YTO-ST]MH1
M=1X)7AJLOTID"E3-%/"Y4O<K.; [>9+Y\>-;,?MA--;XP*_ARM0X'='PBV\M
MW[:&3F='..;>"7=0-(!4?4L:" G[>#3G9+JW5F9>S9J"F^[WZ6UWG0(;\##8
M.U\7Z%?A$L'M![FKB5["?,X@2].&,*Q0!SI@#--4!5$>6JHFW&TL7RO^M/PM
M-G8DP>UFC/[19'%F29B88\D,Q^3,Z BX'(@KQ \2RZ+OP9I3@T9JJS(C;8N%
MK9!6%[)?I1\'6 0X]0E:7NK\J:2$*@.O9V.-QN'8QD0GMSS;^\&-MC=15:HK
MV9R!_FK--4>BY4HOJ!4< K!>ZI*@%)+5Q]#!V336?@+2]I?7@_+^G0@E0T-X
MV2>S,-B.5?J;2Y,#';) DYS=DA55+<.\W=JW%BO=%8:UX_^#O7</A^K]_X6G
M)$J%Y!R3*$51RB%D*B'Y:)(08BJG$--)!F-6)40.(2EBBB3$)*<<QUE(3CD?
M9HSS*3,.8S$S:YZES_>SO_O[^^U]/?OW[&?OW_7LY_/'NJZ9M>[[?I]>]_NP
MKG7?-X;D$"H0MR/CL#I&4Y&4,MC/T(N'TV)MMA+HEXGCJR#O9$LJ1B+K;"*C
M/K@"O9;%3PYJE][Y%+VO^J.]"T(M".7'J.6DHK M@5Q$SGQH7B0O^,R P=OY
ML^^6]_/3P_TZ+D%#V^>DY':B92G++ELW(#;8"S+"?[^?L(4D0<<-=SZ TN?M
MSHSK)9]X;'Q7@O7+SPS<RMG6K=Z,JM969V9EVNNGN;X\4M;</-CT)$*B5<S%
M61>!4%1O0%+K4AZ4Q ##-JH-,VLRER#E#[&S*5BK3+94QSA>CHL0_ #N=U #
MJA09 DU\KL!L_R&7#M2M&8P5X0<Q;_,SUA]X]8!Z69FVY3*DX=>O+X=XN[-&
M@JQ+O_"<>WQ"@5?3Z72+A:<6J67U+8./+?J,^?A0ED\R] /:4EQ5O@V;;DI!
M+G49<!%DLZ@VXO@:'&X/,VY"3>0O1]M+A:4FQ7W?/P?=C6TWC'%"1:3%CXY(
MGPO5N&BTY_/)C#=%!Q8;]9:R&HNGE[#Y:RI]Y4\^+G8R[_@>IC1=+NG/G$\N
M D:\V;M85&P%7"O;X0@SEW^RK3_U-EXKR:<W9UP5<)&Q2(T^-Z(@RV]Y@W\/
M-<S*B:5)&$1N@2>U2=%]"O]TMR5!+E1>9]*F^6MAR4+E6-RVACTR3!UABJ@1
M<Q\G&G^4=0R_K^W22:4^M/2T6-2 N\WWJ*"O/HGZQY4F8L./Y1VHT/$6CC;%
MU\)359H>%$6/9,9SB.6*N/-]V\5KBU^6'B;U-6]R7KUT!>&*8#476(4G2#K=
MWD*U+,U(O-*64#:87:S97UQ$U,Q+4_K<WI!7\IY$<G'XA>X3&>D.1CF3 M>"
M(]@6VSE=,2Z'CN27QTD9WY%OV&/ GSV9EGWARNWM.$PM$E0RJD0'BL4CF4_B
MQ],SIRTU5A8FBTW?'[-SG3KNOG=?@^M+A>?*VY*_U?CS*WX'J)_C8U="=*7I
M*<.$Y_WY@!@8BW]U[^'8KK,/63YQ!U?]K+I1""["!<,'M1"WW<(CW[H^2-VT
MM3AV]GEZPJ57I/E]B4^;7IZ@CFX(E$!LK4L<V]*\%!N7&$VFK:QZ%^3F.?%G
M9\PW6<:-<;R\9[D(UCE0D!E/]P.?5<3GD L?U6@^B!-^E7UK5%YN7]C2R+M-
MZ9656NH,(EOT_ @DIEA+[)T?WOOUR(P4I1_[_(U'6,-NI8G63>X!1 =KRA=2
M\"V",!=1>;E<#:=8I3&3!E[RE\E^W^'Q[<J>NX?W;[AX>V-IN])'UCNZ5K;M
M2' U#G4+ Z>\;#FK#C07P4]^LH0SMV#I9DF?++VS^N6LI(_T:/&55X]W2.8T
M7_5?>^5:Z:KJG]9F.,>.,8:DHN<OB(XH?O+_R474.I8_ +(3]0+!P-\^F8=.
MJ>6K+NBVH81:#I:&> GNZ#52?W%VMY!"]!5V!:I,PDO^G?HRNAH50I &*ZGA
MJK5#PIWR7;JH=$/'@N)PZWN/+6)C'SHY73M]:<,FJ45L'\]IN(Y#]2K3]B42
M@_(2!+>Y0KM+A:>$^A0>?*\3XR]!U)G$3F1?\.V&JYC*0QZ.=.2LJE/6=+3$
M['C)SWPG2GW<QA/ZW86_K,E2L5JI%BVS"O-#<U/8V)4MAB:]"ZHA^9Y=5N2I
MG"EQ5.%\E;_2#,UM1CP^*-B)NOWT\4S.F35^=D)_@=J&[?'OPQ6RMZ&?F]W>
M[.L8/M];PBRC W,ZU'DAD%2]9E_T%G?O[)O^EG1<M++?34<GTU\7W[<L),<>
MLKTI'5RN=QS.:JSP/'E@JA>M):)<(T_J4W?\\O=XF5C:_&/IH&LKXJ'!2HX#
M35(%:N6VWG7J9&H.!KF//A1.;0D\@AF\XCJT!YA#"AG?X+G0=7#/Y?#+L=N+
M @H$$'^<WU)Y/-77[(D3H\&H32/&8Z7]UV!I8WC&!4_4-MON8M-,U<18UJKL
MNQ$N E0F5ZCR@(]-57Y@A7%E-VY$8W  .CPK@"<@..G*LTCF<]&3I]67C"I0
M?2;#7,3<X6$?+\H&=_?T:L\FF<'W;:\\LW:'!;[4&'7AVZ:6QK>)VEU%YH?+
M^33*EXD*"F\?B*DD;V>[OG=]7K<3K7K^\Z)G@H3:'W!9]CW"+]=EH2);DWD,
M;*!R$4^1]$MS1M8@.L5-5HR."5DRB2R\N?*281MY8J^5M_"97Z';HH)V+S^8
M*BYX8D[,I1B1DLL'$[,H#I)-+W>SW/*67;&#]IQ"U!GR36S?LRIRKF.28'"-
M#2$G8PB7>4G*/M$UN7K7E]<7VHJ>1-=M'&MUW'FW.G0!%4:D7YY_!&QFFVD&
M4RYVEF(^]G^[4:PGGA]!D_9>=X=7VI[.C[VL_*:U)W1U!MHJ-YQ [+-ECH/J
M=/O&:5M;/S]Y;Y][/'CFU+&\F,\C&YYHO,WV^TPJFRW?S4:!V^D8R_;CQ!VN
MQ>B I3(5'\_9+MZ#NL;":L=KPKY]?_O+N>%D\]U%K5:OL;:F"]/:_MUHC,Y]
M[1-6!9<=,MU0?NRE@L3#X_:@(J.ZDHO(4WSHH7N=FHAFF1A]?1!26.?P<HN5
M='*4H-*(?,03H=-['N.+D>$H_O*]A!Y-U/9]=%5F?0UE2Z] +4-]/-+UT(.C
M3R),<Z[FOGX><#MEZT-/AQ9?.A:4WQQ\[SKK)%AO\^JXAC8Q1$&C362!-X(_
MX C;& /RPIEWY;%%ACGS.2>E7+6Q_)9F'XGI]62".'B\_=QEY,V1 H[R%S,3
MH90VHX2V7EM&W')Z2S/KM<[@XMVUS!)(6*^8\P[EQD4$ ;D[XCR\1IKQUG9#
MRNI)<>XB:)^[?)>B2 9S98W9N!_N%6P!V%GX@WPCJD+ZJ4/(G:#IOFLA']V+
M\28>7]]LRSMVOA'5YX3PWEO4\LS^"">Z7 CJ]*VO03\EG"QEN-08A%\S%?N%
MG#,Y+/&A-?G <&'_KI \JF[@(^=;GB=("IRB]8\K*#SDFX(/9??0(X/S#CO4
M2(T&B74L*V?MNQ%PX?GYM.^+DBOO#L@8=DX\$-S4K>!R\R#;:K+,;X6](\FD
M)6;8CK+Z@(WN5%;N]S__0Z#$>*0X_VNX4Q#NJO:Y,+5/G[3V/.:7[THC[>2$
MY/67*3*-01,L_GLWDA[19[P8\SS[4>N]R4\I=))'=L9GIM>^'<TI+U\DGK^3
M,/W<S$ TZN/_W1>_E]0/[T)475"N6P"&2<5<Q/??J[J9OO_\KOT/HZQCFNGL
MJ20'  =YW0U54=Z%KX<6"?>[8E=7^Q>SMAX<N%KN;&NJN-*_>+PK'KTZ27F=
MY79P42#N>_VQILAE."7WE\+V[>,BDB+7?_8E1V#E[NJ-"UQMYB).8J"UXRWY
MIO O1RZB//S^<?/Q!?%<_Q_WYLRYB!97U'R*J>:]"<Y]XDI;]LM0/'2&B2WZ
MKC[*12SVH5FS/SW\X"K_)/RWO-GKOEG+J*HCZTU4^=?ZM55@/M>4Y=7"9IO
M1.-G)M/FQ*_[B;/KI;I74(L,50[3->UB<3T;W[S^>.Y 2I]*%5-U-4(N7X"T
M"A?GD)2[FR:PN*S)8:-&[)IW<9)G5:]Q$:^H_9=*N AB.GD>=EM2+LS8"38'
M#FJ (-@-&*#<2@2FYU<C]3PN+4*$"3C;"H>.M\R94%991 @J!+N3S8SR[0*7
M?8"C$ZB^0O+B*LP]8,MV#<_$W(->__G'O?UFVES<0LRR*X!:7DER[LM?84,#
M *4+IN?N+@Y+SOI'PXZ/ZPV#.YW87$3WD ^6"><_\,^K7,3OQJY=7MNXB/KE
M%@Z$99 N)T?>(K_ 6,0M<A$8G['#66[(1<X]>* $MIM&US)RE8N S4]NAM1G
M+ILS9U8-EHU_TS?L&T_A(E KF)55<EV\5[,)<D'HKX8_UQL:K[TA$]=8+4AH
MX"=Y4L[K]Y"NX20W8$D85A5Y#E*?O6^V',A._D=#"6@(#N:3\MYPRWZV:QJF
M\Q@7(2=-9D&4$?L. ]0GU3'QGZGK^X*02AF&C,WI7,1IY186Q$6,P![^28 %
M%_$V=H(#]V:0/).)70[PR&'DB0F8V=U#>SN!244?+N*1('2< I[+QZQM&0*H
M^EQ$N%_B+G]G5*/JQQ:( &!\AC'TJ&G*TJY2+J(B&-:6 R[&$AXX=1[:A *[
M2\W0,V80>N:7^$_%/SFA&S+VDV!.3"AL?H#Q 2GB!FOL>=;*[^9D,Z.N%#:Q
M>T!U%K[;TLW!MQ#[:_KJ.;Q8,AU&?EW\T/XNU.1A?Y@Q54A]2707E(\<A<J'
M 1>8&_+,.'YAZ$ 7S'9(/CP@&>P A@]T 9.J?[4W^&=[--R^!-JR2&+OT^[F
M\,YS$;\))' 16RSS8?[\8 QL@363<B!M^2L7H;B\(L#2@(',H=#1;P1#\\L!
MVAT 'A8-':]C.!?"/<)A[6PDLMVGE ZLC0(Q:ZQ 3@)J=0V:!Q6;/6C-]Z
M[6"(%P5VH)^I?P>^N5R$-9:.JBM_F4SLEO]3Z(9UH5> 2KV#()IVV*8%$E&5
M-R\-;F;LF_WBX[VC9&"V:;>L,5S-E=IE<Q&M[F9_#E%"_)<5*^D1*D<M82EI
MTTX=;XIB+<LQ='1<?YW4"F?S,I(M$ -CI4Z*B1K5_ @[W:O$$8R9F=7R-Y@T
M>>:7&M0$XP1%'.0B-JUB(9'M !3@&P?Q-JR+^9(,B]D,.X*-L*>06DL*!>PB
MV:QU=3I=AB=SRR\X8\)_&E)C\''XU%77*;FA0%/=TW"O0;@7C\)ZKX)0O1+D
MZ@K'OPIJ^"<I@U)7&G)MQS0 2L) $37%2N&"H8 ^(K39&$Y8K;IVF:\M 1.4
M=2OL3V-#@#=;9+2.07H*3)Z$!Z$Z$MD6AD,:#'$4 ]6)HJNA(:7R0EBO\)33
MXR)(7XFSH<1%SKKMHLC#F@PDAV\9S=X6PT6$?N BJN[04&N"TT10>ITTQJ[-
MJ'OX'_TP/<NH"1:+3"7N*8S0->(B]->GT:,O .-R]0AIIPMDN-T*%LR)BZ!E
MSDH=Y!"0B_/KAH\TAX!U>#%&<#,UQ*4CTV106O6W7#*X."A(YI^=; YR$3?U
M(1BAF-ODG R@967=_II8V7]IEQX^TB(">QE1L2R8?#L7P;!@VNV"DPZXX-6+
M6UX09Q[&K$+K4*M#T9/ !"CHL"W<-76]*YE.Q!&AH)-_W<B<VWH :@UFKV&Z
MOV%Z\H%U^5@.- J(+H4]L+[L7Q0NUS%@_9R KQB8C8HI ,Q@688"?4=@4YNL
MK0JP=I(XFU"P:RK04\0^E3W 1;S[W7 5;NB./\U <[85UT-\3>OVZ[]LQDD1
M7%TJAU/:C5!U)HP(01@M<Y%/$VCBH<"D4Q>*KH>!E%X1Y'"9J 6U&22(7-<7
MYK89FG4>N3@%ZX?.RPFV@AXC8;ST(W<4UJ!$@=;F3P 53X9M3Q'6A6GKZ^7"
MS"^LJV=%?5T][];50^$B$)@>"V!2CM.ROJ&2./9IN3+,+=$:SIZ>P+V/LPT9
MSJA1ERZ ?OTW52\S(^8+U$0["X:6 &OSNIQ%ZYL;50'TG%*XE[XA3"=@"QG,
M<, ;,;"<[5+=T+;]Z[K]M0;;T[4:\E<E0PCR9SBU:C5A$=>W$9(B*. *40O'
M9S#@D81UX!761(H#K1U9 +4*"\-U*3ER3@MH25V!52C.Y,6N;0'NK6_$]-B6
M9O6,/.G:1:8[:,+,P7.^JI$!<+;;4*!MSNLTYS.4R/GK0+#Z+>DTY[_T?=A/
MPSR#/6EHYOI:RC *V^(8).82AIIT7S\N]/=P&*#-B)F*6EWX;1HNPFH&^ ?'
M! "H^LX(YFSWG?B34'HX0[-N-VQ.ZVR 6@?S3#Y]((V3CH;PI'5A.^$PL!.:
M6-]WBLA'\PZ#.9!WAM46<)"\#@@T(XZS/1X>ZL,ZSTO[823E<1$3C;]US+&#
M47=:]1? CH+SGEVZ,.;U/?_JZPJ^&SD$?.N'71ZU<9VL_LT4EB61O8H!V!N
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MA!W1ESBVJ#+-KKO&]N.2#$^]]MV&#^YQ:4(JBP+9$W7"FK6'G"(1&1,1[O-
M '(C7H!U$K0$MK-1K5;5:\>[3?WV?2V*IY9^STAM^OYK4-CP6,1!BCAA$\@S
M\B-8-FID?FL/[F7C3AMD_D'K:XJ21\\_,9;4DNRKUAI/)TQ?'CS\3M;.3]UE
ML3QS023?P+S//_V>ZZ .J=H0G\.Z!E2>RBN3/_69CJI [>S%==#JGV:_*^@8
MHZ_$I.L[I]9=*9#=_P#QT?R-8^ZU#6\PX$&CIZ7H]1T5MJQ\N*FGTK6CC#;G
M.7.AP\ON@I9#H'/BO7O*O.$6&W\%W$3L.#J/N8B7XD03A*"6[N@A4*"BF!#\
M\=O6Q--)MIEOTS(^=91\R[C3&(18LW)GR ]'!A)40</%:EFUUCG\Z7=VUYI<
M'J1)!QM:;E([,MMX6B;<Y=+NGP/RF1XG\<6J*AS(\,5$DYGQ9+3[A?G,11O;
MPN^+I-[J>J3@$J67<BJ73GQV'",\52Y,7_YDM>"JR;C*>5-_2\#GG<3JK0<G
MJJ_1W<?F0?E?4:BGI>H,;UH@^Y9JJ17-\LS<P![7!"1=YP.2+K76,4R93:/G
M#AM5SPN#\E5)8E*H(/S9:*,,ZWK 2WX@LW[LLUKI!X/&G7J6$BT2ZAUL>5"'
MRD4\TA,(J")L;NL^0V?O;-"V$0AQJ2[Q?*"JG/N&:%Y_NO9^HYO%M 7@:NVC
MT1'79+KC9FU=V,$'OJOOXR-;;'-IJN"!@AP7>C"3Q(DG*&%.Y'<<FO_PY:?G
M3Q=' 07'"6C#<4J6!U"I6RJ2 1?IP2/DOIBZ!]_C(T,]G3[3._,&.#%HPY[S
M$'\43R5G(!B<F::$4W*)U>0^':..//+3)!E9N9R.-$V-',X76D^]G-W[7T%G
M'9[[[C3*?Y"TBYX=0P6V31%D6S\Y=-SW4.G3,='1NE<@$74F(RSZ F+:6+',
MR6C%+-IOR'(IMJC<%Y;!W6HEVO2!U>(86;7)EGP\\B&9FAY/R(110C.JB R_
MX]KA1D#2"9_%S<]9W8E<H3>^GM7D'[V(EBZ(H)7'E'+*42XL)(]J*)$6%SSZ
MY>8F6IUT?LS%44>YO*O?D05;MWG7^D44O7,M5VS[M93H@,[OO%_R[;NFAM7G
M3ZW?@S.*C\@]6MI;3H#S@<?W"3^T@1!4X5[0*C5__O6XC_G U29W(CI7]\-N
M(#=7MO/(>)B,2IR'MQ6EN^C2V(O8"P7&J_W8A6,H!V2?#@T]=]J+1A:?'A+O
MP!^EDUINZAYIMVTLCJ7O.!UMI/:J\:.$CM#&[Z<4K[?\M. -#R]X[<*;FEAJ
M^?+YWMI=0GO.C9PZ(GKY-F(W0LFW_6KQ@5DXN7K]!IOY<GZM57F1! FHTT)^
MZ4FQ-4'@FC6);4Q:G=FZ[!6HFV^^[/>$G;ETJ;2%YC+;3Y\8$0\K5:61)7#>
M+!<[>DVF1LS=[NZCAW-#Q$[AOXY>!A)WL:=[*_@BE!5%3YQ&#Q=CVW0FW26U
M#FK-.\=E6OZ<86\9]@-X0/EJ:'?>Q9?%AD3L]9VD4SF&'U$&I# R-5NJMBZ5
M[E)!$;R_>O0CV%)K^=($N1*E!BPY5&.\K(CLLZ  %1T*':)'AN"MW@'N[GHB
M19KQA^:\==W=CSKZ0S;:*8EM<JN=Y7.NFG-NAA;J5QO(,26L[U/0](XCD&7<
MH.,#662;!UOS[52Q:3+_W*'#*?F!XLG)>RR0ST57<])QM"8F'$4>I^)R:PBH
MPZF@)DWLE?R7;H6P5WL/[1E[M6-CPP9#:/*^PZ-F0D(WDJ$S+/@8.H[#31*T
MZ#\2:1['[MP/@H3J]LM+CP!ETM>BBL[I+15]R,AHLLH@N-D^<1!TFK7OLVW(
MBMS,>4NFIB#Y]81 V5\KU4,J;:7^M'2:8WL>1G!HWTKBB6'=[I#0NH?/+YR[
ML6'K%EH).A Z %:/"/;Z763P11P/USP-QGQT]?;6T+[P#'L(Y;1_/TM-NTDA
MN/F'1%B8IT!8@%$5I0=+M:I,]#V)K0)VW.\_;"\FN'UN-)=BPK,C7.2JL>++
MH9D ^QESK8/F;U0_Y2TM+2XJJ=U)E[0]-S,S,S9*, <J5?'6+%T0,SQ>Z,T0
M,*,71#$NG;1T+BUEO'^N?WMO12_31X6_7F>%5Z?0Q5O:'2[Z'B<2>I*$P"F'
M8?(3RK9\_N4L)1DS%:^3-LU;^W2IQV]7BCBL/,0Z'R*K;GGL4S_)5Q/9HTI5
MK"6)HFEH$;Q6QZ_ES& UM)?KO7M.$T4G5/=6*BGGG+1^I%B4)2@,U0*;2LVI
M_HI5XD3!/!:P8\J*V"?VTM<Q]XK'U][<9I=';:/^I4X-/_C>9JED:&EG&C3=
M+WA0N(II7OZ<XHL?:IY>S?>; <B%[T:1]$M9U_5$"96^Y8%I02$JYA=:Y7J.
MB!V9O.+'L_L/<K@O9M:"UK)1=;:;ZL]757ZH37U*%S4\(Y]AD$HQT'T976I+
M^7'V1MM.FKT$3RQ6WYX\TA*<) TF#DM3!$"287YWGD#-EI/A-*QA)2_ZX[53
M<H\V"?&?R%8<1LUFT@NIV""V_EL0655]ND/W5(+Z@1%R<>R$7=BK1878Q-O9
M/7W5DM_&T^(??!KZDF"*.I[E,I;I^+%6R<SFP ?BCSZ2C@)99%05W+<-RQ"
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MI'/NU^<;'BI$\QD^1R"D0RJFT*_K4EZ(12BA#O11Z'ZK K$7]%@K+]Z0QI>
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M83QC^H  8TUFIRKR)K*?/EFX?Z%.H^SK(_D75$_E74^1#[7P$:5WW?5I*Y4
M'QY'=P?-Z[5/=Y7J+1K=[G+W/OG91?_%OG?W;VWT=9$=L#K^=E#JQ5HSJ4C9
M?ZV)KAG6GGDA[9SB2B'0I@HZM*"NJVZ(#$9]T:S>+M^X\"'F7.3%UVB,VFA"
M4$MK4V35[UU.GIKZT%',$E"4,<ZL\IOG=TVXGV5X3L2[]UNT)3SG7%.2#,T&
M:@P(SUR+_0NBTOIZ>FL^V]C4?-;?N73VHNAE?X0HNE9V5QL>^W9P,DFN_59^
MLRSCP=4K;D*'Z(U%/R0EA'P0' ,ORX1$+WOI]'O*$'KTA^_1L>3)%E?#'Q3B
M$"[N&0I+>J@G0C?!O884;TJEDF/&:].FK$+N 0?EE8C.YN/RLD2MBZBG$>XH
MYD%P@F'$#*/_*!D!I' NY^EI 23/G&%;6]Q^D_YGMW(6/[C$QL;Q[E++")+[
M)OU@'"NXOLL8X(+:!CYU?X 1.%Y8+CB^J>QK44DAWPG:D*N-W%+O(\S9VJVG
M=QKL/'0G.?#RZ8=O;R-D L]_*9F&QB#L6LZ%7[#9@X'UC]UZ72/KT* 27SU6
M5F2B!V??FV?K/+WS5,.MH\NV/ES$?(H]!T:( OB(B]@ZS]0  ^Y(SQ9W'AYI
M&Y:LW$\S"&>LKQ(*II,L0!.6+EP\2?K13%HV32)[NNWW%HG'?VKVN7-W1>WQ
MZ-%CYU@^43_$><:GS-DW04$JMD^\B@GM!A\E%Y0E5]XOS.E[UO_LXGX+)\O]
MDL(1/(6;HEK.3[S9_9G^MEB!F%08-S[KL>5C=Z)+YZ"/M0TJ6N\NJ,G'/J;*
M%ME,,9>?76&6"Q5U7?@EV.<9-1Z&]&]/AD2_ Y7J;(%,G":T935CNGCW)=40
MO $G,\/: WGBM=G; ,F51^?6NGOL]4#]8=40R@X575Z:J>(<M/-KD,2^CI2B
M^('C=]3RW,L5K1"[[,-_G&AV!44JBI'5*+XI65%ZY^.I^!TQG@4%#]SE&\8,
MRS9/[$N8KHD9Z#9PMXA]D,<,V3>:3:'DEVT[:/_F0%IF@,=JR3[(&W4418TK
M/\1)PJO2%VU+P,"/H.TY,%TV\YB]/:[]G-Q7X6NW6+IQFQP268\3^W-+PO.;
M86M?(-]"\^/OY] I5=@@FR>^7;$[/L9I)V4Y!WK(WI;2NA:2PZK0S!7#Q#VI
MU!U9XJ$9S8K316C=H6D,Q9#RW:XKOIW5KQ6+\XJ*OBP.O(F+NA8KVI/TJ2)F
MH"OX*1=Q@_S8_B!=+V98H"6XSY\<?#^S94[ Y*2:]2>-@5N]X[D5DPMZ0VJC
M$SRM9EYFE9TV*K:IN?GD1@B;%1H^M>BGF3G>.9\%04/!GT",?D"UGF3[<3^G
M+1YI??JN.^%,\.8NP6^6J>J7]P;*("K2S Z>:&CX]>W)Y;W)Q;R[S"Y=^1_;
M1_^?)R2NG\KUUUJ:4[+U_\T#3_[777P1A&;*XF7RK%\GBAF[?O#>[" 7H6X"
MU9>9PW[%*J?U?R<W&_[=QY>_SRS[K\]/O,B7T_8?.+%@?9?_:O8-$/V>[4@W
M'7J4H5*/*LLK-EOLO["A;Z3_C?# SI,SBWRTX"JB,'L/0WYR:&^>T/?3.$^Y
M?=2B/T;P'H^B9D_)?Q5=F[,F*-#+HT:V[[<[=K7#P\M##U.&]1:*.M;ST%>X
M)\+(;45MH!TGWMA)70.B%JPG!"\UMZ>+-YEY3;*)JTN+**G^+/7,)70-YC.R
M.M'&]4-']G*6\"N9YY5WHZN"%9:B)%OXD,#G^6C;=_#T0$$RKH5GW%ES]ZZ8
M13%]LB]I11A)+K1J&-E+^"O/H H_XPN[V^O'YP,6+WC:&@[.IZU"?)4$7A @
MX<\S1 N>#<_IV;)Z7_'D7/CV(LG><#)#)P;S$870XY^"2ZY2H>*3>>,K%XON
MW %PN)U->=L.S#[<MF%9,<8.""@5?(M'M768T'_%>KSO21\<L_V@B;1T:$+>
M-<[J6[W5I)%TPD\K^PJ!0!XE!$?='CR4RG*+C,^<:?,%B*.[S QP?+W_H0_9
M<!-S_ES$_GE:"^L^%]'^U7W]M$[W^55-0 SH3X-BJ_\SI@3^ A<1\Q0\R$7<
M(7,4SJ]C,(2R< ?)B_JER46\#[&O_^\+I'&NZV:OC'[*-E'YQP=_7N23^833
M.S>8^EEZ9&9,9%'P@V]D5U&Z/,[QX-XOVG2+('Z2Y4?/0]22J^AM=R.9/Z6F
MPIWS7+;_<<CITWW=@M E37K=:WG'OH= KS/R6SM0I9S*1;20H+, (^MDZ1]Z
MZ7J3BWW*K>1AT78N8J*;B]B+ N% R)\-5Z=ZY%5A+J(N$BOL?\F_;2+/ZMU_
MW3T%$K93A?R!!7DN(EQV2&[9>,4HJ<T^\-]T!@WNDU?7OP:-A([[X8([%0=E
M_0Q\Q=E[BS'L-2YBU(B+D$+]"_4Y&O(R\;[/G.@DAAXZ!2S.<!%12/9-+N*)
ME0D70<2P80<]8E3X]&^F_F;J/XVISCE-P^).!8%=CHH^$M>-1NP&M,6(GKTF
MYQ:AUD'V-'WD445Z+.%;EQ9ZW-DY_&UER@>KE9BHH!=<A-RD\J50Y=A"Q0?>
M=4I*WPXDAQK\.Q?@ %97:1M%EJIF@/<P7^R,##H/#[4OM V^,!4)4XM^+\2_
MM+?@P/OVZ%PI#YV4>H( ] W%QT6XE-V8MZ3S/3ZT=/C2-$K)9#S)+[U*)/KI
MXK?9T-MJNQ[>/M9>%AJJE("]>^MEI<&N2Q+_D8-[_M^X+EUJ.R5[CPZLET9T
M$98?)&3'PQ+.[X_R^5AB/V"G7I/R0"*O_032YZO$[O@EMP,I7V9E*+?_/E;U
M_Z/'JO[/F.I?OXU?SRK_-<K?_,\X_>S?A'#[?_O]_.1_^M'!_^7* 8:EN(B/
MV6E<Q",DQPWU+_\0?7\___OYW\__?O[W\[^?_S]ZGGFEEQ,DJ-P2/_)F/G%%
MLT/=^>]32_^S3BW]G[K^AXZ*;TA@>?^(:8!:%@IE$MC-_??J[E!$D>S+J.5M
M<!7V8D.^P0TNHE:?B[C8P@XQ^OO^W_?_<^Z/4T3(HS2]K<  EHLPWED648JJ
MI_2AZ&W(S7H4)F8U_!9+;WYUZ>H$*M O\'_K&;/_?[U$_UEEKQ_U"V$%H%$T
MY]M__!W\_^RU8828Z\WN5&7)+J,YJ;_]KB;0?&E]D];+7$2?Q7__C-__)9=5
M!.$;"O:R(K"7)7.4XW^?@_PO5?C/_[T'(?^?MD!]EYF9G9V1B^?B'_WRIZ-O
M;@_94J_XR%HSZ4#'[((NY42]] U)CJ_5X2Q<O+]9_/'O8H,:/$W^0%7.3/9Q
MWV^+&3?R\W:4HV4,!1N<OZ/Z8I"M':AA72XB#<D.YR)ZNA4-W&??]8ROU=I/
MP.K9,L'1XB)&L5!=)(A&3=5S$?( 4[VAS>A+\+6_F_S=Y/_P)@Z"$6]O^11\
M4<RNVPZ)YJ;-6/H2A?X0X"+N?,4VEG8%WOC$KR7_W, D13SG_1USC%C:)[.K
MA !:75AJV:*G?M6/^BAH!>R^?C7Z64#N22DO>3-[.8-=EZ4"__($]\KUP.!A
M4F"Y>"D#^2R_1%7PYH, M2'*>?E3: .9WLA3*0I)"/56X[WZTL;RFPQX7[^B
M(K1C,+&RDFW+@J 2,'>=Y":U/#8 ;"S=HAGKFF;;V)8U=<@"(9_2G)/8@V^2
M[=RT4RIMZ$VG%K;$?Z<=8#! >G#T7E*_;V''6L\*<B=0Z:BW8=*WQ+K7%E=2
MHS%]6WV[IDG('NQMQ?B#J..D=^N?^_9U# -SFDYW%!_I&L85=GV4G3E?')XU
MO\<\\E4=Q>?NJ:&$.$7)9E_Q #;/,"FX>),V,NB^C,[I=CF[$*>TOO='-U"4
MWCHFC2[<:\:C6::$^B15>N2<''UE!#6[.OS4H9-65A^25Z8WW5<E_=3[H.O6
M;Y-IW_7W:MD;]_7\,'65M<=5S@Z2^IM7O6==5#R-]A5W#;+CB [SOLH_RG7P
M!+K+[ A5.E(<1[G$VIPHS?^N, 3?]*SHZ;[K@<<63U3^0B"B3VWJKK\$5%JR
MC=6?X5Y6,]T8M93J5,X40U_WF<1#K^>TWF0JT'$+R+=.W]\WBU'^XM_2FJ'\
MG>Q"[E.L).9U5T_JVE%+>O?GJEPKRBV^&*=ACM@2>GG3PYX]C[=L$CJM/H'*
M%Y_KI))[TRQSZ!4=^8+2^-,_SR2@!&ZZE]\KD=N6%?#YJ 1B\[V?!W=WHE<\
M#&W),Z?U*581]>WWK6I1V]8/'Q23B@N%"U$PEUY?@^%5+TFPSL[K9 B^.CQ_
M]N:5M]%7KCLYA*E^NYRDZ?C0/X&IQWG_"W C/T'1D]##&/#LGFC(3\=/_Z-_
M;O,Y9H *%Z&DZ_1,Y0AAPOZVE%59L3*;A&WY,%ITH(]C1Q: [!Z<K H%L54
MW0+8["X&'8TQHY>->OL^R.O3#,[SWS'/0E]B"#Q>C=:YL]/'Y)%D@S-2;X/"
MM7HJ$CRX.(BW:2T59J"HW2'EPEP$]GO!FOV[+-W@9N_;3^U/['F:(2;G??#V
M%LD1A0,$1JIL06$S9K[0M#'N:T*<"65T%K*:R5G9G +LB$T;M!\@QV$]1$R5
MB<,6FV)6MRZ@>X.9[^GDN>O4,I-:O9WMRV7'3'+('B<BBC8=*?VB)!_]^(0C
M[ZDH'X7=S"R@SV3$BS0[03>OH0AE+W$1<_?;:.$QZ$5VP!WYQJADGP1;3^MZ
M'71[N2?8S<+AR%5<Q)>6)WI[IU!\^1ZGV=??#PY>S4\<S;7%^1[B#?+Y)=:3
M/EAV19E_33CIF/5Y?-2;E?RXYD'H(+[P5ON1\1?R^?,KRIA?Q<N]2#3^*#A'
M)8<5IX5X_%_LO6=0DU'4+AH510%!$:03D*94"T6*Q$87(BB]1 6D"1&4'A*E
M=Z0K"%&*@ B1+BVA(R BO1,Z4@());R0PHW?+?/=[YP_Y\Z=,W?NG,QD)C_>
M>6?OM==ZUO-DK[VV!E_Q%QQ'1"GG[_V'E28CV8''.VXNK8H^/";AE?MR\>/;
M;K]]<CDQH75K@J,9SRR_2W![2'**%K6.L50$1 .M_7IT51[T2I?/WB=L%[^4
MF4<#XM V,"_@>[N**$65%O)18'-+-P^8.@*=V[1RWK")'.94/(6W_]AV(:HN
M[>9L]&'/G!/A#5(&.0P[A^58I9_?KCP",=_N@T2A*FNB\LVBV.QTDI2S-A<T
MGQZ!'ONMG/CR<*GH-+S@ANU&XY8!!%WT^TN^D=>DM=3$UO1>'3VMLW_(_#?#
M4&""YQ'HK!X#'Y<:^\*80[VA9UQQX^D741,P]QU- %_?G0#O%8A]LKMNBR+<
MH]QWQI?O-T_#.@,::\@QUES!/0\LVQ2"O%;.<&)')CN6I5Q:B@4%GY6EI#S[
M0G:!X.#8Y?Z8E(\75ZOVX?O"%5I^6Q%'(.<>.16R]R!2#@']'C*7G]J;A.\M
MZ/,;A3-Y";9\V$[,-C<IZ#GSSAHN;MZSC6I^W'!G'J9B!@11E(&M#B1KY'?X
MN<MI2BWH]X3H"0?>YG61_?;'C>,_;HW0[?(Z9Z(SQ@DK?Y%OC>V4*%?IP]C3
MM.(& <]2/VVW&+=B/B:U^(1"Z?SAE%#.^C?BW"^$2L\P,[V\<V+<-9^'Y[F$
MA-Q#\S J'^U[@P!I='X_'BGL!W\P:FY"1"2U%[JJI!'SD\L?/+TD9?GAMZ5%
MW,^&*ZL#C4X==*D:(C1$:>O<S%4#0\F6P /+.J9HY5>'<HB31R F1V)5^\H;
MI"15:^B$YN=Y0S_K#YG%D>^Z?VEBO/#[O8809%ZZ;L?6\@;.>&C?Y4M-2A),
MPA]Y$:)]&1-C3F?QGI-3F3=OAW*XS0@E0P<T+KQ^O>Y&43\"5=FY^6(]H^1*
M"$P&.]?TV!$MH =)QWYV$!.HW)>ND9RTB*@V7,B,% !]6OI+=& OR#_K0>9[
M:8U$/;; <TG'')U8H!H.8<P$57_D"'X4)=>"JE\V^?=BVP:RYGH.5@1 'X%.
MJM4,>,O9:G)3Q4CF'6=Y[B?.#VOHY>=]7WV9PN>5G'?!PW1%MIDG-OC.J<8M
MLBFM4$.)8HFX)JQ )%3]SB#:**72,_WN)(W,F5J4SK46F9E\N_;.'Q1\(@'[
M,7=P.RA(H\5NP3AQ(\6\4_CJO]X(?CIS1Z#.K4@(AS?ME*XB_LQ$KDZQE=W!
MOE7^@K_HBY*-MB<?6!^T:CYG3M-K6NVP9H!]1%B#=X$+C(M^Q@\W!X^H4D74
MR\$M.$\Y3C&_)^HQH4386/WAHGQ_G2.V5&W^377UQV*M C(3'61L.C?D[J$(
M;,W71AM<N70AO^7'M4H'#W:!+U.OT/I 3 >*^-A:9HO;-8"G&1V:+0N,3-A@
M39<_YW1>LCHQ^-I=\(:Z_)UC'[@$';VNNJBX>.V=_.:?UCE5]9NJ39KY0,0U
M:5XB(2M6A&3N?<\TKK7V/BNFP\DC_>8=Z[FKQT0<XK40@Q35(U#S_09U4N:\
M-.(FR3?$&Q<&.R_.U)JS_E7_5[/!AKE#7 CAY!N_4;'/4M&["9.LY.PJ6A*=
MHR9N4Q$*Z"X' K)RNWW50<F__54X$7URI*KSDYL?%P2]\\VG(F[X8/N"=JF=
MT)FLDD"/ZAUJ/)H<") ^TP=@K P@%?9[933\NI>?;ID3+/?L\D)60Q';BTG[
MQ%&/I2>:'L.K2G,P/HC+ M&<; F-.>P,]YW)9!5(GFM&549M/K#_N4/-W7\0
M(;>T\YTH\_,_+FWC&V)UF7!J18<(2P#%\Q8$0J9=-9'23>97^E46[F9>;^"+
MOW0A7();FUU7I'#$ )_".2+?"\?LC;K7YUZN;S9L%)I8+=BE!Y"=)EZ;=^/Y
M<1[%L+='($$ZF*H\TG##N<+MT&LMH*-$N5JTIE_T5_93U3<'S69\1EX?)F[R
M861(G53N,(UK&FJ;:*)Z1T9ZRVC64YC =*=$RH7@-N8P*\YX ;Z' Y]OM63T
M*I(W1WO5D8&WT ;I7_O)T,4]:LU:'1K9#Q-#Z#+\, &XH5/5_X+.[V=O!W3-
M]UH;)IC&W"'V5M1/-%\*?^35'=^O++ 9^@P2";JC@G) 3Z[HT[X@G$H!L#GQ
M>1%QO;/NOJ&G<E21ON,T?WGQ7*QG>5V:3:[(;/"9%1[>6KUV#PP 7_?(<=>Z
M<BL+)X3=6>N68:A#%_A$:Q.XO"#LTS#5)>B&[<Q%@[-@Z!VYI74VC['0-UP.
MCF-A?"=41<#I7QAC_.J7</O^J(8I1<EOO74&]/P1 \3%LUU@<I&G)QVJXR\9
MZ0C[(L\4QJ9DI>_M7/F2.G[(JN5U!&*C2P"O%IC?5J)Y *A)@MD?;]V&R<#W
MS<Q%;-\*4AV?/"Y:/*>%:)]7 *[ 0C0X2)WST& -:+Y\>HZ?,K?I2,Z0!B7+
MA-3P74ZDXOQQV*N?-Y;/:>08'?L)GT97!*X7,$8V:A=LM^L_,H%4!S_KAX%<
MT4338MQ)(-T()40]1L*];3A;:'/:G:I7+)ZHVQ0;?DZ#I>3M#K>>Q:R@4W[0
M6<ICY,!$31,X3 T5IW&%> 0R =!G)[<2%=,3+U56; L_\I6-8JNW/V:>!D*,
M3UU[)-7%X4R>7#E$='+W:FKA]FI0B5. PD)-,/82]39))01QXYM.J2N=[S%]
MU.VJ':N>T >SB^F;'ZXGI-H0QNX](=F]A27AB/JH&#O5?JIIT;A4RRU?VP&Z
MB%N2G2OXG$Z64-C[./'G)G@GYZF(ZZ@>TQY=9CM<B6EQ3.RS&8+,X<36(L9Q
MINV5E*I$>4# "RP%UO.DE&,AH@-]%MF'8]M+$ 3*79)U!DT-M%R_[OS>:#:Y
MG/KAGCHGB.GM4!)(LKZ;^IM64%6,F2PF]Q/[F@Q9G-(9"!A<RIX[GUEHO>^E
M_YZS5,>;302FDWH$JK<,'/SH<L\7D*@_4.CHR-ZPETX>1RKDV+FC8<CN(U U
M3S#.K9?';@@A8%_BTI4SI0-_=:J&Z9J^09&CXWD#$6F?[XLA[_PPKS"_P6,<
MW0"<XHL<A'"(W7%W]_0ZS"^IB_M:EM_##?(1D!_=QOR!"/@-:@&OYN2LVV8N
MX6(,_NS6^]35UV>JV\=IZS4M9C>QZXFP&]KD<SBR].AV7UD'Z%<2>?LFC&*&
M.\P&B=3>.IF=/=QL$5V29)SY&'A%4036.X4Y=!QL ZXINDX:\<X+6+ZSS];H
M*Y7YBQHW(/<0=0CN.6LF@(_,--AV0#_.X-XPMYF?B@.S25[$W7MLL>=T1+VN
M+_"($VB(8$,=U/IRX#3W-IIPA0$]Q_YH,OL=*D0@>8C(*A)T7KU-,NC$;1/$
M&^W9<K6\6$%,;Y7]"[8+L;%$81:&>;]83OCA#8BC'9#0[,N G/+7>77UZ2>Z
M1"_/.J@RK^TC\;/=WT[Y-W45%5 Z4@((*ZM37OM*B?NVW#U47>##'#H4>7J(
M:CO?:W46W'J(L'NQ_XI31T.ZD$_VER[+US/B;V3FKT!FB_E7HC7[OR+4:!\U
M7BV@F&__PF 4/O#'X?Q2PV=>\^Z_"YPO^&!;VEI1U??'2J85YXB>. (UX:H*
MPN%*8);&WO"B@NM?<G-<]8N]7:W5K5ET'5X(7KT5*2(LC2?<H%@"S&038GMI
M\8),?11<X4,RM+]RD7/&[FK'?+0%J#@Q[1GHIV#2L2+ZUCP7Q)^8W:N%1$PQ
MTF55WYDI*U>D!NUC@^?LU@E;?;&$-O-3]WZH2)M*5$<KB[]ZJV#T 5.N@%7R
M<Z-SQ6VUWY+>O@5K(?XM7W_7=X'K0DNBXOM%1PO"Q!T^9I'86)/T6F;CC9IM
MP:"#KY[3A&4OV+$CD)O":7J_L#)I/[Q!X<OZR][9^KXR&-[UW-VTBJYE ]YM
M/HGG3Q[((QWMKJU'D^M(X'$P.0E-_@0H@-O4^]@40MR?-_RH"1^N E>%QU_B
MZG;8SFV:;K 7?/';'W/ZW^T[%[LI[5;9842G.:D83:7J=(54_T+GLI]I;W:G
M!738?O>\N_U<BYG/)I:_2%[[L]P&;HZ*,XR*66E8J,)353[LRST>W@L$<ZR:
M9V07^)]"%UBVC/*H^)J<G@]78JJHOQ#V\)AX]GM,"LX) EQ.CT#>0&A!(X3E
MB1XUQ.)Y\3?O7]MZZUF^OQ(4O9'X/>C3=P[^Q=?B)+M7#"\T8O ?*'%PCMY(
M7#<"?(MM_]J)#XC5H#O5\^,[!O0<7X[@U_35*SUKA%T3EU_?7)$>>#V;,4T8
MQSW2UWN,EEG%)6EV P8D5"M84$.:+DD,6LS(?DNN+1'!.6<HUCIGNC4\_:[O
M,?4YDD]:]V?SK7R$%H-?-@%O%\Y@+ZSB.+PQ(8<K;RHA9U==E'"15:\478I[
M%$O$%(V[X+S-4WVIODTRZQD5I/\@E=,<G2I85L!X%GR.ZDZ2>WN)H*$61WX\
MX?/=DE/5EIS-*ANHRFMO/6Q<H'02X[$YH>*!OA7K4F,B#S5 UN4CZWRF*";1
M!QSD0$8T13NC+FJ*:Q$7.C691S7/(V[7\E4.>!,GY=FOG[==B!O^R?2F_XWG
M&[TFS!>L".(.<:L%Q^R:+4VR*SX5\VFUS']4)9UYR?@/B%FV[=WQ-P8,;,SX
M$)BX',@##K I?I6#8:<5XMRV3M*[ E 1'@W63TM<D]Q&KUM;3OQ]>$^Q[9/)
MK_M)'<K4M9OB2Q'<.RD,M5M?$K 6Y-2"KMA/T# D3HQH\VC*UD21^*4..[<'
M>!+BC?B]]R?MU"F&U >,!$.(H[@C>]6D0K<&+8AEX9-FST^\$_9)FU?E 6SM
MJUBZ P2C17G44A8&3/0.Y&#SR6?T[G*+[RW%(*L'49+#?<,]_MA^.%<]O]R:
M@/V"UZ(3,U/L4(KQ[53"OVM%PO_7QL-_[^OOVX:9L&9DNI;QO*IA[_RZH84G
MF *7)JB:X#;OB:K3Z^$B%"\9J]=?S=+E;E93XP. Z)L6@?H[QK:396N*YMV]
MC&AC(YI,,P16Z"N8\H%J\@L!4F)"^J_.!_M'(/Y=< 2N:JL5&NEK;-E:W/5Y
MC3.)<]0JUCI-M>GX;2N-[*LJBROY/H][REXO]$I[=*;K:/2X]25E^>%'\!\(
M#,O[=_[X?[A>__>2P__8@'B'6IRF2AV!X*A#<Z7_R1L0_[\[6/"2+C^<L4:<
MZ,#_")U[LTD[ LFCLWSXP_K&-CPDM_@O@FT\#T?3*RX^T^O22'+[$NMQ$,_V
MF*$O'^9$RWS?;OFO9:-):8G8U4.3Y/(73G%^)\AMP#W2O4YC/Y5687GZ($D\
MW-1 86/R9[F]2=].%TO!,2CI5;S,>#$)_5\;<@ZA8F&5*ZW0-^83[@4)&GJT
M,,\B[>V)@C%Y#XWVNR<$6P7>!NO8/'Z4D<KB+;ZQB.N#_UC%Z(S/2VFSK$D5
M]EMJ7B"9I2\DL*TB1?OEL9-YKFG]TQ,V_G#PAPN%CNZE)]B";XKP;Q,4_HVP
M!&%X! H+=)S?4F\_ GDD&])_TWL;8+NALD(:K:<3@DM^;WB.5 88)&Y-%O4^
MGU^NMH4ZY33 YR,(*&+R+"X&&HYPFJ_N5_K,"27[#FQ)G%+Y/<(A*!OZ,D#X
MM,@NYFFX\Z9HO$660[066WR!Z%L^)I,8$_/X0J^8N)344LUH4@(8.88^C>0%
MUF"G@(1V_#.2HCLG%LV>Z>_5G ?JJ,\)2_=D:W#2B&9H3&Z_UG]GB3U+_&+,
MR__L9KYDJ\D(76<SR ;)MGE!0=Y2T38]Z=F'O@*QR<9N9B^,8:IHX++O!ED!
MVW,$8KT(5O&9QH_[SMBA\-O*"_B;F%?$A-A*,-CYH9N=P(ALU;0DXL W [&N
M^$#'N%9O4?CTFOJPU*_2L,L_5B7LGT>WD KB&VX15UIWUK,OCWRK%)(49*['
M?GCV(#OZS%IG>6SRF/D'!(16@65%/"1Q!?!$: 0]]2[6G[Q471<>>..&TS'[
M&QUOQ\@L>HK)1C;%+Y?2%90J.9CIXS#F!G_2*8X3?^T4*+[1DMG6SAN0"@6Q
M7XGA\EC[E@MOXGYO"'K:#<-B8 PXR+MP_PCT??F?GY2ZD2'MPK+]B N?I]8U
M18>_[1I*CIU0(E#7V?22WZ8].Z77=*+VYK?O>[>^7,SR_[M82A'BS=!/N_3X
M:0F.@7B))5J(%2DJESHY,!Z8 $=^_W#OQ52=[8X.>K]-P'/KH_D/0+V##@;"
M/K66^#E9E8U6?H@ZXU_PNT);=RVO:"[BI;_0NL-0:G_??YC'(YH8]XJ\"$C,
M)?#;^D'-29\']BC6N.]];KYY^/N7TGVF;E0*'%\,P?E,":X(CGX%]N?!$4A>
M/\TC4+OFY>%+ Z\%N,RSM[6<6'C#;*2/_](3 7U*SCX)U?#WWRI ABPFI8M9
MD=6D20F<=(:[(, D">J)8J!^(UO.NO!%/)J6Z0=D//RBM'/Q EA]-&N,;S'>
M36>.F:!'[%D8*0G\ EQH,UD?]7D8M7EWU?>=N*[1J94T"9OD/TY2S"="[,Z3
M9.A\K'1^?1A@@%LL0;E:,O#V72<5^4RAX@A43.N$RM#0=KNV.\VO48&C!7NU
M^C)IYD;KQ#W-WIRB=?[?Z+EI^?5'P_"2REZUD1NR^^E)WXSOAQ3?*#MV>T^R
M@8.1V8)#Z'UU9I\E4HY YTNR'=SS2RK7N^9_>[8EMOS4^7'S<_>5\4:]ARFI
M YJ1.;4*$9"+" '2*[T@@V:L^"!5RXF/5<;B%U^.N,.9"UNB8A4@MSDT<*6&
M8,R>^662JD'4B5-XC3]O-5.)%"TKBP_T/5<I32K*?,)6\/*GCNIO@8&*DD=C
M'>3Z06@&S*L1GYC/;U19ZP.Y)[M54L7[H#K]O.U]H=SK=^>&KI>9V<3/O67R
M$8G._M>+/]B+WH]G/P+-&0&L<Y8D#JIY+?8(% 4=*T6M-.P<@4JVJ9@]E J>
MO-X>](BDOF#^%LNVVF\'C+;SHR(^9TIRU:7O5]CS;<_;U"^(J3]>N%0G[348
MN(JO1<M^_.B.^>LS9-Z7P4R@$$^T9:28742?W\C)OA?F1E$OOHGCDXPZAY1L
MC&G'G]. S,).POSJK89RJXE+J3_JLNGB_D/W/2..7_W5M!CT)V!(58)'>=?V
M7II-M_)PIKGYR(B,@,V4ED>Y[O?/J2WA/C=-^=;T9MF_%&#:>PW(.<+RM!I%
M-+]?0H?Y1$0K#=Q^]E6!X?4'3ZJ^6T+3^B=#IW B-G,JV0=*ATL,CKX?BE4&
MS.F<T)-K^$DKA6PRWH6B^ =)NE;KTQT]Y2&X(#B0J^!F,.%-&)930@7%8 S_
M%/W<LSU4*8W9K!WKU^+6%OW/.<L6$^H=XNOA+J&:)IHJ57<$VBN.+C[D[J\8
M+LD34B% [C5_6]/)D-Q]OMI[8\ Y)WHGX>7_62JWDS!A\+BN'^6$CAHE:Z5M
MC[:JI?1?_\CM6/TN6#,+Q7)@33\]G#=AB>Q6BUN\?+)W*TH^PW=3O_UXX2$(
M\F@=]G)]0JX@ZO4M'5U<PN^R(;F\JA^Q1R NCWP+I$@&M1#@(-G;,1;=@OJ0
MI- *CLY0SO4G]EAC5>ITHF1%KDMN,.T\?LG+VW)&C#F BY?M='>N!'\55^5*
MM,&P/IE2+?1X21^M,)X,[^_ ATS1GI<Z/0*R9@D\[2.:7$,(R\]C?E]H]R:<
M?:U2KLU,79DZ%G_JR2;[R.*)?6@^ K.  61TFL < -(:?=9-+3U>J5I KM)=
M7;^NQM]!0[HRN2,Z]V:70$).C?X*SIYC?+\3?4Y3R0U=V=F1I52)OK"6^!ZA
M.C?^EN.+]?4-]I_^=\4.N(T$EA/?'V_Y>J;;BBKC>R QC6NV+7<8LJ>ME%,G
M-]*I3"]1YQ1Y<2\4 .GK@%2;)PW7A&+;;?:53+\\?;*M_ID/>R/[ZO,H"W##
MNX41G-[(S&5">UU;S/'2YG,/N>2OU0A=BQ\^2";9MYLS$#F! :16 &8^Z-(A
M92ZA34"I,MVT(K2+K,?2_@-LKA/B\VNQ8S$VM3T VK$%2&^U^C6(R:<37=WO
MS?.T"9DBN_(G)EU4KNDP;6T7_TA3=#DM)2IV]L>;Z\=ZG<XH?!TT-@^85EAQ
MQ^]N*Z98MQEVC;LX#:9UXTL.LWTI9];YX2T)$^;D^IA[AMDL?QRR#V0)G9NY
M5Z$O[XH(LAV[%.MCO&JK0.5$-R60Q $*.8*$<"ORZVNK^T6N3G\5US'!S>*P
M'47Y5'& >&WQ1O""[?Z& D5P#<^"<E+@G?";JM14!V*X!MP$)A%I95T7\CS5
MCWLM_$J<I!6=7N'#H(] 3W$3DZWH,KO$>?2_/UC;5T*\;W&89LP/4#9NV-R3
M[JJY$IGX,5A[]V6^):RPZ7?E:#FZ/+,^3C%Y!]<(3TW/L.(SI6W8ZBKXF JX
M=<]L+?@>H._]:]"O <E9PY55XU!%S:QK_(ZTE(D7OT\!RRX#RBQ!"_['A-'Z
M]433SHUQAFSM':QR#V9M5&^N6+>VCIVRT=[YI$E9,L5$H^"8B>X5<LLP7?C?
MN7RS A?BCLE(J')&QV>//RAWNP@+W_L1:&G(3>_%BFVN0DP)9+98^$K$''KC
M,>+:DYG;(_ 7KV^*&7&D@K<B#]UK6(%1Q5R)T.("DG@2)<7[H/)U<]$S%[FA
M"_ MW)<NZJ;7$8BH<P0:Q^L3T<V^0'&A12<D6@.JT3\Q_>M#TDR'RC7"W0!X
MHE 4V(]I]QL#Q-^ .2$N6^,%<UDY9Q0DAY'3GC5;>==M[G[XN7CV^R_4K.8P
MN7-C858!,#T"'=,$^YF^$Y\PBW*!WSP!QFZG_$3QR*+X@8(6-P:_J:>S,L_+
MZ45D?:&J][.=JS'EC$R[I(EUG.JD'R/8A1EHN-^4^S1Y< <R@E=Y%8RFY.LG
M^,L@E@D'RHWG_S#L_8QJ_8JC"7W:#PQ5W^.XZ!?.&WIB2T]0WQJ$&C4/+D4U
M&U2=UF2E-]7YOOTFT$6Q7T4*UN@"DC<?Z[;^-<.#B=*+1Z 7'$ #F&B"&=^?
MFQ7VSG[+OVXNK7JLH?/'$SR15?<(M/45P]!:KB3OM'22 -E_$*%;80U(WO+<
MD[/Z>W= *EVP>FV!Y<RSLLH"Y\7-^1]/N=6,8[,:\PV#+@U04W!B55T=-=?-
M7Z].!W1O[2SM3E&<9A-""716>A_R[)]2GV9P!!7BD6[XYU0\:*#L"/360XG4
M2>64;$'Q=I**Y]MW'6R!XK;PJ[UC\@=3'.ZC(J@FMPF("W3"O@5YF1:J>0FA
M1=3^/I$=$90_Y>+#4 _/,\8:RG'C1D.IYP%?C07 2!H.2*+>]+U!V4..Z8@'
MRGL[+X](+ @T'%CF2M''_5&IWE=41TK,]"<D=I+KJ6(TFZ6EAY_UDWQ'8;K%
M2/AAV3R^[($,<8O.PD<Q L3!<DI\/-;1FI,/9IP[_]A%YY,LH81IBM\JA'W6
MWI>(F7L45&_GJ/ZY'CMU@]5'U?'\D^WC-O8E_GV$SZ1G*V0]&K9!9Z'Q^C3:
MA*3P)E;9FD>,$,]V7IU]SFJ:-Q[ E$.><(QWP,979F\EK>OV+: X<>3?.$]E
M*[CFG=2P]]N(JIL00OJM=5G-RE6&".BI@EM>T5.HE8=3F2:PR47<C3HHW1_M
M."RUZ! MC&I^B!1U$[Y)*Z +(60'$:+%?I1[Q(WS;NDS%_J9L#X%8C<N0J<[
MQ4#?.^.:V?ME1@M74<2'F-@ R4RW@E5\F53\MQ=RSRR>5%537GBV\\=*?XV[
M 6)\S!0(&%H]10XY03]!R]..\RX!+AI(#"CE/J_/'DM-DF36.&YRWZ'K6,;U
MO-CH77@DGFB&"3Z$A!D +"LFI"-03&E3=.N]JD%Y]ZZL\/.._O;&<6/,/3.=
MWV^YJ7FYAN\C!NK6 U=7B!/XMZ9B 77%\J9. R.C/8%3.QQC8"@048*<9.3
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M-X'/;B[7$=/?-JC,N16%CS_O?QT3J.+YMY?_BMBZ[<5:C$LV3__FGKN3<>7
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MIY_?EO*&]0[Y@5^O]5EJ9BU/BC#QT;-[3@MDS?C4E[CK,J_:."0O^;-B<T\
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M+='XF=,@/X^3B0_,QF-8F^0OA+NCD^@ ;+0D(LNOK6AZU55I'&B.2>G[;?/
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M17FZ@$V44[=S V!!6[V<XD[@:Z:IDLZZ$.(MZW1U"+\G7PJ"D[-T!:W$:S4
M)G81"7%WLZ5@$IFNC^3<\L2)CSJ]Q>B _2624#;07CO)K+6<:I4PCYJ!AS!
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M@"A%5'J-C?X" E(#1$6E"0A(DY H2)$6 0$%)$J5&GJ'" 20WD%J2.@]H81
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M9TPZQ>8N=C20?%&N+6JV2L=R0O"7>5K=S\25.P@O1WFZJF/'*:^^( -N']_
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M2-?B\$&*>EIU]JZ6@]8M0^RZ=W?N!&.EA!R5SPVE#GO*!CK (Q?4[4@AOZ#
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MQFL9M.E67Z_Q%EJO[$2M\5\G58W6R_@$-2[F0A\&@#9GB,ES?AMMN?YJ[3B
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MK1QI+'?T3_1Y"-X?HFFD'$$,S5,L(Z]PV4(.F[_IWJ"6IP6S<<^1H'>K:5Q
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M[/,0*KK]:)!C*]5ALF#PL730X],_%XZU\5Q\I-EST4%3[O35SX&95V(J<%M
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MI^$6D+.4"!J4DRD>]#M( V"P$/@2%&%&=?+<+[+/A*XY2#S_2NX="?KV>KL
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MO'P!Y7.D11N%_+7"HM L''%;*'0$OXQCJ'=^"^# M R"B+N%,=5W=CNN20Y
M=>NG'CDQ/Q^V1R+&V!NRY[C9%ZD'F1>P7Y'"TUD\Q+XP/\(1P,6XIM]/2?OT
MD9*X3YZ&0ZB\)"/I.<XKV=;OGN]EGTVY%'NBOI#Y&V2O!UT,P:PJA;HJ&7>
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M&NS5TZKJJ!)C)38H7.Y)!I]UR4:'Y00>!_/+,CWB85*%JW(8V;[XN:QB+]^
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MCCPB."\_0Y->HP/X$&<8E)$7S@;V05Y]M[9U\9/S;/V-TPPC)2^#QU((_70
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MQXW]\GWHW.(EK:,A%\5PS9?\S^LW0LXB)W/CS(Y2<ZZ#V;.;6ONEENW?#CU
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M$_)?29\G[8$M/"]+#)=N[/G*@K=?G]!_N*0[$ \>V"/:QU&55%UH)Q"LE7O
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M- D/1D7P!7,;JI=77?3K9X-J'$B,(6<^D>@ 6M-9.F A<4^?Q@+,;L^GC0F
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M&*.EZ!E8_T_/;*(IYXV)R<@1[*1Z2WV0K,"=#15[D&+X=<L(Q^9*P)DWP4W
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M8RI3IX\Y"2Z"7S2J.7-5?5II?^I^?"-%TC'[(_7#=@QIE^P!?TLJGSK*&2_
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M427X$-2!ZF.J#<2PI/.'$_7B7S?YY&[SB?Z#*V(;]Z>$M@-M'4KAI%+\XN-
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MPAM*"R@@TD*BA./:C'\K5/#2DRU+BZ2S=S8)S/YDJ6H)LA&/+>"&5^H10+;
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MC57F/= YJ#R:5AJDZDML(RDE1"O_OFQL@;$8ZW+#LA$[9HT&>6CD*OKRI#M
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MF5B%F$;0B23<81<=R$X>M0SW,A,N))[A5:E$$=(*++LR:-T"UA-7G-B(3UE
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M(($*'Q&HL<H8@/0A'67 #8:'HSM>'NHS0)4>9NFA&#=A9)5N_""J7@JZ>WX
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M67'.B.S;X[3KYH'&!>Z(@]^4FMT"5!0!%[%K5:/60=!J'+_.BYIGK,RKDTY
MJ)O;=WI.[HD<JS17I@/NQE=\@?;HG,Z\<5E ^MG+ZYM;MXMH \=[-7GFAKP(
MY2Z;Q4_.V,1^H#;_;+E3Y3_Y-&X9G1J-3L-3X&K#I9\.'J[J.W$Q^U;O5)(
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MT P>.;E.R"".%^#W>+OK:U&<HHJK=.6\4L1.>8U>:;U,NF?AZ)QQU.MZR,V
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M!<\%/,%=BY(O,.5)-*;8H@)FH/\0EN:EPTJ%<$91WN0;"^$+KL)A:T*8GG_
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M;M.KO,[MSZ@ >.]T/'2Q"?X X[W'MO'&Q=*07%M0,-"075^=_"JVJ]!>6>'
M\&\!]H6K%0M:R)&KE-E-7:_S%9P;7[Y\6+R'\GB[%0(X[ C2:86'-0L0F+"[
MS RZ?U(4G49F;!_! I8[;2T.-WZ_ 9QM)%G+'M%C*U,5\(E@6(0OC_^:8H5,
MO"32D%)@M.C.Z31[:?CFF,*.R8CN2!;Q6"FQU$FCTDATNLR_#X4$H9T0L14X
MV#9_OGU%G0P%!M8_X?E#B,!3R%E29:*CCB-0]KR]+T+Q>36%SXO-C,X[7^1+
MZ#2R[PAV9=D6QSI(7G+N:BT3VIYRM\6[5[.3M\,[X9>"++),Z=ZV%+;QWU:-
MM2F<GCE"F89?ZW-0Z/%7[KCK'  &&PATS/^MK U?/!^7A@@_BM: &-G%:PX\
MG@=J\S\A\O&HVR_%,BSL?CCM^G"D*Q\KPV\'*4F\=]XN!,1#6AR7]'&?D,:G
M5$8_''635A<JO+#J[_ Z.+O_:TG)6W2B+"]S7,OQC>:O-% 3:JWC1Y2=&61B
MB#+84M+F9TS]!4IV-!5[[R$O=''VF]6SHX.3'/V I)6(LMO:8[=WZ^%M<NO@
MBP24-FX\XGS5=Y<[F_76*^\MS-=N3>LQ .]=*(LZ(>*O4 &?7F%1Q&/0J<;6
M.@^NXHDYD-4DR3<:LNM8$EZ\]3CLF;MPYBR-@'E^N_Z_[>@OS5MUBJ>2:'[P
MQ9,,^$-,!L9CZ345\*HK+L-S;=]E8:L^OC7@6@&QE];8ZNN+_SIT#&42O \!
MLE,!VPP>I!+L2 M,;AS&2VC0Q9F'JDVYI!D.6UL-R%4KJTS-9H4(QLTG@'_"
M:RU(:5WM5 #QS!^X&&F.'$8Y,P$;RF2@*!%,YG6NYG,9U ^7+P-Q>[[O]EX,
MVK].<L=;'W>\40"5/LI5BGE)!>P[!%9;FW/?WEYQ1R4#"ZF L[ [SB !S:M.
MMG)#D^;\]X!ST[N]5M;2;.VSFRUD;99[XON]>'XJ(.FM#A4 KN^B1&?4H/X>
M1B^P1P4XSL6F1;0!N4[2?!/*9M.YL^J4B>?S8U>*--_^VI^>>[%>\XE(8ZL]
M_^10 8@9.RI :]!&)LG%[M9H^( "Z-8&V;MB4,PS)QSQR*H B#D]THR@J4PK
MO%N-$$ %O+"*)[/=AK]$393,#W:@)A&MFF(XQU!XC<_67@TY>X]H@N<G2N7%
MPG17S:X],6[AUW &S?_(W']$$8!/F"]1 0^B3B#S"/3<%*H#S.P=:[101@5$
M?<=:4]PG[$:@-OPQ=&SUW;7LGF%P?R#H5G?WFDJYB^1M3*/[GF104,F!JD-Z
MEO;(RMQ::7PNR"US(G3^N#4S)! 1 Q7*ZUYP=33,^*,%Q,<<= 6LZA?:B<O]
M_&7NP*L+NCZ@Y3V'U0VV>MI( "WQBO\4^:1=-<[Q].1]LHY_Z,/H==!8K89U
MQFJS-.$(*XU/_@U53)OKL )Q;$[Q?UJ><>&9&+.K'>2-Z\[;1V_4S;]ZFT9F
MI#T5+Y(W%M@N'0;&1A LVN:P'S9A_%J0?HD!1_8]427QVV<RO>@:A,1T^14Q
MCW@72V8.B:C>T]&U#AN3_(S:(,I5$KR,%:M#XG"G&,EU@G<WJ(!3G7.P<4LJ
MH*L4M"N]C^@ $6[-D3(<8U S(U3 81PC^0VA"->+!IYIE,O?$E =IP)^'&YU
MIPQ?;.[6Z#SQY9JNY?#4-+-+E.FXYGQK@=U]!_1[A)]+K#K)C-QQ\N"0YX0!
MOT\N;81@+Z^U:7)@KT8R'W^ &E[J9,+$EHN\+Q$[%P70#+CX_*X*GYUSOP^M
M>ZPQ>')S<_'6#4)H\[-K-Z3Q4MFR>BTT90;?4_Q4T%_45JR0W+ IT_XB#I=E
M*JO=SO86]S$W1'= N?BKS8/2;01B!KGLT6G;8WOH<P Z0P%!082W\V!NRS^D
MA\[I'3#!*IN7+P) Z9[%N^O9[KNH7<JZJ).8LF A>8'@3@4([[52 7C&&BI@
M2!R<#,>:(TY4F-DI'0UP\JTZQ)A1.&WS/"))4P'/2\!DMAIEJR"Q2'$1\> _
MOZ9YX<YZ37^LB"?/<(X[5<2G4+,AF+@2.C[,4BCVY?XP]^4".UYK\)VD5Q]2
M>5\"'*7\GO.]^]P/9<XG@7 ,M%&G,MML>7"F.82HP795NSF.S_W$;N%P$R8J
M@)WESMD ;@;Z.*,]/AZ-L/(<G\+[]N[,Y-]F&9O*R?:?;[5&/)=MN?QE QP'
MKD:0<A/W*)W?A*B NS6E11UM[$9?9FJ/]E?-P<+]P=G)C%%BW=*= ]OD+XC^
M^*EH?!(!@_NTQ!4).P^5&!+Y@:SZJ:B4FO;"X6>&.K1?8HW)G?77P!W_SH-O
M-:=&3[;E@YC%# HJ*Y%5044/CYG=V;+2[H_-T:W:;0:4.1I-Z7F!_*S*B7"T
MBO,HWKFZ:3>^@I!.Y/7WW$)3 4C1T$.FU<@][R:7W4[?L&CM5U&W$Z(2SPB)
M>7P4QWLMBK[=UKSISP+&9A1)MO/XUMA+QK;7OBZ1[;J1_#(L.>2U@.P%/.)7
M? A\/_$7:OO-&.I;/ZQON(URS"  0Z+Z'V"X OV1O4/2 SKM(.PZ*G3N4-:?
M9@#H2JF $[9FD5$JP"&3$?J 7))%,,9&/QY7X+\Z97H^IVQS1$MS4"*SNB_#
MVB,V\I@+%% Q<,UB [4SB&NBG(,-JN*+[$ )Y9N?A[T[30\DAD/K[^XF1%X+
M*D2PT;;D8Q)W?!N(\<C]0^H/NB)"XD)9F?"+ \FO$D^61J!9!ULK98;*VGE^
M!0W,X/0@Z;&30![]W(W?:^[/U*2E]DA-ZH,5ZESS,PSS:VT-+"SK*8MM=W]O
M]W2&15[GN.KP,K!"[7/&<AKI%3D==HU@@4\C+"UNH3ZDD6:O8><2_,IF-SUF
M[T,J=>H>%]M_>0;XF\^SB+*'R3C58R)A'/YMNMBU)(6=^WH_JROE]"KH*Q_\
MRJV]#!!5. G&(BD703CI#@M,[Y*A>5M+[6/^'[W7#/6M/I%7=)<?%V%2WDQ2
M! [S\]0-ON8$27?,4@&)+[0?%T1XK%:Y!D["OTWNSK+0IN\ &Q100P8-,I%T
M<"R1DEEO!%Q%K4?*$ZQ^5_NVT]F.$.%0FV:"-%%N2\E28V1RBZ>TPFG<C[6"
MA?4CNU 17SBK\&>A+$',*LTZA\.OP.<SX'SRD'ZA=@,/B83@\K8G-=I1:A/W
M7^HZ?OC4^<^E+R_>Y?(=GN90&%\L?= 4AG7#&4EF#K',Y35%5N#2!^1!V1[S
MJ6"T,(R3,[<@S(W7YF:33>:<0V/L=0:^)RHSAZZ@9"K@UP&<(.JX;34_& =C
MQ4!=<>=[@NT>Q6$WQGE<_O2Z<]MK!=QTC$T>G#,#7%%^O183F$)S2/3#..DV
M^-2]7AKG82&9Y:]G<(SXW')_[2JUG 'IB%XY*)M>1IM<^G#14S_AZU=,-Q50
M-=@"C 76@-HV2"H+L6[,:BV!_+V?KA8%B#1]FM&+>%$K[)OR\(IGC^^[\]IO
M EE"03R:-RFM*($<+"AZ3XJW[8>-CFNQT[ U=]D#MBM:_;7^IC6A[^IF8DOE
M1O(O:TZE(<6'9]T-R>"%97L%E7MY>?U-&/N5_:&3D\S'-)YL6V/X$K,@&BI1
M9OEDR.W(3RGO(N.P\(/6LDV5A! -C$9)#CD&;C\72I$@)T%5"EUFV8:@]X/*
M+0T4<XKGK'*1MZ_[:3]=$?)64]SA99PO#TR$5-%6^QW4%BO=AGI;Z3PKC25I
M2G]J9UG>J%=/_!RJ&R+S]1=*]L)^@>>^P9F6ESIH\%D:#()/L2_JH"$S7FB8
M$/PRX;[908;&64//U=\N4;*EYASG%9G??>_I_1KX'",1C+'QG,6?.$-@]3Q6
M:<E<_;VH00M$KYT7Y6*5A]\"%3 M9#K4J.8CN1?QJF94L.ZCHHF5T_2=GHDE
MM??^H)VO/HA"N OHY/8<'V@[#D1)-K)5H"U;,Z%F 726,/V$8%]*,):7%G!A
M,[B"X?_<ZSET5=)9K((\(C4NY$;'N>P&R+0GTZ#0<@'T#150J4QSC68:-EJO
M->2_[7!OS?U)%[7X4#B%;&(&[1" 5M"_94;]%N#$<S3?N9Y<'O=S\+^XAB%,
M'IA0=03_LFQ,X0C^FT;Y]L>_O\0W1X6YQ=;67!BX^C!K#5.P%?6K)$U1N\P^
MKMD3+F,J^7(H3\DY/]">P]CVQ5[8OX--F WT(2XN@4B3#&V.4/?!><X^)8F4
M.>MF ,=7D<Y9E>XWKI'0(;H3W;**0\D'H:SA_;!$TC\X?"BV 5V/C"(9!9._
M?'=^G![=B[JIUUB(IE,3,G=8C@/<K+M8/?<>7(M!3XL38S5[NS+.CTZ95]75
MUZ3-C W-BOI'%QNPAUO8]%8?H=%%UD.%Q?<M^,G":2<:VZ0OELK*!EK2_<](
MI*%U"CLN/'2I__*<)7:VZ@5B@XM.!NR,O.W!=+KP.X'&M1M9T*@*VW0LS</6
M8S05"4'MH$G%^K'TZ5F")<;HXJ5*U?*3A]F/RFY(O']-G%S[BNF'7P'-?VE6
M)3 %!RT9348L/JK(=I&Y_8VD4&A]R>;<GU:%CRQ2QK\EO+(8&C#5L%94[=CQ
M#B?6KP-)D?X1WM6I>9'>I?=UOO*NT/Y,XO,(LA503,M^G?'5<_ZL@[NWS2V5
M;\X%:0 _@3&Y=;WZ[F8W:W=K;#/ 6!\DT1 VT[7@W@XQ"H-?:N3WP-U?+!L.
M#Y8:OO?CZ=F&I+Z>BY(Q,N"D<VI?,#$$/((81(/?5<UEN9O :FFTH;0.5COO
MC22JNE%!\T1RXB#EQJJWP]1%UHJ8VLLLYPMH^TB;8-_HG$=Z3)A&:$M!S1;+
M8!!PS2_9[BM,\F]9G@_KGP$>=@>+[[)$40$7U45Q;6BE#%9<[<?ZN0B$@,K-
M*N>54"^AB'L"-RWH94/;6!XE6U=E9\]6^KIJU(SWS!K!%OH9X_2@8AL*S6G@
MO8T)',OTP6)9RELBB_]6NZK-E/4TI/Z)N;D2JQ*[CG_W-7O0T8"V>VNS-3D)
MI@G5Q0YN=\SOG8$-S#'.+4K]+)C6&$<N2EK>=<ZUG!F\_J4L.4/W_7[VKV+T
M*YLZ8) Z#32AS0Y[P9=)O 1QK!KZ-Z^RCZL+KX9FUT" (MJ=!\UA/Q-]A]D#
M**%W$ERR%Q^&NNP-?P^_3 +-[YR=E/0NXQE0>VI\7LD5*(<LD;./W'V:)IA-
M+AV!ENM)[6B!P3J2K@U;W_6Z@VYI#+OB&WQ)*9D@H57I20;\!"Z^(S[:]B;A
M/LX=K3C+2/B4;56SI%-0%9SAA#;LK?F&_RBL?4G8WN=UC-TW]ZE/^!\X>"M\
M2FX>TSIXSKE>*L=KB3>/,NIJ<C$O<7:R0+>M8Z4GA#_;M_<\4'"I'&J!OVN'
M"Z(PVA#ODNYI.TO(W[)Z$/9V_D>BFC?H7JTGL#.6$[7@!4>_/#)(5-\!+:R^
MLXLY>KS(>4\SVVH2M!?OXCU7G<)C"#5(,^B^207P:^*>V/:_O-'<NV*+2-V;
MR2 3'T/OD@M)TDNNJH/S?FW2S 14F^OS2IM-GI4_QG4_I>8[H]R?J]VC5Q'S
MM$)P[L=W[DTOX5O(7[UG%(\7I=O X10^&WWS\ %V<>M^&>.4%WRJT;5#'YFN
M "1RZA"_$7%S?(WB1#62XBC)>7%KR+5@2FKB^[U+&*^/^G=IP(6] OC/&5$
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MC3 ^ E&'4#"OP=!Q2M^O&5OVK"O(95\*,['U\9KOB]]Q[3RD=G(]R(EE"G:
M#QS?UA0DB6*/VU#GMN30!?U^Y!+^E>52</_3Q8LJZ'8=CU?KEV6F#QGP6MC<
MY@OD5,K5=22CR>)<V[BK&-+,[X,:2TL%9ZG&II<K5%*Z2:DHB3R)%JUWWW6^
MB6+'.&5'O?L_*YCD]L4.@.1_R-5^[GP/K["DO6"!;YX)C2?<]: "DAE?UFMD
M1Q7[7.AR((4IU.BF$L#[P"6MSS\3/*.^^WS0P7:?L.#R%9O<4&C195!GICB7
M>E#:$W-C'&<ES9*B/E(!/';^&6/PE:]SQ[]H/Z")V]+.EU<[.*-F):K!)XY*
MY'U0YV?HBU>@E20JX+B'"H@5&+")Q(\2TZLM-&<5*\ G]C0YH @J@/.AINH/
MX'[G&N4$3!'+K,I\$10([_/VMI"=NR)_1 6D*('_WH][,DAXFN9.POZM#\A%
M!405;!=,@)_FD;I,M3P=%[4_H_9;]R@$6A=I<^S>-;3[N#*/6^&X)^381ZVG
M_<!5U4WQ.!!'=185('7\;_^TX:STP"=^3;0.V?\5%S^Z+5UF3+&K_AN-;Y5&
M8Y2ID#TB/I-D<X?T?"B58H- [4W!<=[D,*,5KO%UN*I:L7@HB%O>F-8EDC;+
M'1"A/H;D,L1 JM\$_NL7W**$E$OV8B&M'S**#QIU[ER$KXP\I@)0M+GC?+@)
M&]_C3[Q'X7NC<)(-J&2,8ASLQTQKZR+>/]@5>P:^,FA":TOK'N?=ACMN:Z-8
M'X&(1T J@"]G<PR5!+9M@ZMJ2$4=7"5_;U1%[:\4P^=H5)VP<H?R>Y8/?.(Y
M!OK;LV?F& 1^"U5]!W6 $\C1"GA&SE%7!*UTF?WM&X[K@<"&!7C )QYCJ+T^
M\+]:4P'B7/@X=@I,:*P0<1-4C0AG(-5MSAVO2E-4'KI/05JW:#/F09%/HFE&
MSOA(GPKXU4'."Z4",C\<]8C_XL5G8&EJTAM>007 7E(!2]6=Y"+U6TW>9#L*
MB69!NYS)1JRD&/"4/^B$$/\RN]&),B; #CQ@&8?OM8-)OI_G:OS>IU)>3&'(
MA C:"".G&4(GW*"IS](GI_%.V8V/*>.VK."3" CX>!%(43,$U2#?<U%>U,_]
M>_,XT9-KJ)H?H(,C@6DM_R 8)N,R^"1\*_-?S1^":AE"=4AM"G-$',U?\^=L
M*F<NOZ1@:)!J<#3H&^>"*+X32Y.Z3\Z6"FCQAQ..9%"O$><0I-:C/1(#;9+Q
MIJ?A?P>HO0,\.!$XT/*_3JYJ9 .M<OTMXZ4.) 5^AKM*TTN36O\>6A^"A>,V
MX9,$Q F^@UR52AMC.>B(\P!'KE6_#%KE7&3YO[KDQ?_!RM(&%6\'$9@9J "!
M'"*(!EHT)U"UE7LGI/BL6X@,EIV.>5J7=S)9X?/R?\>90RJ%8"@O-&_0!(7
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M+:Y@!^W!L$VD.:&U49*<0ZMBO/8/;",=$=U8ETMZ"+F.\"$GD6BPCQ&#=R5
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MT9,NXPYL@NWF3$"2"5!E5G)S" O^4@N^L&222UI9G2<3:+?^EWL:CLCCHTQ
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MR;'MGY6^=BV-L+]ZF7SNU:>"J80U+"'ZD/X'"N*.C/,,O$*1)FO?1IP8XJ.
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MVLZ^F=@R_BB'0[=DVD,_B>#4O\@(%%,*<&E(L0X'W>1<K@_<,^MIE+_7GYG
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M12%F_=.T6M/9ET,JB-D@<%YA6?KDM$#!=!"R .P0.]\-W^,&M;(H,&I*X4H
MB9OCL"C&<;7B./ @>,?P=.FV%KIKL"'?<\PG?&KZND_?6OQ#^@>,E\G>D X=
M+B(C8Z)2^[+)88^?$J]%#W^Y])K^-G2D8,WK^J=:(Y=$MNO-4>5!'U>J:T+L
MZ%9/&]=NRF.W'I&W4!=,X;M5:;R'&](X$G%FE/=4%<KL=QWNM_VPLKMKDFPW
M\/X2I<3<KFS:]FZX5X!P<PIK YIU/D2:V)FW#_V'^W7V:-LY[A_S./5I@V-/
M<J!Y"T056K=.=X,V9/;\U0W5.?2SJIU#D#2^5I&R\_"H,+$#2!-2Z8KAR[::
MFF[+B:)K&=(G],Z=G3K#\>/CKRTC#J%UL<%H,H&(([!/=.A^'RJ+*(F/A!WR
MG6LOTQ' OHAT$I";+K>4R)6Y4B%^>VH7RW'=S2C2QI:_"!/P(RB8H.:"U>V]
MJ1>0?C]ASKCP%%1\E;%;'MQU&_FB\;305=.6^U>_?O(HN>M[RZGI07W,!OJ=
M5A DWIE>Y&Y2_(18_2,=T85 [+,JF))*H.3K6%^LJLU&>Y3PG;KC]-9<B=<C
ML[M##7?E!ZR0?U3V8YQ@(A3<1/(2_I&#UX<%%:L'%%B3?#;G^9;3#G?-E=''
MV?/OUET^7_M#PK&CP]@BK'L0UU*,@2<MMU&<\7(;M,,@=B3X^7@\WTT*M;:"
M_WDQ93:B_N:7L.ME<=,76[^T"55$'C#@V,TQGI V4[HXBWDN5IR%JH7]6KE&
M*<^AJ.SW/-&CU)8/<@S;1=_X(VZR12]<XL8S=H$7+,^^'_=^//RC))XBG=2)
M0;#29.!/TDY3*B7X?K;DV[FFFSHX:384#BQJV/YP\I4KID5QG3UGI^PE]#+*
M:MJO#+%8TZ2T(G/_)7BHFDI@!"$VSRT+R<XJ#"J01XAHPHVA@9=>F>XZATAI
M$2Q]59H?0^_&W!MJCP-&/N)D[UG>-FB-B1FCY\&\Q'8SVGC<7FLTJ(Z=(-U#
M,X%C.$[7'Q(5*"E7OY:ZXXA7HD8B!*O:I@>;<B&5C[;]Y77HA%Y0P;X9TPUG
MO0G67E=&L"WPF2/A=%25%[&HGC_QDZ('5EJNX4I';[MU6:2 H(2T\W<U<_A]
M"M@@A(@JUN1TT:^.-.M!CQNEVK:Y<(MTJW$40LZ4Q[*5T/'3VOK+![@0TAGR
M0A^14A1A$JQ!= ^V2GM2LQI^Z9WMB''.31OM2D4]9(9VSQ<!AWZ]X&1X*A,H
M@M.RAB>[Z(^AAC_7MZ/<^@KSX-=NPFC[VO-LE-[1)FJH[ZUV3G'Z@\(?',QQ
MV-5>O7?"[P!65<,K+TYQH4XSVS/X2 I5' ]O1.]'>A*=4%$TWH+AQ2'> 4OY
MVQQ9-X*G?&\+BMQUNK'KK+:'?C,G_AM--J\LNO--C<A!V'!<T70T7);5_^T,
MLM+[W4S-+DA\@_E#PY3DR<X,?*T&\O0W[(#<[G8.\9=W7[[+#GIF YC86VO+
MS \]>"4T:,\$E#[1$1\.5]W)1MG:K@SWHA,VFIY3S0+,[>E9)4S@,7D[Y'/:
MZ6[?Z;YE!8F(XW>ZSUX<%W]N]+IAOC:&2SCM+5EFRZ<.)EPE_3$$9W^.XH8@
M8O0_DYS??V@.\I[\U0Z_5_6LT;V.=1= /9_$>O8SO8?4*X0I826TC'<-HJQZ
MD6>'[F5-FHBY1V4WUVT?"5H6]C[.$?G^\;/OP#G15GUED1;S[+%5> C::94F
M[W&JYI%D#T[N,*YS<VO89VY!=IP.8QR(#AJG>UR+G%3]#@HB);N5]U]2V>Z?
M:/-F<Z03R<1W+(D7$;=91Y7)JL]JI -LZY@ YS(M&"RP57CJ]0E6/&P17O4C
M#7=OVE?V/?6Q\/D6B5"-WN1*5M.E9_;KK_B6%G+13ZP9!WPFF #OY:&N4)@S
M3"R@OO;22[ZJ/5\>?<R,N&M R+I<RYKYSO&==3?JZPK!:1P]5%_G/X0)#QET
M",YN_>P>J)(=E6QUSZ?XLYFNK)?G&2W"L= +NU[9&A>B!NJ\],'%F2!+*$(3
M#D/39 ^QN184XXX,X2<6EI-,)@RO=^"9 %>3[0])W3T)=97[AOR]+CU@E2N+
M64,= ,<S_5)P#06RW^%\.@(!T>-ESTJ2;ZQC"-6KMK>*CN9FC9UZ:Z0XQ%57
M/OXY+W)%K@V+@%UC L>[-MW*?6G:0<BN>Y18ZO4 6WQD4Q<+3;[?EWYG$DYZ
MX9@S,EA_V*:Q^ 5RP,TR^0,UMW^)=XVU&1%KST>$$]R('K4:Z/JC8@T0EGCV
M--*$Y(2/)MBH"#Y>+3M/Z-R_=?=:R9Q8<1G!:!P^:%V;X,$X5_DVL^)%O4/6
MC6.)R^3S9R^Y&P"GCKV^<^0NQU3HG;/VC<:8$DE0W\.V8KCKCQ';C^.54@A+
M3 :-&YY>LQ=&M!#C#0@\@JURH9ZCK-6+ G<$*#%;B9ZQS]B6$FT;0D7BMSPZ
M T[6]% 0I'/U(+\69W8 ILXFTZ;I<9[>S/"H7L*[0X(W361:+^PU@$)0@5@E
MO^I77%M?:G[6R,(I]).JXY#B[7NJW,9_;L/JZ#X-8CQ2F&\EQ4232'GAZV]J
M#^J2WV;=L&AX6@ZP_:*5S_^8#^%D K6&GVBV)!=CBA=)$Q__3(>+4F3U,-XX
M\H9?HN!@"T_^N4;V/+^]%DLR)L+A:HTMN05C8R'OZ3JV<6 E1M685I"-F2VS
MBR\^5<@]Z=*$VQ_2A>%&T)PFC?6I,/V2XT"L:H>WK,M=4RF2YNUQ7^"0 9!
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ME)[T0J'3-$I$YYK%B\N*<.U;$"BX5H@T39_W0<I1I"?0414H<G#!6'&*L,&
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M$(,_:7[LY$CP_"6/>]TO -CJ,()UAA=UUJNPZ5UARZ8.+;VJEPS2/T"1Y6K
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M](,QQ^=P8]FF8]M369)&@M]_Z5:S84VW[V'!"4#^CBL4K=%ZJN.<#5YKD[E
M^^"F9'VE?8J M8OK\P^@(*L&*(,)S\:21G%D199U%/MSDGV%?>#=S<<=K3D#
M@_+O?LV#)6T'G?<>[/R0I0.J@-!7F_%X.#$3O[LU1W:EC1]E5^=6!$;83/F5
M;M7[<*SY%^/V'WTVN2D=IP8XS2(U_?8ADY?DH -GB)KJOE%8U<G'_H=OW)0:
MS(V7YJC\[<F3:+D%JA2--14427$I\@ *T,Z3$%CVK JC9>M-H70C>>>ET[]J
M=5E86\,=(W\LO0)# BOZ@X'A%*E24H[]Q/;!WW.FC9#6G..<HU>]S '.?L0S
M:89G)":&_D;7A\!2(?-95_^@OW:P^)!DK[4ORE548"+!=25).N*!#]#ZL8=K
MED\MXN YC@8^-[1\WV&;!4]W1%$_PB"[9VB3&CKY4M$ZLT40]./SAZ8<GJ,Q
M" 5VPT% RG=#\9=:7%&L@26\2]4H1"8N_7^$&%8/&D3(H;$J?Z5PD>@ '"C*
M9B3"![$T?O#]>OUF[JVU8;_R>9/E(,M7MN>;')U!JA\#[W5)L.*4&39^(%%+
MT*W$TT&=FD,Q6+ 7\G*8^Z]U0KG*9,&0_^7/VLMIH_\5RING?0&HO+65EWE,
M76[6H -R4:#Q CTC-7!.,4H.O$<'*(QTE%:[X523Y<.$H>H$8((/*J1DK>7%
MR8>X*N1/PP+%>A$1-P&1  0[-0;FI6DZI]BC(SGQN >(CP6[!Z3.#3VG%A#_
M$KY'IMG3G@0.6MEY@0(06EQ'G[\BXUH/O#$?X2T%4G7^X$\'[8%'G7!T?#>J
M7BJ6=MG=073\,%X.=7;#P'@"_"1*>C'ST5[QVH,'RUDWD/*\"TG:-_P4T96(
M[<ABRODQZ'5E*R^1C9/J=FK!<J*Z?_.3&T$&0:#FU6 ZH%KDU8@Z693BA4?T
M)<> A Y&V"DW1FG OR0?!Q6-I/RBCPG9$QU>W=2O7BGZ :XJ/A^;?T;G+??,
M3Q?ED L+8!V;JZ&1H("'2'"<-T;9;2E43P_Z>!%#DM'?%8&$72*!\+ ^L-#U
M-YH1$(:58"58]UV6X*R5N,TO:"GH\L@_MRA:>3ILF Y KD;3U*"Z.=B16*TK
MU5!%4CJOR0T\#24H]I*MJ=+;0N";*1SR=3E(^-O+?')?X FE+1KT=_TZ?*H]
MN5P:P4\M04' I\-^Z%RJGZ#8:@_/YY>J)S\<59JP5E04<'IE(<&D]WWH)L#Y
M5-H=D!J"PG>FMX-OSP\6@ZIS2Z)P+00)6M&X+W$_X+QYBDTBDR!]3IQFXTP<
MEFZ0<J$#SNS.>*E5H#:70G?UG@5R#&1S].Z>6W>0P?>7L-=\V4B)CS?^SC)W
M-4]#[,F[\[)W&#1XUI+ZY"L.#3'_I\/_WW,+-5O0YU\W'+@B^E1.<NL"_4,8
MT#/W.-WM%1?TSGS@Z]9Q;3 K"?'TW[$S4UQ5B%D=20%_KQ\H\*9=Y=[%J1K'
MVKFYG:W'SCPWS[Y6?2\U%KTSV+6#XG#H;%_;KTINE?M$0/0B6"GJ]C=(.>":
M4?"3UJ3N;KFR=X,!+[?XG&)U]FODU1Z]_.=EH\-^@I !$2B&.^ $D^XN&DYJ
M,1$X3"TA"+;-P5HGY.ZQR5NPCY^+OJC_@FN'Y#_5!W4C^$UOF^$;QTPC3RKY
M:1>GV_YRKQ>E^\3.#'I<,03Y[J5\+]O[Q/"RR@T/7H88[7;DVNQ2_1TM/[A)
M$GV.YNZ3@=5*5DD4%>J7XLFP,R,$15Q I'<'IX'K=0G4V&&9_5)#G*ILM;&>
ML KA73F/Q+<S$G''I;"N1VWW%F6JE8%1P+KHI([+@1HL0BK3..[[(F7'C87^
M^S*=JTQ=ZRDRVI)#TPQK_\QF(*<8<WLW6*Z7#G %HA<[,0W@: 0"JB Y&555
MK!;_^+>?86] Y@LC0.V[>S*R+W^8_B<B$CX<-H%! AD)U374UAC?[7Z2E:1S
M>6-#J*?[1&CG4P0WY_<9R3.<=R.M' W8DMRSFL9"_?</=KB.JJ=-*.VFSTA=
M!(,')#G\2*^.VK3"[O7Z7/:9OW8])5^U=KZ$OV?_4;C_-U(3>ZF7JKAHT /F
M"%R\CVQK&/,;LFAMC'YTWVB419R=ZY/N8IT0A4HM /FP4$+)ZI3[>(->1*28
M%$D9YP4Q^.!>5FT@CMZ0KTP8+1RY<-\H(;?U9K^J\]NP.FHX'; T3..!S7"#
MJ"RE<0&Y1+O&XWW,WOT?#_#&"&6:72-E=G?"3(_I_TE5\O___?_1=U@ #0/:
M"P771E,C+]$!#Q80HZR476H';.D$Y<)!9E6D970]3":O"%,@>\Y3=( _@G;I
MN*"<$<.9M.$35(R2O?AB5@]"90AG^C;N;WUF/'FH0FTN2(UV+6;GF69^JJ$6
M*QX^5T),&8-YFI*DP.\H+L^7YS; ^ P;FXV38!637)S-G^/8S?HEC?3)IP'#
M854:\C'?-P0%GE5<>*<MAT?16/7(RIZ8.HZDP_-M*N.Z^(+^Z8KRN5E]5%-C
M>XSAA7-)K"R%,N/22[[?LI>S6H'.-/YQ!_,6KV C151UH\;ZIJ)GAT1VF$=Q
MUB\%ZL D"F^9S.L9#-LJP2-[IO1]ZB#!D:4M29Q&'_6\FL75-K-<GFD_"K:<
MCH!YC\0ZG,'G)6/_\A 52?$NA>O^-6B;N1X??SYQ/=9SE$"R505M%E5WO8!L
M&C9X<CT5BXOH:Y&WS&Y,J344MRXR]&^33&9K%OWVD'FA^;+S=&H@(TVT/L</
M]/"+"9)F\8O]Z'.]]CI\R.:HN8?)0^TNI^Z72Z:IF"^Y"<B-7-#S']Z;1/ ?
M^K:W5DB6A"@=[*MY5'L^D<B,4T&YA6QN%G<8\) U/#'<;?9T ),(DI2BPTP:
MP/I$44Q+3%VJKY<5VU4A/C9NX:P^?4D\%70ENG0Y=BFS>KH3MO=I-P9,E!N@
M PHS+:9IWS6R!H#)<"#4B!#?[]8K=I;D0%R9T\7;'_;&BG:A^5QNJ*BQ"@YM
M"^?VCUE 1F">9W"(V4O$G49J?GJW1E9<A]BFS8.GD-L>KP0EZGLA/*ND1^&\
MUXOB*J!#*:_O7RM[$)>V;%?K\/G/L-3<GI7A-"FN+JEJC[*UZ-^ZUN&O4TA%
MH9:&P^1A,X*H R4$G")%!TA#X+3>.0Q55.$EB&$PBDK#9L!UJ 0*"!_=Z2 1
MW4TD<GN*B1/ ,9>3IJ;04Q@>)2[> &[C*WIVSB(\78(NNVW_QT5\+>.?OO@O
M+\N,PF<2JHS\WO(:_/1+UA%*(Y@AD+*UC6DLOEBR]CFB-%XBLZ;<N%1[>7LH
M$C!XI27C=>C+TO@#,P<@G@XPC< -4/AY!H[$KB8XE+P[T L5F\>^ONR<-,F7
M89K?_*GK\&4PKB/B7^$2.F P#7J+#D"$(*ARV6VFQ#*2%X&-Z$.MK 1Y)$?K
M"+80JF-A[HUBLK\/#MR:SG,YN;%^:1R+Y6$&1+K7_E$.5HO5S]/,!K.N."16
MZ!W;^GP:TM7X:,#76G<XM0T].@8&D(:Z@QG93Z:"%&!7%_]H3-G86N%Z5?&C
M(0GO0JX3&C.*82V<?8 0AXN,\032QM NN93J#I'F-N1XR?R]NW6]-36F._M9
M CN]T]6D'AHKTHF@V:-*$R#)X#']Z*->",D&C9[?9,"RQE_XO^JK:?I>[U?/
M,BUFGFZ7(YI28UQ(K\C"I&0L/*&(:Y.F$K7AY9+_2G%6(IM+Z.HW;+:RA<0[
M7:\9B6?33 ]\WVPV$/-_M/W=+2D);= 45^M_DQY<AAFU+CGZ&[3F!>NZ >4I
M"@01;^.U?\&]1*QL?C=-($HL3JU\*GG#E!Q:&E,PJQ=LE0!S\3E+FEX\BNRX
M:2^J/]+O(!JQ1=QUTC"XL+X?OGJ]>R0R=7J775@T2@=(8B(_A= !>%,@RS ^
M8A'UEG*_Q34YX,;O-J/\.7GB],O6^LA[AFN5K1^_R?:]#:TLMVP_AXWNYX@'
M-B*WU;&@2X'Z0WTP=IVS)%>5-)SMNLT$9(PG-U&HQNAUEQ6@2<]*,OQEPU]U
MV</)!R$.ZW2 +!*L5X3<>M5_JT#_R89/'?CG[OATV( F69T4-O*$L0%-E-<3
MWN+64N-*ZQ*-\E^V OA3,\6B(3=.;B+<&!]7PP93 \=I'0>[5(6H-@3Q.1WP
MH2KL-QU 9*,#9BLW)T$+%? ]9P<E!J+:->D X^<('=B.&AC/"&%C#<8 VJT.
MLVAI+U$-2,I7UQY:'XH#MN:?<6"P98P-!76#:L'=\=HJ\YJ!KOC#W(-WROW'
M);&NJ2-EU[=\P9JT*<Q>; X'F9^B30?DHZW&Z8!:-TKV:K<BF;<>195(:K=!
M]?:!3@)1,B(?Z(#P:#J ,:HYTS0*6W%7 :S+&?I&?OJ[[2Y+?.SHC3/J4>-2
M9ZH?1(R$0;J5%1,=Q/$8"N\ KB31JX.'%+'(7O(E*-LAMWB-8"R^'O-5+1,J
M<2M#^/[;E^J?DEY#UH 78#^<H59T@*,G';!6X3E$HBZ@8D U1]OA(>2[@>+=
M5O-J>&#L=M@P+E3.V#(DWA*=LX3^DG*;VU#D72NR@N\/R[ZT#OBYNJ:D($)_
M6:)=$USTZT=%#KI?=@<?5I&I>KCKW2A+L:'6ZUR#.I#<<&!FQA?5('K=:J8J
M)>M<TZ:V*<4N5YP!,]2E%S>.S!P8QN5L\SC4"XN9M1GJH6G\5DYF]Q32+_/S
M\O"HMC:&@&:?5I;??9#?N)-VA^/A372;+\Z PB<+2A2[, $5Q%_J#%.=H%V%
M<.:H7<O^H<:0^0&)52J.F??:?;LT+4Q_VK)%$,]M52QP"$-52$#LMCA.-=8'
M:K5X-_%5F0/&7GG(0#RWFTN<^ZE^D]UJ&LNNO=*T;-DUI%'P+,;T(<U??4/'
M[:'J+'*]J.%P>SE$K!F<<@E<=RX2!>%@&.!^U'E2"QWP=+Q^SMAU8C%++UNZ
M^-;ENH33SG&Z2&ZDP*\[J].'--3EZR@&7[&%#3("YG%R8MAU@E]43>DZTG^X
MV( __H+Y3XE7;I<EC.2=O*]Z^WY.'2A6.M9I$ MMECJ:M24H9ZE^@Z*&@0Q=
M$+Z#SJ)P&2PL-=Y6B$Z ^GH%/HDI:FZIRU9^\=*:J99?<$L@5$^3>(Y4M\C!
M4,:B6E9D61(N1,%:2]%[W%VC*J/<UI7I/%GP$2!@0'8P/?-BVVT571Y5"G\T
MEF]#20CT3@M6NN%]T\?SQ8N)!]0/&2W^@MK=\/QRS#=X%QT0@^)">9B*TL8P
M/%K*H B)*6R("?!^6V+!9_$7)LLBS*RI]V,$W\Y;?P3<S%WW#3& 161@&F@C
MOZ@=P8)/EI<L2=55\]-''99TP%MC/(;V^ K!F-8G#3O0AS]%?<N#G^O=G9LF
M?B"LH"[-*?_E,/-2?1@2.=@86Y(-_"#V7N]%S/FMIP'*#?^K)Y@'"EH<F5$D
M-A%,^QDZW?@1 =EM*G)&,4;A3>#/+"%H$;+M/?O'T)W*F;L2SI(/+[KI/\CN
M^6$CQ2)']'Z("<WN&-"_HEZ>DG143'MP$W4\0S8@?L&+)1/DB%!2^)?-S-$_
MUB8%]@^*]<[]R%3[M)CA.YHZ^13H22HA&I%"*VF3,+RQ@A-V9H(V5*KP=PI>
M_.=/*R^SX&)SE.IE;IY7LYUJ#A$)C\-NP+KN(T">\&@TL@<\2\8.)"BCN$EQ
MS./5N[M;BW&B.O-FM?H*(DGY<6FMN:E6_EN?'=MS3*CIE !\#I$)>"%,C)2]
M:$A*]WB!?CM1WYKNLSJOE/?BM\1GSLK"WLI7HT9]SKA%UO'L(YLXA[)&] %X
MZ7U1T&@"L%U0A:K@#*^@ VYW=@!ILW!1F!/H[-K\>5(KGL>L';\:[94_CB7P
M)UA?-7:?D.5/M324?/GE3>!^?] @HH!!$O X6!VFCPKIG[].,BC2"5]4L.Y;
MC=E2[.D+7,[]:/CX9^"/+'E?KDZ%7RQ]@<B>9))L_R<\LLO&ZCU-A>'S-:QZ
M363_RN]T/Q7/6=&M-R:O.[W<??M05U#]@J\5Z+EB5)X4X6C;FK':4>UX[8$>
MGW.;C8DNA>Y'*4$\]C[NQ@\?GWEW97XXX?;07F:7\F35@S0OC%'()D,J=,(I
M/)_02F,VGNW3B$/O91^2A%<D*E%11YGR: )GF\P'$1,/\?!>.LX55\]-?7IP
M8>_"R198%VQ'&V6P+^8=RM/DW/TQBJ,BUEZ,XLF?9?-DB*E;9:Q(]<,+<6=N
M9G:SA_IR.&WAIP0PA>?<(JI7+A?<U3(0U\%$ZL9O^)\T1@,R#F95;SYY:6@A
M'I104;O#FE#RKB&?($SL)NQNCX9@,:?#AM&J"5 I9S^!'664B%URC62A7,IC
MJ/F-N7UO6;O;O*R\J\H?0$%"#[)G]6R/;1IVT;]VJ*'6;=0?&2X*/*\#=G*W
MO4_<W] !#86@?SDL@39TT\=#JZG(?D^D[OD?9[@-87=.$:>#8) +DQ*^=W/A
MHBWNLP[[V)>\GNYL.Q_QH2N)R_OO"E\#TPP,I!B-GC2O.S23+:P;X8P.G-0/
MVS9!WMEL 3$CFMYI=RM[?,66%J4V;6#(<UV8&!@'S)WC+"/86>L%VZQ+UUZR
MB8;T$,.S(?&OV@/*I>47"I,2Z[E;G;P*F?N?@!4T'K>GE3UVF"ND$=M5UV2J
M/3.>95;G:H.$0P=3/%'X1Z9QP2N? DH\@371O;9#PDW9+-LKR%;G3)6SM[ZI
M"%Q^IR\#6DBCB1(PX10.@ES/O!S>+:9-L. Z0I26[($39MG^*%^*NW]/]CK^
MJW3M$S_U164K6\:2M <ZV?VN?@,[35$F=)019-T35%I$^^&"ACNODN%#J84N
MCW^=#7KAM/S+H"6L&\41)D>26OAY!!>@&%= \A2GJFV.MC2*%NU4/IUZQ"V2
M=L=IB).=>0'58R4Y]+"^JLTK[*3$97X*E?4S5G-/G^KCC58.F N!]0"UZ("N
M2Q3%DCF*&BD'IXPTW;9%<(6&[ZA0YO\SDRMW&W_S"W*/QMI>/#> ,YW%6-_?
M.Y36LFDD_%&\P)5W3EP[;$^&3Y7"!:<9^O1RD(6+Z8"Q0%E3DMRY$X88H0-H
M XP\]MFORDOV$:1=L:^?#LA1JNJ0HN'H@.U^*PIO"Q,#8I+DFQ3-29:L'HUB
MY"K8AN<#7)53_Q['T85X^(D[Y$#Y1=743QMYKGA=X(?+YU5>]*MLKR>\BB,Q
MKLZJ3M8@M>)*HJ%\A'/8/M0<-!1_9$8;KZLQRVJ)?VWX(X*4ZR PHTBXV.F<
MPL'BPP +%-_0F-:BS_!S _QT (\E2))R(].0]^_BSCDW[DB%37XL==SZ\8?0
MB$*:I(SJ2F[5YHRL'MG"#*I5IG@- 3/>,2&;05GQNUNV9$ZHNVFTJD8]5V#>
M"D=]3\#+6LFF/.R5U.>L\35:)3)_%JX;]06!MW+(=H'["SZ=BBPD< ^PUBU9
MF:JC^?PU>@7.-)U1-B@S/RUK.1Q^,36BN>/1%Y%3#CUX,-&75$?8)())%4Z$
M5MM)!3]XC'G[5.I7SRSN!RVL%8+/>E\8Q02UPOPFS94%SJ9H819\M@>JPGK#
MF&I)IF1=J#;!)'(DNLZE<+/%OMS4)^0%BW1^[JB=]!6+ M?OG5<>?)[P>?CX
M_=\<,W(:4H'<=\!;I=;_R,IH:!<&&0-/;>%T)*'W2 V$<6(EZ29!V)B:TQ:"
M/WJ,IY4P51>5_O&P\E48+OCU-A:X5;-MH?^9VW?O>[!C.T.!SI*$"1%ZU*]0
M/O)=BLB8 A1<L2;DZX',9IH2;$-AH&N1'YI<<B?>/UN(O'Q#2@#$'B8'=:0B
M41X(MD!$M^6\/,D)+]7SS%@KZW5#V33[/5YGRUF9UWPWBGK=178N+(@AB!V$
M@'[8[!PQ"H_H0[%WX3A$H.)DP?KI-KGB(?$!=]*S\6/CE%NM@G;OSHB??J(F
M01.148R>3S]HV5R^/H+2A;XN([9/M+\@.D .M%"]&+RYXAD&D S@6-2V*A[4
MF\=>,R$$K->5_3F:FU0MZ?S\+*&\-H+<OHI4[PN+H$BG=[^&*N,'\1*-XX&J
M6YR)5RJ7W.*WNNXDR#@^!"R>2TT0RSA>)OQ#IN@"'8#NP0)C="Y15$G6BQP"
M)"0829900:*?*(C&WSPSHF.7QDG(T^T$)&0"K&8Q-?"NO[8+4ENC"["SD+'"
MEBFXET36.Y4_-<9*([?UA9ON7?N3Q#XO9XAX[57AV1$,&C*!?D^O_YK><>(_
MAX!['>QIEZ/48([@8R.#;54ZP =X8BT:EFRURK%E3 ?(2%,9H;F]R+  XI6E
M=$ '0WB")"Q@1P8T#5B.)"D2:P_J@^&M%9FN%9RVZW/"-DR()^G]Z7CQ\H_
MG%CYS/.U)U93\$;7#$A5V \@?U4USCJ?#GCO>?*H\E1/H?Q:CW:/;.J.W(IV
M".VQ#':$S .F ^Z/@!_3&%IO#P+C1VU93J ./FVRHG8L]^"T+-">/@D6(HP(
M5,R2!V^,)';P![::X1$4KG='3VJ;4A6M]">JN!\MW9)O2?C]66S&2NW$ZC<&
M;P(_L^[ 2DVD 55RO$0>;Q!'RAU^EI\QU:I5L4Y^S7N5PYEO%?6-#NC1!"7
M\?_9"W==&ONHT/ 79%ES.SR=1WG[NQ%@MZ$1B74 X3F(W8RQ/0,R);\'BE&8
M<(:7?^](QM\GL,>_J)MSN//+&2UFH/>23>363;5GE>5/5D=[E44LKZAZ0VQ_
M_;("QX7!Q).X7A>95#VQVUT.L:9=A(X@H<8,D2K52P?4JT9W*/WG)P<27&M$
M.<?,_JJ9^]7D]W/P6UUN[2TJMO_<<X<^\&GH%1*" "$.4TNUU!?A[-:!%=B1
M3AB[;8W[(8O-#&3O<XJ0I&.:2UQR5G!Y 73VI=RL,FKN-AE(G!J%N6%(]RB[
MVW*@!CJ@6X]:@ARB _0S0U%N>P]ADUXC'W6((8[?$FP2KM1!I\ AQ_;7#ND
M<6LC]8<AI44!)-OEQNBQP[U="N\<[;\0G!OU=2V#MS>#3^(Z[/_5((8-)D/_
MHP.J+<$G]CYV3<E85-:*'Q8V+W."^+F.>H9A6>_@H*;0^.<\,FOF).?CF?/5
M$^_<&M&(E? _E$ ^GCF%[O =>[,9"J2QR90W?':<V1#CVM^Y#V4!?T_@-H =
M>I 2IB?@-0A*-HQA'/D.Z  J9\.^!&SODPQLB_'%Z*NM-1I.&:W#T&8IFN$^
M(]^W0!EP*^K=@GF DX"G4&XHM+@Q@6\Z0ADD @ULKN6?\L\32S+.:<IWE@U/
M^2Y^=ZCI8OG8L_0$%=,,*)1:3M.A@$D<A-/= T2GB39);.R;D,*)!A@?YMCT
M8LF'?B/^^:=81^QK_3%*>->Z'4,EAMA28U$+^7E2I&E&JF+>F)<F!> @''4]
ME>LIL38#;U[* &K.U\K=L7*ZM0R\G*?GAQ$$O4#QA,V"ST.-%Q!O,1<H9LJ9
M)25_#"I(%;TJ91 7B"?G)Z?8C#]:U<UW;@FX16H;G&W?4CCR#[ 7KQ@]]O.I
MFETS^-LK6=LR73'JB9)H<?>#?</T($E]#%/9%=T%](8P3\LW)&IH%J1=N67W
MBR]F)S_)<.>V@RX>28RBYJ.>@<_,4D"D</SUU3Z'B[_;^AH(S.]WN"[?JLL*
M6C1R>IXI<8Y+1>=(>1WU[2&\$OJ L<_N(UC4F< X, >IFW]B6\&/S3K!QR-H
MM7Z4^7E:?L1 ^C0D>YG&R1 (QM5T@%ORV5D2&S$6;Y6DH.7[=:=!XTNC;429
M?J7_]Q&E4FM"_^%U1&)7<U_ M,\F3UW#1,!&P]PP>,=-5")7NA'AIM ".08-
MBW61@5 _:B[(W2?>08J ?%MOF\Q.L9ZH@N&\F*LZ-"MR_/8F6F1_X&N7Q7_]
M5+DCS_PZ[#MB>'<6UCU_F5J(\H[?1<L.=5IAV&E &X]A'U=T[C=DTY1DX']W
MS;\\'V2WSC66GHEO3C()2YEH<+]G[('TLF^_WH#\*!4T8KN)"KVTW$!)_I6,
M+D=C< @*']L"Z"U4E_MO(,1DW-;"5C/\8Q&<>LU!%QNN\NT=AYU3>]A[2 L_
M'.?%33:8?(&=4!I:$T.OC&'/#,@_++(6-#W+:8B(!RU\@9VE^$ 6=Z/!]9>Z
MJ6*FG"1$Y]YQP(EVRZ7,O:%7/JD&/V<PLM\>V;YH/K-<&8A:*)^"<2LU:RGC
MA["FB<KPN.F;09QKTY:OV&PU(_:RLBU2OB6R#,K'I^@XYNISU9>&2%2/9TR'
MM);LV_A;3LP'$#>*MK*3VK,QX_;0HYN@A90\8$2W%1A8KVGIUC"N92+Z@1%#
M@86N6%XX5+IREW1-K.HZ0\Y,:'QF=0A1>&W[<5+?R-FV&,!.B8/3SH^[E<VY
M8X1RK&":CQB4_NY\M>N\,'2C]KA$'*'P^6C8CH&4A[8&0:%DO;F?X=BL7ISJ
MX]]EJH#D'QF&/\*V7/S7=E?)5?]=7A16J2>.F%*$B^)1>'TZ@&WV+U28@$C>
MZ9X/K.@5NYHM]U=?M\4UD5N5U1:A*)\4:LRAZQ#)4&1V^.NI./C,:B^ZG5KO
M4Q88C!L[,FV65>W=?B5R_=2!<VJX6">1;W^U!W0I$$ECL5I$" 6"^VCLTUIF
M>..G*"_C!P3^:,!'=,VI.Z$_2P6^?KW5*O,S).NE5NLB:IL+-T*2L4PL@<J2
M9!;LPWJZCK)^#R,"ZQR03[UPAC,W_BO08#K'D4B>^7(J.-VO*C:!CXF2[06Q
M.=J&J/@84/,*BZP/T^D [H"Y]JG<03K RY0'3)JCL5CCX=:34I!$_8.UJE=:
MT0KBU#R]ZP/-:H-'RB?B^*PN(=,>6%38)7Q_M)=H=5;1^N^Y>R+WWIV^4',H
M_[KW2"*;E$-CC5T(48S"?#.-;!,OYE<1NE94M-ZX10<$I4E+W!GXLSUX,A88
M0&-]^L\QG5]W.$>:Q&_V$6&<;X:>;HOG&#?$0;1=S.X.O+J N.JLUJ5I\5;B
MZ%@_;^Q6YI6^77-:QP8%@82G)DL47-">^@T9GZ<UW*9PE73AD30V-IR)^)W$
M%_4C_(%!",7MJ\+BMS[RN[XL2/AT50%N#9QJ!<;!ZP,Z,;,CQ \$-M)M[*]F
M MMB<<VY] H#K+M+RX?K7&W-;.JLO;+<5Q-C6,\XA3^A YXSP /GU!&'AA%0
MVS<)!G=RN@/0!\!GOY78O@PIMU=S!=1^N_!%PC#NZ>FY0J\O?",Q#$JU.*+P
ME!"[23T(RD.\97-%H%7_4:W=^KSTV/;4XYH=B4]FUK-/EHRB3;#AB0_/=U5^
MS04Y/?3)*!U:]D='$F<+J=HFDKMDFU2[Z0]AP1++>QZH3R'$W]2"#DVH*_4C
MU(JY@JQI1]'&RY!O;VB@8OPXIQ^5-L?T.X6/7;K@/-,\0[H05C#3=D_<B,&R
MP;&Y\4#2G6U]HQ%3>=:]9/0^\0LA:SN=K$6"FY*L\7.]-N">'&'PME=(G\,U
MI*U%GK _]WDO"^O>Z-=RW (IE\Y*JR,,<NSJIE$+B2LA,IF!6+PCVO#)ZHN:
M!^*IIDTN5[_U7OL6F %YP=!$UG+4=41JE8Q43'[585C.@*D#@B9R!"))@2F?
MP-T(\CG&B(JXIW\?I>?8JJ^<>94H2-@,SSY>I+%,TP'7K/ 5M*XQV/K]A@,G
M0.>[6QQ\:TZ/_<I+=P../PMHAK!:;:'$]Y&T\^2B.5*!+@E)D#-/](9:5Y$R
MC4-R5@5ABHZ_GO#\OOVS]V0;K NVIHW":P?>P3S('.RV@2CRW7D39HHGOU7V
M?YM,W8TW1G>E>\6AA9%=/V2^]T%UL4!.4@&-Q8L0,4#,NXQWK</YA'=(=VCD
M1C7DWY'4"%G:-AAD%9 [/VN?I6-3NYIJ0].B5NE<ILT+K492^,@:'@ZW\*ZQ
M_$6BOUH7<Y(/))&QNLS:HYHR=C>](H_4+4Z]9*DLD#0S)QJ[ ,E^%0[4RIU?
M9>3T\I6CUP$TYUU(0,O87VV6.6,DJ8;!'7%-WP@2KK2!+AU@7.CU^75=LZM=
MO''D8&Z)EJ!3AQ;:%0?&#K_?T &\[@$G.E5N[/E%F$[BM"7RO)BZDY_LC\[#
ML]QR"R@TF2'6>\'A#.7F]A[E 8H\$<4D]B5^"':+?:-VQLCO%6M^PE DTT<E
M%UU9%OW$I^]4'8%<L"Y;)9B0NVKPI>[DJ#"5Z0Y)N][?:(\ FS>NFAXQ_<=G
MS0VW>/?KI7_=>. G*/?@77$&>L4DP L)(P<I'VO'!5B$%@^6SA+KS9&#)<=?
MDRG<41NAY_1(Y 6U:@GX??QJC,C36&'->RP%/C]M\T]6"ADTK!#HT#V],)),
MN9_)\!B>#J342I>FN?V/S]])W1_YXO%G<;X]@'B*^K$!,]NZH-,T?]-%1Y6@
MUYM=7<&98NA%NRL>^?GESUL_>[E5U0&?G8^G*5S)-!,D0V$0U>QAZPI5?H]-
M'GY-;TU4NT89CX.5I=<59UL^+,P^\#2!??H1AG;@'-,R^O<##377ZU!8H/IY
M*S*\FBLKMBWGTU+"C9TS[-&EN(XJ:IO"E39J$DU!@B!?VL([QO0J1?#EC[#\
MM^+K8.6P*=1>^NXL@M8.(U8>'DQOCS#0#"/XT/HVX53FMEDZX'NC0P/L=A$,
MA<"/4Y+3MG8DFADSE]%\L#S[QNJ.Z9'5X\L<G:? I@Q9HDV1*2$9$-5)SYGA
MI^\JOFF8<'.Q$[R6FY TO!'V(I27?7)O/HL.D#;-HG7NT0'KOZ>G_[D#2C:0
MH3HO*8 .3CGD>MU4@Q,,&'9)30;6^IL.0#(6HV<)-IO3K7'_W\W?)*27$T=.
M\:R)'V3O@IY2E:=$2O!-;L/;M+G@:3W&6A0B$VB_:!>;I5'NT7V/8I8'?GZ9
MLW,^LQM^S%I!OD$'_+!$N</(3'3 UI1?"(V-L7S7YK @LM 7AN!FR*NHCW;"
M]O^D;>[$89^CXCSX1'<%@[< \WEJ1/?ZS"[VW'(/F+\^]C'1$L;^M$)0V0/Z
M_?'@H_+>ULM^ N8&V8'J" O&B-_%0*T;D$GG84[@&(*NT'O#L?DMV5(!P*GG
MG:>1(!_8[$ _D!=Z$3^- _48FDSW J/W^F >SA\Q?NSB*>4<.+_ U'>K*TR=
M@Y?%'$9HK'0 5D'Q@8E<+^:"UJLBBD'23=YYD:1^[>)5D:MUWVN9I*84>D9K
MAA7]'N8$EQG-#6Y-ARKMU0SS+I4-*Z@[(M!S)7/V86ZW&92Z7D<X3-YV(?A8
M=I!,<,F1-&:"2\Y&ZOK)KYQ73&V7C#6\$B4""\P-LU_SGMHCXN#DTR3_'_LT
M5B:R.<2\%Q'ZO.SOW)TEYZ_#,!EHL-N@#=%T1E&/A,&9&/=C>&@W/#6FTB$X
M2"(:^.Z0+?9"\!NF^$N<-=1I8;,G;V<L'76>.S#LS%DR'9"^0*V";:G0 2?V
M?E:F?ZH>\-<EJE\GCKN2B_(M@-JL=>V[YNS4H\G@3-0"(@LIA(RBL0=*CTAH
M6,5 S2N"EFN8WIW5.QLPD#>PP12Z_V7-!A9YH'D1^* ^;N"_;^$*7E7/'Y7Q
M&N9;/&%_"V""#C-PP4O]=(A"WUM(K TTN+AH>A%<C2BZ:W>EZ<J#P?-.G8[G
M74:$4W4OBR2+X7<I?#WW\/#H*B7%6/A%+:\"RD-DY//6,87ZI2=-GR]XZ\K'
M7HW2VI;V7P5TW'I5(I&OIGV,V&AVS*JJG*:H^UW]DZ_SN?$ .HPR+NY87$MF
MI?V89R$Q ?MV>4B&&Y9'.C>0S:T3\L6Y-F-2<W+A%SPCGC$;]!MA:];_%4,]
M6Q1MT$2-]"MMNXL?^-)145;]99I;8)%_18 R]O,\NC7 >>F9Y=%6E0>AHM^&
MHU\Q#LRW,E5_4;&W$7FNA\8Z42TA4V(;\V>7"W32H2)]_.2S)I]P9)#!EAR>
M;$6J8ER_E12)%676%:NK^+/1.)4#?Q9TP8Q+T+NKIAZN7_BAK+^E 5T$# @)
MP;#<\O23;MTUMSDZ"E#M$ G[(W:6Y)?_EW2;^)P*A[HM8MAGY@U'7A7I:OG[
MW$ZQIJQ8+W<M4CW+ (R751SM-YRK0P%ZGUH#<LT%XZQZI'4N,7B-Y6)EL%[M
M!DN WRO!]L9]Z*KE=]8';XMX=I$.?\%;Z>10DB_1B&1<3 &2LO"8?@VI^ /C
M^/?\)_Z?A)57/\D9"A2FZ7<->K4QGY6^TMRYB/)(C@5QZ4B$C8$!M.N!BUU6
M</8PX3G2U[&A>W538<:C(@&/AI2'NSDOA#WK A!BFKX?YU1G9,J^3U]Y8';4
MX@_^6O,9L>795VTY44^!*7B'9/WO9^9L0/@GB&-I8)TB-<F8#BCP@FC26/-\
M"1%$:_%4QGS^;QJE9?48TSIH-1J>?G0 @L&-KX&A\PZZ)6A3/S\E_ZG?XL;R
M8]^>)/(ZU_%T DX;*1^W5V(V,/@GR4G#^>NU?SW^W6M\IW@/[*!O<QLQKZCW
M>$UWL>6*_,M?7QP9/&N)@L@-*?(_I9RO;6_!3X4'\5YRD)JJ6MQWS43?2SUK
M*,#=JNMZMGJ_P8BM51/$#%LH@==)=<*B-4#OVJ2P**'9=:$7MKI>MV8&M:*S
MLO7)!C^W7AM1F &G<Z6$$B>#2ULE5UI0$D3[PS6]A^Z*KDB(U:Q._/#A5ML(
MLN/6&NKB&W!X\$K.XF:()D>4OT9P7XCG3WR7:'V(O_[7J\+E7RP>&G4"TN..
MV;!'V[NB6>\/$!=H(\ Z4)*6]<*PDK P6U6RAVO^TPCR0OJJ1-I_"0)IQL]6
MJJ&!I-Q_5;%%J7$4*/Q<_;:W\5]QLT;%XHU'!A>FBZ^F*[TJ-\0F3?UAUI7_
M<FJL&31+IK&&+HQ$,9Q-FQ1^VI;DLACO([HF!-6XMV:CDR&2]Z;F\ATSF_NI
MQDZOS#\QQ1RW9"?^*?=MU1QX6&OB0 N96S&N?:_.G[TY^J)JN6%WV>D]WC1>
M1R*PE<;:A\=8D#XM5("C6PZG4M7B#>I:C=.\F')W,_>^)W5]3NFDSG.%F6'&
MZ8"% OA>(*A6E9K V/BB*>5E,2!!JE?;F,8:@(_& ?N2+](!W><[9!N;DN^/
MKJ8H-69BW)K?";A*7'A@W\-Y1_W#2]2;X!$*G\; $SRL%\'(M[@1HDI^.<FV
MJV6T:7)I'#O_6[JI(4-7_51 3*ZNXZ7+I_7UO!Z8E<A+&KD7J,(4@VV/-Q K
MW85V10Y<DTUR02>AZ" Q!C*9&&N9KD"X1'U?3P=0I6WPR23IQJH@/_*UL.$.
MSB2<K9=J+[='12 !7\G]ZW+YP*;,"[$U#L]-F+=/,DV 6L28VN?@D42*1-;O
M]=N;EIGSED7<!AI&HC^B+I1OG7-47],+0-4CMP;*P\;AWU9[MC5[_JM8O'C.
M:-PO5%)(5R!/K\XB,$",M[8&;73F=;6AH/((T^##BNP6"YG&MC33/5ZXMJ<G
M=]V;#0G*KL]/\IGNL$OC6CS87,6>$X7/ED(//WF)%E75R_*))_+*OCWW#3$"
MX_-HQ+""%FK$V'W8]1LY2>-WT^P=YX$9U_SC5GTYU08A[G8GWZ3*AMT##1@;
M6,SP&)/)4;2;%%5"8S1!MI\/V5+7,.[$-6]8X)YZMK9_J"UAT>.,%G\%J!;6
M_>\.=#W'MCUC,B#NMINO%G)OS0]7:BE^P50H_.A_U"]2 >BZJQ3M*ST_EE;@
M7AWS%\=G_/<ZI&.]KP(Z!X;?54H2>X*N\S?R#["A5*'^. >:=I_ 8E +=?.J
M+2BD<:Q2,D<?#+)RW=^$**<6D?RRMD.GX2" PFMJT#"%8D1TW,V_O;650J__
M##2=:31<29R,"A:)PR<SH+WWB2,.3)2Y1P=\53HYX2'2&+NJ_$]I/_M7T&VL
MZ::0RRCD6/AXWB 4=#3R&73P,3VLZW4;IF:DVS5U=H[,+CDD\OET)T<G ,1Z
MU(('S@!I_V&PJM1P<4;W[/:3=GD#0LD&'7![J =V6BQ^#Z2"6O@\#ZQKH3;
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M:,O#U0SXDK_,GJ.+:E5SV([A.@G51IDB+9/OVE$8F?>=;>#%%]>%%GOGU;Q
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M+>J6+R\L]9,23ZA!M,BM[LY$8$=Z1Z)A9[9P)"3.ZW%OF-*$&V1V<5+19ON
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M@9PW*0GNC+=A!ZL"X0J$W:E9E'[RO^>21.[;^(V=2+R(FN:5;'/9NQ#',2_
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MRI>,P.RJE%MSK+=C+ISV]]GVEJX7ZLRV-750^,J5TPY9:@DA]R9+U_!;&O$
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MK4)"]=# B,?J/R$ZFZE#'3W''\[V2SV13QURS?TN9;')\C[*#,C\9G!P*1F
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M0@-("U;3 &)V;\D2E(8N-NBSF9S;.'"_B*+-C-MPBD7)D\;6(D#.^H"V6!=
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MQ_7,JPSZ[(#F29CQQ&C5Z#&J\H_#3OWE$,3D7T75[<14OX;69$G/]=3#![R
MM0_9U;%& 8/10VRLC3,24GX25X-WD07HZCMOL4KG"R?);<=[)M409!6\H2>
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M0S+_.-A\BFXF#N'[>H  Z&6II(Y0^,(?[5L!/)!+'MGAS.(F/-YL.@^YXYD
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M#W@O<:;:]2!Q9IT^]W!'B2!/8#SWLEE4%5'*OE"614)K_J.OJ[_>*1\(<;/
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M6O2]+[O(I04O!6$J2M4[B/_: Z"))JOU)B4F]EV3BKZW^,_:??KB 4KA!D=
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ME)3S-U>IYD&D*\]TA1:JGI=0UU'AL[ !ZUU@J;G!XV5V[!0-T0&/H7$6I32
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M7*H?2UEG']NZ9O.R?WM_ @"096H5GJK9SM1UD6J"CB,$[Q4HR"1;A!ZK4>F
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M3DS2DPV>&(=+/@["#I':!T<:,PW34XOM,#:V6E 8E"%BGM>)(:F7Y\)C]A8
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MRDAM*T_CPCJK$T% *AIH@5V1TX-=:BIH[PA+D 2^L"@+F,Q#$CW]+\"K<'!
M.EXB\K>_1\K/;ZK+<4S]ZOU%9S9^@91+E;82,Z?G (5-]NDFPA#1_LQ<9A;$
M-%[%85T79>SS92LI*.?@5O\,BD]R.^7"K=^75O_(*XAW>\\P8X^[D'$35&^-
ML)#92PZ\&7T3=;-.[7Z++W?_FK/Z1Y7]FR(T%6YB)?0W.YB(0+R(<10$9S'
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M"Z?0[Z3BA(]D>MQ@^*$WW<;K%I7(^E@A9KV&BW:;IRZU=C-=C-+W=-]*KJ3
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M%)W#F[[[>A847S"#440/_WZNPE[IM+.O:WX#UR2^ON^%JB;>_#115BX;TQ\
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MX2MN(1)$.SNK@\NX3P/AA!UGFIY8N=N]M) O(O8SU]#_[/DX534V$/37)EB
M&M_%N9LRLG='I'TUY8%'KVT]:^VZ<N_?Y0RF:;@UK*/EVU'MC]S6&5)Z]0KI
M;PAV6/_?NXX6D$/. 2L#% [DU%4PF;$<TV:,M>?IQ0A-Q"[)"*,=AO="HP_)
MIN.W/=<PG1D(+Z9&/BT^H;M*-T.P9-FN3*6BY"_0QC>@5-<<BX:(7!JMB[?
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M8WVQ3VSZE3%;Y4JF!44MK9_J\W8V>X72$@<@B?STL:BG2,RH!?$,F\LV2\S
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MB/.,8R3BW+I!8VRF5,B/Q(3B0%*)K9&NO?8]*F]56HAMD3.A\*BRR\4V[1+
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MH"N:,\"H "#/\A:7W@\U%9RHZAN7JN2SL"VV:^2+YD.JJS._?8Y<, [S4EQ
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MK+DE^XN"R3!Q3E0MW8N":T;QYX0#A6EZ=ZEF#\7;)#%?\$&5*'-^!2=*R90
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M("@B)[@54)DW%A1A6#_H;RCF96A<']>FF?57X?*-\XOE<:<>AYXJA1ZC7Z7
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MO 5G&WV;Y8TX8R1DXB,4+OWEU3.Q:X#;4JY/!H6/T7KQ+7/X+J#UZ\4*V*#
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M3WDMHJ[36YW^2=;$YQR^C SCPT1O(M]("@W7S#H6&E:.E'VI/^XO:5KW++&
MP_[5 LMCZ'A/*=%Z6'-/:AH*F%*D]D;10=[G_KQ;LFEJRJS8.JIGZF[GZJ3C
M2(.T3TE25]_7HZ+\5VZTVGA*Y&X8-"8L\NMY42M%Z)['VL$26%&Z^@CX&]R2
MRM.2+3(,K\E<5FO'>+EKM?\>&9>.:FYN;N?F4LVKXA\U"U2R3$7BK>B'B=J=
M_TG49H\%,M7MD"LZN;0SVQ\8:7#MPL08+0G*6L267AA0A*/H2C7M@:6^][^7
MG2*R@]T' *NK$+3@=2^% I_<]_DI 5J1N8W=I+;>2"UV1"^6*_8A]4NB7*2?
M)G=+I\8C7W_!LO@A3P'OCIM)^1=+Y+HLYZ3_ <[8_K==AT4-?UR!P&H*!K;4
M]UNQ\\)(Z=)\*8.M510:HU02^DAGJ'0K5(44J/WRB1J$LV2Q/#]<*ZJ4"+5U
M3_.UG[+3<?=D3T][^4=**J'@ X6MK@BQ^K]X^\Z@)L.FW2@J"B+2I FQT!&B
M4E1:;(" @(""U*B =".]A41!0:G2%85($ZFA(RT10E4!Z9V0T$L@H81 VHGO
M^;Z9<[[S__S(3&;RY,DS]^Y>>UU[;_9>4 J0S?F!.DY_0?4G<SQ*OD_")#2!
M",:&EZW7=^*>3ZPZ<Q3*BR>!%8BN@)SB5;&W9<F.WJ&AOCR9F=5>JGO"I_BO
MYSXPTKR"?P@PD'UU%'Z?^3?K*DF6&$P+M*/*=F!$/'<2PD.4$\]2TC.@[Y2>
M#6Z\T/HX]?;3>/95X=24+RK/+N1*W/5U<.<.I$J504 -BP>(#$CAP;1N</KZ
M$JFXA04X N=Q=1 CZ10J5^"O.X;^UC99W-!,]C[;Z\Q_PO&1WOWK$P\=725"
M1B(_D]G> Z\@\'T=@]TCQ5$:!H+OW*\=]7*J5P9'_>(_PPY(:T6C5%'9C6V5
MYIQH?%0G)+('/XD[S?O.04B#)ZYOK*S&E%@,K6SQ?@7[)(VK@21N)?%J*RC;
M?YKJMYX!DB63"3TRN$=_=XVT7>[_$,]N'MS@#W*2+%HV3-Q1ZZ0'44OSZ.)4
M6P+OZ54-2O+7:5UG;T;&0?O02WWOH/+&=JY-YYD_5F_.?CG[<"B],B:E0<A$
M.2_%<6A'3'$.0979)&KIJ,(D:DW%83<'=C'OTR<RU_OR>\)>I,\8?GB87_3!
M\G+N1?=#L4@+AT :!]NDB!H<\6U@L+=0?I[DN:M&6AM\%\T"@XQ4) &2WVH7
MW&%)3 =HPP0<_#K#_6&^F5]27+,MI(  CS2S"XR 7PWB(*CM4!P$_D6::3!@
M6@D=5SPYW2VRDO9X^AW09MU=3]"*CX")!Y_2XBQ13B9 V.%+VBCZ*50Q7%/L
M8=T;\E3JY11#L:*F,?Q@1/&S6^Z/NM0[G:KW125,SX5?OSB3MKJL'N T9 81
M1K288-SCC&:!+5V>6MQS$BIZY%T&G<_@>=4MF5RAF,XK;@-GI%/.Q%G]F7R=
M''[J>*_OO!6S1K6 \QIT[0Y13+$7+DYW)8&CX>(R&.<Y%._JP8MD1P'W@WPT
MZLC?\?)W*I_?WTD4Y9#:O%BO%OB 2B2-&@SXQ5GN$8!O/7=Z'&6-FW^,$)/$
MUR4*NGUH3BUS"[(9,][SGZ.@:^3+;^H)^;@#^JG%Z+*)N*(Q\3G?XY5;=%SU
M)\[T*M'IQNL=-WI\V.IY@83K.!AT99ZE1N"]$%9VR04K(<,U?^8D$ 'QM@GY
M^K;^H/P#B69!*\4Y2#3S!-7]O(XR.?XU_NFU PRQU)Q;FP78V(^MI\O;G2J*
M7FH2)PNT8OA*G)I)R/?5"(%QO4G).3U,](8:]'9_%<!C#D-5D"7:%\-XJ5[Y
MRUD <FUF;E#?@Z'<NB$OK[+S8883[?C4IA91:<+1U)O)KAU!YV8':68QJP.T
M:<SL@=#1OKI=QPT;Q6C24H?IH:"8EKHLF4$M7WR/!7;"G< &K.IAXF)US9/L
MCT97Z^^>.VU"N'YN**.SPQ00%(C5"'RW"SE+A=XG4?*R2VH\>AQF%(V^ZMV*
MMGP9?WQI0>9+\Z@+(T E8BG:HW"LW]J&-WK'5,C5V\-&N:)@34RKR$'[=NN*
M;)V_Q+W$$^:<(^5-BO\IH,77%.X@>*AK6(=SPU^/_'Z:[T[94^G@-._/31/9
M$_2O,V_X5PS^86P[UX?5YFR#D!)6$7Q:L@4>DVV(\<"0Z1(KVS[=K4]8IX-G
MZ;:<1IG3@L/.B7?D3Y9<%3D;KGBXDR#[UM_8PZ9_G6Z<.[TZH1 Y?.D<YOU2
M^1$GT3F>AG/ZX,N"P8?^]MM!WC#5Z%KD191R*AXI&>329I-W\],EO\QG,ZM^
M_X N3>3 2H &@?G44GE)LNT91,R[ZCCN=LAX'4^V;F$??_/P (I;T$0_ WN.
M"*!T?2]4,SD%?887ON%S<>([*OU?-QF;I@NE=X!>.0@FV)(7/Q$@[_EMIQW<
M1\ 3IW6RQ1AE-R6-_#5S;XI=UGGP]>JAU]$'X76%QO_V;AU/%'9^.BIT='>W
M]I.+VO1"FV5:>6&P2V;K!;E5ZP1 :,8<>S$'\77QNQ%Y5 \"[UO8G2* 0<4
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M<8;8#C&>C<S<^R,'F0OH@B,?QGYA0FY,J5]\.G7EB*75GD68.3S=D 7P#<!
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M*_90.M]FYT1?+/BYA+[Q,&IAZ"F)V:B>6="M<L:5V/31Z7%'\$3)YNNQTYP
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MW"\YLV=5<YXX[WUV;>OZ;(12UP/]F:VQV'B/ ?!LD>0)3 4U<!83BP8F,!7
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M4H(^53>O3[)T#B7H3HE4DAQ^DWZ"ZX;">FXJ2#8M^M0UYXK,;[6E(2;IPRQ
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M2!; K]/W/^=!4]?:<9Q-_ZH<7+LE;I)7!@6L!RYI:4.+E-[0L:H5+<=O*;
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MOT5[#.]MN/9V-R:!=RT$->$WYF\$V:TMUJK 2KT+">>;"K\A<8OS6+-+.PM
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MS2YG)>O:K('2(W12\PW;$:0+*'IL#8J?'$$(Q\*/L[ V,3*&.&<8BSA%'IR
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M$M'C<@SZ8<ZNMN?6;C%^AZ1#5B=LVQ"1,3 NMK3W!5.JRX9$J>_:"_'??1B
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MCOC4]OMI^%BHROV=6Q*^5X7NF:A4?P@,D-]$CH-)^=6T0CK'A,>!LH2N\F#
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MW( 3X,17QBOT!^9"?AA"[*%S%N! _Y6B?[R 2XUJ:WDW2H=> U_VS-:1CC1
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M1_,Y^]F&^(LV9IZBL[3M/(SE6JE)509"L 1B!CDZP[1M&<1B#XS)G,]Z[S
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M"/@J*3J6CFBV5;-@HQJ/ZIZ%JK?P3W@BQ.R>&ITSNS1J6A02R'IJR4_C7O?
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M6,@ **?Z&$JTA\N.ML@@VYZHT"TV*UNW8)=<!;BB&7:T]+R2\CX1[:ROU[[
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M "R*3&=&$:8>,1+R^$A;G _>**#&#W&C.2[0RO'W@UN&75ROWJAA6I4&Y7=
ME:G;@QCD5&3'"3D>X[IC29ZQ''LYMLMKEB;&?]/71#Q"Z0]-.^,%NJV!-W-L
MQUD;A((3J3I3Z,0@:6$>GH.C)M.58+-ZLKC1&,<'@4M0!ECLGMUH@=ZE$]&=
M]7H+F@A3'<$/(?U4S_+45Y:%TPYFSN&]-JNJ*[6'<U3^[5*?WNT-'8=*#3PK
MLYE-%P4\?JQGR?(KH9YG?PP:X^JQ#PRPL2#ST*0J>Z643I\!1'P)F]YH9A7@
M<YQLJ]IU;%R11">/>_USM2_>$NGB_0F_PKF^V3_CNJ3T4T@U]AG\(D'D&_GW
M&8"^"@J >6T]:1ZJRE+^F?4T\8XD[\#G5;?^=]$(Y\M<AJW\;R:^#NDI_P]]
MC@F?@(3A=I0DAY*8"1U+??$LZ7J.;6D#LZ7RLV3V)EW[NH26?:Z5N(=& 2(O
MRG2$5Q)=_R =(9,%&(/M!OL&K$.D<-H*[EC6M>'[@G.SS^]'$:WF;<O7Y9^\
MELV@/W(1>W#D,O3GQEYCGW&WFCSB%X*%L(,3P@S&5I]J65:.P1G>2%5-^DQA
MM&]^T&6K^Z2BW]_XS?!?10;KX'W5N"7VAMH4#N%;T4^2MT*DC0QUMP/5TC:V
MT//*Q-E3'Y*"FCT636(] V#VPM".4$X25\5XTQ,R)T[MJSQO7V_9SL"F-B/M
M*_=KESE/^95>VO5Y_^Q)TJ(0CAM!G4VZ/5.)D/BA^[+VA&DE?7"B-O5VAI<.
MR77OKE@S5';!H,T"0;WF5ZM;NQ^8Q0YC(-.I8RLQZW$JD*4OD&[H54E4E=[]
M*YKSO -&8XN)VKD6["\-7>B,GEZ@HN5>,4,2-<\ ;:ID9O*(K;" ,.Y*9L$W
M0D:83G46T$:B:;^84?3#7957]UKG*L_5""!(0@,XKZ.6EFW6,&-C\)$,0K;)
M(FCA*MC=YH*V7!>>\;SO&T<\+T_(U3Z2'MG13OWNSY5I#%O&E7SC5>,T-0*E
M6K/>OA&AZ$ELCCXA,'N3)[_RFWE .^>$<+1%S:/M[; >'C'KQF=N?SUMXS44
M9O14,[-\SZW64LV\998829H2?3>2.$$15S&X! T]!++^G1A/ZI.[>\L?IY:F
M\G->02^6[D,9_P_&#,]!EX/!\'-B1 !)EH1('%!S5#[FBVL/Z_>3]YPC#_%#
MM_U>"YI$66A:GZZYCVVS&5E:E$7E_3UZD-H<>%AY7(J6;4,Z[4W&8[1VM&XI
MMD@/Y8?:1DC=E C4SMH^BN&Z0Z]/KTWK(6W%K=2M]YK"59#%3V@:!".A>*$S
MRJX$UF=5G>Q0W8 S6;*.\>?GMHM36GZA=*VAG.;";4W7+7'1R-TYS%?=!=.4
M@DP2G"#TC3P$I3^,!Q 2]YY4#!T^H$L+DM1>KH-*FB3[5>84'G]P%(<-CC>
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M>WY4J9")J'J4Z8W72#]TP$P1Q:YGR:[CO[R:Z-TU$%]=J4F#I$WN+\1GT?A
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MRNQWO'$OPDSY2&C^YC?029O9]IZ>UZSH4='PJ[B;$$'S6IWK#BKVOYN_0@A
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MDO!3^$[_FY  T;FS[F >Z*/P-O!Y?V24Q9@\V-;*5<&CW*I/.&+E0:W"A3[
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MA>('&TT;W,K^"=4>4]STE [5L")>? LKO94+4>QDU<I="OK/1WSVJH#+FQ/
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M=L$6AU*QU"CG=^*:EQHG:RI2S/](-M/2X9XG ,Z@QD7&$\!YF&(0+TP0:F+
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M"PY*]KTJUV[JLY\ :O6[()-[5L.YM!PZAY6K \?(ML5$4%*K[]'09/D)(+-
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MG]VZR?C^(>\-L>RS.>_:EI_?S??GU? 0M-D\A GEN>6--6@A=&;6D/^679P
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M%)IL.0/K<!;^C1#S@DH@!+UT!D+S+#XW8M=SFP^=K.R6O8 O%A6EIAQ6YJW
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M=8'-4^5@ZMLH3LSG2I'5/ZUDND^'"!9_20 <AKX\>I?3$P\9$K1D$&H7*L6
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M!51G<1'>M(7$$UB6<-(X,PZ?P4HU"!9A"&)NUPYSG#WH<-\1B[,9J7]%A"H
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M.OW(@M9<LZZ#+I-YF))<RF.9XKJ-']HCY]ZE.PRGMH/.L@%P7#SK\&B3)_F
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MF=B5104$(]*V#(BEF_8F: _Q@U+*N8,2)T-W'-+"_GM;=D^Y_WZH3+2!Q<D
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M7&!@%+[Q1%KIFS ?)K%T;A.(?6 ^H],W+AD]/ED0?>G#PRL*WVTL=@ \VU1
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MH68?_:AC8O79D-HB3)V>0?GVJO_*Q_[I(.M[LB&6<W"HE/7CE0K4OE8WWH?
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MV?AQ;J8?+09" :E?D$HLA9=U@>86^EX+.RD-]P9#C-Y4AQR!;;DM](UU_[_
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M'ZO7!;DTVC3D9')W0F%VL_"=;MOG BOY!J'(G9X4XZ/^>S7&TK;*BQ?7CL:
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MN9G;M5'-CH6;L$28:#LS49-@3KFH)+*-W<BX0+$^9U.4^_>^YV,+&?GU:7I
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M)96<7P&1X^MILO267Q05X.[N5_QG;L;!J=?;$RS0S=9^[J+ZQ]LL\84O\P
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MRR\V(7NEID%@4F;4BRONHIX\+/Z#3M.F?E0 $[S\)((H30IJ^E<0C]#=!V*
MJ.I'Y6]<] GT><'^+N.7<?6N^$.N$'';1S7E_(QZ?GY;?WI?,&%H_H"1NXU0
M7!7FCD;ME$.![R(#*D#BSEM#1?4MS7 AY?2OR27W,E+]?]MHK>*.X]YK<:%1
MHMZ&]W$ZKXH)R:;N7V>VI@(6[IC7#'(G4'BL.D&LD<+8J45?Z#F"N1ZVBDMX
MO+=@LVZF$F;+6?&:,&XZE#G;MC_GI^17>Z+I;]44_D75%[46A3FIW(ETI[7%
M'XYH(L<'E:F:-"-_KTPU';:V&O7XJA1<U?MJT14]HX[)(GI^_Y>!85!*)YX*
M.%7P1BAC::E^Q9O^'@X4%P3CVGRDG[US:SC![EGX:_6HE*LNW=),_*M3/SD,
M?5F?=0MTL_IPBB?>J2B[!* ;I;LGLM>$G$V!!M:9+.)#B-=]]T)USI SH&LR
MHDVUY# ]*B#?R;H%"5=Z"_4$SD;T+S*0"VH]FK%^.]$K72_6$*F4I(RV;+KV
M-"6IM<>VX&S?/EV B,[\.$*$8'<'9U"Z[*+6?4L'MJQM<0>TS=O"J1\:4GCI
MXL\*X?X?R+#<U^/%./ KDL8*1HFHUD,1'2<9EOHOX+4=?VB6/=]NT!<'QMQ7
M8@G*:UY-EMLYZB!E;1ZXW!U/VQHDES]7W+Y;O7$*2Q6%\R4@F""_L^"OM12(
M6F$A<R!"99GO>8E6Q*M"8[>W(3?1-YH"3N("#!=USXD_<G@A2@.DZ-C(&[C2
ME^VFV-?X5]@6F-H[5?8XA/,M3)-88T?#A[]6OW?^>H1TSDJPC5[46<":=Z$8
M2:I)8:3+:#:FKOH12G.0J;+@=:E;_IP5Z[B:@O*(>)V18$7?D]FYD&:ROU4D
MAJ@?M#+DO]FV143Y3^EHPVF/K(7\:@R3\4U>SMX(%FT\*>W&%,UG=TK-GVA&
MA^LW]NW=\"3:J.W(X;A6V#&<:)0@86(Y\#P[O2^<733FT.%I8:Q-4^!:]HN"
MIH]O'NN'#/I5+5PS1PP3=4@*7W%TT\4$7S1S<+=T5K#:J)_I(*2M?4)DA[BN
MBI)A = #G@$*QE(RE1<<%WB.CS U/<0?/Y0\(XXF]LGF0[ 9NQ5;&!7 L(*C
M I(0S*3'3@OGN^UN96\MBN"D9R1S%Y>E6#[K.#;R>!C]LA:N$;HI]_*?W:/,
M+G*3"[7$\\),T.7MT^W7BWWJ05N(RS<MNY\JL@86<2A]JI@1^SDCYNDUU\:6
M/ 6[%,;>#>1HJB\A5':WFK\+6IKKS:UWYYG7[ @Q*O)$\;P'?D?%'KMRO>XZ
MB-3!-BWRPW-<] H&"^94<YX#;G]TNUJGPQ^[=&/PJ.(-3%7#)G0UX&1_=OJ@
M8;/-M>1=V3TSEOGI$U!$.+ 3J%?70 4DJP.WLZ@ V=R/UK(OSP*6Z$R,MW;=
MS^WW&M:?K-"ZFT(%?.C'L-'8R9*&S'8\HEU*)_=#>Y%$WDPJX.X?NT413L)S
M-#!NKPP90U(J#/,[XH\D3HVK$/Q,?^>0]D]\U. _PY_FFE=+PKJ3F;TIRFVX
MX-J80R<PSZ+^ZOQVW2:V^!"'-NC/4<0[7V'E2DZ/8I0%MJ7?I/S4@.[K"U(8
MD;%%T"QGU GP^A((:U$[LV='+J 9L"\F1MA5J;V>+.WY%[]@7J5GUPKM[-Y"
MF\8&B(8A+)K36:0SM.$OBI1*12=]+B593/FWLZUTB##63P;-+2AOF2M[I8D;
MQ<ID"[X=-.B^.M )X#JV"=!1I'G4[>6S95FP>"TZ-/2BC]&9ZK^UA4XN]_."
MZ%;O&*Y;"79_5BCV/+@W#5*,N3>Q!@Y;^#_:._=P)M@^CL^A1XAU<!;J210A
MCT21Y9&<TE)R9CTYSF*/,YG->7(^-))'2W*JF!S+:8Z)0L*PU6:3B+3-F,4V
M[WK_??]XK^O]Z_W#'Y]_[_NZK^O^_>[O]W==O_NG9U7;Q9J#I+2U5&TC^.2[
M\@.=:I9=$_R#"-/X'N_JY?T/!C9Z?Z9$ NG%ZM(7AQRSHH+\A-LH:6IKQ4 T
MB*T)XJ=WX;K6>6;3-@VIH\-$91-K&74G-C,YVU!%UO%OL?H7L!PT4K:=B6G-
MJ&*,YAAEZ)1MFRJM%QXP7'?X"UW8B"$_1\/O'T8,3A+J0RKGRIMBNH)M;?"=
MO+?#T,D;H60;/4NYAQ T#<$3I,ZS.X "54[Q#L#C!7Z]C=RN-X/BVP.I\KR,
M0NP6 .?!!*6$0Y0#HMSTTIIBI6*MVB0T)S;L'%^WEL!^\V2^TIKQ%?6) $P2
M55,J.=Y6C1_#X\Y/VWQ\,;^?Y#+37=\CZAV?EB[\+.>BO@,PPAYE /YACZQL
M0 Q+MAK-O^-;+>X O@OL\\FSO$K42L(.8)PQO101U@;JPXIS8ON)V'MG<))+
M1/^T9O,,GM<8.%6[_65NR*GA,DHN\#W8W%-6"[D@X8C//XG4X[X-W ATY$,A
M#+MUD!D*3A>.%K@@M<$Q(?Z$JM!'75-[&'7&; @'/2UWNQYX6E&B6OV8Y9FT
M4:&9FRZ9SH^CK?@2(]OG.!GFJ=N.3+-R:BS!8Z@R\+SA9$/9^F?XX;R\I2CD
M3;9A##T-Y(]*\3HUI3[9/);J)4V(4%0.(P<J[7G*TM_09>:#YVU-QW,TEE?K
MEK?P&#ZM FJ'K<W?:*%,WV MTIS[!:?=H\=[RE<(P.];E[)&@!BZ%;R*YYP6
M_DQOLOR]XFMJ[9BT/3=8+T-M4_Z$C>/GGGCM9?KWTK,$KAZ*%0]@12=2>N9<
M5PBGA3V#+,ZQC,4DKD/SL!R;/R\;0.X&M*F64#O/JIC83*R&=YH)M6C;G7!2
M*%=-3P>(+&E]$TH0]5'")5C,+M%^UFVU=G)K*Q*YHQ[;-J&SD116E)EIER!&
MZI&C!+)X4"CP$,5SV<OJ09>:O185OJ\D[$OAB=_%3(-9@BO3!/LU^R&<J\TD
M=\8Q8^?Q][Z[]V[M /I=?8(.DG\<]-KK^LC\I!/@P>89\]#?%C(N*!QBR^*Z
MU5+EO(ZI'FGEA%!/&-(-1OF3&1;-[K6\J)@G%V8W1V&=3\8W*]@/8>,75K\.
M136@+TULP&!;P<AHA*A@NW2WZ"O1C=2Q5==(08Y]4U1M=^#5Z_'B6MU5TH_*
MM[\?$Q%-U6X>OY^JT9%T;0>0$K1]"4FFB.NA_%#2Q[-RT,'EDPAPW=*6]S>"
MWL$K=6&*CL3(4VDNU:Q]CQ$S(\@G'!+5.1%Y_)0VC2ZVI*KE IJ2@E])9%CQ
MZ0]J<WIQ''"/ERI#[GZ;?VJXBD%?6V!I[YA-8S9A/S@NKUJ1JU7SKO"IUKMH
M]^ 6IVE67.^3K\G?!J%1A.FHB36KQ=;5\Q'X&3S[2P/O">JE7@0.K:KQTEZO
M_^#,8.=WRNU+8?_L&<.(U-%$]J_DAGB5,F_P)5XS+,PY4=44CG9_6'3K0'[W
M4&4  UKD8.!QNC<FZY3ML[(TS7QKL0!#=LI(DU'AFGG(0;!HN@,MST*[9BX1
M*.HLD%SQV'T=:K59_N:<".J%0R[770*5(M$P^-_BRXC^3*,5UQ-XOQJ;)9Q?
MJ\T*?'2LZNWX.PK['JRJ,GV:B_NT!IK%7>.TUR&'MK*;F97T$69DE7=,F,KS
MF0&H3FU-<EJ^R_Q-88O$_EO[%<T!25[0_RBMDZ;EF)ZD=Z),]0^V%>K9EOOJ
MGMY*!%ZS"GS#B$I &#+H5OPA1A6Z";?OFY>W/5M%=5C;VJC%R.SMI.Y\0D'F
M/Q*S-EH83=A)2ST[DQV E[_IXP6E$'R?!G_#.Q)OW&$I2!P5##HO8W '8*V!
M&R=^_2)XSA4[H&J9/HRZ-+YN-NBX(7NBS&BYQ'957AG1W6ZC\#GSH-:Q"FNP
MP/<I#(-JGG8NAZ)CD5*@#]^T62B^A,X.0+-Y^P1J)A#(,W9W_K8G#'E,L"90
M 7;W:B,NVOD282/K:'];9%D-],,G#U?C6SUE>9--/G\\][7^(D(L!85V:N&'
MU 7*FN]=V+0(_.IDIOUK/#7B A.>Q(UCM+/O,?P*=-N-XNO.KLB=/NF_K8 R
M>-\]))[T1R,@\IY(N&@VD?*KRGM^9*ZL#I0.+YM$CGW% EL*0N&B@@#\(;X@
M-Z;<,8)==9ZYV6W_WU3,@:NGPR<V@RD/X2BO+8Q&Q?'KQ%D]QY;M%E--]AY.
M!1,[7UE$HZMQ+ZO-=DE-P26CP=;YP\:^V3.-^G'+Z1\OR[Q)7\TGN;;=PN;@
M_5#$1CM>,0J&)1[@_N6/DH^/P,I\,H_!N1%M3._Z$C][/##]D'YU5G[TL/"L
M>?Q%8U[$-1G +P$!*:4PP"JJ??UJ35:K*56!A6>)A=@PFF-VK-U;)Y>*&Q'5
MOJX*^_MFT@F@@<TSML#%%W)=<?!/UR&O"K"N@\%8.7)IIAK)CMW#V%P-F2.!
M$B!"7;/SG:@!YT+:UAIY.%IG56<>XV.265U%UY*[<^>F5,$_$@*13Q*A'GXD
M]JO]FI/3??=\,Y.QB7YQY%.Z39Z.7\)" 0 5:12X!>L!27*5&01Q*@.=W*0G
MT?=WE+WJO<H^OP8UIW^K5 S&Y_J+,DRJ1%ZNI;>QIJWC?$<IB>6.**+=//>*
MD.+<% DQP9<TF$GR'IH91<?.&WT_'L;HH^+3W%9HV7ESBK4^'^<37?P20R0O
MM7O>/WI\]J+6(%UD($:>>ZB W<*1VC;A*K0Q!K.#Q1*01]R6Y4'$ C)4_J!]
M#*LTOL/!1"HC>8TD*FM\N #RU.L QX"Q ^A6FAI]2<T1YL#Z[G:^#Y+9W+J<
M!X>95K]7Q#S-$CE]ZG$N^!HP$-V_ Q!!*G-([I[^_1!@APYN13(S4*DR(RCL
M;_V)S>R45UN$4?M)C"5["DLF8U$W9&5JWI00=5=^V$$X8@NH5<SV%<MM:T0
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M1*A ACUT#*E^R(-/:EKTB6OCF6FRX-OI73JSE7BP1!%LI]&$OLLT98WU5.!
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M>T-::3@Y@$8UM2;<)/B^QC@^/I643ZLC?PNI@?6S[X61WWU7EF,P>W3OM+B
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M#$\X;7V?)47J:B';T(6D V4!TE3/JV9OMQBUW,+XCHQ3:6MJ3I<.6Z:O;VN
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M=C,(>F!-;@H?3/*70"S=F/;YL#3VLD0IU""VOSS@7<*CMGKUBB0?F4D3HE!
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MO,)QO7332',"CFCM'=%:LT6Z-#,6,.ZWME9]_-2:0<RFC7(+ZC/_HL4W7B&
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MXO@[N3L"Z>PF)]:VZYZ^=SF^H, )'%3.+H44D>E:^5@\L1(/T=<,D&R"G?9
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M6_*0&:+T7LIGY/Y7/751A*^HP$]3#9^\D?>/ZJ91;BHH;1RUNK![?KE&HV?
M%GF)_47 '5X3V"<J.E!Y$'\Y2[QL5Q6^XJT&F;I+S3+^7$"Z,Z7%,:8BBO$1
MSS1XZY P]6H]XB5$VB*Z&F_23KTPF3@MF";@?&#S I[=GM,=257,1Y35OTLU
MI:Z];K(YCS0;\$E>\8ZT&X\GYU0TSW>)P WCM>:K3>9R)XL:9X+JSQI(1I&M
M%SLR+[,G/3E#9R1<[D1N&)'NT"?@G'(^TDV(Y_&!ZYW 71K0,"-Y:!);*EWL
M_41;43"][#VBY5@>DC1IBWRRP[.E!UTE>M-)E5U@G!DC(2.;NJ5S;6>*LKY5
MCAX7:!N/MNY_7#'P<U>J?1&R.!D8WZ.!9=IB<TCH(TZT<FCV?#Z.-4V;O.2I
M;.3^9O21IVR41F#$.Z)Y US\31IOS!$HDSP'FW'JI37-U<FNK,'Y!;X1Z=CZ
ME=5HI:I)(U^K_-2Z]!DWM5>5Q %<QO!OY15XSCMS-XHS1M%!]ZX!!Z)TLE47
MR('XV4<#8N_3 #S;SA0;\30U*)#C0<K[XJKAZ8*:]Q(S5-;THL/V*-@SB#L-
MD.ZOER/F89:B/-8<;]T8N5T3E+<Q1C U^1&ZQV7#\*9CJ;I(-B.<&HHCO:('
M(F:%)^D:+UN,"C13XMX4B.@8&,)[19O.6N16]-N5>Q4Y",UC\??;C#V?QCI7
MDI5/B634CR[^'[D[YK_')3E%2/J/Q^L1P!M<!.9NCSLVCZRA,ISI_Y!Q]LJK
MX6<=XTJ%[H/A6]UND\8.$='\KVO]Z\,\G4M@PSDQZ4M)")!-?]N3A><%Y\R[
MH,];/9VI3"5Z233@[SUFY3MB/8ETU0YQ9!=$[PH6+;:1<,\36A-.FER.9W?F
M-1&[EZF75(%\&C#&1+@7,DM-5[O@<RA4C;<AVZ3X.W/[R3^X/WT+F48#9@4B
M$_9U"*46W4QOFNCO;(/>1S@%V.O2@'>6'+!6<@[SO&^P[0<ZL*I$Y<F2OEJ*
MT#7#IM;09EUZ:$:XV$+,S_]]6/\\W!>_-;O4?&UE#A;JYYC51UG32.E)14R(
M[$-6K,3G8HBB\J\WA)2\FR%'5KGKUB<$T@]:ZVQJV8PFMW8OZOEQ6N1)M3GH
MI#C4=V]Y:2WS2F%@H?!'[TOR*[)FJ1,6[^DN__3@$56O=,7O!UXK2N7B; IX
M0Y+3)Q/:/[LA3AF_S3/J)" \:M(-_L6M;M:KPFO8(R2#RL90"UDN3,=.^5WS
MU?Y N;]= *'S@$:%O3-.))+['+0U+X^4=$*Z_7.PM_66RH$PE5BXM9[*SV-A
M=8D^RZX&+!&?QU33Z99N$Z_\EJLSR[ULH>^\UWV249BXJ$Q]JTHMF[D9HHA6
M _+45@5N8)7_8I45Q[K<HHC[EF"MONJ061U]A!S XTMS#BG.KR&G])$.%YNL
MFI\YG2)Q+3*=(#\PJ8=+4V+43A'5'_"?)=YGS_3YT-HS?\9?;FOK#.DU>/]&
MT?.^^A/PVX/OC"&@B#LOCYBM:D2*[$[LARS 9)$^KS#MQUN[K[489(U8:#S4
M0-VQA"WDEDN(X^)"^*K<0Y:BOE3D12.O'_S,(54@4^X2_48(PI1,-0F+RSGX
MN;F3P=<GZCN<K/;F""?CPR"S@C'VNUM' AL1I?MOY"SLD\6'O[M]4',J<M.Q
M'9<Y]=;_FOWADCXE>5,@9H-? /_T[*7(JLK0;S2@_D-DH)$ME04ZMM64NCI.
M1+WSRZVYOK,2>H/BL,W;O&+>6-45P_2N3O^Q;,YEIC.&9H3:>WI^VID12GCW
M5HNE,WO.A?^+O?<,:ZKKUH6##500Z9VH-)6F5*FQT43I'2$BO49!I 6B(%T(
M14%%B5)$:D1Z#1WITCN$A%X3ZH(4OCS[^[7+>[[][G/.=<[^KN?'R(]<UY@K
MF6O,<=_W6G..(<$)SE8^=\M?9#P($C*C]_ 0NH\$=/QP^N.CCP%W0FKC?K2O
M[SZT>*7\&M,OA:X?-L5)/V[\:$]2MB\,T%HW/ :=Z@?FBN#!?\IFXZ%,(H-P
MD:R^?=**E]?71&G!*[PJSUC&?CI/UKSU8.K5[IM=PILW2S/&I3,3U)=LDQB$
MWBB2SZ= HM ZA(7]G-SEE(EXM$/Y8!]W8N%P]';C_#6QW#;9+2C2OV0WC:@;
M7GFEG#/E[O:1_TS@LT+;4IL7"^<?&&32]W Q3,XFN\D\7W,(A)_$C;(3$$SV
M,OSUV4KM+->&OFCQQA<X&K%\GW+>8(>YB*+/JDS/NOLCR.SV^\:UE+QZT*,,
M0%<O'L'AXG>"U&PWK]W==^!8,3-_/9IMZ'7=Q210#UR+)$UM@-*41!,2&<@5
M!_<C&.T//OQ%,I\HLL.458[7C[B,+D28VZ<X\I\<'<"8N7>'B)$?$FE<KH^=
MSX)S((COS8XD4VL5]H6CB'8'_>X5#/_1#6 <UV::.HS5$\@)1Y\->O S0M3T
MLOR+NJRKO3(+6\8IAK/IYM,"'Z2Y;B$C;G%Q-1N\%0EOT<SB>^=XK=$L[$T5
M[V>CZ3+_CFLJXS/MR3,N5C,H5,7R@8$]^HM7%[G5%*U70OE>EM6^'QE>Z+BW
M[>QR#/K@5G$,.D]J5,XA1Y)!4$C00@R,PG".^H.VSB+Q+VV^0\(H68A/$0IO
MZY=UKH6(81$F7<X$G.0:UV'Z(XW /K(HHJ07?0P"UW.0I */05\]VBE'HLAU
M\'B%.:[/DC/K&#38G8LD'?UUP'$'>OJ[>S-/MN"VA:/9>>H,C3[=IG89405<
M(%\^S@^9T])DTSO .@_Q^SR.4V=9?9P1T\7!-+K>Y6T>DH9GR*+?/"P/1QBT
ME6;O?B2$FY@0*ZL_N&)*K)EMF;=,)J#^Z8^097@.:4U,]W:G.*:6\AGN=^91
MV>*76^N<+VG0C+P*+G2<@;,!'YV3X H.AC-\49.[3*B!^F8I(JK)8V36O)<P
M&BQB=A'Q8@J*M5.M 3.M=&UBYKUE)ZVGQ=[[>"5)'SC<UEJSK @Y3=#\JH,A
M>+U7#SR<>/&(/%)=@Z$#)II%MYJL8NB&Z]OF0YX\+1$KKRI#2"U.XV&;O]^
M1^IWI/ID/O?X/+EID(>INM5U#-+Q^.1+'%/<?&"PZ\G_9;9A-K3BD.3<!&9\
MH$]4#_/27_KU:POB.#N^2%+W:Z0PT:B#JD<+XNB,>%U&W0<<\3G@I@,?7S/
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M?FY19C%=GT%]=\GL2YW:9QSFY'>E>GOFPX"#<:K+'@JPIM'>,OU#1C*D6;#
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MJZT_>WS5$JP_E%/Z@3%LN^=D5I3_:L&%6\ON2. D20;.34DE2U'/ 9?GNC;
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M_)@'X0E;%^&+BPI71<YOO[ON]9"' &V9VEAELQJ83=TP^%8/7ASEJTOI2B0
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M8,GOC;\<L5W>R+[J>GQ@8!K[3%)2BL89'.-K8<XF:IH5JML,*8_@!FK+NZL
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M1PC,Y!H,HB 2E 4H\GUFHS0];<U-8YK#C2U6T(*UDY<^=LV$Q1%G(TO*2;K
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M[(X89V/;_(XI-4;.](GC;S=O=F>1E@>/LZ%X[!QN+_E*C"WQER=ZJ]D!'7I
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M&D'BIS'T$^SC+(DY38+%BM^I%#5F,FC6L-&7E]5?7K?Y\3[ S_)!]SK]XEH
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M4:' %7D3U2>H\X;0)^4"<:]K%)3@.U\NU9^,/]31WCK?>EFG7"!X]?=2?N=
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MBYO5$:"U":Y"\ :PUBOE-L^;3M<'6/E,Y(?</VQ3H4U!NCV:ON%W.A9L(;(
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M["%. QC[L2HUKQ)Y(;D:#3%)2!+AV,N\1;6N\-)T-ZN_02N)WS8[GDS<JC8
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MS5'Z<-IZFVY-F%<QSE&ZQ[I2YS@H!J8O9$P?;*OJ]#E[OWJ-'_,*+Q=QPKG
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M28M<CU:WZIQF$:A,*BR*81IZ&40III#X:0*3A++ BVF6I -<Z(ZV-;>AH8F
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M:4.5>\B &AJPUMAL*^ALX#E2/Z>&"!B,P#;-9 )E= *L^31J[/A4[)^C $^
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MIT)E@NH%1()!A/7.A6@BAJP0<<12C%D:NU#RZ:FF1K57'1B<0=2.*/W@%)@
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M4"U7L*([R8X# ^6L5\1R;QD"Y]#[2F\07]&9P!*N0$T'+LW^2OT$+$$YW2K
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M')_/9?7P6$<#FV/8F> )X22/H(I,:QN5)1#'D8!()IDB*1<QYRZVT,49IT8
M=7#ITOB;^[(VE7M]Y&A<7H*8*!1%IO57+*AQ+"&(.<YA0E2B"D5B*MB I"L_
M*S%^\M3K+XB=\>GU20_,X496\),1]F<#[?L#:(V\_JQ):VB\&HZ79QW51K0&
M8=\<M+]Q0%3,>U-GNS+C*/H\7Q]O"K\Q-_5/?RZ>ZIP2S<6R6K][-L9H:Y;^
M^;1<M./,4B1XQ$VAE)QJ$M,$!FD68QBK@LLHC27G5BZOD$).[=/3J&E>/]$(
MN!<,]]3INK,5-S\_U_K6YY]&82">FSUBMW5_?C)'A<V@#I$-H1X.BS"8"2QY
M:#NZ6>W/AFR;U=XJ:7Z[4;..;NEV^^;G1E70Z0JTLO7O.^^ T;<;= *K[1"H
M,H%5'RD299QWW=<1?N!U.7M&'VKN\0[A Z.W<\H>>JZAQ^BF5N+ZY8M^!]9Z
M I.)6A_L_UE'0'TJE9QEG(N(I3F4J5(0I5A 4I "2B*R/(^E2C(G+[S%G%,S
M #J1;^H JG7]6LM.[)LN7&RN)7<]6+\,O^T)NU=0@Q^U=WA^V>#Y?HMG(S/X
M= [/ <?NU@AY/G^_/._(!_'60!R>R-O?ZBF)S"09U/4(92(I8@F'.&$8(DES
MB/-<05ZH BM>9$Q95<.].-/4R&<OT>FFG]WD4O'Q,L06YK\OX (3S'B879D"
M-@2[D2SA,Q@&3,':!\0YZ6HSP.NF6>WK<3&QZN &7\4P-P7]62(8BKBAS"R"
MB*D8$D(5S.*(,"EQ3!*GEK&GIYH:A?8EW2V+Z=A&X0RZ=G::'\P"LZ=#.<(@
M[1 N@Q2X0N'KM#>XK/;EBH6>VA7\P1^D>)[KS>F?BY7DR_M%^;]2W-$?;^1"
MJG)=?5W.YQ^:NB)[]>^+0J(,B0(F*N(0$91"P@2%M& LQUB2(G,J!S)<E*FQ
M4-M4XJ5I,MKDLCSW= )K^@.P5BM'7AJ^7I:\-<HJA.:U5@GCQ^NK ;0>H%,$
M&$U JTK0Y@778^J7!H>+,RY-7@W; 8U>/^+0DDH+XP5<U9;\U[+Z^]N5%.7:
M_#2+"QHS+)DVU*1I_(IB2".9P%2J"&-&5.9:5NGD7%,CRAU1Z^*,M:C R.I:
M3^DTP';$YPFVP,RVBY@1[J8/V@WXLIR7_ 7\U?XW")]90.6Y]-+I^48NOW11
M\<,23)=ON;:PXTYCEM^736+U8CU+:%&@!.DM8)[&$$F20R:TF991(:.(J%11
MIV:R%V><&K]L)?/7*NHR['9\XQ7,P*QSKOW35N 0-2 O8!.H%.2I65^I(N0%
M$$X7AKQTXS#B^4#+U7_1^;/LM7GYL*KKUO*7=\M'6BYF0J4%2SF!5,D"HB01
MD'&I^0<1EDN48IHE+M1C,>?4R*??CF@CJAO7V"!MQS:>\0O,-T>A W\U<GHT
M9!Q0\<HT-O..RC4.0.RSC<NM S=/#6M]7/#EH]2;M;9B0;MGF^4\$9@3!#.!
M,XC2%$$<XQ@6"&&I8IGI_[JT@#H_G1/+C-8.JK-RUO2'JSUS 5W+S9,WS$+O
MGUJ@&DEK?U!7U>JG5MK3-1/<-TI6L/C=*YV?<MSMDI7Z!SLFN[N&<<GN@=P'
M_9#</IK$OIE DA.>22@+D_/!N#984H1@Q*-(H8S$J*!NS55.3>7R-HS3&V43
ME^;&'">QM.,,'_@$9HN#DW$C)6C$],<2EX#PR@\G)QN5&2ZIO,\)%Z\?6JZ@
M";IL*6:6R81(*0G$B$M3X1YK$J YC!3E(J5%DD9IE_AE1P)[,U@]V[L97H'?
M_4T,NVPD="TFL N@W9L_!)2QTO];--Y?0&- /O]1G3TGZN_.,7(&_E$%#U/K
MCU\V\/C:U KZ8BI+SY1*4BPC 4D2%Q#17)CR(0+F2!(:)3DF*G(ZCMX,/37'
M0BU96T_;E/KZ\X]W)G>A*?GE6/&K!Z# 121$FD%>I!I E6"(&:7:(*(QCK H
M$J'<+*!A$(YC\_Q&5W^7ZZXJN4EEW7;Y\(FJ'2,.0RHP&3;/62V5Q[/P TW]
MGFUOAQ_WK/I K8.SY\,KAG'>5[FFY4**]W1E^A17MYP_/S[7@2;O] Z)ZTV[
M2!1FIE./E"DS)<]S2*G@4(B81 7G*D=.1\J7IYP:1_8D-*E81D2W5]@"9;M7
MVR]V@5_Y3EC020M^ZB/9"NS10V*/CE>:L)AV5/JPAV&?5ASN'$8WGV152;E[
MIG0G5X]U\\(F(E;*.)<4(9ASSB%*"(.8T!06*LI))"(442?3Z_*44Z.;SWNG
MRWI.RTXT#C#;\8U?\ +S32/L#3@X8#82M]U::YG],8X]/EX9QV+:41G''H9]
MQG&X\XI-'3-=F4VG5+U+K&-G;E<K_>34QTMO7K:7?*$O=7UJ$[*G]Y1E$VCS
MI:[$/B.,%4F<F :G<0X1X0Q2A1%DI"@*2G&1B\QY3^A#LJGQ5[=RSW1><Y=Y
M]9JMT/+)2.T:I>QM!1VV3V.ORQB[+UA+#/I:@9Y:@+V _G6M:N"VZ6.[U0XT
MZGG>QOE$W/\NT(MTXV\B?8)Z= _J=8(K(XCJM@+5[:)?1K.-(Q"?%U^E.=?6
MWQA]P>]+$['=_/,-K<K*W%]+=-?U8*GJD.V9H(5*XY3"G!(%$4:F@)Y0D J:
MI4)$3+KEI804=FK? :,KJ)4%_1B<CXNGYW559^]O- %;5=KD"<M4VU$> KOO
MQE26-O"G)-"J#@^W"@AWF#BM$ *_3H!70.A/1H:%G'.H#[5:KTJ^;EM._+DP
MN3]__/F;?&1R-2,1E821&*HDPA!%J-#V59K!@D41C92,<*3<W*=G9IO:)T +
MYFCMGP?3UDOJ":+@#M).SJ9Y#*@E!3\9U'X&?S7R>J1,*UP\NT;/S3BR5]1"
M^4.'J,U-0VLNT+5LRGZ>*[\@,OT<10@*DIKRP5)!4@CC$TU84J LY6YI-U:S
M3HU&-D(;5\+1.@,6!06N6 1+QX%O:$,[!7R@.J!,@P-*GBLVV,P\<O$&!S .
MZSBXW#RTC\2'<BY7;_5,]\O5RRR5N1(J*Z"B2--19(+:*(^@S(N4*H9Q@:Q[
M7QT9?VK$TX@(:AE!)Z1KXXA=!,]SB0=< K.&&R0#.D4<5?S*+A&[8X[<(>*H
M0H?=(8Y?-C0RO>F!MXE[[W=?8OI=E3F*84Z:FG@(LHP*2"5.D'Y_A4KHIB.!
M?:K+N3FMGM^]9@2CY;N(KH.CJ:0R.)7W+.1V!L35"(X5R-[B91)>>B+>@%]7
MR\ICVRH;/#S'LY^9<.28]LNJ'\:U6]PSH,#F?VIY31?-NP>YHD_R>5WRZE/Y
M6.J7M-V68\1%D5,%949BB H:02I2!%41\XB)/*+,:I-B-]W4C(1.8(?BD)<A
M/<\8_H$*S!F=K* O+&BEO>SJ&(*@0XU-KTB.5&CS+**>2FU:XW*VWN;E4<8K
MNFFMT4[E3?N[K@A2>7/Y*/7-_E%JWRO^_-A$5YAJ,!]64G;)$5^U-353-(\$
M9P*R2"2:H7D**4DT8>."TB3'*2N<RK$'EWAJ)&]DA$H+N6W5L-)B#@AE";K.
MEIZJ*:U>:"_7]:$OO2//GMXW=9$L4U)";INW?#WW3 P+C!ECG?P'S 25>OQ
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M@JVHCI[.@&MKZ2B=QHJ%]K$<7RSON[,1T/3KAPTH[[ANW/# 'WB!1YAR:(3
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M4V//1G1C5GWK9 6T$]9+55>7];)EE#%7(3 /V=>"W2Y5IV%];5L4:J/DMB3
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M=3#;Z]2O.J7TR9)5)V\8V-/[<:E?A/]MRO(IL][ORHJ;FMY?5O*Q?'Z<%:G
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M"<TAPTJS?Y0)B(L"PQA'2*E$_U@X.=W.3S<U"MI*>P.,O"8*J#D@N**3PGG
M[;C''XR!:>=*!-V#J*R \1L(=7[*<8.9K-0_"$BRN\N-8(0LNQ:[G\RRF6,N
M$7,N"I3""$4,HCQ)(&8H@APSRC-"!8F(#9L<&7MJU-&U:N[DLR.)8Z"=9X0K
MH0C\^ENC8/VBG]'WR%M=2?[+_?+;O^N[ZA?Z'\C\")L?Z[?XV'BCO+)G%.G>
MSW.7^"G(M%M7Y;;K3V::V+ZA5:F__UG&J!(QS%4=8J%W?Z1(&60*YT04:40R
M?EUAIDLBN#S-XQ1HNMUIXW9=D::+"U D).=)Q$W'39/T%"&(S6X\HHI'<10Q
M3*A+W&1(^,<(AK2H\51[V=L5,GK<@#LC6."%LC/<0L(?? ?IC'RX:ENVN 6M
MNG51B%>MOF4+T:4J7-;C>/)!ZA^ZW[W_8<+CY4Z8_$*\:4*>JYFV&E5.N3!]
M1DV%6R%,K5L,(ZXB(K.<H<0Q)WRH*%.S/OMY+;R?_R(;-:[TF=DOT4!76A#@
M7\/#9G[>_*%5Y68W)<F<9G7J!/2^.4,:UBEG+\[K^NJ<8;OHPG,?T;UXV6_T
M?Y:KM\_5>OFHV:8^S\PU6:J$$L@+KBUYKHUXS+4Y+T6L\DQOR_/4ZD3A^/!3
M(\!.N$L'FS;(G>>PZ_$(S$NV4#B5$CNM\=4UPXX,/5IQL--J]:N G;EJ8!R(
M?ON;=__S^D&NOFC3:B77Y:K)!FSI8%M@XT[^6+_1(O]]%O,B3V@B]%MLHMMD
MG$$<4P01,Q4)$2XDS9R"0P8*,K77_^M&Z#IDQ#$Z9.AJV!D[8V <F%)Z\'8"
M@[^,H*"6U&<<R95@^0TN&2K,N!$G5T)V$(9R[7C#./'/2GY6[ZMU^4C7LIJE
MI* QEAC&F=[A(948ILM2B%G*"&.",[NC@^/#3XV_M'3FI&PCGQN![4%G1TO#
M 0E,-OM8W( ORWG)7\!?[7^#$,]Q.+S2R=X4HY+$<?7V7_T35[U.7^-?]87K
MZN.BJ<KSZVI953,I4%9D!8$F PNBC I(XDQ @1-$,Y(4*([<CB<"2#F]$XQ:
M2"GJ;N]UE_?*L<U[B+6THZE77I_ 7.>SIW"C*=!+W.AJ?J.UG4[/X#-+,:FF
MP,?D_*?J^GL&:-]M?<]--?"SP1^D>#9A*>_I:E$N[BL]=B=#R;59^JZ</YO8
M7W-FL=V,I8*I@B !,Y%3B)*80(QR 1.$XI1E4BGJUM-^F!Q3LRP[-8Q)M9#K
MKF+,3_.Z'LF3Z19J='+\' Q<(TO*#X]\:%KO@=[I8%BYX?$;4.M1'P2TFNC=
MM-$EC&E[)9Y^N7F@+./R[W6 '7#LE<,-KZO]L>[QUG0M6&A3<VTR@.[T@E8/
MR[FX6U%3+_\=?:EF"(DHBV4"<9$IB(A((<V1A#(F,6.$9U'"7<MM6\\^-<[<
MR+A;#W+=2 R$%MF]'+?]6MB>H09"./BQ*5N#K>#F<'0C^@W80M]*#]Z=0WM0
M66]GU+Q7^[:78/0BX,[@'*L-[CZ(>ZSQN[:@S>UB\4SG7^73<K6>%;$LB,A2
MB%+)(8H(AHPC I$B:802@=+(ZGSDU 138ZI.1M ("1HI[6./CX)XGG]\0!.:
M8MQ0<8I%/J?ZX(#DHX..%I5\3J5^:/+9ZZ[>[+7%H/Z0JV\E/]%5W21!-7'1
MGY5)U;]?F,BT9N]IXM.J[5:C2(LL26()<XP3B"C#)HT^AD5"3 !$D>:)6R)3
M*$FG1BFU/N PE&SP#M'SPCKO(5]ON49T'FZ<@EO/S4T7?R;JG>9;^E2NZ=SH
MU94E&6O7&68%0NU+/4O[6CO7,*"?V=L&FO"Z*.,/4M]#YW^LZ5KJC;9)JYG?
MT1_MF]&>9F_Z(]&$\ECR'"8QT1^-+*;ZHX$)U,9CGE*>L%BI(0'&3E),[8/0
M*?%_AP41NZV [=XW,*[!]\!MA'"KP VH5:AYNE:B"21N]0 _M9K\'*C3U15@
M!@D:=I/D5>*%!X%U*E1XV&#N6^8VJ^,E3MA=N9[+&<6I%#C%L% X@JC(!20(
M<9C'BL6Y2'@669V9'!M\:C16"V4<\G'R$_NY2VQZL=\K'Z!W>9]\#2:!*<@5
M#J=-\BF]!V^0#P8<;7-\2I7^QOCD-8.KQ'$I15VE_6/;=&BG^\=,Y8RSC&.8
MJ"*&*#=AP*E@4"A*"IZF,6'"L4;<^1FG]C)W0E8'39N>%QIHT'7)>-)W.?KJ
M+Z-O9Z-XQ30P&72R-OTI.FGW>R!YK19GAXWO6G$79AV[4IP="$?JQ%G>.+!H
M0)VV-.,%XUDB3-_=3&^&4)%"1O2.B(M4J"@6IH6/4R9Z/:P3DXR07UZGBK?E
MQAPSQAN8[-C 7?G K_SM>8W=$[9W%/2;AMT,/6YR]8XZ!RG3NW^]SD71:[>B
MC?]MS=D93Q/%"E,*(A8<HMB4@A!9 ?,T3A*D*(W30=Z(4Q-.[2._V24/[W)U
M$6,W?X,/Y,9R+?0;2=6.A6V!Z@!IQY>0">(G.#GIJ[@$+D%P:O=_\;Z!NPC]
M6/RN'Y1WRT=:+F91A''"E8)%A!E$A')(.9%0BH+'+$8D5D[G8;O#3XTZC'3
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MH*8_2PN1:>QH?KWSG-V #BAP^0GUG+ XJ?7WG^<X#?7&3X^<AMZGHJ*F)^&
MQLSO__CRY8NFG0<M91.B-4LCG+)8$!AS5-<?TAN13"*(>)1C1%DAI-4G_<3X
M4_NN&@G!4RNB29;4,CIT!SX"X/D/EP=8 G\]:D0ZZ=I$\^L0<6B,?!TR(W5
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M%'%=,'9&,5-8" 8YT<M_I.("XC3*H2E*QA(>DU0X\4F_N*GQR?E(8D_!K0W
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M S-P:/7#_&?.M'_2N3GJ^ZQ)=U4: C9_T'Q\^$'GRED>L2(6$8994<00D:R
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M<J.&Z9JU6>N//I2/9;-]7LV2(LU)7!!8"!Q!5# "*18%5'D:(20E0=(QBR2
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MVMD"JOH/)B>/[\T!56T/6!B#',Z ;Q@WBX/V<48C^*Z0P;NU NS-:!N2:D-
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MO_['?]M^HO\Q[[?_\=_^/U!+ P04    " !EB4M4^"*6J4">  !$60< %0
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M"W,^4JPEC9"\'*WZNT_=3?T=GWD>)<:1(? 1T]F2X"MD_#1=SW "R6D1?&;
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ME:BPR#T90RA!A80E^..O8K<\?#<T='P6.H10N\+%>0WV.1-!%*Y,069X]:_
M (M..R:*411[^8C^^%JTK8_?#1L='XD.(]@^'%=B8PFS-_.,?_XO_#:)4OHB
M3$5V(0:L#BP(0>%85B:@E8CF^/RM!Q^]&RJZ/QP]1J"#(>*??KPGQ+?TPN$-
MC#;'-F_F9;$\W7S:;8IWZV-T[S,&:F?T.&U'=C6J;$PN#JUN/.,*+*B#P<Q)
MGX*3@Z@M;0<ETG>N:,6C<8G#]P3SG6<<Y12>?^KKZ?+T39Y@)(N44J =2RJR
M3LHPGUQBTL8H.%FN(?K:W'KD.&V-AE3:+0_Q8&F.'1N<$[[)*#,4Q8 4A7E9
M3^ A(_/H-3/>&+!DKK@ZWL+?>. X/8T:0V!O2?8!@+<7/?(FSIOHT2;FC2M,
M>PZ,(EK%B@+R66(HR1]_4GGGH>,T,VH,A(,DVN\^_W(Q7RUFT[PY$(%9[;'X
M\01QO3IDP]_^88,U,MR)VB-=@+,5^PSP9;*IX*MN_[OR>CJGATW)]U^<=ZFY
M@E-PA"8-B=DL@4"4'0LE1R:#,CP*0@@\5OU48!4W.K]XZ&9U_8BS]>KRE8V(
M&1<732G_QS[4'6I!+I_Q8K4BX5XOG2"D $$['G'&-,9,X)>%J5Q$4D$F*]OP
M>IN.<7R,9JBX-#(#"'W$3><V]1<Y9%=,Z)AU=):3G:P]:H7D+$JRP4II&<B"
M@ Z/79@>BYP[Y(P+H&/T^R!4CA%V!XAY":N3%_-<__GY[V?3KS"K)_4OUB]A
MN?PVG7_^=YB=X20A=[2.,N,;WRM26!V5HA]+"=88ITUY[ 3K< 3M1%X/B#H*
M!HO6.ND :+_ \G=<0YSA1>7-%"^%-M&\0)9*LF@EDK"".4]VC=&Y$CP2FX^U
M;#L<7H\0-4X@U0Y40\F_ RB]2*DVF%I]P(2T.HBE7W%]R0OXC#*1JIT*M"QJ
M63=D15S%H)3(9._-8PTAC]CL'J%JG&"L'9@&TT ':'HS_TI4+Y;?B(6)=BZF
MFM'@;8Q,2W(%HM"%XDKC3"1'(?LVEN@F%>,TG&V'EH,EW $ZWJU/<'E+)!.+
MJH 1Q+MQ4'O)1 :H/'.&IP0YVH)M K'[M(S3@+8=4HZ4=@=XN4T\N*@UU+2&
M&,D4\FR9]X;"BR*=2^#!J,<._@:*O,9I3MMP]SE8QH<#9+&&V2  >77QV)H,
M=8J?X,]S;JIIQ!2SL+5)E2WZ/"T[Z&1)QUFDFI/M'FWO=#A:MM/4@Q<\2+ ^
MD-@[L# /.?*_+N;ITI>7T@LN#8/@ ^VO+M+"RH$YIZ.LG ;]V(73L+'4-5T]
M>,"# &E \7< IG=?L/;MG7]^B[#"#W70U;ORVPHW IO8(GC1I&T?,AEIKX%,
M:[V"=1"L<%E)>"RE[0A/YS&R>G"/!X'2<,+O $GUI&K][7I-O/[ZZ_0#DI2F
M:8UY8E0.+M56*EA(3AH5 RT"4[[(H)+4ZM$BT,.A]#A=/3C0@V!I0/%W *;W
MRP6MC?6W]S.HXXURY>Y+O?:I^W4,/)>L$P-E%-/%.1:\5!10TGK)1CD4;:S2
M8U3UX&,/ J3!1-\!C&Z$DS>V:%YX$CK2GLQ+J*=2CDQLE"Q94TA62N*CR?J#
MQ.][.D:#5Q6VV,V.%G8'B#FG?V(MVNCKD$Z(A/-J.'WBDCF+47!-NR]_K#G2
ML7'[.',AFEV1[B7.#D+TMU.(T]EF&R4#N*E].UG,2.BK\UWV2C32>T!O!"M<
MU,F+0K,0"_EIFFNC4Z&/;G.QOBN%XX;OS9,UFBBJ RMT@Z^[YV8>C!8J&*:<
MJ@ET!LF>!LL4HI7@O1.JS07%=IK&O7YO@X'M0#M&(1U Z_+F[CU\JV<8)#)Z
M97E&=-QC<:)4'5DM)8M0*RJPT-+$!,R%X 5P8E"TB=GV(+(;\!V%BRW7JT,K
MJ0/\;;S$!]C0QMOBLZJG';64RTKF>21GL42PX.K:?:S;RY%.^8&X:K9S-L+5
M$,+O $,/<4"$>E&09<=K"PNE6)0FLYS )A$,EX\.YQIR6QSWI+L1<HX4>0=.
M_<O%_"LNUU.RIZ\PKF^$J#YC++4<@<?:+DN[Q*)/B8(5[8(.3D&C^_RM)'5C
M?-IY5,.HHP-C=/L0_U)VWVY>"04'6)1@ C,R'5 SX/0C!L>MLA$E-CIO^AYI
MW9BJ=C@;5CT]X.W.'GZ#$UE*R=9(EFI#84UA-%GD>@'I!!EF6CR8VIQ:;:=I
MW+NZIT'8, KI %HWF)BH2)26(!EW!IA6"E@P-C,ADM32H;38)N/_!A'C7LX]
M]<'"7B+OP*%Z1"(F@Y:8R-/DUC(M**B(*0MF;10A60S2M_'&CSP);78_]R18
M&D@A'1BB]Y?/W;!T7N["0P"E8VWNPFF;UI'<0E5[S>4@E: U$@4TP=0#Q(Q=
M SF,GN]=_!XG] YP<Z-9X3G]P@:!@L)3$6S=@*$VNB5VC!-@0W+@[_8+&2RT
MNTW)V!<Q31!SE+@[@,N+G#=W43![#]/\9OX2ODQI=[S!UB19Y[-+G/1K/=,R
MZSH?4C/OE"S@5;'VL1XN1QR!?Y>V<8.W1I :6"4]@"REL].S66V:L(D4:NOE
M)9[@?#7]BN?9R&\7JYJ(_*Y\@C\G)<6$H10FO*P328-EH&DU*1^12Q*?2XT0
MMQ^AXT9VK>#74%D=8/$#KF$ZQ_PS+.?3^>?5#79?89FFZ7I"UEM:C9NA1+4\
MB^(/T"4R0Z&)="8*+&TJ5KY/V[CA8"/$#:R2#D!V7U 4V7(%EAMFO3-,9_J.
M0EW/I*Q9\4*& FUJ$N[3,FX<V A$1XJ\@\.$[P7(DQ2A2.T5RZ'4HC$AF<?
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M<\BTIXT<8N:,%^YB,%!HIW\R,(W=$'=X#.P!L ,4TCG$7N3_<W9>7G#9Z+6
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M@9@VQ"3GPH)N<U1T(,%=9A$W0^T3*+5'"_N!I+F<IG65;97L>35N=+IX2,A
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M'GUH9[1CL#SWI30!$;**-?_:<EV'1)=Z^9N9S-)Q55**I4W3I*/([J15>E=
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MG (909)"7TL4VUQ ?8>PW5#UW.X'AM1&!^#Z%?^X(:CE8D[?)KQQ3WN/OX1
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M!E=<!R#<4/U^.4U(/DE(0(RSF'D]08HU[A.2B9R-*K($;U(3R%W3,&[B93<
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M7_PB@SE[0F9^)/GUF]?Y>3[[5I=-DRKXF&?3^>+W^2KOE;S9\$D#96BV.>=
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M44O7)K5X]Q0]&_.#@&=73I]>;O$ZZ(-WXCT-+/.GOJ:QB;XUA0-5]&T,H]U
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M]3 ::\]=Q7%ZJ= 'E<7X6&5Q@]3H+E_;.%6Z-P>.4N9H??*6LP322DX^;@Z
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MA4.(22A0GEY0%U&!5$8+Y2+CVW6"_QW//2JNCQ//W04</9@T]X9+9NX2<BM
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MMPF'-,S-;%-W\NINL&,MC'M_>6*B<2Q$ U(E,JM1!,!L(YC BT:)V84VIN<
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M6>7BW\B=82;%[8X8P5O]).)[,<M_F!<U>;TWV'_3$C999ML^8K,O8W"LUHK
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M+J6(?>]*P$D;R9L4MV4<C=(LB83W=G_OQ>[*MM^Y++,T@+?IS_\E1GR:@'2
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M2^_TU#N*\7W@N=>X&/P4 >^,3WK@Q_7?#KQK>$-ERL!DYN#>XN\HU*@"C62
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M;W!25K2Y8+@BV1DGK9SJ"W(BX=YE3%2W@<BR&86 RV*Y2@JN!P,-0L3T6/5
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M:E2A* 3.4U[&BM&3)PFF1.+2^-[6_5C21Z#?L%?QE PI)A[EO]$ W]9Y??@
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MY.,>L_"]+'^ECI3#P.5-BH]UZP6JIRNHW8@H6^'+0\*W;!W^O^^V?10JY$K
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M694%1[&(>COXJ]3$WMXF&,*6S"@FE)Z;\RM/EP-JVM%QP?ETU;43!1?V4T+
MF*N"B,3@U#B<P,T"X?21H9HJLEP+Y49$BG5LFN9@U.8=+]3]='6,!^Q_=$T
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M*D^@K4R,*U/+84ZU(Q0>4>W_G/L(!H[D8/@RQ?9$9C<ZJX^TZ@$<CVR-N<"
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M\521=!F&.C<_QMJC![\TP"_[/?CE>9D:\_U>97*KK>1XP6W^\E2'7^:H*W+
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M+HS#*KVP8X[Q.M%9\[95:+11 N^>NTM5QE&!<IV^< FWP3NLFKPT@EBYFVO
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M[A)36C&8%+N=9#<].LIG%D]][?T=TJ08P:GT_;GFJ=A9V?9+B$:[LHT?QT*
M8[BE O'40;CPV3=E_42 C9"E4EN! ?VKCC_JX-!P0':N@G6(#6S?;:(#I1[:
M&^8\DWDP0(*(F93IACS1PLMM.,8C^,64)AZDB9].:>*[;N)[73#-Y$Q-W7!K
MD)V(-NP \H%>KNP?.C]G__ZOSU[^=%,M]O@XG%'[NNSHFEW0@*'\",V>;-VJ
M_])__)07[;K,-O]55/0:]*.?_(>@JWBI&FHX+D^A!_+7(D*O7AV_>/P4I:B#
M1>QR_6 1L&,2L/_L\N%WH%M>/1[_&EYQ]+L?\K;_21/<!%KQY"F=21V"?,IV
MG57_[[\\^9>DJ:_X[]-_"22!=LOC8UA;[*H&LJKW@GS?U>OHU[+;_NMT_24Y
MB6WF4%1619Z7ZEYCN8'-8O:2S*R9H%>WG11R.N]EUN!&]SIEOQ0MM5K\V&7<
MC_$MV*<+GR3[ML+WXPA<M$!F(&[3E-Q]2NYO!^[5G,FVNW]YTB[0?4[.6)CB
M!]YC\2GY?Z8Y&<S)HTG7?,4\3?IETB^3?MGEG!RTLMDR:9/FF33/I'DFRV:R
M;";],NF7_=DWDWZ9],ND7R;]LO]S<M#*9O*<)LVS%[MLFI-)\TR:9](\D^;9
MASF9-,^D>:9=-FF>2?-,FF?2/'LI,-.<3)IGTCR3YGE@NVR:DTGS3)IGTCR3
MYMF'.9DTS[;9,T60H]-S(+HI7B[RJ>ZR\N:RMI/9VIO:FJ_=H=.L[6;6#D3S
MW7I:2?/])Y5AW[J:WB]UOW5=_H-APUCLG@WCQ:OOPH:A"N*C&Y)BQ!D%D!B+
M",$#YA:B2?5Y!9 S)7KWMI9^F4O;)23\K4-\$S;2! &Z".X8Y[UAIA@:OWT9
MIG5Q[V=)SJ/-B:1?,@^FC;TH$RC\0/P)3U\>/WLUSCKPM8P$=[CM]N^>GKR\
M#<_!#^%5W(W'X/G^NA7WS6-PMD(&J?V(8N M1Z7H%D?QZ?&+9\YGO'CRX<Z(
M;DX?OQH+CWR#QS_'F;[V^1$6*%RF1T^.(RH7VS7@#?[E?WU7WN'X/ 5\/E.P
M9!<!I,<X(SL_7:;8YH\DFI/L3;(WR=XD>Y/L3;(WR=XD>Y/L3;(WR=XD>Y/L
M3;(WR=XD>Y/L[53V)@31A"#ZWEB8KY#;V^ __,YNSZ.B]FWFZ?JD#$,E]C\I
MPPOJPQ:^OIW>/D-E\MU#9;AQS+NZ6MP6+>/#2J[#SDQ]8P9]8YX%:<>I;\Q^
M]XWQ!/Y'PS$].055\>2;XYB^YVV?W@;(%*BCJ6'+!'3ZGKTB;B1N/XZ(304Z
MWT'&ILC.%-F9JN"F^MMIE^V'P$R[;-IETRZ;=MD>3MJTRZ9=-NVRJ0'!M+&F
MC;6ODS9MK&EC31MKL@NG7;;K*9EVV;3+IETV[;*'-6G3+IMVV;3+IETV[;*]
M$IAIETV[;-IETR[;PTF;=MFTRZ9=-NVR:9?ME<!,NVS:95]=3YL<%=6B['&T
MR=\SF(79C[;?[JE^]K#VV]<QQ4\5[C?:D>K+U^[(J>9]ZO]P[[OZJ^O_][",
M]3#KZM7>U-6KOJD7#5PL'196V6?%713JLJRO4.?56-"+_2+6NLJ^JY/_K=9=
MUJ@VZ=?8><&T70A:2615U:,&?9V5JLJS)OD?E36SY)WJDH_P46O;+[3PQ"91
M6:QK W[3KZE?1-\E59VLZ@9'F577%?D?)_(<&(M_Z54!;UO5':BA'L;:U5=9
MD[?2Q"(86<%OR*70<P7S0M75XYP!AU=>_?3E\:O'XU_?H4W$36^[9PT=[KMB
M]Z9%SGML /_(W1SV)Y9SQBK9JF#1;I]4TQ1=W6R2-U\6"G3HY'%-$8Y)]B;9
MFV1ODKU)]B;9.US9FZ*<]\OC>2#2^$-&YY M[Q,&0R@T/@B5K+,-133Z"M81
M=%S1)HLRZUN5/#L^/5(S"3-AX$6)RCLY?OS\]%DR+\JRJ*O##/@M=QWP>W[\
M^!1?VC!EYKU=).6N8 N'5-UW>$0Y*Y?KE9O#TL/^/5<-K%W62IRP3:XNX!/B
MWX3M!Q)P&_[!X5J>/'Y^_.39OJYFL?O5?/8"7]H/:1[J;.]\NI_2[(33?;CS
MO?,)/ST^>?+CR/?EKJ?[)*9.#G2V=S[9NOO[MYELF<.]G.MGQT^^YUS'S.^A
M8#_'E_Y0;[*RVQB>\.\PW?<ZLW]4239(=CZ:;QX-4J=9E7.&L]G@]_)G,L_:
MHDV30?H7S'>;VLV21N:MKIS81;T<YEF' 8V,+<EEW707G#--CO[]7Y\\_99]
MGF_HD>G5GRC>!Q3OSR>*]WW=^7%9%@UV_^TN:._.CI,$G?] GUK74+O_-2JH
MB-Y!=70CO44**EDV]8KT2IYUBA1/UE>+"T*6#&$B\XVKT H<PCK#<%!?9HT>
M#3B]75'236%_@_M;+^_FJNYSV"';O;'#.".<;O5E76"S#9 -6#]>@+9+_CO#
M"-_K,BM6N&9M#^NKUVI17\(@L)T'7%VIJV1QH5;4! 3FM,"#:<D_"&4A36H.
M;/Q:-ZN^E*<V"88SQGY#$E,E;ZL<GD _0-S1U44!U\9_4,^[#-X_3SZH<WP(
MGGMGZW537\((@W<!(7MU!Q=FGZ5LOB]2YDH8++]JX%#R!,Y9IS>(Z6V+2Y2B
M]S"&.J?E'I6,X5J"+CO(Y5SL?CDC'E*R45G3.K#$^+%PH_5+O_VZW>\2X;OO
MV)@&2W^U,RODH?MO [_K(KM4"&RMYS F5EE=3=Y85FV,&W95@"\%GME:+1"Q
MZOMD>&'\2-N8\Y3,=]:$SC+>7/'!.%L^QU7.2A /NR*'7W07&5R^) NOKLH-
MCH]/_0XM1/H:_^V\(0S:^)KZ;<V[#AIXP5#TJX^]+0PN5TLZD8L0&EPX%BD/
M*F_!8MW453Z<$+B8S_U%!@;#8+46L,!%U2L]:O,6_.)PMS''.3[+.&=G8$CG
M9$S_ICI<I;$ED'EL4/4=P1NO8 !@><.*] N%:1KC=0_FP)J^I#AI3>C>SJ(L
M%+PR^O-MI[)<'YSZ??"I+<Q*B39UQQF@P,T_MM/1J#7\#S=F@U>\RIHF$_RX
M,Z<T#!_TG]A[2%R"Q<S]&7RT6G?)55/ =%68481IQ>HYD@V%(%G:,(-9R,%W
MG0T X=]#IWB'^>/C9_=]E$=<-8;9#^,WC@=7T*J"[Z0:]*+!^<?)VH)=@0\(
MM^^!_-W<8*[6\ 77$F"B$'[.6BBB;W1//HH_O1[T_(/!9TFL&^#4[^R; /+W
MIM_9CXKSOQ8JY@OZ_M0$W_=$#76#5G4?0'L\1.C<?<]@M*GJZ"3N;%_B+>-3
M=8M#^O3XQ3/G,UY4^7!GSL#IXU>P#+^IMN5BMA'H& >L=['3[W/J[S7]P3/O
M3?>_?>OY/@3%<8,*W7^;M,1]S/G?&I6Q\YY1=%/]$\T$\*1\I4&.5KF_&F7O
M!7C:\@]FRX\@Z.][:K[ISISVY+0G[VU/[J3NY7 /:C8J;Z@.;GL6[\U:F9*:
MR05X4*50^Z:=OKH.:D]R>(@I^Q7V]Z+,FJ+;I!BE:\-,288\-077RL#QC_^<
M9QCP%M*<[/R\4>>2Q=X>8L^2\^)257Z4/>7\#:904B;0^9*MUJ5*,16W%;(9
M2X]%'^"F?S2\RR0,_9!_T0[R. <*;'ZZ+\!FS/KI9.JU.->'C$K9&RC;SV6]
M^(RYK$\710/;*6LHNT99[@_X8R2=>KM,D[PWT#5,*GMHZUPQ.DFU*6Z]HL-D
M:=;6%6VOO_K\')-UJ635.]Q9E5J \Y UE!IGY%E"IT<K=7R8]KQ^</@X.EGP
M-F^^K,L:;A\!4Z)"6"S@RJQ:*$8>4#7G&2@LI0>GJ@B$G/*RY88RLDN;',=9
M8;7&N=DL*?F9E--;_+,O&$6-DGR3UV@-_"YEW0JOGQ'C#ZM=2F3ZD%!X$,[T
MV7)9E 4IW2;YV,]E')3.Q[NX#X6/PF'"O4GWW6"0NT*\^R/R:Q[N&ZP3J3(@
MM N=*W@USC&C%SP@ADE8UY@NOBI:BR[V^.=(]DVEZA/W)%LSK@^$@-GC_"-/
M\MNX2*ZE,M.8A]@D)JLL5P:2P??',WC^ET!RS$">8LFL "(.4B'O#>KS;ZJ"
MNRU<SK^;U\=((0Q82P%4:F"".>I\ )Z*Z,^^ KW:&G 62'TXS@&RAR376%3_
M7P^2IYH8%H-("OL5_ND_)@XO<ABE<1QT43B8V6 TN])=9F3POQVC>7>ENN@<
M@0.X5 A4OYGV2"-X*;>4_HF%V@AD"_73#363!7"IRF"SO@[*YVFMJ3)J4!GU
M8JJ,>E"8Z-C!>Y#G[M[ \]_5;NW.,16&^7HO1B5R)_UWW1G-)"0=_1==IAK=
M#+? Z)L7%.%'NRLJ^D%-SWSW6X!-S]^S+\4*##%]!)_E.$GH*?C;03LNVP'\
M0UF 0_,Z'[8-G-@VW"3:F_%BB?#]P-"TS$QD<L(P^Y*Q]N:MQ/]9]TW;9Y4C
M=2V)70;6#_[O?$8>.?ZY0$ETTIZW<\$&OJ">R.$(2+6LP1^CP 9M$G?<I!/J
M)?@&KT'MX PR!=4%_+;C>H'HI BZ?I'![-%E</-EW_6@8,)KV\,-=S[;DW"G
M\?JW!3@>:D(!%0:^48%Y@\7GJKXJ50X.'P6W,.K&T<"@,J)1JTQ*8^JJ+20Z
MSR&Q(""7%^WB N9"I1PLP_LRYX._N0:1DB-1.K"K, 99-R".\'\@\ZKMZ%1>
MU%6E.!!-.NX'20,\WY-],="3N+8?.S@>7+* A[HQ!O'#T;(>?6Z(=^Q7I6B5
MKFN)W"ABEBS+K,6S>5TWR&=@:TQ!Q(L5U3HY72O<*. P8D/1:/-#OX:J4&TT
MCNF7M]&-(T\^CE.VN#>*G)O)/WEDY68TK&\.T>=H;ZP4+!>.XPJCW5T#_UH2
M54)2K%9P?,*@X%[995:4G _LL9J.PN=T>^RHD:L6!";3AVM^24_$RCJP0W!R
MYQNO_,^^&.B+8<F=+CDCE:7C_+&)'#$-T*8A>P#&$[WDJ:ZLVR8\J9CN>@#&
MEP$%B/EV+(2LDS\__I+&9MH\ZU7L%6,+J0U(_3QD;0R-R$'>5LOA^#:Q=:#R
MLE%!AD&^P4F0 P*OLS*<]_ZTFYG EUZMLZI@SRXS>TIUM.Q<*CC,(.M1^\UG
MB@JN7%G/*321N1$+6)Z<3J=IPH&>-S68G!P8Q?VX/1=>?Q,^)3?0R@:HK)KZ
M@G60+>^$LD9W<]$WC:H6&[FA+SPS0S"0D"UMI-^A,K"O.KXFM=V-]35P@.]>
M_KBC$_K%GIS0G[(OZB L5,L4FSJ21U7?5-89JF;?>QU3U'YJ.3E"Y0M6ZJY(
M#G;,LA14XR[1]B<]42+*1JK?M?G>H62EQ*:\YE99^"WJ_HNZ)%U$5X :IMPU
M*V5#TYO\EEVAGN=?PR%I"OHIN.9:!B_8IX@$G%ZFD7.@K4LT$@+'!.6"$E'A
M&X"3(67!676KT5-;,$14H!I3.7-&>88PN$A8(QY$4F9)J2X+AF)9+4EQ/C!_
MVK[A.;B"<7#4I2(V*;Q)H\ :4GBL=S7[4N9Y10??+A0<R&WLC.=1XNWT*UJ.
M*V?,&WEK!_ZQ?0*&]\6GUQW^J^TR+K[FD[51YS7\BW*>UOIL.0 *'J>#)G&>
M ^,!.U!E#(G(.':KSZ.&K5P3(U5EX3#OI.Y]@I5-\>TPQI+#;RX9E.('N^BL
MP_#GNB'(QM\P@EOA1,$I>M9W%S6B[Y(C,67AXA:.XHZ,+CKT7-TS)*0H6IY<
MP=YL[#RCY!3F[)9OE X6B1'+9@=> <^8*^(06@58'0?;X$R$S%DX(0G'KQJ8
M#G7I\1V@\8UH"(\AQ$@1PP#A]VSL!&*'SQ5B"HFY;WD\UK83X(6F=+!@&5NF
MQ(S!T;$8$X@S!.0,D3V1)PJO@;5A^YBF"ZRTKFB7V8*BDYX I"Y'R+__Z\O3
MDQ<_:5'9Z+RZ,ZD\^T<P!R3>9AE205C!(-8<TG0DZMR5J(PEZO_2#,]L0)'Z
M_V$31$-D8K<KN$A@>0GJ*^I@>?O.F1H]N:V#7J(M,>X1S+.2[XS@*WAL*BT;
M86SEQICJ,F)\2=Q4V1?2N6:WB U)CU<@/6),DGY'C\ [IIL:+M<^@G[ N&]A
M;7?W!S0[]);T:2AVL-%@W[*-G)UGR#Y"VH3.OZ,YYY#((R.YP]BM'OPL]?6Z
MX-+,^*G1(\TDB3\H?;0YK/D<'4_@CWK -9* ;$P1-:IK:I!E$%$,N1F<G_Z9
MGD *(8P;1T[_!&L6M1=U#ZM%\*FY4I5[& ^/S".67+0C49BS<GC-+ WU!9V5
M;712V$W'>8B_.LJ^P9E4&&K@ "$] C2*F(HT#Q)6+U;KNB65@='Y*M4N>+W6
M1\O7KVO$"G([.6\=(8U&9^E";LO BIC@$S'XQ,L)/O&P?#M7W1UH+.#EGL0"
M_OOLTT./!(2N!6A3M ?.B1HMTPQLUG5, U_RI6>8AA%-F""P%\[@>PL";B2^
ML$!G$LY&-H'1]E+"Y$GV+/]43 WX!UH6G/0BW3TDD;OF"0SG$Z>5\XU'<Z6]
M*?X ###]@0F5ZC2#_B)R:SA\K9F'0^7S!DTA=D=U:#MCP]Z8&/.-?I92PS&!
ME5NL"XG7.F,:>\.9/G1#YV0X5V05.$1B+A6G:USSQ%>7=<$1_]"'(ZN?LH8K
M>*0UE ._MFC;GAU>^[K^H&!&6G7]$M*X<4P<*G!(JET::";&ZRVKJ+>@2]_H
M/](KW(JA$IU9M,LLU ='0(>_!,RV!N;U?-JWMQ*H0\!VNO1DLVV!2U*SH87/
M-":XFV%FT:,I3BX)(27W8(8X_/*\KO-6G(+FDKYJ>WRF"1($]BF]?=MI_R <
M)*XI.UO&.X#AL0GJ.^=LG(G\,%2CJ, 4@E%MM%@PL"H4J]3L2_N2BQJ](&(\
MK$WVCQ[O9A?PI6WHP!(K>KZ\X@(=? 8.0T<9Y&8\X*^:A>/D'X1:LRVYT'&0
MA*8WR=@"G,4 /H;=(TH"C]95A04W\"*-*E;SOFF5HWM$45!\T"V!6;*@.!?-
M(EM_4;==FXHJI9VFOE"4H$V]?<(S3CR8[ TH6B6VRDTIM%;.VM+&!;9E'B#Z
M.#_:V(Z]@@>!FGDP.'H;V2>-I: DDSM9J=5<(0VX!L,[55=JB:FIEL,O- (W
MBR.'BR,8ZP;=/%K40\V>O-H3B^FUSI:]^0(26)VKAVX_G;FX&]0KA2/@([Z_
MN*$Z<) K<@]1+O_\^(L^9BE\"1^;!*$&P\VSZK.)<TL,CZ-R]EQ!P>9P-$6Z
M:OY?D\C'IP9TJSK.Y)Q.8'[]*G';==^@?X]#-!E,<;W;?N7T($S-T2T*@-57
M"/5+!WDB&W'@F*27)K4)3R\!*ZE7/!^<E .F72.E:I*:=>)S_LTHA DK6]F,
M+F$$<4EP*2XQO8TEFJ1Q"M2AGNZ2H&:(XC0?DX6=-3I'3-;&2H'=DX-\GF\&
MA\W?SL[>'R[>ZN3Q;A72B11=8WRW33XHG'=8$0Z _UI48 \4%!++BXX_? WK
M@[P-+)0?" H!MSM(6/;>E&CS MGUT4 6UG+B>1I\Y()\T@!43=D?R1^"DB@"
MC#7JHL]*K=F%49V@-!>@!,@2-:(PK^O/.@O)4@.F*'K(QDA7R2_J4I7U>J4D
M!/^Z7JU4@S^7/$2\Y1;:3GQ4.&IPB#"W\=-K6G@117?P<QUM3;U!OD9C<!;8
M["9QAIEAB]:"FV+)!=BE,>"6>8?($J7?8(T:177R? (.EF+8"HB01+&^$P/$
M%)UO7%_L>WFC*V[P/%VT&4Z0; 7%W_5LGV,VM:-K6['?A<&^I8\$VC[#(\3
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MN/][T9F"GM;T_YO3@%5EZ@F]O!)X5_Q2 [>BM?LAU>'SH""(HR_(RI%B"L+
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M@Y@]1:B5"ASM!RF<>X-N8-BW7@GA5'!.:NE+DX-K3!4@RASL0IOT?^">.?C
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M8O8,O^ +N_ "[QMD3>R:GH[(F;XCAAB:)C-]?!I#+9"MUUC?:8C1=*=::N<
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M^"S'PYN*E^)[Z[>9Q2BQ=@ G0;0;98"MCTSN@@'=H H.I]OI*.(C>5QJ?"+
MOP9!NS0HNJW8'JH1^LH[,5*&)H.Q,;+@D>0[EP+9?&F8_(0%:Z4#7\I]?U6%
M=E7*<.-6=_LF-(XM0EQ<#*%-HS.(Q8D^6X..3,")G,)_3O$_3_ _3_$_S^F9
M+Q!*Y(9KXHVUJMH%3<(;T;ASIW[B=LL]G**HK>=W$T;#,Z_!'QX_&<8H=EG\
MB[4$HTW *EMH4*6M[) %P]H, ]UO%-/-7]_5(M)_G>6C=2#H<7Y4\7*M+M 5
M9[R=\<* %PJ'4RGTRE'!9'";7%K[^%A^_"=2,")A31_$[&AJLM)3P#83CRN3
M<VMW*0%FAX"K>C+]*V:H1ZP\UEYRC'&NNBMB (??_?E15]2(<O9I'S/G N$/
M'R@7' I,GG&F6*NQ,!G'&(Y73/:&SQ#0FRGUP9Z$\(0KA?/:1N<&CX0R6YNW
MB/DA^JG\XB:S,=BS3@E4"XMDA@W^?RT5!ENZDZ"+YZ26@L/R>J*A'S=?_6K*
M5Q^$L;IS6U5G>*])$63MM@"$L?A"\RK2O4A(F :]+#0D\VF(NTQT-;3S*V,"
M\*^>P)%_7EP.XT3,Z9JK!?T..1&(D;,1'%]FS)I@W!QWD8IG 4"9P_H#'7J(
M >3?AN,]LF T/H8<BU<;KC<_;?T7NNF!"^_#/R=7H;#MF&U/9+;\9IHDU)G.
M%WHRO:B!\FT]74UF[21MW0T.B2-[Z/Z=VLS+%S-V3_#SB*",3:OK ^6JA>'-
M^8!R$>/L:X26V&!DVYZOQ>Z[&44W7Z/CY,R0Q"/C\<&U5;M#.[0TU"B3;IAT
MPX^D&PZR/&YO:#C'R^,B=7 H!K82CG 7[C;1XMI>5S,6K8_R,!CW79Y&UTW%
M3U/QTR$N^<[7_%"+G[[^;-IWB=FYR$R%3U/ATU3X=,O"IZEFY!XMYPAV;!0.
MEIH&(IAY"4L\M!E$+">N01V!" ;E'62VAM@/RW(:DAX-4R$'#JK:M;#H[?[)
M#R%0J@HV<RQ'' +CB#N2,F0VDV3=:WVB1%VJE^!GPH89<&\XH'M!TS0^(C5U
M\X@7AOP2W?-,DWW*4UX<G]Z]8\:^B]&NY<@ 5G]%%1&'@VX_4?"CCP[JSF%<
MVE(8AB:59K"_2[^X?0[%Y+O6$=<S%:$Z#SGOI.IE"X(F@#Y60PS55C:;Z]AS
M7CB!FNV._'8O/73%MS#@6!?@'KEP#C, J?9%ZL.FQY;2V<3\AOUK7J92)H=(
MEH813*_A@53N\8G+,^8*;P='%BXM>CQCA3*Q@C;EM/<Q06E1E'C;";(12M33
MQQ-DXT%U[+"1#<>): /C$[\R!/M2MV)0:PCK8G6;205)N;'X; 1G@HI+\OK*
M=LX--RD9&$C76"+5;541_C^/=6@C<SF[:@^W;>VK[ZF1;T&X^I&B2UGYT'G1
M_\36QRS+7\M+FEX3472AGM'.V$>T"T):\%N"U8<TA 'X_28W^6I@>-8Z9=F#
MQ ELQ]@);L]NB<P&D/K4=2NOF=B@CQU\ 8NS(B2H;MN8'/V"72CHZ$02#2_9
MX_SS97+T06DZ;XR'T #L%<^2HU\+Q'=CSO.]R3G.DB,IY1W PR,A5H'!7BH3
M;#64L"2-IB]H[I)ECPJI,[KCD\?X J@8$_,>['W;89^!V\ZT;%BA"N/6C70^
MJ#7,(JR0O>/SY BNP3[JU#&GZ#;VNQ<X6X/08O+VO7O)J^3HCRO0VNU%L0Y@
M+S]GB\_G#:$'_-_@2W@_,@]Y\P5D%47(X Z"7YX$O]1QC>"R4WRM1]BG))A!
M^.YI<A0$R@;O:*[7N#]X+)J-\#EL+]!>:!"8@RE PG,[D756P-;!)HZ7]4)0
MRUCMK)JUHC8JII[)]F0$(1XTBITY%\!R?!47]LS .719@2%TR-F&QN.VU78N
M\=Z[A1.NX0WKK8\'=VBXI'9LWF@J)^S0>K^16=578BCB(W;P_ "CSAU!Q O?
M@G)=5=QHP9N6$\P&'YV9'E#>-R '?T,=6>$[@?'@??D$?F:;PGI?P;9X5\,$
M(LK!^P*7@) %=G9YIYUI +]W.<S66^J)CCL+'(VZ>N3WK/#?XP0?B_T'6O]S
M&.FO?4,^$;QHWZ!1%%SRE$;\L6N*14?;WC1/\RY[ACLZHR88+!7.=R_P%M6C
M-Z;DCM:A4'(EZWV=>;K;L7JP+6Y.'N_6ACL)&/.[T9WXT(V[8?#+@1\-C#CX
MVPE^FA)AZO<0=*X(&$-2SLK$(P=9#W,$'RRXV5S%S3V(L :>F!E,:\"(15TS
M,!'$W7D2,R[W+ S/%L=>LAEEPU+OOIT?NXN9I:RSVCHI:[376NHX0E:(>Q^9
M(.Q6*N@O[J1G'V_;'J;4UV-P"_J>O#QLL")526X?+-MM:ZP=5NB06H8@?U)J
M^-^"\</!_!2=/R52KK48'R\;=K9YDAO##']CNL^(*3CB"-SP+:X9NO0S _E6
MS,Q@H_@,B$/HM/=& B-HPPXW[BL)PP5XZHJ7_*IH+_ *Z:(IM"A4*NF:[<LE
M.OUZH./=:$X>P[C/W&H_,VDF/^K(/;P015RP? ^])7(L8!JTT%WI^CGW/1=H
MQC8KG;"2]HYDU$AZJZZ&ZSW@F8"A'NK1=+(/1Y.K0]_Y!M]#/Y'<5Q/5B9)(
M3>D;>L.X9J"4[]6%(OL.#BZWVY/<BVUQ<L9-'J,1ZPSCVM1[GFH0RNS*[Q:0
M769%Z2H:\:H/5LQ/]T',/^CJY3^6RU9U#UVT0Q:U895V3>])6CG/5AGUQ[K*
M].D0I"&=<EW'M BVA<<D*'V-N;V?'+/UU2#'.<*I95MK'JK0/]DQ/(&$/KGO
MG>?LLT^F5*; 0)>-<_[OCQ\>^NY[XW;"\IL@#O>,F'>^Q1WVL1**T:T./'DP
MUDR]ROAND@2R<#28X.0LDG&/A)9M*T1X2KLL8/]B?!Q&L\9G=QH9:Y_Z6W:5
MXJ,O53Y+>)ASI%A$/>)7]'57\)1-<G1R*IT= _JT-U\T](IYFCKJ^/SR]/3Q
M3W_T'3IG GZ%CTY^LE5'-USFU]EJ#BL]MM"G-UKH[[J!KNT=.UZ^L\6R?V)
M(!&XQEQQ+6:RE.@5PS2P:DZ"BRY]R5<F!'1,DTE1,)!UR@(Q&*B.@AHRGMSF
M#!Q VR"9X$>^F'9J6[!K_)3Y<<$!)Q,XX$%9&O'C=M<9ZE?'+PEZ_>'-^P]O
M/KYY]^GLT]L_WGU,DW^<??AP]N[3VS<?D[-WOR2O__CO-^_@WQ\/%"OPZGC'
MSKS!"OS>4S;K@\**')@/5M@/W>(Z,T>.;S:DB796/))SK_Y9)J)%NZ5!#*2
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M6Z&  3^,1G,T&=2D0PTRBDM(G=27VS=P $J1P' H1=2\"HVO,(U_L&+T76/
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MO(.%LQ2N@07SKYIS' 4]D+W?%#SRDO.)YMY&5KC<@M.%IBXIG")#4A'TVW-
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M6R_-QI&&_HF<6BRM"NHCVMCU\"+("U>I>:'F?#-?]P4A*0&V>->(L$&#WL+
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MUHINS+!LSLW=63C&H]Z)-UMSM+/S<7KH,\9M\NMN]IKT.VN/ZPV; J@NJNH
MT#L)J6U!TE6RVB-P20"ZJXW=P1$40O,?'!3$34QWG+WNDOCANM'<WB"&V0;Y
MQ2F":Q/QXD$!LAYK'2S$JJ\UO\@$XGSI07"C@3'1&AJ!)I'15Z_[EM3"''?)
MBNGD@&&@!MY"EPTY-R!5811GIV:A[;<#B$HW2XQY:] U;UY;(XIXOQ8WP,@9
MV602@%;!>:ZF5RU<:HF'[D2+LC9KEST0&A2B\-,0W&+P%CLK1_H7AS!3;DS
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MR(27AZ!6@#^(H]DNM:LDI@1!A2B^1SH3T G@/,5S!=A35B]8BO 3<@G16C]
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M<$#> F:_53\(,/5*DK_E]%T^+YBVCFL.<GK<4MG^/^'5?H&\8B6Q)%35GZ^
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MTO\O$OT/39_^!U!+ 0(4 Q0    ( &6)2U3,UHA7L3\# #:,'P 1
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M &YB:7@M,C R,3$R,S%?9S$N:G!G4$L! A0#%     @ 98E+5$&PTNB:DPD
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M+3(P,C$Q,C,Q7W!R92YX;6Q02P$"% ,4    " !EB4M4A&^1'Q3^  !12P@
M'               @ '+O1$ ;F)I>"TR,#(Q,3(S,65X:&EB:70Q,#$P+FAT
M;5!+ 0(4 Q0    ( &6)2U01-<O/@BD  "=2 0 <              "  1F\
M$@!N8FEX+3(P,C$Q,C,Q97AH:6)I=#$P,3<N:'1M4$L! A0#%     @ 98E+
M5"02>+[; @  @@P  !L              ( !U>42 &YB:7@M,C R,3$R,S%E
M>&AI8FET,C$Q+FAT;5!+ 0(4 Q0    ( &6)2U0W3^]H4P0  .(1   ;
M          "  >GH$@!N8FEX+3(P,C$Q,C,Q97AH:6)I=#(S,2YH=&U02P$"
M% ,4    " !EB4M4Q;R.R!,(  !=)@  &P              @ %U[1( ;F)I
M>"TR,#(Q,3(S,65X:&EB:70S,3$N:'1M4$L! A0#%     @ 98E+5%,D4NO'
M!P  T"8  !L              ( !P?42 &YB:7@M,C R,3$R,S%E>&AI8FET
M,S$R+FAT;5!+ 0(4 Q0    ( &6)2U2;FK>$EP4  ,$M   :
M  "  <']$@!N8FEX+3(P,C$Q,C,Q97AH:6)I=#,R+FAT;5!+ 0(4 Q0    (
M &6)2U0;+KYB=@\  /QI   :              "  9 #$P!N8FEX+3(P,C$Q
F,C,Q97AH:6)I=#0S+FAT;5!+!08     $0 1 )@$   ^$Q,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
